CodeList |
CodeListItem |
NCI attributes |
OID | Name
(CDISC Submission Value) | DataType
Extensible | NCI Code | CDISC Synonym | CDISC Definition | Preferred Term |
---|---|---|---|---|---|---|
CDISC Submission Value [ODM:CodedValue] | ||||||
CL.C141657.TENMW1TC | 10-Meter Walk/Run Functional Test Test Code
(TENMW1TC) | text
Extensible: No | C141657 | 10-Meter Walk/Run Functional Test Test Code | 10-Meter Walk/Run test code. | CDISC Functional Test 10-Meter Walk/Run Test Code Terminology |
TENMW101 | C174106 | TENMW1-Was Walk/Run Performed | 10-Meter Walk/Run - Was the 10-meter walk/run performed? | 10-Meter Walk/Run - Was Walk/Run Performed | ||
TENMW102 | C141700 | TENMW1-Time to Walk/Run 10 Meters | 10-Meter Walk/Run - If yes, time to walk or run 10 meters. | 10-Meter Walk/Run - Time to Walk/Run 10 Meters | ||
TENMW103 | C147592 | TENMW1-Wear Orthoses | 10-Meter Walk/Run - If yes, did subject wear orthoses? | 10-Meter Walk/Run - Wear Orthoses | ||
TENMW104 | C141701 | TENMW1-Test Grade | 10-Meter Walk/Run - Test grade. | 10-Meter Walk/Run - Test Grade | ||
Back to top | ||||||
CL.C141656.TENMW1TN | 10-Meter Walk/Run Functional Test Test Name
(TENMW1TN) | text
Extensible: No | C141656 | 10-Meter Walk/Run Functional Test Test Name | 10-Meter Walk/Run test name. | CDISC Functional Test 10-Meter Walk/Run Test Name Terminology |
TENMW1-Test Grade | C141701 | TENMW1-Test Grade | 10-Meter Walk/Run - Test grade. | 10-Meter Walk/Run - Test Grade | ||
TENMW1-Time to Walk/Run 10 Meters | C141700 | TENMW1-Time to Walk/Run 10 Meters | 10-Meter Walk/Run - If yes, time to walk or run 10 meters. | 10-Meter Walk/Run - Time to Walk/Run 10 Meters | ||
TENMW1-Was Walk/Run Performed | C174106 | TENMW1-Was Walk/Run Performed | 10-Meter Walk/Run - Was the 10-meter walk/run performed? | 10-Meter Walk/Run - Was Walk/Run Performed | ||
TENMW1-Wear Orthoses | C147592 | TENMW1-Wear Orthoses | 10-Meter Walk/Run - If yes, did subject wear orthoses? | 10-Meter Walk/Run - Wear Orthoses | ||
Back to top | ||||||
CL.C141663.A4STR1TC | 4-Stair Ascend Functional Test Test Code
(A4STR1TC) | text
Extensible: No | C141663 | 4-Stair Ascend Functional Test Test Code | 4-Stair Ascend test code. | CDISC Functional Test 4-Stair Ascend Test Code Terminology |
A4STR101 | C174103 | A4STR1-Was 4-Stair Ascend Performed | 4-Stair Ascend - Was the 4-stair ascend performed? | 4-Stair Ascend - Was 4-Stair Ascend Performed | ||
A4STR102 | C141706 | A4STR1-Time to Do 4-Stair Ascend | 4-Stair Ascend - If yes, time taken to do 4-stair ascend. | 4-Stair Ascend - Time to Do 4-Stair Ascend | ||
A4STR103 | C147590 | A4STR1-Wear Orthoses | 4-Stair Ascend - If yes, did subject wear orthoses? | 4-Stair Ascend - Wear Orthoses | ||
A4STR104 | C141707 | A4STR1-Test Grade | 4-Stair Ascend - Test grade. | 4-Stair Ascend - Test Grade | ||
Back to top | ||||||
CL.C141662.A4STR1TN | 4-Stair Ascend Functional Test Test Name
(A4STR1TN) | text
Extensible: No | C141662 | 4-Stair Ascend Functional Test Test Name | 4-Stair Ascend test name. | CDISC Functional Test 4-Stair Ascend Test Name Terminology |
A4STR1-Test Grade | C141707 | A4STR1-Test Grade | 4-Stair Ascend - Test grade. | 4-Stair Ascend - Test Grade | ||
A4STR1-Time to Do 4-Stair Ascend | C141706 | A4STR1-Time to Do 4-Stair Ascend | 4-Stair Ascend - If yes, time taken to do 4-stair ascend. | 4-Stair Ascend - Time to Do 4-Stair Ascend | ||
A4STR1-Was 4-Stair Ascend Performed | C174103 | A4STR1-Was 4-Stair Ascend Performed | 4-Stair Ascend - Was the 4-stair ascend performed? | 4-Stair Ascend - Was 4-Stair Ascend Performed | ||
A4STR1-Wear Orthoses | C147590 | A4STR1-Wear Orthoses | 4-Stair Ascend - If yes, did subject wear orthoses? | 4-Stair Ascend - Wear Orthoses | ||
Back to top | ||||||
CL.C141661.D4STR1TC | 4-Stair Descend Functional Test Test Code
(D4STR1TC) | text
Extensible: No | C141661 | 4-Stair Descend Functional Test Test Code | 4-Stair Descend test code. | CDISC Functional Test 4-Stair Descend Test Code Terminology |
D4STR101 | C174104 | D4STR1-Was 4-Stair Descend Performed | 4-Stair Descend - Was the 4-stair descend performed? | 4-Stair Descend - Was 4-Stair Descend Performed | ||
D4STR102 | C141704 | D4STR1-Time to Do 4-Stair Descend | 4-Stair Descend - If yes, time taken to do 4-stair descend. | 4-Stair Descend - Time to Do 4-Stair Descend | ||
D4STR103 | C147591 | D4STR1-Wear Orthoses | 4-Stair Descend - If yes, did subject wear orthoses? | 4-Stair Descend - Wear Orthoses | ||
D4STR104 | C141705 | D4STR1-Test Grade | 4-Stair Descend - Test grade. | 4-Stair Descend - Test Grade | ||
Back to top | ||||||
CL.C141660.D4STR1TN | 4-Stair Descend Functional Test Test Name
(D4STR1TN) | text
Extensible: No | C141660 | 4-Stair Descend Functional Test Test Name | 4-Stair Descend test name. | CDISC Functional Test 4-Stair Descend Test Name Terminology |
D4STR1-Test Grade | C141705 | D4STR1-Test Grade | 4-Stair Descend - Test grade. | 4-Stair Descend - Test Grade | ||
D4STR1-Time to Do 4-Stair Descend | C141704 | D4STR1-Time to Do 4-Stair Descend | 4-Stair Descend - If yes, time taken to do 4-stair descend. | 4-Stair Descend - Time to Do 4-Stair Descend | ||
D4STR1-Was 4-Stair Descend Performed | C174104 | D4STR1-Was 4-Stair Descend Performed | 4-Stair Descend - Was the 4-stair descend performed? | 4-Stair Descend - Was 4-Stair Descend Performed | ||
D4STR1-Wear Orthoses | C147591 | D4STR1-Wear Orthoses | 4-Stair Descend - If yes, did subject wear orthoses? | 4-Stair Descend - Wear Orthoses | ||
Back to top | ||||||
CL.C115388.SIXMW1TC | 6 Minute Walk Functional Test Test Code
(SIXMW1TC) | text
Extensible: No | C115388 | 6 Minute Walk Functional Test Test Code | 6 Minute Walk Test test code. | CDISC Functional Test 6MWT Test Code Terminology |
SIXMW101 | C115800 | SIXMW1-Distance at 1 Minute | 6 Minute Walk Test - Distance at 1 minute. | 6MWT - Distance at 1 Minute | ||
SIXMW102 | C115801 | SIXMW1-Distance at 2 Minutes | 6 Minute Walk Test - Distance at 2 minutes. | 6MWT - Distance at 2 Minutes | ||
SIXMW103 | C115802 | SIXMW1-Distance at 3 Minutes | 6 Minute Walk Test - Distance at 3 minutes. | 6MWT - Distance at 3 Minutes | ||
SIXMW104 | C115803 | SIXMW1-Distance at 4 Minutes | 6 Minute Walk Test - Distance at 4 minutes. | 6MWT - Distance at 4 Minutes | ||
SIXMW105 | C115804 | SIXMW1-Distance at 5 Minutes | 6 Minute Walk Test - Distance at 5 minutes. | 6MWT - Distance at 5 Minutes | ||
SIXMW106 | C115805 | SIXMW1-Distance at 6 Minutes | 6 Minute Walk Test - Distance at 6 minutes. | 6MWT - Distance at 6 Minutes | ||
Back to top | ||||||
CL.C115387.SIXMW1TN | 6 Minute Walk Functional Test Test Name
(SIXMW1TN) | text
Extensible: No | C115387 | 6 Minute Walk Functional Test Test Name | 6 Minute Walk Test test name. | CDISC Functional Test 6MWT Test Name Terminology |
SIXMW1-Distance at 1 Minute | C115800 | SIXMW1-Distance at 1 Minute | 6 Minute Walk Test - Distance at 1 minute. | 6MWT - Distance at 1 Minute | ||
SIXMW1-Distance at 2 Minutes | C115801 | SIXMW1-Distance at 2 Minutes | 6 Minute Walk Test - Distance at 2 minutes. | 6MWT - Distance at 2 Minutes | ||
SIXMW1-Distance at 3 Minutes | C115802 | SIXMW1-Distance at 3 Minutes | 6 Minute Walk Test - Distance at 3 minutes. | 6MWT - Distance at 3 Minutes | ||
SIXMW1-Distance at 4 Minutes | C115803 | SIXMW1-Distance at 4 Minutes | 6 Minute Walk Test - Distance at 4 minutes. | 6MWT - Distance at 4 Minutes | ||
SIXMW1-Distance at 5 Minutes | C115804 | SIXMW1-Distance at 5 Minutes | 6 Minute Walk Test - Distance at 5 minutes. | 6MWT - Distance at 5 Minutes | ||
SIXMW1-Distance at 6 Minutes | C115805 | SIXMW1-Distance at 6 Minutes | 6 Minute Walk Test - Distance at 6 minutes. | 6MWT - Distance at 6 Minutes | ||
Back to top | ||||||
CL.C182464.AIMS0101T07OR | Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0101 Through AIMS0107 TN/TC
(AIMS0101T07OR) | text
Extensible: No | C182464 | Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0101 Through AIMS0107 TN/TC | Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107 test and test code. | CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Response Terminology |
Mild | C182674 | AIMS0101 through AIMS0107-Mild | Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-Mild. | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - Mild | ||
Minimal, may be extreme normal | C182673 | AIMS0101 through AIMS0107-Minimal, may be extreme normal | Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-Minimal, may be extreme normal. | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - Minimal, may be extreme normal | ||
Moderate | C182675 | AIMS0101 through AIMS0107-Moderate | Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-Moderate. | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - Moderate | ||
None | C182672 | AIMS0101 through AIMS0107-None | Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-None. | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - None | ||
Severe | C182676 | AIMS0101 through AIMS0107-Severe | Abnormal Involuntary Movement Scale original result for AIMS0101 through AIMS0107-Severe. | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Original Result - Severe | ||
Back to top | ||||||
CL.C182465.AIMS0108T09OR | Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0108 Through AIMS0109 TN/TC
(AIMS0108T09OR) | text
Extensible: No | C182465 | Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0108 Through AIMS0109 TN/TC | Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109 test and test code. | CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Response Terminology |
Mild | C182684 | AIMS0108 through AIMS0109-Mild | Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-Mild. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - Mild | ||
Minimal | C182683 | AIMS0108 through AIMS0109-Minimal | Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-Minimal. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - Minimal | ||
Moderate | C182685 | AIMS0108 through AIMS0109-Moderate | Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-Moderate. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - Moderate | ||
None, normal | C182682 | AIMS0108 through AIMS0109-None, normal | Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-None, normal. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - None, normal | ||
Severe | C182686 | AIMS0108 through AIMS0109-Severe | Abnormal Involuntary Movement Scale original result for AIMS0108 through AIMS0109-Severe. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Original Result - Severe | ||
Back to top | ||||||
CL.C182466.AIMS0110OR | Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0110 TN/TC
(AIMS0110OR) | text
Extensible: No | C182466 | Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0110 TN/TC | Abnormal Involuntary Movement Scale original result for AIMS0110 test and test code. | CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0110 Original Response Terminology |
Aware, mild distress | C182694 | AIMS0110-Aware, mild distress | Abnormal Involuntary Movement Scale original result for AIMS0110-Aware, mild distress. | Abnormal Involuntary Movement Scale AIMS0110 Original Result - Aware, mild distress | ||
Aware, moderate distress | C182695 | AIMS0110-Aware, moderate distress | Abnormal Involuntary Movement Scale original result for AIMS0110-Aware, moderate distress. | Abnormal Involuntary Movement Scale AIMS0110 Original Result - Aware, moderate distress | ||
Aware, no distress | C182693 | AIMS0110-Aware, no distress | Abnormal Involuntary Movement Scale original result for AIMS0110-Aware, no distress. | Abnormal Involuntary Movement Scale AIMS0110 Original Result - Aware, no distress | ||
Aware, severe distress | C182696 | AIMS0110-Aware, severe distress | Abnormal Involuntary Movement Scale original result for AIMS0110-Aware, severe distress. | Abnormal Involuntary Movement Scale AIMS0110 Original Result - Aware, severe distress | ||
No awareness | C182692 | AIMS0110-No awareness | Abnormal Involuntary Movement Scale original result for AIMS0110-No awareness. | Abnormal Involuntary Movement Scale AIMS0110 Original Result - No awareness | ||
Back to top | ||||||
CL.C182467.AIMS0111T12OR | Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0111 Through AIMS0112 TN/TC
(AIMS0111T12OR) | text
Extensible: No | C182467 | Abnormal Involuntary Movement Scale Clinical Classification ORRES for AIMS0111 Through AIMS0112 TN/TC | Abnormal Involuntary Movement Scale original result for AIMS0111 through AIMS0112 test and test code. | CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0111 Through AIMS0112 Original Response Terminology |
No | C182702 | AIMS0111 through AIMS0112-No | Abnormal Involuntary Movement Scale original result for AIMS0111 through AIMS0112-No. | Abnormal Involuntary Movement Scale AIMS0111 Through AIMS0112 Original Result - No | ||
Yes | C182703 | AIMS0111 through AIMS0112-Yes | Abnormal Involuntary Movement Scale original result for AIMS0111 through AIMS0112-Yes. | Abnormal Involuntary Movement Scale AIMS0111 Through AIMS0112 Original Result - Yes | ||
Back to top | ||||||
CL.C182502.AIMS0101T07STR | Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0101 Through AIMS0107 TN/TC
(AIMS0101T07STR) | text
Extensible: No | C182502 | Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0101 Through AIMS0107 TN/TC | Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107 test and test code. | CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Response Terminology |
0 | C182677 | AIMS0101 through AIMS0107-0 | Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-None. | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 0 | ||
1 | C182678 | AIMS0101 through AIMS0107-1 | Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-Minimal, may be extreme normal . | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 1 | ||
2 | C182679 | AIMS0101 through AIMS0107-2 | Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-Mild. | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 2 | ||
3 | C182680 | AIMS0101 through AIMS0107-3 | Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-Moderate. | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 3 | ||
4 | C182681 | AIMS0101 through AIMS0107-4 | Abnormal Involuntary Movement Scale standardized character result for AIMS0101 through AIMS0107-Severe. | Abnormal Involuntary Movement Scale AIMS0101 Through AIMS0107 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182503.AIMS0108T09STR | Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0108 Through AIMS0109 TN/TC
(AIMS0108T09STR) | text
Extensible: No | C182503 | Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0108 Through AIMS0109 TN/TC | Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109 test and test code. | CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Response Terminology |
0 | C182687 | AIMS0108 through AIMS0109-0 | Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-None, normal. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 0 | ||
1 | C182688 | AIMS0108 through AIMS0109-1 | Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-Minimal. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 1 | ||
2 | C182689 | AIMS0108 through AIMS0109-2 | Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-Mild. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 2 | ||
3 | C182690 | AIMS0108 through AIMS0109-3 | Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-Moderate. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 3 | ||
4 | C182691 | AIMS0108 through AIMS0109-4 | Abnormal Involuntary Movement Scale standardized character result for AIMS0108 through AIMS0109-Severe. | Abnormal Involuntary Movement Scale AIMS0108 Through AIMS0109 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182504.AIMS0110STR | Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0110 TN/TC
(AIMS0110STR) | text
Extensible: No | C182504 | Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0110 TN/TC | Abnormal Involuntary Movement Scale standardized character result for AIMS0110 test and test code. | CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Response Terminology |
0 | C182697 | AIMS0110-0 | Abnormal Involuntary Movement Scale standardized character result for AIMS0110-No awareness. | Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 0 | ||
1 | C182698 | AIMS0110-1 | Abnormal Involuntary Movement Scale standardized character result for AIMS0110-Aware, no distress. | Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 1 | ||
2 | C182699 | AIMS0110-2 | Abnormal Involuntary Movement Scale standardized character result for AIMS0110-Aware, mild distress. | Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 2 | ||
3 | C182700 | AIMS0110-3 | Abnormal Involuntary Movement Scale standardized character result for AIMS0110-Aware, moderate distress. | Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 3 | ||
4 | C182701 | AIMS0110-4 | Abnormal Involuntary Movement Scale standardized character result for AIMS0110-Aware, severe distress. | Abnormal Involuntary Movement Scale AIMS0110 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182505.AIMS0111T12STR | Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0111 Through AIMS0112 TN/TC
(AIMS0111T12STR) | text
Extensible: No | C182505 | Abnormal Involuntary Movement Scale Clinical Classification STRESC for AIMS0111 Through AIMS0112 TN/TC | Abnormal Involuntary Movement Scale standardized character result for AIMS0111 through AIMS0112 test and test code. | CDISC Clinical Classification Abnormal Involuntary Movement Scale AIMS0111 Through AIMS0112 Standardized Character Response Terminology |
0 | C182704 | AIMS0111 through AIMS0112-0 | Abnormal Involuntary Movement Scale standardized character result for AIMS0111 through AIMS0112-No. | Abnormal Involuntary Movement Scale AIMS0111 through AIMS0112 Standardized Character Result 0 | ||
1 | C182705 | AIMS0111 through AIMS0112-1 | Abnormal Involuntary Movement Scale standardized character result for AIMS0111 through AIMS0112-Yes. | Abnormal Involuntary Movement Scale AIMS0111 through AIMS0112 Standardized Character Result 1 | ||
Back to top | ||||||
CL.C101805.AIMS01TC | Abnormal Involuntary Movement Scale Clinical Classification Test Code
(AIMS01TC) | text
Extensible: No | C101805 | Abnormal Involuntary Movement Scale Clinical Classification Test Code | Abnormal Involuntary Movement Scale test code. | CDISC Clinical Classification AIMS Test Code Terminology |
AIMS0101 | C102034 | AIMS01-Muscles of Facial Expression | Abnormal Involuntary Movement Scale - Facial and Oral Movements, Muscles of facial expression, e.g., movements of forehead, eyebrows, periorbital area, cheeks. Include frowning, blinking, grimacing of upper face. | AIMS - Muscles of Facial Expression | ||
AIMS0102 | C102035 | AIMS01-Lips and Perioral Area | Abnormal Involuntary Movement Scale - Facial and Oral Movements, Lips and perioral area, e.g., puckering, pouting, smacking. | AIMS - Lips and Perioral Area | ||
AIMS0103 | C102036 | AIMS01-Jaw | Abnormal Involuntary Movement Scale - Facial and Oral Movements, Jaw, e.g., biting, clenching, chewing, mouth opening, lateral movement. | AIMS - Jaw | ||
AIMS0104 | C102037 | AIMS01-Tongue | Abnormal Involuntary Movement Scale - Facial and Oral Movements, Tongue. Rate only increase in movement both in and out of mouth, not inability to sustain movement. | AIMS - Tongue | ||
AIMS0105 | C102038 | AIMS01-Upper Extremities | Abnormal Involuntary Movement Scale - Extremity Movements, Upper (arms, wrists, hands, fingers). Include movements that are choreic (rapid, objectively purposeless, irregular, spontaneous) or athetoid (slow, irregular, complex, serpentine). Do not include tremor (repetitive, regular, rhythmic movements). | AIMS - Upper Extremities | ||
AIMS0106 | C102039 | AIMS01-Lower Extremities | Abnormal Involuntary Movement Scale - Extremity Movements, Lower (legs, knees, ankles, toes), e.g., lateral knee movement, foot tapping, heel dropping, foot squirming, inversion and eversion of foot. | AIMS - Lower Extremities | ||
AIMS0107 | C102040 | AIMS01-Neck, Shoulders, Hips | Abnormal Involuntary Movement Scale - Trunk Movements, Neck, shoulders, hips, e.g., rocking, twisting, squirming, pelvic gyrations. Include diaphragmatic movements. | AIMS - Neck, Shoulders, Hips | ||
AIMS0108 | C102041 | AIMS01-Severity of Abnormal Movements | Abnormal Involuntary Movement Scale - Global Judgments, Severity of abnormal movements, based on the highest single score on the above items. | AIMS - Severity of Abnormal Movements | ||
AIMS0109 | C102042 | AIMS01-Incapacitation due Abn Movements | Abnormal Involuntary Movement Scale - Global Judgments, Incapacitation due to abnormal movements. | AIMS - Incapacitation Due to Abnormal Movements | ||
AIMS0110 | C102043 | AIMS01-Patient Awareness Abn Movements | Abnormal Involuntary Movement Scale - Global Judgments, Patient's awareness of abnormal movements. | AIMS - Patient's Awareness of Abnormal Movements | ||
AIMS0111 | C102044 | AIMS01-Current Problems Teeth/Dentures | Abnormal Involuntary Movement Scale - Dental Status, Current problems with teeth and/or dentures. | AIMS - Current Teeth/Dentures Problems | ||
AIMS0112 | C102045 | AIMS01-Patient Usually Wear Dentures | Abnormal Involuntary Movement Scale - Dental Status, Does patient usually wear dentures? | AIMS - Patient Usually Wears Dentures | ||
Back to top | ||||||
CL.C101806.AIMS01TN | Abnormal Involuntary Movement Scale Clinical Classification Test Name
(AIMS01TN) | text
Extensible: No | C101806 | Abnormal Involuntary Movement Scale Clinical Classification Test Name | Abnormal Involuntary Movement Scale test name. | CDISC Clinical Classification AIMS Test Name Terminology |
AIMS01-Current Problems Teeth/Dentures | C102044 | AIMS01-Current Problems Teeth/Dentures | Abnormal Involuntary Movement Scale - Dental Status, Current problems with teeth and/or dentures. | AIMS - Current Teeth/Dentures Problems | ||
AIMS01-Incapacitation due Abn Movements | C102042 | AIMS01-Incapacitation due Abn Movements | Abnormal Involuntary Movement Scale - Global Judgments, Incapacitation due to abnormal movements. | AIMS - Incapacitation Due to Abnormal Movements | ||
AIMS01-Jaw | C102036 | AIMS01-Jaw | Abnormal Involuntary Movement Scale - Facial and Oral Movements, Jaw, e.g., biting, clenching, chewing, mouth opening, lateral movement. | AIMS - Jaw | ||
AIMS01-Lips and Perioral Area | C102035 | AIMS01-Lips and Perioral Area | Abnormal Involuntary Movement Scale - Facial and Oral Movements, Lips and perioral area, e.g., puckering, pouting, smacking. | AIMS - Lips and Perioral Area | ||
AIMS01-Lower Extremities | C102039 | AIMS01-Lower Extremities | Abnormal Involuntary Movement Scale - Extremity Movements, Lower (legs, knees, ankles, toes), e.g., lateral knee movement, foot tapping, heel dropping, foot squirming, inversion and eversion of foot. | AIMS - Lower Extremities | ||
AIMS01-Muscles of Facial Expression | C102034 | AIMS01-Muscles of Facial Expression | Abnormal Involuntary Movement Scale - Facial and Oral Movements, Muscles of facial expression, e.g., movements of forehead, eyebrows, periorbital area, cheeks. Include frowning, blinking, grimacing of upper face. | AIMS - Muscles of Facial Expression | ||
AIMS01-Neck, Shoulders, Hips | C102040 | AIMS01-Neck, Shoulders, Hips | Abnormal Involuntary Movement Scale - Trunk Movements, Neck, shoulders, hips, e.g., rocking, twisting, squirming, pelvic gyrations. Include diaphragmatic movements. | AIMS - Neck, Shoulders, Hips | ||
AIMS01-Patient Awareness Abn Movements | C102043 | AIMS01-Patient Awareness Abn Movements | Abnormal Involuntary Movement Scale - Global Judgments, Patient's awareness of abnormal movements. | AIMS - Patient's Awareness of Abnormal Movements | ||
AIMS01-Patient Usually Wear Dentures | C102045 | AIMS01-Patient Usually Wear Dentures | Abnormal Involuntary Movement Scale - Dental Status, Does patient usually wear dentures? | AIMS - Patient Usually Wears Dentures | ||
AIMS01-Severity of Abnormal Movements | C102041 | AIMS01-Severity of Abnormal Movements | Abnormal Involuntary Movement Scale - Global Judgments, Severity of abnormal movements, based on the highest single score on the above items. | AIMS - Severity of Abnormal Movements | ||
AIMS01-Tongue | C102037 | AIMS01-Tongue | Abnormal Involuntary Movement Scale - Facial and Oral Movements, Tongue. Rate only increase in movement both in and out of mouth, not inability to sustain movement. | AIMS - Tongue | ||
AIMS01-Upper Extremities | C102038 | AIMS01-Upper Extremities | Abnormal Involuntary Movement Scale - Extremity Movements, Upper (arms, wrists, hands, fingers). Include movements that are choreic (rapid, objectively purposeless, irregular, spontaneous) or athetoid (slow, irregular, complex, serpentine). Do not include tremor (repetitive, regular, rhythmic movements). | AIMS - Upper Extremities | ||
Back to top | ||||||
CL.C189265.ACCPARTY | Accountable Party
(ACCPARTY) | text
Extensible: Yes | C189265 | Accountable Party | Terminology relevant to the role of the individual or entity responsible for the receipt of the transferred object (e.g., device, specimen). | CDISC SDTM Accountable Party Terminology |
CLINICAL STUDY SITE | C70777 | Site | Any healthcare organization, institution, facility or provider directly involved in conducting or facilitating a particular clinical study. | Clinical Study Site | ||
COURIER | C165460 | A person or group that facilitates the exchange of items or information. | Courier | |||
INVESTIGATOR SITE | C80403 | The location at which a study investigator conducts study activities. | Study Site | |||
LABORATORY | C37984 | An organization with the capability and competency to perform scientific research, experiments, and measurements. (BRIDG) | Laboratory | |||
MANUFACTURER | C25392 | Manufacturer | The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG) | Manufacturer | ||
SPONSOR | C70793 | Clinical Study Sponsor;Sponsor;Study Sponsor | An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] | Clinical Study Sponsor | ||
STORAGE FACILITY | C189365 | The organization that manages the storage of items. | Storage Facility | |||
SUBJECT | C41189 | An individual who is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study. | Study Subject | |||
Back to top | ||||||
CL.C66767.ACN | Action Taken with Study Treatment
(ACN) | text
Extensible: No | C66767 | Action Taken with Study Treatment | Terminology specifying changes to the study treatment as a result of an adverse event. | CDISC SDTM Action Taken with Study Treatment Terminology |
DOSE INCREASED | C49503 | An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI) | Dose Increased | |||
DOSE NOT CHANGED | C49504 | An indication that a medication schedule was maintained. (NCI) | Dose Not Changed | |||
DOSE RATE REDUCED | C150826 | An indication that the administration of a medication was modified by reducing the rate at which the dose was given, without reducing the total dose administered. | Dose Rate Reduced | |||
DOSE REDUCED | C49505 | An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI) | Dose Reduced | |||
DRUG INTERRUPTED | C49501 | An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI) | Drug Interrupted | |||
DRUG WITHDRAWN | C49502 | An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI) | Drug Withdrawn | |||
NOT APPLICABLE | C48660 | NA;Not Applicable | Determination of a value is not relevant in the current context. (NCI) | Not Applicable | ||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C101865.ACSPCAT | Acute Coronary Syndrome Presentation Category
(ACSPCAT) | text
Extensible: No | C101865 | Acute Coronary Syndrome Presentation Category | A classification of the presentation of acute coronary syndrome. | CDISC SDTM Acute Coronary Syndrome Presentation Category Terminology |
NON-ST ELEVATION MYOCARDIAL INFARCTION | C80383 | NON-STEMI;NSTEMI | A myocardial infarction that does not produce elevation in the ST segments of the ECG. | Non-ST Elevation Myocardial Infarction by ECG Finding | ||
OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
ST ELEVATION MYOCARDIAL INFARCTION | C101888 | STEMI | A myocardial infarction that produces elevation in the ST segments of the ECG. | ST Elevation Myocardial Infarction by ECG Finding | ||
STABLE ANGINA | C66914 | Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications. | Stable Angina | |||
UNSTABLE ANGINA | C66911 | Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest. | Unstable Angina | |||
Back to top | ||||||
CL.C182484.APCH101OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH101 TN/TC
(APCH101OR) | text
Extensible: No | C182484 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH101 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH101 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH101 Original Response Terminology |
30-31.9 | C182888 | APCH101-30-31.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH101-30-31.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 30-31.9 | ||
32-33.9 | C182887 | APCH101-32-33.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH101-32-33.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 32-33.9 | ||
34-35.9 | C182886 | APCH101-34-35.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH101-34-35.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 34-35.9 | ||
36-38.4 | C182885 | APCH101-36-38.4 | Acute Physiology and Chronic Health Evaluation II original result for APCH101-36-38.4. | Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 36-38.4 | ||
38.5-38.9 | C182884 | APCH101-38.5-38.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH101-38.5-38.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 38.5-38.9 | ||
39-40.9 | C182883 | APCH101-39-40.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH101-39-40.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - 39-40.9 | ||
<=29.9 | C182889 | APCH101-<=29.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH101-Less than or equal to 29.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - <=29.9 | ||
>=41 | C182882 | APCH101->=41 | Acute Physiology and Chronic Health Evaluation II original result for APCH101-Greater than or equal to 41. | Acute Physiology and Chronic Health Evaluation II APCH101 Original Result - >=41 | ||
Back to top | ||||||
CL.C182485.APCH102OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH102 TN/TC
(APCH102OR) | text
Extensible: No | C182485 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH102 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH102 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH102 Original Response Terminology |
110-129 | C182897 | APCH102-110-129 | Acute Physiology and Chronic Health Evaluation II original result for APCH102-110-129. | Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - 110-129 | ||
130-159 | C182896 | APCH102-130-159 | Acute Physiology and Chronic Health Evaluation II original result for APCH102-130-159. | Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - 130-159 | ||
50-69 | C182899 | APCH102-50-69 | Acute Physiology and Chronic Health Evaluation II original result for APCH102-50-69. | Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - 50-69 | ||
70-109 | C182898 | APCH102-70-109 | Acute Physiology and Chronic Health Evaluation II original result for APCH102-70-109. | Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - 70-109 | ||
<=49 | C182900 | APCH102-<=49 | Acute Physiology and Chronic Health Evaluation II original result for APCH102-Less than or equal to 49. | Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - <=49 | ||
>=160 | C182895 | APCH102->=160 | Acute Physiology and Chronic Health Evaluation II original result for APCH102-Greater than or equal to 160. | Acute Physiology and Chronic Health Evaluation II APCH102 Original Result - >=160 | ||
Back to top | ||||||
CL.C182486.APCH103OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH103 TN/TC
(APCH103OR) | text
Extensible: No | C182486 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH103 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH103 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH103 Original Response Terminology |
110-139 | C182907 | APCH103-110-139 | Acute Physiology and Chronic Health Evaluation II original result for APCH103-110-139. | Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 110-139 | ||
140-179 | C182906 | APCH103-140-179 | Acute Physiology and Chronic Health Evaluation II original result for APCH103-140-179. | Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 140-179 | ||
40-54 | C182910 | APCH103-40-54 | Acute Physiology and Chronic Health Evaluation II original result for APCH103-40-54. | Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 40-54 | ||
55-69 | C182909 | APCH103-55-69 | Acute Physiology and Chronic Health Evaluation II original result for APCH103-55-69. | Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 55-69 | ||
70-109 | C182908 | APCH103-70-109 | Acute Physiology and Chronic Health Evaluation II original result for APCH103-70-109. | Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - 70-109 | ||
<=39 | C182911 | APCH103-<=39 | Acute Physiology and Chronic Health Evaluation II original result for APCH103-Less than or equal to 39. | Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - <=39 | ||
>=180 | C182905 | APCH103->=180 | Acute Physiology and Chronic Health Evaluation II original result for APCH103-Greater than or equal to 180. | Acute Physiology and Chronic Health Evaluation II APCH103 Original Result - >=180 | ||
Back to top | ||||||
CL.C182487.APCH104OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH104 TN/TC
(APCH104OR) | text
Extensible: No | C182487 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH104 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH104 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH104 Original Response Terminology |
10-11 | C182920 | APCH104-10-11 | Acute Physiology and Chronic Health Evaluation II original result for APCH104-10-11. | Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 10-11 | ||
12-24 | C182919 | APCH104-12-24 | Acute Physiology and Chronic Health Evaluation II original result for APCH104-12-24. | Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 12-24 | ||
25-34 | C182918 | APCH104-25-34 | Acute Physiology and Chronic Health Evaluation II original result for APCH104-25-34. | Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 25-34 | ||
35-49 | C182917 | APCH104-35-49 | Acute Physiology and Chronic Health Evaluation II original result for APCH104-35-49. | Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 35-49 | ||
6-9 | C182921 | APCH104-6-9 | Acute Physiology and Chronic Health Evaluation II original result for APCH104-6-9. | Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - 6-9 | ||
<=5 | C182922 | APCH104-<=5 | Acute Physiology and Chronic Health Evaluation II original result for APCH104-Less than or equal to 5. | Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - <=5 | ||
>=50 | C182916 | APCH104->=50 | Acute Physiology and Chronic Health Evaluation II original result for APCH104-Greater than or equal to 50. | Acute Physiology and Chronic Health Evaluation II APCH104 Original Result - >=50 | ||
Back to top | ||||||
CL.C182488.APCH105AOR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH105A TN/TC
(APCH105AOR) | text
Extensible: No | C182488 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH105A TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH105A test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH105A Original Response Terminology |
200-349 | C182930 | APCH105A-200-349 | Acute Physiology and Chronic Health Evaluation II original result for APCH105A-200-349. | Acute Physiology and Chronic Health Evaluation II APCH105A Original Result - 200-349 | ||
350-499 | C182929 | APCH105A-350-499 | Acute Physiology and Chronic Health Evaluation II original result for APCH105A-350-499. | Acute Physiology and Chronic Health Evaluation II APCH105A Original Result - 350-499 | ||
<200 | C182931 | APCH105A-<200 | Acute Physiology and Chronic Health Evaluation II original result for APCH105A-Less than 200. | Acute Physiology and Chronic Health Evaluation II APCH105A Original Result - <200 | ||
>=500 | C182928 | APCH105A->=500 | Acute Physiology and Chronic Health Evaluation II original result for APCH105A-Greater than or equal to 500. | Acute Physiology and Chronic Health Evaluation II APCH105A Original Result - >=500 | ||
Back to top | ||||||
CL.C182489.APCH105BOR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH105B TN/TC
(APCH105BOR) | text
Extensible: No | C182489 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH105B TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH105B test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH105B Original Response Terminology |
55-60 | C182938 | APCH105B-55-60 | Acute Physiology and Chronic Health Evaluation II original result for APCH105B-55-60. | Acute Physiology and Chronic Health Evaluation II APCH105B Original Result - 55-60 | ||
61-70 | C182937 | APCH105B-61-70 | Acute Physiology and Chronic Health Evaluation II original result for APCH105B-61-70. | Acute Physiology and Chronic Health Evaluation II APCH105B Original Result - 61-70 | ||
<55 | C182939 | APCH105B-<55 | Acute Physiology and Chronic Health Evaluation II original result for APCH105B-Less than 55. | Acute Physiology and Chronic Health Evaluation II APCH105B Original Result - <55 | ||
>70 | C182936 | APCH105B->70 | Acute Physiology and Chronic Health Evaluation II original result for APCH105B-Greater than 70. | Acute Physiology and Chronic Health Evaluation II APCH105B Original Result - >70 | ||
Back to top | ||||||
CL.C182490.APCH106AOR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH106A TN/TC
(APCH106AOR) | text
Extensible: No | C182490 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH106A TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH106A test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH106A Original Response Terminology |
7.15-7.24 | C182949 | APCH106A-7.15-7.24 | Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.15-7.24. | Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.15-7.24 | ||
7.25-7.32 | C182948 | APCH106A-7.25-7.32 | Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.25-7.32. | Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.25-7.32 | ||
7.33-7.49 | C182947 | APCH106A-7.33-7.49 | Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.33-7.49. | Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.33-7.49 | ||
7.5-7.59 | C182946 | APCH106A-7.5-7.59 | Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.5-7.59. | Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.5-7.59 | ||
7.6-7.69 | C182945 | APCH106A-7.6-7.69 | Acute Physiology and Chronic Health Evaluation II original result for APCH106A-7.6-7.69. | Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - 7.6-7.69 | ||
<7.15 | C182950 | APCH106A-<7.15 | Acute Physiology and Chronic Health Evaluation II original result for APCH106A-Less than 7.15. | Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - <7.15 | ||
>=7.7 | C182944 | APCH106A->=7.7 | Acute Physiology and Chronic Health Evaluation II original result for APCH106A-Greater than or equal to 7.7. | Acute Physiology and Chronic Health Evaluation II APCH106A Original Result - >=7.7 | ||
Back to top | ||||||
CL.C182491.APCH106BOR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH106B TN/TC
(APCH106BOR) | text
Extensible: No | C182491 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH106B TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH106B test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH106B Original Response Terminology |
15-17.9 | C182961 | APCH106B-15-17.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH106B-15-17.9. | Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 15-17.9 | ||
18-21.9 | C182960 | APCH106B-18-21.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH106B-18-21.9. | Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 18-21.9 | ||
22-31.9 | C182959 | APCH106B-22-31.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH106B-22-31.9. | Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 22-31.9 | ||
32-40.9 | C182958 | APCH106B-32-40.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH106B-32-40.9. | Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 32-40.9 | ||
41-51.9 | C182957 | APCH106B-41-51.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH106B-41-51.9. | Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - 41-51.9 | ||
<15 | C182962 | APCH106B-<15 | Acute Physiology and Chronic Health Evaluation II original result for APCH106B-Less than 15. | Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - <15 | ||
>=52 | C182956 | APCH106B->=52 | Acute Physiology and Chronic Health Evaluation II original result for APCH106B-Greater than or equal to 52. | Acute Physiology and Chronic Health Evaluation II APCH106B Original Result - >=52 | ||
Back to top | ||||||
CL.C182492.APCH107OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH107 TN/TC
(APCH107OR) | text
Extensible: No | C182492 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH107 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH107 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH107 Original Response Terminology |
111-119 | C182974 | APCH107-111-119 | Acute Physiology and Chronic Health Evaluation II original result for APCH107-111-119. | Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 111-119 | ||
120-129 | C182973 | APCH107-120-129 | Acute Physiology and Chronic Health Evaluation II original result for APCH107-120-129. | Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 120-129 | ||
130-149 | C182972 | APCH107-130-149 | Acute Physiology and Chronic Health Evaluation II original result for APCH107-130-149. | Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 130-149 | ||
150-154 | C182971 | APCH107-150-154 | Acute Physiology and Chronic Health Evaluation II original result for APCH107-150-154. | Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 150-154 | ||
155-159 | C182970 | APCH107-155-159 | Acute Physiology and Chronic Health Evaluation II original result for APCH107-155-159. | Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 155-159 | ||
160-179 | C182969 | APCH107-160-179 | Acute Physiology and Chronic Health Evaluation II original result for APCH107-160-179. | Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - 160-179 | ||
<=110 | C182975 | APCH107-<=110 | Acute Physiology and Chronic Health Evaluation II original result for APCH107-Less than or equal to 110. | Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - <=110 | ||
>=180 | C182968 | APCH107->=180 | Acute Physiology and Chronic Health Evaluation II original result for APCH107-Greater than or equal to 180. | Acute Physiology and Chronic Health Evaluation II APCH107 Original Result - >=180 | ||
Back to top | ||||||
CL.C182493.APCH108OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH108 TN/TC
(APCH108OR) | text
Extensible: No | C182493 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH108 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH108 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH108 Original Response Terminology |
2.5-2.9 | C182986 | APCH108-2.5-2.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH108-2.5-2.9. | Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 2.5-2.9 | ||
3-3.4 | C182985 | APCH108-3-3.4 | Acute Physiology and Chronic Health Evaluation II original result for APCH108-3-3.4. | Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 3-3.4 | ||
3.5-5.4 | C182984 | APCH108-3.5-5.4 | Acute Physiology and Chronic Health Evaluation II original result for APCH108-3.5-5.4. | Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 3.5-5.4 | ||
5.5-5.9 | C182983 | APCH108-5.5-5.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH108-5.5-5.9. | Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 5.5-5.9 | ||
6-6.9 | C182982 | APCH108-6-6.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH108-6-6.9. | Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - 6-6.9 | ||
<2.5 | C182987 | APCH108-<2.5 | Acute Physiology and Chronic Health Evaluation II original result for APCH108-Less than 2.5. | Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - <2.5 | ||
>=7 | C182981 | APCH108->=7 | Acute Physiology and Chronic Health Evaluation II original result for APCH108-Greater than or equal to 7. | Acute Physiology and Chronic Health Evaluation II APCH108 Original Result - >=7 | ||
Back to top | ||||||
CL.C182494.APCH109OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH109 TN/TC
(APCH109OR) | text
Extensible: No | C182494 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH109 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH109 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH109 Original Response Terminology |
0.6-1.4 | C182999 | APCH109-0.6-1.4 | Acute Physiology and Chronic Health Evaluation II original result for APCH109-0.6-1.4. | Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 0.6-1.4 | ||
1.5-1.9 and acute renal failure | C182995 | APCH109-1.5-1.9 and acute renal failure | Acute Physiology and Chronic Health Evaluation II original result for APCH109-1.5-1.9 and acute renal failure. | Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 1.5-1.9 and acute renal failure | ||
1.5-1.9 | C182998 | APCH109-1.5-1.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH109-1.5-1.9. | Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 1.5-1.9 | ||
2-3.4 and acute renal failure | C182994 | APCH109-2-3.4 and acute renal failure | Acute Physiology and Chronic Health Evaluation II original result for APCH109-2-3.4 and acute renal failure. | Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 2-3.4 and acute renal failure | ||
2-3.4 | C182997 | APCH109-2-3.4 | Acute Physiology and Chronic Health Evaluation II original result for APCH109-2-3.4. | Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - 2-3.4 | ||
<0.6 | C183000 | APCH109-<0.6 | Acute Physiology and Chronic Health Evaluation II original result for APCH109-Less than 0.6. | Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - <0.6 | ||
>=3.5 and acute renal failure | C182993 | APCH109->=3.5 and acute renal failure | Acute Physiology and Chronic Health Evaluation II original result for APCH109-Greater than or equal to 3.5 and acute renal failure. | Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - >=3.5 and acute renal failure | ||
>=3.5 | C182996 | APCH109->=3.5 | Acute Physiology and Chronic Health Evaluation II original result for APCH109-Greater than or equal to 3.5. | Acute Physiology and Chronic Health Evaluation II APCH109 Original Result - >=3.5 | ||
Back to top | ||||||
CL.C182495.APCH110OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH110 TN/TC
(APCH110OR) | text
Extensible: No | C182495 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH110 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH110 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH110 Original Response Terminology |
20-29.9 | C183011 | APCH110-20-29.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH110-20-29.9. | Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - 20-29.9 | ||
30-45.9 | C183010 | APCH110-30-45.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH110-30-45.9. | Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - 30-45.9 | ||
46-49.9 | C183009 | APCH110-46-49.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH110-46-49.9. | Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - 46-49.9 | ||
50-59.9 | C183008 | APCH110-50-59.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH110-50-59.9. | Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - 50-59.9 | ||
<20 | C183012 | APCH110-<20 | Acute Physiology and Chronic Health Evaluation II original result for APCH110-Less than 20. | Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - <20 | ||
>=60 | C183007 | APCH110->=60 | Acute Physiology and Chronic Health Evaluation II original result for APCH110-Greater than or equal to 60. | Acute Physiology and Chronic Health Evaluation II APCH110 Original Result - >=60 | ||
Back to top | ||||||
CL.C182496.APCH111OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH111 TN/TC
(APCH111OR) | text
Extensible: No | C182496 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH111 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH111 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH111 Original Response Terminology |
1-2.9 | C183021 | APCH111-1-2.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH111-1-2.9. | Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - 1-2.9 | ||
15-19.9 | C183019 | APCH111-15-19.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH111-15-19.9. | Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - 15-19.9 | ||
20-39.9 | C183018 | APCH111-20-39.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH111-20-39.9. | Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - 20-39.9 | ||
3-14.9 | C183020 | APCH111-3-14.9 | Acute Physiology and Chronic Health Evaluation II original result for APCH111-3-14.9. | Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - 3-14.9 | ||
<1 | C183022 | APCH111-<1 | Acute Physiology and Chronic Health Evaluation II original result for APCH111-Less than 1. | Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - <1 | ||
>=40 | C183017 | APCH111->=40 | Acute Physiology and Chronic Health Evaluation II original result for APCH111-Greater than or equal to 40. | Acute Physiology and Chronic Health Evaluation II APCH111 Original Result - >=40 | ||
Back to top | ||||||
CL.C182497.APCH114OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH114 TN/TC
(APCH114OR) | text
Extensible: No | C182497 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH114 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH114 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH114 Original Response Terminology |
45-54 | C183028 | APCH114-45-54 | Acute Physiology and Chronic Health Evaluation II original result for APCH114-45-54. | Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - 45-54 | ||
55-64 | C183029 | APCH114-55-64 | Acute Physiology and Chronic Health Evaluation II original result for APCH114-55-64. | Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - 55-64 | ||
65-74 | C183030 | APCH114-65-74 | Acute Physiology and Chronic Health Evaluation II original result for APCH114-65-74. | Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - 65-74 | ||
<=44 | C183027 | APCH114-<=44 | Acute Physiology and Chronic Health Evaluation II original result for APCH114-Less than or equal to 44. | Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - <=44 | ||
>=75 | C183031 | APCH114->=75 | Acute Physiology and Chronic Health Evaluation II original result for APCH114-Greater than or equal to 75. | Acute Physiology and Chronic Health Evaluation II APCH114 Original Result - >=75 | ||
Back to top | ||||||
CL.C182498.APCH115OR | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH115 TN/TC
(APCH115OR) | text
Extensible: No | C182498 | Acute Physiology and Chronic Health Evaluation II Clinical Classification ORRES for APCH115 TN/TC | Acute Physiology and Chronic Health Evaluation II original result for APCH115 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH115 Original Response Terminology |
for elective postoperative patients | C183038 | APCH115-for elective postoperative patients | Acute Physiology and Chronic Health Evaluation II original result for APCH115-for elective postoperative patients. | Acute Physiology and Chronic Health Evaluation II APCH115 Original Result - for elective postoperative patients | ||
for nonoperative or emergency postoperative patients | C183037 | APCH115-for nonoperative or emergency postoperative patients | Acute Physiology and Chronic Health Evaluation II original result for APCH115-for nonoperative or emergency postoperative patients. | Acute Physiology and Chronic Health Evaluation II APCH115 Original Result - for nonoperative or emergency postoperative patients | ||
Back to top | ||||||
CL.C182522.APCH101STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH101 TN/TC
(APCH101STR) | text
Extensible: No | C182522 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH101 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Response Terminology |
0 | C182894 | APCH101-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-36-38.4. | Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 0 | ||
1 | C182893 | APCH101-1 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-38.5-38.9; 34-35.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 1 | ||
2 | C182892 | APCH101-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-32-33.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 2 | ||
3 | C182891 | APCH101-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-39-40.9; 30-31.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 3 | ||
4 | C182890 | APCH101-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH101-Greater than or equal to 41; Less than or equal to 29.9. | Acute Physiology and Chronic Health Evaluation II APCH101 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182523.APCH102STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH102 TN/TC
(APCH102STR) | text
Extensible: No | C182523 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH102 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Response Terminology |
0 | C182904 | APCH102-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102-70-109. | Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Result 0 | ||
2 | C182903 | APCH102-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102-110-129; 50-69. | Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Result 2 | ||
3 | C182902 | APCH102-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102-130-159. | Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Result 3 | ||
4 | C182901 | APCH102-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH102-Greater than or equal to 160; less than or equal to 49. | Acute Physiology and Chronic Health Evaluation II APCH102 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182524.APCH103STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH103 TN/TC
(APCH103STR) | text
Extensible: No | C182524 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH103 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Response Terminology |
0 | C182915 | APCH103-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103-70-109. | Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Result 0 | ||
2 | C182914 | APCH103-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103-110-139; 55-69. | Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Result 2 | ||
3 | C182913 | APCH103-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103-140-179; 40-54. | Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Result 3 | ||
4 | C182912 | APCH103-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH103-Greater than or equal to 180; Less than or equal 39. | Acute Physiology and Chronic Health Evaluation II APCH103 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182525.APCH104STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH104 TN/TC
(APCH104STR) | text
Extensible: No | C182525 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH104 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Response Terminology |
0 | C182927 | APCH104-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-12-24. | Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 0 | ||
1 | C182926 | APCH104-1 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-25-34; 10-11. | Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 1 | ||
2 | C182925 | APCH104-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-6-9. | Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 2 | ||
3 | C182924 | APCH104-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-35-49. | Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 3 | ||
4 | C182923 | APCH104-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH104-Greater than or equal to 50; Less than or equal to 5. | Acute Physiology and Chronic Health Evaluation II APCH104 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182526.APCH105ASTR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH105A TN/TC
(APCH105ASTR) | text
Extensible: No | C182526 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH105A TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Response Terminology |
0 | C182935 | APCH105A-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A-Less than 200. | Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Result 0 | ||
2 | C182934 | APCH105A-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A-200-349. | Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Result 2 | ||
3 | C182933 | APCH105A-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A-350-499. | Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Result 3 | ||
4 | C182932 | APCH105A-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105A-Greater than or equal to 500. | Acute Physiology and Chronic Health Evaluation II APCH105A Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182527.APCH105BSTR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH105B TN/TC
(APCH105BSTR) | text
Extensible: No | C182527 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH105B TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Response Terminology |
0 | C182940 | APCH105B-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B-Greater than 70. | Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Result 0 | ||
1 | C182941 | APCH105B-1 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B-61-70. | Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Result 1 | ||
3 | C182942 | APCH105B-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B-55-60. | Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Result 3 | ||
4 | C182943 | APCH105B-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH105B-Less than 55. | Acute Physiology and Chronic Health Evaluation II APCH105B Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182528.APCH106ASTR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH106A TN/TC
(APCH106ASTR) | text
Extensible: No | C182528 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH106A TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Response Terminology |
0 | C182955 | APCH106A-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-7.33-7.49. | Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 0 | ||
1 | C182954 | APCH106A-1 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-7.5-7.59. | Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 1 | ||
2 | C182953 | APCH106A2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-7.25-7.32. | Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 2 | ||
3 | C182952 | APCH106A-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-7.6-7.69; 7.15-7.24. | Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 3 | ||
4 | C182951 | APCH106A-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106A-Greater than or equal to 7.7; Less than 7.15. | Acute Physiology and Chronic Health Evaluation II APCH106A Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182529.APCH106BSTR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH106B TN/TC
(APCH106BSTR) | text
Extensible: No | C182529 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH106B TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Response Terminology |
0 | C182967 | APCH106B-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-22-31.9. | Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 0 | ||
1 | C182966 | APCH106B-1 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-32-40.9. | Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 1 | ||
2 | C182965 | APCH106B-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-18-21.9. | Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 2 | ||
3 | C182964 | APCH106B-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-41-51.9; 15-17.9. | Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 3 | ||
4 | C182963 | APCH106B-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH106B-Greater than or equal to 52; Less than 15. | Acute Physiology and Chronic Health Evaluation II APCH106B Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182530.APCH107STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH107 TN/TC
(APCH107STR) | text
Extensible: No | C182530 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH107 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Response Terminology |
0 | C182980 | APCH107-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-130-149. | Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 0 | ||
1 | C182979 | APCH107-1 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-150-154. | Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 1 | ||
2 | C182978 | APCH107-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-155-159; 120-129. | Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 2 | ||
3 | C182977 | APCH107-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-160-179; 111-119. | Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 3 | ||
4 | C182976 | APCH107-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH107-Greater than or equal to 180; Less than or equal to 110. | Acute Physiology and Chronic Health Evaluation II APCH107 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182531.APCH108STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH108 TN/TC
(APCH108STR) | text
Extensible: No | C182531 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH108 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Response Terminology |
0 | C182992 | APCH108-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-3.5-5.4. | Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 0 | ||
1 | C182991 | APCH108-1 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-5.5-5.9; 3-3.4. | Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 1 | ||
2 | C182990 | APCH108-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-2.5-2.9. | Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 2 | ||
3 | C182989 | APCH108-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-6-6.9. | Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 3 | ||
4 | C182988 | APCH108-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH108-Greater than or equal to 7; Less than 2.5. | Acute Physiology and Chronic Health Evaluation II APCH108 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182532.APCH109STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH109 TN/TC
(APCH109STR) | text
Extensible: No | C182532 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH109 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Response Terminology |
0 | C183006 | APCH109-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-0.6-1.4. | Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 0 | ||
2 | C183005 | APCH109-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-1.5-1.9; Less than 0.6. | Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 2 | ||
3 | C183004 | APCH109-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-2-3.4. | Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 3 | ||
4 | C183003 | APCH109-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-1.5-1.9 and acute renal failure; Greater than or equal to 3.5. | Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 4 | ||
6 | C183002 | APCH109-6 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-2-3.4 and acute renal failure. | Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 6 | ||
8 | C183001 | APCH109-8 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH109-Greater than or equal to 3.5 and acute renal failure. | Acute Physiology and Chronic Health Evaluation II APCH109 Standardized Character Result 8 | ||
Back to top | ||||||
CL.C182533.APCH110STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH110 TN/TC
(APCH110STR) | text
Extensible: No | C182533 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH110 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Response Terminology |
0 | C183016 | APCH110-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110-30-45.9. | Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Result 0 | ||
1 | C183015 | APCH110-1 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110-46-49.9. | Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Result 1 | ||
2 | C183014 | APCH110-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110-50-59.9; 20-29.9. | Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Result 2 | ||
4 | C183013 | APCH110-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH110-Greater than or equal to 60; Less than 20. | Acute Physiology and Chronic Health Evaluation II APCH110 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182534.APCH111STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH111 TN/TC
(APCH111STR) | text
Extensible: No | C182534 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH111 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Response Terminology |
0 | C183026 | APCH111-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111-3-14.9. | Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Result 0 | ||
1 | C183025 | APCH111-1 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111-15-19.9. | Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Result 1 | ||
2 | C183024 | APCH111-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111-20-39.9; 1-2.9. | Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Result 2 | ||
4 | C183023 | APCH111-4 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH111-Greater than or equal to 40; Less than 1. | Acute Physiology and Chronic Health Evaluation II APCH111 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C182535.APCH114STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH114 TN/TC
(APCH114STR) | text
Extensible: No | C182535 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH114 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Response Terminology |
0 | C183032 | APCH114-0 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-Less than or equal to 44. | Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 0 | ||
2 | C183033 | APCH114-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-45-54. | Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 2 | ||
3 | C183034 | APCH114-3 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-55-64. | Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 3 | ||
5 | C183035 | APCH114-5 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-65-74. | Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 5 | ||
6 | C183036 | APCH114-6 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH114-Greater than or equal to 75. | Acute Physiology and Chronic Health Evaluation II APCH114 Standardized Character Result 6 | ||
Back to top | ||||||
CL.C182536.APCH115STR | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH115 TN/TC
(APCH115STR) | text
Extensible: No | C182536 | Acute Physiology and Chronic Health Evaluation II Clinical Classification STRESC for APCH115 TN/TC | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH115 test and test code. | CDISC Clinical Classification Acute Physiology and Chronic Health Evaluation II APCH115 Standardized Character Response Terminology |
2 | C183040 | APCH115-2 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH115-for elective postoperative patients. | Acute Physiology and Chronic Health Evaluation II APCH115 Standardized Character Result 2 | ||
5 | C183039 | APCH115-5 | Acute Physiology and Chronic Health Evaluation II standardized character result for APCH115-for nonoperative or emergency postoperative patients. | Acute Physiology and Chronic Health Evaluation II APCH115 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C120985.APCH1TC | Acute Physiology and Chronic Health Evaluation II Clinical Classification Test Code
(APCH1TC) | text
Extensible: No | C120985 | Acute Physiology and Chronic Health Evaluation II Clinical Classification Test Code | Acute Physiology and Chronic Health Evaluation II test code. | CDISC Clinical Classification APACHE II Test Code Terminology |
APCH101 | C121096 | APCH1-Temperature - Rectal | Acute Physiology and Chronic Health Evaluation II - Temperature - rectal (degree C). | APACHE II - Temperature, Rectal | ||
APCH102 | C121097 | APCH1-Mean Arterial Pressure | Acute Physiology and Chronic Health Evaluation II - Mean arterial pressure - mmHg. | APACHE II - Mean Arterial Pressure | ||
APCH103 | C121098 | APCH1-Heart Rate | Acute Physiology and Chronic Health Evaluation II - Heart rate (ventricular response). | APACHE II - Heart Rate | ||
APCH104 | C121099 | APCH1-Respiratory Rate | Acute Physiology and Chronic Health Evaluation II - Respiratory rate (non-ventilated or ventilated). | APACHE II - Respiratory Rate | ||
APCH105A | C121100 | APCH1-Oxygenation: A-aDO2 | Acute Physiology and Chronic Health Evaluation II - Oxygenation (mmHg): FIO2 greater than or equal to 0.5 record A-aDO2. | APACHE II - Oxygenation, A-aDO2 | ||
APCH105B | C121101 | APCH1-Oxygenation: PaO2 | Acute Physiology and Chronic Health Evaluation II - Oxygenation (mmHg): FIO2 less than 0.5 record only PaO2. | APACHE II - Oxygenation, PaO2 | ||
APCH106A | C121102 | APCH1-Arterial pH | Acute Physiology and Chronic Health Evaluation II - Arterial pH (preferred). | APACHE II - Arterial pH | ||
APCH106B | C121103 | APCH1-Serum HCO3 | Acute Physiology and Chronic Health Evaluation II - Serum HCO3 (venous mMol/L) (Not preferred, use if no ABGs). | APACHE II - Serum HCO3 | ||
APCH107 | C121104 | APCH1-Serum Sodium | Acute Physiology and Chronic Health Evaluation II - Serum sodium (mMol/L). | APACHE II - Serum Sodium | ||
APCH108 | C121105 | APCH1-Serum Potassium | Acute Physiology and Chronic Health Evaluation II - Serum potassium (mMol/L). | APACHE II - Serum Potassium | ||
APCH109 | C121106 | APCH1-Serum Creatinine | Acute Physiology and Chronic Health Evaluation II - Serum creatinine (mg/100 mL) (double point score for acute renal failure). | APACHE II - Serum Creatinine | ||
APCH110 | C121107 | APCH1-Hematocrit | Acute Physiology and Chronic Health Evaluation II - Hematocrit (%). | APACHE II - Hematocrit | ||
APCH111 | C121108 | APCH1-White Blood Count | Acute Physiology and Chronic Health Evaluation II - White blood count (total/mm3) (in 1,000s). | APACHE II - White Blood Count | ||
APCH112 | C121109 | APCH1-15 Minus Glasgow Coma Score | Acute Physiology and Chronic Health Evaluation II - Glasgow coma score: Score equals 15 minus actual GCS. | APACHE II - 15 Minus Glasgow Coma Score | ||
APCH113 | C121110 | APCH1-A: Total Acute Physiology Score | Acute Physiology and Chronic Health Evaluation II - A: Total acute physiology score. | APACHE II - A, Total Acute Physiology Score | ||
APCH114 | C121111 | APCH1-B: Age Points | Acute Physiology and Chronic Health Evaluation II - B: Age points (years). | APACHE II - B, Age Points | ||
APCH115 | C121112 | APCH1-C: Chronic Health Points | Acute Physiology and Chronic Health Evaluation II - C: Chronic health points. | APACHE II - C, Chronic Health Points | ||
APCH116 | C121113 | APCH1-Total APACHE II Score | Acute Physiology and Chronic Health Evaluation II - Total APACHE II score. | APACHE II - Total APACHE II Score | ||
Back to top | ||||||
CL.C120984.APCH1TN | Acute Physiology and Chronic Health Evaluation II Clinical Classification Test Name
(APCH1TN) | text
Extensible: No | C120984 | Acute Physiology and Chronic Health Evaluation II Clinical Classification Test Name | Acute Physiology and Chronic Health Evaluation II test name. | CDISC Clinical Classification APACHE II Test Name Terminology |
APCH1-15 Minus Glasgow Coma Score | C121109 | APCH1-15 Minus Glasgow Coma Score | Acute Physiology and Chronic Health Evaluation II - Glasgow coma score: Score equals 15 minus actual GCS. | APACHE II - 15 Minus Glasgow Coma Score | ||
APCH1-A: Total Acute Physiology Score | C121110 | APCH1-A: Total Acute Physiology Score | Acute Physiology and Chronic Health Evaluation II - A: Total acute physiology score. | APACHE II - A, Total Acute Physiology Score | ||
APCH1-Arterial pH | C121102 | APCH1-Arterial pH | Acute Physiology and Chronic Health Evaluation II - Arterial pH (preferred). | APACHE II - Arterial pH | ||
APCH1-B: Age Points | C121111 | APCH1-B: Age Points | Acute Physiology and Chronic Health Evaluation II - B: Age points (years). | APACHE II - B, Age Points | ||
APCH1-C: Chronic Health Points | C121112 | APCH1-C: Chronic Health Points | Acute Physiology and Chronic Health Evaluation II - C: Chronic health points. | APACHE II - C, Chronic Health Points | ||
APCH1-Heart Rate | C121098 | APCH1-Heart Rate | Acute Physiology and Chronic Health Evaluation II - Heart rate (ventricular response). | APACHE II - Heart Rate | ||
APCH1-Hematocrit | C121107 | APCH1-Hematocrit | Acute Physiology and Chronic Health Evaluation II - Hematocrit (%). | APACHE II - Hematocrit | ||
APCH1-Mean Arterial Pressure | C121097 | APCH1-Mean Arterial Pressure | Acute Physiology and Chronic Health Evaluation II - Mean arterial pressure - mmHg. | APACHE II - Mean Arterial Pressure | ||
APCH1-Oxygenation: A-aDO2 | C121100 | APCH1-Oxygenation: A-aDO2 | Acute Physiology and Chronic Health Evaluation II - Oxygenation (mmHg): FIO2 greater than or equal to 0.5 record A-aDO2. | APACHE II - Oxygenation, A-aDO2 | ||
APCH1-Oxygenation: PaO2 | C121101 | APCH1-Oxygenation: PaO2 | Acute Physiology and Chronic Health Evaluation II - Oxygenation (mmHg): FIO2 less than 0.5 record only PaO2. | APACHE II - Oxygenation, PaO2 | ||
APCH1-Respiratory Rate | C121099 | APCH1-Respiratory Rate | Acute Physiology and Chronic Health Evaluation II - Respiratory rate (non-ventilated or ventilated). | APACHE II - Respiratory Rate | ||
APCH1-Serum Creatinine | C121106 | APCH1-Serum Creatinine | Acute Physiology and Chronic Health Evaluation II - Serum creatinine (mg/100 mL) (double point score for acute renal failure). | APACHE II - Serum Creatinine | ||
APCH1-Serum HCO3 | C121103 | APCH1-Serum HCO3 | Acute Physiology and Chronic Health Evaluation II - Serum HCO3 (venous mMol/L) (Not preferred, use if no ABGs). | APACHE II - Serum HCO3 | ||
APCH1-Serum Potassium | C121105 | APCH1-Serum Potassium | Acute Physiology and Chronic Health Evaluation II - Serum potassium (mMol/L). | APACHE II - Serum Potassium | ||
APCH1-Serum Sodium | C121104 | APCH1-Serum Sodium | Acute Physiology and Chronic Health Evaluation II - Serum sodium (mMol/L). | APACHE II - Serum Sodium | ||
APCH1-Temperature - Rectal | C121096 | APCH1-Temperature - Rectal | Acute Physiology and Chronic Health Evaluation II - Temperature - rectal (degree C). | APACHE II - Temperature, Rectal | ||
APCH1-Total APACHE II Score | C121113 | APCH1-Total APACHE II Score | Acute Physiology and Chronic Health Evaluation II - Total APACHE II score. | APACHE II - Total APACHE II Score | ||
APCH1-White Blood Count | C121108 | APCH1-White Blood Count | Acute Physiology and Chronic Health Evaluation II - White blood count (total/mm3) (in 1,000s). | APACHE II - White Blood Count | ||
Back to top | ||||||
CL.C132311.ADTNQRS | Administration Technique Response
(ADTNQRS) | text
Extensible: Yes | C132311 | Administration Technique Response | Terminology relevant to the product administration technique used. | CDISC SDTM Administration Technique Response Terminology |
HEAF | C85996 | A multiple puncture tuberculin skin test in which a Heaf gun (device containing 6 needles arranged in a circular pattern) is dipped into tuberculin purified protein derivative and pushed into the skin of the flexor surface of the left forearm. (NCI) | Heaf Tuberculin Skin Test | |||
MANTOUX | C85997 | A single puncture tuberculin skin test in which a standard dose of 5 Tuberculin units of purified protein derivative is injected under the skin of the inner surface of the forearm. | Mantoux Tuberculin Skin Test | |||
TINE | C85998 | A multiple puncture tuberculin skin test in which tuberculin antigen (either purified protein derivative or old) is pushed into the skin via a device containing 4-6 needles that are coated in tuberculin antigen. (NCI) | Tine Tuberculin Skin Test | |||
Back to top | ||||||
CL.C101807.AVL01TC | ADNI Auditory Verbal Learning Functional Test Test Code
(AVL01TC) | text
Extensible: No | C101807 | ADNI Auditory Verbal Learning Functional Test Test Code | ADNI AVLT test code. | CDISC Functional Test ADNI AVLT Test Code Terminology |
AVL01001 | C101896 | AVL01-List A Recall 1 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 1. | ADNI AVLT - List A Recall 1 Word 1 | ||
AVL01002 | C101897 | AVL01-List A Recall 1 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 2. | ADNI AVLT - List A Recall 1 Word 2 | ||
AVL01003 | C101898 | AVL01-List A Recall 1 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 3. | ADNI AVLT - List A Recall 1 Word 3 | ||
AVL01004 | C101899 | AVL01-List A Recall 1 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 4. | ADNI AVLT - List A Recall 1 Word 4 | ||
AVL01005 | C101900 | AVL01-List A Recall 1 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 5. | ADNI AVLT - List A Recall 1 Word 5 | ||
AVL01006 | C101901 | AVL01-List A Recall 1 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 6. | ADNI AVLT - List A Recall 1 Word 6 | ||
AVL01007 | C101902 | AVL01-List A Recall 1 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 7. | ADNI AVLT - List A Recall 1 Word 7 | ||
AVL01008 | C101903 | AVL01-List A Recall 1 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 8. | ADNI AVLT - List A Recall 1 Word 8 | ||
AVL01009 | C101904 | AVL01-List A Recall 1 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 9. | ADNI AVLT - List A Recall 1 Word 9 | ||
AVL01010 | C101905 | AVL01-List A Recall 1 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 10. | ADNI AVLT - List A Recall 1 Word 10 | ||
AVL01011 | C101906 | AVL01-List A Recall 1 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 11. | ADNI AVLT - List A Recall 1 Word 11 | ||
AVL01012 | C101907 | AVL01-List A Recall 1 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 12. | ADNI AVLT - List A Recall 1 Word 12 | ||
AVL01013 | C101908 | AVL01-List A Recall 1 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 13. | ADNI AVLT - List A Recall 1 Word 13 | ||
AVL01014 | C101909 | AVL01-List A Recall 1 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 14. | ADNI AVLT - List A Recall 1 Word 14 | ||
AVL01015 | C101910 | AVL01-List A Recall 1 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 15. | ADNI AVLT - List A Recall 1 Word 15 | ||
AVL01016 | C101911 | AVL01-List A Recall 1 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, first attempt. | ADNI AVLT - List A Recall 1 Total | ||
AVL01017 | C101912 | AVL01-List A Intrusions 1 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, first attempt. | ADNI AVLT - List A Intrusions 1 | ||
AVL01018 | C101913 | AVL01-List A Recall 2 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 1. | ADNI AVLT - List A Recall 2 Word 1 | ||
AVL01019 | C101914 | AVL01-List A Recall 2 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 2. | ADNI AVLT - List A Recall 2 Word 2 | ||
AVL01020 | C101915 | AVL01-List A Recall 2 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 3. | ADNI AVLT - List A Recall 2 Word 3 | ||
AVL01021 | C101916 | AVL01-List A Recall 2 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 4. | ADNI AVLT - List A Recall 2 Word 4 | ||
AVL01022 | C101917 | AVL01-List A Recall 2 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 5. | ADNI AVLT - List A Recall 2 Word 5 | ||
AVL01023 | C101918 | AVL01-List A Recall 2 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 6. | ADNI AVLT - List A Recall 2 Word 6 | ||
AVL01024 | C101919 | AVL01-List A Recall 2 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 7. | ADNI AVLT - List A Recall 2 Word 7 | ||
AVL01025 | C101920 | AVL01-List A Recall 2 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 8. | ADNI AVLT - List A Recall 2 Word 8 | ||
AVL01026 | C101921 | AVL01-List A Recall 2 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 9. | ADNI AVLT - List A Recall 2 Word 9 | ||
AVL01027 | C101922 | AVL01-List A Recall 2 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 10. | ADNI AVLT - List A Recall 2 Word 10 | ||
AVL01028 | C101923 | AVL01-List A Recall 2 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 11. | ADNI AVLT - List A Recall 2 Word 11 | ||
AVL01029 | C101924 | AVL01-List A Recall 2 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 12. | ADNI AVLT - List A Recall 2 Word 12 | ||
AVL01030 | C101925 | AVL01-List A Recall 2 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 13. | ADNI AVLT - List A Recall 2 Word 13 | ||
AVL01031 | C101926 | AVL01-List A Recall 2 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 14. | ADNI AVLT - List A Recall 2 Word 14 | ||
AVL01032 | C101927 | AVL01-List A Recall 2 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 15. | ADNI AVLT - List A Recall 2 Word 15 | ||
AVL01033 | C101928 | AVL01-List A Recall 2 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, second attempt. | ADNI AVLT - List A Recall 2 Total | ||
AVL01034 | C101929 | AVL01-List A Intrusions 2 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, second attempt. | ADNI AVLT - List A Intrusions 2 | ||
AVL01035 | C101930 | AVL01-List A Recall 3 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 1. | ADNI AVLT - List A Recall 3 Word 1 | ||
AVL01036 | C101931 | AVL01-List A Recall 3 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 2. | ADNI AVLT - List A Recall 3 Word 2 | ||
AVL01037 | C101932 | AVL01-List A Recall 3 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 3. | ADNI AVLT - List A Recall 3 Word 3 | ||
AVL01038 | C101933 | AVL01-List A Recall 3 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 4. | ADNI AVLT - List A Recall 3 Word 4 | ||
AVL01039 | C101934 | AVL01-List A Recall 3 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 5. | ADNI AVLT - List A Recall 3 Word 5 | ||
AVL01040 | C101935 | AVL01-List A Recall 3 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 6. | ADNI AVLT - List A Recall 3 Word 6 | ||
AVL01041 | C101936 | AVL01-List A Recall 3 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 7. | ADNI AVLT - List A Recall 3 Word 7 | ||
AVL01042 | C101937 | AVL01-List A Recall 3 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 8. | ADNI AVLT - List A Recall 3 Word 8 | ||
AVL01043 | C101938 | AVL01-List A Recall 3 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 9. | ADNI AVLT - List A Recall 3 Word 9 | ||
AVL01044 | C101939 | AVL01-List A Recall 3 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 10. | ADNI AVLT - List A Recall 3 Word 10 | ||
AVL01045 | C101940 | AVL01-List A Recall 3 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 11. | ADNI AVLT - List A Recall 3 Word 11 | ||
AVL01046 | C101941 | AVL01-List A Recall 3 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 12. | ADNI AVLT - List A Recall 3 Word 12 | ||
AVL01047 | C101942 | AVL01-List A Recall 3 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 13. | ADNI AVLT - List A Recall 3 Word 13 | ||
AVL01048 | C101943 | AVL01-List A Recall 3 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 14. | ADNI AVLT - List A Recall 3 Word 14 | ||
AVL01049 | C101944 | AVL01-List A Recall 3 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 15. | ADNI AVLT - List A Recall 3 Word 15 | ||
AVL01050 | C101945 | AVL01-List A Recall 3 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, third attempt. | ADNI AVLT - List A Recall 3 Total | ||
AVL01051 | C101946 | AVL01-List A Intrusions 3 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, third attempt. | ADNI AVLT - List A Intrusions 3 | ||
AVL01052 | C101947 | AVL01-List A Recall 4 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 1. | ADNI AVLT - List A Recall 4 Word 1 | ||
AVL01053 | C101948 | AVL01-List A Recall 4 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 2. | ADNI AVLT - List A Recall 4 Word 2 | ||
AVL01054 | C101949 | AVL01-List A Recall 4 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 3. | ADNI AVLT - List A Recall 4 Word 3 | ||
AVL01055 | C101950 | AVL01-List A Recall 4 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 4. | ADNI AVLT - List A Recall 4 Word 4 | ||
AVL01056 | C101951 | AVL01-List A Recall 4 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 5. | ADNI AVLT - List A Recall 4 Word 5 | ||
AVL01057 | C101952 | AVL01-List A Recall 4 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 6. | ADNI AVLT - List A Recall 4 Word 6 | ||
AVL01058 | C101953 | AVL01-List A Recall 4 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 7. | ADNI AVLT - List A Recall 4 Word 7 | ||
AVL01059 | C101954 | AVL01-List A Recall 4 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 8. | ADNI AVLT - List A Recall 4 Word 8 | ||
AVL01060 | C101955 | AVL01-List A Recall 4 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 9. | ADNI AVLT - List A Recall 4 Word 9 | ||
AVL01061 | C101956 | AVL01-List A Recall 4 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 10. | ADNI AVLT - List A Recall 4 Word 10 | ||
AVL01062 | C101957 | AVL01-List A Recall 4 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 11. | ADNI AVLT - List A Recall 4 Word 11 | ||
AVL01063 | C101958 | AVL01-List A Recall 4 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 12. | ADNI AVLT - List A Recall 4 Word 12 | ||
AVL01064 | C101959 | AVL01-List A Recall 4 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 13. | ADNI AVLT - List A Recall 4 Word 13 | ||
AVL01065 | C101960 | AVL01-List A Recall 4 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 14. | ADNI AVLT - List A Recall 4 Word 14 | ||
AVL01066 | C101961 | AVL01-List A Recall 4 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 15. | ADNI AVLT - List A Recall 4 Word 15 | ||
AVL01067 | C101962 | AVL01-List A Recall 4 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, fourth attempt. | ADNI AVLT - List A Recall 4 Total | ||
AVL01068 | C101963 | AVL01-List A Intrusions 4 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, fourth attempt. | ADNI AVLT - List A Intrusions 4 | ||
AVL01069 | C101964 | AVL01-List A Recall 5 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 1. | ADNI AVLT - List A Recall 5 Word 1 | ||
AVL01070 | C101965 | AVL01-List A Recall 5 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 2. | ADNI AVLT - List A Recall 5 Word 2 | ||
AVL01071 | C101966 | AVL01-List A Recall 5 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 3. | ADNI AVLT - List A Recall 5 Word 3 | ||
AVL01072 | C101967 | AVL01-List A Recall 5 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 4. | ADNI AVLT - List A Recall 5 Word 4 | ||
AVL01073 | C101968 | AVL01-List A Recall 5 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 5. | ADNI AVLT - List A Recall 5 Word 5 | ||
AVL01074 | C101969 | AVL01-List A Recall 5 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 6. | ADNI AVLT - List A Recall 5 Word 6 | ||
AVL01075 | C101970 | AVL01-List A Recall 5 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 7. | ADNI AVLT - List A Recall 5 Word 7 | ||
AVL01076 | C101971 | AVL01-List A Recall 5 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 8. | ADNI AVLT - List A Recall 5 Word 8 | ||
AVL01077 | C101972 | AVL01-List A Recall 5 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 9. | ADNI AVLT - List A Recall 5 Word 9 | ||
AVL01078 | C101973 | AVL01-List A Recall 5 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 10. | ADNI AVLT - List A Recall 5 Word 10 | ||
AVL01079 | C101974 | AVL01-List A Recall 5 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 11. | ADNI AVLT - List A Recall 5 Word 11 | ||
AVL01080 | C101975 | AVL01-List A Recall 5 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 12. | ADNI AVLT - List A Recall 5 Word 12 | ||
AVL01081 | C101976 | AVL01-List A Recall 5 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 13. | ADNI AVLT - List A Recall 5 Word 13 | ||
AVL01082 | C101977 | AVL01-List A Recall 5 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 14. | ADNI AVLT - List A Recall 5 Word 14 | ||
AVL01083 | C101978 | AVL01-List A Recall 5 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 15. | ADNI AVLT - List A Recall 5 Word 15 | ||
AVL01084 | C101979 | AVL01-List A Recall 5 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, fifth attempt. | ADNI AVLT - List A Recall 5 Total | ||
AVL01085 | C101980 | AVL01-List A Intrusions 5 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, fifth attempt. | ADNI AVLT - List A Intrusions 5 | ||
AVL01086 | C101981 | AVL01-List A Recall 6 (After B) Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 1. | ADNI AVLT - List A Recall 6 (After B) Word 1 | ||
AVL01087 | C101982 | AVL01-List A Recall 6 (After B) Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 2. | ADNI AVLT - List A Recall 6 (After B) Word 2 | ||
AVL01088 | C101983 | AVL01-List A Recall 6 (After B) Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 3. | ADNI AVLT - List A Recall 6 (After B) Word 3 | ||
AVL01089 | C101984 | AVL01-List A Recall 6 (After B) Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 4. | ADNI AVLT - List A Recall 6 (After B) Word 4 | ||
AVL01090 | C101985 | AVL01-List A Recall 6 (After B) Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 5. | ADNI AVLT - List A Recall 6 (After B) Word 5 | ||
AVL01091 | C101986 | AVL01-List A Recall 6 (After B) Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 6. | ADNI AVLT - List A Recall 6 (After B) Word 6 | ||
AVL01092 | C101987 | AVL01-List A Recall 6 (After B) Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 7. | ADNI AVLT - List A Recall 6 (After B) Word 7 | ||
AVL01093 | C101988 | AVL01-List A Recall 6 (After B) Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 8. | ADNI AVLT - List A Recall 6 (After B) Word 8 | ||
AVL01094 | C101989 | AVL01-List A Recall 6 (After B) Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 9. | ADNI AVLT - List A Recall 6 (After B) Word 9 | ||
AVL01095 | C101990 | AVL01-List A Recall 6 (After B) Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 10. | ADNI AVLT - List A Recall 6 (After B) Word 10 | ||
AVL01096 | C101991 | AVL01-List A Recall 6 (After B) Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 11. | ADNI AVLT - List A Recall 6 (After B) Word 11 | ||
AVL01097 | C101992 | AVL01-List A Recall 6 (After B) Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 12. | ADNI AVLT - List A Recall 6 (After B) Word 12 | ||
AVL01098 | C101993 | AVL01-List A Recall 6 (After B) Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 13. | ADNI AVLT - List A Recall 6 (After B) Word 13 | ||
AVL01099 | C101994 | AVL01-List A Recall 6 (After B) Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 14. | ADNI AVLT - List A Recall 6 (After B) Word 14 | ||
AVL01100 | C101995 | AVL01-List A Recall 6 (After B) Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 15. | ADNI AVLT - List A Recall 6 (After B) Word 15 | ||
AVL01101 | C101996 | AVL01-List A Recall 6 (After B) Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, sixth attempt (after List B recall). | ADNI AVLT - List A Recall 6 (After B) Total | ||
AVL01102 | C101997 | AVL01-List A Intrusions 6 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, sixth attempt (after List B recall). | ADNI AVLT - List A Intrusions 6 | ||
AVL01103 | C101998 | AVL01-List B Recall Word 1 | Auditory Verbal Learning Test Version A - List B, Word 1. | ADNI AVLT - List B Recall Word 1 | ||
AVL01104 | C101999 | AVL01-List B Recall Word 2 | Auditory Verbal Learning Test Version A - List B, Word 2. | ADNI AVLT - List B Recall Word 2 | ||
AVL01105 | C102000 | AVL01-List B Recall Word 3 | Auditory Verbal Learning Test Version A - List B, Word 3. | ADNI AVLT - List B Recall Word 3 | ||
AVL01106 | C102001 | AVL01-List B Recall Word 4 | Auditory Verbal Learning Test Version A - List B, Word 4. | ADNI AVLT - List B Recall Word 4 | ||
AVL01107 | C102002 | AVL01-List B Recall Word 5 | Auditory Verbal Learning Test Version A - List B, Word 5. | ADNI AVLT - List B Recall Word 5 | ||
AVL01108 | C102003 | AVL01-List B Recall Word 6 | Auditory Verbal Learning Test Version A - List B, Word 6. | ADNI AVLT - List B Recall Word 6 | ||
AVL01109 | C102004 | AVL01-List B Recall Word 7 | Auditory Verbal Learning Test Version A - List B, Word 7. | ADNI AVLT - List B Recall Word 7 | ||
AVL01110 | C102005 | AVL01-List B Recall Word 8 | Auditory Verbal Learning Test Version A - List B, Word 8. | ADNI AVLT - List B Recall Word 8 | ||
AVL01111 | C102006 | AVL01-List B Recall Word 9 | Auditory Verbal Learning Test Version A - List B, Word 9. | ADNI AVLT - List B Recall Word 9 | ||
AVL01112 | C102007 | AVL01-List B Recall Word 10 | Auditory Verbal Learning Test Version A - List B, Word 10. | ADNI AVLT - List B Recall Word 10 | ||
AVL01113 | C102008 | AVL01-List B Recall Word 11 | Auditory Verbal Learning Test Version A - List B, Word 11. | ADNI AVLT - List B Recall Word 11 | ||
AVL01114 | C102009 | AVL01-List B Recall Word 12 | Auditory Verbal Learning Test Version A - List B, Word 12. | ADNI AVLT - List B Recall Word 12 | ||
AVL01115 | C102010 | AVL01-List B Recall Word 13 | Auditory Verbal Learning Test Version A - List B, Word 13. | ADNI AVLT - List B Recall Word 13 | ||
AVL01116 | C102011 | AVL01-List B Recall Word 14 | Auditory Verbal Learning Test Version A - List B, Word 14. | ADNI AVLT - List B Recall Word 14 | ||
AVL01117 | C102012 | AVL01-List B Recall Word 15 | Auditory Verbal Learning Test Version A - List B, Word 15. | ADNI AVLT - List B Recall Word 15 | ||
AVL01118 | C102013 | AVL01-List B Recall Total | Auditory Verbal Learning Test Version A - The number of words recalled from List B. | ADNI AVLT - List B Recall Total | ||
AVL01119 | C102014 | AVL01-List B Intrusions | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List B. | ADNI AVLT - List B Intrusions | ||
AVL01120 | C102015 | AVL01-List A 30 Min Delay Recall Word 1 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 1. | ADNI AVLT - List A 30 Min Delay Recall Word 1 | ||
AVL01121 | C102016 | AVL01-List A 30 Min Delay Recall Word 2 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 2. | ADNI AVLT - List A 30 Min Delay Recall Word 2 | ||
AVL01122 | C102017 | AVL01-List A 30 Min Delay Recall Word 3 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 3. | ADNI AVLT - List A 30 Min Delay Recall Word 3 | ||
AVL01123 | C102018 | AVL01-List A 30 Min Delay Recall Word 4 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 4. | ADNI AVLT - List A 30 Min Delay Recall Word 4 | ||
AVL01124 | C102019 | AVL01-List A 30 Min Delay Recall Word 5 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 5. | ADNI AVLT - List A 30 Min Delay Recall Word 5 | ||
AVL01125 | C102020 | AVL01-List A 30 Min Delay Recall Word 6 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 6. | ADNI AVLT - List A 30 Min Delay Recall Word 6 | ||
AVL01126 | C102021 | AVL01-List A 30 Min Delay Recall Word 7 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 7. | ADNI AVLT - List A 30 Min Delay Recall Word 7 | ||
AVL01127 | C102022 | AVL01-List A 30 Min Delay Recall Word 8 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 8. | ADNI AVLT - List A 30 Min Delay Recall Word 8 | ||
AVL01128 | C102023 | AVL01-List A 30 Min Delay Recall Word 9 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 9. | ADNI AVLT - List A 30 Min Delay Recall Word 9 | ||
AVL01129 | C102024 | AVL01-List A 30 Min Delay Recall Word 10 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 10. | ADNI AVLT - List A 30 Min Delay Recall Word 10 | ||
AVL01130 | C102025 | AVL01-List A 30 Min Delay Recall Word 11 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 11. | ADNI AVLT - List A 30 Min Delay Recall Word 11 | ||
AVL01131 | C102026 | AVL01-List A 30 Min Delay Recall Word 12 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 12. | ADNI AVLT - List A 30 Min Delay Recall Word 12 | ||
AVL01132 | C102027 | AVL01-List A 30 Min Delay Recall Word 13 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 13. | ADNI AVLT - List A 30 Min Delay Recall Word 13 | ||
AVL01133 | C102028 | AVL01-List A 30 Min Delay Recall Word 14 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 14. | ADNI AVLT - List A 30 Min Delay Recall Word 14 | ||
AVL01134 | C102029 | AVL01-List A 30 Min Delay Recall Word 15 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 15. | ADNI AVLT - List A 30 Min Delay Recall Word 15 | ||
AVL01135 | C102030 | AVL01-List A 30 Min Delay Recall Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, 30 Minute Delay recall. | ADNI AVLT - List A 30 Min Delay Recall Total | ||
AVL01136 | C102031 | AVL01-List A 30 Min Delay Intrusions | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, 30 Minute Delay. | ADNI AVLT - List A 30 Min Delay Intrusions | ||
AVL01137 | C102032 | AVL01-List A Recognition Total | Auditory Verbal Learning Test Version A - The number of words correct on recognition test. | ADNI AVLT - List A Recognition Total | ||
AVL01138 | C102033 | AVL01-List A Recognition Intrusions | Auditory Verbal Learning Test Version A - The number of intrusions on recognition test. | ADNI AVLT - List A Recognition Intrusions | ||
Back to top | ||||||
CL.C101808.AVL01TN | ADNI Auditory Verbal Learning Functional Test Test Name
(AVL01TN) | text
Extensible: No | C101808 | ADNI Auditory Verbal Learning Functional Test Test Name | ADNI AVLT test name. | CDISC Functional Test ADNI AVLT Test Name Terminology |
AVL01-List A 30 Min Delay Intrusions | C102031 | AVL01-List A 30 Min Delay Intrusions | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, 30 Minute Delay. | ADNI AVLT - List A 30 Min Delay Intrusions | ||
AVL01-List A 30 Min Delay Recall Total | C102030 | AVL01-List A 30 Min Delay Recall Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, 30 Minute Delay recall. | ADNI AVLT - List A 30 Min Delay Recall Total | ||
AVL01-List A 30 Min Delay Recall Word 1 | C102015 | AVL01-List A 30 Min Delay Recall Word 1 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 1. | ADNI AVLT - List A 30 Min Delay Recall Word 1 | ||
AVL01-List A 30 Min Delay Recall Word 10 | C102024 | AVL01-List A 30 Min Delay Recall Word 10 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 10. | ADNI AVLT - List A 30 Min Delay Recall Word 10 | ||
AVL01-List A 30 Min Delay Recall Word 11 | C102025 | AVL01-List A 30 Min Delay Recall Word 11 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 11. | ADNI AVLT - List A 30 Min Delay Recall Word 11 | ||
AVL01-List A 30 Min Delay Recall Word 12 | C102026 | AVL01-List A 30 Min Delay Recall Word 12 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 12. | ADNI AVLT - List A 30 Min Delay Recall Word 12 | ||
AVL01-List A 30 Min Delay Recall Word 13 | C102027 | AVL01-List A 30 Min Delay Recall Word 13 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 13. | ADNI AVLT - List A 30 Min Delay Recall Word 13 | ||
AVL01-List A 30 Min Delay Recall Word 14 | C102028 | AVL01-List A 30 Min Delay Recall Word 14 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 14. | ADNI AVLT - List A 30 Min Delay Recall Word 14 | ||
AVL01-List A 30 Min Delay Recall Word 15 | C102029 | AVL01-List A 30 Min Delay Recall Word 15 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 15. | ADNI AVLT - List A 30 Min Delay Recall Word 15 | ||
AVL01-List A 30 Min Delay Recall Word 2 | C102016 | AVL01-List A 30 Min Delay Recall Word 2 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 2. | ADNI AVLT - List A 30 Min Delay Recall Word 2 | ||
AVL01-List A 30 Min Delay Recall Word 3 | C102017 | AVL01-List A 30 Min Delay Recall Word 3 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 3. | ADNI AVLT - List A 30 Min Delay Recall Word 3 | ||
AVL01-List A 30 Min Delay Recall Word 4 | C102018 | AVL01-List A 30 Min Delay Recall Word 4 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 4. | ADNI AVLT - List A 30 Min Delay Recall Word 4 | ||
AVL01-List A 30 Min Delay Recall Word 5 | C102019 | AVL01-List A 30 Min Delay Recall Word 5 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 5. | ADNI AVLT - List A 30 Min Delay Recall Word 5 | ||
AVL01-List A 30 Min Delay Recall Word 6 | C102020 | AVL01-List A 30 Min Delay Recall Word 6 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 6. | ADNI AVLT - List A 30 Min Delay Recall Word 6 | ||
AVL01-List A 30 Min Delay Recall Word 7 | C102021 | AVL01-List A 30 Min Delay Recall Word 7 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 7. | ADNI AVLT - List A 30 Min Delay Recall Word 7 | ||
AVL01-List A 30 Min Delay Recall Word 8 | C102022 | AVL01-List A 30 Min Delay Recall Word 8 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 8. | ADNI AVLT - List A 30 Min Delay Recall Word 8 | ||
AVL01-List A 30 Min Delay Recall Word 9 | C102023 | AVL01-List A 30 Min Delay Recall Word 9 | Auditory Verbal Learning Test Version A - List A, 30 Minute Delay Recall, Word 9. | ADNI AVLT - List A 30 Min Delay Recall Word 9 | ||
AVL01-List A Intrusions 1 | C101912 | AVL01-List A Intrusions 1 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, first attempt. | ADNI AVLT - List A Intrusions 1 | ||
AVL01-List A Intrusions 2 | C101929 | AVL01-List A Intrusions 2 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, second attempt. | ADNI AVLT - List A Intrusions 2 | ||
AVL01-List A Intrusions 3 | C101946 | AVL01-List A Intrusions 3 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, third attempt. | ADNI AVLT - List A Intrusions 3 | ||
AVL01-List A Intrusions 4 | C101963 | AVL01-List A Intrusions 4 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, fourth attempt. | ADNI AVLT - List A Intrusions 4 | ||
AVL01-List A Intrusions 5 | C101980 | AVL01-List A Intrusions 5 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, fifth attempt. | ADNI AVLT - List A Intrusions 5 | ||
AVL01-List A Intrusions 6 | C101997 | AVL01-List A Intrusions 6 | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List A, sixth attempt (after List B recall). | ADNI AVLT - List A Intrusions 6 | ||
AVL01-List A Recall 1 Total | C101911 | AVL01-List A Recall 1 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, first attempt. | ADNI AVLT - List A Recall 1 Total | ||
AVL01-List A Recall 1 Word 1 | C101896 | AVL01-List A Recall 1 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 1. | ADNI AVLT - List A Recall 1 Word 1 | ||
AVL01-List A Recall 1 Word 10 | C101905 | AVL01-List A Recall 1 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 10. | ADNI AVLT - List A Recall 1 Word 10 | ||
AVL01-List A Recall 1 Word 11 | C101906 | AVL01-List A Recall 1 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 11. | ADNI AVLT - List A Recall 1 Word 11 | ||
AVL01-List A Recall 1 Word 12 | C101907 | AVL01-List A Recall 1 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 12. | ADNI AVLT - List A Recall 1 Word 12 | ||
AVL01-List A Recall 1 Word 13 | C101908 | AVL01-List A Recall 1 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 13. | ADNI AVLT - List A Recall 1 Word 13 | ||
AVL01-List A Recall 1 Word 14 | C101909 | AVL01-List A Recall 1 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 14. | ADNI AVLT - List A Recall 1 Word 14 | ||
AVL01-List A Recall 1 Word 15 | C101910 | AVL01-List A Recall 1 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 15. | ADNI AVLT - List A Recall 1 Word 15 | ||
AVL01-List A Recall 1 Word 2 | C101897 | AVL01-List A Recall 1 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 2. | ADNI AVLT - List A Recall 1 Word 2 | ||
AVL01-List A Recall 1 Word 3 | C101898 | AVL01-List A Recall 1 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 3. | ADNI AVLT - List A Recall 1 Word 3 | ||
AVL01-List A Recall 1 Word 4 | C101899 | AVL01-List A Recall 1 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 4. | ADNI AVLT - List A Recall 1 Word 4 | ||
AVL01-List A Recall 1 Word 5 | C101900 | AVL01-List A Recall 1 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 5. | ADNI AVLT - List A Recall 1 Word 5 | ||
AVL01-List A Recall 1 Word 6 | C101901 | AVL01-List A Recall 1 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 6. | ADNI AVLT - List A Recall 1 Word 6 | ||
AVL01-List A Recall 1 Word 7 | C101902 | AVL01-List A Recall 1 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 7. | ADNI AVLT - List A Recall 1 Word 7 | ||
AVL01-List A Recall 1 Word 8 | C101903 | AVL01-List A Recall 1 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 8. | ADNI AVLT - List A Recall 1 Word 8 | ||
AVL01-List A Recall 1 Word 9 | C101904 | AVL01-List A Recall 1 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 1, Word 9. | ADNI AVLT - List A Recall 1 Word 9 | ||
AVL01-List A Recall 2 Total | C101928 | AVL01-List A Recall 2 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, second attempt. | ADNI AVLT - List A Recall 2 Total | ||
AVL01-List A Recall 2 Word 1 | C101913 | AVL01-List A Recall 2 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 1. | ADNI AVLT - List A Recall 2 Word 1 | ||
AVL01-List A Recall 2 Word 10 | C101922 | AVL01-List A Recall 2 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 10. | ADNI AVLT - List A Recall 2 Word 10 | ||
AVL01-List A Recall 2 Word 11 | C101923 | AVL01-List A Recall 2 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 11. | ADNI AVLT - List A Recall 2 Word 11 | ||
AVL01-List A Recall 2 Word 12 | C101924 | AVL01-List A Recall 2 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 12. | ADNI AVLT - List A Recall 2 Word 12 | ||
AVL01-List A Recall 2 Word 13 | C101925 | AVL01-List A Recall 2 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 13. | ADNI AVLT - List A Recall 2 Word 13 | ||
AVL01-List A Recall 2 Word 14 | C101926 | AVL01-List A Recall 2 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 14. | ADNI AVLT - List A Recall 2 Word 14 | ||
AVL01-List A Recall 2 Word 15 | C101927 | AVL01-List A Recall 2 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 15. | ADNI AVLT - List A Recall 2 Word 15 | ||
AVL01-List A Recall 2 Word 2 | C101914 | AVL01-List A Recall 2 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 2. | ADNI AVLT - List A Recall 2 Word 2 | ||
AVL01-List A Recall 2 Word 3 | C101915 | AVL01-List A Recall 2 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 3. | ADNI AVLT - List A Recall 2 Word 3 | ||
AVL01-List A Recall 2 Word 4 | C101916 | AVL01-List A Recall 2 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 4. | ADNI AVLT - List A Recall 2 Word 4 | ||
AVL01-List A Recall 2 Word 5 | C101917 | AVL01-List A Recall 2 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 5. | ADNI AVLT - List A Recall 2 Word 5 | ||
AVL01-List A Recall 2 Word 6 | C101918 | AVL01-List A Recall 2 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 6. | ADNI AVLT - List A Recall 2 Word 6 | ||
AVL01-List A Recall 2 Word 7 | C101919 | AVL01-List A Recall 2 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 7. | ADNI AVLT - List A Recall 2 Word 7 | ||
AVL01-List A Recall 2 Word 8 | C101920 | AVL01-List A Recall 2 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 8. | ADNI AVLT - List A Recall 2 Word 8 | ||
AVL01-List A Recall 2 Word 9 | C101921 | AVL01-List A Recall 2 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 2, Word 9. | ADNI AVLT - List A Recall 2 Word 9 | ||
AVL01-List A Recall 3 Total | C101945 | AVL01-List A Recall 3 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, third attempt. | ADNI AVLT - List A Recall 3 Total | ||
AVL01-List A Recall 3 Word 1 | C101930 | AVL01-List A Recall 3 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 1. | ADNI AVLT - List A Recall 3 Word 1 | ||
AVL01-List A Recall 3 Word 10 | C101939 | AVL01-List A Recall 3 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 10. | ADNI AVLT - List A Recall 3 Word 10 | ||
AVL01-List A Recall 3 Word 11 | C101940 | AVL01-List A Recall 3 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 11. | ADNI AVLT - List A Recall 3 Word 11 | ||
AVL01-List A Recall 3 Word 12 | C101941 | AVL01-List A Recall 3 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 12. | ADNI AVLT - List A Recall 3 Word 12 | ||
AVL01-List A Recall 3 Word 13 | C101942 | AVL01-List A Recall 3 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 13. | ADNI AVLT - List A Recall 3 Word 13 | ||
AVL01-List A Recall 3 Word 14 | C101943 | AVL01-List A Recall 3 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 14. | ADNI AVLT - List A Recall 3 Word 14 | ||
AVL01-List A Recall 3 Word 15 | C101944 | AVL01-List A Recall 3 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 15. | ADNI AVLT - List A Recall 3 Word 15 | ||
AVL01-List A Recall 3 Word 2 | C101931 | AVL01-List A Recall 3 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 2. | ADNI AVLT - List A Recall 3 Word 2 | ||
AVL01-List A Recall 3 Word 3 | C101932 | AVL01-List A Recall 3 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 3. | ADNI AVLT - List A Recall 3 Word 3 | ||
AVL01-List A Recall 3 Word 4 | C101933 | AVL01-List A Recall 3 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 4. | ADNI AVLT - List A Recall 3 Word 4 | ||
AVL01-List A Recall 3 Word 5 | C101934 | AVL01-List A Recall 3 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 5. | ADNI AVLT - List A Recall 3 Word 5 | ||
AVL01-List A Recall 3 Word 6 | C101935 | AVL01-List A Recall 3 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 6. | ADNI AVLT - List A Recall 3 Word 6 | ||
AVL01-List A Recall 3 Word 7 | C101936 | AVL01-List A Recall 3 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 7. | ADNI AVLT - List A Recall 3 Word 7 | ||
AVL01-List A Recall 3 Word 8 | C101937 | AVL01-List A Recall 3 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 8. | ADNI AVLT - List A Recall 3 Word 8 | ||
AVL01-List A Recall 3 Word 9 | C101938 | AVL01-List A Recall 3 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 3, Word 9. | ADNI AVLT - List A Recall 3 Word 9 | ||
AVL01-List A Recall 4 Total | C101962 | AVL01-List A Recall 4 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, fourth attempt. | ADNI AVLT - List A Recall 4 Total | ||
AVL01-List A Recall 4 Word 1 | C101947 | AVL01-List A Recall 4 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 1. | ADNI AVLT - List A Recall 4 Word 1 | ||
AVL01-List A Recall 4 Word 10 | C101956 | AVL01-List A Recall 4 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 10. | ADNI AVLT - List A Recall 4 Word 10 | ||
AVL01-List A Recall 4 Word 11 | C101957 | AVL01-List A Recall 4 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 11. | ADNI AVLT - List A Recall 4 Word 11 | ||
AVL01-List A Recall 4 Word 12 | C101958 | AVL01-List A Recall 4 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 12. | ADNI AVLT - List A Recall 4 Word 12 | ||
AVL01-List A Recall 4 Word 13 | C101959 | AVL01-List A Recall 4 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 13. | ADNI AVLT - List A Recall 4 Word 13 | ||
AVL01-List A Recall 4 Word 14 | C101960 | AVL01-List A Recall 4 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 14. | ADNI AVLT - List A Recall 4 Word 14 | ||
AVL01-List A Recall 4 Word 15 | C101961 | AVL01-List A Recall 4 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 15. | ADNI AVLT - List A Recall 4 Word 15 | ||
AVL01-List A Recall 4 Word 2 | C101948 | AVL01-List A Recall 4 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 2. | ADNI AVLT - List A Recall 4 Word 2 | ||
AVL01-List A Recall 4 Word 3 | C101949 | AVL01-List A Recall 4 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 3. | ADNI AVLT - List A Recall 4 Word 3 | ||
AVL01-List A Recall 4 Word 4 | C101950 | AVL01-List A Recall 4 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 4. | ADNI AVLT - List A Recall 4 Word 4 | ||
AVL01-List A Recall 4 Word 5 | C101951 | AVL01-List A Recall 4 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 5. | ADNI AVLT - List A Recall 4 Word 5 | ||
AVL01-List A Recall 4 Word 6 | C101952 | AVL01-List A Recall 4 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 6. | ADNI AVLT - List A Recall 4 Word 6 | ||
AVL01-List A Recall 4 Word 7 | C101953 | AVL01-List A Recall 4 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 7. | ADNI AVLT - List A Recall 4 Word 7 | ||
AVL01-List A Recall 4 Word 8 | C101954 | AVL01-List A Recall 4 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 8. | ADNI AVLT - List A Recall 4 Word 8 | ||
AVL01-List A Recall 4 Word 9 | C101955 | AVL01-List A Recall 4 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 4, Word 9. | ADNI AVLT - List A Recall 4 Word 9 | ||
AVL01-List A Recall 5 Total | C101979 | AVL01-List A Recall 5 Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, fifth attempt. | ADNI AVLT - List A Recall 5 Total | ||
AVL01-List A Recall 5 Word 1 | C101964 | AVL01-List A Recall 5 Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 1. | ADNI AVLT - List A Recall 5 Word 1 | ||
AVL01-List A Recall 5 Word 10 | C101973 | AVL01-List A Recall 5 Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 10. | ADNI AVLT - List A Recall 5 Word 10 | ||
AVL01-List A Recall 5 Word 11 | C101974 | AVL01-List A Recall 5 Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 11. | ADNI AVLT - List A Recall 5 Word 11 | ||
AVL01-List A Recall 5 Word 12 | C101975 | AVL01-List A Recall 5 Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 12. | ADNI AVLT - List A Recall 5 Word 12 | ||
AVL01-List A Recall 5 Word 13 | C101976 | AVL01-List A Recall 5 Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 13. | ADNI AVLT - List A Recall 5 Word 13 | ||
AVL01-List A Recall 5 Word 14 | C101977 | AVL01-List A Recall 5 Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 14. | ADNI AVLT - List A Recall 5 Word 14 | ||
AVL01-List A Recall 5 Word 15 | C101978 | AVL01-List A Recall 5 Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 15. | ADNI AVLT - List A Recall 5 Word 15 | ||
AVL01-List A Recall 5 Word 2 | C101965 | AVL01-List A Recall 5 Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 2. | ADNI AVLT - List A Recall 5 Word 2 | ||
AVL01-List A Recall 5 Word 3 | C101966 | AVL01-List A Recall 5 Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 3. | ADNI AVLT - List A Recall 5 Word 3 | ||
AVL01-List A Recall 5 Word 4 | C101967 | AVL01-List A Recall 5 Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 4. | ADNI AVLT - List A Recall 5 Word 4 | ||
AVL01-List A Recall 5 Word 5 | C101968 | AVL01-List A Recall 5 Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 5. | ADNI AVLT - List A Recall 5 Word 5 | ||
AVL01-List A Recall 5 Word 6 | C101969 | AVL01-List A Recall 5 Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 6. | ADNI AVLT - List A Recall 5 Word 6 | ||
AVL01-List A Recall 5 Word 7 | C101970 | AVL01-List A Recall 5 Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 7. | ADNI AVLT - List A Recall 5 Word 7 | ||
AVL01-List A Recall 5 Word 8 | C101971 | AVL01-List A Recall 5 Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 8. | ADNI AVLT - List A Recall 5 Word 8 | ||
AVL01-List A Recall 5 Word 9 | C101972 | AVL01-List A Recall 5 Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 5, Word 9. | ADNI AVLT - List A Recall 5 Word 9 | ||
AVL01-List A Recall 6 (After B) Total | C101996 | AVL01-List A Recall 6 (After B) Total | Auditory Verbal Learning Test Version A - The number of words recalled from List A, sixth attempt (after List B recall). | ADNI AVLT - List A Recall 6 (After B) Total | ||
AVL01-List A Recall 6 (After B) Word 1 | C101981 | AVL01-List A Recall 6 (After B) Word 1 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 1. | ADNI AVLT - List A Recall 6 (After B) Word 1 | ||
AVL01-List A Recall 6 (After B) Word 10 | C101990 | AVL01-List A Recall 6 (After B) Word 10 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 10. | ADNI AVLT - List A Recall 6 (After B) Word 10 | ||
AVL01-List A Recall 6 (After B) Word 11 | C101991 | AVL01-List A Recall 6 (After B) Word 11 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 11. | ADNI AVLT - List A Recall 6 (After B) Word 11 | ||
AVL01-List A Recall 6 (After B) Word 12 | C101992 | AVL01-List A Recall 6 (After B) Word 12 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 12. | ADNI AVLT - List A Recall 6 (After B) Word 12 | ||
AVL01-List A Recall 6 (After B) Word 13 | C101993 | AVL01-List A Recall 6 (After B) Word 13 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 13. | ADNI AVLT - List A Recall 6 (After B) Word 13 | ||
AVL01-List A Recall 6 (After B) Word 14 | C101994 | AVL01-List A Recall 6 (After B) Word 14 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 14. | ADNI AVLT - List A Recall 6 (After B) Word 14 | ||
AVL01-List A Recall 6 (After B) Word 15 | C101995 | AVL01-List A Recall 6 (After B) Word 15 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 15. | ADNI AVLT - List A Recall 6 (After B) Word 15 | ||
AVL01-List A Recall 6 (After B) Word 2 | C101982 | AVL01-List A Recall 6 (After B) Word 2 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 2. | ADNI AVLT - List A Recall 6 (After B) Word 2 | ||
AVL01-List A Recall 6 (After B) Word 3 | C101983 | AVL01-List A Recall 6 (After B) Word 3 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 3. | ADNI AVLT - List A Recall 6 (After B) Word 3 | ||
AVL01-List A Recall 6 (After B) Word 4 | C101984 | AVL01-List A Recall 6 (After B) Word 4 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 4. | ADNI AVLT - List A Recall 6 (After B) Word 4 | ||
AVL01-List A Recall 6 (After B) Word 5 | C101985 | AVL01-List A Recall 6 (After B) Word 5 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 5. | ADNI AVLT - List A Recall 6 (After B) Word 5 | ||
AVL01-List A Recall 6 (After B) Word 6 | C101986 | AVL01-List A Recall 6 (After B) Word 6 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 6. | ADNI AVLT - List A Recall 6 (After B) Word 6 | ||
AVL01-List A Recall 6 (After B) Word 7 | C101987 | AVL01-List A Recall 6 (After B) Word 7 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 7. | ADNI AVLT - List A Recall 6 (After B) Word 7 | ||
AVL01-List A Recall 6 (After B) Word 8 | C101988 | AVL01-List A Recall 6 (After B) Word 8 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 8. | ADNI AVLT - List A Recall 6 (After B) Word 8 | ||
AVL01-List A Recall 6 (After B) Word 9 | C101989 | AVL01-List A Recall 6 (After B) Word 9 | Auditory Verbal Learning Test Version A - List A, Recall 6 (after B Recall), Word 9. | ADNI AVLT - List A Recall 6 (After B) Word 9 | ||
AVL01-List A Recognition Intrusions | C102033 | AVL01-List A Recognition Intrusions | Auditory Verbal Learning Test Version A - The number of intrusions on recognition test. | ADNI AVLT - List A Recognition Intrusions | ||
AVL01-List A Recognition Total | C102032 | AVL01-List A Recognition Total | Auditory Verbal Learning Test Version A - The number of words correct on recognition test. | ADNI AVLT - List A Recognition Total | ||
AVL01-List B Intrusions | C102014 | AVL01-List B Intrusions | Auditory Verbal Learning Test Version A - The number of intrusions while recalling List B. | ADNI AVLT - List B Intrusions | ||
AVL01-List B Recall Total | C102013 | AVL01-List B Recall Total | Auditory Verbal Learning Test Version A - The number of words recalled from List B. | ADNI AVLT - List B Recall Total | ||
AVL01-List B Recall Word 1 | C101998 | AVL01-List B Recall Word 1 | Auditory Verbal Learning Test Version A - List B, Word 1. | ADNI AVLT - List B Recall Word 1 | ||
AVL01-List B Recall Word 10 | C102007 | AVL01-List B Recall Word 10 | Auditory Verbal Learning Test Version A - List B, Word 10. | ADNI AVLT - List B Recall Word 10 | ||
AVL01-List B Recall Word 11 | C102008 | AVL01-List B Recall Word 11 | Auditory Verbal Learning Test Version A - List B, Word 11. | ADNI AVLT - List B Recall Word 11 | ||
AVL01-List B Recall Word 12 | C102009 | AVL01-List B Recall Word 12 | Auditory Verbal Learning Test Version A - List B, Word 12. | ADNI AVLT - List B Recall Word 12 | ||
AVL01-List B Recall Word 13 | C102010 | AVL01-List B Recall Word 13 | Auditory Verbal Learning Test Version A - List B, Word 13. | ADNI AVLT - List B Recall Word 13 | ||
AVL01-List B Recall Word 14 | C102011 | AVL01-List B Recall Word 14 | Auditory Verbal Learning Test Version A - List B, Word 14. | ADNI AVLT - List B Recall Word 14 | ||
AVL01-List B Recall Word 15 | C102012 | AVL01-List B Recall Word 15 | Auditory Verbal Learning Test Version A - List B, Word 15. | ADNI AVLT - List B Recall Word 15 | ||
AVL01-List B Recall Word 2 | C101999 | AVL01-List B Recall Word 2 | Auditory Verbal Learning Test Version A - List B, Word 2. | ADNI AVLT - List B Recall Word 2 | ||
AVL01-List B Recall Word 3 | C102000 | AVL01-List B Recall Word 3 | Auditory Verbal Learning Test Version A - List B, Word 3. | ADNI AVLT - List B Recall Word 3 | ||
AVL01-List B Recall Word 4 | C102001 | AVL01-List B Recall Word 4 | Auditory Verbal Learning Test Version A - List B, Word 4. | ADNI AVLT - List B Recall Word 4 | ||
AVL01-List B Recall Word 5 | C102002 | AVL01-List B Recall Word 5 | Auditory Verbal Learning Test Version A - List B, Word 5. | ADNI AVLT - List B Recall Word 5 | ||
AVL01-List B Recall Word 6 | C102003 | AVL01-List B Recall Word 6 | Auditory Verbal Learning Test Version A - List B, Word 6. | ADNI AVLT - List B Recall Word 6 | ||
AVL01-List B Recall Word 7 | C102004 | AVL01-List B Recall Word 7 | Auditory Verbal Learning Test Version A - List B, Word 7. | ADNI AVLT - List B Recall Word 7 | ||
AVL01-List B Recall Word 8 | C102005 | AVL01-List B Recall Word 8 | Auditory Verbal Learning Test Version A - List B, Word 8. | ADNI AVLT - List B Recall Word 8 | ||
AVL01-List B Recall Word 9 | C102006 | AVL01-List B Recall Word 9 | Auditory Verbal Learning Test Version A - List B, Word 9. | ADNI AVLT - List B Recall Word 9 | ||
Back to top | ||||||
CL.C66781.AGEU | Age Unit
(AGEU) | text
Extensible: No | C66781 | Age Unit | Those units of time that are routinely used to express the age of a subject. | CDISC SDTM Age Unit Terminology |
DAYS | C25301 | A unit of measurement of time equal to 24 hours. | Day | |||
HOURS | C25529 | h;Hours;hr | A unit of measurement of time equal to 60 minutes. | Hour | ||
MONTHS | C29846 | Month | One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI) | Month | ||
WEEKS | C29844 | Week | Any period of seven consecutive days. (NCI) | Week | ||
YEARS | C29848 | Year | The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI) | Year | ||
Back to top | ||||||
CL.C112435.AQ01TC | Airway Questionnaire 20 Questionnaire Test Code
(AQ01TC) | text
Extensible: No | C112435 | Airway Questionnaire 20 Questionnaire Test Code | Airway Questionnaire 20 test code. | CDISC Questionnaire AQ20 Test Code Terminology |
AQ0101 | C112529 | AQ01-Cough Often During Day | Airway Questionnaire 20 - Do you cough often during the day? | AQ20 - Cough Often During the Day | ||
AQ0102 | C112530 | AQ01-Feel Restless Due to Chest Trouble | Airway Questionnaire 20 - Does your chest trouble often make you feel restless? | AQ20 - Chest Trouble Make You Feel Restless | ||
AQ0103 | C112531 | AQ01-Gardening Make You Breathless | Airway Questionnaire 20 - Does gardening make you breathless? | AQ20 - Gardening Make You Breathless | ||
AQ0104 | C112532 | AQ01-Chest Upset at Friend House | Airway Questionnaire 20 - Do you worry when going to a friend's house that there might be something there that will upset your chest? | AQ20 - Worry When Going to Friend House Something Will Upset Your Chest | ||
AQ0105 | C112533 | AQ01-Chest Prob Smell/Fume/Smoke/Perfume | Airway Questionnaire 20 - Do you get chest problems when you come into contact with strong smells, exhaust fumes, cigarette smoke, perfume etc? | AQ20 - Get Chest Problems When Contact With Strong Smells | ||
AQ0106 | C112534 | AQ01-Partner Upset by Your Chest Trouble | Airway Questionnaire 20 - Does your partner find your chest trouble upsetting? | AQ20 - Partner Find Your Chest Trouble Upsetting | ||
AQ0107 | C112535 | AQ01-Breathless When Trying to Sleep | Airway Questionnaire 20 - Do you feel breathless when trying to sleep? | AQ20 - Feel Breathless When Trying to Sleep | ||
AQ0108 | C112536 | AQ01-Long Term Effects of Drugs | Airway Questionnaire 20 - Do you worry about the long term effects of the drugs you take for your chest trouble? | AQ20 - Worry About Long Term Effects of Drugs for Chest Trouble | ||
AQ0109 | C112537 | AQ01-Emotional Upset Worse Chest Trouble | Airway Questionnaire 20 - Does getting emotionally upset make your chest trouble worse? | AQ20 - Getting Emotionally Upset Make Chest Trouble Worse | ||
AQ0110 | C112538 | AQ01-Difficulty Getting Around the House | Airway Questionnaire 20 - Are there times when you have difficulty getting around the house because of your chest trouble? | AQ20 - Difficulty Getting Around the House Because of Chest Trouble | ||
AQ0111 | C112539 | AQ01-Breathless Carry out Work Activity | Airway Questionnaire 20 - Does your chest problem make you breathless when you do things at work? (paid employment). | AQ20 - Chest Problem Make You Breathless at Work | ||
AQ0112 | C112540 | AQ01-Breathless Walking Upstairs | Airway Questionnaire 20 - Does walking upstairs make you breathless? | AQ20 - Walking Upstairs Make You Breathless | ||
AQ0113 | C112541 | AQ01-Get Breathless Doing Housework | Airway Questionnaire 20 - Do you get breathless doing housework? | AQ20 - Get Breathless Doing Housework | ||
AQ0114 | C112542 | AQ01-Go Home Sooner Than Others | Airway Questionnaire 20 - Does your chest trouble make you go home sooner than others after a night out? | AQ20 - Chest Trouble Make You Go Home Sooner Than Others | ||
AQ0115 | C112543 | AQ01-Breathlessness When Laugh | Airway Questionnaire 20 - Do you suffer from breathlessness when you laugh? | AQ20 - Suffer From Breathlessness When Laugh | ||
AQ0116 | C112544 | AQ01-Impatient Due to Chest Trouble | Airway Questionnaire 20 - Does your chest trouble often make you feel impatient? | AQ20 - Chest Trouble Make You Feel Impatient | ||
AQ0117 | C112545 | AQ01-Full Life Limited by Chest Trouble | Airway Questionnaire 20 - Do you think the fullness of your life is limited by your chest trouble? | AQ20 - Fullness of Life is Limited by Chest Trouble | ||
AQ0118 | C112546 | AQ01-Drained After a Cold | Airway Questionnaire 20 - Do you feel drained after a cold because of your chest trouble? | AQ20 - Feel Drained After a Cold Because of Chest Trouble | ||
AQ0119 | C112547 | AQ01-Feeling of Chest Heaviness | Airway Questionnaire 20 - Do you have a feeling of chest heaviness? | AQ20 - Feeling of Chest Heaviness | ||
AQ0120 | C112548 | AQ01-Worry About Chest Trouble | Airway Questionnaire 20 - Do you worry a lot about your chest trouble? | AQ20 - Worry a Lot About Chest Trouble | ||
Back to top | ||||||
CL.C112434.AQ01TN | Airway Questionnaire 20 Questionnaire Test Name
(AQ01TN) | text
Extensible: No | C112434 | Airway Questionnaire 20 Questionnaire Test Name | Airway Questionnaire 20 test name. | CDISC Questionnaire AQ20 Test Name Terminology |
AQ01-Breathless Carry out Work Activity | C112539 | AQ01-Breathless Carry out Work Activity | Airway Questionnaire 20 - Does your chest problem make you breathless when you do things at work? (paid employment). | AQ20 - Chest Problem Make You Breathless at Work | ||
AQ01-Breathless Walking Upstairs | C112540 | AQ01-Breathless Walking Upstairs | Airway Questionnaire 20 - Does walking upstairs make you breathless? | AQ20 - Walking Upstairs Make You Breathless | ||
AQ01-Breathless When Trying to Sleep | C112535 | AQ01-Breathless When Trying to Sleep | Airway Questionnaire 20 - Do you feel breathless when trying to sleep? | AQ20 - Feel Breathless When Trying to Sleep | ||
AQ01-Breathlessness When Laugh | C112543 | AQ01-Breathlessness When Laugh | Airway Questionnaire 20 - Do you suffer from breathlessness when you laugh? | AQ20 - Suffer From Breathlessness When Laugh | ||
AQ01-Chest Prob Smell/Fume/Smoke/Perfume | C112533 | AQ01-Chest Prob Smell/Fume/Smoke/Perfume | Airway Questionnaire 20 - Do you get chest problems when you come into contact with strong smells, exhaust fumes, cigarette smoke, perfume etc? | AQ20 - Get Chest Problems When Contact With Strong Smells | ||
AQ01-Chest Upset at Friend House | C112532 | AQ01-Chest Upset at Friend House | Airway Questionnaire 20 - Do you worry when going to a friend's house that there might be something there that will upset your chest? | AQ20 - Worry When Going to Friend House Something Will Upset Your Chest | ||
AQ01-Cough Often During Day | C112529 | AQ01-Cough Often During Day | Airway Questionnaire 20 - Do you cough often during the day? | AQ20 - Cough Often During the Day | ||
AQ01-Difficulty Getting Around the House | C112538 | AQ01-Difficulty Getting Around the House | Airway Questionnaire 20 - Are there times when you have difficulty getting around the house because of your chest trouble? | AQ20 - Difficulty Getting Around the House Because of Chest Trouble | ||
AQ01-Drained After a Cold | C112546 | AQ01-Drained After a Cold | Airway Questionnaire 20 - Do you feel drained after a cold because of your chest trouble? | AQ20 - Feel Drained After a Cold Because of Chest Trouble | ||
AQ01-Emotional Upset Worse Chest Trouble | C112537 | AQ01-Emotional Upset Worse Chest Trouble | Airway Questionnaire 20 - Does getting emotionally upset make your chest trouble worse? | AQ20 - Getting Emotionally Upset Make Chest Trouble Worse | ||
AQ01-Feel Restless Due to Chest Trouble | C112530 | AQ01-Feel Restless Due to Chest Trouble | Airway Questionnaire 20 - Does your chest trouble often make you feel restless? | AQ20 - Chest Trouble Make You Feel Restless | ||
AQ01-Feeling of Chest Heaviness | C112547 | AQ01-Feeling of Chest Heaviness | Airway Questionnaire 20 - Do you have a feeling of chest heaviness? | AQ20 - Feeling of Chest Heaviness | ||
AQ01-Full Life Limited by Chest Trouble | C112545 | AQ01-Full Life Limited by Chest Trouble | Airway Questionnaire 20 - Do you think the fullness of your life is limited by your chest trouble? | AQ20 - Fullness of Life is Limited by Chest Trouble | ||
AQ01-Gardening Make You Breathless | C112531 | AQ01-Gardening Make You Breathless | Airway Questionnaire 20 - Does gardening make you breathless? | AQ20 - Gardening Make You Breathless | ||
AQ01-Get Breathless Doing Housework | C112541 | AQ01-Get Breathless Doing Housework | Airway Questionnaire 20 - Do you get breathless doing housework? | AQ20 - Get Breathless Doing Housework | ||
AQ01-Go Home Sooner Than Others | C112542 | AQ01-Go Home Sooner Than Others | Airway Questionnaire 20 - Does your chest trouble make you go home sooner than others after a night out? | AQ20 - Chest Trouble Make You Go Home Sooner Than Others | ||
AQ01-Impatient Due to Chest Trouble | C112544 | AQ01-Impatient Due to Chest Trouble | Airway Questionnaire 20 - Does your chest trouble often make you feel impatient? | AQ20 - Chest Trouble Make You Feel Impatient | ||
AQ01-Long Term Effects of Drugs | C112536 | AQ01-Long Term Effects of Drugs | Airway Questionnaire 20 - Do you worry about the long term effects of the drugs you take for your chest trouble? | AQ20 - Worry About Long Term Effects of Drugs for Chest Trouble | ||
AQ01-Partner Upset by Your Chest Trouble | C112534 | AQ01-Partner Upset by Your Chest Trouble | Airway Questionnaire 20 - Does your partner find your chest trouble upsetting? | AQ20 - Partner Find Your Chest Trouble Upsetting | ||
AQ01-Worry About Chest Trouble | C112548 | AQ01-Worry About Chest Trouble | Airway Questionnaire 20 - Do you worry a lot about your chest trouble? | AQ20 - Worry a Lot About Chest Trouble | ||
Back to top | ||||||
CL.C141655.AJCC1TC | AJCC TNM Staging System 7th Edition Clinical Classification Test Code
(AJCC1TC) | text
Extensible: No | C141655 | AJCC TNM Staging System 7th Edition Clinical Classification Test Code | AJCC TNM Staging System 7th Edition test code. | CDISC Clinical Classification AJCC v7 Test Code Terminology |
AJCC101 | C141696 | AJCC1-Primary Tumor (T) | AJCC TNM Staging System 7th Edition - Primary tumor (T). | AJCC v7 - Primary Tumor (T) | ||
AJCC102 | C141697 | AJCC1-Regional Lymph Nodes (N) | AJCC TNM Staging System 7th Edition - Regional lymph nodes (N). | AJCC v7 - Regional Lymph Nodes (N) | ||
AJCC103 | C141698 | AJCC1-Distant Metastasis (M) | AJCC TNM Staging System 7th Edition - Distant metastasis (M). | AJCC v7 - Distant Metastasis (M) | ||
AJCC104 | C141699 | AJCC1-Anatomic Stage | AJCC TNM Staging System 7th Edition - Anatomic stage. | AJCC v7 - Anatomic Stage | ||
AJCC105 | C176205 | AJCC1-Residual Tumor (R) | AJCC TNM Staging System 7th Edition - Residual tumor (R). | AJCC v7 - Residual Tumor (R) | ||
Back to top | ||||||
CL.C141654.AJCC1TN | AJCC TNM Staging System 7th Edition Clinical Classification Test Name
(AJCC1TN) | text
Extensible: No | C141654 | AJCC TNM Staging System 7th Edition Clinical Classification Test Name | AJCC TNM Staging System 7th Edition test name. | CDISC Clinical Classification AJCC v7 Test Name Terminology |
AJCC1-Anatomic Stage | C141699 | AJCC1-Anatomic Stage | AJCC TNM Staging System 7th Edition - Anatomic stage. | AJCC v7 - Anatomic Stage | ||
AJCC1-Distant Metastasis (M) | C141698 | AJCC1-Distant Metastasis (M) | AJCC TNM Staging System 7th Edition - Distant metastasis (M). | AJCC v7 - Distant Metastasis (M) | ||
AJCC1-Primary Tumor (T) | C141696 | AJCC1-Primary Tumor (T) | AJCC TNM Staging System 7th Edition - Primary tumor (T). | AJCC v7 - Primary Tumor (T) | ||
AJCC1-Regional Lymph Nodes (N) | C141697 | AJCC1-Regional Lymph Nodes (N) | AJCC TNM Staging System 7th Edition - Regional lymph nodes (N). | AJCC v7 - Regional Lymph Nodes (N) | ||
AJCC1-Residual Tumor (R) | C176205 | AJCC1-Residual Tumor (R) | AJCC TNM Staging System 7th Edition - Residual tumor (R). | AJCC v7 - Residual Tumor (R) | ||
Back to top | ||||||
CL.C135012.AJCCGRD | AJCC Tumor Grade Response
(AJCCGRD) | text
Extensible: No | C135012 | AJCC Tumor Grade Response | Terminology relevant to the American Joint Committee on Cancer (AJCC) tumor grading system responses. | CDISC SDTM AJCC Tumor Grade Response Terminology |
GRADE 1 | C28077 | G1 | A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that a cancerous lesion is well differentiated. | Grade 1 | ||
GRADE 2 | C28078 | G2 | A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that a cancerous lesion is moderately differentiated. | Grade 2 | ||
GRADE 3 | C28079 | G3 | A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that a cancerous lesion is poorly differentiated. | Grade 3 | ||
GRADE 4 | C28082 | G4 | A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that a cancerous lesion is undifferentiated. | Grade 4 | ||
GRADE X | C113730 | GX | A morphologic qualifier by the American Joint Cancer Committee (AJCC) indicating that the grade of a cancerous lesion cannot be assessed. | Grade X | ||
Back to top | ||||||
CL.C119062.ADTC01TC | Alcohol Use Disorder Identification Test-Consumption Questions Questionnaire Test Code
(ADTC01TC) | text
Extensible: No | C119062 | Alcohol Use Disorder Identification Test-Consumption Questions Questionnaire Test Code | Alcohol Use Disorder Identification Test-Consumption Questions test code. | CDISC Questionnaire AUDIT-C Test Code Terminology |
ADTC0101 | C119119 | ADTC01-How Often Drink Alcohol | Alcohol Use Disorder Identification Test-Consumption questions - How often do you have a drink containing alcohol? | AUDIT-C - How Often Have Alcohol Drink | ||
ADTC0102 | C119120 | ADTC01-Alcohol Drinks on a Typical Day | Alcohol Use Disorder Identification Test-Consumption questions - How many standard drinks containing alcohol do you have on a typical day? | AUDIT-C - How Many Alcohol Drinks on a Typical Day | ||
ADTC0103 | C119121 | ADTC01-Six or More Drinks One Occasion | Alcohol Use Disorder Identification Test-Consumption questions - How often do you have six or more drinks on one occasion? | AUDIT-C - How Often Have Six or More Drinks | ||
Back to top | ||||||
CL.C119061.ADTC01TN | Alcohol Use Disorder Identification Test-Consumption Questions Questionnaire Test Name
(ADTC01TN) | text
Extensible: No | C119061 | Alcohol Use Disorder Identification Test-Consumption Questions Questionnaire Test Name | Alcohol Use Disorder Identification Test-Consumption Questions test name. | CDISC Questionnaire AUDIT-C Test Name Terminology |
ADTC01-Alcohol Drinks on a Typical Day | C119120 | ADTC01-Alcohol Drinks on a Typical Day | Alcohol Use Disorder Identification Test-Consumption questions - How many standard drinks containing alcohol do you have on a typical day? | AUDIT-C - How Many Alcohol Drinks on a Typical Day | ||
ADTC01-How Often Drink Alcohol | C119119 | ADTC01-How Often Drink Alcohol | Alcohol Use Disorder Identification Test-Consumption questions - How often do you have a drink containing alcohol? | AUDIT-C - How Often Have Alcohol Drink | ||
ADTC01-Six or More Drinks One Occasion | C119121 | ADTC01-Six or More Drinks One Occasion | Alcohol Use Disorder Identification Test-Consumption questions - How often do you have six or more drinks on one occasion? | AUDIT-C - How Often Have Six or More Drinks | ||
Back to top | ||||||
CL.C119060.ADT01TC | Alcohol Use Disorder Identification Test: Self-Report Version Questionnaire Test Code
(ADT01TC) | text
Extensible: No | C119060 | Alcohol Use Disorder Identification Test: Self-Report Version Questionnaire Test Code | Alcohol Use Disorder Identification Test: Self-Report Version test code. | CDISC Questionnaire AUDIT-SR Test Code Terminology |
ADT0101 | C119108 | ADT01-How Often Drink Alcohol | Alcohol Use Disorder Identification Test: Self-Report Version - How often do you have a drink containing alcohol? | AUDIT - How Often Have Alcohol Drink | ||
ADT0102 | C119109 | ADT01-Alcohol Drinks on a Typical Day | Alcohol Use Disorder Identification Test: Self-Report Version - How many drinks containing alcohol do you have on a typical day when you are drinking? | AUDIT - How Many Alcohol Drinks on a Typical Day | ||
ADT0103 | C119110 | ADT01-Six or More Drinks One Occasion | Alcohol Use Disorder Identification Test: Self-Report Version - How often do you have six or more drinks on one occasion? | AUDIT - How Often Have Six or More Drinks | ||
ADT0104 | C119111 | ADT01-Not Able Stop Drinking Once Start | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you found that you were not able to stop drinking once you had started? | AUDIT - How Often Last Year You Found Not Able to Stop Drinking | ||
ADT0105 | C119112 | ADT01-Failed to Do as Expected | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you failed to do what was normally expected of you because of drinking? | AUDIT - How Often Last Year You Failed to Do Normally Expected of You | ||
ADT0106 | C119113 | ADT01-Need Drink Morning After Drinking | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you needed a first drink in the morning to get yourself going after a heavy drinking session? | AUDIT - How Often Last Year Need a Drink in the Morning to Get Going | ||
ADT0107 | C119114 | ADT01-Feeling of Guilt or Remorse | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you had a feeling of guilt or remorse after drinking? | AUDIT - How Often Last Year You Feel Guilt or Remorse After Drinking | ||
ADT0108 | C119115 | ADT01-Unable to Remember What Happened | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you been unable to remember what happened the night before because of your drinking? | AUDIT - How Often Last Year You Unable to Remember What Happened the Night Before | ||
ADT0109 | C119116 | ADT01-Injured Because of Your Drinking | Alcohol Use Disorder Identification Test: Self-Report Version - Have you or someone else been injured because of your drinking? | AUDIT - Injured Because of Drinking | ||
ADT0110 | C119117 | ADT01-Suggested to Cut Down | Alcohol Use Disorder Identification Test: Self-Report Version - Has a relative, friend, doctor, or other health care worker been concerned about your drinking or suggested you cut down? | AUDIT - Concerned About Your Drinking | ||
ADT0111 | C119118 | ADT01-Total | Alcohol Use Disorder Identification Test: Self-Report Version - Total. | AUDIT - Total | ||
Back to top | ||||||
CL.C119059.ADT01TN | Alcohol Use Disorder Identification Test: Self-Report Version Questionnaire Test Name
(ADT01TN) | text
Extensible: No | C119059 | Alcohol Use Disorder Identification Test: Self-Report Version Questionnaire Test Name | Alcohol Use Disorder Identification Test: Self-Report Version test name. | CDISC Questionnaire AUDIT-SR Test Name Terminology |
ADT01-Alcohol Drinks on a Typical Day | C119109 | ADT01-Alcohol Drinks on a Typical Day | Alcohol Use Disorder Identification Test: Self-Report Version - How many drinks containing alcohol do you have on a typical day when you are drinking? | AUDIT - How Many Alcohol Drinks on a Typical Day | ||
ADT01-Failed to Do as Expected | C119112 | ADT01-Failed to Do as Expected | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you failed to do what was normally expected of you because of drinking? | AUDIT - How Often Last Year You Failed to Do Normally Expected of You | ||
ADT01-Feeling of Guilt or Remorse | C119114 | ADT01-Feeling of Guilt or Remorse | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you had a feeling of guilt or remorse after drinking? | AUDIT - How Often Last Year You Feel Guilt or Remorse After Drinking | ||
ADT01-How Often Drink Alcohol | C119108 | ADT01-How Often Drink Alcohol | Alcohol Use Disorder Identification Test: Self-Report Version - How often do you have a drink containing alcohol? | AUDIT - How Often Have Alcohol Drink | ||
ADT01-Injured Because of Your Drinking | C119116 | ADT01-Injured Because of Your Drinking | Alcohol Use Disorder Identification Test: Self-Report Version - Have you or someone else been injured because of your drinking? | AUDIT - Injured Because of Drinking | ||
ADT01-Need Drink Morning After Drinking | C119113 | ADT01-Need Drink Morning After Drinking | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you needed a first drink in the morning to get yourself going after a heavy drinking session? | AUDIT - How Often Last Year Need a Drink in the Morning to Get Going | ||
ADT01-Not Able Stop Drinking Once Start | C119111 | ADT01-Not Able Stop Drinking Once Start | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you found that you were not able to stop drinking once you had started? | AUDIT - How Often Last Year You Found Not Able to Stop Drinking | ||
ADT01-Six or More Drinks One Occasion | C119110 | ADT01-Six or More Drinks One Occasion | Alcohol Use Disorder Identification Test: Self-Report Version - How often do you have six or more drinks on one occasion? | AUDIT - How Often Have Six or More Drinks | ||
ADT01-Suggested to Cut Down | C119117 | ADT01-Suggested to Cut Down | Alcohol Use Disorder Identification Test: Self-Report Version - Has a relative, friend, doctor, or other health care worker been concerned about your drinking or suggested you cut down? | AUDIT - Concerned About Your Drinking | ||
ADT01-Total | C119118 | ADT01-Total | Alcohol Use Disorder Identification Test: Self-Report Version - Total. | AUDIT - Total | ||
ADT01-Unable to Remember What Happened | C119115 | ADT01-Unable to Remember What Happened | Alcohol Use Disorder Identification Test: Self-Report Version - How often during the last year have you been unable to remember what happened the night before because of your drinking? | AUDIT - How Often Last Year You Unable to Remember What Happened the Night Before | ||
Back to top | ||||||
CL.C161623.AVPU01TC | Alert Verbal Painful Unresponsive Scale Clinical Classification Test Code
(AVPU01TC) | text
Extensible: No | C161623 | Alert Verbal Painful Unresponsive Scale Clinical Classification Test Code | Alert Verbal Painful Unresponsive Scale test code. | CDISC Clinical Classification AVPU Test Code Terminology |
AVPU0101 | C161740 | AVPU01-Responsiveness | Alert Verbal Painful Unresponsive Scale - Responsivenesss. | AVPU - Responsiveness | ||
Back to top | ||||||
CL.C161622.AVPU01TN | Alert Verbal Painful Unresponsive Scale Clinical Classification Test Name
(AVPU01TN) | text
Extensible: No | C161622 | Alert Verbal Painful Unresponsive Scale Clinical Classification Test Name | Alert Verbal Painful Unresponsive Scale test name. | CDISC Clinical Classification AVPU Test Name Terminology |
AVPU01-Responsiveness | C161740 | AVPU01-Responsiveness | Alert Verbal Painful Unresponsive Scale - Responsivenesss. | AVPU - Responsiveness | ||
Back to top | ||||||
CL.C100132.ADCTC | Alzheimer's Disease Assessment Scale - Cognitive CDISC Version Questionnaire Test Code
(ADCTC) | text
Extensible: No | C100132 | Alzheimer's Disease Assessment Scale - Cognitive CDISC Version Questionnaire Test Code | ADAS-Cog CDISC Version test code. | CDISC Questionnaire ADAS-Cog CDISC Version Test Code Terminology |
ADCCMD | C100209 | Commands | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for commands. | CDISC ADAS-Cog - Commands Summary Score | ||
ADCCMD01 | C100210 | Commands: Fist | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for making a fist. | CDISC ADAS-Cog - Commands: Fist | ||
ADCCMD02 | C100211 | Commands: Ceiling | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for pointing to the ceiling then to the floor. | CDISC ADAS-Cog - Commands: Ceiling | ||
ADCCMD03 | C100212 | Commands: Pencil | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for put the pencil on top of the card and then put it back. | CDISC ADAS-Cog - Commands: Pencil | ||
ADCCMD04 | C100213 | Commands: Watch | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for put the watch on the other side of the pencil and then turn over the card. | CDISC ADAS-Cog - Commands: Watch | ||
ADCCMD05 | C100214 | Commands: Shoulder | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for tap each shoulder twice with two fingers keeping your eyes shut. | CDISC ADAS-Cog - Commands: Shoulder | ||
ADCCMP | C100278 | Comprehension | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ability to comprehend speech. | CDISC ADAS-Cog - Comprehension | ||
ADCCON | C100279 | Concentration/Distractibility | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ability to concentrate or easily be distracted. | CDISC ADAS-Cog - Concentration/Distractibility | ||
ADCCP | C100226 | Constructional Praxis | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for constructional praxis. | CDISC ADAS-Cog - Constructional Praxis Summary Score | ||
ADCCP01 | C100227 | Constructional Praxis: Circle | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a circle. | CDISC ADAS-Cog - Constructional Praxis: Circle | ||
ADCCP02 | C100228 | Constructional Praxis: 2 Rectangles | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying two overlapping rectangles. | CDISC ADAS-Cog - Constructional Praxis: 2 Rectangles | ||
ADCCP03 | C100229 | Constructional Praxis: Diamond | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a diamond. | CDISC ADAS-Cog - Constructional Praxis: Diamond | ||
ADCCP04 | C100230 | Constructional Praxis: Cube | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a cube. | CDISC ADAS-Cog - Constructional Praxis: Cube | ||
ADCCPS | C100231 | Attempt to Draw | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis attempted to draw, but drew no forms correctly. | CDISC ADAS-Cog - Attempt to Draw | ||
ADCDIF | C100277 | Word Finding Difficulty in Spont Speech | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Difficulty finding the desired word in spontaneous speech. | CDISC ADAS-Cog - Word Difficulty in Spontaneous Speech | ||
ADCDRL | C100215 | Delayed Word Recall | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for delayed word recall. | CDISC ADAS-Cog - Delayed Word Recall Summary Score | ||
ADCDRL01 | C100216 | Delayed Word Recall: Word [1] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 1. | CDISC ADAS-Cog - Delayed Word Recall: Word 1 | ||
ADCDRL02 | C100217 | Delayed Word Recall: Word [2] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 2. | CDISC ADAS-Cog - Delayed Word Recall: Word 2 | ||
ADCDRL03 | C100218 | Delayed Word Recall: Word [3] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 3. | CDISC ADAS-Cog - Delayed Word Recall: Word 3 | ||
ADCDRL04 | C100219 | Delayed Word Recall: Word [4] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 4. | CDISC ADAS-Cog - Delayed Word Recall: Word 4 | ||
ADCDRL05 | C100220 | Delayed Word Recall: Word [5] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 5. | CDISC ADAS-Cog - Delayed Word Recall: Word 5 | ||
ADCDRL06 | C100221 | Delayed Word Recall: Word [6] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 6. | CDISC ADAS-Cog - Delayed Word Recall: Word 6 | ||
ADCDRL07 | C100222 | Delayed Word Recall: Word [7] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 7. | CDISC ADAS-Cog - Delayed Word Recall: Word 7 | ||
ADCDRL08 | C100223 | Delayed Word Recall: Word [8] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 8. | CDISC ADAS-Cog - Delayed Word Recall: Word 8 | ||
ADCDRL09 | C100224 | Delayed Word Recall: Word [9] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 9. | CDISC ADAS-Cog - Delayed Word Recall: Word 9 | ||
ADCDRL10 | C100225 | Delayed Word Recall: Word [10] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 10. | CDISC ADAS-Cog - Delayed Word Recall: Word 10 | ||
ADCIP | C100232 | Ideational Praxis | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for ideational praxis. | CDISC ADAS-Cog - Ideational Praxis Summary Score | ||
ADCIP01 | C100233 | Ideational Praxis: Fold | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for folding the paper. | CDISC ADAS-Cog - Ideational Praxis: Fold | ||
ADCIP02 | C100234 | Ideational Praxis: Insert | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for put the paper in the envelop. | CDISC ADAS-Cog - Ideational Praxis: Insert | ||
ADCIP03 | C100235 | Ideational Praxis: Seal | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for seal the envelop. | CDISC ADAS-Cog - Ideational Praxis: Seal | ||
ADCIP04 | C100236 | Ideational Praxis: Address | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for address the envelop to yourself. | CDISC ADAS-Cog - Ideational Praxis: Address | ||
ADCIP05 | C100237 | Ideational Praxis: Stamp | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for showing where the stamp goes. | CDISC ADAS-Cog - Ideational Praxis: Stamp | ||
ADCMZ | C100284 | Executive Function Maze | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for the executive function maze tasks. | CDISC ADAS-Cog - Executive Function Maze Summary Score | ||
ADCMZ01 | C100285 | Executive Function Maze: Errors | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of errors during the executive function maze task. | CDISC ADAS-Cog - Executive Function Maze: Errors | ||
ADCMZ02 | C100286 | Executive Function Maze: Time | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - The time in seconds stored in ISO 8601 time for the executive function maze task. | CDISC ADAS-Cog - Executive Function Maze: Time | ||
ADCNC | C100280 | Number Cancellation | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for the number cancellation tasks. | CDISC ADAS-Cog - Number Cancellation Summary Score | ||
ADCNC01 | C100281 | Number Cancellation: Correct | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of targets hit during the number cancellation task. | CDISC ADAS-Cog - Number Cancellation: Correct | ||
ADCNC02 | C100282 | Number Cancellation: Errors | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of errors during the number cancellation task. | CDISC ADAS-Cog - Number Cancellation: Errors | ||
ADCNC03 | C100283 | Number Cancellation: Remind | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of times reminded for the number cancellation task. | CDISC ADAS-Cog - Number Cancellation: Remind | ||
ADCOF | C100191 | Naming Objects and Fingers | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task summary score for object and fingers. | CDISC ADAS-Cog - Naming Objects and Fingers Summary Score | ||
ADCOFF01 | C100204 | Naming Objects and Fingers: Thumb | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, thumb. | CDISC ADAS-Cog - Naming Objects and Fingers: Thumb | ||
ADCOFF02 | C100205 | Naming Objects and Fingers: Pointer | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, index, or pointer finger. | CDISC ADAS-Cog - Naming Objects and Fingers: Pointer | ||
ADCOFF03 | C100206 | Naming Objects and Fingers: Middle | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, middle finger. | CDISC ADAS-Cog - Naming Objects and Fingers: Middle | ||
ADCOFF04 | C100207 | Naming Objects and Fingers: Ring | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, ring finger. | CDISC ADAS-Cog - Naming Objects and Fingers: Ring | ||
ADCOFF05 | C100208 | Naming Objects and Fingers: Pinky | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, little finger or pinky. | CDISC ADAS-Cog - Naming Objects and Fingers: Pinky | ||
ADCOFO01 | C100192 | Naming Objects and Fingers: 1 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 1. | CDISC ADAS-Cog - Naming Objects and Fingers: 1 | ||
ADCOFO02 | C100193 | Naming Objects and Fingers: 2 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 2. | CDISC ADAS-Cog - Naming Objects and Fingers: 2 | ||
ADCOFO03 | C100194 | Naming Objects and Fingers: 3 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 3. | CDISC ADAS-Cog - Naming Objects and Fingers: 3 | ||
ADCOFO04 | C100195 | Naming Objects and Fingers: 4 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 4. | CDISC ADAS-Cog - Naming Objects and Fingers: 4 | ||
ADCOFO05 | C100196 | Naming Objects and Fingers: 5 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 5. | CDISC ADAS-Cog - Naming Objects and Fingers: 5 | ||
ADCOFO06 | C100197 | Naming Objects and Fingers: 6 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 6. | CDISC ADAS-Cog - Naming Objects and Fingers: 6 | ||
ADCOFO07 | C100198 | Naming Objects and Fingers: 7 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 7. | CDISC ADAS-Cog - Naming Objects and Fingers: 7 | ||
ADCOFO08 | C100199 | Naming Objects and Fingers: 8 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 8. | CDISC ADAS-Cog - Naming Objects and Fingers: 8 | ||
ADCOFO09 | C100200 | Naming Objects and Fingers: 9 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 9. | CDISC ADAS-Cog - Naming Objects and Fingers: 9 | ||
ADCOFO10 | C100201 | Naming Objects and Fingers: 10 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 10. | CDISC ADAS-Cog - Naming Objects and Fingers: 10 | ||
ADCOFO11 | C100202 | Naming Objects and Fingers: 11 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 11. | CDISC ADAS-Cog - Naming Objects and Fingers: 11 | ||
ADCOFO12 | C100203 | Naming Objects and Fingers: 12 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 12. | CDISC ADAS-Cog - Naming Objects and Fingers: 12 | ||
ADCOR | C100238 | Orientation | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for orientation. | CDISC ADAS-Cog - Orientation Summary Score | ||
ADCOR01 | C100239 | Orientation: Full Name | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing one's own full name. | CDISC ADAS-Cog - Orientation: Full Name | ||
ADCOR02 | C100240 | Orientation: Month | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current month. | CDISC ADAS-Cog - Orientation: Month | ||
ADCOR03 | C100241 | Orientation: Date | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current day. | CDISC ADAS-Cog - Orientation: Date | ||
ADCOR04 | C100242 | Orientation: Year | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current year. | CDISC ADAS-Cog - Orientation: Year | ||
ADCOR05 | C100243 | Orientation: Day of Week | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current day of the week. | CDISC ADAS-Cog - Orientation: Day of Week | ||
ADCOR06 | C100244 | Orientation: Season | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current season. | CDISC ADAS-Cog - Orientation: Season | ||
ADCOR07 | C100245 | Orientation: Place | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current place. | CDISC ADAS-Cog - Orientation: Place | ||
ADCOR08 | C100246 | Orientation: Time | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the approximate current clock time. | CDISC ADAS-Cog - Orientation: Time | ||
ADCRG | C100247 | Word Recognition | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for word recognition across trials 1-3. | CDISC ADAS-Cog - Word Recognition Summary Score | ||
ADCRGT01 | C100248 | Word Recognition Trial 1 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 1. | CDISC ADAS-Cog - Word Recognition Trial 1 Summary Score | ||
ADCRGT02 | C100249 | Word Recognition Trial 2 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 2. | CDISC ADAS-Cog - Word Recognition Trial 2 Summary Score | ||
ADCRGT03 | C100250 | Word Recognition Trial 3 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 3. | CDISC ADAS-Cog - Word Recognition Trial 3 Summary Score | ||
ADCRGW01 | C100251 | Word Recognition: Word [1] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 1 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 1 | ||
ADCRGW02 | C100252 | Word Recognition: Word [2] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 2 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 2 | ||
ADCRGW03 | C100253 | Word Recognition: Word [3] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 3 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 3 | ||
ADCRGW04 | C100254 | Word Recognition: Word [4] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 4 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 4 | ||
ADCRGW05 | C100255 | Word Recognition: Word [5] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 5 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 5 | ||
ADCRGW06 | C100256 | Word Recognition: Word [6] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 6 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 6 | ||
ADCRGW07 | C100257 | Word Recognition: Word [7] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 7 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 7 | ||
ADCRGW08 | C100258 | Word Recognition: Word [8] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 8 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 8 | ||
ADCRGW09 | C100259 | Word Recognition: Word [9] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 9 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 9 | ||
ADCRGW10 | C100260 | Word Recognition: Word [10] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 10 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 10 | ||
ADCRGW11 | C100261 | Word Recognition: Word [11] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 11 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 11 | ||
ADCRGW12 | C100262 | Word Recognition: Word [12] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 12 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 12 | ||
ADCRGW13 | C100263 | Word Recognition: Word [13] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 13 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 13 | ||
ADCRGW14 | C100264 | Word Recognition: Word [14] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 14 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 14 | ||
ADCRGW15 | C100265 | Word Recognition: Word [15] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 15 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 15 | ||
ADCRGW16 | C100266 | Word Recognition: Word [16] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 16 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 16 | ||
ADCRGW17 | C100267 | Word Recognition: Word [17] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 17 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 17 | ||
ADCRGW18 | C100268 | Word Recognition: Word [18] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 18 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 18 | ||
ADCRGW19 | C100269 | Word Recognition: Word [19] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 19 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 19 | ||
ADCRGW20 | C100270 | Word Recognition: Word [20] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 20 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 20 | ||
ADCRGW21 | C100271 | Word Recognition: Word [21] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 21 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 21 | ||
ADCRGW22 | C100272 | Word Recognition: Word [22] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 22 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 22 | ||
ADCRGW23 | C100273 | Word Recognition: Word [23] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 23 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 23 | ||
ADCRGW24 | C100274 | Word Recognition: Word [24] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 24 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 24 | ||
ADCRI | C100275 | Remembering Test Instructions | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Remembering test instructions. | CDISC ADAS-Cog - Remembering Test Instructions | ||
ADCRL | C100177 | Word Recall | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word average score of trials 1, 2, 3. | CDISC ADAS-Cog - Word Recall Average Score | ||
ADCRLT01 | C100178 | Word Recall Trial 1 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 1. | CDISC ADAS-Cog - Word Recall Trial 1 Subscore | ||
ADCRLT02 | C100179 | Word Recall Trial 2 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 2. | CDISC ADAS-Cog - Word Recall Trial 2 Subscore | ||
ADCRLT03 | C100180 | Word Recall Trial 3 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 3. | CDISC ADAS-Cog - Word Recall Trial 3 Subscore | ||
ADCRLW01 | C100181 | Word Recall: Word [1] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 1 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 1 | ||
ADCRLW02 | C100182 | Word Recall: Word [2] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 2 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 2 | ||
ADCRLW03 | C100183 | Word Recall: Word [3] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 3 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 3 | ||
ADCRLW04 | C100184 | Word Recall: Word [4] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 4 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 4 | ||
ADCRLW05 | C100185 | Word Recall: Word [5] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 5 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 5 | ||
ADCRLW06 | C100186 | Word Recall: Word [6] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 6 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 6 | ||
ADCRLW07 | C100187 | Word Recall: Word [7] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 7 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 7 | ||
ADCRLW08 | C100188 | Word Recall: Word [8] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 8 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 8 | ||
ADCRLW09 | C100189 | Word Recall: Word [9] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 9 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 9 | ||
ADCRLW10 | C100190 | Word Recall: Word [10] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 10 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 10 | ||
ADCSL | C100276 | Spoken Language Ability | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Global rating of the quality of speech, or difficulty in making oneself understood. | CDISC ADAS-Cog - Spoken Language Ability | ||
Back to top | ||||||
CL.C100131.ADCTN | Alzheimer's Disease Assessment Scale - Cognitive CDISC Version Questionnaire Test Name
(ADCTN) | text
Extensible: No | C100131 | Alzheimer's Disease Assessment Scale - Cognitive CDISC Version Questionnaire Test Name | ADAS-Cog CDISC Version test name. | CDISC Questionnaire ADAS-Cog CDISC Version Test Name Terminology |
Attempt to Draw | C100231 | Attempt to Draw | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis attempted to draw, but drew no forms correctly. | CDISC ADAS-Cog - Attempt to Draw | ||
Commands | C100209 | Commands | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for commands. | CDISC ADAS-Cog - Commands Summary Score | ||
Commands: Ceiling | C100211 | Commands: Ceiling | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for pointing to the ceiling then to the floor. | CDISC ADAS-Cog - Commands: Ceiling | ||
Commands: Fist | C100210 | Commands: Fist | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for making a fist. | CDISC ADAS-Cog - Commands: Fist | ||
Commands: Pencil | C100212 | Commands: Pencil | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for put the pencil on top of the card and then put it back. | CDISC ADAS-Cog - Commands: Pencil | ||
Commands: Shoulder | C100214 | Commands: Shoulder | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for tap each shoulder twice with two fingers keeping your eyes shut. | CDISC ADAS-Cog - Commands: Shoulder | ||
Commands: Watch | C100213 | Commands: Watch | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Commands task for put the watch on the other side of the pencil and then turn over the card. | CDISC ADAS-Cog - Commands: Watch | ||
Comprehension | C100278 | Comprehension | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ability to comprehend speech. | CDISC ADAS-Cog - Comprehension | ||
Concentration/Distractibility | C100279 | Concentration/Distractibility | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ability to concentrate or easily be distracted. | CDISC ADAS-Cog - Concentration/Distractibility | ||
Constructional Praxis | C100226 | Constructional Praxis | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for constructional praxis. | CDISC ADAS-Cog - Constructional Praxis Summary Score | ||
Constructional Praxis: 2 Rectangles | C100228 | Constructional Praxis: 2 Rectangles | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying two overlapping rectangles. | CDISC ADAS-Cog - Constructional Praxis: 2 Rectangles | ||
Constructional Praxis: Circle | C100227 | Constructional Praxis: Circle | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a circle. | CDISC ADAS-Cog - Constructional Praxis: Circle | ||
Constructional Praxis: Cube | C100230 | Constructional Praxis: Cube | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a cube. | CDISC ADAS-Cog - Constructional Praxis: Cube | ||
Constructional Praxis: Diamond | C100229 | Constructional Praxis: Diamond | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Constructional praxis task for copying a diamond. | CDISC ADAS-Cog - Constructional Praxis: Diamond | ||
Delayed Word Recall | C100215 | Delayed Word Recall | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for delayed word recall. | CDISC ADAS-Cog - Delayed Word Recall Summary Score | ||
Delayed Word Recall: Word [10] | C100225 | Delayed Word Recall: Word [10] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 10. | CDISC ADAS-Cog - Delayed Word Recall: Word 10 | ||
Delayed Word Recall: Word [1] | C100216 | Delayed Word Recall: Word [1] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 1. | CDISC ADAS-Cog - Delayed Word Recall: Word 1 | ||
Delayed Word Recall: Word [2] | C100217 | Delayed Word Recall: Word [2] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 2. | CDISC ADAS-Cog - Delayed Word Recall: Word 2 | ||
Delayed Word Recall: Word [3] | C100218 | Delayed Word Recall: Word [3] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 3. | CDISC ADAS-Cog - Delayed Word Recall: Word 3 | ||
Delayed Word Recall: Word [4] | C100219 | Delayed Word Recall: Word [4] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 4. | CDISC ADAS-Cog - Delayed Word Recall: Word 4 | ||
Delayed Word Recall: Word [5] | C100220 | Delayed Word Recall: Word [5] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 5. | CDISC ADAS-Cog - Delayed Word Recall: Word 5 | ||
Delayed Word Recall: Word [6] | C100221 | Delayed Word Recall: Word [6] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 6. | CDISC ADAS-Cog - Delayed Word Recall: Word 6 | ||
Delayed Word Recall: Word [7] | C100222 | Delayed Word Recall: Word [7] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 7. | CDISC ADAS-Cog - Delayed Word Recall: Word 7 | ||
Delayed Word Recall: Word [8] | C100223 | Delayed Word Recall: Word [8] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 8. | CDISC ADAS-Cog - Delayed Word Recall: Word 8 | ||
Delayed Word Recall: Word [9] | C100224 | Delayed Word Recall: Word [9] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Delayed word recall task for word 9. | CDISC ADAS-Cog - Delayed Word Recall: Word 9 | ||
Executive Function Maze | C100284 | Executive Function Maze | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for the executive function maze tasks. | CDISC ADAS-Cog - Executive Function Maze Summary Score | ||
Executive Function Maze: Errors | C100285 | Executive Function Maze: Errors | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of errors during the executive function maze task. | CDISC ADAS-Cog - Executive Function Maze: Errors | ||
Executive Function Maze: Time | C100286 | Executive Function Maze: Time | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - The time in seconds stored in ISO 8601 time for the executive function maze task. | CDISC ADAS-Cog - Executive Function Maze: Time | ||
Ideational Praxis | C100232 | Ideational Praxis | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for ideational praxis. | CDISC ADAS-Cog - Ideational Praxis Summary Score | ||
Ideational Praxis: Address | C100236 | Ideational Praxis: Address | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for address the envelop to yourself. | CDISC ADAS-Cog - Ideational Praxis: Address | ||
Ideational Praxis: Fold | C100233 | Ideational Praxis: Fold | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for folding the paper. | CDISC ADAS-Cog - Ideational Praxis: Fold | ||
Ideational Praxis: Insert | C100234 | Ideational Praxis: Insert | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for put the paper in the envelop. | CDISC ADAS-Cog - Ideational Praxis: Insert | ||
Ideational Praxis: Seal | C100235 | Ideational Praxis: Seal | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for seal the envelop. | CDISC ADAS-Cog - Ideational Praxis: Seal | ||
Ideational Praxis: Stamp | C100237 | Ideational Praxis: Stamp | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Ideational praxis task for showing where the stamp goes. | CDISC ADAS-Cog - Ideational Praxis: Stamp | ||
Naming Objects and Fingers | C100191 | Naming Objects and Fingers | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task summary score for object and fingers. | CDISC ADAS-Cog - Naming Objects and Fingers Summary Score | ||
Naming Objects and Fingers: 1 | C100192 | Naming Objects and Fingers: 1 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 1. | CDISC ADAS-Cog - Naming Objects and Fingers: 1 | ||
Naming Objects and Fingers: 10 | C100201 | Naming Objects and Fingers: 10 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 10. | CDISC ADAS-Cog - Naming Objects and Fingers: 10 | ||
Naming Objects and Fingers: 11 | C100202 | Naming Objects and Fingers: 11 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 11. | CDISC ADAS-Cog - Naming Objects and Fingers: 11 | ||
Naming Objects and Fingers: 12 | C100203 | Naming Objects and Fingers: 12 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 12. | CDISC ADAS-Cog - Naming Objects and Fingers: 12 | ||
Naming Objects and Fingers: 2 | C100193 | Naming Objects and Fingers: 2 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 2. | CDISC ADAS-Cog - Naming Objects and Fingers: 2 | ||
Naming Objects and Fingers: 3 | C100194 | Naming Objects and Fingers: 3 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 3. | CDISC ADAS-Cog - Naming Objects and Fingers: 3 | ||
Naming Objects and Fingers: 4 | C100195 | Naming Objects and Fingers: 4 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 4. | CDISC ADAS-Cog - Naming Objects and Fingers: 4 | ||
Naming Objects and Fingers: 5 | C100196 | Naming Objects and Fingers: 5 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 5. | CDISC ADAS-Cog - Naming Objects and Fingers: 5 | ||
Naming Objects and Fingers: 6 | C100197 | Naming Objects and Fingers: 6 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 6. | CDISC ADAS-Cog - Naming Objects and Fingers: 6 | ||
Naming Objects and Fingers: 7 | C100198 | Naming Objects and Fingers: 7 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 7. | CDISC ADAS-Cog - Naming Objects and Fingers: 7 | ||
Naming Objects and Fingers: 8 | C100199 | Naming Objects and Fingers: 8 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 8. | CDISC ADAS-Cog - Naming Objects and Fingers: 8 | ||
Naming Objects and Fingers: 9 | C100200 | Naming Objects and Fingers: 9 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for object 9. | CDISC ADAS-Cog - Naming Objects and Fingers: 9 | ||
Naming Objects and Fingers: Middle | C100206 | Naming Objects and Fingers: Middle | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, middle finger. | CDISC ADAS-Cog - Naming Objects and Fingers: Middle | ||
Naming Objects and Fingers: Pinky | C100208 | Naming Objects and Fingers: Pinky | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, little finger or pinky. | CDISC ADAS-Cog - Naming Objects and Fingers: Pinky | ||
Naming Objects and Fingers: Pointer | C100205 | Naming Objects and Fingers: Pointer | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, index, or pointer finger. | CDISC ADAS-Cog - Naming Objects and Fingers: Pointer | ||
Naming Objects and Fingers: Ring | C100207 | Naming Objects and Fingers: Ring | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, ring finger. | CDISC ADAS-Cog - Naming Objects and Fingers: Ring | ||
Naming Objects and Fingers: Thumb | C100204 | Naming Objects and Fingers: Thumb | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Naming task for fingers of the dominant hand, thumb. | CDISC ADAS-Cog - Naming Objects and Fingers: Thumb | ||
Number Cancellation | C100280 | Number Cancellation | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for the number cancellation tasks. | CDISC ADAS-Cog - Number Cancellation Summary Score | ||
Number Cancellation: Correct | C100281 | Number Cancellation: Correct | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of targets hit during the number cancellation task. | CDISC ADAS-Cog - Number Cancellation: Correct | ||
Number Cancellation: Errors | C100282 | Number Cancellation: Errors | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of errors during the number cancellation task. | CDISC ADAS-Cog - Number Cancellation: Errors | ||
Number Cancellation: Remind | C100283 | Number Cancellation: Remind | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Number of times reminded for the number cancellation task. | CDISC ADAS-Cog - Number Cancellation: Remind | ||
Orientation | C100238 | Orientation | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for orientation. | CDISC ADAS-Cog - Orientation Summary Score | ||
Orientation: Date | C100241 | Orientation: Date | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current day. | CDISC ADAS-Cog - Orientation: Date | ||
Orientation: Day of Week | C100243 | Orientation: Day of Week | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current day of the week. | CDISC ADAS-Cog - Orientation: Day of Week | ||
Orientation: Full Name | C100239 | Orientation: Full Name | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing one's own full name. | CDISC ADAS-Cog - Orientation: Full Name | ||
Orientation: Month | C100240 | Orientation: Month | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current month. | CDISC ADAS-Cog - Orientation: Month | ||
Orientation: Place | C100245 | Orientation: Place | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current place. | CDISC ADAS-Cog - Orientation: Place | ||
Orientation: Season | C100244 | Orientation: Season | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current season. | CDISC ADAS-Cog - Orientation: Season | ||
Orientation: Time | C100246 | Orientation: Time | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the approximate current clock time. | CDISC ADAS-Cog - Orientation: Time | ||
Orientation: Year | C100242 | Orientation: Year | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Orientation task for knowing the current year. | CDISC ADAS-Cog - Orientation: Year | ||
Remembering Test Instructions | C100275 | Remembering Test Instructions | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Remembering test instructions. | CDISC ADAS-Cog - Remembering Test Instructions | ||
Spoken Language Ability | C100276 | Spoken Language Ability | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Global rating of the quality of speech, or difficulty in making oneself understood. | CDISC ADAS-Cog - Spoken Language Ability | ||
Word Finding Difficulty in Spont Speech | C100277 | Word Finding Difficulty in Spont Speech | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Difficulty finding the desired word in spontaneous speech. | CDISC ADAS-Cog - Word Difficulty in Spontaneous Speech | ||
Word Recall Trial 1 | C100178 | Word Recall Trial 1 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 1. | CDISC ADAS-Cog - Word Recall Trial 1 Subscore | ||
Word Recall Trial 2 | C100179 | Word Recall Trial 2 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 2. | CDISC ADAS-Cog - Word Recall Trial 2 Subscore | ||
Word Recall Trial 3 | C100180 | Word Recall Trial 3 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recall task trial 3. | CDISC ADAS-Cog - Word Recall Trial 3 Subscore | ||
Word Recall | C100177 | Word Recall | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word average score of trials 1, 2, 3. | CDISC ADAS-Cog - Word Recall Average Score | ||
Word Recall: Word [10] | C100190 | Word Recall: Word [10] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 10 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 10 | ||
Word Recall: Word [1] | C100181 | Word Recall: Word [1] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 1 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 1 | ||
Word Recall: Word [2] | C100182 | Word Recall: Word [2] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 2 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 2 | ||
Word Recall: Word [3] | C100183 | Word Recall: Word [3] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 3 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 3 | ||
Word Recall: Word [4] | C100184 | Word Recall: Word [4] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 4 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 4 | ||
Word Recall: Word [5] | C100185 | Word Recall: Word [5] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 5 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 5 | ||
Word Recall: Word [6] | C100186 | Word Recall: Word [6] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 6 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 6 | ||
Word Recall: Word [7] | C100187 | Word Recall: Word [7] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 7 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 7 | ||
Word Recall: Word [8] | C100188 | Word Recall: Word [8] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 8 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 8 | ||
Word Recall: Word [9] | C100189 | Word Recall: Word [9] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recall task word 9 for trial 1, 2, 3. | CDISC ADAS-Cog - Word Recall: Word 9 | ||
Word Recognition Trial 1 | C100248 | Word Recognition Trial 1 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 1. | CDISC ADAS-Cog - Word Recognition Trial 1 Summary Score | ||
Word Recognition Trial 2 | C100249 | Word Recognition Trial 2 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 2. | CDISC ADAS-Cog - Word Recognition Trial 2 Summary Score | ||
Word Recognition Trial 3 | C100250 | Word Recognition Trial 3 | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Sub-score for word recognition trial 3. | CDISC ADAS-Cog - Word Recognition Trial 3 Summary Score | ||
Word Recognition | C100247 | Word Recognition | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Summary score for word recognition across trials 1-3. | CDISC ADAS-Cog - Word Recognition Summary Score | ||
Word Recognition: Word [10] | C100260 | Word Recognition: Word [10] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 10 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 10 | ||
Word Recognition: Word [11] | C100261 | Word Recognition: Word [11] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 11 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 11 | ||
Word Recognition: Word [12] | C100262 | Word Recognition: Word [12] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 12 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 12 | ||
Word Recognition: Word [13] | C100263 | Word Recognition: Word [13] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 13 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 13 | ||
Word Recognition: Word [14] | C100264 | Word Recognition: Word [14] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 14 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 14 | ||
Word Recognition: Word [15] | C100265 | Word Recognition: Word [15] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 15 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 15 | ||
Word Recognition: Word [16] | C100266 | Word Recognition: Word [16] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 16 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 16 | ||
Word Recognition: Word [17] | C100267 | Word Recognition: Word [17] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 17 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 17 | ||
Word Recognition: Word [18] | C100268 | Word Recognition: Word [18] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 18 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 18 | ||
Word Recognition: Word [19] | C100269 | Word Recognition: Word [19] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 19 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 19 | ||
Word Recognition: Word [1] | C100251 | Word Recognition: Word [1] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 1 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 1 | ||
Word Recognition: Word [20] | C100270 | Word Recognition: Word [20] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 20 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 20 | ||
Word Recognition: Word [21] | C100271 | Word Recognition: Word [21] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 21 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 21 | ||
Word Recognition: Word [22] | C100272 | Word Recognition: Word [22] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 22 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 22 | ||
Word Recognition: Word [23] | C100273 | Word Recognition: Word [23] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 23 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 23 | ||
Word Recognition: Word [24] | C100274 | Word Recognition: Word [24] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 24 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 24 | ||
Word Recognition: Word [2] | C100252 | Word Recognition: Word [2] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 2 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 2 | ||
Word Recognition: Word [3] | C100253 | Word Recognition: Word [3] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 3 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 3 | ||
Word Recognition: Word [4] | C100254 | Word Recognition: Word [4] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 4 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 4 | ||
Word Recognition: Word [5] | C100255 | Word Recognition: Word [5] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 5 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 5 | ||
Word Recognition: Word [6] | C100256 | Word Recognition: Word [6] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 6 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 6 | ||
Word Recognition: Word [7] | C100257 | Word Recognition: Word [7] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 7 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 7 | ||
Word Recognition: Word [8] | C100258 | Word Recognition: Word [8] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 8 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 8 | ||
Word Recognition: Word [9] | C100259 | Word Recognition: Word [9] | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version - Word recognition task for word 9 Trials 1, 2, 3. | CDISC ADAS-Cog - Word Recognition: Word 9 | ||
Back to top | ||||||
CL.C106651.ADL03TC | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version Questionnaire Test Code
(ADL03TC) | text
Extensible: No | C106651 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version Questionnaire Test Code | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version test code. | CDISC Questionnaire ADCS-ADL MCI Test Code Terminology |
ADL0301 | C106891 | ADL03-Find Personal Belongings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? | ADCS-ADL MCI - Find Personal Belongings | ||
ADL0301A | C106892 | ADL03-Find Belongings Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he /she usually performed. | ADCS-ADL MCI - Description of Usual Performance of Finding Belongings | ||
ADL0302 | C106893 | ADL03-Select First Clothes for the Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} select his/her first set of clothes for the day? | ADCS-ADL MCI - Select First Clothes for the Day | ||
ADL0302A | C106894 | ADL03-Usual Dressing Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her usual performance. | ADCS-ADL MCI - Description of Usual Performance of Selecting First Clothes for the Day | ||
ADL0303 | C106895 | ADL03-Usual Physically Dressing Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Regarding physically getting dressed, which best describes his/her usual performance in the past 4 weeks. | ADCS-ADL MCI - Description of Usual Performance of Physically Getting Dressed | ||
ADL0304 | C106896 | ADL03-Clean Room | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} clean a living-, sitting-, or family room? | ADCS-ADL MCI - Clean Room | ||
ADL0304A | C106897 | ADL03-Clean Room Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. | ADCS-ADL MCI - Description of Usual Performance of Cleaning Room | ||
ADL0305 | C106898 | ADL03-Balance Checkbook | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} balance his/her checkbook or credit card statement? | ADCS-ADL MCI - Balance Checkbook | ||
ADL0305A | C106899 | ADL03-Balance Checkbook Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. | ADCS-ADL MCI - Description of Usual Performance of Balancing Checkbook | ||
ADL0306 | C106900 | ADL03-Write Things Down | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} ever write things down? | ADCS-ADL MCI - Write Things Down | ||
ADL0306A | C106901 | ADL03-Most Complicated Writings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes the most complicated things that he/she wrote. | ADCS-ADL MCI - Description of Usual Performance of Most Complicated Things Written | ||
ADL0307 | C106902 | ADL03-Clean Laundry | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} clean a load of laundry? | ADCS-ADL MCI - Clean Laundry | ||
ADL0307A | C106903 | ADL03-Laundry Cleaning Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. | ADCS-ADL MCI - Description of Usual Performance of Clean Laundry | ||
ADL0308 | C106904 | ADL03-Keep Appointments | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} keep appointments or meetings with other people, such as relatives, a doctor, the hairdresser, etc.? | ADCS-ADL MCI - Keep Appointments | ||
ADL0308A | C106905 | ADL03-Aware of Appointment Ahead of Time | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her awareness of the meeting ahead of time. | ADCS-ADL MCI - Description of Awareness of the Meeting Ahead of Time | ||
ADL0309 | C106906 | ADL03-Use a Telephone | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} use a telephone? | ADCS-ADL MCI - Use a Telephone | ||
ADL0309A | C106907 | ADL03-Highest Telephone Use Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her highest level of performance. | ADCS-ADL MCI - Description of Highest Level of Performance of Telephone Use | ||
ADL0310 | C106908 | ADL03-Make a Meal | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} make him/herself a meal or snack at home? | ADCS-ADL MCI - Make a Meal or Snack | ||
ADL0310A | C106909 | ADL03-Highest Level of Food Preparation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her highest level of food preparation. | ADCS-ADL MCI - Description of Highest Level of Food Preparation | ||
ADL0311 | C106910 | ADL03-Get Around Outside Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? | ADCS-ADL MCI - Travel Outside Home | ||
ADL0311A | C106911 | ADL03-Get Around Optimal Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her optimal performance. | ADCS-ADL MCI - Description of Optimal Performance of Travelling Outside Home | ||
ADL0312 | C106912 | ADL03-Talk About Current Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} talk about current events? | ADCS-ADL MCI - Talk About Current Events | ||
ADL0312A | C106913 | ADL03-Regional, National, International | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, did {S} talk about regional, national or international events? | ADCS-ADL MCI - Talk About Regional, National or International Events | ||
ADL0312B | C106914 | ADL03-Talk About Outside Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about events outside home involving family, friends, or neighbors? | ADCS-ADL MCI - Talk About Outside Home Events | ||
ADL0312C | C106915 | ADL03-Talk About at Home Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about events that occurred at home that he/she took part in or watched? | ADCS-ADL MCI - Talk About at Home Events | ||
ADL0312D | C106916 | ADL03-Talk Without Repeating | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} converse without repeating him/herself, or asking the same questions repeatedly? | ADCS-ADL MCI - Converse Without Repeating | ||
ADL0313 | C106917 | ADL03-Read More Than 5 Minutes | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} read a magazine, newspaper or book for more than 5 minutes at a time? | ADCS-ADL MCI - Read More Than 5 Minutes | ||
ADL0313A | C106918 | ADL03-Select/Ask for Something to Read | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select or ask for something to read? | ADCS-ADL MCI - Select or Ask for Something to Read | ||
ADL0313B | C106919 | ADL03-Talk Within 1 Hour After Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about what he/she read while or shortly after reading (less than 1 hour)? | ADCS-ADL MCI - Talk Within 1 Hour After Reading | ||
ADL0313C | C106920 | ADL03-Talk Within 1 Day After Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about what he/she read 1-24 hours after reading? | ADCS-ADL MCI - Talk Within 24 Hours After Reading | ||
ADL0314 | C106921 | ADL03-Watch Television | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} watch television? | ADCS-ADL MCI - Watch Television | ||
ADL0314A | C106922 | ADL03-Select Television Program | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select or ask for different programs or his/her favorite show? | ADCS-ADL MCI - Select or Ask for Programs or Show | ||
ADL0314B | C106923 | ADL03-Talk About TV Content While Watch | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about the content of a program while watching it? | ADCS-ADL MCI - Talk About Content of Program While Watching | ||
ADL0314C | C106924 | ADL03-Talk About TV Content Within a Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about the content of a program within a day (24 hours) after watching it? | ADCS-ADL MCI - Talk About Content of Program After Watching Within a Day | ||
ADL0315 | C106925 | ADL03-Go Shopping | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} ever go shopping at a store? | ADCS-ADL MCI - Go Shopping At a Store | ||
ADL0315A | C106926 | ADL03-Select Items Without Help | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select correct items without supervision or help? | ADCS-ADL MCI - Select Correct Items Without Help | ||
ADL0315B | C106927 | ADL03-Pay Items On His/Her Own | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually pay for items on his/her own? | ADCS-ADL MCI - Pay for Items on His or Her Own | ||
ADL0316 | C106928 | ADL03-Left On His/Her Own | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, was {S} ever left on his/her own? | ADCS-ADL MCI - Left on His or Her Own | ||
ADL0316A | C106929 | ADL03-Left Away From Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left away from home, for 15 minutes or longer, during the day? | ADCS-ADL MCI - Left Away From Home Longer Than 15 Minutes | ||
ADL0316B | C106930 | ADL03-Left at Home for 1 Hour or Longer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left at home, for an hour or longer, during the day? | ADCS-ADL MCI - Left at Home Longer Than an Hour | ||
ADL0316C | C106931 | ADL03-Left at Home for Less Than 1 Hour | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left at home, for less than 1 hour, during the day? | ADCS-ADL MCI - Left at Home Less Than an Hour | ||
ADL0317 | C106932 | ADL03-Use Household Appliance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} use a household appliance to do chores? | ADCS-ADL MCI - Use Household Appliance | ||
ADL0317A | C107089 | ADL03-Appliance: Washer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: washer. | ADCS-ADL MCI - Use Household Appliance: Washer | ||
ADL0317B | C107090 | ADL03-Appliance: Dryer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: dryer. | ADCS-ADL MCI - Use Household Appliance: Dryer | ||
ADL0317C | C107091 | ADL03-Appliance: Vacuum | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: vacuum. | ADCS-ADL MCI - Use Household Appliance: Vacuum | ||
ADL0317D | C106933 | ADL03-Appliance: Dishwasher | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: dishwasher. | ADCS-ADL MCI - Use Household Appliance: Dishwasher | ||
ADL0317E | C106934 | ADL03-Appliance: Power Tools | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: power tool (s). | ADCS-ADL MCI - Use Household Appliance: Power Tools | ||
ADL0317F | C106935 | ADL03-Appliance: Toaster Oven | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: toaster oven. | ADCS-ADL MCI - Use Household Appliance: Toaster Oven | ||
ADL0317G | C106936 | ADL03-Appliance: Range | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: range. | ADCS-ADL MCI - Use Household Appliance: Range | ||
ADL0317H | C106937 | ADL03-Appliance: Microwave | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: microwave. | ADCS-ADL MCI - Use Household Appliance: Microwave | ||
ADL0317I | C106938 | ADL03-Appliance: Food Processor | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: food processor. | ADCS-ADL MCI - Use Household Appliance: Food Processor | ||
ADL0317J | C106939 | ADL03-Appliance: Other | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: other. | ADCS-ADL MCI - Use Household Appliance: Other | ||
ADL0317K | C106940 | ADL03-Appliance: Other Specify | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: other specify. | ADCS-ADL MCI - Use Household Appliance: Other Specify | ||
ADL0317L | C106941 | ADL03-Use Common Used Appliances (q17a) | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - For the 1 or 2 most commonly used appliances, which best describes how {S} usually used them. | ADCS-ADL MCI - Description of Usual Use of Commonly Used Appliances | ||
ADL0318 | C106942 | ADL03-Perform Pastime | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} perform a pastime, hobby or game? | ADCS-ADL MCI - Perform Pastime, Hobby or Game | ||
ADL0318A | C106943 | ADL03-Pastime: Card or Board Games | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: card or board games. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Card or Board Games | ||
ADL0318B | C106944 | ADL03-Pastime: Bingo | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: bingo. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Bingo | ||
ADL0318C | C106945 | ADL03-Pastime: Crosswords | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: crosswords. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Crosswords | ||
ADL0318D | C106946 | ADL03-Pastime: Art | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: art. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Art | ||
ADL0318E | C106947 | ADL03-Pastime: Musical Instrument | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: musical instrument. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Musical Instrument | ||
ADL0318F | C106948 | ADL03-Pastime: Knitting | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: knitting. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Knitting | ||
ADL0318G | C106949 | ADL03-Pastime: Sewing | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: sewing. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Sewing | ||
ADL0318H | C106950 | ADL03-Pastime: Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: reading. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Reading | ||
ADL0318I | C106951 | ADL03-Pastime: Gardening | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: gardening. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Gardening | ||
ADL0318J | C106952 | ADL03-Pastime: Golf | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: golf. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Golf | ||
ADL0318K | C106953 | ADL03-Pastime: Tennis | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: tennis. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Tennis | ||
ADL0318L | C106954 | ADL03-Pastime: Workshop | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: workshop. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Workshop | ||
ADL0318M | C106955 | ADL03-Pastime: Fishing | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: fishing. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Fishing | ||
ADL0318N | C106956 | ADL03-Pastime: Other | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: other. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Other | ||
ADL0318O | C106957 | ADL03-Pastime: Other Specify | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: other specify. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Other Specify | ||
ADL0318P | C106958 | ADL03-Hobbies Needed Help (Q18a) | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} require supervision, or help, to perform any of these hobbies? | ADCS-ADL MCI - Require Help to Perform Hobbies | ||
ADL0318Q | C106959 | ADL03-Hobbies Unable to Perform (Q18b) | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - List any hobby (ies) that the subject has lost the ability to perform. | ADCS-ADL MCI - List Hobbies Lost Ability to Perform | ||
ADL0319 | C106960 | ADL03-Drive Car | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} drive a car? | ADCS-ADL MCI - Drive a Car | ||
ADL0319A | C106961 | ADL03-Drive Car Optimal Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her optimal performance. | ADCS-ADL MCI - Description of Optimal Performance of Driving Car | ||
ADL0320 | C106962 | ADL03-Take Medications Regularly | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, did {S} take his/her medications regularly? | ADCS-ADL MCI - Take Medications Regularly | ||
ADL0320A | C106963 | ADL03-Take Medications Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, was this. | ADCS-ADL MCI - Description of Taking Medications Regularly | ||
ADL0321 | C106964 | ADL03-Complete Complex Activities | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, did {S} usually carry through complex or time-consuming activities to completion? | ADCS-ADL MCI - Carry Through Complex Activities to Completion | ||
ADL0321A | C106965 | ADL03-Extent Needed Reminders | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes extent to which he/she needed reminders. | ADCS-ADL MCI - Description of Extent Needing Reminder | ||
ADL0322 | C106966 | ADL03-Initiate Complex Activities | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, to what extent did {S} initiate complex daily activities or projects (e.g., hobbies, travel)? | ADCS-ADL MCI - Initiate Complex Daily Activities | ||
ADL0323 | C106967 | ADL03-Time to Complete Complex Tasks | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, how long did it usually take {S} to complete complex or time-consuming tasks or activities? | ADCS-ADL MCI - Time Taken to Complete Complex Activities | ||
ADL0324 | C106968 | ADL03-Extenuating Circumstances | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Has an extenuating circumstance (such as a physical health problem, change in residence, change in support network, death of a family member, etc.) contributed to a recent alteration in the subject's activities of daily living? | ADCS-ADL MCI - Extenuating Circumstance | ||
ADL0324A | C106969 | ADL03-Explain Circumstance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, explain. | ADCS-ADL MCI - Explain Extenuating Circumstance | ||
ADL0325 | C107092 | ADL03-Total Points for 'Don't Know' | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Were any questions (1-18) answered 'Don't Know'? If yes, calculate total points for 'Don't Know'. | ADCS-ADL MCI - Points for Questions (1-18) Answered 'Don't Know' | ||
ADL0326 | C106970 | ADL03-Subscore for Items 1 to 3 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 1. | ADCS-ADL MCI - Subscore for Items 1 to 3 | ||
ADL0327 | C106971 | ADL03-Subscore for Items 4 to 7 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 2. | ADCS-ADL MCI - Subscore for Items 4 to 7 | ||
ADL0328 | C106972 | ADL03-Subscore for Items 8 to 10 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 3. | ADCS-ADL MCI - Subscore for Items 8 to 10 | ||
ADL0329 | C106973 | ADL03-Subscore for Items 11 to 12d | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 4. | ADCS-ADL MCI - Subscore for Items 11 to 12 | ||
ADL0330 | C106974 | ADL03-Subscore for Items 13 to 14c | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 5. | ADCS-ADL MCI - Subscore for Items 13 to 14 | ||
ADL0331 | C106975 | ADL03-Subscore for Items 15 to 16c | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 6. | ADCS-ADL MCI - Subscore for Items 15 to 16 | ||
ADL0332 | C106976 | ADL03-Subscore for Item 17 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 7. | ADCS-ADL MCI - Subscore for Item 17 | ||
ADL0333 | C106977 | ADL03-Subscore for Item 18 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 8. | ADCS-ADL MCI - Subscore for Item 18 | ||
ADL0334 | C106978 | ADL03-Total ADCS-ADL Score | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Total Score. | ADCS-ADL MCI - ADL Total Score | ||
Back to top | ||||||
CL.C106650.ADL03TN | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version Questionnaire Test Name
(ADL03TN) | text
Extensible: No | C106650 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version Questionnaire Test Name | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory MCI Version test name. | CDISC Questionnaire ADCS-ADL MCI Test Name Terminology |
ADL03-Appliance: Dishwasher | C106933 | ADL03-Appliance: Dishwasher | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: dishwasher. | ADCS-ADL MCI - Use Household Appliance: Dishwasher | ||
ADL03-Appliance: Dryer | C107090 | ADL03-Appliance: Dryer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: dryer. | ADCS-ADL MCI - Use Household Appliance: Dryer | ||
ADL03-Appliance: Food Processor | C106938 | ADL03-Appliance: Food Processor | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: food processor. | ADCS-ADL MCI - Use Household Appliance: Food Processor | ||
ADL03-Appliance: Microwave | C106937 | ADL03-Appliance: Microwave | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: microwave. | ADCS-ADL MCI - Use Household Appliance: Microwave | ||
ADL03-Appliance: Other Specify | C106940 | ADL03-Appliance: Other Specify | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: other specify. | ADCS-ADL MCI - Use Household Appliance: Other Specify | ||
ADL03-Appliance: Other | C106939 | ADL03-Appliance: Other | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: other. | ADCS-ADL MCI - Use Household Appliance: Other | ||
ADL03-Appliance: Power Tools | C106934 | ADL03-Appliance: Power Tools | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: power tool (s). | ADCS-ADL MCI - Use Household Appliance: Power Tools | ||
ADL03-Appliance: Range | C106936 | ADL03-Appliance: Range | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: range. | ADCS-ADL MCI - Use Household Appliance: Range | ||
ADL03-Appliance: Toaster Oven | C106935 | ADL03-Appliance: Toaster Oven | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: toaster oven. | ADCS-ADL MCI - Use Household Appliance: Toaster Oven | ||
ADL03-Appliance: Vacuum | C107091 | ADL03-Appliance: Vacuum | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: vacuum. | ADCS-ADL MCI - Use Household Appliance: Vacuum | ||
ADL03-Appliance: Washer | C107089 | ADL03-Appliance: Washer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Check all that were used: washer. | ADCS-ADL MCI - Use Household Appliance: Washer | ||
ADL03-Aware of Appointment Ahead of Time | C106905 | ADL03-Aware of Appointment Ahead of Time | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her awareness of the meeting ahead of time. | ADCS-ADL MCI - Description of Awareness of the Meeting Ahead of Time | ||
ADL03-Balance Checkbook Performance | C106899 | ADL03-Balance Checkbook Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. | ADCS-ADL MCI - Description of Usual Performance of Balancing Checkbook | ||
ADL03-Balance Checkbook | C106898 | ADL03-Balance Checkbook | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} balance his/her checkbook or credit card statement? | ADCS-ADL MCI - Balance Checkbook | ||
ADL03-Clean Laundry | C106902 | ADL03-Clean Laundry | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} clean a load of laundry? | ADCS-ADL MCI - Clean Laundry | ||
ADL03-Clean Room Performance | C106897 | ADL03-Clean Room Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. | ADCS-ADL MCI - Description of Usual Performance of Cleaning Room | ||
ADL03-Clean Room | C106896 | ADL03-Clean Room | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} clean a living-, sitting-, or family room? | ADCS-ADL MCI - Clean Room | ||
ADL03-Complete Complex Activities | C106964 | ADL03-Complete Complex Activities | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, did {S} usually carry through complex or time-consuming activities to completion? | ADCS-ADL MCI - Carry Through Complex Activities to Completion | ||
ADL03-Drive Car Optimal Performance | C106961 | ADL03-Drive Car Optimal Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her optimal performance. | ADCS-ADL MCI - Description of Optimal Performance of Driving Car | ||
ADL03-Drive Car | C106960 | ADL03-Drive Car | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} drive a car? | ADCS-ADL MCI - Drive a Car | ||
ADL03-Explain Circumstance | C106969 | ADL03-Explain Circumstance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, explain. | ADCS-ADL MCI - Explain Extenuating Circumstance | ||
ADL03-Extent Needed Reminders | C106965 | ADL03-Extent Needed Reminders | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes extent to which he/she needed reminders. | ADCS-ADL MCI - Description of Extent Needing Reminder | ||
ADL03-Extenuating Circumstances | C106968 | ADL03-Extenuating Circumstances | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Has an extenuating circumstance (such as a physical health problem, change in residence, change in support network, death of a family member, etc.) contributed to a recent alteration in the subject's activities of daily living? | ADCS-ADL MCI - Extenuating Circumstance | ||
ADL03-Find Belongings Usual Performance | C106892 | ADL03-Find Belongings Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he /she usually performed. | ADCS-ADL MCI - Description of Usual Performance of Finding Belongings | ||
ADL03-Find Personal Belongings | C106891 | ADL03-Find Personal Belongings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? | ADCS-ADL MCI - Find Personal Belongings | ||
ADL03-Get Around Optimal Performance | C106911 | ADL03-Get Around Optimal Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her optimal performance. | ADCS-ADL MCI - Description of Optimal Performance of Travelling Outside Home | ||
ADL03-Get Around Outside Home | C106910 | ADL03-Get Around Outside Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? | ADCS-ADL MCI - Travel Outside Home | ||
ADL03-Go Shopping | C106925 | ADL03-Go Shopping | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} ever go shopping at a store? | ADCS-ADL MCI - Go Shopping At a Store | ||
ADL03-Highest Level of Food Preparation | C106909 | ADL03-Highest Level of Food Preparation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her highest level of food preparation. | ADCS-ADL MCI - Description of Highest Level of Food Preparation | ||
ADL03-Highest Telephone Use Performance | C106907 | ADL03-Highest Telephone Use Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her highest level of performance. | ADCS-ADL MCI - Description of Highest Level of Performance of Telephone Use | ||
ADL03-Hobbies Needed Help (Q18a) | C106958 | ADL03-Hobbies Needed Help (Q18a) | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} require supervision, or help, to perform any of these hobbies? | ADCS-ADL MCI - Require Help to Perform Hobbies | ||
ADL03-Hobbies Unable to Perform (Q18b) | C106959 | ADL03-Hobbies Unable to Perform (Q18b) | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - List any hobby (ies) that the subject has lost the ability to perform. | ADCS-ADL MCI - List Hobbies Lost Ability to Perform | ||
ADL03-Initiate Complex Activities | C106966 | ADL03-Initiate Complex Activities | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, to what extent did {S} initiate complex daily activities or projects (e.g., hobbies, travel)? | ADCS-ADL MCI - Initiate Complex Daily Activities | ||
ADL03-Keep Appointments | C106904 | ADL03-Keep Appointments | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} keep appointments or meetings with other people, such as relatives, a doctor, the hairdresser, etc.? | ADCS-ADL MCI - Keep Appointments | ||
ADL03-Laundry Cleaning Performance | C106903 | ADL03-Laundry Cleaning Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes how he/she usually performed. | ADCS-ADL MCI - Description of Usual Performance of Clean Laundry | ||
ADL03-Left at Home for 1 Hour or Longer | C106930 | ADL03-Left at Home for 1 Hour or Longer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left at home, for an hour or longer, during the day? | ADCS-ADL MCI - Left at Home Longer Than an Hour | ||
ADL03-Left at Home for Less Than 1 Hour | C106931 | ADL03-Left at Home for Less Than 1 Hour | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left at home, for less than 1 hour, during the day? | ADCS-ADL MCI - Left at Home Less Than an Hour | ||
ADL03-Left Away From Home | C106929 | ADL03-Left Away From Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Was {S} left away from home, for 15 minutes or longer, during the day? | ADCS-ADL MCI - Left Away From Home Longer Than 15 Minutes | ||
ADL03-Left On His/Her Own | C106928 | ADL03-Left On His/Her Own | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, was {S} ever left on his/her own? | ADCS-ADL MCI - Left on His or Her Own | ||
ADL03-Make a Meal | C106908 | ADL03-Make a Meal | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} make him/herself a meal or snack at home? | ADCS-ADL MCI - Make a Meal or Snack | ||
ADL03-Most Complicated Writings | C106901 | ADL03-Most Complicated Writings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes the most complicated things that he/she wrote. | ADCS-ADL MCI - Description of Usual Performance of Most Complicated Things Written | ||
ADL03-Pastime: Art | C106946 | ADL03-Pastime: Art | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: art. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Art | ||
ADL03-Pastime: Bingo | C106944 | ADL03-Pastime: Bingo | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: bingo. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Bingo | ||
ADL03-Pastime: Card or Board Games | C106943 | ADL03-Pastime: Card or Board Games | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: card or board games. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Card or Board Games | ||
ADL03-Pastime: Crosswords | C106945 | ADL03-Pastime: Crosswords | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: crosswords. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Crosswords | ||
ADL03-Pastime: Fishing | C106955 | ADL03-Pastime: Fishing | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: fishing. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Fishing | ||
ADL03-Pastime: Gardening | C106951 | ADL03-Pastime: Gardening | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: gardening. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Gardening | ||
ADL03-Pastime: Golf | C106952 | ADL03-Pastime: Golf | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: golf. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Golf | ||
ADL03-Pastime: Knitting | C106948 | ADL03-Pastime: Knitting | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: knitting. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Knitting | ||
ADL03-Pastime: Musical Instrument | C106947 | ADL03-Pastime: Musical Instrument | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: musical instrument. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Musical Instrument | ||
ADL03-Pastime: Other Specify | C106957 | ADL03-Pastime: Other Specify | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: other specify. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Other Specify | ||
ADL03-Pastime: Other | C106956 | ADL03-Pastime: Other | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: other. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Other | ||
ADL03-Pastime: Reading | C106950 | ADL03-Pastime: Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: reading. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Reading | ||
ADL03-Pastime: Sewing | C106949 | ADL03-Pastime: Sewing | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: sewing. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Sewing | ||
ADL03-Pastime: Tennis | C106953 | ADL03-Pastime: Tennis | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: tennis. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Tennis | ||
ADL03-Pastime: Workshop | C106954 | ADL03-Pastime: Workshop | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Which pastimes did he/she perform: workshop. | ADCS-ADL MCI - Perform Pastime, Hobby or Game: Workshop | ||
ADL03-Pay Items On His/Her Own | C106927 | ADL03-Pay Items On His/Her Own | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually pay for items on his/her own? | ADCS-ADL MCI - Pay for Items on His or Her Own | ||
ADL03-Perform Pastime | C106942 | ADL03-Perform Pastime | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} perform a pastime, hobby or game? | ADCS-ADL MCI - Perform Pastime, Hobby or Game | ||
ADL03-Read More Than 5 Minutes | C106917 | ADL03-Read More Than 5 Minutes | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} read a magazine, newspaper or book for more than 5 minutes at a time? | ADCS-ADL MCI - Read More Than 5 Minutes | ||
ADL03-Regional, National, International | C106913 | ADL03-Regional, National, International | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, did {S} talk about regional, national or international events? | ADCS-ADL MCI - Talk About Regional, National or International Events | ||
ADL03-Select First Clothes for the Day | C106893 | ADL03-Select First Clothes for the Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} select his/her first set of clothes for the day? | ADCS-ADL MCI - Select First Clothes for the Day | ||
ADL03-Select Items Without Help | C106926 | ADL03-Select Items Without Help | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select correct items without supervision or help? | ADCS-ADL MCI - Select Correct Items Without Help | ||
ADL03-Select Television Program | C106922 | ADL03-Select Television Program | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select or ask for different programs or his/her favorite show? | ADCS-ADL MCI - Select or Ask for Programs or Show | ||
ADL03-Select/Ask for Something to Read | C106918 | ADL03-Select/Ask for Something to Read | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually select or ask for something to read? | ADCS-ADL MCI - Select or Ask for Something to Read | ||
ADL03-Subscore for Item 17 | C106976 | ADL03-Subscore for Item 17 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 7. | ADCS-ADL MCI - Subscore for Item 17 | ||
ADL03-Subscore for Item 18 | C106977 | ADL03-Subscore for Item 18 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 8. | ADCS-ADL MCI - Subscore for Item 18 | ||
ADL03-Subscore for Items 1 to 3 | C106970 | ADL03-Subscore for Items 1 to 3 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 1. | ADCS-ADL MCI - Subscore for Items 1 to 3 | ||
ADL03-Subscore for Items 11 to 12d | C106973 | ADL03-Subscore for Items 11 to 12d | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 4. | ADCS-ADL MCI - Subscore for Items 11 to 12 | ||
ADL03-Subscore for Items 13 to 14c | C106974 | ADL03-Subscore for Items 13 to 14c | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 5. | ADCS-ADL MCI - Subscore for Items 13 to 14 | ||
ADL03-Subscore for Items 15 to 16c | C106975 | ADL03-Subscore for Items 15 to 16c | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 6. | ADCS-ADL MCI - Subscore for Items 15 to 16 | ||
ADL03-Subscore for Items 4 to 7 | C106971 | ADL03-Subscore for Items 4 to 7 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 2. | ADCS-ADL MCI - Subscore for Items 4 to 7 | ||
ADL03-Subscore for Items 8 to 10 | C106972 | ADL03-Subscore for Items 8 to 10 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Subscore for Page 3. | ADCS-ADL MCI - Subscore for Items 8 to 10 | ||
ADL03-Take Medications Performance | C106963 | ADL03-Take Medications Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, was this. | ADCS-ADL MCI - Description of Taking Medications Regularly | ||
ADL03-Take Medications Regularly | C106962 | ADL03-Take Medications Regularly | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, did {S} take his/her medications regularly? | ADCS-ADL MCI - Take Medications Regularly | ||
ADL03-Talk About at Home Events | C106915 | ADL03-Talk About at Home Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about events that occurred at home that he/she took part in or watched? | ADCS-ADL MCI - Talk About at Home Events | ||
ADL03-Talk About Current Events | C106912 | ADL03-Talk About Current Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} talk about current events? | ADCS-ADL MCI - Talk About Current Events | ||
ADL03-Talk About Outside Events | C106914 | ADL03-Talk About Outside Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about events outside home involving family, friends, or neighbors? | ADCS-ADL MCI - Talk About Outside Home Events | ||
ADL03-Talk About TV Content While Watch | C106923 | ADL03-Talk About TV Content While Watch | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about the content of a program while watching it? | ADCS-ADL MCI - Talk About Content of Program While Watching | ||
ADL03-Talk About TV Content Within a Day | C106924 | ADL03-Talk About TV Content Within a Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} talk about the content of a program within a day (24 hours) after watching it? | ADCS-ADL MCI - Talk About Content of Program After Watching Within a Day | ||
ADL03-Talk Within 1 Day After Reading | C106920 | ADL03-Talk Within 1 Day After Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about what he/she read 1-24 hours after reading? | ADCS-ADL MCI - Talk Within 24 Hours After Reading | ||
ADL03-Talk Within 1 Hour After Reading | C106919 | ADL03-Talk Within 1 Hour After Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} usually talk about what he/she read while or shortly after reading (less than 1 hour)? | ADCS-ADL MCI - Talk Within 1 Hour After Reading | ||
ADL03-Talk Without Repeating | C106916 | ADL03-Talk Without Repeating | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Did {S} converse without repeating him/herself, or asking the same questions repeatedly? | ADCS-ADL MCI - Converse Without Repeating | ||
ADL03-Time to Complete Complex Tasks | C106967 | ADL03-Time to Complete Complex Tasks | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - During the past 4 weeks, how long did it usually take {S} to complete complex or time-consuming tasks or activities? | ADCS-ADL MCI - Time Taken to Complete Complex Activities | ||
ADL03-Total ADCS-ADL Score | C106978 | ADL03-Total ADCS-ADL Score | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Total Score. | ADCS-ADL MCI - ADL Total Score | ||
ADL03-Total Points for 'Don't Know' | C107092 | ADL03-Total Points for 'Don't Know' | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Were any questions (1-18) answered 'Don't Know'? If yes, calculate total points for 'Don't Know'. | ADCS-ADL MCI - Points for Questions (1-18) Answered 'Don't Know' | ||
ADL03-Use a Telephone | C106906 | ADL03-Use a Telephone | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} use a telephone? | ADCS-ADL MCI - Use a Telephone | ||
ADL03-Use Common Used Appliances (q17a) | C106941 | ADL03-Use Common Used Appliances (q17a) | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - For the 1 or 2 most commonly used appliances, which best describes how {S} usually used them. | ADCS-ADL MCI - Description of Usual Use of Commonly Used Appliances | ||
ADL03-Use Household Appliance | C106932 | ADL03-Use Household Appliance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} use a household appliance to do chores? | ADCS-ADL MCI - Use Household Appliance | ||
ADL03-Usual Dressing Performance | C106894 | ADL03-Usual Dressing Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - If yes, which best describes his/her usual performance. | ADCS-ADL MCI - Description of Usual Performance of Selecting First Clothes for the Day | ||
ADL03-Usual Physically Dressing Perform | C106895 | ADL03-Usual Physically Dressing Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - Regarding physically getting dressed, which best describes his/her usual performance in the past 4 weeks. | ADCS-ADL MCI - Description of Usual Performance of Physically Getting Dressed | ||
ADL03-Watch Television | C106921 | ADL03-Watch Television | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} watch television? | ADCS-ADL MCI - Watch Television | ||
ADL03-Write Things Down | C106900 | ADL03-Write Things Down | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, MCI Version - In the past 4 weeks, did {S} ever write things down? | ADCS-ADL MCI - Write Things Down | ||
Back to top | ||||||
CL.C105140.ADL01TC | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Questionnaire Test Code
(ADL01TC) | text
Extensible: No | C105140 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Questionnaire Test Code | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory test code. | CDISC Questionnaire ADCS-ADL Test Code Terminology |
ADL0101 | C105283 | ADL01-Usual Eating Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding eating: which best describes {S} usual performance during the past 4 weeks? | ADCS-ADL - Description of Usual Performance of Eating | ||
ADL0102 | C105284 | ADL01-Optimal Walking Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding walking (or getting around in a wheelchair), in the past 4 weeks, which best describes his/her optimal performance. | ADCS-ADL - Description of Optimal Performance of Walking | ||
ADL0103 | C105285 | ADL01-Usual Bowel/Bladder Function | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding bowel and bladder function at the toilet, which best describes his/her usual performance in the past 4 weeks. | ADCS-ADL - Usual Bowel and Bladder Function at Toilet | ||
ADL0104 | C105286 | ADL01-Usual Bathing Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding bathing, in the past 4 weeks, which best describes his/her usual performance. | ADCS-ADL - Description of Usual Performance of Bathing | ||
ADL0105 | C105287 | ADL01-Optimal Grooming Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding grooming, in the past 4 weeks, which best describes his/her optimal performance. | ADCS-ADL - Description of Optimal Performance of Grooming | ||
ADL0106 | C105288 | ADL01-Select First Clothes for the Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding dressing in the past 4 weeks: Did {S} select his/her first set of clothes for the day? | ADCS-ADL - Select First Clothes for the Day | ||
ADL0106A | C105289 | ADL01-Usual Dressing Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes usual performance. | ADCS-ADL - Description of Usual Performance of Dressing | ||
ADL0106B | C105290 | ADL01-Usual Physically Dressing Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding physically getting dressed, which best describes his/her usual performance in the past 4 weeks. | ADCS-ADL - Description of Usual Performance of Physically Getting Dressed | ||
ADL0107 | C105291 | ADL01-Use a Telephone | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} use a telephone? | ADCS-ADL - Use a Telephone | ||
ADL0107A | C105292 | ADL01-Highest Telephone Use Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of performance. | ADCS-ADL - Description of Highest Performance of Telephone Use | ||
ADL0108 | C105293 | ADL01-Watch Television | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} watch television? | ADCS-ADL - Watch Television | ||
ADL0108A | C105294 | ADL01-Select Television Program | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually select or ask for different programs or his/her favorite show? | ADCS-ADL - Select or Ask for Television Program | ||
ADL0108B | C105295 | ADL01-Talk About TV Content While Watch | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about the content of a program while watching it? | ADCS-ADL - Talk About TV Content While Watching | ||
ADL0108C | C105296 | ADL01-Talk About TV Content Within a Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about the content of a program within a day (24 hours) after watching it? | ADCS-ADL - Talk About TV Content Within a Day After Watching | ||
ADL0109 | C105297 | ADL01-Pay Attention to Conversation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever appear to pay attention to conversation or small talk for at least 5 minutes? | ADCS-ADL - Pay Attention to Conversation | ||
ADL0109A | C105298 | ADL01-Usual Conversation Participation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her usual degree of participation. | ADCS-ADL - Usual Conversation Participation | ||
ADL0110 | C105299 | ADL01-Clear Dishes | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} clear the dishes from the table after a meal or snack? | ADCS-ADL - Clear Dishes After Meal or Snack | ||
ADL0110A | C105300 | ADL01-Clear Dishes Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. | ADCS-ADL - Description of Usual Performance of Clearing Dishes | ||
ADL0111 | C105301 | ADL01-Find Belongings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? | ADCS-ADL - Find Personal Belongings at Home | ||
ADL0111A | C105302 | ADL01-Find Belongings Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. | ADCS-ADL - Description of Usual Performance of Finding Personal Belonging at Home | ||
ADL0112 | C105303 | ADL01-Obtain Beverage | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} obtain a hot or cold beverage for him/herself? | ADCS-ADL - Obtain Beverage for Self | ||
ADL0112A | C105304 | ADL01-Obtain Beverage Highest Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of performance. | ADCS-ADL - Description of Highest Performance of Obtaining Beverage | ||
ADL0113 | C105305 | ADL01-Make a Meal | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} make him/herself a meal or snack at home? | ADCS-ADL - Make a Meal or Snack at Home | ||
ADL0113A | C105306 | ADL01-Highest Level of Food Preparation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of food preparation. | ADCS-ADL - Highest Level of Food Preparation | ||
ADL0114 | C105307 | ADL01-Dispose of Garbage | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} dispose of garbage or litter in an appropriate place or container at home? | ADCS-ADL - Dispose of Garbage in Appropriate Place at Home | ||
ADL0114A | C105308 | ADL01-Dispose Garbage Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. | ADCS-ADL - Description of Usual Performance of Garbage Disposal | ||
ADL0115 | C105309 | ADL01-Get Around Outside Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? | ADCS-ADL - Get Around Outside Home | ||
ADL0115A | C105310 | ADL01-Get Around Optimal Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her optimal performance. | ADCS-ADL - Description of Optimal Performance of Getting Around Outside of Home | ||
ADL0116 | C105311 | ADL01-Go Shopping | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever go shopping? | ADCS-ADL - Go Shopping | ||
ADL0116A | C105312 | ADL01-How Usually Selects Items | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which one best describes how {S} usually selects items. | ADCS-ADL - How Subject Usually Selects Items | ||
ADL0116B | C105313 | ADL01-Pay Without Supervision | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually pay for items without supervision or physical help? | ADCS-ADL - Pay for Items Without Supervision or Physical Help | ||
ADL0117 | C105314 | ADL01-Keep Appointments | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} keep appointments or meetings with other people, such as relatives, a doctor, the hairdresser, etc.? | ADCS-ADL - Keep Appointments or Meetings with Others | ||
ADL0117A | C105315 | ADL01-Aware of Appointment Ahead of Time | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her awareness of the meeting ahead of time. | ADCS-ADL - Description of Awareness of Appointment Ahead of Time | ||
ADL0118 | C105316 | ADL01-Left On His/Her Own | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, was {S} ever left on his/her own? | ADCS-ADL - Subject Left on Their Own | ||
ADL0118A | C105317 | ADL01-Left Away From Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left away from home, for 15 minutes or longer, during the day? | ADCS-ADL - Left Away From Home for Fifteen Minutes or Longer | ||
ADL0118B | C105318 | ADL01-Left at Home for 1 Hour or Longer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left: at home, for an hour or longer, during the day? | ADCS-ADL - Left at Home for One Hour or Longer | ||
ADL0118C | C105319 | ADL01-Left at Home for Less Than 1 Hour | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left at home, for less than 1 hour, during the day? | ADCS-ADL - Left at Home for Less Than One Hour | ||
ADL0119 | C105320 | ADL01-Talk About Current Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} talk about current events? | ADCS-ADL - Talk About Current Events | ||
ADL0119A | C105321 | ADL01-Talk About Events Heard/Read About | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that he/she heard or read about or saw on TV but did not take part in? | ADCS-ADL - Talk About Events on TV that Subject Did not Take Part In | ||
ADL0119B | C105322 | ADL01-Talk About Outside Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that he/she took part in outside home involving family, friends, or neighbors? | ADCS-ADL - Talk About Events Outside of Home that Subject Took Part In | ||
ADL0119C | C105323 | ADL01-Talk About at Home Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that occurred at home that he/she took part in or watched? | ADCS-ADL - Talk About Events at Home that Subject Took Part in or Watched | ||
ADL0120 | C105324 | ADL01-Read More Than 5 Minutes | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} read a magazine, newspaper or book for more than 5 minutes at a time? | ADCS-ADL - Read for More Than Five Minutes | ||
ADL0120A | C105325 | ADL01-Talk Within 1 Hour After Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about details of what he/she read while or shortly (less than 1 hour) after reading? | ADCS-ADL - Talk About What Subject Read Less Than One Hour After Reading | ||
ADL0120B | C105326 | ADL01-Talk 1 Hour or More After Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about what he/she read 1 hour or longer after reading? | ADCS-ADL - Talk About What Subject Read More Than One Hour After Reading | ||
ADL0121 | C105327 | ADL01-Write Things Down | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever write things down? | ADCS-ADL - Write Things Down | ||
ADL0121A | C105328 | ADL01-Most Complicated Writings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes the most complicated things that he/she wrote. | ADCS-ADL - Description of Most Complicated Writings | ||
ADL0122 | C105329 | ADL01-Perform Pastime | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} perform a pastime, hobby or game? | ADCS-ADL - Perform Pastime, Hobby or Game | ||
ADL0122A | C105330 | ADL01-Pastime: Card or Board Games | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: Card or board games. | ADCS-ADL - Pastime: Card or Board Games | ||
ADL0122B | C105331 | ADL01-Pastime: Bingo | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: bingo. | ADCS-ADL - Pastime: Bingo | ||
ADL0122C | C105332 | ADL01-Pastime: Crosswords | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: crosswords. | ADCS-ADL - Pastime: Crosswords | ||
ADL0122D | C105333 | ADL01-Pastime: Art | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: art. | ADCS-ADL - Pastime: Art | ||
ADL0122E | C105334 | ADL01-Pastime: Musical Instrument | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: musical instrument. | ADCS-ADL - Pastime: Musical Instrument | ||
ADL0122F | C105335 | ADL01-Pastime: Knitting | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: knitting. | ADCS-ADL - Pastime: Knitting | ||
ADL0122G | C105336 | ADL01-Pastime: Sewing | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: sewing. | ADCS-ADL - Pastime: Sewing | ||
ADL0122H | C105337 | ADL01-Pastime: Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: reading. | ADCS-ADL - Pastime: Reading | ||
ADL0122I | C105338 | ADL01-Pastime: Gardening | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: gardening. | ADCS-ADL - Pastime: Gardening | ||
ADL0122J | C105339 | ADL01-Pastime: Golf | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: golf. | ADCS-ADL - Pastime: Golf | ||
ADL0122K | C105340 | ADL01-Pastime: Tennis | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: tennis. | ADCS-ADL - Pastime: Tennis | ||
ADL0122L | C105341 | ADL01-Pastime: Workshop | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: workshop. | ADCS-ADL - Pastime: Workshop | ||
ADL0122M | C105342 | ADL01-Pastime: Fishing | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: fishing. | ADCS-ADL - Pastime: Fishing | ||
ADL0122N | C105343 | ADL01-Pastime: Other | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: other. | ADCS-ADL - Pastime: Other | ||
ADL0122O | C105344 | ADL01-Pastime: Other Specify | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: other specify. | ADCS-ADL - Pastime: Other Specify | ||
ADL0122P | C105345 | ADL01-Hobbies Only at Day Care | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If {S} performs hobbies/pastimes only at day care, check here. | ADCS-ADL - Performed Hobbies Only at Day Care | ||
ADL0122Q | C105346 | ADL01-Usual Common Pastimes Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, how did {S} usually perform his/her most common pastimes. | ADCS-ADL - Description of Usual Performance of Common Pastimes | ||
ADL0123 | C105347 | ADL01-Use Household Appliance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} use a household appliance to do chores? | ADCS-ADL - Use Household Appliance to do Chores | ||
ADL0123A | C105348 | ADL01-Appliance: Washer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: washer. | ADCS-ADL - Appliance: Washer | ||
ADL0123B | C105349 | ADL01-Appliance: Dryer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: dryer. | ADCS-ADL - Appliance: Dryer | ||
ADL0123C | C105350 | ADL01-Appliance: Vacuum | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: vacuum. | ADCS-ADL - Appliance: Vacuum | ||
ADL0123D | C105351 | ADL01-Appliance: Dishwasher | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: dishwasher. | ADCS-ADL - Appliance: Dishwasher | ||
ADL0123E | C105352 | ADL01-Appliance: Toaster | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: toaster. | ADCS-ADL - Appliance: Toaster | ||
ADL0123F | C105353 | ADL01-Appliance: Toaster Oven | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: toaster oven. | ADCS-ADL - Appliance: Toaster Oven | ||
ADL0123G | C105354 | ADL01-Appliance: Range | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: range. | ADCS-ADL - Appliance: Range | ||
ADL0123H | C105355 | ADL01-Appliance: Microwave | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: microwave. | ADCS-ADL - Appliance: Microwave | ||
ADL0123I | C105356 | ADL01-Appliance: Food Processor | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: food processor. | ADCS-ADL - Appliance: Food Processor | ||
ADL0123J | C105357 | ADL01-Appliance: Other | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: other. | ADCS-ADL - Appliance: Other | ||
ADL0123K | C105358 | ADL01-Appliance: Other Specify | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: other specify. | ADCS-ADL - Appliance: Other Specify | ||
ADL0123L | C105359 | ADL01-Use Common Used Appliances | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, for the most commonly used appliances, which best describes how {S} usually used them. | ADCS-ADL - Description of Usual Use of Commonly Used Appliances | ||
ADL0124 | C105360 | ADL01-Total ADCS-ADL Score | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Total Score. | ADCS-ADL - Total Score | ||
ADL0125 | C105361 | ADL01-Number Don't Know Responses | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Number of 'Don't Know' Responses. | ADCS-ADL - Number of 'Don't Know' Responses | ||
Back to top | ||||||
CL.C105139.ADL01TN | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Questionnaire Test Name
(ADL01TN) | text
Extensible: No | C105139 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Questionnaire Test Name | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory test name. | CDISC Questionnaire ADCS-ADL Test Name Terminology |
ADL01-Appliance: Dishwasher | C105351 | ADL01-Appliance: Dishwasher | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: dishwasher. | ADCS-ADL - Appliance: Dishwasher | ||
ADL01-Appliance: Dryer | C105349 | ADL01-Appliance: Dryer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: dryer. | ADCS-ADL - Appliance: Dryer | ||
ADL01-Appliance: Food Processor | C105356 | ADL01-Appliance: Food Processor | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: food processor. | ADCS-ADL - Appliance: Food Processor | ||
ADL01-Appliance: Microwave | C105355 | ADL01-Appliance: Microwave | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: microwave. | ADCS-ADL - Appliance: Microwave | ||
ADL01-Appliance: Other Specify | C105358 | ADL01-Appliance: Other Specify | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: other specify. | ADCS-ADL - Appliance: Other Specify | ||
ADL01-Appliance: Other | C105357 | ADL01-Appliance: Other | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: other. | ADCS-ADL - Appliance: Other | ||
ADL01-Appliance: Range | C105354 | ADL01-Appliance: Range | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: range. | ADCS-ADL - Appliance: Range | ||
ADL01-Appliance: Toaster Oven | C105353 | ADL01-Appliance: Toaster Oven | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: toaster oven. | ADCS-ADL - Appliance: Toaster Oven | ||
ADL01-Appliance: Toaster | C105352 | ADL01-Appliance: Toaster | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: toaster. | ADCS-ADL - Appliance: Toaster | ||
ADL01-Appliance: Vacuum | C105350 | ADL01-Appliance: Vacuum | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: vacuum. | ADCS-ADL - Appliance: Vacuum | ||
ADL01-Appliance: Washer | C105348 | ADL01-Appliance: Washer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Check all that were used: washer. | ADCS-ADL - Appliance: Washer | ||
ADL01-Aware of Appointment Ahead of Time | C105315 | ADL01-Aware of Appointment Ahead of Time | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her awareness of the meeting ahead of time. | ADCS-ADL - Description of Awareness of Appointment Ahead of Time | ||
ADL01-Clear Dishes Usual Performance | C105300 | ADL01-Clear Dishes Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. | ADCS-ADL - Description of Usual Performance of Clearing Dishes | ||
ADL01-Clear Dishes | C105299 | ADL01-Clear Dishes | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} clear the dishes from the table after a meal or snack? | ADCS-ADL - Clear Dishes After Meal or Snack | ||
ADL01-Dispose Garbage Usual Performance | C105308 | ADL01-Dispose Garbage Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. | ADCS-ADL - Description of Usual Performance of Garbage Disposal | ||
ADL01-Dispose of Garbage | C105307 | ADL01-Dispose of Garbage | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} dispose of garbage or litter in an appropriate place or container at home? | ADCS-ADL - Dispose of Garbage in Appropriate Place at Home | ||
ADL01-Find Belongings Usual Performance | C105302 | ADL01-Find Belongings Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes how he/she usually performed. | ADCS-ADL - Description of Usual Performance of Finding Personal Belonging at Home | ||
ADL01-Find Belongings | C105301 | ADL01-Find Belongings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? | ADCS-ADL - Find Personal Belongings at Home | ||
ADL01-Get Around Optimal Performance | C105310 | ADL01-Get Around Optimal Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her optimal performance. | ADCS-ADL - Description of Optimal Performance of Getting Around Outside of Home | ||
ADL01-Get Around Outside Home | C105309 | ADL01-Get Around Outside Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? | ADCS-ADL - Get Around Outside Home | ||
ADL01-Go Shopping | C105311 | ADL01-Go Shopping | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever go shopping? | ADCS-ADL - Go Shopping | ||
ADL01-Highest Level of Food Preparation | C105306 | ADL01-Highest Level of Food Preparation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of food preparation. | ADCS-ADL - Highest Level of Food Preparation | ||
ADL01-Highest Telephone Use Performance | C105292 | ADL01-Highest Telephone Use Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of performance. | ADCS-ADL - Description of Highest Performance of Telephone Use | ||
ADL01-Hobbies Only at Day Care | C105345 | ADL01-Hobbies Only at Day Care | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If {S} performs hobbies/pastimes only at day care, check here. | ADCS-ADL - Performed Hobbies Only at Day Care | ||
ADL01-How Usually Selects Items | C105312 | ADL01-How Usually Selects Items | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which one best describes how {S} usually selects items. | ADCS-ADL - How Subject Usually Selects Items | ||
ADL01-Keep Appointments | C105314 | ADL01-Keep Appointments | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} keep appointments or meetings with other people, such as relatives, a doctor, the hairdresser, etc.? | ADCS-ADL - Keep Appointments or Meetings with Others | ||
ADL01-Left at Home for 1 Hour or Longer | C105318 | ADL01-Left at Home for 1 Hour or Longer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left: at home, for an hour or longer, during the day? | ADCS-ADL - Left at Home for One Hour or Longer | ||
ADL01-Left at Home for Less Than 1 Hour | C105319 | ADL01-Left at Home for Less Than 1 Hour | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left at home, for less than 1 hour, during the day? | ADCS-ADL - Left at Home for Less Than One Hour | ||
ADL01-Left Away From Home | C105317 | ADL01-Left Away From Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Was {S} left away from home, for 15 minutes or longer, during the day? | ADCS-ADL - Left Away From Home for Fifteen Minutes or Longer | ||
ADL01-Left On His/Her Own | C105316 | ADL01-Left On His/Her Own | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, was {S} ever left on his/her own? | ADCS-ADL - Subject Left on Their Own | ||
ADL01-Make a Meal | C105305 | ADL01-Make a Meal | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} make him/herself a meal or snack at home? | ADCS-ADL - Make a Meal or Snack at Home | ||
ADL01-Most Complicated Writings | C105328 | ADL01-Most Complicated Writings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes the most complicated things that he/she wrote. | ADCS-ADL - Description of Most Complicated Writings | ||
ADL01-Number Don't Know Responses | C105361 | ADL01-Number Don't Know Responses | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Number of 'Don't Know' Responses. | ADCS-ADL - Number of 'Don't Know' Responses | ||
ADL01-Obtain Beverage Highest Perform | C105304 | ADL01-Obtain Beverage Highest Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her highest level of performance. | ADCS-ADL - Description of Highest Performance of Obtaining Beverage | ||
ADL01-Obtain Beverage | C105303 | ADL01-Obtain Beverage | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} obtain a hot or cold beverage for him/herself? | ADCS-ADL - Obtain Beverage for Self | ||
ADL01-Optimal Grooming Performance | C105287 | ADL01-Optimal Grooming Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding grooming, in the past 4 weeks, which best describes his/her optimal performance. | ADCS-ADL - Description of Optimal Performance of Grooming | ||
ADL01-Optimal Walking Performance | C105284 | ADL01-Optimal Walking Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding walking (or getting around in a wheelchair), in the past 4 weeks, which best describes his/her optimal performance. | ADCS-ADL - Description of Optimal Performance of Walking | ||
ADL01-Pastime: Art | C105333 | ADL01-Pastime: Art | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: art. | ADCS-ADL - Pastime: Art | ||
ADL01-Pastime: Bingo | C105331 | ADL01-Pastime: Bingo | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: bingo. | ADCS-ADL - Pastime: Bingo | ||
ADL01-Pastime: Card or Board Games | C105330 | ADL01-Pastime: Card or Board Games | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: Card or board games. | ADCS-ADL - Pastime: Card or Board Games | ||
ADL01-Pastime: Crosswords | C105332 | ADL01-Pastime: Crosswords | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: crosswords. | ADCS-ADL - Pastime: Crosswords | ||
ADL01-Pastime: Fishing | C105342 | ADL01-Pastime: Fishing | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: fishing. | ADCS-ADL - Pastime: Fishing | ||
ADL01-Pastime: Gardening | C105338 | ADL01-Pastime: Gardening | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: gardening. | ADCS-ADL - Pastime: Gardening | ||
ADL01-Pastime: Golf | C105339 | ADL01-Pastime: Golf | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: golf. | ADCS-ADL - Pastime: Golf | ||
ADL01-Pastime: Knitting | C105335 | ADL01-Pastime: Knitting | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: knitting. | ADCS-ADL - Pastime: Knitting | ||
ADL01-Pastime: Musical Instrument | C105334 | ADL01-Pastime: Musical Instrument | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: musical instrument. | ADCS-ADL - Pastime: Musical Instrument | ||
ADL01-Pastime: Other Specify | C105344 | ADL01-Pastime: Other Specify | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: other specify. | ADCS-ADL - Pastime: Other Specify | ||
ADL01-Pastime: Other | C105343 | ADL01-Pastime: Other | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: other. | ADCS-ADL - Pastime: Other | ||
ADL01-Pastime: Reading | C105337 | ADL01-Pastime: Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: reading. | ADCS-ADL - Pastime: Reading | ||
ADL01-Pastime: Sewing | C105336 | ADL01-Pastime: Sewing | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: sewing. | ADCS-ADL - Pastime: Sewing | ||
ADL01-Pastime: Tennis | C105340 | ADL01-Pastime: Tennis | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: tennis. | ADCS-ADL - Pastime: Tennis | ||
ADL01-Pastime: Workshop | C105341 | ADL01-Pastime: Workshop | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Which pastimes did he/she perform: workshop. | ADCS-ADL - Pastime: Workshop | ||
ADL01-Pay Attention to Conversation | C105297 | ADL01-Pay Attention to Conversation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever appear to pay attention to conversation or small talk for at least 5 minutes? | ADCS-ADL - Pay Attention to Conversation | ||
ADL01-Pay Without Supervision | C105313 | ADL01-Pay Without Supervision | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually pay for items without supervision or physical help? | ADCS-ADL - Pay for Items Without Supervision or Physical Help | ||
ADL01-Perform Pastime | C105329 | ADL01-Perform Pastime | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} perform a pastime, hobby or game? | ADCS-ADL - Perform Pastime, Hobby or Game | ||
ADL01-Read More Than 5 Minutes | C105324 | ADL01-Read More Than 5 Minutes | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} read a magazine, newspaper or book for more than 5 minutes at a time? | ADCS-ADL - Read for More Than Five Minutes | ||
ADL01-Select First Clothes for the Day | C105288 | ADL01-Select First Clothes for the Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding dressing in the past 4 weeks: Did {S} select his/her first set of clothes for the day? | ADCS-ADL - Select First Clothes for the Day | ||
ADL01-Select Television Program | C105294 | ADL01-Select Television Program | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually select or ask for different programs or his/her favorite show? | ADCS-ADL - Select or Ask for Television Program | ||
ADL01-Talk 1 Hour or More After Reading | C105326 | ADL01-Talk 1 Hour or More After Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about what he/she read 1 hour or longer after reading? | ADCS-ADL - Talk About What Subject Read More Than One Hour After Reading | ||
ADL01-Talk About at Home Events | C105323 | ADL01-Talk About at Home Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that occurred at home that he/she took part in or watched? | ADCS-ADL - Talk About Events at Home that Subject Took Part in or Watched | ||
ADL01-Talk About Current Events | C105320 | ADL01-Talk About Current Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} talk about current events? | ADCS-ADL - Talk About Current Events | ||
ADL01-Talk About Events Heard/Read About | C105321 | ADL01-Talk About Events Heard/Read About | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that he/she heard or read about or saw on TV but did not take part in? | ADCS-ADL - Talk About Events on TV that Subject Did not Take Part In | ||
ADL01-Talk About Outside Events | C105322 | ADL01-Talk About Outside Events | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about events that he/she took part in outside home involving family, friends, or neighbors? | ADCS-ADL - Talk About Events Outside of Home that Subject Took Part In | ||
ADL01-Talk About TV Content While Watch | C105295 | ADL01-Talk About TV Content While Watch | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about the content of a program while watching it? | ADCS-ADL - Talk About TV Content While Watching | ||
ADL01-Talk About TV Content Within a Day | C105296 | ADL01-Talk About TV Content Within a Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} talk about the content of a program within a day (24 hours) after watching it? | ADCS-ADL - Talk About TV Content Within a Day After Watching | ||
ADL01-Talk Within 1 Hour After Reading | C105325 | ADL01-Talk Within 1 Hour After Reading | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Did {S} usually talk about details of what he/she read while or shortly (less than 1 hour) after reading? | ADCS-ADL - Talk About What Subject Read Less Than One Hour After Reading | ||
ADL01-Total ADCS-ADL Score | C105360 | ADL01-Total ADCS-ADL Score | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Total Score. | ADCS-ADL - Total Score | ||
ADL01-Use a Telephone | C105291 | ADL01-Use a Telephone | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} use a telephone? | ADCS-ADL - Use a Telephone | ||
ADL01-Use Common Used Appliances | C105359 | ADL01-Use Common Used Appliances | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, for the most commonly used appliances, which best describes how {S} usually used them. | ADCS-ADL - Description of Usual Use of Commonly Used Appliances | ||
ADL01-Use Household Appliance | C105347 | ADL01-Use Household Appliance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} use a household appliance to do chores? | ADCS-ADL - Use Household Appliance to do Chores | ||
ADL01-Usual Bathing Performance | C105286 | ADL01-Usual Bathing Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding bathing, in the past 4 weeks, which best describes his/her usual performance. | ADCS-ADL - Description of Usual Performance of Bathing | ||
ADL01-Usual Bowel/Bladder Function | C105285 | ADL01-Usual Bowel/Bladder Function | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding bowel and bladder function at the toilet, which best describes his/her usual performance in the past 4 weeks. | ADCS-ADL - Usual Bowel and Bladder Function at Toilet | ||
ADL01-Usual Common Pastimes Performance | C105346 | ADL01-Usual Common Pastimes Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, how did {S} usually perform his/her most common pastimes. | ADCS-ADL - Description of Usual Performance of Common Pastimes | ||
ADL01-Usual Conversation Participation | C105298 | ADL01-Usual Conversation Participation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes his/her usual degree of participation. | ADCS-ADL - Usual Conversation Participation | ||
ADL01-Usual Dressing Performance | C105289 | ADL01-Usual Dressing Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - If yes, which best describes usual performance. | ADCS-ADL - Description of Usual Performance of Dressing | ||
ADL01-Usual Eating Performance | C105283 | ADL01-Usual Eating Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding eating: which best describes {S} usual performance during the past 4 weeks? | ADCS-ADL - Description of Usual Performance of Eating | ||
ADL01-Usual Physically Dressing Perform | C105290 | ADL01-Usual Physically Dressing Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - Regarding physically getting dressed, which best describes his/her usual performance in the past 4 weeks. | ADCS-ADL - Description of Usual Performance of Physically Getting Dressed | ||
ADL01-Watch Television | C105293 | ADL01-Watch Television | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} watch television? | ADCS-ADL - Watch Television | ||
ADL01-Write Things Down | C105327 | ADL01-Write Things Down | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory - In the past 4 weeks, did {S} ever write things down? | ADCS-ADL - Write Things Down | ||
Back to top | ||||||
CL.C106653.ADL02TC | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version Questionnaire Test Code
(ADL02TC) | text
Extensible: No | C106653 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version Questionnaire Test Code | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version test code. | CDISC Questionnaire ADCS-ADL Severe Dementia Test Code Terminology |
ADL0201 | C106979 | ADL02-Usual Eating Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding eating, which best describes {S} usual performance during the last 4 weeks? | ADCS-ADL Severe Dementia - Description of Usual Performance of Eating | ||
ADL0202 | C106980 | ADL02-Optimal Walking Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding walking (or getting around in a wheelchair) in the past 4 weeks, which best describes {S} optimal performance? | ADCS-ADL Severe Dementia - Description of Optimal Performance of Walking | ||
ADL0203 | C106981 | ADL02-Usual Bowel/Bladder Function | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding bowel and bladder function at the toilet, which best describes {S} usual performance during the past 4 weeks? | ADCS-ADL Severe Dementia - Usual Bowel and Bladder Function at Toilet | ||
ADL0204 | C106982 | ADL02-Usual Bathing Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding bathing, in the past 4 weeks, which best describes {S} usual performance? | ADCS-ADL Severe Dementia - Description of Usual Performance of Bathing | ||
ADL0205 | C106983 | ADL02-Optimal Grooming Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding grooming, in the past 4 weeks, which best describes {S} optimal performance? | ADCS-ADL Severe Dementia - Description of Optimal Performance of Grooming | ||
ADL0206 | C106984 | ADL02-Usual Physically Dressing Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding physically getting dressed, which best describes {S} usual performance in the past 4 weeks? | ADCS-ADL Severe Dementia - Description of Usual Performance of Physically Getting Dressed | ||
ADL0207 | C106985 | ADL02-Use a Telephone | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} use a telephone? | ADCS-ADL Severe Dementia - Use a Telephone | ||
ADL0207A | C106986 | ADL02-Highest Telephone Use Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} highest level of performance. | ADCS-ADL Severe Dementia - Description of Highest Performance of Telephone Use | ||
ADL0208 | C106987 | ADL02-Watch Television | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} watch television? | ADCS-ADL Severe Dementia - Watch Television | ||
ADL0208A | C106988 | ADL02-Select Television Program | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} usually select or ask for different programs or {S} favorite show? | ADCS-ADL Severe Dementia - Select or Ask for Television Program | ||
ADL0208B | C106989 | ADL02-Talk About TV Content While Watch | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} usually talk about the content of a program while watching it? | ADCS-ADL Severe Dementia - Talk About TV Content While Watching | ||
ADL0208C | C106990 | ADL02-Talk About TV Content Within a Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} talk about the content of a program within a day (24 hours) after watching it? | ADCS-ADL Severe Dementia - Talk About TV Content Within a Day After Watching | ||
ADL0209 | C106991 | ADL02-Pay Attention to Conversation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} ever appear to pay attention to conversation or small talk for at least 5 minutes? | ADCS-ADL Severe Dementia - Pay Attention to Conversation | ||
ADL0209A | C106992 | ADL02-Usual Conversation Participation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} usual degree of participation. | ADCS-ADL Severe Dementia - Usual Conversation Participation | ||
ADL0210 | C106993 | ADL02-Clear Dishes | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} clear the dishes from the table after a meal or snack? | ADCS-ADL Severe Dementia - Clear Dishes After Meal or Snack | ||
ADL0210A | C106994 | ADL02-Clear Dishes Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. | ADCS-ADL Severe Dementia - Description of Usual Performance of Clearing Dishes | ||
ADL0211 | C106995 | ADL02-Find Belongings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? | ADCS-ADL Severe Dementia - Find Personal Belongings at Home | ||
ADL0211A | C106996 | ADL02-Find Belongings Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. | ADCS-ADL Severe Dementia - Description of Usual Performance of Finding Personal Belonging at Home | ||
ADL0212 | C106997 | ADL02-Obtain Beverage | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} obtain a hot or cold beverage for him/herself? | ADCS-ADL Severe Dementia - Obtain Beverage for Self | ||
ADL0212A | C106998 | ADL02-Obtain Beverage Highest Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} highest level of performance. | ADCS-ADL Severe Dementia - Description of Highest Performance of Obtaining Beverage | ||
ADL0213 | C106999 | ADL02-Dispose of Garbage | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} dispose of garbage or litter in an appropriate place or container at home? | ADCS-ADL Severe Dementia - Dispose of Garbage in Appropriate Place at Home | ||
ADL0213A | C107000 | ADL02-Dispose Garbage Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. | ADCS-ADL Severe Dementia - Description of Usual Performance of Garbage Disposal | ||
ADL0214 | C107001 | ADL02-Get Around Outside Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? | ADCS-ADL Severe Dementia - Get Around Outside Home | ||
ADL0214A | C107002 | ADL02-Get Around Optimal Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} optimal performance. | ADCS-ADL Severe Dementia - Description of Optimal Performance of Getting Around Outside of Home | ||
ADL0215 | C107003 | ADL02-Left On His/Her Own | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, was {S} ever left on his/her own? | ADCS-ADL Severe Dementia - Subject Left on Their Own | ||
ADL0215A | C107004 | ADL02-Left Away From Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: away from home for 15 minutes or longer, during the day? | ADCS-ADL Severe Dementia - Alone Away From Home for Fifteen Minutes or Longer | ||
ADL0215B | C107005 | ADL02-Left at Home for 1 Hour or Longer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: at home for an hour or longer during the day? | ADCS-ADL Severe Dementia - Alone at Home for One Hour or Longer | ||
ADL0215C | C107006 | ADL02-Left at Home for Less Than 1 Hour | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: at home for less than 1 hour during the day? | ADCS-ADL Severe Dementia - Alone at Home for Less Than One Hour | ||
ADL0216 | C107007 | ADL02-Run Water Faucet to Wash | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually run water from a faucet to wash {S} hands or face without help? | ADCS-ADL Severe Dementia - Turn On Faucet to Wash Without Help | ||
ADL0217 | C107008 | ADL02-Turn Off Faucet | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn off the faucet after finishing running water without help? | ADCS-ADL Severe Dementia - Turn Off Faucet After Wash Without Help | ||
ADL0218 | C107009 | ADL02-Turn On Light | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn on a light without help when entering a dark room or area? | ADCS-ADL Severe Dementia - Turn On Light Without Help Entering Room | ||
ADL0219 | C107010 | ADL02-Turn Off Light | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn off lights without help when leaving a room or going to sleep? | ADCS-ADL Severe Dementia - Turn Off Light Without Help Leaving Room | ||
ADL0220 | C107011 | ADL02-Sum 1 to 5 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 1-5. | ADCS-ADL Severe Dementia - Sum of Items 1-5 | ||
ADL0221 | C107012 | ADL02-Sum 6 to 8 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 6-8. | ADCS-ADL Severe Dementia - Sum of Items 6-8 | ||
ADL0222 | C107013 | ADL02-Sum 9 to 12 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 9-12. | ADCS-ADL Severe Dementia - Sum of Items 9-12 | ||
ADL0223 | C107014 | ADL02-Sum 13 to 15 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 13-15. | ADCS-ADL Severe Dementia - Sum of Items 13-15 | ||
ADL0224 | C107015 | ADL02-Sum 16 to 19 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 16-19. | ADCS-ADL Severe Dementia - Sum of Items 16-19 | ||
ADL0225 | C107016 | ADL02-Total ADCS-ADL Score | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Total Score. | ADCS-ADL Severe Dementia - Total Score | ||
Back to top | ||||||
CL.C106652.ADL02TN | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version Questionnaire Test Name
(ADL02TN) | text
Extensible: No | C106652 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version Questionnaire Test Name | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Version test name. | CDISC Questionnaire ADCS-ADL Severe Dementia Test Name Terminology |
ADL02-Clear Dishes Usual Performance | C106994 | ADL02-Clear Dishes Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. | ADCS-ADL Severe Dementia - Description of Usual Performance of Clearing Dishes | ||
ADL02-Clear Dishes | C106993 | ADL02-Clear Dishes | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} clear the dishes from the table after a meal or snack? | ADCS-ADL Severe Dementia - Clear Dishes After Meal or Snack | ||
ADL02-Dispose Garbage Usual Performance | C107000 | ADL02-Dispose Garbage Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. | ADCS-ADL Severe Dementia - Description of Usual Performance of Garbage Disposal | ||
ADL02-Dispose of Garbage | C106999 | ADL02-Dispose of Garbage | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} dispose of garbage or litter in an appropriate place or container at home? | ADCS-ADL Severe Dementia - Dispose of Garbage in Appropriate Place at Home | ||
ADL02-Find Belongings Usual Performance | C106996 | ADL02-Find Belongings Usual Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes how {S} usually performed. | ADCS-ADL Severe Dementia - Description of Usual Performance of Finding Personal Belonging at Home | ||
ADL02-Find Belongings | C106995 | ADL02-Find Belongings | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually manage to find his/her personal belongings at home? | ADCS-ADL Severe Dementia - Find Personal Belongings at Home | ||
ADL02-Get Around Optimal Performance | C107002 | ADL02-Get Around Optimal Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} optimal performance. | ADCS-ADL Severe Dementia - Description of Optimal Performance of Getting Around Outside of Home | ||
ADL02-Get Around Outside Home | C107001 | ADL02-Get Around Outside Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} get around (or travel) outside of his/her home? | ADCS-ADL Severe Dementia - Get Around Outside Home | ||
ADL02-Highest Telephone Use Performance | C106986 | ADL02-Highest Telephone Use Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} highest level of performance. | ADCS-ADL Severe Dementia - Description of Highest Performance of Telephone Use | ||
ADL02-Left at Home for 1 Hour or Longer | C107005 | ADL02-Left at Home for 1 Hour or Longer | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: at home for an hour or longer during the day? | ADCS-ADL Severe Dementia - Alone at Home for One Hour or Longer | ||
ADL02-Left at Home for Less Than 1 Hour | C107006 | ADL02-Left at Home for Less Than 1 Hour | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: at home for less than 1 hour during the day? | ADCS-ADL Severe Dementia - Alone at Home for Less Than One Hour | ||
ADL02-Left Away From Home | C107004 | ADL02-Left Away From Home | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Was {S} left: away from home for 15 minutes or longer, during the day? | ADCS-ADL Severe Dementia - Alone Away From Home for Fifteen Minutes or Longer | ||
ADL02-Left On His/Her Own | C107003 | ADL02-Left On His/Her Own | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, was {S} ever left on his/her own? | ADCS-ADL Severe Dementia - Subject Left on Their Own | ||
ADL02-Obtain Beverage Highest Perform | C106998 | ADL02-Obtain Beverage Highest Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} highest level of performance. | ADCS-ADL Severe Dementia - Description of Highest Performance of Obtaining Beverage | ||
ADL02-Obtain Beverage | C106997 | ADL02-Obtain Beverage | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} obtain a hot or cold beverage for him/herself? | ADCS-ADL Severe Dementia - Obtain Beverage for Self | ||
ADL02-Optimal Grooming Performance | C106983 | ADL02-Optimal Grooming Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding grooming, in the past 4 weeks, which best describes {S} optimal performance? | ADCS-ADL Severe Dementia - Description of Optimal Performance of Grooming | ||
ADL02-Optimal Walking Performance | C106980 | ADL02-Optimal Walking Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding walking (or getting around in a wheelchair) in the past 4 weeks, which best describes {S} optimal performance? | ADCS-ADL Severe Dementia - Description of Optimal Performance of Walking | ||
ADL02-Pay Attention to Conversation | C106991 | ADL02-Pay Attention to Conversation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} ever appear to pay attention to conversation or small talk for at least 5 minutes? | ADCS-ADL Severe Dementia - Pay Attention to Conversation | ||
ADL02-Run Water Faucet to Wash | C107007 | ADL02-Run Water Faucet to Wash | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually run water from a faucet to wash {S} hands or face without help? | ADCS-ADL Severe Dementia - Turn On Faucet to Wash Without Help | ||
ADL02-Select Television Program | C106988 | ADL02-Select Television Program | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} usually select or ask for different programs or {S} favorite show? | ADCS-ADL Severe Dementia - Select or Ask for Television Program | ||
ADL02-Sum 1 to 5 | C107011 | ADL02-Sum 1 to 5 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 1-5. | ADCS-ADL Severe Dementia - Sum of Items 1-5 | ||
ADL02-Sum 13 to 15 | C107014 | ADL02-Sum 13 to 15 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 13-15. | ADCS-ADL Severe Dementia - Sum of Items 13-15 | ||
ADL02-Sum 16 to 19 | C107015 | ADL02-Sum 16 to 19 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 16-19. | ADCS-ADL Severe Dementia - Sum of Items 16-19 | ||
ADL02-Sum 6 to 8 | C107012 | ADL02-Sum 6 to 8 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 6-8. | ADCS-ADL Severe Dementia - Sum of Items 6-8 | ||
ADL02-Sum 9 to 12 | C107013 | ADL02-Sum 9 to 12 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Sum of Items 9-12. | ADCS-ADL Severe Dementia - Sum of Items 9-12 | ||
ADL02-Talk About TV Content While Watch | C106989 | ADL02-Talk About TV Content While Watch | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} usually talk about the content of a program while watching it? | ADCS-ADL Severe Dementia - Talk About TV Content While Watching | ||
ADL02-Talk About TV Content Within a Day | C106990 | ADL02-Talk About TV Content Within a Day | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Did {S} talk about the content of a program within a day (24 hours) after watching it? | ADCS-ADL Severe Dementia - Talk About TV Content Within a Day After Watching | ||
ADL02-Total ADCS-ADL Score | C107016 | ADL02-Total ADCS-ADL Score | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Total Score. | ADCS-ADL Severe Dementia - Total Score | ||
ADL02-Turn Off Faucet | C107008 | ADL02-Turn Off Faucet | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn off the faucet after finishing running water without help? | ADCS-ADL Severe Dementia - Turn Off Faucet After Wash Without Help | ||
ADL02-Turn Off Light | C107010 | ADL02-Turn Off Light | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn off lights without help when leaving a room or going to sleep? | ADCS-ADL Severe Dementia - Turn Off Light Without Help Leaving Room | ||
ADL02-Turn On Light | C107009 | ADL02-Turn On Light | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} usually turn on a light without help when entering a dark room or area? | ADCS-ADL Severe Dementia - Turn On Light Without Help Entering Room | ||
ADL02-Use a Telephone | C106985 | ADL02-Use a Telephone | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} use a telephone? | ADCS-ADL Severe Dementia - Use a Telephone | ||
ADL02-Usual Bathing Performance | C106982 | ADL02-Usual Bathing Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding bathing, in the past 4 weeks, which best describes {S} usual performance? | ADCS-ADL Severe Dementia - Description of Usual Performance of Bathing | ||
ADL02-Usual Bowel/Bladder Function | C106981 | ADL02-Usual Bowel/Bladder Function | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding bowel and bladder function at the toilet, which best describes {S} usual performance during the past 4 weeks? | ADCS-ADL Severe Dementia - Usual Bowel and Bladder Function at Toilet | ||
ADL02-Usual Conversation Participation | C106992 | ADL02-Usual Conversation Participation | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - If yes, which best describes {S} usual degree of participation. | ADCS-ADL Severe Dementia - Usual Conversation Participation | ||
ADL02-Usual Eating Performance | C106979 | ADL02-Usual Eating Performance | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding eating, which best describes {S} usual performance during the last 4 weeks? | ADCS-ADL Severe Dementia - Description of Usual Performance of Eating | ||
ADL02-Usual Physically Dressing Perform | C106984 | ADL02-Usual Physically Dressing Perform | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - Regarding physically getting dressed, which best describes {S} usual performance in the past 4 weeks? | ADCS-ADL Severe Dementia - Description of Usual Performance of Physically Getting Dressed | ||
ADL02-Watch Television | C106987 | ADL02-Watch Television | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, Severe Dementia Version - In the past 4 weeks, did {S} watch television? | ADCS-ADL Severe Dementia - Watch Television | ||
Back to top | ||||||
CL.C103459.ACGC01TC | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire Test Code
(ACGC01TC) | text
Extensible: No | C103459 | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire Test Code | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change test code. | CDISC Questionnaire ADCS-CGIC Test Code Terminology |
ACGC0101 | C103531 | ACGC01-Clinical Impression of Change | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change - Clinical impression of change from baseline. | ADCS-CGIC - Clinical Impression of Change from Baseline | ||
Back to top | ||||||
CL.C103458.ACGC01TN | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire Test Name
(ACGC01TN) | text
Extensible: No | C103458 | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire Test Name | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change test name. | CDISC Questionnaire ADCS-CGIC Test Name Terminology |
ACGC01-Clinical Impression of Change | C103531 | ACGC01-Clinical Impression of Change | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change - Clinical impression of change from baseline. | ADCS-CGIC - Clinical Impression of Change from Baseline | ||
Back to top | ||||||
CL.C74456.LOC | Anatomical Location
(LOC) | text
Extensible: Yes | C74456 | Anatomical Location | Terminology codelist used for anatomical location within CDISC. | CDISC SDTM Anatomical Location Terminology |
5TH LUMBAR SPINOUS PROCESS | C116163 | The spinous process of the 5th lumbar vertebra. | Fifth Lumbar Spinous Process | |||
ABDOMINAL AORTA | C32038 | The portion of the descending aorta that lies within the abdomen, beginning below the diaphragm and ending at its division into the right and left common iliac arteries. (NCI) | Abdominal Aorta | |||
ABDOMINAL CAVITY | C12664 | Abdomen | The body cavity between the thoracic and pelvic cavities in mammals. | Abdomen | ||
ABDOMINAL LYMPH NODE | C12360 | Any lymph node within the abdomen. | Intra-Abdominal Lymph Node | |||
ABDOMINAL QUADRANT, LEFT LOWER | C151399 | The left lower quadrant of the abdomen. | Left Lower Quadrant of Abdomen | |||
ABDOMINAL QUADRANT, LEFT UPPER | C151397 | The left upper quadrant of the abdomen. | Left Upper Quadrant of Abdomen | |||
ABDOMINAL QUADRANT, RIGHT LOWER | C151400 | The right lower quadrant of the abdomen. | Right Lower Quadrant of Abdomen | |||
ABDOMINAL QUADRANT, RIGHT UPPER | C151398 | The right upper quadrant of the abdomen. | Right Upper Quadrant of Abdomen | |||
ABDOMINAL REGION | C139186 | Any portion of the body that lies within the boundary, either internally or externally, of the abdomen: superior margin, the thorax; inferior margin, the pelvis; lateral margins, the ribs. | Abdominal Region | |||
ABDOMINAL SKIN | C52758 | Abdominal Skin | The integument that covers the abdomen. | Abdominal Skin | ||
ABDOMINAL WALL | C77608 | The tissue that surrounds the organs present in the abdominal cavity. | Abdominal Wall | |||
ABDUCENS NERVE | C12665 | The sixth cranial nerve. | Abducens Nerve | |||
ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND | C165996 | A muscle of the hand, in general extending from the pisiform bone, the pisohamate ligament, and the flexor retinaculum to the ulnopalmar margin of the proximal phalanx. Primary function is abduction of the little finger and flexion of the phalanx nearest the hand. | Abductor Digiti Minimi Muscle of the Hand | |||
ABDUCTOR DIGITI QUINTI MUSCLE | C163504 | Abductor Digiti Minimi;Abductor Minimi Digiti | A muscle in the foot, in general extending from the medial and lateral processes of the posterior calcaneal tuberosity to the lateral side of the base of the proximal phalanx of the fifth toe and the fifth metatarsal; primary function is to abduct the fifth toe at the metatarsophalangeal joint and support the lateral arch. | Abductor Digiti Minimi Muscle | ||
ABDUCTOR HALLUCIS MUSCLE | C163505 | A muscle in the foot, in general extending from the medial process of the posterior calcaneal tuberosity to the medial side of the base of the proximal phalanx of the big toe; primary function is to abduct and flex the big toe at the metatarsophalangeal joint. | Abductor Hallucis Muscle | |||
ABDUCTOR POLLICIS BREVIS MUSCLE | C165997 | A muscle of the hand, in general extending from the flexor retinaculum and the tubercles of the scaphoid and trapezium bones to the outer side of the base of the proximal phalanx of the thumb. Primary function is abduction of the thumb away from the palm. | Abductor Pollicis Brevis Muscle | |||
ABDUCTOR POLLICIS LONGUS MUSCLE | C52888 | A skeletal muscle of the forearm originating from the posterior surfaces of the ulna and radius and the interosseous membrane. (NCI) | Abductor Pollicis Longus | |||
ACCESSORY RENAL ARTERY | C116183 | An additional renal vessel originating from the aorta and entering the kidney at the proximal or distal end of the organ. Accessory renal arteries are found in 26-30% of humans. | Accessory Renal Artery | |||
ACETABULUM | C32042 | Acetabulum | Two cup shaped areas, one each on the lateral side of the lower pelvis that house the head of the femur to form the ball and socket joint of the hip. (NCI) | Acetabulum | ||
ACHILLES TENDON | C32043 | The tendon that, in general, attaches the gastrocnemius muscle to the calcaneous bone in the tarsus. | Achilles Tendon | |||
ACROMIOCLAVICULAR JOINT | C32047 | Acromioclavicular Joint | The junction of the upper distal end of the scapula to the distal edge of the collarbone, also known as the acromion and the clavicle. (NCI) | Acromioclavicular Joint | ||
ACROMION | C32048 | Acromion | The upper distal process of the scapula. (NCI) | Acromion | ||
ACUTE MARGINAL ARTERY | C102285 | ACUTE MARGINAL ARTERY SEGMENT(S);AMARG | The arteries that arise at the junction of the proximal and mid-right coronary artery conduit segments. | Acute Marginal Artery | ||
ADDUCTOR BREVIS MUSCLE | C163506 | A muscle in the leg, in general extending from the external surface of the body of pubis and the anterior surface of the inferior pubic ramus to the pectineal line and the medial lip of the linea aspera; primary function is to adduct, flex, and rotate the thigh. | Adductor Brevis Muscle | |||
ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD | C163507 | The larger of two heads of the adductor hallucis muscle, in general originating from the sheath of the peroneus longus tendon and the plantar surface of the bases of the second to fourth metatarsal bones in the foot. | Oblique Head of Adductor Hallucis Muscle | |||
ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD | C163508 | The smaller of two heads of the adductor hallucis muscle, in general originating from the deep transverse metatarsal ligament and the plantar surface of the metatarsophalangeal joints of the lateral three toes. | Transverse Head of Adductor Hallucis Muscle | |||
ADDUCTOR LONGUS MUSCLE | C163509 | A muscle in the thigh, in general extending from the external surface of the body of pubis to the middle third of the linea aspera; primary function is to adduct and medially rotate the thigh. | Adductor Longus Muscle | |||
ADDUCTOR MAGNUS MUSCLE | C163510 | A muscle in the thigh, in general extending from the ischiopubic ramus and ischial tuberosity to the gluteal tuberosity of the femur, medial lip of the linea aspera, medial supracondylar ridge, and adductor tubercle; primary function is to adduct, flex, extend, and medially rotate the thigh at the hip joint. | Adductor Magnus Muscle | |||
ADDUCTOR POLLICIS MUSCLE | C186100 | A muscle of the hand that extends from the capitate and bases of the second and third metacarpals for the oblique head, and the anterior surface of body of the third metacarpal for the transverse head, to the base of proximal phalanx and extensor hood of the thumb; primary function is to draw the first metacarpal laterally to oppose the thumb toward the center of palm and rotate it medially. | Adductor Pollicis Muscle | |||
ADRENAL GLAND | C12666 | The endocrine glands adjacent to the kidneys that consist of the outer adrenal cortex and the inner adrenal medulla in mammals. | Adrenal Gland | |||
ALISPHENOID PROCESS | C129430 | Greater Wing of the Sphenoid Bone | The bony process of the sphenoid bone, extending from the side of the body of the sphenoid and curving upward, laterally, and backward. | Sphenoid Wing | ||
ALVEOLAR PROCESS | C89749 | Alveolar Margin;Alveolar Ridge | The thickened bony structures in the mandible and maxilla that contain the sockets of the teeth. | Alveolar Ridge | ||
ALVEOLUS | C12986 | Alveoli | Any of the terminal sacs in the lungs through which gas exchange takes place with the pulmonary capillary blood. | Alveolus | ||
AMNIOTIC FLUID | C13188 | Aqua Amnii | The fluid within the amniotic cavity which surrounds and protects the developing embryo. (NCI) | Amniotic Fluid | ||
AMPULLA OF VATER | C13011 | The junction of the common bile and main pancreatic ducts, which protrudes into the medial aspect of the descending duodenum at the major duodenal papilla. | Ampulla of Vater | |||
AMYGDALA | C12440 | Amygdala;Amygdaloid Body;Amygdaloid Nucleus | A group of nuclei adjacent to the lateral ventricle of the brain within the temporal lobe, and is part of the limbic system. | Amygdala | ||
ANAL CANAL | C12375 | The terminal section of the alimentary canal, which extends from the anorectal junction and ends at the anal opening. (NCI) | Anal Canal | |||
ANAL REGION | C32069 | The area that includes the anus and the perianal skin. | Anal Region | |||
ANAL SPHINCTER | C165177 | The internal and external muscles surrounding the anus that maintain continence. | Anal Sphincter | |||
ANAL VERGE | C25419 | The transitional zone between the moist, hairless, modified skin of the anal canal and the perianal skin. | Anal Margin | |||
ANASTOMOSIS | C15609 | Anastomosis | A natural or surgically-induced connection between tubular structures in the body. (NCI) | Anastomosis | ||
ANCONEUS MUSCLE | C186101 | A muscle of the elbow, in general extending from the lateral epicondyle of the humerus to the lateral surface of the ulnar olecranon; primary function is to extend the forearm and stabilize the elbow joint. | Anconeus Muscle | |||
ANGULAR GYRUS | C32077 | A ridge on the posterior part of the inferior parietal lobule. | Angular Gyrus | |||
ANKLE JOINT ANTERIOR EXTENSOR TENDONS | C161390 | The tendons in the anterior compartment of the leg that cross the tibiotalar joint anteriorly and connect muscles that originate on the surfaces of the tibia and fibula to bones in the toes, enabling dorsiflexion of the foot at the ankle and extension of the toes. (NCI) | Ankle Joint Anterior Extensor Tendons | |||
ANKLE JOINT ANTERIOR FLEXOR TENDONS | C161389 | The tendons in the anterior compartment of the leg that connect muscles that originate on the surfaces of the femur, tibia, and fibula to bones in the toes, enabling plantar flexion of the foot at the ankle. (NCI) | Ankle Joint Anterior Flexor Tendons | |||
ANKLE JOINT | C32078 | Ankle;Ankle Joint | A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus. (NCI) | Ankle Joint | ||
ANKLE MORTISE | C117868 | Talar Mortise | A rectangular socket or bony arch that connects the ends of the tibia and fibula to the talus. | Ankle Mortise | ||
ANORECTUM | C186102 | The distal portion of the gastrointestinal tract that includes the anal canal and rectum. | Anorectum | |||
ANTECUBITAL FOSSA | C103238 | Antecubital Region | A triangular space on the anterior side of the elbow joint. Three main veins of the arm, the brachial artery, the medial nerve and the tendon of the biceps muscle pass through this space. | Antecubital Fossa | ||
ANTERIOR CINGULATE CORTEX | C139185 | The part of the cingulate cortex that lies most frontal, with the most anterior portion of the cortex bending in a horseshoe shape around the genu of the corpus callosum. | Anterior Cingulate Cortex | |||
ANTERIOR CINGULATE GYRUS | C187996 | The part of the cingulate gyrus that lies inferior to the superior frontal gyrus, and is separated from it by the cingulate sulcus; it ends inferior to the rostrum of the corpus callosum. | Anterior Cingulate Gyrus | |||
ANTERIOR HORN OF THE LATERAL VENTRICLE | C32637 | Frontal Horn of the Lateral Ventricle | The part of the lateral ventricle located in the frontal lobe, anterior to the interventricular foramen of Monroe, and bounded by the septum pellucidum, fornix, and genu of the corpus callosum. | Frontal Horn of the Lateral Ventricle | ||
ANTERIOR INFERIOR CEREBELLAR ARTERY | C32091 | AICA | A basilar artery branch that supplies the anterior portion of the inferior surface of the cerebellum. | Anterior Inferior Cerebellar Artery | ||
ANTERIOR MEDIASTINAL LYMPH NODE | C32097 | Prevascular Lymph Node | A lymph node located in the anterior part of the mediastinum. | Anterior Mediastinal Lymph Node | ||
ANTERIOR SUPERIOR ILIAC SPINE | C139187 | A bony projection from the anterior region of the iliac crest, and is the site of attachment for the sartorius and tensor fascia latae muscles and the inguinal ligament. | Anterior Superior Iliac Spine | |||
ANTERIOR TIBIAL ARTERY | C12825 | An artery of the lower extremity that supplies blood to the anterior part of the leg and the foot. | Anterior Tibial Artery | |||
ANTERIOR TIBIAL VEIN | C32115 | The vein that runs parallel to the anterior tibial artery and empties into the popliteal vein. | Anterior Tibial Vein | |||
ANTRUM PYLORI | C12259 | Antrum Pylori | The initial part of the pyloric canal of the stomach. This site contains endocrine cells that produce gastrin and somatostatin. (NCI) | Antrum Pylori | ||
ANUS | C43362 | The distal orifice of the digestive tract located between the rectum and the external surface of the body, comprising glandular, transitional, and squamous epithelium. | Anus | |||
AORTA | C12669 | The major artery of the body; it arises from the left ventricle of the heart and terminally bifurcates into the common iliac arteries. | Aorta | |||
AORTIC ARCH | C32123 | Aortic Arch | The curved segment of the aorta between the ascending and the descending segments. | Aortic Arch | ||
AORTIC BODY | C97112 | A small mass that is located on the inferior surface of the aortic arch. It functions as a peripheral chemoreceptor and is composed of glomus cells. | Aortic Body | |||
AORTIC VALVE ANNULUS | C130167 | A fibrous membrane that attaches to, and provides support for, the aortic valve leaflets. | Aortic Valve Annulus | |||
AORTIC VALVE | C12670 | A cardiac valve located between the left ventricle and the aorta. | Aortic Valve | |||
AORTIC VALVE, LEFT CORONARY CUSP | C127638 | Aortic Valve, Left Semilunar Cusp | The cusp of the aortic valve that overlies the left coronary ostium. | Left Coronary Cusp of the Aortic Valve | ||
AORTIC VALVE, NON-CORONARY CUSP | C127639 | Aortic Valve, Posterior Semilunar Cusp | The cusp of the aortic valve that is positioned posteriorly relative to the left and right aortic cusps. | Non-Coronary Cusp of the Aortic Valve | ||
AORTIC VALVE, RIGHT CORONARY CUSP | C127640 | Aortic Valve, Right Semilunar Cusp | The cusp of the aortic valve that overlies the right coronary ostium. | Right Coronary Cusp of the Aortic Valve | ||
AORTICOPULMONARY SEPTUM | C186103 | The wall that separates the aorta and pulmonary arteries during embryonic development. | Aorticopulmonary Septum | |||
AORTO-ILIAC PERIPHERAL ARTERY | C116166 | The segment of the blood vessels that includes the iliac artery and its origin from the aorta. | Aortoiliac Artery Segment | |||
AORTOCAVAL LYMPH NODE | C118775 | A lymph node located in the area between the abdominal aorta and inferior vena cava. (NCI) | Aortocaval Lymph Node | |||
AORTOPULMONARY WINDOW LYMPH NODE | C116165 | A lymph node located in the aortopulmonary window. | Aortopulmonary Window Lymph Node | |||
APPENDICEAL TIP | C83470 | The distal end of the appendix. (NCI) | Appendiceal Tip | |||
APPENDICULAR SKELETON | C49477 | The part of the skeleton that includes the bones of the upper and lower limbs, including the shoulder and pelvic girdles | Appendicular Skeleton | |||
APPENDIX | C12380 | A pouch-like tissue attached to the cecum, which may exist as a diverticulum. | Appendix | |||
AQUEOUS HUMOR | C13190 | Aqueous Humour | The watery fluid which is present in the anterior and posterior chambers of the eye. (NCI) | Aqueous Humor | ||
ARM SKIN | C52754 | Arm Skin | The integument that covers the arm. | Arm Skin | ||
ARM | C32141 | Arm;Brachium;Upper Arm | The portion of the upper extremity between the shoulder and the elbow. | Arm | ||
ARTERY | C12372 | Artery | A blood vessel that carries blood away from the heart. (NCI) | Artery | ||
ASCENDING AORTA | C32150 | The portion of the aorta that emerges from the left ventricle and precedes the aortic arch. | Ascending Aorta | |||
ASCENDING AORTA, AORTIC ROOT | C127641 | The portion of the ascending aorta between the aortic annulus and the sinotubular junction. | Aortic Root | |||
ASCENDING AORTA, SINOTUBULAR JUNCTION | C127642 | The terminus of the aortic root; the point at which the aorta attains a tubular configuration. | Sinotubular Junction | |||
ASCENDING AORTA, SINUS OF VALSALVA | C33557 | Any one of the naturally occurring sinuses of the aortic root distal to the semilunar valve. | Sinus of Valsalva | |||
ATRIOVENTRICULAR SEPTUM | C186104 | The confluence of the atrial septum and the ventricular septum. | Atrioventricular Septum | |||
ATRIOVENTRICULAR VALVE | C176322 | Either of the two valves in the heart situated between the atria and ventricles, i.e., the mitral valve or the tricuspid valve. | Atrioventricular Valve | |||
AUDITORY OSSICLE | C32164 | Ossicles of the Ear | Any of the small bones in the middle ear that transmit acoustic vibrations from the eardrum to the inner ear. | Auditory Ossicle | ||
AXIAL SKELETON | C32172 | The part of the skeleton that includes the skull and spinal column and sternum and ribs. (NCI) | Axial Skeleton | |||
AXILLA | C12674 | Armpit;Axilla | The underside concavity where the arm and the shoulder are joined. (NCI) | Axilla | ||
AXILLARY ARTERY | C32169 | An artery that originates from the subclavian artery at the lateral margin of the first rib. It supplies the brachial artery. | Axillary Artery | |||
AXILLARY LYMPH NODE LEVEL I | C123461 | Axillary lymph nodes located inferolateral to pectoralis minor. | Axillary Lymph Node Level I | |||
AXILLARY LYMPH NODE LEVEL II | C123462 | Axillary lymph nodes located posterior to pectoralis minor. | Axillary Lymph Node Level II | |||
AXILLARY LYMPH NODE LEVEL III | C123463 | Axillary lymph nodes located superomedial to pectoralis minor. | Axillary Lymph Node Level III | |||
AXILLARY LYMPH NODE | C12904 | Lymph node(s) in the axillary region. | Axillary Lymph Node | |||
AXILLARY VEIN | C32171 | A large blood vessel which returns blood to the heart from the lateral thorax, axilla and upper limb. Each side of the body contains one axillary vein. | Axillary Vein | |||
AZYGOS VEIN | C53029 | A blood vessel which returns blood to the heart from the posterior walls of the thorax and abdomen. | Azygos Vein | |||
BACK | C13062 | Back | The dorsal area between the base of the neck and the sacrum. (NCI) | Back | ||
BASAL GANGLIA | C12447 | Clusters of neurons comprising the globus pallidus, putamen, caudate, nucleus accumbens, substantia nigra and subthalamic nucleus. | Basal Ganglia | |||
BASE OF THE TONGUE | C12228 | The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx. | Base of the Tongue | |||
BASILAR ARTERY | C12676 | An artery of the brain; in general it arises from the union of the two vertebral arteries at the posterior border of the pons and branches at the anterior border to form the two superior and two posterior cerebral arteries. | Basilar Artery | |||
BASILIC VEIN | C32197 | Basilic Vein | One of the moderately large superficial veins of the forearm that transports blood from the hand and the medial aspect of the forearm to the axillary vein. (NCI) | Basilic Vein | ||
BASIOCCIPITAL BONE | C186105 | The basilar portion of the occipital bone; it is present during fetal development and later fuses with the occipital bone. | Basioccipital Bone | |||
BASISPHENOID BONE | C186106 | One of the bones of the orbit, situated rostrally to the basilar part of the occipital bone; it is present during fetal development and later fuses to form the posterior portion of the sphenoid bone. | Basisphenoid Bone | |||
BICEPS BRACHII MUSCLE | C32200 | A muscle of the proximal arm/forelimb, in general extending from the scapula to the radius and adjacent fascia; primary function is flexion of the elbow joint and, in some species, also functions in supination of the antebrachium. | Biceps Brachii | |||
BICEPS FEMORIS MUSCLE | C53147 | A muscle in the thigh, in general extending from the ischial tuberosity and posterior femur to the fibula; primary function is to extend the femorotibial joint. | Biceps Femoris | |||
BILE DUCT | C12376 | Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct. | Bile Duct | |||
BILIARY TRACT | C12678 | Biliary Tract | The duct system that transports bile from its origination by hepatocytes in the liver to the small intestine. It is comprised of the common bile duct that connects the liver and gall bladder to the small intestine and the cystic duct that connects the gall bladder to the common bile duct. (NCI) | Biliary Tract | ||
BLADDER WALL | C48941 | The tissue layers that form the urinary bladder. They include the mucosa, submucosa, smooth muscle, and serosa. | Bladder Wall | |||
BLADDER | C12414 | Urinary Bladder | The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (NCI) | Bladder | ||
BLADDER, APEX | C198292 | The anterosuperior part of the bladder that points towards the abdominal wall. | Bladder Apex | |||
BLADDER, BODY | C198293 | The large area of the bladder situated between the apex and the fundus. | Bladder Body | |||
BLADDER, DOME | C12332 | Dome of the Bladder | The upper, convex surface of the bladder. (NCI) | Dome of the Bladder | ||
BLADDER, FUNDUS | C48939 | Fundus of the Bladder | The portion of the bladder that is formed by the posterior wall and is located opposite to the bladder opening. (NCI) | Bladder Fundus | ||
BLADDER, NECK | C12336 | Neck of the Bladder | The inferior portion of the urinary bladder which is formed as the walls of the bladder converge and become contiguous with the proximal urethra. (NCI) | Bladder Neck | ||
BLADDER, TRIGONE | C12331 | Trigone of the Bladder | The triangular area in the bladder mucosa that is formed by the two ureteral orifices and the urethral orifice. (NCI) | Bladder Trigone | ||
BLOOD VESSEL | C12679 | A tubular structure through which the blood circulates in the body. Blood vessels constitute a network composed of arteries, arterioles, capillaries, venules, and veins. (NCI) | Blood Vessel | |||
BLOOD | C12434 | Peripheral Blood;Whole Blood | A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. | Blood | ||
BODY OF STOMACH | C12258 | Body of Stomach | The main section of the digestive tube that connects the esophagus to the small intestine. The body proper excludes the upper and lower sections of the fundus and pyloric portion respectively. (NCI) | Body of Stomach | ||
BODY | C13041 | Whole Body | The entire physical structure of an organism. It is composed of anatomic systems, regions, cavities, and spaces. (NCI) | Body | ||
BONE MARROW | C12431 | The tissue occupying the spaces of some bones. It consists of blood vessel sinuses and a network of hematopoietic cells. | Bone Marrow | |||
BONE | C12366 | Calcified connective tissue that forms the skeletal components of the body. (NCI) | Bone | |||
BRACHIAL ARTERY | C12681 | An artery of the forelimb; in general it arises from the axillary artery and branches to form the radial and ulnar arteries. | Brachial Artery | |||
BRACHIAL LYMPH NODE | C92221 | Lymph node(s) adjacent to the brachial vein. | Brachial Lymph Node | |||
BRACHIAL PLEXUS | C12682 | Brachial Plexus | A nerve network originating from spinal nerves in the cervical and thoracic vertebrae and giving rise to multiple nerves that innervate the arm/forelimb. | Brachial Plexus | ||
BRACHIAL VEIN | C12883 | A vein of the arm/forelimb; in general it arises from the union of the radial and ulnar veins and drains into the axillary vein. | Brachial Vein | |||
BRACHIALIS MUSCLE | C53149 | A muscle that originates from the lower two-thirds of the anterior surface of the humerus that flexes the elbow. (NCI) | Brachialis | |||
BRACHIOCEPHALIC ARTERY | C32814 | Innominate Artery | An artery of the mediastinum; in general it arises from the aortic arch and branches to form the right subclavian artery and one or both common carotid arteries. | Innominate Artery | ||
BRACHIORADIALIS MUSCLE | C150849 | A muscle in the forearm, in general extending from the proximal two-thirds of the lateral supracondylar ridge of the humerus and inserting into the styloid process of the radius; primary function is flexion of the elbow and pronation and supination of the forearm. | Brachioradialis Muscle | |||
BRAIN STEM | C12441 | Brain Stem | The part of the brain that connects the cerebral hemispheres with the spinal cord. It consists of the mesencephalon, pons, and medulla oblongata. (NCI) | Brain Stem | ||
BRAIN VENTRICLE | C12356 | Brain Ventricle | The four connected cavities (hollow spaces) centrally located within the brain that connect posteriorly with the central canal of the spinal cord. (NCI) | Brain Ventricle | ||
BRAIN VENTRICLE, LATERAL | C12834 | The rostral extensions of the ventricular system of the brain consisting of two cavities, one on each side of the brain within the central regions of each cerebral hemisphere. Cerebrospinal fluid flows from the lateral ventricles into the centrally third ventricle via the foramen of Monroe. (NCI) | Lateral Ventricle | |||
BRAIN | C12439 | Nervous System, Brain | An organ composed of gray and white matter that is the center for intelligence and reasoning. It is protected by the bony cranium. | Brain | ||
BRAIN, EXTERNAL CAPSULE | C32550 | A thin lamina of white matter comprising long association fibers located between the claustrum and putamen in the brain, and which connects the midportion of the superotemporal region with the midportion of the ventral and lateral aspects of the prefrontal cortex. | External Capsule | |||
BRAIN, FOURTH VENTRICLE | C12828 | A diamond-shaped cavity filled with cerebrospinal fluid within the pons, extending between the obex in the caudal medulla and the aqueduct of Sylvius in the cerebellum. | Fourth Ventricle | |||
BRAIN, INTERNAL CAPSULE | C13082 | A white matter structure in the subcortical region of the brain that contains a high concentration of motor and sensory projection nerve fibers. It consists of the anterior limb, genu, posterior limb, and the retrolentiform and sublentiform parts. | Internal Capsule | |||
BRAIN, PERIVENTRICULAR REGION | C132390 | The area of the body surrounding the ventricles of the brain. | Periventricular Region | |||
BRAIN, THIRD VENTRICLE | C12827 | A centrally placed component of the ventricular system of the brain that is located in the diencephalon; the thalamus and the hypothalamus border the third ventricle. | Third Ventricle | |||
BREAST | C12971 | Breast | One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest. (NCI) | Breast | ||
BROAD LIGAMENT | C12318 | A wide fold of peritoneum that connects the uterus to the lateral walls and floor of the pelvis, and also attaches to the ovaries, fallopian tubes, ovarian ligaments, round ligament of the uterus, and ovarian and uterine arteries. | Broad Ligament | |||
BRONCHIAL STUMP | C186107 | The part of a bronchus that remains after resection. | Bronchial Stump | |||
BRONCHIOLE | C12684 | The smallest subdivisions of the bronchial tree, which are both acartilagenous and aglandular. | Bronchiole | |||
BRONCHUS | C12683 | Bronchi | Tubular structure in continuation with the trachea, serving as an air passage. | Bronchus | ||
BUCCAL LYMPH NODE | C154770 | Buccinator Lymph Node | Lymph node(s) that are located superficial to the buccinator muscle. | Buccal Lymph Node | ||
BUCCAL MUCOSA | C12505 | The mucosal membranes located on the inside of the cheek, in the buccal cavity. (NCI) | Buccal Mucosa | |||
BULBAR CONJUNCTIVA | C12902 | The part of the conjunctiva that covers the eyeball. | Bulbar Conjunctiva | |||
BUTTOCK | C89806 | Buttock | Either of the fleshy mounds in the rear pelvic area of the human body formed by the gluteal muscles. | Buttock | ||
C1 VERTEBRA | C32239 | C1 Vertebra | The first of the seven cervical vertebrae. (NCI) | C1 Vertebra | ||
C2 VERTEBRA | C32240 | C2 Vertebra | The second of the seven cervical vertebrae. (NCI) | C2 Vertebra | ||
C3 VERTEBRA | C32241 | C3 Vertebra | The third of the seven cervical vertebrae. (NCI) | C3 Vertebra | ||
C4 VERTEBRA | C32242 | C4 Vertebra | The fourth of the seven cervical vertebrae. (NCI) | C4 Vertebra | ||
C5 VERTEBRA | C32243 | C5 Vertebra | The fifth of the seven cervical vertebrae. (NCI) | C5 Vertebra | ||
C6 VERTEBRA | C32244 | C6 Vertebra | The sixth of the seven cervical vertebrae. (NCI) | C6 Vertebra | ||
C7 VERTEBRA | C32245 | C7 Vertebra | The seventh of the seven cervical vertebrae. (NCI) | C7 Vertebra | ||
CALCANEAL TUBEROSITY | C142295 | A roughened surface on the superior portion of the posterior half of the calcaneus, where the calcaneal (Achilles) tendon inserts. | Calcaneal Tuberosity | |||
CALCANEUS | C32250 | Calcaneum;Calcaneus Bone | The irregular and largest tarsal bone that forms the heel. (NCI) | Calcaneum | ||
CALCARINE SULCUS | C32252 | A cerebral fissure that originates near the occipital lobe and terminates below the corpus callosum. (NCI) | Calcarine Sulcus | |||
CALF MUSCULAR VEIN | C154703 | Any of the veins located within the muscles of the posterior lower leg, such as the gastrocnemial, soleal, and gemellar veins. | Calf Muscular Vein | |||
CALF | C93027 | The posterior aspect of the lower extremity that extends from the knee to the foot. (NCI) | Calf | |||
CANINE TOOTH | C32258 | Canine Tooth | A single-cusped (pointed) and usually single-rooted tooth located between the incisors and premolars. (NCI) | Canine Tooth | ||
CAPITATE BONE | C12856 | Capitate Bone | The largest of eight carpal bones, located in the center of the hand. (NCI) | Capitate Bone | ||
CAPITATE-HAMATE JOINT | C139188 | A condyloid synovial joint within the wrist connecting the capitate bone to the hamate bone. | Capitate-Hamate Joint | |||
CAPITATE-LUNATE JOINT | C139189 | A condyloid synovial joint within the wrist connecting the capitate bone to the lunate bone. | Capitate-Lunate Joint | |||
CARDIAC VALVE | C12729 | A valve located in the heart. | Cardiac Valve | |||
CARDIAC WALL | C139201 | All of the tissue that comprises the solid, outer structure of the heart, including the epicardium, the myocardium, and the endocardium. | Cardiac Wall | |||
CARDIOPHRENIC LYMPH NODE | C121555 | Cardiophrenic Angle Lymph Node | A lymph node located in the angle between the heart and diaphragm. | Cardiophrenic Lymph Node | ||
CARDIOVASCULAR SYSTEM | C12686 | Circulatory System | A collection of organs including the heart and the blood vessels. | Cardiovascular System | ||
CARINA | C25264 | Carina, Tracheal | A ridge at the bifurcation of the trachea where the primary bronchi meet. | Carina | ||
CAROTID ARTERY | C12687 | Common Carotid Artery | An artery of the mediastinum and neck; in general it arises as a primary or secondary branch of the aortic arch and branches into the internal and external carotid arteries. | Common Carotid Artery | ||
CAROTID BODY | C66852 | A cluster of cells that function as chemo-receptors, located near the bifurcation of the carotid artery. | Carotid Body | |||
CARPAL BONE | C12688 | Any of the bones of the joint located between the radius and ulna and metacarpus. | Carpal Bone | |||
CARPOMETACARPAL JOINT 1 | C103912 | CMC1 | A saddle-shaped synovial joint between the metacarpal of the thumb and the trapezium. (NCI) | Carpometacarpal Joint 1 | ||
CARPOMETACARPAL JOINT 2 | C103913 | CMC2 | A plane joint primarily between the second metacarpal and the trapezoid, which also connects with the trapezium and capitate. (NCI) | Carpometacarpal Joint 2 | ||
CARPOMETACARPAL JOINT 3 | C103914 | CMC3 | A plane joint between the third metacarpal and the capitate. (NCI) | Carpometacarpal Joint 3 | ||
CARPOMETACARPAL JOINT 4 | C103915 | CMC4 | A plane joint between the fourth metacarpal and the hamate. (NCI) | Carpometacarpal Joint 4 | ||
CARPOMETACARPAL JOINT 5 | C103916 | CMC5 | A plane joint between the fifth metacarpal and the pisiform. (NCI) | Carpometacarpal Joint 5 | ||
CARPOMETACARPAL JOINT | C32265 | The articulation of the proximal bases of the metacarpal bones and the distal carpal bones in the fingers, and the first metacarpal bone and the trapezium bone of the wrist in the thumb. | Carpometacarpal Joint | |||
CARTILAGE | C12373 | A type of connective tissue composed of chondrocytes and an extracellular matrix composed of collagen, elastin, and ground substance. There are three types of cartilage; namely elastic, hyaline, and fibrocartilage. | Cartilage | |||
CAUDAL VERTEBRA | C176319 | Any of the vertebrae below or posterior to the sacral vertebrae and that form the tail. | Caudal Vertebra | |||
CAUDATE NUCLEUS | C12451 | The gray matter adjacent to each lateral ventricle of the brain that comprises the medial dorsal striatum of the basal ganglia. | Caudate Nucleus | |||
CECUM | C12381 | The pouch-like portion of the proximal large intestine opening into the colon. | Cecum | |||
CELIAC ARTERY | C52846 | Celiac Trunk | An artery of the abdomen; in general it arises from the abdominal aorta below the diaphragm and branches to form the left gastric artery, common hepatic artery, and splenic artery. | Celiac Artery | ||
CELIAC LYMPH NODE | C65166 | Celiac Axis Lymph Node;Celiac Lymph Node | A lymph node at the base of the celiac artery. (NCI) | Celiac Lymph Node | ||
CENTRAL NERVOUS SYSTEM | C12438 | The part of the nervous system that consists of the brain, spinal cord, and meninges. (NCI) | Central Nervous System | |||
CEPHALIC VEIN | C32286 | Vena Cephalica | A vein of the arm/forelimb; in general it arises from the dorsal venous network of the hand/forefoot and drains into the axillary vein. | Cephalic Vein | ||
CEREBELLAR LOBE | C186108 | Any one of the individual lobes that make up the cerebellum of the brain. | Cerebellar Lobe | |||
CEREBELLUM | C12445 | The portion of the brain that extends from the brainstem through the cerebellar folia. | Cerebellum | |||
CEREBRAL ARTERY | C12691 | Any artery supplying the cerebral cortex. | Cerebral Artery | |||
CEREBRAL CORTEX | C12443 | Cerebral Cortex | The outer layer of the cerebrum composed of neurons and unmyelinated nerve fibers. It is responsible for memory, attention, consciousness and other higher levels of mental function. | Cerebral Cortex | ||
CEREBRAL HEMISPHERE, LEFT | C32955 | The left half of the cerebrum. | Left Cerebral Hemisphere | |||
CEREBRAL HEMISPHERE, RIGHT | C33472 | The right half of the cerebrum. | Right Cerebral Hemisphere | |||
CEREBRAL PEDUNCLE | C32291 | The paired anterior portions of the midbrain consisting of the crus cerebri, the tegmentum, and the substantia nigra. | Cerebral Peduncle | |||
CEREBRAL SUBCORTEX | C98712 | Cerebral Subcortex | The layer located below the cerebral cortex that includes the forebrain, midbrain and hindbrain. (NCI) | Cerebral Subcortex | ||
CEREBRAL VEIN | C53037 | Any of the external or internal veins that drain the cerebral hemispheres. | Cerebral Vein | |||
CEREBRUM | C12351 | The portion of the brain comprising the frontal, parietal, temporal, and occipital lobes and extending through the thalamus. | Cerebral Hemisphere | |||
CERVICAL LYMPH NODE | C32298 | Lymph node(s) in the cervical region, or neck. | Cervical Lymph Node | |||
CERVICAL SPINE | C69313 | The set of vertebrae immediately caudal to the skull. | Cervical Spine | |||
CERVICAL VERTEBRA | C12693 | Any one of the seven vertebrae that are caudal to the skull, denoted as C1, C2, C3, C4, C5, C6 or C7. | Cervical Vertebra | |||
CERVICOVAGINAL REGION | C178002 | The region of the body that comprises the uterine cervix and vagina. (NCI) | Cervicovaginal Region | |||
CERVIX UTERI | C12311 | Cervix Uteri;Uterine Cervix | The portion of the uterus (or uterine horns) that empties into the vagina. | Cervix Uteri | ||
CHEEK | C13070 | The soft tissue on the lateral aspects of the face, generally bounded by the eyes, nose, ear, and jaw line. | Cheek | |||
CHEST WALL | C62484 | Chest Wall | The total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura. (NCI) | Chest Wall | ||
CHEST | C25389 | Chest | The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction. (NCI) | Chest | ||
CHIN | C81169 | The part of the face below the lower lip and including the protruding part of the lower jaw. | Mentum | |||
CHORDAE TENDINEAE | C32307 | Chorda Tendinea | Any of the tendons that connect the papillary muscles to the tricuspid and mitral valves. | Chordae Tendineae | ||
CHOROID PLEXUS | C12694 | Blood vessels and ependyma forming villous structures in the ventricles of the brain. | Choroid Plexus | |||
CHOROID | C12344 | A blood vessel-containing membrane of the eye that lies between the retina and the sclera. (NCI) | Choroid | |||
CILIARY BODY | C12345 | Circumferential tissue located behind the iris and composed of muscle and epithelium. | Ciliary Body | |||
CINGULATE CORTEX | C52713 | Part of the medial aspect of the cerebral cortex. (NCI) | Cingulate Cortex | |||
CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY | C102287 | CIRC AV;CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY SEGMENT | The segment of the left circumflex artery that is distal to the third marginal branch, located in the atrioventricular groove. | Circumflex Artery AV Groove Continuation Artery | ||
CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES | C102286 | The left circumflex coronary artery and all of its branches. | Circumflex Artery and its Branches | |||
CLAVICLE | C12695 | The paired bone that is situated between the sternum and the shoulder. | Clavicle | |||
CLAW | C176323 | The curved, pointed appendage on the distal end of a digit, composed of keratin. | Claw | |||
CLITORIS | C12308 | The erectile tissue in the vulva. It is composed of the corpora cavernosa and the glans clitoris. | Clitoris | |||
CLIVUS | C12494 | A sloped depression between the dorsum sellae and foramen magnum at the base of the skull. | Clivus | |||
COCCYGEAL VERTEBRA | C32334 | Coccygeal Vertebra | Four vertebral segments positioned at the base of the spine that are fused. (NCI) | Coccygeal Vertebra | ||
COCCYX | C12696 | Coccyx | A small bone located at the bottom of the spine. The coccyx is a result of 3-5 fused rudimentary vertebrae. (NCI) | Coccyx | ||
COLON LYMPH NODE | C176317 | A lymph node located in the colon. | Colon Lymph Node | |||
COLON WALL | C176315 | The portion of the gastrointestinal tract wall that surrounds the cavity of the colon and contains teniae coli, haustra, and epiploic appendages. | Colon Wall | |||
COLON | C12382 | The portion of the large intestine which extends from the cecum (or small intestine in animals that don't have a cecum) to the rectum. | Colon | |||
COLON, ASCENDING | C12265 | Ascending Colon | The first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen. (NCI) | Ascending Colon | ||
COLON, DESCENDING | C12268 | Descending Colon | The fourth portion of the large intestine (colon) that communicates with the transverse colon in the left-upper quadrant of the abdomen and the rectum below. (NCI) | Descending Colon | ||
COLON, HEPATIC FLEXURE | C12266 | Hepatic Flexure;Right Colic Flexure | The bend at the junction of the ascending and transverse colon. | Hepatic Flexure | ||
COLON, LEFT | C33929 | Left Colon | The portion of the large intestine that includes the descending and sigmoid colon. (NCI) | Left Colon | ||
COLON, RECTOSIGMOID | C103438 | A portion of the large intestine that includes the sigmoid colon and rectum. | Rectosigmoid Colon | |||
COLON, RIGHT | C12383 | Right Colon | The proximal segment of the large intestine that is located in the right side of the abdominal cavity. It includes the cecum (with the attached appendix) and the ascending colon. (NCI) | Right Colon | ||
COLON, SIGMOID | C12384 | Sigmoid Colon | The portion of the colon that connects to the descending colon above and the rectum below. (NCI) | Sigmoid Colon | ||
COLON, SPLENIC FLEXURE | C12267 | Left Colic Flexure;Splenic Flexure | The bend at the junction of the transverse and descending colon. | Splenic Flexure | ||
COLON, TRANSVERSE | C12385 | Transverse Colon | The third division of the colon (large intestine). It communicates with the ascending colon in the upper right-hand quadrant of the abdomen and the descending colon in the upper left-hand quadrant. (NCI) | Transverse Colon | ||
COLONIC MUCOSA | C164003 | The mucosal membranes that line the inner surface of the colon. | Colonic Mucosa | |||
COMMON BILE DUCT | C12698 | Common Duct | A duct that conveys bile from the convergence of the cystic and hepatic duct to the duodenum. | Common Bile Duct | ||
COMMON FEMORAL ARTERY | C32354 | An artery arising from the external iliac artery at the inguinal ligament which bifurcates forming the deep and superficial femoral arteries. | Common Femoral Artery | |||
COMMON FEMORAL VEIN | C154771 | A vein that accompanies the common femoral artery and originates at the confluence of the femoral vein and the deep femoral vein. | Common Femoral Vein | |||
COMMON ILIAC ARTERY | C32357 | An artery arising from the bifurcation of the abdominal aorta which then bifurcates forming the internal and external iliac arteries. | Common Iliac Artery | |||
COMMON ILIAC LYMPH NODE | C103384 | A lymph node located adjacent to the common iliac artery. (NCI) | Common Iliac Lymph Node | |||
COMMON PALMAR DIGITAL ARTERY | C52744 | Any of the arteries arising from the superficial palmar arch which run distally on the second, third and fourth lumbricals muscles to the interdigital clefts where each artery then separates into two proper palmar digital arteries. | Common Palmar Digital Artery | |||
CONJUNCTIVA | C12341 | A thin tissue divided into the palpebral conjunctiva (covering the inner side of the eye lid) and the bulbar conjunctiva (covering the eyeball). (NCI) | Conjunctiva | |||
CORNEA | C12342 | The transparent, avascular tissue covering the front of the eye and is continuous with the sclera. | Cornea | |||
CORNEAL ENDOTHELIUM | C12707 | The endothelial layer of the cornea. | Corneal Endothelium | |||
CORNEAL EPITHELIUM | C12928 | The epithelial layer of the cornea. | Corneal Epithelium | |||
CORNEAL STROMA | C12699 | The stromal layer of the cornea. | Corneal Stroma | |||
CORONARY ARTERY | C12843 | One of the arteries of the heart; in general it arises from the aortic root and supplies the myocardium. | Coronary Artery | |||
CORONARY ARTERY, ANTERIOR DESCENDING | C32089 | Anterior Descending Coronary Artery;Left Anterior Descending Coronary Artery | A left coronary artery branch that descends on the anterior portion of the heart through the anterior interventricular groove. (NCI) | Anterior Descending Coronary Artery | ||
CORONARY ARTERY, LEFT | C12872 | Left Coronary Artery;Left Main Coronary Artery;Left Main Coronary Artery Segment;LM | A coronary artery that arises from the aorta and bifurcates into the left anterior descending artery and the left circumflex artery. (NCI) | Left Coronary Artery | ||
CORONARY ARTERY, RIGHT | C12875 | Right Coronary Artery | A coronary artery that originates above the right coronary cusp and supplies blood predominantly to the right side of the heart. (NCI) | Right Coronary Artery | ||
CORONARY SINUS | C32378 | The coronary vein that terminates in the right atrium and transports deoxygenated blood from the coronary circulation. | Coronary Sinus | |||
CORONARY VEIN | C12882 | A blood vessel in the heart which returns coronary blood to the right atrium. | Coronary Vein | |||
CORPUS CALLOSUM | C12446 | A white matter structure within the brain that connects the left and right cerebral hemispheres. | Corpus Callosum | |||
CORPUS CALLOSUM, BODY | C32216 | An area within the corpus callosum between the genu (anterior region) and the splenium (posterior region). | Body of the Corpus Callosum | |||
CORPUS CALLOSUM, GENU | C32675 | The anterior portion of the corpus callosum that bends down and back. | Genu of the Corpus Callosum | |||
CORPUS CALLOSUM, SPLENIUM | C33610 | The thick, convex posterior region of the corpus callosum. | Splenium of the Corpus Callosum | |||
CORPUS LUTEUM | C26465 | Corpus Luteum | A group of cells that remain of the Graafian follicle following ovulation. This structure is composed of endocrine tissue and produces progesterone. This is needed to prepare the uterine lining for implantation by the fertilized egg. (NCI) | Corpus Luteum | ||
CORPUS STRIATUM | C12448 | The portion of the brain consisting of the neostriatum and globus pallidus. | Corpus Striatum | |||
CORPUS UTERI | C12316 | Uterine Body;Uterus, Corpus | The body of the uterus. | Corpus Uteri | ||
CORRUGATOR SUPERCILII MUSCLE | C163511 | A muscle of the face, in general extending from the medial superciliary arch to the skin above the middle of the supraorbital margins; primary function is to move the eyebrows. | Corrugator Supercilii Muscle | |||
COSTAL CARTILAGE | C32391 | Costal Cartilage | The cartilage positioned between the anterior end of the rib and the sternum. Its elasticity allows the ribcage to expand while breathing. (NCI) | Costal Cartilage | ||
COSTOCHONDRAL JOINT 1 | C102288 | The first hyaline cartilaginous joint between the ribs and costal cartilage. | Costochondral Joint 1 | |||
COSTOCHONDRAL JOINT 7 | C102289 | The seventh hyaline cartilaginous joint between the ribs and costal cartilage. | Costochondral Joint 7 | |||
CRANIAL CAVITY | C77638 | Intracranial Cavity | The space that is formed by the bones of the skull, and contains the brain. | Cranial Cavity | ||
CRANIAL NERVE | C12700 | Any of the 12 paired nerves that originate in the brain stem. (NCI) | Cranial Nerve | |||
CUBOID BONE | C32414 | Cuboid Bone | A bone on the lateral side of the tarsus between the calcaneus and the fourth and fifth metatarsal bones. (NCI) | Cuboid Bone | ||
DELTOID MUSCLE | C32446 | The muscle that creates the rounded contour of the shoulder which originates from the lateral third of the clavicle, the superior surface of the acromion process, and the posterior border of the spine of the scapula and inserts on the lateral side of the shaft of the humerus. (NCI) | Deltoid | |||
DENTAL ARCH | C174321 | The curved or bowlike structure formed by the arrangement of teeth within the jaw. | Dental Arch | |||
DERMAL PAPILLAE OF THE FACE | C186109 | Dermal projection on the face, generally associated with whiskers. (Makris S, Solomon HM, Clark R, Shiota K, Barbellion S, Buschmann J, Ema M, Fujiwara M, Grote K, Hazelden KP, Hew KW, Horimoto M, Ooshima Y, Parkinson M, Wise LD. Terminology of developmental abnormalities in common laboratory mammals (Version 2). Part B. Birth Defects Res B Dev Reprod Toxicol. 2009 Aug;86(4):227-327.) | Dermal Papillae Of The Face | |||
DESCENDING AORTA | C32455 | The portion of the aorta distal to the aortic arch which passes into the chest and abdomen to create the thoracic and abdominal segments. | Descending Aorta | |||
DIAPHRAGM | C12702 | A musculotendinous sheet separating the thoracic cavity from the abdominal cavity. | Diaphragm | |||
DIAPHRAGMATIC LYMPH NODE | C132391 | Lymph node located adjacent to the diaphragm. | Diaphragmatic Lymph Node | |||
DIGIT | C40186 | The most distal structure of the limb, usually containing claws or nails and pads. | Digit | |||
DIGITAL ARTERY | C177918 | A type of artery that supplies blood to the fingers and toes. In the hand, the digital arteries include the common palmar digital arteries that arise from the superficial palmar arch, the proper palmar digital arteries that are branches of the common palmar digital arteries and occasionally have dorsal branches distal to the proximal interphalangeal joints, and the dorsal digital arteries that are branches of the dorsal metacarpal arteries. In the foot, the digital arteries include the plantar digital arteries that arise from the plantar arch and the dorsal digital arteries that are branches of the dorsal metatarsal arteries. (NCI) | Digital Artery | |||
DISTAL CIRCUMFLEX ARTERY | C102290 | DCIRC;DISTAL CIRCUMFLEX ARTERY SEGMENT | The segment of the left circumflex artery that is between the second and third obtuse marginal branches. | Distal Circumflex Artery | ||
DISTAL COMMON BILE DUCT | C60801 | The portion of the common bile duct that is closest to the intestine and furthest from the hepatic and cystic ducts. | Distal Common Bile Duct | |||
DISTAL EXTRAHEPATIC BILE DUCT REGION | C174320 | The area of the body that extends from where the cystic duct meets the common bile duct to the common bile duct's insertion into the small intestine. | Distal Extrahepatic Bile Duct Region | |||
DISTAL FEMUR R1 | C139208 | The portion of the distal femur, identified during a dual x-ray absorptiometry (DXA) scan, that contains primarily metaphyseal or trabecular bone. | Distal Femur R1 | |||
DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT | C114198 | DIP2 of the Foot | A ginglymoid (hinge) synovial joint within the second digit of the foot articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 2 of the Foot | ||
DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND | C114188 | DIP2 of the Hand | A ginglymoid (hinge) synovial joint within the second digit of the hand articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 2 of the Hand | ||
DISTAL INTERPHALANGEAL JOINT 2 | C102291 | DIP2 | A condyloid synovial joint within the second digit of the hand or foot articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 2 | ||
DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT | C114199 | DIP3 of the Foot | A ginglymoid (hinge) synovial joint within the third digit of the foot articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 3 of the Foot | ||
DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND | C114189 | DIP3 of the Hand | A ginglymoid (hinge) synovial joint within the third digit of the hand articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 3 of the Hand | ||
DISTAL INTERPHALANGEAL JOINT 3 | C102292 | DIP3 | A condyloid synovial joint within the third digit of the hand or foot articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 3 | ||
DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT | C114275 | DIP4 of the Foot | A ginglymoid (hinge) synovial joint within the fourth digit of the foot articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 4 of the Foot | ||
DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND | C114273 | DIP4 of the Hand | A ginglymoid (hinge) synovial joint within the fourth digit of the hand articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 4 of the Hand | ||
DISTAL INTERPHALANGEAL JOINT 4 | C102293 | DIP4 | A condyloid synovial joint within the fourth digit of the hand or foot articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 4 | ||
DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT | C114276 | DIP5 of the Foot | A ginglymoid (hinge) synovial joint within the fifth digit of the foot articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 5 of the Foot | ||
DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND | C114274 | DIP5 of the Hand | A ginglymoid (hinge) synovial joint within the fifth digit of the hand articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 5 of the Hand | ||
DISTAL INTERPHALANGEAL JOINT 5 | C102294 | DIP5 | A condyloid synovial joint within the fifth digit of the hand or foot articulating the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 5 | ||
DISTAL LAD ARTERY | C102295 | DISTAL LAD ARTERY SEGMENT;DLAD | The segment of the left anterior descending (LAD) artery that is distal to the third diagonal branch. | Distal Left Anterior Descending Artery | ||
DISTAL PHALANX 2 OF THE HAND | C139190 | The bone that forms the tip of the second finger, as counted from the thenar side of the hand. | Hand Digit 2 Distal Phalanx | |||
DISTAL PHALANX 3 OF THE HAND | C139191 | The bone that forms the tip of the third finger, as counted from the thenar side of the hand. | Hand Digit 3 Distal Phalanx | |||
DISTAL PHALANX 4 OF THE HAND | C139192 | The bone that forms the tip of the fourth finger, as counted from the thenar side of the hand. | Hand Digit 4 Distal Phalanx | |||
DISTAL PHALANX 5 OF THE HAND | C139193 | The bone that forms the tip of the fifth finger, as counted from the thenar side of the hand. | Hand Digit 5 Distal Phalanx | |||
DISTAL RADIOULNAR JOINT | C139194 | The articulation of the distal head of the ulna bone and the ulnar notch of the radius. | Distal Radioulnar Joint | |||
DISTAL RIGHT CORONARY ARTERY CONDUIT | C102296 | DISTAL RIGHT CORONARY ARTERY CONDUIT SEGMENT;DRCA | The section of the right coronary artery distal to the origin of the acute marginal artery. | Distal Right Coronary Artery Conduit | ||
DISTANT LYMPH NODE | C106042 | Lymph node(s) that is distant to the anatomic region of interest. | Distant Lymph Node | |||
DORSAL MOTOR NUCLEUS | C12934 | A brain nucleus located in the medulla oblongata. (NCI) | Dorsal Motor Nucleus | |||
DORSALIS PEDIS ARTERY | C32478 | Dorsal Pedal Artery;Dorsalis Pedis Artery | An artery of the dorsal surface of the foot, originating from the anterior tibial artery of the lower leg. The following arterial branches originate from the dorsalis pedis artery: the arcuate artery of the foot and deep plantar artery. (NCI) | Dorsalis Pedis Artery | ||
DUCTUS ARTERIOSUS | C52854 | An embryonic blood vessel that allows blood to bypass the lungs by connecting the pulmonary artery and the proximal descending aorta. | Ductus Arteriosus | |||
DUODENUM | C12263 | The portion of the small intestine between the stomach and jejunum. | Duodenum | |||
DURA MATER | C32488 | The outermost, toughest, and most fibrous of the three membranes (meninges) that surround and protect the brain and spinal cord. (NCI) | Dura Mater | |||
DURAL VENOUS SINUS | C102627 | Venous channels within the dura mater of the brain which receives both blood from blood vessels within the brain as well as cerebrospinal fluid then drains into the internal jugular vein. Unlike other blood vessels, dural venous sinuses lack valves and other vessel associated layers. | Dural Venous Sinus | |||
EAR | C12394 | A sensory organ that contains auditory and vestibular apparatuses. | Ear | |||
EAR, INNER | C12499 | Internal Ear;Labyrinth | The innermost portion of the ear that contains the vestibule, cochlea and semicircular canals. | Inner Ear | ||
EAR, OUTER | C12292 | Auricle;External Ear;Pinna | The external part of the ear. (NCI) | External Ear | ||
EARLOBE | C32999 | The soft fleshy portion of the lower external ear composed of areolar and adipose connective tissues. (NCI) | Lobule of the Auricle | |||
ELBOW EXTENSOR MUSCLES | C163512 | A group of two muscles in the upper extremity, the triceps brachii and anconeus; primary function is to straighten the arm at the elbow joint. | Elbow Extensors | |||
ELBOW FLEXOR MUSCLES | C163513 | A group of three muscles in the upper extremity, the brachialis, biceps brachii, and the brachioradialis; primary function is to bend the arm at the elbow joint. | Elbow Flexors | |||
ELBOW JOINT | C32497 | Elbow;Elbow Joint | A joint involving the humerus, radius and ulna bones. | Elbow Joint | ||
ENDOCARDIUM | C13004 | The layer of endothelial cells and connective tissue lining the chambers of the heart. (NCI) | Endocardium | |||
ENDOCERVIX | C12309 | The portion of the cervix which is lined by single columnar epithelium (mucosa). (NCI) | Endocervix | |||
ENDOMETRIAL CAVITY | C32514 | Endometrial Cavity | A space inside the uterus lined by a layer of mucous membranes called the endometrium. | Endometrial Cavity | ||
ENDOMETRIUM | C12313 | The mucous membrane comprising the inner layer of the uterine wall. | Endometrium | |||
ENTORHINAL CORTEX | C97338 | A brain region in the medial temporal lobe near the hippocampus. (NCI) | Entorhinal Cortex | |||
EPICARDIUM | C13164 | The outer membranous connective tissue layer of the heart tissue. (NCI) | Epicardium | |||
EPICONDYLE | C69300 | Epicondyle | A bone prominence to which ligaments and tendons of the joints are attached. (NCI) | Epicondyle | ||
EPIDIDYMIS | C12328 | A crescent-like structure located adjacent to the testis. It consists of a single highly coiled duct and is divided into 3 regions: caput (head), corpus (body) and cauda (tail). | Epididymis | |||
EPIDURAL SPACE | C41449 | The body space between the dura mater and the walls of the vertebral canal. | Epidural Spinal Canal Space | |||
EPIGASTRIC LYMPH NODE | C139195 | A parietal lymph node located along the inferior epigastric vessels. | Epigastric Lymph Node | |||
EPIGASTRIC REGION | C32525 | The most superior, central area of the abdomen, lying immediately superior to the umbilicus and bounded laterally by the costal margins. | Epigastric Region | |||
EPIGLOTTIS | C12709 | Epiglottis | A small cartilagenous flap-like valve that closes over the larynx during swallowing to prevent food entering the lungs. (NCI) | Epiglottis | ||
EPITROCHLEAR LYMPH NODE | C98182 | A lymph node located above and adjacent to the elbow. (NCI) | Epitrochlear Lymph Node | |||
ESOPHAGEAL LYMPH NODE | C139196 | Any lymph node located near the esophagus, including cervical, and upper, middle, and lower thoracic lymph nodes. | Esophageal Lymph Node | |||
ESOPHAGEAL MUCOSA | C32538 | The mucosal membranes that line the inner surface of the esophagus. | Esophageal Mucosa | |||
ESOPHAGUS | C12389 | The portion of the digestive tract between the pharynx and stomach. | Esophagus | |||
ESOPHAGUS, ABDOMINAL | C12252 | Abdominal Esophagus | Clinical esophageal segment composed of smooth muscle. It corresponds to the inferior part of the lower third topographic segment of the esophagus. (NCI) | Abdominal Esophagus | ||
ESOPHAGUS, CERVICAL | C12250 | Cervical Esophagus | Clinical esophageal segment composed of skeletal muscle. It corresponds to the superior part of the upper third topographic segment of the esophagus. (NCI) | Cervical Esophagus | ||
ESOPHAGUS, LOWER THIRD | C12255 | Lower Third of the Esophagus | The lower one third of the esophagus in which the muscle layer is composed of muscle cells predominantly of the smooth type. (NCI) | Lower Third of the Esophagus | ||
ESOPHAGUS, MIDDLE THIRD | C12254 | Middle Third of the Esophagus | The middle one third of the esophagus in which the muscle layer is composed of muscle cells of the striated and smooth types. | Middle Third of the Esophagus | ||
ESOPHAGUS, THORACIC LOWER | C198294 | The portion of the thoracic esophagus from midway between the tracheal bifurcation and gastroesophageal junction to gastroesophageal junction, including abdominal esophagus. (SEER) | Lower Thoracic Esophagus | |||
ESOPHAGUS, THORACIC MID | C198295 | Middle Thoracic Esophagus | The portion of the thoracic esophagus from the tracheal bifurcation midway to the gastroesophageal junction. (SEER) | Middle Thoracic Esophagus | ||
ESOPHAGUS, THORACIC UPPER | C198296 | The portion of the thoracic esophagus from the thoracic inlet to the level of the tracheal bifurcation. (SEER) | Upper Thoracic Esophagus | |||
ESOPHAGUS, THORACIC | C12251 | Thoracic Esophagus | Clinical esophageal segment composed of smooth muscle. It includes the middle third topographic segment, as well as parts of the upper and lower thirds. (NCI) | Thoracic Esophagus | ||
ESOPHAGUS, UPPER THIRD | C12253 | Upper Third of the Esophagus | The upper one third of esophagus in which the muscle layer is composed of muscle cells of the striated type. (NCI) | Upper Third of the Esophagus | ||
ETHMOID BONE | C12711 | Ethmoid Bone | A light and spongy bone that is cubical in shape. This bone is positioned at the anterior part of the cranium, sitting between the two orbits, at the roof of the nose. It consists of four parts: a horizontal or cribriform plate; a perpendicular plate; and two lateral masses or labyrinths. (NCI) | Ethmoid Bone | ||
ETHMOID SINUS | C12276 | Ethmoid Sinus | A sinus of the meatuses of the nasal cavity. (NCI) | Ethmoid Sinus | ||
EXOCCIPITAL BONE | C186110 | The lateral portions of the occipital bone lying on either side of the foramen magnum; it is present during fetal development and later fuses with the occipital bone. | Exoccipital Bone | |||
EXTENSOR CARPI RADIALIS MUSCLES | C187833 | A group of two muscles of the hand, the extensor carpi radialis brevis and extensor carpi radialis longus. Primary function is radial extension and abduction or deviation of the wrist. | Extensor Carpi Radialis Muscles | |||
EXTENSOR CARPI ULNARIS MUSCLE | C52914 | A muscle of the wrist, in general extending from the humeral and ulnar heads to the base of the fifth metacarpal bone; primary function is to extend and abduct the wrist toward the ulna. | Extensor Carpi Ulnaris | |||
EXTENSOR DIGITI MINIMI MUSCLE | C186111 | A muscle of the forearm, in general extending from the lateral epicondyle of the humerus to the extensor expansion of the fifth digit; primary function is to extend the fifth digit at the metacarpophalangeal joint. | Extensor Digiti Minimi Muscle | |||
EXTENSOR DIGITORUM BREVIS MUSCLE | C163514 | A muscle in the foot, in general extending from the superolateral surface of the anterior calcaneus to the lateral sides of the tendons of extensor digitorum longus on the second, third and fourth toes; primary function is to extend the second, third and fourth toes. | Extensor Digitorum Brevis Muscle | |||
EXTENSOR DIGITORUM LONGUS MUSCLE | C52918 | Long Digital Extensor Muscle | A muscle extending from the lateral surface of the tibia to the digits; primary function is the extension of the digits and flexion of the tarsal joint. | Extensor Digitorum Longus | ||
EXTENSOR DIGITORUM MUSCLE | C52916 | A muscle of the hand, in general extending from the lateral epicondyle of the humerus to the base of the proximal, middle, and distal phalanges; primary function is to extend the fingers. | Extensor Digitorum Communis | |||
EXTENSOR HALLUCIS BREVIS MUSCLE | C163515 | A muscle in the foot, in general extending from the superior surface of the anterior calcaneus to the dorsal surface of the base of the proximal phalanx of the big toe; primary function is to extend the big toe. | Extensor Hallucis Brevis Muscle | |||
EXTENSOR HALLUCIS LONGUS MUSCLE | C186112 | A muscle of the lower leg, in general extending from the middle third of the medial surface of the fibula and the adjacent interosseous membrane to the base and dorsal center of the distal phalanx of the great toe; primary function is to extend the big toe and dorsiflex the ankle. | Extensor Hallucis Longus Muscle | |||
EXTENSOR INDICIS PROPRIUS MUSCLE | C186113 | A muscle of the forearm, in general extending from the posterior surface of the ulna to the base of the second proximal phalanx and the tendon of the extensor digitorum muscle; primary function is to extend the second digit at metacarpophalangeal and interphalangeal joints. | Extensor Indicis Proprius Muscle | |||
EXTENSOR POLLICIS BREVIS MUSCLE | C186114 | A muscle of the forearm, in general extending from the posterior surface of the distal third of the radius and the adjacent interosseous membrane to the posterior surface of the base of the proximal phalanx of the thumb; primary function is to extend the thumb at the carpometacarpal and metacarpophalangeal joints. | Extensor Pollicis Brevis Muscle | |||
EXTENSOR POLLICIS LONGUS MUSCLE | C186115 | A muscle of the forearm, in general extending from the posterior surface of the middle third of the ulna and the adjacent interosseous membrane to the posterior surface of the base of the distal phalanx of the thumb; primary function is to extend the thumb at the metacarpophalangeal and interphalangeal joints and extend and abduct the wrist joint. | Extensor Pollicis Longus Muscle | |||
EXTERNAL ACOUSTIC MEATUS | C12498 | Auditory Canal;Ear Canal;External Acoustic Meatus;External Auditory Canal;External Auditory Meatus | A tubular structure that runs from the outer ear to the tympanic membrane. | External Acoustic Meatus | ||
EXTERNAL ILIAC ARTERY | C32558 | An artery arising from the bifurcation of the common iliac artery in the lower torso. The external iliac artery becomes the femoral artery and is the main blood supply for the leg. | External Iliac Artery | |||
EXTERNAL ILIAC LYMPH NODE | C88143 | A lymph node located along the external iliac artery. (NCI) | External Iliac Lymph Node | |||
EXTRAABDOMINAL LYMPH NODE | C165584 | A lymph node that is located outside of the abdominal wall. | Extra-Abdominal Lymph Node | |||
EXTRAHEPATIC BILE DUCT | C32573 | The portion of the biliary tract outside the liver; the common hepatic duct joins the cystic duct to form the common bile duct. (NCI) | Extrahepatic Bile Duct | |||
EXTRAHEPATIC PERIHILAR BILE DUCT REGION | C174319 | The area of the body where the right and left hepatic ducts exit the liver and join to form the common hepatic duct that is proximal to the origin of the cystic duct. (PDQ) | Extrahepatic Perihilar Bile Duct Region | |||
EXTRAOCULAR MUSCLE | C33199 | Oculomotor Muscle | A group of muscles in the orbit extending from the posterior orbit to the eye and upper eyelid; primary function is the movement of the eye and retraction of the upper eyelid. | Extraocular Muscle | ||
EYE BULGE | C176325 | The external protuberance of the eyeball beneath the eyelid. (Makris S, Solomon HM, Clark R, Shiota K, Barbellion S, Buschmann J, Ema M, Fujiwara M, Grote K, Hazelden KP, Hew KW, Horimoto M, Ooshima Y, Parkinson M, Wise LD. Terminology of developmental abnormalities in common laboratory mammals (Version 2). Part B. Birth Defects Res B Dev Reprod Toxicol. 2009 Aug;86(4):227-327.) | Eye Bulge | |||
EYE | C12401 | Eyeball | The sensory organ of vision. | Eye | ||
EYE, ANTERIOR CHAMBER | C12667 | The space in the eye filled with aqueous humor and bounded by the cornea, a small portion of the sclera, a small portion of the ciliary body, the iris and lens. (Cline et al., Dictionary of Visual Science, 4th ed, p109) | Anterior Chamber of the Eye | |||
EYE, ANTERIOR SEGMENT | C12668 | The front part of the eye, which is posteriorly bordered by posterior surfaces of the posterior lens capsule, lens zonules, and ciliary body; it includes the cornea, conjunctiva, lacrimal gland, tear film, iris, lens, ciliary body, anterior portion of the sclera, and anterior chamber. | Anterior Eye Segment | |||
EYE, VITREOUS CHAMBER | C33885 | Postremal Chamber | The largest space within the eye which is bounded by the lens and the retina and filled with the gelatinous vitreous humor. (NCI) | Vitreous Chamber | ||
EYEBROW | C32575 | The arched strip of hairs (supercilia) on the brow ridge (supercilium) above each eye socket. | Eyebrow | |||
EYELASH | C32576 | Anyone of the short hairs that grow on the edge of the eyelid. (NCI) | Eyelash | |||
EYELID | C12713 | Palpebra | The section of skin, containing muscle and conjunctiva, that covers and protects the eye. | Eyelid | ||
FACE | C13071 | The portion of the head that contains the structures such as the eyes, nose, mouth, and jaws. | Face | |||
FACET JOINT | C32577 | Facet Joint | A synovial joint between two adjacent vertebrae. The facet joint links the articular process of one vertebra and the inferior articular process of the adjacent vertebra. (NCI) | Facet Joint | ||
FACIAL BONE | C63706 | Facial Bone | Any bone that contributes to the facial structures, except those bones that are part of the braincase. (NCI) | Facial Bone | ||
FACIAL MUSCLE | C13073 | Mimetic Muscles | Any of the muscles of the face that are supplied by the facial nerve and control facial expressions. | Facial Muscle | ||
FACIAL NERVE | C12714 | Seventh Cranial Nerve | A cranial nerve extending from the brain stem between the pons and medulla, which innervates the facial muscles, glands and the tongue. | Facial Nerve | ||
FALCIFORM LIGAMENT | C32582 | A fold of tissue consisting of two layers of peritoneum extending from the notch of the anterior margin of the liver to the anterior abdominal wall and diaphragm. | Falciform Ligament | |||
FALLOPIAN TUBE | C12403 | Fallopian Tube | The tube through which eggs pass from an ovary. | Fallopian Tube | ||
FASCIA | C13108 | A sheet or band of fibrous connective tissue enveloping, separating, or binding together muscles, organs and other soft structures of the body. | Fascia | |||
FAT PAD | C176326 | Encapsulated adipose tissue within the body. | Fat Pad | |||
FAUCES | C181454 | Isthmus of Fauces;Oropharyngeal Isthmus | The anatomical opening formed by the arch of the hard palate at the back of the mouth, where the oral cavity and pharynx meet. | Oropharyngeal Isthmus | ||
FEMALE GENITALIA | C61600 | Female Genitalia | Female internal and external organs of reproduction. | Female Genitalia | ||
FEMALE REPRODUCTIVE SYSTEM | C12402 | The sex organs of the female. | Female Reproductive System | |||
FEMORAL ARTERY | C12715 | An artery of the thigh; in general it arises from the external iliac artery distal to the inguinal ligment and continues as the popliteal artery. | Femoral Artery | |||
FEMORAL CONDYLE | C114186 | The rounded bony projection at the distal end of the femur. | Femoral Condyle | |||
FEMORAL HEAD | C32718 | Femur Head | The highest portion of the femoral bone that articulates with the acetabulum. (NCI) | Head of the Femur | ||
FEMORAL LYMPH NODE | C98183 | A lymph node located in the upper inner portion of the thigh. (NCI) | Femoral Lymph Node | |||
FEMORAL NECK | C61563 | Femoral Neck | The short, constricted portion of the thigh bone between the femur head and the trochanter. (NCI) | Femoral Neck | ||
FEMORAL VEIN | C12716 | A vein of the thigh; in general it arises from the popliteal vein and drains into the external iliac vein. | Femoral Vein | |||
FEMORO-POPLITEAL PERIPHERAL ARTERY | C116167 | The segment of the blood vessels that includes the popliteal artery and its origin from the femoral artery. | Femoropopliteal Artery Segment | |||
FEMUR SHAFT | C96209 | The cylindrical body of the femur. (NCI) | Femoral Shaft | |||
FEMUR | C12717 | Bone, Femoral | The bone positioned between the pelvis and the femorotibial joint. | Femur | ||
FIBULA SHAFT | C120670 | The elongated bony body of the fibula. | Fibular Shaft | |||
FIBULA | C12718 | The long bone that is lateral to the tibia. | Fibula | |||
FIBULAR VEIN | C154772 | A vein that arises from the plantar veins of the foot, accompanies the peroneal artery, and travels up the back of the leg to join the anterior and posterior tibial veins in forming the popliteal vein on the posterior surface of the knee. | Fibular Vein | |||
FINGER EXTENSOR MUSCLES | C163516 | A group of six muscles in the upper extremity, the abductor pollicis longus, extensor pollicis brevis, extensor pollicis longus, extensor indicis, extensor digitorum, and extensor digiti minimi muscles; primary function is to straighten the fingers to open the hand. | Finger Extensors | |||
FINGER EXTENSOR TENDONS | C161384 | The tendons located on the dorsal side of the fingers that connect muscles of the forearm and hand to bones in the fingers, enabling extension of the fingers. (NCI) | Finger Extensor Tendons | |||
FINGER FLEXOR MUSCLES | C163517 | A group of three muscles in the upper extremity, the flexor digitorum superficialis, flexor digitorum profundus, and flexor pollicis longus muscles; primary function is to bend the fingers. | Finger Flexors | |||
FINGER FLEXOR TENDONS | C161383 | The tendons located on the palm side of the fingers that connect the flexor muscles of the forearm and hand to bones in the fingers, enabling flexion towards the palm. (NCI) | Finger Flexor Tendons | |||
FINGER | C32608 | Finger | Any of the digits of the hand. (NCI) | Finger | ||
FINGERNAIL | C32609 | Fingernail | The nail at the end of a finger. (NCI) | Fingernail | ||
FINGERTIP | C187834 | The most distal end of the finger, beyond the nail bed. | Fingertip | |||
FIRST DIAGONAL BRANCH ARTERY | C102297 | 1ST DIAG;FIRST DIAGONAL BRANCH ARTERY SEGMENT | The first artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal. | First Diagonal Branch Artery | ||
FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT | C139197 | A dorsal interosseous muscle of the foot that originates on the lateral side of the first metatarsal and the medial side of the second metatarsal, and inserts into the medial side of the base of the proximal phalanx of the second toe. | First Dorsal Interosseous Muscle of the Foot | |||
FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND | C139198 | A dorsal interosseous muscle of the hand that originates on the proximal half of the lateral border of the index metacarpal and the full length of the medial border of the thumb metacarpal, and inserts into the lateral side of the index finger. | First Dorsal Interosseous Muscle of the Hand | |||
FIRST LEFT POSTEROLATERAL BRANCH ARTERY | C102298 | 1ST LPL;FIRST LEFT POSTEROLATERAL BRANCH ARTERY SEGMENT | In an individual with a left-dominant heart, this is the first branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall. | First Left Posterolateral Branch Artery | ||
FIRST OBTUSE MARGINAL BRANCH ARTERY | C102299 | 1ST OM;FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENT | The first artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal. | First Obtuse Marginal Branch Artery | ||
FIRST RIGHT POSTEROLATERAL ARTERY | C102300 | 1ST RPL;FIRST RIGHT POSTEROLATERAL ARTERY SEGMENT | In an individual with a right-dominant heart, this is the first branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal. | First Right Posterolateral Artery | ||
FLANK | C93028 | The region on either side of the body that extends from the last rib to the hip. | Flank | |||
FLEXOR CARPI RADIALIS MUSCLE | C53155 | A muscle in the forearm running from the head of the humerus to the radial side of the wrist that flexes and radially abducts the hand. (NCI) | Flexor Carpi Radialis | |||
FLEXOR CARPI ULNARIS MUSCLE | C53156 | A muscle in the forearm running from the humeral and ulnar heads to the ulnar side of the wrist that flexes and abducts the hand toward the ulna. (NCI) | Flexor Carpi Ulnaris | |||
FLEXOR DIGITORUM BREVIS MUSCLE | C163518 | A muscle in the foot, in general extending from the medial process of the posterior calcaneal tuberosity to the borders of the middle phalanx of the four lateral toes; primary function is flexion of the four lateral toes and support of the medial and lateral longitudinal arches. | Flexor Digitorum Brevis Muscle | |||
FLEXOR DIGITORUM LONGUS MUSCLE | C52921 | A muscle in the leg/hindlimb and foot/hindpaw, in general extending from the tibia to the phalanges; primary function is to flex the digits. | Flexor Digitorum Longus | |||
FLEXOR DIGITORUM PROFUNDUS MUSCLE | C52923 | A muscle in the forearm beginning at the head of the ulna and ending with four tendons projecting to the second, third, fourth, and fifth fingers which flexes the midcarpal, metacarpophalangeal and interphalangeal joints. (NCI) | Flexor Digitorum Profundus | |||
FLEXOR DIGITORUM SUPERFICIALIS MUSCLE | C150850 | A muscle in the forearm, in general extending from the humeroulnar and radial heads of the forearm to the middle phalanges of the second through fifth digits of the hand; primary function is flexion of the fingers at the proximal interphalangeal joints. | Flexor Digitorum Superficialis Muscle | |||
FLEXOR HALLUCIS BREVIS MUSCLE | C165998 | A muscle in the foot, in general extending from the plantar surface of the cuboid bone to the medial and lateral sesamoid bones at the base of the proximal phalanx of the big toe; primary function is flexion of the big toe and the support of the medial longitudinal arch. | Flexor Hallucis Brevis Muscle | |||
FLEXOR HALLUCIS LONGUS MUSCLE | C52925 | A muscle in the leg and foot, in general extending from the fibula to the distal surface of the big toe phalanx; primary function is to flex the big toe. | Flexor Hallucis Longus | |||
FLEXOR POLLICIS BREVIS MUSCLE | C186116 | A muscle of the hand, whose superficial head extends from the flexor retinaculum and tubercle of the trapezium bone and deep head that extends from the trapezoid and capitate bones, extending to the lateral side of the base of the proximal phalanx of the thumb; primary function is to flex the thumb at the metacarpophalangeal joint. | Flexor Pollicis Brevis Muscle | |||
FLEXOR POLLICIS LONGUS MUSCLE | C150851 | A muscle in the forearm, in general extending from the anterior surface of the radius and interosseous membrane to the palmar aspect of the base of the distal phalanx of the thumb; primary function is flexion of the thumb. | Flexor Pollicis Longus Muscle | |||
FLOOR OF MOUTH | C54187 | The area of the mouth under the ventral surface of the tongue. | Floor of Mouth | |||
FONTANELLE | C32621 | Fontanel;Soft Spot | The membrane-covered space between the skull bones of a neonate or fetus where ossification is not complete and sutures are not fully formed. | Fontanelle | ||
FOOT DIGIT 1 | C52839 | Big Toe | The largest and most medial toe of the foot. (NCI) | Foot Digit 1 | ||
FOOT DIGIT 2 | C52840 | Index Toe | The second toe from the medial side of the foot. (NCI) | Foot Digit 2 | ||
FOOT DIGIT 3 | C52841 | Middle Toe | The middle or third toe from the medial side of the foot. (NCI) | Foot Digit 3 | ||
FOOT DIGIT 4 | C52842 | Fourth Toe | The fourth toe from the medial side of the foot. (NCI) | Foot Digit 4 | ||
FOOT DIGIT 5 | C52843 | Little Toe | The smallest and most lateral toe of the foot. (NCI) | Foot Digit 5 | ||
FOOT PHALANX | C52772 | Foot Phalanx | A bone of the foot. (NCI) | Foot Phalanx | ||
FOOT | C32622 | The entire structure distal to the ankle joint/tarsus, which includes the metatarsus and digit(s). | Foot | |||
FOREARM PRONATOR MUSCLES | C186117 | A group of muscles in the ankle, the brachioradialis, pronator teres, pronator quadratus, and flexor carpi radialis muscles; primary function is to rotate the forearm so that the palm faces downward when the arm is extended at a right angle to the body. | Forearm Pronator Muscles | |||
FOREARM | C32628 | Forearm | The structure on the upper limb, between the elbow and the wrist. (NCI) | Forearm | ||
FOREBRAIN | C40185 | The largest part of the brain composed of the cerebral hemispheres, thalamus, hypothalamus, and the limbic system. (NCI) | Forebrain | |||
FOREHEAD | C89803 | Forehead | The part of the face between the eyebrows and the normal hairline. | Forehead | ||
FORELIMB | C176321 | The anterior, front or upper limb of an animal. | Fore Limb | |||
FOREPAW PHALANX | C186118 | Forepaw Phalange | Any of the bones that make up the digits of the forepaw. | Forepaw Phalanx | ||
FORESKIN | C33049 | Male Prepuce | A fold of skin covering the tip of the penis. | Male Prepuce | ||
FOVEA | C26463 | Fovea Centralis | Area consisting of a small depression in the retina containing only cones and where vision is most acute. | Fovea Centralis | ||
FRONTAL BONE | C32635 | A bone of the skull forming the front part of the skull, root of the nose, and the roof of both orbits. | Frontal Bone | |||
FRONTAL LOBE | C12352 | Frontal Lobe | The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. (NCI) | Frontal Lobe | ||
FRONTAL SINUS | C12277 | Frontal Sinus | The paired, mucosal lined air spaces located above the orbit and communicating with the nasal passages. (NCI) | Frontal Sinus | ||
FRONTALIS MUSCLE | C186119 | A muscle of the forehead, in general extending from the galea aponeurotica at the top of the skull to the skin around the eyebrows and the top of the nose; primary function is to raise the eyebrows. | Frontalis Muscle | |||
FUNDUS OF THE EYE | C135172 | The portion of the interior of the eye that includes the sensory retina, the optic disc, and the macula. | Eye Fundus | |||
FUNDUS OF THE STOMACH | C12257 | The blind sac region of the glandular stomach. | Fundus of the Stomach | |||
FUNDUS UTERI | C12315 | The upper, rounded portion of the uterus that is opposite from the cervix. | Fundus Uteri | |||
GALLBLADDER | C12377 | A sac-like organ located adjacent to the liver that stores and concentrates bile produced by the liver. | Gallbladder | |||
GANGLION | C12719 | Ganglia;Ganglion;Neural Ganglion | A cluster of nervous tissue principally composed of neuronal cell bodies external to the central nervous system (CNS). (NCI) | Ganglion | ||
GASTRIC CARDIA | C12256 | The region of the stomach adjacent to the esophogastric junction. | Gastric Cardia | |||
GASTRIC CURVATURE LYMPH NODE | C154773 | Lymph node(s) located between the two layers of the greater omentum, either superiorly along the cardiac half of the lesser curvature of the stomach or inferiorly along the pyloric half of the greater curvature of the stomach. | Gastric Curvature Lymph Node | |||
GASTRIC MUCOSA | C32656 | Stomach Mucosa | The mucosal membranes that line the inner surface of the stomach. | Gastric Mucosa | ||
GASTROCNEMIUS MUSCLE | C32666 | A bipennate muscle extending from the femoral condyles to the calcaneus; primary function is the extension of the tarsal joint and flexion of the femorotibial joint. | Gastrocnemius Muscle | |||
GASTROCNEMIUS MUSCLE, LATERAL HEAD | C163519 | One of two heads of the gastrocnemius muscle, in general originating from the lateral femoral condyle. | Lateral Head of Gastrocnemius Muscle | |||
GASTROCNEMIUS MUSCLE, MEDIAL HEAD | C163520 | One of two heads of the gastrocnemius muscle, in general originating from the medial femoral condyle. | Medial Head of Gastrocnemius Muscle | |||
GASTROESOPHAGEAL JUNCTION | C32668 | Gastroesophageal Junction | The anatomical location where the esophagus joins to the stomach. (NCI) | Gastroesophageal Junction | ||
GASTROINTESTINAL SYSTEM | C12378 | Gastrointestinal System | The system that includes the esophagus, stomach, small and large intestine, anus, liver, biliary tract, and pancreas. (NCI) | Digestive System | ||
GASTROINTESTINAL TRACT | C34082 | Gastrointestinal Tract | The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff. (NCI) | Gastrointestinal Tract | ||
GASTROINTESTINAL TRACT, LOWER | C33010 | Lower Gastrointestinal Tract | The lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine. (NCI) | Lower Gastrointestinal Tract | ||
GASTROINTESTINAL TRACT, LOWER, WALL | C176241 | The portion of the gastrointestinal tract wall that surrounds the cavities of the duodenum, jejunum, ileum, colon, rectum, and anus. | Lower Gastrointestinal Tract Wall | |||
GASTROINTESTINAL TRACT, UPPER | C33837 | Upper Gastrointestinal Tract | The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum. (NCI) | Upper Gastrointestinal Tract | ||
GASTROINTESTINAL TRACT, UPPER, WALL | C176314 | The portion of the gastrointestinal tract wall that surrounds the cavities of the esophagus and stomach. The proximal duodenum is also sometimes considered part of the upper gastrointestinal tract. | Upper Gastrointestinal Tract Wall | |||
GASTROINTESTINAL TRACT, WALL | C176233 | The multiple layers of specialized tissue that surround the cavity of the gastrointestinal tract, including the mucosa, submucosa, muscular layers, and serosa. | Gastrointestinal Tract Wall | |||
GENIOGLOSSUS MUSCLE | C52928 | A muscle of the tongue, in general extending from the mental spine of the mandible to the hyoid bone at the bottom of the tongue; primary function is to depress and protrude the tongue. | Genioglossus | |||
GENITAL TUBERCLE | C176324 | A protruding body of tissue that forms in the ventral caudal region during embryonic development. | Genital Tubercle | |||
GENITALIA | C25177 | The external sex organs. (NCI) | Genitalia | |||
GENITOURINARY SYSTEM | C12810 | The body system that includes all organs involved in reproduction and in the formation and voidance of urine. | Genitourinary System | |||
GINGIVA | C32677 | Gum | The soft tissue surrounding the neck of individual teeth as well as covering the alveolar bone. The tissue is fibrous and continuous with the periodontal ligament and mucosal covering. (NCI) | Gingiva | ||
GINGIVAL MUCOSA | C139199 | The portion of the oral mucosa that surrounds the cervical aspect of teeth and the alveolar process of the jaw. | Gingival Mucosa | |||
GLENOID FOSSA | C32682 | Glenoid Fossa | The trough in the head of the scapula that receives the head of the humerus to form the shoulder joint. (NCI) | Glenoid Fossa | ||
GLOBUS PALLIDUS | C12449 | Paired nuclei at the base of the forebrain that, along with the putamen, form the lentiform nucleus of the basal ganglia. | Globus Pallidus | |||
GLOMERULUS | C13250 | A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. | Glomerulus | |||
GLOSSOPHARYNGEAL NERVE | C12723 | The ninth cranial nerve. | Glossopharyngeal Nerve | |||
GLOTTIS | C12724 | Glottis | The space in which the vocal cords are located. (NCI) | Glottis | ||
GLOTTIS, ANTERIOR COMMISSURE | C128630 | Laryngeal Anterior Commissure | The anterior surface of the glottic opening, located within the larynx, that constitutes the junction of the conus elasticus and the thyroepiglottic, vestibular, and vocal ligaments. | Laryngeal Anterior Commissure | ||
GLOTTIS, POSTERIOR COMMISSURE | C164282 | Laryngeal Posterior Commissure | The posterior surface of the glottic opening at the level of the vocal cords. | Laryngeal Posterior Commissure | ||
GLUTEAL MUSCLE | C78205 | A group of three muscles (gluteus maximus, gluteus medius, gluteus minimus) extending from the ilium and sacrum to the femur; primary function is extension and abduction of the hip joint. | Gluteal Muscle | |||
GLUTEUS MAXIMUS | C52560 | The outermost and largest muscle of the buttocks. (NCI) | Gluteus Maximus | |||
GLUTEUS MEDIUS | C52933 | A muscle of the hip and buttock, in general extending from the gluteal surface of the ilium to the lateral aspect of the greater trochanter of the femur; primary function is to abduct and rotate the thigh. | Gluteus Medius | |||
GONAD | C12725 | A reproductive organ that produces gametes. | Gonad | |||
GRACILIS MUSCLE | C52935 | A muscle in the thigh, in general extending from the lower half of the symphysis pubis and the upper half of the pubic arch to the upper part of the medial surface of the tibia; primary function is to adduct the thigh, rotate the leg/hindlimb medially and flex the knee. | Gracilis | |||
GREAT SAPHENOUS VEIN | C33004 | Long Saphenous Vein | A long superficial vein originating from the dorsal vein at the big toe and the dorsal venous arch of the foot and extending up the inner leg to empty into the femoral artery in the groin area. | Long Saphenous Vein | ||
GREAT TROCHANTER | C32698 | Great Trochanter | A large, irregular, quadrilateral area of bone found at the neck of the femur. (NCI) | Great Trochanter | ||
GREAT VESSELS | C102955 | Any of the major arteries or veins attached to the cardiac atria or ventricles. | Great Blood Vessel | |||
GREATER CURVATURE OF THE STOMACH | C12262 | Greater Curvature of the Stomach | The lateral and inferior border of the stomach. Attached to it is the greater omentum. (NCI) | Greater Curvature of the Stomach | ||
GUT-ASSOCIATED LYMPHOID TISSUE | C12936 | GALT | Lymphoid tissue located in the mucosa of the digestive tract. | Gut-Associated Lymphoid Tissue | ||
HAIR BULB | C32706 | The lower segment of the hair that circles the dermal papilla and the hair matrix. (NCI) | Hair Bulb | |||
HAIR FOLLICLE | C13317 | A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (NCI) | Hair Follicle | |||
HAIR ROOT | C32711 | The portion of the hair that is enclosed within the hair follicle. (NCI) | Hair Root | |||
HAIR SHAFT | C33543 | Shaft of the Hair | The segment of the hair that projects above the skin surface. (NCI) | Shaft of the Hair | ||
HAIR | C32705 | Hair | The filamentous outgrowth of the epidermis. (NCI) | Hair | ||
HAMATE BONE | C12860 | Hamate Bone | The medial bone in the distal row of carpal bones. (NCI) | Hamate Bone | ||
HAMSTRING MUSCLE | C53042 | A group of three muscles in the lower extremity, the biceps femoris, semimembranosus muscle and semitendinosus muscle; primary function is to extend the hip when the trunk is fixed and flex the knee, and medially rotate the lower leg when the knee is bent. | Hamstring | |||
HAND DIGIT 1 ARTERY | C178000 | Thumb Artery | Any of the arteries that supply blood to the thumb; either the ulnopalmar, radiopalmar, ulnodorsal, or radiodorsal digital artery to the thumb, or the princeps pollicis artery. | Hand Digit 1 Artery | ||
HAND DIGIT 1 | C52834 | Thumb | The thick and short hand digit which is next to the index finger in humans. (NCI) | Hand Digit 1 | ||
HAND DIGIT 2 ARTERY | C177996 | Index Finger Artery | Any of the arteries that supply blood to the index finger, either the radial artery of the index finger or the ulnar proper digital artery. | Hand Digit 2 Artery | ||
HAND DIGIT 2 | C52835 | Index Finger | The second finger from the radial side of the hand, next to the thumb. (NCI) | Hand Digit 2 | ||
HAND DIGIT 3 ARTERY | C177998 | Middle Finger Artery | Any of the arteries that supply blood to the middle finger, either the ulnar or radial proper digital artery. | Hand Digit 3 Artery | ||
HAND DIGIT 3 | C52836 | Middle Finger | The middle or third finger from the radial side of the hand. (NCI) | Hand Digit 3 | ||
HAND DIGIT 4 ARTERY | C177999 | Ring Finger Artery | Any of the arteries that supply blood to the ring finger, either the ulnar or radial proper digital artery. | Hand Digit 4 Artery | ||
HAND DIGIT 4 | C52837 | Ring Finger | The fourth finger from the radial side of the hand. (NCI) | Hand Digit 4 | ||
HAND DIGIT 5 ARTERY | C177997 | Little Finger Artery | Any of the arteries that supply blood to the little finger, either the ulnar or radial proper digital artery. | Hand Digit 5 Artery | ||
HAND DIGIT 5 | C52838 | Little Finger | The fifth and smallest finger from the radial side of the hand. (NCI) | Hand Digit 5 | ||
HAND PHALANX | C52771 | Hand Phalanx | A bone of the hand. (NCI) | Hand Phalanx | ||
HAND | C32712 | Hand | The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits. (NCI) | Hand | ||
HARD PALATE | C12230 | The part of the roof of the mouth supported by bone. | Hard Palate | |||
HEAD AND NECK | C12418 | The area of the body comprising the skull, facial bones and the cervical vertebrae, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature, soft tissue and lymph nodes draining these areas. | Head and Neck | |||
HEAD OF THE FIBULA | C32719 | Fibular Head | The upper rounded part of the fibula that articulates with the tibia. | Head of the Fibula | ||
HEAD OF THE HUMERUS | C32720 | Head of the Humerus | The upper rounded part of the humerus that fits into the glenoid cavity of the scapula. (NCI) | Head of the Humerus | ||
HEAD | C12419 | The portion of the body containing the mouth, the brain and multiple sensory organs. | Head | |||
HEART | C12727 | A hollow muscular organ which receives the blood from the veins and pumps it into the arteries. | Heart | |||
HEART, APEX | C32126 | Apex of the Heart | The most outer superficial part of the heart which is situated on the left 5th intercostal space. (NCI) | Apex of the Heart | ||
HEART, ATRIUM | C12728 | Cardiac Atrium | The smaller chamber(s) of the heart that receives blood from the peripheral circulation and/or the lungs. | Cardiac Atrium | ||
HEART, BASE | C48589 | Base of the Heart | The superior portion of the heart located opposite to the apical portion. It is formed mainly by the left atrium. (NCI) | Base of the Heart | ||
HEART, FORAMEN OVALE | C34241 | An opening between the right and left atria in the fetal heart that allows blood to bypass the lungs and flow directly into the systemic circulation. | Foramen Ovale of the Fetal Heart | |||
HEART, LEFT ATRIAL APPENDAGE | C127643 | A small muscular pouch located in the wall of the left atrium. | Left Atrial Appendage | |||
HEART, LEFT ATRIUM | C12869 | The smaller chamber on the left side of the heart, which receives oxygenated blood from the pulmonary veins and pumps it through the left atrioventricular valve into the left ventricle. | Left Atrium | |||
HEART, LEFT VENTRICLE | C12871 | Left Ventricle | The larger chamber on the left side of the heart, which receives oxygenated blood from the left atrium and pumps it through the aortic valve into the aorta. | Left Ventricle | ||
HEART, LEFT VENTRICULAR OUTFLOW TRACT | C127644 | The structure through which blood flows from the left ventricle into the aortic root. | Left Ventricular Outflow Tract | |||
HEART, LEFT VENTRICULAR WALL | C127645 | The wall of the left ventricle, comprising anterior, inferior, lateral, apical, basal wall; and excluding the interventricular septum. | Left Ventricular Wall | |||
HEART, RIGHT ATRIAL APPENDAGE | C127646 | A small muscular pouch located in the wall of the right atrium. | Right Atrial Appendage | |||
HEART, RIGHT ATRIUM | C12868 | The smaller chamber on the right side of the heart, which receives deoxygenated blood from the body and pumps it through the right atrioventricular valve into the right ventricle. | Right Atrium | |||
HEART, RIGHT VENTRICLE | C12870 | Right Ventricle | The larger chamber on the right side of the heart, which receives deoxygenated blood from the right atrium and pumps it through the pulmonic valve into the pulmonary arteries. | Right Ventricle | ||
HEART, RIGHT VENTRICULAR FREE WALL | C127647 | The lateral segment of the right ventricular wall, excluding the anterior and inferior right ventricular wall. | Right Ventricular Free Wall | |||
HEART, RIGHT VENTRICULAR OUTFLOW TRACT | C127648 | The structure through which blood flows from the right ventricle into the pulmonary trunk. | Right Ventricular Outflow Tract | |||
HEART, RIGHT VENTRICULAR WALL | C127649 | The wall of the right ventricle, comprising anterior, inferior, and lateral walls; and excluding the interventricular septum. | Right Ventricular Wall | |||
HEART, SEPTUM | C49485 | Cardiac Septum | The tissue in the heart that separates the two atria (atrial septum) and the two ventricles (ventricular septum). (NCI) | Heart Septum | ||
HEART, VENTRICLE | C12730 | Cardiac Ventricle | The larger chamber(s) of the heart that receives blood from an atrium and pushes it out of the heart into the peripheral circulation and/or the lungs. | Cardiac Ventricle | ||
HEART, VENTRICULAR CHAMBER | C186120 | The anatomical space of a cardiac ventricle. | Heart, Ventricular Chamber | |||
HEART, VENTRICULAR WALL | C119295 | The tissue layers that form the cardiac ventricle. They include myocardium, endocardium, and pericardium. (NCI) | Ventricular Wall of the Heart | |||
HEEL OF THE FOOT | C161381 | The rounded back part of the foot below the ankle and behind the arch. (NCI) | Heel of the Foot | |||
HEEL OF THE HAND | C161382 | Heel of the Palm | The raised part of the palm of the hand that is adjacent to the wrist. (NCI) | Heel of the Hand | ||
HEPATIC ARTERY | C32729 | An artery arising from the celiac trunk that supplies the liver and branches to form the cystic, gastro-duodenalis and pyloric arteries. | Common Hepatic Artery | |||
HEPATIC LYMPH NODE | C77640 | Lymph node(s) adjacent to the liver. | Hepatic Lymph Node | |||
HEPATIC VEIN | C32736 | The blood vessels that drain blood from the central veins of the liver into the inferior vena cava. | Hepatic Vein | |||
HEPATOBILIARY SYSTEM | C43612 | The body system that includes the liver, gallbladder, and associated ducts. | Hepatobiliary System | |||
HILAR LYMPH NODE | C98187 | A lymph node located in the hilum of the lung within the mediastinum. | Pulmonary Hilar Lymph Node | |||
HILAR | C25724 | Hilar | Refers to the area associated with the hilum. (NCI) | Hilar | ||
HINDLIMB | C77625 | The posterior, rear or lower limb of an animal. | Hind Limb | |||
HINDPAW PHALANX | C186121 | Hindpaw Phalange | Any of the bones that make up the digits of the hindpaw. | Hindpaw Phalanx | ||
HIP ADDUCTORS | C53039 | A group of muscles generally extending from the pubis to the femur; primary function is adduction of the thigh. | Adductor Group of the Leg | |||
HIP FLEXOR MUSCLES | C186122 | A group of muscles in the hip, the psoas major, iliacus, rectus femoris, pectineus, and sartorius; primary function is to move the leg or knee towards the torso and bend at the waist. | Hip Flexor Muscles | |||
HIP JOINT | C32742 | Coxofemoral Joint;Hip Joint | A ball-and-socket joint between the head of the femur and the acetabulum. (NCI) | Hip Joint | ||
HIP | C64193 | Hip | The lateral prominence of the pelvis from the waist to the thigh. (NCI) | Hip | ||
HIPPOCAMPUS | C12444 | A curved gray matter structure of the cerebrum that is part of the limbic system. | Hippocampus | |||
HUMERAL EPICONDYLE | C114187 | The bone prominence at the distal end of the humerus to which ligaments and tendons of the joints are attached. | Humeral Epicondyle | |||
HUMERUS SHAFT | C120671 | The cylindrical, elongated bony body of the humerus. | Humeral Shaft | |||
HUMERUS | C12731 | Bone, Humeral | The bone between the scapulohumeral and humeroulnar joints. | Humerus | ||
HYMENAL RING | C165999 | The outer edge of the hymen or hymenal remnants. | Hymenal Ring | |||
HYOID BONE | C32752 | Hyoid Bone | A U-shaped bone supporting the tongue. This bone is located at the base of the tongue and is suspended from the tips of the styloid processes of the temporal bones by the stylohyoid ligaments. (NCI) | Hyoid Bone | ||
HYPOGLOSSAL NERVE | C12732 | The twelfth cranial nerve. | Hypoglossal Nerve | |||
HYPOPHARYNX | C12246 | Hypopharynx | The lower part of the pharynx that connects to the esophagus. (NCI) | Hypopharynx | ||
HYPOTHALAMUS | C12458 | A small region of the brain composed of multiple nuclei and located underneath the thalamus. | Hypothalamus | |||
ILEOCECAL JUNCTION | C178001 | Ileocecal Region | The segment of the gastrointestinal tract where the terminal ileum transitions to the cecum, and where the ileocecal sphincter regulates the movement of chyme from the small intestine into the large intestine. (NCI) | Ileocecal Junction | ||
ILEUM LYMPH NODE | C176318 | A lymph node located in the ileum. | Ileum Lymph Node | |||
ILEUM WALL | C176316 | The portion of the gastrointestinal tract wall that surrounds the cavity of the ileum and contains collections of lymphatic tissue called Peyer patches, as well as receptors for bile salts and vitamin B12. | Ileum Wall | |||
ILEUM | C12387 | The portion of the small intestine between the jejunum and large intestine. | Ileum | |||
ILEUM, TERMINAL | C33757 | Terminal Ileum | The most distal section of the ileum that is continuous with the cecum. (NCI) | Terminal Ileum | ||
ILIAC CREST | C103818 | A predominate bone structure which borders the ilium wing stretching from the anterior superior iliac spine to the posterior superior iliac spine. | Iliac Crest | |||
ILIAC FOSSA | C103454 | The large smooth and concave surface of the ilium. (NCI) | Iliac Fossa | |||
ILIAC LYMPH NODE | C32761 | Lymph node(s) adjacent to the iliac vessels in the iliosacral region and cranial to the iliofemoral lymph node. | Iliac Lymph Node | |||
ILIAC VEIN | C12734 | Veins in the pelvis, which include the common, external and internal iliac veins. | Iliac Vein | |||
ILIOPSOAS MUSCLE | C32764 | A combination of two muscles found in the thigh, the iliacus and the psoas major, which have different sites of origin but a common insertion on the lesser trochanter of the femur; primary function is flexion of the hip. | Iliopsoas Muscle | |||
ILIOTIBIAL BAND | C139207 | A dense band of avascular, regular connective tissue. It is formed as the union of the superficial and deep layers of the tensor fascia latae, creating a thick band that extends inferiorly, taking its origins from the iliac crest, the tensor fascia latae, and the gluteus maximus, travelling inferiolaterally along the thigh, and inserting on Gerdy's tubercle on the lateral aspect of the tibia. Functionally, the iliotibial band helps to flex, abduct, and medially rotate the femur at the hip joint, and it also helps to stabilize the knee laterally. | Iliotibial Band | |||
ILIUM | C32765 | Ilium | The broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis. (NCI) | Ilium | ||
INCISOR | C32769 | A tooth between the canines in either jaw. | Incisor | |||
INCUS | C32770 | Incus | One of the three bones comprising the middle ear. This anvil-shaped bone is positioned between the malleus and the stapes. (NCI) | Incus | ||
INFERIOR MEDIASTINAL LYMPH NODE | C113695 | A group of lymph nodes located in the inferior part of the mediastinum. (NCI) | Inferior Mediastinal Lymph Node | |||
INFERIOR PUBIC RAMUS | C132392 | The portion of the pubic ramus that lies between the superior pubic ramus and the inferior ramus of the ischium. | Inferior Pubic Ramus | |||
INFERIOR TEMPORAL GYRUS | C32791 | A ridge on the outer surface of the temporal lobe below the middle sulcus. (NCI) | Inferior Temporal Gyrus | |||
INFERIOR VENA CAVA | C12815 | Caudal Vena Cava;Posterior Vena Cava | A large vein that returns blood from the lower half of the body to the heart. | Inferior Vena Cava | ||
INFRACLAVICULAR LYMPH NODE | C63705 | Infraclavicular Lymph Node;Subclavicular Lymph Node | A lymph node located in the area below the clavicle. (NCI) | Infraclavicular Lymph Node | ||
INFRARENAL AORTA | C116179 | The portion of the abdominal aorta distal to the renal arteries. | Infrarenal Aortic Segment | |||
INFRASPINATUS MUSCLE | C32797 | A muscle of the rotator cuff, in general extending from the infraspinatus fossa of the scapula to the greater tubercle of the humerus; primary function is to extend and rotate the arm laterally. | Infraspinatus | |||
INFRATENTORIAL BRAIN | C12509 | The part of the brain below the tentorium cerebellum. (NCI) | Infratentorial Brain | |||
INGUINAL LYMPH NODE | C32801 | Lymph node(s) in the inguinal region. | Inguinal Lymph Node | |||
INGUINAL REGION | C12726 | Groin | The lower region of the anterior abdominal wall located laterally to the pubic region. (NCI) | Inguinal Region | ||
INSULAR CORTEX | C32278 | Central Lobe | A distinct cerebral lobe positioned in the depth of the Sylvian fissures and overlaid entirely by adjacent regions of the cerebral hemispheres. | Central Lobe | ||
INTERATRIAL SEPTUM | C32818 | Atrial Septum;Heart, Atrial Septum | The wall of tissue that separates the right atrium from the left atrium in the heart. | Interatrial Septum | ||
INTERNAL ILIAC ARTERY | C32845 | A short thick blood vessel arising from the bifurcation of the common iliac artery with numerous branches that supply the organs, walls and viscera of the pelvis as well as the inner thigh. | Internal Iliac Artery | |||
INTERNAL ILIAC LYMPH NODE | C88142 | A lymph node located along the internal iliac artery. (NCI) | Internal Iliac Lymph Node | |||
INTERNAL MAMMARY ARTERY | C52941 | An artery of the thoracic wall; in general it arises from the subclavian artery and branches into the musculophrenic and superior epigastric arteries. | Internal Mammary Artery | |||
INTERNAL MAMMARY LYMPH NODE | C32853 | Lymph node(s) in or adjacent to the mammary gland. | Internal Mammary Lymph Node | |||
INTERPARIETAL BONE | C186123 | A bone of the skull situated between the parietal and supraoccipital bones. | Interparietal Bone | |||
INTERPHALANGEAL JOINT 1 OF THE FOOT | C114200 | IP1 of the Foot | A ginglymoid (hinge) synovial joint within the first digit of the foot articulating the proximal and distal phalanges. (NCI) | Interphalangeal Joint 1 of the Foot | ||
INTERPHALANGEAL JOINT 1 | C102301 | IP1 | A ginglymoid (hinge) synovial joint within the first digit of the hand or foot articulating the proximal and distal phalanges. (NCI) | Interphalangeal Joint 1 | ||
INTERPHALANGEAL JOINT 2 OF THE FOOT | C114201 | IP2 of the Foot | A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the foot. (NCI) | Interphalangeal Joint 2 of the Foot | ||
INTERPHALANGEAL JOINT 2 OF THE HAND | C114190 | IP2 of the Hand | A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand. (NCI) | Interphalangeal Joint 2 of the Hand | ||
INTERPHALANGEAL JOINT 2 | C102302 | IP2 | A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand or foot. (NCI) | Interphalangeal Joint 2 | ||
INTERPHALANGEAL JOINT 3 OF THE FOOT | C114202 | IP3 of the Foot | A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the foot. (NCI) | Interphalangeal Joint 3 of the Foot | ||
INTERPHALANGEAL JOINT 3 OF THE HAND | C114191 | IP3 of the Hand | A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand. (NCI) | Interphalangeal Joint 3 of the Hand | ||
INTERPHALANGEAL JOINT 3 | C102303 | IP3 | A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand or foot. (NCI) | Interphalangeal Joint 3 | ||
INTERPHALANGEAL JOINT 4 OF THE FOOT | C114203 | IP4 of the Foot | A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the foot. (NCI) | Interphalangeal Joint 4 of the Foot | ||
INTERPHALANGEAL JOINT 4 OF THE HAND | C114192 | IP4 of the Hand | A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand. (NCI) | Interphalangeal Joint 4 of the Hand | ||
INTERPHALANGEAL JOINT 4 | C102304 | IP4 | A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand or foot. (NCI) | Interphalangeal Joint 4 | ||
INTERPHALANGEAL JOINT 5 OF THE FOOT | C114204 | IP5 of the Foot | A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the foot. (NCI) | Interphalangeal Joint 5 of the Foot | ||
INTERPHALANGEAL JOINT 5 OF THE HAND | C114193 | IP5 of the Hand | A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand. (NCI) | Interphalangeal Joint 5 of the Hand | ||
INTERPHALANGEAL JOINT 5 | C102305 | IP5 | A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand or foot. (NCI) | Interphalangeal Joint 5 | ||
INTERPHALANGEAL JOINT OF THE HAND | C32868 | Interphalangeal Joint of the Hand | The hinge synovial joints between the phalanges of the fingers. (NCI) | Interphalangeal Joint of the Hand | ||
INTERPHALANGEAL OF THE FOOT | C32867 | IP of the Foot | The hinge synovial joints between the bones of the toes. (NCI) | Interphalangeal Joint of the Foot | ||
INTERPHALANGEAL THUMB JOINT | C102306 | Interphalangeal Joint 1 of the Hand;IP THUMB;IP1 of the Hand | A condyloid synovial joint within the thumb articulating the proximal and distal phalanges. | Interphalangeal Thumb Joint | ||
INTERTROCHANTERIC REGION | C120672 | The bony region in the proximal portion of the femur between the greater, lesser and sub- (also called the third) trochanters. | Intertrochanteric Region | |||
INTERVENTRICULAR SEPTUM | C32874 | Heart, Ventricular Septum;Interventricular Septal Wall;Ventricular Septum | The wall that separates the left and right ventricles of the heart. (NCI) | Interventricular Septum | ||
INTESTINAL WALL | C49478 | The tissue that forms the wall of the small and large intestine. | Intestinal Wall Tissue | |||
INTESTINE | C12736 | The portion of the gastrointestinal tract that includes the small and large intestines. | Intestine | |||
INTRAHEPATIC BILE DUCT | C12677 | The bile ducts that pass through and drain bile from the liver. (NCI) | Intrahepatic Bile Duct | |||
INTRAHEPATIC LARGE BILE DUCT | C96803 | Perihilar Bile Duct | The larger bile ducts which are located within the liver and drain bile from the smaller peripheral intrahepatic bile ducts into the right and left hepatic ducts. | Intrahepatic Large Bile Duct | ||
INTRATHORACIC LYMPH NODE | C12359 | Any lymph node within the thoracic cavity. | Intrathoracic Lymph Node | |||
IRIS | C12737 | The tissue in the eye that separates the anterior chamber from the posterior chamber. | Iris | |||
ISCHIAL TUBEROSITY | C105446 | The bony prominence of the lower part of the ischium. (NCI) | Ischial Tuberosity | |||
ISCHIORECTAL FOSSA | C103455 | A tetrahedral region of adipose tissue located in the ischiorectal region with its base between the tuberosity of the ischium and the lower end of the rectum and its apex at the point where the obturator fascia and the Levator ani membrane divide. | Ischiorectal Fossa | |||
ISCHIUM | C32884 | Ischium | The most posterior and ventral bone making up the pelvis. (NCI) | Ischium | ||
JAW | C48821 | The structures of the skull that frame the mouth. | Jaw Bone | |||
JEJUNUM | C12388 | The portion of the small intestine between the duodenum and ileum. | Jejunum | |||
JOINT | C13044 | Articulation;Joint | The connection point between two bones or skeletal elements. The joint may be fixed or movable. (NCI) | Joint | ||
JUGULAR VEIN | C12738 | Vena Jugularis | One of the veins of the neck; in general it arises from the junction of the maxillary and linguofacial veins and drains into the brachiocephalic or the cranial caval vein. | Jugular Vein | ||
KIDNEY INTERPOLAR REGION | C186124 | The portion of the kidney that is located between the upper and lower poles and contains the renal hilum. | Kidney Interpolar Region | |||
KIDNEY | C12415 | The organs of the urinary tract located in the retroperitoneal cavity adjacent to the spine and composed of the renal cortex and the renal medulla. | Kidney | |||
KIDNEY, CORTEX | C12739 | Renal Cortex | The division of the renal parenchyma located between the renal capsule and the renal medulla, which contains glomeruli and tubules for filtering blood. | Renal Cortex | ||
KIDNEY, HILUM | C32740 | Hilar Area of the Kidney | The concave area of the kidney through which the renal artery enters and the renal vein and ureter exit the organ. (NCI) | Hilar Area of the Kidney | ||
KIDNEY, LOWER POLE | C93180 | Lower Pole of the Kidney | The lowermost portion of the kidney. | Lower Pole of Kidney | ||
KIDNEY, MEDULLA | C12740 | Renal Medulla | The deepest division of the renal parenchyma, comprising the renal pyramids, which contain a dense network of nephrons, all of which are part of the blood filtration process. | Renal Medulla | ||
KIDNEY, UPPER POLE | C93179 | Upper Pole of the Kidney | The uppermost portion of the kidney. | Upper Pole of Kidney | ||
KNEE FLEXOR MUSCLES | C186125 | A group of muscles in the knee, the sartorius, popliteus, gastrocnemius, gracilis, semi-tendinosis, semi-membranosis, and bicep femoris muscles; primary function is to flex the knee. | Knee Flexor Muscles | |||
KNEE JOINT TENDONS | C161388 | The tendons that connect the quadriceps muscles to the kneecap, the hamstring muscles to the shin bone and fibula, and the patella to the top part of the fibula, enabling flexion, extension, and slight rotation of the knee. (NCI) | Knee Joint Tendons | |||
KNEE JOINT | C32898 | Femorotibial Joint;Joint, Stifle;Knee;Tibiofemoral Joint | The joint connecting the lower part of the femur with the upper part of the tibia. | Knee Joint | ||
L1 VERTEBRA | C32899 | L1 Vertebra | The first lumbar vertebra counting from the top down. (NCI) | L1 Vertebra | ||
L2 VERTEBRA | C32900 | L2 Vertebra | The second lumbar vertebra counting from the top down. (NCI) | L2 Vertebra | ||
L2-L3 INTERVERTEBRAL SPACE | C112327 | The space between the L2 and L3 vertebrae. | L2-L3 Intervertebral Space | |||
L3 VERTEBRA | C32901 | L3 Vertebra | The third lumbar vertebra counting from the top down. (NCI) | L3 Vertebra | ||
L3-L4 INTERVERTEBRAL SPACE | C112328 | The space between the L3 and L4 vertebrae. | L3-L4 Intervertebral Space | |||
L4 VERTEBRA | C32902 | L4 Vertebra | The fourth lumbar vertebra counting from the top down. (NCI) | L4 Vertebra | ||
L4-L5 INTERVERTEBRAL SPACE | C142296 | The space between the L4 and L5 vertebrae. | L4-L5 Intervertebral Space | |||
L5 VERTEBRA | C32903 | L5 Vertebra | The fifth lumbar vertebra counting from the top down. (NCI) | L5 Vertebra | ||
L5-S1 INTERVERTEBRAL SPACE | C154781 | The space between the L5 and S1 vertebrae. | L5-S1 Intervertebral Space | |||
L6 VERTEBRA | C120673 | A congenital anomaly of the spine, where an extra or supernumerary lumbar vertebra arises from below the 5th lumbar vertebra. | Extra Lumbar Vertebra | |||
LACRIMAL BONE | C32906 | Lacrimal Bone | A small rectangular thin plate forming part of the medial orbit wall. It is located posterior to the frontal process of the maxilla and articulates with the inferior nasal concha, ethmoid, frontal, and maxillary bones. (NCI) | Lacrimal Bone | ||
LACRIMAL GLAND | C12346 | The exocrine glands that produce the watery serous component of tears. | Lacrimal Gland | |||
LAD SEPTAL PERFORATOR ARTERY | C102313 | LAD SEPTAL PERFORATOR ARTERY SEGMENTS;LAD SP | The arteries that arise from the left anterior descending (LAD) artery that supply the interventricular septum. | Left Anterior Descending Septal Perforator Artery | ||
LARGE INTESTINE | C12379 | Large Bowel | The avillous section of the intestine composed of crypts and extending from the terminal small intestine to the external orifice. | Large Intestine | ||
LARYNX | C12420 | The cartilaginous structure of the respiratory tract between the pharynx and the trachea. | Larynx | |||
LATERAL FIRST DIAGONAL BRANCH ARTERY | C102307 | LAT 1ST DIAG;LATERAL FIRST DIAGONAL BRANCH ARTERY SEGMENT | The lateral branch distal to a bifurcation of the first diagonal artery. | Lateral First Diagonal Branch Artery | ||
LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY | C102308 | First Obtuse Marginal Lateral Branch;LAT 1ST OM;LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENT | The lateral branch distal to a bifurcation of the first obtuse marginal artery. | Lateral First Obtuse Marginal Branch Artery | ||
LATERAL HUMERAL EPICONDYLE | C139202 | A bone prominence at the distal end of the humerus to which the radial collateral ligament of the elbow joint, the anconeus and supinator muscles, and the common extensor tendon are attached. | Lateral Humeral Epicondyle | |||
LATERAL RAMUS INTERMEDIUS ARTERY | C102309 | LAT RAMUS;LATERAL RAMUS INTERMEDIUS ARTERY SEGMENT | The lateral branch distal to a bifurcation of the ramus intermedius artery. | Lateral Ramus Intermedius Artery | ||
LATERAL SECOND DIAGONAL BRANCH ARTERY | C102310 | LAT 2ND DIAG;LATERAL SECOND DIAGONAL BRANCH ARTERY SEGMENT | The lateral branch distal to a bifurcation of the second diagonal artery. | Lateral Second Diagonal Branch Artery | ||
LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY | C102311 | LAT 2ND OM;LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENT;Second Obtuse Marginal Lateral Branch | The lateral branch distal to a bifurcation of the second obtuse marginal artery. | Lateral Second Obtuse Marginal Branch Artery | ||
LATERAL THIRD DIAGONAL BRANCH ARTERY | C102312 | LAT 3RD DIAG;LATERAL THIRD DIAGONAL BRANCH ARTERY SEGMENT | The lateral branch distal to a bifurcation of the third diagonal artery. | Lateral Third Diagonal Branch Artery | ||
LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY | C102425 | LAT 3RD OM;LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENT;Third Obtuse Marginal Lateral Branch | The lateral branch distal to a bifurcation of the third obtuse marginal artery. | Lateral Third Obtuse Marginal Branch Artery | ||
LATISSIMUS DORSI MUSCLE | C33150 | Musculus Latissimus Dorsi | A muscle of the back, in general extending from the thoracolumbar vertebrae and scapula to the proximal humerus; primary function is adduction, extension, and medial rotation of the shoulder joint. | Musculus Latissimus Dorsi | ||
LEFT ANTERIOR DESCENDING ARTERY OSTIUM | C116175 | The opening of the left anterior descending coronary artery at its origin. | Left Anterior Descending Artery Ostium | |||
LEFT ATRIOVENTRICULAR ARTERY | C116177 | The first posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations. | Left Atrioventricular Artery | |||
LEFT CIRCUMFLEX ARTERY OSTIUM | C116176 | The opening of the left circumflex artery at its origin. | Left Circumflex Artery Ostium | |||
LEFT CIRCUMFLEX CORONARY ARTERY | C12874 | An artery arising from the bifurcation of the left coronary artery that runs along the coronary groove. | Circumflex Branch of the Left Coronary Artery | |||
LEFT MAIN CORONARY ARTERY BIFURCATION | C116174 | The portion of the distal end of the left main coronary artery that branches into the left anterior descending artery and the left circumflex artery. | Left Main Coronary Artery Bifurcation | |||
LEFT MAIN CORONARY ARTERY BODY | C116173 | The segment of the left main coronary artery that is bounded by its ostium and bifurcation. | Left Main Coronary Artery Body | |||
LEFT MAIN CORONARY ARTERY OSTIUM | C116172 | The opening of the left coronary artery at its origin. | Left Main Coronary Artery Ostium | |||
LEFT POSTERIOR DESCENDING ARTERY | C116178 | The second posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations. | Left Posterior Descending Artery | |||
LEFT POSTEROLATERAL DESCENDING ARTERY | C102314 | LEFT POSTEROLATERAL DESCENDING ARTERY SEGMENT;LPDA | In an individual with a left-dominant heart, this branch arises from the circumflex artery atrioventricular groove continuation and supplies the inferior apex of the heart. | Left Posterolateral Descending Artery | ||
LEFT VENTRICULAR APEX SEGMENT | C127650 | The apical cap division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Apex Segment | |||
LEFT VENTRICULAR APICAL ANTERIOR SEGMENT | C127651 | The anterior portion of the apical division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Apical Anterior Segment | |||
LEFT VENTRICULAR APICAL INFERIOR SEGMENT | C127652 | The inferior portion of the apical division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Apical Inferior Segment | |||
LEFT VENTRICULAR APICAL LATERAL SEGMENT | C127653 | The lateral portion of the apical division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Apical Lateral Segment | |||
LEFT VENTRICULAR APICAL SEPTAL SEGMENT | C127654 | The septal portion of the apical division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Apical Septal Segment | |||
LEFT VENTRICULAR BASAL ANTERIOR SEGMENT | C127655 | The anterior portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Basal Anterior Segment | |||
LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT | C127656 | The anterolateral portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Basal Anterolateral Segment | |||
LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT | C127657 | The anteroseptal portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Basal Anteroseptal Segment | |||
LEFT VENTRICULAR BASAL INFERIOR SEGMENT | C127658 | The inferior portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Basal Inferior Segment | |||
LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT | C127659 | The inferolateral portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Basal Inferolateral Segment | |||
LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT | C127660 | The inferoseptal portion of the basal division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Basal Inferoseptal Segment | |||
LEFT VENTRICULAR EPICARDIUM | C102315 | The outermost layer of cardiac tissue lining of the left ventricle. | Left Ventricular Epicardium | |||
LEFT VENTRICULAR MID ANTERIOR SEGMENT | C127661 | The anterior portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Mid Anterior Segment | |||
LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT | C127662 | The anterolateral portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Mid Anterolateral Segment | |||
LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT | C127663 | The anteroseptal portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Mid Anteroseptal Segment | |||
LEFT VENTRICULAR MID INFERIOR SEGMENT | C127664 | The inferior portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Mid Inferior Segment | |||
LEFT VENTRICULAR MID INFEROLATERAL SEGMENT | C127665 | The inferolateral portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Mid Inferolateral Segment | |||
LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT | C127666 | The inferoseptal portion of the mid-cavity division of the left ventricular myocardium as determined using the AHA 17-Segment Model (Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42.). | Left Ventricular Mid Inferoseptal Segment | |||
LEG SKIN | C52749 | Leg Skin | The integument that covers the leg. | Leg Skin | ||
LEG | C32974 | Leg | The portion of the lower extremity between the knee and the ankle. | Leg | ||
LENS | C12743 | Crystalline Lens;Ocular Lens | The structure of the eye through which light is focused onto the retina. | Lens | ||
LEPTOMENINGES | C32979 | The two innermost layers of tissue that cover the brain and spinal cord, the arachnoid mater and the pia mater. (NCI) | Leptomeninges | |||
LESSER CURVATURE OF THE STOMACH | C12261 | The medial border of the stomach. It is concave in shape and extends from the cardiac orifice to the pyloric orifice. | Lesser Curvature of the Stomach | |||
LESSER TROCHANTER | C32982 | A cone-shaped projection in the shaft of the femur in which the iliopsoas muscle is attached. (NCI) | Lesser Trochanter | |||
LIGAMENT | C13046 | Ligament | Band of fibrous tissue connecting bone to bone or cartilage to bone thereby supporting or strengthening a joint. (NCI) | Ligament | ||
LIMB | C12429 | Extremity | A jointed extremity of the upper/thoracic or lower/pelvic regions. | Limb | ||
LIMB, LOWER | C12742 | Lower Extremity | The limb that is composed of the hip, thigh, leg and foot. (NCI) | Lower Extremity | ||
LIMB, UPPER | C12671 | Upper Extremity | The region of the body that extends distal to the scapulohumeral joint. | Upper Extremity | ||
LINGULA OF THE LUNG | C40373 | A small tongue-like projection from the lower portion of the upper lobe of the left lung. | Lingula of the Lung | |||
LIP | C12220 | Lip;Vermillion of the Lip | Fleshy fold which surrounds the opening of the mouth. (NCI) | Lip | ||
LIP, LOWER | C12222 | External Lower Lip | The external surface of the lower lip. (NCI) | External Lower Lip | ||
LIP, UPPER | C12221 | External Upper Lip | The external surface of the upper lip. (NCI) | External Upper Lip | ||
LIVER FISSURE | C32996 | Liver Fissure | A groove on the surface of the liver. | Liver Fissure | ||
LIVER LOBE | C49579 | Any of the large divisions of the liver. | Liver Lobe | |||
LIVER | C12392 | An abdominal organ that has variable lobation which are composed mainly of hepatic lobules. | Liver | |||
LIVER, CAUDATE LOBE | C33000 | Couinaud Segment I | The lobe of the liver situated posteriorly located between the left lobe and the inferior vena cava. | Caudate Lobe | ||
LIVER, LEFT LOBE ANTEROLATERAL SEGMENT | C79733 | Couinaud Segment III | The lateral segment of the left lobe of the liver, located to the left of the inferior portion of the falciform ligament, anteriorly overlapping the stomach. (NCI) | Left Anterolateral Segment | ||
LIVER, LEFT LOBE INFEROMEDIAL SEGMENT | C79735 | Couinaud Segment IVb | The medial segment of the left lobe of the liver, located inferiorly. (NCI) | Left Inferomedial Segment | ||
LIVER, LEFT LOBE MEDIAL SEGMENT | C198297 | Couinaud Segment IV | The medial segment of the left lobe of the liver. | Left Medial Segment of Liver | ||
LIVER, LEFT LOBE POSTEROLATERAL SEGMENT | C79732 | Couinaud Segment II | The lateral segment of the left lobe of the liver, located to the left of the superior portion of the falciform ligament and the fissure for the ligamentum venosum. (NCI) | Left Posterolateral Segment | ||
LIVER, LEFT LOBE SUPEROMEDIAL SEGMENT | C79734 | Couinaud segment IVa | The medial segment of the left lobe of the liver, located superiorly. (NCI) | Left Superomedial Segment | ||
LIVER, LEFT LOBE | C32965 | The smaller lobe of the liver extending into the left side of the body. | Left Lobe of the Liver | |||
LIVER, QUADRATE LOBE | C112404 | An oblong shaped area of the liver that is situated inferior to the right lobe, bounded by the anterior margin of the liver and the porta hepatis. | Quadrate Lobe of Liver | |||
LIVER, RIGHT LOBE ANTEROINFERIOR SEGMENT | C79736 | Couinaud Segment V | The anterior segment of the right lobe of the liver, located inferiorly. (NCI) | Right Anteroinferior Segment | ||
LIVER, RIGHT LOBE ANTEROSUPERIOR SEGMENT | C79739 | Couinaud Segment VIII | The anterior segment of the right lobe of the liver, located superiorly. (NCI) | Right Anterosuperior Segment | ||
LIVER, RIGHT LOBE POSTEROINFERIOR SEGMENT | C79737 | Couinaud Segment VI | The posterior segment of the right lobe of the liver, located inferiorly. (NCI) | Right Posteroinferior Segment | ||
LIVER, RIGHT LOBE POSTEROSUPERIOR SEGMENT | C79738 | Couinaud Segment VII | The posterior segment of the right lobe of the liver, located superiorly. (NCI) | Right Posterosuperior Segment | ||
LIVER, RIGHT LOBE | C33481 | The larger lobe of the liver extending into the right side of the body. | Right Lobe of the Liver | |||
LOCUS CERULEUS | C97333 | A brainstem nucleus. It is the major brain site for the synthesis and secretion of norepinephrine. (NCI) | Locus Coeruleus | |||
LOWER GASTROINTESTINAL TRACT LYMPH NODE | C176234 | A lymph node located in the lower gastrointestinal tract. | Lower Gastrointestinal Tract Lymph Node | |||
LOWER JUGULAR LYMPH NODE | C132512 | Any lymph nodes located within close proximity to the lower third of the internal jugular vein, extending from the inferior border of the cricoid cartilage (superiorly) to the clavicle (inferiorly). The anterior (medial) boundary is the lateral border of the sternohyoid muscle and the posterior (lateral) boundary is the posterior border of the sternocleidomastoid muscle. (AJCC 8th ed.) | Lower Jugular Lymph Node Group (Level IV) | |||
LOWER RESPIRATORY SYSTEM | C33012 | The part of the respiratory system below the bifurcation of the trachea. It includes the lungs and the parts of the lungs such as the bronchi, bronchioles and alveoli. | Lower Respiratory System | |||
LUMBAR REGION | C34004 | The area of the body below the ribs and above the hipbones. (NCI) | Lumbar Region | |||
LUMBAR SPINE | C69314 | The vertebrae located below the thoracic and above the sacral vertebrae. | Lumbar Spine | |||
LUMBAR VERTEBRA | C12744 | Lumbar Vertebra | Any of the vertebrae situated between the thoracic vertebrae and the sacrum in the lower part of the spine. | Lumbar Vertebra | ||
LUMBOSACRAL SPINE | C48824 | Lumbosacral Region | The part of the spine in the lower back that consists of the lumbar region and the sacrum. | Lumbosacral Region | ||
LUMBRICAL MUSCLES OF THE FOOT | C186126 | A group of muscles in the sole of the foot that extend from the tendons of the flexor digitorum longus muscle to the medial bases of the proximal phalanges and the extensor expansion of the second through fifth digits; primary function is to flex and adduct the lateral four toes at the metatarsophalangeal joints and extend them at the interphalangeal joints. | Lumbrical Muscles of the Foot | |||
LUMBRICAL MUSCLES OF THE HAND | C150852 | One of a group of four short muscles in the hand that extend from the radial and ulnar sides of the tendons of the flexor digitorum profundus to the radial lateral band of the extensor expansion tendon; primary function is extension of the proximal and distal interphalangeal joints. | Lumbrical Muscle | |||
LUNATE BONE | C12786 | Lunate Bone | The bone in the proximal row of carpal bones that lies between the scaphoid and triquetral bones. (NCI) | Lunate Bone | ||
LUNG LOBE | C34021 | Any of the large divisions of the lung. | Lung Lobe | |||
LUNG | C12468 | A thoracic organ that has variable lobation and is the primary respiratory organ of mammals. | Lung | |||
LUNG, HILUM | C49282 | Hilar Area of the Lung | The wedge-shaped area at the central portion of the lung through which the bronchi, vessels and nerves enter or exit the organ. (NCI) | Hilar Area of the Lung | ||
LUNG, LEFT LOWER LOBE | C33020 | Lower Lobe of the Left Lung | The larger lobe of the left lung, situated below and behind the oblique fissure. (NCI) | Lower Lobe of the Left Lung | ||
LUNG, LEFT UPPER LOBE | C33021 | Upper Lobe of the Left Lung | The smaller lobe of the left lung, situated above and in front the oblique fissure, which includes the apex. (NCI) | Upper Lobe of the Left Lung | ||
LUNG, LEFT | C32967 | Left Lung | The 2-lobed lung located on the left side of the body. (NCI) | Left Lung | ||
LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT | C132393 | The anterior basal segment of the inferior lobe of the left lung. | Left Lung, Inferior Lobe, Anterior Basal Segment | |||
LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT | C132394 | The lateral basal segment of the inferior lobe of the left lung. | Left Lung, Inferior Lobe, Lateral Basal Segment | |||
LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT | C132395 | The medial basal segment of the inferior lobe of the left lung. | Left Lung, Inferior Lobe, Medial Basal Segment | |||
LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT | C132396 | The posterior basal segment of the inferior lobe of the left lung. | Left Lung, Inferior Lobe, Posterior Basal Segment | |||
LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT | C132397 | The superior segment of the inferior lobe of the left lung. | Left Lung, Inferior Lobe, Superior Segment | |||
LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT | C132398 | The anterior segment of the superior lobe of the left lung. | Left Lung, Superior Lobe, Anterior Segment | |||
LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT | C132399 | The apicoposterior segment of the superior lobe of the left lung. | Left Lung, Superior Lobe, Apicoposterior Segment | |||
LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT | C132400 | The inferior lingular segment of the superior lobe of the left lung. | Left Lung, Superior Lobe, Inferior Lingular Segment | |||
LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT | C132401 | The superior lingular segment of the superior lobe of the left lung. | Left Lung, Superior Lobe, Superior Lingular Segment | |||
LUNG, RIGHT LOWER LOBE | C33022 | Lower Lobe of the Right Lung | The lobe of the right lung situated below the oblique fissure. (NCI) | Lower Lobe of the Right Lung | ||
LUNG, RIGHT MIDDLE LOBE | C12286 | Middle Lobe of the Right Lung | The smallest lobe of the right lung, situated above the oblique fissure and below the horizontal fissure. (NCI) | Middle Lobe of the Right Lung | ||
LUNG, RIGHT UPPER LOBE | C33023 | Upper Lobe of the Right Lung | The lobe of the right lung, situated above the horizontal fissure, which includes the apex. (NCI) | Upper Lobe of the Right Lung | ||
LUNG, RIGHT | C33483 | Right Lung | The 3-lobed lung located on the right side of the body. (NCI) | Right Lung | ||
LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT | C132402 | The anterior basal segment of the inferior lobe of the right lung. | Right Lung, Inferior Lobe, Anterior Basal Segment | |||
LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT | C132403 | The lateral basal segment of the inferior lobe of the right lung. | Right Lung, Inferior Lobe, Lateral Basal Segment | |||
LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT | C132404 | The medial basal segment of the inferior lobe of the right lung. | Right Lung, Inferior Lobe, Medial Basal Segment | |||
LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT | C132405 | The posterior basal segment of the inferior lobe of the right lung. | Right Lung, Inferior Lobe, Posterior Basal Segment | |||
LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT | C132406 | The superior segment of the inferior lobe of the right lung. | Right Lung, Inferior Lobe, Superior Segment | |||
LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT | C132407 | The lateral segment of the middle lobe of the right lung. | Right Lung, Middle Lobe, Lateral Segment | |||
LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT | C132408 | The medial segment of the middle lobe of the right lung. | Right Lung, Middle Lobe, Medial Segment | |||
LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT | C132409 | The anterior segment of the superior lobe of the right lung. | Right Lung, Superior Lobe, Anterior Segment | |||
LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT | C132410 | The apical segment of the superior lobe of the right lung. | Right Lung, Superior Lobe, Apical Segment | |||
LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT | C132411 | The posterior segment of the superior lobe of the right lung. | Right Lung, Superior Lobe, Posterior Segment | |||
LYMPH NODE HILUM | C33031 | Lymph Node Hilum | The concave side of the lymph node. (NCI) | Lymph Node Hilum | ||
LYMPH NODE | C12745 | Lymphatic Gland | Secondary lymphoid organ associated with lymphatic vessels and consisting of an outer cortex, inner medulla and sinuses. | Lymph Node | ||
MACULA | C26464 | An oval-shaped, yellow pigmented area located on the center of the retina, which contains a high density of cones for high-acuity vision. | Macula | |||
MAIN BRONCHUS, LEFT | C32968 | Left Main Bronchus | One of the two main bronchi. It is narrower but longer than the right main bronchus and connects to the left lung. (NCI) | Left Main Bronchus | ||
MAIN BRONCHUS, RIGHT | C33486 | Right Main Bronchus | One of the two main bronchi. It is wider but shorter than the left main bronchus and connects to the right lung. (NCI) | Right Main Bronchus | ||
MALE GENITALIA | C61599 | Male Genitalia | Male internal and external organs of reproduction. | Male Genitalia | ||
MALE REPRODUCTIVE SYSTEM | C12722 | The sex organs of the male. | Male Reproductive System | |||
MALLEUS | C33051 | Malleus | A hammer-shaped bone, part of three interconnected small bones located in the middle ear. It is attached to the inner surface of the tympanic membrane and its function is to transmit sound vibrations. (NCI) | Malleus | ||
MAMMARY GLAND | C12367 | The exocrine glands of the mammae that produce milk in females, and are composed of lobules, alveolar ducts and alveoli. | Mammary Gland | |||
MANDIBLE | C12290 | Bone, Mandibular;Inferior Maxillary Bone;Lower Jaw;Mandible | The lower jaw bone holding the lower teeth. (NCI) | Mandible | ||
MASSETER MUSCLE | C13074 | A muscle extending from the zygomatic arch to the lateral surface of mandibular ramus; primary function is elevation of the mandible (closing of the mouth). | Masseter Muscle | |||
MASTOID PROCESS | C12503 | Mastoid Process | A honeycombed section of bone located near the base of the skull, protruding behind the outer ear. It is connected to the middle ear. (NCI) | Mastoid Process | ||
MAXILLA | C26470 | The upper jaw bone holding the upper teeth. | Maxilla | |||
MAXILLARY SINUS | C12275 | Maxillary Sinus | A pyramidal-shaped, thin-walled, air-filled cavity located in the maxilla. It is lined by mucus membrane and periosteum (mucoperiosteum) which contains cilia. It is adjacent to the nasal cavity and communicates with the middle meatus of the nose. It is the largest paranasal sinus and is composed of three recesses: alveolar, zygomatic, and infraorbital. (NCI) | Maxillary Sinus | ||
MEDIAL FEMORAL CONDYLE | C139204 | A rounded, bony projection on the inner side of the distal end of the femur to which the medial collateral and the posterior cruciate ligaments are attached. | Medial Femoral Condyle | |||
MEDIAN BASILIC VEIN | C33070 | Median Cubital Vein | A vein between the biceps and pronator radii teres muscles that unites with the common ulnar vein to form the basilic vein within the forearm. | Median Basilic Vein | ||
MEDIAN NERVE | C52815 | A nerve extending from the brachial plexus traveling the length of the arm/thoracic limb, which innervates some flexor muscles of the arm/forelimb and the skin on the palmar aspect of the carpus, metacarpus and digits. | Median Nerve | |||
MEDIAN OR LOWER CERVICAL LYMPH NODE | C103417 | A lymph node located in the median or lower region of the neck. (NCI) | Median Or Lower Cervical Lymph Node | |||
MEDIASTINAL LYMPH NODE | C33073 | Lymph node(s) in the mediastinal region. | Mediastinal Lymph Node | |||
MEDIASTINAL SOFT TISSUE | C164004 | The soft tissue of the mediastinum. | Mediastinal Soft Tissue | |||
MEDIASTINUM | C12748 | The central region of the thoracic cavity of mammals containing a group of organs surrounded by loose connective tissue, which separates the two pleural sacs. | Mediastinum | |||
MEDIASTINUM, ANTERIOR | C32098 | Anterior Mediastinum | The area between the lungs; it contains the thymus, some lymph nodes, and vessels and branches of the internal thoracic artery. (NCI) | Anterior Mediastinum | ||
MEDIASTINUM, MIDDLE | C33123 | Middle Mediastinum | The broadest part of the lower portion of the mediastinum. It contains the heart and the great vessels. (NCI) | Middle Mediastinum | ||
MEDIASTINUM, POSTERIOR | C33368 | Posterior Mediastinum | The part of the lower portion of the mediastinum that is located behind the pericardium. (NCI) | Posterior Mediastinum | ||
MEDIASTINUM, SUPERIOR | C33684 | Superior Mediastinum | The part of the mediastinum that is located between the upper part of the sternum in the front and the upper thoracic vertebrae in the back. (NCI) | Superior Mediastinum | ||
MEDULLA OBLONGATA | C12442 | The portion of the brainstem between the pons and cervical spinal cord. | Medulla Oblongata | |||
MENINGES | C12348 | Any one of three membranes that surround the brain and spinal cord. (NCI) | Meninges | |||
MENTALIS MUSCLE | C186127 | A muscle of the jaw, in general extending from the incisive fossa of the mandible to the skin of the lower lip; primary function is to elevate and protrude the lower lip and elevate the skin of the chin. | Mentalis Muscle | |||
MESENTERIC ARTERY | C52975 | One of the arteries of the abdomen; in general it arises from the abdominal aorta and supplies blood mainly to the intestines. | Mesenteric Artery | |||
MESENTERIC LYMPH NODE | C77641 | Lymph node(s) in or adjacent to the mesentery. | Mesenteric Lymph Node | |||
MESENTERIC VEIN | C53055 | A vein of the abdomen; in general it arises from the intestines and pancreas, combines with the splenic vein, and drains into the portal vein. | Mesenteric Vein | |||
MESENTERY | C33103 | A double layer of peritoneum that attaches to the wall of the abdominal cavity and supports the small intestines. | Mesentery | |||
MESOTHELIUM | C33105 | A simple layer of cells, derived from the mesoderm, that covers the serous membranes including the peritoneum, pericardium, and pleura. | Mesothelium | |||
METACARPAL 1 BASE | C127667 | The proximal end of the first metacarpal bone. | Metacarpal 1 Base | |||
METACARPAL BONE 1 | C52796 | The first of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the trapezium and distally with the thenar phalanx (thumb). | Metacarpal Bone Digit 1 | |||
METACARPAL BONE 2 | C52795 | The second of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the trapezoid and distally with the second phalanx (index finger). | Metacarpal Bone Digit 2 | |||
METACARPAL BONE 3 | C52794 | The third of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the capitate and the second and fourth metacarpals, and distally with the third phalanx (middle finger). | Metacarpal Bone Digit 3 | |||
METACARPAL BONE 4 | C52793 | The fourth of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the capitate, hamate, and third and fifth metacarpal bones, and distally with the fourth phalanx (ring finger). | Metacarpal Bone Digit 4 | |||
METACARPAL BONE 5 | C52792 | The fifth of the five long bones located in the palm of the hand, as counted from the thenar side of the hand; it articulates proximally with the hamate and fourth metacarpal, and distally with the fifth phalanx (small finger). | Metacarpal Bone Digit 5 | |||
METACARPAL BONE | C12751 | Any of the bones between the carpus and the phalanges. | Metacarpal Bone | |||
METACARPOPHALANGEAL JOINT 1 | C102316 | MCP1 | A condyloid synovial joint within the first digit of the hand articulating the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 1 | ||
METACARPOPHALANGEAL JOINT 2 | C102317 | MCP2 | A condyloid synovial joint within the second digit of the hand articulating the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 2 | ||
METACARPOPHALANGEAL JOINT 3 | C102318 | MCP3 | A condyloid synovial joint within the third digit of the hand articulating the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 3 | ||
METACARPOPHALANGEAL JOINT 4 | C102319 | MCP4 | A condyloid synovial joint within the fourth digit of the hand articulating the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 4 | ||
METACARPOPHALANGEAL JOINT 5 | C102320 | MCP5 | A condyloid synovial joint within the fifth digit of the hand articulating the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 5 | ||
METATARSAL BONE | C12752 | Metatarsal Bone | Any of the bones between the tarsus and the phalanges. | Metatarsal Bone | ||
METATARSOPHALANGEAL JOINT 1 | C102321 | MTP1 | A condyloid synovial joint within the first digit of the foot articulating metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 1 | ||
METATARSOPHALANGEAL JOINT 2 | C102322 | MTP2 | A condyloid synovial joint within the second digit of the foot articulating metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 2 | ||
METATARSOPHALANGEAL JOINT 3 | C102323 | MTP3 | A condyloid synovial joint within the third digit of the foot articulating metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 3 | ||
METATARSOPHALANGEAL JOINT 4 | C102324 | MTP4 | A condyloid synovial joint within the fourth digit of the foot articulating metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 4 | ||
METATARSOPHALANGEAL JOINT 5 | C102325 | MTP5 | A condyloid synovial joint within the fifth digit of the foot articulating metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 5 | ||
METATARSOPHALANGEAL JOINT | C33108 | Metatarsophalangeal Joint | A spheroid joint located between the heads of the metatarsal bone and the base of the proximal phalanx of the toe. (NCI) | Metatarsophalangeal Joint | ||
MID-CIRCUMFLEX ARTERY | C102326 | MCIRC;MID-CIRCUMFLEX ARTERY SEGMENT | The segment of the left circumflex artery between the first and second marginal branches. | Mid-Circumflex Artery | ||
MID-JUGULAR LYMPH NODE | C132511 | Any lymph nodes located within close proximity to the middle third of the internal jugular vein, extending from the inferior border of the hyoid bone (superiorly) to the inferior border of the cricoid cartilage (inferiorly). The anterior (medial) boundary is the lateral border of the sternohyoid muscle, and the posterior (lateral) boundary is the posterior border of the sternocleidomastoid muscle. (AJCC 8th ed.) | Middle Jugular Lymph Node Group (Level III) | |||
MID-LAD ARTERY | C102328 | MID-LAD ARTERY SEGMENT;MLAD | The segment of the left anterior descending (LAD) artery between the first and third diagonal branches. | Mid-Left Anterior Descending Artery | ||
MID-RIGHT CORONARY ARTERY CONDUIT | C102329 | Mid-right Coronary Artery;MID-RIGHT CORONARY ARTERY CONDUIT SEGMENT;MRCA | The section of the right coronary artery between the right ventricular artery and the acute marginal artery. | Mid-Right Coronary Artery Conduit | ||
MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES | C102327 | All of the arterial branches distal to the proximal left anterior descending coronary artery. | Mid-Distal Left Anterior Descending Coronary Artery and All Diagonal Coronary Branches | |||
MIDBRAIN | C12510 | Mesencephalon | The portion of the brainstem between the pons and diencephalon. | Mesencephalon | ||
MIDDLE EAR | C12274 | The part of the ear including the eardrum and ossicles. | Middle Ear | |||
MIDDLE FRONTAL GYRUS | C33118 | A ridge on the lateral surface of the frontal lobe, which lies between the superior and inferior frontal sulci, and rostral to the precentral gyrus. | Middle Frontal Gyrus | |||
MIDDLE PHALANX 2 OF THE HAND | C142297 | The long bone in the second finger, as counted from the thenar side of the hand; it is located between, and articulates with, the proximal and distal phalanges. | Hand Digit 2 Middle Phalanx | |||
MIDDLE PHALANX 3 OF THE HAND | C142298 | The long bone in the third finger, as counted from the thenar side of the hand; it is located between, and articulates with, the proximal and distal phalanges. | Hand Digit 3 Middle Phalanx | |||
MIDDLE PHALANX 4 OF THE HAND | C142299 | The long bone in the fourth finger, as counted from the thenar side of the hand; it is located between, and articulates with, the proximal and distal phalanges. | Hand Digit 4 Middle Phalanx | |||
MIDDLE PHALANX 5 OF THE HAND | C142300 | The long bone in the fifth finger, as counted from the thenar side of the hand; it is located between, and articulates with, the proximal and distal phalanges. | Hand Digit 5 Middle Phalanx | |||
MIDDLE TEMPORAL GYRUS | C33125 | A ridge on the outer surface of the temporal lobe between the superior and middle temporal sulci. (NCI) | Middle Temporal Gyrus | |||
MITRAL VALVE ANNULUS | C127306 | A fibrous membrane that attaches to, and provides support for, the mitral valve leaflets. | Mitral Valve Annulus | |||
MITRAL VALVE | C12753 | Left Atrioventricular Valve;Mitral Valve | A cardiac valve located between the left atrium and ventricle. | Mitral Valve | ||
MITRAL VALVE, ANTERIOR ANNULUS | C127668 | Mitral Valve, Anteroseptal Annulus | The portion of the mitral valve annulus that attaches to the anterior mitral valve leaflet. | Anterior Annulus of the Mitral Valve | ||
MITRAL VALVE, ANTERIOR CUSP | C127669 | The cusp of the mitral valve that is anchored to the aortic-mitral curtain. | Anterior Cusp of the Mitral Valve | |||
MITRAL VALVE, POSTERIOR ANNULUS | C127670 | Mitral Valve, Posterolateral Annulus | The portion of the mitral valve annulus that attaches to the posterior mitral valve leaflet. | Posterior Annulus of the Mitral Valve | ||
MITRAL VALVE, POSTERIOR CUSP | C127671 | The cusp of the mitral valve that is located posterior to the two commissures, and which has no attachment to the aortic root. | Posterior Cusp of the Mitral Valve | |||
MOTOR CORTEX | C97339 | A brain region that is located in the dorsal part of the precentral gyrus. (NCI) | Primary Motor Cortex | |||
MUCOSA OF THE LIP | C12226 | The lining of the fleshy folds surrounding the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae. (NCI) | Mucosa of the Lip | |||
MUCOSA | C13166 | Mucosa;Mucous Membrane | The moist, inner lining of some organs and body cavities (such as the nose, mouth, lungs, and stomach). Glands in the mucosa make mucus (a thick, slippery fluid). | Mucosa | ||
MUSCLE | C13056 | A fibrous soft tissue with the ability to contract to produce force and motion. | Muscle | |||
MUSCULOSKELETAL SYSTEM | C12754 | The system of muscles, tendons, ligaments, bones, joints and associated tissues. | Musculoskeletal System | |||
MYOMETRIUM | C12314 | Myometrium | The smooth muscle lining the uterus. (NCI) | Myometrium | ||
NAIL BED | C170605 | The integument under the nail plate. | Nail Bed | |||
NAIL | C33156 | Nail | The cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI) | Nail | ||
NASAL BONE | C33157 | Nasal Bone | A bone of the skull forming the middle and upper part of the face. | Nasal Bone | ||
NASAL CAVITY | C12424 | The upper respiratory tract extending from the nares to the pharynx. | Nasal Cavity | |||
NASAL SEPTUM | C33160 | Nasal Septum | The thin wall between the two nasal cavities. (NCI) | Nasal Septum | ||
NASAL SOFT TISSUE | C164006 | The soft tissue of the nose. | Nasal Soft Tissue | |||
NASOPHARYNX | C12423 | The part of the pharynx above the soft palate, which is continuous with the nasal cavity and extends to the oropharynx. | Nasopharynx | |||
NAVICULAR BONE | C33162 | Navicular Bone | An oval-shaped bone of the tarsus found on the medial side of the foot. (NCI) | Navicular Bone | ||
NECK | C13063 | Neck | The region that connects the head to the rest of the body. (NCI) | Neck | ||
NERVE | C12466 | A bundle of neuronal fibers that transmits electrochemical impulses encoding sensory and motor information from one body part to another. | Nerve | |||
NIPPLE | C12299 | The protuberance in the skin where the ducts of the mammary gland open. | Nipple | |||
NOSE | C12756 | Nose | A structure of special sense serving as an organ of the sense of smell and as an entrance to the respiratory tract. (NCI) | Nose | ||
NOSTRIL | C33178 | Naris;Nostril | One of the two channels of the nose, from the point where they divide to the external opening. (NCI) | Nostril | ||
NUCHAL LYMPH NODE | C142301 | Any lymph node located in the posterior of the neck, including the postauricular, superficial occipital, middle posterior cervical chain, and lower posterior cervical chain. | Nuchal Lymph Node | |||
NUCLEUS ACCUMBENS | C52733 | A nucleus comprising neurons in the forebrain, ventral to the dorsal caudate and putamen. | Accumbens Nucleus | |||
NUCLEUS OF DIAGONAL BAND | C97342 | BASAL NUCLEUS/DIAGONAL BAND | A brain structure that is part of the septal nuclear complex. It is connected with the hippocampus, hypothalamus and amygdala. | Nucleus of Diagonal Band | ||
OBTURATOR EXTERNUS MUSCLE | C33191 | A muscle of the pelvis that originates on the obturator foramen and obturatory membrane and inserts on the trochanteric fossa of the femur. | Obturator Externus Muscle | |||
OBTURATOR INTERNUS MUSCLE | C33192 | A muscle of the pelvis that originates on the ischiopubic ramus and obturator membrane and inserts on the greater trochanter. | Obturator Internus Muscle | |||
OBTURATOR LYMPH NODE | C88141 | A pelvic lymph node located along the obturator artery. | Obturator Lymph Node | |||
OBTURATOR MUSCLE | C33193 | One of two muscles located in the pelvis: the obturator externus muscle or the obturator internus muscle. (NCI) | Obturator Muscle | |||
OCCIPITAL BONE | C12757 | The trapezoidal-shaped bone on the posterior portion of the skull that forms part of the base of the skull. | Occipital Bone | |||
OCCIPITAL LOBE | C12355 | One of the four regions of cortex in each cerebral hemisphere, located posterior to the temporal lobe and inferior to the parietal lobe. | Occipital Lobe | |||
OCCIPITAL LYMPH NODE | C98188 | A lymph node located in the back of the head adjacent to the trapezius muscle. | Occipital Lymph Node | |||
OCCIPITAL SCALP | C103456 | The occipital region of the skin that covers the top of the head. (NCI) | Occipital Scalp | |||
OCULOMOTOR NERVE | C12758 | Third Cranial Nerve | A cranial nerve extending from the oculomotor nucleus and accessory parasympathetic nucleus, which innervates the pupil, lens, upper eyelid, and eye muscles. | Oculomotor Nerve | ||
OLECRANON | C33200 | Olecranon | A prominence at the proximal end of the ulna. It forms the tip of the elbow. (NCI) | Olecranon | ||
OLFACTORY BULB | C28401 | The portion of the vertebrate forebrain that lies behind the ethmoid bones; it begins the rhinencephalon. | Olfactory Bulb | |||
OLFACTORY MUCOSA | C33205 | The part of the nasal mucosa composed of neuroepithelial tissue and mucus-producing Bowman's glands. | Olfactory Mucosa | |||
OLFACTORY NERVE | C12759 | The first cranial nerve. | Olfactory Nerve | |||
OMENTUM | C33209 | A double layer of peritoneum covering abdominal organs. | Omentum | |||
OPHTHALMIC ARTERY | C33216 | An artery arising from the internal carotid artery that branches into two groups of vessels; the orbital group that supplies the orbit and surrounding parts and the ocular group that supplies the globe and muscles of the eye. | Ophthalmic Artery | |||
OPPONENS POLLICIS MUSCLE | C150853 | A muscle of the arm, in general extending from the distal border of the flexor retinaculum and the tubercles of the scaphoid and trapezium, to the lateral aspect of the first metacarpal; primary function is rotation and flexion of the thumb. | Opponens Pollicis Muscle | |||
OPTIC CHIASM | C90609 | An anatomic structure formed by the crossing of the two optic nerves under the hypothalamus. (NCI) | Optic Chiasm | |||
OPTIC DISC | C12760 | Optic Nerve Head | The portion of the retina at which the axons of the ganglion cells exit the eyeball to form the optic nerve. | Optic Disc | ||
OPTIC NERVE | C12761 | Second Cranial Nerve | A cranial nerve extending between the retina and optic chiasma, which innervates the eye. | Optic Nerve | ||
ORAL CAVITY | C12421 | Buccal cavity;Mouth | The cavity of the mouth. | Oral Cavity | ||
ORAL MUCOSA | C77637 | The mucosal membranes that line the oral cavity. | Oral Mucosa | |||
ORBICULARIS OCULI MUSCLE | C52886 | A ring-like band of skeletal muscle on the palpebrae, temple, cheeks, and surrounding the orbit, which originates on the frontal bone, medial palpebral ligament, and lacrimal bone, and which inserts into the lateral palpebral raphe. | Orbicularis Oculi Muscle | |||
ORBIT | C12347 | Eye Socket;Ocular Orbit;Orbit | The bony cavity that contains the eye and its associated structures. | Orbit | ||
OROPHARYNGEAL SOFT TISSUE | C186128 | The soft tissue of the oropharyngeal region. | Oropharyngeal Soft Tissue | |||
OROPHARYNX | C12762 | The part of the pharynx between the soft palate and the upper portion of the epiglottis. (NCI) | Oropharynx | |||
OSTIOMEATAL COMPLEX | C174318 | Osteomeatal Complex | A narrow channel that connects the frontal sinus, anterior ethmoid air cells, and maxillary sinus to the middle meatus, allowing drainage and ventilation. It includes the maxillary ostium, infundibulum, ethmoid bulla, uncinate process, and hiatus semilunaris. | Ostiomeatal Complex | ||
OVARIAN FOLLICLE | C33244 | A spherical aggregation of cells found in the ovaries that contains a single oocyte. (NCI) | Ovarian Follicle | |||
OVARY | C12404 | The female gonad. | Ovary | |||
PALATAL RUGAE | C186129 | Palatine Rugae | The creases or folds in the oral mucosa covering the anterior portion of the hard palate. | Palatal Rugae | ||
PALATE | C12229 | The roof of the oral cavity. It separates the oral cavity from the nasal cavity. | Palate | |||
PALATINE BONE | C52745 | Palatine Bone | An irregularly shaped bone positioned at the back part of the nasal cavity between the maxilla and the pterygoid process of the sphenoid. It forms the posterior part of the hard palate and the lateral wall of the nasal fossa and helps to form the floor of the orbit as well as several adjoining parts. (NCI) | Palatine Bone | ||
PALATINE UVULA | C12232 | The fleshy lobe that is suspended from the back of the soft palate in the oral cavity. | Uvula | |||
PALM | C33252 | The undersurface of the hand. (NCI) | Palmar Region | |||
PALMAR DIGITAL ARTERY | C177994 | A type of artery that supplies blood to the fingers and includes the common palmar digital arteries, the dorsal digital arteries of the hand, and the proper palmar digital arteries. (NCI) | Palmar Digital Artery | |||
PALPEBRAL CONJUNCTIVA | C12901 | The part of the conjunctiva that covers the inner surface of the eyelid. | Palpebral Conjunctiva | |||
PALPEBRAL FISSURE | C174322 | The elliptical shaped curve of the bottom border of the upper eyelid, extending from the medial canthus to the lateral canthus. | Palpebral Fissure | |||
PANCREAS | C12393 | A digestive organ in the abdomen that has both endocrine and exocrine functions. | Pancreas | |||
PANCREAS, BODY | C12270 | Body of the Pancreas | The part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament. (NCI) | Body of the Pancreas | ||
PANCREAS, ENDOCRINE | C12608 | Endocrine Pancreas | The pancreatic tissue that contains the islets of Langerhans. It is responsible for the production and secretions of the pancreatic hormones. (NCI) | Islet of Langerhans | ||
PANCREAS, EXOCRINE | C32546 | Exocrine Pancreas | An enzyme producing region of the pancreatic tissue containing the pancreatic acini and exocrine intralobular ducts which collectively secrete the digestive enzymes into the main pancreatic duct to drain into the duodenal part of the small intestine. (NCI) | Exocrine Pancreas | ||
PANCREAS, HEAD | C12269 | Head of the Pancreas | That portion of the pancreas lying in the concavity of the duodenum. (NCI) | Head of the Pancreas | ||
PANCREAS, NECK | C158551 | The portion of the pancreas that is the junction of the head and body of the pancreas, and lies anterior to the aorta. | Neck of the Pancreas | |||
PANCREAS, TAIL | C12271 | Tail of the Pancreas | The left extremity of the pancreas within the lienorenal ligament. (NCI) | Tail of the Pancreas | ||
PANCREATIC DUCT | C12272 | A duct that conveys pancreatic secretions from the pancreas to the duodenum. | Pancreatic Duct | |||
PAPILLARY MUSCLE | C33259 | Any one of the group of small muscles in the heart ventricles, in general extending from the ventricular wall to the free edge of the atrioventricular valves; primary function is to keep the valves closed during ventricular systole. | Papillary Muscle | |||
PARA-AORTIC LYMPH NODE | C77643 | Lymph Node, Para-Aortic | Lymph node(s) adjacent to the lumbar vertebral column. | Paraaortic Lymph Node | ||
PARACAVAL LYMPH NODE | C117869 | A lymph node located adjacent to the lumbar region of the spine, along the right lateral aspect of the inferior vena cava. (NCI) | Paracaval Lymph Node | |||
PARACOLIC GUTTER | C89787 | Naturally occurring spaces between the colon and the abdominal wall, lateral to the ascending and descending colons. | Paracolic Gutter | |||
PARALARYNGEAL LYMPH NODE | C147453 | A lymph node located adjacent to the larynx, in the parapharyngeal space. | Paralaryngeal Lymph Node | |||
PARAMETRIUM | C12320 | Parametrium | The subserous connective tissue of the pelvic floor of the supracervical portion of the uterus. The parametrium extends laterally between the layers of the broad ligament. (NCI) | Parametrium | ||
PARANASAL SINUS | C12763 | The air-filled cavities adjacent to the nasal cavity lined by a mucous membrane and located in the bones of the skull. | Paranasal Sinus | |||
PARAPHARYNGEAL LYMPH NODE | C142302 | Any lymph node located in the potential space of the neck, which is bounded superiorly by the base of the skull, inferiorly by the greater cornu of the hyoid bone, anteriorly by the investing fascia of the deep cervical fascia covering the medial pterygoid muscle, posteriorly by the prevertebral layer of the deep cervical fascia, medially by the middle (pretracheal) layer of the deep cervical fascia, and laterally by the investing fascia of the deep cervical fascia covering the deep lobe of the parotid. | Parapharyngeal Lymph Node | |||
PARASPINAL MUSCLES | C52902 | Erector Spinae;Extensor Spinae;Sacrospinalis Muscle | A group of three paired epaxial muscle bundles (iliocostalis, longissimus, and spinalis) extending along and lateral to the spinous processes of the cervical, thoracic, and lumbar vertebrae; primary function is extension and rotation of the spine. | Erector Spinae | ||
PARASPINAL REGION | C166000 | The area of the body surrounding the spinal column. | Paraspinal Region | |||
PARASYMPATHETIC GANGLIA | C52557 | A usually small autonomic ganglion of the parasympathetic nervous system. The majority are located near or in the organs that they innervate. (NCI) | Parasympathetic Ganglion | |||
PARATHYROID GLAND | C12765 | Endocrine gland, usually in close proximity to the thyroid gland, that produces parathyroid hormone. | Parathyroid Gland | |||
PARATRACHEAL LYMPH NODE | C103426 | A lymph node located adjacent to the trachea within the mediastinum. (NCI) | Paratracheal Lymph Node | |||
PARATRACHEAL LYMPH NODE, UPPER | C186130 | A lymph node located adjacent to the trachea within the mediastinum, above the inferior margin of the left brachiocephalic vein crossing the trachea on the left and the superior border of the aortic arch on the right. | Upper Paratracheal Lymph Node | |||
PARAVERTEBRAL GANGLIA | C97925 | Paraspinal Ganglion;Spinal Ganglion | A cluster of neuronal cell bodies and their dendrites located just ventral and lateral to the spinal cord that give rise to the sympathetic nervous system. | Para-Spinal Ganglion | ||
PARIETAL BONE | C12766 | A bone of the skull that forms the sides and roof of the skull. | Parietal Bone | |||
PARIETAL LOBE | C12354 | Parietal Lobe | One of the lobes of the cerebral hemisphere located superiorly to the occipital lobe and posteriorly to the frontal lobe. Cognition and visuospatial processing are its main function. (NCI) | Parietal Lobe | ||
PAROTID GLAND LYMPH NODE | C33278 | Parotid Gland Lymph Node | Lymph node(s) in or adjacent to the parotid gland. | Parotid Gland Lymph Node | ||
PAROTID GLAND | C12427 | The salivary gland located adjacent to the ear. | Parotid Gland | |||
PARS COMPACTA | C97341 | A part of the substantia nigra. The pars compacta nerve cells contain melanin and are involved in motor control. (NCI) | Pars Compacta | |||
PATELLA | C33282 | A small bone in front of the femorotibial joint that articulates with the femur. | Patella | |||
PATELLAR TENDON | C187835 | A fibrous band extending from the distal end of the quadriceps femoris to the top of the patella. | Patellar Tendon | |||
PAW | C77660 | The entire structure distal to the ankle joint/tarsus or wrist joint/carpus in quadruped animals. | Paw | |||
PECTORAL LYMPH NODE | C120322 | An axillary lymph node located along the lower edge of the pectoralis minor. (NCI) | Pectoral Lymph Node | |||
PECTORALIS MAJOR MUSCLE | C33284 | Either of two large muscles of the anterior chest wall, which has two heads: the clavicular head, which originates on the medial half of the clavicle, and the sternal head, which originates on the sternum and the first six costal cartilages; the muscles insert onto the lateral lip of the intertubercular groove of the humerus and the crest of the greater tubercle of the humerus respectively; primary function is flexion, adduction, and medial rotation of the shoulder joint. | Pectoralis Major | |||
PECTORALIS MINOR MUSCLE | C33285 | A muscle in the chest, in general extending from the third to fifth ribs near their costal cartilages to the medial border and superior surface of the coracoid process of the scapula; primary function is to stabilize the scapula against the thoracic wall. | Pectoralis Minor | |||
PELVIC BONE | C33287 | Pelvic Bone | The bony structure composed of the ilium, ishium, pubis and sacrum, which are typically fused during maturation. | Pelvic Bone | ||
PELVIC LYMPH NODE | C12363 | Pelvic Lymph Node | Any lymph node within the pelvic region. (NCI) | Pelvic Lymph Node | ||
PELVIC SIDEWALL | C189531 | The part of the pelvic wall that is formed by the piriformis and obturator internus muscles and contains the iliac vessels, pelvic ureters, and lateral pelvic lymph nodes. | Pelvic Sidewall | |||
PELVIS | C12767 | Pelvic Region;Pelvis | The bony, basin-shaped structure formed by the bones of the pelvis. | Pelvis | ||
PENILE ARTERY | C177995 | Any of the arteries that supply blood to the penis, including the common penile artery, which is the termination of the internal pudendal artery, and the bulbourethral, dorsal, and cavernosal branches of the common penile artery. (NCI) | Penile Artery | |||
PENIS | C12409 | The male organ of urination and copulation. (NCI) | Penis | |||
PENIS, BODY | C12325 | The portion of the penis between the glans penis and the radix penis. | Body of the Penis | |||
PENIS, GLANS | C12324 | The most distal portion of the penis covered by the foreskin. | Glans Penis | |||
PENIS, RADIX | C124350 | The portion of the penis between the descending portion of the pubic bone and the body of the penis. | Radix Penis | |||
PERI-ORBITAL SOFT TISSUE | C164007 | The soft tissue of the peri-orbital region. | Periorbital Soft Tissue | |||
PERIANAL REGION | C99148 | The skin area around the anus. (NCI) | Perianal Region | |||
PERICARDIAL CAVITY | C38662 | The body space between the epicardium and the pericardium. | Pericardial Cavity | |||
PERICARDIAL LYMPH NODE | C117870 | A lymph node located anterior to the pericardium, posterior to the xiphoid process, and in the right and left cardiophrenic fat. (NCI) | Pericardial Lymph Node | |||
PERICARDIAL WALL | C127672 | The tissue layers that form the pericardium of the heart, including the fibrous pericardium, and the parietal and visceral layers of the serous pericardium. | Pericardial Wall | |||
PERICARDIUM | C13005 | The membrane surrounding the heart and roots of the vessels at the base of the heart. | Pericardium | |||
PERIFACIAL LYMPH NODE | C170601 | A lymph node located above the mandibular margin of the submandibular triangle and is associated with the anterior facial vein and facial artery. | Perifacial Lymph Node | |||
PERIHILAR LYMPH NODE | C102330 | A lymph node located in the area around the hilum. | Perihilar Lymph Node | |||
PERIMENINGEAL SPACE | C186131 | The space surrounding the meninges. | Perimeningeal Space | |||
PERINEUM | C33301 | Perineum | The area located between the anus and vulva in females, and anus and scrotum in males. (NCI) | Perineum | ||
PERIPANCREATIC LYMPH NODE | C77642 | Lymph node(s) in or adjacent to the pancreas. | Pancreatic Lymph Node | |||
PERIPHERAL NERVE | C12768 | Any nerve outside the brain or spinal cord that connects with peripheral receptors or effectors. (NCI) | Peripheral Nerve | |||
PERIRECTAL LYMPH NODE | C154774 | Lymph node(s) located in the connective tissue adjacent to the rectum. | Perirectal Lymph Node | |||
PERITONEAL CAVITY | C12769 | A part of the abdominal cavity that lies between the visceral and parietal peritoneum. | Peritoneal Cavity | |||
PERITONEAL FLUID | C77612 | The fluid within the peritoneal cavity. | Peritoneal Fluid | |||
PERITONEAL LYMPH NODE | C77644 | A lymph node located in the peritoneum. | Peritoneal Lymph Node | |||
PERITONEUM | C12770 | The membrane that lines the abdominal and pelvic cavities. | Peritoneum | |||
PERIUMBILICAL REGION | C139205 | The region of the body that immediately surrounds the umbilicus. | Periumbilical Region | |||
PERIURETERAL REGION | C132412 | The tissue surrounding the ureter. | Periureteral Region | |||
PERIURETHRAL REGION | C111287 | The tissue surrounding the urethra. | Periurethral Region | |||
PERIVESICAL REGION | C178003 | The region of the body surrounding the urinary bladder. (NCI) | Perivesical Region | |||
PERONEAL ARTERY | C33314 | An artery arising from the posterior tibial artery that supplies the muscles on the lateral side of the lower leg. | Peroneal Artery | |||
PERONEAL NERVE | C52814 | Nerve, Fibular | A branch of the sciatic nerve that includes the common, deep, and/or superficial peroneal nerves, which innervates multiple muscles in the distal region of the leg/hindlimb. | Peroneal Nerve | ||
PERONEUS BREVIS MUSCLE | C186132 | A muscle of the lower leg, in general extending from the distal two-thirds of the lateral surface of the fibula and the anterior intermuscular septum to the tuberosity of the fifth metatarsal bone; primary function is to plantar flex and evert the foot. | Peroneus Brevis Muscle | |||
PERONEUS LONGUS MUSCLE | C53171 | A muscle of the lower leg, in general extending from the superior lateral shaft of the fibula to the first metatarsal and the medial cuneiform; primary function is to plantar flex and evert the foot and support the lateral, longitudinal, and transverse arches. | Peroneus Longus | |||
PHARYNGEAL TONSIL | C33318 | Adenoid | A tonsil in the mucosa of the nasopharynx. | Pharyngeal Tonsil | ||
PHARYNX | C12425 | A passageway in the head and neck that includes the nasopharynx, oropharynx and laryngopharynx. | Pharynx | |||
PINEAL GLAND | C12398 | Pineal Body | A small endocrine gland that arises from the central posterior aspect of the diencephalon. | Pineal Gland | ||
PISIFORM BONE | C12855 | Pisiform Bone | The medial bone of the proximal row of carpal bones. (NCI) | Pisiform Bone | ||
PITUITARY GLAND | C12399 | Hypophysis;Hypophysis Cerebri | A small endocrine gland extending from the hypothalamus at the base of the brain. | Pituitary Gland | ||
PLACENTA | C13272 | An organ present in true mammals during embryonic developmen that provides the fetus with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother. | Placenta | |||
PLANTAR FLEXOR MUSCLES | C186133 | A group of muscles in the ankle, the gastrocnemius, soleus, plantaris, tibialis posterior, flexor hallucis longus, and flexor digitorum longus muscles; primary function is to extend the ankle, flexing the foot downward toward the sole. | Plantar Flexor Muscles | |||
PLEURA | C12469 | The serous membrane that lines the wall of the thoracic cavity and the surface of the lungs. | Pleura | |||
PLEURAL CAVITY | C12840 | A part of the thoracic cavity that lies between the visceral and parietal pleura. | Pleural Cavity | |||
PLEURAL FLUID | C77613 | The fluid within the pleural cavity. | Pleural Fluid | |||
PONS VAROLII | C12511 | Pons Varolii | The portion of the brainstem between the midbrain and medulla oblongata. | Pons Varolii | ||
POPLITEAL ARTERY ABOVE KNEE | C116180 | The segment of the popliteal artery that is located above the knee. | Popliteal Artery Above the Knee | |||
POPLITEAL ARTERY BELOW KNEE | C116181 | The segment of the popliteal artery that is located below the knee. | Popliteal Artery Below the Knee | |||
POPLITEAL ARTERY | C33337 | One of the arteries of the leg; in general it arises from the femoral artery and descends behind the knee joint before branching into the anterior and posterior tibial arteries. | Popliteal Artery | |||
POPLITEAL FOSSA | C103222 | A diamond-shaped depression located in the back of the knee joint bounded by the medial and lateral heads of the gastrocnemius muscle, the semimembranosus muscle, and the biceps femoris. | Popliteal Fossa | |||
POPLITEAL LYMPH NODE | C53146 | Lymph node(s) adjacent to the femorotibial joint. | Popliteal Lymph Node | |||
POPLITEAL VEIN | C33339 | A vein originating from the anterior and posterior tibial veins that ascends the popliteal space to drain blood from the calf, knee joint, and thigh. The popliteal vein ultimately becomes the femoral vein. | Popliteal Vein | |||
PORTA HEPATIS LYMPH NODE | C117871 | A lymph node located in the transverse fissure of the liver. (NCI) | Porta Hepatis Lymph Node | |||
PORTACAVAL LYMPH NODE | C117872 | Portocaval Lymph Node | A lymph node located in the space between the portal vein and inferior vena cava, along the hepatoduodenal ligament. (NCI) | Portacaval Lymph Node | ||
PORTAL LYMPH NODE | C77645 | Periportal Lymph Node | Lymph node(s) adjacent to the portal vein. | Portal Lymph Node | ||
PORTAL VEIN BIFURCATION | C132413 | The portion of the distal end of the main portal vein that branches into the left and right portal veins. | Portal Vein Bifurcation | |||
PORTAL VEIN | C33343 | Hepatic Portal Vein | A vein lying in the lower part of the abdomen; in general it arises from the junction of the mesenteric and splenic veins and draining into the liver. | Portal Vein | ||
POSTCENTRAL GYRUS | C33346 | A ridge on the parietal lobe of the brain, located between the central and postcentral sulci, that corresponds to the primary somatic sensory cortex area. | Postcentral Gyrus | |||
POSTERIOR CERVICAL LYMPH NODE | C103428 | A lymph node located in the posterior region of the neck. (NCI) | Posterior Cervical Lymph Node | |||
POSTERIOR CINGULATE CORTEX | C154778 | The caudal region of the cingulate cortex, located within the medial part of the inferior parietal lobule, that is thought to function as an interface between emotion and cognition. | Posterior Cingulate Cortex | |||
POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY | C102348 | PDSP;POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY SEGMENT | The arteries arising from the right posterior descending artery that supply the interventricular septum. | Septal Perforator Artery | ||
POSTERIOR INFERIOR CEREBELLAR ARTERY | C33362 | PICA | An artery arising from the vertebral artery that supplies the cerebellum, choroid plexus and the lateral medulla. | Posterior Inferior Cerebellar Artery | ||
POSTERIOR POLE OF THE EYE | C142303 | The scleral curvature of the eye comprising the retina, inclusive of the macula and optic disc. | Posterior Pole of the Eye | |||
POSTERIOR SUPERIOR ILIAC SPINE | C139206 | A bony projection from the posterior region of the iliac crest that lies over the sacroiliac joint and is the site of attachment for the thoracolumbar fascia and the posterior sacroiliac and sacrotuberous ligaments. | Posterior Superior Iliac Spine | |||
POSTERIOR TIBIAL ARTERY | C12826 | A terminal branch of the popliteal artery that runs along the tibia from the lower portion of the popliteus muscle to the lower ankle with numerous branches supplying the lower leg and foot. | Posterior Tibial Artery | |||
POSTERIOR TIBIAL VEIN | C33386 | A vein in the foot that originates at the union of the external and internal plantar veins and which becomes the popliteal vein. | Posterior Tibial Vein | |||
POSTEROLATERAL SEGMENTAL ARTERY | C116170 | In an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery in the posterior atrioventricular groove after the origin of the right posterior descending artery. | Posterolateral Coronary Artery | |||
PREAURICULAR LYMPH NODE | C103429 | A lymph node located anterior to the auricle of the ear. (NCI) | Preauricular Lymph Node | |||
PRECENTRAL GYRUS | C33393 | A ridge on the convex side of both cerebral hemispheres, anterior to the postcentral gyrus and parallel to the central sulcus, which separates the pre- and postcentral gyri. | Precentral Gyrus | |||
PRECUNEUS | C112399 | The posteromedial region of the parietal lobe bounded by the marginal branch of the cingulate sulcus anteriorly, by the medial portion of the parieto-occipital fissure posteriorly and by the subparietal sulcus inferiorly. | Precuneus | |||
PREFRONTAL CORTEX | C154779 | The gray matter on the medial, lateral, and orbital surfaces of the anterior part of the frontal cortex, which play a role in complex cognitive control, emotion, and social behavior. | Prefrontal Cortex | |||
PRELARYNGEAL LYMPH NODE | C147454 | A lymph node located anterior to the larynx. | Prelaryngeal Lymph Node | |||
PREMAXILLA BONE | C186134 | Paired bones at the anterior tip of the upper jaw that are generally tooth bearing; they are present during fetal development and later fuse with the maxilla. | Premaxilla Bone | |||
PREPUTIAL GLAND | C79432 | Exocrine glands of the male reproductive system located adjacent to the prepuce. | Preputial Gland | |||
PRESACRAL LYMPH NODE | C154775 | Lymph node(s) located in the mesorectum, between the rectum and the sacrum. | Presacral Lymph Node | |||
PRESACRAL SPACE | C132414 | The potential body space formed between the rectum and the sacrum. | Presacral Space | |||
PRESPHENOID BONE | C186135 | One of the bones of the orbit, situated dorsally to the basisphenoid bone; it is present during fetal development and later fuses to form the anterior portion of the sphenoid bone. | Presphenoid Bone | |||
PRETRACHEAL LYMPH NODE | C147455 | A lymph node located anterior to the trachea, between the isthmus of the thyroid gland and the innominate vein. | Pretracheal Lymph Node | |||
PRIMARY VISUAL CORTEX | C97340 | A brain region in the occipital cortex that receives visual stimuli from the retina. (NCI) | Primary Visual Cortex | |||
PROCERUS MUSCLE | C166001 | A muscle in the face, in general extending from the lower part of the nasal bone to the frontalis muscle in the forehead; primary function is to move the skin between the eyebrows. | Procerus Muscle | |||
PROFUNDA FEMORIS ARTERY | C32436 | An artery arising from the common femoral artery just below the inguinal ligament running close to the femur and ending in the lower third of the thigh with branches supplying the thigh muscles. | Deep Femoral Artery | |||
PROFUNDA FEMORIS VEIN | C154776 | Deep Femoral Vein | A vein located in the upper thigh that connects, through tributaries, to the popliteal and inferior gluteal veins, and joins the superficial femoral vein at the groin to form the common femoral vein. | Deep Femoral Vein | ||
PRONATOR QUADRATUS MUSCLE | C150854 | A muscle of the forearm, in general extending from the distal anteromedial surface of the ulna to the distal anterolateral surface of the radius; primary function is pronation of the forearm. | Pronator Quadratus Muscle | |||
PRONATOR TERES MUSCLE | C53174 | A muscle of the superficial flexor compartment of the forearm, in general extending from the humeral and ulnar heads to the body of the radius; primary function is pronation of the arm and flexion of the elbow. | Pronator Teres Muscle | |||
PROSTATE BED | C90348 | The anatomical space just below the bladder within which the prostate is situated. | Prostate Bed | |||
PROSTATE GLAND | C12410 | The male reproductive accessory gland that produces prostatic fluid and is located adjacent to or around the urethra distal to the urinary bladder in mammals. | Prostate Gland | |||
PROSTATE GLAND, LATERAL LOBE | C13092 | Lateral Lobe of the Prostate | The prostate gland lobe that is located on the lateral side of the organ. (NCI) | Lateral Lobe of the Prostate | ||
PROSTATE GLAND, MIDDLE LOBE | C13094 | Middle Lobe of the Prostate | The upper, smaller part of the prostate between the ejaculatory ducts and the urethra. (NCI) | Middle Lobe of the Prostate | ||
PROSTATE GLAND, POSTERIOR LOBE | C13093 | Posterior Lobe of the Prostate | The prostate gland lobe that is located on the posterior side of the organ. (NCI) | Posterior Lobe of the Prostate | ||
PROXIMAL CIRCUMFLEX ARTERY | C102331 | PCIRC;PROXIMAL CIRCUMFLEX ARTERY SEGMENT | The section of the left circumflex coronary artery that arises from the left main coronary artery and extends to the first marginal branch. | Proximal Circumflex Artery | ||
PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT | C114205 | PIP2 of the Foot | A ginglymoid (hinge) synovial joint within the second digit of the foot articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 2 of the Foot | ||
PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND | C114194 | PIP2 of the Hand | A ginglymoid (hinge) synovial joint within the second digit of the hand articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 2 of the Hand | ||
PROXIMAL INTERPHALANGEAL JOINT 2 | C102332 | PIP2 | A condyloid synovial joint within the second digit of the hand or foot articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 2 | ||
PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT | C114206 | PIP3 of the Foot | A ginglymoid (hinge) synovial joint within the third digit of the foot articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 3 of the Foot | ||
PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND | C114195 | PIP3 of the Hand | A ginglymoid (hinge) synovial joint within the third digit of the hand articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 3 of the Hand | ||
PROXIMAL INTERPHALANGEAL JOINT 3 | C102333 | PIP3 | A condyloid synovial joint within the third digit of the hand or foot articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 3 | ||
PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT | C114207 | PIP4 of the Foot | A condyloid synovial joint within the fourth digit of the hand or foot articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 4 of the Foot | ||
PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND | C114196 | PIP4 of the Hand | A ginglymoid (hinge) synovial joint within the fourth digit of the hand articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 4 of the Hand | ||
PROXIMAL INTERPHALANGEAL JOINT 4 | C102334 | PIP4 | A condyloid synovial joint within the fourth digit of the hand or foot articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 4 | ||
PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT | C114208 | PIP5 of the Foot | A ginglymoid (hinge) synovial joint within the fifth digit of the foot articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 5 of the Foot | ||
PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND | C114197 | PIP5 of the Hand | A ginglymoid (hinge) synovial joint within the fifth digit of the hand articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 5 of the Hand | ||
PROXIMAL INTERPHALANGEAL JOINT 5 | C102335 | PIP5 | A condyloid synovial joint within the fifth digit of the hand or foot articulating the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 5 | ||
PROXIMAL LAD ARTERY | C102336 | PLAD;PROXIMAL LAD ARTERY SEGMENT | The section of the left anterior descending coronary artery that arises from the left main coronary artery and extends to the first diagonal branch. | Proximal Left Anterior Descending Artery | ||
PROXIMAL PHALANX 1 OF THE HAND | C150848 | The long bone in the first finger, as counted from the thenar side of the hand; it is located between, and articulates with, the first metacarpal and the distal phalanx. | Hand Digit 1 Proximal Phalanx | |||
PROXIMAL PHALANX 2 OF THE HAND | C142304 | The long bone in the second finger, as counted from the thenar side of the hand; it is located between, and articulates with, the second metacarpal and the middle phalanx. | Hand Digit 2 Proximal Phalanx | |||
PROXIMAL PHALANX 3 OF THE HAND | C142305 | The long bone in the third finger, as counted from the thenar side of the hand; it is located between, and articulates with, the third metacarpal and the middle phalanx. | Hand Digit 3 Proximal Phalanx | |||
PROXIMAL PHALANX 4 OF THE HAND | C142306 | The long bone in the fourth finger, as counted from the thenar side of the hand; it is located between, and articulates with, the fourth metacarpal and the middle phalanx. | Hand Digit 4 Proximal Phalanx | |||
PROXIMAL PHALANX 5 OF THE HAND | C142307 | The long bone in the fifth finger, as counted from the thenar side of the hand; it is located between, and articulates with, the fifth metacarpal and the middle phalanx. | Hand Digit 5 Proximal Phalanx | |||
PROXIMAL RIGHT CORONARY ARTERY CONDUIT | C102337 | PRCA;PROXIMAL RIGHT CORONARY ARTERY CONDUIT SEGMENT | The section of the right coronary artery proximal to the origin of the right ventricular artery. | Proximal Right Coronary Artery Conduit | ||
PROXIMAL URETHRA | C115335 | The part of the urethra that is close to the bladder. | Proximal Urethra | |||
PUBIC BONE | C33423 | Pubis | Either of the two bones (left and right) that form the front of the pelvis. (NCI) | Pubic Bone | ||
PUBIC SYMPHYSIS | C33425 | Symphysis Pubis | The joint between the left and right pubic bones at the front of the pelvis. (NCI) | Pubic Symphysis | ||
PULMONARY ARTERY BRANCH | C12774 | One of the arteries of the thorax; in general it arises from the pulmonary trunk and branches into the lungs. | Pulmonary Artery | |||
PULMONARY LYMPH NODE | C191304 | A lymph node that is found within the parenchyma of the lung. (NCI) | Pulmonary Lymph Node | |||
PULMONARY TRUNK | C116918 | Main Pulmonary Artery | The artery arising from the right ventricle of the heart that bifurcates into the left and right pulmonary arteries. | Pulmonary Trunk | ||
PULMONARY VALVE | C12775 | A cardiac valve located between the right atrium and the pulmonary artery. | Pulmonary Valve | |||
PULMONARY VALVE, ANTERIOR CUSP | C127673 | Pulmonary Valve, Anterior Semilunar Cusp | The cusp of the pulmonic valve that has no attachment to the cardiac septum. | Anterior Cusp of the Pulmonary Valve | ||
PULMONARY VALVE, LEFT CUSP | C127674 | Pulmonary Valve, Left Semilunar Cusp | The cusp of the pulmonic valve attached to the left side of the cardiac septum. | Left Cusp of the Pulmonary Valve | ||
PULMONARY VALVE, RIGHT CUSP | C127675 | Pulmonary Valve, Right Semilunar Cusp | The cusp of the pulmonic valve attached to the right side of the cardiac septum. | Right Cusp of the Pulmonary Valve | ||
PULMONARY VEIN | C12776 | Any of the veins that carry oxygenated blood from the lungs to the heart. | Pulmonary Vein | |||
PUPIL | C33429 | The round opening in the center of the iris in the eye. | Pupil | |||
PUTAMEN | C12452 | Putamen | The gray matter, located between the globus pallidus and the external capsule of the brain, that comprises the lateral dorsal striatum of the basal ganglia. | Putamen | ||
PYLORIC SPHINCTER | C33433 | Pyloric Sphincter | The muscular structure at the distal portion of the stomach, opening into the duodenum. (NCI) | Pyloric Sphincter | ||
PYLORUS | C12260 | The region of the stomach that connects to the duodenum. | Pylorus | |||
PYRAMIDAL TRACTS, BRAINSTEM | C142308 | The segments of the corticospinal and corticobulbar tracts that either traverse or terminate in the brainstem. (NCI) | Brainstem Portion of the Pyramidal Tracts | |||
PYRAMIDAL TRACTS, INTERNAL CAPSULE | C142309 | The segments of the corticospinal and corticobulbar tracts that traverse the internal capsule. | Internal Capsule of the Pyramidal Tracts | |||
QUADRICEPS MUSCLE | C33441 | A group of muscles in the thigh, in general extending from the pelvis to the patella and tibia; primary function is extension of the femorotibial joint. | Quadriceps Muscle of the Thigh | |||
RADIAL ARTERY | C12838 | Radial Artery | The branch of the brachial artery that passes down the forearm. (NCI) | Radial Artery | ||
RADIAL NERVE | C52812 | A nerve extending from the brachial plexus traveling the length of the arm/forelimb, which innervates the extensor muscles of the elbow, carpus and phalanges, as well as the skin on the dorsal aspect of the carpus, metacarpus and digits. | Radial Nerve | |||
RADIAL SULCUS | C187836 | Musculospiral Groove;Radial Groove;Spiral Groove | A shallow groove in the shaft of the humerus through which the radial nerve and deep brachial artery course. | Radial Sulcus | ||
RADIUS SHAFT | C120674 | The slightly curved, prismoid, elongated bony body of the radius. | Radius Shaft | |||
RADIUS | C12777 | The long bone that lies between the radiohumeral joint and the carpus and is adjacent to the ulna. | Radius Bone | |||
RADIUS-LUNATE JOINT | C142310 | A condyloid synovial joint within the wrist articulating the radius bone to the lunate bone. | Radius-Lunate Joint | |||
RAMUS INTERMEDIUS ARTERY | C102338 | RAMUS;RAMUS ARTERY;RAMUS INTERMEDIUS ARTERY SEGMENT | An artery that arises from the left main coronary artery and is positioned between the left anterior descending coronary artery and the circumflex artery. | Ramus Intermedius Artery | ||
RAPHE | C97335 | A group of nuclei that are located in the midline of the brainstem and release serotonin. (NCI) | Raphe Nuclei | |||
RECTO-UTERINE POUCH | C33447 | An extension of the peritoneum between the uterus and the rectum in females, which is formally bounded thusly: anteriorly by the uterus and posterior fornix of the vagina; posteriorly by the rectum; inferiorly by the peritoneal rectovaginal fold. | Recto-Vaginal Pouch | |||
RECTOSIGMOID JUNCTION | C54188 | The area where the sigmoid colon joins the rectum. | Rectosigmoid Region | |||
RECTOVAGINAL SPACE | C142311 | The anatomical space located between the vagina and rectum, extending from the superior border of the perineal body to the underside of the rectouterine Douglas pouch, which has its formal borders noted thusly: anteriorly by the rectovaginal septum; posteriorly by the anterior rectal wall; and laterally by the descending rectal septa that separate the rectovaginal space from the pararectal space on each side. | Rectovaginal Space | |||
RECTUM | C12390 | The terminal portion of the large intestine extending from the terminus of the colon to the anus or anal canal. | Rectum | |||
RECTUS FEMORIS MUSCLE | C53175 | A muscle in the quadriceps femoris muscle group between the vastus lateralis and vastus medialis and lying on the vastus intermedius; primary function is extension of the femorotibilal joint. | Rectus Femoris | |||
REGIONAL LYMPH NODE | C49018 | Lymph node(s) that drains the lymph from a region of interest. | Regional Lymph Node | |||
RENAL ARTERY | C12778 | One of the arteries of the abdomen; in general it arises from the abdominal aorta and supplies blood to the kidney. | Renal Artery | |||
RENAL BED | C131138 | Kidney Bed | The anatomical space within which the kidney is situated. | Renal Bed | ||
RENAL FOSSA | C142312 | The usual retroperitoneal location of the kidney in the dorsolumbar region of the body. | Renal Fossa | |||
RENAL PAPILLA | C33460 | The tip of a renal pyramid. | Renal Papilla | |||
RENAL PELVIS | C12887 | The funnel-shaped proximal portion of the ureter located within the kidney into which urine is secreted, from the collecting duct system of the kidney. (NCI) | Renal Pelvis | |||
RENAL VEIN | C33462 | A vein arising from the kidney; in general it drains into the caudal vena cava vein. | Renal Vein | |||
RESPIRATORY SYSTEM | C12779 | The organs and anatomic structures involved in inspiration and expiration of air and the exchange of carbon dioxide and oxygen. | Respiratory System | |||
RETINA | C12343 | Retina | A light-sensitive membrane that lines the back wall of the eyeball. The retina is continuous with the optic nerve and this way transmits optical images to the brain. (NCI) | Retina | ||
RETINAL ARTERY | C52997 | An artery arising from the ophthalmic artery that supplies the retina. | Retinal Artery | |||
RETINAL NERVE FIBER LAYER | C32953 | A retina layer that contains the axons of ganglion cells. It collects the visual impulses. (NCI) | Layer of the Ophthalmic Nerve Fibers | |||
RETINAL PIGMENTED EPITHELIAL LAYER | C33470 | A continuous, insulating monolayer of cuboidal/columnar epithelium which extends from the margins of the optic nerve head to the ora serrata where it is continuous with the pigment epithelium of the pars plana. (NCI) | Retinal Pigment Epithelium | |||
RETRO-ORBITAL REGION | C54155 | Retro-Orbital Area | The area behind the orbit of the eye. | Retro-Orbital Region | ||
RETROAURICULAR LYMPH NODE | C142313 | Mastoid Lymph Node;Posterior Auricular Lymph Node | The lymph nodes located immediately posterior to the ear. | Retroauricular Lymph Node | ||
RETROCRURAL LYMPH NODE | C103439 | A lymph node located within the most inferior portion of the posterior mediastinum. (NCI) | Retrocrural Lymph Node | |||
RETROPERITONEAL LYMPH NODE | C98189 | A lymph node located in the retroperitoneal space. (NCI) | Retroperitoneal Lymph Node | |||
RETROPERITONEUM | C12298 | The region of the abdomen outside the peritoneum, where the kidneys lie and the great blood vessels run. | Retroperitoneum | |||
RETROPHARYNGEAL LYMPH NODE | C77649 | Suprapharyngeal Lymph Node | Lymph node(s) in the retropharyngeal space. | Retropharyngeal Lymph Node | ||
RHOMBOID MAJOR MUSCLE | C186136 | A muscle of the back, in general extending from the spinous processes of the second to fifth thoracic vertebrae to the medial border of the scapula; primary function is to stabilize and retract the scapula. | Rhomboid Major Muscle | |||
RHOMBOID MINOR MUSCLE | C186137 | A muscle of the back, in general extending from the nuchal ligament and spinal processes of the seventh cervical and first thoracic vertebrae to the medial border of the scapula; primary function is to stabilize and retract the scapula. | Rhomboid Minor Muscle | |||
RIB 1 | C52770 | Rib 1 | The first rib counting from the top of the rib cage down. (NCI) | Rib 1 | ||
RIB 10 | C52769 | Rib 10 | The tenth rib counting from the top of the rib cage down. (NCI) | Rib 10 | ||
RIB 11 | C52768 | Rib 11 | The eleventh rib counting from the top of the rib cage down. (NCI) | Rib 11 | ||
RIB 12 | C52767 | Rib 12 | The twelfth rib counting from the top of the rib cage down. (NCI) | Rib 12 | ||
RIB 2 | C52766 | Rib 2 | The second rib counting from the top of the rib cage down. (NCI) | Rib 2 | ||
RIB 3 | C52765 | Rib 3 | The third rib counting from the top of the rib cage down. (NCI) | Rib 3 | ||
RIB 4 | C52764 | Rib 4 | The fourth rib counting from the top of the rib cage down. (NCI) | Rib 4 | ||
RIB 5 | C52763 | Rib 5 | The fifth rib counting from the top of the rib cage down. (NCI) | Rib 5 | ||
RIB 6 | C52762 | Rib 6 | The sixth rib counting from the top of the rib cage down. (NCI) | Rib 6 | ||
RIB 7 | C52761 | Rib 7 | The seventh rib counting from the top of the rib cage down. (NCI) | Rib 7 | ||
RIB 8 | C52760 | Rib 8 | The eighth rib counting from the top of the rib cage down. (NCI) | Rib 8 | ||
RIB 9 | C52759 | Rib 9 | The ninth rib counting from the top of the rib cage down. (NCI) | Rib 9 | ||
RIB | C12782 | Any one of the paired bones, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. | Rib | |||
RIGHT ATRIAL ENDOCARDIUM | C102339 | The innermost layer of endothelial cells and connective tissue that lines the right atrium. | Right Atrial Endocardium | |||
RIGHT CORONARY ARTERY OSTIUM | C116169 | The opening of the right coronary artery at its origin. | Right Coronary Artery Ostium | |||
RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES | C102340 | The right coronary artery and all of its branches. | Right Coronary Artery and its Branches | |||
RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY | C102341 | RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY SEGMENT;RPAV | The arterial branch between the right posterior descending artery segment and the first right posterolateral segment. | Right Posterior Atrioventricular Artery | ||
RIGHT POSTERIOR DESCENDING ARTERY | C102342 | RIGHT POSTERIOR DESCENDING ARTERY SEGMENT;RPDA | In an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery between the acute marginal artery and the first right posterolateral segment. It supplies the inferior apex of the heart. | Right Posterior Descending Artery | ||
RIGHT VENTRICULAR BRANCH | C116171 | The branch of the right coronary artery that supplies blood to the right ventricular wall. | Right Ventricular Branch of Right Coronary Artery | |||
RIGHT VENTRICULAR ENDOCARDIUM | C102343 | The innermost layer of endothelial cells and connective tissue that lines the right ventricle. | Right Ventricular Endocardium | |||
ROUND LIGAMENT | C12319 | Band of fibrous tissue that anchors various organs in place. | Round Ligament | |||
SACRAL TUBEROSITY | C105447 | The prominence on the lateral surface of the sacrum, posterior to the auricular surface of the sacrum. (NCI) | Sacral Tuberosity | |||
SACRAL VERTEBRA | C12853 | Any one of the vertebrae situated between the lumbar vertebrae and the caudal vertebrae or coccyx. | Sacral Vertebra | |||
SACROILIAC JOINT | C33507 | Sacroiliac Joint | The joint located between the sacrum and the ilium. (NCI) | Sacroiliac Joint | ||
SACRUM | C33508 | Sacrum | The triangular bone, made up of 5 fused bones of the spine, located in the lower area of the spine between the fifth lumbar vertebra and the coccyx. (NCI) | Sacrum | ||
SALIVARY GLAND | C12426 | Any number of exocrine glands that secrete saliva into the oral cavity. | Salivary Gland | |||
SALIVARY GLAND, SUBLINGUAL | C12234 | The salivary gland located under the tongue in the floor of the oral cavity or adjacent to the submandibular salivary gland. | Sublingual Salivary Gland | |||
SAPHENOUS VEIN | C33511 | Saphenous Vein | A vein of the leg/hindlimb; in general it arises from the venous network of the leg/hindfoot and drains into the femoral vein. | Saphenous Vein | ||
SARTORIUS MUSCLE | C33515 | A muscle in the thigh, in general extending from the anterior superior iliac spine of the pelvic bone to the anteromedial surface of the upper tibia in the pes anserinus; primary function is to flex, abduct, and laterally rotate the thigh at the hip joint, and to flex the leg at the knee joint. | Sartorius Muscle | |||
SCALENE LYMPH NODE | C89780 | Inferior Deep Cervical Lymph Node | A lymph node located in proximity to any of the scalene muscles. | Scalene Lymph Node | ||
SCALP | C89807 | The skin which covers the top of the head and which is usually covered by hair. (NCI) | Scalp | |||
SCAPHOID BONE | C12854 | Scaphoid Bone | A nut-shaped bone of the wrist located in the radial site of the hand. It is one of the eight carpal bones. (NCI) | Scaphoid Bone | ||
SCAPHOID-CAPITATE JOINT | C127676 | A condyloid synovial joint within the wrist articulating the scaphoid bone to the capitate bone. | Scaphoid-Capitate Joint | |||
SCAPHOID-LUNATE JOINT | C142314 | A condyloid synovial joint within the wrist articulating the scaphoid bone to the lunate bone. | Scaphoid-Lunate Joint | |||
SCAPHOID-LUNATE-CAPITATE JOINT | C127677 | A condyloid synovial joint within the wrist articulating the scaphoid, lunate, and capitate bones. | Scaphoid-Lunate-Capitate Joint | |||
SCAPHOID-RADIUS JOINT | C142315 | A condyloid synovial joint within the wrist articulating the scaphoid bone to the radius bone. | Scaphoid-Radius Joint | |||
SCAPHOID-TRAPEZIUM JOINT | C127678 | A condyloid synovial joint within the wrist articulating the scaphoid bone to the trapezium bone. | Scaphoid-Trapezium Joint | |||
SCAPHOID-TRAPEZOID JOINT | C142316 | A condyloid synovial joint within the wrist articulating the scaphoid bone to the trapezoid bone. | Scaphoid-Trapezoid Joint | |||
SCAPULA | C12783 | Shoulder Blade | A bone that articulates with the humerus and is part of the scapulohumeral joint. | Scapula | ||
SCIATIC NERVE | C52810 | A nerve arising from the merge of the lumbar and sacral rami in the pelvis and dividing into the common peroneal and tibial nerves, and which innervates the muscles of the thigh. | Sciatic Nerve | |||
SCLERA | C12784 | The fibrous, outer tunic of the eyeball that is continuous with the cornea. | Sclera | |||
SCROTUM | C12785 | The pouch that encloses the testicles. | Scrotum | |||
SEBACEOUS GLAND | C33519 | Small glands located within the skin that are usually associated with the hair follicle. | Sebaceous Gland | |||
SECOND DIAGONAL BRANCH ARTERY | C102344 | 2ND DIAG;SECOND DIAGONAL BRANCH ARTERY SEGMENT | The second artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal. | Second Diagonal Branch Artery | ||
SECOND LEFT POSTEROLATERAL BRANCH ARTERY | C102345 | 2ND LPL;SECOND LEFT POSTEROLATERAL BRANCH ARTERY SEGMENT | In an individual with a left-dominant heart, this is the second branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall. | Second Left Posterolateral Branch Artery | ||
SECOND OBTUSE MARGINAL BRANCH ARTERY | C102346 | 2ND OM;SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENT | The second artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal. | Second Obtuse Marginal Branch Artery | ||
SECOND RIGHT POSTEROLATERAL ARTERY | C102347 | 2ND RPL;SECOND RIGHT POSTEROLATERAL ARTERY SEGMENT | In an individual with a right-dominant heart, this is the second branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal. | Second Right Posterolateral Artery | ||
SEMIMEMBRANOSUS MUSCLE | C52987 | A muscle located in the posterior compartment of the thigh, in general extending from the ischial tuberosity to the medial tibial condyle; primary function is to extend the leg/hindlimb at the hip and to flex the leg/hindlimb at the knee. | Semimembranosus Muscle | |||
SEMINAL VESICLE | C12787 | Seminal Sacs | A mammalian male reproductive accessory gland located adjacent to the urinary bladder and proximal to the prostate. | Seminal Vesicle | ||
SEMITENDINOSUS MUSCLE | C53176 | A muscle of the thigh, in general extends from the ishium to the medial tibia; primary function is the extension of the hip. | Semitendinosus | |||
SENSORIMOTOR CORTEX | C154777 | The region of the brain that consists of the precentral and postcentral gyri and is involved in somatosensory and motor functions. | Sensorimotor Cortex | |||
SERRATUS ANTERIOR MUSCLE | C33540 | A muscle of the thorax, in general extending from the first through the eighth or ninth rib to the scapula; primary function is anteversion of the arm, protraction of the scapula, and stabilization of the scapula against the thoracic wall. | Serratus Anterior Muscle | |||
SHIN | C154780 | The front part of the leg from below the knee to the ankle. | Shin | |||
SHOULDER JOINT TENDONS | C161387 | The tendons that connect the muscles and bones that comprise the glenohumeral and acromioclavicular joints and enable abduction of the arm and stabilization of the shoulder. (NCI) | Shoulder Joint Tendons | |||
SHOULDER JOINT | C33548 | Shoulder Joint | A ball-and-socket joint at the upper end of the humerus, located at the junction of humerus and scapula. (NCI) | Shoulder Joint | ||
SHOULDER | C25203 | Shoulder | The region of the body between the neck and the upper arm. (NCI) | Shoulder | ||
SIGMOID SINUS | C166111 | Pars Sigmoid | Either of the two dural venous sinuses that receive blood from the transverse sinus and empty into the internal jugular vein. | Sinus Sigmoideus | ||
SINUS | C33556 | Sinus | A recess, cavity, or channel. (NCI) | Sinus | ||
SKIN ABOVE THE EYEBROW | C198298 | The integument that covers the area above the eyebrow. | Skin Above the Eyebrow | |||
SKIN AROUND THE EYE | C170599 | The skin surrounding the eye, including the skin of the eyelid. | Skin Around the Eye | |||
SKIN AROUND THE MOUTH | C170600 | The skin surrounding the mouth, including the skin of the lip. | Skin Around the Mouth | |||
SKIN BETWEEN EYEBROWS | C142317 | The integument that covers the area located medial to the orbital ridges and superior to the nose. | Skin Between the Eyebrows | |||
SKIN FOLD | C170602 | An area of the integument that folds upon itself. | Skinfold | |||
SKIN OF THE AXILLA | C116164 | The integument that covers the underarm. | Skin Of The Axilla | |||
SKIN OF THE BACK | C142318 | The integument that covers the back. | Skin Of The Back | |||
SKIN OF THE BENDING JOINT | C170603 | The integument that covers the bending joint. | Skin of the Bending Joint | |||
SKIN OF THE BUTTOCK | C150855 | The integument that covers the buttock. | Skin of the Buttock | |||
SKIN OF THE CHEST | C161379 | The integument that covers the chest. | Skin of the Chest | |||
SKIN OF THE CHIN | C142319 | The integument that covers the chin. | Skin Of The Chin | |||
SKIN OF THE EAR | C49481 | The integument that covers the ear. | Ear Skin | |||
SKIN OF THE ELBOW | C52755 | The integument that covers the elbow joint. | Elbow Skin | |||
SKIN OF THE FACE | C33561 | The skin or integument that covers the face. | Skin of the Face | |||
SKIN OF THE FINGER | C52720 | The integument that covers the finger. | Hand Digit Skin | |||
SKIN OF THE FOOT | C52750 | The integument that covers the foot. | Foot Skin | |||
SKIN OF THE FOREARM | C161378 | The integument that covers the forearm. | Skin of the Forearm | |||
SKIN OF THE HAND | C52753 | The integument that covers the hand. | Hand Skin | |||
SKIN OF THE HEAD | C52757 | The integument that covers the head, including the face and scalp. | Head Skin | |||
SKIN OF THE INFRASCAPULAR REGION | C161391 | The integument that covers the region of the back, lateral to the vertebral region and below the scapula. (NCI) | Skin of the Infrascapular Region | |||
SKIN OF THE INGUINAL REGION | C161380 | The integument that covers the inguinal region. | Skin of the Inguinal Region | |||
SKIN OF THE KNEE | C64859 | The integument that covers the knee joint. | Knee Skin | |||
SKIN OF THE LIP | C12291 | The skin portion of the lip that contains hair. | Skin of the Lip | |||
SKIN OF THE LOWER LIMB | C164047 | The integument that covers the lower limb. | Skin of the Lower Extremity | |||
SKIN OF THE NECK | C52756 | The integument that covers the neck. | Neck Skin | |||
SKIN OF THE OUTER CANTHUS OF THE EYE | C198299 | The integument that covers the outer corner of the eye were the upper and lower eyelids meet. | Skin of the Outer Canthus of the Eye | |||
SKIN OF THE PALM | C170604 | The integument that covers the palm. | Skin of the Palm | |||
SKIN OF THE SOLE | C170606 | The integument that covers the sole. | Skin of the Sole | |||
SKIN OF THE THIGH | C150856 | The integument that covers the thigh. | Skin of the Thigh | |||
SKIN OF THE TRUNK | C12295 | Skin of the Trunk | The integument that covers the trunk of the body. | Skin of the Trunk | ||
SKIN OF THE UPPER LIMB | C164048 | The integument that covers the upper limb. | Skin of the Upper Extremity | |||
SKIN UNDER THE EYE | C198300 | Skin of the Tear Trough | The integument that covers the area directly below the eye. | Skin Under the Eye | ||
SKIN | C12470 | Integument;Skin | An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. (NCI) | Skin | ||
SKULL | C12789 | Bone, Skull;Cranium;Skull Bone | The bones that form the head, made up of the bones of the braincase and face. (NCI) | Skull | ||
SKULL, BASE | C12493 | Base of the Skull | The portion of the skull that forms the floor on which the brain lies; the internal surface of the cranial base has three large depressions that lie on different levels known as the anterior, middle, and posterior cranial fossae. | Base of the Skull | ||
SMALL INTESTINAL MUCOSA | C33568 | Small Bowel Mucosa | The mucosal membranes that line the inner surface of the small intestine. | Small Intestinal Mucosa | ||
SMALL INTESTINE | C12386 | The villous section of the intestine extending from the pylorus to the proximal large intestine. | Small Intestine | |||
SMALL SAPHENOUS VEIN | C33546 | A superficial vein originating from the dorsal vein at the fifth toe and the dorsal venous arch of the foot; it extends up the back of the leg to empty into the popliteal vein at the knee joint. | Short Saphenous Vein | |||
SNOUT | C186138 | Muzzle | The projection on the anterior portion of the face that includes the nares, mouth, and jaw. | Snout | ||
SOFT PALATE | C12231 | The part of the roof of the mouth not supported by bone. | Soft Palate | |||
SOFT TISSUE | C12471 | Soft Tissue | Refers to muscle, fat, fibrous tissue, blood vessels, organ parenchyma, or other supporting tissue of the body. | Soft Tissue | ||
SOLE | C33326 | The undersurface of the foot. (NCI) | Plantar Region | |||
SOLEUS MUSCLE | C53075 | A muscle in the crus, in general extending from the tibia and fibula to the calcaneous; primary function is plantarflexion of the foot. | Soleus | |||
SPHENOID BONE | C12790 | The butterfly-shaped bone located at the base of the skull that forms the orbit of the eye. | Sphenoid Bone | |||
SPHENOID SINUS | C12278 | Either of the paired paranasal sinuses located in the anterior part of the body of the sphenoid bone, and communicating with the superior meatus of the nasal cavity on the same side. | Sphenoid Sinus | |||
SPINAL ACCESSORY NERVE | C32041 | ACCESSORY NERVE;CRANIAL ACCESSORY NERVE | The eleventh cranial nerve. | Accessory Nerve | ||
SPINAL CORD PARENCHYMA | C186139 | The parenchyma of the spinal cord, which consists of a canal surrounded by a neuron containing gray matter centrally and white matter containing myelinated nerve tracts peripherally. | Spinal Cord Parenchyma | |||
SPINAL CORD | C12464 | Medulla Spinalis | The portion of the central nervous system that lies within the vertebral canal and from which the spinal nerves emerge. | Spinal Cord | ||
SPINAL CORD, CERVICAL | C12892 | The segment of the spinal cord between the end of the brain stem and the thoracic spinal cord. | Cervical Spinal Cord | |||
SPINOUS PROCESS | C116112 | A bony projection arising from the posterior vertebral arch that serves for the attachment of muscles and ligaments. | Spinous Process | |||
SPLEEN | C12432 | An abdominal organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. | Spleen | |||
SPLEEN, HILUM | C33601 | Splenic Hilum | The area of the spleen through which the vessels and nerves enter or exit the organ. (NCI) | Splenic Hilum | ||
SPLENIC ARTERY | C33597 | An artery arising from the celiac trunk with four main branches that supply the spleen, stomach and pancreas. | Splenic Artery | |||
SPLENIC HILAR LYMPH NODE | C33600 | A lymph node located in the hilar region of the spleen. (NCI) | Splenic Hilar Lymph Node | |||
SPLENIC LYMPH NODE | C142320 | Any lymph node located along the splenic artery that receives afferent drainage from the pancreas, spleen, and stomach, and which generally has their efferents join the celiac group of preaortic lymph nodes. | Splenic Lymph Node | |||
SPLENIC VEIN | C33608 | A vein arising from the splenic trabecular vein in the hilum of the spleen that drains into the portal vein. | Splenic Vein | |||
STERNAL MANUBRIUM | C52730 | Sternal Manubrium | The upper segment of the sternum, quadrangular in shape, as well as wider superiorly and narrower inferiorly. The sternal manubrium articulates with the clavicle and first two ribs. (NCI) | Sternal Manubrium | ||
STERNEBRA | C176320 | Any of the segments of the body of the sternum. | Sternebra | |||
STERNOCLAVICULAR JOINT | C33615 | Sternoclavicular Joint | The synovial juncture between the medial end of the clavicle and the anterior segment of the sternum. (NCI) | Sternoclavicular Joint | ||
STERNOCLEIDOMASTOID MUSCLE | C33616 | SCM;Sternomastoid Muscle | A muscle of the neck; in general extending from the manubrium and the clavicle to the mastoid process and the superior nuchal line. Primary function is to flex the neck, move the chin cranially, and assist in elevating the rib cage during inspiration. | Sternocleidomastoid Muscle | ||
STERNUM | C12793 | Sterna | The long, flat bone or sternebrae connecting with the cartilage of some ribs. | Sternum | ||
STOMACH WALL | C186140 | Gastric Wall | The tissue that forms the wall of the stomach. | Stomach Wall | ||
STOMACH | C12391 | The portion of the gastrointestinal tract located between the esophagus and the proximal duodenum. | Stomach | |||
STRIATUM | C142370 | A group of subcortical nuclei of the basal ganglia comprising the caudate and putamen dorsally, and the nucleus accumbens as well as the olfactory tubercle ventrally. | Striatum Nuclei | |||
SUBARACHNOID SPACE | C156507 | Subarachnoid;Subarachnoid Area | The space between the arachnoid membrane and the pia mater. | Subarachnoid Space | ||
SUBCARINAL LYMPH NODE | C117873 | A lymph node located in the thoracic cavity between the lungs. It is bordered by the carina of the trachea, lower lobe bronchus on the left and the bronchus intermedius on the right. (NCI) | Subcarinal Lymph Node | |||
SUBCLAVIAN ARTERY | C33643 | One of the arteries of the thorax; in general it arises from the brachiocephalic artery or the aortic arch and branches into several arteries to supply blood to the head, neck, and arm/forelimb. | Subclavian Artery | |||
SUBCLAVIAN VEIN | C12794 | The vein that drains the axillary vein and joins the internal jugular vein to form the brachiocephalic vein. It runs parallel to the subclavian artery. | Subclavian Vein | |||
SUBCUTIS | C33645 | Subcutaneous Tissue | Adipose and connective tissue located deep to the dermis. | Subcutis | ||
SUBDURAL SPACE | C189532 | The potential body space between the arachnoid membrane and the dura mater. | Subdural Space | |||
SUBGLOTTIS | C12280 | Subglottis | The area of the larynx below the vocal cords down to the trachea. (NCI) | Subglottis | ||
SUBLINGUAL REGION | C102349 | A body region relating to the area under or adjacent to the tongue. | Sublingual Region | |||
SUBMANDIBULAR GLAND | C12233 | Gland, Salivary, Mandibular;Submaxillary Gland | The salivary gland located adjacent to the mandible. | Submandibular Salivary Gland | ||
SUBMANDIBULAR LYMPH NODE | C77650 | Lymph Node, Submandibular | Lymph node(s) adjacent to the mandible. | Submandibular Lymph Node | ||
SUBMENTAL LYMPH NODE | C142322 | Suprahyoid Lymph Nodes | The lymph nodes located between the anterior bellies of the digastric muscles. (NCI) | Submental Lymph Node | ||
SUBSCAPULARIS MUSCLE | C33651 | A muscle in the shoulder, in general extending from the subscapular fossa to the lesser tubercle of the humerus; primary function is to medially rotate the humerus. | Subscapularis Muscle | |||
SUBSTANTIA NIGRA | C12453 | The portion of the midbrain composed of two parts, the pars compacta and pars reticulata. | Substantia Nigra | |||
SUBTALAR JOINT | C33653 | Talocalcaneal Joint | The plane synovial joint between the talus and calcaneus bones of the foot. | Subtalar Joint | ||
SUDORIFEROUS GLAND | C33712 | Sweat Gland | The small coiled tubular glands in the skin that produce and secrete sweat. | Sweat Gland | ||
SUPERFICIAL FEMORAL ARTERY | C33661 | The portion of the femoral artery distal to the branching of the deep femoral artery that runs close to the skin. | Superficial Femoral Artery | |||
SUPERFICIAL LYMPH NODE | C102716 | A lymph node located in a superficial part of the body. | Superficial Lymph Node | |||
SUPERIOR FRONTAL GYRUS | C33674 | A ridge on the frontal lobe of the brain located above the superior frontal sulcus. | Superior Frontal Gyrus | |||
SUPERIOR MEDIASTINAL LYMPH NODE LEVEL VII | C132515 | Lymph nodes in this group include pretracheal, paratracheal, and esophageal groove lymph nodes, extending from the level of the suprasternal notch cephalad and up to the innominate artery caudad. These nodes are at greatest risk of involvement by thyroid cancer and cancer of the esophagus. (AJCC 8th ed.) | Superior Mediastinal Lymph Node Group (Level VII) | |||
SUPERIOR PUBIC RAMUS | C132415 | The portion of the pubic ramus that lies between the body of the ilium and the inferior pubic ramus. | Superior Pubic Ramus | |||
SUPERIOR SAGITTAL SINUS | C12515 | An intracranial venous sinus that lies in a superior and midline location above the interhemispheric fissure along the superior border of the falx cerebri of the brain. The sinus receives blood from the cerebral veins and drains posteriorly into the lateral sinuses of the brain, which in turn drain into the internal jugular veins. | Superior Sagittal Sinus | |||
SUPERIOR TEMPORAL GYRUS | C33698 | A ridge on the outer surface of the temporal lobe between the horizontal portion of the fissure of Sylvius and the superior temporal sulcus. (NCI) | Superior Temporal Gyrus | |||
SUPERIOR VENA CAVA | C12816 | Anterior Vena Cava;Cranial Vena Cava | The large vein that terminates in the right atrium and transports deoxygenated blood from the head, neck, arms, and chest to the heart. | Superior Vena Cava | ||
SUPINATOR MUSCLE | C186141 | A muscle of the forearm, in general extending from the posterior proximal shaft of the ulna and the lateral epicondyle of the humerus to the proximal third of the radius on the anterolateral and posterior surface; primary function is to supinate the forearm. | Supinator Muscle | |||
SUPRACLAVICULAR FOSSA | C142323 | A depression found at the base of the neck that is bounded thusly: superiorly by the posterior belly of the omohyoid muscle; inferiorly by the clavicle; and medially by the sternocleidomastoid muscle. | Supraclavicular Fossa | |||
SUPRACLAVICULAR LYMPH NODE | C12903 | Supraclavicular Lymph Node | A lymph node which is located above the clavicle. (NCI) | Supraclavicular Lymph Node | ||
SUPRAGLOTTIS | C12279 | The upper part of the larynx, including the epiglottis; the area above the vocal cords. | Supraglottis | |||
SUPRAMARGINAL GYRUS | C33706 | A ridge on the anterior part of the inferior parietal lobe of the brain. | Supramarginal Gyrus | |||
SUPRAOCCIPITAL BONE | C186142 | The superior portion of the occipital bone on the dorsal side of the foramen magnum; it is present during fetal development and later fuses with the occipital bone. | Supraoccipital Bone | |||
SUPRAPUBIC REGION | C32755 | The lowest central region of the abdomen, below the umbilical region and between the two iliac regions. (NCI) | Hypogastric Region | |||
SUPRARENAL AORTA | C130168 | The portion of the abdominal aorta cranial to the renal arteries. | Suprarenal Aorta | |||
SUPRASPINATUS MUSCLE | C33709 | One of four muscles surrounding the glenohumeral joint, in general extending from the supraspinous fossa of the scapula to the greater tubercle of the humerus; primary function is to abduct the arm and provide muscular support to the shoulder. | Supraspinatus Muscle | |||
SUPRATENTORIAL BRAIN | C12512 | The part of the brain above the tentorium cerebellum. (NCI) | Supratentorial Brain | |||
SURAL NERVE | C77675 | A minor branch of the sciatic nerve that includes the lateral and caudal sural nerves, which innervates the skin of the crus, tarsus and metatarsus. | Sural Nerve | |||
SUTURE | C186143 | Rigid, fibrous joints between the ossified bones of the skull. | Cranial Suture | |||
SYMPATHETIC GANGLIA | C12467 | A mass containing the cell bodies of sympathetic nerves. Sympathetic ganglia exist as paravertebral ganglia (located bilaterally adjacent to the spinal cord) or prevertebral ganglia (located close to the target organ). | Sympathetic Ganglion | |||
SYNOVIAL FLUID | C33718 | Synovia | The fluid within a joint capsule. | Synovial Fluid | ||
SYNOVIUM | C12473 | Synovial Membrane;Synovial Stratum | The connective tissue and synoviocytes that line the inner surface of the joint capsule. | Synovial Membrane | ||
T1 VERTEBRA | C33720 | T1 Vertebra | The first thoracic vertebra counting from the top down. (NCI) | T1 Vertebra | ||
T10 VERTEBRA | C33721 | T10 Vertebra | The tenth thoracic vertebra counting from the top down. (NCI) | T10 Vertebra | ||
T11 VERTEBRA | C33722 | T11 Vertebra | The eleventh thoracic vertebra counting from the top down. (NCI) | T11 Vertebra | ||
T12 VERTEBRA | C33723 | T12 Vertebra | The twelfth thoracic vertebra counting from the top down. (NCI) | T12 Vertebra | ||
T2 VERTEBRA | C33724 | T2 Vertebra | The second thoracic vertebra counting from the top down. (NCI) | T2 Vertebra | ||
T3 VERTEBRA | C33725 | T3 Vertebra | The third thoracic vertebra counting from the top down. (NCI) | T3 Vertebra | ||
T4 VERTEBRA | C33726 | T4 Vertebra | The fourth thoracic vertebra counting from the top down. (NCI) | T4 Vertebra | ||
T5 VERTEBRA | C33727 | T5 Vertebra | The fifth thoracic vertebra counting from the top down. (NCI) | T5 Vertebra | ||
T6 VERTEBRA | C33728 | T6 Vertebra | The sixth thoracic vertebra counting from the top down. (NCI) | T6 Vertebra | ||
T7 VERTEBRA | C33729 | T7 Vertebra | The seventh thoracic vertebra counting from the top down. (NCI) | T7 Vertebra | ||
T8 VERTEBRA | C33730 | T8 Vertebra | The eighth thoracic vertebra counting from the top down. (NCI) | T8 Vertebra | ||
T9 VERTEBRA | C33731 | T9 Vertebra | The ninth thoracic vertebra counting from the top down. (NCI) | T9 Vertebra | ||
TAIL | C77663 | A flexible appendage caudal to the sacrum. | Tail | |||
TALUS | C52799 | Talus | The bone of the foot that connects with the tibia and fibula to form the ankle joint. (NCI) | Talus | ||
TARSAL JOINT | C33735 | A joint formed by the union of tarsal bones. | Tarsal Joint | |||
TARSUS BONE | C12796 | Bone, Tarsal | Any of the short bones between the tibiotarsal joint and the tarsometatarsal joint. | Tarsal Bone | ||
TECTUM MESENCEPHALI | C12460 | The dorsal part or roof plate of the midbrain, which consists of the pretectal area and the paired superior and inferior colliculi. | Tectum Mesencephali | |||
TEMPLE | C142369 | The flat area on either side of the head that is located posterior to the eye and forehead, anterior to the ear, and superior to the cheekbone. | Temple | |||
TEMPORAL ARTERY | C33741 | A terminal branch of the external carotid artery that branches into the anterior and posterior temporal arteries. (NCI) | Temporal Artery | |||
TEMPORAL BONE | C12797 | Temporal Bone | A large irregular bone situated at the base and side of the skull, connected with the mandible via the temporomandibular joint. The temporal bone consists of the squamous, tympanic and petrous parts. The petrous portion of the temporal bone contains the vestibulocochlear organ of the inner ear. (NCI) | Temporal Bone | ||
TEMPORAL LOBE | C12353 | The second largest of the four cerebral lobes, the temporal lobe is approximately twenty two percent of the total neocortical volume. The temporal lobe can be divided into two main sections: first, the neocortex, comprising its lateral and inferolateral surfaces, and its standard cerebral cortex; and, second, the mesial temporal lobe, which is sometimes referred to as the limbic lobe, and includes the hippocampus, the amygdala, and the parahippocampal gyrus. Grossly, the lobe extends superiorly to the Sylvian fissure, and posteriorly to an imaginary line, the lateral parietotemporal line, which separates the temporal lobe from the inferior parietal lobule superiorly and the occipital lobe inferiorly. The middle cranial fossa forms its anterior and inferior boundaries. | Temporal Lobe | |||
TEMPOROMANDIBULAR JOINT | C32888 | Jaw Joint;TMJ | The joint between the head of the lower mandible and the temporal bone. (NCI) | Jaw Joint | ||
TENDON | C13045 | A band of fibrous connective tissue that joins bone to muscle. (NCI) | Tendon | |||
TENSOR FASCIA LATA MUSCLE | C53072 | Tensor Fasciae Latae Muscle;TFL Muscle | A muscle of the gluteal region, in general extending from the iliac crest to the iliotibial tract of the fascia lata; primary function is to stabilize the knee in extension and in hip flexion. | Tensor Fasciae Lata | ||
TENTORIUM CEREBELLI | C33749 | A laminar extension of the dura mater that lies between, and separates, the cerebrum and the cerebellum. (NCI) | Tentorium Cerebelli | |||
TESTIS | C12412 | Testicle | The male gonad. | Testis | ||
THALAMUS | C12459 | The portion of the diencephalon forming most of each lateral wall of the third ventricle. | Thalamus | |||
THIGH | C33763 | Thigh | A part of the lower limb, located between hip and knee. (NCI) | Thigh | ||
THIRD DIAGONAL BRANCH ARTERY | C102350 | 3RD DIAG;THIRD DIAGONAL BRANCH ARTERY SEGMENT | The third artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal. | Third Diagonal Branch Artery | ||
THIRD OBTUSE MARGINAL BRANCH ARTERY | C102351 | 3RD OM;THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENT | The third artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal. | Third Obtuse Marginal Branch Artery | ||
THIRD POSTEROLATERAL DESCENDING ARTERY | C102352 | 3RD LPL;THIRD POSTEROLATERAL DESCENDING ARTERY SEGMENT | In an individual with a left-dominant heart, this is the third branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall. | Third Posterolateral Descending Artery | ||
THIRD RIGHT POSTEROLATERAL ARTERY | C102353 | 3RD RPL;THIRD RIGHT POSTEROLATERAL ARTERY SEGMENT | In an individual with a right-dominant heart, this is the third branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal. | Third Right Posterolateral Artery | ||
THORACIC AORTA | C33766 | The section of the aorta between the lower border of the fourth dorsal vertebrae and the aortic opening in the diaphragm. (NCI) | Thoracic Aorta | |||
THORACIC ARTERY | C142325 | An artery that branches from the axillary artery or one of its branches, and that supplies the muscles and organs of the thorax. | Thoracic Artery | |||
THORACIC CAVITY | C12905 | The cavity enclosed by the ribs between the diaphragm and the neck. | Thoracic Cavity | |||
THORACIC LYMPH NODE | C33769 | Lymph node located in the thoracic cavity. (NCI) | Thoracic Lymph Node | |||
THORACIC SPINE | C69315 | The vertebrae of the thoracic spine, numbered one through twelve in humans. | Thoracic Spine | |||
THORACIC VERTEBRA | C12798 | Thoracic Vertebra | Any of the vertebrae situated between the cervical and lumbar vertebrae. | Thoracic Vertebra | ||
THORAX | C12799 | Thorax | The division of the body lying between the neck and the abdomen. (NCI) | Thorax | ||
THROAT | C54272 | Throat | The narrow passage from the mouth to the cavity at the back of the mouth. (NCI) | Throat | ||
THYMUS GLAND | C12433 | Thymus Gland | A primary lymphoid organ generally located in the mediastinum near the thoracic inlet and/or along lateral aspects of the neck. | Thymus Gland | ||
THYROID GLAND ISTHMUS | C32887 | The narrow, central portion of the thyroid gland that crosses the trachea anteriorly and connects the two lobes of the gland. (NCI) | Thyroid Gland Isthmus | |||
THYROID GLAND | C12400 | Endocrine gland(s) adjacent to the trachea in mammals that produce thyroxine and other hormones. | Thyroid Gland | |||
THYROID GLAND, LEFT LOBE | C32973 | Left Thyroid Gland Lobe | The cone-like lobe of the thyroid gland that is located in the left side of the trachea. (NCI) | Left Thyroid Gland Lobe | ||
THYROID GLAND, RIGHT LOBE | C33491 | Right Thyroid Gland Lobe | The cone-like lobe of the thyroid gland that is located in the right side of the trachea. (NCI) | Right Thyroid Gland Lobe | ||
TIBIA SHAFT | C120675 | The triangular prismoid, elongated bony body of the tibia. | Tibial Shaft | |||
TIBIA | C12800 | The long bone that is medial to the fibula. | Tibia | |||
TIBIAL GROWTH PLATE | C181455 | Tibial Epiphyseal Plate;Tibial Physis;Tibial Plateau Growth Plate | A layer of cartilaginous tissue located in the tibia of children and adolescents that separates the epiphysis from the metaphysis and is the site of longitudinal bone growth until skeletal maturity. | Tibial Growth Plate | ||
TIBIAL NERVE | C52809 | A branch of the sciatic nerve that divides into the medial and lateral plantar nerves, and which innervates the muscles of the crus and the skin of the tarsus. | Tibial Nerve | |||
TIBIAL-CRURAL PERIPHERAL ARTERY | C116168 | The blood vessels segment that includes the crural artery and the tibial artery. | Tibialcrural Artery | |||
TIBIALIS ANTERIOR MUSCLE | C117874 | A muscle that originates from the lateral condyle of tibia, spans the upper two-thirds of the lateral surface of the tibia, and is attached to the first cuneiform and metatarsal bones of the foot. It is a dorsiflexor of the ankle and invertor of the foot. | Tibialis Anterior Muscle | |||
TIBIALIS POSTERIOR MUSCLE | C140526 | A muscle in the lower leg, in general extending from the inner posterior borders of the tibia and fibula to the posterior tibial tendon at the posterior aspect of the medial malleolus; primary function is to stabilize the ankle, as well as invert and plantar flex the foot at the ankle. | Posterior Tibialis Muscle | |||
TIBIO-PERONEAL TRUNK | C116182 | An arterial trunk that contains parts of the posterior tibial artery and fibular artery. | Tibioperoneal Arterial Trunk | |||
TIBIOTARSAL JOINT | C156506 | The joint connecting the lower part of the tibia with the upper part of the tarsus bones, specifically articulating with the talus bone. | Tibiotarsal Joint | |||
TOE | C33788 | Toe | One of the terminal digits of the foot. (NCI) | Toe | ||
TOENAIL | C33790 | Toenail | A thin, horny translucent plate covering the end of each toe. (NCI) | Toenail | ||
TONGUE | C12422 | The muscular organ in the mouth used in taste perception and food ingestion. | Tongue | |||
TONSIL | C12802 | A secondary lymphoid tissue in the mucosa of the pharynx. | Tonsil | |||
TOOTH CANAL | C66864 | Tooth Canal | The anatomic space in the root of a tooth that contains nerves, blood vessels, and connective tissue. (NCI) | Tooth Canal | ||
TOOTH | C12506 | A hard calcified structure in the jaw; primarily used for eating. | Tooth | |||
TRACHEA | C12428 | Windpipe | The fibrocartilaginous tube extending from the larynx to the bronchi. | Trachea | ||
TRACHEOBRONCHIAL TREE | C117875 | An anatomical structure comprised of trachea, bronchi, and bronchioles that terminate with the alveolar ducts, sacs, and alveoli. (NCI) | Tracheobronchial Tree | |||
TRANSVERSE TARSAL JOINT | C102354 | Mid-Tarsal Joint | A combination of syndesmosis and synovial joints formed by the articulation of the talus with the navicular and the calcaneus with the cuboid. | Transverse Tarsal Joint | ||
TRAPEZIAL BONE | C12857 | Trapezium | A carpal bone on the thumb side of the hand that articulates with the 1st and 2nd metacarpals. (NCI) | Trapezial Bone | ||
TRAPEZIUM-TRAPEZOID JOINT | C142326 | A condyloid synovial joint within the wrist articulating the trapezium bone to the trapezoid bone. | Trapezium-Trapezoid Joint | |||
TRAPEZIUS MUSCLE | C33809 | Trapezius Muscle | One of a pair of flat, large, triangular muscles that extend from the external occipital protuberance and the medial third of the superior nuchal line of the occipital bone to the middle of the back. The trapezius muscle is involved in moving the shoulder and arm. (NCI) | Trapezius Muscle | ||
TRAPEZOID BONE | C12859 | Trapezoid Bone | A carpal bone located between the trapezium and capitate bones. (NCI) | Trapezoid Bone | ||
TRAPEZOID-CAPITATE JOINT | C142327 | A condyloid synovial joint within the wrist articulating the trapezoid bone to the capitate bone. | Trapezoid-Capitate Joint | |||
TRIANGULAR BONE | C12858 | Triquetral Bone | A carpal bone located between the lunate and pisiform bones. (NCI) | Triangular Bone | ||
TRIANGULAR-HAMATE JOINT | C139200 | Triquetral-Hamate Joint;Triquetrum-Hamate Joint | The point of articulation in the wrist between the hamate and the triquetral bones. | Triangular-Hamate Joint | ||
TRIANGULAR-LUNATE JOINT | C139203 | Triquetral-Lunate Joint;Triquetrum-Lunate Joint | The point of articulation in the wrist between the lunate and the triquetral bones. | Lunotriquetral Joint | ||
TRICEPS BRACHII MUSCLE | C90604 | A muscle of the proximal arm/forelimb, in general extending from the scapula and humerus to the olecranon of the ulna; primary function is extension of humeroulnar joint. | Triceps Brachii | |||
TRICUSPID VALVE ANNULUS | C130047 | A fibrous membrane that attaches to, and provides support for, the tricuspid valve leaflets. | Tricuspid Valve Annulus | |||
TRICUSPID VALVE | C12805 | Right Atrioventricular Valve;Tricuspid Valve | A cardiac valve located between the right atrium and ventricle. | Tricuspid Valve | ||
TRICUSPID VALVE, ANTERIOR CUSP | C32799 | The cusp of the tricuspid valve that is located between the atrioventricular orifice and the conus arteriosus. | Anterior Cusp of the Tricuspid Valve | |||
TRICUSPID VALVE, POSTERIOR ANNULUS | C130169 | The portion of the tricuspid valve annulus that attaches to both the posterior and lateral tricuspid valve leaflets. | Posterior Annulus of the Tricuspid Valve | |||
TRICUSPID VALVE, POSTERIOR CUSP | C33055 | The cusp of the tricuspid valve that is located posterior and on the margin of the right ventricle. | Posterior Cusp of the Tricuspid Valve | |||
TRICUSPID VALVE, SEPTAL CUSP | C33534 | The cusp of the tricuspid valve that is attached to the right and left fibrous trigones and the atrial and ventricular septa. | Septal Cusp of the Tricuspid Valve | |||
TRIGEMINAL NERVE | C12806 | Fifth Cranial Nerve | A cranial nerve extending from the pons, which innervates the skin, mucous membranes, and masticatory muscles of the head. | Trigeminal Nerve | ||
TROCHANTER | C33814 | Trochanter | A bony protrusion on the femoral bone to which muscles are attached. (NCI) | Trochanter | ||
TROCHLEAR NERVE | C12808 | Trochlear Nerve | The cranial nerve that controls the superior oblique muscle of the eye. (NCI) | Trochlear Nerve | ||
TRUNK | C33816 | Torso | The body excluding the head, neck and appendages. | Trunk | ||
TUNICA INTIMA | C33820 | Tunica Intima | The inner most layer of the blood vessel wall. The consistency of the intima will vary depending on the type of blood vessel, but will always have an endothelial layer with a basal lamina. It may contain collagen and elastic fibers. (NCI) | Tunica Intima | ||
TYMPANIC MEMBRANE | C12502 | Tympanic Membrane | A thin membrane that separates the external auditory canal from the middle ear. | Tympanic Membrane | ||
ULNA SHAFT | C120676 | The prismatic, elongated bony body of the ulna. | Ulnar Shaft | |||
ULNA | C12809 | The bone that contains the olecranon process, lies between the radiohumeral joint and the carpus, and is adjacent to the radius. | Ulna | |||
ULNAR ARTERY | C12839 | An artery of the forearm; in general it arises from the brachial artery just below the elbow and forms numerous branches supplying the forearm, wrist and hand. | Ulnar Artery | |||
ULNAR NERVE | C52807 | A nerve arising from spinal nerves C8, T1 and T2, which innervates the flexor muscles of the arm/forelimb and skin of the arm/forelimb and lateral manus. | Ulnar Nerve | |||
UMBILICAL ARTERY | C33827 | Either of two arteries located in the umbilical cord. | Umbilical Artery | |||
UMBILICAL CORD | C34320 | Extraembryonic structure that connects the fetus to the placenta. | Umbilical Cord | |||
UMBILICAL VEIN | C33830 | The vein located in the umbilical cord. | Umbilical Vein | |||
UMBILICUS | C77533 | Navel | The depression or scar on the abdomen that marks the former site of attachment of the umbilical cord. (NCI) | Umbilicus | ||
UNCINATE PROCESS OF PANCREAS | C62432 | Uncinate Process of Pancreas | A portion of the pancreas that extends behind the superior mesenteric artery and superior mesenteric vein. (NCI) | Uncinate Process of Pancreas | ||
UPPER CERVICAL LYMPH NODE | C103447 | A lymph node located in the upper region of the neck. (NCI) | Upper Cervical Lymph Node | |||
UPPER RESPIRATORY SYSTEM | C33839 | The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea. | Upper Respiratory System | |||
UPPER URINARY SYSTEM | C142328 | Upper Urinary Tract | The division of the urinary tract comprising the kidney and the ureters. | Upper Urinary System | ||
URACHAL TRACT | C12338 | A cord of fibrous tissue that extends from the urinary bladder to the umbilicus; the urachus is a remnant of the fetal urinary canal. | Urachus | |||
URETER | C12416 | The tube that extends from each kidney to the urinary bladder. | Ureter | |||
URETERIC ORIFICE | C12337 | The opening of the ureter in the bladder that is situated at the lateral angle of the trigone. | Ureteric Orifice | |||
URETHRA | C12417 | The tube that extends from the urinary bladder to the urethral opening. | Urethra | |||
URETHRA, ANTERIOR | C61125 | Anterior Portion of the Urethra | The portion of the urethra that extends from the meatus to the membranous urethra. (NCI) | Anterior Portion of the Urethra | ||
URETHRA, PENILE | C61123 | Penile Portion of the Urethra | The portion of the urethra that spans the corpus spongiosum. (NCI) | Penile Portion of the Urethra | ||
URETHRA, POSTERIOR | C61126 | Posterior Portion of the Urethra | The portion of the urethra that is located on the posterior aspect of the urogenital diaphragm. (NCI) | Posterior Portion of the Urethra | ||
URETHRA, PROSTATIC | C13101 | Prostatic Urethra | That part of the male urethra that passes through the prostate gland. (NCI) | Prostatic Urethra | ||
URETHRAL SPHINCTER | C128573 | One or both of the muscles that surround the urethra and contract to control the flow of urine, either involuntarily (the internal sphincter) or voluntarily (the external sphincter). | Urethral Sphincter | |||
URINARY SYSTEM | C12413 | Urinary System | The organs involved in the creation and excretion of urine. (NCI) | Urinary System | ||
UTERINE ARTERY | C142329 | An artery that arises most often as a branch of the anterior division of the internal iliac artery; it continues medially in the pelvis within the base of the broad ligament, to the exterior surface of the uterus where it branches into the descending, transverse, and ascending divisions, which further branch into the following: the helicine branches that supply the uterus; the vaginal branch, which anastomoses with the vaginal artery to supply the vagina; the ovarian branch, which anastomoses with ovarian artery to supply the ovaries; and the tubal branch that supplies the fallopian tubes. | Uterine Artery | |||
UTERINE HORN | C161570 | The portion of the uterus that connects the oviduct to the corpus uteri. | Uterine Horn | |||
UTERINE LIGAMENT | C61360 | Any of the ligaments attached to the uterus, which may include the anterior, posterior, lateral, sacro-uterine, and round ligaments. | Uterine Ligament | |||
UTERINE WALL | C13039 | Uterus Wall | The tissue that forms the wall of the uterus. | Female Reproductive System Part | ||
UTERUS | C12405 | Womb | A hollow muscular organ within which the fertilized egg implants and the embryo/fetus develops during pregnancy. | Uterus | ||
UVEA | C12811 | Uvea | The pigmented layer of the eyeball between the tough, white outer coat of the eye and the retina. (NCI) | Uvea | ||
VAGINA | C12407 | Vagina | The female genital canal, extending from the uterus to the vulva. (NCI) | Vagina | ||
VAGINAL WALL | C161377 | The tissue layers that enclose the vaginal canal. (NCI) | Vaginal Wall | |||
VAGUS NERVE | C12812 | Tenth Cranial Nerve | A cranial nerve arising from the medulla oblongata, which provides efferent parasympathetic innervation to tissues and viscera in the neck, thorax and abdomen; it also includes somatic and visceral afferent nerve fibers. | Vagus Nerve | ||
VAS DEFERENS | C12813 | Ductus Deferens | A duct carrying spermatozoa from the epididymides to the urethra. | Vas Deferens | ||
VASTUS INTERMEDIUS MUSCLE | C117876 | A muscle in the quadriceps femoris muscle group between the vastus lateralis and vastus medialis deep to the rectus femoris; primary function is the extension of the femorotibial joint. | Vastus Intermedius Muscle | |||
VASTUS LATERALIS MUSCLE | C53073 | A muscle in the quadriceps femoris muscle group lateral to the vastus intermedius; primary function is the extension of the femorotibial joint. | Vastus Lateralis | |||
VASTUS MEDIALIS MUSCLE | C117736 | A muscle in the quadriceps femoris muscle group medial to the vastus intermedius; primary function is the extension of the femorotibial joint. | Vastus Medialis Muscle | |||
VEIN | C12814 | Vein | A blood vessel that carries blood towards the heart. | Vein | ||
VENA CAVA | C12817 | The two major veins (caudal or cranial) that carry deoxygenated blood from the body and drain into the right atrium of the heart. | Vena Cava | |||
VENOUS SINUS | C12877 | An endothelium-lined passageway or channel that drains venous blood. | Venous Sinus | |||
VERTEBRA | C33868 | Vertebra;Vertebral Bone | One of the bones that make up the vertebral column. | Vertebral Bone | ||
VERTEBRAL ARTERY | C12819 | The first branch of the subclavian artery that ascends both sides of the neck and merges at the middle line to form the basilar artery at the level of the pons. | Vertebral Artery | |||
VERTEBRAL COLUMN | C12998 | Vertebral Column | The series of vertebrae and other tissues extending from the skull to the last tailbone. | Vertebral Column | ||
VESICOURETERIC JUNCTION | C106202 | Ureterovesical Junction;UVJ;VUJ | The area where the ureter joins to the urinary bladder. | Ureterovesical Junction | ||
VESTIBULOCOCHLEAR NERVE | C12996 | The eighth cranial nerve. | Vestibulocochlear Nerve | |||
VOCAL CORD | C12822 | Vocal Cord | A pair of small bands of muscle that stretch from the thyroid cartilage in front to the arytenoid cartilage in back of the larynx. The vocal cords help prevent food entering the lungs and produce sound through vibration. (NCI) | Vocal Cord | ||
VOMER | C33888 | Vomer | A thin, paired or unpaired, trapezoidal bone of the skull located in the floor of the nasal cavity. The vomer forms the posterior and inferior parts of the nasal septum. (NCI) | Vomer | ||
VULVA | C12408 | The external, visible part of the female genitalia surrounding the urethral and vaginal opening(s). | Vulva | |||
VULVOVAGINAL REGION | C94529 | The body region comprising the vulva and vagina. | Vulvovaginal Region | |||
WAIST | C64192 | Waist | The abdominal circumference at the navel. (NCI) | Waist | ||
WALDEYER'S TONSILLAR RING | C73468 | The ring of lymphoid tissue located in the pharynx, consisting of the pharyngeal, tubal, palatine, and lingual tonsils. (NCI) | Waldeyer Ring | |||
WARDS TRIANGLE | C122161 | An area of low density in the femoral neck, as seen by radiography, which is bounded by the principle compressive, secondary compressive and primary tensile trabeculae. | Ward's Triangle | |||
WHISKERS | C186144 | Vibrissa;Vibrissae;Whisker | Stiff sensory hairs that project outward from the snout. | Whiskers | ||
WRIST JOINT EXTENSOR MUSCLES | C166003 | A group of muscles in the upper extremity, the extensor carpi radialis longus, extensor carpi radialis brevis, extensor digitorum, extensor digiti minimi, extensor carpi ulnaris, extensor indicis, extensor pollicis longus, extensor pollicis brevis, and abductor pollicis longus muscles; primary function is extension and abduction of the wrist and extension of the fingers. | Wrist Joint Extensor Muscles | |||
WRIST JOINT EXTENSOR TENDONS | C161386 | The tendons located along the back part of the forearm that cross to the thumb side of the wrist and connect muscles of the forearm to the base of hand bones, enabling extension of the wrist. (NCI) | Wrist Joint Extensor Tendons | |||
WRIST JOINT FLEXOR MUSCLES | C166004 | A group of muscles in the upper extremity, the flexor carpi radialis, palmaris longus, flexor carpi ulnaris, flexor digitorum superficialis, flexor digitorum profundus, and flexor pollicis longus muscles; primary function is flexion, adduction, and abduction of the wrist, and flexion and adduction of the fingers. | Wrist Joint Flexor Muscles | |||
WRIST JOINT FLEXOR TENDONS | C161385 | The tendons located along the inside of the forearm that cross at the wrist and connect muscles of the forearm to wrist and hand bones, enabling flexion of the wrist. (NCI) | Wrist Joint Flexor Tendons | |||
WRIST JOINT | C33894 | Radiocarpal Joint;Wrist | A joint between the distal end of the radius and the proximal row of carpal bones. (NCI) | Wrist Joint | ||
XIPHOID PROCESS | C33895 | Xiphoid Process | The cartilage just below the sternal body. (NCI) | Xiphoid Process | ||
ZYGOMATIC BONE | C187837 | Cheekbone;Malar Bone;Zygomatic Buttress | A bone of the eye socket that articulates with the maxilla, the temporal bone, the sphenoid bone and the frontal bone, to form the prominence of the cheek. | Zygomatic Bone | ||
Back to top | ||||||
CL.C120521.AVOUTTRT | Anti-Viral Outcome of Treatment
(AVOUTTRT) | text
Extensible: Yes | C120521 | Anti-Viral Outcome of Treatment | A terminology codelist to describe the anti-viral outcome of treatment. | CDISC SDTM Anti-Viral Outcome of Treatment Terminology |
RAPID VIROLOGIC RESPONSE | C120597 | RVR | A finding of aviremia at a specified timepoint, early during the treatment period. | Rapid Virologic Response | ||
SUSTAINED VIROLOGIC RESPONSE | C120598 | SVR | A finding of aviremia at a predetermined time point after the end of planned or actual treatment. | Sustained Virologic Response | ||
VIRAL BREAKTHROUGH | C120599 | VBT | The subject becomes viremic during the treatment period after a period of treatment-induced aviremia or has an increase in viral load from nadir above a predetermined threshold during the treatment period. | Viral Breakthrough | ||
VIRAL RELAPSE | C120600 | A recurrence of the same virus after a finding of aviremia at the end of planned or actual treatment. | Viral Relapse | |||
VIROLOGIC END OF TREATMENT RESPONSE | C120601 | A finding of aviremia at the end of the planned or actual end of treatment period. | Virologic End Of Treatment Response | |||
VIROLOGIC FAILURE | C120602 | A finding of viremia at or after end of planned or actual treatment, excluding treatment discontinuations for non-virologic reasons. | Virologic Failure | |||
VIROLOGIC NON-RESPONSE | C120603 | The subject remains viremic during the treatment period. | Virologic Non-Response | |||
VIROLOGIC NULL-RESPONSE | C120604 | The subject remains viremic during the treatment period and the decrease in viral load from baseline at a specified timepoint is below or equal to a predetermined threshold. | Virologic Null-Response | |||
VIROLOGIC PARTIAL RESPONSE | C120605 | The subject remains viremic during the treatment period and the decrease in viral load from baseline at a specified timepoint is above a predetermined threshold. | Virologic Partial Response | |||
Back to top | ||||||
CL.C176047.APGR01TC | Apgar Score V1 Clinical Classification Test Code
(APGR01TC) | text
Extensible: No | C176047 | Apgar Score V1 Clinical Classification Test Code | Apgar Score V1 test code. | CDISC Clinical Classification APGAR Score Version 1 Test Code Terminology |
APGR0101 | C176061 | APGR01-Appearance/Color | Apgar Score V1 - Appearance, skin color, or color score. | Apgar Score Version 1 - Appearance or Color | ||
APGR0102 | C176062 | APGR01-Pulse/Heart Rate | Apgar Score V1 - Pulse or heart rate score. | Apgar Score Version 1 - Pulse or Heart Rate | ||
APGR0103 | C176063 | APGR01-Grimace/Reflex Irritability | Apgar Score V1 - Grimace or reflex irritability score. | Apgar Score Version 1 - Grimace or Reflex Irritability | ||
APGR0104 | C176064 | APGR01-Activity/Muscle Tone | Apgar Score V1 - Activity or muscle tone score. | Apgar Score Version 1 - Activity or Muscle Tone | ||
APGR0105 | C176065 | APGR01-Respiration/Respiratory Effort | Apgar Score V1 - Respiration or respiratory effort score. | Apgar Score Version 1 - Respiration or Respiratory Effort | ||
APGR0106 | C176066 | APGR01-Total Apgar Score | Apgar Score V1 - Total Apgar score. | Apgar Score Version 1 - Total Apgar Score | ||
Back to top | ||||||
CL.C176046.APGR01TN | Apgar Score V1 Clinical Classification Test Name
(APGR01TN) | text
Extensible: No | C176046 | Apgar Score V1 Clinical Classification Test Name | Apgar Score V1 test name. | CDISC Clinical Classification APGAR Score Version 1 Test Name Terminology |
APGR01-Activity/Muscle Tone | C176064 | APGR01-Activity/Muscle Tone | Apgar Score V1 - Activity or muscle tone score. | Apgar Score Version 1 - Activity or Muscle Tone | ||
APGR01-Appearance/Color | C176061 | APGR01-Appearance/Color | Apgar Score V1 - Appearance, skin color, or color score. | Apgar Score Version 1 - Appearance or Color | ||
APGR01-Grimace/Reflex Irritability | C176063 | APGR01-Grimace/Reflex Irritability | Apgar Score V1 - Grimace or reflex irritability score. | Apgar Score Version 1 - Grimace or Reflex Irritability | ||
APGR01-Pulse/Heart Rate | C176062 | APGR01-Pulse/Heart Rate | Apgar Score V1 - Pulse or heart rate score. | Apgar Score Version 1 - Pulse or Heart Rate | ||
APGR01-Respiration/Respiratory Effort | C176065 | APGR01-Respiration/Respiratory Effort | Apgar Score V1 - Respiration or respiratory effort score. | Apgar Score Version 1 - Respiration or Respiratory Effort | ||
APGR01-Total Apgar Score | C176066 | APGR01-Total Apgar Score | Apgar Score V1 - Total Apgar score. | Apgar Score Version 1 - Total Apgar Score | ||
Back to top | ||||||
CL.C125741.ASEX01TC | Arizona Sexual Experiences Scale - Female Questionnaire Test Code
(ASEX01TC) | text
Extensible: No | C125741 | Arizona Sexual Experiences Scale - Female Questionnaire Test Code | Arizona Sexual Experiences Scale - Female test code. | CDISC Questionnaire ASEX-Female Version Test Code Terminology |
ASEX0101 | C125763 | ASEX01-Sex Drive | Arizona Sexual Experiences Scale Female - How strong is your sex drive? | ASEX-Female Version - Sex Drive | ||
ASEX0102 | C125764 | ASEX01-Sexually Aroused | Arizona Sexual Experiences Scale Female - How easily are you sexually aroused (turned on)? | ASEX-Female Version - Sexually Aroused | ||
ASEX0103 | C125765 | ASEX01-Vagina Become Moist | Arizona Sexual Experiences Scale Female - How easily does your vagina become moist or wet during sex? | ASEX-Female Version - Vagina Become Moist | ||
ASEX0104 | C125766 | ASEX01-Reach Orgasm | Arizona Sexual Experiences Scale Female - How easily can you reach an orgasm? | ASEX-Female Version - Reach Orgasm | ||
ASEX0105 | C125767 | ASEX01-Orgasms Satisfying | Arizona Sexual Experiences Scale Female - Are your orgasms satisfying? | ASEX-Female Version - Orgasms Satisfying | ||
ASEX0106 | C129254 | ASEX01-Comments | Arizona Sexual Experiences Scale Female - Comments. | ASEX-Female Version - Comments | ||
Back to top | ||||||
CL.C125740.ASEX01TN | Arizona Sexual Experiences Scale - Female Questionnaire Test Name
(ASEX01TN) | text
Extensible: No | C125740 | Arizona Sexual Experiences Scale - Female Questionnaire Test Name | Arizona Sexual Experiences Scale - Female test name. | CDISC Questionnaire ASEX-Female Version Test Name Terminology |
ASEX01-Comments | C129254 | ASEX01-Comments | Arizona Sexual Experiences Scale Female - Comments. | ASEX-Female Version - Comments | ||
ASEX01-Orgasms Satisfying | C125767 | ASEX01-Orgasms Satisfying | Arizona Sexual Experiences Scale Female - Are your orgasms satisfying? | ASEX-Female Version - Orgasms Satisfying | ||
ASEX01-Reach Orgasm | C125766 | ASEX01-Reach Orgasm | Arizona Sexual Experiences Scale Female - How easily can you reach an orgasm? | ASEX-Female Version - Reach Orgasm | ||
ASEX01-Sex Drive | C125763 | ASEX01-Sex Drive | Arizona Sexual Experiences Scale Female - How strong is your sex drive? | ASEX-Female Version - Sex Drive | ||
ASEX01-Sexually Aroused | C125764 | ASEX01-Sexually Aroused | Arizona Sexual Experiences Scale Female - How easily are you sexually aroused (turned on)? | ASEX-Female Version - Sexually Aroused | ||
ASEX01-Vagina Become Moist | C125765 | ASEX01-Vagina Become Moist | Arizona Sexual Experiences Scale Female - How easily does your vagina become moist or wet during sex? | ASEX-Female Version - Vagina Become Moist | ||
Back to top | ||||||
CL.C125743.ASEX02TC | Arizona Sexual Experiences Scale - Male Questionnaire Test Code
(ASEX02TC) | text
Extensible: No | C125743 | Arizona Sexual Experiences Scale - Male Questionnaire Test Code | Arizona Sexual Experiences Scale - Male test code. | CDISC Questionnaire ASEX-Male Version Test Code Terminology |
ASEX0201 | C125768 | ASEX02-Sex Drive | Arizona Sexual Experiences Scale Male - How strong is your sex drive? | ASEX-Male Version - Sex Drive | ||
ASEX0202 | C125769 | ASEX02-Sexually Aroused | Arizona Sexual Experiences Scale Male - How easily are you sexually aroused (turned on)? | ASEX-Male Version - Sexually Aroused | ||
ASEX0203 | C125770 | ASEX02-Keep Erection | Arizona Sexual Experiences Scale Male - Can you easily get and keep an erection? | ASEX-Male Version - Keep Erection | ||
ASEX0204 | C125771 | ASEX02-Reach Orgasm | Arizona Sexual Experiences Scale Male - How easily can you reach an orgasm? | ASEX-Male Version - Reach Orgasm | ||
ASEX0205 | C125772 | ASEX02-Orgasms Satisfying | Arizona Sexual Experiences Scale Male - Are your orgasms satisfying? | ASEX-Male Version - Orgasms Satisfying | ||
ASEX0206 | C129256 | ASEX02-Comments | Arizona Sexual Experiences Scale Male - Comments. | ASEX-Male Version - Comments | ||
Back to top | ||||||
CL.C125742.ASEX02TN | Arizona Sexual Experiences Scale - Male Questionnaire Test Name
(ASEX02TN) | text
Extensible: No | C125742 | Arizona Sexual Experiences Scale - Male Questionnaire Test Name | Arizona Sexual Experiences Scale - Male test name. | CDISC Questionnaire ASEX-Male Version Test Name Terminology |
ASEX02-Comments | C129256 | ASEX02-Comments | Arizona Sexual Experiences Scale Male - Comments. | ASEX-Male Version - Comments | ||
ASEX02-Keep Erection | C125770 | ASEX02-Keep Erection | Arizona Sexual Experiences Scale Male - Can you easily get and keep an erection? | ASEX-Male Version - Keep Erection | ||
ASEX02-Orgasms Satisfying | C125772 | ASEX02-Orgasms Satisfying | Arizona Sexual Experiences Scale Male - Are your orgasms satisfying? | ASEX-Male Version - Orgasms Satisfying | ||
ASEX02-Reach Orgasm | C125771 | ASEX02-Reach Orgasm | Arizona Sexual Experiences Scale Male - How easily can you reach an orgasm? | ASEX-Male Version - Reach Orgasm | ||
ASEX02-Sex Drive | C125768 | ASEX02-Sex Drive | Arizona Sexual Experiences Scale Male - How strong is your sex drive? | ASEX-Male Version - Sex Drive | ||
ASEX02-Sexually Aroused | C125769 | ASEX02-Sexually Aroused | Arizona Sexual Experiences Scale Male - How easily are you sexually aroused (turned on)? | ASEX-Male Version - Sexually Aroused | ||
Back to top | ||||||
CL.C142179.ARMNULRS | Arm Null Reason
(ARMNULRS) | text
Extensible: Yes | C142179 | Arm Null Reason | Terminology relevant to the reason for why an arm and/or an actual arm is null. | CDISC SDTM Arm Null Reason Response Terminology |
ASSIGNED, NOT TREATED | C142238 | The subject, who met eligibility criteria, was assigned to an arm but was not treated. (NCI) | Subject Assigned to Arm But Not Treated | |||
NOT ASSIGNED | C142239 | The subject, who met eligibility criteria, was not assigned to an arm and was not treated. (NCI) | Subject Not Assigned to Arm | |||
SCREEN FAILURE | C49628 | Failure to Meet Inclusion/Exclusion Criteria | The potential subject who does not meet eligibility (inclusion/exclusion) criteria during the screening period. | Trial Screen Failure | ||
UNPLANNED TREATMENT | C142240 | The subject, who met eligibility criteria, was assigned to an arm but received treatment not associated with any of the planned arms. | Subject Received Unplanned Treatment | |||
Back to top | ||||||
CL.C124668.ASSG01TC | ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Code
(ASSG01TC) | text
Extensible: No | C124668 | ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Code | ASSIGN Cardiovascular Disease 10-Year Risk Score test code. | CDISC Clinical Classification ASSIGN Score Test Code Terminology |
ASSG0101 | C124721 | ASSG01-ASSIGN Score | ASSIGN Cardiovascular Disease 10-Year Risk Score - ASSIGN score. | ASSIGN Score - Risk Score | ||
Back to top | ||||||
CL.C124667.ASSG01TN | ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Name
(ASSG01TN) | text
Extensible: No | C124667 | ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Name | ASSIGN Cardiovascular Disease 10-Year Risk Score test name. | CDISC Clinical Classification ASSIGN Score Test Name Terminology |
ASSG01-ASSIGN Score | C124721 | ASSG01-ASSIGN Score | ASSIGN Cardiovascular Disease 10-Year Risk Score - ASSIGN score. | ASSIGN Score - Risk Score | ||
Back to top | ||||||
CL.C163385.ADSD01TC | Asthma Daytime Symptom Diary v1.0 Questionnaire Test Code
(ADSD01TC) | text
Extensible: No | C163385 | Asthma Daytime Symptom Diary v1.0 Questionnaire Test Code | Asthma Daytime Symptom Diary v1.0 test code. | CDISC Questionnaire ADSD Version 1.0 Test Code Terminology |
ADSD0101 | C163818 | ADSD01-Rate Breathing at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your difficulty breathing at its worst since you got up this morning. | ADSD Version 1.0 - Rate Breathing at Its Worst | ||
ADSD0102 | C163819 | ADSD01-Rate Wheezing at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your wheezing at its worst since you got up this morning. | ADSD Version 1.0 - Rate Wheezing at Its Worst | ||
ADSD0103 | C163820 | ADSD01-Rate Shortness of Breath at Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your shortness of breath at its worst since you got up this morning. | ADSD Version 1.0 - Rate Shortness of Breath at Worst | ||
ADSD0104 | C163821 | ADSD01-Rate Chest Tightness at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your chest tightness at its worst since you got up this morning. | ADSD Version 1.0 - Rate Chest Tightness at Its Worst | ||
ADSD0105 | C163822 | ADSD01-Rate Chest Pain at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your chest pain at its worst since you got up this morning. | ADSD Version 1.0 - Rate Chest Pain at Its Worst | ||
ADSD0106 | C163823 | ADSD01-Rate Cough at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your cough at its worst since you got up this morning. | ADSD Version 1.0 - Rate Cough at Its Worst | ||
ADSD0107 | C163824 | ADSD01-Total Score | Asthma Daytime Symptom Diary v1.0 - Total score. | ADSD Version 1.0 - Total Score | ||
Back to top | ||||||
CL.C163384.ADSD01TN | Asthma Daytime Symptom Diary v1.0 Questionnaire Test Name
(ADSD01TN) | text
Extensible: No | C163384 | Asthma Daytime Symptom Diary v1.0 Questionnaire Test Name | Asthma Daytime Symptom Diary v1.0 test name. | CDISC Questionnaire ADSD Version 1.0 Test Name Terminology |
ADSD01-Rate Breathing at Its Worst | C163818 | ADSD01-Rate Breathing at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your difficulty breathing at its worst since you got up this morning. | ADSD Version 1.0 - Rate Breathing at Its Worst | ||
ADSD01-Rate Chest Pain at Its Worst | C163822 | ADSD01-Rate Chest Pain at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your chest pain at its worst since you got up this morning. | ADSD Version 1.0 - Rate Chest Pain at Its Worst | ||
ADSD01-Rate Chest Tightness at Its Worst | C163821 | ADSD01-Rate Chest Tightness at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your chest tightness at its worst since you got up this morning. | ADSD Version 1.0 - Rate Chest Tightness at Its Worst | ||
ADSD01-Rate Cough at Its Worst | C163823 | ADSD01-Rate Cough at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your cough at its worst since you got up this morning. | ADSD Version 1.0 - Rate Cough at Its Worst | ||
ADSD01-Rate Shortness of Breath at Worst | C163820 | ADSD01-Rate Shortness of Breath at Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your shortness of breath at its worst since you got up this morning. | ADSD Version 1.0 - Rate Shortness of Breath at Worst | ||
ADSD01-Rate Wheezing at Its Worst | C163819 | ADSD01-Rate Wheezing at Its Worst | Asthma Daytime Symptom Diary v1.0 - Please rate your wheezing at its worst since you got up this morning. | ADSD Version 1.0 - Rate Wheezing at Its Worst | ||
ADSD01-Total Score | C163824 | ADSD01-Total Score | Asthma Daytime Symptom Diary v1.0 - Total score. | ADSD Version 1.0 - Total Score | ||
Back to top | ||||||
CL.C132313.ASFATSCD | Asthma Findings About Test Code
(ASFATSCD) | text
Extensible: Yes | C132313 | Asthma Findings About Test Code | Terminology relevant to the test codes that describe findings about an asthma event or intervention. | CDISC SDTM Asthma Findings About Test Code Terminology |
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Back to top | ||||||
CL.C132312.ASFATS | Asthma Findings About Test Name
(ASFATS) | text
Extensible: Yes | C132312 | Asthma Findings About Test Name | Terminology relevant to the test names that describe findings about an asthma event or intervention. | CDISC SDTM Asthma Findings About Test Name Terminology |
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Back to top | ||||||
CL.C163387.ANSD01TC | Asthma Nighttime Symptom Diary v1.0 Questionnaire Test Code
(ANSD01TC) | text
Extensible: No | C163387 | Asthma Nighttime Symptom Diary v1.0 Questionnaire Test Code | Asthma Nighttime Symptom Diary v1.0 test code. | CDISC Questionnaire ANSD Version 1.0 Test Code Terminology |
ANSD0101 | C163825 | ANSD01-Rate Breathing at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your difficulty breathing at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Breathing at Its Worst | ||
ANSD0102 | C163826 | ANSD01-Rate Wheezing at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your wheezing at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Wheezing at Its Worst | ||
ANSD0103 | C163827 | ANSD01-Rate Shortness of Breath at Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your shortness of breath at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Shortness of Breath at Worst | ||
ANSD0104 | C163828 | ANSD01-Rate Chest Tightness at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your chest tightness at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Chest Tightness at Its Worst | ||
ANSD0105 | C163829 | ANSD01-Rate Chest Pain at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your chest pain at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Chest Pain at Its Worst | ||
ANSD0106 | C163830 | ANSD01-Rate Cough at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your cough at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Cough at Its Worst | ||
ANSD0107 | C163831 | ANSD01-Total Score | Asthma Nighttime Symptom Diary v1.0 - Total score. | ANSD Version 1.0 - Total Score | ||
Back to top | ||||||
CL.C163386.ANSD01TN | Asthma Nighttime Symptom Diary v1.0 Questionnaire Test Name
(ANSD01TN) | text
Extensible: No | C163386 | Asthma Nighttime Symptom Diary v1.0 Questionnaire Test Name | Asthma Nighttime Symptom Diary v1.0 test name. | CDISC Questionnaire ANSD Version 1.0 Test Name Terminology |
ANSD01-Rate Breathing at Its Worst | C163825 | ANSD01-Rate Breathing at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your difficulty breathing at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Breathing at Its Worst | ||
ANSD01-Rate Chest Pain at Its Worst | C163829 | ANSD01-Rate Chest Pain at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your chest pain at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Chest Pain at Its Worst | ||
ANSD01-Rate Chest Tightness at Its Worst | C163828 | ANSD01-Rate Chest Tightness at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your chest tightness at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Chest Tightness at Its Worst | ||
ANSD01-Rate Cough at Its Worst | C163830 | ANSD01-Rate Cough at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your cough at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Cough at Its Worst | ||
ANSD01-Rate Shortness of Breath at Worst | C163827 | ANSD01-Rate Shortness of Breath at Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your shortness of breath at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Shortness of Breath at Worst | ||
ANSD01-Rate Wheezing at Its Worst | C163826 | ANSD01-Rate Wheezing at Its Worst | Asthma Nighttime Symptom Diary v1.0 - Please rate your wheezing at its worst since you went to bed last night. | ANSD Version 1.0 - Rate Wheezing at Its Worst | ||
ANSD01-Total Score | C163831 | ANSD01-Total Score | Asthma Nighttime Symptom Diary v1.0 - Total score. | ANSD Version 1.0 - Total Score | ||
Back to top | ||||||
CL.C124666.ASCVD1TC | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Clinical Classification Test Code
(ASCVD1TC) | text
Extensible: No | C124666 | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Clinical Classification Test Code | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator test code. | CDISC Clinical Classification Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Test Code Terminology |
ASCVD101 | C124720 | ASCVD1-ASCVD 10-Year Risk Score | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator - Risk score. | ASCVD 10-Year Risk Estimator - Risk Score | ||
Back to top | ||||||
CL.C124665.ASCVD1TN | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Clinical Classification Test Name
(ASCVD1TN) | text
Extensible: No | C124665 | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Clinical Classification Test Name | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator test name. | CDISC Clinical Classification Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Test Name Terminology |
ASCVD1-ASCVD 10-Year Risk Score | C124720 | ASCVD1-ASCVD 10-Year Risk Score | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator - Risk score. | ASCVD 10-Year Risk Estimator - Risk Score | ||
Back to top | ||||||
CL.C182470.ATLAS101OR | ATLAS Clinical Classification ORRES for ATLAS101 TN/TC
(ATLAS101OR) | text
Extensible: No | C182470 | ATLAS Clinical Classification ORRES for ATLAS101 TN/TC | ATLAS original result for ATLAS101 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS101 Original Response Terminology |
60-79 | C182739 | ATLAS101-60-79 | ATLAS original result for ATLAS101-60-79. | ATLAS Score ATLAS101 Original Result - 60-79 | ||
<60 | C182738 | ATLAS101-<60 | ATLAS original result for ATLAS101-Less than 60. | ATLAS Score ATLAS101 Original Result - <60 | ||
>=80 | C182740 | ATLAS101->=80 | ATLAS original result for ATLAS101-Greater than or equal to 80. | ATLAS Score ATLAS101 Original Result - >=80 | ||
Back to top | ||||||
CL.C182471.ATLAS102OR | ATLAS Clinical Classification ORRES for ATLAS102 TN/TC
(ATLAS102OR) | text
Extensible: No | C182471 | ATLAS Clinical Classification ORRES for ATLAS102 TN/TC | ATLAS original result for ATLAS102 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS102 Original Response Terminology |
No | C182744 | ATLAS102-No | ATLAS original result for ATLAS102-No. | ATLAS Score ATLAS102 Original Result - No | ||
Yes | C182745 | ATLAS102-Yes | ATLAS original result for ATLAS102-Yes. | ATLAS Score ATLAS102 Original Result - Yes | ||
Back to top | ||||||
CL.C182472.ATLAS103OR | ATLAS Clinical Classification ORRES for ATLAS103 TN/TC
(ATLAS103OR) | text
Extensible: No | C182472 | ATLAS Clinical Classification ORRES for ATLAS103 TN/TC | ATLAS original result for ATLAS103 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS103 Original Response Terminology |
16,000-25,000 | C182749 | ATLAS103-16,000-25,000 | ATLAS original result for ATLAS103-16,000-25,000. | ATLAS Score ATLAS103 Original Result - 16,000-25,000 | ||
<16,000 | C182748 | ATLAS103-<16,000 | ATLAS original result for ATLAS103-Less than16,000. | ATLAS Score ATLAS103 Original Result - <16,000 | ||
>25,000 | C182750 | ATLAS103->25,000 | ATLAS original result for ATLAS103-Greater than 25,000. | ATLAS Score ATLAS103 Original Result - >25,000 | ||
Back to top | ||||||
CL.C182473.ATLAS104OR | ATLAS Clinical Classification ORRES for ATLAS104 TN/TC
(ATLAS104OR) | text
Extensible: No | C182473 | ATLAS Clinical Classification ORRES for ATLAS104 TN/TC | ATLAS original result for ATLAS104 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS104 Original Response Terminology |
26-35 | C182755 | ATLAS104-26-35 | ATLAS original result for ATLAS104-26-35. | ATLAS Score ATLAS104 Original Result - 26-35 | ||
<=25 | C182756 | ATLAS104-<=25 | ATLAS original result for ATLAS104-Less than or equal to 25. | ATLAS Score ATLAS104 Original Result - <=25 | ||
>35 | C182754 | ATLAS104->35 | ATLAS original result for ATLAS104-Greater than 35. | ATLAS Score ATLAS104 Original Result - >35 | ||
Back to top | ||||||
CL.C182474.ATLAS105OR | ATLAS Clinical Classification ORRES for ATLAS105 TN/TC
(ATLAS105OR) | text
Extensible: No | C182474 | ATLAS Clinical Classification ORRES for ATLAS105 TN/TC | ATLAS original result for ATLAS105 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS105 Original Response Terminology |
121-179 | C182761 | ATLAS105-121-179 | ATLAS original result for ATLAS105-121-179. | ATLAS Score ATLAS105 Original Result - 121-179 | ||
<=120 | C182760 | ATLAS105-<=120 | ATLAS original result for ATLAS105-Less than or equal to 120. | ATLAS Score ATLAS105 Original Result - <=120 | ||
>=180 | C182762 | ATLAS105->=180 | ATLAS original result for ATLAS105-Greater than or equal to 180. | ATLAS Score ATLAS105 Original Result - >=180 | ||
Back to top | ||||||
CL.C182508.ATLAS101STR | ATLAS Clinical Classification STRESC for ATLAS101 TN/TC
(ATLAS101STR) | text
Extensible: No | C182508 | ATLAS Clinical Classification STRESC for ATLAS101 TN/TC | ATLAS standardized character result for ATLAS101 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS101 Standardized Character Response Terminology |
0 | C182741 | ATLAS101-0 | ATLAS standardized character result for ATLAS101-Less than 60. | ATLAS Score ATLAS101 Standardized Character Result 0 | ||
1 | C182742 | ATLAS101-1 | ATLAS standardized character result for ATLAS101-60-79. | ATLAS Score ATLAS101 Standardized Character Result 1 | ||
2 | C182743 | ATLAS101-2 | ATLAS standardized character result for ATLAS101-Greater than or equal to 80. | ATLAS Score ATLAS101 Standardized Character Result 2 | ||
Back to top | ||||||
CL.C182509.ATLAS102STR | ATLAS Clinical Classification STRESC for ATLAS102 TN/TC
(ATLAS102STR) | text
Extensible: No | C182509 | ATLAS Clinical Classification STRESC for ATLAS102 TN/TC | ATLAS standardized character result for ATLAS102 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS102 Standardized Character Response Terminology |
0 | C182746 | ATLAS102-0 | ATLAS standardized character result for ATLAS102-No. | ATLAS Score ATLAS102 Standardized Character Result 0 | ||
2 | C182747 | ATLAS102-2 | ATLAS standardized character result for ATLAS102-Yes. | ATLAS Score ATLAS102 Standardized Character Result 2 | ||
Back to top | ||||||
CL.C182510.ATLAS103STR | ATLAS Clinical Classification STRESC for ATLAS103 TN/TC
(ATLAS103STR) | text
Extensible: No | C182510 | ATLAS Clinical Classification STRESC for ATLAS103 TN/TC | ATLAS standardized character result for ATLAS103 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS103 Standardized Character Response Terminology |
0 | C182751 | ATLAS103-0 | ATLAS standardized character result for ATLAS103-Less than 16,000. | ATLAS Score ATLAS103 Standardized Character Result 0 | ||
1 | C182752 | ATLAS103-1 | ATLAS standardized character result for ATLAS103-16,000-25,000. | ATLAS Score ATLAS103 Standardized Character Result 1 | ||
2 | C182753 | ATLAS103-2 | ATLAS standardized character result for ATLAS103-Greater than 25,000. | ATLAS Score ATLAS103 Standardized Character Result 2 | ||
Back to top | ||||||
CL.C182511.ATLAS104STR | ATLAS Clinical Classification STRESC for ATLAS104 TN/TC
(ATLAS104STR) | text
Extensible: No | C182511 | ATLAS Clinical Classification STRESC for ATLAS104 TN/TC | ATLAS standardized character result for ATLAS104 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS104 Standardized Character Response Terminology |
0 | C182757 | ATLAS104-0 | ATLAS standardized character result for ATLAS104-Greater than 35. | ATLAS Score ATLAS104 Standardized Character Result 0 | ||
1 | C182758 | ATLAS104-1 | ATLAS standardized character result for ATLAS104-26-35. | ATLAS Score ATLAS104 Standardized Character Result 1 | ||
2 | C182759 | ATLAS104-2 | ATLAS standardized character result for ATLAS104-Less than or equal to 25. | ATLAS Score ATLAS104 Standardized Character Result 2 | ||
Back to top | ||||||
CL.C182512.ATLAS105STR | ATLAS Clinical Classification STRESC for ATLAS105 TN/TC
(ATLAS105STR) | text
Extensible: No | C182512 | ATLAS Clinical Classification STRESC for ATLAS105 TN/TC | ATLAS standardized character result for ATLAS105 test and test code. | CDISC Clinical Classification ATLAS Score ATLAS105 Standardized Character Response Terminology |
0 | C182763 | ATLAS105-0 | ATLAS standardized character result for ATLAS105-Less than or equal to 120. | ATLAS Score ATLAS105 Standardized Character Result 0 | ||
1 | C182764 | ATLAS105-1 | ATLAS standardized character result for ATLAS105-121-179. | ATLAS Score ATLAS105 Standardized Character Result 1 | ||
2 | C182765 | ATLAS105-2 | ATLAS standardized character result for ATLAS105-Greater than or equal to 180. | ATLAS Score ATLAS105 Standardized Character Result 2 | ||
Back to top | ||||||
CL.C147538.ATLAS1TC | ATLAS Clinical Classification Test Code
(ATLAS1TC) | text
Extensible: No | C147538 | ATLAS Clinical Classification Test Code | ATLAS test code. | CDISC Clinical Classification ATLAS Test Code Terminology |
ATLAS101 | C147843 | ATLAS1-Age | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Age. | ATLAS - Age | ||
ATLAS102 | C147844 | ATLAS1-Treatment With Antibiotics | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Treatment with systemic antibiotics during CDI therapy (>= 1 day). | ATLAS - Treatment With Antibiotics | ||
ATLAS103 | C147845 | ATLAS1-Leukocyte Count | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Leukocyte count (total). | ATLAS - Leukocyte Count | ||
ATLAS104 | C147846 | ATLAS1-Albumin | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Albumin (serum). | ATLAS - Albumin | ||
ATLAS105 | C147847 | ATLAS1-Serum Creatinine | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Serum creatinine (as a measure of renal function). | ATLAS - Serum Creatinine | ||
ATLAS106 | C147848 | ATLAS1-Score | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Score. | ATLAS - Score | ||
Back to top | ||||||
CL.C147537.ATLAS1TN | ATLAS Clinical Classification Test Name
(ATLAS1TN) | text
Extensible: No | C147537 | ATLAS Clinical Classification Test Name | ATLAS test name. | CDISC Clinical Classification ATLAS Test Name Terminology |
ATLAS1-Age | C147843 | ATLAS1-Age | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Age. | ATLAS - Age | ||
ATLAS1-Albumin | C147846 | ATLAS1-Albumin | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Albumin (serum). | ATLAS - Albumin | ||
ATLAS1-Leukocyte Count | C147845 | ATLAS1-Leukocyte Count | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Leukocyte count (total). | ATLAS - Leukocyte Count | ||
ATLAS1-Score | C147848 | ATLAS1-Score | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Score. | ATLAS - Score | ||
ATLAS1-Serum Creatinine | C147847 | ATLAS1-Serum Creatinine | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Serum creatinine (as a measure of renal function). | ATLAS - Serum Creatinine | ||
ATLAS1-Treatment With Antibiotics | C147844 | ATLAS1-Treatment With Antibiotics | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function - Treatment with systemic antibiotics during CDI therapy (>= 1 day). | ATLAS - Treatment With Antibiotics | ||
Back to top | ||||||
CL.C190863.AUTESTCD | Auricular Findings Test Code
(AUTESTCD) | text
Extensible: Yes | C190863 | Auricular Findings Test Code | A terminology codelist to describe the test code for a physiological examination of the auditory system. | CDISC SDTM Auricular Findings Test Code Terminology |
ABR | C184949 | Auditory Brainstem Response | An assessment of auditory brainstem function in response to auditory stimuli. | Auditory Brainstem Response | ||
AIRBNCND | C198231 | Air to Bone Sound Conduction Comparison | A relative assessment of sound transmission through air conduction versus bone conduction. | Air to Bone Sound Conduction Comparison | ||
AIRPRSSR | C198232 | Air Pressure | The force exerted by air upon a surface. | Air Pressure | ||
HEARLATN | C198233 | Auditory Lateralization;Hearing Lateralization | An auditory assessment that determines the perceived relative volume of sound in the left and right cochlea. | Hearing Lateralization | ||
OAE | C198234 | Otoacoustic Emission | An assessment of the otoacoustic sound emissions from the cochlea when stimulated by soft clicking sounds introduced into the ear canal. | Otoacoustic Emission | ||
PHCMPLNC | C67337 | Physiological Compliance | An index reflecting distensibility of elastic organ(s) defined as the change in volume per unit change in pressure (dV/dP). | Index of Expandability | ||
TMPTRTYP | C191216 | Tympanogram Tracing Type;Tympanogram Type | An interpretive summary of the tympanogram tracing result. | Tympanogram Tracing Type | ||
VOLUME | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
Back to top | ||||||
CL.C190862.AUTEST | Auricular Findings Test Name
(AUTEST) | text
Extensible: Yes | C190862 | Auricular Findings Test Name | A terminology codelist to describe the test name for a physiological examination of the auditory system. | CDISC SDTM Auricular Findings Test Name Terminology |
Air Pressure | C198232 | Air Pressure | The force exerted by air upon a surface. | Air Pressure | ||
Air to Bone Sound Conduction Comparison | C198231 | Air to Bone Sound Conduction Comparison | A relative assessment of sound transmission through air conduction versus bone conduction. | Air to Bone Sound Conduction Comparison | ||
Auditory Brainstem Response | C184949 | Auditory Brainstem Response | An assessment of auditory brainstem function in response to auditory stimuli. | Auditory Brainstem Response | ||
Hearing Lateralization | C198233 | Auditory Lateralization;Hearing Lateralization | An auditory assessment that determines the perceived relative volume of sound in the left and right cochlea. | Hearing Lateralization | ||
Otoacoustic Emission | C198234 | Otoacoustic Emission | An assessment of the otoacoustic sound emissions from the cochlea when stimulated by soft clicking sounds introduced into the ear canal. | Otoacoustic Emission | ||
Physiological Compliance | C67337 | Physiological Compliance | An index reflecting distensibility of elastic organ(s) defined as the change in volume per unit change in pressure (dV/dP). | Index of Expandability | ||
Tympanogram Tracing Type | C191216 | Tympanogram Tracing Type;Tympanogram Type | An interpretive summary of the tympanogram tracing result. | Tympanogram Tracing Type | ||
Volume | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
Back to top | ||||||
CL.C135680.BEBQ01TC | Baby Eating Behaviour Questionnaire Concurrent Version Questionnaire Test Code
(BEBQ01TC) | text
Extensible: No | C135680 | Baby Eating Behaviour Questionnaire Concurrent Version Questionnaire Test Code | Baby Eating Behaviour Questionnaire Concurrent Version test code. | CDISC Questionnaire BEBQ Concurrent Version Test Code Terminology |
BEBQ0101 | C135775 | BEBQ01-Baby Seems Contented Feeding | Baby Eating Behaviour Questionnaire - Concurrent - My baby seems contented while feeding. | BEBQ Concurrent Version - Baby Seems Contented Feeding | ||
BEBQ0102 | C135776 | BEBQ01-Baby Frequently Wants More Milk | Baby Eating Behaviour Questionnaire - Concurrent - My baby frequently wants more milk than I provide. | BEBQ Concurrent Version - Baby Frequently Wants More Milk | ||
BEBQ0103 | C135777 | BEBQ01-Baby Loves Milk | Baby Eating Behaviour Questionnaire - Concurrent - My baby loves milk. | BEBQ Concurrent Version - Baby Loves Milk | ||
BEBQ0104 | C135778 | BEBQ01-Baby Has a Big Appetite | Baby Eating Behaviour Questionnaire - Concurrent - My baby has a big appetite. | BEBQ Concurrent Version - Baby Has a Big Appetite | ||
BEBQ0105 | C135779 | BEBQ01-Baby Finishes Feeding Quickly | Baby Eating Behaviour Questionnaire - Concurrent - My baby finishes feeding quickly. | BEBQ Concurrent Version - Baby Finishes Feeding Quickly | ||
BEBQ0106 | C135780 | BEBQ01-Baby Becomes Distressed Feeding | Baby Eating Behaviour Questionnaire - Concurrent - My baby becomes distressed while feeding. | BEBQ Concurrent Version - Baby Becomes Distressed Feeding | ||
BEBQ0107 | C135781 | BEBQ01-Baby Gets Full Up Easily | Baby Eating Behaviour Questionnaire - Concurrent - My baby gets full up easily. | BEBQ Concurrent Version - Baby Gets Full Up Easily | ||
BEBQ0108 | C135782 | BEBQ01-Baby Would Take Too Much Milk | Baby Eating Behaviour Questionnaire - Concurrent - If allowed to, my baby would take too much milk. | BEBQ Concurrent Version - Baby Would Take Too Much Milk | ||
BEBQ0109 | C135783 | BEBQ01-Baby Takes More Than 30 Minutes | Baby Eating Behaviour Questionnaire - Concurrent - My baby takes more than 30 minutes to finish feeding. | BEBQ Concurrent Version - Baby Takes More Than 30 Minutes | ||
BEBQ0110 | C135784 | BEBQ01-Gets Full Before Taking All Milk | Baby Eating Behaviour Questionnaire - Concurrent - My baby gets full before taking all the milk I think he/she should have. | BEBQ Concurrent Version - Gets Full Before Taking All Milk | ||
BEBQ0111 | C135785 | BEBQ01-Baby Feeds Slowly | Baby Eating Behaviour Questionnaire - Concurrent - My baby feeds slowly. | BEBQ Concurrent Version - Baby Feeds Slowly | ||
BEBQ0112 | C135786 | BEBQ01-Just Eaten Is Happy to Feed Again | Baby Eating Behaviour Questionnaire - Concurrent - Even when my baby has just eaten well he/she is happy to feed again if offered. | BEBQ Concurrent Version - Just Eaten Is Happy to Feed Again | ||
BEBQ0113 | C135787 | BEBQ01-Difficult Manage Complete Feed | Baby Eating Behaviour Questionnaire - Concurrent - My baby finds it difficult to manage a complete feed. | BEBQ Concurrent Version - Difficult Manage Complete Feed | ||
BEBQ0114 | C135788 | BEBQ01-Baby Is Always Demanding a Feed | Baby Eating Behaviour Questionnaire - Concurrent - My baby is always demanding a feed. | BEBQ Concurrent Version - Baby Is Always Demanding a Feed | ||
BEBQ0115 | C135789 | BEBQ01-Baby Sucks More and More Slowly | Baby Eating Behaviour Questionnaire - Concurrent - My baby sucks more and more slowly during the course of a feed. | BEBQ Concurrent Version - Baby Sucks More and More Slowly | ||
BEBQ0116 | C135790 | BEBQ01-Baby Would Always Be Feeding | Baby Eating Behaviour Questionnaire - Concurrent - If given the chance, my baby would always be feeding. | BEBQ Concurrent Version - Baby Would Always Be Feeding | ||
BEBQ0117 | C135791 | BEBQ01-Baby Enjoys Feeding Time | Baby Eating Behaviour Questionnaire - Concurrent - My baby enjoys feeding time. | BEBQ Concurrent Version - Baby Enjoys Feeding Time | ||
BEBQ0118 | C135792 | BEBQ01-Take a Feed Within 30 Minutes | Baby Eating Behaviour Questionnaire - Concurrent - My baby can easily take a feed within 30 minutes of the last one. | BEBQ Concurrent Version - Take a Feed Within 30 Minutes | ||
Back to top | ||||||
CL.C135679.BEBQ01TN | Baby Eating Behaviour Questionnaire Concurrent Version Questionnaire Test Name
(BEBQ01TN) | text
Extensible: No | C135679 | Baby Eating Behaviour Questionnaire Concurrent Version Questionnaire Test Name | Baby Eating Behaviour Questionnaire Concurrent Version test name. | CDISC Questionnaire BEBQ Concurrent Version Test Name Terminology |
BEBQ01-Baby Becomes Distressed Feeding | C135780 | BEBQ01-Baby Becomes Distressed Feeding | Baby Eating Behaviour Questionnaire - Concurrent - My baby becomes distressed while feeding. | BEBQ Concurrent Version - Baby Becomes Distressed Feeding | ||
BEBQ01-Baby Enjoys Feeding Time | C135791 | BEBQ01-Baby Enjoys Feeding Time | Baby Eating Behaviour Questionnaire - Concurrent - My baby enjoys feeding time. | BEBQ Concurrent Version - Baby Enjoys Feeding Time | ||
BEBQ01-Baby Feeds Slowly | C135785 | BEBQ01-Baby Feeds Slowly | Baby Eating Behaviour Questionnaire - Concurrent - My baby feeds slowly. | BEBQ Concurrent Version - Baby Feeds Slowly | ||
BEBQ01-Baby Finishes Feeding Quickly | C135779 | BEBQ01-Baby Finishes Feeding Quickly | Baby Eating Behaviour Questionnaire - Concurrent - My baby finishes feeding quickly. | BEBQ Concurrent Version - Baby Finishes Feeding Quickly | ||
BEBQ01-Baby Frequently Wants More Milk | C135776 | BEBQ01-Baby Frequently Wants More Milk | Baby Eating Behaviour Questionnaire - Concurrent - My baby frequently wants more milk than I provide. | BEBQ Concurrent Version - Baby Frequently Wants More Milk | ||
BEBQ01-Baby Gets Full Up Easily | C135781 | BEBQ01-Baby Gets Full Up Easily | Baby Eating Behaviour Questionnaire - Concurrent - My baby gets full up easily. | BEBQ Concurrent Version - Baby Gets Full Up Easily | ||
BEBQ01-Baby Has a Big Appetite | C135778 | BEBQ01-Baby Has a Big Appetite | Baby Eating Behaviour Questionnaire - Concurrent - My baby has a big appetite. | BEBQ Concurrent Version - Baby Has a Big Appetite | ||
BEBQ01-Baby Is Always Demanding a Feed | C135788 | BEBQ01-Baby Is Always Demanding a Feed | Baby Eating Behaviour Questionnaire - Concurrent - My baby is always demanding a feed. | BEBQ Concurrent Version - Baby Is Always Demanding a Feed | ||
BEBQ01-Baby Loves Milk | C135777 | BEBQ01-Baby Loves Milk | Baby Eating Behaviour Questionnaire - Concurrent - My baby loves milk. | BEBQ Concurrent Version - Baby Loves Milk | ||
BEBQ01-Baby Seems Contented Feeding | C135775 | BEBQ01-Baby Seems Contented Feeding | Baby Eating Behaviour Questionnaire - Concurrent - My baby seems contented while feeding. | BEBQ Concurrent Version - Baby Seems Contented Feeding | ||
BEBQ01-Baby Sucks More and More Slowly | C135789 | BEBQ01-Baby Sucks More and More Slowly | Baby Eating Behaviour Questionnaire - Concurrent - My baby sucks more and more slowly during the course of a feed. | BEBQ Concurrent Version - Baby Sucks More and More Slowly | ||
BEBQ01-Baby Takes More Than 30 Minutes | C135783 | BEBQ01-Baby Takes More Than 30 Minutes | Baby Eating Behaviour Questionnaire - Concurrent - My baby takes more than 30 minutes to finish feeding. | BEBQ Concurrent Version - Baby Takes More Than 30 Minutes | ||
BEBQ01-Baby Would Always Be Feeding | C135790 | BEBQ01-Baby Would Always Be Feeding | Baby Eating Behaviour Questionnaire - Concurrent - If given the chance, my baby would always be feeding. | BEBQ Concurrent Version - Baby Would Always Be Feeding | ||
BEBQ01-Baby Would Take Too Much Milk | C135782 | BEBQ01-Baby Would Take Too Much Milk | Baby Eating Behaviour Questionnaire - Concurrent - If allowed to, my baby would take too much milk. | BEBQ Concurrent Version - Baby Would Take Too Much Milk | ||
BEBQ01-Difficult Manage Complete Feed | C135787 | BEBQ01-Difficult Manage Complete Feed | Baby Eating Behaviour Questionnaire - Concurrent - My baby finds it difficult to manage a complete feed. | BEBQ Concurrent Version - Difficult Manage Complete Feed | ||
BEBQ01-Gets Full Before Taking All Milk | C135784 | BEBQ01-Gets Full Before Taking All Milk | Baby Eating Behaviour Questionnaire - Concurrent - My baby gets full before taking all the milk I think he/she should have. | BEBQ Concurrent Version - Gets Full Before Taking All Milk | ||
BEBQ01-Just Eaten Is Happy to Feed Again | C135786 | BEBQ01-Just Eaten Is Happy to Feed Again | Baby Eating Behaviour Questionnaire - Concurrent - Even when my baby has just eaten well he/she is happy to feed again if offered. | BEBQ Concurrent Version - Just Eaten Is Happy to Feed Again | ||
BEBQ01-Take a Feed Within 30 Minutes | C135792 | BEBQ01-Take a Feed Within 30 Minutes | Baby Eating Behaviour Questionnaire - Concurrent - My baby can easily take a feed within 30 minutes of the last one. | BEBQ Concurrent Version - Take a Feed Within 30 Minutes | ||
Back to top | ||||||
CL.C135682.BEBQ02TC | Baby Eating Behaviour Questionnaire Retrospective Version Questionnaire Test Code
(BEBQ02TC) | text
Extensible: No | C135682 | Baby Eating Behaviour Questionnaire Retrospective Version Questionnaire Test Code | Baby Eating Behaviour Questionnaire Retrospective Version test code. | CDISC Questionnaire BEBQ Retrospective Version Test Code Terminology |
BEBQ0201 | C135793 | BEBQ02-Baby Seemed Contented Feeding | Baby Eating Behaviour Questionnaire - Retrospective - My baby seemed contented while feeding. | BEBQ Retrospective Version - Baby Seemed Contented Feeding | ||
BEBQ0202 | C135794 | BEBQ02-Baby Frequently Wanted More Milk | Baby Eating Behaviour Questionnaire - Retrospective - My baby frequently wanted more milk than I provided. | BEBQ Retrospective Version - Baby Frequently Wanted More Milk | ||
BEBQ0203 | C135795 | BEBQ02-Baby Loved Milk | Baby Eating Behaviour Questionnaire - Retrospective - My baby loved milk. | BEBQ Retrospective Version - Baby Loved Milk | ||
BEBQ0204 | C135796 | BEBQ02-Baby Had a Big Appetite | Baby Eating Behaviour Questionnaire - Retrospective - My baby had a big appetite. | BEBQ Retrospective Version - Baby Had a Big Appetite | ||
BEBQ0205 | C135797 | BEBQ02-Baby Finished Feeding Quickly | Baby Eating Behaviour Questionnaire - Retrospective - My baby finished feeding quickly. | BEBQ Retrospective Version - Baby Finished Feeding Quickly | ||
BEBQ0206 | C135798 | BEBQ02-Baby Became Distressed Feeding | Baby Eating Behaviour Questionnaire - Retrospective - My baby became distressed while feeding. | BEBQ Retrospective Version - Baby Became Distressed Feeding | ||
BEBQ0207 | C135799 | BEBQ02-Baby Got Full Up Easily | Baby Eating Behaviour Questionnaire - Retrospective - My baby got full up easily. | BEBQ Retrospective Version - Baby Got Full Up Easily | ||
BEBQ0208 | C135800 | BEBQ02-Baby Would Take Too Much Milk | Baby Eating Behaviour Questionnaire - Retrospective - If allowed to, my baby would take too much milk. | BEBQ Retrospective Version - Baby Would Take Too Much Milk | ||
BEBQ0209 | C135801 | BEBQ02-Baby Took More Than 30 Minutes | Baby Eating Behaviour Questionnaire - Retrospective - My baby took more than 30 minutes to finish feeding. | BEBQ Retrospective Version - Baby Took More Than 30 Minutes | ||
BEBQ0210 | C135802 | BEBQ02-Got Full Before Taking All Milk | Baby Eating Behaviour Questionnaire - Retrospective - My baby got full before taking all the milk I think he/she should have. | BEBQ Retrospective Version - Got Full Before Taking All Milk | ||
BEBQ0211 | C135803 | BEBQ02-Baby Fed Slowly | Baby Eating Behaviour Questionnaire - Retrospective - My baby fed slowly. | BEBQ Retrospective Version - Baby Fed Slowly | ||
BEBQ0212 | C135804 | BEBQ02-Just Eaten Happy to Feed Again | Baby Eating Behaviour Questionnaire - Retrospective - Even when my baby had just eaten well he/she was happy to feed again if offered. | BEBQ Retrospective Version - Just Eaten Happy to Feed Again | ||
BEBQ0213 | C135805 | BEBQ02-Difficult Manage Complete Feed | Baby Eating Behaviour Questionnaire - Retrospective - My baby found it difficult to manage a complete feed. | BEBQ Retrospective Version - Difficult Manage Complete Feed | ||
BEBQ0214 | C135806 | BEBQ02-Baby Was Always Demanding a Feed | Baby Eating Behaviour Questionnaire - Retrospective - My baby was always demanding a feed. | BEBQ Retrospective Version - Baby Was Always Demanding a Feed | ||
BEBQ0215 | C135807 | BEBQ02-Baby Sucked More and More Slowly | Baby Eating Behaviour Questionnaire - Retrospective - My baby sucked more and more slowly during the course of a feed. | BEBQ Retrospective Version - Baby Sucked More and More Slowly | ||
BEBQ0216 | C135808 | BEBQ02-Baby Would Always Be Feeding | Baby Eating Behaviour Questionnaire - Retrospective - If given the chance, my baby would always be feeding. | BEBQ Retrospective Version - Baby Would Always Be Feeding | ||
BEBQ0217 | C135809 | BEBQ02-Baby Enjoyed Feeding Time | Baby Eating Behaviour Questionnaire - Retrospective - My baby enjoyed feeding time. | BEBQ Retrospective Version - Baby Enjoyed Feeding Time | ||
BEBQ0218 | C135810 | BEBQ02-Take a Feed Within 30 Minutes | Baby Eating Behaviour Questionnaire - Retrospective - My baby could easily take a feed within 30 minutes of the last one. | BEBQ Retrospective Version - Take a Feed Within 30 Minutes | ||
Back to top | ||||||
CL.C135681.BEBQ02TN | Baby Eating Behaviour Questionnaire Retrospective Version Questionnaire Test Name
(BEBQ02TN) | text
Extensible: No | C135681 | Baby Eating Behaviour Questionnaire Retrospective Version Questionnaire Test Name | Baby Eating Behaviour Questionnaire Retrospective Version test name. | CDISC Questionnaire BEBQ Retrospective Version Test Name Terminology |
BEBQ02-Baby Became Distressed Feeding | C135798 | BEBQ02-Baby Became Distressed Feeding | Baby Eating Behaviour Questionnaire - Retrospective - My baby became distressed while feeding. | BEBQ Retrospective Version - Baby Became Distressed Feeding | ||
BEBQ02-Baby Enjoyed Feeding Time | C135809 | BEBQ02-Baby Enjoyed Feeding Time | Baby Eating Behaviour Questionnaire - Retrospective - My baby enjoyed feeding time. | BEBQ Retrospective Version - Baby Enjoyed Feeding Time | ||
BEBQ02-Baby Fed Slowly | C135803 | BEBQ02-Baby Fed Slowly | Baby Eating Behaviour Questionnaire - Retrospective - My baby fed slowly. | BEBQ Retrospective Version - Baby Fed Slowly | ||
BEBQ02-Baby Finished Feeding Quickly | C135797 | BEBQ02-Baby Finished Feeding Quickly | Baby Eating Behaviour Questionnaire - Retrospective - My baby finished feeding quickly. | BEBQ Retrospective Version - Baby Finished Feeding Quickly | ||
BEBQ02-Baby Frequently Wanted More Milk | C135794 | BEBQ02-Baby Frequently Wanted More Milk | Baby Eating Behaviour Questionnaire - Retrospective - My baby frequently wanted more milk than I provided. | BEBQ Retrospective Version - Baby Frequently Wanted More Milk | ||
BEBQ02-Baby Got Full Up Easily | C135799 | BEBQ02-Baby Got Full Up Easily | Baby Eating Behaviour Questionnaire - Retrospective - My baby got full up easily. | BEBQ Retrospective Version - Baby Got Full Up Easily | ||
BEBQ02-Baby Had a Big Appetite | C135796 | BEBQ02-Baby Had a Big Appetite | Baby Eating Behaviour Questionnaire - Retrospective - My baby had a big appetite. | BEBQ Retrospective Version - Baby Had a Big Appetite | ||
BEBQ02-Baby Loved Milk | C135795 | BEBQ02-Baby Loved Milk | Baby Eating Behaviour Questionnaire - Retrospective - My baby loved milk. | BEBQ Retrospective Version - Baby Loved Milk | ||
BEBQ02-Baby Seemed Contented Feeding | C135793 | BEBQ02-Baby Seemed Contented Feeding | Baby Eating Behaviour Questionnaire - Retrospective - My baby seemed contented while feeding. | BEBQ Retrospective Version - Baby Seemed Contented Feeding | ||
BEBQ02-Baby Sucked More and More Slowly | C135807 | BEBQ02-Baby Sucked More and More Slowly | Baby Eating Behaviour Questionnaire - Retrospective - My baby sucked more and more slowly during the course of a feed. | BEBQ Retrospective Version - Baby Sucked More and More Slowly | ||
BEBQ02-Baby Took More Than 30 Minutes | C135801 | BEBQ02-Baby Took More Than 30 Minutes | Baby Eating Behaviour Questionnaire - Retrospective - My baby took more than 30 minutes to finish feeding. | BEBQ Retrospective Version - Baby Took More Than 30 Minutes | ||
BEBQ02-Baby Was Always Demanding a Feed | C135806 | BEBQ02-Baby Was Always Demanding a Feed | Baby Eating Behaviour Questionnaire - Retrospective - My baby was always demanding a feed. | BEBQ Retrospective Version - Baby Was Always Demanding a Feed | ||
BEBQ02-Baby Would Always Be Feeding | C135808 | BEBQ02-Baby Would Always Be Feeding | Baby Eating Behaviour Questionnaire - Retrospective - If given the chance, my baby would always be feeding. | BEBQ Retrospective Version - Baby Would Always Be Feeding | ||
BEBQ02-Baby Would Take Too Much Milk | C135800 | BEBQ02-Baby Would Take Too Much Milk | Baby Eating Behaviour Questionnaire - Retrospective - If allowed to, my baby would take too much milk. | BEBQ Retrospective Version - Baby Would Take Too Much Milk | ||
BEBQ02-Difficult Manage Complete Feed | C135805 | BEBQ02-Difficult Manage Complete Feed | Baby Eating Behaviour Questionnaire - Retrospective - My baby found it difficult to manage a complete feed. | BEBQ Retrospective Version - Difficult Manage Complete Feed | ||
BEBQ02-Got Full Before Taking All Milk | C135802 | BEBQ02-Got Full Before Taking All Milk | Baby Eating Behaviour Questionnaire - Retrospective - My baby got full before taking all the milk I think he/she should have. | BEBQ Retrospective Version - Got Full Before Taking All Milk | ||
BEBQ02-Just Eaten Happy to Feed Again | C135804 | BEBQ02-Just Eaten Happy to Feed Again | Baby Eating Behaviour Questionnaire - Retrospective - Even when my baby had just eaten well he/she was happy to feed again if offered. | BEBQ Retrospective Version - Just Eaten Happy to Feed Again | ||
BEBQ02-Take a Feed Within 30 Minutes | C135810 | BEBQ02-Take a Feed Within 30 Minutes | Baby Eating Behaviour Questionnaire - Retrospective - My baby could easily take a feed within 30 minutes of the last one. | BEBQ Retrospective Version - Take a Feed Within 30 Minutes | ||
Back to top | ||||||
CL.C101809.BARS01TC | Barnes Akathisia Rating Scale Clinical Classification Test Code
(BARS01TC) | text
Extensible: No | C101809 | Barnes Akathisia Rating Scale Clinical Classification Test Code | Barnes Akathisia Rating Scale test code. | CDISC Clinical Classification BARS Test Code Terminology |
BARS0101 | C102046 | BARS01-Objective | Barnes Akathisia Rating Scale - Objective. | BARS - Objective | ||
BARS0102 | C102047 | BARS01-Subjective, Awareness | Barnes Akathisia Rating Scale - Subjective, awareness of restlessness. | BARS - Subjective, Awareness | ||
BARS0103 | C102048 | BARS01-Subjective, Distress | Barnes Akathisia Rating Scale - Subjective, distress related to restlessness. | BARS - Subjective, Distress | ||
BARS0104 | C102049 | BARS01-Global Clinical Assessment | Barnes Akathisia Rating Scale - Global clinical assessment of akathisia. | BARS - Global Clinical Assessment | ||
Back to top | ||||||
CL.C101810.BARS01TN | Barnes Akathisia Rating Scale Clinical Classification Test Name
(BARS01TN) | text
Extensible: No | C101810 | Barnes Akathisia Rating Scale Clinical Classification Test Name | Barnes Akathisia Rating Scale test name. | CDISC Clinical Classification BARS Test Name Terminology |
BARS01-Global Clinical Assessment | C102049 | BARS01-Global Clinical Assessment | Barnes Akathisia Rating Scale - Global clinical assessment of akathisia. | BARS - Global Clinical Assessment | ||
BARS01-Objective | C102046 | BARS01-Objective | Barnes Akathisia Rating Scale - Objective. | BARS - Objective | ||
BARS01-Subjective, Awareness | C102047 | BARS01-Subjective, Awareness | Barnes Akathisia Rating Scale - Subjective, awareness of restlessness. | BARS - Subjective, Awareness | ||
BARS01-Subjective, Distress | C102048 | BARS01-Subjective, Distress | Barnes Akathisia Rating Scale - Subjective, distress related to restlessness. | BARS - Subjective, Distress | ||
Back to top | ||||||
CL.C106655.BDI01TC | Baseline Dyspnea Index Clinical Classification Test Code
(BDI01TC) | text
Extensible: No | C106655 | Baseline Dyspnea Index Clinical Classification Test Code | Baseline Dyspnea Index test code. | CDISC Clinical Classification BDI Test Code Terminology |
BDI0101 | C106701 | BDI01-Functional Impairment | Baseline Dyspnea Index - Functional impairment. | BDI - Functional Impairment | ||
BDI0102 | C106702 | BDI01-Magnitude of Task | Baseline Dyspnea Index - Magnitude of task. | BDI - Magnitude of Task | ||
BDI0103 | C106703 | BDI01-Magnitude of Effort | Baseline Dyspnea Index - Magnitude of effort. | BDI - Magnitude of Effort | ||
BDI0104 | C161764 | BDI01-Baseline Focal Score | Baseline Dyspnea Index - Baseline focal score. | BDI - Baseline Focal Score | ||
Back to top | ||||||
CL.C106654.BDI01TN | Baseline Dyspnea Index Clinical Classification Test Name
(BDI01TN) | text
Extensible: No | C106654 | Baseline Dyspnea Index Clinical Classification Test Name | Baseline Dyspnea Index test name. | CDISC Clinical Classification BDI Test Name Terminology |
BDI01-Baseline Focal Score | C161764 | BDI01-Baseline Focal Score | Baseline Dyspnea Index - Baseline focal score. | BDI - Baseline Focal Score | ||
BDI01-Functional Impairment | C106701 | BDI01-Functional Impairment | Baseline Dyspnea Index - Functional impairment. | BDI - Functional Impairment | ||
BDI01-Magnitude of Effort | C106703 | BDI01-Magnitude of Effort | Baseline Dyspnea Index - Magnitude of effort. | BDI - Magnitude of Effort | ||
BDI01-Magnitude of Task | C106702 | BDI01-Magnitude of Task | Baseline Dyspnea Index - Magnitude of task. | BDI - Magnitude of Task | ||
Back to top | ||||||
CL.C181169.ISBDAGT | Binding Agent for Immunogenicity Tests
(ISBDAGT) | text
Extensible: Yes | C181169 | Binding Agent for Immunogenicity Tests | A terminology codelist relevant to the description of the agent that is binding to the entity in the ISTEST variable. | CDISC SDTM Binding Agent for Immunogenicity Tests Terminology |
AMERICAN COCKROACH ANTIGEN | C189452 | Periplaneta americana Antigen | Antigen(s) from the species Periplaneta americana (American cockroach) that are considered as insect allergen(s). | Periplaneta americana Antigen | ||
AMERICAN HOUSE DUST MITE ANTIGEN | C189458 | Dermatophagoides farinae Antigen | Antigen(s) from the species Dermatophagoides farinae (American house dust mite) that are considered as insect allergen(s). | Dermatophagoides farinae Antigen | ||
ANIMAL MIX ANTIGENS | C181357 | Antigen(s) from a mix of animals that are considered as animal allergen(s). | Animal Mix Antigens | |||
BACTERICIDAL PERMEABILITY-INCREASING PROTEIN | C106602 | Bactericidal/Permeability-Increasing Protein;BPI;RBPI | An antigen encoded by the BPI gene and an endogenous antibiotic, cytotoxic protein in the innate immune system. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases inflammatory bowel disease, systemic lupus erythematosus and rheumatoid arthritis. | Bactericidal Permeability-Increasing Protein | ||
BEE MIX VENOM ANTIGENS | C189454 | Antigen(s) in the Hymenoptera venom from a mix of bees that are considered as insect allergen(s). | Multiple Bee Mix Hymenoptera venom Antigens | |||
BERMUDA GRASS POLLEN | C189477 | Cynodon dactylon Pollen Antigen | Antigen(s) in the pollen of the species Cynodon dactylon (Bermuda grass) that are considered as plant allergen(s). | Cynodon dactylon Pollen Antigen | ||
BETA-2 GLYCOPROTEIN 1 | C142155 | Apo-H;Apolipoprotein H;B2GPI;Beta-2-Glycoprotein I | An antigen of the cardiolipin-binding protein encoded by the APOH gene. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases antiphospholipid syndrome and systemic rheumatic diseases like systemic lupus erythematosus. | Beta-2-Glycoprotein 1 | ||
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ | C187753 | Bordetella pertussis FHA | The approximately 220-250 kDa cell surface, adhesin protein and the virulence factor for Bordetella pertussis. | Bordetella pertussis Filamentous Hemagglutinin | ||
BORDETELLA PERTUSSIS FIMBRIAE ANTIGENS | C187754 | A mixture of fimbriae antigens from Bordetella pertussis. | Bordetella pertussis Fimbriae Antigens | |||
BORDETELLA PERTUSSIS PERTACTIN | C77699 | PRN | The approximately 69 kDa cell surface, autotransporter protein and the virulence factor for Bordetella pertussis. | Bordetella pertussis Pertactin Antigen | ||
BORDETELLA PERTUSSIS TOXIN | C187755 | PT | The approximately 105 kDa secreted exotoxin and the virulence factor for Bordetella pertussis. | Bordetella pertussis Toxin | ||
BOX ELDER POLLEN | C189455 | Acer negundo Pollen Antigen;Boxelder Pollen Antigen | Antigen(s) in the pollen of the species Acer negundo (box elder tree) that are considered as plant allergen(s). | Acer negundo Pollen Antigen | ||
CARDIOLIPIN | C198263 | An antigen of the diphosphatidylglycerol lipid found uniquely in the inner membrane of mitochondria. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases antiphospholipid syndrome and systemic rheumatic diseases. | Cardiolipin | |||
CASHEW NUT ANTIGEN | C189478 | Anacardium occidentale Nut Antigen;Cashew Nut Antigen | Antigen(s) from the seed of the species Anacardium occidentale (cashew nut) that are considered as food allergen(s). | Anacardium occidentale Nut Antigen | ||
CAT DANDER ANTIGEN | C181359 | Domestic Cat Dander Antigen;Felis catus Dander Antigen | Antigen(s) in the dander (skin flakes) of the species Felis catus (domestic cat) that are considered as animal allergen(s). | Cat Dander Antigen | ||
CATHEPSIN | C16389 | Antigen(s) of the lysosomal proteinase or endopeptidase family and are encoded by the CTS gene. They can be considered as autoantigens and are commonly associated with systemic vasculitis, inflammatory rheumatic diseases, autoimmune hepatitis, and chronic inflammatory bowel diseases. | Cathepsin | |||
CENTROMERE B | C181695 | CENP-B;Centromere Protein B;Major Centromere Autoantigen B | An antigen of the centromere protein encoded by the CENPB gene, with a designation of B. It can be considered as an autoantigen and is commonly associated with the autoimmune disease CREST syndrome. | Major Centromere Autoantigen B | ||
CENTROMERE | C193254 | Centromere Protein | Antigen(s) of the centromere protein family and are encoded by the CENP gene. They can be considered as autoantigens and are commonly associated with the autoimmune diseases Sjogren's syndrome, systemic sclerosis, and CREST syndrome. | Centromere Protein | ||
CHEMICAL MIX ANTIGENS | C189466 | Antigen(s) from a mix of workplace or household chemicals that are considered as allergen(s). | Multiple Chemical Mix Antigens | |||
CLOSTRIDIUM TETANI TOXIN | C187757 | TeNT;Tetanospasmin;Tetanus Toxin | The approximately 150 kDa secreted protein toxin and the virulence factor for Clostridium tetani. | Clostridium tetani Toxin | ||
CLOSTRIDIUM TETANI TOXOID | C187758 | The purified and detoxified form of the Clostridium tetani toxin. Toxicity of this toxin is suppressed or inactivated either by heat or with formaldehyde. | Clostridium tetani Toxoid | |||
COMMON RAGWEED POLLEN | C189456 | Ambrosia artemisiifolia Pollen Antigen;Ambrosia elatior Pollen Antigen;Short Ragweed Pollen Antigen | Antigen(s) in the pollen of the species Ambrosia artemisiifolia (common ragweed) that are considered as plant allergen(s). | Ambrosia elatior Pollen Antigen | ||
COMPLEMENT C1Q | C193256 | An antigen of the "q" subcomponent of the C1 complement protein complex. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and severe rheumatoid arthritis. | Complement Component C1q | |||
COMPLEMENT C3D | C154099 | An antigen of the cleaved "d" fragment of the C3 complement protein. It can be considered as an autoantigen and is commonly associated with the autoimmune disease systemic lupus erythematosus. | Complement C3d | |||
CORN ANTIGEN | C189476 | Maize Antigen;Zea mays Antigen | Antigen(s) from the fruit (i.e. kernel/maize) of the species Zea mays (corn) that are considered as food allergen(s). | Zea mays Antigen | ||
CORYLUS AVELLANA NUT ANTIGEN | C189480 | Common Hazel Nut Antigen;Common Hazelnut Antigen;European Hazel Nut Antigen | Antigen(s) from the fruit of the species Corylus avellana (common hazel) that are considered as food allergen(s). | Corylus Avellana Nut Antigen | ||
CORYNEBACTERIUM DIPHTHERIAE TOXOID | C187759 | The purified and detoxified form of the Corynebacterium diphtheriae toxin. Toxicity of this toxin is suppressed or inactivated either by heat or with formaldehyde. | Corynebacterium diphtheriae Toxoid | |||
COW DANDER ANTIGEN | C181361 | Bos taurus Dander Antigen;Cattle Dander Antigen | Antigen(s) in the dander (skin flakes) of the species Bos taurus (cow) that are considered as animal allergen(s). | Cow Dander Antigen | ||
COW MILK ANTIGEN | C189457 | Antigen(s) from the milk produced by a cow that are considered as food allergen(s). | Cow Milk Antigen | |||
CYCLIC CITRULLINATED PEPTIDE | C198264 | CCP | An antigen of the citrulline-containing peptide with a cyclic structure. It can be considered as an autoantigen and is commonly associated with the autoimmune disease rheumatoid arthritis. | Cyclic Citrullinated Peptide | ||
DAIRY MIX ANTIGENS | C189460 | Antigen(s) in the mix of foods made from mammalian milk that are considered as food allergen(s). | Multiple Dairy Mix Antigens | |||
DEOXYRIBONUCLEASE-B | C187763 | DNase B;Group A Streptococcus Deoxyribonuclease-B | The B subtype of nuclease produced by group A beta-hemolytic streptococci. | Group A Streptococcus Deoxyribonuclease-B | ||
DESMOGLEIN 1 | C177652 | An antigen of the cell-cell adhesion protein encoded by the DSG1 gene. It can be considered as an autoantigen and is commonly associated with autoimmune diseases pemphigus foliaceus and pemphigus vulgaris. | Desmoglein-1 | |||
DESMOGLEIN 3 | C101150 | An antigen of the cell-cell adhesion protein encoded by the DSG3 gene. It can be considered as an autoantigen and is commonly associated with autoimmune disease pemphigus vulgaris. | Desmoglein-3 | |||
DOG DANDER ANTIGEN | C181358 | Canis familiaris Dander Antigen;Canis lupus familiaris Dander Antigen | Antigen(s) in the dander (skin flakes) of the species Canis lupus familiaris (dog) that are considered as animal allergen(s). | Dog Dander Antigen | ||
EGG WHITE ANTIGEN | C189461 | Antigen(s) from the clear and liquid substance around the yolk of an egg that are considered as food allergen(s). | Egg White Antigen | |||
ENGLISH PLANTAIN POLLEN | C189479 | Plantago lanceolata Pollen Antigen | Antigen(s) in the pollen of the species Plantago lanceolata (English plantain) that are considered as plant allergen(s). | Plantago lanceolata Pollen Antigen | ||
EPSTEIN-BARR VIRUS CAPSID ANTIGEN | C187761 | EBV-VCA | The approximately 110 kDa structural protein that forms the nucleocapsid of the Epstein-Barr virus. | Epstein-Barr Virus Capsid Antigen | ||
EPSTEIN-BARR VIRUS EARLY D ANTIGEN | C187762 | EBV EA-D;Epstein-Barr Virus Early Antigen Diffuse Component;Epstein-Barr Virus Early Antigen-Diffuse | The approximately 46-55 kDa lytic protein from the Epstein-Barr virus and is the diffuse component of the Epstein-Barr virus-induced early antigen (EA) complex. | Epstein-Barr Virus Early Antigen Diffuse Component | ||
EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN 1 | C128296 | EBNA1;EBV Nuclear Antigen 1 | The approximately 66 kDa DNA-binding protein with a designation nuclear antigen 1, from the 6 nuclear antigens produced by the Epstein-Barr virus. | Epstein-Barr Nuclear Antigen 1 | ||
EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN | C187760 | EBNA | One or more proteins from the 6 nuclear antigens (EBNA 1, 2, 3, 4, 5 and/or 6) produced by the Epstein-Barr virus. | Epstein-Barr Nuclear Antigen | ||
EUROPEAN HOUSE DUST MITE ANTIGEN | C189459 | Dermatophagoides pteronyssinus Antigen | Antigen(s) from the species Dermatophagoides pteronyssinus (European house dust mite) that are considered as insect allergen(s). | Dermatophagoides pteronyssinus Antigen | ||
EXTRACTABLE NUCLEAR AUTOANTIGENS | C198225 | ENAs;Extractable Nuclear Antigens;Saline-extracted Nuclear Antigens | A group of autoimmune substances found in the nucleus of a cell which can be extracted from the saline soluble fraction of cells, and may be comprised of (but not limited to) ribonucleoproteins, Smith antigens, Sjogren's antigens, Scl-70 and/or Jo-1 antigens. | Extractable Nuclear Autoantigen | ||
GERMAN COCKROACH ANTIGEN | C189462 | Blattella germanica Antigen | Antigen(s) from the species Blattella germanica (German cockroach) that are considered as insect allergen(s). | Blattella germanica Antigen | ||
GLIADIN ANTIGEN | C189463 | An antigen and alcohol-soluble fraction of gluten from wheat and other grains that is considered as a food allergen. | Gliadin Antigen | |||
GLUTAMIC ACID DECARBOXYLASE 1 | C185680 | GAD67;Glutamate decarboxylase 67;Glutamic Acid Decarboxylase 67 | An antigen of the 67 kDa isoform of GAD which is encoded by the GAD1 gene. It can be considered as an autoantigen and is commonly associated with the autoimmune disease type 1 diabetes. | Glutamate Decarboxylase 1 | ||
GLUTAMIC ACID DECARBOXYLASE 2 | C185683 | GAD65;Glutamate decarboxylase 65;Glutamic Acid Decarboxylase 65 | An antigen of the 65 kDa isoform of GAD which is encoded by the GAD2 gene. It can be considered as an autoantigen and is commonly associated with the autoimmune disease type 1 diabetes. | Glutamate Decarboxylase 2 | ||
GLUTAMIC ACID DECARBOXYLASE | C193255 | GAD | Any antigen(s) encoded by the GAD gene that catalyze the decarboxylation of glutamate to GABA. They can be considered as autoantigens and are commonly associated with the autoimmune diseases type 1 diabetes, autoimmune polyendocrine syndrome types 1 and 2, and stiff man syndrome. | Glutamate Decarboxylase | ||
GRASS MIX POLLENS | C189465 | Antigen(s) in the pollens of a mix of grasses that are considered as plant allergen(s). | Multiple Grass Mix Pollen Antigens | |||
HEPATITIS B VIRUS CORE ANTIGEN | C187764 | HBcAg;Hepatitis B Virus Capsid Antigen | The approximately 21.5 kDa structural protein that forms the nucleocapsid of the Hepatitis B virus. | Hepatitis B Virus Capsid Antigen | ||
HEPATITIS B VIRUS E ANTIGEN | C187765 | HBeAg;Hepatitis B Virus Early Antigen | The approximately 16-18 kDa nonstructural tolerogen that forms in-between the nucleocapsid and the lipid envelope of, and is secreted by the Hepatitis B virus. | Hepatitis B Virus Early Antigen | ||
HEPATITIS B VIRUS SURFACE ANTIGEN | C62786 | HBsAg | One or more of the three structural surface proteins, small, HBsAg S (26 kDa); middle, HBsAg M (33 kDa); and large, HBsAg L (41 kDa), that form the hepatitis B viral lipid envelope. | Hepatitis B Virus HBsAg Surface Protein Antigen | ||
HERPES SIMPLEX VIRUSES | C187772 | A mixture of different species (or below the species level classifications) of the herpes simplex viruses. | Mixed Herpes Simplex Viruses | |||
HISTONE H1 | C16683 | An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H1. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. | Histone H1 | |||
HISTONE H2A | C16684 | An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H2A. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. | Histone H2A | |||
HISTONE H2B | C17460 | An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H2B. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. | Histone H2B | |||
HISTONE H3 | C16685 | An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H3. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. | Histone H3 | |||
HISTONE H4 | C16686 | An antigen in the core histone family and a subunit of the nucleosome complex, with a designation of H4. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. | Histone H4 | |||
HISTONE | C16687 | Any antigen(s) of the histone nuclear protein family. They can be considered as autoantigens and are commonly associated with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis. | Histone | |||
HIV VIRUSES | C187773 | A mixture of different species (or below the species level classifications) of the human immunodeficiency viruses. | Mixed Human Immunodeficiency Viruses | |||
HIV-1 GP160 | C187766 | The approximately 160 kDa envelope glycoprotein from the human immunodeficiency virus 1. This precursor protein is further cleaved into the gp120 and gp41 proteins. | HIV-1 gp160 | |||
HIV-1 GP41 | C187767 | The approximately 41 kDa transmembrane, envelope glycoprotein from the human immunodeficiency virus 1. This transmembrane protein is cleaved from the precursor GP160 protein. | HIV-1 gp41 | |||
HIV-1 P24 | C187768 | HIV-1 P24 Capsid Protein | The approximately 24 kDa structural protein that forms the nucleocapsid of the human immunodeficiency virus 1. | HIV-1 p24 | ||
HIV-1 P31 | C187769 | HIV-1 IN | The approximately 31 kDa integrase from the human immunodeficiency virus 1. | HIV-1 p31 | ||
HIV-2 GP140 | C187770 | The approximately 140 kDa envelope glycoprotein from the human immunodeficiency virus 2. | HIV-2 gp140 | |||
HIV-2 GP36 | C187771 | The approximately 36 kDa transmembrane, envelope glycoprotein from the human immunodeficiency virus 2. | HIV-2 gp36 | |||
HORSE DANDER ANTIGEN | C181360 | Domestic Horse Dander Antigen;Equus caballus Dander Antigen | Antigen(s) in the dander (skin flakes) of the species Equus caballus (domestic horse) that are considered as animal allergen(s). | Horse Dander Antigen | ||
HTLV VIRUSES | C187774 | A mixture of different species (or below the species level classifications) of the human T-cell lymphotropic viruses. | Mixed Human T-cell Lymphotropic Viruses | |||
HUMAN ALBUMIN | C65218 | HAS;Human Serum Albumin | An antigen of plasma protein and encoded by the ALB gene. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and type 1 diabetes. | Albumin (Human) | ||
INSULINOMA-ASSOCIATED PROTEIN 2 | C148305 | IA-2;INSM2;Zinc Finger Protein IA-6 | An antigen encoded by the INSM2 gene and regulates insulin secretion. It can be considered as an autoantigen and is commonly associated with the autoimmune disease type 1 diabetes. | Insulinoma-Associated Protein 2 | ||
ISLET CELL ANTIGEN 512 | C148308 | IA-2;ICA512;Islet Antigen 2;Islet Cell Autoantigen 3;PTP-IA2;Receptor-type Tyrosine-protein Phosphatase-like N | An antigen encoded by the PTPRN gene and regulates insulin secretion. It can be considered as an autoantigen and is commonly associated with the autoimmune disease type 1 diabetes. | Receptor-Type Tyrosine-Protein Phosphatase-Like N | ||
ISLET CELL AUTOANTIGENS | C198226 | Islet Autoantigens | A group of autoimmune substances found in the pancreatic islet beta cells. They are commonly associated with the autoimmune disease type 1 diabetes. | Islet Cell Autoantigen | ||
ISLET CELL CYTOPLASMIC AUTOANTIGENS | C198265 | A group of autoimmune substances found in the cytoplasm of pancreatic islet cells that are the target of autoantibodies. They are commonly associated with the autoimmune disease type 1 diabetes. | Islet Cell Cytoplasmic Autoantigen | |||
JO-1 ANTIGEN | C183518 | Histidine tRNA Ligase 1, Cytoplasmic;Histidyl-tRNA Synthetase 1 | An antigen encoded by the HARS1 gene that regulates histidyl-transfer RNA synthesis. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases anti-synthetase syndrome, polymyositis and dermatomyositis. | Histidine-tRNA Ligase, Cytoplasmic | ||
JOHNSON GRASS POLLEN | C189481 | Sorghum halepense Pollen;Sorghum halepense Pollen Antigen | Antigen(s) in the pollen of the species Sorghum halepense (Johnson grass) that are considered as plant allergen(s). | Sorghum halepense Pollen Antigen | ||
KEYHOLE LIMPET HEMOCYANIN | C189467 | KLH;Megathura crenulata Hemocyanin | An antigen found in the hemolymph of the species Megathura crenulata (giant keyhole limpet) that is also considered as a food allergen. | Megathura crenulata Hemocyanin Antigen | ||
LACTOFERRIN | C94665 | Lactotransferrin | An antigen encoded by the LTF gene that binds to iron and has antimicrobial function. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases rheumatoid vasculitis and arthritis, systemic lupus erythematosus, ulcerative colitis, and Crohn's disease. | Lactotransferrin | ||
LIVER KIDNEY MICROSOMAL TYPE 1 ANTIGEN | C17287 | CYP2D6;Cytochrome P450 2D6;Liver Kidney Microsomal 1 Antigen | An antigen in the cytochrome P450 mixed-function oxidase system and is encoded by the CYP2D6 gene, it is a major drug metabolizing enzyme. It can be considered as an autoantigen and is commonly associated with the autoimmune hepatitis. | Cytochrome P450 2D6 | ||
MITOCHONDRIAL AUTOANTIGENS | C198227 | A group of autoimmune, multienzyme complexes found within the inner and outer lining of the mitochondria that may be comprised of (but not limited to) M1 through M9 antigens. They are commonly associated with autoimmune hepatitis and primary biliary cholangitis/cirrhosis. | Mitochondrial Autoantigen | |||
MITOCHONDRIAL M2 | C198266 | Mitochondrial Antigen M2;Mitochondrial Autoantigen M2 | Antigen(s) of the inner mitochondrial membrane proteins, with a designation of M2, and may be comprised of (but not limited to) protein X, the E2 component, E1a and E1b subunits of the pyruvate dehydrogenase complex (PDC). They can be considered as autoantigens and are commonly associated with autoimmune hepatitis and primary biliary cholangitis/cirrhosis. | Mitochondrial M2 Antigen | ||
MIXED ANTIGENS | C189482 | Antigen(s) from a mix of types of sources that are considered as allergen(s). | Multiple Mixed Antigens | |||
MOLD MIX ANTIGENS | C189468 | Antigen(s) from a mix of molds that are considered as allergen(s). | Multiple Mold Mix Antigens | |||
MYELOPEROXIDASE | C71145 | MPO | An antigen encoded by the MPO gene that regulates innate immunity through hypohalous acids production. It can be considered as an autoantigen and is commonly associated with autoimmune systemic vasculitis diseases, cystic fibrosis, COPD and other inflammatory conditions. | Myeloperoxidase | ||
NUCLEAR AUTOANTIGENS | C181353 | A group of autoimmune substances found in the nucleus of a cell that are the target of autoantibodies. | Nuclear Autoantigen | |||
NUCLEOSOME | C13268 | Antigen(s) of DNA packaging complexes comprising of a strand of DNA winding around a protein core and an octamer of histones. They can be considered as autoantigens and are commonly and mainly associated with the autoimmune disease systemic lupus erythematosus. | Nucleosome | |||
NUT MIX ANTIGENS | C189469 | Antigen(s) from a mix of edible nuts that are considered as food allergen(s). | Multiple Nut Mix Antigens | |||
OLIVE TREE POLLEN | C189483 | Common Olive Pollen Antigen;Olea europaea Pollen Antigen | Antigen(s) in the pollen of the species Olea europaea (olive tree) that are considered as plant allergen(s). | Olea europaea Pollen Antigen | ||
ORCHARD GRASS POLLEN | C189484 | Cocksfoot Grass Pollen Antigen;Dactylis glomerata Pollen Antigen | Antigen(s) in the pollen of the species Dactylis glomerata (orchard grass) that are considered as plant allergen(s). | Dactylis glomerata Pollen Antigen | ||
OXIDIZED LOW DENSITY LIPOPROTEIN CHOLESTEROL | C198267 | Ox-LDL;Oxidized LDL Cholesterol | An antigen of low density lipoprotein cholesterol that is also oxidized. It can be considered as an autoantigen and is commonly associated inflammatory and autoimmune conditions. | Oxidized Low Density Lipoprotein Cholesterol | ||
PEANUT ANTIGEN | C189453 | Arachis hypogaea Antigen | Antigen(s) from the seed of the species Arachis hypogaea (peanut) that are considered as food allergen(s). | Arachis hypogaea Antigen | ||
PHOSPHATIDYLSERINE | C68417 | An antigen of the phospholipid containing serine in the inner cell membrane. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases of antiphospholipid syndrome and systemic sclerosis. | Phosphatidylserine | |||
PHOSPHOLIPID | C70561 | Antigen(s) of the phosphate-containing lipids. They can be considered as autoantigens and are commonly and mainly associated with the autoimmune diseases antiphospholipid syndrome and systemic rheumatic diseases such as systemic lupus erythematosus. | Phospholipid | |||
PLATELET FACTOR 4-HEPARIN COMPLEX | C198268 | PF4-Heparin | An antigen of the protein complex comprising of platelet factor 4 and heparin. It can be considered as an autoantigen and is commonly associated with the autoimmune disease heparin-induced thrombocytopenia. | Platelet Factor 4-Heparin Complex | ||
PROTEINASE 3 | C17548 | Myeloblastin;PR3;Wegener Granulomatosis Autoantigen | An antigen encoded by the PRTN3 gene that regulates extracellular matrix protein proteolysis. It can be considered as an autoantigen and is commonly associated with the autoimmune systemic vasculitis disease, Wegener's granulomatosis. | Myeloblastin | ||
RIBONUCLEOPROTEIN | C95949 | RNP | Antigen(s) of the ribonucleic acid and RNA-binding protein multienzyme complexes. They can be considered as autoantigens and are commonly associated with the autoimmune diseases mixed connective tissue disease, systemic rheumatic diseases, and progressive systemic sclerosis. | Ribonucleoprotein | ||
RIBOSOMAL P PROTEINS | C198269 | Ribosomal-P | Antigen(s) of the three phosphoproteins, P0, P1 and P2 which are components of ribosomes. They can be considered as autoantigens and are commonly associated with the autoimmune disease systemic lupus erythematosus. | Ribosomal P Protein | ||
RNA POLYMERASE III | C198270 | Pol III;RNAP III | An antigen of the polymerase protein complex with a designation of III, that transcribes DNA into tRNA, rRNA and small RNAs. It can be considered as an autoantigen and is commonly associated with the autoimmune disease systemic sclerosis. | RNA Polymerase III | ||
RUSSIAN THISTLE POLLEN | C189485 | Common Saltwort Pollen Antigen;Kali turgidum Pollen Antigen;Salsola kali Pollen Antigen | Antigen(s) in the pollen of the species Kali turgidum (Russian thistle) that are considered as plant allergen(s). | Kali turgidum Pollen Antigen | ||
SARS-COV-2 NUCLEOCAPSID PROTEIN | C181991 | SARS-CoV-2 Nucleocapsid N Protein | The approximately 45.6 kDa structural protein that forms the nucleocapsid of the Severe Acute Respiratory Syndrome Coronavirus 2 virus (SARS-CoV-2). | SARS-CoV-2 Nucleoprotein | ||
SARS-COV-2 SPIKE PROTEIN | C178209 | SARS-CoV-2 S Protein | The approximately 180-200 kDa transmembrane, receptor binding protein from the Severe Acute Respiratory Syndrome Coronavirus 2 virus (SARS-CoV-2). | SARS-CoV-2 Spike Glycoprotein | ||
SCL-70 | C16516 | DNA Topoisomerase I;Scl-70 Antigen;Scleroderma-70 | An antigen of the nuclear enzyme topoisomerase 1 encoded by the TOP1 gene that relaxes coiled DNA. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic sclerosis and systemic lupus erythematosus. | DNA Topoisomerase 1 | ||
SHELLFISH MIX ANTIGENS | C189470 | Antigen(s) from any member(s) of the aquatic invertebrate animal having a shell and belonging to the phylum Mollusca, the class Crustacea (phylum Arthropoda), or the phylum Echinodermata that are considered as food allergen(s). | Multiple Shellfish Mix Antigens | |||
SILVER BIRCH POLLEN | C189486 | Betula pendula Pollen Antigen;Betula verrucosa Pollen Antigen;European White Birch Pollen Antigen | Antigen(s) in the pollen of the species Betula pendula (silver birch tree) that are considered as plant allergen(s). | Betula pendula Pollen Antigen | ||
SJOGRENS SS-A ANTIGEN | C198271 | Sjogren's Ro Antigen;SSA | Antigen(s) encoded by the Ro gene and are the Sjogren's type A antigens, SSA-52 and SSA-60. They can be considered as autoantigens and are commonly associated with the autoimmune disease Sjogren's Syndrome. | Sjogrens SS-A Antigen | ||
SJOGRENS SS-A52 ANTIGEN | C181355 | Ro52;Sjogrens Ro 52kDa Antigen;SSA-52 | An autoantigen encoded by the Ro52 gene (also called the TRIM21 gene) and has a molecular weight of 52 kDa. It is associated with the autoimmune disease Sjogrens Syndrome. | Sjogrens SS-A52 Antigen | ||
SJOGRENS SS-A60 ANTIGEN | C181354 | Ro60;Sjogrens Ro 60kDa Antigen;SSA-60 | An autoantigen encoded by the Ro60 gene and has a molecular weight of 60 kDa. It is associated with the autoimmune disease Sjogrens Syndrome. | Sjogrens SS-A60 Antigen | ||
SJOGRENS SS-B ANTIGEN | C181356 | Sjogrens La Antigen;SSB | An autoantigen encoded by the SSB gene. It is associated with the autoimmune disease Sjogrens Syndrome. | Sjogrens SS-B Antigen | ||
SMITH ANTIGEN RIBONUCLEOPROTEIN COMPLEX | C198272 | Ribonucleoprotein Smith Complex;Sm/RNP Complex | Antigen(s) of small nuclear ribonucleoprotein (snRNP) complexes family of U1, U2, U4, U5, and U6, which contains a single nuclear RNA (snRNA) molecule, the associated proteins, and the seven core Smith (Sm) proteins. They can be considered as autoantigens and are commonly associated with the autoimmune disease systemic lupus erythematosus. | Smith/Ribonuclear Protein Complex Antigen | ||
SMITH ANTIGENS | C198273 | Smith Autoantigens | Antigen(s) of the extractable nuclear RNA-binding proteins that may be comprised of (but not limited to) Smith B, B', N, D1, D2, D3, E, F and G. They are commonly associated with the autoimmune disease systemic lupus erythematosus. | Smith Antigen | ||
SMOOTH MUSCLE AUTOANTIGENS | C198274 | A group of autoimmune substances found in the smooth muscles that may be comprised of (but not limited to) actin and non-actin cytoskeleton components such as vimentin, tubulin, and desmin. They are commonly associated with autoimmune hepatitis. | Smooth Muscle Autoantigen | |||
SOLUBLE LIVER ANTIGEN | C198275 | SLA;Soluble Liver Autoantigen | A soluble cytosolic liver antigen which is most frequently the 50 kDa UGA serine tRNA-associated protein complex (tRNP(Ser)Sec). It can be considered as an autoantigen and is commonly associated with type 1 and 2 autoimmune hepatitis. | Soluble Liver Antigen | ||
SOYBEAN ANTIGEN | C189464 | Glycine max Antigen | Antigen(s) from the seed of the species Glycine max (soybean) that are considered as food allergen(s). | Glycine max Antigen | ||
STREPTOLYSIN O | C187775 | SLO;Streptococcal Toxin Streptolysin O | The approximately 60 kDa protein that is an oxygen-labile exotoxin produced by beta-hemolytic streptococci. | Streptococcal Toxin Streptolysin O | ||
THYROID PEROXIDASE | C16752 | Thyroperoxidase;TPO | An antigen encoded by the TPO gene that regulates thyroid hormones synthesis. It can be considered as an autoantigen and is commonly associated with autoimmune thyroid disease. | Thyroid Peroxidase | ||
TIMOTHY GRASS POLLEN | C189487 | Phleum pratense Pollen Antigen | Antigen(s) in the pollen of the species Phleum pratense (Timothy grass) that are considered as plant allergen(s). | Phleum pratense Pollen Antigen | ||
TISSUE TRANSGLUTAMINASE | C186641 | TG2;tTG | An antigen of the transglutaminase enzyme family and catalyzes the crosslinking of proteins with a molecular weight of approximate 78 kDa. It can be considered as an autoantigen and is commonly associated with the autoimmune disease celiac disease. | Protein-Glutamine Gamma-Glutamyltransferase 2 | ||
TREE MIX POLLENS | C189471 | Antigen(s) in the pollens of a mix of trees that are considered as plant allergen(s). | Multiple Tree Mix Pollen Antigens | |||
TRITICUM AESTIVUM ANTIGEN | C189472 | Bread Wheat Antigen;Common Wheat Antigen | Antigen(s) from the species Triticum aestivum (common wheat) that are considered as food allergen(s). | Triticum Aestivum Antigen | ||
TRITICUM SPECIES ANTIGEN | C189488 | Antigen(s) from the wheat species within the genus Triticum that are considered as food allergen(s). | Triticum Species Antigen | |||
U1 SMALL NUCLEAR RIBONUCLEOPROTEIN 70 KDA | C198276 | Ribonucleoprotein-70;snRNP70;U1 snRNP 70 kDa | An antigen of the U1 small nuclear ribonucleoprotein (snRNP) complex, which contains the U1-snRNA, the U1-associated proteins 70kDa-U1, U1A, U1C, and the seven core Smith (Sm) proteins. It can be considered as an autoantigen and is commonly associated with the autoimmune diseases systemic lupus erythematosus and mixed connective tissue disease. | U1 Small Nuclear Ribonucleoprotein | ||
VIBRIO CHOLERA TOXIN B SUBUNIT | C187756 | CTB | The approximately 55 kDa, receptor binding B subunit of the Cholera toxin and the virulence factor for Vibrio cholerae. | Cholera Toxin B Subunit | ||
WALNUT ANTIGEN | C189491 | Antigen(s) from the fruit(s) of the Juglans species (walnut) that are considered as food allergen(s). | Walnut Antigen | |||
WEED MIX POLLENS | C189473 | Antigen(s) in the pollens of a mix of weeds that are considered as plant allergen(s). | Multiple Weed Mix Pollen Antigens | |||
WESTERN RAGWEED POLLEN | C189489 | Ambrosia psilostachya Pollen Antigen | Antigen(s) in the pollen of the species Ambrosia psilostachya (Western ragweed) that are considered as plant allergen(s). | Ambrosia psilostachya Pollen Antigen | ||
WHITE ELM POLLEN | C189474 | American elm Pollen Antigen;Ulmus americana Pollen Antigen | Antigen(s) in the pollen of the species Ulmus americana (white elm tree) that are considered as plant allergen(s). | Ulmus americana Pollen Antigen | ||
WHITE OAK POLLEN | C189475 | Quercus alba Pollen Antigen | Antigen(s) in the pollen of the species Quercus alba (white oak tree) that are considered as plant allergen(s). | Quercus alba Pollen Antigen | ||
WILD RYE GRASS POLLEN | C189490 | Elymus triticoides Pollen Antigen;Leymus triticoides Pollen Antigen | Antigen(s) in the pollen of the species Leymus triticoides (wild rye grass) that are considered as plant allergen(s). | Leymus triticoides Pollen Antigen | ||
Back to top | ||||||
CL.C124300.BSTESTCD | Biospecimen Characteristics Test Code
(BSTESTCD) | text
Extensible: Yes | C124300 | Biospecimen Characteristics Test Code | Terminology relevant to the test codes that describe the characteristics of biospecimens and extracted samples. | CDISC SDTM Biospecimen Characteristics Test Code Terminology |
A260A230 | C139281 | A260/A230 Ratio | An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 230nm respectively. | A260 to A230 Ratio | ||
A260A280 | C139280 | A260/A280 Ratio | An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 280nm respectively. | A260 to A280 Ratio | ||
AREA | C25244 | Area | The extent of a 2-dimensional surface enclosed within a boundary. (NCI) | Area | ||
CONC | C41185 | Concentration | The quantity of a specified substance in a unit volume or weight of another substance. | Concentration | ||
FIXNAM | C128948 | Fixative Name | The name of the substance or material that preserves tissues and cells for study. | Name of Fixative | ||
FLUORLBL | C139282 | Fluorescent Label | The type of fluorescent label or dye that is used in a fluorescence-based assay. | Fluorescent Tag Type | ||
I28S18S | C177932 | 28S/18S | An assessment of ribonucleic acid integrity that is measured by determining the ratio of the nucleotide length of 28S rRNA and 18S rRNA, respectively, in a biological specimen. | 28S Ribosomal RNA to 18S Ribosomal RNA Ratio | ||
LENGTH | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
MASS | C43246 | Mass | The amount of matter in an object. | Mass | ||
QUALITY | C25283 | Quality | An assessment of excellence, worth, or fitness for use. | Quality | ||
RIN | C63637 | RNA Integrity Number | A numerical assessment of the integrity of RNA based on the entire electrophoretic trace of the RNA sample, including the presence or absence of degradation products. (NCI) | RNA Integrity Number | ||
SIZE | C25681 | Size | The physical magnitude of something. (NCI) | Size | ||
SPDMSION | C25483 | Dimension;Spatial Dimension | The three dimensional magnitude of an entity expressed as the three axes of length, width, and height (or thickness). | Dimension | ||
SPWEIGHT | C106569 | Specimen Weight | A measurement of the weight of a biological specimen. | Specimen Weight Measurement | ||
TEMP | C25206 | Temperature | The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) | Temperature | ||
THICK | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
TISSPNUM | C176276 | Number of Tissue Samples in Specimen | The total number of tissue samples within the specimen. | Number of Tissue Samples in Specimen | ||
TUMCECE | C123556 | Cancer Cellularity;Neoplastic Cells/Total Cells;Tumor Cells/Total Cells | A relative measurement (ratio or percentage) of the neoplastic cells to total cells in a biological specimen. | Cancer Cellularity Measurement | ||
TUMTORI | C135371 | Tumor Tissue Origin | A characterization of the tumor tissue sample based upon whether it was taken from a tumor that originated after the disease spread. | Tumor Tissue Origin | ||
VBLSIND | C139279 | Sample Viability Indicator | An indication as to whether the sample contains viable (capable of life or normal growth and development) cells or tissues. | Sample Viability Indicator | ||
VBLSPCT | C139278 | Sample Viability Percent | A measurement of the percent of a sample that is viable (capable of life or normal growth and development) for further processing or testing. | Sample Viability Percent Measurement | ||
VOLUME | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
WIDTH | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
Back to top | ||||||
CL.C124299.BSTEST | Biospecimen Characteristics Test Name
(BSTEST) | text
Extensible: Yes | C124299 | Biospecimen Characteristics Test Name | Terminology relevant to the test names that describe the characteristics of biospecimens and extracted samples. | CDISC SDTM Biospecimen Characteristics Test Name Terminology |
28S/18S | C177932 | 28S/18S | An assessment of ribonucleic acid integrity that is measured by determining the ratio of the nucleotide length of 28S rRNA and 18S rRNA, respectively, in a biological specimen. | 28S Ribosomal RNA to 18S Ribosomal RNA Ratio | ||
A260/A230 Ratio | C139281 | A260/A230 Ratio | An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 230nm respectively. | A260 to A230 Ratio | ||
A260/A280 Ratio | C139280 | A260/A280 Ratio | An assessment of nucleic acid purity that is measured by determining the ratio of light absorbance of the nucleic acid sample at 260nm and 280nm respectively. | A260 to A280 Ratio | ||
Area | C25244 | Area | The extent of a 2-dimensional surface enclosed within a boundary. (NCI) | Area | ||
Concentration | C41185 | Concentration | The quantity of a specified substance in a unit volume or weight of another substance. | Concentration | ||
Fixative Name | C128948 | Fixative Name | The name of the substance or material that preserves tissues and cells for study. | Name of Fixative | ||
Fluorescent Label | C139282 | Fluorescent Label | The type of fluorescent label or dye that is used in a fluorescence-based assay. | Fluorescent Tag Type | ||
Length | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
Mass | C43246 | Mass | The amount of matter in an object. | Mass | ||
Number of Tissue Samples in Specimen | C176276 | Number of Tissue Samples in Specimen | The total number of tissue samples within the specimen. | Number of Tissue Samples in Specimen | ||
Quality | C25283 | Quality | An assessment of excellence, worth, or fitness for use. | Quality | ||
RNA Integrity Number | C63637 | RNA Integrity Number | A numerical assessment of the integrity of RNA based on the entire electrophoretic trace of the RNA sample, including the presence or absence of degradation products. (NCI) | RNA Integrity Number | ||
Sample Viability Indicator | C139279 | Sample Viability Indicator | An indication as to whether the sample contains viable (capable of life or normal growth and development) cells or tissues. | Sample Viability Indicator | ||
Sample Viability Percent | C139278 | Sample Viability Percent | A measurement of the percent of a sample that is viable (capable of life or normal growth and development) for further processing or testing. | Sample Viability Percent Measurement | ||
Size | C25681 | Size | The physical magnitude of something. (NCI) | Size | ||
Spatial Dimension | C25483 | Dimension;Spatial Dimension | The three dimensional magnitude of an entity expressed as the three axes of length, width, and height (or thickness). | Dimension | ||
Specimen Weight | C106569 | Specimen Weight | A measurement of the weight of a biological specimen. | Specimen Weight Measurement | ||
Temperature | C25206 | Temperature | The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) | Temperature | ||
Thickness | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
Tumor Cells/Total Cells | C123556 | Cancer Cellularity;Neoplastic Cells/Total Cells;Tumor Cells/Total Cells | A relative measurement (ratio or percentage) of the neoplastic cells to total cells in a biological specimen. | Cancer Cellularity Measurement | ||
Tumor Tissue Origin | C135371 | Tumor Tissue Origin | A characterization of the tumor tissue sample based upon whether it was taken from a tumor that originated after the disease spread. | Tumor Tissue Origin | ||
Volume | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
Width | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
Back to top | ||||||
CL.C124297.BEDECOD | Biospecimen Events Dictionary Derived Term
(BEDECOD) | text
Extensible: Yes | C124297 | Biospecimen Events Dictionary Derived Term | A terminology codelist based on the standardized or preprinted name of the biospecimen event that occurs. | CDISC SDTM Biospecimen Events Dictionary Derived Term Terminology |
ALIQUOTING | C124326 | The act of dividing a liquid item into multiple items of smaller volume. | Aliquotting | |||
ARCHIVE RETRIEVING | C154710 | The act of removing a biological specimen from a biobank or other biorepository for further use. | Archive Sample Retrieval | |||
CENTRIFUGING | C16410 | Separating and isolating components of different density and size in a specimen using centrifugal force. | Centrifugation | |||
COLLECTING | C25453 | The act of gathering an item. | Collection | |||
CONCENTRATING | C85856 | The act of increasing the density of a substance and decreasing its volume. | Concentrate | |||
CONSUMING | C66715 | The act of using something up to the point of depletion. | Consumption | |||
CULTURING | C17201 | The act of maintaining and/or attempting to grow explanted cells in an in vitro environment. | Tissue Culture | |||
DECONTAMINATING | C68769 | The act of ridding of contamination. | Decontamination | |||
DESTROYING | C62100 | The act of demolishing an item to make it unusable or unanalyzable. | Destruction | |||
DILUTING | C64657 | To reduce in strength or concentration by the addition of diluent. | Dilute | |||
EMBEDDING | C48163 | To surround an object with a firm chemical substance such as wax or resin. | Embedding | |||
EXTRACTING | C61575 | The act of taking out, extracting, or withdrawing an entity from a location. | Extraction | |||
FIXING | C25219 | To chemically preserve so as to maintain structural and/or molecular features. | Fixation | |||
FLASH FREEZING | C63521 | To freeze rapidly so as to preserve structure and prevent ice crystal formation. | Quick Freeze | |||
FREEZING | C48160 | The process whereby cold changes the water component from a liquid to a solid. | Freezing | |||
ISOLATING | C128947 | The act of separating out a target entity from a larger set of such entities. | Specimen Isolation | |||
PARTIAL CONSUMING | C174272 | The act of using something up without full depletion. | Partial Consumption | |||
RECEIVING | C25639 | Coming into possession of or acting as the receptacle or recipient of an item conveyed by an intermediary to the intended destination, from a sender. | Receive | |||
RETRIEVING | C25659 | The act of accessing information or removing an item from storage. | Retrieval | |||
SECTIONING | C124327 | To cut a very thin slice of tissue or other substance. | Sectioning | |||
SHIPPING | C40353 | Being transported or conveyed by an intermediary to a destination, from the sender to the intended receiver. | Shipping | |||
STAINING | C23010 | To dye or tint tissues or other biological samples for the purpose of imaging structures. | Staining Method | |||
STORING | C60824 | The act of safekeeping items in a depository. | Storage | |||
THAWING | C48165 | The process whereby heat changes the water component from a solid to a liquid. | Thaw | |||
Back to top | ||||||
CL.C113852.BLCS01TC | Bladder Control Scale Questionnaire Test Code
(BLCS01TC) | text
Extensible: No | C113852 | Bladder Control Scale Questionnaire Test Code | Bladder Control Scale test code. | CDISC Questionnaire Bladder Control Scale Test Code Terminology |
BLCS0101 | C113953 | BLCS01-Lost Control of Bladder | Bladder Control Scale - During the past 4 weeks, how often have you lost control of your bladder or had an accident? | BLCS - Lost Control of Your Bladder | ||
BLCS0102 | C113954 | BLCS01-Almost Lost Control of Bladder | Bladder Control Scale - During the past 4 weeks, how often have you almost lost control of your bladder or had an accident? | BLCS - Almost Lost Control of Your Bladder | ||
BLCS0103 | C113955 | BLCS01-Altered Activity Because Bladder | Bladder Control Scale - During the past 4 weeks, how often have you altered your activities because of bladder problems? | BLCS - Altered Activities Because Bladder Problems | ||
BLCS0104 | C113956 | BLCS01-Bladder Restricted Lifestyle | Bladder Control Scale - During the past 4 weeks, how much have bladder problems restricted your overall lifestyle? | BLCS - Bladder Problems Restrict Overall Lifestyle | ||
Back to top | ||||||
CL.C113851.BLCS01TN | Bladder Control Scale Questionnaire Test Name
(BLCS01TN) | text
Extensible: No | C113851 | Bladder Control Scale Questionnaire Test Name | Bladder Control Scale test name. | CDISC Questionnaire Bladder Control Scale Test Name Terminology |
BLCS01-Almost Lost Control of Bladder | C113954 | BLCS01-Almost Lost Control of Bladder | Bladder Control Scale - During the past 4 weeks, how often have you almost lost control of your bladder or had an accident? | BLCS - Almost Lost Control of Your Bladder | ||
BLCS01-Altered Activity Because Bladder | C113955 | BLCS01-Altered Activity Because Bladder | Bladder Control Scale - During the past 4 weeks, how often have you altered your activities because of bladder problems? | BLCS - Altered Activities Because Bladder Problems | ||
BLCS01-Bladder Restricted Lifestyle | C113956 | BLCS01-Bladder Restricted Lifestyle | Bladder Control Scale - During the past 4 weeks, how much have bladder problems restricted your overall lifestyle? | BLCS - Bladder Problems Restrict Overall Lifestyle | ||
BLCS01-Lost Control of Bladder | C113953 | BLCS01-Lost Control of Bladder | Bladder Control Scale - During the past 4 weeks, how often have you lost control of your bladder or had an accident? | BLCS - Lost Control of Your Bladder | ||
Back to top | ||||||
CL.C113846.BCR101TC | Borg CR10 Scale Questionnaire Test Code
(BCR101TC) | text
Extensible: No | C113846 | Borg CR10 Scale Questionnaire Test Code | Borg CR10 scale test code. | CDISC Questionnaire Borg CR10 Test Code Terminology |
BCR10101 | C113888 | BCR101-Rating | Borg CR10 Scale - Rating. | Borg CR10 - Rating | ||
Back to top | ||||||
CL.C113845.BCR101TN | Borg CR10 Scale Questionnaire Test Name
(BCR101TN) | text
Extensible: No | C113845 | Borg CR10 Scale Questionnaire Test Name | Borg CR10 scale test name. | CDISC Questionnaire Borg CR10 Test Name Terminology |
BCR101-Rating | C113888 | BCR101-Rating | Borg CR10 Scale - Rating. | Borg CR10 - Rating | ||
Back to top | ||||||
CL.C113854.BWCS01TC | Bowel Control Scale Questionnaire Test Code
(BWCS01TC) | text
Extensible: No | C113854 | Bowel Control Scale Questionnaire Test Code | Bowel Control Scale test code. | CDISC Questionnaire Bowel Control Scale Test Code Terminology |
BWCS0101 | C113957 | BWCS01-Been Constipated | Bowel Control Scale - During the past 4 weeks, how often have you been constipated? | BWCS - Been Constipated | ||
BWCS0102 | C113958 | BWCS01-Lost Control of Bowels | Bowel Control Scale - During the past 4 weeks, how often have you lost control of your bowels or had an accident? | BWCS - Lost Control of Your Bowels | ||
BWCS0103 | C113959 | BWCS01-Almost Lost Control of Bowels | Bowel Control Scale - During the past 4 weeks, how often have you almost lost control of your bowels or almost had an accident? | BWCS - Almost Lost Control of Your Bowels | ||
BWCS0104 | C113960 | BWCS01-Altered Activity Because Bowels | Bowel Control Scale - During the past 4 weeks, how often have you altered your activities because of bowel control problems? | BWCS - Altered Activities Because Bowel Control Problems | ||
BWCS0105 | C113961 | BWCS01-Bowels Restricted Lifestyle | Bowel Control Scale - During the past 4 weeks, how much have bowel problems restricted your overall lifestyle? | BWCS - Bowel Problems Restrict Overall Lifestyle | ||
Back to top | ||||||
CL.C113853.BWCS01TN | Bowel Control Scale Questionnaire Test Name
(BWCS01TN) | text
Extensible: No | C113853 | Bowel Control Scale Questionnaire Test Name | Bowel Control Scale test name. | CDISC Questionnaire Bowel Control Scale Test Name Terminology |
BWCS01-Almost Lost Control of Bowels | C113959 | BWCS01-Almost Lost Control of Bowels | Bowel Control Scale - During the past 4 weeks, how often have you almost lost control of your bowels or almost had an accident? | BWCS - Almost Lost Control of Your Bowels | ||
BWCS01-Altered Activity Because Bowels | C113960 | BWCS01-Altered Activity Because Bowels | Bowel Control Scale - During the past 4 weeks, how often have you altered your activities because of bowel control problems? | BWCS - Altered Activities Because Bowel Control Problems | ||
BWCS01-Been Constipated | C113957 | BWCS01-Been Constipated | Bowel Control Scale - During the past 4 weeks, how often have you been constipated? | BWCS - Been Constipated | ||
BWCS01-Bowels Restricted Lifestyle | C113961 | BWCS01-Bowels Restricted Lifestyle | Bowel Control Scale - During the past 4 weeks, how much have bowel problems restricted your overall lifestyle? | BWCS - Bowel Problems Restrict Overall Lifestyle | ||
BWCS01-Lost Control of Bowels | C113958 | BWCS01-Lost Control of Bowels | Bowel Control Scale - During the past 4 weeks, how often have you lost control of your bowels or had an accident? | BWCS - Lost Control of Your Bowels | ||
Back to top | ||||||
CL.C125923.BRDGMOOD | BRIDG Activity Mood
(BRDGMOOD) | text
Extensible: Yes | C125923 | BRIDG Activity Mood | The modes that may be applied to an entity as it passes through various phases of a life cycle or business process. | CDISC SDTM BRIDG Activity Mood Terminology |
PERFORMED | C38000 | To execute and carry through to completion. | Performed | |||
SCHEDULED | C125937 | To order a planned list of activities or events. | Scheduled | |||
Back to top | ||||||
CL.C120983.BACS1TC | Brief Assessment of Cognition in Schizophrenia Functional Test Test Code
(BACS1TC) | text
Extensible: No | C120983 | Brief Assessment of Cognition in Schizophrenia Functional Test Test Code | Brief Assessment of Cognition in Schizophrenia test code. | CDISC Functional Test BACS Test Code Terminology |
BACS101 | C121050 | BACS1-Number of Items Recalled | Brief Assessment of Cognition in Schizophrenia - Verbal Memory-Number of items recalled on each trial. | BACS - Number of Items Recalled | ||
BACS101A | C121051 | BACS1-Number of Items Recalled Total | Brief Assessment of Cognition in Schizophrenia - Verbal Memory-Total number of items recalled. | BACS - Number of Items Recalled Total | ||
BACS102 | C121052 | BACS1-Number of Correct Sequences | Brief Assessment of Cognition in Schizophrenia - Digit Sequencing-Number of correct sequences. | BACS - Number of Correct Sequences | ||
BACS103A | C121053 | BACS1-Number of Tokens Left on the Table | Brief Assessment of Cognition in Schizophrenia - Token Motor Task-Total number of tokens left on the table. | BACS - Number of Tokens Left on the Table | ||
BACS103B | C121054 | BACS1-Total Number Tokens in Container | Brief Assessment of Cognition in Schizophrenia - Token Motor Task-Total number of tokens placed in the container. | BACS - Total Number Tokens in Container | ||
BACS103C | C121055 | BACS1-Number Tokens Incorrectly Placed | Brief Assessment of Cognition in Schizophrenia Questionnaire - Token Motor Task-Total number of tokens incorrectly placed in container. | BACS - Number Tokens Incorrectly Placed | ||
BACS103D | C121056 | BACS1-Number of Tokens Correctly Placed | Brief Assessment of Cognition in Schizophrenia Questionnaire - Token Motor Task-Number of tokens correctly placed. | BACS - Number of Tokens Correctly Placed | ||
BACS104A | C121057 | BACS1-Category Instances | Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Category instances. | BACS - Category Instances | ||
BACS104B | C121058 | BACS1-Letter Fluency 1 | Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Letter fluency 1. | BACS - Letter Fluency 1 | ||
BACS104C | C121059 | BACS1-Letter Fluency 2 | Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Letter fluency 2. | BACS - Letter Fluency 2 | ||
BACS104D | C121060 | BACS1-Verbal Fluency Total | Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Total number of Verbal Fluency items. | BACS - Verbal Fluency Total | ||
BACS105 | C121061 | BACS1-Symbol Coding Raw Score | Brief Assessment of Cognition in Schizophrenia Questionnaire - Symbol Coding-Raw score. | BACS - Symbol Coding Raw Score | ||
BACS106 | C121062 | BACS1-Tower of London Correct Responses | Brief Assessment of Cognition in Schizophrenia Questionnaire - Tower of London-Number of correct responses. | BACS - Tower of London Correct Responses | ||
Back to top | ||||||
CL.C120982.BACS1TN | Brief Assessment of Cognition in Schizophrenia Functional Test Test Name
(BACS1TN) | text
Extensible: No | C120982 | Brief Assessment of Cognition in Schizophrenia Functional Test Test Name | Brief Assessment of Cognition in Schizophrenia test name. | CDISC Functional Test BACS Test Name Terminology |
BACS1-Category Instances | C121057 | BACS1-Category Instances | Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Category instances. | BACS - Category Instances | ||
BACS1-Letter Fluency 1 | C121058 | BACS1-Letter Fluency 1 | Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Letter fluency 1. | BACS - Letter Fluency 1 | ||
BACS1-Letter Fluency 2 | C121059 | BACS1-Letter Fluency 2 | Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Letter fluency 2. | BACS - Letter Fluency 2 | ||
BACS1-Number of Correct Sequences | C121052 | BACS1-Number of Correct Sequences | Brief Assessment of Cognition in Schizophrenia - Digit Sequencing-Number of correct sequences. | BACS - Number of Correct Sequences | ||
BACS1-Number of Items Recalled Total | C121051 | BACS1-Number of Items Recalled Total | Brief Assessment of Cognition in Schizophrenia - Verbal Memory-Total number of items recalled. | BACS - Number of Items Recalled Total | ||
BACS1-Number of Items Recalled | C121050 | BACS1-Number of Items Recalled | Brief Assessment of Cognition in Schizophrenia - Verbal Memory-Number of items recalled on each trial. | BACS - Number of Items Recalled | ||
BACS1-Number of Tokens Correctly Placed | C121056 | BACS1-Number of Tokens Correctly Placed | Brief Assessment of Cognition in Schizophrenia Questionnaire - Token Motor Task-Number of tokens correctly placed. | BACS - Number of Tokens Correctly Placed | ||
BACS1-Number of Tokens Left on the Table | C121053 | BACS1-Number of Tokens Left on the Table | Brief Assessment of Cognition in Schizophrenia - Token Motor Task-Total number of tokens left on the table. | BACS - Number of Tokens Left on the Table | ||
BACS1-Number Tokens Incorrectly Placed | C121055 | BACS1-Number Tokens Incorrectly Placed | Brief Assessment of Cognition in Schizophrenia Questionnaire - Token Motor Task-Total number of tokens incorrectly placed in container. | BACS - Number Tokens Incorrectly Placed | ||
BACS1-Symbol Coding Raw Score | C121061 | BACS1-Symbol Coding Raw Score | Brief Assessment of Cognition in Schizophrenia Questionnaire - Symbol Coding-Raw score. | BACS - Symbol Coding Raw Score | ||
BACS1-Total Number Tokens in Container | C121054 | BACS1-Total Number Tokens in Container | Brief Assessment of Cognition in Schizophrenia - Token Motor Task-Total number of tokens placed in the container. | BACS - Total Number Tokens in Container | ||
BACS1-Tower of London Correct Responses | C121062 | BACS1-Tower of London Correct Responses | Brief Assessment of Cognition in Schizophrenia Questionnaire - Tower of London-Number of correct responses. | BACS - Tower of London Correct Responses | ||
BACS1-Verbal Fluency Total | C121060 | BACS1-Verbal Fluency Total | Brief Assessment of Cognition in Schizophrenia Questionnaire - Verbal Fluency-Total number of Verbal Fluency items. | BACS - Verbal Fluency Total | ||
Back to top | ||||||
CL.C100162.BPI1TC | Brief Pain Inventory Questionnaire Test Code
(BPI1TC) | text
Extensible: No | C100162 | Brief Pain Inventory Questionnaire Test Code | Brief Pain Inventory test code. | CDISC Questionnaire BPI Test Code Terminology |
BPI101 | C100287 | BPI1-Marital Status | Brief Pain Inventory - Marital status. | BPI - Marital Status | ||
BPI102 | C100288 | BPI1-Education | Brief Pain Inventory - Education. | BPI - Education | ||
BPI102A | C100289 | BPI1-Professional Degree | Brief Pain Inventory - Education. Professional degree. | BPI - Professional Degree | ||
BPI103 | C100290 | BPI1-Current Occupation | Brief Pain Inventory - Current occupation. | BPI - Current Occupation | ||
BPI104 | C100291 | BPI1-Spouse's Occupation | Brief Pain Inventory - Spouse's occupation. | BPI - Spouse's Occupation | ||
BPI105 | C100292 | BPI1-Current Job Status | Brief Pain Inventory - Which of the following best describes your current job status? | BPI - Current Job Status | ||
BPI106 | C100293 | BPI1-How Long Since Diagnosis | Brief Pain Inventory - How long has it been since you first learned your diagnosis? | BPI - How Long Since Diagnosis | ||
BPI107 | C100294 | BPI1-Pain Due to Present Disease | Brief Pain Inventory - Have you ever had pain due to your present disease? | BPI - Pain Due to Present Disease | ||
BPI108 | C100295 | BPI1-Pain One of Your Symptoms | Brief Pain Inventory - When you first received your diagnosis, was pain one of your symptoms? | BPI - Pain as a Symptom | ||
BPI109 | C100296 | BPI1-Surgery in Past Month | Brief Pain Inventory - Have you had surgery in the past month? | BPI - Surgery in Past Month | ||
BPI109A | C100297 | BPI1-Kind of Surgery in Past Month | Brief Pain Inventory - What kind of surgery have you had in the past month? | BPI - Kind of Surgery in Past Month | ||
BPI110 | C100298 | BPI1-Pain Other than Everyday Kinds | Brief Pain Inventory - Have you had pain other than these everyday kinds of pain during the last week? | BPI - Pain Other than Everyday Kinds | ||
BPI110A | C100299 | BPI1-Pain Medications in the Last 7 Days | Brief Pain Inventory - Did you take pain medications in the last 7 days? | BPI - Pain Medications in the Last 7 Days | ||
BPI110B | C100300 | BPI1-Pain Requires Medication Daily | Brief Pain Inventory - I feel I have some form of pain that requires medication each and every day. | BPI - Pain Requires Medication Daily | ||
BPI111A | C100301 | BPI1-Areas of Pain | Brief Pain Inventory - On the diagram, shade in the areas where you feel pain. | BPI - Areas of Pain | ||
BPI111B | C100302 | BPI1-Area Hurts Most | Brief Pain Inventory - On the diagram, put an X on the area that hurts the most. | BPI - Area Hurts Most | ||
BPI112 | C100303 | BPI1-Pain at its Worst in Last Week | Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain at its worst in the last week. | BPI - Pain at its Worst in Last Week | ||
BPI113 | C100304 | BPI1-Pain at its Least in Last Week | Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain at its least in the last week. | BPI - Pain at its Least in Last Week | ||
BPI114 | C100305 | BPI1-Pain on the Average | Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain on the average. | BPI - Pain on the Average | ||
BPI115 | C100306 | BPI1-Pain Right Now | Brief Pain Inventory - Please rate your pain by circling the one number that tells how much pain you have right now. | BPI - Pain Right Now | ||
BPI116 | C100307 | BPI1-Things that Make Pain Feel Better | Brief Pain Inventory - What kinds of things make your pain feel better? | BPI - Things that Make Pain Feel Better | ||
BPI117 | C100308 | BPI1-Things that Make your Pain Worse | Brief Pain Inventory - What kinds of things make your pain feel worse? | BPI - Things that Make your Pain Worse | ||
BPI118 | C100309 | BPI1-Treatments Receiving for Pain | Brief Pain Inventory - What treatments or medications are you receiving for your pain? | BPI - Treatments Receiving for Pain | ||
BPI119 | C100310 | BPI1-Relief Pain Treatments Provided | Brief Pain Inventory - In the last week, how much relief have pain treatments or medications provided? Please circle the one percentage that most shows how much relief you have received. | BPI - Relief Pain Treatments Provided | ||
BPI120 | C100311 | BPI1-Hours before Pain Returns | Brief Pain Inventory - If you take pain medication, how many hours does it take before the pain returns? | BPI - Hours before Pain Returns | ||
BPI1211 | C100312 | BPI1-Pain Due to Effects of Treatment | Brief Pain Inventory - I believe my pain is due to the effects of treatment. | BPI - Pain Due to Effects of Treatment | ||
BPI1212 | C100313 | BPI1-Pain Due to Primary Disease | Brief Pain Inventory - I believe my pain is due to my primary disease. | BPI - Pain Due to Primary Disease | ||
BPI1213 | C100314 | BPI1-Pain Due to Unrelated Med Condition | Brief Pain Inventory - I believe my pain is due to a medical condition unrelated to my primary disease. | BPI - Pain Due to Unrelated Medical Condition | ||
BPI1213A | C100315 | BPI1-Describe Unrelated Med Condition | Brief Pain Inventory - I believe my pain is due to a medical condition unrelated to my primary disease. Please describe condition. | BPI - Describe Unrelated Medical Condition | ||
BPI122A | C100316 | BPI1-Aching | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: aching. | BPI - Aching | ||
BPI122B | C100317 | BPI1-Throbbing | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: throbbing. | BPI - Throbbing | ||
BPI122C | C100318 | BPI1-Shooting | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: shooting. | BPI - Shooting | ||
BPI122D | C100319 | BPI1-Stabbing | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: stabbing. | BPI - Stabbing | ||
BPI122E | C100320 | BPI1-Gnawing | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: gnawing. | BPI - Gnawing | ||
BPI122F | C100321 | BPI1-Sharp | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: sharp. | BPI - Sharp | ||
BPI122G | C100322 | BPI1-Tender | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: tender. | BPI - Tender | ||
BPI122H | C100323 | BPI1-Burning | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: burning. | BPI - Burning | ||
BPI122I | C100324 | BPI1-Exhausting | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: exhausting. | BPI - Exhausting | ||
BPI122J | C100325 | BPI1-Tiring | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: tiring. | BPI - Tiring | ||
BPI122K | C100326 | BPI1-Penetrating | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: penetrating. | BPI - Penetrating | ||
BPI122L | C100327 | BPI1-Nagging | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: nagging. | BPI - Nagging | ||
BPI122M | C100328 | BPI1-Numb | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: numb. | BPI - Numb | ||
BPI122N | C100329 | BPI1-Miserable | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: miserable. | BPI - Miserable | ||
BPI122O | C100330 | BPI1-Unbearable | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: unbearable. | BPI - Unbearable | ||
BPI123A | C100331 | BPI1-Pain Interfered General Activity | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your general activity. | BPI - Pain Interfered with General Activity | ||
BPI123B | C100332 | BPI1-Pain Interfered with Mood | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your mood. | BPI - Pain Interfered with Mood | ||
BPI123C | C100333 | BPI1-Pain Interfered Walking Ability | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your walking ability. | BPI - Pain Interfered with Walking Ability | ||
BPI123D | C100334 | BPI1-Pain Interfered with Normal Work | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your normal work. | BPI - Pain Interfered with Normal Work | ||
BPI123E | C100335 | BPI1-Pain Interfered with Relations | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your relations with other people. | BPI - Pain Interfered with Relations | ||
BPI123F | C100336 | BPI1-Pain Interfered with Sleep | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your sleep. | BPI - Pain Interfered with Sleep | ||
BPI123G | C100337 | BPI1-Pain Interfered Enjoyment of Life | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your enjoyment of life. | BPI - Pain Interfered with Enjoyment of Life | ||
BPI124 | C100338 | BPI1-Prefer to Take Pain Medicine | Brief Pain Inventory - I prefer to take my pain medicine. | BPI - Prefer to Take Pain Medicine | ||
BPI125 | C100339 | BPI1-Take my Pain Medicine | Brief Pain Inventory - I take my pain medicine (in a 24 hour period). | BPI - Take my Pain Medicine | ||
BPI126 | C100340 | BPI1-Need Stronger Type of Pain Med | Brief Pain Inventory - Do you feel you need a stronger type of pain medication? | BPI - Need Stronger Type of Pain Medication | ||
BPI127 | C100341 | BPI1-Need more Pain Med than Prescribed | Brief Pain Inventory - Do you feel you need to take more of the pain medication than your doctor has prescribed? | BPI - Need more Pain Medication than Prescribed | ||
BPI128 | C100342 | BPI1-Concerned Use Too Much Pain Med | Brief Pain Inventory - Are you concerned that you use too much pain medication? | BPI - Concerned with Too Much Pain Medication Use | ||
BPI128A | C100343 | BPI1-Why Concerned Use Too Much Pain Med | Brief Pain Inventory - Are you concerned that you use too much pain medication? If Yes, why? | BPI - Why Concerned with Too Much Pain Medication Use | ||
BPI129 | C100344 | BPI1-Problems with Side Effects Pain Med | Brief Pain Inventory - Are you having problems with side effects from your pain medication? | BPI - Problems with Side Effects Pain Medication | ||
BPI129A | C100345 | BPI1-Which Side Effects from Pain Med | Brief Pain Inventory - Are you having problems with side effects from your pain medication? Which side effects? | BPI - What Side Effects from Pain Medication | ||
BPI130 | C100346 | BPI1-Need Further Info about Pain Med | Brief Pain Inventory - Do you feel you need to receive further information about your pain medication? | BPI - Need Further Information about Pain Medication | ||
BPI131A | C100347 | BPI1-Warm Compresses to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: warm compresses. | BPI - Warm Compresses to Relieve Pain | ||
BPI131B | C100348 | BPI1-Cold Compresses to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: cold compresses. | BPI - Cold Compresses to Relieve Pain | ||
BPI131C | C100349 | BPI1-Relaxation Techniques Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: relaxation techniques. | BPI - Relaxation Techniques Relieve Pain | ||
BPI131D | C100350 | BPI1-Distraction to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: distraction. | BPI - Distraction to Relieve Pain | ||
BPI131E | C100351 | BPI1-Biofeedback to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: biofeedback. | BPI - Biofeedback to Relieve Pain | ||
BPI131F | C100352 | BPI1-Hypnosis to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: hypnosis. | BPI - Hypnosis to Relieve Pain | ||
BPI131G | C100353 | BPI1-Other to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: other. | BPI - Other Methods to Relieve Pain | ||
BPI131H | C100354 | BPI1-Other specify to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: other. Please specify. | BPI - Specified Other Method to Relieve Pain | ||
BPI132 | C100355 | BPI1-Meds not Prescribed Taken for Pain | Brief Pain Inventory - Medications not prescribed by my doctor that I take for pain are. | BPI - Medications not Prescribed Taken for Pain | ||
Back to top | ||||||
CL.C100161.BPI1TN | Brief Pain Inventory Questionnaire Test Name
(BPI1TN) | text
Extensible: No | C100161 | Brief Pain Inventory Questionnaire Test Name | Brief Pain Inventory test name. | CDISC Questionnaire BPI Test Name Terminology |
BPI1-Aching | C100316 | BPI1-Aching | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: aching. | BPI - Aching | ||
BPI1-Area Hurts Most | C100302 | BPI1-Area Hurts Most | Brief Pain Inventory - On the diagram, put an X on the area that hurts the most. | BPI - Area Hurts Most | ||
BPI1-Areas of Pain | C100301 | BPI1-Areas of Pain | Brief Pain Inventory - On the diagram, shade in the areas where you feel pain. | BPI - Areas of Pain | ||
BPI1-Biofeedback to Relieve Pain | C100351 | BPI1-Biofeedback to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: biofeedback. | BPI - Biofeedback to Relieve Pain | ||
BPI1-Burning | C100323 | BPI1-Burning | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: burning. | BPI - Burning | ||
BPI1-Cold Compresses to Relieve Pain | C100348 | BPI1-Cold Compresses to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: cold compresses. | BPI - Cold Compresses to Relieve Pain | ||
BPI1-Concerned Use Too Much Pain Med | C100342 | BPI1-Concerned Use Too Much Pain Med | Brief Pain Inventory - Are you concerned that you use too much pain medication? | BPI - Concerned with Too Much Pain Medication Use | ||
BPI1-Current Job Status | C100292 | BPI1-Current Job Status | Brief Pain Inventory - Which of the following best describes your current job status? | BPI - Current Job Status | ||
BPI1-Current Occupation | C100290 | BPI1-Current Occupation | Brief Pain Inventory - Current occupation. | BPI - Current Occupation | ||
BPI1-Describe Unrelated Med Condition | C100315 | BPI1-Describe Unrelated Med Condition | Brief Pain Inventory - I believe my pain is due to a medical condition unrelated to my primary disease. Please describe condition. | BPI - Describe Unrelated Medical Condition | ||
BPI1-Distraction to Relieve Pain | C100350 | BPI1-Distraction to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: distraction. | BPI - Distraction to Relieve Pain | ||
BPI1-Education | C100288 | BPI1-Education | Brief Pain Inventory - Education. | BPI - Education | ||
BPI1-Exhausting | C100324 | BPI1-Exhausting | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: exhausting. | BPI - Exhausting | ||
BPI1-Gnawing | C100320 | BPI1-Gnawing | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: gnawing. | BPI - Gnawing | ||
BPI1-Hours before Pain Returns | C100311 | BPI1-Hours before Pain Returns | Brief Pain Inventory - If you take pain medication, how many hours does it take before the pain returns? | BPI - Hours before Pain Returns | ||
BPI1-How Long Since Diagnosis | C100293 | BPI1-How Long Since Diagnosis | Brief Pain Inventory - How long has it been since you first learned your diagnosis? | BPI - How Long Since Diagnosis | ||
BPI1-Hypnosis to Relieve Pain | C100352 | BPI1-Hypnosis to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: hypnosis. | BPI - Hypnosis to Relieve Pain | ||
BPI1-Kind of Surgery in Past Month | C100297 | BPI1-Kind of Surgery in Past Month | Brief Pain Inventory - What kind of surgery have you had in the past month? | BPI - Kind of Surgery in Past Month | ||
BPI1-Marital Status | C100287 | BPI1-Marital Status | Brief Pain Inventory - Marital status. | BPI - Marital Status | ||
BPI1-Meds not Prescribed Taken for Pain | C100355 | BPI1-Meds not Prescribed Taken for Pain | Brief Pain Inventory - Medications not prescribed by my doctor that I take for pain are. | BPI - Medications not Prescribed Taken for Pain | ||
BPI1-Miserable | C100329 | BPI1-Miserable | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: miserable. | BPI - Miserable | ||
BPI1-Nagging | C100327 | BPI1-Nagging | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: nagging. | BPI - Nagging | ||
BPI1-Need Further Info about Pain Med | C100346 | BPI1-Need Further Info about Pain Med | Brief Pain Inventory - Do you feel you need to receive further information about your pain medication? | BPI - Need Further Information about Pain Medication | ||
BPI1-Need more Pain Med than Prescribed | C100341 | BPI1-Need more Pain Med than Prescribed | Brief Pain Inventory - Do you feel you need to take more of the pain medication than your doctor has prescribed? | BPI - Need more Pain Medication than Prescribed | ||
BPI1-Need Stronger Type of Pain Med | C100340 | BPI1-Need Stronger Type of Pain Med | Brief Pain Inventory - Do you feel you need a stronger type of pain medication? | BPI - Need Stronger Type of Pain Medication | ||
BPI1-Numb | C100328 | BPI1-Numb | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: numb. | BPI - Numb | ||
BPI1-Other specify to Relieve Pain | C100354 | BPI1-Other specify to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: other. Please specify. | BPI - Specified Other Method to Relieve Pain | ||
BPI1-Other to Relieve Pain | C100353 | BPI1-Other to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: other. | BPI - Other Methods to Relieve Pain | ||
BPI1-Pain at its Least in Last Week | C100304 | BPI1-Pain at its Least in Last Week | Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain at its least in the last week. | BPI - Pain at its Least in Last Week | ||
BPI1-Pain at its Worst in Last Week | C100303 | BPI1-Pain at its Worst in Last Week | Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain at its worst in the last week. | BPI - Pain at its Worst in Last Week | ||
BPI1-Pain Due to Effects of Treatment | C100312 | BPI1-Pain Due to Effects of Treatment | Brief Pain Inventory - I believe my pain is due to the effects of treatment. | BPI - Pain Due to Effects of Treatment | ||
BPI1-Pain Due to Present Disease | C100294 | BPI1-Pain Due to Present Disease | Brief Pain Inventory - Have you ever had pain due to your present disease? | BPI - Pain Due to Present Disease | ||
BPI1-Pain Due to Primary Disease | C100313 | BPI1-Pain Due to Primary Disease | Brief Pain Inventory - I believe my pain is due to my primary disease. | BPI - Pain Due to Primary Disease | ||
BPI1-Pain Due to Unrelated Med Condition | C100314 | BPI1-Pain Due to Unrelated Med Condition | Brief Pain Inventory - I believe my pain is due to a medical condition unrelated to my primary disease. | BPI - Pain Due to Unrelated Medical Condition | ||
BPI1-Pain Interfered Enjoyment of Life | C100337 | BPI1-Pain Interfered Enjoyment of Life | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your enjoyment of life. | BPI - Pain Interfered with Enjoyment of Life | ||
BPI1-Pain Interfered General Activity | C100331 | BPI1-Pain Interfered General Activity | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your general activity. | BPI - Pain Interfered with General Activity | ||
BPI1-Pain Interfered Walking Ability | C100333 | BPI1-Pain Interfered Walking Ability | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your walking ability. | BPI - Pain Interfered with Walking Ability | ||
BPI1-Pain Interfered with Mood | C100332 | BPI1-Pain Interfered with Mood | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your mood. | BPI - Pain Interfered with Mood | ||
BPI1-Pain Interfered with Normal Work | C100334 | BPI1-Pain Interfered with Normal Work | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your normal work. | BPI - Pain Interfered with Normal Work | ||
BPI1-Pain Interfered with Relations | C100335 | BPI1-Pain Interfered with Relations | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your relations with other people. | BPI - Pain Interfered with Relations | ||
BPI1-Pain Interfered with Sleep | C100336 | BPI1-Pain Interfered with Sleep | Brief Pain Inventory - Circle the one number that describes how, during the past week, pain has interfered with your sleep. | BPI - Pain Interfered with Sleep | ||
BPI1-Pain Medications in the Last 7 Days | C100299 | BPI1-Pain Medications in the Last 7 Days | Brief Pain Inventory - Did you take pain medications in the last 7 days? | BPI - Pain Medications in the Last 7 Days | ||
BPI1-Pain on the Average | C100305 | BPI1-Pain on the Average | Brief Pain Inventory - Please rate your pain by circling the one number that best describes your pain on the average. | BPI - Pain on the Average | ||
BPI1-Pain One of Your Symptoms | C100295 | BPI1-Pain One of Your Symptoms | Brief Pain Inventory - When you first received your diagnosis, was pain one of your symptoms? | BPI - Pain as a Symptom | ||
BPI1-Pain Other than Everyday Kinds | C100298 | BPI1-Pain Other than Everyday Kinds | Brief Pain Inventory - Have you had pain other than these everyday kinds of pain during the last week? | BPI - Pain Other than Everyday Kinds | ||
BPI1-Pain Requires Medication Daily | C100300 | BPI1-Pain Requires Medication Daily | Brief Pain Inventory - I feel I have some form of pain that requires medication each and every day. | BPI - Pain Requires Medication Daily | ||
BPI1-Pain Right Now | C100306 | BPI1-Pain Right Now | Brief Pain Inventory - Please rate your pain by circling the one number that tells how much pain you have right now. | BPI - Pain Right Now | ||
BPI1-Penetrating | C100326 | BPI1-Penetrating | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: penetrating. | BPI - Penetrating | ||
BPI1-Prefer to Take Pain Medicine | C100338 | BPI1-Prefer to Take Pain Medicine | Brief Pain Inventory - I prefer to take my pain medicine. | BPI - Prefer to Take Pain Medicine | ||
BPI1-Problems with Side Effects Pain Med | C100344 | BPI1-Problems with Side Effects Pain Med | Brief Pain Inventory - Are you having problems with side effects from your pain medication? | BPI - Problems with Side Effects Pain Medication | ||
BPI1-Professional Degree | C100289 | BPI1-Professional Degree | Brief Pain Inventory - Education. Professional degree. | BPI - Professional Degree | ||
BPI1-Relaxation Techniques Relieve Pain | C100349 | BPI1-Relaxation Techniques Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: relaxation techniques. | BPI - Relaxation Techniques Relieve Pain | ||
BPI1-Relief Pain Treatments Provided | C100310 | BPI1-Relief Pain Treatments Provided | Brief Pain Inventory - In the last week, how much relief have pain treatments or medications provided? Please circle the one percentage that most shows how much relief you have received. | BPI - Relief Pain Treatments Provided | ||
BPI1-Sharp | C100321 | BPI1-Sharp | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: sharp. | BPI - Sharp | ||
BPI1-Shooting | C100318 | BPI1-Shooting | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: shooting. | BPI - Shooting | ||
BPI1-Spouse's Occupation | C100291 | BPI1-Spouse's Occupation | Brief Pain Inventory - Spouse's occupation. | BPI - Spouse's Occupation | ||
BPI1-Stabbing | C100319 | BPI1-Stabbing | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: stabbing. | BPI - Stabbing | ||
BPI1-Surgery in Past Month | C100296 | BPI1-Surgery in Past Month | Brief Pain Inventory - Have you had surgery in the past month? | BPI - Surgery in Past Month | ||
BPI1-Take my Pain Medicine | C100339 | BPI1-Take my Pain Medicine | Brief Pain Inventory - I take my pain medicine (in a 24 hour period). | BPI - Take my Pain Medicine | ||
BPI1-Tender | C100322 | BPI1-Tender | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: tender. | BPI - Tender | ||
BPI1-Things that Make Pain Feel Better | C100307 | BPI1-Things that Make Pain Feel Better | Brief Pain Inventory - What kinds of things make your pain feel better? | BPI - Things that Make Pain Feel Better | ||
BPI1-Things that Make your Pain Worse | C100308 | BPI1-Things that Make your Pain Worse | Brief Pain Inventory - What kinds of things make your pain feel worse? | BPI - Things that Make your Pain Worse | ||
BPI1-Throbbing | C100317 | BPI1-Throbbing | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: throbbing. | BPI - Throbbing | ||
BPI1-Tiring | C100325 | BPI1-Tiring | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: tiring. | BPI - Tiring | ||
BPI1-Treatments Receiving for Pain | C100309 | BPI1-Treatments Receiving for Pain | Brief Pain Inventory - What treatments or medications are you receiving for your pain? | BPI - Treatments Receiving for Pain | ||
BPI1-Unbearable | C100330 | BPI1-Unbearable | Brief Pain Inventory - Check Yes or No if the adjective applies to your pain: unbearable. | BPI - Unbearable | ||
BPI1-Warm Compresses to Relieve Pain | C100347 | BPI1-Warm Compresses to Relieve Pain | Brief Pain Inventory - Other methods I use to relieve pain include: warm compresses. | BPI - Warm Compresses to Relieve Pain | ||
BPI1-Which Side Effects from Pain Med | C100345 | BPI1-Which Side Effects from Pain Med | Brief Pain Inventory - Are you having problems with side effects from your pain medication? Which side effects? | BPI - What Side Effects from Pain Medication | ||
BPI1-Why Concerned Use Too Much Pain Med | C100343 | BPI1-Why Concerned Use Too Much Pain Med | Brief Pain Inventory - Are you concerned that you use too much pain medication? If Yes, why? | BPI - Why Concerned with Too Much Pain Medication Use | ||
Back to top | ||||||
CL.C100164.BPI2TC | Brief Pain Inventory Short Form Questionnaire Test Code
(BPI2TC) | text
Extensible: No | C100164 | Brief Pain Inventory Short Form Questionnaire Test Code | Brief Pain Inventory Short Form test code. | CDISC Questionnaire BPI Short Form Test Code Terminology |
BPI201 | C100356 | BPI2-Pain Other Than Everyday Kinds | Brief Pain Inventory Short Form - Have you had pain other than these everyday kinds of pain today? | BPI Short Form - Pain Other Than Everyday Kinds | ||
BPI202A | C100357 | BPI2-Areas of Pain | Brief Pain Inventory Short Form - On the diagram, shade in the areas where you feel pain. | BPI Short Form - Areas of Pain | ||
BPI202B | C100358 | BPI2-Area Hurts Most | Brief Pain Inventory Short Form - On the diagram, put an X on the area that hurts the most. | BPI Short Form - Area that Hurts Most | ||
BPI203 | C100359 | BPI2-Pain at its Worst in Last 24 Hours | Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain at its worst in the last 24 hours. | BPI Short Form - Pain at its Worst in Last 24 Hours | ||
BPI204 | C100360 | BPI2-Pain at its Least in Last 24 Hours | Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain at its least in the last 24 hours. | BPI Short Form - Pain at its Least in Last 24 Hours | ||
BPI205 | C100361 | BPI2-Pain on the Average | Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain on the average. | BPI Short Form - Pain on the Average | ||
BPI206 | C100362 | BPI2-Pain Right Now | Brief Pain Inventory Short Form - Please rate your pain by circling the one number that tells how much pain you have right now. | BPI Short Form - Pain Right Now | ||
BPI207 | C100363 | BPI2-Treatments Receiving for Pain | Brief Pain Inventory Short Form - What treatments or medications are you receiving for your pain? | BPI Short Form - Treatments or Medications Receiving for Pain | ||
BPI208 | C100364 | BPI2-Relief Pain Treatments Provided | Brief Pain Inventory Short Form - In the last 24 hours, how much relief have pain treatments or medications provided? Please circle the one percentage that most shows how much relief you have received. | BPI Short Form - Relief from Pain Treatments Provided | ||
BPI209A | C100365 | BPI2-Pain Interfered General Activity | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your general activity. | BPI Short Form - Pain Interfered with General Activity | ||
BPI209B | C100366 | BPI2-Pain Interfered with Mood | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your mood. | BPI Short Form - Pain Interfered with Mood | ||
BPI209C | C100367 | BPI2-Pain Interfered Walking Ability | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your walking ability. | BPI Short Form - Pain Interfered with Walking Ability | ||
BPI209D | C100368 | BPI2-Pain Interfered with Normal Work | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your normal work. | BPI Short Form - Pain Interfered with Normal Work | ||
BPI209E | C100369 | BPI2-Pain Interfered with Relations | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your relations with other people. | BPI Short Form - Pain Interfered with Relations | ||
BPI209F | C100370 | BPI2-Pain Interfered with Sleep | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your sleep. | BPI Short Form - Pain Interfered with Sleep | ||
BPI209G | C100371 | BPI2-Pain Interfered Enjoyment of Life | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your enjoyment of life. | BPI Short Form - Pain Interfered with Enjoyment of Life | ||
Back to top | ||||||
CL.C100163.BPI2TN | Brief Pain Inventory Short Form Questionnaire Test Name
(BPI2TN) | text
Extensible: No | C100163 | Brief Pain Inventory Short Form Questionnaire Test Name | Brief Pain Inventory Short Form test name. | CDISC Questionnaire BPI Short Form Test Name Terminology |
BPI2-Area Hurts Most | C100358 | BPI2-Area Hurts Most | Brief Pain Inventory Short Form - On the diagram, put an X on the area that hurts the most. | BPI Short Form - Area that Hurts Most | ||
BPI2-Areas of Pain | C100357 | BPI2-Areas of Pain | Brief Pain Inventory Short Form - On the diagram, shade in the areas where you feel pain. | BPI Short Form - Areas of Pain | ||
BPI2-Pain at its Least in Last 24 Hours | C100360 | BPI2-Pain at its Least in Last 24 Hours | Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain at its least in the last 24 hours. | BPI Short Form - Pain at its Least in Last 24 Hours | ||
BPI2-Pain at its Worst in Last 24 Hours | C100359 | BPI2-Pain at its Worst in Last 24 Hours | Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain at its worst in the last 24 hours. | BPI Short Form - Pain at its Worst in Last 24 Hours | ||
BPI2-Pain Interfered Enjoyment of Life | C100371 | BPI2-Pain Interfered Enjoyment of Life | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your enjoyment of life. | BPI Short Form - Pain Interfered with Enjoyment of Life | ||
BPI2-Pain Interfered General Activity | C100365 | BPI2-Pain Interfered General Activity | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your general activity. | BPI Short Form - Pain Interfered with General Activity | ||
BPI2-Pain Interfered Walking Ability | C100367 | BPI2-Pain Interfered Walking Ability | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your walking ability. | BPI Short Form - Pain Interfered with Walking Ability | ||
BPI2-Pain Interfered with Mood | C100366 | BPI2-Pain Interfered with Mood | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your mood. | BPI Short Form - Pain Interfered with Mood | ||
BPI2-Pain Interfered with Normal Work | C100368 | BPI2-Pain Interfered with Normal Work | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your normal work. | BPI Short Form - Pain Interfered with Normal Work | ||
BPI2-Pain Interfered with Relations | C100369 | BPI2-Pain Interfered with Relations | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your relations with other people. | BPI Short Form - Pain Interfered with Relations | ||
BPI2-Pain Interfered with Sleep | C100370 | BPI2-Pain Interfered with Sleep | Brief Pain Inventory Short Form - Circle the one number that describes how, during the past 24 hours, pain has interfered with your sleep. | BPI Short Form - Pain Interfered with Sleep | ||
BPI2-Pain on the Average | C100361 | BPI2-Pain on the Average | Brief Pain Inventory Short Form - Please rate your pain by circling the one number that best describes your pain on the average. | BPI Short Form - Pain on the Average | ||
BPI2-Pain Other Than Everyday Kinds | C100356 | BPI2-Pain Other Than Everyday Kinds | Brief Pain Inventory Short Form - Have you had pain other than these everyday kinds of pain today? | BPI Short Form - Pain Other Than Everyday Kinds | ||
BPI2-Pain Right Now | C100362 | BPI2-Pain Right Now | Brief Pain Inventory Short Form - Please rate your pain by circling the one number that tells how much pain you have right now. | BPI Short Form - Pain Right Now | ||
BPI2-Relief Pain Treatments Provided | C100364 | BPI2-Relief Pain Treatments Provided | Brief Pain Inventory Short Form - In the last 24 hours, how much relief have pain treatments or medications provided? Please circle the one percentage that most shows how much relief you have received. | BPI Short Form - Relief from Pain Treatments Provided | ||
BPI2-Treatments Receiving for Pain | C100363 | BPI2-Treatments Receiving for Pain | Brief Pain Inventory Short Form - What treatments or medications are you receiving for your pain? | BPI Short Form - Treatments or Medications Receiving for Pain | ||
Back to top | ||||||
CL.C161625.BPRS01TC | Brief Psychiatric Rating Scale 1988 Version Clinical Classification Test Code
(BPRS01TC) | text
Extensible: No | C161625 | Brief Psychiatric Rating Scale 1988 Version Clinical Classification Test Code | Brief Psychiatric Rating Scale 1988 Version test code. | CDISC Clinical Classification BPRS 1988 Version Test Code Terminology |
BPRS0101 | C161741 | BPRS01-Somatic Concern | Brief Psychiatric Rating Scale 1988 Version - Somatic concern. | BPRS 1988 Version - Somatic Concern | ||
BPRS0102 | C161742 | BPRS01-Anxiety | Brief Psychiatric Rating Scale 1988 Version - Anxiety. | BPRS 1988 Version - Anxiety | ||
BPRS0103 | C161743 | BPRS01-Emotional Withdrawal | Brief Psychiatric Rating Scale 1988 Version - Emotional withdrawal. | BPRS 1988 Version - Emotional Withdrawal | ||
BPRS0104 | C161744 | BPRS01-Conceptual Disorganization | Brief Psychiatric Rating Scale 1988 Version - Conceptual disorganization. | BPRS 1988 Version - Conceptual Disorganization | ||
BPRS0105 | C161745 | BPRS01-Guilt Feelings | Brief Psychiatric Rating Scale 1988 Version - Guilt feelings. | BPRS 1988 Version - Guilt Feelings | ||
BPRS0106 | C161746 | BPRS01-Tension | Brief Psychiatric Rating Scale 1988 Version - Tension. | BPRS 1988 Version - Tension | ||
BPRS0107 | C161747 | BPRS01-Mannerisms and Posturing | Brief Psychiatric Rating Scale 1988 Version - Mannerisms and posturing. | BPRS 1988 Version - Mannerisms and Posturing | ||
BPRS0108 | C161748 | BPRS01-Grandiosity | Brief Psychiatric Rating Scale 1988 Version - Grandiosity. | BPRS 1988 Version - Grandiosity | ||
BPRS0109 | C161749 | BPRS01-Depressive Mood | Brief Psychiatric Rating Scale 1988 Version - Depressive mood. | BPRS 1988 Version - Depressive Mood | ||
BPRS0110 | C161750 | BPRS01-Hostility | Brief Psychiatric Rating Scale 1988 Version - Hostility. | BPRS 1988 Version - Hostility | ||
BPRS0111 | C161751 | BPRS01-Suspiciousness | Brief Psychiatric Rating Scale 1988 Version - Suspiciousness. | BPRS 1988 Version - Suspiciousness | ||
BPRS0112 | C161752 | BPRS01-Hallucinatory Behavior | Brief Psychiatric Rating Scale 1988 Version - Hallucinatory behavior. | BPRS 1988 Version - Hallucinatory Behavior | ||
BPRS0113 | C161753 | BPRS01-Motor Retardation | Brief Psychiatric Rating Scale 1988 Version - Motor retardation. | BPRS 1988 Version - Motor Retardation | ||
BPRS0114 | C161754 | BPRS01-Uncooperativeness | Brief Psychiatric Rating Scale 1988 Version - Uncooperativeness. | BPRS 1988 Version - Uncooperativeness | ||
BPRS0115 | C161755 | BPRS01-Unusual Thought Content | Brief Psychiatric Rating Scale 1988 Version - Unusual thought content. | BPRS 1988 Version - Unusual Thought Content | ||
BPRS0116 | C161756 | BPRS01-Blunted Affect | Brief Psychiatric Rating Scale 1988 Version - Blunted affect. | BPRS 1988 Version - Blunted Affect | ||
BPRS0117 | C161757 | BPRS01-Excitement | Brief Psychiatric Rating Scale 1988 Version - Excitement. | BPRS 1988 Version - Excitement | ||
BPRS0118 | C161758 | BPRS01-Disorientation | Brief Psychiatric Rating Scale 1988 Version - Disorientation. | BPRS 1988 Version - Disorientation | ||
BPRS0119 | C161759 | BPRS01-Total Score | Brief Psychiatric Rating Scale 1988 Version - Total score. | BPRS 1988 Version - Total Score | ||
Back to top | ||||||
CL.C161624.BPRS01TN | Brief Psychiatric Rating Scale 1988 Version Clinical Classification Test Name
(BPRS01TN) | text
Extensible: No | C161624 | Brief Psychiatric Rating Scale 1988 Version Clinical Classification Test Name | Brief Psychiatric Rating Scale 1988 Version test name. | CDISC Clinical Classification BPRS 1988 Version Test Name Terminology |
BPRS01-Anxiety | C161742 | BPRS01-Anxiety | Brief Psychiatric Rating Scale 1988 Version - Anxiety. | BPRS 1988 Version - Anxiety | ||
BPRS01-Blunted Affect | C161756 | BPRS01-Blunted Affect | Brief Psychiatric Rating Scale 1988 Version - Blunted affect. | BPRS 1988 Version - Blunted Affect | ||
BPRS01-Conceptual Disorganization | C161744 | BPRS01-Conceptual Disorganization | Brief Psychiatric Rating Scale 1988 Version - Conceptual disorganization. | BPRS 1988 Version - Conceptual Disorganization | ||
BPRS01-Depressive Mood | C161749 | BPRS01-Depressive Mood | Brief Psychiatric Rating Scale 1988 Version - Depressive mood. | BPRS 1988 Version - Depressive Mood | ||
BPRS01-Disorientation | C161758 | BPRS01-Disorientation | Brief Psychiatric Rating Scale 1988 Version - Disorientation. | BPRS 1988 Version - Disorientation | ||
BPRS01-Emotional Withdrawal | C161743 | BPRS01-Emotional Withdrawal | Brief Psychiatric Rating Scale 1988 Version - Emotional withdrawal. | BPRS 1988 Version - Emotional Withdrawal | ||
BPRS01-Excitement | C161757 | BPRS01-Excitement | Brief Psychiatric Rating Scale 1988 Version - Excitement. | BPRS 1988 Version - Excitement | ||
BPRS01-Grandiosity | C161748 | BPRS01-Grandiosity | Brief Psychiatric Rating Scale 1988 Version - Grandiosity. | BPRS 1988 Version - Grandiosity | ||
BPRS01-Guilt Feelings | C161745 | BPRS01-Guilt Feelings | Brief Psychiatric Rating Scale 1988 Version - Guilt feelings. | BPRS 1988 Version - Guilt Feelings | ||
BPRS01-Hallucinatory Behavior | C161752 | BPRS01-Hallucinatory Behavior | Brief Psychiatric Rating Scale 1988 Version - Hallucinatory behavior. | BPRS 1988 Version - Hallucinatory Behavior | ||
BPRS01-Hostility | C161750 | BPRS01-Hostility | Brief Psychiatric Rating Scale 1988 Version - Hostility. | BPRS 1988 Version - Hostility | ||
BPRS01-Mannerisms and Posturing | C161747 | BPRS01-Mannerisms and Posturing | Brief Psychiatric Rating Scale 1988 Version - Mannerisms and posturing. | BPRS 1988 Version - Mannerisms and Posturing | ||
BPRS01-Motor Retardation | C161753 | BPRS01-Motor Retardation | Brief Psychiatric Rating Scale 1988 Version - Motor retardation. | BPRS 1988 Version - Motor Retardation | ||
BPRS01-Somatic Concern | C161741 | BPRS01-Somatic Concern | Brief Psychiatric Rating Scale 1988 Version - Somatic concern. | BPRS 1988 Version - Somatic Concern | ||
BPRS01-Suspiciousness | C161751 | BPRS01-Suspiciousness | Brief Psychiatric Rating Scale 1988 Version - Suspiciousness. | BPRS 1988 Version - Suspiciousness | ||
BPRS01-Tension | C161746 | BPRS01-Tension | Brief Psychiatric Rating Scale 1988 Version - Tension. | BPRS 1988 Version - Tension | ||
BPRS01-Total Score | C161759 | BPRS01-Total Score | Brief Psychiatric Rating Scale 1988 Version - Total score. | BPRS 1988 Version - Total Score | ||
BPRS01-Uncooperativeness | C161754 | BPRS01-Uncooperativeness | Brief Psychiatric Rating Scale 1988 Version - Uncooperativeness. | BPRS 1988 Version - Uncooperativeness | ||
BPRS01-Unusual Thought Content | C161755 | BPRS01-Unusual Thought Content | Brief Psychiatric Rating Scale 1988 Version - Unusual thought content. | BPRS 1988 Version - Unusual Thought Content | ||
Back to top | ||||||
CL.C189693.BPRSA118OR | Brief Psychiatric Rating Scale-Anchored Clinical Classification ORRES for BPRSA118 TN/TC
(BPRSA118OR) | text
Extensible: No | C189693 | Brief Psychiatric Rating Scale-Anchored Clinical Classification ORRES for BPRSA118 TN/TC | Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 test and test code. | CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Response Terminology |
Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or Not assessed | C189740 | BPRSA118-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness;or Not assessed | Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or not assessed. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Cannot be Assessed Adequately Because of Severe Formal Thought Disorder, Uncooperativeness, or Marked Evasiveness/Guardedness; or Not Assessed | ||
Mild | C189735 | BPRSA118-Mild | Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Mild. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Mild | ||
Moderate | C189736 | BPRSA118-Moderate | Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Moderate. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Moderate | ||
Moderately Severe | C189737 | BPRSA118-Moderately Severe | Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Moderately severe. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Moderately Severe | ||
Not observed | C189733 | BPRSA118-Not observed | Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Not observed. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Not Observed | ||
Severe | C189738 | BPRSA118-Severe | Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Severe. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Severe | ||
Very Mild | C189734 | BPRSA118-Very Mild | Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Very mild. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Very Mild | ||
Very Severe | C189739 | BPRSA118-Very Severe | Brief Psychiatric Rating Scale-Anchored original result for BPRSA118 with response-Very severe. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Original Result - Very Severe | ||
Back to top | ||||||
CL.C189689.BPRSA1SET1OR | Brief Psychiatric Rating Scale-Anchored Clinical Classification ORRES the Same as BPRSA101 TN/TC
(BPRSA1SET1OR) | text
Extensible: No | C189689 | Brief Psychiatric Rating Scale-Anchored Clinical Classification ORRES the Same as BPRSA101 TN/TC | Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115 test and test code. | CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Response Terminology |
Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or Not assessed | C189710 | BPRSA1SET1-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness;or Not assessed | Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or not assessed. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Cannot be Assessed Adequately Because of Severe Formal Thought Disorder, Uncooperativeness, or Marked Evasiveness/Guardedness; or Not Assessed | ||
Mild | C189705 | BPRSA1SET1-Mild | Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Mild. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Mild | ||
Moderate | C189706 | BPRSA1SET1-Moderate | Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Moderate. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Moderate | ||
Moderately Severe | C189707 | BPRSA1SET1-Moderately Severe | Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Moderately severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Moderately Severe | ||
Not reported | C189703 | BPRSA1SET1-Not reported | Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Not reported. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Not Reported | ||
Severe | C189708 | BPRSA1SET1-Severe | Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Severe | ||
Very Mild | C189704 | BPRSA1SET1-Very Mild | Brief Psychiatric Rating Scale-Anchored original result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Very mild. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Very Mild | ||
Very Severe | C189709 | BPRSA1SET1-Very Severe | Brief Psychiatric Rating Scale-Anchored original result for BPRSA101 and items with equivalent response set-Very severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Original Result - Very Severe | ||
Back to top | ||||||
CL.C189691.BPRSA1SET2OR | Brief Psychiatric Rating Scale-Anchored Clinical Classification ORRES the Same as BPRSA103 TN/TC
(BPRSA1SET2OR) | text
Extensible: No | C189691 | Brief Psychiatric Rating Scale-Anchored Clinical Classification ORRES the Same as BPRSA103 TN/TC | Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117 test and test code. | CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Response Terminology |
Mild | C189721 | BPRSA1SET2-Mild | Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Mild. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Mild | ||
Moderate | C189722 | BPRSA1SET2-Moderate | Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Moderate. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Moderate | ||
Moderately Severe | C189723 | BPRSA1SET2-Moderately Severe | Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Moderately severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Moderately Severe | ||
Not observed | C189719 | BPRSA1SET2-Not observed | Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Not observed. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Not observed | ||
Severe | C189724 | BPRSA1SET2-Severe | Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Severe | ||
Very Mild | C189720 | BPRSA1SET2-Very Mild | Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Very mild. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Very Mild | ||
Very Severe | C189725 | BPRSA1SET2-Very Severe | Brief Psychiatric Rating Scale-Anchored original result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Very severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Original Result - Very Severe | ||
Back to top | ||||||
CL.C189694.BPRSA118STR | Brief Psychiatric Rating Scale-Anchored Clinical Classification STRESC for BPRSA118 TN/TC
(BPRSA118STR) | text
Extensible: No | C189694 | Brief Psychiatric Rating Scale-Anchored Clinical Classification STRESC for BPRSA118 TN/TC | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118 test and test code. | CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Response Terminology |
1 | C189741 | BPRSA118-1 | Brief Psychiatric Rating Scale-Anchored standardized character result BPRSA118-Not observed. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 1 | ||
2 | C189742 | BPRSA118-2 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Very mild. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 2 | ||
3 | C189743 | BPRSA118-3 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Mild. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 3 | ||
4 | C189744 | BPRSA118-4 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Moderate. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 4 | ||
5 | C189745 | BPRSA118-5 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Moderately severe. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 5 | ||
6 | C189746 | BPRSA118-6 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Severe. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 6 | ||
7 | C189747 | BPRSA118-7 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Very severe. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 7 | ||
9 | C189748 | BPRSA118-9 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA118-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or not assessed. | Brief Psychiatric Rating Scale-Anchored BPRSA118 Standardized Character Result 9 | ||
Back to top | ||||||
CL.C189690.BPRSA1SET1STR | Brief Psychiatric Rating Scale-Anchored Clinical Classification STRESC the Same as BPRSA101 TN/TC
(BPRSA1SET1STR) | text
Extensible: No | C189690 | Brief Psychiatric Rating Scale-Anchored Clinical Classification STRESC the Same as BPRSA101 TN/TC | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115 test and test code. | CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Response Terminology |
1 | C189711 | BPRSA1SET1-1 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Not reported. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 1 | ||
2 | C189712 | BPRSA1SET1-2 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Very mild. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 2 | ||
3 | C189713 | BPRSA1SET1-3 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Mild. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 3 | ||
4 | C189714 | BPRSA1SET1-4 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Moderate. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 4 | ||
5 | C189715 | BPRSA1SET1-5 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Moderately severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 5 | ||
6 | C189716 | BPRSA1SET1-6 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 6 | ||
7 | C189717 | BPRSA1SET1-7 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Very severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 7 | ||
9 | C189718 | BPRSA1SET1-9 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA101, BPRSA102, BPRSA105, BPRSA108, BPRSA109, BPRSA110, BPRSA111, BPRSA112, and BPRSA115-Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or not assessed. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET1 Standardized Character Result 9 | ||
Back to top | ||||||
CL.C189692.BPRSA1SET2STR | Brief Psychiatric Rating Scale-Anchored Clinical Classification STRESC the Same as BPRSA103 TN/TC
(BPRSA1SET2STR) | text
Extensible: No | C189692 | Brief Psychiatric Rating Scale-Anchored Clinical Classification STRESC the Same as BPRSA103 TN/TC | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117 test and test code. | CDISC Clinical Classification Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Response Terminology |
1 | C189726 | BPRSA1SET2-1 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Not observed. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 1 | ||
2 | C189727 | BPRSA1SET2-2 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Very mild. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 2 | ||
3 | C189728 | BPRSA1SET2-3 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Mild. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 3 | ||
4 | C189729 | BPRSA1SET2-4 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Moderate. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 4 | ||
5 | C189730 | BPRSA1SET2-5 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Moderately severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 5 | ||
6 | C189731 | BPRSA1SET2-6 | Brief Psychiatric Rating Scale-Anchored standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 6 | ||
7 | C189732 | BPRSA1SET2-7 | Brief Psychiatric Rating Scale-Anchored Standardized character result for BPRSA103, BPRSA104, BPRSA106, BPRSA107, BPRSA113, BPRSA114, BPRSA116, and BPRSA117-Very severe. | Brief Psychiatric Rating Scale-Anchored BPRSA1SET2 Standardized Character Result 7 | ||
Back to top | ||||||
CL.C100134.BPRSA1TC | Brief Psychiatric Rating Scale-Anchored Clinical Classification Test Code
(BPRSA1TC) | text
Extensible: No | C100134 | Brief Psychiatric Rating Scale-Anchored Clinical Classification Test Code | The Brief Psychiatric Rating Scale-Anchored test code. | CDISC Clinical Classification BPRS-Anchored Test Code Terminology |
BPRSA101 | C100372 | BPRSA1-Somatic Concern | Brief Psychiatric Rating Scale-Anchored - Somatic Concern. | BPRS-Anchored - Somatic Concern | ||
BPRSA102 | C100373 | BPRSA1-Anxiety | Brief Psychiatric Rating Scale-Anchored - Anxiety. | BPRS-Anchored - Anxiety | ||
BPRSA103 | C100374 | BPRSA1-Emotional Withdrawal | Brief Psychiatric Rating Scale-Anchored - Emotional Withdrawal. | BPRS-Anchored - Emotional Withdrawal | ||
BPRSA104 | C100375 | BPRSA1-Conceptual Disorganization | Brief Psychiatric Rating Scale-Anchored - Conceptual Disorganization. | BPRS-Anchored - Conceptual Disorganization | ||
BPRSA105 | C100376 | BPRSA1-Guilt Feelings | Brief Psychiatric Rating Scale-Anchored - Guilt Feelings. | BPRS-Anchored - Guilt Feelings | ||
BPRSA106 | C100377 | BPRSA1-Tension | Brief Psychiatric Rating Scale-Anchored - Tension. | BPRS-Anchored - Tension | ||
BPRSA107 | C100378 | BPRSA1-Mannerisms and Posturing | Brief Psychiatric Rating Scale-Anchored - Mannerisms and Posturing. | BPRS-Anchored - Mannerisms and Posturing | ||
BPRSA108 | C100379 | BPRSA1-Grandiosity | Brief Psychiatric Rating Scale-Anchored - Grandiosity. | BPRS-Anchored - Grandiosity | ||
BPRSA109 | C100380 | BPRSA1-Depressive Mood | Brief Psychiatric Rating Scale-Anchored - Depressive Mood. | BPRS-Anchored - Depressive Mood | ||
BPRSA110 | C100381 | BPRSA1-Hostility | Brief Psychiatric Rating Scale-Anchored - Hostility. | BPRS-Anchored - Hostility | ||
BPRSA111 | C100382 | BPRSA1-Suspiciousness | Brief Psychiatric Rating Scale-Anchored - Suspiciousness. | BPRS-Anchored - Suspiciousness | ||
BPRSA112 | C100383 | BPRSA1-Hallucinatory Behavior | Brief Psychiatric Rating Scale-Anchored - Hallucinatory Behavior. | BPRS-Anchored - Hallucinatory Behavior | ||
BPRSA113 | C100384 | BPRSA1-Motor Retardation | Brief Psychiatric Rating Scale-Anchored - Motor Retardation. | BPRS-Anchored - Motor Retardation | ||
BPRSA114 | C100385 | BPRSA1-Uncooperativeness | Brief Psychiatric Rating Scale-Anchored - Uncooperativeness. | BPRS-Anchored - Uncooperativeness | ||
BPRSA115 | C100386 | BPRSA1-Unusual Thought Content | Brief Psychiatric Rating Scale-Anchored - Unusual Thought Content. | BPRS-Anchored - Unusual Thought Content | ||
BPRSA116 | C100387 | BPRSA1-Blunted Affect | Brief Psychiatric Rating Scale-Anchored - Blunted Affect. | BPRS-Anchored - Blunted Affect | ||
BPRSA117 | C100388 | BPRSA1-Excitement | Brief Psychiatric Rating Scale-Anchored - Excitement. | BPRS-Anchored - Excitement | ||
BPRSA118 | C100389 | BPRSA1-Disorientation | Brief Psychiatric Rating Scale-Anchored - Disorientation. | BPRS-Anchored - Disorientation | ||
Back to top | ||||||
CL.C100133.BPRSA1TN | Brief Psychiatric Rating Scale-Anchored Clinical Classification Test Name
(BPRSA1TN) | text
Extensible: No | C100133 | Brief Psychiatric Rating Scale-Anchored Clinical Classification Test Name | The Brief Psychiatric Rating Scale-Anchored test name. | CDISC Clinical Classification BPRS-Anchored Test Name Terminology |
BPRSA1-Anxiety | C100373 | BPRSA1-Anxiety | Brief Psychiatric Rating Scale-Anchored - Anxiety. | BPRS-Anchored - Anxiety | ||
BPRSA1-Blunted Affect | C100387 | BPRSA1-Blunted Affect | Brief Psychiatric Rating Scale-Anchored - Blunted Affect. | BPRS-Anchored - Blunted Affect | ||
BPRSA1-Conceptual Disorganization | C100375 | BPRSA1-Conceptual Disorganization | Brief Psychiatric Rating Scale-Anchored - Conceptual Disorganization. | BPRS-Anchored - Conceptual Disorganization | ||
BPRSA1-Depressive Mood | C100380 | BPRSA1-Depressive Mood | Brief Psychiatric Rating Scale-Anchored - Depressive Mood. | BPRS-Anchored - Depressive Mood | ||
BPRSA1-Disorientation | C100389 | BPRSA1-Disorientation | Brief Psychiatric Rating Scale-Anchored - Disorientation. | BPRS-Anchored - Disorientation | ||
BPRSA1-Emotional Withdrawal | C100374 | BPRSA1-Emotional Withdrawal | Brief Psychiatric Rating Scale-Anchored - Emotional Withdrawal. | BPRS-Anchored - Emotional Withdrawal | ||
BPRSA1-Excitement | C100388 | BPRSA1-Excitement | Brief Psychiatric Rating Scale-Anchored - Excitement. | BPRS-Anchored - Excitement | ||
BPRSA1-Grandiosity | C100379 | BPRSA1-Grandiosity | Brief Psychiatric Rating Scale-Anchored - Grandiosity. | BPRS-Anchored - Grandiosity | ||
BPRSA1-Guilt Feelings | C100376 | BPRSA1-Guilt Feelings | Brief Psychiatric Rating Scale-Anchored - Guilt Feelings. | BPRS-Anchored - Guilt Feelings | ||
BPRSA1-Hallucinatory Behavior | C100383 | BPRSA1-Hallucinatory Behavior | Brief Psychiatric Rating Scale-Anchored - Hallucinatory Behavior. | BPRS-Anchored - Hallucinatory Behavior | ||
BPRSA1-Hostility | C100381 | BPRSA1-Hostility | Brief Psychiatric Rating Scale-Anchored - Hostility. | BPRS-Anchored - Hostility | ||
BPRSA1-Mannerisms and Posturing | C100378 | BPRSA1-Mannerisms and Posturing | Brief Psychiatric Rating Scale-Anchored - Mannerisms and Posturing. | BPRS-Anchored - Mannerisms and Posturing | ||
BPRSA1-Motor Retardation | C100384 | BPRSA1-Motor Retardation | Brief Psychiatric Rating Scale-Anchored - Motor Retardation. | BPRS-Anchored - Motor Retardation | ||
BPRSA1-Somatic Concern | C100372 | BPRSA1-Somatic Concern | Brief Psychiatric Rating Scale-Anchored - Somatic Concern. | BPRS-Anchored - Somatic Concern | ||
BPRSA1-Suspiciousness | C100382 | BPRSA1-Suspiciousness | Brief Psychiatric Rating Scale-Anchored - Suspiciousness. | BPRS-Anchored - Suspiciousness | ||
BPRSA1-Tension | C100377 | BPRSA1-Tension | Brief Psychiatric Rating Scale-Anchored - Tension. | BPRS-Anchored - Tension | ||
BPRSA1-Uncooperativeness | C100385 | BPRSA1-Uncooperativeness | Brief Psychiatric Rating Scale-Anchored - Uncooperativeness. | BPRS-Anchored - Uncooperativeness | ||
BPRSA1-Unusual Thought Content | C100386 | BPRSA1-Unusual Thought Content | Brief Psychiatric Rating Scale-Anchored - Unusual Thought Content. | BPRS-Anchored - Unusual Thought Content | ||
Back to top | ||||||
CL.C130239.BUERS1TC | Brooke Upper Extremity Rating Scale Clinical Classification Test Code
(BUERS1TC) | text
Extensible: No | C130239 | Brooke Upper Extremity Rating Scale Clinical Classification Test Code | Brooke Upper Extremity Rating Scale test code. | CDISC Clinical Classification BUERS Test Code Terminology |
BUERS101 | C130326 | BUERS1-Brooke Upper Extremity Rating | Brooke Upper Extremity Rating Scale - Brooke upper extremity rating scale. | BUERS - Brooke Upper Extremity Rating Scale | ||
Back to top | ||||||
CL.C130238.BUERS1TN | Brooke Upper Extremity Rating Scale Clinical Classification Test Name
(BUERS1TN) | text
Extensible: No | C130238 | Brooke Upper Extremity Rating Scale Clinical Classification Test Name | Brooke Upper Extremity Rating Scale test name. | CDISC Clinical Classification BUERS Test Name Terminology |
BUERS1-Brooke Upper Extremity Rating | C130326 | BUERS1-Brooke Upper Extremity Rating | Brooke Upper Extremity Rating Scale - Brooke upper extremity rating scale. | BUERS - Brooke Upper Extremity Rating Scale | ||
Back to top | ||||||
CL.C101842.CACRDSC | Canadian Cardiovascular Society Classification
(CACRDSC) | text
Extensible: No | C101842 | Canadian Cardiovascular Society Classification | The anginal classifications as measured by the Canadian Cardiovascular Society grading scale. | CDISC SDTM Canadian Cardiovascular Society Classification Terminology |
CCS CLASS 1 | C77265 | Canadian Cardiovascular Society Classification 1 | Ordinary physical activity, such as walking or climbing stairs, does not cause angina. Angina occurs with strenuous, rapid, or prolonged exertion at work or recreation. | Canadian Cardiovascular Society Grading Scale Class I | ||
CCS CLASS 2 | C77266 | Canadian Cardiovascular Society Classification 2 | Slight limitation of ordinary activity. Angina occurs on walking or climbing stairs rapidly, walking uphill, walking or climbing stairs after meals, or in cold, in wind, or under emotional stress, or only during the few hours after awakening. Angina occurs on walking more than 2 blocks on the level and climbing more than 1 flight of ordinary stairs at a normal pace and in normal conditions. | Canadian Cardiovascular Society Grading Scale Class II | ||
CCS CLASS 3 | C77267 | Canadian Cardiovascular Society Classification 3 | Marked limitations of ordinary physical activity. Angina occurs on walking 1 to 2 blocks on the level and climbing 1 flight of stairs in normal conditions and at a normal pace. | Canadian Cardiovascular Society Grading Scale Class III | ||
CCS CLASS 4 | C77268 | Canadian Cardiovascular Society Classification 4 | Inability to perform any physical activity without discomfort - anginal symptoms may be present at rest. | Canadian Cardiovascular Society Grading Scale Class IV | ||
Back to top | ||||||
CL.C101859.CVPRCIND | Cardiac Procedure Indication
(CVPRCIND) | text
Extensible: Yes | C101859 | Cardiac Procedure Indication | The reason that a subject had a cardiac procedure. | CDISC SDTM Cardiac Procedure Indication Terminology |
CANDIDATE TO RECEIVE CARDIAC TRANSPLANT | C99919 | The intended recipient of a heart transplant. | Candidate to Receive Cardiac Transplant | |||
CARDIAC ARREST/ARRHYTHMIA ETIOLOGY UNKNOWN | C100033 | An episode of cardiac arrest or arrhythmia where the etiology was unknown. | Cardiac Arrest/Arrhythmia Etiology Unknown | |||
CARDIOMYOPATHY | C34830 | A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive. | Cardiomyopathy | |||
CHRONIC TOTAL OCCLUSION | C99938 | A longstanding, complete blockage of a vessel. | Chronic Total Occlusion Vessel | |||
DONOR FOR CARDIAC TRANSPLANT | C99947 | The subject contributing a heart for a cardiac transplant. | Donor for Cardiac Transplant | |||
END OF EXPECTED BATTERY LIFE | C99949 | The battery that supplies the device has reached the end of its life. | End of Expected Battery Life | |||
FAULTY CONNECTOR/HEADER | C100035 | There is a faulty connector/header in the device. | Faulty Device Connector/Header | |||
GENERATOR IS BEING REPLACED AT THE TIME OF LEAD REVISION | C99925 | A cardiac lead requires revision, at which time the generator to the device will be replaced. | Cardiac Device Generator is Being Replaced at Time of Lead Revision | |||
GENERATOR MALFUNCTION | C99943 | The device has a generator malfunction. | Device Generator Malfunction | |||
IMMEDIATE PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) | C99961 | An immediate percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation. | Immediate Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction | |||
INFECTION | C26726 | A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. (NCI) | Infectious Disorder | |||
LEAD EROSION | C99931 | A cardiac lead has damaged local tissue enough to require treatment. | Cardiac Lead Erosion | |||
LEFT VENTRICULAR SYSTOLIC DYSFUNCTION | C64251 | The degree of impairment of the left cardiac ventricle to contract efficiently. | Left Ventricular Systolic Dysfunction | |||
MANUFACTURER RECALL | C100045 | An imperative issued by the manufacturer of a device that the device needs to be returned to a designated source for repair or replacement. | Manufacturer Recall | |||
MANUFACTURER RECOGNIZED A RECURRING PERFORMANCE FAILURE | C99980 | The device manufacturer had recognized a recurrent performance failure in the device. | Manufacturer Recognized a Recurring Performance Failure | |||
MEDICAL CONDITION OR PROCEDURE AFFECTS IMPLANTATION SITE | C99982 | The medical condition or the procedure affects the device implantation site. | Medical Condition or Procedure Affects Implantation Site | |||
MEDICAL OR SURGICAL PROCEDURE REQUIRING RELOCATION OF LEAD | C99983 | An intended medical or surgical procedure necessitates the relocation of a cardiac lead. | Medical or Surgical Procedure Requiring Relocation of Lead | |||
PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR HIGH RISK NON-ST ELEVATION MYOCARDIAL INFARCTION OR UNSTABLE ANGINA | C99999 | Includes patients with unstable angina or Non-STEMI who have high risk features for short-term risk of death or nonfatal MI. High risk features includes at least one of the following: history of accelerating tempo of ischemic symptoms in preceding 48 hours; character of pain - prolonged ongoing (greater than 20 minutes) rest pain; clinical findings - pulmonary edema, most likely due to ischemia or new or worsening mitral regurgitation murmur; or S3 or new worsening rales or Hypotension, bradycardia, tachycardia or age greater than 75 years; ECG - angina at rest with transient ST-segment changes greater than 0.5 mm or bundle-branch block, new or presumed new or sustained ventricular tachycardia; cardiac markers - NSTEMI patients with elevated cardiac TnT, Tnl, or CK-MB. | Percutaneous Coronary Intervention for High Risk Non-ST Elevation Myocardial Infarction or Unstable Angina | |||
PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (STABLE AFTER SUCCESSFUL FULL-DOSE THROMBOLYTICS) | C100001 | A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia after a successful dose of thrombolytic therapy. | Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable After Successful Full-Dose Thrombolytic Therapy | |||
PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (STABLE, >12 HRS FROM SYMPTOM ONSET) | C100000 | A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is past twelve hours since onset of symptoms. | Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable-Over 12 Hours From Symptom Onset | |||
PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (UNSTABLE, >12 HRS FROM SYMPTOM ONSET) | C100002 | A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject has recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is past twelve hours since onset of symptoms. | Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Unstable-Over 12 Hours From Symptom Onset | |||
POST-CARDIAC TRANSPLANT | C100005 | A procedure to evaluate the health of the an individual after receiving a heart transplant. | Post-Cardiac Transplant Evaluation | |||
PRE-OPERATIVE EVALUATION FOR NON-CARDIOVASCULAR SURGERY | C100006 | A procedure to evaluate the health of the cardiac system to determine feasibility of a non-cardiac related surgical procedure. | Pre-Operative Evaluation for Non-Cardiovascular Surgery | |||
PRIMARY PREVENTION | C15306 | A procedure performed to avoid the first occurrence of a disease condition. | Primary Prevention | |||
RESCUE PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (AFTER FAILED FULL-DOSE THROMBOLYTICS) | C100008 | A percutaneous coronary intervention is imperative for a myocardial infarction that presents with ST segment elevation after an unsatisfactory response to a full dose of thrombolytic therapy. | Rescue Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction After Failed Full-Dose Thrombolytic Therapy | |||
SECONDARY PREVENTION | C15712 | A procedure performed to avoid a subsequent occurrence of a disease condition. | Secondary Prevention | |||
SPONTANEOUS SUSTAINED VENTRICULAR TACHYCARDIA | C100014 | Ventricular tachycardia that occurs without provocation and does not resolve spontaneously. | Spontaneous Sustained Ventricular Tachycardia by ECG Finding | |||
STAGED PERCUTANEOUS CORONARY INTERVENTION (PCI) | C100015 | A subsequent Percutaneous Coronary Intervention in a planned series of procedures, where the first PCI could have been during a prior admission, or during this admission. | Staged Percutaneous Coronary Intervention | |||
SYNCOPE WITH HIGH RISK CHARACTERISTICS | C100018 | A sudden loss of consciousness with loss of postural tone not related to anesthesia with high risk characteristics. High risk characteristics include non-ischemic dilated cardiomyopathy, or ischemic heart disease with significant ventricular dysfunction, hypertrophic cardiomyopathy, Brugada Syndrome, or Long QT Syndrome. | Syncope with High Risk Cardiac Characteristics | |||
SYNCOPE WITH INDUCIBLE VENTRICULAR TACHYCARDIA | C100019 | Sudden loss of consciousness with loss of postural tone not related to anesthesia with ventricular tachycardia (VT) that can be induced during an electrophysiological study. | Syncope with Inducible Ventricular Tachycardia by ECG Finding | |||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
UPGRADE TO A DEVICE WITH ADDITIONAL PACING CAPABILITIES | C100030 | A device with additional pacing capabilities is replacing the current device. | Upgrade to Cardiac Device with Additional Pacing Capabilities | |||
VENTRICULAR FIBRILLATION | C50799 | Ventricular Fibrillation is characterized by rapid, usually more than 300 bpm (cycle length: 180 ms or less), grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. | Ventricular Fibrillation | |||
Back to top | ||||||
CL.C101866.CRYDFMAN | Cardiac Rhythm Device Failure Manifestation
(CRYDFMAN) | text
Extensible: Yes | C101866 | Cardiac Rhythm Device Failure Manifestation | The effect that a cardiac rhythm device malfunction had on the ability to stimulate the heart. | CDISC SDTM Cardiac Rhythm Device Failure Manifestation Terminology |
ATRIAL PACING MALFUNCTION | C99921 | The cardiac rhythm device malfunction affected atrial pacing. | Cardiac Atrial Pacing Malfunction | |||
DEFIBRILLATION MALFUNCTION | C99923 | The cardiac rhythm device malfunction affected the defibrillator. | Cardiac Defibrillator Malfunction | |||
LEFT VENTRICULAR PACING MALFUNCTION | C99973 | The cardiac rhythm device malfunction affected the left ventricular (LV) pacing. | Left Cardiac Ventricular Pacing Malfunction | |||
RIGHT VENTRICULAR PACING MALFUNCTION | C100011 | The cardiac rhythm device malfunction affected the right ventricular (RV) pacing. | Right Cardiac Ventricle Pacing Malfunction | |||
Back to top | ||||||
CL.C119016.CVFARS | Cardiovascular Findings About Results
(CVFARS) | text
Extensible: No | C119016 | Cardiovascular Findings About Results | Terminology responses used for the cardiovascular findings about test codes and names codelist within CDISC. | CDISC SDTM Cardiovascular Findings About Results Terminology |
ANGIOGRAPHY | C20080 | The X-ray examination of blood vessels or chambers of the heart after introduction of a radiopaque substance. | X-ray Angiography | |||
AUGMENTATION OF ORAL DIURETIC THERAPY | C119199 | Initiation or intensification of orally administered medication(s) that promote diuresis to treat heart failure. | Oral Diuretic Therapy Augmentation for Heart Failure | |||
AUTOPSY | C25153 | A postmortem examination of the body. | Autopsy | |||
CLINICALLY SIGNIFICANT OR RAPID WEIGHT GAIN | C119200 | Weight gain thought to be related to fluid retention. | Weight Gain Due to Fluid Retention | |||
CORONARY LESION ON ANGIOGRAPHY | C119201 | Angiographic evidence of new or worse greater than or equal to 70 percent lesion and/or thrombus in an epicardial coronary artery believed to be responsible for the myocardial ischemic symptoms/signs. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Coronary Lesion by Angiographic Finding | |||
CORONARY REVASCULARIZATION | C119202 | Need for coronary revascularization procedure (PCI or CABG) for the presumed culprit lesion(s). This criterion would be fulfilled if revascularization was undertaken during the unscheduled hospitalization, or subsequent to transfer to another institution without interceding home discharge. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Coronary Revascularization Procedure | |||
DECREASED EXERCISE TOLERANCE | C119203 | Reduced ability to withstand or participate in activities that induce physical or mental exertion. | Decreased Exercise Tolerance | |||
DYSPNEA | C2998 | Includes dyspnea on exertion, dyspnea at rest, orthopnea, and paroxysmal nocturnal dyspnea. | Dyspnea | |||
FATIGUE | C3036 | Unusual tiredness and inability to perform usual activities. | Fatigue | |||
HEART FAILURE HOSPITALIZATION | C119204 | An event where the patient is admitted to the hospital with a primary diagnosis of heart failure (HF), where the length of stay is at least 24 hours (or extends over a calendar date), where the patient exhibits new or worsening symptoms of HF on presentation, has objective evidence of new or worsening HF, and receives initiation or intensification of treatment specifically for HF. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Hospitalization Due to Heart Failure | |||
HEMORRHAGIC STROKE | C95803 | An acute episode of focal or global cerebral or spinal dysfunction caused by intraparenchymal, intraventricular, or subarachnoid hemorrhage. | Hemorrhagic Stroke | |||
INCREASE IN HEART FAILURE BIOMARKER | C119205 | Biomarker increase (B-type natriuretic peptide (BNP)/ N-terminal pro-BNP (NT-proBNP)) consistent with decompensation of heart failure (such as BNP greater than 500 pg/mL or NT-proBNP greater than 2,000 pg/mL). In patients with chronically elevated natriuretic peptides, a significant increase above baseline is required. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Increase in B-type Natriuretic Peptide or N-terminal pro-B-type Natriuretic Peptide | |||
INCREASED JUGULAR VENOUS PRESSURE OR HEPATOJUGULAR REFLUX | C119206 | Increase in the estimated height of the mean jugular venous waveform above the right atrium in cm. | Increase in Jugular Venous Pressure | |||
INCREASING ABDOMINAL DISTENTION OR ASCITES | C2885 | Ascites | Abnormal collection of fluid in the peritoneal cavity. | Ascites | ||
INDUCIBLE MYOCARDIAL ISCHEMIA | C119207 | Definite evidence of inducible myocardial ischemia believed to be responsible for the myocardial ischemic symptoms/signs, demonstrated by any of the following: a) an early positive exercise stress test, defined as ST elevation of greater than or equal to 2 mm ST depression prior to 5 mets, b) stress echocardiography (reversible wall motion abnormality), c) myocardial scintigraphy (reversible perfusion defect), d) MRI (myocardial perfusion deficit under pharmacologic stress). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Inducible Myocardial Ischemia | |||
INTRAVENOUS DIURETIC, INOTROPE, OR VASODILATOR THERAPY | C119208 | Initiation or intensification of medication(s) administered by vein to treat heart failure, to increase the production of urine, increase cardiac performance, and/or reduce cardiac preload or afterload. | Intravenous Diuretic, Inotropic or Vasodilator Augmentation for Heart Failure | |||
INVASIVE DIAGNOSTIC EVIDENCE OF HEART FAILURE | C119209 | Invasive diagnostic evidence with right heart catheterization showing a pulmonary capillary wedge pressure (pulmonary artery occlusion pressure) greater than or equal to 18 mmHg, central venous pressure greater than or equal to 12 mmHg, or a cardiac index less than 2.2 L/min/m2. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Heart Failure by Invasive Diagnostic Technique | |||
ISCHEMIC STROKE | C95802 | Ischemic stroke is defined as an acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of central nervous system tissue. | Ischemic Stroke | |||
LOSS OF A SIDE BRANCH | C119210 | Angiographic loss of patency of a side branch. | Loss of Patency of Side Branch | |||
LOSS OF MAJOR CORONARY | C119211 | Angiographic loss of patency of a major epicardial vessel. | Loss of Patency of Major Vessel | |||
MECHANICAL OR SURGICAL INTERVENTION | C119212 | Mechanical circulatory support (e.g., intra-aortic balloon pump, ventricular assist device, extracorporeal membrane oxygenation, total artificial heart) or mechanical fluid removal (e.g., ultrafiltration, hemofiltration, dialysis). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Vasculature Mechanical or Surgical Intervention | |||
NEW LOSS OF VIABLE MYOCARDIUM | C119213 | Non-invasive imaging evidence of a loss of viable myocardium when compared with the most recent previous non-invasive imaging study. | New Loss of Viable Myocardium by Non-invasive Imaging Technique | |||
NEW REGIONAL WALL MOTION ABNORMALITY | C119214 | Non-invasive imaging evidence of a decrease in regional wall motion contractility compared with the most recent previous non-invasive imaging study. | New Regional Wall Motion Abnormality by Non-invasive Imaging Technique | |||
NON-INVASIVE DIAGNOSTIC EVIDENCE OF HEART FAILURE | C119215 | Non-invasive diagnostic evidence of clinically significant elevated left- or right-sided ventricular filling pressure or low cardiac output. For example, echocardiographic criteria could include: E/e' greater than 15 or D-dominant pulmonary venous inflow pattern, plethoric inferior vena cava with minimal collapse on inspiration, or decreased left ventricular outflow tract (LVOT) minute stroke distance (time velocity integral (TVI)). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Heart Failure by Non-invasive Diagnostic Technique | |||
PERIPHERAL EDEMA | C78262 | Increased tissue fluid indicated by perceptible pitting indentation on lower leg, foot or sacrum after palpation. | Edema Limbs | |||
PULMONARY RALES/CRACKLES/CREPITATIONS | C119216 | Abnormal breath sounds caused by the accumulation of fluid in the lungs. | Rales | |||
RADIOLOGICAL EVIDENCE OF PULMONARY CONGESTION | C119217 | Imaging findings consistent with increased intravascular blood volume in the lungs. | Pulmonary Congestion by Radiological Technique | |||
RESTING ECG CHANGES | C119218 | New or worsening ST or T wave changes on resting ECG (in the absence of confounders, such as LBBB or LVH), defined as either: a) Transient ST elevation (duration less than 20 minutes): new ST elevation at the J point in any two contiguous leads (other than leads V2-V3) of greater than or equal to 0.1 mV. In leads V2-V3, the following cut-points apply: greater than or equal to 0.2 mV in men greater than or equal to 40 years, greater than or equal to 0.25 mV in men less than 40 years, and greater than or equal to 0.15 mV in women, or b) ST depression and T-wave changes: new horizontal or down-sloping ST depression greater than or equal to 0.05 mV in two contiguous leads and/or new T inversion greater than or equal to 0.3 mV in two contiguous leads with prominent R wave or R/S ratio greater than 1. | Resting ECG Changes | |||
S3 GALLOP | C61455 | Presence of mid-diastolic heart sound. | S3 Gallop | |||
SLOW-FLOW/NO-FLOW/EMBOLIZATION | C119219 | Angiographic reduction of flow into the coronary microcirculation. | Flow Reduced in Coronary Microcirculation | |||
STENT THROMBOSIS ARC ACUTE | C123439 | 0 to 24 hours after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | Academic Research Council Acute Stent Thrombosis | |||
STENT THROMBOSIS ARC LATE | C123440 | Greater than 30 days to 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | Academic Research Council Late Stent Thrombosis | |||
STENT THROMBOSIS ARC SUBACUTE | C123441 | Greater than 24 hours to 30 days after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | Academic Research Council Subacute Stent Thrombosis | |||
STENT THROMBOSIS ARC VERY LATE | C123442 | Greater than 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | Academic Research Council Very Late Stent Thrombosis | |||
TYPE 1 MYOCARDIAL INFARCTION | C119220 | Spontaneous clinical syndrome related to atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection, with resulting intraluminal thrombus, and leading to decreased myocardial blood flow or distal platelet emboli with ensuing myocyte necrosis. This classification requires a) detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value greater than 99th percentile of the upper reference limit (URL) and b) at least one of the following: symptoms of myocardial ischemia; new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB) on the ECG; development of pathological Q waves on the ECG; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality; identification of an intracoronary thrombus by angiography or autopsy. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 1 Myocardial Infarction | |||
TYPE 2 MYOCARDIAL INFARCTION | C119221 | Ischemic imbalance: Spontaneous clinical syndrome where a condition other than coronary artery disease contributes to an imbalance between myocardial oxygen supply and/or demand, e.g. coronary endothelial dysfunction, coronary artery spasm, coronary embolism, tachy-/brady-arrhythmias, anemia, respiratory failure, hypotension, and hypertension with or without left ventricular hypertrophy. This classification requires detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value greater than 99th percentile of the upper reference limit (URL) and b) at least one of the following: symptoms of myocardial ischemia; new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB) on the ECG; development of pathological Q waves on the ECG; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 2 Myocardial Infarction | |||
TYPE 3 MYOCARDIAL INFARCTION | C119222 | Death, No Biomarkers: Death where symptoms suggestive of myocardial ischemia are present, and with (presumed) new ischemic changes or new LBBB on ECG, but where death occurs before cardiac biomarkers can be obtained, or before cardiac biomarker values could rise. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 3 Myocardial Infarction | |||
TYPE 4A MYOCARDIAL INFARCTION | C119223 | PCI Related: PCI Related Myocardial infarction associated with and occurring within 48h of percutaneous coronary intervention, with elevation of cardiac biomarker values to greater than 5x 99th percentile of the upper reference limit (URL) in patients with normal baseline values (less than or equal to 99th percentile URL), or a rise of cardiac biomarker values greater than or equal to 20% if the baseline values are elevated and are stable or falling. This classification also requires at least one of the following: symptoms of myocardial ischemia; new ischemic ECG changes or new LBBB; angiographic loss of patency of a major coronary artery or a side branch or persistent slow- or no-flow or embolization; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 4A Myocardial Infarction | |||
TYPE 4B MYOCARDIAL INFARCTION | C119224 | Stent Thrombosis: Myocardial infarction associated with stent thrombosis as detected by coronary angiography or at autopsy, where symptoms suggestive of myocardial ischemia are present, and with a rise and/or fall of cardiac biomarkers values, with at least one value greater than 99th percentile of the upper reference limit. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 4B Myocardial Infarction | |||
TYPE 4C MYOCARDIAL INFARCTION | C119225 | Stent Restenosis: Myocardial infarction associated with stent restenosis as detected by coronary angiography or at autopsy, occurring more than 48h after percutaneous coronary intervention, without evidence of stent thrombosis but with symptoms suggestive of myocardial ischemia, and with elevation of cardiac biomarker values to greater than 99th percentile of the upper reference limit (URL). This classification also requires the following: does not meet criteria for any other classification of myocardial infarction; presence of a greater than or equal to 50 percent stenosis at the site of previous successful stent PCI. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 4C Myocardial Infarction | |||
TYPE 5 MYOCARDIAL INFARCTION | C119226 | CABG Related: Myocardial infarction associated with and occurring within 48h of coronary artery bypass graft surgery, with elevation of cardiac biomarker values to greater than 10x 99th percentile of the upper reference limit (URL) in patients with normal baseline cardiac biomarker values (less than or equal to 99th percentile URL). This classification also requires at least one of the following: new pathologic Q waves or new LBBB on ECG; angiographic new graft or new native coronary artery occlusion; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 5 Myocardial Infarction | |||
UNDETERMINED STROKE | C3390 | An acute episode of focal or global neurological dysfunction caused by presumed brain, spinal cord, or retinal vascular injury as a result of hemorrhage or infarction but with insufficient information to allow categorization as ischemic or hemorrhagic. | Stroke | |||
URGENT HEART FAILURE VISIT | C119227 | An event where the patient has an urgent, unscheduled office/practice or emergency department visit for a primary diagnosis of heart failure (HF) but is not admitted to the hospital, where the patient exhibits new or worsening symptoms of HF on presentation, has objective evidence of new or worsening HF, and receives initiation or intensification of treatment specifically for HF, with the exception that changes to oral diuretic therapy do no qualify as initiation or intensification of treatment. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | ER or Office Visit Due to Heart Failure | |||
VOLUME OVERLOAD | C50591 | Excessive accumulation of intravascular fluid resulting from compromised regulatory mechanisms. | Hypervolemia | |||
WORSENED END-ORGAN PERFUSION | C119228 | Decreased blood supply to the vital organs (kidney, liver, lungs, heart, brain). | Worsened End-Organ Perfusion | |||
Back to top | ||||||
CL.C119015.CVFATSCD | Cardiovascular Findings About Test Code
(CVFATSCD) | text
Extensible: No | C119015 | Cardiovascular Findings About Test Code | Terminology relevant to the test codes that describe findings about a cardiovascular event or intervention. | CDISC SDTM Cardiovascular Findings About Test Code Terminology |
ACMITYPE | C118936 | Acute Myocardial Infarction Type | Categorization of the type of acute myocardial infarction. | Acute Myocardial Infarction Type | ||
CATMTHID | C119229 | Coronary Artery Thrombosis Method Ident | The method by which the coronary artery thrombosis event is determined or diagnosed. | Coronary Artery Thrombosis Method of Identification | ||
ENDPTIND | C119230 | Endpoint Event Indicator | An indication as to whether the event meets the criteria for being a clinical endpoint. | Endpoint Event Indicator | ||
HETYPE | C119231 | Healthcare Encounter Type | Categorization of the type of healthcare encounter. | Healthcare Encounter Type | ||
HFLBFNW | C119232 | Heart Failure New/Worsening Lab Findings | Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. | Lab Findings of New or Worsening Heart Failure | ||
HFPEFNW | C119233 | Heart Failure New/Worsening PE Findings | Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. | Physical Examination Findings of New or Worsening Heart Failure | ||
HFTHERIN | C119234 | Heart Failure Therapy, Intensification | Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. | Heart Failure Therapy Intensification Type | ||
ISCDIND | C119235 | Ischemic Discomfort Indicator | An indicator as to whether the subject has symptoms of ischemic discomfort. | Ischemic Discomfort Indicator | ||
ISCETYP | C119236 | Ischemic Evidence Type | Categorization of the type of objective evidence of new or worsening ischemia. | Ischemic Evidence Type | ||
MI12EXC | C119237 | Exclusion of Type 1 and Type 2 MI | An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. | Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator | ||
NINVIMGC | C123443 | Non-Invasive Imaging Change | A description of the clinical change to the subject after a non-invasive imaging procedure. | Clinical Change by Non-Invasive Imaging Procedure | ||
NWSYMP | C119238 | New or Worsening Symptoms | A description of the new or worsening symptoms related to a clinical event. | New or Worsening Symptom | ||
PCIAAC | C119239 | PCI Acute Angiographic Complication | Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. | Acute Myocardial Infarction From PCI Complication Type | ||
PRSUCIND | C119240 | Procedure Success Indicator | An indication as to whether the procedure is considered successful. | Procedure Success Indicator | ||
PRUSTAT | C101230 | Procedure Urgency Status Type | The degree of urgency in which a medical procedure must be performed. | Triage Status | ||
STCTIMNG | C123424 | Stent Thrombosis, Coronary, ARC Timing | Categorization of the timing of coronary stent thrombosis occurrence per the classification schema described by the Academic Research Consortium (ARC). | Academic Research Council Coronary Stent Thrombosis Timing | ||
STROKTYP | C119579 | Stroke Type | Categorization of the type of stroke. | Stroke Type | ||
SYMPINDC | C119241 | Symptom Indicator | An indication as to whether the subject had symptoms related to the clinical event. | Symptom Indicator | ||
SYMSTDTC | C119242 | Symptom Onset Date | The date time of the onset of symptoms of the clinical event. | Symptom Onset Date | ||
VOC48IND | C119243 | Vessel Occlusion After CABG 48 Ind | An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. | Vessel Occlusion 48 Hours after CABG Indicator | ||
Back to top | ||||||
CL.C119014.CVFATS | Cardiovascular Findings About Test Name
(CVFATS) | text
Extensible: No | C119014 | Cardiovascular Findings About Test Name | Terminology relevant to the test names that describe findings about a cardiovascular event or intervention. | CDISC SDTM Cardiovascular Findings About Test Name Terminology |
Acute Myocardial Infarction Type | C118936 | Acute Myocardial Infarction Type | Categorization of the type of acute myocardial infarction. | Acute Myocardial Infarction Type | ||
Coronary Artery Thrombosis Method Ident | C119229 | Coronary Artery Thrombosis Method Ident | The method by which the coronary artery thrombosis event is determined or diagnosed. | Coronary Artery Thrombosis Method of Identification | ||
Endpoint Event Indicator | C119230 | Endpoint Event Indicator | An indication as to whether the event meets the criteria for being a clinical endpoint. | Endpoint Event Indicator | ||
Exclusion of Type 1 and Type 2 MI | C119237 | Exclusion of Type 1 and Type 2 MI | An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. | Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator | ||
Healthcare Encounter Type | C119231 | Healthcare Encounter Type | Categorization of the type of healthcare encounter. | Healthcare Encounter Type | ||
Heart Failure New/Worsening Lab Findings | C119232 | Heart Failure New/Worsening Lab Findings | Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. | Lab Findings of New or Worsening Heart Failure | ||
Heart Failure New/Worsening PE Findings | C119233 | Heart Failure New/Worsening PE Findings | Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. | Physical Examination Findings of New or Worsening Heart Failure | ||
Heart Failure Therapy, Intensification | C119234 | Heart Failure Therapy, Intensification | Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. | Heart Failure Therapy Intensification Type | ||
Ischemic Discomfort Indicator | C119235 | Ischemic Discomfort Indicator | An indicator as to whether the subject has symptoms of ischemic discomfort. | Ischemic Discomfort Indicator | ||
Ischemic Evidence Type | C119236 | Ischemic Evidence Type | Categorization of the type of objective evidence of new or worsening ischemia. | Ischemic Evidence Type | ||
New or Worsening Symptoms | C119238 | New or Worsening Symptoms | A description of the new or worsening symptoms related to a clinical event. | New or Worsening Symptom | ||
Non-Invasive Imaging Change | C123443 | Non-Invasive Imaging Change | A description of the clinical change to the subject after a non-invasive imaging procedure. | Clinical Change by Non-Invasive Imaging Procedure | ||
PCI Acute Angiographic Complication | C119239 | PCI Acute Angiographic Complication | Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. | Acute Myocardial Infarction From PCI Complication Type | ||
Procedure Success Indicator | C119240 | Procedure Success Indicator | An indication as to whether the procedure is considered successful. | Procedure Success Indicator | ||
Procedure Urgency Status Type | C101230 | Procedure Urgency Status Type | The degree of urgency in which a medical procedure must be performed. | Triage Status | ||
Stent Thrombosis, Coronary, ARC Timing | C123424 | Stent Thrombosis, Coronary, ARC Timing | Categorization of the timing of coronary stent thrombosis occurrence per the classification schema described by the Academic Research Consortium (ARC). | Academic Research Council Coronary Stent Thrombosis Timing | ||
Stroke Type | C119579 | Stroke Type | Categorization of the type of stroke. | Stroke Type | ||
Symptom Indicator | C119241 | Symptom Indicator | An indication as to whether the subject had symptoms related to the clinical event. | Symptom Indicator | ||
Symptom Onset Date | C119242 | Symptom Onset Date | The date time of the onset of symptoms of the clinical event. | Symptom Onset Date | ||
Vessel Occlusion After CABG 48 Ind | C119243 | Vessel Occlusion After CABG 48 Ind | An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. | Vessel Occlusion 48 Hours after CABG Indicator | ||
Back to top | ||||||
CL.C101847.CVTESTCD | Cardiovascular Test Code
(CVTESTCD) | text
Extensible: Yes | C101847 | Cardiovascular Test Code | A terminology codelist to describe the test code for a physiological examination of the cardiovascular system. | CDISC SDTM Cardiovascular Test Code Terminology |
AAUGIX | C122038 | Aortic Augmentation Index | The augmentation pressure divided by the aortic pulse pressure (aortic systolic minus aortic diastolic pressure) multiplied by 100, expressed as a percentage. | Aortic Augmentation Index | ||
AAUGIX75 | C122083 | Aortic Augmentation Index at 75bpm | The aortic augmentation index normalized to a heart rate of 75 beats per minute. | Aortic Augmentation Index at 75bpm | ||
AAUGPR | C122084 | Aortic Augmentation Pressure | The difference between the second pressure peak in the aortic wave, secondary to the pressure wave reflection from the sites of peripheral arterial impedance mismatch (P2) and the first pressure peak in the aortic wave form, secondary to ventricular ejection (P1). | Aortic Augmentation Pressure | ||
AAUGPRP1 | C122085 | Aortic Augmentation Pressure Peak P1 | The first pressure peak in the aortic wave form secondary to ventricular ejection. | Augmentation Pressure Point P1 | ||
AAUGPRP2 | C122086 | Aortic Augmentation Pressure Peak P2 | The second pressure peak in the aortic waveform secondary to pressure wave reflection from the periphery. | Augmentation Pressure Point P2 | ||
ACRCTIND | C139033 | Aortic Coarctation Indicator | An indication as to whether there is coarctation of the aorta. | Aortic Coarctation Indicator | ||
ACRCTSEV | C139037 | Aortic Coarctation Severity | The assessment of the severity of aortic coarctation. | Aortic Coarctation Severity | ||
ADUCSEV | C139035 | Aortic Ductal Coarctation Severity;Aortic Juxta-ductal Coarctation Severity | The assessment of the severity of ductal aortic coarctation. | Aortic Juxta-ductal Coarctation Severity | ||
ANEURIND | C139038 | Aneurysm Indicator | An indication as to whether there is the presence of one or more aneurysms. | Aneurysm Indicator | ||
ANNAVEL | C127535 | Annular a' Velocity | The peak velocity of the annular motion during late ventricular diastole (the active filling of the ventricle). | Annular a' Velocity | ||
ANNEVEL | C127536 | Annular e' Velocity | The peak velocity of the annular motion during early ventricular diastole (the passive filling of the ventricle). | Annular e' Velocity | ||
ANNSVEL | C139045 | Annular S' Velocity | The peak velocity of the annular motion during ventricular systole. | Annular S' Velocity | ||
APOSCSEV | C139036 | Aortic Postductal Coarctation Severity | The assessment of the severity of postductal aortic coarctation. | Aortic Postductal Coarctation Severity | ||
APRECSEV | C139034 | Aortic Preductal Coarctation Severity | The assessment of the severity of preductal aortic coarctation. | Aortic Preductal Coarctation Severity | ||
APSE | C139042 | Annular Plane Systolic Excursion | The longitudinal displacement of a cardiac valve annulus toward the apex of the heart. | Annular Plane Systolic Excursion | ||
AREAEVD | C127537 | Area, End Ventricular Diastole | The 2-dimensional surface enclosed within a boundary of a cardiovascular structure and measured at end ventricular diastole. | Area at End Ventricular Diastole | ||
AREAEVS | C127538 | Area, End Ventricular Systole | The 2-dimensional surface enclosed within a boundary of a cardiovascular structure and measured at end ventricular systole. | Area at End Ventricular Systole | ||
ARGJWLVD | C127539 | Aortic Regur Jet Width LVOT Diam Rt;Aortic Regurgitant Jet Width to Left Ventricular Outflow Tract Diameter Ratio | A relative measurement (ratio) of the aortic regurgitant jet width to left ventricular outflow tract (LVOT) diameter. | Aortic Regurgitant Jet Width to Left Ventricular Outflow Tract Diameter Ratio | ||
AVRGF | C127540 | Aortic Valve Regurgitant Fraction | A measurement of the volume of retrograde blood flow across the orifice of the aortic valve expressed as a percentage of the anterograde flow volume. | Aortic Valve Regurgitant Fraction | ||
AVRGJW | C127541 | Aortic Valve Regurgitant Jet Width | The measured width of the regurgitant jet of blood into the left ventricular outflow tract. | Aortic Valve Regurgitant Jet Width | ||
AVRGVOL | C127542 | Aortic Valve Regurgitant Volume | A measurement of the volume of retrograde blood flow across the orifice of the aortic valve. | Aortic Valve Regurgitant Volume | ||
AVVCA | C127543 | Aortic Valve Vena Contracta Area | The area of the vena contracta of the aortic valve. | Aortic Valve Vena Contracta Area | ||
AVVCW | C127544 | Aortic Valve Vena Contracta Width | The width of the vena contracta of the aortic valve. | Aortic Valve Vena Contracta Width | ||
BLDFLRT | C94866 | Blood Flow Rate | The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. | Blood Flow Rate | ||
CANRFIND | C119331 | Coronary Artery No Reflow Indicator | An indication as to whether there is a new acute reduction in coronary flow (TIMI grade 0-1) in the absence of dissection, thrombus, spasm, or high-grade residual stenosis at the original PCI lesion site. | Coronary No Reflow at PCI Site Indicator | ||
CARDIDX | C119245 | Cardiac Index | The measure of an individual's cardiac output divided by the individual's body surface area (CI= CO/BSA). | Cardiac Index | ||
CARDOUT | C119246 | Cardiac Output | The total volume of blood pumped by the heart over a set period of time, conventionally one minute; it is calculated as heart rate times stroke volume (CO= HR x SV). | Cardiac Output | ||
CMHYIND | C139063 | Cardiac Muscle Hypertrophy Indicator | An indication as to whether there is a hypertrophied cardiac muscle. | Heart Chamber Hypertrophy Indicator | ||
COARTDOM | C100086 | Coronary Artery Dominance | The pattern of the epicardial vessels supplying the posterolateral and posterior descending coronary arteries. | Coronary Artery Dominance | ||
CSDIA | C139032 | Cross-sectional Diameter | A measurement of a structure taken along the plane that is perpendicular to the long axis. | Cross-sectional Diameter | ||
CSDIAEVD | C127545 | Cross-sec Diameter, EVD;Cross-sectional Diameter, End Ventricular Diastole | The cross sectional diameter of a cardiovascular structure measured at end ventricular diastole. | Cross-sectional Diameter at End Ventricular Diastole | ||
CSDIAEVS | C127546 | Cross-sec Diameter, EVS;Cross-sectional Diameter, End Ventricular Systole | The cross sectional diameter of a cardiovascular structure measured at end ventricular systole. | Cross-sectional Diameter at End Ventricular Systole | ||
CSDIAMVS | C127547 | Cross-sec Diameter, MVS;Cross-sectional Diameter, Mid Ventricular Systole | The cross sectional diameter of a cardiovascular structure measured at mid ventricular systole. | Cross-sectional Diameter at Mid Ventricular Systole | ||
CSPDIND | C127548 | Cusp Doming Indicator | An indication as to whether there is doming of a cardiac valve cusp. | Cusp Doming Indicator | ||
CSPDSEV | C127549 | Cusp Doming Severity | The assessment of the severity of doming of a cardiac valve cusp. | Cusp Doming Severity | ||
CSPFIND | C127550 | Cusp Flail Indicator | An indication as to whether there is a flailing cardiac valve cusp. | Cusp Flail Indicator | ||
CSPFSEV | C127551 | Cusp Flail Severity | The assessment of the severity of a flailing cardiac valve cusp. | Cusp Flail Severity | ||
CSPFT | C127552 | Cusp Flail Timing | The time point during the cardiac cycle when the flail of one or more cardiac valve cusps occurs. | Cusp Flail Timing | ||
CSPPIND | C127553 | Cusp Prolapse Indicator | An indication as to whether there is a prolapsing cardiac valve cusp. | Cusp Prolapse Indicator | ||
CSPPSEV | C127554 | Cusp Prolapse Severity | The assessment of the severity of a prolapsing cardiac valve cusp. | Cusp Prolapse Severity | ||
CSPPT | C127555 | Cusp Prolapse Timing | The time point during the cardiac cycle when the prolapse of one or more cardiac valve cusps occurs. | Cusp Prolapse Timing | ||
CSPRMIND | C127556 | Cusp Restricted Motion Indicator | An indication as to whether there is restricted motion of a cardiac valve cusp. | Cusp Restricted Motion Indicator | ||
CSPRMSEV | C127557 | Cusp Restricted Motion Severity | The assessment of the severity of restricted motion of a cardiac valve cusp. | Cusp Restricted Motion Severity | ||
CSPTEIND | C127558 | Cusp Tethering Indicator | An indication as to whether there is tethering of a cardiac valve cusp. | Cusp Tethering Indicator | ||
CSPTESEV | C127559 | Cusp Tethering Severity | The assessment of the severity of tethering of a cardiac valve cusp. | Cusp Tethering Severity | ||
CSPTIND | C127560 | Cusp Thickening Indicator | An indication as to whether there is a thickened cardiac valve cusp. | Cusp Thickening Indicator | ||
CSPTSEV | C127561 | Cusp Thickening Severity | The assessment of the severity of a thickening cardiac cusp. | Cusp Thickening Severity | ||
CTPIND | C127562 | Chordae Tendineae Prolapse Indicator | An indication as to whether there is prolapsing of a cardiac valve chordae tendinae. | Chordae Tendineae Prolapse Indicator | ||
CVLREGTS | C102244 | Cardiac Valvular Regurgitation Severity | The qualitative measurement of the severity of cardiac valvular regurgitation. | Cardiac Valvular Regurgitation Severity | ||
CVLSTNS | C102245 | Cardiac Valvular Stenosis Severity | The qualitative measurement of the severity of cardiac valvular stenosis. | Cardiac Valvular Stenosis Severity | ||
CVRGIND | C139055 | Cardiac Valvular Regurgitation Indicator | An indication as to whether a specific cardiac valve is regurgitant. | Cardiac Valvular Regurgitation Indicator | ||
CVRGJDR | C127563 | Cardiac Valve Regur Jet Direction;Cardiac Valve Regurgitation Jet Direction | The trajectory of the retrograde blood flow from a cardiac valve. | Cardiac Valve Regurgitant Jet Direction | ||
CVRGLE | C139056 | Cardiac Valvular Regur Likely Etiology;Cardiac Valvular Regurgitation Likely Etiology | An estimation as to the cause of the pathology responsible for the cardiac valve regurgitation. | Cardiac Valvular Regurgitation Likely Etiology | ||
CWMTYP | C127564 | Cardiac Wall Motion Type | The assessment of the movement of the cardiac muscle, either as a whole or at one or more specific anatomical locations. | Cardiac Wall Motion Type | ||
DEBAKADC | C139041 | DeBakey AoD Classification;DeBakey Aortic Dissection Classification | The type of aortic dissection present as defined by the DeBakey Classification System (DeBakey ME, Henly WS, Cooley DA, Morris GC Jr, Crawford ES, Beall AC Jr. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg. 1965 Jan;49:130-49). | DeBakey Aortic Dissection Classification | ||
DEPTH | C25333 | Depth | The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) | Depth | ||
DIMSSNDX | C147148 | Dimensionless Index;Dimensionless Velocity Index | The ratio of the blood velocity in the left ventricular outflow tract (LVOT) to the maximum blood velocity across the aortic valve. | Dimensionless Index | ||
DISECIND | C139039 | Dissection Indicator | An indication as to whether there is the presence of blood vessel dissection. | Dissection Indicator | ||
EFFRGOA | C127565 | Effective Regurgitant Orifice Area | A measurement of the effective regurgitant orifice area of the valve. | Effective Regurgitant Orifice Area | ||
EJWAMP | C122088 | Ejection Wave Amplitude | The magnitude of the ejection wave that occurs when blood is ejected into the aorta by the left ventricle. | Ejection Wave Amplitude | ||
EOA | C147149 | Effective Orifice Area | The calculated estimate of the area of a cardiac valve at the point of maximum opening. | Effective Orifice Area | ||
EOAINDEX | C147150 | Effective Orifice Area Index | The ratio of the effective orifice area (EOA) to the body surface area (BSA). | Effective Orifice Area Index | ||
ERGJIND | C139057 | Eccentric Regurgitant Jet Indicator | An indication as to whether an eccentric regurgitant jet direction is present. | Eccentric Regurgitant Jet Indicator | ||
FAC | C142241 | Fractional Area Change | The percent reduction in the area of a given structure with the following formula: (EDA-ESA)/EDA times 100, where EDA is end diastolic area and ESA is end systolic area. | Fractional Area Change | ||
FBODYIND | C147151 | Observed Foreign Body Indicator | An indication as to whether a medical or non-medical foreign body is present in a subject. | Observed Foreign Body Indicator | ||
HCENLIND | C139062 | Heart Chamber Enlargement Indicator | An indication as to whether there is an enlarged heart chamber. | Heart Chamber Enlargement Indicator | ||
HCVOLEVD | C135372 | Heart Chamber Volume, End Ventricular Diastole;Heart Chamber Volume, EVD | The volume of blood remaining in a heart chamber at end ventricular diastole. | Heart Chamber Volume at End Ventricular Diastole | ||
HCVOLEVS | C135373 | Heart Chamber Volume, End Ventricular Systole;Heart Chamber Volume, EVS | The volume of blood remaining in a heart chamber at end ventricular systole. | Heart Chamber Volume at End Ventricular Systole | ||
INRSTIND | C116148 | In-Stent Restenosis Indicator | An indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent. | In-Stent Restenosis Indicator | ||
INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
ISHMYOP | C80494 | Ischemic Myocardium Percentage | The percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia). | Ischemic Myocardium Percentage | ||
IVCCSIND | C130055 | Inferior Vena Cava Collapse Indicator;Inferior Vena Cava Collapse Sniff Ind | An indication as to whether inferior vena cava collapse occurred with sniff. | Inferior Vena Cava Collapse Due to Sniff Test Indicator | ||
LCDIAEVD | C127566 | Largest Cross-sec Diameter, EVD;Largest Cross-sectional Diameter, End Ventricular Diastole | The largest cross sectional diameter of a vascular structure measured at end ventricular diastole. | Largest Cross-sectional Diameter at End Ventricular Diastole | ||
LENGTH | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
LGTHCK | C127567 | Largest Cross-sec Thickness;Largest Cross-sectional Thickness | The assessment of the largest cross-sectional thickness of a tissue. | Largest Cross-sectional Thickness | ||
LLMLOSS | C116146 | Late Lumen Loss | The difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography. | Late Lumen Loss Measurement | ||
LRSTIND | C116147 | Lesion Restenosis Indicator | An indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site. | Lesion Restenosis Indicator | ||
LVEF | C99524 | Left Ventricular Ejection Fraction | The percent or fraction of the left ventricular end diastolic volume ejected during systole that can be measured by visual estimation or calculation. | Left Ventricular Ejection Fraction | ||
LVEF_C | C135374 | Left Ventricular Ejection Fraction, Cal;Left Ventricular Ejection Fraction, Calculated | A calculated estimation of the percent or fraction of the volume of blood ejected from the left ventricle during left ventricular systole, calculated as the left ventricular stroke volume divided by the left ventricular end diastolic volume. | Calculated Left Ventricular Ejection Fraction | ||
LVEF_E | C135375 | Left Ventricular Ejection Fraction, Est;Left Ventricular Ejection Fraction, Estimated | A visual estimation of the percent or fraction of the volume of blood ejected from the left ventricle during left ventricular systole. | Estimated Left Ventricular Ejection Fraction | ||
LVFS | C38020 | Left Ventricular Fractional Shortening | The reduction in the length of the end-diastolic diameter dimension that occurs between end-systole and end-diastole, expressed as a fraction of the end-diastolic dimension. Calculation of the left ventricular fractional shortening is per the following formula: [(end-diastolic dimension minus end-systolic dimension) divided by end-diastolic dimension] multiplied by 100. | Left Ventricular Fractional Shortening | ||
LVMAS_E | C142242 | Left Ventricular Mass, Estimated | The weight of the left ventricle in grams as estimated by a formula that uses estimated measurements from echocardiographic exams, as well as constants like the specific gravity of the myocardium. Left ventricular mass is estimated using the following equation, LV Mass (g) = 0.8 {1.04[([LVEDD + IVSd + PWd]^3 - LVEDD^3)]} + 0.6, where LVEDD is LV end-diastolic dimension, IVSd is interventricular septal thickness at end-diastole, and PWd is posterior wall thickness at end-diastole. | Estimated Mass of Left Ventricle | ||
LVMASIDX | C142243 | Left Ventricular Mass Index | The left ventricular mass divided by the subject's body surface area. | Left Ventricular Mass Index | ||
LVOTPVEL | C127568 | Left Ventricular Outflow Tract Peak Velocity;LVOT Peak Velocity | A measurement of the maximum velocity of blood flow measured in the left ventricular outflow tract during left ventricular systole. | Left Ventricular Outflow Tract Peak Velocity | ||
LVOTVTI | C127569 | Left Ventricular Outflow Tract Velocity Time Integral;LVOT Velocity Time Integral | The integral of all of the instantaneous flow velocities within the left ventricular outflow tract during left ventricular systole. | Left Ventricular Outflow Tract Velocity Time Integral | ||
MASS | C43246 | Mass | The amount of matter in an object. | Mass | ||
MAXPEFFW | C139048 | Maximal Pericardial Effusion Width | The quantitative measurement of the maximum separation between the parietal and visceral pericardia during diastole. | Maximal Pericardial Effusion Width | ||
MBFVEL | C127570 | Mean Blood Flow Velocity | A measurement of the mean velocity of blood across an area or tissue. | Mean Blood Flow Velocity | ||
MEANBP_E | C135376 | Mean Blood Pressure, Estimated | The estimated average blood pressure. (NCI) | Estimated Mean Blood Pressure | ||
MEANVDIA | C116143 | Mean Vessel Diameter | The mean of the inside diameters of the normal blood vessel segments. | Mean Vessel Diameter | ||
MGPRES | C147152 | Mean Pressure Gradient | A value that represents the mean pressure gradient that exists between two points across a structure. | Mean Pressure Gradient | ||
MINLDIAM | C116144 | Minimum Vessel Lumen Diameter | The minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view. | Minimum Vessel Lumen Diameter | ||
MITRALEA | C127571 | Mitral E/A Ratio | The ratio of the peak early ventricular diastolic (E) transmitral velocity to the peak late ventricular diastolic (A) transmitral velocity. | Mitral E/A Ratio | ||
MITRALEE | C127572 | Mitral E/e' Ratio | The ratio of the peak early ventricular diastolic (E) transmitral velocity to the peak early mitral annular motion velocity (e'). | Mitral E/e' Ratio | ||
MJDIA | C135377 | Major Axis Cross-sec. Diameter;Major Axis Cross-sectional Diameter | The cross sectional diameter of a tissue, organ, or structure measured along its major axis. (NCI) | Major Axis Cross-sectional Diameter | ||
MJDIAEVD | C127573 | Major Axis Cross-sec Diameter, EVD;Major Axis Cross-sectional Diameter, End Ventricular Diastole | The cross sectional diameter of a cardiovascular structure measured along its major axis at end ventricular diastole. | Major Axis Cross-sectional Diameter at End Ventricular Diastole | ||
MJDIAEVS | C127574 | Major Axis Cross-sec Diameter, EVS;Major Axis Cross-sectional Diameter, End Ventricular Systole | The cross sectional diameter of a cardiovascular structure measured along its major axis at end ventricular systole. | Major Axis Cross-sectional Diameter at End Ventricular Systole | ||
MJDIAMVS | C139053 | Major Axis Cross-sec. Diameter, MVS;Major Axis Cross-sectional Diameter, Mid Ventricular Systole | The cross-sectional diameter of a cardiovascular structure measured along its major axis at mid ventricular systole. | Major Axis Cross-sectional Diameter at Mid Ventricular Systole | ||
MJIDEVD | C139059 | Major Axis Internal Diameter, End Ventricular Diastole;Major Axis Internal Diameter, EVD | The internal diameter of a cardiovascular structure measured along its major axis at end ventricular diastole. | Major Axis Internal Diameter at End Ventricular Diastole | ||
MJIDEVS | C139058 | Major Axis Internal Diameter, End Ventricular Systole;Major Axis Internal Diameter, EVS | The internal diameter of a cardiovascular structure measured along its major axis at end ventricular systole. | Major Axis Internal Diameter at End Ventricular Systole | ||
MNDIA | C135378 | Minor Axis Cross-sec. Diameter;Minor Axis Cross-sectional Diameter | The cross sectional diameter of a tissue, organ, or structure measured along its minor axis. (NCI) | Minor Axis Cross-sectional Diameter | ||
MNDIAEVD | C127575 | Minor Axis Cross-sec Diameter, EVD;Minor Axis Cross-sectional Diameter, End Ventricular Diastole | The cross sectional diameter of a cardiovascular structure measured along its minor axis at end ventricular diastole. | Minor Axis Cross-sectional Diameter at End Ventricular Diastole | ||
MNDIAEVS | C127576 | Minor Axis Cross-sec Diameter, EVS;Minor Axis Cross-sectional Diameter, End Ventricular Systole | The cross sectional diameter of a cardiovascular structure measured along its minor axis at end ventricular systole. | Minor Axis Cross-sectional Diameter at End Ventricular Systole | ||
MNDIAMVS | C139052 | Minor Axis Cross-sec. Diameter, MVS;Minor Axis Cross-sectional Diameter, Mid Ventricular Systole | The cross-sectional diameter of a cardiovascular structure measured along its minor axis at mid ventricular systole. | Minor Axis Cross-sectional Diameter at Mid Ventricular Systole | ||
MNIDEVD | C139061 | Minor Axis Internal Diameter, End Ventricular Diastole;Minor Axis Internal Diameter, EVD | The internal diameter of a cardiovascular structure measured along its minor axis at end ventricular diastole. | Minor Axis Internal Diameter at End Ventricular Diastole | ||
MNIDEVS | C139060 | Minor Axis Internal Diameter, End Ventricular Systole;Minor Axis Internal Diameter, EVS | The internal diameter of a cardiovascular structure measured along its minor axis at end ventricular systole. | Minor Axis Internal Diameter at End Ventricular Systole | ||
MPI | C139043 | Myocardial Performance Index | A calculated result that uses the following base formula to quantify both systolic and diastolic ventricular function: MPI = (IVCT + IVRT)/VET, where IVCT is isovolumetric contraction time, IVRT is isovolumetric relaxation time, and VET is ventricular ejection time. | Myocardial Performance Index | ||
MRGJALA | C127577 | Mitral Regur Jet Area L Atrial Area Rt;Mitral Regurgitant Jet Area to Left Atrial Area Ratio | A relative measurement (ratio) of the mitral regurgitant jet area to left atrial area. | Mitral Regurgitant Jet Area to Left Atrial Area Ratio | ||
MVRGF | C127578 | Mitral Valve Regurgitant Fraction | A measurement of the volume of retrograde blood flow across the orifice of the mitral valve expressed as a percentage of the anterograde flow volume. | Mitral Valve Regurgitant Fraction | ||
MVRGJA | C127579 | Mitral Valve Regurgitant Jet Area | The measured area of the regurgitant jet of blood into the left atrium. | Mitral Valve Regurgitant Jet Area | ||
MVRGVOL | C127580 | Mitral Valve Regurgitant Volume | A measurement of the volume of retrograde blood flow across the orifice of the mitral valve. | Mitral Valve Regurgitant Volume | ||
MVVCA | C127581 | Mitral Valve Vena Contracta Area | The area of the vena contracta of the mitral valve. | Mitral Valve Vena Contracta Area | ||
MVVCW | C127582 | Mitral Valve Vena Contracta Width | The width of the vena contracta of the mitral valve. | Mitral Valve Vena Contracta Width | ||
NCVALTYP | C139050 | Native Cardiac Valve Intervention Type | A description of what kind of intervention has been performed on a native cardiac valve. | Native Cardiac Valve Intervention Type | ||
NUMCUSPS | C139054 | Number of Cusps | A quantitative determination of the number of cusps composing a given cardiac valve. | Number of Cardiac Valve Cusps | ||
NUMDCAV | C99996 | Number of Diseased Coronary Vessels | Number of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area. | Number of Diseased Coronary Artery Vessels | ||
OBMDILOC | C146994 | Obs Med Device Type In Intended Loc;Observed Medical Device In The Intended Location | A description of the type of medical device that is found in a subject and is in its intended location. | Observed Medical Device Type In Intended Location | ||
OBMDNLOC | C147153 | Obs Med Device Type Not In Intended Loc | A description of the type of medical device that is found in a subject but is not in its intended location. | Observed Medical Device Type Not Present In Intended Location Type | ||
OBNMFBT | C147154 | Observed Non-Medical Foreign Body Type | A description of the type of non-medical foreign body that is found in a subject. | Observed Non-Medical Foreign Body Type | ||
PAHTNIND | C135379 | Pulmonary Arterial Hypertension Ind;Pulmonary Arterial Hypertension Indicator | An indication as to whether pulmonary arterial hypertension is present. | Pulmonary Arterial Hypertension Indicator | ||
PBFVEL | C127583 | Peak Blood Flow Velocity | A measurement of the maximum velocity of blood across an area or tissue. | Peak Blood Flow Velocity | ||
PCTDIAST | C116145 | Percent Diameter Stenosis | The value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD). | Percent Diameter Stenosis | ||
PCVALTYP | C139051 | Prosthetic Cardiac Valve Type | A description of the type of artificial cardiac valve in use. | Prosthetic Cardiac Valve Type | ||
PEFFIND | C139046 | Pericardial Effusion Indicator | An indication as to whether there is effusion between the parietal and visceral pericardia. | Pericardial Effusion Indicator | ||
PEFFSIZE | C139047 | Pericardial Effusion Size | The qualitative description of the overall size of a pericardial effusion as assessed at the point of greatest separation between the parietal and visceral pericardia during diastole. | Pericardial Effusion Size | ||
PGPRES | C147155 | Peak Pressure Gradient | A value that represents the maximum pressure gradient that exists between two points across a structure. | Peak Pressure Gradient | ||
PKAVEL | C127584 | Peak A Velocity | The peak velocity of blood flow across a cardiac valve during late ventricular diastole (the active filling of the ventricle). | Peak A Velocity | ||
PKEVEL | C127585 | Peak E Velocity | The peak velocity of blood flow across a cardiac valve during early ventricular diastole (the passive filling of the ventricle). | Peak E Velocity | ||
PPRR | C139044 | Peak Pressure Rise Rate | The greatest rate of increase in peak pressure. | Peak Pressure Rise Rate | ||
PRESHT | C147156 | Pressure Half Time | The amount of time required for the peak transvalvular pressure gradient to decrease to one half of the value. | Pressure Half Time | ||
PRGJWRVD | C127586 | Pulmonic Regur Jet Width RVOT Diam Rt;Pulmonic Regurgitant Jet Width to Right Ventricular Outflow Tract Diameter Ratio | A relative measurement (ratio) of the pulmonic regurgitant jet width to right ventricular outflow tract (RVOT) diameter. | Pulmonic Regurgitant Jet Width to Right Ventricular Outflow Tract Diameter Ratio | ||
PVEINDOM | C127587 | Pulmonary Vein Dominance | The determination of whether blood flow in the pulmonary veins is greater during ventricular systole or diastole. | Pulmonary Vein Dominance | ||
PVR | C119247 | Pulmonary Vascular Resistance | The resistance to blood flow through the pulmonary vasculature. | Pulmonary Vascular Resistance | ||
PVRGF | C127588 | Pulmonary Valve Regurgitant Fraction | A measurement of the volume of retrograde blood flow across the orifice of the pulmonic valve expressed as a percentage of the anterograde flow volume. | Pulmonary Valve Regurgitant Fraction | ||
PVRGJW | C127589 | Pulmonic Valve Regurgitant Jet Width | The measured width of the regurgitant jet of blood into the right ventricular outflow tract. | Pulmonic Valve Regurgitant Jet Width | ||
PVRGVOL | C127590 | Pulmonary Valve Regurgitant Volume | A measurement of the volume of retrograde blood flow across the orifice of the pulmonic valve. | Pulmonary Valve Regurgitant Volume | ||
PVVCA | C127591 | Pulmonary Valve Vena Contracta Area | The area of the vena contracta of the pulmonic valve. | Pulmonary Valve Vena Contracta Area | ||
PVVCW | C127592 | Pulmonary Valve Vena Contracta Width | The width of the vena contracta of the pulmonic valve. | Pulmonary Valve Vena Contracta Width | ||
PWV | C122087 | Pulse Wave Velocity | The distance traveled by the peak of the ventricular ejection pressure wave per unit of time. | Pulse Wave Velocity | ||
RFLMAG | C122089 | Reflection Magnitude | The reflected-to-forward pressure wave amplitude ratio. (Hashimoto J et al, J Hypertens. 2008 May;26(5):1017-24) | Reflection Magnitude | ||
RFLWAMP | C122090 | Reflection Wave Amplitude | The summation of the numerous waves being reflected by sites of impedance mismatch where central elastic arteries join more muscular arteries. | Reflection Wave Amplitude | ||
RVEF_C | C135380 | Right Ventricular Ejection Fraction, Cal;Right Ventricular Ejection Fraction, Calculated | A calculated estimation of the percent or fraction of the volume of blood ejected from the right ventricle during right ventricular systole, calculated as the right ventricular stroke volume divided by the right ventricular end diastolic volume. | Calculated Right Ventricular Ejection Fraction | ||
RVEF_E | C135381 | Right Ventricular Ejection Fraction, Est;Right Ventricular Ejection Fraction, Estimated | A visual estimation of the percent or fraction of the volume of blood ejected from the right ventricle during right ventricular systole. | Estimated Right Ventricular Ejection Fraction | ||
SAMIND | C127593 | SAM Indicator;Systolic Anterior Motion Indicator | An indication as to whether there is systolic anterior motion of a cardiac valve and its associated structures. | Systolic Anterior Motion Indicator | ||
SAMSEV | C127594 | SAM Severity;Systolic Anterior Motion Severity | The assessment of the severity of the systolic anterior motion of a cardiac valve and its associated structures. | Systolic Anterior Motion Severity | ||
STANFADC | C139040 | Stanford AoD Classification;Stanford Aortic Dissection Classification | The type of aortic dissection present as defined by the Stanford Classification System (Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE. Management of acute aortic dissections. Ann Thorac Surg. 1970 Sep;10(3):237-47). | Stanford Aortic Dissection Classification | ||
STROKVOL | C94989 | Stroke Volume | The difference in the volumes of blood between the points of maximum dilation and maximum contraction. This is the end diastolic volume minus the end systolic volume. | Stroke Volume | ||
SVR | C119248 | Systemic Vascular Resistance;Total Peripheral Resistance | The resistance to blood flow through the systemic vasculature. | Systemic Vascular Resistance | ||
SYSPRS_E | C139031 | Systolic Pressure, Estimated | A quantitative estimate of the pressure in a given cardiovascular structure during ventricular systole. | Estimated Systolic Blood Pressure | ||
THCKEVD | C127595 | Cross-sec Thickness, EVD;Cross-sectional Thickness, End Ventricular Diastole | The cross-sectional thickness of a cardiovascular structure measured at end ventricular diastole. | Cross-sectional Thickness at End Ventricular Diastole | ||
THCKEVS | C127596 | Cross-sec Thickness, EVS;Cross-sectional Thickness, End Ventricular Systole | The cross-sectional thickness of a cardiovascular structure measured at end ventricular systole. | Cross-sectional Thickness at End Ventricular Systole | ||
TRGJARA | C127597 | Tricus Regur Jet Area R Atrial Area Rt;Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio | A relative measurement (ratio) of the tricuspid regurgitant jet area to the right atrial area. | Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio | ||
TVRGF | C127598 | Tricuspid Valve Regurgitant Fraction | A measurement of the volume of retrograde blood flow across the orifice of the tricuspid valve expressed as a percentage of the anterograde flow volume. | Tricuspid Valve Regurgitant Fraction | ||
TVRGJA | C127599 | Tricuspid Valve Regurgitant Jet Area | The measured area of the regurgitant jet of blood into the right atrium. | Tricuspid Valve Regurgitant Jet Area | ||
TVRGVOL | C127600 | Tricuspid Valve Regurgitant Volume | A measurement of the volume of retrograde blood flow across the orifice of the tricuspid valve. | Tricuspid Valve Regurgitant Volume | ||
TVVCA | C127601 | Tricuspid Valve Vena Contracta Area | The area of the vena contracta of the tricuspid valve. | Tricuspid Valve Vena Contracta Area | ||
TVVCW | C127602 | Tricuspid Valve Vena Contracta Width | The width of the vena contracta of the tricuspid valve. | Tricuspid Valve Vena Contracta Width | ||
VAREANDX | C147157 | Valve Area Index | The ratio of the valve area to the body surface area. | Valve Area Index | ||
VELTI | C127603 | Velocity Time Integral, Blood Flow | The integral of all of the forward flow velocities during the time of blood flow across or within a specified area. | Blood Flow Velocity Time Integral | ||
VLSTNIND | C142244 | Cardiac Valvular Stenosis Indicator | An indication as to whether the cardiac valve in question has stenosis. | Cardiac Valvular Stenosis Indicator | ||
VLSTNSLE | C142245 | Cardiac Valve Stenosis Likely Etiology | A description of the likely cause of the pathology responsible for the cardiac valve stenosis. | Cardiac Valve Stenosis Likely Etiology | ||
VLVAREA | C147158 | Valve Area | The quantitative measurement estimating the surface area of a valve. | Valve Area | ||
WEIGHT | C25208 | Weight | The vertical force exerted by a mass as a result of gravity. (NCI) | Weight | ||
WIDTH | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
Back to top | ||||||
CL.C101846.CVTEST | Cardiovascular Test Name
(CVTEST) | text
Extensible: Yes | C101846 | Cardiovascular Test Name | A terminology codelist to describe the test name for a physiological examination of the cardiovascular system. | CDISC SDTM Cardiovascular Test Name Terminology |
Aneurysm Indicator | C139038 | Aneurysm Indicator | An indication as to whether there is the presence of one or more aneurysms. | Aneurysm Indicator | ||
Annular a' Velocity | C127535 | Annular a' Velocity | The peak velocity of the annular motion during late ventricular diastole (the active filling of the ventricle). | Annular a' Velocity | ||
Annular e' Velocity | C127536 | Annular e' Velocity | The peak velocity of the annular motion during early ventricular diastole (the passive filling of the ventricle). | Annular e' Velocity | ||
Annular Plane Systolic Excursion | C139042 | Annular Plane Systolic Excursion | The longitudinal displacement of a cardiac valve annulus toward the apex of the heart. | Annular Plane Systolic Excursion | ||
Annular S' Velocity | C139045 | Annular S' Velocity | The peak velocity of the annular motion during ventricular systole. | Annular S' Velocity | ||
Aortic Augmentation Index at 75bpm | C122083 | Aortic Augmentation Index at 75bpm | The aortic augmentation index normalized to a heart rate of 75 beats per minute. | Aortic Augmentation Index at 75bpm | ||
Aortic Augmentation Index | C122038 | Aortic Augmentation Index | The augmentation pressure divided by the aortic pulse pressure (aortic systolic minus aortic diastolic pressure) multiplied by 100, expressed as a percentage. | Aortic Augmentation Index | ||
Aortic Augmentation Pressure Peak P1 | C122085 | Aortic Augmentation Pressure Peak P1 | The first pressure peak in the aortic wave form secondary to ventricular ejection. | Augmentation Pressure Point P1 | ||
Aortic Augmentation Pressure Peak P2 | C122086 | Aortic Augmentation Pressure Peak P2 | The second pressure peak in the aortic waveform secondary to pressure wave reflection from the periphery. | Augmentation Pressure Point P2 | ||
Aortic Augmentation Pressure | C122084 | Aortic Augmentation Pressure | The difference between the second pressure peak in the aortic wave, secondary to the pressure wave reflection from the sites of peripheral arterial impedance mismatch (P2) and the first pressure peak in the aortic wave form, secondary to ventricular ejection (P1). | Aortic Augmentation Pressure | ||
Aortic Coarctation Indicator | C139033 | Aortic Coarctation Indicator | An indication as to whether there is coarctation of the aorta. | Aortic Coarctation Indicator | ||
Aortic Coarctation Severity | C139037 | Aortic Coarctation Severity | The assessment of the severity of aortic coarctation. | Aortic Coarctation Severity | ||
Aortic Ductal Coarctation Severity | C139035 | Aortic Ductal Coarctation Severity;Aortic Juxta-ductal Coarctation Severity | The assessment of the severity of ductal aortic coarctation. | Aortic Juxta-ductal Coarctation Severity | ||
Aortic Postductal Coarctation Severity | C139036 | Aortic Postductal Coarctation Severity | The assessment of the severity of postductal aortic coarctation. | Aortic Postductal Coarctation Severity | ||
Aortic Preductal Coarctation Severity | C139034 | Aortic Preductal Coarctation Severity | The assessment of the severity of preductal aortic coarctation. | Aortic Preductal Coarctation Severity | ||
Aortic Regur Jet Width LVOT Diam Rt | C127539 | Aortic Regur Jet Width LVOT Diam Rt;Aortic Regurgitant Jet Width to Left Ventricular Outflow Tract Diameter Ratio | A relative measurement (ratio) of the aortic regurgitant jet width to left ventricular outflow tract (LVOT) diameter. | Aortic Regurgitant Jet Width to Left Ventricular Outflow Tract Diameter Ratio | ||
Aortic Valve Regurgitant Fraction | C127540 | Aortic Valve Regurgitant Fraction | A measurement of the volume of retrograde blood flow across the orifice of the aortic valve expressed as a percentage of the anterograde flow volume. | Aortic Valve Regurgitant Fraction | ||
Aortic Valve Regurgitant Jet Width | C127541 | Aortic Valve Regurgitant Jet Width | The measured width of the regurgitant jet of blood into the left ventricular outflow tract. | Aortic Valve Regurgitant Jet Width | ||
Aortic Valve Regurgitant Volume | C127542 | Aortic Valve Regurgitant Volume | A measurement of the volume of retrograde blood flow across the orifice of the aortic valve. | Aortic Valve Regurgitant Volume | ||
Aortic Valve Vena Contracta Area | C127543 | Aortic Valve Vena Contracta Area | The area of the vena contracta of the aortic valve. | Aortic Valve Vena Contracta Area | ||
Aortic Valve Vena Contracta Width | C127544 | Aortic Valve Vena Contracta Width | The width of the vena contracta of the aortic valve. | Aortic Valve Vena Contracta Width | ||
Area, End Ventricular Diastole | C127537 | Area, End Ventricular Diastole | The 2-dimensional surface enclosed within a boundary of a cardiovascular structure and measured at end ventricular diastole. | Area at End Ventricular Diastole | ||
Area, End Ventricular Systole | C127538 | Area, End Ventricular Systole | The 2-dimensional surface enclosed within a boundary of a cardiovascular structure and measured at end ventricular systole. | Area at End Ventricular Systole | ||
Blood Flow Rate | C94866 | Blood Flow Rate | The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. | Blood Flow Rate | ||
Cardiac Index | C119245 | Cardiac Index | The measure of an individual's cardiac output divided by the individual's body surface area (CI= CO/BSA). | Cardiac Index | ||
Cardiac Muscle Hypertrophy Indicator | C139063 | Cardiac Muscle Hypertrophy Indicator | An indication as to whether there is a hypertrophied cardiac muscle. | Heart Chamber Hypertrophy Indicator | ||
Cardiac Output | C119246 | Cardiac Output | The total volume of blood pumped by the heart over a set period of time, conventionally one minute; it is calculated as heart rate times stroke volume (CO= HR x SV). | Cardiac Output | ||
Cardiac Valve Regur Jet Direction | C127563 | Cardiac Valve Regur Jet Direction;Cardiac Valve Regurgitation Jet Direction | The trajectory of the retrograde blood flow from a cardiac valve. | Cardiac Valve Regurgitant Jet Direction | ||
Cardiac Valve Stenosis Likely Etiology | C142245 | Cardiac Valve Stenosis Likely Etiology | A description of the likely cause of the pathology responsible for the cardiac valve stenosis. | Cardiac Valve Stenosis Likely Etiology | ||
Cardiac Valvular Regur Likely Etiology | C139056 | Cardiac Valvular Regur Likely Etiology;Cardiac Valvular Regurgitation Likely Etiology | An estimation as to the cause of the pathology responsible for the cardiac valve regurgitation. | Cardiac Valvular Regurgitation Likely Etiology | ||
Cardiac Valvular Regurgitation Indicator | C139055 | Cardiac Valvular Regurgitation Indicator | An indication as to whether a specific cardiac valve is regurgitant. | Cardiac Valvular Regurgitation Indicator | ||
Cardiac Valvular Regurgitation Severity | C102244 | Cardiac Valvular Regurgitation Severity | The qualitative measurement of the severity of cardiac valvular regurgitation. | Cardiac Valvular Regurgitation Severity | ||
Cardiac Valvular Stenosis Indicator | C142244 | Cardiac Valvular Stenosis Indicator | An indication as to whether the cardiac valve in question has stenosis. | Cardiac Valvular Stenosis Indicator | ||
Cardiac Valvular Stenosis Severity | C102245 | Cardiac Valvular Stenosis Severity | The qualitative measurement of the severity of cardiac valvular stenosis. | Cardiac Valvular Stenosis Severity | ||
Cardiac Wall Motion Type | C127564 | Cardiac Wall Motion Type | The assessment of the movement of the cardiac muscle, either as a whole or at one or more specific anatomical locations. | Cardiac Wall Motion Type | ||
Chordae Tendineae Prolapse Indicator | C127562 | Chordae Tendineae Prolapse Indicator | An indication as to whether there is prolapsing of a cardiac valve chordae tendinae. | Chordae Tendineae Prolapse Indicator | ||
Coronary Artery Dominance | C100086 | Coronary Artery Dominance | The pattern of the epicardial vessels supplying the posterolateral and posterior descending coronary arteries. | Coronary Artery Dominance | ||
Coronary Artery No Reflow Indicator | C119331 | Coronary Artery No Reflow Indicator | An indication as to whether there is a new acute reduction in coronary flow (TIMI grade 0-1) in the absence of dissection, thrombus, spasm, or high-grade residual stenosis at the original PCI lesion site. | Coronary No Reflow at PCI Site Indicator | ||
Cross-sec Diameter, EVD | C127545 | Cross-sec Diameter, EVD;Cross-sectional Diameter, End Ventricular Diastole | The cross sectional diameter of a cardiovascular structure measured at end ventricular diastole. | Cross-sectional Diameter at End Ventricular Diastole | ||
Cross-sec Diameter, EVS | C127546 | Cross-sec Diameter, EVS;Cross-sectional Diameter, End Ventricular Systole | The cross sectional diameter of a cardiovascular structure measured at end ventricular systole. | Cross-sectional Diameter at End Ventricular Systole | ||
Cross-sec Diameter, MVS | C127547 | Cross-sec Diameter, MVS;Cross-sectional Diameter, Mid Ventricular Systole | The cross sectional diameter of a cardiovascular structure measured at mid ventricular systole. | Cross-sectional Diameter at Mid Ventricular Systole | ||
Cross-sec Thickness, EVD | C127595 | Cross-sec Thickness, EVD;Cross-sectional Thickness, End Ventricular Diastole | The cross-sectional thickness of a cardiovascular structure measured at end ventricular diastole. | Cross-sectional Thickness at End Ventricular Diastole | ||
Cross-sec Thickness, EVS | C127596 | Cross-sec Thickness, EVS;Cross-sectional Thickness, End Ventricular Systole | The cross-sectional thickness of a cardiovascular structure measured at end ventricular systole. | Cross-sectional Thickness at End Ventricular Systole | ||
Cross-sectional Diameter | C139032 | Cross-sectional Diameter | A measurement of a structure taken along the plane that is perpendicular to the long axis. | Cross-sectional Diameter | ||
Cusp Doming Indicator | C127548 | Cusp Doming Indicator | An indication as to whether there is doming of a cardiac valve cusp. | Cusp Doming Indicator | ||
Cusp Doming Severity | C127549 | Cusp Doming Severity | The assessment of the severity of doming of a cardiac valve cusp. | Cusp Doming Severity | ||
Cusp Flail Indicator | C127550 | Cusp Flail Indicator | An indication as to whether there is a flailing cardiac valve cusp. | Cusp Flail Indicator | ||
Cusp Flail Severity | C127551 | Cusp Flail Severity | The assessment of the severity of a flailing cardiac valve cusp. | Cusp Flail Severity | ||
Cusp Flail Timing | C127552 | Cusp Flail Timing | The time point during the cardiac cycle when the flail of one or more cardiac valve cusps occurs. | Cusp Flail Timing | ||
Cusp Prolapse Indicator | C127553 | Cusp Prolapse Indicator | An indication as to whether there is a prolapsing cardiac valve cusp. | Cusp Prolapse Indicator | ||
Cusp Prolapse Severity | C127554 | Cusp Prolapse Severity | The assessment of the severity of a prolapsing cardiac valve cusp. | Cusp Prolapse Severity | ||
Cusp Prolapse Timing | C127555 | Cusp Prolapse Timing | The time point during the cardiac cycle when the prolapse of one or more cardiac valve cusps occurs. | Cusp Prolapse Timing | ||
Cusp Restricted Motion Indicator | C127556 | Cusp Restricted Motion Indicator | An indication as to whether there is restricted motion of a cardiac valve cusp. | Cusp Restricted Motion Indicator | ||
Cusp Restricted Motion Severity | C127557 | Cusp Restricted Motion Severity | The assessment of the severity of restricted motion of a cardiac valve cusp. | Cusp Restricted Motion Severity | ||
Cusp Tethering Indicator | C127558 | Cusp Tethering Indicator | An indication as to whether there is tethering of a cardiac valve cusp. | Cusp Tethering Indicator | ||
Cusp Tethering Severity | C127559 | Cusp Tethering Severity | The assessment of the severity of tethering of a cardiac valve cusp. | Cusp Tethering Severity | ||
Cusp Thickening Indicator | C127560 | Cusp Thickening Indicator | An indication as to whether there is a thickened cardiac valve cusp. | Cusp Thickening Indicator | ||
Cusp Thickening Severity | C127561 | Cusp Thickening Severity | The assessment of the severity of a thickening cardiac cusp. | Cusp Thickening Severity | ||
DeBakey AoD Classification | C139041 | DeBakey AoD Classification;DeBakey Aortic Dissection Classification | The type of aortic dissection present as defined by the DeBakey Classification System (DeBakey ME, Henly WS, Cooley DA, Morris GC Jr, Crawford ES, Beall AC Jr. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg. 1965 Jan;49:130-49). | DeBakey Aortic Dissection Classification | ||
Depth | C25333 | Depth | The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) | Depth | ||
Dimensionless Index | C147148 | Dimensionless Index;Dimensionless Velocity Index | The ratio of the blood velocity in the left ventricular outflow tract (LVOT) to the maximum blood velocity across the aortic valve. | Dimensionless Index | ||
Dissection Indicator | C139039 | Dissection Indicator | An indication as to whether there is the presence of blood vessel dissection. | Dissection Indicator | ||
Eccentric Regurgitant Jet Indicator | C139057 | Eccentric Regurgitant Jet Indicator | An indication as to whether an eccentric regurgitant jet direction is present. | Eccentric Regurgitant Jet Indicator | ||
Effective Orifice Area Index | C147150 | Effective Orifice Area Index | The ratio of the effective orifice area (EOA) to the body surface area (BSA). | Effective Orifice Area Index | ||
Effective Orifice Area | C147149 | Effective Orifice Area | The calculated estimate of the area of a cardiac valve at the point of maximum opening. | Effective Orifice Area | ||
Effective Regurgitant Orifice Area | C127565 | Effective Regurgitant Orifice Area | A measurement of the effective regurgitant orifice area of the valve. | Effective Regurgitant Orifice Area | ||
Ejection Wave Amplitude | C122088 | Ejection Wave Amplitude | The magnitude of the ejection wave that occurs when blood is ejected into the aorta by the left ventricle. | Ejection Wave Amplitude | ||
Fractional Area Change | C142241 | Fractional Area Change | The percent reduction in the area of a given structure with the following formula: (EDA-ESA)/EDA times 100, where EDA is end diastolic area and ESA is end systolic area. | Fractional Area Change | ||
Heart Chamber Enlargement Indicator | C139062 | Heart Chamber Enlargement Indicator | An indication as to whether there is an enlarged heart chamber. | Heart Chamber Enlargement Indicator | ||
Heart Chamber Volume, EVD | C135372 | Heart Chamber Volume, End Ventricular Diastole;Heart Chamber Volume, EVD | The volume of blood remaining in a heart chamber at end ventricular diastole. | Heart Chamber Volume at End Ventricular Diastole | ||
Heart Chamber Volume, EVS | C135373 | Heart Chamber Volume, End Ventricular Systole;Heart Chamber Volume, EVS | The volume of blood remaining in a heart chamber at end ventricular systole. | Heart Chamber Volume at End Ventricular Systole | ||
In-Stent Restenosis Indicator | C116148 | In-Stent Restenosis Indicator | An indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent. | In-Stent Restenosis Indicator | ||
Inferior Vena Cava Collapse Sniff Ind | C130055 | Inferior Vena Cava Collapse Indicator;Inferior Vena Cava Collapse Sniff Ind | An indication as to whether inferior vena cava collapse occurred with sniff. | Inferior Vena Cava Collapse Due to Sniff Test Indicator | ||
Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
Ischemic Myocardium Percentage | C80494 | Ischemic Myocardium Percentage | The percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia). | Ischemic Myocardium Percentage | ||
Largest Cross-sec Diameter, EVD | C127566 | Largest Cross-sec Diameter, EVD;Largest Cross-sectional Diameter, End Ventricular Diastole | The largest cross sectional diameter of a vascular structure measured at end ventricular diastole. | Largest Cross-sectional Diameter at End Ventricular Diastole | ||
Largest Cross-sec Thickness | C127567 | Largest Cross-sec Thickness;Largest Cross-sectional Thickness | The assessment of the largest cross-sectional thickness of a tissue. | Largest Cross-sectional Thickness | ||
Late Lumen Loss | C116146 | Late Lumen Loss | The difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography. | Late Lumen Loss Measurement | ||
Left Ventricular Ejection Fraction | C99524 | Left Ventricular Ejection Fraction | The percent or fraction of the left ventricular end diastolic volume ejected during systole that can be measured by visual estimation or calculation. | Left Ventricular Ejection Fraction | ||
Left Ventricular Ejection Fraction, Cal | C135374 | Left Ventricular Ejection Fraction, Cal;Left Ventricular Ejection Fraction, Calculated | A calculated estimation of the percent or fraction of the volume of blood ejected from the left ventricle during left ventricular systole, calculated as the left ventricular stroke volume divided by the left ventricular end diastolic volume. | Calculated Left Ventricular Ejection Fraction | ||
Left Ventricular Ejection Fraction, Est | C135375 | Left Ventricular Ejection Fraction, Est;Left Ventricular Ejection Fraction, Estimated | A visual estimation of the percent or fraction of the volume of blood ejected from the left ventricle during left ventricular systole. | Estimated Left Ventricular Ejection Fraction | ||
Left Ventricular Fractional Shortening | C38020 | Left Ventricular Fractional Shortening | The reduction in the length of the end-diastolic diameter dimension that occurs between end-systole and end-diastole, expressed as a fraction of the end-diastolic dimension. Calculation of the left ventricular fractional shortening is per the following formula: [(end-diastolic dimension minus end-systolic dimension) divided by end-diastolic dimension] multiplied by 100. | Left Ventricular Fractional Shortening | ||
Left Ventricular Mass Index | C142243 | Left Ventricular Mass Index | The left ventricular mass divided by the subject's body surface area. | Left Ventricular Mass Index | ||
Left Ventricular Mass, Estimated | C142242 | Left Ventricular Mass, Estimated | The weight of the left ventricle in grams as estimated by a formula that uses estimated measurements from echocardiographic exams, as well as constants like the specific gravity of the myocardium. Left ventricular mass is estimated using the following equation, LV Mass (g) = 0.8 {1.04[([LVEDD + IVSd + PWd]^3 - LVEDD^3)]} + 0.6, where LVEDD is LV end-diastolic dimension, IVSd is interventricular septal thickness at end-diastole, and PWd is posterior wall thickness at end-diastole. | Estimated Mass of Left Ventricle | ||
Length | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
Lesion Restenosis Indicator | C116147 | Lesion Restenosis Indicator | An indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site. | Lesion Restenosis Indicator | ||
LVOT Peak Velocity | C127568 | Left Ventricular Outflow Tract Peak Velocity;LVOT Peak Velocity | A measurement of the maximum velocity of blood flow measured in the left ventricular outflow tract during left ventricular systole. | Left Ventricular Outflow Tract Peak Velocity | ||
LVOT Velocity Time Integral | C127569 | Left Ventricular Outflow Tract Velocity Time Integral;LVOT Velocity Time Integral | The integral of all of the instantaneous flow velocities within the left ventricular outflow tract during left ventricular systole. | Left Ventricular Outflow Tract Velocity Time Integral | ||
Major Axis Cross-sec Diameter, EVD | C127573 | Major Axis Cross-sec Diameter, EVD;Major Axis Cross-sectional Diameter, End Ventricular Diastole | The cross sectional diameter of a cardiovascular structure measured along its major axis at end ventricular diastole. | Major Axis Cross-sectional Diameter at End Ventricular Diastole | ||
Major Axis Cross-sec Diameter, EVS | C127574 | Major Axis Cross-sec Diameter, EVS;Major Axis Cross-sectional Diameter, End Ventricular Systole | The cross sectional diameter of a cardiovascular structure measured along its major axis at end ventricular systole. | Major Axis Cross-sectional Diameter at End Ventricular Systole | ||
Major Axis Cross-sec. Diameter | C135377 | Major Axis Cross-sec. Diameter;Major Axis Cross-sectional Diameter | The cross sectional diameter of a tissue, organ, or structure measured along its major axis. (NCI) | Major Axis Cross-sectional Diameter | ||
Major Axis Cross-sec. Diameter, MVS | C139053 | Major Axis Cross-sec. Diameter, MVS;Major Axis Cross-sectional Diameter, Mid Ventricular Systole | The cross-sectional diameter of a cardiovascular structure measured along its major axis at mid ventricular systole. | Major Axis Cross-sectional Diameter at Mid Ventricular Systole | ||
Major Axis Internal Diameter, EVD | C139059 | Major Axis Internal Diameter, End Ventricular Diastole;Major Axis Internal Diameter, EVD | The internal diameter of a cardiovascular structure measured along its major axis at end ventricular diastole. | Major Axis Internal Diameter at End Ventricular Diastole | ||
Major Axis Internal Diameter, EVS | C139058 | Major Axis Internal Diameter, End Ventricular Systole;Major Axis Internal Diameter, EVS | The internal diameter of a cardiovascular structure measured along its major axis at end ventricular systole. | Major Axis Internal Diameter at End Ventricular Systole | ||
Mass | C43246 | Mass | The amount of matter in an object. | Mass | ||
Maximal Pericardial Effusion Width | C139048 | Maximal Pericardial Effusion Width | The quantitative measurement of the maximum separation between the parietal and visceral pericardia during diastole. | Maximal Pericardial Effusion Width | ||
Mean Blood Flow Velocity | C127570 | Mean Blood Flow Velocity | A measurement of the mean velocity of blood across an area or tissue. | Mean Blood Flow Velocity | ||
Mean Blood Pressure, Estimated | C135376 | Mean Blood Pressure, Estimated | The estimated average blood pressure. (NCI) | Estimated Mean Blood Pressure | ||
Mean Pressure Gradient | C147152 | Mean Pressure Gradient | A value that represents the mean pressure gradient that exists between two points across a structure. | Mean Pressure Gradient | ||
Mean Vessel Diameter | C116143 | Mean Vessel Diameter | The mean of the inside diameters of the normal blood vessel segments. | Mean Vessel Diameter | ||
Minimum Vessel Lumen Diameter | C116144 | Minimum Vessel Lumen Diameter | The minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view. | Minimum Vessel Lumen Diameter | ||
Minor Axis Cross-sec Diameter, EVD | C127575 | Minor Axis Cross-sec Diameter, EVD;Minor Axis Cross-sectional Diameter, End Ventricular Diastole | The cross sectional diameter of a cardiovascular structure measured along its minor axis at end ventricular diastole. | Minor Axis Cross-sectional Diameter at End Ventricular Diastole | ||
Minor Axis Cross-sec Diameter, EVS | C127576 | Minor Axis Cross-sec Diameter, EVS;Minor Axis Cross-sectional Diameter, End Ventricular Systole | The cross sectional diameter of a cardiovascular structure measured along its minor axis at end ventricular systole. | Minor Axis Cross-sectional Diameter at End Ventricular Systole | ||
Minor Axis Cross-sec. Diameter | C135378 | Minor Axis Cross-sec. Diameter;Minor Axis Cross-sectional Diameter | The cross sectional diameter of a tissue, organ, or structure measured along its minor axis. (NCI) | Minor Axis Cross-sectional Diameter | ||
Minor Axis Cross-sec. Diameter, MVS | C139052 | Minor Axis Cross-sec. Diameter, MVS;Minor Axis Cross-sectional Diameter, Mid Ventricular Systole | The cross-sectional diameter of a cardiovascular structure measured along its minor axis at mid ventricular systole. | Minor Axis Cross-sectional Diameter at Mid Ventricular Systole | ||
Minor Axis Internal Diameter, EVD | C139061 | Minor Axis Internal Diameter, End Ventricular Diastole;Minor Axis Internal Diameter, EVD | The internal diameter of a cardiovascular structure measured along its minor axis at end ventricular diastole. | Minor Axis Internal Diameter at End Ventricular Diastole | ||
Minor Axis Internal Diameter, EVS | C139060 | Minor Axis Internal Diameter, End Ventricular Systole;Minor Axis Internal Diameter, EVS | The internal diameter of a cardiovascular structure measured along its minor axis at end ventricular systole. | Minor Axis Internal Diameter at End Ventricular Systole | ||
Mitral E/A Ratio | C127571 | Mitral E/A Ratio | The ratio of the peak early ventricular diastolic (E) transmitral velocity to the peak late ventricular diastolic (A) transmitral velocity. | Mitral E/A Ratio | ||
Mitral E/e' Ratio | C127572 | Mitral E/e' Ratio | The ratio of the peak early ventricular diastolic (E) transmitral velocity to the peak early mitral annular motion velocity (e'). | Mitral E/e' Ratio | ||
Mitral Regur Jet Area L Atrial Area Rt | C127577 | Mitral Regur Jet Area L Atrial Area Rt;Mitral Regurgitant Jet Area to Left Atrial Area Ratio | A relative measurement (ratio) of the mitral regurgitant jet area to left atrial area. | Mitral Regurgitant Jet Area to Left Atrial Area Ratio | ||
Mitral Valve Regurgitant Fraction | C127578 | Mitral Valve Regurgitant Fraction | A measurement of the volume of retrograde blood flow across the orifice of the mitral valve expressed as a percentage of the anterograde flow volume. | Mitral Valve Regurgitant Fraction | ||
Mitral Valve Regurgitant Jet Area | C127579 | Mitral Valve Regurgitant Jet Area | The measured area of the regurgitant jet of blood into the left atrium. | Mitral Valve Regurgitant Jet Area | ||
Mitral Valve Regurgitant Volume | C127580 | Mitral Valve Regurgitant Volume | A measurement of the volume of retrograde blood flow across the orifice of the mitral valve. | Mitral Valve Regurgitant Volume | ||
Mitral Valve Vena Contracta Area | C127581 | Mitral Valve Vena Contracta Area | The area of the vena contracta of the mitral valve. | Mitral Valve Vena Contracta Area | ||
Mitral Valve Vena Contracta Width | C127582 | Mitral Valve Vena Contracta Width | The width of the vena contracta of the mitral valve. | Mitral Valve Vena Contracta Width | ||
Myocardial Performance Index | C139043 | Myocardial Performance Index | A calculated result that uses the following base formula to quantify both systolic and diastolic ventricular function: MPI = (IVCT + IVRT)/VET, where IVCT is isovolumetric contraction time, IVRT is isovolumetric relaxation time, and VET is ventricular ejection time. | Myocardial Performance Index | ||
Native Cardiac Valve Intervention Type | C139050 | Native Cardiac Valve Intervention Type | A description of what kind of intervention has been performed on a native cardiac valve. | Native Cardiac Valve Intervention Type | ||
Number of Cusps | C139054 | Number of Cusps | A quantitative determination of the number of cusps composing a given cardiac valve. | Number of Cardiac Valve Cusps | ||
Number of Diseased Coronary Vessels | C99996 | Number of Diseased Coronary Vessels | Number of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area. | Number of Diseased Coronary Artery Vessels | ||
Obs Med Device Type In Intended Loc | C146994 | Obs Med Device Type In Intended Loc;Observed Medical Device In The Intended Location | A description of the type of medical device that is found in a subject and is in its intended location. | Observed Medical Device Type In Intended Location | ||
Obs Med Device Type Not In Intended Loc | C147153 | Obs Med Device Type Not In Intended Loc | A description of the type of medical device that is found in a subject but is not in its intended location. | Observed Medical Device Type Not Present In Intended Location Type | ||
Observed Foreign Body Indicator | C147151 | Observed Foreign Body Indicator | An indication as to whether a medical or non-medical foreign body is present in a subject. | Observed Foreign Body Indicator | ||
Observed Non-Medical Foreign Body Type | C147154 | Observed Non-Medical Foreign Body Type | A description of the type of non-medical foreign body that is found in a subject. | Observed Non-Medical Foreign Body Type | ||
Peak A Velocity | C127584 | Peak A Velocity | The peak velocity of blood flow across a cardiac valve during late ventricular diastole (the active filling of the ventricle). | Peak A Velocity | ||
Peak Blood Flow Velocity | C127583 | Peak Blood Flow Velocity | A measurement of the maximum velocity of blood across an area or tissue. | Peak Blood Flow Velocity | ||
Peak E Velocity | C127585 | Peak E Velocity | The peak velocity of blood flow across a cardiac valve during early ventricular diastole (the passive filling of the ventricle). | Peak E Velocity | ||
Peak Pressure Gradient | C147155 | Peak Pressure Gradient | A value that represents the maximum pressure gradient that exists between two points across a structure. | Peak Pressure Gradient | ||
Peak Pressure Rise Rate | C139044 | Peak Pressure Rise Rate | The greatest rate of increase in peak pressure. | Peak Pressure Rise Rate | ||
Percent Diameter Stenosis | C116145 | Percent Diameter Stenosis | The value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD). | Percent Diameter Stenosis | ||
Pericardial Effusion Indicator | C139046 | Pericardial Effusion Indicator | An indication as to whether there is effusion between the parietal and visceral pericardia. | Pericardial Effusion Indicator | ||
Pericardial Effusion Size | C139047 | Pericardial Effusion Size | The qualitative description of the overall size of a pericardial effusion as assessed at the point of greatest separation between the parietal and visceral pericardia during diastole. | Pericardial Effusion Size | ||
Pressure Half Time | C147156 | Pressure Half Time | The amount of time required for the peak transvalvular pressure gradient to decrease to one half of the value. | Pressure Half Time | ||
Prosthetic Cardiac Valve Type | C139051 | Prosthetic Cardiac Valve Type | A description of the type of artificial cardiac valve in use. | Prosthetic Cardiac Valve Type | ||
Pulmonary Arterial Hypertension Ind | C135379 | Pulmonary Arterial Hypertension Ind;Pulmonary Arterial Hypertension Indicator | An indication as to whether pulmonary arterial hypertension is present. | Pulmonary Arterial Hypertension Indicator | ||
Pulmonary Valve Regurgitant Fraction | C127588 | Pulmonary Valve Regurgitant Fraction | A measurement of the volume of retrograde blood flow across the orifice of the pulmonic valve expressed as a percentage of the anterograde flow volume. | Pulmonary Valve Regurgitant Fraction | ||
Pulmonary Valve Regurgitant Volume | C127590 | Pulmonary Valve Regurgitant Volume | A measurement of the volume of retrograde blood flow across the orifice of the pulmonic valve. | Pulmonary Valve Regurgitant Volume | ||
Pulmonary Valve Vena Contracta Area | C127591 | Pulmonary Valve Vena Contracta Area | The area of the vena contracta of the pulmonic valve. | Pulmonary Valve Vena Contracta Area | ||
Pulmonary Valve Vena Contracta Width | C127592 | Pulmonary Valve Vena Contracta Width | The width of the vena contracta of the pulmonic valve. | Pulmonary Valve Vena Contracta Width | ||
Pulmonary Vascular Resistance | C119247 | Pulmonary Vascular Resistance | The resistance to blood flow through the pulmonary vasculature. | Pulmonary Vascular Resistance | ||
Pulmonary Vein Dominance | C127587 | Pulmonary Vein Dominance | The determination of whether blood flow in the pulmonary veins is greater during ventricular systole or diastole. | Pulmonary Vein Dominance | ||
Pulmonic Regur Jet Width RVOT Diam Rt | C127586 | Pulmonic Regur Jet Width RVOT Diam Rt;Pulmonic Regurgitant Jet Width to Right Ventricular Outflow Tract Diameter Ratio | A relative measurement (ratio) of the pulmonic regurgitant jet width to right ventricular outflow tract (RVOT) diameter. | Pulmonic Regurgitant Jet Width to Right Ventricular Outflow Tract Diameter Ratio | ||
Pulmonic Valve Regurgitant Jet Width | C127589 | Pulmonic Valve Regurgitant Jet Width | The measured width of the regurgitant jet of blood into the right ventricular outflow tract. | Pulmonic Valve Regurgitant Jet Width | ||
Pulse Wave Velocity | C122087 | Pulse Wave Velocity | The distance traveled by the peak of the ventricular ejection pressure wave per unit of time. | Pulse Wave Velocity | ||
Reflection Magnitude | C122089 | Reflection Magnitude | The reflected-to-forward pressure wave amplitude ratio. (Hashimoto J et al, J Hypertens. 2008 May;26(5):1017-24) | Reflection Magnitude | ||
Reflection Wave Amplitude | C122090 | Reflection Wave Amplitude | The summation of the numerous waves being reflected by sites of impedance mismatch where central elastic arteries join more muscular arteries. | Reflection Wave Amplitude | ||
Right Ventricular Ejection Fraction, Cal | C135380 | Right Ventricular Ejection Fraction, Cal;Right Ventricular Ejection Fraction, Calculated | A calculated estimation of the percent or fraction of the volume of blood ejected from the right ventricle during right ventricular systole, calculated as the right ventricular stroke volume divided by the right ventricular end diastolic volume. | Calculated Right Ventricular Ejection Fraction | ||
Right Ventricular Ejection Fraction, Est | C135381 | Right Ventricular Ejection Fraction, Est;Right Ventricular Ejection Fraction, Estimated | A visual estimation of the percent or fraction of the volume of blood ejected from the right ventricle during right ventricular systole. | Estimated Right Ventricular Ejection Fraction | ||
Stanford AoD Classification | C139040 | Stanford AoD Classification;Stanford Aortic Dissection Classification | The type of aortic dissection present as defined by the Stanford Classification System (Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE. Management of acute aortic dissections. Ann Thorac Surg. 1970 Sep;10(3):237-47). | Stanford Aortic Dissection Classification | ||
Stroke Volume | C94989 | Stroke Volume | The difference in the volumes of blood between the points of maximum dilation and maximum contraction. This is the end diastolic volume minus the end systolic volume. | Stroke Volume | ||
Systemic Vascular Resistance | C119248 | Systemic Vascular Resistance;Total Peripheral Resistance | The resistance to blood flow through the systemic vasculature. | Systemic Vascular Resistance | ||
Systolic Anterior Motion Indicator | C127593 | SAM Indicator;Systolic Anterior Motion Indicator | An indication as to whether there is systolic anterior motion of a cardiac valve and its associated structures. | Systolic Anterior Motion Indicator | ||
Systolic Anterior Motion Severity | C127594 | SAM Severity;Systolic Anterior Motion Severity | The assessment of the severity of the systolic anterior motion of a cardiac valve and its associated structures. | Systolic Anterior Motion Severity | ||
Systolic Pressure, Estimated | C139031 | Systolic Pressure, Estimated | A quantitative estimate of the pressure in a given cardiovascular structure during ventricular systole. | Estimated Systolic Blood Pressure | ||
Tricus Regur Jet Area R Atrial Area Rt | C127597 | Tricus Regur Jet Area R Atrial Area Rt;Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio | A relative measurement (ratio) of the tricuspid regurgitant jet area to the right atrial area. | Tricuspid Regurgitant Jet Area to Right Atrial Area Ratio | ||
Tricuspid Valve Regurgitant Fraction | C127598 | Tricuspid Valve Regurgitant Fraction | A measurement of the volume of retrograde blood flow across the orifice of the tricuspid valve expressed as a percentage of the anterograde flow volume. | Tricuspid Valve Regurgitant Fraction | ||
Tricuspid Valve Regurgitant Jet Area | C127599 | Tricuspid Valve Regurgitant Jet Area | The measured area of the regurgitant jet of blood into the right atrium. | Tricuspid Valve Regurgitant Jet Area | ||
Tricuspid Valve Regurgitant Volume | C127600 | Tricuspid Valve Regurgitant Volume | A measurement of the volume of retrograde blood flow across the orifice of the tricuspid valve. | Tricuspid Valve Regurgitant Volume | ||
Tricuspid Valve Vena Contracta Area | C127601 | Tricuspid Valve Vena Contracta Area | The area of the vena contracta of the tricuspid valve. | Tricuspid Valve Vena Contracta Area | ||
Tricuspid Valve Vena Contracta Width | C127602 | Tricuspid Valve Vena Contracta Width | The width of the vena contracta of the tricuspid valve. | Tricuspid Valve Vena Contracta Width | ||
Valve Area Index | C147157 | Valve Area Index | The ratio of the valve area to the body surface area. | Valve Area Index | ||
Valve Area | C147158 | Valve Area | The quantitative measurement estimating the surface area of a valve. | Valve Area | ||
Velocity Time Integral, Blood Flow | C127603 | Velocity Time Integral, Blood Flow | The integral of all of the forward flow velocities during the time of blood flow across or within a specified area. | Blood Flow Velocity Time Integral | ||
Weight | C25208 | Weight | The vertical force exerted by a mass as a result of gravity. (NCI) | Weight | ||
Width | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
Back to top | ||||||
CL.C127263.CASEFIND | Case Finding
(CASEFIND) | text
Extensible: Yes | C127263 | Case Finding | Terminology relevant to how actively a search was performed for identifying individuals with a particular disease. | CDISC SDTM Case Finding Terminology |
ACTIVE CASE SEARCH | C127515 | Purposefully looking for subjects with a particular characteristic or disease. | Active Case Search | |||
PASSIVE CASE SEARCH | C127516 | Finding subjects with a particular characteristic or disease without actively searching. | Passive Case Search | |||
Back to top | ||||||
CL.C181171.CPCAT | Category for Cell Phenotyping
(CPCAT) | text
Extensible: Yes | C181171 | Category for Cell Phenotyping | Terminology relevant to the category of cell phenotyping tests. | CDISC SDTM Category for Cell Phenotyping Terminology |
CELL FUNCTION | C181251 | An assay type that examines a cellular pathway or biological process. | Cell Function Assay | |||
IMMUNOPHENOTYPING | C181250 | An assay type that examines the types of markers or antigens associated with the cell surface, nucleus, or cytoplasm. | Immunophenotyping Assay | |||
TARGET ENGAGEMENT | C181182 | An assay type that examines the interaction of ligands with their target biomolecules. | Target Engagement Assay | |||
Back to top | ||||||
CL.C118971.CCCAT | Category of Clinical Classification
(CCCAT) | text
Extensible: Yes | C118971 | Category of Clinical Classification | A grouping of observations within the Disease Response and Clin Classification domain. | CDISC Clinical Classification Category Terminology |
AIMS | C102111 | AIMS01 | Abnormal Involuntary Movement Scale (AIMS) (Guy W. Ed. ECDEU Assessment Manual for Psychopharmacology. Rockville MD: US Dept of Health, Education and Welfare. 1976, Publication No. (ADM) 76-338). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Abnormal Involuntary Movement Scale Clinical Classification | ||
AJCC V7 | C125755 | AJCC1 | AJCC TNM Staging System 7th Edition (AJCC V7) (Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual (7th ed). New York, NY: Springer; 2010). No part of the AJCC V7 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Springer 2010. All rights reserved. | AJCC Cancer Staging Manual 7th Edition | ||
AJCC V8 | C146985 | AJCC2 | AJCC TNM Staging System 8th Edition (AJCC V8) (Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017. AJCC Cancer Staging Manual, Eighth Edition. Copyright 2017 American College of Surgeons. All rights reserved). No part of the AJCC V8 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright American College of Surgeons 2017. All rights reserved. | AJCC Cancer Staging Manual 8th Edition | ||
APACHE II | C121005 | APCH1 | Acute Physiology and Chronic Health Evaluation II (APACHE II) (Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985; 13(10):818-29). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Acute Physiology and Chronic Health Evaluation II Clinical Classification | ||
APGAR SCORE V1 | C176057 | APGR01 | Apgar Score V1 (APGAR SCORE V1) (Apgar, Virginia 1953. A Proposal for a New Method of Evaluation of the Newborn Infant. Cur Res in Anesth Analg. 1953 Jul-Aug;32(4):260-7. Butterfield J, Covey MJ. Practical Epigram of the Apgar Score. JAMA. 1962; 181(4):353). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Apgar Score Version 1 Clinical Classification | ||
ARC STC GRADE | C119107 | STCG01 | Stent Thrombosis Coronary ARC Grade (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Stent Thrombosis Coronary ARC Grade Clinical Classification | ||
ASCVD 10-YEAR RISK | C124705 | ASCVD1 | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator (Goff Jr DC et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129: S49-S73). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Atherosclerotic Cardiovascular Disease 10-Year Risk Estimator Clinical Classification | ||
ASSIGN CVD 10-YEAR RISK | C124706 | ASSG01 | ASSIGN Cardiovascular Disease 10-Year Risk Score (Woodward M, Brindle P, Tunstall-Pedoe H, for the SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 93: 172-176). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | ASSIGN Cardiovascular Disease 10-Year Risk Score Clinical Classification | ||
ATLAS | C147589 | ATLAS1 | Age, treatment with systemic antibiotics, leukocyte count, serum albumin, and serum creatinine as a measure of renal function (ATLAS) (Miller, M.A., Louie,T., Mullane, K., Weiss, K., Lentnek, A., Golan, Y., et al. (2013). Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infectious Diseases, 13: 148). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | ATLAS Score Clinical Classification | ||
AVPU | C161656 | AVPU01 | Alert Verbal Painful Unresponsive (AVPU) Scale (American College of Surgeons Committee on Trauma. Advanced trauma life support course for physicians. Chicago, IL: American College of Surgeons; 1989. Kelly CA, Upex A, Bateman DN. Comparison of consciousness level assessment in the poisoned patient using the alert/verbal/painful/unresponsive scale and the Glasgow Coma Scale. Annals of Emergency Medicine 2004 Aug;44(2):108-13). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Alert Verbal Painful Unresponsive Scale Clinical Classification | ||
BARS | C102113 | BARS01 | Barnes Akathisia Rating Scale (BARS) (Barnes TR: A Rating Scale for Drug-Induced Akathisia. British Journal of Psychiatry 154:672-676, 1989). | Barnes Akathisia Rating Scale Clinical Classification | ||
BDI | C106693 | BDI01 | Baseline Dyspnea Index (BDI) (Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85: 751-758). No part of the BDI may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Donald A. Mahler, MD and payment of any applicable fees. Copyright Donald A. Mahler. All rights reserved. | Baseline Dyspnea Index Clinical Classification | ||
BODE INDEX | C121006 | BODE01 | The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index (BODE Index) (Bartolome R. Celli, M.D., Claudia G. Cote, M.D., Jose M. Marin, M.D., Ciro Casanova, M.D., Maria Montes de Oca, M.D., Reina A. Mendez, M.D., Victor Pinto Plata, M.D., and Howard J. Cabral, Ph.D.; N Engl J Med 2004;350:1005-12). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index Clinical Classification | ||
BPRS 1988 VERSION | C161657 | BPRS01 | Brief Psychiatric Rating Scale 1988 Version (BPRS 1988 VERSION) (Overall, JE, Gorham DR: The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacology Bulletin 24:97-99, 1988). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Brief Psychiatric Rating Scale 1988 Version Clinical Classification | ||
BPRS-A | C100761 | BPRSA1 | Brief Psychiatric Rating Scale - Anchored (BPRS-A) (Woerner MB, Mannuzza S, and Kane JM. Anchoring the BPRS: An Aid to Improved Reliability. Psychopharmacology Bulletin 1988; 24(1):112-117). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Brief Psychiatric Rating Scale A Clinical Classification | ||
BUERS | C130304 | BUERS1 | Brooke Upper Extremity Rating Scale (BUERS) (Brooke MG, Griggs RC, Mendell JR, Fenichel, GM, Shumate JB and Peggegrino RJ (1981). Clinical trial in duchenne dystrophy. I The Design of the Protocol. Muscle and Nerve: 4:186-197). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Brooke Upper Extremity Rating Scale Clinical Classification | ||
CAPS DSM-5 WITH DSM IV SCORING 2016 VERSION | C187509 | CAP01 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version (CAPS DSM-5 WITH DSM IV SCORING 2016 VERSION) (2016 Version Copyrighted. Sara Freedman, Michal Achituv, Arieh Y Shalev. Center for Traumatic Stress Studies. Shaare Zedek Medical Center, Jerusalem). No part of the CAPS DSM-5 WITH DSM IV SCORING 2016 VERSION may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the copyright holders and payment of any applicable fees. Copyright Sara Freedman, Michal Achituv, Arieh Y Shalev. All rights reserved. | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Clinical Classification | ||
CDAI V1 | C176059 | CDAI01 | Crohn's Disease Activity Index Version 1 (CDAI V1) (Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439-44). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Crohn's Disease Activity Index Version 1 Clinical Classification | ||
CDC HIV CLASSIFICATION FOR ADULTS AND ADOLESCENTS | C124715 | CHIVC1 | CDC Classification System for HIV-Infected Adults and Adolescents (Centers for Disease Control and Prevention. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Center for Disease Control and Prevention Classification System for HIV-Infected Adults and Adolescents Clinical Classification | ||
CDRS-R | C155323 | CDRS1 | Children's Depression Rating Scale, Revised (CDRS-R) (Copyright 1995 by WESTERN PSYCHOLOGICAL SERVICES. Not to be reproduced in whole or in part without written permission. All rights reserved). No part of the CDRS-R may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of WESTERN PSYCHOLOGICAL SERVICES and payment of any applicable fees. Copyright WESTERN PSYCHOLOGICAL SERVICES. All rights reserved. | Children's Depression Rating Scale, Revised Clinical Classification | ||
CHILD-PUGH CLASSIFICATION | C121007 | CPS01 | Child-Pugh Classification (Guidance for Industry Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER). May 2003, Clinical Pharmacology. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM072123.pdf; http://www.halaven.com/sites/default/files/ChildPugh_FlashCard.pdf). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Child-Pugh Clinical Classification | ||
CIRS-G | C189701 | CIRSG1 | Cumulative Illness Rating Scale for Geriatrics (CIRS-G) (A Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics (CIRS-G), May 1991, written by Mark D. Miller, M.D. with Adele Towers, M.D., University of Pittsburgh School of Medicine, Department of Geriatric Psychiatry, Western Psychiatric Institute and Clinic, 3811 O'Hara Street Pittsburgh, Pennsylvania 15213). No part of the CIRS-G may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Mark D. Miller and Adele Towers and payment of any applicable fees. Copyright Mark D. Miller and Adele Towers 1991. All rights reserved. | Cumulative Illness Rating Scale for Geriatrics Clinical Classification | ||
COVI | C156675 | COVI01 | Covi Anxiety Scale (COVI) (Lipman RS. Differentiating anxiety and depression in anxiety disorders: use of rating scales. Psychopharmacol Bull 1982; 18(4):69-77). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Covi Anxiety Scale Clinical Classification | ||
CRS-R | C124711 | CRSR01 | JFK Coma Recovery Scale-Revised (CRS-R) (Joseph T. Giacino, Kathleen Kalmar, John Whyte. The JFK Coma Recovery Scale-Revised: Measurement Characteristics and Diagnostic Utility. Arch Phys Med Rehabil Vol 85, December 2004). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | JFK Coma Recovery Scale-Revised Clinical Classification | ||
DISEASE STEPS | C112519 | DS01 | Disease Steps (DS) (Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology. 1995 Feb;45(2):251-5). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Disease Steps Clinical Classification | ||
DRS | C115796 | DRS01 | Disability Rating Scale (DRS) (Rappaport et al. (1982) Disability Rating Scale for Severe Head Trauma Patients: Coma to Community. Archives of Physical Medicine and Rehabilitation, 63:118-123). | Disability Rating Scale Clinical Classification | ||
E-TRIP | C161658 | ETRP01 | Emory Treatment Resistance Interview for PTSD (E-TRIP) (Dunlop BW, Kaye JL, Youngner C, Rothbaum B. Assessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP). Behav Sci (Basel) 2014; Dec 8; 4(4):511-527). No part of the E-TRIP may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Boadie W. Dunlop, MD and payment of any applicable fees. Copyright Boadie W. Dunlop, MD, 2018. All rights reserved. | Emory Treatment Resistance Interview for PTSD Clinical Classification | ||
ECOG | C102116 | ECOG1 | Eastern Cooperative Oncology Group (ECOG) Performance Status (Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649-55). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Eastern Cooperative Oncology Group Performance Status Clinical Classification | ||
EDSS | C112520 | EDSS01 | Kurtzke Expanded Disability Status Scale (EDSS) (Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444-52). | Kurtzke Expanded Disability Status Scale Clinical Classification | ||
ESRSA | C117997 | ESRSA1 | Extrapyramidal Symptom Rating Scale-Abbreviated (ESRS-A) (Copyright 2006 Larry Alphs, MD, PhD, Guy Chouinard, MD, All Rights Reserved). | Extrapyramidal Symptom Rating Scale-Abbreviated Clinical Classification | ||
FAQ | C111381 | FAQ01 | Functional Activities Questionnaire (FAQ) (Pfeiffer, RI.; Kurosaki, TT.; Harrah, CH. Jr.; Chance, JM.; and Filos, S. (1982). Measurement of functional activities in older adults in the community. Journal of Gerontology, 37(3), 323-329.). No part of the FAQ may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Robert I Pfeffer and payment of any applicable fees. Copyright Robert I Pfeffer 1987. All rights reserved. | Functional Activities Questionnaire Clinical Classification | ||
FAQ-NACC UDS V2.0 | C111382 | FAQNA1 | Functional Assessment Questionnaire-NACC UDS V2.0 (FAQ-NACC UDS V2.0) (Pfeffer, RI.; Kurosaki, TT.; Harrah, CH. Jr.; Chance, JM.; and Filos, S. (1982). Measurement of functional activities in older adults in the community. Journal of Gerontology, 37(3), 323-329.). (Reproduced with permission. Copyright 2011 University of Washington. Created and published by the ADC Clinical Task Force. John C. Morris, MD, Chair, and the National Alzheimer's Coordinating Center. U01 AG016976 - Walter A. Kukull, PhD, Director). No part of the FAQ-NACC UDS V2.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the University of Washington and payment of any applicable fees. Copyright University of Washington 2011. All rights reserved. | Functional Assessment Questionnaire-NACC UDS Version 2.0 Clinical Classification | ||
FAS-NACC UDS V3.0 | C170643 | FASNA1 | Functional Assessment Scale-NACC UDS v3.0 (FAS-NACC UDS V3.0) (These materials discuss and/or include NACC Functional Assessment Scale (FAS) v3.0 which is owned exclusively by the University of Washington. Copyright Reproduced with permission. Copyright 2006, 2008, 2015, 2017 University of Washington. Created and published by the ADC Clinical Task Force (John C. Morris, MD, Chair) and the National Alzheimer's Coordinating Center (U01 AG016976 - Walter A. Kukull, PhD, Director). All rights reserved). No part of the FAS-NACC UDS V3.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without prior written permission of the University of Washington and payment of any applicable fees. Copyright 2006, 2008, 2015, 2017 University of Washington. All rights reserved. | Functional Assessment Scale-NACC UDS Version 3.0 Clinical Classification | ||
FHS CVD 10-YEAR RISK | C124707 | FCVD1 | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score (D'Agostino Sr RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, and Kannel WB. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation 2008; 117: 743-753). | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification | ||
GCS NINDS V1.0 | C124710 | GCS01 | Glasgow Coma Scale (GCS) The National Institute of Neurological Disorders and Stroke (NINDS) Version 1.0 (GCS NINDS V1.0) (Graham Teasdale and Bryan Jennett. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974 Jul 13; 2(7872):81-4. The NINDS Common Data Elements Traumatic Brain Injury website is at: https://wiki.cdisc.org/pages/viewpage.action?pageId=129043959.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Glasgow Coma Scale-NINDS Version 1.0 Clinical Classification | ||
GDRS | C187510 | GDRS1 | Global Dystonia Severity Rating Scale (GDRS) (Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T; Dystonia Study Group. Rating scales for dystonia: a multicenter assessment. Mov Disord. 2003 Mar;18(3):303-12. Copyright 2018 International Parkinson and Movement Disorder Society. All rights reserved.). No part of the Global Dystonia Severity Rating Scale may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the International Parkinson and Movement Disorder Society and payment of any applicable fees. Copyright International Parkinson and Movement Disorder Society 2018. All rights reserved. | Global Dystonia Severity Rating Scale Clinical Classification | ||
HAM-A | C102118 | HAMA1 | The Hamilton Anxiety Rating Scale (HAM-A) (Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55). | Hamilton Anxiety Rating Scale Clinical Classification | ||
HAMD 17 | C100767 | HAMD1 | The Hamilton Depression Rating Scale 17-Item (HAMD 17) (Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6(4):278-96. Assessment Scales in Depression, Mania and Anxiety, Raymond W Lam, Erin E. Michalak, Richard P Swinson, Copyright 2005 Taylor & Francis, an imprint of the Taylor & Francis Group. Guy W, ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare, 1976. The Hamilton Rating Scale for Depression: The making of a ''gold standard'' and the unmaking of a chronic illness, 1960-1980). | Hamilton Depression Rating Scale 17 Item Clinical Classification | ||
HAMD 21 | C102119 | HAMD2 | The Hamilton Depression Rating Scale 21-Item (HAMD 21) (Hedlund and Vieweg, The Hamilton rating scale for depression. Journal of Operational Psychiatry, 1979;10(2):149-165). | Hamilton Depression Rating Scale 21-Item Clinical Classification | ||
HAMD 24 | C130307 | HAMD3 | The Hamilton Depression Rating Scale 24-Item (HAM-D24) (Clinical Psychometrics: Per Bech, MD; John Wiley & Sons, Ltd. 2012). | Hamilton Depression Rating Scale-24 Item Clinical Classification | ||
HAMD 6 CLINICIAN VERSION | C130306 | HAMD4 | The Hamilton Depression Rating Scale 6 - Clinician Version (HAM-D6 - Clinician Version) (Clinical Research: Rating scales in depression: limitations and pitfalls; Per Bech, MD; Copyright 2006 LLS SAS. All rights reserved). | Hamilton Depression Rating Scale 6 Clinician Version Clinical Classification | ||
HAS-BLED | C138332 | HSB01 | HAS-BLED Bleeding Risk Score (HAS-BLED) (This image was published in Chest, 138 (5), Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY, A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation: The Euro Heart Survey, Copyright Elsevier (2010). http://www.sciencedirect.com/science/journal/00123692). | HAS-BLED Bleeding Risk Score Clinical Classification | ||
HBI | C191036 | HBI01 | Harvey-Bradshaw Index (HBI) (Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Harvey-Bradshaw Index Clinical Classification | ||
IDS-C | C130308 | IDSC1 | Inventory of Depressive Symptomatology - Clinician-Rated (IDS-C) (Copyright UT Southwestern Medical Center at Dallas. Rush, A.J., Giles, D.E., Schlesser, M.A., Fulton, C.L.,Weissenburger, J.E. and Burns, C.T. The Inventory of Depressive Symptomatology (IDS): Preliminary findings. Psychiatry Research, 18:65-87, 1986). | Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification | ||
KDIGO AKI | C170645 | KDIGO1 | Kidney Disease: Improving Global Outcomes Staging For Acute Kidney Injury (KDIGO AKI) (Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter., Suppl. 2012; 2:1-138). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury Clinical Classification | ||
KDPI | C130310 | KDPI01 | Kidney Donor Profile Index (KDPI) (OPTN/UNOS. A guide to calculating and interpreting the Kidney Donor Profile Index (KDPI). [Accessed April 18, 2016]. Available at: https://optn.transplant.hrsa.gov/media/1512/guide_to_calculating_interpreting_kdpi.pdf. Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation 2009 Jul 27;88(2):231-6). | Kidney Donor Profile Index Clinical Classification | ||
KFSS | C112522 | KFSS1 | Kurtzke Functional Systems Scores (FSS) (Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444-52). | Kurtzke Functional Systems Scores Clinical Classification | ||
KPS SCALE | C100768 | KPSS01 | The Karnofsky Performance Status Scale (KPSS) (Karnofsky DA, Burchenal JH. (1949). "The Clinical Evaluation of Chemotherapeutic Agents in Cancer." In: MacLeod CM (Ed), Evaluation of Chemotherapeutic Agents. Columbia Univ Press. Page 196). | Karnofsky Performance Status Scale Clinical Classification | ||
LPPS SCALE | C138333 | LPPSS1 | The Lansky Play-Performance Status Scale (LPSS) (Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer. 1987 Oct 1;60(7):1651-6). | The Lansky Play-Performance Status Scale Clinical Classification | ||
MELD | C121008 | MELD01 | Model for End Stage Liver Disease (MELD) (Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (April 2000). A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 (4): 864-71). | Model for End Stage Liver Disease Clinical Classification | ||
MONTREAL CLASSIFICATION CROHN'S | C191037 | MCHR01 | Montreal Classification for Crohn's Disease (MONTREAL CROHN'S) (Silverberg MS, Satsangi J, Ahmad T, Silverberg MS, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A):5A-36A). These materials discuss and/or include the Montreal Classification for Crohn's Disease (MONTREAL CLASSIFICATION CROHN'S), is owned by the consortium of the 2005 Montreal World Congress of Gastroenterology. Use of the Montreal Classification for Crohn's Disease is subject to the consortium's terms of use. | Montreal Classification for Crohn's Disease Clinical Classification | ||
MVAI | C191038 | MVAI1 | Modified Van Assche Index (MVAI) (van Rijn KL, Lansdorp CA, Tielbeek JAW, Nio CY, Buskens CJ, D'Haens GRAM, Lowenberg M, Stoker J. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease. Clin Imaging. 2020 Feb;59(2):179-187). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Modified Van Assche Index Clinical Classification | ||
NEWS2 | C171357 | NEWS1 | National Early Warning Score 2 (NEWS2) (Royal College of Physicians. National Early Warning Score (NEWS) 2: Standardising the assessment of acute-illness severity in the NHS. Updated report of a working party. London: RCP, 2017). | National Early Warning Score 2 Clinical Classification | ||
NHLBI CAD GRADE | C119105 | CADG01 | Coronary Artery Dissection NHLBI Grade (Coronary Artery angiographic changes after PTCA: Manual of Operations NHBLI PTCA Registry 1985-6:9). | Coronary Artery Dissection NHLBI Grade Clinical Classification | ||
NSA-16 | C121009 | NSA01 | Negative Symptom Assessment-16 (NSA-16) (Version 2.0, Copyright 2006, Larry Alphs, MD, PhD, All Right Reserved). | Negative Symptom Assessment-16 Clinical Classification | ||
NSAA | C132531 | NSAA1 | North Star Ambulatory Assessment (NSAA) (Copyright the North Star Clinical Network UK. Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, Manzur A, Muntoni F; North Star Clinical Network for Paediatric Neuromuscular Disease. Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int. 2012 Jun;17(2):101-9. The support of Muscular Dystrophy United Kingdom in developing the North Star Ambulatory Assessment is gratefully acknowledged). | North Star Ambulatory Assessment Clinical Classification | ||
PANSS | C124712 | PANSS1 | Positive and Negative Syndrome Scale (PANSS) (Copyright 1992 Multi-Health Systems Inc. All rights reserved). | Positive and Negative Syndrome Scale Clinical Classification | ||
PASI BOZEK | C191042 | PASI05 | Psoriasis Area and Severity Index Version Bozek (PASI BOZEK) (Bożek A, Reich A. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017;26(5):851- 856). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Psoriasis Area and Severity Index Bozek Version Clinical Classification | ||
PASI EMA | C191041 | PASI04 | Psoriasis Area and Severity Index Version EMA (PASI EMA) (European Medical Agency Committee for Medicinal Products for Human Use (CHMP). Guideline on Clinical Investigation of Medicinal Products Indicated for the Treatment of Psoriasis. Published November 18, 2004. [Accessed June 15, 2022]. Available at: https://www.ema.europa.eu/en/clinical-investigation-medicinal-products-indicated-treatment-psoriasis). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Psoriasis Area and Severity Index European Medical Agency Version Clinical Classification | ||
PASI FELDMAN | C179972 | PASI02 | Psoriasis Area and Severity Index Version Feldman (PASI FELDMAN) (Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(Suppl 2):ii65-ii73). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Psoriasis Area and Severity Index Feldman Version Clinical Classification | ||
PASI FREDRIKSSON | C191040 | PASI03 | Psoriasis Area and Severity Index Version Fredriksson (PASI FREDRIKSSON) (Fredriksson T, Pettersson U. Severe Psoriasis - Oral Therapy with a New Retinoid. Dermatologica. 1978; 157(4):238-244). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Psoriasis Area and Severity Index Fredriksson Version Clinical Classification | ||
QIDS-C | C130309 | QIDSC1 | Quick Inventory of Depressive Symptomatology - Clinician-Rated (QIDS-C) (Copyright UT Southwestern Medical Center at Dallas. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54:573-583, 2003). | Quick Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification | ||
RASS | C171417 | RASS01 | Richmond Agitation-Sedation Scale (RASS) (Sessler CN, Gosnell M, Grap MJ, Brophy GT, O'Neal PV, Keane KA et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care patients. Am J Respir Crit Care Med. 2002 Nov 15;166:1338-1344. Copyright Virginia Commonwealth University 2000. All Rights Reserved). | Richmond Agitation-Sedation Scale Clinical Classification | ||
REYNOLDS CVD 10-YEAR RISK | C124708 | RCVD01 | Reynolds Cardiovascular Disease 10-Year Risk Score (Ridker PM, Buring JE, Rifai N, Cook NR. Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score. Jama 2007; 297: 611-619), (Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men. Circulation2008; 118(22): 2243-2251). | Reynolds Cardiovascular Disease 10-Year Risk Score Clinical Classification | ||
RSSS | C174061 | RSSS01 | Rett Syndrome Severity Scale (RSSS) (Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA. The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab. 2007 Jun;92(6):2087-99). | Rett Syndrome Severity Scale Clinical Classification | ||
RUTGEERTS SCORE | C191039 | RUTG01 | Rutgeerts Score (RUTGEERTS SCORE) (Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99 (4): 956-963). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Rutgeerts Score Clinical Classification | ||
SAS | C171418 | SAS01 | Riker Sedation-Agitation Scale (SAS) (Riker, Richard R. MD, FCCP; Picard, Jean T. BSN, CCRN; Fraser, Gilles L. PharmD. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Critical Care Medicine. July 1999; 27:7:1325-1329. Copyright Lippincott Williams & Wilkins, Inc. 1999. All Rights Reserved). | Riker Sedation-Agitation Scale Clinical Classification | ||
SES-CD V1 | C176060 | SES01 | Simple Endoscopic Score for Crohn's Disease Version 1 (SES-CD V1) (Daperno M, D'Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, Sostegni R, Rocca R, Pera A, Gevers A, Mary JY, Colombel JF, Rutgeerts P. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004; 60 (4): 505-512). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Simple Endoscopic Score for Crohn's Disease Version 1 Clinical Classification | ||
TANNER SCALE BOY | C124703 | TANN02 | Tanner Scale Boy (Marshall WA, Tanner JM. Variations in pattern of pubertal changes in boys. Arch Dis Child 1970 Feb;45(239):13-23). | Tanner Scale Boy Version | ||
TANNER SCALE GIRL | C124704 | TANN01 | Tanner Scale Girl (Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969 Jun; 44(235): 291-303). | Tanner Scale Girl Version | ||
TDI | C106694 | TDI01 | Transition Dyspnea Index (TDI) (Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85: 751-758). | Transition Dyspnea Index Clinical Classification | ||
TIMI THROMBUS GRADE | C119104 | TIMG01 | Coronary Thrombus TIMI Grade (TIMI Definitions for Commonly Used Terms in Clinical Trials. Available at http://www.timi.org/wp-content/uploads/2010/10/TIMI-Definitions.pdf. Accessed November 30, 2013). | Coronary Thrombus TIMI Grade Clinical Classification | ||
UHDRS 1999 | C155324 | UHDR1 | Unified Huntington's Disease Rating Scale '99 (UHDRS 1999) (Huntington Study Group. (1996). Unified Huntington's Disease Rating Scale: Reliability and Consistency. Movement Disorders, 11(2), 136-142). | Unified Huntington's Disease Rating Scale 1999 Version Clinical Classification | ||
UPDRS | C100778 | UPD1 | Unified Parkinson's Disease Rating Scale (UPDRS) (Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease, Vol 2. Florham Park, NJ. Macmillan Health Care Information 1987, pp 153-163, 293-304). | Unified Parkinson's Disease Rating Scale Clinical Classification | ||
VALG | C141685 | VALG01 | Veterans Administration Lung Study Group (VALG) (Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease? Micke P, Faldum A, Metz T, Beeh K.-M, Bittinger F, Hengstler J.-G, Buhl R, Lung Cancer 2002;37:271-276). | Veterans Administration Lung Study Group Clinical Classification | ||
VLERS | C130305 | VLERS1 | Vignos Lower Extremity Rating Scale (VLERS) (Vignos PJ, Spencer CE, Archibald KC. (1963) Management of progressive muscular dystrophy in childhood.JAMA 184:389-96. Brooke MG, Griggs RC, Mendell JR, Fenichel, GM, Shumate JB and Peggegrino RJ (1981). Clinical trial in duchenne dystrophy. I The Design of the Protocol. Muscle and Nerve: 4:186-197). | Vignos Lower Extremity Rating Scale Clinical Classification | ||
WEST HAVEN HEPATIC ENCEPHALOPATHY GRADE | C124709 | WHEG01 | West Haven Hepatic Encephalopathy Grade (Blei AT, Cordoba J. Hepatic Encephalopathy. Am J Gastroenterol. 2001 Jul. 96(7):1968-76). | West Haven Hepatic Encephalopathy Grade Clinical Classification | ||
WHO HIV STAGING FOR ADULTS AND ADOLESCENTS | C124713 | WHIVS1 | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents (Copyright World Health Organization 2007, World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children; 2007. Retrieved from http://www.who.int/hiv/pub/vct/hivstaging/en/). | World Health Organization Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification | ||
WHO HIV STAGING FOR CHILDREN | C124714 | WHIVS2 | WHO Clinical Staging of HIV/AIDS for Children (Copyright World Health Organization 2007, World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children; 2007. Retrieved from http://www.who.int/hiv/pub/vct/hivstaging/en/). | World Health Organization Clinical Staging of HIV/AIDS for Children Clinical Classification | ||
Back to top | ||||||
CL.C111109.DECAT | Category of Device Events
(DECAT) | text
Extensible: Yes | C111109 | Category of Device Events | A terminology codelist based on the category of related records for the device event. | CDISC SDTM Device Events Category Terminology |
CALIBRATION FAILURE | C62994 | Calibrate, Failure To;Failure to Calibrate | Issue associated with the failure of the device to perform a self-calibration procedure or process designed to assure the accuracy and proper performance of the device. (FDA) | Failure to Calibrate Problem | ||
COMPUTER SOFTWARE ISSUE | C63269 | Software Malfunction | Issue associated with written programs, codes, and/or software system that affects device performance or communication with another device. (NCI) | Computer Software Problem | ||
DATA STORAGE FAILURE | C116121 | Issue associated with the failure of the software to store collected data. | Data Storage Failure | |||
DEVICE OPERATIONAL ISSUE | C62954 | Device Operational Malfunction | Issue associated with any deviations from specifications relating to device operations (e.g. deployment, connection, electrical, computer software, infusion/flow, output, protective-measure, and incompatibility issues). | Medical Device Operational Issue | ||
NON-STUDY EQUIPMENT ISSUE | C112361 | Non-Study Equipment Malfunction | Issue associated with any deviations from specifications relating to non-study device or equipment operations. | Non-Study Device Issue | ||
SCHEDULED MAINTENANCE | C111309 | An inspection and/or surveillance activity that has been anticipated to occur and was assigned a time or date when that activity is to be performed. (NCI) | Scheduled Maintenance | |||
SOFTWARE UPDATE | C67227 | All program coding after initial deployment to correct coding errors, enhance the functionality of the software, and perfect the functioning of the software. (NCI) | Software Maintenance | |||
Back to top | ||||||
CL.C74558.DSCAT | Category of Disposition Event
(DSCAT) | text
Extensible: No | C74558 | Category of Disposition Event | Classifications that describe and group pertinent events that occur throughout the conduct of a clinical trial. | CDISC SDTM Category For Disposition Event Terminology |
DISPOSITION EVENT | C74590 | Disposition Event | The group of incidents that occur during a clinical trial and describe whether a subject completed the study epoch or the reason this event did not occur. The subject's disposition is often described for each phase of the study. | Protocol Disposition Event | ||
OTHER EVENT | C150824 | Other Event | Other important events that occur during a trial but are not driven by protocol requirements. | Non-Protocol Disposition Event | ||
PROTOCOL MILESTONE | C74588 | Protocol Milestone | Occurrences within some epochs that are initiated by a protocol-specified event. The most common protocol milestone is "Informed Consent Obtained" which usually documents the start of the study. | Protocol Milestone | ||
Back to top | ||||||
CL.C115304.FTCAT | Category of Functional Test
(FTCAT) | text
Extensible: Yes | C115304 | Category of Functional Test | A grouping of observations within the Functional Tests domain. | CDISC Functional Test Category Terminology |
10-METER WALK/RUN | C141686 | Ten Meter Walk/Run;TENMW1 | 10-Meter Walk/Run (McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357-68.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | 10-Meter Walk/Run Test Functional Test | ||
4-STAIR ASCEND | C141689 | A4STR1 | 4 Stair Ascend (McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357-68.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Four Stair Ascend Test Functional Test | ||
4-STAIR DESCEND | C141688 | D4STR1 | 4-Stair Descend (McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357-68.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Four Stair Descend Test Functional Test | ||
AVLT | C102112 | AVL01 | The Alzheimer's Disease Neuroimaging Initiative's (ADNI) version of the Auditory Verbal Learning Test (AVLT Version A) modified from Rey A. L'examen clinique en psychologie [Clinical tests in psychology]. Paris: Presses Universitaires de France; 1964. | Alzheimer's Disease Neuroimaging Initiative Auditory Verbal Learning Test Functional Test | ||
AVLT-REY | C123668 | AVL02 | Auditory Verbal Learning Test (AVLT-Rey) (Modified from Rey A. L'examen clinique en psychologie [Clinical tests in psychology]. Paris: Presses Universitaires de France; 1964. Test-Retest Reliability of a New Form of Auditory Verbal Learning Test (AVLT); Archives of Clinical Neuropsycology, Vol. 9, No. 4, pp. 303-316, 1994. Performance of Healthy Subjects and Patients with Resection from the Anterior Temporal Lobe on Matched Tests of Verbal and Visuoperceptual Learning; Journal of Clinical and Experimental Neuropsychology 1996, Vol. 18, No. 3, pp. 416-430). | Rey Auditory Verbal Learning Functional Test | ||
BACS | C121004 | BACS1 | Brief Assessment of Cognition in Schizophrenia (BACS) (Richard Keefe, PhD, Copyright 1999 Duke University Medical Center, Licenses available through Neurocog Trials, Inc.). | Brief Assessment of Cognition in Schizophrenia Functional Test | ||
COWAT | C114144 | COWAT1 | Controlled Oral Word Association Test (COWAT) (Benton, A.L., Hamsher, K., & Sivan, A.B. (1994). Multilingual Aphasia Examination (3rd ed.). Iowa City, IA: AJA Associates). | Controlled Oral Word Association Test | ||
EMOTION RECOGNITION | C150909 | EMO1 | Emotion Recognition (Ekman P, Friesen WV. Measuring facial movement. Environmental Psychology and Nonverbal Behavior. 1976;1(1):56-75). | Emotion Recognition Test Functional Test | ||
HAUSER AMBULATION INDEX | C115790 | HAI01 | Hauser Ambulation Index (AI) (Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, Mills JA, Weiner HL. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med. 1983 Jan 27;308(4):173-80). | Hauser Ambulation Index Functional Test | ||
HD-CAB | C166278 | HDCAB1 | Huntington's Disease Cognitive Assessment Battery (HD-CAB) (Copyright 2014 Monash University. All Rights Reserved. Stout, J.C. et al. HD-CAB: A cognitive assessment battery for clinical trials in Huntington's disease. Movement Disorders. 2014;29(10):1281-1288). | Huntington's Disease Cognitive Assessment Battery Functional Test | ||
MMSE | C74982 | MMS1 | Mini-Mental State Examination (MMSE) (MMSE Copyright 1975, 1998, 2001 by MiniMental, LLC All rights reserved. Published 2001 by Psychological Assessment Resources, Inc. May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc.). | Mini-Mental Status Exam | ||
MMSE-2 STANDARD VERSION | C150910 | MMS2 | Mini-Mental State Examination 2 Standard Version (MMSE-2 STANDARD VERSION) (MMSE-2 Copyright 2010 by Mini Mental, LLC. All rights reserved. Published 2010 by Psychological Assessment Resources, Inc (PAR). May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc.). | Mini-Mental State Examination 2 Standard Version Functional Test | ||
MOCA | C123667 | MOCA01 | Montreal Cognitive Assessment (MoCA) (Copyright Z. Nasreddine MD. Ziad S. Nasreddine, Natalie A. Phillips, Valerie Bedirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L. Cummings and Howard Chertkow. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9). | Montreal Cognitive Assessment Functional Test | ||
NHPT | C115791 | NHPT01 | Nine-Hole Peg Test (NHPT) (Copyright 2001, National Multiple Sclerosis Society). | Nine-Hole Peg Functional Test | ||
PACED TAPPING | C150911 | PTAP1 | Paced Tapping (Rowe KC, Paulsen JS, Langbehn DR, et al. Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology. 2010;24(4):435-442). | Paced Tapping Test Functional Test | ||
PASAT | C115792 | PASAT1 | Paced Auditory Serial Addition Test (PASAT) (Copyright 2001, National Multiple Sclerosis Society). | Paced Auditory Serial Addition Functional Test | ||
PUL V1.2 | C138334 | PUL01 | Performance of the Upper Limb Module for DMD Version 1.2 (PUL V1.2) (Mayhew A, Mazzone ES, Eagle M, et al. (2013). Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy. Dev Med Child Neurol; 55:1038-45). | Performance of the Upper Limb Module for DMD 1.2 Functional Test | ||
PUL V2.0 | C138335 | PUL02 | Performance of the Upper Limb Module for DMD Version 2.0 (PUL V2.0) (Mayhew A, Mazzone ES, Eagle M, et al. (2013). Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy. Dev Med Child Neurol; 55:1038-45). | Performance of the Upper Limb Module for DMD 2.0 Functional Test | ||
RISING FROM FLOOR | C141687 | RISEF1;Stand From Supine | Rising From Floor (McDonald CM, Henricson EK, Abresch RT, et al. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve. 2013;48(3):357-68.). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Rising From Floor Test Functional Test | ||
ROCKPORT ONE MILE WALK TEST V1.0 | C166279 | ROCK01 | Rockport One Mile Walk Test Version 1.0 (ROCKPORT ONE MILE WALK TEST V1.0) (Kline GM, Porcari JP, Hintermeister R, et. al. 1987. Estimation of VO2 Max from a one mile track walk, gender, age, and body weight. Medicine and Science in sports and Exercise. 19:253-59). | Rockport One Mile Walk Test Version 1.0 Functional Test | ||
SDMT | C115793 | SDMT01 | Symbol Digit Modalities Test (SDMT) (Copyright 1973 by Western Psychological Services). | Symbol Digit Modalities Functional Test | ||
SIX MINUTE WALK | C115789 | SIXMW1 | 6 Minute Walk Test (6MWT) (Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Multiple Sclerosis 2008; 14: 383-390). | 6 Minute Walk Functional Test | ||
SPPB V1.2 | C170646 | SPPB1 | Short Physical Performance Battery V1.2 (SPPB V1.2) (Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000 April;55(4):M221-M231). | Short Physical Performance Battery Version 1.2 Functional Test | ||
T25FW | C115794 | T25FW1 | Timed 25-Foot Walk (T25FW) (Copyright 2001, National Multiple Sclerosis Society). | Timed 25-Foot Walk Functional Test | ||
TMT | C92205 | TMT01 | Trail Making Test (TMT) [(Copyright Owner: Dr. Jim Hom, The Neuropsychology Center, 500 N. Central Expressway, Suite 272, Plano TX 75074-6877. Ph: 469-429-8890, www.neuropsych.com.)(Manual: Army Individual Test. War Department, The Adjutant General's Office, 1944.)(Reitan RM. The Relation of the Trail Making Test to Organic Brain Damage; Journal of Consulting Psychology 1955 Oct 19(5):393-4.)(Reitan R.M. (1958). The validity of the Trail Making Test as an indicator of organic brain damage; Perceptual and Motor Skills, 8, 271-276.)]. | Trail Making Test | ||
TUG | C115795 | TUG01 | Timed Up and Go (TUG) (Podsiadlo D, Richardson S. The Timed 'Up & Go': a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991; 39:142-148). | Timed Up and Go Functional Test | ||
Back to top | ||||||
CL.C66797.IECAT | Category of Inclusion/Exclusion
(IECAT) | text
Extensible: No | C66797 | Category of Inclusion/Exclusion | A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI) | CDISC SDTM Category for Inclusion And Or Exclusion Terminology |
EXCLUSION | C25370 | List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary) | Exclusion Criteria | |||
INCLUSION | C25532 | The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study. NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary) | Inclusion Criteria | |||
Back to top | ||||||
CL.C124298.ONCRSCAT | Category of Oncology Response Assessment
(ONCRSCAT) | text
Extensible: Yes | C124298 | Category of Oncology Response Assessment | The named criteria used for the grouping of assessments of response to treatment or therapy observations for oncology studies within the Disease Response and Clinical Classification domain. | CDISC SDTM Category of Oncology Response Assessment Terminology |
ADY NEUROBLASTOMA 1995 | C179778 | A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. (N Ady, J M Zucker, B Asselain, V Edeline, F Bonnin, J Michon, R Gongora, L Manil. A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma. Eur J Cancer. 1995;31A(2):256-61.) | Ady Neuroblastoma 1995 Oncology Response Criteria | |||
AJCC V4 | C191343 | AJCC Manual for Staging of Cancer 4th Edition (AJCC V4) (Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. AJCC manual for staging of cancer (4th ed). Philadelphia, PA: J.B. Lippincott; 1992). No part of the AJCC V4 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright J.B. Lippincott Company 1992. All rights reserved. | AJCC Cancer Staging Manual 4th Edition | |||
AJCC V5 | C191344 | AJCC Cancer Staging Manual 5th Edition (AJCC V5) (Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbo JW, editors. AJCC cancer staging manual (5th ed). Philadelphia, PA: Lippincott-Raven; 1997). No part of the AJCC V5 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Lippincott-Raven 1997. All rights reserved. | AJCC Cancer Staging Manual 5th Edition | |||
AJCC V6 | C186612 | AJCC Cancer Staging Manual 6th Edition (AJCC V6) (Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. AJCC cancer staging manual (6th ed). New York, NY: Springer; 2002). No part of the AJCC V6 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Springer 2002. All rights reserved. | AJCC Cancer Staging Manual 6th Edition | |||
AJCC V7 | C125755 | AJCC1 | AJCC TNM Staging System 7th Edition (AJCC V7) (Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual (7th ed). New York, NY: Springer; 2010). No part of the AJCC V7 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright Springer 2010. All rights reserved. | AJCC Cancer Staging Manual 7th Edition | ||
AJCC V8 | C146985 | AJCC2 | AJCC TNM Staging System 8th Edition (AJCC V8) (Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017. AJCC Cancer Staging Manual, Eighth Edition. Copyright 2017 American College of Surgeons. All rights reserved). No part of the AJCC V8 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Springer and payment of any applicable fees. Copyright American College of Surgeons 2017. All rights reserved. | AJCC Cancer Staging Manual 8th Edition | ||
BLAZER COLORECTAL CANCER 2008 | C125990 | Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases. (Blazer DG 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey JN. Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases. J Clin Oncol. 2008 Nov 20;26(33):5344-51.) | Blazer Colorectal Cancer 2008 Oncology Response Criteria | |||
BOONSIRIKAMCHAI COLORECTAL CANCER 2011 | C125991 | CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. (Boonsirikamchai P, Asran MA, Maru DM, Vauthey JN, Kaur H, Kopetz S, Loyer EM. CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. AJR Am J Roentgenol. 2011 Dec;197(6):W1060-6.) | Boonsirikamchai Colorectal Cancer 2011 Oncology Response Criteria | |||
BRUGGEMANN MRD 2010 | C125992 | Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. (Bruggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cave H, Dombret H, Fielding AK, Foa R, Gokbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ; European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL); International Berlin-Frankfurt-Munster Study Group (I-BFM-SG). Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia. 2010 Mar;24(3):521-35.) | Bruggemann MRD 2010 Oncology Response Criteria | |||
BURCOMBE BREAST CANCER 2005 | C125993 | Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. (Burcombe RJ, Makris A, Richman PI, Daley FM, Noble S, Pittam M, Wright D, Allen SA, Dove J, Wilson GD. Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. Br J Cancer. 2005 Jan 17;92(1):147-55.) | Burcombe Breast Cancer 2005 Oncology Response Criteria | |||
CHESON CLL 2006 | C125994 | CLL response criteria. (Cheson BD. CLL response criteria.Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 10; suppl 12.) | Cheson CLL 2006 Oncology Response Criteria | |||
CHESON CLL 2012 | C125995 | Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia. (Cheson BD, Byrd JC, Rai KR, Kay NE, O'Brien SM, Flinn IW, Wiestner A, Kipps TJ. Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia. J Clin Oncol. 2012 Aug 10;30(23):2820-2.) | Cheson CLL 2012 Oncology Response Criteria | |||
CHESON HODGKINS NON-HODGKINS LYMPHOMA 2008 | C125996 | New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma. (Cheson BD. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma. Radiol Clin North Am. 2008 Mar;46(2):213-23, vii.) | Cheson Hodgkins Non-Hodgkins Lymphoma 2008 Oncology Response Criteria | |||
CHESON LYMPHOMA 2008 | C125997 | New response criteria for lymphomas in clinical trials. (Cheson BD. New response criteria for lymphomas in clinical trials. Ann Oncol. 2008 Jun;19 Suppl 4:iv35-8.) | Cheson Lymphoma 2008 Oncology Response Criteria | |||
CHESON MALIGNANT LYMPHOMA 2007 | C125998 | Revised response criteria for malignant lymphoma. (Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V; International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007 Feb 10;25(5):579-86. Epub 2007 Jan 22.) | Cheson Malignant Lymphoma 2007 Oncology Response Criteria | |||
CHESON NON-HODGKINS HODGKINS LYMPHOMA 1993 | C125999 | Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. (Chevallier B, Roche H, Olivier JP, Chollet P, Hurteloup P. Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol. 1993 Jun;16(3):223-8.) | Cheson Non-Hodgkins Hodgkins Lymphoma 1993 Oncology Response Criteria | |||
CHESON NON-HODGKINS LYMPHOMA 1999 | C126000 | Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas. (Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas. J Clin Oncol. 1999 Apr;17(4):1244.) | Cheson Non-Hodgkins Lymphoma 1999 Oncology Response Criteria | |||
CHOI GIST 2008 | C122394 | Response Evaluation of Gastrointestinal Stromal Tumors. (Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Response Evaluation of Gastrointestinal Stromal Tumors. Oncologist. 2008;13 Suppl 2:4-7.) | Choi Response Criteria in the Evaluation of Gastrointestinal Stromal Tumors | |||
CHOLLET BREAST CANCER 2002 | C126001 | Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. (Chollet P, Amat S, Cure H, de Latour M, Le Bouedec G, Mouret-Reynier MA, Ferriere JP, Achard JL, Dauplat J, Penault-Llorca F. Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer. 2002 Apr 8;86(7):1041-6.) | Chollet Breast Cancer 2002 Oncology Response Criteria | |||
DIMOPOULOS IWWM-7 CONSENSUS 2014 | C187965 | Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders: IWWM-7 consensus. (Meletios A Dimopoulos, Efstathios Kastritis, Roger G. Owen, Robert A Kyle, Ola Landgren, Enrica Morra, Xavier Leleu, Ramon Garcia-Sanz, Nikhil Munshi, Kenneth C Anderson, Evangelos Terpos, Irene M Ghobrial, Pierre Morel, David Maloney, Mathias Rummel, Veronique Leblond, Ranjana H Advani, Morie A Gertz, Charalampia Kyriakou, Sheeba K Thomas, Bart Barlogie, Stephanie A Gregory, Eva Kimby, Giampaolo Merlini, Steven P Treon. Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders: IWWM-7 consensus. Blood. 2014 Aug 28;124(9):1404-11). | Dimopoulos IWWM-7 Consensus 2014 Oncology Response Criteria | |||
DIMOPOULOS WALDENSTROMS MACROGLOBULINEMIA 2018 | C178056 | Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia. (Dimopoulos MA, Tedeschi A, Trotman J, Garcia Sanz R, Macdonald D, Leblond V, Mahe B, Herbaux C, Tam C, Orsucci L, Palomba ML, Matous JV, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C. Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia for the iNNOVATE Study Group and the European Consortium for Waldenstrom's Macroglobulinemia. N Engl J Med 2018;378:2399-410.) | Dimopoulos Waldenstroms Macroglobulinemia 2018 Oncology Response Criteria | |||
DOHNER AML 2010 | C126002 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. (Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Lowenberg B, Bloomfield CD; European LeukemiaNet Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010 Jan 21;115(3):453-74.) | Dohner AML 2010 Oncology Response Criteria | |||
DURIE MULTIPLE MYELOMA 2006 | C126003 | International uniform response criteria for multiple myeloma. (Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV; International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia. 2006 Sep;20(9):1467-73. Epub 2006 Jul 20.) | Durie Multiple Myeloma 2006 Oncology Response Criteria | |||
EASL BRUIX LIVER CANCER 2001 | C126004 | Clinical management, of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference-European Association for the Study of the Liver. (Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J; EASL Panel of Experts on HCC. Clinical management, of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference-European Association for the Study of the Liver. J Hepatol. 2001 Sep;35(3):421-30.) | EASL Bruix Liver Cancer 2001 Oncology Response Criteria | |||
EBMT BLADE MYELOMA 1998 | C126005 | Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. (Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G, Gertz M, Giralt S, Jagannath S, Vesole D. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol. 1998 Sep;102(5):1115-23.) | EBMT Blade Myeloma 1998 Oncology Response Criteria | |||
ELN DOHNER AML 2017 | C179779 | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. (Hartmut Dohner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R. Appelbaum, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood (2017) 129 (4): 424-447.) | ELN Dohner AML 2017 Oncology Response Criteria | |||
EORTC OLSEN MYCOSIS FUNGOIDES AND SEZARY SYNDROME 2011 | C126006 | Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. (Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre MF, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC; International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011 Jun 20;29(18):2598-607.) | EORTC Olsen Mycosis Fungoides And Sezary Syndrome 2011 Oncology Response Criteria | |||
EUROPEAN LEUKEMIANET BACCARANI CML 2006 | C126007 | Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. (Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, Apperley J, Cervantes F, Cortes J, Deininger M, Gratwohl A, Guilhot F, Horowitz M, Hughes T, Kantarjian H, Larson R, Niederwieser D, Silver R, Hehlmann R; European LeukemiaNet. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2006 Sep 15;108(6):1809-20. Epub 2006 May 18.) | European Leukemianet Baccarani CML 2006 Oncology Response Criteria | |||
FAROOQUI SUPP CLL 2014 | C128990 | Supplement to: Farooqui MZH, Valdez J, Martyr S, et al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. Lancet Oncol 2014; published online Dec 31. http://dx.doi.org/10.1016/S1470-2045(14)71182-9. (Available at http://www.thelancet.com/cms/attachment/2026086364/2045255220/mmc1.pdf. Accessed April 27, 2016) | Supplement to Farooqui CLL 2014 Oncology Response Criteria | |||
GCIG RUSTIN OVARIAN CANCER 2011 | C126008 | Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). (Rustin GJ, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, du Bois A, Kristensen G, Jakobsen A, Sagae S, Greven K, Parmar M, Friedlander M, Cervantes A, Vermorken J; Gynecological Cancer Intergroup. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer. 2011 Feb;21(2):419-23.) | GCIG Rustin Ovarian Cancer 2011 Oncology Response Criteria | |||
GUILHOT CML 2007 | C126009 | Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase. (Guilhot F, Apperley J, Kim DW, Bullorsky EO, Baccarani M, Roboz GJ, Amadori S, de Souza CA, Lipton JH, Hochhaus A, Heim D, Larson RA, Branford S, Muller MC, Agarwal P, Gollerkeri A, Talpaz M. Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase. Blood. 2007 May 15;109(10):4143-50. Epub 2007 Jan 30.) | Guilhot CML 2007 Oncology Response Criteria | |||
GUPPY OVARIAN CANCER 2002 | C126010 | CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer? (Guppy AE, Rustin GJS. CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer? Oncologist. 2002;7(5):437-43.) | Guppy Ovarian Cancer 2002 Oncology Response Criteria | |||
HAMAOKA BREAST CANCER 2010 | C126011 | Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer. (Hamaoka T, Costelloe CM, Madewell JE, Liu P, Berry DA, Islam R, Theriault RL, Hortobagyi GN, Ueno NT. Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer. Br J Cancer. 2010 Feb 16;102(4):651-7.) | Hamaoka Breast Cancer 2010 Oncology Response Criteria | |||
HARTMAN PANCREATIC CANCER 2012 | C126013 | Assessing treatment effect in pancreatic cancer. (Hartman DJ, Krasinskas AM. Assessing treatment effect in pancreatic cancer. Arch Pathol Lab Med. 2012 Jan;136(1):100-9.) | Hartman Pancreatic Cancer 2012 Oncology Response Criteria | |||
HARTMANN GERM CELL CANCER 2002 | C126012 | Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. (Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Bokemeyer C. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors. Ann Oncol. 2002 Jul;13(7):1017-28.) | Hartmann Germ Cell Cancer 2002 Oncology Response Criteria | |||
IRANO 2015 | C158263 | Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. (Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, Prins R, Sampson JH, Wen PY, Reardon DA. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol. 2015 Nov;16(15):e534-e542.) | IRANO Okada 2015 Oncology Response Criteria | |||
iRECIST | C136711 | iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. (Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litiere S, Dancey J, Chen A, Hodi FS, Therasse P, Hoekstra OS, Shankar LK, Wolchok JD, Ballinger M, Caramella C, de Vries EG; RECIST working group. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017 Mar;18(3):e143-e152.) | Immune-Modified Response Evaluation Criteria in Solid Tumors | |||
ITMIG MRECIST BENVENISTE THYMIC EPITHELIAL TUMORS 2014 | C179780 | A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. (Marcelo F Benveniste, Robert J Korst, Arun Rajan, Frank C Detterbeck, Edith M Marom, International Thymic Malignancy Interest Group. A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. J Thorac Oncol. 2014 Sep;9(9 Suppl 2):S119-24.) | ITMIG MRECIST Benveniste Thymic Epithelial Tumors 2014 Oncology Response Criteria | |||
itRECIST GOLDMACHER 2020 | C179781 | Intratumoral RECIST | Response criteria for intratumoral immunotherapy in solid tumors: itRECIST (Goldmacher GV, Khilnani AD, MD1, Andtbacka RHI, Luke JJ, Hodi FS, Marabelle A, Harrington K, Perrone A, Tse A, Madoff DC, Schwartz LH. Response criteria for intratumoral immunotherapy in solid tumors: itRECIST. J Clin Oncol. 2020 Aug 10;38(23):2667-2676.) | itRECIST Goldmacher 2020 Oncology Response Criteria | ||
IWC HALLEK CLL 2008 | C126014 | Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. (Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ. International Workshop on Chronic Lymphocytic Leukemia.Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008 Jun 15;111(12):5446-56.) | IWC Hallek CLL 2008 Oncology Response Criteria | |||
IWC HALLEK CLL 2018 | C178055 | Guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the 2008 International Workshop on Chronic Lymphocytic Leukemia (iwCLL) published consensus guidelines for the design and conduct of clinical trials for patients with CLL. (Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Chiorazzi N, Stilgenbauer S, Rai KR, Byrd JC, Eichhorst B, O'Brien S, Robak T, Seymour JF, Kipps TJ. Blood. 2018 Jun 21;131(25):2745-60.) | IWC Hallek CLL 2018 Oncology Response Criteria | |||
IWG CHESON AML 2003 | C126015 | Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. (Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, Schiffer CA, Doehner H, Tallman MS, Lister TA, Lo-Coco F, Willemze R, Biondi A, Hiddemann W, Larson RA, Lowenberg B, Sanz MA, Head DR, Ohno R, Bloomfield CD; International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 2003 Dec 15;21(24):4642-9.) | IWG Cheson AML 2003 Oncology Response Criteria | |||
IWG CHESON MDS 2000 | C126016 | Report of an international working group to standardize response criteria for myelodysplastic syndromes. (Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD, Lowenberg B, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Gore S, Greenberg PL; World Health Organization(WHO) international working group. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood. 2000 Dec 1;96(12):3671-4.) | IWG Cheson MDS 2000 Oncology Response Criteria | |||
IWG CHESON MDS 2006 | C126017 | Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. (Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 2006 Jul 15;108(2):419-25. Epub 2006 Apr 11.) | IWG Cheson MDS 2006 Oncology Response Criteria | |||
JACINTO CERVICAL CANCER 2007 | C126018 | Preoperative external beam radiotherapy and reduced dose brachytherapy for carcinoma of the cervix: survival and pathological response. (Jacinto AA, Castilho MS, Novaes PE, Novick PR, Viani GA, Salvajoli JV, Ferrigno R, Pellizzon AC, Lima SS, Maia MA, Fogaroli RC. Preoperative external beam radiotherapy and reduced dose brachytherapy for carcinoma of the cervix: survival and pathological response. Radiat Oncol. 2007 Feb 22;2:9.) | Jacinto Cervical Cancer 2007 Oncology Response Criteria | |||
JAPANESE CLASSIFICATION GASTRIC CANCER 2011 | C126019 | Japanese classification of gastric carcinoma: 3rd English edition. ([No authors listed]. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011 Jun;14(2):101-12.) | Japanese Classification Gastric Cancer 2011 Oncology Response Criteria | |||
JUWEID NON-HODGKINS LYMPHOMA 2005 | C126020 | Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. (Juweid ME, Wiseman GA, Vose JM, Ritchie JM, Menda Y, Wooldridge JE, Mottaghy FM, Rohren EM, Blumstein NM, Stolpen A, Link BK, Reske SN, Graham MM, Cheson BD. Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.J Clin Oncol. 2005 Jul 20;23(21):4652-61.) | Juweid Non-Hodgkins Lymphoma 2005 Oncology Response Criteria | |||
KEAM BREAST CANCER 2013 | C126021 | Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancer. (Keam B, Im SA, Lim Y, Han SW, Moon HG, Oh DY, Cho N, Lee SH, Han W, Moon WK, Kim DW, Kim TY, Park IA, Noh DY. Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancer. Ann Surg Oncol. 2013 Jul;20(7):2242-9.) | Keam Breast Cancer 2013 Oncology Response Criteria | |||
KIMBY WALDENSTROMS MACROGLOBULINEMIA 2006 | C126022 | Update on Recommendations for Assessing Response from the Third International Workshop on Waldenstrom's Macroglobulinemia. (Kimby E, Treon SP, Anagnostopoulos A, Dimopoulos M, Garcia-Sanz R, Gertz MA, Johnson S, LeBlond V, Fermand JP, Maloney DG, Merlini G, Morel P, Morra E, Nichols G, Ocio EM, Owen R, Stone M, Blade J. Update on Recommendations for Assessing Response from the Third International Workshop on Waldenstrom's Macroglobulinemia. Clin Lymphoma Myeloma. 2006 Mar;6(5):380-3.) | Kimby Waldenstroms Macroglobulinemia 2006 Oncology Response Criteria | |||
KUKER LYMPHOMA 2005 | C126023 | Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. (Kuker W, Nagele T, Thiel E, Weller M, Herrlinger U. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. Neurology. 2005 Oct 11;65(7):1129-31.) | Kuker Lymphoma 2005 Oncology Response Criteria | |||
KUMAR IMWG 2016 | C147478 | International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. (Kumar S, Paiva B, Anderson KC, Durie B, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016 Aug;17(8):e328-46.) | Kumar IMWG 2016 Oncology Response Criteria | |||
LEE LUNG CANCER 2011 | C126024 | New CT response criteria in non-small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy. (Lee HY, Lee KS, Ahn MJ, Hwang HS, Lee JW, Park K, Ahn JS, Kim TS, Yi CA, Chung MJ. New CT response criteria in non-small cell lung cancer: proposal and application in EGFR tyrosine kinase inhibitor therapy. Lung Cancer. 2011 Jul;73(1):63-9.) | Lee Lung Cancer 2011 Oncology Response Criteria | |||
LUGANO CLASSIFICATION | C126025 | Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. (Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Espanol de Medula Osea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. J Clin Oncol. 2014 Sep 20;32(27):3059-68.) | Lugano Classification Oncology Response Criteria | |||
MACDONALD GLIOMA 1990 | C126026 | Response criteria for phase II studies of supratentorial malignant glioma. (Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990 Jul;8(7):1277-80.) | Macdonald Glioma 1990 Oncology Response Criteria | |||
MASS | C126027 | Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. (Smith AD, Shah SN, Rini BI, Lieber ML, Remer EM. Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. AJR Am J Roentgenol. 2010 Jun;194(6):1470-8.) | Morphology, Attenuation, Size, and Structure Criteria | |||
MDS/MPN IWC SAVONA MDS MPN 2015 | C191342 | An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. (Savona MR, Malcovati L, Komrokji R, et al. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. Blood. 2015;125(12):1857-1865.) | MDS/MPN IWC Savona 2015 Oncology Response Criteria | |||
MINKOV LANGERHANS CELL HISTIOCYTOSIS 2009 | C126028 | Langerhans Cell Histiocytosis: Histiocyte Society Evaluation and Treatment Guidelines April 2009. (Minkov, M., Grois, N., McClain, K., Nanduri, V., Rodriguez-Galindo, C., Simonitsch-Klupp, I., Visser, J., Weitzman, S., Whitlock, J., Windebank, K. (April 2009). Langerhans Cell Histiocytosis: Histiocyte Society Evaluation and Treatment Guidelines April 2009 [pdf]. Retrieved from https://www.histiocytesociety.org/document.doc?id=290) | Minkov Langerhans Cell Histiocytosis 2009 Oncology Response Criteria | |||
MONTSERRAT CLL 1989 | C126029 | Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. International Workshop on Chronic Lymphocytic Leukemia. ([No authors listed]. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. International Workshop on Chronic Lymphocytic Leukemia. Ann Intern Med. 1989 Feb 1;110(3):236-8.) | Montserrat CLL 1989 Oncology Response Criteria | |||
MRANO VAN DEN BENT GLIOMA 2011 | C126030 | Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. (van den Bent MJ, Wefel JS, Schiff D, Taphoorn MJ, Jaeckle K, Junck L, Armstrong T, Choucair A, Waldman AD, Gorlia T, Chamberlain M, Baumert BG, Vogelbaum MA, Macdonald DR, Reardon DA, Wen PY, Chang SM, Jacobs AH. Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol. 2011 Jun;12(6):583-93.) | Modified RANO Van Den Bent Glioma 2011 Oncology Response Criteria | |||
MRECIST ARMATO MESOTHELIOMA 2018 | C179782 | Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. (Armato SG 3rd, Nowak AK. Revised modified response evaluation criteria in solid tumors for assessment of response in malignant pleural mesothelioma (Version 1.1). J. Thorac. Oncol. 2018 Apr;13(7):1012-21.) | MRECIST Armato Mesothelioma 2018 Oncology Response Criteria | |||
MRECIST BYRNE MESOTHELIOMA 2004 | C126031 | Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. (Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol. 2004 Feb;15(2):257-60.) | Modified RECIST Byrne Mesothelioma 2004 Oncology Response Criteria | |||
MRECIST LENCIONI LIVER CANCER 2010 | C126032 | Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. (Lencioni R, Llovet JM. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. Semin Liver Dis. 2010 Feb;30(1):52-60.) | Modified RECIST Lencioni Liver Cancer 2010 Oncology Response Criteria | |||
MURPHY PROSTATE CANCER 1980 | C126033 | Response criteria for the prostate of the USA National Prostatic Cancer Project. (Murphy GP, Slack NH. Response criteria for the prostate of the USA National Prostatic Cancer Project. Prostate. 1980;1(3):375-82.) | Murphy Prostate Cancer 1980 Oncology Response Criteria | |||
NCCN ALL MRD 2014 | C126034 | NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Acute Lymphoblastic Leukemia Version 1.2014 06/06/14 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Acute Lymphoblastic Leukemia Version 1.2014 06/06/14) | NCCN ALL MRD 2014 Oncology Response Criteria | |||
NCIWG CHESON CLL 1996 | C126035 | National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. (Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996 Jun 15;87(12):4990-7.) | NCIWG Cheson CLL 1996 Oncology Response Criteria | |||
OWEN WALDESTROMS MACROGLOBULINEMIA 2013 | C179783 | Response assessment in Waldenstrom macroglobulinaemia: update from the VIth International Workshop. (Roger G. Owen, Robert A. Kyle, Marvin J. Stone, Andy C. Rawstron, Veronique Leblond, et al. Response assessment in Waldenstrom macroglobulinaemia: update from the VIth International Workshop. Br J Haematol. 2013 Jan;160(2):171-6.) | Owen Waldenstroms Macroglobulinemia 2013 Oncology Response Criteria | |||
PALUMBO MULTIPLE MYELOMA 2009 | C126036 | Palumbo IMWG 2009 | International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. (Palumbo A, Sezer O, Kyle R, Miguel JS, Orlowski RZ, Moreau P, Niesvizky R, Morgan G, Comenzo R, Sonneveld P, Kumar S, Hajek R, Giralt S, Bringhen S, Anderson KC, Richardson PG, Cavo M, Davies F, Blade J, Einsele H, Dimopoulos MA, Spencer A, Dispenzieri A, Reiman T, Shimizu K, Lee JH, Attal M, Boccadoro M, Mateos M, Chen W, Ludwig H, Joshua D, Chim J, Hungria V, Turesson I, Durie BG, Lonial S; IMWG. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia. 2009 Oct;23(10):1716-30.) | Palumbo Multiple Myeloma 2009 Oncology Response Criteria | ||
PCWG BUBLEY PROSTATE CANCER 1999 | C126037 | PCWG1 | Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. (Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Wilding G, et al. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol. 1999 Nov;17(11):3461-7.) | PCWG Bubley Prostate Cancer 1999 Oncology Response Criteria | ||
PCWG SCHER PROSTATE CANCER 2008 | C126038 | PCWG2 | Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. (Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M; Prostate Cancer Clinical Trials Working Group. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol. 2008 Mar 1;26(7):1148-59.) | PCWG Scher Prostate Cancer 2008 Oncology Response Criteria | ||
PCWG SCHER PROSTATE CANCER 2016 | C132454 | PCWG3 | Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. (Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, Antonarakis ES, Beer TM, Carducci MA, Chi KN, Corn PG, de Bono JS, Dreicer R, George DJ, Heath EI, Hussain M, Kelly WK, Liu G, Logothetis C, Nanus D, Stein MN, Rathkopf DE, Slovin SF, Ryan CJ, Sartor O, Small EJ, Smith MR, Sternberg CN, Taplin ME, Wilding G, Nelson PS, Schwartz LH, Halabi S, Kantoff PW, Armstrong AJ. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016 Apr 20;34(12):1402-18.) | PCWG Scher Prostate Cancer 2016 Oncology Response Criteria | ||
PERCIST | C126039 | From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. (Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009 May;50 Suppl 1:122S-50S.) | PET Response Criteria in Solid Tumors | |||
PETIT BREAST CANCER 2001 | C126040 | Chemotherapy Response of Breast Cancer Depends on HER-2 Status and Anthracycline Dose Intensity in the Neoadjuvant Setting. (Petit T, Borel C, Ghnassia JP, Rodier JF, Escande A, Mors R, Haegele P. Chemotherapy Response of Breast Cancer Depends on HER-2 Status and Anthracycline Dose Intensity in the Neoadjuvant Setting. Clin Cancer Res. 2001 Jun;7(6):1577-81.) | Petit Breast Cancer 2001 Oncology Response Criteria | |||
PRINCE TCELL LYMPHOMA 2010 | C126041 | Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients with Cutaneous T-cell Lymphoma. (Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Sun Y, Straus D, Acosta M, Negro-Vilar A. Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients with Cutaneous T-cell Lymphoma. J Clin Oncol. 2010 Apr 10;28(11):1870-7.) | Prince T Cell Lymphoma 2010 Oncology Response Criteria | |||
PROTOCOL DEFINED RESPONSE CRITERIA | C126042 | A description of the disease response to treatment as characterized by the clinical trial protocol. | Protocol Defined Response Criteria | |||
RAJKUMAR MYELOMA 2011 | C126043 | Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. (Rajkumar SV, Harousseau JL, Durie B, Anderson KC, Dimopoulos M, Kyle R, Blade J, Richardson P, Orlowski R, Siegel D, Jagannath S, Facon T, Avet-Loiseau H, Lonial S, Palumbo A, Zonder J, Ludwig H, Vesole D, Sezer O, Munshi NC, San Miguel J; International Myeloma Workshop Consensus Panel 1. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood. 2011 May 5;117(18):4691-5.) | Rajkumar Myeloma 2011 Oncology Response Criteria | |||
RANO ELLINGSON 2017 | C158262 | Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials (Benjamin M. Ellingson, Patrick Y. Wen, Timothy F. Cloughesy. Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials. Neurotherapeutics (2017) 14:307-320). | RANO Ellingson 2017 Oncology Response Criteria | |||
RANO | C114879 | Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group. (Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group. J Clin Oncol. 2010 Apr 10;28(11):1963-72.) | Response Assessment in Neuro-Oncology Criteria | |||
RECICL | C126044 | Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). (Kudo M, Kubo S, Takayasu K, Sakamoto M, Tanaka M, Ikai I, Furuse J, Nakamura K, Makuuchi M; Liver Cancer Study Group of Japan (Committee for Response Evaluation Criteria in Cancer of the Liver, Liver Cancer Study Group of Japan). Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). Hepatol Res. 2010 Jul;40(7):686-92.) | Response Evaluation Criteria in Cancer of the Liver | |||
RECIST 1.0 | C124414 | Response Evaluation Criteria in Solid Tumors (RECIST) version 1.0 (Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubenstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New Guidelines to Evaluate the Response to Treatment in Solid Tumors. Journal of the National Cancer Institute 2000; 92(3):205-216). | Response Evaluation Criteria in Solid Tumors Version 1.0 | |||
RECIST 1.1 | C124415 | Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 (E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij. New response evaluation criteria in solid tumours; Revised RECIST guideline (version 1.1). European Journal of Cancer 2009; 45:228-247). | Response Evaluation Criteria in Solid Tumors Version 1.1 | |||
SACT | C126045 | Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT. (Smith AD, Lieber ML, Shah SN. Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT. AJR Am J Roentgenol. 2010 Jan;194(1):157-65.) | Size and Attenuation CT Criteria | |||
SCHER PROSTATE CANCER 2011 | C126046 | End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice. (Scher HI, Morris MJ, Basch E, Heller G. End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice. J Clin Oncol. 2011 Sep 20;29(27):3695-704.) | Scher Prostate Cancer 2011 Oncology Response Criteria | |||
SCHWARZ CERVICAL CANCER 2009 | C126047 | The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries. (Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D. The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries. J Nucl Med. 2009 May;50 Suppl 1:64S-73S.) | Schwarz Cervical Cancer 2009 Oncology Response Criteria | |||
SHINDOH COLORECTAL CANCER 2013 | C126048 | Non-Size-Based Response Criteria to Preoperative Chemotherapy in Patients With Colorectal Liver Metastases: The Morphologic Response Criteria. (Shindoh J, Chun YS, Loyer EM, Vauthey JN. Non-Size-Based Response Criteria to Preoperative Chemotherapy in Patients With Colorectal Liver Metastases: The Morphologic Response Criteria. Curr Colorectal Cancer Rep. 2013 Jun 1;9(2):198-202.) | Shindoh Colorectal Cancer 2013 Oncology Response Criteria | |||
SIOPEN LEWINGTON NEUROBLASTOMA 2017 | C179784 | 123I-MIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting, method by an international panel. (Lewington V., Lambert B., Poetschger U., Bar Sever Z., Giammarile F., McEwan A.J.B., Rita Castellani R., Lynch T., Shulkin B., Drobics M., Staudenherz A., Landenstein R. 123I-MIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting, method by an international panel. J Nucl Med Mol Imaging. 2017 Feb;44(2):234-241.) | SIOPEN Lewington Neuroblastoma 2017 Oncology Response Criteria | |||
TSUKASAKI LEUKEMIA LYMPHOMA 2009 | C126049 | Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting. (Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, O'Mahony D, Janik JE, Bittencourt AL, Taylor GP, Yamaguchi K, Utsunomiya A, Tobinai K, Watanabe T. Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting. J Clin Oncol. 2009 Jan 20;27(3):453-9.) | Tsukasaki Leukemia Lymphoma 2009 Oncology Response Criteria | |||
UNSPECIFIED | C38046 | Not stated explicitly or in detail. | Unspecified | |||
WHO BREAST CANCER 2006 | C126050 | Guidelines for Management of Breast Cancer. (WHO (2006). Guidelines for Management of Breast Cancer. Retrieved from http://applications.emro.who.int/dsaf/dsa697.pdf) | Guidelines for Management of Breast Cancer WHO 2006 | |||
WOLCHOK SOLID TUMORS 2009 | C126051 | irRC | Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. (Wolchok JD, Hoos A, O'Day S, Weber JS, Hamid O, Lebbe C, Maio M, Binder M, Bohnsack O, Nichol G, Humphrey R, Hodi FS. Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. Clin Cancer Res. 2009 Dec 1;15(23):7412-20.) | Wolchok Solid Tumors 2009 Oncology Response Criteria | ||
Back to top | ||||||
CL.C100129.QSCAT | Category of Questionnaire
(QSCAT) | text
Extensible: Yes | C100129 | Category of Questionnaire | A grouping of observations within the Questionnaires domain. | CDISC Questionnaire Category Terminology |
ABC | C187516 | ABC01 | Activities-Specific Balance Confidence Scale (ABC) (Powell LE, Myers AM. The Activities-specific Balance Confidence (ABC) Scale. J Gerontol A Biol Sci Med Sci. 1995 Jan;50A(1):M28-34. ABC scale Anita M. Myers, 1995. All rights reserved.). No part of the Activities-Specific Balance Confidence Scale may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Anita M. Myers and payment of any applicable fees. Copyright Anita M. Myers, 1995. All rights reserved. | Activities-Specific Balance Confidence Scale Questionnaire | ||
ACQ | C122370 | ACQ01 | Asthma Control Questionnaire (ACQ) (The Asthma Control Questionnaire is copyrighted. It may not be changed, translated or sold [paper or software] without the permission of Elizabeth Juniper. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-907). | Asthma Control Questionnaire | ||
ACT | C123658 | ACT01 | Asthma Control Test (ACT) (Asthma Control Test copyright, QualityMetric Incorporated 2002, 2004. All Rights Reserved. Asthma Control Test is a trademark of QualityMetric Incorporated. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004 Jan;113(1):59-65). | Asthma Control Test Questionnaire | ||
ADAS-COG | C100762 | ADC | The CDISC version of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog CDISC Version) containing 15 summary-level tests. This version is based on combining the total pool of ADAS-Cog tests that were observed during a review of multiple case report forms administered in clinical trials of Alzheimer's disease, as well as the CRF administered in the Alzheimer's Disease Neuroimaging Initiative (ADNI) observational study. (Modified from Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19(3):448-450. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141(11):1356-1364. Mohs RC, Knopman D, Petersen RC et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997;11 Suppl 2:S13-S21. Wouters H, van Gool WA, Schmand B, Lindeboom R. Revising the ADAS-cog for a more accurate assessment of cognitive impairment. Alzheimer Dis Assoc Disord 2008;22(3):236-244.). | Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire | ||
ADCS-ADL MCI | C106888 | ADL03 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL), MCI Version (Galasko, D., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., Ferris, S., and the ADCS. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease. Alzheimer's Disease and Associated Disorders, 1997. Volume 11(2): S33-S39). | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Mild Cognitive Impairment Questionnaire | ||
ADCS-ADL SEVERE DEMENTIA | C106889 | ADL02 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL), Severe Dementia Version (Galasko, D., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., Ferris, S., and the ADCS. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease. Alzheimer's Disease and Associated Disorders, 1997. Volume 11(2): S33-S39). | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory Severe Dementia Questionnaire | ||
ADCS-ADL | C105166 | ADL01 | Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL) (Galasko, D., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., Ferris, S., and the ADCS. "An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease." Alzheimer's Disease and Associated Disorders, 1997. Volume 11(2): S33-S39). | Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory Questionnaire | ||
ADCS-CGIC | C103515 | ACGC01 | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) (Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH, and the Alzheimer's Disease Cooperative Study. Validity and Reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. Alzheimer Disease and Associated Disorders. 1997; 11(2):S22-S32). | Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Questionnaire | ||
ADHD-RS-IV HOME VERSION | C122371 | ADHD01 | ADHD Rating Scale-IV (ADHD-RS-IV) Home Version (Copyright 1998. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York: The Guilford Press; 1998). | ADHD Rating Scale-IV Home Version Questionnaire | ||
ADSD V1.0 | C163811 | ADSD01 | Asthma Daytime Symptom Diary v1.0 (ADSD V1.0) (Version 1.0 Copyright 2018 Critical Path Institute. All Rights Reserved. Gater A, Nelsen L, Fleming S, Lundy J.J, Bonner N, Hall R, Marshall C, Staunton H, Krishnan JA, Stoloff S, Schatz M, Haughney J on behalf of the Patient-Reported Outcome Consortium's Asthma Working Group. Assessing asthma symptoms in adolescents and adults: qualitative research supporting development of the Asthma Daily Symptom Diary. Value in Health 2016; 19:440-450. Patient-Reported Outcome (PRO) Consortium - Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) User Manual, Version 1: March 30, 2019). No part of the ADSD V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved. | Asthma Daytime Symptom Diary V1.0 Questionnaire | ||
ANSD V1.0 | C163812 | ANSD01 | Asthma Nighttime Symptom Diary v1.0 (ANSD V1.0) (Version 1.0 Copyright 2018 Critical Path Institute. All Rights Reserved. Gater A, Nelsen L, Fleming S, Lundy J.J, Bonner N, Hall R, Marshall C, Staunton H, Krishnan JA, Stoloff S, Schatz M, Haughney J on behalf of the Patient-Reported Outcome Consortium's Asthma Working Group. Assessing asthma symptoms in adolescents and adults: qualitative research supporting development of the Asthma Daily Symptom Diary. Value in Health 2016; 19:440-450. Patient-Reported Outcome (PRO) Consortium - Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) User Manual, Version 1: March 30, 2019). No part of the ANSD V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved. | Asthma Nighttime Symptom Diary V1.0 Questionnaire | ||
AQ20 | C112518 | AQ01 | Airway Questionnaire 20 (AQ20) (Barley EA, Quirk FH, Jones PW. Asthma health status in clinical practice: validity of a new short and simple instrument. Respir Med 1998; 92:1207-14. Copyright Reserved P.W. Jones, PhD FRCP). | Airway Questionnaire 20 | ||
AQLQ | C122372 | AQLQ01 | Asthma Quality of Life Questionnaire (AQLQ) (The AQLQ is copyrighted. It may not be altered, sold [paper or electronic], translated or adapted for another medium without the permission of Elizabeth Juniper. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47:76-83). | Asthma Quality of Life Questionnaire | ||
ASEX-FEMALE | C125757 | ASEX01 | Arizona Sexual Experiences Scale (ASEX)-Female (Copyright 1997 by Arizona Board of Regents, University of Arizona. All rights reserved). | Arizona Sexual Experiences Scale-Female Version Questionnaire | ||
ASEX-MALE | C125758 | ASEX02 | Arizona Sexual Experiences Scale (ASEX)-Male (Copyright 1997 by Arizona Board of Regents, University of Arizona. All rights reserved). | Arizona Sexual Experiences Scale-Male Version Questionnaire | ||
AUDIT-C | C119098 | ADTC01 | Alcohol Use Disorder Identification Test-Consumption Questions (AUDIT-C) (Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA; for the Ambulatory Care Quality Improvement Project (ACQUIP). The AUDIT Alcohol Consumption Questions (AUDIT-C) An Effective Brief Screening Test for Problem Drinking. Arch Intern Med. Sep 14 1998;158:1789-1795). | Alcohol Use Disorder Identification Test Alcohol Consumption Questions Questionnaire | ||
AUDIT-SR | C119097 | ADT01 | Alcohol Use Disorder Identification Test: Self-Report Version (AUDIT) (Saunders JB, Aasland, OG, Babor, TF, De La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with harmful Alcohol Consumption-II. Addiction (1993) 88:791-804). | Alcohol Use Disorder Identification Test Self-Report Version Questionnaire | ||
BEBQ CONCURRENT | C135735 | BEBQ01 | Baby Eating Behaviour Questionnaire - Concurrent (BEBQ CONCURRENT) (Llewellyn, C. H., van Jaarsveld, C. H., Johnson, L., Carnell, S., & Wardle, J. Development and factor structure of the Baby Eating Behaviour Questionnaire in the Gemini birth cohort. Appetite 57.2, 2011, 388-396). | Baby Eating Behaviour Questionnaire Concurrent Version | ||
BEBQ RETROSPECTIVE | C135736 | BEBQ02 | Baby Eating Behaviour Questionnaire - Retrospective (BEBQ RETROSPECTIVE) (Llewellyn, C. H., van Jaarsveld, C. H., Johnson, L., Carnell, S., & Wardle, J. Development and factor structure of the Baby Eating Behaviour Questionnaire in the Gemini birth cohort. Appetite 57.2, 2011, 388-396). | Baby Eating Behaviour Questionnaire Retrospective Version | ||
BECK DEPRESSION INVENTORY-II | C187512 | BD01;BDI-II | Beck Depression Inventory-Second Edition (BECK DEPRESSION INVENTORY-II) (The Psychological Corporation Harcourt Brace & Company Copyright 1996, by Aaron T. Beck. All rights reserved. Beck AT, Steer RA, Brown GK. BDI-II Manual. The Psychological Corporation, San Antonio, TX, USA. 1996; 38p. Copyright 1996, 1987 Aaron T Beck). No part of the Beck Depression Inventory-Second Edition may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Psychological Corporation Harcourt Brace & Company and payment of any applicable fees. Copyright Psychological Corporation Harcourt Brace & Company 1996 and Aaron T. Beck. All rights reserved. | Beck Depression Inventory-Second Edition Questionnaire | ||
BFI | C74297 | BFI01 | Brief Fatigue Inventory (BFI) (Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999 Mar 1;85(5):1186-96. Copyright 1999. The University of Texas M. D. Anderson Cancer Center. All rights reserved). No part of the Brief Fatigue Inventory may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the University of Texas M. D. Anderson Cancer Center and payment of any applicable fees. Copyright the University of Texas M. D. Anderson Cancer Center 1999. All rights reserved. | Brief Fatigue Inventory | ||
BIS-11 | C172402 | BIS01 | Barratt Impulsiveness Scale 1995 Version (BIS-11) (Patton JH, Stanford MS, and Barratt ES (1995). Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology, 51, 768-774. Copyright International Society for Research on Impulsivity and it's licensor's. All Rights Reserved). | Barratt Impulsiveness Scale 1995 Version Questionnaire | ||
BLCS | C113874 | BLCS01 | Bladder Control Scale (BLCS) (1997 by the National Multiple Sclerosis Society. All rights reserved). | Bladder Control Scale Questionnaire | ||
BORG CR10 | C113872 | BCR101 | Borg CR10 Scale (BORG CR10) (Borg CR10 Scale. Copyright Gunnar Borg, 1981, 1982, 1998). | Borg Category-Ratio 10 Scale Questionnaire | ||
BPI SHORT FORM | C100760 | BPI2 | Brief Pain Inventory Short Form (BPI2) (copyright 1991 Charles S. Cleeland, PhD, Pain Research Group, All Right Reserved). | Brief Pain Inventory Short Form Questionnaire | ||
BPI | C100759 | BPI1 | Brief Pain Inventory (BPI) (copyright 1991 Charles S. Cleeland, PhD, Pain Research Group, All Right Reserved). | Brief Pain Inventory Questionnaire | ||
BSFS | C125393 | BSFS01 | Bristol Stool Form Scale (BSFS) (Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997 Sep;32(9):920-4. Copyright by ROME Foundation. All rights reserved). | Bristol Stool Scale | ||
BSI-18 | C43524 | BSI181 | Brief Symptom Inventory-18 (BSI-18) (Leonard R. Derogatis. Brief Symptom Inventory (BSI)-18: Administration, scoring and procedures manual. Minneapolis 2001: NCS Pearson, Inc). | Brief Symptom Inventory 18 | ||
BWCS | C113875 | BWCS01 | Bowel Control Scale (BWCS) (1997 by the National Multiple Sclerosis Society. All rights reserved). | Bowel Control Scale Questionnaire | ||
C-SSRS ALREADY ENROLLED SUBJECTS | C106695 | CSS05 | Columbia-Suicide Severity Rating Scale (C-SSRS) Already Enrolled Subjects Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire | ||
C-SSRS BASELINE | C100765 | CSS01 | Columbia-Suicide Severity Rating Scale (C-SSRS) Baseline Version 2009-01-14 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Baseline Questionnaire | ||
C-SSRS BASELINE/SCREENING VERSION PHASE 1 STUDY | C105164 | CSS03 | Columbia-Suicide Severity Rating Scale (C-SSRS) Baseline/Screening Version Phase 1 Study Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study 1/14/09 Questionnaire | ||
C-SSRS BASELINE/SCREENING VERSION | C106696 | CSS04 | Columbia-Suicide Severity Rating Scale (C-SSRS) Baseline/Screening Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire | ||
C-SSRS CHILDREN'S BASELINE | C111377 | CSS06 | Columbia-Suicide Severity Rating Scale (C-SSRS) Children's Baseline Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire | ||
C-SSRS CHILDREN'S BASELINE/SCREENING | C111378 | CSS07 | Columbia-Suicide Severity Rating Scale (C-SSRS) Children's Baseline/Screening Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire | ||
C-SSRS CHILDREN'S SINCE LAST VISIT | C111379 | CSS08 | Columbia-Suicide Severity Rating Scale (C-SSRS) Children's Since Last Visit Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire | ||
C-SSRS LIFETIME/RECENT VERSION | C117996 | CSS11 | Columbia-Suicide Severity Rating Scale (C-SSRS) Lifetime/Recent Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire | ||
C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED LIFETIME/RECENT | C113873 | CSS10 | Columbia-Suicide Severity Rating Scale (C-SSRS) Pediatric/Cognitively Impaired Lifetime/Recent Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire | ||
C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-LIFETIME RECENT-CLINICAL | C123661 | CSS12 | Columbia-Suicide Severity Rating Scale (C-SSRS) Pediatric/Cognitively Impaired - Lifetime Recent - Clinical Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc). | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Lifetime Recent - Clinical Questionnaire | ||
C-SSRS PEDIATRIC/COGNITIVELY IMPAIRED-SINCE LAST VISIT-CLINICAL | C123662 | CSS13 | Columbia-Suicide Severity Rating Scale (C-SSRS) Pediatric/Cognitively Impaired - Since Last Visit - Clinical Version 6/23/2010 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc). | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired - Since Last Visit - Clinical Questionnaire | ||
C-SSRS SCREENING | C111380 | CSS09 | Columbia-Suicide Severity Rating Scale (C-SSRS) Screening Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Screening Questionnaire | ||
C-SSRS SINCE LAST VISIT | C103516 | CSS02 | Columbia-Suicide Severity Rating Scale (C-SSRS) Since Last Visit Version 1/14/2009 (Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc.). | Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire | ||
CCQ 1 WEEK VERSION | C119100 | CCQ02 | Clinical COPD Questionnaire (CCQ) 1 Week Version (The CCQ is copyrighted 1999. It may not be altered, sold (paper or electronic), translated or adapted for another medium without the permission of T. van der Molen, Dept. of General Practice, University Medical Center Groningen, Postbus 196, 9700 AD Groningen, The Netherlands.). | Clinical COPD Questionnaire 1 Week Version | ||
CCQ 24 HOUR VERSION | C119099 | CCQ01 | Clinical COPD Questionnaire (CCQ) 24 Hour Version (The CCQ is copyrighted 1999. It may not be altered, sold (paper or electronic), translated or adapted for another medium without the permission of T. van der Molen, Dept. of General Practice, University Medical Center Groningen, Postbus 196, 9700 AD Groningen, The Netherlands.). | Clinical COPD Questionnaire 24 Hour Version | ||
CDLQ | C119092 | CDLQ1 | Children's Dermatology Life Quality Index (CDLQI) (Copyright of M.S. Lewis-Jones, A.Y. Finlay, May 1993, this must not be copied without the permission of the authors). | Children's Dermatology Life Quality Index Questionnaire | ||
CDR | C102114 | CDR01 | Clinical Dementia Rating (CDR) (Morris, JC. Clinical Dementia Rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. International Psychogeriatrics 1997: 9, Suppl. 1, 173-176). | Clinical Dementia Rating Questionnaire | ||
CES | C132532 | CES01 | Combat Exposure Scale (CES) (Keane, T.M., Fairbank, J.A., Caddell, J.M., Zimering, R.T., Taylor, K.L., & Mora, C. (1989). Clinical evaluation of a measure to assess combat exposure (PDF). Psychological Assessment, 1, 53-55). | Combat Exposure Scale Questionnaire | ||
CGI | C135738 | CGI02 | Clinical Global Impression (CGI) generic modification for any disease/condition concept use case (Modified from Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976). | Clinical Global Impression Generic Modification Version Questionnaire | ||
CHART-SF INTERVIEW VERSION | C117995 | CHSF1 | Craig Handicap Assessment and Reporting Technique - Short Form Interview Version (CHART-SF INTERVIEW VERSION) (Whiteneck GG, Charlifue SW, Gerhart KA, Overholser JD, Richardson GN. Quantifying handicap: a new measure of long-term rehabilitation outcomes. Arch Phys Med Rehabil. 1992;73:519-526). | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version Questionnaire | ||
CHART-SF PAPER VERSION | C119101 | CHSF2 | Craig Handicap Assessment and Reporting Technique - Short Form Paper Version (CHART-SF PAPER VERSION) (Whiteneck GG, Charlifue SW, Gerhart KA, Overholser JD, Richardson GN. Quantifying handicap: a new measure of long-term rehabilitation outcomes. Arch Phys Med Rehabil. 1992;73:519-526). | Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire | ||
COMM | C100764 | COMM1 | Current Opioid Misuse Measure (COMM) (copyright 2010 Inflexxion, Inc., All rights reserved). | Current Opioid Misuse Measure Questionnaire | ||
COPD ASSESSMENT TEST | C125756 | CAT01 | COPD Assessment Test (CAT) (COPD Assessment Test and the CAT logo is a trade mark of the GlaxoSmithKline group of companie. Copyright 2009 GlaxoSmithKline group of companies. All rights reserved). | COPD Assessment Test Questionnaire | ||
COWS | C102115 | COWS1 | The Clinical Opiate Withdrawal Scale (COWS) (Wesson DR and Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs 2003;35(2):253-259). | Clinical Opiate Withdrawal Scale Questionnaire | ||
CRQ-SAS FIRST ADMINISTRATION VERSION | C121002 | CRQ01 | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version (Copyright 2001 McMaster University, Hamilton, Ontario, Canada. The Chronic Respiratory Questionnaire Self-Administered including the standardized Dyspnea Domain (CRQSAS), Principal authors G.H. Guyatt and Dr. H.J. Schunemann, is the copyright of McMaster University (Copyright 2001, McMaster University). | Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire | ||
CRQ-SAS FOLLOW-UP ADMINISTRATION VERSION | C121003 | CRQ02 | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version (Copyright 2001 McMaster University, Hamilton, Ontario, Canada. The Chronic Respiratory Questionnaire Self-Administered including the standardized Dyspnea Domain (CRQSAS), Principal authors G.H. Guyatt and Dr. H.J. Schunemann, is the copyright of McMaster University (Copyright 2001, McMaster University). | Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire | ||
DAD | C105165 | DAD01 | Disability Assessment for Dementia (DAD) (copyright 1994 by L. Gauthier I. Gelinas. All rights reserved.). | Disability Assessment for Dementia Questionnaire | ||
DIBSS-C V1.0 | C183575 | DIBC01 | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 (DIBSS-C V1.0) (Copyright 2018 by the Critical Path Institute. All rights reserved. Fehnel S, Ervin C, McLeod L, Carson RT, Reasner DS, Hanlon J, Eremenco S, Coons SJ. Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C). Poster presented at ISPOR Europe 2018; November 10-14, 2018. Barcelona, Spain. Fehnel SE, Ervin CM, Carson RT, Rigoni G, Lackner JM, Coons SJ. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research. Value in Health 2017;20(4):618-626. Patient-Reported Outcome (PRO) Consortium Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) v1.0 User Manual). No part of the DIBSS-C V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved. | Diary for Irritable Bowel Syndrome Symptoms-Constipation Version 1.0 Questionnaire | ||
DLQI | C119102 | DLQI1 | Dermatology Life Quality Index (DLQI) (Copyright Dermatology Life Quality Index. A Y Finlay, G K Khan, April 1992 and Cardiff University. www.dermatology.org.uk. Finlay A. Y. and Khan, G. K. 1994. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clinical and Experimental Dermatology 19 (3), pp.210-216.). No part of the DLQI may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Cardiff University and payment of any applicable fees. Copyright AY Finlay, GK Khan and Cardiff University. All rights reserved. | Dermatology Life Quality Index Questionnaire | ||
DRRI-2 | C141694 | DRRI1 | Deployment Risk and Resilience Inventory-2 (DRRI-2) (Vogt, D., Smith, B. N., King, D. W., & King, L. A. (2012). The Deployment Risk and Resilience Inventory-2 (DRRI-2) [Measurement instrument]. Available from http.ptsd.va.gov). | Deployment Risk and Resilience Inventory-2 Questionnaire | ||
EORTC QLQ-ANL27 | C183596 | EOR30 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer (EORTC QLQ-ANL27) (QLQ-ANL27 Copyright 2016 EORTC Quality of Life Group. All rights reserved). No part of the EORTC QLQ-ANL27 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2016. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Anal Cancer | ||
EORTC QLQ-BIL21 | C183592 | EOR24 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer (EORTC QLQ-BIL21) (QLQ-BIL21 Copyright 2011 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-BIL21 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2011. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cholangiocarcinoma and Gallbladder Cancer | ||
EORTC QLQ-BM22 | C183577 | EOR03 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases (EORTC QLQ-BM22) (QLQ-BM22 Copyright 2008 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-BM22 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2008. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Bone Metastases | ||
EORTC QLQ-BN20 | C121794 | EOR04 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Brain (EORTC QLQ-BN20) (QLQ-BN20 Copyright 1994 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-BN20 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1994. All rights reserved. | Quality of Life Questionnaire-Brain Neoplasm 20 | ||
EORTC QLQ-BR23 V1.0 | C148236 | EOR05 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Version 1.0 (EORTC QLQ-BR23 V1.0) (QLQ-BR23 Copyright 1994 EORTC Quality of Life Group. All rights reserved. (Validated module). Version 1.0). No part of the EORTC QLQ-BR23 V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1994. All rights reserved. | Quality of Life Questionnaire BR-23 | ||
EORTC QLQ-BR45 PHASE IV MODULE | C183597 | EOR31 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Phase IV Module (EORTC QLQ-BR45 PHASE IV MODULE) (QLQ-BR45 Copyright 2018 EORTC Quality of Life Group. All rights reserved. (Phase IV module)). No part of the EORTC QLQ-BR45 PHASE IV MODULE may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2018. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Cancer Phase IV Module Version | ||
EORTC QLQ-BRECON23 | C183598 | EOR32 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Reconstruction (EORTC QLQ-BRECON23) (QLQ-BRECON23 Copyright 2017 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-BRECON23 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2017. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Breast Reconstruction | ||
EORTC QLQ-C15-PAL V1.0 | C161653 | EOR02 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0 (EORTC QLQ-C15-PAL V1.0) (Copyright 1995 and 2005 EORTC Quality of Life Group. All rights reserved. Version 1.0. (Validated module)). No part of the EORTC QLQ-C15-PAL V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1995 and 2005. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0 | ||
EORTC QLQ-C30 V3.0 | C161654 | EOR01 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 (EORTC QLQ-C30 V3.0) (Copyright 1995 EORTC Quality of Life Group. All rights reserved. Version 3.0. (Validated module)). No part of the EORTC QLQ-C30 V3.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1995. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 | ||
EORTC QLQ-CIPN20 | C125719 | EOR25 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy (EORTC QLQ-CIPN20) (QLQ-CIPN20 Copyright 2003 EORTC Quality of Life Group. All rights reserved). No part of the EORTC QLQ-CIPN20 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2003. All rights reserved. | Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20 | ||
EORTC QLQ-CLL17 | C183595 | EOR29 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic Lymphocytic Leukaemia (EORTC QLQ-CLL17) (QLQ-CLL17 Copyright 2015 EORTC Quality of Life Group. All rights reserved). No part of the EORTC QLQ-CLL17 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2015. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Chronic lymphocytic leukemia | ||
EORTC QLQ-CR29 V2.1 | C170644 | EOR06 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 (EORTC QLQ-CR29 V2.1) (QLQ-CR29 Copyright 2006 EORTC Quality of Life Group. All rights reserved. Version 2.1. (Validated module)). No part of the EORTC QLQ-CR29 V2.1 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2006. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Cancer Module Version 2.1 | ||
EORTC QLQ-CX24 | C183578 | EOR07 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cervical (EORTC QLQ-CX24) (QLQ-CX24 Copyright 2003 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-CX24 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2003. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cervical | ||
EORTC QLQ-ELD14 | C183579 | EOR08 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Elderly Cancer Patients (EORTC QLQ-ELD14) (QLQ-ELD14 Copyright 2001 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-ELD14 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2001. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Elderly Cancer Patients | ||
EORTC QLQ-EN24 | C183580 | EOR09 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Endometrial (EORTC QLQ-EN24) (QLQ-EN24 Copyright 2010 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-EN24 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2010. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Endometrial | ||
EORTC QLQ-FA12 | C183581 | EOR10 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Cancer Related Fatigue (EORTC QLQ-FA12) (QLQ-FA12 Copyright 2016 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-FA12 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2016. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Cancer Related Fatigue | ||
EORTC QLQ-GINET21 DATE 20TH FEBRUARY 2006 | C183585 | EOR15 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Neuroendocrine Carcinoid, Date 20th February 2006 Version (EORTC QLQ-GINET21 DATE 20TH FEBRUARY 2006) (QLQ-G.I.NET21 Copyright 2004 EORTC Quality of Life Group. All rights reserved. Date: 20th February 2006. (Validated module)). No part of the EORTC QLQ-GINET21 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2004. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Neuroendocrine Carcinoid, Date 20th February 2006 Version | ||
EORTC QLQ-H&N35 V1 | C136497 | EOR11 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Head & Neck Version 1 (EORTC QLQ-H&N35 V1) (Copyright QLQ-H&N35 1994 EORTC Quality of Life Group, version 1. All rights reserved. (Validated module)). No part of the EORTC QLQ-H&N35 V1 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1994. All rights reserved. | Quality of Life Questionnaire - Head & Neck 35 | ||
EORTC QLQ-HCC18 | C183586 | EOR16 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Hepatocellular Carcinoma (EORTC QLQ-HCC18) (QLQ-HCC18 Copyright 2002 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-HCC18 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2002. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Hepatocellular Carcinoma | ||
EORTC QLQ-INFO25 | C183587 | EOR17 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Information (EORTC QLQ-INFO25) (QLQ-C30-INFO25 Copyright 2004 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-INFO25 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2004. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Information | ||
EORTC QLQ-LC13 | C168555 | EOR18 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module (EORTC QLQ-LC13) (QLQ-C30-LC13 Copyright 1994 EORTC Quality of life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-LC13 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1994. All rights reserved. | EORTC Quality of Life Questionnaire - Lung Cancer Module | ||
EORTC QLQ-LMC21 | C183582 | EOR12 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases (EORTC QLQ-LMC21) (QLQ-LMC21 Copyright 2002 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-LMC21 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2002. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Liver Metastases | ||
EORTC QLQ-MY20 | C122694 | EOR19 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Multiple Myeloma (EORTC QLQ-MY20) (QLQ-MY20 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-MY20 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1999. All rights reserved. | Quality of Life Questionnaire-Multiple Myeloma 20 | ||
EORTC QLQ-NMIBC24 | C183594 | EOR28 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer (EORTC QLQ-NMIBC24) (QLQ-NMIBC24 Copyright 1994 EORTC Quality of Life Group. All rights reserved). No part of the EORTC QLQ-NMIBC24 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1994. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Non-Muscle-Invasive Bladder Cancer | ||
EORTC QLQ-OES18 | C183588 | EOR20 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophageal (EORTC QLQ-OES18) (QLQ-OES18 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-OES18 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1999. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophageal | ||
EORTC QLQ-OG25 PHASE IV MODULE | C183589 | EOR21 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oesophago-Gastric Phase IV Module (EORTC QLQ-OG25 PHASE IV MODULE) (QLQ-OG25 Copyright 2007 EORTC Quality of Life Group. All rights reserved. (Phase IV module)). No part of the EORTC QLQ-OG25 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2007. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Esophago-Gastric Phase IV Module Version | ||
EORTC QLQ-OH15 | C183583 | EOR13 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Oral Health (EORTC QLQ-OH15) (QLQ-OH15 Copyright 2016 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-OH15 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 2016. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Oral Health | ||
EORTC QLQ-OV28 | C183590 | EOR22 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian (EORTC QLQ-OV28) (QLQ-OV28 Copyright 1997 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-OV28 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1997. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Ovarian | ||
EORTC QLQ-PAN26 PHASE III MODULE | C183593 | EOR26 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Pancreatic Cancer Phase III Module (EORTC QLQ-PAN26 PHASE III MODULE) (QLQ-C30-PAN26 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Phase III module)). No part of the EORTC QLQ-PAN26 PHASE III MODULE may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1999. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Pancreatic Cancer Phase III Module Version | ||
EORTC QLQ-PR25 | C183591 | EOR23 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Prostate (EORTC QLQ-PR25) (QLQ-PR25 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-PR25 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1999. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Prostate | ||
EORTC QLQ-STO22 | C183584 | EOR14 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Gastric (EORTC QLQ-STO22) (QLQ-STO22 Copyright 1999 EORTC Quality of Life Group. All rights reserved. (Validated module)). No part of the EORTC QLQ-STO22 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the EORTC Quality of Life Group and payment of any applicable fees. Copyright EORTC Quality of Life Group 1999. All rights reserved. | European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Gastric | ||
EPDS | C132533 | EPDS01 | Edinburgh Postnatal Depression Scale (EPDS) (Copyright by Cox, J.L., Holden, J.M., and Sagovsky, R. 1987. Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 150:782-786). | Edinburgh Postnatal Depression Scale Questionnaire | ||
EPIC-26 | C127367 | EPIC1 | The Expanded Prostate Cancer Index Composite Short Form (EPIC-26) (Copyright 2002. The University of Michigan. All rights reserved). | The Expanded Prostate Cancer Index Composite Short Form Questionnaire | ||
EPIC-CP | C127368 | EPIC2 | Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP) (Copyright 2016 Beth Israel Deaconess Medical Center 330 Brookline Avenue, Boston, MA 02215). | Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire | ||
EQ-5D-3L | C66957 | EQ5D01 | European Quality of Life Five Dimension Three Level Scale (EQ-5D-3L) (Copyright 1990 EuroQol Group. EQ-5D is a trade mark of the EuroQol Group). | European Quality of Life Five Dimension Three Level Questionnaire | ||
EQ-5D-5L | C102117 | EQ5D02 | European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L) (Copyright 2009 EuroQol Group. EQ-5D is a trade mark of the EuroQol Group). | European Quality of Life Five Dimension Five Level Scale Questionnaire | ||
ESS | C103517 | ESS01 | Epworth Sleepiness Scale (ESS) (copyright Murray W. Johns, 1990-1997. All rights reserved.). | Epworth Sleepiness Scale Questionnaire | ||
EXACT | C123666 | EXACT1 | Exacerbations of Chronic Pulmonary Disease Tool (EXACT) Patient-Reported Outcome (PRO) (Nancy K. Leidy, EXACT-PRO Initiative, Evidera, 7101 Wisconsin Avenue, Suite 1400, Bethesda, MD; EXACT copyright 2013, Evidera, Inc. All rights reserved). This also includes the subset EXACT-Respiratory Symptoms (E-RS) questions. http://www.exactproinitiative.com | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire | ||
EXPANDED DRS-PI CAREGIVER VERSION | C125759 | ED1 | Expanded Disability Rating Scale - Postacute Interview Caregiver Version (EXPANDED DRS-PI CAREGIVER VERSION) (Malec JF, Hammond FM, Giacino JT, Whyte J, Wright J. Structured Interview to Improve the Reliability and Psychometric Integrity of the Disability Rating Scale. Arch Phys Med Rehabil Sept 2012;93:1603-1608). | Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire | ||
EXPANDED DRS-PI SURVIVOR VERSION | C125760 | ED2 | Expanded Disability Rating Scale - Postacute Interview Survivor Version (EXPANDED DRS-PI SURVIVOR VERSION) (Malec JF, Hammond FM, Giacino JT, Whyte J, Wright J. Structured Interview to Improve the Reliability and Psychometric Integrity of the Disability Rating Scale. Arch Phys Med Rehabil Sept 2012;93:1603-1608). | Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire | ||
FAACT V4 | C179973 | FAC065 | Functional Assessment of Anorexia/Cachexia Treatment Version 4 (FAACT V4) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). | Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire | ||
FACIT-DYSPNEA 33 ITEM BANK | C155325 | FAC100 | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank (FACIT-DYSPNEA 33 ITEM BANK) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire | ||
FACIT-DYSPNEA SF | C121853 | FAC084 | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form (FACIT-DYSPNEA SF) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | FACIT-Dyspnea 10 Item Short Form | ||
FACIT-F V4 | C129105 | FAC071 | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 (FACIT-F V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire | ||
FACIT-FATIGUE 13-ITEM V4 | C147585 | FAC070 | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 (FACIT-FATIGUE 13-Item V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire | ||
FACIT-SEARCHABLE ITEM LIBRARY ADULT | C183576 | FSIL | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult (FACIT-SEARCHABLE ITEM LIBRARY ADULT) (These materials discuss and/or include the FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved). | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Version Questionnaire | ||
FACT-B V4 | C129108 | FAC005 | Functional Assessment of Cancer Therapy-Breast Version 4 (FACT-B V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire | ||
FACT-BL V4 | C155326 | FAC006 | Functional Assessment of Cancer Therapy-Bladder Version 4 (FACT-BL V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire | ||
FACT-BMT V4 | C147583 | FAC061 | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 (FACT-BMT V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire | ||
FACT-BP V4 | C179974 | FAC074 | Functional Assessment of Cancer Therapy-Bone Pain Version 4 (FACT-BP V4) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). These materials discuss and/or include the Functional Assessment of Cancer Therapy-Bone Pain Version 4 (FACT-BP V4), which is owned exclusively by David Cella, Ph.D. No part of the FACT-BP V4 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of David Cella, Ph.D. and payment of any applicable fees. Copyright David Cella 1987, 1997. All rights reserved. | Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire | ||
FACT-BRM V4 | C150914 | FAC062 | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 (FACT-BRM V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire | ||
FACT-C V4 | C150912 | FAC008 | Functional Assessment of Cancer Therapy-Colorectal Version 4 (FACT-C V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire | ||
FACT-COG V3 | C103850 | FAC075 | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 (FACT-COG V3) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | FACT-Cognitive Function | ||
FACT-G V4 | C127369 | FAC001 | Functional Assessment of Cancer Therapy-General Version 4 (FACT-G V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-General Version 4 Questionnaire | ||
FACT-HEP V4 | C130312 | FAC015 | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 (FACT-HEP V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire | ||
FACT-L V4 | C150916 | FAC016 | Functional Assessment of Cancer Therapy-Lung Version 4 (FACT-L V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire | ||
FACT-LEU V4 | C130311 | FAC017 | Functional Assessment of Cancer Therapy-Leukemia Version 4 (FACT-LEU V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire | ||
FACT-LYM V4 | C130313 | FAC018 | Functional Assessment of Cancer Therapy-Lymphoma Version 4 (FACT-LYM V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire | ||
FACT-P V4 | C127371 | FAC023 | Functional Assessment of Cancer Therapy-Prostate Version 4 (FACT-P V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire | ||
FACT-TAXANE V4 | C150913 | FAC063 | Functional Assessment of Cancer Therapy-Taxane Version 4 (FACT-Taxane V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire | ||
FACT/GOG-NTX V4 | C150915 | FAC057 | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 (FACT/GOG-NTX V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire | ||
FAMS | C112521 | FAMS01 | Functional Assessment of Multiple Sclerosis Version 4 (FAMS) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Multiple Sclerosis Questionnaire | ||
FBRSI | C138336 | FAC029 | Functional Assessment of Cancer Therapy-Brain Symptom Index (FBRSI) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire | ||
FES | C193325 | FES01 | Falls Efficacy Scale (FES) (Reprinted with permission, Mary E. Tinetti, M.D. Copyright; 2006. Tinetti ME, Richman D, Powell L. Falls efficacy as a measure of fear of falling. J Gerontol 1990;45:239-243). These materials discuss and/or include the Falls Efficacy Scale, which are owned exclusively by Mary E. Tinetti, M.D. No part of the Falls Efficacy Scale may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Mary E. Tinetti, M.D. and payment of any applicable fees. Reprinted with permission, Mary E. Tinetti, M.D. Copyright; 2006 All rights reserved. | Falls Efficacy Scale Questionnaire | ||
FIQR | C103518 | FIQR01 | Revised Fibromyalgia Impact Questionnaire (FIQR) (copyright 2009 Bennett RM and Friend. All Rights Reserved.). No part of the FIQR may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Bennett RM and Friend and payment of any applicable fees. Copyright Bennett RM and Friend, 2009. All rights reserved. | Revised Fibromyalgia Impact Questionnaire | ||
FKSI-15 | C118498 | FAC039 | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 (FKSI-15) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | FKSI-15 Questionnaire | ||
FKSI-DRS V4 | C150917 | FAC041 | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 (FKSI-DRS V4) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire | ||
FLSI | C138338 | FAC043 | Functional Assessment of Cancer Therapy-Lung Symptom Index (FLSI) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire | ||
FLU-IIQ ONCE DAILY | C119093 | FLUIQ1 | Influenza Intensity and Impact Questionnaire (Flu-iiQ) Once Daily (FLU-IIQ ONCE DAILY) (Copyright RH Osborne 2006. No part of the FLU-IIQ ONCE DAILY may be copied or reproduced in any form without written permission from the author: measuredsolutions (at) bigpond (dot) com). No part of the Flu-iiQ may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of RH Osborne and payment of any applicable fees. Copyright RH Osborne, 2006. All rights reserved. | Influenza Intensity and Impact Questionnaire Once Daily Version | ||
FLU-IIQ TWICE DAILY | C119094 | FLUIQ2 | Influenza Intensity and Impact Questionnaire (Flu-iiQ) Twice Daily (FLU-IIQ TWICE DAILY) (Copyright RH Osborne 2006. No part of the Flu-iiQ may be copied or reproduced in any form without written permission from the author: measuredsolutions (at) bigpond (dot) com). No part of the FLU-IIQ TWICE DAILY may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of RH Osborne and payment of any applicable fees. Copyright RH Osborne, 2006. All rights reserved. | Influenza Intensity and Impact Questionnaire Twice Daily Version | ||
FOSI | C129109 | FAC049 | Functional Assessment of Cancer Therapy-Ovarian Symptom Index (FOSI) (These materials discuss and/or include FACIT Measurement System, which is owned exclusively by Dr. David Cella. No part of the FACIT Measurement System may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of Dr. David Cella and payment of any applicable fees. Copyright Dr. David Cella. All rights reserved.) | Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire | ||
FPSR | C100766 | FPSR1 | Faces Pain Scale - Revised (FPS-R) (Hicks CL, von Baeyer CL, van Korlaar I, Goodenough B. Faces Pain Scale-Revised: Toward a Common Metric in Pediatric Pain Measurement. Pain 2001; 93:173-183). | Faces Pain Scale Revised Questionnaire | ||
FSS | C106621 | FSS01 | Fatigue Severity Scale (FSS) (Copyright Lauren B. Krupp). | Fatigue Severity Scale | ||
GAD-7 V2 | C163813 | GAD02 | Generalized Anxiety Disorder - 7 Version 2 (GAD-7 V2) (Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166:1092-1097). | Generalized Anxiety Disorder - 7 Version 2 Questionnaire | ||
GAD-7 | C103519 | GAD01 | Generalized Anxiety Disorder - 7 (GAD-7) (Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166:1092-1097). | Generalized Anxiety Disorder - 7 Questionnaire | ||
GCGI | C105169 | GCGI01 | The General Clinical Global Impressions (GCGI v1) questions were created by STANDARDS (Standardized Analgesic Database for Research, Discovery, and Submissions) and sponsored by ACTTION (Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks) www.acttion.org; 2012-08-07 v1. | STANDARDS General Clinical Global Impressions Questionnaire | ||
GDS SHORT FORM | C106698 | GDS02 | Geriatric Depression Scale Short Form (GDS Short Form) (Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986 June;5(1/2):165-173). | Geriatric Depression Scale Short Form Questionnaire | ||
GDS | C106697 | GDS01 | Geriatric Depression Scale (GDS) (Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatry Res. 1983;17(1):37-49). | Geriatric Depression Scale Questionnaire | ||
GMSS VERSION TYPE 1 DIABETES | C163814 | GMSS01 | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes (GMSS VERSION TYPE 1 DIABETES) (Polonsky WH, Fisher L, Hessler D, Edelman SV. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life. Diabetes Technol Ther 2015; 17(9): 657-663). | The Glucose Monitoring Satisfaction Survey Version: Type 1 Diabetes Questionnaire | ||
GOSE | C115797 | GOSE1 | Extended Glasgow Outcome Scale (GOSE) (Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: Guidelines for their use. Journal of Neurotrauma 1998;15:573-585). | Extended Glasgow Outcome Scale Questionnaire | ||
HADS | C103520 | HADS01 | Hospital Anxiety and Depression Scale (HADS) (copyright 1983, 1992, 1994 by R.P. Snaith and A.S. Zigmond. All rights reserved.). | Hospital Anxiety and Depression Scale Questionnaire | ||
HAEM-A-QOL | C122381 | HM09 | Hemophilia Quality of Life Questionnaire Adult Version (Haem-A-QoL) (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group; Von Mackensen S, Scalone L, Ravera S, Mantovani L, Gringeri A, The COCHE Study Group. Assessment of health-related quality of life in patients with Hemophilia with the newly developed Hemophilia-specific instrument (Haem-A-QoL). Value Health 2005; 8:A127). | Hemophilia Quality of Life Questionnaire Adult Version | ||
HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP I | C122373 | HM01 | Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Long Version Age Group I (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). | Hemophilia Quality of Life Questionnaire Children's Long Version Age Group I | ||
HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP II | C122374 | HM02 | Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Long Version Age Group II (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). | Hemophilia Quality of Life Questionnaire Children's Long Version Age Group II | ||
HAEMO-QOL CHILDREN'S LONG VERSION AGE GROUP III | C122375 | HM03 | Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Long Version Age Group III (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). | Hemophilia Quality of Life Questionnaire Children's Long Version Age Group III | ||
HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP I | C122376 | HM04 | Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Short Version Age Group I (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). | Hemophilia Quality of Life Questionnaire Children's Short Version Age Group I | ||
HAEMO-QOL CHILDREN'S SHORT VERSION AGE GROUP II/III | C122377 | HM05 | Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Children's Short Version Age Group II/III (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). | Hemophilia Quality of Life Questionnaire Children's Short Version Age Group II/III | ||
HAEMO-QOL PARENT'S LONG VERSION AGE GROUP I | C122378 | HM06 | Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Parent's Long Version Age Group I (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). | Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group I | ||
HAEMO-QOL PARENT'S LONG VERSION AGE GROUP II | C122379 | HM07 | Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Parent's Long Version Age Group II (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). | Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group II | ||
HAEMO-QOL PARENT'S LONG VERSION AGE GROUP III | C122380 | HM08 | Hemophilia Quality of Life (HAEMO-QOL) Questionnaire Parent's Long Version Age Group III (The Haemo-QoL questionnaire-set is a joint property of the Haemo-QoL Study Centre at the University of Hamburg, Germany and Bayer Biological Products, Research Triangle Park, North Carolina, USA. Development of new translations, modified versions or any other derivatives - such as electronic versions - are not permitted without special permission and involvement of the Haemo-QoL Study Group). | Hemophilia Quality of Life Questionnaire Parent's Long Version Age Group III | ||
HAMD 6 SELF-REPORT VERSION | C130314 | HAMDS1 | The Hamilton Depression Rating Scale 6 Self-Report Version (HAM-D6 - Self-Report Version) (Clinical Research: Rating scales in depression: limitations and pitfalls; Per Bech, MD; Copyright 2006 LLS SAS. All rights reserved). | Hamilton Depression Rating Scale 6 Self-Report Version Questionnaire | ||
HAQ-DI WITH VAS | C106699 | HAQ01 | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale (HAQ-DI WITH VAS) (Fries JF. The assessment of disability: from first to future principles. Br J Rheumatol. 1983 Aug; 22(3 Suppl):48-58). | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire | ||
HAQ-DI WITHOUT VAS | C132534 | HAQ02 | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale (HAQ-DI WITHOUT VAS) (Copyright 2003 Fries JF. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications. Health and Quality of Life Outcomes 2003. 9 June 2003; 1:20 1-6). | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale | ||
HCS | C163815 | HCS01 | Hypoglycemic Confidence Scale (HCS) (Polonsky WH, Fisher L, Hessler D, Edelman SV. Investigating Hypoglycemic Confidence in Type 1 and Type 2 Diabetes. Diabetes Technol Ther 2017; 19(2): 131-6). | Hypoglycemic Confidence Scale Questionnaire | ||
IBDQ | C174070 | IBDQ01 | Quality of Life in Inflammatory Bowel Disease Questionnaire (IBDQ) (Copyright 1989, McMaster University, Hamilton, Ontario, Canada. The Inflammatory Bowel Disease Questionnaire, authored by Dr. Jan Irvine et. al., was made under license from McMaster University, Hamilton, Canada (Copyright 1989, McMaster University). The IBDQ is provided under license from McMaster University and may not be copied, distributed or used in any way without the prior written consent of McMaster University. Contact the McMaster Industry Liaison Office at: milo at mcmaster.ca for licensing details). | Quality of Life in Inflammatory Bowel Disease Questionnaire | ||
IDS-SR | C130315 | IDSR1 | Inventory of Depressive Symptomatology - Self-Report (IDS-SR) (Copyright UT Southwestern Medical Center at Dallas. Rush, A.J., Carmody, T. and Reimitz, P.E. The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research, 9:45-59, 2000). | Inventory of Depressive Symptomatology Self-Report Version Questionnaire | ||
IIEF | C103521 | IIEF01 | International Index of Erectile Function (IIEF) (Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, and Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997 49(6): 822-830). | International Index of Erectile Function Questionnaire | ||
IPAQ-LF PHONE VERSION | C141692 | IPAQ02 | International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format (IPAQ-LF PHONE VERSION)(Booth, M.L. (2000). Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s114-20. Retrieved from the International Physical Activity Questionnaire website: http://www.ipaq.ki.se). | International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format | ||
IPAQ-LF SELF-ADMINISTERED VERSION | C141691 | IPAQ03 | International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format (IPAQ-LF SELF-ADMINISTERED VERSION) (Booth, M.L. (2000). Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s114-20. Retrieved from the International Physical Activity Questionnaire website: http://www.ipaq.ki.se). | International Physical Activity Questionnaire (August 2002) Long Last 7 Days Self-Administered Format | ||
IPAQ-SF PHONE VERSION | C141693 | IPAQ01 | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format (IPAQ-SF PHONE VERSION)(Booth, M.L. (2000). Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s114-20. Retrieved from the International Physical Activity Questionnaire website: http://www.ipaq.ki.se). | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format | ||
IPAQ-SF SELF-ADMINISTERED VERSION | C141690 | IPAQ04 | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format (IPAQ-SF SELF-ADMINISTERED VERSION)(Booth, M.L. (2000). Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s114-20. Retrieved from the International Physical Activity Questionnaire website: http://www.ipaq.ki.se). | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format | ||
IPSS | C113446 | I-PSS;IPS01 | International Prostate Symptom Score (IPSS) (Barry MJ, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-1557). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | International Prostate Symptom Score | ||
IVIS | C113876 | IVIS01 | Impact of Visual Impairment Scale (IVIS) (1997 by the National Multiple Sclerosis Society. All rights reserved). | Impact of Visual Impairment Scale Questionnaire | ||
KDQOL-36 V1 | C193324 | KDQ1 | Kidney Disease and Quality of Life-36 Version 1 (KDQOL-36 V1) (Copyright 2000 by RAND and the University of Arizona). No part of the KDQOL-36 V1 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of RAND and the University of Arizona and payment of any applicable fees. Copyright RAND and the University of Arizona 2000. All rights reserved. | Kidney Disease and Quality of Life-36 Version 1 Questionnaire | ||
LCSS | C187515 | LCSS1 | Lung Cancer Symptom Scale (LCSS) (Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer. 1993;29A Suppl 1:S51-8. U.S. Copyright 1995, Reproduced by permission of Quality of Life Research Associates, LLC). No part of the Lung Cancer Symptom Scale may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Quality of Life Research Associates, LLC and payment of any applicable fees. Copyright Quality of Life Research Associates, LLC 1995. All rights reserved. | Lung Cancer Symptom Scale Questionnaire | ||
LEC-5 STANDARD VERSION | C135740 | LEC01 | Life Events Checklist for DSM-5, Standard Version (LEC-5 STANDARD VERSION) (Weathers, F.W., Blake, D.D., Schnurr, P.P., Kaloupek, D.G., Marx, B.P., & Keane, T.M. (2013). The Life Events Checklist for DSM-5 (LEC-5). Retrieved from the National Center for PTSD website: http://www.ptsd.va.gov). | Life Events Checklist for DSM-5 Standard Version Questionnaire | ||
MADRS | C122382 | MADRS1 | Montgomery-Asberg Depression Rating Scale (MADRS) (Copyright Stuart Montgomery 1978, Measures of Depression, Fulcrum Press, London. Stuart A. Montgomery and Marie Asberg. A new depression scale designed to be sensitive to change. Br. J. Psychiat. (1979), 134:382-389). | Montgomery-Asberg Depression Rating Scale Questionnaire | ||
MDQ-T | C123660 | MDQ01 | Menstrual Distress Questionnaire Form-T (Today) (MDQ-T) (Copyright 1968, 1989, 1991, 2000, 2010 by Rudolf H. Moos. All Rights Reserved. Published by Mind Garden, Inc. Moos RH. The development of a menstrual distress questionnaire. Psychosom Med. 1968 Nov-Dec;30(6):853-67). | Menstrual Distress Questionnaire Form-T (Today) | ||
MDS-UPDRS | C100769 | UPD2 | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) (copyright 2008 Movement Disorder Society. All Rights Reserved). | Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire | ||
MFIS | C113877 | MFIS01 | Modified Fatigue Impact Scale (MFIS) (1997 by the National Multiple Sclerosis Society. All rights reserved). | Modified Fatigue Impact Scale Questionnaire | ||
MHIS-NACC | C112523 | MHIS01 | Modified Hachinski Ischemic Scale-NACC Version (MHIS-NACC) Reproduced with permission. Copyright 2011 University of Washington. Created and published by the ADC Clinical Task Force (John C. Morris, MD, Chair) and the National Alzheimer's Coordinating Center (Walter A. Kukull, PhD, Director). This publication was funded by the National Institutes of Health through the National Institute on Aging (Cooperative Agreement U01 AG016976). | Modified Hachinski Ischemic Scale-NACC Version Questionnaire | ||
MMRC | C106700 | MMRC01 | Modified Medical Research Council dyspnea scale (MMRC) (Mahler DA, Wells CK. Evaluation of Clinical Methods for Rating Dyspnea. Chest 1988; 93:580-586). | Modified Medical Research Council Dyspnea Scale Questionnaire | ||
MNSI | C100771 | MNSI1 | Michigan Neuropathy Screening Instrument (MNSI) (copyright University of Michigan, 2000, All rights reserved). | Michigan Neuropathy Screening Instrument Questionnaire | ||
MPAI-4 | C115798 | MPAI1 | The Mayo-Portland Adaptability Inventory-4 (MPAI-4) (Malec, J. (2005). The Mayo-Portland Adaptability Inventory-4. The Center for Outcome Measurement in Brain Injury. http://www.tbims.org/combi/mpai). | Mayo-Portland Adaptability Inventory-4 Questionnaire | ||
MRS | C111383 | MRS01 | Modified Rankin Scale (MRS) (Van Swieten J., Koudstaal P., Visser M., Schouten H., and Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients, 1988. Stroke 19: 604-607). | Modified Rankin Scale Questionnaire | ||
MSIS-29 V1 | C123664 | MSIS01 | Multiple Sclerosis Impact Scale version 1 (MSIS-29v1) (Copyright 2000 Neurological Outcome Measures Unit, Institute of Neurology, University College London, UK). | Multiple Sclerosis Impact Scale Version 1 Questionnaire | ||
MSIS-29 V2 | C123665 | MSIS02 | Multiple Sclerosis Impact Scale version 2 (MSIS-29v2) (Copyright 2005 Neurological Outcome Measures Unit, Peninsula Medical School, Plymouth, UK). | Multiple Sclerosis Impact Scale Version 2 Questionnaire | ||
MSQOL-54 | C113878 | MSQL1 | Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) (Copyright 1995, University of California, Los Angeles). | Multiple Sclerosis Quality of Life-54 Instrument Questionnaire | ||
MSWS-12 | C123663 | MSWS01 | 12-Item Multiple Sclerosis Walking Scale (MSWS-12) (Copyright 2000 Neurological Outcome Measures Unit). | 12-Item Multiple Sclerosis Walking Scale Questionnaire | ||
NCCN-FACT FBLSI-18 V2 | C129107 | FAC028 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 (NCCN-FACT FBlSI-18 V2) (Copyright 2001 David Cella, Ph.D. All Rights Reserved;Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire | ||
NCCN-FACT FBRSI-24 V2 | C150918 | FAC030 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 (NCCN-FACT FBRSI-24 V2) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire | ||
NCCN-FACT FHNSI-22 V2 | C150919 | FAC036 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 (NCCN-FACT FHNSI-22 V2) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire | ||
NCCN-FACT FKSI-19 V2 | C129106 | FAC042 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 (NCCN-FACT FKSI-19 V2) (Copyright 2001 David Cella, Ph.D. All Rights Reserved;Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire | ||
NCCN-FACT FOSI-18 V2 | C129110 | FAC050 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 (NCCN-FACT FOSI-18 V2) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire | ||
NCCN-FACT FPSI-17 V2 | C127370 | FAC052 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 (NCCN-FACT-FPSI 17 V2) (Copyright 2001 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire | ||
NPI | C100772 | NPI-12;NPI1 | Neuropsychiatric Inventory (NPI) (copyright JL Cummings, 1994, all rights reserved; permission for commercial use required; npiTEST.net). No part of the NPI may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the JL Cummings and payment of any applicable fees. Copyright JL Cummings, 1994, all rights reserved. | Neuropsychiatric Inventory - 12 Item Version Questionnaire | ||
NPS | C103522 | NPS01 | Neuropathic Pain Scale (NPS) (copyright Brad Galer and Mark Jensen. All rights reserved.). | Neuropathic Pain Scale Questionnaire | ||
NSCLC-SAQ V1.0 | C155327 | NSCLC1 | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 (NSCLC-SAQ V1.0) (Version 1.0 Copyright 2015 Critical Path Institute. All Rights Reserved. McCarrier KP, Atkinson TM, DeBusk KP, Liepa AM, Scanlon M, Coons SJ and on behalf of the Patient-Reported Outcome Consortium. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument. Clinical Therapeutics 2016; 38(4):794-810. Patient-Reported Outcome (PRO) Consortium - Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) Provisional User Manual, Version 6: March 24, 2017). No part of the NSCLC-SAQ V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved). | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 | ||
OAB-Q SHORT FORM | C103524 | OABQ02 | The Overactive Bladder Questionnaire Short Form (OAB-q Short Form) (Karin S. Coyne, Christine L. Thompson, Jin-Shei Lai, and Chris C. Sexton. An Overactive Bladder Symptom and Health-Related Quality of Life Short-Form: Validation of the OAB-q SF. Neurourology and Urodynamics 34:255-263, 2015). | The Overactive Bladder Questionnaire Short Form | ||
OAB-Q | C103523 | OABQ01 | The Overactive Bladder Questionnaire (OAB-q) (Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. Sep 2002; 11(6):563-574). | The Overactive Bladder Questionnaire | ||
OCI | C119095 | OCI01 | Ocular Comfort Index (OCI) (The copyright owner of the Ocular Comfort Index is Dr. Michael Edward Johnson. Michael E. Johnson and Paul J. Murphy. Measurement of Ocular Surface Irritation on a Linear Interval Scale with the Ocular Comfort Index. Investigative Ophthalmology and Visual Science, October 2007, Vol. 48, No.10). | Ocular Comfort Index Questionnaire | ||
ODI V2.1A | C103525 | ODI01 | The Oswestry Disability Index Version 2.1a (ODI v2.1A) (copyright 1980 Jeremy Fairbank. All Rights Reserved.). | The Oswestry Disability Index Version 2.1a Questionnaire | ||
PARENT-DDS | C163816 | DDS02 | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes (PARENT-DDS) (Hessler D, Fisher L, Polonsky W, Johnson N. Understanding the Areas and Correlates of Diabetes-Related Distress in Parent of Teens With Type 1 Diabetes. Journal of Pediatric Psychology 2016; 41(7): 750-758). | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire | ||
PARTNER-DDS | C163817 | DDS03 | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes (PARTNER-DDS) (Polonsky WH, Fisher L, Hessler D, Johnson N. Emotional Distress in the Partners of Type 1 Diabetes Adults: Worries About Hypoglycemia and Other Key Concerns. Diabetes Technology & Therapeutics May 2016; 18(5): 292-297). | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire | ||
PCL-5 | C135741 | PCL01 | The PTSD Checklist for DSM-5 (PCL-5) (Weathers, F.W., Litz, B. T., Keane, T. M., Palmieri, P. A., Marx, B. P., & Schnurr, P. P. (2013). The PTSD Checklist for DSM-5 (PCL-5). Retrieved from the National Center for PTSD website: http://www.ptsd.va.gov). | The PTSD Checklist for DSM-5 Questionnaire | ||
PDDS | C112524 | PDDS01 | Patient Determined Disease Steps (PDDS) (Hohol MJ, Orav EJ, Weiner HL. Disease Steps in multiple sclerosis: A simple approach to evaluate disease progression. Neurology 1995; 45: 251-55). (Hohol MJ, Orav EJ, Weiner HL. Disease Steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Multiple Sclerosis 1999; 5: 349-54). (Marrie RA and Goldman M. Validity of performance scales for disability assessment in multiple sclerosis. Multiple Sclerosis 2007; 13: 1176-1182). (The PDDS and/or PS are provided for use by the NARCOMS Registry: www.narcoms.org/pdds. NARCOMS is supported in part by the Consortium of Multiple Sclerosis Centers (CMSC) and the CMSC Foundation). | Patient Determined Disease Steps Questionnaire | ||
PDQ-39 | C187514 | PD01 | Parkinson's Disease Questionnaire-39 (PDQ-39) (Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995 Jun;4(3):241-8. PDQ-39 copyright Oxford University Innovation Limited 1993. All Rights Reserved. The authors, being Professor Crispin Jenkinson, Professor Ray Fitzpatrick and Ms. Viv Peto, have asserted their moral rights). No part of the Parkinson's Disease Questionnaire-39 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Oxford University Innovation Limited and payment of any applicable fees. Copyright Oxford University Innovation Limited 1993. All Rights Reserved. | Parkinson's Disease Questionnaire-39 | ||
PDQUALIF | C100773 | PDQ01 | Parkinson's Disease Quality of Life Scale (PDQUALIF) (Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J, and The Parkinson Study Group. Development and Testing of the Parkinson's Disease Quality of Life Scale. Movement Disorders, 2003, Vol. 18; 637-645). | Parkinson's Disease Quality of Life Scale Questionnaire | ||
PEDS-FACIT-F | C147586 | FAC099 | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue (PEDS-FACIT-F) (Copyright 1987, 1997 David Cella, Ph.D. All Rights Reserved; Questionnaires and all related subscales, translations, and adaptations ('FACIT System') are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org the right to license usage of the FACIT System to other parties). | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD PARENT REPORT | C138341 | PQL15 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Child Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Child Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE ACUTE V3 CHILD | C138339 | PQL14 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Child (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Child Report Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN PARENT REPORT | C138342 | PQL13 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Teen Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Teen Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TEEN | C138345 | PQL12 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Teen (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Teen Report Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE ACUTE V3 TODDLER PARENT REPORT | C138340 | PQL18 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Toddler Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent of Toddler Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT PARENT REPORT | C138343 | PQL11 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Young Adult Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG ADULT | C138346 | PQL10 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Young Adult (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Adult Report Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD PARENT REPORT | C138344 | PQL17 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Young Child Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Parent Report for Young Child Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE ACUTE V3 YOUNG CHILD | C138347 | PQL16 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Acute Version 3 Young Child (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Acute Version 3.0 Young Child Report Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE V3 CHILD PARENT REPORT | C138350 | PQL06 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Child Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Child Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE V3 CHILD | C138348 | PQL05 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Child (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Version 3.0 Child Report Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE V3 TEEN PARENT REPORT | C138351 | PQL04 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Teen Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Teen Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE V3 TEEN | C138354 | PQL03 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Teen (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Version 3.0 Teen Report Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE V3 TODDLER PARENT REPORT | C138349 | PQL09 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Toddler Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent of Toddler Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT PARENT REPORT | C138352 | PQL02 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Young Adult Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Adults Report Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE V3 YOUNG ADULT | C138355 | PQL01 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Young Adult (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Adult Report Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD PARENT REPORT | C138353 | PQL08 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Young Child Parent Report (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Version 3.0 Parent Report for Young Child Questionnaire | ||
PEDSQL NEUROMUSCULAR MODULE V3 YOUNG CHILD | C138356 | PQL07 | Pediatric Quality of Life (PedsQL) Neuromuscular Module Version 3 Young Child (Copyright 1998 JW Varni, Ph.D. Iannaccone, S.T., Hynan, L.S., Morton, A., Buchanan, R., Limbers, C.A., Varni, J.W., the AmSMART Group (2009). The PedsQL in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders, 19, 805-812. Davis, S.E., Hynan, L.S., Limbers, C.A., Andersen, C.M., Greene, M.C., Varni, J.W., Iannaccone, S.T. (2010). The PedsQL in pediatric patients with Duchenne Muscular Dystrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. Journal of Clinical Neuromuscular Disease, 11, 97-109). | Pediatric Quality of Life Neuromuscular Module Version 3.0 Young Child Report Questionnaire | ||
PGI | C135739 | PGI01 | Patient Global Impression (PGI) generic modification for any disease/condition concept use case (Modified from Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976). | Patient Global Impression Generic Modification Version Questionnaire | ||
PHQ SCREENER VERSION | C125761 | PHQ03 | Patient Health Questionnaire Screener Version (PHQ Screener) (Spitzer RL, Kroenke K, Williams JBW, for the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA 1999;282:1737-1744. http://www.phqscreeners.com/instructions/instructions.pdf). | Patient Health Questionnaire Screener Version | ||
PHQ-15 | C103527 | PHQ02 | Patient Health Questionnaire - 15 (PHQ-15) (Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64:258-266). | Patient Health Questionnaire - 15 Item | ||
PHQ-2 | C123386 | PHQ04 | Patient Health Questionnaire-2 (PHQ-2) (Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener. Medical Care. 2003;41:1284-92). | Patient Health Questionnaire-2 | ||
PHQ-8 | C191043 | PHQ05 | The Patient Health Questionnaire - 8 (PHQ-8) (Kroenke, K, Strine, TW, Spitzer, RL, Williams, JBW, Berry, JT, Mokdad, AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009 Apr;114(1-3):163-73). These materials discuss and/or include the Patient Health Questionnaire - 8 (PHQ-8) which is owned exclusively by the Pfizer. Inc. Use of the PHQ-8 is subject to Pfizer. Inc. terms of use. See (https://www.phqscreeners.com/select-screener PHQ-8 copyright 2009, Pfizer. Inc. | The Patient Health Questionnaire - 8 Item | ||
PHQ-9 | C103526 | PHQ01 | Patient Health Questionnaire - 9 (PHQ-9) (Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606-613). | Patient Health Questionnaire - 9 Item | ||
PI | C105167 | PI01 | Pain Intensity (PI) (STANDARDS, Standardized Analgesic Database for Research, Discovery, and Submissions, and sponsored by ACTTION, Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks. www.acttion.org; 2012-08-07 v1. Handbook of Pain Assessment, Third Edition [Hardcover] Chapter 2 - Self-Report Scales and Procedures for Assessing Pain in Adults: Dennis C. Turk PhD (Editor), Ronald Melzack PhD (Editor)). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | STANDARDS Pain Intensity Questionnaire | ||
PODCI - ADOLESCENT PARENT REPORTED | C135743 | PODCI2 | Pediatric Outcomes Data Collection Instrument (PODCI), Adolescent Parent-Reported (Daltroy LH, Liang MH, Fossel AH, Goldberg MJ, and The Outcomes Instrument Development Work Group. The POSNA Pediatric Musculoskeletal Functional Health Questionnaire:report on reliability, validity, and sensitivity to change. J Pediatr Orthop 1998; 18: 561-71). | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire | ||
PODCI - ADOLESCENT SELF REPORTED | C135744 | PODCI3 | Pediatric Outcomes Data Collection Instrument (PODCI), Adolescent Self-Reported (Daltroy LH, Liang MH, Fossel AH, Goldberg MJ, and The Outcomes Instrument Development Work Group. The POSNA Pediatric Musculoskeletal Functional Health Questionnaire:report on reliability, validity, and sensitivity to change. J Pediatr Orthop 1998; 18: 561-71). | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire | ||
PODCI - PEDIATRIC PARENT REPORTED | C135742 | PODCI1 | Pediatric Outcomes Data Collection Instrument (PODCI), Pediatric Parent-Reported (Daltroy LH, Liang MH, Fossel AH, Goldberg MJ, and The Outcomes Instrument Development Work Group. The POSNA Pediatric Musculoskeletal Functional Health Questionnaire: report on reliability, validity, and sensitivity to change. J Pediatr Orthop 1998; 18: 561-71). | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire | ||
PR | C105168 | PR01 | Pain Relief (PR) (STANDARDS, Standardized Analgesic Database for Research, Discovery, and Submissions, and sponsored by ACTTION, Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks. www.acttion.org; 2012-08-07 v1. Handbook of Pain Assessment, Third Edition [Hardcover] Chapter 2 - Self-Report Scales and Procedures for Assessing Pain in Adults: Dennis C. Turk PhD (Editor), Ronald Melzack PhD (Editor)). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | STANDARDS Pain Relief Questionnaire | ||
PRO-CTCAE V1.0 | C179975 | PT01 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library Version 1.0 (PRO-CTCAE V1.0) (The PRO-CTCAE trademark items and information herein were developed by the Division of Cancer Control and Population Sciences in the National Cancer Institute at the National Institutes of Health, in Bethesda, Maryland, U.S.A. Use of the PRO-CTCAE is subject to NCI's "Terms of Use". PRO-CTCAE Measurement System content should be downloaded using the "Instrument & Form Builder". https://healthcaredelivery.cancer.gov/pro-ctcae/. Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).J Natl Cancer Inst 2014 Sep 29;106(9). National Institutes of Health - National Cancer Institute, Division of Cancer Control & Population Sciences. (2017, July 2) https://healthcaredelivery.cancer.gov/pro-ctcae/overview.html). These materials discuss and/or include the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library Version 1.0 (PRO-CTCAE V1.0) which is owned exclusively by the Division of Cancer Control and Population Sciences in the National Cancer Institute (NCI) at the National Institutes of Health (NIH). No part of the PRO-CTCAE V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying recording, or other electronic or mechanical methods, without the prior written permission of NCI and payment of any applicable fees. PRO-CTCAE V1.0 copyright, National Cancer Institute at the National Institutes of Health. All rights reserved. | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Questionnaire | ||
PROSQOLI | C127372 | PROS01 | Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) (Stockler MR, Osoba D, Corey P, Goodwin PJ, Tannock IF. Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. JClinEpidemiol 1999;52:653-66) | Prostate Cancer Specific Quality of Life Instrument Questionnaire | ||
PSQI | C103849 | PSQI1 | Pittsburgh Sleep Quality Index (PSQI) (Copyright 1989, University of Pittsburgh. Buysse,D.J., Reynolds,C.F., Monk,T.H., Berman,S.R., & Kupfer, D.J. The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric practice and research. Psychiatry Research, 1989, 28(2):193-213). | Pittsburgh Sleep Quality Index | ||
Q-LES-Q | C130317 | QLES1 | Quality Of Life Enjoyment And Satisfaction Questionnaire (Q-LES-Q) (Copyright Jean Endicott, PhD; Unit 123, 1051 Riverside Drive, New York, NY 10032. 212-543-5536; Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321-6). | Quality Of Life Enjoyment And Satisfaction Questionnaire | ||
Q-LES-Q-SF | C130318 | QLES2 | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form (Q-LES-Q-SF) (Copyright Jean Endicott, PhD; Unit 123, 1051 Riverside Drive, New York, NY 10032. 212-543-5536; Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321-6). | Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form | ||
QIDS-SR | C130316 | QIDSR1 | Quick Inventory of Depressive Symptomatology - Self-Report (QIDS-SR) (Copyright UT Southwestern Medical Center at Dallas. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54:573-583, 2003). | Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire | ||
RAND SOCIAL SUPPORT SURVEY INSTRUMENT | C135745 | RSSS01 | RAND Social Support Survey Instrument (Copyright the RAND Corporation. Developed at RAND as part of the Medical Outcomes Study). | RAND Social Support Survey Instrument Questionnaire | ||
RAND-36 V1.0 | C113879 | R3601 | RAND 36-Item Health Survey 1.0 (RAND-36) (Copyright the RAND Corporation. Developed at RAND as part of the Medical Outcomes Study). | RAND 36-Item Health Survey 1.0 Questionnaire | ||
RBDSQ | C187517 | RBD1 | REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) (Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument. Mov Disord. 2007 Dec;22(16):2386-93. RBDSQ 2007 International Parkinson and Movement Disorder Society (MDS). All Rights Reserved). No part of the REM Sleep Behavior Disorder Screening Questionnaire may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of International Parkinson and Movement Disorder Society and payment of any applicable fees. Copyright International Parkinson and Movement Disorder Society 2007. All Rights Reserved. | REM Sleep Behavior Disorder Screening Questionnaire | ||
RDQ | C100774 | RDQ01 | Roland Morris Disability Questionnaire (RDQ) (Roland MO, Morris RW. A study of the natural history of back pain. Part 1: Development of a reliable and sensitive measure of disability in low back pain. Spine 1983;8:141-144). | Roland Morris Disability Questionnaire | ||
RPQ | C119103 | RPQ01 | Rivermead Post Concussion Symptoms Questionnaire (RPQ) (King NS, Crawford S, Wenden FJ, Moss NEG, Wade DT. The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995;242:587-592). | Rivermead Post-Concussion Symptoms Questionnaire | ||
SCOPA-AUT | C187513 | SP1 | Scales for Outcomes in Parkinson's Disease - Autonomic Dysfunction (SCOPA-AUT) (Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004;19:1306-12. Copyright 2019 International Parkinson and Movement Disorder Society. All rights reserved.). No part of the Scales for Outcomes in Parkinson's Disease - Autonomic Dysfunction may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the International Parkinson and Movement Disorder Society and payment of any applicable fees. Copyright International Parkinson and Movement Disorder Society 2019. All rights reserved. | Scales for Outcomes in Parkinson's Disease - Autonomic Dysfunction Questionnaire | ||
SDS | C111384 | SDS01 | Sheehan Disability Scale (Copyright 1983, 2010, 2011 David V. Sheehan. All rights reserved.). | Sheehan Disability Scale Questionnaire | ||
SF10 V1.0 CHILDREN ACUTE | C174065 | SF102 | The Short Form 10 Health Survey for Children, Acute, US Version 1.0 (SF10 v1.0 CHILDREN ACUTE) (copyright 2001, 2005, 2011 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire | ||
SF10 V1.0 CHILDREN STANDARD | C174064 | SF101 | The Short Form 10 Health Survey for Children, Standard, US Version 1.0 (SF10 v1.0 CHILDREN STANDARD) (copyright 2001, 2005 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire | ||
SF12 V1.0 ACUTE | C174067 | SF122 | The Short Form 12 Health Survey, Acute, US Version 1.0 (SF12 v1.0 ACUTE) (copyright 1994, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire | ||
SF12 V1.0 STANDARD | C174066 | SF121 | The Short Form 12 Health Survey, Standard, US Version 1.0 (SF12 v1.0 STANDARD) (copyright 1994, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire | ||
SF12 V2.0 ACUTE | C174069 | SF124 | The Short Form 12 Health Survey, Acute, US Version 2.0 (SF12 v2.0 ACUTE) (copyright 1994, 2002 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire | ||
SF12 V2.0 STANDARD | C174068 | SF123 | The Short Form 12 Health Survey, Standard, US Version 2.0 (SF12 v2.0 STANDARD) (copyright 1994, 2002 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire | ||
SF36 V1.0 ACUTE | C102120 | SF362 | The Short Form 36 Health Survey Acute, US Version 1.0 (SF36 V1.0 ACUTE) (copyright 1988, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire | ||
SF36 V1.0 STANDARD | C100775 | SF361 | The Short Form 36 Health Survey Standard, US Version 1.0 (SF36 V1.0 STANDARD) (copyright 1988, 2002 by Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire | ||
SF36 V2.0 ACUTE | C102121 | SF364 | The Short Form 36 Health Survey Acute, US Version 2.0 (SF36 V2.0 ACUTE) (copyright 1992, 1996, 2000 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire | ||
SF36 V2.0 STANDARD | C102122 | SF363 | The Short Form 36 Health Survey Standard, US Version 2.0 (SF36 V2.0 STANDARD) (copyright 1992, 1996, 2000 Medical Outcomes Trust and QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire | ||
SF6D V2.0 ACUTE | C185761 | SF6D2 | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) (copyright 2021 QualityMetric Incorporated, LLC. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated, LLC. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric and payment of any applicable fees. Copyright QualityMetric Incorporated, LLC. All rights reserved. | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire | ||
SF6D V2.0 STANDARD | C185762 | SF6D1 | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) (copyright 2021 QualityMetric Incorporated, LLC. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated, LLC. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric and payment of any applicable fees. Copyright QualityMetric Incorporated, LLC. All rights reserved. | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire | ||
SF8 V1.0 ACUTE | C174063 | SF82 | The Short Form 8 Health Survey, Acute, US Version 1.0 (SF8 v1.0 ACUTE) (copyright 1999, 2001 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire | ||
SF8 V1.0 STANDARD | C174062 | SF81 | The Short Form 8 Health Survey, Standard, US Version 1.0 (SF8 v1.0 STANDARD) (copyright 1998, 1999 QualityMetric Incorporated. All rights reserved). These materials discuss and/or include one or more of the SF Health Surveys, which are owned exclusively by QualityMetric Incorporated. No part of the SF Health Surveys may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of QualityMetric Incorporated and payment of any applicable fees. Copyright QualityMetric Incorporated. All rights reserved. | Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire | ||
SGRQ PAST 3 MONTHS VERSION | C112525 | SGRQ01 | St. George's Respiratory Questionnaire (SGRQ) Past 3 Months Version (copyright P.W. Jones, St. George's University of London). | St. George's Respiratory Questionnaire Past 3 Months Version | ||
SGRQ PAST 4 WEEKS VERSION | C112526 | SGRQ02 | St. George's Respiratory Questionnaire (SGRQ) Past 4 Weeks Version (copyright P.W. Jones, St. George's University of London). | St. George's Respiratory Questionnaire Past 4 Weeks Version | ||
SGRQ-C | C106890 | SGRQC1 | St. George's Respiratory Questionnaire for COPD Patients (SGRQ-C) (Jones PW, Quirk FH, Baveystock CM, and Littlejohns PA. Self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun; 145(6):1321-7). | St. George's Respiratory Questionnaire for Chronic Obstructive Pulmonary Disease Patients | ||
SHORT-FORM MPQ-2 | C100776 | SFMP2 | Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) (Copyright R. Melzack and the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), 2009, All Rights Reserved). | Short-Form McGill Pain Questionnaire-2 | ||
SIQ | C150920 | SIQ01 | Suicidal Ideation Questionnaire (SIQ) (Copyright 1987 Psychological Assessment Resources, Inc. (PAR). All rights reserved. May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc.). | Suicidal Ideation Questionnaire | ||
SIQ-JR | C150921 | SIQ02 | Suicidal Ideation Questionnaire-JR (SIQ-JR) (Copyright 1987 Psychological Assessment Resources, Inc. (PAR). All rights reserved. May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc.). | Suicidal Ideation Questionnaire-Junior | ||
SIQR | C103528 | SIQR01 | Symptom Impact Questionnaire (SIQR) (copyright 2009 Bennett RM and Friend. All Rights Reserved.). | Symptom Impact Questionnaire | ||
SMDDS V1.0 | C155328 | SMDDS1 | Symptoms of Major Depressive Disorder Scale v1.0 (SMDDS V1.0) (Version 1.0 Copyright 2015 Critical Path Institute. All Rights Reserved. McCarrier KP, Deal LS, Abraham L, Blum SI, Bush EN, Martin M, Thase ME, Coons SJ on behalf of the Patient-Reported Outcome Consortium's Depression Working Group. Patient-centered research to support the development of the Symptoms of Major Depressive Disorder Scale (SMDDS): initial qualitative research. The Patient-Patient-Centered Outcomes Research 2016;9:117-134. Patient-Reported Outcome (PRO) Consortium - Symptoms of Major Depressive Disorder Scale (SMDDS) User Manual, Version 1: October 31, 2017). No part of the SMDDS V1.0 may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the Critical Path Institute and payment of any applicable fees. Copyright Critical Path Institute, 2018. All rights reserved). | Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire | ||
SOAPP-R | C100777 | SOAPR1 | Screener and Opioid Assessment for Patients with Pain Revised (SOAPP-R) (copyright 2007 Inflexxion, Inc., All rights reserved). | Screener and Opioid Assessment for Patients with Pain Revised Questionnaire | ||
SOBDA | C123659 | SOBDA1 | Shortness of Breath with Daily Activities Questionnaire (SOBDA) (Wilcox TK, Chen WH, Howard KA, Wiklund I, Brooks J, Watkins ML, Cates CE, Tabberer MM, Crim C. Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes 2013 11:196). | Shortness of Breath with Daily Activities Questionnaire | ||
SOWS SHORT | C103529 | SOWSB1 | Short Opiate Withdrawal Scale (SOWS SHORT) (Gossop, M. The development of a short opiate withdrawal scale. Addictive Behaviors 1990; 15:487-490). | Short Opiate Withdrawal Scale Questionnaire | ||
SOWS SUBJECTIVE | C102123 | SOWSA1 | The Subjective Opiate Withdrawal Scale (SOWS) (Handelsman, L., Cochrane, K. J., Aronson, M. J. Ness, R., Rubinstein K.J., Kanof, P.D. (1987) Two New Rating Scales for Opiate Withdrawal. American Journal of Alcohol Abuse, 13, 293-308). | Subjective Opiate Withdrawal Scale Questionnaire | ||
SSS | C187511 | SSS01 | Stanford Sleepiness Scale (SSS) (Hoddes E, Dement W, Zarcone V. The development and use of the Stanford Sleepiness Scale (SSS). Psychophysiology 1971;9:150. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 1973 Jul;10(4):431-6). CDISC believes this instrument to be in the public domain, but you should perform your own assessment. | Stanford Sleepiness Scale Questionnaire | ||
SWLS | C115799 | SWLS01 | The Satisfaction With Life Scale (SWLS) (Diener, E., Emmons, R., Larsen, J., and Griffin, S. (1985). The Satisfaction With Life Scale. J Personality Assessment, 49(1): 71-75). | Satisfaction With Life Scale Questionnaire | ||
T1-DDS | C161655 | DDS01 | Diabetes Distress Scale for Adults with Type 1 Diabetes (T1-DDS) (Fisher L, Polonsky WH, Hessler DM, Masharani U, Blumer I, Peters AL, Strycker LA, Bowyer V. Understanding the sources of diabetes distress in adults with type 1 diabetes. J Diabetes Complications 2015; 29(4): 572-7). | Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire | ||
TSCC | C147587 | TSCC01 | Trauma Symptom Checklist for Children (TSCC) (Copyright 1989, 1996 by PAR. All rights reserved. May not be reproduced in whole or in part in any form or by any means without written permission of PAR). | Trauma Symptom Checklist for Children Questionnaire | ||
TSCYC | C147588 | TSCYC1 | Trauma Symptom Checklist for Young Children (TSCYC) (Copyright 1999, 2005 by Psychological Assessment Resources, Inc. (PAR). All rights reserved. May not be reproduced in whole or in part in any form or by any means without written permission of Psychological Assessment Resources, Inc). | Trauma Symptom Checklist for Young Children Questionnaire | ||
TSQM V1.4 | C132535 | TSQM01 | Treatment Satisfaction Questionnaire for Medication - Version 1.4 (TSQM V1.4) (Copyright 2004, Quintiles. All Rights Reserved). | Treatment Satisfaction Questionnaire for Medication Version 1.4 | ||
UPS | C103530 | UPS01 | Urgency Perception Scale (UPS) (copyright Pfizer. All rights reserved.). | Urgency Perception Scale Questionnaire | ||
VFQ-25 INTERVIEWER ADMINISTERED | C112527 | VFQ1 | National Eye Institute Visual Functioning Questionnaire - 25 (VFQ-25) Version 2000 Interviewer-Administered Format (Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Archives of Ophthalmology. 2001; 119:1050-1058). (This instrument was developed at RAND under the sponsorship of the National Eye Institute). | Visual Functioning Questionnaire 25-Interviewer Administered Format Version 2000 | ||
VFQ-25 SELF ADMINISTERED | C112528 | VFQ2 | National Eye Institute Visual Functioning Questionnaire - 25 (VFQ-25) Version 2000 Self-Administered Format (Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Archives of Ophthalmology. 2001; 119:1050-1058). (This instrument was developed at RAND under the sponsorship of the National Eye Institute). | Visual Functioning Questionnaire 25-Self Administered Format Version 2000 | ||
VHI | C92446 | VHI01 | Voice Handicap Index (VHI) (Development and Validation. Barbara H. Jacobson, Alex Johnson, Cynthia Grywalski, Alice Silbergleit, Gary Jaconsen, Michael S. Benninger. American Journal of Speech-Language Pathology, Vol 6(3), 66-70, 1997. The Voice Handicap Index is reprinted with permission from all authors and ASHA. Copyright 1997-2001 American Speech-Language-Hearing Association). No part of the VHI may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the authors and American Speech-Language-Hearing Association and payment of any applicable fees. Copyright American Speech-Language-Hearing Association 1997-2001. All rights reserved. | Voice Handicap Index | ||
WHODAS 2.0 - 12 + 24-ITEM INTERVIEWER | C130325 | WD4 | World Health Organization Disability Assessment Schedule 2.0 - 12+24-item Version, Interviewer-administered (WHODAS 2.0 - 12+24-item Version Interviewer-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 12+24-Item Version, Interviewer-Administered www.who.int/classifications/icf/whodasii/en)). | World Health Organization Disability Assessment Schedule 2.0 12+24-item Version Interviewer-administered Questionnaire | ||
WHODAS 2.0 - 12-ITEM INTERVIEWER | C130322 | WD1 | World Health Organization Disability Assessment Schedule 2.0 - 12-item Version, Interviewer-administered (WHODAS 2.0 - 12-item Version Interviewer-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 12-Item Version, Interviewer-Administered www.who.int/classifications/icf/whodasii/en)). | World Health Organization Disability Assessment Schedule 2.0 12-item Version Interviewer-administered Questionnaire | ||
WHODAS 2.0 - 12-ITEM PROXY | C130323 | WD2 | World Health Organization Disability Assessment Schedule 2.0 - 12-item Version, Proxy-administered (WHODAS 2.0 - 12-item Version Proxy-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 12-Item Version, Proxy-Administered www.who.int/classifications/icf/whodasii/en)). | World Health Organization Disability Assessment Schedule 2.0 12-item Version Proxy-administered Questionnaire | ||
WHODAS 2.0 - 12-ITEM SELF | C130324 | WD3 | World Health Organization Disability Assessment Schedule 2.0 - 12-item Version, Self-administered (WHODAS 2.0 - 12-item Version Self-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 12-Item Version, Self-Administered www.who.int/classifications/icf/whodasii/en)). | World Health Organization Disability Assessment Schedule 2.0 12-item Version Self-administered Questionnaire | ||
WHODAS 2.0 - 36-ITEM INTERVIEWER | C130319 | WD5 | World Health Organization Disability Assessment Schedule 2.0 - 36-item Version, Interviewer-administered (WHODAS 2.0 - 36-item Version Interviewer-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 36-Item Version, Interviewer-Administered www.who.int/classifications/icf/whodasii/en)). | World Health Organization Disability Assessment Schedule 2.0 36-item Version Interviewer-administered Questionnaire | ||
WHODAS 2.0 - 36-ITEM PROXY | C130320 | WD6 | World Health Organization Disability Assessment Schedule 2.0 - 36-item Version, Proxy-administered (WHODAS 2.0 - 36-item Version Proxy-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 36-Item Version, Proxy-Administered www.who.int/classifications/icf/whodasii/en)). | World Health Organization Disability Assessment Schedule 2.0 36-item Version Proxy-administered Questionnaire | ||
WHODAS 2.0 - 36-ITEM SELF | C130321 | WD7 | World Health Organization Disability Assessment Schedule 2.0 - 36-item Version, Self-administered (WHODAS 2.0 - 36-item Version Self-administered) (Reproduced, with permission of WHO, from Measuring Health and Disability: Manual for WHO Disability Assessment Schedule (WHODAS 2.0). Geneva,World Health Organization, 2010 (WHODAS 2.0 36-Item Version, Self-Administered www.who.int/classifications/icf/whodasii/en)). | World Health Organization Disability Assessment Schedule 2.0 36-item Version Self-administered Questionnaire | ||
WLQ | C119096 | WLQ01 | Work Limitations Questionnaire (WLQ) (copyright 1998. The Health Institute, Tufts Medical Center f/k/a New England Medical Center Hospitals, Inc.; Debra Lerner, Ph.D.; Benjamin Amick III, Ph.D.; and GlaxoWellcome, Inc. All Rights Reserved). | Work Limitations Questionnaire | ||
WOMAC LK 3.1 INDEX | C122384 | WOMAC1 | Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Likert Scale Format (WOMAC LK 3.1) (Bellamy N. WOMAC Osteoarthritis Index User Guide. Version V. Brisbane, Australia 2002; WOMAC 3.1 User Guide XI; WOMAC is a registered trade-mark. Copyright 2008. Prof Nicholas Bellamy. All Rights Reserved). | Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Likert Scale Format Questionnaire | ||
WOMAC NRS 3.1 INDEX | C122385 | WOMAC2 | Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Numerical Rating Scale Format (WOMAC NRS 3.1) (Bellamy N. WOMAC Osteoarthritis Index User Guide. Version V. Brisbane, Australia 2002; WOMAC 3.1 User Guide XI; WOMAC is a registered trade-mark. Copyright 2008. Prof Nicholas Bellamy. All Rights Reserved). | Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Numerical Rating Scale Format Questionnaire | ||
WOMAC VA 3.1 INDEX | C122386 | WOMAC3 | Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Visual Analog Scale Format (WOMAC VA 3.1) (Bellamy N. WOMAC Osteoarthritis Index User Guide. Version V. Brisbane, Australia 2002; WOMAC 3.1 User Guide XI; WOMAC is a registered trade-mark. Copyright 2008. Prof Nicholas Bellamy. All Rights Reserved). | Western Ontario and McMaster Universities Osteoarthritis Index Version 3.1 Visual Analog Scale Format Questionnaire | ||
WPAI-GH V2.0 | C123285 | WPAI02 | The Work Productivity and Activity Impairment - General Health Version 2.0 (WPAI-GH V2.0) (Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 1993; 4(5):353-65. http://www.reillyassociates.net/WPAI_GH.html. http://www.reillyassociates.net/WPAI_General.html). | Work Productivity and Activity Impairment General Health V2.0 Questionnaire | ||
WPAI-SHP V2.0 | C100779 | WPAI01 | The Work Productivity and Activity Impairment - Specific Health Problems Questionnaire Version 2.0 (WPAI-SHP V2.0) (Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 1993; 4(5):353-65. These materials discuss and/or include the Work Productivity and Activity Impairment Specific Health Problems Questionnaire Version 2.0 (WPAI-SHP V2.0), which is owned exclusively by Reilly Associates. Use of the WPAI-SHP is subject to Reilly Associates terms of use (See http://www.reillyassociates.net/WPAI_General.html). | Work Productivity and Activity Impairment Specific Health Problems Version 2.0 Questionnaire | ||
YMRS | C102124 | YMRS01 | Young Mania Rating Scale (YMRS) (Young RC, Biggs JT, Ziegler VE et al: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133: 429-435, 1978). | Young Mania Rating Scale Questionnaire | ||
Back to top | ||||||
CL.C150812.CDFATSCD | CDAD Findings About Test Code
(CDFATSCD) | text
Extensible: Yes | C150812 | CDAD Findings About Test Code | Terminology relevant to the test codes that describe findings about Clostridium difficile-associated diarrhea event or intervention. | CDISC SDTM CDAD Findings About Test Code Terminology |
EPSDNUM | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
SEV | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
VOL | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
Back to top | ||||||
CL.C150813.CDFATS | CDAD Findings About Test Name
(CDFATS) | text
Extensible: Yes | C150813 | CDAD Findings About Test Name | Terminology relevant to the test names that describe findings about Clostridium difficile-associated diarrhea event or intervention. | CDISC SDTM CDAD Findings About Test Name Terminology |
Number of Episodes | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
Severity/Intensity | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Volume | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
Back to top | ||||||
CL.C124678.CHIVC1TC | CDC Classification System for HIV-Infected Adults and Adolescents Clinical Classification Test Code
(CHIVC1TC) | text
Extensible: No | C124678 | CDC Classification System for HIV-Infected Adults and Adolescents Clinical Classification Test Code | CDC Classification System for HIV-Infected Adults and Adolescents test code. | CDISC Clinical Classification CDC Classification System for HIV-Infected Adults and Adolescents Test Code Terminology |
CHIVC101 | C124779 | CHIVC1-CDC HIV Infection Category | CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV infection category. | CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV Infection Category | ||
Back to top | ||||||
CL.C124677.CHIVC1TN | CDC Classification System for HIV-Infected Adults and Adolescents Clinical Classification Test Name
(CHIVC1TN) | text
Extensible: No | C124677 | CDC Classification System for HIV-Infected Adults and Adolescents Clinical Classification Test Name | CDC Classification System for HIV-Infected Adults and Adolescents test name. | CDISC Clinical Classification CDC Classification System for HIV-Infected Adults and Adolescents Test Name Terminology |
CHIVC1-CDC HIV Infection Category | C124779 | CHIVC1-CDC HIV Infection Category | CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV infection category. | CDC Classification System for HIV-Infected Adults and Adolescents - CDC HIV Infection Category | ||
Back to top | ||||||
CL.C160925.CTAUGRS | CDISC Therapeutic Area User Guide Response
(CTAUGRS) | text
Extensible: Yes | C160925 | CDISC Therapeutic Area User Guide Response | Terminology relevant to the name and version of the CDISC therapeutic area user guide used in the study. | CDISC Therapeutic Area User Guide Response Terminology |
Acute Kidney Injury Therapeutic Area User Guide v1.0 | C177935 | Version 1.0 of the CDISC Acute Kidney Injury therapeutic area user guide. | CDISC Acute Kidney Injury Therapeutic Area User Guide v1.0 | |||
Alzheimer's Therapeutic Area User Guide v1.0 | C161458 | Version 1.0 of the CDISC Alzheimer's therapeutic area user guide. | CDISC Alzheimer's Therapeutic Area User Guide Version 1.0 | |||
Alzheimer's Therapeutic Area User Guide v2.0 | C161459 | Version 2.0 of the CDISC Alzheimer's therapeutic area user guide. | CDISC Alzheimer's Therapeutic Area User Guide Version 2.0 | |||
Asthma Therapeutic Area User Guide v1.0 | C161460 | Version 1.0 of the CDISC Asthma therapeutic area user guide. | CDISC Asthma Therapeutic Area User Guide Version 1.0 | |||
Breast Cancer Therapeutic Area User Guide v1.0 | C161461 | Version 1.0 of the CDISC Breast Cancer therapeutic area user guide. | CDISC Breast Cancer Therapeutic Area User Guide Version 1.0 | |||
Cardiovascular Studies Therapeutic Area User Guide v1.0 | C161462 | Version 1.0 of the CDISC Cardiovascular Studies therapeutic area user guide. | CDISC Cardiovascular Studies Therapeutic Area User Guide Version 1.0 | |||
CDAD Therapeutic Area User Guide v1.0 | C177936 | Clostridium difficile-associated Diarrhea Therapeutic Area User Guide v1.0 | Version 1.0 of the CDISC CDAD therapeutic area user guide. | CDISC CDAD Therapeutic Area User Guide v1.0 | ||
Chronic Hepatitis C Therapeutic Area User Guide v1.0 | C161438 | Version 1.0 of the CDISC Chronic Hepatitis C therapeutic area user guide. | CDISC Chronic Hepatitis C Therapeutic Area User Guide Version 1.0 | |||
Colorectal Cancer Therapeutic Area User Guide v1.0 | C161463 | Version 1.0 of the CDISC Colorectal Cancer therapeutic area user guide. | CDISC Colorectal Cancer Therapeutic Area User Guide Version 1.0 | |||
COPD Therapeutic Area User Guide v1.0 | C161464 | Version 1.0 of the CDISC COPD therapeutic area user guide. | CDISC COPD Therapeutic Area User Guide Version 1.0 | |||
Crohn's Disease Therapeutic Area User Guide v1.0 | C177937 | Version 1.0 of the CDISC Crohn's Disease therapeutic area user guide. | CDISC Crohn's Disease Therapeutic Area User Guide v1.0 | |||
Diabetes - Type 1 Therapeutic Area User Guide v1.0 - Pediatrics and Devices Modules | C177938 | Version 1.0 of the CDISC Diabetes - Type 1 therapeutic area user guide - Pediatrics and Devices Modules. | CDISC Type 1 Diabetes Therapeutic Area User Guide v1.0 - Pediatrics and Devices Modules | |||
Diabetes Therapeutic Area User Guide v1.0 - Supplement for ADaM | C161313 | Version 1.0 of the CDISC Diabetes therapeutic area user guide ADaM supplement. | CDISC Diabetes Therapeutic Area User Guide Version 1.0 - Supplement for ADaM | |||
Diabetic Kidney Disease Therapeutic Area User Guide v1.0 | C161439 | Version 1.0 of the CDISC Diabetic Kidney Disease therapeutic area user guide. | CDISC Diabetic Kidney Disease Therapeutic Area User Guide Version 1.0 | |||
Duchenne Muscular Dystrophy Therapeutic Area User Guide v1.0 | C161440 | Version 1.0 of the CDISC Duchenne Muscular Dystrophy therapeutic area user guide. | CDISC Duchenne Muscular Dystrophy Therapeutic Area User Guide Version 1.0 | |||
Dyslipidemia Therapeutic Area User Guide v1.0 | C161441 | Version 1.0 of the CDISC Dyslipidemia therapeutic area user guide. | CDISC Dyslipidemia Therapeutic Area User Guide Version 1.0 | |||
Ebola Therapeutic Area User Guide v1.0 | C161442 | Version 1.0 of the CDISC Ebola therapeutic area user guide. | CDISC Ebola Therapeutic Area User Guide Version 1.0 | |||
Heart Failure Therapeutic Area User Guide v1.0 | C177939 | Version 1.0 of the CDISC Heart Failure therapeutic area user guide. | CDISC Heart Failure Therapeutic Area User Guide v1.0 | |||
HIV Therapeutic Area User Guide v1.0 | C161465 | Version 1.0 of the CDISC HIV therapeutic area user guide. | CDISC HIV Therapeutic Area User Guide Version 1.0 | |||
Huntington's Disease Therapeutic Area User Guide v1.0 | C161466 | Version 1.0 of the CDISC Huntington's Disease therapeutic area user guide. | CDISC Huntington's Disease Therapeutic Area User Guide Version 1.0 | |||
Influenza Therapeutic Area User Guide v1.0 | C161444 | Version 1.0 of the CDISC Influenza therapeutic area user guide. | CDISC Influenza Therapeutic Area User Guide Version 1.0 | |||
Influenza Therapeutic Area User Guide v1.1 | C161443 | Version 1.1 of the CDISC Influenza therapeutic area user guide. | CDISC Influenza Therapeutic Area User Guide Version 1.1 | |||
Interim User Guide for COVID-19 v1.0 | C177944 | Version 1.0 of the CDISC interim user guide for COVID-19. | CDISC Interim User Guide for COVID-19 v1.0 | |||
Kidney Transplant Therapeutic Area User Guide v1.0 | C161445 | Version 1.0 of the CDISC Kidney Transplant therapeutic area user guide. | CDISC Kidney Transplant Therapeutic Area User Guide Version 1.0 | |||
Lung Cancer Therapeutic Area User Guide v1.0 | C177940 | Version 1.0 of the CDISC Lung Cancer therapeutic area user guide. | CDISC Lung Cancer Therapeutic Area User Guide v1.0 | |||
Major Depressive Disorder Therapeutic Area User Guide v1.0 | C161446 | Version 1.0 of the CDISC Major Depressive Disorder therapeutic area user guide. | CDISC Major Depressive Disorder Therapeutic Area User Guide Version 1.0 | |||
Malaria Therapeutic Area User Guide v1.0 | C161447 | Version 1.0 of the CDISC Malaria therapeutic area user guide. | CDISC Malaria Therapeutic Area User Guide Version 1.0 | |||
Multiple Sclerosis Therapeutic Area User Guide v1.0 | C161467 | Version 1.0 of the CDISC Multiple Sclerosis therapeutic area user guide. | CDISC Multiple Sclerosis Therapeutic Area User Guide Version 1.0 | |||
Nutrition Therapeutic Area User Guide v1.0 | C177941 | Version 1.0 of the CDISC Nutrition therapeutic area user guide. | CDISC Nutrition Therapeutic Area User Guide v1.0 | |||
Pain Therapeutic Area User Guide v1.0 | C161468 | Version 1.0 of the CDISC Pain therapeutic area user guide. | CDISC Pain Therapeutic Area User Guide Version 1.0 | |||
Pain Therapeutic Area User Guide v1.1 | C161469 | Version 1.1 of the CDISC Pain therapeutic area user guide. | CDISC Pain Therapeutic Area User Guide Version 1.1 | |||
Parkinson's Disease Therapeutic Area User Guide v1.0 | C161470 | Version 1.0 of the Parkinson's Disease CDISC therapeutic area user guide. | CDISC Parkinson's Disease Therapeutic Area User Guide Version 1.0 | |||
Polycystic Kidney Disease (PKD) Therapeutic Area User Guide v1.0 | C161471 | Version 1.0 of the Polycystic Kidney Disease CDISC therapeutic area user guide. | CDISC Polycystic Kidney Disease (PKD) Therapeutic Area User Guide Version 1.0 | |||
Post Traumatic Stress Disorder Therapeutic Area User Guide v1.0 | C161472 | Version 1.0 of the Post Traumatic Stress Disorder CDISC therapeutic area user guide. | CDISC Post Traumatic Stress Disorder Therapeutic Area User Guide Version 1.0 | |||
Prostate Cancer Therapeutic Area User Guide v1.0 | C161448 | Version 1.0 of the CDISC Prostate Cancer therapeutic area user guide. | CDISC Prostate Cancer Therapeutic Area User Guide Version 1.0 | |||
Psoriasis Therapeutic Area User Guide v1.0 | C177942 | Version 1.0 of the CDISC Psoriasis therapeutic area user guide. | CDISC Psoriasis Therapeutic Area User Guide v1.0 | |||
QT Studies Therapeutic Area User Guide v1.0 | C161449 | Version 1.0 of the CDISC QT Studies therapeutic area user guide. | CDISC QT Studies Therapeutic Area User Guide Version 1.0 | |||
Rheumatoid Arthritis Therapeutic Area User Guide v1.0 | C161450 | Version 1.0 of the CDISC Rheumatoid Arthritis therapeutic area user guide. | CDISC Rheumatoid Arthritis Therapeutic Area User Guide Version 1.0 | |||
Schizophrenia Therapeutic Area User Guide v1.0 | C161452 | Version 1.0 of the CDISC Schizophrenia therapeutic area user guide. | CDISC Schizophrenia Therapeutic Area User Guide Version 1.0 | |||
Schizophrenia Therapeutic Area User Guide v1.1 | C161451 | Version 1.1 of the CDISC Schizophrenia therapeutic area user guide. | CDISC Schizophrenia Therapeutic Area User Guide Version 1.1 | |||
Traditional Chinese Medicine - Coronary Artery Disease-Angina Therapeutic Area User Guide v1.0 | C177943 | Version 1.0 of the CDISC Traditional Chinese Medicine - Coronary Artery Disease-Angina therapeutic area user guide. | CDISC Traditional Chinese Medicine - Coronary Artery Disease-Angina Therapeutic Area User Guide v1.0 | |||
Traumatic Brain Injury Therapeutic Area User Guide v1.0 | C161453 | Version 1.0 of the CDISC Traumatic Brain Injury therapeutic area user guide. | CDISC Traumatic Brain Injury Therapeutic Area User Guide Version 1.0 | |||
Tuberculosis Therapeutic Area User Guide v2.0 | C161454 | Version2.0 of the CDISC Tuberculosis therapeutic area user guide. | CDISC Tuberculosis Therapeutic Area User Guide Version 2.0 | |||
Vaccines Therapeutic Area User Guide v1.1 | C161455 | Version 1.1 of the CDISC Vaccines therapeutic area user guide. | CDISC Vaccines Therapeutic Area User Guide Version 1.1 | |||
Virology Therapeutic Area User Guide v2.0 | C161457 | Version 2.0 of the CDISC Virology therapeutic area user guide. | CDISC Virology Therapeutic Area User Guide Version 2.0 | |||
Virology Therapeutic Area User Guide v2.1 | C161456 | Version 2.1 of the CDISC Virology therapeutic area user guide. | CDISC Virology Therapeutic Area User Guide Version 2.1 | |||
Back to top | ||||||
CL.C181173.CPTESTCD | Cell Phenotyping Test Code
(CPTESTCD) | text
Extensible: Yes | C181173 | Cell Phenotyping Test Code | Terminology relevant to the test codes names that describe cell phenotype findings. | CDISC SDTM Cell Phenotyping Test Code Terminology |
ABC | C198236 | Abn Blast Cells;Abnormal Blast Cells | A measurement of the abnormal blast cells in a biological specimen. | Abnormal Blast Count | ||
ABCCE | C198237 | Abn Blast Cells/Total Cells;Abnormal Blast Cells/Total Cells | A relative measurement (ratio or percentage) of the abnormal blast cells to total cells in a biological specimen. | Abnormal Blast to Total Cell Ratio Measurement | ||
AKPC | C198238 | Abn Kappa+ PC;Abn Kappa+ Plasma Cells;Abnormal Kappa+ Plasma Cells | A measurement of the abnormal kappa+ plasma cells in a biological specimen. | Abnormal Kappa Positive Plasma Cell Count | ||
AKPCALPC | C198239 | Abn Kappa+ PC/Abn Lambda+ PC;Abnormal Kappa+ Plasma Cells/Abnormal Lambda+ Plasma Cells | A relative measurement (ratio) of the abnormal kappa+ plasma cells to abnormal lambda+ plasma cells in a biological specimen. | Abnormal Kappa Positive Plasma Cell to Abnormal Lambda Positive Plasma Cell Ratio Measurement | ||
ALPC | C198240 | Abn Lambda+ PC;Abn Lambda+ Plasma Cells;Abnormal Lambda+ Plasma Cells | A measurement of the abnormal lambda+ plasma cells in a biological specimen. | Abnormal Lambda Positive Plasma Cell Count | ||
BLNMABL | C185964 | B-Lymphocytes Naive Mature/B-Lymphocytes;BLym Naive Mat/BLym | A relative measurement (ratio or percentage) of naive mature B-lymphocytes to B-lymphocytes in a biological specimen. | Naive Mature B-Lymphocytes to Total B-Lymphocytes Ratio Measurement | ||
BLNMASP | C187728 | B-Lymphocytes Naive Mature Sub-Population/B-Lymphocytes Naive Mature;BLym Naive Mat Sub/BLym Naive Mat;BLym Naive Mat Sub/BLymNM | A relative measurement (ratio or percentage) a sub-population of naive mature B-lymphocytes to total naive mature B-lymphocytes in a biological specimen. | Naive Mature B-Lymphocyte Subpopulation to Total Naive Mature B-Lymphocyte Ratio Measurement | ||
BLSLY | C187710 | B-Lymphocytes Sub-Population/Lymphocytes;BLym Sub/Lym | A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to lymphocytes in a biological specimen. | B-Lymphocyte Subpopulation to Lymphocyte Ratio Measurement | ||
BLYB1 | C181307 | B-Lymphocytes B1;BLym B1 | A measurement of B-lymphocytes B1 in a biological specimen. | B-Lymphocytes B1 Count | ||
BLYB1A | C184400 | B-Lymphocytes B1a;BLym B1a | A measurement of the B1a B-lymphocytes in a biological specimen. | B-Lymphocyte B1a Count | ||
BLYB1B | C184401 | B-Lymphocytes B1b;BLym B1b | A measurement of the B1b B-lymphocytes in a biological specimen. | B-Lymphocyte B1b Count | ||
BLYB1S | C181308 | B-Lymphocytes B1 Sub-Population;BLym B1 Sub | A measurement of a subpopulation of B-lymphocytes B1 in a biological specimen. | B-Lymphocytes B1 Subpopulation Count | ||
BLYB1T | C184399 | B-Lymphocytes B1 Transitional;BLym B1 Trans | A measurement of the transitional B1 B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte B1 Count | ||
BLYB2IM | C184402 | B-Lymphocytes B2 Immature;BLym B2 Immat | A measurement of the immature B2 B-lymphocytes in a biological specimen. | Immature B-Lymphocyte B2 Count | ||
BLYB2MA | C184403 | B-Lymphocytes B2 Mature;BLym B2 Mat | A measurement of the mature B2 B-lymphocytes in a biological specimen. | Mature B-Lymphocyte B2 Count | ||
BLYB2T | C184404 | B-Lymphocytes B2 Transitional;BLym B2 Trans | A measurement of the transitional B2 B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte B2 Count | ||
BLYCE | C174314 | B-Cell Lymphocytes;B-Cells;B-Lymphocytes | A measurement of the B-lymphocytes in a biological specimen. | B-Lymphocyte Count | ||
BLYCECE | C174317 | B-Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the B-lymphocytes to total cells in a biological specimen. | B-Lymphocyte to Total Cells Ratio Measurement | ||
BLYCELE | C181309 | B Cells/Leukocytes;B-Lymphocytes/Leukocytes;BLym/Leuk | A relative measurement (ratio or percentage) of B-lymphocytes to leukocytes in a biological specimen. | B-Lymphocytes to Leukocytes Ratio Measurement | ||
BLYCELY | C174315 | B-Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the B-lymphocytes to total lymphocytes in a biological specimen. | B-Lymphocyte to Lymphocyte Ratio Measurement | ||
BLYE | C184354 | B-Lymphocytes Effector;BLym Eff | A measurement of the effector B-lymphocytes in a biological specimen. | Effector B-Lymphocyte Count | ||
BLYE1 | C184362 | B-Lymphocytes Effector 1;BLym Eff 1 | A measurement of the effector 1 B-lymphocytes in a biological specimen. | Effector 1 B-Lymphocyte Count | ||
BLYE1S | C184405 | B-Lymphocytes Effector 1 Sub-Population;BLym Eff 1 Sub | A measurement of a sub-population of effector 1 B-lymphocytes in a biological specimen. | Effector 1 B-Lymphocyte Subpopulation Count | ||
BLYE2 | C184363 | B-Lymphocytes Effector 2;BLym Eff 2 | A measurement of the effector 2 B-lymphocytes in a biological specimen. | Effector 2 B-Lymphocyte Count | ||
BLYE2S | C184406 | B-Lymphocytes Effector 2 Sub-Population;BLym Eff 2 Sub | A measurement of a sub-population of effector 2 B-lymphocytes in a biological specimen. | Effector 2 B-Lymphocyte Subpopulation Count | ||
BLYES | C184361 | B-Lymphocytes Effector Sub-Population;BLym Eff Sub | A measurement of a sub-population of effector B-lymphocytes in a biological specimen. | Effector B-Lymphocyte Subpopulation Count | ||
BLYF | C184355 | B-Lymphocytes Follicular;BLym Foll | A measurement of the follicular B-lymphocytes in a biological specimen. | Follicular B-Lymphocyte Count | ||
BLYFS | C184407 | B-Lymphocytes Follicular Sub-Population;BLym Foll Sub | A measurement of a sub-population of follicular B-lymphocytes in a biological specimen. | Follicular B-Lymphocyte Subpopulation Count | ||
BLYGC | C184345 | B-Lymphocytes Germinal Center;BLym Germ Ctr | A measurement of the germinal center B-lymphocytes in a biological specimen. | Germinal Center B-Lymphocyte Count | ||
BLYGCS | C184408 | B-Lymphocytes Germinal Center Sub-Population;BLym Germ Ctr Sub | A measurement of a sub-population of germinal center B-lymphocytes in a biological specimen. | Germinal Center B-Lymphocyte Subpopulation Count | ||
BLYIM | C184346 | B-Lymphocytes Immature;BLym Immat | A measurement of the immature B-lymphocytes in a biological specimen. | Immature B-Lymphocyte Count | ||
BLYM | C184348 | B-Lymphocytes Memory;BLym Mem | A measurement of the memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte Count | ||
BLYMA | C184347 | B-Lymphocytes Mature;BLym Mat | A measurement of the mature B-lymphocytes in a biological specimen. | Mature B-Lymphocyte Count | ||
BLYMBLY | C185965 | B-Lymphocytes Memory/B-Lymphocytes;BLym Mem/BLym | A relative measurement (ratio or percentage) of memory B-lymphocytes to total B-lymphocytes in a biological specimen. | Memory B-Lymphocytes to Total B-Lymphocytes Ratio Measurement | ||
BLYMCB1 | C184410 | B-Lymphocytes Memory cB1;BLym Mem cB1 | A measurement of the cB1 memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte cB1 Count | ||
BLYMCB2 | C184411 | B-Lymphocytes Memory cB2;BLym Mem cB2 | A measurement of the cB2 memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte cB2 Count | ||
BLYMCB3 | C184412 | B-Lymphocytes Memory cB3;BLym Mem cB3 | A measurement of the cB3 memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte cB3 Count | ||
BLYMIM | C184415 | B-Lymphocytes Memory Immature;BLym Mem Immat | A measurement of the memory immature B-lymphocytes in a biological specimen. | Immature Memory B-Lymphocyte Count | ||
BLYMMA | C184416 | B-Lymphocytes Memory Mature;BLym Mem Mat | A measurement of the memory mature B-lymphocytes in a biological specimen. | Mature Memory B-Lymphocyte Count | ||
BLYMNSW | C184359 | B-Lymphocytes Memory Non-Class-Switched;B-Lymphocytes Memory Unswitched;BLym Mem NSw | A measurement of the non-class-switched memory B-lymphocytes in a biological specimen. | Nonclass-switched Memory B-Lymphocyte Count | ||
BLYMNSWS | C184414 | B-Lymphocytes Memory Non-Class-Switched Sub-Population;B-Lymphocytes Memory Unswitched Sub-Population;BLym Mem NSw Sub | A measurement of a sub-population of non-class-switched memory B-lymphocytes in a biological specimen. | Nonclass-switched Memory B-Lymphocyte Subpopulation Count | ||
BLYMS | C184357 | B-Lymphocytes Memory Sub-Population;BLym Mem Sub | A measurement of a sub-population of memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte Subpopulation Count | ||
BLYMSW | C184358 | B-Lymphocytes Memory Class-Switched;B-Lymphocytes Memory Switched;BLym Mem Sw | A measurement of the class-switched memory B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocyte Count | ||
BLYMSWS | C184413 | B-Lymphocytes Memory Class-Switched Sub-Population;BLym Mem Sw Sub | A measurement of a sub-population of class-switched memory B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocyte Subpopulation Count | ||
BLYMZ | C184409 | B-Lymphocytes Marginal Zone;BLym Marg Zn | A measurement of the marginal zone B-lymphocytes in a biological specimen. | Marginal Zone B-Lymphocyte Count | ||
BLYN | C181262 | B-Lymphocytes, Naive;BLym Naive;Naive B Cells;Naive B-Lymphocytes | A measurement of the naive B-lymphocytes in a biological specimen. | Naive B-Lymphocyte Measurement | ||
BLYNBLY | C181264 | B Cell, Naive/B Cell;B-Lymphocyte, Naive/B-Lymphocyte;BLym Naive/Blym;Naive B-Lymphocytes/B-Lymphocytes | A relative measurement (ratio or percentage) of naive B-lymphocytes to B-lymphocytes in a biological specimen. | Naive B-Lymphocytes to Total B-Lymphocytes Ratio Measurement | ||
BLYNMA | C184356 | B-Lymphocytes Naive Mature;BLym Naive Mat | A measurement of the naive mature B-lymphocytes in a biological specimen. | Naive Mature B-Lymphocyte Count | ||
BLYNMAS | C187727 | B-Lymphocytes Naive Mature Sub-Population;BLym Naive Mat Sub | A measurement of a sub-population of naive mature B-lymphocytes in a biological specimen. | Naive Mature B-Lymphocyte Subpopulation Count | ||
BLYNS | C184417 | B-Lymphocytes Naive Sub-Population;BLym Naive Sub | A measurement of a sub-population of naive B-lymphocytes in a biological specimen. | Naive B-Lymphocyte Subpopulation Count | ||
BLYR | C184349 | B-Lymphocytes Regulatory;BLym Reg | A measurement of the regulatory B-lymphocytes in a biological specimen. | Regulatory B-Lymphocyte Count | ||
BLYRS | C184418 | B-Lymphocytes Regulatory Sub-Population;BLym Reg Sub | A measurement of the sub-population of regulatory B-lymphocytes in a biological specimen. | Regulatory B-Lymphocyte Subpopulation Count | ||
BLYS | C181187 | B-Lymphocytes Sub-Population;BLym Sub | A measurement of a subpopulation of B-lymphocytes in a biological specimen. | B-Lymphocytes Subpopulation Count | ||
BLYSBLY | C181265 | B-Lymphocyte Sub-Population/B-Lymphocyte;BLym Sub/BLym | A relative measurement (ratio or percentage) of a subpopulation of B-lymphocytes to B-lymphocytes in a biological specimen. | B-Lymphocytes Subpopulation to Total B-Lymphocytes Ratio Measurement | ||
BLYT | C184360 | B-Lymphocytes Transitional;BLym Trans | A measurement of the transitional B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte Count | ||
BLYT1 | C184419 | B-Lymphocytes Transitional 1;BLym Trans 1 | A measurement of the transitional 1 B-lymphocytes in a biological specimen. | Transitional 1 B-Lymphocyte Count | ||
BLYT2 | C184420 | B-Lymphocytes Transitional 2;BLym Trans 2 | A measurement of the transitional 2 B-lymphocytes in a biological specimen. | Transitional 2 B-Lymphocyte Count | ||
BLYT3 | C184421 | B-Lymphocytes Transitional 3;BLym Trans 3 | A measurement of the transitional 3 B-lymphocytes in a biological specimen. | Transitional 3 B-Lymphocyte Count | ||
BLYTBLY | C185966 | B-Lymphocytes Transitional/B-Lymphocytes;BLym Trans/BLym | A relative measurement (ratio or percentage) of transitional B-lymphocytes to B-lymphocytes in a biological specimen. | Transitional B-Lymphocytes to B-Lymphocytes Ratio Measurement | ||
BLYTS | C187736 | B-Lymphocytes Transitional Sub-Population;BLym Trans Sub | A measurement of a sub-population of transitional B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte Subpopulation Count | ||
BLYTSP | C187737 | B-Lymphocytes Transitional Sub-Population/B-Lymphocytes Transitional;BLym Trans Sub/BLym Trans | A relative measurement (ratio or percentage) of a sub-population of transitional B-lymphocytes to total transitional B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte Subpopulation to Total Transitional B-Lymphocyte Ratio Measurement | ||
BMNSWB | C187730 | B-Lymphocytes Memory Non-Class-Switched/B-Lymphocytes;B-Lymphocytes Memory Unswitched/B-Lymphocytes;BLym Mem NSw/BLym | A relative measurement (ratio or percentage) of the non-class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. | Non-class-switched Memory B-Lymphocyte to Total B-Lymphocyte Ratio Measurement | ||
BMNSWSP | C187729 | B-Lymphocytes Memory Non-Class-Switched Sub-Population/B-Lymphocytes Memory Non-Class-Switched;B-Lymphocytes Memory Unswitched Sub-Population/B-Lymphocytes Memory Unswitched;BLym Mem NSw Sub/BLymMNSw | A relative measurement (ratio or percentage) of a sub-population of non-class-switched memory B-lymphocytes to total non-class-switched memory B-lymphocytes in a biological specimen. | Non-class-switched Memory B-Lymphocyte Subpopulation to Total Non-class-switched Memory B-Lymphocyte Ratio Measurement | ||
BMSG | C187714 | B-Lymphocytes Memory Switched IgG+;BLym Mem Sw IgG+ | A measurement of the IgG+ class-switched memory B-lymphocytes in a biological specimen. | Immunoglobulin G Positive Class-switched Memory B-Lymphocyte Count | ||
BMSGBMS | C187715 | B-Lymphocytes Memory Switched IgG+/B-Lymphocytes Memory Switched;BLym Mem Sw IgG+/BLym Mem Sw | A relative measurement (ratio or percentage) of IgG+ memory switched B-Lymphocytes to class-switched memory B-lymphocytes in a biological specimen. | Immunoglobulin G Positive Memory Switched B-Lymphocyte to Memory Switched B-Lymphocyte Ratio Measurement | ||
BMSM | C187719 | B-Lymphocytes Memory Switched IgM+;BLym Mem Sw IgM+ | A measurement of the IgM+ class-switched memory B-lymphocytes in a biological specimen. | Immunoglobulin M Positive Class-switched Memory B-Lymphocyte Count | ||
BMSMBMS | C187720 | B-Lymphocytes Memory Switched IgM+/B-Lymphocytes Memory Switched;BLym Mem Sw IgM+/BLym Mem Sw | A relative measurement (ratio or percentage) of IgM+ class-switched memory B-Lymphocytes to class-switched memory B-lymphocytes in a biological specimen. | Immunoglobulin M Positive Memory Switched B-Lymphocyte to Memory Switched B-Lymphocyte Ratio Measurement | ||
BMSSBMS | C187711 | B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes Memory Class-Switched;B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes Memory Switched;BLym Mem Sw Sub/BLym Mem Sw | A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to class-switched memory B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocyte Subpopulation to Class-switched Memory B-Lymphocyte Ratio Measurement | ||
BMSU | C187748 | B-Lymphocytes Memory Class-Switched Unconventional;B-Lymphocytes Memory Switched Unconventional;BLym Mem Sw Uncv | A measurement of the unconventional class-switched memory B-lymphocytes in a biological specimen. | Unconventional Class-switched Memory B-Lymphocyte Count | ||
BMSUB | C187751 | B-Lymphocytes Memory Class-Switched Unconventional/B-Lymphocytes;B-Lymphocytes Memory Switched Unconventional/B-Lymphocytes;BLym Mem Sw Uncv/BLym | A relative measurement (ratio or percentage) the unconventional class-switched memory B-lymphocytes to B-lymphocytes in a biological specimen. | Unconventional Class-switched Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement | ||
BMSUS | C187749 | B-Lymphocytes Memory Class-Switched Unconventional Sub-Population;B-Lymphocytes Memory Switched Unconventional Sub-Population;BLym Mem Sw Uncv Sub | A measurement of a sub-population of unconventional class-switched memory B-lymphocytes in a biological specimen. | Unconventional Class-switched Memory B-Lymphocyte Subpopulation Count | ||
BMSUSP | C187750 | B-Lymphocytes Memory Class-Switched Unconventional Sub-Population/B-Lymphocytes Memory Class-Switched Unconventional;B-Lymphocytes Memory Switched Unconventional Sub-Population/B-Lymphocytes Memory Switched Unconventional;BLym Mem Sw Uncv Sub/BLym Mem Sw Uncv | A relative measurement (ratio or percentage) of a sub-population of unconventional class-switched memory B-lymphocytes to unconventional class-switched memory B-lymphocytes in a biological specimen. | Unconventional Class-switched Memory B-Lymphocyte Subpopulation to Unconventional Class-switched Memory B-Lymphocyte Ratio Measurement | ||
BMSWSB | C187712 | B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes;B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes;BLym Mem Sw Sub/BLym | A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocyte Subpopulation to Total B-Lymphocyte Ratio Measurement | ||
BMSWSP | C187713 | B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes Memory Class-Switched;B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes Memory Switched;BLym Mem Sw Sub/BLymMSw | A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to total class-switched memory B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocytes Subpopulation to Total Class-switched Memory B-Lymphocytes Ratio Measurement | ||
BNSBN | C181263 | B-Lymphocytes Naive Sub-Population/B-Lymphocytes, Naive;BLym Naive Sub/BLym Naive | A relative measurement (ratio or percentage) of a subpopulation of naive B-lymphocytes to naive B-lymphocytes in a biological specimen. | Naive B-Lymphocytes Subpopulation to Total B-Lymphocytes Naive Ratio Measurement | ||
C189300 | C189300 | Mono/Non-TBNK Leuk | A relative measurement (ratio or percentage) of the monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells in a biological specimen. | Monocyte to Non-TBNK Leukocyte Ratio Measurement | ||
C189371 | C189371 | Mono Classic Sub-population/Non-TBNK Leukocytes;Mono Classic Sub/Non-TBNK Leuk | A relative measurement (ratio or percentage) of a sub-population of classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Classical Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement | ||
C189373 | C189373 | Mono Intermed Sub/Non-TBNK;Mono Intermed Sub/Non-TBNK Leuk;Monocytes Intermediate Sub-Population/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of a sub-population of intermediate monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Intermediate Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement | ||
C189374 | C189374 | Mono NonClassic Sub/Non-TBNK Leuk;Monocytes Non-Classical Sub-Population/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Non-Classical Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement | ||
C189381 | C189381 | MDSC/Non-TBNK Leuk;MDSC/Non-TBNK Leukocytes;Myeloid-Derived Suppressor Cells/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Myeloid-Derived Suppressor Cell to Non-TBNK Leukocyte Ratio Measurement | ||
C189382 | C189382 | Mono Classic/Non-TBNK Leuk;Monocytes Classical/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of the classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Classical Monocyte to Non-TBNK Leukocyte Ratio Measurement | ||
C189383 | C189383 | Mono Intermed/Non-TBNK Leuk;Monocytes Intermediate/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of the intermediate monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Intermediate Monocyte to Non-TBNK Leukocyte Ratio Measurement | ||
C189384 | C189384 | Mono NonClassic/Non-TBNK Leuk;Monocytes Non-Classical/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of the non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Non-Classical Monocyte to Non-TBNK Leukocyte Ratio Measurement | ||
C191206 | C191206 | T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx SC Mem Sub/TLym Cytx | A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
C191217 | C191217 | T-Lymphocytes Cytotoxic Stem Cell Memory/T-Lymphocytes Cytotoxic;TLym Cytx SC Mem/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic stem cell memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
C191218 | C191218 | T-Lymphocytes Cytotoxic Stem Cell Memory/T-Lymphocytes Cytotoxic Naive;TLym Cytx SC Mem/TLymCN | A relative measurement (ratio or percentage) of the cytotoxic stem cell memory T-lymphocytes to cytotoxic naive T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte to Naive Cytotoxic T-Lymphocyte Ratio Measurement | ||
C191219 | C191219 | T-Lymphocytes Cytotoxic Terminal Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Term Mem Sub/TLym Cytx | A relative measurement (ratio or percentage) of a sub-population of cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
CD16X | C189388 | CD16 Expression | A measurement of cellular CD16 expression in a biological specimen. | CD16 Cell Surface Expression Measurement | ||
CD25X | C198241 | CD25 Expression | A measurement of cellular CD25 expression in a biological specimen. | CD25 Cell Surface Expression Measurement | ||
CD278X | C191220 | CD278 Expression | A measurement of cellular CD278 expression in a biological specimen. | CD278 Cell Surface Expression Measurement | ||
CD279X | C191221 | CD279 Expression | A measurement of cellular CD279 expression in a biological specimen. | CD279 Cell Surface Expression Measurement | ||
CD40X | C82006 | CD40 Expression | A measurement of cellular CD40 expression in a biological specimen. | CD40 Cell Surface Measurement | ||
CD69X | C198242 | CD69 Expression | A measurement of cellular CD69 expression in a biological specimen. | CD69 Cell Surface Expression Measurement | ||
CD80X | C181266 | CD80 Expression | A measurement of cellular CD80 expression in a biological specimen. | CD80 Cell Surface Expression Measurement | ||
CD83X | C181267 | CD83 Expression | A measurement of cellular CD83 expression in a biological specimen. | CD83 Cell Surface Expression Measurement | ||
CD86X | C189389 | CD86 Expression | A measurement of cellular CD86 expression in a biological specimen. | CD86 Cell Surface Expression Measurement | ||
CD95X | C181268 | CD95 Expression | A measurement of cellular CD95 expression in a biological specimen. | CD95 Cell Surface Expression Measurement | ||
CPC | C198235 | Clonal Plasma Cells | A measurement of the clonal plasma cells in a biological specimen. | Clonal Plasma Cell Count | ||
CPCCE | C198243 | Clonal Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the clonal plasma cells to total cells in a biological specimen. | Clonal Plasma Cell to Total Cell Ratio Measurement | ||
DC | C181185 | DC;Dendritic Cells | A measurement of the dendritic cells in a biological specimen. | Dendritic Cells Count | ||
DCCE | C181252 | Dendritic Cells/Total Cells | A relative measurement (ratio or percentage) of the dendritic cells to total cells in a biological specimen. | Dendritic Cells to Total Cells Ratio Measurement | ||
DCLYMONO | C181269 | Dendritic Cells/Lym+Mono;Dendritic Cells/Lymphocytes and Monocytes | A relative measurement (ratio or percentage) of the dendritic cells to lymphocytes and monocytes in a biological specimen. | Dendritic Cells to Lymphocytes and Monocytes Ratio Measurement | ||
DCM | C184350 | cDC;Conventional DC;DC Myeloid;Dendritic Cells Myeloid;mDC | A measurement of the myeloid dendritic cells in a biological specimen. | Myeloid Dendritic Cell Count | ||
DCM1 | C187738 | cDC1;Classical DC Type 1;Conventional DC Type 1;DC Myeloid 1;DC Myeloid Type 1;Dendritic Cells Myeloid 1;mDC1 | A measurement of the type 1 myeloid dendritic cells in a biological specimen. | Type 1 Myeloid Dendritic Cell Count | ||
DCM1DCM | C187742 | cDC1/cDC;Classical DC Type 1/Classical DC;Conventional DC Type 1/Conventional DC;DC Myeloid 1/DC Myeloid;DC Myeloid 1/DCM;mDC1/mDC | A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Type 1 Myeloid Dendritic Cell to Total Myeloid Dendritic Cell Ratio Measurement | ||
DCM1LE | C187741 | cDC1/Leukocytes;Classical DC Type 1/Leukocytes;Conventional DC Type 1/Leukocytes;DC Myeloid 1/Leuk;DC Myeloid 1/Leukocytes;mDC1/Leukocytes | A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to leukocytes in a biological specimen. | Type 1 Myeloid Dendritic Cell to Leukocyte Ratio Measurement | ||
DCM1S | C187739 | cDC1 Sub-Population;Classical DC Type 1 Sub-Population;Conventional DC Type 1 Sub-Population;DC Myeloid 1 Sub;Dendritic Cells Myeloid 1 Sub-Population;mDC1 Sub-Population | A measurement of a sub-population of type 1 myeloid dendritic cells in a biological specimen. | Type 1 Myeloid Dendritic Cell Subpopulation Count | ||
DCM1SDCM | C187740 | cDC1 Sub-Population/cDC;Classical DC Type 1 Sub-Population/Classical DC;Conventional DC Type 1 Sub-Population/Conventional DC;DC Myeloid 1 Sub/DCM;Dendritic Cells Myeloid 1 Sub-Population/Dendritic Cells Myeloid;mDC1 Sub-Population/mDC | A relative measurement (ratio or percentage) of a sub-population of type 1 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Type 1 Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement | ||
DCM2 | C187743 | cDC2;Classical DC Type 2;Conventional DC Type 2;DC Myeloid 2;DC Myeloid Type 2;Dendritic Cells Myeloid 2;mDC2 | A measurement of the type 2 myeloid dendritic cells in a biological specimen. | Type 2 Myeloid Dendritic Cell Count | ||
DCM2DCM | C187747 | cDC2/cDC;Classical DC Type 2/Classical DC;Conventional DC Type 2/Conventional DC;DC Myeloid 2/DC Myeloid;DC Myeloid 2/DCM;mDC2/mDC | A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Type 2 Myeloid Dendritic Cell to Total Myeloid Dendritic Cell Ratio Measurement | ||
DCM2LE | C187746 | cDC2/Leukocytes;Classical DC Type 2/Leukocytes;Conventional DC Type 2/Leukocytes;DC Myeloid 2/Leuk;DC Myeloid 2/Leukocytes;mDC2/Leukocytes | A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to leukocytes in a biological specimen. | Type 2 Myeloid Dendritic Cell to Leukocyte Ratio Measurement | ||
DCM2S | C187744 | cDC2 Sub-Population;Classical DC Type 2 Sub-Population;Conventional DC Type 2 Sub-Population;DC Myeloid 2 Sub;Dendritic Cells Myeloid 2 Sub-Population;mDC2 Sub-Population | A measurement of a sub-population of type 2 myeloid dendritic cells in a biological specimen. | Type 2 Myeloid Dendritic Cell Subpopulation Count | ||
DCM2SDCM | C187745 | cDC2 Sub-Population/cDC;Classical DC Type 2 Sub-Population/Classical DC;Conventional DC Type 2 Sub-Population/Conventional DC;DC Myeloid 2 Sub/DCM;Dendritic Cells Myeloid 2 Sub-Population/Dendritic Cells Myeloid;mDC2 Sub-Population/mDC | A relative measurement (ratio or percentage) of a sub-population of type 2 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Type 2 Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement | ||
DCMDN | C198244 | DC Myeloid Dbl Neg;DC Myeloid Double Negative;Dendritic Cells Myeloid Double Negative;mDC DN | A measurement of the double-negative myeloid dendritic cells (any myeloid dendritic cell that is both CD1c-CD141-) in a biological specimen. | Double-Negative Myeloid Dendritic Cell Count | ||
DCMDNDCM | C198245 | DC Myeloid Dbl Neg/DC Myeloid;Dendritic Cells Myeloid Double Negative/ Dendritic Cells Myeloid;mDC DN/mDC | A relative measurement (ratio or percentage) of the double negative myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Double-Negative Myeloid Dendritic Cell to Myeloid Dendritic Cell Ratio Measurement | ||
DCMLE | C187673 | cDC/Leukocytes;Classical DC/Leukocytes;Conventional DC/Leukocytes;DC Myeloid/Leuk;DC Myeloid/Leukocytes;mDC/Leukocytes | A relative measurement (ratio or percentage) of the myeloid dendritic cells to leukocytes in a biological specimen. | Myeloid Dendritic Cell to Leukocyte Ratio Measurement | ||
DCMP | C187726 | cDC/DC;Classical DC/DC;Conventional DC/DC;DC Myeloid/DC;Dendritic Cells Myeloid/Dendritic Cells;mDC/DC | A relative measurement (ratio or percentage) of the myeloid dendritic cells to total dendritic cells in a biological specimen. | Myeloid Dendritic Cell to Total Dendritic Cell Ratio Measurement | ||
DCMS | C184423 | DC Myeloid Sub;Dendritic Cells Myeloid Sub-Population | A measurement of a sub-population of myeloid dendritic cells in a biological specimen. | Myeloid Dendritic Cell Subpopulation Count | ||
DCMSDC | C187725 | cDC Sub-Population/DC;Classical DC Sub-Population/DC;Conventional DC Sub-Population/DC;DC Myeloid Sub/DC;Dendritic Cells Myeloid Sub-Population/Dendritic Cells;mDC Sub-Population/DC | A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to total dendritic cells in a biological specimen. | Myeloid Dendritic Cell Subpopulation to Total Dendritic Cell Ratio Measurement | ||
DCMSP | C187672 | cDC Sub-Population/cDC;Classical DC Sub-Population/Classical DC;Conventional DC Sub-Population/Conventional DC;DC Myeloid Sub/DCM;Dendritic Cells Myeloid Sub-Population/Dendritic Cells Myeloid;mDC Sub-Population/mDC | A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement | ||
DCP | C181195 | DC Plasmacytoid;Plasmacytoid Dendritic Cells | A measurement of the plasmacytoid dendritic cells in a biological specimen. | Plasmacytoid Dendritic Cell Count | ||
DCPDC | C181272 | DC Plasmacytoid/DC;DC Plasmacytoid/Dendritic Cells;Plasmacytoid Dendritic Cells/Dendritic Cells | A relative measurement (ratio or percentage) of the plasmacytoid dendritic cells to dendritic cells in a biological specimen. | Plasmacytoid Dendritic Cells to Dendritic Cells Ratio Measurement | ||
DCPS | C181270 | DC Plasmacytoid Sub;Plasmacytoid Dendritic Cells Sub-Population | A measurement of a subpopulation of plasmacytoid dendritic cells in a biological specimen. | Plasmacytoid Dendritic Cell Subpopulation Count | ||
DCPSDCP | C181271 | DC Plasmacytoid Sub/DC Plasmacytoid;Plasmacytoid Dendritic Cells Sub-Population/Plasmacytoid Dendritic Cells | A relative measurement (ratio or percentage) of a subpopulation of plasmacytoid dendritic cells to total plasmacytoid dendritic cells in a biological specimen. | Plasmacytoid Dendritic Cells Subpopulation to Dendritic Cells Plasmacytoid Ratio Measurement | ||
DCS | C184422 | DC Sub;Dendritic Cells Sub-Population | A measurement of a sub-population of dendritic cells in a biological specimen. | Dendritic Cell Subpopulation Count | ||
ENDO | C185967 | Endothelial Cells | A measurement of the endothelial cells in a biological specimen. | Endothelial Cell Count | ||
EOS | C64550 | Eosinophils | A measurement of the eosinophils in a biological specimen. | Eosinophil Count | ||
EOSCE | C98720 | Eosinophils/Total Cells | A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). | Eosinophils to Total Cell Ratio Measurement | ||
EOSLE | C64604 | Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. | Eosinophil to Leukocyte Ratio | ||
EOSNUCCE | C150840 | Eosinophils/Nucleated Cells | A relative measurement (ratio or percentage) of eosinophils to nucleated cells in a biological specimen. | Eosinophils to Nucleated Cells Ratio Measurement | ||
EPIC | C64605 | Epithelial Cells | A measurement of the epithelial cells in a biological specimen. | Epithelial Cell Count | ||
EPICCE | C130161 | Epithelial Cells/Total Cells | A relative measurement (ratio or percentage) of the epithelial cells to total cells in a biological specimen. | Epithelial Cells to Total Cells Ratio Measurement | ||
FIBB | C185968 | Fibroblasts | A measurement of the fibroblasts in a biological specimen. | Fibroblast Count | ||
GRAN | C96654 | Granulocytes;Polymorphonuclear Leukocytes | A measurement of the granulocytes in a biological specimen. | Granulocyte Count | ||
HLADRX | C189390 | HLADR Expression | A measurement of cellular HLA-DR expression in a biological specimen. | HLA-DR Cell Surface Expression Measurement | ||
IELY | C184424 | IE Lym;Intraepithelial Lymphocytes | A measurement of the intraepithelial lymphocytes in a biological specimen. | Intraepithelial Lymphocyte Count | ||
INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
KI67X | C191222 | Ki67 Expression | A measurement of cellular Ki67 expression in a biological specimen. | Ki67 Cell Surface Expression Measurement | ||
KPC | C198222 | Kappa+ PC;Kappa+ Plasma Cells | A measurement of the kappa+ plasma cells in a biological specimen. | Kappa Positive Plasma Cell Count | ||
KPCLPC | C198223 | Kappa+ PC/Lambda+ PC;Kappa+ Plasma Cells/Lambda+ Plasma Cells | A relative measurement (ratio) of the kappa+ plasma cells to lambda+ plasma cells in a biological specimen. | Kappa Positive Plasma Cell to Lambda Positive Plasma Cell Ratio Measurement | ||
KRCYMGCE | C98867 | Megakaryocytes/Total Cells | A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryocyte to Total Cell Ratio Measurement | ||
KRCYMGLE | C154722 | Megakaryocytes/Leukocytes | A relative measurement (ratio or percentage) of the megakaryocytes to leukocytes in a biological specimen. | Megakaryocytes to Leukocytes Ratio Measurement | ||
LPC | C198224 | Lambda+ Plasma Cells' Lambda+ PC | A measurement of the lambda+ plasma cells in a biological specimen. | Lambda Positive Plasma Cell Count | ||
LYM | C51949 | Lymphocytes | A measurement of the lymphocytes in a biological specimen. | Lymphocyte Count | ||
LYMCE | C98751 | Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). | Lymphocyte to Total Cell Ratio Measurement | ||
LYMLE | C64820 | Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. | Lymphocyte to Leukocyte Ratio | ||
LYMONO | C181273 | Lym+Mono;Lym+Mono/Leuk;Lymphocytes and Monocytes | A measurement of the leukocytes and monocytes in a biological specimen. | Lymphocytes and Monocytes Count | ||
LYMONOLE | C181274 | Lymphocytes and Monocytes/Leukocytes | A relative measurement (ratio or percentage) of the lymphocytes and monocytes to total leukocytes in a biological specimen. | Lymphocytes and Monocytes to Leukocytes Ratio Measurement | ||
LYS | C181275 | Lym Sub;Lymphocytes Sub;Lymphocytes Sub-Population | A measurement of a subpopulation of lymphocytes in a biological specimen. | Lymphocytes Subpopulation Count | ||
LYSLY | C181276 | Lym Sub/Lym;Lymphocytes Sub-Population/Lymphocytes;Lymphocytes Sub/Lymphocytes | A relative measurement (ratio or percentage) of a subpopulation of lymphocytes to lymphocytes in a biological specimen. | Lymphocyte Subpopulation to Total Lymphocytes Ratio Measurement | ||
LYVLYNV | C181277 | Lym Viable/Lym NonViable;Lymphocytes Viable/Lymphocytes Non-Viable;Lymphocytes Viable/Lymphocytes NonViable | A relative measurement (ratio) of viable lymphocytes to non-viable lymphocytes in a biological specimen. | Viable Lymphocytes to Nonviable Lymphocytes Ratio Measurement | ||
MASTCE | C111246 | Mast Cells;Mastocytes | A measurement of the mast cells in a biological specimen. | Mast Cell Count | ||
MASTCECE | C111247 | Mast Cells/Total Cells | A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. | Mast Cell to Total Cell Ratio Measurement | ||
MCPHG | C74798 | Macrophages | A measurement of the macrophages in a biological specimen. | Macrophage Count | ||
MCPHGCE | C111244 | Macrophages/Total Cells | A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. | Macrophage to Total Cell Ratio Measurement | ||
MCPHGLE | C123460 | Macrophages/Leukocytes | A relative measurement (ratio or percentage) of the macrophages to leukocytes in a biological specimen. | Macrophage to Leukocyte Ratio | ||
MCPHGM1 | C185969 | Macrophages M1 | A measurement of the M1 macrophages in a biological specimen. | M1 Macrophage Count | ||
MCPHGM2 | C185970 | Macrophages M2 | A measurement of the M2 macrophages in a biological specimen. | M2 Macrophage Count | ||
MCPHGS | C185971 | Macrophages Sub;Macrophages Sub-Population | A measurement of a sub-population of macrophages in a biological specimen. | Macrophage Subpopulation Count | ||
MDSC | C185904 | MDSC;Myeloid-Derived Suppressor Cells | A measurement of the myeloid-derived suppressor cells in a biological specimen. | Myeloid-Derived Suppressor Cell Count | ||
MDSCG | C185906 | G-MDSC;gMDSC;MDSC Gran;Myeloid-Derived Suppressor Cells Granulocytic;PMN-MDSC | A measurement of the granulocytic myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell Count | ||
MDSCGS | C185972 | MDSC Gran Sub;Myeloid-Derived Suppressor Cells Granulocytic Sub-Population | A measurement of a subpopulation of granulocytic myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell Subpopulation Count | ||
MDSCM | C185907 | M-MDSC;MDSC Mono;mMDSC;Myeloid-Derived Suppressor Cells Monocytic | A measurement of the monocytic myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell Count | ||
MDSCMS | C185973 | MDSC Mono Sub;Myeloid-Derived Suppressor Cells Monocytic Sub-Population | A measurement of a subpopulation of monocytic myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell Subpopulation Count | ||
MDSCS | C185974 | MDSC Sub;MDSC Sub-Population;Myeloid-Derived Suppressor Cells Sub-Population | A measurement of a subpopulation of myeloid-derived suppressor cells in a biological specimen. | Myeloid-Derived Suppressor Cell Subpopulation Count | ||
MDSDN | C189301 | MDSC Dbl Neg;Myeloid-Derived Suppressor Cells Double Negative | A measurement of the double-negative myeloid-derived suppressor cells (any MDSC that is both CD14-CD15-) in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Cell Count | ||
MDSDNMS | C189375 | MDSC Dbl Neg/MDSC;Myeloid-Derived Suppressor Cells Double Negative/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of the double negative myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSDNS | C189386 | Double-Negative Myeloid-Derived Suppressor Cells Sub-Population;MDSC Dbl Neg Sub;MDSC Double-Negative Sub-Population | A measurement of a sub-population of double-negative myeloid-derived suppressor cells in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Subpopulation Count | ||
MDSDNSMS | C189324 | MDSC Dbl Neg Sub/MDSC;Myeloid-Derived Suppressor Cell Double Negative Sub-Population/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of a sub-population of double-negative myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSDNSP | C189367 | MDSC Dbl Neg Sub/MDSC Dbl Neg;Myeloid-Derived Suppressor Cell Double Negative Sub-Population/Myeloid-Derived Suppressor Cells Double Negative | A relative measurement (ratio or percentage) of a sub-population of double-negative myeloid-derived suppressor cells to all double-negative myeloid-derived suppressor cells in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Cell Subpopulation to Double-Negative Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSGG | C189344 | MDSC Gran/Gran;Myeloid-Derived Suppressor Cells Granulocytic/Granulocytes;PMN-MDSC/Gran | A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to total granulocytes in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell to Granulocyte Ratio Measurement | ||
MDSGLE | C189376 | MDSC Gran/Leuk;Myeloid-Derived Suppressor Cells Granulocytic/Leukocytes;PMN-MDSC/Leuk | A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to total leukocytes in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement | ||
MDSGLYS | C189343 | MDSC Gran/Lym Sub;Myeloid-Derived Suppressor Cells Granulocytic/Lymphocyte Sub-Population;PMN-MDSC/Lym Sub | A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to a sub-population of lymphocytes in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell to Lymphocyte Subpopulation Ratio Measurement | ||
MDSGMS | C189377 | MDSC Gran/MDSC;Myeloid-Derived Suppressor Cells Granulocytic/Myeloid-Derived Suppressor Cells;PMN-MDSC/MDSC | A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSGSMS | C189325 | MDSC Gran Sub/MDSC;Myeloid-Derived Suppressor Cell Granulocytic Sub-Population/Myeloid-Derived Suppressor Cells;PMN-MDSC Sub/MDSC | A relative measurement (ratio or percentage) of a sub-population of granulocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSGSP | C189368 | MDSC Gran Sub/MDSC Gran;Myeloid-Derived Suppressor Cells Granulocytic Sub-Population/Myeloid-Derived Suppressor Cells Granulocytic;PMN-MDSC Sub/MDSC Gran | A relative measurement (ratio or percentage) of a sub-population of granulocytic myeloid-derived suppressor cells to all granulocytic myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell Subpopulation to Granulocytic Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSLE | C189298 | MDSC/Leuk;Myeloid-Derived Suppressor Cells/Leukocytes | A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to total leukocytes in a biological specimen. | Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement | ||
MDSMLE | C189327 | M-MDSC/Leuk;MDSC Mono/Leuk;Myeloid-Derived Suppressor Cells Monocytic/Leukocytes | A relative measurement (ratio or percentage) of the monocytic myeloid-derived suppressor cells to total leukocytes in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement | ||
MDSMM | C189379 | M-MDSC/Mono;MDSC Mono/Mono;Myeloid-Derived Suppressor Cells Monocytic/Monocytes | A relative measurement (ratio) of the monocytic myeloid-derived suppressor cells to total monocytes in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell to Monocyte Ratio Measurement | ||
MDSMMS | C189378 | M-MDSC/MDSC;MDSC Mono/MDSC;Myeloid-Derived Suppressor Cells Monocytic/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of the monocytic myeloid-derived suppressor cells to total myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSMSMS | C189326 | M-MDSC Sub/MDSC;MDSC Mono Sub/MDSC;Myeloid-Derived Suppressor Cell Monocytic Sub-Population/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of a sub-population of monocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSMSP | C189369 | M-MDSC Sub/MDSC Mono;MDSC Mono Sub/MDSC Mono;Myeloid-Derived Suppressor Cell Monocytic Sub-Population/Myeloid-Derived Suppressor Cells Monocytic | A relative measurement (ratio or percentage) of a sub-population of monocytic myeloid-derived suppressor cells to all monocytic myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell Subpopulation to Monocytic Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSNGLE | C189380 | MDSC/Leuk Non-Gran;MDSC/Non-Gran Leuk;Myeloid-Derived Suppressor Cells/Leukocytes Non-Granulocytic | A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to total non-granulocytic leukocytes in a biological specimen. | Myeloid-Derived Suppressor Cell to Non-Granulocytic Leukocyte Ratio Measurement | ||
MDSSMDSS | C189370 | MDSC Sub/MDSC Sub;Myeloid-Derived Suppressor Cells Sub-Population/Myeloid-Derived Suppressor Cells Sub-Population | A relative measurement (ratio or percentage) of a sub-population of myeloid-derived suppressor cells to a sub-population of myeloid-derived suppressor cells in a biological specimen. | Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Subpopulation Ratio Measurement | ||
MDSSP | C189297 | MDSC Sub/MDSC;Myeloid-Derived Suppressor Cell Sub-Population/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of a sub-population of myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MNCL | C181281 | Mono Classic;Monocytes Classical | A measurement of the classical monocytes in a biological specimen. | Classic Monocytes Count | ||
MNCLMN | C198246 | Mono Classic/Mono;Monocytes Classic/Monocytes;Monocytes Classical/Monocytes | A relative measurement (ratio or percentage) of classical monocytes to monocytes in a biological specimen. | Classical Monocyte to Monocyte Ratio Measurement | ||
MNCLS | C189392 | Mono Classic Sub;Monocytes Classical Sub-Population | A measurement of a sub-population of classical monocytes in a biological specimen. | Classical Monocyte Subpopulation Count | ||
MNCLSP | C189394 | Mono Classic Sub/Mono Classic;Monocytes Classical Sub-Population/Monocytes Classical | A relative measurement (ratio or percentage) of a sub-population of classical monocytes to total classical monocytes in a biological specimen. | Classical Monocyte Subpopulation to Classical Monocyte Ratio Measurement | ||
MNIF | C181282 | Mono Inflamm;Monocytes Inflammatory | A measurement of the inflammatory monocytes in a biological specimen. | Inflammatory Monocytes Count | ||
MNIN | C181283 | Mono Intermed;Monocytes Intermediate | A measurement of the intermediate monocytes in a biological specimen. | Intermediate Monocytes Count | ||
MNINLE | C189299 | Mono Intermed/Leuk;Monocytes Intermediate/Leukocytes | A relative measurement (ratio or percentage) of the intermediate monocytes to total leukocytes in a biological specimen. | Intermediate Monocyte to Leukocyte Ratio Measurement | ||
MNINMN | C198247 | Mono Intermed/Mono;Monocytes Intermediate/Monocytes | A relative measurement (ratio or percentage) of intermediate monocytes to monocytes in a biological specimen. | Intermediate Monocyte to Monocyte Ratio Measurement | ||
MNINS | C189395 | Mono Intermed Sub;Monocytes Intermediate Sub-Population | A measurement of a sub-population of intermediate monocytes in a biological specimen. | Intermediate Monocyte Subpopulation Count | ||
MNINSP | C189372 | Mono Intermed Sub/Mono Int;Mono Intermed Sub/Mono Intermed;Monocytes Intermediate Sub-Population/Monocytes Intermediate | A relative measurement (ratio or percentage) of a sub-population of intermediate monocytes to total intermediate monocytes in a biological specimen. | Intermediate Monocyte Subpopulation to Intermediate Monocyte Ratio Measurement | ||
MNMA | C181287 | Mono Mat;Monocytes Mature | A measurement of the mature monocytes in a biological specimen. | Mature Monocytes Count | ||
MNNCL | C181284 | Mono NonClassic;Monocytes Non-Classical | A measurement of the non-classical monocytes in a biological specimen. | Non-Classical Monocytes Count | ||
MNNCLMN | C198248 | Mono NonClassic/Mono | A relative measurement (ratio or percentage) of non-classical monocytes to monocytes in a biological specimen. | Non-Classical Monocyte to Monocyte Ratio Measurement | ||
MNNCLS | C189391 | Mono NonClassic Sub;Monocytes Non-Classical Sub-Population | A measurement of a sub-population of non-classical monocytes in a biological specimen. | Non-Classical Monocyte Subpopulation Count | ||
MNNCLSP | C189393 | Mono NonClassic Sub/Mono NonClassic;Monocytes Non-Classical Sub-Population/Monocytes Non-Classical | A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to total non-classical monocytes in a biological specimen. | Non-Classical Monocyte Subpopulation to Non-Classical Monocyte Ratio Measurement | ||
MNPIF | C181285 | Mono Proinflam;Monocytes Proinflammatory | A measurement of the pro-inflammatory monocytes in a biological specimen. | Proinflammatory Monocytes Count | ||
MNPMNNP | C181279 | Mono Prolif/Mono NonProlif;Monocytes Prolif/Monocytes NonProlif;Monocytes Proliferating/Monocytes Non-Proliferating | A relative measurement (ratio) of proliferating monocytes to non-proliferating monocytes in a biological specimen. | Proliferating Monocytes to Total Monocytes Non-Proliferating Ratio Measurement | ||
MNR | C181286 | Mono Resident;Monocytes Resident | A measurement of the resident monocytes in a biological specimen. | Resident Monocytes Count | ||
MNS | C181278 | Mono Sub;Monocytes Sub;Monocytes Sub-Population | A measurement of a subpopulation of monocytes in a biological specimen. | Monocytes Subpopulation Count | ||
MNSMN | C181280 | Mono Sub/Mono;Monocytes Sub-Population/Monocytes;Monocytes Sub/Monocytes | A relative measurement (ratio or percentage) of a subpopulation of monocytes to monocytes in a biological specimen. | Monocyte Subpopulation to Total Monocytes Ratio Measurement | ||
MONMPHLE | C147396 | Monocytes and Macrophages/Leukocytes | A relative measurement (ratio or percentage) of the monocytes and macrophages to total leukocytes in a biological specimen. | Monocytes and Macrophages to Leukocytes Ratio Measurement | ||
MONO | C64823 | Monocytes | A measurement of the monocytes in a biological specimen. | Monocyte Count | ||
MONOCE | C98872 | Monocytes/Total Cells | A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). | Monocytes to Total Cell Ratio Measurement | ||
MONOIM | C96676 | Immature Monocytes | A measurement of the immature monocytes in a biological specimen. | Immature Monocyte Count | ||
MONOLE | C64824 | Monocytes/Leukocytes | A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. | Monocyte to Leukocyte Ratio | ||
MYC | C184425 | Myel Cells;Myeloid Cells | A measurement of the myeloid cells in a biological specimen. | Myeloid Cell Count | ||
NEUT | C63321 | Neutrophils | A measurement of the neutrophils in a biological specimen. | Absolute Neutrophil Count | ||
NKCE | C98762 | Natural Killer Cells | A measurement of the total natural killer cells in a biological specimen. | Natural Killer Cell Count | ||
NKCECE | C181257 | Natural Killer Cells/Total Cells | A relative measurement (ratio or percentage) of the natural killer cells to total cells in a biological specimen. | Natural Killer Cells to Total Cells Ratio Measurement | ||
NKIM | C189308 | Natural Killer Cells Immature;NK Cells Immat | A measurement of the immature natural killer cells in a biological specimen. | Immature Natural Killer Cell Count | ||
NKIMLE | C189415 | Natural Killer Cells Immature/Leukocytes;NK Cells Immat/Leuk | A relative measurement (ratio or percentage) of the immature natural killer cells to total leukocytes in a biological specimen. | Immature Natural Killer Cell to Leukocyte Ratio Measurement | ||
NKIMLY | C189304 | Natural Killer Cells Immature/Lymphocytes;NK Cells Immat/Lym | A relative measurement (ratio or percentage) of the immature natural killer cells to total lymphocytes in a biological specimen. | Immature Natural Killer Cell to Lymphocyte Ratio Measurement | ||
NKIMNK | C189416 | Natural Killer Cells Immature/Natural Killer Cells;NK Cells Immat/NK | A relative measurement (ratio or percentage) of the immature natural killer cells to total natural killer cells in a biological specimen. | Immature Natural Killer Cell to Natural Killer Cell Ratio Measurement | ||
NKIMS | C189422 | Immature Natural Killer Cells Sub-Population;Immature NK Sub-Population;Immature NKC Sub-Population;Natural Killer Cells Immature Sub-Population;NK Cells Immat Sub | A measurement of a sub-population of immature natural killer cells in a biological specimen. | Immature Natural Killer Cell Subpopulation Count | ||
NKIMSP | C189397 | Natural Killer Cells Immature Sub-Population/Natural Killer Cells Immature;NK Cells Immat Sub/NK Immat | A relative measurement (ratio or percentage) of a sub-population of immature natural killer cells to total immature natural killer cells in a biological specimen. | Immature Natural Killer Cell Subpopulation to Immature Natural Killer Cell Ratio Measurement | ||
NKIN | C189309 | Natural Killer Cells Intermediate;NK Cells Intermed | A measurement of the intermediate natural killer cells in a biological specimen. | Intermediate Natural Killer Cell Count | ||
NKINLE | C189417 | Natural Killer Cells Intermediate/Leukocytes;NK Cells Intermed/Leuk | A relative measurement (ratio or percentage) of the intermediate natural killer cells to total leukocytes in a biological specimen. | Intermediate Natural Killer Cell to Leukocyte Ratio Measurement | ||
NKINLY | C189305 | Natural Killer Cells Intermediate/Lymphocytes;NK Cells Intermed/Lym | A relative measurement (ratio or percentage) of the intermediate natural killer cells to total lymphocytes in a biological specimen. | Intermediate Natural Killer Cell to Lymphocyte Ratio Measurement | ||
NKINNK | C189418 | Natural Killer Cells Intermediate/Natural Killer Cells;NK Cells Intermed/NK | A relative measurement (ratio or percentage) of the intermediate natural killer cells to total natural killer cells in a biological specimen. | Intermediate Natural Killer Cell to Natural Killer Cell Ratio Measurement | ||
NKINS | C189423 | Intermediate Natural Killer Cells Sub-Population;Intermediate NK Sub-Population;Intermediate NKC Sub-Population;Natural Killer Cells Intermediate Sub-Population;NK Cells Intermed Sub | A measurement of a sub-population of intermediate natural killer cells in a biological specimen. | Intermediate Natural Killer Cell Subpopulation Count | ||
NKINSLE | C189398 | Natural Killer Cells Intermediate Sub-Population/Leukocytes;NK Cells Intermed Sub/Leuk | A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total leukocytes in a biological specimen. | Intermediate Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement | ||
NKINSLY | C189399 | Natural Killer Cells Intermediate Sub-Population/Lymphocytes;NK Cells Intermed Sub/Lym | A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total lymphocytes in a biological specimen. | Intermediate Natural Killer Cell Subpopulation to Lymphocyte Ratio Measurement | ||
NKINSP | C189400 | Natural Killer Cells Intermediate Sub-Population/Natural Killer Cells Intermediate;NK Cells Intermed Sub/NK Intermed | A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total intermediate natural killer cells in a biological specimen. | Intermediate Natural Killer Cell Subpopulation to Intermediate Natural Killer Cell Ratio Measurement | ||
NKLE | C181306 | Natural Killer Cells/Leukocytes;NK Cells/Leuk | A relative measurement (ratio or percentage) of the natural killer cells to leukocytes in a biological specimen. | Natural Killer Cells to Leukocytes Ratio Measurement | ||
NKLY | C181258 | Natural Killer Cells/Lymphocytes;NK Cells/Lym | A relative measurement (ratio or percentage) of the natural killer cells to lymphocytes in a biological specimen. | Natural Killer Cells to Lymphocytes Ratio Measurement | ||
NKMA | C189310 | Natural Killer Cells Mature;NK Cells Mat | A measurement of the mature natural killer cells in a biological specimen. | Mature Natural Killer Cell Count | ||
NKMALE | C189419 | Natural Killer Cells Mature/Leukocytes;NK Cells Mat/Leuk | A relative measurement (ratio or percentage) of the mature natural killer cells to total leukocytes in a biological specimen. | Mature Natural Killer Cell to Leukocyte Ratio Measurement | ||
NKMALY | C189306 | Natural Killer Cells Mature/Lymphocytes;NK Cells Mat/Lym | A relative measurement (ratio or percentage) of the mature natural killer cells to total lymphocytes in a biological specimen. | Mature Natural Killer Cell to Lymphocyte Ratio Measurement | ||
NKMANK | C189420 | Natural Killer Cells Mature/Natural Killer Cells;NK Cells Mat/NK | A relative measurement (ratio or percentage) of the mature natural killer cells to total natural killer cells in a biological specimen. | Mature Natural Killer Cell to Natural Killer Cell Ratio Measurement | ||
NKMAS | C189424 | Mature Natural Killer Cells Sub-Population;Mature NK Sub-Population;Mature NKC Sub-Population;Natural Killer Cells Mature Sub-Population;NK Cells Mat Sub | A measurement of a sub-population of mature natural killer cells in a biological specimen. | Mature Natural Killer Cell Subpopulation Count | ||
NKMASLE | C189401 | Natural Killer Cells Mature Sub-Population/Leukocytes;NK Cells Mat Sub/Leuk | A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total leukocytes in a biological specimen. | Mature Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement | ||
NKMASLY | C189402 | Natural Killer Cells Mature Sub-Population/Lymphocytes;NK Cells Mat Sub/Lym | A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total lymphocytes in a biological specimen. | Mature Natural Killer Cell Subpopulation to Lymphocyte Ratio Measurement | ||
NKMASNK | C189303 | Natural Killer Cells Mature Sub-Population/Natural Killer Cells;NK Cells Mat Sub/NK | A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total natural killer cells in a biological specimen. | Mature Natural Killer Cell Subpopulation to Natural Killer Cell Ratio Measurement | ||
NKMASP | C189403 | Natural Killer Cells Mature Sub-Population/Natural Killer Cells Mature;NK Cells Mat Sub/NK Mat | A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total mature natural killer cells in a biological specimen. | Mature Natural Killer Cell Subpopulation to Mature Natural Killer Cell Ratio Measurement | ||
NKS | C181260 | Natural Killer Cells Sub-Population;NK Cells Sub;NK Cells Sub-Population | A measurement of a subpopulation of natural killer cells in a biological specimen. | Natural Killer Cells Subpopulation Count | ||
NKSNK | C181259 | Natural Killer Cells Sub-Population/Natural Killer Cells;NK Cells Sub/NK Cells | A relative measurement (ratio or percentage) of a sub population of natural killer cells to total natural killer cells in a biological specimen. | Natural Killer Cells Subpopulation to Total Natural Killer Cells Ratio Measurement | ||
NKT | C184426 | Natural Killer T-Cells;Natural Killer T-Lymphocytes;NK Tlym | A measurement of the natural killer T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte Count | ||
NKTLY | C189307 | Natural Killer T-Lymphocytes/Lymphocytes;NK TLym/Lym | A relative measurement (ratio or percentage) of the natural killer T-lymphocytes to total lymphocytes in a biological specimen. | Natural Killer T-Lymphocytes to Lymphocytes Ratio Measurement | ||
NKTS | C185975 | Natural Killer T-Cells Sub-Population;Natural Killer T-Lymphocytes Sub-Population;NK TLym Sub | A measurement of a sub-population of natural killer T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte Subpopulation Count | ||
NKTSP | C189404 | Natural Killer T-Lymphocytes Sub-Population/Natural Killer T-Lymphocytes;NK TLym Sub/NKT | A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to total natural killer T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte Subpopulation to Natural Killer T-Lymphocyte Ratio Measurement | ||
NKTSTLY | C189405 | Natural Killer T-Lymphocytes Sub-Population/T-Lymphocytes;NK TLym Sub/TLym | A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to total T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement | ||
NKTTLY | C189421 | Natural Killer T-Lymphocytes/T-Lymphocytes;NK TLym/Tlym | A relative measurement (ratio or percentage) of the natural killer T-lymphocytes to total T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte to T-Lymphocyte Ratio Measurement | ||
NTBNKL | C189387 | Non-TBNK Leuk;Non-TBNK Leukocytes | A measurement of the leukocytes that are not T-cells, B-cells, or natural killer cells in a biological specimen. | Non-TBNK Leukocyte Count | ||
NTBNKLLE | C189385 | Non-TBNK Leuk/Leuk;Non-TBNK Leukocytes/Leukocytes | A relative measurement (ratio or percentage) of the leukocytes that are not T-cells, B-cells, or natural killer cells to total leukocytes in a biological specimen. | Non-TBNK Leukocyte to Leukocyte Ratio Measurement | ||
PB | C74619 | Plasmablast;Precursor Plasma Cells | A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. | Precursor Plasma Cell Count | ||
PBBLY | C185976 | Plasmablasts/B-Lymphocytes;Plasmablasts/BLym;Precursor Plasma Cells/B-Lymphocytes | A relative measurement (ratio or percentage) of plasmablasts to B-lymphocytes in a biological specimen. | Plasmablasts to Total B-Lymphocytes Ratio Measurement | ||
PBG | C187671 | Plasmablasts IgG+ | A measurement of the IgG+ plasmablasts in a biological specimen. | Immunoglobulin G Positive Plasmablast Count | ||
PBGPB | C187718 | Plasmablasts IgG+/PB;Plasmablasts IgG+/Plasmablasts | A relative measurement (ratio or percentage) of the IgG+ plasmablasts to total plasmablasts in a biological specimen. | Immunoglobulin G Positive Plasmablast to Plasmablast Ratio Measurement | ||
PBGS | C187716 | Plasmablasts IgG+ Sub;Plasmablasts IgG+ Sub-Population | A measurement of a sub-population of IgG+ plasmablasts in a biological specimen. | Immunoglobulin G Positive Plasmablast Subpopulation Count | ||
PBGSP | C187717 | Plasmablasts IgG+ Sub-Population/Plasmablasts IgG+;Plasmablasts IgG+ Sub/PB IgG+ | A relative measurement (ratio or percentage) of a sub-population of IgG+ plasmablasts to total IgG+ plasmablasts in a biological specimen. | Immunoglobulin G Positive Plasmablast Subpopulation to Total Immunoglobulin G Positive Plasmablast Ratio Measurement | ||
PBM | C187721 | Plasmablasts IgM+ | A measurement of the IgM+ plasmablasts in a biological specimen. | Immunoglobulin M Positive Plasmablast Count | ||
PBMPB | C187724 | Plasmablasts IgM+/PB;Plasmablasts IgM+/Plasmablasts | A relative measurement (ratio or percentage) of the IgM+ plasmablasts to total plasmablasts in a biological specimen. | Immunoglobulin M Positive Plasmablast to Plasmablast Ratio Measurement | ||
PBMS | C187722 | Plasmablasts IgM+ Sub;Plasmablasts IgM+ Sub-Population | A measurement of a sub-population of IgM+ plasmablasts in a biological specimen. | Immunoglobulin M Positive Plasmablast Subpopulation Count | ||
PBMSP | C187723 | Plasmablasts IgG+ Sub-Population/Plasmablasts IgG+;Plasmablasts IgM+ Sub/PB IgM+ | A relative measurement (ratio or percentage) of a sub-population of IgM+ plasmablasts to total IgM+ plasmablasts in a biological specimen. | Immunoglobulin M Positive Plasmablast Subpopulation to Total Immunoglobulin M Positive Plasmablast Ratio Measurement | ||
PBS | C187731 | Plasmablasts Sub;Plasmablasts Sub-Population;Precursor Plasma Cells Sub-Population | A measurement of a sub-population of plasmablasts in a biological specimen. | Plasmablast Subpopulation Count | ||
PBSBLY | C187732 | Plasmablasts Sub-Population/B-Lymphocytes;Plasmablasts Sub/BLym | A relative measurement (ratio or percentage) of a sub-population of plasmablasts to B-lymphocytes in a biological specimen. | Plasmablast Subpopulation to B-Lymphocyte Ratio Measurement | ||
PBSLE | C187733 | Plasmablasts Sub-Population/Leukocytes;Plasmablasts Sub/Leuk | A relative measurement (ratio or percentage) of a sub-population of plasmablasts to leukocytes in a biological specimen. | Plasmablast Subpopulation to Leukocyte Ratio Measurement | ||
PBSP | C187734 | Plasmablasts Sub-Population/Plasmablasts;Plasmablasts Sub/PB | A relative measurement (ratio or percentage) of a sub-population of plasmablasts to total plasmablasts in a biological specimen. | Plasmablast Subpopulation to Total Plasmablast Ratio Measurement | ||
PC | C128974 | Total Plasma Cells | A measurement of the total plasma cells in a biological specimen. | Plasma Cell Count | ||
PCS | C185977 | Plasma Cells Sub;Plasma Cells Sub-Population;Total Plasma Cells Sub | A measurement of a sub-population of plasma cells in a biological specimen. | Plasma Cell Subpopulation Count | ||
PLAT | C51951 | Platelets | A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. | Platelet Count | ||
PLATS | C185978 | Platelets Sub-Population | A measurement of a sub-population of platelets in a biological specimen. | Platelet Subpopulation Count | ||
PLSNCE | C172494 | Monoclonal Plasma Cells;Monotypic Plasma Cells;Neoplastic Plasma Cells | A measurement of the neoplastic plasma cells in a biological specimen. | Neoplastic Plasma Cell Count | ||
PLSNCECE | C198249 | Neoplastic Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the neoplastic plasma cells to total cells in a biological specimen. | Neoplastic Plasma Cell to Total Cell Ratio Measurement | ||
PLSTCECE | C187987 | Total Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. | Plasma Cell to Total Cell Ratio Measurement | ||
RBC | C51946 | Erythrocytes;Red Blood Cells | A measurement of the total erythrocytes in a biological specimen. | Erythrocyte Count | ||
STMIDX | C181300 | Stimulation Index | A relative measurement (ratio or percentage) of a cell characteristic or response in the presence of a stimulating agent relative to a non-stimulated control. | Stimulation Index Count | ||
TGB | C181295 | Target Bound | A measurement of the bound target in a biological specimen, prior to background subtraction. | Target Bound Measurement | ||
TGBBK | C181294 | Target Bound, Background | A measurement of the background associated with the bound target measurement in a biological specimen. | Target Bound, Background Measurement | ||
TGBDBBK | C181288 | Target Bound, Delta Bound Background | A measurement of the difference between bound target and background target in a biological specimen. | Target, Bound Delta Bound Background Measurement | ||
TGF | C181296 | Target Free | A measurement of the free target in a biological specimen, prior to background subtraction. | Target Free Measurement | ||
TGFBK | C181292 | Target Free, Background | A measurement of the background associated with the free target measurement in a biological specimen. | Target Free, Background Measurement | ||
TGFDFBK | C181289 | Target Free, Delta Free Background | A measurement of the difference between free target and free background target in a biological specimen. | Target, Free Delta Free Background Measurement | ||
TGOCC | C181291 | Percent Occupancy;Percent Saturation;Target Occupancy | A relative measurement (ratio or percentage) of the specifically bound target to total target in a biological specimen. | Target Occupancy Ratio Measurement | ||
TGT | C181297 | Target Total | A measurement of the total target in a biological specimen, prior to background subtraction. | Target Total Measurement | ||
TGTBK | C181293 | Target Total, Background | A measurement of the background associated with the total target measurement in a biological specimen. | Target Total, Background Measurement | ||
TGTDTBK | C181290 | Target Total, Delta Total Background | A measurement of the difference between total target and target total background in a biological specimen. | Target, Total Delta Total Background Measurement | ||
TH171SP | C191223 | T-Lymphocytes Helper 17.1 Sub-Population/T-Lymphocytes Helper 17.1;TLym Help 17.1 Sub/TLymH17.1 | A relative measurement (ratio or percentage) of a sub-population of helper 17.1 T-lymphocytes to total helper 17.1 T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte Subpopulation to Helper 17.1 T-Lymphocyte Ratio Measurement | ||
TH171STH | C191207 | T-Lymphocytes Helper 17.1 Sub-Population/T-Lymphocytes Helper;TLym Help 17.1 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 17.1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TH171TH | C191224 | T-Lymphocytes Helper 17.1/T-Lymphocytes Helper;TLym Help 17.1/TLym Help | A relative measurement (ratio or percentage) of the helper 17.1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TH17SP | C191225 | T-Lymphocytes Helper 17 Sub-Population/T-Lymphocytes Helper 17;TLym Help 17 Sub/TLymH17 | A relative measurement (ratio or percentage) of a sub-population of helper 17 T-lymphocytes to total helper 17 T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte Subpopulation to Helper 17 T-Lymphocyte Ratio Measurement | ||
TH17STH | C191226 | T-Lymphocytes Helper 17 Sub-Population/T-Lymphocytes Helper;TLym Help 17 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 17 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TH17TH | C191227 | T-Lymphocytes Helper 17/T-Lymphocytes Helper;TLym Help 17/TLym Help | A relative measurement (ratio or percentage) of the helper 17 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TH1SP | C191228 | T-Lymphocytes Helper 1 Sub-Population/T-Lymphocytes Helper 1;TLym Help 1 Sub/TLymH1 | A relative measurement (ratio or percentage) of a sub-population of helper 1 T-lymphocytes to total helper 1 T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte Subpopulation to Helper 1 T-Lymphocyte Ratio Measurement | ||
TH1STH | C191229 | T-Lymphocytes Helper 1 Sub-Population/T-Lymphocytes Helper;TLym Help 1 Sub/TLym Helper | A relative measurement (ratio or percentage) of a sub-population of helper 1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TH1TH | C191230 | T-Lymphocytes Helper 1/T-Lymphocytes Helper;TLym Help 1/TLym Help | A relative measurement (ratio or percentage) of the helper 1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TH22SP | C191231 | T-Lymphocytes Helper 22 Sub-Population/T-Lymphocytes Helper 22;TLym Help 22 Sub/TLymH22 | A relative measurement (ratio or percentage) of a sub-population of helper 22 T-lymphocytes to total helper 22 T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte Subpopulation to Helper 22 T-Lymphocyte Ratio Measurement | ||
TH22STH | C191232 | T-Lymphocytes Helper 22 Sub-Population/T-Lymphocytes Helper;TLym Help 22 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 22 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TH22TH | C191233 | T-Lymphocytes Helper 22/T-Lymphocytes Helper;TLym Help 22/TLym Help | A relative measurement (ratio or percentage) of the helper 22 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TH2SP | C191234 | T-Lymphocytes Helper 2 Sub-Population/T-Lymphocytes Helper 2;TLym Help 2 Sub/TLymH2 | A relative measurement (ratio or percentage) of a sub-population of helper 2 T-lymphocytes to total helper 2 T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte Subpopulation to Helper 2 T-Lymphocyte Ratio Measurement | ||
TH2STH | C191235 | T-Lymphocytes Helper 2 Sub-Population/T-Lymphocytes Helper;TLym Help 2 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 2 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TH2TH | C191236 | T-Lymphocytes Helper 2/T-Lymphocytes Helper;TLym Help 2/TLym Help | A relative measurement (ratio or percentage) of the helper 2 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TH9SP | C191237 | T-Lymphocytes Helper 9 Sub-Population/T-Lymphocytes Helper 9;TLym Help 9 Sub/TLymH9 | A relative measurement (ratio or percentage) of a sub-population of helper 9 T-lymphocytes to total helper 9 T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte Subpopulation to Helper 9 T-Lymphocyte Ratio Measurement | ||
TH9STH | C191238 | T-Lymphocytes Helper 9 Sub-Population/T-Lymphocytes Helper;TLym Help 9 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 9 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TH9TH | C191239 | T-Lymphocytes Helper 9/T-Lymphocytes Helper;TLym Help 9/TLym Help | A relative measurement (ratio or percentage) of the helper 9 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
THRNSTHR | C191240 | T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory;TLym Help Reg Naive Sub/TLymHR | A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. | Naive Helper Regulatory T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement | ||
THSCMSTH | C191241 | T Lymphocytes Helper Stem Cell Memory Sub-Population/T-Lymphocytes Helper;TLym Help SC Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper stem cell memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
THSCMTHN | C191242 | T-Lymphocytes Helper Stem Cell Memory/T-Lymphocytes Helper Naive;TLym Help SC Mem/TLymHN | A relative measurement (ratio or percentage) of the helper stem cell memory T-lymphocytes to total helper naive T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement | ||
TLAB | C185979 | T-Lymphocytes Alpha-Beta;TCR Alpha-Beta T-Cells;TLym AB | A measurement of the alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta T-Lymphocyte Count | ||
TLABS | C185980 | T-Lymphocytes Alpha-Beta;TLym AB Sub | A measurement of a sub-population of alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta T-Lymphocyte Subpopulation Count | ||
TLABSP | C189406 | T-Lymphocytes Alpha-Beta Sub-Population/T-Lymphocytes Alpha-Beta;TCR Alpha-Beta T-Cells Sub/TCR Alpha-Beta T-Cells;TLym AB Sub/TLym AB | A relative measurement (ratio or percentage) of a sub-population of alpha-beta T-lymphocytes to total alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta T-Lymphocyte Subpopulation to Alpha-Beta T-Lymphocyte Ratio Measurement | ||
TLABTLY | C189425 | T-Lymphocytes Alpha-Beta/T-Lymphocytes;TCR Alpha-Beta T-Cells/T-Lymphocytes;TLym AB/TLym | A relative measurement (ratio or percentage) of the alpha-beta T-lymphocytes to total T-lymphocytes in a biological specimen. | Alpha-Beta T-Lymphocyte to T-Lymphocyte Ratio Measurement | ||
TLC | C181186 | Cytotoxic T Cells;Cytotoxic T-Lymphocytes;TLym Cytx | A measurement of the cytotoxic T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocyte Count | ||
TLCAB | C185909 | T-Lymphocytes Cytotoxic Alpha-Beta;TLym Cytx AB | A measurement of the cytotoxic alpha-beta T-lymphocytes in a biological specimen. | Cytotoxic Alpha-Beta T-Lymphocyte Count | ||
TLCABS | C185981 | T-Lymphocytes Cytotoxic Alpha-Beta;TLym Cytx AB Sub | A measurement of a sub-population of cytotoxic alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLCCE | C181256 | T Cells, Cytotoxic/Total Cells;T-Lym, CTX/Total Cells;T-Lymphocytes, Cytotoxic/Total Cells;TLym Cytx/Total Cells | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total cells in a biological specimen. | Cytotoxic T-Lymphocytes to Total Cells Ratio Measurement | ||
TLCCM | C185911 | T-Lymphocytes Cytotoxic Central Memory;TLym Cytx Cen Mem | A measurement of the cytotoxic central memory T-lymphocytes in a biological specimen. | Central Memory Cytotoxic T-Lymphocyte Count | ||
TLCCMS | C185982 | T-Lymphocytes Cytotoxic Central Memory Sub-Population;TLym Cytx Cen Mem Sub | A measurement of a sub-population of cytotoxic central memory T-lymphocytes in a biological specimen. | Central Memory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLCCMSP | C189408 | T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Cytotoxic Central Memory;TLym Cytx Cen Mem Sub/TLymCCM | A relative measurement (ratio or percentage) of a sub-population of central memory cytotoxic T-lymphocytes to total central memory cytotoxic T-lymphocytes in a biological specimen. | Central Memory Cytotoxic T-Lymphocyte Subpopulation to Central Memory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCCMSTC | C189407 | T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Cen Mem Sub/TLymC | A relative measurement (ratio or percentage) of a sub-population of central memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Central Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCE | C185912 | T-Lymphocytes Cytotoxic Effector;TLym Cytx Eff | A measurement of the cytotoxic effector T-lymphocytes in a biological specimen. | Effector Cytotoxic T-Lymphocyte Count | ||
TLCEM | C185913 | T-Lymphocytes Cytotoxic Effector Memory;TLym Cytx Eff Mem | A measurement of the cytotoxic effector memory T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte Count | ||
TLCEMS | C185983 | T-Lymphocytes Cytotoxic Effector Memory Sub-Population;TLym Cytx Eff Mem Sub | A measurement of a sub-population of cytotoxic effector memory T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLCEMSP | C189410 | T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic Effector Memory;TLym Cytx Eff Mem Sub/TLymCEM | A relative measurement (ratio or percentage) of a sub-population of effector memory cytotoxic T-lymphocytes to total effector memory cytotoxic T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Effector Memory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCEMSTC | C189409 | T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Eff Mem Sub/TLymC | A relative measurement (ratio or percentage) of a sub-population of effector memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCEMTLC | C191244 | T-Lymphocytes Cytotoxic Effector Memory/T-Lymphocytes Cytotoxic;TLym Cytx Eff Mem/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCES | C185984 | T-Lymphocytes Cytotoxic Effector Sub-Population;TLym Cytx Eff Sub | A measurement of a sub-population of cytotoxic effector T-lymphocytes in a biological specimen. | Effector Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLCGD | C185910 | T-Lymphocytes Cytotoxic Gamma-Delta;TLym Cytx GD | A measurement of the cytotoxic gamma-delta T-lymphocytes in a biological specimen. | Cytotoxic Gamma-Delta T-Lymphocyte Count | ||
TLCGDS | C185985 | T-Lymphocytes Cytotoxic Gamma-Delta;TLym Cytx GD Sub | A measurement of a sub-population of cytotoxic gamma-delta T-lymphocytes in a biological specimen. | Cytotoxic Gamma-Delta T-Lymphocyte Subpopulation Count | ||
TLCLE | C181254 | T Cells, Cytotoxic/Leukocytes;T-Lymphocytes, Cytotoxic/Leukocytes;TLym Cytx/Leuk | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to leukocytes in a biological specimen. | Cytotoxic T-Lymphocytes to Leukocytes Ratio Measurement | ||
TLCLY | C191245 | T-Lymphocytes Cytotoxic/Lymphocytes;TLym Cytx/Lym | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total lymphocytes in a biological specimen. | Cytotoxic T-Lymphocytes to Lymphocytes Ratio Measurement | ||
TLCMSTC | C189411 | T-Lymphocytes Cytotoxic Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Mem Sub/TLymC | A relative measurement (ratio or percentage) of a sub-population of memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCN | C185914 | T-Lymphocytes Cytotoxic Naive;TLym Cytx Naive | A measurement of the cytotoxic naive T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte Count | ||
TLCNM | C186268 | T-Lymphocytes Central Memory;TLym Cen Mem | A measurement of the central memory T-lymphocytes in a biological specimen. | Central Memory T-Lymphocyte Count | ||
TLCNS | C185987 | T-Lymphocytes Cytotoxic Naive Sub-Population;TLym Cytx Naive Sub | A measurement of a sub-population of cytotoxic naive T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLCNSP | C189413 | T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic Naive;TLym Cytx Naive Sub/TLymCN | A relative measurement (ratio or percentage) of a sub-population of naive cytotoxic T-lymphocytes to total naive cytotoxic T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte Subpopulation to Naive Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCNSTC | C189412 | T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Naive Sub/TLymC | A relative measurement (ratio or percentage) of a sub-population of naive cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCNTLC | C191246 | T-Lymphocytes Cytotoxic Naive/T-Lymphocytes Cytotoxic;TLym Cytx Naive/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic naive T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCR | C185915 | T-Lymphocytes Cytotoxic Regulatory;TLym Cytx Reg | A measurement of the cytotoxic regulatory T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte Count | ||
TLCRS | C185988 | T-Lymphocytes Cytotoxic Regulatory Sub-Population;TLym Cytx Reg Sub | A measurement of a sub-population of cytotoxic regulatory T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLCRSP | C191247 | T-Lymphocytes Cytotoxic Regulatory Sub-Population/T-Lymphocytes Cytotoxic Regulatory;TLym Cytx Reg Sub/TLymCR | A relative measurement (ratio or percentage) of a sub-population of cytotoxic regulatory T-lymphocytes to total cytotoxic regulatory T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte Subpopulation to Regulatory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCRSTLC | C191208 | T-Lymphocytes Cytotoxic Regulatory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Reg Sub/TLym Cytx | A relative measurement (ratio or percentage) of a sub-population of cytotoxic regulatory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCRTLC | C191248 | T-Lymphocytes Cytotoxic Regulatory/T-Lymphocytes Cytotoxic;TLym Cytx Reg/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic regulatory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCS | C181299 | Cytotoxic T-Lymphocytes Sub-Population;TLym Cytx Sub | A measurement of the subpopulation of cytotoxic T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLCSCM | C191249 | Cytotoxic Stem Cell Memory T-Lymphocytes;T-Lymphocytes Cytotoxic Stem Cell Memory;TLym Cytx SC Mem;TLymCSCM | A measurement of the cytotoxic stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte Count | ||
TLCSCMS | C191250 | T-Lymphocytes Cytotoxic SC Memory Sub-Population;TLym Cytx SC Mem Sub | A measurement of a sub-population of cytotoxic stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLCSCMSP | C191251 | T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic Stem Cell Memory;TLym Cytx SC Mem Sub/TLymCSCM | A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to total cytotoxic stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Stem Cell Memory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCSTLC | C181298 | Cytotoxic T-Lymphocytes Sub-Population/Cytotoxic T-Lymphocytes;TLym Cytx Sub/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocyte subpopulation to total cytotoxic T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocyte Subpopulation to Total Cytotoxic T-Lymphocytes Ratio Measurement | ||
TLCSTLY | C191252 | T-Lymphocytes Cytotoxic Sub-Population/T-Lymphocytes;TLym Cytx Sub/TLym | A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to total T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement | ||
TLCTM | C185916 | T-Lymphocytes Cytotoxic Terminal Memory;TLym Cytx Term Mem | A measurement of the cytotoxic terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte Count | ||
TLCTMS | C185989 | T-Lymphocytes Cytotoxic Terminal Memory Sub-Population;TLym Cytx Term Mem Sub | A measurement of a sub-population of cytotoxic terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLCTMSP | C189428 | T-lymphocytes Cytotoxic Terminal Memory Sub-Population/T-lymphocytes Cytotoxic Terminal Memory;TLym Cytx Term Mem Sub/TLymCTM | A relative measurement (ratio or percentage) of a sub-population of terminal memory cytotoxic T-lymphocytes to the total terminal memory cytotoxic T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Terminal Memory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLCTMTLC | C189429 | T-lymphocytes Cytotoxic Terminal Memory/T-lymphocytes Cytotoxic;TLym Cytx Term Mem/TLymC | A relative measurement (ratio or percentage) of the terminal memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLEM | C185908 | T-Lymphocytes Effector Memory;TLym Eff Mem | A measurement of the effector memory T-lymphocytes in a biological specimen. | Effector Memory T-Lymphocyte Count | ||
TLEMS | C185990 | T-Lymphocytes Effector Memory Sub-Population;TLym Eff Mem Sub | A measurement of a sub-population of effector memory T-lymphocytes in a biological specimen. | Effector Memory T-Lymphocyte Subpopulation Count | ||
TLGD | C185991 | T-Lymphocytes Gamma-Delta;TCR Gamma-Delta T-Cells;TLym GD | A measurement of the gamma-delta T-lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte Count | ||
TLGDLY | C189302 | T-Lymphocytes Gamma-Delta/Lymphocytes;TCR Gamma-Delta T-Cells/Lymphocyte;TLym GD/Lym | A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to total lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte to Lymphocyte Ratio Measurement | ||
TLGDS | C185992 | T-Lymphocytes Gamma-Delta;TLym GD Sub | A measurement of a sub-population of gamma-delta T-lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte Subpopulation Count | ||
TLGDSP | C189414 | T-Lymphocytes Gamma-Delta Sub-Population/T-Lymphocytes Gamma-Delta;TCR Gamma-Delta T-Cells Sub/TCR Gamma-Delta T-Cells;TLym GD Sub/TLym GD | A relative measurement (ratio or percentage) of a sub-population of gamma-delta T-lymphocytes to total gamma-delta T-lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte Subpopulation to Gamma-Delta T-Lymphocyte Ratio Measurement | ||
TLGDTLY | C189426 | T-Lymphocytes Gamma-Delta/T-Lymphocytes;TCR Gamma-Delta T-Cells/T-Lymphocytes;TLym GD/TLym | A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to total T-lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte to T-Lymphocyte Ratio Measurement | ||
TLH1 | C185917 | T-Lymphocytes Helper 1;Th1;TLym Help 1 | A measurement of the helper 1 T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte Count | ||
TLH17 | C185918 | T-Lymphocytes Helper 17;Th17;TLym Help 17 | A measurement of the helper 17 T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte Count | ||
TLH17_1 | C185919 | T-Lymphocytes Helper 17.1;Th17.1;TLym Help 17.1 | A measurement of the helper 17.1 T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte Count | ||
TLH17_1S | C185993 | T-Lymphocytes Helper 17.1 Sub-Population;Th17.1 Sub;TLym Help 17.1 Sub | A measurement of a sub-population of helper 17.1 T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte Subpopulation Count | ||
TLH17S | C185994 | T-Lymphocytes Helper 17 Sub-Population;Th17 Sub;TLym Help 17 Su | A measurement of a sub-population of helper 17 T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte Subpopulation Count | ||
TLH1S | C185995 | T-Lymphocytes Helper 1 Sub-Population;Th1 Sub;TLym Help 1 Sub | A measurement of a sub-population of helper 1 T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte Subpopulation Count | ||
TLH2 | C185920 | T-Lymphocytes Helper 2;Th2;TLym Help 2 | A measurement of the helper 2 T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte Count | ||
TLH22 | C185921 | T-Lymphocytes Helper 22;Th22;TLym Help 22 | A measurement of the helper 22 T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte Count | ||
TLH22S | C185996 | T-Lymphocytes Helper 22 Sub-Population;Th22 Sub;TLym Help 22 Sub | A measurement of a sub-population of helper 22 T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte Subpopulation Count | ||
TLH2S | C185997 | T-Lymphocytes Helper 2 Sub-Population;Th2 Sub;TLym Help 2 Sub | A measurement of a sub-population of helper 2 T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte Subpopulation Count | ||
TLH9 | C185922 | T-Lymphocytes Helper 9;Th9;TLym Help 9 | A measurement of the helper 9 T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte Count | ||
TLH9S | C185998 | T-Lymphocytes Helper 9 Sub-Population;Th9 Sub;TLym Help 9 Sub | A measurement of a sub-population of helper 22 T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte Subpopulation Count | ||
TLHAB | C185999 | T-Lymphocytes Helper Alpha-Beta;TLym Help AB | A measurement of the helper alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta Helper T-Lymphocyte Count | ||
TLHABS | C186000 | T-Lymphocytes Helper Alpha-Beta;TLym Help AB Sub | A measurement of a sub-population of helper alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta Helper T-Lymphocyte Subpopulation Count | ||
TLHCE | C181255 | T Cells, Helper/Total Cells;T-Lym, Helper/Total Cells;T-Lymphocytes, Helper/Total Cells;TLym Help/Total Cells | A relative measurement (ratio or percentage) of the helper T-lymphocytes to total cells in a biological specimen. | Helper T-Lymphocytes to Total Cells Ratio Measurement | ||
TLHCM | C185923 | T-Lymphocytes Helper Central Memory;TLym Help Cen Mem | A measurement of the helper central memory T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte Count | ||
TLHCMS | C186001 | T-Lymphocytes Helper Central Memory Sub-Population;TLym Help Cen Mem Sub | A measurement of a sub-population of helper central memory T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte Sub-Population Count | ||
TLHCMSP | C191253 | T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper Central Memory;TLym Help Cen Mem Sub/TLymHCM | A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte Subpopulation to Central Memory Helper T-Lymphocyte Ratio Measurement | ||
TLHCMSTH | C191209 | T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper;TLym Help Cen Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLHCMTH | C191254 | T-Lymphocytes Helper Central Memory/T-Lymphocytes Helper;TLym Help Cen Mem/TLym Help | A relative measurement (ratio or percentage) of the helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLHE | C185924 | T-Lymphocytes Helper Effector;TLym Help Eff | A measurement of the helper effector T-lymphocytes in a biological specimen. | Effector Helper T-Lymphocyte Count | ||
TLHEM | C185925 | T-Lymphocytes Helper Effector Memory;TLym Help Eff Mem | A measurement of the helper effector memory T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte Count | ||
TLHEMS | C186002 | T-Lymphocytes Helper Effector Memory Sub-Population;TLym Help Eff Mem Sub | A measurement of a sub-population of helper effector memory T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte Subpopulation Count | ||
TLHEMSP | C191255 | T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper Effector Memory;TLym Help Eff Mem Sub/TLymHEM | A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte Subpopulation to Effector Memory Helper T-Lymphocyte Ratio Measurement | ||
TLHEMSTH | C191256 | T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper;TLym Help Eff Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLHEMTH | C191257 | T-Lymphocytes Helper Effector Memory/T-Lymphocytes Helper;TLym Help Eff Mem/TLym Help | A relative measurement (ratio or percentage) of the helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLHES | C186003 | T-Lymphocytes Helper Effector Sub-Population;TLym Help Eff Sub | A measurement of a sub-population of helper effector T-lymphocytes in a biological specimen. | Effector Helper T-Lymphocyte Subpopulation Count | ||
TLHF | C186004 | T-Lymphocytes Helper Follicular;TLym Help Foll | A measurement of the helper follicular T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte Count | ||
TLHFS | C191258 | Follicular Helper T-Lymphocytes Sub-Population;T-Lymphocytes Helper Follicular Sub-Population;TLym Help Foll Sub | A measurement of a sub-population of follicular helper T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte Subpopulation Count | ||
TLHFSP | C191259 | T-Lymphocytes Helper Foll Sub-Population/T-Lymphocytes Helper Follicular;TLym Help Foll Sub/TLymHF | A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to total helper follicular T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte Subpopulation to Follicular Helper T-Lymphocyte Ratio Measurement | ||
TLHFSTH | C191210 | T-Lymphocytes Helper Foll Sub-Population/T-Lymphocytes Helper;TLym Help Foll Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLHFTH | C191260 | T-Lymphocytes Helper Foll/T-Lymphocytes Helper;TLym Help Foll/TLym Help | A relative measurement (ratio or percentage) of the helper follicular T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLHGD | C186005 | T-Lymphocytes Helper Gamma-Delta;TLym Help GD | A measurement of the helper gamma-delta T-lymphocytes in a biological specimen. | Gamma-Delta Helper T-Lymphocyte Count | ||
TLHGDS | C186006 | T-Lymphocytes Helper Gamma-Delta;TLym Help GD Sub | A measurement of a sub-population of helper gamma-delta T-lymphocytes in a biological specimen. | Helper Gamma-Delta T-Lymphocyte Subpopulation Count | ||
TLHLE | C181253 | T Cells, Helper/Leukocytes;T-Lymphocytes, Helper/Leukocytes;TLym Help/Leuk | A relative measurement (ratio or percentage) of the helper T-lymphocytes to leukocytes in a biological specimen. | Helper T-Lymphocytes to Leukocytes Ratio Measurement | ||
TLHLY | C191261 | T-Lymphocytes Helper/Lymphocytes;TLym Help/Lym | A relative measurement (ratio or percentage) of the helper T-lymphocytes to total lymphocytes in a biological specimen. | Helper T-Lymphocyte to Lymphocyte Ratio Measurement | ||
TLHM | C185926 | T-Lymphocytes Helper Memory;TLym Help Mem | A measurement of the helper memory T-lymphocytes in a biological specimen. | Memory Helper T-Lymphocyte Count | ||
TLHMS | C186007 | T-Lymphocytes Helper Memory Sub-Population;TLym Help Mem Sub | A measurement of a sub-population of helper memory T-lymphocytes in a biological specimen. | Memory Helper T-Lymphocyte Subpopulation Count | ||
TLHMSTH | C191262 | T-Lymphocytes Helper Memory Sub-Population/T-Lymphocytes Helper;TLym Help Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLHN | C185927 | T-Lymphocytes Helper Naive;TLym Help Naive | A measurement of the helper naive T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte Count | ||
TLHNS | C186008 | T-Lymphocytes Helper Naive Sub-Population;TLym Help Naive Sub | A measurement of a sub-population of helper naive T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte Subpopulation Count | ||
TLHNSP | C191263 | T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper Naive;TLym Help Naive Sub/TLymHN | A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to total helper naive T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement | ||
TLHNSTH | C191264 | T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper;TLym Help Naive Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLHNTH | C191265 | T-Lymphocytes Helper Naive/T-Lymphocytes Helper;TLym Help Naive/TLym Help | A relative measurement (ratio or percentage) of the helper naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLHRE | C185929 | T-Lymphocytes Helper Regulatory Effector;TLym Help Reg Eff | A measurement of the helper regulatory effector T-lymphocytes in a biological specimen. | Regulatory Effector Helper T-Lymphocyte Count | ||
TLHRES | C186009 | T-Lymphocytes, Helper Regulatory Effector Sub-Population;TLym Help Reg Eff Sub | A measurement of a sub-population of helper regulatory effector T-lymphocytes in a biological specimen. | Regulatory Effector Helper T-Lymphocyte Subpopulation Count | ||
TLHRM | C185930 | T-Lymphocytes Helper Regulatory Memory;TLym Help Reg Mem | A measurement of the helper regulatory memory T-lymphocytes in a biological specimen. | Regulatory Memory Helper T-Lymphocyte Count | ||
TLHRMS | C186010 | T-Lymphocytes Helper Regulatory Memory Sub-Population;TLym Help Reg Mem Sub | A measurement of a sub-population of helper regulatory memory T-lymphocytes in a biological specimen. | Regulatory Memory Helper T-Lymphocyte Subpopulation Count | ||
TLHRMSP | C191266 | T-Lymphocytes Helper Regulatory Memory Sub-Population/T-Lymphocytes Helper Regulatory Memory;TLym Help Reg Mem Sub/TLymHRM | A relative measurement (ratio or percentage) of a sub-population of helper regulatory memory T-lymphocytes to total helper regulatory memory T-lymphocytes in a biological specimen. | Regulatory Memory Helper T-Lymphocyte Subpopulation to Regulatory Memory Helper T-Lymphocyte Ratio Measurement | ||
TLHRMTHR | C191267 | T-Lymphocytes Helper Regulatory Memory/T-Lymphocytes Helper Regulatory;TLym Help Reg Mem/TLymHR | A relative measurement (ratio or percentage) of the helper regulatory memory T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. | Regulatory Memory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement | ||
TLHRNSP | C191268 | T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory Naive;TLym Help Reg Naive Sub/TLymHRN | A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to total helper regulatory naive T-lymphocytes in a biological specimen. | Naive Regulatory Helper T-Lymphocyte Subpopulation to Naive Regulatory Helper T-Lymphocyte Ratio Measurement | ||
TLHRNTHR | C191269 | T-Lymphocytes Helper Regulatory Naive/T-Lymphocytes Helper Regulatory;TLym Help Reg Naive/TLymHR | A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. | Naive Regulatory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement | ||
TLHRS | C185928 | T-Lymphocytes Helper Regulatory Sub-Population;TLym Help Reg Sub | A measurement of a sub-population of helper regulatory T-lymphocytes in a biological specimen. | Helper Regulatory T-Lymphocyte Subpopulation Count | ||
TLHRSP | C191270 | T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper Regulatory;TLym Help Reg Sub/TLymHR | A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. | Regulatory Helper T-Lymphocyte Subpopulation to Regulatory Helper T-Lymphocyte Ratio Measurement | ||
TLHRSTLH | C191211 | T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper;TLym Help Reg Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Regulatory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLHRTLH | C198250 | T-Lymphocytes Helper Regulatory/T-Lymphocytes Helper;TLym Help Reg/TLym Help | A relative measurement (ratio or percentage) of the helper regulatory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Regulatory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLHSCM | C198251 | T-Lymphocytes Helper Stem Cell Memory;TLym Help SC Mem | A measurement of the helper stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Count | ||
TLHSCMS | C198252 | T-Lymphocytes Helper Stem Cell Memory Sub-Population;TLym Help SC Mem Sub | A measurement of a sub-population of helper stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Subpopulation Count | ||
TLHSCMSP | C198253 | T-Lymphocytes Helper Stem Cell Memory Sub-Population/T-Lymphocytes Helper Stem Cell Memory;TLym Help SC Mem Sub/TLymHSCM | A relative measurement (ratio or percentage) of a sub-population of helper stem cell memory T-lymphocytes to total helper stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Subpopulation to Stem Cell Memory Helper T-Lymphocyte Ratio Measurement | ||
TLHSCMTH | C198254 | T-Lymphocytes Helper Stem Cell Memory/T-Lymphocytes Helper;TLym Help SC Mem/TLym Help | A relative measurement (ratio or percentage) of the helper stem cell memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLHSP | C189427 | T-Lymphocytes Helper Sub-Population/Helper T-Lymphocytes;TLym Help Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLHTM | C185931 | T-Lymphocytes Helper Terminal Memory;TLym Help Term Mem | A measurement of the helper terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte Count | ||
TLHTMS | C186011 | T-Lymphocytes Helper Terminal Memory Sub-Population;TLym Help Term Mem Sub | A measurement of a sub-population of helper terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte Subpopulation Count | ||
TLHTMSP | C198255 | T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper Terminal Memory;TLym Help Term Mem Sub/TLymHTM | A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte Subpopulation to Terminal Memory Helper T-Lymphocyte Ratio Measurement | ||
TLHTMSTH | C198256 | T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper;TLym Help Term Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLHTMTLH | C198257 | T-Lymphocytes Helper Terminal Memory/T-Lymphocytes Helper;TLym Help Term Mem/TLym Help | A relative measurement (ratio or percentage) of the helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLLE | C181184 | T Cells/Leukocytes;T-Lymphocytes/Leukocytes;TLym/Leuk | A relative measurement (ratio or percentage) of the T-lymphocytes to leukocytes in a biological specimen. | T-Lymphocytes to Leukocytes Ratio Measurement | ||
TLN | C186012 | T-Lymphocytes Naive;TLym Naive | A measurement of the naive T-lymphocytes in a biological specimen. | Naive T-Lymphocyte Count | ||
TLR | C186013 | T-Lymphocytes Regulatory;TLym Reg | A measurement of the regulatory T-lymphocytes in a biological specimen. | Regulatory T-Lymphocyte Count | ||
TLRLY | C187735 | T-Lymphocytes Regulatory/Lymphocytes;TLym Reg/Lym | A relative measurement (ratio or percentage) of the regulatory T-lymphocytes to total lymphocytes in a biological specimen. | Regulatory T-Lymphocyte to Total Lymphocyte Ratio Measurement | ||
TLS | C184427 | T-Lymphocytes Sub-Population;TLym Sub | A measurement of a subpopulation of T-lymphocytes in a biological specimen. | T-Lymphocyte Subpopulation Count | ||
TLSTLY | C181261 | T-Lymphocytes Sub-Population/T-Lymphocytes;TLym Sub/Tlym | A relative measurement (ratio or percentage) of the T-lymphocyte subpopulation to total T-lymphocytes in a biological specimen. | T-Lymphocytes Subpopulation to Total T-Lymphocytes Ratio Measurement | ||
TLTM | C186269 | T-Lymphocytes Terminal Memory;TEMRA;TLym Term Mem | A measurement of the terminal memory T-lymphocytes in a biological specimen. | Terminal Memory T-Lymphocyte Count | ||
TLYCE | C122157 | T-Cell Lymphocytes;T-Cells;T-Lymphocytes | A measurement of the total thymocyte-derived lymphocytes in a biological specimen. | T-Lymphocyte Count | ||
TLYCTLY | C181304 | Cytotoxic T Cells/T Cells;Cytotoxic T-Lymphocytes/T-Lymphocytes;TLym Cytx/TLym | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocytes to Total T-Lymphocytes Ratio Measurement | ||
TLYH | C181302 | Helper T Cells;Helper T-Lymphocytes;TLym Help | A measurement of the helper T-lymphocytes in a biological specimen. | Helper T-Lymphocytes Count | ||
TLYHR | C184428 | T-Lymphocytes Helper Regulatory;TLym Help Reg | A measurement of helper regulatory T-lymphocytes in a biological specimen. | Helper Regulatory T-Lymphocyte Count | ||
TLYHRLY | C189396 | T-Lymphocytes Helper Regulatory/Lymphocytes;TLym Help Reg/Lym | A relative measurement (ratio or percentage) of helper regulatory T-lymphocytes to total lymphocytes in a biological specimen. | Helper Regulatory T-Lymphocyte to Lymphocyte Ratio Measurement | ||
TLYHS | C184351 | T-Lymphocytes Helper Sub-Population;TLym Help Sub | A measurement of a subpopulation of helper T-lymphocytes in a biological specimen. | Helper T-Lymphocyte Subpopulation Count | ||
TLYHSLY | C184429 | T-Lymphocytes Helper Subpopulation/Lymphocytes;TLym Help Sub/Lym | A relative measurement (ratio or percentage) of the subpopulation of helper T-lymphocytes to total lymphocytes in a biological specimen. | Helper T-Lymphocyte Subpopulation to Total Lymphocyte Ratio Measurement | ||
TLYHTLY | C181303 | Helper T Cells/T Cells;Helper T-Lymphocytes/T-Lymphocytes;TLym Help/TLym | A relative measurement (ratio or percentage) of the helper T-lymphocytes to total T-lymphocytes in a biological specimen. | Helper T-Lymphocytes to Total T-Lymphocytes Ratio Measurement | ||
TLYHTLYC | C181305 | Helper T Cells/Cytotoxic T Cells;Helper T-Lymphocytes/Cytotoxic T-Lymphocytes;TLym Help/TLym Cytx | A relative measurement (ratio) of the helper T-lymphocytes to cytotoxic T-lymphocytes in a biological specimen. | Helper T-Lymphocytes to Cytotoxic T-Lymphocytes Ratio Measurement | ||
TLYLY | C181301 | T Cells/Lymphocytes;T-Lymphocytes/Lymphocytes;TLym/Lym | A relative measurement (ratio or percentage) of the T-lymphocytes to total lymphocytes in a biological specimen. | T-Lymphocytes to Lymphocytes Ratio Measurement | ||
TLYSLY | C184352 | T-Lymphocytes Sub-Population/Lymphocytes;TLym Sub/Lym | A relative measurement (ratio or percentage) of the subpopulation of T-lymphocytes to total lymphocytes in a biological specimen. | T-Lymphocyte Subpopulation to Total Lymphocyte Ratio Measurement | ||
WBC | C51948 | Leukocytes;White Blood Cells | A measurement of the leukocytes in a biological specimen. | Leukocyte Count | ||
WBCCE | C135451 | Leukocytes/Total Cells;WBC/Total Cells | A relative measurement (ratio or percentage) of the leukocytes to total cells in a biological specimen. | Leukocytes to Total Cells Ratio Measurement | ||
Back to top | ||||||
CL.C181174.CPTEST | Cell Phenotyping Test Name
(CPTEST) | text
Extensible: Yes | C181174 | Cell Phenotyping Test Name | Terminology relevant to the test names that describe cell phenotype findings. | CDISC SDTM Cell Phenotyping Test Name Terminology |
Abn Blast Cells | C198236 | Abn Blast Cells;Abnormal Blast Cells | A measurement of the abnormal blast cells in a biological specimen. | Abnormal Blast Count | ||
Abn Blast Cells/Total Cells | C198237 | Abn Blast Cells/Total Cells;Abnormal Blast Cells/Total Cells | A relative measurement (ratio or percentage) of the abnormal blast cells to total cells in a biological specimen. | Abnormal Blast to Total Cell Ratio Measurement | ||
Abn Kappa+ PC/Abn Lambda+ PC | C198239 | Abn Kappa+ PC/Abn Lambda+ PC;Abnormal Kappa+ Plasma Cells/Abnormal Lambda+ Plasma Cells | A relative measurement (ratio) of the abnormal kappa+ plasma cells to abnormal lambda+ plasma cells in a biological specimen. | Abnormal Kappa Positive Plasma Cell to Abnormal Lambda Positive Plasma Cell Ratio Measurement | ||
Abn Kappa+ Plasma Cells | C198238 | Abn Kappa+ PC;Abn Kappa+ Plasma Cells;Abnormal Kappa+ Plasma Cells | A measurement of the abnormal kappa+ plasma cells in a biological specimen. | Abnormal Kappa Positive Plasma Cell Count | ||
Abn Lambda+ Plasma Cells | C198240 | Abn Lambda+ PC;Abn Lambda+ Plasma Cells;Abnormal Lambda+ Plasma Cells | A measurement of the abnormal lambda+ plasma cells in a biological specimen. | Abnormal Lambda Positive Plasma Cell Count | ||
B-Lymphocytes | C174314 | B-Cell Lymphocytes;B-Cells;B-Lymphocytes | A measurement of the B-lymphocytes in a biological specimen. | B-Lymphocyte Count | ||
B-Lymphocytes/Lymphocytes | C174315 | B-Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the B-lymphocytes to total lymphocytes in a biological specimen. | B-Lymphocyte to Lymphocyte Ratio Measurement | ||
B-Lymphocytes/Total Cells | C174317 | B-Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the B-lymphocytes to total cells in a biological specimen. | B-Lymphocyte to Total Cells Ratio Measurement | ||
BLym B1 Sub | C181308 | B-Lymphocytes B1 Sub-Population;BLym B1 Sub | A measurement of a subpopulation of B-lymphocytes B1 in a biological specimen. | B-Lymphocytes B1 Subpopulation Count | ||
BLym B1 Trans | C184399 | B-Lymphocytes B1 Transitional;BLym B1 Trans | A measurement of the transitional B1 B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte B1 Count | ||
BLym B1 | C181307 | B-Lymphocytes B1;BLym B1 | A measurement of B-lymphocytes B1 in a biological specimen. | B-Lymphocytes B1 Count | ||
BLym B1a | C184400 | B-Lymphocytes B1a;BLym B1a | A measurement of the B1a B-lymphocytes in a biological specimen. | B-Lymphocyte B1a Count | ||
BLym B1b | C184401 | B-Lymphocytes B1b;BLym B1b | A measurement of the B1b B-lymphocytes in a biological specimen. | B-Lymphocyte B1b Count | ||
BLym B2 Immat | C184402 | B-Lymphocytes B2 Immature;BLym B2 Immat | A measurement of the immature B2 B-lymphocytes in a biological specimen. | Immature B-Lymphocyte B2 Count | ||
BLym B2 Mat | C184403 | B-Lymphocytes B2 Mature;BLym B2 Mat | A measurement of the mature B2 B-lymphocytes in a biological specimen. | Mature B-Lymphocyte B2 Count | ||
BLym B2 Trans | C184404 | B-Lymphocytes B2 Transitional;BLym B2 Trans | A measurement of the transitional B2 B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte B2 Count | ||
BLym Eff 1 Sub | C184405 | B-Lymphocytes Effector 1 Sub-Population;BLym Eff 1 Sub | A measurement of a sub-population of effector 1 B-lymphocytes in a biological specimen. | Effector 1 B-Lymphocyte Subpopulation Count | ||
BLym Eff 1 | C184362 | B-Lymphocytes Effector 1;BLym Eff 1 | A measurement of the effector 1 B-lymphocytes in a biological specimen. | Effector 1 B-Lymphocyte Count | ||
BLym Eff 2 Sub | C184406 | B-Lymphocytes Effector 2 Sub-Population;BLym Eff 2 Sub | A measurement of a sub-population of effector 2 B-lymphocytes in a biological specimen. | Effector 2 B-Lymphocyte Subpopulation Count | ||
BLym Eff 2 | C184363 | B-Lymphocytes Effector 2;BLym Eff 2 | A measurement of the effector 2 B-lymphocytes in a biological specimen. | Effector 2 B-Lymphocyte Count | ||
BLym Eff Sub | C184361 | B-Lymphocytes Effector Sub-Population;BLym Eff Sub | A measurement of a sub-population of effector B-lymphocytes in a biological specimen. | Effector B-Lymphocyte Subpopulation Count | ||
BLym Eff | C184354 | B-Lymphocytes Effector;BLym Eff | A measurement of the effector B-lymphocytes in a biological specimen. | Effector B-Lymphocyte Count | ||
BLym Foll Sub | C184407 | B-Lymphocytes Follicular Sub-Population;BLym Foll Sub | A measurement of a sub-population of follicular B-lymphocytes in a biological specimen. | Follicular B-Lymphocyte Subpopulation Count | ||
BLym Foll | C184355 | B-Lymphocytes Follicular;BLym Foll | A measurement of the follicular B-lymphocytes in a biological specimen. | Follicular B-Lymphocyte Count | ||
BLym Germ Ctr Sub | C184408 | B-Lymphocytes Germinal Center Sub-Population;BLym Germ Ctr Sub | A measurement of a sub-population of germinal center B-lymphocytes in a biological specimen. | Germinal Center B-Lymphocyte Subpopulation Count | ||
BLym Germ Ctr | C184345 | B-Lymphocytes Germinal Center;BLym Germ Ctr | A measurement of the germinal center B-lymphocytes in a biological specimen. | Germinal Center B-Lymphocyte Count | ||
BLym Immat | C184346 | B-Lymphocytes Immature;BLym Immat | A measurement of the immature B-lymphocytes in a biological specimen. | Immature B-Lymphocyte Count | ||
BLym Marg Zn | C184409 | B-Lymphocytes Marginal Zone;BLym Marg Zn | A measurement of the marginal zone B-lymphocytes in a biological specimen. | Marginal Zone B-Lymphocyte Count | ||
BLym Mat | C184347 | B-Lymphocytes Mature;BLym Mat | A measurement of the mature B-lymphocytes in a biological specimen. | Mature B-Lymphocyte Count | ||
BLym Mem cB1 | C184410 | B-Lymphocytes Memory cB1;BLym Mem cB1 | A measurement of the cB1 memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte cB1 Count | ||
BLym Mem cB2 | C184411 | B-Lymphocytes Memory cB2;BLym Mem cB2 | A measurement of the cB2 memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte cB2 Count | ||
BLym Mem cB3 | C184412 | B-Lymphocytes Memory cB3;BLym Mem cB3 | A measurement of the cB3 memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte cB3 Count | ||
BLym Mem Immat | C184415 | B-Lymphocytes Memory Immature;BLym Mem Immat | A measurement of the memory immature B-lymphocytes in a biological specimen. | Immature Memory B-Lymphocyte Count | ||
BLym Mem Mat | C184416 | B-Lymphocytes Memory Mature;BLym Mem Mat | A measurement of the memory mature B-lymphocytes in a biological specimen. | Mature Memory B-Lymphocyte Count | ||
BLym Mem NSw Sub | C184414 | B-Lymphocytes Memory Non-Class-Switched Sub-Population;B-Lymphocytes Memory Unswitched Sub-Population;BLym Mem NSw Sub | A measurement of a sub-population of non-class-switched memory B-lymphocytes in a biological specimen. | Nonclass-switched Memory B-Lymphocyte Subpopulation Count | ||
BLym Mem NSw Sub/BLymMNSw | C187729 | B-Lymphocytes Memory Non-Class-Switched Sub-Population/B-Lymphocytes Memory Non-Class-Switched;B-Lymphocytes Memory Unswitched Sub-Population/B-Lymphocytes Memory Unswitched;BLym Mem NSw Sub/BLymMNSw | A relative measurement (ratio or percentage) of a sub-population of non-class-switched memory B-lymphocytes to total non-class-switched memory B-lymphocytes in a biological specimen. | Non-class-switched Memory B-Lymphocyte Subpopulation to Total Non-class-switched Memory B-Lymphocyte Ratio Measurement | ||
BLym Mem NSw | C184359 | B-Lymphocytes Memory Non-Class-Switched;B-Lymphocytes Memory Unswitched;BLym Mem NSw | A measurement of the non-class-switched memory B-lymphocytes in a biological specimen. | Nonclass-switched Memory B-Lymphocyte Count | ||
BLym Mem NSw/BLym | C187730 | B-Lymphocytes Memory Non-Class-Switched/B-Lymphocytes;B-Lymphocytes Memory Unswitched/B-Lymphocytes;BLym Mem NSw/BLym | A relative measurement (ratio or percentage) of the non-class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. | Non-class-switched Memory B-Lymphocyte to Total B-Lymphocyte Ratio Measurement | ||
BLym Mem Sub | C184357 | B-Lymphocytes Memory Sub-Population;BLym Mem Sub | A measurement of a sub-population of memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte Subpopulation Count | ||
BLym Mem Sw IgG+ | C187714 | B-Lymphocytes Memory Switched IgG+;BLym Mem Sw IgG+ | A measurement of the IgG+ class-switched memory B-lymphocytes in a biological specimen. | Immunoglobulin G Positive Class-switched Memory B-Lymphocyte Count | ||
BLym Mem Sw IgG+/BLym Mem Sw | C187715 | B-Lymphocytes Memory Switched IgG+/B-Lymphocytes Memory Switched;BLym Mem Sw IgG+/BLym Mem Sw | A relative measurement (ratio or percentage) of IgG+ memory switched B-Lymphocytes to class-switched memory B-lymphocytes in a biological specimen. | Immunoglobulin G Positive Memory Switched B-Lymphocyte to Memory Switched B-Lymphocyte Ratio Measurement | ||
BLym Mem Sw IgM+ | C187719 | B-Lymphocytes Memory Switched IgM+;BLym Mem Sw IgM+ | A measurement of the IgM+ class-switched memory B-lymphocytes in a biological specimen. | Immunoglobulin M Positive Class-switched Memory B-Lymphocyte Count | ||
BLym Mem Sw IgM+/BLym Mem Sw | C187720 | B-Lymphocytes Memory Switched IgM+/B-Lymphocytes Memory Switched;BLym Mem Sw IgM+/BLym Mem Sw | A relative measurement (ratio or percentage) of IgM+ class-switched memory B-Lymphocytes to class-switched memory B-lymphocytes in a biological specimen. | Immunoglobulin M Positive Memory Switched B-Lymphocyte to Memory Switched B-Lymphocyte Ratio Measurement | ||
BLym Mem Sw Sub | C184413 | B-Lymphocytes Memory Class-Switched Sub-Population;BLym Mem Sw Sub | A measurement of a sub-population of class-switched memory B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocyte Subpopulation Count | ||
BLym Mem Sw Sub/BLym Mem Sw | C187711 | B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes Memory Class-Switched;B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes Memory Switched;BLym Mem Sw Sub/BLym Mem Sw | A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to class-switched memory B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocyte Subpopulation to Class-switched Memory B-Lymphocyte Ratio Measurement | ||
BLym Mem Sw Sub/BLym | C187712 | B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes;B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes;BLym Mem Sw Sub/BLym | A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to total B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocyte Subpopulation to Total B-Lymphocyte Ratio Measurement | ||
BLym Mem Sw Sub/BLymMSw | C187713 | B-Lymphocytes Memory Class-Switched Sub-Population/B-Lymphocytes Memory Class-Switched;B-Lymphocytes Memory Switched Sub-Population/B-Lymphocytes Memory Switched;BLym Mem Sw Sub/BLymMSw | A relative measurement (ratio or percentage) of a sub-population of class-switched memory B-lymphocytes to total class-switched memory B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocytes Subpopulation to Total Class-switched Memory B-Lymphocytes Ratio Measurement | ||
BLym Mem Sw Uncv Sub | C187749 | B-Lymphocytes Memory Class-Switched Unconventional Sub-Population;B-Lymphocytes Memory Switched Unconventional Sub-Population;BLym Mem Sw Uncv Sub | A measurement of a sub-population of unconventional class-switched memory B-lymphocytes in a biological specimen. | Unconventional Class-switched Memory B-Lymphocyte Subpopulation Count | ||
BLym Mem Sw Uncv Sub/BLym Mem Sw Uncv | C187750 | B-Lymphocytes Memory Class-Switched Unconventional Sub-Population/B-Lymphocytes Memory Class-Switched Unconventional;B-Lymphocytes Memory Switched Unconventional Sub-Population/B-Lymphocytes Memory Switched Unconventional;BLym Mem Sw Uncv Sub/BLym Mem Sw Uncv | A relative measurement (ratio or percentage) of a sub-population of unconventional class-switched memory B-lymphocytes to unconventional class-switched memory B-lymphocytes in a biological specimen. | Unconventional Class-switched Memory B-Lymphocyte Subpopulation to Unconventional Class-switched Memory B-Lymphocyte Ratio Measurement | ||
BLym Mem Sw Uncv | C187748 | B-Lymphocytes Memory Class-Switched Unconventional;B-Lymphocytes Memory Switched Unconventional;BLym Mem Sw Uncv | A measurement of the unconventional class-switched memory B-lymphocytes in a biological specimen. | Unconventional Class-switched Memory B-Lymphocyte Count | ||
BLym Mem Sw Uncv/BLym | C187751 | B-Lymphocytes Memory Class-Switched Unconventional/B-Lymphocytes;B-Lymphocytes Memory Switched Unconventional/B-Lymphocytes;BLym Mem Sw Uncv/BLym | A relative measurement (ratio or percentage) the unconventional class-switched memory B-lymphocytes to B-lymphocytes in a biological specimen. | Unconventional Class-switched Memory B-Lymphocyte to B-Lymphocyte Ratio Measurement | ||
BLym Mem Sw | C184358 | B-Lymphocytes Memory Class-Switched;B-Lymphocytes Memory Switched;BLym Mem Sw | A measurement of the class-switched memory B-lymphocytes in a biological specimen. | Class-switched Memory B-Lymphocyte Count | ||
BLym Mem | C184348 | B-Lymphocytes Memory;BLym Mem | A measurement of the memory B-lymphocytes in a biological specimen. | Memory B-Lymphocyte Count | ||
BLym Mem/BLym | C185965 | B-Lymphocytes Memory/B-Lymphocytes;BLym Mem/BLym | A relative measurement (ratio or percentage) of memory B-lymphocytes to total B-lymphocytes in a biological specimen. | Memory B-Lymphocytes to Total B-Lymphocytes Ratio Measurement | ||
BLym Naive Mat Sub | C187727 | B-Lymphocytes Naive Mature Sub-Population;BLym Naive Mat Sub | A measurement of a sub-population of naive mature B-lymphocytes in a biological specimen. | Naive Mature B-Lymphocyte Subpopulation Count | ||
BLym Naive Mat Sub/BLymNM | C187728 | B-Lymphocytes Naive Mature Sub-Population/B-Lymphocytes Naive Mature;BLym Naive Mat Sub/BLym Naive Mat;BLym Naive Mat Sub/BLymNM | A relative measurement (ratio or percentage) a sub-population of naive mature B-lymphocytes to total naive mature B-lymphocytes in a biological specimen. | Naive Mature B-Lymphocyte Subpopulation to Total Naive Mature B-Lymphocyte Ratio Measurement | ||
BLym Naive Mat | C184356 | B-Lymphocytes Naive Mature;BLym Naive Mat | A measurement of the naive mature B-lymphocytes in a biological specimen. | Naive Mature B-Lymphocyte Count | ||
BLym Naive Mat/BLym | C185964 | B-Lymphocytes Naive Mature/B-Lymphocytes;BLym Naive Mat/BLym | A relative measurement (ratio or percentage) of naive mature B-lymphocytes to B-lymphocytes in a biological specimen. | Naive Mature B-Lymphocytes to Total B-Lymphocytes Ratio Measurement | ||
BLym Naive Sub | C184417 | B-Lymphocytes Naive Sub-Population;BLym Naive Sub | A measurement of a sub-population of naive B-lymphocytes in a biological specimen. | Naive B-Lymphocyte Subpopulation Count | ||
BLym Naive Sub/BLym Naive | C181263 | B-Lymphocytes Naive Sub-Population/B-Lymphocytes, Naive;BLym Naive Sub/BLym Naive | A relative measurement (ratio or percentage) of a subpopulation of naive B-lymphocytes to naive B-lymphocytes in a biological specimen. | Naive B-Lymphocytes Subpopulation to Total B-Lymphocytes Naive Ratio Measurement | ||
BLym Naive | C181262 | B-Lymphocytes, Naive;BLym Naive;Naive B Cells;Naive B-Lymphocytes | A measurement of the naive B-lymphocytes in a biological specimen. | Naive B-Lymphocyte Measurement | ||
BLym Naive/BLym | C181264 | B Cell, Naive/B Cell;B-Lymphocyte, Naive/B-Lymphocyte;BLym Naive/Blym;Naive B-Lymphocytes/B-Lymphocytes | A relative measurement (ratio or percentage) of naive B-lymphocytes to B-lymphocytes in a biological specimen. | Naive B-Lymphocytes to Total B-Lymphocytes Ratio Measurement | ||
BLym Reg Sub | C184418 | B-Lymphocytes Regulatory Sub-Population;BLym Reg Sub | A measurement of the sub-population of regulatory B-lymphocytes in a biological specimen. | Regulatory B-Lymphocyte Subpopulation Count | ||
BLym Reg | C184349 | B-Lymphocytes Regulatory;BLym Reg | A measurement of the regulatory B-lymphocytes in a biological specimen. | Regulatory B-Lymphocyte Count | ||
BLym Sub | C181187 | B-Lymphocytes Sub-Population;BLym Sub | A measurement of a subpopulation of B-lymphocytes in a biological specimen. | B-Lymphocytes Subpopulation Count | ||
BLym Sub/BLym | C181265 | B-Lymphocyte Sub-Population/B-Lymphocyte;BLym Sub/BLym | A relative measurement (ratio or percentage) of a subpopulation of B-lymphocytes to B-lymphocytes in a biological specimen. | B-Lymphocytes Subpopulation to Total B-Lymphocytes Ratio Measurement | ||
BLym Sub/Lym | C187710 | B-Lymphocytes Sub-Population/Lymphocytes;BLym Sub/Lym | A relative measurement (ratio or percentage) of a sub-population of B-lymphocytes to lymphocytes in a biological specimen. | B-Lymphocyte Subpopulation to Lymphocyte Ratio Measurement | ||
BLym Trans 1 | C184419 | B-Lymphocytes Transitional 1;BLym Trans 1 | A measurement of the transitional 1 B-lymphocytes in a biological specimen. | Transitional 1 B-Lymphocyte Count | ||
BLym Trans 2 | C184420 | B-Lymphocytes Transitional 2;BLym Trans 2 | A measurement of the transitional 2 B-lymphocytes in a biological specimen. | Transitional 2 B-Lymphocyte Count | ||
BLym Trans 3 | C184421 | B-Lymphocytes Transitional 3;BLym Trans 3 | A measurement of the transitional 3 B-lymphocytes in a biological specimen. | Transitional 3 B-Lymphocyte Count | ||
BLym Trans Sub | C187736 | B-Lymphocytes Transitional Sub-Population;BLym Trans Sub | A measurement of a sub-population of transitional B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte Subpopulation Count | ||
BLym Trans Sub/BLym Trans | C187737 | B-Lymphocytes Transitional Sub-Population/B-Lymphocytes Transitional;BLym Trans Sub/BLym Trans | A relative measurement (ratio or percentage) of a sub-population of transitional B-lymphocytes to total transitional B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte Subpopulation to Total Transitional B-Lymphocyte Ratio Measurement | ||
BLym Trans | C184360 | B-Lymphocytes Transitional;BLym Trans | A measurement of the transitional B-lymphocytes in a biological specimen. | Transitional B-Lymphocyte Count | ||
BLym Trans/BLym | C185966 | B-Lymphocytes Transitional/B-Lymphocytes;BLym Trans/BLym | A relative measurement (ratio or percentage) of transitional B-lymphocytes to B-lymphocytes in a biological specimen. | Transitional B-Lymphocytes to B-Lymphocytes Ratio Measurement | ||
BLym/Leuk | C181309 | B Cells/Leukocytes;B-Lymphocytes/Leukocytes;BLym/Leuk | A relative measurement (ratio or percentage) of B-lymphocytes to leukocytes in a biological specimen. | B-Lymphocytes to Leukocytes Ratio Measurement | ||
CD16 Expression | C189388 | CD16 Expression | A measurement of cellular CD16 expression in a biological specimen. | CD16 Cell Surface Expression Measurement | ||
CD25 Expression | C198241 | CD25 Expression | A measurement of cellular CD25 expression in a biological specimen. | CD25 Cell Surface Expression Measurement | ||
CD278 Expression | C191220 | CD278 Expression | A measurement of cellular CD278 expression in a biological specimen. | CD278 Cell Surface Expression Measurement | ||
CD279 Expression | C191221 | CD279 Expression | A measurement of cellular CD279 expression in a biological specimen. | CD279 Cell Surface Expression Measurement | ||
CD40 Expression | C82006 | CD40 Expression | A measurement of cellular CD40 expression in a biological specimen. | CD40 Cell Surface Measurement | ||
CD69 Expression | C198242 | CD69 Expression | A measurement of cellular CD69 expression in a biological specimen. | CD69 Cell Surface Expression Measurement | ||
CD80 Expression | C181266 | CD80 Expression | A measurement of cellular CD80 expression in a biological specimen. | CD80 Cell Surface Expression Measurement | ||
CD83 Expression | C181267 | CD83 Expression | A measurement of cellular CD83 expression in a biological specimen. | CD83 Cell Surface Expression Measurement | ||
CD86 Expression | C189389 | CD86 Expression | A measurement of cellular CD86 expression in a biological specimen. | CD86 Cell Surface Expression Measurement | ||
CD95 Expression | C181268 | CD95 Expression | A measurement of cellular CD95 expression in a biological specimen. | CD95 Cell Surface Expression Measurement | ||
Clonal Plasma Cells | C198235 | Clonal Plasma Cells | A measurement of the clonal plasma cells in a biological specimen. | Clonal Plasma Cell Count | ||
Clonal Plasma Cells/Total Cells | C198243 | Clonal Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the clonal plasma cells to total cells in a biological specimen. | Clonal Plasma Cell to Total Cell Ratio Measurement | ||
DC Myeloid 1 Sub | C187739 | cDC1 Sub-Population;Classical DC Type 1 Sub-Population;Conventional DC Type 1 Sub-Population;DC Myeloid 1 Sub;Dendritic Cells Myeloid 1 Sub-Population;mDC1 Sub-Population | A measurement of a sub-population of type 1 myeloid dendritic cells in a biological specimen. | Type 1 Myeloid Dendritic Cell Subpopulation Count | ||
DC Myeloid 1 Sub/DCM | C187740 | cDC1 Sub-Population/cDC;Classical DC Type 1 Sub-Population/Classical DC;Conventional DC Type 1 Sub-Population/Conventional DC;DC Myeloid 1 Sub/DCM;Dendritic Cells Myeloid 1 Sub-Population/Dendritic Cells Myeloid;mDC1 Sub-Population/mDC | A relative measurement (ratio or percentage) of a sub-population of type 1 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Type 1 Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement | ||
DC Myeloid 1 | C187738 | cDC1;Classical DC Type 1;Conventional DC Type 1;DC Myeloid 1;DC Myeloid Type 1;Dendritic Cells Myeloid 1;mDC1 | A measurement of the type 1 myeloid dendritic cells in a biological specimen. | Type 1 Myeloid Dendritic Cell Count | ||
DC Myeloid 1/DCM | C187742 | cDC1/cDC;Classical DC Type 1/Classical DC;Conventional DC Type 1/Conventional DC;DC Myeloid 1/DC Myeloid;DC Myeloid 1/DCM;mDC1/mDC | A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Type 1 Myeloid Dendritic Cell to Total Myeloid Dendritic Cell Ratio Measurement | ||
DC Myeloid 1/Leuk | C187741 | cDC1/Leukocytes;Classical DC Type 1/Leukocytes;Conventional DC Type 1/Leukocytes;DC Myeloid 1/Leuk;DC Myeloid 1/Leukocytes;mDC1/Leukocytes | A relative measurement (ratio or percentage) of the type 1 myeloid dendritic cells to leukocytes in a biological specimen. | Type 1 Myeloid Dendritic Cell to Leukocyte Ratio Measurement | ||
DC Myeloid 2 Sub | C187744 | cDC2 Sub-Population;Classical DC Type 2 Sub-Population;Conventional DC Type 2 Sub-Population;DC Myeloid 2 Sub;Dendritic Cells Myeloid 2 Sub-Population;mDC2 Sub-Population | A measurement of a sub-population of type 2 myeloid dendritic cells in a biological specimen. | Type 2 Myeloid Dendritic Cell Subpopulation Count | ||
DC Myeloid 2 Sub/DCM | C187745 | cDC2 Sub-Population/cDC;Classical DC Type 2 Sub-Population/Classical DC;Conventional DC Type 2 Sub-Population/Conventional DC;DC Myeloid 2 Sub/DCM;Dendritic Cells Myeloid 2 Sub-Population/Dendritic Cells Myeloid;mDC2 Sub-Population/mDC | A relative measurement (ratio or percentage) of a sub-population of type 2 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Type 2 Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement | ||
DC Myeloid 2 | C187743 | cDC2;Classical DC Type 2;Conventional DC Type 2;DC Myeloid 2;DC Myeloid Type 2;Dendritic Cells Myeloid 2;mDC2 | A measurement of the type 2 myeloid dendritic cells in a biological specimen. | Type 2 Myeloid Dendritic Cell Count | ||
DC Myeloid 2/DCM | C187747 | cDC2/cDC;Classical DC Type 2/Classical DC;Conventional DC Type 2/Conventional DC;DC Myeloid 2/DC Myeloid;DC Myeloid 2/DCM;mDC2/mDC | A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Type 2 Myeloid Dendritic Cell to Total Myeloid Dendritic Cell Ratio Measurement | ||
DC Myeloid 2/Leuk | C187746 | cDC2/Leukocytes;Classical DC Type 2/Leukocytes;Conventional DC Type 2/Leukocytes;DC Myeloid 2/Leuk;DC Myeloid 2/Leukocytes;mDC2/Leukocytes | A relative measurement (ratio or percentage) of the type 2 myeloid dendritic cells to leukocytes in a biological specimen. | Type 2 Myeloid Dendritic Cell to Leukocyte Ratio Measurement | ||
DC Myeloid Dbl Neg | C198244 | DC Myeloid Dbl Neg;DC Myeloid Double Negative;Dendritic Cells Myeloid Double Negative;mDC DN | A measurement of the double-negative myeloid dendritic cells (any myeloid dendritic cell that is both CD1c-CD141-) in a biological specimen. | Double-Negative Myeloid Dendritic Cell Count | ||
DC Myeloid Dbl Neg/DC Myeloid | C198245 | DC Myeloid Dbl Neg/DC Myeloid;Dendritic Cells Myeloid Double Negative/ Dendritic Cells Myeloid;mDC DN/mDC | A relative measurement (ratio or percentage) of the double negative myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Double-Negative Myeloid Dendritic Cell to Myeloid Dendritic Cell Ratio Measurement | ||
DC Myeloid Sub | C184423 | DC Myeloid Sub;Dendritic Cells Myeloid Sub-Population | A measurement of a sub-population of myeloid dendritic cells in a biological specimen. | Myeloid Dendritic Cell Subpopulation Count | ||
DC Myeloid Sub/DC | C187725 | cDC Sub-Population/DC;Classical DC Sub-Population/DC;Conventional DC Sub-Population/DC;DC Myeloid Sub/DC;Dendritic Cells Myeloid Sub-Population/Dendritic Cells;mDC Sub-Population/DC | A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to total dendritic cells in a biological specimen. | Myeloid Dendritic Cell Subpopulation to Total Dendritic Cell Ratio Measurement | ||
DC Myeloid Sub/DCM | C187672 | cDC Sub-Population/cDC;Classical DC Sub-Population/Classical DC;Conventional DC Sub-Population/Conventional DC;DC Myeloid Sub/DCM;Dendritic Cells Myeloid Sub-Population/Dendritic Cells Myeloid;mDC Sub-Population/mDC | A relative measurement (ratio or percentage) of a sub-population of myeloid dendritic cells to total myeloid dendritic cells in a biological specimen. | Myeloid Dendritic Cell Subpopulation to Total Myeloid Dendritic Cell Ratio Measurement | ||
DC Myeloid | C184350 | cDC;Conventional DC;DC Myeloid;Dendritic Cells Myeloid;mDC | A measurement of the myeloid dendritic cells in a biological specimen. | Myeloid Dendritic Cell Count | ||
DC Myeloid/DC | C187726 | cDC/DC;Classical DC/DC;Conventional DC/DC;DC Myeloid/DC;Dendritic Cells Myeloid/Dendritic Cells;mDC/DC | A relative measurement (ratio or percentage) of the myeloid dendritic cells to total dendritic cells in a biological specimen. | Myeloid Dendritic Cell to Total Dendritic Cell Ratio Measurement | ||
DC Myeloid/Leuk | C187673 | cDC/Leukocytes;Classical DC/Leukocytes;Conventional DC/Leukocytes;DC Myeloid/Leuk;DC Myeloid/Leukocytes;mDC/Leukocytes | A relative measurement (ratio or percentage) of the myeloid dendritic cells to leukocytes in a biological specimen. | Myeloid Dendritic Cell to Leukocyte Ratio Measurement | ||
DC Plasmacytoid Sub | C181270 | DC Plasmacytoid Sub;Plasmacytoid Dendritic Cells Sub-Population | A measurement of a subpopulation of plasmacytoid dendritic cells in a biological specimen. | Plasmacytoid Dendritic Cell Subpopulation Count | ||
DC Plasmacytoid Sub/DC Plasmacytoid | C181271 | DC Plasmacytoid Sub/DC Plasmacytoid;Plasmacytoid Dendritic Cells Sub-Population/Plasmacytoid Dendritic Cells | A relative measurement (ratio or percentage) of a subpopulation of plasmacytoid dendritic cells to total plasmacytoid dendritic cells in a biological specimen. | Plasmacytoid Dendritic Cells Subpopulation to Dendritic Cells Plasmacytoid Ratio Measurement | ||
DC Plasmacytoid | C181195 | DC Plasmacytoid;Plasmacytoid Dendritic Cells | A measurement of the plasmacytoid dendritic cells in a biological specimen. | Plasmacytoid Dendritic Cell Count | ||
DC Plasmacytoid/DC | C181272 | DC Plasmacytoid/DC;DC Plasmacytoid/Dendritic Cells;Plasmacytoid Dendritic Cells/Dendritic Cells | A relative measurement (ratio or percentage) of the plasmacytoid dendritic cells to dendritic cells in a biological specimen. | Plasmacytoid Dendritic Cells to Dendritic Cells Ratio Measurement | ||
DC Sub | C184422 | DC Sub;Dendritic Cells Sub-Population | A measurement of a sub-population of dendritic cells in a biological specimen. | Dendritic Cell Subpopulation Count | ||
Dendritic Cells | C181185 | DC;Dendritic Cells | A measurement of the dendritic cells in a biological specimen. | Dendritic Cells Count | ||
Dendritic Cells/Lym+Mono | C181269 | Dendritic Cells/Lym+Mono;Dendritic Cells/Lymphocytes and Monocytes | A relative measurement (ratio or percentage) of the dendritic cells to lymphocytes and monocytes in a biological specimen. | Dendritic Cells to Lymphocytes and Monocytes Ratio Measurement | ||
Dendritic Cells/Total Cells | C181252 | Dendritic Cells/Total Cells | A relative measurement (ratio or percentage) of the dendritic cells to total cells in a biological specimen. | Dendritic Cells to Total Cells Ratio Measurement | ||
Endothelial Cells | C185967 | Endothelial Cells | A measurement of the endothelial cells in a biological specimen. | Endothelial Cell Count | ||
Eosinophils | C64550 | Eosinophils | A measurement of the eosinophils in a biological specimen. | Eosinophil Count | ||
Eosinophils/Leukocytes | C64604 | Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. | Eosinophil to Leukocyte Ratio | ||
Eosinophils/Nucleated Cells | C150840 | Eosinophils/Nucleated Cells | A relative measurement (ratio or percentage) of eosinophils to nucleated cells in a biological specimen. | Eosinophils to Nucleated Cells Ratio Measurement | ||
Eosinophils/Total Cells | C98720 | Eosinophils/Total Cells | A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). | Eosinophils to Total Cell Ratio Measurement | ||
Epithelial Cells | C64605 | Epithelial Cells | A measurement of the epithelial cells in a biological specimen. | Epithelial Cell Count | ||
Epithelial Cells/Total Cells | C130161 | Epithelial Cells/Total Cells | A relative measurement (ratio or percentage) of the epithelial cells to total cells in a biological specimen. | Epithelial Cells to Total Cells Ratio Measurement | ||
Erythrocytes | C51946 | Erythrocytes;Red Blood Cells | A measurement of the total erythrocytes in a biological specimen. | Erythrocyte Count | ||
Fibroblasts | C185968 | Fibroblasts | A measurement of the fibroblasts in a biological specimen. | Fibroblast Count | ||
Granulocytes | C96654 | Granulocytes;Polymorphonuclear Leukocytes | A measurement of the granulocytes in a biological specimen. | Granulocyte Count | ||
HLADR Expression | C189390 | HLADR Expression | A measurement of cellular HLA-DR expression in a biological specimen. | HLA-DR Cell Surface Expression Measurement | ||
IE Lym | C184424 | IE Lym;Intraepithelial Lymphocytes | A measurement of the intraepithelial lymphocytes in a biological specimen. | Intraepithelial Lymphocyte Count | ||
Immature Monocytes | C96676 | Immature Monocytes | A measurement of the immature monocytes in a biological specimen. | Immature Monocyte Count | ||
Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
Kappa+ PC/Lambda+ PC | C198223 | Kappa+ PC/Lambda+ PC;Kappa+ Plasma Cells/Lambda+ Plasma Cells | A relative measurement (ratio) of the kappa+ plasma cells to lambda+ plasma cells in a biological specimen. | Kappa Positive Plasma Cell to Lambda Positive Plasma Cell Ratio Measurement | ||
Kappa+ Plasma Cells | C198222 | Kappa+ PC;Kappa+ Plasma Cells | A measurement of the kappa+ plasma cells in a biological specimen. | Kappa Positive Plasma Cell Count | ||
Ki67 Expression | C191222 | Ki67 Expression | A measurement of cellular Ki67 expression in a biological specimen. | Ki67 Cell Surface Expression Measurement | ||
Lambda+ Plasma Cells | C198224 | Lambda+ Plasma Cells' Lambda+ PC | A measurement of the lambda+ plasma cells in a biological specimen. | Lambda Positive Plasma Cell Count | ||
Leukocytes | C51948 | Leukocytes;White Blood Cells | A measurement of the leukocytes in a biological specimen. | Leukocyte Count | ||
Leukocytes/Total Cells | C135451 | Leukocytes/Total Cells;WBC/Total Cells | A relative measurement (ratio or percentage) of the leukocytes to total cells in a biological specimen. | Leukocytes to Total Cells Ratio Measurement | ||
Lym Sub | C181275 | Lym Sub;Lymphocytes Sub;Lymphocytes Sub-Population | A measurement of a subpopulation of lymphocytes in a biological specimen. | Lymphocytes Subpopulation Count | ||
Lym Sub/Lym | C181276 | Lym Sub/Lym;Lymphocytes Sub-Population/Lymphocytes;Lymphocytes Sub/Lymphocytes | A relative measurement (ratio or percentage) of a subpopulation of lymphocytes to lymphocytes in a biological specimen. | Lymphocyte Subpopulation to Total Lymphocytes Ratio Measurement | ||
Lym Viable/Lym NonViable | C181277 | Lym Viable/Lym NonViable;Lymphocytes Viable/Lymphocytes Non-Viable;Lymphocytes Viable/Lymphocytes NonViable | A relative measurement (ratio) of viable lymphocytes to non-viable lymphocytes in a biological specimen. | Viable Lymphocytes to Nonviable Lymphocytes Ratio Measurement | ||
Lym+Mono | C181273 | Lym+Mono;Lym+Mono/Leuk;Lymphocytes and Monocytes | A measurement of the leukocytes and monocytes in a biological specimen. | Lymphocytes and Monocytes Count | ||
Lym+Mono/Leuk | C181274 | Lymphocytes and Monocytes/Leukocytes | A relative measurement (ratio or percentage) of the lymphocytes and monocytes to total leukocytes in a biological specimen. | Lymphocytes and Monocytes to Leukocytes Ratio Measurement | ||
Lymphocytes | C51949 | Lymphocytes | A measurement of the lymphocytes in a biological specimen. | Lymphocyte Count | ||
Lymphocytes/Leukocytes | C64820 | Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. | Lymphocyte to Leukocyte Ratio | ||
Lymphocytes/Total Cells | C98751 | Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). | Lymphocyte to Total Cell Ratio Measurement | ||
Macrophages M1 | C185969 | Macrophages M1 | A measurement of the M1 macrophages in a biological specimen. | M1 Macrophage Count | ||
Macrophages M2 | C185970 | Macrophages M2 | A measurement of the M2 macrophages in a biological specimen. | M2 Macrophage Count | ||
Macrophages Sub | C185971 | Macrophages Sub;Macrophages Sub-Population | A measurement of a sub-population of macrophages in a biological specimen. | Macrophage Subpopulation Count | ||
Macrophages | C74798 | Macrophages | A measurement of the macrophages in a biological specimen. | Macrophage Count | ||
Macrophages/Leukocytes | C123460 | Macrophages/Leukocytes | A relative measurement (ratio or percentage) of the macrophages to leukocytes in a biological specimen. | Macrophage to Leukocyte Ratio | ||
Macrophages/Total Cells | C111244 | Macrophages/Total Cells | A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. | Macrophage to Total Cell Ratio Measurement | ||
Mast Cells | C111246 | Mast Cells;Mastocytes | A measurement of the mast cells in a biological specimen. | Mast Cell Count | ||
Mast Cells/Total Cells | C111247 | Mast Cells/Total Cells | A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. | Mast Cell to Total Cell Ratio Measurement | ||
MDSC Dbl Neg Sub | C189386 | Double-Negative Myeloid-Derived Suppressor Cells Sub-Population;MDSC Dbl Neg Sub;MDSC Double-Negative Sub-Population | A measurement of a sub-population of double-negative myeloid-derived suppressor cells in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Subpopulation Count | ||
MDSC Dbl Neg Sub/MDSC Dbl Neg | C189367 | MDSC Dbl Neg Sub/MDSC Dbl Neg;Myeloid-Derived Suppressor Cell Double Negative Sub-Population/Myeloid-Derived Suppressor Cells Double Negative | A relative measurement (ratio or percentage) of a sub-population of double-negative myeloid-derived suppressor cells to all double-negative myeloid-derived suppressor cells in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Cell Subpopulation to Double-Negative Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC Dbl Neg Sub/MDSC | C189324 | MDSC Dbl Neg Sub/MDSC;Myeloid-Derived Suppressor Cell Double Negative Sub-Population/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of a sub-population of double-negative myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC Dbl Neg | C189301 | MDSC Dbl Neg;Myeloid-Derived Suppressor Cells Double Negative | A measurement of the double-negative myeloid-derived suppressor cells (any MDSC that is both CD14-CD15-) in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Cell Count | ||
MDSC Dbl Neg/MDSC | C189375 | MDSC Dbl Neg/MDSC;Myeloid-Derived Suppressor Cells Double Negative/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of the double negative myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Double-Negative Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC Gran Sub | C185972 | MDSC Gran Sub;Myeloid-Derived Suppressor Cells Granulocytic Sub-Population | A measurement of a subpopulation of granulocytic myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell Subpopulation Count | ||
MDSC Gran Sub/MDSC Gran | C189368 | MDSC Gran Sub/MDSC Gran;Myeloid-Derived Suppressor Cells Granulocytic Sub-Population/Myeloid-Derived Suppressor Cells Granulocytic;PMN-MDSC Sub/MDSC Gran | A relative measurement (ratio or percentage) of a sub-population of granulocytic myeloid-derived suppressor cells to all granulocytic myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell Subpopulation to Granulocytic Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC Gran Sub/MDSC | C189325 | MDSC Gran Sub/MDSC;Myeloid-Derived Suppressor Cell Granulocytic Sub-Population/Myeloid-Derived Suppressor Cells;PMN-MDSC Sub/MDSC | A relative measurement (ratio or percentage) of a sub-population of granulocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC Gran | C185906 | G-MDSC;gMDSC;MDSC Gran;Myeloid-Derived Suppressor Cells Granulocytic;PMN-MDSC | A measurement of the granulocytic myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell Count | ||
MDSC Gran/Gran | C189344 | MDSC Gran/Gran;Myeloid-Derived Suppressor Cells Granulocytic/Granulocytes;PMN-MDSC/Gran | A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to total granulocytes in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell to Granulocyte Ratio Measurement | ||
MDSC Gran/Leuk | C189376 | MDSC Gran/Leuk;Myeloid-Derived Suppressor Cells Granulocytic/Leukocytes;PMN-MDSC/Leuk | A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to total leukocytes in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement | ||
MDSC Gran/Lym Sub | C189343 | MDSC Gran/Lym Sub;Myeloid-Derived Suppressor Cells Granulocytic/Lymphocyte Sub-Population;PMN-MDSC/Lym Sub | A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to a sub-population of lymphocytes in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell to Lymphocyte Subpopulation Ratio Measurement | ||
MDSC Gran/MDSC | C189377 | MDSC Gran/MDSC;Myeloid-Derived Suppressor Cells Granulocytic/Myeloid-Derived Suppressor Cells;PMN-MDSC/MDSC | A relative measurement (ratio or percentage) of the granulocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Granulocytic Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC Mono Sub | C185973 | MDSC Mono Sub;Myeloid-Derived Suppressor Cells Monocytic Sub-Population | A measurement of a subpopulation of monocytic myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell Subpopulation Count | ||
MDSC Mono Sub/MDSC Mono | C189369 | M-MDSC Sub/MDSC Mono;MDSC Mono Sub/MDSC Mono;Myeloid-Derived Suppressor Cell Monocytic Sub-Population/Myeloid-Derived Suppressor Cells Monocytic | A relative measurement (ratio or percentage) of a sub-population of monocytic myeloid-derived suppressor cells to all monocytic myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell Subpopulation to Monocytic Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC Mono Sub/MDSC | C189326 | M-MDSC Sub/MDSC;MDSC Mono Sub/MDSC;Myeloid-Derived Suppressor Cell Monocytic Sub-Population/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of a sub-population of monocytic myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC Mono | C185907 | M-MDSC;MDSC Mono;mMDSC;Myeloid-Derived Suppressor Cells Monocytic | A measurement of the monocytic myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell Count | ||
MDSC Mono/Leuk | C189327 | M-MDSC/Leuk;MDSC Mono/Leuk;Myeloid-Derived Suppressor Cells Monocytic/Leukocytes | A relative measurement (ratio or percentage) of the monocytic myeloid-derived suppressor cells to total leukocytes in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement | ||
MDSC Mono/MDSC | C189378 | M-MDSC/MDSC;MDSC Mono/MDSC;Myeloid-Derived Suppressor Cells Monocytic/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of the monocytic myeloid-derived suppressor cells to total myeloid-derived suppressor cells in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC Mono/Mono | C189379 | M-MDSC/Mono;MDSC Mono/Mono;Myeloid-Derived Suppressor Cells Monocytic/Monocytes | A relative measurement (ratio) of the monocytic myeloid-derived suppressor cells to total monocytes in a biological specimen. | Monocytic Myeloid-Derived Suppressor Cell to Monocyte Ratio Measurement | ||
MDSC Sub | C185974 | MDSC Sub;MDSC Sub-Population;Myeloid-Derived Suppressor Cells Sub-Population | A measurement of a subpopulation of myeloid-derived suppressor cells in a biological specimen. | Myeloid-Derived Suppressor Cell Subpopulation Count | ||
MDSC Sub/MDSC Sub | C189370 | MDSC Sub/MDSC Sub;Myeloid-Derived Suppressor Cells Sub-Population/Myeloid-Derived Suppressor Cells Sub-Population | A relative measurement (ratio or percentage) of a sub-population of myeloid-derived suppressor cells to a sub-population of myeloid-derived suppressor cells in a biological specimen. | Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Subpopulation Ratio Measurement | ||
MDSC Sub/MDSC | C189297 | MDSC Sub/MDSC;Myeloid-Derived Suppressor Cell Sub-Population/Myeloid-Derived Suppressor Cells | A relative measurement (ratio or percentage) of a sub-population of myeloid-derived suppressor cells to all myeloid-derived suppressor cells in a biological specimen. | Myeloid-Derived Suppressor Cell Subpopulation to Myeloid-Derived Suppressor Cell Ratio Measurement | ||
MDSC | C185904 | MDSC;Myeloid-Derived Suppressor Cells | A measurement of the myeloid-derived suppressor cells in a biological specimen. | Myeloid-Derived Suppressor Cell Count | ||
MDSC/Leuk | C189298 | MDSC/Leuk;Myeloid-Derived Suppressor Cells/Leukocytes | A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to total leukocytes in a biological specimen. | Myeloid-Derived Suppressor Cell to Leukocyte Ratio Measurement | ||
MDSC/Non-Gran Leuk | C189380 | MDSC/Leuk Non-Gran;MDSC/Non-Gran Leuk;Myeloid-Derived Suppressor Cells/Leukocytes Non-Granulocytic | A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to total non-granulocytic leukocytes in a biological specimen. | Myeloid-Derived Suppressor Cell to Non-Granulocytic Leukocyte Ratio Measurement | ||
MDSC/Non-TBNK Leuk | C189381 | MDSC/Non-TBNK Leuk;MDSC/Non-TBNK Leukocytes;Myeloid-Derived Suppressor Cells/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of the myeloid-derived suppressor cells to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Myeloid-Derived Suppressor Cell to Non-TBNK Leukocyte Ratio Measurement | ||
Megakaryocytes/Leukocytes | C154722 | Megakaryocytes/Leukocytes | A relative measurement (ratio or percentage) of the megakaryocytes to leukocytes in a biological specimen. | Megakaryocytes to Leukocytes Ratio Measurement | ||
Megakaryocytes/Total Cells | C98867 | Megakaryocytes/Total Cells | A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryocyte to Total Cell Ratio Measurement | ||
Mono Classic Sub | C189392 | Mono Classic Sub;Monocytes Classical Sub-Population | A measurement of a sub-population of classical monocytes in a biological specimen. | Classical Monocyte Subpopulation Count | ||
Mono Classic Sub/Mono Classic | C189394 | Mono Classic Sub/Mono Classic;Monocytes Classical Sub-Population/Monocytes Classical | A relative measurement (ratio or percentage) of a sub-population of classical monocytes to total classical monocytes in a biological specimen. | Classical Monocyte Subpopulation to Classical Monocyte Ratio Measurement | ||
Mono Classic Sub/Non-TBNK Leuk | C189371 | Mono Classic Sub-population/Non-TBNK Leukocytes;Mono Classic Sub/Non-TBNK Leuk | A relative measurement (ratio or percentage) of a sub-population of classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Classical Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement | ||
Mono Classic | C181281 | Mono Classic;Monocytes Classical | A measurement of the classical monocytes in a biological specimen. | Classic Monocytes Count | ||
Mono Classic/Mono | C198246 | Mono Classic/Mono;Monocytes Classic/Monocytes;Monocytes Classical/Monocytes | A relative measurement (ratio or percentage) of classical monocytes to monocytes in a biological specimen. | Classical Monocyte to Monocyte Ratio Measurement | ||
Mono Classic/Non-TBNK Leuk | C189382 | Mono Classic/Non-TBNK Leuk;Monocytes Classical/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of the classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Classical Monocyte to Non-TBNK Leukocyte Ratio Measurement | ||
Mono Inflamm | C181282 | Mono Inflamm;Monocytes Inflammatory | A measurement of the inflammatory monocytes in a biological specimen. | Inflammatory Monocytes Count | ||
Mono Intermed Sub | C189395 | Mono Intermed Sub;Monocytes Intermediate Sub-Population | A measurement of a sub-population of intermediate monocytes in a biological specimen. | Intermediate Monocyte Subpopulation Count | ||
Mono Intermed Sub/Mono Intermed | C189372 | Mono Intermed Sub/Mono Int;Mono Intermed Sub/Mono Intermed;Monocytes Intermediate Sub-Population/Monocytes Intermediate | A relative measurement (ratio or percentage) of a sub-population of intermediate monocytes to total intermediate monocytes in a biological specimen. | Intermediate Monocyte Subpopulation to Intermediate Monocyte Ratio Measurement | ||
Mono Intermed Sub/Non-TBNK Leuk | C189373 | Mono Intermed Sub/Non-TBNK;Mono Intermed Sub/Non-TBNK Leuk;Monocytes Intermediate Sub-Population/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of a sub-population of intermediate monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Intermediate Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement | ||
Mono Intermed | C181283 | Mono Intermed;Monocytes Intermediate | A measurement of the intermediate monocytes in a biological specimen. | Intermediate Monocytes Count | ||
Mono Intermed/Leuk | C189299 | Mono Intermed/Leuk;Monocytes Intermediate/Leukocytes | A relative measurement (ratio or percentage) of the intermediate monocytes to total leukocytes in a biological specimen. | Intermediate Monocyte to Leukocyte Ratio Measurement | ||
Mono Intermed/Mono | C198247 | Mono Intermed/Mono;Monocytes Intermediate/Monocytes | A relative measurement (ratio or percentage) of intermediate monocytes to monocytes in a biological specimen. | Intermediate Monocyte to Monocyte Ratio Measurement | ||
Mono Intermed/Non-TBNK Leuk | C189383 | Mono Intermed/Non-TBNK Leuk;Monocytes Intermediate/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of the intermediate monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Intermediate Monocyte to Non-TBNK Leukocyte Ratio Measurement | ||
Mono Mat | C181287 | Mono Mat;Monocytes Mature | A measurement of the mature monocytes in a biological specimen. | Mature Monocytes Count | ||
Mono NonClassic Sub | C189391 | Mono NonClassic Sub;Monocytes Non-Classical Sub-Population | A measurement of a sub-population of non-classical monocytes in a biological specimen. | Non-Classical Monocyte Subpopulation Count | ||
Mono NonClassic Sub/Mono NonClassic | C189393 | Mono NonClassic Sub/Mono NonClassic;Monocytes Non-Classical Sub-Population/Monocytes Non-Classical | A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to total non-classical monocytes in a biological specimen. | Non-Classical Monocyte Subpopulation to Non-Classical Monocyte Ratio Measurement | ||
Mono NonClassic Sub/Non-TBNK Leuk | C189374 | Mono NonClassic Sub/Non-TBNK Leuk;Monocytes Non-Classical Sub-Population/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of a sub-population of non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Non-Classical Monocyte Subpopulation to Non-TBNK Leukocyte Ratio Measurement | ||
Mono NonClassic | C181284 | Mono NonClassic;Monocytes Non-Classical | A measurement of the non-classical monocytes in a biological specimen. | Non-Classical Monocytes Count | ||
Mono NonClassic/Mono | C198248 | Mono NonClassic/Mono | A relative measurement (ratio or percentage) of non-classical monocytes to monocytes in a biological specimen. | Non-Classical Monocyte to Monocyte Ratio Measurement | ||
Mono NonClassic/Non-TBNK Leuk | C189384 | Mono NonClassic/Non-TBNK Leuk;Monocytes Non-Classical/Non-TBNK Leukocytes | A relative measurement (ratio or percentage) of the non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, in a biological specimen. | Non-Classical Monocyte to Non-TBNK Leukocyte Ratio Measurement | ||
Mono Proinflam | C181285 | Mono Proinflam;Monocytes Proinflammatory | A measurement of the pro-inflammatory monocytes in a biological specimen. | Proinflammatory Monocytes Count | ||
Mono Prolif/Mono NonProlif | C181279 | Mono Prolif/Mono NonProlif;Monocytes Prolif/Monocytes NonProlif;Monocytes Proliferating/Monocytes Non-Proliferating | A relative measurement (ratio) of proliferating monocytes to non-proliferating monocytes in a biological specimen. | Proliferating Monocytes to Total Monocytes Non-Proliferating Ratio Measurement | ||
Mono Resident | C181286 | Mono Resident;Monocytes Resident | A measurement of the resident monocytes in a biological specimen. | Resident Monocytes Count | ||
Mono Sub | C181278 | Mono Sub;Monocytes Sub;Monocytes Sub-Population | A measurement of a subpopulation of monocytes in a biological specimen. | Monocytes Subpopulation Count | ||
Mono Sub/Mono | C181280 | Mono Sub/Mono;Monocytes Sub-Population/Monocytes;Monocytes Sub/Monocytes | A relative measurement (ratio or percentage) of a subpopulation of monocytes to monocytes in a biological specimen. | Monocyte Subpopulation to Total Monocytes Ratio Measurement | ||
Mono/Non-TBNK Leuk | C189300 | Mono/Non-TBNK Leuk | A relative measurement (ratio or percentage) of the monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells in a biological specimen. | Monocyte to Non-TBNK Leukocyte Ratio Measurement | ||
Monocytes and Macrophages/Leukocytes | C147396 | Monocytes and Macrophages/Leukocytes | A relative measurement (ratio or percentage) of the monocytes and macrophages to total leukocytes in a biological specimen. | Monocytes and Macrophages to Leukocytes Ratio Measurement | ||
Monocytes | C64823 | Monocytes | A measurement of the monocytes in a biological specimen. | Monocyte Count | ||
Monocytes/Leukocytes | C64824 | Monocytes/Leukocytes | A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. | Monocyte to Leukocyte Ratio | ||
Monocytes/Total Cells | C98872 | Monocytes/Total Cells | A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). | Monocytes to Total Cell Ratio Measurement | ||
Myel Cells | C184425 | Myel Cells;Myeloid Cells | A measurement of the myeloid cells in a biological specimen. | Myeloid Cell Count | ||
Natural Killer Cells | C98762 | Natural Killer Cells | A measurement of the total natural killer cells in a biological specimen. | Natural Killer Cell Count | ||
Natural Killer Cells/Total Cells | C181257 | Natural Killer Cells/Total Cells | A relative measurement (ratio or percentage) of the natural killer cells to total cells in a biological specimen. | Natural Killer Cells to Total Cells Ratio Measurement | ||
Neoplastic Plasma Cells | C172494 | Monoclonal Plasma Cells;Monotypic Plasma Cells;Neoplastic Plasma Cells | A measurement of the neoplastic plasma cells in a biological specimen. | Neoplastic Plasma Cell Count | ||
Neoplastic Plasma Cells/Total Cells | C198249 | Neoplastic Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the neoplastic plasma cells to total cells in a biological specimen. | Neoplastic Plasma Cell to Total Cell Ratio Measurement | ||
Neutrophils | C63321 | Neutrophils | A measurement of the neutrophils in a biological specimen. | Absolute Neutrophil Count | ||
NK Cells Immat Sub | C189422 | Immature Natural Killer Cells Sub-Population;Immature NK Sub-Population;Immature NKC Sub-Population;Natural Killer Cells Immature Sub-Population;NK Cells Immat Sub | A measurement of a sub-population of immature natural killer cells in a biological specimen. | Immature Natural Killer Cell Subpopulation Count | ||
NK Cells Immat Sub/NK Immat | C189397 | Natural Killer Cells Immature Sub-Population/Natural Killer Cells Immature;NK Cells Immat Sub/NK Immat | A relative measurement (ratio or percentage) of a sub-population of immature natural killer cells to total immature natural killer cells in a biological specimen. | Immature Natural Killer Cell Subpopulation to Immature Natural Killer Cell Ratio Measurement | ||
NK Cells Immat | C189308 | Natural Killer Cells Immature;NK Cells Immat | A measurement of the immature natural killer cells in a biological specimen. | Immature Natural Killer Cell Count | ||
NK Cells Immat/Leuk | C189415 | Natural Killer Cells Immature/Leukocytes;NK Cells Immat/Leuk | A relative measurement (ratio or percentage) of the immature natural killer cells to total leukocytes in a biological specimen. | Immature Natural Killer Cell to Leukocyte Ratio Measurement | ||
NK Cells Immat/Lym | C189304 | Natural Killer Cells Immature/Lymphocytes;NK Cells Immat/Lym | A relative measurement (ratio or percentage) of the immature natural killer cells to total lymphocytes in a biological specimen. | Immature Natural Killer Cell to Lymphocyte Ratio Measurement | ||
NK Cells Immat/NK | C189416 | Natural Killer Cells Immature/Natural Killer Cells;NK Cells Immat/NK | A relative measurement (ratio or percentage) of the immature natural killer cells to total natural killer cells in a biological specimen. | Immature Natural Killer Cell to Natural Killer Cell Ratio Measurement | ||
NK Cells Intermed Sub | C189423 | Intermediate Natural Killer Cells Sub-Population;Intermediate NK Sub-Population;Intermediate NKC Sub-Population;Natural Killer Cells Intermediate Sub-Population;NK Cells Intermed Sub | A measurement of a sub-population of intermediate natural killer cells in a biological specimen. | Intermediate Natural Killer Cell Subpopulation Count | ||
NK Cells Intermed Sub/Leuk | C189398 | Natural Killer Cells Intermediate Sub-Population/Leukocytes;NK Cells Intermed Sub/Leuk | A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total leukocytes in a biological specimen. | Intermediate Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement | ||
NK Cells Intermed Sub/Lym | C189399 | Natural Killer Cells Intermediate Sub-Population/Lymphocytes;NK Cells Intermed Sub/Lym | A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total lymphocytes in a biological specimen. | Intermediate Natural Killer Cell Subpopulation to Lymphocyte Ratio Measurement | ||
NK Cells Intermed Sub/NK Intermed | C189400 | Natural Killer Cells Intermediate Sub-Population/Natural Killer Cells Intermediate;NK Cells Intermed Sub/NK Intermed | A relative measurement (ratio or percentage) of a sub-population of intermediate natural killer cells to total intermediate natural killer cells in a biological specimen. | Intermediate Natural Killer Cell Subpopulation to Intermediate Natural Killer Cell Ratio Measurement | ||
NK Cells Intermed | C189309 | Natural Killer Cells Intermediate;NK Cells Intermed | A measurement of the intermediate natural killer cells in a biological specimen. | Intermediate Natural Killer Cell Count | ||
NK Cells Intermed/Leuk | C189417 | Natural Killer Cells Intermediate/Leukocytes;NK Cells Intermed/Leuk | A relative measurement (ratio or percentage) of the intermediate natural killer cells to total leukocytes in a biological specimen. | Intermediate Natural Killer Cell to Leukocyte Ratio Measurement | ||
NK Cells Intermed/Lym | C189305 | Natural Killer Cells Intermediate/Lymphocytes;NK Cells Intermed/Lym | A relative measurement (ratio or percentage) of the intermediate natural killer cells to total lymphocytes in a biological specimen. | Intermediate Natural Killer Cell to Lymphocyte Ratio Measurement | ||
NK Cells Intermed/NK | C189418 | Natural Killer Cells Intermediate/Natural Killer Cells;NK Cells Intermed/NK | A relative measurement (ratio or percentage) of the intermediate natural killer cells to total natural killer cells in a biological specimen. | Intermediate Natural Killer Cell to Natural Killer Cell Ratio Measurement | ||
NK Cells Mat Sub | C189424 | Mature Natural Killer Cells Sub-Population;Mature NK Sub-Population;Mature NKC Sub-Population;Natural Killer Cells Mature Sub-Population;NK Cells Mat Sub | A measurement of a sub-population of mature natural killer cells in a biological specimen. | Mature Natural Killer Cell Subpopulation Count | ||
NK Cells Mat Sub/Leuk | C189401 | Natural Killer Cells Mature Sub-Population/Leukocytes;NK Cells Mat Sub/Leuk | A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total leukocytes in a biological specimen. | Mature Natural Killer Cell Subpopulation to Leukocyte Ratio Measurement | ||
NK Cells Mat Sub/Lym | C189402 | Natural Killer Cells Mature Sub-Population/Lymphocytes;NK Cells Mat Sub/Lym | A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total lymphocytes in a biological specimen. | Mature Natural Killer Cell Subpopulation to Lymphocyte Ratio Measurement | ||
NK Cells Mat Sub/NK Mat | C189403 | Natural Killer Cells Mature Sub-Population/Natural Killer Cells Mature;NK Cells Mat Sub/NK Mat | A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total mature natural killer cells in a biological specimen. | Mature Natural Killer Cell Subpopulation to Mature Natural Killer Cell Ratio Measurement | ||
NK Cells Mat Sub/NK | C189303 | Natural Killer Cells Mature Sub-Population/Natural Killer Cells;NK Cells Mat Sub/NK | A relative measurement (ratio or percentage) of a sub-population of mature natural killer cells to total natural killer cells in a biological specimen. | Mature Natural Killer Cell Subpopulation to Natural Killer Cell Ratio Measurement | ||
NK Cells Mat | C189310 | Natural Killer Cells Mature;NK Cells Mat | A measurement of the mature natural killer cells in a biological specimen. | Mature Natural Killer Cell Count | ||
NK Cells Mat/Leuk | C189419 | Natural Killer Cells Mature/Leukocytes;NK Cells Mat/Leuk | A relative measurement (ratio or percentage) of the mature natural killer cells to total leukocytes in a biological specimen. | Mature Natural Killer Cell to Leukocyte Ratio Measurement | ||
NK Cells Mat/Lym | C189306 | Natural Killer Cells Mature/Lymphocytes;NK Cells Mat/Lym | A relative measurement (ratio or percentage) of the mature natural killer cells to total lymphocytes in a biological specimen. | Mature Natural Killer Cell to Lymphocyte Ratio Measurement | ||
NK Cells Mat/NK | C189420 | Natural Killer Cells Mature/Natural Killer Cells;NK Cells Mat/NK | A relative measurement (ratio or percentage) of the mature natural killer cells to total natural killer cells in a biological specimen. | Mature Natural Killer Cell to Natural Killer Cell Ratio Measurement | ||
NK Cells Sub | C181260 | Natural Killer Cells Sub-Population;NK Cells Sub;NK Cells Sub-Population | A measurement of a subpopulation of natural killer cells in a biological specimen. | Natural Killer Cells Subpopulation Count | ||
NK Cells Sub/NK Cells | C181259 | Natural Killer Cells Sub-Population/Natural Killer Cells;NK Cells Sub/NK Cells | A relative measurement (ratio or percentage) of a sub population of natural killer cells to total natural killer cells in a biological specimen. | Natural Killer Cells Subpopulation to Total Natural Killer Cells Ratio Measurement | ||
NK Cells/Leuk | C181306 | Natural Killer Cells/Leukocytes;NK Cells/Leuk | A relative measurement (ratio or percentage) of the natural killer cells to leukocytes in a biological specimen. | Natural Killer Cells to Leukocytes Ratio Measurement | ||
NK Cells/Lym | C181258 | Natural Killer Cells/Lymphocytes;NK Cells/Lym | A relative measurement (ratio or percentage) of the natural killer cells to lymphocytes in a biological specimen. | Natural Killer Cells to Lymphocytes Ratio Measurement | ||
NK TLym Sub | C185975 | Natural Killer T-Cells Sub-Population;Natural Killer T-Lymphocytes Sub-Population;NK TLym Sub | A measurement of a sub-population of natural killer T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte Subpopulation Count | ||
NK TLym Sub/NKT | C189404 | Natural Killer T-Lymphocytes Sub-Population/Natural Killer T-Lymphocytes;NK TLym Sub/NKT | A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to total natural killer T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte Subpopulation to Natural Killer T-Lymphocyte Ratio Measurement | ||
NK TLym Sub/TLym | C189405 | Natural Killer T-Lymphocytes Sub-Population/T-Lymphocytes;NK TLym Sub/TLym | A relative measurement (ratio or percentage) of a sub-population of natural killer T-lymphocytes to total T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement | ||
NK TLym | C184426 | Natural Killer T-Cells;Natural Killer T-Lymphocytes;NK Tlym | A measurement of the natural killer T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte Count | ||
NK TLym/Lym | C189307 | Natural Killer T-Lymphocytes/Lymphocytes;NK TLym/Lym | A relative measurement (ratio or percentage) of the natural killer T-lymphocytes to total lymphocytes in a biological specimen. | Natural Killer T-Lymphocytes to Lymphocytes Ratio Measurement | ||
NK TLym/TLym | C189421 | Natural Killer T-Lymphocytes/T-Lymphocytes;NK TLym/Tlym | A relative measurement (ratio or percentage) of the natural killer T-lymphocytes to total T-lymphocytes in a biological specimen. | Natural Killer T-Lymphocyte to T-Lymphocyte Ratio Measurement | ||
Non-TBNK Leuk | C189387 | Non-TBNK Leuk;Non-TBNK Leukocytes | A measurement of the leukocytes that are not T-cells, B-cells, or natural killer cells in a biological specimen. | Non-TBNK Leukocyte Count | ||
Non-TBNK Leuk/Leuk | C189385 | Non-TBNK Leuk/Leuk;Non-TBNK Leukocytes/Leukocytes | A relative measurement (ratio or percentage) of the leukocytes that are not T-cells, B-cells, or natural killer cells to total leukocytes in a biological specimen. | Non-TBNK Leukocyte to Leukocyte Ratio Measurement | ||
Plasma Cells Sub | C185977 | Plasma Cells Sub;Plasma Cells Sub-Population;Total Plasma Cells Sub | A measurement of a sub-population of plasma cells in a biological specimen. | Plasma Cell Subpopulation Count | ||
Plasma Cells | C128974 | Total Plasma Cells | A measurement of the total plasma cells in a biological specimen. | Plasma Cell Count | ||
Plasmablasts IgG+ Sub | C187716 | Plasmablasts IgG+ Sub;Plasmablasts IgG+ Sub-Population | A measurement of a sub-population of IgG+ plasmablasts in a biological specimen. | Immunoglobulin G Positive Plasmablast Subpopulation Count | ||
Plasmablasts IgG+ Sub/PB IgG+ | C187717 | Plasmablasts IgG+ Sub-Population/Plasmablasts IgG+;Plasmablasts IgG+ Sub/PB IgG+ | A relative measurement (ratio or percentage) of a sub-population of IgG+ plasmablasts to total IgG+ plasmablasts in a biological specimen. | Immunoglobulin G Positive Plasmablast Subpopulation to Total Immunoglobulin G Positive Plasmablast Ratio Measurement | ||
Plasmablasts IgG+ | C187671 | Plasmablasts IgG+ | A measurement of the IgG+ plasmablasts in a biological specimen. | Immunoglobulin G Positive Plasmablast Count | ||
Plasmablasts IgG+/PB | C187718 | Plasmablasts IgG+/PB;Plasmablasts IgG+/Plasmablasts | A relative measurement (ratio or percentage) of the IgG+ plasmablasts to total plasmablasts in a biological specimen. | Immunoglobulin G Positive Plasmablast to Plasmablast Ratio Measurement | ||
Plasmablasts IgM+ Sub | C187722 | Plasmablasts IgM+ Sub;Plasmablasts IgM+ Sub-Population | A measurement of a sub-population of IgM+ plasmablasts in a biological specimen. | Immunoglobulin M Positive Plasmablast Subpopulation Count | ||
Plasmablasts IgM+ Sub/PB IgM+ | C187723 | Plasmablasts IgG+ Sub-Population/Plasmablasts IgG+;Plasmablasts IgM+ Sub/PB IgM+ | A relative measurement (ratio or percentage) of a sub-population of IgM+ plasmablasts to total IgM+ plasmablasts in a biological specimen. | Immunoglobulin M Positive Plasmablast Subpopulation to Total Immunoglobulin M Positive Plasmablast Ratio Measurement | ||
Plasmablasts IgM+ | C187721 | Plasmablasts IgM+ | A measurement of the IgM+ plasmablasts in a biological specimen. | Immunoglobulin M Positive Plasmablast Count | ||
Plasmablasts IgM+/PB | C187724 | Plasmablasts IgM+/PB;Plasmablasts IgM+/Plasmablasts | A relative measurement (ratio or percentage) of the IgM+ plasmablasts to total plasmablasts in a biological specimen. | Immunoglobulin M Positive Plasmablast to Plasmablast Ratio Measurement | ||
Plasmablasts Sub | C187731 | Plasmablasts Sub;Plasmablasts Sub-Population;Precursor Plasma Cells Sub-Population | A measurement of a sub-population of plasmablasts in a biological specimen. | Plasmablast Subpopulation Count | ||
Plasmablasts Sub/BLym | C187732 | Plasmablasts Sub-Population/B-Lymphocytes;Plasmablasts Sub/BLym | A relative measurement (ratio or percentage) of a sub-population of plasmablasts to B-lymphocytes in a biological specimen. | Plasmablast Subpopulation to B-Lymphocyte Ratio Measurement | ||
Plasmablasts Sub/Leuk | C187733 | Plasmablasts Sub-Population/Leukocytes;Plasmablasts Sub/Leuk | A relative measurement (ratio or percentage) of a sub-population of plasmablasts to leukocytes in a biological specimen. | Plasmablast Subpopulation to Leukocyte Ratio Measurement | ||
Plasmablasts Sub/PB | C187734 | Plasmablasts Sub-Population/Plasmablasts;Plasmablasts Sub/PB | A relative measurement (ratio or percentage) of a sub-population of plasmablasts to total plasmablasts in a biological specimen. | Plasmablast Subpopulation to Total Plasmablast Ratio Measurement | ||
Plasmablasts | C74619 | Plasmablast;Precursor Plasma Cells | A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. | Precursor Plasma Cell Count | ||
Plasmablasts/BLym | C185976 | Plasmablasts/B-Lymphocytes;Plasmablasts/BLym;Precursor Plasma Cells/B-Lymphocytes | A relative measurement (ratio or percentage) of plasmablasts to B-lymphocytes in a biological specimen. | Plasmablasts to Total B-Lymphocytes Ratio Measurement | ||
Platelets Sub | C185978 | Platelets Sub-Population | A measurement of a sub-population of platelets in a biological specimen. | Platelet Subpopulation Count | ||
Platelets | C51951 | Platelets | A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. | Platelet Count | ||
Stimulation Index | C181300 | Stimulation Index | A relative measurement (ratio or percentage) of a cell characteristic or response in the presence of a stimulating agent relative to a non-stimulated control. | Stimulation Index Count | ||
T-Lymphocytes | C122157 | T-Cell Lymphocytes;T-Cells;T-Lymphocytes | A measurement of the total thymocyte-derived lymphocytes in a biological specimen. | T-Lymphocyte Count | ||
Target Bound | C181295 | Target Bound | A measurement of the bound target in a biological specimen, prior to background subtraction. | Target Bound Measurement | ||
Target Bound, Background | C181294 | Target Bound, Background | A measurement of the background associated with the bound target measurement in a biological specimen. | Target Bound, Background Measurement | ||
Target Bound, Delta Bound Background | C181288 | Target Bound, Delta Bound Background | A measurement of the difference between bound target and background target in a biological specimen. | Target, Bound Delta Bound Background Measurement | ||
Target Free | C181296 | Target Free | A measurement of the free target in a biological specimen, prior to background subtraction. | Target Free Measurement | ||
Target Free, Background | C181292 | Target Free, Background | A measurement of the background associated with the free target measurement in a biological specimen. | Target Free, Background Measurement | ||
Target Free, Delta Free Background | C181289 | Target Free, Delta Free Background | A measurement of the difference between free target and free background target in a biological specimen. | Target, Free Delta Free Background Measurement | ||
Target Occupancy | C181291 | Percent Occupancy;Percent Saturation;Target Occupancy | A relative measurement (ratio or percentage) of the specifically bound target to total target in a biological specimen. | Target Occupancy Ratio Measurement | ||
Target Total | C181297 | Target Total | A measurement of the total target in a biological specimen, prior to background subtraction. | Target Total Measurement | ||
Target Total, Background | C181293 | Target Total, Background | A measurement of the background associated with the total target measurement in a biological specimen. | Target Total, Background Measurement | ||
Target Total, Delta Total Background | C181290 | Target Total, Delta Total Background | A measurement of the difference between total target and target total background in a biological specimen. | Target, Total Delta Total Background Measurement | ||
TLym AB Sub | C185980 | T-Lymphocytes Alpha-Beta;TLym AB Sub | A measurement of a sub-population of alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta T-Lymphocyte Subpopulation Count | ||
TLym AB Sub/TLym AB | C189406 | T-Lymphocytes Alpha-Beta Sub-Population/T-Lymphocytes Alpha-Beta;TCR Alpha-Beta T-Cells Sub/TCR Alpha-Beta T-Cells;TLym AB Sub/TLym AB | A relative measurement (ratio or percentage) of a sub-population of alpha-beta T-lymphocytes to total alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta T-Lymphocyte Subpopulation to Alpha-Beta T-Lymphocyte Ratio Measurement | ||
TLym AB | C185979 | T-Lymphocytes Alpha-Beta;TCR Alpha-Beta T-Cells;TLym AB | A measurement of the alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta T-Lymphocyte Count | ||
TLym AB/TLym | C189425 | T-Lymphocytes Alpha-Beta/T-Lymphocytes;TCR Alpha-Beta T-Cells/T-Lymphocytes;TLym AB/TLym | A relative measurement (ratio or percentage) of the alpha-beta T-lymphocytes to total T-lymphocytes in a biological specimen. | Alpha-Beta T-Lymphocyte to T-Lymphocyte Ratio Measurement | ||
TLym Cen Mem | C186268 | T-Lymphocytes Central Memory;TLym Cen Mem | A measurement of the central memory T-lymphocytes in a biological specimen. | Central Memory T-Lymphocyte Count | ||
TLym Cytx AB Sub | C185981 | T-Lymphocytes Cytotoxic Alpha-Beta;TLym Cytx AB Sub | A measurement of a sub-population of cytotoxic alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLym Cytx AB | C185909 | T-Lymphocytes Cytotoxic Alpha-Beta;TLym Cytx AB | A measurement of the cytotoxic alpha-beta T-lymphocytes in a biological specimen. | Cytotoxic Alpha-Beta T-Lymphocyte Count | ||
TLym Cytx Cen Mem Sub | C185982 | T-Lymphocytes Cytotoxic Central Memory Sub-Population;TLym Cytx Cen Mem Sub | A measurement of a sub-population of cytotoxic central memory T-lymphocytes in a biological specimen. | Central Memory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLym Cytx Cen Mem Sub/TLymC | C189407 | T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Cen Mem Sub/TLymC | A relative measurement (ratio or percentage) of a sub-population of central memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Central Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Cen Mem Sub/TLymCCM | C189408 | T-Lymphocytes Cytotoxic Central Memory Sub-Population/T-Lymphocytes Cytotoxic Central Memory;TLym Cytx Cen Mem Sub/TLymCCM | A relative measurement (ratio or percentage) of a sub-population of central memory cytotoxic T-lymphocytes to total central memory cytotoxic T-lymphocytes in a biological specimen. | Central Memory Cytotoxic T-Lymphocyte Subpopulation to Central Memory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Cen Mem | C185911 | T-Lymphocytes Cytotoxic Central Memory;TLym Cytx Cen Mem | A measurement of the cytotoxic central memory T-lymphocytes in a biological specimen. | Central Memory Cytotoxic T-Lymphocyte Count | ||
TLym Cytx Eff Mem Sub | C185983 | T-Lymphocytes Cytotoxic Effector Memory Sub-Population;TLym Cytx Eff Mem Sub | A measurement of a sub-population of cytotoxic effector memory T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLym Cytx Eff Mem Sub/TLymC | C189409 | T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Eff Mem Sub/TLymC | A relative measurement (ratio or percentage) of a sub-population of effector memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Eff Mem Sub/TLymCEM | C189410 | T-Lymphocytes Cytotoxic Effector Memory Sub-Population/T-Lymphocytes Cytotoxic Effector Memory;TLym Cytx Eff Mem Sub/TLymCEM | A relative measurement (ratio or percentage) of a sub-population of effector memory cytotoxic T-lymphocytes to total effector memory cytotoxic T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte Subpopulation to Effector Memory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Eff Mem | C185913 | T-Lymphocytes Cytotoxic Effector Memory;TLym Cytx Eff Mem | A measurement of the cytotoxic effector memory T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte Count | ||
TLym Cytx Eff Mem/TLym Cytx | C191244 | T-Lymphocytes Cytotoxic Effector Memory/T-Lymphocytes Cytotoxic;TLym Cytx Eff Mem/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic effector memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Effector Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Eff Sub | C185984 | T-Lymphocytes Cytotoxic Effector Sub-Population;TLym Cytx Eff Sub | A measurement of a sub-population of cytotoxic effector T-lymphocytes in a biological specimen. | Effector Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLym Cytx Eff | C185912 | T-Lymphocytes Cytotoxic Effector;TLym Cytx Eff | A measurement of the cytotoxic effector T-lymphocytes in a biological specimen. | Effector Cytotoxic T-Lymphocyte Count | ||
TLym Cytx GD Sub | C185985 | T-Lymphocytes Cytotoxic Gamma-Delta;TLym Cytx GD Sub | A measurement of a sub-population of cytotoxic gamma-delta T-lymphocytes in a biological specimen. | Cytotoxic Gamma-Delta T-Lymphocyte Subpopulation Count | ||
TLym Cytx GD | C185910 | T-Lymphocytes Cytotoxic Gamma-Delta;TLym Cytx GD | A measurement of the cytotoxic gamma-delta T-lymphocytes in a biological specimen. | Cytotoxic Gamma-Delta T-Lymphocyte Count | ||
TLym Cytx Mem Sub/TLymC | C189411 | T-Lymphocytes Cytotoxic Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Mem Sub/TLymC | A relative measurement (ratio or percentage) of a sub-population of memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Naive Sub | C185987 | T-Lymphocytes Cytotoxic Naive Sub-Population;TLym Cytx Naive Sub | A measurement of a sub-population of cytotoxic naive T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLym Cytx Naive Sub/TLymC | C189412 | T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Naive Sub/TLymC | A relative measurement (ratio or percentage) of a sub-population of naive cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Naive Sub/TLymCN | C189413 | T-Lymphocytes Cytotoxic Naive Sub-Population/T-Lymphocytes Cytotoxic Naive;TLym Cytx Naive Sub/TLymCN | A relative measurement (ratio or percentage) of a sub-population of naive cytotoxic T-lymphocytes to total naive cytotoxic T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte Subpopulation to Naive Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Naive | C185914 | T-Lymphocytes Cytotoxic Naive;TLym Cytx Naive | A measurement of the cytotoxic naive T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte Count | ||
TLym Cytx Naive/TLym Cytx | C191246 | T-Lymphocytes Cytotoxic Naive/T-Lymphocytes Cytotoxic;TLym Cytx Naive/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic naive T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Naive Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Reg Sub | C185988 | T-Lymphocytes Cytotoxic Regulatory Sub-Population;TLym Cytx Reg Sub | A measurement of a sub-population of cytotoxic regulatory T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLym Cytx Reg Sub/TLym Cytx | C191208 | T-Lymphocytes Cytotoxic Regulatory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Reg Sub/TLym Cytx | A relative measurement (ratio or percentage) of a sub-population of cytotoxic regulatory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Reg Sub/TLymCR | C191247 | T-Lymphocytes Cytotoxic Regulatory Sub-Population/T-Lymphocytes Cytotoxic Regulatory;TLym Cytx Reg Sub/TLymCR | A relative measurement (ratio or percentage) of a sub-population of cytotoxic regulatory T-lymphocytes to total cytotoxic regulatory T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte Subpopulation to Regulatory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Reg | C185915 | T-Lymphocytes Cytotoxic Regulatory;TLym Cytx Reg | A measurement of the cytotoxic regulatory T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte Count | ||
TLym Cytx Reg/TLym Cytx | C191248 | T-Lymphocytes Cytotoxic Regulatory/T-Lymphocytes Cytotoxic;TLym Cytx Reg/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic regulatory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Regulatory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx SC Mem Sub | C191250 | T-Lymphocytes Cytotoxic SC Memory Sub-Population;TLym Cytx SC Mem Sub | A measurement of a sub-population of cytotoxic stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLym Cytx SC Mem Sub/TLym Cytx | C191206 | T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx SC Mem Sub/TLym Cytx | A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx SC Mem Sub/TLymCSCM | C191251 | T-Lymphocytes Cytotoxic Stem Cell Memory Sub-Population/T-Lymphocytes Cytotoxic Stem Cell Memory;TLym Cytx SC Mem Sub/TLymCSCM | A relative measurement (ratio or percentage) of a sub-population of cytotoxic stem cell memory T-lymphocytes to total cytotoxic stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Stem Cell Memory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx SC Mem | C191249 | Cytotoxic Stem Cell Memory T-Lymphocytes;T-Lymphocytes Cytotoxic Stem Cell Memory;TLym Cytx SC Mem;TLymCSCM | A measurement of the cytotoxic stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte Count | ||
TLym Cytx SC Mem/TLym Cytx | C191217 | T-Lymphocytes Cytotoxic Stem Cell Memory/T-Lymphocytes Cytotoxic;TLym Cytx SC Mem/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic stem cell memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx SC Mem/TLymCN | C191218 | T-Lymphocytes Cytotoxic Stem Cell Memory/T-Lymphocytes Cytotoxic Naive;TLym Cytx SC Mem/TLymCN | A relative measurement (ratio or percentage) of the cytotoxic stem cell memory T-lymphocytes to cytotoxic naive T-lymphocytes in a biological specimen. | Stem Cell Memory Cytotoxic T-Lymphocyte to Naive Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Sub | C181299 | Cytotoxic T-Lymphocytes Sub-Population;TLym Cytx Sub | A measurement of the subpopulation of cytotoxic T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLym Cytx Sub/TLym Cytx | C181298 | Cytotoxic T-Lymphocytes Sub-Population/Cytotoxic T-Lymphocytes;TLym Cytx Sub/TLym Cytx | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocyte subpopulation to total cytotoxic T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocyte Subpopulation to Total Cytotoxic T-Lymphocytes Ratio Measurement | ||
TLym Cytx Sub/TLym | C191252 | T-Lymphocytes Cytotoxic Sub-Population/T-Lymphocytes;TLym Cytx Sub/TLym | A relative measurement (ratio or percentage) of a sub-population of cytotoxic T-lymphocytes to total T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement | ||
TLym Cytx Term Mem Sub | C185989 | T-Lymphocytes Cytotoxic Terminal Memory Sub-Population;TLym Cytx Term Mem Sub | A measurement of a sub-population of cytotoxic terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte Subpopulation Count | ||
TLym Cytx Term Mem Sub/TLym Cytx | C191219 | T-Lymphocytes Cytotoxic Terminal Memory Sub-Population/T-Lymphocytes Cytotoxic;TLym Cytx Term Mem Sub/TLym Cytx | A relative measurement (ratio or percentage) of a sub-population of cytotoxic terminal memory T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Term Mem Sub/TLymCTM | C189428 | T-lymphocytes Cytotoxic Terminal Memory Sub-Population/T-lymphocytes Cytotoxic Terminal Memory;TLym Cytx Term Mem Sub/TLymCTM | A relative measurement (ratio or percentage) of a sub-population of terminal memory cytotoxic T-lymphocytes to the total terminal memory cytotoxic T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Terminal Memory Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx Term Mem | C185916 | T-Lymphocytes Cytotoxic Terminal Memory;TLym Cytx Term Mem | A measurement of the cytotoxic terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte Count | ||
TLym Cytx Term Mem/TLymC | C189429 | T-lymphocytes Cytotoxic Terminal Memory/T-lymphocytes Cytotoxic;TLym Cytx Term Mem/TLymC | A relative measurement (ratio or percentage) of the terminal memory cytotoxic T-lymphocytes to total cytotoxic T-lymphocytes in a biological specimen. | Terminal Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement | ||
TLym Cytx | C181186 | Cytotoxic T Cells;Cytotoxic T-Lymphocytes;TLym Cytx | A measurement of the cytotoxic T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocyte Count | ||
TLym Cytx/Leuk | C181254 | T Cells, Cytotoxic/Leukocytes;T-Lymphocytes, Cytotoxic/Leukocytes;TLym Cytx/Leuk | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to leukocytes in a biological specimen. | Cytotoxic T-Lymphocytes to Leukocytes Ratio Measurement | ||
TLym Cytx/Lym | C191245 | T-Lymphocytes Cytotoxic/Lymphocytes;TLym Cytx/Lym | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total lymphocytes in a biological specimen. | Cytotoxic T-Lymphocytes to Lymphocytes Ratio Measurement | ||
TLym Cytx/TLym | C181304 | Cytotoxic T Cells/T Cells;Cytotoxic T-Lymphocytes/T-Lymphocytes;TLym Cytx/TLym | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total T-lymphocytes in a biological specimen. | Cytotoxic T-Lymphocytes to Total T-Lymphocytes Ratio Measurement | ||
TLym Cytx/Total Cells | C181256 | T Cells, Cytotoxic/Total Cells;T-Lym, CTX/Total Cells;T-Lymphocytes, Cytotoxic/Total Cells;TLym Cytx/Total Cells | A relative measurement (ratio or percentage) of the cytotoxic T-lymphocytes to total cells in a biological specimen. | Cytotoxic T-Lymphocytes to Total Cells Ratio Measurement | ||
TLym Eff Mem Sub | C185990 | T-Lymphocytes Effector Memory Sub-Population;TLym Eff Mem Sub | A measurement of a sub-population of effector memory T-lymphocytes in a biological specimen. | Effector Memory T-Lymphocyte Subpopulation Count | ||
TLym Eff Mem | C185908 | T-Lymphocytes Effector Memory;TLym Eff Mem | A measurement of the effector memory T-lymphocytes in a biological specimen. | Effector Memory T-Lymphocyte Count | ||
TLym GD Sub | C185992 | T-Lymphocytes Gamma-Delta;TLym GD Sub | A measurement of a sub-population of gamma-delta T-lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte Subpopulation Count | ||
TLym GD Sub/TLym GD | C189414 | T-Lymphocytes Gamma-Delta Sub-Population/T-Lymphocytes Gamma-Delta;TCR Gamma-Delta T-Cells Sub/TCR Gamma-Delta T-Cells;TLym GD Sub/TLym GD | A relative measurement (ratio or percentage) of a sub-population of gamma-delta T-lymphocytes to total gamma-delta T-lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte Subpopulation to Gamma-Delta T-Lymphocyte Ratio Measurement | ||
TLym GD | C185991 | T-Lymphocytes Gamma-Delta;TCR Gamma-Delta T-Cells;TLym GD | A measurement of the gamma-delta T-lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte Count | ||
TLym GD/Lym | C189302 | T-Lymphocytes Gamma-Delta/Lymphocytes;TCR Gamma-Delta T-Cells/Lymphocyte;TLym GD/Lym | A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to total lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte to Lymphocyte Ratio Measurement | ||
TLym GD/TLym | C189426 | T-Lymphocytes Gamma-Delta/T-Lymphocytes;TCR Gamma-Delta T-Cells/T-Lymphocytes;TLym GD/TLym | A relative measurement (ratio or percentage) of the gamma-delta T-lymphocytes to total T-lymphocytes in a biological specimen. | Gamma-Delta T-Lymphocyte to T-Lymphocyte Ratio Measurement | ||
TLym Help 1 Sub | C185995 | T-Lymphocytes Helper 1 Sub-Population;Th1 Sub;TLym Help 1 Sub | A measurement of a sub-population of helper 1 T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte Subpopulation Count | ||
TLym Help 1 Sub/TLym Help | C191229 | T-Lymphocytes Helper 1 Sub-Population/T-Lymphocytes Helper;TLym Help 1 Sub/TLym Helper | A relative measurement (ratio or percentage) of a sub-population of helper 1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 1 Sub/TLymH1 | C191228 | T-Lymphocytes Helper 1 Sub-Population/T-Lymphocytes Helper 1;TLym Help 1 Sub/TLymH1 | A relative measurement (ratio or percentage) of a sub-population of helper 1 T-lymphocytes to total helper 1 T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte Subpopulation to Helper 1 T-Lymphocyte Ratio Measurement | ||
TLym Help 1 | C185917 | T-Lymphocytes Helper 1;Th1;TLym Help 1 | A measurement of the helper 1 T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte Count | ||
TLym Help 1/TLym Help | C191230 | T-Lymphocytes Helper 1/T-Lymphocytes Helper;TLym Help 1/TLym Help | A relative measurement (ratio or percentage) of the helper 1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 17 Sub | C185994 | T-Lymphocytes Helper 17 Sub-Population;Th17 Sub;TLym Help 17 Su | A measurement of a sub-population of helper 17 T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte Subpopulation Count | ||
TLym Help 17 Sub/TLym Help | C191226 | T-Lymphocytes Helper 17 Sub-Population/T-Lymphocytes Helper;TLym Help 17 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 17 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 17 Sub/TLymH17 | C191225 | T-Lymphocytes Helper 17 Sub-Population/T-Lymphocytes Helper 17;TLym Help 17 Sub/TLymH17 | A relative measurement (ratio or percentage) of a sub-population of helper 17 T-lymphocytes to total helper 17 T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte Subpopulation to Helper 17 T-Lymphocyte Ratio Measurement | ||
TLym Help 17 | C185918 | T-Lymphocytes Helper 17;Th17;TLym Help 17 | A measurement of the helper 17 T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte Count | ||
TLym Help 17.1 Sub | C185993 | T-Lymphocytes Helper 17.1 Sub-Population;Th17.1 Sub;TLym Help 17.1 Sub | A measurement of a sub-population of helper 17.1 T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte Subpopulation Count | ||
TLym Help 17.1 Sub/TLym Help | C191207 | T-Lymphocytes Helper 17.1 Sub-Population/T-Lymphocytes Helper;TLym Help 17.1 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 17.1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 17.1 Sub/TLymH17.1 | C191223 | T-Lymphocytes Helper 17.1 Sub-Population/T-Lymphocytes Helper 17.1;TLym Help 17.1 Sub/TLymH17.1 | A relative measurement (ratio or percentage) of a sub-population of helper 17.1 T-lymphocytes to total helper 17.1 T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte Subpopulation to Helper 17.1 T-Lymphocyte Ratio Measurement | ||
TLym Help 17.1 | C185919 | T-Lymphocytes Helper 17.1;Th17.1;TLym Help 17.1 | A measurement of the helper 17.1 T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte Count | ||
TLym Help 17.1/TLym Help | C191224 | T-Lymphocytes Helper 17.1/T-Lymphocytes Helper;TLym Help 17.1/TLym Help | A relative measurement (ratio or percentage) of the helper 17.1 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 17.1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 17/TLym Help | C191227 | T-Lymphocytes Helper 17/T-Lymphocytes Helper;TLym Help 17/TLym Help | A relative measurement (ratio or percentage) of the helper 17 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 17 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 2 Sub | C185997 | T-Lymphocytes Helper 2 Sub-Population;Th2 Sub;TLym Help 2 Sub | A measurement of a sub-population of helper 2 T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte Subpopulation Count | ||
TLym Help 2 Sub/TLym Help | C191235 | T-Lymphocytes Helper 2 Sub-Population/T-Lymphocytes Helper;TLym Help 2 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 2 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 2 Sub/TLymH2 | C191234 | T-Lymphocytes Helper 2 Sub-Population/T-Lymphocytes Helper 2;TLym Help 2 Sub/TLymH2 | A relative measurement (ratio or percentage) of a sub-population of helper 2 T-lymphocytes to total helper 2 T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte Subpopulation to Helper 2 T-Lymphocyte Ratio Measurement | ||
TLym Help 2 | C185920 | T-Lymphocytes Helper 2;Th2;TLym Help 2 | A measurement of the helper 2 T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte Count | ||
TLym Help 2/TLym Help | C191236 | T-Lymphocytes Helper 2/T-Lymphocytes Helper;TLym Help 2/TLym Help | A relative measurement (ratio or percentage) of the helper 2 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 2 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 22 Sub | C185996 | T-Lymphocytes Helper 22 Sub-Population;Th22 Sub;TLym Help 22 Sub | A measurement of a sub-population of helper 22 T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte Subpopulation Count | ||
TLym Help 22 Sub/TLym Help | C191232 | T-Lymphocytes Helper 22 Sub-Population/T-Lymphocytes Helper;TLym Help 22 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 22 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 22 Sub/TLymH22 | C191231 | T-Lymphocytes Helper 22 Sub-Population/T-Lymphocytes Helper 22;TLym Help 22 Sub/TLymH22 | A relative measurement (ratio or percentage) of a sub-population of helper 22 T-lymphocytes to total helper 22 T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte Subpopulation to Helper 22 T-Lymphocyte Ratio Measurement | ||
TLym Help 22 | C185921 | T-Lymphocytes Helper 22;Th22;TLym Help 22 | A measurement of the helper 22 T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte Count | ||
TLym Help 22/TLym Help | C191233 | T-Lymphocytes Helper 22/T-Lymphocytes Helper;TLym Help 22/TLym Help | A relative measurement (ratio or percentage) of the helper 22 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 22 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 9 Sub | C185998 | T-Lymphocytes Helper 9 Sub-Population;Th9 Sub;TLym Help 9 Sub | A measurement of a sub-population of helper 22 T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte Subpopulation Count | ||
TLym Help 9 Sub/TLym Help | C191238 | T-Lymphocytes Helper 9 Sub-Population/T-Lymphocytes Helper;TLym Help 9 Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper 9 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help 9 Sub/TLymH9 | C191237 | T-Lymphocytes Helper 9 Sub-Population/T-Lymphocytes Helper 9;TLym Help 9 Sub/TLymH9 | A relative measurement (ratio or percentage) of a sub-population of helper 9 T-lymphocytes to total helper 9 T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte Subpopulation to Helper 9 T-Lymphocyte Ratio Measurement | ||
TLym Help 9 | C185922 | T-Lymphocytes Helper 9;Th9;TLym Help 9 | A measurement of the helper 9 T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte Count | ||
TLym Help 9/TLym Help | C191239 | T-Lymphocytes Helper 9/T-Lymphocytes Helper;TLym Help 9/TLym Help | A relative measurement (ratio or percentage) of the helper 9 T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper 9 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help AB Sub | C186000 | T-Lymphocytes Helper Alpha-Beta;TLym Help AB Sub | A measurement of a sub-population of helper alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta Helper T-Lymphocyte Subpopulation Count | ||
TLym Help AB | C185999 | T-Lymphocytes Helper Alpha-Beta;TLym Help AB | A measurement of the helper alpha-beta T-lymphocytes in a biological specimen. | Alpha-Beta Helper T-Lymphocyte Count | ||
TLym Help Cen Mem Sub | C186001 | T-Lymphocytes Helper Central Memory Sub-Population;TLym Help Cen Mem Sub | A measurement of a sub-population of helper central memory T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte Sub-Population Count | ||
TLym Help Cen Mem Sub/TLym Help | C191209 | T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper;TLym Help Cen Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Cen Mem Sub/TLymHCM | C191253 | T-Lymphocytes Helper Central Memory Sub-Population/T-Lymphocytes Helper Central Memory;TLym Help Cen Mem Sub/TLymHCM | A relative measurement (ratio or percentage) of a sub-population of helper central memory T-lymphocytes to total helper central memory T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte Subpopulation to Central Memory Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Cen Mem | C185923 | T-Lymphocytes Helper Central Memory;TLym Help Cen Mem | A measurement of the helper central memory T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte Count | ||
TLym Help Cen Mem/TLym Help | C191254 | T-Lymphocytes Helper Central Memory/T-Lymphocytes Helper;TLym Help Cen Mem/TLym Help | A relative measurement (ratio or percentage) of the helper central memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Central Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Eff Mem Sub | C186002 | T-Lymphocytes Helper Effector Memory Sub-Population;TLym Help Eff Mem Sub | A measurement of a sub-population of helper effector memory T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte Subpopulation Count | ||
TLym Help Eff Mem Sub/TLym Help | C191256 | T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper;TLym Help Eff Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Eff Mem Sub/TLymHEM | C191255 | T-Lymphocytes Helper Effector Memory Sub-Population/T-Lymphocytes Helper Effector Memory;TLym Help Eff Mem Sub/TLymHEM | A relative measurement (ratio or percentage) of a sub-population of helper effector memory T-lymphocytes to total helper effector memory T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte Subpopulation to Effector Memory Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Eff Mem | C185925 | T-Lymphocytes Helper Effector Memory;TLym Help Eff Mem | A measurement of the helper effector memory T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte Count | ||
TLym Help Eff Mem/TLym Help | C191257 | T-Lymphocytes Helper Effector Memory/T-Lymphocytes Helper;TLym Help Eff Mem/TLym Help | A relative measurement (ratio or percentage) of the helper effector memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Effector Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Eff Sub | C186003 | T-Lymphocytes Helper Effector Sub-Population;TLym Help Eff Sub | A measurement of a sub-population of helper effector T-lymphocytes in a biological specimen. | Effector Helper T-Lymphocyte Subpopulation Count | ||
TLym Help Eff | C185924 | T-Lymphocytes Helper Effector;TLym Help Eff | A measurement of the helper effector T-lymphocytes in a biological specimen. | Effector Helper T-Lymphocyte Count | ||
TLym Help Foll Sub | C191258 | Follicular Helper T-Lymphocytes Sub-Population;T-Lymphocytes Helper Follicular Sub-Population;TLym Help Foll Sub | A measurement of a sub-population of follicular helper T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte Subpopulation Count | ||
TLym Help Foll Sub/TLym Help | C191210 | T-Lymphocytes Helper Foll Sub-Population/T-Lymphocytes Helper;TLym Help Foll Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Foll Sub/TLymHF | C191259 | T-Lymphocytes Helper Foll Sub-Population/T-Lymphocytes Helper Follicular;TLym Help Foll Sub/TLymHF | A relative measurement (ratio or percentage) of a sub-population of helper follicular T-lymphocytes to total helper follicular T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte Subpopulation to Follicular Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Foll | C186004 | T-Lymphocytes Helper Follicular;TLym Help Foll | A measurement of the helper follicular T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte Count | ||
TLym Help Foll/TLym Help | C191260 | T-Lymphocytes Helper Foll/T-Lymphocytes Helper;TLym Help Foll/TLym Help | A relative measurement (ratio or percentage) of the helper follicular T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Follicular Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help GD Sub | C186006 | T-Lymphocytes Helper Gamma-Delta;TLym Help GD Sub | A measurement of a sub-population of helper gamma-delta T-lymphocytes in a biological specimen. | Helper Gamma-Delta T-Lymphocyte Subpopulation Count | ||
TLym Help GD | C186005 | T-Lymphocytes Helper Gamma-Delta;TLym Help GD | A measurement of the helper gamma-delta T-lymphocytes in a biological specimen. | Gamma-Delta Helper T-Lymphocyte Count | ||
TLym Help Mem Sub | C186007 | T-Lymphocytes Helper Memory Sub-Population;TLym Help Mem Sub | A measurement of a sub-population of helper memory T-lymphocytes in a biological specimen. | Memory Helper T-Lymphocyte Subpopulation Count | ||
TLym Help Mem Sub/TLym Help | C191262 | T-Lymphocytes Helper Memory Sub-Population/T-Lymphocytes Helper;TLym Help Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Mem | C185926 | T-Lymphocytes Helper Memory;TLym Help Mem | A measurement of the helper memory T-lymphocytes in a biological specimen. | Memory Helper T-Lymphocyte Count | ||
TLym Help Naive Sub | C186008 | T-Lymphocytes Helper Naive Sub-Population;TLym Help Naive Sub | A measurement of a sub-population of helper naive T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte Subpopulation Count | ||
TLym Help Naive Sub/TLym Help | C191264 | T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper;TLym Help Naive Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Naive Sub/TLymHN | C191263 | T-Lymphocytes Helper Naive Sub-Population/T-Lymphocytes Helper Naive;TLym Help Naive Sub/TLymHN | A relative measurement (ratio or percentage) of a sub-population of helper naive T-lymphocytes to total helper naive T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Naive | C185927 | T-Lymphocytes Helper Naive;TLym Help Naive | A measurement of the helper naive T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte Count | ||
TLym Help Naive/TLym Help | C191265 | T-Lymphocytes Helper Naive/T-Lymphocytes Helper;TLym Help Naive/TLym Help | A relative measurement (ratio or percentage) of the helper naive T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Naive Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Reg Eff Sub | C186009 | T-Lymphocytes, Helper Regulatory Effector Sub-Population;TLym Help Reg Eff Sub | A measurement of a sub-population of helper regulatory effector T-lymphocytes in a biological specimen. | Regulatory Effector Helper T-Lymphocyte Subpopulation Count | ||
TLym Help Reg Eff | C185929 | T-Lymphocytes Helper Regulatory Effector;TLym Help Reg Eff | A measurement of the helper regulatory effector T-lymphocytes in a biological specimen. | Regulatory Effector Helper T-Lymphocyte Count | ||
TLym Help Reg Mem Sub | C186010 | T-Lymphocytes Helper Regulatory Memory Sub-Population;TLym Help Reg Mem Sub | A measurement of a sub-population of helper regulatory memory T-lymphocytes in a biological specimen. | Regulatory Memory Helper T-Lymphocyte Subpopulation Count | ||
TLym Help Reg Mem Sub/TLymHRM | C191266 | T-Lymphocytes Helper Regulatory Memory Sub-Population/T-Lymphocytes Helper Regulatory Memory;TLym Help Reg Mem Sub/TLymHRM | A relative measurement (ratio or percentage) of a sub-population of helper regulatory memory T-lymphocytes to total helper regulatory memory T-lymphocytes in a biological specimen. | Regulatory Memory Helper T-Lymphocyte Subpopulation to Regulatory Memory Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Reg Mem | C185930 | T-Lymphocytes Helper Regulatory Memory;TLym Help Reg Mem | A measurement of the helper regulatory memory T-lymphocytes in a biological specimen. | Regulatory Memory Helper T-Lymphocyte Count | ||
TLym Help Reg Mem/TLymHR | C191267 | T-Lymphocytes Helper Regulatory Memory/T-Lymphocytes Helper Regulatory;TLym Help Reg Mem/TLymHR | A relative measurement (ratio or percentage) of the helper regulatory memory T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. | Regulatory Memory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Reg Naive Sub/TLymHR | C191240 | T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory;TLym Help Reg Naive Sub/TLymHR | A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. | Naive Helper Regulatory T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement | ||
TLym Help Reg Naive Sub/TLymHRN | C191268 | T-Lymphocytes Helper Regulatory Naive Sub-Population/T-Lymphocytes Helper Regulatory Naive;TLym Help Reg Naive Sub/TLymHRN | A relative measurement (ratio or percentage) of a sub-population of helper regulatory naive T-lymphocytes to total helper regulatory naive T-lymphocytes in a biological specimen. | Naive Regulatory Helper T-Lymphocyte Subpopulation to Naive Regulatory Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Reg Naive/TLymHR | C191269 | T-Lymphocytes Helper Regulatory Naive/T-Lymphocytes Helper Regulatory;TLym Help Reg Naive/TLymHR | A relative measurement (ratio or percentage) of the helper regulatory naive T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. | Naive Regulatory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Reg Sub | C185928 | T-Lymphocytes Helper Regulatory Sub-Population;TLym Help Reg Sub | A measurement of a sub-population of helper regulatory T-lymphocytes in a biological specimen. | Helper Regulatory T-Lymphocyte Subpopulation Count | ||
TLym Help Reg Sub/TLym Help | C191211 | T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper;TLym Help Reg Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Regulatory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Reg Sub/TLymHR | C191270 | T-Lymphocytes Helper Regulatory Sub-Population/T-Lymphocytes Helper Regulatory;TLym Help Reg Sub/TLymHR | A relative measurement (ratio or percentage) of a sub-population of helper regulatory T-lymphocytes to total helper regulatory T-lymphocytes in a biological specimen. | Regulatory Helper T-Lymphocyte Subpopulation to Regulatory Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Reg | C184428 | T-Lymphocytes Helper Regulatory;TLym Help Reg | A measurement of helper regulatory T-lymphocytes in a biological specimen. | Helper Regulatory T-Lymphocyte Count | ||
TLym Help Reg/Lym | C189396 | T-Lymphocytes Helper Regulatory/Lymphocytes;TLym Help Reg/Lym | A relative measurement (ratio or percentage) of helper regulatory T-lymphocytes to total lymphocytes in a biological specimen. | Helper Regulatory T-Lymphocyte to Lymphocyte Ratio Measurement | ||
TLym Help Reg/TLym Help | C198250 | T-Lymphocytes Helper Regulatory/T-Lymphocytes Helper;TLym Help Reg/TLym Help | A relative measurement (ratio or percentage) of the helper regulatory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Regulatory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help SC Mem Sub | C198252 | T-Lymphocytes Helper Stem Cell Memory Sub-Population;TLym Help SC Mem Sub | A measurement of a sub-population of helper stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Subpopulation Count | ||
TLym Help SC Mem Sub/TLym Help | C191241 | T Lymphocytes Helper Stem Cell Memory Sub-Population/T-Lymphocytes Helper;TLym Help SC Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper stem cell memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help SC Mem Sub/TLymHSCM | C198253 | T-Lymphocytes Helper Stem Cell Memory Sub-Population/T-Lymphocytes Helper Stem Cell Memory;TLym Help SC Mem Sub/TLymHSCM | A relative measurement (ratio or percentage) of a sub-population of helper stem cell memory T-lymphocytes to total helper stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Subpopulation to Stem Cell Memory Helper T-Lymphocyte Ratio Measurement | ||
TLym Help SC Mem | C198251 | T-Lymphocytes Helper Stem Cell Memory;TLym Help SC Mem | A measurement of the helper stem cell memory T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Count | ||
TLym Help SC Mem/TLym Help | C198254 | T-Lymphocytes Helper Stem Cell Memory/T-Lymphocytes Helper;TLym Help SC Mem/TLym Help | A relative measurement (ratio or percentage) of the helper stem cell memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help SC Mem/TLymHN | C191242 | T-Lymphocytes Helper Stem Cell Memory/T-Lymphocytes Helper Naive;TLym Help SC Mem/TLymHN | A relative measurement (ratio or percentage) of the helper stem cell memory T-lymphocytes to total helper naive T-lymphocytes in a biological specimen. | Stem Cell Memory Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Sub | C184351 | T-Lymphocytes Helper Sub-Population;TLym Help Sub | A measurement of a subpopulation of helper T-lymphocytes in a biological specimen. | Helper T-Lymphocyte Subpopulation Count | ||
TLym Help Sub/Lym | C184429 | T-Lymphocytes Helper Subpopulation/Lymphocytes;TLym Help Sub/Lym | A relative measurement (ratio or percentage) of the subpopulation of helper T-lymphocytes to total lymphocytes in a biological specimen. | Helper T-Lymphocyte Subpopulation to Total Lymphocyte Ratio Measurement | ||
TLym Help Sub/TLym Help | C189427 | T-Lymphocytes Helper Sub-Population/Helper T-Lymphocytes;TLym Help Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Term Mem Sub | C186011 | T-Lymphocytes Helper Terminal Memory Sub-Population;TLym Help Term Mem Sub | A measurement of a sub-population of helper terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte Subpopulation Count | ||
TLym Help Term Mem Sub/TLym Help | C198256 | T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper;TLym Help Term Mem Sub/TLym Help | A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Term Mem Sub/TLymHTM | C198255 | T-Lymphocytes Helper Terminal Memory Sub-Population/T-Lymphocytes Helper Terminal Memory;TLym Help Term Mem Sub/TLymHTM | A relative measurement (ratio or percentage) of a sub-population of helper terminal memory T-lymphocytes to total helper terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte Subpopulation to Terminal Memory Helper T-Lymphocyte Ratio Measurement | ||
TLym Help Term Mem | C185931 | T-Lymphocytes Helper Terminal Memory;TLym Help Term Mem | A measurement of the helper terminal memory T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte Count | ||
TLym Help Term Mem/TLym Help | C198257 | T-Lymphocytes Helper Terminal Memory/T-Lymphocytes Helper;TLym Help Term Mem/TLym Help | A relative measurement (ratio or percentage) of the helper terminal memory T-lymphocytes to total helper T-lymphocytes in a biological specimen. | Terminal Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement | ||
TLym Help | C181302 | Helper T Cells;Helper T-Lymphocytes;TLym Help | A measurement of the helper T-lymphocytes in a biological specimen. | Helper T-Lymphocytes Count | ||
TLym Help/Leuk | C181253 | T Cells, Helper/Leukocytes;T-Lymphocytes, Helper/Leukocytes;TLym Help/Leuk | A relative measurement (ratio or percentage) of the helper T-lymphocytes to leukocytes in a biological specimen. | Helper T-Lymphocytes to Leukocytes Ratio Measurement | ||
TLym Help/Lym | C191261 | T-Lymphocytes Helper/Lymphocytes;TLym Help/Lym | A relative measurement (ratio or percentage) of the helper T-lymphocytes to total lymphocytes in a biological specimen. | Helper T-Lymphocyte to Lymphocyte Ratio Measurement | ||
TLym Help/TLym Cytx | C181305 | Helper T Cells/Cytotoxic T Cells;Helper T-Lymphocytes/Cytotoxic T-Lymphocytes;TLym Help/TLym Cytx | A relative measurement (ratio) of the helper T-lymphocytes to cytotoxic T-lymphocytes in a biological specimen. | Helper T-Lymphocytes to Cytotoxic T-Lymphocytes Ratio Measurement | ||
TLym Help/TLym | C181303 | Helper T Cells/T Cells;Helper T-Lymphocytes/T-Lymphocytes;TLym Help/TLym | A relative measurement (ratio or percentage) of the helper T-lymphocytes to total T-lymphocytes in a biological specimen. | Helper T-Lymphocytes to Total T-Lymphocytes Ratio Measurement | ||
TLym Help/Total Cells | C181255 | T Cells, Helper/Total Cells;T-Lym, Helper/Total Cells;T-Lymphocytes, Helper/Total Cells;TLym Help/Total Cells | A relative measurement (ratio or percentage) of the helper T-lymphocytes to total cells in a biological specimen. | Helper T-Lymphocytes to Total Cells Ratio Measurement | ||
TLym Naive | C186012 | T-Lymphocytes Naive;TLym Naive | A measurement of the naive T-lymphocytes in a biological specimen. | Naive T-Lymphocyte Count | ||
TLym Reg | C186013 | T-Lymphocytes Regulatory;TLym Reg | A measurement of the regulatory T-lymphocytes in a biological specimen. | Regulatory T-Lymphocyte Count | ||
TLym Reg/Lym | C187735 | T-Lymphocytes Regulatory/Lymphocytes;TLym Reg/Lym | A relative measurement (ratio or percentage) of the regulatory T-lymphocytes to total lymphocytes in a biological specimen. | Regulatory T-Lymphocyte to Total Lymphocyte Ratio Measurement | ||
TLym Sub | C184427 | T-Lymphocytes Sub-Population;TLym Sub | A measurement of a subpopulation of T-lymphocytes in a biological specimen. | T-Lymphocyte Subpopulation Count | ||
TLym Sub/Lym | C184352 | T-Lymphocytes Sub-Population/Lymphocytes;TLym Sub/Lym | A relative measurement (ratio or percentage) of the subpopulation of T-lymphocytes to total lymphocytes in a biological specimen. | T-Lymphocyte Subpopulation to Total Lymphocyte Ratio Measurement | ||
TLym Sub/TLym | C181261 | T-Lymphocytes Sub-Population/T-Lymphocytes;TLym Sub/Tlym | A relative measurement (ratio or percentage) of the T-lymphocyte subpopulation to total T-lymphocytes in a biological specimen. | T-Lymphocytes Subpopulation to Total T-Lymphocytes Ratio Measurement | ||
TLym Term Mem | C186269 | T-Lymphocytes Terminal Memory;TEMRA;TLym Term Mem | A measurement of the terminal memory T-lymphocytes in a biological specimen. | Terminal Memory T-Lymphocyte Count | ||
TLym/Leuk | C181184 | T Cells/Leukocytes;T-Lymphocytes/Leukocytes;TLym/Leuk | A relative measurement (ratio or percentage) of the T-lymphocytes to leukocytes in a biological specimen. | T-Lymphocytes to Leukocytes Ratio Measurement | ||
TLym/Lym | C181301 | T Cells/Lymphocytes;T-Lymphocytes/Lymphocytes;TLym/Lym | A relative measurement (ratio or percentage) of the T-lymphocytes to total lymphocytes in a biological specimen. | T-Lymphocytes to Lymphocytes Ratio Measurement | ||
Total Plasma Cells/Total Cells | C187987 | Total Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. | Plasma Cell to Total Cell Ratio Measurement | ||
Back to top | ||||||
CL.C181172.CELSTATE | Cell State Response
(CELSTATE) | text
Extensible: Yes | C181172 | Cell State Response | Terminology relevant to the values that describe the subset of the cell population based on a particular functional and/or biological state. | CDISC SDTM Cell State Response Terminology |
ACTIVATED | C64382 | Pertaining to the state of being activated, in which a characteristic function or property has been induced to occur. | Activation | |||
APOPTOTIC | C14156 | Pertaining to the state of being apoptotic, in which programmed cell death is occurring. | Apoptotic | |||
EXHAUSTED | C181246 | Pertaining to the state of being exhausted, in which the entity is functionally inept and incapable of exhibiting the usual array of activities. | Exhaustion | |||
NON-PROLIFERATING | C181247 | Pertaining to the state of non-proliferation, in which the entity is not actively multiplying or increasing in number. | Non-Proliferating | |||
NON-VIABLE | C181248 | Pertaining to the state of being non-viable, in which the entity is not capable of life or normal growth and development. | Non-Viable | |||
PROLIFERATING | C28378 | Pertaining to the state of proliferation, in which the entity is actively multiplying or increasing in number. | Proliferation | |||
SENESCENT | C17467 | Pertaining to the state of being senescent, in which there is irreversible cell-cycle and/or functional arrest related to cell aging or disease. | Senescence | |||
VIABLE | C25324 | Pertaining to the state of being viable, in which the entity is capable of life or normal growth and development. | Viable | |||
Back to top | ||||||
CL.C120989.CPS01TC | Child-Pugh Classification Clinical Classification Test Code
(CPS01TC) | text
Extensible: No | C120989 | Child-Pugh Classification Clinical Classification Test Code | Child-Pugh Classification test code. | CDISC Clinical Classification Child-Pugh Test Code Terminology |
CPS0101 | C121068 | CPS01-Encephalopathy Grade | Child-Pugh Classification - Encephalopathy grade. | Child-Pugh - Encephalopathy Grade | ||
CPS0102 | C121069 | CPS01-Ascites | Child-Pugh Classification - Ascites. | Child-Pugh - Ascites | ||
CPS0103 | C121070 | CPS01-Serum Bilirubin | Child-Pugh Classification - Serum bilirubin, mg/dL. | Child-Pugh - Serum Bilirubin | ||
CPS0104 | C121071 | CPS01-Serum Albumin | Child-Pugh Classification - Serum albumin, g/dL. | Child-Pugh - Serum Albumin | ||
CPS0105A | C121072 | CPS01-PT, Sec Prolonged | Child-Pugh Classification - Prothrombin time, sec prolonged. | Child-Pugh - PT, Sec Prolonged | ||
CPS0105B | C121073 | CPS01-PT, INR | Child-Pugh Classification - Prothrombin time, international normalized ratio (INR). | Child-Pugh - PT, INR | ||
CPS0106 | C121074 | CPS01-Total Score | Child-Pugh Classification - Child-Pugh total score. | Child-Pugh - Total Score | ||
CPS0107 | C121075 | CPS01-Grade | Child-Pugh Classification - Child-Pugh grade. | Child-Pugh - Grade | ||
Back to top | ||||||
CL.C120988.CPS01TN | Child-Pugh Classification Clinical Classification Test Name
(CPS01TN) | text
Extensible: No | C120988 | Child-Pugh Classification Clinical Classification Test Name | Child-Pugh Classification test name. | CDISC Clinical Classification Child-Pugh Test Name Terminology |
CPS01-Ascites | C121069 | CPS01-Ascites | Child-Pugh Classification - Ascites. | Child-Pugh - Ascites | ||
CPS01-Encephalopathy Grade | C121068 | CPS01-Encephalopathy Grade | Child-Pugh Classification - Encephalopathy grade. | Child-Pugh - Encephalopathy Grade | ||
CPS01-Grade | C121075 | CPS01-Grade | Child-Pugh Classification - Child-Pugh grade. | Child-Pugh - Grade | ||
CPS01-PT, INR | C121073 | CPS01-PT, INR | Child-Pugh Classification - Prothrombin time, international normalized ratio (INR). | Child-Pugh - PT, INR | ||
CPS01-PT, Sec Prolonged | C121072 | CPS01-PT, Sec Prolonged | Child-Pugh Classification - Prothrombin time, sec prolonged. | Child-Pugh - PT, Sec Prolonged | ||
CPS01-Serum Albumin | C121071 | CPS01-Serum Albumin | Child-Pugh Classification - Serum albumin, g/dL. | Child-Pugh - Serum Albumin | ||
CPS01-Serum Bilirubin | C121070 | CPS01-Serum Bilirubin | Child-Pugh Classification - Serum bilirubin, mg/dL. | Child-Pugh - Serum Bilirubin | ||
CPS01-Total Score | C121074 | CPS01-Total Score | Child-Pugh Classification - Child-Pugh total score. | Child-Pugh - Total Score | ||
Back to top | ||||||
CL.C154447.CDRS1TC | Children's Depression Rating Scale, Revised Clinical Classification Test Code
(CDRS1TC) | text
Extensible: No | C154447 | Children's Depression Rating Scale, Revised Clinical Classification Test Code | Children's Depression Rating Scale, Revised test code. | CDISC Clinical Classification CDRS-R Test Code Terminology |
CDRS101 | C155329 | CDRS1-Impaired Schoolwork | Children's Depression Rating Scale, Revised - Impaired schoolwork. | CDRS-R - Impaired Schoolwork | ||
CDRS101A | C155330 | CDRS1-Impaired Schoolwork Comment | Children's Depression Rating Scale, Revised - Impaired schoolwork comment. | CDRS-R - Impaired Schoolwork Comment | ||
CDRS102 | C155331 | CDRS1-Difficulty Having Fun | Children's Depression Rating Scale, Revised - Difficulty having fun. | CDRS-R - Difficulty Having Fun | ||
CDRS102A | C155332 | CDRS1-Difficulty Having Fun Comment | Children's Depression Rating Scale, Revised - Difficulty having fun comment. | CDRS-R - Difficulty Having Fun Comment | ||
CDRS103 | C155333 | CDRS1-Social Withdrawal | Children's Depression Rating Scale, Revised - Social withdrawal. | CDRS-R - Social Withdrawal | ||
CDRS103A | C155334 | CDRS1-Social Withdrawal Comment | Children's Depression Rating Scale, Revised - Social withdrawal comment. | CDRS-R - Social Withdrawal Comment | ||
CDRS104 | C155335 | CDRS1-Sleep Disturbance | Children's Depression Rating Scale, Revised - Sleep disturbance. | CDRS-R - Sleep Disturbance | ||
CDRS104A | C155336 | CDRS1-Sleep Disturbance Comment | Children's Depression Rating Scale, Revised - Sleep disturbance comment. | CDRS-R - Sleep Disturbance Comment | ||
CDRS105 | C155337 | CDRS1-Appetite Disturbance | Children's Depression Rating Scale, Revised - Appetite disturbance. | CDRS-R - Appetite Disturbance | ||
CDRS105A | C155338 | CDRS1-Appetite Disturbance Comment | Children's Depression Rating Scale, Revised - Appetite disturbance comment. | CDRS-R - Appetite Disturbance Comment | ||
CDRS106 | C155339 | CDRS1-Excessive Fatigue | Children's Depression Rating Scale, Revised - Excessive fatigue. | CDRS-R - Excessive Fatigue | ||
CDRS106A | C155340 | CDRS1-Excessive Fatigue Comment | Children's Depression Rating Scale, Revised - Excessive fatigue comment. | CDRS-R - Excessive Fatigue Comment | ||
CDRS107 | C155341 | CDRS1-Physical Complaints | Children's Depression Rating Scale, Revised - Physical complaints. | CDRS-R - Physical Complaints | ||
CDRS107A | C155342 | CDRS1-Physical Complaints Comment | Children's Depression Rating Scale, Revised - Physical complaints comment. | CDRS-R - Physical Complaints Comment | ||
CDRS108 | C155343 | CDRS1-Irritability | Children's Depression Rating Scale, Revised - Irritability. | CDRS-R - Irritability | ||
CDRS108A | C155344 | CDRS1-Irritability Comment | Children's Depression Rating Scale, Revised - Irritability comment. | CDRS-R - Irritability Comment | ||
CDRS109 | C155345 | CDRS1-Excessive Guilt | Children's Depression Rating Scale, Revised - Excessive guilt. | CDRS-R - Excessive Guilt | ||
CDRS109A | C155346 | CDRS1-Excessive Guilt Comment | Children's Depression Rating Scale, Revised - Excessive guilt comment. | CDRS-R - Excessive Guilt Comment | ||
CDRS110 | C155347 | CDRS1-Low Self-esteem | Children's Depression Rating Scale, Revised - Low self-esteem. | CDRS-R - Low Self-esteem | ||
CDRS110A | C155348 | CDRS1-Low Self-esteem Comment | Children's Depression Rating Scale, Revised - Low self-esteem comment. | CDRS-R - Low Self-esteem Comment | ||
CDRS111 | C155349 | CDRS1-Depressed Feelings | Children's Depression Rating Scale, Revised - Depressed feelings. | CDRS-R - Depressed Feelings | ||
CDRS111A | C155350 | CDRS1-Depressed Feelings Comment | Children's Depression Rating Scale, Revised - Depressed feelings comment. | CDRS-R - Depressed Feelings Comment | ||
CDRS112 | C155351 | CDRS1-Morbid Ideation | Children's Depression Rating Scale, Revised - Morbid ideation. | CDRS-R - Morbid Ideation | ||
CDRS112A | C155352 | CDRS1-Morbid Ideation Comment | Children's Depression Rating Scale, Revised - Morbid ideation comment. | CDRS-R - Morbid Ideation Comment | ||
CDRS113 | C155353 | CDRS1-Suicidal Ideation | Children's Depression Rating Scale, Revised - Suicidal ideation. | CDRS-R - Suicidal Ideation | ||
CDRS113A | C155354 | CDRS1-Suicidal Ideation Comment | Children's Depression Rating Scale, Revised - Suicidal ideation comment. | CDRS-R - Suicidal Ideation Comment | ||
CDRS114 | C155355 | CDRS1-Excessive Weeping | Children's Depression Rating Scale, Revised - Excessive weeping. | CDRS-R - Excessive Weeping | ||
CDRS114A | C155356 | CDRS1-Excessive Weeping Comment | Children's Depression Rating Scale, Revised - Excessive weeping comment. | CDRS-R - Excessive Weeping Comment | ||
CDRS115 | C155357 | CDRS1-Depressed Facial Affect | Children's Depression Rating Scale, Revised - Depressed facial affect. | CDRS-R - Depressed Facial Affect | ||
CDRS115A | C155358 | CDRS1-Depressed Facial Affect Comment | Children's Depression Rating Scale, Revised - Depressed facial affect comment. | CDRS-R - Depressed Facial Affect Comment | ||
CDRS116 | C155359 | CDRS1-Listless Speech | Children's Depression Rating Scale, Revised - Listless speech. | CDRS-R - Listless Speech | ||
CDRS116A | C155360 | CDRS1-Listless Speech Comment | Children's Depression Rating Scale, Revised - Listless speech comment. | CDRS-R - Listless Speech Comment | ||
CDRS117 | C155361 | CDRS1-Hypoactivity | Children's Depression Rating Scale, Revised - Hypoactivity. | CDRS-R - Hypoactivity | ||
CDRS117A | C155362 | CDRS1-Hypoactivity Comment | Children's Depression Rating Scale, Revised - Hypoactivity comment. | CDRS-R - Hypoactivity Comment | ||
CDRS118 | C155363 | CDRS1-Subtotal 1 | Children's Depression Rating Scale, Revised - Subtotal 1 - sum of questions 1 to 6. | CDRS-R - Subtotal 1 | ||
CDRS119 | C155364 | CDRS1-Subtotal 2 | Children's Depression Rating Scale, Revised - Subtotal 2 - sum of questions 7 to 14. | CDRS-R - Subtotal 2 | ||
CDRS120 | C155365 | CDRS1-Subtotal 3 | Children's Depression Rating Scale, Revised - Subtotal 3 - sum of questions 15 to 17. | CDRS-R - Subtotal 3 | ||
CDRS121 | C155366 | CDRS1-CDRS-R Raw Summary Score | Children's Depression Rating Scale, Revised - CDRS-R raw summary score. | CDRS-R - CDRS-R Raw Summary Score | ||
CDRS122 | C155367 | CDRS1-CDRS-R T-Score | Children's Depression Rating Scale, Revised - CDRS-R T-score. | CDRS-R - CDRS-R T-Score | ||
CDRS123 | C155368 | CDRS1-CDRS-R Percentile | Children's Depression Rating Scale, Revised - CDRS-R Percentile. | CDRS-R - CDRS-R Percentile | ||
CDRS124 | C155369 | CDRS1-CDRS-R T-Score Range | Children's Depression Rating Scale, Revised - CDRS-R T-score range. | CDRS-R - CDRS-R T-Score Range | ||
Back to top | ||||||
CL.C154446.CDRS1TN | Children's Depression Rating Scale, Revised Clinical Classification Test Name
(CDRS1TN) | text
Extensible: No | C154446 | Children's Depression Rating Scale, Revised Clinical Classification Test Name | Children's Depression Rating Scale, Revised test name. | CDISC Clinical Classification CDRS-R Test Name Terminology |
CDRS1-Appetite Disturbance Comment | C155338 | CDRS1-Appetite Disturbance Comment | Children's Depression Rating Scale, Revised - Appetite disturbance comment. | CDRS-R - Appetite Disturbance Comment | ||
CDRS1-Appetite Disturbance | C155337 | CDRS1-Appetite Disturbance | Children's Depression Rating Scale, Revised - Appetite disturbance. | CDRS-R - Appetite Disturbance | ||
CDRS1-CDRS-R Percentile | C155368 | CDRS1-CDRS-R Percentile | Children's Depression Rating Scale, Revised - CDRS-R Percentile. | CDRS-R - CDRS-R Percentile | ||
CDRS1-CDRS-R Raw Summary Score | C155366 | CDRS1-CDRS-R Raw Summary Score | Children's Depression Rating Scale, Revised - CDRS-R raw summary score. | CDRS-R - CDRS-R Raw Summary Score | ||
CDRS1-CDRS-R T-Score Range | C155369 | CDRS1-CDRS-R T-Score Range | Children's Depression Rating Scale, Revised - CDRS-R T-score range. | CDRS-R - CDRS-R T-Score Range | ||
CDRS1-CDRS-R T-Score | C155367 | CDRS1-CDRS-R T-Score | Children's Depression Rating Scale, Revised - CDRS-R T-score. | CDRS-R - CDRS-R T-Score | ||
CDRS1-Depressed Facial Affect Comment | C155358 | CDRS1-Depressed Facial Affect Comment | Children's Depression Rating Scale, Revised - Depressed facial affect comment. | CDRS-R - Depressed Facial Affect Comment | ||
CDRS1-Depressed Facial Affect | C155357 | CDRS1-Depressed Facial Affect | Children's Depression Rating Scale, Revised - Depressed facial affect. | CDRS-R - Depressed Facial Affect | ||
CDRS1-Depressed Feelings Comment | C155350 | CDRS1-Depressed Feelings Comment | Children's Depression Rating Scale, Revised - Depressed feelings comment. | CDRS-R - Depressed Feelings Comment | ||
CDRS1-Depressed Feelings | C155349 | CDRS1-Depressed Feelings | Children's Depression Rating Scale, Revised - Depressed feelings. | CDRS-R - Depressed Feelings | ||
CDRS1-Difficulty Having Fun Comment | C155332 | CDRS1-Difficulty Having Fun Comment | Children's Depression Rating Scale, Revised - Difficulty having fun comment. | CDRS-R - Difficulty Having Fun Comment | ||
CDRS1-Difficulty Having Fun | C155331 | CDRS1-Difficulty Having Fun | Children's Depression Rating Scale, Revised - Difficulty having fun. | CDRS-R - Difficulty Having Fun | ||
CDRS1-Excessive Fatigue Comment | C155340 | CDRS1-Excessive Fatigue Comment | Children's Depression Rating Scale, Revised - Excessive fatigue comment. | CDRS-R - Excessive Fatigue Comment | ||
CDRS1-Excessive Fatigue | C155339 | CDRS1-Excessive Fatigue | Children's Depression Rating Scale, Revised - Excessive fatigue. | CDRS-R - Excessive Fatigue | ||
CDRS1-Excessive Guilt Comment | C155346 | CDRS1-Excessive Guilt Comment | Children's Depression Rating Scale, Revised - Excessive guilt comment. | CDRS-R - Excessive Guilt Comment | ||
CDRS1-Excessive Guilt | C155345 | CDRS1-Excessive Guilt | Children's Depression Rating Scale, Revised - Excessive guilt. | CDRS-R - Excessive Guilt | ||
CDRS1-Excessive Weeping Comment | C155356 | CDRS1-Excessive Weeping Comment | Children's Depression Rating Scale, Revised - Excessive weeping comment. | CDRS-R - Excessive Weeping Comment | ||
CDRS1-Excessive Weeping | C155355 | CDRS1-Excessive Weeping | Children's Depression Rating Scale, Revised - Excessive weeping. | CDRS-R - Excessive Weeping | ||
CDRS1-Hypoactivity Comment | C155362 | CDRS1-Hypoactivity Comment | Children's Depression Rating Scale, Revised - Hypoactivity comment. | CDRS-R - Hypoactivity Comment | ||
CDRS1-Hypoactivity | C155361 | CDRS1-Hypoactivity | Children's Depression Rating Scale, Revised - Hypoactivity. | CDRS-R - Hypoactivity | ||
CDRS1-Impaired Schoolwork Comment | C155330 | CDRS1-Impaired Schoolwork Comment | Children's Depression Rating Scale, Revised - Impaired schoolwork comment. | CDRS-R - Impaired Schoolwork Comment | ||
CDRS1-Impaired Schoolwork | C155329 | CDRS1-Impaired Schoolwork | Children's Depression Rating Scale, Revised - Impaired schoolwork. | CDRS-R - Impaired Schoolwork | ||
CDRS1-Irritability Comment | C155344 | CDRS1-Irritability Comment | Children's Depression Rating Scale, Revised - Irritability comment. | CDRS-R - Irritability Comment | ||
CDRS1-Irritability | C155343 | CDRS1-Irritability | Children's Depression Rating Scale, Revised - Irritability. | CDRS-R - Irritability | ||
CDRS1-Listless Speech Comment | C155360 | CDRS1-Listless Speech Comment | Children's Depression Rating Scale, Revised - Listless speech comment. | CDRS-R - Listless Speech Comment | ||
CDRS1-Listless Speech | C155359 | CDRS1-Listless Speech | Children's Depression Rating Scale, Revised - Listless speech. | CDRS-R - Listless Speech | ||
CDRS1-Low Self-esteem Comment | C155348 | CDRS1-Low Self-esteem Comment | Children's Depression Rating Scale, Revised - Low self-esteem comment. | CDRS-R - Low Self-esteem Comment | ||
CDRS1-Low Self-esteem | C155347 | CDRS1-Low Self-esteem | Children's Depression Rating Scale, Revised - Low self-esteem. | CDRS-R - Low Self-esteem | ||
CDRS1-Morbid Ideation Comment | C155352 | CDRS1-Morbid Ideation Comment | Children's Depression Rating Scale, Revised - Morbid ideation comment. | CDRS-R - Morbid Ideation Comment | ||
CDRS1-Morbid Ideation | C155351 | CDRS1-Morbid Ideation | Children's Depression Rating Scale, Revised - Morbid ideation. | CDRS-R - Morbid Ideation | ||
CDRS1-Physical Complaints Comment | C155342 | CDRS1-Physical Complaints Comment | Children's Depression Rating Scale, Revised - Physical complaints comment. | CDRS-R - Physical Complaints Comment | ||
CDRS1-Physical Complaints | C155341 | CDRS1-Physical Complaints | Children's Depression Rating Scale, Revised - Physical complaints. | CDRS-R - Physical Complaints | ||
CDRS1-Sleep Disturbance Comment | C155336 | CDRS1-Sleep Disturbance Comment | Children's Depression Rating Scale, Revised - Sleep disturbance comment. | CDRS-R - Sleep Disturbance Comment | ||
CDRS1-Sleep Disturbance | C155335 | CDRS1-Sleep Disturbance | Children's Depression Rating Scale, Revised - Sleep disturbance. | CDRS-R - Sleep Disturbance | ||
CDRS1-Social Withdrawal Comment | C155334 | CDRS1-Social Withdrawal Comment | Children's Depression Rating Scale, Revised - Social withdrawal comment. | CDRS-R - Social Withdrawal Comment | ||
CDRS1-Social Withdrawal | C155333 | CDRS1-Social Withdrawal | Children's Depression Rating Scale, Revised - Social withdrawal. | CDRS-R - Social Withdrawal | ||
CDRS1-Subtotal 1 | C155363 | CDRS1-Subtotal 1 | Children's Depression Rating Scale, Revised - Subtotal 1 - sum of questions 1 to 6. | CDRS-R - Subtotal 1 | ||
CDRS1-Subtotal 2 | C155364 | CDRS1-Subtotal 2 | Children's Depression Rating Scale, Revised - Subtotal 2 - sum of questions 7 to 14. | CDRS-R - Subtotal 2 | ||
CDRS1-Subtotal 3 | C155365 | CDRS1-Subtotal 3 | Children's Depression Rating Scale, Revised - Subtotal 3 - sum of questions 15 to 17. | CDRS-R - Subtotal 3 | ||
CDRS1-Suicidal Ideation Comment | C155354 | CDRS1-Suicidal Ideation Comment | Children's Depression Rating Scale, Revised - Suicidal ideation comment. | CDRS-R - Suicidal Ideation Comment | ||
CDRS1-Suicidal Ideation | C155353 | CDRS1-Suicidal Ideation | Children's Depression Rating Scale, Revised - Suicidal ideation. | CDRS-R - Suicidal Ideation | ||
Back to top | ||||||
CL.C120979.CRQ01TC | Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire Test Code
(CRQ01TC) | text
Extensible: No | C120979 | Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire Test Code | Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version test code. | CDISC Questionnaire CRQ-SAS First Administration Version Test Code Terminology |
CRQ0101 | C121010 | CRQ01-Feeling Emotional | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Feeling emotional such as angry or upset. | CRQ-SAS First Administration Version - Feeling Emotional | ||
CRQ0102 | C121011 | CRQ01-Take Care of Basic Needs | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Taking care of your basic needs. | CRQ-SAS First Administration Version - Take Care of Basic Needs | ||
CRQ0103 | C121012 | CRQ01-Walking | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Walking. | CRQ-SAS First Administration Version - Walking | ||
CRQ0104 | C121013 | CRQ01-Performing Chores | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Performing chores. | CRQ-SAS First Administration Version - Performing Chores | ||
CRQ0105 | C121014 | CRQ01-Participate in Social Activities | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Participating in social activities. | CRQ-SAS First Administration Version - Participate in Social Activities | ||
CRQ0106 | C121015 | CRQ01-Felt Frustrated or Impatient | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how much of the time during the last 2 weeks have you felt frustrated or impatient? | CRQ-SAS First Administration Version - Felt Frustrated or Impatient | ||
CRQ0107 | C121016 | CRQ01-Feeling of Fear or Panic | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you have a feeling of fear or panic when you had difficulty getting your breath? | CRQ-SAS First Administration Version - Feeling of Fear or Panic | ||
CRQ0108 | C121017 | CRQ01-Fatigue | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How about fatigue? How tired have you felt over the last 2 weeks? | CRQ-SAS First Administration Version - Fatigue | ||
CRQ0109 | C121018 | CRQ01-Embarrassed by Coughing | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt embarrassed by your coughing or heavy breathing? | CRQ-SAS First Administration Version - Embarrassed by Coughing | ||
CRQ0110 | C121019 | CRQ01-Confident to Deal With Illness | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In the last 2 weeks, how much of the time did you feel very confident and sure that you could deal with your illness? | CRQ-SAS First Administration Version - Feel Confident to Deal With Illness | ||
CRQ0111 | C121020 | CRQ01-Energy | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How much energy have you had in the last 2 weeks? | CRQ-SAS First Administration Version - Energy | ||
CRQ0112 | C121021 | CRQ01-Feel Upset, Worried or Depressed | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how much of the time did you feel upset, worried, or depressed during the last 2 weeks? | CRQ-SAS First Administration Version - Feel Upset, Worried or Depressed | ||
CRQ0113 | C121022 | CRQ01-Control of Breathing Problems | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you feel you had complete control of your breathing problems? | CRQ-SAS First Administration Version - Had Control of Breathing Problems | ||
CRQ0114 | C121023 | CRQ01-Feel Relaxed and Free of Tension | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How much of the time during the last 2 weeks did you feel relaxed and free of tension? | CRQ-SAS First Administration Version - Feel Relaxed and Free of Tension | ||
CRQ0115 | C121024 | CRQ01-Felt Low in Energy | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt low in energy? | CRQ-SAS First Administration Version - Felt Low in Energy | ||
CRQ0116 | C121025 | CRQ01-Felt Discouraged or Down | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how often during the last 2 weeks have you felt discouraged or down in the dumps? | CRQ-SAS First Administration Version - Felt Discouraged or Down | ||
CRQ0117 | C121026 | CRQ01-Felt Worn Out or Sluggish | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt worn out or sluggish? | CRQ-SAS First Administration Version - Felt Worn Out or Sluggish | ||
CRQ0118 | C121027 | CRQ01-Happy, Satisfied or Pleased | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How happy, satisfied, or pleased have you been with your personal life during the last 2 weeks? | CRQ-SAS First Administration Version - Happy, Satisfied or Pleased With Life | ||
CRQ0119 | C121028 | CRQ01-Feel Upset Diff Getting Breath | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you feel upset or scared when you had difficulty getting your breath? | CRQ-SAS First Administration Version - Feel Upset When Had Difficulty Getting Breath | ||
CRQ0120 | C121029 | CRQ01-Felt Restless, Tense or Uptight | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how often during the last 2 weeks have you felt restless, tense, or uptight? | CRQ-SAS First Administration Version - Felt Restless, Tense or Uptight | ||
Back to top | ||||||
CL.C120978.CRQ01TN | Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire Test Name
(CRQ01TN) | text
Extensible: No | C120978 | Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version Questionnaire Test Name | Chronic Respiratory Questionnaire Self-Administered Standardized Format First Administration Version test name. | CDISC Questionnaire CRQ-SAS First Administration Version Test Name Terminology |
CRQ01-Confident to Deal With Illness | C121019 | CRQ01-Confident to Deal With Illness | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In the last 2 weeks, how much of the time did you feel very confident and sure that you could deal with your illness? | CRQ-SAS First Administration Version - Feel Confident to Deal With Illness | ||
CRQ01-Control of Breathing Problems | C121022 | CRQ01-Control of Breathing Problems | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you feel you had complete control of your breathing problems? | CRQ-SAS First Administration Version - Had Control of Breathing Problems | ||
CRQ01-Embarrassed by Coughing | C121018 | CRQ01-Embarrassed by Coughing | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt embarrassed by your coughing or heavy breathing? | CRQ-SAS First Administration Version - Embarrassed by Coughing | ||
CRQ01-Energy | C121020 | CRQ01-Energy | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How much energy have you had in the last 2 weeks? | CRQ-SAS First Administration Version - Energy | ||
CRQ01-Fatigue | C121017 | CRQ01-Fatigue | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How about fatigue? How tired have you felt over the last 2 weeks? | CRQ-SAS First Administration Version - Fatigue | ||
CRQ01-Feel Relaxed and Free of Tension | C121023 | CRQ01-Feel Relaxed and Free of Tension | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How much of the time during the last 2 weeks did you feel relaxed and free of tension? | CRQ-SAS First Administration Version - Feel Relaxed and Free of Tension | ||
CRQ01-Feel Upset Diff Getting Breath | C121028 | CRQ01-Feel Upset Diff Getting Breath | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you feel upset or scared when you had difficulty getting your breath? | CRQ-SAS First Administration Version - Feel Upset When Had Difficulty Getting Breath | ||
CRQ01-Feel Upset, Worried or Depressed | C121021 | CRQ01-Feel Upset, Worried or Depressed | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how much of the time did you feel upset, worried, or depressed during the last 2 weeks? | CRQ-SAS First Administration Version - Feel Upset, Worried or Depressed | ||
CRQ01-Feeling Emotional | C121010 | CRQ01-Feeling Emotional | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Feeling emotional such as angry or upset. | CRQ-SAS First Administration Version - Feeling Emotional | ||
CRQ01-Feeling of Fear or Panic | C121016 | CRQ01-Feeling of Fear or Panic | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks did you have a feeling of fear or panic when you had difficulty getting your breath? | CRQ-SAS First Administration Version - Feeling of Fear or Panic | ||
CRQ01-Felt Discouraged or Down | C121025 | CRQ01-Felt Discouraged or Down | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how often during the last 2 weeks have you felt discouraged or down in the dumps? | CRQ-SAS First Administration Version - Felt Discouraged or Down | ||
CRQ01-Felt Frustrated or Impatient | C121015 | CRQ01-Felt Frustrated or Impatient | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how much of the time during the last 2 weeks have you felt frustrated or impatient? | CRQ-SAS First Administration Version - Felt Frustrated or Impatient | ||
CRQ01-Felt Low in Energy | C121024 | CRQ01-Felt Low in Energy | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt low in energy? | CRQ-SAS First Administration Version - Felt Low in Energy | ||
CRQ01-Felt Restless, Tense or Uptight | C121029 | CRQ01-Felt Restless, Tense or Uptight | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - In general, how often during the last 2 weeks have you felt restless, tense, or uptight? | CRQ-SAS First Administration Version - Felt Restless, Tense or Uptight | ||
CRQ01-Felt Worn Out or Sluggish | C121026 | CRQ01-Felt Worn Out or Sluggish | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How often during the last 2 weeks have you felt worn out or sluggish? | CRQ-SAS First Administration Version - Felt Worn Out or Sluggish | ||
CRQ01-Happy, Satisfied or Pleased | C121027 | CRQ01-Happy, Satisfied or Pleased | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - How happy, satisfied, or pleased have you been with your personal life during the last 2 weeks? | CRQ-SAS First Administration Version - Happy, Satisfied or Pleased With Life | ||
CRQ01-Participate in Social Activities | C121014 | CRQ01-Participate in Social Activities | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Participating in social activities. | CRQ-SAS First Administration Version - Participate in Social Activities | ||
CRQ01-Performing Chores | C121013 | CRQ01-Performing Chores | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Performing chores. | CRQ-SAS First Administration Version - Performing Chores | ||
CRQ01-Take Care of Basic Needs | C121011 | CRQ01-Take Care of Basic Needs | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Taking care of your basic needs. | CRQ-SAS First Administration Version - Take Care of Basic Needs | ||
CRQ01-Walking | C121012 | CRQ01-Walking | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) First Administration Version - Walking. | CRQ-SAS First Administration Version - Walking | ||
Back to top | ||||||
CL.C120981.CRQ02TC | Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire Test Code
(CRQ02TC) | text
Extensible: No | C120981 | Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire Test Code | Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version test code. | CDISC Questionnaire CRQ-SAS Follow-Up Administration Version Test Code Terminology |
CRQ0201 | C121030 | CRQ02-Feeling Emotional | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Feeling emotional such as angry or upset. | CRQ-SAS Follow-Up Administration Version - Feeling Emotional | ||
CRQ0202 | C121031 | CRQ02-Take Care of Basic Needs | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Taking care of your basic needs. | CRQ-SAS Follow-Up Administration Version - Take Care of Basic Needs | ||
CRQ0203 | C121032 | CRQ02-Walking | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Walking. | CRQ-SAS Follow-Up Administration Version - Walking | ||
CRQ0204 | C121033 | CRQ02-Performing Chores | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Performing chores. | CRQ-SAS Follow-Up Administration Version - Performing Chores | ||
CRQ0205 | C121034 | CRQ02-Participate in Social Activities | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Participating in social activities. | CRQ-SAS Follow-Up Administration Version - Participate in Social Activities | ||
CRQ0206 | C121035 | CRQ02-Felt Frustrated or Impatient | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how much of the time during the last 2 weeks have you felt frustrated or impatient? | CRQ-SAS Follow-Up Administration Version - Felt Frustrated or Impatient | ||
CRQ0207 | C121036 | CRQ02-Feeling of Fear or Panic | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you have a feeling of fear or panic when you had difficulty getting your breath? | CRQ-SAS Follow-Up Administration Version - Feeling of Fear or Panic | ||
CRQ0208 | C121037 | CRQ02-Fatigue | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How about fatigue? How tired have you felt over the last 2 weeks? | CRQ-SAS Follow-Up Administration Version - Fatigue | ||
CRQ0209 | C121038 | CRQ02-Embarrassed by Coughing | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt embarrassed by your coughing or heavy breathing? | CRQ-SAS Follow-Up Administration Version - Embarrassed by Coughing | ||
CRQ0210 | C121039 | CRQ02-Confident to Deal With Illness | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In the last 2 weeks, how much of the time did you feel very confident and sure that you could deal with your illness? | CRQ-SAS Follow-Up Administration Version - Feel Confident to Deal With Illness | ||
CRQ0211 | C121040 | CRQ02-Energy | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How much energy have you had in the last 2 weeks? | CRQ-SAS Follow-Up Administration Version - Energy | ||
CRQ0212 | C121041 | CRQ02-Feel Upset, Worried or Depressed | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how much of the time did you feel upset, worried, or depressed during the last 2 weeks? | CRQ-SAS Follow-Up Administration Version - Feel Upset, Worried or Depressed | ||
CRQ0213 | C121042 | CRQ02-Control of Breathing Problems | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you feel you had complete control of your breathing problems? | CRQ-SAS Follow-Up Administration Version - Had Control of Breathing Problems | ||
CRQ0214 | C121043 | CRQ02-Feel Relaxed and Free of Tension | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How much of the time during the last 2 weeks did you feel relaxed and free of tension? | CRQ-SAS Follow-Up Administration Version - Feel Relaxed and Free of Tension | ||
CRQ0215 | C121044 | CRQ02-Felt Low in Energy | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt low in energy? | CRQ-SAS Follow-Up Administration Version - Felt Low in Energy | ||
CRQ0216 | C121045 | CRQ02-Felt Discouraged or Down | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how often during the last 2 weeks have you felt discouraged or down in the dumps? | CRQ-SAS Follow-Up Administration Version - Felt Discouraged or Down | ||
CRQ0217 | C121046 | CRQ02-Felt Worn Out or Sluggish | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt worn out or sluggish? | CRQ-SAS Follow-Up Administration Version - Felt Worn Out or Sluggish | ||
CRQ0218 | C121047 | CRQ02-Happy, Satisfied or Pleased | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How happy, satisfied, or pleased have you been with your personal life during the last 2 weeks? | CRQ-SAS Follow-Up Administration Version - Happy, Satisfied or Pleased With Life | ||
CRQ0219 | C121048 | CRQ02-Feel Upset Diff Getting Breath | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you feel upset or scared when you had difficulty getting your breath? | CRQ-SAS Follow-Up Administration Version - Feel Upset When Had Difficulty Getting Breath | ||
CRQ0220 | C121049 | CRQ02-Felt Restless, Tense or Uptight | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how often during the last 2 weeks have you felt restless, tense, or uptight? | CRQ-SAS Follow-Up Administration Version - Felt Restless, Tense or Uptight | ||
Back to top | ||||||
CL.C120980.CRQ02TN | Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire Test Name
(CRQ02TN) | text
Extensible: No | C120980 | Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version Questionnaire Test Name | Chronic Respiratory Questionnaire Self-Administered Standardized Format Follow-Up Administration Version test name. | CDISC Questionnaire CRQ-SAS Follow-Up Administration Version Test Name Terminology |
CRQ02-Confident to Deal With Illness | C121039 | CRQ02-Confident to Deal With Illness | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In the last 2 weeks, how much of the time did you feel very confident and sure that you could deal with your illness? | CRQ-SAS Follow-Up Administration Version - Feel Confident to Deal With Illness | ||
CRQ02-Control of Breathing Problems | C121042 | CRQ02-Control of Breathing Problems | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you feel you had complete control of your breathing problems? | CRQ-SAS Follow-Up Administration Version - Had Control of Breathing Problems | ||
CRQ02-Embarrassed by Coughing | C121038 | CRQ02-Embarrassed by Coughing | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt embarrassed by your coughing or heavy breathing? | CRQ-SAS Follow-Up Administration Version - Embarrassed by Coughing | ||
CRQ02-Energy | C121040 | CRQ02-Energy | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How much energy have you had in the last 2 weeks? | CRQ-SAS Follow-Up Administration Version - Energy | ||
CRQ02-Fatigue | C121037 | CRQ02-Fatigue | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How about fatigue? How tired have you felt over the last 2 weeks? | CRQ-SAS Follow-Up Administration Version - Fatigue | ||
CRQ02-Feel Relaxed and Free of Tension | C121043 | CRQ02-Feel Relaxed and Free of Tension | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How much of the time during the last 2 weeks did you feel relaxed and free of tension? | CRQ-SAS Follow-Up Administration Version - Feel Relaxed and Free of Tension | ||
CRQ02-Feel Upset Diff Getting Breath | C121048 | CRQ02-Feel Upset Diff Getting Breath | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you feel upset or scared when you had difficulty getting your breath? | CRQ-SAS Follow-Up Administration Version - Feel Upset When Had Difficulty Getting Breath | ||
CRQ02-Feel Upset, Worried or Depressed | C121041 | CRQ02-Feel Upset, Worried or Depressed | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how much of the time did you feel upset, worried, or depressed during the last 2 weeks? | CRQ-SAS Follow-Up Administration Version - Feel Upset, Worried or Depressed | ||
CRQ02-Feeling Emotional | C121030 | CRQ02-Feeling Emotional | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Feeling emotional such as angry or upset. | CRQ-SAS Follow-Up Administration Version - Feeling Emotional | ||
CRQ02-Feeling of Fear or Panic | C121036 | CRQ02-Feeling of Fear or Panic | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks did you have a feeling of fear or panic when you had difficulty getting your breath? | CRQ-SAS Follow-Up Administration Version - Feeling of Fear or Panic | ||
CRQ02-Felt Discouraged or Down | C121045 | CRQ02-Felt Discouraged or Down | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how often during the last 2 weeks have you felt discouraged or down in the dumps? | CRQ-SAS Follow-Up Administration Version - Felt Discouraged or Down | ||
CRQ02-Felt Frustrated or Impatient | C121035 | CRQ02-Felt Frustrated or Impatient | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how much of the time during the last 2 weeks have you felt frustrated or impatient? | CRQ-SAS Follow-Up Administration Version - Felt Frustrated or Impatient | ||
CRQ02-Felt Low in Energy | C121044 | CRQ02-Felt Low in Energy | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt low in energy? | CRQ-SAS Follow-Up Administration Version - Felt Low in Energy | ||
CRQ02-Felt Restless, Tense or Uptight | C121049 | CRQ02-Felt Restless, Tense or Uptight | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - In general, how often during the last 2 weeks have you felt restless, tense, or uptight? | CRQ-SAS Follow-Up Administration Version - Felt Restless, Tense or Uptight | ||
CRQ02-Felt Worn Out or Sluggish | C121046 | CRQ02-Felt Worn Out or Sluggish | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How often during the last 2 weeks have you felt worn out or sluggish? | CRQ-SAS Follow-Up Administration Version - Felt Worn Out or Sluggish | ||
CRQ02-Happy, Satisfied or Pleased | C121047 | CRQ02-Happy, Satisfied or Pleased | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - How happy, satisfied, or pleased have you been with your personal life during the last 2 weeks? | CRQ-SAS Follow-Up Administration Version - Happy, Satisfied or Pleased With Life | ||
CRQ02-Participate in Social Activities | C121034 | CRQ02-Participate in Social Activities | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Participating in social activities. | CRQ-SAS Follow-Up Administration Version - Participate in Social Activities | ||
CRQ02-Performing Chores | C121033 | CRQ02-Performing Chores | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Performing chores. | CRQ-SAS Follow-Up Administration Version - Performing Chores | ||
CRQ02-Take Care of Basic Needs | C121031 | CRQ02-Take Care of Basic Needs | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Taking care of your basic needs. | CRQ-SAS Follow-Up Administration Version - Take Care of Basic Needs | ||
CRQ02-Walking | C121032 | CRQ02-Walking | Chronic Respiratory Questionnaire Self-Administered Standardized Format (CRQ-SAS) Follow-up Administration Version - Walking. | CRQ-SAS Follow-Up Administration Version - Walking | ||
Back to top | ||||||
CL.C119066.CCQ02TC | Clinical COPD Questionnaire 1 Week Version Questionnaire Test Code
(CCQ02TC) | text
Extensible: No | C119066 | Clinical COPD Questionnaire 1 Week Version Questionnaire Test Code | Clinical COPD Questionnaire 1 Week Version test code. | CDISC Questionnaire CCQ 1 Week Version Test Code Terminology |
CCQ0201 | C119132 | CCQ02-Short of Breath at Rest | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Short of breath while at rest? | CCQ 1 Week Version - Short of Breath at Rest | ||
CCQ0202 | C119133 | CCQ02-Short of Breath Physical Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Short of breath while doing physical activities? | CCQ 1 Week Version - Short of Breath Doing Physical Activity | ||
CCQ0203 | C119134 | CCQ02-Concern About Breathing Get Worse | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Concerned about getting a cold or your breathing getting worse? | CCQ 1 Week Version - Concern About Breathing Get Worse | ||
CCQ0204 | C119135 | CCQ02-Depressed for Breathing Problem | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Depressed because of your breathing problems? | CCQ 1 Week Version - Depressed Because of Breathing Problem | ||
CCQ0205 | C119136 | CCQ02-Cough | Clinical COPD Questionnaire 1 Week Version - In general, during the past 7 days, how much of the time: Did you cough? | CCQ 1 Week Version - Did You Cough | ||
CCQ0206 | C119137 | CCQ02-Produce Sputum or Phlegm | Clinical COPD Questionnaire 1 Week Version - In general, during the past 7 days, how much of the time: Did you produce sputum or phlegm? | CCQ 1 Week Version - Produce Sputum or Phlegm | ||
CCQ0207 | C119138 | CCQ02-Breathing Limit Strenuous Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Strenuous physical activities? | CCQ 1 Week Version - Breathing Problems Limit Strenuous Activity | ||
CCQ0208 | C119139 | CCQ02-Breathing Limit Moderate Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Moderate physical activities? | CCQ 1 Week Version - Breathing Problems Limit Moderate Activity | ||
CCQ0209 | C119140 | CCQ02-Breathing Limit Daily Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Daily activities at home? | CCQ 1 Week Version - Breathing Problems Limit Daily Activity | ||
CCQ0210 | C119141 | CCQ02-Breathing Limit Social Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Social activities? | CCQ 1 Week Version - Breathing Problems Limit Social Activity | ||
Back to top | ||||||
CL.C119065.CCQ02TN | Clinical COPD Questionnaire 1 Week Version Questionnaire Test Name
(CCQ02TN) | text
Extensible: No | C119065 | Clinical COPD Questionnaire 1 Week Version Questionnaire Test Name | Clinical COPD Questionnaire 1 Week Version test name. | CDISC Questionnaire CCQ 1 Week Version Test Name Terminology |
CCQ02-Breathing Limit Daily Activity | C119140 | CCQ02-Breathing Limit Daily Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Daily activities at home? | CCQ 1 Week Version - Breathing Problems Limit Daily Activity | ||
CCQ02-Breathing Limit Moderate Activity | C119139 | CCQ02-Breathing Limit Moderate Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Moderate physical activities? | CCQ 1 Week Version - Breathing Problems Limit Moderate Activity | ||
CCQ02-Breathing Limit Social Activity | C119141 | CCQ02-Breathing Limit Social Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Social activities? | CCQ 1 Week Version - Breathing Problems Limit Social Activity | ||
CCQ02-Breathing Limit Strenuous Activity | C119138 | CCQ02-Breathing Limit Strenuous Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how limited were you in these activities because of your breathing problems: Strenuous physical activities? | CCQ 1 Week Version - Breathing Problems Limit Strenuous Activity | ||
CCQ02-Concern About Breathing Get Worse | C119134 | CCQ02-Concern About Breathing Get Worse | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Concerned about getting a cold or your breathing getting worse? | CCQ 1 Week Version - Concern About Breathing Get Worse | ||
CCQ02-Cough | C119136 | CCQ02-Cough | Clinical COPD Questionnaire 1 Week Version - In general, during the past 7 days, how much of the time: Did you cough? | CCQ 1 Week Version - Did You Cough | ||
CCQ02-Depressed for Breathing Problem | C119135 | CCQ02-Depressed for Breathing Problem | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Depressed because of your breathing problems? | CCQ 1 Week Version - Depressed Because of Breathing Problem | ||
CCQ02-Produce Sputum or Phlegm | C119137 | CCQ02-Produce Sputum or Phlegm | Clinical COPD Questionnaire 1 Week Version - In general, during the past 7 days, how much of the time: Did you produce sputum or phlegm? | CCQ 1 Week Version - Produce Sputum or Phlegm | ||
CCQ02-Short of Breath at Rest | C119132 | CCQ02-Short of Breath at Rest | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Short of breath while at rest? | CCQ 1 Week Version - Short of Breath at Rest | ||
CCQ02-Short of Breath Physical Activity | C119133 | CCQ02-Short of Breath Physical Activity | Clinical COPD Questionnaire 1 Week Version - On average, during the past 7 days, how often did you feel: Short of breath while doing physical activities? | CCQ 1 Week Version - Short of Breath Doing Physical Activity | ||
Back to top | ||||||
CL.C119064.CCQ01TC | Clinical COPD Questionnaire 24 Hour Version Questionnaire Test Code
(CCQ01TC) | text
Extensible: No | C119064 | Clinical COPD Questionnaire 24 Hour Version Questionnaire Test Code | Clinical COPD Questionnaire 24 Hour Version test code. | CDISC Questionnaire CCQ 24 Hour Version Test Code Terminology |
CCQ0101 | C119122 | CCQ01-Short of Breath at Rest | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Short of breath while at rest? | CCQ 24 Hour Version - Short of Breath at Rest | ||
CCQ0102 | C119123 | CCQ01-Short of Breath Physical Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Short of breath while doing physical activities? | CCQ 24 Hour Version - Short of Breath Doing Physical Activity | ||
CCQ0103 | C119124 | CCQ01-Concern About Breathing Get Worse | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Concerned about getting a cold or your breathing getting worse? | CCQ 24 Hour Version - Concern About Breathing Get Worse | ||
CCQ0104 | C119125 | CCQ01-Depressed for Breathing Problem | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Depressed because of your breathing problems? | CCQ 24 Hour Version - Depressed Because of Breathing Problem | ||
CCQ0105 | C119126 | CCQ01-Cough | Clinical COPD Questionnaire 24 Hour Version - In general, during the past 24 hours, how much of the time: Did you cough? | CCQ 24 Hour Version - Did You Cough | ||
CCQ0106 | C119127 | CCQ01-Produce Sputum or Phlegm | Clinical COPD Questionnaire 24 Hour Version - In general, during the past 24 hours, how much of the time: Did you produce sputum or phlegm? | CCQ 24 Hour Version - Produce Sputum or Phlegm | ||
CCQ0107 | C119128 | CCQ01-Breathing Limit Strenuous Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Strenuous physical activities? | CCQ 24 Hour Version - Breathing Problems Limit Strenuous Activity | ||
CCQ0108 | C119129 | CCQ01-Breathing Limit Moderate Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Moderate physical activities? | CCQ 24 Hour Version - Breathing Problems Limit Moderate Activity | ||
CCQ0109 | C119130 | CCQ01-Breathing Limit Daily Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Daily activities at home? | CCQ 24 Hour Version - Breathing Problems Limit Daily Activity | ||
CCQ0110 | C119131 | CCQ01-Breathing Limit Social Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Social activities? | CCQ 24 Hour Version - Breathing Problems Limit Social Activity | ||
Back to top | ||||||
CL.C119063.CCQ01TN | Clinical COPD Questionnaire 24 Hour Version Questionnaire Test Name
(CCQ01TN) | text
Extensible: No | C119063 | Clinical COPD Questionnaire 24 Hour Version Questionnaire Test Name | Clinical COPD Questionnaire 24 Hour Version test name. | CDISC Questionnaire CCQ 24 Hour Version Test Name Terminology |
CCQ01-Breathing Limit Daily Activity | C119130 | CCQ01-Breathing Limit Daily Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Daily activities at home? | CCQ 24 Hour Version - Breathing Problems Limit Daily Activity | ||
CCQ01-Breathing Limit Moderate Activity | C119129 | CCQ01-Breathing Limit Moderate Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Moderate physical activities? | CCQ 24 Hour Version - Breathing Problems Limit Moderate Activity | ||
CCQ01-Breathing Limit Social Activity | C119131 | CCQ01-Breathing Limit Social Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Social activities? | CCQ 24 Hour Version - Breathing Problems Limit Social Activity | ||
CCQ01-Breathing Limit Strenuous Activity | C119128 | CCQ01-Breathing Limit Strenuous Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how limited were you in these activities because of your breathing problems: Strenuous physical activities? | CCQ 24 Hour Version - Breathing Problems Limit Strenuous Activity | ||
CCQ01-Concern About Breathing Get Worse | C119124 | CCQ01-Concern About Breathing Get Worse | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Concerned about getting a cold or your breathing getting worse? | CCQ 24 Hour Version - Concern About Breathing Get Worse | ||
CCQ01-Cough | C119126 | CCQ01-Cough | Clinical COPD Questionnaire 24 Hour Version - In general, during the past 24 hours, how much of the time: Did you cough? | CCQ 24 Hour Version - Did You Cough | ||
CCQ01-Depressed for Breathing Problem | C119125 | CCQ01-Depressed for Breathing Problem | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Depressed because of your breathing problems? | CCQ 24 Hour Version - Depressed Because of Breathing Problem | ||
CCQ01-Produce Sputum or Phlegm | C119127 | CCQ01-Produce Sputum or Phlegm | Clinical COPD Questionnaire 24 Hour Version - In general, during the past 24 hours, how much of the time: Did you produce sputum or phlegm? | CCQ 24 Hour Version - Produce Sputum or Phlegm | ||
CCQ01-Short of Breath at Rest | C119122 | CCQ01-Short of Breath at Rest | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Short of breath while at rest? | CCQ 24 Hour Version - Short of Breath at Rest | ||
CCQ01-Short of Breath Physical Activity | C119123 | CCQ01-Short of Breath Physical Activity | Clinical COPD Questionnaire 24 Hour Version - On average, during the past 24 hours, how often did you feel: Short of breath while doing physical activities? | CCQ 24 Hour Version - Short of Breath Doing Physical Activity | ||
Back to top | ||||||
CL.C101811.CDR01TC | Clinical Dementia Rating Questionnaire Test Code
(CDR01TC) | text
Extensible: No | C101811 | Clinical Dementia Rating Questionnaire Test Code | Clinical Dementia Rating test code. | CDISC Questionnaire CDR Test Code Terminology |
CDR0101 | C102050 | CDR01-Memory | Clinical Dementia Rating - Memory. | CDR - Memory | ||
CDR0102 | C102051 | CDR01-Orientation | Clinical Dementia Rating - Orientation. | CDR - Orientation | ||
CDR0103 | C102052 | CDR01-Judgment and Problem Solving | Clinical Dementia Rating - Judgment and problem solving. | CDR - Judgment and Problem Solving | ||
CDR0104 | C102053 | CDR01-Community Affairs | Clinical Dementia Rating - Community affairs. | CDR - Community Affairs | ||
CDR0105 | C102054 | CDR01-Home and Hobbies | Clinical Dementia Rating - Home and hobbies. | CDR - Home and Hobbies | ||
CDR0106 | C102055 | CDR01-Personal Care | Clinical Dementia Rating - Personal care. | CDR - Personal Care | ||
CDR0107 | C113880 | CDR01-Sum of Boxes | Clinical Dementia Rating - Sum of Boxes. | CDR - Sum of Boxes | ||
CDR0108 | C113881 | CDR01-Global CDR | Clinical Dementia Rating - Global CDR. | CDR - Global CDR | ||
Back to top | ||||||
CL.C101812.CDR01TN | Clinical Dementia Rating Questionnaire Test Name
(CDR01TN) | text
Extensible: No | C101812 | Clinical Dementia Rating Questionnaire Test Name | Clinical Dementia Rating test name. | CDISC Questionnaire CDR Test Name Terminology |
CDR01-Community Affairs | C102053 | CDR01-Community Affairs | Clinical Dementia Rating - Community affairs. | CDR - Community Affairs | ||
CDR01-Global CDR | C113881 | CDR01-Global CDR | Clinical Dementia Rating - Global CDR. | CDR - Global CDR | ||
CDR01-Home and Hobbies | C102054 | CDR01-Home and Hobbies | Clinical Dementia Rating - Home and hobbies. | CDR - Home and Hobbies | ||
CDR01-Judgment and Problem Solving | C102052 | CDR01-Judgment and Problem Solving | Clinical Dementia Rating - Judgment and problem solving. | CDR - Judgment and Problem Solving | ||
CDR01-Memory | C102050 | CDR01-Memory | Clinical Dementia Rating - Memory. | CDR - Memory | ||
CDR01-Orientation | C102051 | CDR01-Orientation | Clinical Dementia Rating - Orientation. | CDR - Orientation | ||
CDR01-Personal Care | C102055 | CDR01-Personal Care | Clinical Dementia Rating - Personal care. | CDR - Personal Care | ||
CDR01-Sum of Boxes | C113880 | CDR01-Sum of Boxes | Clinical Dementia Rating - Sum of Boxes. | CDR - Sum of Boxes | ||
Back to top | ||||||
CL.C135686.CGI02TC | Clinical Global Impression Generic Modification Version Questionnaire Test Code
(CGI02TC) | text
Extensible: No | C135686 | Clinical Global Impression Generic Modification Version Questionnaire Test Code | Clinical Global Impression Generic Modification Version test code. | CDISC Questionnaire CGI Generic Modification Version Test Code Terminology |
CGI0201 | C135814 | CGI02-Severity | Clinical Global Impression - Considering your total clinical experience with this particular population, how severe is the subject's condition at this time? | CGI Generic Modification Version - Severity | ||
CGI0202 | C135815 | CGI02-Change | Clinical Global Impression - Rate total change whether or not, in your judgement, it is due entirely to drug treatment. Compared to the subject's condition <at previously assessed protocol specified time point>, how much has the subject changed? | CGI Generic Modification Version - Change | ||
CGI0203 | C135816 | CGI02-Improvement | Clinical Global Impression - Rate total improvement whether or not, in your judgement, it is due entirely to drug treatment. Compared to the subject's condition <at previously assessed protocol specified time point>, how much has the subject improved? | CGI Generic Modification Version - Improvement | ||
Back to top | ||||||
CL.C135685.CGI02TN | Clinical Global Impression Generic Modification Version Questionnaire Test Name
(CGI02TN) | text
Extensible: No | C135685 | Clinical Global Impression Generic Modification Version Questionnaire Test Name | Clinical Global Impression Generic Modification Version test name. | CDISC Questionnaire CGI Generic Modification Version Test Name Terminology |
CGI02-Change | C135815 | CGI02-Change | Clinical Global Impression - Rate total change whether or not, in your judgement, it is due entirely to drug treatment. Compared to the subject's condition <at previously assessed protocol specified time point>, how much has the subject changed? | CGI Generic Modification Version - Change | ||
CGI02-Improvement | C135816 | CGI02-Improvement | Clinical Global Impression - Rate total improvement whether or not, in your judgement, it is due entirely to drug treatment. Compared to the subject's condition <at previously assessed protocol specified time point>, how much has the subject improved? | CGI Generic Modification Version - Improvement | ||
CGI02-Severity | C135814 | CGI02-Severity | Clinical Global Impression - Considering your total clinical experience with this particular population, how severe is the subject's condition at this time? | CGI Generic Modification Version - Severity | ||
Back to top | ||||||
CL.C101813.COWS1TC | Clinical Opiate Withdrawal Scale Questionnaire Test Code
(COWS1TC) | text
Extensible: No | C101813 | Clinical Opiate Withdrawal Scale Questionnaire Test Code | Clinical Opiate Withdrawal Scale test code. | CDISC Questionnaire COWS Test Code Terminology |
COWS101 | C102056 | COWS1-Resting Pulse Rate | Clinical Opiate Withdrawal Scale - Resting pulse rate. | COWS - Resting Pulse Rate | ||
COWS101A | C112467 | COWS1-Resting Pulse Rate Beats/Minute | Clinical Opiate Withdrawal Scale - Resting pulse rate: beats/minute. | COWS - Resting Pulse Rate: Beats/Minute | ||
COWS102 | C102057 | COWS1-Sweating | Clinical Opiate Withdrawal Scale - Sweating. | COWS - Sweating | ||
COWS103 | C102058 | COWS1-Restlessness | Clinical Opiate Withdrawal Scale - Restlessness. | COWS - Restlessness | ||
COWS104 | C102059 | COWS1-Pupil Size | Clinical Opiate Withdrawal Scale - Pupil size. | COWS - Pupil Size | ||
COWS105 | C102060 | COWS1-Bone or Joint Aches | Clinical Opiate Withdrawal Scale - Bone or joint aches. | COWS - Bone or Joint Aches | ||
COWS106 | C102061 | COWS1-Runny Nose or Tearing | Clinical Opiate Withdrawal Scale - Runny nose or tearing. | COWS - Runny Nose or Tearing | ||
COWS107 | C102062 | COWS1-GI Upset | Clinical Opiate Withdrawal Scale - GI upset. | COWS - GI Upset | ||
COWS108 | C102063 | COWS1-Tremor | Clinical Opiate Withdrawal Scale - Tremor. | COWS - Tremor | ||
COWS109 | C102064 | COWS1-Yawning | Clinical Opiate Withdrawal Scale - Yawning. | COWS - Yawning | ||
COWS110 | C102065 | COWS1-Anxiety or Irritability | Clinical Opiate Withdrawal Scale - Anxiety or irritability. | COWS - Anxiety or Irritability | ||
COWS111 | C102066 | COWS1-Gooseflesh Skin | Clinical Opiate Withdrawal Scale - Gooseflesh skin. | COWS - Gooseflesh Skin | ||
COWS112 | C112468 | COWS1-Total Score | Clinical Opiate Withdrawal Scale - Total score. | COWS - Total Score | ||
Back to top | ||||||
CL.C101814.COWS1TN | Clinical Opiate Withdrawal Scale Questionnaire Test Name
(COWS1TN) | text
Extensible: No | C101814 | Clinical Opiate Withdrawal Scale Questionnaire Test Name | Clinical Opiate Withdrawal Scale test name. | CDISC Questionnaire COWS Test Name Terminology |
COWS1-Anxiety or Irritability | C102065 | COWS1-Anxiety or Irritability | Clinical Opiate Withdrawal Scale - Anxiety or irritability. | COWS - Anxiety or Irritability | ||
COWS1-Bone or Joint Aches | C102060 | COWS1-Bone or Joint Aches | Clinical Opiate Withdrawal Scale - Bone or joint aches. | COWS - Bone or Joint Aches | ||
COWS1-GI Upset | C102062 | COWS1-GI Upset | Clinical Opiate Withdrawal Scale - GI upset. | COWS - GI Upset | ||
COWS1-Gooseflesh Skin | C102066 | COWS1-Gooseflesh Skin | Clinical Opiate Withdrawal Scale - Gooseflesh skin. | COWS - Gooseflesh Skin | ||
COWS1-Pupil Size | C102059 | COWS1-Pupil Size | Clinical Opiate Withdrawal Scale - Pupil size. | COWS - Pupil Size | ||
COWS1-Resting Pulse Rate Beats/Minute | C112467 | COWS1-Resting Pulse Rate Beats/Minute | Clinical Opiate Withdrawal Scale - Resting pulse rate: beats/minute. | COWS - Resting Pulse Rate: Beats/Minute | ||
COWS1-Resting Pulse Rate | C102056 | COWS1-Resting Pulse Rate | Clinical Opiate Withdrawal Scale - Resting pulse rate. | COWS - Resting Pulse Rate | ||
COWS1-Restlessness | C102058 | COWS1-Restlessness | Clinical Opiate Withdrawal Scale - Restlessness. | COWS - Restlessness | ||
COWS1-Runny Nose or Tearing | C102061 | COWS1-Runny Nose or Tearing | Clinical Opiate Withdrawal Scale - Runny nose or tearing. | COWS - Runny Nose or Tearing | ||
COWS1-Sweating | C102057 | COWS1-Sweating | Clinical Opiate Withdrawal Scale - Sweating. | COWS - Sweating | ||
COWS1-Total Score | C112468 | COWS1-Total Score | Clinical Opiate Withdrawal Scale - Total score. | COWS - Total Score | ||
COWS1-Tremor | C102063 | COWS1-Tremor | Clinical Opiate Withdrawal Scale - Tremor. | COWS - Tremor | ||
COWS1-Yawning | C102064 | COWS1-Yawning | Clinical Opiate Withdrawal Scale - Yawning. | COWS - Yawning | ||
Back to top | ||||||
CL.C187452.CAP01TC | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Clinical Classification Test Code
(CAP01TC) | text
Extensible: No | C187452 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Clinical Classification Test Code | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version test code. | CDISC Clinical Classification Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Test Code Terminology |
CAP0101A | C187530 | CAP01-Recurrent Distressing Memories | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Recurrent, involuntary, and intrusive distressing memories of the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Memories | ||
CAP0101B | C187531 | CAP01-Recurrent Distressing Recol Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Recollections Frequency | ||
CAP0101C | C187532 | CAP01-Recurrent Distressing Recol Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Recollections Intensity | ||
CAP0102A | C187533 | CAP01-Recurrent Distressing Dream | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Recurrent distressing dreams in which the content and/or affect of the dream is related to the event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream | ||
CAP0102B | C187534 | CAP01-Recurrent Distressing Dream Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent distressing dreams of the event: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream Frequency | ||
CAP0102C | C187535 | CAP01-Recurrent Distressing Dream Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent distressing dreams of the event: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream Intensity | ||
CAP0103A | C187536 | CAP01-Feel as if Event Recurring | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Dissociative reactions (e.g., flashbacks) in which the individual feels or acts as if the traumatic event(s) were recurring. (Such reactions may occur on a continuum, with the most extreme expression being a complete loss of awareness of present surroundings.) | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring | ||
CAP0103B | C187537 | CAP01-Feel as if Event Recurring Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience, illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or when intoxicated.): Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring Frequency | ||
CAP0103C | C187538 | CAP01-Feel as if Event Recurring Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience, illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or when intoxicated.): Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring Intensity | ||
CAP0104A | C187539 | CAP01-Psych Distress at Exposure | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Intense or prolonged psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure | ||
CAP0104B | C187540 | CAP01-Psych Distress at Exposure Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Intense psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure Frequency | ||
CAP0104C | C187541 | CAP01-Psych Distress at Exposure Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Intense psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure Intensity | ||
CAP0105A | C187542 | CAP01-Physiological React to Cues | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Marked physiological reactions to internal or external cues that symbolize or resemble an aspect of the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues | ||
CAP0105B | C187543 | CAP01-Physiological React to Cues Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues Frequency | ||
CAP0105C | C187544 | CAP01-Physiological React to Cues Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues Intensity | ||
CAP0106A | C187545 | CAP01-Avoid Thoughts Associated | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Avoidance or efforts to avoid distressing memories, thoughts, or feelings about or closely associated with the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated | ||
CAP0106B | C187546 | CAP01-Avoid Thoughts Associated Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid thoughts, feelings, or conversations associated with the trauma: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated Frequency | ||
CAP0106C | C187547 | CAP01-Avoid Thoughts Associated Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid thoughts, feelings, or conversations associated with the trauma: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated Intensity | ||
CAP0107A | C187548 | CAP01-Efforts to Avoid External Reminder | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Avoidance or efforts to avoid external reminders (people, places, conversations, activities, objects, situations) that arouse distressing memories, thoughts, or feelings about or closely associated with the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid External Reminder | ||
CAP0107B | C187549 | CAP01-Efforts to Avoid Activities Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid activities, places, or people that arouse recollections of the trauma: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid Activities Frequency | ||
CAP0107C | C187550 | CAP01-Efforts to Avoid Activities Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid activities, places, or people that arouse recollections of the trauma: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid Activities Intensity | ||
CAP0108A | C187551 | CAP01-Inability to Remember Aspect | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Inability to remember an important aspect of the traumatic event(s) (typically dissociative amnesia that is not due to head injury, alcohol, or drugs). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Remember Aspect | ||
CAP0108B | C187552 | CAP01-Inability to Recall Aspect Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Inability to recall an important aspect of the trauma: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Recall Aspect Frequency | ||
CAP0108C | C187553 | CAP01-Inability to Recall Aspect Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Inability to recall an important aspect of the trauma: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Recall Aspect Intensity | ||
CAP0109 | C187554 | CAP01-Persistent Exaggerated Neg Beliefs | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent and exaggerated negative beliefs or expectations about oneself, others, or the world (e.g., "I am bad," "No one can be trusted," "The world is completely dangerous"). (Alternatively, this might be expressed as, e.g., "I've lost my soul forever," "My whole nervous system is permanently ruined."). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Exaggerated Negative Beliefs | ||
CAP0110 | C187555 | CAP01-Persistent Blame of Self/Others | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent, distorted blame of self or others about the cause or consequences of the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Blame of Self or Others | ||
CAP0111 | C187556 | CAP01-Persistent Neg Emotional State | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent negative emotional state (e.g., fear, horror, anger, guilt, or shame). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Negative Emotional State | ||
CAP0112A | C187557 | CAP01-Diminished Interest Activ | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Markedly diminished interest or participation in significant activities. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities | ||
CAP0112B | C187558 | CAP01-Diminished Interest Activ Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Markedly diminished interest or participation in significant activities: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities Frequency | ||
CAP0112C | C187559 | CAP01-Diminished Interest Activ Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Markedly diminished interest or participation in significant activities: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities Intensity | ||
CAP0113A | C187560 | CAP01-Feeling of Detachment | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Feelings of detachment or estrangement from others. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment | ||
CAP0113B | C187561 | CAP01-Feeling of Detachment Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Feeling of detachment or estrangement from others: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment Frequency | ||
CAP0113C | C187562 | CAP01-Feeling of Detachment Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Feeling of detachment or estrangement from others: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment Intensity | ||
CAP0114A | C187563 | CAP01-Inability Positive Emotions | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent inability to experience positive emotions (e.g., inability to experience happiness, satisfaction, or loving feelings). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability Positive Emotions | ||
CAP0114B | C187564 | CAP01-Restricted Range of Affect Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Restricted range of affect (e.g., unable to have loving feelings): Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Restricted Range of Affect Frequency | ||
CAP0114C | C187565 | CAP01-Restricted Range of Affect Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Restricted range of affect (e.g., unable to have loving feelings): Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Restricted Range of Affect Intensity | ||
CAP0114D | C187566 | CAP01-Sense Foreshortened Future Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life span): Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sense Foreshortened Future Frequency | ||
CAP0114E | C187567 | CAP01-Sense Foreshortened Future Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life span): Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sense Foreshortened Future Intensity | ||
CAP0115A | C187568 | CAP01-Irritable Behavior Angry Outbursts | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Irritable behavior and angry outbursts (with little or no provocation) typically expressed as verbal or physical aggression toward people or objects. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritable Behavior Angry Outbursts | ||
CAP0115B | C187569 | CAP01-Irritability/Outbursts Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Irritability or outbursts of anger: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritability or Outbursts Frequency | ||
CAP0115C | C187570 | CAP01-Irritability/Outbursts Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Irritability or outbursts of anger: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritability or Outbursts Intensity | ||
CAP0116 | C187571 | CAP01-Reckless or Self-destructive | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Reckless or self-destructive behavior. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Reckless or Self-destructive | ||
CAP0117A | C187572 | CAP01-Hypervigilance | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Hypervigilance. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance | ||
CAP0117B | C187573 | CAP01-Hypervigilance Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Hypervigilance: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance Frequency | ||
CAP0117C | C187574 | CAP01-Hypervigilance Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Hypervigilance: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance Intensity | ||
CAP0118A | C187575 | CAP01-Exaggerated Response | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Exaggerated startle response. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response | ||
CAP0118B | C187576 | CAP01-Exaggerated Response Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Exaggerated startle response: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response Frequency | ||
CAP0118C | C187577 | CAP01-Exaggerated Response Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Exaggerated startle response: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response Intensity | ||
CAP0119A | C187578 | CAP01-Problems With Concentration | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Problems with concentration. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Problems With Concentration | ||
CAP0119B | C187579 | CAP01-Difficulty Concentrating Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty concentrating: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Concentrating Frequency | ||
CAP0119C | C187580 | CAP01-Difficulty Concentrating Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty concentrating: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Concentrating Intensity | ||
CAP0120A | C187581 | CAP01-Sleep Disturbance | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Sleep disturbance (e.g., difficulty falling or staying asleep or restless sleep). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sleep Disturbance | ||
CAP0120B | C187582 | CAP01-Difficulty Falling Asleep Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty falling or staying asleep: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Falling Asleep Frequency | ||
CAP0120C | C187583 | CAP01-Difficulty Falling Asleep Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty falling or staying asleep: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Falling Asleep Intensity | ||
CAP0121A | C187584 | CAP01-Symptoms Total Months Delay Onset | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Onset of symptoms: Total # months delay in onset. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Total Months Delay Onset | ||
CAP0121B | C187585 | CAP01-Symptoms With Delayed Onset | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Onset of symptoms: With delayed onset (>= 6 months)? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms With Delayed Onset | ||
CAP0122A | C187586 | CAP01-Symptoms Current Months Duration | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [CURRENT] Total # months duration. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Current Months Duration | ||
CAP0122B | C187587 | CAP01-Symptoms Current More Than Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [CURRENT] Duration more than 1 month? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Current More Than Month | ||
CAP0122C | C187588 | CAP01-Symptoms Lifetime Months Duration | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [LIFETIME] Total # months duration. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Lifetime Months Duration | ||
CAP0122D | C187589 | CAP01-Symptoms Lifetime More Than Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [LIFETIME] Duration more than 1 month? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Lifetime More Than Month | ||
CAP0123A | C187590 | CAP01-Subjective Distress Past Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Subjective distress: In the past month. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Subjective Distress Past Month | ||
CAP0123B | C187591 | CAP01-Subjective Distress Lifetime | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Subjective distress: Lifetime. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Subjective Distress Lifetime | ||
CAP0124A | C187592 | CAP01-Social Functioning Past Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in social functioning: In the past month. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Social Functioning Past Month | ||
CAP0124B | C187593 | CAP01-Social Functioning Lifetime | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in social functioning: Lifetime. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Social Functioning Lifetime | ||
CAP0125A | C187594 | CAP01-Occupation Functioning Past Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in occupational or other important area of functioning: In the past month. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Occupation Functioning Past Month | ||
CAP0125B | C187595 | CAP01-Occupation Functioning Lifetime | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in occupational or other important area of functioning: Lifetime. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Occupation Functioning Lifetime | ||
CAP0126 | C187596 | CAP01-Global Validity | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global validity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Validity | ||
CAP0127 | C187597 | CAP01-Global Severity | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global severity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Severity | ||
CAP0128 | C187598 | CAP01-Global Improvement | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global improvement. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Improvement | ||
CAP0129 | C187599 | CAP01-Depersonalization | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Depersonalization: Persistent or recurrent experiences of feeling detached from, and as if one were an outside observer of, one's mental processes or body (e.g., feeling as though one were in a dream; feeling a sense of unreality of self or body or of time moving slowly). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Depersonalization | ||
CAP0130 | C187600 | CAP01-Derealization | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Derealization: Persistent or recurrent experiences of unreality of surroundings (e.g., the world around the individual is experienced as unreal, dreamlike, distant, or distorted). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Derealization | ||
CAP0131 | C187601 | CAP01-DSM IV Total Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV total score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Total Score | ||
CAP0132 | C187602 | CAP01-DSM IV Criterion B Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion B score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion B Score | ||
CAP0133 | C187603 | CAP01-DSM IV Criterion C Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion C score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion C Score | ||
CAP0134 | C187604 | CAP01-DSM IV Criterion D Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion D score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion D Score | ||
CAP0135 | C187605 | CAP01-DSM IV Criterion E Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion E score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion E Score | ||
CAP0136 | C187606 | CAP01-DSM IV Criterion G Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion G score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion G Score | ||
CAP0137 | C187607 | CAP01-DSM IV Dissociation Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV dissociation score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Dissociation Score | ||
CAP0138 | C187608 | CAP01-DSM IV PTSD Diagnosis | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV PTSD diagnosis. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV PTSD Diagnosis | ||
CAP0139 | C187609 | CAP01-DSM IV Other Diagnosis 1 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV other diagnosis 1. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Other Diagnosis 1 | ||
CAP0140 | C187610 | CAP01-DSM IV Other Diagnosis 2 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV other diagnosis 2. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Other Diagnosis 2 | ||
CAP0141 | C187611 | CAP01-DSM-5 Total Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 total score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Total Score | ||
CAP0142 | C187612 | CAP01-DSM-5 Criterion B Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion B score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion B Score | ||
CAP0143 | C187613 | CAP01-DSM-5 Criterion C Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion C score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion C Score | ||
CAP0144 | C187614 | CAP01-DSM-5 Criterion D Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion D score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion D Score | ||
CAP0145 | C187615 | CAP01-DSM-5 Criterion E Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion E score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion E Score | ||
CAP0146 | C187616 | CAP01-DSM-5 Criterion G Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion G score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion G Score | ||
CAP0147 | C187617 | CAP01-DSM-5 Dissociation Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 dissociation score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Dissociation Score | ||
CAP0148 | C187618 | CAP01-DSM-5 PTSD Diagnosis | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 PTSD diagnosis. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 PTSD Diagnosis | ||
CAP0149 | C187619 | CAP01-DSM-5 Other Diagnosis 1 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 other diagnosis 1. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Other Diagnosis 1 | ||
CAP0150 | C187620 | CAP01-DSM-5 Other Diagnosis 2 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 other diagnosis 2. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Other Diagnosis 2 | ||
CAP01A1 | C187518 | CAP01-The Event You Recently Endured | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - The event you have recently endured was: Index event (specify). | CAPS DSM-5 With DSM IV Scoring 2016 Version - The Event You Recently Endured | ||
CAP01A2 | C187519 | CAP01-Exposure Type | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Exposure type. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Exposure Type | ||
CAP01A3 | C187520 | CAP01-Life Threat | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat | ||
CAP01A3A | C187521 | CAP01-Life Threat Self | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat: Self. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat Self | ||
CAP01A3B | C187522 | CAP01-Life Threat Other | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat: Other. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat Other | ||
CAP01A4 | C187523 | CAP01-Serious Injury | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury | ||
CAP01A4A | C187524 | CAP01-Serious Injury Self | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury: Self. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury Self | ||
CAP01A4B | C187525 | CAP01-Serious Injury Other | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury: Other. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury Other | ||
CAP01A5 | C187526 | CAP01-Sexual Violation | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation | ||
CAP01A5A | C187527 | CAP01-Sexual Violation Self | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation: Self. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation Self | ||
CAP01A5B | C187528 | CAP01-Sexual Violation Other | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation: Other. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation Other | ||
CAP01A6 | C187529 | CAP01-Criterion A Met | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Criterion A met? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Criterion A Met | ||
Back to top | ||||||
CL.C187451.CAP01TN | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Clinical Classification Test Name
(CAP01TN) | text
Extensible: No | C187451 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Clinical Classification Test Name | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version test name. | CDISC Clinical Classification Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version Test Name Terminology |
CAP01-Avoid Thoughts Associated Freq | C187546 | CAP01-Avoid Thoughts Associated Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid thoughts, feelings, or conversations associated with the trauma: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated Frequency | ||
CAP01-Avoid Thoughts Associated Intens | C187547 | CAP01-Avoid Thoughts Associated Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid thoughts, feelings, or conversations associated with the trauma: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated Intensity | ||
CAP01-Avoid Thoughts Associated | C187545 | CAP01-Avoid Thoughts Associated | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Avoidance or efforts to avoid distressing memories, thoughts, or feelings about or closely associated with the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Avoid Thoughts Associated | ||
CAP01-Criterion A Met | C187529 | CAP01-Criterion A Met | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Criterion A met? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Criterion A Met | ||
CAP01-Depersonalization | C187599 | CAP01-Depersonalization | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Depersonalization: Persistent or recurrent experiences of feeling detached from, and as if one were an outside observer of, one's mental processes or body (e.g., feeling as though one were in a dream; feeling a sense of unreality of self or body or of time moving slowly). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Depersonalization | ||
CAP01-Derealization | C187600 | CAP01-Derealization | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Derealization: Persistent or recurrent experiences of unreality of surroundings (e.g., the world around the individual is experienced as unreal, dreamlike, distant, or distorted). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Derealization | ||
CAP01-Difficulty Concentrating Freq | C187579 | CAP01-Difficulty Concentrating Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty concentrating: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Concentrating Frequency | ||
CAP01-Difficulty Concentrating Intens | C187580 | CAP01-Difficulty Concentrating Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty concentrating: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Concentrating Intensity | ||
CAP01-Difficulty Falling Asleep Freq | C187582 | CAP01-Difficulty Falling Asleep Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty falling or staying asleep: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Falling Asleep Frequency | ||
CAP01-Difficulty Falling Asleep Intens | C187583 | CAP01-Difficulty Falling Asleep Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Difficulty falling or staying asleep: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Difficulty Falling Asleep Intensity | ||
CAP01-Diminished Interest Activ Freq | C187558 | CAP01-Diminished Interest Activ Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Markedly diminished interest or participation in significant activities: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities Frequency | ||
CAP01-Diminished Interest Activ Intens | C187559 | CAP01-Diminished Interest Activ Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Markedly diminished interest or participation in significant activities: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities Intensity | ||
CAP01-Diminished Interest Activ | C187557 | CAP01-Diminished Interest Activ | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Markedly diminished interest or participation in significant activities. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Diminished Interest Activities | ||
CAP01-DSM IV Criterion B Score | C187602 | CAP01-DSM IV Criterion B Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion B score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion B Score | ||
CAP01-DSM IV Criterion C Score | C187603 | CAP01-DSM IV Criterion C Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion C score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion C Score | ||
CAP01-DSM IV Criterion D Score | C187604 | CAP01-DSM IV Criterion D Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion D score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion D Score | ||
CAP01-DSM IV Criterion E Score | C187605 | CAP01-DSM IV Criterion E Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion E score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion E Score | ||
CAP01-DSM IV Criterion G Score | C187606 | CAP01-DSM IV Criterion G Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV criterion G score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Criterion G Score | ||
CAP01-DSM IV Dissociation Score | C187607 | CAP01-DSM IV Dissociation Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV dissociation score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Dissociation Score | ||
CAP01-DSM IV Other Diagnosis 1 | C187609 | CAP01-DSM IV Other Diagnosis 1 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV other diagnosis 1. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Other Diagnosis 1 | ||
CAP01-DSM IV Other Diagnosis 2 | C187610 | CAP01-DSM IV Other Diagnosis 2 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV other diagnosis 2. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Other Diagnosis 2 | ||
CAP01-DSM IV PTSD Diagnosis | C187608 | CAP01-DSM IV PTSD Diagnosis | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV PTSD diagnosis. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV PTSD Diagnosis | ||
CAP01-DSM IV Total Score | C187601 | CAP01-DSM IV Total Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV total score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM IV Total Score | ||
CAP01-DSM-5 Criterion B Score | C187612 | CAP01-DSM-5 Criterion B Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion B score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion B Score | ||
CAP01-DSM-5 Criterion C Score | C187613 | CAP01-DSM-5 Criterion C Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion C score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion C Score | ||
CAP01-DSM-5 Criterion D Score | C187614 | CAP01-DSM-5 Criterion D Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion D score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion D Score | ||
CAP01-DSM-5 Criterion E Score | C187615 | CAP01-DSM-5 Criterion E Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion E score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion E Score | ||
CAP01-DSM-5 Criterion G Score | C187616 | CAP01-DSM-5 Criterion G Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 criterion G score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Criterion G Score | ||
CAP01-DSM-5 Dissociation Score | C187617 | CAP01-DSM-5 Dissociation Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 dissociation score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Dissociation Score | ||
CAP01-DSM-5 Other Diagnosis 1 | C187619 | CAP01-DSM-5 Other Diagnosis 1 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 other diagnosis 1. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Other Diagnosis 1 | ||
CAP01-DSM-5 Other Diagnosis 2 | C187620 | CAP01-DSM-5 Other Diagnosis 2 | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 other diagnosis 2. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Other Diagnosis 2 | ||
CAP01-DSM-5 PTSD Diagnosis | C187618 | CAP01-DSM-5 PTSD Diagnosis | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 PTSD diagnosis. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 PTSD Diagnosis | ||
CAP01-DSM-5 Total Score | C187611 | CAP01-DSM-5 Total Score | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 total score. | CAPS DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Total Score | ||
CAP01-Efforts to Avoid Activities Freq | C187549 | CAP01-Efforts to Avoid Activities Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid activities, places, or people that arouse recollections of the trauma: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid Activities Frequency | ||
CAP01-Efforts to Avoid Activities Intens | C187550 | CAP01-Efforts to Avoid Activities Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Efforts to avoid activities, places, or people that arouse recollections of the trauma: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid Activities Intensity | ||
CAP01-Efforts to Avoid External Reminder | C187548 | CAP01-Efforts to Avoid External Reminder | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Avoidance or efforts to avoid external reminders (people, places, conversations, activities, objects, situations) that arouse distressing memories, thoughts, or feelings about or closely associated with the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Efforts to Avoid External Reminder | ||
CAP01-Exaggerated Response Freq | C187576 | CAP01-Exaggerated Response Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Exaggerated startle response: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response Frequency | ||
CAP01-Exaggerated Response Intens | C187577 | CAP01-Exaggerated Response Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Exaggerated startle response: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response Intensity | ||
CAP01-Exaggerated Response | C187575 | CAP01-Exaggerated Response | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Exaggerated startle response. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Exaggerated Response | ||
CAP01-Exposure Type | C187519 | CAP01-Exposure Type | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Exposure type. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Exposure Type | ||
CAP01-Feel as if Event Recurring Freq | C187537 | CAP01-Feel as if Event Recurring Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience, illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or when intoxicated.): Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring Frequency | ||
CAP01-Feel as if Event Recurring Intens | C187538 | CAP01-Feel as if Event Recurring Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience, illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or when intoxicated.): Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring Intensity | ||
CAP01-Feel as if Event Recurring | C187536 | CAP01-Feel as if Event Recurring | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Dissociative reactions (e.g., flashbacks) in which the individual feels or acts as if the traumatic event(s) were recurring. (Such reactions may occur on a continuum, with the most extreme expression being a complete loss of awareness of present surroundings.) | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feel as if Event Recurring | ||
CAP01-Feeling of Detachment Freq | C187561 | CAP01-Feeling of Detachment Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Feeling of detachment or estrangement from others: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment Frequency | ||
CAP01-Feeling of Detachment Intens | C187562 | CAP01-Feeling of Detachment Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Feeling of detachment or estrangement from others: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment Intensity | ||
CAP01-Feeling of Detachment | C187560 | CAP01-Feeling of Detachment | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Feelings of detachment or estrangement from others. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Feeling of Detachment | ||
CAP01-Global Improvement | C187598 | CAP01-Global Improvement | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global improvement. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Improvement | ||
CAP01-Global Severity | C187597 | CAP01-Global Severity | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global severity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Severity | ||
CAP01-Global Validity | C187596 | CAP01-Global Validity | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Global validity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Global Validity | ||
CAP01-Hypervigilance Freq | C187573 | CAP01-Hypervigilance Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Hypervigilance: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance Frequency | ||
CAP01-Hypervigilance Intens | C187574 | CAP01-Hypervigilance Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Hypervigilance: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance Intensity | ||
CAP01-Hypervigilance | C187572 | CAP01-Hypervigilance | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Hypervigilance. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Hypervigilance | ||
CAP01-Inability Positive Emotions | C187563 | CAP01-Inability Positive Emotions | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent inability to experience positive emotions (e.g., inability to experience happiness, satisfaction, or loving feelings). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability Positive Emotions | ||
CAP01-Inability to Recall Aspect Freq | C187552 | CAP01-Inability to Recall Aspect Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Inability to recall an important aspect of the trauma: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Recall Aspect Frequency | ||
CAP01-Inability to Recall Aspect Intens | C187553 | CAP01-Inability to Recall Aspect Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Inability to recall an important aspect of the trauma: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Recall Aspect Intensity | ||
CAP01-Inability to Remember Aspect | C187551 | CAP01-Inability to Remember Aspect | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Inability to remember an important aspect of the traumatic event(s) (typically dissociative amnesia that is not due to head injury, alcohol, or drugs). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Inability to Remember Aspect | ||
CAP01-Irritability/Outbursts Freq | C187569 | CAP01-Irritability/Outbursts Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Irritability or outbursts of anger: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritability or Outbursts Frequency | ||
CAP01-Irritability/Outbursts Intens | C187570 | CAP01-Irritability/Outbursts Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Irritability or outbursts of anger: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritability or Outbursts Intensity | ||
CAP01-Irritable Behavior Angry Outbursts | C187568 | CAP01-Irritable Behavior Angry Outbursts | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Irritable behavior and angry outbursts (with little or no provocation) typically expressed as verbal or physical aggression toward people or objects. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Irritable Behavior Angry Outbursts | ||
CAP01-Life Threat Other | C187522 | CAP01-Life Threat Other | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat: Other. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat Other | ||
CAP01-Life Threat Self | C187521 | CAP01-Life Threat Self | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat: Self. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat Self | ||
CAP01-Life Threat | C187520 | CAP01-Life Threat | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Life threat? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Life Threat | ||
CAP01-Occupation Functioning Lifetime | C187595 | CAP01-Occupation Functioning Lifetime | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in occupational or other important area of functioning: Lifetime. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Occupation Functioning Lifetime | ||
CAP01-Occupation Functioning Past Month | C187594 | CAP01-Occupation Functioning Past Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in occupational or other important area of functioning: In the past month. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Occupation Functioning Past Month | ||
CAP01-Persistent Blame of Self/Others | C187555 | CAP01-Persistent Blame of Self/Others | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent, distorted blame of self or others about the cause or consequences of the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Blame of Self or Others | ||
CAP01-Persistent Exaggerated Neg Beliefs | C187554 | CAP01-Persistent Exaggerated Neg Beliefs | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent and exaggerated negative beliefs or expectations about oneself, others, or the world (e.g., "I am bad," "No one can be trusted," "The world is completely dangerous"). (Alternatively, this might be expressed as, e.g., "I've lost my soul forever," "My whole nervous system is permanently ruined."). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Exaggerated Negative Beliefs | ||
CAP01-Persistent Neg Emotional State | C187556 | CAP01-Persistent Neg Emotional State | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Persistent negative emotional state (e.g., fear, horror, anger, guilt, or shame). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Persistent Negative Emotional State | ||
CAP01-Physiological React to Cues Freq | C187543 | CAP01-Physiological React to Cues Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues Frequency | ||
CAP01-Physiological React to Cues Intens | C187544 | CAP01-Physiological React to Cues Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Physiological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues Intensity | ||
CAP01-Physiological React to Cues | C187542 | CAP01-Physiological React to Cues | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Marked physiological reactions to internal or external cues that symbolize or resemble an aspect of the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Physiological Reactions to Cues | ||
CAP01-Problems With Concentration | C187578 | CAP01-Problems With Concentration | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Problems with concentration. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Problems With Concentration | ||
CAP01-Psych Distress at Exposure Freq | C187540 | CAP01-Psych Distress at Exposure Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Intense psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure Frequency | ||
CAP01-Psych Distress at Exposure Intens | C187541 | CAP01-Psych Distress at Exposure Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Intense psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure Intensity | ||
CAP01-Psych Distress at Exposure | C187539 | CAP01-Psych Distress at Exposure | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Intense or prolonged psychological distress at exposure to internal or external cues that symbolize or resemble an aspect of the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Psychological Distress at Exposure | ||
CAP01-Reckless or Self-destructive | C187571 | CAP01-Reckless or Self-destructive | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Reckless or self-destructive behavior. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Reckless or Self-destructive | ||
CAP01-Recurrent Distressing Dream Freq | C187534 | CAP01-Recurrent Distressing Dream Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent distressing dreams of the event: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream Frequency | ||
CAP01-Recurrent Distressing Dream Intens | C187535 | CAP01-Recurrent Distressing Dream Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent distressing dreams of the event: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream Intensity | ||
CAP01-Recurrent Distressing Dream | C187533 | CAP01-Recurrent Distressing Dream | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Recurrent distressing dreams in which the content and/or affect of the dream is related to the event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Dream | ||
CAP01-Recurrent Distressing Memories | C187530 | CAP01-Recurrent Distressing Memories | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Recurrent, involuntary, and intrusive distressing memories of the traumatic event(s). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Memories | ||
CAP01-Recurrent Distressing Recol Freq | C187531 | CAP01-Recurrent Distressing Recol Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions: Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Recollections Frequency | ||
CAP01-Recurrent Distressing Recol Intens | C187532 | CAP01-Recurrent Distressing Recol Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions: Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Recurrent Distressing Recollections Intensity | ||
CAP01-Restricted Range of Affect Freq | C187564 | CAP01-Restricted Range of Affect Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Restricted range of affect (e.g., unable to have loving feelings): Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Restricted Range of Affect Frequency | ||
CAP01-Restricted Range of Affect Intens | C187565 | CAP01-Restricted Range of Affect Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Restricted range of affect (e.g., unable to have loving feelings): Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Restricted Range of Affect Intensity | ||
CAP01-Sense Foreshortened Future Freq | C187566 | CAP01-Sense Foreshortened Future Freq | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life span): Frequency. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sense Foreshortened Future Frequency | ||
CAP01-Sense Foreshortened Future Intens | C187567 | CAP01-Sense Foreshortened Future Intens | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM IV Score: Sense of a foreshortened future (e.g., does not expect to have a career, marriage, children, or a normal life span): Intensity. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sense Foreshortened Future Intensity | ||
CAP01-Serious Injury Other | C187525 | CAP01-Serious Injury Other | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury: Other. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury Other | ||
CAP01-Serious Injury Self | C187524 | CAP01-Serious Injury Self | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury: Self. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury Self | ||
CAP01-Serious Injury | C187523 | CAP01-Serious Injury | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Serious injury? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Serious Injury | ||
CAP01-Sexual Violation Other | C187528 | CAP01-Sexual Violation Other | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation: Other. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation Other | ||
CAP01-Sexual Violation Self | C187527 | CAP01-Sexual Violation Self | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation: Self. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation Self | ||
CAP01-Sexual Violation | C187526 | CAP01-Sexual Violation | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - Sexual violation? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sexual Violation | ||
CAP01-Sleep Disturbance | C187581 | CAP01-Sleep Disturbance | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring: Sleep disturbance (e.g., difficulty falling or staying asleep or restless sleep). | CAPS DSM-5 With DSM IV Scoring 2016 Version - Sleep Disturbance | ||
CAP01-Social Functioning Lifetime | C187593 | CAP01-Social Functioning Lifetime | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in social functioning: Lifetime. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Social Functioning Lifetime | ||
CAP01-Social Functioning Past Month | C187592 | CAP01-Social Functioning Past Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Impairment in social functioning: In the past month. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Social Functioning Past Month | ||
CAP01-Subjective Distress Lifetime | C187591 | CAP01-Subjective Distress Lifetime | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Subjective distress: Lifetime. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Subjective Distress Lifetime | ||
CAP01-Subjective Distress Past Month | C187590 | CAP01-Subjective Distress Past Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Subjective distress: In the past month. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Subjective Distress Past Month | ||
CAP01-Symptoms Current Months Duration | C187586 | CAP01-Symptoms Current Months Duration | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [CURRENT] Total # months duration. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Current Months Duration | ||
CAP01-Symptoms Current More Than Month | C187587 | CAP01-Symptoms Current More Than Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [CURRENT] Duration more than 1 month? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Current More Than Month | ||
CAP01-Symptoms Lifetime Months Duration | C187588 | CAP01-Symptoms Lifetime Months Duration | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [LIFETIME] Total # months duration. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Lifetime Months Duration | ||
CAP01-Symptoms Lifetime More Than Month | C187589 | CAP01-Symptoms Lifetime More Than Month | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Duration of symptoms: [LIFETIME] Duration more than 1 month? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Lifetime More Than Month | ||
CAP01-Symptoms Total Months Delay Onset | C187584 | CAP01-Symptoms Total Months Delay Onset | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Onset of symptoms: Total # months delay in onset. | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms Total Months Delay Onset | ||
CAP01-Symptoms With Delayed Onset | C187585 | CAP01-Symptoms With Delayed Onset | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - DSM-5 Scoring and/or DSM IV Score: Onset of symptoms: With delayed onset (>= 6 months)? | CAPS DSM-5 With DSM IV Scoring 2016 Version - Symptoms With Delayed Onset | ||
CAP01-The Event You Recently Endured | C187518 | CAP01-The Event You Recently Endured | Clinician-Administered PTSD Scale (Current) DSM-5 With DSM IV Scoring 2016 Version - The event you have recently endured was: Index event (specify). | CAPS DSM-5 With DSM IV Scoring 2016 Version - The Event You Recently Endured | ||
Back to top | ||||||
CL.C177908.COLSTYP | Collected Summarized Value Type Response
(COLSTYP) | text
Extensible: Yes | C177908 | Collected Summarized Value Type Response | A terminology codelist relevant to the summary type for the source collected result or dose value. | CDISC SDTM Collected Summarized Value Type Response Terminology |
MAXIMUM | C25564 | The largest value in quantity or degree in a set of values. | Maximum | |||
MEAN | C181249 | A mean of a set of observations where the mathematic calculation is unspecified or unknown. | Mean Based on Unspecified Calculation | |||
MEAN, ARITHMETIC | C53319 | Arithmetic Mean | The sum of the values of all observations or data points divided by the number of observations; an arithmetic average. (CDISC Glossary) | Arithmetic Mean | ||
MEAN, GEOMETRIC | C94906 | Geometric Mean | The n-th root of the multiple products of n values; a geometric average. | Geometric Mean | ||
MEDIAN | C28007 | The middle value in an ordered set of values. In the case of an even number of values, it is the average of the two middle values. | Median | |||
MINIMUM | C25570 | The smallest value in quantity or degree in a set of values. | Minimum | |||
NADIR | C43517 | Lowest | The lowest value in terms of position, place, magnitude, level, or rank. | Lowest | ||
Back to top | ||||||
CL.C106659.CSS05TC | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire Test Code
(CSS05TC) | text
Extensible: No | C106659 | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Already Enrolled Subject test code. | CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Code Terminology |
CSS0501A | C107027 | CSS05-Wish to be Dead-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you wished you were dead or wished you could go to sleep and not wake up? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Wish to Be Dead (Prior to Study Entry) | ||
CSS0501B | C107028 | CSS05-Wish to be Dead-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you wished you were dead or wished you could go to sleep and not wake up? (Since Study Start). | C-SSRS Already Enrolled Subjects - Wish to Be Dead (Since Study Start) | ||
CSS0501C | C107029 | CSS05-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of wishing to be dead. | C-SSRS Already Enrolled Subjects - Description of Wish to Be Dead | ||
CSS0502A | C107030 | CSS05-Non-Spec Suicid Thought-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you actually had any thoughts of killing yourself? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Non-Specific Active Suicidal Thoughts (Prior to Study Entry) | ||
CSS0502B | C107031 | CSS05-Non-Spec Suicid Thought-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you actually had any thoughts of killing yourself? (Since Study Start). | C-SSRS Already Enrolled Subjects - Non-Specific Active Suicidal Thoughts (Since Study Start) | ||
CSS0502C | C107032 | CSS05-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of non-specific active suicidal thoughts. | C-SSRS Already Enrolled Subjects - Description of Non-Specific Active Suicidal Thoughts | ||
CSS0503A | C107033 | CSS05-Idea, No Intent, No Plan-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you been thinking about how you might do this? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Prior to Study Entry) | ||
CSS0503B | C107034 | CSS05-Idea, No Intent, No Plan-Since | Columbia-Suicide Suicide Rating Scale Already Enrolled Subjects - Have you been thinking about how you might do this? (Since Study Start). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Since Study Start) | ||
CSS0503C | C107035 | CSS05-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act | ||
CSS0504A | C107036 | CSS05-Idea, Intent, No Plan-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you had these thoughts and had some intention of acting on them? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Prior to Study Entry) | ||
CSS0504B | C107037 | CSS05-Idea, Intent, No Plan-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you had these thoughts and had some intention of acting on them? (Since Study Start). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Since Study Start) | ||
CSS0504C | C107038 | CSS05-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan | ||
CSS0505A | C107039 | CSS05-Idea, Plan, Intent-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Specific Plan and Intent (Prior to Study Entry) | ||
CSS0505B | C107040 | CSS05-Idea, Plan, Intent-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Since Study Start). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Specific Plan and Intent (Since Study Start) | ||
CSS0505C | C107041 | CSS05-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with specific plan and intent. | C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Specific Plan and Intent | ||
CSS0506A | C107042 | CSS05-Most Severe Idea-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most severe ideation. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Most Severe Ideation (Prior to Study Entry) | ||
CSS0506B | C107043 | CSS05-Most Severe Idea, Desc-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of most severe ideation. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Prior to Study Entry) | ||
CSS0506C | C107044 | CSS05-Most Severe Idea-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most severe ideation. (Since Study Start). | C-SSRS Already Enrolled Subjects - Most Severe Ideation (Since Study Start) | ||
CSS0506D | C107045 | CSS05-Most Severe Idea, Desc-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of most severe ideation. (Since Study Start). | C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Since Study Start) | ||
CSS0507A | C107046 | CSS05-Most Severe Idea, Frequency-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - How many times have you had these thoughts? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Prior to Study Entry) | ||
CSS0507B | C107047 | CSS05-Most Severe Idea, Frequency-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - How many times have you had these thoughts? (Since Study Start). | C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Since Study Start) | ||
CSS0508A | C107048 | CSS05-Most Severe Idea, Duration-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - When you have the thoughts how long do they last? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Prior to Study Entry) | ||
CSS0508B | C107049 | CSS05-Most Severe Idea, Duration-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - When you have the thoughts how long do they last? (Since Study Start). | C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Since Study Start) | ||
CSS0509A | C107050 | CSS05-Most Severe Idea, Control-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Controllability of Most Severe Ideation (Prior to Study Entry) | ||
CSS0509B | C107051 | CSS05-Most Severe Idea, Control-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Since Study Start). | C-SSRS Already Enrolled Subjects - Controllability of Most Severe Ideation (Since Study Start) | ||
CSS0510A | C107052 | CSS05-Most Severe Idea, Deterrents-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Deterrents to Most Severe Ideation (Prior to Study Entry) | ||
CSS0510B | C107053 | CSS05-Most Severe Idea, Deterrents-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Since Study Start). | C-SSRS Already Enrolled Subjects - Deterrents to Most Severe Ideation (Since Study Start) | ||
CSS0511A | C107054 | CSS05-Most Severe Idea, Reasons-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Reasons For Most Severe Ideation (Prior to Study Entry) | ||
CSS0511B | C107055 | CSS05-Most Severe Idea, Reasons-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Since Study Start). | C-SSRS Already Enrolled Subjects - Reasons For Most Severe Ideation (Since Study Start) | ||
CSS0512A | C107056 | CSS05-Actual Attempt-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Actual Suicide Attempt (Prior to Study Entry) | ||
CSS0512B | C107057 | CSS05-Actual Attempt-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Since Study Start). | C-SSRS Already Enrolled Subjects - Actual Suicide Attempt (Since Study Start) | ||
CSS0513A | C107058 | CSS05-Number of Actual Attempts-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of actual attempts. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Number of Actual Suicide Attempts (Prior to Study Entry) | ||
CSS0513B | C107059 | CSS05-Number of Actual Attempts-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of actual attempts. (Since Study Start). | C-SSRS Already Enrolled Subjects - Number of Actual Suicide Attempts (Since Study Start) | ||
CSS0513C | C107060 | CSS05-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of actual attempt. | C-SSRS Already Enrolled Subjects - Description of Actual Suicide Attempt | ||
CSS0514A | C107061 | CSS05-Non-suicid Self-injur Behav-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has the subject engaged in non-suicidal self-injurious behavior? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Non-suicidal Self-injurious Behavior (Prior to Study Entry) | ||
CSS0514B | C107062 | CSS05-Non-suicid Self-injur Behav-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has the subject engaged in non-suicidal self-injurious behavior? (Since Study Start). | C-SSRS Already Enrolled Subjects - Non-suicidal Self-injurious Behavior (Since Study Start) | ||
CSS0515A | C107063 | CSS05-Interrupted Attempt-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Interrupted Suicide Attempt (Prior to Study Entry) | ||
CSS0515B | C107064 | CSS05-Interrupted Attempt-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? (Since Study Start). | C-SSRS Already Enrolled Subjects - Interrupted Suicide Attempt (Since Study Start) | ||
CSS0516A | C107065 | CSS05-Num of Interrupted Attempts-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of interrupted attempts. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Prior to Study Entry) | ||
CSS0516B | C107066 | CSS05-Num of Interrupted Attempts-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of interrupted attempts. (Since Study Start). | C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Since Study Start) | ||
CSS0516C | C107067 | CSS05-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of interrupted attempt. | C-SSRS Already Enrolled Subjects - Description of Interrupted Suicide Attempt | ||
CSS0517A | C107068 | CSS05-Aborted Attempt-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Aborted Suicide Attempt (Prior to Study Entry) | ||
CSS0517B | C107069 | CSS05-Aborted Attempt-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Since Study Start). | C-SSRS Already Enrolled Subjects - Aborted Suicide Attempt (Since Study Start) | ||
CSS0518A | C107070 | CSS05-Number of Aborted Attempts-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of aborted attempts. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Number of Aborted Suicide Attempts (Prior to Study Entry) | ||
CSS0518B | C107071 | CSS05-Number of Aborted Attempts-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of aborted attempts. (Since Study Start). | C-SSRS Already Enrolled Subjects - Number of Aborted Suicide Attempts (Since Study Start) | ||
CSS0518C | C107072 | CSS05-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of aborted attempt. | C-SSRS Already Enrolled Subjects - Description of Aborted Suicide Attempt | ||
CSS0519A | C107073 | CSS05-Preparatory Acts/Behavior-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Prior to Study Entry) | ||
CSS0519B | C107074 | CSS05-Preparatory Acts/Behavior-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Since Study Start). | C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Since Study Start) | ||
CSS0519C | C107075 | CSS05-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of preparatory acts or behavior. | C-SSRS Already Enrolled Subjects - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0520A | C107076 | CSS05-Suicidal Behavior-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Suicidal behavior was present during the assessment period? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Suicidal Behavior (Prior to Study Entry) | ||
CSS0520B | C107077 | CSS05-Suicidal Behavior-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Suicidal behavior was present during the assessment period? (Since Study Start). | C-SSRS Already Enrolled Subjects - Suicidal Behavior (Since Study Start) | ||
CSS0521A | C107078 | CSS05-Completed Suicide-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Completed suicide? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Completed Suicide (Prior to Study Entry) | ||
CSS0521B | C107079 | CSS05-Completed Suicide-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Completed suicide? (Since Study Start). | C-SSRS Already Enrolled Subjects - Completed Suicide (Since Study Start) | ||
CSS0522A | C107080 | CSS05-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt date. | C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Date | ||
CSS0522B | C107081 | CSS05-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt actual lethality/medical damage. | C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0522C | C107082 | CSS05-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt potential lethality. | C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Potential Lethality | ||
CSS0523A | C107083 | CSS05-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt date. | C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Date | ||
CSS0523B | C107084 | CSS05-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt actual lethality/medical damage. | C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0523C | C107085 | CSS05-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt potential lethality. | C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Potential Lethality | ||
CSS0524A | C107086 | CSS05-First Attempt Date | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt date. | C-SSRS Already Enrolled Subjects - First Suicide Attempt Date | ||
CSS0524B | C107087 | CSS05-First Attempt Damage | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt actual lethality/medical damage. | C-SSRS Already Enrolled Subjects - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0524C | C107088 | CSS05-First Attempt Potential | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt potential lethality. | C-SSRS Already Enrolled Subjects - First Suicide Attempt Potential Lethality | ||
Back to top | ||||||
CL.C106658.CSS05TN | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire Test Name
(CSS05TN) | text
Extensible: No | C106658 | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Already Enrolled Subject test name. | CDISC Questionnaire C-SSRS Already Enrolled Subjects Test Name Terminology |
CSS05-Aborted Attempt, Describe | C107072 | CSS05-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of aborted attempt. | C-SSRS Already Enrolled Subjects - Description of Aborted Suicide Attempt | ||
CSS05-Aborted Attempt-Prior | C107068 | CSS05-Aborted Attempt-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Aborted Suicide Attempt (Prior to Study Entry) | ||
CSS05-Aborted Attempt-Since | C107069 | CSS05-Aborted Attempt-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Since Study Start). | C-SSRS Already Enrolled Subjects - Aborted Suicide Attempt (Since Study Start) | ||
CSS05-Actual Attempt, Describe | C107060 | CSS05-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of actual attempt. | C-SSRS Already Enrolled Subjects - Description of Actual Suicide Attempt | ||
CSS05-Actual Attempt-Prior | C107056 | CSS05-Actual Attempt-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Actual Suicide Attempt (Prior to Study Entry) | ||
CSS05-Actual Attempt-Since | C107057 | CSS05-Actual Attempt-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Since Study Start). | C-SSRS Already Enrolled Subjects - Actual Suicide Attempt (Since Study Start) | ||
CSS05-Completed Suicide-Prior | C107078 | CSS05-Completed Suicide-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Completed suicide? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Completed Suicide (Prior to Study Entry) | ||
CSS05-Completed Suicide-Since | C107079 | CSS05-Completed Suicide-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Completed suicide? (Since Study Start). | C-SSRS Already Enrolled Subjects - Completed Suicide (Since Study Start) | ||
CSS05-First Attempt Damage | C107087 | CSS05-First Attempt Damage | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt actual lethality/medical damage. | C-SSRS Already Enrolled Subjects - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS05-First Attempt Date | C107086 | CSS05-First Attempt Date | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt date. | C-SSRS Already Enrolled Subjects - First Suicide Attempt Date | ||
CSS05-First Attempt Potential | C107088 | CSS05-First Attempt Potential | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Initial/first attempt potential lethality. | C-SSRS Already Enrolled Subjects - First Suicide Attempt Potential Lethality | ||
CSS05-Idea, Intent, No Plan, Describe | C107038 | CSS05-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan | ||
CSS05-Idea, Intent, No Plan-Prior | C107036 | CSS05-Idea, Intent, No Plan-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you had these thoughts and had some intention of acting on them? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Prior to Study Entry) | ||
CSS05-Idea, Intent, No Plan-Since | C107037 | CSS05-Idea, Intent, No Plan-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you had these thoughts and had some intention of acting on them? (Since Study Start). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Since Study Start) | ||
CSS05-Idea, No Intent, No Plan, Describe | C107035 | CSS05-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act | ||
CSS05-Idea, No Intent, No Plan-Prior | C107033 | CSS05-Idea, No Intent, No Plan-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you been thinking about how you might do this? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Prior to Study Entry) | ||
CSS05-Idea, No Intent, No Plan-Since | C107034 | CSS05-Idea, No Intent, No Plan-Since | Columbia-Suicide Suicide Rating Scale Already Enrolled Subjects - Have you been thinking about how you might do this? (Since Study Start). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Since Study Start) | ||
CSS05-Idea, Plan, Intent, Describe | C107041 | CSS05-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of active suicidal ideation with specific plan and intent. | C-SSRS Already Enrolled Subjects - Description of Active Suicidal Ideation With Specific Plan and Intent | ||
CSS05-Idea, Plan, Intent-Prior | C107039 | CSS05-Idea, Plan, Intent-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Specific Plan and Intent (Prior to Study Entry) | ||
CSS05-Idea, Plan, Intent-Since | C107040 | CSS05-Idea, Plan, Intent-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Since Study Start). | C-SSRS Already Enrolled Subjects - Active Suicidal Ideation With Specific Plan and Intent (Since Study Start) | ||
CSS05-Interrupted Attempt, Describe | C107067 | CSS05-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of interrupted attempt. | C-SSRS Already Enrolled Subjects - Description of Interrupted Suicide Attempt | ||
CSS05-Interrupted Attempt-Prior | C107063 | CSS05-Interrupted Attempt-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Interrupted Suicide Attempt (Prior to Study Entry) | ||
CSS05-Interrupted Attempt-Since | C107064 | CSS05-Interrupted Attempt-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? (Since Study Start). | C-SSRS Already Enrolled Subjects - Interrupted Suicide Attempt (Since Study Start) | ||
CSS05-Most Lethal Attempt Damage | C107084 | CSS05-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt actual lethality/medical damage. | C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS05-Most Lethal Attempt Date | C107083 | CSS05-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt date. | C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Date | ||
CSS05-Most Lethal Attempt Potential | C107085 | CSS05-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most lethal attempt potential lethality. | C-SSRS Already Enrolled Subjects - Most Lethal Suicide Attempt Potential Lethality | ||
CSS05-Most Recent Attempt Damage | C107081 | CSS05-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt actual lethality/medical damage. | C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS05-Most Recent Attempt Date | C107080 | CSS05-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt date. | C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Date | ||
CSS05-Most Recent Attempt Potential | C107082 | CSS05-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most recent attempt potential lethality. | C-SSRS Already Enrolled Subjects - Most Recent Suicide Attempt Potential Lethality | ||
CSS05-Most Severe Idea, Control-Prior | C107050 | CSS05-Most Severe Idea, Control-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Controllability of Most Severe Ideation (Prior to Study Entry) | ||
CSS05-Most Severe Idea, Control-Since | C107051 | CSS05-Most Severe Idea, Control-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Since Study Start). | C-SSRS Already Enrolled Subjects - Controllability of Most Severe Ideation (Since Study Start) | ||
CSS05-Most Severe Idea, Desc-Prior | C107043 | CSS05-Most Severe Idea, Desc-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of most severe ideation. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Prior to Study Entry) | ||
CSS05-Most Severe Idea, Desc-Since | C107045 | CSS05-Most Severe Idea, Desc-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of most severe ideation. (Since Study Start). | C-SSRS Already Enrolled Subjects - Describe Most Severe Ideation (Since Study Start) | ||
CSS05-Most Severe Idea, Deterrents-Prior | C107052 | CSS05-Most Severe Idea, Deterrents-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Deterrents to Most Severe Ideation (Prior to Study Entry) | ||
CSS05-Most Severe Idea, Deterrents-Since | C107053 | CSS05-Most Severe Idea, Deterrents-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Since Study Start). | C-SSRS Already Enrolled Subjects - Deterrents to Most Severe Ideation (Since Study Start) | ||
CSS05-Most Severe Idea, Duration-Prior | C107048 | CSS05-Most Severe Idea, Duration-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - When you have the thoughts how long do they last? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Prior to Study Entry) | ||
CSS05-Most Severe Idea, Duration-Since | C107049 | CSS05-Most Severe Idea, Duration-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - When you have the thoughts how long do they last? (Since Study Start). | C-SSRS Already Enrolled Subjects - Duration of Most Severe Ideation (Since Study Start) | ||
CSS05-Most Severe Idea, Frequency-Prior | C107046 | CSS05-Most Severe Idea, Frequency-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - How many times have you had these thoughts? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Prior to Study Entry) | ||
CSS05-Most Severe Idea, Frequency-Since | C107047 | CSS05-Most Severe Idea, Frequency-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - How many times have you had these thoughts? (Since Study Start). | C-SSRS Already Enrolled Subjects - Frequency of Most Severe Ideation (Since Study Start) | ||
CSS05-Most Severe Idea, Reasons-Prior | C107054 | CSS05-Most Severe Idea, Reasons-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Reasons For Most Severe Ideation (Prior to Study Entry) | ||
CSS05-Most Severe Idea, Reasons-Since | C107055 | CSS05-Most Severe Idea, Reasons-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Since Study Start). | C-SSRS Already Enrolled Subjects - Reasons For Most Severe Ideation (Since Study Start) | ||
CSS05-Most Severe Idea-Prior | C107042 | CSS05-Most Severe Idea-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most severe ideation. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Most Severe Ideation (Prior to Study Entry) | ||
CSS05-Most Severe Idea-Since | C107044 | CSS05-Most Severe Idea-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Most severe ideation. (Since Study Start). | C-SSRS Already Enrolled Subjects - Most Severe Ideation (Since Study Start) | ||
CSS05-Non-Spec Suicid Thought, Describe | C107032 | CSS05-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of non-specific active suicidal thoughts. | C-SSRS Already Enrolled Subjects - Description of Non-Specific Active Suicidal Thoughts | ||
CSS05-Non-Spec Suicid Thought-Prior | C107030 | CSS05-Non-Spec Suicid Thought-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you actually had any thoughts of killing yourself? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Non-Specific Active Suicidal Thoughts (Prior to Study Entry) | ||
CSS05-Non-Spec Suicid Thought-Since | C107031 | CSS05-Non-Spec Suicid Thought-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you actually had any thoughts of killing yourself? (Since Study Start). | C-SSRS Already Enrolled Subjects - Non-Specific Active Suicidal Thoughts (Since Study Start) | ||
CSS05-Non-suicid Self-injur Behav-Prior | C107061 | CSS05-Non-suicid Self-injur Behav-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has the subject engaged in non-suicidal self-injurious behavior? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Non-suicidal Self-injurious Behavior (Prior to Study Entry) | ||
CSS05-Non-suicid Self-injur Behav-Since | C107062 | CSS05-Non-suicid Self-injur Behav-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Has the subject engaged in non-suicidal self-injurious behavior? (Since Study Start). | C-SSRS Already Enrolled Subjects - Non-suicidal Self-injurious Behavior (Since Study Start) | ||
CSS05-Num of Interrupted Attempts-Prior | C107065 | CSS05-Num of Interrupted Attempts-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of interrupted attempts. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Prior to Study Entry) | ||
CSS05-Num of Interrupted Attempts-Since | C107066 | CSS05-Num of Interrupted Attempts-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of interrupted attempts. (Since Study Start). | C-SSRS Already Enrolled Subjects - Number of Interrupted Suicide Attempts (Since Study Start) | ||
CSS05-Number of Aborted Attempts-Prior | C107070 | CSS05-Number of Aborted Attempts-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of aborted attempts. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Number of Aborted Suicide Attempts (Prior to Study Entry) | ||
CSS05-Number of Aborted Attempts-Since | C107071 | CSS05-Number of Aborted Attempts-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of aborted attempts. (Since Study Start). | C-SSRS Already Enrolled Subjects - Number of Aborted Suicide Attempts (Since Study Start) | ||
CSS05-Number of Actual Attempts-Prior | C107058 | CSS05-Number of Actual Attempts-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of actual attempts. (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Number of Actual Suicide Attempts (Prior to Study Entry) | ||
CSS05-Number of Actual Attempts-Since | C107059 | CSS05-Number of Actual Attempts-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Total number of actual attempts. (Since Study Start). | C-SSRS Already Enrolled Subjects - Number of Actual Suicide Attempts (Since Study Start) | ||
CSS05-Preparatory Acts/Behavior, Descr | C107075 | CSS05-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of preparatory acts or behavior. | C-SSRS Already Enrolled Subjects - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS05-Preparatory Acts/Behavior-Prior | C107073 | CSS05-Preparatory Acts/Behavior-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Prior to Study Entry) | ||
CSS05-Preparatory Acts/Behavior-Since | C107074 | CSS05-Preparatory Acts/Behavior-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Since Study Start). | C-SSRS Already Enrolled Subjects - Preparatory Acts or Behaviors Toward Suicide Attempt (Since Study Start) | ||
CSS05-Suicidal Behavior-Prior | C107076 | CSS05-Suicidal Behavior-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Suicidal behavior was present during the assessment period? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Suicidal Behavior (Prior to Study Entry) | ||
CSS05-Suicidal Behavior-Since | C107077 | CSS05-Suicidal Behavior-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Suicidal behavior was present during the assessment period? (Since Study Start). | C-SSRS Already Enrolled Subjects - Suicidal Behavior (Since Study Start) | ||
CSS05-Wish to be Dead, Describe | C107029 | CSS05-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Description of wishing to be dead. | C-SSRS Already Enrolled Subjects - Description of Wish to Be Dead | ||
CSS05-Wish to be Dead-Prior | C107027 | CSS05-Wish to be Dead-Prior | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you wished you were dead or wished you could go to sleep and not wake up? (Prior to Study Entry). | C-SSRS Already Enrolled Subjects - Wish to Be Dead (Prior to Study Entry) | ||
CSS05-Wish to be Dead-Since | C107028 | CSS05-Wish to be Dead-Since | Columbia-Suicide Severity Rating Scale Already Enrolled Subjects - Have you wished you were dead or wished you could go to sleep and not wake up? (Since Study Start). | C-SSRS Already Enrolled Subjects - Wish to Be Dead (Since Study Start) | ||
Back to top | ||||||
CL.C100168.CSS01TC | Columbia-Suicide Severity Rating Scale Baseline Questionnaire Test Code
(CSS01TC) | text
Extensible: No | C100168 | Columbia-Suicide Severity Rating Scale Baseline Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Baseline test code. | CDISC Questionnaire C-SSRS Baseline Test Code Terminology |
CSS0101 | C100976 | CSS01-Wish to be Dead | Columbia-Suicide Severity Rating Scale Baseline - Have you wished you were dead or wished you could go to sleep and not wake up? | C-SSRS Baseline - Wish to be Dead or go to Sleep and not Wake Up | ||
CSS0101A | C100977 | CSS01-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Baseline - Description of wishing to be dead. | C-SSRS Baseline - Description of Wish to be Dead | ||
CSS0102 | C100978 | CSS01-Non-Specific Suicidal Thought | Columbia-Suicide Severity Rating Scale Baseline - Have you actually had any thoughts of killing yourself? | C-SSRS Baseline - Non-Specific Suicidal Thought | ||
CSS0102A | C100979 | CSS01-Non-Specific Suicid Thought, Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of non-specific active suicidal thoughts. | C-SSRS Baseline - Description of Non-Specific Suicide Thought | ||
CSS0103 | C100980 | CSS01-Suicidal Ideation-No Intent | Columbia-Suicide Severity Rating Scale Baseline - Have you been thinking about how you might do this? | C-SSRS Baseline - Suicidal Ideation-No Intent | ||
CSS0103A | C100981 | CSS01-Suicidal Ideation-No Intent, Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Baseline - Description of Suicidal Ideation-No Intent | ||
CSS0104 | C101014 | CSS01-Ideation With Intent, No Plan | Columbia-Suicide Severity Rating Scale Baseline - Have you have these thoughts and had some intention of acting on them? | C-SSRS Baseline - Ideation With Intent, No Plan | ||
CSS0104A | C101015 | CSS01-Ideation With Intent No Plan Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Baseline - Description of Ideation With Intent, No Plan | ||
CSS0105 | C100982 | CSS01-Ideation With Plan/Intent | Columbia-Suicide Severity Rating Scale Baseline - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? | C-SSRS Baseline - Ideation With Plan/Intent | ||
CSS0105A | C100983 | CSS01-Ideation With Plan/Intent, Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with specific plan and intent. | C-SSRS Baseline - Description of Ideation With Plan and Intent | ||
CSS0106 | C100984 | CSS01-Most Severe Ideation | Columbia-Suicide Severity Rating Scale Baseline - Most severe ideation. | C-SSRS Baseline - Most Severe Ideation | ||
CSS0106A | C100985 | CSS01-Most Severe Ideation, Description | Columbia-Suicide Severity Rating Scale Baseline - Description of most severe ideation. | C-SSRS Baseline - Describe Most Severe Ideation | ||
CSS0107 | C100986 | CSS01-Most Severe Ideation, Frequency | Columbia-Suicide Severity Rating Scale Baseline - How many times have you had these thoughts? | C-SSRS Baseline - Frequency of Most Severe Ideation | ||
CSS0108 | C100987 | CSS01-Most Severe Ideation, Duration | Columbia-Suicide Severity Rating Scale Baseline - When you have the thoughts, how long do they last? | C-SSRS Baseline - Duration of Most Severe Ideation | ||
CSS0109 | C100988 | CSS01-Most Severe Ideation, Control | Columbia-Suicide Severity Rating Scale Baseline - Could/can you stop thinking about killing yourself or wanting to die if you want to? | C-SSRS Baseline - Control over Most Severe Ideation | ||
CSS0110 | C100989 | CSS01-Most Severe Ideation, Deterrents | Columbia-Suicide Severity Rating Scale Baseline - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? | C-SSRS Baseline - Deterrents to Most Severe Ideation | ||
CSS0111 | C100990 | CSS01-Most Severe Ideation, Reasons | Columbia-Suicide Severity Rating Scale Baseline - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? | C-SSRS Baseline - Reasons for Most Severe Ideation | ||
CSS0112 | C100991 | CSS01-Actual Attempt | Columbia-Suicide Severity Rating Scale Baseline - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? | C-SSRS Baseline - Actual Suicide Attempt | ||
CSS0113 | C100992 | CSS01-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Baseline - Total number of actual attempts. | C-SSRS Baseline - Number of Actual Suicide Attempts | ||
CSS0113A | C100993 | CSS01-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline - Description of actual attempt. | C-SSRS Baseline - Description of Actual Suicide Attempts | ||
CSS0114 | C100994 | CSS01-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Baseline - Has the subject engaged in non-suicidal self-injurious behavior. | C-SSRS Baseline - Non-suicidal Self-injurious Behavior | ||
CSS0115 | C100995 | CSS01-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? | C-SSRS Baseline - Interrupted Suicide Attempt | ||
CSS0116 | C100996 | CSS01-Number of Interrupted Attempts | Columbia-Suicide Severity Rating Scale Baseline - Total number of interrupted attempts. | C-SSRS Baseline - Number of Interrupted Suicide Attempts | ||
CSS0116A | C100997 | CSS01-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline - Description of interrupted attempt. | C-SSRS Baseline - Description of Interrupted Suicide Attempt | ||
CSS0117 | C100998 | CSS01-Aborted Attempt | Columbia-Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? | C-SSRS Baseline - Aborted Suicide Attempt | ||
CSS0118 | C100999 | CSS01-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Baseline - Total number of aborted attempts. | C-SSRS Baseline - Number of Aborted Suicide Attempts | ||
CSS0118A | C101000 | CSS01-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline - Description of aborted attempt. | C-SSRS Baseline - Description of Aborted Suicide Attempt | ||
CSS0119 | C101001 | CSS01-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Baseline - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? | C-SSRS Baseline - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0119A | C101002 | CSS01-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of preparatory acts or behavior. | C-SSRS Baseline - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0120 | C101003 | CSS01-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Baseline - Suicidal behavior was present during the assessment period? | C-SSRS Baseline - Suicidal Behavior | ||
CSS0121A | C101004 | CSS01-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt date. | C-SSRS Baseline - Most Recent Suicide Attempt Date | ||
CSS0121B | C101005 | CSS01-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt actual lethality/medical damage. | C-SSRS Baseline - Most Recent Suicide Attempt Damage | ||
CSS0121C | C101006 | CSS01-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt potential lethality. | C-SSRS Baseline - Most Recent Suicide Attempt Potential | ||
CSS0122A | C101007 | CSS01-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt date. | C-SSRS Baseline - Most Lethal Suicide Attempt Date | ||
CSS0122B | C101008 | CSS01-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt actual lethality/medical damage. | C-SSRS Baseline - Most Lethal Suicide Attempt Damage | ||
CSS0122C | C101009 | CSS01-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt potential lethality. | C-SSRS Baseline - Most Lethal Suicide Attempt Potential | ||
CSS0123A | C101010 | CSS01-First Attempt Date | Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt date. | C-SSRS Baseline - First Suicide Attempt Date | ||
CSS0123B | C101011 | CSS01-First Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt actual lethality/medical damage. | C-SSRS Baseline - First Suicide Attempt Damage | ||
CSS0123C | C101012 | CSS01-First Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt potential lethality. | C-SSRS Baseline - First Suicide Attempt Potential | ||
Back to top | ||||||
CL.C100167.CSS01TN | Columbia-Suicide Severity Rating Scale Baseline Questionnaire Test Name
(CSS01TN) | text
Extensible: No | C100167 | Columbia-Suicide Severity Rating Scale Baseline Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Baseline test name. | CDISC Questionnaire C-SSRS Baseline Test Name Terminology |
CSS01-Aborted Attempt | C100998 | CSS01-Aborted Attempt | Columbia-Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? | C-SSRS Baseline - Aborted Suicide Attempt | ||
CSS01-Aborted Attempt, Describe | C101000 | CSS01-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline - Description of aborted attempt. | C-SSRS Baseline - Description of Aborted Suicide Attempt | ||
CSS01-Actual Attempt | C100991 | CSS01-Actual Attempt | Columbia-Suicide Severity Rating Scale Baseline - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? | C-SSRS Baseline - Actual Suicide Attempt | ||
CSS01-Actual Attempt, Describe | C100993 | CSS01-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline - Description of actual attempt. | C-SSRS Baseline - Description of Actual Suicide Attempts | ||
CSS01-First Attempt Damage | C101011 | CSS01-First Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt actual lethality/medical damage. | C-SSRS Baseline - First Suicide Attempt Damage | ||
CSS01-First Attempt Date | C101010 | CSS01-First Attempt Date | Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt date. | C-SSRS Baseline - First Suicide Attempt Date | ||
CSS01-First Attempt Potential | C101012 | CSS01-First Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline - Initial/first attempt potential lethality. | C-SSRS Baseline - First Suicide Attempt Potential | ||
CSS01-Ideation With Intent No Plan Descr | C101015 | CSS01-Ideation With Intent No Plan Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Baseline - Description of Ideation With Intent, No Plan | ||
CSS01-Ideation With Intent, No Plan | C101014 | CSS01-Ideation With Intent, No Plan | Columbia-Suicide Severity Rating Scale Baseline - Have you have these thoughts and had some intention of acting on them? | C-SSRS Baseline - Ideation With Intent, No Plan | ||
CSS01-Ideation With Plan/Intent | C100982 | CSS01-Ideation With Plan/Intent | Columbia-Suicide Severity Rating Scale Baseline - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? | C-SSRS Baseline - Ideation With Plan/Intent | ||
CSS01-Ideation With Plan/Intent, Descr | C100983 | CSS01-Ideation With Plan/Intent, Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with specific plan and intent. | C-SSRS Baseline - Description of Ideation With Plan and Intent | ||
CSS01-Interrupted Attempt | C100995 | CSS01-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Baseline - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? | C-SSRS Baseline - Interrupted Suicide Attempt | ||
CSS01-Interrupted Attempt, Describe | C100997 | CSS01-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline - Description of interrupted attempt. | C-SSRS Baseline - Description of Interrupted Suicide Attempt | ||
CSS01-Most Lethal Attempt Damage | C101008 | CSS01-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt actual lethality/medical damage. | C-SSRS Baseline - Most Lethal Suicide Attempt Damage | ||
CSS01-Most Lethal Attempt Date | C101007 | CSS01-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt date. | C-SSRS Baseline - Most Lethal Suicide Attempt Date | ||
CSS01-Most Lethal Attempt Potential | C101009 | CSS01-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline - Most lethal attempt potential lethality. | C-SSRS Baseline - Most Lethal Suicide Attempt Potential | ||
CSS01-Most Recent Attempt Damage | C101005 | CSS01-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt actual lethality/medical damage. | C-SSRS Baseline - Most Recent Suicide Attempt Damage | ||
CSS01-Most Recent Attempt Date | C101004 | CSS01-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt date. | C-SSRS Baseline - Most Recent Suicide Attempt Date | ||
CSS01-Most Recent Attempt Potential | C101006 | CSS01-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline - Most recent attempt potential lethality. | C-SSRS Baseline - Most Recent Suicide Attempt Potential | ||
CSS01-Most Severe Ideation | C100984 | CSS01-Most Severe Ideation | Columbia-Suicide Severity Rating Scale Baseline - Most severe ideation. | C-SSRS Baseline - Most Severe Ideation | ||
CSS01-Most Severe Ideation, Control | C100988 | CSS01-Most Severe Ideation, Control | Columbia-Suicide Severity Rating Scale Baseline - Could/can you stop thinking about killing yourself or wanting to die if you want to? | C-SSRS Baseline - Control over Most Severe Ideation | ||
CSS01-Most Severe Ideation, Description | C100985 | CSS01-Most Severe Ideation, Description | Columbia-Suicide Severity Rating Scale Baseline - Description of most severe ideation. | C-SSRS Baseline - Describe Most Severe Ideation | ||
CSS01-Most Severe Ideation, Deterrents | C100989 | CSS01-Most Severe Ideation, Deterrents | Columbia-Suicide Severity Rating Scale Baseline - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? | C-SSRS Baseline - Deterrents to Most Severe Ideation | ||
CSS01-Most Severe Ideation, Duration | C100987 | CSS01-Most Severe Ideation, Duration | Columbia-Suicide Severity Rating Scale Baseline - When you have the thoughts, how long do they last? | C-SSRS Baseline - Duration of Most Severe Ideation | ||
CSS01-Most Severe Ideation, Frequency | C100986 | CSS01-Most Severe Ideation, Frequency | Columbia-Suicide Severity Rating Scale Baseline - How many times have you had these thoughts? | C-SSRS Baseline - Frequency of Most Severe Ideation | ||
CSS01-Most Severe Ideation, Reasons | C100990 | CSS01-Most Severe Ideation, Reasons | Columbia-Suicide Severity Rating Scale Baseline - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? | C-SSRS Baseline - Reasons for Most Severe Ideation | ||
CSS01-Non-Specific Suicid Thought, Descr | C100979 | CSS01-Non-Specific Suicid Thought, Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of non-specific active suicidal thoughts. | C-SSRS Baseline - Description of Non-Specific Suicide Thought | ||
CSS01-Non-Specific Suicidal Thought | C100978 | CSS01-Non-Specific Suicidal Thought | Columbia-Suicide Severity Rating Scale Baseline - Have you actually had any thoughts of killing yourself? | C-SSRS Baseline - Non-Specific Suicidal Thought | ||
CSS01-Non-suicidal Self-injurious Behav | C100994 | CSS01-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Baseline - Has the subject engaged in non-suicidal self-injurious behavior. | C-SSRS Baseline - Non-suicidal Self-injurious Behavior | ||
CSS01-Number of Aborted Attempts | C100999 | CSS01-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Baseline - Total number of aborted attempts. | C-SSRS Baseline - Number of Aborted Suicide Attempts | ||
CSS01-Number of Actual Attempts | C100992 | CSS01-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Baseline - Total number of actual attempts. | C-SSRS Baseline - Number of Actual Suicide Attempts | ||
CSS01-Number of Interrupted Attempts | C100996 | CSS01-Number of Interrupted Attempts | Columbia-Suicide Severity Rating Scale Baseline - Total number of interrupted attempts. | C-SSRS Baseline - Number of Interrupted Suicide Attempts | ||
CSS01-Preparatory Acts/Behavior | C101001 | CSS01-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Baseline - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? | C-SSRS Baseline - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS01-Preparatory Acts/Behavior, Descr | C101002 | CSS01-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of preparatory acts or behavior. | C-SSRS Baseline - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS01-Suicidal Behavior | C101003 | CSS01-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Baseline - Suicidal behavior was present during the assessment period? | C-SSRS Baseline - Suicidal Behavior | ||
CSS01-Suicidal Ideation-No Intent | C100980 | CSS01-Suicidal Ideation-No Intent | Columbia-Suicide Severity Rating Scale Baseline - Have you been thinking about how you might do this? | C-SSRS Baseline - Suicidal Ideation-No Intent | ||
CSS01-Suicidal Ideation-No Intent, Descr | C100981 | CSS01-Suicidal Ideation-No Intent, Descr | Columbia-Suicide Severity Rating Scale Baseline - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Baseline - Description of Suicidal Ideation-No Intent | ||
CSS01-Wish to be Dead | C100976 | CSS01-Wish to be Dead | Columbia-Suicide Severity Rating Scale Baseline - Have you wished you were dead or wished you could go to sleep and not wake up? | C-SSRS Baseline - Wish to be Dead or go to Sleep and not Wake Up | ||
CSS01-Wish to be Dead, Describe | C100977 | CSS01-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Baseline - Description of wishing to be dead. | C-SSRS Baseline - Description of Wish to be Dead | ||
Back to top | ||||||
CL.C105132.CSS03TC | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Questionnaire Test Code
(CSS03TC) | text
Extensible: No | C105132 | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Version 1/14/2009 Questionnaire test code. | CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Code Terminology |
CSS0301A | C105210 | CSS03-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Wish to be Dead (Lifetime) | ||
CSS0301B | C105211 | CSS03-Wish to be Dead-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you wished you were dead or wished you could go to sleep and not wake up? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Wish to be Dead (Past 6 Months) | ||
CSS0301C | C105212 | CSS03-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of wishing to be dead. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Wish to be Dead (Lifetime) | ||
CSS0302A | C105213 | CSS03-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you actually had any thoughts of killing yourself? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS0302B | C105214 | CSS03-Non-Spec Suicid Thought-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you actually had any thoughts of killing yourself? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Non-Specific Active Suicidal Thoughts (Past 6 Months) | ||
CSS0302C | C105215 | CSS03-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of non-specific active suicidal thoughts. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS0303A | C105216 | CSS03-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you been thinking about how you might do this? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS0303B | C105217 | CSS03-Idea, No Intent, No Plan-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you been thinking about how you might do this? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 6 Months) | ||
CSS0303C | C105218 | CSS03-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS0304A | C105219 | CSS03-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you had these thoughts and had some intention of acting on them? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS0304B | C105220 | CSS03-Idea, Intent, No Plan-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you had these thoughts and had some intention of acting on them? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 6 Months) | ||
CSS0304C | C105221 | CSS03-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS0305A | C105222 | CSS03-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS0305B | C105223 | CSS03-Idea, Plan, Intent-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Specific Plan and Intent (Past 6 Months) | ||
CSS0305C | C105224 | CSS03-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with specific plan and intent. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS0306A | C105225 | CSS03-Most Severe Idea-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most severe ideation. (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Most Severe Ideation (Lifetime) | ||
CSS0306B | C105226 | CSS03-Most Severe Idea, Desc-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of most severe ideation. (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Describe Most Severe Ideation (Lifetime) | ||
CSS0306C | C105227 | CSS03-Most Severe Idea-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most severe ideation. (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Most Severe Ideation (Past 6 Months) | ||
CSS0306D | C105228 | CSS03-Most Severe Idea, Desc-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of most severe ideation. (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Describe Most Severe Ideation (Past 6 Months) | ||
CSS0307A | C105229 | CSS03-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - How many times have you had these thoughts? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Frequency of Most Severe Ideation (Lifetime) | ||
CSS0307B | C105230 | CSS03-Most Severe Idea, Frequency-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - How many times have you had these thoughts? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Frequency of Most Severe Ideation (Past 6 Months) | ||
CSS0308A | C105231 | CSS03-Most Severe Idea, Duration-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - When you have the thoughts how long do they last? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Duration of Most Severe Ideation (Lifetime) | ||
CSS0308B | C105232 | CSS03-Most Severe Idea, Duration-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - When you have the thoughts how long do they last? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Duration of Most Severe Ideation (Past 6 Months) | ||
CSS0309A | C105233 | CSS03-Most Severe Idea, Control-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Controllability of Most Severe Ideation (Lifetime) | ||
CSS0309B | C105234 | CSS03-Most Severe Idea, Control-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Controllability of Most Severe Ideation (Past 6 Months) | ||
CSS0310A | C105235 | CSS03-Most Severe Idea, Deterrents-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Deterrents to Most Severe Ideation (Lifetime) | ||
CSS0310B | C105236 | CSS03-Most Severe Idea, Deterrents-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Deterrents to Most Severe Ideation (Past 6 Months) | ||
CSS0311A | C105237 | CSS03-Most Severe Idea, Reasons-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Reasons for Most Severe Ideation (Lifetime) | ||
CSS0311B | C105238 | CSS03-Most Severe Idea, Reasons-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Reasons for Most Severe Ideation (Past 6 Months) | ||
CSS0312 | C105239 | CSS03-Actual Attempt | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? | C-SSRS Baseline/Screening Version Phase 1 Study - Actual Suicide Attempt | ||
CSS0313 | C105240 | CSS03-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of actual attempts. | C-SSRS Baseline/Screening Version Phase 1 Study - Number of Actual Suicide Attempts | ||
CSS0313A | C105241 | CSS03-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of actual attempt. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Actual Suicide Attempt | ||
CSS0314 | C105242 | CSS03-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has the subject engaged in non-suicidal self-injurious behavior. | C-SSRS Baseline/Screening Version Phase 1 Study - Non-suicidal Self-injurious Behavior | ||
CSS0315 | C105243 | CSS03-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? | C-SSRS Baseline/Screening Version Phase 1 Study - Interrupted Suicide Attempt | ||
CSS0316 | C105244 | CSS03-Number of Interrupted Attempts | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of interrupted attempts. | C-SSRS Baseline/Screening Version Phase 1 Study - Number of Interrupted Suicide Attempts | ||
CSS0316A | C105245 | CSS03-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of interrupted attempt. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Interrupted Suicide Attempt | ||
CSS0317 | C105246 | CSS03-Aborted Attempt | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? | C-SSRS Baseline/Screening Version Phase 1 Study - Aborted Suicide Attempt | ||
CSS0318 | C105247 | CSS03-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of aborted attempts. | C-SSRS Baseline/Screening Version Phase 1 Study - Number of Aborted Suicide Attempts | ||
CSS0318A | C105248 | CSS03-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of aborted attempt. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Aborted Suicide Attempt | ||
CSS0319 | C105249 | CSS03-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? | C-SSRS Baseline/Screening Version Phase 1 Study - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0319A | C105250 | CSS03-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of preparatory acts or behavior. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0320 | C105251 | CSS03-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Suicidal behavior was present during the assessment period? | C-SSRS Baseline/Screening Version Phase 1 Study - Suicidal Behavior | ||
CSS0321A | C105252 | CSS03-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt date. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Date | ||
CSS0321B | C105253 | CSS03-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0321C | C105254 | CSS03-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt potential lethality. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Potential Lethality | ||
CSS0322A | C105255 | CSS03-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt date. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Date | ||
CSS0322B | C105256 | CSS03-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0322C | C105257 | CSS03-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt potential lethality. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Potential Lethality | ||
CSS0323A | C105258 | CSS03-First Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt date. | C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Date | ||
CSS0323B | C105259 | CSS03-First Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0323C | C105260 | CSS03-First Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt potential lethality. | C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Potential Lethality | ||
Back to top | ||||||
CL.C105131.CSS03TN | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Questionnaire Test Name
(CSS03TN) | text
Extensible: No | C105131 | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study Version 1/14/2009 test name. | CDISC Questionnaire C-SSRS Baseline/Screening Version Phase 1 Study Version 1/14/09 Test Name Terminology |
CSS03-Aborted Attempt | C105246 | CSS03-Aborted Attempt | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? | C-SSRS Baseline/Screening Version Phase 1 Study - Aborted Suicide Attempt | ||
CSS03-Aborted Attempt, Describe | C105248 | CSS03-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of aborted attempt. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Aborted Suicide Attempt | ||
CSS03-Actual Attempt | C105239 | CSS03-Actual Attempt | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? | C-SSRS Baseline/Screening Version Phase 1 Study - Actual Suicide Attempt | ||
CSS03-Actual Attempt, Describe | C105241 | CSS03-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of actual attempt. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Actual Suicide Attempt | ||
CSS03-First Attempt Damage | C105259 | CSS03-First Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS03-First Attempt Date | C105258 | CSS03-First Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt date. | C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Date | ||
CSS03-First Attempt Potential | C105260 | CSS03-First Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Initial/first attempt potential lethality. | C-SSRS Baseline/Screening Version Phase 1 Study - First Suicide Attempt Potential Lethality | ||
CSS03-Idea, Intent, No Plan, Describe | C105221 | CSS03-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS03-Idea, Intent, No Plan-Life | C105219 | CSS03-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you had these thoughts and had some intention of acting on them? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS03-Idea, Intent, No Plan-P6M | C105220 | CSS03-Idea, Intent, No Plan-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you had these thoughts and had some intention of acting on them? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 6 Months) | ||
CSS03-Idea, No Intent, No Plan, Describe | C105218 | CSS03-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS03-Idea, No Intent, No Plan-Life | C105216 | CSS03-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you been thinking about how you might do this? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS03-Idea, No Intent, No Plan-P6M | C105217 | CSS03-Idea, No Intent, No Plan-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you been thinking about how you might do this? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 6 Months) | ||
CSS03-Idea, Plan, Intent, Describe | C105224 | CSS03-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of active suicidal ideation with specific plan and intent. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS03-Idea, Plan, Intent-Life | C105222 | CSS03-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS03-Idea, Plan, Intent-P6M | C105223 | CSS03-Idea, Plan, Intent-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Active Suicidal Ideation with Specific Plan and Intent (Past 6 Months) | ||
CSS03-Interrupted Attempt | C105243 | CSS03-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? | C-SSRS Baseline/Screening Version Phase 1 Study - Interrupted Suicide Attempt | ||
CSS03-Interrupted Attempt, Describe | C105245 | CSS03-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of interrupted attempt. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Interrupted Suicide Attempt | ||
CSS03-Most Lethal Attempt Damage | C105256 | CSS03-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS03-Most Lethal Attempt Date | C105255 | CSS03-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt date. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Date | ||
CSS03-Most Lethal Attempt Potential | C105257 | CSS03-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most lethal attempt potential lethality. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Lethal Suicide Attempt Potential Lethality | ||
CSS03-Most Recent Attempt Damage | C105253 | CSS03-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS03-Most Recent Attempt Date | C105252 | CSS03-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt date. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Date | ||
CSS03-Most Recent Attempt Potential | C105254 | CSS03-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most recent attempt potential lethality. | C-SSRS Baseline/Screening Version Phase 1 Study - Most Recent Suicide Attempt Potential Lethality | ||
CSS03-Most Severe Idea, Control-Life | C105233 | CSS03-Most Severe Idea, Control-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Controllability of Most Severe Ideation (Lifetime) | ||
CSS03-Most Severe Idea, Control-P6M | C105234 | CSS03-Most Severe Idea, Control-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Controllability of Most Severe Ideation (Past 6 Months) | ||
CSS03-Most Severe Idea, Desc-Life | C105226 | CSS03-Most Severe Idea, Desc-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of most severe ideation. (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Describe Most Severe Ideation (Lifetime) | ||
CSS03-Most Severe Idea, Desc-P6M | C105228 | CSS03-Most Severe Idea, Desc-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of most severe ideation. (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Describe Most Severe Ideation (Past 6 Months) | ||
CSS03-Most Severe Idea, Deterrents-Life | C105235 | CSS03-Most Severe Idea, Deterrents-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Deterrents to Most Severe Ideation (Lifetime) | ||
CSS03-Most Severe Idea, Deterrents-P6M | C105236 | CSS03-Most Severe Idea, Deterrents-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Deterrents to Most Severe Ideation (Past 6 Months) | ||
CSS03-Most Severe Idea, Duration-Life | C105231 | CSS03-Most Severe Idea, Duration-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - When you have the thoughts how long do they last? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Duration of Most Severe Ideation (Lifetime) | ||
CSS03-Most Severe Idea, Duration-P6M | C105232 | CSS03-Most Severe Idea, Duration-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - When you have the thoughts how long do they last? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Duration of Most Severe Ideation (Past 6 Months) | ||
CSS03-Most Severe Idea, Frequency-Life | C105229 | CSS03-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - How many times have you had these thoughts? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Frequency of Most Severe Ideation (Lifetime) | ||
CSS03-Most Severe Idea, Frequency-P6M | C105230 | CSS03-Most Severe Idea, Frequency-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - How many times have you had these thoughts? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Frequency of Most Severe Ideation (Past 6 Months) | ||
CSS03-Most Severe Idea, Reasons-Life | C105237 | CSS03-Most Severe Idea, Reasons-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Reasons for Most Severe Ideation (Lifetime) | ||
CSS03-Most Severe Idea, Reasons-P6M | C105238 | CSS03-Most Severe Idea, Reasons-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Reasons for Most Severe Ideation (Past 6 Months) | ||
CSS03-Most Severe Idea-Life | C105225 | CSS03-Most Severe Idea-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most severe ideation. (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Most Severe Ideation (Lifetime) | ||
CSS03-Most Severe Idea-P6M | C105227 | CSS03-Most Severe Idea-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Most severe ideation. (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Most Severe Ideation (Past 6 Months) | ||
CSS03-Non-Spec Suicid Thought, Describe | C105215 | CSS03-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of non-specific active suicidal thoughts. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS03-Non-Spec Suicid Thought-Life | C105213 | CSS03-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you actually had any thoughts of killing yourself? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS03-Non-Spec Suicid Thought-P6M | C105214 | CSS03-Non-Spec Suicid Thought-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you actually had any thoughts of killing yourself? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Non-Specific Active Suicidal Thoughts (Past 6 Months) | ||
CSS03-Non-suicidal Self-injurious Behav | C105242 | CSS03-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Has the subject engaged in non-suicidal self-injurious behavior. | C-SSRS Baseline/Screening Version Phase 1 Study - Non-suicidal Self-injurious Behavior | ||
CSS03-Number of Aborted Attempts | C105247 | CSS03-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of aborted attempts. | C-SSRS Baseline/Screening Version Phase 1 Study - Number of Aborted Suicide Attempts | ||
CSS03-Number of Actual Attempts | C105240 | CSS03-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of actual attempts. | C-SSRS Baseline/Screening Version Phase 1 Study - Number of Actual Suicide Attempts | ||
CSS03-Number of Interrupted Attempts | C105244 | CSS03-Number of Interrupted Attempts | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Total number of interrupted attempts. | C-SSRS Baseline/Screening Version Phase 1 Study - Number of Interrupted Suicide Attempts | ||
CSS03-Preparatory Acts/Behavior | C105249 | CSS03-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? | C-SSRS Baseline/Screening Version Phase 1 Study - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS03-Preparatory Acts/Behavior, Descr | C105250 | CSS03-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of preparatory acts or behavior. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS03-Suicidal Behavior | C105251 | CSS03-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Suicidal behavior was present during the assessment period? | C-SSRS Baseline/Screening Version Phase 1 Study - Suicidal Behavior | ||
CSS03-Wish to be Dead, Describe | C105212 | CSS03-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Description of wishing to be dead. | C-SSRS Baseline/Screening Version Phase 1 Study - Description of Wish to be Dead (Lifetime) | ||
CSS03-Wish to be Dead-Life | C105210 | CSS03-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). | C-SSRS Baseline/Screening Version Phase 1 Study - Wish to be Dead (Lifetime) | ||
CSS03-Wish to be Dead-P6M | C105211 | CSS03-Wish to be Dead-P6M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Phase 1 Study - Have you wished you were dead or wished you could go to sleep and not wake up? (Past 6 Months). | C-SSRS Baseline/Screening Version Phase 1 Study - Wish to be Dead (Past 6 Months) | ||
Back to top | ||||||
CL.C106661.CSS04TC | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire Test Code
(CSS04TC) | text
Extensible: No | C106661 | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Baseline/Screening Version test code. | CDISC Questionnaire C-SSRS Baseline/Screening Version Test Code Terminology |
CSS0401A | C106707 | CSS04-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). | C-SSRS Baseline/Screening Version - Wish to be Dead (Lifetime) | ||
CSS0401B | C106708 | CSS04-Wish to be Dead-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Past _ Months). | C-SSRS Baseline/Screening Version - Wish to be Dead (Past X Months) | ||
CSS0401C | C106709 | CSS04-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of wishing to be dead. | C-SSRS Baseline/Screening Version - Description of Wish to be Dead | ||
CSS0402A | C106710 | CSS04-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you actually had any thoughts of killing yourself? (Lifetime). | C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS0402B | C106711 | CSS04-Non-Spec Suicid Thought-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you actually had any thoughts of killing yourself? (Past _ Months). | C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Past X Months) | ||
CSS0402C | C106712 | CSS04-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of non-specific active suicidal thoughts. | C-SSRS Baseline/Screening Version - Description of Non-Specific Active Suicidal Thoughts | ||
CSS0403A | C106713 | CSS04-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you been thinking about how you might do this? (Lifetime). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS0403B | C106714 | CSS04-Idea, No Intent, No Plan-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you been thinking about how you might do this? (Past _ Months). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past X Months) | ||
CSS0403C | C106715 | CSS04-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS0404A | C107017 | CSS04-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you had these thoughts and had some intention of acting on them? (Lifetime). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS0404B | C107018 | CSS04-Idea, Intent, No Plan-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you had these thoughts and had some intention of acting on them? (Past _ Months). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past X Months) | ||
CSS0404C | C107019 | CSS04-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS0405A | C106716 | CSS04-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS0405B | C106717 | CSS04-Idea, Plan, Intent-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past _ Months). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Specific Plan and Intent (Past X Months) | ||
CSS0405C | C106718 | CSS04-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with specific plan and intent. | C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS0406A | C106719 | CSS04-Most Severe Idea-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most severe ideation. (Lifetime). | C-SSRS Baseline/Screening Version - Most Severe Ideation (Lifetime) | ||
CSS0406B | C106720 | CSS04-Most Severe Idea, Desc-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of most severe ideation. (Lifetime). | C-SSRS Baseline/Screening Version - Describe Most Severe Ideation (Lifetime) | ||
CSS0406C | C106721 | CSS04-Most Severe Idea-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most severe ideation. (Past _ Months). | C-SSRS Baseline/Screening Version - Most Severe Ideation (Past X Months) | ||
CSS0406D | C106722 | CSS04-Most Severe Idea, Desc-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of most severe ideation. (Past _ Months). | C-SSRS Baseline/Screening Version - Describe Most Severe Ideation (Past X Months) | ||
CSS0407A | C106723 | CSS04-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - How many times have you had these thoughts? (Lifetime). | C-SSRS Baseline/Screening Version - Frequency of Most Severe Ideation (Lifetime) | ||
CSS0407B | C106724 | CSS04-Most Severe Idea, Frequency-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - How many times have you had these thoughts? (Past _ Months). | C-SSRS Baseline/Screening Version - Frequency of Most Severe Ideation (Past X Months) | ||
CSS0408A | C106725 | CSS04-Most Severe Idea, Duration-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - When you have the thoughts how long do they last? (Lifetime). | C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Lifetime) | ||
CSS0408B | C106726 | CSS04-Most Severe Idea, Duration-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - When you have the thoughts how long do they last? (Past _ Months). | C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Past X Months) | ||
CSS0409A | C106727 | CSS04-Most Severe Idea, Control-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). | C-SSRS Baseline/Screening Version - Controllability of Most Severe Ideation (Lifetime) | ||
CSS0409B | C106728 | CSS04-Most Severe Idea, Control-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past _ Months). | C-SSRS Baseline/Screening Version - Controllability of Most Severe Ideation (Past X Months) | ||
CSS0410A | C106729 | CSS04-Most Severe Idea, Deterrents-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). | C-SSRS Baseline/Screening Version - Deterrents to Most Severe Ideation (Lifetime) | ||
CSS0410B | C106730 | CSS04-Most Severe Idea, Deterrents-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past _ Months). | C-SSRS Baseline/Screening Version - Deterrents to Most Severe Ideation (Past X Months) | ||
CSS0411A | C106731 | CSS04-Most Severe Idea, Reasons-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). | C-SSRS Baseline/Screening Version - Reasons for Most Severe Ideation (Lifetime) | ||
CSS0411B | C106732 | CSS04-Most Severe Idea, Reasons-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past _ Months). | C-SSRS Baseline/Screening Version - Reasons for Most Severe Ideation (Past X Months) | ||
CSS0412A | C106733 | CSS04-Actual Attempt-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Lifetime). | C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Lifetime) | ||
CSS0412B | C106734 | CSS04-Actual Attempt-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Past _ Years). | C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Past X Years) | ||
CSS0413A | C106735 | CSS04-Number of Actual Attempts-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of actual attempts. (Lifetime). | C-SSRS Baseline/Screening Version - Number of Actual Suicide Attempts (Lifetime) | ||
CSS0413B | C106736 | CSS04-Number of Actual Attempts-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of actual attempts. (Past _ Years). | C-SSRS Baseline/Screening Version - Number of Actual Suicide Attempts (Past X Years) | ||
CSS0413C | C106737 | CSS04-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of actual attempt. | C-SSRS Baseline/Screening Version - Description of Actual Suicide Attempt | ||
CSS0414A | C106738 | CSS04-Non-suicidal Self-injur Behav-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injurious behavior. (Lifetime). | C-SSRS Baseline/Screening Version - Non-suicidal Self-injurious Behavior (Lifetime) | ||
CSS0414B | C106739 | CSS04-Non-suicidal Self-injur Behav-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injurious behavior. (Past _ Years). | C-SSRS Baseline/Screening Version - Non-suicidal Self-injurious Behavior (Past X Years) | ||
CSS0415A | C106740 | CSS04-Interrupted Attempt-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? (Lifetime). | C-SSRS Baseline/Screening Version - Interrupted Suicide Attempt (Lifetime) | ||
CSS0415B | C106741 | CSS04-Interrupted Attempt-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? (Past _ Years). | C-SSRS Baseline/Screening Version - Interrupted Suicide Attempt (Past X Years) | ||
CSS0416A | C106742 | CSS04-Number of Interrupt Attempts-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of interrupted attempts. (Lifetime). | C-SSRS Baseline/Screening Version - Number of Interrupted Suicide Attempts (Lifetime) | ||
CSS0416B | C106743 | CSS04-Number of Interrupt Attempts-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of interrupted attempts. (Past _ Years). | C-SSRS Baseline/Screening Version - Number of Interrupted Suicide Attempts (Past X Years) | ||
CSS0416C | C106744 | CSS04-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of interrupted attempt. | C-SSRS Baseline/Screening Version - Description of Interrupted Suicide Attempt | ||
CSS0417A | C106745 | CSS04-Aborted Attempt-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Lifetime). | C-SSRS Baseline/Screening Version - Aborted Suicide Attempt (Lifetime) | ||
CSS0417B | C106746 | CSS04-Aborted Attempt-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Past _ Years). | C-SSRS Baseline/Screening Version - Aborted Suicide Attempt (Past X Years) | ||
CSS0418A | C106747 | CSS04-Number of Aborted Attempts-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of aborted attempts. (Lifetime). | C-SSRS Baseline/Screening Version - Number of Aborted Suicide Attempts (Lifetime) | ||
CSS0418B | C106748 | CSS04-Number of Aborted Attempts-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of aborted attempts. (Past _ Years). | C-SSRS Baseline/Screening Version - Number of Aborted Suicide Attempts (Past X Years) | ||
CSS0418C | C106749 | CSS04-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of aborted attempt. | C-SSRS Baseline/Screening Version - Description of Aborted Suicide Attempt | ||
CSS0419A | C106750 | CSS04-Preparatory Acts/Behavior-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Lifetime). | C-SSRS Baseline/Screening Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) | ||
CSS0419B | C106751 | CSS04-Preparatory Acts/Behavior-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Past _ Years). | C-SSRS Baseline/Screening Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Past X Years) | ||
CSS0419C | C106752 | CSS04-Preparatory Acts/Behav, Descr | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of preparatory acts or behavior. | C-SSRS Baseline/Screening Version - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0420A | C106753 | CSS04-Suicidal Behavior-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Suicidal behavior was present during the assessment period? (Lifetime). | C-SSRS Baseline/Screening Version - Suicidal Behavior (Lifetime) | ||
CSS0420B | C106754 | CSS04-Suicidal Behavior-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Suicidal behavior was present during the assessment period? (Past _ Years). | C-SSRS Baseline/Screening Version - Suicidal Behavior (Past X Years) | ||
CSS0421A | C106755 | CSS04-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt date. | C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Date | ||
CSS0421B | C106756 | CSS04-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0421C | C106757 | CSS04-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt potential lethality. | C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Potential Lethality | ||
CSS0422A | C106758 | CSS04-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt date. | C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Date | ||
CSS0422B | C106759 | CSS04-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0422C | C106760 | CSS04-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt potential lethality. | C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Potential Lethality | ||
CSS0423A | C106761 | CSS04-First Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt date. | C-SSRS Baseline/Screening Version - First Suicide Attempt Date | ||
CSS0423B | C106762 | CSS04-First Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0423C | C106763 | CSS04-First Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt potential lethality. | C-SSRS Baseline/Screening Version - First Suicide Attempt Potential Lethality | ||
Back to top | ||||||
CL.C106660.CSS04TN | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire Test Name
(CSS04TN) | text
Extensible: No | C106660 | Columbia-Suicide Severity Rating Scale Baseline/Screening Version Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Baseline/Screening Version test name. | CDISC Questionnaire C-SSRS Baseline/Screening Version Test Name Terminology |
CSS04-Aborted Attempt, Describe | C106749 | CSS04-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of aborted attempt. | C-SSRS Baseline/Screening Version - Description of Aborted Suicide Attempt | ||
CSS04-Aborted Attempt-Life | C106745 | CSS04-Aborted Attempt-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Lifetime). | C-SSRS Baseline/Screening Version - Aborted Suicide Attempt (Lifetime) | ||
CSS04-Aborted Attempt-P_Y | C106746 | CSS04-Aborted Attempt-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Past _ Years). | C-SSRS Baseline/Screening Version - Aborted Suicide Attempt (Past X Years) | ||
CSS04-Actual Attempt, Describe | C106737 | CSS04-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of actual attempt. | C-SSRS Baseline/Screening Version - Description of Actual Suicide Attempt | ||
CSS04-Actual Attempt-Life | C106733 | CSS04-Actual Attempt-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Lifetime). | C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Lifetime) | ||
CSS04-Actual Attempt-P_Y | C106734 | CSS04-Actual Attempt-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Past _ Years). | C-SSRS Baseline/Screening Version - Actual Suicide Attempt (Past X Years) | ||
CSS04-First Attempt Damage | C106762 | CSS04-First Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS04-First Attempt Date | C106761 | CSS04-First Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt date. | C-SSRS Baseline/Screening Version - First Suicide Attempt Date | ||
CSS04-First Attempt Potential | C106763 | CSS04-First Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Initial/first attempt potential lethality. | C-SSRS Baseline/Screening Version - First Suicide Attempt Potential Lethality | ||
CSS04-Idea, Intent, No Plan, Describe | C107019 | CSS04-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS04-Idea, Intent, No Plan-Life | C107017 | CSS04-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you had these thoughts and had some intention of acting on them? (Lifetime). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS04-Idea, Intent, No Plan-P_M | C107018 | CSS04-Idea, Intent, No Plan-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you had these thoughts and had some intention of acting on them? (Past _ Months). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past X Months) | ||
CSS04-Idea, No Intent, No Plan, Describe | C106715 | CSS04-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS04-Idea, No Intent, No Plan-Life | C106713 | CSS04-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you been thinking about how you might do this? (Lifetime). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS04-Idea, No Intent, No Plan-P_M | C106714 | CSS04-Idea, No Intent, No Plan-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you been thinking about how you might do this? (Past _ Months). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past X Months) | ||
CSS04-Idea, Plan, Intent, Describe | C106718 | CSS04-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of active suicidal ideation with specific plan and intent. | C-SSRS Baseline/Screening Version - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS04-Idea, Plan, Intent-Life | C106716 | CSS04-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS04-Idea, Plan, Intent-P_M | C106717 | CSS04-Idea, Plan, Intent-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past _ Months). | C-SSRS Baseline/Screening Version - Active Suicidal Ideation with Specific Plan and Intent (Past X Months) | ||
CSS04-Interrupted Attempt, Describe | C106744 | CSS04-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of interrupted attempt. | C-SSRS Baseline/Screening Version - Description of Interrupted Suicide Attempt | ||
CSS04-Interrupted Attempt-Life | C106740 | CSS04-Interrupted Attempt-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? (Lifetime). | C-SSRS Baseline/Screening Version - Interrupted Suicide Attempt (Lifetime) | ||
CSS04-Interrupted Attempt-P_Y | C106741 | CSS04-Interrupted Attempt-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? (Past _ Years). | C-SSRS Baseline/Screening Version - Interrupted Suicide Attempt (Past X Years) | ||
CSS04-Most Lethal Attempt Damage | C106759 | CSS04-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS04-Most Lethal Attempt Date | C106758 | CSS04-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt date. | C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Date | ||
CSS04-Most Lethal Attempt Potential | C106760 | CSS04-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most lethal attempt potential lethality. | C-SSRS Baseline/Screening Version - Most Lethal Suicide Attempt Potential Lethality | ||
CSS04-Most Recent Attempt Damage | C106756 | CSS04-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt actual lethality/medical damage. | C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS04-Most Recent Attempt Date | C106755 | CSS04-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt date. | C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Date | ||
CSS04-Most Recent Attempt Potential | C106757 | CSS04-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most recent attempt potential lethality. | C-SSRS Baseline/Screening Version - Most Recent Suicide Attempt Potential Lethality | ||
CSS04-Most Severe Idea, Control-Life | C106727 | CSS04-Most Severe Idea, Control-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). | C-SSRS Baseline/Screening Version - Controllability of Most Severe Ideation (Lifetime) | ||
CSS04-Most Severe Idea, Control-P_M | C106728 | CSS04-Most Severe Idea, Control-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past _ Months). | C-SSRS Baseline/Screening Version - Controllability of Most Severe Ideation (Past X Months) | ||
CSS04-Most Severe Idea, Desc-Life | C106720 | CSS04-Most Severe Idea, Desc-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of most severe ideation. (Lifetime). | C-SSRS Baseline/Screening Version - Describe Most Severe Ideation (Lifetime) | ||
CSS04-Most Severe Idea, Desc-P_M | C106722 | CSS04-Most Severe Idea, Desc-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of most severe ideation. (Past _ Months). | C-SSRS Baseline/Screening Version - Describe Most Severe Ideation (Past X Months) | ||
CSS04-Most Severe Idea, Deterrents-Life | C106729 | CSS04-Most Severe Idea, Deterrents-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). | C-SSRS Baseline/Screening Version - Deterrents to Most Severe Ideation (Lifetime) | ||
CSS04-Most Severe Idea, Deterrents-P_M | C106730 | CSS04-Most Severe Idea, Deterrents-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past _ Months). | C-SSRS Baseline/Screening Version - Deterrents to Most Severe Ideation (Past X Months) | ||
CSS04-Most Severe Idea, Duration-Life | C106725 | CSS04-Most Severe Idea, Duration-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - When you have the thoughts how long do they last? (Lifetime). | C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Lifetime) | ||
CSS04-Most Severe Idea, Duration-P_M | C106726 | CSS04-Most Severe Idea, Duration-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - When you have the thoughts how long do they last? (Past _ Months). | C-SSRS Baseline/Screening Version - Duration of Most Severe Ideation (Past X Months) | ||
CSS04-Most Severe Idea, Frequency-Life | C106723 | CSS04-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - How many times have you had these thoughts? (Lifetime). | C-SSRS Baseline/Screening Version - Frequency of Most Severe Ideation (Lifetime) | ||
CSS04-Most Severe Idea, Frequency-P_M | C106724 | CSS04-Most Severe Idea, Frequency-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - How many times have you had these thoughts? (Past _ Months). | C-SSRS Baseline/Screening Version - Frequency of Most Severe Ideation (Past X Months) | ||
CSS04-Most Severe Idea, Reasons-Life | C106731 | CSS04-Most Severe Idea, Reasons-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). | C-SSRS Baseline/Screening Version - Reasons for Most Severe Ideation (Lifetime) | ||
CSS04-Most Severe Idea, Reasons-P_M | C106732 | CSS04-Most Severe Idea, Reasons-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past _ Months). | C-SSRS Baseline/Screening Version - Reasons for Most Severe Ideation (Past X Months) | ||
CSS04-Most Severe Idea-Life | C106719 | CSS04-Most Severe Idea-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most severe ideation. (Lifetime). | C-SSRS Baseline/Screening Version - Most Severe Ideation (Lifetime) | ||
CSS04-Most Severe Idea-P_M | C106721 | CSS04-Most Severe Idea-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Most severe ideation. (Past _ Months). | C-SSRS Baseline/Screening Version - Most Severe Ideation (Past X Months) | ||
CSS04-Non-Spec Suicid Thought, Describe | C106712 | CSS04-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of non-specific active suicidal thoughts. | C-SSRS Baseline/Screening Version - Description of Non-Specific Active Suicidal Thoughts | ||
CSS04-Non-Spec Suicid Thought-Life | C106710 | CSS04-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you actually had any thoughts of killing yourself? (Lifetime). | C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS04-Non-Spec Suicid Thought-P_M | C106711 | CSS04-Non-Spec Suicid Thought-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you actually had any thoughts of killing yourself? (Past _ Months). | C-SSRS Baseline/Screening Version - Non-Specific Active Suicidal Thoughts (Past X Months) | ||
CSS04-Non-suicidal Self-injur Behav-Life | C106738 | CSS04-Non-suicidal Self-injur Behav-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injurious behavior. (Lifetime). | C-SSRS Baseline/Screening Version - Non-suicidal Self-injurious Behavior (Lifetime) | ||
CSS04-Non-suicidal Self-injur Behav-P_Y | C106739 | CSS04-Non-suicidal Self-injur Behav-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Has the subject engaged in non-suicidal self-injurious behavior. (Past _ Years). | C-SSRS Baseline/Screening Version - Non-suicidal Self-injurious Behavior (Past X Years) | ||
CSS04-Number of Aborted Attempts-Life | C106747 | CSS04-Number of Aborted Attempts-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of aborted attempts. (Lifetime). | C-SSRS Baseline/Screening Version - Number of Aborted Suicide Attempts (Lifetime) | ||
CSS04-Number of Aborted Attempts-P_Y | C106748 | CSS04-Number of Aborted Attempts-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of aborted attempts. (Past _ Years). | C-SSRS Baseline/Screening Version - Number of Aborted Suicide Attempts (Past X Years) | ||
CSS04-Number of Actual Attempts-Life | C106735 | CSS04-Number of Actual Attempts-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of actual attempts. (Lifetime). | C-SSRS Baseline/Screening Version - Number of Actual Suicide Attempts (Lifetime) | ||
CSS04-Number of Actual Attempts-P_Y | C106736 | CSS04-Number of Actual Attempts-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of actual attempts. (Past _ Years). | C-SSRS Baseline/Screening Version - Number of Actual Suicide Attempts (Past X Years) | ||
CSS04-Number of Interrupt Attempts-Life | C106742 | CSS04-Number of Interrupt Attempts-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of interrupted attempts. (Lifetime). | C-SSRS Baseline/Screening Version - Number of Interrupted Suicide Attempts (Lifetime) | ||
CSS04-Number of Interrupt Attempts-P_Y | C106743 | CSS04-Number of Interrupt Attempts-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Total number of interrupted attempts. (Past _ Years). | C-SSRS Baseline/Screening Version - Number of Interrupted Suicide Attempts (Past X Years) | ||
CSS04-Preparatory Acts/Behav, Descr | C106752 | CSS04-Preparatory Acts/Behav, Descr | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of preparatory acts or behavior. | C-SSRS Baseline/Screening Version - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS04-Preparatory Acts/Behavior-Life | C106750 | CSS04-Preparatory Acts/Behavior-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Lifetime). | C-SSRS Baseline/Screening Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) | ||
CSS04-Preparatory Acts/Behavior-P_Y | C106751 | CSS04-Preparatory Acts/Behavior-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Past _ Years). | C-SSRS Baseline/Screening Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Past X Years) | ||
CSS04-Suicidal Behavior-Life | C106753 | CSS04-Suicidal Behavior-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Suicidal behavior was present during the assessment period? (Lifetime). | C-SSRS Baseline/Screening Version - Suicidal Behavior (Lifetime) | ||
CSS04-Suicidal Behavior-P_Y | C106754 | CSS04-Suicidal Behavior-P_Y | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Suicidal behavior was present during the assessment period? (Past _ Years). | C-SSRS Baseline/Screening Version - Suicidal Behavior (Past X Years) | ||
CSS04-Wish to be Dead, Describe | C106709 | CSS04-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Description of wishing to be dead. | C-SSRS Baseline/Screening Version - Description of Wish to be Dead | ||
CSS04-Wish to be Dead-Life | C106707 | CSS04-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). | C-SSRS Baseline/Screening Version - Wish to be Dead (Lifetime) | ||
CSS04-Wish to be Dead-P_M | C106708 | CSS04-Wish to be Dead-P_M | Columbia-Suicide Severity Rating Scale Baseline/Screening Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Past _ Months). | C-SSRS Baseline/Screening Version - Wish to be Dead (Past X Months) | ||
Back to top | ||||||
CL.C111336.CSS06TC | Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire Test Code
(CSS06TC) | text
Extensible: No | C111336 | Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Children's Baseline test code. | CDISC Questionnaire C-SSRS Children's Baseline Test Code Terminology |
CSS0601 | C111527 | CSS06-Wish to be Dead | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? | C-SSRS Children's Baseline - Wish to be Dead | ||
CSS0601A | C111528 | CSS06-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of wishing to be dead. | C-SSRS Children's Baseline - Description of Wish to be Dead | ||
CSS0602 | C111529 | CSS06-Non-Specific Suicidal Thought | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? | C-SSRS Children's Baseline - Non-Specific Active Suicidal Thoughts | ||
CSS0602A | C111530 | CSS06-Non-Specific Suicid Thought, Descr | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of non-specific active suicidal thoughts. | C-SSRS Children's Baseline - Description of Non-Specific Active Suicidal Thoughts | ||
CSS0603 | C111531 | CSS06-Idea, No Intent, No Plan | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? | C-SSRS Children's Baseline - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS0603A | C111532 | CSS06-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS0604 | C111533 | CSS06-Ideation With Intent, No Plan | Columbia-Suicide Severity Rating Scale Children's Baseline - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. | C-SSRS Children's Baseline - Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS0604A | C111534 | CSS06-Ideation With Intent No Plan Descr | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS0605 | C111535 | CSS06-Ideation With Plan/Intent | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? | C-SSRS Children's Baseline - Active Suicidal Ideation with Specific Plan and Intent | ||
CSS0605A | C111536 | CSS06-Ideation With Plan/Intent, Descr | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with specific plan and intent. | C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS0606 | C111537 | CSS06-Most Severe Ideation | Columbia-Suicide Severity Rating Scale Children's Baseline - Most severe ideation. | C-SSRS Children's Baseline - Most Severe Ideation | ||
CSS0606A | C111538 | CSS06-Most Severe Ideation, Description | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of most severe ideation. | C-SSRS Children's Baseline - Describe Most Severe Ideation | ||
CSS0607 | C111539 | CSS06-Most Severe Ideation, Frequency | Columbia-Suicide Severity Rating Scale Children's Baseline - How many times have you had these thoughts? | C-SSRS Children's Baseline - Frequency of Most Severe Ideation | ||
CSS0607A | C111540 | CSS06-Frequency, Write Response | Columbia-Suicide Severity Rating Scale Children's Baseline - Frequency, write response. | C-SSRS Children's Baseline - Frequency, Write Response | ||
CSS0608 | C111541 | CSS06-Actual Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? | C-SSRS Children's Baseline - Actual Suicide Attempt | ||
CSS0609 | C111542 | CSS06-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of actual attempts. | C-SSRS Children's Baseline - Number of Actual Suicide Attempts | ||
CSS0609A | C111543 | CSS06-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of actual attempt. | C-SSRS Children's Baseline - Description of Actual Suicide Attempt | ||
CSS0610 | C111544 | CSS06-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in non-suicidal self-injurious behavior? | C-SSRS Children's Baseline - Non-suicidal Self-injurious Behavior | ||
CSS0611 | C111545 | CSS06-Self-injur Behav, Intent Unknown | Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in self-injurious behavior, intent unknown? | C-SSRS Children's Baseline - Self-injurious Behavior, Intent Unknown | ||
CSS0612 | C111546 | CSS06-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? | C-SSRS Children's Baseline - Interrupted Suicide Attempt | ||
CSS0613 | C111547 | CSS06-Number of Interrupt Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of interrupted attempts. | C-SSRS Children's Baseline - Number of Interrupted Suicide Attempts | ||
CSS0613A | C111548 | CSS06-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of interrupted attempt. | C-SSRS Children's Baseline - Description of Interrupted Suicide Attempt | ||
CSS0614 | C111549 | CSS06-Aborted Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? | C-SSRS Children's Baseline - Aborted Suicide Attempt | ||
CSS0615 | C111550 | CSS06-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of aborted attempts. | C-SSRS Children's Baseline - Number of Aborted Suicide Attempts | ||
CSS0615A | C111551 | CSS06-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of aborted attempt. | C-SSRS Children's Baseline - Description of Aborted Suicide Attempt | ||
CSS0616 | C111552 | CSS06-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? | C-SSRS Children's Baseline - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0616A | C111553 | CSS06-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of preparatory acts or behavior. | C-SSRS Children's Baseline - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0617 | C111554 | CSS06-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Children's Baseline - Suicidal behavior was present during the assessment period? | C-SSRS Children's Baseline - Suicidal Behavior | ||
CSS0618A | C111555 | CSS06-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt date. | C-SSRS Children's Baseline - Most Recent Suicide Attempt Date | ||
CSS0618B | C111556 | CSS06-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt actual lethality/medical damage. | C-SSRS Children's Baseline - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0618C | C111557 | CSS06-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt potential lethality. | C-SSRS Children's Baseline - Most Recent Suicide Attempt Potential Lethality | ||
CSS0619A | C111558 | CSS06-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt date. | C-SSRS Children's Baseline - Most Lethal Suicide Attempt Date | ||
CSS0619B | C111559 | CSS06-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt actual lethality/medical damage. | C-SSRS Children's Baseline - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0619C | C111560 | CSS06-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt potential lethality. | C-SSRS Children's Baseline - Most Lethal Suicide Attempt Potential Lethality | ||
CSS0620A | C111561 | CSS06-First Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt date. | C-SSRS Children's Baseline - First Suicide Attempt Date | ||
CSS0620B | C111562 | CSS06-First Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt actual lethality/medical damage. | C-SSRS Children's Baseline - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0620C | C111563 | CSS06-First Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt potential lethality. | C-SSRS Children's Baseline - First Suicide Attempt Potential Lethality | ||
Back to top | ||||||
CL.C111335.CSS06TN | Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire Test Name
(CSS06TN) | text
Extensible: No | C111335 | Columbia-Suicide Severity Rating Scale Children's Baseline Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Children's Baseline test name. | CDISC Questionnaire C-SSRS Children's Baseline Test Name Terminology |
CSS06-Aborted Attempt | C111549 | CSS06-Aborted Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? | C-SSRS Children's Baseline - Aborted Suicide Attempt | ||
CSS06-Aborted Attempt, Describe | C111551 | CSS06-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of aborted attempt. | C-SSRS Children's Baseline - Description of Aborted Suicide Attempt | ||
CSS06-Actual Attempt | C111541 | CSS06-Actual Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? | C-SSRS Children's Baseline - Actual Suicide Attempt | ||
CSS06-Actual Attempt, Describe | C111543 | CSS06-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of actual attempt. | C-SSRS Children's Baseline - Description of Actual Suicide Attempt | ||
CSS06-First Attempt Damage | C111562 | CSS06-First Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt actual lethality/medical damage. | C-SSRS Children's Baseline - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS06-First Attempt Date | C111561 | CSS06-First Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt date. | C-SSRS Children's Baseline - First Suicide Attempt Date | ||
CSS06-First Attempt Potential | C111563 | CSS06-First Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline - Initial/first attempt potential lethality. | C-SSRS Children's Baseline - First Suicide Attempt Potential Lethality | ||
CSS06-Frequency, Write Response | C111540 | CSS06-Frequency, Write Response | Columbia-Suicide Severity Rating Scale Children's Baseline - Frequency, write response. | C-SSRS Children's Baseline - Frequency, Write Response | ||
CSS06-Idea, No Intent, No Plan | C111531 | CSS06-Idea, No Intent, No Plan | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? | C-SSRS Children's Baseline - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS06-Idea, No Intent, No Plan, Describe | C111532 | CSS06-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS06-Ideation With Intent No Plan Descr | C111534 | CSS06-Ideation With Intent No Plan Descr | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS06-Ideation With Intent, No Plan | C111533 | CSS06-Ideation With Intent, No Plan | Columbia-Suicide Severity Rating Scale Children's Baseline - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. | C-SSRS Children's Baseline - Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS06-Ideation With Plan/Intent | C111535 | CSS06-Ideation With Plan/Intent | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? | C-SSRS Children's Baseline - Active Suicidal Ideation with Specific Plan and Intent | ||
CSS06-Ideation With Plan/Intent, Descr | C111536 | CSS06-Ideation With Plan/Intent, Descr | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of active suicidal ideation with specific plan and intent. | C-SSRS Children's Baseline - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS06-Interrupted Attempt | C111546 | CSS06-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? | C-SSRS Children's Baseline - Interrupted Suicide Attempt | ||
CSS06-Interrupted Attempt, Describe | C111548 | CSS06-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of interrupted attempt. | C-SSRS Children's Baseline - Description of Interrupted Suicide Attempt | ||
CSS06-Most Lethal Attempt Damage | C111559 | CSS06-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt actual lethality/medical damage. | C-SSRS Children's Baseline - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS06-Most Lethal Attempt Date | C111558 | CSS06-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt date. | C-SSRS Children's Baseline - Most Lethal Suicide Attempt Date | ||
CSS06-Most Lethal Attempt Potential | C111560 | CSS06-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline - Most lethal attempt potential lethality. | C-SSRS Children's Baseline - Most Lethal Suicide Attempt Potential Lethality | ||
CSS06-Most Recent Attempt Damage | C111556 | CSS06-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt actual lethality/medical damage. | C-SSRS Children's Baseline - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS06-Most Recent Attempt Date | C111555 | CSS06-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt date. | C-SSRS Children's Baseline - Most Recent Suicide Attempt Date | ||
CSS06-Most Recent Attempt Potential | C111557 | CSS06-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline - Most recent attempt potential lethality. | C-SSRS Children's Baseline - Most Recent Suicide Attempt Potential Lethality | ||
CSS06-Most Severe Ideation | C111537 | CSS06-Most Severe Ideation | Columbia-Suicide Severity Rating Scale Children's Baseline - Most severe ideation. | C-SSRS Children's Baseline - Most Severe Ideation | ||
CSS06-Most Severe Ideation, Description | C111538 | CSS06-Most Severe Ideation, Description | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of most severe ideation. | C-SSRS Children's Baseline - Describe Most Severe Ideation | ||
CSS06-Most Severe Ideation, Frequency | C111539 | CSS06-Most Severe Ideation, Frequency | Columbia-Suicide Severity Rating Scale Children's Baseline - How many times have you had these thoughts? | C-SSRS Children's Baseline - Frequency of Most Severe Ideation | ||
CSS06-Non-Specific Suicid Thought, Descr | C111530 | CSS06-Non-Specific Suicid Thought, Descr | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of non-specific active suicidal thoughts. | C-SSRS Children's Baseline - Description of Non-Specific Active Suicidal Thoughts | ||
CSS06-Non-Specific Suicidal Thought | C111529 | CSS06-Non-Specific Suicidal Thought | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? | C-SSRS Children's Baseline - Non-Specific Active Suicidal Thoughts | ||
CSS06-Non-suicidal Self-injurious Behav | C111544 | CSS06-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in non-suicidal self-injurious behavior? | C-SSRS Children's Baseline - Non-suicidal Self-injurious Behavior | ||
CSS06-Number of Aborted Attempts | C111550 | CSS06-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of aborted attempts. | C-SSRS Children's Baseline - Number of Aborted Suicide Attempts | ||
CSS06-Number of Actual Attempts | C111542 | CSS06-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of actual attempts. | C-SSRS Children's Baseline - Number of Actual Suicide Attempts | ||
CSS06-Number of Interrupt Attempts | C111547 | CSS06-Number of Interrupt Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline - Total number of interrupted attempts. | C-SSRS Children's Baseline - Number of Interrupted Suicide Attempts | ||
CSS06-Preparatory Acts/Behavior | C111552 | CSS06-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? | C-SSRS Children's Baseline - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS06-Preparatory Acts/Behavior, Descr | C111553 | CSS06-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of preparatory acts or behavior. | C-SSRS Children's Baseline - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS06-Self-injur Behav, Intent Unknown | C111545 | CSS06-Self-injur Behav, Intent Unknown | Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in self-injurious behavior, intent unknown? | C-SSRS Children's Baseline - Self-injurious Behavior, Intent Unknown | ||
CSS06-Suicidal Behavior | C111554 | CSS06-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Children's Baseline - Suicidal behavior was present during the assessment period? | C-SSRS Children's Baseline - Suicidal Behavior | ||
CSS06-Wish to be Dead | C111527 | CSS06-Wish to be Dead | Columbia-Suicide Severity Rating Scale Children's Baseline - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? | C-SSRS Children's Baseline - Wish to be Dead | ||
CSS06-Wish to be Dead, Describe | C111528 | CSS06-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline - Description of wishing to be dead. | C-SSRS Children's Baseline - Description of Wish to be Dead | ||
Back to top | ||||||
CL.C111338.CSS07TC | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire Test Code
(CSS07TC) | text
Extensible: No | C111338 | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening test code. | CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Code Terminology |
CSS0701A | C111385 | CSS07-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Lifetime). | C-SSRS Children's Baseline/Screening - Wish to be Dead (Lifetime) | ||
CSS0701B | C111386 | CSS07-Wish to be Dead-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Wish to be Dead (Past 6 Months) | ||
CSS0701C | C111387 | CSS07-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of wishing to be dead. | C-SSRS Children's Baseline/Screening - Description of Wish to be Dead | ||
CSS0702A | C111388 | CSS07-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Lifetime). | C-SSRS Children's Baseline/Screening - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS0702B | C111389 | CSS07-Non-Spec Suicid Thought-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Non-Specific Active Suicidal Thoughts (Past 6 Months) | ||
CSS0702C | C111390 | CSS07-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of non-specific active suicidal thoughts. | C-SSRS Children's Baseline/Screening - Description of Non-Specific Active Suicidal Thoughts | ||
CSS0703A | C111391 | CSS07-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Lifetime). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS0703B | C111392 | CSS07-Idea, No Intent, No Plan-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 6 Months) | ||
CSS0703C | C111393 | CSS07-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS0704A | C111394 | CSS07-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Lifetime). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS0704B | C111395 | CSS07-Idea, Intent, No Plan-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Past 6 Months). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 6 Months) | ||
CSS0704C | C111396 | CSS07-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS0705A | C111397 | CSS07-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Lifetime). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS0705B | C111398 | CSS07-Idea, Plan, Intent-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Specific Plan and Intent (Past 6 Months) | ||
CSS0705C | C111399 | CSS07-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with specific plan and intent. | C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS0706A | C111400 | CSS07-Most Severe Idea | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most severe ideation. | C-SSRS Children's Baseline/Screening - Most Severe Ideation | ||
CSS0706B | C111401 | CSS07-Most Severe Idea, Desc | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of most severe ideation. | C-SSRS Children's Baseline/Screening - Describe Most Severe Ideation | ||
CSS0707A | C111402 | CSS07-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - How many times have you had these thoughts? (Lifetime). | C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Lifetime) | ||
CSS0707B | C111403 | CSS07-Most Severe Idea, Frequency-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - How many times have you had these thoughts? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Past 6 Months) | ||
CSS0707C | C111404 | CSS07-Frequency, Write Response | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Frequency, write response. | C-SSRS Children's Baseline/Screening - Frequency, Write Response | ||
CSS0708 | C111405 | CSS07-Actual Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? | C-SSRS Children's Baseline/Screening - Actual Suicide Attempt | ||
CSS0709 | C111406 | CSS07-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of actual attempts. | C-SSRS Children's Baseline/Screening - Number of Actual Suicide Attempts | ||
CSS0709A | C111407 | CSS07-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of actual attempt. | C-SSRS Children's Baseline/Screening - Description of Actual Suicide Attempt | ||
CSS0710 | C111408 | CSS07-Non-suicidal Self-injur Behav | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has subject engaged in non-suicidal self-injurious behavior? | C-SSRS Children's Baseline/Screening - Non-suicidal Self-injurious Behavior | ||
CSS0711 | C111409 | CSS07-Self-injur Behav, Intent Unknown | Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in self-injurious behavior, intent unknown? | C-SSRS Children's Baseline/Screening - Self-injurious Behavior, Intent Unknown | ||
CSS0712 | C111410 | CSS07-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? | C-SSRS Children's Baseline/Screening - Interrupted Suicide Attempt | ||
CSS0713 | C111411 | CSS07-Number of Interrupt Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of interrupted attempts. | C-SSRS Children's Baseline/Screening - Number of Interrupted Suicide Attempts | ||
CSS0713A | C111412 | CSS07-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of interrupted attempt. | C-SSRS Children's Baseline/Screening - Description of Interrupted Suicide Attempt | ||
CSS0714 | C111413 | CSS07-Aborted Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? | C-SSRS Children's Baseline/Screening - Aborted Suicide Attempt | ||
CSS0715 | C111414 | CSS07-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of aborted attempts. | C-SSRS Children's Baseline/Screening - Number of Aborted Suicide Attempts | ||
CSS0715A | C111415 | CSS07-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of aborted attempt. | C-SSRS Children's Baseline/Screening - Description of Aborted Suicide Attempt | ||
CSS0716 | C111416 | CSS07-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? | C-SSRS Children's Baseline/Screening - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0716A | C111417 | CSS07-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of preparatory acts or behavior. | C-SSRS Children's Baseline/Screening - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0717 | C111418 | CSS07-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Suicidal behavior was present during the assessment period? | C-SSRS Children's Baseline/Screening - Suicidal Behavior | ||
CSS0718A | C111419 | CSS07-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt date. | C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Date | ||
CSS0718B | C111420 | CSS07-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt actual lethality/medical damage. | C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0718C | C111421 | CSS07-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt potential lethality. | C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Potential Lethality | ||
CSS0719A | C111422 | CSS07-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt date. | C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Date | ||
CSS0719B | C111423 | CSS07-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt actual lethality/medical damage. | C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0719C | C111424 | CSS07-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt potential lethality. | C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Potential Lethality | ||
CSS0720A | C111425 | CSS07-First Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt date. | C-SSRS Children's Baseline/Screening - First Suicide Attempt Date | ||
CSS0720B | C111426 | CSS07-First Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt actual lethality/medical damage. | C-SSRS Children's Baseline/Screening - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0720C | C111427 | CSS07-First Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt potential lethality. | C-SSRS Children's Baseline/Screening - First Suicide Attempt Potential Lethality | ||
Back to top | ||||||
CL.C111337.CSS07TN | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire Test Name
(CSS07TN) | text
Extensible: No | C111337 | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening test name. | CDISC Questionnaire C-SSRS Children's Baseline/Screening Test Name Terminology |
CSS07-Aborted Attempt | C111413 | CSS07-Aborted Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? | C-SSRS Children's Baseline/Screening - Aborted Suicide Attempt | ||
CSS07-Aborted Attempt, Describe | C111415 | CSS07-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of aborted attempt. | C-SSRS Children's Baseline/Screening - Description of Aborted Suicide Attempt | ||
CSS07-Actual Attempt | C111405 | CSS07-Actual Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? | C-SSRS Children's Baseline/Screening - Actual Suicide Attempt | ||
CSS07-Actual Attempt, Describe | C111407 | CSS07-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of actual attempt. | C-SSRS Children's Baseline/Screening - Description of Actual Suicide Attempt | ||
CSS07-First Attempt Damage | C111426 | CSS07-First Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt actual lethality/medical damage. | C-SSRS Children's Baseline/Screening - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS07-First Attempt Date | C111425 | CSS07-First Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt date. | C-SSRS Children's Baseline/Screening - First Suicide Attempt Date | ||
CSS07-First Attempt Potential | C111427 | CSS07-First Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Initial/first attempt potential lethality. | C-SSRS Children's Baseline/Screening - First Suicide Attempt Potential Lethality | ||
CSS07-Frequency, Write Response | C111404 | CSS07-Frequency, Write Response | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Frequency, write response. | C-SSRS Children's Baseline/Screening - Frequency, Write Response | ||
CSS07-Idea, Intent, No Plan, Describe | C111396 | CSS07-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS07-Idea, Intent, No Plan-Life | C111394 | CSS07-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Lifetime). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS07-Idea, Intent, No Plan-P6M | C111395 | CSS07-Idea, Intent, No Plan-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Past 6 Months). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 6 Months) | ||
CSS07-Idea, No Intent, No Plan, Describe | C111393 | CSS07-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS07-Idea, No Intent, No Plan-Life | C111391 | CSS07-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Lifetime). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS07-Idea, No Intent, No Plan-P6M | C111392 | CSS07-Idea, No Intent, No Plan-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 6 Months) | ||
CSS07-Idea, Plan, Intent, Describe | C111399 | CSS07-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of active suicidal ideation with specific plan and intent. | C-SSRS Children's Baseline/Screening - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS07-Idea, Plan, Intent-Life | C111397 | CSS07-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Lifetime). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS07-Idea, Plan, Intent-P6M | C111398 | CSS07-Idea, Plan, Intent-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Active Suicidal Ideation with Specific Plan and Intent (Past 6 Months) | ||
CSS07-Interrupted Attempt | C111410 | CSS07-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? | C-SSRS Children's Baseline/Screening - Interrupted Suicide Attempt | ||
CSS07-Interrupted Attempt, Describe | C111412 | CSS07-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of interrupted attempt. | C-SSRS Children's Baseline/Screening - Description of Interrupted Suicide Attempt | ||
CSS07-Most Lethal Attempt Damage | C111423 | CSS07-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt actual lethality/medical damage. | C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS07-Most Lethal Attempt Date | C111422 | CSS07-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt date. | C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Date | ||
CSS07-Most Lethal Attempt Potential | C111424 | CSS07-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most lethal attempt potential lethality. | C-SSRS Children's Baseline/Screening - Most Lethal Suicide Attempt Potential Lethality | ||
CSS07-Most Recent Attempt Damage | C111420 | CSS07-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt actual lethality/medical damage. | C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS07-Most Recent Attempt Date | C111419 | CSS07-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt date. | C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Date | ||
CSS07-Most Recent Attempt Potential | C111421 | CSS07-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most recent attempt potential lethality. | C-SSRS Children's Baseline/Screening - Most Recent Suicide Attempt Potential Lethality | ||
CSS07-Most Severe Idea | C111400 | CSS07-Most Severe Idea | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Most severe ideation. | C-SSRS Children's Baseline/Screening - Most Severe Ideation | ||
CSS07-Most Severe Idea, Desc | C111401 | CSS07-Most Severe Idea, Desc | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of most severe ideation. | C-SSRS Children's Baseline/Screening - Describe Most Severe Ideation | ||
CSS07-Most Severe Idea, Frequency-Life | C111402 | CSS07-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - How many times have you had these thoughts? (Lifetime). | C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Lifetime) | ||
CSS07-Most Severe Idea, Frequency-P6M | C111403 | CSS07-Most Severe Idea, Frequency-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - How many times have you had these thoughts? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Frequency of Most Severe Ideation (Past 6 Months) | ||
CSS07-Non-Spec Suicid Thought, Describe | C111390 | CSS07-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of non-specific active suicidal thoughts. | C-SSRS Children's Baseline/Screening - Description of Non-Specific Active Suicidal Thoughts | ||
CSS07-Non-Spec Suicid Thought-Life | C111388 | CSS07-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Lifetime). | C-SSRS Children's Baseline/Screening - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS07-Non-Spec Suicid Thought-P6M | C111389 | CSS07-Non-Spec Suicid Thought-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Non-Specific Active Suicidal Thoughts (Past 6 Months) | ||
CSS07-Non-suicidal Self-injur Behav | C111408 | CSS07-Non-suicidal Self-injur Behav | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Has subject engaged in non-suicidal self-injurious behavior? | C-SSRS Children's Baseline/Screening - Non-suicidal Self-injurious Behavior | ||
CSS07-Number of Aborted Attempts | C111414 | CSS07-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of aborted attempts. | C-SSRS Children's Baseline/Screening - Number of Aborted Suicide Attempts | ||
CSS07-Number of Actual Attempts | C111406 | CSS07-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of actual attempts. | C-SSRS Children's Baseline/Screening - Number of Actual Suicide Attempts | ||
CSS07-Number of Interrupt Attempts | C111411 | CSS07-Number of Interrupt Attempts | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Total number of interrupted attempts. | C-SSRS Children's Baseline/Screening - Number of Interrupted Suicide Attempts | ||
CSS07-Preparatory Acts/Behavior | C111416 | CSS07-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? | C-SSRS Children's Baseline/Screening - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS07-Preparatory Acts/Behavior, Descr | C111417 | CSS07-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of preparatory acts or behavior. | C-SSRS Children's Baseline/Screening - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS07-Self-injur Behav, Intent Unknown | C111409 | CSS07-Self-injur Behav, Intent Unknown | Columbia-Suicide Severity Rating Scale Children's Baseline - Has subject engaged in self-injurious behavior, intent unknown? | C-SSRS Children's Baseline/Screening - Self-injurious Behavior, Intent Unknown | ||
CSS07-Suicidal Behavior | C111418 | CSS07-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Suicidal behavior was present during the assessment period? | C-SSRS Children's Baseline/Screening - Suicidal Behavior | ||
CSS07-Wish to be Dead, Describe | C111387 | CSS07-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Description of wishing to be dead. | C-SSRS Children's Baseline/Screening - Description of Wish to be Dead | ||
CSS07-Wish to be Dead-Life | C111385 | CSS07-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Lifetime). | C-SSRS Children's Baseline/Screening - Wish to be Dead (Lifetime) | ||
CSS07-Wish to be Dead-P6M | C111386 | CSS07-Wish to be Dead-P6M | Columbia-Suicide Severity Rating Scale Children's Baseline/Screening - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Past 6 Months). | C-SSRS Children's Baseline/Screening - Wish to be Dead (Past 6 Months) | ||
Back to top | ||||||
CL.C111340.CSS08TC | Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire Test Code
(CSS08TC) | text
Extensible: No | C111340 | Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Children's Since Last Visit test code. | CDISC Questionnaire C-SSRS Children's Since Last Visit Test Code Terminology |
CSS0801 | C111428 | CSS08-Wish to be Dead | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? | C-SSRS Children's Since Last Visit - Wish to be Dead | ||
CSS0801A | C111429 | CSS08-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of wishing to be dead. | C-SSRS Children's Since Last Visit - Description of Wish to be Dead | ||
CSS0802 | C111430 | CSS08-Non-Specific Suicidal Thought | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? | C-SSRS Children's Since Last Visit - Non-Specific Active Suicidal Thoughts | ||
CSS0802A | C111431 | CSS08-Non-Specific Suicid Thought, Descr | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of non-specific active suicidal thoughts. | C-SSRS Children's Since Last Visit - Description of Non-Specific Active Suicidal Thoughts | ||
CSS0803 | C111432 | CSS08-Idea, No Intent, No Plan | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? | C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS0803A | C111433 | CSS08-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS0804 | C111434 | CSS08-Ideation With Intent, No Plan | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. | C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS0804A | C111435 | CSS08-Ideation With Intent No Plan Descr | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS0805 | C111436 | CSS08-Ideation With Plan/Intent | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you decided how or when you would make yourself not alive anymore/kill yourself? Have you planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? | C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Specific Plan and Intent | ||
CSS0805A | C111437 | CSS08-Ideation With Plan/Intent, Descr | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with specific plan and intent. | C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS0806 | C111438 | CSS08-Most Severe Ideation | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most severe ideation. | C-SSRS Children's Since Last Visit - Most Severe Ideation | ||
CSS0806A | C111439 | CSS08-Most Severe Ideation, Description | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of most severe ideation. | C-SSRS Children's Since Last Visit - Describe Most Severe Ideation | ||
CSS0807 | C111440 | CSS08-Most Severe Ideation, Frequency | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - How many times have you had these thoughts? | C-SSRS Children's Since Last Visit - Frequency of Most Severe Ideation | ||
CSS0807A | C111441 | CSS08-Frequency, Write Response | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Frequency, write response. | C-SSRS Children's Since Last Visit - Frequency, Write Response | ||
CSS0808 | C111442 | CSS08-Actual Attempt | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Did you do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you hurt yourself on purpose? Why did you do that? | C-SSRS Children's Since Last Visit - Actual Suicide Attempt | ||
CSS0809 | C111443 | CSS08-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of actual attempts. | C-SSRS Children's Since Last Visit - Number of Actual Suicide Attempts | ||
CSS0809A | C111444 | CSS08-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of actual attempt. | C-SSRS Children's Since Last Visit - Description of Actual Suicide Attempt | ||
CSS0810 | C111445 | CSS08-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has subject engaged in non-suicidal self-injurious behavior? | C-SSRS Children's Since Last Visit - Non-suicidal Self-injurious Behavior | ||
CSS0811 | C111446 | CSS08-Self-injur Behav, Intent Unknown | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has subject engaged in self-injurious behavior, intent unknown? | C-SSRS Children's Since Last Visit - Self-injurious Behavior, Intent Unknown | ||
CSS0812 | C111447 | CSS08-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? | C-SSRS Children's Since Last Visit - Interrupted Suicide Attempt | ||
CSS0813 | C111448 | CSS08-Number of Interrupt Attempts | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of interrupted attempts. | C-SSRS Children's Since Last Visit - Number of Interrupted Suicide Attempts | ||
CSS0813A | C111449 | CSS08-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of interrupted attempt. | C-SSRS Children's Since Last Visit - Description of Interrupted Suicide Attempt | ||
CSS0814 | C111450 | CSS08-Aborted/Self-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? | C-SSRS Children's Since Last Visit - Aborted or Self-interrupted Suicide Attempt | ||
CSS0815 | C111451 | CSS08-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of aborted or self-interrupted attempts. | C-SSRS Children's Since Last Visit - Number of Aborted or Self-interrupted Suicide Attempts | ||
CSS0815A | C111452 | CSS08-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of aborted attempt or self-interrupted attempt. | C-SSRS Children's Since Last Visit - Description of Aborted or Self-interrupted Suicide Attempt | ||
CSS0816 | C111453 | CSS08-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? | C-SSRS Children's Since Last Visit - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0816A | C111454 | CSS08-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of preparatory acts or behavior. | C-SSRS Children's Since Last Visit - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0817 | C111455 | CSS08-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Suicidal behavior was present during the assessment period? | C-SSRS Children's Since Last Visit - Suicidal Behavior | ||
CSS0818 | C111456 | CSS08-Suicide | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Suicide. | C-SSRS Children's Since Last Visit - Suicide | ||
CSS0819A | C111457 | CSS08-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt date. | C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Date | ||
CSS0819B | C111458 | CSS08-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt actual lethality/medical damage. | C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0819C | C111459 | CSS08-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt potential lethality. | C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Potential Lethality | ||
Back to top | ||||||
CL.C111339.CSS08TN | Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire Test Name
(CSS08TN) | text
Extensible: No | C111339 | Columbia-Suicide Severity Rating Scale Children's Since Last Visit Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Children's Since Last Visit test name. | CDISC Questionnaire C-SSRS Children's Since Last Visit Test Name Terminology |
CSS08-Aborted Attempt, Describe | C111452 | CSS08-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of aborted attempt or self-interrupted attempt. | C-SSRS Children's Since Last Visit - Description of Aborted or Self-interrupted Suicide Attempt | ||
CSS08-Aborted/Self-Interrupted Attempt | C111450 | CSS08-Aborted/Self-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? | C-SSRS Children's Since Last Visit - Aborted or Self-interrupted Suicide Attempt | ||
CSS08-Actual Attempt | C111442 | CSS08-Actual Attempt | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Did you do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you hurt yourself on purpose? Why did you do that? | C-SSRS Children's Since Last Visit - Actual Suicide Attempt | ||
CSS08-Actual Attempt, Describe | C111444 | CSS08-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of actual attempt. | C-SSRS Children's Since Last Visit - Description of Actual Suicide Attempt | ||
CSS08-Frequency, Write Response | C111441 | CSS08-Frequency, Write Response | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Frequency, write response. | C-SSRS Children's Since Last Visit - Frequency, Write Response | ||
CSS08-Idea, No Intent, No Plan | C111432 | CSS08-Idea, No Intent, No Plan | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? | C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS08-Idea, No Intent, No Plan, Describe | C111433 | CSS08-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS08-Ideation With Intent No Plan Descr | C111435 | CSS08-Ideation With Intent No Plan Descr | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS08-Ideation With Intent, No Plan | C111434 | CSS08-Ideation With Intent, No Plan | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. | C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS08-Ideation With Plan/Intent | C111436 | CSS08-Ideation With Plan/Intent | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you decided how or when you would make yourself not alive anymore/kill yourself? Have you planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? | C-SSRS Children's Since Last Visit - Active Suicidal Ideation with Specific Plan and Intent | ||
CSS08-Ideation With Plan/Intent, Descr | C111437 | CSS08-Ideation With Plan/Intent, Descr | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of active suicidal ideation with specific plan and intent. | C-SSRS Children's Since Last Visit - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS08-Interrupted Attempt | C111447 | CSS08-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? | C-SSRS Children's Since Last Visit - Interrupted Suicide Attempt | ||
CSS08-Interrupted Attempt, Describe | C111449 | CSS08-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of interrupted attempt. | C-SSRS Children's Since Last Visit - Description of Interrupted Suicide Attempt | ||
CSS08-Most Lethal Attempt Damage | C111458 | CSS08-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt actual lethality/medical damage. | C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS08-Most Lethal Attempt Date | C111457 | CSS08-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt date. | C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Date | ||
CSS08-Most Lethal Attempt Potential | C111459 | CSS08-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most lethal attempt potential lethality. | C-SSRS Children's Since Last Visit - Most Lethal Suicide Attempt Potential Lethality | ||
CSS08-Most Severe Ideation | C111438 | CSS08-Most Severe Ideation | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Most severe ideation. | C-SSRS Children's Since Last Visit - Most Severe Ideation | ||
CSS08-Most Severe Ideation, Description | C111439 | CSS08-Most Severe Ideation, Description | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of most severe ideation. | C-SSRS Children's Since Last Visit - Describe Most Severe Ideation | ||
CSS08-Most Severe Ideation, Frequency | C111440 | CSS08-Most Severe Ideation, Frequency | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - How many times have you had these thoughts? | C-SSRS Children's Since Last Visit - Frequency of Most Severe Ideation | ||
CSS08-Non-Specific Suicid Thought, Descr | C111431 | CSS08-Non-Specific Suicid Thought, Descr | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of non-specific active suicidal thoughts. | C-SSRS Children's Since Last Visit - Description of Non-Specific Active Suicidal Thoughts | ||
CSS08-Non-Specific Suicidal Thought | C111430 | CSS08-Non-Specific Suicidal Thought | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? | C-SSRS Children's Since Last Visit - Non-Specific Active Suicidal Thoughts | ||
CSS08-Non-suicidal Self-injurious Behav | C111445 | CSS08-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has subject engaged in non-suicidal self-injurious behavior? | C-SSRS Children's Since Last Visit - Non-suicidal Self-injurious Behavior | ||
CSS08-Number of Aborted Attempts | C111451 | CSS08-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of aborted or self-interrupted attempts. | C-SSRS Children's Since Last Visit - Number of Aborted or Self-interrupted Suicide Attempts | ||
CSS08-Number of Actual Attempts | C111443 | CSS08-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of actual attempts. | C-SSRS Children's Since Last Visit - Number of Actual Suicide Attempts | ||
CSS08-Number of Interrupt Attempts | C111448 | CSS08-Number of Interrupt Attempts | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Total number of interrupted attempts. | C-SSRS Children's Since Last Visit - Number of Interrupted Suicide Attempts | ||
CSS08-Preparatory Acts/Behavior | C111453 | CSS08-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? | C-SSRS Children's Since Last Visit - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS08-Preparatory Acts/Behavior, Descr | C111454 | CSS08-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of preparatory acts or behavior. | C-SSRS Children's Since Last Visit - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS08-Self-injur Behav, Intent Unknown | C111446 | CSS08-Self-injur Behav, Intent Unknown | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Has subject engaged in self-injurious behavior, intent unknown? | C-SSRS Children's Since Last Visit - Self-injurious Behavior, Intent Unknown | ||
CSS08-Suicidal Behavior | C111455 | CSS08-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Suicidal behavior was present during the assessment period? | C-SSRS Children's Since Last Visit - Suicidal Behavior | ||
CSS08-Suicide | C111456 | CSS08-Suicide | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Suicide. | C-SSRS Children's Since Last Visit - Suicide | ||
CSS08-Wish to be Dead | C111428 | CSS08-Wish to be Dead | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? | C-SSRS Children's Since Last Visit - Wish to be Dead | ||
CSS08-Wish to be Dead, Describe | C111429 | CSS08-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Children's Since Last Visit - Description of wishing to be dead. | C-SSRS Children's Since Last Visit - Description of Wish to be Dead | ||
Back to top | ||||||
CL.C117989.CSS11TC | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire Test Code
(CSS11TC) | text
Extensible: No | C117989 | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version test code. | CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Code Terminology |
CSS1101A | C118019 | CSS11-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). | C-SSRS Lifetime/Recent Version - Wish to be Dead (Lifetime) | ||
CSS1101B | C118020 | CSS11-Wish to be Dead-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Wish to be Dead (Past 1 Month) | ||
CSS1101C | C118021 | CSS11-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of wishing to be dead. | C-SSRS Lifetime/Recent Version - Description of Wish to be Dead | ||
CSS1102A | C118022 | CSS11-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you actually had any thoughts of killing yourself? (Lifetime). | C-SSRS Lifetime/Recent Version - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS1102B | C118023 | CSS11-Non-Spec Suicid Thought-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you actually had any thoughts of killing yourself? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Non-Specific Active Suicidal Thoughts (Past 1 Months) | ||
CSS1102C | C118024 | CSS11-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of non-specific active suicidal thoughts. | C-SSRS Lifetime/Recent Version - Description of Non-Specific Active Suicidal Thoughts | ||
CSS1103A | C118025 | CSS11-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you been thinking about how you might do this? (Lifetime). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS1103B | C118026 | CSS11-Idea, No Intent, No Plan-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you been thinking about how you might do this? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 1 Month) | ||
CSS1103C | C118027 | CSS11-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS1104A | C118028 | CSS11-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you had these thoughts and had some intention of acting on them? (Lifetime). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS1104B | C118029 | CSS11-Idea, Intent, No Plan-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you had these thoughts and had some intention of acting on them? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 1 Month) | ||
CSS1104C | C118030 | CSS11-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS1105A | C118031 | CSS11-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS1105B | C118032 | CSS11-Idea, Plan, Intent-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Specific Plan and Intent (Past 1 Month) | ||
CSS1105C | C118033 | CSS11-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with specific plan and intent. | C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS1106A | C118034 | CSS11-Most Severe Idea-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most severe ideation. (Lifetime). | C-SSRS Lifetime/Recent Version - Most Severe Ideation (Lifetime) | ||
CSS1106B | C118035 | CSS11-Most Severe Idea, Desc-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of most severe ideation. (Lifetime). | C-SSRS Lifetime/Recent Version - Describe Most Severe Ideation (Lifetime) | ||
CSS1106C | C118036 | CSS11-Most Severe Idea-Recent-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most severe ideation. (Recent - Past 1 Month). | C-SSRS Lifetime/Recent Version - Recent Most Severe Ideation (Past 1 Month) | ||
CSS1106D | C118037 | CSS11-Most Severe Idea, Desc-Recent-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of most severe ideation. (Recent - Past 1 Month). | C-SSRS Lifetime/Recent Version - Describe Recent Most Severe Ideation (Past 1 Month) | ||
CSS1107A | C118038 | CSS11-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - How many times have you had these thoughts? (Lifetime). | C-SSRS Lifetime/Recent Version - Frequency of Most Severe Ideation (Lifetime) | ||
CSS1107B | C118039 | CSS11-Most Severe Idea, Frequency-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - How many times have you had these thoughts? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Frequency of Most Severe Ideation (Past 1 Month) | ||
CSS1108A | C118040 | CSS11-Most Severe Idea, Duration-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - When you have the thoughts how long do they last? (Lifetime). | C-SSRS Lifetime/Recent Version - Duration of Most Severe Ideation (Lifetime) | ||
CSS1108B | C118041 | CSS11-Most Severe Idea, Duration-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - When you have the thoughts how long do they last? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Duration of Most Severe Ideation (Past 1 Month) | ||
CSS1109A | C118042 | CSS11-Most Severe Idea, Control-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). | C-SSRS Lifetime/Recent Version - Controllability of Most Severe Ideation (Lifetime) | ||
CSS1109B | C118043 | CSS11-Most Severe Idea, Control-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Controllability of Most Severe Ideation (Past 1 Month) | ||
CSS1110A | C118044 | CSS11-Most Severe Idea, Deterrents-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). | C-SSRS Lifetime/Recent Version - Deterrents to Most Severe Ideation (Lifetime) | ||
CSS1110B | C118045 | CSS11-Most Severe Idea, Deterrents-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Deterrents to Most Severe Ideation (Past 1 Month) | ||
CSS1111A | C118046 | CSS11-Most Severe Idea, Reasons-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). | C-SSRS Lifetime/Recent Version - Reasons for Most Severe Ideation (Lifetime) | ||
CSS1111B | C118047 | CSS11-Most Severe Idea, Reasons-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Reasons for Most Severe Ideation (Past 1 Month) | ||
CSS1112A | C118048 | CSS11-Actual Attempt-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Lifetime). | C-SSRS Lifetime/Recent Version - Actual Suicide Attempt (Lifetime) | ||
CSS1112B | C118049 | CSS11-Actual Attempt-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Actual Suicide Attempt (Past 3 Months) | ||
CSS1113A | C118050 | CSS11-Number of Actual Attempts-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of actual attempts. (Lifetime). | C-SSRS Lifetime/Recent Version - Number of Actual Suicide Attempts (Lifetime) | ||
CSS1113B | C118051 | CSS11-Number of Actual Attempts-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of actual attempts. (Past 3 Months). | C-SSRS Lifetime/Recent Version - Number of Actual Suicide Attempts (Past 3 Months) | ||
CSS1113C | C118052 | CSS11-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of actual attempt. | C-SSRS Lifetime/Recent Version - Description of Actual Suicide Attempt | ||
CSS1114A | C118053 | CSS11-Non-suicid Self-injur Behav-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has subject engaged in non-suicidal self-injurious behavior? (Lifetime). | C-SSRS Lifetime/Recent Version - Non-suicidal Self-injurious Behavior (Lifetime) | ||
CSS1114B | C118054 | CSS11-Non-suicid Self-injur Behav-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has subject engaged in non-suicidal self-injurious behavior? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Non-suicidal Self-injurious Behavior (Past 3 Months) | ||
CSS1115A | C118055 | CSS11-Interrupted Attempt-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Lifetime). | C-SSRS Lifetime/Recent Version - Interrupted Suicide Attempt (Lifetime) | ||
CSS1115B | C118056 | CSS11-Interrupted Attempt-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Interrupted Suicide Attempt (Past 3 Months) | ||
CSS1116A | C118057 | CSS11-Num of Interrupted Attempts-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of interrupted attempts. (Lifetime). | C-SSRS Lifetime/Recent Version - Number of Interrupted Suicide Attempts (Lifetime) | ||
CSS1116B | C118058 | CSS11-Num of Interrupted Attempts-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of interrupted attempts. (Past 3 Months). | C-SSRS Lifetime/Recent Version - Number of Interrupted Suicide Attempts (Past 3 Months) | ||
CSS1116C | C118059 | CSS11-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of interrupted attempt. | C-SSRS Lifetime/Recent Version - Description of Interrupted Suicide Attempt | ||
CSS1117A | C118060 | CSS11-Aborted Attempt-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Lifetime). | C-SSRS Lifetime/Recent Version - Aborted Suicide Attempt (Lifetime) | ||
CSS1117B | C118061 | CSS11-Aborted Attempt-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Aborted Suicide Attempt (Past 3 Months) | ||
CSS1118A | C118062 | CSS11-Number of Aborted Attempts-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of aborted or self-interrupted attempts. (Lifetime). | C-SSRS Lifetime/Recent Version - Number of Aborted Suicide Attempts (Lifetime) | ||
CSS1118B | C118063 | CSS11-Number of Aborted Attempts-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of aborted or self-interrupted attempts. (Past 3 Months). | C-SSRS Lifetime/Recent Version - Number of Aborted Suicide Attempts (Past 3 Months) | ||
CSS1118C | C118064 | CSS11-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of aborted or self-interrupted attempt. | C-SSRS Lifetime/Recent Version - Description of Aborted Suicide Attempt | ||
CSS1119A | C118065 | CSS11-Preparatory Acts/Behavior-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Lifetime). | C-SSRS Lifetime/Recent Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) | ||
CSS1119B | C118066 | CSS11-Preparatory Acts/Behavior-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Past 3 Months) | ||
CSS1119C | C118067 | CSS11-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of preparatory acts or behavior. | C-SSRS Lifetime/Recent Version - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS1120A | C118068 | CSS11-Suicidal Behavior-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Suicidal behavior was present during the assessment period? (Lifetime). | C-SSRS Lifetime/Recent Version - Suicidal Behavior (Lifetime) | ||
CSS1120B | C118069 | CSS11-Suicidal Behavior-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Suicidal behavior was present during the assessment period? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Suicidal Behavior (Past 3 Months) | ||
CSS1121A | C118070 | CSS11-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt date. | C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Date | ||
CSS1121B | C118071 | CSS11-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt actual lethality/medical damage. | C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS1121C | C118072 | CSS11-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt potential lethality. | C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Potential Lethality | ||
CSS1122A | C118073 | CSS11-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt date. | C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Date | ||
CSS1122B | C118074 | CSS11-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt actual lethality/medical damage. | C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS1122C | C118075 | CSS11-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt potential lethality. | C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Potential Lethality | ||
CSS1123A | C118076 | CSS11-First Attempt Date | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt date. | C-SSRS Lifetime/Recent Version - First Suicide Attempt Date | ||
CSS1123B | C118077 | CSS11-First Attempt Damage | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt actual lethality/medical damage. | C-SSRS Lifetime/Recent Version - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS1123C | C118078 | CSS11-First Attempt Potential | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt potential lethality. | C-SSRS Lifetime/Recent Version - First Suicide Attempt Potential Lethality | ||
Back to top | ||||||
CL.C117988.CSS11TN | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire Test Name
(CSS11TN) | text
Extensible: No | C117988 | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version test name. | CDISC Questionnaire C-SSRS Lifetime/Recent Version Test Name Terminology |
CSS11-Aborted Attempt, Describe | C118064 | CSS11-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of aborted or self-interrupted attempt. | C-SSRS Lifetime/Recent Version - Description of Aborted Suicide Attempt | ||
CSS11-Aborted Attempt-Life | C118060 | CSS11-Aborted Attempt-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Lifetime). | C-SSRS Lifetime/Recent Version - Aborted Suicide Attempt (Lifetime) | ||
CSS11-Aborted Attempt-P3M | C118061 | CSS11-Aborted Attempt-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Aborted Suicide Attempt (Past 3 Months) | ||
CSS11-Actual Attempt, Describe | C118052 | CSS11-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of actual attempt. | C-SSRS Lifetime/Recent Version - Description of Actual Suicide Attempt | ||
CSS11-Actual Attempt-Life | C118048 | CSS11-Actual Attempt-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Lifetime). | C-SSRS Lifetime/Recent Version - Actual Suicide Attempt (Lifetime) | ||
CSS11-Actual Attempt-P3M | C118049 | CSS11-Actual Attempt-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Actual Suicide Attempt (Past 3 Months) | ||
CSS11-First Attempt Damage | C118077 | CSS11-First Attempt Damage | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt actual lethality/medical damage. | C-SSRS Lifetime/Recent Version - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS11-First Attempt Date | C118076 | CSS11-First Attempt Date | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt date. | C-SSRS Lifetime/Recent Version - First Suicide Attempt Date | ||
CSS11-First Attempt Potential | C118078 | CSS11-First Attempt Potential | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Initial/first attempt potential lethality. | C-SSRS Lifetime/Recent Version - First Suicide Attempt Potential Lethality | ||
CSS11-Idea, Intent, No Plan, Describe | C118030 | CSS11-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS11-Idea, Intent, No Plan-Life | C118028 | CSS11-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you had these thoughts and had some intention of acting on them? (Lifetime). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Lifetime) | ||
CSS11-Idea, Intent, No Plan-P1M | C118029 | CSS11-Idea, Intent, No Plan-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you had these thoughts and had some intention of acting on them? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Some Intent to Act, without Specific Plan (Past 1 Month) | ||
CSS11-Idea, No Intent, No Plan, Describe | C118027 | CSS11-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS11-Idea, No Intent, No Plan-Life | C118025 | CSS11-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you been thinking about how you might do this? (Lifetime). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Lifetime) | ||
CSS11-Idea, No Intent, No Plan-P1M | C118026 | CSS11-Idea, No Intent, No Plan-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you been thinking about how you might do this? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act (Past 1 Month) | ||
CSS11-Idea, Plan, Intent, Describe | C118033 | CSS11-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of active suicidal ideation with specific plan and intent. | C-SSRS Lifetime/Recent Version - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS11-Idea, Plan, Intent-Life | C118031 | CSS11-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Lifetime). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Specific Plan and Intent (Lifetime) | ||
CSS11-Idea, Plan, Intent-P1M | C118032 | CSS11-Idea, Plan, Intent-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Active Suicidal Ideation with Specific Plan and Intent (Past 1 Month) | ||
CSS11-Interrupted Attempt, Describe | C118059 | CSS11-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of interrupted attempt. | C-SSRS Lifetime/Recent Version - Description of Interrupted Suicide Attempt | ||
CSS11-Interrupted Attempt-Life | C118055 | CSS11-Interrupted Attempt-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Lifetime). | C-SSRS Lifetime/Recent Version - Interrupted Suicide Attempt (Lifetime) | ||
CSS11-Interrupted Attempt-P3M | C118056 | CSS11-Interrupted Attempt-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Interrupted Suicide Attempt (Past 3 Months) | ||
CSS11-Most Lethal Attempt Damage | C118074 | CSS11-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt actual lethality/medical damage. | C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS11-Most Lethal Attempt Date | C118073 | CSS11-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt date. | C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Date | ||
CSS11-Most Lethal Attempt Potential | C118075 | CSS11-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most lethal attempt potential lethality. | C-SSRS Lifetime/Recent Version - Most Lethal Suicide Attempt Potential Lethality | ||
CSS11-Most Recent Attempt Damage | C118071 | CSS11-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt actual lethality/medical damage. | C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS11-Most Recent Attempt Date | C118070 | CSS11-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt date. | C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Date | ||
CSS11-Most Recent Attempt Potential | C118072 | CSS11-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most recent attempt potential lethality. | C-SSRS Lifetime/Recent Version - Most Recent Suicide Attempt Potential Lethality | ||
CSS11-Most Severe Idea, Control-Life | C118042 | CSS11-Most Severe Idea, Control-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Lifetime). | C-SSRS Lifetime/Recent Version - Controllability of Most Severe Ideation (Lifetime) | ||
CSS11-Most Severe Idea, Control-P1M | C118043 | CSS11-Most Severe Idea, Control-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Could/can you stop thinking about killing yourself or wanting to die if you want to? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Controllability of Most Severe Ideation (Past 1 Month) | ||
CSS11-Most Severe Idea, Desc-Life | C118035 | CSS11-Most Severe Idea, Desc-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of most severe ideation. (Lifetime). | C-SSRS Lifetime/Recent Version - Describe Most Severe Ideation (Lifetime) | ||
CSS11-Most Severe Idea, Desc-Recent-P1M | C118037 | CSS11-Most Severe Idea, Desc-Recent-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of most severe ideation. (Recent - Past 1 Month). | C-SSRS Lifetime/Recent Version - Describe Recent Most Severe Ideation (Past 1 Month) | ||
CSS11-Most Severe Idea, Deterrents-Life | C118044 | CSS11-Most Severe Idea, Deterrents-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Lifetime). | C-SSRS Lifetime/Recent Version - Deterrents to Most Severe Ideation (Lifetime) | ||
CSS11-Most Severe Idea, Deterrents-P1M | C118045 | CSS11-Most Severe Idea, Deterrents-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Deterrents to Most Severe Ideation (Past 1 Month) | ||
CSS11-Most Severe Idea, Duration-Life | C118040 | CSS11-Most Severe Idea, Duration-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - When you have the thoughts how long do they last? (Lifetime). | C-SSRS Lifetime/Recent Version - Duration of Most Severe Ideation (Lifetime) | ||
CSS11-Most Severe Idea, Duration-P1M | C118041 | CSS11-Most Severe Idea, Duration-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - When you have the thoughts how long do they last? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Duration of Most Severe Ideation (Past 1 Month) | ||
CSS11-Most Severe Idea, Frequency-Life | C118038 | CSS11-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - How many times have you had these thoughts? (Lifetime). | C-SSRS Lifetime/Recent Version - Frequency of Most Severe Ideation (Lifetime) | ||
CSS11-Most Severe Idea, Frequency-P1M | C118039 | CSS11-Most Severe Idea, Frequency-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - How many times have you had these thoughts? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Frequency of Most Severe Ideation (Past 1 Month) | ||
CSS11-Most Severe Idea, Reasons-Life | C118046 | CSS11-Most Severe Idea, Reasons-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Lifetime). | C-SSRS Lifetime/Recent Version - Reasons for Most Severe Ideation (Lifetime) | ||
CSS11-Most Severe Idea, Reasons-P1M | C118047 | CSS11-Most Severe Idea, Reasons-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Reasons for Most Severe Ideation (Past 1 Month) | ||
CSS11-Most Severe Idea-Life | C118034 | CSS11-Most Severe Idea-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most severe ideation. (Lifetime). | C-SSRS Lifetime/Recent Version - Most Severe Ideation (Lifetime) | ||
CSS11-Most Severe Idea-Recent-P1M | C118036 | CSS11-Most Severe Idea-Recent-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Most severe ideation. (Recent - Past 1 Month). | C-SSRS Lifetime/Recent Version - Recent Most Severe Ideation (Past 1 Month) | ||
CSS11-Non-Spec Suicid Thought, Describe | C118024 | CSS11-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of non-specific active suicidal thoughts. | C-SSRS Lifetime/Recent Version - Description of Non-Specific Active Suicidal Thoughts | ||
CSS11-Non-Spec Suicid Thought-Life | C118022 | CSS11-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you actually had any thoughts of killing yourself? (Lifetime). | C-SSRS Lifetime/Recent Version - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS11-Non-Spec Suicid Thought-P1M | C118023 | CSS11-Non-Spec Suicid Thought-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you actually had any thoughts of killing yourself? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Non-Specific Active Suicidal Thoughts (Past 1 Months) | ||
CSS11-Non-suicid Self-injur Behav-Life | C118053 | CSS11-Non-suicid Self-injur Behav-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has subject engaged in non-suicidal self-injurious behavior? (Lifetime). | C-SSRS Lifetime/Recent Version - Non-suicidal Self-injurious Behavior (Lifetime) | ||
CSS11-Non-suicid Self-injur Behav-P3M | C118054 | CSS11-Non-suicid Self-injur Behav-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Has subject engaged in non-suicidal self-injurious behavior? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Non-suicidal Self-injurious Behavior (Past 3 Months) | ||
CSS11-Num of Interrupted Attempts-Life | C118057 | CSS11-Num of Interrupted Attempts-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of interrupted attempts. (Lifetime). | C-SSRS Lifetime/Recent Version - Number of Interrupted Suicide Attempts (Lifetime) | ||
CSS11-Num of Interrupted Attempts-P3M | C118058 | CSS11-Num of Interrupted Attempts-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of interrupted attempts. (Past 3 Months). | C-SSRS Lifetime/Recent Version - Number of Interrupted Suicide Attempts (Past 3 Months) | ||
CSS11-Number of Aborted Attempts-Life | C118062 | CSS11-Number of Aborted Attempts-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of aborted or self-interrupted attempts. (Lifetime). | C-SSRS Lifetime/Recent Version - Number of Aborted Suicide Attempts (Lifetime) | ||
CSS11-Number of Aborted Attempts-P3M | C118063 | CSS11-Number of Aborted Attempts-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of aborted or self-interrupted attempts. (Past 3 Months). | C-SSRS Lifetime/Recent Version - Number of Aborted Suicide Attempts (Past 3 Months) | ||
CSS11-Number of Actual Attempts-Life | C118050 | CSS11-Number of Actual Attempts-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of actual attempts. (Lifetime). | C-SSRS Lifetime/Recent Version - Number of Actual Suicide Attempts (Lifetime) | ||
CSS11-Number of Actual Attempts-P3M | C118051 | CSS11-Number of Actual Attempts-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Total number of actual attempts. (Past 3 Months). | C-SSRS Lifetime/Recent Version - Number of Actual Suicide Attempts (Past 3 Months) | ||
CSS11-Preparatory Acts/Behavior, Descr | C118067 | CSS11-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of preparatory acts or behavior. | C-SSRS Lifetime/Recent Version - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS11-Preparatory Acts/Behavior-Life | C118065 | CSS11-Preparatory Acts/Behavior-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Lifetime). | C-SSRS Lifetime/Recent Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) | ||
CSS11-Preparatory Acts/Behavior-P3M | C118066 | CSS11-Preparatory Acts/Behavior-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Preparatory Acts or Behaviors Toward Suicide Attempt (Past 3 Months) | ||
CSS11-Suicidal Behavior-Life | C118068 | CSS11-Suicidal Behavior-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Suicidal behavior was present during the assessment period? (Lifetime). | C-SSRS Lifetime/Recent Version - Suicidal Behavior (Lifetime) | ||
CSS11-Suicidal Behavior-P3M | C118069 | CSS11-Suicidal Behavior-P3M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Suicidal behavior was present during the assessment period? (Past 3 Months). | C-SSRS Lifetime/Recent Version - Suicidal Behavior (Past 3 Months) | ||
CSS11-Wish to be Dead, Describe | C118021 | CSS11-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Description of wishing to be dead. | C-SSRS Lifetime/Recent Version - Description of Wish to be Dead | ||
CSS11-Wish to be Dead-Life | C118019 | CSS11-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Lifetime). | C-SSRS Lifetime/Recent Version - Wish to be Dead (Lifetime) | ||
CSS11-Wish to be Dead-P1M | C118020 | CSS11-Wish to be Dead-P1M | Columbia-Suicide Severity Rating Scale Lifetime/Recent Version - Have you wished you were dead or wished you could go to sleep and not wake up? (Past 1 Month). | C-SSRS Lifetime/Recent Version - Wish to be Dead (Past 1 Month) | ||
Back to top | ||||||
CL.C113848.CSS10TC | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire Test Code
(CSS10TC) | text
Extensible: No | C113848 | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent test code. | CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Code Terminology |
CSS1001A | C113889 | CSS10-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Wish to be Dead (Lifetime) | ||
CSS1001B | C113890 | CSS10-Wish to be Dead-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Wish to be Dead (Past 1 Month) | ||
CSS1001C | C113891 | CSS10-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of wishing to be dead. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Wish to be Dead | ||
CSS1002A | C113892 | CSS10-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS1002B | C113893 | CSS10-Non-Spec Suicid Thought-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-Specific Active Suicidal Thoughts (Past 1 Month) | ||
CSS1002C | C113894 | CSS10-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of non-specific active suicidal thoughts. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Non-Specific Active Suicidal Thoughts | ||
CSS1003A | C113895 | CSS10-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Lifetime) | ||
CSS1003B | C113896 | CSS10-Idea, No Intent, No Plan-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Past 1 Month) | ||
CSS1003C | C113897 | CSS10-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act | ||
CSS1004A | C113898 | CSS10-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Lifetime) | ||
CSS1004B | C113899 | CSS10-Idea, Intent, No Plan-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Past 1 Month) | ||
CSS1004C | C113900 | CSS10-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan | ||
CSS1005A | C113901 | CSS10-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Specific Plan and Intent (Lifetime) | ||
CSS1005B | C113902 | CSS10-Idea, Plan, Intent-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Specific Plan and Intent (Past 1 Month) | ||
CSS1005C | C113903 | CSS10-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with specific plan and intent. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Specific Plan and Intent | ||
CSS1006A | C113904 | CSS10-Most Severe Idea-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most severe ideation. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Severe Ideation (Lifetime) | ||
CSS1006B | C113905 | CSS10-Most Severe Idea, Desc-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of most severe ideation. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Lifetime) | ||
CSS1006C | C113906 | CSS10-Most Severe Idea-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most severe ideation. (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Severe Ideation (Past 1 Month) | ||
CSS1006D | C113907 | CSS10-Most Severe Idea, Desc-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of most severe ideation. (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Past 1 Month) | ||
CSS1007A | C113908 | CSS10-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - How many times have you had these thoughts? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency (Lifetime) | ||
CSS1007B | C113909 | CSS10-Most Severe Idea, Frequency-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - How many times have you had these thoughts? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency (Past 1 Month) | ||
CSS1007C | C113910 | CSS10-Frequency, Write Response | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Frequency, write response. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency Write Response | ||
CSS1008A | C113911 | CSS10-Actual Attempt-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Actual Suicide Attempt (Lifetime) | ||
CSS1008B | C113912 | CSS10-Actual Attempt-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Actual Suicide Attempt (Past 3 Month) | ||
CSS1009A | C113913 | CSS10-Number of Actual Attempts-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of actual attempts. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Lifetime) | ||
CSS1009B | C113914 | CSS10-Number of Actual Attempts-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of actual attempts. (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Past 3 Months) | ||
CSS1009C | C113915 | CSS10-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of actual attempt. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Actual Suicide Attempt | ||
CSS1010A | C113916 | CSS10-Non-suicidal Self-injur Behav-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in non-suicidal self-injurious behavior? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-suicidal Self-injurious Behavior (Lifetime) | ||
CSS1010B | C113917 | CSS10-Non-suicidal Self-injur Behav-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in non-suicidal self-injurious behavior? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-suicidal Self-injurious Behavior (Past 3 Months) | ||
CSS1011A | C113918 | CSS10-Self-injur Behav, Intent Unk-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in self-injurious behavior, intent unknown? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Self-injurious Behavior, Intent Unknown (Lifetime) | ||
CSS1011B | C113919 | CSS10-Self-injur Behav, Intent Unk-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in self-injurious behavior, intent unknown? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Self-injurious Behavior, Intent Unknown (Past 3 Months) | ||
CSS1012A | C113920 | CSS10-Interrupted Attempt-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Interrupted Suicide Attempt (Lifetime) | ||
CSS1012B | C113921 | CSS10-Interrupted Attempt-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Interrupted Suicide Attempt (Past 3 Months) | ||
CSS1013A | C113922 | CSS10-Number of Interrupt Attempts-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of interrupted attempts. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Interrupted Suicide Attempts (Lifetime) | ||
CSS1013B | C113923 | CSS10-Number of Interrupt Attempts-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of interrupted attempts. (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Interrupted Suicide Attempts (Past 3 Months) | ||
CSS1013C | C113924 | CSS10-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of interrupted attempt. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Interrupted Suicide Attempt | ||
CSS1014A | C113925 | CSS10-Aborted Attempt-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Lifetime) | ||
CSS1014B | C113926 | CSS10-Aborted Attempt-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Past 3 Months) | ||
CSS1015A | C113927 | CSS10-Number of Aborted Attempts-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of aborted or self-interrupted attempts. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Aborted or Self-interrupted Suicide Attempt (Lifetime) | ||
CSS1015B | C113928 | CSS10-Number of Aborted Attempts-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of aborted or self-interrupted attempts. (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Aborted or Self-interrupted Suicide Attempt (Past 3 Months) | ||
CSS1015C | C113929 | CSS10-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of aborted or self-interrupted attempt. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Aborted Suicide Attempt | ||
CSS1016A | C113930 | CSS10-Preparatory Acts/Behavior-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) | ||
CSS1016B | C113931 | CSS10-Preparatory Acts/Behavior-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Preparatory Acts or Behaviors Toward Suicide Attempt (Past 3 Months) | ||
CSS1016C | C113932 | CSS10-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of preparatory acts or behavior. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS1017A | C113933 | CSS10-Suicidal Behavior-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal behavior was present during the assessment period? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Lifetime) | ||
CSS1017B | C113934 | CSS10-Suicidal Behavior-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal behavior was present during the assessment period? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Past 3 Months) | ||
CSS1018A | C113935 | CSS10-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt date. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Date | ||
CSS1018B | C113936 | CSS10-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt actual lethality/medical damage. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS1018C | C113937 | CSS10-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt potential lethality. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Potential Lethality | ||
CSS1019A | C113938 | CSS10-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt date. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Date | ||
CSS1019B | C113939 | CSS10-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt actual lethality/medical damage. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS1019C | C113940 | CSS10-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt potential lethality. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Potential Lethality | ||
CSS1020A | C113941 | CSS10-First Attempt Date | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt date. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Date | ||
CSS1020B | C113942 | CSS10-First Attempt Damage | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt actual lethality/medical damage. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS1020C | C113943 | CSS10-First Attempt Potential | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt potential lethality. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Potential Lethality | ||
Back to top | ||||||
CL.C113847.CSS10TN | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire Test Name
(CSS10TN) | text
Extensible: No | C113847 | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent test name. | CDISC Questionnaire C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent Test Name Terminology |
CSS10-Aborted Attempt, Describe | C113929 | CSS10-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of aborted or self-interrupted attempt. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Aborted Suicide Attempt | ||
CSS10-Aborted Attempt-Life | C113925 | CSS10-Aborted Attempt-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Lifetime) | ||
CSS10-Aborted Attempt-P3M | C113926 | CSS10-Aborted Attempt-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but you changed your mind (stopped yourself) before you actually did anything? What did you do? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Aborted or Self-interrupted Suicide Attempt (Past 3 Months) | ||
CSS10-Actual Attempt, Describe | C113915 | CSS10-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of actual attempt. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Actual Suicide Attempt | ||
CSS10-Actual Attempt-Life | C113911 | CSS10-Actual Attempt-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Actual Suicide Attempt (Lifetime) | ||
CSS10-Actual Attempt-P3M | C113912 | CSS10-Actual Attempt-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Did you ever do anything to try to kill yourself or make yourself not alive anymore? What did you do? Did you ever hurt yourself on purpose? Why did you do that? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Actual Suicide Attempt (Past 3 Month) | ||
CSS10-First Attempt Damage | C113942 | CSS10-First Attempt Damage | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt actual lethality/medical damage. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS10-First Attempt Date | C113941 | CSS10-First Attempt Date | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt date. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Date | ||
CSS10-First Attempt Potential | C113943 | CSS10-First Attempt Potential | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Initial/first attempt potential lethality. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - First Suicide Attempt Potential Lethality | ||
CSS10-Frequency, Write Response | C113910 | CSS10-Frequency, Write Response | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Frequency, write response. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency Write Response | ||
CSS10-Idea, Intent, No Plan, Describe | C113900 | CSS10-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Some Intent to Act, Without Specific Plan | ||
CSS10-Idea, Intent, No Plan-Life | C113898 | CSS10-Idea, Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Lifetime) | ||
CSS10-Idea, Intent, No Plan-P1M | C113899 | CSS10-Idea, Intent, No Plan-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - When you thought about making yourself not alive anymore (or killing yourself), did you think that this was something you might actually do? This is different from (as opposed to) having the thoughts but knowing you wouldn't do anything about it. (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Some Intent to Act, Without Specific Plan (Past 1 Month) | ||
CSS10-Idea, No Intent, No Plan, Describe | C113897 | CSS10-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act | ||
CSS10-Idea, No Intent, No Plan-Life | C113895 | CSS10-Idea, No Intent, No Plan-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Lifetime) | ||
CSS10-Idea, No Intent, No Plan-P1M | C113896 | CSS10-Idea, No Intent, No Plan-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about how you would do that or how you would make yourself not alive anymore (kill yourself)? What did you think about? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Any Methods (Not Plan) Without Intent to Act (Past 1 Month) | ||
CSS10-Idea, Plan, Intent, Describe | C113903 | CSS10-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of active suicidal ideation with specific plan and intent. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Active Suicidal Ideation With Specific Plan and Intent | ||
CSS10-Idea, Plan, Intent-Life | C113901 | CSS10-Idea, Plan, Intent-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Specific Plan and Intent (Lifetime) | ||
CSS10-Idea, Plan, Intent-P1M | C113902 | CSS10-Idea, Plan, Intent-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you ever decided how or when you would make yourself not alive anymore/kill yourself? Have you ever planned out (worked out the details of) how you would do it? What was your plan? When you made this plan (or worked out these details), was any part of you thinking about actually doing it? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Active Suicidal Ideation With Specific Plan and Intent (Past 1 Month) | ||
CSS10-Interrupted Attempt, Describe | C113924 | CSS10-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of interrupted attempt. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Interrupted Suicide Attempt | ||
CSS10-Interrupted Attempt-Life | C113920 | CSS10-Interrupted Attempt-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Interrupted Suicide Attempt (Lifetime) | ||
CSS10-Interrupted Attempt-P3M | C113921 | CSS10-Interrupted Attempt-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has there been a time when you started to do something to make yourself not alive anymore (end your life or kill yourself) but someone or something stopped you before you actually did anything? What did you do? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Interrupted Suicide Attempt (Past 3 Months) | ||
CSS10-Most Lethal Attempt Damage | C113939 | CSS10-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt actual lethality/medical damage. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS10-Most Lethal Attempt Date | C113938 | CSS10-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt date. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Date | ||
CSS10-Most Lethal Attempt Potential | C113940 | CSS10-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most lethal attempt potential lethality. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Lethal Suicide Attempt Potential Lethality | ||
CSS10-Most Recent Attempt Damage | C113936 | CSS10-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt actual lethality/medical damage. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS10-Most Recent Attempt Date | C113935 | CSS10-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt date. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Date | ||
CSS10-Most Recent Attempt Potential | C113937 | CSS10-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most recent attempt potential lethality. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Recent Suicide Attempt Potential Lethality | ||
CSS10-Most Severe Idea, Desc-Life | C113905 | CSS10-Most Severe Idea, Desc-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of most severe ideation. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Lifetime) | ||
CSS10-Most Severe Idea, Desc-P1M | C113907 | CSS10-Most Severe Idea, Desc-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of most severe ideation. (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Describe Most Severe Ideation (Past 1 Month) | ||
CSS10-Most Severe Idea, Frequency-Life | C113908 | CSS10-Most Severe Idea, Frequency-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - How many times have you had these thoughts? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency (Lifetime) | ||
CSS10-Most Severe Idea, Frequency-P1M | C113909 | CSS10-Most Severe Idea, Frequency-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - How many times have you had these thoughts? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Frequency (Past 1 Month) | ||
CSS10-Most Severe Idea-Life | C113904 | CSS10-Most Severe Idea-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most severe ideation. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Severe Ideation (Lifetime) | ||
CSS10-Most Severe Idea-P1M | C113906 | CSS10-Most Severe Idea-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Most severe ideation. (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Most Severe Ideation (Past 1 Month) | ||
CSS10-Non-Spec Suicid Thought, Describe | C113894 | CSS10-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of non-specific active suicidal thoughts. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Non-Specific Active Suicidal Thoughts | ||
CSS10-Non-Spec Suicid Thought-Life | C113892 | CSS10-Non-Spec Suicid Thought-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-Specific Active Suicidal Thoughts (Lifetime) | ||
CSS10-Non-Spec Suicid Thought-P1M | C113893 | CSS10-Non-Spec Suicid Thought-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about doing something to make yourself not alive anymore? Have you had any thoughts about killing yourself? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-Specific Active Suicidal Thoughts (Past 1 Month) | ||
CSS10-Non-suicidal Self-injur Behav-Life | C113916 | CSS10-Non-suicidal Self-injur Behav-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in non-suicidal self-injurious behavior? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-suicidal Self-injurious Behavior (Lifetime) | ||
CSS10-Non-suicidal Self-injur Behav-P3M | C113917 | CSS10-Non-suicidal Self-injur Behav-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in non-suicidal self-injurious behavior? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Non-suicidal Self-injurious Behavior (Past 3 Months) | ||
CSS10-Number of Aborted Attempts-Life | C113927 | CSS10-Number of Aborted Attempts-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of aborted or self-interrupted attempts. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Aborted or Self-interrupted Suicide Attempt (Lifetime) | ||
CSS10-Number of Aborted Attempts-P3M | C113928 | CSS10-Number of Aborted Attempts-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of aborted or self-interrupted attempts. (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Aborted or Self-interrupted Suicide Attempt (Past 3 Months) | ||
CSS10-Number of Actual Attempts-Life | C113913 | CSS10-Number of Actual Attempts-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of actual attempts. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Lifetime) | ||
CSS10-Number of Actual Attempts-P3M | C113914 | CSS10-Number of Actual Attempts-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of actual attempts. (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Actual Suicide Attempts (Past 3 Months) | ||
CSS10-Number of Interrupt Attempts-Life | C113922 | CSS10-Number of Interrupt Attempts-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of interrupted attempts. (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Interrupted Suicide Attempts (Lifetime) | ||
CSS10-Number of Interrupt Attempts-P3M | C113923 | CSS10-Number of Interrupt Attempts-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Total number of interrupted attempts. (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Number of Interrupted Suicide Attempts (Past 3 Months) | ||
CSS10-Preparatory Acts/Behavior, Descr | C113932 | CSS10-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of preparatory acts or behavior. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS10-Preparatory Acts/Behavior-Life | C113930 | CSS10-Preparatory Acts/Behavior-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Preparatory Acts or Behaviors Toward Suicide Attempt (Lifetime) | ||
CSS10-Preparatory Acts/Behavior-P3M | C113931 | CSS10-Preparatory Acts/Behavior-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you done anything to get ready to make yourself not alive anymore (to end your life or kill yourself) - like giving things away, writing a goodbye note, getting things you need to kill yourself? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Preparatory Acts or Behaviors Toward Suicide Attempt (Past 3 Months) | ||
CSS10-Self-injur Behav, Intent Unk-Life | C113918 | CSS10-Self-injur Behav, Intent Unk-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in self-injurious behavior, intent unknown? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Self-injurious Behavior, Intent Unknown (Lifetime) | ||
CSS10-Self-injur Behav, Intent Unk-P3M | C113919 | CSS10-Self-injur Behav, Intent Unk-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Has subject engaged in self-injurious behavior, intent unknown? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Self-injurious Behavior, Intent Unknown (Past 3 Months) | ||
CSS10-Suicidal Behavior-Life | C113933 | CSS10-Suicidal Behavior-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal behavior was present during the assessment period? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Lifetime) | ||
CSS10-Suicidal Behavior-P3M | C113934 | CSS10-Suicidal Behavior-P3M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal behavior was present during the assessment period? (Past 3 Months). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Suicidal Behavior (Past 3 Months) | ||
CSS10-Wish to be Dead, Describe | C113891 | CSS10-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Description of wishing to be dead. | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Description of Wish to be Dead | ||
CSS10-Wish to be Dead-Life | C113889 | CSS10-Wish to be Dead-Life | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Lifetime). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Wish to be Dead (Lifetime) | ||
CSS10-Wish to be Dead-P1M | C113890 | CSS10-Wish to be Dead-P1M | Columbia-Suicide Severity Rating Scale Pediatric/Cognitively Impaired Lifetime/Recent - Have you thought about being dead or what it would be like to be dead? Have you wished you were dead or wished you could go to sleep and never wake up? Do you ever wish you weren't alive anymore? (Past 1 Month). | C-SSRS Pediatric/Cognitively Impaired Lifetime/Recent - Wish to be Dead (Past 1 Month) | ||
Back to top | ||||||
CL.C111342.CSS09TC | Columbia-Suicide Severity Rating Scale Screening Questionnaire Test Code
(CSS09TC) | text
Extensible: No | C111342 | Columbia-Suicide Severity Rating Scale Screening Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Screening test code. | CDISC Questionnaire C-SSRS Screening Test Code Terminology |
CSS0901 | C111460 | CSS09-Wish to be Dead | Columbia-Suicide Severity Rating Scale Screening - Have you wished you were dead or wished you could go to sleep and not wake up? | C-SSRS Screening - Wish to be Dead | ||
CSS0901A | C111461 | CSS09-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of wishing to be dead. | C-SSRS Screening - Description of Wish to be Dead | ||
CSS0902 | C111462 | CSS09-Non-Spec Suicid Thought | Columbia-Suicide Severity Rating Scale Screening - Have you actually had any thoughts of killing yourself? | C-SSRS Screening - Non-Specific Active Suicidal Thoughts | ||
CSS0902A | C111463 | CSS09-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of non-specific active suicidal thoughts. | C-SSRS Screening - Description of Non-Specific Active Suicidal Thoughts | ||
CSS0903 | C111464 | CSS09-Idea, No Intent, No Plan | Columbia-Suicide Severity Rating Scale Screening - Have you been thinking about how you might do this? | C-SSRS Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS0903A | C111465 | CSS09-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Screening - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS0904 | C111466 | CSS09-Idea, Intent, No Plan | Columbia-Suicide Severity Rating Scale Screening - Have you had these thoughts and had some intention of acting on them? | C-SSRS Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS0904A | C111467 | CSS09-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Screening - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS0905 | C111468 | CSS09-Idea, Plan, Intent | Columbia-Suicide Severity Rating Scale Screening - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? | C-SSRS Screening - Active Suicidal Ideation with Specific Plan and Intent | ||
CSS0905A | C111469 | CSS09-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with specific plan and intent. | C-SSRS Screening - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS0906 | C111470 | CSS09-Most Severe Idea | Columbia-Suicide Severity Rating Scale Screening - Most severe ideation. | C-SSRS Screening - Most Severe Ideation | ||
CSS0906A | C111471 | CSS09-Most Severe Idea, Desc | Columbia-Suicide Severity Rating Scale Screening - Description of most severe ideation. | C-SSRS Screening - Describe Most Severe Ideation | ||
CSS0907 | C111472 | CSS09-Most Severe Idea, Frequency | Columbia-Suicide Severity Rating Scale Screening - How many times have you had these thoughts? | C-SSRS Screening - Frequency of Most Severe Ideation | ||
CSS0908 | C111473 | CSS09-Most Severe Idea, Duration | Columbia-Suicide Severity Rating Scale Screening - When you have the thoughts, how long do they last? | C-SSRS Screening - Duration of Most Severe Ideation | ||
CSS0909 | C111474 | CSS09-Most Severe Idea, Controllability | Columbia-Suicide Severity Rating Scale Screening - Could/can you stop thinking about killing yourself or wanting to die if you want to? | C-SSRS Screening - Controllability of Most Severe Ideation | ||
CSS0910 | C111475 | CSS09-Most Severe Idea, Deterrents | Columbia-Suicide Severity Rating Scale Screening - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? | C-SSRS Screening - Deterrents to Most Severe Ideation | ||
CSS0911 | C111476 | CSS09-Most Severe Idea, Reasons | Columbia-Suicide Severity Rating Scale Screening - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? | C-SSRS Screening - Reasons for Most Severe Ideation | ||
CSS0912 | C111477 | CSS09-Actual Attempt | Columbia-Suicide Severity Rating Scale Screening - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? | C-SSRS Screening - Actual Suicide Attempt | ||
CSS0913 | C111478 | CSS09-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Screening - Total number of actual attempts. | C-SSRS Screening - Number of Actual Suicide Attempts | ||
CSS0913A | C111479 | CSS09-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of actual attempt. | C-SSRS Screening - Description of Actual Suicide Attempt | ||
CSS0914 | C111480 | CSS09-Non-suicidal Self-injur Behav | Columbia-Suicide Severity Rating Scale Screening - Has subject engaged in non-suicidal self-injurious behavior? | C-SSRS Screening - Non-suicidal Self-injurious Behavior | ||
CSS0915 | C111481 | CSS09-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Screening - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? | C-SSRS Screening - Interrupted Suicide Attempt | ||
CSS0916 | C111482 | CSS09-Number of Interrupt Attempts | Columbia-Suicide Severity Rating Scale Screening - Total number of interrupted attempts. | C-SSRS Screening - Number of Interrupted Suicide Attempts | ||
CSS0916A | C111483 | CSS09-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of interrupted attempt. | C-SSRS Screening - Description of Interrupted Suicide Attempt | ||
CSS0917 | C111484 | CSS09-Aborted Attempt | Columbia-Suicide Severity Rating Scale Screening - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? | C-SSRS Screening - Aborted Suicide Attempt | ||
CSS0918 | C111485 | CSS09-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Screening - Total number of aborted attempts. | C-SSRS Screening - Number of Aborted Suicide Attempts | ||
CSS0918A | C111486 | CSS09-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of aborted attempt. | C-SSRS Screening - Description of Aborted Suicide Attempt | ||
CSS0919 | C111487 | CSS09-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Screening - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? | C-SSRS Screening - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0919A | C111488 | CSS09-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Screening - Description of preparatory acts or behavior. | C-SSRS Screening - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0920 | C111489 | CSS09-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Screening - Suicidal behavior was present during the assessment period? | C-SSRS Screening - Suicidal Behavior | ||
CSS0921A | C111490 | CSS09-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Screening - Most recent attempt date. | C-SSRS Screening - Most Recent Suicide Attempt Date | ||
CSS0921B | C111491 | CSS09-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Screening - Most recent attempt actual lethality/medical damage. | C-SSRS Screening - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0921C | C111492 | CSS09-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Screening - Most recent attempt potential lethality. | C-SSRS Screening - Most Recent Suicide Attempt Potential Lethality | ||
CSS0922A | C111493 | CSS09-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt date. | C-SSRS Screening - Most Lethal Suicide Attempt Date | ||
CSS0922B | C111494 | CSS09-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt actual lethality/medical damage. | C-SSRS Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0922C | C111495 | CSS09-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt potential lethality. | C-SSRS Screening - Most Lethal Suicide Attempt Potential Lethality | ||
CSS0923A | C111496 | CSS09-First Attempt Date | Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt date. | C-SSRS Screening - First Suicide Attempt Date | ||
CSS0923B | C111497 | CSS09-First Attempt Damage | Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt actual lethality/medical damage. | C-SSRS Screening - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS0923C | C111498 | CSS09-First Attempt Potential | Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt potential lethality. | C-SSRS Screening - First Suicide Attempt Potential Lethality | ||
Back to top | ||||||
CL.C111341.CSS09TN | Columbia-Suicide Severity Rating Scale Screening Questionnaire Test Name
(CSS09TN) | text
Extensible: No | C111341 | Columbia-Suicide Severity Rating Scale Screening Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Screening test name. | CDISC Questionnaire C-SSRS Screening Test Name Terminology |
CSS09-Aborted Attempt | C111484 | CSS09-Aborted Attempt | Columbia-Suicide Severity Rating Scale Screening - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? | C-SSRS Screening - Aborted Suicide Attempt | ||
CSS09-Aborted Attempt, Describe | C111486 | CSS09-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of aborted attempt. | C-SSRS Screening - Description of Aborted Suicide Attempt | ||
CSS09-Actual Attempt | C111477 | CSS09-Actual Attempt | Columbia-Suicide Severity Rating Scale Screening - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? | C-SSRS Screening - Actual Suicide Attempt | ||
CSS09-Actual Attempt, Describe | C111479 | CSS09-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of actual attempt. | C-SSRS Screening - Description of Actual Suicide Attempt | ||
CSS09-First Attempt Damage | C111497 | CSS09-First Attempt Damage | Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt actual lethality/medical damage. | C-SSRS Screening - First Suicide Attempt Actual Lethality/Medical Damage | ||
CSS09-First Attempt Date | C111496 | CSS09-First Attempt Date | Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt date. | C-SSRS Screening - First Suicide Attempt Date | ||
CSS09-First Attempt Potential | C111498 | CSS09-First Attempt Potential | Columbia-Suicide Severity Rating Scale Screening - Initial/first attempt potential lethality. | C-SSRS Screening - First Suicide Attempt Potential Lethality | ||
CSS09-Idea, Intent, No Plan | C111466 | CSS09-Idea, Intent, No Plan | Columbia-Suicide Severity Rating Scale Screening - Have you had these thoughts and had some intention of acting on them? | C-SSRS Screening - Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS09-Idea, Intent, No Plan, Describe | C111467 | CSS09-Idea, Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Screening - Description of Active Suicidal Ideation with Some Intent to Act, without Specific Plan | ||
CSS09-Idea, No Intent, No Plan | C111464 | CSS09-Idea, No Intent, No Plan | Columbia-Suicide Severity Rating Scale Screening - Have you been thinking about how you might do this? | C-SSRS Screening - Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS09-Idea, No Intent, No Plan, Describe | C111465 | CSS09-Idea, No Intent, No Plan, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Screening - Description of Active Suicidal Ideation with Any Methods (Not Plan) without Intent to Act | ||
CSS09-Idea, Plan, Intent | C111468 | CSS09-Idea, Plan, Intent | Columbia-Suicide Severity Rating Scale Screening - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? | C-SSRS Screening - Active Suicidal Ideation with Specific Plan and Intent | ||
CSS09-Idea, Plan, Intent, Describe | C111469 | CSS09-Idea, Plan, Intent, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of active suicidal ideation with specific plan and intent. | C-SSRS Screening - Description of Active Suicidal Ideation with Specific Plan and Intent | ||
CSS09-Interrupted Attempt | C111481 | CSS09-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Screening - Has there been a time when you started to do something to end your life but someone or something stopped you before you actually did anything? | C-SSRS Screening - Interrupted Suicide Attempt | ||
CSS09-Interrupted Attempt, Describe | C111483 | CSS09-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of interrupted attempt. | C-SSRS Screening - Description of Interrupted Suicide Attempt | ||
CSS09-Most Lethal Attempt Damage | C111494 | CSS09-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt actual lethality/medical damage. | C-SSRS Screening - Most Lethal Suicide Attempt Actual Lethality/Medical Damage | ||
CSS09-Most Lethal Attempt Date | C111493 | CSS09-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt date. | C-SSRS Screening - Most Lethal Suicide Attempt Date | ||
CSS09-Most Lethal Attempt Potential | C111495 | CSS09-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Screening - Most lethal attempt potential lethality. | C-SSRS Screening - Most Lethal Suicide Attempt Potential Lethality | ||
CSS09-Most Recent Attempt Damage | C111491 | CSS09-Most Recent Attempt Damage | Columbia-Suicide Severity Rating Scale Screening - Most recent attempt actual lethality/medical damage. | C-SSRS Screening - Most Recent Suicide Attempt Actual Lethality/Medical Damage | ||
CSS09-Most Recent Attempt Date | C111490 | CSS09-Most Recent Attempt Date | Columbia-Suicide Severity Rating Scale Screening - Most recent attempt date. | C-SSRS Screening - Most Recent Suicide Attempt Date | ||
CSS09-Most Recent Attempt Potential | C111492 | CSS09-Most Recent Attempt Potential | Columbia-Suicide Severity Rating Scale Screening - Most recent attempt potential lethality. | C-SSRS Screening - Most Recent Suicide Attempt Potential Lethality | ||
CSS09-Most Severe Idea | C111470 | CSS09-Most Severe Idea | Columbia-Suicide Severity Rating Scale Screening - Most severe ideation. | C-SSRS Screening - Most Severe Ideation | ||
CSS09-Most Severe Idea, Controllability | C111474 | CSS09-Most Severe Idea, Controllability | Columbia-Suicide Severity Rating Scale Screening - Could/can you stop thinking about killing yourself or wanting to die if you want to? | C-SSRS Screening - Controllability of Most Severe Ideation | ||
CSS09-Most Severe Idea, Desc | C111471 | CSS09-Most Severe Idea, Desc | Columbia-Suicide Severity Rating Scale Screening - Description of most severe ideation. | C-SSRS Screening - Describe Most Severe Ideation | ||
CSS09-Most Severe Idea, Deterrents | C111475 | CSS09-Most Severe Idea, Deterrents | Columbia-Suicide Severity Rating Scale Screening - Are there things-anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? | C-SSRS Screening - Deterrents to Most Severe Ideation | ||
CSS09-Most Severe Idea, Duration | C111473 | CSS09-Most Severe Idea, Duration | Columbia-Suicide Severity Rating Scale Screening - When you have the thoughts, how long do they last? | C-SSRS Screening - Duration of Most Severe Ideation | ||
CSS09-Most Severe Idea, Frequency | C111472 | CSS09-Most Severe Idea, Frequency | Columbia-Suicide Severity Rating Scale Screening - How many times have you had these thoughts? | C-SSRS Screening - Frequency of Most Severe Ideation | ||
CSS09-Most Severe Idea, Reasons | C111476 | CSS09-Most Severe Idea, Reasons | Columbia-Suicide Severity Rating Scale Screening - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? | C-SSRS Screening - Reasons for Most Severe Ideation | ||
CSS09-Non-Spec Suicid Thought | C111462 | CSS09-Non-Spec Suicid Thought | Columbia-Suicide Severity Rating Scale Screening - Have you actually had any thoughts of killing yourself? | C-SSRS Screening - Non-Specific Active Suicidal Thoughts | ||
CSS09-Non-Spec Suicid Thought, Describe | C111463 | CSS09-Non-Spec Suicid Thought, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of non-specific active suicidal thoughts. | C-SSRS Screening - Description of Non-Specific Active Suicidal Thoughts | ||
CSS09-Non-suicidal Self-injur Behav | C111480 | CSS09-Non-suicidal Self-injur Behav | Columbia-Suicide Severity Rating Scale Screening - Has subject engaged in non-suicidal self-injurious behavior? | C-SSRS Screening - Non-suicidal Self-injurious Behavior | ||
CSS09-Number of Aborted Attempts | C111485 | CSS09-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Screening - Total number of aborted attempts. | C-SSRS Screening - Number of Aborted Suicide Attempts | ||
CSS09-Number of Actual Attempts | C111478 | CSS09-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Screening - Total number of actual attempts. | C-SSRS Screening - Number of Actual Suicide Attempts | ||
CSS09-Number of Interrupt Attempts | C111482 | CSS09-Number of Interrupt Attempts | Columbia-Suicide Severity Rating Scale Screening - Total number of interrupted attempts. | C-SSRS Screening - Number of Interrupted Suicide Attempts | ||
CSS09-Preparatory Acts/Behavior | C111487 | CSS09-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Screening - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? | C-SSRS Screening - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS09-Preparatory Acts/Behavior, Descr | C111488 | CSS09-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Screening - Description of preparatory acts or behavior. | C-SSRS Screening - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS09-Suicidal Behavior | C111489 | CSS09-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Screening - Suicidal behavior was present during the assessment period? | C-SSRS Screening - Suicidal Behavior | ||
CSS09-Wish to be Dead | C111460 | CSS09-Wish to be Dead | Columbia-Suicide Severity Rating Scale Screening - Have you wished you were dead or wished you could go to sleep and not wake up? | C-SSRS Screening - Wish to be Dead | ||
CSS09-Wish to be Dead, Describe | C111461 | CSS09-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Screening - Description of wishing to be dead. | C-SSRS Screening - Description of Wish to be Dead | ||
Back to top | ||||||
CL.C103461.CSS02TC | Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire Test Code
(CSS02TC) | text
Extensible: No | C103461 | Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire Test Code | Columbia-Suicide Severity Rating Scale Since Last Visit test code. | CDISC Questionnaire C-SSRS Since Last Visit Test Code Terminology |
CSS0201 | C103772 | CSS02-Wish to be Dead | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you wished you were dead or wished you could go to sleep and not wake up? | C-SSRS Since Last Visit - Wish to be Dead or go to Sleep and not Wake Up | ||
CSS0201A | C103773 | CSS02-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of wishing to be dead. | C-SSRS Since Last Visit - Description of Wish to be Dead | ||
CSS0202 | C103774 | CSS02-Non-Specific Suicidal Thought | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you actually had any thoughts of killing yourself? | C-SSRS Since Last Visit - Non-Specific Suicidal Thought | ||
CSS0202A | C103775 | CSS02-Non-Specific Suicid Thought, Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of non-specific active suicidal thoughts. | C-SSRS Since Last Visit - Description of Non-Specific Suicide Thought | ||
CSS0203 | C103776 | CSS02-Suicidal Ideation-No Intent | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you been thinking about how you might do this? | C-SSRS Since Last Visit - Suicidal Ideation-No Intent | ||
CSS0203A | C103777 | CSS02-Suicidal Ideation-No Intent, Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Since Last Visit - Description of Suicidal Ideation-No Intent | ||
CSS0204 | C103799 | CSS02-Ideation With Intent, No Plan | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you had these thoughts and had some intention of acting on them? | C-SSRS Since Last Visit - Ideation With Intent, No Plan | ||
CSS0204A | C103800 | CSS02-Ideation With Intent No Plan Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Since Last Visit - Description of Ideation With Intent, No Plan | ||
CSS0205 | C103801 | CSS02-Ideation With Plan/Intent | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? | C-SSRS Since Last Visit - Ideation With Plan/Intent | ||
CSS0205A | C103778 | CSS02-Ideation With Plan/Intent, Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with specific plan and intent. | C-SSRS Since Last Visit - Description of Ideation With Plan and Intent | ||
CSS0206 | C103779 | CSS02-Most Severe Ideation | Columbia-Suicide Severity Rating Scale Since Last Visit - Most severe ideation. | C-SSRS Since Last Visit - Most Severe Ideation | ||
CSS0206A | C103780 | CSS02-Most Severe Ideation, Description | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of most severe ideation. | C-SSRS Since Last Visit - Describe Most Severe Ideation | ||
CSS0207 | C103781 | CSS02-Most Severe Ideation, Frequency | Columbia-Suicide Severity Rating Scale Since Last Visit - How many times have you had these thoughts? | C-SSRS Since Last Visit - Frequency of Most Severe Ideation | ||
CSS0208 | C103782 | CSS02-Most Severe Ideation, Duration | Columbia-Suicide Severity Rating Scale Since Last Visit - When you have the thoughts, how long do they last? | C-SSRS Since Last Visit - Duration of Most Severe Ideation | ||
CSS0209 | C103783 | CSS02-Most Severe Ideation, Control | Columbia-Suicide Severity Rating Scale Since Last Visit - Could/can you stop thinking about killing yourself or wanting to die if you want to? | C-SSRS Since Last Visit - Control over Most Severe Ideation | ||
CSS0210 | C103784 | CSS02-Most Severe Ideation, Deterrents | Columbia-Suicide Severity Rating Scale Since Last Visit - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? | C-SSRS Since Last Visit - Deterrents to Most Severe Ideation | ||
CSS0211 | C103785 | CSS02-Most Severe Ideation, Reasons | Columbia-Suicide Severity Rating Scale Since Last Visit - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? | C-SSRS Since Last Visit - Reasons for Most Severe Ideation | ||
CSS0212 | C103786 | CSS02-Actual Attempt | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? | C-SSRS Since Last Visit - Actual Suicide Attempt | ||
CSS0213 | C103787 | CSS02-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of actual attempts. | C-SSRS Since Last Visit - Number of Actual Suicide Attempts | ||
CSS0213A | C103788 | CSS02-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of actual attempt. | C-SSRS Since Last Visit - Description of Actual Suicide Attempts | ||
CSS0214 | C103789 | CSS02-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Since Last Visit - Has the subject engaged in non-suicidal self-injurious behavior. | C-SSRS Since Last Visit - Non-suicidal Self-injurious Behavior | ||
CSS0215 | C103790 | CSS02-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Since Last Visit - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? | C-SSRS Since Last Visit - Interrupted Suicide Attempt | ||
CSS0216 | C103791 | CSS02-Number of Interrupted Attempts | Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of interrupted attempts. | C-SSRS Since Last Visit - Number of Interrupted Suicide Attempts | ||
CSS0216A | C103792 | CSS02-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of interrupted attempt. | C-SSRS Since Last Visit - Description of Interrupted Suicide Attempt | ||
CSS0217 | C103793 | CSS02-Aborted Attempt | Columbia-Suicide Severity Rating Scale Since Last Visit - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? | C-SSRS Since Last Visit - Aborted Suicide Attempt | ||
CSS0218 | C103794 | CSS02-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of aborted attempts. | C-SSRS Since Last Visit - Number of Aborted Suicide Attempts | ||
CSS0218A | C103795 | CSS02-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of aborted attempt. | C-SSRS Since Last Visit - Description of Aborted Suicide Attempt | ||
CSS0219 | C103796 | CSS02-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? | C-SSRS Since Last Visit - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0219A | C103797 | CSS02-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of preparatory acts or behavior. | C-SSRS Since Last Visit - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS0220 | C103798 | CSS02-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Since Last Visit - Suicidal behavior was present during the assessment period? | C-SSRS Since Last Visit - Suicidal Behavior | ||
CSS0221 | C103532 | CSS02-Suicide | Columbia-Suicide Severity Rating Scale Since Last Visit - Suicide. | C-SSRS Since Last Visit - Suicide | ||
CSS0222A | C103533 | CSS02-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt date. | C-SSRS Since Last Visit - Most Lethal Attempt Date | ||
CSS0222B | C103534 | CSS02-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt actual lethality/medical damage. | C-SSRS Since Last Visit - Most Lethal Actual Attempt Lethality/Medical Damage | ||
CSS0222C | C103535 | CSS02-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt potential lethality. | C-SSRS Since Last Visit - Most Lethal Actual Attempt Potential Lethality | ||
Back to top | ||||||
CL.C103460.CSS02TN | Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire Test Name
(CSS02TN) | text
Extensible: No | C103460 | Columbia-Suicide Severity Rating Scale Since Last Visit Questionnaire Test Name | Columbia-Suicide Severity Rating Scale Since Last Visit test name. | CDISC Questionnaire C-SSRS Since Last Visit Test Name Terminology |
CSS02-Aborted Attempt | C103793 | CSS02-Aborted Attempt | Columbia-Suicide Severity Rating Scale Since Last Visit - Has there been a time when you started to do something to try to end your life but you stopped yourself before you actually did anything? | C-SSRS Since Last Visit - Aborted Suicide Attempt | ||
CSS02-Aborted Attempt, Describe | C103795 | CSS02-Aborted Attempt, Describe | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of aborted attempt. | C-SSRS Since Last Visit - Description of Aborted Suicide Attempt | ||
CSS02-Actual Attempt | C103786 | CSS02-Actual Attempt | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you made a suicide attempt? Have you done anything to harm yourself? Have you done anything dangerous where you could have died? | C-SSRS Since Last Visit - Actual Suicide Attempt | ||
CSS02-Actual Attempt, Describe | C103788 | CSS02-Actual Attempt, Describe | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of actual attempt. | C-SSRS Since Last Visit - Description of Actual Suicide Attempts | ||
CSS02-Ideation With Intent No Plan Descr | C103800 | CSS02-Ideation With Intent No Plan Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with some intent to act, without specific plan. | C-SSRS Since Last Visit - Description of Ideation With Intent, No Plan | ||
CSS02-Ideation With Intent, No Plan | C103799 | CSS02-Ideation With Intent, No Plan | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you had these thoughts and had some intention of acting on them? | C-SSRS Since Last Visit - Ideation With Intent, No Plan | ||
CSS02-Ideation With Plan/Intent | C103801 | CSS02-Ideation With Plan/Intent | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you started to work out or worked out the details of how to kill yourself? Do you intend to carry out this plan? | C-SSRS Since Last Visit - Ideation With Plan/Intent | ||
CSS02-Ideation With Plan/Intent, Descr | C103778 | CSS02-Ideation With Plan/Intent, Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with specific plan and intent. | C-SSRS Since Last Visit - Description of Ideation With Plan and Intent | ||
CSS02-Interrupted Attempt | C103790 | CSS02-Interrupted Attempt | Columbia-Suicide Severity Rating Scale Since Last Visit - Has there been a time when you started to do something to try to end your life but someone or something stopped you before you actually did anything? | C-SSRS Since Last Visit - Interrupted Suicide Attempt | ||
CSS02-Interrupted Attempt, Describe | C103792 | CSS02-Interrupted Attempt, Describe | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of interrupted attempt. | C-SSRS Since Last Visit - Description of Interrupted Suicide Attempt | ||
CSS02-Most Lethal Attempt Damage | C103534 | CSS02-Most Lethal Attempt Damage | Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt actual lethality/medical damage. | C-SSRS Since Last Visit - Most Lethal Actual Attempt Lethality/Medical Damage | ||
CSS02-Most Lethal Attempt Date | C103533 | CSS02-Most Lethal Attempt Date | Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt date. | C-SSRS Since Last Visit - Most Lethal Attempt Date | ||
CSS02-Most Lethal Attempt Potential | C103535 | CSS02-Most Lethal Attempt Potential | Columbia-Suicide Severity Rating Scale Since Last Visit - Most lethal attempt potential lethality. | C-SSRS Since Last Visit - Most Lethal Actual Attempt Potential Lethality | ||
CSS02-Most Severe Ideation | C103779 | CSS02-Most Severe Ideation | Columbia-Suicide Severity Rating Scale Since Last Visit - Most severe ideation. | C-SSRS Since Last Visit - Most Severe Ideation | ||
CSS02-Most Severe Ideation, Control | C103783 | CSS02-Most Severe Ideation, Control | Columbia-Suicide Severity Rating Scale Since Last Visit - Could/can you stop thinking about killing yourself or wanting to die if you want to? | C-SSRS Since Last Visit - Control over Most Severe Ideation | ||
CSS02-Most Severe Ideation, Description | C103780 | CSS02-Most Severe Ideation, Description | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of most severe ideation. | C-SSRS Since Last Visit - Describe Most Severe Ideation | ||
CSS02-Most Severe Ideation, Deterrents | C103784 | CSS02-Most Severe Ideation, Deterrents | Columbia-Suicide Severity Rating Scale Since Last Visit - Are there things - anyone or anything (e.g., family, religion, pain of death) - that stopped you from wanting to die or acting on thoughts of committing suicide? | C-SSRS Since Last Visit - Deterrents to Most Severe Ideation | ||
CSS02-Most Severe Ideation, Duration | C103782 | CSS02-Most Severe Ideation, Duration | Columbia-Suicide Severity Rating Scale Since Last Visit - When you have the thoughts, how long do they last? | C-SSRS Since Last Visit - Duration of Most Severe Ideation | ||
CSS02-Most Severe Ideation, Frequency | C103781 | CSS02-Most Severe Ideation, Frequency | Columbia-Suicide Severity Rating Scale Since Last Visit - How many times have you had these thoughts? | C-SSRS Since Last Visit - Frequency of Most Severe Ideation | ||
CSS02-Most Severe Ideation, Reasons | C103785 | CSS02-Most Severe Ideation, Reasons | Columbia-Suicide Severity Rating Scale Since Last Visit - What sort of reasons did you have for thinking about wanting to die or killing yourself? Was it to end the pain or stop the way you were feeling (in other words you couldn't go on living with this pain or how you were feeling) or was it to get attention, revenge or a reaction from others? Or both? | C-SSRS Since Last Visit - Reasons for Most Severe Ideation | ||
CSS02-Non-Specific Suicid Thought, Descr | C103775 | CSS02-Non-Specific Suicid Thought, Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of non-specific active suicidal thoughts. | C-SSRS Since Last Visit - Description of Non-Specific Suicide Thought | ||
CSS02-Non-Specific Suicidal Thought | C103774 | CSS02-Non-Specific Suicidal Thought | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you actually had any thoughts of killing yourself? | C-SSRS Since Last Visit - Non-Specific Suicidal Thought | ||
CSS02-Non-suicidal Self-injurious Behav | C103789 | CSS02-Non-suicidal Self-injurious Behav | Columbia-Suicide Severity Rating Scale Since Last Visit - Has the subject engaged in non-suicidal self-injurious behavior. | C-SSRS Since Last Visit - Non-suicidal Self-injurious Behavior | ||
CSS02-Number of Aborted Attempts | C103794 | CSS02-Number of Aborted Attempts | Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of aborted attempts. | C-SSRS Since Last Visit - Number of Aborted Suicide Attempts | ||
CSS02-Number of Actual Attempts | C103787 | CSS02-Number of Actual Attempts | Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of actual attempts. | C-SSRS Since Last Visit - Number of Actual Suicide Attempts | ||
CSS02-Number of Interrupted Attempts | C103791 | CSS02-Number of Interrupted Attempts | Columbia-Suicide Severity Rating Scale Since Last Visit - Total number of interrupted attempts. | C-SSRS Since Last Visit - Number of Interrupted Suicide Attempts | ||
CSS02-Preparatory Acts/Behavior | C103796 | CSS02-Preparatory Acts/Behavior | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you taken any steps towards making a suicide attempt or preparing to kill yourself (such as collecting pills, getting a gun, giving valuables away or writing a suicide note)? | C-SSRS Since Last Visit - Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS02-Preparatory Acts/Behavior, Descr | C103797 | CSS02-Preparatory Acts/Behavior, Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of preparatory acts or behavior. | C-SSRS Since Last Visit - Description of Preparatory Acts or Behaviors Toward Suicide Attempt | ||
CSS02-Suicidal Behavior | C103798 | CSS02-Suicidal Behavior | Columbia-Suicide Severity Rating Scale Since Last Visit - Suicidal behavior was present during the assessment period? | C-SSRS Since Last Visit - Suicidal Behavior | ||
CSS02-Suicidal Ideation-No Intent | C103776 | CSS02-Suicidal Ideation-No Intent | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you been thinking about how you might do this? | C-SSRS Since Last Visit - Suicidal Ideation-No Intent | ||
CSS02-Suicidal Ideation-No Intent, Descr | C103777 | CSS02-Suicidal Ideation-No Intent, Descr | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of active suicidal ideation with any methods (not plan) without intent to act. | C-SSRS Since Last Visit - Description of Suicidal Ideation-No Intent | ||
CSS02-Suicide | C103532 | CSS02-Suicide | Columbia-Suicide Severity Rating Scale Since Last Visit - Suicide. | C-SSRS Since Last Visit - Suicide | ||
CSS02-Wish to be Dead | C103772 | CSS02-Wish to be Dead | Columbia-Suicide Severity Rating Scale Since Last Visit - Have you wished you were dead or wished you could go to sleep and not wake up? | C-SSRS Since Last Visit - Wish to be Dead or go to Sleep and not Wake Up | ||
CSS02-Wish to be Dead, Describe | C103773 | CSS02-Wish to be Dead, Describe | Columbia-Suicide Severity Rating Scale Since Last Visit - Description of wishing to be dead. | C-SSRS Since Last Visit - Description of Wish to be Dead | ||
Back to top | ||||||
CL.C179945.CES0101OR | Combat Exposure Scale Questionnaire ORRES for CES0101 TN/TC
(CES0101OR) | text
Extensible: No | C179945 | Combat Exposure Scale Questionnaire ORRES for CES0101 TN/TC | Combat Exposure Scale original result for CES0101 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0101 Original Response Terminology |
1-3 times | C180262 | CES0101-1-3 times | Combat Exposure Scale original result for CES0101-1-3 times. | Combat Exposure Scale CES0101 Original Result - 1-3 Times | ||
13-50 times | C180264 | CES0101-13-50 times | Combat Exposure Scale original result for CES0101-13-50 times. | Combat Exposure Scale CES0101 Original Result - 13-50 Times | ||
4-12 times | C180263 | CES0101-4-12 times | Combat Exposure Scale original result for CES0101-4-12 times. | Combat Exposure Scale CES0101 Original Result - 4-12 Times | ||
51+ times | C180265 | CES0101-51+times | Combat Exposure Scale original result for CES0101-51+times. | Combat Exposure Scale CES0101 Original Result - 51+ Times | ||
No | C180261 | CES0101-No | Combat Exposure Scale original result for CES0101-No. | Combat Exposure Scale CES0101 Original Result - No | ||
Back to top | ||||||
CL.C179946.CES0102OR | Combat Exposure Scale Questionnaire ORRES for CES0102 TN/TC
(CES0102OR) | text
Extensible: No | C179946 | Combat Exposure Scale Questionnaire ORRES for CES0102 TN/TC | Combat Exposure Scale original result for CES0102 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0102 Original Response Terminology |
1-3 months | C180268 | CES0102-1-3 months | Combat Exposure Scale original result for CES0102-1-3 months. | Combat Exposure Scale CES0102 Original Result - 1-3 Months | ||
4-6 months | C180269 | CES0102-4-6 months | Combat Exposure Scale original result for CES0102-4-6 months. | Combat Exposure Scale CES0102 Original Result - 4-6 Months | ||
7+ months | C180270 | CES0102-7+ months | Combat Exposure Scale original result for CES0102-7+ months. | Combat Exposure Scale CES0102 Original Result - 7+ Months | ||
<1 month | C180267 | CES0102-<1 month | Combat Exposure Scale original result for CES0102-<1 month. | Combat Exposure Scale CES0102 Original Result - <1 Month | ||
Never | C180266 | CES0102-Never | Combat Exposure Scale original result for CES0102-Never. | Combat Exposure Scale CES0102 Original Result - Never | ||
Back to top | ||||||
CL.C179947.CES0103OR | Combat Exposure Scale Questionnaire ORRES for CES0103 TN/TC
(CES0103OR) | text
Extensible: No | C179947 | Combat Exposure Scale Questionnaire ORRES for CES0103 TN/TC | Combat Exposure Scale original result for CES0103 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0103 Original Response Terminology |
1-2 times | C180272 | CES0103-1-2 times | Combat Exposure Scale original result for CES0103-1-2 times. | Combat Exposure Scale CES0103 Original Result - 1-2 Times | ||
13-25 times | C180274 | CES0103-13-25 times | Combat Exposure Scale original result for CES0103-13-25 times. | Combat Exposure Scale CES0103 Original Result - 13-25 Times | ||
26+ times | C180275 | CES0103-26+times | Combat Exposure Scale original result for CES0103-26+times. | Combat Exposure Scale CES0103 Original Result - 26+ Times | ||
3-12 times | C180273 | CES0103-3-12 times | Combat Exposure Scale original result for CES0103-3-12 times. | Combat Exposure Scale CES0103 Original Result - 3-12 Times | ||
No | C180271 | CES0103-No | Combat Exposure Scale original result for CES0103-No. | Combat Exposure Scale CES0103 Original Result - No | ||
Back to top | ||||||
CL.C179948.CES0104OR | Combat Exposure Scale Questionnaire ORRES for CES0104 TN/TC
(CES0104OR) | text
Extensible: No | C179948 | Combat Exposure Scale Questionnaire ORRES for CES0104 TN/TC | Combat Exposure Scale original result for CES0104 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0104 Original Response Terminology |
1-25% | C180277 | CES0104-1-25% | Combat Exposure Scale original result for CES0104-1-25%. | Combat Exposure Scale CES0104 Original Result - 1-25% | ||
26-50% | C180278 | CES0104-26-50% | Combat Exposure Scale original result for CES0104-26-50%. | Combat Exposure Scale CES0104 Original Result - 26-50% | ||
51-75% | C180279 | CES0104-51-75% | Combat Exposure Scale original result for CES0104-51-75%. | Combat Exposure Scale CES0104 Original Result - 51-75% | ||
76% or more | C180280 | CES0104-76% or more | Combat Exposure Scale original result for CES0104-76% or more. | Combat Exposure Scale CES0104 Original Result - 76% or More | ||
None | C180276 | CES0104-None | Combat Exposure Scale original result for CES0104-None. | Combat Exposure Scale CES0104 Original Result - None | ||
Back to top | ||||||
CL.C179949.CES0105T07OR | Combat Exposure Scale Questionnaire ORRES for CES0105 Through CES0107 TN/TC
(CES0105T07OR) | text
Extensible: No | C179949 | Combat Exposure Scale Questionnaire ORRES for CES0105 Through CES0107 TN/TC | Combat Exposure Scale original result for CES0105 through CES0107 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0105 Through CES0107 Original Response Terminology |
1-2 times | C180282 | CES0105 through CES0107-1-2 times | Combat Exposure Scale original result for CES0105 through CES0107-1-2 times. | Combat Exposure Scale CES0105 Through CES0107 Original Result - 1-2 Times | ||
13-50 times | C180284 | CES0105 through CES0107-13-50 times | Combat Exposure Scale original result for CES0105 through CES0107-13-50 times. | Combat Exposure Scale CES0105 Through CES0107 Original Result - 13-50 Times | ||
3-12 times | C180283 | CES0105 through CES0107-3-12 times | Combat Exposure Scale original result for CES0105 through CES0107-3-12 times. | Combat Exposure Scale CES0105 Through CES0107 Original Result - 3-12 Times | ||
51+ times | C180285 | CES0105 through CES0107-51+ times | Combat Exposure Scale original result for CES0105 through CES0107-51+ times. | Combat Exposure Scale CES0105 Through CES0107 Original Result - 51+ Times | ||
Never | C180281 | CES0105 through CES0107-Never | Combat Exposure Scale original result for CES0105 through CES0107-Never. | Combat Exposure Scale CES0105 Through CES0107 Original Result - Never | ||
Back to top | ||||||
CL.C179950.CES0101STR | Combat Exposure Scale Questionnaire STRESC for CES0101 TN/TC
(CES0101STR) | text
Extensible: No | C179950 | Combat Exposure Scale Questionnaire STRESC for CES0101 TN/TC | Combat Exposure Scale standardized character result for CES0101 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0101 Standardized Character Response Terminology |
1 | C180286 | CES0101-1 | Combat Exposure Scale standardized character result for CES0101-No. | Combat Exposure Scale CES0101 Standardized Character Result 1 | ||
2 | C180287 | CES0101-2 | Combat Exposure Scale standardized character result for CES0101-1-3 times. | Combat Exposure Scale CES0101 Standardized Character Result 2 | ||
3 | C180288 | CES0101-3 | Combat Exposure Scale standardized character result for CES0101-4-12 times. | Combat Exposure Scale CES0101 Standardized Character Result 3 | ||
4 | C180289 | CES0101-4 | Combat Exposure Scale standardized character result for CES0101-13-50 times. | Combat Exposure Scale CES0101 Standardized Character Result 4 | ||
5 | C180290 | CES0101-5 | Combat Exposure Scale standardized character result for CES0101-51+times. | Combat Exposure Scale CES0101 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C179951.CES0102STR | Combat Exposure Scale Questionnaire STRESC for CES0102 TN/TC
(CES0102STR) | text
Extensible: No | C179951 | Combat Exposure Scale Questionnaire STRESC for CES0102 TN/TC | Combat Exposure Scale standardized character result for CES0102 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0102 Standardized Character Response Terminology |
1 | C180291 | CES0102-1 | Combat Exposure Scale standardized character result for CES0102-Never. | Combat Exposure Scale CES0102 Standardized Character Result 1 | ||
2 | C180292 | CES0102-2 | Combat Exposure Scale standardized character result for CES0102-<1 month. | Combat Exposure Scale CES0102 Standardized Character Result 2 | ||
3 | C180293 | CES0102-3 | Combat Exposure Scale standardized character result for CES0102-1-3 months. | Combat Exposure Scale CES0102 Standardized Character Result 3 | ||
4 | C180294 | CES0102-4 | Combat Exposure Scale standardized character result for CES0102-4-6 months. | Combat Exposure Scale CES0102 Standardized Character Result 4 | ||
5 | C180295 | CES0102-5 | Combat Exposure Scale standardized character result for CES0102-7+ months. | Combat Exposure Scale CES0102 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C179952.CES0103STR | Combat Exposure Scale Questionnaire STRESC for CES0103 TN/TC
(CES0103STR) | text
Extensible: No | C179952 | Combat Exposure Scale Questionnaire STRESC for CES0103 TN/TC | Combat Exposure Scale standardized character result for CES0103 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0103 Standardized Character Response Terminology |
1 | C180296 | CES0103-1 | Combat Exposure Scale standardized character result for CES0103-No. | Combat Exposure Scale CES0103 Standardized Character Result 1 | ||
2 | C180297 | CES0103-2 | Combat Exposure Scale standardized character result for CES0103-1-2 times. | Combat Exposure Scale CES0103 Standardized Character Result 2 | ||
3 | C180298 | CES0103-3 | Combat Exposure Scale standardized character result for CES0103-3-12 times. | Combat Exposure Scale CES0103 Standardized Character Result 3 | ||
4 | C180299 | CES0103-4 | Combat Exposure Scale standardized character result for CES0103-13-25 times. | Combat Exposure Scale CES0103 Standardized Character Result 4 | ||
5 | C180300 | CES0103-5 | Combat Exposure Scale standardized character result for CES0103-26+times. | Combat Exposure Scale CES0103 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C179953.CES0104STR | Combat Exposure Scale Questionnaire STRESC for CES0104 TN/TC
(CES0104STR) | text
Extensible: No | C179953 | Combat Exposure Scale Questionnaire STRESC for CES0104 TN/TC | Combat Exposure Scale standardized character result for CES0104 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0104 Standardized Character Response Terminology |
1 | C180301 | CES0104-1 | Combat Exposure Scale standardized character result for CES0104-None. | Combat Exposure Scale CES0104 Standardized Character Result 1 | ||
2 | C180302 | CES0104-2 | Combat Exposure Scale standardized character result for CES0104-1-25%. | Combat Exposure Scale CES0104 Standardized Character Result 2 | ||
3 | C180303 | CES0104-3 | Combat Exposure Scale standardized character result for CES0104-26-50%. | Combat Exposure Scale CES0104 Standardized Character Result 3 | ||
4 | C180304 | CES0104-4 | Combat Exposure Scale standardized character result for CES0104-51-75%. | Combat Exposure Scale CES0104 Standardized Character Result 4 | ||
5 | C180305 | CES0104-5 | Combat Exposure Scale standardized character result for CES0104-76% or more. | Combat Exposure Scale CES0104 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C179954.CES0105T07STR | Combat Exposure Scale Questionnaire STRESC for CES0105 Through CES0107 TN/TC
(CES0105T07STR) | text
Extensible: No | C179954 | Combat Exposure Scale Questionnaire STRESC for CES0105 Through CES0107 TN/TC | Combat Exposure Scale standardized character result for CES0105 through CES0107 test and test code. | CDISC Questionnaire Combat Exposure Scale CES0105 Through CES0107 Standardized Character Response Terminology |
1 | C180306 | CES0105 through CES0107-1 | Combat Exposure Scale standardized character result for CES0105 through CES0107-Never. | Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 1 | ||
2 | C180307 | CES0105 through CES0107-2 | Combat Exposure Scale standardized character result for CES0105 through CES0107-1-2 times. | Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 2 | ||
3 | C180308 | CES0105 through CES0107-3 | Combat Exposure Scale standardized character result for CES0105 through CES0107-3-12 times. | Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 3 | ||
4 | C180309 | CES0105 through CES0107-4 | Combat Exposure Scale standardized character result for CES0105 through CES0107-13-50 times. | Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 4 | ||
5 | C180310 | CES0105 through CES0107-5 | Combat Exposure Scale standardized character result for CES0105 through CES0107-51+ times. | Combat Exposure Scale CES0105 Through CES0107 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C132519.CES01TC | Combat Exposure Scale Questionnaire Test Code
(CES01TC) | text
Extensible: No | C132519 | Combat Exposure Scale Questionnaire Test Code | Combat Exposure Scale test code. | CDISC Questionnaire CES Test Code Terminology |
CES0101 | C132556 | CES01-Ever Combat Patrols/Dangerous Duty | Combat Exposure Scale - Did you ever go on combat patrols or have other dangerous duty? | CES - Ever Combat Patrols or Dangerous Duty | ||
CES0102 | C132557 | CES01-Were You Ever Under Enemy Fire | Combat Exposure Scale - Were you ever under enemy fire? | CES - Were You Ever Under Enemy Fire | ||
CES0103 | C132558 | CES01-Ever Surrounded by the Enemy | Combat Exposure Scale - Were you ever surrounded by the enemy? | CES - Ever Surrounded by the Enemy | ||
CES0104 | C132559 | CES01-Soldiers in Unit KIA, Wounded, MIA | Combat Exposure Scale - What percentage of the soldiers in your unit were killed (KIA), wounded or missing in action (MIA)? | CES - Soldiers in Unit Killed (KIA), Wounded, Missing (MIA) | ||
CES0105 | C132560 | CES01-How Often Fire Rounds at Enemy | Combat Exposure Scale - How often did you fire rounds at the enemy? | CES - How Often Fire Rounds at Enemy | ||
CES0106 | C132561 | CES01-See Someone Hit by Rounds | Combat Exposure Scale - How often did you see someone hit by incoming or outgoing rounds? | CES - See Someone Hit by Rounds | ||
CES0107 | C132562 | CES01-In Danger of Being Injured/Killed | Combat Exposure Scale - How often were you in danger of being injured or killed (i.e., being pinned down, overrun, ambushed, near miss, etc.)? | CES - In Danger of Being Injured or Killed | ||
Back to top | ||||||
CL.C132518.CES01TN | Combat Exposure Scale Questionnaire Test Name
(CES01TN) | text
Extensible: No | C132518 | Combat Exposure Scale Questionnaire Test Name | Combat Exposure Scale test name. | CDISC Questionnaire CES Test Name Terminology |
CES01-Ever Combat Patrols/Dangerous Duty | C132556 | CES01-Ever Combat Patrols/Dangerous Duty | Combat Exposure Scale - Did you ever go on combat patrols or have other dangerous duty? | CES - Ever Combat Patrols or Dangerous Duty | ||
CES01-Ever Surrounded by the Enemy | C132558 | CES01-Ever Surrounded by the Enemy | Combat Exposure Scale - Were you ever surrounded by the enemy? | CES - Ever Surrounded by the Enemy | ||
CES01-How Often Fire Rounds at Enemy | C132560 | CES01-How Often Fire Rounds at Enemy | Combat Exposure Scale - How often did you fire rounds at the enemy? | CES - How Often Fire Rounds at Enemy | ||
CES01-In Danger of Being Injured/Killed | C132562 | CES01-In Danger of Being Injured/Killed | Combat Exposure Scale - How often were you in danger of being injured or killed (i.e., being pinned down, overrun, ambushed, near miss, etc.)? | CES - In Danger of Being Injured or Killed | ||
CES01-See Someone Hit by Rounds | C132561 | CES01-See Someone Hit by Rounds | Combat Exposure Scale - How often did you see someone hit by incoming or outgoing rounds? | CES - See Someone Hit by Rounds | ||
CES01-Soldiers in Unit KIA, Wounded, MIA | C132559 | CES01-Soldiers in Unit KIA, Wounded, MIA | Combat Exposure Scale - What percentage of the soldiers in your unit were killed (KIA), wounded or missing in action (MIA)? | CES - Soldiers in Unit Killed (KIA), Wounded, Missing (MIA) | ||
CES01-Were You Ever Under Enemy Fire | C132557 | CES01-Were You Ever Under Enemy Fire | Combat Exposure Scale - Were you ever under enemy fire? | CES - Were You Ever Under Enemy Fire | ||
Back to top | ||||||
CL.C187681.CMSPSTAT | Commercial Sponsor Status Response
(CMSPSTAT) | text
Extensible: No | C187681 | Commercial Sponsor Status Response | Terminology relevant to the responses for the state or condition of the sponsor as pertains to whether the sponsor is considered a commercial entity. | CDISC SDTM Commercial Sponsor Status Response Terminology |
COMMERCIAL | C187708 | A person or organization that takes responsibility for a trial which is part of the development program for a marketing authorization of a medicinal product at the time of the application. (EUDRACT) | Commercial Clinical Trial Sponsor | |||
NON-COMMERCIAL | C187709 | A person or organization that takes responsibility for a trial that is not part of the development program for a marketing authorization of a medicinal product at the time of the application. (EUDRACT) | Non-commercial Clinical Trial Sponsor | |||
Back to top | ||||||
CL.C66727.NCOMPLT | Completion/Reason for Non-Completion
(NCOMPLT) | text
Extensible: Yes | C66727 | Completion/Reason for Non-Completion | The status of the subject's completion of the study or a segment of the study, or the reason the subject discontinued the study or segment of the study. | CDISC SDTM Reason for Non-Completion Terminology |
ADVERSE EVENT | C41331 | Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience. (CDISC glossary) | Adverse Event | |||
APPROVED DRUG AVAILABLE FOR INDICATION | C172573 | An indication that an approved drug is available for use for the disease indication. | Approved Drug Available For Indication | |||
COMPLETED | C25250 | To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI) | Complete | |||
DEATH | C28554 | Died | The absence of life or state of being dead. (NCI) | Dead | ||
DISEASE RELAPSE | C38155 | Recurrent Disease | The return of a disease after a period of remission. | Recurrent Disease | ||
FAILURE TO MEET CONTINUATION CRITERIA | C139236 | An indication that the subject has not been able to meet protocol-defined continuation criteria and will not continue to participate in the clinical trial. | Failure To Meet Continuation Criteria | |||
FAILURE TO MEET RANDOMIZATION CRITERIA | C105448 | An indication that the subject has been unable to fulfill/satisfy the criteria required for assignment into a randomized group. | Failure to Meet Randomization Criteria | |||
LACK OF EFFICACY | C48226 | The lack of expected or desired effect related to a therapy. (NCI) | Lack of Efficacy | |||
LOGISTICAL PROBLEM | C176343 | A problem with some logistical aspect of a clinical study, either on the part of the participant or the site. | Logistical Problem With Clinical Study | |||
LOST TO FOLLOW-UP | C48227 | The loss or lack of continuation of a subject to follow-up. | Lost To Follow-Up | |||
MET ELIGIBILITY CRITERIA BUT NOT NEEDED | C150884 | Passed Screening But Not Needed;Qualified But Not Needed;Reserve, Not Used | An indication that the subject met inclusion/exclusion criteria but was not needed in the trial. | Subject Met Eligibility Criteria But Was Not Needed | ||
NEVER DOSED | C172572 | An indication that a subject has not ever been dosed with the study treatment or investigational product. | Never Dosed | |||
NO LONGER CLINICALLY BENEFITING | C156551 | NLCB | An indication that a treatment or therapy was changed or discontinued because it is no longer clinically beneficial to the subject or patient, based on the primary therapeutic objective for which it is being administered and assessed. (Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. Scher HI, Morris MJ, Stadler WM, et al.; Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016 Apr 20;34(12):1402-18.) | No Longer Clinically Benefiting | ||
NON-COMPLIANCE WITH NON-STUDY DEVICE | C139240 | An indication that a subject has not followed the instructions related to a device that is not under study. | Non-Compliance With Non-Study Device | |||
NON-COMPLIANCE WITH STUDY DEVICE | C139241 | An indication that a subject has not followed the instructions related to a device under study. | Non-Compliance With Study Device | |||
NON-COMPLIANCE WITH STUDY DRUG | C49631 | An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI) | Non-Compliance With Study Drug | |||
NON-COMPLIANCE WITH STUDY SCHEDULE | C161411 | An indication that a subject has not followed the schedule of study activities. | Non-Compliance With Study Schedule | |||
OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
PARTNER PREGNANCY | C191340 | An indication that the study subject's partner is pregnant. | Partner Pregnancy | |||
PHYSICIAN DECISION | C48250 | A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI) | Physician Decision | |||
PREGNANCY | C191656 | Subject Pregnancy | An indication that the subject is pregnant. | Pregnant Subject | ||
PROGRESSIVE DISEASE | C35571 | Disease Progression;Progressive Disease | A disease process that is increasing in extent or severity. (NCI) | Progressive Disease | ||
PROTOCOL DEVIATION | C50996 | A variation from processes or procedures defined in a protocol. Deviations usually do not preclude the overall evaluability of subject data for either efficacy or safety, and are often acknowledged and accepted in advance by the sponsor. NOTE: Good clinical practice recommends that deviations be summarized by site and by category as part of the report of study results so that the possible importance of the deviations to the findings of the study can be assessed. Compare to protocol violation. [See ICH E3] (CDISC Glossary) | Protocol Deviation | |||
PROTOCOL VIOLATION | C142185 | A significant departure from processes or procedures that were required by the protocol. Violations often result in data that are not deemed evaluable for a per-protocol analysis, and may require that the subject(s) who violate the protocol be discontinued from the study. Compare to protocol deviation. (CDISC Glossary) | Protocol Violation | |||
PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET | C142349 | An indication that the patient has met one or multiple protocol-specified withdrawal criteria and has been removed from the study or from one or more segments of the study. | Protocol-Specified Withdrawal Criterion Met | |||
RANDOMIZED BY MISTAKE WITH STUDY TREATMENT | C139238 | An indication that the subject was randomized but should not have been and study treatment was received in error. | Randomized By Mistake With Study Treatment | |||
RANDOMIZED BY MISTAKE WITHOUT STUDY TREATMENT | C139239 | An indication that the subject was randomized but should not have been however no study treatment was received. | Randomized By Mistake Without Study Treatment | |||
RANDOMIZED BY MISTAKE | C139237 | An indication that the subject was randomized but should not have been. | Randomized By Mistake | |||
RECOVERY | C25746 | A healing process and/or an outcome implying relative health. The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI) | Recovery | |||
REQUIRES PROHIBITED MEDICATION | C191339 | An indication that the study subject needs to be treated with a medication that is prohibited per the protocol. | Requires Prohibited Medication | |||
SCREEN FAILURE | C49628 | Failure to Meet Inclusion/Exclusion Criteria | The potential subject who does not meet eligibility (inclusion/exclusion) criteria during the screening period. | Trial Screen Failure | ||
SCREENING NOT COMPLETED | C166074 | An indication that the subject did not complete the screening process. | Screening Not Completed | |||
SITE TERMINATED BY SPONSOR | C106576 | An indication that a clinical study was stopped at a particular site by its sponsor. (NCI) | Trial Site Terminated by Sponsor | |||
SPONSOR REQUEST | C161410 | An indication that the study subject was removed from the study or from one or more segments of the study (e.g., treatment epoch, long-term follow-up epoch) at the sponsor's request. | Subject Removed at Sponsor Request | |||
STUDY TERMINATED BY SPONSOR | C49632 | An indication that a clinical study was stopped by its sponsor. (NCI) | Study Terminated By Sponsor | |||
TECHNICAL PROBLEMS | C49633 | A problem with some technical aspect of a clinical study, usually related to an instrument. (NCI) | Technical Problem | |||
WITHDRAWAL BY PARENT/GUARDIAN | C102355 | An indication that a study participant has been removed from the study or from one or more segments of the study by the parent or legal guardian. | Study Subject Withdrawal by Parent or Guardian | |||
WITHDRAWAL BY SUBJECT | C49634 | Dropout | The subject-initiated act of discontinuing participation in the study as a whole or one or more aspects of the study (e.g., a study period or use of biospecimens). | Withdrawal by Subject | ||
WITHDRAWAL OF ASSENT | C198355 | Informed Assent Withdrawn | An indication that the assent to participate in the study, or one or more components of the study, has been revoked. | Withdrawal of Assent | ||
WITHDRAWAL OF CONSENT | C176342 | Informed Consent Withdrawn | An indication that the consent to participate in the study, or one or more components of the study, has been revoked. | Study Consent Withdrawn | ||
Back to top | ||||||
CL.C90018.CSTATE | Consciousness State
(CSTATE) | text
Extensible: Yes | C90018 | Consciousness State | Terminology related to the sense of awareness of self and of the environment. | CDISC SEND Consciousness State Terminology |
CONSCIOUS | C88434 | Conscious State | A level of awareness that can be described as being alert. (NCI) | Conscious State | ||
DEPRESSED | C78253 | Depressed Level of Consciousness | A neurologic state characterized by decreased ability to perceive and respond. (NCI) | Depressed Level Of Consciousness | ||
SEMI-CONSCIOUS | C88440 | Semi-conscious State | A level of awareness that can be described as varied and intermittent periods of consciousness and unconsciousness. | Semi-conscious | ||
UNCONSCIOUS | C50635 | Loss of Consciousness;Unconscious State | The neurologic status characterized by the occurrence of a loss of the ability to perceive and respond. | Loss of Consciousness | ||
UNSPECIFIED | C90482 | Unspecified State of Consciousness | The state of consciousness is not controlled. The possibility exists for having multiple conscious states over a period of time. (NCI) | Unspecified State of Consciousness | ||
Back to top | ||||||
CL.C101838.CCRCLSCD | Consensus Cardiac Classification System Test Code
(CCRCLSCD) | text
Extensible: Yes | C101838 | Consensus Cardiac Classification System Test Code | Classification system test code for cardiac parameters that are authored or endorsed by organizations. | CDISC SDTM Consensus Cardiac Classification Systems Test Code Terminology |
CCSGRDS | C66910 | Canadian CV Society Grading Scale | A finding associated with a patient based on the functional classification developed by the Canadian Cardiovascular Society (CCS), for categorizing patients with angina. The classification system comprises four classes, which are defined in terms of the level of physical activity associated with the subject's anginal symptoms. | Canadian Cardiovascular Society Grading Scale Class | ||
KILLIPCL | C66916 | Killip Class | A finding associated with a patient based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure. | Killip Class | ||
LSNCPCLS | C100032 | ACC/AHA Lesion Complexity Class | A classification system for coronary stenosis based upon characteristics that influence the difficulty of percutaneous coronary revascularization. | American College of Cardiology/American Heart Association Lesion Complexity Class | ||
NYHACLS | C66909 | New York Heart Association Class | A finding associated with a patient based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. The classification system is based on the ability to engage in physical activity. The classification system comprises four classes, though NYHA Class III and Class IV are often aggregated for the purpose of outcomes analysis. | New York Heart Association Class | ||
TIMIFLOW | C100021 | TIMI Flow | A grading system for coronary blood flow based on the classification developed by the Thrombolysis in Myocardial Infarction Group. It classifies coronary blood flow into four classes based upon the angiographic appearance of the blood vessels. | Thrombolysis in Myocardial Infarction Flow | ||
Back to top | ||||||
CL.C101837.CCRCLS | Consensus Cardiac Classification System Test Name
(CCRCLS) | text
Extensible: Yes | C101837 | Consensus Cardiac Classification System Test Name | Classification system test name for cardiac parameters that are authored or endorsed by organizations. | CDISC SDTM Consensus Cardiac Classification Systems Test Name Terminology |
ACC/AHA Lesion Complexity Class | C100032 | ACC/AHA Lesion Complexity Class | A classification system for coronary stenosis based upon characteristics that influence the difficulty of percutaneous coronary revascularization. | American College of Cardiology/American Heart Association Lesion Complexity Class | ||
Canadian CV Society Grading Scale | C66910 | Canadian CV Society Grading Scale | A finding associated with a patient based on the functional classification developed by the Canadian Cardiovascular Society (CCS), for categorizing patients with angina. The classification system comprises four classes, which are defined in terms of the level of physical activity associated with the subject's anginal symptoms. | Canadian Cardiovascular Society Grading Scale Class | ||
Killip Class | C66916 | Killip Class | A finding associated with a patient based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure. | Killip Class | ||
New York Heart Association Class | C66909 | New York Heart Association Class | A finding associated with a patient based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. The classification system is based on the ability to engage in physical activity. The classification system comprises four classes, though NYHA Class III and Class IV are often aggregated for the purpose of outcomes analysis. | New York Heart Association Class | ||
TIMI Flow | C100021 | TIMI Flow | A grading system for coronary blood flow based on the classification developed by the Thrombolysis in Myocardial Infarction Group. It classifies coronary blood flow into four classes based upon the angiographic appearance of the blood vessels. | Thrombolysis in Myocardial Infarction Flow | ||
Back to top | ||||||
CL.C102575.CCINVTYP | Contact Case Investigation Contact Type
(CCINVTYP) | text
Extensible: Yes | C102575 | Contact Case Investigation Contact Type | Terminology relevant to the identification and clinical investigation of disease contacts. | CDISC SDTM Contact Case Investigation Contact Type Terminology |
CASUAL CONTACT | C102606 | A way of contracting a disease through everyday interactions (nonsexual) with an infected person. | Casual Contact | |||
CONTACT WITH EXPOSURE DURING MEDICAL PROCEDURE | C102609 | A way of contracting a disease by interacting with an individual that has been exposed to the disease while undergoing a medical procedure. | Contact With Exposure During Medical Procedure | |||
CONTACT WITH EXPOSURE IN CROWD SETTING | C102610 | A way of contracting a disease by physically associating with an infected group of individuals. | Contact With Exposure In Crowd Setting | |||
CONTACT WITH MEDICAL RISK FACTOR | C102611 | A way of contracting a disease by interacting with an individual that is considered at high risk for having the disease. | Contact With Medical Risk Factor | |||
HOUSEHOLD CONTACT | C102646 | A way of contracting a disease through interactions with an infected person in the same residence. | Household Contact | |||
Back to top | ||||||
CL.C127257.CONROL | Contact Role for Clinical Study
(CONROL) | text
Extensible: Yes | C127257 | Contact Role for Clinical Study | The terminology relevant to the role that the responsible individual or entity plays with respect to being a contact for the study. | CDISC SDTM Contact Role for Clinical Study Terminology |
CA APPLICANT | C127522 | The person responsible for the competent authority application. | Competent Authority Applicant | |||
CENTRAL CONTACT FOR RECRUITMENT BACKUP | C127524 | The secondary contact person providing centralized, coordinated recruitment information for the entire study. (clinicaltrials.gov) | Central Contact for Recruitment Backup | |||
CENTRAL CONTACT FOR RECRUITMENT | C127523 | The contact person providing centralized, coordinated recruitment information for the entire study. (clinicaltrials.gov) | Central Contact for Recruitment | |||
CLINICAL NETWORK CONTACT | C127525 | The main or principal contact person for the clinical investigator network. | Clinical Investigator Network Contact | |||
CONTACT FOR PUBLIC QUERIES | C127526 | The study contact person who is responsible for questions from the public. | Public Queries Study Contact | |||
CONTACT FOR SCIENTIFIC QUERIES | C127527 | The study contact person who is responsible for questions from the scientific community. | Scientific Queries Study Contact | |||
FACILITY CONTACT BACKUP | C127529 | The secondary contact person at the facility. | Facility Contact Backup | |||
FACILITY CONTACT | C127528 | The main or principal contact person at the facility. | Facility Contact | |||
FURTHER INFORMATION CONTACT | C127530 | The contact person responsible for disseminating additional information about the study. | Study Further Information Contact | |||
IEC APPLICANT | C127531 | The person responsible for the independent ethics committee application. | Independent Ethics Committee Applicant | |||
INVESTIGATOR | C25936 | A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at the trial site, the investigator is the responsible leader of the team and may be called the principal investigator. | Investigator | |||
LEGAL REPRESENTATIVE FOR THE STUDY | C127532 | An individual with expertise in the law who provides legal counsel and representation for a study. | Legal Representative for the Study | |||
PRIMARY CONTACT | C127533 | The main or principal contact person for the study. | Primary Study Contact | |||
PRINCIPAL INVESTIGATOR | C19924 | A person who has the primary responsibility for the conduct of a clinical study and study-related personnel at a study site. While a single-center study would not include a coordinating investigator, the investigator at the site would fulfill the same responsibilities as a principal investigator. | Principal Investigator | |||
STUDY CHAIR | C51878 | Study Director | A person who has overall responsibility for the technical conduct of a study, as well as for the interpretation, analysis, documentation and reporting of results, and represents the single point of study control. (FDA) | Study Chair | ||
SUBCONTRACTOR CONTACT | C127534 | The main or principal contact person for the subcontractor or subcontracting organization. | Subcontractor Contact | |||
SUBINVESTIGATOR | C54622 | Any member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). (ICH) | Subinvestigator | |||
Back to top | ||||||
CL.C66785.TCNTRL | Control Type Response
(TCNTRL) | text
Extensible: Yes | C66785 | Control Type Response | A terminology codelist relevant to a comparator against which the study treatment is evaluated. | CDISC SDTM Control Type Terminology |
ACTIVE | C49649 | Active Control | A type of control, which has a demonstrated effect, administered as a comparator to subjects in a clinical trial. [From ICH E10] | Active Control | ||
DOSE RESPONSE | C120841 | A type of control using different doses or regimens of the same treatment across the treatment arms. | Dose Response Control | |||
NONE | C41132 | No person or thing, nobody, not any. (NCI) | None | |||
PLACEBO | C49648 | Placebo;Placebo Control | An inactive, identical-appearing drug or treatment that does not contain the test product. | Placebo Control | ||
Back to top | ||||||
CL.C150766.COWAT1TC | Controlled Oral Word Association Test Functional Test Test Code
(COWAT1TC) | text
Extensible: No | C150766 | Controlled Oral Word Association Test Functional Test Test Code | Controlled Oral Word Association Test test code. | CDISC Functional Test COWAT Test Code Terminology |
COWAT101 | C150922 | COWAT1-Another Word That Begins With R | Controlled Oral Word Association Test - Can you tell me another word that begins with R? | COWAT - Another Word That Begins With R | ||
COWAT102 | C150923 | COWAT1-Number Correct Words: C | Controlled Oral Word Association Test - Number correct words: Now I'm going to give you another letter, and again, say all words beginning with that letter that you can think of. You will have a minute for each one. The first letter is C. | COWAT - Number Correct Words: C | ||
COWAT103 | C150924 | COWAT1-Number Correct Words: F | Controlled Oral Word Association Test - Number correct words: Now I am going to give another letter. Tell me as many words as you can that begin with F. Tell me as many words as quickly as you can that begin with F. | COWAT - Number Correct Words: F | ||
COWAT104 | C150925 | COWAT1-Number Correct Words: L | Controlled Oral Word Association Test - Number correct words: Now I am going to give another letter. Tell me as many words as you can that begin with L. Tell me as many words as quickly as you can that begin with L. | COWAT - Number Correct Words: L | ||
Back to top | ||||||
CL.C150765.COWAT1TN | Controlled Oral Word Association Test Functional Test Test Name
(COWAT1TN) | text
Extensible: No | C150765 | Controlled Oral Word Association Test Functional Test Test Name | Controlled Oral Word Association Test test name. | CDISC Functional Test COWAT Test Name Terminology |
COWAT1-Another Word That Begins With R | C150922 | COWAT1-Another Word That Begins With R | Controlled Oral Word Association Test - Can you tell me another word that begins with R? | COWAT - Another Word That Begins With R | ||
COWAT1-Number Correct Words: C | C150923 | COWAT1-Number Correct Words: C | Controlled Oral Word Association Test - Number correct words: Now I'm going to give you another letter, and again, say all words beginning with that letter that you can think of. You will have a minute for each one. The first letter is C. | COWAT - Number Correct Words: C | ||
COWAT1-Number Correct Words: F | C150924 | COWAT1-Number Correct Words: F | Controlled Oral Word Association Test - Number correct words: Now I am going to give another letter. Tell me as many words as you can that begin with F. Tell me as many words as quickly as you can that begin with F. | COWAT - Number Correct Words: F | ||
COWAT1-Number Correct Words: L | C150925 | COWAT1-Number Correct Words: L | Controlled Oral Word Association Test - Number correct words: Now I am going to give another letter. Tell me as many words as you can that begin with L. Tell me as many words as quickly as you can that begin with L. | COWAT - Number Correct Words: L | ||
Back to top | ||||||
CL.C122007.CPFATSCD | COPD Findings About Test Code
(CPFATSCD) | text
Extensible: Yes | C122007 | COPD Findings About Test Code | Terminology relevant to the test codes that describe findings about a COPD event or intervention. | CDISC SDTM COPD Findings About Test Code Terminology |
CUMEXP | C94596 | Cumulative Exposure | The total amount that a subject is exposed to over time. | Cumulative Exposure | ||
EPMLDNUM | C124328 | Number of Mild Episodes | The number of times an event, which is classified as mild, occurred. | Number of Mild Episodes | ||
EPMODNUM | C124329 | Number of Moderate Episodes | The number of times an event, which is classified as moderate, occurred. | Number of Moderate Episodes | ||
EPSEVNUM | C124330 | Number of Severe Episodes | The number of times an event, which is classified as severe, occurred. | Number of Severe Episodes | ||
Back to top | ||||||
CL.C122006.CPFATS | COPD Findings About Test Name
(CPFATS) | text
Extensible: Yes | C122006 | COPD Findings About Test Name | Terminology relevant to the test names that describe findings about a COPD event or intervention. | CDISC SDTM COPD Findings About Test Name Terminology |
Cumulative Exposure | C94596 | Cumulative Exposure | The total amount that a subject is exposed to over time. | Cumulative Exposure | ||
Number of Mild Episodes | C124328 | Number of Mild Episodes | The number of times an event, which is classified as mild, occurred. | Number of Mild Episodes | ||
Number of Moderate Episodes | C124329 | Number of Moderate Episodes | The number of times an event, which is classified as moderate, occurred. | Number of Moderate Episodes | ||
Number of Severe Episodes | C124330 | Number of Severe Episodes | The number of times an event, which is classified as severe, occurred. | Number of Severe Episodes | ||
Back to top | ||||||
CL.C101843.CADPRSN | Coronary Artery Disease Presentation
(CADPRSN) | text
Extensible: No | C101843 | Coronary Artery Disease Presentation | A terminology codelist associated with coronary artery disease presentation. | CDISC SDTM Coronary Artery Disease Presentation Terminology |
NON-ST ELEVATION MYOCARDIAL INFARCTION | C80383 | NON-STEMI;NSTEMI | A myocardial infarction that does not produce elevation in the ST segments of the ECG. | Non-ST Elevation Myocardial Infarction by ECG Finding | ||
ST ELEVATION MYOCARDIAL INFARCTION | C101888 | STEMI | A myocardial infarction that produces elevation in the ST segments of the ECG. | ST Elevation Myocardial Infarction by ECG Finding | ||
STABLE ANGINA | C66914 | Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications. | Stable Angina | |||
UNSTABLE ANGINA | C66911 | Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest. | Unstable Angina | |||
VARIANT ANGINA | C66915 | A variant form of angina pectoris caused by coronary artery vasospasm, usually occurring spontaneously and frequently associated with ST segment elevation. | Variant Angina | |||
Back to top | ||||||
CL.C101849.CADRISK | Coronary Artery Disease Risk
(CADRISK) | text
Extensible: No | C101849 | Coronary Artery Disease Risk | A terminology codelist to describe the relative risk of coronary artery disease. | CDISC SDTM Coronary Artery Disease Risk Terminology |
HIGH CAD RISK | C99955 | High Coronary Artery Disease Risk | The likelihood an individual will develop coronary artery disease is almost certain or greater than 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) | High Coronary Artery Disease Risk | ||
INTERMEDIATE CAD RISK | C99966 | Intermediate Coronary Artery Disease Risk | The likelihood an individual will develop coronary artery disease (CAD) is moderate or between 10% and 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) | Intermediate Coronary Artery Disease Risk | ||
KNOWN CAD | C99968 | Known Coronary Artery Disease | The individual has coronary artery disease (CAD). (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) | Known Coronary Artery Disease | ||
LOW CAD RISK | C99978 | Low Coronary Artery Disease Risk | The likelihood an individual will develop coronary artery disease (CAD) is minimal or less than10%.(Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) | Low Coronary Artery Disease Risk | ||
Back to top | ||||||
CL.C101844.CADSYMP | Coronary Artery Disease Symptoms
(CADSYMP) | text
Extensible: No | C101844 | Coronary Artery Disease Symptoms | A terminology codelist that contains symptoms associated with coronary artery disease. | CDISC SDTM Coronary Artery Disease Symptoms Terminology |
ATYPICAL CORONARY ARTERY DISEASE SYMPTOMS | C99917 | Sharp stabbing chest pain or reproduction of pain on palpation. Less common isolated presentations, primarily in older adults, include nausea and vomiting, diaphoresis, and unexplained fatigue. J Am Coll Cardiol, 2007; 50:1-157, doi:10.1016/j.jacc.2007.02.013 (Published online 6 August 2007). | Atypical Coronary Artery Disease Symptom | |||
NO SYMPTOMS | C3833 | The finding of no indications of a particular disease or injury. | Asymptomatic | |||
NON-CARDIAC CHEST PAIN | C78504 | A discomfort in the chest area that is not related to the heart. | Non-Cardiac Chest Pain | |||
TYPICAL CORONARY ARTERY DISEASE SYMPTOMS | C100024 | Deep, poorly localized chest or arm discomfort that is reproducibly associated with physical exertion or emotional stress and is relieved promptly (ie, in less than 5 minutes) with rest and/or the use of sublingual nitroglycerin. Some patients may have no chest discomfort but present solely with jaw, neck, ear, arm, shoulder, back, or epigastric discomfort or with unexplained dyspnea without discomfort. If these symptoms have a clear relationship to exertion or stress or are relieved promptly with nitrates, they should be considered equivalent to angina. J Am Coll Cardiol, 2007; 50:1-157, doi:10.1016/j.jacc.2007.02.013 (Published online 6 August 2007). | Typical Coronary Artery Disease Symptom | |||
Back to top | ||||||
CL.C119076.CADG01TC | Coronary Artery Dissection NHLBI Grade Clinical Classification Test Code
(CADG01TC) | text
Extensible: No | C119076 | Coronary Artery Dissection NHLBI Grade Clinical Classification Test Code | Coronary Artery Dissection NHLBI Grade test code. | CDISC Clinical Classification NHLBI CAD Grade Test Code Terminology |
CADG0101 | C119196 | CADG01-Coronary Dissection NHLBI Grade | Coronary Artery Dissection NHLBI Grade - A grading system to describe coronary artery dissection per the NHLBI, American College of Cardiology, American Heart Association. | NHLBI CAD Grade - Coronary Artery Dissection NHLBI Grade | ||
Back to top | ||||||
CL.C119075.CADG01TN | Coronary Artery Dissection NHLBI Grade Clinical Classification Test Name
(CADG01TN) | text
Extensible: No | C119075 | Coronary Artery Dissection NHLBI Grade Clinical Classification Test Name | Coronary Artery Dissection NHLBI Grade test name. | CDISC Clinical Classification NHLBI CAD Grade Test Name Terminology |
CADG01-Coronary Dissection NHLBI Grade | C119196 | CADG01-Coronary Dissection NHLBI Grade | Coronary Artery Dissection NHLBI Grade - A grading system to describe coronary artery dissection per the NHLBI, American College of Cardiology, American Heart Association. | NHLBI CAD Grade - Coronary Artery Dissection NHLBI Grade | ||
Back to top | ||||||
CL.C119018.CADGRS | Coronary Artery Dissection NHLBI Grade Responses
(CADGRS) | text
Extensible: No | C119018 | Coronary Artery Dissection NHLBI Grade Responses | A terminology codelist relevant to the National Heart, Lung, and Blood Institute grade for coronary artery dissection and perforation. | CDISC SDTM NHLBI Coronary Artery Dissection Grade Responses Terminology |
CORONARY DISSECTION NHLBI GRADE A | C119588 | Minor radiolucencies within the lumen during contrast injection with no persistence after dye clearance. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type A | |||
CORONARY DISSECTION NHLBI GRADE B | C119589 | Parallel tracts or double lumen separated by a radiolucent area during contrast injection with no persistence after dye clearance. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type B | |||
CORONARY DISSECTION NHLBI GRADE C | C119590 | Extraluminal cap with persistence of contrast after dye clearance from the lumen. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type C | |||
CORONARY DISSECTION NHLBI GRADE D | C119591 | Spiral luminal filling defect with delayed but complete distal flow. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type D | |||
CORONARY DISSECTION NHLBI GRADE E | C119592 | New persistent filling defect with delayed antegrade flow. May represent thrombus. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type E | |||
CORONARY DISSECTION NHLBI GRADE F | C119593 | Non-A-E types with total coronary occlusion and no distal antegrade flow. May represent thrombus. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type F | |||
Back to top | ||||||
CL.C101860.CARTDOM | Coronary Artery Dominance
(CARTDOM) | text
Extensible: No | C101860 | Coronary Artery Dominance | A codelist to describe the pattern of the epicardial vessels supplying the posterior descending artery and the posterolateral branches. | CDISC SDTM Coronary Artery Dominance Terminology |
CO-DOMINANT | C99941 | The right coronary artery supplies the posterior descending artery and the circumflex supplies the posterolateral branches. | Co-Dominant Artery | |||
LEFT DOMINANT | C99971 | The left circumflex artery supplies the posterior descending artery and the posterolateral branches. | Left Cardiac Artery Dominance | |||
RIGHT DOMINANT | C99942 | The right coronary artery supplies the posterior descending artery and the posterolateral branches. | Coronary Artery Right Dominance | |||
Back to top | ||||||
CL.C119074.TIMG01TC | Coronary Thrombus TIMI Grade Clinical Classification Test Code
(TIMG01TC) | text
Extensible: No | C119074 | Coronary Thrombus TIMI Grade Clinical Classification Test Code | Coronary Thrombus TIMI Grade test code. | CDISC Clinical Classification TIMI Thrombus Grade Test Code Terminology |
TIMG0101 | C119195 | TIMG01-Coronary Thrombus TIMI Grade | Coronary Thrombus TIMI Grade - Grade corresponding to thrombus development as defined in the grading system by the Thrombolysis in the Myocardial Infarction Group. | TIMI Thrombus Grade - Coronary Thrombus TIMI Grade | ||
Back to top | ||||||
CL.C119073.TIMG01TN | Coronary Thrombus TIMI Grade Clinical Classification Test Name
(TIMG01TN) | text
Extensible: No | C119073 | Coronary Thrombus TIMI Grade Clinical Classification Test Name | Coronary Thrombus TIMI Grade test name. | CDISC Clinical Classification TIMI Thrombus Grade Test Name Terminology |
TIMG01-Coronary Thrombus TIMI Grade | C119195 | TIMG01-Coronary Thrombus TIMI Grade | Coronary Thrombus TIMI Grade - Grade corresponding to thrombus development as defined in the grading system by the Thrombolysis in the Myocardial Infarction Group. | TIMI Thrombus Grade - Coronary Thrombus TIMI Grade | ||
Back to top | ||||||
CL.C119017.CTTIMIRS | Coronary Thrombus TIMI Grade Responses
(CTTIMIRS) | text
Extensible: No | C119017 | Coronary Thrombus TIMI Grade Responses | A terminology codelist relevant to the Thrombolysis in Myocardial Infarction group grade for the description of coronary thrombus as visualized during angiography. | CDISC SDTM Coronary Thrombus TIMI Grade Responses Terminology |
CORONARY THROMBUS TIMI GRADE 1 | C119583 | Possible thrombus present - angiography demonstrates characteristics such as reduced contrast density, haziness, irregular lesion contour or a smooth convex 'meniscus' at the site of total occlusion suggestive but not diagnostic of thrombus. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 1 | |||
CORONARY THROMBUS TIMI GRADE 2 | C119584 | Small size definite thrombus, with greatest dimensions less than or equal to 1/2 vessel diameter. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 2 | |||
CORONARY THROMBUS TIMI GRADE 3 | C119585 | Moderate size definite thrombus, with greatest linear dimension greater than 1/2 but less than 2 vessel diameters. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 3 | |||
CORONARY THROMBUS TIMI GRADE 4 | C119586 | Large size definite thrombus, with the largest dimension greater than or equal to 2 vessel diameters. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 4 | |||
CORONARY THROMBUS TIMI GRADE 5 | C119587 | Total vessel occlusion. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 5 | |||
Back to top | ||||||
CL.C101850.CVSLDEXT | Coronary Vessel Disease Extent
(CVSLDEXT) | text
Extensible: No | C101850 | Coronary Vessel Disease Extent | A terminology codelist to describe the extent of coronary artery disease. | CDISC SDTM Coronary Vessel Disease Extent Terminology |
INDETERMINATE | C48658 | Inconclusive | Cannot distinguish between two or more possible values in the current context. (NCI) | Indeterminate | ||
INSIGNIFICANT DISEASE | C119244 | A finding of stenosis of less than 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in a major epicardial vessel, without stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in any major epicardial vessel. (NCI) | Insignificant Disease by ECG Finding | |||
NO DISEASE | C99993 | There was no stenosis in any coronary artery or branch vessel. | No Evidence of Coronary Artery Disease | |||
ONE VESSEL DISEASE | C99997 | There was stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in one major epicardial vessel or its major branches. | One Vessel Coronary Disease | |||
THREE VESSEL DISEASE | C100020 | There was one of the following: Stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in all three major epicardial vessels (anterior descending, posterior descending, circumflex) or their major branches; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main and greater than or equal to 70 percent reduction in diameter, or 50 percent reduction in cross-sectional area of the right coronary artery with a right dominant or co-dominant circulation; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main with a left dominant circulation. | Three Vessel Coronary Disease | |||
TWO VESSEL DISEASE | C100023 | There was one of the following: Stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in two major epicardial vessels or their major branches; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main with a right dominant or co-dominant circulation, and no stenosis of greater than or equal to 70 percent reduction in diameter, or 50 percent reduction in cross-sectional area in the right coronary artery. | Two Vessel Coronary Disease | |||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C156673.COVI01TC | Covi Anxiety Scale Clinical Classification Test Code
(COVI01TC) | text
Extensible: No | C156673 | Covi Anxiety Scale Clinical Classification Test Code | Covi Anxiety Scale test code. | CDISC Clinical Classification COVI Test Code Terminology |
COVI0101 | C156676 | COVI01-Verbal Report | Covi Anxiety Scale - Verbal report. | COVI - Verbal Report | ||
COVI0102 | C156677 | COVI01-Behavior | Covi Anxiety Scale - Behavior. | COVI - Behavior | ||
COVI0103 | C156678 | COVI01-Somatic Symptoms of Anxiety | Covi Anxiety Scale - Somatic symptoms of anxiety. | COVI - Somatic Symptoms of Anxiety | ||
COVI0104 | C156679 | COVI01-Total Score | Covi Anxiety Scale - Total score. | COVI - Total Score | ||
Back to top | ||||||
CL.C156672.COVI01TN | Covi Anxiety Scale Clinical Classification Test Name
(COVI01TN) | text
Extensible: No | C156672 | Covi Anxiety Scale Clinical Classification Test Name | Covi Anxiety Scale test name. | CDISC Clinical Classification COVI Test Name Terminology |
COVI01-Behavior | C156677 | COVI01-Behavior | Covi Anxiety Scale - Behavior. | COVI - Behavior | ||
COVI01-Somatic Symptoms of Anxiety | C156678 | COVI01-Somatic Symptoms of Anxiety | Covi Anxiety Scale - Somatic symptoms of anxiety. | COVI - Somatic Symptoms of Anxiety | ||
COVI01-Total Score | C156679 | COVI01-Total Score | Covi Anxiety Scale - Total score. | COVI - Total Score | ||
COVI01-Verbal Report | C156676 | COVI01-Verbal Report | Covi Anxiety Scale - Verbal report. | COVI - Verbal Report | ||
Back to top | ||||||
CL.C171443.C19FATCD | COVID-19 Findings About Test Code
(C19FATCD) | text
Extensible: Yes | C171443 | COVID-19 Findings About Test Code | Terminology relevant to the test codes that describe findings about COVID-19 related events or interventions. | CDISC SDTM COVID-19 Findings About Test Code Terminology |
EPSDNUM | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
SEV | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C171442.C19FAT | COVID-19 Findings About Test Name
(C19FAT) | text
Extensible: Yes | C171442 | COVID-19 Findings About Test Name | Terminology relevant to the test names that describe findings about COVID-19 related events or interventions. | CDISC SDTM COVID-19 Findings About Test Name Terminology |
Number of Episodes | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Severity/Intensity | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C117987.CHSF1TC | Craig Handicap Assessment and Reporting Technique - Short Form Interview Version Questionnaire Test Code
(CHSF1TC) | text
Extensible: No | C117987 | Craig Handicap Assessment and Reporting Technique - Short Form Interview Version Questionnaire Test Code | Craig Handicap Assessment and Reporting Technique - Short Form Interview Version test code. | CDISC Questionnaire CHART-SF Interview Version Test Code Terminology |
CHSF101A | C117998 | CHSF1-Paid Personal Care per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? (hours paid assistance). | CHART-SF Interview Version - Paid Personal Care per Day | ||
CHSF101B | C117999 | CHSF1-Unpaid Personal Care per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? hours unpaid (family, others). | CHART-SF Interview Version - Unpaid Personal Care per Day | ||
CHSF102 | C118000 | CHSF1-Home Cognitive Assistance per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How much time is someone with you in your home to assist you with activities that require remembering, decision making, or judgment? | CHART-SF Interview Version - Cognitive Assistance at Home per Day | ||
CHSF103 | C118001 | CHSF1-Away Cognitive Assistance per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How much of the time is someone with you to help you with remembering, decision making, or judgment when you go away from your home? | CHART-SF Interview Version - Cognitive Assistance Away From Home per Day | ||
CHSF104 | C118002 | CHSF1-Hours Out of Bed per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - On a typical day, how many hours are you out of bed? | CHART-SF Interview Version - Hours Out of Bed per Day | ||
CHSF105 | C118003 | CHSF1-Days Out of the House per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - In a typical week, how many days do you get out of your house and go somewhere? | CHART-SF Interview Version - Days Out of the House per Week | ||
CHSF106 | C118004 | CHSF1-Nights Away From Home Last Year | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - In the last year, how many nights have you spent away from your home? | CHART-SF Interview Version - Nights Away From Home Last Year | ||
CHSF107A | C118005 | CHSF1-Hours of Paid Work per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend working in a job for which you get paid? | CHART-SF Interview Version - Hours of Paid Work per Week | ||
CHSF107B | C118006 | CHSF1-Occupation of Paid Work | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend working in a job for which you get paid? (occupation). | CHART-SF Interview Version - Occupation of Paid Work | ||
CHSF108 | C118007 | CHSF1-Hours of Schoolwork per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in school working toward a degree or in an accredited technical training program? | CHART-SF Interview Version - Hours of Schoolwork per Week | ||
CHSF109 | C118008 | CHSF1-Hours of Homemaking per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in active homemaking including parenting, housekeeping, and food preparation? | CHART-SF Interview Version - Hours of Homemaking per Week | ||
CHSF110 | C118009 | CHSF1-Hours of Home Maintenance per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in home maintenance activities such as gardening, house repairs or home improvement? | CHART-SF Interview Version - Hours of Home Maintenance per Week | ||
CHSF111 | C118010 | CHSF1-Hours of Recreation per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in recreational activities such as sports, exercise, playing cards, or going to movies? | CHART-SF Interview Version - Hours of Recreational Activities per Week | ||
CHSF112 | C118011 | CHSF1-Number of People You Live With | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many people do you live with? | CHART-SF Interview Version - Number of People You Live With | ||
CHSF113 | C118012 | CHSF1-Live With Spouse or Signif Other | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Is one of them your spouse or significant other? | CHART-SF Interview Version - Live With Spouse or Significant Other | ||
CHSF114 | C118013 | CHSF1-Number of Relatives You Live With | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Of the people you live with how many are relatives? | CHART-SF Interview Version - Number of Relatives You Live With | ||
CHSF115 | C118014 | CHSF1-Associates Contacted per Month | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many business or organizational associates do you visit, phone, or write to at least once a month? | CHART-SF Interview Version - Associates Contacted per Month | ||
CHSF116 | C118015 | CHSF1-Friends Contacted per Month | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many friends do you visit, phone, or write to at least once a month? | CHART-SF Interview Version - Friends Contacted per Month | ||
CHSF117 | C118016 | CHSF1-Strangers Spoke with Last Month | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - With how many strangers have you initiated a conversation in the last month? | CHART-SF Interview Version - Initiated Conversation With Strangers Last Month | ||
CHSF118 | C118017 | CHSF1-Combined Household Income Last Yr | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Approximately what was the combined annual income, in the last year, of all family members in your household? | CHART-SF Interview Version - Combined Annual Household Income Last Year | ||
CHSF119 | C118018 | CHSF1-Medical Care Expenses Last Year | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Approximately how much did you pay last year for medical care expenses? | CHART-SF Interview Version - Medical Care Expense Last Year | ||
CHSF120 | C187628 | CHSF1-Physical Independence Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Physical independence subscore. | CHART-SF Interview Version - Physical Independence Subscore | ||
CHSF121 | C187629 | CHSF1-Cognitive Independence Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Cognitive independence subscore. | CHART-SF Interview Version - Cognitive Independence Subscore | ||
CHSF122 | C187630 | CHSF1-Mobility Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Mobility subscore. | CHART-SF Interview Version - Mobility Subscore | ||
CHSF123 | C187631 | CHSF1-Occupation Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Occupation subscore. | CHART-SF Interview Version - Occupation Subscore | ||
CHSF124 | C187632 | CHSF1-Social Integration Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Social integration subscore. | CHART-SF Interview Version - Social Integration Subscore | ||
CHSF125 | C187633 | CHSF1-Economic Self-Sufficiency Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Economic self-sufficiency subscore. | CHART-SF Interview Version - Economic Self-Sufficiency Subscore | ||
CHSF126 | C187634 | CHSF1-Total Score | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Total score. | CHART-SF Interview Version - Total Score | ||
Back to top | ||||||
CL.C117986.CHSF1TN | Craig Handicap Assessment and Reporting Technique - Short Form Interview Version Questionnaire Test Name
(CHSF1TN) | text
Extensible: No | C117986 | Craig Handicap Assessment and Reporting Technique - Short Form Interview Version Questionnaire Test Name | Craig Handicap Assessment and Reporting Technique - Short Form Interview Version test name. | CDISC Questionnaire CHART-SF Interview Version Test Name Terminology |
CHSF1-Associates Contacted per Month | C118014 | CHSF1-Associates Contacted per Month | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many business or organizational associates do you visit, phone, or write to at least once a month? | CHART-SF Interview Version - Associates Contacted per Month | ||
CHSF1-Away Cognitive Assistance per Day | C118001 | CHSF1-Away Cognitive Assistance per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How much of the time is someone with you to help you with remembering, decision making, or judgment when you go away from your home? | CHART-SF Interview Version - Cognitive Assistance Away From Home per Day | ||
CHSF1-Cognitive Independence Subscore | C187629 | CHSF1-Cognitive Independence Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Cognitive independence subscore. | CHART-SF Interview Version - Cognitive Independence Subscore | ||
CHSF1-Combined Household Income Last Yr | C118017 | CHSF1-Combined Household Income Last Yr | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Approximately what was the combined annual income, in the last year, of all family members in your household? | CHART-SF Interview Version - Combined Annual Household Income Last Year | ||
CHSF1-Days Out of the House per Week | C118003 | CHSF1-Days Out of the House per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - In a typical week, how many days do you get out of your house and go somewhere? | CHART-SF Interview Version - Days Out of the House per Week | ||
CHSF1-Economic Self-Sufficiency Subscore | C187633 | CHSF1-Economic Self-Sufficiency Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Economic self-sufficiency subscore. | CHART-SF Interview Version - Economic Self-Sufficiency Subscore | ||
CHSF1-Friends Contacted per Month | C118015 | CHSF1-Friends Contacted per Month | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many friends do you visit, phone, or write to at least once a month? | CHART-SF Interview Version - Friends Contacted per Month | ||
CHSF1-Home Cognitive Assistance per Day | C118000 | CHSF1-Home Cognitive Assistance per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How much time is someone with you in your home to assist you with activities that require remembering, decision making, or judgment? | CHART-SF Interview Version - Cognitive Assistance at Home per Day | ||
CHSF1-Hours of Home Maintenance per Week | C118009 | CHSF1-Hours of Home Maintenance per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in home maintenance activities such as gardening, house repairs or home improvement? | CHART-SF Interview Version - Hours of Home Maintenance per Week | ||
CHSF1-Hours of Homemaking per Week | C118008 | CHSF1-Hours of Homemaking per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in active homemaking including parenting, housekeeping, and food preparation? | CHART-SF Interview Version - Hours of Homemaking per Week | ||
CHSF1-Hours of Paid Work per Week | C118005 | CHSF1-Hours of Paid Work per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend working in a job for which you get paid? | CHART-SF Interview Version - Hours of Paid Work per Week | ||
CHSF1-Hours of Recreation per Week | C118010 | CHSF1-Hours of Recreation per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in recreational activities such as sports, exercise, playing cards, or going to movies? | CHART-SF Interview Version - Hours of Recreational Activities per Week | ||
CHSF1-Hours of Schoolwork per Week | C118007 | CHSF1-Hours of Schoolwork per Week | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend in school working toward a degree or in an accredited technical training program? | CHART-SF Interview Version - Hours of Schoolwork per Week | ||
CHSF1-Hours Out of Bed per Day | C118002 | CHSF1-Hours Out of Bed per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - On a typical day, how many hours are you out of bed? | CHART-SF Interview Version - Hours Out of Bed per Day | ||
CHSF1-Live With Spouse or Signif Other | C118012 | CHSF1-Live With Spouse or Signif Other | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Is one of them your spouse or significant other? | CHART-SF Interview Version - Live With Spouse or Significant Other | ||
CHSF1-Medical Care Expenses Last Year | C118018 | CHSF1-Medical Care Expenses Last Year | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Approximately how much did you pay last year for medical care expenses? | CHART-SF Interview Version - Medical Care Expense Last Year | ||
CHSF1-Mobility Subscore | C187630 | CHSF1-Mobility Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Mobility subscore. | CHART-SF Interview Version - Mobility Subscore | ||
CHSF1-Nights Away From Home Last Year | C118004 | CHSF1-Nights Away From Home Last Year | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - In the last year, how many nights have you spent away from your home? | CHART-SF Interview Version - Nights Away From Home Last Year | ||
CHSF1-Number of People You Live With | C118011 | CHSF1-Number of People You Live With | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many people do you live with? | CHART-SF Interview Version - Number of People You Live With | ||
CHSF1-Number of Relatives You Live With | C118013 | CHSF1-Number of Relatives You Live With | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Of the people you live with how many are relatives? | CHART-SF Interview Version - Number of Relatives You Live With | ||
CHSF1-Occupation of Paid Work | C118006 | CHSF1-Occupation of Paid Work | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours per week do you spend working in a job for which you get paid? (occupation). | CHART-SF Interview Version - Occupation of Paid Work | ||
CHSF1-Occupation Subscore | C187631 | CHSF1-Occupation Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Occupation subscore. | CHART-SF Interview Version - Occupation Subscore | ||
CHSF1-Paid Personal Care per Day | C117998 | CHSF1-Paid Personal Care per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? (hours paid assistance). | CHART-SF Interview Version - Paid Personal Care per Day | ||
CHSF1-Physical Independence Subscore | C187628 | CHSF1-Physical Independence Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Physical independence subscore. | CHART-SF Interview Version - Physical Independence Subscore | ||
CHSF1-Social Integration Subscore | C187632 | CHSF1-Social Integration Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Social integration subscore. | CHART-SF Interview Version - Social Integration Subscore | ||
CHSF1-Strangers Spoke with Last Month | C118016 | CHSF1-Strangers Spoke with Last Month | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - With how many strangers have you initiated a conversation in the last month? | CHART-SF Interview Version - Initiated Conversation With Strangers Last Month | ||
CHSF1-Total Score | C187634 | CHSF1-Total Score | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - Total score. | CHART-SF Interview Version - Total Score | ||
CHSF1-Unpaid Personal Care per Day | C117999 | CHSF1-Unpaid Personal Care per Day | Craig Handicap Assessment and Reporting Technique-Short Form Interview Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? hours unpaid (family, others). | CHART-SF Interview Version - Unpaid Personal Care per Day | ||
Back to top | ||||||
CL.C119068.CHSF2TC | Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire Test Code
(CHSF2TC) | text
Extensible: No | C119068 | Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire Test Code | Craig Handicap Assessment and Reporting Technique - Short Form Paper Version test code. | CDISC Questionnaire CHART-SF Paper Version Test Code Terminology |
CHSF201A | C119142 | CHSF2-Paid Personal Care per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? (hours paid assistance). | CHART-SF Paper Version - Paid Personal Care per Day | ||
CHSF201B | C119143 | CHSF2-Unpaid Personal Care per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? hours unpaid (family, others). | CHART-SF Paper Version - Unpaid Personal Care per Day | ||
CHSF202 | C119144 | CHSF2-Home Cognitive Assistance per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How much time is someone with you in your home to assist you with activities that require remembering, decision making, or judgment? | CHART-SF Paper Version - Cognitive Assistance at Home per Day | ||
CHSF203 | C119145 | CHSF2-Away Cognitive Assistance per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How much of the time is someone with you to help you with remembering, decision making, or judgment when you go away from your home? | CHART-SF Paper Version - Cognitive Assistance Away From Home per Day | ||
CHSF204 | C119146 | CHSF2-Hours Out of Bed per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - On a typical day, how many hours are you out of bed? | CHART-SF Paper Version - Hours Out of Bed per Day | ||
CHSF205 | C119147 | CHSF2-Days Out of the House per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - In a typical week, how many days do you get out of your house and go somewhere? | CHART-SF Paper Version - Days Out of the House per Week | ||
CHSF206 | C119148 | CHSF2-Nights Away From Home Last Year | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - In the last year, how many nights have you spent away from your home? | CHART-SF Paper Version - Nights Away From Home Last Year | ||
CHSF207A | C119149 | CHSF2-Hours of Paid Work per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend working in a job for which you get paid? | CHART-SF Paper Version - Hours of Paid Work per Week | ||
CHSF207B | C119150 | CHSF2-Occupation of Paid Work | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend working in a job for which you get paid? (occupation). | CHART-SF Paper Version - Occupation of Paid Work | ||
CHSF208 | C119151 | CHSF2-Hours of Schoolwork per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in school working toward a degree or in an accredited technical training program? | CHART-SF Paper Version - Hours of Schoolwork per Week | ||
CHSF209 | C119152 | CHSF2-Hours of Homemaking per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in active homemaking including parenting, housekeeping, and food preparation? | CHART-SF Paper Version - Hours of Homemaking per Week | ||
CHSF210 | C119153 | CHSF2-Hours of Home Maintenance per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in home maintenance activities such as gardening, house repairs or home improvement? | CHART-SF Paper Version - Hours of Home Maintenance per Week | ||
CHSF211 | C119154 | CHSF2-Hours of Recreation per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in recreational activities such as sports, exercise, playing cards, or going to movies? | CHART-SF Paper Version - Hours of Recreational Activities per Week | ||
CHSF212 | C119155 | CHSF2-Number of People You Live With | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many people do you live with? | CHART-SF Paper Version - Number of People You Live With | ||
CHSF213 | C119156 | CHSF2-Live With Spouse or Signif Other | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Is one of them your spouse or significant other? | CHART-SF Paper Version - Live With Spouse or Significant Other | ||
CHSF214 | C119157 | CHSF2-Number of Relatives You Live With | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Of the people you live with how many are relatives? | CHART-SF Paper Version - Number of Relatives You Live With | ||
CHSF215 | C119158 | CHSF2-Associates Contacted per Month | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many business or organizational associates do you visit, phone, or write to at least once a month? | CHART-SF Paper Version - Associates Contacted per Month | ||
CHSF216 | C119159 | CHSF2-Friends Contacted per Month | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many friends do you visit, phone, or write to at least once a month? | CHART-SF Paper Version - Friends Contacted per Month | ||
CHSF217 | C119160 | CHSF2-Strangers Spoke with Last Month | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - With how many strangers have you initiated a conversation in the last month? | CHART-SF Paper Version - Initiated Conversation With Strangers Last Month | ||
CHSF218 | C119161 | CHSF2-Combined Household Income Last Yr | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Approximately what was the combined annual income, in the last year, of all family members in your household? | CHART-SF Paper Version - Combined Annual Household Income Last Year | ||
CHSF219 | C119162 | CHSF2-Medical Care Expenses Last Year | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Approximately how much did you pay last year for medical care expenses? | CHART-SF Paper Version - Medical Care Expense Last Year | ||
CHSF220 | C187635 | CHSF2-Physical Independence Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Physical independence subscore. | CHART-SF Paper Version - Physical Independence Subscore | ||
CHSF221 | C187636 | CHSF2-Cognitive Independence Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Cognitive independence subscore. | CHART-SF Paper Version - Cognitive Independence Subscore | ||
CHSF222 | C187637 | CHSF2-Mobility Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Mobility subscore. | CHART-SF Paper Version - Mobility Subscore | ||
CHSF223 | C187638 | CHSF2-Occupation Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Occupation subscore. | CHART-SF Paper Version - Occupation Subscore | ||
CHSF224 | C187639 | CHSF2-Social Integration Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Social integration subscore. | CHART-SF Paper Version - Social Integration Subscore | ||
CHSF225 | C187640 | CHSF2-Economic Self-sufficiency Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Economic self-sufficiency subscore. | CHART-SF Paper Version - Economic Self-sufficiency Subscore | ||
CHSF226 | C187641 | CHSF2-Total Score | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Total score. | CHART-SF Paper Version - Total Score | ||
Back to top | ||||||
CL.C119067.CHSF2TN | Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire Test Name
(CHSF2TN) | text
Extensible: No | C119067 | Craig Handicap Assessment and Reporting Technique - Short Form Paper Version Questionnaire Test Name | Craig Handicap Assessment and Reporting Technique - Short Form Paper Version test name. | CDISC Questionnaire CHART-SF Paper Version Test Name Terminology |
CHSF2-Associates Contacted per Month | C119158 | CHSF2-Associates Contacted per Month | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many business or organizational associates do you visit, phone, or write to at least once a month? | CHART-SF Paper Version - Associates Contacted per Month | ||
CHSF2-Away Cognitive Assistance per Day | C119145 | CHSF2-Away Cognitive Assistance per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How much of the time is someone with you to help you with remembering, decision making, or judgment when you go away from your home? | CHART-SF Paper Version - Cognitive Assistance Away From Home per Day | ||
CHSF2-Cognitive Independence Subscore | C187636 | CHSF2-Cognitive Independence Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Cognitive independence subscore. | CHART-SF Paper Version - Cognitive Independence Subscore | ||
CHSF2-Combined Household Income Last Yr | C119161 | CHSF2-Combined Household Income Last Yr | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Approximately what was the combined annual income, in the last year, of all family members in your household? | CHART-SF Paper Version - Combined Annual Household Income Last Year | ||
CHSF2-Days Out of the House per Week | C119147 | CHSF2-Days Out of the House per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - In a typical week, how many days do you get out of your house and go somewhere? | CHART-SF Paper Version - Days Out of the House per Week | ||
CHSF2-Economic Self-sufficiency Subscore | C187640 | CHSF2-Economic Self-sufficiency Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Economic self-sufficiency subscore. | CHART-SF Paper Version - Economic Self-sufficiency Subscore | ||
CHSF2-Friends Contacted per Month | C119159 | CHSF2-Friends Contacted per Month | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many friends do you visit, phone, or write to at least once a month? | CHART-SF Paper Version - Friends Contacted per Month | ||
CHSF2-Home Cognitive Assistance per Day | C119144 | CHSF2-Home Cognitive Assistance per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How much time is someone with you in your home to assist you with activities that require remembering, decision making, or judgment? | CHART-SF Paper Version - Cognitive Assistance at Home per Day | ||
CHSF2-Hours of Home Maintenance per Week | C119153 | CHSF2-Hours of Home Maintenance per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in home maintenance activities such as gardening, house repairs or home improvement? | CHART-SF Paper Version - Hours of Home Maintenance per Week | ||
CHSF2-Hours of Homemaking per Week | C119152 | CHSF2-Hours of Homemaking per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in active homemaking including parenting, housekeeping, and food preparation? | CHART-SF Paper Version - Hours of Homemaking per Week | ||
CHSF2-Hours of Paid Work per Week | C119149 | CHSF2-Hours of Paid Work per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend working in a job for which you get paid? | CHART-SF Paper Version - Hours of Paid Work per Week | ||
CHSF2-Hours of Recreation per Week | C119154 | CHSF2-Hours of Recreation per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in recreational activities such as sports, exercise, playing cards, or going to movies? | CHART-SF Paper Version - Hours of Recreational Activities per Week | ||
CHSF2-Hours of Schoolwork per Week | C119151 | CHSF2-Hours of Schoolwork per Week | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend in school working toward a degree or in an accredited technical training program? | CHART-SF Paper Version - Hours of Schoolwork per Week | ||
CHSF2-Hours Out of Bed per Day | C119146 | CHSF2-Hours Out of Bed per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - On a typical day, how many hours are you out of bed? | CHART-SF Paper Version - Hours Out of Bed per Day | ||
CHSF2-Live With Spouse or Signif Other | C119156 | CHSF2-Live With Spouse or Signif Other | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Is one of them your spouse or significant other? | CHART-SF Paper Version - Live With Spouse or Significant Other | ||
CHSF2-Medical Care Expenses Last Year | C119162 | CHSF2-Medical Care Expenses Last Year | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Approximately how much did you pay last year for medical care expenses? | CHART-SF Paper Version - Medical Care Expense Last Year | ||
CHSF2-Mobility Subscore | C187637 | CHSF2-Mobility Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Mobility subscore. | CHART-SF Paper Version - Mobility Subscore | ||
CHSF2-Nights Away From Home Last Year | C119148 | CHSF2-Nights Away From Home Last Year | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - In the last year, how many nights have you spent away from your home? | CHART-SF Paper Version - Nights Away From Home Last Year | ||
CHSF2-Number of People You Live With | C119155 | CHSF2-Number of People You Live With | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many people do you live with? | CHART-SF Paper Version - Number of People You Live With | ||
CHSF2-Number of Relatives You Live With | C119157 | CHSF2-Number of Relatives You Live With | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Of the people you live with how many are relatives? | CHART-SF Paper Version - Number of Relatives You Live With | ||
CHSF2-Occupation of Paid Work | C119150 | CHSF2-Occupation of Paid Work | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours per week do you spend working in a job for which you get paid? (occupation). | CHART-SF Paper Version - Occupation of Paid Work | ||
CHSF2-Occupation Subscore | C187638 | CHSF2-Occupation Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Occupation subscore. | CHART-SF Paper Version - Occupation Subscore | ||
CHSF2-Paid Personal Care per Day | C119142 | CHSF2-Paid Personal Care per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? (hours paid assistance). | CHART-SF Paper Version - Paid Personal Care per Day | ||
CHSF2-Physical Independence Subscore | C187635 | CHSF2-Physical Independence Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Physical independence subscore. | CHART-SF Paper Version - Physical Independence Subscore | ||
CHSF2-Social Integration Subscore | C187639 | CHSF2-Social Integration Subscore | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Social integration subscore. | CHART-SF Paper Version - Social Integration Subscore | ||
CHSF2-Strangers Spoke with Last Month | C119160 | CHSF2-Strangers Spoke with Last Month | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - With how many strangers have you initiated a conversation in the last month? | CHART-SF Paper Version - Initiated Conversation With Strangers Last Month | ||
CHSF2-Total Score | C187641 | CHSF2-Total Score | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - Total score. | CHART-SF Paper Version - Total Score | ||
CHSF2-Unpaid Personal Care per Day | C119143 | CHSF2-Unpaid Personal Care per Day | Craig Handicap Assessment and Reporting Technique-Short Form Paper Version - How many hours in a typical 24-hour day do you have someone with you to provide physical assistance for personal care activities such as eating, bathing, dressing, toileting and mobility? hours unpaid (family, others). | CHART-SF Paper Version - Unpaid Personal Care per Day | ||
Back to top | ||||||
CL.C176049.CDAI01TC | Crohn's Disease Activity Index Version 1 Clinical Classification Test Code
(CDAI01TC) | text
Extensible: No | C176049 | Crohn's Disease Activity Index Version 1 Clinical Classification Test Code | Crohn's Disease Activity Index Version 1 test code. | CDISC Clinical Classification CDAI Version 1 Test Code Terminology |
CDAI0101 | C176067 | CDAI01-Weight | Crohn's Disease Activity Index Version 1 - Weight. | CDAI Version 1 - Weight | ||
CDAI0102 | C176068 | CDAI01-Standard Body Weight | Crohn's Disease Activity Index Version 1 - Standard body weight. | CDAI Version 1 - Standard Body Weight | ||
CDAI0103 | C176069 | CDAI01-Daily Number of Stools | Crohn's Disease Activity Index Version 1 - Daily number of very soft/liquid stools in the last 7 days. | CDAI Version 1 - Daily Number of Stools | ||
CDAI0104 | C176070 | CDAI01-Daily Average Abdominal Pain | Crohn's Disease Activity Index Version 1 - Daily average abdominal pain (average daily rating for each of the past 7 days). | CDAI Version 1 - Daily Average Abdominal Pain | ||
CDAI0105 | C176071 | CDAI01-Daily Average General Well-being | Crohn's Disease Activity Index Version 1 - Daily average general well-being (average daily rating for each of the past 7 days). | CDAI Version 1 - Daily Average General Well-being | ||
CDAI0106 | C176072 | CDAI01-Anti-diarrhea/Opiate Use | Crohn's Disease Activity Index Version 1 - Anti-diarrhea/opiate use during past 7 days. | CDAI Version 1 - Anti-diarrhea/Opiate Use | ||
CDAI0107 | C176073 | CDAI01-Abdominal Mass | Crohn's Disease Activity Index Version 1 - Abdominal mass. | CDAI Version 1 - Abdominal Mass | ||
CDAI0108 | C176074 | CDAI01-Hematocrit | Crohn's Disease Activity Index Version 1 - Hematocrit. | CDAI Version 1 - Hematocrit | ||
CDAI0109 | C176075 | CDAI01-Arthritis/Arthralgia | Crohn's Disease Activity Index Version 1 - Arthritis/arthralgia. | CDAI Version 1 - Arthritis/Arthralgia | ||
CDAI0110 | C176076 | CDAI01-Iritis/Uveitis | Crohn's Disease Activity Index Version 1 - Iritis/uveitis. | CDAI Version 1 - Iritis/Uveitis | ||
CDAI0111 | C176077 | CDAI01-Erythema Nodosum | Crohn's Disease Activity Index Version 1 - Erythema nodosum, pyoderma gangrenosum, or aphthous stomatitis. | CDAI Version 1 - Erythema Nodosum | ||
CDAI0112 | C176078 | CDAI01-Anal Fissure/Fistula/Abscess | Crohn's Disease Activity Index Version 1 - Anal fissure, fistula, or abscess. | CDAI Version 1 - Anal Fissure, Fistula or Abscess | ||
CDAI0113 | C176079 | CDAI01-Other Fistula | Crohn's Disease Activity Index Version 1 - Other fistula. | CDAI Version 1 - Other Fistula | ||
CDAI0114 | C176080 | CDAI01-Fever | Crohn's Disease Activity Index Version 1 - Fever/temperature > 100F/37.8C during the past 7 days. | CDAI Version 1 - Fever | ||
CDAI0115 | C176081 | CDAI01-Weight Subscore | Crohn's Disease Activity Index Version 1 - Weight subscore. | CDAI Version 1 - Weight Subscore | ||
CDAI0116 | C176082 | CDAI01-Total Number Stools Subscore | Crohn's Disease Activity Index Version 1 - Total number of very soft/liquid stools in the last 7 days: Subscore. | CDAI Version 1 - Total Number Stools Subscore | ||
CDAI0117 | C176083 | CDAI01-Abdominal Pain Subscore | Crohn's Disease Activity Index Version 1 - Abdominal pain (daily rating for the past 7 days): Subscore. | CDAI Version 1 - Abdominal Pain Subscore | ||
CDAI0118 | C176084 | CDAI01-General Well-being Subscore | Crohn's Disease Activity Index Version 1 - General well-being (daily rating for the past 7 days): Subscore. | CDAI Version 1 - General Well-being Subscore | ||
CDAI0119 | C176085 | CDAI01-Anti-diarrhea/Opiate Use Subscore | Crohn's Disease Activity Index Version 1 - Anti-diarrhea/opiate use subscore. | CDAI Version 1 - Anti-diarrhea/Opiate Use Subscore | ||
CDAI0120 | C176086 | CDAI01-Abdominal Mass Subscore | Crohn's Disease Activity Index Version 1 - Abdominal mass subscore. | CDAI Version 1 - Abdominal Mass Subscore | ||
CDAI0121 | C176087 | CDAI01-Hematocrit Subscore | Crohn's Disease Activity Index Version 1 - Hematocrit subscore. | CDAI Version 1 - Hematocrit Subscore | ||
CDAI0122 | C176088 | CDAI01-Symptoms Manifested Subscore | Crohn's Disease Activity Index Version 1 - Arthritis/arthralgia; iritis/uveitis; erythema nodosum, pyoderma gangrenosum, or aphthous stomatitis; anal fissure, fistula, or abscess; other fistula; fever subscore. | CDAI Version 1 - Symptoms Manifested Subscore | ||
CDAI0123 | C176089 | CDAI01-CDAI Total Score | Crohn's Disease Activity Index Version 1 - CDAI total score. | CDAI Version 1 - CDAI Total Score | ||
Back to top | ||||||
CL.C176048.CDAI01TN | Crohn's Disease Activity Index Version 1 Clinical Classification Test Name
(CDAI01TN) | text
Extensible: No | C176048 | Crohn's Disease Activity Index Version 1 Clinical Classification Test Name | Crohn's Disease Activity Index Version 1 test name. | CDISC Clinical Classification CDAI Version 1 Test Name Terminology |
CDAI01-Abdominal Mass Subscore | C176086 | CDAI01-Abdominal Mass Subscore | Crohn's Disease Activity Index Version 1 - Abdominal mass subscore. | CDAI Version 1 - Abdominal Mass Subscore | ||
CDAI01-Abdominal Mass | C176073 | CDAI01-Abdominal Mass | Crohn's Disease Activity Index Version 1 - Abdominal mass. | CDAI Version 1 - Abdominal Mass | ||
CDAI01-Abdominal Pain Subscore | C176083 | CDAI01-Abdominal Pain Subscore | Crohn's Disease Activity Index Version 1 - Abdominal pain (daily rating for the past 7 days): Subscore. | CDAI Version 1 - Abdominal Pain Subscore | ||
CDAI01-Anal Fissure/Fistula/Abscess | C176078 | CDAI01-Anal Fissure/Fistula/Abscess | Crohn's Disease Activity Index Version 1 - Anal fissure, fistula, or abscess. | CDAI Version 1 - Anal Fissure, Fistula or Abscess | ||
CDAI01-Anti-diarrhea/Opiate Use Subscore | C176085 | CDAI01-Anti-diarrhea/Opiate Use Subscore | Crohn's Disease Activity Index Version 1 - Anti-diarrhea/opiate use subscore. | CDAI Version 1 - Anti-diarrhea/Opiate Use Subscore | ||
CDAI01-Anti-diarrhea/Opiate Use | C176072 | CDAI01-Anti-diarrhea/Opiate Use | Crohn's Disease Activity Index Version 1 - Anti-diarrhea/opiate use during past 7 days. | CDAI Version 1 - Anti-diarrhea/Opiate Use | ||
CDAI01-Arthritis/Arthralgia | C176075 | CDAI01-Arthritis/Arthralgia | Crohn's Disease Activity Index Version 1 - Arthritis/arthralgia. | CDAI Version 1 - Arthritis/Arthralgia | ||
CDAI01-CDAI Total Score | C176089 | CDAI01-CDAI Total Score | Crohn's Disease Activity Index Version 1 - CDAI total score. | CDAI Version 1 - CDAI Total Score | ||
CDAI01-Daily Average Abdominal Pain | C176070 | CDAI01-Daily Average Abdominal Pain | Crohn's Disease Activity Index Version 1 - Daily average abdominal pain (average daily rating for each of the past 7 days). | CDAI Version 1 - Daily Average Abdominal Pain | ||
CDAI01-Daily Average General Well-being | C176071 | CDAI01-Daily Average General Well-being | Crohn's Disease Activity Index Version 1 - Daily average general well-being (average daily rating for each of the past 7 days). | CDAI Version 1 - Daily Average General Well-being | ||
CDAI01-Daily Number of Stools | C176069 | CDAI01-Daily Number of Stools | Crohn's Disease Activity Index Version 1 - Daily number of very soft/liquid stools in the last 7 days. | CDAI Version 1 - Daily Number of Stools | ||
CDAI01-Erythema Nodosum | C176077 | CDAI01-Erythema Nodosum | Crohn's Disease Activity Index Version 1 - Erythema nodosum, pyoderma gangrenosum, or aphthous stomatitis. | CDAI Version 1 - Erythema Nodosum | ||
CDAI01-Fever | C176080 | CDAI01-Fever | Crohn's Disease Activity Index Version 1 - Fever/temperature > 100F/37.8C during the past 7 days. | CDAI Version 1 - Fever | ||
CDAI01-General Well-being Subscore | C176084 | CDAI01-General Well-being Subscore | Crohn's Disease Activity Index Version 1 - General well-being (daily rating for the past 7 days): Subscore. | CDAI Version 1 - General Well-being Subscore | ||
CDAI01-Hematocrit Subscore | C176087 | CDAI01-Hematocrit Subscore | Crohn's Disease Activity Index Version 1 - Hematocrit subscore. | CDAI Version 1 - Hematocrit Subscore | ||
CDAI01-Hematocrit | C176074 | CDAI01-Hematocrit | Crohn's Disease Activity Index Version 1 - Hematocrit. | CDAI Version 1 - Hematocrit | ||
CDAI01-Iritis/Uveitis | C176076 | CDAI01-Iritis/Uveitis | Crohn's Disease Activity Index Version 1 - Iritis/uveitis. | CDAI Version 1 - Iritis/Uveitis | ||
CDAI01-Other Fistula | C176079 | CDAI01-Other Fistula | Crohn's Disease Activity Index Version 1 - Other fistula. | CDAI Version 1 - Other Fistula | ||
CDAI01-Standard Body Weight | C176068 | CDAI01-Standard Body Weight | Crohn's Disease Activity Index Version 1 - Standard body weight. | CDAI Version 1 - Standard Body Weight | ||
CDAI01-Symptoms Manifested Subscore | C176088 | CDAI01-Symptoms Manifested Subscore | Crohn's Disease Activity Index Version 1 - Arthritis/arthralgia; iritis/uveitis; erythema nodosum, pyoderma gangrenosum, or aphthous stomatitis; anal fissure, fistula, or abscess; other fistula; fever subscore. | CDAI Version 1 - Symptoms Manifested Subscore | ||
CDAI01-Total Number Stools Subscore | C176082 | CDAI01-Total Number Stools Subscore | Crohn's Disease Activity Index Version 1 - Total number of very soft/liquid stools in the last 7 days: Subscore. | CDAI Version 1 - Total Number Stools Subscore | ||
CDAI01-Weight Subscore | C176081 | CDAI01-Weight Subscore | Crohn's Disease Activity Index Version 1 - Weight subscore. | CDAI Version 1 - Weight Subscore | ||
CDAI01-Weight | C176067 | CDAI01-Weight | Crohn's Disease Activity Index Version 1 - Weight. | CDAI Version 1 - Weight | ||
Back to top | ||||||
CL.C174223.CRFATSCD | Crohn's Disease Findings About Test Code
(CRFATSCD) | text
Extensible: Yes | C174223 | Crohn's Disease Findings About Test Code | Terminology relevant to the test codes that describe findings about Crohn's Disease event or intervention. | CDISC SDTM Crohn's Disease Findings About Test Code Terminology |
ABSCNUM | C181313 | Number of Abscesses | The number of abscesses observed. | Number of Abscesses | ||
AGESYMST | C174273 | Age Symptoms Started | The age at which illness-specific symptoms first began. | Age Symptom Started | ||
BIOPSIND | C181316 | Biopsy Specimen Taken Indicator | An indication as to whether a biopsy specimen was collected. | Biopsy Specimen Taken Indicator | ||
BIOPSNUM | C181317 | Number of Biopsy Specimens Taken | The total number of biopsy specimens collected. | Number of Biopsy Specimens Taken | ||
BPSPTHAP | C181318 | Pathologic Appearance of Biopsy Site | A description of the appearance of the anatomical site from which a biopsy specimen has been collected. | Pathologic Appearance of Biopsy Site | ||
DCDEPIND | C176284 | Unable to Discon Dependent Indicator;Unable to Discontinue Dependent Indicator | An indication as to whether an individual is unable to discontinue the use of a substance due to dependence. | Unable to Discontinue Use Due to Dependence Indicator | ||
DEVPNUM | C176277 | Number of Devices Present | A determination of the number of devices within a subject. | Number of Devices Present | ||
DVCINSN | C174280 | Number of Devices Inserted | The number of devices inserted into an individual. | Number of Devices Inserted | ||
EXETRIND | C181310 | Expected Efficacious Treatment Reg Ind;Expected Efficacious Treatment Regimen Indicator | An indication as to whether the subject has been on a treatment regimen which, based on defined criteria, is expected to be efficacious. | Expected Efficacious Treatment Regimen Indicator | ||
EXTRSCT | C157443 | Extent of Resection | A description of the relative amount of tissue, blood vessel, or organ that has been removed. | Extent of Resection | ||
FISTATYP | C181314 | Fistula Anatomical Type | A classification based on the anatomical location(s) of the fistula. | Fistula Anatomical Site | ||
FISTNUM | C181312 | Number of Fistulas | The number of fistulas observed. | Number of Fistulas | ||
FNDOSAMT | C176280 | Final Dose Amount | A determination of the final amount of a substance taken as a dose by a subject. | Final Dose Amount | ||
FNDOSFRQ | C176281 | Frequency of Final Dose Amount | A determination of how often a subject takes a substance at the final dose amount. | Frequency of Final Dose Amount | ||
ICJRIND | C174279 | Ileocecal Junction Removed Indicator | An indication as to whether the ileocecal junction was removed. | Ileocecal Junction Removed Indicator | ||
LENRSCT | C174278 | Length of Resection | A measurement of the total length of the removed tissue, blood vessel, or organ. | Length of Resection | ||
LESNUM | C174277 | Number of Lesions | The number of lesions observed. | Number of Lesions | ||
MXDOSAMT | C176278 | Maximum Dose Amount | A determination of the maximum amount of a substance taken as a dose by a subject. | Maximum Dose Amount | ||
MXDOSFRQ | C176279 | Frequency of Maximum Dose Amount | A determination of how often a subject takes a substance at the maximum dose amount. | Frequency of Maximum Dose Amount | ||
PLLDIAM | C181311 | Largest Diameter of Primary Lesion;Longest Diameter of Primary Lesion | The longest diameter of the lesion that has been determined to be the primary lesion. | Longest Diameter of Primary Lesion | ||
PLLOC | C181315 | Anatomical Location of Primary Lesion | The anatomical location of the lesion that has been determined to be the primary lesion. | Anatomical Location of Primary Lesion | ||
PROCPRFN | C174228 | Number of Procedures Performed | The number of procedures performed on or in an individual. | Number of Procedures Performed | ||
RLDEPIND | C176283 | Relapse after Discon Dependent Indicator;Relapse after Discontinue Dependent Indicator | An indication as to whether an individual has had a relapse after discontinuation of a substance due to dependence. | Relapse after Discontinuation Because of Dependence Indicator | ||
SBDEPIND | C176285 | Substance Dependence Indicator | An indication as to whether an individual has become dependent on a substance. | Substance Dependence Indicator | ||
SEV | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
SSDISC | C174281 | Sign/Symptom Leading to Discontinuation | The signs and/or symptoms that result in the discontinuation of treatment or intervention. | Sign or Symptom Leading to Discontinuation | ||
STRCTNUM | C174274 | Number of Strictures | The number of anatomical strictures observed. | Number of Strictures | ||
TPDEPIND | C176282 | Unable to Taper Dependent Indicator | An indication as to whether an individual is incapable of reducing or tapering the amount of a substance taken due to dependence. | Unable to Taper Dependent Indicator | ||
Back to top | ||||||
CL.C174224.CRFATS | Crohn's Disease Findings About Test Name
(CRFATS) | text
Extensible: Yes | C174224 | Crohn's Disease Findings About Test Name | Terminology relevant to the test names that describe findings about Crohn's Disease event or intervention. | CDISC SDTM Crohn's Disease Findings About Test Name Terminology |
Age Symptoms Started | C174273 | Age Symptoms Started | The age at which illness-specific symptoms first began. | Age Symptom Started | ||
Anatomical Location of Primary Lesion | C181315 | Anatomical Location of Primary Lesion | The anatomical location of the lesion that has been determined to be the primary lesion. | Anatomical Location of Primary Lesion | ||
Biopsy Specimen Taken Indicator | C181316 | Biopsy Specimen Taken Indicator | An indication as to whether a biopsy specimen was collected. | Biopsy Specimen Taken Indicator | ||
Expected Efficacious Treatment Reg Ind | C181310 | Expected Efficacious Treatment Reg Ind;Expected Efficacious Treatment Regimen Indicator | An indication as to whether the subject has been on a treatment regimen which, based on defined criteria, is expected to be efficacious. | Expected Efficacious Treatment Regimen Indicator | ||
Extent of Resection | C157443 | Extent of Resection | A description of the relative amount of tissue, blood vessel, or organ that has been removed. | Extent of Resection | ||
Final Dose Amount | C176280 | Final Dose Amount | A determination of the final amount of a substance taken as a dose by a subject. | Final Dose Amount | ||
Fistula Anatomical Type | C181314 | Fistula Anatomical Type | A classification based on the anatomical location(s) of the fistula. | Fistula Anatomical Site | ||
Frequency of Final Dose Amount | C176281 | Frequency of Final Dose Amount | A determination of how often a subject takes a substance at the final dose amount. | Frequency of Final Dose Amount | ||
Frequency of Maximum Dose Amount | C176279 | Frequency of Maximum Dose Amount | A determination of how often a subject takes a substance at the maximum dose amount. | Frequency of Maximum Dose Amount | ||
Ileocecal Junction Removed Indicator | C174279 | Ileocecal Junction Removed Indicator | An indication as to whether the ileocecal junction was removed. | Ileocecal Junction Removed Indicator | ||
Length of Resection | C174278 | Length of Resection | A measurement of the total length of the removed tissue, blood vessel, or organ. | Length of Resection | ||
Longest Diameter of Primary Lesion | C181311 | Largest Diameter of Primary Lesion;Longest Diameter of Primary Lesion | The longest diameter of the lesion that has been determined to be the primary lesion. | Longest Diameter of Primary Lesion | ||
Maximum Dose Amount | C176278 | Maximum Dose Amount | A determination of the maximum amount of a substance taken as a dose by a subject. | Maximum Dose Amount | ||
Number of Abscesses | C181313 | Number of Abscesses | The number of abscesses observed. | Number of Abscesses | ||
Number of Biopsy Specimens Taken | C181317 | Number of Biopsy Specimens Taken | The total number of biopsy specimens collected. | Number of Biopsy Specimens Taken | ||
Number of Devices Inserted | C174280 | Number of Devices Inserted | The number of devices inserted into an individual. | Number of Devices Inserted | ||
Number of Devices Present | C176277 | Number of Devices Present | A determination of the number of devices within a subject. | Number of Devices Present | ||
Number of Fistulas | C181312 | Number of Fistulas | The number of fistulas observed. | Number of Fistulas | ||
Number of Lesions | C174277 | Number of Lesions | The number of lesions observed. | Number of Lesions | ||
Number of Procedures Performed | C174228 | Number of Procedures Performed | The number of procedures performed on or in an individual. | Number of Procedures Performed | ||
Number of Strictures | C174274 | Number of Strictures | The number of anatomical strictures observed. | Number of Strictures | ||
Pathologic Appearance of Biopsy Site | C181318 | Pathologic Appearance of Biopsy Site | A description of the appearance of the anatomical site from which a biopsy specimen has been collected. | Pathologic Appearance of Biopsy Site | ||
Relapse after Discon Dependent Indicator | C176283 | Relapse after Discon Dependent Indicator;Relapse after Discontinue Dependent Indicator | An indication as to whether an individual has had a relapse after discontinuation of a substance due to dependence. | Relapse after Discontinuation Because of Dependence Indicator | ||
Severity/Intensity | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Sign/Symptom Leading to Discontinuation | C174281 | Sign/Symptom Leading to Discontinuation | The signs and/or symptoms that result in the discontinuation of treatment or intervention. | Sign or Symptom Leading to Discontinuation | ||
Substance Dependence Indicator | C176285 | Substance Dependence Indicator | An indication as to whether an individual has become dependent on a substance. | Substance Dependence Indicator | ||
Unable to Discon Dependent Indicator | C176284 | Unable to Discon Dependent Indicator;Unable to Discontinue Dependent Indicator | An indication as to whether an individual is unable to discontinue the use of a substance due to dependence. | Unable to Discontinue Use Due to Dependence Indicator | ||
Unable to Taper Dependent Indicator | C176282 | Unable to Taper Dependent Indicator | An indication as to whether an individual is incapable of reducing or tapering the amount of a substance taken due to dependence. | Unable to Taper Dependent Indicator | ||
Back to top | ||||||
CL.C127264.CLTMDTYP | Culture Medium Type
(CLTMDTYP) | text
Extensible: Yes | C127264 | Culture Medium Type | Terminology relevant to the type of medium used to culture a specimen. | CDISC SDTM Culture Medium Type Terminology |
BLOOD AGAR | C127517 | A solid growth medium mainly consisting of peptones, sodium chloride, meat extracts, and mammalian blood, which is developed for the cultivation of fastidious organisms. The blood in the formulation promotes the presence and visualization of hemolytic reactions, enabling the detection and differentiation of hemolytic bacteria. | Blood Agar Growth Medium | |||
CHROMOGENIC SELECTIVE MEDIUM | C150829 | A solid growth medium mainly consisting of various peptones, taurocholate and a chromogenic substrate which is developed primarily for the isolation and cultivation of Clostridium difficile. | Chromogenic Selective Medium | |||
CYCLOSERINE-CEFOXITIN FRUCTOSE AGAR | C150828 | CCFA | A solid growth medium mainly consisting of proteose peptone, fructose, cycloserine, cefoxitin, fructose, and egg yolk, which is developed primarily for the isolation and cultivation of Clostridium difficile. | Cycloserine-Cefoxitin Fructose Agar | ||
KIRCHNER MEDIUM | C128949 | A liquid growth medium mainly consisting of sodium dihydrogen phosphate, potassium dihydrogen phosphate, magnesium sulphate, trisodium citrate, L-asparagine and phenol red, which is developed for the culture and recovery of Mycobacteria. | Kirchner Growth Medium | |||
LOWENSTEIN JENSEN MEDIUM | C85507 | LJ medium | A growth medium mainly consisting of malachite green, glycerol, asparagine, coagulated eggs, and mineral salts which is developed especially for the cultivation of mycobacterium. | Lowenstein-Jensen Medium | ||
MB REDOX BROTH | C128950 | A liquid and selective growth medium that is modified based on the Kirchner medium by the addition of a mixture of antimicrobial agents (typically polymyxin B, amphotericin B, carbenicillin, and trimethoprim) and colorless tetrazolium salt as a growth indicator, which is developed for the cultivation of mycobacterium. | MB Redox Broth Growth Medium | |||
MIDDLEBROOK 7H10 AGAR | C85509 | A solid growth medium mainly consisting of oleic acid-albumin enrichment, glycerol, dextrose and inorganic compounds, which is developed especially for the primary and secondary cultivation of mycobacterium. | Middlebrook 7H10 Growth Medium | |||
MIDDLEBROOK 7H10S AGAR | C127518 | Middlebrook 7H10 Selective Agar | A solid and selective growth medium that is modified based on the Middlebrook 7H10 agar by the addition of four antimicrobial agents: polymyxin B, carbenicillin, amphotericin B and trimethoprim lactate. | Middlebrook 7H10S Growth Medium | ||
MIDDLEBROOK 7H11 AGAR | C85510 | A solid growth medium that is modified based on the Middlebrook 7H10 agar by the addition of pancreatic digest of casein. | Middlebrook 7H11 Growth Medium | |||
MIDDLEBROOK 7H11S AGAR | C127519 | Middlebrook 7H11 Selective Agar | A solid and selective growth medium that is modified based on the Middlebrook 7H11 agar by the addition of four antimicrobial agents: polymyxin B, carbenicillin, amphotericin B and trimethoprim lactate. | Middlebrook 7H11S Growth Medium | ||
MIDDLEBROOK 7H12 BROTH | C127520 | A liquid growth medium that is modified based on the Middlebrook 7H9 broth by the addition of bovine serum albumin, casein hydrolysate, catalase and 14C-labelled palmitic acid. | Middlebrook 7H12 Growth Medium | |||
MIDDLEBROOK 7H9 BROTH | C127521 | A liquid growth medium mainly consisting of albumin, glycerol, dextrose and inorganic compounds, which is developed especially for the primary and secondary cultivation of mycobacterium. | Middlebrook 7H9 Growth Medium | |||
Back to top | ||||||
CL.C100158.COMM1TC | Current Opioid Misuse Measure Questionnaire Test Code
(COMM1TC) | text
Extensible: No | C100158 | Current Opioid Misuse Measure Questionnaire Test Code | Current Opioid Misuse Measure test code. | CDISC Questionnaire COMM Test Code Terminology |
COMM101 | C100958 | COMM1-Trouble Thinking Clearly/Memory | Current Opioid Misuse Measure - In the past 30 days, how often have you had trouble with thinking clearly or had memory problems? | COMM - Trouble Thinking Clearly or Memory Problems | ||
COMM102 | C100959 | COMM1-Complaints Not Completing Tasks | Current Opioid Misuse Measure - In the past 30 days, how often do people complain that you are not completing necessary tasks? (i.e., doing things that need to be done, such as going to class, work or appointments) | COMM - Complaints Not Completing Tasks | ||
COMM103 | C100960 | COMM1-Other Sources For Pain Medication | Current Opioid Misuse Measure - In the past 30 days, how often have you had to go to someone other than your prescribing physician to get sufficient pain relief from medications? (i.e., another doctor, the Emergency Room, friends, street source) | COMM - Other Sources for Pain Medication | ||
COMM104 | C100961 | COMM1-Taken Meds Other Than Prescribed | Current Opioid Misuse Measure - In the past 30 days, how often have you taken your medications differently from how they are prescribed? | COMM - Taken Medications Other Than Prescribed | ||
COMM105 | C100962 | COMM1-Seriously Thought of Hurting Self | Current Opioid Misuse Measure - In the past 30 days, how often have you seriously thought about hurting yourself? | COMM - Seriously Thought of Hurting Self | ||
COMM106 | C100963 | COMM1-Time Spent Thinking About Opioids | Current Opioid Misuse Measure - In the past 30 days, how much of your time was spent thinking about opioid medications (having enough, taking them, dosing schedule, etc.)? | COMM - Time Spent Thinking About Opioids | ||
COMM107 | C100964 | COMM1-Been in an Argument | Current Opioid Misuse Measure - In the past 30 days, how often have you been in an argument? | COMM - Been in an Argument | ||
COMM108 | C100965 | COMM1-Trouble Controlling Anger | Current Opioid Misuse Measure - In the past 30 days, how often have you had trouble controlling your anger (e.g., road rage, screaming, etc.)? | COMM - Trouble Controlling Anger | ||
COMM109 | C100966 | COMM1-Take Meds Belonging to Others | Current Opioid Misuse Measure - In the past 30 days, how often have you needed to take pain medications belonging to someone else? | COMM - Take Medications Belonging to Others | ||
COMM110 | C100967 | COMM1-Worry About Handling Meds | Current Opioid Misuse Measure - In the past 30 days, how often have you been worried about how you're handling your medications? | COMM - Worry About Handling Medications | ||
COMM111 | C100968 | COMM1-Others Worry About Your Meds | Current Opioid Misuse Measure - In the past 30 days, how often have others been worried about how you're handling your medications? | COMM - Others Worry About Your Medications | ||
COMM112 | C100969 | COMM1-Emergency Phone Call/Clinic Visit | Current Opioid Misuse Measure - In the past 30 days, how often have you had to make an emergency phone call or show up at the clinic without an appointment? | COMM - Emergency Phone Call or Clinic Visit | ||
COMM113 | C100970 | COMM1-Gotten Angry With People | Current Opioid Misuse Measure - In the past 30 days, how often have you gotten angry with people? | COMM - Gotten Angry With People | ||
COMM114 | C100971 | COMM1-Take More Meds Than Prescribed | Current Opioid Misuse Measure - In the past 30 days, how often have you had to take more of your medication than prescribed? | COMM - Take More Medication Than Prescribed | ||
COMM115 | C100972 | COMM1-Borrowed Meds From Others | Current Opioid Misuse Measure - In the past 30 days, how often have you borrowed pain medication from someone else? | COMM - Borrowed Medication From Others | ||
COMM116 | C100973 | COMM1-Used Pain Meds For Other Symptoms | Current Opioid Misuse Measure - In the past 30 days, how often have you used your pain medicine for symptoms other than for pain (e.g., to help you sleep, improve your mood, or relieve stress)? | COMM - Used Pain Medicine For Other Symptoms | ||
COMM117 | C100974 | COMM1-Visit Emergency Room | Current Opioid Misuse Measure - In the past 30 days, how often have you had to visit the Emergency Room? | COMM - Visit Emergency Room | ||
COMM118 | C100975 | COMM1-Score | Current Opioid Misuse Measure - Score. | COMM - Score | ||
Back to top | ||||||
CL.C100157.COMM1TN | Current Opioid Misuse Measure Questionnaire Test Name
(COMM1TN) | text
Extensible: No | C100157 | Current Opioid Misuse Measure Questionnaire Test Name | Current Opioid Misuse Measure test name. | CDISC Questionnaire COMM Test Name Terminology |
COMM1-Been in an Argument | C100964 | COMM1-Been in an Argument | Current Opioid Misuse Measure - In the past 30 days, how often have you been in an argument? | COMM - Been in an Argument | ||
COMM1-Borrowed Meds From Others | C100972 | COMM1-Borrowed Meds From Others | Current Opioid Misuse Measure - In the past 30 days, how often have you borrowed pain medication from someone else? | COMM - Borrowed Medication From Others | ||
COMM1-Complaints Not Completing Tasks | C100959 | COMM1-Complaints Not Completing Tasks | Current Opioid Misuse Measure - In the past 30 days, how often do people complain that you are not completing necessary tasks? (i.e., doing things that need to be done, such as going to class, work or appointments) | COMM - Complaints Not Completing Tasks | ||
COMM1-Emergency Phone Call/Clinic Visit | C100969 | COMM1-Emergency Phone Call/Clinic Visit | Current Opioid Misuse Measure - In the past 30 days, how often have you had to make an emergency phone call or show up at the clinic without an appointment? | COMM - Emergency Phone Call or Clinic Visit | ||
COMM1-Gotten Angry With People | C100970 | COMM1-Gotten Angry With People | Current Opioid Misuse Measure - In the past 30 days, how often have you gotten angry with people? | COMM - Gotten Angry With People | ||
COMM1-Other Sources For Pain Medication | C100960 | COMM1-Other Sources For Pain Medication | Current Opioid Misuse Measure - In the past 30 days, how often have you had to go to someone other than your prescribing physician to get sufficient pain relief from medications? (i.e., another doctor, the Emergency Room, friends, street source) | COMM - Other Sources for Pain Medication | ||
COMM1-Others Worry About Your Meds | C100968 | COMM1-Others Worry About Your Meds | Current Opioid Misuse Measure - In the past 30 days, how often have others been worried about how you're handling your medications? | COMM - Others Worry About Your Medications | ||
COMM1-Score | C100975 | COMM1-Score | Current Opioid Misuse Measure - Score. | COMM - Score | ||
COMM1-Seriously Thought of Hurting Self | C100962 | COMM1-Seriously Thought of Hurting Self | Current Opioid Misuse Measure - In the past 30 days, how often have you seriously thought about hurting yourself? | COMM - Seriously Thought of Hurting Self | ||
COMM1-Take Meds Belonging to Others | C100966 | COMM1-Take Meds Belonging to Others | Current Opioid Misuse Measure - In the past 30 days, how often have you needed to take pain medications belonging to someone else? | COMM - Take Medications Belonging to Others | ||
COMM1-Take More Meds Than Prescribed | C100971 | COMM1-Take More Meds Than Prescribed | Current Opioid Misuse Measure - In the past 30 days, how often have you had to take more of your medication than prescribed? | COMM - Take More Medication Than Prescribed | ||
COMM1-Taken Meds Other Than Prescribed | C100961 | COMM1-Taken Meds Other Than Prescribed | Current Opioid Misuse Measure - In the past 30 days, how often have you taken your medications differently from how they are prescribed? | COMM - Taken Medications Other Than Prescribed | ||
COMM1-Time Spent Thinking About Opioids | C100963 | COMM1-Time Spent Thinking About Opioids | Current Opioid Misuse Measure - In the past 30 days, how much of your time was spent thinking about opioid medications (having enough, taking them, dosing schedule, etc.)? | COMM - Time Spent Thinking About Opioids | ||
COMM1-Trouble Controlling Anger | C100965 | COMM1-Trouble Controlling Anger | Current Opioid Misuse Measure - In the past 30 days, how often have you had trouble controlling your anger (e.g., road rage, screaming, etc.)? | COMM - Trouble Controlling Anger | ||
COMM1-Trouble Thinking Clearly/Memory | C100958 | COMM1-Trouble Thinking Clearly/Memory | Current Opioid Misuse Measure - In the past 30 days, how often have you had trouble with thinking clearly or had memory problems? | COMM - Trouble Thinking Clearly or Memory Problems | ||
COMM1-Used Pain Meds For Other Symptoms | C100973 | COMM1-Used Pain Meds For Other Symptoms | Current Opioid Misuse Measure - In the past 30 days, how often have you used your pain medicine for symptoms other than for pain (e.g., to help you sleep, improve your mood, or relieve stress)? | COMM - Used Pain Medicine For Other Symptoms | ||
COMM1-Visit Emergency Room | C100974 | COMM1-Visit Emergency Room | Current Opioid Misuse Measure - In the past 30 days, how often have you had to visit the Emergency Room? | COMM - Visit Emergency Room | ||
COMM1-Worry About Handling Meds | C100967 | COMM1-Worry About Handling Meds | Current Opioid Misuse Measure - In the past 30 days, how often have you been worried about how you're handling your medications? | COMM - Worry About Handling Medications | ||
Back to top | ||||||
CL.C141673.DRRI1TC | Deployment Risk and Resilience Inventory-2 Questionnaire Test Code
(DRRI1TC) | text
Extensible: No | C141673 | Deployment Risk and Resilience Inventory-2 Questionnaire Test Code | Deployment Risk and Resilience Inventory-2 test code. | CDISC Questionnaire DRRI-2 Test Code Terminology |
DRRI1A01 | C141867 | DRRI1-A: Someone Close to Me Died | Deployment Risk & Resilience Inventory-2 - Before deployment: someone close to me died. | DRRI-2 - A: Someone Close to Me Died | ||
DRRI1A02 | C141868 | DRRI1-A: Went Through Divorce/Was Left | Deployment Risk & Resilience Inventory-2 - Before deployment: I went through a divorce or was left by a significant other. | DRRI-2 - A: Went Through Divorce/Was Left | ||
DRRI1A03 | C141869 | DRRI1-A: Robbed/Had My Home Broken Into | Deployment Risk & Resilience Inventory-2 - Before deployment: I was robbed or had my home broken into. | DRRI-2 - A: Robbed/Had My Home Broken Into | ||
DRRI1A04 | C141870 | DRRI1-A: Saw/Heard Physical Fight Parent | Deployment Risk & Resilience Inventory-2 - Before deployment: I saw or heard physical fighting between my parents or caregivers. | DRRI-2 - A: Saw/Heard Physical Fight Parent | ||
DRRI1A05 | C141871 | DRRI1-A: Physically Punished by Parent | Deployment Risk & Resilience Inventory-2 - Before deployment: I was physically punished by a parent or primary caregiver. | DRRI-2 - A: Physically Punished by Parent | ||
DRRI1A06 | C141872 | DRRI1-A: Unwanted Sex Activity Childhood | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced unwanted sexual activity as a result of force, threat of harm, or manipulation during childhood (before age 18). | DRRI-2 - A: Unwanted Sex Activity Childhood | ||
DRRI1A07 | C141873 | DRRI1-A: Unwanted Sex Activity Adulthood | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced unwanted sexual activity as a result of force, threat of harm, or manipulation during adulthood (age 18 or later). | DRRI-2 - A: Unwanted Sex Activity Adulthood | ||
DRRI1A08 | C141874 | DRRI1-A: Experienced Natural Disaster | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced a natural disaster (for example, a hurricane), a fire, or an accident in which I or someone close to me was hurt or had serious property damage. | DRRI-2 - A: Experienced Natural Disaster | ||
DRRI1A09 | C141875 | DRRI1-A: Someone Close Serious Illness | Deployment Risk & Resilience Inventory-2 - Before deployment: someone close to me experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). | DRRI-2 - A: Someone Close Serious Illness | ||
DRRI1A10 | C141876 | DRRI1-A: Witnessed Someone Assaulted | Deployment Risk & Resilience Inventory-2 - Before deployment: I witnessed someone being seriously assaulted or killed. | DRRI-2 - A: Witnessed Someone Assaulted | ||
DRRI1A11 | C141877 | DRRI1-A: Lost My Job/Trouble Finding Job | Deployment Risk & Resilience Inventory-2 - Before deployment: I lost my job or had serious trouble finding a job. | DRRI-2 - A: Lost My Job/Trouble Finding Job | ||
DRRI1A12 | C141878 | DRRI1-A: Emotionally Mistreated | Deployment Risk & Resilience Inventory-2 - Before deployment: I was emotionally mistreated (for example, ignored or repeatedly told I was no good). | DRRI-2 - A: Emotionally Mistreated | ||
DRRI1A13 | C141879 | DRRI1-A: Serious Financial Problems | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced serious financial problems. | DRRI-2 - A: Serious Financial Problems | ||
DRRI1A14 | C141880 | DRRI1-A: Serious Physical Health Problem | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced serious physical or mental health problems. | DRRI-2 - A: Serious Physical Health Problem | ||
DRRI1A15 | C141881 | DRRI1-A: Dangerous Military Duties | Deployment Risk & Resilience Inventory-2 - Before deployment: I participated in dangerous military duties. | DRRI-2 - A: Dangerous Military Duties | ||
DRRI1A16 | C141882 | DRRI1-A: Injured by Person - Childhood | Deployment Risk & Resilience Inventory-2 - Before deployment: I was seriously physically injured by another person (for example, hit or beaten up) during childhood (before age 18). | DRRI-2 - A: Injured by Person - Childhood | ||
DRRI1A17 | C141883 | DRRI1-A: Injured by Person - Adulthood | Deployment Risk & Resilience Inventory-2 - Before deployment: I was seriously physically injured by another person (for example, hit or beaten up) during adulthood (age 18 or later). | DRRI-2 - A: Injured by Person - Adulthood | ||
DRRI1A18 | C141884 | DRRI1-A: Stressful Legal Problems | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced stressful legal problems (for example, being sued, suing someone else, or being in a custody battle). | DRRI-2 - A: Stressful Legal Problems | ||
DRRI1B01 | C141885 | DRRI1-B: Got Along Well With My Family | Deployment Risk & Resilience Inventory-2 - During childhood: I got along well with my family members. | DRRI-2 - B: Got Along Well With My Family | ||
DRRI1B02 | C141886 | DRRI1-B: Felt Like I Fit in With Family | Deployment Risk & Resilience Inventory-2 - During childhood: I felt like I fit in with my family. | DRRI-2 - B: Felt Like I Fit in With Family | ||
DRRI1B03 | C141887 | DRRI1-B: Family Knew What I Thought/Felt | Deployment Risk & Resilience Inventory-2 - During childhood: family members knew what I thought and how I felt about things. | DRRI-2 - B: Family Knew What I Thought/Felt | ||
DRRI1B04 | C141888 | DRRI1-B: Contribution Family Appreciated | Deployment Risk & Resilience Inventory-2 - During childhood: I felt like my contributions to my family were appreciated. | DRRI-2 - B: Contribution Family Appreciated | ||
DRRI1B05 | C141889 | DRRI1-B: Shared Interests With Family | Deployment Risk & Resilience Inventory-2 - During childhood: I shared many common interests and activities with family members. | DRRI-2 - B: Shared Interests With Family | ||
DRRI1B06 | C141890 | DRRI1-B: Opinions Were Valued by Family | Deployment Risk & Resilience Inventory-2 - During childhood: my opinions were valued by other family members. | DRRI-2 - B: Opinions Were Valued by Family | ||
DRRI1B07 | C141891 | DRRI1-B: I Was Affectionate With Family | Deployment Risk & Resilience Inventory-2 - During childhood: I was affectionate with family members. | DRRI-2 - B: I Was Affectionate With Family | ||
DRRI1B08 | C141892 | DRRI1-B: Played Important Role in Family | Deployment Risk & Resilience Inventory-2 - During childhood: I played an important role in my family. | DRRI-2 - B: Played Important Role in Family | ||
DRRI1B09 | C141893 | DRRI1-B: Spent My Free Time With Family | Deployment Risk & Resilience Inventory-2 - During childhood: I spent as much of my free time with family members as possible. | DRRI-2 - B: Spent My Free Time With Family | ||
DRRI1B10 | C141894 | DRRI1-B: Family Told Me When Problem | Deployment Risk & Resilience Inventory-2 - During childhood: family members told me when they were having a problem. | DRRI-2 - B: Family Told Me When Problem | ||
DRRI1B11 | C141895 | DRRI1-B: I Could Be Myself Around Family | Deployment Risk & Resilience Inventory-2 - During childhood: I could be myself around family members. | DRRI-2 - B: I Could Be Myself Around Family | ||
DRRI1B12 | C141896 | DRRI1-B: Input Sought Family Decisions | Deployment Risk & Resilience Inventory-2 - During childhood: my input was sought on important family decisions. | DRRI-2 - B: Input Sought Family Decisions | ||
DRRI1C01 | C141897 | DRRI1-C: Climate Was Uncomfortable | Deployment Risk & Resilience Inventory-2 - During deployment: the climate was uncomfortable. | DRRI-2 - C: Climate Was Uncomfortable | ||
DRRI1C02 | C141898 | DRRI1-C: Deal With Annoying Animals | Deployment Risk & Resilience Inventory-2 - During deployment: I had to deal with annoying animals, insects, or plants. | DRRI-2 - C: Deal With Annoying Animals | ||
DRRI1C03 | C141899 | DRRI1-C: Food Was of Very Poor Quality | Deployment Risk & Resilience Inventory-2 - During deployment: the food I had to eat was of very poor quality (for example, bad or old MREs). | DRRI-2 - C: Food Was of Very Poor Quality | ||
DRRI1C04 | C141900 | DRRI1-C: Conditions Extremely Unsanitary | Deployment Risk & Resilience Inventory-2 - During deployment: the conditions I lived in were extremely unsanitary. | DRRI-2 - C: Conditions Extremely Unsanitary | ||
DRRI1C05 | C141901 | DRRI1-C: Didn't Have Bathrooms | Deployment Risk & Resilience Inventory-2 - During deployment: I didn't have access to bathrooms or showers when I needed them. | DRRI-2 - C: Didn't Have Bathrooms | ||
DRRI1C06 | C141902 | DRRI1-C: Wasn't Able to Get Privacy | Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to get as much privacy as I needed. | DRRI-2 - C: Wasn't Able to Get Privacy | ||
DRRI1C07 | C141903 | DRRI1-C: I Was Exposed to Awful Smells | Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to awful smells. | DRRI-2 - C: I Was Exposed to Awful Smells | ||
DRRI1C08 | C141904 | DRRI1-C: I Was Subjected to Loud Noises | Deployment Risk & Resilience Inventory-2 - During deployment: I was subjected to loud noises. | DRRI-2 - C: I Was Subjected to Loud Noises | ||
DRRI1C09 | C141905 | DRRI1-C: Restricted Because Local Custom | Deployment Risk & Resilience Inventory-2 - During deployment: my daily activities were restricted because of local religious or ethnic customs. | DRRI-2 - C: Restricted Because Local Custom | ||
DRRI1C10 | C141906 | DRRI1-C: Wasn't Able to Rest | Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to get rest when I needed it. | DRRI-2 - C: Wasn't Able to Rest | ||
DRRI1C11 | C141907 | DRRI1-C: Wasn't Able to Contact Home | Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to contact home when I needed to. | DRRI-2 - C: Wasn't Able to Contact Home | ||
DRRI1C12 | C141908 | DRRI1-C: Hassle With Heavy/Annoying Gear | Deployment Risk & Resilience Inventory-2 - During deployment: I had to hassle with putting on and taking off heavy or annoying gear. | DRRI-2 - C: Hassle With Heavy/Annoying Gear | ||
DRRI1C13 | C141909 | DRRI1-C: Not Allowed to Get Job Done | Deployment Risk & Resilience Inventory-2 - During deployment: I was not allowed to do the things I needed to do to get my job done. | DRRI-2 - C: Not Allowed to Get Job Done | ||
DRRI1C14 | C141910 | DRRI1-C: Not Have Adequate Shelter | Deployment Risk & Resilience Inventory-2 - During deployment: I did not have adequate shelter from uncomfortable living conditions (for example, heat, cold, wet, etc.). | DRRI-2 - C: Not Have Adequate Shelter | ||
DRRI1D01 | C141911 | DRRI1-D: Went on Combat Patrols/Missions | Deployment Risk & Resilience Inventory-2 - During deployment: I went on combat patrols or missions. | DRRI-2 - D: Went on Combat Patrols/Missions | ||
DRRI1D02 | C141912 | DRRI1-D: Assault on Entrenched Positions | Deployment Risk & Resilience Inventory-2 - During deployment: I took part in an assault on entrenched or fortified positions that involved naval and/or land forces. | DRRI-2 - D: Assault on Entrenched Positions | ||
DRRI1D03 | C141913 | DRRI1-D: Witnessed Someone Unit Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed someone from my unit or an ally unit being seriously wounded or killed. | DRRI-2 - D: Witnessed Someone Unit Wounded | ||
DRRI1D04 | C141914 | DRRI1-D: Encountered Land Mines | Deployment Risk & Resilience Inventory-2 - During deployment: I encountered land or water mines, booby traps, or roadside bombs (for example, IEDs). | DRRI-2 - D: Encountered Land Mines | ||
DRRI1D05 | C141915 | DRRI1-D: Exposed Hostile Incoming Fire | Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to hostile incoming fire. | DRRI-2 - D: Exposed Hostile Incoming Fire | ||
DRRI1D06 | C141916 | DRRI1-D: Exposed to Friendly Fire | Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to "friendly" fire. | DRRI-2 - D: Exposed to Friendly Fire | ||
DRRI1D07 | C141917 | DRRI1-D: Vehicle/Part of Convoy Attacked | Deployment Risk & Resilience Inventory-2 - During deployment: I was in a vehicle (for example, a "humvee", helicopter, or boat) or part of a convoy that was attacked. | DRRI-2 - D: Vehicle/Part of Convoy Attacked | ||
DRRI1D08 | C141918 | DRRI1-D: Part of Unit Fired on Enemy | Deployment Risk & Resilience Inventory-2 - During deployment: I was part of a land or naval artillery unit that fired on enemy combatants. | DRRI-2 - D: Part of Unit Fired on Enemy | ||
DRRI1D09 | C141919 | DRRI1-D: Witnessed Enemy Wounded/Killed | Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed enemy combatants being seriously wounded or killed. | DRRI-2 - D: Witnessed Enemy Wounded/Killed | ||
DRRI1D10 | C141920 | DRRI1-D: Witnessed Civilians Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed civilians (for example, women and children) being seriously wounded or killed. | DRRI-2 - D: Witnessed Civilians Wounded | ||
DRRI1D11 | C141921 | DRRI1-D: Injured Combat-Related Incident | Deployment Risk & Resilience Inventory-2 - During deployment: I was injured in a combat-related incident. | DRRI-2 - D: Injured Combat-Related Incident | ||
DRRI1D12 | C141922 | DRRI1-D: Fired My Weapon Enemy Combatant | Deployment Risk & Resilience Inventory-2 - During deployment: I fired my weapon at enemy combatants. | DRRI-2 - D: Fired My Weapon Enemy Combatant | ||
DRRI1D13 | C141923 | DRRI1-D: Think I Wounded/Killed Someone | Deployment Risk & Resilience Inventory-2 - During deployment: I think I wounded or killed someone during combat operations. | DRRI-2 - D: Think I Wounded/Killed Someone | ||
DRRI1D14 | C141924 | DRRI1-D: Locating Explosive Devices | Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in locating or disarming explosive devices. | DRRI-2 - D: Locating Explosive Devices | ||
DRRI1D15 | C141925 | DRRI1-D: Searching Homes/Buildings | Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in searching or clearing homes, buildings, or other locations. | DRRI-2 - D: Searching Homes/Buildings | ||
DRRI1D16 | C141926 | DRRI1-D: Participate Hand-to-hand Combat | Deployment Risk & Resilience Inventory-2 - During deployment: I participated in hand-to-hand combat. | DRRI-2 - D: Participate Hand-to-hand Combat | ||
DRRI1D17 | C141927 | DRRI1-D: Search/Disarm Potential Enemy | Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in searching and/or disarming potential enemy combatants. | DRRI-2 - D: Search/Disarm Potential Enemy | ||
DRRI1E01 | C141928 | DRRI1-E: Saw People Begging for Food | Deployment Risk & Resilience Inventory-2 - During deployment: I saw people begging for food. | DRRI-2 - E: Saw People Begging for Food | ||
DRRI1E02 | C141929 | DRRI1-E: Saw Refugees Who Had Lost Homes | Deployment Risk & Resilience Inventory-2 - During deployment: I saw refugees who had lost their homes or belongings. | DRRI-2 - E: Saw Refugees Who Had Lost Homes | ||
DRRI1E03 | C141930 | DRRI1-E: Observed Homes Been Destroyed | Deployment Risk & Resilience Inventory-2 - During deployment: I observed homes or communities that had been destroyed. | DRRI-2 - E: Observed Homes Been Destroyed | ||
DRRI1E04 | C141931 | DRRI1-E: Took Care Injured/Dying People | Deployment Risk & Resilience Inventory-2 - During deployment: I took care of injured or dying people. | DRRI-2 - E: Took Care Injured/Dying People | ||
DRRI1E05 | C141932 | DRRI1-E: Saw Civilians After Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I saw civilians after they had been severely wounded or disfigured. | DRRI-2 - E: Saw Civilians After Wounded | ||
DRRI1E06 | C141933 | DRRI1-E: Saw Combatants Had Been Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I saw enemy combatants after they had been severely wounded or disfigured. | DRRI-2 - E: Saw Combatants Had Been Wounded | ||
DRRI1E07 | C141934 | DRRI1-E: Saw Americans Had Been Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I saw Americans or allies after they had been severely wounded or disfigured. | DRRI-2 - E: Saw Americans Had Been Wounded | ||
DRRI1E08 | C141935 | DRRI1-E: Saw Bodies of Dead Enemy | Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead enemy combatants. | DRRI-2 - E: Saw Bodies of Dead Enemy | ||
DRRI1E09 | C141936 | DRRI1-E: Saw Bodies of Dead Americans | Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead Americans or allies. | DRRI-2 - E: Saw Bodies of Dead Americans | ||
DRRI1E10 | C141937 | DRRI1-E: Saw Bodies of Dead Civilians | Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead civilians. | DRRI-2 - E: Saw Bodies of Dead Civilians | ||
DRRI1E11 | C141938 | DRRI1-E: Interacted With Detainees | Deployment Risk & Resilience Inventory-2 - During deployment: I interacted with detainees or prisoners of war. | DRRI-2 - E: Interacted With Detainees | ||
DRRI1E12 | C141939 | DRRI1-E: Sight/Sound/Smell Dead Animals | Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to the sight, sound, or smell of dead or dying animals. | DRRI-2 - E: Sight/Sound/Smell Dead Animals | ||
DRRI1E13 | C141940 | DRRI1-E: Involved Handling Human Remains | Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in handling human remains. | DRRI-2 - E: Involved Handling Human Remains | ||
DRRI1F01 | C141941 | DRRI1-F: Took Preventative Pills | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I took preventative pills (for example, to protect against nerve gas). | DRRI-2 - F: Took Preventative Pills | ||
DRRI1F02 | C141942 | DRRI1-F: Received Vaccinations | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I received preventative vaccinations by injection (for example, to prevent anthrax or botulism). | DRRI-2 - F: Received Vaccinations | ||
DRRI1F03 | C141943 | DRRI1-F: Exposed to Nerve Gas Agents | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to nerve gas agents (for example, sarin). | DRRI-2 - F: Exposed to Nerve Gas Agents | ||
DRRI1F04 | C141944 | DRRI1-F: Exposed to Mustard Gas | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to mustard gas or other blistering agents. | DRRI-2 - F: Exposed to Mustard Gas | ||
DRRI1F05 | C141945 | DRRI1-F: Exposed Government-issued DEET | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to government-issued DEET-containing insect repellents. | DRRI-2 - F: Exposed Government-issued DEET | ||
DRRI1F06 | C141946 | DRRI1-F: Exposed to Other Pesticides | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to other pesticides (for example, in flea collars, uniforms, or the environment). | DRRI-2 - F: Exposed to Other Pesticides | ||
DRRI1F07 | C141947 | DRRI1-F: Exposed to Smoke/Air Pollution | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to smoke or other air pollution. | DRRI-2 - F: Exposed to Smoke/Air Pollution | ||
DRRI1F08 | C141948 | DRRI1-F: Exposed to Diesel/Fuel on Skin | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to diesel or other petrochemical fuel on my skin. | DRRI-2 - F: Exposed to Diesel/Fuel on Skin | ||
DRRI1F09 | C141949 | DRRI1-F: Exposed to Fumes From Heaters | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to fumes or exhaust from heaters or generators, including heaters in tents. | DRRI-2 - F: Exposed to Fumes From Heaters | ||
DRRI1F10 | C141950 | DRRI1-F: Exposed to Depleted Uranium | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to depleted uranium in munitions. | DRRI-2 - F: Exposed to Depleted Uranium | ||
DRRI1F11 | C141951 | DRRI1-F: Exposed to Burning Trash/Feces | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to burning trash or burning feces. | DRRI-2 - F: Exposed to Burning Trash/Feces | ||
DRRI1F12 | C141952 | DRRI1-F: Exposed to Chlorine Gas | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to chlorine gas. | DRRI-2 - F: Exposed to Chlorine Gas | ||
DRRI1F13 | C141953 | DRRI1-F: Exposed to Nuclear Weapons | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to nuclear, biological, or chemical weapons. | DRRI-2 - F: Exposed to Nuclear Weapons | ||
DRRI1G01 | C141954 | DRRI1-G: Concerned Infectious Disease | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned about getting an infectious disease. | DRRI-2 - G: Concerned Infectious Disease | ||
DRRI1G02 | C141955 | DRRI1-G: Health Might Suffer NBC Agents | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that my health might suffer due to exposure to nuclear, biological, or chemical (NBC) agents. | DRRI-2 - G: Health Might Suffer NBC Agents | ||
DRRI1G03 | C141956 | DRRI1-G: Felt in Danger of Being Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I felt I was in great danger of being wounded (for example, losing a limb). | DRRI-2 - G: Felt in Danger of Being Wounded | ||
DRRI1G04 | C141957 | DRRI1-G: Concerned Medicine Make Me Sick | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that the medicine I was given to protect me from illness would make me sick. | DRRI-2 - G: Concerned Medicine Make Me Sick | ||
DRRI1G05 | C141958 | DRRI1-G: Concerned Encounter Explosive | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I would encounter an explosive device (for example, a roadside bomb, mine, or booby trap). | DRRI-2 - G: Concerned Encounter Explosive | ||
DRRI1G06 | C141959 | DRRI1-G: Feared Sick From Pesticides | Deployment Risk & Resilience Inventory-2 - During deployment: I feared that I would become sick from pesticides (for example, bug spray) or other routinely used chemicals. | DRRI-2 - G: Feared Sick From Pesticides | ||
DRRI1G07 | C141960 | DRRI1-G: Concern Rocket/Mortar Would Hit | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that a rocket or mortar would hit our living quarters. | DRRI-2 - G: Concern Rocket/Mortar Would Hit | ||
DRRI1G08 | C141961 | DRRI1-G: Concerned Depleted Uranium | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I might be exposed to depleted uranium in munitions. | DRRI-2 - G: Concerned Depleted Uranium | ||
DRRI1G09 | C141962 | DRRI1-G: Thought I Would Never Survive | Deployment Risk & Resilience Inventory-2 - During deployment: I thought I would never survive. | DRRI-2 - G: Thought I Would Never Survive | ||
DRRI1G10 | C141963 | DRRI1-G: Concerned Taken Hostage | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I might be taken hostage. | DRRI-2 - G: Concerned Taken Hostage | ||
DRRI1G11 | C141964 | DRRI1-G: Concerned Locals Against Us | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that the locals who were supposed to be helping us were actually working against us. | DRRI-2 - G: Concerned Locals Against Us | ||
DRRI1G12 | C141965 | DRRI1-G: Concerned Trapped in Crossfire | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned about being trapped in the crossfire of rival factions. | DRRI-2 - G: Concerned Trapped in Crossfire | ||
DRRI1H01 | C141966 | DRRI1-H: Had All Supplies Needed | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I had all the supplies and equipment needed to get my job done. | DRRI-2 - H: Had All Supplies Needed | ||
DRRI1H02 | C141967 | DRRI1-H: Confident Ability Use Equipment | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received made me feel confident in my ability to use my equipment. | DRRI-2 - H: Confident Ability Use Equipment | ||
DRRI1H03 | C141968 | DRRI1-H: Prepared to Deal With Climate | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received prepared me to deal with the region's climate. | DRRI-2 - H: Prepared to Deal With Climate | ||
DRRI1H04 | C141969 | DRRI1-H: Accurately Informed About Role | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I was accurately informed about the role my unit was expected to play in the deployment. | DRRI-2 - H: Accurately Informed About Role | ||
DRRI1H05 | C141970 | DRRI1-H: Had Enough Gear in Case Attack | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I had enough gear to protect myself in case of an attack. | DRRI-2 - H: Had Enough Gear in Case Attack | ||
DRRI1H06 | C141971 | DRRI1-H: Training for Deployment | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I received appropriate training for the nature of the deployment I experienced. | DRRI-2 - H: Training for Deployment | ||
DRRI1H07 | C141972 | DRRI1-H: Military Duties What I Expected | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: my military duties and assignments were what I expected. | DRRI-2 - H: Military Duties What I Expected | ||
DRRI1H08 | C141973 | DRRI1-H: Prepared to Operate as Team | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: my unit was well-prepared to operate as a team during deployment. | DRRI-2 - H: Prepared to Operate as Team | ||
DRRI1H09 | C141974 | DRRI1-H: Confident to Perform Tasks | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received made me feel confident in my ability to perform tasks assigned to me during deployment. | DRRI-2 - H: Confident to Perform Tasks | ||
DRRI1H10 | C141975 | DRRI1-H: Taught Me Everything I Needed | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received taught me everything I needed to know for deployment. | DRRI-2 - H: Taught Me Everything I Needed | ||
DRRI1I01 | C141976 | DRRI1-I: Family Sincerely Interested | Deployment Risk & Resilience Inventory-2 - During deployment: family members and/or friends at home were sincerely interested in hearing what was going on with me. | DRRI-2 - I: Family Sincerely Interested | ||
DRRI1I02 | C141977 | DRRI1-I: Had Family I Could Talk To | Deployment Risk & Resilience Inventory-2 - During deployment: I had family members or friends at home I could talk to when I had a problem. | DRRI-2 - I: Had Family I Could Talk To | ||
DRRI1I03 | C141978 | DRRI1-I: Could Count on Family Advice | Deployment Risk & Resilience Inventory-2 - During deployment: I could count on my family members or friends at home for good advice. | DRRI-2 - I: Could Count on Family Advice | ||
DRRI1I04 | C141979 | DRRI1-I: Relatives Look Out for Family | Deployment Risk & Resilience Inventory-2 - During deployment: relatives or friends at home could be counted on to look out for the well-being of my family or other dependents (including pets). | DRRI-2 - I: Relatives Look Out for Family | ||
DRRI1I05 | C141980 | DRRI1-I: Relatives Take Care of Finances | Deployment Risk & Resilience Inventory-2 - During deployment: relatives or friends at home could be counted on to take care of my finances, property, or belongings if needed. | DRRI-2 - I: Relatives Take Care of Finances | ||
DRRI1I06 | C141981 | DRRI1-I: Happy Communication From Home | Deployment Risk & Resilience Inventory-2 - During deployment: I was happy with the amount of communication I received from people at home. | DRRI-2 - I: Happy Communication From Home | ||
DRRI1I07 | C141982 | DRRI1-I: Happy With Support From Home | Deployment Risk & Resilience Inventory-2 - During deployment: I was happy with the amount of support I received from people at home. | DRRI-2 - I: Happy With Support From Home | ||
DRRI1I08 | C141983 | DRRI1-I: People at Home Show They Cared | Deployment Risk & Resilience Inventory-2 - During deployment: people at home did things to show they cared about me. | DRRI-2 - I: People at Home Show They Cared | ||
DRRI1J01 | C141984 | DRRI1-J: My Unit Was Like Family to Me | Deployment Risk & Resilience Inventory-2 - During deployment: my unit was like family to me. | DRRI-2 - J: My Unit Was Like Family to Me | ||
DRRI1J02 | C141985 | DRRI1-J: People in Unit Were Trustworthy | Deployment Risk & Resilience Inventory-2 - During deployment: people in my unit were trustworthy. | DRRI-2 - J: People in Unit Were Trustworthy | ||
DRRI1J03 | C141986 | DRRI1-J: Fellow Unit Appreciated Efforts | Deployment Risk & Resilience Inventory-2 - During deployment: my fellow unit members appreciated my efforts. | DRRI-2 - J: Fellow Unit Appreciated Efforts | ||
DRRI1J04 | C141987 | DRRI1-J: Felt Valued Fellow Unit Members | Deployment Risk & Resilience Inventory-2 - During deployment: I felt valued by my fellow unit members. | DRRI-2 - J: Felt Valued Fellow Unit Members | ||
DRRI1J05 | C141988 | DRRI1-J: Unit Interested My Well-being | Deployment Risk & Resilience Inventory-2 - During deployment: members of my unit were interested in my well-being. | DRRI-2 - J: Unit Interested My Well-being | ||
DRRI1J06 | C141989 | DRRI1-J: Unit Interested What I Thought | Deployment Risk & Resilience Inventory-2 - During deployment: my fellow unit members were interested in what I thought and how I felt about things. | DRRI-2 - J: Unit Interested What I Thought | ||
DRRI1J07 | C141990 | DRRI1-J: Leader Interested What Thought | Deployment Risk & Resilience Inventory-2 - During deployment: my unit leader(s) were interested in what I thought and how I felt about things. | DRRI-2 - J: Leader Interested What Thought | ||
DRRI1J08 | C141991 | DRRI1-J: Felt Like My Efforts Counted | Deployment Risk & Resilience Inventory-2 - During deployment: I felt like my efforts really counted to the leaders in my unit. | DRRI-2 - J: Felt Like My Efforts Counted | ||
DRRI1J09 | C141992 | DRRI1-J: Service Appreciated by Leaders | Deployment Risk & Resilience Inventory-2 - During deployment: my service was appreciated by the leaders in my unit. | DRRI-2 - J: Service Appreciated by Leaders | ||
DRRI1J10 | C141993 | DRRI1-J: Could Go to Leaders If Problem | Deployment Risk & Resilience Inventory-2 - During deployment: I could go to unit leaders for help if I had a problem or concern. | DRRI-2 - J: Could Go to Leaders If Problem | ||
DRRI1J11 | C141994 | DRRI1-J: Leaders Interested in Welfare | Deployment Risk & Resilience Inventory-2 - During deployment: the leaders of my unit were interested in my personal welfare. | DRRI-2 - J: Leaders Interested in Welfare | ||
DRRI1J12 | C141995 | DRRI1-J: Felt Valued by Leaders of Unit | Deployment Risk & Resilience Inventory-2 - During deployment: I felt valued by the leaders of my unit. | DRRI-2 - J: Felt Valued by Leaders of Unit | ||
DRRI1K01 | C141996 | DRRI1-K: Treated in Overly Critical Way | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: treated me in an overly critical way. | DRRI-2 - K: Treated in Overly Critical Way | ||
DRRI1K02 | C141997 | DRRI1-K: Uncooperative Working With Me | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: behaved in way that was uncooperative when working with me. | DRRI-2 - K: Uncooperative Working With Me | ||
DRRI1K03 | C141998 | DRRI1-K: Had to Work Harder Prove Myself | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: treated me as if I had to work harder than others to prove myself. | DRRI-2 - K: Had to Work Harder Prove Myself | ||
DRRI1K04 | C141999 | DRRI1-K: Questioned My Abilities Perform | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: questioned my abilities or commitment to perform my job effectively. | DRRI-2 - K: Questioned My Abilities Perform | ||
DRRI1K05 | C142000 | DRRI1-K: My Mistakes Worse Than Others | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: acted as though my mistakes were worse than others'. | DRRI-2 - K: My Mistakes Worse Than Others | ||
DRRI1K06 | C142001 | DRRI1-K: Make My Job More Difficult | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: tried to make my job more difficult to do. | DRRI-2 - K: Make My Job More Difficult | ||
DRRI1K07 | C142002 | DRRI1-K: Put Me Down | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: "put me down" or treated me in a condescending way. | DRRI-2 - K: Put Me Down | ||
DRRI1K08 | C142003 | DRRI1-K: Threatened My Physical Safety | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: threatened my physical safety. | DRRI-2 - K: Threatened My Physical Safety | ||
DRRI1K09 | C142004 | DRRI1-K: Made Crude Sexual Remarks at Me | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: made crude and offensive sexual remarks directed at me, either publicly or privately. | DRRI-2 - K: Made Crude Sexual Remarks at Me | ||
DRRI1K10 | C142005 | DRRI1-K: Spread Rumors Sexual Activities | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: spread negative rumors about my sexual activities. | DRRI-2 - K: Spread Rumors Sexual Activities | ||
DRRI1K11 | C142006 | DRRI1-K: Tried to Talk into Sexual Acts | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: tried to talk me into participating in sexual acts when I didn't want to. | DRRI-2 - K: Tried to Talk into Sexual Acts | ||
DRRI1K12 | C142007 | DRRI1-K: Authority Pressure Unwanted Sex | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: used a position of authority to pressure me into unwanted sexual activity. | DRRI-2 - K: Authority Pressure Unwanted Sex | ||
DRRI1K13 | C142008 | DRRI1-K: Offered Reward Take Part in Sex | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: offered me a specific reward or special treatment to take part in sexual behavior. | DRRI-2 - K: Offered Reward Take Part in Sex | ||
DRRI1K14 | C142009 | DRRI1-K: Threatened Me If Not Sex | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: threatened me with some sort of retaliation if I was not sexually cooperative (for example, the threat of negative review or physical violence). | DRRI-2 - K: Threatened Me If Not Sex | ||
DRRI1K15 | C142010 | DRRI1-K: Touched Sexual Way Against Will | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: touched me in a sexual way against my will. | DRRI-2 - K: Touched Sexual Way Against Will | ||
DRRI1K16 | C142011 | DRRI1-K: Physically Forced to Have Sex | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: physically forced me to have sex. | DRRI-2 - K: Physically Forced to Have Sex | ||
DRRI1L01 | C142012 | DRRI1-L: Effect Deployment Relationship | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the effect of the deployment on my relationship with my spouse or significant other. | DRRI-2 - L: Effect Deployment Relationship | ||
DRRI1L02 | C142013 | DRRI1-L: Missing Out on Children Growth | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: missing out on my children's growth and development. | DRRI-2 - L: Missing Out on Children Growth | ||
DRRI1L03 | C142014 | DRRI1-L: Missing Family Events at Home | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: missing important family events at home such as birthdays, weddings, funerals, graduations, etc. | DRRI-2 - L: Missing Family Events at Home | ||
DRRI1L04 | C142015 | DRRI1-L: Safety and Well-being of Spouse | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the safety and well-being of my spouse or significant other. | DRRI-2 - L: Safety and Well-being of Spouse | ||
DRRI1L05 | C142016 | DRRI1-L: Safety and Well-being of Child | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the safety and well-being of my child(ren). | DRRI-2 - L: Safety and Well-being of Child | ||
DRRI1L06 | C142017 | DRRI1-L: Unable to Help Family If Crisis | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: being unable to help my family if there was some kind of crisis or emergency. | DRRI-2 - L: Unable to Help Family If Crisis | ||
DRRI1L07 | C142018 | DRRI1-L: Inability Manage Family Affairs | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my inability to directly manage or control family affairs. | DRRI-2 - L: Inability Manage Family Affairs | ||
DRRI1L08 | C142019 | DRRI1-L: Damaging Career Because Deploy | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: damaging my career because of the deployment. | DRRI-2 - L: Damaging Career Because Deploy | ||
DRRI1L09 | C142020 | DRRI1-L: Care Child/Dependents Receiving | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the care that my child(ren) or other dependents were receiving. | DRRI-2 - L: Care Child/Dependents Receiving | ||
DRRI1L10 | C142021 | DRRI1-L: Being Cheated on by My Spouse | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: being cheated on by my spouse or significant other. | DRRI-2 - L: Being Cheated on by My Spouse | ||
DRRI1L11 | C142022 | DRRI1-L: Family Ability Cope With Stress | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my family's ability to cope with the stress of the deployment. | DRRI-2 - L: Family Ability Cope With Stress | ||
DRRI1L12 | C142023 | DRRI1-L: Spouse Ability Manage Household | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my spouse or significant other's ability to manage the household (for example, chores, bills, home repairs, etc.). | DRRI-2 - L: Spouse Ability Manage Household | ||
DRRI1L13 | C142024 | DRRI1-L: Losing My Civilian Job | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: losing my civilian job because of the deployment. | DRRI-2 - L: Losing My Civilian Job | ||
DRRI1L14 | C142025 | DRRI1-L: Effect Relationship My Children | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the effect of the deployment on my relationship with my child(ren). | DRRI-2 - L: Effect Relationship My Children | ||
DRRI1L15 | C142026 | DRRI1-L: My Family Financial Situation | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my family's financial situation. | DRRI-2 - L: My Family Financial Situation | ||
DRRI1M01 | C142027 | DRRI1-M: Problems Get in Touch Family | Deployment Risk & Resilience Inventory-2 - During deployment: I had problems getting in touch with a family member or other loved one. | DRRI-2 - M: Problems Get in Touch Family | ||
DRRI1M02 | C142028 | DRRI1-M: Someone Close Serious Illness | Deployment Risk & Resilience Inventory-2 - During deployment: someone close to me experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). | DRRI-2 - M: Someone Close Serious Illness | ||
DRRI1M03 | C142029 | DRRI1-M: Family Member Passed Away | Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one passed away. | DRRI-2 - M: Family Member Passed Away | ||
DRRI1M04 | C142030 | DRRI1-M: My Family Had Money Problems | Deployment Risk & Resilience Inventory-2 - During deployment: my family had money problems. | DRRI-2 - M: My Family Had Money Problems | ||
DRRI1M05 | C142031 | DRRI1-M: Spouse Cheated on Me | Deployment Risk & Resilience Inventory-2 - During deployment: a spouse or significant other cheated on me. | DRRI-2 - M: Spouse Cheated on Me | ||
DRRI1M06 | C142032 | DRRI1-M: Spouse Suspected I Cheated | Deployment Risk & Resilience Inventory-2 - During deployment: a spouse or significant other suspected that I had cheated on him/her. | DRRI-2 - M: Spouse Suspected I Cheated | ||
DRRI1M07 | C142033 | DRRI1-M: Relationship With Spouse Ended | Deployment Risk & Resilience Inventory-2 - During deployment: my relationship with a spouse or significant other ended. | DRRI-2 - M: Relationship With Spouse Ended | ||
DRRI1M08 | C142034 | DRRI1-M: Had Major Conflict With Family | Deployment Risk & Resilience Inventory-2 - During deployment: I had a major conflict with a family member or other loved one. | DRRI-2 - M: Had Major Conflict With Family | ||
DRRI1M09 | C142035 | DRRI1-M: Family Had Difficulty Adjusting | Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one had serious difficulty adjusting to my absence. | DRRI-2 - M: Family Had Difficulty Adjusting | ||
DRRI1M10 | C142036 | DRRI1-M: My Home Was Robbed | Deployment Risk & Resilience Inventory-2 - During deployment: my home was robbed and/or my belongings were stolen. | DRRI-2 - M: My Home Was Robbed | ||
DRRI1M11 | C142037 | DRRI1-M: Family Member Wasted Money | Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other person I trusted wasted or mismanaged my money. | DRRI-2 - M: Family Member Wasted Money | ||
DRRI1M12 | C142038 | DRRI1-M: Loved One Things I Disapproved | Deployment Risk & Resilience Inventory-2 - During deployment: I learned that a loved one was doing things I disapproved of. | DRRI-2 - M: Loved One Things I Disapproved | ||
DRRI1M13 | C142039 | DRRI1-M: Fam Dangerous Military Duties | Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one participated in dangerous military duties. | DRRI-2 - M: Fam Dangerous Military Duties | ||
DRRI1M14 | C142040 | DRRI1-M: Family Got Into Trouble | Deployment Risk & Resilience Inventory-2 - During deployment: a family member got into trouble at home, at school, or in the community. | DRRI-2 - M: Family Got Into Trouble | ||
DRRI1N01 | C142041 | DRRI1-N: Robbed/Had My Home Broken Into | Deployment Risk & Resilience Inventory-2 - Since returning: I was robbed or had my home broken into. | DRRI-2 - N: Robbed/Had My Home Broken Into | ||
DRRI1N02 | C142042 | DRRI1-N: Unwanted Sexual Activity | Deployment Risk & Resilience Inventory-2 - Since returning: I experienced unwanted sexual activity as a result of force, threat or harm, or manipulation. | DRRI-2 - N: Unwanted Sexual Activity | ||
DRRI1N03 | C142043 | DRRI1-N: Went Through Divorce/Was Left | Deployment Risk & Resilience Inventory-2 - Since returning: I went through a divorce or have been left by a partner or significant other. | DRRI-2 - N: Went Through Divorce/Was Left | ||
DRRI1N04 | C142044 | DRRI1-N: Problems Getting Healthcare | Deployment Risk & Resilience Inventory-2 - Since returning: I had problems getting access to adequate healthcare. | DRRI-2 - N: Problems Getting Healthcare | ||
DRRI1N05 | C142045 | DRRI1-N: Experienced Natural Disaster | Deployment Risk & Resilience Inventory-2 - Since returning: I experienced a natural disaster (for example, a hurricane), a fire, or an accident in which I or someone close to me was hurt or had serious property damage. | DRRI-2 - N: Experienced Natural Disaster | ||
DRRI1N06 | C142046 | DRRI1-N: Someone Close Serious Illness | Deployment Risk & Resilience Inventory-2 - Since returning: someone close to me has experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). | DRRI-2 - N: Someone Close Serious Illness | ||
DRRI1N07 | C142047 | DRRI1-N: Witnessed Someone Assaulted | Deployment Risk & Resilience Inventory-2 - Since returning: I have witnessed someone being seriously assaulted or killed. | DRRI-2 - N: Witnessed Someone Assaulted | ||
DRRI1N08 | C142048 | DRRI1-N: Lost My Job/Trouble Finding Job | Deployment Risk & Resilience Inventory-2 - Since returning: I lost my job or had serious trouble finding a job. | DRRI-2 - N: Lost My Job/Trouble Finding Job | ||
DRRI1N09 | C142049 | DRRI1-N: Emotionally Mistreated | Deployment Risk & Resilience Inventory-2 - Since returning: I have been emotionally mistreated (for example, ignored or repeatedly told I was no good). | DRRI-2 - N: Emotionally Mistreated | ||
DRRI1N10 | C142050 | DRRI1-N: Serious Financial Problems | Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced serious financial problems. | DRRI-2 - N: Serious Financial Problems | ||
DRRI1N11 | C142051 | DRRI1-N: Serious Physical Health Problem | Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced serious physical or mental health problems. | DRRI-2 - N: Serious Physical Health Problem | ||
DRRI1N12 | C142052 | DRRI1-N: Stressful Legal Problems | Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced stressful legal problems (for example, being sued, suing someone else, or being in a custody battle). | DRRI-2 - N: Stressful Legal Problems | ||
DRRI1N13 | C142053 | DRRI1-N: Injured by Another Person | Deployment Risk & Resilience Inventory-2 - Since returning: I have been seriously physically injured by another person (for example, hit or beaten up). | DRRI-2 - N: Injured by Another Person | ||
DRRI1N14 | C142054 | DRRI1-N: Someone Close to Me Has Died | Deployment Risk & Resilience Inventory-2 - Since returning: someone close to me has died. | DRRI-2 - N: Someone Close to Me Has Died | ||
DRRI1O01 | C142055 | DRRI1-O: People Made Me Feel at Home | Deployment Risk & Resilience Inventory-2 - Since returning: the American people made me feel at home. | DRRI-2 - O: People Made Me Feel at Home | ||
DRRI1O02 | C142056 | DRRI1-O: People Made Me Feel Proud | Deployment Risk & Resilience Inventory-2 - Since returning: people made me feel proud to have served my country in the Armed Forces. | DRRI-2 - O: People Made Me Feel Proud | ||
DRRI1O03 | C142057 | DRRI1-O: Family Make Me Better When Down | Deployment Risk & Resilience Inventory-2 - Since returning: my family members and/or friends make me feel better when I am down. | DRRI-2 - O: Family Make Me Better When Down | ||
DRRI1O04 | C142058 | DRRI1-O: Go to Family When Need Advice | Deployment Risk & Resilience Inventory-2 - Since returning: I can go to family members or friends when I need good advice. | DRRI-2 - O: Go to Family When Need Advice | ||
DRRI1O05 | C142059 | DRRI1-O: Family/Friends Understand | Deployment Risk & Resilience Inventory-2 - Since returning: my family and friends understand what I have been through in the Armed Forces. | DRRI-2 - O: Family/Friends Understand | ||
DRRI1O06 | C142060 | DRRI1-O: I Can Talk About My Deployment | Deployment Risk & Resilience Inventory-2 - Since returning: there are family and/or friends with whom I can talk about my deployment experiences. | DRRI-2 - O: I Can Talk About My Deployment | ||
DRRI1O07 | C142061 | DRRI1-O: Family Would Lend Money | Deployment Risk & Resilience Inventory-2 - Since returning: my family members or friends would lend me money if I needed it. | DRRI-2 - O: Family Would Lend Money | ||
DRRI1O08 | C142062 | DRRI1-O: Family Would Help Move | Deployment Risk & Resilience Inventory-2 - Since returning: my family members or friends would help me move my belongings if I needed help. | DRRI-2 - O: Family Would Help Move | ||
DRRI1O09 | C142063 | DRRI1-O: Someone Would Help With Tasks | Deployment Risk & Resilience Inventory-2 - Since returning: if I were unable to attend to daily chores, there is someone who would help me with these tasks. | DRRI-2 - O: Someone Would Help With Tasks | ||
DRRI1O10 | C142064 | DRRI1-O: When Ill Family Will Help Out | Deployment Risk & Resilience Inventory-2 - Since returning: when I am ill, family members or friends will help out until I am well. | DRRI-2 - O: When Ill Family Will Help Out | ||
DRRI1P01 | C142065 | DRRI1-P: Input Sought Family Decisions | Deployment Risk & Resilience Inventory-2 - Since returning: my input is sought on important family decisions. | DRRI-2 - P: Input Sought Family Decisions | ||
DRRI1P02 | C142066 | DRRI1-P: Feel Like I Fit in With Family | Deployment Risk & Resilience Inventory-2 - Since returning: I feel like I fit in with my family. | DRRI-2 - P: Feel Like I Fit in With Family | ||
DRRI1P03 | C142067 | DRRI1-P: Family Know What I Think/Feel | Deployment Risk & Resilience Inventory-2 - Since returning: family members know what I think and how I feel about things. | DRRI-2 - P: Family Know What I Think/Feel | ||
DRRI1P04 | C142068 | DRRI1-P: Contribution Family Appreciated | Deployment Risk & Resilience Inventory-2 - Since returning: I feel like my contributions to my family are appreciated. | DRRI-2 - P: Contribution Family Appreciated | ||
DRRI1P05 | C142069 | DRRI1-P: Share Interests With Family | Deployment Risk & Resilience Inventory-2 - Since returning: I share many common interests and activities with family members. | DRRI-2 - P: Share Interests With Family | ||
DRRI1P06 | C142070 | DRRI1-P: Opinions Valued by Family | Deployment Risk & Resilience Inventory-2 - Since returning: my opinions are valued by other family members. | DRRI-2 - P: Opinions Valued by Family | ||
DRRI1P07 | C142071 | DRRI1-P: I am Affectionate With Family | Deployment Risk & Resilience Inventory-2 - Since returning: I am affectionate with family members. | DRRI-2 - P: I am Affectionate With Family | ||
DRRI1P08 | C142072 | DRRI1-P: Play Important Role in Family | Deployment Risk & Resilience Inventory-2 - Since returning: I play an important role in my family. | DRRI-2 - P: Play Important Role in Family | ||
DRRI1P09 | C142073 | DRRI1-P: Spend My Free Time With Family | Deployment Risk & Resilience Inventory-2 - Since returning: I spend as much of my free time with family members as possible. | DRRI-2 - P: Spend My Free Time With Family | ||
DRRI1P10 | C142074 | DRRI1-P: Family Tell Me When Problem | Deployment Risk & Resilience Inventory-2 - Since returning: family members tell me when they are having a problem. | DRRI-2 - P: Family Tell Me When Problem | ||
DRRI1P11 | C142075 | DRRI1-P: Can Be Myself Around Family | Deployment Risk & Resilience Inventory-2 - Since returning: I can be myself around family members. | DRRI-2 - P: Can Be Myself Around Family | ||
DRRI1P12 | C142076 | DRRI1-P: I Get Along Well With My Family | Deployment Risk & Resilience Inventory-2 - Since returning: I get along well with my family members. | DRRI-2 - P: I Get Along Well With My Family | ||
Back to top | ||||||
CL.C141672.DRRI1TN | Deployment Risk and Resilience Inventory-2 Questionnaire Test Name
(DRRI1TN) | text
Extensible: No | C141672 | Deployment Risk and Resilience Inventory-2 Questionnaire Test Name | Deployment Risk and Resilience Inventory-2 test name. | CDISC Questionnaire DRRI-2 Test Name Terminology |
DRRI1-A: Dangerous Military Duties | C141881 | DRRI1-A: Dangerous Military Duties | Deployment Risk & Resilience Inventory-2 - Before deployment: I participated in dangerous military duties. | DRRI-2 - A: Dangerous Military Duties | ||
DRRI1-A: Emotionally Mistreated | C141878 | DRRI1-A: Emotionally Mistreated | Deployment Risk & Resilience Inventory-2 - Before deployment: I was emotionally mistreated (for example, ignored or repeatedly told I was no good). | DRRI-2 - A: Emotionally Mistreated | ||
DRRI1-A: Experienced Natural Disaster | C141874 | DRRI1-A: Experienced Natural Disaster | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced a natural disaster (for example, a hurricane), a fire, or an accident in which I or someone close to me was hurt or had serious property damage. | DRRI-2 - A: Experienced Natural Disaster | ||
DRRI1-A: Injured by Person - Adulthood | C141883 | DRRI1-A: Injured by Person - Adulthood | Deployment Risk & Resilience Inventory-2 - Before deployment: I was seriously physically injured by another person (for example, hit or beaten up) during adulthood (age 18 or later). | DRRI-2 - A: Injured by Person - Adulthood | ||
DRRI1-A: Injured by Person - Childhood | C141882 | DRRI1-A: Injured by Person - Childhood | Deployment Risk & Resilience Inventory-2 - Before deployment: I was seriously physically injured by another person (for example, hit or beaten up) during childhood (before age 18). | DRRI-2 - A: Injured by Person - Childhood | ||
DRRI1-A: Lost My Job/Trouble Finding Job | C141877 | DRRI1-A: Lost My Job/Trouble Finding Job | Deployment Risk & Resilience Inventory-2 - Before deployment: I lost my job or had serious trouble finding a job. | DRRI-2 - A: Lost My Job/Trouble Finding Job | ||
DRRI1-A: Physically Punished by Parent | C141871 | DRRI1-A: Physically Punished by Parent | Deployment Risk & Resilience Inventory-2 - Before deployment: I was physically punished by a parent or primary caregiver. | DRRI-2 - A: Physically Punished by Parent | ||
DRRI1-A: Robbed/Had My Home Broken Into | C141869 | DRRI1-A: Robbed/Had My Home Broken Into | Deployment Risk & Resilience Inventory-2 - Before deployment: I was robbed or had my home broken into. | DRRI-2 - A: Robbed/Had My Home Broken Into | ||
DRRI1-A: Saw/Heard Physical Fight Parent | C141870 | DRRI1-A: Saw/Heard Physical Fight Parent | Deployment Risk & Resilience Inventory-2 - Before deployment: I saw or heard physical fighting between my parents or caregivers. | DRRI-2 - A: Saw/Heard Physical Fight Parent | ||
DRRI1-A: Serious Financial Problems | C141879 | DRRI1-A: Serious Financial Problems | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced serious financial problems. | DRRI-2 - A: Serious Financial Problems | ||
DRRI1-A: Serious Physical Health Problem | C141880 | DRRI1-A: Serious Physical Health Problem | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced serious physical or mental health problems. | DRRI-2 - A: Serious Physical Health Problem | ||
DRRI1-A: Someone Close Serious Illness | C141875 | DRRI1-A: Someone Close Serious Illness | Deployment Risk & Resilience Inventory-2 - Before deployment: someone close to me experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). | DRRI-2 - A: Someone Close Serious Illness | ||
DRRI1-A: Someone Close to Me Died | C141867 | DRRI1-A: Someone Close to Me Died | Deployment Risk & Resilience Inventory-2 - Before deployment: someone close to me died. | DRRI-2 - A: Someone Close to Me Died | ||
DRRI1-A: Stressful Legal Problems | C141884 | DRRI1-A: Stressful Legal Problems | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced stressful legal problems (for example, being sued, suing someone else, or being in a custody battle). | DRRI-2 - A: Stressful Legal Problems | ||
DRRI1-A: Unwanted Sex Activity Adulthood | C141873 | DRRI1-A: Unwanted Sex Activity Adulthood | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced unwanted sexual activity as a result of force, threat of harm, or manipulation during adulthood (age 18 or later). | DRRI-2 - A: Unwanted Sex Activity Adulthood | ||
DRRI1-A: Unwanted Sex Activity Childhood | C141872 | DRRI1-A: Unwanted Sex Activity Childhood | Deployment Risk & Resilience Inventory-2 - Before deployment: I experienced unwanted sexual activity as a result of force, threat of harm, or manipulation during childhood (before age 18). | DRRI-2 - A: Unwanted Sex Activity Childhood | ||
DRRI1-A: Went Through Divorce/Was Left | C141868 | DRRI1-A: Went Through Divorce/Was Left | Deployment Risk & Resilience Inventory-2 - Before deployment: I went through a divorce or was left by a significant other. | DRRI-2 - A: Went Through Divorce/Was Left | ||
DRRI1-A: Witnessed Someone Assaulted | C141876 | DRRI1-A: Witnessed Someone Assaulted | Deployment Risk & Resilience Inventory-2 - Before deployment: I witnessed someone being seriously assaulted or killed. | DRRI-2 - A: Witnessed Someone Assaulted | ||
DRRI1-B: Contribution Family Appreciated | C141888 | DRRI1-B: Contribution Family Appreciated | Deployment Risk & Resilience Inventory-2 - During childhood: I felt like my contributions to my family were appreciated. | DRRI-2 - B: Contribution Family Appreciated | ||
DRRI1-B: Family Knew What I Thought/Felt | C141887 | DRRI1-B: Family Knew What I Thought/Felt | Deployment Risk & Resilience Inventory-2 - During childhood: family members knew what I thought and how I felt about things. | DRRI-2 - B: Family Knew What I Thought/Felt | ||
DRRI1-B: Family Told Me When Problem | C141894 | DRRI1-B: Family Told Me When Problem | Deployment Risk & Resilience Inventory-2 - During childhood: family members told me when they were having a problem. | DRRI-2 - B: Family Told Me When Problem | ||
DRRI1-B: Felt Like I Fit in With Family | C141886 | DRRI1-B: Felt Like I Fit in With Family | Deployment Risk & Resilience Inventory-2 - During childhood: I felt like I fit in with my family. | DRRI-2 - B: Felt Like I Fit in With Family | ||
DRRI1-B: Got Along Well With My Family | C141885 | DRRI1-B: Got Along Well With My Family | Deployment Risk & Resilience Inventory-2 - During childhood: I got along well with my family members. | DRRI-2 - B: Got Along Well With My Family | ||
DRRI1-B: I Could Be Myself Around Family | C141895 | DRRI1-B: I Could Be Myself Around Family | Deployment Risk & Resilience Inventory-2 - During childhood: I could be myself around family members. | DRRI-2 - B: I Could Be Myself Around Family | ||
DRRI1-B: I Was Affectionate With Family | C141891 | DRRI1-B: I Was Affectionate With Family | Deployment Risk & Resilience Inventory-2 - During childhood: I was affectionate with family members. | DRRI-2 - B: I Was Affectionate With Family | ||
DRRI1-B: Input Sought Family Decisions | C141896 | DRRI1-B: Input Sought Family Decisions | Deployment Risk & Resilience Inventory-2 - During childhood: my input was sought on important family decisions. | DRRI-2 - B: Input Sought Family Decisions | ||
DRRI1-B: Opinions Were Valued by Family | C141890 | DRRI1-B: Opinions Were Valued by Family | Deployment Risk & Resilience Inventory-2 - During childhood: my opinions were valued by other family members. | DRRI-2 - B: Opinions Were Valued by Family | ||
DRRI1-B: Played Important Role in Family | C141892 | DRRI1-B: Played Important Role in Family | Deployment Risk & Resilience Inventory-2 - During childhood: I played an important role in my family. | DRRI-2 - B: Played Important Role in Family | ||
DRRI1-B: Shared Interests With Family | C141889 | DRRI1-B: Shared Interests With Family | Deployment Risk & Resilience Inventory-2 - During childhood: I shared many common interests and activities with family members. | DRRI-2 - B: Shared Interests With Family | ||
DRRI1-B: Spent My Free Time With Family | C141893 | DRRI1-B: Spent My Free Time With Family | Deployment Risk & Resilience Inventory-2 - During childhood: I spent as much of my free time with family members as possible. | DRRI-2 - B: Spent My Free Time With Family | ||
DRRI1-C: Climate Was Uncomfortable | C141897 | DRRI1-C: Climate Was Uncomfortable | Deployment Risk & Resilience Inventory-2 - During deployment: the climate was uncomfortable. | DRRI-2 - C: Climate Was Uncomfortable | ||
DRRI1-C: Conditions Extremely Unsanitary | C141900 | DRRI1-C: Conditions Extremely Unsanitary | Deployment Risk & Resilience Inventory-2 - During deployment: the conditions I lived in were extremely unsanitary. | DRRI-2 - C: Conditions Extremely Unsanitary | ||
DRRI1-C: Deal With Annoying Animals | C141898 | DRRI1-C: Deal With Annoying Animals | Deployment Risk & Resilience Inventory-2 - During deployment: I had to deal with annoying animals, insects, or plants. | DRRI-2 - C: Deal With Annoying Animals | ||
DRRI1-C: Didn't Have Bathrooms | C141901 | DRRI1-C: Didn't Have Bathrooms | Deployment Risk & Resilience Inventory-2 - During deployment: I didn't have access to bathrooms or showers when I needed them. | DRRI-2 - C: Didn't Have Bathrooms | ||
DRRI1-C: Food Was of Very Poor Quality | C141899 | DRRI1-C: Food Was of Very Poor Quality | Deployment Risk & Resilience Inventory-2 - During deployment: the food I had to eat was of very poor quality (for example, bad or old MREs). | DRRI-2 - C: Food Was of Very Poor Quality | ||
DRRI1-C: Hassle With Heavy/Annoying Gear | C141908 | DRRI1-C: Hassle With Heavy/Annoying Gear | Deployment Risk & Resilience Inventory-2 - During deployment: I had to hassle with putting on and taking off heavy or annoying gear. | DRRI-2 - C: Hassle With Heavy/Annoying Gear | ||
DRRI1-C: I Was Exposed to Awful Smells | C141903 | DRRI1-C: I Was Exposed to Awful Smells | Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to awful smells. | DRRI-2 - C: I Was Exposed to Awful Smells | ||
DRRI1-C: I Was Subjected to Loud Noises | C141904 | DRRI1-C: I Was Subjected to Loud Noises | Deployment Risk & Resilience Inventory-2 - During deployment: I was subjected to loud noises. | DRRI-2 - C: I Was Subjected to Loud Noises | ||
DRRI1-C: Not Allowed to Get Job Done | C141909 | DRRI1-C: Not Allowed to Get Job Done | Deployment Risk & Resilience Inventory-2 - During deployment: I was not allowed to do the things I needed to do to get my job done. | DRRI-2 - C: Not Allowed to Get Job Done | ||
DRRI1-C: Not Have Adequate Shelter | C141910 | DRRI1-C: Not Have Adequate Shelter | Deployment Risk & Resilience Inventory-2 - During deployment: I did not have adequate shelter from uncomfortable living conditions (for example, heat, cold, wet, etc.). | DRRI-2 - C: Not Have Adequate Shelter | ||
DRRI1-C: Restricted Because Local Custom | C141905 | DRRI1-C: Restricted Because Local Custom | Deployment Risk & Resilience Inventory-2 - During deployment: my daily activities were restricted because of local religious or ethnic customs. | DRRI-2 - C: Restricted Because Local Custom | ||
DRRI1-C: Wasn't Able to Contact Home | C141907 | DRRI1-C: Wasn't Able to Contact Home | Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to contact home when I needed to. | DRRI-2 - C: Wasn't Able to Contact Home | ||
DRRI1-C: Wasn't Able to Get Privacy | C141902 | DRRI1-C: Wasn't Able to Get Privacy | Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to get as much privacy as I needed. | DRRI-2 - C: Wasn't Able to Get Privacy | ||
DRRI1-C: Wasn't Able to Rest | C141906 | DRRI1-C: Wasn't Able to Rest | Deployment Risk & Resilience Inventory-2 - During deployment: I wasn't able to get rest when I needed it. | DRRI-2 - C: Wasn't Able to Rest | ||
DRRI1-D: Assault on Entrenched Positions | C141912 | DRRI1-D: Assault on Entrenched Positions | Deployment Risk & Resilience Inventory-2 - During deployment: I took part in an assault on entrenched or fortified positions that involved naval and/or land forces. | DRRI-2 - D: Assault on Entrenched Positions | ||
DRRI1-D: Encountered Land Mines | C141914 | DRRI1-D: Encountered Land Mines | Deployment Risk & Resilience Inventory-2 - During deployment: I encountered land or water mines, booby traps, or roadside bombs (for example, IEDs). | DRRI-2 - D: Encountered Land Mines | ||
DRRI1-D: Exposed Hostile Incoming Fire | C141915 | DRRI1-D: Exposed Hostile Incoming Fire | Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to hostile incoming fire. | DRRI-2 - D: Exposed Hostile Incoming Fire | ||
DRRI1-D: Exposed to Friendly Fire | C141916 | DRRI1-D: Exposed to Friendly Fire | Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to "friendly" fire. | DRRI-2 - D: Exposed to Friendly Fire | ||
DRRI1-D: Fired My Weapon Enemy Combatant | C141922 | DRRI1-D: Fired My Weapon Enemy Combatant | Deployment Risk & Resilience Inventory-2 - During deployment: I fired my weapon at enemy combatants. | DRRI-2 - D: Fired My Weapon Enemy Combatant | ||
DRRI1-D: Injured Combat-Related Incident | C141921 | DRRI1-D: Injured Combat-Related Incident | Deployment Risk & Resilience Inventory-2 - During deployment: I was injured in a combat-related incident. | DRRI-2 - D: Injured Combat-Related Incident | ||
DRRI1-D: Locating Explosive Devices | C141924 | DRRI1-D: Locating Explosive Devices | Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in locating or disarming explosive devices. | DRRI-2 - D: Locating Explosive Devices | ||
DRRI1-D: Part of Unit Fired on Enemy | C141918 | DRRI1-D: Part of Unit Fired on Enemy | Deployment Risk & Resilience Inventory-2 - During deployment: I was part of a land or naval artillery unit that fired on enemy combatants. | DRRI-2 - D: Part of Unit Fired on Enemy | ||
DRRI1-D: Participate Hand-to-hand Combat | C141926 | DRRI1-D: Participate Hand-to-hand Combat | Deployment Risk & Resilience Inventory-2 - During deployment: I participated in hand-to-hand combat. | DRRI-2 - D: Participate Hand-to-hand Combat | ||
DRRI1-D: Search/Disarm Potential Enemy | C141927 | DRRI1-D: Search/Disarm Potential Enemy | Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in searching and/or disarming potential enemy combatants. | DRRI-2 - D: Search/Disarm Potential Enemy | ||
DRRI1-D: Searching Homes/Buildings | C141925 | DRRI1-D: Searching Homes/Buildings | Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in searching or clearing homes, buildings, or other locations. | DRRI-2 - D: Searching Homes/Buildings | ||
DRRI1-D: Think I Wounded/Killed Someone | C141923 | DRRI1-D: Think I Wounded/Killed Someone | Deployment Risk & Resilience Inventory-2 - During deployment: I think I wounded or killed someone during combat operations. | DRRI-2 - D: Think I Wounded/Killed Someone | ||
DRRI1-D: Vehicle/Part of Convoy Attacked | C141917 | DRRI1-D: Vehicle/Part of Convoy Attacked | Deployment Risk & Resilience Inventory-2 - During deployment: I was in a vehicle (for example, a "humvee", helicopter, or boat) or part of a convoy that was attacked. | DRRI-2 - D: Vehicle/Part of Convoy Attacked | ||
DRRI1-D: Went on Combat Patrols/Missions | C141911 | DRRI1-D: Went on Combat Patrols/Missions | Deployment Risk & Resilience Inventory-2 - During deployment: I went on combat patrols or missions. | DRRI-2 - D: Went on Combat Patrols/Missions | ||
DRRI1-D: Witnessed Civilians Wounded | C141920 | DRRI1-D: Witnessed Civilians Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed civilians (for example, women and children) being seriously wounded or killed. | DRRI-2 - D: Witnessed Civilians Wounded | ||
DRRI1-D: Witnessed Enemy Wounded/Killed | C141919 | DRRI1-D: Witnessed Enemy Wounded/Killed | Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed enemy combatants being seriously wounded or killed. | DRRI-2 - D: Witnessed Enemy Wounded/Killed | ||
DRRI1-D: Witnessed Someone Unit Wounded | C141913 | DRRI1-D: Witnessed Someone Unit Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I personally witnessed someone from my unit or an ally unit being seriously wounded or killed. | DRRI-2 - D: Witnessed Someone Unit Wounded | ||
DRRI1-E: Interacted With Detainees | C141938 | DRRI1-E: Interacted With Detainees | Deployment Risk & Resilience Inventory-2 - During deployment: I interacted with detainees or prisoners of war. | DRRI-2 - E: Interacted With Detainees | ||
DRRI1-E: Involved Handling Human Remains | C141940 | DRRI1-E: Involved Handling Human Remains | Deployment Risk & Resilience Inventory-2 - During deployment: I was involved in handling human remains. | DRRI-2 - E: Involved Handling Human Remains | ||
DRRI1-E: Observed Homes Been Destroyed | C141930 | DRRI1-E: Observed Homes Been Destroyed | Deployment Risk & Resilience Inventory-2 - During deployment: I observed homes or communities that had been destroyed. | DRRI-2 - E: Observed Homes Been Destroyed | ||
DRRI1-E: Saw Americans Had Been Wounded | C141934 | DRRI1-E: Saw Americans Had Been Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I saw Americans or allies after they had been severely wounded or disfigured. | DRRI-2 - E: Saw Americans Had Been Wounded | ||
DRRI1-E: Saw Bodies of Dead Americans | C141936 | DRRI1-E: Saw Bodies of Dead Americans | Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead Americans or allies. | DRRI-2 - E: Saw Bodies of Dead Americans | ||
DRRI1-E: Saw Bodies of Dead Civilians | C141937 | DRRI1-E: Saw Bodies of Dead Civilians | Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead civilians. | DRRI-2 - E: Saw Bodies of Dead Civilians | ||
DRRI1-E: Saw Bodies of Dead Enemy | C141935 | DRRI1-E: Saw Bodies of Dead Enemy | Deployment Risk & Resilience Inventory-2 - During deployment: I saw the bodies of dead enemy combatants. | DRRI-2 - E: Saw Bodies of Dead Enemy | ||
DRRI1-E: Saw Civilians After Wounded | C141932 | DRRI1-E: Saw Civilians After Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I saw civilians after they had been severely wounded or disfigured. | DRRI-2 - E: Saw Civilians After Wounded | ||
DRRI1-E: Saw Combatants Had Been Wounded | C141933 | DRRI1-E: Saw Combatants Had Been Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I saw enemy combatants after they had been severely wounded or disfigured. | DRRI-2 - E: Saw Combatants Had Been Wounded | ||
DRRI1-E: Saw People Begging for Food | C141928 | DRRI1-E: Saw People Begging for Food | Deployment Risk & Resilience Inventory-2 - During deployment: I saw people begging for food. | DRRI-2 - E: Saw People Begging for Food | ||
DRRI1-E: Saw Refugees Who Had Lost Homes | C141929 | DRRI1-E: Saw Refugees Who Had Lost Homes | Deployment Risk & Resilience Inventory-2 - During deployment: I saw refugees who had lost their homes or belongings. | DRRI-2 - E: Saw Refugees Who Had Lost Homes | ||
DRRI1-E: Sight/Sound/Smell Dead Animals | C141939 | DRRI1-E: Sight/Sound/Smell Dead Animals | Deployment Risk & Resilience Inventory-2 - During deployment: I was exposed to the sight, sound, or smell of dead or dying animals. | DRRI-2 - E: Sight/Sound/Smell Dead Animals | ||
DRRI1-E: Took Care Injured/Dying People | C141931 | DRRI1-E: Took Care Injured/Dying People | Deployment Risk & Resilience Inventory-2 - During deployment: I took care of injured or dying people. | DRRI-2 - E: Took Care Injured/Dying People | ||
DRRI1-F: Exposed Government-issued DEET | C141945 | DRRI1-F: Exposed Government-issued DEET | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to government-issued DEET-containing insect repellents. | DRRI-2 - F: Exposed Government-issued DEET | ||
DRRI1-F: Exposed to Burning Trash/Feces | C141951 | DRRI1-F: Exposed to Burning Trash/Feces | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to burning trash or burning feces. | DRRI-2 - F: Exposed to Burning Trash/Feces | ||
DRRI1-F: Exposed to Chlorine Gas | C141952 | DRRI1-F: Exposed to Chlorine Gas | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to chlorine gas. | DRRI-2 - F: Exposed to Chlorine Gas | ||
DRRI1-F: Exposed to Depleted Uranium | C141950 | DRRI1-F: Exposed to Depleted Uranium | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to depleted uranium in munitions. | DRRI-2 - F: Exposed to Depleted Uranium | ||
DRRI1-F: Exposed to Diesel/Fuel on Skin | C141948 | DRRI1-F: Exposed to Diesel/Fuel on Skin | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to diesel or other petrochemical fuel on my skin. | DRRI-2 - F: Exposed to Diesel/Fuel on Skin | ||
DRRI1-F: Exposed to Fumes From Heaters | C141949 | DRRI1-F: Exposed to Fumes From Heaters | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to fumes or exhaust from heaters or generators, including heaters in tents. | DRRI-2 - F: Exposed to Fumes From Heaters | ||
DRRI1-F: Exposed to Mustard Gas | C141944 | DRRI1-F: Exposed to Mustard Gas | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to mustard gas or other blistering agents. | DRRI-2 - F: Exposed to Mustard Gas | ||
DRRI1-F: Exposed to Nerve Gas Agents | C141943 | DRRI1-F: Exposed to Nerve Gas Agents | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to nerve gas agents (for example, sarin). | DRRI-2 - F: Exposed to Nerve Gas Agents | ||
DRRI1-F: Exposed to Nuclear Weapons | C141953 | DRRI1-F: Exposed to Nuclear Weapons | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to nuclear, biological, or chemical weapons. | DRRI-2 - F: Exposed to Nuclear Weapons | ||
DRRI1-F: Exposed to Other Pesticides | C141946 | DRRI1-F: Exposed to Other Pesticides | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to other pesticides (for example, in flea collars, uniforms, or the environment). | DRRI-2 - F: Exposed to Other Pesticides | ||
DRRI1-F: Exposed to Smoke/Air Pollution | C141947 | DRRI1-F: Exposed to Smoke/Air Pollution | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I was exposed to smoke or other air pollution. | DRRI-2 - F: Exposed to Smoke/Air Pollution | ||
DRRI1-F: Received Vaccinations | C141942 | DRRI1-F: Received Vaccinations | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I received preventative vaccinations by injection (for example, to prevent anthrax or botulism). | DRRI-2 - F: Received Vaccinations | ||
DRRI1-F: Took Preventative Pills | C141941 | DRRI1-F: Took Preventative Pills | Deployment Risk & Resilience Inventory-2 - Either in preparation for or during my deployment: I took preventative pills (for example, to protect against nerve gas). | DRRI-2 - F: Took Preventative Pills | ||
DRRI1-G: Concern Rocket/Mortar Would Hit | C141960 | DRRI1-G: Concern Rocket/Mortar Would Hit | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that a rocket or mortar would hit our living quarters. | DRRI-2 - G: Concern Rocket/Mortar Would Hit | ||
DRRI1-G: Concerned Depleted Uranium | C141961 | DRRI1-G: Concerned Depleted Uranium | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I might be exposed to depleted uranium in munitions. | DRRI-2 - G: Concerned Depleted Uranium | ||
DRRI1-G: Concerned Encounter Explosive | C141958 | DRRI1-G: Concerned Encounter Explosive | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I would encounter an explosive device (for example, a roadside bomb, mine, or booby trap). | DRRI-2 - G: Concerned Encounter Explosive | ||
DRRI1-G: Concerned Infectious Disease | C141954 | DRRI1-G: Concerned Infectious Disease | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned about getting an infectious disease. | DRRI-2 - G: Concerned Infectious Disease | ||
DRRI1-G: Concerned Locals Against Us | C141964 | DRRI1-G: Concerned Locals Against Us | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that the locals who were supposed to be helping us were actually working against us. | DRRI-2 - G: Concerned Locals Against Us | ||
DRRI1-G: Concerned Medicine Make Me Sick | C141957 | DRRI1-G: Concerned Medicine Make Me Sick | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that the medicine I was given to protect me from illness would make me sick. | DRRI-2 - G: Concerned Medicine Make Me Sick | ||
DRRI1-G: Concerned Taken Hostage | C141963 | DRRI1-G: Concerned Taken Hostage | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that I might be taken hostage. | DRRI-2 - G: Concerned Taken Hostage | ||
DRRI1-G: Concerned Trapped in Crossfire | C141965 | DRRI1-G: Concerned Trapped in Crossfire | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned about being trapped in the crossfire of rival factions. | DRRI-2 - G: Concerned Trapped in Crossfire | ||
DRRI1-G: Feared Sick From Pesticides | C141959 | DRRI1-G: Feared Sick From Pesticides | Deployment Risk & Resilience Inventory-2 - During deployment: I feared that I would become sick from pesticides (for example, bug spray) or other routinely used chemicals. | DRRI-2 - G: Feared Sick From Pesticides | ||
DRRI1-G: Felt in Danger of Being Wounded | C141956 | DRRI1-G: Felt in Danger of Being Wounded | Deployment Risk & Resilience Inventory-2 - During deployment: I felt I was in great danger of being wounded (for example, losing a limb). | DRRI-2 - G: Felt in Danger of Being Wounded | ||
DRRI1-G: Health Might Suffer NBC Agents | C141955 | DRRI1-G: Health Might Suffer NBC Agents | Deployment Risk & Resilience Inventory-2 - During deployment: I was concerned that my health might suffer due to exposure to nuclear, biological, or chemical (NBC) agents. | DRRI-2 - G: Health Might Suffer NBC Agents | ||
DRRI1-G: Thought I Would Never Survive | C141962 | DRRI1-G: Thought I Would Never Survive | Deployment Risk & Resilience Inventory-2 - During deployment: I thought I would never survive. | DRRI-2 - G: Thought I Would Never Survive | ||
DRRI1-H: Accurately Informed About Role | C141969 | DRRI1-H: Accurately Informed About Role | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I was accurately informed about the role my unit was expected to play in the deployment. | DRRI-2 - H: Accurately Informed About Role | ||
DRRI1-H: Confident Ability Use Equipment | C141967 | DRRI1-H: Confident Ability Use Equipment | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received made me feel confident in my ability to use my equipment. | DRRI-2 - H: Confident Ability Use Equipment | ||
DRRI1-H: Confident to Perform Tasks | C141974 | DRRI1-H: Confident to Perform Tasks | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received made me feel confident in my ability to perform tasks assigned to me during deployment. | DRRI-2 - H: Confident to Perform Tasks | ||
DRRI1-H: Had All Supplies Needed | C141966 | DRRI1-H: Had All Supplies Needed | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I had all the supplies and equipment needed to get my job done. | DRRI-2 - H: Had All Supplies Needed | ||
DRRI1-H: Had Enough Gear in Case Attack | C141970 | DRRI1-H: Had Enough Gear in Case Attack | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I had enough gear to protect myself in case of an attack. | DRRI-2 - H: Had Enough Gear in Case Attack | ||
DRRI1-H: Military Duties What I Expected | C141972 | DRRI1-H: Military Duties What I Expected | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: my military duties and assignments were what I expected. | DRRI-2 - H: Military Duties What I Expected | ||
DRRI1-H: Prepared to Deal With Climate | C141968 | DRRI1-H: Prepared to Deal With Climate | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received prepared me to deal with the region's climate. | DRRI-2 - H: Prepared to Deal With Climate | ||
DRRI1-H: Prepared to Operate as Team | C141973 | DRRI1-H: Prepared to Operate as Team | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: my unit was well-prepared to operate as a team during deployment. | DRRI-2 - H: Prepared to Operate as Team | ||
DRRI1-H: Taught Me Everything I Needed | C141975 | DRRI1-H: Taught Me Everything I Needed | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: the training I received taught me everything I needed to know for deployment. | DRRI-2 - H: Taught Me Everything I Needed | ||
DRRI1-H: Training for Deployment | C141971 | DRRI1-H: Training for Deployment | Deployment Risk & Resilience Inventory-2 - In preparation for deployment: I received appropriate training for the nature of the deployment I experienced. | DRRI-2 - H: Training for Deployment | ||
DRRI1-I: Could Count on Family Advice | C141978 | DRRI1-I: Could Count on Family Advice | Deployment Risk & Resilience Inventory-2 - During deployment: I could count on my family members or friends at home for good advice. | DRRI-2 - I: Could Count on Family Advice | ||
DRRI1-I: Family Sincerely Interested | C141976 | DRRI1-I: Family Sincerely Interested | Deployment Risk & Resilience Inventory-2 - During deployment: family members and/or friends at home were sincerely interested in hearing what was going on with me. | DRRI-2 - I: Family Sincerely Interested | ||
DRRI1-I: Had Family I Could Talk To | C141977 | DRRI1-I: Had Family I Could Talk To | Deployment Risk & Resilience Inventory-2 - During deployment: I had family members or friends at home I could talk to when I had a problem. | DRRI-2 - I: Had Family I Could Talk To | ||
DRRI1-I: Happy Communication From Home | C141981 | DRRI1-I: Happy Communication From Home | Deployment Risk & Resilience Inventory-2 - During deployment: I was happy with the amount of communication I received from people at home. | DRRI-2 - I: Happy Communication From Home | ||
DRRI1-I: Happy With Support From Home | C141982 | DRRI1-I: Happy With Support From Home | Deployment Risk & Resilience Inventory-2 - During deployment: I was happy with the amount of support I received from people at home. | DRRI-2 - I: Happy With Support From Home | ||
DRRI1-I: People at Home Show They Cared | C141983 | DRRI1-I: People at Home Show They Cared | Deployment Risk & Resilience Inventory-2 - During deployment: people at home did things to show they cared about me. | DRRI-2 - I: People at Home Show They Cared | ||
DRRI1-I: Relatives Look Out for Family | C141979 | DRRI1-I: Relatives Look Out for Family | Deployment Risk & Resilience Inventory-2 - During deployment: relatives or friends at home could be counted on to look out for the well-being of my family or other dependents (including pets). | DRRI-2 - I: Relatives Look Out for Family | ||
DRRI1-I: Relatives Take Care of Finances | C141980 | DRRI1-I: Relatives Take Care of Finances | Deployment Risk & Resilience Inventory-2 - During deployment: relatives or friends at home could be counted on to take care of my finances, property, or belongings if needed. | DRRI-2 - I: Relatives Take Care of Finances | ||
DRRI1-J: Could Go to Leaders If Problem | C141993 | DRRI1-J: Could Go to Leaders If Problem | Deployment Risk & Resilience Inventory-2 - During deployment: I could go to unit leaders for help if I had a problem or concern. | DRRI-2 - J: Could Go to Leaders If Problem | ||
DRRI1-J: Fellow Unit Appreciated Efforts | C141986 | DRRI1-J: Fellow Unit Appreciated Efforts | Deployment Risk & Resilience Inventory-2 - During deployment: my fellow unit members appreciated my efforts. | DRRI-2 - J: Fellow Unit Appreciated Efforts | ||
DRRI1-J: Felt Like My Efforts Counted | C141991 | DRRI1-J: Felt Like My Efforts Counted | Deployment Risk & Resilience Inventory-2 - During deployment: I felt like my efforts really counted to the leaders in my unit. | DRRI-2 - J: Felt Like My Efforts Counted | ||
DRRI1-J: Felt Valued by Leaders of Unit | C141995 | DRRI1-J: Felt Valued by Leaders of Unit | Deployment Risk & Resilience Inventory-2 - During deployment: I felt valued by the leaders of my unit. | DRRI-2 - J: Felt Valued by Leaders of Unit | ||
DRRI1-J: Felt Valued Fellow Unit Members | C141987 | DRRI1-J: Felt Valued Fellow Unit Members | Deployment Risk & Resilience Inventory-2 - During deployment: I felt valued by my fellow unit members. | DRRI-2 - J: Felt Valued Fellow Unit Members | ||
DRRI1-J: Leader Interested What Thought | C141990 | DRRI1-J: Leader Interested What Thought | Deployment Risk & Resilience Inventory-2 - During deployment: my unit leader(s) were interested in what I thought and how I felt about things. | DRRI-2 - J: Leader Interested What Thought | ||
DRRI1-J: Leaders Interested in Welfare | C141994 | DRRI1-J: Leaders Interested in Welfare | Deployment Risk & Resilience Inventory-2 - During deployment: the leaders of my unit were interested in my personal welfare. | DRRI-2 - J: Leaders Interested in Welfare | ||
DRRI1-J: My Unit Was Like Family to Me | C141984 | DRRI1-J: My Unit Was Like Family to Me | Deployment Risk & Resilience Inventory-2 - During deployment: my unit was like family to me. | DRRI-2 - J: My Unit Was Like Family to Me | ||
DRRI1-J: People in Unit Were Trustworthy | C141985 | DRRI1-J: People in Unit Were Trustworthy | Deployment Risk & Resilience Inventory-2 - During deployment: people in my unit were trustworthy. | DRRI-2 - J: People in Unit Were Trustworthy | ||
DRRI1-J: Service Appreciated by Leaders | C141992 | DRRI1-J: Service Appreciated by Leaders | Deployment Risk & Resilience Inventory-2 - During deployment: my service was appreciated by the leaders in my unit. | DRRI-2 - J: Service Appreciated by Leaders | ||
DRRI1-J: Unit Interested My Well-being | C141988 | DRRI1-J: Unit Interested My Well-being | Deployment Risk & Resilience Inventory-2 - During deployment: members of my unit were interested in my well-being. | DRRI-2 - J: Unit Interested My Well-being | ||
DRRI1-J: Unit Interested What I Thought | C141989 | DRRI1-J: Unit Interested What I Thought | Deployment Risk & Resilience Inventory-2 - During deployment: my fellow unit members were interested in what I thought and how I felt about things. | DRRI-2 - J: Unit Interested What I Thought | ||
DRRI1-K: Authority Pressure Unwanted Sex | C142007 | DRRI1-K: Authority Pressure Unwanted Sex | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: used a position of authority to pressure me into unwanted sexual activity. | DRRI-2 - K: Authority Pressure Unwanted Sex | ||
DRRI1-K: Had to Work Harder Prove Myself | C141998 | DRRI1-K: Had to Work Harder Prove Myself | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: treated me as if I had to work harder than others to prove myself. | DRRI-2 - K: Had to Work Harder Prove Myself | ||
DRRI1-K: Made Crude Sexual Remarks at Me | C142004 | DRRI1-K: Made Crude Sexual Remarks at Me | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: made crude and offensive sexual remarks directed at me, either publicly or privately. | DRRI-2 - K: Made Crude Sexual Remarks at Me | ||
DRRI1-K: Make My Job More Difficult | C142001 | DRRI1-K: Make My Job More Difficult | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: tried to make my job more difficult to do. | DRRI-2 - K: Make My Job More Difficult | ||
DRRI1-K: My Mistakes Worse Than Others | C142000 | DRRI1-K: My Mistakes Worse Than Others | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: acted as though my mistakes were worse than others'. | DRRI-2 - K: My Mistakes Worse Than Others | ||
DRRI1-K: Offered Reward Take Part in Sex | C142008 | DRRI1-K: Offered Reward Take Part in Sex | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: offered me a specific reward or special treatment to take part in sexual behavior. | DRRI-2 - K: Offered Reward Take Part in Sex | ||
DRRI1-K: Physically Forced to Have Sex | C142011 | DRRI1-K: Physically Forced to Have Sex | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: physically forced me to have sex. | DRRI-2 - K: Physically Forced to Have Sex | ||
DRRI1-K: Put Me Down | C142002 | DRRI1-K: Put Me Down | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: "put me down" or treated me in a condescending way. | DRRI-2 - K: Put Me Down | ||
DRRI1-K: Questioned My Abilities Perform | C141999 | DRRI1-K: Questioned My Abilities Perform | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: questioned my abilities or commitment to perform my job effectively. | DRRI-2 - K: Questioned My Abilities Perform | ||
DRRI1-K: Spread Rumors Sexual Activities | C142005 | DRRI1-K: Spread Rumors Sexual Activities | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: spread negative rumors about my sexual activities. | DRRI-2 - K: Spread Rumors Sexual Activities | ||
DRRI1-K: Threatened Me If Not Sex | C142009 | DRRI1-K: Threatened Me If Not Sex | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: threatened me with some sort of retaliation if I was not sexually cooperative (for example, the threat of negative review or physical violence). | DRRI-2 - K: Threatened Me If Not Sex | ||
DRRI1-K: Threatened My Physical Safety | C142003 | DRRI1-K: Threatened My Physical Safety | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: threatened my physical safety. | DRRI-2 - K: Threatened My Physical Safety | ||
DRRI1-K: Touched Sexual Way Against Will | C142010 | DRRI1-K: Touched Sexual Way Against Will | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: touched me in a sexual way against my will. | DRRI-2 - K: Touched Sexual Way Against Will | ||
DRRI1-K: Treated in Overly Critical Way | C141996 | DRRI1-K: Treated in Overly Critical Way | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: treated me in an overly critical way. | DRRI-2 - K: Treated in Overly Critical Way | ||
DRRI1-K: Tried to Talk into Sexual Acts | C142006 | DRRI1-K: Tried to Talk into Sexual Acts | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: tried to talk me into participating in sexual acts when I didn't want to. | DRRI-2 - K: Tried to Talk into Sexual Acts | ||
DRRI1-K: Uncooperative Working With Me | C141997 | DRRI1-K: Uncooperative Working With Me | Deployment Risk & Resilience Inventory-2 - During deployment, the people I worked with: behaved in way that was uncooperative when working with me. | DRRI-2 - K: Uncooperative Working With Me | ||
DRRI1-L: Being Cheated on by My Spouse | C142021 | DRRI1-L: Being Cheated on by My Spouse | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: being cheated on by my spouse or significant other. | DRRI-2 - L: Being Cheated on by My Spouse | ||
DRRI1-L: Care Child/Dependents Receiving | C142020 | DRRI1-L: Care Child/Dependents Receiving | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the care that my child(ren) or other dependents were receiving. | DRRI-2 - L: Care Child/Dependents Receiving | ||
DRRI1-L: Damaging Career Because Deploy | C142019 | DRRI1-L: Damaging Career Because Deploy | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: damaging my career because of the deployment. | DRRI-2 - L: Damaging Career Because Deploy | ||
DRRI1-L: Effect Deployment Relationship | C142012 | DRRI1-L: Effect Deployment Relationship | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the effect of the deployment on my relationship with my spouse or significant other. | DRRI-2 - L: Effect Deployment Relationship | ||
DRRI1-L: Effect Relationship My Children | C142025 | DRRI1-L: Effect Relationship My Children | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the effect of the deployment on my relationship with my child(ren). | DRRI-2 - L: Effect Relationship My Children | ||
DRRI1-L: Family Ability Cope With Stress | C142022 | DRRI1-L: Family Ability Cope With Stress | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my family's ability to cope with the stress of the deployment. | DRRI-2 - L: Family Ability Cope With Stress | ||
DRRI1-L: Inability Manage Family Affairs | C142018 | DRRI1-L: Inability Manage Family Affairs | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my inability to directly manage or control family affairs. | DRRI-2 - L: Inability Manage Family Affairs | ||
DRRI1-L: Losing My Civilian Job | C142024 | DRRI1-L: Losing My Civilian Job | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: losing my civilian job because of the deployment. | DRRI-2 - L: Losing My Civilian Job | ||
DRRI1-L: Missing Family Events at Home | C142014 | DRRI1-L: Missing Family Events at Home | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: missing important family events at home such as birthdays, weddings, funerals, graduations, etc. | DRRI-2 - L: Missing Family Events at Home | ||
DRRI1-L: Missing Out on Children Growth | C142013 | DRRI1-L: Missing Out on Children Growth | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: missing out on my children's growth and development. | DRRI-2 - L: Missing Out on Children Growth | ||
DRRI1-L: My Family Financial Situation | C142026 | DRRI1-L: My Family Financial Situation | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my family's financial situation. | DRRI-2 - L: My Family Financial Situation | ||
DRRI1-L: Safety and Well-being of Child | C142016 | DRRI1-L: Safety and Well-being of Child | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the safety and well-being of my child(ren). | DRRI-2 - L: Safety and Well-being of Child | ||
DRRI1-L: Safety and Well-being of Spouse | C142015 | DRRI1-L: Safety and Well-being of Spouse | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: the safety and well-being of my spouse or significant other. | DRRI-2 - L: Safety and Well-being of Spouse | ||
DRRI1-L: Spouse Ability Manage Household | C142023 | DRRI1-L: Spouse Ability Manage Household | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: my spouse or significant other's ability to manage the household (for example, chores, bills, home repairs, etc.). | DRRI-2 - L: Spouse Ability Manage Household | ||
DRRI1-L: Unable to Help Family If Crisis | C142017 | DRRI1-L: Unable to Help Family If Crisis | Deployment Risk & Resilience Inventory-2 - During deployment, I was concerned about: being unable to help my family if there was some kind of crisis or emergency. | DRRI-2 - L: Unable to Help Family If Crisis | ||
DRRI1-M: Fam Dangerous Military Duties | C142039 | DRRI1-M: Fam Dangerous Military Duties | Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one participated in dangerous military duties. | DRRI-2 - M: Fam Dangerous Military Duties | ||
DRRI1-M: Family Got Into Trouble | C142040 | DRRI1-M: Family Got Into Trouble | Deployment Risk & Resilience Inventory-2 - During deployment: a family member got into trouble at home, at school, or in the community. | DRRI-2 - M: Family Got Into Trouble | ||
DRRI1-M: Family Had Difficulty Adjusting | C142035 | DRRI1-M: Family Had Difficulty Adjusting | Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one had serious difficulty adjusting to my absence. | DRRI-2 - M: Family Had Difficulty Adjusting | ||
DRRI1-M: Family Member Passed Away | C142029 | DRRI1-M: Family Member Passed Away | Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other loved one passed away. | DRRI-2 - M: Family Member Passed Away | ||
DRRI1-M: Family Member Wasted Money | C142037 | DRRI1-M: Family Member Wasted Money | Deployment Risk & Resilience Inventory-2 - During deployment: a family member or other person I trusted wasted or mismanaged my money. | DRRI-2 - M: Family Member Wasted Money | ||
DRRI1-M: Had Major Conflict With Family | C142034 | DRRI1-M: Had Major Conflict With Family | Deployment Risk & Resilience Inventory-2 - During deployment: I had a major conflict with a family member or other loved one. | DRRI-2 - M: Had Major Conflict With Family | ||
DRRI1-M: Loved One Things I Disapproved | C142038 | DRRI1-M: Loved One Things I Disapproved | Deployment Risk & Resilience Inventory-2 - During deployment: I learned that a loved one was doing things I disapproved of. | DRRI-2 - M: Loved One Things I Disapproved | ||
DRRI1-M: My Family Had Money Problems | C142030 | DRRI1-M: My Family Had Money Problems | Deployment Risk & Resilience Inventory-2 - During deployment: my family had money problems. | DRRI-2 - M: My Family Had Money Problems | ||
DRRI1-M: My Home Was Robbed | C142036 | DRRI1-M: My Home Was Robbed | Deployment Risk & Resilience Inventory-2 - During deployment: my home was robbed and/or my belongings were stolen. | DRRI-2 - M: My Home Was Robbed | ||
DRRI1-M: Problems Get in Touch Family | C142027 | DRRI1-M: Problems Get in Touch Family | Deployment Risk & Resilience Inventory-2 - During deployment: I had problems getting in touch with a family member or other loved one. | DRRI-2 - M: Problems Get in Touch Family | ||
DRRI1-M: Relationship With Spouse Ended | C142033 | DRRI1-M: Relationship With Spouse Ended | Deployment Risk & Resilience Inventory-2 - During deployment: my relationship with a spouse or significant other ended. | DRRI-2 - M: Relationship With Spouse Ended | ||
DRRI1-M: Someone Close Serious Illness | C142028 | DRRI1-M: Someone Close Serious Illness | Deployment Risk & Resilience Inventory-2 - During deployment: someone close to me experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). | DRRI-2 - M: Someone Close Serious Illness | ||
DRRI1-M: Spouse Cheated on Me | C142031 | DRRI1-M: Spouse Cheated on Me | Deployment Risk & Resilience Inventory-2 - During deployment: a spouse or significant other cheated on me. | DRRI-2 - M: Spouse Cheated on Me | ||
DRRI1-M: Spouse Suspected I Cheated | C142032 | DRRI1-M: Spouse Suspected I Cheated | Deployment Risk & Resilience Inventory-2 - During deployment: a spouse or significant other suspected that I had cheated on him/her. | DRRI-2 - M: Spouse Suspected I Cheated | ||
DRRI1-N: Emotionally Mistreated | C142049 | DRRI1-N: Emotionally Mistreated | Deployment Risk & Resilience Inventory-2 - Since returning: I have been emotionally mistreated (for example, ignored or repeatedly told I was no good). | DRRI-2 - N: Emotionally Mistreated | ||
DRRI1-N: Experienced Natural Disaster | C142045 | DRRI1-N: Experienced Natural Disaster | Deployment Risk & Resilience Inventory-2 - Since returning: I experienced a natural disaster (for example, a hurricane), a fire, or an accident in which I or someone close to me was hurt or had serious property damage. | DRRI-2 - N: Experienced Natural Disaster | ||
DRRI1-N: Injured by Another Person | C142053 | DRRI1-N: Injured by Another Person | Deployment Risk & Resilience Inventory-2 - Since returning: I have been seriously physically injured by another person (for example, hit or beaten up). | DRRI-2 - N: Injured by Another Person | ||
DRRI1-N: Lost My Job/Trouble Finding Job | C142048 | DRRI1-N: Lost My Job/Trouble Finding Job | Deployment Risk & Resilience Inventory-2 - Since returning: I lost my job or had serious trouble finding a job. | DRRI-2 - N: Lost My Job/Trouble Finding Job | ||
DRRI1-N: Problems Getting Healthcare | C142044 | DRRI1-N: Problems Getting Healthcare | Deployment Risk & Resilience Inventory-2 - Since returning: I had problems getting access to adequate healthcare. | DRRI-2 - N: Problems Getting Healthcare | ||
DRRI1-N: Robbed/Had My Home Broken Into | C142041 | DRRI1-N: Robbed/Had My Home Broken Into | Deployment Risk & Resilience Inventory-2 - Since returning: I was robbed or had my home broken into. | DRRI-2 - N: Robbed/Had My Home Broken Into | ||
DRRI1-N: Serious Financial Problems | C142050 | DRRI1-N: Serious Financial Problems | Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced serious financial problems. | DRRI-2 - N: Serious Financial Problems | ||
DRRI1-N: Serious Physical Health Problem | C142051 | DRRI1-N: Serious Physical Health Problem | Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced serious physical or mental health problems. | DRRI-2 - N: Serious Physical Health Problem | ||
DRRI1-N: Someone Close Serious Illness | C142046 | DRRI1-N: Someone Close Serious Illness | Deployment Risk & Resilience Inventory-2 - Since returning: someone close to me has experienced a serious illness, injury, or mental health problem (for example, cancer, alcohol/drug problem). | DRRI-2 - N: Someone Close Serious Illness | ||
DRRI1-N: Someone Close to Me Has Died | C142054 | DRRI1-N: Someone Close to Me Has Died | Deployment Risk & Resilience Inventory-2 - Since returning: someone close to me has died. | DRRI-2 - N: Someone Close to Me Has Died | ||
DRRI1-N: Stressful Legal Problems | C142052 | DRRI1-N: Stressful Legal Problems | Deployment Risk & Resilience Inventory-2 - Since returning: I have experienced stressful legal problems (for example, being sued, suing someone else, or being in a custody battle). | DRRI-2 - N: Stressful Legal Problems | ||
DRRI1-N: Unwanted Sexual Activity | C142042 | DRRI1-N: Unwanted Sexual Activity | Deployment Risk & Resilience Inventory-2 - Since returning: I experienced unwanted sexual activity as a result of force, threat or harm, or manipulation. | DRRI-2 - N: Unwanted Sexual Activity | ||
DRRI1-N: Went Through Divorce/Was Left | C142043 | DRRI1-N: Went Through Divorce/Was Left | Deployment Risk & Resilience Inventory-2 - Since returning: I went through a divorce or have been left by a partner or significant other. | DRRI-2 - N: Went Through Divorce/Was Left | ||
DRRI1-N: Witnessed Someone Assaulted | C142047 | DRRI1-N: Witnessed Someone Assaulted | Deployment Risk & Resilience Inventory-2 - Since returning: I have witnessed someone being seriously assaulted or killed. | DRRI-2 - N: Witnessed Someone Assaulted | ||
DRRI1-O: Family Make Me Better When Down | C142057 | DRRI1-O: Family Make Me Better When Down | Deployment Risk & Resilience Inventory-2 - Since returning: my family members and/or friends make me feel better when I am down. | DRRI-2 - O: Family Make Me Better When Down | ||
DRRI1-O: Family Would Help Move | C142062 | DRRI1-O: Family Would Help Move | Deployment Risk & Resilience Inventory-2 - Since returning: my family members or friends would help me move my belongings if I needed help. | DRRI-2 - O: Family Would Help Move | ||
DRRI1-O: Family Would Lend Money | C142061 | DRRI1-O: Family Would Lend Money | Deployment Risk & Resilience Inventory-2 - Since returning: my family members or friends would lend me money if I needed it. | DRRI-2 - O: Family Would Lend Money | ||
DRRI1-O: Family/Friends Understand | C142059 | DRRI1-O: Family/Friends Understand | Deployment Risk & Resilience Inventory-2 - Since returning: my family and friends understand what I have been through in the Armed Forces. | DRRI-2 - O: Family/Friends Understand | ||
DRRI1-O: Go to Family When Need Advice | C142058 | DRRI1-O: Go to Family When Need Advice | Deployment Risk & Resilience Inventory-2 - Since returning: I can go to family members or friends when I need good advice. | DRRI-2 - O: Go to Family When Need Advice | ||
DRRI1-O: I Can Talk About My Deployment | C142060 | DRRI1-O: I Can Talk About My Deployment | Deployment Risk & Resilience Inventory-2 - Since returning: there are family and/or friends with whom I can talk about my deployment experiences. | DRRI-2 - O: I Can Talk About My Deployment | ||
DRRI1-O: People Made Me Feel at Home | C142055 | DRRI1-O: People Made Me Feel at Home | Deployment Risk & Resilience Inventory-2 - Since returning: the American people made me feel at home. | DRRI-2 - O: People Made Me Feel at Home | ||
DRRI1-O: People Made Me Feel Proud | C142056 | DRRI1-O: People Made Me Feel Proud | Deployment Risk & Resilience Inventory-2 - Since returning: people made me feel proud to have served my country in the Armed Forces. | DRRI-2 - O: People Made Me Feel Proud | ||
DRRI1-O: Someone Would Help With Tasks | C142063 | DRRI1-O: Someone Would Help With Tasks | Deployment Risk & Resilience Inventory-2 - Since returning: if I were unable to attend to daily chores, there is someone who would help me with these tasks. | DRRI-2 - O: Someone Would Help With Tasks | ||
DRRI1-O: When Ill Family Will Help Out | C142064 | DRRI1-O: When Ill Family Will Help Out | Deployment Risk & Resilience Inventory-2 - Since returning: when I am ill, family members or friends will help out until I am well. | DRRI-2 - O: When Ill Family Will Help Out | ||
DRRI1-P: Can Be Myself Around Family | C142075 | DRRI1-P: Can Be Myself Around Family | Deployment Risk & Resilience Inventory-2 - Since returning: I can be myself around family members. | DRRI-2 - P: Can Be Myself Around Family | ||
DRRI1-P: Contribution Family Appreciated | C142068 | DRRI1-P: Contribution Family Appreciated | Deployment Risk & Resilience Inventory-2 - Since returning: I feel like my contributions to my family are appreciated. | DRRI-2 - P: Contribution Family Appreciated | ||
DRRI1-P: Family Know What I Think/Feel | C142067 | DRRI1-P: Family Know What I Think/Feel | Deployment Risk & Resilience Inventory-2 - Since returning: family members know what I think and how I feel about things. | DRRI-2 - P: Family Know What I Think/Feel | ||
DRRI1-P: Family Tell Me When Problem | C142074 | DRRI1-P: Family Tell Me When Problem | Deployment Risk & Resilience Inventory-2 - Since returning: family members tell me when they are having a problem. | DRRI-2 - P: Family Tell Me When Problem | ||
DRRI1-P: Feel Like I Fit in With Family | C142066 | DRRI1-P: Feel Like I Fit in With Family | Deployment Risk & Resilience Inventory-2 - Since returning: I feel like I fit in with my family. | DRRI-2 - P: Feel Like I Fit in With Family | ||
DRRI1-P: I am Affectionate With Family | C142071 | DRRI1-P: I am Affectionate With Family | Deployment Risk & Resilience Inventory-2 - Since returning: I am affectionate with family members. | DRRI-2 - P: I am Affectionate With Family | ||
DRRI1-P: I Get Along Well With My Family | C142076 | DRRI1-P: I Get Along Well With My Family | Deployment Risk & Resilience Inventory-2 - Since returning: I get along well with my family members. | DRRI-2 - P: I Get Along Well With My Family | ||
DRRI1-P: Input Sought Family Decisions | C142065 | DRRI1-P: Input Sought Family Decisions | Deployment Risk & Resilience Inventory-2 - Since returning: my input is sought on important family decisions. | DRRI-2 - P: Input Sought Family Decisions | ||
DRRI1-P: Opinions Valued by Family | C142070 | DRRI1-P: Opinions Valued by Family | Deployment Risk & Resilience Inventory-2 - Since returning: my opinions are valued by other family members. | DRRI-2 - P: Opinions Valued by Family | ||
DRRI1-P: Play Important Role in Family | C142072 | DRRI1-P: Play Important Role in Family | Deployment Risk & Resilience Inventory-2 - Since returning: I play an important role in my family. | DRRI-2 - P: Play Important Role in Family | ||
DRRI1-P: Share Interests With Family | C142069 | DRRI1-P: Share Interests With Family | Deployment Risk & Resilience Inventory-2 - Since returning: I share many common interests and activities with family members. | DRRI-2 - P: Share Interests With Family | ||
DRRI1-P: Spend My Free Time With Family | C142073 | DRRI1-P: Spend My Free Time With Family | Deployment Risk & Resilience Inventory-2 - Since returning: I spend as much of my free time with family members as possible. | DRRI-2 - P: Spend My Free Time With Family | ||
Back to top | ||||||
CL.C119070.DLQI1TC | Dermatology Life Quality Index Questionnaire Test Code
(DLQI1TC) | text
Extensible: No | C119070 | Dermatology Life Quality Index Questionnaire Test Code | Dermatology Life Quality Index test code. | CDISC Questionnaire DLQI Test Code Terminology |
DLQI101 | C119163 | DLQI1-How Itchy, Sore, Painful, Stinging | Dermatology Life Quality Index - Over the last week, how itchy, sore, painful or stinging has your skin been? | DLQI - Itchy, Sore, Painful or Stinging Skin | ||
DLQI102 | C119164 | DLQI1-How Embarrassed, Self Conscious | Dermatology Life Quality Index - Over the last week, how embarrassed or self conscious have you been because of your skin? | DLQI - Embarrassed Because of Skin | ||
DLQI103 | C119165 | DLQI1-Interfered Shopping, Home, Yard | Dermatology Life Quality Index - Over the last week, how much has your skin interfered with you going shopping or looking after your home or yard? | DLQI - Skin Interfere With Shopping, Looking After Home or Yard | ||
DLQI104 | C119166 | DLQI1-Influenced Clothes You Wear | Dermatology Life Quality Index - Over the last week, how much has your skin influenced the clothes you wear? | DLQI - Skin Influence Clothes You Wear | ||
DLQI105 | C119167 | DLQI1-Affected Social, Leisure Activity | Dermatology Life Quality Index - Over the last week, how much has your skin affected any social or leisure activities? | DLQI - Skin Affect Social or Leisure Activities | ||
DLQI106 | C119168 | DLQI1-Made It Difficult to Do Any Sports | Dermatology Life Quality Index - Over the last week, how much has your skin made it difficult for you to do any sport? | DLQI - Skin Made Difficult to Do Sport | ||
DLQI107 | C119169 | DLQI1-Prevented Working or Studying | Dermatology Life Quality Index - Over the last week, has your skin prevented you from working or studying? | DLQI - Skin Prevent Work or Study | ||
DLQI107A | C119170 | DLQI1-Problem at Work or Studying | Dermatology Life Quality Index - If 'No', over the last week how much has your skin been a problem at work or studying? | DLQI - Skin Has Been a Problem at Work or Study | ||
DLQI108 | C119171 | DLQI1-Problem Partner, Friends, Relative | Dermatology Life Quality Index - Over the last week, how much has your skin created problems with your partner or any of your close friends or relatives? | DLQI - Skin Create Problem With Partner, Friends or Relatives | ||
DLQI109 | C119172 | DLQI1-Caused Any Sexual Difficulties | Dermatology Life Quality Index - Over the last week, how much has your skin caused any sexual difficulties? | DLQI - Skin Cause Sexual Difficulties | ||
DLQI110 | C119173 | DLQI1-How Much a Problem is Treatment | Dermatology Life Quality Index - Over the last week, how much of a problem has the treatment for your skin been, for example by making your home messy, or by taking up time? | DLQI - Treatment for Skin Make Home Messy | ||
DLQI111 | C119174 | DLQI1-Score | Dermatology Life Quality Index - Score. | DLQI - Score | ||
DLQI112 | C187622 | DLQI1-Symptoms and Feelings Subscore | Dermatology Life Quality Index - Symptoms and feelings subscore. | DLQI - Symptoms and Feelings Subscore | ||
DLQI113 | C187623 | DLQI1-Daily Activities Subscore | Dermatology Life Quality Index - Daily activities subscore. | DLQI - Daily Activities Subscore | ||
DLQI114 | C187624 | DLQI1-Leisure Subscore | Dermatology Life Quality Index - Leisure subscore. | DLQI - Leisure Subscore | ||
DLQI115 | C187625 | DLQI1-Work and School Subscore | Dermatology Life Quality Index - Work and school subscore. | DLQI - Work and School Subscore | ||
DLQI116 | C187626 | DLQI1-Personal Relationships Subscore | Dermatology Life Quality Index - Personal relationships subscore. | DLQI - Personal Relationships Subscore | ||
DLQI117 | C187627 | DLQI1-Treatment Subscore | Dermatology Life Quality Index - Treatment subscore. | DLQI - Treatment Subscore | ||
Back to top | ||||||
CL.C119069.DLQI1TN | Dermatology Life Quality Index Questionnaire Test Name
(DLQI1TN) | text
Extensible: No | C119069 | Dermatology Life Quality Index Questionnaire Test Name | Dermatology Life Quality Index test name. | CDISC Questionnaire DLQI Test Name Terminology |
DLQI1-Affected Social, Leisure Activity | C119167 | DLQI1-Affected Social, Leisure Activity | Dermatology Life Quality Index - Over the last week, how much has your skin affected any social or leisure activities? | DLQI - Skin Affect Social or Leisure Activities | ||
DLQI1-Caused Any Sexual Difficulties | C119172 | DLQI1-Caused Any Sexual Difficulties | Dermatology Life Quality Index - Over the last week, how much has your skin caused any sexual difficulties? | DLQI - Skin Cause Sexual Difficulties | ||
DLQI1-Daily Activities Subscore | C187623 | DLQI1-Daily Activities Subscore | Dermatology Life Quality Index - Daily activities subscore. | DLQI - Daily Activities Subscore | ||
DLQI1-How Embarrassed, Self Conscious | C119164 | DLQI1-How Embarrassed, Self Conscious | Dermatology Life Quality Index - Over the last week, how embarrassed or self conscious have you been because of your skin? | DLQI - Embarrassed Because of Skin | ||
DLQI1-How Itchy, Sore, Painful, Stinging | C119163 | DLQI1-How Itchy, Sore, Painful, Stinging | Dermatology Life Quality Index - Over the last week, how itchy, sore, painful or stinging has your skin been? | DLQI - Itchy, Sore, Painful or Stinging Skin | ||
DLQI1-How Much a Problem is Treatment | C119173 | DLQI1-How Much a Problem is Treatment | Dermatology Life Quality Index - Over the last week, how much of a problem has the treatment for your skin been, for example by making your home messy, or by taking up time? | DLQI - Treatment for Skin Make Home Messy | ||
DLQI1-Influenced Clothes You Wear | C119166 | DLQI1-Influenced Clothes You Wear | Dermatology Life Quality Index - Over the last week, how much has your skin influenced the clothes you wear? | DLQI - Skin Influence Clothes You Wear | ||
DLQI1-Interfered Shopping, Home, Yard | C119165 | DLQI1-Interfered Shopping, Home, Yard | Dermatology Life Quality Index - Over the last week, how much has your skin interfered with you going shopping or looking after your home or yard? | DLQI - Skin Interfere With Shopping, Looking After Home or Yard | ||
DLQI1-Leisure Subscore | C187624 | DLQI1-Leisure Subscore | Dermatology Life Quality Index - Leisure subscore. | DLQI - Leisure Subscore | ||
DLQI1-Made It Difficult to Do Any Sports | C119168 | DLQI1-Made It Difficult to Do Any Sports | Dermatology Life Quality Index - Over the last week, how much has your skin made it difficult for you to do any sport? | DLQI - Skin Made Difficult to Do Sport | ||
DLQI1-Personal Relationships Subscore | C187626 | DLQI1-Personal Relationships Subscore | Dermatology Life Quality Index - Personal relationships subscore. | DLQI - Personal Relationships Subscore | ||
DLQI1-Prevented Working or Studying | C119169 | DLQI1-Prevented Working or Studying | Dermatology Life Quality Index - Over the last week, has your skin prevented you from working or studying? | DLQI - Skin Prevent Work or Study | ||
DLQI1-Problem at Work or Studying | C119170 | DLQI1-Problem at Work or Studying | Dermatology Life Quality Index - If 'No', over the last week how much has your skin been a problem at work or studying? | DLQI - Skin Has Been a Problem at Work or Study | ||
DLQI1-Problem Partner, Friends, Relative | C119171 | DLQI1-Problem Partner, Friends, Relative | Dermatology Life Quality Index - Over the last week, how much has your skin created problems with your partner or any of your close friends or relatives? | DLQI - Skin Create Problem With Partner, Friends or Relatives | ||
DLQI1-Score | C119174 | DLQI1-Score | Dermatology Life Quality Index - Score. | DLQI - Score | ||
DLQI1-Symptoms and Feelings Subscore | C187622 | DLQI1-Symptoms and Feelings Subscore | Dermatology Life Quality Index - Symptoms and feelings subscore. | DLQI - Symptoms and Feelings Subscore | ||
DLQI1-Treatment Subscore | C187627 | DLQI1-Treatment Subscore | Dermatology Life Quality Index - Treatment subscore. | DLQI - Treatment Subscore | ||
DLQI1-Work and School Subscore | C187625 | DLQI1-Work and School Subscore | Dermatology Life Quality Index - Work and school subscore. | DLQI - Work and School Subscore | ||
Back to top | ||||||
CL.C111110.DEACNDEV | Device Events Action Taken with Device
(DEACNDEV) | text
Extensible: Yes | C111110 | Device Events Action Taken with Device | A terminology codelist based on the action taken with respect to the device. | CDISC SDTM Device Events Action Taken with Device Terminology |
CALIBRATION | C69187 | The act of checking or adjusting (by comparison with a standard) the accuracy of a measuring instrument. (NCI) | Calibration | |||
REMOVAL | C61575 | The act of taking out, extracting, or withdrawing an entity from a location. | Extraction | |||
REPROGRAMMING | C111306 | The act of rewriting program code or application software. (NCI) | Reprogram | |||
Back to top | ||||||
CL.C106480.DIPARM | Device Identifier Long Name
(DIPARM) | text
Extensible: Yes | C106480 | Device Identifier Long Name | A terminology codelist for the long name of the identifier characteristic of the device. | CDISC SDTM Device Identifier Parameter Long Name Terminology |
Batch Number | C104504 | Batch Identifier;Batch Number | A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous. | Batch Number | ||
Catalog Number | C99286 | Catalog Number | A unique manufacturer-assigned identifier used to distinguish a specific product from others in a catalog of products offered. | Catalog Number | ||
Device Type | C53265 | Device Type | Generic category of medical device within the device classification established by a regulatory authority. | Type of Device | ||
FDA Unique Device Identification | C112279 | FDA Unique Device Identification | A UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number, the serial number and/or expiration date. (FDA) | FDA Unique Device Identifier | ||
Lot Number | C70848 | Lot Identifier;Lot Number | A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product within a batch. | Lot Number | ||
Manufacturer | C25392 | Manufacturer | The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG) | Manufacturer | ||
Model Number | C99285 | Model Identifier;Model Number | The identifier assigned to a particular design of a device, usually an alphanumeric text string. | Model Number | ||
Secure Lead Type | C111191 | Secure Lead Type | The type of locking device used to securely fasten the electrical leads to the device. (NCI) | Electrical Lead Locking Type | ||
Serial Number | C73518 | Serial Number | A unique identifier assigned to an individual object. | Serial Number | ||
Sponsor Device Description | C170568 | Sponsor Device Description | The free-text description of the characteristics of a device provided by a sponsor. | Sponsor Device Description | ||
Stereotactic Surgery Frame Type | C106570 | Stereotactic Surgery Frame Type | The classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI) | Stereotactic Surgery Frame Type | ||
Trade Name | C71898 | Trade Name | The part of the name or logo associated with a specific product or service identifying and distinguishing it from varieties of the same product or service marketed by competing companies. | Proprietary Name | ||
Back to top | ||||||
CL.C106481.DIPARMCD | Device Identifier Short Name
(DIPARMCD) | text
Extensible: Yes | C106481 | Device Identifier Short Name | A terminology codelist for the short name of the identifier characteristic of the device. | CDISC SDTM Device Identifier Parameter Short Name Terminology |
BATCH | C104504 | Batch Identifier;Batch Number | A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous. | Batch Number | ||
CATNUM | C99286 | Catalog Number | A unique manufacturer-assigned identifier used to distinguish a specific product from others in a catalog of products offered. | Catalog Number | ||
DEVTYPE | C53265 | Device Type | Generic category of medical device within the device classification established by a regulatory authority. | Type of Device | ||
FDAUDI | C112279 | FDA Unique Device Identification | A UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number, the serial number and/or expiration date. (FDA) | FDA Unique Device Identifier | ||
LOT | C70848 | Lot Identifier;Lot Number | A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product within a batch. | Lot Number | ||
MANUF | C25392 | Manufacturer | The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG) | Manufacturer | ||
MODEL | C99285 | Model Identifier;Model Number | The identifier assigned to a particular design of a device, usually an alphanumeric text string. | Model Number | ||
SECURLD | C111191 | Secure Lead Type | The type of locking device used to securely fasten the electrical leads to the device. (NCI) | Electrical Lead Locking Type | ||
SERIAL | C73518 | Serial Number | A unique identifier assigned to an individual object. | Serial Number | ||
SFMTYP | C106570 | Stereotactic Surgery Frame Type | The classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI) | Stereotactic Surgery Frame Type | ||
SPDEVDSC | C170568 | Sponsor Device Description | The free-text description of the characteristics of a device provided by a sponsor. | Sponsor Device Description | ||
TRADENAM | C71898 | Trade Name | The part of the name or logo associated with a specific product or service identifying and distinguishing it from varieties of the same product or service marketed by competing companies. | Proprietary Name | ||
Back to top | ||||||
CL.C111111.DOTESTCD | Device Properties Test Code
(DOTESTCD) | text
Extensible: Yes | C111111 | Device Properties Test Code | A terminology codelist based on the test code used to obtain the device property. | CDISC SDTM Device Properties Test Code Terminology |
BULBNUM | C172481 | Number of Bulbs;Number of Light Bulbs | The total number of light bulbs associated with the entity. | Number of Bulbs | ||
COMPOS | C53414 | Composition | The materials from which something is made. | Composition | ||
DIGSMPRT | C142234 | Digital Sampling Rate | The number of digital samples taken or recorded per unit of time. | Digital Sampling Rate | ||
DINTMKNM | C154712 | Dinucleotide Marker Names | The literal identifier of the dinucleotide markers present in an assay kit. | Dinucleotide Marker Name | ||
DVOPBLST | C170567 | Device Output Blinding Status | The blinding condition or state of the information generated and provided by a device. | Device Data Blinded Status | ||
ECSNRTYP | C142235 | Electrical Current Sensor Type | A description of the sensor used to detect electrical current. | Type of Electrical Current Sensor | ||
FDADEVCL | C112278 | FDA Device Classification | The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860). | FDA Device Classification | ||
INDC | C41184 | Indication for Use | A general description of the disease or condition the product will diagnose, treat, prevent, cure, or mitigate. | Indication | ||
IORFAREA | C154711 | Internal Orifice Area | The extent of a 2-dimensional surface enclosed within the boundary of an internal orifice. | Internal Orifice Area | ||
LUMNCTYP | C120606 | Luminescence Type | A classification of light emission. | Luminescence Type | ||
MAGFSTR | C156494 | Magnetic Field Strength | A measurement of the force of magnetism that acts in the region around a magnetic material or a moving electrical charge. | Magnetic Field Strength | ||
MONTMKNM | C150830 | Mononucleotide Marker Names | The literal identifier of the mononucleotide markers present in an assay kit. | Mononucleotide Marker Name | ||
MRICTYPE | C116119 | MRI Coil Type | The classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast. | MRI Coil Type | ||
MULTPLEX | C116118 | Multiplex Probe Parameter | A descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate. | Multiplex Probe Parameter | ||
PENTMKNM | C150831 | Pentanucleotide Marker Names | The literal identifier of the pentanucleotide markers present in an assay kit. | Pentanucleotide Marker Name | ||
PORESIZE | C112332 | Pore Size | A quantitative or qualitative measurement of the physical dimensions of the pores in a material. | Material Pore Size | ||
REAGLOT | C112406 | Reagent Lot | The lot number of the reagent. | Reagent Lot Number | ||
SCRYSTYP | C116120 | Scintillation Crystal Type | The classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure. | Scintillation Crystal Type | ||
SCTTHICK | C176286 | Section Thickness | A measurement of the thickness of a sectioned slice (of tissue or mineral or other substance). | Section Thickness | ||
SFTWRNAM | C150832 | Software Name | The literal identifier of the software program. | Software Name | ||
SFTWRVER | C111093 | Software Version | A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) | Software Version | ||
SHLFLIFE | C70855 | Shelf Life | The period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured. | Medical Product Shelf Life | ||
SIZE | C25681 | Size | The physical magnitude of something. (NCI) | Size | ||
SRGMSHOA | C112421 | Surgical Mesh Open Area | A quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure. | Surgical Mesh Open Area | ||
TEMP | C25206 | Temperature | The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) | Temperature | ||
THICKNSS | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
THRSHCYC | C161328 | Cp Number;Crossing point Number;Ct;Ct Number;Cycle Threshold;Cycle Threshold #;Cycle Threshold Number;Elbow Value;Take-off Point Number;Threshold Cycle;Threshold Cycle Number;TOP Number | The cycle number where the fluorescence of the target is detected above the background signal or a pre-set threshold. This value may be used for the computation of the concentration of a target in a polymerase chain reaction (PCR). | Threshold Cycle | ||
TRTAMT | C158156 | Treatment Amount | The concentration or quantity of the treatment. | Treatment Amount | ||
WAVLGTH | C48158 | Wavelength | The distance (measured in the direction of propagation) between two points in the same phase in consecutive cycles of a wave. (NCI) | Wavelength | ||
Back to top | ||||||
CL.C111112.DOTEST | Device Properties Test Name
(DOTEST) | text
Extensible: Yes | C111112 | Device Properties Test Name | A terminology codelist based on the test name used to obtain the device property. | CDISC SDTM Device Properties Test Name Terminology |
Composition | C53414 | Composition | The materials from which something is made. | Composition | ||
Device Output Blinding Status | C170567 | Device Output Blinding Status | The blinding condition or state of the information generated and provided by a device. | Device Data Blinded Status | ||
Digital Sampling Rate | C142234 | Digital Sampling Rate | The number of digital samples taken or recorded per unit of time. | Digital Sampling Rate | ||
Dinucleotide Marker Names | C154712 | Dinucleotide Marker Names | The literal identifier of the dinucleotide markers present in an assay kit. | Dinucleotide Marker Name | ||
Electrical Current Sensor Type | C142235 | Electrical Current Sensor Type | A description of the sensor used to detect electrical current. | Type of Electrical Current Sensor | ||
FDA Device Classification | C112278 | FDA Device Classification | The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860). | FDA Device Classification | ||
Indication for Use | C41184 | Indication for Use | A general description of the disease or condition the product will diagnose, treat, prevent, cure, or mitigate. | Indication | ||
Internal Orifice Area | C154711 | Internal Orifice Area | The extent of a 2-dimensional surface enclosed within the boundary of an internal orifice. | Internal Orifice Area | ||
Luminescence Type | C120606 | Luminescence Type | A classification of light emission. | Luminescence Type | ||
Magnetic Field Strength | C156494 | Magnetic Field Strength | A measurement of the force of magnetism that acts in the region around a magnetic material or a moving electrical charge. | Magnetic Field Strength | ||
Mononucleotide Marker Names | C150830 | Mononucleotide Marker Names | The literal identifier of the mononucleotide markers present in an assay kit. | Mononucleotide Marker Name | ||
MRI Coil Type | C116119 | MRI Coil Type | The classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast. | MRI Coil Type | ||
Multiplex Probe Parameter | C116118 | Multiplex Probe Parameter | A descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate. | Multiplex Probe Parameter | ||
Number of Bulbs | C172481 | Number of Bulbs;Number of Light Bulbs | The total number of light bulbs associated with the entity. | Number of Bulbs | ||
Pentanucleotide Marker Names | C150831 | Pentanucleotide Marker Names | The literal identifier of the pentanucleotide markers present in an assay kit. | Pentanucleotide Marker Name | ||
Pore Size | C112332 | Pore Size | A quantitative or qualitative measurement of the physical dimensions of the pores in a material. | Material Pore Size | ||
Reagent Lot | C112406 | Reagent Lot | The lot number of the reagent. | Reagent Lot Number | ||
Scintillation Crystal Type | C116120 | Scintillation Crystal Type | The classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure. | Scintillation Crystal Type | ||
Section Thickness | C176286 | Section Thickness | A measurement of the thickness of a sectioned slice (of tissue or mineral or other substance). | Section Thickness | ||
Shelf Life | C70855 | Shelf Life | The period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured. | Medical Product Shelf Life | ||
Size | C25681 | Size | The physical magnitude of something. (NCI) | Size | ||
Software Name | C150832 | Software Name | The literal identifier of the software program. | Software Name | ||
Software Version | C111093 | Software Version | A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) | Software Version | ||
Surgical Mesh Open Area | C112421 | Surgical Mesh Open Area | A quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure. | Surgical Mesh Open Area | ||
Temperature | C25206 | Temperature | The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) | Temperature | ||
Thickness | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
Threshold Cycle | C161328 | Cp Number;Crossing point Number;Ct;Ct Number;Cycle Threshold;Cycle Threshold #;Cycle Threshold Number;Elbow Value;Take-off Point Number;Threshold Cycle;Threshold Cycle Number;TOP Number | The cycle number where the fluorescence of the target is detected above the background signal or a pre-set threshold. This value may be used for the computation of the concentration of a target in a polymerase chain reaction (PCR). | Threshold Cycle | ||
Treatment Amount | C158156 | Treatment Amount | The concentration or quantity of the treatment. | Treatment Amount | ||
Wavelength | C48158 | Wavelength | The distance (measured in the direction of propagation) between two points in the same phase in consecutive cycles of a wave. (NCI) | Wavelength | ||
Back to top | ||||||
CL.C112037.DTDECOD | Device Tracking and Disposition Event Dictionary Derived Term
(DTDECOD) | text
Extensible: Yes | C112037 | Device Tracking and Disposition Event Dictionary Derived Term | A terminology codelist based on the standardized or preprinted name of the device tracking and disposition event that occurs. | CDISC SDTM Device Tracking and Disposition Event Dictionary Derived Term Terminology |
DEPLOYED | C101231 | The act of instantiating, positioning or activating a medical device inside of the body. | Medical Device Deployment | |||
DESTROYED | C112270 | A finding referring to a product that has been demolished. | Destroyed Medical Device | |||
EXPLANTED | C114146 | A status indicating that a device is removed from a surgically or naturally formed cavity of the human body. | Explanted Medical Device | |||
IMPLANTED | C80457 | A status indicating that a device is placed into a surgically or naturally formed cavity of the human body. | Implanted Medical Device | |||
INTENDED BUT NOT USED | C117758 | A status indicating that a device was introduced to the subject for use but did not meet its intended goal and was removed. (NCI) | Device Intended But Not Used | |||
LOST | C112329 | A finding referring to a product that is no longer held or possessed; incapable of being recovered or regained. | Lost Medical Device | |||
RECEIVED | C25639 | Coming into possession of or acting as the receptacle or recipient of an item conveyed by an intermediary to the intended destination, from a sender. | Receive | |||
SHIPPED | C40353 | Being transported or conveyed by an intermediary to a destination, from the sender to the intended receiver. | Shipping | |||
Back to top | ||||||
CL.C129938.DURS | Device-In-Use Response
(DURS) | text
Extensible: Yes | C129938 | Device-In-Use Response | A terminology codelist relevant to the device-in-use responses. | CDISC SDTM Device-In-Use Response Terminology |
2-DIMENSIONAL BIPLANE MODE | C130058 | An ultrasound imaging setting that uses a probe with two 2-dimensional (2D) planes set perpendicularly to each other, allowing for better detection and localization of objects/structures. | 2-Dimensional Biplane Ultrasound Mode | |||
2-DIMENSIONAL SINGLE PLANE MODE | C130059 | An ultrasound imaging setting that uses a linear pattern of beams to produce a standard, 2-dimensional (2-D) image. | 2-Dimensional Single Plane Ultrasound Mode | |||
3-DIMENSIONAL MODE | C130060 | An ultrasound imaging setting that reconstructs planar ultrasound data into three dimensional images of the structure being scanned. | 3-Dimensional Ultrasound Mode | |||
COLOR TISSUE DOPPLER MODE | C130061 | Color Flow Tissue Doppler Mode | An ultrasound imaging setting that uses pulsed wave Doppler signals to depict tissue motion direction and velocity in color images that are superimposed over normal, 2-dimensional (2-D) images. | Color Tissue Doppler Ultrasound Mode | ||
CONTINUOUS-WAVE DOPPLER MODE | C130062 | Continuous Doppler Mode;CW Doppler | An ultrasound imaging setting that uses Doppler signals that are continuously sent and received along a single line to measure both direction and velocity of blood flow. | Continuous-Wave Doppler Ultrasound Mode | ||
M-MODE | C130063 | Motion Mode | An ultrasound imaging setting that uses a single ultrasound beam to provide high temporal resolution of tissue motion. | M-Mode Ultrasound Mode | ||
PULSED-WAVE DOPPLER MODE | C130064 | Pulsed Doppler Mode;PW Doppler | An ultrasound imaging setting that uses intermittent Doppler signals to measure both direction and velocity of blood flow. | Pulsed-Wave Doppler Ultrasound Mode | ||
PULSED-WAVE TISSUE DOPPLER MODE | C130065 | Pulsed Tissue Doppler Mode | An ultrasound imaging setting that uses pulsed wave Doppler signals to measure velocity of tissue movement. | Pulsed-Wave Tissue Doppler Ultrasound Mode | ||
TISSUE DOPPLER MODE | C130066 | An ultrasound imaging setting that uses intermittent Doppler signals to measure velocity of tissue movement. | Tissue Doppler Ultrasound Mode | |||
Back to top | ||||||
CL.C106483.DUTESTCD | Device-In-Use Test Code
(DUTESTCD) | text
Extensible: Yes | C106483 | Device-In-Use Test Code | A terminology codelist for the test code of the test or examination used to obtain the measurement or finding of the device in use. | CDISC SDTM Device-In-Use Test Code Terminology |
ANTPLANE | C102516 | Anatomical Plane | The position and orientation of the image slice relative to the patient-based coordinate system. (NCI) | Image Plane | ||
AQMTRXSZ | C106533 | Image Acquisition Matrix Size | A measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI) | Image Acquisition Matrix Size | ||
ATTCRCT | C94862 | Attenuation Correction Type | The adjustment for the effect of tissue thicknesses through which gamma's travel from an activity concentration origin to the scanner's detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma's path. This makes possible accurate quantitation in image analysis. (NCI) | Attenuation Correction | ||
CAUDRIND | C142236 | Continuous Audio Recording Indicator | An indication as to whether a continuous audio recording is made during the assessment. | Continuous Audio Recording Made Indicator | ||
CBINRATS | C163418 | Carbohydrate to Insulin Ratio Setting | A setting on a device that specifies the ratio of the carbohydrates to insulin in the administered product. | Carbohydrate to Insulin Ratio Device Setting | ||
CHCKSIZE | C117759 | Checkerboard Square Size | A visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway. | Checkerboard Square Size | ||
COILNUM | C112364 | Number of Coil Channels | The number of channels, or elements, in the coil component of the device. | Number of Coil Channels | ||
COILSTR | C106510 | Coil Strength | The maximum voltage allowable to pass through an electromagnetic coil. (NCI) | Coil Strength | ||
DECCORR | C116127 | Decay Correction Indicator | An indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition. | Decay Correction Indicator | ||
ECGELCTN | C154906 | Number of ECG Electrodes;Number of EKG Electrodes;Number of Electrocardiogram Electrodes | The number of electrocardiogram electrodes used in the assessment. | Number of Electrocardiogram Electrodes | ||
ECHOTIME | C82331 | Echo Time | The time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI) | Echo Time | ||
EEGELCTN | C154713 | Number of EEG Electrodes;Number of Electroencephalogram Electrodes | The number of electroencephalogram electrodes used in the assessment. | Number of Electroencephalogram Electrodes | ||
EMGELCTN | C154908 | Number of Electromyogram Electrodes;Number of EMG Electrodes | The number of electromyogram electrodes used in the assessment. | Number of Electromyogram Electrodes | ||
EOGELCTN | C154907 | Number of Electrooculogram Electrodes;Number of EOG Electrodes | The number of electrooculogram electrodes used in the assessment. | Number of Electrooculogram Electrodes | ||
FLDVIEW | C74298 | Field of View | The extent of an area that is visible. (NCI) | Field of View | ||
FLIPANGL | C73792 | Flip Angle | In magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI) | Flip Angle | ||
GLUCALTH | C170566 | Glucose Alert Threshold | A setting on a device that triggers the onset of an alarm when a pre-specified value of glucose level has been reached. | Glucose Alert Threshold | ||
GLUCTLEV | C170565 | Glucose Target Level | A setting on a device where one can set and adjust the target value of blood glucose level. | Glucose Target Level | ||
H2OSUPPR | C156661 | Water Signal Suppression Method | The technique used to mitigate the signal that is generated from body water during imaging. | Water Signal Suppression Method | ||
IMAQDIM | C116126 | Image Acquisition Dimensionality | The number of dimensions that the acquired image(s) are presented in. | Image Acquisition Dimensionality | ||
IMWGTTYP | C116122 | Image Weighting Type | A classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state. | Image Weighting Type | ||
INDLAUMD | C172482 | Insulin Delivery Automation Mode | The setting on a device that will allow the delivery of insulin to a subject, either automatically or manually, in response to the glucose levels within the subject. (NCI) | Insulin Delivery Automation Mode | ||
INTDISTM | C116123 | Interslice Distance | A measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment. | Interslice Distance Measurement | ||
INVRTIME | C116124 | Inversion Time | The time between the inversion and excitation pulses in an inversion recovery pulse sequence. | Inversion Time | ||
MAXBOLUS | C165872 | Max Bolus;Maximum Bolus | A setting and safety feature on a device to control the maximum amount of a substance delivered in a single bolus. | Maximum Bolus Device Setting | ||
MBRMST | C172483 | Missed Bolus Reminder Status | The status of a setting that enables alerts if a bolus is not delivered during a pre-specified time period. (NCI) | Missed Bolus Reminder Status | ||
NUMSLICE | C116125 | Number of Slices | The number of planar cross-sections in an imaging sequence; each slice corresponds to a single image. | Number of Slices | ||
PIXSPCX | C69201 | X-axis Pixel Spacing | A measurement of the distance between the centers of two adjacent pixels located along the X-axis. | Horizontal Pixel Spacing | ||
PIXSPCY | C69210 | Y-axis Pixel Spacing | A measurement of the distance between the centers of two adjacent pixels located along the Y-axis. | Vertical Pixel Spacing | ||
PULOXIND | C142237 | Pulse Oximeter Indicator | An indication as to whether a pulse oximeter is used in the assessment. | Pulse Oximeter Use Indicator | ||
PULSSEQ | C106562 | Pulse Sequence | A serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI) | Pulse Sequence | ||
RANDCORR | C116128 | Randoms Correction Indicator | An indication as to whether the device was set to correct for random noise generated by deflected positrons. | Randoms Correction Indicator | ||
RCBDWDTH | C106563 | Receiver Bandwidth | The range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI) | Receiver Bandwidth | ||
RCFLTRTP | C106564 | Reconstruction Filter Type | A classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image. | Reconstruction Filter Type | ||
RECONDAT | C111303 | Reconstruction of Raw Data Type | The type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI) | Reconstruction of Raw Data Type | ||
REFEQU | C154716 | Reference Equation | A mathematical formula to predict measured outcomes based on values of associated parameters determined to be related to a test. Reference equations are typically derived via regression analysis of parameters postulated to be relevant to the outcome over sample cohorts from large populations, and verified by comparing measured outcomes to predictions over out-of-sample cohorts. | Reference Equation | ||
REPTIME | C82330 | Repetition Time | The amount of time in milliseconds between successive pulse sequences applied to the same slice. | Repetition Time | ||
SFTWRVER | C111093 | Software Version | A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) | Software Version | ||
SIGAMP | C112416 | Signal Amplitude | A measurement of the height of the signal. | Signal Amplitude | ||
SIGFREQ | C112417 | Signal Frequency | A measurement of the number of cycles of a periodic wave or pulse per unit of time. | Signal Frequency | ||
SIGW | C112418 | Signal Width | A measurement of the range of values seen in the time interval between the beginning and end of the pulse wave. | Signal Width | ||
SLICNUM | C111314 | Slice Number | The numeric identifier used to identify an image slice. (NCI) | Slice Number | ||
SPECTWD | C156496 | Spectral Width | The width of the wavelength interval at half maximum amplitude. | Spectral Width | ||
SPSMTIME | C156501 | STEAM Pulse Sequence Mixing Time;Stimulated Echo Acquisition Mode Pulse Sequence Mixing Time | The time elapsed between the second and third pulses of the stimulated echo acquisition mode (STEAM) pulse sequence. | STEAM Pulse Sequence Mixing Time | ||
STHICK | C106534 | Slice Thickness | The dimension between two surfaces of an imaging plane. (NCI) | Image Slice Thickness | ||
STIMPARM | C114145 | Stimulation Parameter | The type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ. | Electrical Stimulation Electrode Type | ||
TRTAMT | C158156 | Treatment Amount | The concentration or quantity of the treatment. | Treatment Amount | ||
ULTRMODE | C130045 | Ultrasound Mode | The image acquisition settings of an ultrasound-based imaging modality, based on parameters including transducer design, ultrasound frequency, and ultrasound signal processing. | Ultrasound Mode | ||
USH2OAVN | C156495 | Number of Unsuppressed Water Averages | The number of averages of the unsuppressed water spectrum signal that are captured during imaging. | Number of Unsuppressed Water Averages | ||
VOXDIMX | C156497 | X-Axis Voxel Dimension | The linear measurement of a voxel along the X-axis. | X-Axis Voxel Dimension | ||
VOXDIMY | C156498 | Y-Axis Voxel Dimension | The linear measurement of a voxel along the Y-axis. | Y-Axis Voxel Dimension | ||
VOXDIMZ | C156499 | Z-Axis Voxel Dimension | The linear measurement of a voxel along the Z-axis. | Z-Axis Voxel Dimension | ||
VOXORIEN | C156500 | Voxel Angle;Voxel Orientation | The angle of the voxel relative to the coordinate system of the scanner. | Voxel Orientation | ||
Back to top | ||||||
CL.C106482.DUTEST | Device-In-Use Test Name
(DUTEST) | text
Extensible: Yes | C106482 | Device-In-Use Test Name | A terminology codelist for the test name of the test or examination used to obtain the measurement or finding of the device in use. | CDISC SDTM Device-In-Use Test Name Terminology |
Anatomical Plane | C102516 | Anatomical Plane | The position and orientation of the image slice relative to the patient-based coordinate system. (NCI) | Image Plane | ||
Attenuation Correction Type | C94862 | Attenuation Correction Type | The adjustment for the effect of tissue thicknesses through which gamma's travel from an activity concentration origin to the scanner's detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma's path. This makes possible accurate quantitation in image analysis. (NCI) | Attenuation Correction | ||
Carbohydrate to Insulin Ratio Setting | C163418 | Carbohydrate to Insulin Ratio Setting | A setting on a device that specifies the ratio of the carbohydrates to insulin in the administered product. | Carbohydrate to Insulin Ratio Device Setting | ||
Checkerboard Square Size | C117759 | Checkerboard Square Size | A visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway. | Checkerboard Square Size | ||
Coil Strength | C106510 | Coil Strength | The maximum voltage allowable to pass through an electromagnetic coil. (NCI) | Coil Strength | ||
Continuous Audio Recording Indicator | C142236 | Continuous Audio Recording Indicator | An indication as to whether a continuous audio recording is made during the assessment. | Continuous Audio Recording Made Indicator | ||
Decay Correction Indicator | C116127 | Decay Correction Indicator | An indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition. | Decay Correction Indicator | ||
Echo Time | C82331 | Echo Time | The time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI) | Echo Time | ||
Field of View | C74298 | Field of View | The extent of an area that is visible. (NCI) | Field of View | ||
Flip Angle | C73792 | Flip Angle | In magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI) | Flip Angle | ||
Glucose Alert Threshold | C170566 | Glucose Alert Threshold | A setting on a device that triggers the onset of an alarm when a pre-specified value of glucose level has been reached. | Glucose Alert Threshold | ||
Glucose Target Level | C170565 | Glucose Target Level | A setting on a device where one can set and adjust the target value of blood glucose level. | Glucose Target Level | ||
Image Acquisition Dimensionality | C116126 | Image Acquisition Dimensionality | The number of dimensions that the acquired image(s) are presented in. | Image Acquisition Dimensionality | ||
Image Acquisition Matrix Size | C106533 | Image Acquisition Matrix Size | A measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI) | Image Acquisition Matrix Size | ||
Image Weighting Type | C116122 | Image Weighting Type | A classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state. | Image Weighting Type | ||
Insulin Delivery Automation Mode | C172482 | Insulin Delivery Automation Mode | The setting on a device that will allow the delivery of insulin to a subject, either automatically or manually, in response to the glucose levels within the subject. (NCI) | Insulin Delivery Automation Mode | ||
Interslice Distance | C116123 | Interslice Distance | A measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment. | Interslice Distance Measurement | ||
Inversion Time | C116124 | Inversion Time | The time between the inversion and excitation pulses in an inversion recovery pulse sequence. | Inversion Time | ||
Maximum Bolus | C165872 | Max Bolus;Maximum Bolus | A setting and safety feature on a device to control the maximum amount of a substance delivered in a single bolus. | Maximum Bolus Device Setting | ||
Missed Bolus Reminder Status | C172483 | Missed Bolus Reminder Status | The status of a setting that enables alerts if a bolus is not delivered during a pre-specified time period. (NCI) | Missed Bolus Reminder Status | ||
Number of Coil Channels | C112364 | Number of Coil Channels | The number of channels, or elements, in the coil component of the device. | Number of Coil Channels | ||
Number of ECG Electrodes | C154906 | Number of ECG Electrodes;Number of EKG Electrodes;Number of Electrocardiogram Electrodes | The number of electrocardiogram electrodes used in the assessment. | Number of Electrocardiogram Electrodes | ||
Number of EEG Electrodes | C154713 | Number of EEG Electrodes;Number of Electroencephalogram Electrodes | The number of electroencephalogram electrodes used in the assessment. | Number of Electroencephalogram Electrodes | ||
Number of EMG Electrodes | C154908 | Number of Electromyogram Electrodes;Number of EMG Electrodes | The number of electromyogram electrodes used in the assessment. | Number of Electromyogram Electrodes | ||
Number of EOG Electrodes | C154907 | Number of Electrooculogram Electrodes;Number of EOG Electrodes | The number of electrooculogram electrodes used in the assessment. | Number of Electrooculogram Electrodes | ||
Number of Slices | C116125 | Number of Slices | The number of planar cross-sections in an imaging sequence; each slice corresponds to a single image. | Number of Slices | ||
Number of Unsuppressed Water Averages | C156495 | Number of Unsuppressed Water Averages | The number of averages of the unsuppressed water spectrum signal that are captured during imaging. | Number of Unsuppressed Water Averages | ||
Pulse Oximeter Indicator | C142237 | Pulse Oximeter Indicator | An indication as to whether a pulse oximeter is used in the assessment. | Pulse Oximeter Use Indicator | ||
Pulse Sequence | C106562 | Pulse Sequence | A serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI) | Pulse Sequence | ||
Randoms Correction Indicator | C116128 | Randoms Correction Indicator | An indication as to whether the device was set to correct for random noise generated by deflected positrons. | Randoms Correction Indicator | ||
Receiver Bandwidth | C106563 | Receiver Bandwidth | The range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI) | Receiver Bandwidth | ||
Reconstruction Filter Type | C106564 | Reconstruction Filter Type | A classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image. | Reconstruction Filter Type | ||
Reconstruction of Raw Data Type | C111303 | Reconstruction of Raw Data Type | The type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI) | Reconstruction of Raw Data Type | ||
Reference Equation | C154716 | Reference Equation | A mathematical formula to predict measured outcomes based on values of associated parameters determined to be related to a test. Reference equations are typically derived via regression analysis of parameters postulated to be relevant to the outcome over sample cohorts from large populations, and verified by comparing measured outcomes to predictions over out-of-sample cohorts. | Reference Equation | ||
Repetition Time | C82330 | Repetition Time | The amount of time in milliseconds between successive pulse sequences applied to the same slice. | Repetition Time | ||
Signal Amplitude | C112416 | Signal Amplitude | A measurement of the height of the signal. | Signal Amplitude | ||
Signal Frequency | C112417 | Signal Frequency | A measurement of the number of cycles of a periodic wave or pulse per unit of time. | Signal Frequency | ||
Signal Width | C112418 | Signal Width | A measurement of the range of values seen in the time interval between the beginning and end of the pulse wave. | Signal Width | ||
Slice Number | C111314 | Slice Number | The numeric identifier used to identify an image slice. (NCI) | Slice Number | ||
Slice Thickness | C106534 | Slice Thickness | The dimension between two surfaces of an imaging plane. (NCI) | Image Slice Thickness | ||
Software Version | C111093 | Software Version | A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) | Software Version | ||
Spectral Width | C156496 | Spectral Width | The width of the wavelength interval at half maximum amplitude. | Spectral Width | ||
STEAM Pulse Sequence Mixing Time | C156501 | STEAM Pulse Sequence Mixing Time;Stimulated Echo Acquisition Mode Pulse Sequence Mixing Time | The time elapsed between the second and third pulses of the stimulated echo acquisition mode (STEAM) pulse sequence. | STEAM Pulse Sequence Mixing Time | ||
Stimulation Parameter | C114145 | Stimulation Parameter | The type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ. | Electrical Stimulation Electrode Type | ||
Treatment Amount | C158156 | Treatment Amount | The concentration or quantity of the treatment. | Treatment Amount | ||
Ultrasound Mode | C130045 | Ultrasound Mode | The image acquisition settings of an ultrasound-based imaging modality, based on parameters including transducer design, ultrasound frequency, and ultrasound signal processing. | Ultrasound Mode | ||
Voxel Orientation | C156500 | Voxel Angle;Voxel Orientation | The angle of the voxel relative to the coordinate system of the scanner. | Voxel Orientation | ||
Water Signal Suppression Method | C156661 | Water Signal Suppression Method | The technique used to mitigate the signal that is generated from body water during imaging. | Water Signal Suppression Method | ||
X-axis Pixel Spacing | C69201 | X-axis Pixel Spacing | A measurement of the distance between the centers of two adjacent pixels located along the X-axis. | Horizontal Pixel Spacing | ||
X-Axis Voxel Dimension | C156497 | X-Axis Voxel Dimension | The linear measurement of a voxel along the X-axis. | X-Axis Voxel Dimension | ||
Y-axis Pixel Spacing | C69210 | Y-axis Pixel Spacing | A measurement of the distance between the centers of two adjacent pixels located along the Y-axis. | Vertical Pixel Spacing | ||
Y-Axis Voxel Dimension | C156498 | Y-Axis Voxel Dimension | The linear measurement of a voxel along the Y-axis. | Y-Axis Voxel Dimension | ||
Z-Axis Voxel Dimension | C156499 | Z-Axis Voxel Dimension | The linear measurement of a voxel along the Z-axis. | Z-Axis Voxel Dimension | ||
Back to top | ||||||
CL.C161621.DDS01TC | Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire Test Code
(DDS01TC) | text
Extensible: No | C161621 | Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire Test Code | Diabetes Distress Scale for Adults with Type 1 Diabetes test code. | CDISC Questionnaire T1-DDS Test Code Terminology |
DDS0101 | C161704 | DDS01-Not Skilled at Managing Diabetes | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I am not as skilled at managing diabetes as I should be. | T1-DDS - Not Skilled at Managing Diabetes | ||
DDS0102 | C161705 | DDS01-I Don't Eat Carefully as I Should | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't eat as carefully as I probably should. | T1-DDS - I Don't Eat Carefully as I Should | ||
DDS0103 | C161706 | DDS01-Don't Notice Signs of Hypoglycemia | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't notice the warning signs of hypoglycemia as well as I used to. | T1-DDS - Don't Notice Signs of Hypoglycemia | ||
DDS0104 | C161707 | DDS01-People Treat Me Differently | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that people treat me differently when they find out I have diabetes. | T1-DDS - People Treat Me Differently | ||
DDS0105 | C161708 | DDS01-Discouraged See High Blood Glucose | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling discouraged when I see high blood glucose numbers that I can't explain. | T1-DDS - Discouraged See High Blood Glucose | ||
DDS0106 | C161709 | DDS01-Family Make Bigger Deal Diabetes | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my family and friends make a bigger deal out of diabetes than they should. | T1-DDS - Family Make Bigger Deal Diabetes | ||
DDS0107 | C161710 | DDS01-Can't Tell Doctor What on My Mind | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I can't tell my diabetes doctor what is really on my mind. | T1-DDS - Can't Tell Doctor What on My Mind | ||
DDS0108 | C161711 | DDS01-Not Taking Insulin as I Should | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I am not taking as much insulin as I should. | T1-DDS - Not Taking Insulin as I Should | ||
DDS0109 | C161712 | DDS01-Too Much Diabetes Equipment w/Me | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that there is too much diabetes equipment and stuff I must always have with me. | T1-DDS - Too Much Diabetes Equipment With Me | ||
DDS0110 | C161713 | DDS01-Have to Hide My Diabetes | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling like I have to hide my diabetes from other people. | T1-DDS - Have to Hide My Diabetes | ||
DDS0111 | C161714 | DDS01-Family Worry About Hypoglycemia | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends and family worry more about hypoglycemia than I want them to. | T1-DDS - Family Worry About Hypoglycemia | ||
DDS0112 | C161715 | DDS01-Don't Check Glucose as I Should | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't check my blood glucose level as often as I probably should. | T1-DDS - Don't Check Glucose as I Should | ||
DDS0113 | C161716 | DDS01-Worried Develop Complications | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling worried that I will develop serious long-term complications, no matter how hard I try. | T1-DDS - Worried Develop Complications | ||
DDS0114 | C161717 | DDS01-Don't Get Help From Doctor | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't get help I really need from my diabetes doctor about managing diabetes. | T1-DDS - Don't Get Help From Doctor | ||
DDS0115 | C161718 | DDS01-Hypoglycemic Event When Asleep | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling frightened that I could have a serious hypoglycemic event when I'm asleep. | T1-DDS - Hypoglycemic Event When Asleep | ||
DDS0116 | C161719 | DDS01-Food and Eating Control My Life | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that thoughts about food and eating control my life. | T1-DDS - Food and Eating Control My Life | ||
DDS0117 | C161720 | DDS01-Family Treat Me More Fragile | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends or family treat me as if I were more fragile or sicker than I really am. | T1-DDS - Family Treat Me More Fragile | ||
DDS0118 | C161721 | DDS01-Doctor Doesn't Understand | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my diabetes doctor doesn't really understand what it's like to have diabetes. | T1-DDS - Doctor Doesn't Understand | ||
DDS0119 | C161722 | DDS01-Less Attractive to Employers | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling concerned that diabetes may make me less attractive to employers. | T1-DDS - Less Attractive to Employers | ||
DDS0120 | C161723 | DDS01-Family Act Like Diabetes Police | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends or family act like 'diabetes police' (bother me too much). | T1-DDS - Family Act Like Diabetes Police | ||
DDS0121 | C161724 | DDS01-Be Perfect w/Diabetes Management | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I've got to be perfect with my diabetes management. | T1-DDS - Be Perfect With Diabetes Management | ||
DDS0122 | C161725 | DDS01-Hypoglycemic Event While Driving | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling frightened that I could have a serious hypoglycemic event while driving. | T1-DDS - Hypoglycemic Event While Driving | ||
DDS0123 | C161726 | DDS01-Eating Is Out of Control | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my eating is out of control. | T1-DDS - Eating Is Out of Control | ||
DDS0124 | C161727 | DDS01-People Think Less of Me | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that people will think less of me if they knew I had diabetes. | T1-DDS - People Think Less of Me | ||
DDS0125 | C161728 | DDS01-Never Be Good Enough | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that no matter how hard I try with my diabetes, it will never be good enough. | T1-DDS - Never Be Good Enough | ||
DDS0126 | C161729 | DDS01-Doctor Doesn't Know Enough | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my diabetes doctor doesn't know enough about diabetes and diabetes care. | T1-DDS - Doctor Doesn't Know Enough | ||
DDS0127 | C161730 | DDS01-Be Safe From Hypoglycemic Event | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I can't ever be safe from the possibility of a serious hypoglycemic event. | T1-DDS - Be Safe From Hypoglycemic Event | ||
DDS0128 | C161731 | DDS01-Don't Give Diabetes Attention | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't give my diabetes as much attention as I probably should. | T1-DDS - Don't Give Diabetes Attention | ||
DDS0129 | C161732 | DDS01-Total Scale | Diabetes Distress Scale for Adults with Type 1 Diabetes - Total scale. | T1-DDS - Total Scale | ||
DDS0130 | C161733 | DDS01-Subscale 1: Powerlessness | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 1 - Powerlessness. | T1-DDS - Subscale 1: Powerlessness | ||
DDS0131 | C161734 | DDS01-Subscale 2: Management Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 2 - Management distress. | T1-DDS - Subscale 2: Management Distress | ||
DDS0132 | C161735 | DDS01-Subscale 3: Hypoglycemia Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 3 - Hypoglycemia distress. | T1-DDS - Subscale 3: Hypoglycemia Distress | ||
DDS0133 | C161736 | DDS01-Subscale 4: Neg Social Perceptions | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 4 - Negative social perceptions. | T1-DDS - Subscale 4: Negative Social Perceptions | ||
DDS0134 | C161737 | DDS01-Subscale 5: Eating Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 5 - Eating distress. | T1-DDS - Subscale 5: Eating Distress | ||
DDS0135 | C161738 | DDS01-Subscale 6: Physician Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 6 - Physician distress. | T1-DDS - Subscale 6: Physician Distress | ||
DDS0136 | C161739 | DDS01-Subscale 7: Friend/Family Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 7 - Friend/family distress. | T1-DDS - Subscale 7: Friend/Family Distress | ||
Back to top | ||||||
CL.C161620.DDS01TN | Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire Test Name
(DDS01TN) | text
Extensible: No | C161620 | Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire Test Name | Diabetes Distress Scale for Adults with Type 1 Diabetes test name. | CDISC Questionnaire T1-DDS Test Name Terminology |
DDS01-Be Perfect w/Diabetes Management | C161724 | DDS01-Be Perfect w/Diabetes Management | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I've got to be perfect with my diabetes management. | T1-DDS - Be Perfect With Diabetes Management | ||
DDS01-Be Safe From Hypoglycemic Event | C161730 | DDS01-Be Safe From Hypoglycemic Event | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I can't ever be safe from the possibility of a serious hypoglycemic event. | T1-DDS - Be Safe From Hypoglycemic Event | ||
DDS01-Can't Tell Doctor What on My Mind | C161710 | DDS01-Can't Tell Doctor What on My Mind | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I can't tell my diabetes doctor what is really on my mind. | T1-DDS - Can't Tell Doctor What on My Mind | ||
DDS01-Discouraged See High Blood Glucose | C161708 | DDS01-Discouraged See High Blood Glucose | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling discouraged when I see high blood glucose numbers that I can't explain. | T1-DDS - Discouraged See High Blood Glucose | ||
DDS01-Doctor Doesn't Know Enough | C161729 | DDS01-Doctor Doesn't Know Enough | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my diabetes doctor doesn't know enough about diabetes and diabetes care. | T1-DDS - Doctor Doesn't Know Enough | ||
DDS01-Doctor Doesn't Understand | C161721 | DDS01-Doctor Doesn't Understand | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my diabetes doctor doesn't really understand what it's like to have diabetes. | T1-DDS - Doctor Doesn't Understand | ||
DDS01-Don't Check Glucose as I Should | C161715 | DDS01-Don't Check Glucose as I Should | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't check my blood glucose level as often as I probably should. | T1-DDS - Don't Check Glucose as I Should | ||
DDS01-Don't Get Help From Doctor | C161717 | DDS01-Don't Get Help From Doctor | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't get help I really need from my diabetes doctor about managing diabetes. | T1-DDS - Don't Get Help From Doctor | ||
DDS01-Don't Give Diabetes Attention | C161731 | DDS01-Don't Give Diabetes Attention | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't give my diabetes as much attention as I probably should. | T1-DDS - Don't Give Diabetes Attention | ||
DDS01-Don't Notice Signs of Hypoglycemia | C161706 | DDS01-Don't Notice Signs of Hypoglycemia | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't notice the warning signs of hypoglycemia as well as I used to. | T1-DDS - Don't Notice Signs of Hypoglycemia | ||
DDS01-Eating Is Out of Control | C161726 | DDS01-Eating Is Out of Control | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my eating is out of control. | T1-DDS - Eating Is Out of Control | ||
DDS01-Family Act Like Diabetes Police | C161723 | DDS01-Family Act Like Diabetes Police | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends or family act like 'diabetes police' (bother me too much). | T1-DDS - Family Act Like Diabetes Police | ||
DDS01-Family Make Bigger Deal Diabetes | C161709 | DDS01-Family Make Bigger Deal Diabetes | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my family and friends make a bigger deal out of diabetes than they should. | T1-DDS - Family Make Bigger Deal Diabetes | ||
DDS01-Family Treat Me More Fragile | C161720 | DDS01-Family Treat Me More Fragile | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends or family treat me as if I were more fragile or sicker than I really am. | T1-DDS - Family Treat Me More Fragile | ||
DDS01-Family Worry About Hypoglycemia | C161714 | DDS01-Family Worry About Hypoglycemia | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that my friends and family worry more about hypoglycemia than I want them to. | T1-DDS - Family Worry About Hypoglycemia | ||
DDS01-Food and Eating Control My Life | C161719 | DDS01-Food and Eating Control My Life | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that thoughts about food and eating control my life. | T1-DDS - Food and Eating Control My Life | ||
DDS01-Have to Hide My Diabetes | C161713 | DDS01-Have to Hide My Diabetes | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling like I have to hide my diabetes from other people. | T1-DDS - Have to Hide My Diabetes | ||
DDS01-Hypoglycemic Event When Asleep | C161718 | DDS01-Hypoglycemic Event When Asleep | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling frightened that I could have a serious hypoglycemic event when I'm asleep. | T1-DDS - Hypoglycemic Event When Asleep | ||
DDS01-Hypoglycemic Event While Driving | C161725 | DDS01-Hypoglycemic Event While Driving | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling frightened that I could have a serious hypoglycemic event while driving. | T1-DDS - Hypoglycemic Event While Driving | ||
DDS01-I Don't Eat Carefully as I Should | C161705 | DDS01-I Don't Eat Carefully as I Should | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I don't eat as carefully as I probably should. | T1-DDS - I Don't Eat Carefully as I Should | ||
DDS01-Less Attractive to Employers | C161722 | DDS01-Less Attractive to Employers | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling concerned that diabetes may make me less attractive to employers. | T1-DDS - Less Attractive to Employers | ||
DDS01-Never Be Good Enough | C161728 | DDS01-Never Be Good Enough | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that no matter how hard I try with my diabetes, it will never be good enough. | T1-DDS - Never Be Good Enough | ||
DDS01-Not Skilled at Managing Diabetes | C161704 | DDS01-Not Skilled at Managing Diabetes | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I am not as skilled at managing diabetes as I should be. | T1-DDS - Not Skilled at Managing Diabetes | ||
DDS01-Not Taking Insulin as I Should | C161711 | DDS01-Not Taking Insulin as I Should | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that I am not taking as much insulin as I should. | T1-DDS - Not Taking Insulin as I Should | ||
DDS01-People Think Less of Me | C161727 | DDS01-People Think Less of Me | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that people will think less of me if they knew I had diabetes. | T1-DDS - People Think Less of Me | ||
DDS01-People Treat Me Differently | C161707 | DDS01-People Treat Me Differently | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that people treat me differently when they find out I have diabetes. | T1-DDS - People Treat Me Differently | ||
DDS01-Subscale 1: Powerlessness | C161733 | DDS01-Subscale 1: Powerlessness | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 1 - Powerlessness. | T1-DDS - Subscale 1: Powerlessness | ||
DDS01-Subscale 2: Management Distress | C161734 | DDS01-Subscale 2: Management Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 2 - Management distress. | T1-DDS - Subscale 2: Management Distress | ||
DDS01-Subscale 3: Hypoglycemia Distress | C161735 | DDS01-Subscale 3: Hypoglycemia Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 3 - Hypoglycemia distress. | T1-DDS - Subscale 3: Hypoglycemia Distress | ||
DDS01-Subscale 4: Neg Social Perceptions | C161736 | DDS01-Subscale 4: Neg Social Perceptions | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 4 - Negative social perceptions. | T1-DDS - Subscale 4: Negative Social Perceptions | ||
DDS01-Subscale 5: Eating Distress | C161737 | DDS01-Subscale 5: Eating Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 5 - Eating distress. | T1-DDS - Subscale 5: Eating Distress | ||
DDS01-Subscale 6: Physician Distress | C161738 | DDS01-Subscale 6: Physician Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 6 - Physician distress. | T1-DDS - Subscale 6: Physician Distress | ||
DDS01-Subscale 7: Friend/Family Distress | C161739 | DDS01-Subscale 7: Friend/Family Distress | Diabetes Distress Scale for Adults with Type 1 Diabetes - Subscale 7 - Friend/family distress. | T1-DDS - Subscale 7: Friend/Family Distress | ||
DDS01-Too Much Diabetes Equipment w/Me | C161712 | DDS01-Too Much Diabetes Equipment w/Me | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling that there is too much diabetes equipment and stuff I must always have with me. | T1-DDS - Too Much Diabetes Equipment With Me | ||
DDS01-Total Scale | C161732 | DDS01-Total Scale | Diabetes Distress Scale for Adults with Type 1 Diabetes - Total scale. | T1-DDS - Total Scale | ||
DDS01-Worried Develop Complications | C161716 | DDS01-Worried Develop Complications | Diabetes Distress Scale for Adults with Type 1 Diabetes - Over the past month, please indicate the degree to which each of the following may have been a problem for you: Feeling worried that I will develop serious long-term complications, no matter how hard I try. | T1-DDS - Worried Develop Complications | ||
Back to top | ||||||
CL.C163395.DDS02TC | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire Test Code
(DDS02TC) | text
Extensible: No | C163395 | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire Test Code | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes test code. | CDISC Questionnaire PARENT-DDS Test Code Terminology |
DDS0201 | C163870 | DDS02-Don't Work Well Together | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that my teen and I just don't work well together when it comes to diabetes. | PARENT-DDS - Don't Work Well Together | ||
DDS0202 | C163871 | DDS02-Unappreciated for Ways I Help | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling unappreciated for all the ways I try to help my teen manage diabetes. | PARENT-DDS - Unappreciated for Ways I Help | ||
DDS0203 | C163872 | DDS02-Trust Teen Take Care of Diabetes | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that I can't trust my teen to take good care of his/her diabetes. | PARENT-DDS - Trust Teen Take Care of Diabetes | ||
DDS0204 | C163873 | DDS02-Low Blood Sugars Away From Home | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying about my teen's low blood sugars when he/she is away from home. | PARENT-DDS - Low Blood Sugars Away From Home | ||
DDS0205 | C163874 | DDS02-Teen Ignore/Forget Diabetes | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen will ignore or forget diabetes if I don't keep reminding him/her. | PARENT-DDS - Teen Ignore or Forget Diabetes | ||
DDS0206 | C163875 | DDS02-Taking Too Much of My Energy | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that diabetes is taking up too much of my mental and physical energy every day. | PARENT-DDS - Taking Too Much of My Energy | ||
DDS0207 | C163876 | DDS02-Help Teen Is a Battle | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that trying to help my teen with his/her diabetes is always a battle. | PARENT-DDS - Help Teen Is a Battle | ||
DDS0208 | C163877 | DDS02-Low Blood Sugars When Sleeping | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying about my teen's low blood sugars when he/she is sleeping. | PARENT-DDS - Low Blood Sugars When Sleeping | ||
DDS0209 | C163878 | DDS02-No One Notices Diabetes Hard on Me | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that no one notices that diabetes is hard on me, not just on my teen. | PARENT-DDS - No One Notices Diabetes Hard on Me | ||
DDS0210 | C163879 | DDS02-Doesn't Do Enough Manage Diabetes | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that my teen doesn't do enough to manage his/her diabetes. | PARENT-DDS - Doesn't Do Enough Manage Diabetes | ||
DDS0211 | C163880 | DDS02-Teen Doesn't Have Right Doctor | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen doesn't have the right doctor for him/her. | PARENT-DDS - Teen Doesn't Have Right Doctor | ||
DDS0212 | C163881 | DDS02-Blame Me If Not Well-controlled | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that others will blame me if my teen's diabetes is not well-controlled. | PARENT-DDS - Blame Me If Not Well-controlled | ||
DDS0213 | C163882 | DDS02-Leave Home and Cannot Protect Him | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen will soon leave home and I cannot protect him. | PARENT-DDS - Leave Home and Cannot Protect Him | ||
DDS0214 | C163883 | DDS02-Teen Ignores My Suggestions | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated because my teen ignores my suggestions about diabetes. | PARENT-DDS - Teen Ignores My Suggestions | ||
DDS0215 | C163884 | DDS02-Lack Support From Friends/Family | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated by the lack of understanding and support for diabetes I get from friends and family members. | PARENT-DDS - Lack Support From Friends and Family | ||
DDS0216 | C163885 | DDS02-Doesn't Get Expert Medical Help | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen doesn't get all of the expert medical help he/she needs. | PARENT-DDS - Doesn't Get Expert Medical Help | ||
DDS0217 | C163886 | DDS02-Motivate Teen Take Care Diabetes | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling uncertain about how to motivate my teen to take better care of his/her diabetes. | PARENT-DDS - Motivate Teen Take Care Diabetes | ||
DDS0218 | C163887 | DDS02-Teen Not Prepared Once Adult | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Concerned that my teen is not prepared to deal with the world of insurance and doctors once he/she is an adult. | PARENT-DDS - Teen Not Prepared Once Adult | ||
DDS0219 | C163888 | DDS02-Only One Takes Responsibility | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated that I am the only one who takes responsibility for helping my teen manage diabetes. | PARENT-DDS - Only One Takes Responsibility | ||
DDS0220 | C163889 | DDS02-My Nagging Hurting Relationship | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my nagging about diabetes is hurting my relationship with my teen. | PARENT-DDS - My Nagging Hurting Relationship | ||
DDS0221 | C163890 | DDS02-Total DDS Score: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Sum of 20 item scores. | PARENT-DDS - Total DDS Score: Sum | ||
DDS0222 | C163891 | DDS02-Total DDS Score: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Mean item score. | PARENT-DDS - Total DDS Score: Mean | ||
DDS0223 | C163892 | DDS02-Total DDS Score: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Total DDS Score: Moderate | ||
DDS0224 | C163893 | DDS02-Personal Distress: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Sum of 6 items (2, 6, 9, 12, 15, 19). | PARENT-DDS - Personal Distress: Sum | ||
DDS0225 | C163894 | DDS02-Personal Distress: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Mean item score. | PARENT-DDS - Personal Distress: Mean | ||
DDS0226 | C163895 | DDS02-Personal Distress: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Personal Distress: Moderate | ||
DDS0227 | C163896 | DDS02-Teen Management Distress: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Sum of 4 items (4, 8, 13, 18). | PARENT-DDS - Teen Management Distress: Sum | ||
DDS0228 | C163897 | DDS02-Teen Management Distress: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Mean item score. | PARENT-DDS - Teen Management Distress: Mean | ||
DDS0229 | C163898 | DDS02-Teen Management Distress: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Teen Management Distress: Moderate | ||
DDS0230 | C163899 | DDS02-Parent/Teen Rel Distress: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Sum of 8 items (1, 3, 5, 7, 10, 14, 17, 20). | PARENT-DDS - Parent/Teen Relationship Distress: Sum | ||
DDS0231 | C163900 | DDS02-Parent/Teen Rel Distress: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Mean item score. | PARENT-DDS - Parent/Teen Relationship Distress: Mean | ||
DDS0232 | C163901 | DDS02-Parent/Teen Rel Distress: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Parent/Teen Relationship Distress: Moderate | ||
DDS0233 | C163902 | DDS02-Healthcare Team Distress: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Sum of 2 items (11, 16). | PARENT-DDS - Healthcare Team Distress: Sum | ||
DDS0234 | C163903 | DDS02-Healthcare Team Distress: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Mean item score. | PARENT-DDS - Healthcare Team Distress: Mean | ||
DDS0235 | C163904 | DDS02-Healthcare Team Distress: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Healthcare Team Distress: Moderate | ||
Back to top | ||||||
CL.C163394.DDS02TN | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire Test Name
(DDS02TN) | text
Extensible: No | C163394 | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes Questionnaire Test Name | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes test name. | CDISC Questionnaire PARENT-DDS Test Name Terminology |
DDS02-Blame Me If Not Well-controlled | C163881 | DDS02-Blame Me If Not Well-controlled | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that others will blame me if my teen's diabetes is not well-controlled. | PARENT-DDS - Blame Me If Not Well-controlled | ||
DDS02-Doesn't Do Enough Manage Diabetes | C163879 | DDS02-Doesn't Do Enough Manage Diabetes | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that my teen doesn't do enough to manage his/her diabetes. | PARENT-DDS - Doesn't Do Enough Manage Diabetes | ||
DDS02-Doesn't Get Expert Medical Help | C163885 | DDS02-Doesn't Get Expert Medical Help | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen doesn't get all of the expert medical help he/she needs. | PARENT-DDS - Doesn't Get Expert Medical Help | ||
DDS02-Don't Work Well Together | C163870 | DDS02-Don't Work Well Together | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that my teen and I just don't work well together when it comes to diabetes. | PARENT-DDS - Don't Work Well Together | ||
DDS02-Healthcare Team Distress: Mean | C163903 | DDS02-Healthcare Team Distress: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Mean item score. | PARENT-DDS - Healthcare Team Distress: Mean | ||
DDS02-Healthcare Team Distress: Moderate | C163904 | DDS02-Healthcare Team Distress: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Healthcare Team Distress: Moderate | ||
DDS02-Healthcare Team Distress: Sum | C163902 | DDS02-Healthcare Team Distress: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Healthcare team distress: Sum of 2 items (11, 16). | PARENT-DDS - Healthcare Team Distress: Sum | ||
DDS02-Help Teen Is a Battle | C163876 | DDS02-Help Teen Is a Battle | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that trying to help my teen with his/her diabetes is always a battle. | PARENT-DDS - Help Teen Is a Battle | ||
DDS02-Lack Support From Friends/Family | C163884 | DDS02-Lack Support From Friends/Family | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated by the lack of understanding and support for diabetes I get from friends and family members. | PARENT-DDS - Lack Support From Friends and Family | ||
DDS02-Leave Home and Cannot Protect Him | C163882 | DDS02-Leave Home and Cannot Protect Him | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen will soon leave home and I cannot protect him. | PARENT-DDS - Leave Home and Cannot Protect Him | ||
DDS02-Low Blood Sugars Away From Home | C163873 | DDS02-Low Blood Sugars Away From Home | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying about my teen's low blood sugars when he/she is away from home. | PARENT-DDS - Low Blood Sugars Away From Home | ||
DDS02-Low Blood Sugars When Sleeping | C163877 | DDS02-Low Blood Sugars When Sleeping | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying about my teen's low blood sugars when he/she is sleeping. | PARENT-DDS - Low Blood Sugars When Sleeping | ||
DDS02-Motivate Teen Take Care Diabetes | C163886 | DDS02-Motivate Teen Take Care Diabetes | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling uncertain about how to motivate my teen to take better care of his/her diabetes. | PARENT-DDS - Motivate Teen Take Care Diabetes | ||
DDS02-My Nagging Hurting Relationship | C163889 | DDS02-My Nagging Hurting Relationship | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my nagging about diabetes is hurting my relationship with my teen. | PARENT-DDS - My Nagging Hurting Relationship | ||
DDS02-No One Notices Diabetes Hard on Me | C163878 | DDS02-No One Notices Diabetes Hard on Me | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that no one notices that diabetes is hard on me, not just on my teen. | PARENT-DDS - No One Notices Diabetes Hard on Me | ||
DDS02-Only One Takes Responsibility | C163888 | DDS02-Only One Takes Responsibility | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated that I am the only one who takes responsibility for helping my teen manage diabetes. | PARENT-DDS - Only One Takes Responsibility | ||
DDS02-Parent/Teen Rel Distress: Mean | C163900 | DDS02-Parent/Teen Rel Distress: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Mean item score. | PARENT-DDS - Parent/Teen Relationship Distress: Mean | ||
DDS02-Parent/Teen Rel Distress: Moderate | C163901 | DDS02-Parent/Teen Rel Distress: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Parent/Teen Relationship Distress: Moderate | ||
DDS02-Parent/Teen Rel Distress: Sum | C163899 | DDS02-Parent/Teen Rel Distress: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Parent/teen relationship distress: Sum of 8 items (1, 3, 5, 7, 10, 14, 17, 20). | PARENT-DDS - Parent/Teen Relationship Distress: Sum | ||
DDS02-Personal Distress: Mean | C163894 | DDS02-Personal Distress: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Mean item score. | PARENT-DDS - Personal Distress: Mean | ||
DDS02-Personal Distress: Moderate | C163895 | DDS02-Personal Distress: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Personal Distress: Moderate | ||
DDS02-Personal Distress: Sum | C163893 | DDS02-Personal Distress: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Personal distress: Sum of 6 items (2, 6, 9, 12, 15, 19). | PARENT-DDS - Personal Distress: Sum | ||
DDS02-Taking Too Much of My Energy | C163875 | DDS02-Taking Too Much of My Energy | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that diabetes is taking up too much of my mental and physical energy every day. | PARENT-DDS - Taking Too Much of My Energy | ||
DDS02-Teen Doesn't Have Right Doctor | C163880 | DDS02-Teen Doesn't Have Right Doctor | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen doesn't have the right doctor for him/her. | PARENT-DDS - Teen Doesn't Have Right Doctor | ||
DDS02-Teen Ignore/Forget Diabetes | C163874 | DDS02-Teen Ignore/Forget Diabetes | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Worrying that my teen will ignore or forget diabetes if I don't keep reminding him/her. | PARENT-DDS - Teen Ignore or Forget Diabetes | ||
DDS02-Teen Ignores My Suggestions | C163883 | DDS02-Teen Ignores My Suggestions | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Frustrated because my teen ignores my suggestions about diabetes. | PARENT-DDS - Teen Ignores My Suggestions | ||
DDS02-Teen Management Distress: Mean | C163897 | DDS02-Teen Management Distress: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Mean item score. | PARENT-DDS - Teen Management Distress: Mean | ||
DDS02-Teen Management Distress: Moderate | C163898 | DDS02-Teen Management Distress: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Teen Management Distress: Moderate | ||
DDS02-Teen Management Distress: Sum | C163896 | DDS02-Teen Management Distress: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Teen management distress: Sum of 4 items (4, 8, 13, 18). | PARENT-DDS - Teen Management Distress: Sum | ||
DDS02-Teen Not Prepared Once Adult | C163887 | DDS02-Teen Not Prepared Once Adult | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Concerned that my teen is not prepared to deal with the world of insurance and doctors once he/she is an adult. | PARENT-DDS - Teen Not Prepared Once Adult | ||
DDS02-Total DDS Score: Mean | C163891 | DDS02-Total DDS Score: Mean | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Mean item score. | PARENT-DDS - Total DDS Score: Mean | ||
DDS02-Total DDS Score: Moderate | C163892 | DDS02-Total DDS Score: Moderate | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Moderate distress or greater? (mean score > 2). | PARENT-DDS - Total DDS Score: Moderate | ||
DDS02-Total DDS Score: Sum | C163890 | DDS02-Total DDS Score: Sum | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - Total DDS score: Sum of 20 item scores. | PARENT-DDS - Total DDS Score: Sum | ||
DDS02-Trust Teen Take Care of Diabetes | C163872 | DDS02-Trust Teen Take Care of Diabetes | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling that I can't trust my teen to take good care of his/her diabetes. | PARENT-DDS - Trust Teen Take Care of Diabetes | ||
DDS02-Unappreciated for Ways I Help | C163871 | DDS02-Unappreciated for Ways I Help | Diabetes Distress Scale for Parents of Teens with Type 1 Diabetes - During the past month, I have been: Feeling unappreciated for all the ways I try to help my teen manage diabetes. | PARENT-DDS - Unappreciated for Ways I Help | ||
Back to top | ||||||
CL.C163397.DDS03TC | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire Test Code
(DDS03TC) | text
Extensible: No | C163397 | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire Test Code | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes test code. | CDISC Questionnaire PARTNER-DDS Test Code Terminology |
DDS0301 | C163905 | DDS03-Worry About Low Blood Sugars | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's low blood sugars. | PARTNER-DDS - Worry About Low Blood Sugars | ||
DDS0302 | C163906 | DDS03-How Involved Managing Diabetes | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling unclear about exactly how much I should be involved in managing my partner's diabetes. | PARTNER-DDS - How Involved Managing Diabetes | ||
DDS0303 | C163907 | DDS03-Partner Shuts Me Out | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that my partner shuts me out of his/her diabetes. | PARTNER-DDS - Partner Shuts Me Out | ||
DDS0304 | C163908 | DDS03-Partner Doesn't Try Hard Enough | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that my partner doesn't try hard enough to manage his/her diabetes. | PARTNER-DDS - Partner Doesn't Try Hard Enough | ||
DDS0305 | C163909 | DDS03-Overwhelmed by Constant Demands | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling overwhelmed by the constant demands of my partner's diabetes. | PARTNER-DDS - Overwhelmed by Constant Demands | ||
DDS0306 | C163910 | DDS03-How to Best Help Partner Manage | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying that don't know how to best help my partner manage diabetes. | PARTNER-DDS - How to Best Help Partner Manage | ||
DDS0307 | C163911 | DDS03-Silent About My Partner's Diabetes | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that I stay silent about my partner's diabetes more than I really should. | PARTNER-DDS - Silent About My Partner's Diabetes | ||
DDS0308 | C163912 | DDS03-Taking Too Much of My Energy | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that diabetes is taking up too much of my mental and physical energy every day. | PARTNER-DDS - Taking Too Much of My Energy | ||
DDS0309 | C163913 | DDS03-No One Notices Diabetes Hard On Me | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that no one notices that diabetes is hard on me, not just on my partner. | PARTNER-DDS - No One Notices Diabetes Hard On Me | ||
DDS0310 | C163914 | DDS03-More I Try The Worse Things Get | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that the more I try to help my partner manage his/her diabetes, the worse things get between us. | PARTNER-DDS - More I Try The Worse Things Get | ||
DDS0311 | C163915 | DDS03-Guilty Not Doing Enough to Help | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling guilty about not doing enough to help my partner with diabetes. | PARTNER-DDS - Guilty Not Doing Enough to Help | ||
DDS0312 | C163916 | DDS03-Can't Get Partner Improve Attitude | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that I can't get my partner to improve his/her attitude about diabetes. | PARTNER-DDS - Can't Get Partner Improve Attitude | ||
DDS0313 | C163917 | DDS03-Failing to Help Partner Manage | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying that I am failing to help my partner manage diabetes more successfully. | PARTNER-DDS - Failing to Help Partner Manage | ||
DDS0314 | C163918 | DDS03-Help My Partner Always a Battle | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that trying to help my partner with his/her diabetes is always a battle. | PARTNER-DDS - Help My Partner Always a Battle | ||
DDS0315 | C163919 | DDS03-Partner Ignores My Suggestions | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated because my partner ignores my suggestions about diabetes. | PARTNER-DDS - Partner Ignores My Suggestions | ||
DDS0316 | C163920 | DDS03-Diabetes Often Interrupts Plans | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that diabetes often interrupts our plans. | PARTNER-DDS - Diabetes Often Interrupts Plans | ||
DDS0317 | C163921 | DDS03-Low Blood Sugars When Sleeping | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's low blood sugars when he/she is sleeping. | PARTNER-DDS - Low Blood Sugars When Sleeping | ||
DDS0318 | C163922 | DDS03-Partner Driving Low Blood Sugars | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's driving because of possible low blood sugars. | PARTNER-DDS - Partner Driving Low Blood Sugars | ||
DDS0319 | C163923 | DDS03-Leaving Alone Low Blood Sugars | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about leaving my partner alone because of the possible danger of low blood sugars. | PARTNER-DDS - Leaving Alone Low Blood Sugars | ||
DDS0320 | C163924 | DDS03-Not Working Well Together | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Concerned that my partner and I are not working well together when it comes to diabetes. | PARTNER-DDS - Not Working Well Together | ||
DDS0321 | C163925 | DDS03-Never Get a Break From Worrying | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that I never get a break from worrying about my partner's diabetes. | PARTNER-DDS - Never Get a Break From Worrying | ||
DDS0322 | C163926 | DDS03-Total DDS Score: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Sum of 21 item scores. | PARTNER-DDS - Total DDS Score: Sum | ||
DDS0323 | C163927 | DDS03-Total DDS Score: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Mean item score. | PARTNER-DDS - Total DDS Score: Mean | ||
DDS0324 | C163928 | DDS03-Total DDS Score: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - Total DDS Score: Moderate | ||
DDS0325 | C163929 | DDS03-Partner Diabetes Management: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Sum of 7 items (3, 4, 10, 12, 14, 15, 20). | PARTNER-DDS - Partner Diabetes Management: Sum | ||
DDS0326 | C163930 | DDS03-Partner Diabetes Management: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Mean item score. | PARTNER-DDS - Partner Diabetes Management: Mean | ||
DDS0327 | C163931 | DDS03-Partner Diabetes Manage: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - Partner Diabetes Manage: Moderate | ||
DDS0328 | C163932 | DDS03-How Best to Help: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Sum of 5 items (2, 6, 7, 11, 13). | PARTNER-DDS - How Best to Help: Sum | ||
DDS0329 | C163933 | DDS03-How Best to Help: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Mean item score. | PARTNER-DDS - How Best to Help: Mean | ||
DDS0330 | C163934 | DDS03-How Best to Help: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - How Best to Help: Moderate | ||
DDS0331 | C163935 | DDS03-Diabetes and Me: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Sum of 5 items (5, 8, 9, 16, 21). | PARTNER-DDS - Diabetes and Me: Sum | ||
DDS0332 | C163936 | DDS03-Diabetes and Me: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Mean item score. | PARTNER-DDS - Diabetes and Me: Mean | ||
DDS0333 | C163937 | DDS03-Diabetes and Me: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - Diabetes and Me: Moderate | ||
DDS0334 | C163938 | DDS03-Hypoglycemia: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Sum of 4 items (1, 17, 18, 19). | PARTNER-DDS - Hypoglycemia: Sum | ||
DDS0335 | C163939 | DDS03-Hypoglycemia: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Mean item score. | PARTNER-DDS - Hypoglycemia: Mean | ||
DDS0336 | C163940 | DDS03-Hypoglycemia: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - Hypoglycemia: Moderate | ||
Back to top | ||||||
CL.C163396.DDS03TN | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire Test Name
(DDS03TN) | text
Extensible: No | C163396 | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes Questionnaire Test Name | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes test name. | CDISC Questionnaire PARTNER-DDS Test Name Terminology |
DDS03-Can't Get Partner Improve Attitude | C163916 | DDS03-Can't Get Partner Improve Attitude | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that I can't get my partner to improve his/her attitude about diabetes. | PARTNER-DDS - Can't Get Partner Improve Attitude | ||
DDS03-Diabetes and Me: Mean | C163936 | DDS03-Diabetes and Me: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Mean item score. | PARTNER-DDS - Diabetes and Me: Mean | ||
DDS03-Diabetes and Me: Moderate | C163937 | DDS03-Diabetes and Me: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - Diabetes and Me: Moderate | ||
DDS03-Diabetes and Me: Sum | C163935 | DDS03-Diabetes and Me: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Diabetes and me: Sum of 5 items (5, 8, 9, 16, 21). | PARTNER-DDS - Diabetes and Me: Sum | ||
DDS03-Diabetes Often Interrupts Plans | C163920 | DDS03-Diabetes Often Interrupts Plans | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that diabetes often interrupts our plans. | PARTNER-DDS - Diabetes Often Interrupts Plans | ||
DDS03-Failing to Help Partner Manage | C163917 | DDS03-Failing to Help Partner Manage | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying that I am failing to help my partner manage diabetes more successfully. | PARTNER-DDS - Failing to Help Partner Manage | ||
DDS03-Guilty Not Doing Enough to Help | C163915 | DDS03-Guilty Not Doing Enough to Help | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling guilty about not doing enough to help my partner with diabetes. | PARTNER-DDS - Guilty Not Doing Enough to Help | ||
DDS03-Help My Partner Always a Battle | C163918 | DDS03-Help My Partner Always a Battle | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that trying to help my partner with his/her diabetes is always a battle. | PARTNER-DDS - Help My Partner Always a Battle | ||
DDS03-How Best to Help: Mean | C163933 | DDS03-How Best to Help: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Mean item score. | PARTNER-DDS - How Best to Help: Mean | ||
DDS03-How Best to Help: Moderate | C163934 | DDS03-How Best to Help: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - How Best to Help: Moderate | ||
DDS03-How Best to Help: Sum | C163932 | DDS03-How Best to Help: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - How best to help: Sum of 5 items (2, 6, 7, 11, 13). | PARTNER-DDS - How Best to Help: Sum | ||
DDS03-How Involved Managing Diabetes | C163906 | DDS03-How Involved Managing Diabetes | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling unclear about exactly how much I should be involved in managing my partner's diabetes. | PARTNER-DDS - How Involved Managing Diabetes | ||
DDS03-How to Best Help Partner Manage | C163910 | DDS03-How to Best Help Partner Manage | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying that don't know how to best help my partner manage diabetes. | PARTNER-DDS - How to Best Help Partner Manage | ||
DDS03-Hypoglycemia: Mean | C163939 | DDS03-Hypoglycemia: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Mean item score. | PARTNER-DDS - Hypoglycemia: Mean | ||
DDS03-Hypoglycemia: Moderate | C163940 | DDS03-Hypoglycemia: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - Hypoglycemia: Moderate | ||
DDS03-Hypoglycemia: Sum | C163938 | DDS03-Hypoglycemia: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Hypoglycemia: Sum of 4 items (1, 17, 18, 19). | PARTNER-DDS - Hypoglycemia: Sum | ||
DDS03-Leaving Alone Low Blood Sugars | C163923 | DDS03-Leaving Alone Low Blood Sugars | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about leaving my partner alone because of the possible danger of low blood sugars. | PARTNER-DDS - Leaving Alone Low Blood Sugars | ||
DDS03-Low Blood Sugars When Sleeping | C163921 | DDS03-Low Blood Sugars When Sleeping | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's low blood sugars when he/she is sleeping. | PARTNER-DDS - Low Blood Sugars When Sleeping | ||
DDS03-More I Try The Worse Things Get | C163914 | DDS03-More I Try The Worse Things Get | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that the more I try to help my partner manage his/her diabetes, the worse things get between us. | PARTNER-DDS - More I Try The Worse Things Get | ||
DDS03-Never Get a Break From Worrying | C163925 | DDS03-Never Get a Break From Worrying | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that I never get a break from worrying about my partner's diabetes. | PARTNER-DDS - Never Get a Break From Worrying | ||
DDS03-No One Notices Diabetes Hard On Me | C163913 | DDS03-No One Notices Diabetes Hard On Me | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that no one notices that diabetes is hard on me, not just on my partner. | PARTNER-DDS - No One Notices Diabetes Hard On Me | ||
DDS03-Not Working Well Together | C163924 | DDS03-Not Working Well Together | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Concerned that my partner and I are not working well together when it comes to diabetes. | PARTNER-DDS - Not Working Well Together | ||
DDS03-Overwhelmed by Constant Demands | C163909 | DDS03-Overwhelmed by Constant Demands | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling overwhelmed by the constant demands of my partner's diabetes. | PARTNER-DDS - Overwhelmed by Constant Demands | ||
DDS03-Partner Diabetes Manage: Moderate | C163931 | DDS03-Partner Diabetes Manage: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - Partner Diabetes Manage: Moderate | ||
DDS03-Partner Diabetes Management: Mean | C163930 | DDS03-Partner Diabetes Management: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Mean item score. | PARTNER-DDS - Partner Diabetes Management: Mean | ||
DDS03-Partner Diabetes Management: Sum | C163929 | DDS03-Partner Diabetes Management: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - My partner's diabetes management: Sum of 7 items (3, 4, 10, 12, 14, 15, 20). | PARTNER-DDS - Partner Diabetes Management: Sum | ||
DDS03-Partner Doesn't Try Hard Enough | C163908 | DDS03-Partner Doesn't Try Hard Enough | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that my partner doesn't try hard enough to manage his/her diabetes. | PARTNER-DDS - Partner Doesn't Try Hard Enough | ||
DDS03-Partner Driving Low Blood Sugars | C163922 | DDS03-Partner Driving Low Blood Sugars | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's driving because of possible low blood sugars. | PARTNER-DDS - Partner Driving Low Blood Sugars | ||
DDS03-Partner Ignores My Suggestions | C163919 | DDS03-Partner Ignores My Suggestions | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated because my partner ignores my suggestions about diabetes. | PARTNER-DDS - Partner Ignores My Suggestions | ||
DDS03-Partner Shuts Me Out | C163907 | DDS03-Partner Shuts Me Out | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Frustrated that my partner shuts me out of his/her diabetes. | PARTNER-DDS - Partner Shuts Me Out | ||
DDS03-Silent About My Partner's Diabetes | C163911 | DDS03-Silent About My Partner's Diabetes | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that I stay silent about my partner's diabetes more than I really should. | PARTNER-DDS - Silent About My Partner's Diabetes | ||
DDS03-Taking Too Much of My Energy | C163912 | DDS03-Taking Too Much of My Energy | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Feeling that diabetes is taking up too much of my mental and physical energy every day. | PARTNER-DDS - Taking Too Much of My Energy | ||
DDS03-Total DDS Score: Mean | C163927 | DDS03-Total DDS Score: Mean | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Mean item score. | PARTNER-DDS - Total DDS Score: Mean | ||
DDS03-Total DDS Score: Moderate | C163928 | DDS03-Total DDS Score: Moderate | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Moderate distress or greater? (mean score > 2). | PARTNER-DDS - Total DDS Score: Moderate | ||
DDS03-Total DDS Score: Sum | C163926 | DDS03-Total DDS Score: Sum | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - Total DDS score: Sum of 21 item scores. | PARTNER-DDS - Total DDS Score: Sum | ||
DDS03-Worry About Low Blood Sugars | C163905 | DDS03-Worry About Low Blood Sugars | Diabetes Distress Scale for Partners of Adults with Type 1 Diabetes - During the past month, I have been: Worrying about my partner's low blood sugars. | PARTNER-DDS - Worry About Low Blood Sugars | ||
Back to top | ||||||
CL.C101857.DIABTHPY | Diabetes Therapy
(DIABTHPY) | text
Extensible: Yes | C101857 | Diabetes Therapy | A terminology codelist that describes the treatment method for diabetes. | CDISC SDTM Diabetes Therapy Terminology |
DIET | C15383 | A form of therapy which includes dietary approaches and special diets. | Special Diet Therapy | |||
INSULIN | C581 | A synthetic or animal-derived form of insulin used in the treatment of diabetes mellitus. | Therapeutic Insulin | |||
NO TREATMENT | C99994 | No treatment for diabetes. | No Treatment for Diabetes | |||
ORAL MEDICATION | C102246 | A pharmacological medication intended for administration through the mouth. | Oral Medication | |||
Back to top | ||||||
CL.C129940.DKFATSCD | Diabetic Kidney Disease Findings About Test Code
(DKFATSCD) | text
Extensible: Yes | C129940 | Diabetic Kidney Disease Findings About Test Code | Terminology relevant to the test codes that describe findings about a diabetic kidney disease event or intervention. | CDISC SDTM Diabetic Kidney Findings About Test Code Terminology |
EVENTNUM | C130057 | Number of Events | The total number of events that have occurred. | Number of Events | ||
Back to top | ||||||
CL.C129939.DKFATS | Diabetic Kidney Disease Findings About Test Name
(DKFATS) | text
Extensible: Yes | C129939 | Diabetic Kidney Disease Findings About Test Name | Terminology relevant to the test names that describe findings about a diabetic kidney disease event or intervention. | CDISC SDTM Diabetic Kidney Findings About Test Name Terminology |
Number of Events | C130057 | Number of Events | The total number of events that have occurred. | Number of Events | ||
Back to top | ||||||
CL.C183549.DIBC01TC | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 Questionnaire Test Code
(DIBC01TC) | text
Extensible: No | C183549 | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 Questionnaire Test Code | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 test code. | CDISC Questionnaire DIBSS-C Version 1.0 Test Code Terminology |
DIBC0101 | C183608 | DIBC01-Rate Worst Abdominal Pain | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal pain in the past 24 hours? | DIBSS-C Version 1.0 - Rate Worst Abdominal Pain | ||
DIBC0102 | C183609 | DIBC01-Rate Worst Abdominal Discomfort | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal discomfort in the past 24 hours? | DIBSS-C Version 1.0 - Rate Worst Abdominal Discomfort | ||
DIBC0103 | C183610 | DIBC01-Rate Worst Abdominal Bloating | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal bloating in the past 24 hours? | DIBSS-C Version 1.0 - Rate Worst Abdominal Bloating | ||
DIBC0104 | C183611 | DIBC01-Other Bowel Movements to Report | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Do you have any other bowel movements to report? | DIBSS-C Version 1.0 - Other Bowel Movements to Report | ||
DIBC0105 | C183612 | DIBC01-Completely Emptied Bowels | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Did you feel like you completely emptied your bowels after your bowel movement? | DIBSS-C Version 1.0 - Completely Emptied Bowels | ||
DIBC0106 | C183613 | DIBC01-How Much Did You Strain | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How much did you strain during your bowel movement? | DIBSS-C Version 1.0 - How Much Did You Strain | ||
DIBC0107 | C183614 | DIBC01-Describe Consistency of Stool | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you describe the consistency of your stool? | DIBSS-C Version 1.0 - Describe Consistency of Stool | ||
DIBC0108 | C183615 | DIBC01-Stool Frequency Weekly Total | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Stool frequency: weekly score, total number of BMs across days on which no laxative, enema, or suppository use was reported. | DIBSS-C Version 1.0 - Stool Frequency Weekly Total | ||
DIBC0109 | C183616 | DIBC01-Stool Frequency Weekly Complete | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Stool frequency: weekly score, the weekly total score minus any BMs reported as not complete. | DIBSS-C Version 1.0 - Stool Frequency Weekly Complete | ||
DIBC0110 | C183617 | DIBC01-Abdominal Symptom Subscale | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Abdominal symptom subscale. | DIBSS-C Version 1.0 - Abdominal Symptom Subscale | ||
Back to top | ||||||
CL.C183548.DIBC01TN | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 Questionnaire Test Name
(DIBC01TN) | text
Extensible: No | C183548 | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 Questionnaire Test Name | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 test name. | CDISC Questionnaire DIBSS-C Version 1.0 Test Name Terminology |
DIBC01-Abdominal Symptom Subscale | C183617 | DIBC01-Abdominal Symptom Subscale | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Abdominal symptom subscale. | DIBSS-C Version 1.0 - Abdominal Symptom Subscale | ||
DIBC01-Completely Emptied Bowels | C183612 | DIBC01-Completely Emptied Bowels | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Did you feel like you completely emptied your bowels after your bowel movement? | DIBSS-C Version 1.0 - Completely Emptied Bowels | ||
DIBC01-Describe Consistency of Stool | C183614 | DIBC01-Describe Consistency of Stool | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you describe the consistency of your stool? | DIBSS-C Version 1.0 - Describe Consistency of Stool | ||
DIBC01-How Much Did You Strain | C183613 | DIBC01-How Much Did You Strain | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How much did you strain during your bowel movement? | DIBSS-C Version 1.0 - How Much Did You Strain | ||
DIBC01-Other Bowel Movements to Report | C183611 | DIBC01-Other Bowel Movements to Report | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Do you have any other bowel movements to report? | DIBSS-C Version 1.0 - Other Bowel Movements to Report | ||
DIBC01-Rate Worst Abdominal Bloating | C183610 | DIBC01-Rate Worst Abdominal Bloating | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal bloating in the past 24 hours? | DIBSS-C Version 1.0 - Rate Worst Abdominal Bloating | ||
DIBC01-Rate Worst Abdominal Discomfort | C183609 | DIBC01-Rate Worst Abdominal Discomfort | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal discomfort in the past 24 hours? | DIBSS-C Version 1.0 - Rate Worst Abdominal Discomfort | ||
DIBC01-Rate Worst Abdominal Pain | C183608 | DIBC01-Rate Worst Abdominal Pain | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - How would you rate your worst abdominal pain in the past 24 hours? | DIBSS-C Version 1.0 - Rate Worst Abdominal Pain | ||
DIBC01-Stool Frequency Weekly Complete | C183616 | DIBC01-Stool Frequency Weekly Complete | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Stool frequency: weekly score, the weekly total score minus any BMs reported as not complete. | DIBSS-C Version 1.0 - Stool Frequency Weekly Complete | ||
DIBC01-Stool Frequency Weekly Total | C183615 | DIBC01-Stool Frequency Weekly Total | Diary for Irritable Bowel Syndrome Symptoms-Constipation v1.0 - Stool frequency: weekly score, total number of BMs across days on which no laxative, enema, or suppository use was reported. | DIBSS-C Version 1.0 - Stool Frequency Weekly Total | ||
Back to top | ||||||
CL.C66788.DICTNAM | Dictionary Name
(DICTNAM) | text
Extensible: Yes | C66788 | Dictionary Name | A name given to a reference source that lists words and gives their meaning. (NCI) | CDISC Dictionary Name Terminology |
CDISC CT | C163415 | CDISC Controlled Terminology;Clinical Data Interchange Standards Consortium Controlled Terminology | A standard terminology developed and maintained by Clinical Data Interchange Standards Consortium (CDISC) and the National Cancer Institute Enterprise Vocabulary Services (NCI-EVS) to support CDISC models, domains and specifications for data representation in regulated research. | Clinical Data Interchange Standards Consortium Controlled Terminology | ||
COSTART | C49471 | Coding Symbols for a Thesaurus of Adverse Reaction Terms | A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI) | Thesaurus of Adverse Reaction Term Coding Symbols | ||
CTCAE | C49704 | Common Terminology Criteria for Adverse Events | A standard terminology developed and maintained by the National Cancer Institute to report adverse events occurring in cancer clinical trials. The CTCAE contains a grading scale for each adverse event term representing the severity of the event. | Common Terminology Criteria for Adverse Events | ||
D-U-N-S NUMBER | C134003 | Data Universal Number System;DUNS Numbers | A proprietary system developed and regulated by Dun & Bradstreet that assigns a unique nine digit numeric identifier to a single business entity location. | Data Universal Numbering System | ||
ICD | C49474 | International Classification of Diseases | A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12) | International Classification of Diseases | ||
ICD-O | C37978 | International Classification of Diseases for Oncology | A World Health Organization (WHO) multi-axial classification of the site, morphology, behaviour, and grading of neoplasms. | International Classification of Diseases for Oncology | ||
LOINC | C49476 | Logical Observation Identifiers Names and Codes | Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI) | Logical Observation Identifiers Names and Codes | ||
MED-RT | C163416 | Medication Reference Terminology;NDF-RT | A standard terminology developed and maintained by the Veterans Health Administration (VHA) that includes terminology to support the mechanism of action, physiologic effect, and asserted pharmacologic classification relationships of medications. MED-RT incorporates terminology from RxNORM, MeSH, and SNOMED CT. | Medication Reference Terminology | ||
MedDRA | C43820 | Medical Dictionary for Regulatory Activities | MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI) | MedDRA | ||
SNOMED | C53489 | Systematized Nomenclature of Medicine | A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI) | Systematized Nomenclature of Medicine | ||
UNII | C163417 | SRS-UNII;Substance Registration System-Unique Ingredient Identifier | A standard terminology developed and maintained by the Department of Veterans Affairs/Veterans Health Administration designated federal collaborative Structured Product Labeling Interagency Expert Panel (SPLIEP). It contains terminology to support the mechanism of action, physiologic effect, and asserted pharmacologic classification relationships of drug ingredients and food allergens. | Substance Registration System-Unique Ingredient Identifier | ||
WHO ATC CLASSIFICATION SYSTEM | C154331 | Anatomical Therapeutic Chemical Classification System | A World Health Organization (WHO) classification system, developed and maintained by the WHO Collaborating Centre for Drug Statistics Methodology, for medicinal substances where active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological, and chemical properties. | Anatomical Therapeutic Chemical Classification System | ||
WHOART | C49468 | World Health Organization Adverse Reaction Terms | A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI) | World Health Organization Adverse Reaction Terminology | ||
WHODD | C49475 | WHODrug Global;World Health Organization Drug Dictionary | A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI) | World Health Organization Drug Dictionary | ||
Back to top | ||||||
CL.C99074.DIR | Directionality
(DIR) | text
Extensible: Yes | C99074 | Directionality | CDISC terminology for anatomical location or specimen further detailing directionality. | CDISC SDTM Directionality Terminology |
ANTERIOR | C25231 | Denoting the front portion of the body or a structure. | Anterior | |||
ANTEROLATERAL | C25422 | Denoting the area of the body in front of and away from the middle line. | Anterolateral | |||
ANTEROMEDIAL | C147159 | Denoting the front portion of the body towards the median plane. | Anteromedial | |||
ANTEROPOSTERIOR | C85512 | Directed from front to back. | Anteroposterior Orientation | |||
ANTEROTEMPORAL | C165868 | Denoting the front portion of the body toward the temple. | Anterotemporal | |||
APICAL | C25423 | Relating to or located at the apex. | Apical | |||
BASAL | C90067 | Relating to or located at the lowest portion of a structure. | Basal | |||
CAUDAL | C73851 | Toward the tail in a body. | Caudal | |||
CENTRAL | C25445 | A point or area that is approximately central within some larger region or structure. (NCI) | Center | |||
CRANIAL | C37936 | Toward the head in a body. | Cranial | |||
CRANIOCAUDAL | C186020 | Pertaining to an anatomical plane extending between the cranial (towards the head) and caudal (towards the tail) portions of a body. | Craniocaudal Plane | |||
DEEP | C25240 | Extending relatively far inward. (NCI) | Deep | |||
DISTAL VOLAR | C147160 | Pertaining to the farthest portion from the palm side of a hand or the sole side of a foot. | Distal Volar | |||
DISTAL | C25237 | Situated farthest from a point of reference. | Distal | |||
DORSAL | C45874 | Pertaining to the back or upper surface of the body. | Dorsal | |||
DORSOLATERAL | C90376 | Toward the back and side of a body. | Dorsolateral | |||
FACIAL | C161327 | Of, or related to, or in the direction of the face. (NCI) | Facial | |||
FORE | C90386 | Of or involving the front of a main body. (NCI) | Fore | |||
FRONTAL | C161325 | Of, or related to, or in the direction of the front of the body, structure, or object. (NCI) | Frontal | |||
HIND | C90393 | Of or involving the back of a main body. (NCI) | Hind | |||
INFERIOR | C25353 | Pertaining to a point below a given reference point. | Inferior | |||
INNER | C37980 | Inside or closer to the inside of the body or object. (NCI) | Inner | |||
INTERMEDIATE | C73705 | Located between two points or extremes. | Intermediate | |||
LATERAL | C25230 | Situated at or extending to the side. | Lateral | |||
LOWER EXTENSOR SURFACE | C147161 | Pertaining to the lower portion of the surface on the opposite side of the joint when it bends. | Lower Extensor Surface | |||
LOWER FLEXOR SURFACE | C147162 | Pertaining to the lower portion of the surface on the same side of the joint when it bends. | Lower Flexor Surface | |||
LOWER MEDIAL | C147163 | Denoting the lower portion of the body towards the median plane. | Lower Medial | |||
LOWER | C25309 | The bottom one of two. (NCI) | Lower | |||
MEDIAL | C25232 | Toward the middle or in a limb toward the median plane. | Medial | |||
MIDLINE | C81170 | A medial line, especially the medial line or medial plane of the body (or some part of the body). | Midline | |||
NASAL | C27958 | Of, or related to, or in the direction of the nose. | Nasal | |||
OCCIPITAL | C161326 | Of, or related to, or in the direction of the occiput, or back of the head. (NCI) | Occipital | |||
OUTER | C38166 | Being on or toward the outside of the body or object. (NCI) | Outer | |||
PARIETO-OCCIPITAL | C170564 | Of, or related to, the area of the body where the parietal and occipital lobes of the brain meet. | Parieto-Occipital | |||
PERIPHERAL | C25233 | On or near an edge or constituting an outer boundary; the outer area. (NCI) | Peripheral | |||
PERIVENTRICULAR | C165869 | Of, or pertaining to, the area surrounding the ventricles of the brain. | Periventricular | |||
POSTERIOR | C25622 | Denoting the back portion of the body or a structure. | Posterior | |||
PROXIMAL VOLAR | C147164 | Pertaining to the nearest portion from the palm side of a hand or the sole side of a foot. | Proximal Volar | |||
PROXIMAL | C25236 | Situated nearest to a point of reference. | Proximal | |||
ROSTRAL | C94393 | Toward the muzzle in the head. | Rostral | |||
SEPTAL | C186021 | Of, or related to, or in the direction of, an anatomical septum. | Septal | |||
SUBCORTICAL | C165870 | Denoting the area below a cortex. | Subcortical | |||
SUPERFICIAL | C25239 | Of or pertaining to the exterior surface. (NCI) | Superficial | |||
SUPERIOR | C25235 | Pertaining to a point above a given reference point. | Superior | |||
SURFACE | C25245 | The extended two-dimensional outer layer or area of a three-dimensional object. (NCI) | Surface | |||
TEMPORAL | C117754 | Of, or related to, or in the direction of the anatomic sites that are located in the temple. | Temporal Anatomic Qualifier | |||
TIP | C90069 | The pointed end of a structure. | Tip | |||
UPPER EXTENSOR SURFACE | C147165 | Pertaining to the upper portion of the surface on the opposite side of the joint when it bends. | Upper Extensor Surface | |||
UPPER FLEXOR SURFACE | C147166 | Pertaining to the upper portion of the surface on the same side of the joint when it bends. | Upper Flexor Surface | |||
UPPER | C25355 | The top one of two. | Upper | |||
VENTRAL | C45875 | Pertaining to the front or lower surface of the body. | Ventral | |||
VENTROLATERAL | C98798 | Of or pertaining to the front and side of a main body. (NCI) | Ventrolateral | |||
VOLAR | C147167 | Pertaining to the palm side of a hand or the sole side of a foot. | Volar | |||
Back to top | ||||||
CL.C105130.DAD01TC | Disability Assessment for Dementia Questionnaire Test Code
(DAD01TC) | text
Extensible: No | C105130 | Disability Assessment for Dementia Questionnaire Test Code | Disability Assessment for Dementia test code. | CDISC Questionnaire DAD Test Code Terminology |
DAD0101 | C105170 | DAD01-Decide to Wash | Disability Assessment for Dementia - Decide to wash himself/herself or to take a bath or shower? | DAD - Decide to Wash or Take a Bath or Shower | ||
DAD0102 | C105171 | DAD01-Decide to Brush Teeth Dentures | Disability Assessment for Dementia - Decide to brush his/her teeth or care for his/her dentures? | DAD - Decide to Brush Teeth or Care for Dentures | ||
DAD0103 | C105172 | DAD01-Decide to Care For Hair | Disability Assessment for Dementia - Decide to care for his/her hair (wash and comb)? | DAD - Decide to Care for His/Her Hair | ||
DAD0104 | C105173 | DAD01-Prepare For Washing Bath Shower | Disability Assessment for Dementia - Prepare the water, towels, and soap for washing, taking a bath or a shower? | DAD - Prepare the Water, Towels, and Soap for Washing, Taking a Bath or Shower | ||
DAD0105 | C105174 | DAD01-Wash and Dry Body Safely | Disability Assessment for Dementia - Wash and dry all parts of his/her body safely and completely? | DAD - Wash and Dry All Parts of Body Safely and Completely | ||
DAD0106 | C105175 | DAD01-Brush Teeth Take Care of Dentures | Disability Assessment for Dementia - Brush his/her teeth or take care of his/her dentures appropriately? | DAD - Brush Teeth or Take Care of Dentures Appropriately | ||
DAD0107 | C105176 | DAD01-Take Care of Hair | Disability Assessment for Dementia - Take care of his/her hair (wash and comb)? | DAD - Take Care of His/Her Hair | ||
DAD0108 | C105177 | DAD01-Decide to Dress | Disability Assessment for Dementia - Decide to dress himself/herself? | DAD - Decide to Dress Himself/Herself | ||
DAD0109 | C105178 | DAD01-Choose Appropriate Clothing | Disability Assessment for Dementia - Choose appropriate clothing (with regard to the occasion, neatness, the weather and color combination)? | DAD - Choose Appropriate Clothing | ||
DAD0110 | C105179 | DAD01-Dress in Appropriate Order | Disability Assessment for Dementia - Dress himself/herself in the appropriate order (undergarments, pant/dress, shoes)? | DAD - Dress in the Appropriate Order | ||
DAD0111 | C105180 | DAD01-Dress Completely | Disability Assessment for Dementia - Dress himself/herself completely? | DAD - Dress Himself/Herself Completely | ||
DAD0112 | C105181 | DAD01-Undress Completely | Disability Assessment for Dementia - Undress himself/herself completely? | DAD - Undress Himself/Herself Completely | ||
DAD0113 | C105182 | DAD01-Use Toilet at Appropriate Times | Disability Assessment for Dementia - Decide to use the toilet at appropriate times? | DAD - Decide to Use the Toilet at Appropriate Times | ||
DAD0114 | C105183 | DAD01-Use Toilet Without Accidents | Disability Assessment for Dementia - Use the toilet without 'accidents'? | DAD - Use the Toilet Without Accidents | ||
DAD0115 | C105184 | DAD01-Decide That He/She Needs to Eat | Disability Assessment for Dementia - Decide that he/she needs to eat? | DAD - Decide That He/She Needs to Eat | ||
DAD0116 | C105185 | DAD01-Choose Appropriate Utensils | Disability Assessment for Dementia - Choose appropriate utensils and seasonings when eating? | DAD - Choose Appropriate Utensils and Seasonings When Eating | ||
DAD0117 | C105186 | DAD01-Eat at Normal Pace With Manners | Disability Assessment for Dementia - Eat his/her meals at a normal pace and with appropriate manners? | DAD - Eat Meals at a Normal Pace and with Appropriate Manners | ||
DAD0118 | C105187 | DAD01-Decide to Prepare Meal Snack | Disability Assessment for Dementia - Decide to prepare a light meal or snack for himself/herself? | DAD - Decide to Prepare a Light Meal or Snack for Himself/Herself | ||
DAD0119 | C105188 | DAD01-Adequately Plan Light Meal Snack | Disability Assessment for Dementia - Adequately plan a light meal or snack (ingredients, cookware)? | DAD - Adequately Plan a Light Meal or Snack | ||
DAD0120 | C105189 | DAD01-Prepare or Cook Light Meal Snack | Disability Assessment for Dementia - Prepare or cook a light meal or a snack safely? | DAD - Safely Prepare or Cook a Light Meal or Snack | ||
DAD0121 | C105190 | DAD01-Telephone Someone at Suitable Time | Disability Assessment for Dementia - Attempt to telephone someone at a suitable time? | DAD - Attempt to Telephone Someone at a Suitable Time | ||
DAD0122 | C105191 | DAD01-Find and Dial Telephone Number | Disability Assessment for Dementia - Find and dial a telephone number correctly? | DAD - Find and Dial a Telephone Number Correctly | ||
DAD0123 | C105192 | DAD01-Carry Out Telephone Conversation | Disability Assessment for Dementia - Carry out an appropriate telephone conversation? | DAD - Carry Out an Appropriate Telephone Conversation | ||
DAD0124 | C105193 | DAD01-Write Convey Telephone Message | Disability Assessment for Dementia - Write and convey a telephone message adequately? | DAD - Write and Convey a Telephone Message Adequately | ||
DAD0125 | C105194 | DAD01-Decide to Go Out | Disability Assessment for Dementia - Decide to go out (walk, visit, shop) at an appropriate time? | DAD - Decide to Go Out at an Appropriate Time | ||
DAD0126 | C105195 | DAD01-Adequately Organize an Outing | Disability Assessment for Dementia - Adequately organize an outing with respect to transportation, keys, destination, weather, necessary money, shopping list? | DAD - Adequately Organize an Outing with Respect to Transportation, Keys, Destination, Weather, Money, Shopping List | ||
DAD0127 | C105196 | DAD01-Go Out Without Getting Lost | Disability Assessment for Dementia - Go out and reach a familiar destination without getting lost? | DAD - Go Out and Reach a Familiar Destination Without Getting Lost | ||
DAD0128 | C105197 | DAD01-Safely Take Transportation | Disability Assessment for Dementia - Safely take the adequate mode of transportation (car, bus, taxi)? | DAD - Safely Take the Adequate Mode of Transportation | ||
DAD0129 | C105198 | DAD01-Return From Store With Items | Disability Assessment for Dementia - Return from the store with the appropriate items? | DAD - Return From the Store with Appropriate Items | ||
DAD0130 | C105199 | DAD01-Show Interest in Personal Affairs | Disability Assessment for Dementia - Show an interest in his/her personal affairs such as his/her finances and written correspondence? | DAD - Show an Interest in Personal Affairs such as Finances and Written Correspondence | ||
DAD0131 | C105200 | DAD01-Organize Finances to Pay Bills | Disability Assessment for Dementia - Organize his/her finances to pay his/her bills (checks, bank statement, bills)? | DAD - Organize Finances to Pay Bills | ||
DAD0132 | C105201 | DAD01-Adequately Organize Correspondence | Disability Assessment for Dementia - Adequately organize his/her correspondence with respect to stationery, address, stamps? | DAD - Adequately Organize Correspondence | ||
DAD0133 | C105202 | DAD01-Handle Money Adequately | Disability Assessment for Dementia - Handle his/her money adequately (deal with cash)? | DAD - Handle Money Adequately | ||
DAD0134 | C105203 | DAD01-Take Medications at Correct Time | Disability Assessment for Dementia - Decide to take his/her medications at the correct time? | DAD - Decide to Take Medications at the Correct Time | ||
DAD0135 | C105204 | DAD01-Take Medications as Prescribed | Disability Assessment for Dementia - Take his/her medications as prescribed (according to the right dosage)? | DAD - Take Medications as Prescribed | ||
DAD0136 | C105205 | DAD01-Show Interest in Leisure Activity | Disability Assessment for Dementia - Show an interest in leisure activity(ies)? | DAD - Show an Interest in Leisure Activities | ||
DAD0137 | C105206 | DAD01-Take Interest in Household Chores | Disability Assessment for Dementia - Take an interest in household chores that he/she used to perform in the past? | DAD - Take an Interest in Household Chores as in the Past | ||
DAD0138 | C105207 | DAD01-Plan Organize Household Chores | Disability Assessment for Dementia - Plan and organize adequately household chores that he/she used to perform in the past? | DAD - Plan and Organize Adequately Household Chores as in the Past | ||
DAD0139 | C105208 | DAD01-Complete Household Chores | Disability Assessment for Dementia - Complete household chores adequately as he/she used to perform in the past? | DAD - Complete Household Chores Adequately as in the Past | ||
DAD0140 | C105209 | DAD01-Stay Safely at Home When Needed | Disability Assessment for Dementia - Stay safely at home by himself/herself when needed? | DAD - Stay Safely at Home When Needed | ||
DAD0141 | C111577 | DAD01-Sub-Total Initiation | Disability Assessment for Dementia - Sub-Total Initiation. | DAD - Sub-Total Initiation | ||
DAD0142 | C111578 | DAD01-Initiation Num Applic Items | Disability Assessment for Dementia - Sub-Total Initiation Number of Applicable Items. | DAD - Total Initiation Number of Applicable Items | ||
DAD0143 | C111579 | DAD01-Sub-Total Planning & Organization | Disability Assessment for Dementia - Sub-Total Planning & Organization. | DAD - Sub-Total Planning and Organization | ||
DAD0144 | C111617 | DAD01-Plan & Org Num Applic Items | Disability Assessment for Dementia - Sub-Total Planning & Organization Number of Applicable Items. | DAD - Plan and Organize Number of Applicable Items | ||
DAD0145 | C111580 | DAD01-Sub-Total Effective Performance | Disability Assessment for Dementia - Sub-Total Effective Performance. | DAD - Sub-Total Effective Performance | ||
DAD0146 | C111581 | DAD01-Effective Perf Num Applic Items | Disability Assessment for Dementia - Sub-Total Effective Performance Number of Applicable Items. | DAD - Sub-Total Effective Performance Number of Applicable Items | ||
DAD0147 | C111582 | DAD01-Total Score | Disability Assessment for Dementia - Total Score. | DAD - Total Score | ||
DAD0148 | C111583 | DAD01-Total Num of Applic Items | Disability Assessment for Dementia - Total Number of Applicable Items. | DAD - Total Number of Applicable Items | ||
DAD0149 | C111584 | DAD01-Total % | Disability Assessment for Dementia - Total %. | DAD - Total Percent | ||
Back to top | ||||||
CL.C105129.DAD01TN | Disability Assessment for Dementia Questionnaire Test Name
(DAD01TN) | text
Extensible: No | C105129 | Disability Assessment for Dementia Questionnaire Test Name | Disability Assessment for Dementia test name. | CDISC Questionnaire DAD Test Name Terminology |
DAD01-Adequately Organize an Outing | C105195 | DAD01-Adequately Organize an Outing | Disability Assessment for Dementia - Adequately organize an outing with respect to transportation, keys, destination, weather, necessary money, shopping list? | DAD - Adequately Organize an Outing with Respect to Transportation, Keys, Destination, Weather, Money, Shopping List | ||
DAD01-Adequately Organize Correspondence | C105201 | DAD01-Adequately Organize Correspondence | Disability Assessment for Dementia - Adequately organize his/her correspondence with respect to stationery, address, stamps? | DAD - Adequately Organize Correspondence | ||
DAD01-Adequately Plan Light Meal Snack | C105188 | DAD01-Adequately Plan Light Meal Snack | Disability Assessment for Dementia - Adequately plan a light meal or snack (ingredients, cookware)? | DAD - Adequately Plan a Light Meal or Snack | ||
DAD01-Brush Teeth Take Care of Dentures | C105175 | DAD01-Brush Teeth Take Care of Dentures | Disability Assessment for Dementia - Brush his/her teeth or take care of his/her dentures appropriately? | DAD - Brush Teeth or Take Care of Dentures Appropriately | ||
DAD01-Carry Out Telephone Conversation | C105192 | DAD01-Carry Out Telephone Conversation | Disability Assessment for Dementia - Carry out an appropriate telephone conversation? | DAD - Carry Out an Appropriate Telephone Conversation | ||
DAD01-Choose Appropriate Clothing | C105178 | DAD01-Choose Appropriate Clothing | Disability Assessment for Dementia - Choose appropriate clothing (with regard to the occasion, neatness, the weather and color combination)? | DAD - Choose Appropriate Clothing | ||
DAD01-Choose Appropriate Utensils | C105185 | DAD01-Choose Appropriate Utensils | Disability Assessment for Dementia - Choose appropriate utensils and seasonings when eating? | DAD - Choose Appropriate Utensils and Seasonings When Eating | ||
DAD01-Complete Household Chores | C105208 | DAD01-Complete Household Chores | Disability Assessment for Dementia - Complete household chores adequately as he/she used to perform in the past? | DAD - Complete Household Chores Adequately as in the Past | ||
DAD01-Decide That He/She Needs to Eat | C105184 | DAD01-Decide That He/She Needs to Eat | Disability Assessment for Dementia - Decide that he/she needs to eat? | DAD - Decide That He/She Needs to Eat | ||
DAD01-Decide to Brush Teeth Dentures | C105171 | DAD01-Decide to Brush Teeth Dentures | Disability Assessment for Dementia - Decide to brush his/her teeth or care for his/her dentures? | DAD - Decide to Brush Teeth or Care for Dentures | ||
DAD01-Decide to Care For Hair | C105172 | DAD01-Decide to Care For Hair | Disability Assessment for Dementia - Decide to care for his/her hair (wash and comb)? | DAD - Decide to Care for His/Her Hair | ||
DAD01-Decide to Dress | C105177 | DAD01-Decide to Dress | Disability Assessment for Dementia - Decide to dress himself/herself? | DAD - Decide to Dress Himself/Herself | ||
DAD01-Decide to Go Out | C105194 | DAD01-Decide to Go Out | Disability Assessment for Dementia - Decide to go out (walk, visit, shop) at an appropriate time? | DAD - Decide to Go Out at an Appropriate Time | ||
DAD01-Decide to Prepare Meal Snack | C105187 | DAD01-Decide to Prepare Meal Snack | Disability Assessment for Dementia - Decide to prepare a light meal or snack for himself/herself? | DAD - Decide to Prepare a Light Meal or Snack for Himself/Herself | ||
DAD01-Decide to Wash | C105170 | DAD01-Decide to Wash | Disability Assessment for Dementia - Decide to wash himself/herself or to take a bath or shower? | DAD - Decide to Wash or Take a Bath or Shower | ||
DAD01-Dress Completely | C105180 | DAD01-Dress Completely | Disability Assessment for Dementia - Dress himself/herself completely? | DAD - Dress Himself/Herself Completely | ||
DAD01-Dress in Appropriate Order | C105179 | DAD01-Dress in Appropriate Order | Disability Assessment for Dementia - Dress himself/herself in the appropriate order (undergarments, pant/dress, shoes)? | DAD - Dress in the Appropriate Order | ||
DAD01-Eat at Normal Pace With Manners | C105186 | DAD01-Eat at Normal Pace With Manners | Disability Assessment for Dementia - Eat his/her meals at a normal pace and with appropriate manners? | DAD - Eat Meals at a Normal Pace and with Appropriate Manners | ||
DAD01-Effective Perf Num Applic Items | C111581 | DAD01-Effective Perf Num Applic Items | Disability Assessment for Dementia - Sub-Total Effective Performance Number of Applicable Items. | DAD - Sub-Total Effective Performance Number of Applicable Items | ||
DAD01-Find and Dial Telephone Number | C105191 | DAD01-Find and Dial Telephone Number | Disability Assessment for Dementia - Find and dial a telephone number correctly? | DAD - Find and Dial a Telephone Number Correctly | ||
DAD01-Go Out Without Getting Lost | C105196 | DAD01-Go Out Without Getting Lost | Disability Assessment for Dementia - Go out and reach a familiar destination without getting lost? | DAD - Go Out and Reach a Familiar Destination Without Getting Lost | ||
DAD01-Handle Money Adequately | C105202 | DAD01-Handle Money Adequately | Disability Assessment for Dementia - Handle his/her money adequately (deal with cash)? | DAD - Handle Money Adequately | ||
DAD01-Initiation Num Applic Items | C111578 | DAD01-Initiation Num Applic Items | Disability Assessment for Dementia - Sub-Total Initiation Number of Applicable Items. | DAD - Total Initiation Number of Applicable Items | ||
DAD01-Organize Finances to Pay Bills | C105200 | DAD01-Organize Finances to Pay Bills | Disability Assessment for Dementia - Organize his/her finances to pay his/her bills (checks, bank statement, bills)? | DAD - Organize Finances to Pay Bills | ||
DAD01-Plan & Org Num Applic Items | C111617 | DAD01-Plan & Org Num Applic Items | Disability Assessment for Dementia - Sub-Total Planning & Organization Number of Applicable Items. | DAD - Plan and Organize Number of Applicable Items | ||
DAD01-Plan Organize Household Chores | C105207 | DAD01-Plan Organize Household Chores | Disability Assessment for Dementia - Plan and organize adequately household chores that he/she used to perform in the past? | DAD - Plan and Organize Adequately Household Chores as in the Past | ||
DAD01-Prepare For Washing Bath Shower | C105173 | DAD01-Prepare For Washing Bath Shower | Disability Assessment for Dementia - Prepare the water, towels, and soap for washing, taking a bath or a shower? | DAD - Prepare the Water, Towels, and Soap for Washing, Taking a Bath or Shower | ||
DAD01-Prepare or Cook Light Meal Snack | C105189 | DAD01-Prepare or Cook Light Meal Snack | Disability Assessment for Dementia - Prepare or cook a light meal or a snack safely? | DAD - Safely Prepare or Cook a Light Meal or Snack | ||
DAD01-Return From Store With Items | C105198 | DAD01-Return From Store With Items | Disability Assessment for Dementia - Return from the store with the appropriate items? | DAD - Return From the Store with Appropriate Items | ||
DAD01-Safely Take Transportation | C105197 | DAD01-Safely Take Transportation | Disability Assessment for Dementia - Safely take the adequate mode of transportation (car, bus, taxi)? | DAD - Safely Take the Adequate Mode of Transportation | ||
DAD01-Show Interest in Leisure Activity | C105205 | DAD01-Show Interest in Leisure Activity | Disability Assessment for Dementia - Show an interest in leisure activity(ies)? | DAD - Show an Interest in Leisure Activities | ||
DAD01-Show Interest in Personal Affairs | C105199 | DAD01-Show Interest in Personal Affairs | Disability Assessment for Dementia - Show an interest in his/her personal affairs such as his/her finances and written correspondence? | DAD - Show an Interest in Personal Affairs such as Finances and Written Correspondence | ||
DAD01-Stay Safely at Home When Needed | C105209 | DAD01-Stay Safely at Home When Needed | Disability Assessment for Dementia - Stay safely at home by himself/herself when needed? | DAD - Stay Safely at Home When Needed | ||
DAD01-Sub-Total Effective Performance | C111580 | DAD01-Sub-Total Effective Performance | Disability Assessment for Dementia - Sub-Total Effective Performance. | DAD - Sub-Total Effective Performance | ||
DAD01-Sub-Total Initiation | C111577 | DAD01-Sub-Total Initiation | Disability Assessment for Dementia - Sub-Total Initiation. | DAD - Sub-Total Initiation | ||
DAD01-Sub-Total Planning & Organization | C111579 | DAD01-Sub-Total Planning & Organization | Disability Assessment for Dementia - Sub-Total Planning & Organization. | DAD - Sub-Total Planning and Organization | ||
DAD01-Take Care of Hair | C105176 | DAD01-Take Care of Hair | Disability Assessment for Dementia - Take care of his/her hair (wash and comb)? | DAD - Take Care of His/Her Hair | ||
DAD01-Take Interest in Household Chores | C105206 | DAD01-Take Interest in Household Chores | Disability Assessment for Dementia - Take an interest in household chores that he/she used to perform in the past? | DAD - Take an Interest in Household Chores as in the Past | ||
DAD01-Take Medications as Prescribed | C105204 | DAD01-Take Medications as Prescribed | Disability Assessment for Dementia - Take his/her medications as prescribed (according to the right dosage)? | DAD - Take Medications as Prescribed | ||
DAD01-Take Medications at Correct Time | C105203 | DAD01-Take Medications at Correct Time | Disability Assessment for Dementia - Decide to take his/her medications at the correct time? | DAD - Decide to Take Medications at the Correct Time | ||
DAD01-Telephone Someone at Suitable Time | C105190 | DAD01-Telephone Someone at Suitable Time | Disability Assessment for Dementia - Attempt to telephone someone at a suitable time? | DAD - Attempt to Telephone Someone at a Suitable Time | ||
DAD01-Total % | C111584 | DAD01-Total % | Disability Assessment for Dementia - Total %. | DAD - Total Percent | ||
DAD01-Total Num of Applic Items | C111583 | DAD01-Total Num of Applic Items | Disability Assessment for Dementia - Total Number of Applicable Items. | DAD - Total Number of Applicable Items | ||
DAD01-Total Score | C111582 | DAD01-Total Score | Disability Assessment for Dementia - Total Score. | DAD - Total Score | ||
DAD01-Undress Completely | C105181 | DAD01-Undress Completely | Disability Assessment for Dementia - Undress himself/herself completely? | DAD - Undress Himself/Herself Completely | ||
DAD01-Use Toilet at Appropriate Times | C105182 | DAD01-Use Toilet at Appropriate Times | Disability Assessment for Dementia - Decide to use the toilet at appropriate times? | DAD - Decide to Use the Toilet at Appropriate Times | ||
DAD01-Use Toilet Without Accidents | C105183 | DAD01-Use Toilet Without Accidents | Disability Assessment for Dementia - Use the toilet without 'accidents'? | DAD - Use the Toilet Without Accidents | ||
DAD01-Wash and Dry Body Safely | C105174 | DAD01-Wash and Dry Body Safely | Disability Assessment for Dementia - Wash and dry all parts of his/her body safely and completely? | DAD - Wash and Dry All Parts of Body Safely and Completely | ||
DAD01-Write Convey Telephone Message | C105193 | DAD01-Write Convey Telephone Message | Disability Assessment for Dementia - Write and convey a telephone message adequately? | DAD - Write and Convey a Telephone Message Adequately | ||
Back to top | ||||||
CL.C115402.DRS01TC | Disability Rating Scale Clinical Classification Test Code
(DRS01TC) | text
Extensible: No | C115402 | Disability Rating Scale Clinical Classification Test Code | Disability Rating Scale test code. | CDISC Clinical Classification DRS Test Code Terminology |
DRS0101 | C115820 | DRS01-Eye Opening | Disability Rating Scale - Eye opening. | DRS - Eye Opening | ||
DRS0102 | C115821 | DRS01-Communication Ability | Disability Rating Scale - Communication ability. | DRS - Communication Ability | ||
DRS0103 | C115822 | DRS01-Motor Response | Disability Rating Scale - Motor response. | DRS - Motor Response | ||
DRS0104 | C115823 | DRS01-Feeding | Disability Rating Scale - Feeding (cognitive ability only). | DRS - Feeding | ||
DRS0105 | C115824 | DRS01-Toileting | Disability Rating Scale - Toileting (cognitive ability only). | DRS - Toileting | ||
DRS0106 | C115825 | DRS01-Grooming | Disability Rating Scale - Grooming (cognitive ability only). | DRS - Grooming | ||
DRS0107 | C115826 | DRS01-Level of Functioning | Disability Rating Scale - Level of functioning (physical, mental, emotional or social function). | DRS - Level of Functioning | ||
DRS0108 | C115827 | DRS01-Employability | Disability Rating Scale - Employability (as a full time worker, homemaker, or student). | DRS - Employability | ||
DRS0109 | C176220 | DRS01-Total Score | Disability Rating Scale - Total score. | DRS - Total Score | ||
Back to top | ||||||
CL.C115401.DRS01TN | Disability Rating Scale Clinical Classification Test Name
(DRS01TN) | text
Extensible: No | C115401 | Disability Rating Scale Clinical Classification Test Name | Disability Rating Scale test name. | CDISC Clinical Classification DRS Test Name Terminology |
DRS01-Communication Ability | C115821 | DRS01-Communication Ability | Disability Rating Scale - Communication ability. | DRS - Communication Ability | ||
DRS01-Employability | C115827 | DRS01-Employability | Disability Rating Scale - Employability (as a full time worker, homemaker, or student). | DRS - Employability | ||
DRS01-Eye Opening | C115820 | DRS01-Eye Opening | Disability Rating Scale - Eye opening. | DRS - Eye Opening | ||
DRS01-Feeding | C115823 | DRS01-Feeding | Disability Rating Scale - Feeding (cognitive ability only). | DRS - Feeding | ||
DRS01-Grooming | C115825 | DRS01-Grooming | Disability Rating Scale - Grooming (cognitive ability only). | DRS - Grooming | ||
DRS01-Level of Functioning | C115826 | DRS01-Level of Functioning | Disability Rating Scale - Level of functioning (physical, mental, emotional or social function). | DRS - Level of Functioning | ||
DRS01-Motor Response | C115822 | DRS01-Motor Response | Disability Rating Scale - Motor response. | DRS - Motor Response | ||
DRS01-Toileting | C115824 | DRS01-Toileting | Disability Rating Scale - Toileting (cognitive ability only). | DRS - Toileting | ||
DRS01-Total Score | C176220 | DRS01-Total Score | Disability Rating Scale - Total score. | DRS - Total Score | ||
Back to top | ||||||
CL.C101863.DISCHDX | Discharge Disposition
(DISCHDX) | text
Extensible: Yes | C101863 | Discharge Disposition | The destination or circumstance at the time of discharge. | CDISC SDTM Discharge Disposition Terminology |
EXPIRED IN A MEDICAL FACILITY | C99944 | The patient died while in a medical center such as a hospital, skilled nursing facility (SNF), intermediate care facility (ICF), or a freestanding hospice center. | Died in a Medical Facility | |||
EXPIRED | C28554 | Died | The absence of life or state of being dead. (NCI) | Dead | ||
FEDERAL HEALTH CARE FACILITY | C99909 | The patient will be admitted to a medical center that is funded by the federal government (e.g. Veterans Affairs Hospital). | Federal Health Care Facility | |||
HOME UNDER CARE OF ORGANIZED HOME HEALTH SERVICE ORGANIZATION IN ANTICIPATION OF COVERED SKILLED CARE | C99959 | The patient will return home but personal health maintenance will be administered and monitored by a member of a healthcare organization that is eligible to receive Medicare funding. | Home Under Care of Organized Home Health Service Organization in Anticipation of Covered Skilled Care | |||
HOME, HOSPICE | C99958 | The patient will receive end-of-life care which will be administered in the patient's home. | Home Hospice | |||
HOME, NURSING CARE | C20883 | The patient will receive professional nursing care provided within the home of the patient. | Home Health Nursing | |||
HOME, SELF CARE | C99957 | A routine discharge where personal health maintenance will be administered and monitored by the patient from their home. | Home Care | |||
HOSPICE - MEDICAL FACILITY | C99910 | The patient will receive end-of-life care which will be administered in a medical center. | Hospice Care at Medical Facility | |||
HOSPITAL-BASED MEDICARE-APPROVED SWING BED | C99960 | The patient will be admitted into a medical center and receive a type of hospital bed that will be paid for my Medicare. | Hospital with Medicare Approved Swing Bed | |||
INPATIENT REHABILITATION FACILITY (IRF) INCLUDING REHABILITATION DISTINCT PART UNITS OF A HOSPITAL | C99911 | The patient will be admitted full time into a free standing rehabilitation center or a rehabilitation center within a general medical facility. | Inpatient Rehabilitation Facility Including Rehabilitation distinct Part Units of a Hospital | |||
INSTITUTION NOT DEFINED | C102247 | The patient will be admitted into an alternative facility not listed. | Institution Not Defined | |||
INTERMEDIATE CARE FACILITY | C99912 | Non-Hospital Intermediate Care Facility | The patient will be admitted to an intermediate care facility. | Intermediate Care Facility | ||
LEFT AGAINST MEDICAL ADVICE OR DISCONTINUED CARE | C99969 | The patient vacated the medical center or ceased medical care contrary to the recommendation of a trained healthcare provider. | Left Against Medical Advice | |||
LONG TERM CARE HOSPITAL | C135382 | The patient will be admitted into a hospital equipped and staffed to provide prolonged care to patients. | Long Term Care Hospital | |||
LONG TERM NURSING CARE FACILITY | C20870 | The patient will be admitted to a long-term nursing care facility. | Long-Term Care Nursing | |||
MEDICARE-CERTIFIED LONG TERM CARE HOSPITAL (LTCH) | C99984 | The patient will be admitted into a Medicare funded medical center for a considerable length of time. | Medicare Certified Long Term Care Hospital | |||
NURSING FACILITY CERTIFIED UNDER MEDICAID BUT NOT CERTIFIED UNDER MEDICARE | C99913 | The patient will be admitted into a medical center which is eligible to receive funding from Medicaid but not Medicare. | Nursing Facility Certified Under Medicaid but Not Certified Under Medicare | |||
PSYCHIATRIC HOSPITAL OR A PSYCHIATRIC-DISTINCT PART UNIT OF A HOSPITAL | C53536 | The patient will be admitted into a free standing medical facility or a unit within a general medical facility used for the treatment of mental health disorders. | Psychiatric Facility | |||
REHABILITATION FACILITY | C53535 | The patient will be admitted to a rehabilitation facility designed for improving, maintaining, or restoring physical strength, cognition, speech, or mobility. | Rehabilitation Center | |||
SHORT TERM GENERAL HOSPITAL | C102248 | The patient will remain in a basic hospital environment for a brief time. | Short Term General Hospital | |||
SKILLED NURSING FACILITY (SNF) WITH MEDICARE CERTIFICATION IN ANTICIPATION OF COVERED SKILLED CARE | C99914 | The patient will be admitted into a medical center equipped with a trained nursing staff that is eligible to receive Medicare funding. | Skilled Nursing Facility with Medicare Certification in Anticipation of Covered Skilled Care | |||
Back to top | ||||||
CL.C102578.DSSOUT | Disease Outcome
(DSSOUT) | text
Extensible: Yes | C102578 | Disease Outcome | Terminology relevant to the measurable result or effect of treatment on a disease. | CDISC SDTM Disease Outcome Terminology |
BACTERIOLOGICAL CURE | C102600 | There are no indicators of bacterial infection in an individual who previously had an infection. | Bacteriological Cure | |||
BACTERIOLOGICAL FAILURE | C102601 | There are indicators of bacterial infection in the individual who previously had an infection. | Bacteriological Failure | |||
CLINICAL CURE | C102607 | There are no signs or symptoms of disease in the individual who previously had a disease. | Clinical Cure | |||
CLINICAL FAILURE | C102608 | There are still signs or symptoms of disease in the individual who previously had an infection. | Clinical Failure | |||
RECURRENT DISEASE | C38155 | Recurrent Disease | The return of a disease after a period of remission. | Recurrent Disease | ||
Back to top | ||||||
CL.C127268.DSPRTYP | Disease Presentation Type
(DSPRTYP) | text
Extensible: Yes | C127268 | Disease Presentation Type | Terminology relevant to the symptoms and/or clinical manifestation of a disease. | CDISC SDTM Disease Presentation Type Terminology |
COMPLEX CYSTIC LESION | C127606 | A lesion that demonstrates both cystic and solid components; the solid components can range from thin walls (septae) to a solid tissue mass. | Complex Cystic Lesion | |||
EFFUSION | C3003 | Abnormal collection of fluid in a body cavity. | Effusion | |||
INCREASING ABDOMINAL DISTENTION OR ASCITES | C2885 | Ascites | Abnormal collection of fluid in the peritoneal cavity. | Ascites | ||
LEPTOMENINGEAL DISEASE | C4958 | A malignant neoplasm that has spread from its original site to the arachnoid mater and the pia mater, the two innermost layers of tissue that cover the brain and spinal cord. | Leptomeningeal Neoplasm | |||
Back to top | ||||||
CL.C112437.DS01TC | Disease Steps Clinical Classification Test Code
(DS01TC) | text
Extensible: No | C112437 | Disease Steps Clinical Classification Test Code | Disease Steps test code. | CDISC Clinical Classification DS Test Code Terminology |
DS0101 | C112549 | DS01-Disease Steps Classification | Disease Steps - Methods: For Disease Steps, classification of a patient is determined by history and neurologic examination as well as course of MS. | DS - Disease Steps Classification | ||
Back to top | ||||||
CL.C112436.DS01TN | Disease Steps Clinical Classification Test Name
(DS01TN) | text
Extensible: No | C112436 | Disease Steps Clinical Classification Test Name | Disease Steps test name. | CDISC Clinical Classification DS Test Name Terminology |
DS01-Disease Steps Classification | C112549 | DS01-Disease Steps Classification | Disease Steps - Methods: For Disease Steps, classification of a patient is determined by history and neurologic examination as well as course of MS. | DS - Disease Steps Classification | ||
Back to top | ||||||
CL.C78732.DATESTCD | Drug Accountability Test Code
(DATESTCD) | text
Extensible: Yes | C78732 | Drug Accountability Test Code | The short name, or code, of the test for the drug accountability assessment. | CDISC SDTM Drug Accountability Test Code Terminology |
DISPAMT | C78721 | Dispensed Amount | The quantity of a product that has been dispensed. (NCI) | Dispensed Amount | ||
LOSTAMT | C189430 | Lost Amount | The quantity of a product reported as lost. | Lost Amount | ||
PREPAMT | C170562 | Prepared Amount | The quantity of a product that has been made ready for use. | Prepared Amount | ||
REMAMT | C170563 | Remaining Amount | The quantity of a product that remains after dosing, consumption, or use. | Remaining Amount | ||
RETAMT | C78722 | Returned Amount | The quantity of a product that has been returned. (NCI) | Returned Amount | ||
Back to top | ||||||
CL.C78731.DATEST | Drug Accountability Test Name
(DATEST) | text
Extensible: Yes | C78731 | Drug Accountability Test Name | The name of the test for the drug accountability assessment. | CDISC SDTM Drug Accountability Test Name Terminology |
Dispensed Amount | C78721 | Dispensed Amount | The quantity of a product that has been dispensed. (NCI) | Dispensed Amount | ||
Lost Amount | C189430 | Lost Amount | The quantity of a product reported as lost. | Lost Amount | ||
Prepared Amount | C170562 | Prepared Amount | The quantity of a product that has been made ready for use. | Prepared Amount | ||
Remaining Amount | C170563 | Remaining Amount | The quantity of a product that remains after dosing, consumption, or use. | Remaining Amount | ||
Returned Amount | C78722 | Returned Amount | The quantity of a product that has been returned. (NCI) | Returned Amount | ||
Back to top | ||||||
CL.C102577.DRSTAT | Drug Resistance Status
(DRSTAT) | text
Extensible: Yes | C102577 | Drug Resistance Status | Terminology relevant to the state or condition of the microbe or lesion to indicate whether it is resistant to drugs normally used in treatment. | CDISC SDTM Drug Resistance Status Terminology |
EXTENSIVE DRUG RESISTANCE | C102633 | XDR | Resistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease. | Extensively Drug Resistance Process | ||
MULTIPLE DRUG RESISTANCE | C17745 | MDR | Simultaneous resistance to a spectrum of unrelated drugs following exposure to a single agent. Mechanisms involve expression of multidrug efflux pumps (p-glycoprotein), altered glutathione metabolism, decreased topoisomerase II activity, and changes in various cellular proteins. | Multidrug Resistance Process | ||
SUSCEPTIBLE | C85563 | Susceptible | The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection. | Antimicrobial Susceptibility Result | ||
Back to top | ||||||
CL.C139018.DMFATSCD | Duchenne Muscular Dystrophy Findings About Test Code
(DMFATSCD) | text
Extensible: Yes | C139018 | Duchenne Muscular Dystrophy Findings About Test Code | Terminology relevant to the test codes that describe findings about a Duchenne muscular dystrophy event or intervention. | CDISC SDTM Duchenne Muscular Dystrophy Findings About Test Code Terminology |
AGEFTUSE | C139175 | Age at Full-Time Use | The age at which the full-time use of a pre-specified object first occurred. | Age at Full-Time Use | ||
Back to top | ||||||
CL.C139019.DMFATS | Duchenne Muscular Dystrophy Findings About Test Name
(DMFATS) | text
Extensible: Yes | C139019 | Duchenne Muscular Dystrophy Findings About Test Name | Terminology relevant to the test cnames that describe findings about a Duchenne muscular dystrophy event or intervention. | CDISC SDTM Duchenne Muscular Dystrophy Findings About Test Name Terminology |
Age at Full-Time Use | C139175 | Age at Full-Time Use | The age at which the full-time use of a pre-specified object first occurred. | Age at Full-Time Use | ||
Back to top | ||||||
CL.C179943.ECOG101OR | Eastern Cooperative Oncology Group Performance Status Clinical Classification ORRES for ECOG101 TN/TC
(ECOG101OR) | text
Extensible: No | C179943 | Eastern Cooperative Oncology Group Performance Status Clinical Classification ORRES for ECOG101 TN/TC | Eastern Cooperative Oncology Group Performance Status original result for ECOG101 test and test code. | CDISC Clinical Classification Eastern Cooperative Oncology Group Performance Status ECOG101 Original Response Terminology |
Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours | C180251 | ECOG101-Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours | Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. | Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Ambulatory And Capable Of All Selfcare But Unable To Carry Out Any Work Activities. Up And About More Than 50% Of Waking Hours | ||
Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours | C180252 | ECOG101-Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours | Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. | Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Capable Of Only Limited Selfcare, Confined To Bed Or Chair More Than 50% Of Waking Hours | ||
Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair | C180253 | ECOG101-Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair | Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. | Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Completely Disabled. Cannot Carry On Any Selfcare. Totally Confined To Bed Or Chair | ||
Dead | C180254 | ECOG101-Dead | Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Dead. | Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Dead | ||
Fully active, able to carry on all pre-disease performance without restriction | C180249 | ECOG101-Fully active, able to carry on all pre-disease performance without restriction | Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Fully active, able to carry on all pre-disease performance without restriction. | Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Fully Active, Able To Carry On All Pre-Disease Performance Without Restriction | ||
Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work | C180250 | ECOG101-Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work | Eastern Cooperative Oncology Group Performance Status original result for ECOG101-Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. | Eastern Cooperative Oncology Group Performance Status ECOG101 Original Result - Restricted In Physically Strenuous Activity But Ambulatory And Able To Carry Out Work Of A Light Or Sedentary Nature, E.G., Light House Work, Office Work | ||
Back to top | ||||||
CL.C179944.ECOG101STR | Eastern Cooperative Oncology Group Performance Status Clinical Classification STRESC for ECOG101 TN/TC
(ECOG101STR) | text
Extensible: No | C179944 | Eastern Cooperative Oncology Group Performance Status Clinical Classification STRESC for ECOG101 TN/TC | Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101 test and test code. | CDISC Clinical Classification Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Response Terminology |
0 | C180255 | ECOG101-0 | Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Fully active, able to carry on all pre-disease performance without restriction. | Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 0 | ||
1 | C180256 | ECOG101-1 | Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. | Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 1 | ||
2 | C180257 | ECOG101-2 | Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours. | Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 2 | ||
3 | C180258 | ECOG101-3 | Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours. | Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 3 | ||
4 | C180259 | ECOG101-4 | Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair. | Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 4 | ||
5 | C180260 | ECOG101-5 | Eastern Cooperative Oncology Group Performance Status standardized character result for ECOG101-Dead. | Eastern Cooperative Oncology Group Performance Status ECOG101 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C101815.ECOG1TC | Eastern Cooperative Oncology Group Performance Status Clinical Classification Test Code
(ECOG1TC) | text
Extensible: No | C101815 | Eastern Cooperative Oncology Group Performance Status Clinical Classification Test Code | Eastern Cooperative Oncology Group Performance Status test code. | CDISC Clinical Classification ECOG Test Code Terminology |
ECOG101 | C102408 | ECOG1-Performance Status | ECOG Performance Status - Performance Status. | ECOG - Performance Status | ||
Back to top | ||||||
CL.C101816.ECOG1TN | Eastern Cooperative Oncology Group Performance Status Clinical Classification Test Name
(ECOG1TN) | text
Extensible: No | C101816 | Eastern Cooperative Oncology Group Performance Status Clinical Classification Test Name | Eastern Cooperative Oncology Group Performance Status test name. | CDISC Clinical Classification ECOG Test Name Terminology |
ECOG1-Performance Status | C102408 | ECOG1-Performance Status | ECOG Performance Status - Performance Status. | ECOG - Performance Status | ||
Back to top | ||||||
CL.C132316.EBFATSCD | Ebola Virus Findings About Test Code
(EBFATSCD) | text
Extensible: Yes | C132316 | Ebola Virus Findings About Test Code | Terminology relevant to the test codes that describe findings about an Ebola virus infection event or intervention. | CDISC SDTM Ebola Virus Findings About Test Code Terminology |
DIAMETER | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
SEV | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C132315.EBFATS | Ebola Virus Findings About Test Name
(EBFATS) | text
Extensible: Yes | C132315 | Ebola Virus Findings About Test Name | Terminology relevant to the test names that describe findings about an Ebola virus infection event or intervention. | CDISC SDTM Ebola Virus Findings About Test Name Terminology |
Diameter | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Severity/Intensity | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C90013.EGLEAD | ECG Lead
(EGLEAD) | text
Extensible: Yes | C90013 | ECG Lead | Terminology related to electrocardiogram lead names. | CDISC SDTM Electrocardiogram Lead Terminology |
LEAD aV6 | C90403 | An augmented unipolar lead placed at the sixth intercostal space on the midaxillary line. (NCI) | Lead Site aV6 | |||
LEAD aVF | C90360 | An augmented unipolar electrocardiogram limb lead in which the positive (red) electrode is situated on the left pelvic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left thoracic limb (black) electrode. Measures the electrical activity of the electrode on the left pelvic limb. | Augmented Vector Foot | |||
LEAD aVF-VENTRAL | C135387 | An augmented unipolar electrocardiogram limb lead in which the positive electrode is situated at the hindquarters proximal to the sacrum and the negative electrode is a combination of the electrode behind the right ear near the right mastoid process and the electrode near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum). | Lead Site aVF-Ventral | |||
LEAD aVL | C90361 | An augmented unipolar electrocardiogram limb lead in which the positive (black) electrode is situated on the left thoracic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left pelvic limb (red) electrode. Measures the electrical activity of the electrode on the left thoracic limb. (NCI) | Augmented Vector Left | |||
LEAD aVL-AXIAL | C135388 | An augmented unipolar electrocardiogram limb lead in which the positive electrode is near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum) and the negative electrode is a combination of the electrode behind the right ear near the right mastoid process and the electrode on hindquarters proximal to the sacrum. | Lead Site aVL-Axial | |||
LEAD aVR | C90362 | An augmented unipolar electrocardiogram limb lead in which the positive (white) electrode is situated on the right thoracic limb and the negative electrode is a combination of the left thoracic limb (black) electrode and the left pelvic limb (red) electrode. Measures the electrical activity of the electrode on the right thoracic limb. (NCI) | Augmented Vector Right | |||
LEAD aVR-DORSAL | C135389 | An augmented unipolar electrocardiogram limb lead in which the positive electrode is behind the right ear near the right mastoid process and the negative electrode is a combination of the electrode at the hindquarters proximal to the sacrum and the electrode near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum). | Lead Site aVR-Dorsal | |||
LEAD AXIAL | C135390 | A bipolar electrocardiogram limb lead which records the voltage between the positive electrode near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum) and the negative electrode behind the right ear near the right mastoid process. | Lead Site Axial | |||
LEAD CM5 | C90404 | A bipolar EKG lead with the right thoracic limb electrode placed on the manubrium and left thoracic limb electrode placed at the surface marking of the V5 position (just above the 5th interspace in the anterior axillary line). The left pelvic limb lead acts as a neutral and may be placed anywhere. The C refers to 'clavicle' where it is often placed. (NCI) | Lead Site CM5 | |||
LEAD CV5RL | C90405 | A unipolar chest lead used mostly in large animals. Placed on the sixth ICS on the right side of the thorax along a line parallel to the level of the point of the humeralradial joint. | Lead Site CV5RL | |||
LEAD CV6LL | C90406 | V1 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the humeralradial joint. | Lead Site CV6LL | |||
LEAD CV6LU | C90407 | V2 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the shoulder. (NCI) | Lead Site CV6LU | |||
LEAD DORSAL | C135391 | A bipolar electrocardiogram limb lead which records the voltage between the negative electrode behind the right ear near the right mastoid process and the positive electrode on the hindquarters proximal to the sacrum. | Lead Site Dorsal | |||
LEAD I | C90408 | A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left thoracic limb. (NCI) | Lead Site I | |||
LEAD II | C90409 | A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left pelvic limb. (NCI) | Lead Site II | |||
LEAD III | C90410 | A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the left thoracic limb and the positive electrode on the left pelvic limb. (NCI) | Lead Site III | |||
LEAD rV2 | C90411 | A unipolar precordial lead placed at the second intercostal space to the left of the sternum. (NCI) | Lead Site rV2 | |||
LEAD V1 | C90412 | Lead C1 | A unipolar electrocardiogram lead site; the electrode is placed at the fourth intercostal space on the anterior chest wall (between ribs 4 and 5) to the right of the sternal border. In small animals, it is placed at the right fifth intercostal space near the sternum. (NCI) | Lead Site V1 | ||
LEAD V10 | C90413 | A unipolar chest lead at which the electrode is placed over the dorsal spinous process of 7th thoracic vertebra. (NCI) | Lead Site V10 | |||
LEAD V2 | C90414 | Lead C2 | A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall at the fourth intercostal space (between ribs 4 and 5) to the left of the sternal border. In small animals it corresponds to V2-V3 where it is placed at the 6th left intercostal space near the sternum. In large animals it is placed over the 6th rib at the level of the costochondral junction on the left side of the thorax. | Lead Site V2 | ||
LEAD V3 | C90415 | Lead C3 | A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall midway between leads V2 and V4. In large and small animals, it is placed over the dorsal spinous process of the 7th thoracic vertebra. (NCI) | Lead Site V3 | ||
LEAD V4 | C90416 | Lead C4 | A unipolar electrocardiogram lead site; the electrode is placed at the fifth intercostal space on the anterior chest wall (between ribs 5 and 6) at the left midclavicular line. In small animals it corresponds to V4-V6 where it is placed at the 6th left intercostal space near the costochondral junction. In large animals it is placed over the 6th rib at the level of a horizontal line drawn through the scapulohumeral articulation on the left side of the thorax. (NCI) | Lead Site V4 | ||
LEAD V5 | C90417 | Lead C5 | A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall level with lead V4 at the left anterior axillary line. In large animals it is placed on the sixth ICS on the right side of the thorax along a line parallel to the level of the point of the shoulder corresponding to the electrical center of the heart (central terminal). (NCI) | Lead Site V5 | ||
LEAD V6 | C90418 | Lead C6 | A unipolar electrocardiogram lead site at which the electrode is placed on the anterior chest wall level with lead V5 at the left midaxillary line . | Lead Site V6 | ||
LEAD VENTRAL | C135392 | A bipolar electrocardiogram limb lead which records the voltage with the positive electrode on the hindquarters proximal to the sacrum and the negative electrode near the apex of the heart (located in the ICS of left 5-6 rib close to the sternum). | Lead Site Ventral | |||
SML | C117760 | Global Median Beat;Superimposition of Multiple Leads | Measurement methodology using multiple leads for the determination of an ECG parameter. This is often visually represented as a superimposition of the median beats from multiple leads. | Superimposition of Multiple Leads | ||
Back to top | ||||||
CL.C172333.EGRDMETH | ECG Read Method Response
(EGRDMETH) | text
Extensible: Yes | C172333 | ECG Read Method Response | Terminology relevant to the method for how the ECG is read, with respect to how much human intervention is involved. | CDISC SDTM ECG Read Method Response Terminology |
AUTOMATIC | C70669 | Of or related to a process performed without human intervention. | Automatic | |||
MANUAL | C63513 | Of or related to a process performed by hand. | Manual | |||
SEMI-AUTOMATIC | C172484 | Of or related to a process performed using a combination of manual and automatic means. | Semi-Automatic | |||
Back to top | ||||||
CL.C71150.EGSTRESC | ECG Result
(EGSTRESC) | text
Extensible: Yes | C71150 | ECG Result | Terminology codelist used with ECG Findings and Abnormalities within CDISC. | CDISC SDTM ECG Finding Terminology |
1ST DEGREE AV BLOCK | C111088 | 1st degree AV block;PR Prolongation;Prolonged PR interval | An electrocardiographic finding of prolonged PR interval for a specific population. For adults one common threshold is a PR interval greater than 0.20 seconds. Note that other thresholds may be applicable. | AV Block First Degree by ECG Finding | ||
2:1 AV BLOCK | C71044 | 2:1 AV block | An electrocardiographic finding of a supraventricular rhythm where the ratio of impulses generated above the atrioventricular node to the number of impulses conducted through to the ventricles is 2:1. This is manifest on the ECG as 2 P waves per QRS complex. | 2:1 Atrioventricular Block by ECG Finding | ||
2ND DEGREE AV BLOCK | C62016 | Second Degree AV Block | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by regular P waves which intermittently are not followed by QRS complexes. | AV Block Second Degree by ECG Finding | ||
3RD DEGREE AV BLOCK | C111091 | 3rd Degree Heart Block;AV block, complete (third-degree);Complete Heart Block | An electrocardiographic finding of complete failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by disassociation of atrial and ventricular rhythms. The atrial rate must be faster than the ventricular rate. | AV Block Third Degree by ECG Finding | ||
50 Hz NOISE | C114165 | 50 Hz Artifact;50 Hz Noise | An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (50 Hz). | 50 Hertz Noise by ECG Finding | ||
60 Hz NOISE | C114164 | 60 Hz Artifact;60 Hz Noise | An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (60 Hz). | 60 Hertz Noise by ECG Finding | ||
ABERRANTLY CONDUCTED COMPLEXES | C116132 | Aberrantly Conducted Beats | An electrocardiographic finding of an abnormally wide QRS complex(es) of supraventricular origin with prolonged QRS duration due to aberrant AV conduction. | Aberrantly Conducted Complexes by ECG Finding | ||
AC NOISE | C114149 | AC Noise | An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (usually 50 Hz or 60 Hz). | Alternating Current Noise by ECG Finding | ||
ACCELERATED IDIOVENTRICULAR RHYTHM | C62266 | Accelerated idioventricular rhythm | An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute. | Accelerated Idioventricular Rhythm by ECG Finding | ||
ACUTE ANTERIOR WALL MYOCARDIAL INFARCTION | C71065 | Acute Anterior MI;Acute Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 and V4, which is suggestive of acute myocardial infarction of the anterior wall of the left ventricle. | Acute Anterior Myocardial Infarction by ECG Finding | ||
ACUTE ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C102591 | Acute Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 through V6, which is suggestive of acute myocardial infarction of the anterolateral wall of the left ventricle. | Acute Anterolateral Myocardial Infarction by ECG Finding | ||
ACUTE ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C102592 | Acute anteroseptal MI;Acute Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 through V4, which is suggestive of acute myocardial infarction of the anteroseptal wall of the left ventricle. | Acute Anteroseptal Myocardial Infarction by ECG Finding | ||
ACUTE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C106496 | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 to V6, I and aVL, which is suggestive of acute myocardial infarction involving the anterior and anterolateral walls of the left ventricle. | Acute Extensive Anterior Wall Myocardial Infarction by ECG Finding | |||
ACUTE HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102593 | Acute High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads I and aVL, which is suggestive of acute myocardial infarction of the high lateral wall of the left ventricle. | Acute High Lateral Myocardial Infarction by ECG Finding | ||
ACUTE INFERIOR WALL MYOCARDIAL INFARCTION | C71066 | Acute Inferior MI;Acute Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads III, aVF and often II, which is suggestive of acute myocardial infarction of the inferior wall of the left ventricle. | Acute Inferior Myocardial Infarction by ECG Finding | ||
ACUTE LATERAL WALL MYOCARDIAL INFARCTION | C71067 | Acute Lateral MI;Acute Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V5, V6, I and aVL, which is suggestive of acute myocardial infarction of the lateral wall of the left ventricle. | Acute Lateral Myocardial Infarction by ECG Finding | ||
ACUTE MYOCARDIAL INFARCTION | C101596 | Acute Myocardial Infarction | An electrocardiographic finding showing a current of injury with ST elevation. No specification is provided for localization. | Acute Myocardial Infarction by ECG Finding | ||
ACUTE POSTERIOR WALL MYOCARDIAL INFARCTION | C71068 | Acute Posterior MI;Acute Posterior Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. | Acute Posterior Myocardial Infarction by ECG Finding | ||
ACUTE RIGHT VENTRICULAR WALL MYOCARDIAL INFARCTION | C102594 | Acute Right ventricular MI;Acute Right Ventricular Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the ventricular wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Additional criteria include ST elevation > 100 microvolts in the right precordial leads V4R through V6R. | Acute Right Ventricular Myocardial Infarction by ECG Finding | ||
ACUTE SEPTAL WALL MYOCARDIAL INFARCTION | C102595 | Acute Septal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1, V2 and often V3, which is suggestive of acute myocardial infarction of the intraventricular septum. | Acute Septal Myocardial Infarction by ECG Finding | ||
ADVANCED/HIGH GRADE AV BLOCK | C102642 | Advanced/High Grade AV Block | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by two or more consecutive non-conducted P waves. | High Grade Atrioventricular Block by ECG Finding | ||
ALL PRECORDIAL ELECTRODES DISCONNECTED | C114159 | An electrocardiographic recording in which all precordial electrodes are disconnected resulting in missing waveforms (flat line) of all leads V1 - V6. | All Precordial Electrodes Are Disconnected by ECG Finding | |||
ANTERIOR WALL MYOCARDIAL INFARCTION | C71069 | Anterior MI;Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle. | Anterior Myocardial Infarction by ECG Finding | ||
ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C35303 | Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle. | Anterolateral Myocardial Infarction by ECG Finding | ||
ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C35304 | Anteroseptal MI;Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle. | Anteroseptal Myocardial Infarction by ECG Finding | ||
ARTIFACT | C114162 | An electrocardiographic recording in which one or more leads display extraneous signals which do not represent cardiac electrical activity. | Artifact Lead Signal by ECG Finding | |||
ASYSTOLE | C116130 | An electrocardiographic finding showing no cardiac electrical activity on the ECG for the entire duration of the recording. | Asystole by ECG Finding | |||
ATRIAL BIGEMINY | C102596 | An electrocardiographic finding of a sinus beat followed by a premature atrial complex for three or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 1-1 ratio. | Atrial Bigeminy by ECG Finding | |||
ATRIAL COUPLETS | C102597 | Atrial Couplets | An electrocardiographic finding in which two premature atrial complexes occur sequentially; there may be one or more occurrences during an electrocardiographic recording. | Atrial Couplet by ECG Finding | ||
ATRIAL ENLARGEMENT | C71039 | Atrial Enlargement | An electrocardiographic finding which comprises left, right or bilateral atrial enlargement. This is may be characterized by prolonged P wave duration, increased P wave amplitude, or multi-component P waves. | Atrial Enlargement by ECG Finding | ||
ATRIAL FIBRILLATION | C111092 | Atrial fibrillation | An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. | Atrial Fibrillation by ECG Finding | ||
ATRIAL FLUTTER | C111094 | Atrial flutter | An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate of 240-340 beats per minute. Multiple P waves typically appear in the inferior leads in a saw tooth like pattern between the QRS complexes. | Atrial Flutter by ECG Finding | ||
ATRIAL TACHYCARDIA WITH AV BLOCK | C119249 | An electrocardiographic finding of an atrial tachycardia which does not display 1:1 AV conduction. | Atrial Tachycardia With AV Block by ECG Finding | |||
ATRIAL TACHYCARDIA | C111105 | Atrial tachycardia | An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate between 101 and 240 beats per minute. The P wave morphology must be distinct from the sinus P wave morphology. | Atrial Tachycardia by ECG Finding | ||
ATRIAL TRIGEMINY | C102598 | Atrial Trigeminy | An electrocardiographic finding of two sinus beats followed by a premature atrial complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 2-1 ratio. | Atrial Trigeminy by ECG Finding | ||
ATRIOVENTRICULAR DISSOCIATION | C71045 | Atrioventricular dissociation;AV Dissociation | An electrocardiographic finding in which the electrical activity of the atria and ventricles are independent of one another. | Atrioventricular Dissociation by ECG Finding | ||
AV MOBITZ I | C111089 | AV Mobitz I;Mobitz I Second Degree AV Block;Second degree AV block- Mobitz type I;Second-degree AV block, Mobitz type I (Wenckebach);Type 1 2nd degree AV Block;Wenckebach | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a progressively lengthening PR interval prior to the block of an atrial impulse. | AV Block Second Degree Mobitz Type I by ECG Finding | ||
AV MOBITZ II | C111090 | Mobitz II AV Block;Mobitz II Second Degree AV Block;Type 2 2nd degree AV Block | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a relatively constant PR interval prior to the block of an atrial impulse. | AV Block Second Degree Mobitz Type II by ECG Finding | ||
AV NODE RE-ENTRY | C35058 | AV Node Reentrant Supraventricular Tachycardia | An electrocardiographic finding of a regular supraventricular tachycardia due to reentry within the AV node. It is characterized by P waves which typically occurs nearly simultaneously with the QRS complex, resulting in a P wave which is obscured by the QRS, merged with the QRS or which may follow the QRS. | Atrioventricular Nodal Reentry Tachycardia by ECG Finding | ||
AV RE-ENTRANT TACHYCARDIA | C62261 | AV Reentrant Supraventricular Tachycardia | An electrocardiographic finding of a regular supraventricular tachycardia which utilizes an atrioventricular bypass tract as its retrograde limb (orthodromic tachycardia) or as its antegrade limb (antidromic tachycardia). QRS complexes during sinus rhythm may show preexcitation. During orthodromic tachycardia the preexcitation is not present and a retrograde P wave may appear after the QRS complex. During antidromic tachycardia the QRS complex is preexcited. | Atrioventricular Reentrant Tachycardia by ECG Finding | ||
BASELINE WANDER | C114147 | An electrocardiographic recording in which the isoelectric line in one or more leads is vertically displaced resulting in low frequency upward and downward movements of the signal with varying amplitudes. | Baseline Wander by ECG Finding | |||
BIFASCICULAR BLOCK | C71046 | Bifascicular block | An electrocardiographic finding comprising right bundle branch block and left anterior fascicular block, or right bundle branch block and left posterior fascicular block. Defects occurring in two of the three divisions of the conduction system of the heart are considered bifascicular blocks. Technically left bundle branch block may be considered a bifascicular block. (NCI) | Bifascicular Block by ECG Finding | ||
BIVENTRICULAR HYPERTROPHY | C106502 | An electrocardiographic finding suggestive of enlargement or thickening of both ventricles, with a combination of findings which are related to LVH and RVH, such as voltage criteria for LVH in the presence of marked right axis deviation. | Biventricular Hypertrophy by ECG Finding | |||
BORDERLINE QTCB | C92228 | Borderline QTcB | An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist. | Borderline QTcB | ||
BORDERLINE QTCF | C92229 | Borderline QTcF | An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist. | Borderline QTcF | ||
BRADYCARDIA | C111120 | Bradycardia | An electrocardiographic finding of abnormally slow heart rate. Thresholds for different age, gender, and patient populations exist. | Bradycardia by ECG Finding | ||
BRUGADA SYNDROME PATTERN | C106503 | An electrocardiographic finding of complete or incomplete right bundle branch block accompanied by ST elevation in leads V1-V3. This may be noted at rest or can be provoked by medication challenge. | Brugada Syndrome Pattern by ECG Finding | |||
CV ENDPOINTS ISCHEMIC ECG CHANGES | C116138 | An electrocardiographic finding, in the absence of left ventricular hypertrophy (LVH) and left bundle branch block pattern on ECG, of either a) new (or presumed new) ST elevation at the J point in two contiguous leads with the following cut-points: greater than or equal to 0.1 mV in all leads other than leads V2-V3 where the following cut points apply: greater than or equal to 0.2 mV in men greater than or equal to 40 years; greater than or equal to 0.25 mV in men less than 40 years, or greater than or equal to 0.15 mV in women; or b) new (or presumed new) horizontal or down-sloping ST depression greater than or equal to 0.05 mV in two contiguous leads and/or T inversion greater than or equal to 0.1 mV in two contiguous leads with prominent R wave or R/S ratio greater than 1. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). | ACC/AHA Ischemic ECG Changes | |||
DELTA WAVE | C62258 | Delta wave | An electrocardiographic finding of initial slurring (delta wave) of the QRS complex due to the presence of an accessory pathway. This characteristic ECG pattern is typically seen in Wolff-Parkinson-White syndrome. | Delta Wave by ECG Finding | ||
DEXTROCARDIA | C102623 | Dextrocardia | An electrocardiographic finding suggestive of dextrocardia with situs inversus, characterized by reversal of normal anterior R wave progression and the appearance of reversal of the right and left arm electrodes. | Dextrocardia by ECG Finding | ||
EARLY R WAVE TRANSITION | C102628 | Early R Wave Progression;Early R Wave Transition | An electrocardiographic finding where the amplitude of the R wave becomes greater than the amplitude of the S wave in the QRS complex at an unusually early point in the precordial leads, usually in leads V1 or V2. | Early R Wave Transition by ECG Finding | ||
EARLY REPOLARIZATION | C102629 | Early Repolarization | An electrocardiographic finding of J point and ST segment elevation in the absence of other signs of acute ischemia or pericarditis. | Early Repolarization | ||
ECG ACQUIRED WITH PRECORDIAL ELECTRODES PLACED ON RIGHT CHEST | C114175 | An electrocardiographic recording in which the precordial electrodes have been placed over the right chest and record a right sided ECG. | ECG Acquired with Precordial Electrodes Placed on the Right Chest | |||
ECG EVALUATION NOT PERFORMED DUE TO CORRUPTED DIGITAL ECG FILE | C114181 | A digital electrocardiographic recording which is corrupted (i.e. ECG signal cannot be restored) such that measurements and/or interpretation cannot be performed. | ECG Evaluation Not Performed Due to Corrupted Digital ECG File | |||
ECG EVALUATION NOT PERFORMED DUE TO POOR QUALITY OF PRINTED ECG | C114180 | A printed electrocardiographic recording with poor printout quality (e.g. a faded paper ECG tracing or ECG with inconsistent printing speed) such that measurements and/or interpretation cannot be performed. | ECG Evaluation Not Performed Due to Poor Quality of Printed ECG | |||
ECG EVALUATION NOT PERFORMED DUE TO UNKNOWN ECG AMPLITUDE GAIN OR RECORDING SPEED | C114178 | An electrocardiographic recording in which measurements and/or interpretation are not performed because the ECG amplitude gain and/or recording speed are not known. | ECG Evaluation Not Performed Due to Unknown ECG Amplitude Gain or Recording Speed | |||
ECTOPIC ATRIAL RHYTHM | C62245 | Ectopic Supraventricular Rhythm | An electrocardiographic finding of a regular atrial rhythm with atrial rate of less than 101 beats per minute which does not originate in the sinus node, and which is characterized by P waves whose morphology differs from the P wave morphology during sinus rhythm. | Ectopic Atrial Rhythm by ECG Finding | ||
ECTOPIC VENTRICULAR RHYTHM | C71042 | Ectopic ventricular rhythm | An electrocardiographic finding of three or more consecutive complexes of ventricular origin. The QRS complexes are wide and have an abnormal morphology. | Ectopic Ventricular Rhythm by ECG Finding | ||
ELECTRICAL ALTERNANS | C71035 | Electrical alternans | An electrocardiographic finding in which there is an alternating pattern of any of the waveform components. (NCI) | Electrical Alternans by ECG Finding | ||
EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C106520 | An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle. | Extensive Anterior Wall Myocardial Infarction by ECG Finding | |||
FUSION COMPLEX | C102639 | Fusion Beat;Fusion Complexes | An electrocardiographic finding that occurs when electrical activation of the atria or ventricles occurs from two separate sites. This results in a P wave or QRS complex that displays merged characteristics of beats originating from the two different sites; there may be one or more occurrences during an electrocardiographic recording. | Fusion Complex | ||
HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102643 | High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle. | High Lateral Myocardial Infarction by ECG Finding | ||
IDIOVENTRICULAR RHYTHM | C50599 | Idioventricular Rhythm | An electrocardiographic finding of three or more consecutive complexes of ventricular origin with a rate less than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. | Idioventricular Rhythm | ||
INCOMPLETE ECG | C114167 | An electrocardiographic recording which is limited in duration or which does not display all of the expected leads. | Incomplete ECG | |||
INCOMPLETE LEFT BUNDLE BRANCH BLOCK | C71047 | Incomplete left bundle branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration less than 120 ms. | Incomplete Left Bundle Branch Block by ECG Finding | ||
INCOMPLETE MEASUREMENTS DUE TO TRUNCATION OF QRS COMPLEXES | C114179 | An electrocardiographic recording in which measurements (particularly of QRS amplitudes) and/or interpretations are not performed because QRS complexes have been truncated. | Incomplete ECG Measurements Due to Truncation of QRS Complexes | |||
INCOMPLETE RIGHT BUNDLE BRANCH BLOCK | C71048 | Incomplete right bundle branch block;Incomplete right bundle-branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration less than 120 ms. | Incomplete Right Bundle Branch Block by ECG Finding | ||
INCOMPLETELY DIGITIZED ECG LEAD(S) | C114169 | A digital electrocardiographic recording which was digitized from paper ECG tracings and which does not contain all leads present on the original paper printout. | Incompletely Digitized ECG Leads | |||
INCORRECTLY SCALED ECG | C114168 | An electrocardiographic recording in which the ECG signal is not displayed at the indicated recording speed and/or amplitude resolution. | Incorrectly Scaled ECG | |||
INDETERMINATE QRS AXIS | C102701 | Indeterminate Axis;Indeterminate QRS Axis;QRS Axis Indeterminate | An electrocardiographic finding in which the frontal plane QRS axis cannot be calculated. | QRS Axis Indeterminate | ||
INFERIOR WALL MYOCARDIAL INFARCTION | C35398 | Inferior MI;Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle. | Inferior Myocardial Infarction by ECG Finding | ||
INSUFFICIENT NUMBER OF BEATS TO COMPLETELY EVALUATE ECG | C114177 | An electrocardiographic recording in which fewer than the required number of cardiac complexes are available for measurement and/or interpretation due to a shorter than planned recording or due to cardiac complexes which are present but are not suitable for measurement and/or interpretation. | Insufficient Number of Beats for Complete ECG Evaluation | |||
INTRAATRIAL CONDUCTION DELAY | C71073 | Intraatrial Conduction Delay | An electrocardiographic finding of a delay in impulse propagation through the atria. This is characterized by broad P waves which are often biphasic in V1. | Intra-Atrial Conduction Delay by ECG Finding | ||
INTRAVENTRICULAR CONDUCTION DELAY, NONSPECIFIC | C62271 | Intraventricular Conduction Defect;Intraventricular conduction delay | An electrocardiographic finding of a widened QRS duration typically greater than 110 ms which does not meet the morphologic criteria for any of the standard bundle branch or fascicular block patterns. | Nonspecific Intraventricular Conduction Delay by ECG Finding | ||
INVALID ECG WAVEFORMS | C114171 | An electrocardiographic recording for which the displayed leads do not represent the individual's true ECG lead information. | Invalid ECG Waveforms | |||
ISORHYTHMIC DISSOCIATION | C62248 | Isorhythmic dissociation | An electrocardiographic finding of a type of atrioventricular dissociation characterized by the atria (P waves) and ventricles (QRS complexes) beating at similar rates, although independently. | Isorhythmic Atrioventricular Dissociation | ||
J POINT ELEVATION | C71030 | J point elevation | An electrocardiographic finding of a significant elevation above the baseline of the J point. | J Point Elevation | ||
JUNCTIONAL BRADYCARDIA | C71074 | Junctional bradycardia | An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally low. | Junctional Bradycardia by ECG Finding | ||
JUNCTIONAL ESCAPE COMPLEXES | C116129 | Junctional Escape Beat;Junctional Escape Complex | An electrocardiographic finding of an escape beat following a pause which originates in the AV junction. This is manifest as a QRS complex of supraventricular origin not preceded by a P wave; there may be one or more occurrences during an electrocardiographic recording. | Junctional Escape Complexes by ECG Finding | ||
JUNCTIONAL ESCAPE RHYTHM | C135393 | An electrocardiographic finding of a junctional rhythm that arises as a physiologic response to extreme slowing or arrest of sinus node activity. In this setting, a faster junctional rhythm may be a normal response to a very slow or absent sinus rate. | Junctional Escape Rhythm by ECG Finding | |||
JUNCTIONAL PREMATURE COMPLEX | C102652 | Junctional Extra Beat;Junctional Premature Complexes | An electrocardiographic finding of an ectopic impulse originating in the AV junction presenting as a QRS complex of supraventricular origin which is not preceded by a P wave; there may be one or more occurrences during an electrocardiographic recording. | Junctional Premature Complex by ECG Finding | ||
JUNCTIONAL RHYTHM | C71051 | Junctional rhythm | An electrocardiographic finding of a rhythm which originates in the AV junction and results in a normal heart rate. It is characterized by retrograde P waves which may be obscured by or may follow the QRS complexes. The QRS complexes may be narrow or may demonstrate aberration. | Junctional Rhythm by ECG Finding | ||
JUNCTIONAL TACHYCARDIA | C35059 | Junctional tachycardia | An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally elevated. | Junctional Tachycardia by ECG Finding | ||
LATE R WAVE TRANSITION | C102653 | Late R Wave Transition | An electrocardiographic finding where the amplitude of the R wave does not become greater than the amplitude of the S wave until an unusually late point in the precordial leads, usually in leads V4 to V6. | Late R Wave Transition by ECG Finding | ||
LATERAL WALL MYOCARDIAL INFARCTION | C35586 | Lateral MI;Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle. | Lateral Myocardial Infarction by ECG Finding | ||
LEFT ANTERIOR FASCICULAR BLOCK | C62267 | Left anterior fascicular block;Left Anterior Hemiblock | An electrocardiographic finding of a slightly widened QRS duration (typically less than 120 ms) with leftward frontal plane QRS axis and typically small Q waves in leads I and aVL. | Left Anterior Fascicular Block by ECG Finding | ||
LEFT ATRIAL ABNORMALITY | C71040 | Left Atrial Enlargement;P-mitrale | An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the left atrium. Electrocardiographic criteria used for the diagnosis of left atrial abnormality may include a bifid p wave, a biphasic p wave and/or a p wave duration of greater than 0.12 seconds. (NCI) | P-mitrale by ECG Finding | ||
LEFT BUNDLE BRANCH BLOCK | C62269 | Complete LBBB;Left bundle branch block;Left bundle-branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration greater than or equal to 120 ms. | Left Bundle Branch Block by ECG Finding | ||
LEFT POSTERIOR FASCICULAR BLOCK | C62268 | Left posterior fascicular block;Left Posterior Hemiblock | An electrocardiographic finding of an S1Q3 pattern and QRS axis greater than or equal to 120 degrees. It is usually seen in association with other abnormalities (e.g. RBBB or RVH). | Left Posterior Fascicular Block by ECG Finding | ||
LEFT VENTRICULAR CONDUCTION DELAY | C92231 | Left Ventricular Conduction Delay | An electrocardiographic finding in which there is evidence that electrical transmission through the left ventricle is impaired. | Left Ventricular Conduction Delay by ECG Finding | ||
LEFT VENTRICULAR HYPERTROPHY WITH STRAIN | C102655 | Left Ventricular Hypertrophy With Strain | An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes, ST depression and T wave inversion. | Left Ventricular Hypertrophy with Strain by ECG Finding | ||
LEFT VENTRICULAR HYPERTROPHY | C71076 | Left Ventricular Hypertrophy | An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes and secondary findings of left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion. | Left Ventricular Hypertrophy by ECG Finding | ||
LIMB ELECTRODE(S) DISCONNECTED | C114151 | An electrocardiographic recording in which one or more of the limb electrodes are disconnected resulting in missing waveforms (often flat lines) of the respective leads. | Disconnected Limb Electrodes by ECG Finding | |||
LIMB ELECTRODES INTERCHANGED | C114150 | Limb Lead Reversal | An electrocardiographic recording in which two or more of the limb electrodes are switched resulting in improper representation of the affected leads. | Interchanged Limb Electrodes by ECG Finding | ||
LOW AMPLITUDE SIGNAL | C114166 | Low Amplitude QRS Complex | An electrocardiographic recording showing smaller than usual QRS complexes in one or more leads. This may represent a technical issue with the ECG acquisition or characteristics of the individual. | Low Amplitude QRS Complex by ECG Finding | ||
LOW QRS VOLTAGE | C71078 | Low QRS voltage | An electrocardiographic finding of a QRS amplitude less than or equal to 0.5 mV in the limb leads or QRS amplitude less than or equal to 1 mV in the precordial leads. | Low QRS Voltage by ECG Finding | ||
LOW VOLTAGE - LIMB LEADS ONLY | C116133 | An electrocardiographic finding of small QRS amplitudes (less than 500 microvolts) in all limb leads. | Low Voltage in Limb Leads Only by ECG Finding | |||
MULTIFOCAL ATRIAL TACHYCARDIA | C71050 | Multifocal atrial tachycardia | An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically 100-150 beats per minute. | Multifocal Atrial Tachycardia by ECG Finding | ||
MUSCLE TREMOR | C114148 | An electrocardiographic recording with intermittent mid to high frequency artifact in one or more leads due to muscular tremor or movement rather than cardiac activity. | Muscle Tremor Artifact | |||
MYOCARDIAL INFARCTION | C101589 | Myocardial Infarction | An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart. No specification is provided for localization. | Myocardial Infarction by ECG Finding | ||
NEW ANTERIOR WALL MYOCARDIAL INFARCTION | C102732 | New Anterior MI;New Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle and which is new compared to prior ECGs. | New Anterior Myocardial Infarction by ECG Finding | ||
NEW ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C102733 | New Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle and which is new compared to prior ECGs. | New Anterolateral Myocardial Infarction by ECG Finding | ||
NEW ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C102734 | New Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle and which is new compared to prior ECGs. | New Anteroseptal Myocardial Infarction by ECG Finding | ||
NEW EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C102735 | New Extensive Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle and which is new compared to prior ECGs. | New Extensive Anterior Myocardial Infarction by ECG Finding | ||
NEW HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102736 | New High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle and which is new compared to prior ECGs. | New High Lateral Myocardial Infarction by ECG Finding | ||
NEW INFERIOR WALL MYOCARDIAL INFARCTION | C102737 | New Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle and which is new compared to prior ECGs. | New Inferior Myocardial Infarction by ECG Finding | ||
NEW LATERAL WALL MYOCARDIAL INFARCTION | C102738 | New Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle and which is new compared to prior ECGs. | New Lateral Myocardial Infarction by ECG Finding | ||
NEW MYOCARDIAL INFARCTION | C102731 | New Myocardial Infarction | An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart and which is new compared to prior ECGs. No specification is provided for localization. | New Myocardial Infarction by ECG Finding | ||
NEW POSTERIOR WALL MYOCARDIAL INFARCTION | C106548 | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, and which is new compared to prior ECGs. Evidence of inferior or lateral myocardial infarction is usually also present. | New Posterior Wall Myocardial Infarction by ECG Finding | |||
NEW SEPTAL WALL MYOCARDIAL INFARCTION | C102739 | New Septal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum and which is new compared to prior ECGs. | New Septal Myocardial Infarction by ECG Finding | ||
NO ECG WAVEFORMS PRESENT | C114163 | An electrocardiographic recording that displays flat lines (no waveforms are visible) in all leads present. | ECG Waveforms Not Present | |||
NON Q WAVE MYOCARDIAL INFARCTION | C71080 | Non Q Wave Myocardial Infarction | An electrocardiographic finding of ST and T wave abnormalities in the absence of pathologic Q waves, which is suggestive of myocardial infarction in one or more regions of the heart. | Non Q Wave Myocardial Infarction by ECG Finding | ||
NON-DIAGNOSTIC Q WAVES | C116134 | An electrocardiographic finding of Q waves which are insufficient for the diagnosis of myocardial infarction. In such cases a myocardial infarction may be suspected, even though ECG criteria are not met. | Non-Diagnostic Q Waves by ECG Finding | |||
NON-SPECIFIC ST-T CHANGES | C71031 | Non-specific ST-T changes | An electrocardiographic finding of changes in the ST segment and T wave that do not meet criteria for ischemia or infarction. (NCI) | Non-Specific ST-T Changes by ECG Finding | ||
NON-SUSTAINED ATRIAL TACHYCARDIA | C102680 | Non-Sustained Atrial Tachycardia | An electrocardiographic finding of an atrial tachycardia which terminates in less than 30 seconds. | Non-Sustained Atrial Tachycardia by ECG Finding | ||
NON-SUSTAINED VENTRICULAR TACHYCARDIA | C71053 | Non-sustained ventricular tachycardia;Ventricular tachycardia, unsustained | An electrocardiographic finding of ventricular tachycardia less than 30 seconds in duration. (NCI) | Non-Sustained Ventricular Tachycardia by ECG Finding | ||
NONCONDUCTED P WAVE PHYSIOLOGY NOT DEFINED | C135394 | An electrocardiographic finding of a P wave that does not conduct to the ventricle or result in ventricular activation. | Nonconducted P Wave Physiology Not Defined by ECG Finding | |||
NORMAL SINUS RHYTHM | C102681 | Normal Sinus Rhythm | An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. There are no extra beats or conduction abnormalities. | Normal Sinus Rhythm | ||
NORTHWEST AXIS | C102634 | Northwest Axis;Right superior axis | An electrocardiographic finding of a frontal plane QRS axis from -90 to +180 degrees. | Extreme Right Axis Deviation | ||
NOTCHED T WAVES | C71032 | Notched T Waves | An electrocardiographic finding of an irregular, u or v shaped deflection within the contour of the T wave. | T Wave Notched by ECG Finding | ||
OLD OR AGE INDETERMINATE ANTERIOR WALL MYOCARDIAL INFARCTION | C102684 | Old Or Age Indeterminate Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Anterior Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C102685 | Old Or Age Indeterminate Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Anterolateral Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C102686 | Old Or Age Indeterminate Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Anteroseptal Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C102687 | Old Or Age Indeterminate Extensive Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Extensive Anterior Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102688 | Old Or Age Indeterminate High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate High Lateral Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE INFERIOR WALL MYOCARDIAL INFARCTION | C102689 | Old Or Age Indeterminate Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Inferior Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE LATERAL WALL MYOCARDIAL INFARCTION | C102690 | Old Or Age Indeterminate Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Lateral Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE POSTERIOR WALL MYOCARDIAL INFARCTION | C102691 | Old Or Age Indeterminate Posterior Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, without evidence of current or ongoing acute infarction. Evidence of inferior or lateral myocardial infarction is usually also present. | Old or Age Indeterminate Posterior Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE SEPTAL WALL MYOCARDIAL INFARCTION | C102693 | Old Or Age Indeterminate Septal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Septal Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE WALL MYOCARDIAL INFARCTION | C101597 | Old Or Age Indeterminate Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart, without evidence of current or ongoing acute infarction. No specification is provided for localization. | Old Myocardial Infarction by ECG Finding | ||
OLD OR AGE UNDETERMINED RIGHT VENTRICULAR MYOCARDIAL INFARCTION | C102692 | An electrocardiographic finding, in the presence of an old or age indeterminate inferior wall myocardial infarction, of Q waves greater than or equal to 40 ms in duration in the right ventricular leads V4R through V6R. | Old or Age Indeterminate Right Ventricular Myocardial Infarction by ECG Finding | |||
OTHER INCORRECT ELECTRODE PLACEMENT | C114176 | An electrocardiographic recording in which one or more electrodes are incorrectly placed but further details are not provided. | Other Incorrect Electrode Placement | |||
P WAVE ABNORMALITY | C90430 | P Wave Abnormality | An electrocardiographic finding for the P wave that is atypical either for the shape, duration, amplitude, axis or polarity. Abnormality of the P wave signifies aberrant propagation of the electrical impulse through the atria. (NCI) | P Wave Abnormality by ECG Finding | ||
P WAVE NOTCHED | C90431 | P Wave Notched | An electrocardiographic finding of P waves with two peaks longer in duration than normal and amplitude greater than normal. | P Wave Notched by ECG Finding | ||
PACED ATRIAL AND VENTRICULAR RHYTHM | C92232 | AV dual-paced complex(es) or rhythm;Paced Atrial And Ventricular Rhythm | An electrocardiographic finding in which both the atrial and ventricular rhythm are controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Atrial And Ventricular Rhythm | ||
PACED ATRIAL RHYTHM | C92233 | Atrial-paced complex(es) or rhythm;Paced Atrial Rhythm | An electrocardiographic finding in which the atrial rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Atrial Rhythm | ||
PACED RHYTHM | C88140 | Atrial and/or Ventricular Paced Rhythm;Paced Rhythm | An electrocardiographic finding in which the cardiac rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Rhythm | ||
PACED VENTRICULAR RHYTHM | C92234 | Paced Ventricular Rhythm;Ventricular-paced complex(es) or rhythm | An electrocardiographic finding in which the ventricular rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Ventricular Rhythm | ||
PAROXYSMAL AV BLOCK | C62250 | Paroxysmal AV block | An electrocardiographic finding of the sudden onset of transient AV block, which is often associated with preexisting conduction disorders. | Paroxysmal Atrioventricular Block by ECG Finding | ||
PAROXYSMAL VENTRICULAR TACHYCARDIA | C34902 | Paroxysmal Ventricular Tachycardia | An episodic form of ventricular tachycardia, with abrupt onset and termination. (NCI) | Paroxysmal Ventricular Tachycardia by ECG Finding | ||
PAUSE GREATER THAN 3.0 SECONDS | C119251 | An electrocardiographic finding of an RR interval with duration greater than 3.0 seconds, regardless of the underlying rhythm. | Pause Greater Than Three Seconds by ECG Finding | |||
PAUSE | C119250 | An electrocardiographic finding of an RR interval which exceeds a predefined duration threshold, regardless of the underlying rhythm. | Pause by ECG Finding | |||
POOR QUALITY ECG | C114172 | An electrocardiographic recording that does not show proper quality for reasons that are not otherwise described. | Poor Quality ECG | |||
POOR R WAVE PROGRESSION | C71033 | Poor R Wave Progression | An electrocardiographic finding of a lack of progression of R wave height across precordial leads. | Poor R Wave Progression by ECG Finding | ||
POSTERIOR WALL MYOCARDIAL INFARCTION | C35399 | Posterior MI;Posterior Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. | Posterior Myocardial Infarction by ECG Finding | ||
PR SEGMENT DEPRESSION | C116135 | PR Depression | An electrocardiographic finding of PR segment depression below the iso-electric line in multiple precordial and/or limb leads. | PR Segment Depression by ECG Finding | ||
PRE-EXCITATION | C34940 | Pre-excitation;Ventricular preexcitation | An electrocardiographic finding characterized by a premature activation of the whole or some part of the ventricle. The PR interval is usually shortened and delta waves are frequently present. | Pre-Excitation Syndrome | ||
PRECORDIAL ELECTRODE V1 DISCONNECTED | C114153 | An electrocardiographic recording in which the electrode for lead V1 is disconnected resulting in missing waveforms (flat line) for lead V1. | Disconnected Precordial Electrode V1 by ECG Finding | |||
PRECORDIAL ELECTRODE V2 DISCONNECTED | C114154 | An electrocardiographic recording in which the electrode for lead V2 is disconnected resulting in missing waveforms (flat line) for lead V2. | Disconnected Precordial Electrode V2 by ECG Finding | |||
PRECORDIAL ELECTRODE V3 DISCONNECTED | C114155 | An electrocardiographic recording in which the electrode for lead V3 is disconnected resulting in missing waveforms (flat line) for lead V3. | Disconnected Precordial Electrode V3 by ECG Finding | |||
PRECORDIAL ELECTRODE V4 DISCONNECTED | C114156 | An electrocardiographic recording in which the electrode for lead V4 is disconnected resulting in missing waveforms (flat line) for lead V4. | Disconnected Precordial Electrode V4 by ECG Finding | |||
PRECORDIAL ELECTRODE V5 DISCONNECTED | C114157 | An electrocardiographic recording in which the electrode for lead V5 is disconnected resulting in missing waveforms (flat line) for lead V5. | Disconnected Precordial Electrode V5 by ECG Finding | |||
PRECORDIAL ELECTRODE V6 DISCONNECTED | C114158 | An electrocardiographic recording in which the electrode for lead V6 is disconnected resulting in missing waveforms (flat line) for lead V6. | Disconnected Precordial Electrode V6 by ECG Finding | |||
PRECORDIAL ELECTRODE(S) POSITIONED INCORRECTLY | C114160 | An electrocardiographic recording in which one or more precordial electrodes are placed incorrectly with respect to the standard chest electrode positions resulting in improper representation of the affected leads. | Incorrectly Positioned Precordial Electrodes by ECG Finding | |||
PRECORDIAL ELECTRODES INTERCHANGED | C114152 | Precordial Lead Reversal | An electrocardiographic recording in which two or more of the precordial electrodes are switched resulting in improper representation of the affected leads. | Interchanged Precordial Electrodes by ECG Finding | ||
PREMATURE ATRIAL COMPLEXES BLOCKED | C102603 | Atrial premature complexes, nonconducted;Non-conducted SVE;Premature Atrial Complex Blocked;Premature Atrial Complexes Non-conducted | An electrocardiographic finding of a premature atrial complexes that are is not conducted to the ventricles, and that are is not followed by a QRS complex; there may be one or more occurrences during an electrocardiographic recording. | Blocked Atrial Premature Complex by ECG Finding | ||
PREMATURE ATRIAL COMPLEXES MULTIFOCAL | C102672 | Multifocal Supraventricular Extra Beats;Multifocal SVE;Premature Atrial Complex Multifocal;Premature Atrial Complexes Multiform | An electrocardiographic finding of premature atrial complexes which have 2 or more distinct morphologies, suggesting origin at more than one atrial site. | Multifocal Atrial Premature Complex by ECG Finding | ||
PREMATURE ATRIAL COMPLEXES UNIFOCAL | C102724 | Premature Atrial Complex Unifocal | An electrocardiographic finding of premature atrial complexes which have a single distinct morphology, suggesting origin at one atrial site. | Unifocal Atrial Premature Complex by ECG Finding | ||
PREMATURE ATRIAL COMPLEXES | C62257 | APC;Atrial premature complex(es);PAC;Premature atrial complex;Supraventricular Extra Beat;Supraventricular Premature Beat;SVE | An electrocardiographic finding of an ectopic impulse originating in the atria and not specifically in the sinus node. The P wave morphology of these complexes is often different from a sinus P wave and the RR intervals preceding these complexes is also shorter than those of the regular beats; there may be one or more occurrences during an electrocardiographic recording. | Atrial Premature Complex by ECG Finding | ||
PREMATURE VENTRICULAR COMPLEX INTERPOLATED | C107100 | Interpolated VE;Interpolated Ventricular Extra Beat;Interpolated VES;Interpolated VPC;Premature Ventricular Complexes Interpolated | An electrocardiographic finding of a premature ventricular complex which occurs between two normal QRS complexes which have normal timing; there may be one or more occurrences during an electrocardiographic recording. | Interpolated Premature Ventricular Complex by ECG Finding | ||
PREMATURE VENTRICULAR COMPLEX | C62256 | Premature Ventricular Complexes;PVC;VE;Ventricular Extra Beat;Ventricular Premature Complexes;VES;VPC | An electrocardiographic finding of an ectopic impulse originating in the ventricles. The QRS morphology of these complexes is different from those of supraventricular origin. The QRS duration is often longer and the RR interval preceding the complexes is usually shorter than that of supraventricular beats; there may be one or more occurrences during an electrocardiographic recording. | Ventricular Premature Complex by ECG Finding | ||
PREMATURE VENTRICULAR COMPLEXES MULTIFOCAL | C102673 | Multifocal Ventricular Extra Beats;Multifocal VES;Multifocal VPCS;Premature Ventricular Complex Multifocal | An electrocardiographic finding of premature ventricular complexes which have two or more distinct morphologies, suggesting origin at more than one ventricular site. | Multifocal Ventricular Premature Complex by ECG Finding | ||
PREMATURE VENTRICULAR COMPLEXES UNIFOCAL | C102725 | Premature Ventricular Complex Unifocal;Unifocal Ventricular Extra Beats;Unifocal VES;Unifocal VPCS | An electrocardiographic finding of premature ventricular complexes which have a single distinct morphology, suggesting origin at one ventricular site. | Unifocal Ventricular Premature Complex by ECG Finding | ||
PROLONGED QT | C71034 | Prolonged QT;Prolonged QT interval | An electrocardiographic finding in which the QT interval not corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist. | Prolonged QT Interval by ECG Finding | ||
PROLONGED ST SEGMENT | C116137 | An electrocardiographic finding of a prolonged ST segment, resulting in a long QT interval, without lengthening of the T wave duration. | Prolonged ST Segment by ECG Finding | |||
Q AXIS, LEFT AXIS DEVIATION | C71094 | Left-axis deviation;Q Axis, Left axis deviation;QRS axis, left axis deviation | An electrocardiographic finding of a frontal plane QRS axis from -30 to -90 degrees. | Q Axis Left Axis Deviation | ||
Q AXIS, RIGHT AXIS DEVIATION | C71095 | Q Axis, Right axis deviation;QRS axis, right axis deviation;Right-axis deviation | An electrocardiographic finding of a frontal plane QRS axis from +90 to +180 degrees. | Q Axis Right Axis Deviation | ||
QRS COMPLEX ABNORMALITY | C90440 | QRS Complex Abnormality | An electrocardiographic finding of a non-specific abnormality of the QRS complex, which is atypical in shape, duration, amplitude, axis or polarity. | QRS Complex Abnormality by ECG Finding | ||
QTC PROLONGATION | C83817 | QTc Prolongation | An electrocardiographic finding in which the QTc interval corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist. | Corrected Prolonged QT Interval by ECG Finding | ||
QTCB PROLONGATION | C107098 | PROLONGED QTcB | An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is prolonged. Thresholds for different age, gender, and patient populations exist. | QTcB Prolongation | ||
QTCF PROLONGATION | C107099 | PROLONGED QTcF | An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is prolonged. Thresholds for different age, gender, and patient populations exist. | QTcF Prolongation | ||
QUALITY PROBLEM NOT OTHERWISE SPECIFIED | C114161 | Unknown Quality Problem | An electrocardiographic artifact or recording error with unknown origin or which is not described otherwise. | Quality Problem Not Otherwise Specified by ECG Finding | ||
R ON T PHENOMENON | C61395 | R on T phenomenon | An electrocardiographic finding in which the R wave of a premature ventricular complex occurs on top of the T wave of the preceding beat. | R On T Phenomenon by ECG Finding | ||
R WAVE NOTCHED | C90444 | R Wave Notched | An electrocardiographic finding of an R wave variant in which there is a small deflection of the R wave, with changing polarity, within the QRS complex. (NCI) | R Wave Notched by ECG Finding | ||
REPOLARIZATION ABNORMALITY SECONDARY TO VENTRICULAR HYPERTROPHY | C102706 | Repolarization Abnormality Secondary To Ventricular Hypertrophy;ST-T change due to ventricular hypertrophy | An electrocardiographic finding of ST depression and T wave inversion in the presence of increased QRS amplitude which are thought to be due to left ventricular hypertrophy. | Repolarization Abnormality Secondary To Ventricular Hypertrophy | ||
REPOLARIZATION ABNORMALITY | C102574 | Repolarization Abnormality | An electrocardiographic finding of an abnormality of T wave duration or morphology or of early repolarization. | Ventricular Repolarization Abnormality | ||
RIGHT ATRIAL ABNORMALITY | C71041 | P-pulmonale;Right Atrial Enlargement | An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the right atrium. Electrocardiographic criteria used for the diagnosis of right atrial abnormality may include a peaked p wave greater than 2.5 millimeters in amplitude in the inferior leads. (NCI) | P-pulmonale by ECG Finding | ||
RIGHT BUNDLE BRANCH BLOCK | C62270 | Complete RBBB;Right bundle branch block;Right bundle-branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration greater than or equal to 120 ms. An RsR' complex is typically present in leads V1 and V2. | Right Bundle Branch Block by ECG Finding | ||
RIGHT VENTRICULAR CONDUCTION DELAY | C92235 | Right Ventricular Conduction Delay;Right Ventricular Delay | An electrocardiographic finding in which there is evidence that electrical transmission through the right ventricle is impaired with a maximal QRS duration of 110 ms and which does not meet the criteria for Incomplete Right Bundle Branch Block. | Right Ventricular Conduction Delay by ECG Finding | ||
RIGHT VENTRICULAR HYPERTROPHY | C71077 | Right ventricular Hypertrophy | An electrocardiographic finding suggestive of a hypertrophied right ventricle, characterized by large R wave amplitudes in the right precordial leads and secondary findings of right atrial enlargement, right axis deviation, and typical pattern of ST depression and T wave inversion in the right precordial leads. | Right Ventricular Hypertrophy by ECG Finding | ||
RSR PRIME | C92227 | RSR' | An electrocardiographic finding in which there are two R waves, which are two deflections above the baseline resulting from a single ventricular depolarization. The first upward deflection in the complex is the R wave. The S is the first downward deflection. A second upward deflection is called the R-prime wave. | RSR' by ECG Finding | ||
SEPTAL MYOCARDIAL INFARCTION | C35519 | Septal myocardial infarction | An electrocardiographic finding suggesting an infarction in the anatomic location of the cardiac septum. (NCI) | Septal Myocardial Infarction by ECG Finding | ||
SHORT PR INTERVAL | C62246 | Short PR interval | An electrocardiographic finding of an abnormally short PR interval. Thresholds for different age, gender, and patient populations exist. | Short PR Interval by ECG Finding | ||
SHORT QTC INTERVAL | C102709 | Short QTc Interval | An electrocardiographic finding of a QT interval corrected for heart rate that is shorter than the lower limit of normal. Thresholds for different age, gender, and patient populations exist. | Short QTc Interval | ||
SHORT QTCB | C112402 | An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is shortened. Thresholds for different age, gender, and patient populations exist. | QTcB Shortened | |||
SHORT QTCF | C112403 | An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is shortened. Thresholds for different age, gender, and patient populations exist. | QTcF Shortened | |||
SHORT ST SEGMENT | C116136 | An electrocardiographic finding of a short or absent ST segment, resulting in a short QT interval, without changes in T wave morphology. | Short ST Segment by ECG Finding | |||
SINOATRIAL EXIT BLOCK | C50553 | SA Block;Sinoatrial Block;Sinoatrial exit block | An electrocardiographic finding in which impaired conduction or automaticity within the sinus node results in the failure of impulse transmission from the sinoatrial node. This is manifest as dropped P waves during sinus rhythm. | Exit Block by ECG Finding | ||
SINUS ARREST/PAUSE | C62242 | Sinus arrest/pause;Sinus pause or arrest | An electrocardiographic finding in which a failure of impulse formation or conduction in the sinus node produces prolongation of the P-P interval or dropped P waves. The threshold for the prolongation of the P-P interval is not well defined. | Sinus Arrest by ECG Finding | ||
SINUS ARRHYTHMIA | C62239 | Respiratory Sinus Arrhythmia;Sinus arrhythmia | An electrocardiographic finding in which the sinus rate fluctuates with the respiratory cycle. | Sinus Arrhythmia by ECG Finding | ||
SINUS BRADYCARDIA | C111097 | Sinus bradycardia | An electrocardiographic finding of abnormally slow heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist. | Sinus Bradycardia by ECG Finding | ||
SINUS RHYTHM | C100076 | Sinus Rhythm | An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. | Sinus Rhythm | ||
SINUS TACHYCARDIA | C111104 | Sinus tachycardia | An electrocardiographic finding of abnormally rapid heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist. | Sinus Tachycardia by ECG Finding | ||
ST DEPRESSION | C41330 | ST depression | An electrocardiographic finding of ST segment depression below the baseline, often described as up sloping, down sloping or horizontal. (NCI) | ST Segment Depression by ECG Finding | ||
ST ELEVATION PERICARDITIS | C71029 | ST elevation pericarditis | An electrocardiographic finding of ST elevation which is concave upwards, and which is often accompanied by PR segment depression. | ST Elevation Pericarditis by ECG Finding | ||
ST ELEVATION | C50540 | ST elevation | An electrocardiographic finding of ST segment elevation above the baseline. (NCI) | ST Segment Elevation by ECG Finding | ||
SUPRAVENTRICULAR BIGEMINY | C161046 | An electrocardiographic finding of a supraventricular QRS complex followed by a premature supraventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio. | Supraventricular Bigeminy by ECG Finding | |||
SUPRAVENTRICULAR COUPLET | C119252 | An electrocardiographic finding in which two premature atrial complexes occur sequentially. | Supraventricular Couplet by ECG Finding | |||
SUPRAVENTRICULAR ESCAPE BEAT | C135395 | Supraventricular Escape Complex;Supraventricular Escape Complexes | An electrocardiographic finding of a compensatory supraventricular complex that occurs following a prolonged RR interval. | Supraventricular Escape Beat by ECG Finding | ||
SUPRAVENTRICULAR PREMATURE COMPLEX, ORIGIN UNKNOWN | C142246 | Supraventricular Premature Complexes, Origin Unknown | An electrocardiographic finding of an ectopic impulse originating from the atria or AV junction for which the site of origin cannot be determined from the surface electrocardiographic recording; there may be one or more occurrences during an electrocardiographic recording. | Supraventricular Premature Complex With Unknown Origin by ECG Finding | ||
SUPRAVENTRICULAR RUN | C120618 | An electrocardiographic finding of three or more consecutive beats of supraventricular origin without reference to rate. | Supraventricular Run by ECG Finding | |||
SUPRAVENTRICULAR TACHYCARDIA | C111100 | Supraventricular tachycardia | An electrocardiographic finding of a tachycardia which does not originate in the ventricles or His Purkinje system. There is an abnormally high heart rate and QRS complexes are typically narrow, but aberration or preexcitation may be present. | Supraventricular Tachycardia by ECG Finding | ||
SUPRAVENTRICULAR TRIGEMINY | C161047 | An electrocardiographic finding of two supraventricular QRS complexes followed by a premature supraventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio. | Supraventricular Trigeminy by ECG Finding | |||
SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES NO REVERSAL | C114173 | An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, but for which an interpretation is performed as though the lead placement is correct. | Suspicion of Limb Electrodes Reversal But Interpretation Assumes No Reversal by ECG Finding | |||
SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES REVERSAL | C114174 | An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, and for which an interpretation is performed as though the leads have in fact been interchanged. | Suspicion of Limb Electrodes Reversal But Interpretation Assumes Reversal by ECG Finding | |||
SUSTAINED VENTRICULAR TACHYCARDIA | C71052 | Sustained ventricular tachycardia | An electrocardiographic finding of ventricular tachycardia greater than 30 seconds in duration. (NCI) | Sustained Ventricular Tachycardia by ECG Finding | ||
T WAVE ALTERNANS | C102718 | T Wave Alternans | An electrocardiographic finding in which there are variations in the shape, amplitude, or direction of the T wave from one beat to the next. | T Wave Alternans by ECG Finding | ||
T WAVE INVERSION | C71085 | T Wave Inversion | An electrocardiographic finding of an inversion of the T wave from the expected axis. (NCI) | T Wave Inversion by ECG Finding | ||
T WAVE PEAKED | C71086 | T wave peaked | An electrocardiographic finding in which the T wave appears increased in amplitude and cresting at a point. (NCI) | T Wave Peaked by ECG Finding | ||
T WAVES BIPHASIC | C71087 | T waves biphasic | An electrocardiographic finding of a T wave with both positive and negative components. | T Waves Biphasic by ECG Finding | ||
T WAVES FLAT | C71088 | T waves flat | An electrocardiographic finding in which the T wave appears decreased in amplitude. (NCI) | T Waves Flat by ECG Finding | ||
TACHYCARDIA | C111121 | Tachycardia | An electrocardiographic finding of abnormally rapid heart rate. Thresholds for different age, gender, and patient populations exist. | Tachycardia by ECG Finding | ||
TORSADES DE POINTES | C50779 | Torsades de pointes;Ventricular tachycardia, torsades de pointes | An electrocardiographic finding of an atypical rapid polymorphic ventricular tachycardia with a characteristic rotation of the QRS complex around the isoelectric baseline, occurring in the setting of a prolonged QT interval. In addition, the QRS complex displays a periodic waxing and waning of amplitude on the electrogram. | Torsades De Pointes by ECG Finding | ||
U WAVE ABNORMALITY | C106579 | Abnormal U Wave | An electrocardiographic finding of U waves which have increased amplitude, are inverted, or merged with the preceding T wave. | U Wave Abnormality by ECG Finding | ||
UNABLE TO DIGITIZE ECG LEADS | C114170 | A statement indicating the inability to digitize a paper ECG. | Inability to Digitize ECG Leads | |||
UNDETERMINED RHYTHM | C116131 | An electrocardiographic finding of a cardiac rhythm whose mechanism cannot be determined from the ECG. | Undetermined Rhythm by ECG Finding | |||
UNDETERMINED SUPRAVENTRICULAR RHYTHM | C120607 | An electrocardiographic finding of a rhythm which does not originate in the ventricles or His Purkinje system, but whose specific electrophysiologic mechanism cannot be determined from the ECG. The QRS complexes are typically narrow, but aberration or preexcitation may be present. | Undetermined Supraventricular Rhythm by ECG Finding | |||
VENTRICULAR BIGEMINY | C71054 | Bigeminy | An electrocardiographic finding of a normal QRS complex followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio. | Ventricular Bigeminy by ECG Finding | ||
VENTRICULAR COUPLET | C62259 | Ventricular Couplets;Ventricular Pair | An electrocardiographic finding in which two premature ventricular complexes occur sequentially; there may be one or more occurrences during an electrocardiographic recording. | Ventricular Couplet by ECG Finding | ||
VENTRICULAR ESCAPE BEAT | C90483 | Ventricular Escape Beats;Ventricular Escape Complex;Ventricular Escape Complexes | An electrocardiographic finding of a compensatory ventricular complex that occurs following a prolonged RR interval; there may be one or more occurrences during an electrocardiographic recording. | Ventricular Escape Beat by ECG Finding | ||
VENTRICULAR FIBRILLATION | C111102 | Ventricular fibrillation | An electrocardiographic finding of a rapid grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. The rate is typically greater than 300 bpm. | Ventricular Fibrillation by ECG Finding | ||
VENTRICULAR FLUTTER | C111115 | Ventricular flutter | A ventricular tachyarrhythmia characterized by a high ventricular rate (180 to 250 beats per minute) with a regular rhythm. The electrocardiogram shows large oscillating sine wave-like complexes occurring as a result of QRS complexes and T waves being merged. The P wave is not visible. (NCI) | Ventricular Flutter by ECG Finding | ||
VENTRICULAR PARASYSTOLE | C102728 | Parasystole;Ventricular Parasystole | An electrocardiographic finding of normal sinus rhythm coexisting with a regular ectopic ventricular rhythm. | Ventricular Parasystole by ECG Finding | ||
VENTRICULAR RUN | C120621 | An electrocardiographic finding of three or more consecutive beats of ventricular origin without reference to rate. | Ventricular Run by ECG Finding | |||
VENTRICULAR TACHYCARDIA | C111103 | Ventricular tachycardia | An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. | Ventricular Tachycardia by ECG Finding | ||
VENTRICULAR TACHYCARDIA, MONOMORPHIC | C62234 | Ventricular tachycardia, monomorphic | An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a uniform morphology. | Monomorphic Ventricular Tachycardia by ECG Finding | ||
VENTRICULAR TACHYCARDIA, POLYMORPHIC | C62236 | Ventricular tachycardia, polymorphic;Ventricular tachycardia, polymorphous | An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a variable morphology and often rate. | Polymorphic Ventricular Tachycardia by ECG Finding | ||
VENTRICULAR TRIGEMINY | C71055 | Trigeminy | An electrocardiographic finding of two normal QRS complexes followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio. | Ventricular Trigeminy by ECG Finding | ||
VOLTAGE CRITERIA SUGGESTING LEFT VENTRICULAR HYPERTROPHY, WITHOUT SECONDARY ECG FINDINGS | C130067 | An electrocardiographic finding of large QRS amplitudes which may indicate left ventricular hypertrophy, but in the absence of any of the secondary findings which are typical of this diagnosis (left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion). | Voltage Criteria Suggesting Left Ventricular Hypertrophy, Without Secondary ECG Findings | |||
WANDERING ATRIAL PACEMAKER | C62240 | Wandering atrial pacemaker | An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically below 100 beats per minute. | Wandering Atrial Pacemaker by ECG Finding | ||
WIDE QRS TACHYCARDIA | C71090 | Wide QRS tachycardia;Wide-QRS tachycardia | An electrocardiographic finding of three or more consecutive wide QRS complexes of uncertain origin with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). | Wide QRS Tachycardia by ECG Finding | ||
WOLFF-PARKINSON-WHITE SYNDROME | C35132 | Wolff-Parkinson-White syndrome;WPW | An electrocardiographic finding of ventricular pre-excitation. The syndrome is characterized by a short PR interval and a long QRS interval with a delta wave. | Wolff-Parkinson-White Syndrome | ||
Back to top | ||||||
CL.C184331.TWOFFMTH | ECG T Wave Offset Method Response
(TWOFFMTH) | text
Extensible: Yes | C184331 | ECG T Wave Offset Method Response | A terminology codelist relevant to the methods used to determine the end of an ECG T wave. | CDISC SDTM ECG T Wave Offset Method Response Terminology |
TANGENT METHOD | C184711 | Slope Method | A method to determine the end of the T wave. A tangent is drawn to the steepest descending slope of the T wave between its summit and the notch; the end of the T-wave is defined as the point of intersection of this tangent with the base line. (Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952; 6: 378-88). | Tangent Method | ||
THRESHOLD METHOD | C184712 | A method to determine the end of the T wave. A line parallel to the isoelectric line at a fraction (e.g. 5%) of the maximum T wave amplitue is constructed. The intercept of the descending limb of the T wave with this line is then defined as the end of the T wave. | Threshold Method | |||
Back to top | ||||||
CL.C71153.EGTESTCD | ECG Test Code
(EGTESTCD) | text
Extensible: Yes | C71153 | ECG Test Code | Terminology codelist used with ECG Tests within CDISC. | CDISC SDTM ECG Test Code Terminology |
AMIEGCHG | C116140 | Acute Myocardial Ischemia ECG Change | An electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). | Acute Myocardial Ischemia by ECG Assessment | ||
AVCOND | C111131 | Atrioventricular Conduction | An electrocardiographic assessment of cardiac atrioventricular conduction. | Atrioventricular Conduction ECG Assessment | ||
AXISVOLT | C111132 | Axis and Voltage | An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. | Axis and Voltage ECG Assessment | ||
CHYPTENL | C111155 | Chamber Hypertrophy or Enlargement | An electrocardiographic assessment of chamber hypertrophy or enlargement. | Chamber Hypertrophy or Enlargement ECG Assessment | ||
EGARMAX | C119253 | ECG Maximum Atrial Rate | An electrocardiographic measurement of the maximum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Maximum Atrial Rate by Electrocardiogram | ||
EGARMED | C119254 | ECG Median Atrial Rate | An electrocardiographic measurement of the median rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Median Atrial Rate by Electrocardiogram | ||
EGARMIN | C119255 | ECG Minimum Atrial Rate | An electrocardiographic measurement of the minimum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Minimum Atrial Rate by Electrocardiogram | ||
EGARMN | C119256 | ECG Mean Atrial Rate | An electrocardiographic measurement of the average rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Mean Atrial Rate by Electrocardiogram | ||
EGCOMP | C117761 | Comparison to a Prior ECG | A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. | Comparison to a Prior ECG | ||
EGHRMAX | C119257 | ECG Maximum Heart Rate | An electrocardiographic measurement of the maximum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the maximum ventricular rate. | Maximum Heart Rate by Electrocardiogram | ||
EGHRMED | C123447 | ECG Median Heart Rate | An electrocardiographic measurement of the median rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the median ventricular rate. | ECG Median Heart Rate | ||
EGHRMIN | C119258 | ECG Minimum Heart Rate | An electrocardiographic measurement of the minimum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the minimum ventricular rate. | Minimum Heart Rate by Electrocardiogram | ||
EGHRMN | C119259 | ECG Mean Heart Rate | An electrocardiographic measurement of the average rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the mean ventricular rate. | Mean Heart Rate by Electrocardiogram | ||
EGHRSI | C120608 | Single RR Heart Rate | An electrocardiographic measurement of a heart rate derived from a single RR interval (interval between two consecutive QRS complexes). | Single Beat RR Extrapolated Heart Rate by ECG Assessment | ||
EGVRMAX | C119260 | ECG Maximum Ventricular Rate | An electrocardiographic measurement of the maximum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Maximum Ventricular Rate by Electrocardiogram | ||
EGVRMED | C119261 | ECG Median Ventricular Rate | An electrocardiographic measurement of the median rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Median Ventricular Rate by Electrocardiogram | ||
EGVRMIN | C119262 | ECG Minimum Ventricular Rate | An electrocardiographic measurement of the minimum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Minimum Ventricular Rate by Electrocardiogram | ||
EGVRMN | C119263 | ECG Mean Ventricular Rate | An electrocardiographic measurement of the average rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Mean Ventricular Rate by Electrocardiogram | ||
INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
IVTIACD | C111238 | Intraventricular-Intraatrial Conduction | An electrocardiographic assessment of intraventricular and intra-atrial conduction. | Intraventricular and Intraatrial Conduction ECG Assessment | ||
JTAG | C117762 | JT Interval, Aggregate | An aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate JT Interval | ||
JTCBAG | C117763 | JTcB Interval, Aggregate | A JT aggregate interval that is corrected for heart rate using Bazett's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate JTCB Interval | ||
JTCBSB | C117764 | JTcB Interval, Single Beat | A JT single beat interval that is corrected for heart rate using Bazett's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat JTCB Interval | ||
JTCFAG | C117765 | JTcF Interval, Aggregate | A JT aggregate interval that is corrected for heart rate using Fridericia's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate JTCF Interval | ||
JTCFSB | C117766 | JTcF Interval, Single Beat | A JT single beat interval that is corrected for heart rate using Fridericia's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat JTCF Interval | ||
JTMAX | C62117 | Summary (Max) JT Interval | The maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Maximum JT Duration | ||
JTMIN | C62116 | Summary (Min) JT Interval | The minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Minimum JT Duration | ||
JTPAG | C117767 | J-Tpeak Interval, Aggregate | An aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate J-T Peak Interval | ||
JTPSB | C117768 | J-Tpeak Interval, Single Beat | An electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads. | Single Beat J-T Peak Interval | ||
JTSB | C117769 | JT Interval, Single Beat | An electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads. | Single Beat JT Interval | ||
MI | C111280 | Myocardial Infarction | An electrocardiographic assessment of findings suggestive of myocardial infarction. | Myocardial Infarction ECG Assessment | ||
NEWQWAVE | C117770 | New Q Wave | An electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). | New Q Wave | ||
P_AXIS | C118164 | P Wave Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane. | P Wave Axis | ||
PACEMAKR | C111285 | Pacemaker | An electrocardiographic assessment of presence of artificial electronic pacing. | Pacemaker ECG Assessment | ||
PPAG | C117771 | PP Interval, Aggregate | An aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate PP Interval | ||
PPSM | C117772 | PP Interval, Single Measurement | An electrocardiographic measurement of the interval between the onsets of two consecutive P waves. | Single Measurement PP Interval | ||
PRAG | C117773 | PQ Interval, Aggregate;PQAG;PR Interval, Aggregate | An aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate PR Interval | ||
PRMAX | C62131 | Summary (Max) PR Duration | The maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Maximum PR Duration | ||
PRMIN | C62125 | Summary (Min) PR Duration | The minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Minimum PR Duration | ||
PRSB | C117774 | PQ Interval, Single Beat;PQSB;PR Interval, Single Beat | An electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads. | Single Beat PR Interval | ||
PWDURAG | C117775 | P Wave Duration, Aggregate | An aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate P Wave Duration | ||
PWDURSB | C117776 | P Wave Duration, Single Beat | An electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads. | Single Beat P Wave Duration | ||
PWHTAG | C117777 | P Wave Amplitude, Aggregate | An aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate P Wave Amplitude | ||
PWHTSB | C117778 | P Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. | Single Beat P Wave Amplitude | ||
QRS_AXIS | C118165 | QRS Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane. | QRS Axis | ||
QRSAG | C117779 | QRS Duration, Aggregate | An aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QRS Duration | ||
QRSSB | C117780 | QRS Duration, Single Beat | An electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. | Single Beat QRS Duration | ||
QRVDVPAG | C117781 | QRS Duration, Ventr. Paced, Aggregate | An aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Paced Ventricular Aggregate QRS Duration | ||
QRVDVPSB | C117782 | QRS Duration, Ventr. Paced, Single Beat | An electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. | Paced Ventricular Single Beat QRS Duration | ||
QTAG | C117783 | QT Interval, Aggregate | An aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QT Interval | ||
QTCAAG | C124332 | QTca Interval, Aggregate | A QT Aggregate interval that is corrected for heart rate using individual probabilistic QT/RR slopes for each subject, based on the measurement of QT intervals from multiple beats within a single ECG or period of a continuous ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QTca Interval | ||
QTCASB | C124333 | QTca Interval, Single Beat | A QT interval that is corrected for heart rate using individual probabilistic QT/RR slopes for each subject, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat QTca Interval | ||
QTCBAG | C117784 | QTcB Interval, Aggregate | A QT aggregate interval that is corrected for heart rate using Bazett's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QTCB Interval | ||
QTCBSB | C117785 | QTcB Interval, Single Beat | A QT single beat interval that is corrected for heart rate using Bazett's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat QTCB Interval | ||
QTCFAG | C117786 | QTcF Interval, Aggregate | A QT aggregate interval that is corrected for heart rate using Fridericia's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QTCF Interval | ||
QTCFSB | C117787 | QTcF Interval, Single Beat | A QT single beat interval that is corrected for heart rate using Fridericia's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat QTCF Interval | ||
QTCLAG | C123448 | QTcL Interval, Aggregate | A QT aggregate interval corrected for heart rate using a linear correction formula. | Aggregate QTcL Interval | ||
QTCLSB | C123449 | QTcL Interval, Single Beat | A QT single beat interval corrected for heart rate using a linear correction formula. | Single Beat QTcL Interval | ||
QTCUNS | C100391 | QTc Correction Method Unspecified | A QT interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods. | Corrected QT Interval | ||
QTCUNSAG | C174285 | QTc Corr Method Unspecified, Aggregate;QTc Correction Method Unspecified, Aggregate | A QT aggregate interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods. | QTc Correction Method Unspecified, Aggregate | ||
QTCUNSSB | C174286 | QTc Corr Method Unspecified, Single Beat;QTc Correction Method Unspecified, Single Beat | A QT interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods, based on a QT interval measured on a single beat utilizing one or more ECG leads. | QTc Correction Method Unspecified, Single Beat | ||
QTCVAG | C123450 | QTcV Interval, Aggregate | A QT aggregate interval corrected for heart rate using the Van der Water's correction formula. | Aggregate QTcV Interval | ||
QTCVSB | C123451 | QTcV Interval, Single Beat | A QT single beat interval corrected for heart rate using the Van der Water's correction formula. | Single Beat QTcV Interval | ||
QTMAX | C62135 | Summary (Max) QT Duration | The maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Maximum QT Duration | ||
QTMIN | C62133 | Summary (Min) QT Duration | The minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Minimum QT Duration | ||
QTSB | C117788 | QT Interval, Single Beat | An electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads. | Single Beat QT Interval | ||
QWAAG | C117789 | Q Wave Amplitude, Aggregate | An aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate Q Wave Amplitude | ||
QWASB | C117790 | Q Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in millivolt. | Single Beat Q Wave Amplitude | ||
RHYNOS | C111307 | Rhythm Not Otherwise Specified | An electrocardiographic assessment of cardiac rhythm not otherwise specified. | Rhythm Not Otherwise Specified ECG Assessment | ||
RRAG | C117791 | RR Interval, Aggregate | An aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate RR Interval | ||
RRMAX | C62094 | Summary (Max) RR Duration | The maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) | Maximum RR Duration | ||
RRMIN | C62093 | Summary (Min) RR Duration | The minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) | Minimum RR Duration | ||
RRSM | C117792 | RR Interval, Single Measurement | An electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats. | RR Interval Single Measurement | ||
RSAAG | C117793 | RS Wave Amplitude, Aggregate | An aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | RS Wave Amplitude Aggregate | ||
RSASB | C117794 | RS Wave Amplitude, Single Beat | An electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads. | RS Wave Amplitude Single Beat | ||
RWAAG | C117795 | R Wave Amplitude, Aggregate | An aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | R Wave Amplitude Aggregate | ||
RWASB | C117796 | R Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. | R Wave Amplitude Single Beat | ||
SNRARRY | C111312 | Sinus Node Rhythms and Arrhythmias | An electrocardiographic assessment of sinus node rhythms and arrhythmias. | Sinus Node Rhythm and Arrhythmia ECG Assessment | ||
SPRARRY | C111320 | Supraventricular Arrhythmias | An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. | Supraventricular Arrhythmia ECG Assessment | ||
SPRTARRY | C111321 | Supraventricular Tachyarrhythmias | An electrocardiographic assessment of supraventricular tachyarrhythmias. | Supraventricular Tachyarrhythmia ECG Assessment | ||
STDAG | C117797 | ST Segment Depression, Aggregate | An aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Depression Aggregate | ||
STDPMAX | C62163 | Summary (Max) ST Depression | The maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. This is usually expressed in millivolt. | Maximum ST Segment Depression by ECG Finding | ||
STDPMIN | C62162 | Summary (Min) ST Depression | The minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. This is usually expressed in millivolt. | Minimum ST Segment Depression by ECG Finding | ||
STDSB | C117798 | ST Segment Depression, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in millivolt. | ST Segment Depression Single Beat | ||
STDVAG | C117799 | ST Segment Deviation, Aggregate | An aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Deviation Aggregate | ||
STDVMAX | C62157 | Summary (Max) ST Deviation | The maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. This is usually expressed in millivolt. | Maximum ST Deviation | ||
STDVMIN | C62156 | Summary (Min) ST Deviation | The minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. This is usually expressed in millivolt. | Minimum ST Deviation | ||
STDVSB | C117800 | ST Segment Deviation, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. | ST Segment Deviation Single Beat | ||
STEAG | C117801 | ST Segment Elevation, Aggregate | An aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Elevation Aggregate | ||
STELMAX | C62160 | Summary (Max) ST Elevation | The maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. This is usually reported in millivolt. | Maximum ST Segment Elevation | ||
STELMIN | C62159 | Summary (Min) ST Elevation | The minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. This is usually reported in millivolt. | Minimum ST Segment Elevation | ||
STESB | C117802 | ST Segment Elevation, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | ST Segment Elevation Single Beat | ||
STSDURAG | C117803 | ST Segment Duration, Aggregate | An aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Duration Aggregate | ||
STSDURSB | C117804 | ST Segment Duration, Single Beat | An electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads. | ST Segment Duration Single Beat | ||
STSTWUW | C111363 | ST Segment, T wave, and U wave | An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. | ST Segment, T wave, and U wave ECG Assessment | ||
SWAAG | C117805 | S Wave Amplitude, Aggregate | An aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | S Wave Amplitude Aggregate | ||
SWASB | C117806 | S Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. | S Wave Amplitude Single Beat | ||
T_AXIS | C118166 | T Wave Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane. | T Wave Axis | ||
TECHQUAL | C117807 | Technical Quality | A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. | ECG Technical Quality | ||
TPTEAG | C117808 | Tpeak-Tend Interval, Aggregate | An aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Peak-T End Interval Aggregate | ||
TPTESB | C117809 | Tpeak-Tend Interval, Single Beat | An electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads. | T Peak-T End Interval Single Beat | ||
TWARAG | C117810 | T Wave Area, Aggregate | An aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Area Aggregate | ||
TWARSB | C117811 | T Wave Area, Single Beat | An electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads. | T Wave Area Single Beat | ||
TWDURAG | C117812 | T Wave Duration, Aggregate | An aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Duration Aggregate | ||
TWDURSB | C117813 | T Wave Duration, Single Beat | An electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads. | T Wave Duration Single Beat | ||
TWHAG | C117814 | T Wave Amplitude, Aggregate | An aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Amplitude Aggregate | ||
TWHSB | C117815 | T Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | T Wave Amplitude Single Beat | ||
VTARRY | C111330 | Ventricular Arrhythmias | An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. | Ventricular Arrhythmia ECG Assessment | ||
VTTARRY | C111331 | Ventricular Tachyarrhythmias | An electrocardiographic assessment of ventricular tachyarrhythmias. | Ventricular Tachyarrhythmia ECG Assessment | ||
Back to top | ||||||
CL.C71151.EGMETHOD | ECG Test Method
(EGMETHOD) | text
Extensible: Yes | C71151 | ECG Test Method | Terminology codelist used with ECG Test Methods within CDISC. | CDISC SDTM ECG Test Method Terminology |
10 LEAD STANDARD | C90349 | 10 Lead Standard | An electrocardiogram lead placement on the subject using a ten electrode lead set to synthesize standard 12 lead electrocardiograph data to elicit an electrical view of the heart. | 10 Lead Standard | ||
12 LEAD 1 LEAD MISSING | C71125 | 12 Lead 1 Lead Missing | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but one standard lead position is missing therefore requiring a Mortara source consistency filter. (NCI) | 12 Lead Placement 1 Lead Missing | ||
12 LEAD CABRERA | C71116 | 12 Lead Cabrera | An electrocardiogram (ECG) lead placement whereby the display of the 12 standard ECG leads is in an orderly sequence in a single horizontal display of: aVL, I, -aVR, II, aVF, III, V1 to V6. In the Cabrera display the limb lead aVR is inverted (-aVR) to obtain the same positive leftward orientation as the other 5 limbs. (NCI) | 12 Lead Placement Cabrera | ||
12 LEAD CONTINUOUS ECG | C123444 | A continuous electrocardiographic (ECG) recording utilizing 12 leads. The positioning of the electrodes may vary from the standard 12 lead ECG placement. Examples include but are not limited to 12 lead Holter with modified Mason-Likar lead placements, 12 lead exercise ECGs, and 12 lead telemetry systems. | 12 Lead Continuous ECG | |||
12 LEAD EASI DOWER TRANSFORMATION | C71123 | 12 Lead EASI Dower Transformation | An electrocardiogram (ECG) lead placement whereby 4 chest electrodes and 1 reference electrode are used to allow for continuous monitoring at the clinical level. This placement creates a 12 lead ECG that allows the acquisition of simultaneous events in the frontal, horizontal and sagittal heart planes with the linear transformation of vectors. This system provides a three-dimensional portrayal of the heart and uses mathematical and fixed coefficients for each lead. (NCI) | Lead Placement EASI Dower Transformation | ||
12 LEAD ECG EXTRACTED FROM 12 LEAD CONTINUOUS ECG RECORDING | C123445 | A standard duration (typically 10 seconds) 12 lead electrocardiogram (ECG) extracted from a 12 lead continuous ECG. | 12 Lead ECG Extracted From 12 Lead Continuous ECG Recording | |||
12 LEAD MASON LIKAR | C71103 | 12 Lead Mason Likar | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified for ECG recording during exercise. Exercise stress testing requires moving the limb electrodes to more central positions on the thorax. The electrodes are placed in bony prominences close to the bases of the respective limbs in order to avoid skeletal muscle artifact, provide stability for recording electrodes and to record waveforms similar to the standard limb sites. (NCI) | 12 Lead Placement Mason Likar | ||
12 LEAD MODIFIED MASON LIKAR | C71110 | 12 Lead Modified Mason Likar | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the Mason Likar lead positions have been modified so that V1 to V6 on the chest are part of a single electrode pad. In addition, lead CM5 is substituted for lead aVR. (NCI) | 12 Lead Placement Mason Likar Modified | ||
12 LEAD NON-STANDARD | C71114 | 12 Lead Non-Standard | An electrocardiogram (ECG) lead placement whereby the limb leads are placed on the torso for easier and faster application in emergency situations. (NCI) | 12 Lead Placement Non-Standard | ||
12 LEAD RIGHT-SIDED PRECORDIAL LEADS | C116139 | 12 Lead Right-sided Precordial Leads;Right-sided Chest Leads | An electrocardiogram (ECG) lead placement whereby the precordial leads are intentionally placed on the right side of the chest. | 12 Lead Placement Right-sided Precordial Leads | ||
12 LEAD SINGLE PAD | C71112 | 12 Lead Single Pad | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that all leads on the chest are part of a single electrode pad. (NCI) | 12 Lead Placement Chest | ||
12 LEAD STANDARD | C71102 | 12 Lead Standard | An electrocardiogram (ECG) lead placement whereby 12 leads are recorded, with each lead representing an electrical view of the heart. The six leads recorded in the frontal plane are derived from the placement of 3 electrodes (RA or Right Arm, LA, or Left Arm, and LL or Left Leg). These bipolar frontal leads form the basis of Einthoven's triangle, and are represented by leads I, II, and III. Three other derived (or augmented) bipolar frontal vectors are also recorded on a standard 12-lead EKG, aVR, aVF, and aVL. 6 unipolar leads, corresponding to V1 - V6 measure the electrical activity in the horizontal plane. The placement for the V leads is as follows: V1: right 4th intercostal space,V2: left 4th intercostal space, V3: halfway between V2 and V4, V4: left 5th intercostal space, mid-clavicular line, V5: horizontal to V4, anterior axillary line, V6: horizontal to V5, mid-axillary line. (NCI) | 12 Lead Placement Standard | ||
12 LEAD UNSPECIFIED | C71101 | 12 Lead Unspecified | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the position of the leads is unspecified. (NCI) | 12 Lead Placement Unspecified | ||
6 LEAD NEHB-SPORI | C132355 | An electrocardiogram (ECG) lead configuration that is primarily used to record ECGs in non-human animals, and which uses six (6) electrodes to generate eight (8) ECG leads (ECG wave forms). The six electrode configuration includes the following: four (4) limb electrodes, which are placed analogous to an Einthoven configuration in humans, and two (2) chest electrodes. The eight (8) ECG leads recorded comprise three standard limb leads (leads I, II, and III), three augmented leads (Leads aVR, aVF, and aVL), and two chest leads, which are generated using two unipolar chest leads, typically CV5RL [rV2] and CV6LL [V2] for canines, or MV1 and MV2 for primates. | 6 Lead NEHB-SPORI | |||
6 LEAD STANDARD | C90350 | 6 Lead Standard | An electrocardiogram lead placement on the subject using a six electrode lead set with three standard leads and three augmented derived leads to elicit an electrical view of the heart. | 6 Lead Standard | ||
7 LEAD STANDARD, NON-HUMAN | C158157 | An electrocardiogram lead placement for non-human species using a five electrode lead set to monitor and/or record 7 ECG leads, analogous to the standard and augmented human limb leads and one chest lead. | 7 Lead Placement Standard for Non-Human Subjects | |||
8 LEAD STANDARD | C132356 | An electrocardiogram (ECG) recorded using 6 electrodes to generate 8 ECG leads (ECG wave forms). The 6 electrode configuration includes 4 limb electrodes in an Einthoven configuration and two chest electrodes. The 8 ECG leads recorded consist of three standard limb leads (leads I, II, and III), three augmented leads (leads aVR, aVF, and aVL), and two chest leads (which are generated using two unipolar chest leads (typically CV5RL [rV2] and CV6LL [V2] for canines or MV1 and MV2 for non-human primates). This lead configuration is typically used to record ECGs in non-human animals. | 8 Lead Standard | |||
BIPOLAR UNCORRECTED XYZ LEAD SYSTEM | C71121 | Bipolar uncorrected XYZ lead system | An electrocardiogram (ECG) lead placement whereby the X+ lead is placed at the right mid-axillary line ate the 4th intercostal space, X- at the left mid-axillary line at he 4th intercostal space, Y+ at the proximal left leg, Y- at the superior aspect of the manubrium, Z+ at the direct posterior to Z- and Z- at the 4th intercostal space at the left sternal margin. (NCI) | Lead Placement Bipolar Uncorrected XYZ | ||
CONTINUOUS AMBULATORY ECG | C123446 | A continuous electrocardiographic (ECG) recording utilizing 1 or more leads that records and stores data directly to the device. The subject need not be restricted to a medical facility, and may be able to participate in their customary activities of daily living. | Continuous Ambulatory ECG | |||
CONTINUOUS ECG RECORDING FOR NON-HUMAN SPECIES USING IMPLANTED LEADS | C154718 | A continuous electrocardiographic (ECG) recording utilizing one or more implanted leads in a non-human species. | Continuous ECG Recording for Non-human Species Using Implanted Leads | |||
CONTINUOUS SURFACE ECG RECORDING FOR NON-HUMAN SPECIES | C154717 | A continuous electrocardiographic (ECG) recording utilizing one or more surface leads in a non-human species. | Continuous Surface ECG Recording for Non-human Species | |||
CUBE LEAD SYSTEM | C71120 | Cube lead system | An electrocardiogram (ECG) lead placement that is a type of uncorrected vectorcardiograph. This lead system is based on a rectangular body axis. It uses an extra number of electrodes to make it three-dimensional. (NCI) | Lead Placement Cube | ||
FRANK LEAD SYSTEM | C71118 | Frank lead system | An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (right to left direction), Y (foot to head direction) and Z (back to front direction) of the heart. For this method a minimum of 4 electrodes are needed that represent the right arm, left arm, left leg and back. However, usually 7 electrodes are used to avoid dependence on the dipole location and facilitate interpretation. (NCI) | Lead Placement Frank | ||
HOLTER CONTINUOUS ECG RECORDING | C38064 | An electrocardiographic method for collecting continuous ECG waveforms with a variable number of discrete leads with duration longer than the standard 10 second ECG. Holter recording may be performed in patients who are ambulatory, and may collect data for 24 hours or longer. | Holter Monitoring | |||
MCFEE-PARUNGAO LEAD SYSTEM | C71119 | McFee-Parungao lead system | An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (back to front), Y (right to left) and Z (foot to head) of the heart. This system places the electrodes closer to the heart to achieve better orthogonality and a homogeneous lead field. (NCI) | Lead Placement McFee-Parungao | ||
PSEUDO-ORTHOGONAL XYZ LEAD SYSTEM | C71122 | Pseudo-orthogonal XYZ lead system | An electrocardiogram (ECG) lead placement that allows monitoring and recording of cardiac electrical activity. A V1-type lead is used whose positive electrode is localized in the 4th intercostal space, 2.5cm from the sternum. Its negative electrode is placed below the left clavicle. An addition of lead V5 and aVF can be made to facilitate interpretation. (NCI) | Lead Placement Pseudo Orthogonal XYZ | ||
STANDARD 12-LEAD AND CC5-CM5-ML | C71128 | Standard 12-lead and CC5-CM5-ML | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the negative reference is at CM5 and the active electrode is at the left leg position. (NCI) | 12 Lead Placement Standard And CC5-CM5-ML | ||
STANDARD 12-LEAD AND CM5-CC5-CH5 | C71126 | Standard 12-lead and CM5-CC5-CH5 | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the bipolar lead groups place the negative of the reference electrode over the manubrium (CM5), the right scapula (CB5), V5R (CC5) or on the forehead (CH5) and the active electrode at V5. (NCI) | 12 Lead Placement Standard And CC5-CM5-CH5 | ||
STANDARD 12-LEAD EXTENDED LEFT | C71131 | Standard 12-lead extended to the left by V7, V8, V9 | An electrocardiogram (ECG) lead placement whereby the standard lead placement is modified by having leads V7, V8 and V9. (NCI) | 12 Lead Placement Standard Extended Left | ||
STANDARD 12-LEAD EXTENDED RIGHT | C71130 | Standard 12-lead extended to the right by V5R, V4R, V3R | An electrocardiogram (ECG) lead placement whereby the rightward oriented V leads progress from V1R, placed instead of the standard V2, to V6R. The V3 lead in the standard placement is replaced by V4R. (NCI) | 12 Lead Placement Standard Extended Right | ||
STANDARD LEADS FOR BICYCLE EXERCISE | C71115 | Limb leads on the back (shoulder and on the hips). (NCI) | Lead Placement Bicycle | |||
STANDARD LEADS ONE INTERCOSTAL SPACE HIGHER | C71117 | Standard leads one intercostal space higher | An electrocardiographic lead placement schema in which the V leads are placed one intercostal space cephalad to the position they would have in the standard lead placement schema. (NCI) | Lead Placement Standard Intercostal Space Higher | ||
VECTORCARDIOGRAPH CORRECTED | C71092 | Vectorcardiograph Corrected | A recording of the electrical activity of the heart displayed in the form of a vector loop, corrected for anatomic inconsistencies. (NCI) | Vectorcardiograph Corrected | ||
VECTORCARDIOGRAPH UNCORRECTED | C71093 | Vectorcardiograph Uncorrected | A recording of the electrical activity of the heart displayed in the form of a vector loop, uncorrected for anatomic inconsistencies. (NCI) | Vectorcardiograph Uncorrected | ||
Back to top | ||||||
CL.C71152.EGTEST | ECG Test Name
(EGTEST) | text
Extensible: Yes | C71152 | ECG Test Name | Terminology codelist used with ECG Test Names within CDISC. | CDISC SDTM ECG Test Name Terminology |
Acute Myocardial Ischemia ECG Change | C116140 | Acute Myocardial Ischemia ECG Change | An electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). | Acute Myocardial Ischemia by ECG Assessment | ||
Atrioventricular Conduction | C111131 | Atrioventricular Conduction | An electrocardiographic assessment of cardiac atrioventricular conduction. | Atrioventricular Conduction ECG Assessment | ||
Axis and Voltage | C111132 | Axis and Voltage | An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. | Axis and Voltage ECG Assessment | ||
Chamber Hypertrophy or Enlargement | C111155 | Chamber Hypertrophy or Enlargement | An electrocardiographic assessment of chamber hypertrophy or enlargement. | Chamber Hypertrophy or Enlargement ECG Assessment | ||
Comparison to a Prior ECG | C117761 | Comparison to a Prior ECG | A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. | Comparison to a Prior ECG | ||
ECG Maximum Atrial Rate | C119253 | ECG Maximum Atrial Rate | An electrocardiographic measurement of the maximum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Maximum Atrial Rate by Electrocardiogram | ||
ECG Maximum Heart Rate | C119257 | ECG Maximum Heart Rate | An electrocardiographic measurement of the maximum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the maximum ventricular rate. | Maximum Heart Rate by Electrocardiogram | ||
ECG Maximum Ventricular Rate | C119260 | ECG Maximum Ventricular Rate | An electrocardiographic measurement of the maximum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Maximum Ventricular Rate by Electrocardiogram | ||
ECG Mean Atrial Rate | C119256 | ECG Mean Atrial Rate | An electrocardiographic measurement of the average rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Mean Atrial Rate by Electrocardiogram | ||
ECG Mean Heart Rate | C119259 | ECG Mean Heart Rate | An electrocardiographic measurement of the average rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the mean ventricular rate. | Mean Heart Rate by Electrocardiogram | ||
ECG Mean Ventricular Rate | C119263 | ECG Mean Ventricular Rate | An electrocardiographic measurement of the average rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Mean Ventricular Rate by Electrocardiogram | ||
ECG Median Atrial Rate | C119254 | ECG Median Atrial Rate | An electrocardiographic measurement of the median rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Median Atrial Rate by Electrocardiogram | ||
ECG Median Heart Rate | C123447 | ECG Median Heart Rate | An electrocardiographic measurement of the median rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the median ventricular rate. | ECG Median Heart Rate | ||
ECG Median Ventricular Rate | C119261 | ECG Median Ventricular Rate | An electrocardiographic measurement of the median rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Median Ventricular Rate by Electrocardiogram | ||
ECG Minimum Atrial Rate | C119255 | ECG Minimum Atrial Rate | An electrocardiographic measurement of the minimum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Minimum Atrial Rate by Electrocardiogram | ||
ECG Minimum Heart Rate | C119258 | ECG Minimum Heart Rate | An electrocardiographic measurement of the minimum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the minimum ventricular rate. | Minimum Heart Rate by Electrocardiogram | ||
ECG Minimum Ventricular Rate | C119262 | ECG Minimum Ventricular Rate | An electrocardiographic measurement of the minimum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Minimum Ventricular Rate by Electrocardiogram | ||
Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
Intraventricular-Intraatrial Conduction | C111238 | Intraventricular-Intraatrial Conduction | An electrocardiographic assessment of intraventricular and intra-atrial conduction. | Intraventricular and Intraatrial Conduction ECG Assessment | ||
J-Tpeak Interval, Aggregate | C117767 | J-Tpeak Interval, Aggregate | An aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate J-T Peak Interval | ||
J-Tpeak Interval, Single Beat | C117768 | J-Tpeak Interval, Single Beat | An electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads. | Single Beat J-T Peak Interval | ||
JT Interval, Aggregate | C117762 | JT Interval, Aggregate | An aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate JT Interval | ||
JT Interval, Single Beat | C117769 | JT Interval, Single Beat | An electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads. | Single Beat JT Interval | ||
JTcB Interval, Aggregate | C117763 | JTcB Interval, Aggregate | A JT aggregate interval that is corrected for heart rate using Bazett's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate JTCB Interval | ||
JTcB Interval, Single Beat | C117764 | JTcB Interval, Single Beat | A JT single beat interval that is corrected for heart rate using Bazett's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat JTCB Interval | ||
JTcF Interval, Aggregate | C117765 | JTcF Interval, Aggregate | A JT aggregate interval that is corrected for heart rate using Fridericia's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate JTCF Interval | ||
JTcF Interval, Single Beat | C117766 | JTcF Interval, Single Beat | A JT single beat interval that is corrected for heart rate using Fridericia's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat JTCF Interval | ||
Myocardial Infarction | C111280 | Myocardial Infarction | An electrocardiographic assessment of findings suggestive of myocardial infarction. | Myocardial Infarction ECG Assessment | ||
New Q Wave | C117770 | New Q Wave | An electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, Simoons ML, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98). | New Q Wave | ||
P Wave Amplitude, Aggregate | C117777 | P Wave Amplitude, Aggregate | An aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate P Wave Amplitude | ||
P Wave Amplitude, Single Beat | C117778 | P Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. | Single Beat P Wave Amplitude | ||
P Wave Axis | C118164 | P Wave Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane. | P Wave Axis | ||
P Wave Duration, Aggregate | C117775 | P Wave Duration, Aggregate | An aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate P Wave Duration | ||
P Wave Duration, Single Beat | C117776 | P Wave Duration, Single Beat | An electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads. | Single Beat P Wave Duration | ||
Pacemaker | C111285 | Pacemaker | An electrocardiographic assessment of presence of artificial electronic pacing. | Pacemaker ECG Assessment | ||
PP Interval, Aggregate | C117771 | PP Interval, Aggregate | An aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate PP Interval | ||
PP Interval, Single Measurement | C117772 | PP Interval, Single Measurement | An electrocardiographic measurement of the interval between the onsets of two consecutive P waves. | Single Measurement PP Interval | ||
PR Interval, Aggregate | C117773 | PQ Interval, Aggregate;PQAG;PR Interval, Aggregate | An aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate PR Interval | ||
PR Interval, Single Beat | C117774 | PQ Interval, Single Beat;PQSB;PR Interval, Single Beat | An electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads. | Single Beat PR Interval | ||
Q Wave Amplitude, Aggregate | C117789 | Q Wave Amplitude, Aggregate | An aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate Q Wave Amplitude | ||
Q Wave Amplitude, Single Beat | C117790 | Q Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in millivolt. | Single Beat Q Wave Amplitude | ||
QRS Axis | C118165 | QRS Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane. | QRS Axis | ||
QRS Duration, Aggregate | C117779 | QRS Duration, Aggregate | An aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QRS Duration | ||
QRS Duration, Single Beat | C117780 | QRS Duration, Single Beat | An electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. | Single Beat QRS Duration | ||
QRS Duration, Ventr. Paced, Aggregate | C117781 | QRS Duration, Ventr. Paced, Aggregate | An aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Paced Ventricular Aggregate QRS Duration | ||
QRS Duration, Ventr. Paced, Single Beat | C117782 | QRS Duration, Ventr. Paced, Single Beat | An electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. | Paced Ventricular Single Beat QRS Duration | ||
QT Interval, Aggregate | C117783 | QT Interval, Aggregate | An aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QT Interval | ||
QT Interval, Single Beat | C117788 | QT Interval, Single Beat | An electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads. | Single Beat QT Interval | ||
QTc Corr Method Unspecified, Aggregate | C174285 | QTc Corr Method Unspecified, Aggregate;QTc Correction Method Unspecified, Aggregate | A QT aggregate interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods. | QTc Correction Method Unspecified, Aggregate | ||
QTc Corr Method Unspecified, Single Beat | C174286 | QTc Corr Method Unspecified, Single Beat;QTc Correction Method Unspecified, Single Beat | A QT interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods, based on a QT interval measured on a single beat utilizing one or more ECG leads. | QTc Correction Method Unspecified, Single Beat | ||
QTc Correction Method Unspecified | C100391 | QTc Correction Method Unspecified | A QT interval that is corrected for heart rate by unspecified correction method, or by non-standard correction methods. | Corrected QT Interval | ||
QTca Interval, Aggregate | C124332 | QTca Interval, Aggregate | A QT Aggregate interval that is corrected for heart rate using individual probabilistic QT/RR slopes for each subject, based on the measurement of QT intervals from multiple beats within a single ECG or period of a continuous ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QTca Interval | ||
QTca Interval, Single Beat | C124333 | QTca Interval, Single Beat | A QT interval that is corrected for heart rate using individual probabilistic QT/RR slopes for each subject, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat QTca Interval | ||
QTcB Interval, Aggregate | C117784 | QTcB Interval, Aggregate | A QT aggregate interval that is corrected for heart rate using Bazett's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QTCB Interval | ||
QTcB Interval, Single Beat | C117785 | QTcB Interval, Single Beat | A QT single beat interval that is corrected for heart rate using Bazett's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat QTCB Interval | ||
QTcF Interval, Aggregate | C117786 | QTcF Interval, Aggregate | A QT aggregate interval that is corrected for heart rate using Fridericia's formula, based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QTCF Interval | ||
QTcF Interval, Single Beat | C117787 | QTcF Interval, Single Beat | A QT single beat interval that is corrected for heart rate using Fridericia's formula, based on a QT interval measured on a single beat utilizing one or more ECG leads. | Single Beat QTCF Interval | ||
QTcL Interval, Aggregate | C123448 | QTcL Interval, Aggregate | A QT aggregate interval corrected for heart rate using a linear correction formula. | Aggregate QTcL Interval | ||
QTcL Interval, Single Beat | C123449 | QTcL Interval, Single Beat | A QT single beat interval corrected for heart rate using a linear correction formula. | Single Beat QTcL Interval | ||
QTcV Interval, Aggregate | C123450 | QTcV Interval, Aggregate | A QT aggregate interval corrected for heart rate using the Van der Water's correction formula. | Aggregate QTcV Interval | ||
QTcV Interval, Single Beat | C123451 | QTcV Interval, Single Beat | A QT single beat interval corrected for heart rate using the Van der Water's correction formula. | Single Beat QTcV Interval | ||
R Wave Amplitude, Aggregate | C117795 | R Wave Amplitude, Aggregate | An aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | R Wave Amplitude Aggregate | ||
R Wave Amplitude, Single Beat | C117796 | R Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. | R Wave Amplitude Single Beat | ||
Rhythm Not Otherwise Specified | C111307 | Rhythm Not Otherwise Specified | An electrocardiographic assessment of cardiac rhythm not otherwise specified. | Rhythm Not Otherwise Specified ECG Assessment | ||
RR Interval, Aggregate | C117791 | RR Interval, Aggregate | An aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate RR Interval | ||
RR Interval, Single Measurement | C117792 | RR Interval, Single Measurement | An electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats. | RR Interval Single Measurement | ||
RS Wave Amplitude, Aggregate | C117793 | RS Wave Amplitude, Aggregate | An aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | RS Wave Amplitude Aggregate | ||
RS Wave Amplitude, Single Beat | C117794 | RS Wave Amplitude, Single Beat | An electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads. | RS Wave Amplitude Single Beat | ||
S Wave Amplitude, Aggregate | C117805 | S Wave Amplitude, Aggregate | An aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | S Wave Amplitude Aggregate | ||
S Wave Amplitude, Single Beat | C117806 | S Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. | S Wave Amplitude Single Beat | ||
Single RR Heart Rate | C120608 | Single RR Heart Rate | An electrocardiographic measurement of a heart rate derived from a single RR interval (interval between two consecutive QRS complexes). | Single Beat RR Extrapolated Heart Rate by ECG Assessment | ||
Sinus Node Rhythms and Arrhythmias | C111312 | Sinus Node Rhythms and Arrhythmias | An electrocardiographic assessment of sinus node rhythms and arrhythmias. | Sinus Node Rhythm and Arrhythmia ECG Assessment | ||
ST Segment Depression, Aggregate | C117797 | ST Segment Depression, Aggregate | An aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Depression Aggregate | ||
ST Segment Depression, Single Beat | C117798 | ST Segment Depression, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in millivolt. | ST Segment Depression Single Beat | ||
ST Segment Deviation, Aggregate | C117799 | ST Segment Deviation, Aggregate | An aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Deviation Aggregate | ||
ST Segment Deviation, Single Beat | C117800 | ST Segment Deviation, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mm) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement is reported in millivolt. | ST Segment Deviation Single Beat | ||
ST Segment Duration, Aggregate | C117803 | ST Segment Duration, Aggregate | An aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Duration Aggregate | ||
ST Segment Duration, Single Beat | C117804 | ST Segment Duration, Single Beat | An electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads. | ST Segment Duration Single Beat | ||
ST Segment Elevation, Aggregate | C117801 | ST Segment Elevation, Aggregate | An aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Elevation Aggregate | ||
ST Segment Elevation, Single Beat | C117802 | ST Segment Elevation, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | ST Segment Elevation Single Beat | ||
ST Segment, T wave, and U wave | C111363 | ST Segment, T wave, and U wave | An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. | ST Segment, T wave, and U wave ECG Assessment | ||
Summary (Max) JT Interval | C62117 | Summary (Max) JT Interval | The maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Maximum JT Duration | ||
Summary (Max) PR Duration | C62131 | Summary (Max) PR Duration | The maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Maximum PR Duration | ||
Summary (Max) QT Duration | C62135 | Summary (Max) QT Duration | The maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Maximum QT Duration | ||
Summary (Max) RR Duration | C62094 | Summary (Max) RR Duration | The maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) | Maximum RR Duration | ||
Summary (Max) ST Depression | C62163 | Summary (Max) ST Depression | The maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. This is usually expressed in millivolt. | Maximum ST Segment Depression by ECG Finding | ||
Summary (Max) ST Deviation | C62157 | Summary (Max) ST Deviation | The maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. This is usually expressed in millivolt. | Maximum ST Deviation | ||
Summary (Max) ST Elevation | C62160 | Summary (Max) ST Elevation | The maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. This is usually reported in millivolt. | Maximum ST Segment Elevation | ||
Summary (Min) JT Interval | C62116 | Summary (Min) JT Interval | The minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Minimum JT Duration | ||
Summary (Min) PR Duration | C62125 | Summary (Min) PR Duration | The minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Minimum PR Duration | ||
Summary (Min) QT Duration | C62133 | Summary (Min) QT Duration | The minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Minimum QT Duration | ||
Summary (Min) RR Duration | C62093 | Summary (Min) RR Duration | The minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) | Minimum RR Duration | ||
Summary (Min) ST Depression | C62162 | Summary (Min) ST Depression | The minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. This is usually expressed in millivolt. | Minimum ST Segment Depression by ECG Finding | ||
Summary (Min) ST Deviation | C62156 | Summary (Min) ST Deviation | The minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. This is usually expressed in millivolt. | Minimum ST Deviation | ||
Summary (Min) ST Elevation | C62159 | Summary (Min) ST Elevation | The minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. This is usually reported in millivolt. | Minimum ST Segment Elevation | ||
Supraventricular Arrhythmias | C111320 | Supraventricular Arrhythmias | An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. | Supraventricular Arrhythmia ECG Assessment | ||
Supraventricular Tachyarrhythmias | C111321 | Supraventricular Tachyarrhythmias | An electrocardiographic assessment of supraventricular tachyarrhythmias. | Supraventricular Tachyarrhythmia ECG Assessment | ||
T Wave Amplitude, Aggregate | C117814 | T Wave Amplitude, Aggregate | An aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Amplitude Aggregate | ||
T Wave Amplitude, Single Beat | C117815 | T Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | T Wave Amplitude Single Beat | ||
T Wave Area, Aggregate | C117810 | T Wave Area, Aggregate | An aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Area Aggregate | ||
T Wave Area, Single Beat | C117811 | T Wave Area, Single Beat | An electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads. | T Wave Area Single Beat | ||
T Wave Axis | C118166 | T Wave Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane. | T Wave Axis | ||
T Wave Duration, Aggregate | C117812 | T Wave Duration, Aggregate | An aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Duration Aggregate | ||
T Wave Duration, Single Beat | C117813 | T Wave Duration, Single Beat | An electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads. | T Wave Duration Single Beat | ||
Technical Quality | C117807 | Technical Quality | A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. | ECG Technical Quality | ||
Tpeak-Tend Interval, Aggregate | C117808 | Tpeak-Tend Interval, Aggregate | An aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Peak-T End Interval Aggregate | ||
Tpeak-Tend Interval, Single Beat | C117809 | Tpeak-Tend Interval, Single Beat | An electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads. | T Peak-T End Interval Single Beat | ||
Ventricular Arrhythmias | C111330 | Ventricular Arrhythmias | An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. | Ventricular Arrhythmia ECG Assessment | ||
Ventricular Tachyarrhythmias | C111331 | Ventricular Tachyarrhythmias | An electrocardiographic assessment of ventricular tachyarrhythmias. | Ventricular Tachyarrhythmia ECG Assessment | ||
Back to top | ||||||
CL.C132521.EPDS01TC | Edinburgh Postnatal Depression Scale Questionnaire Test Code
(EPDS01TC) | text
Extensible: No | C132521 | Edinburgh Postnatal Depression Scale Questionnaire Test Code | Edinburgh Postnatal Depression Scale test code. | CDISC Questionnaire EPDS Test Code Terminology |
EPDS0101 | C132563 | EPDS01-Able to Laugh and See Funny Side | Edinburgh Postnatal Depression Scale - I have been able to laugh and see the funny side of things. | EPDS - Able to Laugh and See Funny Side | ||
EPDS0102 | C132564 | EPDS01-Looked Forward With Enjoyment | Edinburgh Postnatal Depression Scale - I have looked forward with enjoyment to things. | EPDS - Looked Forward With Enjoyment | ||
EPDS0103 | C132565 | EPDS01-Blamed Myself Unnecessarily | Edinburgh Postnatal Depression Scale - I have blamed myself unnecessarily when things went wrong. | EPDS - Blamed Myself Unnecessarily | ||
EPDS0104 | C132566 | EPDS01-Anxious/Worried No Good Reason | Edinburgh Postnatal Depression Scale - I have been anxious or worried for no good reason. | EPDS - Anxious or Worried No Good Reason | ||
EPDS0105 | C132567 | EPDS01-Scared/Panicky for No Good Reason | Edinburgh Postnatal Depression Scale - I have felt scared or panicky for no very good reason. | EPDS - Scared or Panicky for No Good Reason | ||
EPDS0106 | C132568 | EPDS01-Things Getting on Top of Me | Edinburgh Postnatal Depression Scale - Things have been getting on top of me. | EPDS - Things Getting on Top of Me | ||
EPDS0107 | C132569 | EPDS01-Unhappy Had Difficulty Sleeping | Edinburgh Postnatal Depression Scale - I have been so unhappy that I have had difficulty sleeping. | EPDS - Unhappy Had Difficulty Sleeping | ||
EPDS0108 | C132570 | EPDS01-I Have Felt Sad or Miserable | Edinburgh Postnatal Depression Scale - I have felt sad or miserable. | EPDS - I Have Felt Sad or Miserable | ||
EPDS0109 | C132571 | EPDS01-So Unhappy I Have Been Crying | Edinburgh Postnatal Depression Scale - I have been so unhappy that I have been crying. | EPDS - So Unhappy I Have Been Crying | ||
EPDS0110 | C132572 | EPDS01-Thought of Harming Myself | Edinburgh Postnatal Depression Scale - The thought of harming myself has occurred to me. | EPDS - Thought of Harming Myself | ||
Back to top | ||||||
CL.C132520.EPDS01TN | Edinburgh Postnatal Depression Scale Questionnaire Test Name
(EPDS01TN) | text
Extensible: No | C132520 | Edinburgh Postnatal Depression Scale Questionnaire Test Name | Edinburgh Postnatal Depression Scale test name. | CDISC Questionnaire EPDS Test Name Terminology |
EPDS01-Able to Laugh and See Funny Side | C132563 | EPDS01-Able to Laugh and See Funny Side | Edinburgh Postnatal Depression Scale - I have been able to laugh and see the funny side of things. | EPDS - Able to Laugh and See Funny Side | ||
EPDS01-Anxious/Worried No Good Reason | C132566 | EPDS01-Anxious/Worried No Good Reason | Edinburgh Postnatal Depression Scale - I have been anxious or worried for no good reason. | EPDS - Anxious or Worried No Good Reason | ||
EPDS01-Blamed Myself Unnecessarily | C132565 | EPDS01-Blamed Myself Unnecessarily | Edinburgh Postnatal Depression Scale - I have blamed myself unnecessarily when things went wrong. | EPDS - Blamed Myself Unnecessarily | ||
EPDS01-I Have Felt Sad or Miserable | C132570 | EPDS01-I Have Felt Sad or Miserable | Edinburgh Postnatal Depression Scale - I have felt sad or miserable. | EPDS - I Have Felt Sad or Miserable | ||
EPDS01-Looked Forward With Enjoyment | C132564 | EPDS01-Looked Forward With Enjoyment | Edinburgh Postnatal Depression Scale - I have looked forward with enjoyment to things. | EPDS - Looked Forward With Enjoyment | ||
EPDS01-Scared/Panicky for No Good Reason | C132567 | EPDS01-Scared/Panicky for No Good Reason | Edinburgh Postnatal Depression Scale - I have felt scared or panicky for no very good reason. | EPDS - Scared or Panicky for No Good Reason | ||
EPDS01-So Unhappy I Have Been Crying | C132571 | EPDS01-So Unhappy I Have Been Crying | Edinburgh Postnatal Depression Scale - I have been so unhappy that I have been crying. | EPDS - So Unhappy I Have Been Crying | ||
EPDS01-Things Getting on Top of Me | C132568 | EPDS01-Things Getting on Top of Me | Edinburgh Postnatal Depression Scale - Things have been getting on top of me. | EPDS - Things Getting on Top of Me | ||
EPDS01-Thought of Harming Myself | C132572 | EPDS01-Thought of Harming Myself | Edinburgh Postnatal Depression Scale - The thought of harming myself has occurred to me. | EPDS - Thought of Harming Myself | ||
EPDS01-Unhappy Had Difficulty Sleeping | C132569 | EPDS01-Unhappy Had Difficulty Sleeping | Edinburgh Postnatal Depression Scale - I have been so unhappy that I have had difficulty sleeping. | EPDS - Unhappy Had Difficulty Sleeping | ||
Back to top | ||||||
CL.C161627.ETRP01TC | Emory Treatment Resistance Interview for PTSD Clinical Classification Test Code
(ETRP01TC) | text
Extensible: No | C161627 | Emory Treatment Resistance Interview for PTSD Clinical Classification Test Code | Emory Treatment Resistance Interview for PTSD test code. | CDISC Clinical Classification E-TRIP Test Code Terminology |
ETRP0101 | C161760 | ETRP01-Medication Total Points | Emory Treatment Resistance Interview for PTSD - Medication total points. | E-TRIP - Medication Total Points | ||
ETRP0102 | C161761 | ETRP01-Psychotherapy Total Points | Emory Treatment Resistance Interview for PTSD - Psychotherapy total points. | E-TRIP - Psychotherapy Total Points | ||
ETRP0103 | C161762 | ETRP01-Total Points | Emory Treatment Resistance Interview for PTSD - Total points. | E-TRIP - Total Points | ||
Back to top | ||||||
CL.C161626.ETRP01TN | Emory Treatment Resistance Interview for PTSD Clinical Classification Test Name
(ETRP01TN) | text
Extensible: No | C161626 | Emory Treatment Resistance Interview for PTSD Clinical Classification Test Name | Emory Treatment Resistance Interview for PTSD test name. | CDISC Clinical Classification E-TRIP Test Name Terminology |
ETRP01-Medication Total Points | C161760 | ETRP01-Medication Total Points | Emory Treatment Resistance Interview for PTSD - Medication total points. | E-TRIP - Medication Total Points | ||
ETRP01-Psychotherapy Total Points | C161761 | ETRP01-Psychotherapy Total Points | Emory Treatment Resistance Interview for PTSD - Psychotherapy total points. | E-TRIP - Psychotherapy Total Points | ||
ETRP01-Total Points | C161762 | ETRP01-Total Points | Emory Treatment Resistance Interview for PTSD - Total points. | E-TRIP - Total Points | ||
Back to top | ||||||
CL.C150768.EMO1TC | Emotion Recognition Functional Test Test Code
(EMO1TC) | text
Extensible: No | C150768 | Emotion Recognition Functional Test Test Code | Emotion Recognition test code. | CDISC Functional Test ERT Test Code Terminology |
EMO101 | C150926 | EMO1-Total Stimuli Expected | Emotion Recognition - Total number of stimuli (face images) expected to be administered in the task. | ERT - Total Stimuli Expected | ||
EMO102 | C150927 | EMO1-Total Stimuli Administered | Emotion Recognition - Total number of stimuli (face images) actually administered in the task. | ERT - Total Stimuli Administered | ||
EMO103 | C150928 | EMO1-Total Stimuli Completed | Emotion Recognition - Total number of stimuli (face images) actually completed in the task. | ERT - Total Stimuli Completed | ||
EMO103A | C150929 | EMO1-Total Stimuli Response Correct | Emotion Recognition - Total number of stimuli (face images) for which the participant's response was correct. | ERT - Total Stimuli Response Correct | ||
EMO103B | C150930 | EMO1-Total Stimuli Response Incorrect | Emotion Recognition - Total number of stimuli (face images) for which the participant's response was incorrect. | ERT - Total Stimuli Response Incorrect | ||
EMO103C | C150931 | EMO1-Total Stimuli Not Responded | Emotion Recognition - Total number of stimuli (face images) for which the participant has not responded. | ERT - Total Stimuli Not Responded | ||
EMO104 | C150932 | EMO1-Total Negative Stimuli Expected | Emotion Recognition - Total number of negative emotion stimuli (face images) expected to be administered in the task. | ERT - Total Negative Stimuli Expected | ||
EMO105 | C150933 | EMO1-Total Negative Stimuli Administered | Emotion Recognition - Total number of negative emotion stimuli (face images) actually administered in the task. | ERT - Total Negative Stimuli Administered | ||
EMO106 | C150934 | EMO1-Total Negative Stimuli Completed | Emotion Recognition - Total number of negative emotion stimuli (face images) actually completed in the task. | ERT - Total Negative Stimuli Completed | ||
EMO106A | C150935 | EMO1-Total Negative Stimuli Correct | Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant's response was correct. | ERT - Total Negative Stimuli Correct | ||
EMO106B | C150936 | EMO1-Total Negative Stimuli Incorrect | Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant's response was incorrect. | ERT - Total Negative Stimuli Incorrect | ||
EMO106C | C150937 | EMO1-Total Negative Stimuli Not Respond | Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant has not responded. | ERT - Total Negative Stimuli Not Respond | ||
EMO107 | C150938 | EMO1-Number Stimuli Portraying Anger | Emotion Recognition - Number of stimuli defined as portraying anger. | ERT - Number Stimuli Portraying Anger | ||
EMO107A | C150939 | EMO1-Anger Responded as Anger | Emotion Recognition - Number of anger stimuli responded to as anger. | ERT - Anger Responded as Anger | ||
EMO107B | C150940 | EMO1-Anger Responded as Disgust | Emotion Recognition - Number of anger stimuli responded to as disgust. | ERT - Anger Responded as Disgust | ||
EMO107C | C150941 | EMO1-Anger Responded as Fear | Emotion Recognition - Number of anger stimuli responded to as fear. | ERT - Anger Responded as Fear | ||
EMO107D | C150942 | EMO1-Anger Responded as Happiness | Emotion Recognition - Number of anger stimuli responded to as happiness. | ERT - Anger Responded as Happiness | ||
EMO107E | C150943 | EMO1-Anger Responded as Neutral | Emotion Recognition - Number of anger stimuli responded to as neutral. | ERT - Anger Responded as Neutral | ||
EMO107F | C150944 | EMO1-Anger Responded as Sadness | Emotion Recognition - Number of anger stimuli responded to as sadness. | ERT - Anger Responded as Sadness | ||
EMO107G | C150945 | EMO1-Anger Responded as Surprise | Emotion Recognition - Number of anger stimuli responded to as surprise. | ERT - Anger Responded as Surprise | ||
EMO108 | C150946 | EMO1-Number Stimuli Portraying Disgust | Emotion Recognition - Number of stimuli defined as portraying disgust. | ERT - Number Stimuli Portraying Disgust | ||
EMO108A | C150947 | EMO1-Disgust Responded as Anger | Emotion Recognition - Number of disgust stimuli responded to as anger. | ERT - Disgust Responded as Anger | ||
EMO108B | C150948 | EMO1-Disgust Responded as Disgust | Emotion Recognition - Number of disgust stimuli responded to as disgust. | ERT - Disgust Responded as Disgust | ||
EMO108C | C150949 | EMO1-Disgust Responded as Fear | Emotion Recognition - Number of disgust stimuli responded to as fear. | ERT - Disgust Responded as Fear | ||
EMO108D | C150950 | EMO1-Disgust Responded as Happiness | Emotion Recognition - Number of disgust stimuli responded to as happiness. | ERT - Disgust Responded as Happiness | ||
EMO108E | C150951 | EMO1-Disgust Responded as Neutral | Emotion Recognition - Number of disgust stimuli responded to as neutral. | ERT - Disgust Responded as Neutral | ||
EMO108F | C150952 | EMO1-Disgust Responded as Sadness | Emotion Recognition - Number of disgust stimuli responded to as sadness. | ERT - Disgust Responded as Sadness | ||
EMO108G | C150953 | EMO1-Disgust Responded as Surprise | Emotion Recognition - Number of disgust stimuli responded to as surprise. | ERT - Disgust Responded as Surprise | ||
EMO109 | C150954 | EMO1-Number Stimuli Portraying Fear | Emotion Recognition - Number of stimuli defined as portraying fear. | ERT - Number Stimuli Portraying Fear | ||
EMO109A | C150955 | EMO1-Fear Responded as Anger | Emotion Recognition - Number of fear stimuli responded to as anger. | ERT - Fear Responded as Anger | ||
EMO109B | C150956 | EMO1-Fear Responded as Disgust | Emotion Recognition - Number of fear stimuli responded to as disgust. | ERT - Fear Responded as Disgust | ||
EMO109C | C150957 | EMO1-Fear Responded as Fear | Emotion Recognition - Number of fear stimuli responded to as fear. | ERT - Fear Responded as Fear | ||
EMO109D | C150958 | EMO1-Fear Responded as Happiness | Emotion Recognition - Number of fear stimuli responded to as happiness. | ERT - Fear Responded as Happiness | ||
EMO109E | C150959 | EMO1-Fear Responded as Neutral | Emotion Recognition - Number of fear stimuli responded to as neutral. | ERT - Fear Responded as Neutral | ||
EMO109F | C150960 | EMO1-Fear Responded as Sadness | Emotion Recognition - Number of fear stimuli responded to as sadness. | ERT - Fear Responded as Sadness | ||
EMO109G | C150961 | EMO1-Fear Responded as Surprise | Emotion Recognition - Number of fear stimuli responded to as surprise. | ERT - Fear Responded as Surprise | ||
EMO110 | C150962 | EMO1-Number Stimuli Portraying Happiness | Emotion Recognition - Number of stimuli defined as portraying happiness. | ERT - Number Stimuli Portraying Happiness | ||
EMO110A | C150963 | EMO1-Happiness Responded as Anger | Emotion Recognition - Number of happiness stimuli responded to as anger. | ERT - Happiness Responded as Anger | ||
EMO110B | C150964 | EMO1-Happiness Responded as Disgust | Emotion Recognition - Number of happiness stimuli responded to as disgust. | ERT - Happiness Responded as Disgust | ||
EMO110C | C150965 | EMO1-Happiness Responded as Fear | Emotion Recognition - Number of happiness stimuli responded to as fear. | ERT - Happiness Responded as Fear | ||
EMO110D | C150966 | EMO1-Happiness Responded as Happiness | Emotion Recognition - Number of happiness stimuli responded to as happiness. | ERT - Happiness Responded as Happiness | ||
EMO110E | C150967 | EMO1-Happiness Responded as Neutral | Emotion Recognition - Number of happiness stimuli responded to as neutral. | ERT - Happiness Responded as Neutral | ||
EMO110F | C150968 | EMO1-Happiness Responded as Sadness | Emotion Recognition - Number of happiness stimuli responded to as sadness. | ERT - Happiness Responded as Sadness | ||
EMO110G | C150969 | EMO1-Happiness Responded as Surprise | Emotion Recognition - Number of happiness stimuli responded to as surprise. | ERT - Happiness Responded as Surprise | ||
EMO111 | C150970 | EMO1-Number Stimuli Portraying Neutral | Emotion Recognition - Number of stimuli defined as portraying a neutral expression. | ERT - Number Stimuli Portraying Neutral | ||
EMO111A | C150971 | EMO1-Neutral Responded as Anger | Emotion Recognition - Number of neutral stimuli responded to as anger. | ERT - Neutral Responded as Anger | ||
EMO111B | C150972 | EMO1-Neutral Responded as Disgust | Emotion Recognition - Number of neutral stimuli responded to as disgust. | ERT - Neutral Responded as Disgust | ||
EMO111C | C150973 | EMO1-Neutral Responded as Fear | Emotion Recognition - Number of neutral stimuli responded to as fear. | ERT - Neutral Responded as Fear | ||
EMO111D | C150974 | EMO1-Neutral Responded as Happiness | Emotion Recognition - Number of neutral stimuli responded to as happiness. | ERT - Neutral Responded as Happiness | ||
EMO111E | C150975 | EMO1-Neutral Responded as Neutral | Emotion Recognition - Number of neutral stimuli responded to as neutral. | ERT - Neutral Responded as Neutral | ||
EMO111F | C150976 | EMO1-Neutral Responded as Sadness | Emotion Recognition - Number of neutral stimuli responded to as sadness. | ERT - Neutral Responded as Sadness | ||
EMO111G | C150977 | EMO1-Neutral Responded as Surprise | Emotion Recognition - Number of neutral stimuli responded to as surprise. | ERT - Neutral Responded as Surprise | ||
EMO112 | C150978 | EMO1-Number Stimuli Portraying Sadness | Emotion Recognition - Number of stimuli defined as portraying sadness. | ERT - Number Stimuli Portraying Sadness | ||
EMO112A | C150979 | EMO1-Sadness Responded as Anger | Emotion Recognition - Number of sadness stimuli responded to as anger. | ERT - Sadness Responded as Anger | ||
EMO112B | C150980 | EMO1-Sadness Responded as Disgust | Emotion Recognition - Number of sadness stimuli responded to as disgust. | ERT - Sadness Responded as Disgust | ||
EMO112C | C150981 | EMO1-Sadness Responded as Fear | Emotion Recognition - Number of sadness stimuli responded to as fear. | ERT - Sadness Responded as Fear | ||
EMO112D | C150982 | EMO1-Sadness Responded as Happiness | Emotion Recognition - Number of sadness stimuli responded to as happiness. | ERT - Sadness Responded as Happiness | ||
EMO112E | C150983 | EMO1-Sadness Responded as Neutral | Emotion Recognition - Number of sadness stimuli responded to as neutral. | ERT - Sadness Responded as Neutral | ||
EMO112F | C150984 | EMO1-Sadness Responded as Sadness | Emotion Recognition - Number of sadness stimuli responded to as sadness. | ERT - Sadness Responded as Sadness | ||
EMO112G | C150985 | EMO1-Sadness Responded as Surprise | Emotion Recognition - Number of sadness stimuli responded to as surprise. | ERT - Sadness Responded as Surprise | ||
EMO113 | C150986 | EMO1-Number Stimuli Portraying Surprise | Emotion Recognition - Number of stimuli defined as portraying surprise. | ERT - Number Stimuli Portraying Surprise | ||
EMO113A | C150987 | EMO1-Surprise Responded as Anger | Emotion Recognition - Number of surprise stimuli responded to as anger. | ERT - Surprise Responded as Anger | ||
EMO113B | C150988 | EMO1-Surprise Responded as Disgust | Emotion Recognition - Number of surprise stimuli responded to as disgust. | ERT - Surprise Responded as Disgust | ||
EMO113C | C150989 | EMO1-Surprise Responded as Fear | Emotion Recognition - Number of surprise stimuli responded to as fear. | ERT - Surprise Responded as Fear | ||
EMO113D | C150990 | EMO1-Surprise Responded as Happiness | Emotion Recognition - Number of surprise stimuli responded to as happiness. | ERT - Surprise Responded as Happiness | ||
EMO113E | C150991 | EMO1-Surprise Responded as Neutral | Emotion Recognition - Number of surprise stimuli responded to as neutral. | ERT - Surprise Responded as Neutral | ||
EMO113F | C150992 | EMO1-Surprise Responded as Sadness | Emotion Recognition - Number of surprise stimuli responded to as sadness. | ERT - Surprise Responded as Sadness | ||
EMO113G | C150993 | EMO1-Surprise Responded as Surprise | Emotion Recognition - Number of surprise stimuli responded to as surprise. | ERT - Surprise Responded as Surprise | ||
Back to top | ||||||
CL.C150767.EMO1TN | Emotion Recognition Functional Test Test Name
(EMO1TN) | text
Extensible: No | C150767 | Emotion Recognition Functional Test Test Name | Emotion Recognition test name. | CDISC Functional Test ERT Test Name Terminology |
EMO1-Anger Responded as Anger | C150939 | EMO1-Anger Responded as Anger | Emotion Recognition - Number of anger stimuli responded to as anger. | ERT - Anger Responded as Anger | ||
EMO1-Anger Responded as Disgust | C150940 | EMO1-Anger Responded as Disgust | Emotion Recognition - Number of anger stimuli responded to as disgust. | ERT - Anger Responded as Disgust | ||
EMO1-Anger Responded as Fear | C150941 | EMO1-Anger Responded as Fear | Emotion Recognition - Number of anger stimuli responded to as fear. | ERT - Anger Responded as Fear | ||
EMO1-Anger Responded as Happiness | C150942 | EMO1-Anger Responded as Happiness | Emotion Recognition - Number of anger stimuli responded to as happiness. | ERT - Anger Responded as Happiness | ||
EMO1-Anger Responded as Neutral | C150943 | EMO1-Anger Responded as Neutral | Emotion Recognition - Number of anger stimuli responded to as neutral. | ERT - Anger Responded as Neutral | ||
EMO1-Anger Responded as Sadness | C150944 | EMO1-Anger Responded as Sadness | Emotion Recognition - Number of anger stimuli responded to as sadness. | ERT - Anger Responded as Sadness | ||
EMO1-Anger Responded as Surprise | C150945 | EMO1-Anger Responded as Surprise | Emotion Recognition - Number of anger stimuli responded to as surprise. | ERT - Anger Responded as Surprise | ||
EMO1-Disgust Responded as Anger | C150947 | EMO1-Disgust Responded as Anger | Emotion Recognition - Number of disgust stimuli responded to as anger. | ERT - Disgust Responded as Anger | ||
EMO1-Disgust Responded as Disgust | C150948 | EMO1-Disgust Responded as Disgust | Emotion Recognition - Number of disgust stimuli responded to as disgust. | ERT - Disgust Responded as Disgust | ||
EMO1-Disgust Responded as Fear | C150949 | EMO1-Disgust Responded as Fear | Emotion Recognition - Number of disgust stimuli responded to as fear. | ERT - Disgust Responded as Fear | ||
EMO1-Disgust Responded as Happiness | C150950 | EMO1-Disgust Responded as Happiness | Emotion Recognition - Number of disgust stimuli responded to as happiness. | ERT - Disgust Responded as Happiness | ||
EMO1-Disgust Responded as Neutral | C150951 | EMO1-Disgust Responded as Neutral | Emotion Recognition - Number of disgust stimuli responded to as neutral. | ERT - Disgust Responded as Neutral | ||
EMO1-Disgust Responded as Sadness | C150952 | EMO1-Disgust Responded as Sadness | Emotion Recognition - Number of disgust stimuli responded to as sadness. | ERT - Disgust Responded as Sadness | ||
EMO1-Disgust Responded as Surprise | C150953 | EMO1-Disgust Responded as Surprise | Emotion Recognition - Number of disgust stimuli responded to as surprise. | ERT - Disgust Responded as Surprise | ||
EMO1-Fear Responded as Anger | C150955 | EMO1-Fear Responded as Anger | Emotion Recognition - Number of fear stimuli responded to as anger. | ERT - Fear Responded as Anger | ||
EMO1-Fear Responded as Disgust | C150956 | EMO1-Fear Responded as Disgust | Emotion Recognition - Number of fear stimuli responded to as disgust. | ERT - Fear Responded as Disgust | ||
EMO1-Fear Responded as Fear | C150957 | EMO1-Fear Responded as Fear | Emotion Recognition - Number of fear stimuli responded to as fear. | ERT - Fear Responded as Fear | ||
EMO1-Fear Responded as Happiness | C150958 | EMO1-Fear Responded as Happiness | Emotion Recognition - Number of fear stimuli responded to as happiness. | ERT - Fear Responded as Happiness | ||
EMO1-Fear Responded as Neutral | C150959 | EMO1-Fear Responded as Neutral | Emotion Recognition - Number of fear stimuli responded to as neutral. | ERT - Fear Responded as Neutral | ||
EMO1-Fear Responded as Sadness | C150960 | EMO1-Fear Responded as Sadness | Emotion Recognition - Number of fear stimuli responded to as sadness. | ERT - Fear Responded as Sadness | ||
EMO1-Fear Responded as Surprise | C150961 | EMO1-Fear Responded as Surprise | Emotion Recognition - Number of fear stimuli responded to as surprise. | ERT - Fear Responded as Surprise | ||
EMO1-Happiness Responded as Anger | C150963 | EMO1-Happiness Responded as Anger | Emotion Recognition - Number of happiness stimuli responded to as anger. | ERT - Happiness Responded as Anger | ||
EMO1-Happiness Responded as Disgust | C150964 | EMO1-Happiness Responded as Disgust | Emotion Recognition - Number of happiness stimuli responded to as disgust. | ERT - Happiness Responded as Disgust | ||
EMO1-Happiness Responded as Fear | C150965 | EMO1-Happiness Responded as Fear | Emotion Recognition - Number of happiness stimuli responded to as fear. | ERT - Happiness Responded as Fear | ||
EMO1-Happiness Responded as Happiness | C150966 | EMO1-Happiness Responded as Happiness | Emotion Recognition - Number of happiness stimuli responded to as happiness. | ERT - Happiness Responded as Happiness | ||
EMO1-Happiness Responded as Neutral | C150967 | EMO1-Happiness Responded as Neutral | Emotion Recognition - Number of happiness stimuli responded to as neutral. | ERT - Happiness Responded as Neutral | ||
EMO1-Happiness Responded as Sadness | C150968 | EMO1-Happiness Responded as Sadness | Emotion Recognition - Number of happiness stimuli responded to as sadness. | ERT - Happiness Responded as Sadness | ||
EMO1-Happiness Responded as Surprise | C150969 | EMO1-Happiness Responded as Surprise | Emotion Recognition - Number of happiness stimuli responded to as surprise. | ERT - Happiness Responded as Surprise | ||
EMO1-Neutral Responded as Anger | C150971 | EMO1-Neutral Responded as Anger | Emotion Recognition - Number of neutral stimuli responded to as anger. | ERT - Neutral Responded as Anger | ||
EMO1-Neutral Responded as Disgust | C150972 | EMO1-Neutral Responded as Disgust | Emotion Recognition - Number of neutral stimuli responded to as disgust. | ERT - Neutral Responded as Disgust | ||
EMO1-Neutral Responded as Fear | C150973 | EMO1-Neutral Responded as Fear | Emotion Recognition - Number of neutral stimuli responded to as fear. | ERT - Neutral Responded as Fear | ||
EMO1-Neutral Responded as Happiness | C150974 | EMO1-Neutral Responded as Happiness | Emotion Recognition - Number of neutral stimuli responded to as happiness. | ERT - Neutral Responded as Happiness | ||
EMO1-Neutral Responded as Neutral | C150975 | EMO1-Neutral Responded as Neutral | Emotion Recognition - Number of neutral stimuli responded to as neutral. | ERT - Neutral Responded as Neutral | ||
EMO1-Neutral Responded as Sadness | C150976 | EMO1-Neutral Responded as Sadness | Emotion Recognition - Number of neutral stimuli responded to as sadness. | ERT - Neutral Responded as Sadness | ||
EMO1-Neutral Responded as Surprise | C150977 | EMO1-Neutral Responded as Surprise | Emotion Recognition - Number of neutral stimuli responded to as surprise. | ERT - Neutral Responded as Surprise | ||
EMO1-Number Stimuli Portraying Anger | C150938 | EMO1-Number Stimuli Portraying Anger | Emotion Recognition - Number of stimuli defined as portraying anger. | ERT - Number Stimuli Portraying Anger | ||
EMO1-Number Stimuli Portraying Disgust | C150946 | EMO1-Number Stimuli Portraying Disgust | Emotion Recognition - Number of stimuli defined as portraying disgust. | ERT - Number Stimuli Portraying Disgust | ||
EMO1-Number Stimuli Portraying Fear | C150954 | EMO1-Number Stimuli Portraying Fear | Emotion Recognition - Number of stimuli defined as portraying fear. | ERT - Number Stimuli Portraying Fear | ||
EMO1-Number Stimuli Portraying Happiness | C150962 | EMO1-Number Stimuli Portraying Happiness | Emotion Recognition - Number of stimuli defined as portraying happiness. | ERT - Number Stimuli Portraying Happiness | ||
EMO1-Number Stimuli Portraying Neutral | C150970 | EMO1-Number Stimuli Portraying Neutral | Emotion Recognition - Number of stimuli defined as portraying a neutral expression. | ERT - Number Stimuli Portraying Neutral | ||
EMO1-Number Stimuli Portraying Sadness | C150978 | EMO1-Number Stimuli Portraying Sadness | Emotion Recognition - Number of stimuli defined as portraying sadness. | ERT - Number Stimuli Portraying Sadness | ||
EMO1-Number Stimuli Portraying Surprise | C150986 | EMO1-Number Stimuli Portraying Surprise | Emotion Recognition - Number of stimuli defined as portraying surprise. | ERT - Number Stimuli Portraying Surprise | ||
EMO1-Sadness Responded as Anger | C150979 | EMO1-Sadness Responded as Anger | Emotion Recognition - Number of sadness stimuli responded to as anger. | ERT - Sadness Responded as Anger | ||
EMO1-Sadness Responded as Disgust | C150980 | EMO1-Sadness Responded as Disgust | Emotion Recognition - Number of sadness stimuli responded to as disgust. | ERT - Sadness Responded as Disgust | ||
EMO1-Sadness Responded as Fear | C150981 | EMO1-Sadness Responded as Fear | Emotion Recognition - Number of sadness stimuli responded to as fear. | ERT - Sadness Responded as Fear | ||
EMO1-Sadness Responded as Happiness | C150982 | EMO1-Sadness Responded as Happiness | Emotion Recognition - Number of sadness stimuli responded to as happiness. | ERT - Sadness Responded as Happiness | ||
EMO1-Sadness Responded as Neutral | C150983 | EMO1-Sadness Responded as Neutral | Emotion Recognition - Number of sadness stimuli responded to as neutral. | ERT - Sadness Responded as Neutral | ||
EMO1-Sadness Responded as Sadness | C150984 | EMO1-Sadness Responded as Sadness | Emotion Recognition - Number of sadness stimuli responded to as sadness. | ERT - Sadness Responded as Sadness | ||
EMO1-Sadness Responded as Surprise | C150985 | EMO1-Sadness Responded as Surprise | Emotion Recognition - Number of sadness stimuli responded to as surprise. | ERT - Sadness Responded as Surprise | ||
EMO1-Surprise Responded as Anger | C150987 | EMO1-Surprise Responded as Anger | Emotion Recognition - Number of surprise stimuli responded to as anger. | ERT - Surprise Responded as Anger | ||
EMO1-Surprise Responded as Disgust | C150988 | EMO1-Surprise Responded as Disgust | Emotion Recognition - Number of surprise stimuli responded to as disgust. | ERT - Surprise Responded as Disgust | ||
EMO1-Surprise Responded as Fear | C150989 | EMO1-Surprise Responded as Fear | Emotion Recognition - Number of surprise stimuli responded to as fear. | ERT - Surprise Responded as Fear | ||
EMO1-Surprise Responded as Happiness | C150990 | EMO1-Surprise Responded as Happiness | Emotion Recognition - Number of surprise stimuli responded to as happiness. | ERT - Surprise Responded as Happiness | ||
EMO1-Surprise Responded as Neutral | C150991 | EMO1-Surprise Responded as Neutral | Emotion Recognition - Number of surprise stimuli responded to as neutral. | ERT - Surprise Responded as Neutral | ||
EMO1-Surprise Responded as Sadness | C150992 | EMO1-Surprise Responded as Sadness | Emotion Recognition - Number of surprise stimuli responded to as sadness. | ERT - Surprise Responded as Sadness | ||
EMO1-Surprise Responded as Surprise | C150993 | EMO1-Surprise Responded as Surprise | Emotion Recognition - Number of surprise stimuli responded to as surprise. | ERT - Surprise Responded as Surprise | ||
EMO1-Total Negative Stimuli Administered | C150933 | EMO1-Total Negative Stimuli Administered | Emotion Recognition - Total number of negative emotion stimuli (face images) actually administered in the task. | ERT - Total Negative Stimuli Administered | ||
EMO1-Total Negative Stimuli Completed | C150934 | EMO1-Total Negative Stimuli Completed | Emotion Recognition - Total number of negative emotion stimuli (face images) actually completed in the task. | ERT - Total Negative Stimuli Completed | ||
EMO1-Total Negative Stimuli Correct | C150935 | EMO1-Total Negative Stimuli Correct | Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant's response was correct. | ERT - Total Negative Stimuli Correct | ||
EMO1-Total Negative Stimuli Expected | C150932 | EMO1-Total Negative Stimuli Expected | Emotion Recognition - Total number of negative emotion stimuli (face images) expected to be administered in the task. | ERT - Total Negative Stimuli Expected | ||
EMO1-Total Negative Stimuli Incorrect | C150936 | EMO1-Total Negative Stimuli Incorrect | Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant's response was incorrect. | ERT - Total Negative Stimuli Incorrect | ||
EMO1-Total Negative Stimuli Not Respond | C150937 | EMO1-Total Negative Stimuli Not Respond | Emotion Recognition - Total number of negative emotion stimuli (face images) for which the participant has not responded. | ERT - Total Negative Stimuli Not Respond | ||
EMO1-Total Stimuli Administered | C150927 | EMO1-Total Stimuli Administered | Emotion Recognition - Total number of stimuli (face images) actually administered in the task. | ERT - Total Stimuli Administered | ||
EMO1-Total Stimuli Completed | C150928 | EMO1-Total Stimuli Completed | Emotion Recognition - Total number of stimuli (face images) actually completed in the task. | ERT - Total Stimuli Completed | ||
EMO1-Total Stimuli Expected | C150926 | EMO1-Total Stimuli Expected | Emotion Recognition - Total number of stimuli (face images) expected to be administered in the task. | ERT - Total Stimuli Expected | ||
EMO1-Total Stimuli Not Responded | C150931 | EMO1-Total Stimuli Not Responded | Emotion Recognition - Total number of stimuli (face images) for which the participant has not responded. | ERT - Total Stimuli Not Responded | ||
EMO1-Total Stimuli Response Correct | C150929 | EMO1-Total Stimuli Response Correct | Emotion Recognition - Total number of stimuli (face images) for which the participant's response was correct. | ERT - Total Stimuli Response Correct | ||
EMO1-Total Stimuli Response Incorrect | C150930 | EMO1-Total Stimuli Response Incorrect | Emotion Recognition - Total number of stimuli (face images) for which the participant's response was incorrect. | ERT - Total Stimuli Response Incorrect | ||
Back to top | ||||||
CL.C111108.EMPSTAT | Employment Status
(EMPSTAT) | text
Extensible: Yes | C111108 | Employment Status | Terminology relevant to the state of being engaged in an activity or service for wages or salary. | CDISC SDTM Employment Status Terminology |
FULL-TIME | C52658 | Employment involving the standard or customary working time. | Full Time Employment | |||
NOT EMPLOYED | C75563 | The state of not having a job. | Unemployed | |||
PART-TIME | C75562 | Employment involving less than the standard or customary working time. | Part Time Employment | |||
Back to top | ||||||
CL.C127262.SETTING | Environmental Setting
(SETTING) | text
Extensible: Yes | C127262 | Environmental Setting | Terminology relevant to the surroundings or environment. | CDISC SDTM Environmental Setting Terminology |
CHILD CARE CENTER | C127785 | An establishment that provides care for infants and children. | Childcare Center | |||
CLINIC | C51282 | A health care facility where subjects or patients may receive assessments, procedures, or treatments that are provided by physicians and other healthcare providers. | Clinic | |||
FARM | C48953 | A tract of land cultivated for the purpose of agricultural production or devoted to the raising and breeding of domestic animals. | Farm | |||
FIELD | C102650 | A setting outside the clinic or a comparable health care facility, e.g. a doctor's office, the subject's home or workplace, a school, a public park, or a restaurant. | In the Field | |||
HEALTH FACILITY | C21541 | The buildings and organizations where healthcare services are provided. | Healthcare Facility | |||
HOME | C18002 | A person's place of residence. | Home | |||
HOSPITAL | C16696 | An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured. | Hospital | |||
HOUSEHOLD ENVIRONMENT | C102647 | The area in which an individual lives. | Household Environment | |||
INSTITUTION | C41206 | An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization. | Institution | |||
MOTOR VEHICLE | C181529 | A motorized conveyance for people and goods. | Motor Vehicle | |||
NON-HOUSEHOLD ENVIRONMENT | C102679 | An area outside of that in which an individual lives. | Non-household Environment | |||
NOT IN CLINIC | C181530 | Any environmental setting outside of a clinic. | Not In Clinic | |||
OUTPATIENT CLINIC | C16281 | A medical care center that provides healthcare services on an outpatient basis. | Ambulatory Care Facility | |||
PRISON | C85862 | An institution where persons are confined for punishment and to protect the public. | Correctional Institution | |||
SCHOOL | C17118 | An educational institution. | School | |||
SHELTER | C85863 | Temporary housing for displaced or at-risk persons. | Shelter | |||
SOCIAL SETTING | C102712 | The surroundings or environment in which social activities occur. | Social Setting | |||
WORKSITE | C17556 | Place or physical location of work or employment. | Worksite | |||
Back to top | ||||||
CL.C99079.EPOCH | Epoch
(EPOCH) | text
Extensible: Yes | C99079 | Epoch | The name of the EPOCH. | CDISC SDTM Epoch Terminology |
BASELINE | C125938 | A period in a clinical study after eligibility has been met and before the start of treatment, at which baseline measurements are collected. | Baseline Epoch | |||
BLINDED TREATMENT | C102255 | A period in a clinical study during which subjects receive blinded therapeutic treatment. | Blinded Treatment Epoch | |||
CONTINUATION TREATMENT | C123452 | Continuation Phase | A period in a clinical study during which subjects receive continuation treatment. | Continuation Therapy Epoch | ||
FOLLOW-UP | C99158 | A period in a clinical study during which information about the health status of an individual is obtained after study interventions have concluded. | Clinical Study Follow-up | |||
INDUCTION TREATMENT | C123453 | Induction Phase;Intensive Phase | A period in a clinical study during which subjects receive induction treatment. | Induction Therapy Epoch | ||
LONG-TERM FOLLOW-UP | C16032 | A period in a clinical study during which information about the health status of an individual is obtained long after study interventions have concluded. | Long-term Follow-up | |||
OBSERVATION | C165873 | A period in a clinical study during which subjects are observed, without any planned intervention. | Observation Study Epoch | |||
OPEN LABEL TREATMENT | C102256 | A period in a clinical study during which subjects receive open label therapeutic treatment. | Open Label Treatment Epoch | |||
RUN-IN | C98779 | A period in a clinical study that occurs after screening and before randomization, during which the subject is further evaluated and/or prepared for the commencement of the clinical study investigation. | Run-in Period | |||
SCREENING | C48262 | A period in a clinical study during which subjects are evaluated for participation in the study. | Trial Screening | |||
TREATMENT | C101526 | A period in a study during which subjects are receiving investigational therapy or treatment. | Treatment Epoch | |||
WASHOUT | C42872 | A period of time during a study when a subject is taken off of the investigational therapy or treatment in order to reduce the amount of investigational product within the body. | Washout Period | |||
Back to top | ||||||
CL.C103463.ESS01TC | Epworth Sleepiness Scale Questionnaire Test Code
(ESS01TC) | text
Extensible: No | C103463 | Epworth Sleepiness Scale Questionnaire Test Code | Epworth Sleepiness Scale test code. | CDISC Questionnaire ESS Test Code Terminology |
ESS0101 | C103536 | ESS01-Sitting and Reading | Epworth Sleepiness Scale - Sitting and reading. | ESS - Sitting and Reading | ||
ESS0102 | C103537 | ESS01-Watching TV | Epworth Sleepiness Scale - Watching TV. | ESS - Watching TV | ||
ESS0103 | C103538 | ESS01-Sitting Inactive in a Public Place | Epworth Sleepiness Scale - Sitting, inactive in a public place (e.g. a theatre or a meeting). | ESS - Sitting, Inactive in a Public Place | ||
ESS0104 | C103539 | ESS01-Passenger for Hour Without Break | Epworth Sleepiness Scale - As a passenger in a car for an hour without a break. | ESS - As a Passenger in a Car for an Hour Without a Break | ||
ESS0105 | C103540 | ESS01-Lying Down to Rest In Afternoon | Epworth Sleepiness Scale - Lying down to rest in the afternoon when circumstances permit. | ESS - Lying Down to Rest in the Afternoon When Circumstances Permit | ||
ESS0106 | C103541 | ESS01-Sitting and Talking to Someone | Epworth Sleepiness Scale - Sitting and talking to someone. | ESS - Sitting and Talking to Someone | ||
ESS0107 | C103542 | ESS01-Sitting Quietly After Lunch | Epworth Sleepiness Scale - Sitting quietly after a lunch without alcohol. | ESS - Sitting Quietly After a Lunch without Alcohol | ||
ESS0108 | C103543 | ESS01-In Car Stopped Few Minutes Traffic | Epworth Sleepiness Scale - In a car, while stopped for a few minutes in the traffic. | ESS - In a car, While Stopped for a Few Minutes in the Traffic | ||
ESS0109 | C157731 | ESS01-Total Score | Epworth Sleepiness Scale - Total score. | ESS - Total Score | ||
Back to top | ||||||
CL.C103462.ESS01TN | Epworth Sleepiness Scale Questionnaire Test Name
(ESS01TN) | text
Extensible: No | C103462 | Epworth Sleepiness Scale Questionnaire Test Name | Epworth Sleepiness Scale test name. | CDISC Questionnaire ESS Test Name Terminology |
ESS01-In Car Stopped Few Minutes Traffic | C103543 | ESS01-In Car Stopped Few Minutes Traffic | Epworth Sleepiness Scale - In a car, while stopped for a few minutes in the traffic. | ESS - In a car, While Stopped for a Few Minutes in the Traffic | ||
ESS01-Lying Down to Rest In Afternoon | C103540 | ESS01-Lying Down to Rest In Afternoon | Epworth Sleepiness Scale - Lying down to rest in the afternoon when circumstances permit. | ESS - Lying Down to Rest in the Afternoon When Circumstances Permit | ||
ESS01-Passenger for Hour Without Break | C103539 | ESS01-Passenger for Hour Without Break | Epworth Sleepiness Scale - As a passenger in a car for an hour without a break. | ESS - As a Passenger in a Car for an Hour Without a Break | ||
ESS01-Sitting and Reading | C103536 | ESS01-Sitting and Reading | Epworth Sleepiness Scale - Sitting and reading. | ESS - Sitting and Reading | ||
ESS01-Sitting and Talking to Someone | C103541 | ESS01-Sitting and Talking to Someone | Epworth Sleepiness Scale - Sitting and talking to someone. | ESS - Sitting and Talking to Someone | ||
ESS01-Sitting Inactive in a Public Place | C103538 | ESS01-Sitting Inactive in a Public Place | Epworth Sleepiness Scale - Sitting, inactive in a public place (e.g. a theatre or a meeting). | ESS - Sitting, Inactive in a Public Place | ||
ESS01-Sitting Quietly After Lunch | C103542 | ESS01-Sitting Quietly After Lunch | Epworth Sleepiness Scale - Sitting quietly after a lunch without alcohol. | ESS - Sitting Quietly After a Lunch without Alcohol | ||
ESS01-Total Score | C157731 | ESS01-Total Score | Epworth Sleepiness Scale - Total score. | ESS - Total Score | ||
ESS01-Watching TV | C103537 | ESS01-Watching TV | Epworth Sleepiness Scale - Watching TV. | ESS - Watching TV | ||
Back to top | ||||||
CL.C66790.ETHNIC | Ethnic Group
(ETHNIC) | text
Extensible: No | C66790 | Ethnic Group | A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI) | CDISC SDTM Ethnic Group Terminology |
HISPANIC OR LATINO | C17459 | A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race. (NCI) | Hispanic or Latino | |||
NOT HISPANIC OR LATINO | C41222 | A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI) | Not Hispanic or Latino | |||
NOT REPORTED | C43234 | Not reported | Not provided or available. | Not Reported | ||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C128690.ETHNICC | Ethnicity As Collected
(ETHNICC) | text
Extensible: Yes | C128690 | Ethnicity As Collected | A terminology codelist relevant to the ethnicity of an individual as collected on the case report form. | CDISC SDTM Collected Ethnicity Terminology |
ACHANG | C158197 | AC | A Chinese person from the Achang ethnic group. | Achang Chinese | ||
ASHKENAZI JEW | C17950 | A person of Ashkenazi Jewish descent. | Ashkenazi Jew | |||
BAI | C158171 | BA | A Chinese person from the Bai ethnic group. | Bai Chinese | ||
BLANG | C158193 | BL | A Chinese person from the Blang ethnic group. | Blang Chinese | ||
BONAN | C158203 | BN | A Chinese person from the Bonan ethnic group. | Bonan Chinese | ||
BUYEI | C158169 | BY | A Chinese person from the Buyei ethnic group. | Buyei Chinese | ||
CENTRAL AMERICAN | C67118 | A person of Central American descent. | Central American | |||
CHOSEN | C158172 | CS | A Chinese person from the Chosen ethnic group. | Chosen Chinese | ||
CUBAN AMERICAN | C67115 | A person of Cuban and American descent. | Cuban or Cuban American | |||
CUBAN | C107608 | A person of Cuban descent. | Cuban | |||
DAI | C158176 | DA | A Chinese person from the Dai (including several different Tai-speaking groups historically referred to as Bai-yi) ethnic group. | Dai Chinese | ||
DAUR | C158191 | DU | A Chinese person from the Daur ethnic group. | Daur Chinese | ||
DEANG | C158202 | DE | A Chinese person from the Deang ethnic group. | Deang Chinese | ||
DERUNG | C158209 | DR | A Chinese person from the Derung ethnic group. | Derung Chinese | ||
DONG | C158168 | DO | A Chinese person from the Dong ethnic group. | Dong Chinese | ||
DONGXIANG | C158179 | DX | A Chinese person from the Dongxiang ethnic group. | Dongxiang Chinese | ||
EWENKI | C158199 | EW | A Chinese person from the Ewenki ethnic group. | Ewenki Chinese | ||
GAOSHAN | C158211 | GS | A Chinese person from the Gaoshan ethnic group. | Gaoshan Chinese | ||
GELAO | C158180 | GL | A Chinese person from the Gelao ethnic group. | Gelao Chinese | ||
GIN | C158200 | GI | A Chinese person from the Gin ethnic group. | Gin Chinese | ||
HAN | C158158 | HA | A Chinese person from the Han ethnic group (including Chuanqing). | Han Chinese | ||
HANI | C158173 | HN | A Chinese person from the Hani (including Sangkong) ethnic group. | Hani Chinese | ||
HEZHEN | C158210 | HZ | A Chinese person from the Hezhen ethnic group. | Hezhen Chinese | ||
HISPANIC OR LATINO | C17459 | A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race. (NCI) | Hispanic or Latino | |||
HUI | C158160 | HU | A Chinese person from the Hui (including Utsuls of Hainan, descended from Cham refugees) ethnic group. | Hui Chinese | ||
JINGPO | C158190 | JP | A Chinese person from the Jingpo ethnic group. | Jingpo Chinese | ||
JINO | C158201 | JN | A Chinese person from the Jino ethnic group. | Jino Chinese | ||
KAZAK | C158175 | KZ | A Chinese person from the Kazak ethnic group. | Kazak Chinese | ||
KIRGIZ | C158189 | KG | A Chinese person from the Kirgiz ethnic group. | Kirgiz Chinese | ||
LAHU | C158181 | LH | A Chinese person from the Lahu ethnic group. | Lahu Chinese | ||
LATIN AMERICAN | C126531 | A person of Latin American descent. | Latin American | |||
LHOBA | C158212 | LB | A Chinese person from the Lhoba ethnic group. | Lhoba Chinese | ||
LI | C158174 | LI | A Chinese person from the Li ethnic group. | Li Chinese | ||
LISU | C158178 | LS | A Chinese person from the Lisu ethnic group. | Lisu Chinese | ||
MAN | C158161 | MA | A Chinese person from the Man ethnic group. | Man Chinese | ||
MAONAN | C158194 | MN | A Chinese person from the Maonan (including the Then) ethnic group. | Maonan Chinese | ||
MEXICAN AMERICAN | C67114 | A person of Mexican and American descent. | Mexican American | |||
MEXICAN | C67113 | A person of Mexican descent. | Mexican | |||
MIAO | C158163 | MH | A Chinese person from the Miao (Including Hmong) ethnic group. | Miao Chinese | ||
MONBA | C158207 | MB | A Chinese person from the Monba ethnic group. | Monba Chinese | ||
MONGOL | C158167 | MG | A Chinese person from the Mongol ethnic group. | Mongol Chinese | ||
MULAO | C158187 | ML | A Chinese person from the Mulao (including the Qago) ethnic group. | Mulao Chinese | ||
NAXI | C158184 | NX | A Chinese person from the Naxi (including Mosuo) ethnic group. | Naxi Chinese | ||
NOT HISPANIC OR LATINO | C41222 | A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI) | Not Hispanic or Latino | |||
NOT REPORTED | C43234 | Not reported | Not provided or available. | Not Reported | ||
NU | C158198 | NU | A Chinese person from the Nu ethnic group. | Nu Chinese | ||
OROQEN | C158208 | OR | A Chinese person from the Oroqen ethnic group. | Oroqen Chinese | ||
PUERTO RICAN | C67112 | A person of Puerto Rican descent. | Puerto Rican | |||
PUMI | C158196 | PM | A Chinese person from the Pumi ethnic group. | Pumi Chinese | ||
QIANG | C158185 | QI | A Chinese person from the Qiang ethnic group. | Qiang Chinese | ||
RUSS | C158204 | RS | A Chinese person from the Russ ethnic group. | Russ Chinese | ||
SALAR | C158192 | SL | A Chinese person from the Salar ethnic group. | Salar Chinese | ||
SEPHARDIC JEW | C103283 | A person of Sephardic Jewish descent. | Sephardic Jew | |||
SHE | C158177 | SH | A Chinese person from the She ethnic group. | She Chinese | ||
SOUTH AMERICAN | C126532 | A person of South American descent. | South American | |||
SPANISH | C67120 | A person from Spain or of Spanish descent. | Spanish | |||
SUI | C158183 | SU | A Chinese person from the Sui ethnic group. | Sui Chinese | ||
TAJIK | C158195 | TA | A Chinese person from the Tajik ethnic group. | Tajik Chinese | ||
TATAR | C158213 | TT | A Chinese person from the Tatar ethnic group. | Tatar Chinese | ||
TU | C158186 | TU | A Chinese person from the Tu ethnic group. | Tu Chinese | ||
TUJIA | C158165 | TJ | A Chinese person from the Tujia ethnic group. | Tujia Chinese | ||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
UYGUR | C158162 | UG | A Chinese person from the Uygur ethnic group. | Uygur Chinese | ||
UZBEK | C158206 | UZ | A Chinese person from the Uzbek ethnic group. | Uzbek Chinese | ||
VA | C158182 | VA | A Chinese person from the Va ethnic group. | Va Chinese | ||
XIBE | C158188 | XB | A Chinese person from the Xibe ethnic group. | Xibe Chinese | ||
YAO | C158170 | YA | A Chinese person from the Yao ethnic group. | Yao Chinese | ||
YI | C158164 | YI | A Chinese person from the Yi ethnic group. | Yi Chinese | ||
YUGUR | C158205 | YG | A Chinese person from the Yugur ethnic group. | Yugur Chinese | ||
ZANG | C158166 | ZA | A Chinese person from the Zang (including Amdowa, Khampa and some Pumi speakers) ethnic group. | Zang Chinese | ||
ZHUANG | C158159 | ZH | A Chinese person from the Zhuang ethnic group. | Zhuang Chinese | ||
Back to top | ||||||
CL.C170525.EOR06TC | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 Questionnaire Test Code
(EOR06TC) | text
Extensible: No | C170525 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 Questionnaire Test Code | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 test code. | CDISC Questionnaire EORTC QLQ-CR29 Version 2.1 Test Code Terminology |
EOR0631 | C170657 | EOR06-Urinate Frequently During Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you urinate frequently during the day? | EORTC QLQ-CR29 Version 2.1 - Urinate Frequently During Day | ||
EOR0632 | C170658 | EOR06-Urinate Frequently During Night | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you urinate frequently during the night? | EORTC QLQ-CR29 Version 2.1 - Urinate Frequently During Night | ||
EOR0633 | C170659 | EOR06-Unintentional Release of Urine | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had any unintentional release (leakage) of urine? | EORTC QLQ-CR29 Version 2.1 - Unintentional Release of Urine | ||
EOR0634 | C170660 | EOR06-Pain When You Urinated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have pain when you urinated? | EORTC QLQ-CR29 Version 2.1 - Pain When You Urinated | ||
EOR0635 | C170661 | EOR06-Did You Have Abdominal Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have abdominal pain? | EORTC QLQ-CR29 Version 2.1 - Did You Have Abdominal Pain | ||
EOR0636 | C170662 | EOR06-Pain in Buttocks/Anal Area/Rectum | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have pain in your buttocks/anal area/rectum? | EORTC QLQ-CR29 Version 2.1 - Pain in Buttocks/Anal Area/Rectum | ||
EOR0637 | C170663 | EOR06-Bloated Feeling in Your Abdomen | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have a bloated feeling in your abdomen? | EORTC QLQ-CR29 Version 2.1 - Bloated Feeling in Your Abdomen | ||
EOR0638 | C170664 | EOR06-Have You Had Blood in Your Stools | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had blood in your stools? | EORTC QLQ-CR29 Version 2.1 - Have You Had Blood in Your Stools | ||
EOR0639 | C170665 | EOR06-Have You Had Mucus in Your Stools | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had mucus in your stools? | EORTC QLQ-CR29 Version 2.1 - Have You Had Mucus in Your Stools | ||
EOR0640 | C170666 | EOR06-Did You Have a Dry Mouth | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have a dry mouth? | EORTC QLQ-CR29 Version 2.1 - Did You Have a Dry Mouth | ||
EOR0641 | C170667 | EOR06-Lost Hair as Result of Treatment | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you lost hair as a result of your treatment? | EORTC QLQ-CR29 Version 2.1 - Lost Hair as Result of Treatment | ||
EOR0642 | C170668 | EOR06-Problems With Your Sense of Taste | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had problems with your sense of taste? | EORTC QLQ-CR29 Version 2.1 - Problems With Your Sense of Taste | ||
EOR0643 | C170669 | EOR06-Worried About Your Health Future | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Were you worried about your health in the future? | EORTC QLQ-CR29 Version 2.1 - Worried About Your Health Future | ||
EOR0644 | C170670 | EOR06-Worried About Your Weight | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you worried about your weight? | EORTC QLQ-CR29 Version 2.1 - Worried About Your Weight | ||
EOR0645 | C170671 | EOR06-Felt Physically Less Attractive | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you felt physically less attractive as a result of your disease or treatment? | EORTC QLQ-CR29 Version 2.1 - Felt Physically Less Attractive | ||
EOR0646 | C170672 | EOR06-Feeling Less Feminine/Masculine | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you been feeling less feminine/masculine as a result of your disease or treatment? | EORTC QLQ-CR29 Version 2.1 - Feeling Less Feminine/Masculine | ||
EOR0647 | C170673 | EOR06-Been Dissatisfied With Your Body | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you been dissatisfied with your body? | EORTC QLQ-CR29 Version 2.1 - Been Dissatisfied With Your Body | ||
EOR0648 | C170674 | EOR06-Do You Have Stoma Bag | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Do you have a stoma bag (colostomy/ileostomy)? | EORTC QLQ-CR29 Version 2.1 - Do You Have Stoma Bag | ||
EOR06491 | C170675 | EOR06-Unintentional Gas From Stoma Bag | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had unintentional release of gas/flatulence from your stoma bag? | EORTC QLQ-CR29 Version 2.1 - Unintentional Gas From Stoma Bag | ||
EOR06492 | C170682 | EOR06-Unintentional Gas Back Passage | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had unintentional release of gas/flatulence from your back passage? | EORTC QLQ-CR29 Version 2.1 - Unintentional Gas Back Passage | ||
EOR06501 | C170676 | EOR06-Leakage of Stools From Stoma Bag | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had leakage of stools from your stoma bag? | EORTC QLQ-CR29 Version 2.1 - Leakage of Stools From Stoma Bag | ||
EOR06502 | C170683 | EOR06-Leakage of Stools Back Passage | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had leakage of stools from your back passage? | EORTC QLQ-CR29 Version 2.1 - Leakage of Stools Back Passage | ||
EOR06511 | C170677 | EOR06-Sore Skin Around Your Stoma | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had sore skin around your stoma? | EORTC QLQ-CR29 Version 2.1 - Sore Skin Around Your Stoma | ||
EOR06512 | C170684 | EOR06-Sore Skin Around Your Anal Area | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had sore skin around your anal area? | EORTC QLQ-CR29 Version 2.1 - Sore Skin Around Your Anal Area | ||
EOR06521 | C170678 | EOR06-Frequent Bag Changes During Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did frequent bag changes occur during the day? | EORTC QLQ-CR29 Version 2.1 - Frequent Bag Changes During Day | ||
EOR06522 | C170685 | EOR06-Frequent Bowel Movements Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did frequent bowel movements occur during the day? | EORTC QLQ-CR29 Version 2.1 - Frequent Bowel Movements Day | ||
EOR06531 | C170679 | EOR06-Frequent Bag Changes During Night | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did frequent bag changes occur during the night? | EORTC QLQ-CR29 Version 2.1 - Frequent Bag Changes During Night | ||
EOR06532 | C170686 | EOR06-Frequent Bowel Movements Night | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did frequent bowel movements occur during the night? | EORTC QLQ-CR29 Version 2.1 - Frequent Bowel Movements Night | ||
EOR06541 | C170680 | EOR06-Feel Embarrassed Because of Stoma | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you feel embarrassed because of your stoma? | EORTC QLQ-CR29 Version 2.1 - Feel Embarrassed Because of Stoma | ||
EOR06542 | C170687 | EOR06-Embarrassed Because Bowel Movement | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you feel embarrassed because of your bowel movement? | EORTC QLQ-CR29 Version 2.1 - Embarrassed Because Bowel Movement | ||
EOR06551 | C170681 | EOR06-Problems Caring for Your Stoma | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have problems caring for your stoma? | EORTC QLQ-CR29 Version 2.1 - Problems Caring for Your Stoma | ||
EOR0656 | C170688 | EOR06-Men: Extent Interested in Sex | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past 4 weeks: For men only: To what extent were you interested in sex? | EORTC QLQ-CR29 Version 2.1 - Men: Extent Interested in Sex | ||
EOR0657 | C170689 | EOR06-Men: Difficulty Getting Erection | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past 4 weeks: For men only: Did you have difficulty getting or maintaining an erection? | EORTC QLQ-CR29 Version 2.1 - Men: Difficulty Getting Erection | ||
EOR0658 | C170690 | EOR06-Women: Extent Interested in Sex | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past 4 weeks: For women only: To what extent were you interested in sex? | EORTC QLQ-CR29 Version 2.1 - Women: Extent Interested in Sex | ||
EOR0659 | C170691 | EOR06-Women: Pain/Discomfort Intercourse | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past 4 weeks: For women only: Did you have pain or discomfort during intercourse? | EORTC QLQ-CR29 Version 2.1 - Women: Pain or Discomfort Intercourse | ||
Back to top | ||||||
CL.C170524.EOR06TN | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 Questionnaire Test Name
(EOR06TN) | text
Extensible: No | C170524 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 Questionnaire Test Name | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 test name. | CDISC Questionnaire EORTC QLQ-CR29 Version 2.1 Test Name Terminology |
EOR06-Been Dissatisfied With Your Body | C170673 | EOR06-Been Dissatisfied With Your Body | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you been dissatisfied with your body? | EORTC QLQ-CR29 Version 2.1 - Been Dissatisfied With Your Body | ||
EOR06-Bloated Feeling in Your Abdomen | C170663 | EOR06-Bloated Feeling in Your Abdomen | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have a bloated feeling in your abdomen? | EORTC QLQ-CR29 Version 2.1 - Bloated Feeling in Your Abdomen | ||
EOR06-Did You Have a Dry Mouth | C170666 | EOR06-Did You Have a Dry Mouth | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have a dry mouth? | EORTC QLQ-CR29 Version 2.1 - Did You Have a Dry Mouth | ||
EOR06-Did You Have Abdominal Pain | C170661 | EOR06-Did You Have Abdominal Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have abdominal pain? | EORTC QLQ-CR29 Version 2.1 - Did You Have Abdominal Pain | ||
EOR06-Do You Have Stoma Bag | C170674 | EOR06-Do You Have Stoma Bag | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Do you have a stoma bag (colostomy/ileostomy)? | EORTC QLQ-CR29 Version 2.1 - Do You Have Stoma Bag | ||
EOR06-Embarrassed Because Bowel Movement | C170687 | EOR06-Embarrassed Because Bowel Movement | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you feel embarrassed because of your bowel movement? | EORTC QLQ-CR29 Version 2.1 - Embarrassed Because Bowel Movement | ||
EOR06-Feel Embarrassed Because of Stoma | C170680 | EOR06-Feel Embarrassed Because of Stoma | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you feel embarrassed because of your stoma? | EORTC QLQ-CR29 Version 2.1 - Feel Embarrassed Because of Stoma | ||
EOR06-Feeling Less Feminine/Masculine | C170672 | EOR06-Feeling Less Feminine/Masculine | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you been feeling less feminine/masculine as a result of your disease or treatment? | EORTC QLQ-CR29 Version 2.1 - Feeling Less Feminine/Masculine | ||
EOR06-Felt Physically Less Attractive | C170671 | EOR06-Felt Physically Less Attractive | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you felt physically less attractive as a result of your disease or treatment? | EORTC QLQ-CR29 Version 2.1 - Felt Physically Less Attractive | ||
EOR06-Frequent Bag Changes During Day | C170678 | EOR06-Frequent Bag Changes During Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did frequent bag changes occur during the day? | EORTC QLQ-CR29 Version 2.1 - Frequent Bag Changes During Day | ||
EOR06-Frequent Bag Changes During Night | C170679 | EOR06-Frequent Bag Changes During Night | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did frequent bag changes occur during the night? | EORTC QLQ-CR29 Version 2.1 - Frequent Bag Changes During Night | ||
EOR06-Frequent Bowel Movements Day | C170685 | EOR06-Frequent Bowel Movements Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did frequent bowel movements occur during the day? | EORTC QLQ-CR29 Version 2.1 - Frequent Bowel Movements Day | ||
EOR06-Frequent Bowel Movements Night | C170686 | EOR06-Frequent Bowel Movements Night | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did frequent bowel movements occur during the night? | EORTC QLQ-CR29 Version 2.1 - Frequent Bowel Movements Night | ||
EOR06-Have You Had Blood in Your Stools | C170664 | EOR06-Have You Had Blood in Your Stools | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had blood in your stools? | EORTC QLQ-CR29 Version 2.1 - Have You Had Blood in Your Stools | ||
EOR06-Have You Had Mucus in Your Stools | C170665 | EOR06-Have You Had Mucus in Your Stools | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had mucus in your stools? | EORTC QLQ-CR29 Version 2.1 - Have You Had Mucus in Your Stools | ||
EOR06-Leakage of Stools Back Passage | C170683 | EOR06-Leakage of Stools Back Passage | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had leakage of stools from your back passage? | EORTC QLQ-CR29 Version 2.1 - Leakage of Stools Back Passage | ||
EOR06-Leakage of Stools From Stoma Bag | C170676 | EOR06-Leakage of Stools From Stoma Bag | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had leakage of stools from your stoma bag? | EORTC QLQ-CR29 Version 2.1 - Leakage of Stools From Stoma Bag | ||
EOR06-Lost Hair as Result of Treatment | C170667 | EOR06-Lost Hair as Result of Treatment | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you lost hair as a result of your treatment? | EORTC QLQ-CR29 Version 2.1 - Lost Hair as Result of Treatment | ||
EOR06-Men: Difficulty Getting Erection | C170689 | EOR06-Men: Difficulty Getting Erection | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past 4 weeks: For men only: Did you have difficulty getting or maintaining an erection? | EORTC QLQ-CR29 Version 2.1 - Men: Difficulty Getting Erection | ||
EOR06-Men: Extent Interested in Sex | C170688 | EOR06-Men: Extent Interested in Sex | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past 4 weeks: For men only: To what extent were you interested in sex? | EORTC QLQ-CR29 Version 2.1 - Men: Extent Interested in Sex | ||
EOR06-Pain in Buttocks/Anal Area/Rectum | C170662 | EOR06-Pain in Buttocks/Anal Area/Rectum | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have pain in your buttocks/anal area/rectum? | EORTC QLQ-CR29 Version 2.1 - Pain in Buttocks/Anal Area/Rectum | ||
EOR06-Pain When You Urinated | C170660 | EOR06-Pain When You Urinated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have pain when you urinated? | EORTC QLQ-CR29 Version 2.1 - Pain When You Urinated | ||
EOR06-Problems Caring for Your Stoma | C170681 | EOR06-Problems Caring for Your Stoma | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you have problems caring for your stoma? | EORTC QLQ-CR29 Version 2.1 - Problems Caring for Your Stoma | ||
EOR06-Problems With Your Sense of Taste | C170668 | EOR06-Problems With Your Sense of Taste | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had problems with your sense of taste? | EORTC QLQ-CR29 Version 2.1 - Problems With Your Sense of Taste | ||
EOR06-Sore Skin Around Your Anal Area | C170684 | EOR06-Sore Skin Around Your Anal Area | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had sore skin around your anal area? | EORTC QLQ-CR29 Version 2.1 - Sore Skin Around Your Anal Area | ||
EOR06-Sore Skin Around Your Stoma | C170677 | EOR06-Sore Skin Around Your Stoma | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had sore skin around your stoma? | EORTC QLQ-CR29 Version 2.1 - Sore Skin Around Your Stoma | ||
EOR06-Unintentional Gas Back Passage | C170682 | EOR06-Unintentional Gas Back Passage | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had unintentional release of gas/flatulence from your back passage? | EORTC QLQ-CR29 Version 2.1 - Unintentional Gas Back Passage | ||
EOR06-Unintentional Gas From Stoma Bag | C170675 | EOR06-Unintentional Gas From Stoma Bag | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had unintentional release of gas/flatulence from your stoma bag? | EORTC QLQ-CR29 Version 2.1 - Unintentional Gas From Stoma Bag | ||
EOR06-Unintentional Release of Urine | C170659 | EOR06-Unintentional Release of Urine | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you had any unintentional release (leakage) of urine? | EORTC QLQ-CR29 Version 2.1 - Unintentional Release of Urine | ||
EOR06-Urinate Frequently During Day | C170657 | EOR06-Urinate Frequently During Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you urinate frequently during the day? | EORTC QLQ-CR29 Version 2.1 - Urinate Frequently During Day | ||
EOR06-Urinate Frequently During Night | C170658 | EOR06-Urinate Frequently During Night | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Did you urinate frequently during the night? | EORTC QLQ-CR29 Version 2.1 - Urinate Frequently During Night | ||
EOR06-Women: Extent Interested in Sex | C170690 | EOR06-Women: Extent Interested in Sex | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past 4 weeks: For women only: To what extent were you interested in sex? | EORTC QLQ-CR29 Version 2.1 - Women: Extent Interested in Sex | ||
EOR06-Women: Pain/Discomfort Intercourse | C170691 | EOR06-Women: Pain/Discomfort Intercourse | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past 4 weeks: For women only: Did you have pain or discomfort during intercourse? | EORTC QLQ-CR29 Version 2.1 - Women: Pain or Discomfort Intercourse | ||
EOR06-Worried About Your Health Future | C170669 | EOR06-Worried About Your Health Future | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Were you worried about your health in the future? | EORTC QLQ-CR29 Version 2.1 - Worried About Your Health Future | ||
EOR06-Worried About Your Weight | C170670 | EOR06-Worried About Your Weight | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Colorectal Version 2.1 - During the past week: Have you worried about your weight? | EORTC QLQ-CR29 Version 2.1 - Worried About Your Weight | ||
Back to top | ||||||
CL.C161619.EOR01TC | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 Questionnaire Test Code
(EOR01TC) | text
Extensible: No | C161619 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 Questionnaire Test Code | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 test code. | CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Code Terminology |
EOR0101 | C161674 | EOR01-Trouble Doing Strenuous Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble doing strenuous activities, like carrying a heavy shopping bag or a suitcase? | EORTC QLQ-C30 Version 3 - Trouble Doing Strenuous Activities | ||
EOR0102 | C161675 | EOR01-Trouble Taking Long Walk | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble taking a long walk? | EORTC QLQ-C30 Version 3 - Trouble Taking Long Walk | ||
EOR0103 | C161676 | EOR01-Trouble Taking Short Walk Outside | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble taking a short walk outside of the house? | EORTC QLQ-C30 Version 3 - Trouble Taking Short Walk Outside | ||
EOR0104 | C161677 | EOR01-Stay in Bed/Chair During the Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you need to stay in bed or a chair during the day? | EORTC QLQ-C30 Version 3 - Stay in Bed or Chair During the Day | ||
EOR0105 | C161678 | EOR01-Need Help Eating/Dressing/Washing | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you need help with eating, dressing, washing yourself or using the toilet? | EORTC QLQ-C30 Version 3 - Need Help Eating, Dressing, Washing | ||
EOR0106 | C161679 | EOR01-Limited in Work/Daily Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you limited in doing either your work or other daily activities? | EORTC QLQ-C30 Version 3 - Limited in Work or Daily Activities | ||
EOR0107 | C161680 | EOR01-Limited Hobbies/Leisure Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you limited in pursuing your hobbies or other leisure time activities? | EORTC QLQ-C30 Version 3 - Limited Hobbies or Leisure Activities | ||
EOR0108 | C161681 | EOR01-Were You Short of Breath | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you short of breath? | EORTC QLQ-C30 Version 3 - Were You Short of Breath | ||
EOR0109 | C161682 | EOR01-Have You Had Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had pain? | EORTC QLQ-C30 Version 3 - Have You Had Pain | ||
EOR0110 | C161683 | EOR01-Did You Need to Rest | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you need to rest? | EORTC QLQ-C30 Version 3 - Did You Need to Rest | ||
EOR0111 | C161684 | EOR01-Have You Had Trouble Sleeping | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had trouble sleeping? | EORTC QLQ-C30 Version 3 - Have You Had Trouble Sleeping | ||
EOR0112 | C161685 | EOR01-Have You Felt Weak | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you felt weak? | EORTC QLQ-C30 Version 3 - Have You Felt Weak | ||
EOR0113 | C161686 | EOR01-Have You Lacked Appetite | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you lacked appetite? | EORTC QLQ-C30 Version 3 - Have You Lacked Appetite | ||
EOR0114 | C161687 | EOR01-Have You Felt Nauseated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you felt nauseated? | EORTC QLQ-C30 Version 3 - Have You Felt Nauseated | ||
EOR0115 | C161688 | EOR01-Have You Vomited | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you vomited? | EORTC QLQ-C30 Version 3 - Have You Vomited | ||
EOR0116 | C161689 | EOR01-Have You Been Constipated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you been constipated? | EORTC QLQ-C30 Version 3 - Have You Been Constipated | ||
EOR0117 | C161690 | EOR01-Have You Had Diarrhea | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had diarrhea? | EORTC QLQ-C30 Version 3 - Have You Had Diarrhea | ||
EOR0118 | C161691 | EOR01-Were You Tired | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you tired? | EORTC QLQ-C30 Version 3 - Were You Tired | ||
EOR0119 | C161692 | EOR01-Pain Interfere Daily Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did pain interfere with your daily activities? | EORTC QLQ-C30 Version 3 - Pain Interfere Daily Activities | ||
EOR0120 | C161693 | EOR01-Difficulty Concentrating on Things | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had difficulty in concentrating on things, like reading a newspaper or watching television? | EORTC QLQ-C30 Version 3 - Difficulty Concentrating on Things | ||
EOR0121 | C161694 | EOR01-Did You Feel Tense | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel tense? | EORTC QLQ-C30 Version 3 - Did You Feel Tense | ||
EOR0122 | C161695 | EOR01-Did You Worry | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you worry? | EORTC QLQ-C30 Version 3 - Did You Worry | ||
EOR0123 | C161696 | EOR01-Did You Feel Irritable | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel irritable? | EORTC QLQ-C30 Version 3 - Did You Feel Irritable | ||
EOR0124 | C161697 | EOR01-Did You Feel Depressed | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel depressed? | EORTC QLQ-C30 Version 3 - Did You Feel Depressed | ||
EOR0125 | C161698 | EOR01-Had Difficulty Remembering Things | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had difficulty remembering things? | EORTC QLQ-C30 Version 3 - Had Difficulty Remembering Things | ||
EOR0126 | C161699 | EOR01-Condition Interfered Family Life | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment interfered with your family life? | EORTC QLQ-C30 Version 3 - Condition Interfered Family Life | ||
EOR0127 | C161700 | EOR01-Condition Interfered Social Activ | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment interfered with your social activities? | EORTC QLQ-C30 Version 3 - Condition Interfered Social Activities | ||
EOR0128 | C161701 | EOR01-Condition Caused Financial Diff | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment caused you financial difficulties? | EORTC QLQ-C30 Version 3 - Condition Caused Financial Difficulties | ||
EOR0129 | C161702 | EOR01-Rate Your Overall Health | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - How would you rate your overall health during the past week? | EORTC QLQ-C30 Version 3 - Rate Your Overall Health | ||
EOR0130 | C161703 | EOR01-Rate Your Overall Quality of Life | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - How would you rate your overall quality of life during the past week? | EORTC QLQ-C30 Version 3 - Rate Your Overall Quality of Life | ||
EOR0131 | C181142 | EOR01-Global Health Status/QoL | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Global health status/QoL. | EORTC QLQ-C30 Version 3 - EOR01-Global Health Status/QoL | ||
EOR0132 | C181143 | EOR01-FS:Physical Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: physical functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Physical Functioning | ||
EOR0133 | C181144 | EOR01-FS:Role Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: role functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Role Functioning | ||
EOR0134 | C181145 | EOR01-FS:Emotional Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: emotional functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Emotional Functioning | ||
EOR0135 | C181146 | EOR01-FS:Cognitive Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: cognitive functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Cognitive Functioning | ||
EOR0136 | C181147 | EOR01-FS:Social Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: social functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Social Functioning | ||
EOR0137 | C181148 | EOR01-SS:Fatigue | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: fatigue. | EORTC QLQ-C30 Version 3 - EOR01-SS:Fatigue | ||
EOR0138 | C181149 | EOR01-SS:Nausea and Vomiting | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: nausea and vomiting. | EORTC QLQ-C30 Version 3 - EOR01-SS:Nausea and Vomiting | ||
EOR0139 | C181150 | EOR01-SS:Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: pain. | EORTC QLQ-C30 Version 3 - EOR01-SS:Pain | ||
EOR0140 | C181151 | EOR01-SS:Dyspnoea | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: dyspnoea. | EORTC QLQ-C30 Version 3 - EOR01-SS:Dyspnoea | ||
EOR0141 | C181152 | EOR01-SS:Insomnia | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: insomnia. | EORTC QLQ-C30 Version 3 - EOR01-SS:Insomnia | ||
EOR0142 | C181153 | EOR01-SS:Appetite Loss | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: appetite loss. | EORTC QLQ-C30 Version 3 - EOR01-SS:Appetite Loss | ||
EOR0143 | C181154 | EOR01-SS:Constipation | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: constipation. | EORTC QLQ-C30 Version 3 - EOR01-SS:Constipation | ||
EOR0144 | C181155 | EOR01-SS:Diarrhoea | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: diarrhoea. | EORTC QLQ-C30 Version 3 - EOR01-SS:Diarrhoea | ||
EOR0145 | C181156 | EOR01-SS:Financial Difficulties | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: financial difficulties. | EORTC QLQ-C30 Version 3 - EOR01-SS:Financial Difficulties | ||
Back to top | ||||||
CL.C161618.EOR01TN | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 Questionnaire Test Name
(EOR01TN) | text
Extensible: No | C161618 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 Questionnaire Test Name | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 test name. | CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Name Terminology |
EOR01-Condition Caused Financial Diff | C161701 | EOR01-Condition Caused Financial Diff | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment caused you financial difficulties? | EORTC QLQ-C30 Version 3 - Condition Caused Financial Difficulties | ||
EOR01-Condition Interfered Family Life | C161699 | EOR01-Condition Interfered Family Life | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment interfered with your family life? | EORTC QLQ-C30 Version 3 - Condition Interfered Family Life | ||
EOR01-Condition Interfered Social Activ | C161700 | EOR01-Condition Interfered Social Activ | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Has your physical condition or medical treatment interfered with your social activities? | EORTC QLQ-C30 Version 3 - Condition Interfered Social Activities | ||
EOR01-Did You Feel Depressed | C161697 | EOR01-Did You Feel Depressed | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel depressed? | EORTC QLQ-C30 Version 3 - Did You Feel Depressed | ||
EOR01-Did You Feel Irritable | C161696 | EOR01-Did You Feel Irritable | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel irritable? | EORTC QLQ-C30 Version 3 - Did You Feel Irritable | ||
EOR01-Did You Feel Tense | C161694 | EOR01-Did You Feel Tense | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you feel tense? | EORTC QLQ-C30 Version 3 - Did You Feel Tense | ||
EOR01-Did You Need to Rest | C161683 | EOR01-Did You Need to Rest | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you need to rest? | EORTC QLQ-C30 Version 3 - Did You Need to Rest | ||
EOR01-Did You Worry | C161695 | EOR01-Did You Worry | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did you worry? | EORTC QLQ-C30 Version 3 - Did You Worry | ||
EOR01-Difficulty Concentrating on Things | C161693 | EOR01-Difficulty Concentrating on Things | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had difficulty in concentrating on things, like reading a newspaper or watching television? | EORTC QLQ-C30 Version 3 - Difficulty Concentrating on Things | ||
EOR01-FS:Cognitive Functioning | C181146 | EOR01-FS:Cognitive Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: cognitive functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Cognitive Functioning | ||
EOR01-FS:Emotional Functioning | C181145 | EOR01-FS:Emotional Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: emotional functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Emotional Functioning | ||
EOR01-FS:Physical Functioning | C181143 | EOR01-FS:Physical Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: physical functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Physical Functioning | ||
EOR01-FS:Role Functioning | C181144 | EOR01-FS:Role Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: role functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Role Functioning | ||
EOR01-FS:Social Functioning | C181147 | EOR01-FS:Social Functioning | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Functional scale: social functioning. | EORTC QLQ-C30 Version 3 - EOR01-FS:Social Functioning | ||
EOR01-Global Health Status/QoL | C181142 | EOR01-Global Health Status/QoL | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Global health status/QoL. | EORTC QLQ-C30 Version 3 - EOR01-Global Health Status/QoL | ||
EOR01-Had Difficulty Remembering Things | C161698 | EOR01-Had Difficulty Remembering Things | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had difficulty remembering things? | EORTC QLQ-C30 Version 3 - Had Difficulty Remembering Things | ||
EOR01-Have You Been Constipated | C161689 | EOR01-Have You Been Constipated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you been constipated? | EORTC QLQ-C30 Version 3 - Have You Been Constipated | ||
EOR01-Have You Felt Nauseated | C161687 | EOR01-Have You Felt Nauseated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you felt nauseated? | EORTC QLQ-C30 Version 3 - Have You Felt Nauseated | ||
EOR01-Have You Felt Weak | C161685 | EOR01-Have You Felt Weak | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you felt weak? | EORTC QLQ-C30 Version 3 - Have You Felt Weak | ||
EOR01-Have You Had Diarrhea | C161690 | EOR01-Have You Had Diarrhea | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had diarrhea? | EORTC QLQ-C30 Version 3 - Have You Had Diarrhea | ||
EOR01-Have You Had Pain | C161682 | EOR01-Have You Had Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had pain? | EORTC QLQ-C30 Version 3 - Have You Had Pain | ||
EOR01-Have You Had Trouble Sleeping | C161684 | EOR01-Have You Had Trouble Sleeping | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you had trouble sleeping? | EORTC QLQ-C30 Version 3 - Have You Had Trouble Sleeping | ||
EOR01-Have You Lacked Appetite | C161686 | EOR01-Have You Lacked Appetite | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you lacked appetite? | EORTC QLQ-C30 Version 3 - Have You Lacked Appetite | ||
EOR01-Have You Vomited | C161688 | EOR01-Have You Vomited | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Have you vomited? | EORTC QLQ-C30 Version 3 - Have You Vomited | ||
EOR01-Limited Hobbies/Leisure Activities | C161680 | EOR01-Limited Hobbies/Leisure Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you limited in pursuing your hobbies or other leisure time activities? | EORTC QLQ-C30 Version 3 - Limited Hobbies or Leisure Activities | ||
EOR01-Limited in Work/Daily Activities | C161679 | EOR01-Limited in Work/Daily Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you limited in doing either your work or other daily activities? | EORTC QLQ-C30 Version 3 - Limited in Work or Daily Activities | ||
EOR01-Need Help Eating/Dressing/Washing | C161678 | EOR01-Need Help Eating/Dressing/Washing | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you need help with eating, dressing, washing yourself or using the toilet? | EORTC QLQ-C30 Version 3 - Need Help Eating, Dressing, Washing | ||
EOR01-Pain Interfere Daily Activities | C161692 | EOR01-Pain Interfere Daily Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Did pain interfere with your daily activities? | EORTC QLQ-C30 Version 3 - Pain Interfere Daily Activities | ||
EOR01-Rate Your Overall Health | C161702 | EOR01-Rate Your Overall Health | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - How would you rate your overall health during the past week? | EORTC QLQ-C30 Version 3 - Rate Your Overall Health | ||
EOR01-Rate Your Overall Quality of Life | C161703 | EOR01-Rate Your Overall Quality of Life | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - How would you rate your overall quality of life during the past week? | EORTC QLQ-C30 Version 3 - Rate Your Overall Quality of Life | ||
EOR01-SS:Appetite Loss | C181153 | EOR01-SS:Appetite Loss | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: appetite loss. | EORTC QLQ-C30 Version 3 - EOR01-SS:Appetite Loss | ||
EOR01-SS:Constipation | C181154 | EOR01-SS:Constipation | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: constipation. | EORTC QLQ-C30 Version 3 - EOR01-SS:Constipation | ||
EOR01-SS:Diarrhoea | C181155 | EOR01-SS:Diarrhoea | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: diarrhoea. | EORTC QLQ-C30 Version 3 - EOR01-SS:Diarrhoea | ||
EOR01-SS:Dyspnoea | C181151 | EOR01-SS:Dyspnoea | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: dyspnoea. | EORTC QLQ-C30 Version 3 - EOR01-SS:Dyspnoea | ||
EOR01-SS:Fatigue | C181148 | EOR01-SS:Fatigue | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: fatigue. | EORTC QLQ-C30 Version 3 - EOR01-SS:Fatigue | ||
EOR01-SS:Financial Difficulties | C181156 | EOR01-SS:Financial Difficulties | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: financial difficulties. | EORTC QLQ-C30 Version 3 - EOR01-SS:Financial Difficulties | ||
EOR01-SS:Insomnia | C181152 | EOR01-SS:Insomnia | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: insomnia. | EORTC QLQ-C30 Version 3 - EOR01-SS:Insomnia | ||
EOR01-SS:Nausea and Vomiting | C181149 | EOR01-SS:Nausea and Vomiting | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: nausea and vomiting. | EORTC QLQ-C30 Version 3 - EOR01-SS:Nausea and Vomiting | ||
EOR01-SS:Pain | C181150 | EOR01-SS:Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Symptom scale: pain. | EORTC QLQ-C30 Version 3 - EOR01-SS:Pain | ||
EOR01-Stay in Bed/Chair During the Day | C161677 | EOR01-Stay in Bed/Chair During the Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you need to stay in bed or a chair during the day? | EORTC QLQ-C30 Version 3 - Stay in Bed or Chair During the Day | ||
EOR01-Trouble Doing Strenuous Activities | C161674 | EOR01-Trouble Doing Strenuous Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble doing strenuous activities, like carrying a heavy shopping bag or a suitcase? | EORTC QLQ-C30 Version 3 - Trouble Doing Strenuous Activities | ||
EOR01-Trouble Taking Long Walk | C161675 | EOR01-Trouble Taking Long Walk | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble taking a long walk? | EORTC QLQ-C30 Version 3 - Trouble Taking Long Walk | ||
EOR01-Trouble Taking Short Walk Outside | C161676 | EOR01-Trouble Taking Short Walk Outside | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - Do you have any trouble taking a short walk outside of the house? | EORTC QLQ-C30 Version 3 - Trouble Taking Short Walk Outside | ||
EOR01-Were You Short of Breath | C161681 | EOR01-Were You Short of Breath | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you short of breath? | EORTC QLQ-C30 Version 3 - Were You Short of Breath | ||
EOR01-Were You Tired | C161691 | EOR01-Were You Tired | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0 - During the past week: Were you tired? | EORTC QLQ-C30 Version 3 - Were You Tired | ||
Back to top | ||||||
CL.C172400.EOR18TC | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module Questionnaire Test Code
(EOR18TC) | text
Extensible: No | C172400 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module Questionnaire Test Code | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module test code. | CDISC Questionnaire EORTC QLQ-LC13 Test Code Terminology |
EOR1831 | C172403 | EOR18-How Much Did You Cough | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - How much did you cough? | EORTC QLQ-LC13 - How Much Did You Cough | ||
EOR1832 | C172404 | EOR18-Did You Cough Up Blood | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Did you cough up blood? | EORTC QLQ-LC13 - Did You Cough Up Blood | ||
EOR1833 | C172405 | EOR18-Short of Breath When Rested | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Were you short of breath when you rested? | EORTC QLQ-LC13 - Short of Breath When Rested | ||
EOR1834 | C172406 | EOR18-Short of Breath When Walked | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Were you short of breath when you walked? | EORTC QLQ-LC13 - Short of Breath When Walked | ||
EOR1835 | C172407 | EOR18-Short of Breath Climbed Stairs | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Were you short of breath when you climbed stairs? | EORTC QLQ-LC13 - Short of Breath Climbed Stairs | ||
EOR1836 | C172408 | EOR18-Had a Sore Mouth or Tongue | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had a sore mouth or tongue? | EORTC QLQ-LC13 - Had a Sore Mouth or Tongue | ||
EOR1837 | C172409 | EOR18-Have You Had Trouble Swallowing | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had trouble swallowing? | EORTC QLQ-LC13 - Have You Had Trouble Swallowing | ||
EOR1838 | C172410 | EOR18-Had Tingling Hands or Feet | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had tingling hands or feet? | EORTC QLQ-LC13 - Had Tingling Hands or Feet | ||
EOR1839 | C172411 | EOR18-Have You Had Hair Loss | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had hair loss? | EORTC QLQ-LC13 - Have You Had Hair Loss | ||
EOR1840 | C172412 | EOR18-Have You Had Pain in Your Chest | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had pain in your chest? | EORTC QLQ-LC13 - Have You Had Pain in Your Chest | ||
EOR1841 | C172413 | EOR18-Had Pain in Your Arm or Shoulder | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had pain in your arm or shoulder? | EORTC QLQ-LC13 - Had Pain in Your Arm or Shoulder | ||
EOR1842 | C172414 | EOR18-Had Pain in Other Parts of Body | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had pain in other parts of your body? | EORTC QLQ-LC13 - Had Pain in Other Parts of Body | ||
EOR1842A | C172415 | EOR18-If Yes, Where | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - If yes, where. | EORTC QLQ-LC13 - If Yes, Where | ||
EOR1843 | C172416 | EOR18-Did You Take Any Medicine for Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Did you take any medicine for pain? | EORTC QLQ-LC13 - Did You Take Any Medicine for Pain | ||
EOR1843A | C172417 | EOR18-If Yes, How Much Did It Help | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - If yes, how much did it help? | EORTC QLQ-LC13 - If Yes, How Much Did It Help | ||
Back to top | ||||||
CL.C172399.EOR18TN | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module Questionnaire Test Name
(EOR18TN) | text
Extensible: No | C172399 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module Questionnaire Test Name | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module test name. | CDISC Questionnaire EORTC QLQ-LC13 Test Name Terminology |
EOR18-Did You Cough Up Blood | C172404 | EOR18-Did You Cough Up Blood | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Did you cough up blood? | EORTC QLQ-LC13 - Did You Cough Up Blood | ||
EOR18-Did You Take Any Medicine for Pain | C172416 | EOR18-Did You Take Any Medicine for Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Did you take any medicine for pain? | EORTC QLQ-LC13 - Did You Take Any Medicine for Pain | ||
EOR18-Had a Sore Mouth or Tongue | C172408 | EOR18-Had a Sore Mouth or Tongue | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had a sore mouth or tongue? | EORTC QLQ-LC13 - Had a Sore Mouth or Tongue | ||
EOR18-Had Pain in Other Parts of Body | C172414 | EOR18-Had Pain in Other Parts of Body | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had pain in other parts of your body? | EORTC QLQ-LC13 - Had Pain in Other Parts of Body | ||
EOR18-Had Pain in Your Arm or Shoulder | C172413 | EOR18-Had Pain in Your Arm or Shoulder | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had pain in your arm or shoulder? | EORTC QLQ-LC13 - Had Pain in Your Arm or Shoulder | ||
EOR18-Had Tingling Hands or Feet | C172410 | EOR18-Had Tingling Hands or Feet | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had tingling hands or feet? | EORTC QLQ-LC13 - Had Tingling Hands or Feet | ||
EOR18-Have You Had Hair Loss | C172411 | EOR18-Have You Had Hair Loss | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had hair loss? | EORTC QLQ-LC13 - Have You Had Hair Loss | ||
EOR18-Have You Had Pain in Your Chest | C172412 | EOR18-Have You Had Pain in Your Chest | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had pain in your chest? | EORTC QLQ-LC13 - Have You Had Pain in Your Chest | ||
EOR18-Have You Had Trouble Swallowing | C172409 | EOR18-Have You Had Trouble Swallowing | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Have you had trouble swallowing? | EORTC QLQ-LC13 - Have You Had Trouble Swallowing | ||
EOR18-How Much Did You Cough | C172403 | EOR18-How Much Did You Cough | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - How much did you cough? | EORTC QLQ-LC13 - How Much Did You Cough | ||
EOR18-If Yes, How Much Did It Help | C172417 | EOR18-If Yes, How Much Did It Help | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - If yes, how much did it help? | EORTC QLQ-LC13 - If Yes, How Much Did It Help | ||
EOR18-If Yes, Where | C172415 | EOR18-If Yes, Where | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - If yes, where. | EORTC QLQ-LC13 - If Yes, Where | ||
EOR18-Short of Breath Climbed Stairs | C172407 | EOR18-Short of Breath Climbed Stairs | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Were you short of breath when you climbed stairs? | EORTC QLQ-LC13 - Short of Breath Climbed Stairs | ||
EOR18-Short of Breath When Rested | C172405 | EOR18-Short of Breath When Rested | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Were you short of breath when you rested? | EORTC QLQ-LC13 - Short of Breath When Rested | ||
EOR18-Short of Breath When Walked | C172406 | EOR18-Short of Breath When Walked | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Lung Cancer Module - Were you short of breath when you walked? | EORTC QLQ-LC13 - Short of Breath When Walked | ||
Back to top | ||||||
CL.C161617.EOR02TC | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 Questionnaire Test Code
(EOR02TC) | text
Extensible: No | C161617 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 Questionnaire Test Code | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 test code. | CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Code Terminology |
EOR0201 | C161659 | EOR02-Trouble Taking Short Walk Outside | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you have any trouble taking a short walk outside of the house? | EORTC QLQ-C15-PAL Version 1 - Trouble Taking Short Walk Outside | ||
EOR0202 | C161660 | EOR02-Stay in Bed/Chair During the Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you need to stay in bed or a chair during the day? | EORTC QLQ-C15-PAL Version 1 - Stay in Bed or Chair During the Day | ||
EOR0203 | C161661 | EOR02-Need Help Eating/Dressing/Washing | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you need help with eating, dressing, washing yourself or using the toilet? | EORTC QLQ-C15-PAL Version 1 - Need Help Eating, Dressing, Washing | ||
EOR0204 | C161662 | EOR02-Were You Short of Breath | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Were you short of breath? | EORTC QLQ-C15-PAL Version 1 - Were You Short of Breath | ||
EOR0205 | C161663 | EOR02-Have You Had Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you had pain? | EORTC QLQ-C15-PAL Version 1 - Have You Had Pain | ||
EOR0206 | C161664 | EOR02-Have You Had Trouble Sleeping | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you had trouble sleeping? | EORTC QLQ-C15-PAL Version 1 - Have You Had Trouble Sleeping | ||
EOR0207 | C161665 | EOR02-Have You Felt Weak | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you felt weak? | EORTC QLQ-C15-PAL Version 1 - Have You Felt Weak | ||
EOR0208 | C161666 | EOR02-Have You Lacked Appetite | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you lacked appetite? | EORTC QLQ-C15-PAL Version 1 - Have You Lacked Appetite | ||
EOR0209 | C161667 | EOR02-Have You Felt Nauseated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you felt nauseated? | EORTC QLQ-C15-PAL Version 1 - Have You Felt Nauseated | ||
EOR0210 | C161668 | EOR02-Have You Been Constipated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you been constipated? | EORTC QLQ-C15-PAL Version 1 - Have You Been Constipated | ||
EOR0211 | C161669 | EOR02-Were You Tired | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Were you tired? | EORTC QLQ-C15-PAL Version 1 - Were You Tired | ||
EOR0212 | C161670 | EOR02-Pain Interfere Daily Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did pain interfere with your daily activities? | EORTC QLQ-C15-PAL Version 1 - Pain Interfere Daily Activities | ||
EOR0213 | C161671 | EOR02-Did You Feel Tense | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did you feel tense? | EORTC QLQ-C15-PAL Version 1 - Did You Feel Tense | ||
EOR0214 | C161672 | EOR02-Did You Feel Depressed | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did you feel depressed? | EORTC QLQ-C15-PAL Version 1 - Did You Feel Depressed | ||
EOR0215 | C161673 | EOR02-Rate Your Overall Quality of Life | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - How would you rate your overall quality of life during the past week? | EORTC QLQ-C15-PAL Version 1 - Rate Your Overall Quality of Life | ||
Back to top | ||||||
CL.C161616.EOR02TN | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 Questionnaire Test Name
(EOR02TN) | text
Extensible: No | C161616 | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 Questionnaire Test Name | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 test name. | CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Name Terminology |
EOR02-Did You Feel Depressed | C161672 | EOR02-Did You Feel Depressed | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did you feel depressed? | EORTC QLQ-C15-PAL Version 1 - Did You Feel Depressed | ||
EOR02-Did You Feel Tense | C161671 | EOR02-Did You Feel Tense | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did you feel tense? | EORTC QLQ-C15-PAL Version 1 - Did You Feel Tense | ||
EOR02-Have You Been Constipated | C161668 | EOR02-Have You Been Constipated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you been constipated? | EORTC QLQ-C15-PAL Version 1 - Have You Been Constipated | ||
EOR02-Have You Felt Nauseated | C161667 | EOR02-Have You Felt Nauseated | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you felt nauseated? | EORTC QLQ-C15-PAL Version 1 - Have You Felt Nauseated | ||
EOR02-Have You Felt Weak | C161665 | EOR02-Have You Felt Weak | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you felt weak? | EORTC QLQ-C15-PAL Version 1 - Have You Felt Weak | ||
EOR02-Have You Had Pain | C161663 | EOR02-Have You Had Pain | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you had pain? | EORTC QLQ-C15-PAL Version 1 - Have You Had Pain | ||
EOR02-Have You Had Trouble Sleeping | C161664 | EOR02-Have You Had Trouble Sleeping | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you had trouble sleeping? | EORTC QLQ-C15-PAL Version 1 - Have You Had Trouble Sleeping | ||
EOR02-Have You Lacked Appetite | C161666 | EOR02-Have You Lacked Appetite | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Have you lacked appetite? | EORTC QLQ-C15-PAL Version 1 - Have You Lacked Appetite | ||
EOR02-Need Help Eating/Dressing/Washing | C161661 | EOR02-Need Help Eating/Dressing/Washing | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you need help with eating, dressing, washing yourself or using the toilet? | EORTC QLQ-C15-PAL Version 1 - Need Help Eating, Dressing, Washing | ||
EOR02-Pain Interfere Daily Activities | C161670 | EOR02-Pain Interfere Daily Activities | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Did pain interfere with your daily activities? | EORTC QLQ-C15-PAL Version 1 - Pain Interfere Daily Activities | ||
EOR02-Rate Your Overall Quality of Life | C161673 | EOR02-Rate Your Overall Quality of Life | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - How would you rate your overall quality of life during the past week? | EORTC QLQ-C15-PAL Version 1 - Rate Your Overall Quality of Life | ||
EOR02-Stay in Bed/Chair During the Day | C161660 | EOR02-Stay in Bed/Chair During the Day | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you need to stay in bed or a chair during the day? | EORTC QLQ-C15-PAL Version 1 - Stay in Bed or Chair During the Day | ||
EOR02-Trouble Taking Short Walk Outside | C161659 | EOR02-Trouble Taking Short Walk Outside | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - Do you have any trouble taking a short walk outside of the house? | EORTC QLQ-C15-PAL Version 1 - Trouble Taking Short Walk Outside | ||
EOR02-Were You Short of Breath | C161662 | EOR02-Were You Short of Breath | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Were you short of breath? | EORTC QLQ-C15-PAL Version 1 - Were You Short of Breath | ||
EOR02-Were You Tired | C161669 | EOR02-Were You Tired | European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0 - During the past week: Were you tired? | EORTC QLQ-C15-PAL Version 1 - Were You Tired | ||
Back to top | ||||||
CL.C101817.EQ5D02TC | European Quality of Life Five Dimension Five Level Scale Questionnaire Test Code
(EQ5D02TC) | text
Extensible: No | C101817 | European Quality of Life Five Dimension Five Level Scale Questionnaire Test Code | European Quality of Life Five Dimension Five Level Scale test code. | CDISC Questionnaire EQ-5D-5L Test Code Terminology |
EQ5D0201 | C102067 | EQ5D02-Mobility | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Mobility. | EQ-5D-5L - Mobility | ||
EQ5D0202 | C102068 | EQ5D02-Self-Care | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Self-care. | EQ-5D-5L - Self-Care | ||
EQ5D0203 | C102069 | EQ5D02-Usual Activities | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Usual activities. | EQ-5D-5L - Usual Activities | ||
EQ5D0204 | C102070 | EQ5D02-Pain/Discomfort | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Pain/discomfort. | EQ-5D-5L - Pain or Discomfort | ||
EQ5D0205 | C102071 | EQ5D02-Anxiety/Depression | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Anxiety/depression. | EQ-5D-5L - Anxiety or Depression | ||
EQ5D0206 | C102072 | EQ5D02-EQ VAS Score | European Quality of Life Five Dimension Five Level Scale - Indicate how your health is today. | EQ-5D-5L - EQ VAS Score | ||
Back to top | ||||||
CL.C101818.EQ5D02TN | European Quality of Life Five Dimension Five Level Scale Questionnaire Test Name
(EQ5D02TN) | text
Extensible: No | C101818 | European Quality of Life Five Dimension Five Level Scale Questionnaire Test Name | European Quality of Life Five Dimension Five Level Scale test name. | CDISC Questionnaire EQ-5D-5L Test Name Terminology |
EQ5D02-Anxiety/Depression | C102071 | EQ5D02-Anxiety/Depression | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Anxiety/depression. | EQ-5D-5L - Anxiety or Depression | ||
EQ5D02-EQ VAS Score | C102072 | EQ5D02-EQ VAS Score | European Quality of Life Five Dimension Five Level Scale - Indicate how your health is today. | EQ-5D-5L - EQ VAS Score | ||
EQ5D02-Mobility | C102067 | EQ5D02-Mobility | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Mobility. | EQ-5D-5L - Mobility | ||
EQ5D02-Pain/Discomfort | C102070 | EQ5D02-Pain/Discomfort | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Pain/discomfort. | EQ-5D-5L - Pain or Discomfort | ||
EQ5D02-Self-Care | C102068 | EQ5D02-Self-Care | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Self-care. | EQ-5D-5L - Self-Care | ||
EQ5D02-Usual Activities | C102069 | EQ5D02-Usual Activities | European Quality of Life Five Dimension Five Level Scale - Check the one box that best describes your health today: Usual activities. | EQ-5D-5L - Usual Activities | ||
Back to top | ||||||
CL.C100136.EQ5D01TC | European Quality of Life Five Dimension Three Level Scale Questionnaire Test Code
(EQ5D01TC) | text
Extensible: No | C100136 | European Quality of Life Five Dimension Three Level Scale Questionnaire Test Code | European Quality of Life Five Dimension Three Level Scale test code. | CDISC Questionnaire EQ-5D-3L Test Code Terminology |
EQ5D0101 | C100392 | EQ5D01-Mobility | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Mobility. | EQ-5D-3L - Mobility | ||
EQ5D0102 | C100393 | EQ5D01-Self-Care | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Self-care. | EQ-5D-3L - Self-Care | ||
EQ5D0103 | C100394 | EQ5D01-Usual Activities | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Usual activities. | EQ-5D-3L - Usual Activities | ||
EQ5D0104 | C100395 | EQ5D01-Pain/Discomfort | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Pain/discomfort. | EQ-5D-3L - Pain or Discomfort | ||
EQ5D0105 | C100396 | EQ5D01-Anxiety/Depression | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Anxiety/depression. | EQ-5D-3L - Anxiety or Depression | ||
EQ5D0106 | C100397 | EQ5D01-EQ VAS Score | European Quality of Life Five Dimension Three Level Scale - Indicate on this scale how good or bad your own health is today, in your opinion. | EQ-5D-3L - EQ VAS Score | ||
Back to top | ||||||
CL.C100135.EQ5D01TN | European Quality of Life Five Dimension Three Level Scale Questionnaire Test Name
(EQ5D01TN) | text
Extensible: No | C100135 | European Quality of Life Five Dimension Three Level Scale Questionnaire Test Name | European Quality of Life Five Dimension Three Level Scale test name. | CDISC Questionnaire EQ-5D-3L Test Name Terminology |
EQ5D01-Anxiety/Depression | C100396 | EQ5D01-Anxiety/Depression | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Anxiety/depression. | EQ-5D-3L - Anxiety or Depression | ||
EQ5D01-EQ VAS Score | C100397 | EQ5D01-EQ VAS Score | European Quality of Life Five Dimension Three Level Scale - Indicate on this scale how good or bad your own health is today, in your opinion. | EQ-5D-3L - EQ VAS Score | ||
EQ5D01-Mobility | C100392 | EQ5D01-Mobility | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Mobility. | EQ-5D-3L - Mobility | ||
EQ5D01-Pain/Discomfort | C100395 | EQ5D01-Pain/Discomfort | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Pain/discomfort. | EQ-5D-3L - Pain or Discomfort | ||
EQ5D01-Self-Care | C100393 | EQ5D01-Self-Care | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Self-care. | EQ-5D-3L - Self-Care | ||
EQ5D01-Usual Activities | C100394 | EQ5D01-Usual Activities | European Quality of Life Five Dimension Three Level Scale - Indicate which statements best describe your own health state today: Usual activities. | EQ-5D-3L - Usual Activities | ||
Back to top | ||||||
CL.C78735.EVAL | Evaluator
(EVAL) | text
Extensible: Yes | C78735 | Evaluator | Terminology relevant to the role of the person(s) providing an evaluation, appraisal, or interpretation. | CDISC SDTM Evaluator Terminology |
ADJUDICATION COMMITTEE | C78726 | An external committee whose purpose is to evaluate study data and decide whether a study endpoint or other criterion has been met. (NCI) | Adjudication Committee | |||
ADJUDICATOR | C96561 | An individual that presides over and arbitrates between individuals or organizations. | Adjudicator | |||
AUDIOLOGIST | C51804 | A healthcare professional trained in the diagnosis and treatment of hearing loss and other auditory and balance disorders. | Audiologist | |||
CARDIOLOGIST | C125951 | A physician who specializes in the diagnosis and treatment of heart disorders. | Cardiologist | |||
CAREGIVER | C17445 | Caregiver;Caretaker | The primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI) | Caregiver | ||
CERTIFIED ASSESSOR | C189311 | A person authorized through certification to perform an evaluation or assessment. | Certified Assessor | |||
CHILD | C150886 | A biological or non-biological first generation offspring, including but not limited to biological children (including those born outside of marriage), adopted children, step children, and foster children. (NCI) | Child Relation | |||
CLINICAL PATHOLOGIST | C142332 | A physician specializing in medical diagnosis based on laboratory analysis and the macroscopic and the microscopic changes to tissues and organs caused by disease. | Clinical Pathologist | |||
CLINICAL RESEARCH ASSOCIATE | C25465 | Research Associate | A person who is employed by a study sponsor or by a contract research organization (CRO), operates independently from the clinical study site and functions as a monitor, and/or auditor, and/or a project director within a particular trial or institution. (NCI) | Clinical Research Associate | ||
CLINICAL RESEARCH COORDINATOR | C51811 | CRC | A person to whom a clinical investigator delegates routine administrative requirements of a protocol. The duties and responsibilities of a clinical research coordinator may vary across different infrastructures. Generally, the coordinator manages the subject's clinical trial participation and provides a vital linkage between the subject, the investigator, and the sponsor. (NCI) | Clinical Coordinator | ||
CLINICAL STUDY SPONSOR | C70793 | Clinical Study Sponsor;Sponsor;Study Sponsor | An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] | Clinical Study Sponsor | ||
DERMATOLOGIST | C17816 | A doctor who specializes in diagnosis and treatment of skin conditions. | Dermatologist | |||
DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN | C147461 | A pediatrician who specializes in diagnosing and treating developmental and behavioral disorders in children. | Developmental Behavioral Pediatrician | |||
DEVELOPMENTAL PSYCHOLOGIST | C147462 | A psychologist who specializes in diagnosing and treating emotional and behavioral problems associated with developmental delay or disability. | Developmental Psychologist | |||
DOMESTIC PARTNER | C53262 | Domestic Partner | Person declares that a domestic partnership relationship exists. (HL7) | Domestic Partnership | ||
ENDOCRINOLOGIST | C17817 | A physician who specializes in diagnosing and treating conditions affecting the endocrine system. | Endocrinologist | |||
FAMILY MEMBER | C41256 | Family Member | Any of the individuals who are descended from a common progenitor, related by marriage or other legal tie. | Family Member | ||
FORENSIC PATHOLOGIST | C142333 | A physician specializing in the diagnosis of both the cause of death and the manner of death of another human being. | Forensic Pathologist | |||
FRIEND | C72884 | A person whom an individual knows, likes, and trusts. (NCI) | Friend | |||
GUARDIAN | C51828 | An individual who is authorized under applicable State or local law to consent on behalf of a child or incapable person to general medical care including participation in clinical research. (NCI) | Guardian | |||
GYNECOLOGIST | C17720 | A physician who specializes in women's healthcare, including diagnosing and treating diseases and disorders of the female reproductive organs. | Gynecologist | |||
HEALTH CARE PROFESSIONAL | C53287 | A person qualified to be engaged in activity directed at preservation of mental and physical health by diseases prevention and treatment as a source of livelihood. (NCI) | Health Care Professional | |||
HEMATOLOGIST | C17831 | A doctor who specializes in diagnosing and treating diseases and disorders of the blood and blood-forming organs. (NCI) | Hematologist | |||
INDEPENDENT ASSESSOR | C78720 | An individual qualified to perform an evaluation who is masked from a subject's data in order to minimize bias or maximize consistency and quality. (NCI) | Independent Rater | |||
INTERNIST | C17832 | A physician who specializes in internal medicine. | Internist | |||
INTERVIEWER | C63759 | The person who manages an interview and asks the questions. | Interviewer | |||
INVESTIGATOR | C25936 | A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at the trial site, the investigator is the responsible leader of the team and may be called the principal investigator. | Investigator | |||
MICROSCOPIST | C132303 | A health care professional trained in the visualization of structures too small to be seen by the naked eye, using various microscopic techniques. | Microscopist | |||
MIDWIFE | C191271 | A health professional educated in the discipline of midwifery, including care of women during pregnancy, child birth, and post-partum care. | Midwife | |||
NEUROLOGIST | C17721 | A physician who specializes in diagnosing and treating diseases and disorders of the nervous system. | Neurologist | |||
NEUROONCOLOGIST | C93061 | A physician trained in oncology who specializes in tumors of the central nervous system. | Neuro-oncologist | |||
NEURORADIOLOGIST | C93058 | A radiologist who specializes in diagnosing and treating conditions affecting the nervous system. | Neuroradiologist | |||
NON-HEALTH CARE PROFESSIONAL | C134833 | Any individual other than a health care professional. | Non-Healthcare Professional | |||
NUCLEAR MEDICINE PHYSICIAN | C189312 | A type of radiologist who specializes in procedures using radioactive materials to diagnose and/or treat patients. | Nuclear Medicine Physician | |||
OBSTETRICIAN | C191272 | A physician who specializes in the treatment of women as it relates to pregnancy, child birth, and post-partum care. | Obstetrician | |||
ONCOLOGIST | C17821 | A physician who specializes in diagnosing and treating cancer. (NCI) | Oncologist | |||
OPHTHALMOLOGIST | C17822 | A physician with a Doctor of Medicine or Doctor of Osteopathic Medicine degree (or analogous) who specializes in diagnosing and treating eye disorders, including more complex disorders that require surgery. (NCI) | Ophthalmologist | |||
OPTOMETRIST | C132424 | A physician with a Doctor of Optometry degree (or analogous) who specializes in the diagnosis and treatment of eye disorders. | Optometrist | |||
OTOLARYNGOLOGIST | C17823 | Ear, Nose, and Throat Doctor;ENT Doctor;ENT Specialist;Otorhinolaryngologist | A doctor who specializes in treating diseases of the ear, nose, and throat. (NCI) | Otolaryngologist | ||
PARENT | C42709 | A mother or a father. | Parent | |||
PATHOLOGIST | C17723 | A physician who specializes in the science of pathology. | Pathologist | |||
PEDIATRIC CARDIOLOGIST | C191273 | A pediatrician who specializes in the diagnosis and treatment of heart disorders in children. | Pediatric Cardiologist | |||
PEDIATRIC NEUROLOGIST | C147463 | A pediatrician who specializes in the diagnosis and treatment of nervous system disorders in children. | Pediatric Neurologist | |||
PHARMACOKINETICIST | C189313 | A scientist who studies and/or works in the field of pharmacokinetics. | Pharmacokineticist | |||
PHYSIOTHERAPIST | C53422 | Physical Therapist | A healthcare professional trained and certified to apply knowledge of the concepts, principles, and practices of physical therapy for the treatment or prevention of physical disability or disease. | Physical Therapist | ||
PRINCIPAL INVESTIGATOR | C19924 | A person who has the primary responsibility for the conduct of a clinical study and study-related personnel at a study site. While a single-center study would not include a coordinating investigator, the investigator at the site would fulfill the same responsibilities as a principal investigator. | Principal Investigator | |||
PROXY | C119264 | A type of directive that gives a person the authority to make decisions for or provide responses on behalf of another individual. | Proxy | |||
RADIOLOGIST | C17824 | A physician who specializes in the diagnostic and/or therapeutic uses of radiation. (NCI) | Radiologist | |||
RATER | C132304 | An individual qualified to perform an assessment. | Rater | |||
READER | C28747 | An individual who takes non-quantifiable data and provides quantifiable assessments for that data. | Reader | |||
SIBLING | C25204 | A person's brother or sister. | Sibling | |||
SIGNIFICANT OTHER | C119265 | A gender-neutral term for a person's partner in an intimate or romantic relationship without disclosing or presuming marital status or sexual orientation. | Significant Other | |||
SONOGRAPHER | C191274 | A health professional educated in the discipline of ultrasonography. | Sonographer | |||
SPOUSE | C62649 | Spouse | A person's partner in marriage. (NCI) | Spouse | ||
STUDY SUBJECT | C41189 | An individual who is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study. | Study Subject | |||
SUBINVESTIGATOR | C54622 | Any member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). (ICH) | Subinvestigator | |||
UROLOGIST | C17826 | A doctor who specializes in diseases of the urinary organs in females and the genitourinary organs in males. | Urologist | |||
VENDOR | C68608 | A person or agency that promotes or exchanges goods or services for money. (NCI) | Vendor | |||
Back to top | ||||||
CL.C123653.EXACT1TC | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire Test Code
(EXACT1TC) | text
Extensible: No | C123653 | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire Test Code | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome test code. | CDISC Questionnaire EXACT Test Code Terminology |
EXACT101 | C123669 | EXACT1-Chest Feel Congested | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did your chest feel congested today? | EXACT - Chest Feel Congested | ||
EXACT102 | C123670 | EXACT1-How Often Cough | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How often did you cough today? | EXACT - How Often Cough Today | ||
EXACT103 | C123671 | EXACT1-Bring Up Mucus When Coughing | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How much mucus (phlegm) did you bring up when coughing today? | EXACT - Bring Up Mucus When Coughing | ||
EXACT104 | C123672 | EXACT1-Difficult to Bring Up Mucus | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How difficult was it to bring up mucus (phlegm) today? | EXACT - Difficult to Bring Up Mucus | ||
EXACT105 | C123673 | EXACT1-Chest Discomfort | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did you have chest discomfort today? | EXACT - Have Chest Discomfort | ||
EXACT106 | C123674 | EXACT1-Chest Feel Tight | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did your chest feel tight today? | EXACT - Chest Feel Tight | ||
EXACT107 | C123675 | EXACT1-Breathless | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you breathless today? | EXACT - Were You Breathless | ||
EXACT108 | C123676 | EXACT1-Describe How Breathless | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Describe how breathless you were today. | EXACT - Describe How Breathless | ||
EXACT109 | C123677 | EXACT1-Short Breath Personal Care | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual personal care activities like washing or dressing? | EXACT - Short of Breath When Performing Usual Personal Care | ||
EXACT110 | C123678 | EXACT1-Short Breath Indoor Activities | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual indoor activities like cleaning or household work? | EXACT - Short of Breath When Performing Usual Indoor Activities | ||
EXACT111 | C123679 | EXACT1-Short Breath Outside Activities | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual activities outside the home such as yard work or errands? | EXACT - Short of Breath When Performing Usual Activities Outside | ||
EXACT112 | C123680 | EXACT1-Tired or Weak | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you tired or weak today? | EXACT - Tired or Weak | ||
EXACT113 | C123681 | EXACT1-Night Sleep Disturbed | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Last night, was your sleep disturbed? | EXACT - Night Sleep Disturbed | ||
EXACT114 | C123682 | EXACT1-Worried About Lung Problems | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How scared or worried were you about your lung problems today? | EXACT - Worried About Lung Problems | ||
EXACT115 | C177803 | EXACT1-Breathlessness Raw Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Breathlessness raw score. | EXACT - Breathlessness Raw Score | ||
EXACT116 | C177804 | EXACT1-Cough & Sputum Raw Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Cough & sputum raw score. | EXACT - Cough & Sputum Raw Score | ||
EXACT117 | C177805 | EXACT1-Chest Symptoms Raw Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Chest symptoms raw score. | EXACT - Chest Symptoms Raw Score | ||
EXACT118 | C177806 | EXACT1-EXACT Total Raw Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Exact total raw score. | EXACT - EXACT Total Raw Score | ||
EXACT119 | C177807 | EXACT1-Breathlessness Domain Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Breathlessness domain score. | EXACT - Breathlessness Domain Score | ||
EXACT120 | C177808 | EXACT1-Cough & Sputum Domain Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Cough & sputum domain score. | EXACT - Cough & Sputum Domain Score | ||
EXACT121 | C177809 | EXACT1-Chest Symptoms Domain Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Chest symptoms domain score. | EXACT - Chest Symptoms Domain Score | ||
EXACT122 | C177810 | EXACT1-EXACT Total Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Exact total domain score. | EXACT - EXACT Total Score | ||
Back to top | ||||||
CL.C123652.EXACT1TN | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire Test Name
(EXACT1TN) | text
Extensible: No | C123652 | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire Test Name | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome test name. | CDISC Questionnaire EXACT Test Name Terminology |
EXACT1-Breathless | C123675 | EXACT1-Breathless | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you breathless today? | EXACT - Were You Breathless | ||
EXACT1-Breathlessness Domain Score | C177807 | EXACT1-Breathlessness Domain Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Breathlessness domain score. | EXACT - Breathlessness Domain Score | ||
EXACT1-Breathlessness Raw Score | C177803 | EXACT1-Breathlessness Raw Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Breathlessness raw score. | EXACT - Breathlessness Raw Score | ||
EXACT1-Bring Up Mucus When Coughing | C123671 | EXACT1-Bring Up Mucus When Coughing | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How much mucus (phlegm) did you bring up when coughing today? | EXACT - Bring Up Mucus When Coughing | ||
EXACT1-Chest Discomfort | C123673 | EXACT1-Chest Discomfort | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did you have chest discomfort today? | EXACT - Have Chest Discomfort | ||
EXACT1-Chest Feel Congested | C123669 | EXACT1-Chest Feel Congested | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did your chest feel congested today? | EXACT - Chest Feel Congested | ||
EXACT1-Chest Feel Tight | C123674 | EXACT1-Chest Feel Tight | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Did your chest feel tight today? | EXACT - Chest Feel Tight | ||
EXACT1-Chest Symptoms Domain Score | C177809 | EXACT1-Chest Symptoms Domain Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Chest symptoms domain score. | EXACT - Chest Symptoms Domain Score | ||
EXACT1-Chest Symptoms Raw Score | C177805 | EXACT1-Chest Symptoms Raw Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Chest symptoms raw score. | EXACT - Chest Symptoms Raw Score | ||
EXACT1-Cough & Sputum Domain Score | C177808 | EXACT1-Cough & Sputum Domain Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Cough & sputum domain score. | EXACT - Cough & Sputum Domain Score | ||
EXACT1-Cough & Sputum Raw Score | C177804 | EXACT1-Cough & Sputum Raw Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Cough & sputum raw score. | EXACT - Cough & Sputum Raw Score | ||
EXACT1-Describe How Breathless | C123676 | EXACT1-Describe How Breathless | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Describe how breathless you were today. | EXACT - Describe How Breathless | ||
EXACT1-Difficult to Bring Up Mucus | C123672 | EXACT1-Difficult to Bring Up Mucus | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How difficult was it to bring up mucus (phlegm) today? | EXACT - Difficult to Bring Up Mucus | ||
EXACT1-EXACT Total Raw Score | C177806 | EXACT1-EXACT Total Raw Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Exact total raw score. | EXACT - EXACT Total Raw Score | ||
EXACT1-EXACT Total Score | C177810 | EXACT1-EXACT Total Score | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Exact total domain score. | EXACT - EXACT Total Score | ||
EXACT1-How Often Cough | C123670 | EXACT1-How Often Cough | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How often did you cough today? | EXACT - How Often Cough Today | ||
EXACT1-Night Sleep Disturbed | C123681 | EXACT1-Night Sleep Disturbed | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Last night, was your sleep disturbed? | EXACT - Night Sleep Disturbed | ||
EXACT1-Short Breath Indoor Activities | C123678 | EXACT1-Short Breath Indoor Activities | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual indoor activities like cleaning or household work? | EXACT - Short of Breath When Performing Usual Indoor Activities | ||
EXACT1-Short Breath Outside Activities | C123679 | EXACT1-Short Breath Outside Activities | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual activities outside the home such as yard work or errands? | EXACT - Short of Breath When Performing Usual Activities Outside | ||
EXACT1-Short Breath Personal Care | C123677 | EXACT1-Short Breath Personal Care | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you short of breath today when performing your usual personal care activities like washing or dressing? | EXACT - Short of Breath When Performing Usual Personal Care | ||
EXACT1-Tired or Weak | C123680 | EXACT1-Tired or Weak | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - Were you tired or weak today? | EXACT - Tired or Weak | ||
EXACT1-Worried About Lung Problems | C123682 | EXACT1-Worried About Lung Problems | Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome - How scared or worried were you about your lung problems today? | EXACT - Worried About Lung Problems | ||
Back to top | ||||||
CL.C125745.ED1TC | Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire Test Code
(ED1TC) | text
Extensible: No | C125745 | Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire Test Code | Expanded Disability Rating Scale - Postacute Interview Caregiver Version test code. | CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Code Terminology |
ED102_1 | C125773 | ED1-Able to Communicate Clearly | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Is [name] able to communicate with you in a way that you and others clearly understand? | Expanded DRS-PI Caregiver Version - Able to Communicate Clearly | ||
ED102_2 | C125774 | ED1-How They Communicate Primarily | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How do they communicate primarily? | Expanded DRS-PI Caregiver Version - How They Communicate Primarily | ||
ED102_3 | C125775 | ED1-Correct Date and Time | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Is [name] able to give the correct date and time within a few seconds of being asked? | Expanded DRS-PI Caregiver Version - Give Correct Date and Time When Asked | ||
ED102_4 | C125776 | ED1-Few Words or Random Answers/Shouting | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] have only a few words that [s/he] uses over and over or does [s/he] express him/herself only through random answers, shouting or swearing? | Expanded DRS-PI Caregiver Version - Use Few Words or Random Shouting | ||
ED102_5 | C125777 | ED1-Moan/Groan/Sounds Not Understandable | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] only moan, groan or make other sounds that are not understandable? | Expanded DRS-PI Caregiver Version - Make Sounds Not Understandable | ||
ED104_1 | C125778 | ED1-Feed Independently Without Help | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] feed him/herself independently or manage tube feedings appropriately without help or reminders? | Expanded DRS-PI Caregiver Version - Feed Independently Without Help | ||
ED104_2 | C125779 | ED1-Understand Feeding Utensils | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] understand what eating or feeding utensils or equipment are for and how they should be used? | Expanded DRS-PI Caregiver Version - Understand Feeding Utensils | ||
ED104_3 | C125780 | ED1-Know Meal Times | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] know when meal or feeding times are? | Expanded DRS-PI Caregiver Version - Know Meal Times | ||
ED105_1 | C125781 | ED1-Use Toilet Independently | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] use the toilet or manage their bowel and bladder routine independently and appropriately without help or reminders? | Expanded DRS-PI Caregiver Version - Use Toilet Independently | ||
ED105_2 | C125782 | ED1-Manage Clothing When Toileting | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] understand how to manage their clothing or special equipment when toileting or in bowel and bladder management? | Expanded DRS-PI Caregiver Version - Manage Clothing When Toileting | ||
ED105_3 | C125783 | ED1-Know When to Use Toilet | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] know when to use the toilet or to conduct bowel and bladder management? | Expanded DRS-PI Caregiver Version - Know When to Use Toilet | ||
ED106_1 | C125784 | ED1-Can Dress/Groom Independently | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] dress and groom him/herself independently and appropriately or direct someone else in these activities without help or reminders? | Expanded DRS-PI Caregiver Version - Can Dress and Groom Self Independently | ||
ED106_2 | C125785 | ED1-Know How to Bathe/Wash | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] know how to bathe and wash? | Expanded DRS-PI Caregiver Version - Know How to Bathe and Wash | ||
ED106_3 | C125786 | ED1-Understand How to Get Dressed | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] understand how to get dressed? | Expanded DRS-PI Caregiver Version - Understand How to Get Dressed | ||
ED106_4 | C125787 | ED1-Start/Finish Grooming Activities | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [s/he] start and finish these grooming activities without prompting? | Expanded DRS-PI Caregiver Version - Start and Finish Grooming Activities | ||
ED107_1 | C125788 | ED1-Function Completely Independently | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] function completely independently? That is, [s/he] does not require any physical assistance, supervision, equipment, devices or reminders for cognitive, social, behavioral, emotional, and physical function? | Expanded DRS-PI Caregiver Version - Function Completely Independently | ||
ED107_2 | C125789 | ED1-Require Specific Aids/Equipment | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] REQUIRE special aids or equipment such as a brace, walker, wheelchair, memory notebook, day planner, verbal reminders, prompts, cues, or alarm watch because of a disability? | Expanded DRS-PI Caregiver Version - Require Special Aids or Equipment | ||
ED107_3 | C125790 | ED1-Require Physical Assistance | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] require physical assistance from another person to meet daily needs? | Expanded DRS-PI Caregiver Version - Require Physical Assistance | ||
ED107_4 | C125791 | ED1-Require Assistance Thinking Tasks | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] require assistance from another person in tasks that require thinking abilities? | Expanded DRS-PI Caregiver Version - Require Assistance Thinking Tasks | ||
ED107_5 | C125792 | ED1-Require Assistance Managing Emotions | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] require assistance from another person to manage emotions and behavior? | Expanded DRS-PI Caregiver Version - Require Assistance Managing Emotions | ||
ED107_6A | C125793 | ED1-Need a Helper Always Close By | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] take care of some of their needs but also need a helper who is always close by? | Expanded DRS-PI Caregiver Version - Need a Helper Always Close By | ||
ED107_6B | C125794 | ED1-Need Help With All Major Activities | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] need help with all major activities and the assistance of another person all the time? | Expanded DRS-PI Caregiver Version - Need Help With All Major Activities | ||
ED107_6C | C125795 | ED1-Need 24-Hour Care | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] need 24-hour care and is not able to help with their own care at all? | Expanded DRS-PI Caregiver Version - Need 24-Hour Care | ||
ED108_1 | C125796 | ED1-Independent Work/Social Situations | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] function with complete independence in work or social situations? | Expanded DRS-PI Caregiver Version - Function With Independent Work or Social Situations | ||
ED108_2 | C125797 | ED1-Understand/Follow Directions | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] understand, remember, and follow directions? | Expanded DRS-PI Caregiver Version - Understand and Follow Directions | ||
ED108_3 | C125798 | ED1-Keep Track of Time/Schedules | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] keep track of time, schedules and appointments? | Expanded DRS-PI Caregiver Version - Keep Track of Time | ||
ED108_4 | C125799 | ED1-Perform Jobs, Manage Home/School | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can perform in a wide variety of jobs of [his/her] choosing or manage a home independently or participate in school full-time? | Expanded DRS-PI Caregiver Version - Perform Jobs or Manage a Home Independently | ||
ED108_5 | C125800 | ED1-Successful With Accommodations | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be successful at work, school or in home management with some reduction in the work load or with other accommodations due to disabilities? | Expanded DRS-PI Caregiver Version - Successful With Accommodations | ||
ED108_6 | C125801 | ED1-Successful With Limited Choices | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be successful at work, school or in home management but with limited choices in jobs or school courses due to disabilities? | Expanded DRS-PI Caregiver Version - Successful With Limited Choices | ||
ED108_7 | C125802 | ED1-Work With Frequent Support | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be able to work at home or in a special setting like a sheltered workshop in which the work is very routine and there is very frequent supervision and support? | Expanded DRS-PI Caregiver Version - Work With Frequent Supervision and Support | ||
Back to top | ||||||
CL.C125744.ED1TN | Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire Test Name
(ED1TN) | text
Extensible: No | C125744 | Expanded Disability Rating Scale - Postacute Interview Caregiver Version Questionnaire Test Name | Expanded Disability Rating Scale - Postacute Interview Caregiver Version test name. | CDISC Questionnaire Expanded DRS-PI Caregiver Version Test Name Terminology |
ED1-Able to Communicate Clearly | C125773 | ED1-Able to Communicate Clearly | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Is [name] able to communicate with you in a way that you and others clearly understand? | Expanded DRS-PI Caregiver Version - Able to Communicate Clearly | ||
ED1-Can Dress/Groom Independently | C125784 | ED1-Can Dress/Groom Independently | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] dress and groom him/herself independently and appropriately or direct someone else in these activities without help or reminders? | Expanded DRS-PI Caregiver Version - Can Dress and Groom Self Independently | ||
ED1-Correct Date and Time | C125775 | ED1-Correct Date and Time | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Is [name] able to give the correct date and time within a few seconds of being asked? | Expanded DRS-PI Caregiver Version - Give Correct Date and Time When Asked | ||
ED1-Feed Independently Without Help | C125778 | ED1-Feed Independently Without Help | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] feed him/herself independently or manage tube feedings appropriately without help or reminders? | Expanded DRS-PI Caregiver Version - Feed Independently Without Help | ||
ED1-Few Words or Random Answers/Shouting | C125776 | ED1-Few Words or Random Answers/Shouting | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] have only a few words that [s/he] uses over and over or does [s/he] express him/herself only through random answers, shouting or swearing? | Expanded DRS-PI Caregiver Version - Use Few Words or Random Shouting | ||
ED1-Function Completely Independently | C125788 | ED1-Function Completely Independently | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] function completely independently? That is, [s/he] does not require any physical assistance, supervision, equipment, devices or reminders for cognitive, social, behavioral, emotional, and physical function? | Expanded DRS-PI Caregiver Version - Function Completely Independently | ||
ED1-How They Communicate Primarily | C125774 | ED1-How They Communicate Primarily | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How do they communicate primarily? | Expanded DRS-PI Caregiver Version - How They Communicate Primarily | ||
ED1-Independent Work/Social Situations | C125796 | ED1-Independent Work/Social Situations | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] function with complete independence in work or social situations? | Expanded DRS-PI Caregiver Version - Function With Independent Work or Social Situations | ||
ED1-Keep Track of Time/Schedules | C125798 | ED1-Keep Track of Time/Schedules | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] keep track of time, schedules and appointments? | Expanded DRS-PI Caregiver Version - Keep Track of Time | ||
ED1-Know How to Bathe/Wash | C125785 | ED1-Know How to Bathe/Wash | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] know how to bathe and wash? | Expanded DRS-PI Caregiver Version - Know How to Bathe and Wash | ||
ED1-Know Meal Times | C125780 | ED1-Know Meal Times | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] know when meal or feeding times are? | Expanded DRS-PI Caregiver Version - Know Meal Times | ||
ED1-Know When to Use Toilet | C125783 | ED1-Know When to Use Toilet | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] know when to use the toilet or to conduct bowel and bladder management? | Expanded DRS-PI Caregiver Version - Know When to Use Toilet | ||
ED1-Manage Clothing When Toileting | C125782 | ED1-Manage Clothing When Toileting | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] understand how to manage their clothing or special equipment when toileting or in bowel and bladder management? | Expanded DRS-PI Caregiver Version - Manage Clothing When Toileting | ||
ED1-Moan/Groan/Sounds Not Understandable | C125777 | ED1-Moan/Groan/Sounds Not Understandable | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] only moan, groan or make other sounds that are not understandable? | Expanded DRS-PI Caregiver Version - Make Sounds Not Understandable | ||
ED1-Need 24-Hour Care | C125795 | ED1-Need 24-Hour Care | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] need 24-hour care and is not able to help with their own care at all? | Expanded DRS-PI Caregiver Version - Need 24-Hour Care | ||
ED1-Need a Helper Always Close By | C125793 | ED1-Need a Helper Always Close By | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] take care of some of their needs but also need a helper who is always close by? | Expanded DRS-PI Caregiver Version - Need a Helper Always Close By | ||
ED1-Need Help With All Major Activities | C125794 | ED1-Need Help With All Major Activities | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] need help with all major activities and the assistance of another person all the time? | Expanded DRS-PI Caregiver Version - Need Help With All Major Activities | ||
ED1-Perform Jobs, Manage Home/School | C125799 | ED1-Perform Jobs, Manage Home/School | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can perform in a wide variety of jobs of [his/her] choosing or manage a home independently or participate in school full-time? | Expanded DRS-PI Caregiver Version - Perform Jobs or Manage a Home Independently | ||
ED1-Require Assistance Managing Emotions | C125792 | ED1-Require Assistance Managing Emotions | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] require assistance from another person to manage emotions and behavior? | Expanded DRS-PI Caregiver Version - Require Assistance Managing Emotions | ||
ED1-Require Assistance Thinking Tasks | C125791 | ED1-Require Assistance Thinking Tasks | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] require assistance from another person in tasks that require thinking abilities? | Expanded DRS-PI Caregiver Version - Require Assistance Thinking Tasks | ||
ED1-Require Physical Assistance | C125790 | ED1-Require Physical Assistance | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] require physical assistance from another person to meet daily needs? | Expanded DRS-PI Caregiver Version - Require Physical Assistance | ||
ED1-Require Specific Aids/Equipment | C125789 | ED1-Require Specific Aids/Equipment | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] REQUIRE special aids or equipment such as a brace, walker, wheelchair, memory notebook, day planner, verbal reminders, prompts, cues, or alarm watch because of a disability? | Expanded DRS-PI Caregiver Version - Require Special Aids or Equipment | ||
ED1-Start/Finish Grooming Activities | C125787 | ED1-Start/Finish Grooming Activities | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [s/he] start and finish these grooming activities without prompting? | Expanded DRS-PI Caregiver Version - Start and Finish Grooming Activities | ||
ED1-Successful With Accommodations | C125800 | ED1-Successful With Accommodations | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be successful at work, school or in home management with some reduction in the work load or with other accommodations due to disabilities? | Expanded DRS-PI Caregiver Version - Successful With Accommodations | ||
ED1-Successful With Limited Choices | C125801 | ED1-Successful With Limited Choices | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be successful at work, school or in home management but with limited choices in jobs or school courses due to disabilities? | Expanded DRS-PI Caregiver Version - Successful With Limited Choices | ||
ED1-Understand Feeding Utensils | C125779 | ED1-Understand Feeding Utensils | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [name] understand what eating or feeding utensils or equipment are for and how they should be used? | Expanded DRS-PI Caregiver Version - Understand Feeding Utensils | ||
ED1-Understand How to Get Dressed | C125786 | ED1-Understand How to Get Dressed | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Does [s/he] understand how to get dressed? | Expanded DRS-PI Caregiver Version - Understand How to Get Dressed | ||
ED1-Understand/Follow Directions | C125797 | ED1-Understand/Follow Directions | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] understand, remember, and follow directions? | Expanded DRS-PI Caregiver Version - Understand and Follow Directions | ||
ED1-Use Toilet Independently | C125781 | ED1-Use Toilet Independently | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - Can [name] use the toilet or manage their bowel and bladder routine independently and appropriately without help or reminders? | Expanded DRS-PI Caregiver Version - Use Toilet Independently | ||
ED1-Work With Frequent Support | C125802 | ED1-Work With Frequent Support | Expanded Disability Rating Scale - Postacute Interview Caregiver Version - How certain are you that [name] can be able to work at home or in a special setting like a sheltered workshop in which the work is very routine and there is very frequent supervision and support? | Expanded DRS-PI Caregiver Version - Work With Frequent Supervision and Support | ||
Back to top | ||||||
CL.C125747.ED2TC | Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire Test Code
(ED2TC) | text
Extensible: No | C125747 | Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire Test Code | Expanded Disability Rating Scale - Postacute Interview Survivor Version test code. | CDISC Questionnaire Expanded DRS-PI Survivor Version Test Code Terminology |
ED202_3 | C125803 | ED2-Correct Date and Time | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Are you able to give the correct date and time within a few seconds of being asked? | Expanded DRS-PI Survivor Version - Give Correct Date and Time When Asked | ||
ED204_1 | C125804 | ED2-Feed Independently Without Help | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you feed yourself independently or manage tube feedings appropriately without help or reminders? | Expanded DRS-PI Survivor Version - Feed Yourself Independently Without Help | ||
ED204_2 | C125805 | ED2-Understand Feeding Utensils | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand what eating or feeding utensils or equipment are for and how they should be used? | Expanded DRS-PI Survivor Version - Understand Feeding Utensils | ||
ED204_3 | C125806 | ED2-Know Meal Times | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know when meal or feeding times are? | Expanded DRS-PI Survivor Version - Know Meal Times | ||
ED205_1 | C125807 | ED2-Use Toilet Independently | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you use the toilet or manage your bowel and bladder routine independently and appropriately without help or reminders? | Expanded DRS-PI Survivor Version - Use Toilet Independently | ||
ED205_2 | C125808 | ED2-Manage Clothing When Toileting | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand how to manage your clothing or special equipment when toileting or in bowel and bladder management? | Expanded DRS-PI Survivor Version - Manage Clothing When Toileting | ||
ED205_3 | C125809 | ED2-Know When to Use Toilet | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know when to use the toilet or to conduct bowel and bladder management? | Expanded DRS-PI Survivor Version - Know When to Use Toilet | ||
ED206_1 | C125810 | ED2-Can Dress/Groom Independently | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you dress and groom yourself independently and appropriately or direct someone else in these activities without help or reminders? | Expanded DRS-PI Survivor Version - Can Dress and Groom Self Independently | ||
ED206_2 | C125811 | ED2-Know How to Bathe/Wash | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know how to bathe and wash? | Expanded DRS-PI Survivor Version - Know How to Bathe and Wash | ||
ED206_3 | C125812 | ED2-Understand How to Get Dressed | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand how to get dressed? | Expanded DRS-PI Survivor Version - Understand How to Get Dressed | ||
ED206_4 | C125813 | ED2-Start/Finish Grooming Activities | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you start and finish these grooming activities without prompting? | Expanded DRS-PI Survivor Version - Start and Finish Grooming Activities | ||
ED207_1 | C125814 | ED2-Function Completely Independently | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you function completely independently? That is, you do not require any physical assistance, supervision, equipment, devices, or reminders for cognitive, social, behavioral, emotional, and physical function? | Expanded DRS-PI Survivor Version - Function Completely Independently | ||
ED207_2 | C125815 | ED2-Require Specific Aids/Equipment | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you REQUIRE special aids or equipment, such as, a brace, walker, wheelchair, memory notebook, day planner, verbal reminders, prompts, cues, or alarm watch because of a disability? | Expanded DRS-PI Survivor Version - Require Special Aids or Equipment | ||
ED207_3 | C125816 | ED2-Require Physical Assistance | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require physical assistance from another person to meet daily needs? | Expanded DRS-PI Survivor Version - Require Physical Assistance | ||
ED207_4 | C125817 | ED2-Require Assistance Thinking Tasks | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require assistance from another person in tasks that require thinking abilities? | Expanded DRS-PI Survivor Version - Require Assistance Thinking Tasks | ||
ED207_5 | C125818 | ED2-Require Assistance Managing Emotions | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require assistance from another person to manage emotions and behavior? | Expanded DRS-PI Survivor Version - Require Assistance Managing Emotions | ||
ED207_6A | C125819 | ED2-Need a Helper Always Close By | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you take care of some of your needs but also need a helper who is always close by? | Expanded DRS-PI Survivor Version - Need a Helper Always Close By | ||
ED207_6B | C125820 | ED2-Need Help With All Major Activities | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you need help with all major activities and the assistance of another person all the time? | Expanded DRS-PI Survivor Version - Need Help With All Major Activities | ||
ED207_6C | C125821 | ED2-Need 24-Hour Care | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you need 24-hour care and are not able to help with your own care at all? | Expanded DRS-PI Survivor Version - Need 24-Hour Care | ||
ED208_1 | C125822 | ED2-Independent Work/Social Situations | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you function with complete independence in work or social situations? | Expanded DRS-PI Survivor Version - Function With Independent Work or Social Situations | ||
ED208_2 | C125823 | ED2-Understand/Follow Directions | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you understand, remember, and follow directions? | Expanded DRS-PI Survivor Version - Understand and Follow Directions | ||
ED208_3 | C125824 | ED2-Keep Track of Time/Schedules | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you keep track of time, schedules and appointments? | Expanded DRS-PI Survivor Version - Keep Track of Time | ||
ED208_4 | C125825 | ED2-Perform Jobs, Manage Home/School | Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can perform in a wide variety of jobs of your choosing or manage a home independently or participate in school full-time? | Expanded DRS-PI Survivor Version - Perform Jobs or Manage a Home Independently | ||
ED208_5 | C125826 | ED2-Successful With Accommodations | Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be successful at work, school or in home management with some reduction in the work load or with other accommodations due to disabilities? | Expanded DRS-PI Survivor Version - Successful With Accommodations | ||
ED208_6 | C125827 | ED2-Successful With Limited Choices | Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be successful at work, school or in home management but with limited choices in jobs or school courses due to disabilities? | Expanded DRS-PI Survivor Version - Successful With Limited Choices | ||
ED208_7 | C125828 | ED2-Work With Frequent Support | Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be able to work at home or in a special setting like a sheltered workshop in which the work is very routine and there is very frequent supervision and support? | Expanded DRS-PI Survivor Version - Work With Frequent Supervision and Support | ||
Back to top | ||||||
CL.C125746.ED2TN | Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire Test Name
(ED2TN) | text
Extensible: No | C125746 | Expanded Disability Rating Scale - Postacute Interview Survivor Version Questionnaire Test Name | Expanded Disability Rating Scale - Postacute Interview Survivor Version test name. | CDISC Questionnaire Expanded DRS-PI Survivor Version Test Name Terminology |
ED2-Can Dress/Groom Independently | C125810 | ED2-Can Dress/Groom Independently | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you dress and groom yourself independently and appropriately or direct someone else in these activities without help or reminders? | Expanded DRS-PI Survivor Version - Can Dress and Groom Self Independently | ||
ED2-Correct Date and Time | C125803 | ED2-Correct Date and Time | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Are you able to give the correct date and time within a few seconds of being asked? | Expanded DRS-PI Survivor Version - Give Correct Date and Time When Asked | ||
ED2-Feed Independently Without Help | C125804 | ED2-Feed Independently Without Help | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you feed yourself independently or manage tube feedings appropriately without help or reminders? | Expanded DRS-PI Survivor Version - Feed Yourself Independently Without Help | ||
ED2-Function Completely Independently | C125814 | ED2-Function Completely Independently | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you function completely independently? That is, you do not require any physical assistance, supervision, equipment, devices, or reminders for cognitive, social, behavioral, emotional, and physical function? | Expanded DRS-PI Survivor Version - Function Completely Independently | ||
ED2-Independent Work/Social Situations | C125822 | ED2-Independent Work/Social Situations | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you function with complete independence in work or social situations? | Expanded DRS-PI Survivor Version - Function With Independent Work or Social Situations | ||
ED2-Keep Track of Time/Schedules | C125824 | ED2-Keep Track of Time/Schedules | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you keep track of time, schedules and appointments? | Expanded DRS-PI Survivor Version - Keep Track of Time | ||
ED2-Know How to Bathe/Wash | C125811 | ED2-Know How to Bathe/Wash | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know how to bathe and wash? | Expanded DRS-PI Survivor Version - Know How to Bathe and Wash | ||
ED2-Know Meal Times | C125806 | ED2-Know Meal Times | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know when meal or feeding times are? | Expanded DRS-PI Survivor Version - Know Meal Times | ||
ED2-Know When to Use Toilet | C125809 | ED2-Know When to Use Toilet | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you know when to use the toilet or to conduct bowel and bladder management? | Expanded DRS-PI Survivor Version - Know When to Use Toilet | ||
ED2-Manage Clothing When Toileting | C125808 | ED2-Manage Clothing When Toileting | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand how to manage your clothing or special equipment when toileting or in bowel and bladder management? | Expanded DRS-PI Survivor Version - Manage Clothing When Toileting | ||
ED2-Need 24-Hour Care | C125821 | ED2-Need 24-Hour Care | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you need 24-hour care and are not able to help with your own care at all? | Expanded DRS-PI Survivor Version - Need 24-Hour Care | ||
ED2-Need a Helper Always Close By | C125819 | ED2-Need a Helper Always Close By | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you take care of some of your needs but also need a helper who is always close by? | Expanded DRS-PI Survivor Version - Need a Helper Always Close By | ||
ED2-Need Help With All Major Activities | C125820 | ED2-Need Help With All Major Activities | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you need help with all major activities and the assistance of another person all the time? | Expanded DRS-PI Survivor Version - Need Help With All Major Activities | ||
ED2-Perform Jobs, Manage Home/School | C125825 | ED2-Perform Jobs, Manage Home/School | Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can perform in a wide variety of jobs of your choosing or manage a home independently or participate in school full-time? | Expanded DRS-PI Survivor Version - Perform Jobs or Manage a Home Independently | ||
ED2-Require Assistance Managing Emotions | C125818 | ED2-Require Assistance Managing Emotions | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require assistance from another person to manage emotions and behavior? | Expanded DRS-PI Survivor Version - Require Assistance Managing Emotions | ||
ED2-Require Assistance Thinking Tasks | C125817 | ED2-Require Assistance Thinking Tasks | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require assistance from another person in tasks that require thinking abilities? | Expanded DRS-PI Survivor Version - Require Assistance Thinking Tasks | ||
ED2-Require Physical Assistance | C125816 | ED2-Require Physical Assistance | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you require physical assistance from another person to meet daily needs? | Expanded DRS-PI Survivor Version - Require Physical Assistance | ||
ED2-Require Specific Aids/Equipment | C125815 | ED2-Require Specific Aids/Equipment | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you REQUIRE special aids or equipment, such as, a brace, walker, wheelchair, memory notebook, day planner, verbal reminders, prompts, cues, or alarm watch because of a disability? | Expanded DRS-PI Survivor Version - Require Special Aids or Equipment | ||
ED2-Start/Finish Grooming Activities | C125813 | ED2-Start/Finish Grooming Activities | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you start and finish these grooming activities without prompting? | Expanded DRS-PI Survivor Version - Start and Finish Grooming Activities | ||
ED2-Successful With Accommodations | C125826 | ED2-Successful With Accommodations | Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be successful at work, school or in home management with some reduction in the work load or with other accommodations due to disabilities? | Expanded DRS-PI Survivor Version - Successful With Accommodations | ||
ED2-Successful With Limited Choices | C125827 | ED2-Successful With Limited Choices | Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be successful at work, school or in home management but with limited choices in jobs or school courses due to disabilities? | Expanded DRS-PI Survivor Version - Successful With Limited Choices | ||
ED2-Understand Feeding Utensils | C125805 | ED2-Understand Feeding Utensils | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand what eating or feeding utensils or equipment are for and how they should be used? | Expanded DRS-PI Survivor Version - Understand Feeding Utensils | ||
ED2-Understand How to Get Dressed | C125812 | ED2-Understand How to Get Dressed | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Do you understand how to get dressed? | Expanded DRS-PI Survivor Version - Understand How to Get Dressed | ||
ED2-Understand/Follow Directions | C125823 | ED2-Understand/Follow Directions | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you understand, remember, and follow directions? | Expanded DRS-PI Survivor Version - Understand and Follow Directions | ||
ED2-Use Toilet Independently | C125807 | ED2-Use Toilet Independently | Expanded Disability Rating Scale - Postacute Interview Survivor Version - Can you use the toilet or manage your bowel and bladder routine independently and appropriately without help or reminders? | Expanded DRS-PI Survivor Version - Use Toilet Independently | ||
ED2-Work With Frequent Support | C125828 | ED2-Work With Frequent Support | Expanded Disability Rating Scale - Postacute Interview Survivor Version - How certain are you that you can be able to work at home or in a special setting like a sheltered workshop in which the work is very routine and there is very frequent supervision and support? | Expanded DRS-PI Survivor Version - Work With Frequent Supervision and Support | ||
Back to top | ||||||
CL.C115404.GOSE1TC | Extended Glasgow Outcome Scale Questionnaire Test Code
(GOSE1TC) | text
Extensible: No | C115404 | Extended Glasgow Outcome Scale Questionnaire Test Code | Extended Glasgow Outcome Scale test code. | CDISC Questionnaire GOSE Test Code Terminology |
GOSE101 | C115828 | GOSE1-Obey Simple Commands or Say Words | Extended Glasgow Outcome Scale - Is the head injured person able to obey simple commands, or say any words? | GOSE - Consciousness: Obey Simple Commands | ||
GOSE102A | C115829 | GOSE1-Daily Assistance at Home Essential | Extended Glasgow Outcome Scale - Is the assistance of another person at home essential every day for some activities of daily living? | GOSE - Independence in the Home: Assistance Essential for Daily Living | ||
GOSE102B | C115830 | GOSE1-Need Frequent Help at Home | Extended Glasgow Outcome Scale - Do they need frequent help or someone to be around at home most of the time? | GOSE - Independence in the Home: Need Frequent Help at Home | ||
GOSE102C | C115831 | GOSE1-Assistance at Home Before Injury | Extended Glasgow Outcome Scale - Was assistance at home essential before the injury? | GOSE - Independence in the Home: Assistance at Home Before Injury | ||
GOSE103A | C115832 | GOSE1-Shop Without Assistance | Extended Glasgow Outcome Scale - Are they able to shop without assistance? | GOSE - Independence Outside the Home: Able to Shop Without Assistance | ||
GOSE103B | C115833 | GOSE1-Shop Without Assist Before Injury | Extended Glasgow Outcome Scale - Were they able to shop without assistance before the injury? | GOSE - Independence Outside the Home: Able to Shop Without Assistance Before Injury | ||
GOSE104A | C115834 | GOSE1-Travel Locally Without Assistance | Extended Glasgow Outcome Scale - Are they able to travel locally without assistance? | GOSE - Independence Outside the Home: Travel Locally Without Assistance | ||
GOSE104B | C115835 | GOSE1-Travel Without Assist Before Inj | Extended Glasgow Outcome Scale - Were they able to travel without assistance before the injury? | GOSE - Independence Outside the Home: Travel Locally Without Assistance Before Injury | ||
GOSE105A | C115836 | GOSE1-Able to Work to Previous Capacity | Extended Glasgow Outcome Scale - Are they currently able to work to their previous capacity? | GOSE - Work: Able to Work to Previous Capacity | ||
GOSE105B | C115837 | GOSE1-How Restricted Are They | Extended Glasgow Outcome Scale - How restricted are they? | GOSE - Work: How Restricted Are They | ||
GOSE105C | C115838 | GOSE1-Working Before Injury | Extended Glasgow Outcome Scale - Were they either working or seeking employment before the injury (answer 'yes') or were they doing neither (answer 'no')? | GOSE - Work: Working or Seeking Employment Before the Injury | ||
GOSE106A | C115839 | GOSE1-Resume Social/Leisure Outside Home | Extended Glasgow Outcome Scale - Are they able to resume regular social and leisure activities outside home? | GOSE - Social and Leisure Activities: Resume Regular Social and Leisure Activities | ||
GOSE106B | C115840 | GOSE1-Extent Social/Leisure Restriction | Extended Glasgow Outcome Scale - What is the extent of restriction on their social and leisure activities? | GOSE - Social and Leisure Activities: Extent of Restriction on Social and Leisure Activities | ||
GOSE106C | C115841 | GOSE1-Engage Social/Leisure Before Inj | Extended Glasgow Outcome Scale - Did they engage in regular social and leisure activities outside home before the injury? | GOSE - Social and Leisure Activities: Engage Regular Social and Leisure Activities Before Injury | ||
GOSE107A | C115842 | GOSE1-Disruptive Psychological Problems | Extended Glasgow Outcome Scale - Have there been psychological problems which have resulted in ongoing family disruption or disruption to friendships? | GOSE - Family and Friendships: Disruptive Psychological Problems | ||
GOSE107B | C115843 | GOSE1-Extent of Disruption | Extended Glasgow Outcome Scale - What has been the extent of disruption or strain? | GOSE - Family and Friendships: Extent of Disruption or Strain | ||
GOSE107C | C115844 | GOSE1-Family/Friends Probs Before Injury | Extended Glasgow Outcome Scale - Were there problems with family or friends before the injury? | GOSE - Family and Friendships: Problems with Family or Friends Before Injury | ||
GOSE108A | C115845 | GOSE1-Other Problems Related to Injury | Extended Glasgow Outcome Scale - Are there any other current problems relating to the injury which affect daily life? | GOSE - Return to Normal Life: Other Current Problems Relating to Injury | ||
GOSE108B | C115846 | GOSE1-Similar Problems Before Injury | Extended Glasgow Outcome Scale - Were similar problems present before the injury? | GOSE - Return to Normal Life: Similar Problems Before Injury | ||
GOSE109 | C115847 | GOSE1-Since Injury Any Epileptic Fits | Extended Glasgow Outcome Scale - Since the injury has the head injured person had any epileptic fits? | GOSE - Epilepsy: Since Injury Any Epileptic Fits | ||
GOSE110 | C115848 | GOSE1-At Risk of Developing Epilepsy | Extended Glasgow Outcome Scale - Have they been told that they are currently at risk of developing epilepsy? | GOSE - Epilepsy: At Risk of Developing Epilepsy | ||
GOSE111 | C115849 | GOSE1-Most Important Factor in Outcome | Extended Glasgow Outcome Scale - What is the most important factor in outcome? | GOSE - Epilepsy: Most Important Factor in Outcome | ||
GOSE112 | C115850 | GOSE1-GOSE Overall Score | Extended Glasgow Outcome Scale - Scoring: The patient's overall rating is based on the lowest outcome category indicated on the scale. | GOSE - GOSE Overall Score | ||
Back to top | ||||||
CL.C115403.GOSE1TN | Extended Glasgow Outcome Scale Questionnaire Test Name
(GOSE1TN) | text
Extensible: No | C115403 | Extended Glasgow Outcome Scale Questionnaire Test Name | Extended Glasgow Outcome Scale test name. | CDISC Questionnaire GOSE Test Name Terminology |
GOSE1-Able to Work to Previous Capacity | C115836 | GOSE1-Able to Work to Previous Capacity | Extended Glasgow Outcome Scale - Are they currently able to work to their previous capacity? | GOSE - Work: Able to Work to Previous Capacity | ||
GOSE1-Assistance at Home Before Injury | C115831 | GOSE1-Assistance at Home Before Injury | Extended Glasgow Outcome Scale - Was assistance at home essential before the injury? | GOSE - Independence in the Home: Assistance at Home Before Injury | ||
GOSE1-At Risk of Developing Epilepsy | C115848 | GOSE1-At Risk of Developing Epilepsy | Extended Glasgow Outcome Scale - Have they been told that they are currently at risk of developing epilepsy? | GOSE - Epilepsy: At Risk of Developing Epilepsy | ||
GOSE1-Daily Assistance at Home Essential | C115829 | GOSE1-Daily Assistance at Home Essential | Extended Glasgow Outcome Scale - Is the assistance of another person at home essential every day for some activities of daily living? | GOSE - Independence in the Home: Assistance Essential for Daily Living | ||
GOSE1-Disruptive Psychological Problems | C115842 | GOSE1-Disruptive Psychological Problems | Extended Glasgow Outcome Scale - Have there been psychological problems which have resulted in ongoing family disruption or disruption to friendships? | GOSE - Family and Friendships: Disruptive Psychological Problems | ||
GOSE1-Engage Social/Leisure Before Inj | C115841 | GOSE1-Engage Social/Leisure Before Inj | Extended Glasgow Outcome Scale - Did they engage in regular social and leisure activities outside home before the injury? | GOSE - Social and Leisure Activities: Engage Regular Social and Leisure Activities Before Injury | ||
GOSE1-Extent of Disruption | C115843 | GOSE1-Extent of Disruption | Extended Glasgow Outcome Scale - What has been the extent of disruption or strain? | GOSE - Family and Friendships: Extent of Disruption or Strain | ||
GOSE1-Extent Social/Leisure Restriction | C115840 | GOSE1-Extent Social/Leisure Restriction | Extended Glasgow Outcome Scale - What is the extent of restriction on their social and leisure activities? | GOSE - Social and Leisure Activities: Extent of Restriction on Social and Leisure Activities | ||
GOSE1-Family/Friends Probs Before Injury | C115844 | GOSE1-Family/Friends Probs Before Injury | Extended Glasgow Outcome Scale - Were there problems with family or friends before the injury? | GOSE - Family and Friendships: Problems with Family or Friends Before Injury | ||
GOSE1-GOSE Overall Score | C115850 | GOSE1-GOSE Overall Score | Extended Glasgow Outcome Scale - Scoring: The patient's overall rating is based on the lowest outcome category indicated on the scale. | GOSE - GOSE Overall Score | ||
GOSE1-How Restricted Are They | C115837 | GOSE1-How Restricted Are They | Extended Glasgow Outcome Scale - How restricted are they? | GOSE - Work: How Restricted Are They | ||
GOSE1-Most Important Factor in Outcome | C115849 | GOSE1-Most Important Factor in Outcome | Extended Glasgow Outcome Scale - What is the most important factor in outcome? | GOSE - Epilepsy: Most Important Factor in Outcome | ||
GOSE1-Need Frequent Help at Home | C115830 | GOSE1-Need Frequent Help at Home | Extended Glasgow Outcome Scale - Do they need frequent help or someone to be around at home most of the time? | GOSE - Independence in the Home: Need Frequent Help at Home | ||
GOSE1-Obey Simple Commands or Say Words | C115828 | GOSE1-Obey Simple Commands or Say Words | Extended Glasgow Outcome Scale - Is the head injured person able to obey simple commands, or say any words? | GOSE - Consciousness: Obey Simple Commands | ||
GOSE1-Other Problems Related to Injury | C115845 | GOSE1-Other Problems Related to Injury | Extended Glasgow Outcome Scale - Are there any other current problems relating to the injury which affect daily life? | GOSE - Return to Normal Life: Other Current Problems Relating to Injury | ||
GOSE1-Resume Social/Leisure Outside Home | C115839 | GOSE1-Resume Social/Leisure Outside Home | Extended Glasgow Outcome Scale - Are they able to resume regular social and leisure activities outside home? | GOSE - Social and Leisure Activities: Resume Regular Social and Leisure Activities | ||
GOSE1-Shop Without Assist Before Injury | C115833 | GOSE1-Shop Without Assist Before Injury | Extended Glasgow Outcome Scale - Were they able to shop without assistance before the injury? | GOSE - Independence Outside the Home: Able to Shop Without Assistance Before Injury | ||
GOSE1-Shop Without Assistance | C115832 | GOSE1-Shop Without Assistance | Extended Glasgow Outcome Scale - Are they able to shop without assistance? | GOSE - Independence Outside the Home: Able to Shop Without Assistance | ||
GOSE1-Similar Problems Before Injury | C115846 | GOSE1-Similar Problems Before Injury | Extended Glasgow Outcome Scale - Were similar problems present before the injury? | GOSE - Return to Normal Life: Similar Problems Before Injury | ||
GOSE1-Since Injury Any Epileptic Fits | C115847 | GOSE1-Since Injury Any Epileptic Fits | Extended Glasgow Outcome Scale - Since the injury has the head injured person had any epileptic fits? | GOSE - Epilepsy: Since Injury Any Epileptic Fits | ||
GOSE1-Travel Locally Without Assistance | C115834 | GOSE1-Travel Locally Without Assistance | Extended Glasgow Outcome Scale - Are they able to travel locally without assistance? | GOSE - Independence Outside the Home: Travel Locally Without Assistance | ||
GOSE1-Travel Without Assist Before Inj | C115835 | GOSE1-Travel Without Assist Before Inj | Extended Glasgow Outcome Scale - Were they able to travel without assistance before the injury? | GOSE - Independence Outside the Home: Travel Locally Without Assistance Before Injury | ||
GOSE1-Working Before Injury | C115838 | GOSE1-Working Before Injury | Extended Glasgow Outcome Scale - Were they either working or seeking employment before the injury (answer 'yes') or were they doing neither (answer 'no')? | GOSE - Work: Working or Seeking Employment Before the Injury | ||
Back to top | ||||||
CL.C117991.ESRSA1TC | Extrapyramidal Symptom Rating Scale-Abbreviated Clinical Classification Test Code
(ESRSA1TC) | text
Extensible: No | C117991 | Extrapyramidal Symptom Rating Scale-Abbreviated Clinical Classification Test Code | Extrapyramidal Symptom Rating Scale-Abbreviated test code. | CDISC Clinical Classification ESRS-A Test Code Terminology |
ESRSA101 | C118079 | ESRSA1-Rigidity: Upper Limbs | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Upper limbs. | ESRS-A - Rigidity: Upper Limbs | ||
ESRSA102 | C118080 | ESRSA1-Rigidity: Lower Limbs | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Lower limbs. | ESRS-A - Rigidity: Lower Limbs | ||
ESRSA103 | C118081 | ESRSA1-Rigidity: Neck | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Neck. | ESRS-A - Rigidity: Neck | ||
ESRSA104 | C118082 | ESRSA1-Tremor: Face/Jaw/Chin/Lips/Head | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Face, jaw/chin, lips, head. | ESRS-A - Tremor: Face/Jaw/Chin/Lips/Head | ||
ESRSA105 | C118083 | ESRSA1-Tremor: Upper Limbs/Hands | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Upper limbs/hands. | ESRS-A - Tremor: Upper Limbs/Hands | ||
ESRSA106 | C118084 | ESRSA1-Tremor: Lower Limbs/Feet | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Lower limbs/feet. | ESRS-A - Tremor: Lower Limbs/Feet | ||
ESRSA107 | C118085 | ESRSA1-Reduced Facial Expression/Speech | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Reduced facial expression/speech. | ESRS-A - Reduced Facial Expression/Speech | ||
ESRSA108 | C118086 | ESRSA1-Impaired Gait/Posture | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Impaired gait/posture. | ESRS-A - Impaired Gait/Posture | ||
ESRSA109 | C118087 | ESRSA1-Postural Instability | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Postural instability. | ESRS-A - Postural Instability | ||
ESRSA110 | C118088 | ESRSA1-Bradykinesia/Hypokinesia | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Bradykinesia/hypokinesia. | ESRS-A - Bradykinesia/Hypokinesia | ||
ESRSA111 | C118089 | ESRSA1-Dystonia: Tongue | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Tongue. | ESRS-A - Dystonia: Tongue | ||
ESRSA112 | C118090 | ESRSA1-Dystonia: Jaw | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Jaw. | ESRS-A - Dystonia: Jaw | ||
ESRSA113 | C118091 | ESRSA1-Dystonia: Eyes/Face/Larynx | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Eyes, upper face, lower face, larynx. | ESRS-A - Dystonia: Eyes/Upper and Lower Face/Larynx | ||
ESRSA114 | C118092 | ESRSA1-Dystonia: Shoulder/Up Limb/Hand | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Shoulders, upper limbs, hands. | ESRS-A - Dystonia: Shoulder/Upper Limbs/Hands | ||
ESRSA115 | C118093 | ESRSA1-Dystonia: Hips/Lower Limbs/Feet | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Hips, lower limbs, feet. | ESRS-A - Dystonia: Hips/Lower Limbs/Feet | ||
ESRSA116 | C118094 | ESRSA1-Dystonia: Trunk/Neck | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Trunk, neck. | ESRS-A - Dystonia: Trunk/Neck | ||
ESRSA117 | C118095 | ESRSA1-Dyskinesia: Tongue | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Tongue. | ESRS-A - Dyskinesia: Tongue | ||
ESRSA118 | C118096 | ESRSA1-Dyskinesia: Jaw | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Jaw. | ESRS-A - Dyskinesia: Jaw | ||
ESRSA119 | C118097 | ESRSA1-Dyskinesia: Eyes/Up Face/Low Face | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Eyes, upper face, lower face. | ESRS-A - Dyskinesia: Eyes/Upper Face/Lower Face | ||
ESRSA120 | C118098 | ESRSA1-Dyskinesia: Shoulder/Up Limb/Hand | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Shoulders, upper limbs, hands. | ESRS-A - Dyskinesia: Shoulder/Upper Limbs/Hands | ||
ESRSA121 | C118099 | ESRSA1-Dyskinesia: Hips/Lower Limbs/Feet | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Hips, lower limbs, feet. | ESRS-A - Dyskinesia: Hips/Lower Limbs/Feet | ||
ESRSA122 | C118100 | ESRSA1-Dyskinesia: Trunk/Neck | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Trunk, neck. | ESRS-A - Dyskinesia: Trunk/Neck | ||
ESRSA123 | C118101 | ESRSA1-Akathisia: Subjective | Extrapyramidal Symptom Rating Scale-Abbreviated - Akathisia: Subjective. | ESRS-A - Akathisia: Subjective | ||
ESRSA124 | C118102 | ESRSA1-Akathisia: Objective | Extrapyramidal Symptom Rating Scale-Abbreviated - Akathisia: Objective. | ESRS-A - Akathisia: Objective | ||
ESRSA125 | C118103 | ESRSA1-CGI-S Parkinsonism | Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Parkinsonism. | ESRS-A - CGI-S Parkinsonism | ||
ESRSA126 | C118104 | ESRSA1-CGI-S Dystonia | Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Dystonia. | ESRS-A - CGI-S Dystonia | ||
ESRSA127 | C118105 | ESRSA1-CGI-S Dyskinesia | Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Dyskinesia. | ESRS-A - CGI-S Dyskinesia | ||
ESRSA128 | C118106 | ESRSA1-CGI-S Akathisia | Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Akathisia. | ESRS-A - CGI-S Akathisia | ||
Back to top | ||||||
CL.C117990.ESRSA1TN | Extrapyramidal Symptom Rating Scale-Abbreviated Clinical Classification Test Name
(ESRSA1TN) | text
Extensible: No | C117990 | Extrapyramidal Symptom Rating Scale-Abbreviated Clinical Classification Test Name | Extrapyramidal Symptom Rating Scale-Abbreviated test name. | CDISC Clinical Classification ESRS-A Test Name Terminology |
ESRSA1-Akathisia: Objective | C118102 | ESRSA1-Akathisia: Objective | Extrapyramidal Symptom Rating Scale-Abbreviated - Akathisia: Objective. | ESRS-A - Akathisia: Objective | ||
ESRSA1-Akathisia: Subjective | C118101 | ESRSA1-Akathisia: Subjective | Extrapyramidal Symptom Rating Scale-Abbreviated - Akathisia: Subjective. | ESRS-A - Akathisia: Subjective | ||
ESRSA1-Bradykinesia/Hypokinesia | C118088 | ESRSA1-Bradykinesia/Hypokinesia | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Bradykinesia/hypokinesia. | ESRS-A - Bradykinesia/Hypokinesia | ||
ESRSA1-CGI-S Akathisia | C118106 | ESRSA1-CGI-S Akathisia | Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Akathisia. | ESRS-A - CGI-S Akathisia | ||
ESRSA1-CGI-S Dyskinesia | C118105 | ESRSA1-CGI-S Dyskinesia | Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Dyskinesia. | ESRS-A - CGI-S Dyskinesia | ||
ESRSA1-CGI-S Dystonia | C118104 | ESRSA1-CGI-S Dystonia | Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Dystonia. | ESRS-A - CGI-S Dystonia | ||
ESRSA1-CGI-S Parkinsonism | C118103 | ESRSA1-CGI-S Parkinsonism | Extrapyramidal Symptom Rating Scale-Abbreviated - Clinical Global Impression (CGI-S): Parkinsonism. | ESRS-A - CGI-S Parkinsonism | ||
ESRSA1-Dyskinesia: Eyes/Up Face/Low Face | C118097 | ESRSA1-Dyskinesia: Eyes/Up Face/Low Face | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Eyes, upper face, lower face. | ESRS-A - Dyskinesia: Eyes/Upper Face/Lower Face | ||
ESRSA1-Dyskinesia: Hips/Lower Limbs/Feet | C118099 | ESRSA1-Dyskinesia: Hips/Lower Limbs/Feet | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Hips, lower limbs, feet. | ESRS-A - Dyskinesia: Hips/Lower Limbs/Feet | ||
ESRSA1-Dyskinesia: Jaw | C118096 | ESRSA1-Dyskinesia: Jaw | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Jaw. | ESRS-A - Dyskinesia: Jaw | ||
ESRSA1-Dyskinesia: Shoulder/Up Limb/Hand | C118098 | ESRSA1-Dyskinesia: Shoulder/Up Limb/Hand | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Shoulders, upper limbs, hands. | ESRS-A - Dyskinesia: Shoulder/Upper Limbs/Hands | ||
ESRSA1-Dyskinesia: Tongue | C118095 | ESRSA1-Dyskinesia: Tongue | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Tongue. | ESRS-A - Dyskinesia: Tongue | ||
ESRSA1-Dyskinesia: Trunk/Neck | C118100 | ESRSA1-Dyskinesia: Trunk/Neck | Extrapyramidal Symptom Rating Scale-Abbreviated - Dyskinesia: Trunk, neck. | ESRS-A - Dyskinesia: Trunk/Neck | ||
ESRSA1-Dystonia: Eyes/Face/Larynx | C118091 | ESRSA1-Dystonia: Eyes/Face/Larynx | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Eyes, upper face, lower face, larynx. | ESRS-A - Dystonia: Eyes/Upper and Lower Face/Larynx | ||
ESRSA1-Dystonia: Hips/Lower Limbs/Feet | C118093 | ESRSA1-Dystonia: Hips/Lower Limbs/Feet | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Hips, lower limbs, feet. | ESRS-A - Dystonia: Hips/Lower Limbs/Feet | ||
ESRSA1-Dystonia: Jaw | C118090 | ESRSA1-Dystonia: Jaw | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Jaw. | ESRS-A - Dystonia: Jaw | ||
ESRSA1-Dystonia: Shoulder/Up Limb/Hand | C118092 | ESRSA1-Dystonia: Shoulder/Up Limb/Hand | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Shoulders, upper limbs, hands. | ESRS-A - Dystonia: Shoulder/Upper Limbs/Hands | ||
ESRSA1-Dystonia: Tongue | C118089 | ESRSA1-Dystonia: Tongue | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Tongue. | ESRS-A - Dystonia: Tongue | ||
ESRSA1-Dystonia: Trunk/Neck | C118094 | ESRSA1-Dystonia: Trunk/Neck | Extrapyramidal Symptom Rating Scale-Abbreviated - Dystonia: Trunk, neck. | ESRS-A - Dystonia: Trunk/Neck | ||
ESRSA1-Impaired Gait/Posture | C118086 | ESRSA1-Impaired Gait/Posture | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Impaired gait/posture. | ESRS-A - Impaired Gait/Posture | ||
ESRSA1-Postural Instability | C118087 | ESRSA1-Postural Instability | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Postural instability. | ESRS-A - Postural Instability | ||
ESRSA1-Reduced Facial Expression/Speech | C118085 | ESRSA1-Reduced Facial Expression/Speech | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Reduced facial expression/speech. | ESRS-A - Reduced Facial Expression/Speech | ||
ESRSA1-Rigidity: Lower Limbs | C118080 | ESRSA1-Rigidity: Lower Limbs | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Lower limbs. | ESRS-A - Rigidity: Lower Limbs | ||
ESRSA1-Rigidity: Neck | C118081 | ESRSA1-Rigidity: Neck | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Neck. | ESRS-A - Rigidity: Neck | ||
ESRSA1-Rigidity: Upper Limbs | C118079 | ESRSA1-Rigidity: Upper Limbs | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Rigidity: Upper limbs. | ESRS-A - Rigidity: Upper Limbs | ||
ESRSA1-Tremor: Face/Jaw/Chin/Lips/Head | C118082 | ESRSA1-Tremor: Face/Jaw/Chin/Lips/Head | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Face, jaw/chin, lips, head. | ESRS-A - Tremor: Face/Jaw/Chin/Lips/Head | ||
ESRSA1-Tremor: Lower Limbs/Feet | C118084 | ESRSA1-Tremor: Lower Limbs/Feet | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Lower limbs/feet. | ESRS-A - Tremor: Lower Limbs/Feet | ||
ESRSA1-Tremor: Upper Limbs/Hands | C118083 | ESRSA1-Tremor: Upper Limbs/Hands | Extrapyramidal Symptom Rating Scale-Abbreviated - Parkinsonism-Tremor: Upper limbs/hands. | ESRS-A - Tremor: Upper Limbs/Hands | ||
Back to top | ||||||
CL.C100154.FPSR1TC | Faces Pain Scale - Revised Questionnaire Test Code
(FPSR1TC) | text
Extensible: No | C100154 | Faces Pain Scale - Revised Questionnaire Test Code | Faces Pain Scale - Revised test code. | CDISC Questionnaire FPSR Test Code Terminology |
FPSR101 | C101013 | FPSR1-How Much Do You Hurt | Faces Pain Scale - Revised - Point to the face that shows how much you hurt [right now]. | FPSR - How Much Do You Hurt | ||
Back to top | ||||||
CL.C100153.FPSR1TN | Faces Pain Scale - Revised Questionnaire Test Name
(FPSR1TN) | text
Extensible: No | C100153 | Faces Pain Scale - Revised Questionnaire Test Name | Faces Pain Scale - Revised test name. | CDISC Questionnaire FPSR Test Name Terminology |
FPSR1-How Much Do You Hurt | C101013 | FPSR1-How Much Do You Hurt | Faces Pain Scale - Revised - Point to the face that shows how much you hurt [right now]. | FPSR - How Much Do You Hurt | ||
Back to top | ||||||
CL.C193276.FES01TC | Falls Efficacy Scale Questionnaire Test Code
(FES01TC) | text
Extensible: No | C193276 | Falls Efficacy Scale Questionnaire Test Code | Falls Efficacy Scale test code. | CDISC Questionnaire Falls Efficacy Scale Test Code Terminology |
FES0101 | C193363 | FES01-Take a Bath or Shower | Falls Efficacy Scale - Take a bath or shower. | FES - Take a Bath or Shower | ||
FES0102 | C193364 | FES01-Reach Into Cabinets or Closets | Falls Efficacy Scale - Reach into cabinets or closets. | FES - Reach Into Cabinets or Closets | ||
FES0103 | C193365 | FES01-Walk Around the House | Falls Efficacy Scale - Walk around the house. | FES - Walk Around the House | ||
FES0104 | C193366 | FES01-Prepare Meals Not Carrying Objects | Falls Efficacy Scale - Prepare meals not requiring carrying heavy or hot objects. | FES - Prepare Meals Not Carrying Objects | ||
FES0105 | C193367 | FES01-Get In and Out of Bed | Falls Efficacy Scale - Get in and out of bed. | FES - Get In and Out of Bed | ||
FES0106 | C193368 | FES01-Answer the Door or Telephone | Falls Efficacy Scale - Answer the door or telephone. | FES - Answer the Door or Telephone | ||
FES0107 | C193369 | FES01-Get In and Out of Chair | Falls Efficacy Scale - Get in and out of a chair. | FES - Get In and Out of Chair | ||
FES0108 | C193370 | FES01-Get Dressed and Undressed | Falls Efficacy Scale - Get dressed and undressed. | FES - Get Dressed and Undressed | ||
FES0109 | C193371 | FES01-Personal Grooming | Falls Efficacy Scale - Personal grooming (i.e. washing your face). | FES - Personal Grooming | ||
FES0110 | C193372 | FES01-Get On and Off of Toilet | Falls Efficacy Scale - Get on and off of the toilet. | FES - Get On and Off of Toilet | ||
Back to top | ||||||
CL.C193275.FES01TN | Falls Efficacy Scale Questionnaire Test Name
(FES01TN) | text
Extensible: No | C193275 | Falls Efficacy Scale Questionnaire Test Name | Falls Efficacy Scale test name. | CDISC Questionnaire Falls Efficacy Scale Test Name Terminology |
FES01-Answer the Door or Telephone | C193368 | FES01-Answer the Door or Telephone | Falls Efficacy Scale - Answer the door or telephone. | FES - Answer the Door or Telephone | ||
FES01-Get Dressed and Undressed | C193370 | FES01-Get Dressed and Undressed | Falls Efficacy Scale - Get dressed and undressed. | FES - Get Dressed and Undressed | ||
FES01-Get In and Out of Bed | C193367 | FES01-Get In and Out of Bed | Falls Efficacy Scale - Get in and out of bed. | FES - Get In and Out of Bed | ||
FES01-Get In and Out of Chair | C193369 | FES01-Get In and Out of Chair | Falls Efficacy Scale - Get in and out of a chair. | FES - Get In and Out of Chair | ||
FES01-Get On and Off of Toilet | C193372 | FES01-Get On and Off of Toilet | Falls Efficacy Scale - Get on and off of the toilet. | FES - Get On and Off of Toilet | ||
FES01-Personal Grooming | C193371 | FES01-Personal Grooming | Falls Efficacy Scale - Personal grooming (i.e. washing your face). | FES - Personal Grooming | ||
FES01-Prepare Meals Not Carrying Objects | C193366 | FES01-Prepare Meals Not Carrying Objects | Falls Efficacy Scale - Prepare meals not requiring carrying heavy or hot objects. | FES - Prepare Meals Not Carrying Objects | ||
FES01-Reach Into Cabinets or Closets | C193364 | FES01-Reach Into Cabinets or Closets | Falls Efficacy Scale - Reach into cabinets or closets. | FES - Reach Into Cabinets or Closets | ||
FES01-Take a Bath or Shower | C193363 | FES01-Take a Bath or Shower | Falls Efficacy Scale - Take a bath or shower. | FES - Take a Bath or Shower | ||
FES01-Walk Around the House | C193365 | FES01-Walk Around the House | Falls Efficacy Scale - Walk around the house. | FES - Walk Around the House | ||
Back to top | ||||||
CL.C113850.FSS01TC | Fatigue Severity Scale Questionnaire Test Code
(FSS01TC) | text
Extensible: No | C113850 | Fatigue Severity Scale Questionnaire Test Code | Fatigue Severity Scale test code. | CDISC Questionnaire Fatigue Severity Scale Test Code Terminology |
FSS0101 | C113944 | FSS01-Motivation Is Lower When Fatigued | Fatigue Severity Scale - My motivation is lower when I am fatigued. | FSS - Motivation is Lower When Fatigued | ||
FSS0102 | C113945 | FSS01-Exercise Brings on My Fatigue | Fatigue Severity Scale - Exercise brings on my fatigue. | FSS - Exercise Brings on My Fatigue | ||
FSS0103 | C113946 | FSS01-I Am Easily Fatigued | Fatigue Severity Scale - I am easily fatigued. | FSS - I Am Easily Fatigued | ||
FSS0104 | C113947 | FSS01-Interferes With Phys Function | Fatigue Severity Scale - Fatigue interferes with my physical functioning. | FSS - Fatigue Interferes With Physical Functioning | ||
FSS0105 | C113948 | FSS01-Fatigue Causes Frequent Problems | Fatigue Severity Scale - Fatigue causes frequent problems for me. | FSS - Fatigue Causes Frequent Problems | ||
FSS0106 | C113949 | FSS01-Prevents Sustained Phys Function | Fatigue Severity Scale - My fatigue prevents sustained physical functioning. | FSS - Fatigue Prevents Sustained Physical Functioning | ||
FSS0107 | C113950 | FSS01-Fatigue Interferes With Duties | Fatigue Severity Scale - Fatigue interferes with carrying out certain duties and responsibilities. | FSS - Fatigue Interferes With Carrying Out Duties | ||
FSS0108 | C113951 | FSS01-Among My 3 Most Disabling Symptoms | Fatigue Severity Scale - Fatigue is among my three most disabling symptoms. | FSS - Fatigue is Among Most Disabling Symptoms | ||
FSS0109 | C113952 | FSS01-Fatigue Interferes With My Life | Fatigue Severity Scale - Fatigue interferes with my work, family, or social life. | FSS - Fatigue Interferes With Work | ||
Back to top | ||||||
CL.C113849.FSS01TN | Fatigue Severity Scale Questionnaire Test Name
(FSS01TN) | text
Extensible: No | C113849 | Fatigue Severity Scale Questionnaire Test Name | Fatigue Severity Scale test name. | CDISC Questionnaire Fatigue Severity Scale Test Name Terminology |
FSS01-Among My 3 Most Disabling Symptoms | C113951 | FSS01-Among My 3 Most Disabling Symptoms | Fatigue Severity Scale - Fatigue is among my three most disabling symptoms. | FSS - Fatigue is Among Most Disabling Symptoms | ||
FSS01-Exercise Brings on My Fatigue | C113945 | FSS01-Exercise Brings on My Fatigue | Fatigue Severity Scale - Exercise brings on my fatigue. | FSS - Exercise Brings on My Fatigue | ||
FSS01-Fatigue Causes Frequent Problems | C113948 | FSS01-Fatigue Causes Frequent Problems | Fatigue Severity Scale - Fatigue causes frequent problems for me. | FSS - Fatigue Causes Frequent Problems | ||
FSS01-Fatigue Interferes With Duties | C113950 | FSS01-Fatigue Interferes With Duties | Fatigue Severity Scale - Fatigue interferes with carrying out certain duties and responsibilities. | FSS - Fatigue Interferes With Carrying Out Duties | ||
FSS01-Fatigue Interferes With My Life | C113952 | FSS01-Fatigue Interferes With My Life | Fatigue Severity Scale - Fatigue interferes with my work, family, or social life. | FSS - Fatigue Interferes With Work | ||
FSS01-I Am Easily Fatigued | C113946 | FSS01-I Am Easily Fatigued | Fatigue Severity Scale - I am easily fatigued. | FSS - I Am Easily Fatigued | ||
FSS01-Interferes With Phys Function | C113947 | FSS01-Interferes With Phys Function | Fatigue Severity Scale - Fatigue interferes with my physical functioning. | FSS - Fatigue Interferes With Physical Functioning | ||
FSS01-Motivation Is Lower When Fatigued | C113944 | FSS01-Motivation Is Lower When Fatigued | Fatigue Severity Scale - My motivation is lower when I am fatigued. | FSS - Motivation is Lower When Fatigued | ||
FSS01-Prevents Sustained Phys Function | C113949 | FSS01-Prevents Sustained Phys Function | Fatigue Severity Scale - My fatigue prevents sustained physical functioning. | FSS - Fatigue Prevents Sustained Physical Functioning | ||
Back to top | ||||||
CL.C160926.FDATSRS | FDA Technical Specification Response
(FDATSRS) | text
Extensible: Yes | C160926 | FDA Technical Specification Response | Terminology relevant to the version of the FDA technical specification guide used in the study. | CDISC SDTM FDA Technical Specification Response Terminology |
Clinical Endpoint BE Studies v1.0 | C161475 | Version 1.0 of the FDA Clinical Endpoint BE Studies Technical Specifications Guidance. | US FDA Clinical Endpoint BE Studies v1.0 | |||
HIV Technical Specifications Guidance v1.0 | C161473 | Version 1.0 of the FDA HIV Technical Specifications Guidance. | US FDA HIV Technical Specifications Guidance v1.0 | |||
Study Data Technical Conformance Guide v4.2.1 | C161476 | Version 4.2.1 of the FDA Study Data Technical Conformance Guide. | US FDA Study Data Technical Conformance Guide v4.2.1 | |||
Study Data Technical Conformance Guide v4.3 | C165874 | Version 4.3 of the FDA Study Data Technical Conformance Guide. | FDA Study Data Technical Conformance Guide v4.3 | |||
Study Data Technical Conformance Guide v4.4 | C170572 | Version 4.4 of the FDA Study Data Technical Conformance Guide. | FDA Study Data Technical Conformance Guide v4.4 | |||
Study Data Technical Conformance Guide v4.5 | C174287 | Version 4.5 of the FDA Study Data Technical Conformance Guide. | Study Data Technical Conformance Guide v4.5 | |||
Study Data Technical Conformance Guide v4.5.1 | C177946 | Version 4.5.1 of the FDA Study Data Technical Conformance Guide. | Study Data Technical Conformance Guide v4.5.1 | |||
Study Data Technical Conformance Guide v4.6 | C181322 | Version 4.6 of the FDA Study Data Technical Conformance Guide. | Study Data Technical Conformance Guide v4.6 | |||
Study Data Technical Conformance Guide v4.7 | C181323 | Version 4.7 of the FDA Study Data Technical Conformance Guide. | Study Data Technical Conformance Guide v4.7 | |||
Study Data Technical Conformance Guide v4.8 | C187752 | Version 4.8 of the FDA Study Data Technical Conformance Guide. | Study Data Technical Conformance Guide v4.8 | |||
Vaccines Technical Specification Guidance v1.0 | C161474 | Version 1.0 of the FDA Vaccines Technical Specifications Guidance. | US FDA Vaccines Technical Specification Guidance v1.0 | |||
Back to top | ||||||
CL.C101832.FATESTCD | Findings About Test Code
(FATESTCD) | text
Extensible: Yes | C101832 | Findings About Test Code | Terminology relevant to the test codes that describe findings about an event or intervention. | CDISC SDTM Findings About Test Code Terminology |
ABSCNUM | C181313 | Number of Abscesses | The number of abscesses observed. | Number of Abscesses | ||
ACMITYPE | C118936 | Acute Myocardial Infarction Type | Categorization of the type of acute myocardial infarction. | Acute Myocardial Infarction Type | ||
ACNDEV | C117037 | Action Taken With Device | Action taken with respect to a device in a study, which may or may not be the device under study. | Action Taken with Device | ||
ACNSBJ | C163412 | Action Taken With Subject | Action taken with respect to a subject in a study. | Action Taken With Subject | ||
ACUTSTRS | C124437 | Most Severe Acute Stressor | The agent, stimulus, activity, or event that causes stress with an acute frequency, which has the highest level of severity. | Most Severe Acute Stressor | ||
AGEEPSD1 | C124438 | Age At First Episode | The age at which the first episode occurred. | Age at First Episode | ||
AGEFTUSE | C139175 | Age at Full-Time Use | The age at which the full-time use of a pre-specified object first occurred. | Age at Full-Time Use | ||
AGEHOSP1 | C124439 | Age At First Hospitalization | The age at which the first hospitalization event occurred. | Age at First Hospitalization | ||
AGESYMST | C174273 | Age Symptoms Started | The age at which illness-specific symptoms first began. | Age Symptom Started | ||
AGETRT1 | C124440 | Age At First Treatment | The age at which the first treatment for the condition occurred. | Age at First Treatment | ||
ALCDRKN | C184464 | Number of Alcoholic Drinks | The total number of alcoholic drinks. | Number of Alcoholic Drinks Measurement | ||
APPEAR | C25377 | Aper | The outward or visible aspect of an entity. | Appearance | ||
BIOPSIND | C181316 | Biopsy Specimen Taken Indicator | An indication as to whether a biopsy specimen was collected. | Biopsy Specimen Taken Indicator | ||
BIOPSNUM | C181317 | Number of Biopsy Specimens Taken | The total number of biopsy specimens collected. | Number of Biopsy Specimens Taken | ||
BPSPTHAP | C181318 | Pathologic Appearance of Biopsy Site | A description of the appearance of the anatomical site from which a biopsy specimen has been collected. | Pathologic Appearance of Biopsy Site | ||
CALBURN | C172476 | Calories Burned | A measurement of the number of calories expended. | Calories Burned | ||
CATMTHID | C119229 | Coronary Artery Thrombosis Method Ident | The method by which the coronary artery thrombosis event is determined or diagnosed. | Coronary Artery Thrombosis Method of Identification | ||
CHRNSTRS | C124441 | Most Severe Chronic Stressor | The agent, stimulus, activity, or event that causes stress with a chronic frequency, which has the highest level of severity. | Most Severe Chronic Stressor | ||
CLININD | C124442 | Clinic Stay Indicator | An indication as to whether the subject was admitted to a healthcare clinic. | Clinic Stay Indicator | ||
CUMEXP | C94596 | Cumulative Exposure | The total amount that a subject is exposed to over time. | Cumulative Exposure | ||
DACARO | C184449 | Dietary Alpha Carotene | A determination of the alpha carotene in a nutritional product or meal, or a portion thereof. | Dietary Alpha Carotene Measurement | ||
DADDSUG | C172463 | Dietary Added Sugar | A determination of the total added sugars in a nutritional product or meal, or a portion thereof. | Dietary Added Sugar Measurement | ||
DALCOHOL | C184463 | Dietary Alcohol;Dietary Ethanol | A determination of the total amount of alcohol in a nutritional product or meal, or a portion thereof. | Dietary Alcohol Measurement | ||
DARAC | C184441 | Dietary 20:4 Arachidonate;Dietary 20:4 Arachidonic Acid;Dietary Arachidonic Acid | A determination of the total 20:4 arachidonic acid in a nutritional product or meal, or a portion thereof. | Dietary Arachidonic Acid Measurement | ||
DATOCO | C184450 | Dietary Alpha Tocopherol | A determination of the alpha tocopherol in a nutritional product or meal, or a portion thereof. | Dietary Alpha Tocopherol Measurement | ||
DAVITB12 | C184461 | Dietary Added Vitamin B12 | A determination of the total added vitamin B12 in a nutritional product or meal, or a portion thereof. | Dietary Added Vitamin B12 Measurement | ||
DAVITE | C184462 | Dietary Added Vitamin E | A determination of the total added vitamin E in a nutritional product or meal, or a portion thereof. | Dietary Added Vitamin E Measurement | ||
DBCARO | C184451 | Dietary Beta Carotene | A determination of the beta carotene in a nutritional product or meal, or a portion thereof. | Dietary Beta Carotene Measurement | ||
DBEANPEA | C184465 | Dietary Beans and Peas | A determination of the total beans and peas in a nutritional product or meal, or a portion thereof. | Dietary Beans and Peas Measurement | ||
DBUTR | C184446 | Dietary 4:0 Butyrate;Dietary 4:0 Butyric Acid;Dietary Butyric Acid | A determination of the total 4:0 butyric acid in a nutritional product or meal, or a portion thereof. | Dietary Butyric Acid Measurement | ||
DCA | C184453 | Dietary Calcium | A determination of the total calcium in a nutritional product or meal, or a portion thereof. | Dietary Calcium Measurement | ||
DCAFFEIN | C184452 | Dietary Caffeine | A determination of the caffeine in a nutritional product or meal, or a portion thereof. | Dietary Caffeine Measurement | ||
DCAL | C172464 | Dietary Calories | A determination of the total dietary calories in a nutritional product or meal, or a portion thereof. | Dietary Calories Measurement | ||
DCAPO | C184447 | Dietary 6:0 Caproate;Dietary 6:0 Caproic Acid;Dietary Caproic Acid | A determination of the total 6:0 caproic acid in a nutritional product or meal, or a portion thereof. | Dietary Caproic Acid Measurement | ||
DCAPR | C184430 | Dietary 10:0 Caprate;Dietary 10:0 Capric Acid;Dietary Capric Acid | A determination of the total 10:0 capric acid in a nutritional product or meal, or a portion thereof. | Dietary Capric Acid Measurement | ||
DCAPY | C184448 | Dietary 8:0 Caprylate;Dietary 8:0 Caprylic Acid;Dietary Caprylic Acid | A determination of the total 8:0 caprylic acid in a nutritional product or meal, or a portion thereof. | Dietary Caprylic Acid Measurement | ||
DCARBT | C172461 | Dietary Total Carbohydrate | A determination of the total carbohydrate in a nutritional product or meal, or a portion thereof. | Total Dietary Carbohydrate Measurement | ||
DCDEPIND | C176284 | Unable to Discon Dependent Indicator;Unable to Discontinue Dependent Indicator | An indication as to whether an individual is unable to discontinue the use of a substance due to dependence. | Unable to Discontinue Use Due to Dependence Indicator | ||
DCHEESE | C184454 | Dietary Cheese | A determination of the total cheese in a nutritional product or meal, or a portion thereof. | Dietary Cheese Measurement | ||
DCHOLEST | C184466 | Dietary Cholesterol | A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. | Dietary Cholesterol Measurement | ||
DCHOLINE | C184467 | Dietary Choline | A determination of the choline in a nutritional product or meal, or a portion thereof. | Dietary Choline Measurement | ||
DCITMELB | C184468 | Dietary Citrus, Melons, and Berries | A determination of the total citrus, melons, and berries in a nutritional product or meal, or a portion thereof. | Dietary Citrus, Melons, and Berries Measurement | ||
DCPND | C184444 | Dietary 22:5 Clupanodonate;Dietary 22:5 Clupanodonic Acid;Dietary Clupanodonic Acid | A determination of the total 22:5 clupanodonic acid in a nutritional product or meal, or a portion thereof. | Dietary Clupanodonic Acid Measurement | ||
DCRXANB | C186015 | Dietary Beta-Cryptoxanthin | A determination of the beta-cryptoxanthin in a nutritional product or meal, or a portion thereof. | Dietary Beta-Cryptoxanthin Measurement | ||
DCU | C184455 | Dietary Copper | A determination of the total copper in a nutritional product or meal, or a portion thereof. | Dietary Copper Measurement | ||
DDAIRYT | C184337 | Dietary Total Dairy | A determination of the total dairy (food products produced from or containing milk) in a nutritional product or meal, or a portion thereof. | Dietary Dairy Measurement | ||
DDCHX | C184445 | Dietary 22:6 Docosahexaenoate;Dietary 22:6 Docosahexaenoic Acid;Dietary Docosahexaenoic Acid | A determination of the total 22:6 docosahexaenoic acid in a nutritional product or meal, or a portion thereof. | Dietary Docosahexaenoic Acid Measurement | ||
DEGGS | C184471 | Dietary Eggs | A determination of the eggs in a nutritional product or meal, or a portion thereof. | Dietary Eggs Measurement | ||
DERUC | C184443 | Dietary 22:1 Erucate;Dietary 22:1 Erucic Acid;Dietary Erucic Acid | A determination of the total 22:1 erucic acid in a nutritional product or meal, or a portion thereof. | Dietary Erucic Acid Measurement | ||
DEVPNUM | C176277 | Number of Devices Present | A determination of the number of devices within a subject. | Number of Devices Present | ||
DFATM | C172471 | Dietary Fat, Monounsaturated | A determination of the total monounsaturated fat in a nutritional product or meal, or a portion thereof. | Dietary Monounsaturated Fat Measurement | ||
DFATP | C172472 | Dietary Fat, Polyunsaturated | A determination of the total polyunsaturated fat in a nutritional product or meal, or a portion thereof. | Dietary Polyunsaturated Fat Measurement | ||
DFATS | C172470 | Dietary Fat, Saturated | A determination of the total saturated fat in a nutritional product or meal, or a portion thereof. | Dietary Saturated Fat Measurement | ||
DFATT | C172460 | Dietary Fat, Total | A determination of the total fat in a nutritional product or meal, or a portion thereof. | Total Dietary Fat Measurement | ||
DFE | C184456 | Dietary Iron | A determination of the total iron in a nutritional product or meal, or a portion thereof. | Dietary Iron Measurement | ||
DFEQ | C186016 | DFE;Dietary Folate Equivalents | The sum of food folate and normalized folic acid (as food folate equivalents) in a nutritional product or meal, or a portion thereof. | Dietary Folate Equivalents Measurement | ||
DFIBER | C172469 | Dietary Fiber | A determination of the total fiber in a nutritional product or meal, or a portion thereof. | Dietary Fiber Measurement | ||
DFOLFD | C186017 | Dietary Food Folate | A determination of the naturally occurring folate in a nutritional product or meal, or a portion thereof. | Dietary Food Folate Measurement | ||
DFOLIC | C186018 | Dietary Folic Acid | A determination of the folic acid in a nutritional product or meal, or a portion thereof. | Dietary Folic Acid Measurement | ||
DFOLTOT | C186019 | Dietary Total Folate | A determination of the total folate (supplemental folic acid + food folate) in a nutritional product or meal, or a portion thereof. | Dietary Total Folate Measurement | ||
DFRTJUCE | C184472 | Dietary Fruit Juice | A determination of the fruit juice in a nutritional product or meal, or a portion thereof. | Dietary Fruit Juice Measurement | ||
DFRUIT | C172465 | Dietary Fruit | A determination of the total fruit in a nutritional product or meal, or a portion thereof. | Dietary Fruit Measurement | ||
DGADL | C184440 | Dietary 20:1 Gadoleate;Dietary 20:1 Gadoleic Acid;Dietary Gadoleic Acid | A determination of the total 20:1 gadoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Gadoleic Acid Measurement | ||
DGRAIN | C172467 | Dietary Grain | A determination of the total grain in a nutritional product or meal, or a portion thereof. | Dietary Grain Measurement | ||
DGRAINRF | C184484 | Dietary Grain, Refined | A determination of the total refined grains in a nutritional product or meal, or a portion thereof. | Dietary Grain, Refined Measurement | ||
DGRAINWH | C184502 | Dietary Whole Grains | A determination of the whole grains in a nutritional product or meal, or a portion thereof. | Dietary Whole Grains Measurement | ||
DIAMETER | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
DISPAMT | C78721 | Dispensed Amount | The quantity of a product that has been dispensed. (NCI) | Dispensed Amount | ||
DISTANCE | C25167 | Distance | The actual or calculated span between two points (real or virtual). | Distance | ||
DISTR | C198212 | Distribution | Description of the distribution pattern of a finding within the examined area. | Distribution Pattern Finding Description | ||
DK | C184457 | Dietary Potassium | A determination of the total potassium in a nutritional product or meal, or a portion thereof. | Dietary Potassium Measurement | ||
DLAUR | C184431 | Dietary 12:0 Laurate;Dietary 12:0 Lauric Acid;Dietary Lauric Acid | A determination of the total 12:0 lauric acid in a nutritional product or meal, or a portion thereof. | Dietary Lauric Acid Measurement | ||
DLINO | C184437 | Dietary 18:2 Linoleate;Dietary 18:2 Linoleic Acid;Dietary Linoleic Acid | A determination of the total 18:2 linoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Linoleic Acid Measurement | ||
DLINOL | C184438 | Dietary 18:3 Linolenate;Dietary 18:3 Linolenic Acid;Dietary Linolenic Acid | A determination of the total 18:3 linolenic acid in a nutritional product or meal, or a portion thereof. | Dietary Linolenic Acid Measurement | ||
DLUTZXAN | C184473 | Dietary Lutein and Zeaxanthin | A determination of the lutein and zeaxanthin in a nutritional product or meal, or a portion thereof. | Dietary Lutein and Zeaxanthin Measurement | ||
DLYCOP | C184474 | Dietary Lycopene | A determination of the lycopene in a nutritional product or meal, or a portion thereof. | Dietary Lycopene Measurement | ||
DMEAT | C172468 | Dietary Meat | A determination of the total meat in a nutritional product or meal, or a portion thereof. | Dietary Meat Measurement | ||
DMEATCUR | C184469 | Dietary Meat, Cured | A determination of the cured meat in a nutritional product or meal, or a portion thereof. | Dietary Meat, Cured Measurement | ||
DMEATORG | C184480 | Dietary Meat, Organ | A determination of the organ meat in a nutritional product or meal, or a portion thereof. | Dietary Meat, Organ Measurement | ||
DMEATPLS | C184504 | Dietary Meat, Poultry, and Seafood | A determination of the total meat, poultry, and seafood in a nutritional product or meal, or a portion thereof. | Dietary Meat, Poultry, and Seafood Measurement | ||
DMG | C172462 | Dietary Magnesium | A determination of the total magnesium in a nutritional product or meal, or a portion thereof. | Dietary Magnesium Measurement | ||
DMILK | C184475 | Dietary Milk | A determination of the milk in a nutritional product or meal, or a portion thereof. | Dietary Milk Measurement | ||
DMOISTUR | C184476 | Dietary Moisture | A determination of the moisture content in a nutritional product or meal, or a portion thereof. | Dietary Moisture Measurement | ||
DMYRST | C184432 | Dietary 14:0 Myristate;Dietary 14:0 Myristic Acid;Dietary Myristic Acid | A determination of the total 14:0 myristic acid in a nutritional product or meal, or a portion thereof. | Dietary Myristic Acid Measurement | ||
DNA | C184459 | Dietary Sodium | A determination of the total sodium in a nutritional product or meal, or a portion thereof. | Dietary Sodium Measurement | ||
DNIACIN | C184477 | Dietary Niacin;Dietary Vitamin B3 | A determination of the niacin in a nutritional product or meal, or a portion thereof. | Dietary Niacin Measurement | ||
DNUTSEED | C184478 | Dietary Nuts and Seeds | A determination of the total nuts and seeds in a nutritional product or meal, or a portion thereof. | Dietary Nuts and Seeds Measurement | ||
DOILS | C184479 | Dietary Oils | A determination of the oils in a nutritional product or meal, or a portion thereof. | Dietary Oils Measurement | ||
DOLE | C184436 | Dietary 18:1 Oleate;Dietary 18:1 Oleic Acid;Dietary Oleic Acid | A determination of the total 18:1 oleic acid in a nutritional product or meal, or a portion thereof. | Dietary Oleic Acid Measurement | ||
DP | C184481 | Dietary Phosphorus | A determination of the phosphorus in a nutritional product or meal, or a portion thereof. | Dietary Phosphorus Measurement | ||
DPALM | C184433 | Dietary 16:0 Palmitate;Dietary 16:0 Palmitic Acid;Dietary Palmitic Acid | A determination of the total 16:0 palmitic acid in a nutritional product or meal, or a portion thereof. | Dietary Palmitic Acid Measurement | ||
DPALMO | C184434 | Dietary 16:1 Palmitoleate;Dietary 16:1 Palmitoleic Acid;Dietary Palmitoleic Acid | A determination of the total 16:1 palmitoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Palmitoleic Acid Measurement | ||
DPARN | C184439 | Dietary 18:4 Parinarate;Dietary 18:4 Parinaric Acid;Dietary Parinaric Acid | A determination of the total 18:4 parinaric acid in a nutritional product or meal, or a portion thereof. | Dietary Parinaric Acid Measurement | ||
DPOTATO | C184482 | Dietary Potatoes | A determination of the potatoes in a nutritional product or meal, or a portion thereof. | Dietary Potatoes Measurement | ||
DPOULTRY | C184483 | Dietary Poultry | A determination of the poultry in a nutritional product or meal, or a portion thereof. | Dietary Poultry Measurement | ||
DPROT | C172459 | Dietary Protein | A determination of the total protein in a nutritional product or meal, or a portion thereof. | Dietary Protein Measurement | ||
DPROTFD | C184494 | Dietary Protein Foods | A determination of the protein-rich food in a nutritional product or meal, or a portion thereof. | Dietary Protein Foods Measurement | ||
DRETINOL | C184485 | Dietary Retinol;Dietary Vitamin A | A determination of the retinol in a nutritional product or meal, or a portion thereof. | Dietary Retinol Measurement | ||
DRIBFLVN | C184486 | Dietary Riboflavin;Dietary Vitamin B2 | A determination of the riboflavin in a nutritional product or meal, or a portion thereof. | Dietary Riboflavin Measurement | ||
DRSTAT | C102626 | Drug Resistance Status | The state or condition of not responding to a pharmacological agent. | Drug Resistance Status | ||
DSE | C184458 | Dietary Selenium | A determination of the total selenium in a nutritional product or meal, or a portion thereof. | Dietary Selenium Measurement | ||
DSFHN3FA | C184487 | Dietary Seafood High in n-3 Fatty Acids | A determination of the seafood high in n-3 fatty acids in a nutritional product or meal, or a portion thereof. | Dietary Seafood High in n-3 Fatty Acids Measurement | ||
DSFLN3FA | C184488 | Dietary Seafood Low in n-3 Fatty Acids | A determination of the seafood low in n-3 fatty acids in a nutritional product or meal, or a portion thereof. | Dietary Seafood Low in n-3 Fatty Acids Measurement | ||
DSLDFAT | C184489 | Dietary Solid Fats | A determination of the solid fats in a nutritional product or meal, or a portion thereof. | Dietary Solid Fats Measurement | ||
DSOYPROD | C184490 | Dietary Soy Products | A determination of the soy-containing products in a nutritional product or meal, or a portion thereof. | Dietary Soy Products Measurement | ||
DSTER | C184435 | Dietary 18:0 Stearate;Dietary 18:0 Stearic Acid;Dietary Stearic Acid | A determination of the total 18:0 stearic acid in a nutritional product or meal, or a portion thereof. | Dietary Stearic Acid Measurement | ||
DSUGART | C184338 | Dietary Total Sugars | A determination of the total sugars in a nutritional product or meal, or a portion thereof. | Dietary Sugar Measurement | ||
DTHEOBR | C184491 | Dietary Theobromine | A determination of the theobromine in a nutritional product or meal, or a portion thereof. | Dietary Theobromine Measurement | ||
DTHIAMIN | C184492 | Dietary Thiamin;Dietary Thiamine;Dietary Vitamin B1 | A determination of the thiamine in a nutritional product or meal, or a portion thereof. | Dietary Thiamine Measurement | ||
DTMND | C184442 | Dietary 20:5 Timnodonate;Dietary 20:5 Timnodonic Acid;Dietary Timnodonic Acid | A determination of the total 20:5 timnodonic acid in a nutritional product or meal, or a portion thereof. | Dietary Timnodonic Acid Measurement | ||
DTOMATO | C184493 | Dietary Tomatoes | A determination of the tomatoes in a nutritional product or meal, or a portion thereof. | Dietary Tomatoes Measurement | ||
DVCINSN | C174280 | Number of Devices Inserted | The number of devices inserted into an individual. | Number of Devices Inserted | ||
DVEG | C172466 | Dietary Vegetable | A determination of the total vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetable Measurement | ||
DVEGDG | C184470 | Dietary Vegetables, Dark Green | A determination of the total dark green vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Dark Green Measurement | ||
DVEGRO | C184495 | Dietary Vegetables, Red and Orange | A determination of the total red and orange vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Red and Orange Measurement | ||
DVEGSTAR | C184496 | Dietary Vegetables, Starchy | A determination of the total starchy vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Starchy Measurement | ||
DVITA | C184497 | Dietary Vitamin A | A determination of the total vitamin A in a nutritional product or meal, or a portion thereof. | Dietary Vitamin A Measurement | ||
DVITB12 | C184353 | Dietary Vitamin B12 | A determination of the total vitamin B12 in a nutritional product or meal, or a portion thereof. | Dietary Vitamin B12 Measurement | ||
DVITB6 | C184498 | Dietary Vitamin B6 | A determination of the total vitamin B6 in a nutritional product or meal, or a portion thereof. | Dietary Vitamin B6 Measurement | ||
DVITC | C184499 | Dietary Vitamin C | A determination of the total vitamin C in a nutritional product or meal, or a portion thereof. | Dietary Vitamin C Measurement | ||
DVITD | C184500 | Dietary Vitamin D | A determination of the total vitamin D in a nutritional product or meal, or a portion thereof. | Dietary Vitamin D Measurement | ||
DVITK | C184501 | Dietary Vitamin K | A determination of the total vitamin K in a nutritional product or meal, or a portion thereof. | Dietary Vitamin K Measurement | ||
DXCRITMT | C117883 | Diagnostic Criteria Met | A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. | Which Diagnostic Criteria Met | ||
DYOGURT | C184503 | Dietary Yogurt | A determination of the yogurt in a nutritional product or meal, or a portion thereof. | Dietary Yogurt Measurement | ||
DZN | C184460 | Dietary Zinc | A determination of the total Zinc in a nutritional product or meal, or a portion thereof. | Dietary Zinc Measurement | ||
ENDPTIND | C119230 | Endpoint Event Indicator | An indication as to whether the event meets the criteria for being a clinical endpoint. | Endpoint Event Indicator | ||
EPMLDNUM | C124328 | Number of Mild Episodes | The number of times an event, which is classified as mild, occurred. | Number of Mild Episodes | ||
EPMODNUM | C124329 | Number of Moderate Episodes | The number of times an event, which is classified as moderate, occurred. | Number of Moderate Episodes | ||
EPSDNUM | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
EPSEVNUM | C124330 | Number of Severe Episodes | The number of times an event, which is classified as severe, occurred. | Number of Severe Episodes | ||
ESTWT | C174282 | Estimated Entity Weight;Estimated Weight | An approximate determination of the weight of the entity. | Estimated Weight | ||
EVENTFRQ | C25515 | Event Frequency | The number of times an event occurs within a given time period. | Temporal Frequency | ||
EVENTNUM | C130057 | Number of Events | The total number of events that have occurred. | Number of Events | ||
EVRIPIND | C189431 | Event Related to Incr Phys Activity Ind;Event Related to Increased Physical Activity Indicator | An indication as to whether the event of interest is related to increased physical activity. | Event Related to Increased Physical Activity Indicator | ||
EXCDUR | C172475 | Exercise Duration | The length of time an individual spends exercising. | Exercise Duration | ||
EXCINTSY | C172473 | Exercise Intensity | A determination or assessment of the degree or magnitude of an individual's exertion during physical activity. | Exercise Intensity | ||
EXCMPLNC | C172474 | Exercise Compliance | A determination or assessment of the extent to which an individual adheres to a fitness program. | Exercise Compliance | ||
EXETRIND | C181310 | Expected Efficacious Treatment Reg Ind;Expected Efficacious Treatment Regimen Indicator | An indication as to whether the subject has been on a treatment regimen which, based on defined criteria, is expected to be efficacious. | Expected Efficacious Treatment Regimen Indicator | ||
EXTRSCT | C157443 | Extent of Resection | A description of the relative amount of tissue, blood vessel, or organ that has been removed. | Extent of Resection | ||
FISTATYP | C181314 | Fistula Anatomical Type | A classification based on the anatomical location(s) of the fistula. | Fistula Anatomical Site | ||
FISTNUM | C181312 | Number of Fistulas | The number of fistulas observed. | Number of Fistulas | ||
FNDOSAMT | C176280 | Final Dose Amount | A determination of the final amount of a substance taken as a dose by a subject. | Final Dose Amount | ||
FNDOSFRQ | C176281 | Frequency of Final Dose Amount | A determination of how often a subject takes a substance at the final dose amount. | Frequency of Final Dose Amount | ||
GCIRCPI | C187676 | Greatest Circ at Point of Interest;Greatest Circumference at Point of Interest;Largest Circumference at Point of Interest | The circumferential measurement of an entity or object of interest at its widest point. | Greatest Circumference at Point of Interest | ||
HETYPE | C119231 | Healthcare Encounter Type | Categorization of the type of healthcare encounter. | Healthcare Encounter Type | ||
HFLBFNW | C119232 | Heart Failure New/Worsening Lab Findings | Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. | Lab Findings of New or Worsening Heart Failure | ||
HFPEFNW | C119233 | Heart Failure New/Worsening PE Findings | Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. | Physical Examination Findings of New or Worsening Heart Failure | ||
HFTHERIN | C119234 | Heart Failure Therapy, Intensification | Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. | Heart Failure Therapy Intensification Type | ||
HOSPNUM | C124443 | Number Of Hospitalizations | The total number of hospitalization events that have occurred for the condition. | Number of Hospitalizations | ||
ICJRIND | C174279 | Ileocecal Junction Removed Indicator | An indication as to whether the ileocecal junction was removed. | Ileocecal Junction Removed Indicator | ||
ISCDIND | C119235 | Ischemic Discomfort Indicator | An indicator as to whether the subject has symptoms of ischemic discomfort. | Ischemic Discomfort Indicator | ||
ISCETYP | C119236 | Ischemic Evidence Type | Categorization of the type of objective evidence of new or worsening ischemia. | Ischemic Evidence Type | ||
LAPCOMPN | C172478 | Number of Laps Completed | The number of laps completed around a course or circuit. | Number of Laps Completed | ||
LDIAM | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
LENRSCT | C174278 | Length of Resection | A measurement of the total length of the removed tissue, blood vessel, or organ. | Length of Resection | ||
LESNUM | C174277 | Number of Lesions | The number of lesions observed. | Number of Lesions | ||
LOCONSET | C117884 | Localization of Onset | The anatomical location of the beginning or early stages of a disease. | Location of Disease Onset | ||
LONGCRSE | C35461 | Longitudinal Course | A description of the series of events, including signs and symptoms, that define the course of a chronic disease over time. | Clinical Course of Disease | ||
MI12EXC | C119237 | Exclusion of Type 1 and Type 2 MI | An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. | Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator | ||
MXDOSAMT | C176278 | Maximum Dose Amount | A determination of the maximum amount of a substance taken as a dose by a subject. | Maximum Dose Amount | ||
MXDOSFRQ | C176279 | Frequency of Maximum Dose Amount | A determination of how often a subject takes a substance at the maximum dose amount. | Frequency of Maximum Dose Amount | ||
NDLGAUGE | C101687 | Needle Gauge | A number representing the outer diameter of a needle. (NCI) | Needle Gauge | ||
NEARJNT | C187675 | Nearest Joint | The anatomical joint in closest proximity to the entity or object of interest. | Nearest Joint | ||
NINVIMGC | C123443 | Non-Invasive Imaging Change | A description of the clinical change to the subject after a non-invasive imaging procedure. | Clinical Change by Non-Invasive Imaging Procedure | ||
NWSYMP | C119238 | New or Worsening Symptoms | A description of the new or worsening symptoms related to a clinical event. | New or Worsening Symptom | ||
OBJNUM | C174275 | Number of Objects | The number of objects observed. | Number of Objects | ||
OBJTYPE | C174276 | Type of Object | The type of object observed. | Type of Object | ||
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
ORCANIND | C154860 | Origin of Cancer Known Ind;Origin of Cancer Known Indicator | An indication as to whether the primary site of cancer is known. | Cancer Primary Site Known Indicator | ||
OUNIMULT | C117885 | Onset Unifocal or Multifocal | A categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease. | Focality of Disease Onset | ||
PCIAAC | C119239 | PCI Acute Angiographic Complication | Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. | Acute Myocardial Infarction From PCI Complication Type | ||
PDAIND | C184724 | Prevents Daily Activities Indicator | An indication as to whether the event or intervention prevents or has prevented the performance of daily activities. | Prevents Daily Activities Indicator | ||
PLLDIAM | C181311 | Largest Diameter of Primary Lesion;Longest Diameter of Primary Lesion | The longest diameter of the lesion that has been determined to be the primary lesion. | Longest Diameter of Primary Lesion | ||
PLLOC | C181315 | Anatomical Location of Primary Lesion | The anatomical location of the lesion that has been determined to be the primary lesion. | Anatomical Location of Primary Lesion | ||
PPTFCT | C163413 | Precipitating Factor | The factor that causes or triggers the onset of an occurrence. | Precipitating Factor | ||
PREPAMT | C170562 | Prepared Amount | The quantity of a product that has been made ready for use. | Prepared Amount | ||
PROCPRFN | C174228 | Number of Procedures Performed | The number of procedures performed on or in an individual. | Number of Procedures Performed | ||
PRSUCIND | C119240 | Procedure Success Indicator | An indication as to whether the procedure is considered successful. | Procedure Success Indicator | ||
PRURIND | C198213 | Pruritus Indicator | An indicator as to whether the subject has symptoms of itchiness. | Pruritus Indicator | ||
PRUSTAT | C101230 | Procedure Urgency Status Type | The degree of urgency in which a medical procedure must be performed. | Triage Status | ||
PRYSTUOG | C179451 | Primary Site of Tumor Origin | The anatomical location of the primary tumor site of disease. | Primary Tumor Site | ||
QOLIMP | C170617 | QOL Impact;Quality of Life Impact | The effect or consequence of an event or condition on an individual's sense of well-being and ability to enjoy life. | Quality of Life Impact | ||
REMAMT | C170563 | Remaining Amount | The quantity of a product that remains after dosing, consumption, or use. | Remaining Amount | ||
RESCTIND | C154861 | Resected Tumor Ind;Resected Tumor Indicator | An indication as to whether the tumor has been resected. | Tumor Resected Indicator | ||
RETAMT | C78722 | Returned Amount | The quantity of a product that has been returned. (NCI) | Returned Amount | ||
RLDEPIND | C176283 | Relapse after Discon Dependent Indicator;Relapse after Discontinue Dependent Indicator | An indication as to whether an individual has had a relapse after discontinuation of a substance due to dependence. | Relapse after Discontinuation Because of Dependence Indicator | ||
RLDEV | C163414 | Relationship to Device | The relationship of an event to a device, which may or may not be a device under study. | Relationship to Device | ||
SBDEPIND | C176285 | Substance Dependence Indicator | An indication as to whether an individual has become dependent on a substance. | Substance Dependence Indicator | ||
SEV | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
SPEED | C41146 | Speed | A scalar measure of the rate of movement of the object expressed as the distance traveled divided by the elapsed time. | Speed | ||
SSDISC | C174281 | Sign/Symptom Leading to Discontinuation | The signs and/or symptoms that result in the discontinuation of treatment or intervention. | Sign or Symptom Leading to Discontinuation | ||
STCTIMNG | C123424 | Stent Thrombosis, Coronary, ARC Timing | Categorization of the timing of coronary stent thrombosis occurrence per the classification schema described by the Academic Research Consortium (ARC). | Academic Research Council Coronary Stent Thrombosis Timing | ||
STEPSTN | C172479 | Number of Steps Taken | The number of footsteps taken by an individual. | Number of Steps Taken | ||
STRCTNUM | C174274 | Number of Strictures | The number of anatomical strictures observed. | Number of Strictures | ||
STROKTYP | C119579 | Stroke Type | Categorization of the type of stroke. | Stroke Type | ||
SYMPINDC | C119241 | Symptom Indicator | An indication as to whether the subject had symptoms related to the clinical event. | Symptom Indicator | ||
SYMSTDTC | C119242 | Symptom Onset Date | The date time of the onset of symptoms of the clinical event. | Symptom Onset Date | ||
TOTNUM | C127787 | Total Number | A measurement of the total number of entities. | Total Number | ||
TOXGR | C82528 | Toxicity Grade | A standardized categorical classification of the severity of an event or finding. | Toxicity Grade | ||
TPDEPIND | C176282 | Unable to Taper Dependent Indicator | An indication as to whether an individual is incapable of reducing or tapering the amount of a substance taken due to dependence. | Unable to Taper Dependent Indicator | ||
TRTSETT | C124444 | Treatment Environmental Setting;Treatment Setting | The surroundings or environment within which the subject receives therapeutic treatment for the condition. | Treatment Environmental Setting | ||
TTIMPAUS | C172477 | Total Time Paused | The total amount of time during which an event, operation or activity has been interrupted or stopped. | Total Time Paused | ||
TTIMPHAC | C172480 | Total Time Physically Active | The total amount of time during which an individual was actively engaged in physical activity. | Total Time Physically Active | ||
VOC48IND | C119243 | Vessel Occlusion After CABG 48 Ind | An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. | Vessel Occlusion 48 Hours after CABG Indicator | ||
VOL | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
Back to top | ||||||
CL.C101833.FATEST | Findings About Test Name
(FATEST) | text
Extensible: Yes | C101833 | Findings About Test Name | Terminology relevant to the test names that describe findings about an event or intervention. | CDISC SDTM Findings About Test Name Terminology |
Action Taken With Device | C117037 | Action Taken With Device | Action taken with respect to a device in a study, which may or may not be the device under study. | Action Taken with Device | ||
Action Taken With Subject | C163412 | Action Taken With Subject | Action taken with respect to a subject in a study. | Action Taken With Subject | ||
Acute Myocardial Infarction Type | C118936 | Acute Myocardial Infarction Type | Categorization of the type of acute myocardial infarction. | Acute Myocardial Infarction Type | ||
Age At First Episode | C124438 | Age At First Episode | The age at which the first episode occurred. | Age at First Episode | ||
Age At First Hospitalization | C124439 | Age At First Hospitalization | The age at which the first hospitalization event occurred. | Age at First Hospitalization | ||
Age At First Treatment | C124440 | Age At First Treatment | The age at which the first treatment for the condition occurred. | Age at First Treatment | ||
Age at Full-Time Use | C139175 | Age at Full-Time Use | The age at which the full-time use of a pre-specified object first occurred. | Age at Full-Time Use | ||
Age Symptoms Started | C174273 | Age Symptoms Started | The age at which illness-specific symptoms first began. | Age Symptom Started | ||
Anatomical Location of Primary Lesion | C181315 | Anatomical Location of Primary Lesion | The anatomical location of the lesion that has been determined to be the primary lesion. | Anatomical Location of Primary Lesion | ||
Appearance | C25377 | Aper | The outward or visible aspect of an entity. | Appearance | ||
Biopsy Specimen Taken Indicator | C181316 | Biopsy Specimen Taken Indicator | An indication as to whether a biopsy specimen was collected. | Biopsy Specimen Taken Indicator | ||
Calories Burned | C172476 | Calories Burned | A measurement of the number of calories expended. | Calories Burned | ||
Clinic Stay Indicator | C124442 | Clinic Stay Indicator | An indication as to whether the subject was admitted to a healthcare clinic. | Clinic Stay Indicator | ||
Coronary Artery Thrombosis Method Ident | C119229 | Coronary Artery Thrombosis Method Ident | The method by which the coronary artery thrombosis event is determined or diagnosed. | Coronary Artery Thrombosis Method of Identification | ||
Cumulative Exposure | C94596 | Cumulative Exposure | The total amount that a subject is exposed to over time. | Cumulative Exposure | ||
Diagnostic Criteria Met | C117883 | Diagnostic Criteria Met | A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. | Which Diagnostic Criteria Met | ||
Diameter | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
Dietary Added Sugar | C172463 | Dietary Added Sugar | A determination of the total added sugars in a nutritional product or meal, or a portion thereof. | Dietary Added Sugar Measurement | ||
Dietary Added Vitamin B12 | C184461 | Dietary Added Vitamin B12 | A determination of the total added vitamin B12 in a nutritional product or meal, or a portion thereof. | Dietary Added Vitamin B12 Measurement | ||
Dietary Added Vitamin E | C184462 | Dietary Added Vitamin E | A determination of the total added vitamin E in a nutritional product or meal, or a portion thereof. | Dietary Added Vitamin E Measurement | ||
Dietary Alcohol | C184463 | Dietary Alcohol;Dietary Ethanol | A determination of the total amount of alcohol in a nutritional product or meal, or a portion thereof. | Dietary Alcohol Measurement | ||
Dietary Alpha Carotene | C184449 | Dietary Alpha Carotene | A determination of the alpha carotene in a nutritional product or meal, or a portion thereof. | Dietary Alpha Carotene Measurement | ||
Dietary Alpha Tocopherol | C184450 | Dietary Alpha Tocopherol | A determination of the alpha tocopherol in a nutritional product or meal, or a portion thereof. | Dietary Alpha Tocopherol Measurement | ||
Dietary Arachidonic Acid | C184441 | Dietary 20:4 Arachidonate;Dietary 20:4 Arachidonic Acid;Dietary Arachidonic Acid | A determination of the total 20:4 arachidonic acid in a nutritional product or meal, or a portion thereof. | Dietary Arachidonic Acid Measurement | ||
Dietary Beans and Peas | C184465 | Dietary Beans and Peas | A determination of the total beans and peas in a nutritional product or meal, or a portion thereof. | Dietary Beans and Peas Measurement | ||
Dietary Beta Carotene | C184451 | Dietary Beta Carotene | A determination of the beta carotene in a nutritional product or meal, or a portion thereof. | Dietary Beta Carotene Measurement | ||
Dietary Beta-Cryptoxanthin | C186015 | Dietary Beta-Cryptoxanthin | A determination of the beta-cryptoxanthin in a nutritional product or meal, or a portion thereof. | Dietary Beta-Cryptoxanthin Measurement | ||
Dietary Butyric Acid | C184446 | Dietary 4:0 Butyrate;Dietary 4:0 Butyric Acid;Dietary Butyric Acid | A determination of the total 4:0 butyric acid in a nutritional product or meal, or a portion thereof. | Dietary Butyric Acid Measurement | ||
Dietary Caffeine | C184452 | Dietary Caffeine | A determination of the caffeine in a nutritional product or meal, or a portion thereof. | Dietary Caffeine Measurement | ||
Dietary Calcium | C184453 | Dietary Calcium | A determination of the total calcium in a nutritional product or meal, or a portion thereof. | Dietary Calcium Measurement | ||
Dietary Calories | C172464 | Dietary Calories | A determination of the total dietary calories in a nutritional product or meal, or a portion thereof. | Dietary Calories Measurement | ||
Dietary Capric Acid | C184430 | Dietary 10:0 Caprate;Dietary 10:0 Capric Acid;Dietary Capric Acid | A determination of the total 10:0 capric acid in a nutritional product or meal, or a portion thereof. | Dietary Capric Acid Measurement | ||
Dietary Caproic Acid | C184447 | Dietary 6:0 Caproate;Dietary 6:0 Caproic Acid;Dietary Caproic Acid | A determination of the total 6:0 caproic acid in a nutritional product or meal, or a portion thereof. | Dietary Caproic Acid Measurement | ||
Dietary Caprylic Acid | C184448 | Dietary 8:0 Caprylate;Dietary 8:0 Caprylic Acid;Dietary Caprylic Acid | A determination of the total 8:0 caprylic acid in a nutritional product or meal, or a portion thereof. | Dietary Caprylic Acid Measurement | ||
Dietary Cheese | C184454 | Dietary Cheese | A determination of the total cheese in a nutritional product or meal, or a portion thereof. | Dietary Cheese Measurement | ||
Dietary Cholesterol | C184466 | Dietary Cholesterol | A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. | Dietary Cholesterol Measurement | ||
Dietary Choline | C184467 | Dietary Choline | A determination of the choline in a nutritional product or meal, or a portion thereof. | Dietary Choline Measurement | ||
Dietary Citrus, Melons, and Berries | C184468 | Dietary Citrus, Melons, and Berries | A determination of the total citrus, melons, and berries in a nutritional product or meal, or a portion thereof. | Dietary Citrus, Melons, and Berries Measurement | ||
Dietary Clupanodonic Acid | C184444 | Dietary 22:5 Clupanodonate;Dietary 22:5 Clupanodonic Acid;Dietary Clupanodonic Acid | A determination of the total 22:5 clupanodonic acid in a nutritional product or meal, or a portion thereof. | Dietary Clupanodonic Acid Measurement | ||
Dietary Copper | C184455 | Dietary Copper | A determination of the total copper in a nutritional product or meal, or a portion thereof. | Dietary Copper Measurement | ||
Dietary Docosahexaenoic Acid | C184445 | Dietary 22:6 Docosahexaenoate;Dietary 22:6 Docosahexaenoic Acid;Dietary Docosahexaenoic Acid | A determination of the total 22:6 docosahexaenoic acid in a nutritional product or meal, or a portion thereof. | Dietary Docosahexaenoic Acid Measurement | ||
Dietary Eggs | C184471 | Dietary Eggs | A determination of the eggs in a nutritional product or meal, or a portion thereof. | Dietary Eggs Measurement | ||
Dietary Erucic Acid | C184443 | Dietary 22:1 Erucate;Dietary 22:1 Erucic Acid;Dietary Erucic Acid | A determination of the total 22:1 erucic acid in a nutritional product or meal, or a portion thereof. | Dietary Erucic Acid Measurement | ||
Dietary Fat, Monounsaturated | C172471 | Dietary Fat, Monounsaturated | A determination of the total monounsaturated fat in a nutritional product or meal, or a portion thereof. | Dietary Monounsaturated Fat Measurement | ||
Dietary Fat, Polyunsaturated | C172472 | Dietary Fat, Polyunsaturated | A determination of the total polyunsaturated fat in a nutritional product or meal, or a portion thereof. | Dietary Polyunsaturated Fat Measurement | ||
Dietary Fat, Saturated | C172470 | Dietary Fat, Saturated | A determination of the total saturated fat in a nutritional product or meal, or a portion thereof. | Dietary Saturated Fat Measurement | ||
Dietary Fat, Total | C172460 | Dietary Fat, Total | A determination of the total fat in a nutritional product or meal, or a portion thereof. | Total Dietary Fat Measurement | ||
Dietary Fiber | C172469 | Dietary Fiber | A determination of the total fiber in a nutritional product or meal, or a portion thereof. | Dietary Fiber Measurement | ||
Dietary Folate Equivalents | C186016 | DFE;Dietary Folate Equivalents | The sum of food folate and normalized folic acid (as food folate equivalents) in a nutritional product or meal, or a portion thereof. | Dietary Folate Equivalents Measurement | ||
Dietary Folic Acid | C186018 | Dietary Folic Acid | A determination of the folic acid in a nutritional product or meal, or a portion thereof. | Dietary Folic Acid Measurement | ||
Dietary Food Folate | C186017 | Dietary Food Folate | A determination of the naturally occurring folate in a nutritional product or meal, or a portion thereof. | Dietary Food Folate Measurement | ||
Dietary Fruit Juice | C184472 | Dietary Fruit Juice | A determination of the fruit juice in a nutritional product or meal, or a portion thereof. | Dietary Fruit Juice Measurement | ||
Dietary Fruit | C172465 | Dietary Fruit | A determination of the total fruit in a nutritional product or meal, or a portion thereof. | Dietary Fruit Measurement | ||
Dietary Gadoleic Acid | C184440 | Dietary 20:1 Gadoleate;Dietary 20:1 Gadoleic Acid;Dietary Gadoleic Acid | A determination of the total 20:1 gadoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Gadoleic Acid Measurement | ||
Dietary Grain | C172467 | Dietary Grain | A determination of the total grain in a nutritional product or meal, or a portion thereof. | Dietary Grain Measurement | ||
Dietary Grain, Refined | C184484 | Dietary Grain, Refined | A determination of the total refined grains in a nutritional product or meal, or a portion thereof. | Dietary Grain, Refined Measurement | ||
Dietary Iron | C184456 | Dietary Iron | A determination of the total iron in a nutritional product or meal, or a portion thereof. | Dietary Iron Measurement | ||
Dietary Lauric Acid | C184431 | Dietary 12:0 Laurate;Dietary 12:0 Lauric Acid;Dietary Lauric Acid | A determination of the total 12:0 lauric acid in a nutritional product or meal, or a portion thereof. | Dietary Lauric Acid Measurement | ||
Dietary Linoleic Acid | C184437 | Dietary 18:2 Linoleate;Dietary 18:2 Linoleic Acid;Dietary Linoleic Acid | A determination of the total 18:2 linoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Linoleic Acid Measurement | ||
Dietary Linolenic Acid | C184438 | Dietary 18:3 Linolenate;Dietary 18:3 Linolenic Acid;Dietary Linolenic Acid | A determination of the total 18:3 linolenic acid in a nutritional product or meal, or a portion thereof. | Dietary Linolenic Acid Measurement | ||
Dietary Luteinzeaxanthin | C184473 | Dietary Lutein and Zeaxanthin | A determination of the lutein and zeaxanthin in a nutritional product or meal, or a portion thereof. | Dietary Lutein and Zeaxanthin Measurement | ||
Dietary Lycopene | C184474 | Dietary Lycopene | A determination of the lycopene in a nutritional product or meal, or a portion thereof. | Dietary Lycopene Measurement | ||
Dietary Magnesium | C172462 | Dietary Magnesium | A determination of the total magnesium in a nutritional product or meal, or a portion thereof. | Dietary Magnesium Measurement | ||
Dietary Meat | C172468 | Dietary Meat | A determination of the total meat in a nutritional product or meal, or a portion thereof. | Dietary Meat Measurement | ||
Dietary Meat, Cured | C184469 | Dietary Meat, Cured | A determination of the cured meat in a nutritional product or meal, or a portion thereof. | Dietary Meat, Cured Measurement | ||
Dietary Meat, Organ | C184480 | Dietary Meat, Organ | A determination of the organ meat in a nutritional product or meal, or a portion thereof. | Dietary Meat, Organ Measurement | ||
Dietary Meat, Poultry, and Seafood | C184504 | Dietary Meat, Poultry, and Seafood | A determination of the total meat, poultry, and seafood in a nutritional product or meal, or a portion thereof. | Dietary Meat, Poultry, and Seafood Measurement | ||
Dietary Milk | C184475 | Dietary Milk | A determination of the milk in a nutritional product or meal, or a portion thereof. | Dietary Milk Measurement | ||
Dietary Moisture | C184476 | Dietary Moisture | A determination of the moisture content in a nutritional product or meal, or a portion thereof. | Dietary Moisture Measurement | ||
Dietary Myristic Acid | C184432 | Dietary 14:0 Myristate;Dietary 14:0 Myristic Acid;Dietary Myristic Acid | A determination of the total 14:0 myristic acid in a nutritional product or meal, or a portion thereof. | Dietary Myristic Acid Measurement | ||
Dietary Niacin | C184477 | Dietary Niacin;Dietary Vitamin B3 | A determination of the niacin in a nutritional product or meal, or a portion thereof. | Dietary Niacin Measurement | ||
Dietary Nuts and Seeds | C184478 | Dietary Nuts and Seeds | A determination of the total nuts and seeds in a nutritional product or meal, or a portion thereof. | Dietary Nuts and Seeds Measurement | ||
Dietary Oils | C184479 | Dietary Oils | A determination of the oils in a nutritional product or meal, or a portion thereof. | Dietary Oils Measurement | ||
Dietary Oleic Acid | C184436 | Dietary 18:1 Oleate;Dietary 18:1 Oleic Acid;Dietary Oleic Acid | A determination of the total 18:1 oleic acid in a nutritional product or meal, or a portion thereof. | Dietary Oleic Acid Measurement | ||
Dietary Palmitic Acid | C184433 | Dietary 16:0 Palmitate;Dietary 16:0 Palmitic Acid;Dietary Palmitic Acid | A determination of the total 16:0 palmitic acid in a nutritional product or meal, or a portion thereof. | Dietary Palmitic Acid Measurement | ||
Dietary Palmitoleic Acid | C184434 | Dietary 16:1 Palmitoleate;Dietary 16:1 Palmitoleic Acid;Dietary Palmitoleic Acid | A determination of the total 16:1 palmitoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Palmitoleic Acid Measurement | ||
Dietary Parinaric Acid | C184439 | Dietary 18:4 Parinarate;Dietary 18:4 Parinaric Acid;Dietary Parinaric Acid | A determination of the total 18:4 parinaric acid in a nutritional product or meal, or a portion thereof. | Dietary Parinaric Acid Measurement | ||
Dietary Phosphorus | C184481 | Dietary Phosphorus | A determination of the phosphorus in a nutritional product or meal, or a portion thereof. | Dietary Phosphorus Measurement | ||
Dietary Potassium | C184457 | Dietary Potassium | A determination of the total potassium in a nutritional product or meal, or a portion thereof. | Dietary Potassium Measurement | ||
Dietary Potatoes | C184482 | Dietary Potatoes | A determination of the potatoes in a nutritional product or meal, or a portion thereof. | Dietary Potatoes Measurement | ||
Dietary Poultry | C184483 | Dietary Poultry | A determination of the poultry in a nutritional product or meal, or a portion thereof. | Dietary Poultry Measurement | ||
Dietary Protein Foods | C184494 | Dietary Protein Foods | A determination of the protein-rich food in a nutritional product or meal, or a portion thereof. | Dietary Protein Foods Measurement | ||
Dietary Protein | C172459 | Dietary Protein | A determination of the total protein in a nutritional product or meal, or a portion thereof. | Dietary Protein Measurement | ||
Dietary Retinol | C184485 | Dietary Retinol;Dietary Vitamin A | A determination of the retinol in a nutritional product or meal, or a portion thereof. | Dietary Retinol Measurement | ||
Dietary Riboflavin | C184486 | Dietary Riboflavin;Dietary Vitamin B2 | A determination of the riboflavin in a nutritional product or meal, or a portion thereof. | Dietary Riboflavin Measurement | ||
Dietary Seafood High in n-3 Fatty Acids | C184487 | Dietary Seafood High in n-3 Fatty Acids | A determination of the seafood high in n-3 fatty acids in a nutritional product or meal, or a portion thereof. | Dietary Seafood High in n-3 Fatty Acids Measurement | ||
Dietary Seafood Low in n-3 Fatty Acids | C184488 | Dietary Seafood Low in n-3 Fatty Acids | A determination of the seafood low in n-3 fatty acids in a nutritional product or meal, or a portion thereof. | Dietary Seafood Low in n-3 Fatty Acids Measurement | ||
Dietary Selenium | C184458 | Dietary Selenium | A determination of the total selenium in a nutritional product or meal, or a portion thereof. | Dietary Selenium Measurement | ||
Dietary Sodium | C184459 | Dietary Sodium | A determination of the total sodium in a nutritional product or meal, or a portion thereof. | Dietary Sodium Measurement | ||
Dietary Solid Fats | C184489 | Dietary Solid Fats | A determination of the solid fats in a nutritional product or meal, or a portion thereof. | Dietary Solid Fats Measurement | ||
Dietary Soy Products | C184490 | Dietary Soy Products | A determination of the soy-containing products in a nutritional product or meal, or a portion thereof. | Dietary Soy Products Measurement | ||
Dietary Stearic Acid | C184435 | Dietary 18:0 Stearate;Dietary 18:0 Stearic Acid;Dietary Stearic Acid | A determination of the total 18:0 stearic acid in a nutritional product or meal, or a portion thereof. | Dietary Stearic Acid Measurement | ||
Dietary Theobromine | C184491 | Dietary Theobromine | A determination of the theobromine in a nutritional product or meal, or a portion thereof. | Dietary Theobromine Measurement | ||
Dietary Thiamine | C184492 | Dietary Thiamin;Dietary Thiamine;Dietary Vitamin B1 | A determination of the thiamine in a nutritional product or meal, or a portion thereof. | Dietary Thiamine Measurement | ||
Dietary Timnodonic Acid | C184442 | Dietary 20:5 Timnodonate;Dietary 20:5 Timnodonic Acid;Dietary Timnodonic Acid | A determination of the total 20:5 timnodonic acid in a nutritional product or meal, or a portion thereof. | Dietary Timnodonic Acid Measurement | ||
Dietary Tomatoes | C184493 | Dietary Tomatoes | A determination of the tomatoes in a nutritional product or meal, or a portion thereof. | Dietary Tomatoes Measurement | ||
Dietary Total Carbohydrate | C172461 | Dietary Total Carbohydrate | A determination of the total carbohydrate in a nutritional product or meal, or a portion thereof. | Total Dietary Carbohydrate Measurement | ||
Dietary Total Dairy | C184337 | Dietary Total Dairy | A determination of the total dairy (food products produced from or containing milk) in a nutritional product or meal, or a portion thereof. | Dietary Dairy Measurement | ||
Dietary Total Folate | C186019 | Dietary Total Folate | A determination of the total folate (supplemental folic acid + food folate) in a nutritional product or meal, or a portion thereof. | Dietary Total Folate Measurement | ||
Dietary Total Sugars | C184338 | Dietary Total Sugars | A determination of the total sugars in a nutritional product or meal, or a portion thereof. | Dietary Sugar Measurement | ||
Dietary Vegetable | C172466 | Dietary Vegetable | A determination of the total vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetable Measurement | ||
Dietary Vegetables, Dark Green | C184470 | Dietary Vegetables, Dark Green | A determination of the total dark green vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Dark Green Measurement | ||
Dietary Vegetables, Red and Orange | C184495 | Dietary Vegetables, Red and Orange | A determination of the total red and orange vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Red and Orange Measurement | ||
Dietary Vegetables, Starchy | C184496 | Dietary Vegetables, Starchy | A determination of the total starchy vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Starchy Measurement | ||
Dietary Vitamin A | C184497 | Dietary Vitamin A | A determination of the total vitamin A in a nutritional product or meal, or a portion thereof. | Dietary Vitamin A Measurement | ||
Dietary Vitamin B12 | C184353 | Dietary Vitamin B12 | A determination of the total vitamin B12 in a nutritional product or meal, or a portion thereof. | Dietary Vitamin B12 Measurement | ||
Dietary Vitamin B6 | C184498 | Dietary Vitamin B6 | A determination of the total vitamin B6 in a nutritional product or meal, or a portion thereof. | Dietary Vitamin B6 Measurement | ||
Dietary Vitamin C | C184499 | Dietary Vitamin C | A determination of the total vitamin C in a nutritional product or meal, or a portion thereof. | Dietary Vitamin C Measurement | ||
Dietary Vitamin D | C184500 | Dietary Vitamin D | A determination of the total vitamin D in a nutritional product or meal, or a portion thereof. | Dietary Vitamin D Measurement | ||
Dietary Vitamin K | C184501 | Dietary Vitamin K | A determination of the total vitamin K in a nutritional product or meal, or a portion thereof. | Dietary Vitamin K Measurement | ||
Dietary Whole Grains | C184502 | Dietary Whole Grains | A determination of the whole grains in a nutritional product or meal, or a portion thereof. | Dietary Whole Grains Measurement | ||
Dietary Yogurt | C184503 | Dietary Yogurt | A determination of the yogurt in a nutritional product or meal, or a portion thereof. | Dietary Yogurt Measurement | ||
Dietary Zinc | C184460 | Dietary Zinc | A determination of the total Zinc in a nutritional product or meal, or a portion thereof. | Dietary Zinc Measurement | ||
Dispensed Amount | C78721 | Dispensed Amount | The quantity of a product that has been dispensed. (NCI) | Dispensed Amount | ||
Distance | C25167 | Distance | The actual or calculated span between two points (real or virtual). | Distance | ||
Distribution | C198212 | Distribution | Description of the distribution pattern of a finding within the examined area. | Distribution Pattern Finding Description | ||
Drug Resistance Status | C102626 | Drug Resistance Status | The state or condition of not responding to a pharmacological agent. | Drug Resistance Status | ||
Endpoint Event Indicator | C119230 | Endpoint Event Indicator | An indication as to whether the event meets the criteria for being a clinical endpoint. | Endpoint Event Indicator | ||
Estimated Weight | C174282 | Estimated Entity Weight;Estimated Weight | An approximate determination of the weight of the entity. | Estimated Weight | ||
Event Frequency | C25515 | Event Frequency | The number of times an event occurs within a given time period. | Temporal Frequency | ||
Event Related to Incr Phys Activity Ind | C189431 | Event Related to Incr Phys Activity Ind;Event Related to Increased Physical Activity Indicator | An indication as to whether the event of interest is related to increased physical activity. | Event Related to Increased Physical Activity Indicator | ||
Exclusion of Type 1 and Type 2 MI | C119237 | Exclusion of Type 1 and Type 2 MI | An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. | Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator | ||
Exercise Compliance | C172474 | Exercise Compliance | A determination or assessment of the extent to which an individual adheres to a fitness program. | Exercise Compliance | ||
Exercise Duration | C172475 | Exercise Duration | The length of time an individual spends exercising. | Exercise Duration | ||
Exercise Intensity | C172473 | Exercise Intensity | A determination or assessment of the degree or magnitude of an individual's exertion during physical activity. | Exercise Intensity | ||
Expected Efficacious Treatment Reg Ind | C181310 | Expected Efficacious Treatment Reg Ind;Expected Efficacious Treatment Regimen Indicator | An indication as to whether the subject has been on a treatment regimen which, based on defined criteria, is expected to be efficacious. | Expected Efficacious Treatment Regimen Indicator | ||
Extent of Resection | C157443 | Extent of Resection | A description of the relative amount of tissue, blood vessel, or organ that has been removed. | Extent of Resection | ||
Final Dose Amount | C176280 | Final Dose Amount | A determination of the final amount of a substance taken as a dose by a subject. | Final Dose Amount | ||
Fistula Anatomical Type | C181314 | Fistula Anatomical Type | A classification based on the anatomical location(s) of the fistula. | Fistula Anatomical Site | ||
Frequency of Final Dose Amount | C176281 | Frequency of Final Dose Amount | A determination of how often a subject takes a substance at the final dose amount. | Frequency of Final Dose Amount | ||
Frequency of Maximum Dose Amount | C176279 | Frequency of Maximum Dose Amount | A determination of how often a subject takes a substance at the maximum dose amount. | Frequency of Maximum Dose Amount | ||
Greatest Circ at Point of Interest | C187676 | Greatest Circ at Point of Interest;Greatest Circumference at Point of Interest;Largest Circumference at Point of Interest | The circumferential measurement of an entity or object of interest at its widest point. | Greatest Circumference at Point of Interest | ||
Healthcare Encounter Type | C119231 | Healthcare Encounter Type | Categorization of the type of healthcare encounter. | Healthcare Encounter Type | ||
Heart Failure New/Worsening Lab Findings | C119232 | Heart Failure New/Worsening Lab Findings | Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. | Lab Findings of New or Worsening Heart Failure | ||
Heart Failure New/Worsening PE Findings | C119233 | Heart Failure New/Worsening PE Findings | Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. | Physical Examination Findings of New or Worsening Heart Failure | ||
Heart Failure Therapy, Intensification | C119234 | Heart Failure Therapy, Intensification | Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. | Heart Failure Therapy Intensification Type | ||
Ileocecal Junction Removed Indicator | C174279 | Ileocecal Junction Removed Indicator | An indication as to whether the ileocecal junction was removed. | Ileocecal Junction Removed Indicator | ||
Ischemic Discomfort Indicator | C119235 | Ischemic Discomfort Indicator | An indicator as to whether the subject has symptoms of ischemic discomfort. | Ischemic Discomfort Indicator | ||
Ischemic Evidence Type | C119236 | Ischemic Evidence Type | Categorization of the type of objective evidence of new or worsening ischemia. | Ischemic Evidence Type | ||
Length of Resection | C174278 | Length of Resection | A measurement of the total length of the removed tissue, blood vessel, or organ. | Length of Resection | ||
Localization of Onset | C117884 | Localization of Onset | The anatomical location of the beginning or early stages of a disease. | Location of Disease Onset | ||
Longest Diameter of Primary Lesion | C181311 | Largest Diameter of Primary Lesion;Longest Diameter of Primary Lesion | The longest diameter of the lesion that has been determined to be the primary lesion. | Longest Diameter of Primary Lesion | ||
Longest Diameter | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
Longitudinal Course | C35461 | Longitudinal Course | A description of the series of events, including signs and symptoms, that define the course of a chronic disease over time. | Clinical Course of Disease | ||
Maximum Dose Amount | C176278 | Maximum Dose Amount | A determination of the maximum amount of a substance taken as a dose by a subject. | Maximum Dose Amount | ||
Most Severe Acute Stressor | C124437 | Most Severe Acute Stressor | The agent, stimulus, activity, or event that causes stress with an acute frequency, which has the highest level of severity. | Most Severe Acute Stressor | ||
Most Severe Chronic Stressor | C124441 | Most Severe Chronic Stressor | The agent, stimulus, activity, or event that causes stress with a chronic frequency, which has the highest level of severity. | Most Severe Chronic Stressor | ||
Nearest Joint | C187675 | Nearest Joint | The anatomical joint in closest proximity to the entity or object of interest. | Nearest Joint | ||
Needle Gauge | C101687 | Needle Gauge | A number representing the outer diameter of a needle. (NCI) | Needle Gauge | ||
New or Worsening Symptoms | C119238 | New or Worsening Symptoms | A description of the new or worsening symptoms related to a clinical event. | New or Worsening Symptom | ||
Non-Invasive Imaging Change | C123443 | Non-Invasive Imaging Change | A description of the clinical change to the subject after a non-invasive imaging procedure. | Clinical Change by Non-Invasive Imaging Procedure | ||
Number of Abscesses | C181313 | Number of Abscesses | The number of abscesses observed. | Number of Abscesses | ||
Number of Alcoholic Drinks | C184464 | Number of Alcoholic Drinks | The total number of alcoholic drinks. | Number of Alcoholic Drinks Measurement | ||
Number of Biopsy Specimens Taken | C181317 | Number of Biopsy Specimens Taken | The total number of biopsy specimens collected. | Number of Biopsy Specimens Taken | ||
Number of Devices Inserted | C174280 | Number of Devices Inserted | The number of devices inserted into an individual. | Number of Devices Inserted | ||
Number of Devices Present | C176277 | Number of Devices Present | A determination of the number of devices within a subject. | Number of Devices Present | ||
Number of Episodes | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
Number of Events | C130057 | Number of Events | The total number of events that have occurred. | Number of Events | ||
Number of Fistulas | C181312 | Number of Fistulas | The number of fistulas observed. | Number of Fistulas | ||
Number Of Hospitalizations | C124443 | Number Of Hospitalizations | The total number of hospitalization events that have occurred for the condition. | Number of Hospitalizations | ||
Number of Laps Completed | C172478 | Number of Laps Completed | The number of laps completed around a course or circuit. | Number of Laps Completed | ||
Number of Lesions | C174277 | Number of Lesions | The number of lesions observed. | Number of Lesions | ||
Number of Mild Episodes | C124328 | Number of Mild Episodes | The number of times an event, which is classified as mild, occurred. | Number of Mild Episodes | ||
Number of Moderate Episodes | C124329 | Number of Moderate Episodes | The number of times an event, which is classified as moderate, occurred. | Number of Moderate Episodes | ||
Number of Objects | C174275 | Number of Objects | The number of objects observed. | Number of Objects | ||
Number of Procedures Performed | C174228 | Number of Procedures Performed | The number of procedures performed on or in an individual. | Number of Procedures Performed | ||
Number of Severe Episodes | C124330 | Number of Severe Episodes | The number of times an event, which is classified as severe, occurred. | Number of Severe Episodes | ||
Number of Steps Taken | C172479 | Number of Steps Taken | The number of footsteps taken by an individual. | Number of Steps Taken | ||
Number of Strictures | C174274 | Number of Strictures | The number of anatomical strictures observed. | Number of Strictures | ||
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Onset Unifocal or Multifocal | C117885 | Onset Unifocal or Multifocal | A categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease. | Focality of Disease Onset | ||
Origin of Cancer Known Ind | C154860 | Origin of Cancer Known Ind;Origin of Cancer Known Indicator | An indication as to whether the primary site of cancer is known. | Cancer Primary Site Known Indicator | ||
Pathologic Appearance of Biopsy Site | C181318 | Pathologic Appearance of Biopsy Site | A description of the appearance of the anatomical site from which a biopsy specimen has been collected. | Pathologic Appearance of Biopsy Site | ||
PCI Acute Angiographic Complication | C119239 | PCI Acute Angiographic Complication | Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. | Acute Myocardial Infarction From PCI Complication Type | ||
Precipitating Factor | C163413 | Precipitating Factor | The factor that causes or triggers the onset of an occurrence. | Precipitating Factor | ||
Prepared Amount | C170562 | Prepared Amount | The quantity of a product that has been made ready for use. | Prepared Amount | ||
Prevents Daily Activities Indicator | C184724 | Prevents Daily Activities Indicator | An indication as to whether the event or intervention prevents or has prevented the performance of daily activities. | Prevents Daily Activities Indicator | ||
Primary Site of Tumor Origin | C179451 | Primary Site of Tumor Origin | The anatomical location of the primary tumor site of disease. | Primary Tumor Site | ||
Procedure Success Indicator | C119240 | Procedure Success Indicator | An indication as to whether the procedure is considered successful. | Procedure Success Indicator | ||
Procedure Urgency Status Type | C101230 | Procedure Urgency Status Type | The degree of urgency in which a medical procedure must be performed. | Triage Status | ||
Pruritus Indicator | C198213 | Pruritus Indicator | An indicator as to whether the subject has symptoms of itchiness. | Pruritus Indicator | ||
QOL Impact | C170617 | QOL Impact;Quality of Life Impact | The effect or consequence of an event or condition on an individual's sense of well-being and ability to enjoy life. | Quality of Life Impact | ||
Relapse after Discon Dependent Indicator | C176283 | Relapse after Discon Dependent Indicator;Relapse after Discontinue Dependent Indicator | An indication as to whether an individual has had a relapse after discontinuation of a substance due to dependence. | Relapse after Discontinuation Because of Dependence Indicator | ||
Relationship to Device | C163414 | Relationship to Device | The relationship of an event to a device, which may or may not be a device under study. | Relationship to Device | ||
Remaining Amount | C170563 | Remaining Amount | The quantity of a product that remains after dosing, consumption, or use. | Remaining Amount | ||
Resected Tumor Ind | C154861 | Resected Tumor Ind;Resected Tumor Indicator | An indication as to whether the tumor has been resected. | Tumor Resected Indicator | ||
Returned Amount | C78722 | Returned Amount | The quantity of a product that has been returned. (NCI) | Returned Amount | ||
Severity/Intensity | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Sign/Symptom Leading to Discontinuation | C174281 | Sign/Symptom Leading to Discontinuation | The signs and/or symptoms that result in the discontinuation of treatment or intervention. | Sign or Symptom Leading to Discontinuation | ||
Speed | C41146 | Speed | A scalar measure of the rate of movement of the object expressed as the distance traveled divided by the elapsed time. | Speed | ||
Stent Thrombosis, Coronary, ARC Timing | C123424 | Stent Thrombosis, Coronary, ARC Timing | Categorization of the timing of coronary stent thrombosis occurrence per the classification schema described by the Academic Research Consortium (ARC). | Academic Research Council Coronary Stent Thrombosis Timing | ||
Stroke Type | C119579 | Stroke Type | Categorization of the type of stroke. | Stroke Type | ||
Substance Dependence Indicator | C176285 | Substance Dependence Indicator | An indication as to whether an individual has become dependent on a substance. | Substance Dependence Indicator | ||
Symptom Indicator | C119241 | Symptom Indicator | An indication as to whether the subject had symptoms related to the clinical event. | Symptom Indicator | ||
Symptom Onset Date | C119242 | Symptom Onset Date | The date time of the onset of symptoms of the clinical event. | Symptom Onset Date | ||
Total Number | C127787 | Total Number | A measurement of the total number of entities. | Total Number | ||
Total Time Paused | C172477 | Total Time Paused | The total amount of time during which an event, operation or activity has been interrupted or stopped. | Total Time Paused | ||
Total Time Physically Active | C172480 | Total Time Physically Active | The total amount of time during which an individual was actively engaged in physical activity. | Total Time Physically Active | ||
Toxicity Grade | C82528 | Toxicity Grade | A standardized categorical classification of the severity of an event or finding. | Toxicity Grade | ||
Treatment Setting | C124444 | Treatment Environmental Setting;Treatment Setting | The surroundings or environment within which the subject receives therapeutic treatment for the condition. | Treatment Environmental Setting | ||
Type of Object | C174276 | Type of Object | The type of object observed. | Type of Object | ||
Unable to Discon Dependent Indicator | C176284 | Unable to Discon Dependent Indicator;Unable to Discontinue Dependent Indicator | An indication as to whether an individual is unable to discontinue the use of a substance due to dependence. | Unable to Discontinue Use Due to Dependence Indicator | ||
Unable to Taper Dependent Indicator | C176282 | Unable to Taper Dependent Indicator | An indication as to whether an individual is incapable of reducing or tapering the amount of a substance taken due to dependence. | Unable to Taper Dependent Indicator | ||
Vessel Occlusion After CABG 48 Ind | C119243 | Vessel Occlusion After CABG 48 Ind | An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. | Vessel Occlusion 48 Hours after CABG Indicator | ||
Volume | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
Back to top | ||||||
CL.C76351.SKINCLAS | Fitzpatrick Skin Classification Response
(SKINCLAS) | text
Extensible: Yes | C76351 | Fitzpatrick Skin Classification Response | A terminology codelist relevant to the classification system used to categorize the sensitivity of a subject's skin to sunlight. (Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871.) | CDISC SDTM Skin Classification Terminology |
TYPEI | C74569 | TYPE1 | Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lightly complected blondes. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type I | ||
TYPEII | C74570 | TYPE2 | Individuals who frequently burn but are able to tan to a small degree after extended sun exposure. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type II | ||
TYPEIII | C74571 | TYPE3 | Individuals who burn infrequently and tan readily. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type III | ||
TYPEIV | C74572 | TYPE4 | Individuals who rarely burn and tan heavily with moderate sun exposures, especially individuals of Asian, American Indian, Mediterranean and Latin American descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type IV | ||
TYPEV | C74573 | TYPE5 | Individuals who have dark constitutive pigmentation but become noticeably darker with sun exposure, especially light complected black individuals, those of Indian descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type V | ||
TYPEVI | C74574 | TYPE6 | Individuals who have the heaviest constitutive pigmentation, especially dark skinned black individuals. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type VI | ||
Back to top | ||||||
CL.C124670.FCVD1TC | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Code
(FCVD1TC) | text
Extensible: No | C124670 | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Code | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score test code. | CDISC Clinical Classification FHS CVD 10-Year Risk Score Test Code Terminology |
FCVD101 | C124722 | FCVD1-Framingham CVD 10-Year Risk Score | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score - Cardiovascular disease 10-year risk score. | FHS CVD 10-Year Risk Score - Risk Score | ||
Back to top | ||||||
CL.C124669.FCVD1TN | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Name
(FCVD1TN) | text
Extensible: No | C124669 | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Name | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score test name. | CDISC Clinical Classification FHS CVD 10-Year Risk Score Test Name Terminology |
FCVD1-Framingham CVD 10-Year Risk Score | C124722 | FCVD1-Framingham CVD 10-Year Risk Score | Framingham Heart Study Cardiovascular Disease 10-Year Risk Score - Cardiovascular disease 10-year risk score. | FHS CVD 10-Year Risk Score - Risk Score | ||
Back to top | ||||||
CL.C71113.FREQ | Frequency
(FREQ) | text
Extensible: Yes | C71113 | Frequency | The terminology that includes terms pertaining to frequency within CDISC. | CDISC SDTM Frequency Terminology |
1 TIME PER WEEK | C64526 | One Time Per Week | One time per week. (NCI) | Once Weekly | ||
10 DAYS PER MONTH | C139179 | 10 Days Monthly | Ten days per month. (NCI) | Ten Days Per Month | ||
2 TIMES PER CYCLE | C176288 | Two times per cycle. | Two Times Per Cycle | |||
2 TIMES PER WEEK | C64497 | BIS;Twice per week | Two times per week. (NCI) | Twice Weekly | ||
2 TIMES PER YEAR | C98861 | 2 Times Per Year | Two times per year. (NCI) | Two Times Yearly | ||
3 TIMES PER CYCLE | C176289 | Three times per cycle. | Three Times Per Cycle | |||
3 TIMES PER MONTH | C98859 | 3 Times Per Month | Three times per month. (NCI) | Three Times Monthly | ||
3 TIMES PER WEEK | C64528 | Three times a week;TIS | Three times per week. (NCI) | Three Times Weekly | ||
3 TIMES PER YEAR | C98860 | 3 Times Per Year | Three times per year. (NCI) | Three Times Yearly | ||
4 TIMES PER MONTH | C98852 | 4 Times Per Month | Four times per month. (NCI) | Four Times Monthly | ||
4 TIMES PER WEEK | C64531 | 4 times per week;QIS | Four times per week. (NCI) | Four Times Weekly | ||
4 TIMES PER YEAR | C98853 | 4 Times Per Year | Four times per year. (NCI) | Four Times Yearly | ||
5 TIMES PER DAY | C98849 | 5 Times Daily | Five times per day. (NCI) | Five Times Daily | ||
5 TIMES PER MONTH | C98850 | 5 Times Per Month | Five times per month. (NCI) | Five Times Monthly | ||
5 TIMES PER WEEK | C85552 | 5 Times Per Week | Five times per week. (NCI) | Five Times Weekly | ||
5 TIMES PER YEAR | C98851 | 5 Times Per Year | Five times per year. (NCI) | Five Times Yearly | ||
6 TIMES PER DAY | C98855 | 6 Times Daily | Six times per day. (NCI) | Six Times Daily | ||
6 TIMES PER MONTH | C98856 | 6 Times Per Month | Six times per month. (NCI) | Six Times Monthly | ||
6 TIMES PER WEEK | C98857 | 6 Times Per Week | Six times per week. (NCI) | Six Times Weekly | ||
6 TIMES PER YEAR | C98858 | 6 Times Per Year | Six times per year. (NCI) | Six Times Yearly | ||
7 TIMES PER DAY | C139180 | 7 Times Daily | Seven times per day. (NCI) | Seven Times Per Day | ||
7 TIMES PER WEEK | C98854 | 7 Times Per Week | Seven times per week. (NCI) | Seven Times Weekly | ||
8 TIMES PER DAY | C139181 | 8 Times Daily | Eight times per day. (NCI) | Eight Times Per Day | ||
9 TIMES PER DAY | C139182 | 9 Times Daily | Nine times per day. (NCI) | Nine Times Per Day | ||
AD LIBITUM | C64636 | Ad Libitum | As much as desired. | As Much as Desired | ||
BID | C64496 | BD;Twice per day | Two times per day, at unspecified times. (NCI) | Twice Daily | ||
BIM | C71129 | Twice per month | Twice per month. (NCI) | Twice Per Month | ||
CONTINUOUS | C53279 | Continuous | Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI) | Continue | ||
EVERY 10 WEEKS | C189433 | Every 10 Weeks;Q10S | Every 10 weeks. | Every Ten Weeks | ||
EVERY 10 YEARS | C189435 | Every 10 years. | Every Ten Years | |||
EVERY 12 WEEKS | C161332 | Q12S | Every twelve weeks. | Every Twelve Weeks | ||
EVERY 13 WEEKS | C189434 | Every 13 Weeks;Q13S | Every 13 weeks. | Every Thirteen Weeks | ||
EVERY 16 WEEKS | C161336 | Q16S | Every sixteen weeks. | Every Sixteen Weeks | ||
EVERY 2 WEEKS | C71127 | Every 2 weeks;Q2S | Every two weeks. (NCI) | Every Two Weeks | ||
EVERY 3 WEEKS | C64535 | Every 3 weeks;Q3S | Every three weeks. (NCI) | Every Three Weeks | ||
EVERY 3 YEARS | C161333 | Every three years. | Every Three Years | |||
EVERY 4 WEEKS | C64529 | Every 4 weeks;Q4S | Every four weeks. (NCI) | Every Four Weeks | ||
EVERY 4 YEARS | C189432 | Every four years. | Every Four Years | |||
EVERY 5 WEEKS | C103390 | Every 5 weeks;Q5S | Every five weeks. (NCI) | Every Five Weeks | ||
EVERY 5 YEARS | C161334 | Every five years. | Every Five Years | |||
EVERY 6 WEEKS | C89788 | Every 6 Weeks;Q6S | Every six weeks. (NCI) | Every Six Weeks | ||
EVERY 7 WEEKS | C116149 | Every 7 weeks;Q7S | Every seven weeks. | Every Seven Weeks | ||
EVERY 8 WEEKS | C103389 | Every 8 weeks;Q8S | Every eight weeks. (NCI) | Every Eight Weeks | ||
EVERY AFTERNOON | C154484 | Every afternoon. | Every Afternoon | |||
EVERY EVENING | C160957 | Every evening. | Every Evening | |||
EVERY WEEK | C67069 | Every week;Per Week;QS | Every week. (NCI) | Weekly | ||
INTERMITTENT | C71325 | Intermittent | Periodically stopping and starting. (NCI) | Intermittent | ||
OCCASIONAL | C64954 | Occasional | Not occurring regularly or at short intervals. | Infrequent | ||
ONCE | C64576 | One time. | Once | |||
PA | C74924 | /Year;Every Year;Per Annum;Per Year | A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days. | Per Year | ||
PRN | C64499 | As needed | As needed. (NCI) | As Needed | ||
Q10H | C64500 | Every 10 hours | Every ten hours. (NCI) | Every Ten Hours | ||
Q11H | C64501 | Every 11 hours | Every eleven hours. (NCI) | Every Eleven Hours | ||
Q12H | C64502 | Every 12 hours | Every twelve hours. (NCI) | Every Twelve Hours | ||
Q13H | C64503 | Every 13 hours | Every thirteen hours. (NCI) | Every Thirteen Hours | ||
Q14H | C64504 | Every 14 hours | Every fourteen hours. (NCI) | Every Fourteen Hours | ||
Q15H | C64505 | Every 15 hours | Every fifteen hours. (NCI) | Every Fifteen Hours | ||
Q16H | C64506 | Every 16 hours | Every sixteen hours. (NCI) | Every Sixteen Hours | ||
Q17H | C64507 | Every 17 hours | Every seventeen hours. (NCI) | Every Seventeen Hours | ||
Q18H | C64508 | Every 18 hours | Every eighteen hours. (NCI) | Every Eighteen Hours | ||
Q19H | C64509 | Every 19 hours | Every nineteen hours. (NCI) | Every Nineteen Hours | ||
Q20H | C64511 | Every 20 hours | Every twenty hours. (NCI) | Every Twenty Hours | ||
Q21H | C64512 | Every 21 hours | Every twenty-one hours. (NCI) | Every Twenty-One Hours | ||
Q22H | C64513 | Every 22 hours | Every twenty-two hours. (NCI) | Every Twenty-Two Hours | ||
Q23H | C64514 | Every 23 hours | Every twenty-three hours. (NCI) | Every Twenty-Three Hours | ||
Q24H | C64515 | Every 24 hours | Every twenty-four hours. (NCI) | Every Twenty-Four Hours | ||
Q2H | C64516 | Every 2 hours | Every two hours. (NCI) | Every Two Hours | ||
Q2M | C64536 | Every two months | Every two months. (NCI) | Every Two Months | ||
Q36H | C89791 | Every 36 Hours | Every thirty-six hours. (NCI) | Every Thirty-six Hours | ||
Q3D | C64533 | Every 3 days | Every three days. (NCI) | Every Three Days | ||
Q3H | C64517 | Every 3 hours | Every three hours. (NCI) | Every Three Hours | ||
Q3M | C64537 | Every 3 months | Every three months. (NCI) | Every Three Months | ||
Q45MIN | C139183 | Every 45 Minutes | Every forty-five minutes. (NCI) | Every Forty-Five Minutes | ||
Q48H | C89790 | Every 48 Hours | Every forty-eight hours. (NCI) | Every Forty-eight Hours | ||
Q4D | C64534 | Every 4 days | Every four days. (NCI) | Every Four Days | ||
Q4H | C64518 | Every 4 hours | Every four hours. (NCI) | Every Four Hours | ||
Q4M | C64538 | Every 4 months | Every four months. (NCI) | Every Four Months | ||
Q5D | C71124 | Every 5 days | Every five days. (NCI) | Every Five Days | ||
Q5H | C64519 | Every 5 hours | Every five hours. (NCI) | Every Five Hours | ||
Q6D | C161335 | Every six days. | Every Six Days | |||
Q6H | C64520 | Every 6 hours | Every six hours. (NCI) | Every Six Hours | ||
Q6M | C89789 | Every 6 Months | Every six months. (NCI) | Every Six Months | ||
Q72H | C174288 | Every 72 hours | Every seventy-two hours. | Every Seventy Two Hours | ||
Q7D | C139177 | Every 7 Days | Every seven days. (NCI) | Every Seven Days | ||
Q7H | C64521 | Every 7 hours | Every seven hours. (NCI) | Every Seven Hours | ||
Q8H | C64523 | Every 8 hours | Every eight hours. (NCI) | Every Eight Hours | ||
Q96H | C189436 | Every 96 Hours | Every 96 hours. | Every Ninety-Six Hours | ||
Q9H | C64524 | Every 9 hours | Every nine hours. (NCI) | Every Nine Hours | ||
QAM | C64595 | Every Morning | Every morning. (NCI) | Every Morning | ||
QD | C25473 | /day;Daily;Per Day | A rate of occurrences within a period of time equal to one day. | Daily | ||
QH | C64510 | Every hour | Every hour. (NCI) | Every Hour | ||
QHS | C64593 | Every day at bedtime. | Hour Of Sleep | |||
QID | C64530 | 4 times per day | Four times per day. (NCI) | Four Times Daily | ||
QM | C64498 | Every Month;Per Month | Every month. (NCI) | Monthly | ||
QN | C139178 | Every night. | Every Night | |||
QOD | C64525 | Every other day;Every Second Day;Every Two Days;Q2D | Every other day. (NCI) | Every Other Day | ||
QPM | C64596 | Every day, on or after 12:00 pm. | QPM | |||
THRICE | C156502 | Three times. | Thrice | |||
TID | C64527 | 3 times per day | Three times per day. (NCI) | Three Times Daily | ||
TWICE | C65134 | Two times. (NCI) | Twice | |||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C111344.FAQ01TC | Functional Activities Questionnaire Clinical Classification Test Code
(FAQ01TC) | text
Extensible: No | C111344 | Functional Activities Questionnaire Clinical Classification Test Code | Functional Activities Questionnaire test code. | CDISC Clinical Classification FAQ Test Code Terminology |
FAQ0101 | C111499 | FAQ01-Write Checks/Pay Bills/Checkbook | Functional Activities Questionnaire - Writing checks, paying bills, balancing checkbook. | FAQ - Write checks, Pay bills, Balance checkbook | ||
FAQ0102 | C111500 | FAQ01-Assembling | Functional Activities Questionnaire - Assembling tax records, business affairs, or papers. | FAQ - Assemble | ||
FAQ0103 | C111501 | FAQ01-Shopping Alone | Functional Activities Questionnaire - Shopping alone for clothes, household necessities, or groceries. | FAQ - Shop Alone | ||
FAQ0104 | C111502 | FAQ01-Playing a Game of Skill | Functional Activities Questionnaire - Playing a game of skill, working on a hobby. | FAQ - Play Game of Skill, Work on Hobby | ||
FAQ0105 | C111503 | FAQ01-Heat Water/Make Coffee/Stove Off | Functional Activities Questionnaire - Heating water, making a cup of coffee, turning off stove after use. | FAQ - Heat water, Make Coffee, Turn Off Stove | ||
FAQ0106 | C111504 | FAQ01-Preparing a Balanced Meal | Functional Activities Questionnaire - Preparing a balanced meal. | FAQ - Prepare a Meal | ||
FAQ0107 | C111505 | FAQ01-Keeping Track of Current Events | Functional Activities Questionnaire - Keeping track of current events. | FAQ - Keep Track of Current Events | ||
FAQ0108 | C111506 | FAQ01-Paying Attention | Functional Activities Questionnaire - Paying attention to, understanding, discussing TV, book, magazine. | FAQ - Pay Attention, Understand, Discuss | ||
FAQ0109 | C111507 | FAQ01-Remembering | Functional Activities Questionnaire - Remembering appointments, family occasions, holidays, medications. | FAQ - Remember | ||
FAQ0110 | C111508 | FAQ01-Traveling | Functional Activities Questionnaire - Traveling out of neighborhood, driving, arranging to take buses. | FAQ - Travel | ||
FAQ0111 | C111509 | FAQ01-Total Score | Functional Activities Questionnaire - Total Score. | FAQ - Total Score | ||
Back to top | ||||||
CL.C111343.FAQ01TN | Functional Activities Questionnaire Clinical Classification Test Name
(FAQ01TN) | text
Extensible: No | C111343 | Functional Activities Questionnaire Clinical Classification Test Name | Functional Activities Questionnaire test name. | CDISC Clinical Classification FAQ Test Name Terminology |
FAQ01-Assembling | C111500 | FAQ01-Assembling | Functional Activities Questionnaire - Assembling tax records, business affairs, or papers. | FAQ - Assemble | ||
FAQ01-Heat Water/Make Coffee/Stove Off | C111503 | FAQ01-Heat Water/Make Coffee/Stove Off | Functional Activities Questionnaire - Heating water, making a cup of coffee, turning off stove after use. | FAQ - Heat water, Make Coffee, Turn Off Stove | ||
FAQ01-Keeping Track of Current Events | C111505 | FAQ01-Keeping Track of Current Events | Functional Activities Questionnaire - Keeping track of current events. | FAQ - Keep Track of Current Events | ||
FAQ01-Paying Attention | C111506 | FAQ01-Paying Attention | Functional Activities Questionnaire - Paying attention to, understanding, discussing TV, book, magazine. | FAQ - Pay Attention, Understand, Discuss | ||
FAQ01-Playing a Game of Skill | C111502 | FAQ01-Playing a Game of Skill | Functional Activities Questionnaire - Playing a game of skill, working on a hobby. | FAQ - Play Game of Skill, Work on Hobby | ||
FAQ01-Preparing a Balanced Meal | C111504 | FAQ01-Preparing a Balanced Meal | Functional Activities Questionnaire - Preparing a balanced meal. | FAQ - Prepare a Meal | ||
FAQ01-Remembering | C111507 | FAQ01-Remembering | Functional Activities Questionnaire - Remembering appointments, family occasions, holidays, medications. | FAQ - Remember | ||
FAQ01-Shopping Alone | C111501 | FAQ01-Shopping Alone | Functional Activities Questionnaire - Shopping alone for clothes, household necessities, or groceries. | FAQ - Shop Alone | ||
FAQ01-Total Score | C111509 | FAQ01-Total Score | Functional Activities Questionnaire - Total Score. | FAQ - Total Score | ||
FAQ01-Traveling | C111508 | FAQ01-Traveling | Functional Activities Questionnaire - Traveling out of neighborhood, driving, arranging to take buses. | FAQ - Travel | ||
FAQ01-Write Checks/Pay Bills/Checkbook | C111499 | FAQ01-Write Checks/Pay Bills/Checkbook | Functional Activities Questionnaire - Writing checks, paying bills, balancing checkbook. | FAQ - Write checks, Pay bills, Balance checkbook | ||
Back to top | ||||||
CL.C179938.FAC065TC | Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire Test Code
(FAC065TC) | text
Extensible: No | C179938 | Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire Test Code | Functional Assessment of Anorexia/Cachexia Treatment Version 4 test code. | CDISC Questionnaire FAACT Version 4 Test Code Terminology |
FAC06501 | C179976 | FAC065-I Have a Lack of Energy | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have a lack of energy. | FAACT Version 4 - I Have a Lack of Energy | ||
FAC06502 | C179977 | FAC065-I Have Nausea | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have nausea. | FAACT Version 4 - I Have Nausea | ||
FAC06503 | C179978 | FAC065-Trouble Meeting Needs of Family | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Because of my physical condition, I have trouble meeting the needs of my family. | FAACT Version 4 - Trouble Meeting Needs of Family | ||
FAC06504 | C179979 | FAC065-I Have Pain | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have pain. | FAACT Version 4 - I Have Pain | ||
FAC06505 | C179980 | FAC065-Bothered by Treatment Side Effect | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am bothered by side effects of treatment. | FAACT Version 4 - Bothered by Treatment Side Effect | ||
FAC06506 | C179981 | FAC065-I Feel Ill | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel ill. | FAACT Version 4 - I Feel Ill | ||
FAC06507 | C179982 | FAC065-I Am Forced to Spend Time in Bed | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am forced to spend time in bed. | FAACT Version 4 - I Am Forced to Spend Time in Bed | ||
FAC06508 | C179983 | FAC065-I Feel Close to My Friends | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel close to my friends. | FAACT Version 4 - I Feel Close to My Friends | ||
FAC06509 | C179984 | FAC065-Get Emotional Support From Family | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I get emotional support from my family. | FAACT Version 4 - Get Emotional Support From Family | ||
FAC06510 | C179985 | FAC065-I Get Support From My Friends | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I get support from my friends. | FAACT Version 4 - I Get Support From My Friends | ||
FAC06511 | C179986 | FAC065-My Family Has Accepted My Illness | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My family accepts my illness. | FAACT Version 4 - My Family Has Accepted My Illness | ||
FAC06512 | C179987 | FAC065-Satisfied Communication Illness | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with family communication about my illness. | FAACT Version 4 - Satisfied Communication Illness | ||
FAC06513 | C179988 | FAC065-I Feel Close to My Partner | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel close to my partner (or the person who is my main support). | FAACT Version 4 - I Feel Close to My Partner | ||
FAC06514 | C179989 | FAC065-I Am Satisfied With My Sex Life | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with my sex life. | FAACT Version 4 - I Am Satisfied With My Sex Life | ||
FAC06515 | C179990 | FAC065-I Feel Sad | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel sad. | FAACT Version 4 - I Feel Sad | ||
FAC06516 | C179991 | FAC065-Satisfied With How I Am Coping | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with how I am coping with my illness. | FAACT Version 4 - Satisfied With How I Am Coping | ||
FAC06517 | C179992 | FAC065-Losing Hope Against Illness | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am losing hope in the fight against my illness. | FAACT Version 4 - Losing Hope Against Illness | ||
FAC06518 | C179993 | FAC065-I Feel Nervous | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel nervous. | FAACT Version 4 - I Feel Nervous | ||
FAC06519 | C179994 | FAC065-I Worry About Dying | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I worry about dying. | FAACT Version 4 - I Worry About Dying | ||
FAC06520 | C179995 | FAC065-Worry My Condition Will Get Worse | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I worry that my condition will get worse. | FAACT Version 4 - Worry My Condition Will Get Worse | ||
FAC06521 | C179996 | FAC065-I Am Able to Work | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am able to work (include work at home). | FAACT Version 4 - I Am Able to Work | ||
FAC06522 | C179997 | FAC065-My Work Is Fulfilling | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My work (include work at home) is fulfilling. | FAACT Version 4 - My Work Is Fulfilling | ||
FAC06523 | C179998 | FAC065-I Am Able to Enjoy Life | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am able to enjoy life. | FAACT Version 4 - I Am Able to Enjoy Life | ||
FAC06524 | C179999 | FAC065-I Have Accepted My Illness | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have accepted my illness. | FAACT Version 4 - I Have Accepted My Illness | ||
FAC06525 | C180000 | FAC065-I Am Sleeping Well | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am sleeping well. | FAACT Version 4 - I Am Sleeping Well | ||
FAC06526 | C180001 | FAC065-Enjoy Things I Usually Do for Fun | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am enjoying the things I usually do for fun. | FAACT Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC06527 | C180002 | FAC065-Content With Quality of My Life | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am content with the quality of my life right now. | FAACT Version 4 - Content With Quality of My Life | ||
FAC06528 | C180003 | FAC065-I Have a Good Appetite | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have a good appetite. | FAACT Version 4 - I Have a Good Appetite | ||
FAC06529 | C180004 | FAC065-Amount I Eat Is Sufficient | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - The amount I eat is sufficient to meet my needs. | FAACT Version 4 - Amount I Eat Is Sufficient | ||
FAC06530 | C180005 | FAC065-I Am Worried About My Weight | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am worried about my weight. | FAACT Version 4 - I Am Worried About My Weight | ||
FAC06531 | C180006 | FAC065-Most Food Tastes Unpleasant to Me | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Most food tastes unpleasant to me. | FAACT Version 4 - Most Food Tastes Unpleasant to Me | ||
FAC06532 | C180007 | FAC065-I Am Concerned How Thin I Look | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am concerned about how thin I look. | FAACT Version 4 - I Am Concerned How Thin I Look | ||
FAC06533 | C180008 | FAC065-Interest in Food Drops Try to Eat | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My interest in food drops as soon as I try to eat. | FAACT Version 4 - Interest in Food Drops Try to Eat | ||
FAC06534 | C180009 | FAC065-Have Difficulty Eating Rich Foods | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have difficulty eating rich or "heavy" foods. | FAACT Version 4 - Have Difficulty Eating Rich Foods | ||
FAC06535 | C180010 | FAC065-My Family Pressuring Me to Eat | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My family or friends are pressuring me to eat. | FAACT Version 4 - My Family Pressuring Me to Eat | ||
FAC06536 | C180011 | FAC065-I Have Been Vomiting | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have been vomiting. | FAACT Version 4 - I Have Been Vomiting | ||
FAC06537 | C180012 | FAC065-I Seem to Get Full Quickly | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - When I eat, I seem to get full quickly. | FAACT Version 4 - I Seem to Get Full Quickly | ||
FAC06538 | C180013 | FAC065-I Have Pain in My Stomach Area | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have pain in my stomach area. | FAACT Version 4 - I Have Pain in My Stomach Area | ||
FAC06539 | C180014 | FAC065-My General Health Is Improving | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My general health is improving. | FAACT Version 4 - My General Health Is Improving | ||
FAC06540 | C180015 | FAC065-Physical Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Physical Well-Being: Subscale score. | FAACT Version 4 - Physical Subscale Score | ||
FAC06541 | C180016 | FAC065-Social/Family Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Social/Family Well-Being: Subscale score. | FAACT Version 4 - Social/Family Subscale Score | ||
FAC06542 | C180017 | FAC065-Emotional Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Emotional Well-Being: Subscale score. | FAACT Version 4 - Emotional Subscale Score | ||
FAC06543 | C180018 | FAC065-Functional Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Functional Well-Being: Subscale score. | FAACT Version 4 - Functional Subscale Score | ||
FAC06544 | C180019 | FAC065-Additional Concern Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Additional Concerns: Well-Being subscale score. | FAACT Version 4 - Additional Concern Subscale Score | ||
FAC06545 | C180020 | FAC065-Trial Outcome Index Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - FAACT trial outcome index. | FAACT Version 4 - Trial Outcome Index Score | ||
FAC06546 | C180021 | FAC065-FACT-G Total Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - FACT-G total score. | FAACT Version 4 - FACT-G Total Score | ||
FAC06547 | C180022 | FAC065-Total Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Total score. | FAACT Version 4 - Total Score | ||
Back to top | ||||||
CL.C179937.FAC065TN | Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire Test Name
(FAC065TN) | text
Extensible: No | C179937 | Functional Assessment of Anorexia/Cachexia Treatment Version 4 Questionnaire Test Name | Functional Assessment of Anorexia/Cachexia Treatment Version 4 test name. | CDISC Questionnaire FAACT Version 4 Test Name Terminology |
FAC065-Additional Concern Subscale Score | C180019 | FAC065-Additional Concern Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Additional Concerns: Well-Being subscale score. | FAACT Version 4 - Additional Concern Subscale Score | ||
FAC065-Amount I Eat Is Sufficient | C180004 | FAC065-Amount I Eat Is Sufficient | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - The amount I eat is sufficient to meet my needs. | FAACT Version 4 - Amount I Eat Is Sufficient | ||
FAC065-Bothered by Treatment Side Effect | C179980 | FAC065-Bothered by Treatment Side Effect | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am bothered by side effects of treatment. | FAACT Version 4 - Bothered by Treatment Side Effect | ||
FAC065-Content With Quality of My Life | C180002 | FAC065-Content With Quality of My Life | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am content with the quality of my life right now. | FAACT Version 4 - Content With Quality of My Life | ||
FAC065-Emotional Subscale Score | C180017 | FAC065-Emotional Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Emotional Well-Being: Subscale score. | FAACT Version 4 - Emotional Subscale Score | ||
FAC065-Enjoy Things I Usually Do for Fun | C180001 | FAC065-Enjoy Things I Usually Do for Fun | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am enjoying the things I usually do for fun. | FAACT Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC065-FACT-G Total Score | C180021 | FAC065-FACT-G Total Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - FACT-G total score. | FAACT Version 4 - FACT-G Total Score | ||
FAC065-Functional Subscale Score | C180018 | FAC065-Functional Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Functional Well-Being: Subscale score. | FAACT Version 4 - Functional Subscale Score | ||
FAC065-Get Emotional Support From Family | C179984 | FAC065-Get Emotional Support From Family | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I get emotional support from my family. | FAACT Version 4 - Get Emotional Support From Family | ||
FAC065-Have Difficulty Eating Rich Foods | C180009 | FAC065-Have Difficulty Eating Rich Foods | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have difficulty eating rich or "heavy" foods. | FAACT Version 4 - Have Difficulty Eating Rich Foods | ||
FAC065-I Am Able to Enjoy Life | C179998 | FAC065-I Am Able to Enjoy Life | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am able to enjoy life. | FAACT Version 4 - I Am Able to Enjoy Life | ||
FAC065-I Am Able to Work | C179996 | FAC065-I Am Able to Work | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am able to work (include work at home). | FAACT Version 4 - I Am Able to Work | ||
FAC065-I Am Concerned How Thin I Look | C180007 | FAC065-I Am Concerned How Thin I Look | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am concerned about how thin I look. | FAACT Version 4 - I Am Concerned How Thin I Look | ||
FAC065-I Am Forced to Spend Time in Bed | C179982 | FAC065-I Am Forced to Spend Time in Bed | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am forced to spend time in bed. | FAACT Version 4 - I Am Forced to Spend Time in Bed | ||
FAC065-I Am Satisfied With My Sex Life | C179989 | FAC065-I Am Satisfied With My Sex Life | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with my sex life. | FAACT Version 4 - I Am Satisfied With My Sex Life | ||
FAC065-I Am Sleeping Well | C180000 | FAC065-I Am Sleeping Well | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am sleeping well. | FAACT Version 4 - I Am Sleeping Well | ||
FAC065-I Am Worried About My Weight | C180005 | FAC065-I Am Worried About My Weight | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am worried about my weight. | FAACT Version 4 - I Am Worried About My Weight | ||
FAC065-I Feel Close to My Friends | C179983 | FAC065-I Feel Close to My Friends | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel close to my friends. | FAACT Version 4 - I Feel Close to My Friends | ||
FAC065-I Feel Close to My Partner | C179988 | FAC065-I Feel Close to My Partner | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel close to my partner (or the person who is my main support). | FAACT Version 4 - I Feel Close to My Partner | ||
FAC065-I Feel Ill | C179981 | FAC065-I Feel Ill | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel ill. | FAACT Version 4 - I Feel Ill | ||
FAC065-I Feel Nervous | C179993 | FAC065-I Feel Nervous | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel nervous. | FAACT Version 4 - I Feel Nervous | ||
FAC065-I Feel Sad | C179990 | FAC065-I Feel Sad | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I feel sad. | FAACT Version 4 - I Feel Sad | ||
FAC065-I Get Support From My Friends | C179985 | FAC065-I Get Support From My Friends | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I get support from my friends. | FAACT Version 4 - I Get Support From My Friends | ||
FAC065-I Have a Good Appetite | C180003 | FAC065-I Have a Good Appetite | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have a good appetite. | FAACT Version 4 - I Have a Good Appetite | ||
FAC065-I Have a Lack of Energy | C179976 | FAC065-I Have a Lack of Energy | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have a lack of energy. | FAACT Version 4 - I Have a Lack of Energy | ||
FAC065-I Have Accepted My Illness | C179999 | FAC065-I Have Accepted My Illness | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have accepted my illness. | FAACT Version 4 - I Have Accepted My Illness | ||
FAC065-I Have Been Vomiting | C180011 | FAC065-I Have Been Vomiting | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have been vomiting. | FAACT Version 4 - I Have Been Vomiting | ||
FAC065-I Have Nausea | C179977 | FAC065-I Have Nausea | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have nausea. | FAACT Version 4 - I Have Nausea | ||
FAC065-I Have Pain in My Stomach Area | C180013 | FAC065-I Have Pain in My Stomach Area | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have pain in my stomach area. | FAACT Version 4 - I Have Pain in My Stomach Area | ||
FAC065-I Have Pain | C179979 | FAC065-I Have Pain | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I have pain. | FAACT Version 4 - I Have Pain | ||
FAC065-I Seem to Get Full Quickly | C180012 | FAC065-I Seem to Get Full Quickly | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - When I eat, I seem to get full quickly. | FAACT Version 4 - I Seem to Get Full Quickly | ||
FAC065-I Worry About Dying | C179994 | FAC065-I Worry About Dying | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I worry about dying. | FAACT Version 4 - I Worry About Dying | ||
FAC065-Interest in Food Drops Try to Eat | C180008 | FAC065-Interest in Food Drops Try to Eat | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My interest in food drops as soon as I try to eat. | FAACT Version 4 - Interest in Food Drops Try to Eat | ||
FAC065-Losing Hope Against Illness | C179992 | FAC065-Losing Hope Against Illness | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am losing hope in the fight against my illness. | FAACT Version 4 - Losing Hope Against Illness | ||
FAC065-Most Food Tastes Unpleasant to Me | C180006 | FAC065-Most Food Tastes Unpleasant to Me | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Most food tastes unpleasant to me. | FAACT Version 4 - Most Food Tastes Unpleasant to Me | ||
FAC065-My Family Has Accepted My Illness | C179986 | FAC065-My Family Has Accepted My Illness | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My family accepts my illness. | FAACT Version 4 - My Family Has Accepted My Illness | ||
FAC065-My Family Pressuring Me to Eat | C180010 | FAC065-My Family Pressuring Me to Eat | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My family or friends are pressuring me to eat. | FAACT Version 4 - My Family Pressuring Me to Eat | ||
FAC065-My General Health Is Improving | C180014 | FAC065-My General Health Is Improving | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My general health is improving. | FAACT Version 4 - My General Health Is Improving | ||
FAC065-My Work Is Fulfilling | C179997 | FAC065-My Work Is Fulfilling | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - My work (include work at home) is fulfilling. | FAACT Version 4 - My Work Is Fulfilling | ||
FAC065-Physical Subscale Score | C180015 | FAC065-Physical Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Physical Well-Being: Subscale score. | FAACT Version 4 - Physical Subscale Score | ||
FAC065-Satisfied Communication Illness | C179987 | FAC065-Satisfied Communication Illness | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with family communication about my illness. | FAACT Version 4 - Satisfied Communication Illness | ||
FAC065-Satisfied With How I Am Coping | C179991 | FAC065-Satisfied With How I Am Coping | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I am satisfied with how I am coping with my illness. | FAACT Version 4 - Satisfied With How I Am Coping | ||
FAC065-Social/Family Subscale Score | C180016 | FAC065-Social/Family Subscale Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Social/Family Well-Being: Subscale score. | FAACT Version 4 - Social/Family Subscale Score | ||
FAC065-Total Score | C180022 | FAC065-Total Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Total score. | FAACT Version 4 - Total Score | ||
FAC065-Trial Outcome Index Score | C180020 | FAC065-Trial Outcome Index Score | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - FAACT trial outcome index. | FAACT Version 4 - Trial Outcome Index Score | ||
FAC065-Trouble Meeting Needs of Family | C179978 | FAC065-Trouble Meeting Needs of Family | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - Because of my physical condition, I have trouble meeting the needs of my family. | FAACT Version 4 - Trouble Meeting Needs of Family | ||
FAC065-Worry My Condition Will Get Worse | C179995 | FAC065-Worry My Condition Will Get Worse | Functional Assessment of Anorexia/Cachexia Treatment Version 4 - I worry that my condition will get worse. | FAACT Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C150778.FAC062TC | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire Test Code
(FAC062TC) | text
Extensible: No | C150778 | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 test code. | CDISC Questionnaire FACT-BRM Version 4 Test Code Terminology |
FAC06201 | C151156 | FAC062-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have a lack of energy. | FACT-BRM Version 4 - I Have a Lack of Energy | ||
FAC06202 | C151157 | FAC062-I Have Nausea | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have nausea. | FACT-BRM Version 4 - I Have Nausea | ||
FAC06203 | C151158 | FAC062-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-BRM Version 4 - Trouble Meeting Needs of Family | ||
FAC06204 | C151159 | FAC062-I Have Pain | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have pain. | FACT-BRM Version 4 - I Have Pain | ||
FAC06205 | C151160 | FAC062-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-BRM Version 4 - Bothered by Treatment Side Effect | ||
FAC06206 | C151161 | FAC062-I Feel Ill | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I feel ill. | FACT-BRM Version 4 - I Feel Ill | ||
FAC06207 | C151162 | FAC062-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-BRM Version 4 - I Am Forced to Spend Time in Bed | ||
FAC06208 | C151163 | FAC062-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-BRM Version 4 - I Feel Close to My Friends | ||
FAC06209 | C151164 | FAC062-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-BRM Version 4 - Get Emotional Support From Family | ||
FAC06210 | C151165 | FAC062-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-BRM Version 4 - I Get Support From My Friends | ||
FAC06211 | C151166 | FAC062-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-BRM Version 4 - My Family Has Accepted My Illness | ||
FAC06212 | C151167 | FAC062-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-BRM Version 4 - Satisfied Communication Illness | ||
FAC06213 | C151168 | FAC062-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-BRM Version 4 - I Feel Close to My Partner | ||
FAC06214 | C151169 | FAC062-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-BRM Version 4 - I Am Satisfied With My Sex Life | ||
FAC06215 | C151170 | FAC062-I Feel Sad | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I feel sad. | FACT-BRM Version 4 - I Feel Sad | ||
FAC06216 | C151171 | FAC062-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-BRM Version 4 - Satisfied With How I Am Coping | ||
FAC06217 | C151172 | FAC062-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-BRM Version 4 - Losing Hope Against Illness | ||
FAC06218 | C151173 | FAC062-I Feel Nervous | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I feel nervous. | FACT-BRM Version 4 - I Feel Nervous | ||
FAC06219 | C151174 | FAC062-I Worry About Dying | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I worry about dying. | FACT-BRM Version 4 - I Worry About Dying | ||
FAC06220 | C151175 | FAC062-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-BRM Version 4 - Worry My Condition Will Get Worse | ||
FAC06221 | C151176 | FAC062-I Am Able to Work | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-BRM Version 4 - I Am Able to Work | ||
FAC06222 | C151177 | FAC062-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-BRM Version 4 - My Work Is Fulfilling | ||
FAC06223 | C151178 | FAC062-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-BRM Version 4 - I Am Able to Enjoy Life | ||
FAC06224 | C151179 | FAC062-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I have accepted my illness. | FACT-BRM Version 4 - I Have Accepted My Illness | ||
FAC06225 | C151180 | FAC062-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am sleeping well. | FACT-BRM Version 4 - I Am Sleeping Well | ||
FAC06226 | C151181 | FAC062-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-BRM Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC06227 | C151182 | FAC062-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-BRM Version 4 - Content With Quality of My Life | ||
FAC06228 | C151183 | FAC062-I Get Tired Easily | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I get tired easily. | FACT-BRM Version 4 - I Get Tired Easily | ||
FAC06229 | C151184 | FAC062-I Feel Weak All Over | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I feel weak all over. | FACT-BRM Version 4 - I Feel Weak All Over | ||
FAC06230 | C151185 | FAC062-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I have a good appetite. | FACT-BRM Version 4 - I Have a Good Appetite | ||
FAC06231 | C151186 | FAC062-I Have Pain in My Joints | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I have pain in my joints. | FACT-BRM Version 4 - I Have Pain in My Joints | ||
FAC06232 | C151187 | FAC062-I Am Bothered by the Chills | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by the chills. | FACT-BRM Version 4 - I Am Bothered by the Chills | ||
FAC06233 | C151188 | FAC062-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by fevers (episodes of high body temperature). | FACT-BRM Version 4 - I Am Bothered by Fevers | ||
FAC06234 | C151189 | FAC062-I Am Bothered by Sweating | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by sweating. | FACT-BRM Version 4 - I Am Bothered by Sweating | ||
FAC06235 | C151190 | FAC062-I Have Trouble Concentrating | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have trouble concentrating. | FACT-BRM Version 4 - I Have Trouble Concentrating | ||
FAC06236 | C151191 | FAC062-I Have Trouble Remembering Things | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have trouble remembering things. | FACT-BRM Version 4 - I Have Trouble Remembering Things | ||
FAC06237 | C151192 | FAC062-I Get Depressed Easily | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I get depressed easily. | FACT-BRM Version 4 - I Get Depressed Easily | ||
FAC06238 | C151193 | FAC062-I Get Annoyed Easily | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I get annoyed easily. | FACT-BRM Version 4 - I Get Annoyed Easily | ||
FAC06239 | C151194 | FAC062-I Have Emotional Ups and Downs | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have emotional ups and downs. | FACT-BRM Version 4 - I Have Emotional Ups and Downs | ||
FAC06240 | C151195 | FAC062-I Feel Motivated to Do Things | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I feel motivated to do things. | FACT-BRM Version 4 - I Feel Motivated to Do Things | ||
Back to top | ||||||
CL.C150777.FAC062TN | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire Test Name
(FAC062TN) | text
Extensible: No | C150777 | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 test name. | CDISC Questionnaire FACT-BRM Version 4 Test Name Terminology |
FAC062-Bothered by Treatment Side Effect | C151160 | FAC062-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-BRM Version 4 - Bothered by Treatment Side Effect | ||
FAC062-Content With Quality of My Life | C151182 | FAC062-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-BRM Version 4 - Content With Quality of My Life | ||
FAC062-Enjoy Things I Usually Do for Fun | C151181 | FAC062-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-BRM Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC062-Get Emotional Support From Family | C151164 | FAC062-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-BRM Version 4 - Get Emotional Support From Family | ||
FAC062-I Am Able to Enjoy Life | C151178 | FAC062-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-BRM Version 4 - I Am Able to Enjoy Life | ||
FAC062-I Am Able to Work | C151176 | FAC062-I Am Able to Work | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-BRM Version 4 - I Am Able to Work | ||
FAC062-I Am Bothered by Fevers | C151188 | FAC062-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by fevers (episodes of high body temperature). | FACT-BRM Version 4 - I Am Bothered by Fevers | ||
FAC062-I Am Bothered by Sweating | C151189 | FAC062-I Am Bothered by Sweating | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by sweating. | FACT-BRM Version 4 - I Am Bothered by Sweating | ||
FAC062-I Am Bothered by the Chills | C151187 | FAC062-I Am Bothered by the Chills | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I am bothered by the chills. | FACT-BRM Version 4 - I Am Bothered by the Chills | ||
FAC062-I Am Forced to Spend Time in Bed | C151162 | FAC062-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-BRM Version 4 - I Am Forced to Spend Time in Bed | ||
FAC062-I Am Satisfied With My Sex Life | C151169 | FAC062-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-BRM Version 4 - I Am Satisfied With My Sex Life | ||
FAC062-I Am Sleeping Well | C151180 | FAC062-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I am sleeping well. | FACT-BRM Version 4 - I Am Sleeping Well | ||
FAC062-I Feel Close to My Friends | C151163 | FAC062-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-BRM Version 4 - I Feel Close to My Friends | ||
FAC062-I Feel Close to My Partner | C151168 | FAC062-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-BRM Version 4 - I Feel Close to My Partner | ||
FAC062-I Feel Ill | C151161 | FAC062-I Feel Ill | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I feel ill. | FACT-BRM Version 4 - I Feel Ill | ||
FAC062-I Feel Motivated to Do Things | C151195 | FAC062-I Feel Motivated to Do Things | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I feel motivated to do things. | FACT-BRM Version 4 - I Feel Motivated to Do Things | ||
FAC062-I Feel Nervous | C151173 | FAC062-I Feel Nervous | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I feel nervous. | FACT-BRM Version 4 - I Feel Nervous | ||
FAC062-I Feel Sad | C151170 | FAC062-I Feel Sad | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I feel sad. | FACT-BRM Version 4 - I Feel Sad | ||
FAC062-I Feel Weak All Over | C151184 | FAC062-I Feel Weak All Over | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I feel weak all over. | FACT-BRM Version 4 - I Feel Weak All Over | ||
FAC062-I Get Annoyed Easily | C151193 | FAC062-I Get Annoyed Easily | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I get annoyed easily. | FACT-BRM Version 4 - I Get Annoyed Easily | ||
FAC062-I Get Depressed Easily | C151192 | FAC062-I Get Depressed Easily | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I get depressed easily. | FACT-BRM Version 4 - I Get Depressed Easily | ||
FAC062-I Get Support From My Friends | C151165 | FAC062-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-BRM Version 4 - I Get Support From My Friends | ||
FAC062-I Get Tired Easily | C151183 | FAC062-I Get Tired Easily | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I get tired easily. | FACT-BRM Version 4 - I Get Tired Easily | ||
FAC062-I Have a Good Appetite | C151185 | FAC062-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I have a good appetite. | FACT-BRM Version 4 - I Have a Good Appetite | ||
FAC062-I Have a Lack of Energy | C151156 | FAC062-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have a lack of energy. | FACT-BRM Version 4 - I Have a Lack of Energy | ||
FAC062-I Have Accepted My Illness | C151179 | FAC062-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: I have accepted my illness. | FACT-BRM Version 4 - I Have Accepted My Illness | ||
FAC062-I Have Emotional Ups and Downs | C151194 | FAC062-I Have Emotional Ups and Downs | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have emotional ups and downs. | FACT-BRM Version 4 - I Have Emotional Ups and Downs | ||
FAC062-I Have Nausea | C151157 | FAC062-I Have Nausea | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have nausea. | FACT-BRM Version 4 - I Have Nausea | ||
FAC062-I Have Pain in My Joints | C151186 | FAC062-I Have Pain in My Joints | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Physical: I have pain in my joints. | FACT-BRM Version 4 - I Have Pain in My Joints | ||
FAC062-I Have Pain | C151159 | FAC062-I Have Pain | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: I have pain. | FACT-BRM Version 4 - I Have Pain | ||
FAC062-I Have Trouble Concentrating | C151190 | FAC062-I Have Trouble Concentrating | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have trouble concentrating. | FACT-BRM Version 4 - I Have Trouble Concentrating | ||
FAC062-I Have Trouble Remembering Things | C151191 | FAC062-I Have Trouble Remembering Things | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Additional Concerns-Mental: I have trouble remembering things. | FACT-BRM Version 4 - I Have Trouble Remembering Things | ||
FAC062-I Worry About Dying | C151174 | FAC062-I Worry About Dying | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I worry about dying. | FACT-BRM Version 4 - I Worry About Dying | ||
FAC062-Losing Hope Against Illness | C151172 | FAC062-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-BRM Version 4 - Losing Hope Against Illness | ||
FAC062-My Family Has Accepted My Illness | C151166 | FAC062-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-BRM Version 4 - My Family Has Accepted My Illness | ||
FAC062-My Work Is Fulfilling | C151177 | FAC062-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-BRM Version 4 - My Work Is Fulfilling | ||
FAC062-Satisfied Communication Illness | C151167 | FAC062-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-BRM Version 4 - Satisfied Communication Illness | ||
FAC062-Satisfied With How I Am Coping | C151171 | FAC062-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-BRM Version 4 - Satisfied With How I Am Coping | ||
FAC062-Trouble Meeting Needs of Family | C151158 | FAC062-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-BRM Version 4 - Trouble Meeting Needs of Family | ||
FAC062-Worry My Condition Will Get Worse | C151175 | FAC062-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Biologic Response Modifiers Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-BRM Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C154453.FAC006TC | Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire Test Code
(FAC006TC) | text
Extensible: No | C154453 | Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Bladder Version 4 test code. | CDISC Questionnaire FACT-BL Version 4 Test Code Terminology |
FAC00601 | C155581 | FAC006-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have a lack of energy. | FACT-BL Version 4 - I Have a Lack of Energy | ||
FAC00602 | C155582 | FAC006-I Have Nausea | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have nausea. | FACT-BL Version 4 - I Have Nausea | ||
FAC00603 | C155583 | FAC006-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-BL Version 4 - Trouble Meeting Needs of Family | ||
FAC00604 | C155584 | FAC006-I Have Pain | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have pain. | FACT-BL Version 4 - I Have Pain | ||
FAC00605 | C155585 | FAC006-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-BL Version 4 - Bothered by Treatment Side Effect | ||
FAC00606 | C155586 | FAC006-I Feel Ill | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I feel ill. | FACT-BL Version 4 - I Feel Ill | ||
FAC00607 | C155587 | FAC006-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-BL Version 4 - I Am Forced to Spend Time in Bed | ||
FAC00608 | C155588 | FAC006-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-BL Version 4 - I Feel Close to My Friends | ||
FAC00609 | C155589 | FAC006-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-BL Version 4 - Get Emotional Support From Family | ||
FAC00610 | C155590 | FAC006-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-BL Version 4 - I Get Support From My Friends | ||
FAC00611 | C155591 | FAC006-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-BL Version 4 - My Family Has Accepted My Illness | ||
FAC00612 | C155592 | FAC006-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-BL Version 4 - Satisfied Communication Illness | ||
FAC00613 | C155593 | FAC006-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-BL Version 4 - I Feel Close to My Partner | ||
FAC00614 | C155594 | FAC006-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-BL Version 4 - I Am Satisfied With My Sex Life | ||
FAC00615 | C155595 | FAC006-I Feel Sad | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I feel sad. | FACT-BL Version 4 - I Feel Sad | ||
FAC00616 | C155596 | FAC006-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-BL Version 4 - Satisfied With How I Am Coping | ||
FAC00617 | C155597 | FAC006-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-BL Version 4 - Losing Hope Against Illness | ||
FAC00618 | C155598 | FAC006-I Feel Nervous | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I feel nervous. | FACT-BL Version 4 - I Feel Nervous | ||
FAC00619 | C155599 | FAC006-I Worry About Dying | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I worry about dying. | FACT-BL Version 4 - I Worry About Dying | ||
FAC00620 | C155600 | FAC006-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-BL Version 4 - Worry My Condition Will Get Worse | ||
FAC00621 | C155601 | FAC006-I Am Able to Work | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-BL Version 4 - I Am Able to Work | ||
FAC00622 | C155602 | FAC006-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-BL Version 4 - My Work Is Fulfilling | ||
FAC00623 | C155603 | FAC006-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-BL Version 4 - I Am Able to Enjoy Life | ||
FAC00624 | C155604 | FAC006-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I have accepted my illness. | FACT-BL Version 4 - I Have Accepted My Illness | ||
FAC00625 | C155605 | FAC006-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am sleeping well. | FACT-BL Version 4 - I Am Sleeping Well | ||
FAC00626 | C155606 | FAC006-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-BL Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC00627 | C155607 | FAC006-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-BL Version 4 - Content With Quality of My Life | ||
FAC00628 | C155608 | FAC006-Trouble Controlling My Urine | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have trouble controlling my urine. | FACT-BL Version 4 - Trouble Controlling My Urine | ||
FAC00629 | C155609 | FAC006-I Am Losing Weight | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am losing weight. | FACT-BL Version 4 - I Am Losing Weight | ||
FAC00630 | C155610 | FAC006-I Have Control of My Bowels | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have control of my bowels. | FACT-BL Version 4 - I Have Control of My Bowels | ||
FAC00631 | C155611 | FAC006-I Urinate More Frequently | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I urinate more frequently than usual. | FACT-BL Version 4 - I Urinate More Frequently | ||
FAC00632 | C155612 | FAC006-I Have Diarrhea | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have diarrhea (diarrhoea). | FACT-BL Version 4 - I Have Diarrhea | ||
FAC00633 | C155613 | FAC006-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have a good appetite. | FACT-BL Version 4 - I Have a Good Appetite | ||
FAC00634 | C155614 | FAC006-I Like the Appearance of My Body | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I like the appearance of my body. | FACT-BL Version 4 - I Like the Appearance of My Body | ||
FAC00635 | C155615 | FAC006-It Burns When I Urinate | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: It burns when I urinate. | FACT-BL Version 4 - It Burns When I Urinate | ||
FAC00636 | C155616 | FAC006-I Am Interested in Sex | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am interested in sex. | FACT-BL Version 4 - I Am Interested in Sex | ||
FAC00637 | C155617 | FAC006-Able to Have/Maintain Erection | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: (For men only) I am able to have and maintain an erection. | FACT-BL Version 4 - Able to Have/Maintain Erection | ||
FAC00638 | C155618 | FAC006-Do You Have an Ostomy Appliance | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Do you have an ostomy appliance? | FACT-BL Version 4 - Do You Have an Ostomy Appliance | ||
FAC00639 | C155619 | FAC006-Embarrassed by Ostomy Appliance | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am embarrassed by my ostomy appliance. | FACT-BL Version 4 - Embarrassed by Ostomy Appliance | ||
FAC00640 | C155620 | FAC006-Caring for Ostomy Is Difficult | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Caring for my ostomy appliance is difficult. | FACT-BL Version 4 - Caring for Ostomy Appliance Is Difficult | ||
FAC00641 | C180202 | FAC006-Physical Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: Subscale score. | FACT-BL Version 4 - Physical Subscale Score | ||
FAC00642 | C180203 | FAC006-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: Subscale score. | FACT-BL Version 4 - Social/Family Subscale Score | ||
FAC00643 | C180204 | FAC006-Emotional Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: Subscale score. | FACT-BL Version 4 - Emotional Subscale Score | ||
FAC00644 | C180205 | FAC006-Functional Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: Subscale score. | FACT-BL Version 4 - Functional Subscale Score | ||
FAC00645 | C180206 | FAC006-Additional Concern Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Subscale score. | FACT-BL Version 4 - Additional Concern Subscale Score | ||
FAC00646 | C180207 | FAC006-Trial Outcome Index Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Trial outcome index score. | FACT-BL Version 4 - Trial Outcome Index Score | ||
FAC00647 | C180208 | FAC006-FACT-G Total Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - FACT-G total score. | FACT-BL Version 4 - FACT-G Total Score | ||
FAC00648 | C180209 | FAC006-Total Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Total score. | FACT-BL Version 4 - Total Score | ||
Back to top | ||||||
CL.C154452.FAC006TN | Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire Test Name
(FAC006TN) | text
Extensible: No | C154452 | Functional Assessment of Cancer Therapy-Bladder Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Bladder Version 4 test name. | CDISC Questionnaire FACT-BL Version 4 Test Name Terminology |
FAC006-Able to Have/Maintain Erection | C155617 | FAC006-Able to Have/Maintain Erection | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: (For men only) I am able to have and maintain an erection. | FACT-BL Version 4 - Able to Have/Maintain Erection | ||
FAC006-Additional Concern Subscale Score | C180206 | FAC006-Additional Concern Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Subscale score. | FACT-BL Version 4 - Additional Concern Subscale Score | ||
FAC006-Bothered by Treatment Side Effect | C155585 | FAC006-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-BL Version 4 - Bothered by Treatment Side Effect | ||
FAC006-Caring for Ostomy Is Difficult | C155620 | FAC006-Caring for Ostomy Is Difficult | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Caring for my ostomy appliance is difficult. | FACT-BL Version 4 - Caring for Ostomy Appliance Is Difficult | ||
FAC006-Content With Quality of My Life | C155607 | FAC006-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-BL Version 4 - Content With Quality of My Life | ||
FAC006-Do You Have an Ostomy Appliance | C155618 | FAC006-Do You Have an Ostomy Appliance | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: Do you have an ostomy appliance? | FACT-BL Version 4 - Do You Have an Ostomy Appliance | ||
FAC006-Embarrassed by Ostomy Appliance | C155619 | FAC006-Embarrassed by Ostomy Appliance | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am embarrassed by my ostomy appliance. | FACT-BL Version 4 - Embarrassed by Ostomy Appliance | ||
FAC006-Emotional Subscale Score | C180204 | FAC006-Emotional Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: Subscale score. | FACT-BL Version 4 - Emotional Subscale Score | ||
FAC006-Enjoy Things I Usually Do for Fun | C155606 | FAC006-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-BL Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC006-FACT-G Total Score | C180208 | FAC006-FACT-G Total Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - FACT-G total score. | FACT-BL Version 4 - FACT-G Total Score | ||
FAC006-Functional Subscale Score | C180205 | FAC006-Functional Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: Subscale score. | FACT-BL Version 4 - Functional Subscale Score | ||
FAC006-Get Emotional Support From Family | C155589 | FAC006-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-BL Version 4 - Get Emotional Support From Family | ||
FAC006-I Am Able to Enjoy Life | C155603 | FAC006-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-BL Version 4 - I Am Able to Enjoy Life | ||
FAC006-I Am Able to Work | C155601 | FAC006-I Am Able to Work | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-BL Version 4 - I Am Able to Work | ||
FAC006-I Am Forced to Spend Time in Bed | C155587 | FAC006-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-BL Version 4 - I Am Forced to Spend Time in Bed | ||
FAC006-I Am Interested in Sex | C155616 | FAC006-I Am Interested in Sex | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am interested in sex. | FACT-BL Version 4 - I Am Interested in Sex | ||
FAC006-I Am Losing Weight | C155609 | FAC006-I Am Losing Weight | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I am losing weight. | FACT-BL Version 4 - I Am Losing Weight | ||
FAC006-I Am Satisfied With My Sex Life | C155594 | FAC006-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-BL Version 4 - I Am Satisfied With My Sex Life | ||
FAC006-I Am Sleeping Well | C155605 | FAC006-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I am sleeping well. | FACT-BL Version 4 - I Am Sleeping Well | ||
FAC006-I Feel Close to My Friends | C155588 | FAC006-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-BL Version 4 - I Feel Close to My Friends | ||
FAC006-I Feel Close to My Partner | C155593 | FAC006-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-BL Version 4 - I Feel Close to My Partner | ||
FAC006-I Feel Ill | C155586 | FAC006-I Feel Ill | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I feel ill. | FACT-BL Version 4 - I Feel Ill | ||
FAC006-I Feel Nervous | C155598 | FAC006-I Feel Nervous | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I feel nervous. | FACT-BL Version 4 - I Feel Nervous | ||
FAC006-I Feel Sad | C155595 | FAC006-I Feel Sad | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I feel sad. | FACT-BL Version 4 - I Feel Sad | ||
FAC006-I Get Support From My Friends | C155590 | FAC006-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-BL Version 4 - I Get Support From My Friends | ||
FAC006-I Have a Good Appetite | C155613 | FAC006-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have a good appetite. | FACT-BL Version 4 - I Have a Good Appetite | ||
FAC006-I Have a Lack of Energy | C155581 | FAC006-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have a lack of energy. | FACT-BL Version 4 - I Have a Lack of Energy | ||
FAC006-I Have Accepted My Illness | C155604 | FAC006-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: I have accepted my illness. | FACT-BL Version 4 - I Have Accepted My Illness | ||
FAC006-I Have Control of My Bowels | C155610 | FAC006-I Have Control of My Bowels | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have control of my bowels. | FACT-BL Version 4 - I Have Control of My Bowels | ||
FAC006-I Have Diarrhea | C155612 | FAC006-I Have Diarrhea | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have diarrhea (diarrhoea). | FACT-BL Version 4 - I Have Diarrhea | ||
FAC006-I Have Nausea | C155582 | FAC006-I Have Nausea | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have nausea. | FACT-BL Version 4 - I Have Nausea | ||
FAC006-I Have Pain | C155584 | FAC006-I Have Pain | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: I have pain. | FACT-BL Version 4 - I Have Pain | ||
FAC006-I Like the Appearance of My Body | C155614 | FAC006-I Like the Appearance of My Body | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I like the appearance of my body. | FACT-BL Version 4 - I Like the Appearance of My Body | ||
FAC006-I Urinate More Frequently | C155611 | FAC006-I Urinate More Frequently | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I urinate more frequently than usual. | FACT-BL Version 4 - I Urinate More Frequently | ||
FAC006-I Worry About Dying | C155599 | FAC006-I Worry About Dying | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I worry about dying. | FACT-BL Version 4 - I Worry About Dying | ||
FAC006-It Burns When I Urinate | C155615 | FAC006-It Burns When I Urinate | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: It burns when I urinate. | FACT-BL Version 4 - It Burns When I Urinate | ||
FAC006-Losing Hope Against Illness | C155597 | FAC006-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-BL Version 4 - Losing Hope Against Illness | ||
FAC006-My Family Has Accepted My Illness | C155591 | FAC006-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-BL Version 4 - My Family Has Accepted My Illness | ||
FAC006-My Work Is Fulfilling | C155602 | FAC006-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Bladder Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-BL Version 4 - My Work Is Fulfilling | ||
FAC006-Physical Subscale Score | C180202 | FAC006-Physical Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: Subscale score. | FACT-BL Version 4 - Physical Subscale Score | ||
FAC006-Satisfied Communication Illness | C155592 | FAC006-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-BL Version 4 - Satisfied Communication Illness | ||
FAC006-Satisfied With How I Am Coping | C155596 | FAC006-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-BL Version 4 - Satisfied With How I Am Coping | ||
FAC006-Social/Family Subscale Score | C180203 | FAC006-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Social/Family Well-Being: Subscale score. | FACT-BL Version 4 - Social/Family Subscale Score | ||
FAC006-Total Score | C180209 | FAC006-Total Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Total score. | FACT-BL Version 4 - Total Score | ||
FAC006-Trial Outcome Index Score | C180207 | FAC006-Trial Outcome Index Score | Functional Assessment of Cancer Therapy-Bladder Version 4 - Trial outcome index score. | FACT-BL Version 4 - Trial Outcome Index Score | ||
FAC006-Trouble Controlling My Urine | C155608 | FAC006-Trouble Controlling My Urine | Functional Assessment of Cancer Therapy-Bladder Version 4 - Additional Concerns: I have trouble controlling my urine. | FACT-BL Version 4 - Trouble Controlling My Urine | ||
FAC006-Trouble Meeting Needs of Family | C155583 | FAC006-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Bladder Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-BL Version 4 - Trouble Meeting Needs of Family | ||
FAC006-Worry My Condition Will Get Worse | C155600 | FAC006-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Bladder Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-BL Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C147540.FAC061TC | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire Test Code
(FAC061TC) | text
Extensible: No | C147540 | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 test code. | CDISC Questionnaire FACT-BMT Version 4 Test Code Terminology |
FAC06101 | C147593 | FAC061-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have a lack of energy. | FACT-BMT Version 4 - I Have a Lack of Energy | ||
FAC06102 | C147594 | FAC061-I Have Nausea | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have nausea. | FACT-BMT Version 4 - I Have Nausea | ||
FAC06103 | C147595 | FAC061-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - Because of my physical condition, I have trouble meeting the needs of my family. | FACT-BMT Version 4 - Trouble Meeting Needs of Family | ||
FAC06104 | C147596 | FAC061-I Have Pain | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have pain. | FACT-BMT Version 4 - I Have Pain | ||
FAC06105 | C147597 | FAC061-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by side effects of treatment. | FACT-BMT Version 4 - Bothered by Treatment Side Effect | ||
FAC06106 | C147598 | FAC061-I Feel Ill | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel ill. | FACT-BMT Version 4 - I Feel Ill | ||
FAC06107 | C147599 | FAC061-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am forced to spend time in bed. | FACT-BMT Version 4 - I Am Forced to Spend Time in Bed | ||
FAC06108 | C147600 | FAC061-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel close to my friends. | FACT-BMT Version 4 - I Feel Close to My Friends | ||
FAC06109 | C147601 | FAC061-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get emotional support from my family. | FACT-BMT Version 4 - Get Emotional Support From Family | ||
FAC06110 | C147602 | FAC061-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get support from my friends. | FACT-BMT Version 4 - I Get Support From My Friends | ||
FAC06111 | C147603 | FAC061-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My family has accepted my illness. | FACT-BMT Version 4 - My Family Has Accepted My Illness | ||
FAC06112 | C147604 | FAC061-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with family communication about my illness. | FACT-BMT Version 4 - Satisfied Communication Illness | ||
FAC06113 | C147605 | FAC061-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel close to my partner (or the person who is my main support). | FACT-BMT Version 4 - I Feel Close to My Partner | ||
FAC06114 | C147606 | FAC061-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with my sex life. | FACT-BMT Version 4 - I Am Satisfied With My Sex Life | ||
FAC06115 | C147607 | FAC061-I Feel Sad | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel sad. | FACT-BMT Version 4 - I Feel Sad | ||
FAC06116 | C147608 | FAC061-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with how I am coping with my illness. | FACT-BMT Version 4 - Satisfied With How I Am Coping | ||
FAC06117 | C147609 | FAC061-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am losing hope in the fight against my illness. | FACT-BMT Version 4 - Losing Hope Against Illness | ||
FAC06118 | C147610 | FAC061-I Feel Nervous | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel nervous. | FACT-BMT Version 4 - I Feel Nervous | ||
FAC06119 | C147611 | FAC061-I Worry About Dying | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry about dying. | FACT-BMT Version 4 - I Worry About Dying | ||
FAC06120 | C147612 | FAC061-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry that my condition will get worse. | FACT-BMT Version 4 - Worry My Condition Will Get Worse | ||
FAC06121 | C147613 | FAC061-I Am Able to Work | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to work (include work at home). | FACT-BMT Version 4 - I Am Able to Work | ||
FAC06122 | C147614 | FAC061-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My work (include work at home) is fulfilling. | FACT-BMT Version 4 - My Work Is Fulfilling | ||
FAC06123 | C147615 | FAC061-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to enjoy life. | FACT-BMT Version 4 - I Am Able to Enjoy Life | ||
FAC06124 | C147616 | FAC061-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have accepted my illness. | FACT-BMT Version 4 - I Have Accepted My Illness | ||
FAC06125 | C147617 | FAC061-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am sleeping well. | FACT-BMT Version 4 - I Am Sleeping Well | ||
FAC06126 | C147618 | FAC061-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am enjoying the things I usually do for fun. | FACT-BMT Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC06127 | C147619 | FAC061-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am content with the quality of my life right now. | FACT-BMT Version 4 - Content With Quality of My Life | ||
FAC06128 | C147620 | FAC061-I Am Concerned About Keeping Job | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am concerned about keeping my job (include work at home). | FACT-BMT Version 4 - I Am Concerned About Keeping Job | ||
FAC06129 | C147621 | FAC061-I Feel Distant From Other People | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel distant from other people. | FACT-BMT Version 4 - I Feel Distant From Other People | ||
FAC06130 | C147622 | FAC061-I Worry Transplant Will Not Work | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry that the transplant will not work. | FACT-BMT Version 4 - I Worry Transplant Will Not Work | ||
FAC06131 | C147623 | FAC061-Side Effect of Treatment Worse | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - The side effects of treatment are worse than I had imagined. | FACT-BMT Version 4 - Side Effect of Treatment Worse | ||
FAC06132 | C147624 | FAC061-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have a good appetite. | FACT-BMT Version 4 - I Have a Good Appetite | ||
FAC06133 | C147625 | FAC061-I Like the Appearance of My Body | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I like the appearance of my body. | FACT-BMT Version 4 - I Like the Appearance of My Body | ||
FAC06134 | C147626 | FAC061-I Am Able to Get Around by Myself | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to get around by myself. | FACT-BMT Version 4 - I Am Able to Get Around by Myself | ||
FAC06135 | C147627 | FAC061-I Get Tired Easily | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get tired easily. | FACT-BMT Version 4 - I Get Tired Easily | ||
FAC06136 | C147628 | FAC061-I Am Interested in Sex | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am interested in sex. | FACT-BMT Version 4 - I Am Interested in Sex | ||
FAC06137 | C147629 | FAC061-Concerns Ability to Have Children | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have concerns about my ability to have children. | FACT-BMT Version 4 - Concerns Ability to Have Children | ||
FAC06138 | C147630 | FAC061-Confidence in My Nurse(s) | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have confidence in my nurse(s). | FACT-BMT Version 4 - Confidence in My Nurse(s) | ||
FAC06139 | C147631 | FAC061-I Regret Bone Marrow Transplant | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I regret having the bone marrow transplant. | FACT-BMT Version 4 - I Regret Bone Marrow Transplant | ||
FAC06140 | C147632 | FAC061-I Can Remember Things | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I can remember things. | FACT-BMT Version 4 - I Can Remember Things | ||
FAC06141 | C147633 | FAC061-I Am Able to Concentrate | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to concentrate. | FACT-BMT Version 4 - I Am Able to Concentrate | ||
FAC06142 | C147634 | FAC061-I Have Frequent Colds/Infections | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have frequent colds/infections. | FACT-BMT Version 4 - I Have Frequent Colds/Infections | ||
FAC06143 | C147635 | FAC061-My Eyesight Is Blurry | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My eyesight is blurry. | FACT-BMT Version 4 - My Eyesight Is Blurry | ||
FAC06144 | C147636 | FAC061-Bothered by Change in Food Tastes | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by a change in the way food tastes. | FACT-BMT Version 4 - Bothered by Change in Food Tastes | ||
FAC06145 | C147637 | FAC061-I Have Tremors | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have tremors. | FACT-BMT Version 4 - I Have Tremors | ||
FAC06146 | C147638 | FAC061-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have been short of breath. | FACT-BMT Version 4 - I Have Been Short of Breath | ||
FAC06147 | C147639 | FAC061-I Am Bothered by Skin Problems | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by skin problems. | FACT-BMT Version 4 - I Am Bothered by Skin Problems | ||
FAC06148 | C147640 | FAC061-I Have Trouble With My Bowels | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have trouble with my bowels. | FACT-BMT Version 4 - I Have Trouble With My Bowels | ||
FAC06149 | C147641 | FAC061-Illness Is Hardship for My Family | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My illness is a personal hardship for my close family members. | FACT-BMT Version 4 - Illness Is Hardship for My Family | ||
FAC06150 | C147642 | FAC061-Cost of Treatment Is Burden on Me | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - The cost of my treatment is a burden on me or my family. | FACT-BMT Version 4 - Cost of Treatment Is Burden on Me | ||
Back to top | ||||||
CL.C147539.FAC061TN | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire Test Name
(FAC061TN) | text
Extensible: No | C147539 | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 test name. | CDISC Questionnaire FACT-BMT Version 4 Test Name Terminology |
FAC061-Bothered by Change in Food Tastes | C147636 | FAC061-Bothered by Change in Food Tastes | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by a change in the way food tastes. | FACT-BMT Version 4 - Bothered by Change in Food Tastes | ||
FAC061-Bothered by Treatment Side Effect | C147597 | FAC061-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by side effects of treatment. | FACT-BMT Version 4 - Bothered by Treatment Side Effect | ||
FAC061-Concerns Ability to Have Children | C147629 | FAC061-Concerns Ability to Have Children | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have concerns about my ability to have children. | FACT-BMT Version 4 - Concerns Ability to Have Children | ||
FAC061-Confidence in My Nurse(s) | C147630 | FAC061-Confidence in My Nurse(s) | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have confidence in my nurse(s). | FACT-BMT Version 4 - Confidence in My Nurse(s) | ||
FAC061-Content With Quality of My Life | C147619 | FAC061-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am content with the quality of my life right now. | FACT-BMT Version 4 - Content With Quality of My Life | ||
FAC061-Cost of Treatment Is Burden on Me | C147642 | FAC061-Cost of Treatment Is Burden on Me | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - The cost of my treatment is a burden on me or my family. | FACT-BMT Version 4 - Cost of Treatment Is Burden on Me | ||
FAC061-Enjoy Things I Usually Do for Fun | C147618 | FAC061-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am enjoying the things I usually do for fun. | FACT-BMT Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC061-Get Emotional Support From Family | C147601 | FAC061-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get emotional support from my family. | FACT-BMT Version 4 - Get Emotional Support From Family | ||
FAC061-I Am Able to Concentrate | C147633 | FAC061-I Am Able to Concentrate | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to concentrate. | FACT-BMT Version 4 - I Am Able to Concentrate | ||
FAC061-I Am Able to Enjoy Life | C147615 | FAC061-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to enjoy life. | FACT-BMT Version 4 - I Am Able to Enjoy Life | ||
FAC061-I Am Able to Get Around by Myself | C147626 | FAC061-I Am Able to Get Around by Myself | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to get around by myself. | FACT-BMT Version 4 - I Am Able to Get Around by Myself | ||
FAC061-I Am Able to Work | C147613 | FAC061-I Am Able to Work | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am able to work (include work at home). | FACT-BMT Version 4 - I Am Able to Work | ||
FAC061-I Am Bothered by Skin Problems | C147639 | FAC061-I Am Bothered by Skin Problems | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am bothered by skin problems. | FACT-BMT Version 4 - I Am Bothered by Skin Problems | ||
FAC061-I Am Concerned About Keeping Job | C147620 | FAC061-I Am Concerned About Keeping Job | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am concerned about keeping my job (include work at home). | FACT-BMT Version 4 - I Am Concerned About Keeping Job | ||
FAC061-I Am Forced to Spend Time in Bed | C147599 | FAC061-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am forced to spend time in bed. | FACT-BMT Version 4 - I Am Forced to Spend Time in Bed | ||
FAC061-I Am Interested in Sex | C147628 | FAC061-I Am Interested in Sex | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am interested in sex. | FACT-BMT Version 4 - I Am Interested in Sex | ||
FAC061-I Am Satisfied With My Sex Life | C147606 | FAC061-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with my sex life. | FACT-BMT Version 4 - I Am Satisfied With My Sex Life | ||
FAC061-I Am Sleeping Well | C147617 | FAC061-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am sleeping well. | FACT-BMT Version 4 - I Am Sleeping Well | ||
FAC061-I Can Remember Things | C147632 | FAC061-I Can Remember Things | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I can remember things. | FACT-BMT Version 4 - I Can Remember Things | ||
FAC061-I Feel Close to My Friends | C147600 | FAC061-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel close to my friends. | FACT-BMT Version 4 - I Feel Close to My Friends | ||
FAC061-I Feel Close to My Partner | C147605 | FAC061-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel close to my partner (or the person who is my main support). | FACT-BMT Version 4 - I Feel Close to My Partner | ||
FAC061-I Feel Distant From Other People | C147621 | FAC061-I Feel Distant From Other People | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel distant from other people. | FACT-BMT Version 4 - I Feel Distant From Other People | ||
FAC061-I Feel Ill | C147598 | FAC061-I Feel Ill | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel ill. | FACT-BMT Version 4 - I Feel Ill | ||
FAC061-I Feel Nervous | C147610 | FAC061-I Feel Nervous | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel nervous. | FACT-BMT Version 4 - I Feel Nervous | ||
FAC061-I Feel Sad | C147607 | FAC061-I Feel Sad | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I feel sad. | FACT-BMT Version 4 - I Feel Sad | ||
FAC061-I Get Support From My Friends | C147602 | FAC061-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get support from my friends. | FACT-BMT Version 4 - I Get Support From My Friends | ||
FAC061-I Get Tired Easily | C147627 | FAC061-I Get Tired Easily | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I get tired easily. | FACT-BMT Version 4 - I Get Tired Easily | ||
FAC061-I Have a Good Appetite | C147624 | FAC061-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have a good appetite. | FACT-BMT Version 4 - I Have a Good Appetite | ||
FAC061-I Have a Lack of Energy | C147593 | FAC061-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have a lack of energy. | FACT-BMT Version 4 - I Have a Lack of Energy | ||
FAC061-I Have Accepted My Illness | C147616 | FAC061-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have accepted my illness. | FACT-BMT Version 4 - I Have Accepted My Illness | ||
FAC061-I Have Been Short of Breath | C147638 | FAC061-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have been short of breath. | FACT-BMT Version 4 - I Have Been Short of Breath | ||
FAC061-I Have Frequent Colds/Infections | C147634 | FAC061-I Have Frequent Colds/Infections | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have frequent colds/infections. | FACT-BMT Version 4 - I Have Frequent Colds/Infections | ||
FAC061-I Have Nausea | C147594 | FAC061-I Have Nausea | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have nausea. | FACT-BMT Version 4 - I Have Nausea | ||
FAC061-I Have Pain | C147596 | FAC061-I Have Pain | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have pain. | FACT-BMT Version 4 - I Have Pain | ||
FAC061-I Have Tremors | C147637 | FAC061-I Have Tremors | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have tremors. | FACT-BMT Version 4 - I Have Tremors | ||
FAC061-I Have Trouble With My Bowels | C147640 | FAC061-I Have Trouble With My Bowels | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I have trouble with my bowels. | FACT-BMT Version 4 - I Have Trouble With My Bowels | ||
FAC061-I Like the Appearance of My Body | C147625 | FAC061-I Like the Appearance of My Body | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I like the appearance of my body. | FACT-BMT Version 4 - I Like the Appearance of My Body | ||
FAC061-I Regret Bone Marrow Transplant | C147631 | FAC061-I Regret Bone Marrow Transplant | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I regret having the bone marrow transplant. | FACT-BMT Version 4 - I Regret Bone Marrow Transplant | ||
FAC061-I Worry About Dying | C147611 | FAC061-I Worry About Dying | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry about dying. | FACT-BMT Version 4 - I Worry About Dying | ||
FAC061-I Worry Transplant Will Not Work | C147622 | FAC061-I Worry Transplant Will Not Work | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry that the transplant will not work. | FACT-BMT Version 4 - I Worry Transplant Will Not Work | ||
FAC061-Illness Is Hardship for My Family | C147641 | FAC061-Illness Is Hardship for My Family | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My illness is a personal hardship for my close family members. | FACT-BMT Version 4 - Illness Is Hardship for My Family | ||
FAC061-Losing Hope Against Illness | C147609 | FAC061-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am losing hope in the fight against my illness. | FACT-BMT Version 4 - Losing Hope Against Illness | ||
FAC061-My Eyesight Is Blurry | C147635 | FAC061-My Eyesight Is Blurry | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My eyesight is blurry. | FACT-BMT Version 4 - My Eyesight Is Blurry | ||
FAC061-My Family Has Accepted My Illness | C147603 | FAC061-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My family has accepted my illness. | FACT-BMT Version 4 - My Family Has Accepted My Illness | ||
FAC061-My Work Is Fulfilling | C147614 | FAC061-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - My work (include work at home) is fulfilling. | FACT-BMT Version 4 - My Work Is Fulfilling | ||
FAC061-Satisfied Communication Illness | C147604 | FAC061-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with family communication about my illness. | FACT-BMT Version 4 - Satisfied Communication Illness | ||
FAC061-Satisfied With How I Am Coping | C147608 | FAC061-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I am satisfied with how I am coping with my illness. | FACT-BMT Version 4 - Satisfied With How I Am Coping | ||
FAC061-Side Effect of Treatment Worse | C147623 | FAC061-Side Effect of Treatment Worse | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - The side effects of treatment are worse than I had imagined. | FACT-BMT Version 4 - Side Effect of Treatment Worse | ||
FAC061-Trouble Meeting Needs of Family | C147595 | FAC061-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - Because of my physical condition, I have trouble meeting the needs of my family. | FACT-BMT Version 4 - Trouble Meeting Needs of Family | ||
FAC061-Worry My Condition Will Get Worse | C147612 | FAC061-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Bone Marrow Transplant Version 4 - I worry that my condition will get worse. | FACT-BMT Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C179940.FAC074TC | Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire Test Code
(FAC074TC) | text
Extensible: No | C179940 | Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Bone Pain Version 4 test code. | CDISC Questionnaire FACT-BP Version 4 Test Code Terminology |
FAC07401 | C180023 | FAC074-How Many Places in Body Felt Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: In how many places in your body have you felt bone pain. | FACT-BP Version 4 - How Many Places in Body Felt Pain | ||
FAC07402 | C180024 | FAC074-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have certain parts of my body where I experience pain. | FACT-BP Version 4 - Certain Parts of Body Have Pain | ||
FAC07403 | C180025 | FAC074-I Have Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have bone pain. | FACT-BP Version 4 - I Have Bone Pain | ||
FAC07404 | C180026 | FAC074-Hurts When Put Weight/Pressure on | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: It hurts when I put weight or pressure on the place where I have bone pain. | FACT-BP Version 4 - Hurts When Put Weight/Pressure on | ||
FAC07405 | C180027 | FAC074-Bone Pain Even When I Sit Still | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have bone pain even when I sit stil. | FACT-BP Version 4 - Bone Pain Even When I Sit Still | ||
FAC07406 | C180028 | FAC074-Need Help Doing Usual Activities | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I need help doing my usual activities because of bone pain. | FACT-BP Version 4 - Need Help Doing Usual Activities | ||
FAC07407 | C180029 | FAC074-Rest During Day Due to Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am forced to rest during the day due to bone pain. | FACT-BP Version 4 - Rest During Day Due to Bone Pain | ||
FAC07408 | C180030 | FAC074-Trouble Walking Because Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have trouble walking because of bone pain. | FACT-BP Version 4 - Trouble Walking Because Bone Pain | ||
FAC07409 | C180031 | FAC074-Bone Pain Interferes Care Myself | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my ability to care for myself (bathing, dressing, eating, etc.). | FACT-BP Version 4 - Bone Pain Interferes Care Myself | ||
FAC07410 | C180032 | FAC074-Bone Pain Interferes w/Social | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my social activities. | FACT-BP Version 4 - Bone Pain Interferes w/Social | ||
FAC07411 | C180033 | FAC074-Bone Pain Interferes w/My Sleep | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my sleep. | FACT-BP Version 4 - Bone Pain Interferes w/My Sleep | ||
FAC07412 | C180034 | FAC074-I am Frustrated by My Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am frustrated by my bone pain. | FACT-BP Version 4 - I am Frustrated by My Bone Pain | ||
FAC07413 | C180035 | FAC074-I Feel Depressed about Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I feel depressed about my bone pain. | FACT-BP Version 4 - I Feel Depressed about Bone Pain | ||
FAC07414 | C180036 | FAC074-I Worry Bone Pain Will Get Worse | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I worry that my bone pain will get worse. | FACT-BP Version 4 - I Worry Bone Pain Will Get Worse | ||
FAC07415 | C180037 | FAC074-Bone Pain Interferes w/My Family | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: My bone pain interferes with my family life. | FACT-BP Version 4 - Bone Pain Interferes w/My Family | ||
FAC07416 | C180038 | FAC074-Pain Interferes Vigorous Activity | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my ability to do vigorous activity (exercise, heavy lifting, etc.). | FACT-BP Version 4 - Pain Interferes Vigorous Activity | ||
FAC07417 | C180039 | FAC074-Trouble Concentrating Due to Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have trouble concentrating due to my bone pain. | FACT-BP Version 4 - Trouble Concentrating Due to Pain | ||
FAC07418 | C180040 | FAC074-Difficulty Coping w/My Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have difficulty coping with my bone pain. | FACT-BP Version 4 - Difficulty Coping w/My Bone Pain | ||
FAC07419 | C180041 | FAC074-Difficulty Working Due to Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have difficulty working due to my bone pain (including work at home) | FACT-BP Version 4 - Difficulty Working Due to Pain | ||
FAC07420 | C180042 | FAC074-Content With Quality of My Life | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am content with the quality of my life right now. | FACT-BP Version 4 - Content With Quality of My Life | ||
FAC07421 | C180043 | FAC074-Total Score | Functional Assessment of Cancer therapy - BP: BP subscale score. | FACT-BP Version 4 - Total Score | ||
Back to top | ||||||
CL.C179939.FAC074TN | Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire Test Name
(FAC074TN) | text
Extensible: No | C179939 | Functional Assessment of Cancer Therapy-Bone Pain Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Bone Pain Version 4 test name. | CDISC Questionnaire FACT-BP Version 4 Test Name Terminology |
FAC074-Bone Pain Even When I Sit Still | C180027 | FAC074-Bone Pain Even When I Sit Still | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have bone pain even when I sit stil. | FACT-BP Version 4 - Bone Pain Even When I Sit Still | ||
FAC074-Bone Pain Interferes Care Myself | C180031 | FAC074-Bone Pain Interferes Care Myself | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my ability to care for myself (bathing, dressing, eating, etc.). | FACT-BP Version 4 - Bone Pain Interferes Care Myself | ||
FAC074-Bone Pain Interferes w/My Family | C180037 | FAC074-Bone Pain Interferes w/My Family | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: My bone pain interferes with my family life. | FACT-BP Version 4 - Bone Pain Interferes w/My Family | ||
FAC074-Bone Pain Interferes w/My Sleep | C180033 | FAC074-Bone Pain Interferes w/My Sleep | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my sleep. | FACT-BP Version 4 - Bone Pain Interferes w/My Sleep | ||
FAC074-Bone Pain Interferes w/Social | C180032 | FAC074-Bone Pain Interferes w/Social | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my social activities. | FACT-BP Version 4 - Bone Pain Interferes w/Social | ||
FAC074-Certain Parts of Body Have Pain | C180024 | FAC074-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have certain parts of my body where I experience pain. | FACT-BP Version 4 - Certain Parts of Body Have Pain | ||
FAC074-Content With Quality of My Life | C180042 | FAC074-Content With Quality of My Life | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am content with the quality of my life right now. | FACT-BP Version 4 - Content With Quality of My Life | ||
FAC074-Difficulty Coping w/My Bone Pain | C180040 | FAC074-Difficulty Coping w/My Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have difficulty coping with my bone pain. | FACT-BP Version 4 - Difficulty Coping w/My Bone Pain | ||
FAC074-Difficulty Working Due to Pain | C180041 | FAC074-Difficulty Working Due to Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have difficulty working due to my bone pain (including work at home) | FACT-BP Version 4 - Difficulty Working Due to Pain | ||
FAC074-How Many Places in Body Felt Pain | C180023 | FAC074-How Many Places in Body Felt Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: In how many places in your body have you felt bone pain. | FACT-BP Version 4 - How Many Places in Body Felt Pain | ||
FAC074-Hurts When Put Weight/Pressure on | C180026 | FAC074-Hurts When Put Weight/Pressure on | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: It hurts when I put weight or pressure on the place where I have bone pain. | FACT-BP Version 4 - Hurts When Put Weight/Pressure on | ||
FAC074-I am Frustrated by My Bone Pain | C180034 | FAC074-I am Frustrated by My Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am frustrated by my bone pain. | FACT-BP Version 4 - I am Frustrated by My Bone Pain | ||
FAC074-I Feel Depressed about Bone Pain | C180035 | FAC074-I Feel Depressed about Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I feel depressed about my bone pain. | FACT-BP Version 4 - I Feel Depressed about Bone Pain | ||
FAC074-I Have Bone Pain | C180025 | FAC074-I Have Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have bone pain. | FACT-BP Version 4 - I Have Bone Pain | ||
FAC074-I Worry Bone Pain Will Get Worse | C180036 | FAC074-I Worry Bone Pain Will Get Worse | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I worry that my bone pain will get worse. | FACT-BP Version 4 - I Worry Bone Pain Will Get Worse | ||
FAC074-Need Help Doing Usual Activities | C180028 | FAC074-Need Help Doing Usual Activities | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I need help doing my usual activities because of bone pain. | FACT-BP Version 4 - Need Help Doing Usual Activities | ||
FAC074-Pain Interferes Vigorous Activity | C180038 | FAC074-Pain Interferes Vigorous Activity | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: Bone pain interferes with my ability to do vigorous activity (exercise, heavy lifting, etc.). | FACT-BP Version 4 - Pain Interferes Vigorous Activity | ||
FAC074-Rest During Day Due to Bone Pain | C180029 | FAC074-Rest During Day Due to Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I am forced to rest during the day due to bone pain. | FACT-BP Version 4 - Rest During Day Due to Bone Pain | ||
FAC074-Total Score | C180043 | FAC074-Total Score | Functional Assessment of Cancer therapy - BP: BP subscale score. | FACT-BP Version 4 - Total Score | ||
FAC074-Trouble Concentrating Due to Pain | C180039 | FAC074-Trouble Concentrating Due to Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have trouble concentrating due to my bone pain. | FACT-BP Version 4 - Trouble Concentrating Due to Pain | ||
FAC074-Trouble Walking Because Bone Pain | C180030 | FAC074-Trouble Walking Because Bone Pain | Functional Assessment of Cancer Therapy - BP: for patients with bone pain: I have trouble walking because of bone pain. | FACT-BP Version 4 - Trouble Walking Because Bone Pain | ||
Back to top | ||||||
CL.C138221.FAC029TC | Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire Test Code
(FAC029TC) | text
Extensible: No | C138221 | Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire Test Code | Functional Assessment of Cancer Therapy-Brain Symptom Index test code. | CDISC Questionnaire FBRSI Test Code Terminology |
FAC02901 | C138429 | FAC029-I Get Headaches | Functional Assessment of Cancer Therapy-Brain Symptom Index - I get headaches. | FBRSI - I Get Headaches | ||
FAC02902 | C138430 | FAC029-I Have Had Seizures | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have had seizures (convulsions). | FBRSI - I Have Had Seizures | ||
FAC02903 | C138431 | FAC029-Have Weakness in My Arms or Legs | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have weakness in my arms or legs. | FBRSI - Have Weakness in My Arms or Legs | ||
FAC02904 | C138432 | FAC029-I Need Help in Caring for Myself | Functional Assessment of Cancer Therapy-Brain Symptom Index - I need help in caring for myself (bathing, dressing, eating, etc.). | FBRSI - I Need Help in Caring for Myself | ||
FAC02905 | C138433 | FAC029-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have a lack of energy. | FBRSI - I Have a Lack of Energy | ||
FAC02906 | C138434 | FAC029-Difficulty Expressing My Thoughts | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have difficulty expressing my thoughts. | FBRSI - Difficulty Expressing My Thoughts | ||
FAC02907 | C138435 | FAC029-I Have Trouble With Coordination | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have trouble with coordination. | FBRSI - I Have Trouble With Coordination | ||
FAC02908 | C138436 | FAC029-Frustrated I Cannot Do Things | Functional Assessment of Cancer Therapy-Brain Symptom Index - I get frustrated that I cannot do things I used to. | FBRSI - Frustrated I Cannot Do Things | ||
FAC02909 | C138437 | FAC029-I Have Nausea | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have nausea. | FBRSI - I Have Nausea | ||
FAC02910 | C138438 | FAC029-Able to Find the Right Words | Functional Assessment of Cancer Therapy-Brain Symptom Index - I am able to find the right word(s) to say what I mean. | FBRSI - Able to Find the Right Words | ||
FAC02911 | C138439 | FAC029-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Brain Symptom Index - I am losing hope in the fight against my illness. | FBRSI - Losing Hope Against Illness | ||
FAC02912 | C138440 | FAC029-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Brain Symptom Index - Because of my physical condition, I have trouble meeting the needs of my family. | FBRSI - Trouble Meeting Needs of Family | ||
FAC02913 | C138441 | FAC029-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Brain Symptom Index - I worry that my condition will get worse. | FBRSI - Worry My Condition Will Get Worse | ||
FAC02914 | C138442 | FAC029-I Am Afraid of Having a Seizure | Functional Assessment of Cancer Therapy-Brain Symptom Index - I am afraid of having a seizure (convulsion). | FBRSI - I Am Afraid of Having a Seizure | ||
FAC02915 | C138443 | FAC029-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Brain Symptom Index - I am able to enjoy life. | FBRSI - I Am Able to Enjoy Life | ||
Back to top | ||||||
CL.C138220.FAC029TN | Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire Test Name
(FAC029TN) | text
Extensible: No | C138220 | Functional Assessment of Cancer Therapy-Brain Symptom Index Questionnaire Test Name | Functional Assessment of Cancer Therapy-Brain Symptom Index test name. | CDISC Questionnaire FBRSI Test Name Terminology |
FAC029-Able to Find the Right Words | C138438 | FAC029-Able to Find the Right Words | Functional Assessment of Cancer Therapy-Brain Symptom Index - I am able to find the right word(s) to say what I mean. | FBRSI - Able to Find the Right Words | ||
FAC029-Difficulty Expressing My Thoughts | C138434 | FAC029-Difficulty Expressing My Thoughts | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have difficulty expressing my thoughts. | FBRSI - Difficulty Expressing My Thoughts | ||
FAC029-Frustrated I Cannot Do Things | C138436 | FAC029-Frustrated I Cannot Do Things | Functional Assessment of Cancer Therapy-Brain Symptom Index - I get frustrated that I cannot do things I used to. | FBRSI - Frustrated I Cannot Do Things | ||
FAC029-Have Weakness in My Arms or Legs | C138431 | FAC029-Have Weakness in My Arms or Legs | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have weakness in my arms or legs. | FBRSI - Have Weakness in My Arms or Legs | ||
FAC029-I Am Able to Enjoy Life | C138443 | FAC029-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Brain Symptom Index - I am able to enjoy life. | FBRSI - I Am Able to Enjoy Life | ||
FAC029-I Am Afraid of Having a Seizure | C138442 | FAC029-I Am Afraid of Having a Seizure | Functional Assessment of Cancer Therapy-Brain Symptom Index - I am afraid of having a seizure (convulsion). | FBRSI - I Am Afraid of Having a Seizure | ||
FAC029-I Get Headaches | C138429 | FAC029-I Get Headaches | Functional Assessment of Cancer Therapy-Brain Symptom Index - I get headaches. | FBRSI - I Get Headaches | ||
FAC029-I Have a Lack of Energy | C138433 | FAC029-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have a lack of energy. | FBRSI - I Have a Lack of Energy | ||
FAC029-I Have Had Seizures | C138430 | FAC029-I Have Had Seizures | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have had seizures (convulsions). | FBRSI - I Have Had Seizures | ||
FAC029-I Have Nausea | C138437 | FAC029-I Have Nausea | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have nausea. | FBRSI - I Have Nausea | ||
FAC029-I Have Trouble With Coordination | C138435 | FAC029-I Have Trouble With Coordination | Functional Assessment of Cancer Therapy-Brain Symptom Index - I have trouble with coordination. | FBRSI - I Have Trouble With Coordination | ||
FAC029-I Need Help in Caring for Myself | C138432 | FAC029-I Need Help in Caring for Myself | Functional Assessment of Cancer Therapy-Brain Symptom Index - I need help in caring for myself (bathing, dressing, eating, etc.). | FBRSI - I Need Help in Caring for Myself | ||
FAC029-Losing Hope Against Illness | C138439 | FAC029-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Brain Symptom Index - I am losing hope in the fight against my illness. | FBRSI - Losing Hope Against Illness | ||
FAC029-Trouble Meeting Needs of Family | C138440 | FAC029-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Brain Symptom Index - Because of my physical condition, I have trouble meeting the needs of my family. | FBRSI - Trouble Meeting Needs of Family | ||
FAC029-Worry My Condition Will Get Worse | C138441 | FAC029-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Brain Symptom Index - I worry that my condition will get worse. | FBRSI - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C129094.FAC005TC | Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire Test Code
(FAC005TC) | text
Extensible: No | C129094 | Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Breast Version 4 test code. | CDISC Questionnaire FACT-B Version 4 Test Code Terminology |
FAC00501 | C129188 | FAC005-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have a lack of energy. | FACT-B Version 4 - I Have a Lack of Energy | ||
FAC00502 | C129189 | FAC005-I Have Nausea | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have nausea. | FACT-B Version 4 - I Have Nausea | ||
FAC00503 | C129190 | FAC005-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-B Version 4 - Trouble Meeting Needs of Family | ||
FAC00504 | C129191 | FAC005-I Have Pain | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have pain. | FACT-B Version 4 - I Have Pain | ||
FAC00505 | C129192 | FAC005-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-B Version 4 - Bothered by Treatment Side Effect | ||
FAC00506 | C129193 | FAC005-I Feel Ill | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I feel ill. | FACT-B Version 4 - I Feel Ill | ||
FAC00507 | C129194 | FAC005-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-B Version 4 - I Am Forced to Spend Time in Bed | ||
FAC00508 | C129195 | FAC005-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-B Version 4 - I Feel Close to My Friends | ||
FAC00509 | C129196 | FAC005-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-B Version 4 - Get Emotional Support From Family | ||
FAC00510 | C129197 | FAC005-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-B Version 4 - I Get Support From My Friends | ||
FAC00511 | C129198 | FAC005-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-B Version 4 - My Family Has Accepted My Illness | ||
FAC00512 | C129199 | FAC005-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-B Version 4 - Satisfied Family Communication of Illness | ||
FAC00513 | C129200 | FAC005-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-B Version 4 - I Feel Close to My Partner | ||
FAC00514 | C129201 | FAC005-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-B Version 4 - I Am Satisfied With My Sex Life | ||
FAC00515 | C129202 | FAC005-I Feel Sad | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I feel sad. | FACT-B Version 4 - I Feel Sad | ||
FAC00516 | C129203 | FAC005-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-B Version 4 - Satisfied With How I Am Coping | ||
FAC00517 | C129204 | FAC005-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-B Version 4 - Losing Hope Against Illness | ||
FAC00518 | C129205 | FAC005-I Feel Nervous | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I feel nervous. | FACT-B Version 4 - I Feel Nervous | ||
FAC00519 | C129206 | FAC005-I Worry About Dying | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I worry about dying. | FACT-B Version 4 - I Worry About Dying | ||
FAC00520 | C129207 | FAC005-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-B Version 4 - Worry My Condition Will Get Worse | ||
FAC00521 | C129208 | FAC005-I Am Able to Work | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-B Version 4 - I Am Able to Work | ||
FAC00522 | C129209 | FAC005-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-B Version 4 - My Work Is Fulfilling | ||
FAC00523 | C129210 | FAC005-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-B Version 4 - I Am Able to Enjoy Life | ||
FAC00524 | C129211 | FAC005-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I have accepted my illness. | FACT-B Version 4 - I Have Accepted My Illness | ||
FAC00525 | C129212 | FAC005-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am sleeping well. | FACT-B Version 4 - I Am Sleeping Well | ||
FAC00526 | C129213 | FAC005-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-B Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC00527 | C129214 | FAC005-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-B Version 4 - Content With Quality of My Life | ||
FAC00528 | C129215 | FAC005-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I have been short of breath. | FACT-B Version 4 - I Have Been Short of Breath | ||
FAC00529 | C129216 | FAC005-Self-conscious About Way I Dress | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am self-conscious about the way I dress. | FACT-B Version 4 - Self-conscious About Way I Dress | ||
FAC00530 | C129217 | FAC005-One/Both Arms Are Swollen/Tender | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: One or both of my arms are swollen or tender. | FACT-B Version 4 - One or Both Arms Are Swollen or Tender | ||
FAC00531 | C129218 | FAC005-I Feel Sexually Attractive | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I feel sexually attractive. | FACT-B Version 4 - I Feel Sexually Attractive | ||
FAC00532 | C129219 | FAC005-I Am Bothered by Hair Loss | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am bothered by hair loss. | FACT-B Version 4 - I Am Bothered by Hair Loss | ||
FAC00533 | C129220 | FAC005-Worry Family Will Get Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I worry that other members of my family might someday get the same illness I have. | FACT-B Version 4 - Worry Family Will Get Illness | ||
FAC00534 | C129221 | FAC005-Worry About the Effect of Stress | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I worry about the effect of stress on my illness. | FACT-B Version 4 - Worry About the Effect of Stress | ||
FAC00535 | C129222 | FAC005-I Am Bothered by Change in Weight | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am bothered by a change in weight. | FACT-B Version 4 - I Am Bothered by Change in Weight | ||
FAC00536 | C129223 | FAC005-I Am Able to Feel Like a Woman | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am able to feel like a woman. | FACT-B Version 4 - I Am Able to Feel Like a Woman | ||
FAC00537 | C129224 | FAC005-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. | FACT-B Version 4 - Certain Parts of Body Have Pain | ||
FAC00538 | C180194 | FAC005-Physical Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: Subscale score. | FACT-B Version 4 - Physical Subscale Score | ||
FAC00539 | C180195 | FAC005-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: Subscale score. | FACT-B Version 4 - Social/Family Subscale Score | ||
FAC00540 | C180196 | FAC005-Emotional Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: Subscale score. | FACT-B Version 4 - Emotional Subscale Score | ||
FAC00541 | C180197 | FAC005-Functional Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: Subscale score. | FACT-B Version 4 - Functional Subscale Score | ||
FAC00542 | C180198 | FAC005-Additional Concern Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: Subscale score. | FACT-B Version 4 - Additional Concern Subscale Score | ||
FAC00543 | C180199 | FAC005-Trial Outcome Index Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Trial outcome index score. | FACT-B Version 4 - Trial Outcome Index Score | ||
FAC00544 | C180200 | FAC005-FACT-G Total Score | Functional Assessment of Cancer Therapy-Breast Version 4 - FACT-G total score. | FACT-B Version 4 - FACT-G Total Score | ||
FAC00545 | C180201 | FAC005-Total Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Total score. | FACT-B Version 4 - Total Score | ||
Back to top | ||||||
CL.C129093.FAC005TN | Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire Test Name
(FAC005TN) | text
Extensible: No | C129093 | Functional Assessment of Cancer Therapy-Breast Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Breast Version 4 test name. | CDISC Questionnaire FACT-B Version 4 Test Name Terminology |
FAC005-Additional Concern Subscale Score | C180198 | FAC005-Additional Concern Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: Subscale score. | FACT-B Version 4 - Additional Concern Subscale Score | ||
FAC005-Bothered by Treatment Side Effect | C129192 | FAC005-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-B Version 4 - Bothered by Treatment Side Effect | ||
FAC005-Certain Parts of Body Have Pain | C129224 | FAC005-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. | FACT-B Version 4 - Certain Parts of Body Have Pain | ||
FAC005-Content With Quality of My Life | C129214 | FAC005-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-B Version 4 - Content With Quality of My Life | ||
FAC005-Emotional Subscale Score | C180196 | FAC005-Emotional Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: Subscale score. | FACT-B Version 4 - Emotional Subscale Score | ||
FAC005-Enjoy Things I Usually Do for Fun | C129213 | FAC005-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-B Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC005-FACT-G Total Score | C180200 | FAC005-FACT-G Total Score | Functional Assessment of Cancer Therapy-Breast Version 4 - FACT-G total score. | FACT-B Version 4 - FACT-G Total Score | ||
FAC005-Functional Subscale Score | C180197 | FAC005-Functional Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: Subscale score. | FACT-B Version 4 - Functional Subscale Score | ||
FAC005-Get Emotional Support From Family | C129196 | FAC005-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-B Version 4 - Get Emotional Support From Family | ||
FAC005-I Am Able to Enjoy Life | C129210 | FAC005-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-B Version 4 - I Am Able to Enjoy Life | ||
FAC005-I Am Able to Feel Like a Woman | C129223 | FAC005-I Am Able to Feel Like a Woman | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am able to feel like a woman. | FACT-B Version 4 - I Am Able to Feel Like a Woman | ||
FAC005-I Am Able to Work | C129208 | FAC005-I Am Able to Work | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-B Version 4 - I Am Able to Work | ||
FAC005-I Am Bothered by Change in Weight | C129222 | FAC005-I Am Bothered by Change in Weight | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am bothered by a change in weight. | FACT-B Version 4 - I Am Bothered by Change in Weight | ||
FAC005-I Am Bothered by Hair Loss | C129219 | FAC005-I Am Bothered by Hair Loss | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am bothered by hair loss. | FACT-B Version 4 - I Am Bothered by Hair Loss | ||
FAC005-I Am Forced to Spend Time in Bed | C129194 | FAC005-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-B Version 4 - I Am Forced to Spend Time in Bed | ||
FAC005-I Am Satisfied With My Sex Life | C129201 | FAC005-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-B Version 4 - I Am Satisfied With My Sex Life | ||
FAC005-I Am Sleeping Well | C129212 | FAC005-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I am sleeping well. | FACT-B Version 4 - I Am Sleeping Well | ||
FAC005-I Feel Close to My Friends | C129195 | FAC005-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-B Version 4 - I Feel Close to My Friends | ||
FAC005-I Feel Close to My Partner | C129200 | FAC005-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-B Version 4 - I Feel Close to My Partner | ||
FAC005-I Feel Ill | C129193 | FAC005-I Feel Ill | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I feel ill. | FACT-B Version 4 - I Feel Ill | ||
FAC005-I Feel Nervous | C129205 | FAC005-I Feel Nervous | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I feel nervous. | FACT-B Version 4 - I Feel Nervous | ||
FAC005-I Feel Sad | C129202 | FAC005-I Feel Sad | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I feel sad. | FACT-B Version 4 - I Feel Sad | ||
FAC005-I Feel Sexually Attractive | C129218 | FAC005-I Feel Sexually Attractive | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I feel sexually attractive. | FACT-B Version 4 - I Feel Sexually Attractive | ||
FAC005-I Get Support From My Friends | C129197 | FAC005-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-B Version 4 - I Get Support From My Friends | ||
FAC005-I Have a Lack of Energy | C129188 | FAC005-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have a lack of energy. | FACT-B Version 4 - I Have a Lack of Energy | ||
FAC005-I Have Accepted My Illness | C129211 | FAC005-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: I have accepted my illness. | FACT-B Version 4 - I Have Accepted My Illness | ||
FAC005-I Have Been Short of Breath | C129215 | FAC005-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I have been short of breath. | FACT-B Version 4 - I Have Been Short of Breath | ||
FAC005-I Have Nausea | C129189 | FAC005-I Have Nausea | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have nausea. | FACT-B Version 4 - I Have Nausea | ||
FAC005-I Have Pain | C129191 | FAC005-I Have Pain | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: I have pain. | FACT-B Version 4 - I Have Pain | ||
FAC005-I Worry About Dying | C129206 | FAC005-I Worry About Dying | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I worry about dying. | FACT-B Version 4 - I Worry About Dying | ||
FAC005-Losing Hope Against Illness | C129204 | FAC005-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-B Version 4 - Losing Hope Against Illness | ||
FAC005-My Family Has Accepted My Illness | C129198 | FAC005-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-B Version 4 - My Family Has Accepted My Illness | ||
FAC005-My Work Is Fulfilling | C129209 | FAC005-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Breast Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-B Version 4 - My Work Is Fulfilling | ||
FAC005-One/Both Arms Are Swollen/Tender | C129217 | FAC005-One/Both Arms Are Swollen/Tender | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: One or both of my arms are swollen or tender. | FACT-B Version 4 - One or Both Arms Are Swollen or Tender | ||
FAC005-Physical Subscale Score | C180194 | FAC005-Physical Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: Subscale score. | FACT-B Version 4 - Physical Subscale Score | ||
FAC005-Satisfied Communication Illness | C129199 | FAC005-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-B Version 4 - Satisfied Family Communication of Illness | ||
FAC005-Satisfied With How I Am Coping | C129203 | FAC005-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-B Version 4 - Satisfied With How I Am Coping | ||
FAC005-Self-conscious About Way I Dress | C129216 | FAC005-Self-conscious About Way I Dress | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I am self-conscious about the way I dress. | FACT-B Version 4 - Self-conscious About Way I Dress | ||
FAC005-Social/Family Subscale Score | C180195 | FAC005-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Social/Family Well-Being: Subscale score. | FACT-B Version 4 - Social/Family Subscale Score | ||
FAC005-Total Score | C180201 | FAC005-Total Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Total score. | FACT-B Version 4 - Total Score | ||
FAC005-Trial Outcome Index Score | C180199 | FAC005-Trial Outcome Index Score | Functional Assessment of Cancer Therapy-Breast Version 4 - Trial outcome index score. | FACT-B Version 4 - Trial Outcome Index Score | ||
FAC005-Trouble Meeting Needs of Family | C129190 | FAC005-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Breast Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-B Version 4 - Trouble Meeting Needs of Family | ||
FAC005-Worry About the Effect of Stress | C129221 | FAC005-Worry About the Effect of Stress | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I worry about the effect of stress on my illness. | FACT-B Version 4 - Worry About the Effect of Stress | ||
FAC005-Worry Family Will Get Illness | C129220 | FAC005-Worry Family Will Get Illness | Functional Assessment of Cancer Therapy-Breast Version 4 - Additional Concerns: I worry that other members of my family might someday get the same illness I have. | FACT-B Version 4 - Worry Family Will Get Illness | ||
FAC005-Worry My Condition Will Get Worse | C129207 | FAC005-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Breast Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-B Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C166184.FAC075TC | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 Questionnaire Test Code
(FAC075TC) | text
Extensible: No | C166184 | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 test code. | CDISC Questionnaire FACT-COG Version 3 Test Code Terminology |
FAC07501 | C166280 | FAC075-I Have Trouble Forming Thoughts | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble forming thoughts. | FACT-COG Version 3 - I Have Trouble Forming Thoughts | ||
FAC07502 | C166281 | FAC075-My Thinking Has Been Slow | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My thinking has been slow. | FACT-COG Version 3 - My Thinking Has Been Slow | ||
FAC07503 | C166282 | FAC075-I Have Had Trouble Concentrating | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble concentrating. | FACT-COG Version 3 - I Have Had Trouble Concentrating | ||
FAC07504 | C166283 | FAC075-Trouble Finding Familiar Place | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble finding my way to a familiar place. | FACT-COG Version 3 - Trouble Finding Familiar Place | ||
FAC07505 | C166284 | FAC075-Trouble Remember Where Put Things | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble remembering where I put things, like my keys or my wallet. | FACT-COG Version 3 - Trouble Remember Where Put Things | ||
FAC07506 | C166285 | FAC075-Trouble Remembering New Info | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble remembering new information, like phone numbers or simple instructions. | FACT-COG Version 3 - Trouble Remembering New Info | ||
FAC07507 | C166286 | FAC075-Trouble Recalling Name of Object | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble recalling the name of an object while talking to someone. | FACT-COG Version 3 - Trouble Recalling Name of Object | ||
FAC07508 | C166287 | FAC075-Trouble Finding Right Words | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble finding the right word(s) to express myself. | FACT-COG Version 3 - Trouble Finding Right Words | ||
FAC07509 | C166288 | FAC075-Used Wrong Word When Refer Object | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have used the wrong word when I referred to an object. | FACT-COG Version 3 - Used Wrong Word When Refer Object | ||
FAC07510 | C166289 | FAC075-Trouble Saying What I Mean | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble saying what I mean in conversations with others. | FACT-COG Version 3 - Trouble Saying What I Mean | ||
FAC07511 | C166290 | FAC075-Walked Into a Room and Forgotten | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have walked into a room and forgotten what I meant to get or do there. | FACT-COG Version 3 - Walked Into a Room and Forgotten | ||
FAC07512 | C166291 | FAC075-Work Hard to Pay Attention | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work really hard to pay attention or I would make a mistake. | FACT-COG Version 3 - Work Hard to Pay Attention | ||
FAC07513 | C166292 | FAC075-Forgotten Names After Introduced | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have forgotten names of people soon after being introduced. | FACT-COG Version 3 - Forgotten Names After Introduced | ||
FAC07514 | C166293 | FAC075-Reaction Everyday Situations Slow | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My reactions in everyday situations have been slow. | FACT-COG Version 3 - Reaction Everyday Situations Slow | ||
FAC07515 | C166294 | FAC075-Work Harder Than Usual to Track | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work harder than usual to keep track of what I was doing. | FACT-COG Version 3 - Work Harder Than Usual to Track | ||
FAC07516 | C166295 | FAC075-My Thinking Slower Than Usual | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My thinking has been slower than usual. | FACT-COG Version 3 - My Thinking Slower Than Usual | ||
FAC07517 | C166296 | FAC075-Work Harder Than Usual to Express | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work harder than usual to express myself clearly. | FACT-COG Version 3 - Work Harder Than Usual to Express | ||
FAC07518 | C166297 | FAC075-Use Written Lists More Often | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to use written lists more often than usual so I would not forget things. | FACT-COG Version 3 - Use Written Lists More Often | ||
FAC07519 | C166298 | FAC075-Trouble Keeping Track Interrupted | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have trouble keeping track of what I am doing if I am interrupted. | FACT-COG Version 3 - Trouble Keeping Track Interrupted | ||
FAC07520 | C166299 | FAC075-Trouble Shifting Back and Forth | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have trouble shifting back and forth between different activities that require thinking. | FACT-COG Version 3 - Trouble Shifting Back and Forth | ||
FAC07521 | C166300 | FAC075-Told Me Trouble Remembering Info | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble remembering information. | FACT-COG Version 3 - Told Me Trouble Remembering Info | ||
FAC07522 | C166301 | FAC075-Told Me Trouble Speaking Clearly | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble speaking clearly. | FACT-COG Version 3 - Told Me Trouble Speaking Clearly | ||
FAC07523 | C166302 | FAC075-Told Me Trouble Thinking Clearly | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble thinking clearly. | FACT-COG Version 3 - Told Me Trouble Thinking Clearly | ||
FAC07524 | C166303 | FAC075-People Told Me I Seemed Confused | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed confused. | FACT-COG Version 3 - People Told Me I Seemed Confused | ||
FAC07525 | C166304 | FAC075-I Have Been Able to Concentrate | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to concentrate. | FACT-COG Version 3 - I Have Been Able to Concentrate | ||
FAC07526 | C166305 | FAC075-Able to Bring to Mind Words | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to bring to mind words that I wanted to use while talking to someone. | FACT-COG Version 3 - Able to Bring to Mind Words | ||
FAC07527 | C166306 | FAC075-Able Remember Things Where Left | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to remember things, like where I left my keys or wallet. | FACT-COG Version 3 - Able Remember Things Where Left | ||
FAC07528 | C166307 | FAC075-Able Remember to Do Things | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to remember to do things, like take medicine or buy something I needed. | FACT-COG Version 3 - Able Remember to Do Things | ||
FAC07529 | C166308 | FAC075-Able to Pay Attention w/o Effort | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to pay attention and keep track of what I am doing without extra effort. | FACT-COG Version 3 - Able to Pay Attention Without Effort | ||
FAC07530 | C166309 | FAC075-Mind Is as Sharp as Always Been | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: My mind is as sharp as it has always been. | FACT-COG Version 3 - Mind Is as Sharp as Always Been | ||
FAC07531 | C166310 | FAC075-Memory Is as Good as Always Been | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: My memory is as good as it has always been. | FACT-COG Version 3 - Memory Is as Good as Always Been | ||
FAC07532 | C166311 | FAC075-Able to Shift Between Activities | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to shift back and forth between two activities that require thinking. | FACT-COG Version 3 - Able to Shift Between Activities | ||
FAC07533 | C166312 | FAC075-Able to Track What I Am Doing | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to keep track of what I am doing, even if I am interrupted. | FACT-COG Version 3 - Able to Track What I Am Doing | ||
FAC07534 | C166313 | FAC075-Been Upset about These Problems | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: I have been upset about these problems. | FACT-COG Version 3 - Been Upset about These Problems | ||
FAC07535 | C166314 | FAC075-Problems Interfered Ability Work | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with my ability to work. | FACT-COG Version 3 - Problems Interfered Ability Work | ||
FAC07536 | C166315 | FAC075-Problems Interfered Ability Enjoy | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with my ability to do things I enjoy. | FACT-COG Version 3 - Problems Interfered Ability Enjoy | ||
FAC07537 | C166316 | FAC075-Problems Interfered Quality Life | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with the quality of my life. | FACT-COG Version 3 - Problems Interfered Quality Life | ||
FAC07538 | C166317 | FAC075-Cognitive Impairments Score | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: Subscale score. | FACT-COG Version 3 - Cognitive Impairments Score | ||
FAC07539 | C166318 | FAC075-Comments From Others Score | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Subscale score. | FACT-COG Version 3 - Comments From Others Score | ||
FAC07540 | C166319 | FAC075-Cognitive Abilities Score | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: Subscale score. | FACT-COG Version 3 - Cognitive Abilities Score | ||
FAC07541 | C166320 | FAC075-Impact on Quality of Life Score | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: Subscale score. | FACT-COG Version 3 - Impact on Quality of Life Score | ||
Back to top | ||||||
CL.C166183.FAC075TN | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 Questionnaire Test Name
(FAC075TN) | text
Extensible: No | C166183 | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 test name. | CDISC Questionnaire FACT-COG Version 3 Test Name Terminology |
FAC075-Able Remember Things Where Left | C166306 | FAC075-Able Remember Things Where Left | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to remember things, like where I left my keys or wallet. | FACT-COG Version 3 - Able Remember Things Where Left | ||
FAC075-Able Remember to Do Things | C166307 | FAC075-Able Remember to Do Things | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to remember to do things, like take medicine or buy something I needed. | FACT-COG Version 3 - Able Remember to Do Things | ||
FAC075-Able to Bring to Mind Words | C166305 | FAC075-Able to Bring to Mind Words | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to bring to mind words that I wanted to use while talking to someone. | FACT-COG Version 3 - Able to Bring to Mind Words | ||
FAC075-Able to Pay Attention w/o Effort | C166308 | FAC075-Able to Pay Attention w/o Effort | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to pay attention and keep track of what I am doing without extra effort. | FACT-COG Version 3 - Able to Pay Attention Without Effort | ||
FAC075-Able to Shift Between Activities | C166311 | FAC075-Able to Shift Between Activities | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to shift back and forth between two activities that require thinking. | FACT-COG Version 3 - Able to Shift Between Activities | ||
FAC075-Able to Track What I Am Doing | C166312 | FAC075-Able to Track What I Am Doing | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I am able to keep track of what I am doing, even if I am interrupted. | FACT-COG Version 3 - Able to Track What I Am Doing | ||
FAC075-Been Upset about These Problems | C166313 | FAC075-Been Upset about These Problems | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: I have been upset about these problems. | FACT-COG Version 3 - Been Upset about These Problems | ||
FAC075-Cognitive Abilities Score | C166319 | FAC075-Cognitive Abilities Score | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: Subscale score. | FACT-COG Version 3 - Cognitive Abilities Score | ||
FAC075-Cognitive Impairments Score | C166317 | FAC075-Cognitive Impairments Score | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: Subscale score. | FACT-COG Version 3 - Cognitive Impairments Score | ||
FAC075-Comments From Others Score | C166318 | FAC075-Comments From Others Score | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Subscale score. | FACT-COG Version 3 - Comments From Others Score | ||
FAC075-Forgotten Names After Introduced | C166292 | FAC075-Forgotten Names After Introduced | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have forgotten names of people soon after being introduced. | FACT-COG Version 3 - Forgotten Names After Introduced | ||
FAC075-I Have Been Able to Concentrate | C166304 | FAC075-I Have Been Able to Concentrate | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: I have been able to concentrate. | FACT-COG Version 3 - I Have Been Able to Concentrate | ||
FAC075-I Have Had Trouble Concentrating | C166282 | FAC075-I Have Had Trouble Concentrating | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble concentrating. | FACT-COG Version 3 - I Have Had Trouble Concentrating | ||
FAC075-I Have Trouble Forming Thoughts | C166280 | FAC075-I Have Trouble Forming Thoughts | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble forming thoughts. | FACT-COG Version 3 - I Have Trouble Forming Thoughts | ||
FAC075-Impact on Quality of Life Score | C166320 | FAC075-Impact on Quality of Life Score | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: Subscale score. | FACT-COG Version 3 - Impact on Quality of Life Score | ||
FAC075-Memory Is as Good as Always Been | C166310 | FAC075-Memory Is as Good as Always Been | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: My memory is as good as it has always been. | FACT-COG Version 3 - Memory Is as Good as Always Been | ||
FAC075-Mind Is as Sharp as Always Been | C166309 | FAC075-Mind Is as Sharp as Always Been | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Abilities: My mind is as sharp as it has always been. | FACT-COG Version 3 - Mind Is as Sharp as Always Been | ||
FAC075-My Thinking Has Been Slow | C166281 | FAC075-My Thinking Has Been Slow | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My thinking has been slow. | FACT-COG Version 3 - My Thinking Has Been Slow | ||
FAC075-My Thinking Slower Than Usual | C166295 | FAC075-My Thinking Slower Than Usual | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My thinking has been slower than usual. | FACT-COG Version 3 - My Thinking Slower Than Usual | ||
FAC075-People Told Me I Seemed Confused | C166303 | FAC075-People Told Me I Seemed Confused | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed confused. | FACT-COG Version 3 - People Told Me I Seemed Confused | ||
FAC075-Problems Interfered Ability Enjoy | C166315 | FAC075-Problems Interfered Ability Enjoy | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with my ability to do things I enjoy. | FACT-COG Version 3 - Problems Interfered Ability Enjoy | ||
FAC075-Problems Interfered Ability Work | C166314 | FAC075-Problems Interfered Ability Work | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with my ability to work. | FACT-COG Version 3 - Problems Interfered Ability Work | ||
FAC075-Problems Interfered Quality Life | C166316 | FAC075-Problems Interfered Quality Life | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Impact on Quality of Life: These problems have interfered with the quality of my life. | FACT-COG Version 3 - Problems Interfered Quality Life | ||
FAC075-Reaction Everyday Situations Slow | C166293 | FAC075-Reaction Everyday Situations Slow | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: My reactions in everyday situations have been slow. | FACT-COG Version 3 - Reaction Everyday Situations Slow | ||
FAC075-Told Me Trouble Remembering Info | C166300 | FAC075-Told Me Trouble Remembering Info | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble remembering information. | FACT-COG Version 3 - Told Me Trouble Remembering Info | ||
FAC075-Told Me Trouble Speaking Clearly | C166301 | FAC075-Told Me Trouble Speaking Clearly | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble speaking clearly. | FACT-COG Version 3 - Told Me Trouble Speaking Clearly | ||
FAC075-Told Me Trouble Thinking Clearly | C166302 | FAC075-Told Me Trouble Thinking Clearly | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Comments From Others: Other people have told me I seemed to have trouble thinking clearly. | FACT-COG Version 3 - Told Me Trouble Thinking Clearly | ||
FAC075-Trouble Finding Familiar Place | C166283 | FAC075-Trouble Finding Familiar Place | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble finding my way to a familiar place. | FACT-COG Version 3 - Trouble Finding Familiar Place | ||
FAC075-Trouble Finding Right Words | C166287 | FAC075-Trouble Finding Right Words | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble finding the right word(s) to express myself. | FACT-COG Version 3 - Trouble Finding Right Words | ||
FAC075-Trouble Keeping Track Interrupted | C166298 | FAC075-Trouble Keeping Track Interrupted | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have trouble keeping track of what I am doing if I am interrupted. | FACT-COG Version 3 - Trouble Keeping Track Interrupted | ||
FAC075-Trouble Recalling Name of Object | C166286 | FAC075-Trouble Recalling Name of Object | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble recalling the name of an object while talking to someone. | FACT-COG Version 3 - Trouble Recalling Name of Object | ||
FAC075-Trouble Remember Where Put Things | C166284 | FAC075-Trouble Remember Where Put Things | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble remembering where I put things, like my keys or my wallet. | FACT-COG Version 3 - Trouble Remember Where Put Things | ||
FAC075-Trouble Remembering New Info | C166285 | FAC075-Trouble Remembering New Info | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble remembering new information, like phone numbers or simple instructions. | FACT-COG Version 3 - Trouble Remembering New Info | ||
FAC075-Trouble Saying What I Mean | C166289 | FAC075-Trouble Saying What I Mean | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had trouble saying what I mean in conversations with others. | FACT-COG Version 3 - Trouble Saying What I Mean | ||
FAC075-Trouble Shifting Back and Forth | C166299 | FAC075-Trouble Shifting Back and Forth | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have trouble shifting back and forth between different activities that require thinking. | FACT-COG Version 3 - Trouble Shifting Back and Forth | ||
FAC075-Use Written Lists More Often | C166297 | FAC075-Use Written Lists More Often | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to use written lists more often than usual so I would not forget things. | FACT-COG Version 3 - Use Written Lists More Often | ||
FAC075-Used Wrong Word When Refer Object | C166288 | FAC075-Used Wrong Word When Refer Object | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have used the wrong word when I referred to an object. | FACT-COG Version 3 - Used Wrong Word When Refer Object | ||
FAC075-Walked Into a Room and Forgotten | C166290 | FAC075-Walked Into a Room and Forgotten | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have walked into a room and forgotten what I meant to get or do there. | FACT-COG Version 3 - Walked Into a Room and Forgotten | ||
FAC075-Work Hard to Pay Attention | C166291 | FAC075-Work Hard to Pay Attention | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work really hard to pay attention or I would make a mistake. | FACT-COG Version 3 - Work Hard to Pay Attention | ||
FAC075-Work Harder Than Usual to Express | C166296 | FAC075-Work Harder Than Usual to Express | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work harder than usual to express myself clearly. | FACT-COG Version 3 - Work Harder Than Usual to Express | ||
FAC075-Work Harder Than Usual to Track | C166294 | FAC075-Work Harder Than Usual to Track | Functional Assessment of Cancer Therapy-Cognitive Function Version 3 - Perceived Cognitive Impairments: I have had to work harder than usual to keep track of what I was doing. | FACT-COG Version 3 - Work Harder Than Usual to Track | ||
Back to top | ||||||
CL.C150774.FAC008TC | Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire Test Code
(FAC008TC) | text
Extensible: No | C150774 | Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Colorectal Version 4 test code. | CDISC Questionnaire FACT-C Version 4 Test Code Terminology |
FAC00801 | C151076 | FAC008-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have a lack of energy. | FACT-C Version 4 - I Have a Lack of Energy | ||
FAC00802 | C151077 | FAC008-I Have Nausea | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have nausea. | FACT-C Version 4 - I Have Nausea | ||
FAC00803 | C151078 | FAC008-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-C Version 4 - Trouble Meeting Needs of Family | ||
FAC00804 | C151079 | FAC008-I Have Pain | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have pain. | FACT-C Version 4 - I Have Pain | ||
FAC00805 | C151080 | FAC008-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-C Version 4 - Bothered by Treatment Side Effect | ||
FAC00806 | C151081 | FAC008-I Feel Ill | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I feel ill. | FACT-C Version 4 - I Feel Ill | ||
FAC00807 | C151082 | FAC008-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-C Version 4 - I Am Forced to Spend Time in Bed | ||
FAC00808 | C151083 | FAC008-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-C Version 4 - I Feel Close to My Friends | ||
FAC00809 | C151084 | FAC008-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-C Version 4 - Get Emotional Support From Family | ||
FAC00810 | C151085 | FAC008-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-C Version 4 - I Get Support From My Friends | ||
FAC00811 | C151086 | FAC008-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-C Version 4 - My Family Has Accepted My Illness | ||
FAC00812 | C151087 | FAC008-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-C Version 4 - Satisfied Communication Illness | ||
FAC00813 | C151088 | FAC008-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-C Version 4 - I Feel Close to My Partner | ||
FAC00814 | C151089 | FAC008-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-C Version 4 - I Am Satisfied With My Sex Life | ||
FAC00815 | C151090 | FAC008-I Feel Sad | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I feel sad. | FACT-C Version 4 - I Feel Sad | ||
FAC00816 | C151091 | FAC008-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-C Version 4 - Satisfied With How I Am Coping | ||
FAC00817 | C151092 | FAC008-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-C Version 4 - Losing Hope Against Illness | ||
FAC00818 | C151093 | FAC008-I Feel Nervous | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I feel nervous. | FACT-C Version 4 - I Feel Nervous | ||
FAC00819 | C151094 | FAC008-I Worry About Dying | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I worry about dying. | FACT-C Version 4 - I Worry About Dying | ||
FAC00820 | C151095 | FAC008-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-C Version 4 - Worry My Condition Will Get Worse | ||
FAC00821 | C151096 | FAC008-I Am Able to Work | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-C Version 4 - I Am Able to Work | ||
FAC00822 | C151097 | FAC008-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-C Version 4 - My Work Is Fulfilling | ||
FAC00823 | C151098 | FAC008-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-C Version 4 - I Am Able to Enjoy Life | ||
FAC00824 | C151099 | FAC008-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I have accepted my illness. | FACT-C Version 4 - I Have Accepted My Illness | ||
FAC00825 | C151100 | FAC008-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am sleeping well. | FACT-C Version 4 - I Am Sleeping Well | ||
FAC00826 | C151101 | FAC008-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-C Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC00827 | C151102 | FAC008-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-C Version 4 - Content With Quality of My Life | ||
FAC00828 | C151103 | FAC008-Swelling/Cramps in Stomach Area | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. | FACT-C Version 4 - Swelling/Cramps in Stomach Area | ||
FAC00829 | C151104 | FAC008-I Am Losing Weight | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I am losing weight. | FACT-C Version 4 - I Am Losing Weight | ||
FAC00830 | C151105 | FAC008-I Have Control of My Bowels | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have control of my bowels. | FACT-C Version 4 - I Have Control of My Bowels | ||
FAC00831 | C151106 | FAC008-I Can Digest My Food Well | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I can digest my food well. | FACT-C Version 4 - I Can Digest My Food Well | ||
FAC00832 | C151107 | FAC008-I Have Diarrhea | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have diarrhea (diarrhoea). | FACT-C Version 4 - I Have Diarrhea | ||
FAC00833 | C151108 | FAC008-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have a good appetite. | FACT-C Version 4 - I Have a Good Appetite | ||
FAC00834 | C151109 | FAC008-I Like the Appearance of My Body | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I like the appearance of my body. | FACT-C Version 4 - I Like the Appearance of My Body | ||
FAC00835 | C151110 | FAC008-Do You Have an Ostomy Appliance | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Do you have an ostomy appliance? | FACT-C Version 4 - Do You Have an Ostomy Appliance | ||
FAC00836 | C151111 | FAC008-Embarrassed by Ostomy Appliance | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I am embarrassed by my ostomy appliance. | FACT-C Version 4 - Embarrassed by Ostomy Appliance | ||
FAC00837 | C151112 | FAC008-Caring for Ostomy Is Difficult | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Caring for my ostomy appliance is difficult. | FACT-C Version 4 - Caring for Ostomy Is Difficult | ||
FAC00838 | C163941 | FAC008-Physical Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: Subscale score. | FACT-C Version 4 - Physical Subscale Score | ||
FAC00839 | C163942 | FAC008-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: Subscale score. | FACT-C Version 4 - Social/Family Subscale Score | ||
FAC00840 | C163943 | FAC008-Emotional Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: Subscale score. | FACT-C Version 4 - Emotional Subscale Score | ||
FAC00841 | C163944 | FAC008-Functional Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: Subscale score. | FACT-C Version 4 - Functional Subscale Score | ||
FAC00842 | C163945 | FAC008-Additional Concern Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Subscale score. | FACT-C Version 4 - Additional Concern Subscale Score | ||
FAC00843 | C166339 | FAC008-Trial Outcome Index Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Trial outcome index score. | FACT-C Version 4 - Trial Outcome Index Score | ||
FAC00844 | C166340 | FAC008-FACT-G Total Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - FACT-G total score. | FACT-C Version 4 - FACT-G Total Score | ||
FAC00845 | C163946 | FAC008-Total Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Total score. | FACT-C Version 4 - Total Score | ||
Back to top | ||||||
CL.C150773.FAC008TN | Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire Test Name
(FAC008TN) | text
Extensible: No | C150773 | Functional Assessment of Cancer Therapy-Colorectal Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Colorectal Version 4 test name. | CDISC Questionnaire FACT-C Version 4 Test Name Terminology |
FAC008-Additional Concern Subscale Score | C163945 | FAC008-Additional Concern Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Subscale score. | FACT-C Version 4 - Additional Concern Subscale Score | ||
FAC008-Bothered by Treatment Side Effect | C151080 | FAC008-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-C Version 4 - Bothered by Treatment Side Effect | ||
FAC008-Caring for Ostomy Is Difficult | C151112 | FAC008-Caring for Ostomy Is Difficult | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Caring for my ostomy appliance is difficult. | FACT-C Version 4 - Caring for Ostomy Is Difficult | ||
FAC008-Content With Quality of My Life | C151102 | FAC008-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-C Version 4 - Content With Quality of My Life | ||
FAC008-Do You Have an Ostomy Appliance | C151110 | FAC008-Do You Have an Ostomy Appliance | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: Do you have an ostomy appliance? | FACT-C Version 4 - Do You Have an Ostomy Appliance | ||
FAC008-Embarrassed by Ostomy Appliance | C151111 | FAC008-Embarrassed by Ostomy Appliance | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I am embarrassed by my ostomy appliance. | FACT-C Version 4 - Embarrassed by Ostomy Appliance | ||
FAC008-Emotional Subscale Score | C163943 | FAC008-Emotional Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: Subscale score. | FACT-C Version 4 - Emotional Subscale Score | ||
FAC008-Enjoy Things I Usually Do for Fun | C151101 | FAC008-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-C Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC008-FACT-G Total Score | C166340 | FAC008-FACT-G Total Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - FACT-G total score. | FACT-C Version 4 - FACT-G Total Score | ||
FAC008-Functional Subscale Score | C163944 | FAC008-Functional Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: Subscale score. | FACT-C Version 4 - Functional Subscale Score | ||
FAC008-Get Emotional Support From Family | C151084 | FAC008-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-C Version 4 - Get Emotional Support From Family | ||
FAC008-I Am Able to Enjoy Life | C151098 | FAC008-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-C Version 4 - I Am Able to Enjoy Life | ||
FAC008-I Am Able to Work | C151096 | FAC008-I Am Able to Work | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-C Version 4 - I Am Able to Work | ||
FAC008-I Am Forced to Spend Time in Bed | C151082 | FAC008-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-C Version 4 - I Am Forced to Spend Time in Bed | ||
FAC008-I Am Losing Weight | C151104 | FAC008-I Am Losing Weight | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I am losing weight. | FACT-C Version 4 - I Am Losing Weight | ||
FAC008-I Am Satisfied With My Sex Life | C151089 | FAC008-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-C Version 4 - I Am Satisfied With My Sex Life | ||
FAC008-I Am Sleeping Well | C151100 | FAC008-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I am sleeping well. | FACT-C Version 4 - I Am Sleeping Well | ||
FAC008-I Can Digest My Food Well | C151106 | FAC008-I Can Digest My Food Well | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I can digest my food well. | FACT-C Version 4 - I Can Digest My Food Well | ||
FAC008-I Feel Close to My Friends | C151083 | FAC008-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-C Version 4 - I Feel Close to My Friends | ||
FAC008-I Feel Close to My Partner | C151088 | FAC008-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-C Version 4 - I Feel Close to My Partner | ||
FAC008-I Feel Ill | C151081 | FAC008-I Feel Ill | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I feel ill. | FACT-C Version 4 - I Feel Ill | ||
FAC008-I Feel Nervous | C151093 | FAC008-I Feel Nervous | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I feel nervous. | FACT-C Version 4 - I Feel Nervous | ||
FAC008-I Feel Sad | C151090 | FAC008-I Feel Sad | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I feel sad. | FACT-C Version 4 - I Feel Sad | ||
FAC008-I Get Support From My Friends | C151085 | FAC008-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-C Version 4 - I Get Support From My Friends | ||
FAC008-I Have a Good Appetite | C151108 | FAC008-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have a good appetite. | FACT-C Version 4 - I Have a Good Appetite | ||
FAC008-I Have a Lack of Energy | C151076 | FAC008-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have a lack of energy. | FACT-C Version 4 - I Have a Lack of Energy | ||
FAC008-I Have Accepted My Illness | C151099 | FAC008-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: I have accepted my illness. | FACT-C Version 4 - I Have Accepted My Illness | ||
FAC008-I Have Control of My Bowels | C151105 | FAC008-I Have Control of My Bowels | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have control of my bowels. | FACT-C Version 4 - I Have Control of My Bowels | ||
FAC008-I Have Diarrhea | C151107 | FAC008-I Have Diarrhea | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have diarrhea (diarrhoea). | FACT-C Version 4 - I Have Diarrhea | ||
FAC008-I Have Nausea | C151077 | FAC008-I Have Nausea | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have nausea. | FACT-C Version 4 - I Have Nausea | ||
FAC008-I Have Pain | C151079 | FAC008-I Have Pain | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: I have pain. | FACT-C Version 4 - I Have Pain | ||
FAC008-I Like the Appearance of My Body | C151109 | FAC008-I Like the Appearance of My Body | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I like the appearance of my body. | FACT-C Version 4 - I Like the Appearance of My Body | ||
FAC008-I Worry About Dying | C151094 | FAC008-I Worry About Dying | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I worry about dying. | FACT-C Version 4 - I Worry About Dying | ||
FAC008-Losing Hope Against Illness | C151092 | FAC008-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-C Version 4 - Losing Hope Against Illness | ||
FAC008-My Family Has Accepted My Illness | C151086 | FAC008-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-C Version 4 - My Family Has Accepted My Illness | ||
FAC008-My Work Is Fulfilling | C151097 | FAC008-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-C Version 4 - My Work Is Fulfilling | ||
FAC008-Physical Subscale Score | C163941 | FAC008-Physical Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: Subscale score. | FACT-C Version 4 - Physical Subscale Score | ||
FAC008-Satisfied Communication Illness | C151087 | FAC008-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-C Version 4 - Satisfied Communication Illness | ||
FAC008-Satisfied With How I Am Coping | C151091 | FAC008-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-C Version 4 - Satisfied With How I Am Coping | ||
FAC008-Social/Family Subscale Score | C163942 | FAC008-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Social/Family Well-Being: Subscale score. | FACT-C Version 4 - Social/Family Subscale Score | ||
FAC008-Swelling/Cramps in Stomach Area | C151103 | FAC008-Swelling/Cramps in Stomach Area | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. | FACT-C Version 4 - Swelling/Cramps in Stomach Area | ||
FAC008-Total Score | C163946 | FAC008-Total Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Total score. | FACT-C Version 4 - Total Score | ||
FAC008-Trial Outcome Index Score | C166339 | FAC008-Trial Outcome Index Score | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Trial outcome index score. | FACT-C Version 4 - Trial Outcome Index Score | ||
FAC008-Trouble Meeting Needs of Family | C151078 | FAC008-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-C Version 4 - Trouble Meeting Needs of Family | ||
FAC008-Worry My Condition Will Get Worse | C151095 | FAC008-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Colorectal Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-C Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C130255.FAC015TC | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire Test Code
(FAC015TC) | text
Extensible: No | C130255 | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 test code. | CDISC Questionnaire FACT-HEP Version 4 Test Code Terminology |
FAC01501 | C130458 | FAC015-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have a lack of energy. | FACT-HEP Version 4 - I Have a Lack of Energy | ||
FAC01502 | C130459 | FAC015-I Have Nausea | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have nausea. | FACT-HEP Version 4 - I Have Nausea | ||
FAC01503 | C130460 | FAC015-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-HEP Version 4 - Trouble Meeting Needs of Family | ||
FAC01504 | C130461 | FAC015-I Have Pain | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have pain. | FACT-HEP Version 4 - I Have Pain | ||
FAC01505 | C130462 | FAC015-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-HEP Version 4 - Bothered by Treatment Side Effect | ||
FAC01506 | C130463 | FAC015-I Feel Ill | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I feel ill. | FACT-HEP Version 4 - I Feel Ill | ||
FAC01507 | C130464 | FAC015-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-HEP Version 4 - I Am Forced to Spend Time in Bed | ||
FAC01508 | C130465 | FAC015-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-HEP Version 4 - I Feel Close to My Friends | ||
FAC01509 | C130466 | FAC015-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-HEP Version 4 - Get Emotional Support From Family | ||
FAC01510 | C130467 | FAC015-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-HEP Version 4 - I Get Support From My Friends | ||
FAC01511 | C130468 | FAC015-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-HEP Version 4 - My Family Has Accepted My Illness | ||
FAC01512 | C130469 | FAC015-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-HEP Version 4 - Satisfied With Communication About Illness | ||
FAC01513 | C130470 | FAC015-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-HEP Version 4 - I Feel Close to My Partner | ||
FAC01514 | C130471 | FAC015-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-HEP Version 4 - I Am Satisfied With My Sex Life | ||
FAC01515 | C130472 | FAC015-I Feel Sad | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I feel sad. | FACT-HEP Version 4 - I Feel Sad | ||
FAC01516 | C130473 | FAC015-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-HEP Version 4 - Satisfied With How I Am Coping | ||
FAC01517 | C130474 | FAC015-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-HEP Version 4 - Losing Hope Against Illness | ||
FAC01518 | C130475 | FAC015-I Feel Nervous | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I feel nervous. | FACT-HEP Version 4 - I Feel Nervous | ||
FAC01519 | C130476 | FAC015-I Worry About Dying | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I worry about dying. | FACT-HEP Version 4 - I Worry About Dying | ||
FAC01520 | C130477 | FAC015-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-HEP Version 4 - Worry My Condition Will Get Worse | ||
FAC01521 | C130478 | FAC015-I Am Able to Work | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-HEP Version 4 - I Am Able to Work | ||
FAC01522 | C130479 | FAC015-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-HEP Version 4 - My Work Is Fulfilling | ||
FAC01523 | C130480 | FAC015-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-HEP Version 4 - I Am Able to Enjoy Life | ||
FAC01524 | C130481 | FAC015-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I have accepted my illness. | FACT-HEP Version 4 - I Have Accepted My Illness | ||
FAC01525 | C130482 | FAC015-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am sleeping well. | FACT-HEP Version 4 - I Am Sleeping Well | ||
FAC01526 | C130483 | FAC015-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-HEP Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC01527 | C130484 | FAC015-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-HEP Version 4 - Content With Quality of My Life | ||
FAC01528 | C130485 | FAC015-Swelling/Cramps in Stomach Area | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. | FACT-HEP Version 4 - Swelling or Cramps in Stomach Area | ||
FAC01529 | C130486 | FAC015-I Am Losing Weight | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am losing weight. | FACT-HEP Version 4 - I Am Losing Weight | ||
FAC01530 | C130487 | FAC015-I Have Control of My Bowels | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have control of my bowels. | FACT-HEP Version 4 - I Have Control of My Bowels | ||
FAC01531 | C130488 | FAC015-I Can Digest My Food Well | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I can digest my food well. | FACT-HEP Version 4 - I Can Digest My Food Well | ||
FAC01532 | C130489 | FAC015-I Have Diarrhea | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have diarrhea (diarrhoea). | FACT-HEP Version 4 - I Have Diarrhea | ||
FAC01533 | C130490 | FAC015-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have a good appetite. | FACT-HEP Version 4 - I Have a Good Appetite | ||
FAC01534 | C130491 | FAC015-Unhappy About Change in My Appear | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am unhappy about a change in my appearance. | FACT-HEP Version 4 - Unhappy About Change in My Appearance | ||
FAC01535 | C130492 | FAC015-I Have Pain in My Back | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have pain in my back. | FACT-HEP Version 4 - I Have Pain in My Back | ||
FAC01536 | C130493 | FAC015-I Am Bothered by Constipation | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am bothered by constipation. | FACT-HEP Version 4 - I Am Bothered by Constipation | ||
FAC01537 | C130494 | FAC015-I Feel Fatigued | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I feel fatigued. | FACT-HEP Version 4 - I Feel Fatigued | ||
FAC01538 | C130495 | FAC015-Able to Do My Usual Activities | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am able to do my usual activities. | FACT-HEP Version 4 - Able to Do My Usual Activities | ||
FAC01539 | C130496 | FAC015-Bothered by Jaundice/Yellow Skin | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am bothered by jaundice or yellow color to my skin. | FACT-HEP Version 4 - Bothered by Jaundice or Yellow Skin | ||
FAC01540 | C130497 | FAC015-I Have Had Fevers | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had fevers (episodes of high body temperature). | FACT-HEP Version 4 - I Have Had Fevers | ||
FAC01541 | C130498 | FAC015-I Have Had Itching | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had itching. | FACT-HEP Version 4 - I Have Had Itching | ||
FAC01542 | C130499 | FAC015-Had Change in the Way Food Tastes | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had a change in the way food tastes. | FACT-HEP Version 4 - Had Change in the Way Food Tastes | ||
FAC01543 | C130500 | FAC015-I Have Had Chills | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had chills. | FACT-HEP Version 4 - I Have Had Chills | ||
FAC01544 | C130501 | FAC015-My Mouth Is Dry | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: My mouth is dry. | FACT-HEP Version 4 - My Mouth Is Dry | ||
FAC01545 | C130502 | FAC015-Discomfort/Pain in Stomach Area | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have discomfort or pain in my stomach area. | FACT-HEP Version 4 - Discomfort or Pain in Stomach Area | ||
FAC01546 | C180210 | FAC015-Physical Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: Subscale score. | FACT-HEP Version 4 - Physical Subscale Score | ||
FAC01547 | C180211 | FAC015-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: Subscale score. | FACT-HEP Version 4 - Social/Family Subscale Score | ||
FAC01548 | C180212 | FAC015-Emotional Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: Subscale score. | FACT-HEP Version 4 - Emotional Subscale Score | ||
FAC01549 | C180213 | FAC015-Functional Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: Subscale score. | FACT-HEP Version 4 - Functional Subscale Score | ||
FAC01550 | C180214 | FAC015-Additional Concern Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: Subscale score. | FACT-HEP Version 4 - Additional Concern Subscale Score | ||
FAC01551 | C180215 | FAC015-Trial Outcome Index Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Trial outcome index score. | FACT-HEP Version 4 - Trial Outcome Index Score | ||
FAC01552 | C180216 | FAC015-FACT-G Total Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - FACT-G total score. | FACT-HEP Version 4 - FACT-G Total Score | ||
FAC01553 | C180217 | FAC015-Total Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Total score. | FACT-HEP Version 4 - Total Score | ||
Back to top | ||||||
CL.C130254.FAC015TN | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire Test Name
(FAC015TN) | text
Extensible: No | C130254 | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 test name. | CDISC Questionnaire FACT-HEP Version 4 Test Name Terminology |
FAC015-Able to Do My Usual Activities | C130495 | FAC015-Able to Do My Usual Activities | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am able to do my usual activities. | FACT-HEP Version 4 - Able to Do My Usual Activities | ||
FAC015-Additional Concern Subscale Score | C180214 | FAC015-Additional Concern Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: Subscale score. | FACT-HEP Version 4 - Additional Concern Subscale Score | ||
FAC015-Bothered by Jaundice/Yellow Skin | C130496 | FAC015-Bothered by Jaundice/Yellow Skin | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am bothered by jaundice or yellow color to my skin. | FACT-HEP Version 4 - Bothered by Jaundice or Yellow Skin | ||
FAC015-Bothered by Treatment Side Effect | C130462 | FAC015-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-HEP Version 4 - Bothered by Treatment Side Effect | ||
FAC015-Content With Quality of My Life | C130484 | FAC015-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-HEP Version 4 - Content With Quality of My Life | ||
FAC015-Discomfort/Pain in Stomach Area | C130502 | FAC015-Discomfort/Pain in Stomach Area | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have discomfort or pain in my stomach area. | FACT-HEP Version 4 - Discomfort or Pain in Stomach Area | ||
FAC015-Emotional Subscale Score | C180212 | FAC015-Emotional Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: Subscale score. | FACT-HEP Version 4 - Emotional Subscale Score | ||
FAC015-Enjoy Things I Usually Do for Fun | C130483 | FAC015-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-HEP Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC015-FACT-G Total Score | C180216 | FAC015-FACT-G Total Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - FACT-G total score. | FACT-HEP Version 4 - FACT-G Total Score | ||
FAC015-Functional Subscale Score | C180213 | FAC015-Functional Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: Subscale score. | FACT-HEP Version 4 - Functional Subscale Score | ||
FAC015-Get Emotional Support From Family | C130466 | FAC015-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-HEP Version 4 - Get Emotional Support From Family | ||
FAC015-Had Change in the Way Food Tastes | C130499 | FAC015-Had Change in the Way Food Tastes | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had a change in the way food tastes. | FACT-HEP Version 4 - Had Change in the Way Food Tastes | ||
FAC015-I Am Able to Enjoy Life | C130480 | FAC015-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-HEP Version 4 - I Am Able to Enjoy Life | ||
FAC015-I Am Able to Work | C130478 | FAC015-I Am Able to Work | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-HEP Version 4 - I Am Able to Work | ||
FAC015-I Am Bothered by Constipation | C130493 | FAC015-I Am Bothered by Constipation | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am bothered by constipation. | FACT-HEP Version 4 - I Am Bothered by Constipation | ||
FAC015-I Am Forced to Spend Time in Bed | C130464 | FAC015-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-HEP Version 4 - I Am Forced to Spend Time in Bed | ||
FAC015-I Am Losing Weight | C130486 | FAC015-I Am Losing Weight | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am losing weight. | FACT-HEP Version 4 - I Am Losing Weight | ||
FAC015-I Am Satisfied With My Sex Life | C130471 | FAC015-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-HEP Version 4 - I Am Satisfied With My Sex Life | ||
FAC015-I Am Sleeping Well | C130482 | FAC015-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I am sleeping well. | FACT-HEP Version 4 - I Am Sleeping Well | ||
FAC015-I Can Digest My Food Well | C130488 | FAC015-I Can Digest My Food Well | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I can digest my food well. | FACT-HEP Version 4 - I Can Digest My Food Well | ||
FAC015-I Feel Close to My Friends | C130465 | FAC015-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-HEP Version 4 - I Feel Close to My Friends | ||
FAC015-I Feel Close to My Partner | C130470 | FAC015-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-HEP Version 4 - I Feel Close to My Partner | ||
FAC015-I Feel Fatigued | C130494 | FAC015-I Feel Fatigued | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I feel fatigued. | FACT-HEP Version 4 - I Feel Fatigued | ||
FAC015-I Feel Ill | C130463 | FAC015-I Feel Ill | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I feel ill. | FACT-HEP Version 4 - I Feel Ill | ||
FAC015-I Feel Nervous | C130475 | FAC015-I Feel Nervous | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I feel nervous. | FACT-HEP Version 4 - I Feel Nervous | ||
FAC015-I Feel Sad | C130472 | FAC015-I Feel Sad | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I feel sad. | FACT-HEP Version 4 - I Feel Sad | ||
FAC015-I Get Support From My Friends | C130467 | FAC015-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-HEP Version 4 - I Get Support From My Friends | ||
FAC015-I Have a Good Appetite | C130490 | FAC015-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have a good appetite. | FACT-HEP Version 4 - I Have a Good Appetite | ||
FAC015-I Have a Lack of Energy | C130458 | FAC015-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have a lack of energy. | FACT-HEP Version 4 - I Have a Lack of Energy | ||
FAC015-I Have Accepted My Illness | C130481 | FAC015-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: I have accepted my illness. | FACT-HEP Version 4 - I Have Accepted My Illness | ||
FAC015-I Have Control of My Bowels | C130487 | FAC015-I Have Control of My Bowels | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have control of my bowels. | FACT-HEP Version 4 - I Have Control of My Bowels | ||
FAC015-I Have Diarrhea | C130489 | FAC015-I Have Diarrhea | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have diarrhea (diarrhoea). | FACT-HEP Version 4 - I Have Diarrhea | ||
FAC015-I Have Had Chills | C130500 | FAC015-I Have Had Chills | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had chills. | FACT-HEP Version 4 - I Have Had Chills | ||
FAC015-I Have Had Fevers | C130497 | FAC015-I Have Had Fevers | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had fevers (episodes of high body temperature). | FACT-HEP Version 4 - I Have Had Fevers | ||
FAC015-I Have Had Itching | C130498 | FAC015-I Have Had Itching | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have had itching. | FACT-HEP Version 4 - I Have Had Itching | ||
FAC015-I Have Nausea | C130459 | FAC015-I Have Nausea | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have nausea. | FACT-HEP Version 4 - I Have Nausea | ||
FAC015-I Have Pain in My Back | C130492 | FAC015-I Have Pain in My Back | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have pain in my back. | FACT-HEP Version 4 - I Have Pain in My Back | ||
FAC015-I Have Pain | C130461 | FAC015-I Have Pain | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: I have pain. | FACT-HEP Version 4 - I Have Pain | ||
FAC015-I Worry About Dying | C130476 | FAC015-I Worry About Dying | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I worry about dying. | FACT-HEP Version 4 - I Worry About Dying | ||
FAC015-Losing Hope Against Illness | C130474 | FAC015-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-HEP Version 4 - Losing Hope Against Illness | ||
FAC015-My Family Has Accepted My Illness | C130468 | FAC015-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-HEP Version 4 - My Family Has Accepted My Illness | ||
FAC015-My Mouth Is Dry | C130501 | FAC015-My Mouth Is Dry | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: My mouth is dry. | FACT-HEP Version 4 - My Mouth Is Dry | ||
FAC015-My Work Is Fulfilling | C130479 | FAC015-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-HEP Version 4 - My Work Is Fulfilling | ||
FAC015-Physical Subscale Score | C180210 | FAC015-Physical Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: Subscale score. | FACT-HEP Version 4 - Physical Subscale Score | ||
FAC015-Satisfied Communication Illness | C130469 | FAC015-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-HEP Version 4 - Satisfied With Communication About Illness | ||
FAC015-Satisfied With How I Am Coping | C130473 | FAC015-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-HEP Version 4 - Satisfied With How I Am Coping | ||
FAC015-Social/Family Subscale Score | C180211 | FAC015-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Social/Family Well-Being: Subscale score. | FACT-HEP Version 4 - Social/Family Subscale Score | ||
FAC015-Swelling/Cramps in Stomach Area | C130485 | FAC015-Swelling/Cramps in Stomach Area | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I have swelling or cramps in my stomach area. | FACT-HEP Version 4 - Swelling or Cramps in Stomach Area | ||
FAC015-Total Score | C180217 | FAC015-Total Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Total score. | FACT-HEP Version 4 - Total Score | ||
FAC015-Trial Outcome Index Score | C180215 | FAC015-Trial Outcome Index Score | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Trial outcome index score. | FACT-HEP Version 4 - Trial Outcome Index Score | ||
FAC015-Trouble Meeting Needs of Family | C130460 | FAC015-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-HEP Version 4 - Trouble Meeting Needs of Family | ||
FAC015-Unhappy About Change in My Appear | C130491 | FAC015-Unhappy About Change in My Appear | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Additional Concerns: I am unhappy about a change in my appearance. | FACT-HEP Version 4 - Unhappy About Change in My Appearance | ||
FAC015-Worry My Condition Will Get Worse | C130477 | FAC015-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Hepatobiliary Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-HEP Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C138223.FAC039TC | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 Questionnaire Test Code
(FAC039TC) | text
Extensible: No | C138223 | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 test code. | CDISC Questionnaire FKSI-15 Test Code Terminology |
FAC03901 | C138444 | FAC039-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have a lack of energy. | FKSI-15 - I Have a Lack of Energy | ||
FAC03902 | C138445 | FAC039-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am bothered by side effects of treatment. | FKSI-15 - Bothered by Treatment Side Effect | ||
FAC03903 | C138446 | FAC039-I Have Pain | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have pain. | FKSI-15 - I Have Pain | ||
FAC03904 | C138447 | FAC039-I Am Losing Weight | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am losing weight. | FKSI-15 - I Am Losing Weight | ||
FAC03905 | C138448 | FAC039-I Have Bone Pain | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have bone pain. | FKSI-15 - I Have Bone Pain | ||
FAC03906 | C138449 | FAC039-I Feel Fatigued | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I feel fatigued. | FKSI-15 - I Feel Fatigued | ||
FAC03907 | C138450 | FAC039-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am able to enjoy life. | FKSI-15 - I Am Able to Enjoy Life | ||
FAC03908 | C138451 | FAC039-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have been short of breath. | FKSI-15 - I Have Been Short of Breath | ||
FAC03909 | C138452 | FAC039-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I worry that my condition will get worse. | FKSI-15 - Worry My Condition Will Get Worse | ||
FAC03910 | C138453 | FAC039-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have a good appetite. | FKSI-15 - I Have a Good Appetite | ||
FAC03911 | C138454 | FAC039-I Have Been Coughing | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have been coughing. | FKSI-15 - I Have Been Coughing | ||
FAC03912 | C138455 | FAC039-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am bothered by fevers (episodes of high body temperature). | FKSI-15 - I Am Bothered by Fevers | ||
FAC03913 | C138456 | FAC039-I Am Able to Work | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am able to work (include work at home). | FKSI-15 - I Am Able to Work | ||
FAC03914 | C138457 | FAC039-I Have Had Blood in My Urine | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have had blood in my urine. | FKSI-15 - I Have Had Blood in My Urine | ||
FAC03915 | C138458 | FAC039-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am sleeping well. | FKSI-15 - I Am Sleeping Well | ||
Back to top | ||||||
CL.C138222.FAC039TN | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 Questionnaire Test Name
(FAC039TN) | text
Extensible: No | C138222 | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 test name. | CDISC Questionnaire FKSI-15 Test Name Terminology |
FAC039-Bothered by Treatment Side Effect | C138445 | FAC039-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am bothered by side effects of treatment. | FKSI-15 - Bothered by Treatment Side Effect | ||
FAC039-I Am Able to Enjoy Life | C138450 | FAC039-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am able to enjoy life. | FKSI-15 - I Am Able to Enjoy Life | ||
FAC039-I Am Able to Work | C138456 | FAC039-I Am Able to Work | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am able to work (include work at home). | FKSI-15 - I Am Able to Work | ||
FAC039-I Am Bothered by Fevers | C138455 | FAC039-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am bothered by fevers (episodes of high body temperature). | FKSI-15 - I Am Bothered by Fevers | ||
FAC039-I Am Losing Weight | C138447 | FAC039-I Am Losing Weight | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am losing weight. | FKSI-15 - I Am Losing Weight | ||
FAC039-I Am Sleeping Well | C138458 | FAC039-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I am sleeping well. | FKSI-15 - I Am Sleeping Well | ||
FAC039-I Feel Fatigued | C138449 | FAC039-I Feel Fatigued | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I feel fatigued. | FKSI-15 - I Feel Fatigued | ||
FAC039-I Have a Good Appetite | C138453 | FAC039-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have a good appetite. | FKSI-15 - I Have a Good Appetite | ||
FAC039-I Have a Lack of Energy | C138444 | FAC039-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have a lack of energy. | FKSI-15 - I Have a Lack of Energy | ||
FAC039-I Have Been Coughing | C138454 | FAC039-I Have Been Coughing | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have been coughing. | FKSI-15 - I Have Been Coughing | ||
FAC039-I Have Been Short of Breath | C138451 | FAC039-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have been short of breath. | FKSI-15 - I Have Been Short of Breath | ||
FAC039-I Have Bone Pain | C138448 | FAC039-I Have Bone Pain | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have bone pain. | FKSI-15 - I Have Bone Pain | ||
FAC039-I Have Had Blood in My Urine | C138457 | FAC039-I Have Had Blood in My Urine | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have had blood in my urine. | FKSI-15 - I Have Had Blood in My Urine | ||
FAC039-I Have Pain | C138446 | FAC039-I Have Pain | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I have pain. | FKSI-15 - I Have Pain | ||
FAC039-Worry My Condition Will Get Worse | C138452 | FAC039-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Kidney Symptom Index-15 - I worry that my condition will get worse. | FKSI-15 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C150784.FAC041TC | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire Test Code
(FAC041TC) | text
Extensible: No | C150784 | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 test code. | CDISC Questionnaire FKSI-DRS Version 4 Test Code Terminology |
FAC04101 | C151271 | FAC041-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have a lack of energy. | FKSI-DRS Version 4 - I Have a Lack of Energy | ||
FAC04102 | C151272 | FAC041-I Have Pain | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have pain. | FKSI-DRS Version 4 - I Have Pain | ||
FAC04103 | C151273 | FAC041-I Am Losing Weight | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I am losing weight. | FKSI-DRS Version 4 - I Am Losing Weight | ||
FAC04104 | C151274 | FAC041-I Have Bone Pain | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have bone pain. | FKSI-DRS Version 4 - I Have Bone Pain | ||
FAC04105 | C151275 | FAC041-I Feel Fatigued | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I feel fatigued. | FKSI-DRS Version 4 - I Feel Fatigued | ||
FAC04106 | C151276 | FAC041-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have been short of breath. | FKSI-DRS Version 4 - I Have Been Short of Breath | ||
FAC04107 | C151277 | FAC041-I Have Been Coughing | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have been coughing. | FKSI-DRS Version 4 - I Have Been Coughing | ||
FAC04108 | C151278 | FAC041-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I am bothered by fevers (episodes of high body temperature). | FKSI-DRS Version 4 - I Am Bothered by Fevers | ||
FAC04109 | C151279 | FAC041-I Have Had Blood in My Urine | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have had blood in my urine. | FKSI-DRS Version 4 - I Have Had Blood in My Urine | ||
Back to top | ||||||
CL.C150783.FAC041TN | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire Test Name
(FAC041TN) | text
Extensible: No | C150783 | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 test name. | CDISC Questionnaire FKSI-DRS Version 4 Test Name Terminology |
FAC041-I Am Bothered by Fevers | C151278 | FAC041-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I am bothered by fevers (episodes of high body temperature). | FKSI-DRS Version 4 - I Am Bothered by Fevers | ||
FAC041-I Am Losing Weight | C151273 | FAC041-I Am Losing Weight | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I am losing weight. | FKSI-DRS Version 4 - I Am Losing Weight | ||
FAC041-I Feel Fatigued | C151275 | FAC041-I Feel Fatigued | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I feel fatigued. | FKSI-DRS Version 4 - I Feel Fatigued | ||
FAC041-I Have a Lack of Energy | C151271 | FAC041-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have a lack of energy. | FKSI-DRS Version 4 - I Have a Lack of Energy | ||
FAC041-I Have Been Coughing | C151277 | FAC041-I Have Been Coughing | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have been coughing. | FKSI-DRS Version 4 - I Have Been Coughing | ||
FAC041-I Have Been Short of Breath | C151276 | FAC041-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have been short of breath. | FKSI-DRS Version 4 - I Have Been Short of Breath | ||
FAC041-I Have Bone Pain | C151274 | FAC041-I Have Bone Pain | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have bone pain. | FKSI-DRS Version 4 - I Have Bone Pain | ||
FAC041-I Have Had Blood in My Urine | C151279 | FAC041-I Have Had Blood in My Urine | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have had blood in my urine. | FKSI-DRS Version 4 - I Have Had Blood in My Urine | ||
FAC041-I Have Pain | C151272 | FAC041-I Have Pain | Functional Assessment of Cancer Therapy-Kidney Symptom Index-Disease-Related Symptoms Version 4 - I have pain. | FKSI-DRS Version 4 - I Have Pain | ||
Back to top | ||||||
CL.C130253.FAC017TC | Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire Test Code
(FAC017TC) | text
Extensible: No | C130253 | Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Leukemia Version 4 test code. | CDISC Questionnaire FACT-LEU Version 4 Test Code Terminology |
FAC01701 | C130414 | FAC017-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have a lack of energy. | FACT-LEU Version 4 - I Have a Lack of Energy | ||
FAC01702 | C130415 | FAC017-I Have Nausea | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have nausea. | FACT-LEU Version 4 - I Have Nausea | ||
FAC01703 | C130416 | FAC017-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-LEU Version 4 - Trouble Meeting Needs of Family | ||
FAC01704 | C130417 | FAC017-I Have Pain | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have pain. | FACT-LEU Version 4 - I Have Pain | ||
FAC01705 | C130418 | FAC017-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-LEU Version 4 - Bothered by Treatment Side Effect | ||
FAC01706 | C130419 | FAC017-I Feel Ill | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I feel ill. | FACT-LEU Version 4 - I Feel Ill | ||
FAC01707 | C130420 | FAC017-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-LEU Version 4 - I Am Forced to Spend Time in Bed | ||
FAC01708 | C130421 | FAC017-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-LEU Version 4 - I Feel Close to My Friends | ||
FAC01709 | C130422 | FAC017-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-LEU Version 4 - Get Emotional Support From Family | ||
FAC01710 | C130423 | FAC017-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-LEU Version 4 - I Get Support From My Friends | ||
FAC01711 | C130424 | FAC017-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-LEU Version 4 - My Family Has Accepted My Illness | ||
FAC01712 | C130425 | FAC017-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-LEU Version 4 - Satisfied Communication Illness | ||
FAC01713 | C130426 | FAC017-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-LEU Version 4 - I Feel Close to My Partner | ||
FAC01714 | C130427 | FAC017-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-LEU Version 4 - I Am Satisfied With My Sex Life | ||
FAC01715 | C130428 | FAC017-I Feel Sad | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I feel sad. | FACT-LEU Version 4 - I Feel Sad | ||
FAC01716 | C130429 | FAC017-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-LEU Version 4 - Satisfied With How I Am Coping | ||
FAC01717 | C130430 | FAC017-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-LEU Version 4 - Losing Hope Against Illness | ||
FAC01718 | C130431 | FAC017-I Feel Nervous | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I feel nervous. | FACT-LEU Version 4 - I Feel Nervous | ||
FAC01719 | C130432 | FAC017-I Worry About Dying | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I worry about dying. | FACT-LEU Version 4 - I Worry About Dying | ||
FAC01720 | C130433 | FAC017-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-LEU Version 4 - Worry My Condition Will Get Worse | ||
FAC01721 | C130434 | FAC017-I Am Able to Work | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-LEU Version 4 - I Am Able to Work | ||
FAC01722 | C130435 | FAC017-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-LEU Version 4 - My Work Is Fulfilling | ||
FAC01723 | C130436 | FAC017-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-LEU Version 4 - I Am Able to Enjoy Life | ||
FAC01724 | C130437 | FAC017-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I have accepted my illness. | FACT-LEU Version 4 - I Have Accepted My Illness | ||
FAC01725 | C130438 | FAC017-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am sleeping well. | FACT-LEU Version 4 - I Am Sleeping Well | ||
FAC01726 | C130439 | FAC017-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-LEU Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC01727 | C130440 | FAC017-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-LEU Version 4 - Content With Quality of My Life | ||
FAC01728 | C130441 | FAC017-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by fevers (episodes of high body temperature). | FACT-LEU Version 4 - I Am Bothered by Fevers | ||
FAC01729 | C130442 | FAC017-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. | FACT-LEU Version 4 - Certain Parts of Body Have Pain | ||
FAC01730 | C130443 | FAC017-I Am Bothered by the Chills | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by the chills. | FACT-LEU Version 4 - I Am Bothered by the Chills | ||
FAC01731 | C130444 | FAC017-I Have Night Sweats | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have night sweats. | FACT-LEU Version 4 - I Have Night Sweats | ||
FAC01732 | C130445 | FAC017-Bothered by Lumps or Swelling | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). | FACT-LEU Version 4 - Bothered by Lumps or Swelling | ||
FAC01733 | C130446 | FAC017-I Bleed Easily | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I bleed easily. | FACT-LEU Version 4 - I Bleed Easily | ||
FAC01734 | C130447 | FAC017-I Bruise Easily | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I bruise easily. | FACT-LEU Version 4 - I Bruise Easily | ||
FAC01735 | C130448 | FAC017-I Feel Weak All Over | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel weak all over. | FACT-LEU Version 4 - I Feel Weak All Over | ||
FAC01736 | C130449 | FAC017-I Get Tired Easily | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I get tired easily. | FACT-LEU Version 4 - I Get Tired Easily | ||
FAC01737 | C130450 | FAC017-I Am Losing Weight | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am losing weight. | FACT-LEU Version 4 - I Am Losing Weight | ||
FAC01738 | C130451 | FAC017-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have a good appetite. | FACT-LEU Version 4 - I Have a Good Appetite | ||
FAC01739 | C130452 | FAC017-Able to Do My Usual Activities | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am able to do my usual activities. | FACT-LEU Version 4 - Able to Do My Usual Activities | ||
FAC01740 | C130453 | FAC017-I Worry About Getting Infections | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I worry about getting infections. | FACT-LEU Version 4 - I Worry About Getting Infections | ||
FAC01741 | C130454 | FAC017-Uncertain About My Future Health | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel uncertain about my future health. | FACT-LEU Version 4 - Uncertain About My Future Health | ||
FAC01742 | C130455 | FAC017-Worry I Might Get New Symptoms | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I worry that I might get new symptoms of my illness. | FACT-LEU Version 4 - Worry I Might Get New Symptoms | ||
FAC01743 | C130456 | FAC017-I Have Emotional Ups and Downs | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have emotional ups and downs. | FACT-LEU Version 4 - I Have Emotional Ups and Downs | ||
FAC01744 | C130457 | FAC017-Feel Isolated Because of Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel isolated from others because of my illness or treatment. | FACT-LEU Version 4 - Feel Isolated Because of Illness | ||
Back to top | ||||||
CL.C130252.FAC017TN | Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire Test Name
(FAC017TN) | text
Extensible: No | C130252 | Functional Assessment of Cancer Therapy-Leukemia Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Leukemia Version 4 test name. | CDISC Questionnaire FACT-LEU Version 4 Test Name Terminology |
FAC017-Able to Do My Usual Activities | C130452 | FAC017-Able to Do My Usual Activities | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am able to do my usual activities. | FACT-LEU Version 4 - Able to Do My Usual Activities | ||
FAC017-Bothered by Lumps or Swelling | C130445 | FAC017-Bothered by Lumps or Swelling | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). | FACT-LEU Version 4 - Bothered by Lumps or Swelling | ||
FAC017-Bothered by Treatment Side Effect | C130418 | FAC017-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-LEU Version 4 - Bothered by Treatment Side Effect | ||
FAC017-Certain Parts of Body Have Pain | C130442 | FAC017-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. | FACT-LEU Version 4 - Certain Parts of Body Have Pain | ||
FAC017-Content With Quality of My Life | C130440 | FAC017-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-LEU Version 4 - Content With Quality of My Life | ||
FAC017-Enjoy Things I Usually Do for Fun | C130439 | FAC017-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-LEU Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC017-Feel Isolated Because of Illness | C130457 | FAC017-Feel Isolated Because of Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel isolated from others because of my illness or treatment. | FACT-LEU Version 4 - Feel Isolated Because of Illness | ||
FAC017-Get Emotional Support From Family | C130422 | FAC017-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-LEU Version 4 - Get Emotional Support From Family | ||
FAC017-I Am Able to Enjoy Life | C130436 | FAC017-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-LEU Version 4 - I Am Able to Enjoy Life | ||
FAC017-I Am Able to Work | C130434 | FAC017-I Am Able to Work | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-LEU Version 4 - I Am Able to Work | ||
FAC017-I Am Bothered by Fevers | C130441 | FAC017-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by fevers (episodes of high body temperature). | FACT-LEU Version 4 - I Am Bothered by Fevers | ||
FAC017-I Am Bothered by the Chills | C130443 | FAC017-I Am Bothered by the Chills | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am bothered by the chills. | FACT-LEU Version 4 - I Am Bothered by the Chills | ||
FAC017-I Am Forced to Spend Time in Bed | C130420 | FAC017-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-LEU Version 4 - I Am Forced to Spend Time in Bed | ||
FAC017-I Am Losing Weight | C130450 | FAC017-I Am Losing Weight | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I am losing weight. | FACT-LEU Version 4 - I Am Losing Weight | ||
FAC017-I Am Satisfied With My Sex Life | C130427 | FAC017-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-LEU Version 4 - I Am Satisfied With My Sex Life | ||
FAC017-I Am Sleeping Well | C130438 | FAC017-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I am sleeping well. | FACT-LEU Version 4 - I Am Sleeping Well | ||
FAC017-I Bleed Easily | C130446 | FAC017-I Bleed Easily | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I bleed easily. | FACT-LEU Version 4 - I Bleed Easily | ||
FAC017-I Bruise Easily | C130447 | FAC017-I Bruise Easily | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I bruise easily. | FACT-LEU Version 4 - I Bruise Easily | ||
FAC017-I Feel Close to My Friends | C130421 | FAC017-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-LEU Version 4 - I Feel Close to My Friends | ||
FAC017-I Feel Close to My Partner | C130426 | FAC017-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-LEU Version 4 - I Feel Close to My Partner | ||
FAC017-I Feel Ill | C130419 | FAC017-I Feel Ill | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I feel ill. | FACT-LEU Version 4 - I Feel Ill | ||
FAC017-I Feel Nervous | C130431 | FAC017-I Feel Nervous | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I feel nervous. | FACT-LEU Version 4 - I Feel Nervous | ||
FAC017-I Feel Sad | C130428 | FAC017-I Feel Sad | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I feel sad. | FACT-LEU Version 4 - I Feel Sad | ||
FAC017-I Feel Weak All Over | C130448 | FAC017-I Feel Weak All Over | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel weak all over. | FACT-LEU Version 4 - I Feel Weak All Over | ||
FAC017-I Get Support From My Friends | C130423 | FAC017-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-LEU Version 4 - I Get Support From My Friends | ||
FAC017-I Get Tired Easily | C130449 | FAC017-I Get Tired Easily | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I get tired easily. | FACT-LEU Version 4 - I Get Tired Easily | ||
FAC017-I Have a Good Appetite | C130451 | FAC017-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have a good appetite. | FACT-LEU Version 4 - I Have a Good Appetite | ||
FAC017-I Have a Lack of Energy | C130414 | FAC017-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have a lack of energy. | FACT-LEU Version 4 - I Have a Lack of Energy | ||
FAC017-I Have Accepted My Illness | C130437 | FAC017-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: I have accepted my illness. | FACT-LEU Version 4 - I Have Accepted My Illness | ||
FAC017-I Have Emotional Ups and Downs | C130456 | FAC017-I Have Emotional Ups and Downs | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have emotional ups and downs. | FACT-LEU Version 4 - I Have Emotional Ups and Downs | ||
FAC017-I Have Nausea | C130415 | FAC017-I Have Nausea | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have nausea. | FACT-LEU Version 4 - I Have Nausea | ||
FAC017-I Have Night Sweats | C130444 | FAC017-I Have Night Sweats | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I have night sweats. | FACT-LEU Version 4 - I Have Night Sweats | ||
FAC017-I Have Pain | C130417 | FAC017-I Have Pain | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: I have pain. | FACT-LEU Version 4 - I Have Pain | ||
FAC017-I Worry About Dying | C130432 | FAC017-I Worry About Dying | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I worry about dying. | FACT-LEU Version 4 - I Worry About Dying | ||
FAC017-I Worry About Getting Infections | C130453 | FAC017-I Worry About Getting Infections | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I worry about getting infections. | FACT-LEU Version 4 - I Worry About Getting Infections | ||
FAC017-Losing Hope Against Illness | C130430 | FAC017-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-LEU Version 4 - Losing Hope Against Illness | ||
FAC017-My Family Has Accepted My Illness | C130424 | FAC017-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-LEU Version 4 - My Family Has Accepted My Illness | ||
FAC017-My Work Is Fulfilling | C130435 | FAC017-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-LEU Version 4 - My Work Is Fulfilling | ||
FAC017-Satisfied Communication Illness | C130425 | FAC017-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-LEU Version 4 - Satisfied Communication Illness | ||
FAC017-Satisfied With How I Am Coping | C130429 | FAC017-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-LEU Version 4 - Satisfied With How I Am Coping | ||
FAC017-Trouble Meeting Needs of Family | C130416 | FAC017-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-LEU Version 4 - Trouble Meeting Needs of Family | ||
FAC017-Uncertain About My Future Health | C130454 | FAC017-Uncertain About My Future Health | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I feel uncertain about my future health. | FACT-LEU Version 4 - Uncertain About My Future Health | ||
FAC017-Worry I Might Get New Symptoms | C130455 | FAC017-Worry I Might Get New Symptoms | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Additional Concerns: I worry that I might get new symptoms of my illness. | FACT-LEU Version 4 - Worry I Might Get New Symptoms | ||
FAC017-Worry My Condition Will Get Worse | C130433 | FAC017-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Leukemia Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-LEU Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C138225.FAC043TC | Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire Test Code
(FAC043TC) | text
Extensible: No | C138225 | Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire Test Code | Functional Assessment of Cancer Therapy-Lung Symptom Index test code. | CDISC Questionnaire FLSI Test Code Terminology |
FAC04301 | C138459 | FAC043-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have been short of breath. | FLSI - I Have Been Short of Breath | ||
FAC04302 | C138460 | FAC043-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have a lack of energy. | FLSI - I Have a Lack of Energy | ||
FAC04303 | C138461 | FAC043-I Have Pain | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have pain. | FLSI - I Have Pain | ||
FAC04304 | C138462 | FAC043-I Am Losing Weight | Functional Assessment of Cancer Therapy-Lung Symptom Index - I am losing weight. | FLSI - I Am Losing Weight | ||
FAC04305 | C138463 | FAC043-I Have Been Coughing | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have been coughing. | FLSI - I Have Been Coughing | ||
FAC04306 | C138464 | FAC043-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have certain parts of my body where I experience pain. | FLSI - Certain Parts of Body Have Pain | ||
Back to top | ||||||
CL.C138224.FAC043TN | Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire Test Name
(FAC043TN) | text
Extensible: No | C138224 | Functional Assessment of Cancer Therapy-Lung Symptom Index Questionnaire Test Name | Functional Assessment of Cancer Therapy-Lung Symptom Index test name. | CDISC Questionnaire FLSI Test Name Terminology |
FAC043-Certain Parts of Body Have Pain | C138464 | FAC043-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have certain parts of my body where I experience pain. | FLSI - Certain Parts of Body Have Pain | ||
FAC043-I Am Losing Weight | C138462 | FAC043-I Am Losing Weight | Functional Assessment of Cancer Therapy-Lung Symptom Index - I am losing weight. | FLSI - I Am Losing Weight | ||
FAC043-I Have a Lack of Energy | C138460 | FAC043-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have a lack of energy. | FLSI - I Have a Lack of Energy | ||
FAC043-I Have Been Coughing | C138463 | FAC043-I Have Been Coughing | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have been coughing. | FLSI - I Have Been Coughing | ||
FAC043-I Have Been Short of Breath | C138459 | FAC043-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have been short of breath. | FLSI - I Have Been Short of Breath | ||
FAC043-I Have Pain | C138461 | FAC043-I Have Pain | Functional Assessment of Cancer Therapy-Lung Symptom Index - I have pain. | FLSI - I Have Pain | ||
Back to top | ||||||
CL.C150782.FAC016TC | Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire Test Code
(FAC016TC) | text
Extensible: No | C150782 | Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Lung Version 4 test code. | CDISC Questionnaire FACT-L Version 4 Test Code Terminology |
FAC01601 | C151234 | FAC016-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have a lack of energy. | FACT-L Version 4 - I Have a Lack of Energy | ||
FAC01602 | C151235 | FAC016-I Have Nausea | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have nausea. | FACT-L Version 4 - I Have Nausea | ||
FAC01603 | C151236 | FAC016-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-L Version 4 - Trouble Meeting Needs of Family | ||
FAC01604 | C151237 | FAC016-I Have Pain | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have pain. | FACT-L Version 4 - I Have Pain | ||
FAC01605 | C151238 | FAC016-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-L Version 4 - Bothered by Treatment Side Effect | ||
FAC01606 | C151239 | FAC016-I Feel Ill | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I feel ill. | FACT-L Version 4 - I Feel Ill | ||
FAC01607 | C151240 | FAC016-I am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-L Version 4 - I am Forced to Spend Time in Bed | ||
FAC01608 | C151241 | FAC016-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-L Version 4 - I Feel Close to My Friends | ||
FAC01609 | C151242 | FAC016-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-L Version 4 - Get Emotional Support From Family | ||
FAC01610 | C151243 | FAC016-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-L Version 4 - I Get Support From My Friends | ||
FAC01611 | C151244 | FAC016-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-L Version 4 - My Family Has Accepted My Illness | ||
FAC01612 | C151245 | FAC016-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-L Version 4 - Satisfied Communication Illness | ||
FAC01613 | C151246 | FAC016-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-L Version 4 - I Feel Close to My Partner | ||
FAC01614 | C151247 | FAC016-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-L Version 4 - I Am Satisfied With My Sex Life | ||
FAC01615 | C151248 | FAC016-I Feel Sad | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I feel sad. | FACT-L Version 4 - I Feel Sad | ||
FAC01616 | C151249 | FAC016-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-L Version 4 - Satisfied With How I Am Coping | ||
FAC01617 | C151250 | FAC016-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-L Version 4 - Losing Hope Against Illness | ||
FAC01618 | C151251 | FAC016-I Feel Nervous | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I feel nervous. | FACT-L Version 4 - I Feel Nervous | ||
FAC01619 | C151252 | FAC016-I Worry About Dying | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I worry about dying. | FACT-L Version 4 - I Worry About Dying | ||
FAC01620 | C151253 | FAC016-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-L Version 4 - Worry My Condition Will Get Worse | ||
FAC01621 | C151254 | FAC016-I Am Able to Work | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-L Version 4 - I Am Able to Work | ||
FAC01622 | C151255 | FAC016-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-L Version 4 - My Work Is Fulfilling | ||
FAC01623 | C151256 | FAC016-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-L Version 4 - I Am Able to Enjoy Life | ||
FAC01624 | C151257 | FAC016-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I have accepted my illness. | FACT-L Version 4 - I Have Accepted My Illness | ||
FAC01625 | C151258 | FAC016-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am sleeping well. | FACT-L Version 4 - I Am Sleeping Well | ||
FAC01626 | C151259 | FAC016-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-L Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC01627 | C151260 | FAC016-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-L Version 4 - Content With Quality of My Life | ||
FAC01628 | C151261 | FAC016-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have been short of breath. | FACT-L Version 4 - I Have Been Short of Breath | ||
FAC01629 | C151262 | FAC016-I Am Losing Weight | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I am losing weight. | FACT-L Version 4 - I Am Losing Weight | ||
FAC01630 | C151263 | FAC016-My Thinking Is Clear | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: My thinking is clear. | FACT-L Version 4 - My Thinking Is Clear | ||
FAC01631 | C151264 | FAC016-I Have Been Coughing | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have been coughing. | FACT-L Version 4 - I Have Been Coughing | ||
FAC01632 | C151265 | FAC016-I Am Bothered by Hair Loss | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I am bothered by hair loss. | FACT-L Version 4 - I Am Bothered by Hair Loss | ||
FAC01633 | C151266 | FAC016-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have a good appetite. | FACT-L Version 4 - I Have a Good Appetite | ||
FAC01634 | C151267 | FAC016-I Feel Tightness in My Chest | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I feel tightness in my chest. | FACT-L Version 4 - I Feel Tightness in My Chest | ||
FAC01635 | C151268 | FAC016-Breathing Is Easy for Me | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: Breathing is easy for me. | FACT-L Version 4 - Breathing Is Easy for Me | ||
FAC01636 | C151269 | FAC016-Have You Ever Smoked | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: Have you ever smoked? | FACT-L Version 4 - Have You Ever Smoked | ||
FAC01637 | C151270 | FAC016-I Regret My Smoking | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I regret my smoking. | FACT-L Version 4 - I Regret My Smoking | ||
Back to top | ||||||
CL.C150781.FAC016TN | Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire Test Name
(FAC016TN) | text
Extensible: No | C150781 | Functional Assessment of Cancer Therapy-Lung Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Lung Version 4 test name. | CDISC Questionnaire FACT-L Version 4 Test Name Terminology |
FAC016-Bothered by Treatment Side Effect | C151238 | FAC016-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-L Version 4 - Bothered by Treatment Side Effect | ||
FAC016-Breathing Is Easy for Me | C151268 | FAC016-Breathing Is Easy for Me | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: Breathing is easy for me. | FACT-L Version 4 - Breathing Is Easy for Me | ||
FAC016-Content With Quality of My Life | C151260 | FAC016-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-L Version 4 - Content With Quality of My Life | ||
FAC016-Enjoy Things I Usually Do for Fun | C151259 | FAC016-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-L Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC016-Get Emotional Support From Family | C151242 | FAC016-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-L Version 4 - Get Emotional Support From Family | ||
FAC016-Have You Ever Smoked | C151269 | FAC016-Have You Ever Smoked | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: Have you ever smoked? | FACT-L Version 4 - Have You Ever Smoked | ||
FAC016-I Am Able to Enjoy Life | C151256 | FAC016-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-L Version 4 - I Am Able to Enjoy Life | ||
FAC016-I Am Able to Work | C151254 | FAC016-I Am Able to Work | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-L Version 4 - I Am Able to Work | ||
FAC016-I Am Bothered by Hair Loss | C151265 | FAC016-I Am Bothered by Hair Loss | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I am bothered by hair loss. | FACT-L Version 4 - I Am Bothered by Hair Loss | ||
FAC016-I am Forced to Spend Time in Bed | C151240 | FAC016-I am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-L Version 4 - I am Forced to Spend Time in Bed | ||
FAC016-I Am Losing Weight | C151262 | FAC016-I Am Losing Weight | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I am losing weight. | FACT-L Version 4 - I Am Losing Weight | ||
FAC016-I Am Satisfied With My Sex Life | C151247 | FAC016-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-L Version 4 - I Am Satisfied With My Sex Life | ||
FAC016-I Am Sleeping Well | C151258 | FAC016-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I am sleeping well. | FACT-L Version 4 - I Am Sleeping Well | ||
FAC016-I Feel Close to My Friends | C151241 | FAC016-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-L Version 4 - I Feel Close to My Friends | ||
FAC016-I Feel Close to My Partner | C151246 | FAC016-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-L Version 4 - I Feel Close to My Partner | ||
FAC016-I Feel Ill | C151239 | FAC016-I Feel Ill | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I feel ill. | FACT-L Version 4 - I Feel Ill | ||
FAC016-I Feel Nervous | C151251 | FAC016-I Feel Nervous | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I feel nervous. | FACT-L Version 4 - I Feel Nervous | ||
FAC016-I Feel Sad | C151248 | FAC016-I Feel Sad | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I feel sad. | FACT-L Version 4 - I Feel Sad | ||
FAC016-I Feel Tightness in My Chest | C151267 | FAC016-I Feel Tightness in My Chest | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I feel tightness in my chest. | FACT-L Version 4 - I Feel Tightness in My Chest | ||
FAC016-I Get Support From My Friends | C151243 | FAC016-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-L Version 4 - I Get Support From My Friends | ||
FAC016-I Have a Good Appetite | C151266 | FAC016-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have a good appetite. | FACT-L Version 4 - I Have a Good Appetite | ||
FAC016-I Have a Lack of Energy | C151234 | FAC016-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have a lack of energy. | FACT-L Version 4 - I Have a Lack of Energy | ||
FAC016-I Have Accepted My Illness | C151257 | FAC016-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: I have accepted my illness. | FACT-L Version 4 - I Have Accepted My Illness | ||
FAC016-I Have Been Coughing | C151264 | FAC016-I Have Been Coughing | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have been coughing. | FACT-L Version 4 - I Have Been Coughing | ||
FAC016-I Have Been Short of Breath | C151261 | FAC016-I Have Been Short of Breath | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I have been short of breath. | FACT-L Version 4 - I Have Been Short of Breath | ||
FAC016-I Have Nausea | C151235 | FAC016-I Have Nausea | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have nausea. | FACT-L Version 4 - I Have Nausea | ||
FAC016-I Have Pain | C151237 | FAC016-I Have Pain | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: I have pain. | FACT-L Version 4 - I Have Pain | ||
FAC016-I Regret My Smoking | C151270 | FAC016-I Regret My Smoking | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: I regret my smoking. | FACT-L Version 4 - I Regret My Smoking | ||
FAC016-I Worry About Dying | C151252 | FAC016-I Worry About Dying | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I worry about dying. | FACT-L Version 4 - I Worry About Dying | ||
FAC016-Losing Hope Against Illness | C151250 | FAC016-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-L Version 4 - Losing Hope Against Illness | ||
FAC016-My Family Has Accepted My Illness | C151244 | FAC016-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-L Version 4 - My Family Has Accepted My Illness | ||
FAC016-My Thinking Is Clear | C151263 | FAC016-My Thinking Is Clear | Functional Assessment of Cancer Therapy-Lung Version 4 - Additional Concerns: My thinking is clear. | FACT-L Version 4 - My Thinking Is Clear | ||
FAC016-My Work Is Fulfilling | C151255 | FAC016-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Lung Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-L Version 4 - My Work Is Fulfilling | ||
FAC016-Satisfied Communication Illness | C151245 | FAC016-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Lung Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-L Version 4 - Satisfied Communication Illness | ||
FAC016-Satisfied With How I Am Coping | C151249 | FAC016-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-L Version 4 - Satisfied With How I Am Coping | ||
FAC016-Trouble Meeting Needs of Family | C151236 | FAC016-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Lung Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-L Version 4 - Trouble Meeting Needs of Family | ||
FAC016-Worry My Condition Will Get Worse | C151253 | FAC016-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Lung Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-L Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C130257.FAC018TC | Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire Test Code
(FAC018TC) | text
Extensible: No | C130257 | Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Lymphoma Version 4 test code. | CDISC Questionnaire FACT-LYM Version 4 Test Code Terminology |
FAC01801 | C130503 | FAC018-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have a lack of energy. | FACT-LYM Version 4 - I Have a Lack of Energy | ||
FAC01802 | C130504 | FAC018-I Have Nausea | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have nausea. | FACT-LYM Version 4 - I Have Nausea | ||
FAC01803 | C130505 | FAC018-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-LYM Version 4 - Trouble Meeting Needs of Family | ||
FAC01804 | C130506 | FAC018-I Have Pain | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have pain. | FACT-LYM Version 4 - I Have Pain | ||
FAC01805 | C130507 | FAC018-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-LYM Version 4 - Bothered by Treatment Side Effect | ||
FAC01806 | C130508 | FAC018-I Feel Ill | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I feel ill. | FACT-LYM Version 4 - I Feel Ill | ||
FAC01807 | C130509 | FAC018-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-LYM Version 4 - I Am Forced to Spend Time in Bed | ||
FAC01808 | C130510 | FAC018-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-LYM Version 4 - I Feel Close to My Friends | ||
FAC01809 | C130511 | FAC018-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-LYM Version 4 - Get Emotional Support From Family | ||
FAC01810 | C130512 | FAC018-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-LYM Version 4 - I Get Support From My Friends | ||
FAC01811 | C130513 | FAC018-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-LYM Version 4 - My Family Has Accepted My Illness | ||
FAC01812 | C130514 | FAC018-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-LYM Version 4 - Satisfied With Communication About Illness | ||
FAC01813 | C130515 | FAC018-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-LYM Version 4 - I Feel Close to My Partner | ||
FAC01814 | C130516 | FAC018-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-LYM Version 4 - I Am Satisfied With My Sex Life | ||
FAC01815 | C130517 | FAC018-I Feel Sad | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I feel sad. | FACT-LYM Version 4 - I Feel Sad | ||
FAC01816 | C130518 | FAC018-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-LYM Version 4 - Satisfied With How I Am Coping | ||
FAC01817 | C130519 | FAC018-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-LYM Version 4 - Losing Hope Against Illness | ||
FAC01818 | C130520 | FAC018-I Feel Nervous | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I feel nervous. | FACT-LYM Version 4 - I Feel Nervous | ||
FAC01819 | C130521 | FAC018-I Worry About Dying | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I worry about dying. | FACT-LYM Version 4 - I Worry About Dying | ||
FAC01820 | C130522 | FAC018-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-LYM Version 4 - Worry My Condition Will Get Worse | ||
FAC01821 | C130523 | FAC018-I Am Able to Work | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-LYM Version 4 - I Am Able to Work | ||
FAC01822 | C130524 | FAC018-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-LYM Version 4 - My Work Is Fulfilling | ||
FAC01823 | C130525 | FAC018-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-LYM Version 4 - I Am Able to Enjoy Life | ||
FAC01824 | C130526 | FAC018-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I have accepted my illness. | FACT-LYM Version 4 - I Have Accepted My Illness | ||
FAC01825 | C130527 | FAC018-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am sleeping well. | FACT-LYM Version 4 - I Am Sleeping Well | ||
FAC01826 | C130528 | FAC018-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-LYM Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC01827 | C130529 | FAC018-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-LYM Version 4 - Content With Quality of My Life | ||
FAC01828 | C130530 | FAC018-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. | FACT-LYM Version 4 - Certain Parts of Body Have Pain | ||
FAC01829 | C130531 | FAC018-Bothered by Lumps or Swelling | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). | FACT-LYM Version 4 - Bothered by Lumps or Swelling | ||
FAC01830 | C130532 | FAC018-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by fevers (episodes of high body temperature). | FACT-LYM Version 4 - I Am Bothered by Fevers | ||
FAC01831 | C130533 | FAC018-I Have Night Sweats | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have night sweats. | FACT-LYM Version 4 - I Have Night Sweats | ||
FAC01832 | C130534 | FAC018-I Am Bothered by Itching | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by itching. | FACT-LYM Version 4 - I Am Bothered by Itching | ||
FAC01833 | C130535 | FAC018-I Have Trouble Sleeping at Night | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have trouble sleeping at night. | FACT-LYM Version 4 - I Have Trouble Sleeping at Night | ||
FAC01834 | C130536 | FAC018-I Get Tired Easily | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I get tired easily. | FACT-LYM Version 4 - I Get Tired Easily | ||
FAC01835 | C130537 | FAC018-I Am Losing Weight | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am losing weight. | FACT-LYM Version 4 - I Am Losing Weight | ||
FAC01836 | C130538 | FAC018-I Have a Loss of Appetite | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have a loss of appetite. | FACT-LYM Version 4 - I Have a Loss of Appetite | ||
FAC01837 | C130539 | FAC018-I Have Trouble Concentrating | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have trouble concentrating. | FACT-LYM Version 4 - I Have Trouble Concentrating | ||
FAC01838 | C130540 | FAC018-I Worry About Getting Infections | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I worry about getting infections. | FACT-LYM Version 4 - I Worry About Getting Infections | ||
FAC01839 | C130541 | FAC018-Worry I Might Get New Symptoms | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I worry that I might get new symptoms of my illness. | FACT-LYM Version 4 - Worry I Might Get New Symptoms | ||
FAC01840 | C130542 | FAC018-Feel Isolated Because of Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I feel isolated from others because of my illness or treatment. | FACT-LYM Version 4 - Feel Isolated Because of Illness | ||
FAC01841 | C130543 | FAC018-I Have Emotional Ups and Downs | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have emotional ups and downs. | FACT-LYM Version 4 - I Have Emotional Ups and Downs | ||
FAC01842 | C130544 | FAC018-Difficulty Planning for Future | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: Because of my illness, I have difficulty planning for the future. | FACT-LYM Version 4 - Difficulty Planning for Future | ||
Back to top | ||||||
CL.C130256.FAC018TN | Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire Test Name
(FAC018TN) | text
Extensible: No | C130256 | Functional Assessment of Cancer Therapy-Lymphoma Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Lymphoma Version 4 test name. | CDISC Questionnaire FACT-LYM Version 4 Test Name Terminology |
FAC018-Bothered by Lumps or Swelling | C130531 | FAC018-Bothered by Lumps or Swelling | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). | FACT-LYM Version 4 - Bothered by Lumps or Swelling | ||
FAC018-Bothered by Treatment Side Effect | C130507 | FAC018-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-LYM Version 4 - Bothered by Treatment Side Effect | ||
FAC018-Certain Parts of Body Have Pain | C130530 | FAC018-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. | FACT-LYM Version 4 - Certain Parts of Body Have Pain | ||
FAC018-Content With Quality of My Life | C130529 | FAC018-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-LYM Version 4 - Content With Quality of My Life | ||
FAC018-Difficulty Planning for Future | C130544 | FAC018-Difficulty Planning for Future | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: Because of my illness, I have difficulty planning for the future. | FACT-LYM Version 4 - Difficulty Planning for Future | ||
FAC018-Enjoy Things I Usually Do for Fun | C130528 | FAC018-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-LYM Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC018-Feel Isolated Because of Illness | C130542 | FAC018-Feel Isolated Because of Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I feel isolated from others because of my illness or treatment. | FACT-LYM Version 4 - Feel Isolated Because of Illness | ||
FAC018-Get Emotional Support From Family | C130511 | FAC018-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-LYM Version 4 - Get Emotional Support From Family | ||
FAC018-I Am Able to Enjoy Life | C130525 | FAC018-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-LYM Version 4 - I Am Able to Enjoy Life | ||
FAC018-I Am Able to Work | C130523 | FAC018-I Am Able to Work | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-LYM Version 4 - I Am Able to Work | ||
FAC018-I Am Bothered by Fevers | C130532 | FAC018-I Am Bothered by Fevers | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by fevers (episodes of high body temperature). | FACT-LYM Version 4 - I Am Bothered by Fevers | ||
FAC018-I Am Bothered by Itching | C130534 | FAC018-I Am Bothered by Itching | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am bothered by itching. | FACT-LYM Version 4 - I Am Bothered by Itching | ||
FAC018-I Am Forced to Spend Time in Bed | C130509 | FAC018-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-LYM Version 4 - I Am Forced to Spend Time in Bed | ||
FAC018-I Am Losing Weight | C130537 | FAC018-I Am Losing Weight | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I am losing weight. | FACT-LYM Version 4 - I Am Losing Weight | ||
FAC018-I Am Satisfied With My Sex Life | C130516 | FAC018-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-LYM Version 4 - I Am Satisfied With My Sex Life | ||
FAC018-I Am Sleeping Well | C130527 | FAC018-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I am sleeping well. | FACT-LYM Version 4 - I Am Sleeping Well | ||
FAC018-I Feel Close to My Friends | C130510 | FAC018-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-LYM Version 4 - I Feel Close to My Friends | ||
FAC018-I Feel Close to My Partner | C130515 | FAC018-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-LYM Version 4 - I Feel Close to My Partner | ||
FAC018-I Feel Ill | C130508 | FAC018-I Feel Ill | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I feel ill. | FACT-LYM Version 4 - I Feel Ill | ||
FAC018-I Feel Nervous | C130520 | FAC018-I Feel Nervous | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I feel nervous. | FACT-LYM Version 4 - I Feel Nervous | ||
FAC018-I Feel Sad | C130517 | FAC018-I Feel Sad | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I feel sad. | FACT-LYM Version 4 - I Feel Sad | ||
FAC018-I Get Support From My Friends | C130512 | FAC018-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-LYM Version 4 - I Get Support From My Friends | ||
FAC018-I Get Tired Easily | C130536 | FAC018-I Get Tired Easily | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I get tired easily. | FACT-LYM Version 4 - I Get Tired Easily | ||
FAC018-I Have a Lack of Energy | C130503 | FAC018-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have a lack of energy. | FACT-LYM Version 4 - I Have a Lack of Energy | ||
FAC018-I Have a Loss of Appetite | C130538 | FAC018-I Have a Loss of Appetite | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have a loss of appetite. | FACT-LYM Version 4 - I Have a Loss of Appetite | ||
FAC018-I Have Accepted My Illness | C130526 | FAC018-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: I have accepted my illness. | FACT-LYM Version 4 - I Have Accepted My Illness | ||
FAC018-I Have Emotional Ups and Downs | C130543 | FAC018-I Have Emotional Ups and Downs | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have emotional ups and downs. | FACT-LYM Version 4 - I Have Emotional Ups and Downs | ||
FAC018-I Have Nausea | C130504 | FAC018-I Have Nausea | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have nausea. | FACT-LYM Version 4 - I Have Nausea | ||
FAC018-I Have Night Sweats | C130533 | FAC018-I Have Night Sweats | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have night sweats. | FACT-LYM Version 4 - I Have Night Sweats | ||
FAC018-I Have Pain | C130506 | FAC018-I Have Pain | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: I have pain. | FACT-LYM Version 4 - I Have Pain | ||
FAC018-I Have Trouble Concentrating | C130539 | FAC018-I Have Trouble Concentrating | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have trouble concentrating. | FACT-LYM Version 4 - I Have Trouble Concentrating | ||
FAC018-I Have Trouble Sleeping at Night | C130535 | FAC018-I Have Trouble Sleeping at Night | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I have trouble sleeping at night. | FACT-LYM Version 4 - I Have Trouble Sleeping at Night | ||
FAC018-I Worry About Dying | C130521 | FAC018-I Worry About Dying | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I worry about dying. | FACT-LYM Version 4 - I Worry About Dying | ||
FAC018-I Worry About Getting Infections | C130540 | FAC018-I Worry About Getting Infections | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I worry about getting infections. | FACT-LYM Version 4 - I Worry About Getting Infections | ||
FAC018-Losing Hope Against Illness | C130519 | FAC018-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-LYM Version 4 - Losing Hope Against Illness | ||
FAC018-My Family Has Accepted My Illness | C130513 | FAC018-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-LYM Version 4 - My Family Has Accepted My Illness | ||
FAC018-My Work Is Fulfilling | C130524 | FAC018-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-LYM Version 4 - My Work Is Fulfilling | ||
FAC018-Satisfied Communication Illness | C130514 | FAC018-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-LYM Version 4 - Satisfied With Communication About Illness | ||
FAC018-Satisfied With How I Am Coping | C130518 | FAC018-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-LYM Version 4 - Satisfied With How I Am Coping | ||
FAC018-Trouble Meeting Needs of Family | C130505 | FAC018-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-LYM Version 4 - Trouble Meeting Needs of Family | ||
FAC018-Worry I Might Get New Symptoms | C130541 | FAC018-Worry I Might Get New Symptoms | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Additional Concerns: I worry that I might get new symptoms of my illness. | FACT-LYM Version 4 - Worry I Might Get New Symptoms | ||
FAC018-Worry My Condition Will Get Worse | C130522 | FAC018-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Lymphoma Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-LYM Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C129096.FAC049TC | Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire Test Code
(FAC049TC) | text
Extensible: No | C129096 | Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire Test Code | Functional Assessment of Cancer Therapy-Ovarian Symptom Index test code. | CDISC Questionnaire FOSI Test Code Terminology |
FAC04901 | C129225 | FAC049-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have a lack of energy. | FOSI - I Have a Lack of Energy | ||
FAC04902 | C129226 | FAC049-I Have Been Vomiting | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have been vomiting. | FOSI - I Have Been Vomiting | ||
FAC04903 | C129227 | FAC049-I Have Pain | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have pain. | FOSI - I Have Pain | ||
FAC04904 | C129228 | FAC049-I Have Nausea | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have nausea. | FOSI - I Have Nausea | ||
FAC04905 | C129229 | FAC049-I Have Swelling in Stomach Area | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have swelling in my stomach area. | FOSI - I Have Swelling in Stomach Area | ||
FAC04906 | C129230 | FAC049-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I worry that my condition will get worse. | FOSI - Worry My Condition Will Get Worse | ||
FAC04907 | C129231 | FAC049-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I am content with the quality of my life right now. | FOSI - Content With Quality of My Life | ||
FAC04908 | C129232 | FAC049-I Have Cramps in My Stomach Area | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have cramps in my stomach area. | FOSI - I Have Cramps in My Stomach Area | ||
Back to top | ||||||
CL.C129095.FAC049TN | Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire Test Name
(FAC049TN) | text
Extensible: No | C129095 | Functional Assessment of Cancer Therapy-Ovarian Symptom Index Questionnaire Test Name | Functional Assessment of Cancer Therapy-Ovarian Symptom Index test name. | CDISC Questionnaire FOSI Test Name Terminology |
FAC049-Content With Quality of My Life | C129231 | FAC049-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I am content with the quality of my life right now. | FOSI - Content With Quality of My Life | ||
FAC049-I Have a Lack of Energy | C129225 | FAC049-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have a lack of energy. | FOSI - I Have a Lack of Energy | ||
FAC049-I Have Been Vomiting | C129226 | FAC049-I Have Been Vomiting | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have been vomiting. | FOSI - I Have Been Vomiting | ||
FAC049-I Have Cramps in My Stomach Area | C129232 | FAC049-I Have Cramps in My Stomach Area | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have cramps in my stomach area. | FOSI - I Have Cramps in My Stomach Area | ||
FAC049-I Have Nausea | C129228 | FAC049-I Have Nausea | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have nausea. | FOSI - I Have Nausea | ||
FAC049-I Have Pain | C129227 | FAC049-I Have Pain | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have pain. | FOSI - I Have Pain | ||
FAC049-I Have Swelling in Stomach Area | C129229 | FAC049-I Have Swelling in Stomach Area | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I have swelling in my stomach area. | FOSI - I Have Swelling in Stomach Area | ||
FAC049-Worry My Condition Will Get Worse | C129230 | FAC049-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Ovarian Symptom Index - I worry that my condition will get worse. | FOSI - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C150776.FAC063TC | Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire Test Code
(FAC063TC) | text
Extensible: No | C150776 | Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy-Taxane Version 4 test code. | CDISC Questionnaire FACT-Taxane Version 4 Test Code Terminology |
FAC06301 | C151113 | FAC063-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have a lack of energy. | FACT-Taxane Version 4 - I Have a Lack of Energy | ||
FAC06302 | C151114 | FAC063-I Have Nausea | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have nausea. | FACT-Taxane Version 4 - I Have Nausea | ||
FAC06303 | C151115 | FAC063-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-Taxane Version 4 - Trouble Meeting Needs of Family | ||
FAC06304 | C151116 | FAC063-I Have Pain | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have pain. | FACT-Taxane Version 4 - I Have Pain | ||
FAC06305 | C151117 | FAC063-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-Taxane Version 4 - Bothered by Treatment Side Effect | ||
FAC06306 | C151118 | FAC063-I Feel Ill | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I feel ill. | FACT-Taxane Version 4 - I Feel Ill | ||
FAC06307 | C151119 | FAC063-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-Taxane Version 4 - I Am Forced to Spend Time in Bed | ||
FAC06308 | C151120 | FAC063-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-Taxane Version 4 - I Feel Close to My Friends | ||
FAC06309 | C151121 | FAC063-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-Taxane Version 4 - Get Emotional Support From Family | ||
FAC06310 | C151122 | FAC063-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-Taxane Version 4 - I Get Support From My Friends | ||
FAC06311 | C151123 | FAC063-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-Taxane Version 4 - My Family Has Accepted My Illness | ||
FAC06312 | C151124 | FAC063-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-Taxane Version 4 - Satisfied Communication Illness | ||
FAC06313 | C151125 | FAC063-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-Taxane Version 4 - I Feel Close to My Partner | ||
FAC06314 | C151126 | FAC063-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-Taxane Version 4 - I Am Satisfied With My Sex Life | ||
FAC06315 | C151127 | FAC063-I Feel Sad | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I feel sad. | FACT-Taxane Version 4 - I Feel Sad | ||
FAC06316 | C151128 | FAC063-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-Taxane Version 4 - Satisfied With How I Am Coping | ||
FAC06317 | C151129 | FAC063-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-Taxane Version 4 - Losing Hope Against Illness | ||
FAC06318 | C151130 | FAC063-I Feel Nervous | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I feel nervous. | FACT-Taxane Version 4 - I Feel Nervous | ||
FAC06319 | C151131 | FAC063-I Worry About Dying | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I worry about dying. | FACT-Taxane Version 4 - I Worry About Dying | ||
FAC06320 | C151132 | FAC063-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-Taxane Version 4 - Worry My Condition Will Get Worse | ||
FAC06321 | C151133 | FAC063-I Am Able to Work | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-Taxane Version 4 - I Am Able to Work | ||
FAC06322 | C151134 | FAC063-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-Taxane Version 4 - My Work Is Fulfilling | ||
FAC06323 | C151135 | FAC063-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-Taxane Version 4 - I Am Able to Enjoy Life | ||
FAC06324 | C151136 | FAC063-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I have accepted my illness. | FACT-Taxane Version 4 - I Have Accepted My Illness | ||
FAC06325 | C151137 | FAC063-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am sleeping well. | FACT-Taxane Version 4 - I Am Sleeping Well | ||
FAC06326 | C151138 | FAC063-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-Taxane Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC06327 | C151139 | FAC063-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-Taxane Version 4 - Content With Quality of My Life | ||
FAC06328 | C151140 | FAC063-Numbness or Tingling in My Hands | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have numbness or tingling in my hands. | FACT-Taxane Version 4 - Numbness or Tingling in My Hands | ||
FAC06329 | C151141 | FAC063-Numbness or Tingling in My Feet | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have numbness or tingling in my feet. | FACT-Taxane Version 4 - Numbness or Tingling in My Feet | ||
FAC06330 | C151142 | FAC063-I Feel Discomfort in My Hands | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel discomfort in my hands. | FACT-Taxane Version 4 - I Feel Discomfort in My Hands | ||
FAC06331 | C151143 | FAC063-I Feel Discomfort in My Feet | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel discomfort in my feet. | FACT-Taxane Version 4 - I Feel Discomfort in My Feet | ||
FAC06332 | C151144 | FAC063-Have Joint Pain or Muscle Cramps | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have joint pain or muscle cramps. | FACT-Taxane Version 4 - Have Joint Pain or Muscle Cramps | ||
FAC06333 | C151145 | FAC063-I Feel Weak All Over | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel weak all over. | FACT-Taxane Version 4 - I Feel Weak All Over | ||
FAC06334 | C151146 | FAC063-I Have Trouble Hearing | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble hearing. | FACT-Taxane Version 4 - I Have Trouble Hearing | ||
FAC06335 | C151147 | FAC063-Get Ringing or Buzzing in My Ears | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I get a ringing or buzzing in my ears. | FACT-Taxane Version 4 - Get Ringing or Buzzing in My Ears | ||
FAC06336 | C151148 | FAC063-I Have Trouble Buttoning Buttons | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble buttoning buttons. | FACT-Taxane Version 4 - I Have Trouble Buttoning Buttons | ||
FAC06337 | C151149 | FAC063-Trouble Feeling Shape of Objects | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble feeling the shape of small objects when they are in my hand. | FACT-Taxane Version 4 - Trouble Feeling Shape of Objects | ||
FAC06338 | C151150 | FAC063-I Have Trouble Walking | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble walking. | FACT-Taxane Version 4 - I Have Trouble Walking | ||
FAC06339 | C151151 | FAC063-I Feel Bloated | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel bloated. | FACT-Taxane Version 4 - I Feel Bloated | ||
FAC06340 | C151152 | FAC063-My Hands Are Swollen | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: My hands are swollen. | FACT-Taxane Version 4 - My Hands Are Swollen | ||
FAC06341 | C151153 | FAC063-My Legs or Feet Are Swollen | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: My legs or feet are swollen. | FACT-Taxane Version 4 - My Legs or Feet Are Swollen | ||
FAC06342 | C151154 | FAC063-I Have Pain in My Fingertips | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have pain in my fingertips. | FACT-Taxane Version 4 - I Have Pain in My Fingertips | ||
FAC06343 | C151155 | FAC063-Bothered by My Hands/Nails Look | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I am bothered by the way my hands or nails look. | FACT-Taxane Version 4 - Bothered by My Hands/Nails Look | ||
Back to top | ||||||
CL.C150775.FAC063TN | Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire Test Name
(FAC063TN) | text
Extensible: No | C150775 | Functional Assessment of Cancer Therapy-Taxane Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy-Taxane Version 4 test name. | CDISC Questionnaire FACT-Taxane Version 4 Test Name Terminology |
FAC063-Bothered by My Hands/Nails Look | C151155 | FAC063-Bothered by My Hands/Nails Look | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I am bothered by the way my hands or nails look. | FACT-Taxane Version 4 - Bothered by My Hands/Nails Look | ||
FAC063-Bothered by Treatment Side Effect | C151117 | FAC063-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-Taxane Version 4 - Bothered by Treatment Side Effect | ||
FAC063-Content With Quality of My Life | C151139 | FAC063-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-Taxane Version 4 - Content With Quality of My Life | ||
FAC063-Enjoy Things I Usually Do for Fun | C151138 | FAC063-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-Taxane Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC063-Get Emotional Support From Family | C151121 | FAC063-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-Taxane Version 4 - Get Emotional Support From Family | ||
FAC063-Get Ringing or Buzzing in My Ears | C151147 | FAC063-Get Ringing or Buzzing in My Ears | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I get a ringing or buzzing in my ears. | FACT-Taxane Version 4 - Get Ringing or Buzzing in My Ears | ||
FAC063-Have Joint Pain or Muscle Cramps | C151144 | FAC063-Have Joint Pain or Muscle Cramps | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have joint pain or muscle cramps. | FACT-Taxane Version 4 - Have Joint Pain or Muscle Cramps | ||
FAC063-I Am Able to Enjoy Life | C151135 | FAC063-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-Taxane Version 4 - I Am Able to Enjoy Life | ||
FAC063-I Am Able to Work | C151133 | FAC063-I Am Able to Work | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-Taxane Version 4 - I Am Able to Work | ||
FAC063-I Am Forced to Spend Time in Bed | C151119 | FAC063-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-Taxane Version 4 - I Am Forced to Spend Time in Bed | ||
FAC063-I Am Satisfied With My Sex Life | C151126 | FAC063-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-Taxane Version 4 - I Am Satisfied With My Sex Life | ||
FAC063-I Am Sleeping Well | C151137 | FAC063-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I am sleeping well. | FACT-Taxane Version 4 - I Am Sleeping Well | ||
FAC063-I Feel Bloated | C151151 | FAC063-I Feel Bloated | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel bloated. | FACT-Taxane Version 4 - I Feel Bloated | ||
FAC063-I Feel Close to My Friends | C151120 | FAC063-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-Taxane Version 4 - I Feel Close to My Friends | ||
FAC063-I Feel Close to My Partner | C151125 | FAC063-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-Taxane Version 4 - I Feel Close to My Partner | ||
FAC063-I Feel Discomfort in My Feet | C151143 | FAC063-I Feel Discomfort in My Feet | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel discomfort in my feet. | FACT-Taxane Version 4 - I Feel Discomfort in My Feet | ||
FAC063-I Feel Discomfort in My Hands | C151142 | FAC063-I Feel Discomfort in My Hands | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel discomfort in my hands. | FACT-Taxane Version 4 - I Feel Discomfort in My Hands | ||
FAC063-I Feel Ill | C151118 | FAC063-I Feel Ill | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I feel ill. | FACT-Taxane Version 4 - I Feel Ill | ||
FAC063-I Feel Nervous | C151130 | FAC063-I Feel Nervous | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I feel nervous. | FACT-Taxane Version 4 - I Feel Nervous | ||
FAC063-I Feel Sad | C151127 | FAC063-I Feel Sad | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I feel sad. | FACT-Taxane Version 4 - I Feel Sad | ||
FAC063-I Feel Weak All Over | C151145 | FAC063-I Feel Weak All Over | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I feel weak all over. | FACT-Taxane Version 4 - I Feel Weak All Over | ||
FAC063-I Get Support From My Friends | C151122 | FAC063-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-Taxane Version 4 - I Get Support From My Friends | ||
FAC063-I Have a Lack of Energy | C151113 | FAC063-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have a lack of energy. | FACT-Taxane Version 4 - I Have a Lack of Energy | ||
FAC063-I Have Accepted My Illness | C151136 | FAC063-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: I have accepted my illness. | FACT-Taxane Version 4 - I Have Accepted My Illness | ||
FAC063-I Have Nausea | C151114 | FAC063-I Have Nausea | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have nausea. | FACT-Taxane Version 4 - I Have Nausea | ||
FAC063-I Have Pain in My Fingertips | C151154 | FAC063-I Have Pain in My Fingertips | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have pain in my fingertips. | FACT-Taxane Version 4 - I Have Pain in My Fingertips | ||
FAC063-I Have Pain | C151116 | FAC063-I Have Pain | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: I have pain. | FACT-Taxane Version 4 - I Have Pain | ||
FAC063-I Have Trouble Buttoning Buttons | C151148 | FAC063-I Have Trouble Buttoning Buttons | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble buttoning buttons. | FACT-Taxane Version 4 - I Have Trouble Buttoning Buttons | ||
FAC063-I Have Trouble Hearing | C151146 | FAC063-I Have Trouble Hearing | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble hearing. | FACT-Taxane Version 4 - I Have Trouble Hearing | ||
FAC063-I Have Trouble Walking | C151150 | FAC063-I Have Trouble Walking | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble walking. | FACT-Taxane Version 4 - I Have Trouble Walking | ||
FAC063-I Worry About Dying | C151131 | FAC063-I Worry About Dying | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I worry about dying. | FACT-Taxane Version 4 - I Worry About Dying | ||
FAC063-Losing Hope Against Illness | C151129 | FAC063-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-Taxane Version 4 - Losing Hope Against Illness | ||
FAC063-My Family Has Accepted My Illness | C151123 | FAC063-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-Taxane Version 4 - My Family Has Accepted My Illness | ||
FAC063-My Hands Are Swollen | C151152 | FAC063-My Hands Are Swollen | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: My hands are swollen. | FACT-Taxane Version 4 - My Hands Are Swollen | ||
FAC063-My Legs or Feet Are Swollen | C151153 | FAC063-My Legs or Feet Are Swollen | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: My legs or feet are swollen. | FACT-Taxane Version 4 - My Legs or Feet Are Swollen | ||
FAC063-My Work Is Fulfilling | C151134 | FAC063-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Taxane Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-Taxane Version 4 - My Work Is Fulfilling | ||
FAC063-Numbness or Tingling in My Feet | C151141 | FAC063-Numbness or Tingling in My Feet | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have numbness or tingling in my feet. | FACT-Taxane Version 4 - Numbness or Tingling in My Feet | ||
FAC063-Numbness or Tingling in My Hands | C151140 | FAC063-Numbness or Tingling in My Hands | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have numbness or tingling in my hands. | FACT-Taxane Version 4 - Numbness or Tingling in My Hands | ||
FAC063-Satisfied Communication Illness | C151124 | FAC063-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Taxane Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-Taxane Version 4 - Satisfied Communication Illness | ||
FAC063-Satisfied With How I Am Coping | C151128 | FAC063-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-Taxane Version 4 - Satisfied With How I Am Coping | ||
FAC063-Trouble Feeling Shape of Objects | C151149 | FAC063-Trouble Feeling Shape of Objects | Functional Assessment of Cancer Therapy-Taxane Version 4 - Additional Concerns: I have trouble feeling the shape of small objects when they are in my hand. | FACT-Taxane Version 4 - Trouble Feeling Shape of Objects | ||
FAC063-Trouble Meeting Needs of Family | C151115 | FAC063-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Taxane Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-Taxane Version 4 - Trouble Meeting Needs of Family | ||
FAC063-Worry My Condition Will Get Worse | C151132 | FAC063-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Taxane Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-Taxane Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C150780.FAC057TC | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire Test Code
(FAC057TC) | text
Extensible: No | C150780 | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire Test Code | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 test code. | CDISC Questionnaire FACT/GOG-NTX Version 4 Test Code Terminology |
FAC05701 | C151196 | FAC057-I Have a Lack of Energy | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have a lack of energy. | FACT/GOG-NTX Version 4 - I Have a Lack of Energy | ||
FAC05702 | C151197 | FAC057-I Have Nausea | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have nausea. | FACT/GOG-NTX Version 4 - I Have Nausea | ||
FAC05703 | C151198 | FAC057-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT/GOG-NTX Version 4 - Trouble Meeting Needs of Family | ||
FAC05704 | C151199 | FAC057-I Have Pain | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have pain. | FACT/GOG-NTX Version 4 - I Have Pain | ||
FAC05705 | C151200 | FAC057-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT/GOG-NTX Version 4 - Bothered by Treatment Side Effect | ||
FAC05706 | C151201 | FAC057-I Feel Ill | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I feel ill. | FACT/GOG-NTX Version 4 - I Feel Ill | ||
FAC05707 | C151202 | FAC057-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT/GOG-NTX Version 4 - I Am Forced to Spend Time in Bed | ||
FAC05708 | C151203 | FAC057-I Feel Close to My Friends | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT/GOG-NTX Version 4 - I Feel Close to My Friends | ||
FAC05709 | C151204 | FAC057-Get Emotional Support From Family | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT/GOG-NTX Version 4 - Get Emotional Support From Family | ||
FAC05710 | C151205 | FAC057-I Get Support From My Friends | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I get support from my friends. | FACT/GOG-NTX Version 4 - I Get Support From My Friends | ||
FAC05711 | C151206 | FAC057-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT/GOG-NTX Version 4 - My Family Has Accepted My Illness | ||
FAC05712 | C151207 | FAC057-Satisfied Communication Illness | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT/GOG-NTX Version 4 - Satisfied Communication Illness | ||
FAC05713 | C151208 | FAC057-I Feel Close to My Partner | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT/GOG-NTX Version 4 - I Feel Close to My Partner | ||
FAC05714 | C151209 | FAC057-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT/GOG-NTX Version 4 - I Am Satisfied With My Sex Life | ||
FAC05715 | C151210 | FAC057-I Feel Sad | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I feel sad. | FACT/GOG-NTX Version 4 - I Feel Sad | ||
FAC05716 | C151211 | FAC057-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT/GOG-NTX Version 4 - Satisfied With How I Am Coping | ||
FAC05717 | C151212 | FAC057-Losing Hope Against Illness | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT/GOG-NTX Version 4 - Losing Hope Against Illness | ||
FAC05718 | C151213 | FAC057-I Feel Nervous | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I feel nervous. | FACT/GOG-NTX Version 4 - I Feel Nervous | ||
FAC05719 | C151214 | FAC057-I Worry About Dying | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I worry about dying. | FACT/GOG-NTX Version 4 - I Worry About Dying | ||
FAC05720 | C151215 | FAC057-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT/GOG-NTX Version 4 - Worry My Condition Will Get Worse | ||
FAC05721 | C151216 | FAC057-I Am Able to Work | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT/GOG-NTX Version 4 - I Am Able to Work | ||
FAC05722 | C151217 | FAC057-My Work Is Fulfilling | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT/GOG-NTX Version 4 - My Work Is Fulfilling | ||
FAC05723 | C151218 | FAC057-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am able to enjoy life. | FACT/GOG-NTX Version 4 - I Am Able to Enjoy Life | ||
FAC05724 | C151219 | FAC057-I Have Accepted My Illness | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I have accepted my illness. | FACT/GOG-NTX Version 4 - I Have Accepted My Illness | ||
FAC05725 | C151220 | FAC057-I Am Sleeping Well | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am sleeping well. | FACT/GOG-NTX Version 4 - I Am Sleeping Well | ||
FAC05726 | C151221 | FAC057-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT/GOG-NTX Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC05727 | C151222 | FAC057-Content With Quality of My Life | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT/GOG-NTX Version 4 - Content With Quality of My Life | ||
FAC05728 | C151223 | FAC057-Numbness or Tingling in My Hands | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have numbness or tingling in my hands. | FACT/GOG-NTX Version 4 - Numbness or Tingling in My Hands | ||
FAC05729 | C151224 | FAC057-Numbness or Tingling in My Feet | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have numbness or tingling in my feet. | FACT/GOG-NTX Version 4 - Numbness or Tingling in My Feet | ||
FAC05730 | C151225 | FAC057-I Feel Discomfort in My Hands | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel discomfort in my hands. | FACT/GOG-NTX Version 4 - I Feel Discomfort in My Hands | ||
FAC05731 | C151226 | FAC057-I Feel Discomfort in My Feet | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel discomfort in my feet. | FACT/GOG-NTX Version 4 - I Feel Discomfort in My Feet | ||
FAC05732 | C151227 | FAC057-Have Joint Pain or Muscle Cramps | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have joint pain or muscle cramps. | FACT/GOG-NTX Version 4 - Have Joint Pain or Muscle Cramps | ||
FAC05733 | C151228 | FAC057-I Feel Weak All Over | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel weak all over. | FACT/GOG-NTX Version 4 - I Feel Weak All Over | ||
FAC05734 | C151229 | FAC057-I Have Trouble Hearing | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble hearing. | FACT/GOG-NTX Version 4 - I Have Trouble Hearing | ||
FAC05735 | C151230 | FAC057-Get Ringing or Buzzing in My Ears | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I get a ringing or buzzing in my ears. | FACT/GOG-NTX Version 4 - Get Ringing or Buzzing in My Ears | ||
FAC05736 | C151231 | FAC057-I Have Trouble Buttoning Buttons | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble buttoning buttons. | FACT/GOG-NTX Version 4 - I Have Trouble Buttoning Buttons | ||
FAC05737 | C151232 | FAC057-Trouble Feeling Shape of Objects | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble feeling the shape of small objects when they are in my hand. | FACT/GOG-NTX Version 4 - Trouble Feeling Shape of Objects | ||
FAC05738 | C151233 | FAC057-I Have Trouble Walking | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble walking. | FACT/GOG-NTX Version 4 - I Have Trouble Walking | ||
Back to top | ||||||
CL.C150779.FAC057TN | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire Test Name
(FAC057TN) | text
Extensible: No | C150779 | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 Questionnaire Test Name | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 test name. | CDISC Questionnaire FACT/GOG-NTX Version 4 Test Name Terminology |
FAC057-Bothered by Treatment Side Effect | C151200 | FAC057-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT/GOG-NTX Version 4 - Bothered by Treatment Side Effect | ||
FAC057-Content With Quality of My Life | C151222 | FAC057-Content With Quality of My Life | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT/GOG-NTX Version 4 - Content With Quality of My Life | ||
FAC057-Enjoy Things I Usually Do for Fun | C151221 | FAC057-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT/GOG-NTX Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC057-Get Emotional Support From Family | C151204 | FAC057-Get Emotional Support From Family | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT/GOG-NTX Version 4 - Get Emotional Support From Family | ||
FAC057-Get Ringing or Buzzing in My Ears | C151230 | FAC057-Get Ringing or Buzzing in My Ears | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I get a ringing or buzzing in my ears. | FACT/GOG-NTX Version 4 - Get Ringing or Buzzing in My Ears | ||
FAC057-Have Joint Pain or Muscle Cramps | C151227 | FAC057-Have Joint Pain or Muscle Cramps | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have joint pain or muscle cramps. | FACT/GOG-NTX Version 4 - Have Joint Pain or Muscle Cramps | ||
FAC057-I Am Able to Enjoy Life | C151218 | FAC057-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am able to enjoy life. | FACT/GOG-NTX Version 4 - I Am Able to Enjoy Life | ||
FAC057-I Am Able to Work | C151216 | FAC057-I Am Able to Work | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT/GOG-NTX Version 4 - I Am Able to Work | ||
FAC057-I Am Forced to Spend Time in Bed | C151202 | FAC057-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT/GOG-NTX Version 4 - I Am Forced to Spend Time in Bed | ||
FAC057-I Am Satisfied With My Sex Life | C151209 | FAC057-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT/GOG-NTX Version 4 - I Am Satisfied With My Sex Life | ||
FAC057-I Am Sleeping Well | C151220 | FAC057-I Am Sleeping Well | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I am sleeping well. | FACT/GOG-NTX Version 4 - I Am Sleeping Well | ||
FAC057-I Feel Close to My Friends | C151203 | FAC057-I Feel Close to My Friends | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT/GOG-NTX Version 4 - I Feel Close to My Friends | ||
FAC057-I Feel Close to My Partner | C151208 | FAC057-I Feel Close to My Partner | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT/GOG-NTX Version 4 - I Feel Close to My Partner | ||
FAC057-I Feel Discomfort in My Feet | C151226 | FAC057-I Feel Discomfort in My Feet | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel discomfort in my feet. | FACT/GOG-NTX Version 4 - I Feel Discomfort in My Feet | ||
FAC057-I Feel Discomfort in My Hands | C151225 | FAC057-I Feel Discomfort in My Hands | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel discomfort in my hands. | FACT/GOG-NTX Version 4 - I Feel Discomfort in My Hands | ||
FAC057-I Feel Ill | C151201 | FAC057-I Feel Ill | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I feel ill. | FACT/GOG-NTX Version 4 - I Feel Ill | ||
FAC057-I Feel Nervous | C151213 | FAC057-I Feel Nervous | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I feel nervous. | FACT/GOG-NTX Version 4 - I Feel Nervous | ||
FAC057-I Feel Sad | C151210 | FAC057-I Feel Sad | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I feel sad. | FACT/GOG-NTX Version 4 - I Feel Sad | ||
FAC057-I Feel Weak All Over | C151228 | FAC057-I Feel Weak All Over | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I feel weak all over. | FACT/GOG-NTX Version 4 - I Feel Weak All Over | ||
FAC057-I Get Support From My Friends | C151205 | FAC057-I Get Support From My Friends | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I get support from my friends. | FACT/GOG-NTX Version 4 - I Get Support From My Friends | ||
FAC057-I Have a Lack of Energy | C151196 | FAC057-I Have a Lack of Energy | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have a lack of energy. | FACT/GOG-NTX Version 4 - I Have a Lack of Energy | ||
FAC057-I Have Accepted My Illness | C151219 | FAC057-I Have Accepted My Illness | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: I have accepted my illness. | FACT/GOG-NTX Version 4 - I Have Accepted My Illness | ||
FAC057-I Have Nausea | C151197 | FAC057-I Have Nausea | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have nausea. | FACT/GOG-NTX Version 4 - I Have Nausea | ||
FAC057-I Have Pain | C151199 | FAC057-I Have Pain | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: I have pain. | FACT/GOG-NTX Version 4 - I Have Pain | ||
FAC057-I Have Trouble Buttoning Buttons | C151231 | FAC057-I Have Trouble Buttoning Buttons | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble buttoning buttons. | FACT/GOG-NTX Version 4 - I Have Trouble Buttoning Buttons | ||
FAC057-I Have Trouble Hearing | C151229 | FAC057-I Have Trouble Hearing | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble hearing. | FACT/GOG-NTX Version 4 - I Have Trouble Hearing | ||
FAC057-I Have Trouble Walking | C151233 | FAC057-I Have Trouble Walking | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble walking. | FACT/GOG-NTX Version 4 - I Have Trouble Walking | ||
FAC057-I Worry About Dying | C151214 | FAC057-I Worry About Dying | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I worry about dying. | FACT/GOG-NTX Version 4 - I Worry About Dying | ||
FAC057-Losing Hope Against Illness | C151212 | FAC057-Losing Hope Against Illness | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT/GOG-NTX Version 4 - Losing Hope Against Illness | ||
FAC057-My Family Has Accepted My Illness | C151206 | FAC057-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT/GOG-NTX Version 4 - My Family Has Accepted My Illness | ||
FAC057-My Work Is Fulfilling | C151217 | FAC057-My Work Is Fulfilling | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT/GOG-NTX Version 4 - My Work Is Fulfilling | ||
FAC057-Numbness or Tingling in My Feet | C151224 | FAC057-Numbness or Tingling in My Feet | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have numbness or tingling in my feet. | FACT/GOG-NTX Version 4 - Numbness or Tingling in My Feet | ||
FAC057-Numbness or Tingling in My Hands | C151223 | FAC057-Numbness or Tingling in My Hands | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have numbness or tingling in my hands. | FACT/GOG-NTX Version 4 - Numbness or Tingling in My Hands | ||
FAC057-Satisfied Communication Illness | C151207 | FAC057-Satisfied Communication Illness | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT/GOG-NTX Version 4 - Satisfied Communication Illness | ||
FAC057-Satisfied With How I Am Coping | C151211 | FAC057-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT/GOG-NTX Version 4 - Satisfied With How I Am Coping | ||
FAC057-Trouble Feeling Shape of Objects | C151232 | FAC057-Trouble Feeling Shape of Objects | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Additional Concerns: I have trouble feeling the shape of small objects when they are in my hand. | FACT/GOG-NTX Version 4 - Trouble Feeling Shape of Objects | ||
FAC057-Trouble Meeting Needs of Family | C151198 | FAC057-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT/GOG-NTX Version 4 - Trouble Meeting Needs of Family | ||
FAC057-Worry My Condition Will Get Worse | C151215 | FAC057-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT/GOG-NTX Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C147542.FAC084TC | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form Questionnaire Test Code
(FAC084TC) | text
Extensible: No | C147542 | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form Questionnaire Test Code | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form test code. | CDISC Questionnaire FACIT-Dyspnea 10 Item Short Form Test Code Terminology |
FAC08401 | C147643 | FAC084-Part I: Dressing Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. | FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Without Help | ||
FAC08402 | C147644 | FAC084-Part I: Dressing Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Why Not | ||
FAC08403 | C147645 | FAC084-Part I: Walk 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps | ||
FAC08404 | C147646 | FAC084-Part I: Walk 50 Steps Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps Why Not | ||
FAC08405 | C147647 | FAC084-Part I: Walk Up 20 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs | ||
FAC08406 | C147648 | FAC084-Part I: Walk Up 20 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs Why Not | ||
FAC08407 | C147649 | FAC084-Part I: Preparing Meals | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Preparing Meals. | FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals | ||
FAC08408 | C147650 | FAC084-Part I: Preparing Meals Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Preparing Meals. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals Why Not | ||
FAC08409 | C147651 | FAC084-Part I: Washing Dishes | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. | FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes | ||
FAC08410 | C147652 | FAC084-Part I: Washing Dishes Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes Why Not | ||
FAC08411 | C147653 | FAC084-Part I: Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. | FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping | ||
FAC08412 | C147654 | FAC084-Part I: Sweeping/Mopping Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping Why Not | ||
FAC08413 | C147655 | FAC084-Part I: Making a Bed | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. | FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed | ||
FAC08414 | C147656 | FAC084-Part I: Making a Bed Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed Why Not | ||
FAC08415 | C147657 | FAC084-Part I: Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs | ||
FAC08416 | C147658 | FAC084-Part I: Lifting 10-20 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs Why Not | ||
FAC08417 | C147659 | FAC084-Part I: Carry 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs | ||
FAC08418 | C147660 | FAC084-Part I: Carry 10-20 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs Why Not | ||
FAC08419 | C147661 | FAC084-Part I: Walk for 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile | ||
FAC08420 | C147662 | FAC084-Part I: Walk for 1/2 Mile Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile Why Not | ||
FAC08421 | C147663 | FAC084-Part II: Dressing Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dressing yourself without help. | FACIT-Dyspnea 10 Item Short Form - Part II: Dressing Without Help | ||
FAC08422 | C147664 | FAC084-Part II: Walk 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea 10 Item Short Form - Part II: Walk 50 Steps | ||
FAC08423 | C147665 | FAC084-Part II: Walk Up 20 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 20 stairs (2 flights) without stopping. | FACIT-Dyspnea 10 Item Short Form - Part II: Walk Up 20 Stairs | ||
FAC08424 | C147666 | FAC084-Part II: Preparing Meals | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Preparing meals. | FACIT-Dyspnea 10 Item Short Form - Part II: Preparing Meals | ||
FAC08425 | C147667 | FAC084-Part II: Washing Dishes | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Washing dishes. | FACIT-Dyspnea 10 Item Short Form - Part II: Washing Dishes | ||
FAC08426 | C147668 | FAC084-Part II: Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Sweeping or mopping. | FACIT-Dyspnea 10 Item Short Form - Part II: Sweeping/Mopping | ||
FAC08427 | C147669 | FAC084-Part II: Making a Bed | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Making a bed. | FACIT-Dyspnea 10 Item Short Form - Part II: Making a Bed | ||
FAC08428 | C147670 | FAC084-Part II: Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Dyspnea 10 Item Short Form - Part II: Lifting 10-20 Lbs | ||
FAC08429 | C147671 | FAC084-Part II: Carry 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Dyspnea 10 Item Short Form - Part II: Carry 10-20 Lbs | ||
FAC08430 | C147672 | FAC084-Part II: Walk for 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Dyspnea 10 Item Short Form - Part II: Walk for 1/2 Mile | ||
Back to top | ||||||
CL.C147541.FAC084TN | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form Questionnaire Test Name
(FAC084TN) | text
Extensible: No | C147541 | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form Questionnaire Test Name | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form test name. | CDISC Questionnaire FACIT-Dyspnea 10 Item Short Form Test Name Terminology |
FAC084-Part I: Carry 10-20 Lbs Why Not | C147660 | FAC084-Part I: Carry 10-20 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs Why Not | ||
FAC084-Part I: Carry 10-20 Lbs | C147659 | FAC084-Part I: Carry 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Dyspnea 10 Item Short Form - Part I: Carry 10-20 Lbs | ||
FAC084-Part I: Dressing Why Not | C147644 | FAC084-Part I: Dressing Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Why Not | ||
FAC084-Part I: Dressing Without Help | C147643 | FAC084-Part I: Dressing Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. | FACIT-Dyspnea 10 Item Short Form - Part I: Dressing Without Help | ||
FAC084-Part I: Lifting 10-20 Lbs Why Not | C147658 | FAC084-Part I: Lifting 10-20 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs Why Not | ||
FAC084-Part I: Lifting 10-20 Lbs | C147657 | FAC084-Part I: Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Dyspnea 10 Item Short Form - Part I: Lifting 10-20 Lbs | ||
FAC084-Part I: Making a Bed Why Not | C147656 | FAC084-Part I: Making a Bed Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed Why Not | ||
FAC084-Part I: Making a Bed | C147655 | FAC084-Part I: Making a Bed | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. | FACIT-Dyspnea 10 Item Short Form - Part I: Making a Bed | ||
FAC084-Part I: Preparing Meals Why Not | C147650 | FAC084-Part I: Preparing Meals Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Preparing Meals. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals Why Not | ||
FAC084-Part I: Preparing Meals | C147649 | FAC084-Part I: Preparing Meals | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Preparing Meals. | FACIT-Dyspnea 10 Item Short Form - Part I: Preparing Meals | ||
FAC084-Part I: Sweeping/Mopping Why Not | C147654 | FAC084-Part I: Sweeping/Mopping Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping Why Not | ||
FAC084-Part I: Sweeping/Mopping | C147653 | FAC084-Part I: Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. | FACIT-Dyspnea 10 Item Short Form - Part I: Sweeping/Mopping | ||
FAC084-Part I: Walk 50 Steps Why Not | C147646 | FAC084-Part I: Walk 50 Steps Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps Why Not | ||
FAC084-Part I: Walk 50 Steps | C147645 | FAC084-Part I: Walk 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk 50 Steps | ||
FAC084-Part I: Walk for 1/2 Mile Why Not | C147662 | FAC084-Part I: Walk for 1/2 Mile Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile Why Not | ||
FAC084-Part I: Walk for 1/2 Mile | C147661 | FAC084-Part I: Walk for 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk for 1/2 Mile | ||
FAC084-Part I: Walk Up 20 Stairs Why Not | C147648 | FAC084-Part I: Walk Up 20 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs Why Not | ||
FAC084-Part I: Walk Up 20 Stairs | C147647 | FAC084-Part I: Walk Up 20 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. | FACIT-Dyspnea 10 Item Short Form - Part I: Walk Up 20 Stairs | ||
FAC084-Part I: Washing Dishes Why Not | C147652 | FAC084-Part I: Washing Dishes Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes Why Not | ||
FAC084-Part I: Washing Dishes | C147651 | FAC084-Part I: Washing Dishes | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part I. Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. | FACIT-Dyspnea 10 Item Short Form - Part I: Washing Dishes | ||
FAC084-Part II: Carry 10-20 Lbs | C147671 | FAC084-Part II: Carry 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Dyspnea 10 Item Short Form - Part II: Carry 10-20 Lbs | ||
FAC084-Part II: Dressing Without Help | C147663 | FAC084-Part II: Dressing Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dressing yourself without help. | FACIT-Dyspnea 10 Item Short Form - Part II: Dressing Without Help | ||
FAC084-Part II: Lifting 10-20 Lbs | C147670 | FAC084-Part II: Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Dyspnea 10 Item Short Form - Part II: Lifting 10-20 Lbs | ||
FAC084-Part II: Making a Bed | C147669 | FAC084-Part II: Making a Bed | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Making a bed. | FACIT-Dyspnea 10 Item Short Form - Part II: Making a Bed | ||
FAC084-Part II: Preparing Meals | C147666 | FAC084-Part II: Preparing Meals | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Preparing meals. | FACIT-Dyspnea 10 Item Short Form - Part II: Preparing Meals | ||
FAC084-Part II: Sweeping/Mopping | C147668 | FAC084-Part II: Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Sweeping or mopping. | FACIT-Dyspnea 10 Item Short Form - Part II: Sweeping/Mopping | ||
FAC084-Part II: Walk 50 Steps | C147664 | FAC084-Part II: Walk 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea 10 Item Short Form - Part II: Walk 50 Steps | ||
FAC084-Part II: Walk for 1/2 Mile | C147672 | FAC084-Part II: Walk for 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Dyspnea 10 Item Short Form - Part II: Walk for 1/2 Mile | ||
FAC084-Part II: Walk Up 20 Stairs | C147665 | FAC084-Part II: Walk Up 20 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 20 stairs (2 flights) without stopping. | FACIT-Dyspnea 10 Item Short Form - Part II: Walk Up 20 Stairs | ||
FAC084-Part II: Washing Dishes | C147667 | FAC084-Part II: Washing Dishes | Functional Assessment of Chronic Illness Therapy-Dyspnea 10 Item Short Form - Part II Functional Limitation. Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Washing dishes. | FACIT-Dyspnea 10 Item Short Form - Part II: Washing Dishes | ||
Back to top | ||||||
CL.C154451.FAC100TC | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire Test Code
(FAC100TC) | text
Extensible: No | C154451 | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire Test Code | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank test code. | CDISC Questionnaire FACIT-Dyspnea Scale 33 Item Bank Version Test Code Terminology |
FAC10001 | C155482 | FAC100-Sev: Dressing Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Without Help | ||
FAC10002 | C155483 | FAC100-Sev: Dressing Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Why Not | ||
FAC10003 | C155484 | FAC100-Sev: Walk 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps | ||
FAC10004 | C155485 | FAC100-Sev: Walk 50 Steps Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps Why Not | ||
FAC10005 | C155486 | FAC100-Sev: Walk Up 20 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs | ||
FAC10006 | C155487 | FAC100-Sev: Walk Up 20 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs Why Not | ||
FAC10007 | C155488 | FAC100-Sev: Preparing Meals | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Preparing meals. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals | ||
FAC10008 | C155489 | FAC100-Sev: Preparing Meals Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Preparing meals. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals Why Not | ||
FAC10009 | C155490 | FAC100-Sev: Washing Dishes | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes | ||
FAC10010 | C155491 | FAC100-Sev: Washing Dishes Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes Why Not | ||
FAC10011 | C155492 | FAC100-Sev: Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping | ||
FAC10012 | C155493 | FAC100-Sev: Sweeping/Mopping Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping Why Not | ||
FAC10013 | C155494 | FAC100-Sev: Making a Bed | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed | ||
FAC10014 | C155495 | FAC100-Sev: Making a Bed Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed Why Not | ||
FAC10015 | C155496 | FAC100-Sev: Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs | ||
FAC10016 | C155497 | FAC100-Sev: Lifting 10-20 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs Why Not | ||
FAC10017 | C155498 | FAC100-Sev: Carry 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs | ||
FAC10018 | C155499 | FAC100-Sev: Carry 10-20 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs Why Not | ||
FAC10019 | C155500 | FAC100-Sev: Walk for 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile | ||
FAC10020 | C155501 | FAC100-Sev: Walk for 1/2 Mile Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile Why Not | ||
FAC10021 | C155502 | FAC100-Sev: Bath Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a bath without help. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help | ||
FAC10022 | C155503 | FAC100-Sev: Bath Without Help Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a bath without help. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help Why Not | ||
FAC10023 | C155504 | FAC100-Sev: Taking a Shower | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a shower. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower | ||
FAC10024 | C155505 | FAC100-Sev: Taking a Shower Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a shower. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower Why Not | ||
FAC10025 | C155506 | FAC100-Sev: Putting on Socks | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Putting on socks or stockings. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks | ||
FAC10026 | C155507 | FAC100-Sev: Putting on Socks Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Putting on socks or stockings. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks Why Not | ||
FAC10027 | C155508 | FAC100-Sev: Standing 5 Minutes | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Standing for at least 5 minutes. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes | ||
FAC10028 | C155509 | FAC100-Sev: Standing 5 Minutes Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Standing for at least 5 minutes. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes Why Not | ||
FAC10029 | C155510 | FAC100-Sev: Walking 10 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 10 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps | ||
FAC10030 | C155511 | FAC100-Sev: Walking 10 Steps Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 10 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps Why Not | ||
FAC10031 | C155512 | FAC100-Sev: Walking 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile | ||
FAC10032 | C155513 | FAC100-Sev: Walking 1/2 Mile Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile Why Not | ||
FAC10033 | C155514 | FAC100-Sev: Walking Up 5 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 5 stairs without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs | ||
FAC10034 | C155515 | FAC100-Sev: Walking Up 5 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 5 stairs without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs Why Not | ||
FAC10035 | C155516 | FAC100-Sev: Walking Up 10 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 10 stairs (1 flight) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs | ||
FAC10036 | C155517 | FAC100-Sev: Walking Up 10 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 10 stairs (1 flight) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs Why Not | ||
FAC10037 | C155518 | FAC100-Sev: Walking Up 30 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 30 stairs (3 flights) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs | ||
FAC10038 | C155519 | FAC100-Sev: Walking Up 30 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 30 stairs (3 flights) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs Why Not | ||
FAC10039 | C155520 | FAC100-Sev: Lift Less Than 5 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs | ||
FAC10040 | C155521 | FAC100-Sev: Lift Less Than 5 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs Why Not | ||
FAC10041 | C155522 | FAC100-Sev: Lifting 5-10 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs | ||
FAC10042 | C155523 | FAC100-Sev: Lifting 5-10 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs Why Not | ||
FAC10043 | C155524 | FAC100-Sev: Lift More Than 20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs | ||
FAC10044 | C155525 | FAC100-Sev: Lift More Than 20 Lb Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs Why Not | ||
FAC10045 | C155526 | FAC100-Sev: Carrying Less Than 5 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Lbs | ||
FAC10046 | C155527 | FAC100-Sev: Carrying Less Than 5 Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Why Not | ||
FAC10047 | C155528 | FAC100-Sev: Carrying 5-10 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs | ||
FAC10048 | C155529 | FAC100-Sev: Carrying 5-10 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs Why Not | ||
FAC10049 | C155530 | FAC100-Sev: Get In/Out of a Car | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Getting in or out of a car. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car | ||
FAC10050 | C155531 | FAC100-Sev: Get In/Out of a Car Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Getting in or out of a car. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car Why Not | ||
FAC10051 | C155532 | FAC100-Sev: Dining Out | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dining out. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out | ||
FAC10052 | C155533 | FAC100-Sev: Dining Out Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dining out. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out Why Not | ||
FAC10053 | C155534 | FAC100-Sev: Low-intensity Activ | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Low-intensity leisure activity (gardening, etc.). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity | ||
FAC10054 | C155535 | FAC100-Sev: Low-intensity Activ Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Low-intensity leisure activity (gardening, etc.). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity Why Not | ||
FAC10055 | C155536 | FAC100-Sev: Moderate Activity | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Moderate-intensity leisure activity (bicycling on level terrain, etc.). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity | ||
FAC10056 | C155537 | FAC100-Sev: Moderate Activity Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Moderate-intensity leisure activity (bicycling on level terrain, etc.). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity Why Not | ||
FAC10057 | C155538 | FAC100-Sev: Walk Fast 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 50 steps without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps | ||
FAC10058 | C155539 | FAC100-Sev: Walk Fast 50 Steps Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 50 steps without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps Why Not | ||
FAC10059 | C155540 | FAC100-Sev: Walking Fast 1 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for at least 1 mile ( a little more than 1.5 km) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile | ||
FAC10060 | C155541 | FAC100-Sev: Walking Fast 1 Mile Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for at least 1 mile ( a little more than 1.5 km) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile Why Not | ||
FAC10061 | C155542 | FAC100-Sev: Singing or Humming | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Singing or humming. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming | ||
FAC10062 | C155543 | FAC100-Sev: Singing or Humming Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Singing or humming. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming Why Not | ||
FAC10063 | C155544 | FAC100-Sev: Talking While Walking | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Talking while walking. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walking | ||
FAC10064 | C155545 | FAC100-Sev: Talking While Walk Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Talking while walking. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walk Why Not | ||
FAC10065 | C155546 | FAC100-Sev: Scrubbing the Floor | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Scrubbing the floor or counter. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor | ||
FAC10066 | C155547 | FAC100-Sev: Scrubbing the Floor Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Scrubbing the floor or counter. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor Why Not | ||
FAC10067 | C155548 | FAC100-Limit: Dressing Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dressing yourself without help. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dressing Without Help | ||
FAC10068 | C155549 | FAC100-Limit: Walk 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk 50 Steps | ||
FAC10069 | C155550 | FAC100-Limit: Walk Up 20 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 20 stairs (2 flights) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Up 20 Stairs | ||
FAC10070 | C155551 | FAC100-Limit: Preparing Meals | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Preparing meals. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Preparing Meals | ||
FAC10071 | C155552 | FAC100-Limit: Washing Dishes | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Washing dishes. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Washing Dishes | ||
FAC10072 | C155553 | FAC100-Limit: Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Sweeping or mopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Sweeping/Mopping | ||
FAC10073 | C155554 | FAC100-Limit: Making a Bed | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Making a bed. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Making a Bed | ||
FAC10074 | C155555 | FAC100-Limit: Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 10-20 Lbs | ||
FAC10075 | C155556 | FAC100-Limit: Carry 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carry 10-20 Lbs | ||
FAC10076 | C155557 | FAC100-Limit: Walk for 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk for 1/2 Mile | ||
FAC10077 | C155558 | FAC100-Limit: Taking a Bath Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Taking a bath without help. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Bath Without Help | ||
FAC10078 | C155559 | FAC100-Limit: Taking a Shower | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Taking a shower. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Shower | ||
FAC10079 | C155560 | FAC100-Limit: Putting on Socks | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Putting on socks or stockings. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Putting on Socks | ||
FAC10080 | C155561 | FAC100-Limit: Standing 5 Minutes | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Standing for at least 5 minutes. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Standing 5 Minutes | ||
FAC10081 | C155562 | FAC100-Limit: Walking 10 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 10 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 10 Steps | ||
FAC10082 | C155563 | FAC100-Limit: Walking 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 1/2 Mile | ||
FAC10083 | C155564 | FAC100-Limit: Walking Up 5 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 5 stairs without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 5 Stairs | ||
FAC10084 | C155565 | FAC100-Limit: Walking Up 10 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 10 stairs (1 flight) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 10 Stairs | ||
FAC10085 | C155566 | FAC100-Limit: Walking Up 30 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 30 stairs (3 flights) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 30 Stairs | ||
FAC10086 | C155567 | FAC100-Limit: Scrubbing the Floor | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Scrubbing the floor or counter. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Scrubbing the Floor | ||
FAC10087 | C155568 | FAC100-Limit: Lifting Less Than 5 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting Less Than 5 Lbs | ||
FAC10088 | C155569 | FAC100-Limit: Lifting 5-10 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 5-10 Lbs | ||
FAC10089 | C155570 | FAC100-Limit: Lifting More Than 20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting More Than 20 Lbs | ||
FAC10090 | C155571 | FAC100-Limit: Carrying Less Than 5 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying Less Than 5 Lbs | ||
FAC10091 | C155572 | FAC100-Limit: Carrying 5-10 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying 5-10 Lbs | ||
FAC10092 | C155573 | FAC100-Limit: Get In/Out of a Car | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Getting in or out of a car. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Get In/Out of a Car | ||
FAC10093 | C155574 | FAC100-Limit: Dining Out | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dining out. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dining Out | ||
FAC10094 | C155575 | FAC100-Limit: Low-intensity Activity | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Low-intensity leisure activity (gardening, etc.). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Low-intensity Activity | ||
FAC10095 | C155576 | FAC100-Limit: Moderate Activity | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Moderate-intensity leisure activity (bicycling on level terrain, etc.). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Moderate Activity | ||
FAC10096 | C155577 | FAC100-Limit: Walk Fast 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 50 steps without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Fast 50 Steps | ||
FAC10097 | C155578 | FAC100-Limit: Walking Fast 1 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Fast 1 Mile | ||
FAC10098 | C155579 | FAC100-Limit: Singing or Humming | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Singing or humming. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Singing or Humming | ||
FAC10099 | C155580 | FAC100-Limit: Talking While Walking | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Talking while walking. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Talking While Walking | ||
Back to top | ||||||
CL.C154450.FAC100TN | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire Test Name
(FAC100TN) | text
Extensible: No | C154450 | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank Questionnaire Test Name | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank test name. | CDISC Questionnaire FACIT-Dyspnea Scale 33 Item Bank Version Test Name Terminology |
FAC100-Limit: Carry 10-20 Lbs | C155556 | FAC100-Limit: Carry 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carry 10-20 Lbs | ||
FAC100-Limit: Carrying 5-10 Lbs | C155572 | FAC100-Limit: Carrying 5-10 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying 5-10 Lbs | ||
FAC100-Limit: Carrying Less Than 5 Lbs | C155571 | FAC100-Limit: Carrying Less Than 5 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Carrying Less Than 5 Lbs | ||
FAC100-Limit: Dining Out | C155574 | FAC100-Limit: Dining Out | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dining out. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dining Out | ||
FAC100-Limit: Dressing Without Help | C155548 | FAC100-Limit: Dressing Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Dressing yourself without help. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Dressing Without Help | ||
FAC100-Limit: Get In/Out of a Car | C155573 | FAC100-Limit: Get In/Out of a Car | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Getting in or out of a car. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Get In/Out of a Car | ||
FAC100-Limit: Lifting 10-20 Lbs | C155555 | FAC100-Limit: Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 10-20 Lbs | ||
FAC100-Limit: Lifting 5-10 Lbs | C155569 | FAC100-Limit: Lifting 5-10 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting 5-10 Lbs | ||
FAC100-Limit: Lifting Less Than 5 Lbs | C155568 | FAC100-Limit: Lifting Less Than 5 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting Less Than 5 Lbs | ||
FAC100-Limit: Lifting More Than 20 Lbs | C155570 | FAC100-Limit: Lifting More Than 20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Lifting More Than 20 Lbs | ||
FAC100-Limit: Low-intensity Activity | C155575 | FAC100-Limit: Low-intensity Activity | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Low-intensity leisure activity (gardening, etc.). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Low-intensity Activity | ||
FAC100-Limit: Making a Bed | C155554 | FAC100-Limit: Making a Bed | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Making a bed. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Making a Bed | ||
FAC100-Limit: Moderate Activity | C155576 | FAC100-Limit: Moderate Activity | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Moderate-intensity leisure activity (bicycling on level terrain, etc.). | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Moderate Activity | ||
FAC100-Limit: Preparing Meals | C155551 | FAC100-Limit: Preparing Meals | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Preparing meals. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Preparing Meals | ||
FAC100-Limit: Putting on Socks | C155560 | FAC100-Limit: Putting on Socks | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Putting on socks or stockings. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Putting on Socks | ||
FAC100-Limit: Scrubbing the Floor | C155567 | FAC100-Limit: Scrubbing the Floor | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Scrubbing the floor or counter. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Scrubbing the Floor | ||
FAC100-Limit: Singing or Humming | C155579 | FAC100-Limit: Singing or Humming | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Singing or humming. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Singing or Humming | ||
FAC100-Limit: Standing 5 Minutes | C155561 | FAC100-Limit: Standing 5 Minutes | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Standing for at least 5 minutes. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Standing 5 Minutes | ||
FAC100-Limit: Sweeping/Mopping | C155553 | FAC100-Limit: Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Sweeping or mopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Sweeping/Mopping | ||
FAC100-Limit: Taking a Bath Without Help | C155558 | FAC100-Limit: Taking a Bath Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Taking a bath without help. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Bath Without Help | ||
FAC100-Limit: Taking a Shower | C155559 | FAC100-Limit: Taking a Shower | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Taking a shower. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Taking a Shower | ||
FAC100-Limit: Talking While Walking | C155580 | FAC100-Limit: Talking While Walking | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Talking while walking. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Talking While Walking | ||
FAC100-Limit: Walk 50 Steps | C155549 | FAC100-Limit: Walk 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk 50 Steps | ||
FAC100-Limit: Walk Fast 50 Steps | C155577 | FAC100-Limit: Walk Fast 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 50 steps without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Fast 50 Steps | ||
FAC100-Limit: Walk for 1/2 Mile | C155557 | FAC100-Limit: Walk for 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk for 1/2 Mile | ||
FAC100-Limit: Walk Up 20 Stairs | C155550 | FAC100-Limit: Walk Up 20 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 20 stairs (2 flights) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walk Up 20 Stairs | ||
FAC100-Limit: Walking 1/2 Mile | C155563 | FAC100-Limit: Walking 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 1/2 Mile | ||
FAC100-Limit: Walking 10 Steps | C155562 | FAC100-Limit: Walking 10 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking 10 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking 10 Steps | ||
FAC100-Limit: Walking Fast 1 Mile | C155578 | FAC100-Limit: Walking Fast 1 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Fast 1 Mile | ||
FAC100-Limit: Walking Up 10 Stairs | C155565 | FAC100-Limit: Walking Up 10 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 10 stairs (1 flight) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 10 Stairs | ||
FAC100-Limit: Walking Up 30 Stairs | C155566 | FAC100-Limit: Walking Up 30 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 30 stairs (3 flights) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 30 Stairs | ||
FAC100-Limit: Walking Up 5 Stairs | C155564 | FAC100-Limit: Walking Up 5 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Walking up 5 stairs without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Walking Up 5 Stairs | ||
FAC100-Limit: Washing Dishes | C155552 | FAC100-Limit: Washing Dishes | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Functional Limitation: Considering your shortness of breath over the past 7 days, rate the amount of difficulty you had when doing the following activities: Washing dishes. | FACIT-Dyspnea Scale 33 Item Bank Version - Limit: Washing Dishes | ||
FAC100-Sev: Bath Without Help Why Not | C155503 | FAC100-Sev: Bath Without Help Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a bath without help. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help Why Not | ||
FAC100-Sev: Bath Without Help | C155502 | FAC100-Sev: Bath Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a bath without help. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Bath Without Help | ||
FAC100-Sev: Carry 10-20 Lbs Why Not | C155499 | FAC100-Sev: Carry 10-20 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs Why Not | ||
FAC100-Sev: Carry 10-20 Lbs | C155498 | FAC100-Sev: Carry 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carry 10-20 Lbs | ||
FAC100-Sev: Carrying 5-10 Lbs Why Not | C155529 | FAC100-Sev: Carrying 5-10 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs Why Not | ||
FAC100-Sev: Carrying 5-10 Lbs | C155528 | FAC100-Sev: Carrying 5-10 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying 5-10 Lbs | ||
FAC100-Sev: Carrying Less Than 5 Lbs | C155526 | FAC100-Sev: Carrying Less Than 5 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Lbs | ||
FAC100-Sev: Carrying Less Than 5 Why Not | C155527 | FAC100-Sev: Carrying Less Than 5 Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Carrying Less Than 5 Why Not | ||
FAC100-Sev: Dining Out Why Not | C155533 | FAC100-Sev: Dining Out Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dining out. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out Why Not | ||
FAC100-Sev: Dining Out | C155532 | FAC100-Sev: Dining Out | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dining out. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dining Out | ||
FAC100-Sev: Dressing Why Not | C155483 | FAC100-Sev: Dressing Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Why Not | ||
FAC100-Sev: Dressing Without Help | C155482 | FAC100-Sev: Dressing Without Help | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Dressing yourself without help. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Dressing Without Help | ||
FAC100-Sev: Get In/Out of a Car Why Not | C155531 | FAC100-Sev: Get In/Out of a Car Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Getting in or out of a car. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car Why Not | ||
FAC100-Sev: Get In/Out of a Car | C155530 | FAC100-Sev: Get In/Out of a Car | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Getting in or out of a car. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Get In/Out of a Car | ||
FAC100-Sev: Lift Less Than 5 Lbs Why Not | C155521 | FAC100-Sev: Lift Less Than 5 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs Why Not | ||
FAC100-Sev: Lift Less Than 5 Lbs | C155520 | FAC100-Sev: Lift Less Than 5 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing less than 5 lbs (about 2 kg, like a houseplant). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift Less Than 5 Lbs | ||
FAC100-Sev: Lift More Than 20 Lb Why Not | C155525 | FAC100-Sev: Lift More Than 20 Lb Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs Why Not | ||
FAC100-Sev: Lift More Than 20 Lbs | C155524 | FAC100-Sev: Lift More Than 20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lift More Than 20 Lbs | ||
FAC100-Sev: Lifting 10-20 Lbs Why Not | C155497 | FAC100-Sev: Lifting 10-20 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs Why Not | ||
FAC100-Sev: Lifting 10-20 Lbs | C155496 | FAC100-Sev: Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 10-20 Lbs | ||
FAC100-Sev: Lifting 5-10 Lbs Why Not | C155523 | FAC100-Sev: Lifting 5-10 Lbs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs Why Not | ||
FAC100-Sev: Lifting 5-10 Lbs | C155522 | FAC100-Sev: Lifting 5-10 Lbs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Lifting 5-10 Lbs | ||
FAC100-Sev: Low-intensity Activ Why Not | C155535 | FAC100-Sev: Low-intensity Activ Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Low-intensity leisure activity (gardening, etc.). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity Why Not | ||
FAC100-Sev: Low-intensity Activ | C155534 | FAC100-Sev: Low-intensity Activ | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Low-intensity leisure activity (gardening, etc.). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Low-intensity Activity | ||
FAC100-Sev: Making a Bed Why Not | C155495 | FAC100-Sev: Making a Bed Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed Why Not | ||
FAC100-Sev: Making a Bed | C155494 | FAC100-Sev: Making a Bed | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Making a bed. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Making a Bed | ||
FAC100-Sev: Moderate Activity Why Not | C155537 | FAC100-Sev: Moderate Activity Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Moderate-intensity leisure activity (bicycling on level terrain, etc.). Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity Why Not | ||
FAC100-Sev: Moderate Activity | C155536 | FAC100-Sev: Moderate Activity | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Moderate-intensity leisure activity (bicycling on level terrain, etc.). | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Moderate Activity | ||
FAC100-Sev: Preparing Meals Why Not | C155489 | FAC100-Sev: Preparing Meals Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Preparing meals. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals Why Not | ||
FAC100-Sev: Preparing Meals | C155488 | FAC100-Sev: Preparing Meals | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Preparing meals. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Preparing Meals | ||
FAC100-Sev: Putting on Socks Why Not | C155507 | FAC100-Sev: Putting on Socks Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Putting on socks or stockings. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks Why Not | ||
FAC100-Sev: Putting on Socks | C155506 | FAC100-Sev: Putting on Socks | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Putting on socks or stockings. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Putting on Socks | ||
FAC100-Sev: Scrubbing the Floor Why Not | C155547 | FAC100-Sev: Scrubbing the Floor Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Scrubbing the floor or counter. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor Why Not | ||
FAC100-Sev: Scrubbing the Floor | C155546 | FAC100-Sev: Scrubbing the Floor | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Scrubbing the floor or counter. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Scrubbing the Floor | ||
FAC100-Sev: Singing or Humming Why Not | C155543 | FAC100-Sev: Singing or Humming Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Singing or humming. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming Why Not | ||
FAC100-Sev: Singing or Humming | C155542 | FAC100-Sev: Singing or Humming | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Singing or humming. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Singing or Humming | ||
FAC100-Sev: Standing 5 Minutes Why Not | C155509 | FAC100-Sev: Standing 5 Minutes Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Standing for at least 5 minutes. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes Why Not | ||
FAC100-Sev: Standing 5 Minutes | C155508 | FAC100-Sev: Standing 5 Minutes | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Standing for at least 5 minutes. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Standing 5 Minutes | ||
FAC100-Sev: Sweeping/Mopping Why Not | C155493 | FAC100-Sev: Sweeping/Mopping Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping Why Not | ||
FAC100-Sev: Sweeping/Mopping | C155492 | FAC100-Sev: Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Sweeping or mopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Sweeping/Mopping | ||
FAC100-Sev: Taking a Shower Why Not | C155505 | FAC100-Sev: Taking a Shower Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a shower. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower Why Not | ||
FAC100-Sev: Taking a Shower | C155504 | FAC100-Sev: Taking a Shower | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Taking a shower. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Taking a Shower | ||
FAC100-Sev: Talking While Walk Why Not | C155545 | FAC100-Sev: Talking While Walk Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Talking while walking. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walk Why Not | ||
FAC100-Sev: Talking While Walking | C155544 | FAC100-Sev: Talking While Walking | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Talking while walking. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Talking While Walking | ||
FAC100-Sev: Walk 50 Steps Why Not | C155485 | FAC100-Sev: Walk 50 Steps Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps Why Not | ||
FAC100-Sev: Walk 50 Steps | C155484 | FAC100-Sev: Walk 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk 50 Steps | ||
FAC100-Sev: Walk Fast 50 Steps Why Not | C155539 | FAC100-Sev: Walk Fast 50 Steps Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 50 steps without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps Why Not | ||
FAC100-Sev: Walk Fast 50 Steps | C155538 | FAC100-Sev: Walk Fast 50 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 50 steps without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Fast 50 Steps | ||
FAC100-Sev: Walk for 1/2 Mile Why Not | C155501 | FAC100-Sev: Walk for 1/2 Mile Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile Why Not | ||
FAC100-Sev: Walk for 1/2 Mile | C155500 | FAC100-Sev: Walk for 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk for 1/2 Mile | ||
FAC100-Sev: Walk Up 20 Stairs Why Not | C155487 | FAC100-Sev: Walk Up 20 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs Why Not | ||
FAC100-Sev: Walk Up 20 Stairs | C155486 | FAC100-Sev: Walk Up 20 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 20 stairs (2 flights) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walk Up 20 Stairs | ||
FAC100-Sev: Walking 1/2 Mile Why Not | C155513 | FAC100-Sev: Walking 1/2 Mile Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile Why Not | ||
FAC100-Sev: Walking 1/2 Mile | C155512 | FAC100-Sev: Walking 1/2 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 1/2 mile (almost 1 km) on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 1/2 Mile | ||
FAC100-Sev: Walking 10 Steps Why Not | C155511 | FAC100-Sev: Walking 10 Steps Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 10 steps/paces on flat ground at a normal speed without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps Why Not | ||
FAC100-Sev: Walking 10 Steps | C155510 | FAC100-Sev: Walking 10 Steps | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking 10 steps/paces on flat ground at a normal speed without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking 10 Steps | ||
FAC100-Sev: Walking Fast 1 Mile Why Not | C155541 | FAC100-Sev: Walking Fast 1 Mile Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for at least 1 mile ( a little more than 1.5 km) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile Why Not | ||
FAC100-Sev: Walking Fast 1 Mile | C155540 | FAC100-Sev: Walking Fast 1 Mile | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking (faster than your usual speed) for at least 1 mile ( a little more than 1.5 km) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Fast 1 Mile | ||
FAC100-Sev: Walking Up 10 Stairs Why Not | C155517 | FAC100-Sev: Walking Up 10 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 10 stairs (1 flight) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs Why Not | ||
FAC100-Sev: Walking Up 10 Stairs | C155516 | FAC100-Sev: Walking Up 10 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 10 stairs (1 flight) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 10 Stairs | ||
FAC100-Sev: Walking Up 30 Stairs Why Not | C155519 | FAC100-Sev: Walking Up 30 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 30 stairs (3 flights) without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs Why Not | ||
FAC100-Sev: Walking Up 30 Stairs | C155518 | FAC100-Sev: Walking Up 30 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 30 stairs (3 flights) without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 30 Stairs | ||
FAC100-Sev: Walking Up 5 Stairs Why Not | C155515 | FAC100-Sev: Walking Up 5 Stairs Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 5 stairs without stopping. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs Why Not | ||
FAC100-Sev: Walking Up 5 Stairs | C155514 | FAC100-Sev: Walking Up 5 Stairs | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Walking up 5 stairs without stopping. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Walking Up 5 Stairs | ||
FAC100-Sev: Washing Dishes Why Not | C155491 | FAC100-Sev: Washing Dishes Why Not | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. Please indicate why you did not do this in the past 7 days. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes Why Not | ||
FAC100-Sev: Washing Dishes | C155490 | FAC100-Sev: Washing Dishes | Functional Assessment of Chronic Illness Therapy-Dyspnea Scale 33 Item Bank - Dyspnea Severity: Over the past 7 days, how short of breath did you get with each of these activities?: Washing dishes. | FACIT-Dyspnea Scale 33 Item Bank Version - Severity: Washing Dishes | ||
Back to top | ||||||
CL.C147544.FAC070TC | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire Test Code
(FAC070TC) | text
Extensible: No | C147544 | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire Test Code | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 test code. | CDISC Questionnaire FACIT-Fatigue 13-Item Version 4 Test Code Terminology |
FAC07001 | C147673 | FAC070-I Feel Fatigued | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel fatigued. | FACIT-Fatigue 13-Item Version 4 - I Feel Fatigued | ||
FAC07002 | C147674 | FAC070-I Feel Weak All Over | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel weak all over. | FACIT-Fatigue 13-Item Version 4 - I Feel Weak All Over | ||
FAC07003 | C147675 | FAC070-I Feel Listless | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel listless ("washed out"). | FACIT-Fatigue 13-Item Version 4 - I Feel Listless | ||
FAC07004 | C147676 | FAC070-I Feel Tired | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel tired. | FACIT-Fatigue 13-Item Version 4 - I Feel Tired | ||
FAC07005 | C147677 | FAC070-Trouble Starting Things | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have trouble starting things because I am tired. | FACIT-Fatigue 13-Item Version 4 - Trouble Starting Things | ||
FAC07006 | C147678 | FAC070-Trouble Finishing Things | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have trouble finishing things because I am tired. | FACIT-Fatigue 13-Item Version 4 - Trouble Finishing Things | ||
FAC07007 | C147679 | FAC070-I Have Energy | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have energy. | FACIT-Fatigue 13-Item Version 4 - I Have Energy | ||
FAC07008 | C147680 | FAC070-Able to Do My Usual Activities | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am able to do my usual activities. | FACIT-Fatigue 13-Item Version 4 - Able to Do My Usual Activities | ||
FAC07009 | C147681 | FAC070-I Need to Sleep During the Day | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I need to sleep during the day. | FACIT-Fatigue 13-Item Version 4 - I Need to Sleep During the Day | ||
FAC07010 | C147682 | FAC070-I Am Too Tired to Eat | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am too tired to eat. | FACIT-Fatigue 13-Item Version 4 - I Am Too Tired to Eat | ||
FAC07011 | C147683 | FAC070-Need Help Doing Usual Activities | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I need help doing my usual activities. | FACIT-Fatigue 13-Item Version 4 - Need Help Doing Usual Activities | ||
FAC07012 | C147684 | FAC070-Frustrated by Being Too Tired | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am frustrated by being too tired to do the things I want to do. | FACIT-Fatigue 13-Item Version 4 - Frustrated by Being Too Tired | ||
FAC07013 | C147685 | FAC070-Limit Social Activity, I am Tired | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have to limit my social activity because I am tired. | FACIT-Fatigue 13-Item Version 4 - Limit Social Activity, I am Tired | ||
FAC07014 | C163947 | FAC070-Total Score | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - Total score. | FACIT-Fatigue 13-Item Version 4 - Total Score | ||
Back to top | ||||||
CL.C147543.FAC070TN | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire Test Name
(FAC070TN) | text
Extensible: No | C147543 | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 Questionnaire Test Name | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 test name. | CDISC Questionnaire FACIT-Fatigue 13-Item Version 4 Test Name Terminology |
FAC070-Able to Do My Usual Activities | C147680 | FAC070-Able to Do My Usual Activities | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am able to do my usual activities. | FACIT-Fatigue 13-Item Version 4 - Able to Do My Usual Activities | ||
FAC070-Frustrated by Being Too Tired | C147684 | FAC070-Frustrated by Being Too Tired | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am frustrated by being too tired to do the things I want to do. | FACIT-Fatigue 13-Item Version 4 - Frustrated by Being Too Tired | ||
FAC070-I Am Too Tired to Eat | C147682 | FAC070-I Am Too Tired to Eat | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I am too tired to eat. | FACIT-Fatigue 13-Item Version 4 - I Am Too Tired to Eat | ||
FAC070-I Feel Fatigued | C147673 | FAC070-I Feel Fatigued | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel fatigued. | FACIT-Fatigue 13-Item Version 4 - I Feel Fatigued | ||
FAC070-I Feel Listless | C147675 | FAC070-I Feel Listless | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel listless ("washed out"). | FACIT-Fatigue 13-Item Version 4 - I Feel Listless | ||
FAC070-I Feel Tired | C147676 | FAC070-I Feel Tired | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel tired. | FACIT-Fatigue 13-Item Version 4 - I Feel Tired | ||
FAC070-I Feel Weak All Over | C147674 | FAC070-I Feel Weak All Over | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I feel weak all over. | FACIT-Fatigue 13-Item Version 4 - I Feel Weak All Over | ||
FAC070-I Have Energy | C147679 | FAC070-I Have Energy | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have energy. | FACIT-Fatigue 13-Item Version 4 - I Have Energy | ||
FAC070-I Need to Sleep During the Day | C147681 | FAC070-I Need to Sleep During the Day | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I need to sleep during the day. | FACIT-Fatigue 13-Item Version 4 - I Need to Sleep During the Day | ||
FAC070-Limit Social Activity, I am Tired | C147685 | FAC070-Limit Social Activity, I am Tired | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have to limit my social activity because I am tired. | FACIT-Fatigue 13-Item Version 4 - Limit Social Activity, I am Tired | ||
FAC070-Need Help Doing Usual Activities | C147683 | FAC070-Need Help Doing Usual Activities | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I need help doing my usual activities. | FACIT-Fatigue 13-Item Version 4 - Need Help Doing Usual Activities | ||
FAC070-Total Score | C163947 | FAC070-Total Score | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - Total score. | FACIT-Fatigue 13-Item Version 4 - Total Score | ||
FAC070-Trouble Finishing Things | C147678 | FAC070-Trouble Finishing Things | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have trouble finishing things because I am tired. | FACIT-Fatigue 13-Item Version 4 - Trouble Finishing Things | ||
FAC070-Trouble Starting Things | C147677 | FAC070-Trouble Starting Things | Functional Assessment of Chronic Illness Therapy-Fatigue 13-Item Scale Version 4 - I have trouble starting things because I am tired. | FACIT-Fatigue 13-Item Version 4 - Trouble Starting Things | ||
Back to top | ||||||
CL.C129088.FAC071TC | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire Test Code
(FAC071TC) | text
Extensible: No | C129088 | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire Test Code | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 test code. | CDISC Questionnaire FACIT-F Version 4 Test Code Terminology |
FAC07101 | C129111 | FAC071-I Have a Lack of Energy | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have a lack of energy. | FACIT-F Version 4 - I Have a Lack of Energy | ||
FAC07102 | C129112 | FAC071-I Have Nausea | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have nausea. | FACIT-F Version 4 - I Have Nausea | ||
FAC07103 | C129113 | FAC071-Trouble Meeting Needs of Family | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACIT-F Version 4 - Trouble Meeting Needs of Family | ||
FAC07104 | C129114 | FAC071-I Have Pain | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have pain. | FACIT-F Version 4 - I Have Pain | ||
FAC07105 | C129115 | FAC071-Bothered by Treatment Side Effect | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACIT-F Version 4 - Bothered by Treatment Side Effect | ||
FAC07106 | C129116 | FAC071-I Feel Ill | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I feel ill. | FACIT-F Version 4 - I Feel Ill | ||
FAC07107 | C129117 | FAC071-I Am Forced to Spend Time in Bed | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACIT-F Version 4 - I Am Forced to Spend Time in Bed | ||
FAC07108 | C129118 | FAC071-I Feel Close to My Friends | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I feel close to my friends. | FACIT-F Version 4 - I Feel Close to My Friends | ||
FAC07109 | C129119 | FAC071-Get Emotional Support From Family | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACIT-F Version 4 - Get Emotional Support From Family | ||
FAC07110 | C129120 | FAC071-I Get Support From My Friends | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I get support from my friends. | FACIT-F Version 4 - I Get Support From My Friends | ||
FAC07111 | C129121 | FAC071-My Family Has Accepted My Illness | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACIT-F Version 4 - My Family Has Accepted My Illness | ||
FAC07112 | C129122 | FAC071-Satisfied Communication Illness | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACIT-F Version 4 - Satisfied Family Communication of Illness | ||
FAC07113 | C129123 | FAC071-I Feel Close to My Partner | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACIT-F Version 4 - I Feel Close to My Partner | ||
FAC07114 | C129124 | FAC071-I Am Satisfied With My Sex Life | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACIT-F Version 4 - I Am Satisfied With My Sex Life | ||
FAC07115 | C129125 | FAC071-I Feel Sad | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I feel sad. | FACIT-F Version 4 - I Feel Sad | ||
FAC07116 | C129126 | FAC071-Satisfied With How I Am Coping | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACIT-F Version 4 - Satisfied With How I Am Coping | ||
FAC07117 | C129127 | FAC071-Losing Hope Against Illness | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACIT-F Version 4 - Losing Hope Against Illness | ||
FAC07118 | C129128 | FAC071-I Feel Nervous | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I feel nervous. | FACIT-F Version 4 - I Feel Nervous | ||
FAC07119 | C129129 | FAC071-I Worry About Dying | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I worry about dying. | FACIT-F Version 4 - I Worry About Dying | ||
FAC07120 | C129130 | FAC071-Worry My Condition Will Get Worse | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACIT-F Version 4 - Worry My Condition Will Get Worse | ||
FAC07121 | C129131 | FAC071-I Am Able to Work | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am able to work (include work at home). | FACIT-F Version 4 - I Am Able to Work | ||
FAC07122 | C129132 | FAC071-My Work Is Fulfilling | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACIT-F Version 4 - My Work Is Fulfilling | ||
FAC07123 | C129133 | FAC071-I Am Able to Enjoy Life | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am able to enjoy life. | FACIT-F Version 4 - I Am Able to Enjoy Life | ||
FAC07124 | C129134 | FAC071-I Have Accepted My Illness | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I have accepted my illness. | FACIT-F Version 4 - I Have Accepted My Illness | ||
FAC07125 | C129135 | FAC071-I Am Sleeping Well | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am sleeping well. | FACIT-F Version 4 - I Am Sleeping Well | ||
FAC07126 | C129136 | FAC071-Enjoy Things I Usually Do for Fun | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACIT-F Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC07127 | C129137 | FAC071-Content With Quality of My Life | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACIT-F Version 4 - Content With Quality of My Life | ||
FAC07128 | C129138 | FAC071-I Feel Fatigued | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel fatigued. | FACIT-F Version 4 - I Feel Fatigued | ||
FAC07129 | C129139 | FAC071-I Feel Weak All Over | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel weak all over. | FACIT-F Version 4 - I Feel Weak All Over | ||
FAC07130 | C129140 | FAC071-I Feel Listless | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel listless ('washed out'). | FACIT-F Version 4 - I Feel Listless | ||
FAC07131 | C129141 | FAC071-I Feel Tired | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel tired. | FACIT-F Version 4 - I Feel Tired | ||
FAC07132 | C129142 | FAC071-Trouble Starting Things | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have trouble starting things because I am tired. | FACIT-F Version 4 - Trouble Starting Things | ||
FAC07133 | C129143 | FAC071-Trouble Finishing Things | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have trouble finishing things because I am tired. | FACIT-F Version 4 - Trouble Finishing Things | ||
FAC07134 | C129144 | FAC071-I Have Energy | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have energy. | FACIT-F Version 4 - I Have Energy | ||
FAC07135 | C129145 | FAC071-Able to Do My Usual Activities | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am able to do my usual activities. | FACIT-F Version 4 - Able to Do My Usual Activities | ||
FAC07136 | C129146 | FAC071-I Need to Sleep During the Day | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I need to sleep during the day. | FACIT-F Version 4 - I Need to Sleep During the Day | ||
FAC07137 | C129147 | FAC071-I Am Too Tired to Eat | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am too tired to eat. | FACIT-F Version 4 - I Am Too Tired to Eat | ||
FAC07138 | C129148 | FAC071-Need Help Doing Usual Activities | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I need help doing my usual activities. | FACIT-F Version 4 - Need Help Doing Usual Activities | ||
FAC07139 | C129149 | FAC071-Frustrated by Being Too Tired | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am frustrated by being too tired to do the things I want to do. | FACIT-F Version 4 - Frustrated by Being Too Tired | ||
FAC07140 | C129150 | FAC071-Limit Social Activity, I am Tired | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have to limit my social activity because I am tired. | FACIT-F Version 4 - Limit Social Activity, I am Tired | ||
FAC07141 | C166341 | FAC071-Physical Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: Subscale score. | FACIT-F Version 4 - Physical Subscale Score | ||
FAC07142 | C166342 | FAC071-Social/Family Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Socia/Family Well-Being: Subscale score. | FACIT-F Version 4 - Social/Family Subscale Score | ||
FAC07143 | C166343 | FAC071-Emotional Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: Subscale score. | FACIT-F Version 4 - Emotional Subscale Score | ||
FAC07144 | C166344 | FAC071-Functional Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: Subscale score. | FACIT-F Version 4 - Functional Subscale Score | ||
FAC07145 | C166345 | FAC071-Additional Concern Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: Subscale score. | FACIT-F Version 4 - Additional Concern Subscale Score | ||
FAC07146 | C166346 | FAC071-Trial Outcome Index Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Trial outcome index score. | FACIT-F Version 4 - Trial Outcome Index Score | ||
FAC07147 | C166347 | FAC071-FACT-G Total Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - FACT-G total score. | FACIT-F Version 4 - FACT-G Total Score | ||
FAC07148 | C166348 | FAC071-Total Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Total score. | FACIT-F Version 4 - Total Score | ||
Back to top | ||||||
CL.C129087.FAC071TN | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire Test Name
(FAC071TN) | text
Extensible: No | C129087 | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 Questionnaire Test Name | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 test name. | CDISC Questionnaire FACIT-F Version 4 Test Name Terminology |
FAC071-Able to Do My Usual Activities | C129145 | FAC071-Able to Do My Usual Activities | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am able to do my usual activities. | FACIT-F Version 4 - Able to Do My Usual Activities | ||
FAC071-Additional Concern Subscale Score | C166345 | FAC071-Additional Concern Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: Subscale score. | FACIT-F Version 4 - Additional Concern Subscale Score | ||
FAC071-Bothered by Treatment Side Effect | C129115 | FAC071-Bothered by Treatment Side Effect | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACIT-F Version 4 - Bothered by Treatment Side Effect | ||
FAC071-Content With Quality of My Life | C129137 | FAC071-Content With Quality of My Life | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACIT-F Version 4 - Content With Quality of My Life | ||
FAC071-Emotional Subscale Score | C166343 | FAC071-Emotional Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: Subscale score. | FACIT-F Version 4 - Emotional Subscale Score | ||
FAC071-Enjoy Things I Usually Do for Fun | C129136 | FAC071-Enjoy Things I Usually Do for Fun | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACIT-F Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC071-FACT-G Total Score | C166347 | FAC071-FACT-G Total Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - FACT-G total score. | FACIT-F Version 4 - FACT-G Total Score | ||
FAC071-Frustrated by Being Too Tired | C129149 | FAC071-Frustrated by Being Too Tired | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am frustrated by being too tired to do the things I want to do. | FACIT-F Version 4 - Frustrated by Being Too Tired | ||
FAC071-Functional Subscale Score | C166344 | FAC071-Functional Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: Subscale score. | FACIT-F Version 4 - Functional Subscale Score | ||
FAC071-Get Emotional Support From Family | C129119 | FAC071-Get Emotional Support From Family | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACIT-F Version 4 - Get Emotional Support From Family | ||
FAC071-I Am Able to Enjoy Life | C129133 | FAC071-I Am Able to Enjoy Life | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am able to enjoy life. | FACIT-F Version 4 - I Am Able to Enjoy Life | ||
FAC071-I Am Able to Work | C129131 | FAC071-I Am Able to Work | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am able to work (include work at home). | FACIT-F Version 4 - I Am Able to Work | ||
FAC071-I Am Forced to Spend Time in Bed | C129117 | FAC071-I Am Forced to Spend Time in Bed | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACIT-F Version 4 - I Am Forced to Spend Time in Bed | ||
FAC071-I Am Satisfied With My Sex Life | C129124 | FAC071-I Am Satisfied With My Sex Life | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACIT-F Version 4 - I Am Satisfied With My Sex Life | ||
FAC071-I Am Sleeping Well | C129135 | FAC071-I Am Sleeping Well | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I am sleeping well. | FACIT-F Version 4 - I Am Sleeping Well | ||
FAC071-I Am Too Tired to Eat | C129147 | FAC071-I Am Too Tired to Eat | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I am too tired to eat. | FACIT-F Version 4 - I Am Too Tired to Eat | ||
FAC071-I Feel Close to My Friends | C129118 | FAC071-I Feel Close to My Friends | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I feel close to my friends. | FACIT-F Version 4 - I Feel Close to My Friends | ||
FAC071-I Feel Close to My Partner | C129123 | FAC071-I Feel Close to My Partner | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACIT-F Version 4 - I Feel Close to My Partner | ||
FAC071-I Feel Fatigued | C129138 | FAC071-I Feel Fatigued | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel fatigued. | FACIT-F Version 4 - I Feel Fatigued | ||
FAC071-I Feel Ill | C129116 | FAC071-I Feel Ill | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I feel ill. | FACIT-F Version 4 - I Feel Ill | ||
FAC071-I Feel Listless | C129140 | FAC071-I Feel Listless | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel listless ('washed out'). | FACIT-F Version 4 - I Feel Listless | ||
FAC071-I Feel Nervous | C129128 | FAC071-I Feel Nervous | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I feel nervous. | FACIT-F Version 4 - I Feel Nervous | ||
FAC071-I Feel Sad | C129125 | FAC071-I Feel Sad | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I feel sad. | FACIT-F Version 4 - I Feel Sad | ||
FAC071-I Feel Tired | C129141 | FAC071-I Feel Tired | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel tired. | FACIT-F Version 4 - I Feel Tired | ||
FAC071-I Feel Weak All Over | C129139 | FAC071-I Feel Weak All Over | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I feel weak all over. | FACIT-F Version 4 - I Feel Weak All Over | ||
FAC071-I Get Support From My Friends | C129120 | FAC071-I Get Support From My Friends | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I get support from my friends. | FACIT-F Version 4 - I Get Support From My Friends | ||
FAC071-I Have a Lack of Energy | C129111 | FAC071-I Have a Lack of Energy | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have a lack of energy. | FACIT-F Version 4 - I Have a Lack of Energy | ||
FAC071-I Have Accepted My Illness | C129134 | FAC071-I Have Accepted My Illness | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: I have accepted my illness. | FACIT-F Version 4 - I Have Accepted My Illness | ||
FAC071-I Have Energy | C129144 | FAC071-I Have Energy | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have energy. | FACIT-F Version 4 - I Have Energy | ||
FAC071-I Have Nausea | C129112 | FAC071-I Have Nausea | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have nausea. | FACIT-F Version 4 - I Have Nausea | ||
FAC071-I Have Pain | C129114 | FAC071-I Have Pain | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: I have pain. | FACIT-F Version 4 - I Have Pain | ||
FAC071-I Need to Sleep During the Day | C129146 | FAC071-I Need to Sleep During the Day | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I need to sleep during the day. | FACIT-F Version 4 - I Need to Sleep During the Day | ||
FAC071-I Worry About Dying | C129129 | FAC071-I Worry About Dying | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I worry about dying. | FACIT-F Version 4 - I Worry About Dying | ||
FAC071-Limit Social Activity, I am Tired | C129150 | FAC071-Limit Social Activity, I am Tired | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have to limit my social activity because I am tired. | FACIT-F Version 4 - Limit Social Activity, I am Tired | ||
FAC071-Losing Hope Against Illness | C129127 | FAC071-Losing Hope Against Illness | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACIT-F Version 4 - Losing Hope Against Illness | ||
FAC071-My Family Has Accepted My Illness | C129121 | FAC071-My Family Has Accepted My Illness | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACIT-F Version 4 - My Family Has Accepted My Illness | ||
FAC071-My Work Is Fulfilling | C129132 | FAC071-My Work Is Fulfilling | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACIT-F Version 4 - My Work Is Fulfilling | ||
FAC071-Need Help Doing Usual Activities | C129148 | FAC071-Need Help Doing Usual Activities | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I need help doing my usual activities. | FACIT-F Version 4 - Need Help Doing Usual Activities | ||
FAC071-Physical Subscale Score | C166341 | FAC071-Physical Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: Subscale score. | FACIT-F Version 4 - Physical Subscale Score | ||
FAC071-Satisfied Communication Illness | C129122 | FAC071-Satisfied Communication Illness | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACIT-F Version 4 - Satisfied Family Communication of Illness | ||
FAC071-Satisfied With How I Am Coping | C129126 | FAC071-Satisfied With How I Am Coping | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACIT-F Version 4 - Satisfied With How I Am Coping | ||
FAC071-Social/Family Subscale Score | C166342 | FAC071-Social/Family Subscale Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Socia/Family Well-Being: Subscale score. | FACIT-F Version 4 - Social/Family Subscale Score | ||
FAC071-Total Score | C166348 | FAC071-Total Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Total score. | FACIT-F Version 4 - Total Score | ||
FAC071-Trial Outcome Index Score | C166346 | FAC071-Trial Outcome Index Score | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Trial outcome index score. | FACIT-F Version 4 - Trial Outcome Index Score | ||
FAC071-Trouble Finishing Things | C129143 | FAC071-Trouble Finishing Things | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have trouble finishing things because I am tired. | FACIT-F Version 4 - Trouble Finishing Things | ||
FAC071-Trouble Meeting Needs of Family | C129113 | FAC071-Trouble Meeting Needs of Family | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACIT-F Version 4 - Trouble Meeting Needs of Family | ||
FAC071-Trouble Starting Things | C129142 | FAC071-Trouble Starting Things | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Additional Concerns: I have trouble starting things because I am tired. | FACIT-F Version 4 - Trouble Starting Things | ||
FAC071-Worry My Condition Will Get Worse | C129130 | FAC071-Worry My Condition Will Get Worse | Functional Assessment of Chronic Illness Therapy-Fatigue Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACIT-F Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C183551.FSILTC | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Questionnaire Test Code
(FSILTC) | text
Extensible: No | C183551 | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Questionnaire Test Code | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult test code. | CDISC Questionnaire FACIT-Searchable Item Library Adult Version Test Code Terminology |
FSIL0001 | C183618 | FSIL-Fatigue Keeps Me From Doing Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My fatigue keeps me from doing the things I want to do. | FACIT-Searchable Item Library Adult Version - Fatigue Keeps Me From Doing Things | ||
FSIL0002 | C183619 | FSIL-Bothered by Swelling Certain Areas | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling in certain areas of my body. | FACIT-Searchable Item Library Adult Version - Bothered by Swelling Certain Areas | ||
FSIL0003 | C183620 | FSIL-Bothered by Mouth Sores/Tenderness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by mouth sores or tenderness. | FACIT-Searchable Item Library Adult Version - Bothered by Mouth Sores/Tenderness | ||
FSIL0004 | C183621 | FSIL-Because of Sores Eating Difficult | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my mouth sores, eating is difficult. | FACIT-Searchable Item Library Adult Version - Because of Sores Eating Difficult | ||
FSIL0005 | C183622 | FSIL-The Skin on My Hands Hurts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin on my hands hurts. | FACIT-Searchable Item Library Adult Version - The Skin on My Hands Hurts | ||
FSIL0006 | C183623 | FSIL-Hand Pain Interferes Daily Activ | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Hand pain or tenderness interferes with my daily activities. | FACIT-Searchable Item Library Adult Version - Hand Pain Interferes Daily Activ | ||
FSIL0007 | C183624 | FSIL-The Skin on My Feet Hurts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin on my feet hurts. | FACIT-Searchable Item Library Adult Version - The Skin on My Feet Hurts | ||
FSIL0008 | C183625 | FSIL-Pain on My Feet Interferes Walking | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Pain on the bottom of my feet interferes with my walking. | FACIT-Searchable Item Library Adult Version - Pain on My Feet Interferes Walking | ||
FSIL0009 | C183626 | FSIL-Limit Activities Because Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my activities because of diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Limit Activities Because Diarrhea | ||
FSIL0010 | C183627 | FSIL-Bothered by a Skin Rash | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a skin rash. | FACIT-Searchable Item Library Adult Version - Bothered by a Skin Rash | ||
FSIL0011 | C183628 | FSIL-Amount I Eat Is Sufficient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The amount I eat is sufficient to meet my needs. | FACIT-Searchable Item Library Adult Version - Amount I Eat Is Sufficient | ||
FSIL0012 | C183629 | FSIL-I Seem to Get Full Quickly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: When I eat, I seem to get full quickly. | FACIT-Searchable Item Library Adult Version - I Seem to Get Full Quickly | ||
FSIL0013 | C183630 | FSIL-I Have Pain in My Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my stomach area. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Stomach Area | ||
FSIL0014 | C183631 | FSIL-My General Health Is Improving | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My general health is improving. | FACIT-Searchable Item Library Adult Version - My General Health Is Improving | ||
FSIL0015 | C183632 | FSIL-Worried About My Weight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am worried about my weight. | FACIT-Searchable Item Library Adult Version - Worried About My Weight | ||
FSIL0016 | C183633 | FSIL-Most Food Tastes Unpleasant to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Most food tastes unpleasant to me. | FACIT-Searchable Item Library Adult Version - Most Food Tastes Unpleasant to Me | ||
FSIL0017 | C183634 | FSIL-Concerned About How Thin I Look | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about how thin I look. | FACIT-Searchable Item Library Adult Version - Concerned About How Thin I Look | ||
FSIL0018 | C183635 | FSIL-Interest in Food Drops Try to Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My interest in food drops as soon as I try to eat. | FACIT-Searchable Item Library Adult Version - Interest in Food Drops Try to Eat | ||
FSIL0019 | C183636 | FSIL-Have Difficulty Eating Rich Foods | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty eating rich or "heavy" foods. | FACIT-Searchable Item Library Adult Version - Have Difficulty Eating Rich Foods | ||
FSIL0020 | C183637 | FSIL-My Family Pressuring Me to Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family or friends are pressuring me to eat. | FACIT-Searchable Item Library Adult Version - My Family Pressuring Me to Eat | ||
FSIL0021 | C183638 | FSIL-Stomach Pain Interferes Functioning | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Stomach pain interferes with my daily functioning. | FACIT-Searchable Item Library Adult Version - Stomach Pain Interferes Functioning | ||
FSIL0022 | C183639 | FSIL-I Have Been Emotionally Distressed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been emotionally distressed. | FACIT-Searchable Item Library Adult Version - I Have Been Emotionally Distressed | ||
FSIL0023 | C183640 | FSIL-I Feel Listless | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel listless ("washed out"). | FACIT-Searchable Item Library Adult Version - I Feel Listless | ||
FSIL0024 | C183641 | FSIL-I Get Headaches | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get headaches. | FACIT-Searchable Item Library Adult Version - I Get Headaches | ||
FSIL0025 | C183642 | FSIL-I Have Pain in My Chest | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my chest. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Chest | ||
FSIL0026 | C183643 | FSIL-Too Tired to Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am too tired to eat. | FACIT-Searchable Item Library Adult Version - Too Tired to Eat | ||
FSIL0027 | C183644 | FSIL-Motivated to Do Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am motivated to do my usual activities. | FACIT-Searchable Item Library Adult Version - Motivated to Do Activities | ||
FSIL0028 | C183645 | FSIL-Need Help Doing Usual Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help doing my usual activities. | FACIT-Searchable Item Library Adult Version - Need Help Doing Usual Activities | ||
FSIL0029 | C183646 | FSIL-Frustrated by Being Too Tired | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by being too tired to do the things I want to do. | FACIT-Searchable Item Library Adult Version - Frustrated by Being Too Tired | ||
FSIL0030 | C183647 | FSIL-Limit Social Activity B/c Tired | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because I am tired. | FACIT-Searchable Item Library Adult Version - Limit Social Activity B/c Tired | ||
FSIL0031 | C183648 | FSIL-I Feel Tired | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel tired. | FACIT-Searchable Item Library Adult Version - I Feel Tired | ||
FSIL0032 | C183649 | FSIL-Trouble Starting Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble starting things because I am tired. | FACIT-Searchable Item Library Adult Version - Trouble Starting Things | ||
FSIL0033 | C183650 | FSIL-Trouble Finishing Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble finishing things because I am tired. | FACIT-Searchable Item Library Adult Version - Trouble Finishing Things | ||
FSIL0034 | C183651 | FSIL-I Have Energy | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have energy. | FACIT-Searchable Item Library Adult Version - I Have Energy | ||
FSIL0035 | C183652 | FSIL-I Have Trouble Walking | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking. | FACIT-Searchable Item Library Adult Version - I Have Trouble Walking | ||
FSIL0036 | C183653 | FSIL-Able to Do My Usual Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to do my usual activities. | FACIT-Searchable Item Library Adult Version - Able to Do My Usual Activities | ||
FSIL0037 | C183654 | FSIL-I Need to Sleep During the Day | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need to sleep during the day. | FACIT-Searchable Item Library Adult Version - I Need to Sleep During the Day | ||
FSIL0038 | C183655 | FSIL-I Feel Lightheaded | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel lightheaded (dizzy). | FACIT-Searchable Item Library Adult Version - I Feel Lightheaded | ||
FSIL0039 | C183656 | FSIL-I Have Been Short of Breath | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been short of breath. | FACIT-Searchable Item Library Adult Version - I Have Been Short of Breath | ||
FSIL0040 | C183657 | FSIL-Movement of Arm This Side Painful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Movement of my arm on this side is painful. | FACIT-Searchable Item Library Adult Version - Movement of Arm This Side Painful | ||
FSIL0041 | C183658 | FSIL-Poor Range Arm Movements This Side | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a poor range of arm movements on this side. | FACIT-Searchable Item Library Adult Version - Poor Range Arm Movements This Side | ||
FSIL0042 | C183659 | FSIL-My Arm on This Side Feels Numb | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My arm on this side feels numb. | FACIT-Searchable Item Library Adult Version - My Arm on This Side Feels Numb | ||
FSIL0043 | C183660 | FSIL-Have Stiffness of Arm on This Side | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stiffness of my arm on this side. | FACIT-Searchable Item Library Adult Version - Have Stiffness of Arm on This Side | ||
FSIL0044 | C183661 | FSIL-Self-conscious About Way I Dress | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am self-conscious about the way I dress. | FACIT-Searchable Item Library Adult Version - Self-conscious About Way I Dress | ||
FSIL0045 | C183662 | FSIL-One/Both Arms Are Swollen/Tender | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: One or both of my arms are swollen or tender. | FACIT-Searchable Item Library Adult Version - One/Both Arms Are Swollen/Tender | ||
FSIL0046 | C183663 | FSIL-I Feel Sexually Attractive | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel sexually attractive. | FACIT-Searchable Item Library Adult Version - I Feel Sexually Attractive | ||
FSIL0047 | C183664 | FSIL-Bothered by Hair Loss | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by hair loss. | FACIT-Searchable Item Library Adult Version - Bothered by Hair Loss | ||
FSIL0048 | C183665 | FSIL-Worry Family Will Get Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that other members of my family might someday get the same illness I have. | FACIT-Searchable Item Library Adult Version - Worry Family Will Get Illness | ||
FSIL0049 | C183666 | FSIL-Worry About the Effect of Stress | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the effect of stress on my illness. | FACIT-Searchable Item Library Adult Version - Worry About the Effect of Stress | ||
FSIL0050 | C183667 | FSIL-Bothered by Change in Weight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in weight. | FACIT-Searchable Item Library Adult Version - Bothered by Change in Weight | ||
FSIL0051 | C183668 | FSIL-Able to Feel Like a Woman | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to feel like a woman. | FACIT-Searchable Item Library Adult Version - Able to Feel Like a Woman | ||
FSIL0052 | C183669 | FSIL-Have Trouble Controlling My Urine | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble controlling my urine. | FACIT-Searchable Item Library Adult Version - Have Trouble Controlling My Urine | ||
FSIL0053 | C183670 | FSIL-I Urinate More Frequently | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I urinate more frequently than usual. | FACIT-Searchable Item Library Adult Version - I Urinate More Frequently | ||
FSIL0054 | C183671 | FSIL-It Burns When I Urinate | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It burns when I urinate. | FACIT-Searchable Item Library Adult Version - It Burns When I Urinate | ||
FSIL0055 | C183672 | FSIL-Interested in Sex | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am interested in sex. | FACIT-Searchable Item Library Adult Version - Interested in Sex | ||
FSIL0056 | C183673 | FSIL-Able to Have/Maintain Erection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to have and maintain an erection. (For men only) | FACIT-Searchable Item Library Adult Version - Able to Have/Maintain Erection | ||
FSIL0057 | C183674 | FSIL-Concerned About Keeping My Job | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about keeping my job (include work at home). | FACIT-Searchable Item Library Adult Version - Concerned About Keeping My Job | ||
FSIL0058 | C183675 | FSIL-I Can Remember Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can remember things. | FACIT-Searchable Item Library Adult Version - I Can Remember Things | ||
FSIL0059 | C183676 | FSIL-I Have Frequent Colds/Infections | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have frequent colds/infections. | FACIT-Searchable Item Library Adult Version - I Have Frequent Colds/Infections | ||
FSIL0060 | C183677 | FSIL-My Eyesight Is Blurry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyesight is blurry. | FACIT-Searchable Item Library Adult Version - My Eyesight Is Blurry | ||
FSIL0061 | C183678 | FSIL-Bothered by Change in Food Tastes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in the way food tastes. | FACIT-Searchable Item Library Adult Version - Bothered by Change in Food Tastes | ||
FSIL0062 | C183679 | FSIL-I Have Tremors | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have tremors. | FACIT-Searchable Item Library Adult Version - I Have Tremors | ||
FSIL0063 | C183680 | FSIL-Bothered by Skin Problems | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by skin problems. | FACIT-Searchable Item Library Adult Version - Bothered by Skin Problems | ||
FSIL0064 | C183681 | FSIL-I Have Trouble With My Bowels | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with my bowels. | FACIT-Searchable Item Library Adult Version - I Have Trouble With My Bowels | ||
FSIL0065 | C183682 | FSIL-Illness Is Hardship for My Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness is a personal hardship for my close family members. | FACIT-Searchable Item Library Adult Version - Illness Is Hardship for My Family | ||
FSIL0066 | C183683 | FSIL-Cost of Treatment Is Burden on Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The cost of my treatment is a burden on me or my family. | FACIT-Searchable Item Library Adult Version - Cost of Treatment Is Burden on Me | ||
FSIL0067 | C183684 | FSIL-I Feel Distant From Other People | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel distant from other people. | FACIT-Searchable Item Library Adult Version - I Feel Distant From Other People | ||
FSIL0068 | C183685 | FSIL-I Worry Transplant Will Not Work | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that the transplant will not work. | FACIT-Searchable Item Library Adult Version - I Worry Transplant Will Not Work | ||
FSIL0069 | C183686 | FSIL-Side Effects of Treatment Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The side effects of treatment are worse than I had imagined. | FACIT-Searchable Item Library Adult Version - Side Effects of Treatment Worse | ||
FSIL0070 | C183687 | FSIL-Able to Get Around by Myself | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to get around by myself. | FACIT-Searchable Item Library Adult Version - Able to Get Around by Myself | ||
FSIL0071 | C183688 | FSIL-I Get Tired Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get tired easily. | FACIT-Searchable Item Library Adult Version - I Get Tired Easily | ||
FSIL0072 | C183689 | FSIL-Concerns Ability to Have Children | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have concerns about my ability to have children. | FACIT-Searchable Item Library Adult Version - Concerns Ability to Have Children | ||
FSIL0073 | C183690 | FSIL-Confidence in My Nurse(s) | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my nurse(s). | FACIT-Searchable Item Library Adult Version - Confidence in My Nurse(s) | ||
FSIL0074 | C183691 | FSIL-I Regret Bone Marrow Transplant | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I regret having the bone marrow transplant. | FACIT-Searchable Item Library Adult Version - I Regret Bone Marrow Transplant | ||
FSIL0075 | C183692 | FSIL-I Have Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have bone pain. | FACIT-Searchable Item Library Adult Version - I Have Bone Pain | ||
FSIL0076 | C183693 | FSIL-Frustrated by My Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my bone pain. | FACIT-Searchable Item Library Adult Version - Frustrated by My Bone Pain | ||
FSIL0077 | C183694 | FSIL-I Feel Depressed about Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel depressed about my bone pain. | FACIT-Searchable Item Library Adult Version - I Feel Depressed about Bone Pain | ||
FSIL0078 | C183695 | FSIL-I Worry Bone Pain Will Get Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my bone pain will get worse. | FACIT-Searchable Item Library Adult Version - I Worry Bone Pain Will Get Worse | ||
FSIL0079 | C183696 | FSIL-Family Trouble Understand Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has trouble understanding when my bone pain interferes with my activity. | FACIT-Searchable Item Library Adult Version - Family Trouble Understand Bone Pain | ||
FSIL0080 | C183697 | FSIL-Hurts When Put Weight/Pressure on | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It hurts when I put weight or pressure on the place where I have bone pain. | FACIT-Searchable Item Library Adult Version - Hurts When Put Weight/Pressure on | ||
FSIL0081 | C183698 | FSIL-Bone Pain Even When I Sit/Lie Still | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have bone pain even when I sit or lie still. | FACIT-Searchable Item Library Adult Version - Bone Pain Even When I Sit/Lie Still | ||
FSIL0082 | C183699 | FSIL-Need Help Doing Activ B/c Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help doing my usual activities because of bone pain. | FACIT-Searchable Item Library Adult Version - Need Help Doing Activ B/c Bone Pain | ||
FSIL0083 | C183700 | FSIL-Rest During Day B/c of Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am forced to rest during the day because of bone pain. | FACIT-Searchable Item Library Adult Version - Rest During Day B/c of Bone Pain | ||
FSIL0084 | C183701 | FSIL-Trouble Walking Because Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking because of bone pain. | FACIT-Searchable Item Library Adult Version - Trouble Walking Because Bone Pain | ||
FSIL0085 | C183702 | FSIL-Bone Pain Interferes Care Myself | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain interferes with my ability to care for myself (bathing, dressing, eating, etc.). | FACIT-Searchable Item Library Adult Version - Bone Pain Interferes Care Myself | ||
FSIL0086 | C183703 | FSIL-Bone Pain Interferes w/Social | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain interferes with my social activities. | FACIT-Searchable Item Library Adult Version - Bone Pain Interferes w/Social | ||
FSIL0087 | C183704 | FSIL-Bone Pain Wakes Me Up at Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain wakes me up at night. | FACIT-Searchable Item Library Adult Version - Bone Pain Wakes Me Up at Night | ||
FSIL0088 | C183705 | FSIL-Able to Concentrate | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to concentrate. | FACIT-Searchable Item Library Adult Version - Able to Concentrate | ||
FSIL0089 | C183706 | FSIL-Bothered by Change in Personality | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my personality. | FACIT-Searchable Item Library Adult Version - Bothered by Change in Personality | ||
FSIL0090 | C183707 | FSIL-Make Decisions Take Responsibility | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to make decisions and take responsibility. | FACIT-Searchable Item Library Adult Version - Make Decisions Take Responsibility | ||
FSIL0091 | C183708 | FSIL-Bothered by Drop in My Contribution | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the drop in my contribution to the family. | FACIT-Searchable Item Library Adult Version - Bothered by Drop in My Contribution | ||
FSIL0092 | C183709 | FSIL-Able to Put My Thoughts Together | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to put my thoughts together. | FACIT-Searchable Item Library Adult Version - Able to Put My Thoughts Together | ||
FSIL0093 | C183710 | FSIL-I Need Help in Caring for Myself | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help in caring for myself (bathing, dressing, eating, etc.). | FACIT-Searchable Item Library Adult Version - I Need Help in Caring for Myself | ||
FSIL0094 | C183711 | FSIL-Able to Put My thoughts Into Action | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to put my thoughts into action. | FACIT-Searchable Item Library Adult Version - Able to Put My thoughts Into Action | ||
FSIL0095 | C183712 | FSIL-Able to Read Like I Used to | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to read like I used to. | FACIT-Searchable Item Library Adult Version - Able to Read Like I Used to | ||
FSIL0096 | C183713 | FSIL-Able to Write Like I Used to | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to write like I used to. | FACIT-Searchable Item Library Adult Version - Able to Write Like I Used to | ||
FSIL0097 | C183714 | FSIL-Able to Drive a Vehicle | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to drive a vehicle (my car, truck, etc.). | FACIT-Searchable Item Library Adult Version - Able to Drive a Vehicle | ||
FSIL0098 | C183715 | FSIL-Trouble Feeling Arm/Hands/Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling sensations in my arm, hands or legs. | FACIT-Searchable Item Library Adult Version - Trouble Feeling Arm/Hands/Legs | ||
FSIL0099 | C183716 | FSIL-I Have Had Seizures | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had seizures (convulsions). | FACIT-Searchable Item Library Adult Version - I Have Had Seizures | ||
FSIL0100 | C183717 | FSIL-Have Weakness in My Arms or Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have weakness in my arms or legs. | FACIT-Searchable Item Library Adult Version - Have Weakness in My Arms or Legs | ||
FSIL0101 | C183718 | FSIL-I Have Trouble With Coordination | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with coordination. | FACIT-Searchable Item Library Adult Version - I Have Trouble With Coordination | ||
FSIL0102 | C183719 | FSIL-I Can Remember New Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can remember new things. | FACIT-Searchable Item Library Adult Version - I Can Remember New Things | ||
FSIL0103 | C183720 | FSIL-Frustrated I Cannot Do Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get frustrated that I cannot do things I used to. | FACIT-Searchable Item Library Adult Version - Frustrated I Cannot Do Things | ||
FSIL0104 | C183721 | FSIL-Afraid of Having a Seizure | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid of having a seizure (convulsion). | FACIT-Searchable Item Library Adult Version - Afraid of Having a Seizure | ||
FSIL0105 | C183722 | FSIL-I Have Trouble With My Eyesight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with my eyesight. | FACIT-Searchable Item Library Adult Version - I Have Trouble With My Eyesight | ||
FSIL0106 | C183723 | FSIL-I Feel Independent | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel independent. | FACIT-Searchable Item Library Adult Version - I Feel Independent | ||
FSIL0107 | C183724 | FSIL-Able to Find the Right Words | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to find the right word(s) to say what I mean. | FACIT-Searchable Item Library Adult Version - Able to Find the Right Words | ||
FSIL0108 | C183725 | FSIL-Difficulty Expressing My Thoughts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty expressing my thoughts. | FACIT-Searchable Item Library Adult Version - Difficulty Expressing My Thoughts | ||
FSIL0109 | C183726 | FSIL-I Have Pain in My Joints | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my joints. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Joints | ||
FSIL0110 | C183727 | FSIL-Bothered by Sweating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by sweating. | FACIT-Searchable Item Library Adult Version - Bothered by Sweating | ||
FSIL0111 | C183728 | FSIL-Bothered by the Chills | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the chills. | FACIT-Searchable Item Library Adult Version - Bothered by the Chills | ||
FSIL0112 | C183729 | FSIL-Bothered by Fevers | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by fevers (episodes of high body temperature). | FACIT-Searchable Item Library Adult Version - Bothered by Fevers | ||
FSIL0113 | C183730 | FSIL-Bothered by Dry Mouth | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by dry mouth. | FACIT-Searchable Item Library Adult Version - Bothered by Dry Mouth | ||
FSIL0114 | C183731 | FSIL-I Get Depressed Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get depressed easily. | FACIT-Searchable Item Library Adult Version - I Get Depressed Easily | ||
FSIL0115 | C183732 | FSIL-I Get Annoyed Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get annoyed easily. | FACIT-Searchable Item Library Adult Version - I Get Annoyed Easily | ||
FSIL0116 | C183733 | FSIL-I Have Emotional Ups and Downs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have emotional ups and downs. | FACIT-Searchable Item Library Adult Version - I Have Emotional Ups and Downs | ||
FSIL0117 | C183734 | FSIL-Treatment Bone Disease Takes Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Treatment for bone disease takes up my time. | FACIT-Searchable Item Library Adult Version - Treatment Bone Disease Takes Time | ||
FSIL0118 | C183735 | FSIL-Bothered by Effects Treatment Bone | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by side effects of treatment for bone disease. | FACIT-Searchable Item Library Adult Version - Bothered by Effects Treatment Bone | ||
FSIL0119 | C183736 | FSIL-Satisfied With Results of Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the results of the treatment for your bone disease so far? | FACIT-Searchable Item Library Adult Version - Satisfied With Results of Treatment | ||
FSIL0120 | C183737 | FSIL-Treatment Bone Disease to Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this treatment for bone disease to others with your illness? | FACIT-Searchable Item Library Adult Version - Treatment Bone Disease to Others | ||
FSIL0121 | C183738 | FSIL-Choose This Treatment Bone Again | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this treatment for bone disease again? | FACIT-Searchable Item Library Adult Version - Choose This Treatment Bone Again | ||
FSIL0122 | C183739 | FSIL-Treatment Takes Up My Family's Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment for bone disease takes up my family's time. | FACIT-Searchable Item Library Adult Version - Treatment Takes Up My Family's Time | ||
FSIL0123 | C183740 | FSIL-Worry About Side Effects Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about side effects from treatment for bone disease. | FACIT-Searchable Item Library Adult Version - Worry About Side Effects Treatment | ||
FSIL0124 | C183741 | FSIL-Taking Drug Infusion Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Taking the drug by infusion is inconvenient. | FACIT-Searchable Item Library Adult Version - Taking Drug Infusion Inconvenient | ||
FSIL0125 | C183742 | FSIL-Infusion Causes Me Physical Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The infusion for my bone treatment causes me physical pain. | FACIT-Searchable Item Library Adult Version - Infusion Causes Me Physical Pain | ||
FSIL0126 | C183743 | FSIL-Treatment Causes Me Physical Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment for bone disease causes me physical pain. | FACIT-Searchable Item Library Adult Version - Treatment Causes Me Physical Pain | ||
FSIL0127 | C183744 | FSIL-Receiving Treatment Is Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Receiving treatment for bone disease is inconvenient. | FACIT-Searchable Item Library Adult Version - Receiving Treatment Is Inconvenient | ||
FSIL0128 | C183745 | FSIL-Waiting Breakfast Is Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Waiting up to 60 minutes before eating breakfast in the morning is inconvenient. | FACIT-Searchable Item Library Adult Version - Waiting Breakfast Is Inconvenient | ||
FSIL0129 | C183746 | FSIL-Having Blood Drawn Is Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Having my blood drawn is inconvenient. | FACIT-Searchable Item Library Adult Version - Having Blood Drawn Is Inconvenient | ||
FSIL0130 | C183747 | FSIL-Worry Treatment Not Effective | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment for bone disease will not be effective. | FACIT-Searchable Item Library Adult Version - Worry Treatment Not Effective | ||
FSIL0131 | C183748 | FSIL-Treatment Seems Harmful to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Treatment for bone disease seems harmful to me. | FACIT-Searchable Item Library Adult Version - Treatment Seems Harmful to Me | ||
FSIL0132 | C183749 | FSIL-Treatment Schedule Stressful to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment schedule for bone disease is stressful to me. | FACIT-Searchable Item Library Adult Version - Treatment Schedule Stressful to Me | ||
FSIL0133 | C183750 | FSIL-Treatment Schedule Stressful Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment schedule for bone disease is stressful to my family. | FACIT-Searchable Item Library Adult Version - Treatment Schedule Stressful Family | ||
FSIL0134 | C183751 | FSIL-Believe Treatment Will Take Up Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that treatment for bone disease will take up my time. | FACIT-Searchable Item Library Adult Version - Believe Treatment Will Take Up Time | ||
FSIL0135 | C183752 | FSIL-Believe Will Be Bothered by Effects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that I will be bothered by side effects of treatment for bone disease. | FACIT-Searchable Item Library Adult Version - Believe Will Be Bothered by Effects | ||
FSIL0136 | C183753 | FSIL-Believe Eating Will Be Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that waiting up to 60 minutes before eating breakfast in the morning will be inconvenient. | FACIT-Searchable Item Library Adult Version - Believe Eating Will Be Inconvenient | ||
FSIL0137 | C183754 | FSIL-Believe Infusion Will Cause Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that an infusion for my bone treatment will cause me physical pain. | FACIT-Searchable Item Library Adult Version - Believe Infusion Will Cause Pain | ||
FSIL0138 | C183755 | FSIL-Believe Blood Will Be Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that having my blood drawn will be inconvenient. | FACIT-Searchable Item Library Adult Version - Believe Blood Will Be Inconvenient | ||
FSIL0139 | C183756 | FSIL-Believe Treatment Take Family Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment for bone disease will take up my family's time. | FACIT-Searchable Item Library Adult Version - Believe Treatment Take Family Time | ||
FSIL0140 | C183757 | FSIL-Believe Treatment Will Cause Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment for bone disease will cause me physical pain. | FACIT-Searchable Item Library Adult Version - Believe Treatment Will Cause Pain | ||
FSIL0141 | C183758 | FSIL-Believe Treatment Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that receiving treatment for bone disease will be inconvenient. | FACIT-Searchable Item Library Adult Version - Believe Treatment Inconvenient | ||
FSIL0142 | C183759 | FSIL-Believe Treatment Will Be Harmful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that treatment for bone disease will be harmful to me. | FACIT-Searchable Item Library Adult Version - Believe Treatment Will Be Harmful | ||
FSIL0143 | C183760 | FSIL-Believe Schedule Stressful to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment schedule for bone disease will be stressful to me. | FACIT-Searchable Item Library Adult Version - Believe Schedule Stressful to Me | ||
FSIL0144 | C183761 | FSIL-Believe Schedule Stressful Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment schedule for bone disease will be stressful to my family. | FACIT-Searchable Item Library Adult Version - Believe Schedule Stressful Family | ||
FSIL0145 | C183762 | FSIL-Swelling/Cramps in Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling or cramps in my stomach area. | FACIT-Searchable Item Library Adult Version - Swelling/Cramps in Stomach Area | ||
FSIL0146 | C183763 | FSIL-Losing Weight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am losing weight. | FACIT-Searchable Item Library Adult Version - Losing Weight | ||
FSIL0147 | C183764 | FSIL-I Have Control of My Bowels | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have control of my bowels. | FACIT-Searchable Item Library Adult Version - I Have Control of My Bowels | ||
FSIL0148 | C183765 | FSIL-I Can Digest My Food Well | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can digest my food well. | FACIT-Searchable Item Library Adult Version - I Can Digest My Food Well | ||
FSIL0149 | C183766 | FSIL-I Have Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - I Have Diarrhea | ||
FSIL0150 | C183767 | FSIL-I Have a Good Appetite | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a good appetite. | FACIT-Searchable Item Library Adult Version - I Have a Good Appetite | ||
FSIL0151 | C183768 | FSIL-I Like the Appearance of My Body | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I like the appearance of my body. | FACIT-Searchable Item Library Adult Version - I Like the Appearance of My Body | ||
FSIL0152 | C183769 | FSIL-Embarrassed by Ostomy Appliance | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my ostomy appliance. | FACIT-Searchable Item Library Adult Version - Embarrassed by Ostomy Appliance | ||
FSIL0153 | C183770 | FSIL-Caring for Ostomy Is Difficult | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Caring for my ostomy appliance is difficult. | FACIT-Searchable Item Library Adult Version - Caring for Ostomy Is Difficult | ||
FSIL0154 | C183771 | FSIL-Bothered by Hot Flashes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by hot flashes. | FACIT-Searchable Item Library Adult Version - Bothered by Hot Flashes | ||
FSIL0155 | C183772 | FSIL-My Breasts Are Swollen | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breasts are swollen. | FACIT-Searchable Item Library Adult Version - My Breasts Are Swollen | ||
FSIL0156 | C183773 | FSIL-My Breasts Are Painful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breasts are painful. | FACIT-Searchable Item Library Adult Version - My Breasts Are Painful | ||
FSIL0157 | C183774 | FSIL-Discomfort in My Pelvic Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort in my pelvic area. | FACIT-Searchable Item Library Adult Version - Discomfort in My Pelvic Area | ||
FSIL0158 | C183775 | FSIL-Accepted I Have This Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have accepted that I have this infection. | FACIT-Searchable Item Library Adult Version - Accepted I Have This Infection | ||
FSIL0159 | C183776 | FSIL-Worry Infection Will Get Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that the infection will get worse. | FACIT-Searchable Item Library Adult Version - Worry Infection Will Get Worse | ||
FSIL0160 | C183777 | FSIL-Hidden Problem Others Not Notice | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have hidden this problem so others will not notice. | FACIT-Searchable Item Library Adult Version - Hidden Problem Others Not Notice | ||
FSIL0161 | C183778 | FSIL-Concerns Ability Become Pregnant | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have concerns about my ability to become pregnant. | FACIT-Searchable Item Library Adult Version - Concerns Ability Become Pregnant | ||
FSIL0162 | C183779 | FSIL-Worry About Attitudes Towards Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about other people's attitudes towards me. | FACIT-Searchable Item Library Adult Version - Worry About Attitudes Towards Me | ||
FSIL0163 | C183780 | FSIL-Embarrassed About the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel embarrassed about the infection. | FACIT-Searchable Item Library Adult Version - Embarrassed About the Infection | ||
FSIL0164 | C183781 | FSIL-Blame Myself for the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I tend to blame myself for the infection. | FACIT-Searchable Item Library Adult Version - Blame Myself for the Infection | ||
FSIL0165 | C183782 | FSIL-Careful Who I told About Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I was careful who I told about the infection. | FACIT-Searchable Item Library Adult Version - Careful Who I told About Infection | ||
FSIL0166 | C183783 | FSIL-Difficulty Telling Partner/Spouse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had difficulty telling my partner/spouse about the infection. | FACIT-Searchable Item Library Adult Version - Difficulty Telling Partner/Spouse | ||
FSIL0167 | C183784 | FSIL-Frustrated by the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by the infection. | FACIT-Searchable Item Library Adult Version - Frustrated by the Infection | ||
FSIL0168 | C183785 | FSIL-I Have Pain in My Pelvic Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my pelvic area. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Pelvic Area | ||
FSIL0169 | C183786 | FSIL-Depressed About the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am depressed about the infection. | FACIT-Searchable Item Library Adult Version - Depressed About the Infection | ||
FSIL0170 | C183787 | FSIL-Get Emotional Support Partner | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from my partner/spouse. | FACIT-Searchable Item Library Adult Version - Get Emotional Support Partner | ||
FSIL0171 | C183788 | FSIL-Emotional Support Family Members | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from family members. | FACIT-Searchable Item Library Adult Version - Emotional Support Family Members | ||
FSIL0172 | C183789 | FSIL-I Have Cramping in My Pelvic Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cramping in my pelvic area. | FACIT-Searchable Item Library Adult Version - I Have Cramping in My Pelvic Area | ||
FSIL0173 | C183790 | FSIL-Limit My Sexual Activity Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of the infection. | FACIT-Searchable Item Library Adult Version - Limit My Sexual Activity Infection | ||
FSIL0174 | C183791 | FSIL-Worry About Spreading the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about spreading the infection. | FACIT-Searchable Item Library Adult Version - Worry About Spreading the Infection | ||
FSIL0175 | C183792 | FSIL-Received Treatment That Was Right | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I received the treatment that was right for me. | FACIT-Searchable Item Library Adult Version - Received Treatment That Was Right | ||
FSIL0176 | C183793 | FSIL-Doctor Gave Explanations Understand | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor gave me explanations that I could understand. | FACIT-Searchable Item Library Adult Version - Doctor Gave Explanations Understand | ||
FSIL0177 | C183794 | FSIL-Doctor Explained Possible Benefits | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor explained the possible benefits of my treatment. | FACIT-Searchable Item Library Adult Version - Doctor Explained Possible Benefits | ||
FSIL0178 | C183795 | FSIL-Can Manage Things Around Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I can manage things that come up around this infection. | FACIT-Searchable Item Library Adult Version - Can Manage Things Around Infection | ||
FSIL0179 | C183796 | FSIL-Able to Maintain My Balance | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to maintain my balance. | FACIT-Searchable Item Library Adult Version - Able to Maintain My Balance | ||
FSIL0180 | C183797 | FSIL-Able to Walk | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to walk. | FACIT-Searchable Item Library Adult Version - Able to Walk | ||
FSIL0181 | C183798 | FSIL-I Have Strength in My Arm(s) | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have strength in my arm(s). | FACIT-Searchable Item Library Adult Version - I Have Strength in My Arm(s) | ||
FSIL0182 | C183799 | FSIL-I Have Strength in My Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have strength in my legs. | FACIT-Searchable Item Library Adult Version - I Have Strength in My Legs | ||
FSIL0183 | C183800 | FSIL-I Have Numbness in My Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness in my legs. | FACIT-Searchable Item Library Adult Version - I Have Numbness in My Legs | ||
FSIL0184 | C183801 | FSIL-I Have Pain in My Back | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my back. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Back | ||
FSIL0185 | C183802 | FSIL-I Have Trouble Forming Thoughts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble forming thoughts. | FACIT-Searchable Item Library Adult Version - I Have Trouble Forming Thoughts | ||
FSIL0186 | C183803 | FSIL-My Thinking Has Been Slow | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking has been slow. | FACIT-Searchable Item Library Adult Version - My Thinking Has Been Slow | ||
FSIL0187 | C183804 | FSIL-Work Harder Than Usual to Track | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work harder than usual to keep track of what I was doing. | FACIT-Searchable Item Library Adult Version - Work Harder Than Usual to Track | ||
FSIL0188 | C183805 | FSIL-My Thinking Slower Than Usual | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking has been slower than usual. | FACIT-Searchable Item Library Adult Version - My Thinking Slower Than Usual | ||
FSIL0189 | C183806 | FSIL-Work Harder Than Usual to Express | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work harder than usual to express myself clearly. | FACIT-Searchable Item Library Adult Version - Work Harder Than Usual to Express | ||
FSIL0190 | C183807 | FSIL-Use Written Lists More Often | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to use written lists more often than usual so I would not forget things. | FACIT-Searchable Item Library Adult Version - Use Written Lists More Often | ||
FSIL0191 | C183808 | FSIL-I Have Had Trouble Concentrating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble concentrating. | FACIT-Searchable Item Library Adult Version - I Have Had Trouble Concentrating | ||
FSIL0192 | C183809 | FSIL-Walked Into a Room and Forgotten | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have walked into a room and forgotten what I meant to get or do there. | FACIT-Searchable Item Library Adult Version - Walked Into a Room and Forgotten | ||
FSIL0193 | C183810 | FSIL-Work Hard to Pay Attention | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work really hard to pay attention or I would make a mistake. | FACIT-Searchable Item Library Adult Version - Work Hard to Pay Attention | ||
FSIL0194 | C183811 | FSIL-Forgotten Names After Introduced | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have forgotten names of people soon after being introduced. | FACIT-Searchable Item Library Adult Version - Forgotten Names After Introduced | ||
FSIL0195 | C183812 | FSIL-Reaction Everyday Situations Slow | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My reactions in everyday situations have been slow. | FACIT-Searchable Item Library Adult Version - Reaction Everyday Situations Slow | ||
FSIL0196 | C183813 | FSIL-Trouble Remember Where Put Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble remembering where I put things, like my keys or my wallet. | FACIT-Searchable Item Library Adult Version - Trouble Remember Where Put Things | ||
FSIL0197 | C183814 | FSIL-Trouble Remembering New Info | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble remembering new information, like phone numbers or simple instructions. | FACIT-Searchable Item Library Adult Version - Trouble Remembering New Info | ||
FSIL0198 | C183815 | FSIL-Trouble Finding Familiar Place | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble finding my way to a familiar place. | FACIT-Searchable Item Library Adult Version - Trouble Finding Familiar Place | ||
FSIL0199 | C183816 | FSIL-Trouble Keeping Track Interrupted | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble keeping track of what I am doing if I am interrupted. | FACIT-Searchable Item Library Adult Version - Trouble Keeping Track Interrupted | ||
FSIL0200 | C183817 | FSIL-Trouble Shifting Back and Forth | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble shifting back and forth between different activities that require thinking. | FACIT-Searchable Item Library Adult Version - Trouble Shifting Back and Forth | ||
FSIL0201 | C183818 | FSIL-Told Me Trouble Remembering Info | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble remembering information. | FACIT-Searchable Item Library Adult Version - Told Me Trouble Remembering Info | ||
FSIL0202 | C183819 | FSIL-Told Me Trouble Speaking Clearly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble speaking clearly. | FACIT-Searchable Item Library Adult Version - Told Me Trouble Speaking Clearly | ||
FSIL0203 | C183820 | FSIL-Told Me Trouble Thinking Clearly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble thinking clearly. | FACIT-Searchable Item Library Adult Version - Told Me Trouble Thinking Clearly | ||
FSIL0204 | C183821 | FSIL-People Told Me I Seemed Confused | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed confused. | FACIT-Searchable Item Library Adult Version - People Told Me I Seemed Confused | ||
FSIL0205 | C183822 | FSIL-I Have Been Able to Concentrate | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to concentrate. | FACIT-Searchable Item Library Adult Version - I Have Been Able to Concentrate | ||
FSIL0206 | C183823 | FSIL-Mind Is as Sharp as Always Been | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mind is as sharp as it has always been. | FACIT-Searchable Item Library Adult Version - Mind Is as Sharp as Always Been | ||
FSIL0207 | C183824 | FSIL-Memory Is as Good as Always Been | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My memory is as good as it has always been. | FACIT-Searchable Item Library Adult Version - Memory Is as Good as Always Been | ||
FSIL0208 | C183825 | FSIL-Able to Pay Attention w/o Effort | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to pay attention and keep track of what I am doing without extra effort. | FACIT-Searchable Item Library Adult Version - Able to Pay Attention w/o Effort | ||
FSIL0209 | C183826 | FSIL-Able Remember Things Where Left | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to remember things, like where I left my keys or wallet. | FACIT-Searchable Item Library Adult Version - Able Remember Things Where Left | ||
FSIL0210 | C183827 | FSIL-Able Remember to Do Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to remember to do things, like take medicine or buy something I needed. | FACIT-Searchable Item Library Adult Version - Able Remember to Do Things | ||
FSIL0211 | C183828 | FSIL-Able to Shift Between Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to shift back and forth between two activities that require thinking. | FACIT-Searchable Item Library Adult Version - Able to Shift Between Activities | ||
FSIL0212 | C183829 | FSIL-Able to Track What I Am Doing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to keep track of what I am doing, even if I am interrupted. | FACIT-Searchable Item Library Adult Version - Able to Track What I Am Doing | ||
FSIL0213 | C183830 | FSIL-Able to Bring to Mind Words | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to bring to mind words that I wanted to use while talking to someone. | FACIT-Searchable Item Library Adult Version - Able to Bring to Mind Words | ||
FSIL0214 | C183831 | FSIL-I Have Been Upset About Problems | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been upset about these problems. | FACIT-Searchable Item Library Adult Version - I Have Been Upset About Problems | ||
FSIL0215 | C183832 | FSIL-Problems Interfered Ability Work | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with my ability to work. | FACIT-Searchable Item Library Adult Version - Problems Interfered Ability Work | ||
FSIL0216 | C183833 | FSIL-Problems Interfered Ability Enjoy | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with my ability to do things I enjoy. | FACIT-Searchable Item Library Adult Version - Problems Interfered Ability Enjoy | ||
FSIL0217 | C183834 | FSIL-Problems Interfered Quality Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with the quality of my life. | FACIT-Searchable Item Library Adult Version - Problems Interfered Quality Life | ||
FSIL0218 | C183835 | FSIL-Trouble Recalling Name of Object | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble recalling the name of an object while talking to someone. | FACIT-Searchable Item Library Adult Version - Trouble Recalling Name of Object | ||
FSIL0219 | C183836 | FSIL-Trouble Finding Right Words | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble finding the right word(s) to express myself. | FACIT-Searchable Item Library Adult Version - Trouble Finding Right Words | ||
FSIL0220 | C183837 | FSIL-Used Wrong Word When Refer Object | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have used the wrong word when I referred to an object. | FACIT-Searchable Item Library Adult Version - Used Wrong Word When Refer Object | ||
FSIL0221 | C183838 | FSIL-Trouble Saying What I Mean | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble saying what I mean in conversations with others. | FACIT-Searchable Item Library Adult Version - Trouble Saying What I Mean | ||
FSIL0222 | C183839 | FSIL-Chemo Treatment Takes Up My Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Chemotherapy treatment takes up my time. | FACIT-Searchable Item Library Adult Version - Chemo Treatment Takes Up My Time | ||
FSIL0223 | C183840 | FSIL-Satisfied With Results Chemo | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the current results of your chemotherapy? | FACIT-Searchable Item Library Adult Version - Satisfied With Results Chemo | ||
FSIL0224 | C183841 | FSIL-Recommend Chemo to Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this chemotherapy to others with your illness? | FACIT-Searchable Item Library Adult Version - Recommend Chemo to Others | ||
FSIL0225 | C183842 | FSIL-Choose This Chemo Again | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this chemotherapy again? | FACIT-Searchable Item Library Adult Version - Choose This Chemo Again | ||
FSIL0226 | C183843 | FSIL-Rate This Chemo | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How would you rate this chemotherapy? | FACIT-Searchable Item Library Adult Version - Rate This Chemo | ||
FSIL0227 | C183844 | FSIL-Chemo Takes Family Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy treatment takes up my family's time. | FACIT-Searchable Item Library Adult Version - Chemo Takes Family Time | ||
FSIL0228 | C183845 | FSIL-Worry Side Effects From Chemo | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about side effects from chemotherapy treatment. | FACIT-Searchable Item Library Adult Version - Worry Side Effects From Chemo | ||
FSIL0229 | C183846 | FSIL-Chemo Causes Physical Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy treatment causes me physical pain. | FACIT-Searchable Item Library Adult Version - Chemo Causes Physical Pain | ||
FSIL0230 | C183847 | FSIL-Receiving Chemo Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Receiving chemotherapy is inconvenient. | FACIT-Searchable Item Library Adult Version - Receiving Chemo Inconvenient | ||
FSIL0231 | C183848 | FSIL-Worry Chemo Not Effective | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my chemotherapy will not be effective. | FACIT-Searchable Item Library Adult Version - Worry Chemo Not Effective | ||
FSIL0232 | C183849 | FSIL-Chemo Seems Harmful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Chemotherapy treatment seems harmful to me. | FACIT-Searchable Item Library Adult Version - Chemo Seems Harmful | ||
FSIL0233 | C183850 | FSIL-Chemo Schedule Is Stressful Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy schedule is stressful to me. | FACIT-Searchable Item Library Adult Version - Chemo Schedule Is Stressful Me | ||
FSIL0234 | C183851 | FSIL-Chemo Schedule Is Stressful Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy schedule is stressful to my family. | FACIT-Searchable Item Library Adult Version - Chemo Schedule Is Stressful Family | ||
FSIL0235 | C183852 | FSIL-Believe Chemo Take Up My Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe chemotherapy treatment will take up my time. | FACIT-Searchable Item Library Adult Version - Believe Chemo Take Up My Time | ||
FSIL0236 | C183853 | FSIL-Believe Chemo Cause Physical Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy treatment will cause me physical pain. | FACIT-Searchable Item Library Adult Version - Believe Chemo Cause Physical Pain | ||
FSIL0237 | C183854 | FSIL-Believe Chemo Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe receiving chemotherapy will be inconvenient. | FACIT-Searchable Item Library Adult Version - Believe Chemo Inconvenient | ||
FSIL0238 | C183855 | FSIL-Believe Chemo Harmful to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe chemotherapy treatment will be harmful to me. | FACIT-Searchable Item Library Adult Version - Believe Chemo Harmful to Me | ||
FSIL0239 | C183856 | FSIL-Believe Chemo Schedule Stressful Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy schedule will be stressful to me. | FACIT-Searchable Item Library Adult Version - Believe Chemo Schedule Stressful Me | ||
FSIL0240 | C183857 | FSIL-Believe Chemo Sched Stress Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy schedule will be stressful to my family. | FACIT-Searchable Item Library Adult Version - Believe Chemo Sched Stress Family | ||
FSIL0241 | C183858 | FSIL-My Skin Itches | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin itches. | FACIT-Searchable Item Library Adult Version - My Skin Itches | ||
FSIL0242 | C183859 | FSIL-Trouble Sleeping B/c Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble sleeping because of my skin condition. | FACIT-Searchable Item Library Adult Version - Trouble Sleeping B/c Skin Condition | ||
FSIL0243 | C183860 | FSIL-Family Bothered by Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family is bothered by my skin condition. | FACIT-Searchable Item Library Adult Version - Family Bothered by Skin Condition | ||
FSIL0244 | C183861 | FSIL-Difficulty Doing Things B/c of Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty doing things with my hands because of the condition of my skin. | FACIT-Searchable Item Library Adult Version - Difficulty Doing Things B/c of Skin | ||
FSIL0245 | C183862 | FSIL-Difficulty Walking B/c of Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty walking because of my skin condition. | FACIT-Searchable Item Library Adult Version - Difficulty Walking B/c of Skin | ||
FSIL0246 | C183863 | FSIL-Bothered Red/Pink Appearance Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the red or pink appearance of my skin. | FACIT-Searchable Item Library Adult Version - Bothered Red/Pink Appearance Skin | ||
FSIL0247 | C183864 | FSIL-Bothered by Uncertainty Prognosis | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by uncertainty about my prognosis. | FACIT-Searchable Item Library Adult Version - Bothered by Uncertainty Prognosis | ||
FSIL0248 | C183865 | FSIL-Tired Dealing With Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am tired of dealing with my skin condition. | FACIT-Searchable Item Library Adult Version - Tired Dealing With Skin Condition | ||
FSIL0249 | C183866 | FSIL-Painful Lesions/Tumors on My Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have painful lesions or tumors on my skin. | FACIT-Searchable Item Library Adult Version - Painful Lesions/Tumors on My Skin | ||
FSIL0250 | C183867 | FSIL-Bothered Inconvenience Treat Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the inconvenience of treatment for my skin condition. | FACIT-Searchable Item Library Adult Version - Bothered Inconvenience Treat Skin | ||
FSIL0251 | C183868 | FSIL-Skin Feels Sensitive or Raw | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin feels sensitive or "raw". | FACIT-Searchable Item Library Adult Version - Skin Feels Sensitive or Raw | ||
FSIL0252 | C183869 | FSIL-Painful Cracks Skin on Hands/Feet | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have painful cracks in the skin on my hands or feet. | FACIT-Searchable Item Library Adult Version - Painful Cracks Skin on Hands/Feet | ||
FSIL0253 | C183870 | FSIL-My Skin Feels Irritated | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin feels irritated. | FACIT-Searchable Item Library Adult Version - My Skin Feels Irritated | ||
FSIL0254 | C183871 | FSIL-Worry Skin condition Get Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my skin condition may get worse. | FACIT-Searchable Item Library Adult Version - Worry Skin condition Get Worse | ||
FSIL0255 | C183872 | FSIL-Embarrassed by Appearance of Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by the appearance of my skin. | FACIT-Searchable Item Library Adult Version - Embarrassed by Appearance of Skin | ||
FSIL0256 | C183873 | FSIL-Frustrated by My Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my skin condition. | FACIT-Searchable Item Library Adult Version - Frustrated by My Skin Condition | ||
FSIL0257 | C183874 | FSIL-Skin Is Dry or Flaky | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin is dry or "flaky". | FACIT-Searchable Item Library Adult Version - Skin Is Dry or Flaky | ||
FSIL0258 | C183875 | FSIL-Bothered Discharge/Bleeding Vagina | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discharge or bleeding from my vagina. | FACIT-Searchable Item Library Adult Version - Bothered Discharge/Bleeding Vagina | ||
FSIL0259 | C183876 | FSIL-Bothered by Odor From Vagina | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by odor coming from my vagina. | FACIT-Searchable Item Library Adult Version - Bothered by Odor From Vagina | ||
FSIL0260 | C183877 | FSIL-Afraid to Have Sex | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid to have sex. | FACIT-Searchable Item Library Adult Version - Afraid to Have Sex | ||
FSIL0261 | C183878 | FSIL-Vagina Feels Too Narrow/Short | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My vagina feels too narrow or short. | FACIT-Searchable Item Library Adult Version - Vagina Feels Too Narrow/Short | ||
FSIL0262 | C183879 | FSIL-Afraid Treatment May Harm Body | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid the treatment may harm my body. | FACIT-Searchable Item Library Adult Version - Afraid Treatment May Harm Body | ||
FSIL0263 | C183880 | FSIL-Bothered by Constipation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by constipation. | FACIT-Searchable Item Library Adult Version - Bothered by Constipation | ||
FSIL0264 | C183881 | FSIL-I Have Discomfort When I Urinate | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort when I urinate. | FACIT-Searchable Item Library Adult Version - I Have Discomfort When I Urinate | ||
FSIL0265 | C183882 | FSIL-Limit Social Activity B/c Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because of diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Limit Social Activity B/c Diarrhea | ||
FSIL0266 | C183883 | FSIL-Limit Physical Activ B/c Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my physical activity because of diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Limit Physical Activ B/c Diarrhea | ||
FSIL0267 | C183884 | FSIL-Limit Sexual Activity B/c Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Limit Sexual Activity B/c Diarrhea | ||
FSIL0268 | C183885 | FSIL-Embarrassed by Having Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by having diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Embarrassed by Having Diarrhea | ||
FSIL0269 | C183886 | FSIL-Abdominal Cramps Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have abdominal cramps or discomfort due to my diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Abdominal Cramps Diarrhea | ||
FSIL0270 | C183887 | FSIL-Diarrhea Keeps/Wakes Me Up at Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My problem with diarrhea (diarrhoea) keeps/wakes me up at night. | FACIT-Searchable Item Library Adult Version - Diarrhea Keeps/Wakes Me Up at Night | ||
FSIL0271 | C183888 | FSIL-Dressing Yourself Without Help | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Dressing yourself without help. | FACIT-Searchable Item Library Adult Version - Dressing Yourself Without Help | ||
FSIL0272 | C183889 | FSIL-Walking 50 Steps Flat Normal Speed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Searchable Item Library Adult Version - Walking 50 Steps Flat Normal Speed | ||
FSIL0273 | C183890 | FSIL-Walking Up 20 Stairs w/o Stopping | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking up 20 stairs (2 flights) without stopping. | FACIT-Searchable Item Library Adult Version - Walking Up 20 Stairs w/o Stopping | ||
FSIL0274 | C183891 | FSIL-Preparing Meals | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Preparing meals. | FACIT-Searchable Item Library Adult Version - Preparing Meals | ||
FSIL0275 | C183892 | FSIL-Washing Dishes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Washing dishes. | FACIT-Searchable Item Library Adult Version - Washing Dishes | ||
FSIL0276 | C183893 | FSIL-Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Sweeping or mopping. | FACIT-Searchable Item Library Adult Version - Sweeping/Mopping | ||
FSIL0277 | C183894 | FSIL-Making a Bed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Making a bed. | FACIT-Searchable Item Library Adult Version - Making a Bed | ||
FSIL0278 | C183895 | FSIL-Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Searchable Item Library Adult Version - Lifting 10-20 Lbs | ||
FSIL0279 | C183896 | FSIL-Carrying 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Searchable Item Library Adult Version - Carrying 10-20 Lbs | ||
FSIL0280 | C183897 | FSIL-Walking for 1/2 Mile w/o Stopping | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Searchable Item Library Adult Version - Walking for 1/2 Mile w/o Stopping | ||
FSIL0281 | C183898 | FSIL-Difficulty Swallowing Solid Foods | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing solid foods. | FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Solid Foods | ||
FSIL0282 | C183899 | FSIL-Difficulty Swallowing Soft Foods | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing soft or mashed foods. | FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Soft Foods | ||
FSIL0283 | C183900 | FSIL-Difficulty Swallowing Liquids | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing liquids. | FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Liquids | ||
FSIL0284 | C183901 | FSIL-Pain in My Chest When I Swallow | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my chest when I swallow. | FACIT-Searchable Item Library Adult Version - Pain in My Chest When I Swallow | ||
FSIL0285 | C183902 | FSIL-I Choke When I Swallow | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I choke when I swallow. | FACIT-Searchable Item Library Adult Version - I Choke When I Swallow | ||
FSIL0286 | C183903 | FSIL-Enjoy Meals With Family/Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to enjoy meals with family or friends. | FACIT-Searchable Item Library Adult Version - Enjoy Meals With Family/Friends | ||
FSIL0287 | C183904 | FSIL-Wake at Night Because of Coughing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wake at night because of coughing. | FACIT-Searchable Item Library Adult Version - Wake at Night Because of Coughing | ||
FSIL0288 | C183905 | FSIL-Pleasant Feel Fullness Tube Feeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I experience a pleasant feeling of fullness during or after my tube feeding. | FACIT-Searchable Item Library Adult Version - Pleasant Feel Fullness Tube Feeding | ||
FSIL0289 | C183906 | FSIL-I Have the Desire to Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have the desire to eat. | FACIT-Searchable Item Library Adult Version - I Have the Desire to Eat | ||
FSIL0290 | C183907 | FSIL-Worry Feeding Tube Health Is Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that having a feeding tube means my health is worse. | FACIT-Searchable Item Library Adult Version - Worry Feeding Tube Health Is Worse | ||
FSIL0291 | C183908 | FSIL-Worry Tube Coming Out by Accident | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the tube coming out by accident. | FACIT-Searchable Item Library Adult Version - Worry Tube Coming Out by Accident | ||
FSIL0292 | C183909 | FSIL-Worry Tube Getting Plugged/Blocked | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the tube getting plugged or blocked. | FACIT-Searchable Item Library Adult Version - Worry Tube Getting Plugged/Blocked | ||
FSIL0293 | C183910 | FSIL-Worry Infection From Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting an infection from the feeding tube. | FACIT-Searchable Item Library Adult Version - Worry Infection From Feeding Tube | ||
FSIL0294 | C183911 | FSIL-Worry Losing Weight Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about losing weight because I have a feeding tube. | FACIT-Searchable Item Library Adult Version - Worry Losing Weight Feeding Tube | ||
FSIL0295 | C183912 | FSIL-Lost Food Choices Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I have lost control of my food choices because I have a feeding tube. | FACIT-Searchable Item Library Adult Version - Lost Food Choices Feeding Tube | ||
FSIL0296 | C183913 | FSIL-Dependent on Others Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel dependent on others because I have a feeding tube. | FACIT-Searchable Item Library Adult Version - Dependent on Others Feeding Tube | ||
FSIL0297 | C183914 | FSIL-Left Out When Others Are Eating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel left out when others are eating. | FACIT-Searchable Item Library Adult Version - Left Out When Others Are Eating | ||
FSIL0298 | C183915 | FSIL-Confident Nutrition Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am more confident about my nutrition because of my feeding tube. | FACIT-Searchable Item Library Adult Version - Confident Nutrition Feeding Tube | ||
FSIL0299 | C183916 | FSIL-Uncomfortably Full Tube Feeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel uncomfortably full during or after my tube feeding. | FACIT-Searchable Item Library Adult Version - Uncomfortably Full Tube Feeding | ||
FSIL0300 | C183917 | FSIL-Feeding Tube Was Right Decision | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Getting a feeding tube was the right decision for me. | FACIT-Searchable Item Library Adult Version - Feeding Tube Was Right Decision | ||
FSIL0301 | C183918 | FSIL-Constipation Dur/After Tube Feeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have constipation during or after my tube feeding. | FACIT-Searchable Item Library Adult Version - Constipation Dur/After Tube Feeding | ||
FSIL0302 | C183919 | FSIL-Vomiting Dur/After Tube Feeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I experience vomiting during or after my tube feeding. | FACIT-Searchable Item Library Adult Version - Vomiting Dur/After Tube Feeding | ||
FSIL0303 | C183920 | FSIL-Tube Feed Limits Do Inside House | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits what I can do inside the house (for example housework, watching TV or reading). | FACIT-Searchable Item Library Adult Version - Tube Feed Limits Do Inside House | ||
FSIL0304 | C183921 | FSIL-Tube Feeding Limits Do Outside | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits what I can do outside of the house (for example shopping, driving or yard work). | FACIT-Searchable Item Library Adult Version - Tube Feeding Limits Do Outside | ||
FSIL0305 | C183922 | FSIL-Tube Feeding Limits Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits my activities with my friends. | FACIT-Searchable Item Library Adult Version - Tube Feeding Limits Activities | ||
FSIL0306 | C183923 | FSIL-Dur Tube Feeding Eat/Drink by Mouth | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: During the use of tube feeding, I can eat and drink by mouth. | FACIT-Searchable Item Library Adult Version - Dur Tube Feeding Eat/Drink by Mouth | ||
FSIL0307 | C183924 | FSIL-Miss Food/Drink Mouth Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I miss being able to take more food or drink by mouth now that I have a feeding tube. | FACIT-Searchable Item Library Adult Version - Miss Food/Drink Mouth Feeding Tube | ||
FSIL0308 | C183925 | FSIL-Trouble Digesting Food | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble digesting food. | FACIT-Searchable Item Library Adult Version - Trouble Digesting Food | ||
FSIL0309 | C183926 | FSIL-Discomfort/Pain in My Pelvic Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain in my pelvic area. | FACIT-Searchable Item Library Adult Version - Discomfort/Pain in My Pelvic Area | ||
FSIL0310 | C183927 | FSIL-I Have Hot Flashes/Hot Flushes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have hot flashes/hot flushes. | FACIT-Searchable Item Library Adult Version - I Have Hot Flashes/Hot Flushes | ||
FSIL0311 | C183928 | FSIL-I Have Gained Weight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have gained weight. | FACIT-Searchable Item Library Adult Version - I Have Gained Weight | ||
FSIL0312 | C183929 | FSIL-Have Breast Sensitivity/Tenderness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have breast sensitivity/tenderness. | FACIT-Searchable Item Library Adult Version - Have Breast Sensitivity/Tenderness | ||
FSIL0313 | C183930 | FSIL-I Have Mood Swings | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have mood swings. | FACIT-Searchable Item Library Adult Version - I Have Mood Swings | ||
FSIL0314 | C183931 | FSIL-Irritable | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am irritable. | FACIT-Searchable Item Library Adult Version - Irritable | ||
FSIL0315 | C183932 | FSIL-I Have Cold Sweats | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cold sweats. | FACIT-Searchable Item Library Adult Version - I Have Cold Sweats | ||
FSIL0316 | C183933 | FSIL-I Have Night Sweats | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have night sweats. | FACIT-Searchable Item Library Adult Version - I Have Night Sweats | ||
FSIL0317 | C183934 | FSIL-I Have Vaginal Discharge | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal discharge. | FACIT-Searchable Item Library Adult Version - I Have Vaginal Discharge | ||
FSIL0318 | C183935 | FSIL-I Have Vaginal Itching/Irritation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal itching/irritation. | FACIT-Searchable Item Library Adult Version - I Have Vaginal Itching/Irritation | ||
FSIL0319 | C183936 | FSIL-I Have Vaginal Bleeding or Spotting | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal bleeding or spotting. | FACIT-Searchable Item Library Adult Version - I Have Vaginal Bleeding or Spotting | ||
FSIL0320 | C183937 | FSIL-I Have Vaginal Dryness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal dryness. | FACIT-Searchable Item Library Adult Version - I Have Vaginal Dryness | ||
FSIL0321 | C183938 | FSIL-Have Pain/Discomfort w/Intercourse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain or discomfort with intercourse. | FACIT-Searchable Item Library Adult Version - Have Pain/Discomfort w/Intercourse | ||
FSIL0322 | C183939 | FSIL-I Have Lost Interest in Sex | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have lost interest in sex. | FACIT-Searchable Item Library Adult Version - I Have Lost Interest in Sex | ||
FSIL0323 | C183940 | FSIL-Enough Money to Cover Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I know that I have enough money in savings, retirement, or assets to cover the costs of my treatment. | FACIT-Searchable Item Library Adult Version - Enough Money to Cover Treatment | ||
FSIL0324 | C183941 | FSIL-Reduced Satisfaction Financial | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My cancer or treatment has reduced my satisfaction with my present financial situation. | FACIT-Searchable Item Library Adult Version - Reduced Satisfaction Financial | ||
FSIL0325 | C183942 | FSIL-In control of Financial Situation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel in control of my financial situation. | FACIT-Searchable Item Library Adult Version - In control of Financial Situation | ||
FSIL0326 | C183943 | FSIL-Illness a Financial Hardship | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness has been a financial hardship to my family and me. | FACIT-Searchable Item Library Adult Version - Illness a Financial Hardship | ||
FSIL0327 | C183944 | FSIL-Medical Expense More Than I Thought | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My out-of-pocket medical expenses are more than I thought they would be. | FACIT-Searchable Item Library Adult Version - Medical Expense More Than I Thought | ||
FSIL0328 | C183945 | FSIL-Worry Financial Problems in Future | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the financial problems I will have in the future as a result of my illness or treatment. | FACIT-Searchable Item Library Adult Version - Worry Financial Problems in Future | ||
FSIL0329 | C183946 | FSIL-No Choice Money Spend on Care | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel I have no choice about the amount of money I spend on care. | FACIT-Searchable Item Library Adult Version - No Choice Money Spend on Care | ||
FSIL0330 | C183947 | FSIL-Frustrated Cannot Work as Usual | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated that I cannot work or contribute as much as I usually do. | FACIT-Searchable Item Library Adult Version - Frustrated Cannot Work as Usual | ||
FSIL0331 | C183948 | FSIL-Satisfied With Financial Situation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my current financial situation. | FACIT-Searchable Item Library Adult Version - Satisfied With Financial Situation | ||
FSIL0332 | C183949 | FSIL-Able to Meet My Monthly Expenses | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to meet my monthly expenses. | FACIT-Searchable Item Library Adult Version - Able to Meet My Monthly Expenses | ||
FSIL0333 | C183950 | FSIL-Feel Financially Stressed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel financially stressed. | FACIT-Searchable Item Library Adult Version - Feel Financially Stressed | ||
FSIL0334 | C183951 | FSIL-Concerned Keeping My Job and Income | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about keeping my job and income, including work at home. | FACIT-Searchable Item Library Adult Version - Concerned Keeping My Job and Income | ||
FSIL0335 | C183952 | FSIL-I Have a Loss of Appetite | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a loss of appetite. | FACIT-Searchable Item Library Adult Version - I Have a Loss of Appetite | ||
FSIL0336 | C183953 | FSIL-Digestive Problems Interfere Activ | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My digestive problems interfere with my usual activities. | FACIT-Searchable Item Library Adult Version - Digestive Problems Interfere Activ | ||
FSIL0337 | C183954 | FSIL-Have Trouble Swallowing Food | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble swallowing food. | FACIT-Searchable Item Library Adult Version - Have Trouble Swallowing Food | ||
FSIL0338 | C183955 | FSIL-Bothered by Gas | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by gas (flatulence). | FACIT-Searchable Item Library Adult Version - Bothered by Gas | ||
FSIL0339 | C183956 | FSIL-Bothered by Reflux or Heartburn | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by reflux or heartburn. | FACIT-Searchable Item Library Adult Version - Bothered by Reflux or Heartburn | ||
FSIL0340 | C183957 | FSIL-Bothered by Change in Eating Habits | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my eating habits. | FACIT-Searchable Item Library Adult Version - Bothered by Change in Eating Habits | ||
FSIL0341 | C183958 | FSIL-Fullness/Heaviness in Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a feeling of fullness or heaviness in my stomach area. | FACIT-Searchable Item Library Adult Version - Fullness/Heaviness in Stomach Area | ||
FSIL0342 | C183959 | FSIL-Discomfort or Pain When I Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain when I eat. | FACIT-Searchable Item Library Adult Version - Discomfort or Pain When I Eat | ||
FSIL0343 | C183960 | FSIL-Stomach Problems That Worry Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stomach problems that worry me. | FACIT-Searchable Item Library Adult Version - Stomach Problems That Worry Me | ||
FSIL0344 | C183961 | FSIL-Avoid Going Out to Eat B/c Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid going out to eat because of my illness. | FACIT-Searchable Item Library Adult Version - Avoid Going Out to Eat B/c Illness | ||
FSIL0345 | C183962 | FSIL-I Feel Sad | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel sad. | FACIT-Searchable Item Library Adult Version - I Feel Sad | ||
FSIL0346 | C183963 | FSIL-Satisfied With How I Am Coping | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with how I am coping with my illness. | FACIT-Searchable Item Library Adult Version - Satisfied With How I Am Coping | ||
FSIL0347 | C183964 | FSIL-Losing Hope Fight Against Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am losing hope in the fight against my illness. | FACIT-Searchable Item Library Adult Version - Losing Hope Fight Against Illness | ||
FSIL0348 | C183965 | FSIL-I Feel Nervous | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel nervous. | FACIT-Searchable Item Library Adult Version - I Feel Nervous | ||
FSIL0349 | C183966 | FSIL-I Worry About Dying | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about dying. | FACIT-Searchable Item Library Adult Version - I Worry About Dying | ||
FSIL0350 | C183967 | FSIL-Worry My Condition Will Get Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my condition will get worse. | FACIT-Searchable Item Library Adult Version - Worry My Condition Will Get Worse | ||
FSIL0351 | C183968 | FSIL-Able to Work | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to work (include work at home). | FACIT-Searchable Item Library Adult Version - Able to Work | ||
FSIL0352 | C183969 | FSIL-My Work Is Fulfilling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My work (include work at home) is fulfilling. | FACIT-Searchable Item Library Adult Version - My Work Is Fulfilling | ||
FSIL0353 | C183970 | FSIL-Able to Enjoy Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to enjoy life. | FACIT-Searchable Item Library Adult Version - Able to Enjoy Life | ||
FSIL0354 | C183971 | FSIL-I Have Accepted My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have accepted my illness. | FACIT-Searchable Item Library Adult Version - I Have Accepted My Illness | ||
FSIL0355 | C183972 | FSIL-Sleeping Well | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am sleeping well. | FACIT-Searchable Item Library Adult Version - Sleeping Well | ||
FSIL0356 | C183973 | FSIL-Enjoy Things I Usually Do for Fun | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am enjoying the things I usually do for fun. | FACIT-Searchable Item Library Adult Version - Enjoy Things I Usually Do for Fun | ||
FSIL0357 | C183974 | FSIL-Content With Quality of My Life Now | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am content with the quality of my life right now. | FACIT-Searchable Item Library Adult Version - Content With Quality of My Life Now | ||
FSIL0358 | C183975 | FSIL-I Have a Lack of Energy | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a lack of energy. | FACIT-Searchable Item Library Adult Version - I Have a Lack of Energy | ||
FSIL0359 | C183976 | FSIL-I Have Nausea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have nausea. | FACIT-Searchable Item Library Adult Version - I Have Nausea | ||
FSIL0360 | C183977 | FSIL-Trouble Meeting Needs of Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my physical condition, I have trouble meeting the needs of my family. | FACIT-Searchable Item Library Adult Version - Trouble Meeting Needs of Family | ||
FSIL0361 | C183978 | FSIL-I Have Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain. | FACIT-Searchable Item Library Adult Version - I Have Pain | ||
FSIL0362 | C183979 | FSIL-Bothered by Side Effects Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by side effects of treatment. | FACIT-Searchable Item Library Adult Version - Bothered by Side Effects Treatment | ||
FSIL0363 | C183980 | FSIL-I Feel Ill | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel ill. | FACIT-Searchable Item Library Adult Version - I Feel Ill | ||
FSIL0364 | C183981 | FSIL-Forced to Spend Time in Bed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am forced to spend time in bed. | FACIT-Searchable Item Library Adult Version - Forced to Spend Time in Bed | ||
FSIL0365 | C183982 | FSIL-Believe Bothered by Side Effects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe I will be bothered by side effects of treatment. | FACIT-Searchable Item Library Adult Version - Believe Bothered by Side Effects | ||
FSIL0366 | C183983 | FSIL-I Have Confidence in My Doctor(s) | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my doctor(s). | FACIT-Searchable Item Library Adult Version - I Have Confidence in My Doctor(s) | ||
FSIL0367 | C183984 | FSIL-Doctor Available Answer Questions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor is available to answer my questions. | FACIT-Searchable Item Library Adult Version - Doctor Available Answer Questions | ||
FSIL0368 | C183985 | FSIL-I Feel Close to My Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my friends. | FACIT-Searchable Item Library Adult Version - I Feel Close to My Friends | ||
FSIL0369 | C183986 | FSIL-Emotional Support From My Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from my family. | FACIT-Searchable Item Library Adult Version - Emotional Support From My Family | ||
FSIL0370 | C183987 | FSIL-I Get Support From My Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get support from my friends. | FACIT-Searchable Item Library Adult Version - I Get Support From My Friends | ||
FSIL0371 | C183988 | FSIL-My Family Has Accepted My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has accepted my illness. | FACIT-Searchable Item Library Adult Version - My Family Has Accepted My Illness | ||
FSIL0372 | C183989 | FSIL-Satisfied Communication Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with family communication about my illness. | FACIT-Searchable Item Library Adult Version - Satisfied Communication Illness | ||
FSIL0373 | C183990 | FSIL-I Feel Close to My Partner | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my partner (or the person who is my main support). | FACIT-Searchable Item Library Adult Version - I Feel Close to My Partner | ||
FSIL0374 | C183991 | FSIL-Satisfied With My Sex Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my sex life. | FACIT-Searchable Item Library Adult Version - Satisfied With My Sex Life | ||
FSIL0375 | C183992 | FSIL-I Feel Close to My Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my family. | FACIT-Searchable Item Library Adult Version - I Feel Close to My Family | ||
FSIL0376 | C183993 | FSIL-Family Is Well Despite My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family is doing well despite my illness. | FACIT-Searchable Item Library Adult Version - Family Is Well Despite My Illness | ||
FSIL0377 | C183994 | FSIL-Illness Caused Problems w/ Sex Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness or treatment has caused problems with my sex life. | FACIT-Searchable Item Library Adult Version - Illness Caused Problems w/ Sex Life | ||
FSIL0378 | C183995 | FSIL-Unhappy About Change in My Appear | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy about a change in my appearance. | FACIT-Searchable Item Library Adult Version - Unhappy About Change in My Appear | ||
FSIL0379 | C183996 | FSIL-Bothered by Jaundice/Yellow Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by jaundice or yellow color to my skin. | FACIT-Searchable Item Library Adult Version - Bothered by Jaundice/Yellow Skin | ||
FSIL0380 | C183997 | FSIL-I Have Had Fevers | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had fevers (episodes of high body temperature). | FACIT-Searchable Item Library Adult Version - I Have Had Fevers | ||
FSIL0381 | C183998 | FSIL-I Have Had Itching | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had itching. | FACIT-Searchable Item Library Adult Version - I Have Had Itching | ||
FSIL0382 | C183999 | FSIL-Had Change in the Way Food Tastes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had a change in the way food tastes. | FACIT-Searchable Item Library Adult Version - Had Change in the Way Food Tastes | ||
FSIL0383 | C184000 | FSIL-I Have Had Chills | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had chills. | FACIT-Searchable Item Library Adult Version - I Have Had Chills | ||
FSIL0384 | C184001 | FSIL-Discomfort/Pain in Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain in my stomach area. | FACIT-Searchable Item Library Adult Version - Discomfort/Pain in Stomach Area | ||
FSIL0385 | C184002 | FSIL-Unhappy With My Appearance | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy with my appearance. | FACIT-Searchable Item Library Adult Version - Unhappy With My Appearance | ||
FSIL0386 | C184003 | FSIL-Embarrassed by My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my illness. | FACIT-Searchable Item Library Adult Version - Embarrassed by My Illness | ||
FSIL0387 | C184004 | FSIL-Hopeful About the Future | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am hopeful about the future. | FACIT-Searchable Item Library Adult Version - Hopeful About the Future | ||
FSIL0388 | C184005 | FSIL-I Feel Weak All Over | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel weak all over. | FACIT-Searchable Item Library Adult Version - I Feel Weak All Over | ||
FSIL0389 | C184006 | FSIL-Hard to Tell People About Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It is hard to tell other people about my infection. | FACIT-Searchable Item Library Adult Version - Hard to Tell People About Infection | ||
FSIL0390 | C184007 | FSIL-Have People to Help Me if I Need It | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have people to help me if I need it. | FACIT-Searchable Item Library Adult Version - Have People to Help Me if I Need It | ||
FSIL0391 | C184008 | FSIL-Worry About Spreading My Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about spreading my infection. | FACIT-Searchable Item Library Adult Version - Worry About Spreading My Infection | ||
FSIL0392 | C184009 | FSIL-Concerned What the Future Holds | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about what the future holds for me. | FACIT-Searchable Item Library Adult Version - Concerned What the Future Holds | ||
FSIL0393 | C184010 | FSIL-I Feel Motivated to Do Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel motivated to do things. | FACIT-Searchable Item Library Adult Version - I Feel Motivated to Do Things | ||
FSIL0394 | C184011 | FSIL-I Feel Fatigued | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel fatigued. | FACIT-Searchable Item Library Adult Version - I Feel Fatigued | ||
FSIL0395 | C184012 | FSIL-I Have Trouble Concentrating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble concentrating. | FACIT-Searchable Item Library Adult Version - I Have Trouble Concentrating | ||
FSIL0396 | C184013 | FSIL-I Have Trouble Remembering Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble remembering things. | FACIT-Searchable Item Library Adult Version - I Have Trouble Remembering Things | ||
FSIL0397 | C184014 | FSIL-Able to Eat the Foods That I Like | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to eat the foods that I like. | FACIT-Searchable Item Library Adult Version - Able to Eat the Foods That I Like | ||
FSIL0398 | C184015 | FSIL-Able to Communicate With Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to communicate with others. | FACIT-Searchable Item Library Adult Version - Able to Communicate With Others | ||
FSIL0399 | C184016 | FSIL-I Can Eat Solid Foods | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can eat solid foods. | FACIT-Searchable Item Library Adult Version - I Can Eat Solid Foods | ||
FSIL0400 | C184017 | FSIL-Pain in My Mouth, Throat or Neck | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my mouth, throat or neck. | FACIT-Searchable Item Library Adult Version - Pain in My Mouth, Throat or Neck | ||
FSIL0401 | C184018 | FSIL-My Mouth Is Dry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mouth is dry. | FACIT-Searchable Item Library Adult Version - My Mouth Is Dry | ||
FSIL0402 | C184019 | FSIL-I Have Trouble Breathing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble breathing. | FACIT-Searchable Item Library Adult Version - I Have Trouble Breathing | ||
FSIL0403 | C184020 | FSIL-Voice Has Usual Quality & Strength | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My voice has its usual quality and strength. | FACIT-Searchable Item Library Adult Version - Voice Has Usual Quality & Strength | ||
FSIL0404 | C184021 | FSIL-Able to Eat as Much Food as I Want | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to eat as much food as I want. | FACIT-Searchable Item Library Adult Version - Able to Eat as Much Food as I Want | ||
FSIL0405 | C184022 | FSIL-Unhappy With How Face & Neck Look | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy with how my face and neck look. | FACIT-Searchable Item Library Adult Version - Unhappy With How Face & Neck Look | ||
FSIL0406 | C184023 | FSIL-Can Swallow Naturally and Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can swallow naturally and easily. | FACIT-Searchable Item Library Adult Version - Can Swallow Naturally and Easily | ||
FSIL0407 | C184024 | FSIL-Smoke Cigarettes/Other Tobacco | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I smoke cigarettes or other tobacco products. | FACIT-Searchable Item Library Adult Version - Smoke Cigarettes/Other Tobacco | ||
FSIL0408 | C184025 | FSIL-I Drink Alcohol | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I drink alcohol (e.g. beer, wine, etc.). | FACIT-Searchable Item Library Adult Version - I Drink Alcohol | ||
FSIL0409 | C184026 | FSIL-I Have Been Bothered by Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been bothered by diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - I Have Been Bothered by Diarrhea | ||
FSIL0410 | C184027 | FSIL-Bothered by Blistering of My Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by blistering of my skin. | FACIT-Searchable Item Library Adult Version - Bothered by Blistering of My Skin | ||
FSIL0411 | C184028 | FSIL-I Have Been Wheezing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been wheezing (whistling sound when I breathe). | FACIT-Searchable Item Library Adult Version - I Have Been Wheezing | ||
FSIL0412 | C184029 | FSIL-Stiffness/Tightness in My Joints | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stiffness or tightness in my joints. | FACIT-Searchable Item Library Adult Version - Stiffness/Tightness in My Joints | ||
FSIL0413 | C184030 | FSIL-Joint Stiffness/Tight Limits Activ | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Joint stiffness or tightness limits my usual activities. | FACIT-Searchable Item Library Adult Version - Joint Stiffness/Tight Limits Activ | ||
FSIL0414 | C184031 | FSIL-Joint Pain Limits My Usual Activ | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Joint pain limits my usual activities. | FACIT-Searchable Item Library Adult Version - Joint Pain Limits My Usual Activ | ||
FSIL0415 | C184032 | FSIL-I Have Episodes of Heart Racing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have episodes of heart racing. | FACIT-Searchable Item Library Adult Version - I Have Episodes of Heart Racing | ||
FSIL0416 | C184033 | FSIL-My Eyes Feel Sandy or Gritty | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyes feel sandy or gritty. | FACIT-Searchable Item Library Adult Version - My Eyes Feel Sandy or Gritty | ||
FSIL0417 | C184034 | FSIL-I Have Pain in My Sinus Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my sinus area. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Sinus Area | ||
FSIL0418 | C184035 | FSIL-Bothered by Dry Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by dry skin. | FACIT-Searchable Item Library Adult Version - Bothered by Dry Skin | ||
FSIL0419 | C184036 | FSIL-Bothered by Vitiligo | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by vitiligo (white patches appearing on my skin). | FACIT-Searchable Item Library Adult Version - Bothered by Vitiligo | ||
FSIL0420 | C184037 | FSIL-Pain/Soreness/Aches in Some Muscles | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel pain, soreness or aches in some of my muscles. | FACIT-Searchable Item Library Adult Version - Pain/Soreness/Aches in Some Muscles | ||
FSIL0421 | C184038 | FSIL-Worry Neg Impacts Long-term Health | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about negative impacts that my treatment may have upon my long-term health. | FACIT-Searchable Item Library Adult Version - Worry Neg Impacts Long-term Health | ||
FSIL0422 | C184039 | FSIL-Bothered by Short-term Reactions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by short-term treatment reactions that I experience immediately after, or within 24 hours of, an infusion (such as chills, dizziness, hives, rashes lasting no more than 24 hours). | FACIT-Searchable Item Library Adult Version - Bothered by Short-term Reactions | ||
FSIL0423 | C184040 | FSIL-Troubled Not Knowing Side Effects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am troubled by not knowing when exactly my side effects will happen, how long they will last and how bad they will be. | FACIT-Searchable Item Library Adult Version - Troubled Not Knowing Side Effects | ||
FSIL0424 | C184041 | FSIL-Bothered New Allergy-like Reactions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by new allergy-like reactions (e.g., to foods, insects, pollen). | FACIT-Searchable Item Library Adult Version - Bothered New Allergy-like Reactions | ||
FSIL0425 | C184042 | FSIL-Bothered by Cracking/Peeling Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by cracking or peeling of my skin. | FACIT-Searchable Item Library Adult Version - Bothered by Cracking/Peeling Skin | ||
FSIL0426 | C184043 | FSIL-Move My Bowels More Than Usual | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I move my bowels more frequently than usual. | FACIT-Searchable Item Library Adult Version - Move My Bowels More Than Usual | ||
FSIL0427 | C184044 | FSIL-Condition Wakes/Keeps Me Up Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My condition wakes or keeps me up at night. | FACIT-Searchable Item Library Adult Version - Condition Wakes/Keeps Me Up Night | ||
FSIL0428 | C184045 | FSIL-Move Bowels Freq to Avoid Accidents | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I must move my bowels frequently to avoid accidents. | FACIT-Searchable Item Library Adult Version - Move Bowels Freq to Avoid Accidents | ||
FSIL0429 | C184046 | FSIL-Far From Home/Work W/o Fear Soilage | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can be far from home/work without fearing soilage. | FACIT-Searchable Item Library Adult Version - Far From Home/Work W/o Fear Soilage | ||
FSIL0430 | C184047 | FSIL-Wear Pads/Protect Prevent Soiling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wear pads or protection to prevent soiling my underwear. | FACIT-Searchable Item Library Adult Version - Wear Pads/Protect Prevent Soiling | ||
FSIL0431 | C184048 | FSIL-Comfortable Discuss Cond w/Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am comfortable discussing my condition with friends. | FACIT-Searchable Item Library Adult Version - Comfortable Discuss Cond w/Friends | ||
FSIL0432 | C184049 | FSIL-Afraid to Be Far From a Toilet | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid to be far from a toilet. | FACIT-Searchable Item Library Adult Version - Afraid to Be Far From a Toilet | ||
FSIL0433 | C184050 | FSIL-Limit My Social Activity | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because of my condition. | FACIT-Searchable Item Library Adult Version - Limit My Social Activity | ||
FSIL0434 | C184051 | FSIL-Limit Physical Activ B/c Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my physical activity because of my condition. | FACIT-Searchable Item Library Adult Version - Limit Physical Activ B/c Condition | ||
FSIL0435 | C184052 | FSIL-Limit Sexual Activ B/c Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of my condition. | FACIT-Searchable Item Library Adult Version - Limit Sexual Activ B/c Condition | ||
FSIL0436 | C184053 | FSIL-Embarrassed by My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my condition. | FACIT-Searchable Item Library Adult Version - Embarrassed by My Condition | ||
FSIL0437 | C184054 | FSIL-My Condition Wakes Me Up at Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My condition wakes me up at night. | FACIT-Searchable Item Library Adult Version - My Condition Wakes Me Up at Night | ||
FSIL0438 | C184055 | FSIL-Urinate Frequently to Avoid Leaking | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I must urinate frequently to avoid leaking. | FACIT-Searchable Item Library Adult Version - Urinate Frequently to Avoid Leaking | ||
FSIL0439 | C184056 | FSIL-Wear Protection Leakage of Urine | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wear protection for leakage of urine. | FACIT-Searchable Item Library Adult Version - Wear Protection Leakage of Urine | ||
FSIL0440 | C184057 | FSIL-My Thinking Is Clear | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking is clear. | FACIT-Searchable Item Library Adult Version - My Thinking Is Clear | ||
FSIL0441 | C184058 | FSIL-I Have Been Coughing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been coughing. | FACIT-Searchable Item Library Adult Version - I Have Been Coughing | ||
FSIL0442 | C184059 | FSIL-I Feel Tightness in My Chest | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel tightness in my chest. | FACIT-Searchable Item Library Adult Version - I Feel Tightness in My Chest | ||
FSIL0443 | C184060 | FSIL-Breathing Is Easy for Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Breathing is easy for me. | FACIT-Searchable Item Library Adult Version - Breathing Is Easy for Me | ||
FSIL0444 | C184061 | FSIL-I Regret My Smoking | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I regret my smoking. | FACIT-Searchable Item Library Adult Version - I Regret My Smoking | ||
FSIL0445 | C184062 | FSIL-Bothered by Lumps or Swelling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). | FACIT-Searchable Item Library Adult Version - Bothered by Lumps or Swelling | ||
FSIL0446 | C184063 | FSIL-Frustrated Unable Do Things I Want | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by being unable to do the things I want to do. | FACIT-Searchable Item Library Adult Version - Frustrated Unable Do Things I Want | ||
FSIL0447 | C184064 | FSIL-I Feel Discouraged About My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discouraged about my illness. | FACIT-Searchable Item Library Adult Version - I Feel Discouraged About My Illness | ||
FSIL0448 | C184065 | FSIL-Difficulty Planning for Future | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my illness, I have difficulty planning for the future. | FACIT-Searchable Item Library Adult Version - Difficulty Planning for Future | ||
FSIL0449 | C184066 | FSIL-Uncertain About My Future Health | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel uncertain about my future health. | FACIT-Searchable Item Library Adult Version - Uncertain About My Future Health | ||
FSIL0450 | C184067 | FSIL-Worry I Might Get New Symptoms | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that I might get new symptoms of my illness. | FACIT-Searchable Item Library Adult Version - Worry I Might Get New Symptoms | ||
FSIL0451 | C184068 | FSIL-Feel Isolated Because of Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel isolated from others because of my illness or treatment. | FACIT-Searchable Item Library Adult Version - Feel Isolated Because of Illness | ||
FSIL0452 | C184069 | FSIL-Worry Support Myself/Family Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about being able to support myself or my family due to my illness. | FACIT-Searchable Item Library Adult Version - Worry Support Myself/Family Illness | ||
FSIL0453 | C184070 | FSIL-Bothered by Itching | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by itching. | FACIT-Searchable Item Library Adult Version - Bothered by Itching | ||
FSIL0454 | C184071 | FSIL-I Have Trouble Sleeping at Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble sleeping at night. | FACIT-Searchable Item Library Adult Version - I Have Trouble Sleeping at Night | ||
FSIL0455 | C184072 | FSIL-Nervous Making Decisions Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get nervous about making decisions regarding treatment. | FACIT-Searchable Item Library Adult Version - Nervous Making Decisions Treatment | ||
FSIL0456 | C184073 | FSIL-Pain at My Melanoma/Surgical Site | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain at my melanoma site or surgical site. | FACIT-Searchable Item Library Adult Version - Pain at My Melanoma/Surgical Site | ||
FSIL0457 | C184074 | FSIL-I Have Swelling at My Melanoma Site | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling at my melanoma site. | FACIT-Searchable Item Library Adult Version - I Have Swelling at My Melanoma Site | ||
FSIL0458 | C184075 | FSIL-Swelling as a Result of Surgery | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling as a result of surgery. | FACIT-Searchable Item Library Adult Version - Swelling as a Result of Surgery | ||
FSIL0459 | C184076 | FSIL-Bothered by the Amount of Swelling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the amount of swelling. | FACIT-Searchable Item Library Adult Version - Bothered by the Amount of Swelling | ||
FSIL0460 | C184077 | FSIL-Movement of Swollen Area Is Painful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Movement of my swollen area is painful. | FACIT-Searchable Item Library Adult Version - Movement of Swollen Area Is Painful | ||
FSIL0461 | C184078 | FSIL-Swelling Keeps Me From Doing Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Swelling keeps me from doing the things I want to do. | FACIT-Searchable Item Library Adult Version - Swelling Keeps Me From Doing Things | ||
FSIL0462 | C184079 | FSIL-Swelling Keeps Me From Wearing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Swelling keeps me from wearing clothes or shoes I want to wear. | FACIT-Searchable Item Library Adult Version - Swelling Keeps Me From Wearing | ||
FSIL0463 | C184080 | FSIL-I Feel Numbness at My Surgical Site | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel numbness at my surgical site. | FACIT-Searchable Item Library Adult Version - I Feel Numbness at My Surgical Site | ||
FSIL0464 | C184081 | FSIL-Good Range of Movement in Arm/Leg | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have good range of movement in my arm or leg. | FACIT-Searchable Item Library Adult Version - Good Range of Movement in Arm/Leg | ||
FSIL0465 | C184082 | FSIL-Noticed New Changes in My Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have noticed new changes in my skin (lumps, bumps, color (colour)). | FACIT-Searchable Item Library Adult Version - Noticed New Changes in My Skin | ||
FSIL0466 | C184083 | FSIL-Worry Appearance of Surgical Scars | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the appearance of surgical scars. | FACIT-Searchable Item Library Adult Version - Worry Appearance of Surgical Scars | ||
FSIL0467 | C184084 | FSIL-I Have Aches and Pains in My Bones | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have aches and pains in my bones. | FACIT-Searchable Item Library Adult Version - I Have Aches and Pains in My Bones | ||
FSIL0468 | C184085 | FSIL-I Have Noticed Blood in My Stool | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have noticed blood in my stool. | FACIT-Searchable Item Library Adult Version - I Have Noticed Blood in My Stool | ||
FSIL0469 | C184086 | FSIL-Isolate From Others B/c Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I isolate myself from others because of my condition. | FACIT-Searchable Item Library Adult Version - Isolate From Others B/c Condition | ||
FSIL0470 | C184087 | FSIL-I Have Difficulty Thinking Clearly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty thinking clearly (remembering, concentrating). | FACIT-Searchable Item Library Adult Version - I Have Difficulty Thinking Clearly | ||
FSIL0471 | C184088 | FSIL-Trouble Walking Because of Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking because of pain. | FACIT-Searchable Item Library Adult Version - Trouble Walking Because of Pain | ||
FSIL0472 | C184089 | FSIL-Trouble Getting Around in Public | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble getting around in public places. | FACIT-Searchable Item Library Adult Version - Trouble Getting Around in Public | ||
FSIL0473 | C184090 | FSIL-I Need to Rest During the Day | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need to rest during the day. | FACIT-Searchable Item Library Adult Version - I Need to Rest During the Day | ||
FSIL0474 | C184091 | FSIL-My Thinking Is Slower Than Before | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking is slower than before. | FACIT-Searchable Item Library Adult Version - My Thinking Is Slower Than Before | ||
FSIL0475 | C184092 | FSIL-I Have Trouble Learning New Tasks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble learning new tasks or directions. | FACIT-Searchable Item Library Adult Version - I Have Trouble Learning New Tasks | ||
FSIL0476 | C184093 | FSIL-Family Trouble Understand Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has trouble understanding when my condition gets worse. | FACIT-Searchable Item Library Adult Version - Family Trouble Understand Worse | ||
FSIL0477 | C184094 | FSIL-I Feel Left Out of Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel "left out" of things. | FACIT-Searchable Item Library Adult Version - I Feel Left Out of Things | ||
FSIL0478 | C184095 | FSIL-Heat Worsens My Symptoms | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Heat worsens my symptoms. | FACIT-Searchable Item Library Adult Version - Heat Worsens My Symptoms | ||
FSIL0479 | C184096 | FSIL-Bothered by Muscle Spasms | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by muscle spasms. | FACIT-Searchable Item Library Adult Version - Bothered by Muscle Spasms | ||
FSIL0480 | C184097 | FSIL-Take My Condition Into Account | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to take my condition into account when making plans. | FACIT-Searchable Item Library Adult Version - Take My Condition Into Account | ||
FSIL0481 | C184098 | FSIL-Bothered by Headaches | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by headaches. | FACIT-Searchable Item Library Adult Version - Bothered by Headaches | ||
FSIL0482 | C184099 | FSIL-Bothered by Muscle Pains | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by muscle pains. | FACIT-Searchable Item Library Adult Version - Bothered by Muscle Pains | ||
FSIL0483 | C184100 | FSIL-I Feel Trapped by My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel trapped by my condition. | FACIT-Searchable Item Library Adult Version - I Feel Trapped by My Condition | ||
FSIL0484 | C184101 | FSIL-Depressed About My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am depressed about my condition. | FACIT-Searchable Item Library Adult Version - Depressed About My Condition | ||
FSIL0485 | C184102 | FSIL-I Feel Useless | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel useless. | FACIT-Searchable Item Library Adult Version - I Feel Useless | ||
FSIL0486 | C184103 | FSIL-Feel Overwhelmed by My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel overwhelmed by my condition. | FACIT-Searchable Item Library Adult Version - Feel Overwhelmed by My Condition | ||
FSIL0487 | C184104 | FSIL-Frustrated by My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my condition. | FACIT-Searchable Item Library Adult Version - Frustrated by My Condition | ||
FSIL0488 | C184105 | FSIL-Worry Getting Sick Low Blood Counts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting sick due to low blood counts. | FACIT-Searchable Item Library Adult Version - Worry Getting Sick Low Blood Counts | ||
FSIL0489 | C184106 | FSIL-Avoid Public Places Fear Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid public places for fear of getting an infection. | FACIT-Searchable Item Library Adult Version - Avoid Public Places Fear Infection | ||
FSIL0490 | C184107 | FSIL-I Worry About Getting Infections | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting infections. | FACIT-Searchable Item Library Adult Version - I Worry About Getting Infections | ||
FSIL0491 | C184108 | FSIL-Worry Not improve Treatment Delayed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry my condition will not improve if my treatment is delayed. | FACIT-Searchable Item Library Adult Version - Worry Not improve Treatment Delayed | ||
FSIL0492 | C184109 | FSIL-I Have Mouth Sores | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have mouth sores. | FACIT-Searchable Item Library Adult Version - I Have Mouth Sores | ||
FSIL0493 | C184110 | FSIL-Partner Worries My Blood Counts Low | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My partner worries about me when my blood counts are low. | FACIT-Searchable Item Library Adult Version - Partner Worries My Blood Counts Low | ||
FSIL0494 | C184111 | FSIL-Low Blood Counts Interfere Relation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My low blood counts interfere with my intimate relationships. | FACIT-Searchable Item Library Adult Version - Low Blood Counts Interfere Relation | ||
FSIL0495 | C184112 | FSIL-I Have Weakness in My Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have weakness in my legs. | FACIT-Searchable Item Library Adult Version - I Have Weakness in My Legs | ||
FSIL0496 | C184113 | FSIL-Diff Moving Neck & Shoulders Stiff | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty moving my neck and shoulders because of stiffness. | FACIT-Searchable Item Library Adult Version - Diff Moving Neck & Shoulders Stiff | ||
FSIL0497 | C184114 | FSIL-Bothered by Ringing in My Ear | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by ringing in my ear(s). | FACIT-Searchable Item Library Adult Version - Bothered by Ringing in My Ear | ||
FSIL0498 | C184115 | FSIL-Bothered by Worsening Eyesight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by worsening eyesight. | FACIT-Searchable Item Library Adult Version - Bothered by Worsening Eyesight | ||
FSIL0499 | C184116 | FSIL-I Have Trouble Smelling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble smelling. | FACIT-Searchable Item Library Adult Version - I Have Trouble Smelling | ||
FSIL0500 | C184117 | FSIL-I Can Enjoy the Taste of Food | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can enjoy the taste of food. | FACIT-Searchable Item Library Adult Version - I Can Enjoy the Taste of Food | ||
FSIL0501 | C184118 | FSIL-Bothered by Having a Blocked Nose | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by having a blocked nose. | FACIT-Searchable Item Library Adult Version - Bothered by Having a Blocked Nose | ||
FSIL0502 | C184119 | FSIL-Numbness or Tingling in My Hands | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my hands. | FACIT-Searchable Item Library Adult Version - Numbness or Tingling in My Hands | ||
FSIL0503 | C184120 | FSIL-Pain in Hands/Feet Exposed to Cold | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my hands or feet when I am exposed to cold temperatures. | FACIT-Searchable Item Library Adult Version - Pain in Hands/Feet Exposed to Cold | ||
FSIL0504 | C184121 | FSIL-Difficulty Breathing Exposed Cold | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty breathing when I am exposed to cold temperatures. | FACIT-Searchable Item Library Adult Version - Difficulty Breathing Exposed Cold | ||
FSIL0505 | C184122 | FSIL-Numbness or Tingling in My Feet | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my feet. | FACIT-Searchable Item Library Adult Version - Numbness or Tingling in My Feet | ||
FSIL0506 | C184123 | FSIL-I Feel Discomfort in My Hands | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discomfort in my hands. | FACIT-Searchable Item Library Adult Version - I Feel Discomfort in My Hands | ||
FSIL0507 | C184124 | FSIL-I Feel Discomfort in My Feet | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discomfort in my feet. | FACIT-Searchable Item Library Adult Version - I Feel Discomfort in My Feet | ||
FSIL0508 | C184125 | FSIL-Have Joint Pain or Muscle Cramps | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have joint pain or muscle cramps. | FACIT-Searchable Item Library Adult Version - Have Joint Pain or Muscle Cramps | ||
FSIL0509 | C184126 | FSIL-I Have Trouble Hearing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble hearing. | FACIT-Searchable Item Library Adult Version - I Have Trouble Hearing | ||
FSIL0510 | C184127 | FSIL-Get Ringing or Buzzing in My Ears | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get a ringing or buzzing in my ears. | FACIT-Searchable Item Library Adult Version - Get Ringing or Buzzing in My Ears | ||
FSIL0511 | C184128 | FSIL-I Have Trouble Buttoning Buttons | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble buttoning buttons. | FACIT-Searchable Item Library Adult Version - I Have Trouble Buttoning Buttons | ||
FSIL0512 | C184129 | FSIL-Trouble Feeling Shape of Objects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling the shape of small objects when they are in my hand. | FACIT-Searchable Item Library Adult Version - Trouble Feeling Shape of Objects | ||
FSIL0513 | C184130 | FSIL-I Have Swelling in Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling in my stomach area. | FACIT-Searchable Item Library Adult Version - I Have Swelling in Stomach Area | ||
FSIL0514 | C184131 | FSIL-I Have Been Vomiting | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been vomiting. | FACIT-Searchable Item Library Adult Version - I Have Been Vomiting | ||
FSIL0515 | C184132 | FSIL-I Have Cramps in My Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cramps in my stomach area. | FACIT-Searchable Item Library Adult Version - I Have Cramps in My Stomach Area | ||
FSIL0516 | C184133 | FSIL-I Have Aches/Pains That Bother Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have aches and pains that bother me. | FACIT-Searchable Item Library Adult Version - I Have Aches/Pains That Bother Me | ||
FSIL0517 | C184134 | FSIL-Certain Parts of Body Have Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have certain parts of my body where I experience pain. | FACIT-Searchable Item Library Adult Version - Certain Parts of Body Have Pain | ||
FSIL0518 | C184135 | FSIL-Pain Keeps Me From Doing Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pain keeps me from doing things I want to do. | FACIT-Searchable Item Library Adult Version - Pain Keeps Me From Doing Things | ||
FSIL0519 | C184136 | FSIL-Satisfied With Comfort Level | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my present comfort level. | FACIT-Searchable Item Library Adult Version - Satisfied With Comfort Level | ||
FSIL0520 | C184137 | FSIL-Able to Feel Like a Man | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to feel like a man. | FACIT-Searchable Item Library Adult Version - Able to Feel Like a Man | ||
FSIL0521 | C184138 | FSIL-I Have Trouble Moving My Bowels | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble moving my bowels. | FACIT-Searchable Item Library Adult Version - I Have Trouble Moving My Bowels | ||
FSIL0522 | C184139 | FSIL-I Have Difficulty Urinating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty urinating. | FACIT-Searchable Item Library Adult Version - I Have Difficulty Urinating | ||
FSIL0523 | C184140 | FSIL-Problem Urinating Limits Activity | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My problems with urinating limit my activities. | FACIT-Searchable Item Library Adult Version - Problem Urinating Limits Activity | ||
FSIL0524 | C184141 | FSIL-I Maintain Contact With My Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I maintain contact with my friends. | FACIT-Searchable Item Library Adult Version - I Maintain Contact With My Friends | ||
FSIL0525 | C184142 | FSIL-I Have Peace of Mind | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have peace of mind. | FACIT-Searchable Item Library Adult Version - I Have Peace of Mind | ||
FSIL0526 | C184143 | FSIL-Able to Make Decisions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to make decisions. | FACIT-Searchable Item Library Adult Version - Able to Make Decisions | ||
FSIL0527 | C184144 | FSIL-Able to Reconcile With Other People | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to reconcile (make peace) with other people. | FACIT-Searchable Item Library Adult Version - Able to Reconcile With Other People | ||
FSIL0528 | C184145 | FSIL-Discuss Concerns w/ People Closest | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to openly discuss my concerns with the people closest to me. | FACIT-Searchable Item Library Adult Version - Discuss Concerns w/ People Closest | ||
FSIL0529 | C184146 | FSIL-Family Who Take My Responsibilities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have family members who will take on my responsibilities. | FACIT-Searchable Item Library Adult Version - Family Who Take My Responsibilities | ||
FSIL0530 | C184147 | FSIL-Feel That My Family Appreciates Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that my family appreciates me. | FACIT-Searchable Item Library Adult Version - Feel That My Family Appreciates Me | ||
FSIL0531 | C184148 | FSIL-I Feel Like a Burden to My Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel like a burden to my family. | FACIT-Searchable Item Library Adult Version - I Feel Like a Burden to My Family | ||
FSIL0532 | C184149 | FSIL-Constipated | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am constipated. | FACIT-Searchable Item Library Adult Version - Constipated | ||
FSIL0533 | C184150 | FSIL-Have Swelling in Parts of My Body | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling in parts of my body. | FACIT-Searchable Item Library Adult Version - Have Swelling in Parts of My Body | ||
FSIL0534 | C184151 | FSIL-My Mouth and Throat Are Dry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mouth and throat are dry. | FACIT-Searchable Item Library Adult Version - My Mouth and Throat Are Dry | ||
FSIL0535 | C184152 | FSIL-I Feel Useful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel useful. | FACIT-Searchable Item Library Adult Version - I Feel Useful | ||
FSIL0536 | C184153 | FSIL-I Make Each Day Count | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I make each day count. | FACIT-Searchable Item Library Adult Version - I Make Each Day Count | ||
FSIL0537 | C184154 | FSIL-Told Family Members About Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have told family members about my infection. | FACIT-Searchable Item Library Adult Version - Told Family Members About Infection | ||
FSIL0538 | C184155 | FSIL-Do You Have an Ostomy Appliance | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Do you have an ostomy appliance? | FACIT-Searchable Item Library Adult Version - Do You Have an Ostomy Appliance | ||
FSIL0539 | C184156 | FSIL-Have You Ever Smoked | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Have you ever smoked? | FACIT-Searchable Item Library Adult Version - Have You Ever Smoked | ||
FSIL0540 | C184157 | FSIL-Which Side Was Breast Operation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: On which side was your breast operation? | FACIT-Searchable Item Library Adult Version - Which Side Was Breast Operation | ||
FSIL0541 | C184158 | FSIL-How Many Places in Body Felt Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: In how many places in your body have you felt bone pain? | FACIT-Searchable Item Library Adult Version - How Many Places in Body Felt Pain | ||
FSIL0542 | C184159 | FSIL-Told Partner/Spouse About Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have told my partner/spouse about my infection. | FACIT-Searchable Item Library Adult Version - Told Partner/Spouse About Infection | ||
FSIL0543 | C184160 | FSIL-I Have Had Blood in My Urine | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had blood in my urine. | FACIT-Searchable Item Library Adult Version - I Have Had Blood in My Urine | ||
FSIL0544 | C184161 | FSIL-Inconvenient to Come for Radiation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It is inconvenient for me to come for my radiation treatments. | FACIT-Searchable Item Library Adult Version - Inconvenient to Come for Radiation | ||
FSIL0545 | C184162 | FSIL-I Have Difficultly Raising My Arm | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficultly raising my arm. | FACIT-Searchable Item Library Adult Version - I Have Difficultly Raising My Arm | ||
FSIL0546 | C184163 | FSIL-Difficulty Moving My Arm Sideways | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty moving my arm sideways. | FACIT-Searchable Item Library Adult Version - Difficulty Moving My Arm Sideways | ||
FSIL0547 | C184164 | FSIL-Numbness/Tingling in Arm/Shoulder | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my arm, shoulder, or breast. | FACIT-Searchable Item Library Adult Version - Numbness/Tingling in Arm/Shoulder | ||
FSIL0548 | C184165 | FSIL-I Have Difficulty Breathing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty breathing. | FACIT-Searchable Item Library Adult Version - I Have Difficulty Breathing | ||
FSIL0549 | C184166 | FSIL-Bothered by Appearance Skin Breast | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the appearance of the skin in my breast area. | FACIT-Searchable Item Library Adult Version - Bothered by Appearance Skin Breast | ||
FSIL0550 | C184167 | FSIL-I Have Pain in My Breast | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my breast. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Breast | ||
FSIL0551 | C184168 | FSIL-I Have Pain in Arm and/or Shoulder | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my arm and/or shoulder. | FACIT-Searchable Item Library Adult Version - I Have Pain in Arm and/or Shoulder | ||
FSIL0552 | C184169 | FSIL-My Chest Area Is Sore | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chest area (not including the breast itself) is sore. | FACIT-Searchable Item Library Adult Version - My Chest Area Is Sore | ||
FSIL0553 | C184170 | FSIL-Bothered by Swelling in My Breast | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling in my breast. | FACIT-Searchable Item Library Adult Version - Bothered by Swelling in My Breast | ||
FSIL0554 | C184171 | FSIL-My Breast Is Sensitive/Tender | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breast is sensitive/tender. | FACIT-Searchable Item Library Adult Version - My Breast Is Sensitive/Tender | ||
FSIL0555 | C184172 | FSIL-My Underarm Area Sensitive/Tender | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My underarm area is sensitive/tender. | FACIT-Searchable Item Library Adult Version - My Underarm Area Sensitive/Tender | ||
FSIL0556 | C184173 | FSIL-Skin in Breast Area Itchy/Flaky/Dry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin in my breast area is itchy, flaky or dry. | FACIT-Searchable Item Library Adult Version - Skin in Breast Area Itchy/Flaky/Dry | ||
FSIL0557 | C184174 | FSIL-Bothered by Skin Problems Underarm | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by skin problems in my underarm area. | FACIT-Searchable Item Library Adult Version - Bothered by Skin Problems Underarm | ||
FSIL0558 | C184175 | FSIL-I Feel Peaceful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel peaceful. | FACIT-Searchable Item Library Adult Version - I Feel Peaceful | ||
FSIL0559 | C184176 | FSIL-Strength in Faith/Spiritual Beliefs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I find strength in my faith or spiritual beliefs. | FACIT-Searchable Item Library Adult Version - Strength in Faith/Spiritual Beliefs | ||
FSIL0560 | C184177 | FSIL-Illness Strengthen Faith/Spiritual | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness has strengthened my faith or spiritual beliefs. | FACIT-Searchable Item Library Adult Version - Illness Strengthen Faith/Spiritual | ||
FSIL0561 | C184178 | FSIL-Whatever Happens Illness Will Be OK | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I know that whatever happens with my illness, things will be okay. | FACIT-Searchable Item Library Adult Version - Whatever Happens Illness Will Be OK | ||
FSIL0562 | C184179 | FSIL-I Feel Connected to Higher Power | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel connected to a higher power (or God). | FACIT-Searchable Item Library Adult Version - I Feel Connected to Higher Power | ||
FSIL0563 | C184180 | FSIL-I Feel Connected to Other People | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel connected to other people. | FACIT-Searchable Item Library Adult Version - I Feel Connected to Other People | ||
FSIL0564 | C184181 | FSIL-I Feel Loved | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel loved. | FACIT-Searchable Item Library Adult Version - I Feel Loved | ||
FSIL0565 | C184182 | FSIL-I Feel Love for Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel love for others. | FACIT-Searchable Item Library Adult Version - I Feel Love for Others | ||
FSIL0566 | C184183 | FSIL-Forgive Others for Harm Caused Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to forgive others for any harm they have ever caused me. | FACIT-Searchable Item Library Adult Version - Forgive Others for Harm Caused Me | ||
FSIL0567 | C184184 | FSIL-Feel Forgiven for Harm I Caused | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel forgiven for any harm I may have ever caused. | FACIT-Searchable Item Library Adult Version - Feel Forgiven for Harm I Caused | ||
FSIL0568 | C184185 | FSIL-Feel Sense of Thankfulness for Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Throughout the course of my day, I feel a sense of thankfulness for my life. | FACIT-Searchable Item Library Adult Version - Feel Sense of Thankfulness for Life | ||
FSIL0569 | C184186 | FSIL-I Have a Reason for Living | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a reason for living. | FACIT-Searchable Item Library Adult Version - I Have a Reason for Living | ||
FSIL0570 | C184187 | FSIL-Thankfulness Others Bring to Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Throughout the course of my day, I feel a sense of thankfulness for what others bring to my life. | FACIT-Searchable Item Library Adult Version - Thankfulness Others Bring to Life | ||
FSIL0571 | C184188 | FSIL-I Feel Hopeful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel hopeful. | FACIT-Searchable Item Library Adult Version - I Feel Hopeful | ||
FSIL0572 | C184189 | FSIL-Appreciation for Beauty of Nature | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of appreciation for the beauty of nature. | FACIT-Searchable Item Library Adult Version - Appreciation for Beauty of Nature | ||
FSIL0573 | C184190 | FSIL-Compassion for Others Difficulties | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel compassion for others in the difficulties they are facing. | FACIT-Searchable Item Library Adult Version - Compassion for Others Difficulties | ||
FSIL0574 | C184191 | FSIL-My Life Has Been Productive | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My life has been productive. | FACIT-Searchable Item Library Adult Version - My Life Has Been Productive | ||
FSIL0575 | C184192 | FSIL-Have Trouble Feeling Peace of Mind | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling peace of mind. | FACIT-Searchable Item Library Adult Version - Have Trouble Feeling Peace of Mind | ||
FSIL0576 | C184193 | FSIL-Feel Sense of Purpose in My Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of purpose in my life. | FACIT-Searchable Item Library Adult Version - Feel Sense of Purpose in My Life | ||
FSIL0577 | C184194 | FSIL-Reach Into Myself for Comfort | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to reach down deep into myself for comfort. | FACIT-Searchable Item Library Adult Version - Reach Into Myself for Comfort | ||
FSIL0578 | C184195 | FSIL-Feel Sense of Harmony Within Myself | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of harmony within myself. | FACIT-Searchable Item Library Adult Version - Feel Sense of Harmony Within Myself | ||
FSIL0579 | C184196 | FSIL-My Life Lacks Meaning and Purpose | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My life lacks meaning and purpose. | FACIT-Searchable Item Library Adult Version - My Life Lacks Meaning and Purpose | ||
FSIL0580 | C184197 | FSIL-Comfort in Faith/Spiritual Beliefs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I find comfort in my faith or spiritual beliefs. | FACIT-Searchable Item Library Adult Version - Comfort in Faith/Spiritual Beliefs | ||
FSIL0581 | C184198 | FSIL-Difficult Times Strengthened Faith | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Difficult times have strengthened my faith or spiritual beliefs. | FACIT-Searchable Item Library Adult Version - Difficult Times Strengthened Faith | ||
FSIL0582 | C184199 | FSIL-During Difficult Times Things Be OK | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Even during difficult times, I know that things will be okay. | FACIT-Searchable Item Library Adult Version - During Difficult Times Things Be OK | ||
FSIL0583 | C184200 | FSIL-Bothered by Increased Facial Hair | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by increased facial hair. | FACIT-Searchable Item Library Adult Version - Bothered by Increased Facial Hair | ||
FSIL0584 | C184201 | FSIL-Bothered by Sensitivity Fingernails | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by sensitivity around my fingernails or toenails. | FACIT-Searchable Item Library Adult Version - Bothered by Sensitivity Fingernails | ||
FSIL0585 | C184202 | FSIL-My Eyes Are Dry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyes are dry. | FACIT-Searchable Item Library Adult Version - My Eyes Are Dry | ||
FSIL0586 | C184203 | FSIL-Skin Cond Interferes w/ Social Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition interferes with my social life. | FACIT-Searchable Item Library Adult Version - Skin Cond Interferes w/ Social Life | ||
FSIL0587 | C184204 | FSIL-My Skin Condition Affects My Mood | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition affects my mood. | FACIT-Searchable Item Library Adult Version - My Skin Condition Affects My Mood | ||
FSIL0588 | C184205 | FSIL-Embarrassed by My Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my skin condition. | FACIT-Searchable Item Library Adult Version - Embarrassed by My Skin Condition | ||
FSIL0589 | C184206 | FSIL-Unattractive B/c How My Skin Looks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel unattractive because of how my skin looks. | FACIT-Searchable Item Library Adult Version - Unattractive B/c How My Skin Looks | ||
FSIL0590 | C184207 | FSIL-Sensitivity Fingernails Diff Tasks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Sensitivity around my fingernails makes it difficult to perform household tasks. | FACIT-Searchable Item Library Adult Version - Sensitivity Fingernails Diff Tasks | ||
FSIL0591 | C184208 | FSIL-Skin Condition Interferes w/ Sleep | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition interferes with my ability to sleep. | FACIT-Searchable Item Library Adult Version - Skin Condition Interferes w/ Sleep | ||
FSIL0592 | C184209 | FSIL-Skin Condition Make Life Difficult | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Changes in my skin condition make daily life difficult. | FACIT-Searchable Item Library Adult Version - Skin Condition Make Life Difficult | ||
FSIL0593 | C184210 | FSIL-Avoid Public B/c How My Skin Looks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid going out in public because of how my skin looks. | FACIT-Searchable Item Library Adult Version - Avoid Public B/c How My Skin Looks | ||
FSIL0594 | C184211 | FSIL-Skin Side Effects Interfered Tasks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin side effects from treatment have interfered with household tasks. | FACIT-Searchable Item Library Adult Version - Skin Side Effects Interfered Tasks | ||
FSIL0595 | C184212 | FSIL-My Skin or Scalp Feels Irritated | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp feels irritated. | FACIT-Searchable Item Library Adult Version - My Skin or Scalp Feels Irritated | ||
FSIL0596 | C184213 | FSIL-My Skin or Scalp Is Dry or Flaky | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp is dry or "flaky". | FACIT-Searchable Item Library Adult Version - My Skin or Scalp Is Dry or Flaky | ||
FSIL0597 | C184214 | FSIL-My Skin or Scalp Itches | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp itches. | FACIT-Searchable Item Library Adult Version - My Skin or Scalp Itches | ||
FSIL0598 | C184215 | FSIL-My Skin Bleeds Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin bleeds easily. | FACIT-Searchable Item Library Adult Version - My Skin Bleeds Easily | ||
FSIL0599 | C184216 | FSIL-Bothered by Skin Sensitivity to Sun | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my skin's sensitivity to the sun. | FACIT-Searchable Item Library Adult Version - Bothered by Skin Sensitivity to Sun | ||
FSIL0600 | C184217 | FSIL-Pharmacist Advises Use of Medicines | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist advises me on the proper use of my medicines. | FACIT-Searchable Item Library Adult Version - Pharmacist Advises Use of Medicines | ||
FSIL0601 | C184218 | FSIL-Pharmacist Advises Adverse Effects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist advises me on the adverse (side) effects of my medicines. | FACIT-Searchable Item Library Adult Version - Pharmacist Advises Adverse Effects | ||
FSIL0602 | C184219 | FSIL-I Have Confidence in My Pharmacist | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my pharmacist(s). | FACIT-Searchable Item Library Adult Version - I Have Confidence in My Pharmacist | ||
FSIL0603 | C184220 | FSIL-Pharmacist Available Questions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist is available to answer my questions. | FACIT-Searchable Item Library Adult Version - Pharmacist Available Questions | ||
FSIL0604 | C184221 | FSIL-Helps Arrangements Obtain Medicines | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist helps with the arrangements necessary to obtain my medicines. | FACIT-Searchable Item Library Adult Version - Helps Arrangements Obtain Medicines | ||
FSIL0605 | C184222 | FSIL-Pharmacist Aware Treatment Needs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist is aware of my treatment-related needs. | FACIT-Searchable Item Library Adult Version - Pharmacist Aware Treatment Needs | ||
FSIL0606 | C184223 | FSIL-Pharmacist Responds Treatment Needs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist responds to my treatment-related needs. | FACIT-Searchable Item Library Adult Version - Pharmacist Responds Treatment Needs | ||
FSIL0607 | C184224 | FSIL-I Feel Bloated | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel bloated. | FACIT-Searchable Item Library Adult Version - I Feel Bloated | ||
FSIL0608 | C184225 | FSIL-My Hands Are Swollen | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My hands are swollen. | FACIT-Searchable Item Library Adult Version - My Hands Are Swollen | ||
FSIL0609 | C184226 | FSIL-My Legs or Feet Are Swollen | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My legs or feet are swollen. | FACIT-Searchable Item Library Adult Version - My Legs or Feet Are Swollen | ||
FSIL0610 | C184227 | FSIL-I Have Pain in My Fingertips | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my fingertips. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Fingertips | ||
FSIL0611 | C184228 | FSIL-Bothered by My Hands/Nails Look | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the way my hands or nails look. | FACIT-Searchable Item Library Adult Version - Bothered by My Hands/Nails Look | ||
FSIL0612 | C184229 | FSIL-I Bleed Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I bleed easily. | FACIT-Searchable Item Library Adult Version - I Bleed Easily | ||
FSIL0613 | C184230 | FSIL-Avoid or Limit Physical Activity | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid or limit physical activity (because of concern with bleeding or bruising). | FACIT-Searchable Item Library Adult Version - Avoid or Limit Physical Activity | ||
FSIL0614 | C184231 | FSIL-Avoid or Limit Social Activity | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid or limit social activity (because of concern with bleeding or bruising). | FACIT-Searchable Item Library Adult Version - Avoid or Limit Social Activity | ||
FSIL0615 | C184232 | FSIL-Frustrated Not Do Usual Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by not being able to do my usual activities. | FACIT-Searchable Item Library Adult Version - Frustrated Not Do Usual Activities | ||
FSIL0616 | C184233 | FSIL-Worry Treatment Will Be Delayed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment will be delayed (because of low blood counts). | FACIT-Searchable Item Library Adult Version - Worry Treatment Will Be Delayed | ||
FSIL0617 | C184234 | FSIL-Worry Treatment Dose Will Reduced | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment dose will be reduced (because of low blood counts). | FACIT-Searchable Item Library Adult Version - Worry Treatment Dose Will Reduced | ||
FSIL0618 | C184235 | FSIL-Women: Bothered by Vaginal Bleeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: For women only: I am bothered by vaginal bleeding. | FACIT-Searchable Item Library Adult Version - Women: Bothered by Vaginal Bleeding | ||
FSIL0619 | C184236 | FSIL-I Bruise Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I bruise easily. | FACIT-Searchable Item Library Adult Version - I Bruise Easily | ||
FSIL0620 | C184237 | FSIL-Worry Problems Bruising/Bleeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about problems with bruising or bleeding. | FACIT-Searchable Item Library Adult Version - Worry Problems Bruising/Bleeding | ||
FSIL0621 | C184238 | FSIL-Worry About Serious Bleeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the possibility of serious bleeding. | FACIT-Searchable Item Library Adult Version - Worry About Serious Bleeding | ||
FSIL0622 | C184239 | FSIL-Bothered by Nosebleeds | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by nosebleeds. | FACIT-Searchable Item Library Adult Version - Bothered by Nosebleeds | ||
FSIL0623 | C184240 | FSIL-Bothered by Bleeding in Gums/Mouth | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by bleeding in my gums or mouth. | FACIT-Searchable Item Library Adult Version - Bothered by Bleeding in Gums/Mouth | ||
FSIL0624 | C184241 | FSIL-Bothered by Bruising Beneath Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by pinpoint bruising beneath my skin. | FACIT-Searchable Item Library Adult Version - Bothered by Bruising Beneath Skin | ||
FSIL0625 | C184242 | FSIL-Bothered by Blood in My Urine/Stool | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by blood in my urine or stool. | FACIT-Searchable Item Library Adult Version - Bothered by Blood in My Urine/Stool | ||
FSIL0626 | C184243 | FSIL-Inconvenienced Platelet Transfusion | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am inconvenienced by platelet transfusions. | FACIT-Searchable Item Library Adult Version - Inconvenienced Platelet Transfusion | ||
FSIL0627 | C184244 | FSIL-Effectiveness of Treatment So Far | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Compared to what you expected, how do you rate the effectiveness of the treatment so far? | FACIT-Searchable Item Library Adult Version - Effectiveness of Treatment So Far | ||
FSIL0628 | C184245 | FSIL-Doctor Explain Benefits Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) explain the possible benefits of your treatment? | FACIT-Searchable Item Library Adult Version - Doctor Explain Benefits Treatment | ||
FSIL0629 | C184246 | FSIL-Doctor Explain Side Effects/Risks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) explain the possible side effects or risks of your treatment? | FACIT-Searchable Item Library Adult Version - Doctor Explain Side Effects/Risks | ||
FSIL0630 | C184247 | FSIL-Have Opportunity to Ask Questions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have an opportunity to ask questions? | FACIT-Searchable Item Library Adult Version - Have Opportunity to Ask Questions | ||
FSIL0631 | C184248 | FSIL-Get to Say Things Important to You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you get to say the things that were important to you? | FACIT-Searchable Item Library Adult Version - Get to Say Things Important to You | ||
FSIL0632 | C184249 | FSIL-Doctor Understand Important to You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to understand what was important to you? | FACIT-Searchable Item Library Adult Version - Doctor Understand Important to You | ||
FSIL0633 | C184250 | FSIL-Doctor Show Genuine Concern for You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) show genuine concern for you? | FACIT-Searchable Item Library Adult Version - Doctor Show Genuine Concern for You | ||
FSIL0634 | C184251 | FSIL-Doctor Seem Understand Your Needs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to understand your needs? | FACIT-Searchable Item Library Adult Version - Doctor Seem Understand Your Needs | ||
FSIL0635 | C184252 | FSIL-Able to Talk to Doctor When Needed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Were you able to talk to your doctor(s) when you needed to? | FACIT-Searchable Item Library Adult Version - Able to Talk to Doctor When Needed | ||
FSIL0636 | C184253 | FSIL-Treatment Staff Discuss Work | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your normal work (including housework)? | FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Work | ||
FSIL0637 | C184254 | FSIL-Side Effects of Treatment So Far | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Compared to what you expected, how do you rate the side effects of treatment so far? | FACIT-Searchable Item Library Adult Version - Side Effects of Treatment So Far | ||
FSIL0638 | C184255 | FSIL-Treatment Staff Discuss Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your normal daily activities? | FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Activities | ||
FSIL0639 | C184256 | FSIL-Treatment Staff Discuss Relation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your personal relationships? | FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Relation | ||
FSIL0640 | C184257 | FSIL-Treatment Staff Discuss Emotionally | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect you emotionally? | FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Emotionally | ||
FSIL0641 | C184258 | FSIL-Doctor Experience Treating Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel your doctor(s) had experience treating your illness? | FACIT-Searchable Item Library Adult Version - Doctor Experience Treating Illness | ||
FSIL0642 | C184259 | FSIL-Doctor Knew Medical Developments | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel your doctor(s) knew about the latest medical developments for your illness? | FACIT-Searchable Item Library Adult Version - Doctor Knew Medical Developments | ||
FSIL0643 | C184260 | FSIL-Treatment Staff Thorough Examining | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Was the treatment staff thorough in examining and treating you? | FACIT-Searchable Item Library Adult Version - Treatment Staff Thorough Examining | ||
FSIL0644 | C184261 | FSIL-Participate Decisions Health Care | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Were you encouraged to participate in decisions about your health care? | FACIT-Searchable Item Library Adult Version - Participate Decisions Health Care | ||
FSIL0645 | C184262 | FSIL-Have Enough Time to Make Decisions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have enough time to make decisions about your health care? | FACIT-Searchable Item Library Adult Version - Have Enough Time to Make Decisions | ||
FSIL0646 | C184263 | FSIL-Doctor Evaluate Effects Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) help you evaluate the effects of your treatment so far? | FACIT-Searchable Item Library Adult Version - Doctor Evaluate Effects Treatment | ||
FSIL0647 | C184264 | FSIL-Doctor Seem Respect Your Opinions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to respect your opinions? | FACIT-Searchable Item Library Adult Version - Doctor Seem Respect Your Opinions | ||
FSIL0648 | C184265 | FSIL-Nurse Explanations You Understand | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) give explanations that you could understand? | FACIT-Searchable Item Library Adult Version - Nurse Explanations You Understand | ||
FSIL0649 | C184266 | FSIL-Nurse Show Genuine Concern for You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) show genuine concern for you? | FACIT-Searchable Item Library Adult Version - Nurse Show Genuine Concern for You | ||
FSIL0650 | C184267 | FSIL-Nurse Seem to Understand Your Needs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) seem to understand your needs? | FACIT-Searchable Item Library Adult Version - Nurse Seem to Understand Your Needs | ||
FSIL0651 | C184268 | FSIL-Treatment Staff Answered Honestly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel that the treatment staff answered your questions honestly? | FACIT-Searchable Item Library Adult Version - Treatment Staff Answered Honestly | ||
FSIL0652 | C184269 | FSIL-Treatment Staff Respect Privacy | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff respect your privacy? | FACIT-Searchable Item Library Adult Version - Treatment Staff Respect Privacy | ||
FSIL0653 | C184270 | FSIL-Have Confidence in Your Doctor | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have confidence in your doctor(s)? | FACIT-Searchable Item Library Adult Version - Have Confidence in Your Doctor | ||
FSIL0654 | C184271 | FSIL-Trust Doctor Suggestions Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you trust your doctor(s)' suggestions for treatment? | FACIT-Searchable Item Library Adult Version - Trust Doctor Suggestions Treatment | ||
FSIL0655 | C184272 | FSIL-Recommend Clinic/Office to Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this clinic or office to others? | FACIT-Searchable Item Library Adult Version - Recommend Clinic/Office to Others | ||
FSIL0656 | C184273 | FSIL-Choose This Clinic/Office Again | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this clinic or office again? | FACIT-Searchable Item Library Adult Version - Choose This Clinic/Office Again | ||
FSIL0657 | C184274 | FSIL-Received Treatment Right for You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Do you feel you received the treatment that was right for you? | FACIT-Searchable Item Library Adult Version - Received Treatment Right for You | ||
FSIL0658 | C184275 | FSIL-Rate the Care You Received | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How do you rate the care you received? | FACIT-Searchable Item Library Adult Version - Rate the Care You Received | ||
FSIL0659 | C184276 | FSIL-Satisfied With Effects of Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the effects of this treatment so far? | FACIT-Searchable Item Library Adult Version - Satisfied With Effects of Treatment | ||
FSIL0660 | C184277 | FSIL-Recommend This Treatment to Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this treatment to others with your illness? | FACIT-Searchable Item Library Adult Version - Recommend This Treatment to Others | ||
FSIL0661 | C184278 | FSIL-Choose This Treatment Again | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this treatment again? | FACIT-Searchable Item Library Adult Version - Choose This Treatment Again | ||
FSIL0662 | C184279 | FSIL-Rate This Treatment Overall | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How do you rate this treatment overall? | FACIT-Searchable Item Library Adult Version - Rate This Treatment Overall | ||
FSIL0663 | C184280 | FSIL-Doctor Explanations You Understand | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) give explanations that you could understand? | FACIT-Searchable Item Library Adult Version - Doctor Explanations You Understand | ||
FSIL0664 | C184281 | FSIL-Bothered by Discharge From Vulva | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discharge or bleeding from my vulva. | FACIT-Searchable Item Library Adult Version - Bothered by Discharge From Vulva | ||
FSIL0665 | C184282 | FSIL-Bothered by Odor From Vulva | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by odor coming from my vulva. | FACIT-Searchable Item Library Adult Version - Bothered by Odor From Vulva | ||
FSIL0666 | C184283 | FSIL-Bothered by Swelling/Fluid in Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling/fluid in my legs. | FACIT-Searchable Item Library Adult Version - Bothered by Swelling/Fluid in Legs | ||
FSIL0667 | C184284 | FSIL-Bothered by Discomfort Groin/Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discomfort in my groin or legs. | FACIT-Searchable Item Library Adult Version - Bothered by Discomfort Groin/Legs | ||
FSIL0668 | C184285 | FSIL-Bothered by Itching/Burning Vulva | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by itching/burning in my vulva area. | FACIT-Searchable Item Library Adult Version - Bothered by Itching/Burning Vulva | ||
FSIL0669 | C184286 | FSIL-Bothered by Pain/Numbness in Vulva | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by pain or numbness in my vulva area. | FACIT-Searchable Item Library Adult Version - Bothered by Pain/Numbness in Vulva | ||
FSIL0670 | C184287 | FSIL-I Have Trouble Bending | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble bending. | FACIT-Searchable Item Library Adult Version - I Have Trouble Bending | ||
FSIL0671 | C184288 | FSIL-I Have Discomfort When I Am Sitting | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort when I am sitting. | FACIT-Searchable Item Library Adult Version - I Have Discomfort When I Am Sitting | ||
FSIL0672 | C184289 | FSIL-Bothered by Compression Stockings | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by wearing compression stockings. | FACIT-Searchable Item Library Adult Version - Bothered by Compression Stockings | ||
FSIL0673 | C184290 | FSIL-Satisfied With Urinary Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my urinary condition. | FACIT-Searchable Item Library Adult Version - Satisfied With Urinary Condition | ||
FSIL0674 | C184291 | FSIL-Caring Urinary Condition Difficult | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Caring for my urinary condition is difficult. | FACIT-Searchable Item Library Adult Version - Caring Urinary Condition Difficult | ||
Back to top | ||||||
CL.C183550.FSILTN | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Questionnaire Test Name
(FSILTN) | text
Extensible: No | C183550 | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult Questionnaire Test Name | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult test name. | CDISC Questionnaire FACIT-Searchable Item Library Adult Version Test Name Terminology |
FSIL-Abdominal Cramps Diarrhea | C183886 | FSIL-Abdominal Cramps Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have abdominal cramps or discomfort due to my diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Abdominal Cramps Diarrhea | ||
FSIL-Able Remember Things Where Left | C183826 | FSIL-Able Remember Things Where Left | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to remember things, like where I left my keys or wallet. | FACIT-Searchable Item Library Adult Version - Able Remember Things Where Left | ||
FSIL-Able Remember to Do Things | C183827 | FSIL-Able Remember to Do Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to remember to do things, like take medicine or buy something I needed. | FACIT-Searchable Item Library Adult Version - Able Remember to Do Things | ||
FSIL-Able to Bring to Mind Words | C183830 | FSIL-Able to Bring to Mind Words | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to bring to mind words that I wanted to use while talking to someone. | FACIT-Searchable Item Library Adult Version - Able to Bring to Mind Words | ||
FSIL-Able to Communicate With Others | C184015 | FSIL-Able to Communicate With Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to communicate with others. | FACIT-Searchable Item Library Adult Version - Able to Communicate With Others | ||
FSIL-Able to Concentrate | C183705 | FSIL-Able to Concentrate | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to concentrate. | FACIT-Searchable Item Library Adult Version - Able to Concentrate | ||
FSIL-Able to Do My Usual Activities | C183653 | FSIL-Able to Do My Usual Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to do my usual activities. | FACIT-Searchable Item Library Adult Version - Able to Do My Usual Activities | ||
FSIL-Able to Drive a Vehicle | C183714 | FSIL-Able to Drive a Vehicle | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to drive a vehicle (my car, truck, etc.). | FACIT-Searchable Item Library Adult Version - Able to Drive a Vehicle | ||
FSIL-Able to Eat as Much Food as I Want | C184021 | FSIL-Able to Eat as Much Food as I Want | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to eat as much food as I want. | FACIT-Searchable Item Library Adult Version - Able to Eat as Much Food as I Want | ||
FSIL-Able to Eat the Foods That I Like | C184014 | FSIL-Able to Eat the Foods That I Like | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to eat the foods that I like. | FACIT-Searchable Item Library Adult Version - Able to Eat the Foods That I Like | ||
FSIL-Able to Enjoy Life | C183970 | FSIL-Able to Enjoy Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to enjoy life. | FACIT-Searchable Item Library Adult Version - Able to Enjoy Life | ||
FSIL-Able to Feel Like a Man | C184137 | FSIL-Able to Feel Like a Man | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to feel like a man. | FACIT-Searchable Item Library Adult Version - Able to Feel Like a Man | ||
FSIL-Able to Feel Like a Woman | C183668 | FSIL-Able to Feel Like a Woman | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to feel like a woman. | FACIT-Searchable Item Library Adult Version - Able to Feel Like a Woman | ||
FSIL-Able to Find the Right Words | C183724 | FSIL-Able to Find the Right Words | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to find the right word(s) to say what I mean. | FACIT-Searchable Item Library Adult Version - Able to Find the Right Words | ||
FSIL-Able to Get Around by Myself | C183687 | FSIL-Able to Get Around by Myself | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to get around by myself. | FACIT-Searchable Item Library Adult Version - Able to Get Around by Myself | ||
FSIL-Able to Have/Maintain Erection | C183673 | FSIL-Able to Have/Maintain Erection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to have and maintain an erection. (For men only) | FACIT-Searchable Item Library Adult Version - Able to Have/Maintain Erection | ||
FSIL-Able to Maintain My Balance | C183796 | FSIL-Able to Maintain My Balance | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to maintain my balance. | FACIT-Searchable Item Library Adult Version - Able to Maintain My Balance | ||
FSIL-Able to Make Decisions | C184143 | FSIL-Able to Make Decisions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to make decisions. | FACIT-Searchable Item Library Adult Version - Able to Make Decisions | ||
FSIL-Able to Meet My Monthly Expenses | C183949 | FSIL-Able to Meet My Monthly Expenses | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to meet my monthly expenses. | FACIT-Searchable Item Library Adult Version - Able to Meet My Monthly Expenses | ||
FSIL-Able to Pay Attention w/o Effort | C183825 | FSIL-Able to Pay Attention w/o Effort | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to pay attention and keep track of what I am doing without extra effort. | FACIT-Searchable Item Library Adult Version - Able to Pay Attention w/o Effort | ||
FSIL-Able to Put My thoughts Into Action | C183711 | FSIL-Able to Put My thoughts Into Action | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to put my thoughts into action. | FACIT-Searchable Item Library Adult Version - Able to Put My thoughts Into Action | ||
FSIL-Able to Put My Thoughts Together | C183709 | FSIL-Able to Put My Thoughts Together | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to put my thoughts together. | FACIT-Searchable Item Library Adult Version - Able to Put My Thoughts Together | ||
FSIL-Able to Read Like I Used to | C183712 | FSIL-Able to Read Like I Used to | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to read like I used to. | FACIT-Searchable Item Library Adult Version - Able to Read Like I Used to | ||
FSIL-Able to Reconcile With Other People | C184144 | FSIL-Able to Reconcile With Other People | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to reconcile (make peace) with other people. | FACIT-Searchable Item Library Adult Version - Able to Reconcile With Other People | ||
FSIL-Able to Shift Between Activities | C183828 | FSIL-Able to Shift Between Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to shift back and forth between two activities that require thinking. | FACIT-Searchable Item Library Adult Version - Able to Shift Between Activities | ||
FSIL-Able to Talk to Doctor When Needed | C184252 | FSIL-Able to Talk to Doctor When Needed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Were you able to talk to your doctor(s) when you needed to? | FACIT-Searchable Item Library Adult Version - Able to Talk to Doctor When Needed | ||
FSIL-Able to Track What I Am Doing | C183829 | FSIL-Able to Track What I Am Doing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to keep track of what I am doing, even if I am interrupted. | FACIT-Searchable Item Library Adult Version - Able to Track What I Am Doing | ||
FSIL-Able to Walk | C183797 | FSIL-Able to Walk | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to walk. | FACIT-Searchable Item Library Adult Version - Able to Walk | ||
FSIL-Able to Work | C183968 | FSIL-Able to Work | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to work (include work at home). | FACIT-Searchable Item Library Adult Version - Able to Work | ||
FSIL-Able to Write Like I Used to | C183713 | FSIL-Able to Write Like I Used to | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to write like I used to. | FACIT-Searchable Item Library Adult Version - Able to Write Like I Used to | ||
FSIL-Accepted I Have This Infection | C183775 | FSIL-Accepted I Have This Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have accepted that I have this infection. | FACIT-Searchable Item Library Adult Version - Accepted I Have This Infection | ||
FSIL-Afraid of Having a Seizure | C183721 | FSIL-Afraid of Having a Seizure | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid of having a seizure (convulsion). | FACIT-Searchable Item Library Adult Version - Afraid of Having a Seizure | ||
FSIL-Afraid to Be Far From a Toilet | C184049 | FSIL-Afraid to Be Far From a Toilet | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid to be far from a toilet. | FACIT-Searchable Item Library Adult Version - Afraid to Be Far From a Toilet | ||
FSIL-Afraid to Have Sex | C183877 | FSIL-Afraid to Have Sex | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid to have sex. | FACIT-Searchable Item Library Adult Version - Afraid to Have Sex | ||
FSIL-Afraid Treatment May Harm Body | C183879 | FSIL-Afraid Treatment May Harm Body | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am afraid the treatment may harm my body. | FACIT-Searchable Item Library Adult Version - Afraid Treatment May Harm Body | ||
FSIL-Amount I Eat Is Sufficient | C183628 | FSIL-Amount I Eat Is Sufficient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The amount I eat is sufficient to meet my needs. | FACIT-Searchable Item Library Adult Version - Amount I Eat Is Sufficient | ||
FSIL-Appreciation for Beauty of Nature | C184189 | FSIL-Appreciation for Beauty of Nature | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of appreciation for the beauty of nature. | FACIT-Searchable Item Library Adult Version - Appreciation for Beauty of Nature | ||
FSIL-Avoid Going Out to Eat B/c Illness | C183961 | FSIL-Avoid Going Out to Eat B/c Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid going out to eat because of my illness. | FACIT-Searchable Item Library Adult Version - Avoid Going Out to Eat B/c Illness | ||
FSIL-Avoid or Limit Physical Activity | C184230 | FSIL-Avoid or Limit Physical Activity | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid or limit physical activity (because of concern with bleeding or bruising). | FACIT-Searchable Item Library Adult Version - Avoid or Limit Physical Activity | ||
FSIL-Avoid or Limit Social Activity | C184231 | FSIL-Avoid or Limit Social Activity | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid or limit social activity (because of concern with bleeding or bruising). | FACIT-Searchable Item Library Adult Version - Avoid or Limit Social Activity | ||
FSIL-Avoid Public B/c How My Skin Looks | C184210 | FSIL-Avoid Public B/c How My Skin Looks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid going out in public because of how my skin looks. | FACIT-Searchable Item Library Adult Version - Avoid Public B/c How My Skin Looks | ||
FSIL-Avoid Public Places Fear Infection | C184106 | FSIL-Avoid Public Places Fear Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I avoid public places for fear of getting an infection. | FACIT-Searchable Item Library Adult Version - Avoid Public Places Fear Infection | ||
FSIL-Because of Sores Eating Difficult | C183621 | FSIL-Because of Sores Eating Difficult | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my mouth sores, eating is difficult. | FACIT-Searchable Item Library Adult Version - Because of Sores Eating Difficult | ||
FSIL-Believe Blood Will Be Inconvenient | C183755 | FSIL-Believe Blood Will Be Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that having my blood drawn will be inconvenient. | FACIT-Searchable Item Library Adult Version - Believe Blood Will Be Inconvenient | ||
FSIL-Believe Bothered by Side Effects | C183982 | FSIL-Believe Bothered by Side Effects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe I will be bothered by side effects of treatment. | FACIT-Searchable Item Library Adult Version - Believe Bothered by Side Effects | ||
FSIL-Believe Chemo Cause Physical Pain | C183853 | FSIL-Believe Chemo Cause Physical Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy treatment will cause me physical pain. | FACIT-Searchable Item Library Adult Version - Believe Chemo Cause Physical Pain | ||
FSIL-Believe Chemo Harmful to Me | C183855 | FSIL-Believe Chemo Harmful to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe chemotherapy treatment will be harmful to me. | FACIT-Searchable Item Library Adult Version - Believe Chemo Harmful to Me | ||
FSIL-Believe Chemo Inconvenient | C183854 | FSIL-Believe Chemo Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe receiving chemotherapy will be inconvenient. | FACIT-Searchable Item Library Adult Version - Believe Chemo Inconvenient | ||
FSIL-Believe Chemo Sched Stress Family | C183857 | FSIL-Believe Chemo Sched Stress Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy schedule will be stressful to my family. | FACIT-Searchable Item Library Adult Version - Believe Chemo Sched Stress Family | ||
FSIL-Believe Chemo Schedule Stressful Me | C183856 | FSIL-Believe Chemo Schedule Stressful Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe my chemotherapy schedule will be stressful to me. | FACIT-Searchable Item Library Adult Version - Believe Chemo Schedule Stressful Me | ||
FSIL-Believe Chemo Take Up My Time | C183852 | FSIL-Believe Chemo Take Up My Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe chemotherapy treatment will take up my time. | FACIT-Searchable Item Library Adult Version - Believe Chemo Take Up My Time | ||
FSIL-Believe Eating Will Be Inconvenient | C183753 | FSIL-Believe Eating Will Be Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that waiting up to 60 minutes before eating breakfast in the morning will be inconvenient. | FACIT-Searchable Item Library Adult Version - Believe Eating Will Be Inconvenient | ||
FSIL-Believe Infusion Will Cause Pain | C183754 | FSIL-Believe Infusion Will Cause Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that an infusion for my bone treatment will cause me physical pain. | FACIT-Searchable Item Library Adult Version - Believe Infusion Will Cause Pain | ||
FSIL-Believe Schedule Stressful Family | C183761 | FSIL-Believe Schedule Stressful Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment schedule for bone disease will be stressful to my family. | FACIT-Searchable Item Library Adult Version - Believe Schedule Stressful Family | ||
FSIL-Believe Schedule Stressful to Me | C183760 | FSIL-Believe Schedule Stressful to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment schedule for bone disease will be stressful to me. | FACIT-Searchable Item Library Adult Version - Believe Schedule Stressful to Me | ||
FSIL-Believe Treatment Inconvenient | C183758 | FSIL-Believe Treatment Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that receiving treatment for bone disease will be inconvenient. | FACIT-Searchable Item Library Adult Version - Believe Treatment Inconvenient | ||
FSIL-Believe Treatment Take Family Time | C183756 | FSIL-Believe Treatment Take Family Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment for bone disease will take up my family's time. | FACIT-Searchable Item Library Adult Version - Believe Treatment Take Family Time | ||
FSIL-Believe Treatment Will Be Harmful | C183759 | FSIL-Believe Treatment Will Be Harmful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that treatment for bone disease will be harmful to me. | FACIT-Searchable Item Library Adult Version - Believe Treatment Will Be Harmful | ||
FSIL-Believe Treatment Will Cause Pain | C183757 | FSIL-Believe Treatment Will Cause Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that my treatment for bone disease will cause me physical pain. | FACIT-Searchable Item Library Adult Version - Believe Treatment Will Cause Pain | ||
FSIL-Believe Treatment Will Take Up Time | C183751 | FSIL-Believe Treatment Will Take Up Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that treatment for bone disease will take up my time. | FACIT-Searchable Item Library Adult Version - Believe Treatment Will Take Up Time | ||
FSIL-Believe Will Be Bothered by Effects | C183752 | FSIL-Believe Will Be Bothered by Effects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I believe that I will be bothered by side effects of treatment for bone disease. | FACIT-Searchable Item Library Adult Version - Believe Will Be Bothered by Effects | ||
FSIL-Blame Myself for the Infection | C183781 | FSIL-Blame Myself for the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I tend to blame myself for the infection. | FACIT-Searchable Item Library Adult Version - Blame Myself for the Infection | ||
FSIL-Bone Pain Even When I Sit/Lie Still | C183698 | FSIL-Bone Pain Even When I Sit/Lie Still | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have bone pain even when I sit or lie still. | FACIT-Searchable Item Library Adult Version - Bone Pain Even When I Sit/Lie Still | ||
FSIL-Bone Pain Interferes Care Myself | C183702 | FSIL-Bone Pain Interferes Care Myself | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain interferes with my ability to care for myself (bathing, dressing, eating, etc.). | FACIT-Searchable Item Library Adult Version - Bone Pain Interferes Care Myself | ||
FSIL-Bone Pain Interferes w/Social | C183703 | FSIL-Bone Pain Interferes w/Social | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain interferes with my social activities. | FACIT-Searchable Item Library Adult Version - Bone Pain Interferes w/Social | ||
FSIL-Bone Pain Wakes Me Up at Night | C183704 | FSIL-Bone Pain Wakes Me Up at Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Bone pain wakes me up at night. | FACIT-Searchable Item Library Adult Version - Bone Pain Wakes Me Up at Night | ||
FSIL-Bothered by a Skin Rash | C183627 | FSIL-Bothered by a Skin Rash | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a skin rash. | FACIT-Searchable Item Library Adult Version - Bothered by a Skin Rash | ||
FSIL-Bothered by Appearance Skin Breast | C184166 | FSIL-Bothered by Appearance Skin Breast | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the appearance of the skin in my breast area. | FACIT-Searchable Item Library Adult Version - Bothered by Appearance Skin Breast | ||
FSIL-Bothered by Bleeding in Gums/Mouth | C184240 | FSIL-Bothered by Bleeding in Gums/Mouth | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by bleeding in my gums or mouth. | FACIT-Searchable Item Library Adult Version - Bothered by Bleeding in Gums/Mouth | ||
FSIL-Bothered by Blistering of My Skin | C184027 | FSIL-Bothered by Blistering of My Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by blistering of my skin. | FACIT-Searchable Item Library Adult Version - Bothered by Blistering of My Skin | ||
FSIL-Bothered by Blood in My Urine/Stool | C184242 | FSIL-Bothered by Blood in My Urine/Stool | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by blood in my urine or stool. | FACIT-Searchable Item Library Adult Version - Bothered by Blood in My Urine/Stool | ||
FSIL-Bothered by Bruising Beneath Skin | C184241 | FSIL-Bothered by Bruising Beneath Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by pinpoint bruising beneath my skin. | FACIT-Searchable Item Library Adult Version - Bothered by Bruising Beneath Skin | ||
FSIL-Bothered by Change in Eating Habits | C183957 | FSIL-Bothered by Change in Eating Habits | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my eating habits. | FACIT-Searchable Item Library Adult Version - Bothered by Change in Eating Habits | ||
FSIL-Bothered by Change in Food Tastes | C183678 | FSIL-Bothered by Change in Food Tastes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in the way food tastes. | FACIT-Searchable Item Library Adult Version - Bothered by Change in Food Tastes | ||
FSIL-Bothered by Change in Personality | C183706 | FSIL-Bothered by Change in Personality | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my personality. | FACIT-Searchable Item Library Adult Version - Bothered by Change in Personality | ||
FSIL-Bothered by Change in Weight | C183667 | FSIL-Bothered by Change in Weight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in weight. | FACIT-Searchable Item Library Adult Version - Bothered by Change in Weight | ||
FSIL-Bothered by Compression Stockings | C184289 | FSIL-Bothered by Compression Stockings | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by wearing compression stockings. | FACIT-Searchable Item Library Adult Version - Bothered by Compression Stockings | ||
FSIL-Bothered by Constipation | C183880 | FSIL-Bothered by Constipation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by constipation. | FACIT-Searchable Item Library Adult Version - Bothered by Constipation | ||
FSIL-Bothered by Cracking/Peeling Skin | C184042 | FSIL-Bothered by Cracking/Peeling Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by cracking or peeling of my skin. | FACIT-Searchable Item Library Adult Version - Bothered by Cracking/Peeling Skin | ||
FSIL-Bothered by Discharge From Vulva | C184281 | FSIL-Bothered by Discharge From Vulva | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discharge or bleeding from my vulva. | FACIT-Searchable Item Library Adult Version - Bothered by Discharge From Vulva | ||
FSIL-Bothered by Discomfort Groin/Legs | C184284 | FSIL-Bothered by Discomfort Groin/Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discomfort in my groin or legs. | FACIT-Searchable Item Library Adult Version - Bothered by Discomfort Groin/Legs | ||
FSIL-Bothered by Drop in My Contribution | C183708 | FSIL-Bothered by Drop in My Contribution | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the drop in my contribution to the family. | FACIT-Searchable Item Library Adult Version - Bothered by Drop in My Contribution | ||
FSIL-Bothered by Dry Mouth | C183730 | FSIL-Bothered by Dry Mouth | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by dry mouth. | FACIT-Searchable Item Library Adult Version - Bothered by Dry Mouth | ||
FSIL-Bothered by Dry Skin | C184035 | FSIL-Bothered by Dry Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by dry skin. | FACIT-Searchable Item Library Adult Version - Bothered by Dry Skin | ||
FSIL-Bothered by Effects Treatment Bone | C183735 | FSIL-Bothered by Effects Treatment Bone | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by side effects of treatment for bone disease. | FACIT-Searchable Item Library Adult Version - Bothered by Effects Treatment Bone | ||
FSIL-Bothered by Fevers | C183729 | FSIL-Bothered by Fevers | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by fevers (episodes of high body temperature). | FACIT-Searchable Item Library Adult Version - Bothered by Fevers | ||
FSIL-Bothered by Gas | C183955 | FSIL-Bothered by Gas | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by gas (flatulence). | FACIT-Searchable Item Library Adult Version - Bothered by Gas | ||
FSIL-Bothered by Hair Loss | C183664 | FSIL-Bothered by Hair Loss | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by hair loss. | FACIT-Searchable Item Library Adult Version - Bothered by Hair Loss | ||
FSIL-Bothered by Having a Blocked Nose | C184118 | FSIL-Bothered by Having a Blocked Nose | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by having a blocked nose. | FACIT-Searchable Item Library Adult Version - Bothered by Having a Blocked Nose | ||
FSIL-Bothered by Headaches | C184098 | FSIL-Bothered by Headaches | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by headaches. | FACIT-Searchable Item Library Adult Version - Bothered by Headaches | ||
FSIL-Bothered by Hot Flashes | C183771 | FSIL-Bothered by Hot Flashes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by hot flashes. | FACIT-Searchable Item Library Adult Version - Bothered by Hot Flashes | ||
FSIL-Bothered by Increased Facial Hair | C184200 | FSIL-Bothered by Increased Facial Hair | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by increased facial hair. | FACIT-Searchable Item Library Adult Version - Bothered by Increased Facial Hair | ||
FSIL-Bothered by Itching | C184070 | FSIL-Bothered by Itching | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by itching. | FACIT-Searchable Item Library Adult Version - Bothered by Itching | ||
FSIL-Bothered by Itching/Burning Vulva | C184285 | FSIL-Bothered by Itching/Burning Vulva | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by itching/burning in my vulva area. | FACIT-Searchable Item Library Adult Version - Bothered by Itching/Burning Vulva | ||
FSIL-Bothered by Jaundice/Yellow Skin | C183996 | FSIL-Bothered by Jaundice/Yellow Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by jaundice or yellow color to my skin. | FACIT-Searchable Item Library Adult Version - Bothered by Jaundice/Yellow Skin | ||
FSIL-Bothered by Lumps or Swelling | C184062 | FSIL-Bothered by Lumps or Swelling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by lumps or swelling in certain parts of my body (e.g., neck, armpits, or groin). | FACIT-Searchable Item Library Adult Version - Bothered by Lumps or Swelling | ||
FSIL-Bothered by Mouth Sores/Tenderness | C183620 | FSIL-Bothered by Mouth Sores/Tenderness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by mouth sores or tenderness. | FACIT-Searchable Item Library Adult Version - Bothered by Mouth Sores/Tenderness | ||
FSIL-Bothered by Muscle Pains | C184099 | FSIL-Bothered by Muscle Pains | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by muscle pains. | FACIT-Searchable Item Library Adult Version - Bothered by Muscle Pains | ||
FSIL-Bothered by Muscle Spasms | C184096 | FSIL-Bothered by Muscle Spasms | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by muscle spasms. | FACIT-Searchable Item Library Adult Version - Bothered by Muscle Spasms | ||
FSIL-Bothered by My Hands/Nails Look | C184228 | FSIL-Bothered by My Hands/Nails Look | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the way my hands or nails look. | FACIT-Searchable Item Library Adult Version - Bothered by My Hands/Nails Look | ||
FSIL-Bothered by Nosebleeds | C184239 | FSIL-Bothered by Nosebleeds | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by nosebleeds. | FACIT-Searchable Item Library Adult Version - Bothered by Nosebleeds | ||
FSIL-Bothered by Odor From Vagina | C183876 | FSIL-Bothered by Odor From Vagina | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by odor coming from my vagina. | FACIT-Searchable Item Library Adult Version - Bothered by Odor From Vagina | ||
FSIL-Bothered by Odor From Vulva | C184282 | FSIL-Bothered by Odor From Vulva | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by odor coming from my vulva. | FACIT-Searchable Item Library Adult Version - Bothered by Odor From Vulva | ||
FSIL-Bothered by Pain/Numbness in Vulva | C184286 | FSIL-Bothered by Pain/Numbness in Vulva | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by pain or numbness in my vulva area. | FACIT-Searchable Item Library Adult Version - Bothered by Pain/Numbness in Vulva | ||
FSIL-Bothered by Reflux or Heartburn | C183956 | FSIL-Bothered by Reflux or Heartburn | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by reflux or heartburn. | FACIT-Searchable Item Library Adult Version - Bothered by Reflux or Heartburn | ||
FSIL-Bothered by Ringing in My Ear | C184114 | FSIL-Bothered by Ringing in My Ear | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by ringing in my ear(s). | FACIT-Searchable Item Library Adult Version - Bothered by Ringing in My Ear | ||
FSIL-Bothered by Sensitivity Fingernails | C184201 | FSIL-Bothered by Sensitivity Fingernails | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by sensitivity around my fingernails or toenails. | FACIT-Searchable Item Library Adult Version - Bothered by Sensitivity Fingernails | ||
FSIL-Bothered by Short-term Reactions | C184039 | FSIL-Bothered by Short-term Reactions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by short-term treatment reactions that I experience immediately after, or within 24 hours of, an infusion (such as chills, dizziness, hives, rashes lasting no more than 24 hours). | FACIT-Searchable Item Library Adult Version - Bothered by Short-term Reactions | ||
FSIL-Bothered by Side Effects Treatment | C183979 | FSIL-Bothered by Side Effects Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by side effects of treatment. | FACIT-Searchable Item Library Adult Version - Bothered by Side Effects Treatment | ||
FSIL-Bothered by Skin Problems Underarm | C184174 | FSIL-Bothered by Skin Problems Underarm | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by skin problems in my underarm area. | FACIT-Searchable Item Library Adult Version - Bothered by Skin Problems Underarm | ||
FSIL-Bothered by Skin Problems | C183680 | FSIL-Bothered by Skin Problems | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by skin problems. | FACIT-Searchable Item Library Adult Version - Bothered by Skin Problems | ||
FSIL-Bothered by Skin Sensitivity to Sun | C184216 | FSIL-Bothered by Skin Sensitivity to Sun | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by a change in my skin's sensitivity to the sun. | FACIT-Searchable Item Library Adult Version - Bothered by Skin Sensitivity to Sun | ||
FSIL-Bothered by Sweating | C183727 | FSIL-Bothered by Sweating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by sweating. | FACIT-Searchable Item Library Adult Version - Bothered by Sweating | ||
FSIL-Bothered by Swelling Certain Areas | C183619 | FSIL-Bothered by Swelling Certain Areas | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling in certain areas of my body. | FACIT-Searchable Item Library Adult Version - Bothered by Swelling Certain Areas | ||
FSIL-Bothered by Swelling in My Breast | C184170 | FSIL-Bothered by Swelling in My Breast | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling in my breast. | FACIT-Searchable Item Library Adult Version - Bothered by Swelling in My Breast | ||
FSIL-Bothered by Swelling/Fluid in Legs | C184283 | FSIL-Bothered by Swelling/Fluid in Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by swelling/fluid in my legs. | FACIT-Searchable Item Library Adult Version - Bothered by Swelling/Fluid in Legs | ||
FSIL-Bothered by the Amount of Swelling | C184076 | FSIL-Bothered by the Amount of Swelling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the amount of swelling. | FACIT-Searchable Item Library Adult Version - Bothered by the Amount of Swelling | ||
FSIL-Bothered by the Chills | C183728 | FSIL-Bothered by the Chills | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the chills. | FACIT-Searchable Item Library Adult Version - Bothered by the Chills | ||
FSIL-Bothered by Uncertainty Prognosis | C183864 | FSIL-Bothered by Uncertainty Prognosis | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by uncertainty about my prognosis. | FACIT-Searchable Item Library Adult Version - Bothered by Uncertainty Prognosis | ||
FSIL-Bothered by Vitiligo | C184036 | FSIL-Bothered by Vitiligo | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by vitiligo (white patches appearing on my skin). | FACIT-Searchable Item Library Adult Version - Bothered by Vitiligo | ||
FSIL-Bothered by Worsening Eyesight | C184115 | FSIL-Bothered by Worsening Eyesight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by worsening eyesight. | FACIT-Searchable Item Library Adult Version - Bothered by Worsening Eyesight | ||
FSIL-Bothered Discharge/Bleeding Vagina | C183875 | FSIL-Bothered Discharge/Bleeding Vagina | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by discharge or bleeding from my vagina. | FACIT-Searchable Item Library Adult Version - Bothered Discharge/Bleeding Vagina | ||
FSIL-Bothered Inconvenience Treat Skin | C183867 | FSIL-Bothered Inconvenience Treat Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the inconvenience of treatment for my skin condition. | FACIT-Searchable Item Library Adult Version - Bothered Inconvenience Treat Skin | ||
FSIL-Bothered New Allergy-like Reactions | C184041 | FSIL-Bothered New Allergy-like Reactions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by new allergy-like reactions (e.g., to foods, insects, pollen). | FACIT-Searchable Item Library Adult Version - Bothered New Allergy-like Reactions | ||
FSIL-Bothered Red/Pink Appearance Skin | C183863 | FSIL-Bothered Red/Pink Appearance Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am bothered by the red or pink appearance of my skin. | FACIT-Searchable Item Library Adult Version - Bothered Red/Pink Appearance Skin | ||
FSIL-Breathing Is Easy for Me | C184060 | FSIL-Breathing Is Easy for Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Breathing is easy for me. | FACIT-Searchable Item Library Adult Version - Breathing Is Easy for Me | ||
FSIL-Can Manage Things Around Infection | C183795 | FSIL-Can Manage Things Around Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I can manage things that come up around this infection. | FACIT-Searchable Item Library Adult Version - Can Manage Things Around Infection | ||
FSIL-Can Swallow Naturally and Easily | C184023 | FSIL-Can Swallow Naturally and Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can swallow naturally and easily. | FACIT-Searchable Item Library Adult Version - Can Swallow Naturally and Easily | ||
FSIL-Careful Who I told About Infection | C183782 | FSIL-Careful Who I told About Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I was careful who I told about the infection. | FACIT-Searchable Item Library Adult Version - Careful Who I told About Infection | ||
FSIL-Caring for Ostomy Is Difficult | C183770 | FSIL-Caring for Ostomy Is Difficult | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Caring for my ostomy appliance is difficult. | FACIT-Searchable Item Library Adult Version - Caring for Ostomy Is Difficult | ||
FSIL-Caring Urinary Condition Difficult | C184291 | FSIL-Caring Urinary Condition Difficult | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Caring for my urinary condition is difficult. | FACIT-Searchable Item Library Adult Version - Caring Urinary Condition Difficult | ||
FSIL-Carrying 10-20 Lbs | C183896 | FSIL-Carrying 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Carrying something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries) from one room to another. | FACIT-Searchable Item Library Adult Version - Carrying 10-20 Lbs | ||
FSIL-Certain Parts of Body Have Pain | C184134 | FSIL-Certain Parts of Body Have Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have certain parts of my body where I experience pain. | FACIT-Searchable Item Library Adult Version - Certain Parts of Body Have Pain | ||
FSIL-Chemo Causes Physical Pain | C183846 | FSIL-Chemo Causes Physical Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy treatment causes me physical pain. | FACIT-Searchable Item Library Adult Version - Chemo Causes Physical Pain | ||
FSIL-Chemo Schedule Is Stressful Family | C183851 | FSIL-Chemo Schedule Is Stressful Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy schedule is stressful to my family. | FACIT-Searchable Item Library Adult Version - Chemo Schedule Is Stressful Family | ||
FSIL-Chemo Schedule Is Stressful Me | C183850 | FSIL-Chemo Schedule Is Stressful Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy schedule is stressful to me. | FACIT-Searchable Item Library Adult Version - Chemo Schedule Is Stressful Me | ||
FSIL-Chemo Seems Harmful | C183849 | FSIL-Chemo Seems Harmful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Chemotherapy treatment seems harmful to me. | FACIT-Searchable Item Library Adult Version - Chemo Seems Harmful | ||
FSIL-Chemo Takes Family Time | C183844 | FSIL-Chemo Takes Family Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chemotherapy treatment takes up my family's time. | FACIT-Searchable Item Library Adult Version - Chemo Takes Family Time | ||
FSIL-Chemo Treatment Takes Up My Time | C183839 | FSIL-Chemo Treatment Takes Up My Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Chemotherapy treatment takes up my time. | FACIT-Searchable Item Library Adult Version - Chemo Treatment Takes Up My Time | ||
FSIL-Choose This Chemo Again | C183842 | FSIL-Choose This Chemo Again | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this chemotherapy again? | FACIT-Searchable Item Library Adult Version - Choose This Chemo Again | ||
FSIL-Choose This Clinic/Office Again | C184273 | FSIL-Choose This Clinic/Office Again | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this clinic or office again? | FACIT-Searchable Item Library Adult Version - Choose This Clinic/Office Again | ||
FSIL-Choose This Treatment Again | C184278 | FSIL-Choose This Treatment Again | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this treatment again? | FACIT-Searchable Item Library Adult Version - Choose This Treatment Again | ||
FSIL-Choose This Treatment Bone Again | C183738 | FSIL-Choose This Treatment Bone Again | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you choose this treatment for bone disease again? | FACIT-Searchable Item Library Adult Version - Choose This Treatment Bone Again | ||
FSIL-Comfort in Faith/Spiritual Beliefs | C184197 | FSIL-Comfort in Faith/Spiritual Beliefs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I find comfort in my faith or spiritual beliefs. | FACIT-Searchable Item Library Adult Version - Comfort in Faith/Spiritual Beliefs | ||
FSIL-Comfortable Discuss Cond w/Friends | C184048 | FSIL-Comfortable Discuss Cond w/Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am comfortable discussing my condition with friends. | FACIT-Searchable Item Library Adult Version - Comfortable Discuss Cond w/Friends | ||
FSIL-Compassion for Others Difficulties | C184190 | FSIL-Compassion for Others Difficulties | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel compassion for others in the difficulties they are facing. | FACIT-Searchable Item Library Adult Version - Compassion for Others Difficulties | ||
FSIL-Concerned About How Thin I Look | C183634 | FSIL-Concerned About How Thin I Look | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about how thin I look. | FACIT-Searchable Item Library Adult Version - Concerned About How Thin I Look | ||
FSIL-Concerned About Keeping My Job | C183674 | FSIL-Concerned About Keeping My Job | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about keeping my job (include work at home). | FACIT-Searchable Item Library Adult Version - Concerned About Keeping My Job | ||
FSIL-Concerned Keeping My Job and Income | C183951 | FSIL-Concerned Keeping My Job and Income | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about keeping my job and income, including work at home. | FACIT-Searchable Item Library Adult Version - Concerned Keeping My Job and Income | ||
FSIL-Concerned What the Future Holds | C184009 | FSIL-Concerned What the Future Holds | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am concerned about what the future holds for me. | FACIT-Searchable Item Library Adult Version - Concerned What the Future Holds | ||
FSIL-Concerns Ability Become Pregnant | C183778 | FSIL-Concerns Ability Become Pregnant | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have concerns about my ability to become pregnant. | FACIT-Searchable Item Library Adult Version - Concerns Ability Become Pregnant | ||
FSIL-Concerns Ability to Have Children | C183689 | FSIL-Concerns Ability to Have Children | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have concerns about my ability to have children. | FACIT-Searchable Item Library Adult Version - Concerns Ability to Have Children | ||
FSIL-Condition Wakes/Keeps Me Up Night | C184044 | FSIL-Condition Wakes/Keeps Me Up Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My condition wakes or keeps me up at night. | FACIT-Searchable Item Library Adult Version - Condition Wakes/Keeps Me Up Night | ||
FSIL-Confidence in My Nurse(s) | C183690 | FSIL-Confidence in My Nurse(s) | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my nurse(s). | FACIT-Searchable Item Library Adult Version - Confidence in My Nurse(s) | ||
FSIL-Confident Nutrition Feeding Tube | C183915 | FSIL-Confident Nutrition Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am more confident about my nutrition because of my feeding tube. | FACIT-Searchable Item Library Adult Version - Confident Nutrition Feeding Tube | ||
FSIL-Constipated | C184149 | FSIL-Constipated | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am constipated. | FACIT-Searchable Item Library Adult Version - Constipated | ||
FSIL-Constipation Dur/After Tube Feeding | C183918 | FSIL-Constipation Dur/After Tube Feeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have constipation during or after my tube feeding. | FACIT-Searchable Item Library Adult Version - Constipation Dur/After Tube Feeding | ||
FSIL-Content With Quality of My Life Now | C183974 | FSIL-Content With Quality of My Life Now | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am content with the quality of my life right now. | FACIT-Searchable Item Library Adult Version - Content With Quality of My Life Now | ||
FSIL-Cost of Treatment Is Burden on Me | C183683 | FSIL-Cost of Treatment Is Burden on Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The cost of my treatment is a burden on me or my family. | FACIT-Searchable Item Library Adult Version - Cost of Treatment Is Burden on Me | ||
FSIL-Dependent on Others Feeding Tube | C183913 | FSIL-Dependent on Others Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel dependent on others because I have a feeding tube. | FACIT-Searchable Item Library Adult Version - Dependent on Others Feeding Tube | ||
FSIL-Depressed About My Condition | C184101 | FSIL-Depressed About My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am depressed about my condition. | FACIT-Searchable Item Library Adult Version - Depressed About My Condition | ||
FSIL-Depressed About the Infection | C183786 | FSIL-Depressed About the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am depressed about the infection. | FACIT-Searchable Item Library Adult Version - Depressed About the Infection | ||
FSIL-Diarrhea Keeps/Wakes Me Up at Night | C183887 | FSIL-Diarrhea Keeps/Wakes Me Up at Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My problem with diarrhea (diarrhoea) keeps/wakes me up at night. | FACIT-Searchable Item Library Adult Version - Diarrhea Keeps/Wakes Me Up at Night | ||
FSIL-Diff Moving Neck & Shoulders Stiff | C184113 | FSIL-Diff Moving Neck & Shoulders Stiff | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty moving my neck and shoulders because of stiffness. | FACIT-Searchable Item Library Adult Version - Diff Moving Neck & Shoulders Stiff | ||
FSIL-Difficult Times Strengthened Faith | C184198 | FSIL-Difficult Times Strengthened Faith | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Difficult times have strengthened my faith or spiritual beliefs. | FACIT-Searchable Item Library Adult Version - Difficult Times Strengthened Faith | ||
FSIL-Difficulty Breathing Exposed Cold | C184121 | FSIL-Difficulty Breathing Exposed Cold | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty breathing when I am exposed to cold temperatures. | FACIT-Searchable Item Library Adult Version - Difficulty Breathing Exposed Cold | ||
FSIL-Difficulty Doing Things B/c of Skin | C183861 | FSIL-Difficulty Doing Things B/c of Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty doing things with my hands because of the condition of my skin. | FACIT-Searchable Item Library Adult Version - Difficulty Doing Things B/c of Skin | ||
FSIL-Difficulty Expressing My Thoughts | C183725 | FSIL-Difficulty Expressing My Thoughts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty expressing my thoughts. | FACIT-Searchable Item Library Adult Version - Difficulty Expressing My Thoughts | ||
FSIL-Difficulty Moving My Arm Sideways | C184163 | FSIL-Difficulty Moving My Arm Sideways | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty moving my arm sideways. | FACIT-Searchable Item Library Adult Version - Difficulty Moving My Arm Sideways | ||
FSIL-Difficulty Planning for Future | C184065 | FSIL-Difficulty Planning for Future | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my illness, I have difficulty planning for the future. | FACIT-Searchable Item Library Adult Version - Difficulty Planning for Future | ||
FSIL-Difficulty Swallowing Liquids | C183900 | FSIL-Difficulty Swallowing Liquids | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing liquids. | FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Liquids | ||
FSIL-Difficulty Swallowing Soft Foods | C183899 | FSIL-Difficulty Swallowing Soft Foods | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing soft or mashed foods. | FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Soft Foods | ||
FSIL-Difficulty Swallowing Solid Foods | C183898 | FSIL-Difficulty Swallowing Solid Foods | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty swallowing solid foods. | FACIT-Searchable Item Library Adult Version - Difficulty Swallowing Solid Foods | ||
FSIL-Difficulty Telling Partner/Spouse | C183783 | FSIL-Difficulty Telling Partner/Spouse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had difficulty telling my partner/spouse about the infection. | FACIT-Searchable Item Library Adult Version - Difficulty Telling Partner/Spouse | ||
FSIL-Difficulty Walking B/c of Skin | C183862 | FSIL-Difficulty Walking B/c of Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty walking because of my skin condition. | FACIT-Searchable Item Library Adult Version - Difficulty Walking B/c of Skin | ||
FSIL-Digestive Problems Interfere Activ | C183953 | FSIL-Digestive Problems Interfere Activ | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My digestive problems interfere with my usual activities. | FACIT-Searchable Item Library Adult Version - Digestive Problems Interfere Activ | ||
FSIL-Discomfort in My Pelvic Area | C183774 | FSIL-Discomfort in My Pelvic Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort in my pelvic area. | FACIT-Searchable Item Library Adult Version - Discomfort in My Pelvic Area | ||
FSIL-Discomfort or Pain When I Eat | C183959 | FSIL-Discomfort or Pain When I Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain when I eat. | FACIT-Searchable Item Library Adult Version - Discomfort or Pain When I Eat | ||
FSIL-Discomfort/Pain in My Pelvic Area | C183926 | FSIL-Discomfort/Pain in My Pelvic Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain in my pelvic area. | FACIT-Searchable Item Library Adult Version - Discomfort/Pain in My Pelvic Area | ||
FSIL-Discomfort/Pain in Stomach Area | C184001 | FSIL-Discomfort/Pain in Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort or pain in my stomach area. | FACIT-Searchable Item Library Adult Version - Discomfort/Pain in Stomach Area | ||
FSIL-Discuss Concerns w/ People Closest | C184145 | FSIL-Discuss Concerns w/ People Closest | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to openly discuss my concerns with the people closest to me. | FACIT-Searchable Item Library Adult Version - Discuss Concerns w/ People Closest | ||
FSIL-Do You Have an Ostomy Appliance | C184155 | FSIL-Do You Have an Ostomy Appliance | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Do you have an ostomy appliance? | FACIT-Searchable Item Library Adult Version - Do You Have an Ostomy Appliance | ||
FSIL-Doctor Available Answer Questions | C183984 | FSIL-Doctor Available Answer Questions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor is available to answer my questions. | FACIT-Searchable Item Library Adult Version - Doctor Available Answer Questions | ||
FSIL-Doctor Evaluate Effects Treatment | C184263 | FSIL-Doctor Evaluate Effects Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) help you evaluate the effects of your treatment so far? | FACIT-Searchable Item Library Adult Version - Doctor Evaluate Effects Treatment | ||
FSIL-Doctor Experience Treating Illness | C184258 | FSIL-Doctor Experience Treating Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel your doctor(s) had experience treating your illness? | FACIT-Searchable Item Library Adult Version - Doctor Experience Treating Illness | ||
FSIL-Doctor Explain Benefits Treatment | C184245 | FSIL-Doctor Explain Benefits Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) explain the possible benefits of your treatment? | FACIT-Searchable Item Library Adult Version - Doctor Explain Benefits Treatment | ||
FSIL-Doctor Explain Side Effects/Risks | C184246 | FSIL-Doctor Explain Side Effects/Risks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) explain the possible side effects or risks of your treatment? | FACIT-Searchable Item Library Adult Version - Doctor Explain Side Effects/Risks | ||
FSIL-Doctor Explained Possible Benefits | C183794 | FSIL-Doctor Explained Possible Benefits | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor explained the possible benefits of my treatment. | FACIT-Searchable Item Library Adult Version - Doctor Explained Possible Benefits | ||
FSIL-Doctor Explanations You Understand | C184280 | FSIL-Doctor Explanations You Understand | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) give explanations that you could understand? | FACIT-Searchable Item Library Adult Version - Doctor Explanations You Understand | ||
FSIL-Doctor Gave Explanations Understand | C183793 | FSIL-Doctor Gave Explanations Understand | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My doctor gave me explanations that I could understand. | FACIT-Searchable Item Library Adult Version - Doctor Gave Explanations Understand | ||
FSIL-Doctor Knew Medical Developments | C184259 | FSIL-Doctor Knew Medical Developments | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel your doctor(s) knew about the latest medical developments for your illness? | FACIT-Searchable Item Library Adult Version - Doctor Knew Medical Developments | ||
FSIL-Doctor Seem Respect Your Opinions | C184264 | FSIL-Doctor Seem Respect Your Opinions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to respect your opinions? | FACIT-Searchable Item Library Adult Version - Doctor Seem Respect Your Opinions | ||
FSIL-Doctor Seem Understand Your Needs | C184251 | FSIL-Doctor Seem Understand Your Needs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to understand your needs? | FACIT-Searchable Item Library Adult Version - Doctor Seem Understand Your Needs | ||
FSIL-Doctor Show Genuine Concern for You | C184250 | FSIL-Doctor Show Genuine Concern for You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) show genuine concern for you? | FACIT-Searchable Item Library Adult Version - Doctor Show Genuine Concern for You | ||
FSIL-Doctor Understand Important to You | C184249 | FSIL-Doctor Understand Important to You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your doctor(s) seem to understand what was important to you? | FACIT-Searchable Item Library Adult Version - Doctor Understand Important to You | ||
FSIL-Dressing Yourself Without Help | C183888 | FSIL-Dressing Yourself Without Help | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Dressing yourself without help. | FACIT-Searchable Item Library Adult Version - Dressing Yourself Without Help | ||
FSIL-Dur Tube Feeding Eat/Drink by Mouth | C183923 | FSIL-Dur Tube Feeding Eat/Drink by Mouth | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: During the use of tube feeding, I can eat and drink by mouth. | FACIT-Searchable Item Library Adult Version - Dur Tube Feeding Eat/Drink by Mouth | ||
FSIL-During Difficult Times Things Be OK | C184199 | FSIL-During Difficult Times Things Be OK | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Even during difficult times, I know that things will be okay. | FACIT-Searchable Item Library Adult Version - During Difficult Times Things Be OK | ||
FSIL-Effectiveness of Treatment So Far | C184244 | FSIL-Effectiveness of Treatment So Far | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Compared to what you expected, how do you rate the effectiveness of the treatment so far? | FACIT-Searchable Item Library Adult Version - Effectiveness of Treatment So Far | ||
FSIL-Embarrassed About the Infection | C183780 | FSIL-Embarrassed About the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel embarrassed about the infection. | FACIT-Searchable Item Library Adult Version - Embarrassed About the Infection | ||
FSIL-Embarrassed by Appearance of Skin | C183872 | FSIL-Embarrassed by Appearance of Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by the appearance of my skin. | FACIT-Searchable Item Library Adult Version - Embarrassed by Appearance of Skin | ||
FSIL-Embarrassed by Having Diarrhea | C183885 | FSIL-Embarrassed by Having Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by having diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Embarrassed by Having Diarrhea | ||
FSIL-Embarrassed by My Condition | C184053 | FSIL-Embarrassed by My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my condition. | FACIT-Searchable Item Library Adult Version - Embarrassed by My Condition | ||
FSIL-Embarrassed by My Illness | C184003 | FSIL-Embarrassed by My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my illness. | FACIT-Searchable Item Library Adult Version - Embarrassed by My Illness | ||
FSIL-Embarrassed by My Skin Condition | C184205 | FSIL-Embarrassed by My Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my skin condition. | FACIT-Searchable Item Library Adult Version - Embarrassed by My Skin Condition | ||
FSIL-Embarrassed by Ostomy Appliance | C183769 | FSIL-Embarrassed by Ostomy Appliance | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am embarrassed by my ostomy appliance. | FACIT-Searchable Item Library Adult Version - Embarrassed by Ostomy Appliance | ||
FSIL-Emotional Support Family Members | C183788 | FSIL-Emotional Support Family Members | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from family members. | FACIT-Searchable Item Library Adult Version - Emotional Support Family Members | ||
FSIL-Emotional Support From My Family | C183986 | FSIL-Emotional Support From My Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from my family. | FACIT-Searchable Item Library Adult Version - Emotional Support From My Family | ||
FSIL-Enjoy Meals With Family/Friends | C183903 | FSIL-Enjoy Meals With Family/Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to enjoy meals with family or friends. | FACIT-Searchable Item Library Adult Version - Enjoy Meals With Family/Friends | ||
FSIL-Enjoy Things I Usually Do for Fun | C183973 | FSIL-Enjoy Things I Usually Do for Fun | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am enjoying the things I usually do for fun. | FACIT-Searchable Item Library Adult Version - Enjoy Things I Usually Do for Fun | ||
FSIL-Enough Money to Cover Treatment | C183940 | FSIL-Enough Money to Cover Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I know that I have enough money in savings, retirement, or assets to cover the costs of my treatment. | FACIT-Searchable Item Library Adult Version - Enough Money to Cover Treatment | ||
FSIL-Family Bothered by Skin Condition | C183860 | FSIL-Family Bothered by Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family is bothered by my skin condition. | FACIT-Searchable Item Library Adult Version - Family Bothered by Skin Condition | ||
FSIL-Family Is Well Despite My Illness | C183993 | FSIL-Family Is Well Despite My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family is doing well despite my illness. | FACIT-Searchable Item Library Adult Version - Family Is Well Despite My Illness | ||
FSIL-Family Trouble Understand Bone Pain | C183696 | FSIL-Family Trouble Understand Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has trouble understanding when my bone pain interferes with my activity. | FACIT-Searchable Item Library Adult Version - Family Trouble Understand Bone Pain | ||
FSIL-Family Trouble Understand Worse | C184093 | FSIL-Family Trouble Understand Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has trouble understanding when my condition gets worse. | FACIT-Searchable Item Library Adult Version - Family Trouble Understand Worse | ||
FSIL-Family Who Take My Responsibilities | C184146 | FSIL-Family Who Take My Responsibilities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have family members who will take on my responsibilities. | FACIT-Searchable Item Library Adult Version - Family Who Take My Responsibilities | ||
FSIL-Far From Home/Work W/o Fear Soilage | C184046 | FSIL-Far From Home/Work W/o Fear Soilage | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can be far from home/work without fearing soilage. | FACIT-Searchable Item Library Adult Version - Far From Home/Work W/o Fear Soilage | ||
FSIL-Fatigue Keeps Me From Doing Things | C183618 | FSIL-Fatigue Keeps Me From Doing Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My fatigue keeps me from doing the things I want to do. | FACIT-Searchable Item Library Adult Version - Fatigue Keeps Me From Doing Things | ||
FSIL-Feeding Tube Was Right Decision | C183917 | FSIL-Feeding Tube Was Right Decision | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Getting a feeding tube was the right decision for me. | FACIT-Searchable Item Library Adult Version - Feeding Tube Was Right Decision | ||
FSIL-Feel Financially Stressed | C183950 | FSIL-Feel Financially Stressed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel financially stressed. | FACIT-Searchable Item Library Adult Version - Feel Financially Stressed | ||
FSIL-Feel Forgiven for Harm I Caused | C184184 | FSIL-Feel Forgiven for Harm I Caused | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel forgiven for any harm I may have ever caused. | FACIT-Searchable Item Library Adult Version - Feel Forgiven for Harm I Caused | ||
FSIL-Feel Isolated Because of Illness | C184068 | FSIL-Feel Isolated Because of Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel isolated from others because of my illness or treatment. | FACIT-Searchable Item Library Adult Version - Feel Isolated Because of Illness | ||
FSIL-Feel Overwhelmed by My Condition | C184103 | FSIL-Feel Overwhelmed by My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel overwhelmed by my condition. | FACIT-Searchable Item Library Adult Version - Feel Overwhelmed by My Condition | ||
FSIL-Feel Sense of Harmony Within Myself | C184195 | FSIL-Feel Sense of Harmony Within Myself | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of harmony within myself. | FACIT-Searchable Item Library Adult Version - Feel Sense of Harmony Within Myself | ||
FSIL-Feel Sense of Purpose in My Life | C184193 | FSIL-Feel Sense of Purpose in My Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel a sense of purpose in my life. | FACIT-Searchable Item Library Adult Version - Feel Sense of Purpose in My Life | ||
FSIL-Feel Sense of Thankfulness for Life | C184185 | FSIL-Feel Sense of Thankfulness for Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Throughout the course of my day, I feel a sense of thankfulness for my life. | FACIT-Searchable Item Library Adult Version - Feel Sense of Thankfulness for Life | ||
FSIL-Feel That My Family Appreciates Me | C184147 | FSIL-Feel That My Family Appreciates Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that my family appreciates me. | FACIT-Searchable Item Library Adult Version - Feel That My Family Appreciates Me | ||
FSIL-Forced to Spend Time in Bed | C183981 | FSIL-Forced to Spend Time in Bed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am forced to spend time in bed. | FACIT-Searchable Item Library Adult Version - Forced to Spend Time in Bed | ||
FSIL-Forgive Others for Harm Caused Me | C184183 | FSIL-Forgive Others for Harm Caused Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to forgive others for any harm they have ever caused me. | FACIT-Searchable Item Library Adult Version - Forgive Others for Harm Caused Me | ||
FSIL-Forgotten Names After Introduced | C183811 | FSIL-Forgotten Names After Introduced | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have forgotten names of people soon after being introduced. | FACIT-Searchable Item Library Adult Version - Forgotten Names After Introduced | ||
FSIL-Frustrated by Being Too Tired | C183646 | FSIL-Frustrated by Being Too Tired | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by being too tired to do the things I want to do. | FACIT-Searchable Item Library Adult Version - Frustrated by Being Too Tired | ||
FSIL-Frustrated by My Bone Pain | C183693 | FSIL-Frustrated by My Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my bone pain. | FACIT-Searchable Item Library Adult Version - Frustrated by My Bone Pain | ||
FSIL-Frustrated by My Condition | C184104 | FSIL-Frustrated by My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my condition. | FACIT-Searchable Item Library Adult Version - Frustrated by My Condition | ||
FSIL-Frustrated by My Skin Condition | C183873 | FSIL-Frustrated by My Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by my skin condition. | FACIT-Searchable Item Library Adult Version - Frustrated by My Skin Condition | ||
FSIL-Frustrated by the Infection | C183784 | FSIL-Frustrated by the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by the infection. | FACIT-Searchable Item Library Adult Version - Frustrated by the Infection | ||
FSIL-Frustrated Cannot Work as Usual | C183947 | FSIL-Frustrated Cannot Work as Usual | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated that I cannot work or contribute as much as I usually do. | FACIT-Searchable Item Library Adult Version - Frustrated Cannot Work as Usual | ||
FSIL-Frustrated I Cannot Do Things | C183720 | FSIL-Frustrated I Cannot Do Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get frustrated that I cannot do things I used to. | FACIT-Searchable Item Library Adult Version - Frustrated I Cannot Do Things | ||
FSIL-Frustrated Not Do Usual Activities | C184232 | FSIL-Frustrated Not Do Usual Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by not being able to do my usual activities. | FACIT-Searchable Item Library Adult Version - Frustrated Not Do Usual Activities | ||
FSIL-Frustrated Unable Do Things I Want | C184063 | FSIL-Frustrated Unable Do Things I Want | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am frustrated by being unable to do the things I want to do. | FACIT-Searchable Item Library Adult Version - Frustrated Unable Do Things I Want | ||
FSIL-Fullness/Heaviness in Stomach Area | C183958 | FSIL-Fullness/Heaviness in Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a feeling of fullness or heaviness in my stomach area. | FACIT-Searchable Item Library Adult Version - Fullness/Heaviness in Stomach Area | ||
FSIL-Get Emotional Support Partner | C183787 | FSIL-Get Emotional Support Partner | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get emotional support from my partner/spouse. | FACIT-Searchable Item Library Adult Version - Get Emotional Support Partner | ||
FSIL-Get Ringing or Buzzing in My Ears | C184127 | FSIL-Get Ringing or Buzzing in My Ears | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get a ringing or buzzing in my ears. | FACIT-Searchable Item Library Adult Version - Get Ringing or Buzzing in My Ears | ||
FSIL-Get to Say Things Important to You | C184248 | FSIL-Get to Say Things Important to You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you get to say the things that were important to you? | FACIT-Searchable Item Library Adult Version - Get to Say Things Important to You | ||
FSIL-Good Range of Movement in Arm/Leg | C184081 | FSIL-Good Range of Movement in Arm/Leg | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have good range of movement in my arm or leg. | FACIT-Searchable Item Library Adult Version - Good Range of Movement in Arm/Leg | ||
FSIL-Had Change in the Way Food Tastes | C183999 | FSIL-Had Change in the Way Food Tastes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had a change in the way food tastes. | FACIT-Searchable Item Library Adult Version - Had Change in the Way Food Tastes | ||
FSIL-Hand Pain Interferes Daily Activ | C183623 | FSIL-Hand Pain Interferes Daily Activ | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Hand pain or tenderness interferes with my daily activities. | FACIT-Searchable Item Library Adult Version - Hand Pain Interferes Daily Activ | ||
FSIL-Hard to Tell People About Infection | C184006 | FSIL-Hard to Tell People About Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It is hard to tell other people about my infection. | FACIT-Searchable Item Library Adult Version - Hard to Tell People About Infection | ||
FSIL-Have Breast Sensitivity/Tenderness | C183929 | FSIL-Have Breast Sensitivity/Tenderness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have breast sensitivity/tenderness. | FACIT-Searchable Item Library Adult Version - Have Breast Sensitivity/Tenderness | ||
FSIL-Have Confidence in Your Doctor | C184270 | FSIL-Have Confidence in Your Doctor | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have confidence in your doctor(s)? | FACIT-Searchable Item Library Adult Version - Have Confidence in Your Doctor | ||
FSIL-Have Difficulty Eating Rich Foods | C183636 | FSIL-Have Difficulty Eating Rich Foods | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty eating rich or "heavy" foods. | FACIT-Searchable Item Library Adult Version - Have Difficulty Eating Rich Foods | ||
FSIL-Have Enough Time to Make Decisions | C184262 | FSIL-Have Enough Time to Make Decisions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have enough time to make decisions about your health care? | FACIT-Searchable Item Library Adult Version - Have Enough Time to Make Decisions | ||
FSIL-Have Joint Pain or Muscle Cramps | C184125 | FSIL-Have Joint Pain or Muscle Cramps | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have joint pain or muscle cramps. | FACIT-Searchable Item Library Adult Version - Have Joint Pain or Muscle Cramps | ||
FSIL-Have Opportunity to Ask Questions | C184247 | FSIL-Have Opportunity to Ask Questions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you have an opportunity to ask questions? | FACIT-Searchable Item Library Adult Version - Have Opportunity to Ask Questions | ||
FSIL-Have Pain/Discomfort w/Intercourse | C183938 | FSIL-Have Pain/Discomfort w/Intercourse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain or discomfort with intercourse. | FACIT-Searchable Item Library Adult Version - Have Pain/Discomfort w/Intercourse | ||
FSIL-Have People to Help Me if I Need It | C184007 | FSIL-Have People to Help Me if I Need It | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have people to help me if I need it. | FACIT-Searchable Item Library Adult Version - Have People to Help Me if I Need It | ||
FSIL-Have Stiffness of Arm on This Side | C183660 | FSIL-Have Stiffness of Arm on This Side | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stiffness of my arm on this side. | FACIT-Searchable Item Library Adult Version - Have Stiffness of Arm on This Side | ||
FSIL-Have Swelling in Parts of My Body | C184150 | FSIL-Have Swelling in Parts of My Body | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling in parts of my body. | FACIT-Searchable Item Library Adult Version - Have Swelling in Parts of My Body | ||
FSIL-Have Trouble Controlling My Urine | C183669 | FSIL-Have Trouble Controlling My Urine | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble controlling my urine. | FACIT-Searchable Item Library Adult Version - Have Trouble Controlling My Urine | ||
FSIL-Have Trouble Feeling Peace of Mind | C184192 | FSIL-Have Trouble Feeling Peace of Mind | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling peace of mind. | FACIT-Searchable Item Library Adult Version - Have Trouble Feeling Peace of Mind | ||
FSIL-Have Trouble Swallowing Food | C183954 | FSIL-Have Trouble Swallowing Food | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble swallowing food. | FACIT-Searchable Item Library Adult Version - Have Trouble Swallowing Food | ||
FSIL-Have Weakness in My Arms or Legs | C183717 | FSIL-Have Weakness in My Arms or Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have weakness in my arms or legs. | FACIT-Searchable Item Library Adult Version - Have Weakness in My Arms or Legs | ||
FSIL-Have You Ever Smoked | C184156 | FSIL-Have You Ever Smoked | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Have you ever smoked? | FACIT-Searchable Item Library Adult Version - Have You Ever Smoked | ||
FSIL-Having Blood Drawn Is Inconvenient | C183746 | FSIL-Having Blood Drawn Is Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Having my blood drawn is inconvenient. | FACIT-Searchable Item Library Adult Version - Having Blood Drawn Is Inconvenient | ||
FSIL-Heat Worsens My Symptoms | C184095 | FSIL-Heat Worsens My Symptoms | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Heat worsens my symptoms. | FACIT-Searchable Item Library Adult Version - Heat Worsens My Symptoms | ||
FSIL-Helps Arrangements Obtain Medicines | C184221 | FSIL-Helps Arrangements Obtain Medicines | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist helps with the arrangements necessary to obtain my medicines. | FACIT-Searchable Item Library Adult Version - Helps Arrangements Obtain Medicines | ||
FSIL-Hidden Problem Others Not Notice | C183777 | FSIL-Hidden Problem Others Not Notice | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have hidden this problem so others will not notice. | FACIT-Searchable Item Library Adult Version - Hidden Problem Others Not Notice | ||
FSIL-Hopeful About the Future | C184004 | FSIL-Hopeful About the Future | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am hopeful about the future. | FACIT-Searchable Item Library Adult Version - Hopeful About the Future | ||
FSIL-How Many Places in Body Felt Pain | C184158 | FSIL-How Many Places in Body Felt Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: In how many places in your body have you felt bone pain? | FACIT-Searchable Item Library Adult Version - How Many Places in Body Felt Pain | ||
FSIL-Hurts When Put Weight/Pressure on | C183697 | FSIL-Hurts When Put Weight/Pressure on | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It hurts when I put weight or pressure on the place where I have bone pain. | FACIT-Searchable Item Library Adult Version - Hurts When Put Weight/Pressure on | ||
FSIL-I Bleed Easily | C184229 | FSIL-I Bleed Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I bleed easily. | FACIT-Searchable Item Library Adult Version - I Bleed Easily | ||
FSIL-I Bruise Easily | C184236 | FSIL-I Bruise Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I bruise easily. | FACIT-Searchable Item Library Adult Version - I Bruise Easily | ||
FSIL-I Can Digest My Food Well | C183765 | FSIL-I Can Digest My Food Well | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can digest my food well. | FACIT-Searchable Item Library Adult Version - I Can Digest My Food Well | ||
FSIL-I Can Eat Solid Foods | C184016 | FSIL-I Can Eat Solid Foods | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can eat solid foods. | FACIT-Searchable Item Library Adult Version - I Can Eat Solid Foods | ||
FSIL-I Can Enjoy the Taste of Food | C184117 | FSIL-I Can Enjoy the Taste of Food | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can enjoy the taste of food. | FACIT-Searchable Item Library Adult Version - I Can Enjoy the Taste of Food | ||
FSIL-I Can Remember New Things | C183719 | FSIL-I Can Remember New Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can remember new things. | FACIT-Searchable Item Library Adult Version - I Can Remember New Things | ||
FSIL-I Can Remember Things | C183675 | FSIL-I Can Remember Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I can remember things. | FACIT-Searchable Item Library Adult Version - I Can Remember Things | ||
FSIL-I Choke When I Swallow | C183902 | FSIL-I Choke When I Swallow | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I choke when I swallow. | FACIT-Searchable Item Library Adult Version - I Choke When I Swallow | ||
FSIL-I Drink Alcohol | C184025 | FSIL-I Drink Alcohol | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I drink alcohol (e.g. beer, wine, etc.). | FACIT-Searchable Item Library Adult Version - I Drink Alcohol | ||
FSIL-I Feel Bloated | C184224 | FSIL-I Feel Bloated | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel bloated. | FACIT-Searchable Item Library Adult Version - I Feel Bloated | ||
FSIL-I Feel Close to My Family | C183992 | FSIL-I Feel Close to My Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my family. | FACIT-Searchable Item Library Adult Version - I Feel Close to My Family | ||
FSIL-I Feel Close to My Friends | C183985 | FSIL-I Feel Close to My Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my friends. | FACIT-Searchable Item Library Adult Version - I Feel Close to My Friends | ||
FSIL-I Feel Close to My Partner | C183990 | FSIL-I Feel Close to My Partner | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel close to my partner (or the person who is my main support). | FACIT-Searchable Item Library Adult Version - I Feel Close to My Partner | ||
FSIL-I Feel Connected to Higher Power | C184179 | FSIL-I Feel Connected to Higher Power | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel connected to a higher power (or God). | FACIT-Searchable Item Library Adult Version - I Feel Connected to Higher Power | ||
FSIL-I Feel Connected to Other People | C184180 | FSIL-I Feel Connected to Other People | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel connected to other people. | FACIT-Searchable Item Library Adult Version - I Feel Connected to Other People | ||
FSIL-I Feel Depressed about Bone Pain | C183694 | FSIL-I Feel Depressed about Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel depressed about my bone pain. | FACIT-Searchable Item Library Adult Version - I Feel Depressed about Bone Pain | ||
FSIL-I Feel Discomfort in My Feet | C184124 | FSIL-I Feel Discomfort in My Feet | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discomfort in my feet. | FACIT-Searchable Item Library Adult Version - I Feel Discomfort in My Feet | ||
FSIL-I Feel Discomfort in My Hands | C184123 | FSIL-I Feel Discomfort in My Hands | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discomfort in my hands. | FACIT-Searchable Item Library Adult Version - I Feel Discomfort in My Hands | ||
FSIL-I Feel Discouraged About My Illness | C184064 | FSIL-I Feel Discouraged About My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel discouraged about my illness. | FACIT-Searchable Item Library Adult Version - I Feel Discouraged About My Illness | ||
FSIL-I Feel Distant From Other People | C183684 | FSIL-I Feel Distant From Other People | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel distant from other people. | FACIT-Searchable Item Library Adult Version - I Feel Distant From Other People | ||
FSIL-I Feel Fatigued | C184011 | FSIL-I Feel Fatigued | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel fatigued. | FACIT-Searchable Item Library Adult Version - I Feel Fatigued | ||
FSIL-I Feel Hopeful | C184188 | FSIL-I Feel Hopeful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel hopeful. | FACIT-Searchable Item Library Adult Version - I Feel Hopeful | ||
FSIL-I Feel Ill | C183980 | FSIL-I Feel Ill | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel ill. | FACIT-Searchable Item Library Adult Version - I Feel Ill | ||
FSIL-I Feel Independent | C183723 | FSIL-I Feel Independent | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel independent. | FACIT-Searchable Item Library Adult Version - I Feel Independent | ||
FSIL-I Feel Left Out of Things | C184094 | FSIL-I Feel Left Out of Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel "left out" of things. | FACIT-Searchable Item Library Adult Version - I Feel Left Out of Things | ||
FSIL-I Feel Lightheaded | C183655 | FSIL-I Feel Lightheaded | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel lightheaded (dizzy). | FACIT-Searchable Item Library Adult Version - I Feel Lightheaded | ||
FSIL-I Feel Like a Burden to My Family | C184148 | FSIL-I Feel Like a Burden to My Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel like a burden to my family. | FACIT-Searchable Item Library Adult Version - I Feel Like a Burden to My Family | ||
FSIL-I Feel Listless | C183640 | FSIL-I Feel Listless | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel listless ("washed out"). | FACIT-Searchable Item Library Adult Version - I Feel Listless | ||
FSIL-I Feel Love for Others | C184182 | FSIL-I Feel Love for Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel love for others. | FACIT-Searchable Item Library Adult Version - I Feel Love for Others | ||
FSIL-I Feel Loved | C184181 | FSIL-I Feel Loved | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel loved. | FACIT-Searchable Item Library Adult Version - I Feel Loved | ||
FSIL-I Feel Motivated to Do Things | C184010 | FSIL-I Feel Motivated to Do Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel motivated to do things. | FACIT-Searchable Item Library Adult Version - I Feel Motivated to Do Things | ||
FSIL-I Feel Nervous | C183965 | FSIL-I Feel Nervous | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel nervous. | FACIT-Searchable Item Library Adult Version - I Feel Nervous | ||
FSIL-I Feel Numbness at My Surgical Site | C184080 | FSIL-I Feel Numbness at My Surgical Site | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel numbness at my surgical site. | FACIT-Searchable Item Library Adult Version - I Feel Numbness at My Surgical Site | ||
FSIL-I Feel Peaceful | C184175 | FSIL-I Feel Peaceful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel peaceful. | FACIT-Searchable Item Library Adult Version - I Feel Peaceful | ||
FSIL-I Feel Sad | C183962 | FSIL-I Feel Sad | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel sad. | FACIT-Searchable Item Library Adult Version - I Feel Sad | ||
FSIL-I Feel Sexually Attractive | C183663 | FSIL-I Feel Sexually Attractive | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel sexually attractive. | FACIT-Searchable Item Library Adult Version - I Feel Sexually Attractive | ||
FSIL-I Feel Tightness in My Chest | C184059 | FSIL-I Feel Tightness in My Chest | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel tightness in my chest. | FACIT-Searchable Item Library Adult Version - I Feel Tightness in My Chest | ||
FSIL-I Feel Tired | C183648 | FSIL-I Feel Tired | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel tired. | FACIT-Searchable Item Library Adult Version - I Feel Tired | ||
FSIL-I Feel Trapped by My Condition | C184100 | FSIL-I Feel Trapped by My Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel trapped by my condition. | FACIT-Searchable Item Library Adult Version - I Feel Trapped by My Condition | ||
FSIL-I Feel Useful | C184152 | FSIL-I Feel Useful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel useful. | FACIT-Searchable Item Library Adult Version - I Feel Useful | ||
FSIL-I Feel Useless | C184102 | FSIL-I Feel Useless | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel useless. | FACIT-Searchable Item Library Adult Version - I Feel Useless | ||
FSIL-I Feel Weak All Over | C184005 | FSIL-I Feel Weak All Over | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel weak all over. | FACIT-Searchable Item Library Adult Version - I Feel Weak All Over | ||
FSIL-I Get Annoyed Easily | C183732 | FSIL-I Get Annoyed Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get annoyed easily. | FACIT-Searchable Item Library Adult Version - I Get Annoyed Easily | ||
FSIL-I Get Depressed Easily | C183731 | FSIL-I Get Depressed Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get depressed easily. | FACIT-Searchable Item Library Adult Version - I Get Depressed Easily | ||
FSIL-I Get Headaches | C183641 | FSIL-I Get Headaches | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get headaches. | FACIT-Searchable Item Library Adult Version - I Get Headaches | ||
FSIL-I Get Support From My Friends | C183987 | FSIL-I Get Support From My Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get support from my friends. | FACIT-Searchable Item Library Adult Version - I Get Support From My Friends | ||
FSIL-I Get Tired Easily | C183688 | FSIL-I Get Tired Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get tired easily. | FACIT-Searchable Item Library Adult Version - I Get Tired Easily | ||
FSIL-I Have a Good Appetite | C183767 | FSIL-I Have a Good Appetite | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a good appetite. | FACIT-Searchable Item Library Adult Version - I Have a Good Appetite | ||
FSIL-I Have a Lack of Energy | C183975 | FSIL-I Have a Lack of Energy | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a lack of energy. | FACIT-Searchable Item Library Adult Version - I Have a Lack of Energy | ||
FSIL-I Have a Loss of Appetite | C183952 | FSIL-I Have a Loss of Appetite | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a loss of appetite. | FACIT-Searchable Item Library Adult Version - I Have a Loss of Appetite | ||
FSIL-I Have a Reason for Living | C184186 | FSIL-I Have a Reason for Living | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a reason for living. | FACIT-Searchable Item Library Adult Version - I Have a Reason for Living | ||
FSIL-I Have Accepted My Illness | C183971 | FSIL-I Have Accepted My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have accepted my illness. | FACIT-Searchable Item Library Adult Version - I Have Accepted My Illness | ||
FSIL-I Have Aches and Pains in My Bones | C184084 | FSIL-I Have Aches and Pains in My Bones | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have aches and pains in my bones. | FACIT-Searchable Item Library Adult Version - I Have Aches and Pains in My Bones | ||
FSIL-I Have Aches/Pains That Bother Me | C184133 | FSIL-I Have Aches/Pains That Bother Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have aches and pains that bother me. | FACIT-Searchable Item Library Adult Version - I Have Aches/Pains That Bother Me | ||
FSIL-I Have Been Able to Concentrate | C183822 | FSIL-I Have Been Able to Concentrate | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been able to concentrate. | FACIT-Searchable Item Library Adult Version - I Have Been Able to Concentrate | ||
FSIL-I Have Been Bothered by Diarrhea | C184026 | FSIL-I Have Been Bothered by Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been bothered by diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - I Have Been Bothered by Diarrhea | ||
FSIL-I Have Been Coughing | C184058 | FSIL-I Have Been Coughing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been coughing. | FACIT-Searchable Item Library Adult Version - I Have Been Coughing | ||
FSIL-I Have Been Emotionally Distressed | C183639 | FSIL-I Have Been Emotionally Distressed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been emotionally distressed. | FACIT-Searchable Item Library Adult Version - I Have Been Emotionally Distressed | ||
FSIL-I Have Been Short of Breath | C183656 | FSIL-I Have Been Short of Breath | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been short of breath. | FACIT-Searchable Item Library Adult Version - I Have Been Short of Breath | ||
FSIL-I Have Been Upset About Problems | C183831 | FSIL-I Have Been Upset About Problems | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been upset about these problems. | FACIT-Searchable Item Library Adult Version - I Have Been Upset About Problems | ||
FSIL-I Have Been Vomiting | C184131 | FSIL-I Have Been Vomiting | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been vomiting. | FACIT-Searchable Item Library Adult Version - I Have Been Vomiting | ||
FSIL-I Have Been Wheezing | C184028 | FSIL-I Have Been Wheezing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have been wheezing (whistling sound when I breathe). | FACIT-Searchable Item Library Adult Version - I Have Been Wheezing | ||
FSIL-I Have Bone Pain | C183692 | FSIL-I Have Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have bone pain. | FACIT-Searchable Item Library Adult Version - I Have Bone Pain | ||
FSIL-I Have Cold Sweats | C183932 | FSIL-I Have Cold Sweats | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cold sweats. | FACIT-Searchable Item Library Adult Version - I Have Cold Sweats | ||
FSIL-I Have Confidence in My Doctor(s) | C183983 | FSIL-I Have Confidence in My Doctor(s) | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my doctor(s). | FACIT-Searchable Item Library Adult Version - I Have Confidence in My Doctor(s) | ||
FSIL-I Have Confidence in My Pharmacist | C184219 | FSIL-I Have Confidence in My Pharmacist | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have confidence in my pharmacist(s). | FACIT-Searchable Item Library Adult Version - I Have Confidence in My Pharmacist | ||
FSIL-I Have Control of My Bowels | C183764 | FSIL-I Have Control of My Bowels | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have control of my bowels. | FACIT-Searchable Item Library Adult Version - I Have Control of My Bowels | ||
FSIL-I Have Cramping in My Pelvic Area | C183789 | FSIL-I Have Cramping in My Pelvic Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cramping in my pelvic area. | FACIT-Searchable Item Library Adult Version - I Have Cramping in My Pelvic Area | ||
FSIL-I Have Cramps in My Stomach Area | C184132 | FSIL-I Have Cramps in My Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have cramps in my stomach area. | FACIT-Searchable Item Library Adult Version - I Have Cramps in My Stomach Area | ||
FSIL-I Have Diarrhea | C183766 | FSIL-I Have Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - I Have Diarrhea | ||
FSIL-I Have Difficultly Raising My Arm | C184162 | FSIL-I Have Difficultly Raising My Arm | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficultly raising my arm. | FACIT-Searchable Item Library Adult Version - I Have Difficultly Raising My Arm | ||
FSIL-I Have Difficulty Breathing | C184165 | FSIL-I Have Difficulty Breathing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty breathing. | FACIT-Searchable Item Library Adult Version - I Have Difficulty Breathing | ||
FSIL-I Have Difficulty Thinking Clearly | C184087 | FSIL-I Have Difficulty Thinking Clearly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty thinking clearly (remembering, concentrating). | FACIT-Searchable Item Library Adult Version - I Have Difficulty Thinking Clearly | ||
FSIL-I Have Difficulty Urinating | C184139 | FSIL-I Have Difficulty Urinating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have difficulty urinating. | FACIT-Searchable Item Library Adult Version - I Have Difficulty Urinating | ||
FSIL-I Have Discomfort When I Am Sitting | C184288 | FSIL-I Have Discomfort When I Am Sitting | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort when I am sitting. | FACIT-Searchable Item Library Adult Version - I Have Discomfort When I Am Sitting | ||
FSIL-I Have Discomfort When I Urinate | C183881 | FSIL-I Have Discomfort When I Urinate | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have discomfort when I urinate. | FACIT-Searchable Item Library Adult Version - I Have Discomfort When I Urinate | ||
FSIL-I Have Emotional Ups and Downs | C183733 | FSIL-I Have Emotional Ups and Downs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have emotional ups and downs. | FACIT-Searchable Item Library Adult Version - I Have Emotional Ups and Downs | ||
FSIL-I Have Energy | C183651 | FSIL-I Have Energy | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have energy. | FACIT-Searchable Item Library Adult Version - I Have Energy | ||
FSIL-I Have Episodes of Heart Racing | C184032 | FSIL-I Have Episodes of Heart Racing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have episodes of heart racing. | FACIT-Searchable Item Library Adult Version - I Have Episodes of Heart Racing | ||
FSIL-I Have Frequent Colds/Infections | C183676 | FSIL-I Have Frequent Colds/Infections | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have frequent colds/infections. | FACIT-Searchable Item Library Adult Version - I Have Frequent Colds/Infections | ||
FSIL-I Have Gained Weight | C183928 | FSIL-I Have Gained Weight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have gained weight. | FACIT-Searchable Item Library Adult Version - I Have Gained Weight | ||
FSIL-I Have Had Blood in My Urine | C184160 | FSIL-I Have Had Blood in My Urine | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had blood in my urine. | FACIT-Searchable Item Library Adult Version - I Have Had Blood in My Urine | ||
FSIL-I Have Had Chills | C184000 | FSIL-I Have Had Chills | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had chills. | FACIT-Searchable Item Library Adult Version - I Have Had Chills | ||
FSIL-I Have Had Fevers | C183997 | FSIL-I Have Had Fevers | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had fevers (episodes of high body temperature). | FACIT-Searchable Item Library Adult Version - I Have Had Fevers | ||
FSIL-I Have Had Itching | C183998 | FSIL-I Have Had Itching | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had itching. | FACIT-Searchable Item Library Adult Version - I Have Had Itching | ||
FSIL-I Have Had Seizures | C183716 | FSIL-I Have Had Seizures | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had seizures (convulsions). | FACIT-Searchable Item Library Adult Version - I Have Had Seizures | ||
FSIL-I Have Had Trouble Concentrating | C183808 | FSIL-I Have Had Trouble Concentrating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble concentrating. | FACIT-Searchable Item Library Adult Version - I Have Had Trouble Concentrating | ||
FSIL-I Have Hot Flashes/Hot Flushes | C183927 | FSIL-I Have Hot Flashes/Hot Flushes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have hot flashes/hot flushes. | FACIT-Searchable Item Library Adult Version - I Have Hot Flashes/Hot Flushes | ||
FSIL-I Have Lost Interest in Sex | C183939 | FSIL-I Have Lost Interest in Sex | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have lost interest in sex. | FACIT-Searchable Item Library Adult Version - I Have Lost Interest in Sex | ||
FSIL-I Have Mood Swings | C183930 | FSIL-I Have Mood Swings | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have mood swings. | FACIT-Searchable Item Library Adult Version - I Have Mood Swings | ||
FSIL-I Have Mouth Sores | C184109 | FSIL-I Have Mouth Sores | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have mouth sores. | FACIT-Searchable Item Library Adult Version - I Have Mouth Sores | ||
FSIL-I Have Nausea | C183976 | FSIL-I Have Nausea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have nausea. | FACIT-Searchable Item Library Adult Version - I Have Nausea | ||
FSIL-I Have Night Sweats | C183933 | FSIL-I Have Night Sweats | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have night sweats. | FACIT-Searchable Item Library Adult Version - I Have Night Sweats | ||
FSIL-I Have Noticed Blood in My Stool | C184085 | FSIL-I Have Noticed Blood in My Stool | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have noticed blood in my stool. | FACIT-Searchable Item Library Adult Version - I Have Noticed Blood in My Stool | ||
FSIL-I Have Numbness in My Legs | C183800 | FSIL-I Have Numbness in My Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness in my legs. | FACIT-Searchable Item Library Adult Version - I Have Numbness in My Legs | ||
FSIL-I Have Pain in Arm and/or Shoulder | C184168 | FSIL-I Have Pain in Arm and/or Shoulder | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my arm and/or shoulder. | FACIT-Searchable Item Library Adult Version - I Have Pain in Arm and/or Shoulder | ||
FSIL-I Have Pain in My Back | C183801 | FSIL-I Have Pain in My Back | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my back. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Back | ||
FSIL-I Have Pain in My Breast | C184167 | FSIL-I Have Pain in My Breast | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my breast. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Breast | ||
FSIL-I Have Pain in My Chest | C183642 | FSIL-I Have Pain in My Chest | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my chest. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Chest | ||
FSIL-I Have Pain in My Fingertips | C184227 | FSIL-I Have Pain in My Fingertips | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my fingertips. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Fingertips | ||
FSIL-I Have Pain in My Joints | C183726 | FSIL-I Have Pain in My Joints | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my joints. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Joints | ||
FSIL-I Have Pain in My Pelvic Area | C183785 | FSIL-I Have Pain in My Pelvic Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my pelvic area. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Pelvic Area | ||
FSIL-I Have Pain in My Sinus Area | C184034 | FSIL-I Have Pain in My Sinus Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my sinus area. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Sinus Area | ||
FSIL-I Have Pain in My Stomach Area | C183630 | FSIL-I Have Pain in My Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my stomach area. | FACIT-Searchable Item Library Adult Version - I Have Pain in My Stomach Area | ||
FSIL-I Have Pain | C183978 | FSIL-I Have Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain. | FACIT-Searchable Item Library Adult Version - I Have Pain | ||
FSIL-I Have Peace of Mind | C184142 | FSIL-I Have Peace of Mind | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have peace of mind. | FACIT-Searchable Item Library Adult Version - I Have Peace of Mind | ||
FSIL-I Have Strength in My Arm(s) | C183798 | FSIL-I Have Strength in My Arm(s) | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have strength in my arm(s). | FACIT-Searchable Item Library Adult Version - I Have Strength in My Arm(s) | ||
FSIL-I Have Strength in My Legs | C183799 | FSIL-I Have Strength in My Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have strength in my legs. | FACIT-Searchable Item Library Adult Version - I Have Strength in My Legs | ||
FSIL-I Have Swelling at My Melanoma Site | C184074 | FSIL-I Have Swelling at My Melanoma Site | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling at my melanoma site. | FACIT-Searchable Item Library Adult Version - I Have Swelling at My Melanoma Site | ||
FSIL-I Have Swelling in Stomach Area | C184130 | FSIL-I Have Swelling in Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling in my stomach area. | FACIT-Searchable Item Library Adult Version - I Have Swelling in Stomach Area | ||
FSIL-I Have the Desire to Eat | C183906 | FSIL-I Have the Desire to Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have the desire to eat. | FACIT-Searchable Item Library Adult Version - I Have the Desire to Eat | ||
FSIL-I Have Tremors | C183679 | FSIL-I Have Tremors | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have tremors. | FACIT-Searchable Item Library Adult Version - I Have Tremors | ||
FSIL-I Have Trouble Bending | C184287 | FSIL-I Have Trouble Bending | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble bending. | FACIT-Searchable Item Library Adult Version - I Have Trouble Bending | ||
FSIL-I Have Trouble Breathing | C184019 | FSIL-I Have Trouble Breathing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble breathing. | FACIT-Searchable Item Library Adult Version - I Have Trouble Breathing | ||
FSIL-I Have Trouble Buttoning Buttons | C184128 | FSIL-I Have Trouble Buttoning Buttons | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble buttoning buttons. | FACIT-Searchable Item Library Adult Version - I Have Trouble Buttoning Buttons | ||
FSIL-I Have Trouble Concentrating | C184012 | FSIL-I Have Trouble Concentrating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble concentrating. | FACIT-Searchable Item Library Adult Version - I Have Trouble Concentrating | ||
FSIL-I Have Trouble Forming Thoughts | C183802 | FSIL-I Have Trouble Forming Thoughts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble forming thoughts. | FACIT-Searchable Item Library Adult Version - I Have Trouble Forming Thoughts | ||
FSIL-I Have Trouble Hearing | C184126 | FSIL-I Have Trouble Hearing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble hearing. | FACIT-Searchable Item Library Adult Version - I Have Trouble Hearing | ||
FSIL-I Have Trouble Learning New Tasks | C184092 | FSIL-I Have Trouble Learning New Tasks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble learning new tasks or directions. | FACIT-Searchable Item Library Adult Version - I Have Trouble Learning New Tasks | ||
FSIL-I Have Trouble Moving My Bowels | C184138 | FSIL-I Have Trouble Moving My Bowels | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble moving my bowels. | FACIT-Searchable Item Library Adult Version - I Have Trouble Moving My Bowels | ||
FSIL-I Have Trouble Remembering Things | C184013 | FSIL-I Have Trouble Remembering Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble remembering things. | FACIT-Searchable Item Library Adult Version - I Have Trouble Remembering Things | ||
FSIL-I Have Trouble Sleeping at Night | C184071 | FSIL-I Have Trouble Sleeping at Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble sleeping at night. | FACIT-Searchable Item Library Adult Version - I Have Trouble Sleeping at Night | ||
FSIL-I Have Trouble Smelling | C184116 | FSIL-I Have Trouble Smelling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble smelling. | FACIT-Searchable Item Library Adult Version - I Have Trouble Smelling | ||
FSIL-I Have Trouble Walking | C183652 | FSIL-I Have Trouble Walking | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking. | FACIT-Searchable Item Library Adult Version - I Have Trouble Walking | ||
FSIL-I Have Trouble With Coordination | C183718 | FSIL-I Have Trouble With Coordination | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with coordination. | FACIT-Searchable Item Library Adult Version - I Have Trouble With Coordination | ||
FSIL-I Have Trouble With My Bowels | C183681 | FSIL-I Have Trouble With My Bowels | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with my bowels. | FACIT-Searchable Item Library Adult Version - I Have Trouble With My Bowels | ||
FSIL-I Have Trouble With My Eyesight | C183722 | FSIL-I Have Trouble With My Eyesight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble with my eyesight. | FACIT-Searchable Item Library Adult Version - I Have Trouble With My Eyesight | ||
FSIL-I Have Vaginal Bleeding or Spotting | C183936 | FSIL-I Have Vaginal Bleeding or Spotting | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal bleeding or spotting. | FACIT-Searchable Item Library Adult Version - I Have Vaginal Bleeding or Spotting | ||
FSIL-I Have Vaginal Discharge | C183934 | FSIL-I Have Vaginal Discharge | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal discharge. | FACIT-Searchable Item Library Adult Version - I Have Vaginal Discharge | ||
FSIL-I Have Vaginal Dryness | C183937 | FSIL-I Have Vaginal Dryness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal dryness. | FACIT-Searchable Item Library Adult Version - I Have Vaginal Dryness | ||
FSIL-I Have Vaginal Itching/Irritation | C183935 | FSIL-I Have Vaginal Itching/Irritation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have vaginal itching/irritation. | FACIT-Searchable Item Library Adult Version - I Have Vaginal Itching/Irritation | ||
FSIL-I Have Weakness in My Legs | C184112 | FSIL-I Have Weakness in My Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have weakness in my legs. | FACIT-Searchable Item Library Adult Version - I Have Weakness in My Legs | ||
FSIL-I Like the Appearance of My Body | C183768 | FSIL-I Like the Appearance of My Body | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I like the appearance of my body. | FACIT-Searchable Item Library Adult Version - I Like the Appearance of My Body | ||
FSIL-I Maintain Contact With My Friends | C184141 | FSIL-I Maintain Contact With My Friends | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I maintain contact with my friends. | FACIT-Searchable Item Library Adult Version - I Maintain Contact With My Friends | ||
FSIL-I Make Each Day Count | C184153 | FSIL-I Make Each Day Count | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I make each day count. | FACIT-Searchable Item Library Adult Version - I Make Each Day Count | ||
FSIL-I Need Help in Caring for Myself | C183710 | FSIL-I Need Help in Caring for Myself | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help in caring for myself (bathing, dressing, eating, etc.). | FACIT-Searchable Item Library Adult Version - I Need Help in Caring for Myself | ||
FSIL-I Need to Rest During the Day | C184090 | FSIL-I Need to Rest During the Day | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need to rest during the day. | FACIT-Searchable Item Library Adult Version - I Need to Rest During the Day | ||
FSIL-I Need to Sleep During the Day | C183654 | FSIL-I Need to Sleep During the Day | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need to sleep during the day. | FACIT-Searchable Item Library Adult Version - I Need to Sleep During the Day | ||
FSIL-I Regret Bone Marrow Transplant | C183691 | FSIL-I Regret Bone Marrow Transplant | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I regret having the bone marrow transplant. | FACIT-Searchable Item Library Adult Version - I Regret Bone Marrow Transplant | ||
FSIL-I Regret My Smoking | C184061 | FSIL-I Regret My Smoking | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I regret my smoking. | FACIT-Searchable Item Library Adult Version - I Regret My Smoking | ||
FSIL-I Seem to Get Full Quickly | C183629 | FSIL-I Seem to Get Full Quickly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: When I eat, I seem to get full quickly. | FACIT-Searchable Item Library Adult Version - I Seem to Get Full Quickly | ||
FSIL-I Urinate More Frequently | C183670 | FSIL-I Urinate More Frequently | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I urinate more frequently than usual. | FACIT-Searchable Item Library Adult Version - I Urinate More Frequently | ||
FSIL-I Worry About Dying | C183966 | FSIL-I Worry About Dying | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about dying. | FACIT-Searchable Item Library Adult Version - I Worry About Dying | ||
FSIL-I Worry About Getting Infections | C184107 | FSIL-I Worry About Getting Infections | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting infections. | FACIT-Searchable Item Library Adult Version - I Worry About Getting Infections | ||
FSIL-I Worry Bone Pain Will Get Worse | C183695 | FSIL-I Worry Bone Pain Will Get Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my bone pain will get worse. | FACIT-Searchable Item Library Adult Version - I Worry Bone Pain Will Get Worse | ||
FSIL-I Worry Transplant Will Not Work | C183685 | FSIL-I Worry Transplant Will Not Work | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that the transplant will not work. | FACIT-Searchable Item Library Adult Version - I Worry Transplant Will Not Work | ||
FSIL-Illness a Financial Hardship | C183943 | FSIL-Illness a Financial Hardship | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness has been a financial hardship to my family and me. | FACIT-Searchable Item Library Adult Version - Illness a Financial Hardship | ||
FSIL-Illness Caused Problems w/ Sex Life | C183994 | FSIL-Illness Caused Problems w/ Sex Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness or treatment has caused problems with my sex life. | FACIT-Searchable Item Library Adult Version - Illness Caused Problems w/ Sex Life | ||
FSIL-Illness Is Hardship for My Family | C183682 | FSIL-Illness Is Hardship for My Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness is a personal hardship for my close family members. | FACIT-Searchable Item Library Adult Version - Illness Is Hardship for My Family | ||
FSIL-Illness Strengthen Faith/Spiritual | C184177 | FSIL-Illness Strengthen Faith/Spiritual | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My illness has strengthened my faith or spiritual beliefs. | FACIT-Searchable Item Library Adult Version - Illness Strengthen Faith/Spiritual | ||
FSIL-In control of Financial Situation | C183942 | FSIL-In control of Financial Situation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel in control of my financial situation. | FACIT-Searchable Item Library Adult Version - In control of Financial Situation | ||
FSIL-Inconvenienced Platelet Transfusion | C184243 | FSIL-Inconvenienced Platelet Transfusion | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am inconvenienced by platelet transfusions. | FACIT-Searchable Item Library Adult Version - Inconvenienced Platelet Transfusion | ||
FSIL-Inconvenient to Come for Radiation | C184161 | FSIL-Inconvenient to Come for Radiation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It is inconvenient for me to come for my radiation treatments. | FACIT-Searchable Item Library Adult Version - Inconvenient to Come for Radiation | ||
FSIL-Infusion Causes Me Physical Pain | C183742 | FSIL-Infusion Causes Me Physical Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The infusion for my bone treatment causes me physical pain. | FACIT-Searchable Item Library Adult Version - Infusion Causes Me Physical Pain | ||
FSIL-Interest in Food Drops Try to Eat | C183635 | FSIL-Interest in Food Drops Try to Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My interest in food drops as soon as I try to eat. | FACIT-Searchable Item Library Adult Version - Interest in Food Drops Try to Eat | ||
FSIL-Interested in Sex | C183672 | FSIL-Interested in Sex | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am interested in sex. | FACIT-Searchable Item Library Adult Version - Interested in Sex | ||
FSIL-Irritable | C183931 | FSIL-Irritable | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am irritable. | FACIT-Searchable Item Library Adult Version - Irritable | ||
FSIL-Isolate From Others B/c Condition | C184086 | FSIL-Isolate From Others B/c Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I isolate myself from others because of my condition. | FACIT-Searchable Item Library Adult Version - Isolate From Others B/c Condition | ||
FSIL-It Burns When I Urinate | C183671 | FSIL-It Burns When I Urinate | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: It burns when I urinate. | FACIT-Searchable Item Library Adult Version - It Burns When I Urinate | ||
FSIL-Joint Pain Limits My Usual Activ | C184031 | FSIL-Joint Pain Limits My Usual Activ | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Joint pain limits my usual activities. | FACIT-Searchable Item Library Adult Version - Joint Pain Limits My Usual Activ | ||
FSIL-Joint Stiffness/Tight Limits Activ | C184030 | FSIL-Joint Stiffness/Tight Limits Activ | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Joint stiffness or tightness limits my usual activities. | FACIT-Searchable Item Library Adult Version - Joint Stiffness/Tight Limits Activ | ||
FSIL-Left Out When Others Are Eating | C183914 | FSIL-Left Out When Others Are Eating | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel left out when others are eating. | FACIT-Searchable Item Library Adult Version - Left Out When Others Are Eating | ||
FSIL-Lifting 10-20 Lbs | C183895 | FSIL-Lifting 10-20 Lbs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Lifting something weighing 10-20 lbs (about 4.5-9kg, like a large bag of groceries). | FACIT-Searchable Item Library Adult Version - Lifting 10-20 Lbs | ||
FSIL-Limit Activities Because Diarrhea | C183626 | FSIL-Limit Activities Because Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my activities because of diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Limit Activities Because Diarrhea | ||
FSIL-Limit My Sexual Activity Infection | C183790 | FSIL-Limit My Sexual Activity Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of the infection. | FACIT-Searchable Item Library Adult Version - Limit My Sexual Activity Infection | ||
FSIL-Limit My Social Activity | C184050 | FSIL-Limit My Social Activity | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because of my condition. | FACIT-Searchable Item Library Adult Version - Limit My Social Activity | ||
FSIL-Limit Physical Activ B/c Condition | C184051 | FSIL-Limit Physical Activ B/c Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my physical activity because of my condition. | FACIT-Searchable Item Library Adult Version - Limit Physical Activ B/c Condition | ||
FSIL-Limit Physical Activ B/c Diarrhea | C183883 | FSIL-Limit Physical Activ B/c Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my physical activity because of diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Limit Physical Activ B/c Diarrhea | ||
FSIL-Limit Sexual Activ B/c Condition | C184052 | FSIL-Limit Sexual Activ B/c Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of my condition. | FACIT-Searchable Item Library Adult Version - Limit Sexual Activ B/c Condition | ||
FSIL-Limit Sexual Activity B/c Diarrhea | C183884 | FSIL-Limit Sexual Activity B/c Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my sexual activity because of diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Limit Sexual Activity B/c Diarrhea | ||
FSIL-Limit Social Activity B/c Diarrhea | C183882 | FSIL-Limit Social Activity B/c Diarrhea | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because of diarrhea (diarrhoea). | FACIT-Searchable Item Library Adult Version - Limit Social Activity B/c Diarrhea | ||
FSIL-Limit Social Activity B/c Tired | C183647 | FSIL-Limit Social Activity B/c Tired | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to limit my social activity because I am tired. | FACIT-Searchable Item Library Adult Version - Limit Social Activity B/c Tired | ||
FSIL-Losing Hope Fight Against Illness | C183964 | FSIL-Losing Hope Fight Against Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am losing hope in the fight against my illness. | FACIT-Searchable Item Library Adult Version - Losing Hope Fight Against Illness | ||
FSIL-Losing Weight | C183763 | FSIL-Losing Weight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am losing weight. | FACIT-Searchable Item Library Adult Version - Losing Weight | ||
FSIL-Lost Food Choices Feeding Tube | C183912 | FSIL-Lost Food Choices Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I have lost control of my food choices because I have a feeding tube. | FACIT-Searchable Item Library Adult Version - Lost Food Choices Feeding Tube | ||
FSIL-Low Blood Counts Interfere Relation | C184111 | FSIL-Low Blood Counts Interfere Relation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My low blood counts interfere with my intimate relationships. | FACIT-Searchable Item Library Adult Version - Low Blood Counts Interfere Relation | ||
FSIL-Make Decisions Take Responsibility | C183707 | FSIL-Make Decisions Take Responsibility | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to make decisions and take responsibility. | FACIT-Searchable Item Library Adult Version - Make Decisions Take Responsibility | ||
FSIL-Making a Bed | C183894 | FSIL-Making a Bed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Making a bed. | FACIT-Searchable Item Library Adult Version - Making a Bed | ||
FSIL-Medical Expense More Than I Thought | C183944 | FSIL-Medical Expense More Than I Thought | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My out-of-pocket medical expenses are more than I thought they would be. | FACIT-Searchable Item Library Adult Version - Medical Expense More Than I Thought | ||
FSIL-Memory Is as Good as Always Been | C183824 | FSIL-Memory Is as Good as Always Been | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My memory is as good as it has always been. | FACIT-Searchable Item Library Adult Version - Memory Is as Good as Always Been | ||
FSIL-Mind Is as Sharp as Always Been | C183823 | FSIL-Mind Is as Sharp as Always Been | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mind is as sharp as it has always been. | FACIT-Searchable Item Library Adult Version - Mind Is as Sharp as Always Been | ||
FSIL-Miss Food/Drink Mouth Feeding Tube | C183924 | FSIL-Miss Food/Drink Mouth Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I miss being able to take more food or drink by mouth now that I have a feeding tube. | FACIT-Searchable Item Library Adult Version - Miss Food/Drink Mouth Feeding Tube | ||
FSIL-Most Food Tastes Unpleasant to Me | C183633 | FSIL-Most Food Tastes Unpleasant to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Most food tastes unpleasant to me. | FACIT-Searchable Item Library Adult Version - Most Food Tastes Unpleasant to Me | ||
FSIL-Motivated to Do Activities | C183644 | FSIL-Motivated to Do Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am motivated to do my usual activities. | FACIT-Searchable Item Library Adult Version - Motivated to Do Activities | ||
FSIL-Move Bowels Freq to Avoid Accidents | C184045 | FSIL-Move Bowels Freq to Avoid Accidents | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I must move my bowels frequently to avoid accidents. | FACIT-Searchable Item Library Adult Version - Move Bowels Freq to Avoid Accidents | ||
FSIL-Move My Bowels More Than Usual | C184043 | FSIL-Move My Bowels More Than Usual | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I move my bowels more frequently than usual. | FACIT-Searchable Item Library Adult Version - Move My Bowels More Than Usual | ||
FSIL-Movement of Arm This Side Painful | C183657 | FSIL-Movement of Arm This Side Painful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Movement of my arm on this side is painful. | FACIT-Searchable Item Library Adult Version - Movement of Arm This Side Painful | ||
FSIL-Movement of Swollen Area Is Painful | C184077 | FSIL-Movement of Swollen Area Is Painful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Movement of my swollen area is painful. | FACIT-Searchable Item Library Adult Version - Movement of Swollen Area Is Painful | ||
FSIL-My Arm on This Side Feels Numb | C183659 | FSIL-My Arm on This Side Feels Numb | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My arm on this side feels numb. | FACIT-Searchable Item Library Adult Version - My Arm on This Side Feels Numb | ||
FSIL-My Breast Is Sensitive/Tender | C184171 | FSIL-My Breast Is Sensitive/Tender | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breast is sensitive/tender. | FACIT-Searchable Item Library Adult Version - My Breast Is Sensitive/Tender | ||
FSIL-My Breasts Are Painful | C183773 | FSIL-My Breasts Are Painful | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breasts are painful. | FACIT-Searchable Item Library Adult Version - My Breasts Are Painful | ||
FSIL-My Breasts Are Swollen | C183772 | FSIL-My Breasts Are Swollen | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My breasts are swollen. | FACIT-Searchable Item Library Adult Version - My Breasts Are Swollen | ||
FSIL-My Chest Area Is Sore | C184169 | FSIL-My Chest Area Is Sore | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My chest area (not including the breast itself) is sore. | FACIT-Searchable Item Library Adult Version - My Chest Area Is Sore | ||
FSIL-My Condition Wakes Me Up at Night | C184054 | FSIL-My Condition Wakes Me Up at Night | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My condition wakes me up at night. | FACIT-Searchable Item Library Adult Version - My Condition Wakes Me Up at Night | ||
FSIL-My Eyes Are Dry | C184202 | FSIL-My Eyes Are Dry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyes are dry. | FACIT-Searchable Item Library Adult Version - My Eyes Are Dry | ||
FSIL-My Eyes Feel Sandy or Gritty | C184033 | FSIL-My Eyes Feel Sandy or Gritty | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyes feel sandy or gritty. | FACIT-Searchable Item Library Adult Version - My Eyes Feel Sandy or Gritty | ||
FSIL-My Eyesight Is Blurry | C183677 | FSIL-My Eyesight Is Blurry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My eyesight is blurry. | FACIT-Searchable Item Library Adult Version - My Eyesight Is Blurry | ||
FSIL-My Family Has Accepted My Illness | C183988 | FSIL-My Family Has Accepted My Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family has accepted my illness. | FACIT-Searchable Item Library Adult Version - My Family Has Accepted My Illness | ||
FSIL-My Family Pressuring Me to Eat | C183637 | FSIL-My Family Pressuring Me to Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My family or friends are pressuring me to eat. | FACIT-Searchable Item Library Adult Version - My Family Pressuring Me to Eat | ||
FSIL-My General Health Is Improving | C183631 | FSIL-My General Health Is Improving | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My general health is improving. | FACIT-Searchable Item Library Adult Version - My General Health Is Improving | ||
FSIL-My Hands Are Swollen | C184225 | FSIL-My Hands Are Swollen | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My hands are swollen. | FACIT-Searchable Item Library Adult Version - My Hands Are Swollen | ||
FSIL-My Legs or Feet Are Swollen | C184226 | FSIL-My Legs or Feet Are Swollen | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My legs or feet are swollen. | FACIT-Searchable Item Library Adult Version - My Legs or Feet Are Swollen | ||
FSIL-My Life Has Been Productive | C184191 | FSIL-My Life Has Been Productive | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My life has been productive. | FACIT-Searchable Item Library Adult Version - My Life Has Been Productive | ||
FSIL-My Life Lacks Meaning and Purpose | C184196 | FSIL-My Life Lacks Meaning and Purpose | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My life lacks meaning and purpose. | FACIT-Searchable Item Library Adult Version - My Life Lacks Meaning and Purpose | ||
FSIL-My Mouth and Throat Are Dry | C184151 | FSIL-My Mouth and Throat Are Dry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mouth and throat are dry. | FACIT-Searchable Item Library Adult Version - My Mouth and Throat Are Dry | ||
FSIL-My Mouth Is Dry | C184018 | FSIL-My Mouth Is Dry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My mouth is dry. | FACIT-Searchable Item Library Adult Version - My Mouth Is Dry | ||
FSIL-My Skin Bleeds Easily | C184215 | FSIL-My Skin Bleeds Easily | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin bleeds easily. | FACIT-Searchable Item Library Adult Version - My Skin Bleeds Easily | ||
FSIL-My Skin Condition Affects My Mood | C184204 | FSIL-My Skin Condition Affects My Mood | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition affects my mood. | FACIT-Searchable Item Library Adult Version - My Skin Condition Affects My Mood | ||
FSIL-My Skin Feels Irritated | C183870 | FSIL-My Skin Feels Irritated | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin feels irritated. | FACIT-Searchable Item Library Adult Version - My Skin Feels Irritated | ||
FSIL-My Skin Itches | C183858 | FSIL-My Skin Itches | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin itches. | FACIT-Searchable Item Library Adult Version - My Skin Itches | ||
FSIL-My Skin or Scalp Feels Irritated | C184212 | FSIL-My Skin or Scalp Feels Irritated | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp feels irritated. | FACIT-Searchable Item Library Adult Version - My Skin or Scalp Feels Irritated | ||
FSIL-My Skin or Scalp Is Dry or Flaky | C184213 | FSIL-My Skin or Scalp Is Dry or Flaky | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp is dry or "flaky". | FACIT-Searchable Item Library Adult Version - My Skin or Scalp Is Dry or Flaky | ||
FSIL-My Skin or Scalp Itches | C184214 | FSIL-My Skin or Scalp Itches | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin or scalp itches. | FACIT-Searchable Item Library Adult Version - My Skin or Scalp Itches | ||
FSIL-My Thinking Has Been Slow | C183803 | FSIL-My Thinking Has Been Slow | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking has been slow. | FACIT-Searchable Item Library Adult Version - My Thinking Has Been Slow | ||
FSIL-My Thinking Is Clear | C184057 | FSIL-My Thinking Is Clear | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking is clear. | FACIT-Searchable Item Library Adult Version - My Thinking Is Clear | ||
FSIL-My Thinking Is Slower Than Before | C184091 | FSIL-My Thinking Is Slower Than Before | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking is slower than before. | FACIT-Searchable Item Library Adult Version - My Thinking Is Slower Than Before | ||
FSIL-My Thinking Slower Than Usual | C183805 | FSIL-My Thinking Slower Than Usual | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My thinking has been slower than usual. | FACIT-Searchable Item Library Adult Version - My Thinking Slower Than Usual | ||
FSIL-My Underarm Area Sensitive/Tender | C184172 | FSIL-My Underarm Area Sensitive/Tender | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My underarm area is sensitive/tender. | FACIT-Searchable Item Library Adult Version - My Underarm Area Sensitive/Tender | ||
FSIL-My Work Is Fulfilling | C183969 | FSIL-My Work Is Fulfilling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My work (include work at home) is fulfilling. | FACIT-Searchable Item Library Adult Version - My Work Is Fulfilling | ||
FSIL-Need Help Doing Activ B/c Bone Pain | C183699 | FSIL-Need Help Doing Activ B/c Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help doing my usual activities because of bone pain. | FACIT-Searchable Item Library Adult Version - Need Help Doing Activ B/c Bone Pain | ||
FSIL-Need Help Doing Usual Activities | C183645 | FSIL-Need Help Doing Usual Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I need help doing my usual activities. | FACIT-Searchable Item Library Adult Version - Need Help Doing Usual Activities | ||
FSIL-Nervous Making Decisions Treatment | C184072 | FSIL-Nervous Making Decisions Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I get nervous about making decisions regarding treatment. | FACIT-Searchable Item Library Adult Version - Nervous Making Decisions Treatment | ||
FSIL-No Choice Money Spend on Care | C183946 | FSIL-No Choice Money Spend on Care | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel I have no choice about the amount of money I spend on care. | FACIT-Searchable Item Library Adult Version - No Choice Money Spend on Care | ||
FSIL-Noticed New Changes in My Skin | C184082 | FSIL-Noticed New Changes in My Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have noticed new changes in my skin (lumps, bumps, color (colour)). | FACIT-Searchable Item Library Adult Version - Noticed New Changes in My Skin | ||
FSIL-Numbness or Tingling in My Feet | C184122 | FSIL-Numbness or Tingling in My Feet | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my feet. | FACIT-Searchable Item Library Adult Version - Numbness or Tingling in My Feet | ||
FSIL-Numbness or Tingling in My Hands | C184119 | FSIL-Numbness or Tingling in My Hands | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my hands. | FACIT-Searchable Item Library Adult Version - Numbness or Tingling in My Hands | ||
FSIL-Numbness/Tingling in Arm/Shoulder | C184164 | FSIL-Numbness/Tingling in Arm/Shoulder | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have numbness or tingling in my arm, shoulder, or breast. | FACIT-Searchable Item Library Adult Version - Numbness/Tingling in Arm/Shoulder | ||
FSIL-Nurse Explanations You Understand | C184265 | FSIL-Nurse Explanations You Understand | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) give explanations that you could understand? | FACIT-Searchable Item Library Adult Version - Nurse Explanations You Understand | ||
FSIL-Nurse Seem to Understand Your Needs | C184267 | FSIL-Nurse Seem to Understand Your Needs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) seem to understand your needs? | FACIT-Searchable Item Library Adult Version - Nurse Seem to Understand Your Needs | ||
FSIL-Nurse Show Genuine Concern for You | C184266 | FSIL-Nurse Show Genuine Concern for You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did your nurse(s) show genuine concern for you? | FACIT-Searchable Item Library Adult Version - Nurse Show Genuine Concern for You | ||
FSIL-One/Both Arms Are Swollen/Tender | C183662 | FSIL-One/Both Arms Are Swollen/Tender | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: One or both of my arms are swollen or tender. | FACIT-Searchable Item Library Adult Version - One/Both Arms Are Swollen/Tender | ||
FSIL-Pain at My Melanoma/Surgical Site | C184073 | FSIL-Pain at My Melanoma/Surgical Site | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain at my melanoma site or surgical site. | FACIT-Searchable Item Library Adult Version - Pain at My Melanoma/Surgical Site | ||
FSIL-Pain in Hands/Feet Exposed to Cold | C184120 | FSIL-Pain in Hands/Feet Exposed to Cold | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my hands or feet when I am exposed to cold temperatures. | FACIT-Searchable Item Library Adult Version - Pain in Hands/Feet Exposed to Cold | ||
FSIL-Pain in My Chest When I Swallow | C183901 | FSIL-Pain in My Chest When I Swallow | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my chest when I swallow. | FACIT-Searchable Item Library Adult Version - Pain in My Chest When I Swallow | ||
FSIL-Pain in My Mouth, Throat or Neck | C184017 | FSIL-Pain in My Mouth, Throat or Neck | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have pain in my mouth, throat or neck. | FACIT-Searchable Item Library Adult Version - Pain in My Mouth, Throat or Neck | ||
FSIL-Pain Keeps Me From Doing Things | C184135 | FSIL-Pain Keeps Me From Doing Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pain keeps me from doing things I want to do. | FACIT-Searchable Item Library Adult Version - Pain Keeps Me From Doing Things | ||
FSIL-Pain on My Feet Interferes Walking | C183625 | FSIL-Pain on My Feet Interferes Walking | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Pain on the bottom of my feet interferes with my walking. | FACIT-Searchable Item Library Adult Version - Pain on My Feet Interferes Walking | ||
FSIL-Pain/Soreness/Aches in Some Muscles | C184037 | FSIL-Pain/Soreness/Aches in Some Muscles | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel pain, soreness or aches in some of my muscles. | FACIT-Searchable Item Library Adult Version - Pain/Soreness/Aches in Some Muscles | ||
FSIL-Painful Cracks Skin on Hands/Feet | C183869 | FSIL-Painful Cracks Skin on Hands/Feet | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have painful cracks in the skin on my hands or feet. | FACIT-Searchable Item Library Adult Version - Painful Cracks Skin on Hands/Feet | ||
FSIL-Painful Lesions/Tumors on My Skin | C183866 | FSIL-Painful Lesions/Tumors on My Skin | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have painful lesions or tumors on my skin. | FACIT-Searchable Item Library Adult Version - Painful Lesions/Tumors on My Skin | ||
FSIL-Participate Decisions Health Care | C184261 | FSIL-Participate Decisions Health Care | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Were you encouraged to participate in decisions about your health care? | FACIT-Searchable Item Library Adult Version - Participate Decisions Health Care | ||
FSIL-Partner Worries My Blood Counts Low | C184110 | FSIL-Partner Worries My Blood Counts Low | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My partner worries about me when my blood counts are low. | FACIT-Searchable Item Library Adult Version - Partner Worries My Blood Counts Low | ||
FSIL-People Told Me I Seemed Confused | C183821 | FSIL-People Told Me I Seemed Confused | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed confused. | FACIT-Searchable Item Library Adult Version - People Told Me I Seemed Confused | ||
FSIL-Pharmacist Advises Adverse Effects | C184218 | FSIL-Pharmacist Advises Adverse Effects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist advises me on the adverse (side) effects of my medicines. | FACIT-Searchable Item Library Adult Version - Pharmacist Advises Adverse Effects | ||
FSIL-Pharmacist Advises Use of Medicines | C184217 | FSIL-Pharmacist Advises Use of Medicines | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist advises me on the proper use of my medicines. | FACIT-Searchable Item Library Adult Version - Pharmacist Advises Use of Medicines | ||
FSIL-Pharmacist Available Questions | C184220 | FSIL-Pharmacist Available Questions | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist is available to answer my questions. | FACIT-Searchable Item Library Adult Version - Pharmacist Available Questions | ||
FSIL-Pharmacist Aware Treatment Needs | C184222 | FSIL-Pharmacist Aware Treatment Needs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist is aware of my treatment-related needs. | FACIT-Searchable Item Library Adult Version - Pharmacist Aware Treatment Needs | ||
FSIL-Pharmacist Responds Treatment Needs | C184223 | FSIL-Pharmacist Responds Treatment Needs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My pharmacist responds to my treatment-related needs. | FACIT-Searchable Item Library Adult Version - Pharmacist Responds Treatment Needs | ||
FSIL-Pleasant Feel Fullness Tube Feeding | C183905 | FSIL-Pleasant Feel Fullness Tube Feeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I experience a pleasant feeling of fullness during or after my tube feeding. | FACIT-Searchable Item Library Adult Version - Pleasant Feel Fullness Tube Feeding | ||
FSIL-Poor Range Arm Movements This Side | C183658 | FSIL-Poor Range Arm Movements This Side | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have a poor range of arm movements on this side. | FACIT-Searchable Item Library Adult Version - Poor Range Arm Movements This Side | ||
FSIL-Preparing Meals | C183891 | FSIL-Preparing Meals | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Preparing meals. | FACIT-Searchable Item Library Adult Version - Preparing Meals | ||
FSIL-Problem Urinating Limits Activity | C184140 | FSIL-Problem Urinating Limits Activity | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My problems with urinating limit my activities. | FACIT-Searchable Item Library Adult Version - Problem Urinating Limits Activity | ||
FSIL-Problems Interfered Ability Enjoy | C183833 | FSIL-Problems Interfered Ability Enjoy | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with my ability to do things I enjoy. | FACIT-Searchable Item Library Adult Version - Problems Interfered Ability Enjoy | ||
FSIL-Problems Interfered Ability Work | C183832 | FSIL-Problems Interfered Ability Work | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with my ability to work. | FACIT-Searchable Item Library Adult Version - Problems Interfered Ability Work | ||
FSIL-Problems Interfered Quality Life | C183834 | FSIL-Problems Interfered Quality Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: These problems have interfered with the quality of my life. | FACIT-Searchable Item Library Adult Version - Problems Interfered Quality Life | ||
FSIL-Rate the Care You Received | C184275 | FSIL-Rate the Care You Received | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How do you rate the care you received? | FACIT-Searchable Item Library Adult Version - Rate the Care You Received | ||
FSIL-Rate This Chemo | C183843 | FSIL-Rate This Chemo | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How would you rate this chemotherapy? | FACIT-Searchable Item Library Adult Version - Rate This Chemo | ||
FSIL-Rate This Treatment Overall | C184279 | FSIL-Rate This Treatment Overall | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: How do you rate this treatment overall? | FACIT-Searchable Item Library Adult Version - Rate This Treatment Overall | ||
FSIL-Reach Into Myself for Comfort | C184194 | FSIL-Reach Into Myself for Comfort | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am able to reach down deep into myself for comfort. | FACIT-Searchable Item Library Adult Version - Reach Into Myself for Comfort | ||
FSIL-Reaction Everyday Situations Slow | C183812 | FSIL-Reaction Everyday Situations Slow | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My reactions in everyday situations have been slow. | FACIT-Searchable Item Library Adult Version - Reaction Everyday Situations Slow | ||
FSIL-Received Treatment Right for You | C184274 | FSIL-Received Treatment Right for You | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Do you feel you received the treatment that was right for you? | FACIT-Searchable Item Library Adult Version - Received Treatment Right for You | ||
FSIL-Received Treatment That Was Right | C183792 | FSIL-Received Treatment That Was Right | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel that I received the treatment that was right for me. | FACIT-Searchable Item Library Adult Version - Received Treatment That Was Right | ||
FSIL-Receiving Chemo Inconvenient | C183847 | FSIL-Receiving Chemo Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Receiving chemotherapy is inconvenient. | FACIT-Searchable Item Library Adult Version - Receiving Chemo Inconvenient | ||
FSIL-Receiving Treatment Is Inconvenient | C183744 | FSIL-Receiving Treatment Is Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Receiving treatment for bone disease is inconvenient. | FACIT-Searchable Item Library Adult Version - Receiving Treatment Is Inconvenient | ||
FSIL-Recommend Chemo to Others | C183841 | FSIL-Recommend Chemo to Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this chemotherapy to others with your illness? | FACIT-Searchable Item Library Adult Version - Recommend Chemo to Others | ||
FSIL-Recommend Clinic/Office to Others | C184272 | FSIL-Recommend Clinic/Office to Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this clinic or office to others? | FACIT-Searchable Item Library Adult Version - Recommend Clinic/Office to Others | ||
FSIL-Recommend This Treatment to Others | C184277 | FSIL-Recommend This Treatment to Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this treatment to others with your illness? | FACIT-Searchable Item Library Adult Version - Recommend This Treatment to Others | ||
FSIL-Reduced Satisfaction Financial | C183941 | FSIL-Reduced Satisfaction Financial | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My cancer or treatment has reduced my satisfaction with my present financial situation. | FACIT-Searchable Item Library Adult Version - Reduced Satisfaction Financial | ||
FSIL-Rest During Day B/c of Bone Pain | C183700 | FSIL-Rest During Day B/c of Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am forced to rest during the day because of bone pain. | FACIT-Searchable Item Library Adult Version - Rest During Day B/c of Bone Pain | ||
FSIL-Satisfied Communication Illness | C183989 | FSIL-Satisfied Communication Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with family communication about my illness. | FACIT-Searchable Item Library Adult Version - Satisfied Communication Illness | ||
FSIL-Satisfied With Comfort Level | C184136 | FSIL-Satisfied With Comfort Level | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my present comfort level. | FACIT-Searchable Item Library Adult Version - Satisfied With Comfort Level | ||
FSIL-Satisfied With Effects of Treatment | C184276 | FSIL-Satisfied With Effects of Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the effects of this treatment so far? | FACIT-Searchable Item Library Adult Version - Satisfied With Effects of Treatment | ||
FSIL-Satisfied With Financial Situation | C183948 | FSIL-Satisfied With Financial Situation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my current financial situation. | FACIT-Searchable Item Library Adult Version - Satisfied With Financial Situation | ||
FSIL-Satisfied With How I Am Coping | C183963 | FSIL-Satisfied With How I Am Coping | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with how I am coping with my illness. | FACIT-Searchable Item Library Adult Version - Satisfied With How I Am Coping | ||
FSIL-Satisfied With My Sex Life | C183991 | FSIL-Satisfied With My Sex Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my sex life. | FACIT-Searchable Item Library Adult Version - Satisfied With My Sex Life | ||
FSIL-Satisfied With Results Chemo | C183840 | FSIL-Satisfied With Results Chemo | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the current results of your chemotherapy? | FACIT-Searchable Item Library Adult Version - Satisfied With Results Chemo | ||
FSIL-Satisfied With Results of Treatment | C183736 | FSIL-Satisfied With Results of Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Are you satisfied with the results of the treatment for your bone disease so far? | FACIT-Searchable Item Library Adult Version - Satisfied With Results of Treatment | ||
FSIL-Satisfied With Urinary Condition | C184290 | FSIL-Satisfied With Urinary Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am satisfied with my urinary condition. | FACIT-Searchable Item Library Adult Version - Satisfied With Urinary Condition | ||
FSIL-Self-conscious About Way I Dress | C183661 | FSIL-Self-conscious About Way I Dress | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am self-conscious about the way I dress. | FACIT-Searchable Item Library Adult Version - Self-conscious About Way I Dress | ||
FSIL-Sensitivity Fingernails Diff Tasks | C184207 | FSIL-Sensitivity Fingernails Diff Tasks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Sensitivity around my fingernails makes it difficult to perform household tasks. | FACIT-Searchable Item Library Adult Version - Sensitivity Fingernails Diff Tasks | ||
FSIL-Side Effects of Treatment So Far | C184254 | FSIL-Side Effects of Treatment So Far | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Compared to what you expected, how do you rate the side effects of treatment so far? | FACIT-Searchable Item Library Adult Version - Side Effects of Treatment So Far | ||
FSIL-Side Effects of Treatment Worse | C183686 | FSIL-Side Effects of Treatment Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The side effects of treatment are worse than I had imagined. | FACIT-Searchable Item Library Adult Version - Side Effects of Treatment Worse | ||
FSIL-Skin Cond Interferes w/ Social Life | C184203 | FSIL-Skin Cond Interferes w/ Social Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition interferes with my social life. | FACIT-Searchable Item Library Adult Version - Skin Cond Interferes w/ Social Life | ||
FSIL-Skin Condition Interferes w/ Sleep | C184208 | FSIL-Skin Condition Interferes w/ Sleep | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin condition interferes with my ability to sleep. | FACIT-Searchable Item Library Adult Version - Skin Condition Interferes w/ Sleep | ||
FSIL-Skin Condition Make Life Difficult | C184209 | FSIL-Skin Condition Make Life Difficult | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Changes in my skin condition make daily life difficult. | FACIT-Searchable Item Library Adult Version - Skin Condition Make Life Difficult | ||
FSIL-Skin Feels Sensitive or Raw | C183868 | FSIL-Skin Feels Sensitive or Raw | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin feels sensitive or "raw". | FACIT-Searchable Item Library Adult Version - Skin Feels Sensitive or Raw | ||
FSIL-Skin in Breast Area Itchy/Flaky/Dry | C184173 | FSIL-Skin in Breast Area Itchy/Flaky/Dry | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin in my breast area is itchy, flaky or dry. | FACIT-Searchable Item Library Adult Version - Skin in Breast Area Itchy/Flaky/Dry | ||
FSIL-Skin Is Dry or Flaky | C183874 | FSIL-Skin Is Dry or Flaky | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My skin is dry or "flaky". | FACIT-Searchable Item Library Adult Version - Skin Is Dry or Flaky | ||
FSIL-Skin Side Effects Interfered Tasks | C184211 | FSIL-Skin Side Effects Interfered Tasks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin side effects from treatment have interfered with household tasks. | FACIT-Searchable Item Library Adult Version - Skin Side Effects Interfered Tasks | ||
FSIL-Sleeping Well | C183972 | FSIL-Sleeping Well | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am sleeping well. | FACIT-Searchable Item Library Adult Version - Sleeping Well | ||
FSIL-Smoke Cigarettes/Other Tobacco | C184024 | FSIL-Smoke Cigarettes/Other Tobacco | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I smoke cigarettes or other tobacco products. | FACIT-Searchable Item Library Adult Version - Smoke Cigarettes/Other Tobacco | ||
FSIL-Stiffness/Tightness in My Joints | C184029 | FSIL-Stiffness/Tightness in My Joints | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stiffness or tightness in my joints. | FACIT-Searchable Item Library Adult Version - Stiffness/Tightness in My Joints | ||
FSIL-Stomach Pain Interferes Functioning | C183638 | FSIL-Stomach Pain Interferes Functioning | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Stomach pain interferes with my daily functioning. | FACIT-Searchable Item Library Adult Version - Stomach Pain Interferes Functioning | ||
FSIL-Stomach Problems That Worry Me | C183960 | FSIL-Stomach Problems That Worry Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have stomach problems that worry me. | FACIT-Searchable Item Library Adult Version - Stomach Problems That Worry Me | ||
FSIL-Strength in Faith/Spiritual Beliefs | C184176 | FSIL-Strength in Faith/Spiritual Beliefs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I find strength in my faith or spiritual beliefs. | FACIT-Searchable Item Library Adult Version - Strength in Faith/Spiritual Beliefs | ||
FSIL-Sweeping/Mopping | C183893 | FSIL-Sweeping/Mopping | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Sweeping or mopping. | FACIT-Searchable Item Library Adult Version - Sweeping/Mopping | ||
FSIL-Swelling as a Result of Surgery | C184075 | FSIL-Swelling as a Result of Surgery | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling as a result of surgery. | FACIT-Searchable Item Library Adult Version - Swelling as a Result of Surgery | ||
FSIL-Swelling Keeps Me From Doing Things | C184078 | FSIL-Swelling Keeps Me From Doing Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Swelling keeps me from doing the things I want to do. | FACIT-Searchable Item Library Adult Version - Swelling Keeps Me From Doing Things | ||
FSIL-Swelling Keeps Me From Wearing | C184079 | FSIL-Swelling Keeps Me From Wearing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Swelling keeps me from wearing clothes or shoes I want to wear. | FACIT-Searchable Item Library Adult Version - Swelling Keeps Me From Wearing | ||
FSIL-Swelling/Cramps in Stomach Area | C183762 | FSIL-Swelling/Cramps in Stomach Area | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have swelling or cramps in my stomach area. | FACIT-Searchable Item Library Adult Version - Swelling/Cramps in Stomach Area | ||
FSIL-Take My Condition Into Account | C184097 | FSIL-Take My Condition Into Account | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have to take my condition into account when making plans. | FACIT-Searchable Item Library Adult Version - Take My Condition Into Account | ||
FSIL-Taking Drug Infusion Inconvenient | C183741 | FSIL-Taking Drug Infusion Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Taking the drug by infusion is inconvenient. | FACIT-Searchable Item Library Adult Version - Taking Drug Infusion Inconvenient | ||
FSIL-Thankfulness Others Bring to Life | C184187 | FSIL-Thankfulness Others Bring to Life | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Throughout the course of my day, I feel a sense of thankfulness for what others bring to my life. | FACIT-Searchable Item Library Adult Version - Thankfulness Others Bring to Life | ||
FSIL-The Skin on My Feet Hurts | C183624 | FSIL-The Skin on My Feet Hurts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin on my feet hurts. | FACIT-Searchable Item Library Adult Version - The Skin on My Feet Hurts | ||
FSIL-The Skin on My Hands Hurts | C183622 | FSIL-The Skin on My Hands Hurts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: The skin on my hands hurts. | FACIT-Searchable Item Library Adult Version - The Skin on My Hands Hurts | ||
FSIL-Tired Dealing With Skin Condition | C183865 | FSIL-Tired Dealing With Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am tired of dealing with my skin condition. | FACIT-Searchable Item Library Adult Version - Tired Dealing With Skin Condition | ||
FSIL-Told Family Members About Infection | C184154 | FSIL-Told Family Members About Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have told family members about my infection. | FACIT-Searchable Item Library Adult Version - Told Family Members About Infection | ||
FSIL-Told Me Trouble Remembering Info | C183818 | FSIL-Told Me Trouble Remembering Info | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble remembering information. | FACIT-Searchable Item Library Adult Version - Told Me Trouble Remembering Info | ||
FSIL-Told Me Trouble Speaking Clearly | C183819 | FSIL-Told Me Trouble Speaking Clearly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble speaking clearly. | FACIT-Searchable Item Library Adult Version - Told Me Trouble Speaking Clearly | ||
FSIL-Told Me Trouble Thinking Clearly | C183820 | FSIL-Told Me Trouble Thinking Clearly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Other people have told me I seemed to have trouble thinking clearly. | FACIT-Searchable Item Library Adult Version - Told Me Trouble Thinking Clearly | ||
FSIL-Told Partner/Spouse About Infection | C184159 | FSIL-Told Partner/Spouse About Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have told my partner/spouse about my infection. | FACIT-Searchable Item Library Adult Version - Told Partner/Spouse About Infection | ||
FSIL-Too Tired to Eat | C183643 | FSIL-Too Tired to Eat | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am too tired to eat. | FACIT-Searchable Item Library Adult Version - Too Tired to Eat | ||
FSIL-Treatment Bone Disease Takes Time | C183734 | FSIL-Treatment Bone Disease Takes Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Treatment for bone disease takes up my time. | FACIT-Searchable Item Library Adult Version - Treatment Bone Disease Takes Time | ||
FSIL-Treatment Bone Disease to Others | C183737 | FSIL-Treatment Bone Disease to Others | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Would you recommend this treatment for bone disease to others with your illness? | FACIT-Searchable Item Library Adult Version - Treatment Bone Disease to Others | ||
FSIL-Treatment Causes Me Physical Pain | C183743 | FSIL-Treatment Causes Me Physical Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment for bone disease causes me physical pain. | FACIT-Searchable Item Library Adult Version - Treatment Causes Me Physical Pain | ||
FSIL-Treatment Schedule Stressful Family | C183750 | FSIL-Treatment Schedule Stressful Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment schedule for bone disease is stressful to my family. | FACIT-Searchable Item Library Adult Version - Treatment Schedule Stressful Family | ||
FSIL-Treatment Schedule Stressful to Me | C183749 | FSIL-Treatment Schedule Stressful to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment schedule for bone disease is stressful to me. | FACIT-Searchable Item Library Adult Version - Treatment Schedule Stressful to Me | ||
FSIL-Treatment Seems Harmful to Me | C183748 | FSIL-Treatment Seems Harmful to Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Treatment for bone disease seems harmful to me. | FACIT-Searchable Item Library Adult Version - Treatment Seems Harmful to Me | ||
FSIL-Treatment Staff Answered Honestly | C184268 | FSIL-Treatment Staff Answered Honestly | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you feel that the treatment staff answered your questions honestly? | FACIT-Searchable Item Library Adult Version - Treatment Staff Answered Honestly | ||
FSIL-Treatment Staff Discuss Activities | C184255 | FSIL-Treatment Staff Discuss Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your normal daily activities? | FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Activities | ||
FSIL-Treatment Staff Discuss Emotionally | C184257 | FSIL-Treatment Staff Discuss Emotionally | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect you emotionally? | FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Emotionally | ||
FSIL-Treatment Staff Discuss Relation | C184256 | FSIL-Treatment Staff Discuss Relation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your personal relationships? | FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Relation | ||
FSIL-Treatment Staff Discuss Work | C184253 | FSIL-Treatment Staff Discuss Work | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff discuss how your health and treatment may affect your normal work (including housework)? | FACIT-Searchable Item Library Adult Version - Treatment Staff Discuss Work | ||
FSIL-Treatment Staff Respect Privacy | C184269 | FSIL-Treatment Staff Respect Privacy | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did the treatment staff respect your privacy? | FACIT-Searchable Item Library Adult Version - Treatment Staff Respect Privacy | ||
FSIL-Treatment Staff Thorough Examining | C184260 | FSIL-Treatment Staff Thorough Examining | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Was the treatment staff thorough in examining and treating you? | FACIT-Searchable Item Library Adult Version - Treatment Staff Thorough Examining | ||
FSIL-Treatment Takes Up My Family's Time | C183739 | FSIL-Treatment Takes Up My Family's Time | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My treatment for bone disease takes up my family's time. | FACIT-Searchable Item Library Adult Version - Treatment Takes Up My Family's Time | ||
FSIL-Trouble Digesting Food | C183925 | FSIL-Trouble Digesting Food | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble digesting food. | FACIT-Searchable Item Library Adult Version - Trouble Digesting Food | ||
FSIL-Trouble Feeling Arm/Hands/Legs | C183715 | FSIL-Trouble Feeling Arm/Hands/Legs | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling sensations in my arm, hands or legs. | FACIT-Searchable Item Library Adult Version - Trouble Feeling Arm/Hands/Legs | ||
FSIL-Trouble Feeling Shape of Objects | C184129 | FSIL-Trouble Feeling Shape of Objects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble feeling the shape of small objects when they are in my hand. | FACIT-Searchable Item Library Adult Version - Trouble Feeling Shape of Objects | ||
FSIL-Trouble Finding Familiar Place | C183815 | FSIL-Trouble Finding Familiar Place | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble finding my way to a familiar place. | FACIT-Searchable Item Library Adult Version - Trouble Finding Familiar Place | ||
FSIL-Trouble Finding Right Words | C183836 | FSIL-Trouble Finding Right Words | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble finding the right word(s) to express myself. | FACIT-Searchable Item Library Adult Version - Trouble Finding Right Words | ||
FSIL-Trouble Finishing Things | C183650 | FSIL-Trouble Finishing Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble finishing things because I am tired. | FACIT-Searchable Item Library Adult Version - Trouble Finishing Things | ||
FSIL-Trouble Getting Around in Public | C184089 | FSIL-Trouble Getting Around in Public | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble getting around in public places. | FACIT-Searchable Item Library Adult Version - Trouble Getting Around in Public | ||
FSIL-Trouble Keeping Track Interrupted | C183816 | FSIL-Trouble Keeping Track Interrupted | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble keeping track of what I am doing if I am interrupted. | FACIT-Searchable Item Library Adult Version - Trouble Keeping Track Interrupted | ||
FSIL-Trouble Meeting Needs of Family | C183977 | FSIL-Trouble Meeting Needs of Family | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Because of my physical condition, I have trouble meeting the needs of my family. | FACIT-Searchable Item Library Adult Version - Trouble Meeting Needs of Family | ||
FSIL-Trouble Recalling Name of Object | C183835 | FSIL-Trouble Recalling Name of Object | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble recalling the name of an object while talking to someone. | FACIT-Searchable Item Library Adult Version - Trouble Recalling Name of Object | ||
FSIL-Trouble Remember Where Put Things | C183813 | FSIL-Trouble Remember Where Put Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble remembering where I put things, like my keys or my wallet. | FACIT-Searchable Item Library Adult Version - Trouble Remember Where Put Things | ||
FSIL-Trouble Remembering New Info | C183814 | FSIL-Trouble Remembering New Info | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble remembering new information, like phone numbers or simple instructions. | FACIT-Searchable Item Library Adult Version - Trouble Remembering New Info | ||
FSIL-Trouble Saying What I Mean | C183838 | FSIL-Trouble Saying What I Mean | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had trouble saying what I mean in conversations with others. | FACIT-Searchable Item Library Adult Version - Trouble Saying What I Mean | ||
FSIL-Trouble Shifting Back and Forth | C183817 | FSIL-Trouble Shifting Back and Forth | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble shifting back and forth between different activities that require thinking. | FACIT-Searchable Item Library Adult Version - Trouble Shifting Back and Forth | ||
FSIL-Trouble Sleeping B/c Skin Condition | C183859 | FSIL-Trouble Sleeping B/c Skin Condition | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble sleeping because of my skin condition. | FACIT-Searchable Item Library Adult Version - Trouble Sleeping B/c Skin Condition | ||
FSIL-Trouble Starting Things | C183649 | FSIL-Trouble Starting Things | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble starting things because I am tired. | FACIT-Searchable Item Library Adult Version - Trouble Starting Things | ||
FSIL-Trouble Walking Because Bone Pain | C183701 | FSIL-Trouble Walking Because Bone Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking because of bone pain. | FACIT-Searchable Item Library Adult Version - Trouble Walking Because Bone Pain | ||
FSIL-Trouble Walking Because of Pain | C184088 | FSIL-Trouble Walking Because of Pain | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have trouble walking because of pain. | FACIT-Searchable Item Library Adult Version - Trouble Walking Because of Pain | ||
FSIL-Troubled Not Knowing Side Effects | C184040 | FSIL-Troubled Not Knowing Side Effects | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am troubled by not knowing when exactly my side effects will happen, how long they will last and how bad they will be. | FACIT-Searchable Item Library Adult Version - Troubled Not Knowing Side Effects | ||
FSIL-Trust Doctor Suggestions Treatment | C184271 | FSIL-Trust Doctor Suggestions Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Did you trust your doctor(s)' suggestions for treatment? | FACIT-Searchable Item Library Adult Version - Trust Doctor Suggestions Treatment | ||
FSIL-Tube Feed Limits Do Inside House | C183920 | FSIL-Tube Feed Limits Do Inside House | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits what I can do inside the house (for example housework, watching TV or reading). | FACIT-Searchable Item Library Adult Version - Tube Feed Limits Do Inside House | ||
FSIL-Tube Feeding Limits Activities | C183922 | FSIL-Tube Feeding Limits Activities | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits my activities with my friends. | FACIT-Searchable Item Library Adult Version - Tube Feeding Limits Activities | ||
FSIL-Tube Feeding Limits Do Outside | C183921 | FSIL-Tube Feeding Limits Do Outside | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Tube feeding limits what I can do outside of the house (for example shopping, driving or yard work). | FACIT-Searchable Item Library Adult Version - Tube Feeding Limits Do Outside | ||
FSIL-Unattractive B/c How My Skin Looks | C184206 | FSIL-Unattractive B/c How My Skin Looks | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel unattractive because of how my skin looks. | FACIT-Searchable Item Library Adult Version - Unattractive B/c How My Skin Looks | ||
FSIL-Uncertain About My Future Health | C184066 | FSIL-Uncertain About My Future Health | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel uncertain about my future health. | FACIT-Searchable Item Library Adult Version - Uncertain About My Future Health | ||
FSIL-Uncomfortably Full Tube Feeding | C183916 | FSIL-Uncomfortably Full Tube Feeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I feel uncomfortably full during or after my tube feeding. | FACIT-Searchable Item Library Adult Version - Uncomfortably Full Tube Feeding | ||
FSIL-Unhappy About Change in My Appear | C183995 | FSIL-Unhappy About Change in My Appear | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy about a change in my appearance. | FACIT-Searchable Item Library Adult Version - Unhappy About Change in My Appear | ||
FSIL-Unhappy With How Face & Neck Look | C184022 | FSIL-Unhappy With How Face & Neck Look | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy with how my face and neck look. | FACIT-Searchable Item Library Adult Version - Unhappy With How Face & Neck Look | ||
FSIL-Unhappy With My Appearance | C184002 | FSIL-Unhappy With My Appearance | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am unhappy with my appearance. | FACIT-Searchable Item Library Adult Version - Unhappy With My Appearance | ||
FSIL-Urinate Frequently to Avoid Leaking | C184055 | FSIL-Urinate Frequently to Avoid Leaking | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I must urinate frequently to avoid leaking. | FACIT-Searchable Item Library Adult Version - Urinate Frequently to Avoid Leaking | ||
FSIL-Use Written Lists More Often | C183807 | FSIL-Use Written Lists More Often | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to use written lists more often than usual so I would not forget things. | FACIT-Searchable Item Library Adult Version - Use Written Lists More Often | ||
FSIL-Used Wrong Word When Refer Object | C183837 | FSIL-Used Wrong Word When Refer Object | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have used the wrong word when I referred to an object. | FACIT-Searchable Item Library Adult Version - Used Wrong Word When Refer Object | ||
FSIL-Vagina Feels Too Narrow/Short | C183878 | FSIL-Vagina Feels Too Narrow/Short | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My vagina feels too narrow or short. | FACIT-Searchable Item Library Adult Version - Vagina Feels Too Narrow/Short | ||
FSIL-Voice Has Usual Quality & Strength | C184020 | FSIL-Voice Has Usual Quality & Strength | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: My voice has its usual quality and strength. | FACIT-Searchable Item Library Adult Version - Voice Has Usual Quality & Strength | ||
FSIL-Vomiting Dur/After Tube Feeding | C183919 | FSIL-Vomiting Dur/After Tube Feeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I experience vomiting during or after my tube feeding. | FACIT-Searchable Item Library Adult Version - Vomiting Dur/After Tube Feeding | ||
FSIL-Waiting Breakfast Is Inconvenient | C183745 | FSIL-Waiting Breakfast Is Inconvenient | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Waiting up to 60 minutes before eating breakfast in the morning is inconvenient. | FACIT-Searchable Item Library Adult Version - Waiting Breakfast Is Inconvenient | ||
FSIL-Wake at Night Because of Coughing | C183904 | FSIL-Wake at Night Because of Coughing | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wake at night because of coughing. | FACIT-Searchable Item Library Adult Version - Wake at Night Because of Coughing | ||
FSIL-Walked Into a Room and Forgotten | C183809 | FSIL-Walked Into a Room and Forgotten | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have walked into a room and forgotten what I meant to get or do there. | FACIT-Searchable Item Library Adult Version - Walked Into a Room and Forgotten | ||
FSIL-Walking 50 Steps Flat Normal Speed | C183889 | FSIL-Walking 50 Steps Flat Normal Speed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking 50 steps/paces on flat ground at a normal speed without stopping. | FACIT-Searchable Item Library Adult Version - Walking 50 Steps Flat Normal Speed | ||
FSIL-Walking for 1/2 Mile w/o Stopping | C183897 | FSIL-Walking for 1/2 Mile w/o Stopping | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking (faster than your usual speed) for 1/2 mile (almost 1 km) without stopping. | FACIT-Searchable Item Library Adult Version - Walking for 1/2 Mile w/o Stopping | ||
FSIL-Walking Up 20 Stairs w/o Stopping | C183890 | FSIL-Walking Up 20 Stairs w/o Stopping | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Walking up 20 stairs (2 flights) without stopping. | FACIT-Searchable Item Library Adult Version - Walking Up 20 Stairs w/o Stopping | ||
FSIL-Washing Dishes | C183892 | FSIL-Washing Dishes | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: Washing dishes. | FACIT-Searchable Item Library Adult Version - Washing Dishes | ||
FSIL-Wear Pads/Protect Prevent Soiling | C184047 | FSIL-Wear Pads/Protect Prevent Soiling | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wear pads or protection to prevent soiling my underwear. | FACIT-Searchable Item Library Adult Version - Wear Pads/Protect Prevent Soiling | ||
FSIL-Wear Protection Leakage of Urine | C184056 | FSIL-Wear Protection Leakage of Urine | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I wear protection for leakage of urine. | FACIT-Searchable Item Library Adult Version - Wear Protection Leakage of Urine | ||
FSIL-Whatever Happens Illness Will Be OK | C184178 | FSIL-Whatever Happens Illness Will Be OK | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I know that whatever happens with my illness, things will be okay. | FACIT-Searchable Item Library Adult Version - Whatever Happens Illness Will Be OK | ||
FSIL-Which Side Was Breast Operation | C184157 | FSIL-Which Side Was Breast Operation | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: On which side was your breast operation? | FACIT-Searchable Item Library Adult Version - Which Side Was Breast Operation | ||
FSIL-Women: Bothered by Vaginal Bleeding | C184235 | FSIL-Women: Bothered by Vaginal Bleeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: For women only: I am bothered by vaginal bleeding. | FACIT-Searchable Item Library Adult Version - Women: Bothered by Vaginal Bleeding | ||
FSIL-Work Hard to Pay Attention | C183810 | FSIL-Work Hard to Pay Attention | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work really hard to pay attention or I would make a mistake. | FACIT-Searchable Item Library Adult Version - Work Hard to Pay Attention | ||
FSIL-Work Harder Than Usual to Express | C183806 | FSIL-Work Harder Than Usual to Express | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work harder than usual to express myself clearly. | FACIT-Searchable Item Library Adult Version - Work Harder Than Usual to Express | ||
FSIL-Work Harder Than Usual to Track | C183804 | FSIL-Work Harder Than Usual to Track | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I have had to work harder than usual to keep track of what I was doing. | FACIT-Searchable Item Library Adult Version - Work Harder Than Usual to Track | ||
FSIL-Worried About My Weight | C183632 | FSIL-Worried About My Weight | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I am worried about my weight. | FACIT-Searchable Item Library Adult Version - Worried About My Weight | ||
FSIL-Worry About Attitudes Towards Me | C183779 | FSIL-Worry About Attitudes Towards Me | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about other people's attitudes towards me. | FACIT-Searchable Item Library Adult Version - Worry About Attitudes Towards Me | ||
FSIL-Worry About Serious Bleeding | C184238 | FSIL-Worry About Serious Bleeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the possibility of serious bleeding. | FACIT-Searchable Item Library Adult Version - Worry About Serious Bleeding | ||
FSIL-Worry About Side Effects Treatment | C183740 | FSIL-Worry About Side Effects Treatment | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about side effects from treatment for bone disease. | FACIT-Searchable Item Library Adult Version - Worry About Side Effects Treatment | ||
FSIL-Worry About Spreading My Infection | C184008 | FSIL-Worry About Spreading My Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about spreading my infection. | FACIT-Searchable Item Library Adult Version - Worry About Spreading My Infection | ||
FSIL-Worry About Spreading the Infection | C183791 | FSIL-Worry About Spreading the Infection | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about spreading the infection. | FACIT-Searchable Item Library Adult Version - Worry About Spreading the Infection | ||
FSIL-Worry About the Effect of Stress | C183666 | FSIL-Worry About the Effect of Stress | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the effect of stress on my illness. | FACIT-Searchable Item Library Adult Version - Worry About the Effect of Stress | ||
FSIL-Worry Appearance of Surgical Scars | C184083 | FSIL-Worry Appearance of Surgical Scars | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the appearance of surgical scars. | FACIT-Searchable Item Library Adult Version - Worry Appearance of Surgical Scars | ||
FSIL-Worry Chemo Not Effective | C183848 | FSIL-Worry Chemo Not Effective | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my chemotherapy will not be effective. | FACIT-Searchable Item Library Adult Version - Worry Chemo Not Effective | ||
FSIL-Worry Family Will Get Illness | C183665 | FSIL-Worry Family Will Get Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that other members of my family might someday get the same illness I have. | FACIT-Searchable Item Library Adult Version - Worry Family Will Get Illness | ||
FSIL-Worry Feeding Tube Health Is Worse | C183907 | FSIL-Worry Feeding Tube Health Is Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that having a feeding tube means my health is worse. | FACIT-Searchable Item Library Adult Version - Worry Feeding Tube Health Is Worse | ||
FSIL-Worry Financial Problems in Future | C183945 | FSIL-Worry Financial Problems in Future | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the financial problems I will have in the future as a result of my illness or treatment. | FACIT-Searchable Item Library Adult Version - Worry Financial Problems in Future | ||
FSIL-Worry Getting Sick Low Blood Counts | C184105 | FSIL-Worry Getting Sick Low Blood Counts | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting sick due to low blood counts. | FACIT-Searchable Item Library Adult Version - Worry Getting Sick Low Blood Counts | ||
FSIL-Worry I Might Get New Symptoms | C184067 | FSIL-Worry I Might Get New Symptoms | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that I might get new symptoms of my illness. | FACIT-Searchable Item Library Adult Version - Worry I Might Get New Symptoms | ||
FSIL-Worry Infection From Feeding Tube | C183910 | FSIL-Worry Infection From Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about getting an infection from the feeding tube. | FACIT-Searchable Item Library Adult Version - Worry Infection From Feeding Tube | ||
FSIL-Worry Infection Will Get Worse | C183776 | FSIL-Worry Infection Will Get Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that the infection will get worse. | FACIT-Searchable Item Library Adult Version - Worry Infection Will Get Worse | ||
FSIL-Worry Losing Weight Feeding Tube | C183911 | FSIL-Worry Losing Weight Feeding Tube | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about losing weight because I have a feeding tube. | FACIT-Searchable Item Library Adult Version - Worry Losing Weight Feeding Tube | ||
FSIL-Worry My Condition Will Get Worse | C183967 | FSIL-Worry My Condition Will Get Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my condition will get worse. | FACIT-Searchable Item Library Adult Version - Worry My Condition Will Get Worse | ||
FSIL-Worry Neg Impacts Long-term Health | C184038 | FSIL-Worry Neg Impacts Long-term Health | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about negative impacts that my treatment may have upon my long-term health. | FACIT-Searchable Item Library Adult Version - Worry Neg Impacts Long-term Health | ||
FSIL-Worry Not improve Treatment Delayed | C184108 | FSIL-Worry Not improve Treatment Delayed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry my condition will not improve if my treatment is delayed. | FACIT-Searchable Item Library Adult Version - Worry Not improve Treatment Delayed | ||
FSIL-Worry Problems Bruising/Bleeding | C184237 | FSIL-Worry Problems Bruising/Bleeding | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about problems with bruising or bleeding. | FACIT-Searchable Item Library Adult Version - Worry Problems Bruising/Bleeding | ||
FSIL-Worry Side Effects From Chemo | C183845 | FSIL-Worry Side Effects From Chemo | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about side effects from chemotherapy treatment. | FACIT-Searchable Item Library Adult Version - Worry Side Effects From Chemo | ||
FSIL-Worry Skin condition Get Worse | C183871 | FSIL-Worry Skin condition Get Worse | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my skin condition may get worse. | FACIT-Searchable Item Library Adult Version - Worry Skin condition Get Worse | ||
FSIL-Worry Support Myself/Family Illness | C184069 | FSIL-Worry Support Myself/Family Illness | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about being able to support myself or my family due to my illness. | FACIT-Searchable Item Library Adult Version - Worry Support Myself/Family Illness | ||
FSIL-Worry Treatment Dose Will Reduced | C184234 | FSIL-Worry Treatment Dose Will Reduced | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment dose will be reduced (because of low blood counts). | FACIT-Searchable Item Library Adult Version - Worry Treatment Dose Will Reduced | ||
FSIL-Worry Treatment Not Effective | C183747 | FSIL-Worry Treatment Not Effective | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment for bone disease will not be effective. | FACIT-Searchable Item Library Adult Version - Worry Treatment Not Effective | ||
FSIL-Worry Treatment Will Be Delayed | C184233 | FSIL-Worry Treatment Will Be Delayed | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry that my treatment will be delayed (because of low blood counts). | FACIT-Searchable Item Library Adult Version - Worry Treatment Will Be Delayed | ||
FSIL-Worry Tube Coming Out by Accident | C183908 | FSIL-Worry Tube Coming Out by Accident | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the tube coming out by accident. | FACIT-Searchable Item Library Adult Version - Worry Tube Coming Out by Accident | ||
FSIL-Worry Tube Getting Plugged/Blocked | C183909 | FSIL-Worry Tube Getting Plugged/Blocked | Functional Assessment of Chronic Illness Therapy-Searchable Item Library Adult: I worry about the tube getting plugged or blocked. | FACIT-Searchable Item Library Adult Version - Worry Tube Getting Plugged/Blocked | ||
Back to top | ||||||
CL.C112441.FAMS01TC | Functional Assessment of Multiple Sclerosis Version 4 Questionnaire Test Code
(FAMS01TC) | text
Extensible: No | C112441 | Functional Assessment of Multiple Sclerosis Version 4 Questionnaire Test Code | Functional Assessment of Multiple Sclerosis Version 4 test code. | CDISC Questionnaire FAMS Test Code Terminology |
FAMS0101 | C112551 | FAMS01-Trouble Meeting Needs of Family | Functional Assessment of Multiple Sclerosis - Mobility: Because of my physical condition, I have trouble meeting the needs of my family. | FAMS - Have Trouble Meeting Needs of Family Because of My Condition | ||
FAMS0102 | C112552 | FAMS01-I Am Able to Work | Functional Assessment of Multiple Sclerosis - Mobility: I am able to work (include work at home). | FAMS - I Am Able to Work | ||
FAMS0103 | C112553 | FAMS01-I Have Trouble Walking | Functional Assessment of Multiple Sclerosis - Mobility: I have trouble walking. | FAMS - I Have Trouble Walking | ||
FAMS0104 | C112554 | FAMS01-Limit My Social Activity | Functional Assessment of Multiple Sclerosis - Mobility: I have to limit my social activity because of my condition. | FAMS - Limit Social Activity Because of Condition | ||
FAMS0105 | C112555 | FAMS01-I Have Strength in My Legs | Functional Assessment of Multiple Sclerosis - Mobility: I have strength in my legs. | FAMS - I Have Strength in My Legs | ||
FAMS0106 | C112556 | FAMS01-Trouble Getting Around in Public | Functional Assessment of Multiple Sclerosis - Mobility: I have trouble getting around in public places. | FAMS - Trouble Getting Around in Public Places | ||
FAMS0107 | C112557 | FAMS01-Take My Condition Into Account | Functional Assessment of Multiple Sclerosis - Mobility: I have to take my condition into account when making plans. | FAMS - Have to Take Condition Into Account When Making Plans | ||
FAMS0108 | C112558 | FAMS01-I Have Nausea | Functional Assessment of Multiple Sclerosis - Symptoms: I have nausea. | FAMS - I Have Nausea | ||
FAMS0109 | C112559 | FAMS01-I Have Pain | Functional Assessment of Multiple Sclerosis - Symptoms: I have pain. | FAMS - I Have Pain | ||
FAMS0110 | C112560 | FAMS01-I Feel Ill | Functional Assessment of Multiple Sclerosis - Symptoms: I feel ill. | FAMS - I Feel Ill | ||
FAMS0111 | C112561 | FAMS01-I Feel Weak All Over | Functional Assessment of Multiple Sclerosis - Symptoms: I feel weak all over. | FAMS - I Feel Weak All Over | ||
FAMS0112 | C112562 | FAMS01-I Have Pain in My Joints | Functional Assessment of Multiple Sclerosis - Symptoms: I have pain in my joints. | FAMS - I Have Pain in My Joints | ||
FAMS0113 | C112563 | FAMS01-I Am Bothered by Headaches | Functional Assessment of Multiple Sclerosis - Symptoms: I am bothered by headaches. | FAMS - Bothered by Headaches | ||
FAMS0114 | C112564 | FAMS01-I Am Bothered by Muscle Pains | Functional Assessment of Multiple Sclerosis - Symptoms: I am bothered by muscle pains. | FAMS - Bothered by Muscle Pains | ||
FAMS0115 | C112565 | FAMS01-I Feel Sad | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel sad. | FAMS - I Feel Sad | ||
FAMS0116 | C112566 | FAMS01-Losing Hope Against Illness | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am losing hope in the fight against my illness. | FAMS - Losing Hope in Fight Against My Illness | ||
FAMS0117 | C112567 | FAMS01-I Am Able to Enjoy Life | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am able to enjoy life. | FAMS - I Am Able to Enjoy Life | ||
FAMS0118 | C112568 | FAMS01-I Feel Trapped by My Condition | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel trapped by my condition. | FAMS - Feel Trapped by My Condition | ||
FAMS0119 | C112569 | FAMS01-I Am Depressed About My Condition | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am depressed about my condition. | FAMS - Depressed About My Condition | ||
FAMS0120 | C112570 | FAMS01-I Feel Useless | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel useless. | FAMS - I Feel Useless | ||
FAMS0121 | C112571 | FAMS01-Feel Overwhelmed by My Condition | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel overwhelmed by my condition. | FAMS - Feel Overwhelmed by My Condition | ||
FAMS0122 | C112572 | FAMS01-My Work Is Fulfilling | Functional Assessment of Multiple Sclerosis - General Contentment: My work (include work at home) is fulfilling. | FAMS - My Work is Fulfilling | ||
FAMS0123 | C112573 | FAMS01-I Have Accepted My Illness | Functional Assessment of Multiple Sclerosis - General Contentment: I have accepted my illness. | FAMS - I Have Accepted My Illness | ||
FAMS0124 | C112574 | FAMS01-Enjoy Things I Usually Do for Fun | Functional Assessment of Multiple Sclerosis - General Contentment: I am enjoying the things I usually do for fun. | FAMS - Enjoying Things I Usually Do for Fun | ||
FAMS0125 | C112575 | FAMS01-Content With Quality of My Life | Functional Assessment of Multiple Sclerosis - General Contentment: I am content with the quality of my life right now. | FAMS - Content With Quality of My Life Now | ||
FAMS0126 | C112576 | FAMS01-I Am Frustrated by My Condition | Functional Assessment of Multiple Sclerosis - General Contentment: I am frustrated by my condition. | FAMS - I Am Frustrated by My Condition | ||
FAMS0127 | C112577 | FAMS01-Feel Sense of Purpose in My Life | Functional Assessment of Multiple Sclerosis - General Contentment: I feel a sense of purpose in my life. | FAMS - Feel Sense of Purpose in My Life | ||
FAMS0128 | C112578 | FAMS01-I Feel Motivated to Do Things | Functional Assessment of Multiple Sclerosis - General Contentment: I feel motivated to do things. | FAMS - Feel Motivated to Do Things | ||
FAMS0129 | C112579 | FAMS01-I Have a Lack of Energy | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have a lack of energy. | FAMS - Have a Lack of Energy | ||
FAMS0130 | C112580 | FAMS01-I Feel Tired | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I feel tired. | FAMS - I Feel Tired | ||
FAMS0131 | C112581 | FAMS01-Trouble Starting Things | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble starting things because I am tired. | FAMS - Trouble Starting Things Because I Am Tired | ||
FAMS0132 | C112582 | FAMS01-Trouble Finishing Things | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble finishing things because I am tired. | FAMS - Trouble Finishing Things Because I Am Tired | ||
FAMS0133 | C112583 | FAMS01-I Need to Rest During the Day | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I need to rest during the day. | FAMS - Need to Rest During the Day | ||
FAMS0134 | C112584 | FAMS01-I Have Trouble Remembering Things | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble remembering things. | FAMS - Trouble Remembering Things | ||
FAMS0135 | C112585 | FAMS01-I Have Trouble Concentrating | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble concentrating. | FAMS - Trouble Concentrating | ||
FAMS0136 | C112586 | FAMS01-My Thinking Is Slower Than Before | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: My thinking is slower than before. | FAMS - My Thinking is Slower Than Before | ||
FAMS0137 | C112587 | FAMS01-I Have Trouble Learning New Tasks | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble learning new tasks or directions. | FAMS - Trouble Learning New Tasks or Directions | ||
FAMS0138 | C112588 | FAMS01-I Feel Close to My Friends | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I feel close to my friends. | FAMS - Feel Close to My Friends | ||
FAMS0139 | C112589 | FAMS01-Get Emotional Support From Family | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I get emotional support from my family. | FAMS - Get Emotional Support From Family | ||
FAMS0140 | C112590 | FAMS01-I Get Support From My Friends | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I get support from my friends. | FAMS - Get Support From Friends | ||
FAMS0141 | C112591 | FAMS01-My Family Has Accepted My Illness | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: My family has accepted my illness. | FAMS - Family Has Accepted My Illness | ||
FAMS0142 | C112592 | FAMS01-Satisfied Communication Illness | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I am satisfied with family communication about my illness. | FAMS - Satisfied With Family Communication About My Illness | ||
FAMS0143 | C112593 | FAMS01-Trouble Understanding Worsening | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: My family has trouble understanding when my condition gets worse. | FAMS - Family Has Trouble Understanding When My Condition Gets Worse | ||
FAMS0144 | C112594 | FAMS01-I Feel Left Out of Things | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I feel 'left out' of things. | FAMS - Feel Left Out of Things | ||
FAMS0145 | C112595 | FAMS01-Bothered by Treatment Side Effect | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by side effects of treatment. | FAMS - Bothered by Side Effects of Treatment | ||
FAMS0146 | C112596 | FAMS01-I Am Forced to Spend Time in Bed | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am forced to spend time in bed. | FAMS - Forced to Spend Time in Bed | ||
FAMS0147 | C112597 | FAMS01-I Feel Close to My Partner | Functional Assessment of Multiple Sclerosis - Additional Concerns: I feel close to my partner (or the person who is my main support). | FAMS - Feel Close to My Partner | ||
FAMS0148 | C112598 | FAMS01-I Am Satisfied With My Sex Life | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am satisfied with my sex life. | FAMS - Satisfied With My Sex Life | ||
FAMS0149 | C112599 | FAMS01-Satisfied With How I Am Coping | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am satisfied with how I am coping with my illness. | FAMS - Satisfied With How I Am Coping With Illness | ||
FAMS0150 | C112600 | FAMS01-I Feel Nervous | Functional Assessment of Multiple Sclerosis - Additional Concerns: I feel nervous. | FAMS - I Feel Nervous | ||
FAMS0151 | C112601 | FAMS01-Worry My Condition Will Get Worse | Functional Assessment of Multiple Sclerosis - Additional Concerns: I worry that my condition will get worse. | FAMS - Worry My Condition Will Get Worse | ||
FAMS0152 | C112602 | FAMS01-I Am Sleeping Well | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am sleeping well. | FAMS - I Am Sleeping Well | ||
FAMS0153 | C112603 | FAMS01-Heat Worsens My Symptoms | Functional Assessment of Multiple Sclerosis - Additional Concerns: Heat worsens my symptoms. | FAMS - Heat Worsens My Symptoms | ||
FAMS0154 | C112604 | FAMS01-Have Trouble Controlling My Urine | Functional Assessment of Multiple Sclerosis - Additional Concerns: I have trouble controlling my urine. | FAMS - Trouble Controlling My Urine | ||
FAMS0155 | C112605 | FAMS01-I Urinate More Frequently | Functional Assessment of Multiple Sclerosis - Additional Concerns: I urinate more frequently than usual. | FAMS - Urinate More Frequently Than Usual | ||
FAMS0156 | C112606 | FAMS01-I Am Bothered by the Chills | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by the chills. | FAMS - Bothered by Chills | ||
FAMS0157 | C112607 | FAMS01-I Am Bothered by Fevers | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by fevers (episodes of high body temperature). | FAMS - Bothered by Fevers | ||
FAMS0158 | C112608 | FAMS01-I Am Bothered by Muscle Spasms | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by muscle spasms. | FAMS - Bothered by Muscle Spasms | ||
Back to top | ||||||
CL.C112440.FAMS01TN | Functional Assessment of Multiple Sclerosis Version 4 Questionnaire Test Name
(FAMS01TN) | text
Extensible: No | C112440 | Functional Assessment of Multiple Sclerosis Version 4 Questionnaire Test Name | Functional Assessment of Multiple Sclerosis Version 4 test name. | CDISC Questionnaire FAMS Test Name Terminology |
FAMS01-Bothered by Treatment Side Effect | C112595 | FAMS01-Bothered by Treatment Side Effect | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by side effects of treatment. | FAMS - Bothered by Side Effects of Treatment | ||
FAMS01-Content With Quality of My Life | C112575 | FAMS01-Content With Quality of My Life | Functional Assessment of Multiple Sclerosis - General Contentment: I am content with the quality of my life right now. | FAMS - Content With Quality of My Life Now | ||
FAMS01-Enjoy Things I Usually Do for Fun | C112574 | FAMS01-Enjoy Things I Usually Do for Fun | Functional Assessment of Multiple Sclerosis - General Contentment: I am enjoying the things I usually do for fun. | FAMS - Enjoying Things I Usually Do for Fun | ||
FAMS01-Feel Overwhelmed by My Condition | C112571 | FAMS01-Feel Overwhelmed by My Condition | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel overwhelmed by my condition. | FAMS - Feel Overwhelmed by My Condition | ||
FAMS01-Feel Sense of Purpose in My Life | C112577 | FAMS01-Feel Sense of Purpose in My Life | Functional Assessment of Multiple Sclerosis - General Contentment: I feel a sense of purpose in my life. | FAMS - Feel Sense of Purpose in My Life | ||
FAMS01-Get Emotional Support From Family | C112589 | FAMS01-Get Emotional Support From Family | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I get emotional support from my family. | FAMS - Get Emotional Support From Family | ||
FAMS01-Have Trouble Controlling My Urine | C112604 | FAMS01-Have Trouble Controlling My Urine | Functional Assessment of Multiple Sclerosis - Additional Concerns: I have trouble controlling my urine. | FAMS - Trouble Controlling My Urine | ||
FAMS01-Heat Worsens My Symptoms | C112603 | FAMS01-Heat Worsens My Symptoms | Functional Assessment of Multiple Sclerosis - Additional Concerns: Heat worsens my symptoms. | FAMS - Heat Worsens My Symptoms | ||
FAMS01-I Am Able to Enjoy Life | C112567 | FAMS01-I Am Able to Enjoy Life | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am able to enjoy life. | FAMS - I Am Able to Enjoy Life | ||
FAMS01-I Am Able to Work | C112552 | FAMS01-I Am Able to Work | Functional Assessment of Multiple Sclerosis - Mobility: I am able to work (include work at home). | FAMS - I Am Able to Work | ||
FAMS01-I Am Bothered by Fevers | C112607 | FAMS01-I Am Bothered by Fevers | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by fevers (episodes of high body temperature). | FAMS - Bothered by Fevers | ||
FAMS01-I Am Bothered by Headaches | C112563 | FAMS01-I Am Bothered by Headaches | Functional Assessment of Multiple Sclerosis - Symptoms: I am bothered by headaches. | FAMS - Bothered by Headaches | ||
FAMS01-I Am Bothered by Muscle Pains | C112564 | FAMS01-I Am Bothered by Muscle Pains | Functional Assessment of Multiple Sclerosis - Symptoms: I am bothered by muscle pains. | FAMS - Bothered by Muscle Pains | ||
FAMS01-I Am Bothered by Muscle Spasms | C112608 | FAMS01-I Am Bothered by Muscle Spasms | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by muscle spasms. | FAMS - Bothered by Muscle Spasms | ||
FAMS01-I Am Bothered by the Chills | C112606 | FAMS01-I Am Bothered by the Chills | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am bothered by the chills. | FAMS - Bothered by Chills | ||
FAMS01-I Am Depressed About My Condition | C112569 | FAMS01-I Am Depressed About My Condition | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am depressed about my condition. | FAMS - Depressed About My Condition | ||
FAMS01-I Am Forced to Spend Time in Bed | C112596 | FAMS01-I Am Forced to Spend Time in Bed | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am forced to spend time in bed. | FAMS - Forced to Spend Time in Bed | ||
FAMS01-I Am Frustrated by My Condition | C112576 | FAMS01-I Am Frustrated by My Condition | Functional Assessment of Multiple Sclerosis - General Contentment: I am frustrated by my condition. | FAMS - I Am Frustrated by My Condition | ||
FAMS01-I Am Satisfied With My Sex Life | C112598 | FAMS01-I Am Satisfied With My Sex Life | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am satisfied with my sex life. | FAMS - Satisfied With My Sex Life | ||
FAMS01-I Am Sleeping Well | C112602 | FAMS01-I Am Sleeping Well | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am sleeping well. | FAMS - I Am Sleeping Well | ||
FAMS01-I Feel Close to My Friends | C112588 | FAMS01-I Feel Close to My Friends | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I feel close to my friends. | FAMS - Feel Close to My Friends | ||
FAMS01-I Feel Close to My Partner | C112597 | FAMS01-I Feel Close to My Partner | Functional Assessment of Multiple Sclerosis - Additional Concerns: I feel close to my partner (or the person who is my main support). | FAMS - Feel Close to My Partner | ||
FAMS01-I Feel Ill | C112560 | FAMS01-I Feel Ill | Functional Assessment of Multiple Sclerosis - Symptoms: I feel ill. | FAMS - I Feel Ill | ||
FAMS01-I Feel Left Out of Things | C112594 | FAMS01-I Feel Left Out of Things | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I feel 'left out' of things. | FAMS - Feel Left Out of Things | ||
FAMS01-I Feel Motivated to Do Things | C112578 | FAMS01-I Feel Motivated to Do Things | Functional Assessment of Multiple Sclerosis - General Contentment: I feel motivated to do things. | FAMS - Feel Motivated to Do Things | ||
FAMS01-I Feel Nervous | C112600 | FAMS01-I Feel Nervous | Functional Assessment of Multiple Sclerosis - Additional Concerns: I feel nervous. | FAMS - I Feel Nervous | ||
FAMS01-I Feel Sad | C112565 | FAMS01-I Feel Sad | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel sad. | FAMS - I Feel Sad | ||
FAMS01-I Feel Tired | C112580 | FAMS01-I Feel Tired | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I feel tired. | FAMS - I Feel Tired | ||
FAMS01-I Feel Trapped by My Condition | C112568 | FAMS01-I Feel Trapped by My Condition | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel trapped by my condition. | FAMS - Feel Trapped by My Condition | ||
FAMS01-I Feel Useless | C112570 | FAMS01-I Feel Useless | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I feel useless. | FAMS - I Feel Useless | ||
FAMS01-I Feel Weak All Over | C112561 | FAMS01-I Feel Weak All Over | Functional Assessment of Multiple Sclerosis - Symptoms: I feel weak all over. | FAMS - I Feel Weak All Over | ||
FAMS01-I Get Support From My Friends | C112590 | FAMS01-I Get Support From My Friends | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I get support from my friends. | FAMS - Get Support From Friends | ||
FAMS01-I Have a Lack of Energy | C112579 | FAMS01-I Have a Lack of Energy | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have a lack of energy. | FAMS - Have a Lack of Energy | ||
FAMS01-I Have Accepted My Illness | C112573 | FAMS01-I Have Accepted My Illness | Functional Assessment of Multiple Sclerosis - General Contentment: I have accepted my illness. | FAMS - I Have Accepted My Illness | ||
FAMS01-I Have Nausea | C112558 | FAMS01-I Have Nausea | Functional Assessment of Multiple Sclerosis - Symptoms: I have nausea. | FAMS - I Have Nausea | ||
FAMS01-I Have Pain in My Joints | C112562 | FAMS01-I Have Pain in My Joints | Functional Assessment of Multiple Sclerosis - Symptoms: I have pain in my joints. | FAMS - I Have Pain in My Joints | ||
FAMS01-I Have Pain | C112559 | FAMS01-I Have Pain | Functional Assessment of Multiple Sclerosis - Symptoms: I have pain. | FAMS - I Have Pain | ||
FAMS01-I Have Strength in My Legs | C112555 | FAMS01-I Have Strength in My Legs | Functional Assessment of Multiple Sclerosis - Mobility: I have strength in my legs. | FAMS - I Have Strength in My Legs | ||
FAMS01-I Have Trouble Concentrating | C112585 | FAMS01-I Have Trouble Concentrating | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble concentrating. | FAMS - Trouble Concentrating | ||
FAMS01-I Have Trouble Learning New Tasks | C112587 | FAMS01-I Have Trouble Learning New Tasks | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble learning new tasks or directions. | FAMS - Trouble Learning New Tasks or Directions | ||
FAMS01-I Have Trouble Remembering Things | C112584 | FAMS01-I Have Trouble Remembering Things | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble remembering things. | FAMS - Trouble Remembering Things | ||
FAMS01-I Have Trouble Walking | C112553 | FAMS01-I Have Trouble Walking | Functional Assessment of Multiple Sclerosis - Mobility: I have trouble walking. | FAMS - I Have Trouble Walking | ||
FAMS01-I Need to Rest During the Day | C112583 | FAMS01-I Need to Rest During the Day | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I need to rest during the day. | FAMS - Need to Rest During the Day | ||
FAMS01-I Urinate More Frequently | C112605 | FAMS01-I Urinate More Frequently | Functional Assessment of Multiple Sclerosis - Additional Concerns: I urinate more frequently than usual. | FAMS - Urinate More Frequently Than Usual | ||
FAMS01-Limit My Social Activity | C112554 | FAMS01-Limit My Social Activity | Functional Assessment of Multiple Sclerosis - Mobility: I have to limit my social activity because of my condition. | FAMS - Limit Social Activity Because of Condition | ||
FAMS01-Losing Hope Against Illness | C112566 | FAMS01-Losing Hope Against Illness | Functional Assessment of Multiple Sclerosis - Emotional Well-Being: I am losing hope in the fight against my illness. | FAMS - Losing Hope in Fight Against My Illness | ||
FAMS01-My Family Has Accepted My Illness | C112591 | FAMS01-My Family Has Accepted My Illness | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: My family has accepted my illness. | FAMS - Family Has Accepted My Illness | ||
FAMS01-My Thinking Is Slower Than Before | C112586 | FAMS01-My Thinking Is Slower Than Before | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: My thinking is slower than before. | FAMS - My Thinking is Slower Than Before | ||
FAMS01-My Work Is Fulfilling | C112572 | FAMS01-My Work Is Fulfilling | Functional Assessment of Multiple Sclerosis - General Contentment: My work (include work at home) is fulfilling. | FAMS - My Work is Fulfilling | ||
FAMS01-Satisfied Communication Illness | C112592 | FAMS01-Satisfied Communication Illness | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: I am satisfied with family communication about my illness. | FAMS - Satisfied With Family Communication About My Illness | ||
FAMS01-Satisfied With How I Am Coping | C112599 | FAMS01-Satisfied With How I Am Coping | Functional Assessment of Multiple Sclerosis - Additional Concerns: I am satisfied with how I am coping with my illness. | FAMS - Satisfied With How I Am Coping With Illness | ||
FAMS01-Take My Condition Into Account | C112557 | FAMS01-Take My Condition Into Account | Functional Assessment of Multiple Sclerosis - Mobility: I have to take my condition into account when making plans. | FAMS - Have to Take Condition Into Account When Making Plans | ||
FAMS01-Trouble Finishing Things | C112582 | FAMS01-Trouble Finishing Things | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble finishing things because I am tired. | FAMS - Trouble Finishing Things Because I Am Tired | ||
FAMS01-Trouble Getting Around in Public | C112556 | FAMS01-Trouble Getting Around in Public | Functional Assessment of Multiple Sclerosis - Mobility: I have trouble getting around in public places. | FAMS - Trouble Getting Around in Public Places | ||
FAMS01-Trouble Meeting Needs of Family | C112551 | FAMS01-Trouble Meeting Needs of Family | Functional Assessment of Multiple Sclerosis - Mobility: Because of my physical condition, I have trouble meeting the needs of my family. | FAMS - Have Trouble Meeting Needs of Family Because of My Condition | ||
FAMS01-Trouble Starting Things | C112581 | FAMS01-Trouble Starting Things | Functional Assessment of Multiple Sclerosis - Thinking and Fatigue: I have trouble starting things because I am tired. | FAMS - Trouble Starting Things Because I Am Tired | ||
FAMS01-Trouble Understanding Worsening | C112593 | FAMS01-Trouble Understanding Worsening | Functional Assessment of Multiple Sclerosis - Family/Social Well-Being: My family has trouble understanding when my condition gets worse. | FAMS - Family Has Trouble Understanding When My Condition Gets Worse | ||
FAMS01-Worry My Condition Will Get Worse | C112601 | FAMS01-Worry My Condition Will Get Worse | Functional Assessment of Multiple Sclerosis - Additional Concerns: I worry that my condition will get worse. | FAMS - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C111346.FAQNA1TC | Functional Assessment Questionnaire-NACC UDS V2.0 Clinical Classification Test Code
(FAQNA1TC) | text
Extensible: No | C111346 | Functional Assessment Questionnaire-NACC UDS V2.0 Clinical Classification Test Code | Functional Assessment Questionnaire-NACC UDS V2.0 test code. | CDISC Clinical Classification FAQ-NACC UDS Version 2.0 Test Code Terminology |
FAQNA101 | C111510 | FAQNA1-Write Checks/Pay Bills/Checkbook | Functional Assessment Questionnaire-NACC UDS V2.0 - Writing checks, paying bills, or balancing a checkbook. | FAQ-NACC UDS Version 2.0 - Write checks, Pay bills, Balance checkbook | ||
FAQNA102 | C111511 | FAQNA1-Assembling | Functional Assessment Questionnaire-NACC UDS V2.0 - Assembling tax records, business affairs, or other papers. | FAQ-NACC UDS Version 2.0 - Assemble | ||
FAQNA103 | C111512 | FAQNA1-Shopping Alone | Functional Assessment Questionnaire-NACC UDS V2.0 - Shopping alone for clothes, household necessities, or groceries. | FAQ-NACC UDS Version 2.0 - Shop Alone | ||
FAQNA104 | C111513 | FAQNA1-Playing a Game of Skill | Functional Assessment Questionnaire-NACC UDS V2.0 - Playing a game of skill such as bridge or chess, working on a hobby. | FAQ-NACC UDS Version 2.0 - Play Game of Skill, Work on Hobby | ||
FAQNA105 | C111514 | FAQNA1-Heat Water/Make Coffee/Stove Off | Functional Assessment Questionnaire-NACC UDS V2.0 - Heating water, making a cup of coffee, turning off the stove. | FAQ-NACC UDS Version 2.0 - Heat water, Make Coffee, Turn Off Stove | ||
FAQNA106 | C111515 | FAQNA1-Preparing a Balanced Meal | Functional Assessment Questionnaire-NACC UDS V2.0 - Preparing a balanced meal. | FAQ-NACC UDS Version 2.0 - Prepare a Meal | ||
FAQNA107 | C111516 | FAQNA1-Keeping Track of Current Events | Functional Assessment Questionnaire-NACC UDS V2.0 - Keeping track of current events. | FAQ-NACC UDS Version 2.0 - Keep Track of Current Events | ||
FAQNA108 | C111517 | FAQNA1-Paying Attention | Functional Assessment Questionnaire-NACC UDS V2.0 - Paying attention to and understanding a TV program, book, or magazine. | FAQ-NACC UDS Version 2.0 - Pay Attention, Understand, Discuss | ||
FAQNA109 | C111518 | FAQNA1-Remembering | Functional Assessment Questionnaire-NACC UDS V2.0 - Remembering appointments, family occasions, holidays, medications. | FAQ-NACC UDS Version 2.0 - Remember | ||
FAQNA110 | C111519 | FAQNA1-Traveling | Functional Assessment Questionnaire-NACC UDS V2.0 - Traveling out of the neighborhood, driving, or arranging to take public transportation. | FAQ-NACC UDS Version 2.0 - Travel | ||
Back to top | ||||||
CL.C111345.FAQNA1TN | Functional Assessment Questionnaire-NACC UDS V2.0 Clinical Classification Test Name
(FAQNA1TN) | text
Extensible: No | C111345 | Functional Assessment Questionnaire-NACC UDS V2.0 Clinical Classification Test Name | Functional Assessment Questionnaire-NACC UDS V2.0 test name. | CDISC Clinical Classification FAQ-NACC UDS Version 2.0 Test Name Terminology |
FAQNA1-Assembling | C111511 | FAQNA1-Assembling | Functional Assessment Questionnaire-NACC UDS V2.0 - Assembling tax records, business affairs, or other papers. | FAQ-NACC UDS Version 2.0 - Assemble | ||
FAQNA1-Heat Water/Make Coffee/Stove Off | C111514 | FAQNA1-Heat Water/Make Coffee/Stove Off | Functional Assessment Questionnaire-NACC UDS V2.0 - Heating water, making a cup of coffee, turning off the stove. | FAQ-NACC UDS Version 2.0 - Heat water, Make Coffee, Turn Off Stove | ||
FAQNA1-Keeping Track of Current Events | C111516 | FAQNA1-Keeping Track of Current Events | Functional Assessment Questionnaire-NACC UDS V2.0 - Keeping track of current events. | FAQ-NACC UDS Version 2.0 - Keep Track of Current Events | ||
FAQNA1-Paying Attention | C111517 | FAQNA1-Paying Attention | Functional Assessment Questionnaire-NACC UDS V2.0 - Paying attention to and understanding a TV program, book, or magazine. | FAQ-NACC UDS Version 2.0 - Pay Attention, Understand, Discuss | ||
FAQNA1-Playing a Game of Skill | C111513 | FAQNA1-Playing a Game of Skill | Functional Assessment Questionnaire-NACC UDS V2.0 - Playing a game of skill such as bridge or chess, working on a hobby. | FAQ-NACC UDS Version 2.0 - Play Game of Skill, Work on Hobby | ||
FAQNA1-Preparing a Balanced Meal | C111515 | FAQNA1-Preparing a Balanced Meal | Functional Assessment Questionnaire-NACC UDS V2.0 - Preparing a balanced meal. | FAQ-NACC UDS Version 2.0 - Prepare a Meal | ||
FAQNA1-Remembering | C111518 | FAQNA1-Remembering | Functional Assessment Questionnaire-NACC UDS V2.0 - Remembering appointments, family occasions, holidays, medications. | FAQ-NACC UDS Version 2.0 - Remember | ||
FAQNA1-Shopping Alone | C111512 | FAQNA1-Shopping Alone | Functional Assessment Questionnaire-NACC UDS V2.0 - Shopping alone for clothes, household necessities, or groceries. | FAQ-NACC UDS Version 2.0 - Shop Alone | ||
FAQNA1-Traveling | C111519 | FAQNA1-Traveling | Functional Assessment Questionnaire-NACC UDS V2.0 - Traveling out of the neighborhood, driving, or arranging to take public transportation. | FAQ-NACC UDS Version 2.0 - Travel | ||
FAQNA1-Write Checks/Pay Bills/Checkbook | C111510 | FAQNA1-Write Checks/Pay Bills/Checkbook | Functional Assessment Questionnaire-NACC UDS V2.0 - Writing checks, paying bills, or balancing a checkbook. | FAQ-NACC UDS Version 2.0 - Write checks, Pay bills, Balance checkbook | ||
Back to top | ||||||
CL.C170523.FASNA1TC | Functional Assessment Scale-NACC UDS Version 3.0 Clinical Classification Test Code
(FASNA1TC) | text
Extensible: No | C170523 | Functional Assessment Scale-NACC UDS Version 3.0 Clinical Classification Test Code | Functional Assessment Scale-NACC UDS Version 3.0 test code. | CDISC Clinical Classification FAS-NACC UDS Version 3.0 Test Code Terminology |
FASNA101 | C170647 | FASNA1-Writing Checks, Paying Bills | Functional Assessment Scale-NACC UDS V3.0 - Writing checks, paying bills, or balancing a checkbook. | FAS-NACC UDS Version 3.0 - Writing Checks, Paying Bills | ||
FASNA102 | C170648 | FASNA1-Assembling Tax Records | Functional Assessment Scale-NACC UDS V3.0 - Assembling tax records, business affairs, or other papers. | FAS-NACC UDS Version 3.0 - Assembling Tax Records | ||
FASNA103 | C170649 | FASNA1-Shopping Alone for Clothes | Functional Assessment Scale-NACC UDS V3.0 - Shopping alone for clothes, household necessities, or groceries. | FAS-NACC UDS Version 3.0 - Shopping Alone for Clothes | ||
FASNA104 | C170650 | FASNA1-Playing a Game of Skill | Functional Assessment Scale-NACC UDS V3.0 - Playing a game of skill such as bridge or chess, working on a hobby. | FAS-NACC UDS Version 3.0 - Playing a Game of Skill | ||
FASNA105 | C170651 | FASNA1-Heating Water, Making Coffee | Functional Assessment Scale-NACC UDS V3.0 - Heating water, making a cup of coffee, turning off the stove. | FAS-NACC UDS Version 3.0 - Heating Water, Making Coffee | ||
FASNA106 | C170652 | FASNA1-Preparing a Balanced Meal | Functional Assessment Scale-NACC UDS V3.0 - Preparing a balanced meal. | FAS-NACC UDS Version 3.0 - Preparing a Balanced Meal | ||
FASNA107 | C170653 | FASNA1-Keeping Track of Current Events | Functional Assessment Scale-NACC UDS V3.0 - Keeping track of current events. | FAS-NACC UDS Version 3.0 - Keeping Track of Current Events | ||
FASNA108 | C170654 | FASNA1-Paying Attention/Understanding TV | Functional Assessment Scale-NACC UDS V3.0 - Paying attention to and understanding a TV program, book, or magazine. | FAS-NACC UDS Version 3.0 - Paying Attention and Understanding TV | ||
FASNA109 | C170655 | FASNA1-Remembering Appointments | Functional Assessment Scale-NACC UDS V3.0 - Remembering appointments, family occasions, holidays, medications. | FAS-NACC UDS Version 3.0 - Remembering Appointments | ||
FASNA110 | C170656 | FASNA1-Traveling Out of the Neighborhood | Functional Assessment Scale-NACC UDS V3.0 - Traveling out of the neighborhood, driving, or arranging to take public transportation. | FAS-NACC UDS Version 3.0 - Traveling Out of the Neighborhood | ||
Back to top | ||||||
CL.C170522.FASNA1TN | Functional Assessment Scale-NACC UDS Version 3.0 Clinical Classification Test Name
(FASNA1TN) | text
Extensible: No | C170522 | Functional Assessment Scale-NACC UDS Version 3.0 Clinical Classification Test Name | Functional Assessment Scale-NACC UDS Version 3.0 test name. | CDISC Clinical Classification FAS-NACC UDS Version 3.0 Test Name Terminology |
FASNA1-Assembling Tax Records | C170648 | FASNA1-Assembling Tax Records | Functional Assessment Scale-NACC UDS V3.0 - Assembling tax records, business affairs, or other papers. | FAS-NACC UDS Version 3.0 - Assembling Tax Records | ||
FASNA1-Heating Water, Making Coffee | C170651 | FASNA1-Heating Water, Making Coffee | Functional Assessment Scale-NACC UDS V3.0 - Heating water, making a cup of coffee, turning off the stove. | FAS-NACC UDS Version 3.0 - Heating Water, Making Coffee | ||
FASNA1-Keeping Track of Current Events | C170653 | FASNA1-Keeping Track of Current Events | Functional Assessment Scale-NACC UDS V3.0 - Keeping track of current events. | FAS-NACC UDS Version 3.0 - Keeping Track of Current Events | ||
FASNA1-Paying Attention/Understanding TV | C170654 | FASNA1-Paying Attention/Understanding TV | Functional Assessment Scale-NACC UDS V3.0 - Paying attention to and understanding a TV program, book, or magazine. | FAS-NACC UDS Version 3.0 - Paying Attention and Understanding TV | ||
FASNA1-Playing a Game of Skill | C170650 | FASNA1-Playing a Game of Skill | Functional Assessment Scale-NACC UDS V3.0 - Playing a game of skill such as bridge or chess, working on a hobby. | FAS-NACC UDS Version 3.0 - Playing a Game of Skill | ||
FASNA1-Preparing a Balanced Meal | C170652 | FASNA1-Preparing a Balanced Meal | Functional Assessment Scale-NACC UDS V3.0 - Preparing a balanced meal. | FAS-NACC UDS Version 3.0 - Preparing a Balanced Meal | ||
FASNA1-Remembering Appointments | C170655 | FASNA1-Remembering Appointments | Functional Assessment Scale-NACC UDS V3.0 - Remembering appointments, family occasions, holidays, medications. | FAS-NACC UDS Version 3.0 - Remembering Appointments | ||
FASNA1-Shopping Alone for Clothes | C170649 | FASNA1-Shopping Alone for Clothes | Functional Assessment Scale-NACC UDS V3.0 - Shopping alone for clothes, household necessities, or groceries. | FAS-NACC UDS Version 3.0 - Shopping Alone for Clothes | ||
FASNA1-Traveling Out of the Neighborhood | C170656 | FASNA1-Traveling Out of the Neighborhood | Functional Assessment Scale-NACC UDS V3.0 - Traveling out of the neighborhood, driving, or arranging to take public transportation. | FAS-NACC UDS Version 3.0 - Traveling Out of the Neighborhood | ||
FASNA1-Writing Checks, Paying Bills | C170647 | FASNA1-Writing Checks, Paying Bills | Functional Assessment Scale-NACC UDS V3.0 - Writing checks, paying bills, or balancing a checkbook. | FAS-NACC UDS Version 3.0 - Writing Checks, Paying Bills | ||
Back to top | ||||||
CL.C128682.GASTROCD | Gastrointestinal Test Code
(GASTROCD) | text
Extensible: Yes | C128682 | Gastrointestinal Test Code | A terminology codelist based on the test codes for physiological findings related to the gastrointestinal system. | CDISC SDTM Gastrointestinal Test Code Terminology |
BWOBIND | C156503 | Bowel Obstruction Indicator | An indication as to whether bowel obstruction has occurred. | Bowel Obstruction Indicator | ||
BWPFIND | C156504 | Bowel Perforation Indicator | An indication as to whether bowel perforation has occurred. | Bowel Perforation Indicator | ||
DIAMETER | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
ELASTIC | C119332 | Elasticity | A quantitative measurement of an organ's ability to deform in response to physiological force and return to its normal shape by passive elastic recoil. | Organ Elasticity | ||
GIEXAM | C198259 | Gastrointestinal System Examination | An observation, assessment or examination of the gastrointestinal system. | Gastrointestinal System Examination | ||
LVINVIND | C156505 | Lymphovascular Invasion Indicator | An indication as to whether lymphovascular invasion by tumor cells has occurred. | Lymphovascular Invasion Indicator | ||
PAREAULC | C176291 | Percent Area Covered By Ulcers | A measurement of the percentage of area examined that is covered by ulcerations. | Percent Ulcer Area | ||
PDFF | C189437 | Proton Density Fat Fraction | An estimated measurement of the fat in a targeted tissue through proton density assessments via magnetic resonance imaging. | Proton Density Fat Fraction | ||
RTAVDIST | C139184 | Rectal Tumor to Anal Verge Distance | A measurement of the distance between the rectal tumor and the anal margin. | Rectal Tumor to Anal Verge Distance | ||
STRCTNUM | C174274 | Number of Strictures | The number of anatomical strictures observed. | Number of Strictures | ||
THICK | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
Back to top | ||||||
CL.C128681.GASTRO | Gastrointestinal Test Name
(GASTRO) | text
Extensible: Yes | C128681 | Gastrointestinal Test Name | A terminology codelist based on the test names for physiological findings related to the gastrointestinal system. | CDISC SDTM Gastrointestinal Test Name Terminology |
Bowel Obstruction Indicator | C156503 | Bowel Obstruction Indicator | An indication as to whether bowel obstruction has occurred. | Bowel Obstruction Indicator | ||
Bowel Perforation Indicator | C156504 | Bowel Perforation Indicator | An indication as to whether bowel perforation has occurred. | Bowel Perforation Indicator | ||
Diameter | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
Elasticity | C119332 | Elasticity | A quantitative measurement of an organ's ability to deform in response to physiological force and return to its normal shape by passive elastic recoil. | Organ Elasticity | ||
Gastrointestinal System Examination | C198259 | Gastrointestinal System Examination | An observation, assessment or examination of the gastrointestinal system. | Gastrointestinal System Examination | ||
Lymphovascular Invasion Indicator | C156505 | Lymphovascular Invasion Indicator | An indication as to whether lymphovascular invasion by tumor cells has occurred. | Lymphovascular Invasion Indicator | ||
Number of Strictures | C174274 | Number of Strictures | The number of anatomical strictures observed. | Number of Strictures | ||
Percent Area Covered By Ulcers | C176291 | Percent Area Covered By Ulcers | A measurement of the percentage of area examined that is covered by ulcerations. | Percent Ulcer Area | ||
Proton Density Fat Fraction | C189437 | Proton Density Fat Fraction | An estimated measurement of the fat in a targeted tissue through proton density assessments via magnetic resonance imaging. | Proton Density Fat Fraction | ||
Rectal Tumor to Anal Verge Distance | C139184 | Rectal Tumor to Anal Verge Distance | A measurement of the distance between the rectal tumor and the anal margin. | Rectal Tumor to Anal Verge Distance | ||
Thickness | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
Back to top | ||||||
CL.C105138.GCGI01TC | General Clinical Global Impressions Questionnaire Test Code
(GCGI01TC) | text
Extensible: No | C105138 | General Clinical Global Impressions Questionnaire Test Code | General Clinical Global Impressions test code. | CDISC Questionnaire GCGI v1 Test Code Terminology |
GCGI0101 | C105278 | GCGI01-Global Severity of Pain | General Clinical Global Impressions - Global severity of pain. | GCGI - Global Severity of Pain | ||
GCGI0102 | C105279 | GCGI01-Global Improvement of Pain | General Clinical Global Impressions - Global improvement of pain. | GCGI - Global Improvement of Pain | ||
GCGI0103 | C105280 | GCGI01-Global Disease Status of Pain | General Clinical Global Impressions - Global disease status of pain. | GCGI - Global Disease Status of Pain | ||
GCGI0104 | C105281 | GCGI01-Pain Treatment Preference | General Clinical Global Impressions - Pain treatment preference. | GCGI - Pain Treatment Preference | ||
GCGI0105 | C105282 | GCGI01-Global Rating of Pain Medication | General Clinical Global Impressions - Global rating of pain medication. | GCGI - Global Rating of Pain Medication | ||
Back to top | ||||||
CL.C105137.GCGI01TN | General Clinical Global Impressions Questionnaire Test Name
(GCGI01TN) | text
Extensible: No | C105137 | General Clinical Global Impressions Questionnaire Test Name | General Clinical Global Impressions test name. | CDISC Questionnaire GCGI v1 Test Name Terminology |
GCGI01-Global Disease Status of Pain | C105280 | GCGI01-Global Disease Status of Pain | General Clinical Global Impressions - Global disease status of pain. | GCGI - Global Disease Status of Pain | ||
GCGI01-Global Improvement of Pain | C105279 | GCGI01-Global Improvement of Pain | General Clinical Global Impressions - Global improvement of pain. | GCGI - Global Improvement of Pain | ||
GCGI01-Global Rating of Pain Medication | C105282 | GCGI01-Global Rating of Pain Medication | General Clinical Global Impressions - Global rating of pain medication. | GCGI - Global Rating of Pain Medication | ||
GCGI01-Global Severity of Pain | C105278 | GCGI01-Global Severity of Pain | General Clinical Global Impressions - Global severity of pain. | GCGI - Global Severity of Pain | ||
GCGI01-Pain Treatment Preference | C105281 | GCGI01-Pain Treatment Preference | General Clinical Global Impressions - Pain treatment preference. | GCGI - Pain Treatment Preference | ||
Back to top | ||||||
CL.C103467.GAD01TC | Generalized Anxiety Disorder - 7 Questionnaire Test Code
(GAD01TC) | text
Extensible: No | C103467 | Generalized Anxiety Disorder - 7 Questionnaire Test Code | Generalized Anxiety Disorder - 7 test code. | CDISC Questionnaire GAD-7 Test Code Terminology |
GAD0101 | C103565 | GAD01-Feeling Nervous Anxious or On Edge | Generalized Anxiety Disorder - 7 - Feeling nervous, anxious or on edge. | GAD-7 - Feeling Nervous Anxious or On Edge | ||
GAD0102 | C103566 | GAD01-Not Able to Stop/Control Worrying | Generalized Anxiety Disorder - 7 - Not being able to stop or control worrying. | GAD-7 - Not Being Able to Stop or Control Worrying | ||
GAD0103 | C103567 | GAD01-Worrying Too Much About Things | Generalized Anxiety Disorder - 7 - Worrying too much about different things. | GAD-7 - Worrying Too Much About Different Things | ||
GAD0104 | C103568 | GAD01-Trouble Relaxing | Generalized Anxiety Disorder - 7 - Trouble relaxing. | GAD-7 - Trouble Relaxing | ||
GAD0105 | C103569 | GAD01-Being Restless Hard to Sit Still | Generalized Anxiety Disorder - 7 - Being so restless that it is hard to sit still. | GAD-7 - Being so Restless That it is Hard to Sit Still | ||
GAD0106 | C103570 | GAD01-Becoming Easily Annoyed/Irritable | Generalized Anxiety Disorder - 7 - Becoming easily annoyed or irritable. | GAD-7 - Becoming Easily Annoyed or Irritable | ||
GAD0107 | C103571 | GAD01-Feel Afraid/Something Awful Happen | Generalized Anxiety Disorder - 7 - Feeling afraid as if something awful might happen. | GAD-7 - Feel Afraid as if Something Awful Might Happen | ||
GAD0108 | C103572 | GAD01-Difficult to Work/Take Care Things | Generalized Anxiety Disorder - 7 - If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? | GAD-7 - Problems Made it Difficult to Work, Take Care of Things, or Get Along with Other People | ||
GAD0109 | C113886 | GAD01-Total Score | Generalized Anxiety Disorder - 7 - Total score. | GAD-7 - Total Score | ||
Back to top | ||||||
CL.C103466.GAD01TN | Generalized Anxiety Disorder - 7 Questionnaire Test Name
(GAD01TN) | text
Extensible: No | C103466 | Generalized Anxiety Disorder - 7 Questionnaire Test Name | Generalized Anxiety Disorder - 7 test name. | CDISC Questionnaire GAD-7 Test Name Terminology |
GAD01-Becoming Easily Annoyed/Irritable | C103570 | GAD01-Becoming Easily Annoyed/Irritable | Generalized Anxiety Disorder - 7 - Becoming easily annoyed or irritable. | GAD-7 - Becoming Easily Annoyed or Irritable | ||
GAD01-Being Restless Hard to Sit Still | C103569 | GAD01-Being Restless Hard to Sit Still | Generalized Anxiety Disorder - 7 - Being so restless that it is hard to sit still. | GAD-7 - Being so Restless That it is Hard to Sit Still | ||
GAD01-Difficult to Work/Take Care Things | C103572 | GAD01-Difficult to Work/Take Care Things | Generalized Anxiety Disorder - 7 - If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? | GAD-7 - Problems Made it Difficult to Work, Take Care of Things, or Get Along with Other People | ||
GAD01-Feel Afraid/Something Awful Happen | C103571 | GAD01-Feel Afraid/Something Awful Happen | Generalized Anxiety Disorder - 7 - Feeling afraid as if something awful might happen. | GAD-7 - Feel Afraid as if Something Awful Might Happen | ||
GAD01-Feeling Nervous Anxious or On Edge | C103565 | GAD01-Feeling Nervous Anxious or On Edge | Generalized Anxiety Disorder - 7 - Feeling nervous, anxious or on edge. | GAD-7 - Feeling Nervous Anxious or On Edge | ||
GAD01-Not Able to Stop/Control Worrying | C103566 | GAD01-Not Able to Stop/Control Worrying | Generalized Anxiety Disorder - 7 - Not being able to stop or control worrying. | GAD-7 - Not Being Able to Stop or Control Worrying | ||
GAD01-Total Score | C113886 | GAD01-Total Score | Generalized Anxiety Disorder - 7 - Total score. | GAD-7 - Total Score | ||
GAD01-Trouble Relaxing | C103568 | GAD01-Trouble Relaxing | Generalized Anxiety Disorder - 7 - Trouble relaxing. | GAD-7 - Trouble Relaxing | ||
GAD01-Worrying Too Much About Things | C103567 | GAD01-Worrying Too Much About Things | Generalized Anxiety Disorder - 7 - Worrying too much about different things. | GAD-7 - Worrying Too Much About Different Things | ||
Back to top | ||||||
CL.C163389.GAD02TC | Generalized Anxiety Disorder - 7 Version 2 Questionnaire Test Code
(GAD02TC) | text
Extensible: No | C163389 | Generalized Anxiety Disorder - 7 Version 2 Questionnaire Test Code | Generalized Anxiety Disorder - 7 Version 2 test code. | CDISC Questionnaire GAD-7 Version 2 Test Code Terminology |
GAD0201 | C163832 | GAD02-Feeling Nervous Anxious or On Edge | Generalized Anxiety Disorder - 7 Version 2 - Feeling nervous, anxious or on edge. | GAD-7 Version 2 - Feeling Nervous Anxious or On Edge | ||
GAD0202 | C163833 | GAD02-Not Able to Stop/Control Worrying | Generalized Anxiety Disorder - 7 Version 2 - Not being able to stop or control worrying. | GAD-7 Version 2 - Not Able to Stop or Control Worrying | ||
GAD0203 | C163834 | GAD02-Worrying Too Much About Things | Generalized Anxiety Disorder - 7 Version 2 - Worrying too much about different things. | GAD-7 Version 2 - Worrying Too Much About Things | ||
GAD0204 | C163835 | GAD02-Trouble Relaxing | Generalized Anxiety Disorder - 7 Version 2 - Trouble relaxing. | GAD-7 Version 2 - Trouble Relaxing | ||
GAD0205 | C163836 | GAD02-Being Restless Hard to Sit Still | Generalized Anxiety Disorder - 7 Version 2 - Being so restless that it is hard to sit still. | GAD-7 Version 2 - Being Restless Hard to Sit Still | ||
GAD0206 | C163837 | GAD02-Becoming Easily Annoyed/Irritable | Generalized Anxiety Disorder - 7 Version 2 - Becoming easily annoyed or irritable. | GAD-7 Version 2 - Becoming Easily Annoyed or Irritable | ||
GAD0207 | C163838 | GAD02-Feel Afraid/Something Awful Happen | Generalized Anxiety Disorder - 7 Version 2 - Feeling afraid as if something awful might happen. | GAD-7 Version 2 - Feel Afraid If Something Awful Happen | ||
GAD0208 | C163839 | GAD02-Total Score | Generalized Anxiety Disorder - 7 Version 2 - Total score. | GAD-7 Version 2 - Total Score | ||
Back to top | ||||||
CL.C163388.GAD02TN | Generalized Anxiety Disorder - 7 Version 2 Questionnaire Test Name
(GAD02TN) | text
Extensible: No | C163388 | Generalized Anxiety Disorder - 7 Version 2 Questionnaire Test Name | Generalized Anxiety Disorder - 7 Version 2 test name. | CDISC Questionnaire GAD-7 Version 2 Test Name Terminology |
GAD02-Becoming Easily Annoyed/Irritable | C163837 | GAD02-Becoming Easily Annoyed/Irritable | Generalized Anxiety Disorder - 7 Version 2 - Becoming easily annoyed or irritable. | GAD-7 Version 2 - Becoming Easily Annoyed or Irritable | ||
GAD02-Being Restless Hard to Sit Still | C163836 | GAD02-Being Restless Hard to Sit Still | Generalized Anxiety Disorder - 7 Version 2 - Being so restless that it is hard to sit still. | GAD-7 Version 2 - Being Restless Hard to Sit Still | ||
GAD02-Feel Afraid/Something Awful Happen | C163838 | GAD02-Feel Afraid/Something Awful Happen | Generalized Anxiety Disorder - 7 Version 2 - Feeling afraid as if something awful might happen. | GAD-7 Version 2 - Feel Afraid If Something Awful Happen | ||
GAD02-Feeling Nervous Anxious or On Edge | C163832 | GAD02-Feeling Nervous Anxious or On Edge | Generalized Anxiety Disorder - 7 Version 2 - Feeling nervous, anxious or on edge. | GAD-7 Version 2 - Feeling Nervous Anxious or On Edge | ||
GAD02-Not Able to Stop/Control Worrying | C163833 | GAD02-Not Able to Stop/Control Worrying | Generalized Anxiety Disorder - 7 Version 2 - Not being able to stop or control worrying. | GAD-7 Version 2 - Not Able to Stop or Control Worrying | ||
GAD02-Total Score | C163839 | GAD02-Total Score | Generalized Anxiety Disorder - 7 Version 2 - Total score. | GAD-7 Version 2 - Total Score | ||
GAD02-Trouble Relaxing | C163835 | GAD02-Trouble Relaxing | Generalized Anxiety Disorder - 7 Version 2 - Trouble relaxing. | GAD-7 Version 2 - Trouble Relaxing | ||
GAD02-Worrying Too Much About Things | C163834 | GAD02-Worrying Too Much About Things | Generalized Anxiety Disorder - 7 Version 2 - Worrying too much about different things. | GAD-7 Version 2 - Worrying Too Much About Things | ||
Back to top | ||||||
CL.C111114.GENSMP | Genetic Sample Type
(GENSMP) | text
Extensible: Yes | C111114 | Genetic Sample Type | Terminology relevant to the type of nucleic acid which was derived from the collected sample. | CDISC SDTM Genetic Sample Type Terminology |
7SK RNA | C95951 | 7SK Small Nuclear RNA;7SK snRNA | 7SK small nuclear RNA is encoded by the human RN7SK gene. This oligoribonucleotide may play a role in the regulation of the enzymatic activity of RNA polymerase II. | 7SK Small Nuclear RNA | ||
cDNA | C324 | Complementary DNA | Single-stranded DNA that is complementary to messenger RNA or DNA that has been synthesized from messenger RNA by reverse transcriptase. | cDNA | ||
cfDNA | C128274 | Cell Free Circulating DNA;Cell Free DNA;Circulating Cell Free DNA | DNA in blood plasma and other body fluids that has been released from a cell due to a biological process. | Circulating Cell-Free DNA | ||
cpDNA | C111158 | Chloroplast DNA | The DNA that is located in the photosynthetic, chlorophyll-containing organelle in the cells of young leaves and stems of higher plants. (NCI) | Chloroplast DNA | ||
ctDNA | C113243 | Cell-Free Circulating Tumor DNA;Circulating Tumor DNA | A type of cell-free DNA composed of small fragments of tumor DNA that are released by tumor cells into the bloodstream of the host. | Circulating Tumor-Derived DNA | ||
DNA | C449 | Deoxyribonucleic Acid;Double-stranded DNA;dsDNA | A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone; associated with the transmission of genetic information. | DNA | ||
dsRNA | C95938 | Double-stranded RNA | An RNA complex consisting of two base-paired strands of complementary RNA. | Double-Stranded RNA | ||
gDNA | C95940 | Genomic DNA | The DNA that is part of the normal chromosomal complement of an organism. | Genomic DNA | ||
gRNA | C95952 | Guide RNA | A small RNA involved in post-transcriptional mitochondrial RNA modification (RNA editing) in kinetoplastids. | Guide RNA | ||
hnRNA | C28454 | Heterogeneous Nuclear RNA | A diverse assortment of nascent, immature, unprocessed RNA transcripts synthesized from DNA templates that are found in eukaryotic nuclei before post-transcriptional modifications. | hnRNA | ||
miRNA | C25966 | MicroRNA;miRNA | A sequence of single-stranded RNA which is typically 20-25 nucleotides in length and may regulate the expression of other genes. miRNAs are transcribed from DNA, but are not translated into proteins. | MicroRNA | ||
mRNA | C813 | Messenger RNA | A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein. | Messenger RNA | ||
msDNA | C111279 | Multicopy Single-stranded DNA | A DNA/RNA chimera comprised of a single-stranded DNA molecule covalently bound to an internal guanosine of a RNA molecule. (NCI) | Multicopy Single-stranded DNA | ||
msdRNA | C111278 | MSR | The RNA portion of the msDNA molecule, which contains two stem-loop structures and varies widely in length across bacterial species. (NCI) | msdRNA | ||
mtDNA | C28512 | mDNA;Mitochondrial DNA | Typically small, circular, intronless, and maternally inherited, mitochondrial DNA (mtDNA) is the multicopy deoxyribonucleic acid genome of mitochondria, intracellular organelles responsible for vital respiratory chain and oxidative phosphorylation reactions in higher eukaryotes. Replicated and transcribed by a separate enzymatic machinery from that of nuclear DNA, mtDNA encodes only a subset of mitochondrial functions. | Mitochondrial DNA | ||
nDNA | C95941 | Nuclear DNA | The DNA that is normally located in the nucleus of a eukaryotic cell. | Nuclear DNA | ||
pDNA | C754 | Plasmid;Plasmid DNA | A small cellular inclusion consisting of a ring of DNA that is not in a chromosome but is capable of autonomous replication. | Plasmid | ||
piRNA | C95953 | piRNA;Piwi-Interacting RNA | Single-stranded RNA molecules that are expressed in animal cells and form complexes with Piwi proteins. They are involved in transcriptional gene silencing. | Piwi-Interacting RNA | ||
pre-mRNA | C111298 | Precursor mRNA | A primary RNA transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature mRNA. (NCI) | Precursor mRNA | ||
pri-miRNA | C25967 | Pri-microRNA;Pri-MIR;Pri-miRNA;Primary MicroRNA | The pri-miRNA is a primary transcript derived from a gene whose sole products are miRNA(s). A unique pathway involving the nuclear microprocessor complex participates in the cleavage of such transcripts, which can be substantially longer than the 65-110 nt pre-miRNA. | Pri-miRNA | ||
rDNA | C95943 | Ribosomal DNA;Ribosomal RNA Genes | The genomic sequences that code for ribosomal RNA molecules. | Ribosomal RNA Gene | ||
RIBOZYME | C1292 | Catalytic RNA;Ribonucleic Enzyme | RNA that contains an intron sequence which has an enzyme-like catalytic activity. This intron sequence can function like an enzyme in reactions with other RNA molecules and thus synthesize new molecules even in the absence of protein. | Ribozyme | ||
RNA | C812 | Ribonucleic Acid | Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis. | Ribonucleic Acid | ||
rRNA | C814 | Ribosomal RNA;rRNA | An RNA molecule that associates with multiple proteins to form ribosomes. | Ribosomal RNA | ||
siRNA | C2191 | siRNA;Small Interfering RNA | A 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference. | Small Interfering RNA | ||
snoRNA | C111316 | Small Nucleolar RNA;snoRNA | A small RNA molecule located in the cell nucleolus that associates with proteins to form small nucleolar ribonucleoprotein particles that are involved in modification of other RNAs. | Small Nucleolar RNA | ||
snRNA | C815 | Small Nuclear Ribonucleic Acid;Small Nuclear RNA;snRNA;U-RNA | A small RNA molecule (100-300 nucleotides) located in the cell nucleus that is involved in RNA splicing, transcriptional regulation, telomere maintenance and rRNA modification. | Small Nuclear RNA | ||
SRP RNA | C95950 | 7SL RNA;Signal Recognition Particle RNA;SRP RNA;srpRNA | A non-coding RNA that is part of the signal recognition particle. It is involved in the co-translational targeting of proteins to membranes. | Signal Recognition Particle RNA | ||
ssDNA | C111311 | Single-stranded DNA | A long linear single-stranded polymer formed from nucleotides attached to a deoxyribose backbone. (NCI) | Single-stranded DNA | ||
tmRNA | C95954 | 10Sa RNA;SsrA;Transfer-Messenger RNA | An RNA encoded by the bacterial ssrA gene. It is involved in the recycling of stalled ribosomes and the targeting of both defective mRNA molecules and incomplete nascent proteins for degradation. | Transfer-Messenger RNA | ||
TRANSPOSON | C95942 | Jumping Gene;Jumping Genes;Transposable Element | A class of mobile genetic elements that can move from one genomic position to another. | Transposon | ||
tRNA | C816 | Transfer RNA;Triplet Codon-Amino Acid Adaptor;tRNA | A class of short adaptor RNAs that transfers a specific amino acid to a growing polypeptide chain at the ribosomal site of protein synthesis during translation. | Transfer RNA | ||
Back to top | ||||||
CL.C181181.GFANMET | Genomic Findings Analytical Method Calculation Formula
(GFANMET) | text
Extensible: Yes | C181181 | Genomic Findings Analytical Method Calculation Formula | Terminology relevant to the formula names associated with a genomic findings test calculation. | CDISC SDTM Genomic Findings Analytical Method Calculation Formula Terminology |
ADME VARIANT PROFILE | C189438 | Unique pattern of nucleotide variation of genes that are involved in drug absorption, distribution, metabolism, and excretion (ADME). | ADME Variant Profile | |||
COUNTS PER MILLION FORMULA | C181324 | CPM | A formula that normalizes transcript fragment counts based on the total number of transcript fragments that are sequenced. CPM equals the number of reads divided by the number of sequenced transcript fragments, and multiplied by 1,000,000. | Transcript Fragment Count per Million Formula | ||
DIFFERENCES OF LOG2 INTENSITIES FORMULA | C181328 | A formula that compares gene expression by calculating the log2 fold difference between two gene expression intensities, or 2^(Value 2 Intensity - Value 1 Intensity). | Differences Of Log2 Intensities Formula | |||
FRAGMENTS PER KILOBASE MILLION FORMULA | C181325 | FPKM | A formula that calculates the number of fragments per million fragments sampled (calculated by dividing the fragment counts by a per million scaling factor, which is derived by taking the total fragments in the sample and dividing by 1,000,000) divided by the length of the gene, in kilobases. Fragments are represented by either paired or single end reads. | Fragments Per Kilobase Million Formula | ||
IFN-1 GENE SIGNATURE | C181329 | A unique pattern of gene expression of one to many combinations of genes that is associated with type 1 interferon activity. | IFN-1 Gene Signature | |||
READS PER KILOBASE MILLION FORMULA | C181326 | RPKM | A formula that calculates the number of fragments per million fragments sampled (calculated by dividing the fragment counts by a per million scaling factor, which is derived by taking the total fragments in the sample and dividing by 1,000,000) divided by the length of the gene, in kilobases. Fragments are represented by single end reads. | Reads Per Kilobase Million Formula | ||
TRANSCRIPTS PER MILLION FORMULA | C181327 | TPM | A formula that identifies the reads per kilobase (RPK, derived by dividing the read counts by the length of each gene, in kilobases) divided by a per million scaling factor (which is the count of RPK values in a sample divided by 1,000,000). | Transcripts Per Million Formula | ||
Back to top | ||||||
CL.C181178.GFTESTCD | Genomic Findings Test Code
(GFTESTCD) | text
Extensible: Yes | C181178 | Genomic Findings Test Code | Terminology relevant to the test codes that describe genomic findings. | CDISC SDTM Genomic Findings Test Code Terminology |
CPNUMVAR | C181330 | Copy Number Variation;Gene Copy Number Variation | An assessment of the variability in the number of replicas of a gene within a genome. | Copy Number Variation Assessment | ||
GENESIG | C181333 | Gene Expression Signature;Gene Signature | An assessment of the unique pattern of gene expression of one to many genes associated with a normal or abnormal biological process. | Gene Signature Assessment | ||
MICRISTB | C181332 | Microsatellite Instability | An assessment of the variability in length of microsatellite sequences. | Microsatellite Instability Length Assessment | ||
SEQREAR | C189439 | Sequence Rearrangement | Any product of a process affecting a nucleic acid sequence that results in the gain, loss, inversion, or translocation of nucleic acid. | Sequence Rearrangement | ||
SHRTVAR | C181334 | Short Variation | An assessment of the variability in a short sequence of nucleotides (generally defined as 50 base pairs or less), when compared to a reference sequence. | Short Variation Assessment | ||
SNV | C181331 | Single Nucleotide Variation | An assessment of the variability in a nucleotide found within a specified position of the genome, when compared to a reference nucleotide. | Single Nucleotide Variation Assessment | ||
TMB | C181335 | Tumor Mutation Burden;Tumor Mutational Burden | A quantitative or qualitative assessment of the number of genomic alterations found in genetic material from tumor cells, when compared to a reference sequence. | Tumor Mutation Burden Assessment | ||
TRNSCPTN | C17208 | Transcription | An assessment of transcribed RNA molecules in a biological specimen. | Transcription | ||
VARPROF | C189441 | Variant Profile | An assessment of the unique pattern of sequence variation of one to many loci associated with a normal or abnormal biological process. | Variant Profile Assessment | ||
VNTR | C189440 | Tandem Repeat Variation;Variable Nucleotide Tandem Repeats;Variable Number Tandem Repeats | An assessment of the variations in the number of tandem repeat nucleotide sequences, which are end-to-end adjacent copies of a short (2 to 60 nucleotides) DNA sequence. | Variable Number Tandem Repeats Assessment | ||
Back to top | ||||||
CL.C181180.GFTSDTL | Genomic Findings Test Detail
(GFTSDTL) | text
Extensible: Yes | C181180 | Genomic Findings Test Detail | Terminology relevant to the reportable qualifying the genomic assessment. | CDISC SDTM Genomic Findings Test Detail Terminology |
ALLELE SEQUENCE | C189447 | The determination of the nucleotide sequence of the allele at a specific locus. | Allele Sequence Analysis | |||
COPY NUMBER ALTERATION INTERPRETATION | C181337 | An interpretive summary of the number of replicas of a gene or gene segment within a genome, as compared to a reference or assumed state. | Copy Number Alteration Interpretation | |||
COPY NUMBER RATIO | C181349 | A relative measurement (ratio) of the number of altered copies in the sample to the number of copies in the reference sequence. | Copy Number Ratio | |||
DETECTION | C174330 | The determination of presence or absence of an entity in a specimen. | Biological Detection Test | |||
FRAGMENT COUNT | C181340 | The absolute number of fragments of genetic material that were detected. | Fragment Count | |||
GENETIC TRANSCRIPTION INDICATOR | C181338 | An indication as to whether a genetic sequence is transcribed into RNA. | Genetic Transcription Indicator | |||
GENETIC TRANSCRIPTION INTERPRETATION | C181339 | An interpretive summary of the pattern of genetic transcription. | Genetic Transcription Interpretation | |||
GENOTYPE | C45447 | The determination of the nucleotide sequence of the genetic material at a specific locus. | Genotyping | |||
MICROSATELLITE INSTABILITY OVERALL STATUS | C139285 | Microsatellite Instability Overall Stat;MSIOSTAT | The overall state or condition of the variability in length of multiple, assessed microsatellite sequences. | Microsatellite Instability Overall Status | ||
NORMALIZED LEVEL | C181341 | A value that is adjusted via a formula or calculation, to facilitate comparison. | Normalized Level | |||
NORMALIZED NUMBER OF SEQUENCE VARIANTS | C189448 | A quantitative assessment of the number of sequence variants within a region of interest, which has been normalized. | Number of Normalized Sequence Variants Assessment | |||
NUCLEOTIDE SEQUENCE | C45374 | The sequence of nucleotides within a genetic region of interest. | Nucleotide Sequence | |||
NUMBER OF ALTERED EXONS | C181348 | The number of affected exons as compared to the reference sequence. | Number of Altered Exons | |||
NUMBER OF CAG REPEATS | C189314 | A quantitative assessment of the number of repeating genetic sequences made up of cytosine, adenine, and guanine trinucleotides. | Number of CAG Repeats | |||
NUMBER OF GENE COPIES | C181336 | Gene Copy Number | The number of replicas of a particular gene sequence in a genome. | Number of Gene Copies | ||
NUMBER OF SEQUENCE VARIANTS | C181350 | A quantitative assessment of the number of sequence variants within a region of interest. | Number of Sequence Variants | |||
PERCENTILE RANK | C181342 | A relative ranking of the percent of total that the entity would equal or exceed. | Percentile Rank | |||
PREDICTED AMINO ACID CHANGE | C181343 | Inferred Amino Acid Change | An inferred amino acid modification, based on sequence analysis of a genetic variation. | Predicted Amino Acid Change | ||
PREDICTED CODING SEQUENCE CHANGE | C181344 | Inferred Coding Sequence Change | An inferred coding sequence modification, based on sequence analysis of a genetic variation. | Predicted Coding Sequence Change | ||
PREDICTED DIPLOTYPE | C189449 | Inferred Diplotype;Predicted Haplotype Pair | A description of the inferred nucleotide sequence at one or more paired loci. | Predicted Diplotype | ||
PREDICTED IN-FRAME INDICATOR | C189446 | An indication as to whether the genomic variation product retains the original reading frame, as inferred from the coding sequence. | Predicted In-Frame Indicator | |||
PREDICTED NUMBER OF CAG REPEATS | C189451 | An inferred number of repeating genetic sequences made up of cytosine, adenine, and guanine trinucleotides. | Predicted Number of CAG Repeats | |||
PREDICTED PHENOTYPE | C189450 | The observable characteristics as inferred from changes in the underlying genomic material. | Predicted Phenotype | |||
READ DEPTH | C155320 | Depth of Coverage;Total Mapped Reads;Total Read Depth | The total number of times a particular locus (site, nucleotide, amplicon, region) was sequenced. | Read Depth | ||
REARRANGEMENT GENE 1 | C189443 | The first or primary gene involved in the sequence rearrangement. | Rearrangement Gene 1 Symbol | |||
REARRANGEMENT GENE 2 | C189444 | The second gene involved in the sequence rearrangement. | Rearrangement Gene 2 Symbol | |||
REARRANGEMENT IMPACT CLASSIFICATION | C189657 | A categorization of the phenotypic or clinical significance of the genetic rearrangement. | Genetic Rearrangement Functional Impact Classification | |||
REARRANGEMENT TYPE | C189445 | The characterization or classification of the structural changes to the gene(s) as a consequence of the rearrangement. | Rearrangement Type Classification | |||
SCORE | C25338 | Score | A number or range of numeric values that assess and order a result or response for purposes of comparison. | Score | ||
VARIANT IMPACT CLASSIFICATION | C181345 | A categorization of the phenotypic or clinical significance of the genomic variation. | Genetic Variation Functional Impact Classification | |||
VARIANT READ DEPTH | C181346 | Variant Mapped Reads | The number of times a particular variant within a locus (site, nucleotide, amplicon, region) was sequenced. | Variant Read Depth | ||
VARIANT READ DEPTH/READ DEPTH | C181347 | Variant Mapped Reads/Total Mapped Reads;Variant Read Depth/Total Read Depth | A relative measurement (ratio or percentage) of the variant read depth to total read depth. | Variant Read Depth to Read Depth | ||
VARIANT SEQUENCE BURDEN INTERPRETATION | C181351 | An interpretive summary of the magnitude of the variant burden within the tumor. | Variant Sequence Tumor Burden Interpretation | |||
Back to top | ||||||
CL.C181179.GFTEST | Genomic Findings Test Name
(GFTEST) | text
Extensible: Yes | C181179 | Genomic Findings Test Name | Terminology relevant to the test names that describe genomic findings. | CDISC SDTM Genomic Findings Test Name Terminology |
Copy Number Variation | C181330 | Copy Number Variation;Gene Copy Number Variation | An assessment of the variability in the number of replicas of a gene within a genome. | Copy Number Variation Assessment | ||
Gene Signature | C181333 | Gene Expression Signature;Gene Signature | An assessment of the unique pattern of gene expression of one to many genes associated with a normal or abnormal biological process. | Gene Signature Assessment | ||
Microsatellite Instability | C181332 | Microsatellite Instability | An assessment of the variability in length of microsatellite sequences. | Microsatellite Instability Length Assessment | ||
Sequence Rearrangement | C189439 | Sequence Rearrangement | Any product of a process affecting a nucleic acid sequence that results in the gain, loss, inversion, or translocation of nucleic acid. | Sequence Rearrangement | ||
Short Variation | C181334 | Short Variation | An assessment of the variability in a short sequence of nucleotides (generally defined as 50 base pairs or less), when compared to a reference sequence. | Short Variation Assessment | ||
Single Nucleotide Variation | C181331 | Single Nucleotide Variation | An assessment of the variability in a nucleotide found within a specified position of the genome, when compared to a reference nucleotide. | Single Nucleotide Variation Assessment | ||
Transcription | C17208 | Transcription | An assessment of transcribed RNA molecules in a biological specimen. | Transcription | ||
Tumor Mutation Burden | C181335 | Tumor Mutation Burden;Tumor Mutational Burden | A quantitative or qualitative assessment of the number of genomic alterations found in genetic material from tumor cells, when compared to a reference sequence. | Tumor Mutation Burden Assessment | ||
Variable Number Tandem Repeats | C189440 | Tandem Repeat Variation;Variable Nucleotide Tandem Repeats;Variable Number Tandem Repeats | An assessment of the variations in the number of tandem repeat nucleotide sequences, which are end-to-end adjacent copies of a short (2 to 60 nucleotides) DNA sequence. | Variable Number Tandem Repeats Assessment | ||
Variant Profile | C189441 | Variant Profile | An assessment of the unique pattern of sequence variation of one to many loci associated with a normal or abnormal biological process. | Variant Profile Assessment | ||
Back to top | ||||||
CL.C181177.INHERTGF | Genomic Inheritability Type Response
(INHERTGF) | text
Extensible: Yes | C181177 | Genomic Inheritability Type Response | Terminology relevant to whether the variation can be passed to the next generation. | CDISC SDTM Genomic Inheritability Type Response Terminology |
GERMLINE VARIATION | C17666 | Any inheritable variation in the DNA that is transmitted to the progeny with some frequency. | Germline Variation | |||
MITOCHONDRIAL VARIATION | C181352 | Any inheritable variation that appears in mitochondrial DNA that is transmitted to the progeny with some frequency. | Mitochondrial DNA Variation | |||
SOMATIC VARIATION | C18060 | Any non-inheritable variation in the DNA that is not transmitted to the progeny but will be maintained during any mitosis within the individual. | Somatic Variation | |||
Back to top | ||||||
CL.C181176.SYMTYPGF | Genomic Symbol Type Response
(SYMTYPGF) | text
Extensible: Yes | C181176 | Genomic Symbol Type Response | Terminology relevant to the type of genomic entity that is represented by the published gene symbol. | CDISC SDTM Genomic Symbol Type Response Terminology |
CIRCULAR RNA | C181535 | circRNA | A sequence of single-stranded RNA that forms a covalently closed continuous loop. | Circular RNA | ||
ENDOGENOUS RETROVIRUS | C14334 | Integrated retroviral elements that are transmitted through the germline. (HGNC) | Endogenous Retrovirus | |||
FRAGILE SITE | C13375 | A heritable locus on a chromosome that is prone to DNA breakage. (HGNC) | Chromosome Fragile Site | |||
GENE WITH PROTEIN PRODUCT | C181531 | A protein-coding gene (the protein may be predicted or of unknown function). (HGNC) | Protein-Encoding Gene | |||
LONG NON-CODING RNA | C88924 | lncRNA | A non-coding transcript typically greater than 200bp in length. (Ensembl) | LincRNA | ||
MICRO RNA | C25966 | MicroRNA;miRNA | A sequence of single-stranded RNA which is typically 20-25 nucleotides in length and may regulate the expression of other genes. miRNAs are transcribed from DNA, but are not translated into proteins. | MicroRNA | ||
NONSENSE MEDIATED DECAY | C148643 | A transcript with a premature stop codon considered likely to be subjected to targeted degradation. (Ensembl) | Non-Sense Mediated Decay Mutation | |||
PIWI-INTERACTING RNA | C95953 | piRNA;Piwi-Interacting RNA | Single-stranded RNA molecules that are expressed in animal cells and form complexes with Piwi proteins. They are involved in transcriptional gene silencing. | Piwi-Interacting RNA | ||
PROCESSED TRANSCRIPT | C181532 | A transcript that doesn't contain an open reading frame (ORF). (Ensembl) | Processed Transcript | |||
PSEUDOGENE | C40415 | Genomic DNA sequences that are similar to protein-coding genes but do not encode a functional protein. (HGNC) | Pseudogene | |||
READTHROUGH TRANSCRIPT | C181194 | A naturally occurring transcript containing coding sequences from two or more genes that can also be transcribed individually. (HGNC) | Readthrough Transcript | |||
RETAINED INTRON | C181533 | An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene. (Ensembl) | Retained Intron | |||
RIBOSOMAL RNA | C814 | Ribosomal RNA;rRNA | An RNA molecule that associates with multiple proteins to form ribosomes. | Ribosomal RNA | ||
SMALL CYTOPLASMIC RNA | C181538 | scRNA | Non-protein coding genes that encode small cytoplasmic RNAs (scRNAs). (HGNC) | Small Cytoplasmic RNA | ||
SMALL INTERFERING RNA | C2191 | siRNA;Small Interfering RNA | A 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference. | Small Interfering RNA | ||
SMALL NON-CODING RNA | C181534 | Small ncRNA | A non-coding transcript typically less than 200bp in length. | Small Non-Coding RNA | ||
SMALL NUCLEAR RNA | C815 | Small Nuclear Ribonucleic Acid;Small Nuclear RNA;snRNA;U-RNA | A small RNA molecule (100-300 nucleotides) located in the cell nucleus that is involved in RNA splicing, transcriptional regulation, telomere maintenance and rRNA modification. | Small Nuclear RNA | ||
SMALL NUCLEOLAR RNA | C111316 | Small Nucleolar RNA;snoRNA | A small RNA molecule located in the cell nucleolus that associates with proteins to form small nucleolar ribonucleoprotein particles that are involved in modification of other RNAs. | Small Nucleolar RNA | ||
STOP CODON READTHROUGH TRANSCRIPT | C181537 | A transcript containing a stop codon that is translated, and termination occurs instead at a canonical stop codon further downstream. (Ensembl) | Stop Codon Readthrough Transcript | |||
TRANSFER RNA | C816 | Transfer RNA;Triplet Codon-Amino Acid Adaptor;tRNA | A class of short adaptor RNAs that transfers a specific amino acid to a growing polypeptide chain at the ribosomal site of protein synthesis during translation. | Transfer RNA | ||
TRANSPOSABLE ELEMENT | C95942 | Jumping Gene;Jumping Genes;Transposable Element | A class of mobile genetic elements that can move from one genomic position to another. | Transposon | ||
VAULT RNA | C181536 | vaultRNA;vtRNA | Small, untranslated RNAs associated with vault complexes. | Vault RNA | ||
VIRUS INTEGRATION SITE | C181539 | Viral Integration Site Sequence;VIS | Target sequence for the integration of viral DNA into the genome. (HGNC) | Virus Integration Site | ||
Back to top | ||||||
CL.C106663.GDS01TC | Geriatric Depression Scale Questionnaire Test Code
(GDS01TC) | text
Extensible: No | C106663 | Geriatric Depression Scale Questionnaire Test Code | Geriatric Depression Scale test code. | CDISC Questionnaire GDS Test Code Terminology |
GDS0101 | C106764 | GDS01-Satisfied With Life | Geriatric Depression Scale - Are you basically satisfied with your life? | GDS - Basically Satisfied With Life | ||
GDS0102 | C106765 | GDS01-Dropped Activities and Interests | Geriatric Depression Scale - Have you dropped many of your activities and interests? | GDS - Dropped Activities and Interests | ||
GDS0103 | C106766 | GDS01-Life Is Empty | Geriatric Depression Scale - Do you feel that your life is empty? | GDS - Feel Life Is Empty | ||
GDS0104 | C106767 | GDS01-Bored Often | Geriatric Depression Scale - Do you often get bored? | GDS - Often Get Bored | ||
GDS0105 | C106768 | GDS01-Hopeful About Future | Geriatric Depression Scale - Are you hopeful about the future? | GDS - Hopeful About Future | ||
GDS0106 | C106769 | GDS01-Bothered by Thoughts | Geriatric Depression Scale - Are you bothered by thoughts you can't get out of your head? | GDS - Bothered by Thoughts | ||
GDS0107 | C106770 | GDS01-Good Spirits Most of Time | Geriatric Depression Scale - Are you in good spirits most of the time? | GDS - Good Spirits Most of Time | ||
GDS0108 | C106771 | GDS01-Afraid of Something Bad Happening | Geriatric Depression Scale - Are you afraid that something bad is going to happen to you? | GDS - Afraid of Something Bad Happening | ||
GDS0109 | C106772 | GDS01-Feel Happy Most of Time | Geriatric Depression Scale - Do you feel happy most of the time? | GDS - Feel Happy Most of Time | ||
GDS0110 | C106773 | GDS01-Often Feel Helpless | Geriatric Depression Scale - Do you often feel helpless? | GDS - Often Feel Helpless | ||
GDS0111 | C106774 | GDS01-Get Restless and Fidgety | Geriatric Depression Scale - Do you often get restless and fidgety? | GDS - Get Restless and Fidgety | ||
GDS0112 | C106775 | GDS01-Prefer to Stay Home | Geriatric Depression Scale - Do you prefer to stay at home, rather than going out and doing new things? | GDS - Prefer to Stay Home | ||
GDS0113 | C106776 | GDS01-Worry About Future | Geriatric Depression Scale - Do you frequently worry about the future? | GDS - Frequently Worry About Future | ||
GDS0114 | C106777 | GDS01-Memory Problems | Geriatric Depression Scale - Do you feel you have more problems with memory than most? | GDS - More Memory Problems Than Most | ||
GDS0115 | C106778 | GDS01-Wonderful to Be Alive | Geriatric Depression Scale - Do you think it is wonderful to be alive now? | GDS - Think Wonderful to Be Alive | ||
GDS0116 | C106779 | GDS01-Feel Downhearted and Blue | Geriatric Depression Scale - Do you often feel downhearted and blue? | GDS - Feel Downhearted and Blue | ||
GDS0117 | C106780 | GDS01-Feel Worthless | Geriatric Depression Scale - Do you feel pretty worthless the way you are now? | GDS - Feel Worthless | ||
GDS0118 | C106781 | GDS01-Worry About the Past | Geriatric Depression Scale - Do you worry a lot about the past? | GDS - Worry About the Past | ||
GDS0119 | C106782 | GDS01-Find Life Exciting | Geriatric Depression Scale - Do you find life very exciting? | GDS - Find Life Exciting | ||
GDS0120 | C106783 | GDS01-Hard to Start New Projects | Geriatric Depression Scale - Is it hard for you to get started on new projects? | GDS - Hard to Start New Projects | ||
GDS0121 | C106784 | GDS01-Feel Full of Energy | Geriatric Depression Scale - Do you feel full of energy? | GDS - Feel Full of Energy | ||
GDS0122 | C106785 | GDS01-Feel Hopeless | Geriatric Depression Scale - Do you feel that your situation is hopeless? | GDS - Feel Situation Is Hopeless | ||
GDS0123 | C106786 | GDS01-Most People Better Off Than You | Geriatric Depression Scale - Do you think that most people are better off than you are? | GDS - Think Most People Better Off Than You | ||
GDS0124 | C106787 | GDS01-Often Upset Over Little Things | Geriatric Depression Scale -Do you frequently get upset over little things? | GDS - Often Upset Over Little Things | ||
GDS0125 | C106788 | GDS01-Frequently Feel Like Crying | Geriatric Depression Scale - Do you frequently feel like crying? | GDS - Frequently Feel Like Crying | ||
GDS0126 | C106789 | GDS01-Trouble Concentrating | Geriatric Depression Scale - Do you have trouble concentrating? | GDS - Have Trouble Concentrating | ||
GDS0127 | C106790 | GDS01-Enjoy Getting Up in the Morning | Geriatric Depression Scale - Do you enjoy getting up in the morning? | GDS - Enjoy Getting Up in the Morning | ||
GDS0128 | C106791 | GDS01-Avoid Social Gatherings | Geriatric Depression Scale - Do you prefer to avoid social gatherings? | GDS - Prefer to Avoid Social Gatherings | ||
GDS0129 | C106792 | GDS01-Easy to Make Decisions | Geriatric Depression Scale - Is it easy for you to make decisions? | GDS - Easy to Make Decisions | ||
GDS0130 | C106793 | GDS01-Mind as Clear as It Used to Be | Geriatric Depression Scale - Is your mind as clear as it used to be? | GDS - Mind as Clear as It Used to Be | ||
GDS0131 | C163949 | GDS01-Total Score | Geriatric Depression Scale - Total score. | GDS - Total Score | ||
Back to top | ||||||
CL.C106662.GDS01TN | Geriatric Depression Scale Questionnaire Test Name
(GDS01TN) | text
Extensible: No | C106662 | Geriatric Depression Scale Questionnaire Test Name | Geriatric Depression Scale test name. | CDISC Questionnaire GDS Test Name Terminology |
GDS01-Afraid of Something Bad Happening | C106771 | GDS01-Afraid of Something Bad Happening | Geriatric Depression Scale - Are you afraid that something bad is going to happen to you? | GDS - Afraid of Something Bad Happening | ||
GDS01-Avoid Social Gatherings | C106791 | GDS01-Avoid Social Gatherings | Geriatric Depression Scale - Do you prefer to avoid social gatherings? | GDS - Prefer to Avoid Social Gatherings | ||
GDS01-Bored Often | C106767 | GDS01-Bored Often | Geriatric Depression Scale - Do you often get bored? | GDS - Often Get Bored | ||
GDS01-Bothered by Thoughts | C106769 | GDS01-Bothered by Thoughts | Geriatric Depression Scale - Are you bothered by thoughts you can't get out of your head? | GDS - Bothered by Thoughts | ||
GDS01-Dropped Activities and Interests | C106765 | GDS01-Dropped Activities and Interests | Geriatric Depression Scale - Have you dropped many of your activities and interests? | GDS - Dropped Activities and Interests | ||
GDS01-Easy to Make Decisions | C106792 | GDS01-Easy to Make Decisions | Geriatric Depression Scale - Is it easy for you to make decisions? | GDS - Easy to Make Decisions | ||
GDS01-Enjoy Getting Up in the Morning | C106790 | GDS01-Enjoy Getting Up in the Morning | Geriatric Depression Scale - Do you enjoy getting up in the morning? | GDS - Enjoy Getting Up in the Morning | ||
GDS01-Feel Downhearted and Blue | C106779 | GDS01-Feel Downhearted and Blue | Geriatric Depression Scale - Do you often feel downhearted and blue? | GDS - Feel Downhearted and Blue | ||
GDS01-Feel Full of Energy | C106784 | GDS01-Feel Full of Energy | Geriatric Depression Scale - Do you feel full of energy? | GDS - Feel Full of Energy | ||
GDS01-Feel Happy Most of Time | C106772 | GDS01-Feel Happy Most of Time | Geriatric Depression Scale - Do you feel happy most of the time? | GDS - Feel Happy Most of Time | ||
GDS01-Feel Hopeless | C106785 | GDS01-Feel Hopeless | Geriatric Depression Scale - Do you feel that your situation is hopeless? | GDS - Feel Situation Is Hopeless | ||
GDS01-Feel Worthless | C106780 | GDS01-Feel Worthless | Geriatric Depression Scale - Do you feel pretty worthless the way you are now? | GDS - Feel Worthless | ||
GDS01-Find Life Exciting | C106782 | GDS01-Find Life Exciting | Geriatric Depression Scale - Do you find life very exciting? | GDS - Find Life Exciting | ||
GDS01-Frequently Feel Like Crying | C106788 | GDS01-Frequently Feel Like Crying | Geriatric Depression Scale - Do you frequently feel like crying? | GDS - Frequently Feel Like Crying | ||
GDS01-Get Restless and Fidgety | C106774 | GDS01-Get Restless and Fidgety | Geriatric Depression Scale - Do you often get restless and fidgety? | GDS - Get Restless and Fidgety | ||
GDS01-Good Spirits Most of Time | C106770 | GDS01-Good Spirits Most of Time | Geriatric Depression Scale - Are you in good spirits most of the time? | GDS - Good Spirits Most of Time | ||
GDS01-Hard to Start New Projects | C106783 | GDS01-Hard to Start New Projects | Geriatric Depression Scale - Is it hard for you to get started on new projects? | GDS - Hard to Start New Projects | ||
GDS01-Hopeful About Future | C106768 | GDS01-Hopeful About Future | Geriatric Depression Scale - Are you hopeful about the future? | GDS - Hopeful About Future | ||
GDS01-Life Is Empty | C106766 | GDS01-Life Is Empty | Geriatric Depression Scale - Do you feel that your life is empty? | GDS - Feel Life Is Empty | ||
GDS01-Memory Problems | C106777 | GDS01-Memory Problems | Geriatric Depression Scale - Do you feel you have more problems with memory than most? | GDS - More Memory Problems Than Most | ||
GDS01-Mind as Clear as It Used to Be | C106793 | GDS01-Mind as Clear as It Used to Be | Geriatric Depression Scale - Is your mind as clear as it used to be? | GDS - Mind as Clear as It Used to Be | ||
GDS01-Most People Better Off Than You | C106786 | GDS01-Most People Better Off Than You | Geriatric Depression Scale - Do you think that most people are better off than you are? | GDS - Think Most People Better Off Than You | ||
GDS01-Often Feel Helpless | C106773 | GDS01-Often Feel Helpless | Geriatric Depression Scale - Do you often feel helpless? | GDS - Often Feel Helpless | ||
GDS01-Often Upset Over Little Things | C106787 | GDS01-Often Upset Over Little Things | Geriatric Depression Scale -Do you frequently get upset over little things? | GDS - Often Upset Over Little Things | ||
GDS01-Prefer to Stay Home | C106775 | GDS01-Prefer to Stay Home | Geriatric Depression Scale - Do you prefer to stay at home, rather than going out and doing new things? | GDS - Prefer to Stay Home | ||
GDS01-Satisfied With Life | C106764 | GDS01-Satisfied With Life | Geriatric Depression Scale - Are you basically satisfied with your life? | GDS - Basically Satisfied With Life | ||
GDS01-Total Score | C163949 | GDS01-Total Score | Geriatric Depression Scale - Total score. | GDS - Total Score | ||
GDS01-Trouble Concentrating | C106789 | GDS01-Trouble Concentrating | Geriatric Depression Scale - Do you have trouble concentrating? | GDS - Have Trouble Concentrating | ||
GDS01-Wonderful to Be Alive | C106778 | GDS01-Wonderful to Be Alive | Geriatric Depression Scale - Do you think it is wonderful to be alive now? | GDS - Think Wonderful to Be Alive | ||
GDS01-Worry About Future | C106776 | GDS01-Worry About Future | Geriatric Depression Scale - Do you frequently worry about the future? | GDS - Frequently Worry About Future | ||
GDS01-Worry About the Past | C106781 | GDS01-Worry About the Past | Geriatric Depression Scale - Do you worry a lot about the past? | GDS - Worry About the Past | ||
Back to top | ||||||
CL.C106665.GDS02TC | Geriatric Depression Scale Short Form Questionnaire Test Code
(GDS02TC) | text
Extensible: No | C106665 | Geriatric Depression Scale Short Form Questionnaire Test Code | Geriatric Depression Scale Short Form test code. | CDISC Questionnaire GDS-SF Test Code Terminology |
GDS0201 | C106794 | GDS02-Satisfied With Life | Geriatric Depression Scale Short Form - Are you basically satisfied with your life? | GDS-SF - Basically Satisfied With Life | ||
GDS0202 | C106795 | GDS02-Dropped Activities and Interests | Geriatric Depression Scale Short Form - Have you dropped many of your activities and interests? | GDS-SF - Dropped Activities and Interests | ||
GDS0203 | C106796 | GDS02-Life Is Empty | Geriatric Depression Scale Short Form - Do you feel that your life is empty? | GDS-SF - Feel Life Is Empty | ||
GDS0204 | C106797 | GDS02-Bored Often | Geriatric Depression Scale Short Form - Do you often get bored? | GDS-SF - Often Get Bored | ||
GDS0205 | C106798 | GDS02-Good Spirits Most of Time | Geriatric Depression Scale Short Form - Are you in good spirits most of the time? | GDS-SF - Good Spirits Most of Time | ||
GDS0206 | C106799 | GDS02-Afraid of Something Bad Happening | Geriatric Depression Scale Short Form - Are you afraid that something bad is going to happen to you? | GDS-SF - Afraid of Something Bad Happening | ||
GDS0207 | C106800 | GDS02-Feel Happy Most of Time | Geriatric Depression Scale Short Form - Do you feel happy most of the time? | GDS-SF - Feel Happy Most of Time | ||
GDS0208 | C106801 | GDS02-Often Feel Helpless | Geriatric Depression Scale Short Form - Do you often feel helpless? | GDS-SF - Often Feel Helpless | ||
GDS0209 | C106802 | GDS02-Prefer to Stay Home | Geriatric Depression Scale Short Form - Do you prefer to stay at home rather than going out and doing new things? | GDS-SF - Prefer to Stay Home | ||
GDS0210 | C106803 | GDS02-Memory Problems | Geriatric Depression Scale Short Form - Do you feel you have more problems with memory than most? | GDS-SF - More Memory Problems Than Most | ||
GDS0211 | C106804 | GDS02-Wonderful to Be Alive | Geriatric Depression Scale Short Form - Do you think it is wonderful to be alive now? | GDS-SF - Think Wonderful to Be Alive | ||
GDS0212 | C106805 | GDS02-Feel Worthless | Geriatric Depression Scale Short Form - Do you feel pretty worthless the way you are now? | GDS-SF - Feel Worthless | ||
GDS0213 | C106806 | GDS02-Feel Full of Energy | Geriatric Depression Scale Short Form - Do you feel full of energy? | GDS-SF - Feel Full of Energy | ||
GDS0214 | C106807 | GDS02-Feel Hopeless | Geriatric Depression Scale Short Form - Do you feel that your situation is hopeless? | GDS-SF - Feel Situation is Hopeless | ||
GDS0215 | C106808 | GDS02-Most People Better Off Than You | Geriatric Depression Scale Short Form - Do you think that most people are better off than you are? | GDS-SF - Think Most People Better Off Than You | ||
GDS0216 | C163948 | GDS02-Total Score | Geriatric Depression Scale Short Form - Total score. | GDS-SF - Total Score | ||
Back to top | ||||||
CL.C106664.GDS02TN | Geriatric Depression Scale Short Form Questionnaire Test Name
(GDS02TN) | text
Extensible: No | C106664 | Geriatric Depression Scale Short Form Questionnaire Test Name | Geriatric Depression Scale Short Form test name. | CDISC Questionnaire GDS-SF Test Name Terminology |
GDS02-Afraid of Something Bad Happening | C106799 | GDS02-Afraid of Something Bad Happening | Geriatric Depression Scale Short Form - Are you afraid that something bad is going to happen to you? | GDS-SF - Afraid of Something Bad Happening | ||
GDS02-Bored Often | C106797 | GDS02-Bored Often | Geriatric Depression Scale Short Form - Do you often get bored? | GDS-SF - Often Get Bored | ||
GDS02-Dropped Activities and Interests | C106795 | GDS02-Dropped Activities and Interests | Geriatric Depression Scale Short Form - Have you dropped many of your activities and interests? | GDS-SF - Dropped Activities and Interests | ||
GDS02-Feel Full of Energy | C106806 | GDS02-Feel Full of Energy | Geriatric Depression Scale Short Form - Do you feel full of energy? | GDS-SF - Feel Full of Energy | ||
GDS02-Feel Happy Most of Time | C106800 | GDS02-Feel Happy Most of Time | Geriatric Depression Scale Short Form - Do you feel happy most of the time? | GDS-SF - Feel Happy Most of Time | ||
GDS02-Feel Hopeless | C106807 | GDS02-Feel Hopeless | Geriatric Depression Scale Short Form - Do you feel that your situation is hopeless? | GDS-SF - Feel Situation is Hopeless | ||
GDS02-Feel Worthless | C106805 | GDS02-Feel Worthless | Geriatric Depression Scale Short Form - Do you feel pretty worthless the way you are now? | GDS-SF - Feel Worthless | ||
GDS02-Good Spirits Most of Time | C106798 | GDS02-Good Spirits Most of Time | Geriatric Depression Scale Short Form - Are you in good spirits most of the time? | GDS-SF - Good Spirits Most of Time | ||
GDS02-Life Is Empty | C106796 | GDS02-Life Is Empty | Geriatric Depression Scale Short Form - Do you feel that your life is empty? | GDS-SF - Feel Life Is Empty | ||
GDS02-Memory Problems | C106803 | GDS02-Memory Problems | Geriatric Depression Scale Short Form - Do you feel you have more problems with memory than most? | GDS-SF - More Memory Problems Than Most | ||
GDS02-Most People Better Off Than You | C106808 | GDS02-Most People Better Off Than You | Geriatric Depression Scale Short Form - Do you think that most people are better off than you are? | GDS-SF - Think Most People Better Off Than You | ||
GDS02-Often Feel Helpless | C106801 | GDS02-Often Feel Helpless | Geriatric Depression Scale Short Form - Do you often feel helpless? | GDS-SF - Often Feel Helpless | ||
GDS02-Prefer to Stay Home | C106802 | GDS02-Prefer to Stay Home | Geriatric Depression Scale Short Form - Do you prefer to stay at home rather than going out and doing new things? | GDS-SF - Prefer to Stay Home | ||
GDS02-Satisfied With Life | C106794 | GDS02-Satisfied With Life | Geriatric Depression Scale Short Form - Are you basically satisfied with your life? | GDS-SF - Basically Satisfied With Life | ||
GDS02-Total Score | C163948 | GDS02-Total Score | Geriatric Depression Scale Short Form - Total score. | GDS-SF - Total Score | ||
GDS02-Wonderful to Be Alive | C106804 | GDS02-Wonderful to Be Alive | Geriatric Depression Scale Short Form - Do you think it is wonderful to be alive now? | GDS-SF - Think Wonderful to Be Alive | ||
Back to top | ||||||
CL.C124682.GCS01TC | Glasgow Coma Scale NINDS Version 1.0 Clinical Classification Test Code
(GCS01TC) | text
Extensible: No | C124682 | Glasgow Coma Scale NINDS Version 1.0 Clinical Classification Test Code | Glasgow Coma Scale NINDS Version 1.0 test code. | CDISC Clinical Classification Glasgow Coma Scale-NINDS Version 1.0 Test Code Terminology |
GCS0101 | C124724 | GCS01-Best Eye Response | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Best eye response. | Glasgow Coma Scale-NINDS Version 1.0 - Best Eye Response | ||
GCS0102 | C124725 | GCS01-Motor Response | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Motor response. | Glasgow Coma Scale-NINDS Version 1.0 - Motor Response | ||
GCS0103 | C124726 | GCS01-Verbal Response | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Verbal response. | Glasgow Coma Scale-NINDS Version 1.0 - Verbal Response | ||
GCS0104 | C124727 | GCS01-Total Score | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Total score. | Glasgow Coma Scale-NINDS Version 1.0 - Total Score | ||
GCS0105A | C124728 | GCS01-Confounder: GCS Accurate | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: GCS accurate. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: GCS Accurate | ||
GCS0105B | C124729 | GCS01-Confounder: Paralytic | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: paralytic. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Paralytic | ||
GCS0105C | C124730 | GCS01-Confounder: Alcohol/Drug of Abuse | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: alcohol/drugs of abuse. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Alcohol or Drug of Abuse | ||
GCS0105D | C124731 | GCS01-Confounder: C-Spine Injury | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: C-spine injury. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: C-Spine Injury | ||
GCS0105E | C124732 | GCS01-Confounder: Hypoxia/Hypotension | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: hypoxia/hypotension. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypoxia or Hypotension | ||
GCS0105F | C124733 | GCS01-Confounder: Hypothermia | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: hypothermia. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypothermia | ||
GCS0105G | C124734 | GCS01-Confounder: Sedation | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: sedation. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Sedation | ||
GCS0105H | C124735 | GCS01-Confounder: Unknown | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: unknown. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Unknown | ||
Back to top | ||||||
CL.C124681.GCS01TN | Glasgow Coma Scale NINDS Version 1.0 Clinical Classification Test Name
(GCS01TN) | text
Extensible: No | C124681 | Glasgow Coma Scale NINDS Version 1.0 Clinical Classification Test Name | Glasgow Coma Scale NINDS Version 1.0 test name. | CDISC Clinical Classification Glasgow Coma Scale-NINDS Version 1.0 Test Name Terminology |
GCS01-Best Eye Response | C124724 | GCS01-Best Eye Response | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Best eye response. | Glasgow Coma Scale-NINDS Version 1.0 - Best Eye Response | ||
GCS01-Confounder: Alcohol/Drug of Abuse | C124730 | GCS01-Confounder: Alcohol/Drug of Abuse | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: alcohol/drugs of abuse. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Alcohol or Drug of Abuse | ||
GCS01-Confounder: C-Spine Injury | C124731 | GCS01-Confounder: C-Spine Injury | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: C-spine injury. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: C-Spine Injury | ||
GCS01-Confounder: GCS Accurate | C124728 | GCS01-Confounder: GCS Accurate | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: GCS accurate. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: GCS Accurate | ||
GCS01-Confounder: Hypothermia | C124733 | GCS01-Confounder: Hypothermia | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: hypothermia. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypothermia | ||
GCS01-Confounder: Hypoxia/Hypotension | C124732 | GCS01-Confounder: Hypoxia/Hypotension | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: hypoxia/hypotension. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypoxia or Hypotension | ||
GCS01-Confounder: Paralytic | C124729 | GCS01-Confounder: Paralytic | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: paralytic. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Paralytic | ||
GCS01-Confounder: Sedation | C124734 | GCS01-Confounder: Sedation | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: sedation. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Sedation | ||
GCS01-Confounder: Unknown | C124735 | GCS01-Confounder: Unknown | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - GCS Confounder Type: unknown. | Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Unknown | ||
GCS01-Motor Response | C124725 | GCS01-Motor Response | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Motor response. | Glasgow Coma Scale-NINDS Version 1.0 - Motor Response | ||
GCS01-Total Score | C124727 | GCS01-Total Score | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Total score. | Glasgow Coma Scale-NINDS Version 1.0 - Total Score | ||
GCS01-Verbal Response | C124726 | GCS01-Verbal Response | Glasgow Coma Scale The National Institute of Neurological Disorders and Stroke Version 1.0 - Verbal response. | Glasgow Coma Scale-NINDS Version 1.0 - Verbal Response | ||
Back to top | ||||||
CL.C117737.GRAFTTYP | Graft Type
(GRAFTTYP) | text
Extensible: Yes | C117737 | Graft Type | A terminology codelist relevant to the type of graft implanted in the subject. | CDISC SDTM Graft Type Terminology |
ARTERIAL GRAFT, FREE | C117816 | A vessel graft comprised of an artery that has been completely detached from its original location. (NCI) | Free Arterial Graft | |||
ARTERIAL GRAFT, IN-SITU | C117817 | A vessel graft comprised of an artery whose origin remains intact. | In Situ Arterial Graft | |||
AUTOLOGOUS VEIN GRAFT | C117818 | A vessel graft comprised of a vein harvested from a different anatomical location. | Autologous Vein Graft | |||
CADAVERIC GRAFT, ARTERIAL | C117819 | An arterial graft harvested from a cadaver. (NCI) | Cadaveric Arterial Graft | |||
CADAVERIC GRAFT, VENOUS | C117820 | A venous graft harvested from a cadaver. (NCI) | Cadaveric Venous Graft | |||
COMPOSITE GRAFT | C117821 | A vessel graft comprised of two or more conduit materials. | Composite Vessel Graft | |||
SAPHENOUS VEIN GRAFT | C117822 | SVG | A vessel graft comprised of the saphenous vein. | Saphenous Vein Graft | ||
SYNTHETIC GRAFT | C117823 | A vessel graft comprised of non-biological material. | Synthetic Vessel Graft | |||
Back to top | ||||||
CL.C182468.HAMA101T14OR | Hamilton Anxiety Rating Scale Clinical Classification ORRES for HAMA101 Through HAMA114 TN/TC
(HAMA101T14OR) | text
Extensible: No | C182468 | Hamilton Anxiety Rating Scale Clinical Classification ORRES for HAMA101 Through HAMA114 TN/TC | Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114 test and test code. | CDISC Clinical Classification Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Response Terminology |
Mild | C182707 | HAMA101 through HAMA114-Mild | Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Mild. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Mild | ||
Moderate | C182708 | HAMA101 through HAMA114-Moderate | Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Moderate. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Moderate | ||
Not present | C182706 | HAMA101 through HAMA114-Not present | Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Not present. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Not present | ||
Severe | C182709 | HAMA101 through HAMA114-Severe | Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Severe. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Severe | ||
Very severe | C182710 | HAMA101 through HAMA114-Very severe | Hamilton Anxiety Rating Scale original result for HAMA101 through HAMA114-Very severe. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Original Result - Very severe | ||
Back to top | ||||||
CL.C182506.HAMA101T14STR | Hamilton Anxiety Rating Scale Clinical Classification STRESC for HAMA101 Through HAMA114 TN/TC
(HAMA101T14STR) | text
Extensible: No | C182506 | Hamilton Anxiety Rating Scale Clinical Classification STRESC for HAMA101 Through HAMA114 TN/TC | Hamilton Anxiety Rating Scale standardized character result for HAMA101 through HAMA114 test and test code. | CDISC Clinical Classification Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Response Terminology |
0 | C182711 | HAMA101 through HAMA114-0 | Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Not present. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 0 | ||
1 | C182712 | HAMA101 through HAMA114-1 | Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Mild. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 1 | ||
2 | C182713 | HAMA101 through HAMA114-2 | Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Moderate. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 2 | ||
3 | C182714 | HAMA101 through HAMA114-3 | Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Severe. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 3 | ||
4 | C182715 | HAMA101 through HAMA114-4 | Hamilton Anxiety Rating Scale standard character result for HAMA101 through HAMA114-Very severe. | Hamilton Anxiety Rating Scale HAMA101 Through HAMA114 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C101819.HAMA1TC | Hamilton Anxiety Rating Scale Clinical Classification Test Code
(HAMA1TC) | text
Extensible: No | C101819 | Hamilton Anxiety Rating Scale Clinical Classification Test Code | Hamilton Anxiety Rating Scale test code. | CDISC Clinical Classification HAMA Test Code Terminology |
HAMA101 | C102073 | HAMA1-Anxious Mood | Hamilton Anxiety Rating Scale - Anxious mood: worries, anticipation of the worst, fearful anticipation, irritability. | HAMA - Anxious Mood | ||
HAMA102 | C102074 | HAMA1-Tension | Hamilton Anxiety Rating Scale - Tension: feelings of tension, fatigability, startle response, moved to tears easily, trembling, feelings of restlessness, inability to relax. | HAMA - Tension | ||
HAMA103 | C102075 | HAMA1-Fears | Hamilton Anxiety Rating Scale - Fears: of dark, of strangers, of being left alone, of animals, of traffic, of crowds. | HAMA - Fears | ||
HAMA104 | C102076 | HAMA1-Insomnia | Hamilton Anxiety Rating Scale - Insomnia: difficulty falling asleep, broken sleep, unsatisfying sleep and fatigue on waking, dreams, nightmares, night terrors. | HAMA - Insomnia | ||
HAMA105 | C102077 | HAMA1-Intellectual | Hamilton Anxiety Rating Scale - Intellectual: difficulty in concentration, poor memory. | HAMA - Intellectual | ||
HAMA106 | C102078 | HAMA1-Depressed Mood | Hamilton Anxiety Rating Scale - Depressed mood: loss of interest, lack of pleasure in hobbies, depression, early waking, diurnal swing. | HAMA - Depressed Mood | ||
HAMA107 | C102079 | HAMA1-Somatic (Muscular) | Hamilton Anxiety Rating Scale - Somatic (muscular): pains and aches, twitching, stiffness, myoclonic jerks, grinding of teeth, unsteady voice, increased muscular tone. | HAMA - Somatic (Muscular) | ||
HAMA108 | C102080 | HAMA1-Somatic (Sensory) | Hamilton Anxiety Rating Scale - Somatic (sensory): tinnitus, blurring of vision, hot and cold flushes, feelings of weakness, pricking sensation. | HAMA - Somatic (Sensory) | ||
HAMA109 | C102081 | HAMA1-Cardiovascular Symptoms | Hamilton Anxiety Rating Scale - Cardiovascular symptoms: tachycardia, palpitations, pain in chest, throbbing of vessels, fainting feelings, missing beat. | HAMA - Cardiovascular Symptoms | ||
HAMA110 | C102082 | HAMA1-Respiratory Symptoms | Hamilton Anxiety Rating Scale - Respiratory symptoms: pressure or constriction in chest, choking feelings, sighing, dyspnea. | HAMA - Respiratory Symptoms | ||
HAMA111 | C102083 | HAMA1-Gastrointestinal Symptoms | Hamilton Anxiety Rating Scale - Gastrointestinal symptoms: difficulty swallowing, wind abdominal pain, burning sensations, abdominal fullness, nausea, vomiting, borborygmi, looseness of bowels, loss of weight, constipation. | HAMA - Gastrointestinal Symptoms | ||
HAMA112 | C102084 | HAMA1-Genitourinary Symptoms | Hamilton Anxiety Rating Scale - Genitourinary symptoms: frequency of micturition, urgency of micturition, amenorrhea, menorrhagia, development of frigidity, premature ejaculation, loss of libido, impotence. | HAMA - Genitourinary Symptoms | ||
HAMA113 | C102085 | HAMA1-Autonomic Symptoms | Hamilton Anxiety Rating Scale - Autonomic symptoms: dry mouth, flushing, pallor, tendency to sweat, giddiness, tension, headache, raising of hair. | HAMA - Autonomic Symptoms | ||
HAMA114 | C102086 | HAMA1-Behavior at Interview | Hamilton Anxiety Rating Scale - Behavior at interview: fidgeting, restlessness or pacing, tremor of hands, furrowed brow, strained face, sighing or rapid respiration, facial pallor, swallowing, etc. | HAMA - Behavior at Interview | ||
HAMA115 | C155646 | HAMA1-Total Score | Hamilton Anxiety Rating Scale - Total score. | HAMA - Total Score | ||
Back to top | ||||||
CL.C101820.HAMA1TN | Hamilton Anxiety Rating Scale Clinical Classification Test Name
(HAMA1TN) | text
Extensible: No | C101820 | Hamilton Anxiety Rating Scale Clinical Classification Test Name | Hamilton Anxiety Rating Scale test name. | CDISC Clinical Classification HAMA Test Name Terminology |
HAMA1-Anxious Mood | C102073 | HAMA1-Anxious Mood | Hamilton Anxiety Rating Scale - Anxious mood: worries, anticipation of the worst, fearful anticipation, irritability. | HAMA - Anxious Mood | ||
HAMA1-Autonomic Symptoms | C102085 | HAMA1-Autonomic Symptoms | Hamilton Anxiety Rating Scale - Autonomic symptoms: dry mouth, flushing, pallor, tendency to sweat, giddiness, tension, headache, raising of hair. | HAMA - Autonomic Symptoms | ||
HAMA1-Behavior at Interview | C102086 | HAMA1-Behavior at Interview | Hamilton Anxiety Rating Scale - Behavior at interview: fidgeting, restlessness or pacing, tremor of hands, furrowed brow, strained face, sighing or rapid respiration, facial pallor, swallowing, etc. | HAMA - Behavior at Interview | ||
HAMA1-Cardiovascular Symptoms | C102081 | HAMA1-Cardiovascular Symptoms | Hamilton Anxiety Rating Scale - Cardiovascular symptoms: tachycardia, palpitations, pain in chest, throbbing of vessels, fainting feelings, missing beat. | HAMA - Cardiovascular Symptoms | ||
HAMA1-Depressed Mood | C102078 | HAMA1-Depressed Mood | Hamilton Anxiety Rating Scale - Depressed mood: loss of interest, lack of pleasure in hobbies, depression, early waking, diurnal swing. | HAMA - Depressed Mood | ||
HAMA1-Fears | C102075 | HAMA1-Fears | Hamilton Anxiety Rating Scale - Fears: of dark, of strangers, of being left alone, of animals, of traffic, of crowds. | HAMA - Fears | ||
HAMA1-Gastrointestinal Symptoms | C102083 | HAMA1-Gastrointestinal Symptoms | Hamilton Anxiety Rating Scale - Gastrointestinal symptoms: difficulty swallowing, wind abdominal pain, burning sensations, abdominal fullness, nausea, vomiting, borborygmi, looseness of bowels, loss of weight, constipation. | HAMA - Gastrointestinal Symptoms | ||
HAMA1-Genitourinary Symptoms | C102084 | HAMA1-Genitourinary Symptoms | Hamilton Anxiety Rating Scale - Genitourinary symptoms: frequency of micturition, urgency of micturition, amenorrhea, menorrhagia, development of frigidity, premature ejaculation, loss of libido, impotence. | HAMA - Genitourinary Symptoms | ||
HAMA1-Insomnia | C102076 | HAMA1-Insomnia | Hamilton Anxiety Rating Scale - Insomnia: difficulty falling asleep, broken sleep, unsatisfying sleep and fatigue on waking, dreams, nightmares, night terrors. | HAMA - Insomnia | ||
HAMA1-Intellectual | C102077 | HAMA1-Intellectual | Hamilton Anxiety Rating Scale - Intellectual: difficulty in concentration, poor memory. | HAMA - Intellectual | ||
HAMA1-Respiratory Symptoms | C102082 | HAMA1-Respiratory Symptoms | Hamilton Anxiety Rating Scale - Respiratory symptoms: pressure or constriction in chest, choking feelings, sighing, dyspnea. | HAMA - Respiratory Symptoms | ||
HAMA1-Somatic (Muscular) | C102079 | HAMA1-Somatic (Muscular) | Hamilton Anxiety Rating Scale - Somatic (muscular): pains and aches, twitching, stiffness, myoclonic jerks, grinding of teeth, unsteady voice, increased muscular tone. | HAMA - Somatic (Muscular) | ||
HAMA1-Somatic (Sensory) | C102080 | HAMA1-Somatic (Sensory) | Hamilton Anxiety Rating Scale - Somatic (sensory): tinnitus, blurring of vision, hot and cold flushes, feelings of weakness, pricking sensation. | HAMA - Somatic (Sensory) | ||
HAMA1-Tension | C102074 | HAMA1-Tension | Hamilton Anxiety Rating Scale - Tension: feelings of tension, fatigability, startle response, moved to tears easily, trembling, feelings of restlessness, inability to relax. | HAMA - Tension | ||
HAMA1-Total Score | C155646 | HAMA1-Total Score | Hamilton Anxiety Rating Scale - Total score. | HAMA - Total Score | ||
Back to top | ||||||
CL.C100138.HAMD1TC | Hamilton Depression Rating Scale - 17 Item Clinical Classification Test Code
(HAMD1TC) | text
Extensible: No | C100138 | Hamilton Depression Rating Scale - 17 Item Clinical Classification Test Code | The Hamilton Depression Rating Scale - 17 Item test code. | CDISC Clinical Classification HAMD 17 Test Code Terminology |
HAMD101 | C100398 | HAMD1-Depressed Mood | Hamilton Depression Rating Scale 17 Item - Depressed mood. | HAMD-17 - Depressed Mood | ||
HAMD102 | C100399 | HAMD1-Feelings of Guilt | Hamilton Depression Rating Scale 17 Item - Feelings of guilt. | HAMD-17 - Feelings of Guilt | ||
HAMD103 | C100400 | HAMD1-Suicide | Hamilton Depression Rating Scale 17 Item - Suicide. | HAMD-17 - Suicide | ||
HAMD104 | C100401 | HAMD1-Insomnia Early - Early Night | Hamilton Depression Rating Scale 17 Item - Insomnia: early in the night. | HAMD-17 - Insomnia - Early Night | ||
HAMD105 | C100402 | HAMD1-Insomnia Middle - Middle Night | Hamilton Depression Rating Scale 17 Item - Insomnia: middle of the night. | HAMD-17 - Insomnia - Middle Night | ||
HAMD106 | C100403 | HAMD1-Insomnia Early Hours - Morning | Hamilton Depression Rating Scale 17 Item - Insomnia: early hours of the morning. | HAMD-17 - Insomnia - Early Morning | ||
HAMD107 | C100404 | HAMD1-Work and Activities | Hamilton Depression Rating Scale 17 Item - Work and activities. | HAMD-17 - Work and Activities | ||
HAMD108 | C100405 | HAMD1-Retardation | Hamilton Depression Rating Scale 17 Item - Retardation. | HAMD-17 - Retardation | ||
HAMD109 | C100406 | HAMD1-Agitation | Hamilton Depression Rating Scale 17 Item - Agitation. | HAMD-17 - Agitation | ||
HAMD110 | C100407 | HAMD1-Anxiety Psychic | Hamilton Depression Rating Scale 17 Item - Anxiety psychic. | HAMD-17 - Psychic Anxiety | ||
HAMD111 | C100408 | HAMD1-Anxiety Somatic | Hamilton Depression Rating Scale 17 Item - Anxiety somatic: physiological concomitants of anxiety. | HAMD-17 - Somatic Anxiety | ||
HAMD112 | C100409 | HAMD1-Somatic Symptoms Gastrointestinal | Hamilton Depression Rating Scale 17 Item - Somatic symptoms gastrointestinal. | HAMD-17 - Somatic Symptoms Gastrointestinal | ||
HAMD113 | C100410 | HAMD1-General Somatic Symptoms | Hamilton Depression Rating Scale 17 Item - General somatic symptoms. | HAMD-17 - General Somatic Symptoms | ||
HAMD114 | C100411 | HAMD1-Genital Symptoms | Hamilton Depression Rating Scale 17 Item - Genital symptoms. | HAMD-17 - Genital Symptoms | ||
HAMD115 | C100412 | HAMD1-Hypochondriasis | Hamilton Depression Rating Scale 17 Item - Hypochondriasis. | HAMD-17 - Hypochondriasis | ||
HAMD116A | C100413 | HAMD1-Loss of WT According to Patient | Hamilton Depression Rating Scale 17 Item - Loss of weight according to the patient. | HAMD-17 - Loss of Weight According to Patient | ||
HAMD116B | C100414 | HAMD1-Loss of WT According to WK Meas | Hamilton Depression Rating Scale 17 Item - Loss of weight according to weekly measurements. | HAMD-17 - Loss of Weight According to Weekly Measurements | ||
HAMD117 | C100415 | HAMD1-Insight | Hamilton Depression Rating Scale 17 Item - Insight. | HAMD-17 - Insight | ||
HAMD118 | C100416 | HAMD1-Total Score | Hamilton Depression Rating Scale 17 Item - Total Score. | HAMD-17 - Total Score | ||
Back to top | ||||||
CL.C100137.HAMD1TN | Hamilton Depression Rating Scale - 17 Item Clinical Classification Test Name
(HAMD1TN) | text
Extensible: No | C100137 | Hamilton Depression Rating Scale - 17 Item Clinical Classification Test Name | The Hamilton Depression Rating Scale - 17 Item test name. | CDISC Clinical Classification HAMD 17 Test Name Terminology |
HAMD1-Agitation | C100406 | HAMD1-Agitation | Hamilton Depression Rating Scale 17 Item - Agitation. | HAMD-17 - Agitation | ||
HAMD1-Anxiety Psychic | C100407 | HAMD1-Anxiety Psychic | Hamilton Depression Rating Scale 17 Item - Anxiety psychic. | HAMD-17 - Psychic Anxiety | ||
HAMD1-Anxiety Somatic | C100408 | HAMD1-Anxiety Somatic | Hamilton Depression Rating Scale 17 Item - Anxiety somatic: physiological concomitants of anxiety. | HAMD-17 - Somatic Anxiety | ||
HAMD1-Depressed Mood | C100398 | HAMD1-Depressed Mood | Hamilton Depression Rating Scale 17 Item - Depressed mood. | HAMD-17 - Depressed Mood | ||
HAMD1-Feelings of Guilt | C100399 | HAMD1-Feelings of Guilt | Hamilton Depression Rating Scale 17 Item - Feelings of guilt. | HAMD-17 - Feelings of Guilt | ||
HAMD1-General Somatic Symptoms | C100410 | HAMD1-General Somatic Symptoms | Hamilton Depression Rating Scale 17 Item - General somatic symptoms. | HAMD-17 - General Somatic Symptoms | ||
HAMD1-Genital Symptoms | C100411 | HAMD1-Genital Symptoms | Hamilton Depression Rating Scale 17 Item - Genital symptoms. | HAMD-17 - Genital Symptoms | ||
HAMD1-Hypochondriasis | C100412 | HAMD1-Hypochondriasis | Hamilton Depression Rating Scale 17 Item - Hypochondriasis. | HAMD-17 - Hypochondriasis | ||
HAMD1-Insight | C100415 | HAMD1-Insight | Hamilton Depression Rating Scale 17 Item - Insight. | HAMD-17 - Insight | ||
HAMD1-Insomnia Early - Early Night | C100401 | HAMD1-Insomnia Early - Early Night | Hamilton Depression Rating Scale 17 Item - Insomnia: early in the night. | HAMD-17 - Insomnia - Early Night | ||
HAMD1-Insomnia Early Hours - Morning | C100403 | HAMD1-Insomnia Early Hours - Morning | Hamilton Depression Rating Scale 17 Item - Insomnia: early hours of the morning. | HAMD-17 - Insomnia - Early Morning | ||
HAMD1-Insomnia Middle - Middle Night | C100402 | HAMD1-Insomnia Middle - Middle Night | Hamilton Depression Rating Scale 17 Item - Insomnia: middle of the night. | HAMD-17 - Insomnia - Middle Night | ||
HAMD1-Loss of WT According to Patient | C100413 | HAMD1-Loss of WT According to Patient | Hamilton Depression Rating Scale 17 Item - Loss of weight according to the patient. | HAMD-17 - Loss of Weight According to Patient | ||
HAMD1-Loss of WT According to WK Meas | C100414 | HAMD1-Loss of WT According to WK Meas | Hamilton Depression Rating Scale 17 Item - Loss of weight according to weekly measurements. | HAMD-17 - Loss of Weight According to Weekly Measurements | ||
HAMD1-Retardation | C100405 | HAMD1-Retardation | Hamilton Depression Rating Scale 17 Item - Retardation. | HAMD-17 - Retardation | ||
HAMD1-Somatic Symptoms Gastrointestinal | C100409 | HAMD1-Somatic Symptoms Gastrointestinal | Hamilton Depression Rating Scale 17 Item - Somatic symptoms gastrointestinal. | HAMD-17 - Somatic Symptoms Gastrointestinal | ||
HAMD1-Suicide | C100400 | HAMD1-Suicide | Hamilton Depression Rating Scale 17 Item - Suicide. | HAMD-17 - Suicide | ||
HAMD1-Total Score | C100416 | HAMD1-Total Score | Hamilton Depression Rating Scale 17 Item - Total Score. | HAMD-17 - Total Score | ||
HAMD1-Work and Activities | C100404 | HAMD1-Work and Activities | Hamilton Depression Rating Scale 17 Item - Work and activities. | HAMD-17 - Work and Activities | ||
Back to top | ||||||
CL.C130245.HAMD3TC | Hamilton Depression Rating Scale - 24 Item Clinical Classification Test Code
(HAMD3TC) | text
Extensible: No | C130245 | Hamilton Depression Rating Scale - 24 Item Clinical Classification Test Code | Hamilton Depression Rating Scale - 24 Item test code. | CDISC Clinical Classification HAMD 24 Test Code Terminology |
HAMD301 | C130335 | HAMD3-Depressed Mood | Hamilton Depression Rating Scale 24 Item - Depressed mood. | HAMD 24 - Depressed Mood | ||
HAMD302 | C130336 | HAMD3-Low Self-Esteem, Guilt | Hamilton Depression Rating Scale 24 Item - Low self-esteem, guilt. | HAMD 24 - Low Self-esteem, Guilt | ||
HAMD303 | C130337 | HAMD3-Suicidal Thoughts | Hamilton Depression Rating Scale 24 Item - Suicidal thoughts. | HAMD 24 - Suicidal Thoughts | ||
HAMD304 | C130338 | HAMD3-Insomnia - Initial | Hamilton Depression Rating Scale 24 Item - Insomnia - initial. | HAMD 24 - Insomnia - Initial | ||
HAMD305 | C130339 | HAMD3-Insomnia - Middle | Hamilton Depression Rating Scale 24 Item - Insomnia - middle. | HAMD 24 - Insomnia - Middle | ||
HAMD306 | C130340 | HAMD3-Insomnia - Late | Hamilton Depression Rating Scale 24 Item - Insomnia - late. | HAMD 24 - Insomnia - Late | ||
HAMD307 | C130341 | HAMD3-Work and Interests | Hamilton Depression Rating Scale 24 Item - Work and interests. | HAMD 24 - Work and Interests | ||
HAMD308 | C130342 | HAMD3-Psychomotor Retardation | Hamilton Depression Rating Scale 24 Item - Psychomotor retardation. | HAMD 24 - Psychomotor Retardation | ||
HAMD309 | C130343 | HAMD3-Psychomotor Agitation | Hamilton Depression Rating Scale 24 Item - Psychomotor agitation. | HAMD 24 - Psychomotor Agitation | ||
HAMD310 | C130344 | HAMD3-Anxiety - Psychic | Hamilton Depression Rating Scale 24 Item - Anxiety - psychic. | HAMD 24 - Anxiety, Psychic | ||
HAMD311 | C130345 | HAMD3-Anxiety - Somatic | Hamilton Depression Rating Scale 24 Item - Anxiety - somatic. | HAMD 24 - Anxiety, Somatic | ||
HAMD312 | C130346 | HAMD3-GI Symptoms (Appetite) | Hamilton Depression Rating Scale 24 Item - Gastrointestinal symptoms (appetite). | HAMD 24 - Gastrointestinal Symptoms (Appetite) | ||
HAMD313 | C130347 | HAMD3-Somatic Symptoms - General | Hamilton Depression Rating Scale 24 Item - Somatic symptoms - general. | HAMD 24 - Somatic Symptoms, General | ||
HAMD314 | C130348 | HAMD3-Sexual Disturbances | Hamilton Depression Rating Scale 24 Item - Sexual disturbances. | HAMD 24 - Sexual Disturbances | ||
HAMD315 | C130349 | HAMD3-Hypochondriasis (Somatisation) | Hamilton Depression Rating Scale 24 Item - Hypochondriasis (somatisation). | HAMD 24 - Hypochondriasis (Somatisation) | ||
HAMD316 | C130350 | HAMD3-Insight | Hamilton Depression Rating Scale 24 Item - Insight. | HAMD 24 - Insight | ||
HAMD317 | C130351 | HAMD3-Weight Loss | Hamilton Depression Rating Scale 24 Item - Weight loss. | HAMD 24 - Weight Loss | ||
HAMD318 | C130352 | HAMD3-Diurnal Variation | Hamilton Depression Rating Scale 24 Item - Diurnal variation. | HAMD 24 - Diurnal Variation | ||
HAMD319 | C130353 | HAMD3-Depersonalization/Derealization | Hamilton Depression Rating Scale 24 Item - Depersonalization/derealization. | HAMD 24 - Depersonalization and Derealisation | ||
HAMD320 | C130354 | HAMD3-Paranoid Symptoms | Hamilton Depression Rating Scale 24 Item - Paranoid symptoms. | HAMD 24 - Paranoid Symptoms | ||
HAMD321 | C130355 | HAMD3-Observational/Compulsive Symptoms | Hamilton Depression Rating Scale 24 Item - Observational/compulsive symptoms. | HAMD 24 - Obsessional and Compulsive Symptoms | ||
HAMD322 | C130356 | HAMD3-Helplessness | Hamilton Depression Rating Scale 24 Item - Helplessness. | HAMD 24 - Helplessness | ||
HAMD323 | C130357 | HAMD3-Hopelessness | Hamilton Depression Rating Scale 24 Item - Hopelessness. | HAMD 24 - Hopelessness | ||
HAMD324 | C130358 | HAMD3-Worthlessness | Hamilton Depression Rating Scale 24 Item - Worthlessness. | HAMD 24 - Worthlessness | ||
HAMD325 | C130359 | HAMD3-Total Score | Hamilton Depression Rating Scale 24 Item - Total score. | HAMD 24 - Total Score | ||
Back to top | ||||||
CL.C130244.HAMD3TN | Hamilton Depression Rating Scale - 24 Item Clinical Classification Test Name
(HAMD3TN) | text
Extensible: No | C130244 | Hamilton Depression Rating Scale - 24 Item Clinical Classification Test Name | Hamilton Depression Rating Scale - 24 Item test name. | CDISC Clinical Classification HAMD 24 Test Name Terminology |
HAMD3-Anxiety - Psychic | C130344 | HAMD3-Anxiety - Psychic | Hamilton Depression Rating Scale 24 Item - Anxiety - psychic. | HAMD 24 - Anxiety, Psychic | ||
HAMD3-Anxiety - Somatic | C130345 | HAMD3-Anxiety - Somatic | Hamilton Depression Rating Scale 24 Item - Anxiety - somatic. | HAMD 24 - Anxiety, Somatic | ||
HAMD3-Depersonalization/Derealization | C130353 | HAMD3-Depersonalization/Derealization | Hamilton Depression Rating Scale 24 Item - Depersonalization/derealization. | HAMD 24 - Depersonalization and Derealisation | ||
HAMD3-Depressed Mood | C130335 | HAMD3-Depressed Mood | Hamilton Depression Rating Scale 24 Item - Depressed mood. | HAMD 24 - Depressed Mood | ||
HAMD3-Diurnal Variation | C130352 | HAMD3-Diurnal Variation | Hamilton Depression Rating Scale 24 Item - Diurnal variation. | HAMD 24 - Diurnal Variation | ||
HAMD3-GI Symptoms (Appetite) | C130346 | HAMD3-GI Symptoms (Appetite) | Hamilton Depression Rating Scale 24 Item - Gastrointestinal symptoms (appetite). | HAMD 24 - Gastrointestinal Symptoms (Appetite) | ||
HAMD3-Helplessness | C130356 | HAMD3-Helplessness | Hamilton Depression Rating Scale 24 Item - Helplessness. | HAMD 24 - Helplessness | ||
HAMD3-Hopelessness | C130357 | HAMD3-Hopelessness | Hamilton Depression Rating Scale 24 Item - Hopelessness. | HAMD 24 - Hopelessness | ||
HAMD3-Hypochondriasis (Somatisation) | C130349 | HAMD3-Hypochondriasis (Somatisation) | Hamilton Depression Rating Scale 24 Item - Hypochondriasis (somatisation). | HAMD 24 - Hypochondriasis (Somatisation) | ||
HAMD3-Insight | C130350 | HAMD3-Insight | Hamilton Depression Rating Scale 24 Item - Insight. | HAMD 24 - Insight | ||
HAMD3-Insomnia - Initial | C130338 | HAMD3-Insomnia - Initial | Hamilton Depression Rating Scale 24 Item - Insomnia - initial. | HAMD 24 - Insomnia - Initial | ||
HAMD3-Insomnia - Late | C130340 | HAMD3-Insomnia - Late | Hamilton Depression Rating Scale 24 Item - Insomnia - late. | HAMD 24 - Insomnia - Late | ||
HAMD3-Insomnia - Middle | C130339 | HAMD3-Insomnia - Middle | Hamilton Depression Rating Scale 24 Item - Insomnia - middle. | HAMD 24 - Insomnia - Middle | ||
HAMD3-Low Self-Esteem, Guilt | C130336 | HAMD3-Low Self-Esteem, Guilt | Hamilton Depression Rating Scale 24 Item - Low self-esteem, guilt. | HAMD 24 - Low Self-esteem, Guilt | ||
HAMD3-Observational/Compulsive Symptoms | C130355 | HAMD3-Observational/Compulsive Symptoms | Hamilton Depression Rating Scale 24 Item - Observational/compulsive symptoms. | HAMD 24 - Obsessional and Compulsive Symptoms | ||
HAMD3-Paranoid Symptoms | C130354 | HAMD3-Paranoid Symptoms | Hamilton Depression Rating Scale 24 Item - Paranoid symptoms. | HAMD 24 - Paranoid Symptoms | ||
HAMD3-Psychomotor Agitation | C130343 | HAMD3-Psychomotor Agitation | Hamilton Depression Rating Scale 24 Item - Psychomotor agitation. | HAMD 24 - Psychomotor Agitation | ||
HAMD3-Psychomotor Retardation | C130342 | HAMD3-Psychomotor Retardation | Hamilton Depression Rating Scale 24 Item - Psychomotor retardation. | HAMD 24 - Psychomotor Retardation | ||
HAMD3-Sexual Disturbances | C130348 | HAMD3-Sexual Disturbances | Hamilton Depression Rating Scale 24 Item - Sexual disturbances. | HAMD 24 - Sexual Disturbances | ||
HAMD3-Somatic Symptoms - General | C130347 | HAMD3-Somatic Symptoms - General | Hamilton Depression Rating Scale 24 Item - Somatic symptoms - general. | HAMD 24 - Somatic Symptoms, General | ||
HAMD3-Suicidal Thoughts | C130337 | HAMD3-Suicidal Thoughts | Hamilton Depression Rating Scale 24 Item - Suicidal thoughts. | HAMD 24 - Suicidal Thoughts | ||
HAMD3-Total Score | C130359 | HAMD3-Total Score | Hamilton Depression Rating Scale 24 Item - Total score. | HAMD 24 - Total Score | ||
HAMD3-Weight Loss | C130351 | HAMD3-Weight Loss | Hamilton Depression Rating Scale 24 Item - Weight loss. | HAMD 24 - Weight Loss | ||
HAMD3-Work and Interests | C130341 | HAMD3-Work and Interests | Hamilton Depression Rating Scale 24 Item - Work and interests. | HAMD 24 - Work and Interests | ||
HAMD3-Worthlessness | C130358 | HAMD3-Worthlessness | Hamilton Depression Rating Scale 24 Item - Worthlessness. | HAMD 24 - Worthlessness | ||
Back to top | ||||||
CL.C130243.HAMD4TC | Hamilton Depression Rating Scale - 6 Clinician Version Clinical Classification Test Code
(HAMD4TC) | text
Extensible: No | C130243 | Hamilton Depression Rating Scale - 6 Clinician Version Clinical Classification Test Code | Hamilton Depression Rating Scale - 6 Clinician Version test code. | CDISC Clinical Classification HAM-D6 Clinician Version Test Code Terminology |
HAMD401 | C130328 | HAMD4-Depressed Mood | The Hamilton Depression Rating Scale 6 - Clinician Version - Depressed mood. | HAM-D6 - Clinician Version - Depressed Mood | ||
HAMD402 | C130329 | HAMD4-Low Self-esteem and Guilt | The Hamilton Depression Rating Scale 6 - Clinician Version - Low self-esteem and guilt. | HAM-D6 - Clinician Version - Low Self-esteem and Guilt | ||
HAMD403 | C130330 | HAMD4-Social Life Activities/Interests | The Hamilton Depression Rating Scale 6 - Clinician Version - Social life activities and interests. | HAM-D6 - Clinician Version - Social Life Activities or Interests | ||
HAMD404 | C130331 | HAMD4-Psychomotor Retardation, General | The Hamilton Depression Rating Scale 6 - Clinician Version - Psychomotor retardation, general. | HAM-D6 - Clinician Version - Psychomotor Retardation, General | ||
HAMD405 | C130332 | HAMD4-Psychic Anxiety | The Hamilton Depression Rating Scale 6 - Clinician Version - Psychic anxiety. | HAM-D6 - Clinician Version - Psychic Anxiety | ||
HAMD406 | C130333 | HAMD4-Tiredness and Pains | The Hamilton Depression Rating Scale 6 - Clinician Version - Tiredness and pains. | HAM-D6 - Clinician Version - Tiredness and Pains | ||
HAMD407 | C130334 | HAMD4-Total Score | The Hamilton Depression Rating Scale 6 - Clinician Version - Total score. | HAM-D6 - Clinician Version - Total Score | ||
Back to top | ||||||
CL.C130242.HAMD4TN | Hamilton Depression Rating Scale - 6 Clinician Version Clinical Classification Test Name
(HAMD4TN) | text
Extensible: No | C130242 | Hamilton Depression Rating Scale - 6 Clinician Version Clinical Classification Test Name | Hamilton Depression Rating Scale - 6 Clinician Version test name. | CDISC Clinical Classification HAM-D6 Clinician Version Test Name Terminology |
HAMD4-Depressed Mood | C130328 | HAMD4-Depressed Mood | The Hamilton Depression Rating Scale 6 - Clinician Version - Depressed mood. | HAM-D6 - Clinician Version - Depressed Mood | ||
HAMD4-Low Self-esteem and Guilt | C130329 | HAMD4-Low Self-esteem and Guilt | The Hamilton Depression Rating Scale 6 - Clinician Version - Low self-esteem and guilt. | HAM-D6 - Clinician Version - Low Self-esteem and Guilt | ||
HAMD4-Psychic Anxiety | C130332 | HAMD4-Psychic Anxiety | The Hamilton Depression Rating Scale 6 - Clinician Version - Psychic anxiety. | HAM-D6 - Clinician Version - Psychic Anxiety | ||
HAMD4-Psychomotor Retardation, General | C130331 | HAMD4-Psychomotor Retardation, General | The Hamilton Depression Rating Scale 6 - Clinician Version - Psychomotor retardation, general. | HAM-D6 - Clinician Version - Psychomotor Retardation, General | ||
HAMD4-Social Life Activities/Interests | C130330 | HAMD4-Social Life Activities/Interests | The Hamilton Depression Rating Scale 6 - Clinician Version - Social life activities and interests. | HAM-D6 - Clinician Version - Social Life Activities or Interests | ||
HAMD4-Tiredness and Pains | C130333 | HAMD4-Tiredness and Pains | The Hamilton Depression Rating Scale 6 - Clinician Version - Tiredness and pains. | HAM-D6 - Clinician Version - Tiredness and Pains | ||
HAMD4-Total Score | C130334 | HAMD4-Total Score | The Hamilton Depression Rating Scale 6 - Clinician Version - Total score. | HAM-D6 - Clinician Version - Total Score | ||
Back to top | ||||||
CL.C130259.HAMDS1TC | Hamilton Depression Rating Scale - 6 Self-Report Questionnaire Test Code
(HAMDS1TC) | text
Extensible: No | C130259 | Hamilton Depression Rating Scale - 6 Self-Report Questionnaire Test Code | Hamilton Depression Rating Scale - 6 Self-Report test code. | CDISC Questionnaire HAM-D6 Self-Report Version Test Code Terminology |
HAMDS101 | C130545 | HAMDS1-Depressed Mood | Hamilton Depression Rating Scale 6 - Self-Report Version - (1)=Depressed mood per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Depressed Mood | ||
HAMDS102 | C130546 | HAMDS1-Low Self-esteem and Guilt | Hamilton Depression Rating Scale 6 - Self-Report Version - (2)=Low self-esteem and guilt per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Low Self-esteem and Guilt | ||
HAMDS103 | C130547 | HAMDS1-Social Life Activities/Interests | Hamilton Depression Rating Scale 6 - Self-Report Version - (3)=Social life activities and interests per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Social Life Activities or Interests | ||
HAMDS104 | C130548 | HAMDS1-Psychomotor Retardation, General | Hamilton Depression Rating Scale 6 - Self-Report Version - (4)=Psychomotor retardation, general per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Psychomotor Retardation | ||
HAMDS105 | C130549 | HAMDS1-Psychic Anxiety | Hamilton Depression Rating Scale 6 - Self-Report Version - (5)=Psychic anxiety per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Psychic Anxiety | ||
HAMDS106 | C130550 | HAMDS1-Tiredness and Pains | Hamilton Depression Rating Scale 6 - Self-Report Version - (6)=Tiredness and pains per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Tiredness and Pains | ||
Back to top | ||||||
CL.C130258.HAMDS1TN | Hamilton Depression Rating Scale - 6 Self-Report Questionnaire Test Name
(HAMDS1TN) | text
Extensible: No | C130258 | Hamilton Depression Rating Scale - 6 Self-Report Questionnaire Test Name | Hamilton Depression Rating Scale - 6 Self-Report test name. | CDISC Questionnaire HAM-D6 Self-Report Version Test Name Terminology |
HAMDS1-Depressed Mood | C130545 | HAMDS1-Depressed Mood | Hamilton Depression Rating Scale 6 - Self-Report Version - (1)=Depressed mood per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Depressed Mood | ||
HAMDS1-Low Self-esteem and Guilt | C130546 | HAMDS1-Low Self-esteem and Guilt | Hamilton Depression Rating Scale 6 - Self-Report Version - (2)=Low self-esteem and guilt per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Low Self-esteem and Guilt | ||
HAMDS1-Psychic Anxiety | C130549 | HAMDS1-Psychic Anxiety | Hamilton Depression Rating Scale 6 - Self-Report Version - (5)=Psychic anxiety per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Psychic Anxiety | ||
HAMDS1-Psychomotor Retardation, General | C130548 | HAMDS1-Psychomotor Retardation, General | Hamilton Depression Rating Scale 6 - Self-Report Version - (4)=Psychomotor retardation, general per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Psychomotor Retardation | ||
HAMDS1-Social Life Activities/Interests | C130547 | HAMDS1-Social Life Activities/Interests | Hamilton Depression Rating Scale 6 - Self-Report Version - (3)=Social life activities and interests per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Social Life Activities or Interests | ||
HAMDS1-Tiredness and Pains | C130550 | HAMDS1-Tiredness and Pains | Hamilton Depression Rating Scale 6 - Self-Report Version - (6)=Tiredness and pains per clinician version: How you have been feeling over the past three days, including today. | HAM-D6 Self-Report Version - Tiredness and Pains | ||
Back to top | ||||||
CL.C101821.HAMD2TC | Hamilton Depression Rating Scale 21-Item Clinical Classification Test Code
(HAMD2TC) | text
Extensible: No | C101821 | Hamilton Depression Rating Scale 21-Item Clinical Classification Test Code | Hamilton Depression Rating Scale 21-Item test code. | CDISC Clinical Classification HAMD 21 Test Code Terminology |
HAMD201 | C102087 | HAMD2-Depressed Mood | Hamilton Depression Rating Scale 21 Item - Depressed mood: sadness, hopeless, helpless, worthless. | HAMD-21 - Depressed Mood | ||
HAMD202 | C102088 | HAMD2-Feelings of Guilt | Hamilton Depression Rating Scale 21 Item - Feelings of guilt. | HAMD-21 - Feelings of Guilt | ||
HAMD203 | C102089 | HAMD2-Suicide | Hamilton Depression Rating Scale 21 Item - Suicide. | HAMD-21 - Suicide | ||
HAMD204 | C102090 | HAMD2-Insomnia Early | Hamilton Depression Rating Scale 21 Item - Insomnia early. | HAMD-21 - Insomnia Early | ||
HAMD205 | C102091 | HAMD2-Insomnia Middle | Hamilton Depression Rating Scale 21 Item - Insomnia middle. | HAMD-21 - Insomnia Middle | ||
HAMD206 | C102092 | HAMD2-Insomnia Late | Hamilton Depression Rating Scale 21 Item - Insomnia late. | HAMD-21 - Insomnia Late | ||
HAMD207 | C102093 | HAMD2-Work and Activities | Hamilton Depression Rating Scale 21 Item - Work and activities. | HAMD-21 - Work and Activities | ||
HAMD208 | C102094 | HAMD2-Retardation | Hamilton Depression Rating Scale 21 Item - Retardation: psychomotor (slowness of thought and speech; impaired ability to concentrate; decreased motor activity). | HAMD-21 - Retardation | ||
HAMD209 | C102095 | HAMD2-Agitation | Hamilton Depression Rating Scale 21 Item - Agitation. | HAMD-21 - Agitation | ||
HAMD210 | C102096 | HAMD2-Anxiety Psychological | Hamilton Depression Rating Scale 21 Item - Anxiety Psychological. | HAMD-21 - Anxiety Psychological | ||
HAMD211 | C102097 | HAMD2-Anxiety Somatic | Hamilton Depression Rating Scale 21 Item - Anxiety somatic: physiological concomitants of anxiety, (i.e., effects of autonomic overactivity, 'butterflies,' indigestion, stomach cramps, belching, diarrhea, palpitations, hyperventilation, paresthesia, sweating, flushing, tremor, headache, urinary frequency). | HAMD-21 - Anxiety Somatic | ||
HAMD212 | C102098 | HAMD2-Somatic Symptoms Gastro-intestinal | Hamilton Depression Rating Scale 21 Item - Somatic symptoms gastro-intestinal. | HAMD-21 - Somatic Symptoms Gastro-intestinal | ||
HAMD213 | C102099 | HAMD2-Somatic Symptoms General | Hamilton Depression Rating Scale 21 Item - Somatic symptoms general. | HAMD-21 - Somatic Symptoms General | ||
HAMD214 | C102100 | HAMD2-Genital Symptoms | Hamilton Depression Rating Scale 21 Item - Genital symptoms: symptoms such as: loss of libido; impaired sexual performance; menstrual disturbances. | HAMD-21 - Genital Symptoms | ||
HAMD215 | C102101 | HAMD2-Hypochondriasis | Hamilton Depression Rating Scale 21 Item - Hypochondriasis. | HAMD-21 - Hypochondriasis | ||
HAMD216A | C102102 | HAMD2-Loss of Weight by History | Hamilton Depression Rating Scale 21 Item - Loss of weight when rating by history. | HAMD-21 - Loss of Weight by History | ||
HAMD216B | C102103 | HAMD2-Loss of Weight Measured | Hamilton Depression Rating Scale 21 Item - Loss of weight on weekly ratings by war psychiatrist, when actual weight changes are measured. | HAMD-21 - Loss of Weight Measured | ||
HAMD217 | C102104 | HAMD2-Insight | Hamilton Depression Rating Scale 21 Item - Insight. | HAMD-21 - Insight | ||
HAMD218A | C102105 | HAMD2-Diurnal Variation | Hamilton Depression Rating Scale 21 Item - Diurnal variation. | HAMD-21 - Diurnal Variation | ||
HAMD218B | C102106 | HAMD2-Diurnal Variation Severity | Hamilton Depression Rating Scale 21 Item - Diurnal variation severity. | HAMD-21 - Diurnal Variation Severity | ||
HAMD219 | C102107 | HAMD2-Depersonalization/Derealization | Hamilton Depression Rating Scale 21 Item - Depersonalization and derealization: such as feelings of unreality; nihilistic ideas. | HAMD-21 - Depersonalization and Derealization | ||
HAMD220 | C102108 | HAMD2-Paranoid Symptoms | Hamilton Depression Rating Scale 21 Item - Paranoid symptoms. | HAMD-21 - Paranoid Symptoms | ||
HAMD221 | C102109 | HAMD2-Obsessional/Compulsive Symptoms | Hamilton Depression Rating Scale 21 Item - Obsessional and compulsive symptoms. | HAMD-21 - Obsessional and Compulsive Symptoms | ||
HAMD222 | C102110 | HAMD2-Total Score | Hamilton Depression Rating Scale 21 Item - Total score. | HAMD-21 - Total Score | ||
Back to top | ||||||
CL.C101822.HAMD2TN | Hamilton Depression Rating Scale 21-Item Clinical Classification Test Name
(HAMD2TN) | text
Extensible: No | C101822 | Hamilton Depression Rating Scale 21-Item Clinical Classification Test Name | Hamilton Depression Rating Scale 21-Item test name. | CDISC Clinical Classification HAMD 21 Test Name Terminology |
HAMD2-Agitation | C102095 | HAMD2-Agitation | Hamilton Depression Rating Scale 21 Item - Agitation. | HAMD-21 - Agitation | ||
HAMD2-Anxiety Psychological | C102096 | HAMD2-Anxiety Psychological | Hamilton Depression Rating Scale 21 Item - Anxiety Psychological. | HAMD-21 - Anxiety Psychological | ||
HAMD2-Anxiety Somatic | C102097 | HAMD2-Anxiety Somatic | Hamilton Depression Rating Scale 21 Item - Anxiety somatic: physiological concomitants of anxiety, (i.e., effects of autonomic overactivity, 'butterflies,' indigestion, stomach cramps, belching, diarrhea, palpitations, hyperventilation, paresthesia, sweating, flushing, tremor, headache, urinary frequency). | HAMD-21 - Anxiety Somatic | ||
HAMD2-Depersonalization/Derealization | C102107 | HAMD2-Depersonalization/Derealization | Hamilton Depression Rating Scale 21 Item - Depersonalization and derealization: such as feelings of unreality; nihilistic ideas. | HAMD-21 - Depersonalization and Derealization | ||
HAMD2-Depressed Mood | C102087 | HAMD2-Depressed Mood | Hamilton Depression Rating Scale 21 Item - Depressed mood: sadness, hopeless, helpless, worthless. | HAMD-21 - Depressed Mood | ||
HAMD2-Diurnal Variation Severity | C102106 | HAMD2-Diurnal Variation Severity | Hamilton Depression Rating Scale 21 Item - Diurnal variation severity. | HAMD-21 - Diurnal Variation Severity | ||
HAMD2-Diurnal Variation | C102105 | HAMD2-Diurnal Variation | Hamilton Depression Rating Scale 21 Item - Diurnal variation. | HAMD-21 - Diurnal Variation | ||
HAMD2-Feelings of Guilt | C102088 | HAMD2-Feelings of Guilt | Hamilton Depression Rating Scale 21 Item - Feelings of guilt. | HAMD-21 - Feelings of Guilt | ||
HAMD2-Genital Symptoms | C102100 | HAMD2-Genital Symptoms | Hamilton Depression Rating Scale 21 Item - Genital symptoms: symptoms such as: loss of libido; impaired sexual performance; menstrual disturbances. | HAMD-21 - Genital Symptoms | ||
HAMD2-Hypochondriasis | C102101 | HAMD2-Hypochondriasis | Hamilton Depression Rating Scale 21 Item - Hypochondriasis. | HAMD-21 - Hypochondriasis | ||
HAMD2-Insight | C102104 | HAMD2-Insight | Hamilton Depression Rating Scale 21 Item - Insight. | HAMD-21 - Insight | ||
HAMD2-Insomnia Early | C102090 | HAMD2-Insomnia Early | Hamilton Depression Rating Scale 21 Item - Insomnia early. | HAMD-21 - Insomnia Early | ||
HAMD2-Insomnia Late | C102092 | HAMD2-Insomnia Late | Hamilton Depression Rating Scale 21 Item - Insomnia late. | HAMD-21 - Insomnia Late | ||
HAMD2-Insomnia Middle | C102091 | HAMD2-Insomnia Middle | Hamilton Depression Rating Scale 21 Item - Insomnia middle. | HAMD-21 - Insomnia Middle | ||
HAMD2-Loss of Weight by History | C102102 | HAMD2-Loss of Weight by History | Hamilton Depression Rating Scale 21 Item - Loss of weight when rating by history. | HAMD-21 - Loss of Weight by History | ||
HAMD2-Loss of Weight Measured | C102103 | HAMD2-Loss of Weight Measured | Hamilton Depression Rating Scale 21 Item - Loss of weight on weekly ratings by war psychiatrist, when actual weight changes are measured. | HAMD-21 - Loss of Weight Measured | ||
HAMD2-Obsessional/Compulsive Symptoms | C102109 | HAMD2-Obsessional/Compulsive Symptoms | Hamilton Depression Rating Scale 21 Item - Obsessional and compulsive symptoms. | HAMD-21 - Obsessional and Compulsive Symptoms | ||
HAMD2-Paranoid Symptoms | C102108 | HAMD2-Paranoid Symptoms | Hamilton Depression Rating Scale 21 Item - Paranoid symptoms. | HAMD-21 - Paranoid Symptoms | ||
HAMD2-Retardation | C102094 | HAMD2-Retardation | Hamilton Depression Rating Scale 21 Item - Retardation: psychomotor (slowness of thought and speech; impaired ability to concentrate; decreased motor activity). | HAMD-21 - Retardation | ||
HAMD2-Somatic Symptoms Gastro-intestinal | C102098 | HAMD2-Somatic Symptoms Gastro-intestinal | Hamilton Depression Rating Scale 21 Item - Somatic symptoms gastro-intestinal. | HAMD-21 - Somatic Symptoms Gastro-intestinal | ||
HAMD2-Somatic Symptoms General | C102099 | HAMD2-Somatic Symptoms General | Hamilton Depression Rating Scale 21 Item - Somatic symptoms general. | HAMD-21 - Somatic Symptoms General | ||
HAMD2-Suicide | C102089 | HAMD2-Suicide | Hamilton Depression Rating Scale 21 Item - Suicide. | HAMD-21 - Suicide | ||
HAMD2-Total Score | C102110 | HAMD2-Total Score | Hamilton Depression Rating Scale 21 Item - Total score. | HAMD-21 - Total Score | ||
HAMD2-Work and Activities | C102093 | HAMD2-Work and Activities | Hamilton Depression Rating Scale 21 Item - Work and activities. | HAMD-21 - Work and Activities | ||
Back to top | ||||||
CL.C190885.HBI0101OR | Harvey-Bradshaw Index Clinical Classification ORRES for HBI0101 TN/TC
(HBI0101OR) | text
Extensible: No | C190885 | Harvey-Bradshaw Index Clinical Classification ORRES for HBI0101 TN/TC | Harvey-Bradshaw Index original result for HBI0101 test and test code. | CDISC Clinical Classification Harvey-Bradshaw Index HBI0101 Original Response Terminology |
poor | C190960 | HBI0101-poor | Harvey-Bradshaw Index original result for HBI0101-Poor. | Harvey-Bradshaw Index HBI0101 Original Result - Poor | ||
slightly below par | C190959 | HBI0101-slightly below par | Harvey-Bradshaw Index original result for HBI0101-Slightly below par. | Harvey-Bradshaw Index HBI0101 Original Result - Slightly Below Par | ||
terrible | C190962 | HBI0101-terrible | Harvey-Bradshaw Index original result for HBI0101-Terrible. | Harvey-Bradshaw Index HBI0101 Original Result - Terrible | ||
very poor | C190961 | HBI0101-very poor | Harvey-Bradshaw Index original result for HBI0101-Very poor. | Harvey-Bradshaw Index HBI0101 Original Result - Very Poor | ||
very well | C190958 | HBI0101-very well | Harvey-Bradshaw Index original result for HBI0101-Very well. | Harvey-Bradshaw Index HBI0101 Original Result - Very Well | ||
Back to top | ||||||
CL.C190887.HBI0102OR | Harvey-Bradshaw Index Clinical Classification ORRES for HBI0102 TN/TC
(HBI0102OR) | text
Extensible: No | C190887 | Harvey-Bradshaw Index Clinical Classification ORRES for HBI0102 TN/TC | Harvey-Bradshaw Index original result for HBI0102 test and test code. | CDISC Clinical Classification Harvey-Bradshaw Index HBI0102 Original Response Terminology |
mild | C190969 | HBI0102-mild | Harvey-Bradshaw Index original result for HBI0102-Mild. | Harvey-Bradshaw Index HBI0102 Original Result - Mild | ||
moderate | C190970 | HBI0102-moderate | Harvey-Bradshaw Index original result for HBI0102-Moderate. | Harvey-Bradshaw Index HBI0102 Original Result - Moderate | ||
none | C190968 | HBI0102-none | Harvey-Bradshaw Index original result for HBI0102-None. | Harvey-Bradshaw Index HBI0102 Original Result - None | ||
severe | C190971 | HBI0102-severe | Harvey-Bradshaw Index original result for HBI0102-Severe. | Harvey-Bradshaw Index HBI0102 Original Result - Severe | ||
Back to top | ||||||
CL.C190889.HBI0104OR | Harvey-Bradshaw Index Clinical Classification ORRES for HBI0104 TN/TC
(HBI0104OR) | text
Extensible: No | C190889 | Harvey-Bradshaw Index Clinical Classification ORRES for HBI0104 TN/TC | Harvey-Bradshaw Index original result for HBI0104 test and test code. | CDISC Clinical Classification Harvey-Bradshaw Index HBI0104 Original Response Terminology |
definite and tender | C190979 | HBI0104-definite and tender | Harvey-Bradshaw Index original result for HBI0104-Definite and tender. | Harvey-Bradshaw Index HBI0104 Original Result - Definite and Tender | ||
definite | C190978 | HBI0104-definite | Harvey-Bradshaw Index original result for HBI0104-Definite. | Harvey-Bradshaw Index HBI0104 Original Result - Definite | ||
dubious | C190977 | HBI0104-dubious | Harvey-Bradshaw Index original result for HBI0104-Dubious. | Harvey-Bradshaw Index HBI0104 Original Result - Dubious | ||
none | C190976 | HBI0104-none | Harvey-Bradshaw Index original result for HBI0104-None. | Harvey-Bradshaw Index HBI0104 Original Result - None | ||
Back to top | ||||||
CL.C190891.HBI0105AT05HOR | Harvey-Bradshaw Index Clinical Classification ORRES for HBI0105A Through HBI0105H TN/TC
(HBI0105AT05HOR) | text
Extensible: No | C190891 | Harvey-Bradshaw Index Clinical Classification ORRES for HBI0105A Through HBI0105H TN/TC | Harvey-Bradshaw Index original result for HBI0105A through HBI0105H test and test code. | CDISC Clinical Classification Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Response Terminology |
no | C190984 | HBI0105A through HBI0105H-no | Harvey-Bradshaw Index original result for HBI0105A through HBI0105H-No. | Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Result - No | ||
yes | C190985 | HBI0105A through HBI0105H-yes | Harvey-Bradshaw Index original result for HBI0105A through HBI0105H-Yes. | Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Result - Yes | ||
Back to top | ||||||
CL.C190886.HBI0101STR | Harvey-Bradshaw Index Clinical Classification STRESC for HBI0101 TN/TC
(HBI0101STR) | text
Extensible: No | C190886 | Harvey-Bradshaw Index Clinical Classification STRESC for HBI0101 TN/TC | Harvey-Bradshaw Index standardized character result for HBI0101 test and test code. | CDISC Clinical Classification Harvey-Bradshaw Index HBI0101 Standardized Character Response Terminology |
0 | C190963 | HBI0101-0 | Harvey-Bradshaw Index standardized character result for HBI0101-Very well. | Harvey-Bradshaw Index HBI0101 Standardized Character Result 0 | ||
1 | C190964 | HBI0101-1 | Harvey-Bradshaw Index standardized character result for HBI0101-Slightly below par. | Harvey-Bradshaw Index HBI0101 Standardized Character Result 1 | ||
2 | C190965 | HBI0101-2 | Harvey-Bradshaw Index standardized character result for HBI0101-Poor. | Harvey-Bradshaw Index HBI0101 Standardized Character Result 2 | ||
3 | C190966 | HBI0101-3 | Harvey-Bradshaw Index standardized character result for HBI0101-Very poor. | Harvey-Bradshaw Index HBI0101 Standardized Character Result 3 | ||
4 | C190967 | HBI0101-4 | Harvey-Bradshaw Index standardized character result for HBI0101-Terrible. | Harvey-Bradshaw Index HBI0101 Standardized Character Result 4 | ||
Back to top | ||||||
CL.C190888.HBI0102STR | Harvey-Bradshaw Index Clinical Classification STRESC for HBI0102 TN/TC
(HBI0102STR) | text
Extensible: No | C190888 | Harvey-Bradshaw Index Clinical Classification STRESC for HBI0102 TN/TC | Harvey-Bradshaw Index standardized character result for HBI0102 test and test code. | CDISC Clinical Classification Harvey-Bradshaw Index HBI0102 Standardized Character Response Terminology |
0 | C190972 | HBI0102-0 | Harvey-Bradshaw Index standardized character result for HBI0102-None. | Harvey-Bradshaw Index HBI0102 Standardized Character Result 0 | ||
1 | C190973 | HBI0102-1 | Harvey-Bradshaw Index standardized character result for HBI0102-Mild. | Harvey-Bradshaw Index HBI0102 Standardized Character Result 1 | ||
2 | C190974 | HBI0102-2 | Harvey-Bradshaw Index standardized character result for HBI0102-Moderate. | Harvey-Bradshaw Index HBI0102 Standardized Character Result 2 | ||
3 | C190975 | HBI0102-3 | Harvey-Bradshaw Index standardized character result for HBI0102-Severe. | Harvey-Bradshaw Index HBI0102 Standardized Character Result 3 | ||
Back to top | ||||||
CL.C190890.HBI0104STR | Harvey-Bradshaw Index Clinical Classification STRESC for HBI0104 TN/TC
(HBI0104STR) | text
Extensible: No | C190890 | Harvey-Bradshaw Index Clinical Classification STRESC for HBI0104 TN/TC | Harvey-Bradshaw Index standardized character result for HBI0104 test and test code. | CDISC Clinical Classification Harvey-Bradshaw Index HBI0104 Standardized Character Response Terminology |
0 | C190980 | HBI0104-0 | Harvey-Bradshaw Index standardized character result for HBI0104-None. | Harvey-Bradshaw Index HBI0104 Standardized Character Result 0 | ||
1 | C190981 | HBI0104-1 | Harvey-Bradshaw Index standardized character result for HBI0104-Dubious. | Harvey-Bradshaw Index HBI0104 Standardized Character Result 1 | ||
2 | C190982 | HBI0104-2 | Harvey-Bradshaw Index standardized character result for HBI0104-Definite. | Harvey-Bradshaw Index HBI0104 Standardized Character Result 2 | ||
3 | C190983 | HBI0104-3 | Harvey-Bradshaw Index standardized character result for HBI0104-Definite and tender. | Harvey-Bradshaw Index HBI0104 Standardized Character Result 3 | ||
Back to top | ||||||
CL.C190892.HBI0105AT05HSTR | Harvey-Bradshaw Index Clinical Classification STRESC for HBI0105A Through HBI0105H TN/TC
(HBI0105AT05HSTR) | text
Extensible: No | C190892 | Harvey-Bradshaw Index Clinical Classification STRESC for HBI0105A Through HBI0105H TN/TC | Harvey-Bradshaw Index standardized character result for HBI0105A through HBI0105H test and test code. | CDISC Clinical Classification Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Response Terminology |
0 | C190986 | HBI0105A through HBI0105H-0 | Harvey-Bradshaw Index standardized character result for HBI0105A through HBI0105H-No. | Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Result 0 | ||
1 | C190987 | HBI0105A through HBI0105H-1 | Harvey-Bradshaw Index standardized character result for HBI0105A through HBI0105H-Yes. | Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Result 1 | ||
Back to top | ||||||
CL.C190926.HBI01TC | Harvey-Bradshaw Index Clinical Classification Test Code
(HBI01TC) | text
Extensible: No | C190926 | Harvey-Bradshaw Index Clinical Classification Test Code | Harvey-Bradshaw Index test code. | CDISC Clinical Classification Harvey-Bradshaw Index Test Code Terminology |
HBI0101 | C191044 | HBI01-General Well-being | Harvey-Bradshaw Index - Patient's general well-being (for the previous day). | HBI - General Well-being | ||
HBI0102 | C191045 | HBI01-Abdominal Pain | Harvey-Bradshaw Index - Abdominal pain (for the previous day). | HBI - Abdominal Pain | ||
HBI0103 | C191046 | HBI01-Number Liquid Stools | Harvey-Bradshaw Index - Number of liquid stools (for the previous day). | HBI - Number Liquid Stools | ||
HBI0104 | C191047 | HBI01-Abdominal Mass | Harvey-Bradshaw Index - Abdominal mass. | HBI - Abdominal Mass | ||
HBI0105A | C191048 | HBI01-Complication: Arthralgia | Harvey-Bradshaw Index - Complication: Arthralgia. | HBI - Complication: Arthralgia | ||
HBI0105B | C191049 | HBI01-Complication: Uveitis | Harvey-Bradshaw Index - Complication: Uveitis. | HBI - Complication: Uveitis | ||
HBI0105C | C191050 | HBI01-Complication: Erythema Nodosum | Harvey-Bradshaw Index - Complication: Erythema nodosum. | HBI - Complication: Erythema Nodosum | ||
HBI0105D | C191051 | HBI01-Complication: Aphthous Ulcers | Harvey-Bradshaw Index - Complication: Aphthous ulcers. | HBI - Complication: Aphthous Ulcers | ||
HBI0105E | C191052 | HBI01-Complication: Pyoderma Gangrenosum | Harvey-Bradshaw Index - Complication: Pyoderma gangrenosum. | HBI - Complication: Pyoderma Gangrenosum | ||
HBI0105F | C191053 | HBI01-Complication: Anal Fistula | Harvey-Bradshaw Index - Complication: Anal fissures. | HBI - Complication: Anal Fistula | ||
HBI0105G | C191054 | HBI01-Complication: New Fistula | Harvey-Bradshaw Index - Complication: New fistula. | HBI - Complication: New Fistula | ||
HBI0105H | C191055 | HBI01-Complication: Abscess | Harvey-Bradshaw Index - Complication: Abscess. | HBI - Complication: Abscess | ||
HBI0106 | C191056 | HBI01-Total Score | Harvey-Bradshaw Index - Total score. | HBI - Total Score | ||
Back to top | ||||||
CL.C190925.HBI01TN | Harvey-Bradshaw Index Clinical Classification Test Name
(HBI01TN) | text
Extensible: No | C190925 | Harvey-Bradshaw Index Clinical Classification Test Name | Harvey-Bradshaw Index test name. | CDISC Clinical Classification Harvey-Bradshaw Index Test Name Terminology |
HBI01-Abdominal Mass | C191047 | HBI01-Abdominal Mass | Harvey-Bradshaw Index - Abdominal mass. | HBI - Abdominal Mass | ||
HBI01-Abdominal Pain | C191045 | HBI01-Abdominal Pain | Harvey-Bradshaw Index - Abdominal pain (for the previous day). | HBI - Abdominal Pain | ||
HBI01-Complication: Abscess | C191055 | HBI01-Complication: Abscess | Harvey-Bradshaw Index - Complication: Abscess. | HBI - Complication: Abscess | ||
HBI01-Complication: Anal Fistula | C191053 | HBI01-Complication: Anal Fistula | Harvey-Bradshaw Index - Complication: Anal fissures. | HBI - Complication: Anal Fistula | ||
HBI01-Complication: Aphthous Ulcers | C191051 | HBI01-Complication: Aphthous Ulcers | Harvey-Bradshaw Index - Complication: Aphthous ulcers. | HBI - Complication: Aphthous Ulcers | ||
HBI01-Complication: Arthralgia | C191048 | HBI01-Complication: Arthralgia | Harvey-Bradshaw Index - Complication: Arthralgia. | HBI - Complication: Arthralgia | ||
HBI01-Complication: Erythema Nodosum | C191050 | HBI01-Complication: Erythema Nodosum | Harvey-Bradshaw Index - Complication: Erythema nodosum. | HBI - Complication: Erythema Nodosum | ||
HBI01-Complication: New Fistula | C191054 | HBI01-Complication: New Fistula | Harvey-Bradshaw Index - Complication: New fistula. | HBI - Complication: New Fistula | ||
HBI01-Complication: Pyoderma Gangrenosum | C191052 | HBI01-Complication: Pyoderma Gangrenosum | Harvey-Bradshaw Index - Complication: Pyoderma gangrenosum. | HBI - Complication: Pyoderma Gangrenosum | ||
HBI01-Complication: Uveitis | C191049 | HBI01-Complication: Uveitis | Harvey-Bradshaw Index - Complication: Uveitis. | HBI - Complication: Uveitis | ||
HBI01-General Well-being | C191044 | HBI01-General Well-being | Harvey-Bradshaw Index - Patient's general well-being (for the previous day). | HBI - General Well-being | ||
HBI01-Number Liquid Stools | C191046 | HBI01-Number Liquid Stools | Harvey-Bradshaw Index - Number of liquid stools (for the previous day). | HBI - Number Liquid Stools | ||
HBI01-Total Score | C191056 | HBI01-Total Score | Harvey-Bradshaw Index - Total score. | HBI - Total Score | ||
Back to top | ||||||
CL.C138213.HSB01TC | HAS-BLED Bleeding Risk Score Clinical Classification Test Code
(HSB01TC) | text
Extensible: No | C138213 | HAS-BLED Bleeding Risk Score Clinical Classification Test Code | HAS-BLED Bleeding Risk Score test code. | CDISC Clinical Classification HAS-BLED Test Code Terminology |
HSB0101 | C138357 | HSB01-Hypertension | HAS-BLED Bleeding Risk Score - Hypertension. | HAS-BLED - Hypertension | ||
HSB0102 | C138358 | HSB01-Abnormal Renal and Liver Function | HAS-BLED Bleeding Risk Score - Abnormal renal and liver function. | HAS-BLED - Abnormal Renal and Liver Function | ||
HSB0103 | C138359 | HSB01-Stroke | HAS-BLED Bleeding Risk Score - Stroke. | HAS-BLED - Stroke | ||
HSB0104 | C138360 | HSB01-Bleeding | HAS-BLED Bleeding Risk Score - Bleeding. | HAS-BLED - Bleeding | ||
HSB0105 | C138361 | HSB01-Labile INRs | HAS-BLED Bleeding Risk Score - Labile INRs. | HAS-BLED - Labile INRs | ||
HSB0106 | C138362 | HSB01-Elderly | HAS-BLED Bleeding Risk Score - Elderly. | HAS-BLED - Elderly | ||
HSB0107 | C138363 | HSB01-Drugs or Alcohol | HAS-BLED Bleeding Risk Score - Drugs or alcohol. | HAS-BLED - Drugs or Alcohol | ||
Back to top | ||||||
CL.C138212.HSB01TN | HAS-BLED Bleeding Risk Score Clinical Classification Test Name
(HSB01TN) | text
Extensible: No | C138212 | HAS-BLED Bleeding Risk Score Clinical Classification Test Name | HAS-BLED Bleeding Risk Score test name. | CDISC Clinical Classification HAS-BLED Test Name Terminology |
HSB01-Abnormal Renal and Liver Function | C138358 | HSB01-Abnormal Renal and Liver Function | HAS-BLED Bleeding Risk Score - Abnormal renal and liver function. | HAS-BLED - Abnormal Renal and Liver Function | ||
HSB01-Bleeding | C138360 | HSB01-Bleeding | HAS-BLED Bleeding Risk Score - Bleeding. | HAS-BLED - Bleeding | ||
HSB01-Drugs or Alcohol | C138363 | HSB01-Drugs or Alcohol | HAS-BLED Bleeding Risk Score - Drugs or alcohol. | HAS-BLED - Drugs or Alcohol | ||
HSB01-Elderly | C138362 | HSB01-Elderly | HAS-BLED Bleeding Risk Score - Elderly. | HAS-BLED - Elderly | ||
HSB01-Hypertension | C138357 | HSB01-Hypertension | HAS-BLED Bleeding Risk Score - Hypertension. | HAS-BLED - Hypertension | ||
HSB01-Labile INRs | C138361 | HSB01-Labile INRs | HAS-BLED Bleeding Risk Score - Labile INRs. | HAS-BLED - Labile INRs | ||
HSB01-Stroke | C138359 | HSB01-Stroke | HAS-BLED Bleeding Risk Score - Stroke. | HAS-BLED - Stroke | ||
Back to top | ||||||
CL.C115390.HAI01TC | Hauser Ambulation Index Functional Test Test Code
(HAI01TC) | text
Extensible: No | C115390 | Hauser Ambulation Index Functional Test Test Code | Hauser Ambulation Index test code. | CDISC Functional Test HAI Test Code Terminology |
HAI0101 | C115806 | HAI01-Ambulation Index | Hauser Ambulation Index - Ambulation index. | HAI - Ambulation Index | ||
Back to top | ||||||
CL.C115389.HAI01TN | Hauser Ambulation Index Functional Test Test Name
(HAI01TN) | text
Extensible: No | C115389 | Hauser Ambulation Index Functional Test Test Name | Hauser Ambulation Index test name. | CDISC Functional Test HAI Test Name Terminology |
HAI01-Ambulation Index | C115806 | HAI01-Ambulation Index | Hauser Ambulation Index - Ambulation index. | HAI - Ambulation Index | ||
Back to top | ||||||
CL.C106667.HAQ01TC | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire Test Code
(HAQ01TC) | text
Extensible: No | C106667 | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire Test Code | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale test code. | CDISC Questionnaire HAQ-DI With VAS Test Code Terminology |
HAQ0101 | C106809 | HAQ01-Dress Yourself | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Dressing & Grooming: Are you able to dress yourself, including tying shoelaces and doing buttons? | HAQ-DI With VAS - Able to Dress Yourself | ||
HAQ0102 | C106810 | HAQ01-Shampoo Your Hair | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Dressing & Grooming: Are you able to shampoo your hair? | HAQ-DI With VAS - Able to Shampoo Hair | ||
HAQ0103 | C106811 | HAQ01-Stand Up From a Straight Chair | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Arising: Are you able to stand up from a straight chair? | HAQ-DI With VAS - Able to Stand Up From Chair | ||
HAQ0104 | C106812 | HAQ01-Get In and Out of Bed | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Arising: Are you able to get in and out of bed? | HAQ-DI With VAS - Able to Get In and Out of Bed | ||
HAQ0105 | C106813 | HAQ01-Cut Your Meat | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to cut your meat? | HAQ-DI With VAS - Able to Cut Meat | ||
HAQ0106 | C106814 | HAQ01-Lift a Full Cup or Glass to Mouth | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to lift a full cup or glass to your mouth? | HAQ-DI With VAS - Able to Lift Cup or Glass to Mouth | ||
HAQ0107 | C106815 | HAQ01-Open a New Milk Carton | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to open a new milk carton? | HAQ-DI With VAS - Able to Open Milk Carton | ||
HAQ0108 | C106816 | HAQ01-Walk Outdoors on Flat Ground | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Walking: Are you able to walk outdoors on flat ground? | HAQ-DI With VAS - Able to Walk Outdoors On Flat Ground | ||
HAQ0109 | C106817 | HAQ01-Climb Up Five Steps | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Walking: Are you able to climb up five steps? | HAQ-DI With VAS - Able to Climb Up Steps | ||
HAQ0110 | C106818 | HAQ01-Aid: Cane | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Cane. | HAQ-DI With VAS - Aids or Devices - Cane | ||
HAQ0111 | C106819 | HAQ01-Aid: Walker | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Walker. | HAQ-DI With VAS - Aids or Devices - Walker | ||
HAQ0112 | C106820 | HAQ01-Aid: Crutches | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Crutches. | HAQ-DI With VAS - Aids or Devices - Crutches | ||
HAQ0113 | C106821 | HAQ01-Aid: Wheelchair | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Wheelchair. | HAQ-DI With VAS - Aids or Devices - Wheelchair | ||
HAQ0114 | C106822 | HAQ01-Aid: Devices Used for Dressing | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Devices used for dressing (button hook, zipper pull, long-handled shoe horn, etc.). | HAQ-DI With VAS - Aids or Devices - Used For Dressing | ||
HAQ0115 | C106823 | HAQ01-Aid: Built Up or Special Utensils | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Built up or special utensils. | HAQ-DI With VAS - Aids or Devices - Built Up or Special Utensils | ||
HAQ0116 | C106824 | HAQ01-Aid: Special or Built Up Chair | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Special or built up chair. | HAQ-DI With VAS - Aids or Devices - Special or Built Up Chair | ||
HAQ0117 | C106825 | HAQ01-Othr Aid (Dress/Arising/Eat/Walk) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. | HAQ-DI With VAS - Aids or Devices For Dress/Arising/Eat/Walk-Other | ||
HAQ0118 | C106826 | HAQ01-Spec Aid (Dress/Arising/Eat/Walk) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). | HAQ-DI With VAS - Aids or Devices For Dress/Arising/Eat/Walk-Specify | ||
HAQ0119 | C106827 | HAQ01-Help: Dressing and Grooming | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Dressing and grooming. | HAQ-DI With VAS - Help From Another Person - Dressing and Grooming | ||
HAQ0120 | C106828 | HAQ01-Help: Arising | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Arising. | HAQ-DI With VAS - Help From Another Person - Arising | ||
HAQ0121 | C106829 | HAQ01-Help: Eating | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Eating. | HAQ-DI With VAS - Help From Another Person - Eating | ||
HAQ0122 | C106830 | HAQ01-Help: Walking | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Walking. | HAQ-DI With VAS - Help From Another Person - Walking | ||
HAQ0123 | C106831 | HAQ01-Wash and Dry Your Body | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to wash and dry your body? | HAQ-DI With VAS - Able to Wash and Dry Body | ||
HAQ0124 | C106832 | HAQ01-Take a Tub Bath | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to take a tub bath? | HAQ-DI With VAS - Able to Take Tub Bath | ||
HAQ0125 | C106833 | HAQ01-Get On and Off The Toilet | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to get on and off the toilet? | HAQ-DI With VAS - Able to Get On and Off Toilet | ||
HAQ0126 | C106834 | HAQ01-Reach-Get Down 5 Lb Obj Above Head | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Reach: Are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head? | HAQ-DI With VAS - Able to Reach and Get Down Object From Above Head | ||
HAQ0127 | C106835 | HAQ01-Bend Down Pick Up Clothing - Floor | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Reach: Are you able to bend down to pick up clothing from the floor? | HAQ-DI With VAS - Able to Bend Down and Pick Up Clothing From Floor | ||
HAQ0128 | C106836 | HAQ01-Open Car Doors | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to open car doors? | HAQ-DI With VAS - Able to Open Car Doors | ||
HAQ0129 | C106837 | HAQ01-Open Jars Previously Opened | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to open jars which have been previously opened? | HAQ-DI With VAS - Able to Open Previously Opened Jars | ||
HAQ0130 | C106838 | HAQ01-Turn Faucets On And Off | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to turn faucets on and off? | HAQ-DI With VAS - Able to Turn Faucets On and Off | ||
HAQ0131 | C106839 | HAQ01-Run Errands and Shop | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to run errands and shop? | HAQ-DI With VAS - Able to Run Errands and Shop | ||
HAQ0132 | C106840 | HAQ01-Get In and Out of a Car | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to get in and out of a car? | HAQ-DI With VAS - Able to Get In and Out of Car | ||
HAQ0133 | C106841 | HAQ01-Able to Do Chores | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to do chores such as vacuuming or yardwork? | HAQ-DI With VAS - Able to Do Chores - Vacuuming or Yardwork | ||
HAQ0134 | C106842 | HAQ01-Aid: Raised Toilet Seat | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Raised toilet seat. | HAQ-DI With VAS - Aids or Devices - Raised Toilet Seat | ||
HAQ0135 | C106843 | HAQ01-Aid: Bathtub Seat | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub seat. | HAQ-DI With VAS - Aids or Devices - Bathtub Seat | ||
HAQ0136 | C107020 | HAQ01-Aid: Jar Opener (Previously Open) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Jar opener (for jars previously opened). | HAQ-DI With VAS - Aids or Devices - Jar Opener (Jars Previously Opened) | ||
HAQ0137 | C106844 | HAQ01-Aid: Bathtub Bar | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub bar. | HAQ-DI With VAS - Aids or Devices - Bathtub Bar | ||
HAQ0138 | C106845 | HAQ01-Aid: Long-Handled Appl Reach | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances for reach. | HAQ-DI With VAS - Aids or Devices - Long-Handled Appliances for Reach | ||
HAQ0139 | C106846 | HAQ01-Aid: Long-Handled Appl Bathroom | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances in bathroom. | HAQ-DI With VAS - Aids or Devices - Long-Handled Appliances in Bathroom | ||
HAQ0140 | C107093 | HAQ01-Othr Aid (Hygiene/Reach/Grip/Act) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. | HAQ-DI With VAS - Aids or Devices For Hygiene/Reach/Grip/Act-Other | ||
HAQ0141 | C107094 | HAQ01-Spec Aid (Hygiene/Reach/Grip/Act) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). | HAQ-DI With VAS - Aids or Devices For Hygiene/Reach/Grip/Act-Specify | ||
HAQ0142 | C106847 | HAQ01-Help: Hygiene | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Hygiene. | HAQ-DI With VAS - Help From Another Person - Hygiene | ||
HAQ0143 | C106848 | HAQ01-Help: Reach | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Reach. | HAQ-DI With VAS - Help From Another Person - Reach | ||
HAQ0144 | C106849 | HAQ01-Help: Gripping and Opening Things | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Gripping and opening things. | HAQ-DI With VAS - Help From Another Person - Gripping and Opening Things | ||
HAQ0145 | C106850 | HAQ01-Help: Errands and Chores | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Errands and chores. | HAQ-DI With VAS - Help From Another Person - Errands and Chores | ||
HAQ0146 | C106851 | HAQ01-Severity of Pain | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - How much pain have you had because of your illness in the past week? | HAQ-DI With VAS - Severity of Pain in the Past Week | ||
Back to top | ||||||
CL.C106666.HAQ01TN | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire Test Name
(HAQ01TN) | text
Extensible: No | C106666 | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale Questionnaire Test Name | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale test name. | CDISC Questionnaire HAQ-DI With VAS Test Name Terminology |
HAQ01-Able to Do Chores | C106841 | HAQ01-Able to Do Chores | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to do chores such as vacuuming or yardwork? | HAQ-DI With VAS - Able to Do Chores - Vacuuming or Yardwork | ||
HAQ01-Aid: Bathtub Bar | C106844 | HAQ01-Aid: Bathtub Bar | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub bar. | HAQ-DI With VAS - Aids or Devices - Bathtub Bar | ||
HAQ01-Aid: Bathtub Seat | C106843 | HAQ01-Aid: Bathtub Seat | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub seat. | HAQ-DI With VAS - Aids or Devices - Bathtub Seat | ||
HAQ01-Aid: Built Up or Special Utensils | C106823 | HAQ01-Aid: Built Up or Special Utensils | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Built up or special utensils. | HAQ-DI With VAS - Aids or Devices - Built Up or Special Utensils | ||
HAQ01-Aid: Cane | C106818 | HAQ01-Aid: Cane | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Cane. | HAQ-DI With VAS - Aids or Devices - Cane | ||
HAQ01-Aid: Crutches | C106820 | HAQ01-Aid: Crutches | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Crutches. | HAQ-DI With VAS - Aids or Devices - Crutches | ||
HAQ01-Aid: Devices Used for Dressing | C106822 | HAQ01-Aid: Devices Used for Dressing | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Devices used for dressing (button hook, zipper pull, long-handled shoe horn, etc.). | HAQ-DI With VAS - Aids or Devices - Used For Dressing | ||
HAQ01-Aid: Jar Opener (Previously Open) | C107020 | HAQ01-Aid: Jar Opener (Previously Open) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Jar opener (for jars previously opened). | HAQ-DI With VAS - Aids or Devices - Jar Opener (Jars Previously Opened) | ||
HAQ01-Aid: Long-Handled Appl Bathroom | C106846 | HAQ01-Aid: Long-Handled Appl Bathroom | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances in bathroom. | HAQ-DI With VAS - Aids or Devices - Long-Handled Appliances in Bathroom | ||
HAQ01-Aid: Long-Handled Appl Reach | C106845 | HAQ01-Aid: Long-Handled Appl Reach | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances for reach. | HAQ-DI With VAS - Aids or Devices - Long-Handled Appliances for Reach | ||
HAQ01-Aid: Raised Toilet Seat | C106842 | HAQ01-Aid: Raised Toilet Seat | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Raised toilet seat. | HAQ-DI With VAS - Aids or Devices - Raised Toilet Seat | ||
HAQ01-Aid: Special or Built Up Chair | C106824 | HAQ01-Aid: Special or Built Up Chair | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Special or built up chair. | HAQ-DI With VAS - Aids or Devices - Special or Built Up Chair | ||
HAQ01-Aid: Walker | C106819 | HAQ01-Aid: Walker | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Walker. | HAQ-DI With VAS - Aids or Devices - Walker | ||
HAQ01-Aid: Wheelchair | C106821 | HAQ01-Aid: Wheelchair | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Wheelchair. | HAQ-DI With VAS - Aids or Devices - Wheelchair | ||
HAQ01-Bend Down Pick Up Clothing - Floor | C106835 | HAQ01-Bend Down Pick Up Clothing - Floor | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Reach: Are you able to bend down to pick up clothing from the floor? | HAQ-DI With VAS - Able to Bend Down and Pick Up Clothing From Floor | ||
HAQ01-Climb Up Five Steps | C106817 | HAQ01-Climb Up Five Steps | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Walking: Are you able to climb up five steps? | HAQ-DI With VAS - Able to Climb Up Steps | ||
HAQ01-Cut Your Meat | C106813 | HAQ01-Cut Your Meat | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to cut your meat? | HAQ-DI With VAS - Able to Cut Meat | ||
HAQ01-Dress Yourself | C106809 | HAQ01-Dress Yourself | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Dressing & Grooming: Are you able to dress yourself, including tying shoelaces and doing buttons? | HAQ-DI With VAS - Able to Dress Yourself | ||
HAQ01-Get In and Out of a Car | C106840 | HAQ01-Get In and Out of a Car | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to get in and out of a car? | HAQ-DI With VAS - Able to Get In and Out of Car | ||
HAQ01-Get In and Out of Bed | C106812 | HAQ01-Get In and Out of Bed | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Arising: Are you able to get in and out of bed? | HAQ-DI With VAS - Able to Get In and Out of Bed | ||
HAQ01-Get On and Off The Toilet | C106833 | HAQ01-Get On and Off The Toilet | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to get on and off the toilet? | HAQ-DI With VAS - Able to Get On and Off Toilet | ||
HAQ01-Help: Arising | C106828 | HAQ01-Help: Arising | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Arising. | HAQ-DI With VAS - Help From Another Person - Arising | ||
HAQ01-Help: Dressing and Grooming | C106827 | HAQ01-Help: Dressing and Grooming | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Dressing and grooming. | HAQ-DI With VAS - Help From Another Person - Dressing and Grooming | ||
HAQ01-Help: Eating | C106829 | HAQ01-Help: Eating | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Eating. | HAQ-DI With VAS - Help From Another Person - Eating | ||
HAQ01-Help: Errands and Chores | C106850 | HAQ01-Help: Errands and Chores | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Errands and chores. | HAQ-DI With VAS - Help From Another Person - Errands and Chores | ||
HAQ01-Help: Gripping and Opening Things | C106849 | HAQ01-Help: Gripping and Opening Things | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Gripping and opening things. | HAQ-DI With VAS - Help From Another Person - Gripping and Opening Things | ||
HAQ01-Help: Hygiene | C106847 | HAQ01-Help: Hygiene | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Hygiene. | HAQ-DI With VAS - Help From Another Person - Hygiene | ||
HAQ01-Help: Reach | C106848 | HAQ01-Help: Reach | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Reach. | HAQ-DI With VAS - Help From Another Person - Reach | ||
HAQ01-Help: Walking | C106830 | HAQ01-Help: Walking | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Usually need help from another person: Walking. | HAQ-DI With VAS - Help From Another Person - Walking | ||
HAQ01-Lift a Full Cup or Glass to Mouth | C106814 | HAQ01-Lift a Full Cup or Glass to Mouth | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to lift a full cup or glass to your mouth? | HAQ-DI With VAS - Able to Lift Cup or Glass to Mouth | ||
HAQ01-Open a New Milk Carton | C106815 | HAQ01-Open a New Milk Carton | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Eating: Are you able to open a new milk carton? | HAQ-DI With VAS - Able to Open Milk Carton | ||
HAQ01-Open Car Doors | C106836 | HAQ01-Open Car Doors | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to open car doors? | HAQ-DI With VAS - Able to Open Car Doors | ||
HAQ01-Open Jars Previously Opened | C106837 | HAQ01-Open Jars Previously Opened | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to open jars which have been previously opened? | HAQ-DI With VAS - Able to Open Previously Opened Jars | ||
HAQ01-Othr Aid (Dress/Arising/Eat/Walk) | C106825 | HAQ01-Othr Aid (Dress/Arising/Eat/Walk) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. | HAQ-DI With VAS - Aids or Devices For Dress/Arising/Eat/Walk-Other | ||
HAQ01-Othr Aid (Hygiene/Reach/Grip/Act) | C107093 | HAQ01-Othr Aid (Hygiene/Reach/Grip/Act) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. | HAQ-DI With VAS - Aids or Devices For Hygiene/Reach/Grip/Act-Other | ||
HAQ01-Reach-Get Down 5 Lb Obj Above Head | C106834 | HAQ01-Reach-Get Down 5 Lb Obj Above Head | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Reach: Are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head? | HAQ-DI With VAS - Able to Reach and Get Down Object From Above Head | ||
HAQ01-Run Errands and Shop | C106839 | HAQ01-Run Errands and Shop | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Activities: Are you able to run errands and shop? | HAQ-DI With VAS - Able to Run Errands and Shop | ||
HAQ01-Severity of Pain | C106851 | HAQ01-Severity of Pain | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - How much pain have you had because of your illness in the past week? | HAQ-DI With VAS - Severity of Pain in the Past Week | ||
HAQ01-Shampoo Your Hair | C106810 | HAQ01-Shampoo Your Hair | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Dressing & Grooming: Are you able to shampoo your hair? | HAQ-DI With VAS - Able to Shampoo Hair | ||
HAQ01-Spec Aid (Dress/Arising/Eat/Walk) | C106826 | HAQ01-Spec Aid (Dress/Arising/Eat/Walk) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). | HAQ-DI With VAS - Aids or Devices For Dress/Arising/Eat/Walk-Specify | ||
HAQ01-Spec Aid (Hygiene/Reach/Grip/Act) | C107094 | HAQ01-Spec Aid (Hygiene/Reach/Grip/Act) | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). | HAQ-DI With VAS - Aids or Devices For Hygiene/Reach/Grip/Act-Specify | ||
HAQ01-Stand Up From a Straight Chair | C106811 | HAQ01-Stand Up From a Straight Chair | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Arising: Are you able to stand up from a straight chair? | HAQ-DI With VAS - Able to Stand Up From Chair | ||
HAQ01-Take a Tub Bath | C106832 | HAQ01-Take a Tub Bath | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to take a tub bath? | HAQ-DI With VAS - Able to Take Tub Bath | ||
HAQ01-Turn Faucets On And Off | C106838 | HAQ01-Turn Faucets On And Off | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Grip: Are you able to turn faucets on and off? | HAQ-DI With VAS - Able to Turn Faucets On and Off | ||
HAQ01-Walk Outdoors on Flat Ground | C106816 | HAQ01-Walk Outdoors on Flat Ground | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Walking: Are you able to walk outdoors on flat ground? | HAQ-DI With VAS - Able to Walk Outdoors On Flat Ground | ||
HAQ01-Wash and Dry Your Body | C106831 | HAQ01-Wash and Dry Your Body | Health Assessment Questionnaire Disability Index With Pain Visual Analog Scale - Hygiene: Are you able to wash and dry your body? | HAQ-DI With VAS - Able to Wash and Dry Body | ||
Back to top | ||||||
CL.C132523.HAQ02TC | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale Questionnaire Test Code
(HAQ02TC) | text
Extensible: No | C132523 | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale Questionnaire Test Code | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale test code. | CDISC Questionnaire HAQ-DI Without VAS Test Code Terminology |
HAQ0201 | C132573 | HAQ02-Dress Yourself | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Dressing & Grooming: Are you able to dress yourself, including tying shoelaces and doing buttons? | HAQ-DI Without VAS - Dress Yourself | ||
HAQ0202 | C132574 | HAQ02-Shampoo Your Hair | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Dressing & Grooming: Are you able to shampoo your hair? | HAQ-DI Without VAS - Shampoo Your Hair | ||
HAQ0203 | C132575 | HAQ02-Stand Up From a Straight Chair | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Arising: Are you able to stand up from a straight chair? | HAQ-DI Without VAS - Stand Up From a Straight Chair | ||
HAQ0204 | C132576 | HAQ02-Get In and Out of Bed | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Arising: Are you able to get in and out of bed? | HAQ-DI Without VAS - Get In and Out of Bed | ||
HAQ0205 | C132577 | HAQ02-Cut Your Meat | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to cut your meat? | HAQ-DI Without VAS - Cut Your Meat | ||
HAQ0206 | C132578 | HAQ02-Lift a Full Cup or Glass to Mouth | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to lift a full cup or glass to your mouth? | HAQ-DI Without VAS - Lift a Full Cup or Glass to Mouth | ||
HAQ0207 | C132579 | HAQ02-Open a New Milk Carton | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to open a new milk carton? | HAQ-DI Without VAS - Open a New Milk Carton | ||
HAQ0208 | C132580 | HAQ02-Walk Outdoors on Flat Ground | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Walking: Are you able to walk outdoors on flat ground? | HAQ-DI Without VAS - Walk Outdoors on Flat Ground | ||
HAQ0209 | C132581 | HAQ02-Climb Up Five Steps | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Walking: Are you able to climb up five steps? | HAQ-DI Without VAS - Climb Up Five Steps | ||
HAQ0210 | C132582 | HAQ02-Aid: Cane | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Cane. | HAQ-DI Without VAS - Aid: Cane | ||
HAQ0211 | C132583 | HAQ02-Aid: Walker | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Walker. | HAQ-DI Without VAS - Aid: Walker | ||
HAQ0212 | C132584 | HAQ02-Aid: Crutches | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Crutches. | HAQ-DI Without VAS - Aid: Crutches | ||
HAQ0213 | C132585 | HAQ02-Aid: Wheelchair | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Wheelchair. | HAQ-DI Without VAS - Aid: Wheelchair | ||
HAQ0214 | C132586 | HAQ02-Aid: Devices Used for Dressing | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Devices used for Dressing (button hook, zipper pull, long-handled shoe horn, etc.). | HAQ-DI Without VAS - Aid: Devices Used for Dressing | ||
HAQ0215 | C132587 | HAQ02-Aid: Built Up or Special Utensils | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Built up or special utensils. | HAQ-DI Without VAS - Aid: Built Up or Special Utensils | ||
HAQ0216 | C132588 | HAQ02-Aid: Special or Built Up Chair | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Special or built up chair. | HAQ-DI Without VAS - Aid: Special or Built Up Chair | ||
HAQ0217 | C132589 | HAQ02-Othr Aid (Dress/Arising/Eat/Walk) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. | HAQ-DI Without VAS - Other Aid (Dress or Arising or Eat or Walk) | ||
HAQ0218 | C132590 | HAQ02-Spec Aid (Dress/Arising/Eat/Walk) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). | HAQ-DI Without VAS - Special Aid (Dress or Arising or Eat or Walk) | ||
HAQ0219 | C132591 | HAQ02-Help: Dressing and Grooming | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Dressing and grooming. | HAQ-DI Without VAS - Help: Dressing and Grooming | ||
HAQ0220 | C132592 | HAQ02-Help: Arising | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Arising. | HAQ-DI Without VAS - Help: Arising | ||
HAQ0221 | C132593 | HAQ02-Help: Eating | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Eating. | HAQ-DI Without VAS - Help: Eating | ||
HAQ0222 | C132594 | HAQ02-Help: Walking | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Walking. | HAQ-DI Without VAS - Help: Walking | ||
HAQ0223 | C132595 | HAQ02-Wash and Dry Your Body | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to wash and dry your body? | HAQ-DI Without VAS - Wash and Dry Your Body | ||
HAQ0224 | C132596 | HAQ02-Take a Tub Bath | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to take a tub bath? | HAQ-DI Without VAS - Take a Tub Bath | ||
HAQ0225 | C132597 | HAQ02-Get On and Off The Toilet | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to get on and off the toilet? | HAQ-DI Without VAS - Get On and Off The Toilet | ||
HAQ0226 | C132598 | HAQ02-Reach-Get Down 5 Lb Obj Above Head | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Reach: Are you able to reach and get down a 5-pound object (such as a bag of sugar) from just above your head? | HAQ-DI Without VAS - Reach-Get Down 5 Lb Object Above Head | ||
HAQ0227 | C132599 | HAQ02-Bend Down Pick Up Clothing - Floor | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Reach: Are you able to bend down to pick up clothing from the floor? | HAQ-DI Without VAS - Bend Down Pick Up Clothing - Floor | ||
HAQ0228 | C132600 | HAQ02-Open Car Doors | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to open car doors? | HAQ-DI Without VAS - Open Car Doors | ||
HAQ0229 | C132601 | HAQ02-Open Jars Previously Opened | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to open jars which have been previously opened? | HAQ-DI Without VAS - Open Jars Previously Opened | ||
HAQ0230 | C132602 | HAQ02-Turn Faucets On And Off | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to turn faucets on and off? | HAQ-DI Without VAS - Turn Faucets On And Off | ||
HAQ0231 | C132603 | HAQ02-Run Errands and Shop | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to run errands and shop? | HAQ-DI Without VAS - Run Errands and Shop | ||
HAQ0232 | C132604 | HAQ02-Get In and Out of a Car | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to get in and out of a car? | HAQ-DI Without VAS - Get In and Out of a Car | ||
HAQ0233 | C132605 | HAQ02-Able to Do Chores | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to do chores such as vacuuming or yardwork? | HAQ-DI Without VAS - Able to Do Chores | ||
HAQ0234 | C132606 | HAQ02-Aid: Raised Toilet Seat | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Raised toilet seat. | HAQ-DI Without VAS - Aid: Raised Toilet Seat | ||
HAQ0235 | C132607 | HAQ02-Aid: Bathtub Seat | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub seat. | HAQ-DI Without VAS - Aid: Bathtub Seat | ||
HAQ0236 | C132608 | HAQ02-Aid: Jar Opener (Previously Open) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Jar opener (for jars previously opened). | HAQ-DI Without VAS - Aid: Jar Opener (Previously Open) | ||
HAQ0237 | C132609 | HAQ02-Aid: Bathtub Bar | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub bar. | HAQ-DI Without VAS - Aid: Bathtub Bar | ||
HAQ0238 | C132610 | HAQ02-Aid: Long-Handled Appl Reach | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances for reach. | HAQ-DI Without VAS - Aid: Long-Handled Appliances Reach | ||
HAQ0239 | C132611 | HAQ02-Aid: Long-Handled Appl Bathroom | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances in bathroom. | HAQ-DI Without VAS - Aid: Long-Handled Appliances Bathroom | ||
HAQ0240 | C132612 | HAQ02-Othr Aid (Hygiene/Reach/Grip/Act) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. | HAQ-DI Without VAS - Other Aid (Hygiene or Reach or Grip or Act) | ||
HAQ0241 | C132613 | HAQ02-Spec Aid (Hygiene/Reach/Grip/Act) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). | HAQ-DI Without VAS - Special Aid (Hygiene or Reach or Grip or Act) | ||
HAQ0242 | C132614 | HAQ02-Help: Hygiene | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Hygiene. | HAQ-DI Without VAS - Help: Hygiene | ||
HAQ0243 | C132615 | HAQ02-Help: Reach | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Reach. | HAQ-DI Without VAS - Help: Reach | ||
HAQ0244 | C132616 | HAQ02-Help: Gripping and Opening Things | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Gripping and opening things. | HAQ-DI Without VAS - Help: Gripping and Opening Things | ||
HAQ0245 | C132617 | HAQ02-Help: Errands and Chores | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Errands and chores. | HAQ-DI Without VAS - Help: Errands and Chores | ||
Back to top | ||||||
CL.C132522.HAQ02TN | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale Questionnaire Test Name
(HAQ02TN) | text
Extensible: No | C132522 | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale Questionnaire Test Name | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale test name. | CDISC Questionnaire HAQ-DI Without VAS Test Name Terminology |
HAQ02-Able to Do Chores | C132605 | HAQ02-Able to Do Chores | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to do chores such as vacuuming or yardwork? | HAQ-DI Without VAS - Able to Do Chores | ||
HAQ02-Aid: Bathtub Bar | C132609 | HAQ02-Aid: Bathtub Bar | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub bar. | HAQ-DI Without VAS - Aid: Bathtub Bar | ||
HAQ02-Aid: Bathtub Seat | C132607 | HAQ02-Aid: Bathtub Seat | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Bathtub seat. | HAQ-DI Without VAS - Aid: Bathtub Seat | ||
HAQ02-Aid: Built Up or Special Utensils | C132587 | HAQ02-Aid: Built Up or Special Utensils | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Built up or special utensils. | HAQ-DI Without VAS - Aid: Built Up or Special Utensils | ||
HAQ02-Aid: Cane | C132582 | HAQ02-Aid: Cane | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Cane. | HAQ-DI Without VAS - Aid: Cane | ||
HAQ02-Aid: Crutches | C132584 | HAQ02-Aid: Crutches | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Crutches. | HAQ-DI Without VAS - Aid: Crutches | ||
HAQ02-Aid: Devices Used for Dressing | C132586 | HAQ02-Aid: Devices Used for Dressing | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Devices used for Dressing (button hook, zipper pull, long-handled shoe horn, etc.). | HAQ-DI Without VAS - Aid: Devices Used for Dressing | ||
HAQ02-Aid: Jar Opener (Previously Open) | C132608 | HAQ02-Aid: Jar Opener (Previously Open) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Jar opener (for jars previously opened). | HAQ-DI Without VAS - Aid: Jar Opener (Previously Open) | ||
HAQ02-Aid: Long-Handled Appl Bathroom | C132611 | HAQ02-Aid: Long-Handled Appl Bathroom | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances in bathroom. | HAQ-DI Without VAS - Aid: Long-Handled Appliances Bathroom | ||
HAQ02-Aid: Long-Handled Appl Reach | C132610 | HAQ02-Aid: Long-Handled Appl Reach | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Long-handled appliances for reach. | HAQ-DI Without VAS - Aid: Long-Handled Appliances Reach | ||
HAQ02-Aid: Raised Toilet Seat | C132606 | HAQ02-Aid: Raised Toilet Seat | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Raised toilet seat. | HAQ-DI Without VAS - Aid: Raised Toilet Seat | ||
HAQ02-Aid: Special or Built Up Chair | C132588 | HAQ02-Aid: Special or Built Up Chair | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Special or built up chair. | HAQ-DI Without VAS - Aid: Special or Built Up Chair | ||
HAQ02-Aid: Walker | C132583 | HAQ02-Aid: Walker | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Walker. | HAQ-DI Without VAS - Aid: Walker | ||
HAQ02-Aid: Wheelchair | C132585 | HAQ02-Aid: Wheelchair | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Wheelchair. | HAQ-DI Without VAS - Aid: Wheelchair | ||
HAQ02-Bend Down Pick Up Clothing - Floor | C132599 | HAQ02-Bend Down Pick Up Clothing - Floor | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Reach: Are you able to bend down to pick up clothing from the floor? | HAQ-DI Without VAS - Bend Down Pick Up Clothing - Floor | ||
HAQ02-Climb Up Five Steps | C132581 | HAQ02-Climb Up Five Steps | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Walking: Are you able to climb up five steps? | HAQ-DI Without VAS - Climb Up Five Steps | ||
HAQ02-Cut Your Meat | C132577 | HAQ02-Cut Your Meat | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to cut your meat? | HAQ-DI Without VAS - Cut Your Meat | ||
HAQ02-Dress Yourself | C132573 | HAQ02-Dress Yourself | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Dressing & Grooming: Are you able to dress yourself, including tying shoelaces and doing buttons? | HAQ-DI Without VAS - Dress Yourself | ||
HAQ02-Get In and Out of a Car | C132604 | HAQ02-Get In and Out of a Car | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to get in and out of a car? | HAQ-DI Without VAS - Get In and Out of a Car | ||
HAQ02-Get In and Out of Bed | C132576 | HAQ02-Get In and Out of Bed | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Arising: Are you able to get in and out of bed? | HAQ-DI Without VAS - Get In and Out of Bed | ||
HAQ02-Get On and Off The Toilet | C132597 | HAQ02-Get On and Off The Toilet | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to get on and off the toilet? | HAQ-DI Without VAS - Get On and Off The Toilet | ||
HAQ02-Help: Arising | C132592 | HAQ02-Help: Arising | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Arising. | HAQ-DI Without VAS - Help: Arising | ||
HAQ02-Help: Dressing and Grooming | C132591 | HAQ02-Help: Dressing and Grooming | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Dressing and grooming. | HAQ-DI Without VAS - Help: Dressing and Grooming | ||
HAQ02-Help: Eating | C132593 | HAQ02-Help: Eating | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Eating. | HAQ-DI Without VAS - Help: Eating | ||
HAQ02-Help: Errands and Chores | C132617 | HAQ02-Help: Errands and Chores | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Errands and chores. | HAQ-DI Without VAS - Help: Errands and Chores | ||
HAQ02-Help: Gripping and Opening Things | C132616 | HAQ02-Help: Gripping and Opening Things | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Gripping and opening things. | HAQ-DI Without VAS - Help: Gripping and Opening Things | ||
HAQ02-Help: Hygiene | C132614 | HAQ02-Help: Hygiene | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Hygiene. | HAQ-DI Without VAS - Help: Hygiene | ||
HAQ02-Help: Reach | C132615 | HAQ02-Help: Reach | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Reach. | HAQ-DI Without VAS - Help: Reach | ||
HAQ02-Help: Walking | C132594 | HAQ02-Help: Walking | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Usually need help from another person: Walking. | HAQ-DI Without VAS - Help: Walking | ||
HAQ02-Lift a Full Cup or Glass to Mouth | C132578 | HAQ02-Lift a Full Cup or Glass to Mouth | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to lift a full cup or glass to your mouth? | HAQ-DI Without VAS - Lift a Full Cup or Glass to Mouth | ||
HAQ02-Open a New Milk Carton | C132579 | HAQ02-Open a New Milk Carton | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Eating: Are you able to open a new milk carton? | HAQ-DI Without VAS - Open a New Milk Carton | ||
HAQ02-Open Car Doors | C132600 | HAQ02-Open Car Doors | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to open car doors? | HAQ-DI Without VAS - Open Car Doors | ||
HAQ02-Open Jars Previously Opened | C132601 | HAQ02-Open Jars Previously Opened | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to open jars which have been previously opened? | HAQ-DI Without VAS - Open Jars Previously Opened | ||
HAQ02-Othr Aid (Dress/Arising/Eat/Walk) | C132589 | HAQ02-Othr Aid (Dress/Arising/Eat/Walk) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. | HAQ-DI Without VAS - Other Aid (Dress or Arising or Eat or Walk) | ||
HAQ02-Othr Aid (Hygiene/Reach/Grip/Act) | C132612 | HAQ02-Othr Aid (Hygiene/Reach/Grip/Act) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other. | HAQ-DI Without VAS - Other Aid (Hygiene or Reach or Grip or Act) | ||
HAQ02-Reach-Get Down 5 Lb Obj Above Head | C132598 | HAQ02-Reach-Get Down 5 Lb Obj Above Head | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Reach: Are you able to reach and get down a 5-pound object (such as a bag of sugar) from just above your head? | HAQ-DI Without VAS - Reach-Get Down 5 Lb Object Above Head | ||
HAQ02-Run Errands and Shop | C132603 | HAQ02-Run Errands and Shop | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Activities: Are you able to run errands and shop? | HAQ-DI Without VAS - Run Errands and Shop | ||
HAQ02-Shampoo Your Hair | C132574 | HAQ02-Shampoo Your Hair | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Dressing & Grooming: Are you able to shampoo your hair? | HAQ-DI Without VAS - Shampoo Your Hair | ||
HAQ02-Spec Aid (Dress/Arising/Eat/Walk) | C132590 | HAQ02-Spec Aid (Dress/Arising/Eat/Walk) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). | HAQ-DI Without VAS - Special Aid (Dress or Arising or Eat or Walk) | ||
HAQ02-Spec Aid (Hygiene/Reach/Grip/Act) | C132613 | HAQ02-Spec Aid (Hygiene/Reach/Grip/Act) | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Aids or devices that you usually use for any of these activities: Other (specify). | HAQ-DI Without VAS - Special Aid (Hygiene or Reach or Grip or Act) | ||
HAQ02-Stand Up From a Straight Chair | C132575 | HAQ02-Stand Up From a Straight Chair | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Arising: Are you able to stand up from a straight chair? | HAQ-DI Without VAS - Stand Up From a Straight Chair | ||
HAQ02-Take a Tub Bath | C132596 | HAQ02-Take a Tub Bath | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to take a tub bath? | HAQ-DI Without VAS - Take a Tub Bath | ||
HAQ02-Turn Faucets On And Off | C132602 | HAQ02-Turn Faucets On And Off | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Grip: Are you able to turn faucets on and off? | HAQ-DI Without VAS - Turn Faucets On And Off | ||
HAQ02-Walk Outdoors on Flat Ground | C132580 | HAQ02-Walk Outdoors on Flat Ground | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Walking: Are you able to walk outdoors on flat ground? | HAQ-DI Without VAS - Walk Outdoors on Flat Ground | ||
HAQ02-Wash and Dry Your Body | C132595 | HAQ02-Wash and Dry Your Body | Health Assessment Questionnaire Disability Index Without Pain Visual Analog Scale - Hygiene: Are you able to wash and dry your body? | HAQ-DI Without VAS - Wash and Dry Your Body | ||
Back to top | ||||||
CL.C171444.HODECOD | Health Care Encounters Dictionary Derived Term
(HODECOD) | text
Extensible: Yes | C171444 | Health Care Encounters Dictionary Derived Term | A terminology codelist based on the standardized or preprinted name of the healthcare encounter that occurs. | CDISC SDTM Health Care Encounters Dictionary Derived Term Terminology |
ADULT DAYCARE FACILITY VISIT | C198260 | The subject or patient has interacted with a healthcare professional at an adult daycare facility. | Adult Daycare Facility Visit | |||
CARDIAC CATHETERIZATION LABORATORY VISIT | C171501 | The subject or patient has interacted with a healthcare professional at a cardiac catheterization unit. | Cardiac Catheterization Laboratory Visit | |||
CARDIAC INTENSIVE CARE UNIT STAY | C171502 | CICU Stay;Coronary Intensive Care Unit Stay | The subject or patient has been admitted as an inpatient to a cardiac intensive care unit in a hospital. | Cardiac Intensive Care Unit Stay | ||
CARDIOLOGY UNIT VISIT | C177950 | The subject or patient has interacted with a healthcare professional at a cardiology unit in a hospital. | Cardiology Unit Visit | |||
DIETARY SPECIALIST VISIT | C177948 | The subject or patient has interacted with a dietary specialist. | Dietary Specialist Visit | |||
EMERGENCY ROOM VISIT | C176294 | The subject or patient has interacted with a healthcare professional at an emergency room. | Emergency Room Visit | |||
GENERAL WARD STAY | C171509 | General Medical Unit Stay | The subject or patient has been admitted as an inpatient to a general medical unit of a hospital. | General Ward Stay | ||
HEALTHCARE PROFESSIONAL VISIT | C177947 | The subject or patient has interacted with a healthcare professional. | Healthcare Professional Visit | |||
HOME HEALTHCARE VISIT | C184507 | The subject or patient has interacted with a healthcare professional within a residence. | Home Healthcare Visit | |||
HOSPICE FACILITY STAY | C198261 | The subject or patient has been admitted as an inpatient to a hospice facility. | Hospice Facility Stay | |||
HOSPITAL STAY | C171453 | Inpatient Hospital Stay;Inpatient Hospitalization | The subject or patient has been admitted as an inpatient to a hospital. | Hospital Stay | ||
INTENSIVE CARE UNIT STAY | C171454 | ICU Stay | The subject or patient has been admitted as an inpatient to a intensive care unit in a hospital. | Intensive Care Unit Stay | ||
MENTAL HEALTH SPECIALIST VISIT | C177949 | The subject or patient has interacted with a mental health specialist. | Mental Health Specialist Visit | |||
NEURO INTENSIVE CARE UNIT STAY | C171517 | Neuro-ICU Stay;Neuro-Trauma ICU Stay | The subject or patient has been admitted as an inpatient to a neuro-intensive care unit in a hospital. | Neuro Intensive Care Unit Stay | ||
NURSING HOME STAY | C171518 | The subject or patient has been admitted as an inpatient to a nursing home. | Nursing Home Stay | |||
OUTPATIENT CLINIC VISIT | C154474 | Ambulatory Care Clinic Visit;Ambulatory Care Facility Visit;Ambulatory Center Visit | The subject or patient has interacted with a healthcare professional at an outpatient clinic. | Ambulatory Visit | ||
PHYSICAL THERAPY FACILITY VISIT | C171520 | The subject or patient has interacted with a healthcare professional at a physical therapy facility. | Physical Therapy Facility Visit | |||
PRIMARY CARE PHYSICIAN'S OFFICE VISIT | C176292 | The subject or patient has interacted with a primary care physician. | Primary Care Physician's Office Visit | |||
PSYCHIATRIC WARD STAY | C171522 | The subject or patient has been admitted as an inpatient to a psychiatric ward. | Psychiatric Ward Stay | |||
REHABILITATION FACILITY STAY | C171523 | The subject or patient has been admitted as an inpatient to a rehabilitation facility. | Rehabilitation Facility Stay | |||
SKILLED NURSING FACILITY STAY | C171534 | The subject or patient has been admitted as an inpatient to a skilled nursing facility. | Skilled Nursing Facility Stay | |||
SPECIALTY CARE PHYSICIAN'S OFFICE VISIT | C176293 | The subject or patient has interacted with a specialty care physician. | Specialty Care Physician's Office Visit | |||
SURGICAL INTENSIVE CARE UNIT STAY | C171535 | SICU Stay | The subject or patient has been admitted as an inpatient to a surgical intensive care unit in a hospital. | Surgical Intensive Care Unit Stay | ||
Back to top | ||||||
CL.C184330.HEGRDMTH | Holter ECG Read Method Response
(HEGRDMTH) | text
Extensible: Yes | C184330 | Holter ECG Read Method Response | Terminology relevant to the method for how the Holter ECG is read, with respect to how much human intervention is involved. | CDISC SDTM Holter ECG Read Method Response Terminology |
AUTOMATIC | C70669 | Of or related to a process performed without human intervention. | Automatic | |||
MANUAL | C63513 | Of or related to a process performed by hand. | Manual | |||
SEMI-AUTOMATIC | C172484 | Of or related to a process performed using a combination of manual and automatic means. | Semi-Automatic | |||
Back to top | ||||||
CL.C120522.HESTRESC | Holter ECG Results
(HESTRESC) | text
Extensible: Yes | C120522 | Holter ECG Results | Terminology relevant to the responses that describe Holter ECG interpretative findings. | CDISC SDTM Holter ECG Results Terminology |
1ST DEGREE AV BLOCK | C111088 | 1st degree AV block;PR Prolongation;Prolonged PR interval | An electrocardiographic finding of prolonged PR interval for a specific population. For adults one common threshold is a PR interval greater than 0.20 seconds. Note that other thresholds may be applicable. | AV Block First Degree by ECG Finding | ||
2:1 AV BLOCK | C71044 | 2:1 AV block | An electrocardiographic finding of a supraventricular rhythm where the ratio of impulses generated above the atrioventricular node to the number of impulses conducted through to the ventricles is 2:1. This is manifest on the ECG as 2 P waves per QRS complex. | 2:1 Atrioventricular Block by ECG Finding | ||
2ND DEGREE AV BLOCK | C62016 | Second Degree AV Block | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by regular P waves which intermittently are not followed by QRS complexes. | AV Block Second Degree by ECG Finding | ||
3RD DEGREE AV BLOCK | C111091 | 3rd Degree Heart Block;AV block, complete (third-degree);Complete Heart Block | An electrocardiographic finding of complete failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by disassociation of atrial and ventricular rhythms. The atrial rate must be faster than the ventricular rate. | AV Block Third Degree by ECG Finding | ||
50 Hz NOISE | C114165 | 50 Hz Artifact;50 Hz Noise | An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (50 Hz). | 50 Hertz Noise by ECG Finding | ||
60 Hz NOISE | C114164 | 60 Hz Artifact;60 Hz Noise | An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (60 Hz). | 60 Hertz Noise by ECG Finding | ||
ABERRANTLY CONDUCTED COMPLEXES | C116132 | Aberrantly Conducted Beats | An electrocardiographic finding of an abnormally wide QRS complex(es) of supraventricular origin with prolonged QRS duration due to aberrant AV conduction. | Aberrantly Conducted Complexes by ECG Finding | ||
AC NOISE | C114149 | AC Noise | An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (usually 50 Hz or 60 Hz). | Alternating Current Noise by ECG Finding | ||
ACCELERATED IDIOVENTRICULAR RHYTHM | C62266 | Accelerated idioventricular rhythm | An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute. | Accelerated Idioventricular Rhythm by ECG Finding | ||
ACUTE ANTERIOR WALL MYOCARDIAL INFARCTION | C71065 | Acute Anterior MI;Acute Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 and V4, which is suggestive of acute myocardial infarction of the anterior wall of the left ventricle. | Acute Anterior Myocardial Infarction by ECG Finding | ||
ACUTE ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C102591 | Acute Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 through V6, which is suggestive of acute myocardial infarction of the anterolateral wall of the left ventricle. | Acute Anterolateral Myocardial Infarction by ECG Finding | ||
ACUTE ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C102592 | Acute anteroseptal MI;Acute Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 through V4, which is suggestive of acute myocardial infarction of the anteroseptal wall of the left ventricle. | Acute Anteroseptal Myocardial Infarction by ECG Finding | ||
ACUTE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C106496 | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 to V6, I and aVL, which is suggestive of acute myocardial infarction involving the anterior and anterolateral walls of the left ventricle. | Acute Extensive Anterior Wall Myocardial Infarction by ECG Finding | |||
ACUTE HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102593 | Acute High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads I and aVL, which is suggestive of acute myocardial infarction of the high lateral wall of the left ventricle. | Acute High Lateral Myocardial Infarction by ECG Finding | ||
ACUTE INFERIOR WALL MYOCARDIAL INFARCTION | C71066 | Acute Inferior MI;Acute Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads III, aVF and often II, which is suggestive of acute myocardial infarction of the inferior wall of the left ventricle. | Acute Inferior Myocardial Infarction by ECG Finding | ||
ACUTE LATERAL WALL MYOCARDIAL INFARCTION | C71067 | Acute Lateral MI;Acute Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V5, V6, I and aVL, which is suggestive of acute myocardial infarction of the lateral wall of the left ventricle. | Acute Lateral Myocardial Infarction by ECG Finding | ||
ACUTE MYOCARDIAL INFARCTION | C101596 | Acute Myocardial Infarction | An electrocardiographic finding showing a current of injury with ST elevation. No specification is provided for localization. | Acute Myocardial Infarction by ECG Finding | ||
ACUTE POSTERIOR WALL MYOCARDIAL INFARCTION | C71068 | Acute Posterior MI;Acute Posterior Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. | Acute Posterior Myocardial Infarction by ECG Finding | ||
ACUTE RIGHT VENTRICULAR WALL MYOCARDIAL INFARCTION | C102594 | Acute Right ventricular MI;Acute Right Ventricular Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the ventricular wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Additional criteria include ST elevation > 100 microvolts in the right precordial leads V4R through V6R. | Acute Right Ventricular Myocardial Infarction by ECG Finding | ||
ACUTE SEPTAL WALL MYOCARDIAL INFARCTION | C102595 | Acute Septal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1, V2 and often V3, which is suggestive of acute myocardial infarction of the intraventricular septum. | Acute Septal Myocardial Infarction by ECG Finding | ||
ADVANCED/HIGH GRADE AV BLOCK | C102642 | Advanced/High Grade AV Block | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by two or more consecutive non-conducted P waves. | High Grade Atrioventricular Block by ECG Finding | ||
ALL PRECORDIAL ELECTRODES DISCONNECTED | C114159 | An electrocardiographic recording in which all precordial electrodes are disconnected resulting in missing waveforms (flat line) of all leads V1 - V6. | All Precordial Electrodes Are Disconnected by ECG Finding | |||
ANTERIOR WALL MYOCARDIAL INFARCTION | C71069 | Anterior MI;Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle. | Anterior Myocardial Infarction by ECG Finding | ||
ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C35303 | Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle. | Anterolateral Myocardial Infarction by ECG Finding | ||
ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C35304 | Anteroseptal MI;Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle. | Anteroseptal Myocardial Infarction by ECG Finding | ||
ARTIFACT | C114162 | An electrocardiographic recording in which one or more leads display extraneous signals which do not represent cardiac electrical activity. | Artifact Lead Signal by ECG Finding | |||
ASYSTOLE | C116130 | An electrocardiographic finding showing no cardiac electrical activity on the ECG for the entire duration of the recording. | Asystole by ECG Finding | |||
ATRIAL BIGEMINY | C102596 | An electrocardiographic finding of a sinus beat followed by a premature atrial complex for three or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 1-1 ratio. | Atrial Bigeminy by ECG Finding | |||
ATRIAL COUPLETS | C102597 | Atrial Couplets | An electrocardiographic finding in which two premature atrial complexes occur sequentially; there may be one or more occurrences during an electrocardiographic recording. | Atrial Couplet by ECG Finding | ||
ATRIAL ENLARGEMENT | C71039 | Atrial Enlargement | An electrocardiographic finding which comprises left, right or bilateral atrial enlargement. This is may be characterized by prolonged P wave duration, increased P wave amplitude, or multi-component P waves. | Atrial Enlargement by ECG Finding | ||
ATRIAL FIBRILLATION | C111092 | Atrial fibrillation | An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. | Atrial Fibrillation by ECG Finding | ||
ATRIAL FLUTTER | C111094 | Atrial flutter | An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate of 240-340 beats per minute. Multiple P waves typically appear in the inferior leads in a saw tooth like pattern between the QRS complexes. | Atrial Flutter by ECG Finding | ||
ATRIAL TACHYCARDIA WITH AV BLOCK | C119249 | An electrocardiographic finding of an atrial tachycardia which does not display 1:1 AV conduction. | Atrial Tachycardia With AV Block by ECG Finding | |||
ATRIAL TACHYCARDIA | C111105 | Atrial tachycardia | An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate between 101 and 240 beats per minute. The P wave morphology must be distinct from the sinus P wave morphology. | Atrial Tachycardia by ECG Finding | ||
ATRIAL TRIGEMINY | C102598 | Atrial Trigeminy | An electrocardiographic finding of two sinus beats followed by a premature atrial complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 2-1 ratio. | Atrial Trigeminy by ECG Finding | ||
ATRIOVENTRICULAR DISSOCIATION | C71045 | Atrioventricular dissociation;AV Dissociation | An electrocardiographic finding in which the electrical activity of the atria and ventricles are independent of one another. | Atrioventricular Dissociation by ECG Finding | ||
AV MOBITZ I | C111089 | AV Mobitz I;Mobitz I Second Degree AV Block;Second degree AV block- Mobitz type I;Second-degree AV block, Mobitz type I (Wenckebach);Type 1 2nd degree AV Block;Wenckebach | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a progressively lengthening PR interval prior to the block of an atrial impulse. | AV Block Second Degree Mobitz Type I by ECG Finding | ||
AV MOBITZ II | C111090 | Mobitz II AV Block;Mobitz II Second Degree AV Block;Type 2 2nd degree AV Block | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a relatively constant PR interval prior to the block of an atrial impulse. | AV Block Second Degree Mobitz Type II by ECG Finding | ||
AV NODE RE-ENTRY | C35058 | AV Node Reentrant Supraventricular Tachycardia | An electrocardiographic finding of a regular supraventricular tachycardia due to reentry within the AV node. It is characterized by P waves which typically occurs nearly simultaneously with the QRS complex, resulting in a P wave which is obscured by the QRS, merged with the QRS or which may follow the QRS. | Atrioventricular Nodal Reentry Tachycardia by ECG Finding | ||
AV RE-ENTRANT TACHYCARDIA | C62261 | AV Reentrant Supraventricular Tachycardia | An electrocardiographic finding of a regular supraventricular tachycardia which utilizes an atrioventricular bypass tract as its retrograde limb (orthodromic tachycardia) or as its antegrade limb (antidromic tachycardia). QRS complexes during sinus rhythm may show preexcitation. During orthodromic tachycardia the preexcitation is not present and a retrograde P wave may appear after the QRS complex. During antidromic tachycardia the QRS complex is preexcited. | Atrioventricular Reentrant Tachycardia by ECG Finding | ||
BASELINE WANDER | C114147 | An electrocardiographic recording in which the isoelectric line in one or more leads is vertically displaced resulting in low frequency upward and downward movements of the signal with varying amplitudes. | Baseline Wander by ECG Finding | |||
BIFASCICULAR BLOCK | C71046 | Bifascicular block | An electrocardiographic finding comprising right bundle branch block and left anterior fascicular block, or right bundle branch block and left posterior fascicular block. Defects occurring in two of the three divisions of the conduction system of the heart are considered bifascicular blocks. Technically left bundle branch block may be considered a bifascicular block. (NCI) | Bifascicular Block by ECG Finding | ||
BIVENTRICULAR HYPERTROPHY | C106502 | An electrocardiographic finding suggestive of enlargement or thickening of both ventricles, with a combination of findings which are related to LVH and RVH, such as voltage criteria for LVH in the presence of marked right axis deviation. | Biventricular Hypertrophy by ECG Finding | |||
BORDERLINE QTCB | C92228 | Borderline QTcB | An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist. | Borderline QTcB | ||
BORDERLINE QTCF | C92229 | Borderline QTcF | An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist. | Borderline QTcF | ||
BRADYCARDIA | C111120 | Bradycardia | An electrocardiographic finding of abnormally slow heart rate. Thresholds for different age, gender, and patient populations exist. | Bradycardia by ECG Finding | ||
BRUGADA SYNDROME PATTERN | C106503 | An electrocardiographic finding of complete or incomplete right bundle branch block accompanied by ST elevation in leads V1-V3. This may be noted at rest or can be provoked by medication challenge. | Brugada Syndrome Pattern by ECG Finding | |||
DEFIBRILLATOR DISCHARGE | C120609 | An electrocardiographic finding of an artifact generated by an external or internal cardioversion or defibrillation shock. | Defibrillator Discharge by ECG Finding | |||
DELTA WAVE | C62258 | Delta wave | An electrocardiographic finding of initial slurring (delta wave) of the QRS complex due to the presence of an accessory pathway. This characteristic ECG pattern is typically seen in Wolff-Parkinson-White syndrome. | Delta Wave by ECG Finding | ||
DEXTROCARDIA | C102623 | Dextrocardia | An electrocardiographic finding suggestive of dextrocardia with situs inversus, characterized by reversal of normal anterior R wave progression and the appearance of reversal of the right and left arm electrodes. | Dextrocardia by ECG Finding | ||
EARLY R WAVE TRANSITION | C102628 | Early R Wave Progression;Early R Wave Transition | An electrocardiographic finding where the amplitude of the R wave becomes greater than the amplitude of the S wave in the QRS complex at an unusually early point in the precordial leads, usually in leads V1 or V2. | Early R Wave Transition by ECG Finding | ||
EARLY REPOLARIZATION | C102629 | Early Repolarization | An electrocardiographic finding of J point and ST segment elevation in the absence of other signs of acute ischemia or pericarditis. | Early Repolarization | ||
ECG ACQUIRED WITH PRECORDIAL ELECTRODES PLACED ON RIGHT CHEST | C114175 | An electrocardiographic recording in which the precordial electrodes have been placed over the right chest and record a right sided ECG. | ECG Acquired with Precordial Electrodes Placed on the Right Chest | |||
ECG EVALUATION NOT PERFORMED DUE TO CORRUPTED DIGITAL ECG FILE | C114181 | A digital electrocardiographic recording which is corrupted (i.e. ECG signal cannot be restored) such that measurements and/or interpretation cannot be performed. | ECG Evaluation Not Performed Due to Corrupted Digital ECG File | |||
ECTOPIC ATRIAL RHYTHM | C62245 | Ectopic Supraventricular Rhythm | An electrocardiographic finding of a regular atrial rhythm with atrial rate of less than 101 beats per minute which does not originate in the sinus node, and which is characterized by P waves whose morphology differs from the P wave morphology during sinus rhythm. | Ectopic Atrial Rhythm by ECG Finding | ||
ECTOPIC VENTRICULAR RHYTHM | C71042 | Ectopic ventricular rhythm | An electrocardiographic finding of three or more consecutive complexes of ventricular origin. The QRS complexes are wide and have an abnormal morphology. | Ectopic Ventricular Rhythm by ECG Finding | ||
ELECTRICAL ALTERNANS | C71035 | Electrical alternans | An electrocardiographic finding in which there is an alternating pattern of any of the waveform components. (NCI) | Electrical Alternans by ECG Finding | ||
EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C106520 | An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle. | Extensive Anterior Wall Myocardial Infarction by ECG Finding | |||
FREQUENT PREMATURE ATRIAL COMPLEXES | C120610 | An electrocardiographic finding during a continuous recording in which the frequency of atrial premature complexes exceeds the normal threshold. Note that different thresholds may apply to different patient populations. | Frequent Premature Atrial Complexes by ECG Finding | |||
FREQUENT PREMATURE VENTRICULAR COMPLEXES | C120611 | An electrocardiographic finding during a continuous recording in which the frequency of ventricular premature complexes exceeds the normal threshold. Note that different thresholds may apply to different patient populations. | Frequent Premature Ventricular Complexes by ECG Finding | |||
FUSION COMPLEX | C102639 | Fusion Beat;Fusion Complexes | An electrocardiographic finding that occurs when electrical activation of the atria or ventricles occurs from two separate sites. This results in a P wave or QRS complex that displays merged characteristics of beats originating from the two different sites; there may be one or more occurrences during an electrocardiographic recording. | Fusion Complex | ||
HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102643 | High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle. | High Lateral Myocardial Infarction by ECG Finding | ||
HOLTER LEAD FAIL | C120612 | A continuous, ambulatory electrocardiographic recording during which one or more electrodes are disconnected, at least temporarily, resulting in one or more invalid ECG waveforms. | Holter Lead Fail by ECG Finding | |||
IDIOVENTRICULAR RHYTHM | C50599 | Idioventricular Rhythm | An electrocardiographic finding of three or more consecutive complexes of ventricular origin with a rate less than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. | Idioventricular Rhythm | ||
INCOMPLETE LEFT BUNDLE BRANCH BLOCK | C71047 | Incomplete left bundle branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration less than 120 ms. | Incomplete Left Bundle Branch Block by ECG Finding | ||
INCOMPLETE RIGHT BUNDLE BRANCH BLOCK | C71048 | Incomplete right bundle branch block;Incomplete right bundle-branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration less than 120 ms. | Incomplete Right Bundle Branch Block by ECG Finding | ||
INDETERMINATE QRS AXIS | C102701 | Indeterminate Axis;Indeterminate QRS Axis;QRS Axis Indeterminate | An electrocardiographic finding in which the frontal plane QRS axis cannot be calculated. | QRS Axis Indeterminate | ||
INFERIOR WALL MYOCARDIAL INFARCTION | C35398 | Inferior MI;Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle. | Inferior Myocardial Infarction by ECG Finding | ||
INTRAATRIAL CONDUCTION DELAY | C71073 | Intraatrial Conduction Delay | An electrocardiographic finding of a delay in impulse propagation through the atria. This is characterized by broad P waves which are often biphasic in V1. | Intra-Atrial Conduction Delay by ECG Finding | ||
INTRAVENTRICULAR CONDUCTION DELAY, NONSPECIFIC | C62271 | Intraventricular Conduction Defect;Intraventricular conduction delay | An electrocardiographic finding of a widened QRS duration typically greater than 110 ms which does not meet the morphologic criteria for any of the standard bundle branch or fascicular block patterns. | Nonspecific Intraventricular Conduction Delay by ECG Finding | ||
ISORHYTHMIC DISSOCIATION | C62248 | Isorhythmic dissociation | An electrocardiographic finding of a type of atrioventricular dissociation characterized by the atria (P waves) and ventricles (QRS complexes) beating at similar rates, although independently. | Isorhythmic Atrioventricular Dissociation | ||
J POINT ELEVATION | C71030 | J point elevation | An electrocardiographic finding of a significant elevation above the baseline of the J point. | J Point Elevation | ||
JUNCTIONAL BRADYCARDIA | C71074 | Junctional bradycardia | An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally low. | Junctional Bradycardia by ECG Finding | ||
JUNCTIONAL ESCAPE COMPLEXES | C116129 | Junctional Escape Beat;Junctional Escape Complex | An electrocardiographic finding of an escape beat following a pause which originates in the AV junction. This is manifest as a QRS complex of supraventricular origin not preceded by a P wave; there may be one or more occurrences during an electrocardiographic recording. | Junctional Escape Complexes by ECG Finding | ||
JUNCTIONAL ESCAPE RHYTHM | C135393 | An electrocardiographic finding of a junctional rhythm that arises as a physiologic response to extreme slowing or arrest of sinus node activity. In this setting, a faster junctional rhythm may be a normal response to a very slow or absent sinus rate. | Junctional Escape Rhythm by ECG Finding | |||
JUNCTIONAL PREMATURE COMPLEX | C102652 | Junctional Extra Beat;Junctional Premature Complexes | An electrocardiographic finding of an ectopic impulse originating in the AV junction presenting as a QRS complex of supraventricular origin which is not preceded by a P wave; there may be one or more occurrences during an electrocardiographic recording. | Junctional Premature Complex by ECG Finding | ||
JUNCTIONAL RHYTHM | C71051 | Junctional rhythm | An electrocardiographic finding of a rhythm which originates in the AV junction and results in a normal heart rate. It is characterized by retrograde P waves which may be obscured by or may follow the QRS complexes. The QRS complexes may be narrow or may demonstrate aberration. | Junctional Rhythm by ECG Finding | ||
JUNCTIONAL TACHYCARDIA | C35059 | Junctional tachycardia | An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally elevated. | Junctional Tachycardia by ECG Finding | ||
LATE R WAVE TRANSITION | C102653 | Late R Wave Transition | An electrocardiographic finding where the amplitude of the R wave does not become greater than the amplitude of the S wave until an unusually late point in the precordial leads, usually in leads V4 to V6. | Late R Wave Transition by ECG Finding | ||
LATERAL WALL MYOCARDIAL INFARCTION | C35586 | Lateral MI;Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle. | Lateral Myocardial Infarction by ECG Finding | ||
LEFT ANTERIOR FASCICULAR BLOCK | C62267 | Left anterior fascicular block;Left Anterior Hemiblock | An electrocardiographic finding of a slightly widened QRS duration (typically less than 120 ms) with leftward frontal plane QRS axis and typically small Q waves in leads I and aVL. | Left Anterior Fascicular Block by ECG Finding | ||
LEFT ATRIAL ABNORMALITY | C71040 | Left Atrial Enlargement;P-mitrale | An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the left atrium. Electrocardiographic criteria used for the diagnosis of left atrial abnormality may include a bifid p wave, a biphasic p wave and/or a p wave duration of greater than 0.12 seconds. (NCI) | P-mitrale by ECG Finding | ||
LEFT BUNDLE BRANCH BLOCK | C62269 | Complete LBBB;Left bundle branch block;Left bundle-branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration greater than or equal to 120 ms. | Left Bundle Branch Block by ECG Finding | ||
LEFT POSTERIOR FASCICULAR BLOCK | C62268 | Left posterior fascicular block;Left Posterior Hemiblock | An electrocardiographic finding of an S1Q3 pattern and QRS axis greater than or equal to 120 degrees. It is usually seen in association with other abnormalities (e.g. RBBB or RVH). | Left Posterior Fascicular Block by ECG Finding | ||
LEFT VENTRICULAR CONDUCTION DELAY | C92231 | Left Ventricular Conduction Delay | An electrocardiographic finding in which there is evidence that electrical transmission through the left ventricle is impaired. | Left Ventricular Conduction Delay by ECG Finding | ||
LEFT VENTRICULAR HYPERTROPHY WITH STRAIN | C102655 | Left Ventricular Hypertrophy With Strain | An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes, ST depression and T wave inversion. | Left Ventricular Hypertrophy with Strain by ECG Finding | ||
LEFT VENTRICULAR HYPERTROPHY | C71076 | Left Ventricular Hypertrophy | An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes and secondary findings of left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion. | Left Ventricular Hypertrophy by ECG Finding | ||
LIMB ELECTRODE(S) DISCONNECTED | C114151 | An electrocardiographic recording in which one or more of the limb electrodes are disconnected resulting in missing waveforms (often flat lines) of the respective leads. | Disconnected Limb Electrodes by ECG Finding | |||
LIMB ELECTRODES INTERCHANGED | C114150 | Limb Lead Reversal | An electrocardiographic recording in which two or more of the limb electrodes are switched resulting in improper representation of the affected leads. | Interchanged Limb Electrodes by ECG Finding | ||
LOW AMPLITUDE SIGNAL | C114166 | Low Amplitude QRS Complex | An electrocardiographic recording showing smaller than usual QRS complexes in one or more leads. This may represent a technical issue with the ECG acquisition or characteristics of the individual. | Low Amplitude QRS Complex by ECG Finding | ||
LOW QRS VOLTAGE | C71078 | Low QRS voltage | An electrocardiographic finding of a QRS amplitude less than or equal to 0.5 mV in the limb leads or QRS amplitude less than or equal to 1 mV in the precordial leads. | Low QRS Voltage by ECG Finding | ||
LOW VOLTAGE - LIMB LEADS ONLY | C116133 | An electrocardiographic finding of small QRS amplitudes (less than 500 microvolts) in all limb leads. | Low Voltage in Limb Leads Only by ECG Finding | |||
MARKED SINUS BRADYCARDIA | C120613 | An electrocardiographic finding of sinus bradycardia with a heart rate below a threshold of clinical concern. Note that different thresholds (for rate and/or duration) may apply to different patient populations. | Marked Sinus Bradycardia by ECG Finding | |||
MULTIFOCAL ATRIAL TACHYCARDIA | C71050 | Multifocal atrial tachycardia | An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically 100-150 beats per minute. | Multifocal Atrial Tachycardia by ECG Finding | ||
MUSCLE TREMOR | C114148 | An electrocardiographic recording with intermittent mid to high frequency artifact in one or more leads due to muscular tremor or movement rather than cardiac activity. | Muscle Tremor Artifact | |||
MYOCARDIAL INFARCTION | C101589 | Myocardial Infarction | An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart. No specification is provided for localization. | Myocardial Infarction by ECG Finding | ||
NEW ANTERIOR WALL MYOCARDIAL INFARCTION | C102732 | New Anterior MI;New Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle and which is new compared to prior ECGs. | New Anterior Myocardial Infarction by ECG Finding | ||
NEW ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C102733 | New Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle and which is new compared to prior ECGs. | New Anterolateral Myocardial Infarction by ECG Finding | ||
NEW ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C102734 | New Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle and which is new compared to prior ECGs. | New Anteroseptal Myocardial Infarction by ECG Finding | ||
NEW EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C102735 | New Extensive Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle and which is new compared to prior ECGs. | New Extensive Anterior Myocardial Infarction by ECG Finding | ||
NEW HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102736 | New High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle and which is new compared to prior ECGs. | New High Lateral Myocardial Infarction by ECG Finding | ||
NEW INFERIOR WALL MYOCARDIAL INFARCTION | C102737 | New Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle and which is new compared to prior ECGs. | New Inferior Myocardial Infarction by ECG Finding | ||
NEW LATERAL WALL MYOCARDIAL INFARCTION | C102738 | New Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle and which is new compared to prior ECGs. | New Lateral Myocardial Infarction by ECG Finding | ||
NEW MYOCARDIAL INFARCTION | C102731 | New Myocardial Infarction | An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart and which is new compared to prior ECGs. No specification is provided for localization. | New Myocardial Infarction by ECG Finding | ||
NEW POSTERIOR WALL MYOCARDIAL INFARCTION | C106548 | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, and which is new compared to prior ECGs. Evidence of inferior or lateral myocardial infarction is usually also present. | New Posterior Wall Myocardial Infarction by ECG Finding | |||
NEW SEPTAL WALL MYOCARDIAL INFARCTION | C102739 | New Septal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum and which is new compared to prior ECGs. | New Septal Myocardial Infarction by ECG Finding | ||
NO ECG WAVEFORMS PRESENT | C114163 | An electrocardiographic recording that displays flat lines (no waveforms are visible) in all leads present. | ECG Waveforms Not Present | |||
NON Q WAVE MYOCARDIAL INFARCTION | C71080 | Non Q Wave Myocardial Infarction | An electrocardiographic finding of ST and T wave abnormalities in the absence of pathologic Q waves, which is suggestive of myocardial infarction in one or more regions of the heart. | Non Q Wave Myocardial Infarction by ECG Finding | ||
NON-DIAGNOSTIC Q WAVES | C116134 | An electrocardiographic finding of Q waves which are insufficient for the diagnosis of myocardial infarction. In such cases a myocardial infarction may be suspected, even though ECG criteria are not met. | Non-Diagnostic Q Waves by ECG Finding | |||
NON-SPECIFIC ST-T CHANGES | C71031 | Non-specific ST-T changes | An electrocardiographic finding of changes in the ST segment and T wave that do not meet criteria for ischemia or infarction. (NCI) | Non-Specific ST-T Changes by ECG Finding | ||
NON-SUSTAINED ATRIAL TACHYCARDIA | C102680 | Non-Sustained Atrial Tachycardia | An electrocardiographic finding of an atrial tachycardia which terminates in less than 30 seconds. | Non-Sustained Atrial Tachycardia by ECG Finding | ||
NON-SUSTAINED VENTRICULAR TACHYCARDIA | C71053 | Non-sustained ventricular tachycardia;Ventricular tachycardia, unsustained | An electrocardiographic finding of ventricular tachycardia less than 30 seconds in duration. (NCI) | Non-Sustained Ventricular Tachycardia by ECG Finding | ||
NONCONDUCTED P WAVE PHYSIOLOGY NOT DEFINED | C135394 | An electrocardiographic finding of a P wave that does not conduct to the ventricle or result in ventricular activation. | Nonconducted P Wave Physiology Not Defined by ECG Finding | |||
NONSUSTAINED SUPRAVENTRICULAR TACHYCARDIA | C120614 | An electrocardiographic finding of a supraventricular tachycardia with duration shorter than 30 seconds (though other duration thresholds may be applied). | Nonsustained Supraventricular Tachycardia by ECG Finding | |||
NORMAL SINUS RHYTHM | C102681 | Normal Sinus Rhythm | An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. There are no extra beats or conduction abnormalities. | Normal Sinus Rhythm | ||
NORTHWEST AXIS | C102634 | Northwest Axis;Right superior axis | An electrocardiographic finding of a frontal plane QRS axis from -90 to +180 degrees. | Extreme Right Axis Deviation | ||
NOTCHED T WAVES | C71032 | Notched T Waves | An electrocardiographic finding of an irregular, u or v shaped deflection within the contour of the T wave. | T Wave Notched by ECG Finding | ||
OLD OR AGE INDETERMINATE ANTERIOR WALL MYOCARDIAL INFARCTION | C102684 | Old Or Age Indeterminate Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Anterior Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C102685 | Old Or Age Indeterminate Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Anterolateral Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C102686 | Old Or Age Indeterminate Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Anteroseptal Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C102687 | Old Or Age Indeterminate Extensive Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Extensive Anterior Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102688 | Old Or Age Indeterminate High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate High Lateral Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE INFERIOR WALL MYOCARDIAL INFARCTION | C102689 | Old Or Age Indeterminate Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Inferior Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE LATERAL WALL MYOCARDIAL INFARCTION | C102690 | Old Or Age Indeterminate Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Lateral Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE POSTERIOR WALL MYOCARDIAL INFARCTION | C102691 | Old Or Age Indeterminate Posterior Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, without evidence of current or ongoing acute infarction. Evidence of inferior or lateral myocardial infarction is usually also present. | Old or Age Indeterminate Posterior Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE SEPTAL WALL MYOCARDIAL INFARCTION | C102693 | Old Or Age Indeterminate Septal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Septal Myocardial Infarction by ECG Finding | ||
OLD OR AGE INDETERMINATE WALL MYOCARDIAL INFARCTION | C101597 | Old Or Age Indeterminate Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart, without evidence of current or ongoing acute infarction. No specification is provided for localization. | Old Myocardial Infarction by ECG Finding | ||
OLD OR AGE UNDETERMINED RIGHT VENTRICULAR MYOCARDIAL INFARCTION | C102692 | An electrocardiographic finding, in the presence of an old or age indeterminate inferior wall myocardial infarction, of Q waves greater than or equal to 40 ms in duration in the right ventricular leads V4R through V6R. | Old or Age Indeterminate Right Ventricular Myocardial Infarction by ECG Finding | |||
OTHER INCORRECT ELECTRODE PLACEMENT | C114176 | An electrocardiographic recording in which one or more electrodes are incorrectly placed but further details are not provided. | Other Incorrect Electrode Placement | |||
P WAVE ABNORMALITY | C90430 | P Wave Abnormality | An electrocardiographic finding for the P wave that is atypical either for the shape, duration, amplitude, axis or polarity. Abnormality of the P wave signifies aberrant propagation of the electrical impulse through the atria. (NCI) | P Wave Abnormality by ECG Finding | ||
P WAVE NOTCHED | C90431 | P Wave Notched | An electrocardiographic finding of P waves with two peaks longer in duration than normal and amplitude greater than normal. | P Wave Notched by ECG Finding | ||
PACED ATRIAL AND VENTRICULAR RHYTHM | C92232 | AV dual-paced complex(es) or rhythm;Paced Atrial And Ventricular Rhythm | An electrocardiographic finding in which both the atrial and ventricular rhythm are controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Atrial And Ventricular Rhythm | ||
PACED ATRIAL RHYTHM | C92233 | Atrial-paced complex(es) or rhythm;Paced Atrial Rhythm | An electrocardiographic finding in which the atrial rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Atrial Rhythm | ||
PACED RHYTHM | C88140 | Atrial and/or Ventricular Paced Rhythm;Paced Rhythm | An electrocardiographic finding in which the cardiac rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Rhythm | ||
PACED VENTRICULAR RHYTHM | C92234 | Paced Ventricular Rhythm;Ventricular-paced complex(es) or rhythm | An electrocardiographic finding in which the ventricular rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Ventricular Rhythm | ||
PAROXYSMAL ATRIAL FIBRILLATION | C120615 | An electrocardiographic finding of atrial fibrillation which occurs intermittently during the recording. Other rhythms which may be present are sinus rhythm, junctional rhythm, or an atrial paced rhythm. | Paroxysmal Atrial Fibrillation by ECG Finding | |||
PAROXYSMAL AV BLOCK | C62250 | Paroxysmal AV block | An electrocardiographic finding of the sudden onset of transient AV block, which is often associated with preexisting conduction disorders. | Paroxysmal Atrioventricular Block by ECG Finding | ||
PAROXYSMAL VENTRICULAR TACHYCARDIA | C34902 | Paroxysmal Ventricular Tachycardia | An episodic form of ventricular tachycardia, with abrupt onset and termination. (NCI) | Paroxysmal Ventricular Tachycardia by ECG Finding | ||
PAUSE GREATER THAN 3.0 SECONDS | C119251 | An electrocardiographic finding of an RR interval with duration greater than 3.0 seconds, regardless of the underlying rhythm. | Pause Greater Than Three Seconds by ECG Finding | |||
PAUSE | C119250 | An electrocardiographic finding of an RR interval which exceeds a predefined duration threshold, regardless of the underlying rhythm. | Pause by ECG Finding | |||
PERSISTENT ATRIAL FIBRILLATION | C120616 | An electrocardiographic finding of atrial fibrillation which is present during the entire recording. | Persistent Atrial Fibrillation by ECG Finding | |||
POOR QUALITY ECG | C114172 | An electrocardiographic recording that does not show proper quality for reasons that are not otherwise described. | Poor Quality ECG | |||
POOR R WAVE PROGRESSION | C71033 | Poor R Wave Progression | An electrocardiographic finding of a lack of progression of R wave height across precordial leads. | Poor R Wave Progression by ECG Finding | ||
POSTERIOR WALL MYOCARDIAL INFARCTION | C35399 | Posterior MI;Posterior Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. | Posterior Myocardial Infarction by ECG Finding | ||
PR SEGMENT DEPRESSION | C116135 | PR Depression | An electrocardiographic finding of PR segment depression below the iso-electric line in multiple precordial and/or limb leads. | PR Segment Depression by ECG Finding | ||
PRE-EXCITATION | C34940 | Pre-excitation;Ventricular preexcitation | An electrocardiographic finding characterized by a premature activation of the whole or some part of the ventricle. The PR interval is usually shortened and delta waves are frequently present. | Pre-Excitation Syndrome | ||
PRECORDIAL ELECTRODE V1 DISCONNECTED | C114153 | An electrocardiographic recording in which the electrode for lead V1 is disconnected resulting in missing waveforms (flat line) for lead V1. | Disconnected Precordial Electrode V1 by ECG Finding | |||
PRECORDIAL ELECTRODE V2 DISCONNECTED | C114154 | An electrocardiographic recording in which the electrode for lead V2 is disconnected resulting in missing waveforms (flat line) for lead V2. | Disconnected Precordial Electrode V2 by ECG Finding | |||
PRECORDIAL ELECTRODE V3 DISCONNECTED | C114155 | An electrocardiographic recording in which the electrode for lead V3 is disconnected resulting in missing waveforms (flat line) for lead V3. | Disconnected Precordial Electrode V3 by ECG Finding | |||
PRECORDIAL ELECTRODE V4 DISCONNECTED | C114156 | An electrocardiographic recording in which the electrode for lead V4 is disconnected resulting in missing waveforms (flat line) for lead V4. | Disconnected Precordial Electrode V4 by ECG Finding | |||
PRECORDIAL ELECTRODE V5 DISCONNECTED | C114157 | An electrocardiographic recording in which the electrode for lead V5 is disconnected resulting in missing waveforms (flat line) for lead V5. | Disconnected Precordial Electrode V5 by ECG Finding | |||
PRECORDIAL ELECTRODE V6 DISCONNECTED | C114158 | An electrocardiographic recording in which the electrode for lead V6 is disconnected resulting in missing waveforms (flat line) for lead V6. | Disconnected Precordial Electrode V6 by ECG Finding | |||
PRECORDIAL ELECTRODE(S) POSITIONED INCORRECTLY | C114160 | An electrocardiographic recording in which one or more precordial electrodes are placed incorrectly with respect to the standard chest electrode positions resulting in improper representation of the affected leads. | Incorrectly Positioned Precordial Electrodes by ECG Finding | |||
PRECORDIAL ELECTRODES INTERCHANGED | C114152 | Precordial Lead Reversal | An electrocardiographic recording in which two or more of the precordial electrodes are switched resulting in improper representation of the affected leads. | Interchanged Precordial Electrodes by ECG Finding | ||
PREMATURE ATRIAL COMPLEXES BLOCKED | C102603 | Atrial premature complexes, nonconducted;Non-conducted SVE;Premature Atrial Complex Blocked;Premature Atrial Complexes Non-conducted | An electrocardiographic finding of a premature atrial complexes that are is not conducted to the ventricles, and that are is not followed by a QRS complex; there may be one or more occurrences during an electrocardiographic recording. | Blocked Atrial Premature Complex by ECG Finding | ||
PREMATURE ATRIAL COMPLEXES MULTIFOCAL | C102672 | Multifocal Supraventricular Extra Beats;Multifocal SVE;Premature Atrial Complex Multifocal;Premature Atrial Complexes Multiform | An electrocardiographic finding of premature atrial complexes which have 2 or more distinct morphologies, suggesting origin at more than one atrial site. | Multifocal Atrial Premature Complex by ECG Finding | ||
PREMATURE ATRIAL COMPLEXES UNIFOCAL | C102724 | Premature Atrial Complex Unifocal | An electrocardiographic finding of premature atrial complexes which have a single distinct morphology, suggesting origin at one atrial site. | Unifocal Atrial Premature Complex by ECG Finding | ||
PREMATURE ATRIAL COMPLEXES | C62257 | APC;Atrial premature complex(es);PAC;Premature atrial complex;Supraventricular Extra Beat;Supraventricular Premature Beat;SVE | An electrocardiographic finding of an ectopic impulse originating in the atria and not specifically in the sinus node. The P wave morphology of these complexes is often different from a sinus P wave and the RR intervals preceding these complexes is also shorter than those of the regular beats; there may be one or more occurrences during an electrocardiographic recording. | Atrial Premature Complex by ECG Finding | ||
PREMATURE VENTRICULAR COMPLEX INTERPOLATED | C107100 | Interpolated VE;Interpolated Ventricular Extra Beat;Interpolated VES;Interpolated VPC;Premature Ventricular Complexes Interpolated | An electrocardiographic finding of a premature ventricular complex which occurs between two normal QRS complexes which have normal timing; there may be one or more occurrences during an electrocardiographic recording. | Interpolated Premature Ventricular Complex by ECG Finding | ||
PREMATURE VENTRICULAR COMPLEX | C62256 | Premature Ventricular Complexes;PVC;VE;Ventricular Extra Beat;Ventricular Premature Complexes;VES;VPC | An electrocardiographic finding of an ectopic impulse originating in the ventricles. The QRS morphology of these complexes is different from those of supraventricular origin. The QRS duration is often longer and the RR interval preceding the complexes is usually shorter than that of supraventricular beats; there may be one or more occurrences during an electrocardiographic recording. | Ventricular Premature Complex by ECG Finding | ||
PREMATURE VENTRICULAR COMPLEXES MULTIFOCAL | C102673 | Multifocal Ventricular Extra Beats;Multifocal VES;Multifocal VPCS;Premature Ventricular Complex Multifocal | An electrocardiographic finding of premature ventricular complexes which have two or more distinct morphologies, suggesting origin at more than one ventricular site. | Multifocal Ventricular Premature Complex by ECG Finding | ||
PREMATURE VENTRICULAR COMPLEXES UNIFOCAL | C102725 | Premature Ventricular Complex Unifocal;Unifocal Ventricular Extra Beats;Unifocal VES;Unifocal VPCS | An electrocardiographic finding of premature ventricular complexes which have a single distinct morphology, suggesting origin at one ventricular site. | Unifocal Ventricular Premature Complex by ECG Finding | ||
PROLONGED QT | C71034 | Prolonged QT;Prolonged QT interval | An electrocardiographic finding in which the QT interval not corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist. | Prolonged QT Interval by ECG Finding | ||
PROLONGED ST SEGMENT | C116137 | An electrocardiographic finding of a prolonged ST segment, resulting in a long QT interval, without lengthening of the T wave duration. | Prolonged ST Segment by ECG Finding | |||
Q AXIS, LEFT AXIS DEVIATION | C71094 | Left-axis deviation;Q Axis, Left axis deviation;QRS axis, left axis deviation | An electrocardiographic finding of a frontal plane QRS axis from -30 to -90 degrees. | Q Axis Left Axis Deviation | ||
Q AXIS, RIGHT AXIS DEVIATION | C71095 | Q Axis, Right axis deviation;QRS axis, right axis deviation;Right-axis deviation | An electrocardiographic finding of a frontal plane QRS axis from +90 to +180 degrees. | Q Axis Right Axis Deviation | ||
QRS COMPLEX ABNORMALITY | C90440 | QRS Complex Abnormality | An electrocardiographic finding of a non-specific abnormality of the QRS complex, which is atypical in shape, duration, amplitude, axis or polarity. | QRS Complex Abnormality by ECG Finding | ||
QTC PROLONGATION | C83817 | QTc Prolongation | An electrocardiographic finding in which the QTc interval corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist. | Corrected Prolonged QT Interval by ECG Finding | ||
QTCB PROLONGATION | C107098 | PROLONGED QTcB | An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is prolonged. Thresholds for different age, gender, and patient populations exist. | QTcB Prolongation | ||
QTCF PROLONGATION | C107099 | PROLONGED QTcF | An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is prolonged. Thresholds for different age, gender, and patient populations exist. | QTcF Prolongation | ||
QUALITY PROBLEM NOT OTHERWISE SPECIFIED | C114161 | Unknown Quality Problem | An electrocardiographic artifact or recording error with unknown origin or which is not described otherwise. | Quality Problem Not Otherwise Specified by ECG Finding | ||
R ON T PHENOMENON | C61395 | R on T phenomenon | An electrocardiographic finding in which the R wave of a premature ventricular complex occurs on top of the T wave of the preceding beat. | R On T Phenomenon by ECG Finding | ||
R WAVE NOTCHED | C90444 | R Wave Notched | An electrocardiographic finding of an R wave variant in which there is a small deflection of the R wave, with changing polarity, within the QRS complex. (NCI) | R Wave Notched by ECG Finding | ||
REPOLARIZATION ABNORMALITY SECONDARY TO VENTRICULAR HYPERTROPHY | C102706 | Repolarization Abnormality Secondary To Ventricular Hypertrophy;ST-T change due to ventricular hypertrophy | An electrocardiographic finding of ST depression and T wave inversion in the presence of increased QRS amplitude which are thought to be due to left ventricular hypertrophy. | Repolarization Abnormality Secondary To Ventricular Hypertrophy | ||
REPOLARIZATION ABNORMALITY | C102574 | Repolarization Abnormality | An electrocardiographic finding of an abnormality of T wave duration or morphology or of early repolarization. | Ventricular Repolarization Abnormality | ||
RIGHT ATRIAL ABNORMALITY | C71041 | P-pulmonale;Right Atrial Enlargement | An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the right atrium. Electrocardiographic criteria used for the diagnosis of right atrial abnormality may include a peaked p wave greater than 2.5 millimeters in amplitude in the inferior leads. (NCI) | P-pulmonale by ECG Finding | ||
RIGHT BUNDLE BRANCH BLOCK | C62270 | Complete RBBB;Right bundle branch block;Right bundle-branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration greater than or equal to 120 ms. An RsR' complex is typically present in leads V1 and V2. | Right Bundle Branch Block by ECG Finding | ||
RIGHT VENTRICULAR CONDUCTION DELAY | C92235 | Right Ventricular Conduction Delay;Right Ventricular Delay | An electrocardiographic finding in which there is evidence that electrical transmission through the right ventricle is impaired with a maximal QRS duration of 110 ms and which does not meet the criteria for Incomplete Right Bundle Branch Block. | Right Ventricular Conduction Delay by ECG Finding | ||
RIGHT VENTRICULAR HYPERTROPHY | C71077 | Right ventricular Hypertrophy | An electrocardiographic finding suggestive of a hypertrophied right ventricle, characterized by large R wave amplitudes in the right precordial leads and secondary findings of right atrial enlargement, right axis deviation, and typical pattern of ST depression and T wave inversion in the right precordial leads. | Right Ventricular Hypertrophy by ECG Finding | ||
RSR PRIME | C92227 | RSR' | An electrocardiographic finding in which there are two R waves, which are two deflections above the baseline resulting from a single ventricular depolarization. The first upward deflection in the complex is the R wave. The S is the first downward deflection. A second upward deflection is called the R-prime wave. | RSR' by ECG Finding | ||
SEPTAL MYOCARDIAL INFARCTION | C35519 | Septal myocardial infarction | An electrocardiographic finding suggesting an infarction in the anatomic location of the cardiac septum. (NCI) | Septal Myocardial Infarction by ECG Finding | ||
SHORT PR INTERVAL | C62246 | Short PR interval | An electrocardiographic finding of an abnormally short PR interval. Thresholds for different age, gender, and patient populations exist. | Short PR Interval by ECG Finding | ||
SHORT QTC INTERVAL | C102709 | Short QTc Interval | An electrocardiographic finding of a QT interval corrected for heart rate that is shorter than the lower limit of normal. Thresholds for different age, gender, and patient populations exist. | Short QTc Interval | ||
SHORT QTCB | C112402 | An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is shortened. Thresholds for different age, gender, and patient populations exist. | QTcB Shortened | |||
SHORT QTCF | C112403 | An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is shortened. Thresholds for different age, gender, and patient populations exist. | QTcF Shortened | |||
SHORT ST SEGMENT | C116136 | An electrocardiographic finding of a short or absent ST segment, resulting in a short QT interval, without changes in T wave morphology. | Short ST Segment by ECG Finding | |||
SINOATRIAL EXIT BLOCK | C50553 | SA Block;Sinoatrial Block;Sinoatrial exit block | An electrocardiographic finding in which impaired conduction or automaticity within the sinus node results in the failure of impulse transmission from the sinoatrial node. This is manifest as dropped P waves during sinus rhythm. | Exit Block by ECG Finding | ||
SINUS ARREST/PAUSE | C62242 | Sinus arrest/pause;Sinus pause or arrest | An electrocardiographic finding in which a failure of impulse formation or conduction in the sinus node produces prolongation of the P-P interval or dropped P waves. The threshold for the prolongation of the P-P interval is not well defined. | Sinus Arrest by ECG Finding | ||
SINUS ARRHYTHMIA | C62239 | Respiratory Sinus Arrhythmia;Sinus arrhythmia | An electrocardiographic finding in which the sinus rate fluctuates with the respiratory cycle. | Sinus Arrhythmia by ECG Finding | ||
SINUS BRADYCARDIA | C111097 | Sinus bradycardia | An electrocardiographic finding of abnormally slow heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist. | Sinus Bradycardia by ECG Finding | ||
SINUS RHYTHM | C100076 | Sinus Rhythm | An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. | Sinus Rhythm | ||
SINUS SLOWING WITH AV BLOCK | C120617 | An electrocardiographic finding in which slowing of the sinus rate and AV block occur simultaneously. | Sinus Slowing With AV Block by ECG Finding | |||
SINUS TACHYCARDIA | C111104 | Sinus tachycardia | An electrocardiographic finding of abnormally rapid heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist. | Sinus Tachycardia by ECG Finding | ||
ST DEPRESSION | C41330 | ST depression | An electrocardiographic finding of ST segment depression below the baseline, often described as up sloping, down sloping or horizontal. (NCI) | ST Segment Depression by ECG Finding | ||
ST ELEVATION PERICARDITIS | C71029 | ST elevation pericarditis | An electrocardiographic finding of ST elevation which is concave upwards, and which is often accompanied by PR segment depression. | ST Elevation Pericarditis by ECG Finding | ||
ST ELEVATION | C50540 | ST elevation | An electrocardiographic finding of ST segment elevation above the baseline. (NCI) | ST Segment Elevation by ECG Finding | ||
SUPRAVENTRICULAR BIGEMINY | C161046 | An electrocardiographic finding of a supraventricular QRS complex followed by a premature supraventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio. | Supraventricular Bigeminy by ECG Finding | |||
SUPRAVENTRICULAR COUPLET | C119252 | An electrocardiographic finding in which two premature atrial complexes occur sequentially. | Supraventricular Couplet by ECG Finding | |||
SUPRAVENTRICULAR ESCAPE BEAT | C135395 | Supraventricular Escape Complex;Supraventricular Escape Complexes | An electrocardiographic finding of a compensatory supraventricular complex that occurs following a prolonged RR interval. | Supraventricular Escape Beat by ECG Finding | ||
SUPRAVENTRICULAR PREMATURE COMPLEX, ORIGIN UNKNOWN | C142246 | Supraventricular Premature Complexes, Origin Unknown | An electrocardiographic finding of an ectopic impulse originating from the atria or AV junction for which the site of origin cannot be determined from the surface electrocardiographic recording; there may be one or more occurrences during an electrocardiographic recording. | Supraventricular Premature Complex With Unknown Origin by ECG Finding | ||
SUPRAVENTRICULAR RUN | C120618 | An electrocardiographic finding of three or more consecutive beats of supraventricular origin without reference to rate. | Supraventricular Run by ECG Finding | |||
SUPRAVENTRICULAR TACHYCARDIA | C111100 | Supraventricular tachycardia | An electrocardiographic finding of a tachycardia which does not originate in the ventricles or His Purkinje system. There is an abnormally high heart rate and QRS complexes are typically narrow, but aberration or preexcitation may be present. | Supraventricular Tachycardia by ECG Finding | ||
SUPRAVENTRICULAR TRIGEMINY | C161047 | An electrocardiographic finding of two supraventricular QRS complexes followed by a premature supraventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio. | Supraventricular Trigeminy by ECG Finding | |||
SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES NO REVERSAL | C114173 | An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, but for which an interpretation is performed as though the lead placement is correct. | Suspicion of Limb Electrodes Reversal But Interpretation Assumes No Reversal by ECG Finding | |||
SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES REVERSAL | C114174 | An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, and for which an interpretation is performed as though the leads have in fact been interchanged. | Suspicion of Limb Electrodes Reversal But Interpretation Assumes Reversal by ECG Finding | |||
SUSTAINED SUPRAVENTRICULAR TACHYCARDIA | C120619 | An electrocardiographic finding of a supraventricular tachycardia with duration greater than 30 seconds (though other duration thresholds may be applied). | Sustained Supraventricular Tachycardia by ECG Finding | |||
SUSTAINED VENTRICULAR TACHYCARDIA | C71052 | Sustained ventricular tachycardia | An electrocardiographic finding of ventricular tachycardia greater than 30 seconds in duration. (NCI) | Sustained Ventricular Tachycardia by ECG Finding | ||
T WAVE ALTERNANS | C102718 | T Wave Alternans | An electrocardiographic finding in which there are variations in the shape, amplitude, or direction of the T wave from one beat to the next. | T Wave Alternans by ECG Finding | ||
T WAVE INVERSION | C71085 | T Wave Inversion | An electrocardiographic finding of an inversion of the T wave from the expected axis. (NCI) | T Wave Inversion by ECG Finding | ||
T WAVE PEAKED | C71086 | T wave peaked | An electrocardiographic finding in which the T wave appears increased in amplitude and cresting at a point. (NCI) | T Wave Peaked by ECG Finding | ||
T WAVES BIPHASIC | C71087 | T waves biphasic | An electrocardiographic finding of a T wave with both positive and negative components. | T Waves Biphasic by ECG Finding | ||
T WAVES FLAT | C71088 | T waves flat | An electrocardiographic finding in which the T wave appears decreased in amplitude. (NCI) | T Waves Flat by ECG Finding | ||
TACHYCARDIA | C111121 | Tachycardia | An electrocardiographic finding of abnormally rapid heart rate. Thresholds for different age, gender, and patient populations exist. | Tachycardia by ECG Finding | ||
TORSADES DE POINTES | C50779 | Torsades de pointes;Ventricular tachycardia, torsades de pointes | An electrocardiographic finding of an atypical rapid polymorphic ventricular tachycardia with a characteristic rotation of the QRS complex around the isoelectric baseline, occurring in the setting of a prolonged QT interval. In addition, the QRS complex displays a periodic waxing and waning of amplitude on the electrogram. | Torsades De Pointes by ECG Finding | ||
U WAVE ABNORMALITY | C106579 | Abnormal U Wave | An electrocardiographic finding of U waves which have increased amplitude, are inverted, or merged with the preceding T wave. | U Wave Abnormality by ECG Finding | ||
UNDETERMINED RHYTHM | C116131 | An electrocardiographic finding of a cardiac rhythm whose mechanism cannot be determined from the ECG. | Undetermined Rhythm by ECG Finding | |||
UNDETERMINED SUPRAVENTRICULAR RHYTHM | C120607 | An electrocardiographic finding of a rhythm which does not originate in the ventricles or His Purkinje system, but whose specific electrophysiologic mechanism cannot be determined from the ECG. The QRS complexes are typically narrow, but aberration or preexcitation may be present. | Undetermined Supraventricular Rhythm by ECG Finding | |||
VENTRICULAR BIGEMINY | C71054 | Bigeminy | An electrocardiographic finding of a normal QRS complex followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio. | Ventricular Bigeminy by ECG Finding | ||
VENTRICULAR COUPLET | C62259 | Ventricular Couplets;Ventricular Pair | An electrocardiographic finding in which two premature ventricular complexes occur sequentially; there may be one or more occurrences during an electrocardiographic recording. | Ventricular Couplet by ECG Finding | ||
VENTRICULAR ESCAPE BEAT | C90483 | Ventricular Escape Beats;Ventricular Escape Complex;Ventricular Escape Complexes | An electrocardiographic finding of a compensatory ventricular complex that occurs following a prolonged RR interval; there may be one or more occurrences during an electrocardiographic recording. | Ventricular Escape Beat by ECG Finding | ||
VENTRICULAR FIBRILLATION | C111102 | Ventricular fibrillation | An electrocardiographic finding of a rapid grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. The rate is typically greater than 300 bpm. | Ventricular Fibrillation by ECG Finding | ||
VENTRICULAR FLUTTER | C111115 | Ventricular flutter | A ventricular tachyarrhythmia characterized by a high ventricular rate (180 to 250 beats per minute) with a regular rhythm. The electrocardiogram shows large oscillating sine wave-like complexes occurring as a result of QRS complexes and T waves being merged. The P wave is not visible. (NCI) | Ventricular Flutter by ECG Finding | ||
VENTRICULAR PARASYSTOLE | C102728 | Parasystole;Ventricular Parasystole | An electrocardiographic finding of normal sinus rhythm coexisting with a regular ectopic ventricular rhythm. | Ventricular Parasystole by ECG Finding | ||
VENTRICULAR QUADRIGEMINY | C120620 | An electrocardiographic finding of three normal QRS complexes followed by a premature ventricular complex for three or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 3-1 ratio. | Ventricular Quadrigeminy by ECG Finding | |||
VENTRICULAR RUN | C120621 | An electrocardiographic finding of three or more consecutive beats of ventricular origin without reference to rate. | Ventricular Run by ECG Finding | |||
VENTRICULAR TACHYCARDIA | C111103 | Ventricular tachycardia | An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. | Ventricular Tachycardia by ECG Finding | ||
VENTRICULAR TACHYCARDIA, MONOMORPHIC | C62234 | Ventricular tachycardia, monomorphic | An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a uniform morphology. | Monomorphic Ventricular Tachycardia by ECG Finding | ||
VENTRICULAR TACHYCARDIA, POLYMORPHIC | C62236 | Ventricular tachycardia, polymorphic;Ventricular tachycardia, polymorphous | An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a variable morphology and often rate. | Polymorphic Ventricular Tachycardia by ECG Finding | ||
VENTRICULAR TRIGEMINY | C71055 | Trigeminy | An electrocardiographic finding of two normal QRS complexes followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio. | Ventricular Trigeminy by ECG Finding | ||
VOLTAGE CRITERIA SUGGESTING LEFT VENTRICULAR HYPERTROPHY, WITHOUT SECONDARY ECG FINDINGS | C130067 | An electrocardiographic finding of large QRS amplitudes which may indicate left ventricular hypertrophy, but in the absence of any of the secondary findings which are typical of this diagnosis (left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion). | Voltage Criteria Suggesting Left Ventricular Hypertrophy, Without Secondary ECG Findings | |||
WANDERING ATRIAL PACEMAKER | C62240 | Wandering atrial pacemaker | An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically below 100 beats per minute. | Wandering Atrial Pacemaker by ECG Finding | ||
WIDE QRS TACHYCARDIA | C71090 | Wide QRS tachycardia;Wide-QRS tachycardia | An electrocardiographic finding of three or more consecutive wide QRS complexes of uncertain origin with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). | Wide QRS Tachycardia by ECG Finding | ||
WOLFF-PARKINSON-WHITE SYNDROME | C35132 | Wolff-Parkinson-White syndrome;WPW | An electrocardiographic finding of ventricular pre-excitation. The syndrome is characterized by a short PR interval and a long QRS interval with a delta wave. | Wolff-Parkinson-White Syndrome | ||
Back to top | ||||||
CL.C120523.HETESTCD | Holter ECG Test Code
(HETESTCD) | text
Extensible: Yes | C120523 | Holter ECG Test Code | Terminology relevant to the test codes that describe Holter ECG interpretative findings. | CDISC SDTM Holter ECG Test Code Terminology |
AVCOND | C111131 | Atrioventricular Conduction | An electrocardiographic assessment of cardiac atrioventricular conduction. | Atrioventricular Conduction ECG Assessment | ||
AXISVOLT | C111132 | Axis and Voltage | An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. | Axis and Voltage ECG Assessment | ||
CHYPTENL | C111155 | Chamber Hypertrophy or Enlargement | An electrocardiographic assessment of chamber hypertrophy or enlargement. | Chamber Hypertrophy or Enlargement ECG Assessment | ||
EGCOMP | C117761 | Comparison to a Prior ECG | A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. | Comparison to a Prior ECG | ||
INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
IVTIACD | C111238 | Intraventricular-Intraatrial Conduction | An electrocardiographic assessment of intraventricular and intra-atrial conduction. | Intraventricular and Intraatrial Conduction ECG Assessment | ||
MI | C111280 | Myocardial Infarction | An electrocardiographic assessment of findings suggestive of myocardial infarction. | Myocardial Infarction ECG Assessment | ||
PACEMAKR | C111285 | Pacemaker | An electrocardiographic assessment of presence of artificial electronic pacing. | Pacemaker ECG Assessment | ||
RHYNOS | C111307 | Rhythm Not Otherwise Specified | An electrocardiographic assessment of cardiac rhythm not otherwise specified. | Rhythm Not Otherwise Specified ECG Assessment | ||
SNRARRY | C111312 | Sinus Node Rhythms and Arrhythmias | An electrocardiographic assessment of sinus node rhythms and arrhythmias. | Sinus Node Rhythm and Arrhythmia ECG Assessment | ||
SPRARRY | C111320 | Supraventricular Arrhythmias | An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. | Supraventricular Arrhythmia ECG Assessment | ||
SPRTARRY | C111321 | Supraventricular Tachyarrhythmias | An electrocardiographic assessment of supraventricular tachyarrhythmias. | Supraventricular Tachyarrhythmia ECG Assessment | ||
STSTWUW | C111363 | ST Segment, T wave, and U wave | An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. | ST Segment, T wave, and U wave ECG Assessment | ||
TECHQUAL | C117807 | Technical Quality | A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. | ECG Technical Quality | ||
VTARRY | C111330 | Ventricular Arrhythmias | An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. | Ventricular Arrhythmia ECG Assessment | ||
VTTARRY | C111331 | Ventricular Tachyarrhythmias | An electrocardiographic assessment of ventricular tachyarrhythmias. | Ventricular Tachyarrhythmia ECG Assessment | ||
Back to top | ||||||
CL.C120524.HETEST | Holter ECG Test Name
(HETEST) | text
Extensible: Yes | C120524 | Holter ECG Test Name | Terminology relevant to the test names that describe Holter ECG interpretative findings. | CDISC SDTM Holter ECG Test Name Terminology |
Atrioventricular Conduction | C111131 | Atrioventricular Conduction | An electrocardiographic assessment of cardiac atrioventricular conduction. | Atrioventricular Conduction ECG Assessment | ||
Axis and Voltage | C111132 | Axis and Voltage | An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. | Axis and Voltage ECG Assessment | ||
Chamber Hypertrophy or Enlargement | C111155 | Chamber Hypertrophy or Enlargement | An electrocardiographic assessment of chamber hypertrophy or enlargement. | Chamber Hypertrophy or Enlargement ECG Assessment | ||
Comparison to a Prior ECG | C117761 | Comparison to a Prior ECG | A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. | Comparison to a Prior ECG | ||
Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
Intraventricular-Intraatrial Conduction | C111238 | Intraventricular-Intraatrial Conduction | An electrocardiographic assessment of intraventricular and intra-atrial conduction. | Intraventricular and Intraatrial Conduction ECG Assessment | ||
Myocardial Infarction | C111280 | Myocardial Infarction | An electrocardiographic assessment of findings suggestive of myocardial infarction. | Myocardial Infarction ECG Assessment | ||
Pacemaker | C111285 | Pacemaker | An electrocardiographic assessment of presence of artificial electronic pacing. | Pacemaker ECG Assessment | ||
Rhythm Not Otherwise Specified | C111307 | Rhythm Not Otherwise Specified | An electrocardiographic assessment of cardiac rhythm not otherwise specified. | Rhythm Not Otherwise Specified ECG Assessment | ||
Sinus Node Rhythms and Arrhythmias | C111312 | Sinus Node Rhythms and Arrhythmias | An electrocardiographic assessment of sinus node rhythms and arrhythmias. | Sinus Node Rhythm and Arrhythmia ECG Assessment | ||
ST Segment, T wave, and U wave | C111363 | ST Segment, T wave, and U wave | An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. | ST Segment, T wave, and U wave ECG Assessment | ||
Supraventricular Arrhythmias | C111320 | Supraventricular Arrhythmias | An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. | Supraventricular Arrhythmia ECG Assessment | ||
Supraventricular Tachyarrhythmias | C111321 | Supraventricular Tachyarrhythmias | An electrocardiographic assessment of supraventricular tachyarrhythmias. | Supraventricular Tachyarrhythmia ECG Assessment | ||
Technical Quality | C117807 | Technical Quality | A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. | ECG Technical Quality | ||
Ventricular Arrhythmias | C111330 | Ventricular Arrhythmias | An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. | Ventricular Arrhythmia ECG Assessment | ||
Ventricular Tachyarrhythmias | C111331 | Ventricular Tachyarrhythmias | An electrocardiographic assessment of ventricular tachyarrhythmias. | Ventricular Tachyarrhythmia ECG Assessment | ||
Back to top | ||||||
CL.C103469.HADS01TC | Hospital Anxiety and Depression Scale Questionnaire Test Code
(HADS01TC) | text
Extensible: No | C103469 | Hospital Anxiety and Depression Scale Questionnaire Test Code | Hospital Anxiety and Depression Scale test code. | CDISC Questionnaire HADS Test Code Terminology |
HADS0101 | C103573 | HADS01-I Feel Tense or Wound Up | Hospital Anxiety and Depression Scale - I feel tense or 'wound up.' | HADS - I Feel Tense or Wound Up | ||
HADS0102 | C103574 | HADS01-Enjoy the Things I Used to Enjoy | Hospital Anxiety and Depression Scale - I still enjoy the things I used to enjoy. | HADS - I Still Enjoy the Things I Used to Enjoy | ||
HADS0103 | C103575 | HADS01-Something Awful About to Happen | Hospital Anxiety and Depression Scale - I get a sort of frightened feeling as if something awful is about to happen. | HADS - I Get a Frightened Feeling Something Awful is About to Happen | ||
HADS0104 | C103576 | HADS01-I Can Laugh and See Funny Side | Hospital Anxiety and Depression Scale - I can laugh and see the funny side of things. | HADS - I Can Laugh and See Funny Side of Things | ||
HADS0105 | C103577 | HADS01-Worrying Thoughts Go Through Mind | Hospital Anxiety and Depression Scale - Worrying thoughts go through my mind. | HADS - Worrying Thoughts Go Through My Mind | ||
HADS0106 | C103578 | HADS01-I Feel Cheerful | Hospital Anxiety and Depression Scale - I feel cheerful. | HADS - I Feel Cheerful | ||
HADS0107 | C103579 | HADS01-Sit at Ease and Feel Relaxed | Hospital Anxiety and Depression Scale - I can sit at ease and feel relaxed. | HADS - I Can Sit at Ease and Feel Relaxed | ||
HADS0108 | C103580 | HADS01-I Feel as if I am Slowed Down | Hospital Anxiety and Depression Scale - I feel as if I am slowed down. | HADS - I Feel as if I am Slowed Down | ||
HADS0109 | C103581 | HADS01-Butterflies in the Stomach | Hospital Anxiety and Depression Scale - I get a sort of frightened feeling like 'butterflies' in the stomach. | HADS - I Get Frightened Feeling Like Butterflies in the Stomach | ||
HADS0110 | C103582 | HADS01-Lost Interest in My Appearance | Hospital Anxiety and Depression Scale - I have lost interest in my appearance. | HADS - I Have Lost Interest in My Appearance | ||
HADS0111 | C103583 | HADS01-Feel Restless be on the Move | Hospital Anxiety and Depression Scale - I feel restless as if I have to be on the move. | HADS - I Feel Restless as if I Have to be on the Move | ||
HADS0112 | C103584 | HADS01-Look Forward with Enjoyment | Hospital Anxiety and Depression Scale - I look forward with enjoyment to things. | HADS - I Look Forward with Enjoyment to Things | ||
HADS0113 | C103585 | HADS01-I Get Sudden Feelings of Panic | Hospital Anxiety and Depression Scale - I get sudden feelings of panic. | HADS - I Get Sudden Feelings of Panic | ||
HADS0114 | C103586 | HADS01-Enjoy Good Book/Radio/Television | Hospital Anxiety and Depression Scale - I can enjoy a good book or radio or television programme. | HADS - I Can Enjoy a Good Book or Radio or Television Programme | ||
HADS0115 | C118111 | HADS01-Total Score Anxiety | Hospital Anxiety and Depression Scale - Total score anxiety. | HADS - Total Score Anxiety | ||
HADS0116 | C118112 | HADS01-Total Score Depression | Hospital Anxiety and Depression Scale - Total score depression. | HADS - Total Score Depression | ||
Back to top | ||||||
CL.C103468.HADS01TN | Hospital Anxiety and Depression Scale Questionnaire Test Name
(HADS01TN) | text
Extensible: No | C103468 | Hospital Anxiety and Depression Scale Questionnaire Test Name | Hospital Anxiety and Depression Scale test name. | CDISC Questionnaire HADS Test Name Terminology |
HADS01-Butterflies in the Stomach | C103581 | HADS01-Butterflies in the Stomach | Hospital Anxiety and Depression Scale - I get a sort of frightened feeling like 'butterflies' in the stomach. | HADS - I Get Frightened Feeling Like Butterflies in the Stomach | ||
HADS01-Enjoy Good Book/Radio/Television | C103586 | HADS01-Enjoy Good Book/Radio/Television | Hospital Anxiety and Depression Scale - I can enjoy a good book or radio or television programme. | HADS - I Can Enjoy a Good Book or Radio or Television Programme | ||
HADS01-Enjoy the Things I Used to Enjoy | C103574 | HADS01-Enjoy the Things I Used to Enjoy | Hospital Anxiety and Depression Scale - I still enjoy the things I used to enjoy. | HADS - I Still Enjoy the Things I Used to Enjoy | ||
HADS01-Feel Restless be on the Move | C103583 | HADS01-Feel Restless be on the Move | Hospital Anxiety and Depression Scale - I feel restless as if I have to be on the move. | HADS - I Feel Restless as if I Have to be on the Move | ||
HADS01-I Can Laugh and See Funny Side | C103576 | HADS01-I Can Laugh and See Funny Side | Hospital Anxiety and Depression Scale - I can laugh and see the funny side of things. | HADS - I Can Laugh and See Funny Side of Things | ||
HADS01-I Feel as if I am Slowed Down | C103580 | HADS01-I Feel as if I am Slowed Down | Hospital Anxiety and Depression Scale - I feel as if I am slowed down. | HADS - I Feel as if I am Slowed Down | ||
HADS01-I Feel Cheerful | C103578 | HADS01-I Feel Cheerful | Hospital Anxiety and Depression Scale - I feel cheerful. | HADS - I Feel Cheerful | ||
HADS01-I Feel Tense or Wound Up | C103573 | HADS01-I Feel Tense or Wound Up | Hospital Anxiety and Depression Scale - I feel tense or 'wound up.' | HADS - I Feel Tense or Wound Up | ||
HADS01-I Get Sudden Feelings of Panic | C103585 | HADS01-I Get Sudden Feelings of Panic | Hospital Anxiety and Depression Scale - I get sudden feelings of panic. | HADS - I Get Sudden Feelings of Panic | ||
HADS01-Look Forward with Enjoyment | C103584 | HADS01-Look Forward with Enjoyment | Hospital Anxiety and Depression Scale - I look forward with enjoyment to things. | HADS - I Look Forward with Enjoyment to Things | ||
HADS01-Lost Interest in My Appearance | C103582 | HADS01-Lost Interest in My Appearance | Hospital Anxiety and Depression Scale - I have lost interest in my appearance. | HADS - I Have Lost Interest in My Appearance | ||
HADS01-Sit at Ease and Feel Relaxed | C103579 | HADS01-Sit at Ease and Feel Relaxed | Hospital Anxiety and Depression Scale - I can sit at ease and feel relaxed. | HADS - I Can Sit at Ease and Feel Relaxed | ||
HADS01-Something Awful About to Happen | C103575 | HADS01-Something Awful About to Happen | Hospital Anxiety and Depression Scale - I get a sort of frightened feeling as if something awful is about to happen. | HADS - I Get a Frightened Feeling Something Awful is About to Happen | ||
HADS01-Total Score Anxiety | C118111 | HADS01-Total Score Anxiety | Hospital Anxiety and Depression Scale - Total score anxiety. | HADS - Total Score Anxiety | ||
HADS01-Total Score Depression | C118112 | HADS01-Total Score Depression | Hospital Anxiety and Depression Scale - Total score depression. | HADS - Total Score Depression | ||
HADS01-Worrying Thoughts Go Through Mind | C103577 | HADS01-Worrying Thoughts Go Through Mind | Hospital Anxiety and Depression Scale - Worrying thoughts go through my mind. | HADS - Worrying Thoughts Go Through My Mind | ||
Back to top | ||||||
CL.C166188.HDCAB1TC | Huntington's Disease Cognitive Assessment Battery Functional Test Test Code
(HDCAB1TC) | text
Extensible: No | C166188 | Huntington's Disease Cognitive Assessment Battery Functional Test Test Code | Huntington's Disease Cognitive Assessment Battery test code. | CDISC Functional Test HD-CAB Test Code Terminology |
HDCAB101 | C166331 | HDCAB1-Paced Tapping | Huntington's Disease Cognitive Assessment Battery - Paced Tapping key variable for composite score: 1/SD of the inter-tap interval for the self-paced taps. | HD-CAB - Paced Tapping | ||
HDCAB102 | C166332 | HDCAB1-Emotion Recognition | Huntington's Disease Cognitive Assessment Battery - Emotion Recognition key variable for composite score: Number of correct responses to the negative expressions (anger, fear, sadness, disgust) out of 24 possible. | HD-CAB - Emotion Recognition | ||
HDCAB103 | C166333 | HDCAB1-One Touch Stockings of Cambridge | Huntington's Disease Cognitive Assessment Battery - One Touch Stockings of Cambridge key variable for composite score: Mean time to correct response (sec) averaged across all 10 trials (reverse scored). | HD-CAB - One Touch Stockings of Cambridge | ||
HDCAB104 | C166334 | HDCAB1-Symbol Digit Modalities Test | Huntington's Disease Cognitive Assessment Battery - Symbol Digit Modalities Test key variable for composite score: Number of correct responses in 90 seconds out of 110 possible responses. | HD-CAB - Symbol Digit Modalities Test | ||
HDCAB105 | C166335 | HDCAB1-Hopkins Verbal Learning Test Rev | Huntington's Disease Cognitive Assessment Battery - Hopkins Verbal Learning Test - Revised key variable for composite score: Total number of words correctly recalled over Trials 1-4 out of 48 possible. | HD-CAB - Hopkins Verbal Learning Test Revised | ||
HDCAB106 | C166336 | HDCAB1-Trail Making Test-B | Huntington's Disease Cognitive Assessment Battery - Trail Making Test-B key variable for composite score: Time to completion (sec) of TMT Part B with upper time limit of 240 seconds (reverse scored). | HD-CAB - Trail Making Test-B | ||
HDCAB107 | C166337 | HDCAB1-HD-CAB Total Score | Huntington's Disease Cognitive Assessment Battery - HD-CAB total score. | HD-CAB - HD-CAB Total Score | ||
Back to top | ||||||
CL.C166187.HDCAB1TN | Huntington's Disease Cognitive Assessment Battery Functional Test Test Name
(HDCAB1TN) | text
Extensible: No | C166187 | Huntington's Disease Cognitive Assessment Battery Functional Test Test Name | Huntington's Disease Cognitive Assessment Battery test name. | CDISC Functional Test HD-CAB Test Name Terminology |
HDCAB1-Emotion Recognition | C166332 | HDCAB1-Emotion Recognition | Huntington's Disease Cognitive Assessment Battery - Emotion Recognition key variable for composite score: Number of correct responses to the negative expressions (anger, fear, sadness, disgust) out of 24 possible. | HD-CAB - Emotion Recognition | ||
HDCAB1-HD-CAB Total Score | C166337 | HDCAB1-HD-CAB Total Score | Huntington's Disease Cognitive Assessment Battery - HD-CAB total score. | HD-CAB - HD-CAB Total Score | ||
HDCAB1-Hopkins Verbal Learning Test Rev | C166335 | HDCAB1-Hopkins Verbal Learning Test Rev | Huntington's Disease Cognitive Assessment Battery - Hopkins Verbal Learning Test - Revised key variable for composite score: Total number of words correctly recalled over Trials 1-4 out of 48 possible. | HD-CAB - Hopkins Verbal Learning Test Revised | ||
HDCAB1-One Touch Stockings of Cambridge | C166333 | HDCAB1-One Touch Stockings of Cambridge | Huntington's Disease Cognitive Assessment Battery - One Touch Stockings of Cambridge key variable for composite score: Mean time to correct response (sec) averaged across all 10 trials (reverse scored). | HD-CAB - One Touch Stockings of Cambridge | ||
HDCAB1-Paced Tapping | C166331 | HDCAB1-Paced Tapping | Huntington's Disease Cognitive Assessment Battery - Paced Tapping key variable for composite score: 1/SD of the inter-tap interval for the self-paced taps. | HD-CAB - Paced Tapping | ||
HDCAB1-Symbol Digit Modalities Test | C166334 | HDCAB1-Symbol Digit Modalities Test | Huntington's Disease Cognitive Assessment Battery - Symbol Digit Modalities Test key variable for composite score: Number of correct responses in 90 seconds out of 110 possible responses. | HD-CAB - Symbol Digit Modalities Test | ||
HDCAB1-Trail Making Test-B | C166336 | HDCAB1-Trail Making Test-B | Huntington's Disease Cognitive Assessment Battery - Trail Making Test-B key variable for composite score: Time to completion (sec) of TMT Part B with upper time limit of 240 seconds (reverse scored). | HD-CAB - Trail Making Test-B | ||
Back to top | ||||||
CL.C163393.HCS01TC | Hypoglycemic Confidence Scale Questionnaire Test Code
(HCS01TC) | text
Extensible: No | C163393 | Hypoglycemic Confidence Scale Questionnaire Test Code | Hypoglycemic Confidence Scale test code. | CDISC Questionnaire HCS Test Code Terminology |
HCS0101 | C163860 | HCS01-When You Are Exercising | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are exercising? | HCS - When You Are Exercising | ||
HCS0102 | C163861 | HCS01-When You Are Sleeping | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are sleeping? | HCS - When You Are Sleeping | ||
HCS0103 | C163862 | HCS01-When You Are Driving | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are driving? | HCS - When You Are Driving | ||
HCS0104 | C163863 | HCS01-When You Are in Social Situations | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are in social situations? | HCS - When You Are in Social Situations | ||
HCS0105 | C163864 | HCS01-When You Are Alone | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are alone? | HCS - When You Are Alone | ||
HCS0106 | C163865 | HCS01-Avoid Serious Problems | Hypoglycemic Confidence Scale - In general, how confident are you that you can: Avoid serious problems due to hypoglycemia? | HCS - Avoid Serious Problems | ||
HCS0107 | C163866 | HCS01-Catch Before Sugars Get Too Low | Hypoglycemic Confidence Scale - In general, how confident are you that you can: Catch and respond to hypoglycemia before your blood sugars get too low? | HCS - Catch Before Sugars Get Too Low | ||
HCS0108 | C163867 | HCS01-Continue to Do Things Really Want | Hypoglycemic Confidence Scale - In general, how confident are you that you can: Continue to do the things you really want to do in your life, despite the risks of hypoglycemia? | HCS - Continue to Do Things Really Want | ||
HCS0109 | C163868 | HCS01-Your Ability to Avoid Problems | Hypoglycemic Confidence Scale - If you have a spouse or partner: What is your best guess about how confident your spouse or partner feels about your ability to avoid serious problems due to hypoglycemia? | HCS - Your Ability to Avoid Problems | ||
HCS0110 | C163869 | HCS01-Mean HCS Score | Hypoglycemic Confidence Scale - Mean HCS score. | HCS - Mean HCS Score | ||
Back to top | ||||||
CL.C163392.HCS01TN | Hypoglycemic Confidence Scale Questionnaire Test Name
(HCS01TN) | text
Extensible: No | C163392 | Hypoglycemic Confidence Scale Questionnaire Test Name | Hypoglycemic Confidence Scale test name. | CDISC Questionnaire HCS Test Name Terminology |
HCS01-Avoid Serious Problems | C163865 | HCS01-Avoid Serious Problems | Hypoglycemic Confidence Scale - In general, how confident are you that you can: Avoid serious problems due to hypoglycemia? | HCS - Avoid Serious Problems | ||
HCS01-Catch Before Sugars Get Too Low | C163866 | HCS01-Catch Before Sugars Get Too Low | Hypoglycemic Confidence Scale - In general, how confident are you that you can: Catch and respond to hypoglycemia before your blood sugars get too low? | HCS - Catch Before Sugars Get Too Low | ||
HCS01-Continue to Do Things Really Want | C163867 | HCS01-Continue to Do Things Really Want | Hypoglycemic Confidence Scale - In general, how confident are you that you can: Continue to do the things you really want to do in your life, despite the risks of hypoglycemia? | HCS - Continue to Do Things Really Want | ||
HCS01-Mean HCS Score | C163869 | HCS01-Mean HCS Score | Hypoglycemic Confidence Scale - Mean HCS score. | HCS - Mean HCS Score | ||
HCS01-When You Are Alone | C163864 | HCS01-When You Are Alone | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are alone? | HCS - When You Are Alone | ||
HCS01-When You Are Driving | C163862 | HCS01-When You Are Driving | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are driving? | HCS - When You Are Driving | ||
HCS01-When You Are Exercising | C163860 | HCS01-When You Are Exercising | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are exercising? | HCS - When You Are Exercising | ||
HCS01-When You Are in Social Situations | C163863 | HCS01-When You Are in Social Situations | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are in social situations? | HCS - When You Are in Social Situations | ||
HCS01-When You Are Sleeping | C163861 | HCS01-When You Are Sleeping | Hypoglycemic Confidence Scale - How confident are you that you can stay safe from serious problems with hypoglycemia: When you are sleeping? | HCS - When You Are Sleeping | ||
HCS01-Your Ability to Avoid Problems | C163868 | HCS01-Your Ability to Avoid Problems | Hypoglycemic Confidence Scale - If you have a spouse or partner: What is your best guess about how confident your spouse or partner feels about your ability to avoid serious problems due to hypoglycemia? | HCS - Your Ability to Avoid Problems | ||
Back to top | ||||||
CL.C120525.ISTESTCD | Immunogenicity Specimen Assessments Test Code
(ISTESTCD) | text
Extensible: Yes | C120525 | Immunogenicity Specimen Assessments Test Code | Terminology relevant to the immunogenicity specimen test codes of the CDISC Study Data Tabulation Model. | CDISC SDTM Immunogenicity Specimen Assessments Test Code Terminology |
ABSCCL | C181399 | Antibody-secreting Cells | A measurement of the antibody-secreting cells in a biological specimen. | Antibody-secreting Cells Measurement | ||
ADA_BAB | C147272 | Binding Antidrug Antibody | A measurement of the binding antidrug antibody in a biological specimen. A binding antidrug antibody is an antibody that binds to a test article, and/or portion(s) of the test article. | Binding Antidrug Antibody Measurement | ||
ADA_NAB | C147273 | Neutralizing Binding Antidrug Antibody | A measurement of the neutralizing binding antidrug antibody in a biological specimen. A neutralizing binding antidrug antibody is a type of ADA that binds to the functional portion of a test article leading to diminished or negated pharmacological activity. | Neutralizing Binding Antidrug Antibody Measurement | ||
ADA_NX | C147274 | Neutraliz Cross-React Bind Antidrug AB;Neutralizing Cross-Reactive Binding Antidrug Antibody | A measurement of the neutralizing cross-reactive binding antidrug antibody in a biological specimen. A neutralizing cross-reactive binding antidrug antibody is a type of ADA that binds to an endogenous molecule that is structurally similar to an analogue test article and diminishes or negates its function. | Neutralizing Cross-Reacting Binding Antidrug Antibody Measurement | ||
ADA_X | C147275 | Cross-Reactive Binding Antidrug Antibody | A measurement of the cross-reactive binding antidrug antibody in a biological specimen. A cross-reactive binding antidrug antibody is a type of ADA that binds to the endogenous molecule that is structurally similar to an analogue test article. | Cross-Reactive Binding Antidrug Antibody Measurement | ||
ADBIGA | C181362 | Binding Antidrug IgA Antibody | A measurement of the binding antidrug IgA antibody in a biological specimen. | Binding Antidrug IgA Antibody Measurement | ||
ADBIGE | C181363 | Binding Antidrug IgE Antibody | A measurement of the binding antidrug IgE antibody in a biological specimen. | Binding Antidrug IgE Antibody Measurement | ||
ADBIGG | C181188 | Binding Antidrug IgG Antibody | A measurement of the binding antidrug IgG antibody in a biological specimen. | Binding Antidrug IgG Antibody Measurement | ||
ADBIGG1 | C181366 | Binding Antidrug IgG1 Antibody | A measurement of the binding antidrug IgG1 antibody in a biological specimen. | Binding Antidrug IgG1 Antibody Measurement | ||
ADBIGG2 | C181367 | Binding Antidrug IgG2 Antibody | A measurement of the binding antidrug IgG2 antibody in a biological specimen. | Binding Antidrug IgG2 Antibody Measurement | ||
ADBIGG3 | C181368 | Binding Antidrug IgG3 Antibody | A measurement of the binding antidrug IgG3 antibody in a biological specimen. | Binding Antidrug IgG3 Antibody Measurement | ||
ADBIGG4 | C181369 | Binding Antidrug IgG4 Antibody | A measurement of the binding antidrug IgG4 antibody in a biological specimen. | Binding Antidrug IgG4 Antibody Measurement | ||
ADBIGGM | C181365 | Binding Antidrug IgG/IgM Antibody | A measurement of the binding antidrug IgG and/or IgM antibody in a biological specimen. | Binding Antidrug IgG/IgM Antibody Measurement | ||
ADBIGM | C181364 | Binding Antidrug IgM Antibody | A measurement of the binding antidrug IgM antibody in a biological specimen. | Binding Antidrug IgM Antibody Measurement | ||
ADBXIGA | C181378 | Cross-Reactive Binding Antidrug IgA AB;Cross-Reactive Binding Antidrug IgA Antibody | A measurement of the cross-reactive binding antidrug IgA antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgA Antibody Measurement | ||
ADBXIGE | C181379 | Cross-Reactive Binding Antidrug IgE AB;Cross-Reactive Binding Antidrug IgE Antibody | A measurement of the cross-reactive binding antidrug IgE antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgE Antibody Measurement | ||
ADBXIGG | C181190 | Cross-Reactive Binding Antidrug IgG AB;Cross-Reactive Binding Antidrug IgG Antibody | A measurement of the cross-reactive binding antidrug IgG antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG Antibody Measurement | ||
ADBXIGG1 | C181382 | Cross-Reactive Binding Antidrug IgG1 AB;Cross-Reactive Binding Antidrug IgG1 Antibody | A measurement of the cross-reactive binding antidrug IgG1 antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG1 Antibody Measurement | ||
ADBXIGG2 | C181383 | Cross-Reactive Binding Antidrug IgG2 AB;Cross-Reactive Binding Antidrug IgG2 Antibody | A measurement of the cross-reactive binding antidrug IgG2 antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG2 Antibody Measurement | ||
ADBXIGG3 | C181384 | Cross-Reactive Binding Antidrug IgG3 AB;Cross-Reactive Binding Antidrug IgG3 Antibody | A measurement of the cross-reactive binding antidrug IgG3 antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG3 Antibody Measurement | ||
ADBXIGG4 | C181385 | Cross-Reactive Binding Antidrug IgG4 AB;Cross-Reactive Binding Antidrug IgG4 Antibody | A measurement of the cross-reactive binding antidrug IgG4 antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG4 Antibody Measurement | ||
ADBXIGGM | C181381 | Cross-Reactive Binding ADA IgG/IgM;Cross-Reactive Binding Antidrug IgG/IgM Antibody | A measurement of the cross-reactive binding antidrug IgG and/or IgM antibody in a biological specimen. | Cross-Reactive Binding Antidrug Antibody IgG/IgM Measurement | ||
ADBXIGM | C181380 | Cross-Reactive Binding Antidrug IgM AB;Cross-Reactive Binding Antidrug IgM Antibody | A measurement of the cross-reactive binding antidrug IgM antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgM Antibody Measurement | ||
ADNIGA | C181370 | Neutralizing Binding Antidrug IgA AB;Neutralizing Binding Antidrug IgA Antibody | A measurement of the neutralizing binding antidrug IgA antibody in a biological specimen. | Neutralizing Binding Antidrug IgA Antibody Measurement | ||
ADNIGE | C181371 | Neutralizing Binding Antidrug IgE AB;Neutralizing Binding Antidrug IgE Antibody | A measurement of the neutralizing binding antidrug IgE antibody in a biological specimen. | Neutralizing Binding Antidrug IgE Antibody Measurement | ||
ADNIGG | C181189 | Neutralizing Binding Antidrug IgG AB;Neutralizing Binding Antidrug IgG Antibody | A measurement of the neutralizing binding antidrug IgG antibody in a biological specimen. | Neutralizing Binding Antidrug IgG Antibody Measurement | ||
ADNIGG1 | C181374 | Neutralizing Binding Antidrug IgG1 AB;Neutralizing Binding Antidrug IgG1 Antibody | A measurement of the neutralizing binding antidrug IgG1 antibody in a biological specimen. | Neutralizing Binding Antidrug IgG1 Antibody Measurement | ||
ADNIGG2 | C181375 | Neutralizing Binding Antidrug IgG2 AB;Neutralizing Binding Antidrug IgG2 Antibody | A measurement of the neutralizing binding antidrug IgG2 antibody in a biological specimen. | Neutralizing Binding Antidrug IgG2 Antibody Measurement | ||
ADNIGG3 | C181376 | Neutralizing Binding Antidrug IgG3 AB;Neutralizing Binding Antidrug IgG3 Antibody | A measurement of the neutralizing binding antidrug IgG3 antibody in a biological specimen. | Neutralizing Binding Antidrug IgG3 Antibody Measurement | ||
ADNIGG4 | C181377 | Neutralizing Binding Antidrug IgG4 AB;Neutralizing Binding Antidrug IgG4 Antibody | A measurement of the neutralizing binding antidrug IgG4 antibody in a biological specimen. | Neutralizing Binding Antidrug IgG4 Antibody Measurement | ||
ADNIGGM | C181373 | Neutralizing Binding Antidrug IgG/IgM AB | A measurement of the neutralizing binding antidrug IgG and/or IgM antibody in a biological specimen. | Neutralizing Binding Antidrug IgG/IgM Antibody Measurement | ||
ADNIGM | C181372 | Neutralizing Binding Antidrug IgM AB;Neutralizing Binding Antidrug IgM Antibody | A measurement of the neutralizing binding antidrug IgM antibody in a biological specimen. | Neutralizing Binding Antidrug IgM Antibody Measurement | ||
ADNXIGA | C181386 | Neut Cross-Reactive Binding ADA IgA;Neutralizing Cross-Reactive Binding Antidrug IgA Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgA antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgA Measurement | ||
ADNXIGE | C181387 | Neut Cross-Reactive Binding ADA IgE;Neutralizing Cross-Reactive Binding Antidrug IgE Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgE antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgE Measurement | ||
ADNXIGG | C181191 | Neut Cross-Reactive Binding ADA IgG;Neutralizing Cross-Reactive Binding Antidrug IgG Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG Measurement | ||
ADNXIGG1 | C181390 | Neut Cross-Reactive Binding ADA IgG1;Neutralizing Cross-Reactive Binding Antidrug IgG1 Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG1 antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG1 Measurement | ||
ADNXIGG2 | C181391 | Neut Cross-Reactive Binding ADA IgG2;Neutralizing Cross-Reactive Binding Antidrug IgG2 Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG2 antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG2 Measurement | ||
ADNXIGG3 | C181392 | Neut Cross-Reactive Binding ADA IgG3;Neutralizing Cross-Reactive Binding Antidrug IgG3 Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG3 antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG3 Measurement | ||
ADNXIGG4 | C181393 | Neut Cross-Reactive Binding ADA IgG4;Neutralizing Cross-Reactive Binding Antidrug IgG4 Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG4 antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG4 Measurement | ||
ADNXIGGM | C181389 | Neut Cross-Reactive Binding ADA IgG/IgM;Neutralizing Cross-Reactive Binding Antidrug IgG/IgM Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG and/or IgM antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG/IgM Measurement | ||
ADNXIGM | C181388 | Neut Cross-Reactive Binding ADA IgM;Neutralizing Cross-Reactive Binding Antidrug IgM Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgM antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgM Measurement | ||
ARAB | C182150 | Allergen-induced Antibody | A measurement of the binding allergen-induced antibody in a biological specimen. | Allergen-induced Antibody Measurement | ||
ARIGAAB | C187776 | Allergen-induced IgA Antibody | A measurement of the binding allergen-induced IgA antibody in a biological specimen. | Allergen-induced IgA Antibody Measurement | ||
ARIGEAB | C181398 | Allergen-induced IgE Antibody | A measurement of the binding allergen-induced IgE antibody in a biological specimen. | Allergen-induced IgE Antibody Measurement | ||
ARIGG4AB | C187778 | Allergen-induced IgG4 Antibody | A measurement of the binding allergen-induced IgG4 antibody in a biological specimen. | Allergen-induced IgG4 Antibody Measurement | ||
ARIGGAB | C187777 | Allergen-induced IgG Antibody | A measurement of the binding allergen-induced IgG antibody in a biological specimen. | Allergen-induced IgG Antibody Measurement | ||
ARIGMAB | C187779 | Allergen-induced IgM Antibody | A measurement of the binding allergen-induced IgM antibody in a biological specimen. | Allergen-induced IgM Antibody Measurement | ||
ATAB | C181397 | Autoantibody | A measurement of the binding autoantibody in a biological specimen. | Autoantibody Measurement | ||
ATIGAAB | C198278 | IgA Autoantibody | A measurement of the binding IgA autoantibody in a biological specimen. | IgA Autoantibody Measurement | ||
ATIGGAB | C198279 | IgG Autoantibody | A measurement of the binding IgG autoantibody in a biological specimen. | IgG Autoantibody Measurement | ||
ATIGMAB | C198280 | IgM Autoantibody | A measurement of the binding IgM autoantibody in a biological specimen. | IgM Autoantibody Measurement | ||
CYKSCCL | C181400 | Cytokine-secreting Cells | A measurement of the cytokine-secreting cells in a biological specimen. | Cytokine-secreting Cells Measurement | ||
HIV1SR | C158217 | HIV-1 Seroreactivity | A measurement of the HIV-1 seroreactivity in a biological specimen. | HIV-1 Seroreactivity Measurement | ||
HIV2SR | C158216 | HIV-2 Seroreactivity | A measurement of the HIV-2 seroreactivity in a biological specimen. | HIV-2 Seroreactivity Measurement | ||
MBAB | C187780 | Microbial-induced Antibody | A measurement of the binding microbial-induced antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced Antibody Measurement | ||
MBFAB | C181395 | Functional Microbial-induced Antibody | A measurement of the functional binding microbial-induced antibody in a biological specimen. A functional microbial-induced antibody is defined as antibodies that have agonist or antagonist effects on pathogens or their toxins in the presence of other effector molecules or cells. For example, the effects of functional antibodies can include neutralization, phagocytosis, antibody-dependent cellular cytotoxicity, and complement-mediated lysis. The production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Functional Microbial-induced Antibody Measurement | ||
MBIAMAB | C187781 | Microbial-induced IgA/IgM Antibody | A measurement of the binding microbial-induced IgA and/or IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgA and/or IgM Antibody Measurement | ||
MBIG_MAB | C187784 | Microbial-induced IgG + IgM Antibody | A measurement of the binding microbial-induced IgG and IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgG and IgM Antibody Measurement | ||
MBIGAAB | C187782 | Microbial-induced IgA Antibody | A measurement of the binding microbial-induced IgA antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgA Antibody Measurement | ||
MBIGEAB | C187783 | Microbial-induced IgE Antibody | A measurement of the binding microbial-induced IgE antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgE Antibody Measurement | ||
MBIGGAB | C181394 | Microbial-induced IgG Antibody | A measurement of the binding microbial-induced IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgG Antibody Measurement | ||
MBIGMAB | C187785 | Microbial-induced IgG/IgM Antibody | A measurement of the binding microbial-induced IgG and/or IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgG and/or IgM Antibody Measurement | ||
MBIMAB | C187786 | Microbial-induced IgM Antibody | A measurement of the binding microbial-induced IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgM Antibody Measurement | ||
MBIMAGAB | C187787 | Microbial-induced IgM/IgA/IgG Antibody | A measurement of the binding microbial-induced IgM, IgA and/or IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgM, IgA, and/or IgG Antibody Measurement | ||
MBNAB | C181396 | Neutralizing Microbial-induced Antibody | A measurement of the neutralizing binding microbial-induced antibody in a biological specimen. A neutralizing microbial-induced antibody is a type of functional antibody that's defined as antibodies that bind to, block and prevent microbes from infecting cells. The production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Neutralizing Microbial-induced Antibody Measurement | ||
TLYMPIDX | C161337 | T-Lymphocyte Proliferation Index | A relative measurement (ratio or percentage) of T-lymphocyte proliferation due to stimulation by an antigen of interest to a non-stimulated T-lymphocyte proliferation control. | T-Lymphocyte Proliferation Index | ||
Back to top | ||||||
CL.C120526.ISTEST | Immunogenicity Specimen Assessments Test Name
(ISTEST) | text
Extensible: Yes | C120526 | Immunogenicity Specimen Assessments Test Name | Terminology relevant to the immunogenicity specimen test names of the CDISC Study Data Tabulation Model. | CDISC SDTM Immunogenicity Specimen Assessments Test Name Terminology |
Allergen-induced Antibody | C182150 | Allergen-induced Antibody | A measurement of the binding allergen-induced antibody in a biological specimen. | Allergen-induced Antibody Measurement | ||
Allergen-induced IgA Antibody | C187776 | Allergen-induced IgA Antibody | A measurement of the binding allergen-induced IgA antibody in a biological specimen. | Allergen-induced IgA Antibody Measurement | ||
Allergen-induced IgE Antibody | C181398 | Allergen-induced IgE Antibody | A measurement of the binding allergen-induced IgE antibody in a biological specimen. | Allergen-induced IgE Antibody Measurement | ||
Allergen-induced IgG Antibody | C187777 | Allergen-induced IgG Antibody | A measurement of the binding allergen-induced IgG antibody in a biological specimen. | Allergen-induced IgG Antibody Measurement | ||
Allergen-induced IgG4 Antibody | C187778 | Allergen-induced IgG4 Antibody | A measurement of the binding allergen-induced IgG4 antibody in a biological specimen. | Allergen-induced IgG4 Antibody Measurement | ||
Allergen-induced IgM Antibody | C187779 | Allergen-induced IgM Antibody | A measurement of the binding allergen-induced IgM antibody in a biological specimen. | Allergen-induced IgM Antibody Measurement | ||
Antibody-secreting Cells | C181399 | Antibody-secreting Cells | A measurement of the antibody-secreting cells in a biological specimen. | Antibody-secreting Cells Measurement | ||
Autoantibody | C181397 | Autoantibody | A measurement of the binding autoantibody in a biological specimen. | Autoantibody Measurement | ||
Binding Antidrug Antibody | C147272 | Binding Antidrug Antibody | A measurement of the binding antidrug antibody in a biological specimen. A binding antidrug antibody is an antibody that binds to a test article, and/or portion(s) of the test article. | Binding Antidrug Antibody Measurement | ||
Binding Antidrug IgA Antibody | C181362 | Binding Antidrug IgA Antibody | A measurement of the binding antidrug IgA antibody in a biological specimen. | Binding Antidrug IgA Antibody Measurement | ||
Binding Antidrug IgE Antibody | C181363 | Binding Antidrug IgE Antibody | A measurement of the binding antidrug IgE antibody in a biological specimen. | Binding Antidrug IgE Antibody Measurement | ||
Binding Antidrug IgG Antibody | C181188 | Binding Antidrug IgG Antibody | A measurement of the binding antidrug IgG antibody in a biological specimen. | Binding Antidrug IgG Antibody Measurement | ||
Binding Antidrug IgG/IgM Antibody | C181365 | Binding Antidrug IgG/IgM Antibody | A measurement of the binding antidrug IgG and/or IgM antibody in a biological specimen. | Binding Antidrug IgG/IgM Antibody Measurement | ||
Binding Antidrug IgG1 Antibody | C181366 | Binding Antidrug IgG1 Antibody | A measurement of the binding antidrug IgG1 antibody in a biological specimen. | Binding Antidrug IgG1 Antibody Measurement | ||
Binding Antidrug IgG2 Antibody | C181367 | Binding Antidrug IgG2 Antibody | A measurement of the binding antidrug IgG2 antibody in a biological specimen. | Binding Antidrug IgG2 Antibody Measurement | ||
Binding Antidrug IgG3 Antibody | C181368 | Binding Antidrug IgG3 Antibody | A measurement of the binding antidrug IgG3 antibody in a biological specimen. | Binding Antidrug IgG3 Antibody Measurement | ||
Binding Antidrug IgG4 Antibody | C181369 | Binding Antidrug IgG4 Antibody | A measurement of the binding antidrug IgG4 antibody in a biological specimen. | Binding Antidrug IgG4 Antibody Measurement | ||
Binding Antidrug IgM Antibody | C181364 | Binding Antidrug IgM Antibody | A measurement of the binding antidrug IgM antibody in a biological specimen. | Binding Antidrug IgM Antibody Measurement | ||
Cross-Reactive Binding ADA IgG/IgM | C181381 | Cross-Reactive Binding ADA IgG/IgM;Cross-Reactive Binding Antidrug IgG/IgM Antibody | A measurement of the cross-reactive binding antidrug IgG and/or IgM antibody in a biological specimen. | Cross-Reactive Binding Antidrug Antibody IgG/IgM Measurement | ||
Cross-Reactive Binding Antidrug Antibody | C147275 | Cross-Reactive Binding Antidrug Antibody | A measurement of the cross-reactive binding antidrug antibody in a biological specimen. A cross-reactive binding antidrug antibody is a type of ADA that binds to the endogenous molecule that is structurally similar to an analogue test article. | Cross-Reactive Binding Antidrug Antibody Measurement | ||
Cross-Reactive Binding Antidrug IgA AB | C181378 | Cross-Reactive Binding Antidrug IgA AB;Cross-Reactive Binding Antidrug IgA Antibody | A measurement of the cross-reactive binding antidrug IgA antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgA Antibody Measurement | ||
Cross-Reactive Binding Antidrug IgE AB | C181379 | Cross-Reactive Binding Antidrug IgE AB;Cross-Reactive Binding Antidrug IgE Antibody | A measurement of the cross-reactive binding antidrug IgE antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgE Antibody Measurement | ||
Cross-Reactive Binding Antidrug IgG AB | C181190 | Cross-Reactive Binding Antidrug IgG AB;Cross-Reactive Binding Antidrug IgG Antibody | A measurement of the cross-reactive binding antidrug IgG antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG Antibody Measurement | ||
Cross-Reactive Binding Antidrug IgG1 AB | C181382 | Cross-Reactive Binding Antidrug IgG1 AB;Cross-Reactive Binding Antidrug IgG1 Antibody | A measurement of the cross-reactive binding antidrug IgG1 antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG1 Antibody Measurement | ||
Cross-Reactive Binding Antidrug IgG2 AB | C181383 | Cross-Reactive Binding Antidrug IgG2 AB;Cross-Reactive Binding Antidrug IgG2 Antibody | A measurement of the cross-reactive binding antidrug IgG2 antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG2 Antibody Measurement | ||
Cross-Reactive Binding Antidrug IgG3 AB | C181384 | Cross-Reactive Binding Antidrug IgG3 AB;Cross-Reactive Binding Antidrug IgG3 Antibody | A measurement of the cross-reactive binding antidrug IgG3 antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG3 Antibody Measurement | ||
Cross-Reactive Binding Antidrug IgG4 AB | C181385 | Cross-Reactive Binding Antidrug IgG4 AB;Cross-Reactive Binding Antidrug IgG4 Antibody | A measurement of the cross-reactive binding antidrug IgG4 antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgG4 Antibody Measurement | ||
Cross-Reactive Binding Antidrug IgM AB | C181380 | Cross-Reactive Binding Antidrug IgM AB;Cross-Reactive Binding Antidrug IgM Antibody | A measurement of the cross-reactive binding antidrug IgM antibody in a biological specimen. | Cross-Reactive Binding Antidrug IgM Antibody Measurement | ||
Cytokine-secreting Cells | C181400 | Cytokine-secreting Cells | A measurement of the cytokine-secreting cells in a biological specimen. | Cytokine-secreting Cells Measurement | ||
Functional Microbial-induced Antibody | C181395 | Functional Microbial-induced Antibody | A measurement of the functional binding microbial-induced antibody in a biological specimen. A functional microbial-induced antibody is defined as antibodies that have agonist or antagonist effects on pathogens or their toxins in the presence of other effector molecules or cells. For example, the effects of functional antibodies can include neutralization, phagocytosis, antibody-dependent cellular cytotoxicity, and complement-mediated lysis. The production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Functional Microbial-induced Antibody Measurement | ||
HIV-1 Seroreactivity | C158217 | HIV-1 Seroreactivity | A measurement of the HIV-1 seroreactivity in a biological specimen. | HIV-1 Seroreactivity Measurement | ||
HIV-2 Seroreactivity | C158216 | HIV-2 Seroreactivity | A measurement of the HIV-2 seroreactivity in a biological specimen. | HIV-2 Seroreactivity Measurement | ||
IgA Autoantibody | C198278 | IgA Autoantibody | A measurement of the binding IgA autoantibody in a biological specimen. | IgA Autoantibody Measurement | ||
IgG Autoantibody | C198279 | IgG Autoantibody | A measurement of the binding IgG autoantibody in a biological specimen. | IgG Autoantibody Measurement | ||
IgM Autoantibody | C198280 | IgM Autoantibody | A measurement of the binding IgM autoantibody in a biological specimen. | IgM Autoantibody Measurement | ||
Microbial-induced Antibody | C187780 | Microbial-induced Antibody | A measurement of the binding microbial-induced antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced Antibody Measurement | ||
Microbial-induced IgA Antibody | C187782 | Microbial-induced IgA Antibody | A measurement of the binding microbial-induced IgA antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgA Antibody Measurement | ||
Microbial-induced IgA/IgM Antibody | C187781 | Microbial-induced IgA/IgM Antibody | A measurement of the binding microbial-induced IgA and/or IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgA and/or IgM Antibody Measurement | ||
Microbial-induced IgE Antibody | C187783 | Microbial-induced IgE Antibody | A measurement of the binding microbial-induced IgE antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgE Antibody Measurement | ||
Microbial-induced IgG + IgM Antibody | C187784 | Microbial-induced IgG + IgM Antibody | A measurement of the binding microbial-induced IgG and IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgG and IgM Antibody Measurement | ||
Microbial-induced IgG Antibody | C181394 | Microbial-induced IgG Antibody | A measurement of the binding microbial-induced IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgG Antibody Measurement | ||
Microbial-induced IgG/IgM Antibody | C187785 | Microbial-induced IgG/IgM Antibody | A measurement of the binding microbial-induced IgG and/or IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgG and/or IgM Antibody Measurement | ||
Microbial-induced IgM Antibody | C187786 | Microbial-induced IgM Antibody | A measurement of the binding microbial-induced IgM antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgM Antibody Measurement | ||
Microbial-induced IgM/IgA/IgG Antibody | C187787 | Microbial-induced IgM/IgA/IgG Antibody | A measurement of the binding microbial-induced IgM, IgA and/or IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Microbial-induced IgM, IgA, and/or IgG Antibody Measurement | ||
Neut Cross-Reactive Binding ADA IgA | C181386 | Neut Cross-Reactive Binding ADA IgA;Neutralizing Cross-Reactive Binding Antidrug IgA Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgA antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgA Measurement | ||
Neut Cross-Reactive Binding ADA IgE | C181387 | Neut Cross-Reactive Binding ADA IgE;Neutralizing Cross-Reactive Binding Antidrug IgE Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgE antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgE Measurement | ||
Neut Cross-Reactive Binding ADA IgG | C181191 | Neut Cross-Reactive Binding ADA IgG;Neutralizing Cross-Reactive Binding Antidrug IgG Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG Measurement | ||
Neut Cross-Reactive Binding ADA IgG/IgM | C181389 | Neut Cross-Reactive Binding ADA IgG/IgM;Neutralizing Cross-Reactive Binding Antidrug IgG/IgM Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG and/or IgM antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG/IgM Measurement | ||
Neut Cross-Reactive Binding ADA IgG1 | C181390 | Neut Cross-Reactive Binding ADA IgG1;Neutralizing Cross-Reactive Binding Antidrug IgG1 Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG1 antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG1 Measurement | ||
Neut Cross-Reactive Binding ADA IgG2 | C181391 | Neut Cross-Reactive Binding ADA IgG2;Neutralizing Cross-Reactive Binding Antidrug IgG2 Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG2 antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG2 Measurement | ||
Neut Cross-Reactive Binding ADA IgG3 | C181392 | Neut Cross-Reactive Binding ADA IgG3;Neutralizing Cross-Reactive Binding Antidrug IgG3 Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG3 antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG3 Measurement | ||
Neut Cross-Reactive Binding ADA IgG4 | C181393 | Neut Cross-Reactive Binding ADA IgG4;Neutralizing Cross-Reactive Binding Antidrug IgG4 Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgG4 antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgG4 Measurement | ||
Neut Cross-Reactive Binding ADA IgM | C181388 | Neut Cross-Reactive Binding ADA IgM;Neutralizing Cross-Reactive Binding Antidrug IgM Antibody | A measurement of the neutralizing cross-reactive binding antidrug IgM antibody in a biological specimen. | Neutralizing Cross-Reactive Binding Antidrug Antibody IgM Measurement | ||
Neutraliz Cross-React Bind Antidrug AB | C147274 | Neutraliz Cross-React Bind Antidrug AB;Neutralizing Cross-Reactive Binding Antidrug Antibody | A measurement of the neutralizing cross-reactive binding antidrug antibody in a biological specimen. A neutralizing cross-reactive binding antidrug antibody is a type of ADA that binds to an endogenous molecule that is structurally similar to an analogue test article and diminishes or negates its function. | Neutralizing Cross-Reacting Binding Antidrug Antibody Measurement | ||
Neutralizing Binding Antidrug Antibody | C147273 | Neutralizing Binding Antidrug Antibody | A measurement of the neutralizing binding antidrug antibody in a biological specimen. A neutralizing binding antidrug antibody is a type of ADA that binds to the functional portion of a test article leading to diminished or negated pharmacological activity. | Neutralizing Binding Antidrug Antibody Measurement | ||
Neutralizing Binding Antidrug IgA AB | C181370 | Neutralizing Binding Antidrug IgA AB;Neutralizing Binding Antidrug IgA Antibody | A measurement of the neutralizing binding antidrug IgA antibody in a biological specimen. | Neutralizing Binding Antidrug IgA Antibody Measurement | ||
Neutralizing Binding Antidrug IgE AB | C181371 | Neutralizing Binding Antidrug IgE AB;Neutralizing Binding Antidrug IgE Antibody | A measurement of the neutralizing binding antidrug IgE antibody in a biological specimen. | Neutralizing Binding Antidrug IgE Antibody Measurement | ||
Neutralizing Binding Antidrug IgG AB | C181189 | Neutralizing Binding Antidrug IgG AB;Neutralizing Binding Antidrug IgG Antibody | A measurement of the neutralizing binding antidrug IgG antibody in a biological specimen. | Neutralizing Binding Antidrug IgG Antibody Measurement | ||
Neutralizing Binding Antidrug IgG/IgM AB | C181373 | Neutralizing Binding Antidrug IgG/IgM AB | A measurement of the neutralizing binding antidrug IgG and/or IgM antibody in a biological specimen. | Neutralizing Binding Antidrug IgG/IgM Antibody Measurement | ||
Neutralizing Binding Antidrug IgG1 AB | C181374 | Neutralizing Binding Antidrug IgG1 AB;Neutralizing Binding Antidrug IgG1 Antibody | A measurement of the neutralizing binding antidrug IgG1 antibody in a biological specimen. | Neutralizing Binding Antidrug IgG1 Antibody Measurement | ||
Neutralizing Binding Antidrug IgG2 AB | C181375 | Neutralizing Binding Antidrug IgG2 AB;Neutralizing Binding Antidrug IgG2 Antibody | A measurement of the neutralizing binding antidrug IgG2 antibody in a biological specimen. | Neutralizing Binding Antidrug IgG2 Antibody Measurement | ||
Neutralizing Binding Antidrug IgG3 AB | C181376 | Neutralizing Binding Antidrug IgG3 AB;Neutralizing Binding Antidrug IgG3 Antibody | A measurement of the neutralizing binding antidrug IgG3 antibody in a biological specimen. | Neutralizing Binding Antidrug IgG3 Antibody Measurement | ||
Neutralizing Binding Antidrug IgG4 AB | C181377 | Neutralizing Binding Antidrug IgG4 AB;Neutralizing Binding Antidrug IgG4 Antibody | A measurement of the neutralizing binding antidrug IgG4 antibody in a biological specimen. | Neutralizing Binding Antidrug IgG4 Antibody Measurement | ||
Neutralizing Binding Antidrug IgM AB | C181372 | Neutralizing Binding Antidrug IgM AB;Neutralizing Binding Antidrug IgM Antibody | A measurement of the neutralizing binding antidrug IgM antibody in a biological specimen. | Neutralizing Binding Antidrug IgM Antibody Measurement | ||
Neutralizing Microbial-induced Antibody | C181396 | Neutralizing Microbial-induced Antibody | A measurement of the neutralizing binding microbial-induced antibody in a biological specimen. A neutralizing microbial-induced antibody is a type of functional antibody that's defined as antibodies that bind to, block and prevent microbes from infecting cells. The production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe. | Neutralizing Microbial-induced Antibody Measurement | ||
T-Lymphocyte Proliferation Index | C161337 | T-Lymphocyte Proliferation Index | A relative measurement (ratio or percentage) of T-lymphocyte proliferation due to stimulation by an antigen of interest to a non-stimulated T-lymphocyte proliferation control. | T-Lymphocyte Proliferation Index | ||
Back to top | ||||||
CL.C189267.ISFTSDTL | Immunogenicity Specimen Test Details
(ISFTSDTL) | text
Extensible: Yes | C189267 | Immunogenicity Specimen Test Details | Terminology relevant to the additional descriptions of the test being performed to produce the immunogenicity specimen test findings. | CDISC SDTM Immunogenicity Specimen Test Details Terminology |
50% Focus Reduction Neutralization Titer | C191284 | FRNT50 | The reciprocal of the highest sample dilution level that results in a 50% or greater reduction in the formation of viral foci. This should be reported as a titer from a focus reduction neutralization assay. | Fifty Percent Focus Reduction Neutralization Titer | ||
50% Inhibitory Concentration | C191279 | Half-maximal Inhibitory Concentration | The concentration of the inhibitory molecule that results in a 50% or greater reduction in infectivity, biological or biochemical function. This should be reported as mass or arbitrary unit per volume. | Fifty Percent Inhibitory Concentration | ||
50% Neutralization Titer | C189121 | Half-maximal Neutralization Titer;NT50 | The reciprocal of the highest sample dilution level that results in a 50% or greater reduction in infectivity, biological or biochemical function. This should be reported as a titer. | 50 Percent Neutralization Endpoint Titer | ||
50% Plaque Reduction Neutralization Titer | C191283 | PRNT50 | The reciprocal of the highest sample dilution level that results in a 50% or greater reduction in the formation of viral plaques. This should be reported as a titer from a plaque reduction neutralization assay. | Fifty Percent Plaque Reduction Neutralization Endpoint Titer | ||
80% Inhibitory Concentration | C191281 | The concentration of the inhibitory molecule that results in a 80% or greater reduction in infectivity, biological or biochemical function. This should be reported as mass or arbitrary unit per volume. | Eighty Percent Inhibitory Concentration | |||
80% Neutralization Titer | C191280 | 80% Neutralizing Titer | The reciprocal of the highest sample dilution level that results in a 80% or greater reduction in infectivity, biological or biochemical function. This should be reported as a titer. | Eighty Percent Neutralization Endpoint Titer | ||
90% Inhibitory Concentration | C191282 | IC90 | The concentration of the inhibitory molecule that results in a 90% or greater reduction in infectivity, biological or biochemical function. This should be reported as mass or arbitrary unit per volume. | Ninety Percent Inhibitory Concentration | ||
90% Neutralization Titer | C189122 | 90% Neutralizing Titer;NT90 | The reciprocal of the highest sample dilution level that results in a 90% or greater reduction in infectivity, biological or biochemical function. This should be reported as a titer. | 90 Percent Neutralization Endpoint Titer | ||
RAST SCORE | C189493 | RAST Class;RAST Rating | A score system used to evaluate the severity of allergy by measuring the amount of circulating allergen-specific antibody, using the radioallergosorbent test. | RAST Score | ||
SIGNAL/CUTOFF RATIO | C198277 | S/Co;Signal/Cutoff | A relative measurement (ratio) of the signal strength of a pre-specified analyte in a specimen to the signal strength of an internal cutoff standard. | Signal to Cutoff Ratio Measurement | ||
STAINING PATTERN | C189492 | A determination of the distribution pattern of a stained entity. | Staining Distribution Pattern | |||
Back to top | ||||||
CL.C113856.IVIS01TC | Impact of Visual Impairment Scale Questionnaire Test Code
(IVIS01TC) | text
Extensible: No | C113856 | Impact of Visual Impairment Scale Questionnaire Test Code | Impact of Visual Impairment Scale test code. | CDISC Questionnaire Impact of Visual Impairment Scale Test Code Terminology |
IVIS0101 | C113962 | IVIS01-Read or Access Personal Letters | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access personal letters or notes? | IVIS - Read or Access Personal Letters | ||
IVIS0102 | C113963 | IVIS01-Read or Access Printed Materials | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access printed materials, such as books, magazines, newspaper, etc.? | IVIS - Read or Access Printed Materials | ||
IVIS0103 | C113964 | IVIS01-Read or Access Dials | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access dials, such as on stoves, thermostats, etc.? | IVIS - Read or Access Dials | ||
IVIS0104 | C113965 | IVIS01-Watch TV/ID Faces From Distance | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to watch television or identify faces from a distance? | IVIS - Watch TV or Identify Faces From Distance | ||
IVIS0105 | C113966 | IVIS01-Identify House Number/Street Sign | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to identify house numbers, street signs, etc.? | IVIS - Identify House Numbers or Street Signs | ||
Back to top | ||||||
CL.C113855.IVIS01TN | Impact of Visual Impairment Scale Questionnaire Test Name
(IVIS01TN) | text
Extensible: No | C113855 | Impact of Visual Impairment Scale Questionnaire Test Name | Impact of Visual Impairment Scale test name. | CDISC Questionnaire Impact of Visual Impairment Scale Test Name Terminology |
IVIS01-Identify House Number/Street Sign | C113966 | IVIS01-Identify House Number/Street Sign | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to identify house numbers, street signs, etc.? | IVIS - Identify House Numbers or Street Signs | ||
IVIS01-Read or Access Dials | C113964 | IVIS01-Read or Access Dials | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access dials, such as on stoves, thermostats, etc.? | IVIS - Read or Access Dials | ||
IVIS01-Read or Access Personal Letters | C113962 | IVIS01-Read or Access Personal Letters | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access personal letters or notes? | IVIS - Read or Access Personal Letters | ||
IVIS01-Read or Access Printed Materials | C113963 | IVIS01-Read or Access Printed Materials | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to read or access printed materials, such as books, magazines, newspaper, etc.? | IVIS - Read or Access Printed Materials | ||
IVIS01-Watch TV/ID Faces From Distance | C113965 | IVIS01-Watch TV/ID Faces From Distance | Impact of Visual Impairment Scale - During the past 4 weeks, how difficult did you find it to watch television or identify faces from a distance? | IVIS - Watch TV or Identify Faces From Distance | ||
Back to top | ||||||
CL.C170445.INTEGUCD | Integumentary System Test Code
(INTEGUCD) | text
Extensible: Yes | C170445 | Integumentary System Test Code | A terminology codelist to describe the test codes for examinations of the integumentary system. | CDISC SDTM Integumentary System Test Code Terminology |
ABSABSA | C170575 | Affected Body Surface Area/Total Body Surface Area;Affected BSA/Total BSA | A relative measurement (ratio or percentage) of the affected body surface area to total body surface area. | Affected Body Surface Area to Total Body Surface Area Ratio Measurement | ||
IGEXAM | C198262 | Integumentary System Examination | An observation, assessment or examination of the integumentary system. | Integumentary System Examination | ||
SKINTYP | C74580 | Skin Type | A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands. | Skin Type | ||
Back to top | ||||||
CL.C170444.INTEGU | Integumentary System Test Name
(INTEGU) | text
Extensible: Yes | C170444 | Integumentary System Test Name | A terminology codelist to describe the test names for examinations of the integumentary system. | CDISC SDTM Integumentary System Test Name Terminology |
Affected BSA/Total BSA | C170575 | Affected Body Surface Area/Total Body Surface Area;Affected BSA/Total BSA | A relative measurement (ratio or percentage) of the affected body surface area to total body surface area. | Affected Body Surface Area to Total Body Surface Area Ratio Measurement | ||
Integumentary System Examination | C198262 | Integumentary System Examination | An observation, assessment or examination of the integumentary system. | Integumentary System Examination | ||
Skin Type | C74580 | Skin Type | A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands. | Skin Type | ||
Back to top | ||||||
CL.C103471.IIEF01TC | International Index of Erectile Function Questionnaire Test Code
(IIEF01TC) | text
Extensible: No | C103471 | International Index of Erectile Function Questionnaire Test Code | International Index of Erectile Function test code. | CDISC Questionnaire IIEF Test Code Terminology |
IIEF0101 | C103587 | IIEF01-Erection During Sexual Activity;IIEF01-Erection Frequency | International Index of Erectile Function - Over the past four weeks how often were you able to get an erection during sexual activity? | IIEF - Able to Get an Erection During Sexual Activity | ||
IIEF0102 | C103588 | IIEF01-Erection Firmness;IIEF01-Erection Hard Enough to Penetrate | International Index of Erectile Function - Over the past four weeks when you had erections with sexual stimulation, how often were your erections hard enough for penetration? | IIEF - Erections Hard Enough for Penetration | ||
IIEF0103 | C103589 | IIEF01-Able to Penetrate Your Partner;IIEF01-Penetration Ability | International Index of Erectile Function - Over the past four weeks when you attempted sexual intercourse, how often were you able to penetrate (enter) your partner? | IIEF - Able to Penetrate Your Partner | ||
IIEF0104 | C103590 | IIEF01-Maintain Erection After Penetrate;IIEF01-Maintenance Frequency | International Index of Erectile Function - Over the past four weeks during sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner? | IIEF - Able to Maintain Your Erection After You Had Penetrated Your Partner | ||
IIEF0105 | C103591 | IIEF01-Maintain Erection to Completion;IIEF01-Maintenance Ability | International Index of Erectile Function - Over the past four weeks during sexual intercourse, how difficult was it to maintain your erection to completion of intercourse? | IIEF - Maintain Your Erection to Completion of Intercourse | ||
IIEF0106 | C103592 | IIEF01-Intercourse Frequency;IIEF01-Times Attempted Sexual Intercours | International Index of Erectile Function - Over the past four weeks how many times have you attempted sexual intercourse? | IIEF - How Many Times Have You Attempted Sexual Intercourse | ||
IIEF0107 | C103593 | IIEF01-How Often was it Satisfactory;IIEF01-Intercourse Satisfaction | International Index of Erectile Function - Over the past four weeks when you attempted sexual intercourse, how often was it satisfactory for you? | IIEF - How Often was it Satisfactory for You | ||
IIEF0108 | C103594 | IIEF01-Enjoyed Sexual Intercourse;IIEF01-Intercourse Enjoyment | International Index of Erectile Function - Over the past four weeks how much have you enjoyed sexual intercourse? | IIEF - How Much Have You Enjoyed Sexual Intercourse | ||
IIEF0109 | C103595 | IIEF01-Ejaculation Frequency;IIEF01-How Often Did You Ejaculate | International Index of Erectile Function - Over the past four weeks when you had sexual stimulation or intercourse, how often did you ejaculate? | IIEF - How Often Did You Ejaculate | ||
IIEF0110 | C103596 | IIEF01-Did You Have Feeling of Orgasm;IIEF01-Orgasm Frequency | International Index of Erectile Function - Over the past four weeks when you had sexual stimulation or intercourse, how often did you have the feeling of orgasm with our without ejaculation? | IIEF - Did You Have Feeling of Orgasm With or Without Ejaculation | ||
IIEF0111 | C103597 | IIEF01-Desire Frequency;IIEF01-Have You Felt Sexual Desire | International Index of Erectile Function - Over the past four weeks how often have you felt sexual desire? | IIEF - How Often Have You Felt Sexual Desire | ||
IIEF0112 | C103598 | IIEF01-Desire Level;IIEF01-Rate Your Level of Sexual Desire | International Index of Erectile Function - Over the past four weeks how would you rate your level of sexual desire? | IIEF - Rate Your Level of Sexual Desire | ||
IIEF0113 | C103599 | IIEF01-Overall Satisfaction;IIEF01-Satisfied with Overall Sex Life | International Index of Erectile Function - Over the past four weeks how satisfied have you been with your overall sex life? | IIEF - Satisfied with Overall Sex Life | ||
IIEF0114 | C103600 | IIEF01-Relationship Satisfaction;IIEF01-Satisfy with Sexual Relationship | International Index of Erectile Function - Over the past four weeks how satisfied have you been with your sexual relationship with your partner? | IIEF - Satisfied with Your Sexual Relationship with Your Partner | ||
IIEF0115 | C103601 | IIEF01-Confidence to Get/Keep Erection;IIEF01-Erection Confidence | International Index of Erectile Function - Over the past four weeks how do you rate your confidence that you could get and keep an erection? | IIEF - Your Confidence to Get and Keep an Erection | ||
Back to top | ||||||
CL.C103470.IIEF01TN | International Index of Erectile Function Questionnaire Test Name
(IIEF01TN) | text
Extensible: No | C103470 | International Index of Erectile Function Questionnaire Test Name | International Index of Erectile Function test name. | CDISC Questionnaire IIEF Test Name Terminology |
IIEF01-Able to Penetrate Your Partner | C103589 | IIEF01-Able to Penetrate Your Partner;IIEF01-Penetration Ability | International Index of Erectile Function - Over the past four weeks when you attempted sexual intercourse, how often were you able to penetrate (enter) your partner? | IIEF - Able to Penetrate Your Partner | ||
IIEF01-Confidence to Get/Keep Erection | C103601 | IIEF01-Confidence to Get/Keep Erection;IIEF01-Erection Confidence | International Index of Erectile Function - Over the past four weeks how do you rate your confidence that you could get and keep an erection? | IIEF - Your Confidence to Get and Keep an Erection | ||
IIEF01-Did You Have Feeling of Orgasm | C103596 | IIEF01-Did You Have Feeling of Orgasm;IIEF01-Orgasm Frequency | International Index of Erectile Function - Over the past four weeks when you had sexual stimulation or intercourse, how often did you have the feeling of orgasm with our without ejaculation? | IIEF - Did You Have Feeling of Orgasm With or Without Ejaculation | ||
IIEF01-Enjoyed Sexual Intercourse | C103594 | IIEF01-Enjoyed Sexual Intercourse;IIEF01-Intercourse Enjoyment | International Index of Erectile Function - Over the past four weeks how much have you enjoyed sexual intercourse? | IIEF - How Much Have You Enjoyed Sexual Intercourse | ||
IIEF01-Erection During Sexual Activity | C103587 | IIEF01-Erection During Sexual Activity;IIEF01-Erection Frequency | International Index of Erectile Function - Over the past four weeks how often were you able to get an erection during sexual activity? | IIEF - Able to Get an Erection During Sexual Activity | ||
IIEF01-Erection Hard Enough to Penetrate | C103588 | IIEF01-Erection Firmness;IIEF01-Erection Hard Enough to Penetrate | International Index of Erectile Function - Over the past four weeks when you had erections with sexual stimulation, how often were your erections hard enough for penetration? | IIEF - Erections Hard Enough for Penetration | ||
IIEF01-Have You Felt Sexual Desire | C103597 | IIEF01-Desire Frequency;IIEF01-Have You Felt Sexual Desire | International Index of Erectile Function - Over the past four weeks how often have you felt sexual desire? | IIEF - How Often Have You Felt Sexual Desire | ||
IIEF01-How Often Did You Ejaculate | C103595 | IIEF01-Ejaculation Frequency;IIEF01-How Often Did You Ejaculate | International Index of Erectile Function - Over the past four weeks when you had sexual stimulation or intercourse, how often did you ejaculate? | IIEF - How Often Did You Ejaculate | ||
IIEF01-How Often was it Satisfactory | C103593 | IIEF01-How Often was it Satisfactory;IIEF01-Intercourse Satisfaction | International Index of Erectile Function - Over the past four weeks when you attempted sexual intercourse, how often was it satisfactory for you? | IIEF - How Often was it Satisfactory for You | ||
IIEF01-Maintain Erection After Penetrate | C103590 | IIEF01-Maintain Erection After Penetrate;IIEF01-Maintenance Frequency | International Index of Erectile Function - Over the past four weeks during sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner? | IIEF - Able to Maintain Your Erection After You Had Penetrated Your Partner | ||
IIEF01-Maintain Erection to Completion | C103591 | IIEF01-Maintain Erection to Completion;IIEF01-Maintenance Ability | International Index of Erectile Function - Over the past four weeks during sexual intercourse, how difficult was it to maintain your erection to completion of intercourse? | IIEF - Maintain Your Erection to Completion of Intercourse | ||
IIEF01-Rate Your Level of Sexual Desire | C103598 | IIEF01-Desire Level;IIEF01-Rate Your Level of Sexual Desire | International Index of Erectile Function - Over the past four weeks how would you rate your level of sexual desire? | IIEF - Rate Your Level of Sexual Desire | ||
IIEF01-Satisfied with Overall Sex Life | C103599 | IIEF01-Overall Satisfaction;IIEF01-Satisfied with Overall Sex Life | International Index of Erectile Function - Over the past four weeks how satisfied have you been with your overall sex life? | IIEF - Satisfied with Overall Sex Life | ||
IIEF01-Satisfy with Sexual Relationship | C103600 | IIEF01-Relationship Satisfaction;IIEF01-Satisfy with Sexual Relationship | International Index of Erectile Function - Over the past four weeks how satisfied have you been with your sexual relationship with your partner? | IIEF - Satisfied with Your Sexual Relationship with Your Partner | ||
IIEF01-Times Attempted Sexual Intercours | C103592 | IIEF01-Intercourse Frequency;IIEF01-Times Attempted Sexual Intercours | International Index of Erectile Function - Over the past four weeks how many times have you attempted sexual intercourse? | IIEF - How Many Times Have You Attempted Sexual Intercourse | ||
Back to top | ||||||
CL.C141665.IPAQ04TC | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format Questionnaire Test Code
(IPAQ04TC) | text
Extensible: No | C141665 | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format Questionnaire Test Code | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format test code. | CDISC Questionnaire IPAQ Short Last 7 Days Self-administered Format Version Test Code Terminology |
IPA0401 | C141708 | IPA04-Days Vigorous Physical Activities | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling?: days per week. | IPAQ Short Last 7 Days Self-administered Format Version - Days Vigorous Physical Activities | ||
IPA0402 | C141710 | IPA04-Vigorous Physical Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend doing vigorous physical activities on one of those days?: hours and minutes per day. | IPAQ Short Last 7 Days Self-administered Format Version - Vigorous Physical Hr and Min per Day | ||
IPA0403 | C141713 | IPA04-Days Moderate Physical Activities | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis?: days per week. | IPAQ Short Last 7 Days Self-administered Format Version - Days Moderate Physical Activities | ||
IPA0404 | C141715 | IPA04-Moderate Physical Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend doing moderate physical activities on one of those days?: hours and minutes per day. | IPAQ Short Last 7 Days Self-administered Format Version - Moderate Physical Hr and Min per Day | ||
IPA0405 | C141718 | IPA04-Days Walk at Least 10 Minutes | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time?: days per week. | IPAQ Short Last 7 Days Self-administered Format Version - Days Walk at Least 10 Minutes | ||
IPA0406 | C141720 | IPA04-Walking Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend walking on one of those days?: hours and minutes per day. | IPAQ Short Last 7 Days Self-administered Format Version - Walking Hr and Min per Day | ||
IPA0407 | C141723 | IPA04-Sitting Weekday Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, how much time did you spend sitting on a weekday?: hours and minutes per day. | IPAQ Short Last 7 Days Self-administered Format Version - Sitting Weekday Hr and Min per Day | ||
Back to top | ||||||
CL.C141664.IPAQ04TN | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format Questionnaire Test Name
(IPAQ04TN) | text
Extensible: No | C141664 | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format Questionnaire Test Name | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Self-Administered Format test name. | CDISC Questionnaire IPAQ Short Last 7 Days Self-administered Format Version Test Name Terminology |
IPA04-Days Moderate Physical Activities | C141713 | IPA04-Days Moderate Physical Activities | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis?: days per week. | IPAQ Short Last 7 Days Self-administered Format Version - Days Moderate Physical Activities | ||
IPA04-Days Vigorous Physical Activities | C141708 | IPA04-Days Vigorous Physical Activities | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling?: days per week. | IPAQ Short Last 7 Days Self-administered Format Version - Days Vigorous Physical Activities | ||
IPA04-Days Walk at Least 10 Minutes | C141718 | IPA04-Days Walk at Least 10 Minutes | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time?: days per week. | IPAQ Short Last 7 Days Self-administered Format Version - Days Walk at Least 10 Minutes | ||
IPA04-Moderate Physical Hr & Min per Day | C141715 | IPA04-Moderate Physical Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend doing moderate physical activities on one of those days?: hours and minutes per day. | IPAQ Short Last 7 Days Self-administered Format Version - Moderate Physical Hr and Min per Day | ||
IPA04-Sitting Weekday Hr & Min per Day | C141723 | IPA04-Sitting Weekday Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - During the last 7 days, how much time did you spend sitting on a weekday?: hours and minutes per day. | IPAQ Short Last 7 Days Self-administered Format Version - Sitting Weekday Hr and Min per Day | ||
IPA04-Vigorous Physical Hr & Min per Day | C141710 | IPA04-Vigorous Physical Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend doing vigorous physical activities on one of those days?: hours and minutes per day. | IPAQ Short Last 7 Days Self-administered Format Version - Vigorous Physical Hr and Min per Day | ||
IPA04-Walking Hr & Min per Day | C141720 | IPA04-Walking Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Self-Administered Format - How much time did you usually spend walking on one of those days?: hours and minutes per day. | IPAQ Short Last 7 Days Self-administered Format Version - Walking Hr and Min per Day | ||
Back to top | ||||||
CL.C141671.IPAQ01TC | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format Questionnaire Test Code
(IPAQ01TC) | text
Extensible: No | C141671 | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format Questionnaire Test Code | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format test code. | CDISC Questionnaire IPAQ Short Last 7 Days Telephone Format Version Test Code Terminology |
IPA0101 | C141848 | IPA01-Days Vigorous Physical Activities | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities? | IPAQ Short Last 7 Days Telephone Format Version - Days Vigorous Physical Activities | ||
IPA0102A | C141849 | IPA01-Vigorous Physical Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend doing vigorous physical activities on one of those days?: Hours and minutes per day. | IPAQ Short Last 7 Days Telephone Format Version - Vigorous Physical Hr and Min per Day | ||
IPA0102B | C141851 | IPA01-Total Vigorous Hr & Min per Week | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time in total would you spend over the last 7 days doing vigorous physical activities?: Hours and minutes per week. | IPAQ Short Last 7 Days Telephone Format Version - Total Vigorous Hr and Min per Week | ||
IPA0103 | C141853 | IPA01-Days Moderate Physical Activities | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities? | IPAQ Short Last 7 Days Telephone Format Version - Days Moderate Physical Activities | ||
IPA0104A | C141854 | IPA01-Moderate Physical Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend doing moderate physical activities on one of those days?: Hours and minutes per day. | IPAQ Short Last 7 Days Telephone Format Version - Moderate Physical Hr and Min per Day | ||
IPA0104B | C141856 | IPA01-Total Moderate Hr & Min per Week | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities?: Hours and minutes per week. | IPAQ Short Last 7 Days Telephone Format Version - Total Moderate Hr and Min per Week | ||
IPA0105 | C141858 | IPA01-Days Walk at Least 10 Minutes | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time? | IPAQ Short Last 7 Days Telephone Format Version - Days Walk at Least 10 Minutes | ||
IPA0106A | C141859 | IPA01-Walking Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend walking on one of those days?: Hours and minutes per day. | IPAQ Short Last 7 Days Telephone Format Version - Walking Hr and Min per Day | ||
IPA0106B | C141861 | IPA01-Total Walking Hr & Min per Week | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent walking over the last 7 days?: Hours and minutes per week. | IPAQ Short Last 7 Days Telephone Format Version - Total Walking Hr and Min per Week | ||
IPA0107A | C141863 | IPA01-Sitting Hr & Min per Weekday | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: Hours and minutes per weekday. | IPAQ Short Last 7 Days Telephone Format Version - Sitting Hr and Min per Weekday | ||
IPA0107B | C141865 | IPA01-Total Sitting Hr & Min Wednesday | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent sitting last Wednesday?: Hours and minutes on Wednesday. | IPAQ Short Last 7 Days Telephone Format Version - Total Sitting Hr and Min Wednesday | ||
Back to top | ||||||
CL.C141670.IPAQ01TN | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format Questionnaire Test Name
(IPAQ01TN) | text
Extensible: No | C141670 | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format Questionnaire Test Name | International Physical Activity Questionnaire (August 2002) Short Last 7 Days Telephone Format test name. | CDISC Questionnaire IPAQ Short Last 7 Days Telephone Format Version Test Name Terminology |
IPA01-Days Moderate Physical Activities | C141853 | IPA01-Days Moderate Physical Activities | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities? | IPAQ Short Last 7 Days Telephone Format Version - Days Moderate Physical Activities | ||
IPA01-Days Vigorous Physical Activities | C141848 | IPA01-Days Vigorous Physical Activities | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities? | IPAQ Short Last 7 Days Telephone Format Version - Days Vigorous Physical Activities | ||
IPA01-Days Walk at Least 10 Minutes | C141858 | IPA01-Days Walk at Least 10 Minutes | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time? | IPAQ Short Last 7 Days Telephone Format Version - Days Walk at Least 10 Minutes | ||
IPA01-Moderate Physical Hr & Min per Day | C141854 | IPA01-Moderate Physical Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend doing moderate physical activities on one of those days?: Hours and minutes per day. | IPAQ Short Last 7 Days Telephone Format Version - Moderate Physical Hr and Min per Day | ||
IPA01-Sitting Hr & Min per Weekday | C141863 | IPA01-Sitting Hr & Min per Weekday | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: Hours and minutes per weekday. | IPAQ Short Last 7 Days Telephone Format Version - Sitting Hr and Min per Weekday | ||
IPA01-Total Moderate Hr & Min per Week | C141856 | IPA01-Total Moderate Hr & Min per Week | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities?: Hours and minutes per week. | IPAQ Short Last 7 Days Telephone Format Version - Total Moderate Hr and Min per Week | ||
IPA01-Total Sitting Hr & Min Wednesday | C141865 | IPA01-Total Sitting Hr & Min Wednesday | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent sitting last Wednesday?: Hours and minutes on Wednesday. | IPAQ Short Last 7 Days Telephone Format Version - Total Sitting Hr and Min Wednesday | ||
IPA01-Total Vigorous Hr & Min per Week | C141851 | IPA01-Total Vigorous Hr & Min per Week | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time in total would you spend over the last 7 days doing vigorous physical activities?: Hours and minutes per week. | IPAQ Short Last 7 Days Telephone Format Version - Total Vigorous Hr and Min per Week | ||
IPA01-Total Walking Hr & Min per Week | C141861 | IPA01-Total Walking Hr & Min per Week | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - What is the total amount of time you spent walking over the last 7 days?: Hours and minutes per week. | IPAQ Short Last 7 Days Telephone Format Version - Total Walking Hr and Min per Week | ||
IPA01-Vigorous Physical Hr & Min per Day | C141849 | IPA01-Vigorous Physical Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend doing vigorous physical activities on one of those days?: Hours and minutes per day. | IPAQ Short Last 7 Days Telephone Format Version - Vigorous Physical Hr and Min per Day | ||
IPA01-Walking Hr & Min per Day | C141859 | IPA01-Walking Hr & Min per Day | International Physical Activity Questionnaire (August 2002) - Short Last 7 Days Telephone Format - How much time did you usually spend walking on one of those days?: Hours and minutes per day. | IPAQ Short Last 7 Days Telephone Format Version - Walking Hr and Min per Day | ||
Back to top | ||||||
CL.C141669.IPAQ02TC | International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format Questionnaire Test Code
(IPAQ02TC) | text
Extensible: No | C141669 | International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format Questionnaire Test Code | International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format test code. | CDISC Questionnaire IPAQ Long Last 7 Days Telephone Format Version Test Code Terminology |
IPA0201 | C141779 | IPA02-Currently Have Job or Unpaid Work | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - Do you currently have a job or do any unpaid work outside your home? | IPAQ Long Last 7 Days Telephone Format Version - Currently Have Job or Unpaid Work | ||
IPA0202 | C141780 | IPA02-Days Vigorous as Part of Work | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities as part of your work? | IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous as Part of Work | ||
IPA0203A | C141781 | IPA02-Vigorous Work Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities as part of your work?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Hr and Min per Day | ||
IPA0203B | C141783 | IPA02-Vigorous Work Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities as part of your work?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Hr and Min per Week | ||
IPA0204 | C141785 | IPA02-Days Moderate as Part of Work | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities as part of your work? | IPAQ Long Last 7 Days Telephone Format Version - Days Moderate as Part of Work | ||
IPA0205A | C141786 | IPA02-Moderate Work Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities as part of your work?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Hr and Min per Day | ||
IPA0205B | C141788 | IPA02-Moderate Work Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities as part of your work?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Hr and Min per Week | ||
IPA0206 | C141790 | IPA02-Days Walk as Part of Your Work | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk as part of your work? | IPAQ Long Last 7 Days Telephone Format Version - Days Walk as Part of Your Work | ||
IPA0207A | C141791 | IPA02-Walking Work Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking as part of your work?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Walking Work Hr and Min per Day | ||
IPA0207B | C141793 | IPA02-Walking Work Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent walking over the last 7 days as part of your work?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Walking Work Hr and Min per Week | ||
IPA0208 | C141795 | IPA02-Days Travel in a Motor Vehicle | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, car or tram? | IPAQ Long Last 7 Days Telephone Format Version - Days Travel in a Motor Vehicle | ||
IPA0209A | C141796 | IPA02-Traveling Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days traveling in a car, bus, train or other kind of motor vehicle?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Traveling Hr and Min per Day | ||
IPA0209B | C141798 | IPA02-Traveling Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days traveling in a motor vehicle?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Traveling Hr and Min per Week | ||
IPA0210 | C141800 | IPA02-Days Bicycle Place to Place | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you bicycle to go from place to place? | IPAQ Long Last 7 Days Telephone Format Version - Days Bicycle Place to Place | ||
IPA0211A | C141801 | IPA02-Bicycle Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days to bicycle from place to place?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Bicycle Hr and Min per Day | ||
IPA0211B | C141803 | IPA02-Bicycling Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent bicycling over the last 7 days to travel from place to place?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Bicycling Hr and Min per Week | ||
IPA0212 | C141805 | IPA02-Days Walk Place to Place | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk to go from place to place? | IPAQ Long Last 7 Days Telephone Format Version - Days Walk Place to Place | ||
IPA0213A | C141806 | IPA02-Walking Place Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking from place to place?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Walking Place Hr and Min per Day | ||
IPA0213B | C141808 | IPA02-Walking Place Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days walking from place to place?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Walking Place Hr and Min per Week | ||
IPA0214 | C141810 | IPA02-Days Vigorous in the Garden/Yard | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities in the garden or yard? | IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in the Garden/Yard | ||
IPA0215A | C141811 | IPA02-Vigorous Garden Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities in the garden or yard?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Hr and Min per Day | ||
IPA0215B | C141813 | IPA02-Vigorous Garden Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities in the garden or yard?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Hr and Min per Week | ||
IPA0216 | C141815 | IPA02-Days Moderate in the Garden/Yard | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate activities in the garden or yard? | IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in the Garden/Yard | ||
IPA0217A | C141816 | IPA02-Moderate Garden Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities in the garden or yard?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Hr and Min per Day | ||
IPA0217B | C141818 | IPA02-Moderate Garden Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities in the garden or yard?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Hr and Min per Week | ||
IPA0218 | C141820 | IPA02-Days Moderate Inside Your Home | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate activities inside your home? | IPAQ Long Last 7 Days Telephone Format Version - Days Moderate Inside Your Home | ||
IPA0219A | C141821 | IPA02-Moderate Home Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities inside your home?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Hr and Min per Day | ||
IPA0219B | C141823 | IPA02-Moderate Home Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities inside your home?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Hr and Min per Week | ||
IPA0220 | C141825 | IPA02-Days Walk in Your Leisure Time | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - Not counting any walking you have already mentioned, during the last 7 days, on how many days did you walk for at least 10 minutes at a time in your leisure time? | IPAQ Long Last 7 Days Telephone Format Version - Days Walk in Your Leisure Time | ||
IPA0221A | C141826 | IPA02-Walking Leisure Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking in your leisure time?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Hr and Min per Day | ||
IPA0221B | C141828 | IPA02-Walking Leisure Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days walking in your leisure time?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Hr and Min per Week | ||
IPA0222 | C141830 | IPA02-Days Vigorous in Your Leisure Time | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities in your leisure time? | IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in Your Leisure Time | ||
IPA0223A | C141831 | IPA02-Vigorous Leisure Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities in your leisure time?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Hr and Min per Day | ||
IPA0223B | C141833 | IPA02-Vigorous Leisure Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities in your leisure time?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Hr and Min per Week | ||
IPA0224 | C141835 | IPA02-Days Moderate in Your Leisure Time | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities in your leisure time? | IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in Your Leisure Time | ||
IPA0225A | C141836 | IPA02-Moderate Leisure Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities in your leisure time?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Hr and Min per Day | ||
IPA0225B | C141838 | IPA02-Moderate Leisure Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities in your leisure time?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Hr and Min per Week | ||
IPA0226A | C141840 | IPA02-Sitting Weekday Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekday Hr and Min per Day | ||
IPA0226B | C141842 | IPA02-Sitting Hr & Min on Wednesday | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time in total did you spend sitting on Wednesday?: Hours and minutes on Wednesday. | IPAQ Long Last 7 Days Telephone Format Version - Sitting Hr and Min on Wednesday | ||
IPA0227A | C141844 | IPA02-Sitting Weekend Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekend day?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekend Hr and Min per Day | ||
IPA0227B | C141846 | IPA02-Sitting Hr & Min on Saturday | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time in total did you spend sitting on Saturday?: Hours and minutes on Saturday. | IPAQ Long Last 7 Days Telephone Format Version - Sitting Hr and Min on Saturday | ||
Back to top | ||||||
CL.C141668.IPAQ02TN | International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format Questionnaire Test Name
(IPAQ02TN) | text
Extensible: No | C141668 | International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format Questionnaire Test Name | International Physical Activity Questionnaire (November 2002) Long Last 7 Days Telephone Format test name. | CDISC Questionnaire IPAQ Long Last 7 Days Telephone Format Version Test Name Terminology |
IPA02-Bicycle Hr & Min per Day | C141801 | IPA02-Bicycle Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days to bicycle from place to place?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Bicycle Hr and Min per Day | ||
IPA02-Bicycling Hr & Min per Week | C141803 | IPA02-Bicycling Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent bicycling over the last 7 days to travel from place to place?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Bicycling Hr and Min per Week | ||
IPA02-Currently Have Job or Unpaid Work | C141779 | IPA02-Currently Have Job or Unpaid Work | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - Do you currently have a job or do any unpaid work outside your home? | IPAQ Long Last 7 Days Telephone Format Version - Currently Have Job or Unpaid Work | ||
IPA02-Days Bicycle Place to Place | C141800 | IPA02-Days Bicycle Place to Place | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you bicycle to go from place to place? | IPAQ Long Last 7 Days Telephone Format Version - Days Bicycle Place to Place | ||
IPA02-Days Moderate as Part of Work | C141785 | IPA02-Days Moderate as Part of Work | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities as part of your work? | IPAQ Long Last 7 Days Telephone Format Version - Days Moderate as Part of Work | ||
IPA02-Days Moderate in the Garden/Yard | C141815 | IPA02-Days Moderate in the Garden/Yard | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate activities in the garden or yard? | IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in the Garden/Yard | ||
IPA02-Days Moderate in Your Leisure Time | C141835 | IPA02-Days Moderate in Your Leisure Time | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate physical activities in your leisure time? | IPAQ Long Last 7 Days Telephone Format Version - Days Moderate in Your Leisure Time | ||
IPA02-Days Moderate Inside Your Home | C141820 | IPA02-Days Moderate Inside Your Home | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do moderate activities inside your home? | IPAQ Long Last 7 Days Telephone Format Version - Days Moderate Inside Your Home | ||
IPA02-Days Travel in a Motor Vehicle | C141795 | IPA02-Days Travel in a Motor Vehicle | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, car or tram? | IPAQ Long Last 7 Days Telephone Format Version - Days Travel in a Motor Vehicle | ||
IPA02-Days Vigorous as Part of Work | C141780 | IPA02-Days Vigorous as Part of Work | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities as part of your work? | IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous as Part of Work | ||
IPA02-Days Vigorous in the Garden/Yard | C141810 | IPA02-Days Vigorous in the Garden/Yard | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities in the garden or yard? | IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in the Garden/Yard | ||
IPA02-Days Vigorous in Your Leisure Time | C141830 | IPA02-Days Vigorous in Your Leisure Time | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you do vigorous physical activities in your leisure time? | IPAQ Long Last 7 Days Telephone Format Version - Days Vigorous in Your Leisure Time | ||
IPA02-Days Walk as Part of Your Work | C141790 | IPA02-Days Walk as Part of Your Work | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk as part of your work? | IPAQ Long Last 7 Days Telephone Format Version - Days Walk as Part of Your Work | ||
IPA02-Days Walk in Your Leisure Time | C141825 | IPA02-Days Walk in Your Leisure Time | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - Not counting any walking you have already mentioned, during the last 7 days, on how many days did you walk for at least 10 minutes at a time in your leisure time? | IPAQ Long Last 7 Days Telephone Format Version - Days Walk in Your Leisure Time | ||
IPA02-Days Walk Place to Place | C141805 | IPA02-Days Walk Place to Place | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, on how many days did you walk to go from place to place? | IPAQ Long Last 7 Days Telephone Format Version - Days Walk Place to Place | ||
IPA02-Moderate Garden Hr & Min per Day | C141816 | IPA02-Moderate Garden Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities in the garden or yard?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Hr and Min per Day | ||
IPA02-Moderate Garden Hr & Min per Week | C141818 | IPA02-Moderate Garden Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities in the garden or yard?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Garden Hr and Min per Week | ||
IPA02-Moderate Home Hr & Min per Day | C141821 | IPA02-Moderate Home Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities inside your home?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Hr and Min per Day | ||
IPA02-Moderate Home Hr & Min per Week | C141823 | IPA02-Moderate Home Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities inside your home?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Home Hr and Min per Week | ||
IPA02-Moderate Leisure Hr & Min per Day | C141836 | IPA02-Moderate Leisure Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities in your leisure time?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Hr and Min per Day | ||
IPA02-Moderate Leisure Hr & Min per Week | C141838 | IPA02-Moderate Leisure Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities in your leisure time?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Leisure Hr and Min per Week | ||
IPA02-Moderate Work Hr & Min per Day | C141786 | IPA02-Moderate Work Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing moderate physical activities as part of your work?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Hr and Min per Day | ||
IPA02-Moderate Work Hr & Min per Week | C141788 | IPA02-Moderate Work Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing moderate physical activities as part of your work?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Moderate Work Hr and Min per Week | ||
IPA02-Sitting Hr & Min on Saturday | C141846 | IPA02-Sitting Hr & Min on Saturday | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time in total did you spend sitting on Saturday?: Hours and minutes on Saturday. | IPAQ Long Last 7 Days Telephone Format Version - Sitting Hr and Min on Saturday | ||
IPA02-Sitting Hr & Min on Wednesday | C141842 | IPA02-Sitting Hr & Min on Wednesday | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time in total did you spend sitting on Wednesday?: Hours and minutes on Wednesday. | IPAQ Long Last 7 Days Telephone Format Version - Sitting Hr and Min on Wednesday | ||
IPA02-Sitting Weekday Hr & Min per Day | C141840 | IPA02-Sitting Weekday Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekday Hr and Min per Day | ||
IPA02-Sitting Weekend Hr & Min per Day | C141844 | IPA02-Sitting Weekend Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - During the last 7 days, how much time did you usually spend sitting on a weekend day?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Sitting Weekend Hr and Min per Day | ||
IPA02-Traveling Hr & Min per Day | C141796 | IPA02-Traveling Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days traveling in a car, bus, train or other kind of motor vehicle?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Traveling Hr and Min per Day | ||
IPA02-Traveling Hr & Min per Week | C141798 | IPA02-Traveling Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days traveling in a motor vehicle?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Traveling Hr and Min per Week | ||
IPA02-Vigorous Garden Hr & Min per Day | C141811 | IPA02-Vigorous Garden Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities in the garden or yard?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Hr and Min per Day | ||
IPA02-Vigorous Garden Hr & Min per Week | C141813 | IPA02-Vigorous Garden Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities in the garden or yard?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Garden Hr and Min per Week | ||
IPA02-Vigorous Leisure Hr & Min per Day | C141831 | IPA02-Vigorous Leisure Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities in your leisure time?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Hr and Min per Day | ||
IPA02-Vigorous Leisure Hr & Min per Week | C141833 | IPA02-Vigorous Leisure Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities in your leisure time?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Leisure Hr and Min per Week | ||
IPA02-Vigorous Work Hr & Min per Day | C141781 | IPA02-Vigorous Work Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days doing vigorous physical activities as part of your work?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Hr and Min per Day | ||
IPA02-Vigorous Work Hr & Min per Week | C141783 | IPA02-Vigorous Work Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days doing vigorous physical activities as part of your work?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Vigorous Work Hr and Min per Week | ||
IPA02-Walking Leisure Hr & Min per Day | C141826 | IPA02-Walking Leisure Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking in your leisure time?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Hr and Min per Day | ||
IPA02-Walking Leisure Hr & Min per Week | C141828 | IPA02-Walking Leisure Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days walking in your leisure time?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Walking Leisure Hr and Min per Week | ||
IPA02-Walking Place Hr & Min per Day | C141806 | IPA02-Walking Place Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking from place to place?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Walking Place Hr and Min per Day | ||
IPA02-Walking Place Hr & Min per Week | C141808 | IPA02-Walking Place Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent over the last 7 days walking from place to place?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Walking Place Hr and Min per Week | ||
IPA02-Walking Work Hr & Min per Day | C141791 | IPA02-Walking Work Hr & Min per Day | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - How much time did you usually spend on one of those days walking as part of your work?: Hours and minutes per day. | IPAQ Long Last 7 Days Telephone Format Version - Walking Work Hr and Min per Day | ||
IPA02-Walking Work Hr & Min per Week | C141793 | IPA02-Walking Work Hr & Min per Week | International Physical Activity Questionnaire (November 2002) - Long Last 7 Days Telephone Format - What is the total amount of time you spent walking over the last 7 days as part of your work?: Hours and minutes per week. | IPAQ Long Last 7 Days Telephone Format Version - Walking Work Hr and Min per Week | ||
Back to top | ||||||
CL.C141667.IPAQ03TC | International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format Questionnaire Test Code
(IPAQ03TC) | text
Extensible: No | C141667 | International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format Questionnaire Test Code | International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format test code. | CDISC Questionnaire IPAQ Long Last 7 Days Self-Administered Format Version Test Code Terminology |
IPA0301 | C141726 | IPA03-Currently Have Job or Unpaid Work | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - Do you currently have a job or do any unpaid work outside your home? | IPAQ Long Last 7 Days Self-Administered Format Version - Currently Have Job or Unpaid Work | ||
IPA0302 | C141727 | IPA03-Days Vigorous as Part of Work | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous as Part of Work | ||
IPA0303 | C141729 | IPA03-Vigorous Work Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities as part of your work?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Work Hr and Min per Day | ||
IPA0304 | C141731 | IPA03-Days Moderate as Part of Work | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like carrying light loads as part of your work?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate as Part of Work | ||
IPA0305 | C141733 | IPA03-Moderate Work Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities as part of your work?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Work Hr and Min per Day | ||
IPA0306 | C141735 | IPA03-Days Walk as Part of Your Work | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time as part of your work?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk as Part of Your Work | ||
IPA0307 | C141737 | IPA03-Walking Work Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking as part of your work?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Walking Work Hr and Min per Day | ||
IPA0308 | C141739 | IPA03-Days Travel in a Motor Vehicle | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, car or tram?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Travel in a Motor Vehicle | ||
IPA0309 | C141741 | IPA03-Traveling Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days traveling in a train, bus, car, tram, or other kind of motor vehicle?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Traveling Hr and Min per Day | ||
IPA0310 | C141743 | IPA03-Days Bicycle Place to Place | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you bicycle for at least 10 minutes at a time to go from place to place?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Bicycle Place to Place | ||
IPA0311 | C141745 | IPA03-Bicycle Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days to bicycle from place to place?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Bicycle Hr and Min per Day | ||
IPA0312 | C141747 | IPA03-Days Walk Place to Place | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time to go from place to place?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk Place to Place | ||
IPA0313 | C141749 | IPA03-Walking Place Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking from place to place?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Walking Place Hr and Min per Day | ||
IPA0314 | C141751 | IPA03-Days Vigorous in the Garden/Yard | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in the Garden/Yard | ||
IPA0315 | C141753 | IPA03-Vigorous Garden Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities in the garden or yard?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Garden Hr and Min per Day | ||
IPA0316 | C141755 | IPA03-Days Moderate in the Garden/Yard | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in the Garden/Yard | ||
IPA0317 | C141757 | IPA03-Moderate Garden Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities in the garden or yard?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Garden Hr and Min per Day | ||
IPA0318 | C141759 | IPA03-Days Moderate Inside Home | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate Inside Home | ||
IPA0319 | C141761 | IPA03-Moderate Home Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities inside your home?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Home Hr and Min per Day | ||
IPA0320 | C141763 | IPA03-Days Walk in Leisure Time | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time in your leisure time?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk in Leisure Time | ||
IPA0321 | C141765 | IPA03-Walking Leisure Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking in your leisure time?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Walking Leisure Hr and Min per Day | ||
IPA0322 | C141767 | IPA03-Days Vigorous in Leisure Time | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in Leisure Time | ||
IPA0323 | C141769 | IPA03-Vigorous Leisure Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities in your leisure time?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Leisure Hr and Min per Day | ||
IPA0324 | C141771 | IPA03-Days Moderate in Leisure Time | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in Leisure Time | ||
IPA0325 | C141773 | IPA03-Moderate Leisure Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities in your leisure time?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Leisure Hr and Min per Day | ||
IPA0326 | C141775 | IPA03-Sitting Weekday Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekday Hr and Min per Day | ||
IPA0327 | C141777 | IPA03-Sitting Weekend Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, how much time did you usually spend sitting on a weekend day?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekend Hr and Min per Day | ||
Back to top | ||||||
CL.C141666.IPAQ03TN | International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format Questionnaire Test Name
(IPAQ03TN) | text
Extensible: No | C141666 | International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format Questionnaire Test Name | International Physical Activity Questionnaire (October 2002) Long Last 7 Days Self-Administered Format test name. | CDISC Questionnaire IPAQ Long Last 7 Days Self-Administered Format Version Test Name Terminology |
IPA03-Bicycle Hr & Min per Day | C141745 | IPA03-Bicycle Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days to bicycle from place to place?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Bicycle Hr and Min per Day | ||
IPA03-Currently Have Job or Unpaid Work | C141726 | IPA03-Currently Have Job or Unpaid Work | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - Do you currently have a job or do any unpaid work outside your home? | IPAQ Long Last 7 Days Self-Administered Format Version - Currently Have Job or Unpaid Work | ||
IPA03-Days Bicycle Place to Place | C141743 | IPA03-Days Bicycle Place to Place | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you bicycle for at least 10 minutes at a time to go from place to place?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Bicycle Place to Place | ||
IPA03-Days Moderate as Part of Work | C141731 | IPA03-Days Moderate as Part of Work | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like carrying light loads as part of your work?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate as Part of Work | ||
IPA03-Days Moderate in Leisure Time | C141771 | IPA03-Days Moderate in Leisure Time | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in Leisure Time | ||
IPA03-Days Moderate in the Garden/Yard | C141755 | IPA03-Days Moderate in the Garden/Yard | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate in the Garden/Yard | ||
IPA03-Days Moderate Inside Home | C141759 | IPA03-Days Moderate Inside Home | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Moderate Inside Home | ||
IPA03-Days Travel in a Motor Vehicle | C141739 | IPA03-Days Travel in a Motor Vehicle | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, car or tram?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Travel in a Motor Vehicle | ||
IPA03-Days Vigorous as Part of Work | C141727 | IPA03-Days Vigorous as Part of Work | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous as Part of Work | ||
IPA03-Days Vigorous in Leisure Time | C141767 | IPA03-Days Vigorous in Leisure Time | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in Leisure Time | ||
IPA03-Days Vigorous in the Garden/Yard | C141751 | IPA03-Days Vigorous in the Garden/Yard | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Vigorous in the Garden/Yard | ||
IPA03-Days Walk as Part of Your Work | C141735 | IPA03-Days Walk as Part of Your Work | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time as part of your work?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk as Part of Your Work | ||
IPA03-Days Walk in Leisure Time | C141763 | IPA03-Days Walk in Leisure Time | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time in your leisure time?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk in Leisure Time | ||
IPA03-Days Walk Place to Place | C141747 | IPA03-Days Walk Place to Place | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, on how many days did you walk for at least 10 minutes at a time to go from place to place?: days per week. | IPAQ Long Last 7 Days Self-Administered Format Version - Days Walk Place to Place | ||
IPA03-Moderate Garden Hr & Min per Day | C141757 | IPA03-Moderate Garden Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities in the garden or yard?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Garden Hr and Min per Day | ||
IPA03-Moderate Home Hr & Min per Day | C141761 | IPA03-Moderate Home Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities inside your home?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Home Hr and Min per Day | ||
IPA03-Moderate Leisure Hr & Min per Day | C141773 | IPA03-Moderate Leisure Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities in your leisure time?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Leisure Hr and Min per Day | ||
IPA03-Moderate Work Hr & Min per Day | C141733 | IPA03-Moderate Work Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing moderate physical activities as part of your work?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Moderate Work Hr and Min per Day | ||
IPA03-Sitting Weekday Hr & Min per Day | C141775 | IPA03-Sitting Weekday Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, how much time did you usually spend sitting on a weekday?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekday Hr and Min per Day | ||
IPA03-Sitting Weekend Hr & Min per Day | C141777 | IPA03-Sitting Weekend Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - During the last 7 days, how much time did you usually spend sitting on a weekend day?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Sitting Weekend Hr and Min per Day | ||
IPA03-Traveling Hr & Min per Day | C141741 | IPA03-Traveling Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days traveling in a train, bus, car, tram, or other kind of motor vehicle?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Traveling Hr and Min per Day | ||
IPA03-Vigorous Garden Hr & Min per Day | C141753 | IPA03-Vigorous Garden Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities in the garden or yard?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Garden Hr and Min per Day | ||
IPA03-Vigorous Leisure Hr & Min per Day | C141769 | IPA03-Vigorous Leisure Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities in your leisure time?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Leisure Hr and Min per Day | ||
IPA03-Vigorous Work Hr & Min per Day | C141729 | IPA03-Vigorous Work Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days doing vigorous physical activities as part of your work?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Vigorous Work Hr and Min per Day | ||
IPA03-Walking Leisure Hr & Min per Day | C141765 | IPA03-Walking Leisure Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking in your leisure time?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Walking Leisure Hr and Min per Day | ||
IPA03-Walking Place Hr & Min per Day | C141749 | IPA03-Walking Place Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking from place to place?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Walking Place Hr and Min per Day | ||
IPA03-Walking Work Hr & Min per Day | C141737 | IPA03-Walking Work Hr & Min per Day | International Physical Activity Questionnaire (October 2002) - Long Last 7 Days Self-Administered Format - How much time did you usually spend on one of those days walking as part of your work?: hours and minutes per day. | IPAQ Long Last 7 Days Self-Administered Format Version - Walking Work Hr and Min per Day | ||
Back to top | ||||||
CL.C182461.IPS0101T06OR | International Prostate Symptom Score Questionnaire ORRES for IPS0101 Through IPS0106 TN/TC
(IPS0101T06OR) | text
Extensible: No | C182461 | International Prostate Symptom Score Questionnaire ORRES for IPS0101 Through IPS0106 TN/TC | International Prostate Symptom Score original result for IPS0101 through IPS0106 test and test code. | CDISC Questionnaire International Prostate Symptom Score IPS0101 Through IPS0106 Original Response Terminology |
About Half the Time | C182637 | IPS0101 through IPS0106-About Half the Time | International Prostate Symptom Score original result for IPS0101 through IPS0106-About half the time. | International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - About Half the Time | ||
Almost Always | C182639 | IPS0101 through IPS0106-Almost Always | International Prostate Symptom Score original result for IPS0101 through IPS0106-Almost always. | International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - Almost Always | ||
Less Than 1 Time in 5 | C182635 | IPS0101 through IPS0106-Less Than 1 Time in 5 | International Prostate Symptom Score original result for IPS0101 through IPS0106-Less than 1 time in 5. | International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - Less Than 1 Time in 5 | ||
Less Than Half the Time | C182636 | IPS0101 through IPS0106-Less Than Half the Time | International Prostate Symptom Score original result for IPS0101 through IPS0106-Less than half the time. | International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - Less Than Half the Time | ||
More Than Half the Time | C182638 | IPS0101 through IPS0106-More Than Half the Time | International Prostate Symptom Score original result for IPS0101 through IPS0106-More than half the time. | International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - More Than Half the Time | ||
Not at All | C182634 | IPS0101 through IPS0106-Not at All | International Prostate Symptom Score original result for IPS0101 through IPS0106-Not at all. | International Prostate Symptom Score IPS0101 Through IPS0106 Original Result - Not at All | ||
Back to top | ||||||
CL.C182462.IPS0107OR | International Prostate Symptom Score Questionnaire ORRES for IPS0107 TN/TC
(IPS0107OR) | text
Extensible: No | C182462 | International Prostate Symptom Score Questionnaire ORRES for IPS0107 TN/TC | International Prostate Symptom Score original result for IPS0107 test and test code. | CDISC Questionnaire International Prostate Symptom Score IPS0107 Original Response Terminology |
1 Time | C182647 | IPS0107-1 Time | International Prostate Symptom Score original result for IPS0107-1 time. | International Prostate Symptom Score IPS0107 Original Result - 1 Time | ||
2 Times | C182648 | IPS0107-2 Times | International Prostate Symptom Score original result for IPS0107-2 times. | International Prostate Symptom Score IPS0107 Original Result - 2 Times | ||
3 Times | C182649 | IPS0107-3 Times | International Prostate Symptom Score original result for IPS0107-3 times. | International Prostate Symptom Score IPS0107 Original Result - 3 Times | ||
4 Times | C182650 | IPS0107-4 Times | International Prostate Symptom Score original result for IPS0107-4 times. | International Prostate Symptom Score IPS0107 Original Result - 4 Times | ||
5 or More Times | C182651 | IPS0107-5 or More Times | International Prostate Symptom Score original result for IPS0107-5 or more times. | International Prostate Symptom Score IPS0107 Original Result - 5 or More Times | ||
None | C182646 | IPS0107-None | International Prostate Symptom Score original result for IPS0107-None. | International Prostate Symptom Score IPS0107 Original Result - None | ||
Back to top | ||||||
CL.C182463.IPS0109OR | International Prostate Symptom Score Questionnaire ORRES for IPS0109 TN/TC
(IPS0109OR) | text
Extensible: No | C182463 | International Prostate Symptom Score Questionnaire ORRES for IPS0109 TN/TC | International Prostate Symptom Score original result for IPS0109 test and test code. | CDISC Questionnaire International Prostate Symptom Score IPS0109 Original Response Terminology |
Delighted | C182658 | IPS0109-Delighted | International Prostate Symptom Score original result for IPS0109-Delighted. | International Prostate Symptom Score IPS0109 Original Result - Delighted | ||
Mixed (about equally satisfied and dissatisfied) | C182661 | IPS0109-Mixed (about equally satisfied and dissatisfied) | International Prostate Symptom Score original result for IPS0109-Mixed (about equally satisfied and dissatisfied). | International Prostate Symptom Score IPS0109 Original Result - Mixed (about equally satisfied and dissatisfied) | ||
Mostly dissatisfied | C182662 | IPS0109-Mostly dissatisfied | International Prostate Symptom Score original result for IPS0109-Mostly dissatisfied. | International Prostate Symptom Score IPS0109 Original Result - Mostly dissatisfied | ||
Mostly satisfied | C182660 | IPS0109-Mostly satisfied | International Prostate Symptom Score original result for IPS0109-Mostly satisfied. | International Prostate Symptom Score IPS0109 Original Result - Mostly satisfied | ||
Pleased | C182659 | IPS0109-Pleased | International Prostate Symptom Score original result for IPS0109-Pleased. | International Prostate Symptom Score IPS0109 Original Result - Pleased | ||
Terrible | C182664 | IPS0109-Terrible | International Prostate Symptom Score original result for IPS0109-Terrible. | International Prostate Symptom Score IPS0109 Original Result - Terrible | ||
Unhappy | C182663 | IPS0109-Unhappy | International Prostate Symptom Score original result for IPS0109-Unhappy. | International Prostate Symptom Score IPS0109 Original Result - Unhappy | ||
Back to top | ||||||
CL.C182499.IPS0101T06STR | International Prostate Symptom Score Questionnaire STRESC for IPS0101 Through IPS0106 TN/TC
(IPS0101T06STR) | text
Extensible: No | C182499 | International Prostate Symptom Score Questionnaire STRESC for IPS0101 Through IPS0106 TN/TC | International Prostate Symptom Score standardized character result for IPS0101 Through IPS0106 test and test code. | CDISC Questionnaire International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Response Terminology |
0 | C182640 | IPS0101 through IPS0106-0 | International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-Not at all. | International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 0 | ||
1 | C182641 | IPS0101 through IPS0106-1 | International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-Less than 1 time in 5. | International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 1 | ||
2 | C182642 | IPS0101 through IPS0106-2 | International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-Less than half the time. | International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 2 | ||
3 | C182643 | IPS0101 through IPS0106-3 | International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-About half the time. | International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 3 | ||
4 | C182644 | IPS0101 through IPS0106-4 | International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-More than half the time. | International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 4 | ||
5 | C182645 | IPS0101 through IPS0106-5 | International Prostate Symptom Score standardized character result for IPS0101 through IPS0106-Almost always. | International Prostate Symptom Score IPS0101 Through IPS0106 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C182500.IPS0107STR | International Prostate Symptom Score Questionnaire STRESC for IPS0107 TN/TC
(IPS0107STR) | text
Extensible: No | C182500 | International Prostate Symptom Score Questionnaire STRESC for IPS0107 TN/TC | International Prostate Symptom Score standardized character result for IPS0107 test and test code. | CDISC Questionnaire International Prostate Symptom Score IPS0107 Standardized Character Response Terminology |
0 | C182652 | IPS0107-0 | International Prostate Symptom Score standardized character result for IPS0107-None. | International Prostate Symptom Score IPS0107 Standardized Character Result 0 | ||
1 | C182653 | IPS0107-1 | International Prostate Symptom Score standardized character result for IPS0107-1 time. | International Prostate Symptom Score IPS0107 Standardized Character Result 1 | ||
2 | C182654 | IPS0107-2 | International Prostate Symptom Score standardized character result for IPS0107-2 times. | International Prostate Symptom Score IPS0107 Standardized Character Result 2 | ||
3 | C182655 | IPS0107-3 | International Prostate Symptom Score standardized character result for IPS0107-3 times. | International Prostate Symptom Score IPS0107 Standardized Character Result 3 | ||
4 | C182656 | IPS0107-4 | International Prostate Symptom Score standardized character result for IPS0107-4 times. | International Prostate Symptom Score IPS0107 Standardized Character Result 4 | ||
5 | C182657 | IPS0107-5 | International Prostate Symptom Score standardized character result for IPS0107-5 or more times. | International Prostate Symptom Score IPS0107 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C182501.IPS0109STR | International Prostate Symptom Score Questionnaire STRESC for IPS0109 TN/TC
(IPS0109STR) | text
Extensible: No | C182501 | International Prostate Symptom Score Questionnaire STRESC for IPS0109 TN/TC | International Prostate Symptom Score standardized character result for IPS0109 test and test code. | CDISC Questionnaire International Prostate Symptom Score IPS0109 Standardized Character Response Terminology |
0 | C182665 | IPS0109-0 | International Prostate Symptom Score standardized character result for IPS0109-Delighted. | International Prostate Symptom Score IPS0109 Standardized Character Result 0 | ||
1 | C182666 | IPS0109-1 | International Prostate Symptom Score standardized character result for IPS0109-Pleased. | International Prostate Symptom Score IPS0109 Standardized Character Result 1 | ||
2 | C182667 | IPS0109-2 | International Prostate Symptom Score standardized character result for IPS0109-Mostly satisfied. | International Prostate Symptom Score IPS0109 Standardized Character Result 2 | ||
3 | C182668 | IPS0109-3 | International Prostate Symptom Score standardized character result for IPS0109-Mixed (about equally satisfied and dissatisfied). | International Prostate Symptom Score IPS0109 Standardized Character Result 3 | ||
4 | C182669 | IPS0109-4 | International Prostate Symptom Score standardized character result for IPS0109-Mostly dissatisfied. | International Prostate Symptom Score IPS0109 Standardized Character Result 4 | ||
5 | C182670 | IPS0109-5 | International Prostate Symptom Score standardized character result for IPS0109-Unhappy. | International Prostate Symptom Score IPS0109 Standardized Character Result 5 | ||
6 | C182671 | IPS0109-6 | International Prostate Symptom Score standardized character result for IPS0109-Terrible. | International Prostate Symptom Score IPS0109 Standardized Character Result 6 | ||
Back to top | ||||||
CL.C183547.IPS01TC | International Prostate Symptom Score Questionnaire Test Code
(IPS01TC) | text
Extensible: No | C183547 | International Prostate Symptom Score Questionnaire Test Code | International Prostate Symptom Score test code. | CDISC Questionnaire IPSS Test Code Terminology |
IPS0101 | C183599 | IPS01-Sensation of Not Emptying Bladder | International Prostate Symptom Score - During the last month or so, how often have you had a sensation of not emptying your bladder completely after you finished urinating? | IPSS - Sensation of Not Emptying Bladder | ||
IPS0102 | C183600 | IPS01-Urinate Again Less Than 2 Hours | International Prostate Symptom Score - During the last month or so, how often have you had to urinate again less than 2 hours after you finished urinating? | IPSS - Urinate Again Less Than 2 Hours | ||
IPS0103 | C183601 | IPS01-Stop Start Several Times Urinated | International Prostate Symptom Score - During the last month or so, how often have you found you stopped and started again several times when you urinated? | IPSS - Stop Start Several Times Urinated | ||
IPS0104 | C183602 | IPS01-Difficult to Postpone Urination | International Prostate Symptom Score - During the last month or so, how often have you found it difficult to postpone urination? | IPSS - Difficult to Postpone Urination | ||
IPS0105 | C183603 | IPS01-Had Weak Urinary Stream | International Prostate Symptom Score - During the last month or so, how often have you had a weak urinary stream? | IPSS - Had Weak Urinary Stream | ||
IPS0106 | C183604 | IPS01-Push or Strain to Begin Urination | International Prostate Symptom Score - During the last month or so, how often have you had to push or strain to begin urination? | IPSS - Push or Strain to Begin Urination | ||
IPS0107 | C183605 | IPS01-Times Get Up to Urinate at Night | International Prostate Symptom Score - During the last month, how many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning? | IPSS - Times Get Up to Urinate at Night | ||
IPS0108 | C183606 | IPS01-Total Score | International Prostate Symptom Score - AUA symptom total score. | IPSS - Total Score | ||
IPS0109 | C183607 | IPS01-Life With Symptoms Feel About It | International Prostate Symptom Score - If you were to spend the rest of your life with your prostate symptoms just as they are now, how would you feel about that? | IPSS - Life With Symptoms Feel About It | ||
Back to top | ||||||
CL.C183546.IPS01TN | International Prostate Symptom Score Questionnaire Test Name
(IPS01TN) | text
Extensible: No | C183546 | International Prostate Symptom Score Questionnaire Test Name | International Prostate Symptom Score test name. | CDISC Questionnaire IPSS Test Name Terminology |
IPS01-Difficult to Postpone Urination | C183602 | IPS01-Difficult to Postpone Urination | International Prostate Symptom Score - During the last month or so, how often have you found it difficult to postpone urination? | IPSS - Difficult to Postpone Urination | ||
IPS01-Had Weak Urinary Stream | C183603 | IPS01-Had Weak Urinary Stream | International Prostate Symptom Score - During the last month or so, how often have you had a weak urinary stream? | IPSS - Had Weak Urinary Stream | ||
IPS01-Life With Symptoms Feel About It | C183607 | IPS01-Life With Symptoms Feel About It | International Prostate Symptom Score - If you were to spend the rest of your life with your prostate symptoms just as they are now, how would you feel about that? | IPSS - Life With Symptoms Feel About It | ||
IPS01-Push or Strain to Begin Urination | C183604 | IPS01-Push or Strain to Begin Urination | International Prostate Symptom Score - During the last month or so, how often have you had to push or strain to begin urination? | IPSS - Push or Strain to Begin Urination | ||
IPS01-Sensation of Not Emptying Bladder | C183599 | IPS01-Sensation of Not Emptying Bladder | International Prostate Symptom Score - During the last month or so, how often have you had a sensation of not emptying your bladder completely after you finished urinating? | IPSS - Sensation of Not Emptying Bladder | ||
IPS01-Stop Start Several Times Urinated | C183601 | IPS01-Stop Start Several Times Urinated | International Prostate Symptom Score - During the last month or so, how often have you found you stopped and started again several times when you urinated? | IPSS - Stop Start Several Times Urinated | ||
IPS01-Times Get Up to Urinate at Night | C183605 | IPS01-Times Get Up to Urinate at Night | International Prostate Symptom Score - During the last month, how many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning? | IPSS - Times Get Up to Urinate at Night | ||
IPS01-Total Score | C183606 | IPS01-Total Score | International Prostate Symptom Score - AUA symptom total score. | IPSS - Total Score | ||
IPS01-Urinate Again Less Than 2 Hours | C183600 | IPS01-Urinate Again Less Than 2 Hours | International Prostate Symptom Score - During the last month or so, how often have you had to urinate again less than 2 hours after you finished urinating? | IPSS - Urinate Again Less Than 2 Hours | ||
Back to top | ||||||
CL.C99076.INTMODEL | Intervention Model Response
(INTMODEL) | text
Extensible: Yes | C99076 | Intervention Model Response | A terminology codelist relevant to the trial design developed to compare treatment groups. | CDISC SDTM Intervention Model Terminology |
CROSS-OVER | C82637 | Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study. | Crossover Study | |||
FACTORIAL | C82638 | Two or more interventions, each alone or in combination, are evaluated in parallel against a control group. This study design allows for the comparison of active drug to placebo, presence of drug-drug interactions, and comparison of active drugs against each other. | Factorial Study | |||
PARALLEL | C82639 | Participants are assigned to one of two or more treatment groups in parallel for the duration of the study. | Parallel Study | |||
SEQUENTIAL | C142568 | Groups of participants are assigned to receive interventions based on prior milestones being reached in the study. (clinicaltrials.gov) | Group Sequential Design | |||
SINGLE GROUP | C82640 | All trial participants are assigned to a single treatment group for the duration of the study. | Single Group Study | |||
Back to top | ||||||
CL.C99078.INTTYPE | Intervention Type Response
(INTTYPE) | text
Extensible: No | C99078 | Intervention Type Response | A terminology codelist relevant to the kind of product or procedure studied in a trial. | CDISC SDTM Intervention Type Terminology |
BEHAVIORAL THERAPY | C15184 | A technique used to change the behavior of a subject (e.g., psychotherapy, lifestyle counseling, or hypnosis). | Behavioral Intervention | |||
BIOLOGIC | C307 | A product of biological origin applicable to the prevention, treatment, or cure of a disease or condition, for example: virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product. (FDA 21 CFR 600.3) | Biological Agent | |||
DEVICE | C16830 | Medical Device | Any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination for, one or more specific medical purpose(s). [After REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on medical devices] | Medical Device | ||
DIETARY SUPPLEMENT | C1505 | Preparations containing ingredient(s) intended to supplement the diet. | Dietary Supplement | |||
DRUG | C1909 | An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)). | Pharmacologic Substance | |||
GENETIC | C15238 | Gene Therapy | Introduction of genetic material into cells in order to correct or treat an inherited or acquired disease. | Gene Therapy | ||
OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
PROCEDURE | C98769 | Medical Procedure | Any activity performed by manual and/or instrumental means for the purpose of diagnosis, assessment, therapy, prevention, or palliative care. | Physical Medical Procedure | ||
RADIATION | C15313 | Radiation Therapy;Radiotherapy | Use of targeted or whole body radiation to treat a disease. | Radiation Therapy | ||
Back to top | ||||||
CL.C130247.IDSC1TC | Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Code
(IDSC1TC) | text
Extensible: No | C130247 | Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Code | Inventory of Depressive Symptomatology Clinician-Rated Version test code. | CDISC Clinical Classification IDS-C Test Code Terminology |
IDSC101 | C130360 | IDSC1-Sleep Onset Insomnia | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sleep onset insomnia. | IDS-C - Sleep Onset Insomnia | ||
IDSC102 | C130361 | IDSC1-Mid-Nocturnal Insomnia | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mid-nocturnal insomnia. | IDS-C - Mid-Nocturnal Insomnia | ||
IDSC103 | C130362 | IDSC1-Early Morning Insomnia | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Early morning insomnia. | IDS-C - Early Morning Insomnia | ||
IDSC104 | C130363 | IDSC1-Hypersomnia | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Hypersomnia. | IDS-C - Hypersomnia | ||
IDSC105 | C130364 | IDSC1-Mood (Sad) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (sad). | IDS-C - Mood (Sad) | ||
IDSC106 | C130365 | IDSC1-Mood (Irritable) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (irritable). | IDS-C - Mood (Irritable) | ||
IDSC107 | C130366 | IDSC1-Mood (Anxious) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (anxious). | IDS-C - Mood (Anxious) | ||
IDSC108 | C130367 | IDSC1-Reactivity of Mood | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Reactivity of mood. | IDS-C - Reactivity of Mood | ||
IDSC109 | C130368 | IDSC1-Mood Variation | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood variation. | IDS-C - Mood Variation | ||
IDSC109A | C130369 | IDSC1-Mood Worse Morn/Afternoon/Night | Inventory of Depressive Symptomatology - Clinician-Rated - Is mood typically worse in morning, afternoon, or night. | IDS-C - Mood Worse in Morning, Afternoon, or Night | ||
IDSC109B | C130370 | IDSC1-Mood Attributed to Environment | Inventory of Depressive Symptomatology - Clinician-Rated - Is mood variation attributed to environment by the patient? | IDS-C - Mood Variation Attributed to Environment | ||
IDSC110 | C130371 | IDSC1-Quality of Mood | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Quality of mood. | IDS-C - Quality of Mood | ||
IDSC111 | C130372 | IDSC1-Appetite (Decreased) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (decreased). | IDS-C - Appetite (Decreased) | ||
IDSC112 | C130373 | IDSC1-Appetite (Increased) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (increased). | IDS-C - Appetite (Increased) | ||
IDSC113 | C130374 | IDSC1-Weight (Decrease) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (decrease) within the last two weeks. | IDS-C - Weight (Decrease) | ||
IDSC114 | C130375 | IDSC1-Weight (Increase) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (increase) within the last two weeks. | IDS-C - Weight (Increase) | ||
IDSC115 | C130376 | IDSC1-Concentration/Decision Making | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Concentration/decision making. | IDS-C - Concentration or Decision Making | ||
IDSC116 | C130377 | IDSC1-Outlook (Self) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (self). | IDS-C - Outlook (Self) | ||
IDSC117 | C130378 | IDSC1-Outlook (Future) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (future). | IDS-C - Outlook (Future) | ||
IDSC118 | C130379 | IDSC1-Suicidal Ideation | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Suicidal ideation. | IDS-C - Suicidal Ideation | ||
IDSC119 | C130380 | IDSC1-Involvement | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Involvement. | IDS-C - Involvement | ||
IDSC120 | C130381 | IDSC1-Energy/Fatiguability | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Energy/fatiguability. | IDS-C - Energy or Fatiguability | ||
IDSC121 | C130382 | IDSC1-Pleasure/Enjoyment (Exclude Sex) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Pleasure/enjoyment (exclude sexual activities). | IDS-C - Pleasure or Enjoyment | ||
IDSC122 | C130383 | IDSC1-Sexual Interest | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sexual interest. | IDS-C - Sexual Interest | ||
IDSC123 | C130384 | IDSC1-Psychomotor Slowing | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor slowing. | IDS-C - Psychomotor Slowing | ||
IDSC124 | C130385 | IDSC1-Psychomotor Agitation | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor agitation. | IDS-C - Psychomotor Agitation | ||
IDSC125 | C130386 | IDSC1-Somatic Complaints | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Somatic complaints. | IDS-C - Somatic Complaints | ||
IDSC126 | C130387 | IDSC1-Sympathetic Arousal | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sympathetic arousal. | IDS-C - Sympathetic Arousal | ||
IDSC127 | C130388 | IDSC1-Panic/Phobic Symptoms | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Panic/phobic symptoms. | IDS-C - Panic or Phobic Symptoms | ||
IDSC128 | C130389 | IDSC1-Gastrointestinal | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Gastrointestinal. | IDS-C - Gastrointestinal | ||
IDSC129 | C130390 | IDSC1-Interpersonal Sensitivity | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Interpersonal sensitivity. | IDS-C - Interpersonal Sensitivity | ||
IDSC130 | C130391 | IDSC1-Leaden Paralysis/Physical Energy | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Leaden paralysis/physical energy. | IDS-C - Leaden Paralysis or Physical Energy | ||
IDSC131 | C130392 | IDSC1-Score | Inventory of Depressive Symptomatology - Clinician-Rated - Score. | IDS-C - Score | ||
Back to top | ||||||
CL.C130246.IDSC1TN | Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Name
(IDSC1TN) | text
Extensible: No | C130246 | Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Name | Inventory of Depressive Symptomatology Clinician-Rated Version test name. | CDISC Clinical Classification IDS-C Test Name Terminology |
IDSC1-Appetite (Decreased) | C130372 | IDSC1-Appetite (Decreased) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (decreased). | IDS-C - Appetite (Decreased) | ||
IDSC1-Appetite (Increased) | C130373 | IDSC1-Appetite (Increased) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (increased). | IDS-C - Appetite (Increased) | ||
IDSC1-Concentration/Decision Making | C130376 | IDSC1-Concentration/Decision Making | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Concentration/decision making. | IDS-C - Concentration or Decision Making | ||
IDSC1-Early Morning Insomnia | C130362 | IDSC1-Early Morning Insomnia | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Early morning insomnia. | IDS-C - Early Morning Insomnia | ||
IDSC1-Energy/Fatiguability | C130381 | IDSC1-Energy/Fatiguability | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Energy/fatiguability. | IDS-C - Energy or Fatiguability | ||
IDSC1-Gastrointestinal | C130389 | IDSC1-Gastrointestinal | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Gastrointestinal. | IDS-C - Gastrointestinal | ||
IDSC1-Hypersomnia | C130363 | IDSC1-Hypersomnia | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Hypersomnia. | IDS-C - Hypersomnia | ||
IDSC1-Interpersonal Sensitivity | C130390 | IDSC1-Interpersonal Sensitivity | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Interpersonal sensitivity. | IDS-C - Interpersonal Sensitivity | ||
IDSC1-Involvement | C130380 | IDSC1-Involvement | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Involvement. | IDS-C - Involvement | ||
IDSC1-Leaden Paralysis/Physical Energy | C130391 | IDSC1-Leaden Paralysis/Physical Energy | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Leaden paralysis/physical energy. | IDS-C - Leaden Paralysis or Physical Energy | ||
IDSC1-Mid-Nocturnal Insomnia | C130361 | IDSC1-Mid-Nocturnal Insomnia | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mid-nocturnal insomnia. | IDS-C - Mid-Nocturnal Insomnia | ||
IDSC1-Mood (Anxious) | C130366 | IDSC1-Mood (Anxious) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (anxious). | IDS-C - Mood (Anxious) | ||
IDSC1-Mood (Irritable) | C130365 | IDSC1-Mood (Irritable) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (irritable). | IDS-C - Mood (Irritable) | ||
IDSC1-Mood (Sad) | C130364 | IDSC1-Mood (Sad) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (sad). | IDS-C - Mood (Sad) | ||
IDSC1-Mood Attributed to Environment | C130370 | IDSC1-Mood Attributed to Environment | Inventory of Depressive Symptomatology - Clinician-Rated - Is mood variation attributed to environment by the patient? | IDS-C - Mood Variation Attributed to Environment | ||
IDSC1-Mood Variation | C130368 | IDSC1-Mood Variation | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood variation. | IDS-C - Mood Variation | ||
IDSC1-Mood Worse Morn/Afternoon/Night | C130369 | IDSC1-Mood Worse Morn/Afternoon/Night | Inventory of Depressive Symptomatology - Clinician-Rated - Is mood typically worse in morning, afternoon, or night. | IDS-C - Mood Worse in Morning, Afternoon, or Night | ||
IDSC1-Outlook (Future) | C130378 | IDSC1-Outlook (Future) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (future). | IDS-C - Outlook (Future) | ||
IDSC1-Outlook (Self) | C130377 | IDSC1-Outlook (Self) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (self). | IDS-C - Outlook (Self) | ||
IDSC1-Panic/Phobic Symptoms | C130388 | IDSC1-Panic/Phobic Symptoms | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Panic/phobic symptoms. | IDS-C - Panic or Phobic Symptoms | ||
IDSC1-Pleasure/Enjoyment (Exclude Sex) | C130382 | IDSC1-Pleasure/Enjoyment (Exclude Sex) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Pleasure/enjoyment (exclude sexual activities). | IDS-C - Pleasure or Enjoyment | ||
IDSC1-Psychomotor Agitation | C130385 | IDSC1-Psychomotor Agitation | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor agitation. | IDS-C - Psychomotor Agitation | ||
IDSC1-Psychomotor Slowing | C130384 | IDSC1-Psychomotor Slowing | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor slowing. | IDS-C - Psychomotor Slowing | ||
IDSC1-Quality of Mood | C130371 | IDSC1-Quality of Mood | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Quality of mood. | IDS-C - Quality of Mood | ||
IDSC1-Reactivity of Mood | C130367 | IDSC1-Reactivity of Mood | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Reactivity of mood. | IDS-C - Reactivity of Mood | ||
IDSC1-Score | C130392 | IDSC1-Score | Inventory of Depressive Symptomatology - Clinician-Rated - Score. | IDS-C - Score | ||
IDSC1-Sexual Interest | C130383 | IDSC1-Sexual Interest | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sexual interest. | IDS-C - Sexual Interest | ||
IDSC1-Sleep Onset Insomnia | C130360 | IDSC1-Sleep Onset Insomnia | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sleep onset insomnia. | IDS-C - Sleep Onset Insomnia | ||
IDSC1-Somatic Complaints | C130386 | IDSC1-Somatic Complaints | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Somatic complaints. | IDS-C - Somatic Complaints | ||
IDSC1-Suicidal Ideation | C130379 | IDSC1-Suicidal Ideation | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Suicidal ideation. | IDS-C - Suicidal Ideation | ||
IDSC1-Sympathetic Arousal | C130387 | IDSC1-Sympathetic Arousal | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sympathetic arousal. | IDS-C - Sympathetic Arousal | ||
IDSC1-Weight (Decrease) | C130374 | IDSC1-Weight (Decrease) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (decrease) within the last two weeks. | IDS-C - Weight (Decrease) | ||
IDSC1-Weight (Increase) | C130375 | IDSC1-Weight (Increase) | Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (increase) within the last two weeks. | IDS-C - Weight (Increase) | ||
Back to top | ||||||
CL.C130261.IDSR1TC | Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Code
(IDSR1TC) | text
Extensible: No | C130261 | Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Code | Inventory of Depressive Symptomatology Self-Report Version test code. | CDISC Questionnaire IDS-SR Test Code Terminology |
IDSR101 | C130551 | IDSR1-Falling Asleep | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Falling asleep. | IDS-SR - Falling Asleep | ||
IDSR102 | C130552 | IDSR1-Sleep During the Night | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleep during the night. | IDS-SR - Sleep During the Night | ||
IDSR103 | C130553 | IDSR1-Waking Up Too Early | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Waking up too early. | IDS-SR - Waking Up Too Early | ||
IDSR104 | C130554 | IDSR1-Sleeping Too Much | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleeping too much. | IDS-SR - Sleeping Too Much | ||
IDSR105 | C130555 | IDSR1-Feeling Sad | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling sad. | IDS-SR - Feeling Sad | ||
IDSR106 | C130556 | IDSR1-Feeling Irritable | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling irritable. | IDS-SR - Feeling Irritable | ||
IDSR107 | C130557 | IDSR1-Feeling Anxious or Tense | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling anxious or tense. | IDS-SR - Feeling Anxious or Tense | ||
IDSR108 | C130558 | IDSR1-Your Mood to Good/Desired Events | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Response of your mood to good or desired events. | IDS-SR - Response of Your Mood to Good or Desired Events | ||
IDSR109 | C130559 | IDSR1-Mood in Relation to Time of Day | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Mood in relation to the time of day. | IDS-SR - Mood in Relation to the Time of Day | ||
IDSR109A | C130560 | IDSR1-Mood Worse Morn/Afternoon/Night | Inventory of Depressive Symptomatology - Self-Report - Is your mood typically worse in the morning, afternoon or night? | IDS-SR - Mood Worse in Morning, Afternoon, or Night | ||
IDSR109B | C130561 | IDSR1-Mood Attributed to Environment | Inventory of Depressive Symptomatology - Self-Report - Is your mood variation attributed to the environment? | IDS-SR - Mood Variation Attributed to Environment | ||
IDSR110 | C130562 | IDSR1-Quality of Your Mood | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: The quality of your mood. | IDS-SR - The Quality of Your Mood | ||
IDSR111 | C130563 | IDSR1-Decreased Appetite | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Decreased appetite. | IDS-SR - Decreased Appetite | ||
IDSR112 | C130564 | IDSR1-Increased Appetite | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Increased appetite. | IDS-SR - Increased Appetite | ||
IDSR113 | C130565 | IDSR1-Weight (Decrease) | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Weight (decrease). | IDS-SR - Weight (Decrease) | ||
IDSR114 | C130566 | IDSR1-Weight (Increase) | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Weight (increase). | IDS-SR - Weight (Increase) | ||
IDSR115 | C130567 | IDSR1-Concentration/Decision Making | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Concentration/decision making. | IDS-SR - Concentration or Decision Making | ||
IDSR116 | C130568 | IDSR1-View of Myself | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of myself. | IDS-SR - View of Myself | ||
IDSR117 | C130569 | IDSR1-View of My Future | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of my future. | IDS-SR - View of My Future | ||
IDSR118 | C130570 | IDSR1-Thoughts of Death or Suicide | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Thoughts of death or suicide. | IDS-SR - Thoughts of Death or Suicide | ||
IDSR119 | C130571 | IDSR1-General Interest | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: General interest. | IDS-SR - General Interest | ||
IDSR120 | C130572 | IDSR1-Energy Level | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Energy level. | IDS-SR - Energy Level | ||
IDSR121 | C130573 | IDSR1-Pleasure/Enjoyment (Exclude Sex) | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Capacity for pleasure or enjoyment (excluding sex). | IDS-SR - Capacity for Pleasure or Enjoyment | ||
IDSR122 | C130574 | IDSR1-Interest in Sex | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Interest in sex. | IDS-SR - Interest in Sex | ||
IDSR123 | C130575 | IDSR1-Feeling Slowed Down | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling slowed down. | IDS-SR - Feeling Slowed Down | ||
IDSR124 | C130576 | IDSR1-Feeling Restless | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling restless. | IDS-SR - Feeling Restless | ||
IDSR125 | C130577 | IDSR1-Aches and Pains | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Aches and pains. | IDS-SR - Aches and Pains | ||
IDSR126 | C130578 | IDSR1-Other Bodily Symptoms | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Other bodily symptoms. | IDS-SR - Other Bodily Symptoms | ||
IDSR127 | C130579 | IDSR1-Panic/Phobic Symptoms | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Panic/phobic symptoms. | IDS-SR - Panic or Phobic Symptoms | ||
IDSR128 | C130580 | IDSR1-Constipation/Diarrhea | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Constipation/diarrhea. | IDS-SR - Constipation or Diarrhea | ||
IDSR129 | C130581 | IDSR1-Interpersonal Sensitivity | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Interpersonal sensitivity. | IDS-SR - Interpersonal Sensitivity | ||
IDSR130 | C130582 | IDSR1-Leaden Paralysis/Physical Energy | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Leaden paralysis/physical energy. | IDS-SR - Leaden Paralysis or Physical Energy | ||
IDSR131 | C130583 | IDSR1-Score | Inventory of Depressive Symptomatology - Self-Report - Score. | IDS-SR - Score | ||
Back to top | ||||||
CL.C130260.IDSR1TN | Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Name
(IDSR1TN) | text
Extensible: No | C130260 | Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Name | Inventory of Depressive Symptomatology Self-Report Version test name. | CDISC Questionnaire IDS-SR Test Name Terminology |
IDSR1-Aches and Pains | C130577 | IDSR1-Aches and Pains | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Aches and pains. | IDS-SR - Aches and Pains | ||
IDSR1-Concentration/Decision Making | C130567 | IDSR1-Concentration/Decision Making | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Concentration/decision making. | IDS-SR - Concentration or Decision Making | ||
IDSR1-Constipation/Diarrhea | C130580 | IDSR1-Constipation/Diarrhea | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Constipation/diarrhea. | IDS-SR - Constipation or Diarrhea | ||
IDSR1-Decreased Appetite | C130563 | IDSR1-Decreased Appetite | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Decreased appetite. | IDS-SR - Decreased Appetite | ||
IDSR1-Energy Level | C130572 | IDSR1-Energy Level | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Energy level. | IDS-SR - Energy Level | ||
IDSR1-Falling Asleep | C130551 | IDSR1-Falling Asleep | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Falling asleep. | IDS-SR - Falling Asleep | ||
IDSR1-Feeling Anxious or Tense | C130557 | IDSR1-Feeling Anxious or Tense | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling anxious or tense. | IDS-SR - Feeling Anxious or Tense | ||
IDSR1-Feeling Irritable | C130556 | IDSR1-Feeling Irritable | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling irritable. | IDS-SR - Feeling Irritable | ||
IDSR1-Feeling Restless | C130576 | IDSR1-Feeling Restless | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling restless. | IDS-SR - Feeling Restless | ||
IDSR1-Feeling Sad | C130555 | IDSR1-Feeling Sad | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling sad. | IDS-SR - Feeling Sad | ||
IDSR1-Feeling Slowed Down | C130575 | IDSR1-Feeling Slowed Down | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling slowed down. | IDS-SR - Feeling Slowed Down | ||
IDSR1-General Interest | C130571 | IDSR1-General Interest | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: General interest. | IDS-SR - General Interest | ||
IDSR1-Increased Appetite | C130564 | IDSR1-Increased Appetite | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Increased appetite. | IDS-SR - Increased Appetite | ||
IDSR1-Interest in Sex | C130574 | IDSR1-Interest in Sex | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Interest in sex. | IDS-SR - Interest in Sex | ||
IDSR1-Interpersonal Sensitivity | C130581 | IDSR1-Interpersonal Sensitivity | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Interpersonal sensitivity. | IDS-SR - Interpersonal Sensitivity | ||
IDSR1-Leaden Paralysis/Physical Energy | C130582 | IDSR1-Leaden Paralysis/Physical Energy | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Leaden paralysis/physical energy. | IDS-SR - Leaden Paralysis or Physical Energy | ||
IDSR1-Mood Attributed to Environment | C130561 | IDSR1-Mood Attributed to Environment | Inventory of Depressive Symptomatology - Self-Report - Is your mood variation attributed to the environment? | IDS-SR - Mood Variation Attributed to Environment | ||
IDSR1-Mood in Relation to Time of Day | C130559 | IDSR1-Mood in Relation to Time of Day | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Mood in relation to the time of day. | IDS-SR - Mood in Relation to the Time of Day | ||
IDSR1-Mood Worse Morn/Afternoon/Night | C130560 | IDSR1-Mood Worse Morn/Afternoon/Night | Inventory of Depressive Symptomatology - Self-Report - Is your mood typically worse in the morning, afternoon or night? | IDS-SR - Mood Worse in Morning, Afternoon, or Night | ||
IDSR1-Other Bodily Symptoms | C130578 | IDSR1-Other Bodily Symptoms | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Other bodily symptoms. | IDS-SR - Other Bodily Symptoms | ||
IDSR1-Panic/Phobic Symptoms | C130579 | IDSR1-Panic/Phobic Symptoms | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Panic/phobic symptoms. | IDS-SR - Panic or Phobic Symptoms | ||
IDSR1-Pleasure/Enjoyment (Exclude Sex) | C130573 | IDSR1-Pleasure/Enjoyment (Exclude Sex) | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Capacity for pleasure or enjoyment (excluding sex). | IDS-SR - Capacity for Pleasure or Enjoyment | ||
IDSR1-Quality of Your Mood | C130562 | IDSR1-Quality of Your Mood | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: The quality of your mood. | IDS-SR - The Quality of Your Mood | ||
IDSR1-Score | C130583 | IDSR1-Score | Inventory of Depressive Symptomatology - Self-Report - Score. | IDS-SR - Score | ||
IDSR1-Sleep During the Night | C130552 | IDSR1-Sleep During the Night | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleep during the night. | IDS-SR - Sleep During the Night | ||
IDSR1-Sleeping Too Much | C130554 | IDSR1-Sleeping Too Much | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleeping too much. | IDS-SR - Sleeping Too Much | ||
IDSR1-Thoughts of Death or Suicide | C130570 | IDSR1-Thoughts of Death or Suicide | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Thoughts of death or suicide. | IDS-SR - Thoughts of Death or Suicide | ||
IDSR1-View of My Future | C130569 | IDSR1-View of My Future | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of my future. | IDS-SR - View of My Future | ||
IDSR1-View of Myself | C130568 | IDSR1-View of Myself | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of myself. | IDS-SR - View of Myself | ||
IDSR1-Waking Up Too Early | C130553 | IDSR1-Waking Up Too Early | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Waking up too early. | IDS-SR - Waking Up Too Early | ||
IDSR1-Weight (Decrease) | C130565 | IDSR1-Weight (Decrease) | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Weight (decrease). | IDS-SR - Weight (Decrease) | ||
IDSR1-Weight (Increase) | C130566 | IDSR1-Weight (Increase) | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Weight (increase). | IDS-SR - Weight (Increase) | ||
IDSR1-Your Mood to Good/Desired Events | C130558 | IDSR1-Your Mood to Good/Desired Events | Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Response of your mood to good or desired events. | IDS-SR - Response of Your Mood to Good or Desired Events | ||
Back to top | ||||||
CL.C124684.CRSR01TC | JFK Coma Recovery Scale-Revised Clinical Classification Test Code
(CRSR01TC) | text
Extensible: No | C124684 | JFK Coma Recovery Scale-Revised Clinical Classification Test Code | JFK Coma Recovery Scale-Revised test code. | CDISC Clinical Classification CRS-R Test Code Terminology |
CRSR0101 | C124736 | CRSR01-Diagnosis | JFK Coma Recovery Scale-Revised - Diagnosis. | CRS-R - Diagnosis | ||
CRSR0102 | C124737 | CRSR01-Etiology | JFK Coma Recovery Scale-Revised - Etiology. | CRS-R - Etiology | ||
CRSR0103 | C124738 | CRSR01-Date of Onset | JFK Coma Recovery Scale-Revised - Date of onset. | CRS-R - Date of Onset | ||
CRSR0104 | C124739 | CRSR01-Date of Admission | JFK Coma Recovery Scale-Revised - Date of admission. | CRS-R - Date of Admission | ||
CRSR0105 | C124740 | CRSR01-Auditory Function Scale | JFK Coma Recovery Scale-Revised - Auditory function scale. | CRS-R - Auditory Function Scale | ||
CRSR0106 | C124741 | CRSR01-Visual Function Scale | JFK Coma Recovery Scale-Revised - Visual function scale. | CRS-R - Visual Function Scale | ||
CRSR0107 | C124742 | CRSR01-Motor Function Scale | JFK Coma Recovery Scale-Revised - Motor function scale. | CRS-R - Motor Function Scale | ||
CRSR0108 | C124743 | CRSR01-Oromotor/Verbal Function | JFK Coma Recovery Scale-Revised - Oromotor/verbal function scale. | CRS-R - Oromotor/Verbal Function | ||
CRSR0109 | C124744 | CRSR01-Communication Scale | JFK Coma Recovery Scale-Revised - Communication scale. | CRS-R - Communication Scale | ||
CRSR0110 | C124745 | CRSR01-Arousal Scale | JFK Coma Recovery Scale-Revised - Arousal scale. | CRS-R - Arousal Scale | ||
CRSR0111 | C124746 | CRSR01-Total Score | JFK Coma Recovery Scale-Revised - Total score. | CRS-R - Total Score | ||
Back to top | ||||||
CL.C124683.CRSR01TN | JFK Coma Recovery Scale-Revised Clinical Classification Test Name
(CRSR01TN) | text
Extensible: No | C124683 | JFK Coma Recovery Scale-Revised Clinical Classification Test Name | JFK Coma Recovery Scale-Revised test name. | CDISC Clinical Classification CRS-R Test Name Terminology |
CRSR01-Arousal Scale | C124745 | CRSR01-Arousal Scale | JFK Coma Recovery Scale-Revised - Arousal scale. | CRS-R - Arousal Scale | ||
CRSR01-Auditory Function Scale | C124740 | CRSR01-Auditory Function Scale | JFK Coma Recovery Scale-Revised - Auditory function scale. | CRS-R - Auditory Function Scale | ||
CRSR01-Communication Scale | C124744 | CRSR01-Communication Scale | JFK Coma Recovery Scale-Revised - Communication scale. | CRS-R - Communication Scale | ||
CRSR01-Date of Admission | C124739 | CRSR01-Date of Admission | JFK Coma Recovery Scale-Revised - Date of admission. | CRS-R - Date of Admission | ||
CRSR01-Date of Onset | C124738 | CRSR01-Date of Onset | JFK Coma Recovery Scale-Revised - Date of onset. | CRS-R - Date of Onset | ||
CRSR01-Diagnosis | C124736 | CRSR01-Diagnosis | JFK Coma Recovery Scale-Revised - Diagnosis. | CRS-R - Diagnosis | ||
CRSR01-Etiology | C124737 | CRSR01-Etiology | JFK Coma Recovery Scale-Revised - Etiology. | CRS-R - Etiology | ||
CRSR01-Motor Function Scale | C124742 | CRSR01-Motor Function Scale | JFK Coma Recovery Scale-Revised - Motor function scale. | CRS-R - Motor Function Scale | ||
CRSR01-Oromotor/Verbal Function | C124743 | CRSR01-Oromotor/Verbal Function | JFK Coma Recovery Scale-Revised - Oromotor/verbal function scale. | CRS-R - Oromotor/Verbal Function | ||
CRSR01-Total Score | C124746 | CRSR01-Total Score | JFK Coma Recovery Scale-Revised - Total score. | CRS-R - Total Score | ||
CRSR01-Visual Function Scale | C124741 | CRSR01-Visual Function Scale | JFK Coma Recovery Scale-Revised - Visual function scale. | CRS-R - Visual Function Scale | ||
Back to top | ||||||
CL.C182469.KPSS0101OR | Karnofsky Performance Status Scale Clinical Classification ORRES for KPSS0101 TN/TC
(KPSS0101OR) | text
Extensible: No | C182469 | Karnofsky Performance Status Scale Clinical Classification ORRES for KPSS0101 TN/TC | Karnofsky Performance Status Scale original result for KPSS0101 test and test code. | CDISC Clinical Classification Karnofsky Performance Status Scale KPSS0101 Original Response Terminology |
Able to carry on normal activity; minor signs or symptoms of disease. | C182717 | KPSS0101-Able to carry on normal activity;minor signs or symptoms of disease | Karnofsky Performance Status Scale original result for KPSS0101-Able to carry on normal activity; minor signs or symptoms of disease. | Karnofsky Performance Status Scale KPSS0101 Original Result - Able to carry on normal activity; minor signs or symptoms of disease | ||
Cares for self; unable to carry on normal activity or to do active work. | C182719 | KPSS0101-Cares for self;unable to carry on normal activity or to do active work | Karnofsky Performance Status Scale original result for KPSS0101-Cares for self; unable to carry on normal activity or to do active work. | Karnofsky Performance Status Scale KPSS0101 Original Result - Cares for self; unable to carry on normal activity or to do active work | ||
Dead | C182726 | KPSS0101-Dead | Karnofsky Performance Status Scale original result for KPSS0101-Dead. | Karnofsky Performance Status Scale KPSS0101 Original Result - Dead | ||
Disabled; requires special care and assistance. | C182722 | KPSS0101-Disabled;requires special care and assistance | Karnofsky Performance Status Scale original result for KPSS0101-Disabled; requires special care and assistance. | Karnofsky Performance Status Scale KPSS0101 Original Result - Disabled; requires special care and assistance | ||
Moribund; fatal processes progressing rapidly. | C182725 | KPSS0101-Moribund;fatal processes progressing rapidly | Karnofsky Performance Status Scale original result for KPSS0101-Moribund; fatal processes progressing rapidly. | Karnofsky Performance Status Scale KPSS0101 Original Result - Moribund; fatal processes progressing rapidly | ||
Normal activity with effort; some signs or symptoms of disease. | C182718 | KPSS0101-Normal activity with effort;some signs or symptoms of disease | Karnofsky Performance Status Scale original result for KPSS0101-Normal activity with effort; some signs or symptoms of disease. | Karnofsky Performance Status Scale KPSS0101 Original Result - Normal activity with effort; some signs or symptoms of disease | ||
Normal no complaints; no evidence of disease. | C182716 | KPSS0101-Normal no complaints;no evidence of disease | Karnofsky Performance Status Scale original result for KPSS0101-Normal no complaints; no evidence of disease. | Karnofsky Performance Status Scale KPSS0101 Original Result - Normal no complaints; no evidence of disease | ||
Requires considerable assistance and frequent medical care. | C182721 | KPSS0101-Requires considerable assistance and frequent medical care | Karnofsky Performance Status Scale original result for KPSS0101-Requires considerable assistance and frequent medical care. | Karnofsky Performance Status Scale KPSS0101 Original Result - Requires considerable assistance and frequent medical care | ||
Requires occasional assistance, but is able to care for most of his personal needs. | C182720 | KPSS0101-Requires occasional assistance, but is able to care for most of his personal needs | Karnofsky Performance Status Scale original result for KPSS0101-Requires occasional assistance, but is able to care for most of his personal needs. | Karnofsky Performance Status Scale KPSS0101 Original Result - Requires occasional assistance, but is able to care for most of his personal needs | ||
Severely disabled; hospital admission is indicated although death not imminent. | C182723 | KPSS0101-Severely disabled;hospital admission is indicated although death not imminent | Karnofsky Performance Status Scale original result for KPSS0101-Severely disabled; hospital admission is indicated although death not imminent. | Karnofsky Performance Status Scale KPSS0101 Original Result - Severely disabled; hospital admission is indicated although death not imminent | ||
Very sick; hospital admission necessary; active supportive treatment necessary. | C182724 | KPSS0101-Very sick;hospital admission necessary;active supportive treatment necessary | Karnofsky Performance Status Scale original result for KPSS0101-Very sick; hospital admission necessary; active supportive treatment necessary. | Karnofsky Performance Status Scale KPSS0101 Original Result - Very sick; hospital admission necessary; active supportive treatment necessary | ||
Back to top | ||||||
CL.C182507.KPSS0101STR | Karnofsky Performance Status Scale Clinical Classification STRESC for KPSS0101 TN/TC
(KPSS0101STR) | text
Extensible: No | C182507 | Karnofsky Performance Status Scale Clinical Classification STRESC for KPSS0101 TN/TC | Karnofsky Performance Status Scale standardized character result for KPSS0101 test and test code. | CDISC Clinical Classification Karnofsky Performance Status Scale KPSS0101 Standardized Character Response Terminology |
0 | C182737 | KPSS0101-0 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Dead. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 0 | ||
10 | C182736 | KPSS0101-10 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Moribund; fatal processes progressing rapidly. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 10 | ||
100 | C182727 | KPSS0101-100 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Normal no complaints; no evidence of disease. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 100 | ||
20 | C182735 | KPSS0101-20 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Very sick; hospital admission necessary; active supportive treatment necessary. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 20 | ||
30 | C182734 | KPSS0101-30 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Severely disabled; hospital admission is indicated although death not imminent. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 30 | ||
40 | C182733 | KPSS0101-40 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Disabled; requires special care and assistance. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 40 | ||
50 | C182732 | KPSS0101-50 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Requires considerable assistance and frequent medical care. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 50 | ||
60 | C182731 | KPSS0101-60 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Requires occasional assistance, but is able to care for most of his personal needs. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 60 | ||
70 | C182730 | KPSS0101-70 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Cares for self; unable to carry on normal activity or to do active work. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 70 | ||
80 | C182729 | KPSS0101-80 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Normal activity with effort; some signs or symptoms of disease. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 80 | ||
90 | C182728 | KPSS0101-90 | Karnofsky Performance Status Scale standardized character result for KPSS0101-Able to carry on normal activity; minor signs or symptoms of disease. | Karnofsky Performance Status Scale KPSS0101 Standardized Character Result 90 | ||
Back to top | ||||||
CL.C100170.KPSS01TC | Karnofsky Performance Status Scale Clinical Classification Test Code
(KPSS01TC) | text
Extensible: No | C100170 | Karnofsky Performance Status Scale Clinical Classification Test Code | Karnofsky Performance Status Scale test code. | CDISC Clinical Classification KPS Scale Test Code Terminology |
KPSS0101 | C100417 | KPSS01-Karnofsky Performance Status | Karnofsky Performance Status Scale - Karnofsky Performance Status. | KPS Scale - Karnofsky Performance Status | ||
Back to top | ||||||
CL.C100169.KPSS01TN | Karnofsky Performance Status Scale Clinical Classification Test Name
(KPSS01TN) | text
Extensible: No | C100169 | Karnofsky Performance Status Scale Clinical Classification Test Name | Karnofsky Performance Status Scale test name. | CDISC Clinical Classification KPS Scale Test Name Terminology |
KPSS01-Karnofsky Performance Status | C100417 | KPSS01-Karnofsky Performance Status | Karnofsky Performance Status Scale - Karnofsky Performance Status. | KPS Scale - Karnofsky Performance Status | ||
Back to top | ||||||
CL.C193274.KDQ1TC | Kidney Disease and Quality of Life-36 Version 1 Questionnaire Test Code
(KDQ1TC) | text
Extensible: No | C193274 | Kidney Disease and Quality of Life-36 Version 1 Questionnaire Test Code | Kidney Disease and Quality of Life-36 Version 1 test code. | CDISC Questionnaire Kidney Disease and Quality of Life-36 Version 1 Test Code Terminology |
KDQ101 | C193326 | KDQ1-In General You Say Your Health Is | Kidney Disease and Quality of Life-36 Version 1 - In general, would you say your health is. | KDQOL-36 Version 1 - In General You Say Your Health Is | ||
KDQ102 | C193327 | KDQ1-Limit Moderate Activities | Kidney Disease and Quality of Life-36 Version 1 - Does your health now limit you in these activities? If so, how much: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | KDQOL-36 Version 1 - Limit Moderate Activities | ||
KDQ103 | C193328 | KDQ1-Limit Climbing Several Flights | Kidney Disease and Quality of Life-36 Version 1 - Does your health now limit you in these activities? If so, how much: Climbing several flights of stairs. | KDQOL-36 Version 1 - Limit Climbing Several Flights | ||
KDQ104 | C193329 | KDQ1-Physical: Accomplished Less | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. | KDQOL-36 Version 1 - Physical: Accomplished Less | ||
KDQ105 | C193330 | KDQ1-Physical: Limited Kind of Work | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. | KDQOL-36 Version 1 - Physical: Limited Kind of Work | ||
KDQ106 | C193331 | KDQ1-Emotional: Accomplished Less | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious): Accomplished less than you would like. | KDQOL-36 Version 1 - Emotional: Accomplished Less | ||
KDQ107 | C193332 | KDQ1-Emotional: Did Work Less Carefully | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious): Didn't do work or other activities as carefully as usual. | KDQOL-36 Version 1 - Emotional: Did Work Less Carefully | ||
KDQ108 | C193333 | KDQ1-Pain Interfere With Normal Work | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | KDQOL-36 Version 1 - Pain Interfere With Normal Work | ||
KDQ109 | C193334 | KDQ1-Have You Felt Calm and Peaceful | Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Have you felt calm and peaceful? | KDQOL-36 Version 1 - Have You Felt Calm and Peaceful | ||
KDQ110 | C193335 | KDQ1-Did You Have a Lot of Energy | Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Did you have a lot of energy? | KDQOL-36 Version 1 - Did You Have a Lot of Energy | ||
KDQ111 | C193336 | KDQ1-You Felt Downhearted and Blue | Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Have you felt downhearted and blue? | KDQOL-36 Version 1 - You Felt Downhearted and Blue | ||
KDQ112 | C193337 | KDQ1-Time Phys/Emotional Interfered | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | KDQOL-36 Version 1 - Time Physical or Emotional Interfered | ||
KDQ113 | C193338 | KDQ1-Kidney Disease Interferes w/ Life | Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: My kidney disease interferes too much with my life. | KDQOL-36 Version 1 - Kidney Disease Interferes With Life | ||
KDQ114 | C193339 | KDQ1-Time Spent Deal w/ Kidney Disease | Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: Too much of my time is spent dealing with my kidney disease. | KDQOL-36 Version 1 - Time Spent Deal With Kidney Disease | ||
KDQ115 | C193340 | KDQ1-Frustrated Deal w/ Kidney Disease | Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: I feel frustrated dealing with my kidney disease. | KDQOL-36 Version 1 - Frustrated Deal With Kidney Disease | ||
KDQ116 | C193341 | KDQ1-I Feel Like a Burden on My Family | Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: I feel like a burden on my family. | KDQOL-36 Version 1 - I Feel Like a Burden on My Family | ||
KDQ117 | C193342 | KDQ1-Bothered by Soreness in Muscles | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Soreness in your muscles? | KDQOL-36 Version 1 - Bothered by Soreness in Muscles | ||
KDQ118 | C193343 | KDQ1-Bothered by Chest Pain | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Chest pain? | KDQOL-36 Version 1 - Bothered by Chest Pain | ||
KDQ119 | C193344 | KDQ1-Bothered by Cramps | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Cramps? | KDQOL-36 Version 1 - Bothered by Cramps | ||
KDQ120 | C193345 | KDQ1-Bothered by Itchy Skin | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Itchy skin? | KDQOL-36 Version 1 - Bothered by Itchy Skin | ||
KDQ121 | C193346 | KDQ1-Bothered by Dry Skin | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Dry skin? | KDQOL-36 Version 1 - Bothered by Dry Skin | ||
KDQ122 | C193347 | KDQ1-Bothered by Shortness of Breath | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Shortness of breath? | KDQOL-36 Version 1 - Bothered by Shortness of Breath | ||
KDQ123 | C193348 | KDQ1-Bothered by Faintness or Dizziness | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Faintness or dizziness? | KDQOL-36 Version 1 - Bothered by Faintness or Dizziness | ||
KDQ124 | C193349 | KDQ1-Bothered by Lack of Appetite | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Lack of appetite? | KDQOL-36 Version 1 - Bothered by Lack of Appetite | ||
KDQ125 | C193350 | KDQ1-Bothered by Washed Out or Drained | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Washed out or drained? | KDQOL-36 Version 1 - Bothered by Washed Out or Drained | ||
KDQ126 | C193351 | KDQ1-Bothered by Numbness in Hands/Feet | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Numbness in hands or feet? | KDQOL-36 Version 1 - Bothered by Numbness in Hands or Feet | ||
KDQ127 | C193352 | KDQ1-Bothered by Nausea/Upset Stomach | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Nausea or upset stomach? | KDQOL-36 Version 1 - Bothered by Nausea or Upset Stomach | ||
KDQ128A | C193353 | KDQ1-Bothered by Problems w/ Access Site | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: (Hemodialysis patient only) Problems with your access site? | KDQOL-36 Version 1 - Bothered by Problems With Access Site | ||
KDQ128B | C193354 | KDQ1-Bothered by Problems Catheter Site | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: (Peritoneal dialysis patient only) Problems with your catheter site? | KDQOL-36 Version 1 - Bothered by Problems Catheter Site | ||
KDQ129 | C193355 | KDQ1-Bother Fluid Restriction | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Fluid restriction? | KDQOL-36 Version 1 - Bother Fluid Restriction | ||
KDQ130 | C193356 | KDQ1-Bother Dietary Restriction | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Dietary restriction? | KDQOL-36 Version 1 - Bother Dietary Restriction | ||
KDQ131 | C193357 | KDQ1-Bother Ability to Work Around House | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your ability to work around the house? | KDQOL-36 Version 1 - Bother Ability to Work Around House | ||
KDQ132 | C193358 | KDQ1-Bother Your Ability to Travel | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your ability to travel? | KDQOL-36 Version 1 - Bother Your Ability to Travel | ||
KDQ133 | C193359 | KDQ1-Bother Dependent on Doctors/Staff | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Being dependent on doctors and other medical staff? | KDQOL-36 Version 1 - Bother Dependent on Doctors and Staff | ||
KDQ134 | C193360 | KDQ1-Bother Stress Caused by Disease | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Stress or worries caused by kidney disease? | KDQOL-36 Version 1 - Bother Stress Caused by Disease | ||
KDQ135 | C193361 | KDQ1-Bother Your Sex Life | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your sex life? | KDQOL-36 Version 1 - Bother Your Sex Life | ||
KDQ136 | C193362 | KDQ1-Bother Your Personal Appearance | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your personal appearance? | KDQOL-36 Version 1 - Bother Your Personal Appearance | ||
Back to top | ||||||
CL.C193273.KDQ1TN | Kidney Disease and Quality of Life-36 Version 1 Questionnaire Test Name
(KDQ1TN) | text
Extensible: No | C193273 | Kidney Disease and Quality of Life-36 Version 1 Questionnaire Test Name | Kidney Disease and Quality of Life-36 Version 1 test name. | CDISC Questionnaire Kidney Disease and Quality of Life-36 Version 1 Test Name Terminology |
KDQ1-Bother Ability to Work Around House | C193357 | KDQ1-Bother Ability to Work Around House | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your ability to work around the house? | KDQOL-36 Version 1 - Bother Ability to Work Around House | ||
KDQ1-Bother Dependent on Doctors/Staff | C193359 | KDQ1-Bother Dependent on Doctors/Staff | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Being dependent on doctors and other medical staff? | KDQOL-36 Version 1 - Bother Dependent on Doctors and Staff | ||
KDQ1-Bother Dietary Restriction | C193356 | KDQ1-Bother Dietary Restriction | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Dietary restriction? | KDQOL-36 Version 1 - Bother Dietary Restriction | ||
KDQ1-Bother Fluid Restriction | C193355 | KDQ1-Bother Fluid Restriction | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Fluid restriction? | KDQOL-36 Version 1 - Bother Fluid Restriction | ||
KDQ1-Bother Stress Caused by Disease | C193360 | KDQ1-Bother Stress Caused by Disease | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Stress or worries caused by kidney disease? | KDQOL-36 Version 1 - Bother Stress Caused by Disease | ||
KDQ1-Bother Your Ability to Travel | C193358 | KDQ1-Bother Your Ability to Travel | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your ability to travel? | KDQOL-36 Version 1 - Bother Your Ability to Travel | ||
KDQ1-Bother Your Personal Appearance | C193362 | KDQ1-Bother Your Personal Appearance | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your personal appearance? | KDQOL-36 Version 1 - Bother Your Personal Appearance | ||
KDQ1-Bother Your Sex Life | C193361 | KDQ1-Bother Your Sex Life | Kidney Disease and Quality of Life-36 Version 1 - How much does kidney disease bother you in each of the following areas: Your sex life? | KDQOL-36 Version 1 - Bother Your Sex Life | ||
KDQ1-Bothered by Chest Pain | C193343 | KDQ1-Bothered by Chest Pain | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Chest pain? | KDQOL-36 Version 1 - Bothered by Chest Pain | ||
KDQ1-Bothered by Cramps | C193344 | KDQ1-Bothered by Cramps | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Cramps? | KDQOL-36 Version 1 - Bothered by Cramps | ||
KDQ1-Bothered by Dry Skin | C193346 | KDQ1-Bothered by Dry Skin | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Dry skin? | KDQOL-36 Version 1 - Bothered by Dry Skin | ||
KDQ1-Bothered by Faintness or Dizziness | C193348 | KDQ1-Bothered by Faintness or Dizziness | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Faintness or dizziness? | KDQOL-36 Version 1 - Bothered by Faintness or Dizziness | ||
KDQ1-Bothered by Itchy Skin | C193345 | KDQ1-Bothered by Itchy Skin | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Itchy skin? | KDQOL-36 Version 1 - Bothered by Itchy Skin | ||
KDQ1-Bothered by Lack of Appetite | C193349 | KDQ1-Bothered by Lack of Appetite | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Lack of appetite? | KDQOL-36 Version 1 - Bothered by Lack of Appetite | ||
KDQ1-Bothered by Nausea/Upset Stomach | C193352 | KDQ1-Bothered by Nausea/Upset Stomach | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Nausea or upset stomach? | KDQOL-36 Version 1 - Bothered by Nausea or Upset Stomach | ||
KDQ1-Bothered by Numbness in Hands/Feet | C193351 | KDQ1-Bothered by Numbness in Hands/Feet | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Numbness in hands or feet? | KDQOL-36 Version 1 - Bothered by Numbness in Hands or Feet | ||
KDQ1-Bothered by Problems Catheter Site | C193354 | KDQ1-Bothered by Problems Catheter Site | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: (Peritoneal dialysis patient only) Problems with your catheter site? | KDQOL-36 Version 1 - Bothered by Problems Catheter Site | ||
KDQ1-Bothered by Problems w/ Access Site | C193353 | KDQ1-Bothered by Problems w/ Access Site | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: (Hemodialysis patient only) Problems with your access site? | KDQOL-36 Version 1 - Bothered by Problems With Access Site | ||
KDQ1-Bothered by Shortness of Breath | C193347 | KDQ1-Bothered by Shortness of Breath | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Shortness of breath? | KDQOL-36 Version 1 - Bothered by Shortness of Breath | ||
KDQ1-Bothered by Soreness in Muscles | C193342 | KDQ1-Bothered by Soreness in Muscles | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Soreness in your muscles? | KDQOL-36 Version 1 - Bothered by Soreness in Muscles | ||
KDQ1-Bothered by Washed Out or Drained | C193350 | KDQ1-Bothered by Washed Out or Drained | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, to what extent were you bothered by each of the following: Washed out or drained? | KDQOL-36 Version 1 - Bothered by Washed Out or Drained | ||
KDQ1-Did You Have a Lot of Energy | C193335 | KDQ1-Did You Have a Lot of Energy | Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Did you have a lot of energy? | KDQOL-36 Version 1 - Did You Have a Lot of Energy | ||
KDQ1-Emotional: Accomplished Less | C193331 | KDQ1-Emotional: Accomplished Less | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious): Accomplished less than you would like. | KDQOL-36 Version 1 - Emotional: Accomplished Less | ||
KDQ1-Emotional: Did Work Less Carefully | C193332 | KDQ1-Emotional: Did Work Less Carefully | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious): Didn't do work or other activities as carefully as usual. | KDQOL-36 Version 1 - Emotional: Did Work Less Carefully | ||
KDQ1-Frustrated Deal w/ Kidney Disease | C193340 | KDQ1-Frustrated Deal w/ Kidney Disease | Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: I feel frustrated dealing with my kidney disease. | KDQOL-36 Version 1 - Frustrated Deal With Kidney Disease | ||
KDQ1-Have You Felt Calm and Peaceful | C193334 | KDQ1-Have You Felt Calm and Peaceful | Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Have you felt calm and peaceful? | KDQOL-36 Version 1 - Have You Felt Calm and Peaceful | ||
KDQ1-I Feel Like a Burden on My Family | C193341 | KDQ1-I Feel Like a Burden on My Family | Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: I feel like a burden on my family. | KDQOL-36 Version 1 - I Feel Like a Burden on My Family | ||
KDQ1-In General You Say Your Health Is | C193326 | KDQ1-In General You Say Your Health Is | Kidney Disease and Quality of Life-36 Version 1 - In general, would you say your health is. | KDQOL-36 Version 1 - In General You Say Your Health Is | ||
KDQ1-Kidney Disease Interferes w/ Life | C193338 | KDQ1-Kidney Disease Interferes w/ Life | Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: My kidney disease interferes too much with my life. | KDQOL-36 Version 1 - Kidney Disease Interferes With Life | ||
KDQ1-Limit Climbing Several Flights | C193328 | KDQ1-Limit Climbing Several Flights | Kidney Disease and Quality of Life-36 Version 1 - Does your health now limit you in these activities? If so, how much: Climbing several flights of stairs. | KDQOL-36 Version 1 - Limit Climbing Several Flights | ||
KDQ1-Limit Moderate Activities | C193327 | KDQ1-Limit Moderate Activities | Kidney Disease and Quality of Life-36 Version 1 - Does your health now limit you in these activities? If so, how much: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | KDQOL-36 Version 1 - Limit Moderate Activities | ||
KDQ1-Pain Interfere With Normal Work | C193333 | KDQ1-Pain Interfere With Normal Work | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | KDQOL-36 Version 1 - Pain Interfere With Normal Work | ||
KDQ1-Physical: Accomplished Less | C193329 | KDQ1-Physical: Accomplished Less | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. | KDQOL-36 Version 1 - Physical: Accomplished Less | ||
KDQ1-Physical: Limited Kind of Work | C193330 | KDQ1-Physical: Limited Kind of Work | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. | KDQOL-36 Version 1 - Physical: Limited Kind of Work | ||
KDQ1-Time Phys/Emotional Interfered | C193337 | KDQ1-Time Phys/Emotional Interfered | Kidney Disease and Quality of Life-36 Version 1 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | KDQOL-36 Version 1 - Time Physical or Emotional Interfered | ||
KDQ1-Time Spent Deal w/ Kidney Disease | C193339 | KDQ1-Time Spent Deal w/ Kidney Disease | Kidney Disease and Quality of Life-36 Version 1 - How true or false is each of the following statements for you: Too much of my time is spent dealing with my kidney disease. | KDQOL-36 Version 1 - Time Spent Deal With Kidney Disease | ||
KDQ1-You Felt Downhearted and Blue | C193336 | KDQ1-You Felt Downhearted and Blue | Kidney Disease and Quality of Life-36 Version 1 - How much of the time during the past 4 weeks: Have you felt downhearted and blue? | KDQOL-36 Version 1 - You Felt Downhearted and Blue | ||
Back to top | ||||||
CL.C170529.KDIGO1TC | Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury Clinical Classification Test Code
(KDIGO1TC) | text
Extensible: No | C170529 | Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury Clinical Classification Test Code | Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury test code. | CDISC Clinical Classification KDIGO-AKI Test Code Terminology |
KDIGO101 | C170692 | KDIGO1-KDIGO AKI Stage | Kidney Disease: Improving Global Outcomes Staging For Acute Kidney Injury - KDIGO AKI stage. | KDIGO-AKI - KDIGO AKI Stage | ||
Back to top | ||||||
CL.C170528.KDIGO1TN | Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury Clinical Classification Test Name
(KDIGO1TN) | text
Extensible: No | C170528 | Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury Clinical Classification Test Name | Kidney Disease Improving Global Outcomes Staging For Acute Kidney Injury test name. | CDISC Clinical Classification KDIGO-AKI Test Name Terminology |
KDIGO1-KDIGO AKI Stage | C170692 | KDIGO1-KDIGO AKI Stage | Kidney Disease: Improving Global Outcomes Staging For Acute Kidney Injury - KDIGO AKI stage. | KDIGO-AKI - KDIGO AKI Stage | ||
Back to top | ||||||
CL.C130251.KDPI01TC | Kidney Donor Profile Index Clinical Classification Test Code
(KDPI01TC) | text
Extensible: No | C130251 | Kidney Donor Profile Index Clinical Classification Test Code | Kidney Donor Profile Index test code. | CDISC Clinical Classification KDPI Test Code Terminology |
KDPI0101 | C130393 | KDPI01-KDPI Score | Kidney Donor Profile Index - KDPI score. | KDPI - KDPI Score | ||
Back to top | ||||||
CL.C130250.KDPI01TN | Kidney Donor Profile Index Clinical Classification Test Name
(KDPI01TN) | text
Extensible: No | C130250 | Kidney Donor Profile Index Clinical Classification Test Name | Kidney Donor Profile Index test name. | CDISC Clinical Classification KDPI Test Name Terminology |
KDPI01-KDPI Score | C130393 | KDPI01-KDPI Score | Kidney Donor Profile Index - KDPI score. | KDPI - KDPI Score | ||
Back to top | ||||||
CL.C101840.KILLIPC | Killip Class Responses
(KILLIPC) | text
Extensible: No | C101840 | Killip Class Responses | A terminology codelist based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure. | CDISC SDTM Killip Class Responses Terminology |
KILLIP CLASS I | C77269 | The absence of rales over the lung fields and absence of third heart sound (S3). (ACC/AHA) | Killip Class I | |||
KILLIP CLASS II | C77270 | The presence of rales over 50% or less of the lung fields or the presence of a third heart sound (S3).(ACC/AHA) | Killip Class II | |||
KILLIP CLASS III | C77271 | The presence of rales over more than 50% of the lung fields. (ACC/AHA) | Killip Class III | |||
KILLIP CLASS IV | C77272 | The presence of cardiogenic shock (systolic BP less than 90 mm Hg) for greater than 30 minutes, not responsive to fluid resuscitation alone, and felt to be secondary to cardiac dysfunction. (ACC/AHA) | Killip Class IV | |||
Back to top | ||||||
CL.C112439.EDSS01TC | Kurtzke Expanded Disability Status Scale Clinical Classification Test Code
(EDSS01TC) | text
Extensible: No | C112439 | Kurtzke Expanded Disability Status Scale Clinical Classification Test Code | Kurtzke Expanded Disability Status Scale test code. | CDISC Clinical Classification EDSS Test Code Terminology |
EDSS0101 | C112550 | EDSS01-Expanded Disability Score | Kurtzke Expanded Disability Status Scale - Expanded disability score. | EDSS - Expanded Disability Score | ||
Back to top | ||||||
CL.C112438.EDSS01TN | Kurtzke Expanded Disability Status Scale Clinical Classification Test Name
(EDSS01TN) | text
Extensible: No | C112438 | Kurtzke Expanded Disability Status Scale Clinical Classification Test Name | Kurtzke Expanded Disability Status Scale test name. | CDISC Clinical Classification EDSS Test Name Terminology |
EDSS01-Expanded Disability Score | C112550 | EDSS01-Expanded Disability Score | Kurtzke Expanded Disability Status Scale - Expanded disability score. | EDSS - Expanded Disability Score | ||
Back to top | ||||||
CL.C182475.KFSS101OR | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS101 TN/TC
(KFSS101OR) | text
Extensible: No | C182475 | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS101 TN/TC | Kurtzke Functional System Scores original result for KFSS101 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS101 Original Response Terminology |
Abnormal signs without disability | C182767 | KFSS101-Abnormal signs without disability | Kurtzke Functional System Scores original result for KFSS101-Abnormal signs without disability. | Kurtzke Functional System Scores KFSS101 Original Result - Abnormal signs without disability | ||
Marked paraparesis or hemiparesis; moderate quadriparesis; or monoplegia | C182770 | KFSS101-Marked paraparesis or hemiparesis;moderate quadriparesis;or monoplegia | Kurtzke Functional System Scores original result for KFSS101-Marked paraparesis or hemiparesis; moderate quadriparesis; or monoplegia. | Kurtzke Functional System Scores KFSS101 Original Result - Marked paraparesis or hemiparesis; moderate quadriparesis; or monoplegia | ||
Mild or moderate paraparesis or hemiparesis; severe monoparesis | C182769 | KFSS101-Mild or moderate paraparesis or hemiparesis;severe monoparesis | Kurtzke Functional System Scores original result for KFSS101-Mild or moderate paraparesis or hemiparesis; severe monoparesis. | Kurtzke Functional System Scores KFSS101 Original Result - Mild or moderate paraparesis or hemiparesis; severe monoparesis | ||
Minimal disability | C182768 | KFSS101-Minimal disability | Kurtzke Functional System Scores original result for KFSS101-Minimal disability. | Kurtzke Functional System Scores KFSS101 Original Result - Minimal disability | ||
Normal | C182766 | KFSS101-Normal | Kurtzke Functional System Scores original result for KFSS101-Normal. | Kurtzke Functional System Scores KFSS101 Original Result - Normal | ||
Paraplegia, hemiplegia, or marked quadriparesis | C182771 | KFSS101-Paraplegia, hemiplegia, or marked quadriparesis | Kurtzke Functional System Scores original result for KFSS101-Paraplegia, hemiplegia, or marked quadriparesis. | Kurtzke Functional System Scores KFSS101 Original Result - Paraplegia, hemiplegia, or marked quadriparesis | ||
Quadriplegia | C182772 | KFSS101-Quadriplegia | Kurtzke Functional System Scores original result for KFSS101-Quadriplegia. | Kurtzke Functional System Scores KFSS101 Original Result - Quadriplegia | ||
Unknown | C182773 | KFSS101-Unknown | Kurtzke Functional System Scores original result for KFSS101-Unknown. | Kurtzke Functional System Scores KFSS101 Original Result - Unknown | ||
Back to top | ||||||
CL.C182476.KFSS102OR | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS102 TN/TC
(KFSS102OR) | text
Extensible: No | C182476 | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS102 TN/TC | Kurtzke Functional System Scores original result for KFSS102 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS102 Original Response Terminology |
Abnormal signs without disability | C182783 | KFSS102-Abnormal signs without disability | Kurtzke Functional System Scores original result for KFSS102-Abnormal signs without disability. | Kurtzke Functional System Scores KFSS102 Original Result - Abnormal signs without disability | ||
Mild ataxia | C182784 | KFSS102-Mild ataxia | Kurtzke Functional System Scores original result for KFSS102-Mild ataxia. | Kurtzke Functional System Scores KFSS102 Original Result - Mild ataxia | ||
Moderate truncal or limb ataxia | C182785 | KFSS102-Moderate truncal or limb ataxias | Kurtzke Functional System Scores original result for KFSS102-Moderate truncal or limb ataxia. | Kurtzke Functional System Scores KFSS102 Original Result - Moderate truncal or limb ataxia | ||
Normal | C182782 | KFSS102-Normal | Kurtzke Functional System Scores original result for KFSS102-Normal. | Kurtzke Functional System Scores KFSS102 Original Result - Normal | ||
Severe ataxia, all limbs | C182786 | KFSS102-Severe ataxia, all limbs | Kurtzke Functional System Scores original result for KFSS102-Severe ataxia, all limbs. | Kurtzke Functional System Scores KFSS102 Original Result - Severe ataxia, all limbs | ||
Unable to perform coordinated movements due to ataxia | C182787 | KFSS102-Unable to perform coordinated movements due to ataxia | Kurtzke Functional System Scores original result for KFSS102-Unable to perform coordinated movements due to ataxia. | Kurtzke Functional System Scores KFSS102 Original Result - Unable to perform coordinated movements due to ataxia | ||
Unknown | C182788 | KFSS102-Unknown | Kurtzke Functional System Scores original result for KFSS102-Unknown. | Kurtzke Functional System Scores KFSS102 Original Result - Unknown | ||
Back to top | ||||||
CL.C182478.KFSS103OR | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS103 TN/TC
(KFSS103OR) | text
Extensible: No | C182478 | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS103 TN/TC | Kurtzke Functional System Scores original result for KFSS103 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS103 Original Response Terminology |
Inability to swallow or speak | C182805 | KFSS103-Inability to swallow or speak | Kurtzke Functional System Scores original result for KFSS103-Inability to swallow or speak. | Kurtzke Functional System Scores KFSS103 Original Result - Inability to swallow or speak | ||
Marked dysarthria or other marked disability | C182804 | KFSS103-Marked dysarthria or other marked disability | Kurtzke Functional System Scores original result for KFSS103-Marked dysarthria or other marked disability. | Kurtzke Functional System Scores KFSS103 Original Result - Marked dysarthria or other marked disability | ||
Moderate nystagmus or other mild disability | C182802 | KFSS103-Moderate nystagmus or other mild disability | Kurtzke Functional System Scores original result for KFSS103-Moderate nystagmus or other mild disability. | Kurtzke Functional System Scores KFSS103 Original Result - Moderate nystagmus or other mild disability | ||
Normal | C182800 | KFSS103-Normal. | Kurtzke Functional System Scores original result for KFSS103-Normal. | Kurtzke Functional System Scores KFSS103 Original Result - Normal | ||
Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves | C182803 | KFSS103-Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves | Kurtzke Functional System Scores original result for KFSS103-Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves. | Kurtzke Functional System Scores KFSS103 Original Result - Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves | ||
Signs only | C182801 | KFSS103-Signs only | Kurtzke Functional System Scores original result for KFSS103-Signs only. | Kurtzke Functional System Scores KFSS103 Original Result - Signs only | ||
Unknown | C182806 | KFSS103-Unknown | Kurtzke Functional System Scores original result for KFSS103-Unknown. | Kurtzke Functional System Scores KFSS103 Original Result - Unknown | ||
Back to top | ||||||
CL.C182479.KFSS104OR | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS104 TN/TC
(KFSS104OR) | text
Extensible: No | C182479 | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS104 TN/TC | Kurtzke Functional System Scores original result for KFSS104 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS104 Original Response Terminology |
Loss (essentially) of sensation in one or two limbs; or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head | C182819 | KFSS104-Loss (essentially) of sensation in one or two limbs;or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head | Kurtzke Functional System Scores original result for KFSS104-Loss (essentially) of sensation in one or two limbs; or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head. | Kurtzke Functional System Scores KFSS104 Original Result - Loss (essentially) of sensation in one or two limbs; or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head | ||
Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs; or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs | C182818 | KFSS104-Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs;or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs | Kurtzke Functional System Scores original result for KFSS104-Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs; or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs. | Kurtzke Functional System Scores KFSS104 Original Result - Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs; or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs | ||
Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs; or vibratory (c/s figure writing) decrease alone in three or four limbs | C182816 | KFSS104-Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs;or vibratory (c/s figure writing) decrease alone in three or four limbs | Kurtzke Functional System Scores original result for KFSS104-Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs; or vibratory (c/s figure writing) decrease alone in three or four limbs. | Kurtzke Functional System Scores KFSS104 Original Result - Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs; or vibratory (c/s figure writing) decrease alone in three or four limbs | ||
Moderate decrease in touch or pain or position sense, and/or lost vibration in 1 or 2 limbs; or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in 3 or 4 limbs | C182817 | KFSS104-Moderate decrease in touch or pain or position sense, and/or lost vibration in 1 or 2 limbs;or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in 3 or 4 limbs | Kurtzke Functional System Scores original result for KFSS104-Moderate decrease in touch or pain or position sense, and/or lost vibration in 1 or 2 limbs; or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in 3 or 4 limbs. | Kurtzke Functional System Scores KFSS104 Original Result - Moderate decrease in touch or pain or position sense, and/or lost vibration in 1 or 2 limbs; or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in 3 or 4 limbs | ||
Normal | C182814 | KFSS104-Normal | Kurtzke Functional System Scores original result for KFSS104-Normal. | Kurtzke Functional System Scores KFSS104 Original Result - Normal | ||
Sensation essentially lost below the head | C182820 | KFSS104-Sensation essentially lost below the head | Kurtzke Functional System Scores original result for KFSS104-Sensation essentially lost below the head. | Kurtzke Functional System Scores KFSS104 Original Result - Sensation essentially lost below the head | ||
Unknown | C182821 | KFSS104-Unknown | Kurtzke Functional System Scores original result for KFSS104-Unknown. | Kurtzke Functional System Scores KFSS104 Original Result - Unknown | ||
Vibration or figure-writing decrease only, in one or two limbs | C182815 | KFSS104-Vibration or figure-writing decrease only, in one or two limbs | Kurtzke Functional System Scores original result for KFSS104-Vibration or figure-writing decrease only, in one or two limbs. | Kurtzke Functional System Scores KFSS104 Original Result - Vibration or figure-writing decrease only, in one or two limbs | ||
Back to top | ||||||
CL.C182480.KFSS105OR | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS105 TN/TC
(KFSS105OR) | text
Extensible: No | C182480 | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS105 TN/TC | Kurtzke Functional System Scores original result for KFSS105 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS105 Original Response Terminology |
Frequent urinary incontinence | C182833 | KFSS105-Frequent urinary incontinence | Kurtzke Functional System Scores original result for KFSS105-Frequent urinary incontinence. | Kurtzke Functional System Scores KFSS105 Original Result - Frequent urinary incontinence | ||
In need of almost constant catheterization | C182834 | KFSS105-In need of almost constant catheterization | Kurtzke Functional System Scores original result for KFSS105-In need of almost constant catheterization. | Kurtzke Functional System Scores KFSS105 Original Result - In need of almost constant catheterization | ||
Loss of bladder function | C182835 | KFSS105-Loss of bladder function | Kurtzke Functional System Scores original result for KFSS105-Loss of bladder function. | Kurtzke Functional System Scores KFSS105 Original Result - Loss of bladder function | ||
Loss of bowel and bladder function | C182836 | KFSS105-Loss of bowel and bladder function | Kurtzke Functional System Scores original result for KFSS105-Loss of bowel and bladder function. | Kurtzke Functional System Scores KFSS105 Original Result - Loss of bowel and bladder function | ||
Mild urinary hesitancy, urgency, or retention | C182831 | KFSS105-Mild urinary hesitancy, urgency, or retention | Kurtzke Functional System Scores original result for KFSS105-Mild urinary hesitancy, urgency, or retention. | Kurtzke Functional System Scores KFSS105 Original Result - Mild urinary hesitancy, urgency, or retention | ||
Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinence | C182832 | KFSS105-Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinence | Kurtzke Functional System Scores original result for KFSS105-Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinences. | Kurtzke Functional System Scores KFSS105 Original Result - Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinence | ||
Normal | C182830 | KFSS105-Normal | Kurtzke Functional System Scores original result for KFSS105-Normal. | Kurtzke Functional System Scores KFSS105 Original Result - Normal | ||
Unknown | C182837 | KFSS105-Unknown | Kurtzke Functional System Scores original result for KFSS105-Unknown. | Kurtzke Functional System Scores KFSS105 Original Result - Unknown | ||
Back to top | ||||||
CL.C182481.KFSS106OR | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS106 TN/TC
(KFSS106OR) | text
Extensible: No | C182481 | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS106 TN/TC | Kurtzke Functional System Scores original result for KFSS106 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS106 Original Response Terminology |
Grade 5 plus maximal visual acuity of better eye of 20/60 or less | C182852 | KFSS106-Grade 5 plus maximal visual acuity of better eye of 20/60 or less | Kurtzke Functional System Scores original result for KFSS106-Grade 5 plus maximal visual acuity of better eye of 20/60 or less. | Kurtzke Functional System Scores KFSS106 Original Result - Grade 5 plus maximal visual acuity of better eye of 20/60 or less | ||
Normal | C182846 | KFSS106-Normal | Kurtzke Functional System Scores original result for KFSS106-Normal. | Kurtzke Functional System Scores KFSS106 Original Result - Normal | ||
Scotoma with visual acuity (corrected) better than 20/30 | C182847 | KFSS106-Scotoma with visual acuity (corrected) better than 20/30 | Kurtzke Functional System Scores original result for KFSS106-Scotoma with visual acuity (corrected) better than 20/30. | Kurtzke Functional System Scores KFSS106 Original Result - Scotoma with visual acuity (corrected) better than 20/30 | ||
Unknown | C182853 | KFSS106-Unknown | Kurtzke Functional System Scores original result for KFSS106-Unknown. | Kurtzke Functional System Scores KFSS106 Original Result - Unknown | ||
Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99 | C182849 | KFSS106-Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99 | Kurtzke Functional System Scores original result for KFSS106-Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99. | Kurtzke Functional System Scores KFSS106 Original Result - Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99 | ||
Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200; grade 3 plus maximal acuity of better eye of 20/60 or less | C182850 | KFSS106-Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200;grade 3 plus maximal acuity of better eye of 20/60 or less | Kurtzke Functional System Scores original result for KFSS106-Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200; grade 3 plus maximal acuity of better eye of 20/60 or less. | Kurtzke Functional System Scores KFSS106 Original Result - Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200; grade 3 plus maximal acuity of better eye of 20/60 or less | ||
Worse eye with maximal visual acuity (corrected) less than 20/200; grade 4 plus maximal acuity of better eye of 20/60 or less | C182851 | KFSS106-Worse eye with maximal visual acuity (corrected) less than 20/200;grade 4 plus maximal acuity of better eye of 20/60 or less | Kurtzke Functional System Scores original result for KFSS106-Worse eye with maximal visual acuity (corrected) less than 20/200; grade 4 plus maximal acuity of better eye of 20/60 or less. | Kurtzke Functional System Scores KFSS106 Original Result - Worse eye with maximal visual acuity (corrected) less than 20/200; grade 4 plus maximal acuity of better eye of 20/60 or less | ||
Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59 | C182848 | KFSS106-Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59 | Kurtzke Functional System Scores original result for KFSS106-Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59. | Kurtzke Functional System Scores KFSS106 Original Result - Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59 | ||
Back to top | ||||||
CL.C182482.KFSS107OR | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS107 TN/TC
(KFSS107OR) | text
Extensible: No | C182482 | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS107 TN/TC | Kurtzke Functional System Scores original result for KFSS107 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS107 Original Response Terminology |
Dementia or chronic brain syndrome - severe or incompetent | C182867 | KFSS107-Dementia or chronic brain syndrome - severe or incompetent | Kurtzke Functional System Scores original result for KFSS107-Dementia or chronic brain syndrome - severe or incompetent. | Kurtzke Functional System Scores KFSS107 Original Result - Dementia or chronic brain syndrome - severe or incompetent | ||
Marked decrease in mentation (chronic brain syndrome - moderate) | C182866 | KFSS107-Marked decrease in mentation (chronic brain syndrome - moderate) | Kurtzke Functional System Scores original result for KFSS107-Marked decrease in mentation (chronic brain syndrome - moderate). | Kurtzke Functional System Scores KFSS107 Original Result - Marked decrease in mentation (chronic brain syndrome - moderate) | ||
Mild decrease in mentation | C182864 | KFSS107-Mild decrease in mentation | Kurtzke Functional System Scores original result for KFSS107-Mild decrease in mentation. | Kurtzke Functional System Scores KFSS107 Original Result - Mild decrease in mentation | ||
Moderate decrease in mentation | C182865 | KFSS107-Moderate decrease in mentation | Kurtzke Functional System Scores original result for KFSS107-Moderate decrease in mentation. | Kurtzke Functional System Scores KFSS107 Original Result - Moderate decrease in mentation | ||
Mood alteration only (does not affect DSS score) | C182863 | KFSS107-Mood alteration only (does not affect DSS score) | Kurtzke Functional System Scores original result for KFSS107-Mood alteration only (does not affect DSS score). | Kurtzke Functional System Scores KFSS107 Original Result - Mood alteration only (does not affect DSS score) | ||
Normal | C182862 | KFSS107-Normal | Kurtzke Functional System Scores original result for KFSS107-Normal. | Kurtzke Functional System Scores KFSS107 Original Result - Normal | ||
Unknown | C182868 | KFSS107-Unknown | Kurtzke Functional System Scores original result for KFSS107-Unknown. | Kurtzke Functional System Scores KFSS107 Original Result - Unknown | ||
Back to top | ||||||
CL.C182483.KFSS108OR | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS108 TN/TC
(KFSS108OR) | text
Extensible: No | C182483 | Kurtzke Functional System Scores Clinical Classification ORRES for KFSS108 TN/TC | Kurtzke Functional System Scores original result for KFSS108 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS108 Original Response Terminology |
Any other neurologic findings attributed to MS (specify) | C182877 | KFSS108-Any other neurologic findings attributed to MS (specify) | Kurtzke Functional System Scores original result for KFSS108-Any other neurologic findings attributed to MS (specify). | Kurtzke Functional System Scores KFSS108 Original Result - Any other neurologic findings attributed to MS (specify) | ||
None | C182876 | KFSS108-None | Kurtzke Functional System Scores original result for KFSS108-None. | Kurtzke Functional System Scores KFSS108 Original Result - None | ||
Unknown | C182878 | KFSS108-Unknown | Kurtzke Functional System Scores original result for KFSS108-Unknown. | Kurtzke Functional System Scores KFSS108 Original Result - Unknown | ||
Back to top | ||||||
CL.C182477.KFSS1SET1OR | Kurtzke Functional System Scores Clinical Classification ORRES the Same as KFSS102A TN/TC
(KFSS1SET1OR) | text
Extensible: No | C182477 | Kurtzke Functional System Scores Clinical Classification ORRES the Same as KFSS102A TN/TC | Kurtzke Functional System Scores original result for KFSS102A and KFSS106A test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS1SET1 Original Response Terminology |
CHECKED | C182796 | KFSS1SET1-CHECKED | Kurtzke Functional System Scores original result for KFSS102 and KFSS106A-Checked. | Kurtzke Functional System Scores KFSS1SET1 Original Result - Checked | ||
NOT CHECKED | C182797 | KFSS1SET1-NOT CHECKED | Kurtzke Functional System Scores original result for KFSS102 and KFSS106A-Not checked. | Kurtzke Functional System Scores KFSS1SET1 Original Result - Not Checked | ||
Back to top | ||||||
CL.C182513.KFSS101STR | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS101 TN/TC
(KFSS101STR) | text
Extensible: No | C182513 | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS101 TN/TC | Kurtzke Functional System Scores standardized character result for KFSS101 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS101 Standardized Character Response Terminology |
0 | C182774 | KFSS101-0 | Kurtzke Functional System Scores standardized character result for KFSS101-Normal. | Kurtzke Functional System Scores KFSS101 Standardized Character Result 0 | ||
1 | C182775 | KFSS101-1 | Kurtzke Functional System Scores standardized character result for KFSS101-Abnormal signs without disability. | Kurtzke Functional System Scores KFSS101 Standardized Character Result 1 | ||
2 | C182776 | KFSS101-2 | Kurtzke Functional System Scores standardized character result for KFSS101-Minimal disability. | Kurtzke Functional System Scores KFSS101 Standardized Character Result 2 | ||
3 | C182777 | KFSS101-3 | Kurtzke Functional System Scores standardized character result for KFSS101-Mild or moderate paraparesis or hemiparesis; severe monoparesis. | Kurtzke Functional System Scores KFSS101 Standardized Character Result 3 | ||
4 | C182778 | KFSS101-4 | Kurtzke Functional System Scores standardized character result for KFSS101-Marked paraparesis or hemiparesis; moderate quadriparesis; or monoplegia. | Kurtzke Functional System Scores KFSS101 Standardized Character Result 4 | ||
5 | C182779 | KFSS101-5 | Kurtzke Functional System Scores standardized character result for KFSS101-Paraplegia, hemiplegia, or marked quadriparesis. | Kurtzke Functional System Scores KFSS101 Standardized Character Result 5 | ||
6 | C182780 | KFSS101-6 | Kurtzke Functional System Scores standardized character result for KFSS101-Quadriplegia. | Kurtzke Functional System Scores KFSS101 Standardized Character Result 6 | ||
Unknown | C182781 | KFSS101-Unknown | Kurtzke Functional System Scores standardized character result for KFSS101-Unknown. | Kurtzke Functional System Scores KFSS101 Standardized Character Result Unknown | ||
Back to top | ||||||
CL.C182514.KFSS102STR | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS102 TN/TC
(KFSS102STR) | text
Extensible: No | C182514 | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS102 TN/TC | Kurtzke Functional System Scores standardized character result for KFSS102 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS102 Standardized Character Response Terminology |
0 | C182789 | KFSS102-0 | Kurtzke Functional System Scores standardized character result for KFSS102-Normal. | Kurtzke Functional System Scores KFSS102 Standardized Character Result 0 | ||
1 | C182790 | KFSS102-1 | Kurtzke Functional System Scores standardized character result for KFSS102-Abnormal signs without disability. | Kurtzke Functional System Scores KFSS102 Standardized Character Result 1 | ||
2 | C182791 | KFSS102-2 | Kurtzke Functional System Scores standardized character result for KFSS102-Mild ataxia. | Kurtzke Functional System Scores KFSS102 Standardized Character Result 2 | ||
3 | C182792 | KFSS102-3 | Kurtzke Functional System Scores standardized character result for KFSS102-Moderate truncal or limb ataxia. | Kurtzke Functional System Scores KFSS102 Standardized Character Result 3 | ||
4 | C182793 | KFSS102-4 | Kurtzke Functional System Scores standardized character result for KFSS102-Severe ataxia, all limbs. | Kurtzke Functional System Scores KFSS102 Standardized Character Result 4 | ||
5 | C182794 | KFSS102-5 | Kurtzke Functional System Scores standardized character result for KFSS102-Unable to perform coordinated movements due to ataxia. | Kurtzke Functional System Scores KFSS102 Standardized Character Result 5 | ||
Unknown | C182795 | KFSS102-Unknown | Kurtzke Functional System Scores standardized character result for KFSS102-Unknown. | Kurtzke Functional System Scores KFSS102 Standardized Character Result Unknown | ||
Back to top | ||||||
CL.C182516.KFSS103STR | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS103 TN/TC
(KFSS103STR) | text
Extensible: No | C182516 | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS103 TN/TC | Kurtzke Functional System Scores standardized character result for KFSS103 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS103 Standardized Character Response Terminology |
0 | C182807 | KFSS103-0 | Kurtzke Functional System Scores standardized character result for KFSS103-Normal. | Kurtzke Functional System Scores KFSS103 Standardized Character Result 0 | ||
1 | C182808 | KFSS103-1 | Kurtzke Functional System Scores standardized character result for KFSS103-Signs only. | Kurtzke Functional System Scores KFSS103 Standardized Character Result 1 | ||
2 | C182809 | KFSS103-2 | Kurtzke Functional System Scores standardized character result for KFSS103-Moderate nystagmus or other mild disability. | Kurtzke Functional System Scores KFSS103 Standardized Character Result 2 | ||
3 | C182810 | KFSS103-3 | Kurtzke Functional System Scores standardized character result for KFSS103-Severe nystagmus, marked extraocular weakness, or moderate disability of other cranial nerves. | Kurtzke Functional System Scores KFSS103 Standardized Character Result 3 | ||
4 | C182811 | KFSS103-4 | Kurtzke Functional System Scores standardized character result for KFSS103-Marked dysarthria or other marked disability. | Kurtzke Functional System Scores KFSS103 Standardized Character Result 4 | ||
5 | C182812 | KFSS103-5 | Kurtzke Functional System Scores standardized character result for KFSS103-Inability to swallow or speak. | Kurtzke Functional System Scores KFSS103 Standardized Character Result 5 | ||
Unknown | C182813 | KFSS103-Unknown | Kurtzke Functional System Scores standardized character result for KFSS103-Unknown. | Kurtzke Functional System Scores KFSS103 Standardized Character Result Unknown | ||
Back to top | ||||||
CL.C182517.KFSS104STR | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS104 TN/TC
(KFSS104STR) | text
Extensible: No | C182517 | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS104 TN/TC | Kurtzke Functional System Scores standardized character result for KFSS104 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS104 Standardized Character Response Terminology |
0 | C182822 | KFSS104-0 | Kurtzke Functional System Scores standardized character result for KFSS104-Normal. | Kurtzke Functional System Scores KFSS104 Standardized Character Result 0 | ||
1 | C182823 | KFSS104-1 | Kurtzke Functional System Scores standardized character result for KFSS104-Vibration or figure-writing decrease only, in one or two limbs. | Kurtzke Functional System Scores KFSS104 Standardized Character Result 1 | ||
2 | C182824 | KFSS104-2 | Kurtzke Functional System Scores standardized character result for KFSS104-Mild decrease in touch or pain or position sense, and/or moderate decrease in vibration in one or two limbs; or vibratory (c/s figure writing) decrease alone in three or four limbs. | Kurtzke Functional System Scores KFSS104 Standardized Character Result 2 | ||
3 | C182825 | KFSS104-3 | Kurtzke Functional System Scores standardized character result for KFSS104-Moderate decrease in touch or pain or position sense, and/or lost vibration in 1 or 2 limbs; or mild decrease in touch or pain and/or moderate decrease in all proprioceptive tests in 3 or 4 limbs. | Kurtzke Functional System Scores KFSS104 Standardized Character Result 3 | ||
4 | C182826 | KFSS104-4 | Kurtzke Functional System Scores standardized character result for KFSS104-Marked decrease in touch or pain or loss of proprioception, alone or combined, in one or two limbs; or moderate decrease in touch or pain and/or severe proprioceptive decrease in more than two limbs. | Kurtzke Functional System Scores KFSS104 Standardized Character Result 4 | ||
5 | C182827 | KFSS104-5 | Kurtzke Functional System Scores standardized character result for KFSS104-Loss (essentially) of sensation in one or two limbs; or moderate decrease in touch or pain and/or loss of proprioception for most of the body below the head. | Kurtzke Functional System Scores KFSS104 Standardized Character Result 5 | ||
6 | C182828 | KFSS104-6 | Kurtzke Functional System Scores standardized character result for KFSS104-Sensation essentially lost below the head. | Kurtzke Functional System Scores KFSS104 Standardized Character Result 6 | ||
Unknown | C182829 | KFSS104-Unknown | Kurtzke Functional System Scores standardized character result for KFSS104-Unknown. | Kurtzke Functional System Scores KFSS104 Standardized Character Result Unknown | ||
Back to top | ||||||
CL.C182518.KFSS105STR | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS105 TN/TC
(KFSS105STR) | text
Extensible: No | C182518 | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS105 TN/TC | Kurtzke Functional System Scores standardized character result for KFSS105 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS105 Standardized Character Response Terminology |
0 | C182838 | KFSS105-0 | Kurtzke Functional System Scores standardized character result for KFSS105-Normal. | Kurtzke Functional System Scores KFSS105 Standardized Character Result 0 | ||
1 | C182839 | KFSS105-1 | Kurtzke Functional System Scores standardized character result for KFSS105-Mild urinary hesitancy, urgency, or retention. | Kurtzke Functional System Scores KFSS105 Standardized Character Result 1 | ||
2 | C182840 | KFSS105-2 | Kurtzke Functional System Scores standardized character result for KFSS105-Moderate hesitancy, urgency, retention of bowel or bladder, or rare urinary incontinences. | Kurtzke Functional System Scores KFSS105 Standardized Character Result 2 | ||
3 | C182841 | KFSS105-3 | Kurtzke Functional System Scores standardized character result for KFSS105-Frequent urinary incontinence. | Kurtzke Functional System Scores KFSS105 Standardized Character Result 3 | ||
4 | C182842 | KFSS105-4 | Kurtzke Functional System Scores standardized character result for KFSS105-In need of almost constant catheterization. | Kurtzke Functional System Scores KFSS105 Standardized Character Result 4 | ||
5 | C182843 | KFSS105-5 | Kurtzke Functional System Scores standardized character result for KFSS105-Loss of bladder function. | Kurtzke Functional System Scores KFSS105 Standardized Character Result 5 | ||
6 | C182844 | KFSS105-6 | Kurtzke Functional System Scores standardized character result for KFSS105-Loss of bowel and bladder function. | Kurtzke Functional System Scores KFSS105 Standardized Character Result 6 | ||
Unknown | C182845 | KFSS105-Unknown | Kurtzke Functional System Scores standardized character result for KFSS105-Unknown. | Kurtzke Functional System Scores KFSS105 Standardized Character Result Unknown | ||
Back to top | ||||||
CL.C182519.KFSS106STR | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS106 TN/TC
(KFSS106STR) | text
Extensible: No | C182519 | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS106 TN/TC | Kurtzke Functional System Scores standardized character result for KFSS106 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS106 Standardized Character Response Terminology |
0 | C182854 | KFSS106-0 | Kurtzke Functional System Scores standardized character result for KFSS106-Normal. | Kurtzke Functional System Scores KFSS106 Standardized Character Result 0 | ||
1 | C182855 | KFSS106-1 | Kurtzke Functional System Scores standardized character result for KFSS106-Scotoma with visual acuity (corrected) better than 20/30. | Kurtzke Functional System Scores KFSS106 Standardized Character Result 1 | ||
2 | C182856 | KFSS106-2 | Kurtzke Functional System Scores standardized character result for KFSS106-Worse eye with scotoma with maximal visual acuity (corrected) of 20/30 to 20/59. | Kurtzke Functional System Scores KFSS106 Standardized Character Result 2 | ||
3 | C182857 | KFSS106-3 | Kurtzke Functional System Scores standardized character result for KFSS106-Worse eye with large scotoma, or moderate decrease in fields, but with maximal visual acuity (corrected) of 20/60 to 20/99. | Kurtzke Functional System Scores KFSS106 Standardized Character Result 3 | ||
4 | C182858 | KFSS106-4 | Kurtzke Functional System Scores standardized character result for KFSS106-Worse eye with marked decrease of fields and maximal visual acuity (corrected) of 20/100 to 20/200; grade 3 plus maximal acuity of better eye of 20/60 or less. | Kurtzke Functional System Scores KFSS106 Standardized Character Result 4 | ||
5 | C182859 | KFSS106-5 | Kurtzke Functional System Scores standardized character result for KFSS106-Worse eye with maximal visual acuity (corrected) less than 20/200; grade 4 plus maximal acuity of better eye of 20/60 or less. | Kurtzke Functional System Scores KFSS106 Standardized Character Result 5 | ||
6 | C182860 | KFSS106-6 | Kurtzke Functional System Scores standardized character result for KFSS106-Grade 5 plus maximal visual acuity of better eye of 20/60 or less. | Kurtzke Functional System Scores KFSS106 Standardized Character Result 6 | ||
Unknown | C182861 | KFSS106-Unknown | Kurtzke Functional System Scores standardized character result for KFSS106-Unknown. | Kurtzke Functional System Scores KFSS106 Standardized Character Result Unknown | ||
Back to top | ||||||
CL.C182520.KFSS107STR | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS107 TN/TC
(KFSS107STR) | text
Extensible: No | C182520 | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS107 TN/TC | Kurtzke Functional System Scores standardized character result for KFSS107 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS107 Standardized Character Response Terminology |
0 | C182869 | KFSS107-0 | Kurtzke Functional System Scores standardized character result for KFSS107-Normal. | Kurtzke Functional System Scores KFSS107 Standardized Character Result 0 | ||
1 | C182870 | KFSS107-1 | Kurtzke Functional System Scores standardized character result for KFSS107-Mood alteration only (does not affect DSS score). | Kurtzke Functional System Scores KFSS107 Standardized Character Result 1 | ||
2 | C182871 | KFSS107-2 | Kurtzke Functional System Scores standardized character result for KFSS107-Mild decrease in mentation. | Kurtzke Functional System Scores KFSS107 Standardized Character Result 2 | ||
3 | C182872 | KFSS107-3 | Kurtzke Functional System Scores standardized character result for KFSS107-Moderate decrease in mentation. | Kurtzke Functional System Scores KFSS107 Standardized Character Result 3 | ||
4 | C182873 | KFSS107-4 | Kurtzke Functional System Scores standardized character result for KFSS107-Marked decrease in mentation (chronic brain syndrome - moderate). | Kurtzke Functional System Scores KFSS107 Standardized Character Result 4 | ||
5 | C182874 | KFSS107-5 | Kurtzke Functional System Scores standardized character result for KFSS107-Dementia or chronic brain syndrome - severe or incompetent. | Kurtzke Functional System Scores KFSS107 Standardized Character Result 5 | ||
Unknown | C182875 | KFSS107-Unknown | Kurtzke Functional System Scores standardized character result for KFSS107-Unknown. | Kurtzke Functional System Scores KFSS107 Standardized Character Result Unknown | ||
Back to top | ||||||
CL.C182521.KFSS108STR | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS108 TN/TC
(KFSS108STR) | text
Extensible: No | C182521 | Kurtzke Functional System Scores Clinical Classification STRESC for KFSS108 TN/TC | Kurtzke Functional System Scores standardized character result for KFSS108 test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS108 Standardized Character Response Terminology |
0 | C182879 | KFSS108-0 | Kurtzke Functional System Scores standardized character result for KFSS108-None. | Kurtzke Functional System Scores KFSS108 Standardized Character Result 0 | ||
1 | C182880 | KFSS108-1 | Kurtzke Functional System Scores standardized character result for KFSS108-Any other neurologic findings attributed to MS (specify). | Kurtzke Functional System Scores KFSS108 Standardized Character Result 1 | ||
Unknown | C182881 | KFSS108-Unknown | Kurtzke Functional System Scores standardized character result for KFSS108-Unknown. | Kurtzke Functional System Scores KFSS108 Standardized Character Result Unknown | ||
Back to top | ||||||
CL.C182515.KFSS1SET1STR | Kurtzke Functional System Scores Clinical Classification STRESC the Same as KFSS102A TN/TC
(KFSS1SET1STR) | text
Extensible: No | C182515 | Kurtzke Functional System Scores Clinical Classification STRESC the Same as KFSS102A TN/TC | Kurtzke Functional System Scores standardized character result for KFSS102A and KFSS106A test and test code. | CDISC Clinical Classification Kurtzke Functional System Scores KFSS1SET1 Standardized Character Response Terminology |
CHECKED | C182798 | KFSS1SET1-CHECKED | Kurtzke Functional System Scores standardized character result for KFSS102A and KFSS106A-Checked. | Kurtzke Functional System Scores KFSS1SET1 Standardized Character Result Checked - Checked | ||
NOT CHECKED | C182799 | KFSS1SET1-NOT CHECKED | Kurtzke Functional System Scores standardized character result for KFSS102A and KFSS106A-Not checked. | Kurtzke Functional System Scores KFSS1SET1 Standardized Character Result Not Checked - Not Checked | ||
Back to top | ||||||
CL.C112443.KFSS1TC | Kurtzke Functional Systems Scores Clinical Classification Test Code
(KFSS1TC) | text
Extensible: No | C112443 | Kurtzke Functional Systems Scores Clinical Classification Test Code | Kurtzke Functional Systems Scores test code. | CDISC Clinical Classification KFSS Test Code Terminology |
KFSS101 | C112609 | KFSS1-Pyramidal Functions | Kurtzke Functional Systems Scores - Pyramidal functions. | KFSS - Pyramidal Functions | ||
KFSS102 | C112610 | KFSS1-Cerebellar Functions | Kurtzke Functional Systems Scores - Cerebellar functions. | KFSS - Cerebellar Functions | ||
KFSS102A | C112611 | KFSS1-Weakness Interferes With Testing | Kurtzke Functional Systems Scores - Check here when weakness (grade 3 or more on pyramidal) interferes with testing. | KFSS - Weakness Interferes With Testing | ||
KFSS103 | C112612 | KFSS1-Brain Stem Functions | Kurtzke Functional Systems Scores - Brain stem functions. | KFSS - Brain Stem Functions | ||
KFSS104 | C112613 | KFSS1-Sensory Functions | Kurtzke Functional Systems Scores - Sensory functions. | KFSS - Sensory Functions | ||
KFSS105 | C112614 | KFSS1-Bowel and Bladder Functions | Kurtzke Functional Systems Scores - Bowel and bladder functions. | KFSS - Bowel and Bladder Functions | ||
KFSS106 | C112615 | KFSS1-Visual or Optic Functions | Kurtzke Functional Systems Scores - Visual (or optic) functions. | KFSS - Visual (or Optic) Functions | ||
KFSS106A | C112616 | KFSS1-Presence of Temporal Pallor | Kurtzke Functional Systems Scores - Check here for presence of temporal pallor. | KFSS - Presence of Temporal Pallor | ||
KFSS107 | C112617 | KFSS1-Cerebral or Mental Functions | Kurtzke Functional Systems Scores - Cerebral (or mental) functions. | KFSS - Cerebral (or Mental) Functions | ||
KFSS108 | C113884 | KFSS1-Other Functions | Kurtzke Functional Systems Scores - Other functions. | KFSS - Other Functions | ||
KFSS108A | C113885 | KFSS1-Other Functions Specify | Kurtzke Functional Systems Scores - Any other neurologic findings attributed to MS (specify). | KFSS - Other Functions Specify | ||
Back to top | ||||||
CL.C112442.KFSS1TN | Kurtzke Functional Systems Scores Clinical Classification Test Name
(KFSS1TN) | text
Extensible: No | C112442 | Kurtzke Functional Systems Scores Clinical Classification Test Name | Kurtzke Functional Systems Scores test name. | CDISC Clinical Classification KFSS Test Name Terminology |
KFSS1-Bowel and Bladder Functions | C112614 | KFSS1-Bowel and Bladder Functions | Kurtzke Functional Systems Scores - Bowel and bladder functions. | KFSS - Bowel and Bladder Functions | ||
KFSS1-Brain Stem Functions | C112612 | KFSS1-Brain Stem Functions | Kurtzke Functional Systems Scores - Brain stem functions. | KFSS - Brain Stem Functions | ||
KFSS1-Cerebellar Functions | C112610 | KFSS1-Cerebellar Functions | Kurtzke Functional Systems Scores - Cerebellar functions. | KFSS - Cerebellar Functions | ||
KFSS1-Cerebral or Mental Functions | C112617 | KFSS1-Cerebral or Mental Functions | Kurtzke Functional Systems Scores - Cerebral (or mental) functions. | KFSS - Cerebral (or Mental) Functions | ||
KFSS1-Other Functions Specify | C113885 | KFSS1-Other Functions Specify | Kurtzke Functional Systems Scores - Any other neurologic findings attributed to MS (specify). | KFSS - Other Functions Specify | ||
KFSS1-Other Functions | C113884 | KFSS1-Other Functions | Kurtzke Functional Systems Scores - Other functions. | KFSS - Other Functions | ||
KFSS1-Presence of Temporal Pallor | C112616 | KFSS1-Presence of Temporal Pallor | Kurtzke Functional Systems Scores - Check here for presence of temporal pallor. | KFSS - Presence of Temporal Pallor | ||
KFSS1-Pyramidal Functions | C112609 | KFSS1-Pyramidal Functions | Kurtzke Functional Systems Scores - Pyramidal functions. | KFSS - Pyramidal Functions | ||
KFSS1-Sensory Functions | C112613 | KFSS1-Sensory Functions | Kurtzke Functional Systems Scores - Sensory functions. | KFSS - Sensory Functions | ||
KFSS1-Visual or Optic Functions | C112615 | KFSS1-Visual or Optic Functions | Kurtzke Functional Systems Scores - Visual (or optic) functions. | KFSS - Visual (or Optic) Functions | ||
KFSS1-Weakness Interferes With Testing | C112611 | KFSS1-Weakness Interferes With Testing | Kurtzke Functional Systems Scores - Check here when weakness (grade 3 or more on pyramidal) interferes with testing. | KFSS - Weakness Interferes With Testing | ||
Back to top | ||||||
CL.C160922.LBANMET | Laboratory Analytical Method Calculation Formula
(LBANMET) | text
Extensible: Yes | C160922 | Laboratory Analytical Method Calculation Formula | Terminology relevant to the formula names associated with a laboratory test calculation. | CDISC SDTM Laboratory Analytical Method Calculation Formula Terminology |
ASH FIBROSURE FORMULA | C172486 | ASH FibroSURE Formula;ASH Test | A proprietary algorithm derived from the FibroTest liver fibrosis algorithm that is used to measure liver fibrosis, hepatic steatosis, and alcoholic steatohepatitis. It includes ten serum markers: alpha-2-macroglobulin, apolipoprotein A1, total bilirubin, gamma-glutamyltransferase, haptoglobin, alanine aminotransferase, aspartate aminotransferase, glucose, total cholesterol, and triglycerides, and adjusts for age, gender, height, and weight. (NCI) | ASH Fibrosure Formula | ||
CKD-EPI CREATININE FORMULA | C161338 | A formula to estimate glomerular filtration rate that takes into account sex, age, race, and serum creatinine (SCr). eGFR(mL/min/1.73 m2)=141 x min(SCr/k, 1)^a x max(SCr/k, 1)^-1.209 x 0.993^Age x 1.018 [if female] x 1.159 [if black] where: SCr is in mg/dL; k=0.7 for Female and 0.9 for Male; a=-0.329 for female and -0.411 for male. (Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.) | CKD-EPI Creatinine Formula | |||
CKD-EPI CREATININE-CYSTATIN C FORMULA | C161340 | A formula to estimate glomerular filtration rate that takes into account sex, age, race, serum creatinine (SCr) and serum cystatin C (Scys). eGFR(mL/min/1.73 m2)=135 x min(SCr/k, 1)a x max(SCr/k, 1)-0.601 x min(Scys/0.8, 1)-0.375 x max(Scys/0.8, 1)-0.711 x 0.995^Age x 0.969 [if female] x 1.08 [if black]. (Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.) | CKD-EPI Creatinine-Cystatin C Formula | |||
CKD-EPI CYSTATIN C FORMULA | C161339 | A formula to estimate glomerular filtration rate that takes into account sex, age, race, and serum cystatin C (Scys). eGFR(mL/min/1.73 m2)=133 x min(Scys/0.8, 1)^-0.499 x max (Scys/0.8, 1)^-1.328 x 0.996^Age x 0.932 [if female]. (Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.) | CKD-EPI Cystatin C Formula | |||
CKD-EPI FORMULA | C161341 | Chronic Kidney Disease Epidemiology Collaboration Formula;CKD-EPI GFR Formula | An unspecified CKD-EPI-based formula to estimate glomerular filtration rate that takes into account factors such as sex, age, race, and biomarker measurements. | CKD-EPI Formula | ||
COCKCROFT-GAULT FORMULA | C161342 | A formula to estimate creatinine clearance that takes into account sex, age, weight, and serum creatinine (SCr). CCr=(140 - Age) x Wgt (Kg) / 72xCrt (mg/dL) x 1 (if M) or 0.85 (if F), for conventional units. CCr=(140 - Age) x Wgt (Kg) / 72xCrt (MCMOL/L) x 88.4 x 1 (if M) or 0.85 (if F) [If Wgt is in lbs; Wgt (Kg) = Wgt (lbs) x 0.45], for SI units. (Cockcroft, D.W. and M.H. Gault. Prediction of creatinine clearance from serum creatinine. Nephron. 1976. 16(1):31-41.) | Cockcroft-Gault Formula | |||
FIBROMETER FORMULA | C172489 | A formula that estimates liver pathology through the assessment of a six-parameter blood test, taking into account subject age. Fibrometer regression function = -0.007 platelets (Giga/L) - 0.049 prothrombin index (%) + 0.012 aspartate aminotransferase (UI/L) + 0.005 alpha2-macroglobulin (mg/dL) + 0.021 hyaluronate (g/L) - 0.270 urea (mmol/L) + 0.027 age (years) + 3.718. (Cales P, Oberti F, Michalak S et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005 Dec;42(6):1373-81.) | Fibrometer Formula | |||
FIBROSIS 4 FORMULA | C170576 | FIB-4 Formula | A formula that estimates liver pathology through the assessment of a three-parameter blood test, taking into account subject age. FIB-4 = age ([yr] x AST [U/L]) / ((PLT [10(9)/L]) x (ALT [U/L])(1/2)). (Sterling RK, Lissen E, Clumeck N, et. al. Development of a simple noninvasive index to predict significant fibrosis patients with HIV/HCV co-infection. Hepatology 2006;43:1317-1325.) | Fibrosis 4 Formula | ||
FIBROTEST FORMULA | C172485 | FibroSURE Formula;FibroTest Formula;FibroTest-HCV Formula;FibroTest/FibroSURE Formula | A formula that estimates liver pathology through the assessment of a six-parameter blood test, taking into account subject age and sex. z = 4.467 x log10[Alpha2-Macroglobulin(g/L)] - 1.357 x log10[Haptoglobulin(g/L) + 1.017 x log10[Gamma Glutamyl Transferase (IU/L)] +0.0281 x [Age] + 1.737 x log10[Bilirubin umol/L] - 1.184 x [Apolipoprotein A1(g/L)] + 0.301 x [Sex (female=0, Male=1) - 5.54. (US Patent 6631330) | Fibrotest Formula | ||
GMI % FORMULA | C174289 | Glucose Management Indicator % Formula | A formula to calculate the glucose management indicator (GMI) as a percentage. GMI = 3.31 + 0.02392 x [mean glucose in mg/dL]. (Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018 Nov; 41(11): 2275-2280.) | Glucose Management Indicator Percentage Formula | ||
GMI MMOL/MOL FORMULA | C174290 | Glucose Management Indicator mmol/mol Formula | A formula to calculate the glucose management indicator (GMI) in mmol/mol. GMI = 12.71 + 4.70587 x [mean glucose in mmol/L]. (Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018 Nov; 41(11): 2275-2280.) | Glucose Management Indicator Mmol/mol Formula | ||
HEPASCORE FORMULA | C172488 | Hepatoscore Formula | A formula that estimates liver pathology through the assessment of a four-parameter blood test, taking into account subject age and sex. Hepascore = y/(1 + y) with y = exp (-4.185818 - (0.0249 x age) + (0.7464 x 1 if male, 0 if female gender) + (1.0039 x a2 macroglobulin) + (0.0302 x hyaluronate) + (0.0691 x bilirubin) - (0.0012 x gamma-glutamyl transferase)). (Adams LA, Bulsara M, Rossi E et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005 Oct;51(10):1867-73.) | Hepascore Formula | ||
IDMS-MDRD STUDY EQUATION WITH JSN-CKDI COEFFICIENT 0.741 IMAI 2007 | C181401 | A formula to estimate glomerular filtration rate in Japanese subjects that takes into account age, sex, and serum creatinine. eGFR (mL/min/1.73 m2) = 0.741 x SCr^-1.154 x 175 x Age^-0.203 x 0.742 (if female). (Enyu Imai, Masaru Horio, Kosaku Nitta, Kunihiro Yamagata, Kunitoshi Iseki, Yusuke Tsukamoto, Sadayoshi Ito, Hirofumi Makino, Akira Hishida, Seiichi Matsuo. Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan. Am J Kidney Dis. 2007 Dec;50(6):927-37.) | IDMS-MDRD Study Equation With JSN-CKDI Coefficient 0.741 Imai et al. 2007 | |||
MDRD 4 VARIABLE FORMULA | C161343 | A formula to estimate glomerular filtration rate that takes into account age, sex, race, and serum creatinine (Scr). eGFR (mL/min/1.73 m2) = 186 x (Scr)^-1.154 x (Age)^-0.203 x (0.742 if female) x (1.210 if African American). (Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70.) | MDRD 4 Variable Formula | |||
MDRD 5 VARIABLE FORMULA | C161344 | A formula to estimate glomerular filtration rate that takes into account age, sex, race, serum creatinine and serum urea nitrogen. eGFR (mL/min/1.73 m = 270 x creatinine (mg/dl)^-1.007 x age^-0.180 x 1.178 (if black) x 0.762 (if female) x serum urea nitrogen^-0.169. (Levey AS, Greene T, Kusek JW, Beck GJ, MDRD study group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.) | MDRD 5 Variable Formula | |||
MDRD 6 VARIABLE FORMULA | C161345 | A formula to estimate glomerular filtration rate that takes into account age, sex, race, serum creatinine, serum urea nitrogen, and albumin. eGFR (mL/min/1.73 m2) = 170 x (SCr/88.4)^-0.999 x age^-0.176 x (SU x 2.78)^-0.170 x albumin^0.318 x (0.762, if female) x (1.18, if African American). (Levey AS, Greene T, Kusek JW, Beck GJ, MDRD study group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.) | MDRD 6 Variable Formula | |||
MDRD ENZYMATIC FORMULA | C161346 | IDMS MDRD | A formula to estimate glomerular filtration rate that takes into account age, sex, race, and serum creatinine. eGFR (mL/min/1.73 m2)=175 x (serum Cr [conv mg/dL])^-1.154 x (Age)^ -0.203 x (0.742 if female) x (1.212 if black), for conventional units. eGFR=175 x (serum Cr [SI UMOL/L]/88.4)^-1.154 x (Age)^ -0.203 x (0.742 if female) x (1.212 if black), for SI units. (Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.) | MDRD Enzymatic Formula | ||
MDRD ENZYMATIC JAPANESE FORMULA | C161347 | A formula to estimate glomerular filtration rate in Japanese subjects that takes into account age, sex, and serum creatinine. eGFR (ml/min/1.73m2) = 194 x PD93 power^-1.094 x Age power^- 0.287 x Sex; where PD93 = Serum Cr (mg/dL), Sex = 1.00 for male and 0.739 for female. (Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis. 2007 Dec;50(6):927-37.) | MDRD Enzymatic Japanese Formula | |||
MDRD FORMULA | C176295 | MDRD GFR Formula;Modification of Diet in Renal Disease Formula | An unspecified MDRD-based formula to estimate glomerular filtration rate that takes into account factors such as sex, age, race, and biomarker measurements. | Modification of Diet in Renal Disease Formula | ||
NASH FIBROSURE FORMULA | C172487 | NASH FibroSURE Formula;NASH Test | A proprietary algorithm derived from the FibroTest liver fibrosis algorithm that is used to measure liver fibrosis, hepatic steatosis, and non-alcoholic steatohepatitis. It includes ten serum markers: alpha-2-macroglobulin, apolipoprotein A1, total bilirubin, gamma-glutamyltransferase, haptoglobin, alanine aminotransferase, aspartate aminotransferase, glucose, total cholesterol, and triglycerides, and adjusts for age, gender, height, and weight. (NCI) | NASH Fibrosure Formula | ||
SCHWARTZ METHOD FOR CHILDREN FORMULA | C161348 | A formula to estimate glomerular filtration rate in children that takes into account age, height, and serum creatinine. eGFR (mL/min/1.73 m2) = k x Height (cm)/Serum creatinine (mg/dL) where k=0.33 for pre-term babies, 0.45 for full-term babies and 0.55 for girls ages 1-13 or 0.70 for boys ages 1-13. (Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr. 1985 Mar;106(3):522-6.) | Schwartz Method For Children Formula | |||
Back to top | ||||||
CL.C65047.LBTESTCD | Laboratory Test Code
(LBTESTCD) | text
Extensible: Yes | C65047 | Laboratory Test Code | Terminology used for laboratory test codes of the CDISC Study Data Tabulation Model. | CDISC SDTM Laboratory Test Code Terminology |
A1AGLP | C100429 | Alpha-1 Acid Glycoprotein | A measurement of the alpha-1 acid glycoprotein in a biological specimen. | Alpha-1 Acid Glycoprotein Measurement | ||
A1ANTRPF | C181404 | Alpha-1 Antitrypsin, Functional | A measurement of the functional alpha-1 antitrypsin in a biological specimen. | Functional Alpha-1 Antitrypsin Measurement | ||
A1ANTRYP | C80167 | Alpha-1 Antitrypsin;Serum Trypsin Inhibitor | A measurement of the alpha-1 antitrypsin in a biological specimen. | Alpha-1 Antitrypsin Measurement | ||
A1MCGEXR | C186022 | Alpha-1 Microglobulin Excretion Rate | A measurement of the amount of alpha-1 microglobulin being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Alpha-1 Microglobulin Excretion Rate Measurement | ||
A1MCREAT | C100462 | Alpha-1 Microglobulin/Creatinine | A relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen. | Alpha-1 Microglobulin to Creatinine Ratio Measurement | ||
A1MICG | C100461 | Alpha-1 Microglobulin;Protein HC | A measurement of the alpha-1 microglobulin in a biological specimen. | Alpha-1 Microglobulin Measurement | ||
A2MACG | C80168 | Alpha-2 Macroglobulin | A measurement of the alpha-2 macroglobulin in a biological specimen. | Alpha-2 Macroglobulin Measurement | ||
A73OXC | C172524 | 7-Alpha hydroxy-4-cholesten-3-one;7-alpha-Hydroxy-4-cholesten-3-one | A measurement of the 7-alpha-hydroxy-4-cholesten-3-one in a biological specimen. | 7-alpha-Hydroxy-4-cholesten-3-one Measurement | ||
AAMAPAC | C154761 | Alpha-Aminoadipate;Alpha-Aminoadipic Acid | A measurement of the alpha-aminoadipic acid in a biological specimen. | Alpha-Aminoadipic Acid Measurement | ||
AAMBTAC | C154759 | Alpha-aminobutyrate;Alpha-Aminobutyric Acid;Homoalanine | A measurement of the alpha-aminobutyric acid in a biological specimen. | Alpha-Aminobutyric Acid Measurement | ||
AAP | C100430 | Alanine Aminopeptidase | A measurement of the alanine aminopeptidase in a biological specimen. | Alanine Aminopeptidase Measurement | ||
AATZPL | C189527 | AAT Z-Polymer;Alpha-1 Antitrypsin Z-Polymer | A measurement of the polymers of Z-variant alpha-1 antitrypsin in a biological specimen. | Alpha-1 Antitrypsin Z-Polymer Measurement | ||
ABFBCA | C184526 | AB-FUBINACA | A measurement of the synthetic cannabinoid AB-FUBINACA in a biological specimen. | AB-FUBINACA Measurement | ||
ABNCE | C111124 | Abnormal Cells | A measurement of the abnormal cells in a biological specimen. | Abnormal Cell Count | ||
ABNCECE | C150835 | Abnormal Cells/Total Cells | A relative measurement (ratio or percentage) of abnormal cells to total cells in a biological specimen. | Abnormal Cells to Total Cells Ratio Measurement | ||
ABNCELE | C150834 | Abnormal Cells/Leukocytes | A relative measurement (ratio or percentage) of abnormal cells to leukocytes in a biological specimen. | Abnormal Cells to Leukocytes Ratio Measurement | ||
ABO | C125939 | ABO Blood Group | The characterization of the blood type of an individual by testing for the presence of A antigen and B antigen on the surface of red blood cells. | ABO Blood Group Determination | ||
ABOA1 | C135397 | ABO A1 Subtype | The characterization of the ABO blood group A1 subtype in an individual. (NCI) | ABO A1 Subtype Determination | ||
ABPNCA | C184527 | AB-PINACA | A measurement of the synthetic cannabinoid AB-PINACA in a biological specimen. | AB-PINACA Measurement | ||
ACANT | C74699 | Acanthocytes | A measurement of the acanthocytes in a biological specimen. | Acanthocyte Count | ||
ACANTRBC | C74633 | Acanthocytes/Erythrocytes | A relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen. | Acanthocyte to Erythrocyte Ratio Measurement | ||
ACE | C80169 | Angiotensin Converting Enzyme | A measurement of the angiotensin converting enzyme in a biological specimen. | Angiotensin Converting Enzyme Measurement | ||
ACETAMIN | C135398 | Acetaminophen;Paracetamol | A measurement of the acetaminophen in a biological specimen. | Acetaminophen Measurement | ||
ACETOAC | C92247 | Acetoacetate;Acetoacetic Acid | A measurement of the acetoacetic acid in a biological specimen. | Acetoacetic Acid Measurement | ||
ACETONE | C147288 | Acetone | A measurement of the acetone in a biological specimen. | Acetone Measurement | ||
ACH | C74838 | Acetylcholine | A measurement of the acetylcholine hormone in a biological specimen. | Acetylcholine Measurement | ||
ACHE | C96560 | Acetylcholinesterase | A measurement of the acetylcholinesterase in a biological specimen. | Acetylcholinesterase Measurement | ||
ACHRAB | C96559 | Acetylcholine Receptor Antibody | A measurement of the acetylcholine receptor antibody in a biological specimen. | Acetylcholine Receptor Antibody Measurement | ||
ACPHOS | C80163 | Acid Phosphatase | A measurement of the acid phosphatase in a biological specimen. | Acid Phosphatase Measurement | ||
ACRNCRNF | C147289 | Acylcarnitine/Carnitine, Free | A relative measurement (ratio or percentage) of the acylcarnitine to free carnitine in a biological specimen. | Acylcarnitine to Free Carnitine Ratio Measurement | ||
ACSPGM | C189522 | Acid Sphingomyelinase | A measurement of the acid sphingomyelinase in a biological specimen. | Sphingomyelin Phosphodiesterase Measurement | ||
ACT | C103348 | Activated Clotting Time;Activated Coagulation Time | A measurement of the inhibition of blood coagulation in response to anticoagulant therapies. | Activated Coagulation Time | ||
ACTACEXR | C189521 | Acetoacetate Excretion Rate;Acetoacetic Acid Excretion Rate | A measurement of the amount of acetoacetic acid being excreted in a biological specimen over a defined period of time (e.g. one hour). | Acetoacetic Acid Excretion Rate Measurement | ||
ACTB | C184510 | Actin Beta;B-Actin;Beta-Actin | A measurement of the beta-actin in a biological specimen. | Beta-Actin Measurement | ||
ACTH | C74780 | Adrenocorticotropic Hormone;Corticotropin | A measurement of the adrenocorticotropic hormone in a biological specimen. | Adrenocorticotropic Hormone Measurement | ||
ACYCRNTN | C156535 | Acylcarnitine | A measurement of the acylcarnitine in a biological specimen. | Acylcarnitine Measurement | ||
ACYGLYCN | C156534 | Acylglycine | A measurement of the acylglycine in a biological specimen. | Acylglycine Measurement | ||
ACYLCAOX | C92286 | Acyl CoA Oxidase;Acyl Coenzyme A Oxidase;Fatty Acyl Coenzyme A Oxidase | A measurement of the acyl coenzyme A oxidase in a biological specimen. | Acyl Coenzyme A Oxidase Measurement | ||
ADAM8 | C147290 | A Disintegrin And Metalloproteinase Domain 8;ADAM Metallopeptidase Domain 8;CD156a Antigen | A measurement of the ADAM metallopeptidase domain 8 protein in a biological specimen. | ADAM Metallopeptidase Domain 8 Measurement | ||
ADAMTS13 | C187684 | A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 13;ADAM Metallopeptidase With Thrombospondin Type 1 Motif 13;von Willebrand Coagulation Factor Cleaving Protease ADAMTS13 | A measurement of the von Willebrand coagulation factor cleaving protease, ADAMTS13, in a biological specimen. | von Willebrand Coagulation Factor Cleaving Protease Measurement | ||
ADBPNCA | C184529 | ADB-PINACA | A measurement of the synthetic cannabinoid ADB-PINACA in a biological specimen. | ADB-PINACA Measurement | ||
ADH | C74847 | Antidiuretic Hormone;Vasopressin | A measurement of the antidiuretic hormone in a biological specimen. | Antidiuretic Hormone Measurement | ||
ADMA | C158233 | Asymmetric Dimethylarginine;N,N-dimethylarginine | A measurement of asymmetric dimethylarginine in a biological specimen. | Asymmetric Dimethylarginine Measurement | ||
ADMTS13A | C187830 | A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 13 Activity;ADAM Metallopeptidase With Thrombospondin Type 1 Motif 13 Activity;ADAMTS13 Activity;von Willebrand Coagulation Factor Cleaving Protease ADAMTS13 Activity | A measurement of the biological activity of von Willebrand coagulation factor cleaving protease, ADAMTS13, in a biological specimen. | von Willebrand Coagulation Factor Cleaving Protease Activity Measurement | ||
ADP | C102257 | Adenosine Diphosphate | A measurement of the adenosine diphosphate in a biological specimen. | Adenosine Diphosphate Measurement | ||
ADPNCTN | C74839 | Adiponectin | A measurement of the total adiponectin hormone in a biological specimen. | Adiponectin Measurement | ||
ADPNHMW | C132363 | Adiponectin, High Molecular Weight | A measurement of the high molecular weight adiponectin hormone in a biological specimen. | High Molecular Weight Adiponectin Measurement | ||
ADSDNA | C74913 | Anti-Double Stranded DNA | A measurement of the anti-double stranded DNA antibody in a biological specimen. | Anti-Double Stranded DNA Measurement | ||
AFACTXAA | C98706 | Anti-Factor Xa Activity | A measurement of the ability of antithrombin to inactivate activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen. | Anti-Factor Xa Activity Measurement | ||
AFP | C74732 | Alpha Fetoprotein;Alpha-1-Fetoprotein | A measurement of the alpha fetoprotein in a biological specimen. | Alpha-fetoprotein Measurement | ||
AFPADJBW | C147291 | Alpha Fetoprotein Adj for Body Weight | A measurement of alpha fetoprotein, which has been adjusted for body weight, in a biological specimen. | Alpha Fetoprotein Adjusted for Body Weight Measurement | ||
AFPL1 | C96562 | Alpha Fetoprotein L1 | A measurement of the alpha fetoprotein L1 in a biological specimen. | Alpha Fetoprotein L1 Measurement | ||
AFPL2 | C96563 | Alpha Fetoprotein L2 | A measurement of the alpha fetoprotein L2 in a biological specimen. | Alpha Fetoprotein L2 Measurement | ||
AFPL3 | C96564 | Alpha Fetoprotein L3 | A measurement of the alpha fetoprotein L3 in a biological specimen. | Alpha Fetoprotein L3 Measurement | ||
AFPL3AFP | C96565 | A Fetoprotein L3/A Fetoprotein | A relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen. | Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement | ||
AG1_5 | C124334 | 1,5-Anhydroglucitol | A measurement of the 1,5-anhydroglucitol in a biological specimen. | 1,5-Anhydroglucitol Measurement | ||
AHBDH | C111126 | Alpha Hydroxybutyrate Dehydrogenase | A measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen. | Alpha Hydroxybutyrate Dehydrogenase Measurement | ||
AHTRZLM | C181418 | Alpha-Hydroxytriazolam | A measurement of the alpha-hydroxytriazolam a biological specimen. | Alpha-Hydroxytriazolam Measurement | ||
ALA | C122091 | Alanine | A measurement of the alanine in a biological specimen. | Alanine Measurement | ||
ALA1ALB | C147292 | Apolipoprotein A1/Apolipoprotein B | A relative measurement (ratio or percentage) of the Apolipoprotein A1 to Apolipoprotein B in a biological specimen. | Apolipoprotein A1 to Apolipoprotein B Ratio Measurement | ||
ALAALB | C158222 | Apolipoprotein A/Apolipoprotein B | A relative measurement (ratio) of the total apolipoprotein A to apolipoprotein B in a biological specimen. | Apolipoprotein A to Apolipoprotein B Ratio Measurement | ||
ALB | C64431 | Albumin;Microalbumin | A measurement of the albumin protein in a biological specimen. | Albumin Measurement | ||
ALBC | C147293 | Albumin Clearance | A measurement of the albumin clearance in a biological specimen. | Albumin Clearance | ||
ALBCREAT | C74761 | Albumin/Creatinine;Microalbumin/Creatinine Ratio | A relative measurement (ratio) of the albumin to the creatinine in a biological specimen. | Albumin To Creatinine Protein Ratio Measurement | ||
ALBEXR | C150814 | Albumin Excretion Rate | A measurement of the amount of albumin excreted in a biological specimen over a defined period of time (e.g. one hour). | Albumin Excretion Rate | ||
ALBGALB | C158228 | Glycated Albumin/Albumin;Glycosylated Albumin/Albumin | A relative measurement (ratio or percentage) of the glycated albumin to total albumin in a biological specimen. | Glycated Albumin to Albumin Ratio Measurement | ||
ALBGLOB | C74894 | Albumin/Globulin | The ratio of albumin to globulin in a biological specimen. | Albumin to Globulin Ratio Measurement | ||
ALBGLYCA | C122092 | Glycated Albumin | A measurement of the glycated albumin present in a biological specimen. | Glycated Albumin Measurement | ||
ALBIDX | C154734 | Albumin Index | A relative measurement (ratio) of the albumin in cerebrospinal fluid to albumin in serum or plasma in a biological specimen. | Albumin Index | ||
ALBPROT | C103453 | Albumin/Total Protein | A relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen. | Albumin to Total Protein Ratio Measurement | ||
ALDEPX | C154743 | Aldrin Epoxidase | A measurement of the aldrin epoxidase in a biological specimen. | Aldrin Epoxidase Measurement | ||
ALDOLASE | C74731 | Aldolase | A measurement of the aldolase enzyme in a biological specimen. | Aldolase Measurement | ||
ALDSTRN | C74841 | Aldosterone | A measurement of the aldosterone hormone in a biological specimen. | Aldosterone Measurement | ||
ALFNTNL | C184566 | Alfentanil | A measurement of the alfentanil in a biological specimen. | Alfentanil Measurement | ||
ALLOILE | C154762 | Alloisoleucine | A measurement of the alloisoleucine in a biological specimen. | Alloisoleucine Measurement | ||
ALOX5 | C184519 | 5-Lipoxygenase;5-LO;5-LOX;ALOX5;Arachidonate 5-Lipoxygenase | A measurement of the arachidonate 5-lipoxygenase in a biological specimen. | Arachidonate 5-Lipoxygenase Measurement | ||
ALP | C64432 | Alkaline Phosphatase | A measurement of the alkaline phosphatase in a biological specimen. | Alkaline Phosphatase Measurement | ||
ALPBALP | C147294 | Alk Phos, Bone/Total Alk Phos;Alkaline Phosphatase, Bone/Total Alkaline Phosphatase | A relative measurement (ratio or percentage) of the bone specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. | Bone Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement | ||
ALPBS | C92287 | Bone Specific Alkaline Phosphatase | A measurement of the bone specific alkaline phosphatase isoform in a biological specimen. | Bone Specific Alkaline Phosphatase Measurement | ||
ALPCREAT | C79438 | Alkaline Phosphatase/Creatinine | A relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen. | Alkaline Phosphatase to Creatinine Ratio Measurement | ||
ALPEXR | C165942 | Alkaline Phosphatase Excretion Rate | A measurement of the amount of alkaline phosphatase being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Alkaline Phosphatase Excretion Rate | ||
ALPIALP | C147295 | Alk Phos, Intestinal/Total Alk Phos;Alkaline Phosphatase, Intestinal/Total Alkaline Phosphatase | A relative measurement (ratio or percentage) of the intestinal specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. | Intestinal Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement | ||
ALPIS | C119266 | Intestinal Specific Alkaline Phosphatase | A measurement of the intestinal specific alkaline phosphatase isoform in a biological specimen. | Intestinal Specific Alkaline Phosphatase Measurement | ||
ALPISOE | C139091 | Alkaline Phosphatase Isoenzyme | A measurement of the alkaline phosphatase isoenzyme in a biological specimen. | Alkaline Phosphatase Isoenzyme Measurement | ||
ALPLALP | C147296 | Alk Phos, Liver/Total Alk Phos;Alkaline Phosphatase, Liver/Total Alkaline Phosphatase | A relative measurement (ratio or percentage) of the liver specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. | Liver Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement | ||
ALPLBALP | C189497 | Alk Phos, Liver + Bone/Total Alk Phos | A relative measurement (ratio or percentage) of the liver and bone specific alkaline phosphatase isoforms to total alkaline phosphatase in a biological specimen. | Liver and Bone Specific Alkaline Phosphatase Isoform to Alkaline Phosphatase Ratio Measurement | ||
ALPLS | C119267 | Liver Specific Alkaline Phosphatase | A measurement of the liver specific alkaline phosphatase isoform in a biological specimen. | Liver Specific Alkaline Phosphatase Measurement | ||
ALPPALP | C184508 | Alk Phos, Placental/Total Alk Phos;Alkaline Phosphatase, Placental/Total Alkaline Phosphatase | A relative measurement (ratio or percentage) of the placental specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. | Placental Alkaline Phosphatase to Total Alkaline Phosphatase Measurement | ||
ALPPS | C184509 | Placental Specific Alkaline Phosphatase | A measurement of the placental specific alkaline phosphatase isoform in a biological specimen. | Placental Specific Alkaline Phosphatase Measurement | ||
ALPRZLM | C75370 | Alprazolam | A measurement of the alprazolam present in a biological specimen. | Alprazolam Measurement | ||
ALS | C163419 | Acid Labile Subunit;ALS;IGFALS;Insulin Like Growth Factor Binding Protein Acid Labile Subunit | A measurement of the acid labile subunit in a biological specimen. | Acid Labile Subunit Measurement | ||
ALT | C64433 | Alanine Aminotransferase;SGPT | A measurement of the alanine aminotransferase in a biological specimen. | Alanine Aminotransferase Measurement | ||
ALTAST | C106498 | ALT/AST | A relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample. | Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement | ||
ALTCPHRL | C103349 | Alpha Tocopherol | A measurement of the alpha tocopherol in a biological specimen. | Alpha Tocopherol Measurement | ||
ALUMINUM | C111127 | Al;Aluminum | A measurement of aluminum in a biological specimen. | Aluminum Measurement | ||
AM2201 | C184539 | AM-2201;AM2201 | A measurement of the synthetic cannabinoid AM-2201 in a biological specimen. | AM-2201 Measurement | ||
AM694N5H | C184538 | AM694 N-5-hydroxypentyl | A measurement of the synthetic cannabinoid metabolite AM694 N-5-hydroxypentyl in a biological specimen. | AM694 N-5-hydroxypentyl Measurement | ||
AMA | C81975 | Antimitochondrial Antibodies;Mitochondrial Antibody | A measurement of the antimitochondrial antibodies in a biological specimen. | Antimitochondrial Antibody Measurement | ||
AMABARAB | C147297 | ACH Receptor Modulation Antibody/ACH Receptor Antibody;ACH Receptor Modulatn Ab/ACH Receptor Ab | A relative measurement (ratio or percentage) of the acetylcholine receptor modulation antibody to the total acetylcholine receptor antibodies in a biological specimen. | Acetylcholine Receptor Modulation Antibody to Acetylcholine Receptor Antibody Ratio Measurement | ||
AMACR | C132364 | Alpha-Methylacyl Coenzyme A Racemase | A measurement of the alpha-methylacyl coenzyme A racemase in a biological specimen. | Alpha-Methylacyl Coenzyme A Racemase Measurement | ||
AMBRBTL | C75363 | Amobarbital | A measurement of the amobarbital present in a biological specimen. | Amobarbital Measurement | ||
AMCRMRNA | C132365 | AMACR mRNA | A measurement of the alpha-methylacyl coenzyme A racemase mRNA in a biological specimen. | Alpha-Methylacyl Coenzyme A Racemase mRNA Measurement | ||
AMH | C120625 | Anti-Mullerian Hormone | A measurement of the anti-Mullerian hormone in a biological specimen. | Anti-Mullerian Hormone Measurement | ||
AMITRPTL | C186023 | Amitriptyline | A measurement of the amitriptyline in a biological specimen. | Amitriptyline Measurement | ||
AMMONIA | C74799 | Ammonia;NH3 | A measurement of the ammonia in a biological specimen. | Ammonia Measurement | ||
AMNM | C186024 | Ammonium;Ammonium Ion;NH4+ | A measurement of the ammonium ion (NH4+) in a biological specimen. | Ammonium Measurement | ||
AMNMCRT | C186025 | Ammonium/Creatinine | A relative measurement (ratio) of ammonium to creatinine in a biological specimen. | Ammonium to Creatinine Ratio Measurement | ||
AMNOACID | C81183 | AA;Amino Acids | A measurement of the total amino acids in a biological specimen. | Amino Acid Measurement | ||
AMORPHSD | C74666 | Amorphous Debris;Amorphous Sediment | A measurement of the amorphous sediment present in a biological specimen. | Amorphous Sediment Measurement | ||
AMPEA | C75347 | Alpha-Methylphenethylamine;Amphetamine | A measurement of the alpha-methylphenethylamine in a biological specimen. | Amphetamine Measurement | ||
AMPHET | C74687 | Amphetamine | A measurement of any amphetamine class drug present in a biological specimen. | Amphetamine Drug Class Measurement | ||
AMPHETD | C102262 | d-amphetamine;Dextroamphetamine | A measurement of the dextroamphetamine in a biological specimen. | Dextroamphetamine Measurement | ||
AMYLASE | C64434 | Amylase | A measurement of the total enzyme amylase in a biological specimen. | Amylase Measurement | ||
AMYLASEM | C111243 | Macroamylase | A measurement of macroamylase in a biological specimen. | Macroamylase Measurement | ||
AMYLASEP | C98767 | Amylase, Pancreatic;Pancreatic Amylase Isoenzyme | A measurement of the pancreatic enzyme amylase in a biological specimen. | Pancreatic Amylase Measurement | ||
AMYLASES | C98780 | Amylase, Salivary;Salivary Amylase Isoenzyme | A measurement of the salivary enzyme amylase in a biological specimen. | Salivary Amylase Measurement | ||
AMYLB38 | C103352 | Amyloid Beta 1-38;Amyloid Beta 38;Amyloid Beta 38 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen. | Amyloid Beta 1-38 Measurement | ||
AMYLB40 | C103353 | Amyloid Beta 1-40;Amyloid Beta 40;Amyloid Beta 40 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen. | Amyloid Beta 1-40 Measurement | ||
AMYLB41 | C184518 | Amyloid Beta 1-41;Amyloid Beta 41;Amyloid Beta 41 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 41 in a biological specimen. | Amyloid Beta 1-41 Measurement | ||
AMYLB42 | C84809 | Amyloid Beta 1-42;Amyloid Beta 42;Amyloid Beta 42 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen. | Beta Amyloid 42 Measurement | ||
AMYLOIDA | C125940 | Amyloid A | A measurement of the total amyloid A in a biological specimen. | Amyloid A Measurement | ||
AMYLOIDB | C81999 | Amyloid, Beta;Beta Amyloid | A measurement of the total amyloid beta in a biological specimen. | Beta Amyloid Measurement | ||
AMYLOIDP | C81998 | Amyloid P;Amyloid P Component;SAP;Serum Amyloid P Component | A measurement of the total amyloid P in a biological specimen. | Amyloid P Measurement | ||
ANA | C74916 | Antinuclear Antibodies | A measurement of the total antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen. | Antinuclear Antibody Measurement | ||
ANAB | C176313 | Anti-Neutrophil Antibody | A measurement of the total anti-neutrophil antibody in a biological specimen. | Anti-Neutrophil Antibody Measurement | ||
ANABASN | C147298 | Anabasine | A measurement of the anabasine in a biological specimen. | Anabasine Measurement | ||
ANAG | C147299 | Alpha-N-acetylglucosaminidase | A measurement of the alpha-N-acetylglucosaminidase in a biological specimen. | Alpha-N-acetylglucosaminidase Measurement | ||
ANAIGGAB | C122093 | Antinuclear IgG Antibody | A measurement of the antinuclear IgG antibody in a biological specimen. | Antinuclear IgG Antibody Measurement | ||
ANCAB | C120626 | Anti-Neutrophil Cytoplasmic Antibody | A measurement of the anti-neutrophil cytoplasmic antibody in a biological specimen. | Anti-Neutrophil Cytoplasmic Antibody Measurement | ||
ANCATYAB | C147300 | Anti-Neutrophil Cytoplasmic Antibody, Atypical;Neutrophil Cytoplasmic Ab, Atypical | A measurement of the atypical (cytoplasmic staining usually uniform and no interlobular accentuation) neutrophil cytoplasmic antibodies in a biological specimen. | Atypical Neutrophil Cytoplasmic Antibody Measurement | ||
ANCCLSAB | C147301 | Anti-Neutrophil Cytoplasmic Antibody, Classic;Neutrophil Cytoplasmic Ab, Classic | A measurement of the classic (cytoplasmic granular fluorescence with central interlobular accentuation) neutrophil cytoplasmic antibodies in a biological specimen. | Classic Neutrophil Cytoplasmic Antibody Measurement | ||
ANCIGAB | C163420 | Anti-Neutrophil Cytoplasmic IgG Antibody | A measurement of the anti-neutrophil cytoplasmic IgG antibody in a biological specimen. | Anti-Neutrophil Cytoplasmic IgG Antibody Measurement | ||
ANCPNCAB | C147302 | Anti-Neutrophil Cytoplasmic Antibody, Perinuclear;Neutrophil Cytoplasmic Ab, Perinuclear | A measurement of the perinuclear (perinuclear staining without nuclear extension) neutrophil cytoplasmic antibodies in a biological specimen. | Perinuclear Neutrophil Cytoplasmic Antibody Measurement | ||
ANDSTNDL | C74842 | Androstenediol | A measurement of the androstenediol metabolite in a biological specimen. | Androstenediol Metabolite Measurement | ||
ANDSTNDN | C74843 | 4-Androstenedione;Androstenedione | A measurement of the androstenedione hormone in a biological specimen. | Androstenedione Measurement | ||
ANDSTRN | C186026 | Androsterone | A measurement of the androsterone in a biological specimen. | Androsterone Measurement | ||
ANGLBIND | C91372 | Antiglobulin Test, Indirect;Indirect Coombs Test | A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen. | Indirect Antiglobulin Test | ||
ANGLOBDR | C81974 | Antiglobulin Test Polyspecific, Direct;Antiglobulin Test, Direct;Direct Coombs Test | A measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo. | Direct Antiglobulin Test | ||
ANGPT1 | C111128 | Angiopoietin 1 | A measurement of angiopoietin 1 in a biological specimen. | Angiopoietin 1 Measurement | ||
ANGPT2 | C163421 | ANG2;Angiopoietin 2 | A measurement of angiopoietin 2 in a biological specimen. | Angiopoietin 2 Measurement | ||
ANGTNS1 | C74844 | Angiotensin I | A measurement of the angiotensin I hormone in a biological specimen. | Angiotensin I Measurement | ||
ANGTNS2 | C74845 | Angiotensin II | A measurement of the angiotensin II hormone in a biological specimen. | Angiotensin II Measurement | ||
ANGTNSGN | C74846 | Angiotensin Precursor;Angiotensinogen | A measurement of the angiotensinogen hormone in a biological specimen. | Angiotensinogen Measurement | ||
ANIONG | C74685 | Anion Gap | A computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen. | Anion Gap Measurement | ||
ANIONG3 | C147303 | Anion Gap 3 | A computed estimate of the unmeasured anions (computed as sodium minus the chloride and bicarbonate) in a biological specimen. | Anion Gap 3 Measurement | ||
ANIONG4 | C147304 | Anion Gap 4 | A computed estimate of the unmeasured anions (computed as the difference between the sum of serum sodium + serum potassium and the sum of the serum bicarbonate+ chloride) in a biological specimen. | Anion Gap 4 Measurement | ||
ANISO | C74797 | Anisocytes;Anisocytosis | A measurement of the variability in the size of the red blood cells in a whole blood specimen. | Anisocyte Measurement | ||
ANISOCHR | C161354 | Anisochromia | A measurement of the color variation of erythrocytes in a biological specimen. | Anisochromia Measurement | ||
ANLRDN | C184568 | Anileridine | A measurement of the anileridine in a biological specimen. | Anileridine Measurement | ||
ANP | C74886 | Atrial Natriuretic Peptide;Atriopeptin | A measurement of the atrial natriuretic peptide in a biological specimen. | Atrial Natriuretic Peptide Measurement | ||
ANPPROMR | C172523 | Mid-Reg Pro-Atrial Natriuretic Peptide;Mid-Regional Pro-Atrial Natriuretic Peptide;MR-proANP;MRproANP | A measurement of the mid-regional pro-atrial natriuretic peptide in a biological specimen. | Mid-Regional Pro-Atrial Natriuretic Peptide Measurement | ||
ANPPRONT | C139088 | N-terminal pro-Atrial Natriuretic Peptide;N-Terminal ProA-type Natriuretic Peptide;NT proANP II | A measurement of the N-terminal proA-type natriuretic peptide in a biological specimen. | N-Terminal ProA-type Natriuretic Peptide Measurement | ||
ANTHRMA | C81958 | Antithrombin Activity;Antithrombin III Activity | A measurement of the antithrombin activity in a biological specimen. | Antithrombin Activity Measurement | ||
ANTHRMAG | C81977 | Antithrombin;Antithrombin Antigen;Antithrombin III;Antithrombin III Antigen | A measurement of the antithrombin antigen in a biological specimen. | Antithrombin Antigen Measurement | ||
ANTIDPRS | C74691 | Antidepressants | A measurement of any antidepressant class drug present in a biological specimen. | Antidepressant Measurement | ||
ANUAB | C120627 | Anti-Nucleosome Antibody | A measurement of the anti-nucleosome antibody in a biological specimen. | Anti-Nucleosome Antibody Measurement | ||
APAPCYS | C172525 | Acetaminophen Protein Adduct;Acetaminophen-Cysteine Adduct;APAP-CYS;APAP-Protein | A measurement of the acetaminophen-cysteine adducts in a biological specimen. | Acetaminophen-Cysteine Adduct Measurement | ||
APLAB | C102258 | Antiphospholipid Antibodies | A measurement of the total antiphospholipid antibodies in a biological specimen. | Antiphospholipid Antibody Measurement | ||
APLASCPD | C161372 | APTT-LA Screen to Confirm Percent Difference;PTT-LA Screen to Confirm Pct Difference | A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen aPTT - Confirm aPTT)/Screen aPTT]x100. | APTT-LA Screen to Confirm Percent Difference | ||
APLIGGAB | C124335 | Anti-Phospholipid IgG Antibody | A measurement of the antiphospholipid IgG antibody in a biological specimen. | Anti-Phospholipid IgG Antibody Measurement | ||
APLIGMAB | C124336 | Anti-Phospholipid IgM Antibody | A measurement of the antiphospholipid IgM antibody in a biological specimen. | Anti-Phospholipid IgM Antibody Measurement | ||
APLSMA2 | C103351 | Alpha-2 Antiplasmin;Alpha-2 Plasmin Inhibitor | A measurement of the alpha-2 antiplasmin in a biological specimen. | Alpha-2 Antiplasmin Measurement | ||
APLSMA2A | C122094 | Alpha-2 Antiplasmin Activity | A measurement of the alpha-2 antiplasmin activity in a biological specimen. | Alpha-2 Antiplasmin Activity Measurement | ||
APOA | C124337 | Apolipoprotein A | A measurement of the total apolipoprotein A in a biological specimen. | Apolipoprotein A Measurement | ||
APOA1 | C74733 | Apolipoprotein A1 | A measurement of the apolipoprotein A1 in a biological specimen. | Apolipoprotein A1 Measurement | ||
APOA2 | C82000 | Apolipoprotein AII | A measurement of the apolipoprotein AII in a biological specimen. | Apolipoprotein AII Measurement | ||
APOA4 | C103354 | Apolipoprotein A4 | A measurement of the apolipoprotein A4 in a biological specimen. | Apolipoprotein A4 Measurement | ||
APOA5 | C103355 | Apolipoprotein A5 | A measurement of the apolipoprotein A5 in a biological specimen. | Apolipoprotein A5 Measurement | ||
APOB | C74734 | Apolipoprotein B | A measurement of the total apolipoprotein B in a biological specimen. | Apolipoprotein B Measurement | ||
APOB100 | C120628 | Apolipoprotein B100 | A measurement of the apolipoprotein B100 in a biological specimen. | Apolipoprotein B100 Measurement | ||
APOB48 | C120629 | Apolipoprotein B48 | A measurement of the apolipoprotein B48 in a biological specimen. | Apolipoprotein B48 Measurement | ||
APOBAPA1 | C103356 | Apolipoprotein B/Apolipoprotein A1 | A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen. | Apolipoprotein B to Apolipoprotein A1 Ratio Measurement | ||
APOC1 | C120630 | Apolipoprotein CI | A measurement of the apolipoprotein CI in a biological specimen. | Apolipoprotein CI Measurement | ||
APOC2 | C100427 | Apolipoprotein C2;Apolipoprotein CII | A measurement of the apolipoprotein C2 in a biological specimen. | Apolipoprotein C2 Measurement | ||
APOC3 | C82001 | Apolipoprotein CIII | A measurement of the apolipoprotein CIII in a biological specimen. | Apolipoprotein CIII Measurement | ||
APOD | C198281 | Apolipoprotein D | A measurement of the apolipoprotein D in a biological specimen. | Apolipoprotein D Measurement | ||
APOE | C82002 | Apolipoprotein E | A measurement of the apolipoprotein E in a biological specimen. | Apolipoprotein E Measurement | ||
APOE4 | C92293 | Apolipoprotein E4 | A measurement of the apolipoprotein E4 in a biological specimen. | Apolipoprotein E4 Measurement | ||
APOH | C82003 | Apolipoprotein H | A measurement of the apolipoprotein H in a biological specimen. | Apolipoprotein H Measurement | ||
APOJ | C100428 | Apolipoprotein J;Clusterin | A measurement of the apolipoprotein J in a biological specimen. | Apolipoprotein J Measurement | ||
APOJCRT | C111130 | Apolipoprotein J/Creatinine;Clusterin/Creatinine | A relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen. | Apolipoprotein J to Creatinine Ratio Measurement | ||
APPA | C119268 | Amyloid Alpha Precursor Protein | A measurement of the amyloid alpha precursor protein present in a biological specimen. | Amyloid Alpha Precursor Protein Measurement | ||
APPB | C105438 | Amyloid Beta Precursor;Amyloid Beta Precursor Protein;Amyloid Precursor Beta;Amyloid Precursor Protein | A measurement of the amyloid beta precursor protein present in a biological specimen. | Amyloid Beta Precursor Protein Measurement | ||
APPEAR | C179695 | Specimen Appearance | The outward or visible aspect of a specimen. | Specimen Appearance Assessment | ||
APPT | C119269 | Total Amyloid Precursor Protein | A measurement of the total amyloid precursor protein present in a biological specimen. | Total Amyloid Precursor Protein Measurement | ||
APRBRBTL | C184578 | Aprobarbital | A measurement of the aprobarbital in a biological specimen. | Aprobarbital Measurement | ||
APRI | C156512 | APRI Score;AST to Platelet Ratio Index | A calculation that indicates the likely presence of liver cirrhosis and fibrosis, measured as the relative measurement of aspartate aminotransferase (AST) to AST upper limit of normal, divided by the platelet count, and multiplied by 100. | Aspartate Aminotransferase to Platelet Ratio Index | ||
APRIL | C111123 | A Proliferation-Inducing Ligand;CD256;TNFSF13;Tumor Necrosis Factor Ligand Superfamily Member 13 | A measurement of the a proliferation-inducing ligand in a biological specimen. | A Proliferation-Inducing Ligand Measurement | ||
APROTCRS | C100471 | Activated Protein C Resistance;Factor V Leiden Screen | A measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen. | Activated Protein C Resistance Measurement | ||
APTT | C38462 | Activated Partial Thromboplastin Time | A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a biological specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. | Activated Partial Thromboplastin Time | ||
APTTLAAC | C161369 | APTT-LA Actual/Control;Lupus Anticoagulant Sensitive APTT Actual/Control | A relative measurement (ratio or percentage) of the Lupus anticoagulant sensitive APTT in a subject's specimen when compared to a control specimen. | APTT-LA Actual to Control Ratio Measurement | ||
APTTLAS | C102277 | APTT-LA;Lupus Anticoagulant Sensitive APTT | A measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen. | Lupus Anticoagulant Sensitive APTT Measurement | ||
APTTSTND | C98862 | Activated Partial Thromboplastin Time/Standard Thromboplastin Time;Activated PTT/Standard;Activated PTT/Standard PTT | A relative measurement (ratio or percentage) of the subject's activated partial thromboplastin time to a standard or control partial thromboplastin time. | Activated PTT/Standard Ratio Measurement | ||
ARA | C102259 | Arachidonic Acid | A measurement of the arachidonic acid present in a biological specimen. | Arachidonic Acid Measurement | ||
ARG | C122095 | Arginine | A measurement of the arginine in a biological specimen. | Arginine Measurement | ||
ARGSAC | C154763 | Argininosuccinate;Argininosuccinic Acid | A measurement of the argininosuccinic acid in a biological specimen. | Argininosuccinic Acid Measurement | ||
ARPIPZL | C177974 | Aripiprazole | A measurement of the aripiprazole in a biological specimen. | Aripiprazole Measurement | ||
ARR | C124338 | Aldosterone/Renin Activity | A relative measurement (ratio) of the aldosterone to renin activity in a biological specimen. | Aldosterone to Renin Activity Ratio Measurement | ||
ARSENIC | C147305 | Arsenic;As | A measurement of the arsenic in a biological specimen. | Arsenic Measurement | ||
ASENAPN | C177985 | Asenapine | A measurement of the asenapine in a biological specimen. | Asenapine Measurement | ||
ASMACT | C163422 | Alpha-Actin 2;Alpha-SMA;Alpha-Smooth Muscle Actin | A measurement of the alpha-smooth muscle actin in a biological specimen. | Alpha-Smooth Muscle Actin Measurement | ||
ASN | C122096 | Asparagine | A measurement of the asparagine in a biological specimen. | Asparagine Measurement | ||
ASP | C122097 | Aspartate;Aspartic Acid | A measurement of the aspartic acid in a biological specimen. | Aspartic Acid Measurement | ||
ASSDNA | C92269 | Anti-Single Stranded DNA IgG | A measurement of the anti-single stranded DNA IgG antibody in a biological specimen. | Anti-Single Stranded DNA IgG Measurement | ||
AST | C64467 | Aspartate Aminotransferase;SGOT | A measurement of the aspartate aminotransferase in a biological specimen. | Aspartate Aminotransferase Measurement | ||
ASTAG | C81978 | Aspartate Aminotransferase Antigen;SGOT Antigen | A measurement of the aspartate aminotransferase antigen in a biological specimen. | Aspartate Aminotransferase Antigen Measurement | ||
ASTALT | C176297 | AST/ALT | A relative measurement (ratio or percentage) of the aspartate aminotransferase (AST) to alanine aminotransferase (ALT) present in a sample. | Aspartate Aminotransferase to Alanine Aminotransferase Ratio Measurement | ||
ASTCK | C158225 | Aspartate Aminotransferase/CPK;Aspartate Aminotransferase/Creatine Kinase;AST/Creatine Kinase | A relative measurement (ratio) of the aspartate aminotransferase to creatine kinase in a biological specimen. | Aspartate Aminotransferase to Creatine Kinase Ratio Measurement | ||
ASTCREAT | C117830 | Aspartate Aminotransferase/Creatinine | A relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen. | Aspartate Aminotransferase to Creatinine Ratio Measurement | ||
ASTDLG3A | C186027 | 3-Alpha-Androstanediol Glucuronide | A measurement of the 3-alpha-androstanediol glucuronide in a biological specimen. | 3-Alpha-Androstanediol Glucuronide Measurement | ||
ASYNP | C142272 | Alpha Synuclein Protein | A measurement of the alpha synuclein protein in a biological specimen. | Alpha Synuclein Protein Measurement | ||
ATHMBAAC | C147306 | Antithrombin Activity Actual/Antithrombin Activity Control;Antithrombin Activity Actual/Control;Antithrombin Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of antithrombin in a subject's specimen when compared to the same activity in a control specimen. | Antithrombin Activity Actual to Control Ratio Measurement | ||
ATHMBAC | C170592 | Antithrombin Actual/Control;Antithrombin Actual/Normal | A relative measurement (ratio or percentage) of the Antithrombin in a subject's specimen when compared to a control specimen. | Antithrombin Actual to Control Ratio Measurement | ||
ATHPIDX | C154726 | AIP;Atherogenic Index;Atherogenic Index of Plasma | A measurement of the base 10 logarithm of the ratio of molar concentration of plasma triglyceride to high density lipoprotein cholesterol in a biological specimen. | Atherogenic Index of Plasma | ||
ATP | C147307 | Adenosine Triphosphate | A measurement of the adenosine triphosphate in a biological specimen. | Adenosine Triphosphate Measurement | ||
ATPVITE | C103350 | Alpha Tocopherol/Vitamin E | A relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen. | Alpha Tocopherol to Vitamin E Ratio Measurement | ||
AUERRODS | C74657 | Auer Rods | A measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen. | Auer Rod Measurement | ||
AXL | C165943 | ARK;AXL Receptor Tyrosine Kinase;JTK11;Tyro7;UFO | A measurement of the AXL receptor tyrosine kinase in a biological specimen. | AXL Receptor Tyrosine Kinase Measurement | ||
AZURGRAN | C116185 | Azurophilic Granulation;Azurophilic Granules | An observation of azurophilic granules in a biological specimen. | Azurophilic Granule Measurement | ||
B1BGLP | C127607 | Beta-1B Glycoprotein;Hemopexin;HPX | A measurement of the beta-1B glycoprotein in a biological specimen. | Beta-1B Glycoprotein Measurement | ||
B2G1GAAB | C147308 | Beta-2 Glycoprotein 1 IgA Antibody | A measurement of the beta-2 glycoprotein 1 IgG antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgA Antibody Measurement | ||
B2G1GGAB | C103358 | Beta-2 Glycoprotein 1 IgG Antibody | A measurement of the Beta-2 glycoprotein 1 IgG antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgG Antibody Measurement | ||
B2G1GMAB | C103359 | Beta-2 Glycoprotein 1 IgM Antibody | A measurement of the Beta-2 glycoprotein 1 IgM antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgM Antibody Measurement | ||
B2GLYAB | C81979 | Beta-2 Glycoprotein Antibody | A measurement of the beta-2 glycoprotein antibody in a biological specimen. | Beta-2 Glycoprotein Antibody Measurement | ||
B2MCREAT | C127608 | Beta-2 Microglobulin/Creatinine | A relative measurement (ratio) of the beta-2 microglobulin to creatinine in a biological specimen. | Beta-2 Microglobulin to Creatinine Ratio Measurement | ||
B2MICG | C81980 | Beta-2 Microglobulin | A measurement of the beta-2 microglobulin in a biological specimen. | Beta-2 Microglobulin Measurement | ||
BACT | C64469 | Bacteria | A measurement of the bacteria in a biological specimen. | Bacterial Count | ||
BAFF | C111135 | B-Cell Activating Factor | A measurement of the B-cell activating factor in a biological specimen. | B-Cell Activating Factor Measurement | ||
BALA | C154764 | Beta Alanine | A measurement of the beta alanine in a biological specimen. | Beta Alanine Measurement | ||
BAMBTAC | C154765 | BABA;Beta-aminobutyrate;Beta-Aminobutyric Acid | A measurement of the beta-aminobutyric acid in a biological specimen. | Beta-Aminobutyric Acid Measurement | ||
BARB | C74688 | Barbiturates | A measurement of any barbiturate class drug present in a biological specimen. | Barbiturate Drug Class Measurement | ||
BASEDEF | C147309 | Base Deficit | A measurement of the amount of alkali required to return a biological specimen to a normal pH under standard conditions. | Base Deficit | ||
BASEEXCS | C119270 | Actual Base Excess;Base Excess | A calculated measurement of the amount of acid required to return blood to a normal pH under standard conditions. | Base Excess Measurement | ||
BASO | C64470 | Basophils | A measurement of the basophils in a biological specimen. | Absolute Basophil Count | ||
BASOB | C130154 | Basophils Band Form | A measurement of the banded basophils in a biological specimen. | Basophil Band Form Count | ||
BASOBLE | C130155 | Basophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded basophils to leukocytes in a biological specimen. | Basophil Band Form to Leukocytes Ratio Measurement | ||
BASOCE | C98865 | Basophils/Total Cells | A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). | Basophil to Total Cell Ratio Measurement | ||
BASOIM | C96670 | Immature Basophils | A measurement of the immature basophils in a biological specimen. | Immature Basophil Count | ||
BASOIMLE | C96671 | Immature Basophils/Leukocytes | A relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen. | Immature Basophil to Leukocyte Ratio Measurement | ||
BASOLE | C64471 | Basophils/Leukocytes | A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen. | Basophil to Leukocyte Ratio | ||
BASOMM | C135399 | Basophilic Metamyelocytes | A measurement of the basophilic metamyelocytes in a biological specimen. | Basophilic Metamyelocyte Count | ||
BASOMYL | C135400 | Basophilic Myelocytes | A measurement of the basophilic myelocytes in a biological specimen. | Basophilic Myelocyte Count | ||
BASOMYLY | C181448 | Basophilic Myelocytes/Lymphocytes | A relative measurement (ratio or percentage) of the basophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). | Basophilic Myelocytes to Lymphocytes Ratio Measurement | ||
BASOSG | C135401 | Basophils, Segmented | A measurement of the segmented basophils in a biological specimen. | Segmented Basophil Count | ||
BCEFNCTN | C123455 | Beta-cell Function | A measurement of the beta cell function (insulin production and secretion) in a biological specimen. | Beta-Cell Function Measurement | ||
BCMAS | C170577 | Soluble B Cell Maturation Antigen;Soluble BCM;Soluble BCMA;Soluble CD269;Soluble TNF Receptor Superfamily Member 17;Soluble TNFRSF13A | A measurement of the soluble B cell maturation antigen in a biological specimen. | Soluble B Cell Maturation Antigen Measurement | ||
BD2 | C122102 | Beta-defensin 2 | A measurement of the beta-defensin 2 in a biological specimen. | Beta-defensin 2 Measurement | ||
BDNF | C82004 | Brain-Derived Neurotrophic Factor | A measurement of the brain-derived neurotrophic factor in a biological specimen. | Brain-Derived Neurotrophic Factor Measurement | ||
BETACRTN | C100472 | b-Carotene;Beta Carotene;Beta Carotin | A measurement of the beta carotene in a biological specimen. | Beta Carotene Measurement | ||
BETAINES | C172517 | Betaines | A measurement of the betaine class compounds in a biological specimen. | Betaines Measurement | ||
BFTNN | C184531 | Bufotenine | A measurement of the bufotenine in a biological specimen. | Bufotenine Measurement | ||
BGTCPHRL | C172497 | Beta and Gamma Tocopherol;Beta+Gamma Tocopherol | A measurement of the beta and gamma tocopherol in a biological specimen. | Beta and Gamma Tocopherol Measurement | ||
BHBACTAC | C186028 | Beta-Hydroxybutyrate/Acetoacetate | A relative measurement (ratio) of the beta-hydroxybutyrate to acetoacetate in a biological specimen. | Beta-Hydroxybutyrate to Acetoacetate Ratio Measurement | ||
BHBEXR | C189520 | 3-Hydroxybutyrate Excretion Rate;B-Hydroxybutyrate Excretion Rate;Beta-Hydroxybutyrate Excretion Rate;BHB Excretion Rate | A measurement of the amount of beta-Hydroxybutyrate being excreted in a biological specimen over a defined period of time (e.g. one hour). | Beta-Hydroxybutyrate Excretion Rate Measurement | ||
BHYXBTR | C96568 | 3-Hydroxybutyrate;B-Hydroxybutyrate;Beta-Hydroxybutyrate;Beta-Hydroxybutyric Acid;BHB | A measurement of the total Beta-hydroxybutyrate in a biological specimen. | Beta-Hydroxybutyrate Measurement | ||
BICARB | C74667 | Bicarbonate;HCO3 | A measurement of the bicarbonate in a biological specimen. | Bicarbonate Measurement | ||
BILDIR | C64481 | Direct Bilirubin | A measurement of the conjugated or water-soluble bilirubin in a biological specimen. | Direct Bilirubin Measurement | ||
BILDIRBI | C158226 | Direct Bilirubin/Bilirubin | A relative measurement (ratio or percentage) of the direct bilirubin to total bilirubin in a biological specimen. | Direct Bilirubin to Bilirubin Ratio Measurement | ||
BILEAC | C74800 | Bile Acid;Bile Acids;Bile Salt;Bile Salts | A measurement of the total bile acids in a biological specimen. | Bile Acid Measurement | ||
BILI | C38037 | Bilirubin;Total Bilirubin | A measurement of the total bilirubin in a biological specimen. | Total Bilirubin Measurement | ||
BILIND | C64483 | Indirect Bilirubin | A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen. | Indirect Bilirubin Measurement | ||
BITECE | C74700 | Bite Cells | A measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen. | Bite Cell Count | ||
BJPROT | C111136 | Bence-Jones Protein | A measurement of the total Bence-Jones protein in a biological specimen. | Bence-Jones Protein Measurement | ||
BLAST | C74605 | Blasts | A measurement of the blast cells in a biological specimen. | Blast Count | ||
BLASTCE | C150836 | Blasts/Total Cells | A relative measurement (ratio or percentage) of the blasts to total cells in a biological specimen. | Blasts to Total Cells Ratio Measurement | ||
BLASTERY | C147311 | Basophilic Erythroblast | A measurement of the basophilic erythroblasts in a biological specimen taken from a non-human organism. | Basophilic Erythroblast Count | ||
BLASTIMM | C103407 | Immunoblastic Lymphocytes;Immunoblasts | A measurement of the immunoblasts in a biological specimen. | Immunoblast Count | ||
BLASTLE | C64487 | Blasts/Leukocytes | A relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen. | Blast to Leukocyte Ratio | ||
BLASTLM | C74630 | Leukemic Blasts | A measurement of the leukemic blasts (lymphoblasts and/or myeloblasts that remain in an immature state even when outside the bone marrow) in a biological specimen. | Leukemic Blast Count | ||
BLASTNCE | C147312 | Blasts/Nucleated Cells | A relative measurement (ratio or percentage) of the blasts to the total nucleated cells in a biological specimen. | Blasts to Nucleated Cells Ratio Measurement | ||
BLASTRUB | C100446 | Proerythroblast;Pronormoblast;Rubriblast | A measurement of the rubriblasts in a biological specimen. | Proerythroblast Measurement | ||
BLEEDT | C89775 | Bleeding Time;Clotting Time Homeostasis | A measurement of the time from the start to cessation of an induced bleed. | Bleeding Time | ||
BLISTCE | C127609 | Blister Cell | A measurement of the blister cells in a biological specimen. | Blister Cell Count | ||
BLSTIMLY | C106535 | Immunoblasts/Lymphocytes;Lymphocytes, Immunoblastic/Lymphocytes | A relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample. | Immunoblasts to Lymphocytes Ratio Measurement | ||
BLSTLMLY | C74641 | Leukemic Blasts/Lymphocytes | A relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts and/or myeloblasts) to mature lymphocytes in a biological specimen. | Leukemic Blast to Lymphocyte Ratio Measurement | ||
BLSTLY | C102278 | Lymphoblasts;Lymphoid Blasts | A measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen. | Lymphoblast Count | ||
BLSTLYLE | C105444 | Lymphoblasts/Leukocytes | A relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen. | Lymphoblast to Leukocyte Ratio Measurement | ||
BLSTLYLY | C189503 | Lymphoblasts/Lymphocytes | A relative measurement (ratio or percentage) of the lymphoblasts to lymphocytes in a biological specimen. | Lymphoblast to Lymphocyte Ratio Measurement | ||
BLSTMBCE | C98761 | Myeloblasts/Total Cells | A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). | Myeloblast to Total Cell Ratio Measurement | ||
BLSTMGK | C98752 | Megakaryoblasts | A measurement of the megakaryoblasts in a biological specimen. | Megakaryoblast Cell Count | ||
BLSTMKCE | C98753 | Megakaryoblasts/Total Cells | A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryoblast to Total Cell Ratio Measurement | ||
BLSTMKLE | C187813 | Megakaryoblasts/Leukocytes | A relative measurement (ratio or percentage) of megakaryoblasts to total leukocytes in a biological specimen. | Megakaryoblasts to Leukocytes Ratio Measurement | ||
BLSTNM | C189501 | Normoblasts | A measurement of the normoblasts in a biological specimen. | Normoblast Count | ||
BLSTNMCE | C98764 | Normoblasts/Total Cells | A relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Normoblast to Total Cell Ratio Measurement | ||
BLSTRBCE | C98870 | Proerythroblast/Total Cells;Pronormoblasts/Total Cells;Rubriblast/Total Cells | A relative measurement (ratio or percentage) of the rubriblasts to total cells in a biological specimen (for example a bone marrow specimen). | Pronormoblast to Total Cell Ratio Measurement | ||
BLSTRSID | C100419 | Ringed Sideroblasts | A measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen. | Ring Sideroblast Measurement | ||
BLSTSID | C100418 | Sideroblast | A measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen. | Sideroblast Measurement | ||
BLYCE | C174314 | B-Cell Lymphocytes;B-Cells;B-Lymphocytes | A measurement of the B-lymphocytes in a biological specimen. | B-Lymphocyte Count | ||
BLYCECE | C174317 | B-Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the B-lymphocytes to total cells in a biological specimen. | B-Lymphocyte to Total Cells Ratio Measurement | ||
BLYCELE | C174316 | B-Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the B-lymphocytes to leukocytes in a biological specimen. | B-Lymphocyte to Leukocyte Ratio Measurement | ||
BLYCELY | C174315 | B-Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the B-lymphocytes to total lymphocytes in a biological specimen. | B-Lymphocyte to Lymphocyte Ratio Measurement | ||
BLYMXM | C128951 | B-lymphocyte Crossmatch | A measurement to determine human leukocyte antigens (HLA) histocompatibility between the recipient and the donor by examining the presence or absence of the recipient's anti-HLA antibody reactivity towards HLA antigens expressed on the donor B-lymphocytes. | B-lymphocyte Crossmatch Measurement | ||
BNP | C74735 | B-Type Natriuretic Peptide;Brain Natriuretic Peptide | A measurement of the brain (B-type) natriuretic peptide in a biological specimen. | Brain Natriuretic Peptide Measurement | ||
BNPPRO | C82032 | Pro-Brain Natriuretic Peptide;ProB-type Natriuretic Peptide;proBNP | A measurement of the proB-type natriuretic peptide in a biological specimen. | ProB-Type Natriuretic Peptide Measurement | ||
BNPPRONT | C96610 | N-terminal pro-Brain Natriuretic Peptide;N-Terminal ProB-type Natriuretic Peptide;NT proBNP II | A measurement of the N-terminal proB-type natriuretic peptide in a biological specimen. | N-Terminal ProB-type Natriuretic Peptide Measurement | ||
BNZDZPN | C74692 | Benzodiazepine | A measurement of any benzodiazepine class drug present in a biological specimen. | Benzodiazepine Measurement | ||
BNZLCGN | C75350 | Benzoylecgonine | A measurement of the benzoylecgonine in a biological specimen. | Benzoylecgonine Measurement | ||
BOLDNON | C75380 | Boldenone | A measurement of the boldenone in a biological specimen. | Boldenone Measurement | ||
BOLSTRN | C184579 | Bolasterone | A measurement of the bolasterone in a biological specimen. | Bolasterone Measurement | ||
BPIAB | C120631 | Bactericidal/Permeability-Inc Protein Ab;BPI Auto-antibody | A measurement of the bactericidal/permeability-increasing protein antibody in a biological specimen. | Bactericidal/Permeability-Increasing Protein Antibody Measurement | ||
BRBTL | C184608 | Barbital | A measurement of the barbital in a biological specimen. | Barbital Measurement | ||
BRMZPM | C184609 | Bromazepam | A measurement of the bromazepam in a biological specimen. | Bromazepam Measurement | ||
BRVRCTM | C184639 | Brivaracetam | A measurement of the brivaracetam in a biological specimen. | Brivaracetam Measurement | ||
BRXPIPZL | C177973 | Brexpiprazole | A measurement of the brexpiprazole in a biological specimen. | Brexpiprazole Measurement | ||
BTECERBC | C74634 | Bite Cells/Erythrocytes | A relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen. | Bite Cell to Erythrocyte Ratio Measurement | ||
BTK | C165772 | Agammaglobulinemia Tyrosine Kinase;ATK;B-cell Progenitor Kinase;Bruton Tyrosine Kinase;Bruton's Tyrosine Kinase;Tyrosine-protein kinase BTK | A measurement of the Bruton's tyrosine kinase in a biological specimen. | Bruton's Tyrosine Kinase Measurement | ||
BTKFR | C165944 | Bruton's Tyrosine Kinase, Free | A measurement of the free Bruton's tyrosine kinase in a biological specimen. | Free Bruton's Tyrosine Kinase Measurement | ||
BTLBARTL | C75364 | Butabarbital | A measurement of the butabarbital in a biological specimen. | Butabarbital Measurement | ||
BTLBTL | C75365 | Butalbital | A measurement of the butalbital present in a biological specimen. | Butalbital Measurement | ||
BTRPHNL | C184610 | Butorphanol | A measurement of the butorphanol in a biological specimen. | Butorphanol Measurement | ||
BUCHE | C111142 | Acylcholine Acylhydrolase;Butyrylcholinesterase;Non-neuronal Cholinesterase;Plasma Cholinesterase;Pseudocholinesterase | A measurement of the total butyrylcholinesterase in a biological specimen. | Butyrylcholinesterase Measurement | ||
BUPREN | C75352 | Buprenorphine | A measurement of the buprenorphine drug present in a biological specimen. | Buprenorphine Measurement | ||
BURRCE | C74701 | Burr Cells;Echinocytes | A measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen. | Burr Cell Count | ||
BUTYLN | C184532 | Butylone | A measurement of the butylone in a biological specimen. | Butylone Measurement | ||
BZP | C184554 | 1-benzylpiperazine;Benzylpiperazine;N-benzylpiperazine | A measurement of the benzylpiperazine in a biological specimen. | Benzylpiperazine Measurement | ||
C130068 | C130068 | Bermuda Grass Pollen IgE | A measurement of the Cynodon dactylon pollen antigen IgE antibody in a biological specimen. | Bermuda Grass Pollen IgE Measurement | ||
C130069 | C130069 | Bermuda Grass Pollen IgA | A measurement of the Cynodon dactylon pollen antigen IgA antibody in a biological specimen. | Bermuda Grass Pollen IgA Measurement | ||
C130070 | C130070 | Bermuda Grass Pollen IgG | A measurement of the Cynodon dactylon pollen antigen IgG antibody in a biological specimen. | Bermuda Grass Pollen IgG Measurement | ||
C130071 | C130071 | Bermuda Grass Pollen IgG4 | A measurement of the Cynodon dactylon pollen antigen IgG4 antibody in a biological specimen. | Bermuda Grass Pollen IgG4 Measurement | ||
C130072 | C130072 | Birch Pollen IgE | A measurement of the Betula pollen antigen IgE antibody in a biological specimen. | Birch Pollen IgE Measurement | ||
C130073 | C130073 | Birch Pollen IgA | A measurement of the Betula pollen antigen IgA antibody in a biological specimen. | Birch Pollen IgA Measurement | ||
C130074 | C130074 | Birch Pollen IgG | A measurement of the Betula pollen antigen IgG antibody in a biological specimen. | Birch Pollen IgG Measurement | ||
C130075 | C130075 | Birch Pollen IgG4 | A measurement of the Betula pollen antigen IgG4 antibody in a biological specimen. | Birch Pollen IgG4 Measurement | ||
C130076 | C130076 | Silver Birch Pollen IgE | A measurement of the Betula verrucosa pollen antigen IgE antibody in a biological specimen. | Silver Birch Pollen IgE Measurement | ||
C130077 | C130077 | Silver Birch Pollen IgA | A measurement of the Betula verrucosa pollen antigen IgA antibody in a biological specimen. | Silver Birch Pollen IgA Measurement | ||
C130078 | C130078 | Silver Birch Pollen IgG | A measurement of the Betula verrucosa pollen antigen IgG antibody in a biological specimen. | Silver Birch Pollen IgG Measurement | ||
C130079 | C130079 | Silver Birch Pollen IgG4 | A measurement of the Betula verrucosa pollen antigen IgG4 antibody in a biological specimen. | Silver Birch Pollen IgG4 Measurement | ||
C130080 | C130080 | Cocksfoot Grass Pollen IgE;Orchard Grass Pollen IgE | A measurement of the Dactylis glomerata pollen antigen IgE antibody in a biological specimen. | Orchard Grass Pollen IgE Measurement | ||
C130081 | C130081 | Cocksfoot Grass Pollen IgA;Orchard Grass Pollen IgA | A measurement of the Dactylis glomerata pollen antigen IgA antibody in a biological specimen. | Orchard Grass Pollen IgA Measurement | ||
C130082 | C130082 | Cocksfoot Grass Pollen IgG;Orchard Grass Pollen IgG | A measurement of the Dactylis glomerata pollen antigen IgG antibody in a biological specimen. | Orchard Grass Pollen IgG Measurement | ||
C130083 | C130083 | Cocksfoot Grass Pollen IgG4;Orchard Grass Pollen IgG4 | A measurement of the Dactylis glomerata pollen antigen IgG4 antibody in a biological specimen. | Orchard Grass Pollen IgG4 Measurement | ||
C130084 | C130084 | English Plantain Pollen IgE | A measurement of the Plantagio lanceolata pollen antigen IgE antibody in a biological specimen. | English Plantain Pollen IgE Measurement | ||
C130085 | C130085 | English Plantain Pollen IgA | A measurement of the Plantagio lanceolata pollen antigen IgA antibody in a biological specimen. | English Plantain Pollen IgA Measurement | ||
C130086 | C130086 | English Plantain Pollen IgG | A measurement of the Plantagio lanceolata pollen antigen IgG antibody in a biological specimen. | English Plantain Pollen IgG Measurement | ||
C130087 | C130087 | English Plantain Pollen IgG4 | A measurement of the Plantagio lanceolata pollen antigen IgG4 antibody in a biological specimen. | English Plantain Pollen IgG4 Measurement | ||
C130088 | C130088 | Timothy Grass Pollen IgE | A measurement of the Phleum pratense pollen antigen IgE antibody in a biological specimen. | Timothy Grass Pollen IgE Measurement | ||
C130089 | C130089 | Timothy Grass Pollen IgA | A measurement of the Phleum pratense pollen antigen IgA antibody in a biological specimen. | Timothy Grass Pollen IgA Measurement | ||
C130090 | C130090 | Timothy Grass Pollen IgG | A measurement of the Phleum pratense pollen antigen IgG antibody in a biological specimen. | Timothy Grass Pollen IgG Measurement | ||
C130091 | C130091 | Timothy Grass Pollen IgG4 | A measurement of the Phleum pratense pollen antigen IgG4 antibody in a biological specimen. | Timothy Grass Pollen IgG4 Measurement | ||
C130092 | C130092 | Western Ragweed Pollen IgE | A measurement of the Ambrosia psilostachya pollen antigen IgE antibody in a biological specimen. | Western Ragweed Pollen IgE Measurement | ||
C130093 | C130093 | Western Ragweed Pollen IgA | A measurement of the Ambrosia psilostachya pollen antigen IgA antibody in a biological specimen. | Western Ragweed Pollen IgA Measurement | ||
C130094 | C130094 | Western Ragweed Pollen IgG | A measurement of the Ambrosia psilostachya pollen antigen IgG antibody in a biological specimen. | Western Ragweed Pollen IgG Measurement | ||
C130095 | C130095 | Western Ragweed Pollen IgG4 | A measurement of the Ambrosia psilostachya pollen antigen IgG4 antibody in a biological specimen. | Western Ragweed Pollen IgG4 Measurement | ||
C130100 | C130100 | Mixed Antigen IgE Antibody | A measurement of the mixed antigen IgE antibody in a biological specimen. | Mixed Antigen IgE Antibody Measurement | ||
C130101 | C130101 | Tree Mix Pollen Antigen IgE Antibody | A measurement of the tree mix pollen antigen IgE antibody in a biological specimen. | Tree Mix Pollen Antigen IgE Antibody Measurement | ||
C130102 | C130102 | Tree Mix Pollen Antigen IgG Antibody | A measurement of the tree mix pollen antigen IgG antibody in a biological specimen. | Tree Mix Pollen Antigen IgG Antibody Measurement | ||
C130103 | C130103 | Grass Mix Pollen Antigen IgE Antibody | A measurement of the grass mix pollen antigen IgE antibody in a biological specimen. | Grass Mix Pollen Antigen IgE Antibody Measurement | ||
C130104 | C130104 | Grass Mix Pollen Antigen IgG Antibody | A measurement of the grass mix pollen antigen IgG antibody in a biological specimen. | Grass Mix Pollen Antigen IgG Antibody Measurement | ||
C130105 | C130105 | Grass Mix Pollen Antigen IgA Antibody | A measurement of the grass mix pollen antigen IgA antibody in a biological specimen. | Grass Mix Pollen Antigen IgA Antibody Measurement | ||
C130106 | C130106 | Weed Mix Pollen Antigen IgE Antibody | A measurement of the weed mix pollen antigen IgE antibody in a biological specimen. | Weed Mix Pollen Antigen IgE Antibody Measurement | ||
C130107 | C130107 | Weed Mix Pollen Antigen IgG Antibody | A measurement of the weed mix pollen antigen IgG antibody in a biological specimen. | Weed Mix Pollen Antigen IgG Antibody Measurement | ||
C130108 | C130108 | Weed Mix Pollen Antigen IgA Antibody | A measurement of the weed mix pollen antigen IgA antibody in a biological specimen. | Weed Mix Pollen Antigen IgA Antibody Measurement | ||
C130109 | C130109 | Mold Mix Antigen IgE Antibody | A measurement of the mold mix antigen IgE antibody in a biological specimen. | Mold Mix Antigen IgE Antibody Measurement | ||
C130110 | C130110 | Mold Mix Antigen IgG Antibody | A measurement of the mold mix antigen IgG antibody in a biological specimen. | Mold Mix Antigen IgG Antibody Measurement | ||
C130111 | C130111 | Mold Mix Antigen IgA Antibody | A measurement of the mold mix antigen IgA antibody in a biological specimen. | Mold Mix Antigen IgA Antibody Measurement | ||
C130112 | C130112 | Animal Mix Antigen IgE Antibody | A measurement of the animal mix antigen IgE antibody in a biological specimen. | Animal Mix Antigen IgE Antibody Measurement | ||
C130113 | C130113 | Animal Mix Antigen IgG Antibody | A measurement of the animal mix antigen IgG antibody in a biological specimen. | Animal Mix Antigen IgG Antibody Measurement | ||
C130114 | C130114 | Industrial Mix Antigen IgE Antibody | A measurement of the industrial mix antigen IgE antibody in a biological specimen. | Industrial Mix Antigen IgE Antibody Measurement | ||
C130115 | C130115 | Industrial Mix Antigen IgG Antibody | A measurement of the industrial mix antigen IgG antibody in a biological specimen. | Industrial Mix Antigen IgG Antibody Measurement | ||
C130116 | C130116 | Bee Mix Antigen IgE Antibody | A measurement of the bee mix antigen IgE antibody in a biological specimen. | Bee Mix Antigen IgE Antibody Measurement | ||
C130117 | C130117 | Bee Mix Antigen IgG Antibody | A measurement of the bee mix antigen IgG antibody in a biological specimen. | Bee Mix Antigen IgG Antibody Measurement | ||
C130118 | C130118 | Bee Mix Antigen IgG4 Antibody | A measurement of the bee mix antigen IgG4 antibody in a biological specimen. | Bee Mix Antigen IgG4 Antibody Measurement | ||
C130119 | C130119 | Dairy Mix Antigen IgG Antibody | A measurement of the dairy mix antigen IgG antibody in a biological specimen. | Dairy Mix Antigen IgG Antibody Measurement | ||
C130120 | C130120 | Shellfish Mix Antigen IgE Antibody | A measurement of the shellfish mix antigen IgE antibody in a biological specimen. | Shellfish Mix Antigen IgE Antibody Measurement | ||
C130121 | C130121 | Shellfish Mix Antigen IgG Antibody | A measurement of the shellfish mix antigen IgG antibody in a biological specimen. | Shellfish Mix Antigen IgG Antibody Measurement | ||
C130122 | C130122 | Nut Mix Antigen IgE Antibody | A measurement of the nut mix antigen IgE antibody in a biological specimen. | Nut Mix Antigen IgE Antibody Measurement | ||
C130123 | C130123 | Nut Mix Antigen IgG Antibody | A measurement of the nut mix antigen IgG antibody in a biological specimen. | Nut Mix Antigen IgG Antibody Measurement | ||
C130124 | C130124 | Cat Dander Antigen IgE Antibody | A measurement of the Felis catus dander antigen IgE antibody in a biological specimen. | Cat Dander Antigen IgE Antibody Measurement | ||
C130125 | C130125 | Cat Dander Antigen IgG Antibody | A measurement of the Felis catus dander antigen IgG antibody in a biological specimen. | Cat Dander Antigen IgG Antibody Measurement | ||
C130126 | C130126 | Cat Dander Antigen IgA Antibody | A measurement of the Felis catus dander antigen IgA antibody in a biological specimen. | Cat Dander Antigen IgA Antibody Measurement | ||
C130127 | C130127 | Cat Dander Antigen IgG4 Antibody | A measurement of the Felis catus dander antigen IgG4 antibody in a biological specimen. | Cat Dander Antigen IgG4 Antibody Measurement | ||
C130128 | C130128 | Dog Dander Antigen IgE Antibody | A measurement of the Canis lupus dander antigen IgE antibody in a biological specimen. | Dog Dander Antigen IgE Antibody Measurement | ||
C130129 | C130129 | Dog Dander Antigen IgG Antibody | A measurement of the Canis lupus dander antigen IgG antibody in a biological specimen. | Dog Dander Antigen IgG Antibody Measurement | ||
C130130 | C130130 | Dog Dander Antigen IgA Antibody | A measurement of the Canis lupus dander antigen IgA antibody in a biological specimen. | Dog Dander Antigen IgA Antibody Measurement | ||
C130131 | C130131 | Dog Dander Antigen IgG4 Antibody | A measurement of the Canis lupus dander antigen IgG4 antibody in a biological specimen. | Dog Dander Antigen IgG4 Antibody Measurement | ||
C130132 | C130132 | American House Dust Mite IgE Antibody;D. farinae Antigen IgE Antibody;Dermatophagoides farinae IgE Antibody | A measurement of the Dermatophagoides farinae antigen IgE antibody in a biological specimen. | Dermatophagoides farinae Antigen IgE Antibody Measurement | ||
C130133 | C130133 | American House Dust Mite IgG Antibody;D. farinae Antigen IgG Antibody;Dermatophagoides farinae IgG Antibody | A measurement of the Dermatophagoides farinae antigen IgG antibody in a biological specimen. | Dermatophagoides farinae Antigen IgG Antibody Measurement | ||
C130134 | C130134 | D. pteronyssinus Antigen IgE Antibody;Dermatophagoides pteronyssinus IgE Antibody;European House Dust Mite IgE Antibody | A measurement of the Dermatophagoides pteronyssinus antigen IgE antibody in a biological specimen. | Dermatophagoides pteronyssinus Antigen IgE Antibody Measurement | ||
C130135 | C130135 | D. pteronyssinus Antigen IgG Antibody;Dermatophagoides pteronyssinus IgG Antibody;European House Dust Mite IgG Antibody | A measurement of the Dermatophagoides pteronyssinus antigen IgG antibody in a biological specimen. | Dermatophagoides pteronyssinus Antigen IgG Antibody Measurement | ||
C130136 | C130136 | American Cockroach Antigen IgE Antibody | A measurement of the Periplaneta americana antigen IgE antibody in a biological specimen. | American Cockroach Antigen IgE Antibody Measurement | ||
C130137 | C130137 | American Cockroach Antigen IgA Antibody | A measurement of the Periplaneta americana antigen IgA antibody in a biological specimen. | American Cockroach Antigen IgA Antibody Measurement | ||
C130138 | C130138 | American Cockroach Antigen IgG Antibody | A measurement of the Periplaneta americana antigen IgG antibody in a biological specimen. | American Cockroach Antigen IgG Antibody Measurement | ||
C130139 | C130139 | American Cockroach Antigen IgG4 Antibody | A measurement of the Periplaneta americana antigen IgG4 antibody in a biological specimen. | American Cockroach Antigen IgG4 Antibody Measurement | ||
C130140 | C130140 | German Cockroach Antigen IgE Antibody | A measurement of the Blattella germanica antigen IgE antibody in a biological specimen. | German Cockroach Antigen IgE Antibody Measurement | ||
C130141 | C130141 | German Cockroach Antigen IgA Antibody | A measurement of the Blattella germanica antigen IgA antibody in a biological specimen. | German Cockroach Antigen IgA Antibody Measurement | ||
C130142 | C130142 | German Cockroach Antigen IgG Antibody | A measurement of the Blattella germanica antigen IgG antibody in a biological specimen. | German Cockroach Antigen IgG Antibody Measurement | ||
C130143 | C130143 | German Cockroach Antigen IgG4 Antibody | A measurement of the Blattella germanica antigen IgG4 antibody in a biological specimen. | German Cockroach Antigen IgG4 Antibody Measurement | ||
C147276 | C147276 | Arachis hypogaea Antigen IgE Antibody;Peanut Antigen IgE Antibody | A measurement of the Arachis hypogaea antigen IgE antibody in a biological specimen. | Arachis hypogaea Antigen IgE Antibody Measurement | ||
C147277 | C147277 | Bread Wheat Antigen IgE Antibody;Triticum aestivum Antigen IgE Antibody | A measurement of the Triticum aestivum antigen IgE antibody in a biological specimen. | Triticum aestivum Antigen IgE Antibody Measurement | ||
C147278 | C147278 | Glycine max Antigen IgE Antibody;Soybean Antigen IgE Antibody | A measurement of the Glycine max antigen IgE antibody in a biological specimen. | Glycine max Antigen IgE Antibody Measurement | ||
C147279 | C147279 | Corn Antigen IgE Antibody;Zea mays Antigen IgE Antibody | A measurement of the Zea mays antigen IgE antibody in a biological specimen. | Zea mays Antigen IgE Antibody Measurement | ||
C147280 | C147280 | Cow Milk Protein Antigen IgE Antibody | A measurement of the cow milk protein antigen IgE antibody in a biological specimen. | Cow Milk Protein Antigen IgE Antibody Measurement | ||
C147281 | C147281 | Egg White Antigen IgE Antibody | A measurement of the egg white antigen IgE antibody in a biological specimen. | Egg White Antigen IgE Antibody Measurement | ||
C147282 | C147282 | White Oak Pollen IgE Antibody | A measurement of the Quercus alba pollen antigen IgE antibody in a biological specimen. | White Oak Pollen IgE Antibody Measurement | ||
C147283 | C147283 | White Elm Pollen IgG Antibody | A measurement of the Ulmus americana pollen antigen IgG antibody in a biological specimen. | White Elm Pollen IgG Antibody Measurement | ||
C147284 | C147284 | Boxelder Pollen IgE Antibody | A measurement of the Acer negundo pollen antigen IgE antibody in a biological specimen. | Boxelder Pollen IgE Antibody Measurement | ||
C147285 | C147285 | Common Ragweed Pollen IgE Antibody | A measurement of the Ambrosia elatior pollen antigen IgE antibody in a biological specimen. | Common Ragweed Pollen IgE Antibody Measurement | ||
C165875 | C165875 | Bermuda Grass Pollen IgE AB RAST Score | A classification of the amount of Cynodon dactylon pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Bermuda Grass Pollen IgE Antibody RAST Score Measurement | ||
C165876 | C165876 | Birch Pollen IgE AB RAST Score | A classification of the amount of Betula pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Birch Pollen IgE Antibody RAST Score Measurement | ||
C165877 | C165877 | Cat Dander IgE AB RAST Score | A classification of the amount of Felis catus dander antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Cat Dander IgE Antibody RAST Score Measurement | ||
C165878 | C165878 | German Cockroach IgE AB RAST Score | A classification of the amount of Blattella germanica antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | German Cockroach IgE Antibody RAST Score Measurement | ||
C165879 | C165879 | American House Dust Mite IgE Antibody RAST Score;D. farinae IgE AB RAST Score;Dermatophagoides farinae IgE Antibody RAST Score | A classification of the amount of Dermatophagoides farinae IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dermatophagoides farinae IgE Antibody RAST Score Measurement | ||
C165880 | C165880 | D. pteronyssinus IgE AB RAST Score;Dermatophagoides pteronyssinus IgE Antibody RAST Score;European House Dust Mite IgE Antibody RAST Score | A classification of the amount of Dermatophagoides pteronyssinus antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dermatophagoides pteronyssinus IgE Antibody RAST Score Measurement | ||
C165881 | C165881 | White Elm Pollen IgE Antibody | A measurement of the Ulmus americana pollen antigen IgE antibody in a biological specimen. | White Elm Pollen IgE Antibody Measurement | ||
C165882 | C165882 | White Elm Pollen IgE AB RAST Score | A classification of the amount of Ulmus americana pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | White Elm Pollen IgE Antibody RAST Score Measurement | ||
C165883 | C165883 | Orchard Grass Pollen IgE AB RAST Score | A classification of the amount of Dactylis glomerata pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Orchard Grass Pollen IgE Antibody RAST Score Measurement | ||
C165884 | C165884 | Olive Tree Pollen IgE Antibody | A measurement of the Olea europaea pollen antigen IgE antibody in a biological specimen. | Olive Tree Pollen IgE Antibody Measurement | ||
C165885 | C165885 | Olive Tree Pollen IgE AB RAST Score | A classification of the amount of Olea europaea pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Olive Tree Pollen IgE Antibody RAST Score Measurement | ||
C165886 | C165886 | White Oak Pollen IgE AB RAST Score | A classification of the amount of Quercus alba pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | White Oak Pollen IgE Antibody RAST Score Measurement | ||
C165887 | C165887 | English Plantain Pollen IgE AB RAST Score;EnglishPlantain Pollen IgE AB RAST Score | A classification of the amount of Plantagio lanceolata pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | English Plantain Pollen IgE Antibody RAST Score Measurement | ||
C165888 | C165888 | Russian Thistle Pollen IgE Antibody | A measurement of the Salsola tragus pollen antigen IgE antibody in a biological specimen. | Russian Thistle Pollen IgE Antibody Measurement | ||
C165889 | C165889 | Russian Thistle Pollen IgE AB RAST Score | A classification of the amount of Salsola tragus pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Russian Thistle Pollen IgE Antibody RAST Score Measurement | ||
C165890 | C165890 | Timothy Grass Pollen IgE AB RAST Score | A classification of the amount of Phleum pratense pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Timothy Grass Pollen IgE Antibody RAST Score Measurement | ||
C165891 | C165891 | Western Ragweed Pollen IgE AB RAST Score | A classification of the amount of Ambrosia psilostachya pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Western Ragweed Pollen IgE Antibody RAST Score Measurement | ||
C165892 | C165892 | Wild Rye Pollen IgE Antibody | A measurement of the Elymus tricoides pollen antigen IgE antibody in a biological specimen. | Wild Rye Pollen IgE Antibody Measurement | ||
C165893 | C165893 | Wild Rye Pollen IgE AB RAST Score | A classification of the amount of Elymus tricoides pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Wild Rye Pollen IgE Antibody RAST Score Measurement | ||
C165894 | C165894 | American House Dust Mite IgG4 Antibody;D. farinae Antigen IgG4 Antibody;Dermatophagoides farinae IgG4 Antibody | A measurement of the Dermatophagoides farinae antigen IgG4 antibody in a biological specimen. | Dermatophagoides farinae Antigen IgG4 Antibody Measurement | ||
C165895 | C165895 | Johnson Grass Pollen IgG4 Antibody | A measurement of the Sorghum halepense pollen IgG4 antibody in a biological specimen. | Johnson Grass Pollen IgG4 Antibody Measurement | ||
C165896 | C165896 | D. pteronyssinus Antigen IgG4 Antibody;Dermatophagoides pteronyssinus IgG4 Antibody;European House Dust Mite IgG4 Antibody | A measurement of the Dermatophagoides pteronyssinus antigen IgG4 antibody in a biological specimen. | Dermatophagoides pteronyssinus Antigen IgG4 Antibody Measurement | ||
C165897 | C165897 | Bermuda Grass Pollen IgG AB RAST Score | A classification of the amount of Cynodon dactylon pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Bermuda Grass Pollen IgG Antibody RAST Score Measurement | ||
C165898 | C165898 | Birch Pollen IgG AB RAST Score | A classification of the amount of Betula pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Birch Pollen IgG Antibody RAST Score Measurement | ||
C165899 | C165899 | Silver Birch Pollen IgG AB RAST Score | A classification of the amount of Betula verrucosa pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Silver Birch Pollen IgG Antibody RAST Score Measurement | ||
C165900 | C165900 | Cocksfoot Grass Pollen IgG RAST Score;Orchard Grass Pollen IgG AB RAST Score | A classification of the amount of Dactylis glomerata pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Orchard Grass Pollen IgG Antibody RAST Score Measurement | ||
C165901 | C165901 | English Plantain Pollen IgG AB RAST Score;EnglishPlantain Pollen IgG AB RAST Score | A classification of the amount of Plantagio lanceolata pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | English Plantain Pollen IgG Antibody RAST Score Measurement | ||
C165902 | C165902 | Timothy Grass Pollen IgG AB RAST Score | A classification of the amount of Phleum pratense pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Timothy Grass Pollen IgG Antibody RAST Score Measurement | ||
C165903 | C165903 | Western Ragweed Pollen IgG AB RAST Score | A classification of the amount of Ambrosia psilostachya pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Western Ragweed Pollen IgG Antibody RAST Score Measurement | ||
C165904 | C165904 | Tree Mix Pollen IgG AB RAST Score | A classification of the amount of tree mix pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Tree Mix Pollen IgG Antibody RAST Score Measurement | ||
C165905 | C165905 | Grass Mix Pollen IgG AB RAST Score | A classification of the amount of tree grass pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Grass Mix Pollen IgG Antibody RAST Score Measurement | ||
C165906 | C165906 | Weed Mix Pollen IgG AB RAST Score | A classification of the amount of weed mix pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Weed Mix Pollen IgG Antibody RAST Score Measurement | ||
C165907 | C165907 | Mold Mix IgG AB RAST Score | A classification of the amount of mold mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mold Mix IgG Antibody RAST Score Measurement | ||
C165908 | C165908 | Animal Mix IgG AB RAST Score | A classification of the amount of animal mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Animal Mix IgG Antibody RAST Score Measurement | ||
C165909 | C165909 | Industrial Mix IgG AB RAST Score | A classification of the amount of industrial mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Industrial Mix IgG Antibody RAST Score Measurement | ||
C165910 | C165910 | Bee Mix IgG AB RAST Score | A classification of the amount of bee mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Bee Mix IgG Antibody RAST Score Measurement | ||
C165911 | C165911 | Dairy Mix IgG AB RAST Score | A classification of the amount of dairy mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dairy Mix IgG Antibody RAST Score Measurement | ||
C165912 | C165912 | Shellfish Mix IgG AB RAST Score | A classification of the amount of shellfish mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Shellfish Mix IgG Antibody RAST Score Measurement | ||
C165913 | C165913 | Nut Mix IgG AB RAST Score | A classification of the amount of nut mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Nut Mix IgG Antibody RAST Score Measurement | ||
C165914 | C165914 | Cat Dander IgG AB RAST Score | A classification of the amount of Felis cattus dander IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Cat Dander IgG Antibody RAST Score Measurement | ||
C165915 | C165915 | Dog Dander IgG AB RAST Score | A classification of the amount of Canis lupus IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dog Dander IgG Antibody RAST Score Measurement | ||
C165916 | C165916 | American House Dust Mite IgG Antibody RAST Score;D. farinae IgG AB RAST Score | A classification of the amount of D. farinae antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dermatophagoides farinae IgG Antibody RAST Score Measurement | ||
C165917 | C165917 | D. pteronyssinus Antigen IgG AB RAST Score;Dermatophagoides pteronyssinus IgG Antibody;European House Dust Mite IgG Antibody | A classification of the amount of D. pteronyssinus antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dermatophagoides pteronyssinus IgG Antibody RAST Score Measurement | ||
C165918 | C165918 | American Cockroach IgG AB RAST Score | A classification of the amount of Periplaneta americana antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | American Cockroach IgG Antibody RAST Score Measurement | ||
C165919 | C165919 | German Cockroach IgG AB RAST Score | A classification of the amount of Blattella germanica antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | German Cockroach IgG Antibody RAST Score Measurement | ||
C165920 | C165920 | White Elm Pollen IgG AB RAST Score | A classification of the amount of Ulmus americana pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | White Elm Pollen IgG Antibody RAST Score Measurement | ||
C165921 | C165921 | Silver Birch Pollen IgE AB RAST Score | A classification of the amount of Betula pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Silver Birch Pollen IgE Antibody RAST Score Measurement | ||
C165922 | C165922 | Mixed Antigen IgE Antibody RAST Score | A classification of the amount of mixed antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mixed Antigen IgE Antibody RAST Score Measurement | ||
C165923 | C165923 | Tree Mix Pollen IgE AB RAST Score | A classification of the amount of tree mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Tree Mix Pollen IgE Antibody RAST Score Measurement | ||
C165924 | C165924 | Grass Mix Pollen IgE AB RAST Score | A classification of the amount of grass mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Grass Mix Pollen IgE Antibody RAST Score Measurement | ||
C165925 | C165925 | Weed Mix Pollen IgE AB RAST Score | A classification of the amount of weed mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Weed Mix Pollen IgE Antibody RAST Score Measurement | ||
C165926 | C165926 | Mold Mix IgE AB RAST Score | A classification of the amount of mold mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mold Mix IgE Antibody RAST Score Measurement | ||
C165927 | C165927 | Animal Mix IgE AB RAST Score | A classification of the amount of animal mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Animal Mix IgE Antibody RAST Score Measurement | ||
C165928 | C165928 | Industrial Mix IgE AB RAST Score | A classification of the amount of industrial mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Industrial Mix IgE Antibody RAST Score Measurement | ||
C165929 | C165929 | Bee Mix IgE AB RAST Score | A classification of the amount of bee mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Bee Mix IgE Antibody RAST Score Measurement | ||
C165930 | C165930 | Shellfish Mix IgE AB RAST Score | A classification of the amount of shellfish mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Shellfish Mix IgE Antibody RAST Score Measurement | ||
C165931 | C165931 | Nut Mix IgE AB RAST Score | A classification of the amount of nut mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Nut Mix IgE Antibody RAST Score Measurement | ||
C165932 | C165932 | Dog Dander IgE AB RAST Score | A classification of the amount of canis lupus dander IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dog Dander IgE Antibody RAST Score Measurement | ||
C165933 | C165933 | American Cockroach IgE AB RAST Score | A classification of the amount of Periplaneta americana antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | American Cockroach IgE Antibody RAST Score Measurement | ||
C165934 | C165934 | Arachis hypogaea IgE AB RAST Score | A classification of the amount of Arachis hypogaea antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Arachis hypogaea IgE Antibody RAST Score Measurement | ||
C165935 | C165935 | Triticum aestivum IgE AB RAST Score | A classification of the amount of Triticum aestivum antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Triticum aestivum IgE Antibody RAST Score Measurement | ||
C165936 | C165936 | Glycine max IgE AB RAST Score | A classification of the amount of Glycine max antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Glycine max IgE Antibody RAST Score Measurement | ||
C165937 | C165937 | Zea mays IgE AB RAST Score | A classification of the amount of Zea mays IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Zea mays IgE Antibody RAST Score Measurement | ||
C165938 | C165938 | Cow Milk Protein IgE AB RAST Score | A classification of the amount of cow milk protein IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Cow Milk Protein IgE Antibody RAST Score Measurement | ||
C165939 | C165939 | Egg White IgE AB RAST Score | A classification of the amount of egg white antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Egg White IgE Antibody RAST Score Measurement | ||
C165940 | C165940 | Boxelder Pollen IgE AB RAST Score | A classification of the amount of Acer negundo pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Boxelder Pollen IgE Antibody RAST Score Measurement | ||
C165941 | C165941 | Common Ragweed Pollen IgE AB RAST Score | A classification of the amount of Ambrosia artemisiifolia pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Common Ragweed Pollen IgE Antibody RAST Score Measurement | ||
C177958 | C177958 | Anacardium occidentale Nut Antigen IgE Antibody;Cashew Antigen IgE Antibody | A measurement of the cashew antigen IgE antibody in a biological specimen. | Cashew Antigen IgE Antibody Measurement | ||
C177959 | C177959 | Triticum Species Antigen IgE Antibody;Wheat Antigen IgE Antibody | A measurement of any of the Triticum species of wheat antigen IgE antibody in a biological specimen. | Triticum Species Antigen IgE Antibody Measurement | ||
C177960 | C177960 | Corylus Species Nut Antigen IgE Antibody;Hazelnut Antigen IgE Antibody | A measurement of the hazelnut antigen IgE antibody in a biological specimen. | Hazelnut Antigen IgE Antibody Measurement | ||
C177961 | C177961 | Juglans Species Nut Antigen IgE Antibody;Walnut Antigen IgE Antibody | A measurement of the walnut antigen IgE antibody in a biological specimen. | Walnut Antigen IgE Antibody Measurement | ||
C1INH | C147313 | Complement C1 Esterase Inhibitor | A measurement of the complement C1 esterase inhibitor in a biological specimen. | Complement C1 Esterase Inhibitor Measurement | ||
C1Q | C186029 | Complement C1q | A measurement of the complement C1q in a biological specimen. | Complement C1q Measurement | ||
C1QAB | C80173 | Complement C1q Antibody | A measurement of the complement C1q antibody in a biological specimen. | Complement C1q Antibody Measurement | ||
C3 | C80174 | Complement C3 | A measurement of the complement C3 in a biological specimen. | Complement C3 Measurement | ||
C3A | C80175 | Complement C3a | A measurement of the complement C3a in a biological specimen. | Complement C3a Measurement | ||
C3ADARG | C163423 | Acylation-Stimulating Protein;ASP;Complement C3a DesArg | A measurement of the complement C3a DesArg in a biological specimen. | Complement C3a DesArg Measurement | ||
C3B | C80176 | Complement C3b | A measurement of the complement C3b in a biological specimen. | Complement C3b Measurement | ||
C3C | C184521 | Complement C3c | A measurement of the complement C3c in a biological specimen. | Complement C3c Measurement | ||
C3DAB | C119271 | Complement C3d Antibody | A measurement of the complement C3d antibody in a biological specimen. | Complement C3d Antibody Measurement | ||
C3M | C165945 | Collagen III Neo-Peptide C3M | A measurement of the collagen III neo-peptide C3M in a biological specimen. | Collagen III Neo-Peptide C3M Measurement | ||
C4 | C80177 | Complement C4 | A measurement of the complement C4 in a biological specimen. | Complement C4 Measurement | ||
C4A | C80178 | Complement C4a | A measurement of the complement C4a in a biological specimen. | Complement C4a Measurement | ||
C4D | C127610 | Complement C4d | A measurement of the complement C4d in a biological specimen. | Complement C4d Measurement | ||
C5 | C160935 | Complement C5 | A measurement of the total complement C5 in a biological specimen. | Complement C5 Measurement | ||
C5A | C80179 | Complement C5a | A measurement of the complement C5a in a biological specimen. | Complement C5a Measurement | ||
C5B9 | C158235 | Complement C5b-9 | A measurement of the complement C5b-9 in a biological specimen. | Complement C5b-9 Measurement | ||
C5B9S | C170579 | sC5b-9;Smac;Soluble Complement C5b-9;Soluble MAC;Soluble Membrane Attack Complex;TCC;Terminal Complement Complex | A measurement of the soluble complement C5b-9 in a biological specimen. | Soluble Complement C5b-9 Measurement | ||
C5FR | C161357 | Complement C5, Free | A measurement of the free complement C5 in a biological specimen. | Free Complement C5 Measurement | ||
CA | C64488 | Calcium | A measurement of the calcium in a biological specimen. | Calcium Measurement | ||
CA125AG | C79089 | CA125;CA125AG;Cancer Antigen 125;Carbohydrate Antigen 125;MUC16;Mucin-16;Mucin-16, Cell Surface Associated | A measurement of the cancer antigen 125 in a biological specimen. | CA-125 Measurement | ||
CA15_3AG | C103362 | Cancer Antigen 15-3;Carbohydrate Antigen 15-3 | A measurement of the cancer antigen 15-3 in a biological specimen. | Cancer Antigen 15-3 Measurement | ||
CA19_9AG | C81982 | Cancer Antigen 19-9;Carbohydrate Antigen 19-9 | A measurement of the cancer antigen 19-9 in a biological specimen. | Cancer Antigen 19-9 Measurement | ||
CA1AG | C103361 | Cancer Antigen 1 | A measurement of the cancer antigen 1 in a biological specimen. | Cancer Antigen 1 Measurement | ||
CA242AG | C172526 | Cancer Antigen 242;Carbohydrate Antigen 242 | A measurement of the cancer antigen 242 in a biological specimen. | Cancer Antigen 242 Measurement | ||
CA2729AG | C111143 | Cancer Antigen 27-29 | A measurement of the cancer antigen 27-29 in a biological specimen. | Cancer Antigen 27-29 Measurement | ||
CA50AG | C187794 | CA50;Cancer Antigen 50;Carbohydrate Antigen 50 | A measurement of the cancer antigen 50 in a biological specimen. | Cancer Antigen 50 Measurement | ||
CA72_4AG | C106505 | CA 72-4;Cancer Antigen 72-4;Carbohydrate Antigen 72-4 | A measurement of the cancer antigen 72-4 in a biological specimen. | Cancer Antigen 72-4 Measurement | ||
CABOT | C74702 | Cabot Rings | A measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen. | Cabot Ring Count | ||
CACLR | C96589 | Calcium Clearance | A measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute). | Calcium Clearance Measurement | ||
CACR | C119272 | Calcium Corrected | A measurement of calcium, which has been corrected using an unspecified protein, in a biological specimen. | Calcium Corrected Measurement | ||
CACRALB | C154753 | Calcium Corrected for Albumin | A measurement of calcium, which has been corrected for albumin, in a biological specimen. | Albumin Corrected Calcium Measurement | ||
CACREAT | C79439 | Calcium/Creatinine | A relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen. | Calcium to Creatinine Ratio Measurement | ||
CACRTP | C147314 | Calcium Corrected for Total Protein | A measurement of calcium, which has been corrected for total protein, in a biological specimen. | Calcium Corrected for Total Protein Measurement | ||
CAEXR | C150815 | Calcium Excretion Rate | A measurement of the amount of calcium being excreted in a biological specimen over a defined period of time (e.g. one hour). | Calcium Excretion Rate | ||
CAFFEINE | C75346 | Caffeine | A measurement of the caffeine in a biological specimen. | Caffeine Measurement | ||
CAION | C81948 | Calcium, Ionized | A measurement of the ionized calcium in a biological specimen. | Ionized Calcium Measurement | ||
CAIONPH | C125941 | Calcium, Ionized pH Adjusted | A measurement of the pH adjusted ionized calcium in a biological specimen. | Ionized pH Adjusted Calcium Measurement | ||
CALB | C125942 | Calbindin | A measurement of the total calbindin in a biological specimen. | Calbindin Measurement | ||
CALPRO | C82005 | Calprotectin | A measurement of the calprotectin in a biological specimen. | Calprotectin Measurement | ||
CAMP | C124339 | Cyclic Adenosine 3,5-Monophosphate | A measurement of cyclic adenosine 3,5-monophosphate in a biological specimen. | Cyclic Adenosine 3,5-Monophosphate Measurement | ||
CAMPCRT | C186030 | Cyclic Adenosine 3,5-Monophosphate/Creatinine;Cyclic Adenosine Monophosphate/Creat;Cyclic Adenosine Monophosphate/Creatinine | A relative measurement (ratio) of the cyclic adenosine 3,5-monophosphate to creatinine in a biological specimen. | Cyclic Adenosine 3,5 Monophosphate to Creatinine Ratio Measurement | ||
CAN | C176310 | Coefficient of Nitrogen Absorption | A measurement of the coefficient of nitrogen absorption in a biological specimen. | Coefficient of Nitrogen Absorption Measurement | ||
CANNAB | C74689 | Cannabinoids | A measurement of any cannabinoid class drug present in a biological specimen. | Cannabinoid Drug Class Measurement | ||
CANNABM | C165946 | Cannabinoid Metabolites;Cannabis Metabolites;Marijuana Metabolites | A measurement of any cannabinoid drug class metabolite(s) present in a biological specimen. | Cannabinoid Metabolite Measurement | ||
CANNABS | C135402 | Cannabinoids, Synthetic | A measurement of any synthetic cannabinoid class drug present in a biological specimen. | Synthetic Cannabinoid Measurement | ||
CAOXAEXR | C187793 | Calcium Oxalate Excretion Rate | A measurement of the amount of calcium oxalate being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Calcium Oxalate Excretion Rate | ||
CAPHOS | C139087 | Calcium/Phosphate;Calcium/Phosphorus | A relative measurement (ratio) of the calcium to phosphorus in a biological specimen. | Calcium to Phosphorus Ratio Measurement | ||
CAPHOSPD | C103360 | Calcium - Phosphorus Product | A measurement of the product of the calcium and phosphate measurements in a biological specimen. | Calcium and Phosphorus Product Measurement | ||
CARBXHGB | C96591 | Carboxyhemoglobin | A measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen. | Carboxyhemoglobin Measurement | ||
CARIPRZN | C177975 | Cariprazine | A measurement of the cariprazine in a biological specimen. | Cariprazine Measurement | ||
CARNIT | C74682 | Carnitine | A measurement of the total carnitine in a biological specimen. | Total Carnitine Measurement | ||
CARNITAT | C92288 | Carnitine Acetyl Transferase | A measurement of the carnitine acetyl transferase in a biological specimen. | Carnitine Acetyl Transferase Measurement | ||
CARNITF | C74677 | Carnitine, Free | A measurement of the free carnitine in a biological specimen. | Free Carnitine Measurement | ||
CARNTEXR | C163424 | Carnitine Excretion Rate | A measurement of the amount of carnitine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Carnitine Excretion Rate | ||
CARTP | C142273 | CART;Cocaine Amphetamine-Reg Transcript Prot;Cocaine and Amphetamine-Regulated Transcript Protein | A measurement of the cocaine and amphetamine-regulated transcript protein in a biological specimen. | Cocaine Amphetamine-Regulated Transcript Protein Measurement | ||
CASEIN | C198282 | Casein | A measurement of the casein in a biological specimen. | Casein Measurement | ||
CASTS | C74763 | Casts | A statement that indicates casts were looked for in a biological specimen. | Cast Present Or Absent | ||
CASULPH | C96590 | Calcium Sulphate | A measurement of the calcium sulphate in a biological specimen. | Calcium Sulphate Measurement | ||
CATHNON | C184534 | Cathinone | A measurement of the cathinone in a biological specimen. | Cathinone Measurement | ||
CATNINB | C103357 | Beta Catenin | A measurement of the beta catenin in a biological specimen. | Beta Catenin Measurement | ||
CBA | C135403 | Ba Fragment of Complement Factor B;Ba Fragment of Factor B;Complement Ba | A measurement of the Ba fragment of complement factor B in a biological specimen. | Complement Ba Measurement | ||
CBANH9 | C172510 | CA9;CAIX;Carbonic Anhydrase 9 | A measurement of the carbonic anhydrase 9 in a biological specimen. | Carbonic Anhydrase 9 Measurement | ||
CBB | C80172 | Bb Fragment of Complement Factor B;Bb Fragment of Factor B;Complement Bb | A measurement of the Bb fragment of complement factor B in a biological specimen. | Complement Bb Measurement | ||
CBS | C172520 | Cystathionine Beta-Synthase | A measurement of the cystathionine beta-synthase in a biological specimen. | Cystathionine Beta-Synthase Measurement | ||
CCK | C74850 | Cholecystokinin;Pancreozymin | A measurement of the cholecystokinin hormone in a biological specimen. | Cholecystokinin Measurement | ||
CCL12 | C130156 | Chemokine (C-C Motif) Ligand 12;Monocyte Chemotactic Protein 5 | A measurement of the CCL12, chemokine (C-C motif) ligand 12, in a biological specimen. | Chemokine (C-C Motif) Ligand 12 Measurement | ||
CCL13 | C165947 | C-C Motif Chemokine Ligand 13;Chemokine (C-C Motif) Ligand 13;CKb10;MCP-4;NCC1;SCYA13;SCYL1 | A measurement of the CCL13, chemokine (C-C motif) ligand 13, in a biological specimen. | Chemokine (C-C Motif) Ligand 13 Measurement | ||
CCL16 | C165948 | Chemokine (C-C Motif) Ligand 16;CKb12;HCC-4;ILINCK;LCC-1;LEC;LMC;Mtn-1;NCC4;SCYA16;SCYL4 | A measurement of the CCL16, chemokine (C-C motif) ligand 16, in a biological specimen. | Chemokine (C-C Motif) Ligand 16 Measurement | ||
CCL17 | C112236 | ABCD-2;Chemokine (C-C Motif) Ligand 17;SCYA17;TARC;Thymus and Activation Regulated Chemokine | A measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen. | Chemokine (C-C Motif) Ligand 17 Measurement | ||
CCL18 | C112237 | AMAC-1;AMAC1;Chemokine (C-C Motif) Ligand 18;CKB7;DC-CK1;DCCK1;Macrophage inflammatory protein-4;MIP4;PARC;Pulmonary and Activation-Regulated Chemokine;SCYA18 | A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen. | Chemokine (C-C Motif) Ligand 18 Measurement | ||
CCL19 | C130157 | Chemokine (C-C Motif) Ligand 19;Macrophage Inflammatory Protein 3 Beta;MIP3B | A measurement of the CCL19, chemokine (C-C motif) ligand 19, in a biological specimen. | Chemokine (C-C Motif) Ligand 19 Measurement | ||
CCL20 | C161362 | CCL20;Chemokine (C-C Motif) Ligand 20;LARC;Liver Activation Regulated Chemokine;Macrophage Inflammatory Protein-3 Alpha;MIP3A | A measurement of the chemokine (C-C motif) ligand 20 in a biological specimen. | Chemokine (C-C Motif) Ligand 20 Measurement | ||
CCL21 | C147315 | 6Ckine;Chemokine (C-C Motif) Ligand 21;Secondary Lymphoid Tissue Chemokine | A measurement of the CCL21, chemokine (C-C motif) ligand 21, in a biological specimen. | Chemokine (C-C Motif) Ligand 21 Measurement | ||
CCL23 | C165949 | Chemokine (C-C Motif) Ligand 23;CK-BETA-8;Ckb-8-1;CKb8;Hmrp-2a;MIP3;MPIF-1;SCYA23 | A measurement of the CCL23, chemokine (C-C motif) ligand 23, in a biological specimen. | Chemokine (C-C Motif) Ligand 23 Measurement | ||
CCL25 | C165950 | Chemokine (C-C Motif) Ligand 25;Ckb15;SCYA25;TECK | A measurement of the CCL25, chemokine (C-C motif) ligand 25, in a biological specimen. | Chemokine (C-C Motif) Ligand 25 Measurement | ||
CCL2EXR | C156520 | Chemokine (C-C Motif) Ligand 2 Excr Rate;Chemokine (C-C Motif) Ligand 2 Excretion Rate;MCP1 Excretion Rate | A measurement of the amount of chemokine (C-C Motif) ligand 2 being excreted in a biological specimen over a defined period of time (e.g. one hour). | Chemokine (C-C Motif) Ligand 2 Excretion Rate | ||
CCL7 | C130158 | Chemokine (C-C Motif) Ligand 7;MCP3;Monocyte Chemotactic Protein 3 | A measurement of the CCL7, chemokine (C-C motif) ligand 7, in a biological specimen. | Chemokine (C-C Motif) Ligand 7 Measurement | ||
CCL8 | C165951 | Chemokine (C-C Motif) Ligand 8;HC14;MCP2;SCYA10;SCYA8 | A measurement of the CCL8, chemokine (C-C motif) ligand 8, in a biological specimen. | Chemokine (C-C Motif) Ligand 8 Measurement | ||
CCPAB | C96595 | Cyclic Citrullinated Peptide Antibody | A measurement of the cyclic citrullinated peptide antibody in a biological specimen. | Cyclic Citrullinated Peptide Antibody Measurement | ||
CCPIGGAB | C147316 | Cyclic Citrullinated Peptide IgG Ab;Cyclic Citrullinated Peptide IgG Antibody | A measurement of the cyclic citrullinated peptide IgG antibody in a biological specimen. | Cyclic Citrullinated Peptide IgG Antibody Measurement | ||
CCR5 | C122103 | C-C Chemokine Receptor Type 5;CD195 | A measurement of the CCR5, chemokine (C-C motif) receptor type 5, in a biological specimen. | C-C Chemokine Receptor Type 5 Measurement | ||
CD163S | C154728 | Soluble CD163 | A measurement of the soluble CD163 in a biological specimen. | Soluble CD163 Measurement | ||
CD38S | C187826 | Cyclic ADP Ribose Hydrolase;Soluble CD38 | A measurement of the soluble CD38 protein in a biological specimen. | Soluble CD38 Measurement | ||
CDCA | C172498 | Chenic Acid;Chenocholic Acid;Chenodeoxycholate;Chenodeoxycholic Acid | A measurement of the chenodeoxycholate in a biological specimen. | Chenodeoxycholate Measurement | ||
CDCACM | C176239 | Chenodeoxycholate Compounds;Chenodeoxycholic Acid Compounds | A measurement of the chenodeoxycholic acid, glycochenodeoxycholic acid, and taurochenodeoxycholic acid in a biological specimen. | Chenodeoxycholate Compounds Measurement | ||
CDT | C101016 | Carbohydrate-Deficient Transferrin | A measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen. | Carbohydrate-Deficient Transferrin Measurement | ||
CDTTFRN | C125943 | Carb-Deficient Transferrin/Transferrin | A relative measurement (ratio or percentage) of the carbohydrate-deficient transferrin to total transferrin in a biological specimen. | Carbohydrate-Deficient Transferrin to Transferrin Ratio Measurement | ||
CEA | C81983 | Carcinoembryonic Antigen | A measurement of the carcinoembryonic antigen in a biological specimen. | Carcinoembryonic Antigen Measurement | ||
CEACAM1 | C172511 | BGP;Biliary Glycoprotein;Carcinoembryonic Antigen Cell Adhesion Molecule 1;CD66a;CEA Cell Adhesion Molecule 1;CEA Related Cell Adhesion Molecule 1 | A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 1 in a biological specimen. | CEA Cell Adhesion Molecule 1 Measurement | ||
CEACAM5 | C191212 | Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5;CD66e;CEA Cell Adhesion Molecule 5 | A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. | CEA Cell Adhesion Molecule 5 Measurement | ||
CEACAM5S | C191290 | Soluble Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5;Soluble CD66e;Soluble CEA Cell Adhesion Molecule 5 | A measurement of the soluble carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. | Soluble CEA Cell Adhesion Molecule 5 Measurement | ||
CEC | C96592 | Circulating Endothelial Cells | A measurement of the circulating endothelial cells in a biological specimen. | Circulating Endothelial Cell Count | ||
CEIMCE | C111234 | Immature Cells/Total Cells | A relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen. | Immature Cell to Total Cell Ratio Measurement | ||
CELLS | C48938 | Cells | A measurement of the total cells in a biological specimen. | Cell Count | ||
CELLSIM | C96672 | Immature Cells | A measurement of the total immature cells in a blood specimen. | Immature Cell Count | ||
CELLULAR | C111153 | Cellularity;Cellularity Grade | A measurement of the degree, quality or condition of cells in a biological specimen. | Cellularity Measurement | ||
CEMORPH | C17768 | Cell Morphology | An examination or assessment of the form and structure of cells. | Cellular Morphology | ||
CENTROAB | C111154 | Centromere B Antibodies | A measurement of centromere B antibodies in a biological specimen. | Centromere B Antibody Measurement | ||
CETP | C120632 | Cholesteryl Ester Transfer Protein | A measurement of the cholesteryl ester transfer protein in a biological specimen. | Cholesteryl Ester Transfer Protein Measurement | ||
CETPA | C103380 | Cholesteryl Ester Transfer Protein Act | A measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen. | Cholesteryl Ester Transfer Protein Activity Measurement | ||
CFA | C176311 | Coefficient of Fat Absorption | A measurement of the coefficient of fat absorption in a biological specimen. | Coefficient of Fat Absorption Measurement | ||
CGA | C122108 | Chromogranin A | A measurement of the chromogranin A in a biological specimen. | Chromogranin A Measurement | ||
CGADJMW | C161374 | Choriogonadotropin Adj for Maternal Wt;Choriogonadotropin Adjusted for Maternal Weight | A measurement of choriogonadotropin, which has been adjusted for maternal body weight, in a biological specimen. | Choriogonadotropin Adjusted for Maternal Weight Measurement | ||
CGMP | C111165 | Cyclic Guanosine Monophosphate | A measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen. | Cyclic Guanosine Monophosphate Measurement | ||
CH100 | C147317 | CH100;Complement CH100;Total Hemolytic Complement CH100 | A measurement of the complement required to lyse 100 percent of red blood cells in a biological specimen. | Complement CH100 Measurement | ||
CH50 | C100423 | CH50;Complement CH50;Total Hemolytic Complement CH50 | A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen. | CH50 Measurement | ||
CHCM | C139067 | Corpuscular HGB Concentration Mean | A direct measurement of the concentration of hemoglobin within individual erythrocytes in a biological specimen, reported as a mean. | Corpuscular Hemoglobin Concentration Mean | ||
CHCMR | C138970 | Ret. Corpuscular HGB Concentration Mean;Reticulocyte Corpuscular Hemoglobin Concentration Mean | An indirect measurement of the average concentration of hemoglobin per reticulocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit. | Reticulocyte Corpuscular Hemoglobin Concentration Mean | ||
CHCNT | C139066 | Cellular Hemoglobin Content;CH;Corpuscular Hemoglobin Content | A measurement of the mean erythrocyte hemoglobin content within an individual erythrocyte, calculated as the product of cell volume and cell hemoglobin concentration. | Corpuscular Hemoglobin Content | ||
CHDH7A25 | C181430 | 7alpha,25-Dihydroxycholesterol | A measurement of the 7alpha,25-dihydroxycholesterol in a biological specimen. | 7alpha,25-Dihydroxycholesterol Measurement | ||
CHDH7A27 | C181431 | 7alpha,27-Dihydroxycholesterol | A measurement of the 7alpha,27-dihydroxycholesterol in a biological specimen. | 7alpha,27-Dihydroxycholesterol Measurement | ||
CHDW | C139068 | Corpuscular Hemoglobin Concentration Distribution Width;Corpuscular HGB Conc Distribution Width | A measurement of the standard deviation of hemoglobin concentrations in erythrocytes in a biological specimen, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content. | Corpuscular Hemoglobin Concentration Distribution Width | ||
CHDWR | C139069 | Ret Corpuscular HGB Conc Distr Width;Reticulocyte Corpuscular Hemoglobin Distribution Width | A measurement of the standard deviation of hemoglobin concentrations in reticulocytes in a biological specimen, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content. | Reticulocyte Corpuscular Hemoglobin Distribution Width | ||
CHE24S25 | C181423 | 24(S),25-Epoxycholesterol | A measurement of the 24(S),25-epoxycholesterol in a biological specimen. | 24(S),25-Epoxycholesterol Measurement | ||
CHITTDS | C187795 | Chitinase 1;Chitotriosidase;Chitotriosidase-1 | A measurement of the chitotriosidase-1 in a biological specimen. | Chitotriosidase-1 Measurement | ||
CHLMCRN | C120633 | Chylomicrons | A measurement of the chylomicrons in a biological specimen. | Chylomicrons Measurement | ||
CHLMCRNT | C174302 | Chylomicron Triglyceride | A measurement of the chylomicron triglyceride in a biological specimen. | Chylomicron Triglyceride Measurement | ||
CHLRHDRT | C184612 | Chloral Hydrate;Mickey Finn;Trichloroacetaldehyde Monohydrate | A measurement of the chloral hydrate in a biological specimen. | Chloral Hydrate Measurement | ||
CHLRPMZN | C177968 | Chlorpromazine | A measurement of the chlorpromazine in a biological specimen. | Chlorpromazine Measurement | ||
CHOL | C105586 | Cholesterol;Total Cholesterol | A measurement of the cholesterol in a biological specimen. | Cholesterol Measurement | ||
CHOLATE | C172499 | Cholate;Cholic Acid | A measurement of the cholate in a biological specimen. | Cholate Measurement | ||
CHOLCM | C176232 | Cholate Compounds;Cholic Acid Compounds | A measurement of the cholic acid, glycocholic acid, hyocholic acid, and taurocholic acid in a biological specimen. | Cholate Compounds Measurement | ||
CHOLH20S | C181420 | 20(S)-Hydroxycholesterol;20-Alpha-Hydroxycholesterol | A measurement of the 20(S)-hydroxycholesterol in a biological specimen. | 20(S)-Hydroxycholesterol Measurement | ||
CHOLH22R | C181421 | 22(R)-Hydroxycholesterol | A measurement of the 22(R)-hydroxycholesterol in a biological specimen. | 22(R)-Hydroxycholesterol Measurement | ||
CHOLH22S | C181422 | 22(S)-Hydroxycholesterol | A measurement of the 22(S)-hydroxycholesterol in a biological specimen. | 22(S)-Hydroxycholesterol Measurement | ||
CHOLH24R | C181424 | 24(R)-Hydroxycholesterol | A measurement of the 24(R)-hydroxycholesterol in a biological specimen. | 24(R)-Hydroxycholesterol Measurement | ||
CHOLH24S | C181425 | 24(S)-Hydroxycholesterol | A measurement of the 24(S)-hydroxycholesterol in a biological specimen. | 24(S)-Hydroxycholesterol Measurement | ||
CHOLH25 | C181426 | 25-Hydroxycholesterol | A measurement of the 25-hydroxycholesterol in a biological specimen. | 25-Hydroxycholesterol Measurement | ||
CHOLH27 | C181427 | 27-Hydroxycholesterol | A measurement of the 27-hydroxycholesterol in a biological specimen. | 27-Hydroxycholesterol Measurement | ||
CHOLH7A | C181432 | 7alpha-Hydroxycholesterol | A measurement of the 7alpha-hydroxycholesterol in a biological specimen. | 7alpha-Hydroxycholesterol Measurement | ||
CHOLH7B | C181433 | 7beta-Hydroxycholesterol | A measurement of the 7beta-hydroxycholesterol in a biological specimen. | 7beta-Hydroxycholesterol Measurement | ||
CHOLHDL | C80171 | Cholesterol/HDL-Cholesterol | A relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen. | Cholesterol to HDL-Cholesterol Ratio Measurement | ||
CHOLINES | C92289 | Cholinesterase | A measurement of the cholinesterase in a biological specimen. | Cholinesterase Measurement | ||
CHOLK7 | C181434 | 7-Ketocholesterol;7-Oxocholesterol | A measurement of the 7-ketocholesterol in a biological specimen. | 7-Ketocholesterol Measurement | ||
CHOLOH4B | C156514 | 4-Beta-Hydroxycholesterol | A measurement of the 4-beta-hydroxycholesterol in a biological specimen. | 4-Beta-Hydroxycholesterol Measurement | ||
CHOLSTNL | C181435 | 5alpha-Cholestanol;Beta-Cholestanol;Cholestanol;Dehydrocholesterol;Zymostanol | A measurement of the cholestanol in a biological specimen. | Cholestanol Measurement | ||
CHOLSULF | C181436 | Cholesterol Sulfate | A measurement of the cholesterol sulfate in a biological specimen. | Cholesterol Sulfate Measurement | ||
CHRMTNAB | C147318 | Chromatin Antibodies | A measurement of the chromatin antibodies in a biological specimen. | Chromatin Antibody Measurement | ||
CHYTRYP | C111159 | Chymotrypsin | A measurement of the total chymotrypsin in a biological specimen. | Chymotrypsin Measurement | ||
CIC | C127611 | Circulating Immune Complexes | A measurement of the circulating immune complexes in a biological specimen. | Circulating Immune Complex Measurement | ||
CIT | C122109 | Citrulline | A measurement of the citrulline in a biological specimen. | Citrulline Measurement | ||
CITCREAT | C122110 | Citrate/Creatinine;Citric Acid/Creatinine | A relative measurement (ratio or percentage) of the citrate to creatinine in a biological specimen. | Citrate to Creatinine Ratio Measurement | ||
CITRATE | C92248 | Citrate;Citric Acid | A measurement of the citrate in a biological specimen. | Citrate Measurement | ||
CITRTEXR | C163425 | Citrate Excretion Rate | A measurement of the amount of citrate being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Citrate Excretion Rate | ||
CK | C64489 | CPK;Creatine Kinase;Creatine Phosphokinase | A measurement of the total creatine kinase in a biological specimen. | Creatine Kinase Measurement | ||
CKBB | C64490 | Creatine Kinase BB | A measurement of the homozygous B-type creatine kinase in a biological specimen. | Creatine Kinase BB Measurement | ||
CKBBCK | C79466 | Creatine Kinase BB/Total Creatine Kinase | A relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase BB to Total Creatine Kinase Ratio Measurement | ||
CKMB | C64491 | Creatine Kinase MB | A measurement of the heterozygous MB-type creatine kinase in a biological specimen. | Creatine Kinase MB Measurement | ||
CKMBCK | C79441 | Creatine Kinase MB/Total Creatine Kinase | A relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase MB to Total Creatine Kinase Ratio Measurement | ||
CKMM | C64494 | Creatine Kinase MM | A measurement of the homozygous M-type creatine kinase in a biological specimen. | Creatine Kinase MM Measurement | ||
CKMMCK | C79442 | Creatine Kinase MM/Total Creatine Kinase | A relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase MM to Total Creatine Kinase Ratio Measurement | ||
CKMT1CK | C147319 | CK, Macromolecular Type 1/Total CK;Creatine Kinase, Macromolecular Type 1/Total Creatine Kinase | A relative measurement (ratio or percentage) of the macromolecular type 1 creatine kinase to total creatine kinase in a biological specimen. | Macromolecular Type 1 Creatine Kinase to Total Creatine Kinase Ratio Measurement | ||
CKMT2CK | C147320 | CK, Macromolecular Type 2/Total CK;Creatine Kinase, Macromolecular Type 2/Total Creatine Kinase | A relative measurement (ratio or percentage) of the macromolecular type 2 creatine kinase to total creatine kinase in a biological specimen. | Macromolecular Type 2 Creatine Kinase to Total Creatine Kinase Ratio Measurement | ||
CL | C64495 | Chloride | A measurement of the chloride in a biological specimen. | Chloride Measurement | ||
CLARITY | C96594 | Clarity | A measurement of the transparency of a biological specimen. | Clarity Measurement | ||
CLCLR | C106509 | Chloride Clearance | A measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute). | Chloride Clearance Measurement | ||
CLCREAT | C79440 | Chloride/Creatinine | A relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen. | Chloride to Creatinine Ratio Measurement | ||
CLCTONN | C74848 | Calcitonin | A measurement of the calcitonin hormone in a biological specimen. | Calcitonin Measurement | ||
CLCTRIOL | C74849 | Calcitriol | A measurement of the calcitriol hormone in a biological specimen. | Calcitriol Measurement | ||
CLEPNSQE | C135405 | Columnar Epi Cells/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the columnar epithelial cells to non-squamous epithelial cells in a biological specimen. | Columnar Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement | ||
CLEXR | C150816 | Chloride Excretion Rate | A measurement of the amount of chloride being excreted in a biological specimen over a defined period of time (e.g. one hour). | Chloride Excretion Rate | ||
CLNZPM | C139082 | Clonazepam | A measurement of the clonazepam present in a biological specimen. | Clonazepam Measurement | ||
CLOBAZAM | C184613 | Clobazam;cloBAZam | A measurement of the clobazam in a biological specimen. | Clobazam Measurement | ||
CLOSTBL | C184581 | Clostebol | A measurement of the clostebol in a biological specimen. | Clostebol Measurement | ||
CLOTRTC | C181438 | Clot Retraction;Clot Retraction, Qualitative | A qualitative assessment of clot retraction in a biological specimen. | Qualitative Clot Retraction Measurement | ||
CLOTRTCT | C181437 | Clot Retraction Time | A measurement of the amount of time it takes for a clot to retract, or pull away from, the wall of a glass collection container. | Clot Retraction Time Measurement | ||
CLPHTRMN | C184580 | Chlorphentermine | A measurement of the chlorphentermine in a biological specimen. | Chlorphentermine Measurement | ||
CLRDZPXD | C75371 | Chlordiazepoxide | A measurement of the chlordiazepoxide present in a biological specimen. | Chlordiazepoxide Measurement | ||
CLRZPT | C139077 | Clorazepate | A measurement of the clorazepate present in a biological specimen. | Clorazepate Measurement | ||
CLT | C187805 | Clot Lysis Time;ECLT;ELT;Euglobulin Clot Lysis Time;Euglobulin Lysis Time | A measurement of the amount of time it takes for dissolution of a fibrin clot in a biological specimen. | Euglobulin Clot Lysis Time | ||
CLUECE | C102261 | Clue Cells | A measurement of the clue cells in a biological specimen. | Clue Cell Count | ||
CLZPMAOM | C186031 | Clonazepam and/or Metabolites | A measurement of the clonazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both clonazepam and its metabolites. | Clonazepam and/or Metabolites Measurement | ||
CMONOX | C139084 | Carbon Monoxide | A measurement of the carbon monoxide in a biological specimen. | Carbon Monoxide Measurement | ||
CMPK2 | C163426 | Cytidine-Uridine Monophosphate Kinase 2;Cytidine/Uridine Monophosphate Kinase 2 | A measurement of the cytidine-uridine monophosphate kinase 2 in a biological specimen. | Cytidine-Uridine Monophosphate Kinase 2 Measurement | ||
CNTIGGAB | C122111 | Centromere IgG Antibody;Centromere Protein B | A measurement of the centromere IgG antibody in a biological specimen. | Centromere IgG Antibody Measurement | ||
CO2 | C64545 | Carbon Dioxide | A measurement of the carbon dioxide gas in a biological specimen. | Carbon Dioxide Measurement | ||
COAGIDX | C112239 | CI;Coagulation Index | A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation. | Coagulation Index Measurement | ||
COCAAOM | C172490 | Cocaine and/or Metabolites | A measurement of the cocaine and/or its metabolite(s) present in a biological specimen, for an assay that can measure both cocaine and its metabolites. | Cocaine And/Or Metabolites Measurement | ||
COCAETH | C156510 | Cocaethylene;Cocaine Ethyl | A measurement of the cocaethylene present in a biological specimen. | Cocaethylene Measurement | ||
COCAINE | C74690 | Cocaine | A measurement of the cocaine present in a biological specimen. | Cocaine Measurement | ||
COCAM | C172491 | Cocaine Metabolites | A measurement of any cocaine drug class metabolite(s) present in a biological specimen. | Cocaine Metabolites Measurement | ||
COCBNZEC | C142274 | Cocaine Benzoylecgonine Ecgonine | A measurement of the cocaine, benzoylecgonine, and/or ecgonine in a biological specimen. | Cocaine, Benzoylecgonine, and/or Ecgonine Measurement | ||
CODEINE | C74877 | Codeine | A measurement of the codeine present in a biological specimen. | Codeine Measurement | ||
COL4 | C103383 | Collagen Type IV | A measurement of the collagen type IV in a biological specimen. | Collagen Type IV Measurement | ||
COLOR | C64546 | Color | A measurement of the color of a biological specimen. | Color Assessment | ||
COMP | C111145 | Cartilage Oligomeric Matrix Protein | A measurement of the cartilage oligomeric matrix protein in a biological specimen. | Cartilage Oligomeric Matrix Protein Measurement | ||
CONDUCTU | C102282 | Urine Conductivity | A measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine. | Urine Conductivity | ||
CONSIST | C95110 | Consistency | A description about the firmness or make-up of an entity. | Consistency | ||
COPEP | C127612 | Copeptin | A measurement of the copeptin in a biological specimen. | Copeptin Measurement | ||
COPPER | C111161 | Copper;Cu | A measurement of copper in a biological specimen. | Copper Measurement | ||
COQ10 | C147321 | Coenzyme Q10;Ubiquinone 10 | A measurement of the ubiquinone 10 in a biological specimen. | Ubiquinone 10 Measurement | ||
CORCREAT | C106512 | Cortisol/Creatinine | A relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample. | Cortisol to Creatinine Ratio Measurement | ||
CORTFR | C88113 | Cortisol, Free | A measurement of the free, unbound cortisol in a biological specimen. | Free Cortisol Measurement | ||
CORTISOL | C74781 | Cortisol;Total Cortisol | A measurement of the cortisol in a biological specimen. | Cortisol Measurement | ||
CORTOLA | C186032 | Alpha Cortol;alpha-Cortol | A measurement of the alpha cortol in a biological specimen. | Alpha Cortol Measurement | ||
CORTOLNA | C186033 | Alpha Cortolone;alpha-Cortolone | A measurement of the alpha cortolone in a biological specimen. | Alpha Cortolone Measurement | ||
COTININE | C92249 | Cotinine | A measurement of the cotinine in a biological specimen. | Cotinine Measurement | ||
CPB2 | C165953 | Carboxypeptidase B2;CPU;PCPB;TAFI | A measurement of the carboxypeptidase B2 in a biological specimen. | Carboxypeptidase B2 Measurement | ||
CPEPCRT | C150837 | C-peptide/Creatinine | A relative measurement (ratio or percentage) of the C-peptide to creatinine in a biological specimen. | C-peptide to Creatinine Ratio Measurement | ||
CPEPEXR | C187796 | C-Peptide Excretion Rate | A measurement of the amount of C-peptide being excreted in a biological specimen over a defined amount of time (e.g. one hour). | C-Peptide Excretion Rate | ||
CPEPTIDE | C74736 | C-peptide | A measurement of the C (connecting) peptide of insulin in a biological specimen. | C-peptide Measurement | ||
CRBMZPN | C147322 | Carbamazepine | A measurement of the carbamazepine in a biological specimen. | Carbamazepine Measurement | ||
CRDIGAAB | C122112 | Cardiolipin IgA Antibody | A measurement of the cardiolipin IgA antibody in a biological specimen. | Cardiolipin IgA Antibody Measurement | ||
CRDIGGAB | C111144 | Anti-Cardiolipin IgG Antibody;Cardiolipin IgG Antibody | A measurement of the cardiolipin IgG antibody in a biological specimen. | Cardiolipin IgG Antibody Measurement | ||
CRDIGMAB | C103363 | Cardiolipin IgM Antibody | A measurement of the cardiolipin IgM antibodies in a biological specimen. | Cardiolipin IgM Antibody Measurement | ||
CREAT | C64547 | Creatinine | A measurement of the creatinine in a biological specimen. | Creatinine Measurement | ||
CREATCLR | C25747 | Creatinine Clearance | A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). | Creatinine Clearance | ||
CREATEXR | C150817 | Creatinine Excretion Rate | A measurement of the amount of creatinine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Creatinine Excretion Rate | ||
CRENCE | C74703 | Crenated Cells | A measurement of the crenated cells in a biological specimen. | Crenated Cell Measurement | ||
CRH | C74851 | Corticotropin Releasing Factor;Corticotropin Releasing Hormone | A measurement of the corticotropin releasing hormone in a biological specimen. | Corticotropin Releasing Hormone Measurement | ||
CRLPLSMN | C100432 | Caeruloplasmin;Ceruloplasmin | A measurement of ceruloplasmin in a biological specimen. | Ceruloplasmin Measurement | ||
CRNTESTR | C147323 | Carnitine Esters | A measurement of the total carnitine esters in a biological specimen. | Carnitine Ester Measurement | ||
CRP | C64548 | C Reactive Protein | A measurement of the C reactive protein in a biological specimen. | C-Reactive Protein Measurement | ||
CRSPRDL | C184611 | Carisoprodol | A measurement of the carisoprodol in a biological specimen. | Carisoprodol Measurement | ||
CRTCLRBS | C147324 | Creatinine Clearance Adjusted for BSA | A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body surface area. | Creatinine Clearance Adjusted for BSA | ||
CRTCLRE | C150847 | Creatinine Clearance, Estimated | An estimate of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). | Estimated Creatinine Clearance | ||
CRTCREAT | C106511 | Corticosterone/Creatinine | A relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample. | Corticosterone to Creatinine Ratio Measurement | ||
CRTFREXR | C163427 | Cortisol, Free Excretion Rate | A measurement of the amount of free cortisol being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Free Cortisol Excretion Rate | ||
CRTN | C186034 | Carotene | A measurement of the total carotenes in a biological specimen. | Carotene Measurement | ||
CRTRONE | C79434 | Corticosterone | A measurement of corticosterone in a biological specimen. | Corticosterone Measurement | ||
CRYGLBSR | C147325 | Cryoglobulin Volume/Serum Volume | A relative measurement (ratio or percentage) of the volume of cryoglobulin to total serum volume in a biological specimen. | Cryoglobulin Volume to Serum Volume Ratio Measurement | ||
CRYOFBRN | C147326 | Cryofibrinogen | A measurement of the cryofibrinogen in a biological specimen. | Cryofibrinogen Measurement | ||
CRYOGLBN | C111164 | Cryoglobulin | A measurement of cryoglobulin in a biological specimen. | Cryoglobulin Measurement | ||
CRYSTALS | C74673 | Crystals | A statement that indicates crystals were looked for in a biological specimen. | Crystal Present Or Absent | ||
CSAB | C120634 | Cathepsin Antibody | A measurement of the total cathepsin antibody in a biological specimen. | Cathepsin Antibody Measurement | ||
CSBACT | C74762 | Bacterial Casts | A measurement of the bacterial casts present in a biological specimen. | Bacterial Cast Measurement | ||
CSBROAD | C96588 | Broad Casts | A measurement of the broad casts in a biological specimen. | Broad Casts Measurement | ||
CSCELL | C74764 | Cellular Casts | A measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen. | Cellular Cast Measurement | ||
CSCYL | C150838 | Cylindroid Casts;Cylindroid Pseudocasts | A measurement of cylindroid casts (casts with a tapering end) in a biological specimen. | Cylindroid Cast Measurement | ||
CSEPI | C74779 | Epithelial Casts | A measurement of the epithelial cell casts present in a biological specimen. | Epithelial-Cast Measurement | ||
CSEPI846 | C112220 | 846-Epitope;Aggrecan Chondroitin Sulfate Epitope 846;Chondroitin Sulfate Epitope 846;Chondroitin Sulfate Proteoglycan 1 Epitope 846;CS846 | A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen. | Aggrecan Chondroitin Sulfate Epitope 846 Measurement | ||
CSEPIR | C174229 | Renal Epithelial Casts | A measurement of the renal epithelial cell casts in a biological specimen. | Renal Epithelial Casts Measurement | ||
CSEPIRT | C174292 | Renal Tubular Epithelial Casts | A measurement of the renal tubular epithelial cell casts in a biological specimen. | Renal Tubular Epithelial Casts Measurement | ||
CSFAT | C74766 | Fatty Casts | A measurement of the fatty casts present in a biological specimen. | Fatty Cast Measurement | ||
CSFIGIDX | C154735 | CSF IgG Index;CSF Index;IgG Index | A relative measurement (ratio) of the IgG to albumin in cerebrospinal fluid to the IgG to albumin in serum. | IgG Index | ||
CSGRAN | C74768 | Granular Casts | A measurement of the granular (coarse and fine) casts present in a biological specimen. | Granular Cast Measurement | ||
CSGRANC | C74765 | Granular Coarse Casts | A measurement of the coarse granular casts present in a biological specimen. | Coarse Granular Cast Measurement | ||
CSGRANF | C74769 | Granular Fine Casts | A measurement of the fine granular casts present in a biological specimen. | Granular Fine Cast Measurement | ||
CSHYAL | C74770 | Hyaline Casts | A measurement of the hyaline casts present in a biological specimen. | Hyaline Cast Measurement | ||
CSHYGR | C174305 | Hyalogranular Casts | A measurement of the hyalogranular casts in a biological specimen. | Hyalogranular Casts | ||
CSMIX | C74771 | Mixed Casts | A measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen. | Mixed Cast Count | ||
CSPATH | C186035 | Non-Hyalin Casts;Non-Hyaline Casts;Pathologic Casts | A measurement of the pathologic (non-hyaline) casts present in a biological specimen. | Pathologic Cast Measurement | ||
CSPIG | C189518 | Pigment Casts;Pigmented Casts | A measurement of the pigment casts present in a biological specimen. | Pigment Cast Measurement | ||
CSRBC | C74772 | Erythrocyte Casts;RBC Casts | A measurement of the red blood cell casts present in a biological specimen. | Red Blood Cell Cast Measurement | ||
CSUNCLA | C74776 | Unclassified Casts | A measurement of the unclassifiable casts present in a biological specimen. | Unclassified Cast Measurement | ||
CSWAX | C74777 | Waxy Casts | A measurement of the waxy casts present in a biological specimen. | Waxy Cell Cast Measurement | ||
CSWBC | C74778 | WBC Casts | A measurement of the white blood cell casts present in a biological specimen. | White Blood Cell Cast Measurement | ||
CTC | C96593 | Circulating Tumor Cells | A measurement of the circulating tumor cells in a biological specimen. | Circulating Tumor Cell Count | ||
CTCAPOP | C186036 | Circulating Tumor Cells, Apoptotic | A measurement of the apoptotic circulating tumor cells in a biological specimen. | Apoptotic Circulating Tumor Cell Count | ||
CTCHLMN | C186037 | Catecholamines | A measurement of the total catecholamines in a biological specimen. | Catecholamine Measurement | ||
CTCTRAD | C186038 | Circulating Tumor Cells, Traditional | A measurement of the traditional circulating tumor cells in a biological specimen. | Traditional Circulating Tumor Cell Count | ||
CTGF | C189504 | Cellular Communication Network Factor 2;CN2;Connective Tissue Growth Factor;IGFBP8 | A measurement of the connective tissue growth factor in a biological specimen. | Connective Tissue Growth Factor Measurement | ||
CTLCREAT | C189500 | Citrulline/Creatinine | A relative measurement (ratio or percentage) of the citrulline to creatinine in a biological specimen. | Citrulline to Creatinine Ratio Measurement | ||
CTLPRM | C147327 | Citalopram | A measurement of the citalopram present in a biological specimen. | Citalopram Measurement | ||
CTLPRMD | C189494 | Desmethyl Citalopram;Desmethylcitalopram;Norcitalopram | A measurement of the desmethylcitalopram in a biological specimen. | Desmethylcitalopram Measurement | ||
CTLPRMDD | C189655 | Di-Desmethylcitalopram | A measurement of the di-desmethylcitalopram in a biological specimen. | Di-Desmethylcitalopram Measurement | ||
CTOT | C80160 | Complement Total;Total Hemolytic Complement | A measurement of the total complement in a biological specimen. | Complement Measurement | ||
CTXI | C82038 | C-Terminal Telopeptide of Type I Collagen;Type I Collagen C-Telopeptides;Type I Collagen X-linked C-telopeptide | A measurement of the type I collagen cross-linked C-telopeptides in a biological specimen. | Type I Collagen C-Telopeptide Measurement | ||
CTXIB | C187792 | Beta Isomer of C-Terminal Telopeptide of Type I Collagen;Type I Collagen C-Telopeptides Beta | A measurement of the beta isomer of type I collagen cross-linked C-telopeptides in a biological specimen. | Beta Isomer of C-Terminal Telopeptide of Type I Collagen Measurement | ||
CTXICRT | C127613 | Type I Collagen C-Telopeptides/Creat;Type I Collagen X-Linked C-Telopeptides/Creatinine | A relative measurement (ratio or percentage) of the type I collagen cross-linked C-telopeptides to creatinine in a biological specimen. | Type I Collagen C-Telopeptide to Creatinine Ratio Measurement | ||
CTXII | C82040 | Type II Collagen C-Telopeptides;Type II Collagen X-Linked C-Telopeptides | A measurement of the type II collagen cross-linked C-telopeptides in a biological specimen. | Type II Collagen C-Telopeptide Measurement | ||
CTXIICRT | C122113 | Type II Collagen C-Telopeptides/Creat;Type II Collagen X-Linked C-Telopeptides/Creatinine | A relative measurement (ratio or percentage) of the type II collagen cross-linked C-telopeptides to creatinine in a biological specimen. | Type II Collagen C-Telopeptides to Creatinine Ratio Measurement | ||
CX3CL1 | C161361 | Chemokine (C-X3-C motif) Ligand 1;Fractalkine;Neurotactin | A measurement of the chemokine (C-X3-C motif) ligand 1 in a biological specimen. | Chemokine (C-X3-C Motif) Ligand 1 Measurement | ||
CXCL1 | C128952 | Chemokine (C-X-C Motif) Ligand 1;GRO Alpha;GRO/KC;Melanoma Growth Stimulating Activity, Alpha | A measurement of the CXCL1, chemokine (C-X-C motif) ligand 1, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 1 Measurement | ||
CXCL10 | C112238 | Chemokine (C-X-C Motif) Ligand 10;Interferon Gamma-induced Protein 10;Interferon-inducible Protein-10;IP-10;Small-inducible Cytokine B10 | A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 10 Measurement | ||
CXCL11 | C161360 | Chemokine (C-X-C Motif) Ligand 11;I-TAC;IFN-inducible T Cell Alpha Chemoattractant;ITAC | A measurement of the chemokine (C-X-C motif) ligand 11 in a biological specimen. | Chemokine (C-X-C Motif) Ligand 11 Measurement | ||
CXCL12 | C165954 | Chemokine (C-X-C Motif) Ligand 12;IRH;PBSF;SCYB12;SDF1;SDF1A;SDF1B;Stromal Cell-Derived Factor-1 Alpha;Stromal Cell-Derived Factor-1 Beta;TLSF;TPAR1 | A measurement of the CXCL12, chemokine (C-X-C motif) ligand 12, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 12 Measurement | ||
CXCL13 | C147328 | B Lymphocyte Chemoattractant;Chemokine (C-X-C Motif) Ligand 13 | A measurement of the CXCL13, chemokine (C-X-C motif) ligand 13, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 13 Measurement | ||
CXCL2 | C186039 | Chemokine (C-X-C Motif) Ligand 2;GRO Beta;GRO2;MIP2-Alpha | A measurement of the CXCL2, chemokine (C-X-C motif) ligand 2, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 2 Measurement | ||
CXCL3 | C147329 | Chemokine (C-X-C Motif) Ligand 3;GRO Gamma;Macrophage Inflammatory Protein 2-Beta;MIP2 Beta;MIP2B | A measurement of the CXCL3, chemokine (C-X-C motif) ligand 3, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 3 Measurement | ||
CXCL4 | C147330 | Chemokine (C-X-C Motif) Ligand 4;Oncostatin A;Platelet Factor 4;PLF4 | A measurement of the CXCL4, chemokine (C-X-C motif) ligand 4, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 4 Measurement | ||
CXCL6 | C130159 | Chemokine (C-X-C Motif) Ligand 6;GCP2;Granulocyte Chemotactic Protein 2 | A measurement of the CXCL6, chemokine (C-X-C motif) ligand 6, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 6 Measurement | ||
CXCL7 | C165955 | B-TG1;Beta-TG;Chemokine (C-X-C Motif) Ligand 7;CTAP-III;CTAP3;CTAPIII;LA-PF4;LDGF;MDGF;NAP-2;Neutrophil-Activating Peptide 2;PBP;PPBP;Pro-Platelet Basic Protein;SCYB7;TC1;TC2;TGB;TGB1;THBGB;THBGB1 | A measurement of the pro-platelet basic protein in a biological specimen. | Chemokine (C-X-C Motif) Ligand 7 Measurement | ||
CXCL9 | C165956 | Chemokine (C-X-C Motif) Ligand 9;CMK;crg-10;Humig;MIG;SCYB9 | A measurement of the CXCL9, chemokine (C-X-C motif) ligand 9, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 9 Measurement | ||
CXCR3 | C100431 | CD183;Chemokine (C-X-C Motif) Receptor 3;CXCR3;GPR9 | A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen. | Chemokine Receptor CXCR3 Measurement | ||
CXCR4 | C187797 | CD184;Chemokine (C-X-C Motif) Receptor 4;LPS-Associated Protein 3;Stromal Cell-Derived Factor 1 Receptor | A measurement of the CXCR4, chemokine (C-X-C motif) receptor 4, in a biological specimen. | C-X-C Chemokine Receptor Type 4 Measurement | ||
CYAMMBIU | C105590 | Acid Ammonium Urate Crystals;Ammonium Biurate Crystals;Ammonium Urate Crystals | A measurement of the ammonium biurate crystals present in a biological specimen. | Ammonium Biurate Crystals Measurement | ||
CYAMMOX | C74759 | Ammonium Oxalate Crystals | A measurement of the ammonium oxalate crystals present in a urine specimen. | Urine Ammonium Oxalate Crystal Measurement | ||
CYAMORPH | C74665 | Amorphous Crystals | A measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen. | Amorphous Crystal Measurement | ||
CYAMPPH | C92243 | Amorphous Phosphate Crystals | A measurement of the amorphous phosphate crystals in a biological specimen. | Amorphous Phosphate Crystals Measurement | ||
CYAMPURT | C92244 | Amorphous Urate Crystals | A measurement of the amorphous urate crystals in a biological specimen. | Amorphous Urate Crystals Measurement | ||
CYBILI | C74668 | Bilirubin Crystals | A measurement of the bilirubin crystals present in a biological specimen. | Bilirubin Crystal Measurement | ||
CYCACAR | C74669 | Calcium Carbonate Crystals | A measurement of the calcium carbonate crystals present in a biological specimen. | Calcium Carbonate Crystal Measurement | ||
CYCAOXA | C74670 | Calcium Oxalate Crystals | A measurement of the calcium oxalate crystals present in a biological specimen. | Calcium Oxalate Crystal Measurement | ||
CYCAPHOS | C74671 | Calcium Phosphate Crystals | A measurement of the calcium phosphate crystals present in a biological specimen. | Calcium Phosphate Crystal Measurement | ||
CYCASULF | C124340 | Calcium Sulfate Crystals | A measurement of the calcium sulfate crystals present in a biological specimen. | Calcium Sulfate Crystals Measurement | ||
CYCHOL | C74672 | Cholesterol Crystals | A measurement of the cholesterol crystals present in a biological specimen. | Cholesterol Crystal Measurement | ||
CYCYSTIN | C74674 | Cystine Crystals | A measurement of the cystine crystals present in a biological specimen. | Cystine Crystal Measurement | ||
CYDCPHOS | C135407 | Dicalcium Phosphate Crystals | A measurement of dicalcium phosphate crystals in a biological specimen. | Dicalcium Phosphate Crystals Measurement | ||
CYDRUG | C156533 | Drug Crystals | A measurement of the drug crystals in a biological specimen. | Drug Crystal Measurement | ||
CYFRA18 | C130160 | Cytokeratin 18 Fragment | A measurement of the cytokeratin 18 fragment in a biological specimen. | Cytokeratin 18 Fragment Measurement | ||
CYFRA211 | C106514 | CYFRA21-1;Cytokeratin 19 Fragment 21-1 | A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen. | Cytokeratin 19 Fragment 21-1 Measurement | ||
CYHGBC | C112288 | Hemoglobin C Crystals | A measurement of hemoglobin C crystals in a biological specimen. | Hemoglobin C Crystals Measurement | ||
CYHIPPAC | C74754 | Hippurate Crystals;Hippuric Acid Crystals | A measurement of the hippuric acid crystals present in a biological specimen. | Hippuric Acid Crystal Measurement | ||
CYLEUC | C74680 | Leucine Crystals | A measurement of the leucine crystals present in a biological specimen. | Leucine Crystal Measurement | ||
CYMSU | C74681 | Monosodium Urate Crystals;Sodium Urate Crystals | A measurement of the monosodium urate crystals present in a biological specimen. | Monosodium Urate Crystal Measurement | ||
CYP2C9 | C161355 | Cytochrome P450 2C9 | A measurement of the cytochrome P450 2C9 enzyme in a biological specimen. | Cytochrome P450 2C9 Measurement | ||
CYPHOS | C174304 | Phosphate Crystals | A measurement of the total phosphate crystals in a biological specimen. | Phosphate Crystals Measurement | ||
CYSCREAT | C106513 | Cystatin C/Creatinine | A relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample. | Cystatin C to Creatinine Ratio Measurement | ||
CYSLTR1 | C189517 | CysLTR1;Cysteinyl Leukotriene Receptor 1 | A measurement of the cysteinyl leukotriene receptor 1 in a biological specimen. | Cysteinyl Leukotriene Receptor 1 Measurement | ||
CYSTARCH | C81951 | Starch Crystals;Starch Granules | A measurement of the starch crystals in a biological specimen. | Starch Crystal Measurement | ||
CYSTATC | C92290 | Cystatin C | A measurement of the cystatin C in a biological specimen. | Cystatin C Measurement | ||
CYSTEINE | C172518 | Cysteine | A measurement of the cysteine in a biological specimen. | Cysteine Measurement | ||
CYSTHION | C147331 | Cystathionine | A measurement of the cystathionine in a biological specimen. | Cystathionine Measurement | ||
CYSTINE | C105441 | Cystine | A measurement of the cystine in a biological specimen. | Cystine Measurement | ||
CYSULFA | C74755 | Sulfa Crystals;Sulfonamide Crystals | A measurement of the sulfa crystals present in a biological specimen. | Sulfa Crystal Measurement | ||
CYTRPHOS | C74756 | Ammonium Magnesium Phosphate Crystals;Struvite Crystals;Triple Phosphate Crystals | A measurement of the triple phosphate crystals present in a biological specimen. | Triple Phosphate Crystal Measurement | ||
CYTYRO | C74683 | Tyrosine Crystals | A measurement of the tyrosine crystals present in a biological specimen. | Tyrosine Crystal Measurement | ||
CYUNCLA | C74757 | Unclassified Crystals | A measurement of the unclassifiable crystals present in a biological specimen. | Unclassified Crystal Measurement | ||
CYURIAC | C74684 | Uric Acid Crystals | A measurement of the uric acid crystals (including acid urate and urate crystals) present in a biological specimen. | Uric Acid Crystal Measurement | ||
DALA | C156537 | 5-Aminolevulinic Acid;5ALA;dALA;Delta Aminolevulinate;Delta Aminolevulinic Acid | A measurement of the delta aminolevulinic acid in a biological specimen. | Delta Aminolevulinate Measurement | ||
DALACRT | C156538 | Delta Aminolevulinate/Creatinine | A relative measurement (ratio or percentage) of the delta aminolevulinate to creatinine in a biological specimen. | Delta Aminolevulinate to Creatinine Ratio Measurement | ||
DCA | C172500 | Deoxycholate;Deoxycholic Acid | A measurement of the deoxycholate in a biological specimen. | Deoxycholate Measurement | ||
DCCARNIT | C156536 | C10;Decanoylcarnitine | A measurement of the decanoylcarnitine in a biological specimen. | Decanoylcarnitine Measurement | ||
DDIMER | C82621 | D-Dimer | A measurement of the d-dimers in a biological specimen. | D-Dimer Measurement | ||
DDNAIGAB | C154769 | Anti-Double Stranded DNA IgG | A measurement of the double stranded DNA IgG antibody in a biological specimen. | Anti-Double Stranded DNA IgG Measurement | ||
DDX58 | C163428 | DEAD Box Protein 58;DExD/H-Box Helicase 58;Probable ATP-Dependent RNA Helicase DDX58 | A measurement of the DEAD box protein 58 in a biological specimen. | DEAD Box Protein 58 Measurement | ||
DECORIN | C172512 | DCN;Decorin | A measurement of the decorin in a biological specimen. | Decorin Measurement | ||
DENSITY | C45781 | Density | A measurement of the compactness of a biological specimen expressed in mass per unit volume. | Density | ||
DESIPRMN | C186040 | Desipramine | A measurement of the desipramine in a biological specimen. | Desipramine Measurement | ||
DETHPRPN | C184614 | Diethylpropion | A measurement of the diethylpropion in a biological specimen. | Diethylpropion Measurement | ||
DFI | C135408 | DNA Fragmentation Index | A measurement of the deoxyribonucleic acid fragmentation within the nucleated cells of a biological specimen. | DNA Fragmentation Index | ||
DGNWBC | C111190 | Degenerated Leukocytes;Degenerated WBC;Degenerated White Blood Cells | A measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen. | Degenerated Leukocyte Count | ||
DHEA | C74852 | Dehydroepiandrosterone;Dehydroisoandrosterone | A measurement of the dehydroepiandrosterone hormone in a biological specimen. | Dehydroepiandrosterone Measurement | ||
DHEAS | C96629 | Dehydroepiandrosterone Sulfate;DHEA Sulfate;DHEA-S;sDHEA | A measurement of the sulfated Dehydroepiandrosterone in a biological specimen. | Sulfated DHEA Measurement | ||
DHPG | C101017 | 3,4-Dihydroxyphenylglycol;3.4 Dihydroxyphenylglycol | A measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen. | 3,4-Dihydroxyphenylglycol Measurement | ||
DHT | C74853 | Androstanalone;Androstanolone;Dihydrotestosterone | A measurement of the dihydrotestosterone hormone in a biological specimen. | Dihydrotestosterone Measurement | ||
DIHYDCDN | C74878 | Dihydrocodeine | A measurement of the dihydrocodeine present in a biological specimen. | Dihydrocodeine Measurement | ||
DKK1 | C165957 | Dickkopf WNT Signaling Pathway Inhibitor 1;DKK-1;SK | A measurement of the dickkopf WNT signaling pathway inhibitor 1 in a biological specimen. | Dickkopf WNT Signaling Path Inhibitor 1 Measurement | ||
DMG | C172519 | Dimethylglycine | A measurement of the dimethylglycine in a biological specimen. | Dimethylglycine Measurement | ||
DMTNN | C184536 | Dimethyltryptamine;DMT;N,N-Dimethyltryptamine | A measurement of the N,N-dimethyltryptamine in a biological specimen. | N,N-Dimethyltryptamine Measurement | ||
DNA | C135409 | Deoxyribonucleic Acid | A measurement of a targeted deoxyribonucleic acid (DNA) in a biological specimen. | Deoxyribonucleic Acid Measurement | ||
DNAAB | C81973 | Anti-DNA Antibodies;Anti-ds-DNA Antibodies | A measurement of the anti-DNA antibodies in a biological specimen. | Anti-DNA Antibody Measurement | ||
DNASEBAB | C100463 | Anti-Dnase B;DNase-B Antibody | A measurement of Dnase-B antibody in a biological specimen. | DNase-B Antibody Measurement | ||
DNPSEPHD | C174298 | (+)-Norpseudoephedrine;Cathine;D-Norpseudoephedrine | A measurement of the D-norpseudoephedrine in a biological specimen. | D-Norpseudoephedrine Measurement | ||
DOHLE | C74610 | Dohle Bodies | A measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen. | Dohle Body Measurement | ||
DOPAC | C103345 | 3,4-Dihydroxyphenylacetic Acid | A measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen. | 3,4-Dihydroxyphenylacetic Acid Measurement | ||
DOPAMEXR | C163429 | Dopamine Excretion Rate | A measurement of the amount of dopamine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Dopamine Excretion Rate | ||
DOPAMINE | C74854 | Dopamine | A measurement of the dopamine hormone in a biological specimen. | Dopamine Measurement | ||
DOXMTST | C184582 | Desoxymethyltestosterone | A measurement of the desoxymethyltestosterone in a biological specimen. | Desoxymethyltestosterone Measurement | ||
DOXPN | C191285 | Doxepin | A measurement of the doxepin present in a biological specimen. | Doxepin Measurement | ||
DOXPNAOM | C186041 | Doxepin and/or Metabolites | A measurement of the doxepin and/or its metabolite(s) present in a biological specimen, for an assay that can measure both doxepin and its metabolites. | Doxepin And/Or Metabolites Measurement | ||
DPD | C79443 | Deoxypyridinoline | A measurement of the deoxypyridinoline in a biological specimen. | Deoxypyridinoline Measurement | ||
DPDCREAT | C79444 | Deoxypyridinoline/Creatinine | A relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen. | Deoxypyridinoline to Creatinine Ratio Measurement | ||
DPHNOXLT | C184569 | Diphenoxylate | A measurement of the diphenoxylate in a biological specimen. | Diphenoxylate Measurement | ||
DPIPANON | C184540 | Dipipanone | A measurement of the dipipanone in a biological specimen. | Dipipanone Measurement | ||
DPPIV | C177992 | Dipeptidyl Peptidase-4 | A measurement of the dipeptidyl peptidase-4 in a biological specimen. | Dipeptidyl Peptidase-4 Measurement | ||
DRSTNLN | C184583 | Dromostanolone;Drostanolone;Medrosteron;Medrotestron;Metholone | A measurement of the drostanolone in a biological specimen. | Drostanolone Measurement | ||
DRUGSCR | C78139 | Drug Screen | An indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen. | Drug Test | ||
DRVTSCPD | C161373 | dRVVT Screen to Confirm Pct Difference;dRVVT Screen to Confirm Percent Difference | A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen dRVVT - Confirm dRVVT)/Screen dRVVT]x100. | dRVVT Screen to Confirm Percent Difference | ||
DRVVT | C96696 | Dilute Russell's Viper Venom Time;Lupus Anticoagulant Test | A measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom. | Dilute Russell's Viper Venom Time Measurement | ||
DRVVTRT | C103386 | Dilute Russell's Viper Venom Time Ratio;Lupus Anticoagulant Ratio | A relative measurement of the dilute Russell's viper venom time in a subject sample to a control sample. | Dilute Russell's Viper Venom Time to Control Ratio Measurement | ||
DRVVTSCR | C163430 | DRVVT Screen to Confirm Ratio | A relative measurement (ratio) of the dilute Russell's viper venom time without the presence of excess phospholipid to the dRVVT in the presence of excess phospholipid. | Dilute Russell's Viper Venom Time to Confirm Ratio Measurement | ||
DSG1AB | C122114 | Desmoglein 1 Antibody | A measurement of the desmoglein 1 antibody in a biological specimen. | Desmoglein 1 Antibody Measurement | ||
DSG3AB | C122115 | Desmoglein 3 Antibody | A measurement of the desmoglein 3 antibody in a biological specimen. | Desmoglein 3 Antibody Measurement | ||
DSVLFXN | C147333 | Desvenlafaxine;O-Desmethylvenlafaxine | A measurement of the desvenlafaxine present in a biological specimen. | Desvenlafaxine Measurement | ||
DTPACLR | C100441 | DTPA Clearance | A measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) by excretion of urine for a specified unit of time (e.g. one minute). | Diethylene Triamine Pentaacetic Acid Clearance | ||
DULOXTN | C187798 | Duloxetine | A measurement of the duloxetine in a biological specimen. | Duloxetine Measurement | ||
DXCSD11 | C186042 | 11-Deoxycorticoids;11-Deoxycorticosteroid;11-Deoxycorticosteroids | A measurement of the total 11-deoxycorticosteroids in a biological specimen. | 11-Deoxycorticosteroid Measurement | ||
DXCSL11 | C186043 | 11-Deoxycortisol | A measurement of the 11-deoxycortisol in a biological specimen. | 11-Deoxycortisol Measurement | ||
DXCSL21 | C186044 | 21-Deoxycortisol | A measurement of the 21-deoxycortisol in a biological specimen. | 21-Deoxycortisol Measurement | ||
DXCSN11 | C186045 | 11-Deoxycorticosterone;21-Hydroxyprogesterone;Cortexone;Deoxycortone;Desoxycortone | A measurement of the 11-deoxycorticosterone in a biological specimen. | 11-Deoxycorticosterone Measurement | ||
DXCSN21 | C186046 | 21-Deoxycorticosterone | A measurement of the 21-deoxycorticosterone in a biological specimen. | 21-Deoxycorticosterone Measurement | ||
DZPM | C75372 | Diazepam | A measurement of the diazepam present in a biological specimen. | Diazepam Measurement | ||
E1S | C163431 | E1S;Estrone 3-Sulfate;Estrone Sulfate | A measurement of the estrone sulfate in a biological specimen. | Estrone Sulfate Measurement | ||
EAGLUC | C142275 | EAG;Estimated Average Glucose;Glucose, Estimated;Glucose, Estimated Average | A computed estimate of the blood glucose based on the value of the glycated hemoglobin | Estimated Average Glucose Measurement | ||
ECCENTCY | C96598 | Eccentrocytes | A measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen. | Eccentrocyte Count | ||
ECT | C100422 | Ecarin Clotting Time | A measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin. | Ecarin Clotting Time Measurement | ||
EDDP | C75353 | 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine;EDDP | A measurement of the methadone metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine present in a biological specimen. | EDDP Measurement | ||
EDMAB | C163432 | Endomysial Antibody;Endomysium Antibody | A measurement of the endomysial antibody in a biological specimen. | Endomysial Antibody Measurement | ||
EDMIGAAB | C147334 | Endomysial IgA Antibody;Endomysium IgA Antibody | A measurement of the endomysial IgA antibody in a biological specimen. | Endomysial IgA Antibody Measurement | ||
EDN | C184644 | Eosinophil Protein-X;Eosinophil-Derived Neurotoxin;RAF3;Ribonuclease A Family Member 2 | A measurement of the eosinophil-derived neurotoxin in a biological specimen. | Eosinophil-Derived Neurotoxin Measurement | ||
EDTACLR | C100440 | EDTA Clearance | A measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) by excretion of urine for a specified unit of time (e.g. one minute). | EDTA Clearance | ||
EGF | C82009 | Epidermal Growth Factor | A measurement of the epidermal growth factor in a biological specimen. | Epidermal Growth Factor Measurement | ||
EGFR | C112273 | Epidermal Growth Factor Receptor;ERBB1;HER1 | A measurement of the epidermal growth factor receptor in a biological specimen. | Epidermal Growth Factor Receptor Measurement | ||
EGFRFR | C181452 | Epidermal Growth Factor Receptor, Free | A measurement of the free (unbound) epidermal growth factor receptor in a biological specimen. | Free Epidermal Growth Factor Receptor Measurement | ||
ELA1 | C82028 | Pancreatic Elastase 1 | A measurement of the pancreatic elastase 1 in a biological specimen. | Pancreatic Elastase Measurement | ||
ELA1PMN | C82029 | Pancreatic Elastase 1, Polymorphonuclear | A measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen. | Polymorphonuclear Pancreatic Elastase Measurement | ||
ELA2 | C82026 | Neutrophil Elastase | A measurement of the neutrophil elastase in a biological specimen. | Neutrophil Elastase Measurement | ||
ELA2PMN | C82027 | Neutrophil Elastase, Polymorphonuclear | A measurement of the polymorphonuclear neutrophil elastase in a biological specimen. | Polymorphonuclear Neutrophil Elastase Measurement | ||
ELLIPCY | C64549 | Elliptocytes | A measurement of the elliptocytes (elliptically shaped cell with blunt ends and a long axis twice the length of its short axis) in a biological specimen. | Elliptocyte Count | ||
EMA | C184555 | Ethylamphetamine;Etilamfetamine;N-Ethylamphetamine | A measurement of the ethylamphetamine in a biological specimen. | Ethylamphetamine Measurement | ||
ENA78 | C82010 | Epith Neutrophil-Activating Peptide 78 | A measurement of the epithelial neutrophil-activating peptide in a biological specimen. | Epithelial Neutrophil-Activating Peptide 78 Measurement | ||
ENAAB | C92270 | Anti-ENA;Extractable Nuclear Antigen Antibody | A measurement of the extractable nuclear antigen antibody in a biological specimen. | Extractable Nuclear Antigen Antibody Measurement | ||
ENDOSTN | C172509 | Collagen Type XVIII Alpha 1 Chain;Endostatin | A measurement of the endostatin in a biological specimen. | Endostatin Measurement | ||
ENDOTH1 | C82008 | Endothelin-1 | A measurement of the endothelin-1 in a biological specimen. | Endothelin-1 Measurement | ||
ENDOTH3 | C187800 | Endothelin-3;ET-3 | A measurement of the endothelin-3 in a biological specimen. | Endothelin-3 Measurement | ||
ENRAGE | C82011 | Extracell Newly Ident RAGE Bind Protein;S100 Calcium Binding Protein A12 | A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen. | Extracell Newly Ident RAGE Bind Protein Measurement | ||
EOS | C64550 | Eosinophils | A measurement of the eosinophils in a biological specimen. | Eosinophil Count | ||
EOSB | C114216 | Eosinophils Band Form | A measurement of the banded eosinophils in a biological specimen. | Eosinophil Band Form Count | ||
EOSBLE | C114217 | Eosinophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen. | Eosinophil Band Form to Leukocyte Ratio | ||
EOSCE | C98720 | Eosinophils/Total Cells | A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). | Eosinophils to Total Cell Ratio Measurement | ||
EOSIM | C96673 | Immature Eosinophils | A measurement of the immature eosinophils in a biological specimen. | Immature Eosinophil Count | ||
EOSIMLE | C96674 | Immature Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen. | Immature Eosinophil to Leukocyte Ratio Measurement | ||
EOSLE | C64604 | Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. | Eosinophil to Leukocyte Ratio | ||
EOSMM | C84819 | Eosinophilic Metamyelocytes | A measurement of the eosinphilic metamyelocytes in a biological specimen. | Eosinophilic Metamyelocyte Count | ||
EOSMYL | C84821 | Eosinophilic Myelocytes | A measurement of the eosinophilic myelocytes in a biological specimen. | Eosinophilic Myelocyte Count | ||
EOSMYLLY | C181449 | Eosinophilic Myelocytes/Lymphocytes | A relative measurement (ratio or percentage) of the eosinophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). | Eosinophilic Myelocytes to Lymphocytes Ratio Measurement | ||
EOSNSQE | C135411 | Eosinophils/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the eosinophils to non-squamous epithelial cells in a biological specimen. | Eosinophils to Non-Squamous Epithelial Cells Ratio Measurement | ||
EOSNUCCE | C150840 | Eosinophils/Nucleated Cells | A relative measurement (ratio or percentage) of eosinophils to nucleated cells in a biological specimen. | Eosinophils to Nucleated Cells Ratio Measurement | ||
EOSPSD | C165958 | Pseudo-Eosinophils | A measurement of the pseudo-eosinophils in a biological specimen. | Pseudo-Eosinophil Count | ||
EOSPSDLE | C165959 | Pseudo-Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of the pseudo-eosinophils to the leukocytes in a biological specimen. | Pseudo-Eosinophils to Leukocyte Ratio Measurement | ||
EOSSG | C135412 | Eosinophils, Segmented | A measurement of the segmented eosinophils in a biological specimen. | Segmented Eosinophil Count | ||
EOTAXIN1 | C81952 | Chemokine Ligand 11;Eotaxin-1 | A measurement of the eotaxin-1 in a biological specimen. | Eotaxin-1 Measurement | ||
EOTAXIN2 | C81953 | Chemokine Ligand 24;Eotaxin-2 | A measurement of the eotaxin-2 in a biological specimen. | Eotaxin-2 Measurement | ||
EOTAXIN3 | C81954 | CCL26;Chemokine (C-C Motif) Ligand 26;Chemokine Ligand 26;Eotaxin-3 | A measurement of the eotaxin-3 in a biological specimen. | Eotaxin-3 Measurement | ||
EPHD | C174296 | Ephedrine | A measurement of the ephedrine in a biological specimen. | Ephedrine Measurement | ||
EPIC | C64605 | Epithelial Cells | A measurement of the epithelial cells in a biological specimen. | Epithelial Cell Count | ||
EPICCE | C130161 | Epithelial Cells/Total Cells | A relative measurement (ratio or percentage) of the epithelial cells to total cells in a biological specimen. | Epithelial Cells to Total Cells Ratio Measurement | ||
EPICCLMP | C187801 | Epithelial Cell Clumps | A measurement of the epithelial cell clumps in a biological specimen. | Epithelial Cell Clumps Measurement | ||
EPIN | C79445 | Adrenaline;Epinephrine | A measurement of the epinephrine hormone in a biological specimen. | Epinephrine Measurement | ||
EPINEXR | C163433 | Epinephrine Excretion Rate | A measurement of the amount of epinephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Epinephrine Excretion Rate | ||
EPINSQCE | C135413 | Non-Squamous Epithelial Cells | A measurement of the non-squamous epithelial cells in a biological specimen. | Non-Squamous Epithelial Cell Count | ||
EPINSQE | C135414 | Epi Cells/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the epithelial cells to non-squamous epithelial cells in a biological specimen. | Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement | ||
EPIRCE | C170595 | Renal Epithelial Cells | A measurement of the renal epithelial cells in a biological specimen. | Renal Epithelial Cells Measurement | ||
EPIROCE | C74698 | Round Epithelial Cells | A measurement of the round epithelial cells present in a biological specimen. | Round Epithelial Cell Count | ||
EPISCECE | C132366 | Squamous Epithelial Cells/Total Cells | A relative measurement (ratio or percentage) of the squamous epithelial cells to total cells in a biological specimen. | Squamous Epithelial Cells to Total Cells Ratio Measurement | ||
EPISQCE | C74773 | Squamous Cells;Squamous Epithelial Cells | A measurement of the squamous epithelial cells present in a biological specimen. | Squamous Epithelial Cell Count | ||
EPISQTCE | C74774 | Squamous Transitional Epithelial Cells | A measurement of the squamous transitional epithelial cells present in a biological specimen. | Squamous Transitional Epithelial Cell Count | ||
EPITCE | C92251 | Transitional Epithelial Cells | A measurement of the transitional epithelial cells present in a biological specimen. | Transitional Epithelial Cells Measurement | ||
EPITUCE | C74775 | Renal Tubular Epithelial Cells;Tubular Epithelial Cells | A measurement of the tubular epithelial cells present in a biological specimen. | Tubular Epithelial Cell Count | ||
EPO | C74855 | Erythropoietin;Hematopoietin | A measurement of the erythropoietin hormone in a biological specimen. | Erythropoietin Measurement | ||
EPSTI1 | C163434 | BRESI1;Epithelial Stromal Interaction Protein 1 | A measurement of the epithelial stromal interaction protein 1 in a biological specimen. | Epithelial Stromal Interaction 1 Measurement | ||
ERCECE | C154719 | Erythroid Cells/Total Cells | A relative measurement (ratio or percentage) of the erythroid cells to total cells in a biological specimen. | Erythroid Cells to Total Cells Ratio Measurement | ||
ERCEMIDX | C135415 | Erythroid Maturation Index | A relative measurement (ratio) of the sum of erythroid maturation phase cells (pool) to the sum of erythroid proliferative phase cells (pool) in a biological specimen. | Erythroid Maturation Index | ||
ERCEMPOL | C135416 | Erythroid Maturation Pool | A measurement of the erythroid maturation phase cells (polychromatic rubricytes, normochromic rubricytes, and metarubricytes) in a biological specimen. | Erythroid Maturation Pool Count | ||
ERCENC | C154720 | Erythroid Cells/Nucleated Cells | A relative measurement (ratio or percentage) of the erythroid cells to total nucleated cells in a biological specimen. | Erythroid Cells to Nucleated Cells Ratio Measurement | ||
ERCEPIDX | C135417 | Erythroid Proliferation Index | A relative measurement (ratio) of the sum of erythroid proliferative phase cells (pool) to the sum of erythroid maturation phase cells (pool) in a biological specimen. | Erythroid Proliferation Index | ||
ERCEPPOL | C135418 | Erythroid Proliferation Pool | A measurement of the erythroid proliferative phase cells (rubriblasts, prorubricytes, and basophilic rubricytes) in a biological specimen. | Erythroid Proliferation Pool Count | ||
ERFE | C186047 | Erythroferrone | A measurement of the erythroferrone in a biological specimen. | Erythroferrone Measurement | ||
ERPCE | C187802 | Erythroid Precursor Cells;Erythroid Precursors | A measurement of the erythroid precursors in a biological specimen. | Erythroid Precursor Cell Count | ||
ERPCECE | C187803 | Erythroid Precursor Cells/Total Cells;Erythroid Precursors/Total Cells | A relative measurement (ratio or percentage) of the erythroid precursors to total cells in a biological specimen. | Erythroid Precursor Cells to Total Cells Ratio Measurement | ||
ESCTLPRM | C187804 | Escitalopram | A measurement of the escitalopram in a biological specimen. | Escitalopram Measurement | ||
ESELECT | C154736 | E-Selectin | A measurement of total E-selectin in a biological specimen. | E-selectin Measurement | ||
ESELS | C119273 | sE-selectin;Soluble E-Selectin | A measurement of the soluble E-Selectin in a biological specimen. | Soluble E-Selectin Measurement | ||
ESR | C74611 | Biernacki Reaction;Erythrocyte Sedimentation Rate | The distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour). | Erythrocyte Sedimentation Rate Measurement | ||
ESTAZLM | C184615 | Estazolam | A measurement of the estazolam in a biological specimen. | Estazolam Measurement | ||
ESTFR | C150842 | Estradiol, Free | A measurement of the unbound estradiol in a biological specimen. | Free Estradiol Measurement | ||
ESTFREST | C150843 | Estradiol, Free/Estradiol | A relative measurement (ratio or percentage) of unbound estradiol to total estradiol in a biological specimen. | Free Estradiol to Estradiol Ratio Measurement | ||
ESTRCPT | C112274 | ER;ESR;Estrogen Receptor;Oestrogen Receptor | A measurement of estrogen receptor protein in a biological specimen. | Estrogen Receptor Measurement | ||
ESTRDIOL | C74782 | Estradiol;Oestradiol | A measurement of the estradiol in a biological specimen. | Estradiol Measurement | ||
ESTRIOL | C74856 | Estriol;Oestriol | A measurement of the estriol hormone in a biological specimen. | Estriol Measurement | ||
ESTRIOLF | C81963 | Estriol, Free;Unconjugated Estriol | A measurement of the free estriol in a biological specimen. | Free Estriol Measurement | ||
ESTROGEN | C147335 | Estrogen;Oestrogen | A measurement of the estrogen hormone in a biological specimen. | Estrogen Measurement | ||
ESTRONE | C74857 | Estrone;Oestrone | A measurement of the estrone hormone in a biological specimen. | Estrone Measurement | ||
ETG | C170584 | Ethyl Glucuronide | A measurement of the ethyl glucuronide in a biological specimen. | Ethyl Glucuronide Measurement | ||
ETGETS | C170583 | Ethyl Glucuronide Ethyl Sulfate | A measurement of the ethyl glucuronide and/or ethyl sulfate in a biological specimen. | Ethyl Glucuronide And Ethyl Sulfate Measurement | ||
ETHANOL | C74693 | Alcohol;Ethanol | A measurement of the ethanol present in a biological specimen. | Ethanol Measurement | ||
ETHCHVNL | C184616 | Ethchlorvynol | A measurement of the ethchlorvynol in a biological specimen. | Ethchlorvynol Measurement | ||
ETHESTNL | C184584 | Ethylestrenol | A measurement of the ethylestrenol in a biological specimen. | Ethylestrenol Measurement | ||
ETHNMATE | C184617 | Ethinamate | A measurement of the ethinamate in a biological specimen. | Ethinamate Measurement | ||
ETP | C102266 | Endogenous Thrombin Potential | A measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample. | Endogenous Thrombin Potential Measurement | ||
ETPAUC | C102263 | Endogenous Thrombin Potential Area Under Curve;ETP Area Under Curve | A measurement of the area under the thrombin generation curve. | Endogenous Thrombin Potential Area Under Curve Measurement | ||
ETPLT | C102264 | Endogenous Thrombin Potential Lag Time;ETP Lag Time | A measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. | Endogenous Thrombin Potential Lag Time Measurement | ||
ETPLTR | C102265 | Endogenous Thrombin Potential Lag Time Relative;ETP Lag Time Relative | A relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. | Endogenous Thrombin Potential Lag Time Relative Measurement | ||
ETPPH | C102267 | Endogenous Thrombin Potential Peak Height;ETP Peak Height | A measurement of the maximum concentration of thrombin generated during a thrombin generation test. | Endogenous Thrombin Potential Peak Height Measurement | ||
ETPPHR | C102268 | Endogenous Thrombin Potential Peak Height Relative;ETP Peak Height Relative | A relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test. | Endogenous Thrombin Potential Peak Height Relative Measurement | ||
ETPTP | C102269 | Endogenous Thrombin Potential Time to Peak;ETP Time to Peak | A measurement of the time it takes to generate the maximum concentration of thrombin. | Endogenous Thrombin Potential Time to Peak Measurement | ||
ETPTPR | C102270 | Endogenous Thrombin Potential Time to Peak Relative;ETP Time to Peak Relative | A relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin. | Endogenous Thrombin Potential Time to Peak Relative Measurement | ||
ETS | C170585 | Ethyl Sulfate | A measurement of the ethyl sulfate in a biological specimen. | Ethyl Sulfate Measurement | ||
EUDCA | C176304 | Epimerized Ursodeoxycholate;Epimerized Ursodeoxycholic Acid | A measurement of the epimerized ursodeoxycholate in a biological specimen. | Epimerized Ursodeoxycholate Measurement | ||
EZOGABIN | C184640 | Ezogabine | A measurement of the ezogabine in a biological specimen. | Ezogabine Measurement | ||
FABP1 | C82012 | FABP1;Fatty Acid Binding Protein 1;L-FABP;L-Type Fatty Acid-Binding Protein;Liver Fatty Acid-Binding Protein | A measurement of the fatty acid binding protein 1 in a biological specimen. | Fatty Acid Binding Protein 1 Measurement | ||
FABP3 | C106521 | Fatty Acid Binding Protein 3 | A measurement of the fatty acid binding protein 3 in a biological specimen. | Fatty Acid Binding Protein 3 Measurement | ||
FACTII | C96626 | Factor II;Prothrombin | A measurement of the coagulation factor II in a biological specimen. | Prothrombin Measurement | ||
FACTIII | C81959 | Factor III;Tissue Factor, CD142 | A measurement of the coagulation factor III in a biological specimen. | Factor III Measurement | ||
FACTIX | C98725 | Christmas Factor;Factor IX | A measurement of the coagulation factor IX in a biological specimen. | Factor IX Measurement | ||
FACTIXA | C103395 | Christmas Factor Activity;Factor IX Activity | A measurement of the biological activity of coagulation factor IX in a biological specimen. | Factor IX Activity Measurement | ||
FACTV | C98726 | Factor V;Labile Factor | A measurement of the coagulation factor V in a biological specimen. | Factor V Measurement | ||
FACTVA | C103396 | Factor V Activity;Labile Factor Activity | A measurement of the biological activity of coagulation factor V in a biological specimen. | Factor V Activity Measurement | ||
FACTVII | C81960 | Factor VII;Proconvertin;Stable Factor | A measurement of the coagulation factor VII in a biological specimen. | Factor VII Measurement | ||
FACTVIIA | C103397 | Factor VII Activity;Proconvertin Activity;Stable Factor Activity | A measurement of the biological activity of coagulation factor VII in a biological specimen. | Factor VII Activity Measurement | ||
FACTVIII | C81961 | Anti-hemophilic Factor;Factor VIII | A measurement of the coagulation factor VIII in a biological specimen. | Factor VIII Measurement | ||
FACTVL | C102271 | Factor V Leiden | A measurement of the coagulation factor V Leiden in a biological specimen. | Factor V Leiden Measurement | ||
FACTVW | C98799 | von Willebrand Factor;von Willebrand Factor Antigen | A measurement of the von Willebrand coagulation factor in a biological specimen. | von Willebrand Factor Measurement | ||
FACTVWA | C122117 | von Willebrand Factor Activity | A measurement of the biological activity of von Willebrand coagulation factor in a biological specimen. | von Willebrand Factor Activity Measurement | ||
FACTVWMU | C147336 | von Willebrand Factor Multimers | A measurement of the von Willebrand Factor multimers (an aggregate of multiple von Willebrand factor antigens that are held together with non-covalent bonds) in a biological specimen. | von Willebrand Factor Multimers Measurement | ||
FACTX | C98727 | Factor X | A measurement of the coagulation factor X in a biological specimen. | Factor X Measurement | ||
FACTXA | C122118 | Factor X Activity | A measurement of the biological activity of coagulation factor X in a biological specimen. | Factor X Activity Measurement | ||
FACTXI | C163435 | Factor XI | A measurement of the factor XI in a biological specimen. | Factor XI Measurement | ||
FACTXIA | C163436 | Factor XI Activity | A measurement of the biological activity of coagulation factor XI in a biological specimen. | Factor XI Activity Measurement | ||
FACTXII | C163437 | Factor XII | A measurement of the factor XII in a biological specimen. | Factor XII Measurement | ||
FACTXIIA | C163438 | Factor XII Activity | A measurement of the biological activity of coagulation factor XII in a biological specimen. | Factor XII Activity Measurement | ||
FACTXIII | C112277 | Factor XIII;Fibrin Stabilizing Factor | A measurement of the coagulation factor XIII in a biological specimen. | Factor XIII Measurement | ||
FACTXIV | C102272 | Autoprothrombin IIA;Factor XIV;Protein C;Protein C Antigen | A measurement of the coagulation factor XIV in a biological specimen. | Factor XIV Measurement | ||
FACTXIVA | C105442 | Factor XIV Activity;Protein C Activity;Protein C Function | A measurement of the biological activity of coagulation factor XIV in a biological specimen. | Factor XIV Activity Measurement | ||
FAI | C124341 | Free Androgen Index | A measurement of the androgen status in a biological specimen. This is calculated by a mathematical formula that takes into account the total testosterone level, sex hormone binding globulin, and a constant. | Free Androgen Index | ||
FAS | C165960 | ALPS1A;APT1;CD95;Fas Cell Surface Death Receptor;FAS1;FASTM;TNF Receptor Superfamily Member 6;TNFRSF6 | A measurement of the Fas cell surface death receptor in a biological specimen. | Fas Cell Surface Death Receptor Measurement | ||
FAT | C96648 | Fat | A measurement of the fat in a biological specimen. | Fat Measurement | ||
FATACFR | C80200 | Free Fatty Acid;Non-Esterified Fatty Acid, Free | A measurement of the total non-esterified fatty acids in a biological specimen. | Non-esterified Fatty Acids Measurement | ||
FATACFRS | C80206 | Free Fatty Acid, Saturated;Non-esterified Fatty Acid, Saturated | A measurement of the saturated non-esterified fatty acids in a biological specimen. | Saturated Non-esterified Fatty Acids Measurement | ||
FATACFRU | C80209 | Free Fatty Acid, Unsaturated;Non-esterified Fatty Acid, Unsaturated | A measurement of the unsaturated non-esterified fatty acids in a biological specimen. | Unsaturated Non-esterified Fatty Acids Measurement | ||
FATACVLC | C147337 | Fatty Acids, Very Long Chain | A measurement of the very long chain fatty acids (containing 22 or more carbon atoms) in a biological specimen. | Very Long Chain Fatty Acids Measurement | ||
FATBODOV | C81947 | Fat Bodies, Oval | A measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen. | Oval Fat Body Measurement | ||
FATDROP | C98728 | Fat Droplet | A measurement of the triglyceride aggregates within a biological specimen. | Fat Droplet Measurement | ||
FATLVIDX | C156516 | Fatty Liver Index;FLI | A calculation that indicates the likely presence of fatty liver disease, taking into account waist circumference, body mass index, triglyceride concentrations, and gamma-glutamyltransferase activity. (Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006 Nov 2;6:33.) | Fatty Liver Index | ||
FATTOTSD | C187806 | Fat/Total Solids | A relative measurement (ratio or percentage) of the fat to total solid material in a biological specimen (for example a stool specimen). | Fats to Total Solids Ratio Measurement | ||
FBNCTCE | C172507 | Fibronectin, Cellular;Insoluble Fibronectin | A measurement of the cellular fibronectin in a biological specimen. | Cellular Fibronectin Measurement | ||
FBNCTFT | C92786 | Fibronectin, Fetal | A measurement of the fetal isoform of fibronectin in a biological specimen | Fetal Fibronectin Test | ||
FBNCTMFT | C177951 | Fibronectin, Maternal + Fetal | A measurement of the maternal plasma fibronectin and fetal fibronectin in a biological specimen. | Maternal and Fetal Fibronectin Measurement | ||
FBNCTPL | C172508 | Fibronectin, Plasma;Soluble Fibronectin | A measurement of the plasma fibronectin in a biological specimen. | Plasma Fibronectin Measurement | ||
FBRTST | C105443 | FibroSURE Score;FibroTest Score | A biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taking into account the age and gender of the patient. | FibroTest Score Measurement | ||
FCT8INH | C154752 | Factor VIII Inhibitor | A measurement of the factor VIII Inhibitor in a biological specimen. | Factor VIII Inhibitor Measurement | ||
FCTVIIAA | C103398 | Factor VIIa Activity | A measurement of the biological activity of coagulation factor VIIa in a biological specimen. | Factor VIIa Activity Measurement | ||
FCTVIIIA | C103399 | Anti-hemophilic Factor Activity;Factor VIII Activity;Factor VIII:C | A measurement of the biological activity of coagulation factor VIII in a biological specimen. | Factor VIII Activity Measurement | ||
FCTXIIIA | C174313 | Factor XIII Activity | A measurement of the biological activity of coagulation factor XIII in a biological specimen. | Factor XIII Activity Measurement | ||
FDP | C82013 | Fibrin Degradation Products | A measurement of the fibrin degradation products in a biological specimen. | Fibrin Degradation Products Measurement | ||
FECA | C114219 | Fractional Calcium Excretion | A measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine. | Fractional Excretion of Calcium | ||
FECL | C114220 | Fractional Chloride Excretion | A measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine. | Fractional Excretion of Chloride | ||
FEK | C114222 | Fractional Potassium Excretion | A measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine. | Fractional Excretion of Potassium | ||
FEMG | C122119 | Fractional Magnesium Excretion | A measurement of the fractional excretion of magnesium that is computed based upon the concentrations of magnesium and creatinine in both blood and urine. | Fractional Excretion of Magnesium | ||
FEN3M | C184525 | 3-Methylfentanyl | A measurement of the 3-methylfentanyl in a biological specimen. | 3-Methylfentanyl Measurement | ||
FENA | C107435 | Fractional Sodium Excretion | A measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine. | Fractional Excretion of Sodium | ||
FENACE | C184528 | Acetyl Fentanyl;Acetylfentanyl | A measurement of the acetylfentanyl in a biological specimen. | Acetylfentanyl Measurement | ||
FENAM | C184537 | Alpha-Methylfentanyl | A measurement of the alpha-methylfentanyl in a biological specimen. | Alpha-Methylfentanyl Measurement | ||
FENBOHT | C184530 | Beta-Hydroxythiofentanyl | A measurement of the beta-hydroxythiofentanyl in a biological specimen. | Beta-Hydroxythiofentanyl Measurement | ||
FENBUT | C184533 | Butyrfentanyl;Butyryl Fentanyl;Butyrylfentanyl | A measurement of the butyrylfentanyl in a biological specimen. | Butyrylfentanyl Measurement | ||
FENCMFMN | C184618 | Fencamfamin;Fencamfamine | A measurement of the fencamfamin in a biological specimen. | Fencamfamin Measurement | ||
FENFLRMN | C184619 | Fenfluramine | A measurement of the fenfluramine in a biological specimen. | Fenfluramine Measurement | ||
FENFUR | C184541 | Furanyl Fentanyl;Furanylfentanyl | A measurement of the furanylfentanyl in a biological specimen. | Furanylfentanyl Measurement | ||
FENPF | C184558 | Para-Fluorofentanyl | A measurement of the para-fluorofentanyl in a biological specimen. | Para-Fluorofentanyl Measurement | ||
FENPRPRX | C184620 | Fenproporex | A measurement of the fenproporex in a biological specimen. | Fenproporex Measurement | ||
FENTANYL | C147338 | Fentanyl | A measurement of the fentanyl in a biological specimen. | Fentanyl Measurement | ||
FENVAL | C184607 | Valeryl Fentanyl;Valerylfentanyl | A measurement of the valerylfentanyl in a biological specimen. | Valerylfentanyl Measurement | ||
FEP | C147339 | Erythrocyte Protoporphyrin, Free | A measurement of the free erythrocyte protoporphyrin (zinc bound plus unbound protoporphyrin) in a biological specimen. | Free Erythrocyte Protoporphyrin Measurement | ||
FEPI | C114221 | Fractional Inorganic Phosphate Excretion;Fractional Phosphorus Excretion | A measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine. | Fractional Excretion of Phosphate | ||
FERRITIN | C74737 | Ferritin | A measurement of the ferritin in a biological specimen. | Ferritin Measurement | ||
FGF19 | C154727 | FGF 19;Fibroblast Growth Factor 19 | A measurement of the fibroblast growth factor 19 in a biological specimen. | Fibroblast Growth Factor 19 Measurement | ||
FGF21 | C112280 | FGF 21;Fibroblast Growth Factor 21 | A measurement of the fibroblast growth factor 21 in a biological specimen. | Fibroblast Growth Factor 21 Measurement | ||
FGF23 | C96650 | Fibroblast Growth Factor 23;Phosphatonin | A measurement of the total fibroblast growth factor 23 in a biological specimen. | Fibroblast Growth Factor 23 Measurement | ||
FGF23C | C135419 | Fibroblast Growth Factor 23, C-Terminal | A measurement of the C-terminal fibroblast growth factor 23 in a biological specimen. | C-Terminal Fibroblast Growth Factor 23 Measurement | ||
FGF23I | C135420 | Fibroblast Growth Factor 23, Intact | A measurement of the intact fibroblast growth factor 23 in a biological specimen. | Intact Fibroblast Growth Factor 23 Measurement | ||
FGF9 | C130162 | FGF 9;Fibroblast Growth Factor 9 | A measurement of the fibroblast growth factor 9 in a biological specimen. | Fibroblast Growth Factor 9 Measurement | ||
FGFBF | C82014 | FGF2;Fibroblast Growth Factor Basic Form | A measurement of the basic form of fibroblast growth factor in a biological specimen. | Fibroblast Growth Factor Basic Form Measurement | ||
FIBMONO | C189498 | Fibrin Monomer;Soluble Fibrin Monomer | A measurement of the fibrin monomer in a biological specimen. | Fibrin Monomer Measurement | ||
FIBRINO | C64606 | Fibrinogen;Fibrinogen Antigen | A measurement of the total fibrinogen (functional and non-functional) in a biological specimen. | Fibrinogen Measurement | ||
FIBRINOF | C139075 | Fibrinogen, Functional | A measurement of the functional fibrinogen (fibrinogen that is capable of being converted to fibrin) in a biological specimen. | Functional Fibrinogen Measurement | ||
FICOLIN3 | C198283 | FCN3;Ficolin-3 | A measurement of the ficolin-3 in a biological specimen. | Ficolin-3 Measurement | ||
FIO2 | C38082 | Fraction of Inspired Oxygen | A measurement of the volumetric fraction of oxygen in the inhaled gas. | Fraction of Inspired Oxygen | ||
FIXAAC | C170588 | Factor IX Activity Actual/Control;Factor IX Activity Actual/Factor IX Activity Control;Factor IX Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor IX dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor IX Activity Actual to Control Ratio Measurement | ||
FLNTRZPM | C139081 | Flunitrazepam | A measurement of the flunitrazepam present in a biological specimen. | Flunitrazepam Measurement | ||
FLRZPM | C75373 | Flurazepam | A measurement of the flurazepam present in a biological specimen. | Flurazepam Measurement | ||
FLT3 | C174307 | CD135;FMS-like Receptor Tyrosine Kinase 3 | A measurement of the FMS-like receptor tyrosine kinase 3 in a biological specimen. | FMS-like Receptor Tyrosine Kinase 3 Measurement | ||
FLT3L | C174306 | FMS-like Tyrosine Kinase 3 Ligand | A measurement of the FMS-like tyrosine kinase 3 ligand in a biological specimen. | FMS-like Tyrosine Kinase 3 Ligand Measurement | ||
FLUDOUTE | C171508 | Fluid Output, Estimated | An estimate of the total volume of fluid discharged over a set period of time. | Estimated Fluid Output | ||
FLUIDOUT | C171455 | Fluid Output | A measurement of the total volume of fluid discharged over a set period of time. | Fluid Output | ||
FLUORIDE | C122120 | Fluoride | A measurement of the fluoride in a biological specimen. | Fluoride Measurement | ||
FLUOXTN | C158219 | Fluoxetine | A measurement of the fluoxetine drug present in a biological specimen. | Fluoxetine Measurement | ||
FLUOXTNN | C187816 | Norfluoxetine | A measurement of the norfluoxetine in a biological specimen. | Norfluoxetine Measurement | ||
FLUPHZN | C177980 | Fluphenazine | A measurement of the fluphenazine in a biological specimen. | Fluphenazine Measurement | ||
FLUVOXAM | C147340 | Fluvoxamine | A measurement of the fluvoxamine present in a biological specimen. | Fluvoxamine Measurement | ||
FLXMSTRN | C184585 | Fluoxymesterone | A measurement of the fluoxymesterone in a biological specimen. | Fluoxymesterone Measurement | ||
FNZPMAOM | C186048 | Flunitrazepam and/or Metabolites | A measurement of the flunitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flunitrazepam and its metabolites. | Flunitrazepam and/or Metabolites Measurement | ||
FOLHMRNA | C132367 | Folate Hydrolase mRNA | A measurement of the folate hydrolase mRNA in a biological specimen. | Folate Hydrolase mRNA Measurement | ||
FPP | C147341 | Protoporphyrin, Free | A measurement of the free protoporphyrin (unbound to iron in hemoglobin) in a biological specimen. | Free Protoporphyrin Measurement | ||
FRFEABS | C161349 | Fractional Iron Absorption | A relative measurement (ratio or percentage) of the iron absorbed into tissue or cells to the total available iron. | Fractional Iron Absorption | ||
FRNG | C186049 | Glycated Ferritin | A measurement of the glycated ferritin in a biological specimen. | Glycated Ferritin Measurement | ||
FRNGFRN | C186050 | Glycated Ferritin/Ferritin | A relative measurement (ratio or percentage) of the glycated ferritin to total ferritin in a biological specimen. | Glycated Ferritin to Ferritin Ratio Measurement | ||
FRTNHC | C172521 | Apoferritin;Ferritin Heavy Chain;FTH;FTH1 | A measurement of the ferritin heavy chain in a biological specimen. | Ferritin Heavy Chain Measurement | ||
FRTNLC | C172522 | Ferritin Light Chain;FTL;L Apoferritin | A measurement of the ferritin light chain in a biological specimen. | Ferritin Light Chain Measurement | ||
FRUCT | C74678 | Fructosamine;Glycated Serum Protein | A measurement of the fructosamine in a biological specimen. | Fructosamine Measurement | ||
FRUCTOSE | C147342 | Fructose | A measurement of the fructose in a biological specimen. | Fructose Measurement | ||
FRUMCRTP | C161350 | Fructosamine Corrected for Total Protein | A measurement of fructosamine, which has been corrected for total protein, in a biological specimen. | Fructosamine Corrected for Total Protein Measurement | ||
FRZPMAOM | C186051 | Flurazepam and/or Metabolites | A measurement of the flurazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flurazepam and its metabolites. | Flurazepam and/or Metabolites Measurement | ||
FSH | C74783 | Follicle Stimulating Hormone | A measurement of the follicle stimulating hormone (FSH) in a biological specimen. | Follicle Stimulating Hormone Measurement | ||
FUNGI | C154813 | Fungi;Fungus | A measurement of the fungi in a biological specimen. | Fungi Measurement | ||
FUNGIFIL | C147343 | Fungi, Filamentous | A measurement of the filamentous fungi in a biological specimen. | Filamentous Fungi Count | ||
FUNGYLK | C147344 | Fungi, Yeast-Like | A measurement of the yeast-like fungi in a biological specimen. | Yeast-Like Fungi Count | ||
FURAZBL | C184586 | Furazabol | A measurement of the furazabol in a biological specimen. | Furazabol Measurement | ||
FVAAC | C170587 | Factor V Activity Actual/Control;Factor V Activity Actual/Factor V Activity Control;Factor V Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor V dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor V Activity Actual to Control Ratio Measurement | ||
FVIIAAC | C170589 | Factor VII Activity Actual/Control;Factor VII Activity Actual/Factor VII Activity Control;Factor VII Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor VII dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor VII Activity Actual to Control Ratio Measurement | ||
FVIIIAAC | C147345 | Factor VIII Activity Actual/Control;Factor VIII Activity Actual/Factor VIII Activity Control;Factor VIII Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor VIII dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor VIII Activity Actual to Control Ratio Measurement | ||
FXAAC | C170586 | Factor X Activity Actual/Control;Factor X Activity Actual/Factor X Activity Control;Factor X Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor X dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor X Activity Actual/Control Ratio Measurement | ||
FXAC | C170590 | Factor X Actual/Control;Factor X Actual/Normal | A relative measurement (ratio or percentage) of the factor X in a subject's specimen when compared to a control specimen. | Factor X Actual to Control Ratio Measurement | ||
FXIVAAC | C147346 | Factor XIV Activity Actual/Control;Factor XIV Activity Actual/Factor XIV Activity Control;Factor XIV Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor XIV dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor XIV Activity Actual to Control Ratio Measurement | ||
FXIVAC | C170594 | Factor XIV Actual/Control;Protein C Actual/Control | A relative measurement (ratio or percentage) of the factor XIV in a subject's specimen when compared to a control specimen. | Factor XIV Actual to Control Ratio Measurement | ||
G6PD | C80184 | Glucose-6-Phosphate Dehydrogenase | A measurement of the glucose-6-phosphate dehydrogenase in a biological specimen. | Glucose-6-Phosphate Dehydrogenase Measurement | ||
G6PDA | C139065 | Glucose-6-Phosphate Dehydrogenase Act | A measurement of the biological activity of glucose-6-phosphate dehydrogenase in a biological specimen. | Glucose-6-Phosphate Dehydrogenase Activity | ||
G6PDRBC | C132368 | G6PD-Deficient Erythrocytes | A measurement of the glucose-6-phosphate dehydrogenase deficient erythrocytes in a biological specimen. | G6PD-Deficient Erythrocytes Count | ||
G6PDRBRB | C132369 | G6PD-Deficient Erythrocytes/Erythrocytes | A relative measurement (ratio or percentage) of G6PD-deficient erythrocytes to total erythrocytes in a biological specimen. | G6PD-Deficient Erythrocytes to Erythrocytes Ratio Measurement | ||
GAA | C189502 | Acid Alpha-Glucosidase;Acid Maltase;Alpha-1,4-glucosidase | A measurement of the acid alpha-glucosidase in a biological specimen. | Acid Alpha-Glucosidase Measurement | ||
GAD1 | C82015 | Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 67 | A measurement of the glutamic acid decarboxylase 1 in a biological specimen. | Glutamic Acid Decarboxylase 1 Measurement | ||
GAD2 | C82016 | Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 65 | A measurement of the glutamic acid decarboxylase 2 in a biological specimen. | Glutamic Acid Decarboxylase 2 Measurement | ||
GAD2AB | C82017 | Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase 65 Antibody | A measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen. | Glutamic Acid Decarboxylase 2 Antibody Measurement | ||
GADAB | C96653 | GAD Antibody;Glutamic Acid Decarboxylase Antibody | A measurement of the glutamic acid decarboxylase antibody in a biological specimen. | Glutamic Acid Decarboxylase Antibody Measurement | ||
GAL | C81308 | Galactose | A measurement of the galactose in a biological specimen. | Galactose Measurement | ||
GAL1PHOS | C186052 | Galactose-1-Phosphate | A measurement of the galactose-1-phosphate in a biological specimen. | Galactose-1-Phosphate Measurement | ||
GAL1PUT | C81251 | G1PUT;Galactose 1 Phosphate Uridyl Transferase;Galactose-1-Phos Uridylyltransferase;Galactose-1-Phosphate Uridylyltransferase;GALT | A measurement of the galactose-1-phosphate uridyltransferase in a biological specimen. | Galactose-1-Phosphate Uridyltransferase Measurement | ||
GALANIN | C80182 | Galanin | A measurement of the galanin in a biological specimen. | Galanin Measurement | ||
GALM | C163439 | Galactose Mutarotase | A measurement of the galactose mutarotase in a biological specimen. | Galactose Mutarotase Measurement | ||
GAMBTAC | C154766 | GABA;Gamma-aminobutyrate;Gamma-Aminobutyric Acid | A measurement of the gamma-aminobutyric acid in a biological specimen. | Gamma-Aminobutyric Acid Measurement | ||
GAPDH | C184524 | GAPDH;Glyceraldehyde 3 Phosphate Dehydrogenase;Glyceraldehyde-3-Phosphate Dehydrogenase | A measurement of the glyceraldehyde-3-phosphate dehydrogenase in a biological specimen. | Glyceraldehyde-3-Phosphate Dehydrogenase Measurement | ||
GASTRIN | C74858 | Gastrin | A measurement of the gastrin hormone in a biological specimen. | Gastrin Measurement | ||
GATCPHRL | C116211 | Gamma Tocopherol | A measurement of the gamma tocopherol in a biological specimen. | Gamma Tocopherol Measurement | ||
GBA | C184520 | Beta-Glucocerebrosidase;GBA;Glucocerebrosidase Beta;Glucosylceramidase;Glucosylceramidase Beta | A measurement of the glucosylceramidase beta in a biological specimen. | Glucosylceramidase Beta Measurement | ||
GBP1 | C163440 | Guanylate Binding Protein 1 | A measurement of the guanylate binding protein 1 in a biological specimen. | Guanylate Binding Protein 1 Measurement | ||
GBP2 | C163441 | Guanylate Binding Protein 2 | A measurement of the guanylate binding protein 2 in a biological specimen. | Guanylate Binding Protein 2 Measurement | ||
GCDCA | C176305 | Glycochenodeoxycholate;Glycochenodeoxycholic Acid | A measurement of the glycochenodeoxycholate in a biological specimen. | Glycochenodeoxycholate Measurement | ||
GCHT | C176299 | Cholylglycine;Glycocholate;Glycocholic Acid | A measurement of the glycocholate in a biological specimen. | Glycocholate Measurement | ||
GCSF | C82018 | Granulocyte Colony Stimulating Factor | A measurement of the granulocyte colony stimulating factor in a biological specimen. | Granulocyte Colony Stimulating Factor Measurement | ||
GDA | C150845 | Guanase;Guanine Aminohydrolase;Guanine Deaminase | A measurement of the guanine deaminase in a biological specimen. | Guanine Deaminase Measurement | ||
GDF11 | C135422 | BMP-11;Bone Morphogenetic Protein 11;Growth Differentiation Factor 11 | A measurement of the growth differentiation factor 11 in a biological specimen. | Growth Differentiation Factor 11 Measurement | ||
GDF15 | C181406 | GDF-15;Growth Differentiation Factor 15;Macrophage Inhibitory Cytokine-1;MIC-1 | A measurement of the growth differentiation factor 15 in a biological specimen. | Growth Differentiation Factor 15 Measurement | ||
GDF8 | C135423 | Growth Differentiation Factor 8;Myostatin | A measurement of the growth differentiation factor 8 in a biological specimen. | Growth Differentiation Factor 8 Measurement | ||
GDIGA1 | C165961 | Galactose-Deficient IgA1;Gd-IgA1 | A measurement of the galactose-deficient IgA1 in a biological specimen. | Galactose-Deficient IgA1 Measurement | ||
GEC | C124342 | Galactose Elimination Capacity | A liver function test that measures galactose elimination capacity in a biological specimen. | Galactose Elimination Capacity | ||
GFAP | C189528 | Glial Fibrillary Acidic Protein | A measurement of the glial fibrillary acidic protein in a biological specimen. | Glial Fibrillary Acidic Protein Measurement | ||
GFR | C90505 | Glomerular Filtration Rate | A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time. | Glomerular Filtration Rate | ||
GFRBSA | C98734 | Glomerular Filtration Rate Adj for BSA | A measurement of the glomerular filtration rate adjusted for body surface area. | Glomerular Filtration Rate Adjusted for BSA | ||
GFRBSB2M | C100450 | GFR from B-2 Microglobulin Adj for BSA | A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area. | Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement | ||
GFRBSBTP | C100449 | GFR from Beta-Trace Protein Adj for BSA | A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area. | Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement | ||
GFRBSCCC | C127614 | GFR from Cystatin C and Creat Adj BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on cystatin C and creatinine. | Glomeluar Filtration Rate from Cystatin C and Creatinine Adjusted for BSA | ||
GFRBSCRT | C98735 | GFR from Creatinine Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on creatinine. | Glomerular Filtration Rate from Creatinine Adjusted for BSA | ||
GFRBSCU | C163442 | GFR from Creat and UreaN Adj BSA;GFR from Creatinine and Urea Nitrogen Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on creatinine and urea nitrogen. | Glomerular Filtration Rate from Creatinine and Urea Nitrogen Adjusted for Body Surface Area Measurement | ||
GFRBSCUA | C163443 | GFR from Creat,UreaN,Alb Adj BSA;GFR from Creatinine, Urea Nitrogen and Albumin Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on creatinine, urea nitrogen, and albumin. | Glomerular Filtration Rate from Creatinine, Urea Nitrogen, and Albumin Adjusted for Body Surface Area Measurement | ||
GFRBSCYC | C98736 | GFR from Cystatin C Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on cystatin C. | Glomerular Filtration Rate from Cystatin C Adjusted for BSA | ||
GFRE | C110935 | Glomerular Filtration Rate, Estimated | A kidney function test that estimates the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time. | Estimated Glomerular Filtration Rate | ||
GGT | C64847 | Gamma Glutamyl Transferase | A measurement of the gamma glutamyl transferase in a biological specimen. | Gamma Glutamyl Transpeptidase Measurement | ||
GGTCREAT | C79446 | Gamma Glutamyl Transferase/Creatinine | A relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen. | Gamma Glutamyl Transferase to Creatinine Ratio Measurement | ||
GGTEXR | C165962 | Gamma Glutamyl Transferase Excretion Rate | A measurement of the amount of gamma glutamyl transferase being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Gamma Glutamyl Transferase Excretion Rate | ||
GHB | C75357 | 4-Hydroxybutanoic Acid;Gamma-Hydroxybutyrate;Gamma-Hydroxybutyric Acid | A measurement of the gamma-hydroxybutyrate in a biological specimen. | Gamma-Hydroxybutyrate Measurement | ||
GHBP | C163444 | GH Binding Protein;Growth Hormone Binding Protein;Somatotropin Receptor | A measurement of the growth hormone binding protein in a biological specimen. | Growth Hormone Binding Protein Measurement | ||
GHRELIN | C112286 | Ghrelin;Growth Hormone Secretagogue Receptor Ligand;Motilin-related Peptide;Total Ghrelin | A measurement of total ghrelin in a biological specimen. | Ghrelin Measurement | ||
GHRELINA | C112219 | Active Ghrelin | A measurement of active ghrelin in a biological specimen. | Active Ghrelin Measurement | ||
GIPI | C106537 | Glucose-dep Insulinotropic Pep, Intact;Intact Gastric Inhibitory Polypeptide;Intact GIP;Intact Glucose-dependent Insulinotropic Peptide | A measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen. | Intact Glucose-dependent Insulinotropic Peptide Measurement | ||
GL1 | C184522 | GL1;Glucocerebroside;Glucosylceramide | A measurement of the glucosylceramide in a biological specimen. | Glucosylceramide Measurement | ||
GLBCREAT | C142276 | Globulin/Creatinine | A relative measurement (ratio or percentage) of the globulin to creatinine in a biological specimen. | Globulin to Creatinine Ratio Measurement | ||
GLCHT | C176308 | Glycolithocholate;Glycolithocholic Acid | A measurement of the glycolithocholate in a biological specimen. | Glycolithocholate Measurement | ||
GLCTN3 | C172493 | Galactose-Specific Lectin 3;Galectin-3;GALIG;MAC-2 | A measurement of the galectin-3 in a biological specimen. | Galectin-3 Measurement | ||
GLCTN3BP | C186053 | Galectin-3 Binding Protein;LGALS3BP;M2BP;Mac-2 Binding Protein | A measurement of the galectin-3 binding protein in a biological specimen. | Galectin-3 Binding Protein Measurement | ||
GLDAB | C147347 | Gliadin Antibody | A measurement of the total gliadin antibodies in a biological specimen. | Gliadin Antibody Measurement | ||
GLDH | C79448 | Glutamate Dehydrogenase | A measurement of the glutamate dehydrogenase in a biological specimen. | Glutamate Dehydrogenase Measurement | ||
GLDIGAAB | C147348 | Gliadin IgA Antibody | A measurement of the gliadin IgA antibody in a biological specimen. | Gliadin IgA Antibody Measurement | ||
GLDIGGAB | C147349 | Gliadin IgG Antibody | A measurement of the gliadin IgG antibody in a biological specimen. | Gliadin IgG Antibody Measurement | ||
GLN | C122121 | Glutamine | A measurement of the glutamine in a biological specimen. | Glutamine Measurement | ||
GLOBA | C163445 | Alpha Globulin | A measurement of the total alpha globulins in a biological specimen. | Alpha Globulin Measurement | ||
GLOBA1 | C92252 | A1-Globulin;Alpha-1 Globulin | A measurement of the proteins contributing to the alpha 1 fraction in a biological specimen. | Alpha-1 Globulin Measurement | ||
GLOBA1PT | C92253 | Alpha-1 Globulin/Total Protein | A relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen. | Alpha-1 Globulin to Total Protein Ratio Measurement | ||
GLOBA2 | C92254 | A2-Globulin;Alpha-2 Globulin | A measurement of the proteins contributing to the alpha 2 fraction in a biological specimen. | Alpha-2 Globulin Measurement | ||
GLOBA2PT | C92255 | Alpha-2 Globulin/Total Protein | A relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen. | Alpha-2 Globulin to Total Protein Ratio Measurement | ||
GLOBB | C92256 | Beta Globulin | A measurement of the proteins contributing to the beta fraction in a biological specimen. | Beta Globulin Measurement | ||
GLOBB1 | C119274 | Beta-1 Globulin | A measurement of the beta-1 globulin in a biological specimen. | Beta-1 Globulin Measurement | ||
GLOBB1BP | C142277 | Beta-1 Globulin/Beta Protein | A relative measurement (ratio or percentage) of the beta-1-fraction proteins to the total beta protein fraction in a biological specimen. | Beta-1 Globulin to Total Beta Protein Ratio Measurement | ||
GLOBB1PT | C119275 | Beta-1 Globulin/Total Protein | A relative measurement (ratio or percentage) of beta-1-fraction proteins to total proteins in a biological specimen. | Beta-1 Globulin to Total Protein Ratio Measurement | ||
GLOBB2 | C119276 | Beta-2 Globulin | A measurement of the beta-2 globulin in a biological specimen. | Beta-2 Globulin Measurement | ||
GLOBB2PT | C119277 | Beta-2 Globulin/Total Protein | A relative measurement (ratio or percentage) of beta-2-fraction proteins to total proteins in a biological specimen. | Beta-2 Globulin to Total Protein Ratio Measurement | ||
GLOBBPT | C92294 | Beta Globulin/Total Protein | A relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen. | Beta Globulin to Total Protein Ratio Measurement | ||
GLOBG | C92257 | Gamma Globulin | A measurement of the proteins contributing to the gamma fraction in a biological specimen. | Gamma Globulin Measurement | ||
GLOBGPT | C92295 | Gamma Globulin/Total Protein | A relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen. | Gamma Globulin to Total Protein Ratio Measurement | ||
GLOBUL | C74738 | Globulin | A measurement of the globulin protein in a biological specimen. | Globulin Protein Measurement | ||
GLP1 | C80183 | Glucagon-Like Peptide-1;Total Glucagon-Like Peptide-1 | A measurement of the total glucagon-like peptide-1 in a biological specimen. | Glucagon-like Peptide-1 Measurement | ||
GLP1AC | C80164 | Glucagon-Like Peptide-1, Active Form | A measurement of the active form of glucagon-like peptide-1 in a biological specimen. | Active Glucagon-like Peptide-1 Measurement | ||
GLP1IAC | C154768 | Glucagon-Like Peptide-1, Inactive Form | A measurement of the inactive form of glucagon-like peptide-1 in a biological specimen. | Inactive Glucagon-Like Peptide-1 Measurement | ||
GLTRCE | C150844 | Glitter Cells | A measurement of the glitter cells in a biological specimen. | Glitter Cell Count | ||
GLTTHMD | C184571 | Glutethimide | A measurement of the glutethimide in a biological specimen. | Glutethimide Measurement | ||
GLUBD13 | C132370 | 1,3-Beta-D-Glucan | A measurement of the 1,3-beta-D-glucan in a biological specimen. | 1,3-Beta-D-Glucan Measurement | ||
GLUC | C105585 | Glucose | A measurement of the glucose in a biological specimen. | Glucose Measurement | ||
GLUCAGON | C74859 | Glucagon | A measurement of the glucagon hormone in a biological specimen. | Glucagon Measurement | ||
GLUCCLR | C96652 | Glucose Clearance | A measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute). | Glucose Clearance Measurement | ||
GLUCCRT | C79447 | Glucose/Creatinine | A relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen. | Glucose to Creatinine Ratio Measurement | ||
GLUCEXR | C150818 | Glucose Excretion Rate | A measurement of the amount of glucose being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Glucose Excretion Rate | ||
GLUCPE | C163446 | Plasma Equivalent Glucose | A measurement of the plasma equivalent glucose in a biological specimen. | Plasma Equivalent Glucose Measurement | ||
GLUCPED | C163447 | Plasma Equivalent Glucose Distribution | A measurement of the plasma equivalent glucose distribution in a biological specimen. | Plasma Equivalent Glucose Distribution Measurement | ||
GLUCWBE | C176296 | Whole Blood Equivalent Glucose | A measurement of the whole blood equivalent glucose in a biological specimen. | Whole Blood Equivalent Glucose Measurement | ||
GLURLGLU | C186054 | Glucose, Enriched/Glucose;Glucose, Radiolabeled/Glucose | A relative measurement (ratio or percentage) of radiolabeled glucose to total glucose in a biological specimen. | Radiolabeled Glucose to Glucose Ratio Measurement | ||
GLUTAM | C74739 | Glutamate;Glutamic Acid | A measurement of the glutamate in a biological specimen. | Glutamate Measurement | ||
GLY | C122122 | Glycine | A measurement of the glycine in a biological specimen. | Glycine Measurement | ||
GLYCREAT | C158221 | Glycine/Creatinine | A relative measurement (ratio) of the glycine to the creatinine in a biological specimen. | Glycine to Creatinine Ratio Measurement | ||
GLYCRL | C132371 | Glycerol | A measurement of the total glycerol in a biological specimen. | Glycerol Measurement | ||
GLYCRLFR | C100448 | Free Glycerin;Free Glycerol | A measurement of the amount of unbound glycerol in a biological specimen. | Free Glycerol Measurement | ||
GM3 | C184516 | Ganglioside GM3;Monosialodihexosylganglioside | A measurement of the ganglioside GM3 in a biological specimen. | Ganglioside GM3 Measurement | ||
GMCSF | C82019 | Granulocyte Macrophage Colony Stm Factor | A measurement of the granulocyte macrophage colony stimulating factor in a biological specimen. | Granulocyte Macrophage Colony Stm Factor Measurement | ||
GMI | C174310 | Glucose Management Indicator | An approximate measure (expressed as a % or mmol/mol) of an individual's expected hemoglobin A1c/hemoglobin level, based on the mean glucose measured over a period of at least 10 days by continuous glucose monitoring. | Glucose Management Indicator | ||
GNRH | C74860 | Gonadotropin Releasing Hormone;Luteinising Hormone Releasing Hormone | A measurement of the gonadotropin releasing hormone in a biological specimen. | Gonadotropin Releasing Hormone Measurement | ||
GOLD | C80186 | Gold | A measurement of the gold in a biological specimen. | Gold Measurement | ||
GPBB | C198284 | Glycogen Phosphorylase Isoenzyme BB | A measurement of the glycogen phosphorylase isoenzyme BB in a biological specimen. | Glycogen Phosphorylase Isoenzyme BB Measurement | ||
GPDA | C187807 | Glycylproline Dipeptidyl Aminopeptidase;GPDA | A measurement of the glycylproline dipeptidyl aminopeptidase in a biological specimen. | Glycylproline Dipeptidyl Aminopeptidase Measurement | ||
GRAN | C96654 | Granulocytes;Polymorphonuclear Leukocytes | A measurement of the granulocytes in a biological specimen. | Granulocyte Count | ||
GRANB | C186055 | Banded Granulocytes;Granulocytes Band Form | A measurement of the banded granulocytes in a biological specimen. | Granulocytes Band Form Count | ||
GRANBCE | C127615 | Granulocytes Band Form/Total Cells | A relative measurement (ratio or percentage) of the banded granulocytes to total cells in a biological specimen. | Band Form Granulocyte to Total Cell Ratio Measurement | ||
GRANCE | C98866 | Granulocytes/Total Cells | A relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen). | Granulocyte to Total Cell Ratio Measurement | ||
GRANIM | C96675 | Immature Granulocytes | A measurement of the total immature granulocytes in a biological specimen. | Immature Granulocyte Count | ||
GRANIMLE | C100445 | Immature Granulocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen). | Immature Granulocytes to Leukocytes Ratio Measurement | ||
GRANLE | C147351 | Granulocytes/Leukocytes;Polymorphonuclear Leukocytes/Leukocytes | A relative measurement (ratio or percentage) of the granulocytes to total leukocytes in a biological specimen. | Granulocytes to Leukocytes Ratio Measurement | ||
GRANSG | C186056 | Granulocytes Segmented | A measurement of the segmented granulocytes in a biological specimen. | Segmented Granulocyte Count | ||
GRANSGCE | C127616 | Granulocytes Segmented/Total Cells | A relative measurement (ratio or percentage) of the segmented granulocytes to total cells in a biological specimen. | Segmented Granulocyte to Total Cell Ratio Measurement | ||
GRANULIN | C165963 | Granulin | A measurement of the granulin in a biological specimen. | Granulin Measurement | ||
GRN | C165964 | Progranulin | A measurement of the progranulin in a biological specimen. | Progranulin Measurement | ||
GRO | C186057 | Growth Regulated Oncogene | A measurement of the total growth regulated oncogene proteins in a biological specimen. | Growth Regulated Oncogene Measurement | ||
GRWHIH | C74861 | Growth Hormone Inhibiting Hormone;Somatostatin | A measurement of the growth hormone inhibiting hormone in a biological specimen. | Growth Hormone Inhibiting Hormone Measurement | ||
GRWHRH | C74862 | Growth Hormone Releasing Hormone;Somatocrinin | A measurement of the growth hormone releasing hormone in a biological specimen. | Growth Hormone Releasing Hormone Measurement | ||
GST | C80185 | Glutathione S-Transferase, Total | A measurement of the total glutathione-s-transferase in a biological specimen. | Glutathione-S-Transferase Measurement | ||
GSTAL | C79433 | Alpha Glutathione-S-Transferase | A measurement of the alpha form of glutathione S-transferase in a biological specimen. | Alpha Glutathione-S-Transferase Measurement | ||
GSTALCRT | C80166 | Glutathione S-Transferase, Alpha/Creat | A relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen. | Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
GSTALEXR | C119278 | Alpha-GST Excretion Rate | A measurement of the amount of Alpha Glutathione-S-Transferase being excreted in a biological specimen over a defined period of time (e.g. one hour). | Alpha-GST Excretion Rate | ||
GSTCREAT | C79435 | Glutathione-S-Transferase/Creatinine | A relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen. | Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
GSTMU | C79457 | Mu Glutathione-S-Transferase | A measurement of the mu form of glutathione S-transferase in a biological specimen. | Mu Glutathione-S-Transferase Measurement | ||
GSTMUCRT | C79458 | Mu Glutathione-S-Transferase/Creatinine | A relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen. | Mu Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
GSTPI | C80203 | Glutathione S-Transferase, Pi | A measurement of the Pi glutathione-s-transferase in a biological specimen. | Pi Glutathione S-Transferase Measurement | ||
GSTPIEXR | C119279 | Pi-GST Excretion Rate | A measurement of the amount of Pi Glutathione-S-Transferase being excreted in a biological specimen over a defined period of time (e.g. one hour). | Pi-GST Excretion Rate | ||
GSTTH | C80207 | Glutathione S-Transferase, Theta | A measurement of the theta glutathione-s-transferase in a biological specimen. | Theta Glutathione S-Transferase Measurement | ||
GSTY1 | C163449 | Glutathione S-Transferase, Y1 | A measurement of the Y1 subunit of glutathione-s-transferase in a biological specimen. | Glutathione S-Transferase Y1 Subunit Measurement | ||
GUDCA | C176302 | Glycoursodeoxycholate;Glycoursodeoxycholic Acid | A measurement of the glycoursodeoxycholate in a biological specimen. | Glycoursodeoxycholate Measurement | ||
GUSA | C80165 | Glucuronidase, Alpha | A measurement of the alpha glucuronidase in a biological specimen. | Alpha Glucuronidase Measurement | ||
GUSB | C80170 | Glucuronidase, Beta | A measurement of the beta glucuronidase in a biological specimen. | Beta Glucuronidase Measurement | ||
H2FLRZPM | C181419 | 2-Hydroxyethylflurazepam;Hydroxyethylflurazepam | A measurement of the hydroxyethylflurazepam a biological specimen. | Hydroxyethylflurazepam Measurement | ||
H411DC6A | C186058 | 6-Alpha Hydroxytetrahydro-11-Dehydrocorticosterone;6a OH-tetrahydro-11-DeH-Corticosterone | A measurement of the 6-alpha hydroxytetrahydro-11-dehydrocorticosterone in a biological specimen. | 6a OH-tetrahydro-11-DeH-Corticosterone Measurement | ||
H411DS6A | C186059 | 6-Alpha Hydroxytetrahydro-11-Deoxycortisol;6a OH-tetrahydro-11-Deoxycortisol | A measurement of the 6-alpha hydroxytetrahydro-11-deoxycortisol in a biological specimen. | 6a OH-tetrahydro-11-Deoxycortisol Measurement | ||
HAHA | C165965 | Human Anti-Human Antibody | A measurement of the total human anti-human antibody in a biological specimen. | Human Anti-Human Antibody Measurement | ||
HAIRYCE | C74604 | Hairy Cells | A measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen. | Hairy Cell Count | ||
HALBAB | C103405 | Human Albumin Antibody | A measurement of the human albumin antibody in a biological specimen. | Human Albumin Antibody Measurement | ||
HALLUC | C75343 | Hallucinogen | A measurement of any hallucinogenic class drug present in a biological specimen. | Hallucinogen Measurement | ||
HALOPRDL | C177964 | Haloperidol | A measurement of the haloperidol in a biological specimen. | Haloperidol Measurement | ||
HALPRZLA | C177954 | Alpha-Hydroxyalprazolam | A measurement of the alpha-hydroxyalprazolam in a biological specimen. | Alpha-Hydroxyalprazolam Measurement | ||
HALPRZLM | C147352 | Hydroxyalprazolam | A measurement of the total hydroxyalprazolam present in a biological specimen. | Hydroxyalprazolam Measurement | ||
HAMAB | C103406 | HAMA;Human Anti-Mouse Antibody | A measurement of the human anti-mouse antibody in a biological specimen. | Human Anti-Mouse Antibody Measurement | ||
HAPTOG | C74740 | Haptoglobin | A measurement of the haptoglobin protein in a biological specimen. | Haptoglobin Protein Measurement | ||
HASIGEAB | C98740 | Human Anti-Sheep IgE Antibody | A measurement of the human anti-sheep IgE antibodies in a biological specimen. | Human Anti-Sheep IgE Antibody Measurement | ||
HASIGGAB | C98741 | Human Anti-Sheep IgG Antibody | A measurement of the human anti-sheep IgG antibodies in a biological specimen. | Human Anti-Sheep IgG Antibody Measurement | ||
HASIGMAB | C98742 | Human Anti-Sheep IgM Antibody | A measurement of the human anti-sheep IgM antibodies in a biological specimen. | Human Anti-Sheep IgM Antibody Measurement | ||
HBA1A | C163450 | Glycated Hemoglobin 1A;Glycosylated Hemoglobin 1A;Hemoglobin A1A | A measurement of the glycosylated hemoglobin A1A in a biological specimen. | Hemoglobin A1A Measurement | ||
HBA1B | C163451 | Glycated Hemoglobin 1B;Glycosylated Hemoglobin 1B;Hemoglobin A1B | A measurement of the glycosylated hemoglobin A1B in a biological specimen. | Hemoglobin A1B Measurement | ||
HBA1C | C64849 | Glycated Hemoglobin;Glycosylated Hemoglobin A1C;HbA1c;Hemoglobin A1C | A measurement of the glycosylated hemoglobin A1C in a biological specimen. | Glycosylated Hemoglobin Measurement | ||
HBA1CHGB | C111207 | Hemoglobin A1C/Hemoglobin | A relative measurement (ratio or percentage) of the glycosylated hemoglobin to total hemoglobin in a biological specimen. | Hemoglobin A1C to Hemoglobin Ratio Measurement | ||
HBA2PHB | C147353 | Hemoglobin A2 Prime/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin A2 prime to total hemoglobin in a biological specimen. | Hemoglobin A2 Prime to Total Hemoglobin Ratio Measurement | ||
HBBARTHB | C147354 | Hemoglobin Barts/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin Barts to total hemoglobin in a biological specimen. | Hemoglobin Barts to Total Hemoglobin Ratio Measurement | ||
HBCOHGB | C147355 | Carboxyhemoglobin/Total Hemoglobin | A relative measurement (ratio or percentage) of the amount of carboxyhemoglobin compared to total hemoglobin in a biological specimen. | Carboxyhemoglobin to Total Hemoglobin Ratio Measurement | ||
HBGCHTHB | C147356 | Hemoglobin G Coushatta/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin G Coushatta to total hemoglobin in a biological specimen. | Hemoglobin G Coushatta to Total Hemoglobin Ratio Measurement | ||
HBHIB | C158234 | HBH Inclusion Bodies;Hemoglobin H Inclusion Bodies;HGH Inclusion Bodies | A measurement of the hemoglobin H inclusion bodies in a biological specimen. | Hemoglobin H Inclusion Bodies Measurement | ||
HBLEPRHB | C147357 | Hemoglobin Lepore/Total Hemoglobin | A relative measurement (ratio or percentage) of the Lepore hemoglobin to total hemoglobin in a biological specimen. | Hemoglobin Lepore to Total Hemoglobin Ratio Measurement | ||
HBOARBHB | C147358 | Hemoglobin O-Arab/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin O-Arab to total hemoglobin in a biological specimen. | Hemoglobin O-Arab to Total Hemoglobin Ratio Measurement | ||
HBOXHGB | C147359 | FO2 Hb;Fractioned Oxyhemoglobin;Oxyhemoglobin/Total Hemoglobin | A relative measurement (ratio or percentage) of the amount of oxyhemoglobin compared to total hemoglobin in a biological specimen. | Oxyhemoglobin to Total Hemoglobin Ratio Measurement | ||
HCG | C64851 | Choriogonadotropin Beta;Pregnancy Test | A measurement of the Choriogonadotropin Beta in a biological specimen. | Choriogonadotropin Beta Measurement | ||
HCGFR | C147360 | Choriogonadotropin Beta, Free | A measurement of the free choriogonadotropin beta in a biological specimen. | Free Choriogonadotropin Beta Measurement | ||
HCGND | C147128 | Choriogonadotropin | A measurement of the total choriogonadotropin in a biological specimen. | Choriogonadotropin Measurement | ||
HCGNDI | C147361 | Choriogonadotropin, Intact | A measurement of the intact choriogonadotropin in a biological specimen. | Intact Choriogonadotropin Measurement | ||
HCH4 | C186060 | H+CH4;Hydrogen+Methane | A measurement of the hydrogen and methane in a biological specimen. | Hydrogen and Methane Measurement | ||
HCHT | C176300 | Hyocholate;Hyocholic Acid | A measurement of the hyocholate in a biological specimen. | Hyocholate Measurement | ||
HCOA3 | C181428 | 3-HCOA;3-Hydroxy-5-cholestenoic acid;3beta-Hydroxy-5-Cholestenoic Acid | A measurement of the 3beta-hydroxy-5-cholestenoic acid in a biological specimen. | 3beta-Hydroxy-5-Cholestenoic Acid Measurement | ||
HCT | C64796 | Erythrocyte Volume Fraction;EVF;Hematocrit;Packed Cell Volume;PCV | The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes). | Hematocrit Measurement | ||
HDL | C105587 | HDL Cholesterol | A measurement of the high density lipoprotein cholesterol in a biological specimen. | High Density Lipoprotein Cholesterol Measurement | ||
HDL2 | C80187 | HDL-Cholesterol Subclass 2 | A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen. | HDL-Cholesterol Subclass 2 Measurement | ||
HDL3 | C80188 | HDL-Cholesterol Subclass 3 | A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen. | HDL-Cholesterol Subclass 3 Measurement | ||
HDLCCHOL | C147362 | HDL Cholesterol/Total Cholesterol | A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to total cholesterol in a biological specimen. | HDL Cholesterol to Total Cholesterol Ratio Measurement | ||
HDLCLDLC | C100425 | HDL Cholesterol/LDL Cholesterol | A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen. | HDL Cholesterol to LDL Cholesterol Ratio Measurement | ||
HDLPL | C156513 | HDL Phospholipid;HDL-PL | A measurement of the high density lipoprotein phospholipid in a biological specimen. | HDL Phospholipid Measurement | ||
HDLPSZ | C103402 | HDL Particle Size | A measurement of the average particle size of high-density lipoprotein in a biological specimen. | HDL Particle Size Measurement | ||
HDR51AGT | C189510 | HLA-DR51 Antigen Type | The identification of the type of human leukocyte antigen, class II, antigen-D-related 51 (HLA-DR51), in a biological specimen. | HLA-DR51 Antigen Measurement | ||
HDR52AGT | C189511 | HLA-DR52 Antigen Type | The identification of the type of human leukocyte antigen, class II, antigen-D-related 52 (HLA-DR52), in a biological specimen. | HLA-DR52 Antigen Measurement | ||
HDR53AGT | C189512 | HLA-DR53 Antigen Type | The identification of the type of human leukocyte antigen, class II, antigen-D-related 53 (HLA-DR53), in a biological specimen. | HLA-DR53 Antigen Measurement | ||
HDW | C106525 | Hemoglobin Concentration Distribution Width;Hemoglobin Distribution Width | A measurement of the distribution of the hemoglobin concentration in red blood cells. | Hemoglobin Distribution Width Measurement | ||
HDWR | C139070 | Ret Hemoglobin Distribution Width;Reticulocyte Hemoglobin Concentration Distribution Width | A measurement of the distribution of the hemoglobin concentration in reticulocytes. | Reticulocyte Hemoglobin Distribution Width | ||
HE4 | C163452 | Human Epididymis Protein 4 | A measurement of the human epididymis protein 4 in a biological specimen. | Human Epididymis Protein 4 Measurement | ||
HEINZ | C74709 | Heinz Bodies;Heinz-Erhlich Bodies | A measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen. | Heinz-Ehrlich Body Measurement | ||
HEINZRBC | C111206 | Heinz Bodies/Erythrocytes | A relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen. | Heinz Body to Erythrocyte Ratio Measurement | ||
HELMETCE | C74658 | Helmet Cells | A measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen. | Helmet Cell Count | ||
HELMOV10 | C165966 | Helicase MOV-10 Protein;Moloney Leukemia Virus 10 Protein | A measurement of helicase MOV-10 protein in a biological specimen. | Helicase MOV-10 Protein Measurement | ||
HEMOLYSI | C111208 | Hemolysis;Hemolytic Index | A measurement of the destruction of red blood cells in a biological specimen. | Hemolytic Index | ||
HEPARIN | C165967 | Heparin | A measurement of the heparin in a biological specimen. | Heparin Measurement | ||
HEPCIDIN | C174387 | Hepcidin | A measurement of the total hepcidin in a biological specimen. | Hepcidin Measurement | ||
HER2 | C112312 | ERBB2;HER2/NEU;Human Epidermal Growth Factor Receptor 2 | A measurement of HER2 protein in a biological specimen. | Human Epidermal Growth Factor Receptor 2 Measurement | ||
HER2S | C112291 | HER2 Antigen;HER2/NEU Antigen;HER2/NEU Shed Antigen;Soluble HER2;Soluble HER2/NEU | A measurement of the soluble HER2 protein in a biological specimen. | Soluble HER2 Antigen Measurement | ||
HERC5 | C163453 | E3 ISG15--Protein Ligase HERC5;HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 5;Hect Domain and RLD 5 | A measurement of the hect domain and RLD 5 in a biological specimen. | Hect Domain and RLD 5 Measurement | ||
HETRPH | C116186 | Heterophils | A measurement of heterophils (granular leukocytes) in a biological specimen from avian species. | Heterophil Measurement | ||
HETRPHLE | C116187 | Heterophils/Leukocytes | A relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species. | Heterophils to Leukocytes Ratio Measurement | ||
HEXA | C181411 | Beta-Hexosaminidase Subunit Alpha;Beta-N-Acetylhexosaminidase Subunit Alpha;Hexosaminidase A;Hexosaminidase Subunit A;Hexosaminidase Subunit Alpha;N-Acetyl-Beta-Glucosaminidase Subunit Alpha | A measurement of the hexosaminidase A in a biological specimen. | Hexosaminidase A Measurement | ||
HEXK | C96668 | Hexokinase | A measurement of the hexokinase in a biological specimen. | Hexokinase Measurement | ||
HGB | C64848 | Hemoglobin;Hemoglobin Monomer | A measurement of the total erythrocyte associated hemoglobin in a biological specimen. | Hemoglobin Measurement | ||
HGBA | C92258 | Hemoglobin A | A measurement of the hemoglobin A in a biological specimen. | Hemoglobin A Measurement | ||
HGBA1HGB | C147363 | Hemoglobin A1/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin A1 to total hemoglobin in a biological specimen. | Hemoglobin A1 to Total Hemoglobin Ratio Measurement | ||
HGBA2 | C92259 | Hemoglobin A2 | A measurement of the hemoglobin A2 in a biological specimen. | Hemoglobin A2 Measurement | ||
HGBA2HGB | C81277 | Hemoglobin A2/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin A2 to total hemoglobin in a biological specimen. | Hemoglobin A2 to Total Hemoglobin Ratio Measurement | ||
HGBAHGB | C81276 | Hemoglobin A/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin A to total hemoglobin in a biological specimen. | Hemoglobin A to Total Hemoglobin Ratio Measurement | ||
HGBB | C92260 | Hemoglobin B | A measurement of the hemoglobin B in a biological specimen. | Hemoglobin B Measurement | ||
HGBC | C92261 | Hemoglobin C | A measurement of the hemoglobin C in a biological specimen. | Hemoglobin C Measurement | ||
HGBCHGB | C81278 | Hemoglobin C/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin C to total hemoglobin in a biological specimen. | Hemoglobin C to Total Hemoglobin Ratio Measurement | ||
HGBCS | C156515 | Hemoglobin Casts | A measurement of the hemoglobin casts present in a biological specimen. | Hemoglobin Cast Measurement | ||
HGBDHGB | C147364 | Hemoglobin D/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin D to total hemoglobin in a biological specimen. | Hemoglobin D to Total Hemoglobin Ratio Measurement | ||
HGBDOXY | C124343 | Deoxyhemoglobin | A measurement of the deoxyhemoglobin, hemoglobin without oxygen, in a biological specimen. | Deoxyhemoglobin Measurement | ||
HGBEHGB | C147365 | Hemoglobin E/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin E to total hemoglobin in a biological specimen. | Hemoglobin E to Total Hemoglobin Ratio Measurement | ||
HGBF | C92262 | Fetal Hemoglobin;Hemoglobin F | A measurement of the hemoglobin F in a biological specimen. | Hemoglobin F Measurement | ||
HGBFHGB | C147366 | Hemoglobin F/Total Hemoglobin | A relative measurement (ratio or percentage) of the fetal hemoglobin (hemoglobin F) to total hemoglobin in a biological specimen. | Hemoglobin F to Total Hemoglobin Ratio Measurement | ||
HGBFPATN | C161363 | Hemoglobin Fraction Pattern | A description of the hemoglobin fraction pattern in a biological specimen. | Hemoglobin Fraction Pattern | ||
HGBFR | C127617 | Hemoglobin, Free | A measurement of the hemoglobin external to erythrocytes in a biological specimen. | Free Hemoglobin Measurement | ||
HGBMET | C96689 | Methemoglobin | A measurement of the methemoglobin in a biological specimen. | Methemoglobin Measurement | ||
HGBMHGB | C147367 | FMET HB;Fractionated Methemoglobin;Methemoglobin/Total Hemoglobin | A relative measurement (ratio or percentage) of the amount of methemoglobin compared to total hemoglobin in a biological specimen. | Methemoglobin to Total Hemoglobin Ratio Measurement | ||
HGBOXY | C96616 | Oxyhemoglobin | A measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen. | Oxyhemoglobin Measurement | ||
HGBS | C122123 | Hemoglobin S;Sickle Hemoglobin | A measurement of the hemoglobin S in a biological specimen. | Hemoglobin S Measurement | ||
HGBSHGB | C81279 | Hemoglobin S/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin S to total hemoglobin in a biological specimen. | Hemoglobin S to Total Hemoglobin Ratio Measurement | ||
HGBTET | C135425 | Hemoglobin Tetramer | A measurement of the hemoglobin tetramer in a biological specimen. | Hemoglobin Tetramer Measurement | ||
HGBVAR | C103845 | Hemoglobin Variants | A statement that indicates a defined set of hemoglobin variants were looked for in a biological specimen. | Hemoglobin Variant Measurement | ||
HGF | C135426 | Hepatocyte Growth Factor | A measurement of the hepatocyte growth factor in a biological specimen. | Hepatocyte Growth Factor Measurement | ||
HGFR | C172514 | c-Met;Hepatocyte Growth Factor Receptor;MET Proto-Oncogene, Receptor Tyrosine Kinase;Tyrosine-Protein Kinase Met | A measurement of the hepatocyte growth factor receptor in a biological specimen. | Hepatocyte Growth Factor Receptor Measurement | ||
HGFRFR | C181453 | Hepatocyte Growth Factor Receptor, Free | A measurement of the free (unbound) hepatocyte growth factor receptor in a biological specimen. | Free Hepatocyte Growth Factor Receptor Measurement | ||
HGPRT | C187809 | Hypoxanthine-Guanine Phosphoribosyltransferase;Hypoxanthine-Guanine PRT | A measurement of the hypoxanthine-guanine phosphoribosyltransferase in a biological specimen. | Hypoxanthine-Guanine Phosphoribosyltransferase Measurement | ||
HIS | C122124 | Histidine | A measurement of the histidine in a biological specimen. | Histidine Measurement | ||
HIST1AB | C112293 | Histone 1 Antibody | A measurement of the total histone 1 antibodies in a biological specimen. | Histone 1 Antibody Measurement | ||
HIST2AAB | C112294 | Histone 2A Antibody | A measurement of the total histone 2A antibodies in a biological specimen. | Histone 2A Antibody Measurement | ||
HIST2BAB | C112295 | Histone 2B Antibody | A measurement of the total histone 2B antibodies in a biological specimen. | Histone 2B Antibody Measurement | ||
HIST3AB | C112296 | Histone 3 Antibody | A measurement of the total histone 3 antibodies in a biological specimen. | Histone 3 Antibody Measurement | ||
HIST4AB | C112297 | Histone 4 Antibody | A measurement of the total histone 4 antibodies in a biological specimen. | Histone 4 Antibody Measurement | ||
HISTAB | C111209 | Anti-Histone Antibodies;Histone Antibodies | A measurement of histone antibodies in a biological specimen. | Histone Antibody Measurement | ||
HISTAMIN | C80189 | Histamine | A measurement of the histamine in a biological specimen. | Histamine Measurement | ||
HLAA | C154746 | HLA Class IA Antigen | A measurement of the HLA class IA antigen in a biological specimen. | HLA Class IA Histocompatibility Antigen Measurement | ||
HLAA03 | C181440 | HLA A03 Antigen;HLA-A03 Antigen | A measurement of the HLA A03 antigen in a biological specimen. | HLA A03 Histocompatibility Antigen Measurement | ||
HLAA2 | C181441 | HLA A2 Antigen;HLA-A2 Antigen | A measurement of the HLA A2 antigen in a biological specimen. | HLA A2 Histocompatibility Antigen Measurement | ||
HLAA23A | C128953 | HLA-A23 Antibody | A measurement of the human leukocyte antigen A23 (HLA-A23) antibody in a biological specimen. | HLA-A23 Antibody Measurement | ||
HLAA24 | C181442 | HLA A24 Antigen;HLA-A24 Antigen | A measurement of the HLA A24 antigen in a biological specimen. | HLA A24 Histocompatibility Antigen Measurement | ||
HLAA2AB | C128954 | HLA-A2 Antibody | A measurement of the human leukocyte antigen A2 (HLA-A2) antibody in a biological specimen. | HLA-A2 Antibody Measurement | ||
HLAA3 | C181443 | HLA A3 Antigen;HLA-A3 Antigen | A measurement of the HLA A3 antigen in a biological specimen. | HLA A3 Histocompatibility Antigen Measurement | ||
HLAAAGT | C128955 | HLA-A Antigen Type | The identification of the type of human leukocyte antigen, class I, group A (HLA-A), in a biological specimen. | HLA-A Antigen Type | ||
HLAAMSC | C128956 | HLA-A Mismatch Count | A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class I, group A (HLA-A). | HLA-A Mismatch Count | ||
HLAB | C154747 | HLA Class IB Antigen | A measurement of the HLA class IB antigen in a biological specimen. | HLA Class IB Histocompatibility Antigen Measurement | ||
HLAB27AG | C100460 | HLA-B27 Antigen;Human Leukocyte Antigen B27 | A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen. | HLA-B27 Antigen Measurement | ||
HLABAGT | C128957 | HLA-B Antigen Type | The identification of the type of human leukocyte antigen, class I, group B (HLA-B), in a biological specimen. | HLA-B Antigen Type | ||
HLABMSC | C128958 | HLA-B Mismatch Count | A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class I, group B (HLA-B). | HLA-B Mismatch Count | ||
HLAC | C154748 | HLA Class IC Antigen | A measurement of the HLA class IC antigen in a biological specimen. | HLA Class IC Histocompatibility Antigen Measurement | ||
HLACW | C181439 | HLA Cw Antigen;HLA-Cw Antigen | A measurement of the HLA Cw antigen in a biological specimen. | HLA Cw Histocompatibility Antigen Measurement | ||
HLADPA1 | C181417 | HLA DP Alpha1 Antigen;HLA-DP Alpha1 Antigen | A measurement of the HLA DP alpha1 antigen in a biological specimen. | HLA DP Alpha1 Histocompatibility Antigen Measurement | ||
HLADPB | C181444 | HLA DP Beta Antigen;HLA-DP Beta Antigen | A measurement of the total HLA DP beta antigen in a biological specimen. | HLA DP Beta Histocompatibility Antigen Measurement | ||
HLADPB1 | C154751 | HLA DP Beta1 Antigen | A measurement of the HLA DP beta1 antigen in a biological specimen. | HLA DP Beta1 Histocompatibility Antigen Measurement | ||
HLADQ2 | C186061 | HLA DQ2 Antigen;HLA-DQ2 Antigen | A measurement of the HLA DQ2 antigen in a biological specimen. | HLA DQ2 Antigen Measurement | ||
HLADQ8 | C186062 | HLA DQ8 Antigen;HLA-DQ8 Antigen | A measurement of the HLA DQ8 antigen in a biological specimen. | HLA DQ8 Antigen Measurement | ||
HLADQA1 | C181416 | HLA DQ Alpha1 Antigen;HLA-DQ Alpha1 Antigen | A measurement of the HLA DQ alpha1 antigen in a biological specimen. | HLA DQ Alpha1 Histocompatibility Antigen Measurement | ||
HLADQB1 | C154750 | HLA DQ Beta1 Antigen | A measurement of the HLA DQ beta1 antigen in a biological specimen. | HLA DQ Beta1 Histocompatibility Antigen Measurement | ||
HLADR | C176962 | HLA DR Antigen;HLA-DR Antigen | A measurement of the total HLA DR antigen in a biological specimen. | HLA DR Histocompatibility Antigen Measurement | ||
HLADR51A | C128959 | HLA-DR51 Antibody | A measurement of the human leukocyte antigen DR51 (HLA-DR51) antibody in a biological specimen. | HLA-DR51 Antibody Measurement | ||
HLADR52A | C128960 | HLA-DR52 Antibody | A measurement of the human leukocyte antigen DR52 (HLA-DR52) antibody in a biological specimen. | HLA-DR52 Antibody Measurement | ||
HLADR53A | C128961 | HLA-DR53 Antibody | A measurement of the human leukocyte antigen DR53 (HLA-DR53) antibody in a biological specimen. | HLA-DR53 Antibody Measurement | ||
HLADRAGT | C128962 | HLA-DR Antigen Type | The identification of the type of human leukocyte antigen, class II, antigen-D-related (HLA-DR), in a biological specimen. | HLA-DR Antigen Type | ||
HLADRB | C181192 | HLA DR Beta Antigen;HLA-DR Beta Antigen | A measurement of the total HLA DR beta antigen in a biological specimen. | HLA DR Beta Histocompatibility Antigen Measurement | ||
HLADRB1 | C154749 | HLA DR Beta1 Antigen | A measurement of the HLA DR beta1 antigen in a biological specimen. | HLA DR Beta1 Histocompatibility Antigen Measurement | ||
HLADRB2 | C181415 | HLA DR Beta2 Antigen;HLA-DR Beta2 Antigen | A measurement of the HLA DR beta2 antigen in a biological specimen. | HLA DR Beta 2 Histocompatibility Antigen Measurement | ||
HLADRB3 | C181412 | HLA DR Beta3 Antigen;HLA-DR Beta3 Antigen | A measurement of the HLA DR beta3 antigen in a biological specimen. | HLA DR Beta 3 Histocompatibility Antigen Measurement | ||
HLADRB4 | C181413 | HLA DR Beta4 Antigen;HLA-DR Beta4 Antigen | A measurement of the HLA DR beta4 antigen in a biological specimen. | HLA DR Beta 4 Histocompatibility Antigen Measurement | ||
HLADRB5 | C181414 | HLA DR Beta5 Antigen;HLA-DR Beta5 Antigen | A measurement of the HLA DR beta5 antigen in a biological specimen. | HLA DR Beta 5 Histocompatibility Antigen Measurement | ||
HLADRMSC | C128963 | HLA-DR Mismatch Count | A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class II, antigen-D-related (HLA-DR). | HLA-DR Mismatch Count | ||
HLAIAB | C128964 | HLA Class I Antibody | A measurement of the human leukocyte antigen (HLA) antibody class I in a biological specimen. | HLA Class I Antibody Measurement | ||
HLAIIAB | C128965 | HLA Class II Antibody | A measurement of the human leukocyte antigen (HLA) antibody class II in a biological specimen. | HLA Class II Antibody Measurement | ||
HLAIIPRA | C128966 | HLA Class II Panel Reactive Antibody | A measurement of the panel reactive antibody (the reactivity between host immune cells and donor) human leukocyte antigen class II in a biological specimen. | HLA Class II Panel Reactive Antibody Measurement | ||
HLAIPRA | C128967 | HLA Class I Panel Reactive Antibody | A measurement of the panel reactive antibody (the reactivity between host immune cells and donor) human leukocyte antigen class I in a biological specimen. | HLA Class I Panel Reactive Antibody Measurement | ||
HLAMSC | C128933 | HLA Mismatch Count | A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigens (HLA). | HLA Mismatch Count | ||
HLZPM | C139078 | Halazepam | A measurement of the halazepam present in a biological specimen. | Halazepam Measurement | ||
HMOSIDRN | C96659 | Hemosiderin | A measurement of the hemosiderin complex in a biological specimen. | Hemosiderin Measurement | ||
HOMOCIT | C154758 | Homocitrulline | A measurement of the homocitrulline in a biological specimen. | Homocitrulline Measurement | ||
HOMOCY | C74741 | Homocysteine | A measurement of the homocysteine amino acid in a biological specimen. | Homocysteine Acid Measurement | ||
HORBCRBC | C181409 | Hypochromic Erythrocytes/Erythrocytes | A relative measurement (ratio or percentage) of the hypochromic erythrocytes to total erythrocytes in a biological specimen. | Hypochromic Erythrocytes to Erythrocytes Ratio Measurement | ||
HOWJOL | C74704 | Howell-Jolly Bodies | A measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen. | Howell-Jolly Body Measurement | ||
HPOCROM | C64802 | Hypochromia;Hypochromic Erythrocytes | An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level. | Hypochromia | ||
HRRBCRBC | C181408 | Hyperchromic Erythrocytes/Erythrocytes | A relative measurement (ratio or percentage) of the hyperchromic erythrocytes to total erythrocytes in a biological specimen. | Hyperchromic Erythrocytes to Erythrocytes Ratio Measurement | ||
HRYCECE | C135427 | Hairy Cells/Total Cells | A relative measurement (ratio or percentage) of the hairy cells to total cells in a biological specimen. | Hairy Cells to Total Cells Ratio Measurement | ||
HRYCELE | C135428 | Hairy Cells/Leukocytes | A relative measurement (ratio or percentage) of the hairy cells (B-cell lymphocytes with hairy projections from the cytoplasm) to all leukocytes in a biological specimen. | Hairy Cells to Leukocytes Ratio Measurement | ||
HRYCELY | C74640 | Hairy Cells/Lymphocytes | A relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen . | Hairy Cell to Lymphocyte Ratio Measurement | ||
HSP70 | C147368 | Heat Shock Protein 70 | A measurement of the heat shock protein 70 in a biological specimen. | Heat Shock Protein 70 Measurement | ||
HSP90A | C147369 | Heat Shock Protein 90 Alpha | A measurement of the heat shock protein 90 alpha in a biological specimen. | Heat Shock Protein 90 Alpha Measurement | ||
HTTP | C142279 | Huntingtin Protein;Total Huntingtin Protein | A measurement of the total huntingtin protein in a biological specimen. | Huntingtin Protein Measurement | ||
HTTPM | C142280 | Huntingtin Protein, Mutant | A measurement of the mutant huntingtin protein in a biological specimen. | Mutant Huntingtin Protein Measurement | ||
HTTPWT | C191292 | Huntingtin Protein, Wild Type | A measurement of the wild type huntingtin protein in a biological specimen. | Wild Type Huntingtin Protein Measurement | ||
HVA | C74863 | Homovanillic Acid | A measurement of the homovanillic acid metabolite in a biological specimen. | Homovanillic Acid Measurement | ||
HXANSD11 | C186063 | 11-Hydroxyandrostenedione | A measurement of the 11-hydroxyandrostenedione in a biological specimen. | 11-Hydroxyandrostenedione Measurement | ||
HXANST11 | C186064 | 11-Hydroxyandrosterone | A measurement of the 11-hydroxyandrosterone in a biological specimen. | 11-Hydroxyandrosterone Measurement | ||
HXCSD17 | C186065 | 17-Hydroxycorticoid;17-Hydroxycorticosteroid;17-Hydroxycorticosteroids | A measurement of the 17-hydroxycorticosteroids in a biological specimen. | 17-Hydroxycorticosteroid Measurement | ||
HXCSL18 | C186066 | 18-Hydroxycortisol | A measurement of the 18-hydroxycortisol in a biological specimen. | 18-Hydroxycortisol Measurement | ||
HXCSN18 | C186067 | 18-Hydroxycorticosterone | A measurement of the 18-hydroxycorticosterone in a biological specimen. | 18-Hydroxycorticosterone Measurement | ||
HXDX18 | C186068 | 18-Hydroxydeoxycorticosterone | A measurement of the 18-hydroxydeoxycorticosterone in a biological specimen. | 18-Hydroxydeoxycorticosterone Measurement | ||
HXETCL11 | C186069 | 11-Hydroxyetiocholanolone | A measurement of the 11-hydroxyetiocholanolone in a biological specimen. | 11-Hydroxyetiocholanolone Measurement | ||
HXGLUR2 | C191293 | 2-Hydroxyglutarate;2-Hydroxyglutaric Acid;Alpha-Hydroxyglutaric Acid | A measurement of the 2-hydroxyglutarate in a biological specimen. | 2-Hydroxyglutarate Measurement | ||
HXNE4 | C187788 | 4-HNE;4-hydroxy-2-nonenal;4-Hydroxynonenal;HNE | A measurement of the 4-hydroxynonenal in a biological specimen. | 4-Hydroxynonenal Measurement | ||
HXPRGN17 | C186070 | 17-Hydroxypregnenolone | A measurement of the 17-hydroxypregnenolone in a biological specimen. | 17-Hydroxypregnenolone Measurement | ||
HYALUAC | C112319 | Hyaluronic Acid | A measurement of hyaluronic acid in a biological specimen. | Hyaluronic Acid Measurement | ||
HYDCDN | C74879 | Hydrocodone | A measurement of the hydrocodone present in a biological specimen. | Hydrocodone Measurement | ||
HYDMDZ1 | C154732 | 1'-Hydroxymidazolam;1-Hydroxymidazolam;Alpha-Hydroxymidazolam | A measurement of the 1-Hydroxymidazolam present in a biological specimen. | 1-Hydroxymidazolam Measurement | ||
HYDMDZ4 | C154731 | 4-Hydroxymidazolam | A measurement of the 4-hydroxymidazolam present in a biological specimen. | 4-Hydroxymidazolam Measurement | ||
HYDMRPHN | C74880 | Hydromorphone | A measurement of the hydromorphone present in a biological specimen. | Hydromorphone Measurement | ||
HYDROGEN | C102275 | Hydrogen | A measurement of the hydrogen in a biological specimen. | Hydrogen Measurement | ||
HYPERCHR | C96669 | Hyperchromia;Hyperchromic Erythrocytes | A measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration. | Hyperchromia Measurement | ||
HYPGST17 | C147370 | 17-Hydroxyprogesterone;17-OHP | A measurement of the 17-Hydroxyprogesterone in a biological specimen. | 17-Hydroxyprogesterone Measurement | ||
HYPRLN | C80190 | Hydroxyproline | A measurement of the total hydroxyproline in a biological specimen. | Hydroxyproline Measurement | ||
HYPSEGCE | C74612 | Hypersegmented Cells | A measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen. | Hypersegmented Neutrophil Measurement | ||
HYXLYS | C154767 | Hydroxylysine | A measurement of the hydroxylysine in a biological specimen. | Hydroxylysine Measurement | ||
IA2AB | C119284 | Insulinoma-Associated Protein 2 Antibody | A measurement of the insulinoma-associated protein 2 antibody in a biological specimen. | Insulinoma-Associated Protein 2 Antibody Measurement | ||
IA5OHEXR | C163454 | 5-Hydroxyindoleacetic Acid Excretion Rate;5-HydroxyindoleaceticAcid Excretion Rate | A measurement of the amount of 5-hydroxyindoleacetic acid being excreted in a biological specimen over a defined amount of time (e.g. one hour). | 5-Hydroxyindoleacetic Acid Excretion Rate | ||
IAA5OH | C112217 | 5-Hydroxyindoleacetate;5-Hydroxyindoleacetic Acid | A measurement of 5-hydroxyindoleacetic acid in a biological specimen. | 5-Hydroxyindoleacetic Acid Measurement | ||
IAA5OHCR | C170578 | 5-Hydroxyindoleacetic Acid/Creatinine | A relative measurement (ratio or percentage) of the 5-hydroxyindoleacetic acid to creatinine in a biological specimen. | 5-Hydroxyindoleacetic Acid to Creatinine Ratio Measurement | ||
IAPOB | C184514 | IDL Apolipoprotein B | A measurement of the apolipoprotein B in the intermediate density lipoprotein fraction of a biological specimen. | IDL Apolipoprotein B Measurement | ||
IAPP | C127622 | Amylin;Islet Amyloid Polypeptide | A measurement of the islet amyloid polypeptide in a biological specimen. | Islet Amyloid Polypeptide Measurement | ||
IBCT | C74718 | Total Iron Binding Capacity | A measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen. | Total Iron Binding Capacity | ||
IBCU | C74719 | Unsaturated Iron Binding Capacity | A measurement of the binding capacity of unsaturated iron in a biological specimen. | Unsaturated Iron Binding Capacity Measurement | ||
IC512AB | C81985 | IA-2 Antibody;ICA-512 Antibody;Islet Antigen 2 Autoantibody;Islet Cell 512 Antibody;Islet Cell Antigen 512 Autoantibody | A measurement of the islet cell 512 antibody in a biological specimen. | Islet Cell 512 Antibody Measurement | ||
IC512AG | C81986 | Islet Cell 512 Antigen | A measurement of the islet cell 512 antigen in a biological specimen. | Islet Cell 512 Antigen Measurement | ||
ICAB | C154725 | Islet Cell Antibody | A measurement of the total islet cell antibodies in a biological specimen. | Islet Cell Antibody Measurement | ||
ICAIGGAB | C122126 | Islet Cell Cytoplasmic IgG Antibody | A measurement of the islet cell cytoplasmic IgG antibody in a biological specimen. | Islet Cell Cytoplasmic IgG Antibody Measurement | ||
ICAM | C124344 | Intercellular Adhesion Molecule | A measurement of the total intercellular adhesion molecule in a biological specimen. | Intercellular Adhesion Molecule Measurement | ||
ICAM1 | C124345 | CD54;Intercellular Adhesion Molecule 1 | A measurement of the intercellular adhesion molecule 1 in a biological specimen. | Intercellular Adhesion Molecule 1 Measurement | ||
ICAM3 | C165968 | Intercellular Adhesion Molecule 3 | A measurement of the intercellular adhesion molecule 3 in a biological specimen. | Intercellular Adhesion Molecule 3 Measurement | ||
ICG | C184512 | Indocyanine Green | A measurement of the indocyanine green in a biological specimen. | Indocyanine Green Measurement | ||
ICGCLR | C184513 | Indocyanine Green Clearance | A measurement of the volume of serum or plasma that would be cleared of indocyanine green by excretion for a specified unit of time (e.g. one minute). | Indocyanine Green Clearance Measurement | ||
ICTERUSI | C111232 | Icteric Index;Icterus | A measurement of the yellow color of a biological specimen, due to the presence of bile pigments. | Icteric Index | ||
IDL | C112325 | IDL Cholesterol;Intermediate Density Lipoprotein | A measurement of the intermediate density lipoprotein in a biological specimen. | Intermediate Density Lipoprotein Cholesterol Measurement | ||
IDLLDL | C187810 | IDL Cholesterol/LDL Cholesterol | A relative measurement (ratio) of the amount of intermediate density lipoprotein cholesterol compared to low density lipoprotein cholesterol in a biological specimen. | IDL Cholesterol to LDL Cholesterol Ratio Measurement | ||
IDLP | C116197 | IDL Particles;Intermediate Density Lipoproteins Particles | A measurement of the concentration of IDL particles in a biological specimen. | IDL Particles Measurement | ||
IDLT | C189507 | IDL Triglyceride | A measurement of the intermediate density lipoprotein triglyceride in a biological specimen. | IDL Triglyceride Measurement | ||
IDLVLDL3 | C147371 | IDL Cholesterol and VLDL Cholesterol Subtype 3;IDL+VLDL Cholesterol Subtype 3 | A measurement of the intermediate density lipoprotein cholesterol and the very low density lipoprotein cholesterol subtype 3 in a biological specimen. | IDL Cholesterol and VLDL Cholesterol Subtype 3 Measurement | ||
IFI27 | C163455 | Interferon Alpha-Induced Protein 27;Interferon Alpha-Inducible Protein 27 | A measurement of the interferon alpha-inducible protein 27 in a biological specimen. | Interferon Alpha-Inducible Protein 27 Measurement | ||
IFI44 | C163456 | Interferon-Induced Protein 44 | A measurement of the interferon-induced protein 44 in a biological specimen. | Interferon-Induced Protein 44 Measurement | ||
IFI44L | C163457 | Interferon-Induced Protein 44-Like | A measurement of the interferon-induced protein 44-like in a biological specimen. | Interferon-Induced Protein 44-Like Measurement | ||
IFI6 | C163458 | Interferon Alpha-Inducible Protein 6 | A measurement of the interferon alpha-inducible protein 6 in a biological specimen. | Interferon Alpha-Inducible Protein 6 Measurement | ||
IFIT1 | C163459 | Interferon-Induced 56 kDa Protein;Interferon-Induced Protein With Tetratricopeptide Repeats 1 | A measurement of the interferon-induced 56 KDa protein in a biological specimen. | Interferon-Induced 56 kDa Protein Measurement | ||
IFIT3 | C163460 | Interferon-Induced 60 kDa Protein;Interferon-Induced Protein With Tetratricopeptide Repeats 3 | A measurement of the interferon-induced 60 KDa protein in a biological specimen. | Interferon-Induced 60 kDa Protein Measurement | ||
IFNA | C81994 | Interferon Alpha | A measurement of the total interferon alpha in a biological specimen. | Interferon Alpha Measurement | ||
IFNA2 | C184646 | Interferon Alpha Type 2 | A measurement of the interferon alpha type 2 in a biological specimen. | Interferon Alpha Type 2 Measurement | ||
IFNB | C81995 | Interferon Beta | A measurement of the interferon beta in a biological specimen. | Interferon Beta Measurement | ||
IFNG | C81996 | Interferon Gamma | A measurement of the interferon gamma in a biological specimen. | Interferon Gamma Measurement | ||
IGA | C81969 | Immunoglobulin A | A measurement of the total immunoglobulin A in a biological specimen. | Immunoglobulin A Measurement | ||
IGAC3 | C184515 | IgA/C3;IgA/Complement C3;Immunoglobulin A/Complement C3 | A relative measurement (ratio) of the immunoglobulin A to complement C3 in a biological specimen. | Immunoglobulin A to Complement C3 Measurement | ||
IGAGM | C111233 | IgG IgM IgA Total | A measurement of the total IgG, IgM, and IgA in a biological specimen. | IgG IgM IgA Total Measurement | ||
IGD | C98745 | Immunoglobulin D | A measurement of the Immunoglobulin D in a biological specimen. | Immunoglobulin D Measurement | ||
IGE | C81970 | Immunoglobulin E | A measurement of the Immunoglobulin E in a biological specimen. | Immunoglobulin E Measurement | ||
IGF1 | C74864 | Insulin-like Growth Factor-1 | A measurement of the insulin-like growth factor-1 in a biological specimen. | Insulin Like Growth Factor-1 Measurement | ||
IGF2 | C74865 | Insulin-like Growth Factor-2 | A measurement of the insulin-like growth factor-2 in a biological specimen. | Insulin Like Growth Factor-2 Measurement | ||
IGFBP1 | C128968 | Insulin-Like Growth Factor Binding Prot1;Insulin-Like Growth Factor Binding Protein 1 | A measurement of the total insulin-like growth factor binding protein 1 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 1 Measurement | ||
IGFBP2 | C128969 | Insulin-Like Growth Factor Binding Prot2;Insulin-Like Growth Factor Binding Protein 2 | A measurement of the insulin-like growth factor binding protein 2 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 2 Measurement | ||
IGFBP3 | C112322 | Insulin-Like Growth Factor Binding Prot3;Insulin-Like Growth Factor Binding Protein 3 | A measurement of the insulin-like growth factor binding protein 3 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 3 Measurement | ||
IGFBP7 | C165969 | AGM;FSTL2;IBP-7;IGFBP-7;IGFBP-7v;IGFBPRP1;Insulin-Like Growth Factor Binding Prot7;Insulin-like Growth Factor Binding Protein 7;MAC25;PSF;RAMSVPS;TAF | A measurement of the insulin-like growth factor binding protein 7 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 7 Measurement | ||
IGG | C81971 | Immunoglobulin G | A measurement of the total immunoglobulin G in a biological specimen. | Immunoglobulin G Measurement | ||
IGG1 | C122127 | Immunoglobulin G Subclass 1 | A measurement of the immunoglobulin G subclass 1 in a biological specimen. | Immunoglobulin G Subclass 1 Measurement | ||
IGG2 | C122128 | Immunoglobulin G Subclass 2 | A measurement of the immunoglobulin G subclass 2 in a biological specimen. | Immunoglobulin G Subclass 2 Measurement | ||
IGG3 | C122129 | Immunoglobulin G Subclass 3 | A measurement of the immunoglobulin G subclass 3 in a biological specimen. | Immunoglobulin G Subclass 3 Measurement | ||
IGG4 | C122130 | Immunoglobulin G Subclass 4 | A measurement of the immunoglobulin G subclass 4 in a biological specimen. | Immunoglobulin G Subclass 4 Measurement | ||
IGGALB | C147372 | IgG/Albumin;Immunoglobulin G/Albumin | A relative measurement (ratio or percentage) of the immunoglobulin G to albumin in a biological specimen. | Immunoglobulin G to Albumin Ratio Measurement | ||
IGGC | C147373 | IgG Clearance | A measurement of the IgG clearance in a biological specimen. | IgG Clearance | ||
IGGCALBC | C147374 | IgG Clearance/Albumin Clearance | A relative measurement (ratio) of the IgG clearance to albumin clearance in a biological specimen. | IgG Clearance to Albumin Clearance Ratio Measurement | ||
IGGCREAT | C119285 | Immunoglobulin G/Creatinine | A relative measurement (ratio or percentage) of the immunoglobulin G to creatinine in a biological specimen. | Immunoglobulin G to Creatinine Ratio Measurement | ||
IGGSYNRT | C147375 | IgG Synthesis Rate | A measurement of the IgG synthesis rate in a biological specimen. | IgG Synthesis Rate | ||
IGHG2 | C154737 | Immunoglobulin Heavy Constant Gamma 2 | A measurement of the immunoglobulin heavy constant gamma 2 in a biological specimen. | Immunoglobulin Heavy Constant Gamma 2 Measurement | ||
IGHG4 | C154738 | Immunoglobulin Heavy Constant Gamma 4 | A measurement of the immunoglobulin heavy constant gamma 4 in a biological specimen. | Immunoglobulin Heavy Constant Gamma 4 Measurement | ||
IGM | C81972 | Immunoglobulin M | A measurement of the total immunoglobulin M in a biological specimen. | Immunoglobulin M Measurement | ||
IGSOL | C117835 | Soluble Immunoglobulin | A measurement of the soluble total immunoglobulin in a biological specimen. | Soluble Immunoglobulin Measurement | ||
IL122340 | C128970 | Interleukin 12+23 p40 | A measurement of the p40 subunit of the interleukins 12 and 23 in a biological specimen. | Interleukin 12+23 p40 Measurement | ||
IL18BP | C172513 | Interleukin 18 Binding Protein | A measurement of the interleukin 18 binding protein in a biological specimen. | Interleukin 18 Binding Protein Measurement | ||
IL18EXR | C156519 | Interleukin 18 Excretion Rate | A measurement of the amount of interleukin 18 being excreted in a biological specimen over a defined period of time (e.g. one hour). | Interleukin 18 Excretion Rate | ||
IL1EXR | C156518 | Interleukin 1 Excretion Rate | A measurement of the amount of interleukin 1 being excreted in a biological specimen over a defined period of time (e.g. one hour). | Interleukin 1 Excretion Rate | ||
IL1R2 | C165970 | CD121b;CDw121b;IL-1R-2;IL-1RT2;IL1R2c;IL1RB;Interleukin 1 Receptor Type 2 | A measurement of the interleukin 1 receptor type 2 in a biological specimen. | Interleukin 1 Receptor Type 2 Measurement | ||
IL1RL1 | C142281 | Interleukin 1 Receptor-Like 1;Protein ST2;sST2 | A measurement of the interleukin 1 receptor-like 1 in a biological specimen. | Interleukin 1 Receptor-Like 1 Measurement | ||
IL1SR1 | C117836 | Soluble Interleukin-1 Receptor Type I | A measurement of the soluble interleukin-1 receptor type I in a biological specimen. | Soluble Interleukin-1 Receptor Type I Measurement | ||
IL2R | C158147 | Interleukin 2 Receptor | A measurement of the interleukin 2 receptor in a biological specimen. | Interleukin 2 Receptor Measurement | ||
IL2RA | C142282 | CD25;IL-2Ra;Interleukin 2 Receptor Subunit Alpha | A measurement of the interleukin 2 receptor subunit alpha in a biological specimen. | Interleukin 2 Receptor Subunit Alpha Measurement | ||
IL2RB | C142283 | IL-2Rb;Interleukin 2 Receptor Subunit Beta | A measurement of the interleukin 2 receptor subunit beta in a biological specimen. | Interleukin 2 Receptor Subunit Beta Measurement | ||
IL2SR | C158220 | sCD25;Soluble CD25;Soluble IL-2Ra;Soluble Interleukin 2 Receptor;Soluble Interleukin 2 Receptor Subunit Alpha | A measurement of the soluble interleukin 2 receptor in a biological specimen. | Soluble Interleukin 2 Receptor Measurement | ||
IL6SR | C117837 | Soluble Interleukin 6 Receptor | A measurement of the soluble interleukin 6 receptor in a biological specimen. | Soluble Interleukin 6 Receptor Measurement | ||
ILE | C103410 | Isoleucine | A measurement of the isoleucine in a biological specimen. | Isoleucine Measurement | ||
ILOPRDN | C177984 | Iloperidone | A measurement of the iloperidone in a biological specimen. | Iloperidone Measurement | ||
IMIPRMN | C186071 | Imipramine | A measurement of the imipramine in a biological specimen. | Imipramine Measurement | ||
IMMGLB | C81869 | Immunoglobulin | A measurement of the total immunoglobulin in a biological specimen. | Immunoglobulin Measurement | ||
IMMGLC | C147376 | Immunoglobulin Light Chains | A measurement of the total immunoglobulin (kappa and lambda) light chains in a biological specimen. | Immunoglobulin Light Chain Measurement | ||
IMMGLCFR | C156517 | Immunoglobulin Light Chains, Free | A measurement of the total free immunoglobulin (kappa and lambda) light chains in a biological specimen. | Free Immunoglobulin Light Chain Measurement | ||
INCLBOD | C116184 | Inclusion Bodies | A measurement of the inclusion bodies in a biological specimen. | Inclusion Body Measurement | ||
INCLBRBC | C161375 | Erythrocyte Inclusion Bodies | A measurement of the erythrocyte inclusion bodies in a biological specimen. | Erythrocyte Inclusion Bodies Measurement | ||
INDICAN | C82044 | Indican | A measurement of the indican present in a biological specimen. | Indican Measurement | ||
INGAPAB | C81987 | Islet Neogenesis Assoc Protein Antibody | A measurement of the islet neogenesis associated protein antibody in a biological specimen. | Islet Neogenesis Associated Protein Antibody Measurement | ||
INHIBINA | C82020 | Inhibin A | A measurement of the inhibin A in a biological specimen. | Inhibin A Measurement | ||
INHIBINB | C96681 | Inhibin B | A measurement of the inhibin B in a biological specimen. | Inhibin B Measurement | ||
INLCLR | C98748 | Inulin Clearance | A measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute). | Inulin Clearance | ||
INR | C64805 | Prothrombin Intl. Normalized Ratio | A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test. | International Normalized Ratio of Prothrombin Time | ||
INSAAB | C119286 | Insulin Autoantibody | A measurement of the antibody to endogenous insulin in a biological specimen. | Insulin Autoantibody Measurement | ||
INSAB | C119287 | Insulin Antibody | A measurement of the antibody to insulin in a biological specimen. | Insulin Antibody Measurement | ||
INSLNFR | C147377 | Insulin, Free | A measurement of the free insulin in a biological specimen. | Free Insulin Measurement | ||
INSULIN | C74788 | Insulin | A measurement of the insulin in a biological specimen. | Insulin Measurement | ||
INSULINI | C186072 | Insulin, Intact | A measurement of the intact insulin in a biological specimen. | Intact Insulin Measurement | ||
INSULINR | C123458 | Insulin Resistance | A measurement of the insulin resistance (a cell's inability to respond to insulin) in a biological specimen. | Insulin Resistance Measurement | ||
INSULINS | C123459 | Insulin Sensitivity | A measurement of the insulin sensitivity (cells are stimulated by lower than normal insulin levels) in a biological specimen. | Insulin Sensitivity Measurement | ||
INTLK1 | C74805 | Interleukin 1 | A measurement of the interleukin 1 in a biological specimen. | Interleukin 1 Measurement | ||
INTLK10 | C74806 | Interleukin 10 | A measurement of the interleukin 10 in a biological specimen. | Interleukin 10 Measurement | ||
INTLK11 | C74807 | Interleukin 11 | A measurement of the interleukin 11 in a biological specimen. | Interleukin 11 Measurement | ||
INTLK12 | C74808 | Interleukin 12;Interleukin 12 p70 | A measurement of the interleukin 12 in a biological specimen. | Interleukin 12 Measurement | ||
INTLK12B | C127623 | Interleukin 12 Beta;Interleukin 12 Beta Subunit;Interleukin 12 p40;Interleukin 12 p40 Subunit | A measurement of p40 subunit of Interleukin 12 in a biological specimen. | Interleukin 12 Beta Measurement | ||
INTLK13 | C74809 | Interleukin 13 | A measurement of the interleukin 13 in a biological specimen. | Interleukin 13 Measurement | ||
INTLK14 | C74810 | Interleukin 14 | A measurement of the interleukin 14 in a biological specimen. | Interleukin 14 Measurement | ||
INTLK15 | C74811 | Interleukin 15 | A measurement of the interleukin 15 in a biological specimen. | Interleukin 15 Measurement | ||
INTLK16 | C74812 | Interleukin 16 | A measurement of the interleukin 16 in a biological specimen. | Interleukin 16 Measurement | ||
INTLK17 | C74813 | IL-17A;Interleukin 17;Interleukin 17A | A measurement of the interleukin 17 in a biological specimen. | Interleukin 17 Measurement | ||
INTLK18 | C74814 | Interleukin 18 | A measurement of the interleukin 18 in a biological specimen. | Interleukin 18 Measurement | ||
INTLK19 | C74815 | Interleukin 19 | A measurement of the interleukin 19 in a biological specimen. | Interleukin 19 Measurement | ||
INTLK1A | C122131 | Interleukin 1 Alpha | A measurement of interleukin 1 alpha in a biological specimen. | Interleukin 1 Alpha Measurement | ||
INTLK1B | C112323 | IL-1B;IL1Beta;Interleukin 1 Beta;Interleukin 1B | A measurement of interleukin 1 beta in a biological specimen. | Interleukin 1 Beta Measurement | ||
INTLK1RA | C112324 | IL-1RA;Interleukin 1 Receptor Antagonist | A measurement of the interleukin 1 receptor antagonist in a biological specimen. | Interleukin 1 Receptor Antagonist Measurement | ||
INTLK2 | C74816 | Interleukin 2 | A measurement of the interleukin 2 in a biological specimen. | Interleukin 2 Measurement | ||
INTLK20 | C74817 | Interleukin 20 | A measurement of the interleukin 20 in a biological specimen. | Interleukin 20 Measurement | ||
INTLK21 | C74818 | Interleukin 21 | A measurement of the interleukin 21 in a biological specimen. | Interleukin 21 Measurement | ||
INTLK22 | C74819 | Interleukin 22 | A measurement of the interleukin 22 in a biological specimen. | Interleukin 22 Measurement | ||
INTLK23 | C74820 | Interleukin 23;Interleukin 23 p59 | A measurement of the interleukin 23 in a biological specimen. | Interleukin 23 Measurement | ||
INTLK24 | C74821 | Interleukin 24 | A measurement of the interleukin 24 in a biological specimen. | Interleukin 24 Measurement | ||
INTLK25 | C74822 | Interleukin 25 | A measurement of the interleukin 25 in a biological specimen. | Interleukin 25 Measurement | ||
INTLK26 | C74823 | Interleukin 26 | A measurement of the interleukin 26 in a biological specimen. | Interleukin 26 Measurement | ||
INTLK27 | C74824 | Interleukin 27 | A measurement of the interleukin 27 in a biological specimen. | Interleukin 27 Measurement | ||
INTLK28 | C74825 | Interleukin 28 | A measurement of the interleukin 28 in a biological specimen. | Interleukin 28 Measurement | ||
INTLK29 | C74826 | Interleukin 29 | A measurement of the interleukin 29 in a biological specimen. | Interleukin 29 Measurement | ||
INTLK3 | C74827 | Interleukin 3 | A measurement of the interleukin 3 in a biological specimen. | Interleukin 3 Measurement | ||
INTLK30 | C74828 | Interleukin 30 | A measurement of the interleukin 30 in a biological specimen. | Interleukin 30 Measurement | ||
INTLK31 | C74829 | Interleukin 31 | A measurement of the interleukin 31 in a biological specimen. | Interleukin 31 Measurement | ||
INTLK32 | C74830 | Interleukin 32 | A measurement of the interleukin 32 in a biological specimen. | Interleukin 32 Measurement | ||
INTLK33 | C74831 | Interleukin 33 | A measurement of the interleukin 33 in a biological specimen. | Interleukin 33 Measurement | ||
INTLK4 | C74832 | Interleukin 4 | A measurement of the interleukin 4 in a biological specimen. | Interleukin 4 Measurement | ||
INTLK5 | C74833 | Interleukin 5 | A measurement of the interleukin 5 in a biological specimen. | Interleukin 5 Measurement | ||
INTLK6 | C74834 | Interleukin 6 | A measurement of the interleukin 6 in a biological specimen. | Interleukin 6 Measurement | ||
INTLK7 | C74835 | Interleukin 7 | A measurement of the interleukin 7 in a biological specimen. | Interleukin 7 Measurement | ||
INTLK8 | C74836 | Interleukin 8 | A measurement of the interleukin 8 in a biological specimen. | Interleukin 8 Measurement | ||
INTLK9 | C74837 | Interleukin 9 | A measurement of the interleukin 9 in a biological specimen. | Interleukin 9 Measurement | ||
INULIN | C125945 | Inulin | A measurement of the inulin in a biological specimen. | Inulin Measurement | ||
IODINE | C181193 | Iodine | A measurement of the total iodine in a biological specimen. | Iodine Measurement | ||
IODINEFR | C181445 | Iodine, Free | A measurement of the free (unbound) iodine in a biological specimen. | Free Iodine Measurement | ||
IOHEXCLR | C100439 | Iohexol Clearance | A measurement of the volume of serum or plasma that would be cleared of Iohexol by excretion of urine for a specified unit of time (e.g. one minute). | Iohexol Clearance | ||
IOHEXOL | C125946 | Iohexol | A measurement of iohexol in a biological specimen. | Iohexol Measurement | ||
IOTCLR | C98749 | Iothalamate Clearance | A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute). | Iothalamate Clearance | ||
IOTCLRBS | C98750 | Iothalamate Clearance Adjusted for BSA | A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body surface area. | Iothalamate Clearance Adjusted for BSA | ||
IRF | C102276 | Immature Reticulocyte Fraction | A measurement of the immature reticulocyte fraction present in a biological specimen. | Immature Reticulocyte Fraction Measurement | ||
IRON | C74679 | FE;Iron | A measurement of the iron in a biological specimen. | Iron Measurement | ||
IRONEXR | C150819 | Iron Excretion Rate | A measurement of the amount of iron being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Iron Excretion Rate | ||
ISG15 | C163461 | ISG15 Ubiquitin-Like Modifier;Ubiquitin-Like Protein ISG15 | A measurement of the ubiquitin-like protein ISG15 in a biological specimen. | Ubiquitin-Like Protein ISG15 Measurement | ||
ISOPRF2 | C80180 | F2-Isoprostane | A measurement of the F2-isoprostane in a biological specimen. | F2 Isoprostane Measurement | ||
JO1AB | C100459 | Jo-1 Antibody | A measurement of the Jo-1 antibody in a biological specimen. | Jo-1 Antibody Measurement | ||
JWH018 | C184542 | JWH-018;JWH018 | A measurement of the synthetic cannabinoid JWH-018 in a biological specimen. | JWH-018 Measurement | ||
JWH073 | C184543 | JWH-073;JWH073 | A measurement of the synthetic cannabinoid JWH-073 in a biological specimen. | JWH-073 Measurement | ||
JWH081 | C184546 | JWH-081;JWH081 | A measurement of the synthetic cannabinoid JWH-081 in a biological specimen. | JWH-081 Measurement | ||
JWH122 | C184547 | JWH-122;JWH122 | A measurement of the synthetic cannabinoid JWH-122 in a biological specimen. | JWH-122 Measurement | ||
JWH200 | C184544 | JWH-200;JWH200 | A measurement of the synthetic cannabinoid JWH-200 in a biological specimen. | JWH-200 Measurement | ||
JWH250 | C184545 | JWH-250;JWH250 | A measurement of the synthetic cannabinoid JWH-250 in a biological specimen. | JWH-250 Measurement | ||
JWH398 | C184548 | JWH-398;JWH398 | A measurement of the synthetic cannabinoid JWH-398 in a biological specimen. | JWH-398 Measurement | ||
K | C64853 | Potassium | A measurement of the potassium in a biological specimen. | Potassium Measurement | ||
KAPPALC | C147379 | Kappa Light Chain | A measurement of the total kappa light chains in a biological specimen. | Kappa Light Chain Measurement | ||
KBEMIDON | C184549 | Ketobemidone | A measurement of the ketobemidone in a biological specimen. | Ketobemidone Measurement | ||
KCLR | C106560 | Potassium Clearance | A measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute). | Potassium Clearance Measurement | ||
KCREAT | C79462 | Potassium/Creatinine | A relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen. | Potassium to Creatinine Ratio Measurement | ||
KERAT | C147380 | Keratocyte | A measurement of the keratocytes in a biological specimen. | Keratocyte Count | ||
KETAMINE | C184587 | Ketamine | A measurement of the ketamine in a biological specimen. | Ketamine Measurement | ||
KETONEBD | C111239 | Ketone Bodies | A measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen. | Ketone Body Measurement | ||
KETONES | C64854 | Ketones | A measurement of the ketones in a biological specimen. | Ketone Measurement | ||
KEXR | C150820 | Potassium Excretion Rate | A measurement of the amount of potassium being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Potassium Excretion Rate | ||
KI67 | C123557 | Ki-67;KI67;MKI67;pKi-67 | A measurement of the Ki-67 protein in a biological specimen. | Ki67 Measurement | ||
KIM1 | C100433 | Hepatitis A Virus Cellular Receptor 1;Kidney Injury Molecule-1;KIM-1 | A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen. | Kidney Injury Molecule-1 Measurement | ||
KIM1CRT | C177955 | Kidney Injury Molecule-1/Creatinine | A relative measurement (ratio or percentage) of the kidney injury molecule-1 to creatinine in a biological specimen. | Kidney Injury Molecule-1/Creatinine Ratio Measurement | ||
KIM1EXR | C163462 | Kidney Injury Molecule-1 Excretion Rate | A measurement of the amount of kidney injury molecule-1 being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Kidney Injury Molecule-1 Excretion Rate | ||
KIM1S | C165971 | Soluble Hepatitis A Virus Cellular Receptor 1;Soluble Kidney Injury Molecule-1;Soluble KIM-1 | A measurement of the soluble kidney injury molecule-1 in a biological specimen. | Soluble Kidney Injury Molecule-1 Measurement | ||
KL6 | C154724 | KL-6;Krebs von den Lungen-6 Antigen | A measurement of the Krebs von den Lungen-6 in a biological specimen. | Krebs von den Lungen-6 Measurement | ||
KLCFR | C98730 | Bence-Jones, Kappa;Kappa Light Chain, Free | A measurement of the free kappa light chain in a biological specimen. | Free Kappa Light Chain Measurement | ||
KLCLLC | C161351 | Kappa Lambda Ratio;Kappa Light Chain/Lambda Light Chain | A relative measurement (ratio) of the total kappa light chain to total lambda light chain in a biological specimen. | Kappa Light Chain to Lambda Light Chain Ratio Measurement | ||
KLCLLCFR | C98731 | Kappa Lt Chain,Free/Lambda Lt Chain,Free | A relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen. | Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement | ||
KLHIGGAB | C132372 | Keyhole Limpet Hemocyanin IgG Antibody | A measurement of the keyhole limpet hemocyanin IgG antibody in a biological specimen. | Keyhole Limpet Hemocyanin IgG Antibody Measurement | ||
KLHIGMAB | C132373 | Keyhole Limpet Hemocyanin IgM Antibody | A measurement of the keyhole limpet hemocyanin IgM antibody in a biological specimen. | Keyhole Limpet Hemocyanin IgM Antibody Measurement | ||
KLK2 | C132374 | Kallikrein-2 | A measurement of the kallikrein-2 in a biological specimen. | Kallikrein-2 Measurement | ||
KLOTHO | C127624 | Klotho | A measurement of the total klotho protein in a biological specimen. | Klotho Protein Measurement | ||
KRCYMG | C96688 | Megakaryocytes | A measurement of the megakaryocytes per unit of a biological specimen. | Megakaryocyte Count | ||
KRCYMGCE | C98867 | Megakaryocytes/Total Cells | A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryocyte to Total Cell Ratio Measurement | ||
KRCYMGLE | C154722 | Megakaryocytes/Leukocytes | A relative measurement (ratio or percentage) of the megakaryocytes to leukocytes in a biological specimen. | Megakaryocytes to Leukocytes Ratio Measurement | ||
KTANST11 | C186073 | 11-Ketoandrosterone | A measurement of the 11-ketoandrosterone in a biological specimen. | 11-Ketoandrosterone Measurement | ||
KTBDEXR | C189519 | Ketone Bodies Excretion Rate | A measurement of the amount of ketone bodies being excreted in a biological specimen over a defined period of time (e.g. one hour). | Ketone Bodies Excretion Rate Measurement | ||
KTETCL11 | C186074 | 11-Ketoetiocholanolone | A measurement of the 11-ketoetiocholanolone in a biological specimen. | 11-Ketoetiocholanolone Measurement | ||
KTGSTR17 | C186075 | 17-Ketogenic steroids | A measurement of the total 17-ketogenic steroids in a biological specimen. | 17-Ketogenic Steroid Measurement | ||
KTSTR17 | C186076 | 17-Ketosteroids | A measurement of the total 17-ketosteroids in a biological specimen. | 17-Ketosteroid Measurement | ||
KURLOFCE | C96682 | Kurloff Cells | A measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family. | Kurloff Cells Measurement | ||
KYNURNN | C154740 | Kynurenine | A measurement of the kynurenine in a biological specimen. | Kynurenine Measurement | ||
LACOSMD | C184641 | Lacosamide | A measurement of the lacosamide in a biological specimen. | Lacosamide Measurement | ||
LACTICAC | C79450 | 2-hydroxypropanoic acid;Lactate;Lactic Acid | A measurement of the lactic acid in a biological specimen. | Lactic Acid Measurement | ||
LACTOSE | C186077 | Lactose | A measurement of the lactose in a biological specimen. | Lactose Measurement | ||
LACTULOS | C154741 | Lactulose | A measurement of the lactulose in a biological specimen. | Lactulose Measurement | ||
LAG3S | C172504 | Soluble CD223 Antigen;Soluble LAG-3;Soluble Lymphocyte Activation Gene 3 Protein;Soluble Lymphocyte Activation Gene-3 | A measurement of the soluble lymphocyte activation gene-3 protein in a biological specimen. | Soluble Lymphocyte Activation Gene-3 Measurement | ||
LAM | C125947 | Lipoarabinomannan | A measurement of the lipoarabinomannan in a biological specimen. | Lipoarabinomannan Measurement | ||
LAMP2 | C191288 | CD107b;Lysosomal Associated Membrane Protein 2;Lysosomal Membrane Associated Protein 2;Lysosome-Associated Membrane Protein 2 | A measurement of the lysosomal associated membrane protein 2 present in a biological specimen. | Lysosome-Associated Membrane Protein 2 Measurement | ||
LAP | C122132 | Cytosol Aminopeptidase;LAP3;Leucine Aminopeptidase;Leucine Aminopeptidase 3;Leucyl Aminopeptidase | A measurement of the total leucine aminopeptidase present in a biological specimen. | Leucine Aminopeptidase Measurement | ||
LAPOB | C189508 | LDL Apolipoprotein B | A measurement of the apolipoprotein B in the low density lipoprotein fraction of a biological specimen. | LDL Fraction Apoliprotein B Measurement | ||
LCHLCM | C176240 | Lithocholate Compounds;Lithocholic Acid Compounds | A measurement of the lithocholic acid, glycolithocholic acid, and taurolithocholic acid in a biological specimen. | Lithocholate Compounds Measurement | ||
LCHT | C176307 | Lithocholate;Lithocholic Acid | A measurement of the lithocholate in a biological specimen. | Lithocholate Measurement | ||
LCN2 | C106539 | Lipocalin-2;Neutrophil Gelatinase-Associated Lipocalin;NGAL;Oncogene 24p3 | A measurement of lipocalin-2 in a biological specimen. | Lipocalin-2 Measurement | ||
LCN2CREA | C106540 | Lipocalin-2/Creatinine;Neutrophil Gelatinase-Associated Lipocalin/Creatinine;NGAL/Creatinine | A relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample. | Lipocalin-2 to Creatinine Ratio Measurement | ||
LCTHSPGM | C147381 | Lecithin/Sphingomyelin;LS Ratio | A relative measurement (ratio) of the lecithin to sphingomyelin in a biological specimen. | Lecithin to Sphingomyelin Ratio Measurement | ||
LDH | C64855 | Lactate Dehydrogenase | A measurement of the lactate dehydrogenase in a biological specimen. | Lactate Dehydrogenase Measurement | ||
LDH1 | C74887 | LDH Isoenzyme 1 | A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 1 Measurement | ||
LDH1LDH | C79451 | LDH Isoenzyme 1/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 1 to LDH Ratio Measurement | ||
LDH2 | C74888 | LDH Isoenzyme 2 | A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 2 Measurement | ||
LDH2LDH | C79452 | LDH Isoenzyme 2/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 2 to LDH Ratio Measurement | ||
LDH3 | C74889 | LDH Isoenzyme 3 | A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 3 Measurement | ||
LDH3LDH | C79453 | LDH Isoenzyme 3/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 3 to LDH Ratio Measurement | ||
LDH4 | C74890 | LDH Isoenzyme 4 | A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 4 Measurement | ||
LDH4LDH | C79454 | LDH Isoenzyme 4/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 4 to LDH Ratio Measurement | ||
LDH5 | C74891 | LDH Isoenzyme 5 | A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 5 Measurement | ||
LDH5LDH | C79455 | LDH Isoenzyme 5/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 5 to LDH Ratio Measurement | ||
LDHCREAT | C79449 | Lactate Dehydrogenase/Creatinine | A relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen. | Lactate Dehydrogenase to Creatinine Ratio Measurement | ||
LDHEXR | C165972 | Lactate Dehydrogenase Excretion Rate | A measurement of the amount of lactate dehydrogenase being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Lactate Dehydrogenase Excretion Rate | ||
LDL | C105588 | LDL Cholesterol | A measurement of the low density lipoprotein cholesterol in a biological specimen. | Low Density Lipoprotein Cholesterol Measurement | ||
LDLHDL | C121182 | LDL Cholesterol/HDL Cholesterol | A relative measurement (ratio) of the low density lipoprotein cholesterol to high density lipoprotein cholesterol in a biological specimen. | LDL Cholesterol to HDL Cholesterol Ratio Measurement | ||
LDLOXAB | C119288 | Oxidized LDL Cholesterol Antibody | A measurement of the total oxidized low density lipoprotein cholesterol antibody in a biological specimen. | Oxidized LDL Cholesterol Antibody Measurement | ||
LDLOXI | C120635 | Oxidized LDL Cholesterol | A measurement of the oxidized low density lipoprotein cholesterol in a biological specimen. | Oxidized LDL Cholesterol Measurement | ||
LDLP | C120636 | LDL Particles | A measurement of the concentration of the total LDL particles in a biological specimen. | LDL Particles Measurement | ||
LDLPATT | C120637 | LDL Subtype Pattern | A description of the low density lipoprotein particle pattern (an interpretation of the amounts of LDL particles based on size and density) in a biological specimen. | LDL Subtype Pattern | ||
LDLPSZ | C103412 | LDL Particle Size | A measurement of the average particle size of low-density lipoprotein in a biological specimen. | LDL Particle Size Measurement | ||
LDLT | C189506 | LDL Triglyceride | A measurement of the low density lipoprotein triglyceride in a biological specimen. | LDL Triglyceride Measurement | ||
LEAD | C147382 | Lead;Pb | A measurement of the lead in a biological specimen. | Lead Measurement | ||
LEIM | C127625 | Immature Leukocytes | A measurement of the immature leukocytes in a biological specimen. | Immature Leukocyte Count | ||
LEIMLE | C127626 | Immature Leukocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature leukocytes to leukocytes in a biological specimen. | Immature Leukocyte to Leukocytes Ratio Measurement | ||
LEPTIN | C74866 | Leptin | A measurement of the leptin hormone in a biological specimen. | Leptin Measurement | ||
LEPTO | C174293 | Leptocytes | A measurement of the leptocytes in a biological specimen. | Leptocyte Measurement | ||
LEU | C122133 | Leucine | A measurement of the leucine in a biological specimen. | Leucine Measurement | ||
LEUKASE | C64856 | Leukocyte Esterase | A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen. | Leukocyte Esterase Measurement | ||
LEUKCE | C116195 | Leukemic Cells;Residual Leukemic Cells | A measurement of the leukemic cells in a biological specimen. | Leukemic Cells Measurement | ||
LEUKCRBC | C147383 | Leukocytes Corrected for Nucleated Erythrocytes;Leuks Corrected for Nucl Erythrocytes | A measurement of the leukocytes corrected for nucleated erythrocytes in a biological specimen. | Leukocytes Corrected for Nucleated Erythrocytes Count | ||
LGLUCLE | C79467 | Large Unstained Cells/Leukocytes | A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen. | Large Unstained Cells to Leukocytes Ratio Measurement | ||
LGUNSCE | C74659 | Large Unstained Cells | A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen. | Large Unstained Cell Count | ||
LH | C74790 | Luteinizing Hormone;Lutropin | A measurement of the luteinizing hormone in a biological specimen. | Luteinizing Hormone Measurement | ||
LIF | C130163 | Leukemia Inhibitory Factor | A measurement of leukemia inhibitory factor in a biological specimen. | Leukemia Inhibitory Factor Measurement | ||
LIPASEG | C117840 | Gastric Triacylglycerol Lipase;Lipase, Gastric;LIPF | A measurement of the gastric triacylglycerol lipase in a biological specimen. | Gastric Lipase Measurement | ||
LIPASEH | C187808 | Hepatic Triacylglycerol Lipase;Lipase, Hepatic;LIPH | A measurement of the hepatic triacylglycerol lipase in a biological specimen. | Hepatic Triacylglycerol Lipase Measurement | ||
LIPASEP | C117841 | Lipase, Pancreatic;Pancreatic Triacylglycerol Lipase;PNLIP | A measurement of the pancreatic triacylglycerol lipase in a biological specimen. | Pancreatic Lipase Measurement | ||
LIPASET | C117748 | Lipase;Total Lipase;Triacylglycerol Lipase | A measurement of the total triacylglycerol lipase in a biological specimen. | Lipase Measurement | ||
LIPASLAL | C117842 | Acid Cholesteryl Ester Hydrolase;LAL;LIPA;Lipase, Lysosomal Acid;Lysosomal Lipase | A measurement of the lysosomal acid lipase in a biological specimen. | Lysosomal Acid Lipase Measurement | ||
LIPEMIAI | C111242 | Lipemia;Lipemic Index | A measurement of the abnormally high concentration of lipid in a biological specimen. | Lipemic Index | ||
LIPID | C74949 | Lipid;Total Lipid | A measurement of the total lipids (cholesterol, lipoproteins, and triglycerides) in a biological specimen. | Lipid Measurement | ||
LIQUFT | C142284 | Liquefaction Time | A measurement of the time it takes for a gelatinous or semi-solid substance to change to a liquid. | Liquefaction Time Measurement | ||
LITHIUM | C189505 | Lithium | A measurement of the lithium in a biological specimen. | Lithium Measurement | ||
LKM1AB | C96683 | Liver Kidney Microsomal Type 1 Antibody;LKM-1 | A measurement of the liver kidney microsomal type 1 antibody in a biological specimen. | Liver Kidney Microsomal Type 1 Antibody Measurement | ||
LKM1IAAB | C100456 | Liver Kidney Microsomal Type 1 IgA Ab | A measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgA Antibody Measurement | ||
LKM1IGAB | C100454 | Liver Kidney Microsomal Type 1 IgG Ab | A measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgG Antibody Measurement | ||
LKM1IMAB | C100455 | Liver Kidney Microsomal Type 1 IgM Ab | A measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgM Antibody Measurement | ||
LLCFR | C98732 | Bence-Jones, Lambda;Lambda Light Chain, Free | A measurement of the free lambda light chain in a biological specimen. | Free Lambda Light Chain Measurement | ||
LMBDLC | C147384 | Lambda Light Chain | A measurement of the total lambda light chains in a biological specimen. | Lambda Light Chain Measurement | ||
LMP2GPDH | C191289 | LAMP2/GAPDH;Lysosomal Associated Membrane Protein 2/Glyceraldehyde-3-Phosphate Dehydrogenase | A relative measurement (ratio) of the lysosomal associated membrane protein 2 to glyceraldehyde-3-phosphate dehydrogenase in a biological specimen. | Lysosomal Associated Membrane Protein 2 to Glyceraldehyde-3-Phosphate Dehydrogenase Ratio Measurement | ||
LOPRAZLM | C184621 | Loprazolam | A measurement of the loprazolam in a biological specimen. | Loprazolam Measurement | ||
LOX1 | C198285 | Lectin-Like Oxidized LDL Receptor-1;LOX-1 | A measurement of the lectin-like oxidized LDL Receptor-1 in a biological specimen. | Lectin-Like Oxidized LDL Receptor-1 Measurement | ||
LOXAPN | C177977 | Loxapine | A measurement of the loxapine in a biological specimen. | Loxapine Measurement | ||
LPA | C82022 | Lipoprotein-a | A measurement of the lipoprotein-a in a biological specimen. | Lipoprotein a Measurement | ||
LPL | C174291 | Lipoprotein Lipase | A measurement of the lipoprotein lipase in a biological specimen. | Lipoprotein Lipase Measurement | ||
LPPLA2 | C120638 | Lipoprotein Associated Phospholipase A2 | A measurement of the lipoprotein associated phospholipase A2 in a biological specimen. | Lipoprotein Associated Phospholipase A2 Measurement | ||
LRG1 | C165973 | HMFT1766;Leucine Rich Alpha-2-Glycoprotein 1 | A measurement of the leucine rich alpha-2-glycoprotein 1 in a biological specimen. | Leucine Rich Alpha-2-Glycoprotein 1 Measurement | ||
LRMZPM | C184622 | Lormetazepam | A measurement of the lormetazepam in a biological specimen. | Lormetazepam Measurement | ||
LRZPM | C75374 | Lorazepam | A measurement of the lorazepam present in a biological specimen. | Lorazepam Measurement | ||
LSD | C75354 | Acid;Lysergate Diethylamide;Lysergic Acid Diethylamide | A measurement of the lysergic acid diethylamine (LSD) in a biological specimen. | Lysergide Measurement | ||
LSELS | C172495 | sL-Selectin;Soluble CD62L;Soluble L-Selectin | A measurement of the soluble L-selectin in a biological specimen. | Soluble L-Selectin Measurement | ||
LTA | C132375 | Lymphotoxin Alpha;TNF-beta;Tumor Necrosis Factor Beta | A measurement of the lymphotoxin alpha in a biological specimen. | Lymphotoxin Alpha Measurement | ||
LTB4 | C103413 | Leukotriene B4 | A measurement of the leukotriene B4 in a biological specimen. | Leukotriene B4 Measurement | ||
LTC4SN | C189516 | Leukotriene C4 Synthase | A measurement of the leukotriene C4 synthase in a biological specimen. | Leukotriene C4 Synthase Measurement | ||
LTD4 | C103414 | Leukotriene D4 | A measurement of the leukotriene D4 in a biological specimen. | Leukotriene D4 Measurement | ||
LTE4 | C103415 | Leukotriene E4 | A measurement of the leukotriene E4 in a biological specimen. | Leukotriene E4 Measurement | ||
LTF | C82021 | Lactoferrin;Lactotransferrin | A measurement of the lactoferrin in a biological specimen. | Lactoferrin Measurement | ||
LTFAB | C120639 | Lactoferrin Antibody | A measurement of the lactoferrin antibody in a biological specimen. | Lactoferrin Antibody Measurement | ||
LURASIDN | C177963 | Lurasidone | A measurement of the lurasidone in a biological specimen. | Lurasidone Measurement | ||
LVFBRSC | C147385 | Liver Fibrosis Score | A scoring system that evaluates liver pathology through the assessment of multiple blood test parameters, taking into account additional demographic factors such as the age and/or gender of the subject. | Liver Fibrosis Score | ||
LVRPHNL | C184572 | Levorphanol | A measurement of the levorphanol in a biological specimen. | Levorphanol Measurement | ||
LVTRCTM | C147386 | Levetiracetam | A measurement of the levetiracetam in a biological specimen. | Levetiracetam Measurement | ||
LY6E | C163463 | Lymphocyte Antigen 6 Family Member E;Lymphocyte Antigen 6E | A measurement of the lymphocyte antigen 6E in a biological specimen. | Lymphocyte Antigen 6E Measurement | ||
LYM | C51949 | Lymphocytes | A measurement of the lymphocytes in a biological specimen. | Lymphocyte Count | ||
LYMA | C119289 | Lymphocytes Activated | A measurement of the total activated lymphocytes in a biological specimen. | Activated Lymphocytes Measurement | ||
LYMAT | C64818 | Lymphocytes Atypical;Lymphocytes, Variant;Reactive Lymphocytes | A measurement of the atypical lymphocytes in a biological specimen. | Atypical Lymphocyte Count | ||
LYMATLE | C64819 | Lymphocytes Atypical/Leukocytes;Lymphocytes, Variant/Leukocytes;Reactive Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen. | Atypical Lymphocyte to Leukocyte Ratio Measurement | ||
LYMATLY | C74654 | Atypical Lymphocytes/Lymphocytes;Lymphocytes Atypical/Lymphocytes;Reactive Lymphocytes/Lymphocytes;Variant Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the atypical lymphocytes to all lymphocytes in a biological specimen. | Reactive Lymphocyte to Lymphocyte Ratio Measurement | ||
LYMCE | C98751 | Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). | Lymphocyte to Total Cell Ratio Measurement | ||
LYMCLF | C147387 | Lymphocytes, Clefted | A measurement of the clefted lymphocytes in a biological specimen. | Clefted Lymphocytes Count | ||
LYMCLFLE | C147388 | Lymphocytes, Clefted/Leukocytes | A relative measurement (ratio or percentage) of the clefted lymphocytes to total leukocytes in a biological specimen. | Clefted Lymphocytes to Leukocytes Ratio Measurement | ||
LYMIM | C100444 | Immature Lymphocytes | A measurement of the immature lymphocytes in a biological specimen. | Immature Lymphocytes Measurement | ||
LYMIMLE | C100443 | Immature Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen. | Immature Lymphocytes to Leukocytes Ratio Measurement | ||
LYMLE | C64820 | Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. | Lymphocyte to Leukocyte Ratio | ||
LYMLG | C158236 | Large Lymphocytes | A measurement of the large lymphocytes (approximately between 10 um and 20 um in diameter) in a biological specimen. | Large Lymphocyte Count | ||
LYMMCE | C74613 | Lymphoma Cells | A measurement of the malignant lymphocytes in a biological specimen. | Lymphoma Cell Count | ||
LYMMCECE | C186078 | Lymphoma Cells/Total Cells | A relative measurement (ratio or percentage) of the lymphoma cells to total cells in a biological specimen. | Lymphoma Cell to Total Cell Ratio Measurement | ||
LYMMCELE | C147389 | Lymphoma Cells/Leukocytes | A relative measurement (ratio or percentage) of the malignant lymphocytes to all leukocytes in a biological specimen. | Lymphoma Cells to Leukocytes Ratio Measurement | ||
LYMMCELY | C74910 | Lymphoma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen. | Lymphoma Cell to Lymphocyte Ratio Measurement | ||
LYMNE | C186079 | Lymphocytes/Neutrophils | A relative measurement (ratio) of lymphocytes to neutrophils in a biological specimen. | Lymphocyte to Neutrophil Ratio Measurement | ||
LYMNSQE | C135430 | Lymphocytes/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the lymphocytes to non-squamous epithelial cells in a biological specimen. | Lymphocytes to Non-Squamous Epithelial Cells Ratio Measurement | ||
LYMPHOID | C139064 | Lymphoid Cells | A measurement of the total lymphoid lineage cells in a biological specimen. | Lymphoid Cell Count | ||
LYMPHOTC | C81955 | Chemokine Ligand 1;Lymphotactin | A measurement of the lymphotactin in a biological specimen. | Lymphotactin Measurement | ||
LYMPL | C74618 | Plasmacytoid Lymphocytes;Plymphocytes | A measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen. | Plasmacytoid Lymphocyte Count | ||
LYMPLLE | C158229 | Plasmacytoid Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes to all leukocytes in a biological specimen. | Plasmacytoid Lymphocytes to Leukocytes Ratio Measurement | ||
LYMPLLY | C74648 | Plasmacytoid Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen. | Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement | ||
LYMVAC | C111329 | Vacuolated Lymphocytes | A measurement of the vacuolated lymphocytes in a biological specimen. | Vacuolated Lymphocyte Count | ||
LYMVACLE | C127627 | Vacuolated Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the vacuolated lymphocytes to leukocytes in a biological specimen. | Vacuolated Lymphocyte to Leukocyte Ratio Measurement | ||
LYS | C122134 | Lysine | A measurement of the lysine in a biological specimen. | Lysine Measurement | ||
LYSOGL1 | C184523 | Glucopsychosine;Glucosylsphingosine;Lyso-GL1 | A measurement of the glucopsychosine in a biological specimen. | Glucopsychosine Measurement | ||
LYSOZYME | C120640 | Lysozyme | A measurement of lysozyme in a biological specimen. | Lysozyme Measurement | ||
MABCHMCA | C184550 | MAB-CHMINACA | A measurement of the synthetic cannabinoid MAB-CHMINACA in a biological specimen. | MAB-CHMINACA Measurement | ||
MACROBLD | C147390 | Macroscopic Blood;Visible Blood | A measurement of the blood in body products such as a urine or stool sample, and visibly detectable on gross examination. | Macroscopic Blood Measurement | ||
MACROCY | C64821 | Macrocytes | A measurement of the macrocytes in a biological specimen. | Macrocyte Count | ||
MANNITOL | C154742 | Mannitol | A measurement of the mannitol in a biological specimen. | Mannitol Measurement | ||
MASTCE | C111246 | Mast Cells;Mastocytes | A measurement of the mast cells in a biological specimen. | Mast Cell Count | ||
MASTCECE | C111247 | Mast Cells/Total Cells | A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. | Mast Cell to Total Cell Ratio Measurement | ||
MASTCELE | C187812 | Mast Cells/Leukocytes | A relative measurement (ratio or percentage) of mast cells to total leukocytes in a biological specimen. | Mast Cells to Leukocytes Ratio Measurement | ||
MAYHEG | C74614 | May-Hegglin Anomaly | A measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes. | May-Hegglin Anomaly Measurement | ||
MAZINDOL | C184623 | Mazindol | A measurement of the mazindol in a biological specimen. | Mazindol Measurement | ||
MBP | C122135 | Myelin Basic Protein | A measurement of the myelin basic protein in a biological specimen. | Myelin Basic Protein Measurement | ||
MCA2 | C177957 | 2-Methylcitrate;2-Methylcitric Acid;MCA;Methylcitrate;Methylcitric Acid | A measurement of the 2-methylcitrate in a biological specimen. | 2-Methylcitrate Measurement | ||
MCATHNON | C184552 | Ephedrone;Methcathinone | A measurement of the methcathinone in a biological specimen. | Methcathinone Measurement | ||
MCH | C64797 | Ery. Mean Corpuscular Hemoglobin | A measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen, calculated as the product of hemoglobin times ten, divided by the number of erythrocytes. | Erythrocyte Mean Corpuscular Hemoglobin | ||
MCHC | C64798 | Ery. Mean Corpuscular HGB Concentration | An indirect measurement of the average concentration of hemoglobin per erythrocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit. | Erythrocyte Mean Corpuscular Hemoglobin Concentration | ||
MCP1 | C82025 | CCL2;Chemokine (C-C Motif) Ligand 2;Monocyte Chemotactic Protein 1 | A measurement of the monocyte chemotactic protein 1 in a biological specimen. | Monocyte Chemotactic Protein 1 Measurement | ||
MCPHG | C74798 | Macrophages | A measurement of the macrophages in a biological specimen. | Macrophage Count | ||
MCPHGCE | C111244 | Macrophages/Total Cells | A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. | Macrophage to Total Cell Ratio Measurement | ||
MCPHGLE | C123460 | Macrophages/Leukocytes | A relative measurement (ratio or percentage) of the macrophages to leukocytes in a biological specimen. | Macrophage to Leukocyte Ratio | ||
MCPHNSQE | C135431 | Macrophages/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the macrophages to non-squamous epithelial cells in a biological specimen. | Macrophages to Non-Squamous Epithelial Cells Ratio Measurement | ||
MCPROT | C92291 | Abnormal Gamma Protein Band;M Protein;M-Spike Paraprotein;M-Spike Protein;Monoclonal Immunoglobulin Protein;Monoclonal Protein;Monoclonal Protein Spike;Myeloma Protein;Paraprotein | A measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen. | Monoclonal Protein Measurement | ||
MCSF | C80191 | Macrophage Colony Stimulating Factor | A measurement of the macrophage colony stimulating factor in a biological specimen. | Macrophage Colony Stimulating Factor Measurement | ||
MCV | C64799 | Ery. Mean Corpuscular Volume;Erythrocytes Mean Corpuscular Volume;RBC Mean Corpuscular Volume | A measurement of the mean cellular volume per erythrocyte in a biological specimen. | Erythrocyte Mean Corpuscular Volume | ||
MCVRETIC | C114215 | MCV Reticulocytes;MCVr;Mean Corpuscular Volume Reticulocytes | A measurement of the mean volume of reticulocytes in a biological specimen. | Reticulocyte Mean Corpuscular Volume | ||
MDA | C174294 | 3,4-methylenedioxyamphetamine | A measurement of the 3,4-methylenedioxyamphetamine in a biological specimen. | 3,4-methylenedioxyamphetamine Measurement | ||
MDALD | C187811 | Malondialdehyde;MDA | A measurement of the malondialdehyde in a biological specimen. | Malondialdehyde Measurement | ||
MDC | C81956 | C-C Motif Chemokine Ligand 22;CCL22;Chemokine (C-C Motif) Ligand 22;Chemokine Ligand 22;Macrophage-Derived Chemokine | A measurement of the macrophage-derived chemokine in a biological specimen. | Macrophage-Derived Chemokine Measurement | ||
MDEA | C174295 | 3,4-methylenedioxy-N-ethylamphetamine;Eve;MDE | A measurement of the 3,4-methylenedioxy-N-ethylamphetamine in a biological specimen. | 3,4-methylenedioxy-N-ethylamphetamine Measurement | ||
MDMA | C75359 | 3,4-methylenedioxymethamphetamine;Ecstasy | A measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen. | 3,4-Methylenedioxymethamphetamine Measurement | ||
MDZLM | C139083 | Midazolam | A measurement of the midazolam present in a biological specimen. | Midazolam Measurement | ||
MDZPM | C139079 | Medazepam | A measurement of the medazepam present in a biological specimen. | Medazepam Measurement | ||
MECONIUM | C147391 | Meconium | A measurement of the meconium in a biological specimen. | Meconium Measurement | ||
MENGL | C111250 | Meningeal Cells | A measurement of the mengingeal cells in a biological specimen. | Meningeal Cell Count | ||
MENGLCE | C111251 | Meningeal Cells/Total Cells | A relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen. | Meningeal Cell to Total Cell Ratio Measurement | ||
MEPRDN | C147392 | Meperidine | A measurement of the meperidine in a biological specimen. | Meperidine Measurement | ||
MERCECE | C127628 | Erythroid Precursors/Total Cells;Maturing Erythroid Cells/Total Cells;Maturing Erythroid/Total Cells;Total Erythroid Precursors/Total Cells | A relative measurement (ratio or percentage) of the maturing erythroid cells to total cells in a biological specimen. | Maturing Erythroid Cell to Total Cell Ratio Measurement | ||
MERCURY | C147393 | Hg;Mercury | A measurement of the mercury in a biological specimen. | Mercury Measurement | ||
MESCALIN | C75355 | 3,4,5-trimethoxyphenethylamine;Mescaline | A measurement of the mescaline in a biological specimen. | Mescaline Measurement | ||
MESORDZN | C177979 | Mesoridazine | A measurement of the mesoridazine in a biological specimen. | Mesoridazine Measurement | ||
MET | C122238 | Methionine | A measurement of the methionine in a biological specimen. | Methionine Measurement | ||
METAMY | C74615 | Metamyelocytes | A measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen. | Metamyelocyte Count | ||
METAMYCE | C98754 | Metamyelocytes/Total Cells | A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). | Metamyelocyte to Total Cell Ratio Measurement | ||
METAMYLE | C74645 | Metamyelocytes/Leukocytes | A relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen. | Metamyelocyte to Leukocyte Ratio Measurement | ||
METANEPH | C116198 | Metadrenaline;Metanephrine | A measurement of the metanephrine in a biological specimen. | Metanephrine Measurement | ||
METANEXR | C163468 | Metanephrine Excretion Rate | A measurement of the amount of metanephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Metanephrine Excretion Rate | ||
METARBCE | C128971 | Metarubricyte/Total Cells | A relative measurement (ratio or percentage) of the metarubricytes to total cells in a biological specimen. | Metarubricyte to Total Cell Ratio Measurement | ||
METARBLE | C165974 | Metarubricytes/Leukocytes | A relative measurement (ratio or percentage) of the metarubricytes to leukocytes in a biological specimen. | Metarubricyte to Leukocyte Ratio Measurement | ||
METARUB | C128972 | Acidophilic Erythroblast;Metarubricyte;Orthochromatophilic Normoblast;Orthochromic Erythroblast;Orthochromic Normoblast | A measurement of the metarubricytes in a biological specimen. | Metarubricyte Count | ||
METASE | C187814 | Methyltransferase | A measurement of the total methyltransferase in a biological specimen. | Methyltransferase Measurement | ||
METHAMPH | C75348 | Methamphetamine | A measurement of the methamphetamine drug present in a biological specimen. | Methamphetamine Measurement | ||
METHANE | C186080 | CH4;Methane | A measurement of the methane in a biological specimen. | Methane Measurement | ||
METHANOL | C147394 | Methanol | A measurement of the methanol in a biological specimen. | Methanol Measurement | ||
METHDN | C74881 | Methadone | A measurement of the methadone present in a biological specimen. | Methadone Measurement | ||
METHPHEN | C170581 | Methylphenidate | A measurement of the methylphenidate in a biological specimen. | Methylphenidate Measurement | ||
METHQLDN | C74882 | Methaqualone | A measurement of the methaqualone present in a biological specimen. | Methaqualone Measurement | ||
MFENRX | C184624 | Mefenorex | A measurement of the mefenorex in a biological specimen. | Mefenorex Measurement | ||
MG | C64840 | Magnesium | A measurement of the magnesium in a biological specimen. | Magnesium Measurement | ||
MGB | C79436 | Myoglobin | A measurement of myoglobin in a biological specimen. | Myoglobin Measurement | ||
MGBCREAT | C106546 | Myoglobin/Creatinine | A relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample. | Myoglobin to Creatinine Ratio Measurement | ||
MGCREAT | C79456 | Magnesium/Creatinine | A relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen. | Magnesium to Creatinine Ratio Measurement | ||
MGION | C175951 | Magnesium, Ionized | A measurement of the ionized magnesium in a biological specimen. | Ionized Magnesium Measurement | ||
MICA | C172502 | MHC Class I Chain Related Protein A | A measurement of the MHC class I chain related protein A in a biological specimen. | MHC Class I Chain Related Protein A Measurement | ||
MICROCY | C64822 | Microcytes | A measurement of the microcytes in a biological specimen. | Microcyte Count | ||
MIDCEF | C116199 | Mid Cell Fraction;Mid Cells | A measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen. | Mid Cell Fraction Measurement | ||
MIP1 | C163464 | Macrophage Inflammatory Protein 1 | A measurement of total macrophage inflammatory protein 1 in a biological specimen. | Macrophage Inflammatory Protein 1 Measurement | ||
MIP1A | C82023 | Chemokine Ligand 3;Macrophage Inflammatory Protein 1 Alpha | A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen. | Macrophage Inflammatory Protein 1 Alpha Measurement | ||
MIP1B | C82024 | Chemokine Ligand 4;Macrophage Inflammatory Protein 1 Beta | A measurement of the macrophage inflammatory protein 1 beta in a biological specimen. | Macrophage Inflammatory Protein 1 Beta Measurement | ||
MIP1G | C130164 | Macrophage Inflammatory Protein 1 Gamma | A measurement of the macrophage inflammatory protein 1 gamma in a biological specimen. | Macrophage Inflammatory Protein 1 Gamma Measurement | ||
MITOM2AB | C147395 | Mitochondrial M2 Antibody | A measurement of the mitochondrial antibodies of M2 specificity in a biological specimen. | Mitochondrial M2 Antibody Measurement | ||
MKCMKBMP | C135432 | Megakaryocyte and Megakaryoblast Morph;Megakaryocyte and Megakaryoblast Morphology | An examination or assessment of the form and structure of megakaryoblasts and megakaryocytes. | Megakaryocyte and Megakaryoblast Morphology Assessment | ||
MLATONIN | C74867 | Melatonin | A measurement of the melatonin hormone in a biological specimen. | Melatonin Measurement | ||
MLIGCE | C74660 | Malignant Cells, NOS | A measurement of the malignant cells of all types in a biological specimen. | Malignant Cell Count | ||
MLIGCEBC | C74643 | Malignant Cells, NOS/Blood Cells | A relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen. | Malignant Cell to Blood Cell Ratio Measurement | ||
MLNCPRN | C187815 | Milnacipran | A measurement of the milnacipran in a biological specimen. | Milnacipran Measurement | ||
MLR | C16790 | Mixed Leukocyte Reaction;Mixed Lymphocyte Reaction | A measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals. | Mixed Lymphocyte Reaction Test | ||
MM2IGAB | C163465 | Mitochondrial M2 IgG Antibody | A measurement of the mitochondrial IgG antibodies of M2 specificity in a biological specimen. | Mitochondrial M2 IgG Antibody Measurement | ||
MMA | C96690 | Methylmalonate;Methylmalonic Acid | A measurement of the methylmalonic acid in a biological specimen. | Methylmalonic Acid Measurement | ||
MMARG | C181407 | Monomethylarginine;Tilarginine | A measurement of the monomethylarginine in a biological specimen. | Monomethylarginine Measurement | ||
MMIF | C163466 | Macrophage Migration Inhibitory Factor;MIF | A measurement of the macrophage migration inhibitory factor in a biological specimen. | Macrophage Migration Inhibitory Factor Measurement | ||
MMP1 | C80192 | Interstitial Collagenase;Matrix Metalloproteinase 1 | A measurement of the matrix metalloproteinase 1 in a biological specimen. | Matrix Metalloproteinase 1 Measurement | ||
MMP2 | C80193 | Gelatinase A;Matrix Metalloproteinase 2 | A measurement of the matrix metalloproteinase 2 in a biological specimen. | Matrix Metalloproteinase 2 Measurement | ||
MMP3 | C80194 | Matrix Metalloproteinase 3;Stromelysin 1 | A measurement of the matrix metalloproteinase 3 in a biological specimen. | Matrix Metalloproteinase 3 Measurement | ||
MMP7 | C80195 | Matrilysin;Matrix Metalloproteinase 7 | A measurement of the matrix metalloproteinase 7 in a biological specimen. | Matrix Metalloproteinase 7 Measurement | ||
MMP8 | C80196 | Matrix Metalloproteinase 8;Neutrophil Collagenase | A measurement of the matrix metalloproteinase 8 in a biological specimen. | Matrix Metalloproteinase 8 Measurement | ||
MMP9 | C80197 | Gelatinase B;Matrix Metalloproteinase 9 | A measurement of the matrix metalloproteinase 9 in a biological specimen. | Matrix Metalloproteinase 9 Measurement | ||
MMYCECE | C127629 | Maturing Myeloid/Total Cells | A relative measurement (ratio or percentage) of the maturing myeloid cells to total cells in a biological specimen. | Maturing Myeloid Cell to Total Cell Ratio Measurement | ||
MNC | C154757 | Mononuclear Cells;Mononucleated Cells | A measurement of the mononuclear cells in a biological specimen. | Mononuclear Cell Count | ||
MNCAT | C187790 | Mononuclear Cells Atypical | A measurement of the atypical mononuclear cells in a biological specimen. | Atypical Mononuclear Cell Count | ||
MNCATLE | C187791 | Mononuclear Cells Atypical/Leukocytes | A relative measurement (ratio or percentage) of the atypical mononuclear cells to leukocytes in a biological specimen. | Atypical Mononuclear Cells to Leukocytes Ratio Measurement | ||
MOCYCE | C111276 | Monocytoid Cells | A measurement of the monocytoid cells in a biological specimen. | Monocytoid Cell Count | ||
MOCYCECE | C111277 | Monocytoid Cells/Total Cells | A relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen. | Monocytoid Cell to Total Cell Ratio Measurement | ||
MOCYCELE | C120641 | Monocytoid Cells/Leukocytes | A relative measurement (ratio or percentage) of the monocytoid cells to leukocytes in a biological specimen. | Monocytoid Cells to Leukocytes Ratio Measurement | ||
MODAFNIL | C184628 | Modafinil | A measurement of the modafinil in a biological specimen. | Modafinil Measurement | ||
MOHXITAL | C184626 | Methohexital | A measurement of the methohexital in a biological specimen. | Methohexital Measurement | ||
MOLINDN | C177981 | Molindone | A measurement of the molindone in a biological specimen. | Molindone Measurement | ||
MONMPHLE | C147396 | Monocytes and Macrophages/Leukocytes | A relative measurement (ratio or percentage) of the monocytes and macrophages to total leukocytes in a biological specimen. | Monocytes and Macrophages to Leukocytes Ratio Measurement | ||
MONO | C64823 | Monocytes | A measurement of the monocytes in a biological specimen. | Monocyte Count | ||
MONOBL | C74631 | Monoblasts | A measurement of the monoblast cells in a biological specimen. | Monoblast Count | ||
MONOBLCE | C187677 | Monoblasts/Total Cells | A relative measurement (ratio or percentage) of the monoblasts to total cells in a biological specimen. | Monoblast to Total Cell Ratio Measurement | ||
MONOBLLE | C74646 | Monoblasts/Leukocytes | A relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen. | Monoblast to Leukocyte Ratio Measurement | ||
MONOCE | C98872 | Monocytes/Total Cells | A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). | Monocytes to Total Cell Ratio Measurement | ||
MONOIM | C96676 | Immature Monocytes | A measurement of the immature monocytes in a biological specimen. | Immature Monocyte Count | ||
MONOIMLE | C96677 | Immature Monocytes/Leukocytes | A relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen. | Immature Monocyte to Leukocyte Ratio Measurement | ||
MONOLE | C64824 | Monocytes/Leukocytes | A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. | Monocyte to Leukocyte Ratio | ||
MONOMA | C106544 | Monocytes/Macrocytes | A relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample. | Monocytes to Macrocytes Ratio Measurement | ||
MONONSQE | C135433 | Monocytes/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the monocytes to non-squamous epithelial cells in a biological specimen. | Monocytes to Non-Squamous Epithelial Cells Ratio Measurement | ||
MONOPTPT | C147397 | M Protein/Total Protein;M-Spike Protein/Total Protein;Monoclonal Protein Spike/Total Protein;Monoclonal Protein/Total Protein;Myeloma Protein/Total Protein | A relative measurement (ratio or percentage) of the monoclonal protein to total protein in a biological specimen. | Monoclonal Protein to Total Protein Ratio Measurement | ||
MORPHDS | C184535 | Desomorphine | A measurement of the desomorphine in a biological specimen. | Desomorphine Measurement | ||
MORPHET | C184570 | Ethylmorphine | A measurement of the ethylmorphine in a biological specimen. | Ethylmorphine Measurement | ||
MORPHINE | C74883 | Morphine | A measurement of the morphine present in a biological specimen. | Morphine Measurement | ||
MORPHNC | C184556 | Nicomorphine | A measurement of the nicomorphine in a biological specimen. | Nicomorphine Measurement | ||
MORPHNR | C184557 | Normorphine | A measurement of the normorphine in a biological specimen. | Normorphine Measurement | ||
MPC | C96686 | Mean Platelet Component | A measurement of the mean platelet component (platelet activity) in a blood specimen. | Mean Platelet Component Measurement | ||
MPHDRN | C184551 | Mephedrone | A measurement of the mephedrone in a biological specimen. | Mephedrone Measurement | ||
MPHNBRB | C75366 | Mephobarbital;Methylphenobarbital | A measurement of the methylphenobarbital in a biological specimen. | Mephobarbital Measurement | ||
MPIGISO | C186081 | Immunoglobulin Immunofixation Interpretation;Monoclonal Prot Immunoglobulin Isotype;Monoclonal Protein Immunoglobulin Class;Monoclonal Protein Immunoglobulin Isotype | The identification of the monoclonal protein immunoglobulin isotype in a biological specimen. | Monoclonal Protein Immunoglobulin Isotype Determination | ||
MPM | C114214 | Mean Platelet Dry Mass | A measurement of the mean platelet dry mass in a biological specimen. | Mean Platelet Dry Mass | ||
MPO | C80198 | Myeloperoxidase | A measurement of the myeloperoxidase in a biological specimen. | Myeloperoxidase Measurement | ||
MPOAB | C92280 | Myeloperoxidase Antibody | A measurement of the myeloperoxidase antibody in a biological specimen. | Myeloperoxidase Antibody Measurement | ||
MPRBMATE | C184625 | Meprobamate | A measurement of the meprobamate in a biological specimen. | Meprobamate Measurement | ||
MPROTEXR | C163467 | M Protein Excretion Rate;M-Spike Protein Excretion Rate;Monoclonal Protein Excretion Rate;Monoclonal Protein Spike Excretion Rate;Myeloma Protein Excretion Rate | A measurement of the amount of Monoclonal Protein being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Monoclonal Protein Excretion Rate | ||
MPROTR | C158218 | Monoclonal Protein Band Region;Monoclonal Protein Region;Monoclonal Protein Spike Region | The identification of the protein zone (e.g., alpha-1 globulin, beta globulin, etc.) within which the monoclonal protein is observed. | Monoclonal Protein Spike Region Identification | ||
MPRYLON | C184591 | Methyprylon | A measurement of the methyprylon in a biological specimen. | Methyprylon Measurement | ||
MPV | C74730 | Mean Platelet Volume | A measurement of the average size of the platelets present in a blood sample. | Mean Platelet Volume Measurement | ||
MPXI | C119290 | Myeloperoxidase Index | The mean peroxidase activity index or staining intensity of the neutrophil population relative to the archetype. | Neutrophil Myeloperoxidase Index | ||
MSHA | C187789 | Alpha Melanocyte Stimulating Hormone;Alpha-MSH | A measurement of the alpha melanocyte stimulating hormone in a biological specimen. | Alpha Melanocyte Stimulating Hormone Measurement | ||
MSTHCE | C147398 | Mesothelial Cells | A measurement of the mesothelial cells in a biological specimen. | Mesothelial Cells Count | ||
MSTHCELE | C147399 | Mesothelial Cells/Leukocytes | A relative measurement (ratio or percentage) of the mesothelial cells to total leukocytes in a biological specimen. | Mesothelial Cells to Leukocytes Ratio Measurement | ||
MSTRLN | C184588 | Mesterelone;Mesterolone | A measurement of the mesterolone in a biological specimen. | Mesterolone Measurement | ||
MTESTOS | C184590 | Methyltestosterone | A measurement of the methyltestosterone in a biological specimen. | Methyltestosterone Measurement | ||
MTHSTRN | C184589 | Methasterone | A measurement of the methasterone in a biological specimen. | Methasterone Measurement | ||
MTHXT3 | C186082 | 3-Methoxytyramine | A measurement of the total 3-methoxytyramine in a biological specimen. | Total 3-Methoxytyramine Measurement | ||
MTHXT3FR | C186083 | 3-Methoxytyramine, Free | A measurement of the free 3-methoxytyramine in a biological specimen. | Free 3-Methoxytyramine Measurement | ||
MTNEPHFR | C147400 | Metanephrine, Free | A measurement of the free metanephrine in a biological specimen. | Free Metanephrine Measurement | ||
MTNMTEXR | C177991 | Metanephrine+Normetanephrine Excr Rate;Metanephrine+Normetanephrine Excretion Rate | A measurement of the amount of metanephrine and normetanephrine being excreted in a biological specimen over a defined amount of time (e.g., one hour). | Metanephrine and Normetanephrine Excretion Rate | ||
MTNNMTN | C177990 | Metanephrine+Normetanephrine | A measurement of the metanephrine and normetanephrine in a biological specimen. | Metanephrine and Normetanephrine Measurement | ||
MUCTHR | C74721 | Mucous Threads | A measurement of the mucous threads present in a biological specimen. | Mucous Thread Measurement | ||
MUG | C127630 | Murinoglobulin | A measurement of the murinoglobulin in a biological specimen. | Murinoglobulin Measurement | ||
MX1 | C163469 | Interferon-Induced GTP-Binding Protein Mx1;Interferon-Induced Protein p78 | A measurement of the interferon-induced protein P78 in a biological specimen. | Interferon-Induced Protein p78 Measurement | ||
MYBLA | C74632 | Myeloblasts;Myeloid Blasts | A measurement of the myeloblast cells in a biological specimen. | Myeloblast Count | ||
MYBLALE | C64825 | Myeloblasts/Leukocytes | A relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen. | Myeloblast to Leukocyte Ratio | ||
MYBLAT1 | C92283 | Type I Myeloblasts | A measurement of type I myeloblast cells per unit of a biological specimen. | Type I Myeloblasts Measurement | ||
MYBLAT2 | C92284 | Type II Myeloblasts | A measurement of type II myeloblast cells per unit of a biological specimen. | Type II Myeloblasts Measurement | ||
MYBLAT3 | C92285 | Type III Myeloblasts | A measurement of type III myeloblast cells per unit of a biological specimen. | Type III Myeloblasts Measurement | ||
MYCEMIDX | C135434 | Myeloid Maturation Index | A relative measurement (ratio) of the sum of myeloid maturation phase cells (pool) to the sum of myeloid proliferative phase cells (pool) in a biological specimen. | Myeloid Maturation Index | ||
MYCEMPOL | C135435 | Myeloid Maturation Pool | A measurement of the myeloid maturation phase cells (metamyelocytes, band neutrophils, and segmented neutrophils) in a biological specimen. | Myeloid Maturation Pool Count | ||
MYCEPIDX | C135436 | Myeloid Proliferation Index | A relative measurement (ratio) of the sum of myeloid proliferative phase cells (pool) to the sum of myeloid maturation phase cells (pool) in a biological specimen. | Myeloid Proliferation Index | ||
MYCEPPOL | C135437 | Myeloid Proliferation Pool | A measurement of the myeloid proliferative phase cells (myeloblasts, promyelocytes, and myelocytes) in a biological specimen. | Myeloid Proliferation Pool Count | ||
MYCY | C74662 | Myelocytes | A measurement of the myelocytes in a biological specimen. | Myelocyte Count | ||
MYCYCE | C98868 | Myelocytes/Total Cells | A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). | Myelocyte to Total Cell Ratio Measurement | ||
MYCYLE | C64826 | Myelocytes/Leukocytes | A relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen. | Myelocyte to Leukocyte Ratio | ||
MYELINAB | C103418 | Myelin Antibodies | A measurement of the myelin antibodies in a biological specimen. | Myelin Antibodies Measurement | ||
MYL3 | C106547 | Cardiac myosin light chain 1;Myosin light chain 1, slow-twitch muscle B/ventricular isoform;Myosin Light Chain 3 | A measurement of myosin light chain 3 in a biological specimen. | Myosin Light Chain 3 Measurement | ||
MYPC | C130165 | Myeloid Progenitor Cells | A measurement of the myeloid progenitor cells in a biological specimen. | Myeloid Progenitor Cell Count | ||
MYPCCE | C186084 | Myeloid Progenitor Cells/Total Cells | A relative measurement (ratio or percentage) of the myeloid progenitor cells to total cells in a biological specimen. | Myeloid Progenitor Cell to Total Cell Ratio Measurement | ||
MYPCERPC | C92242 | Myeloid/Erythroid Ratio | A relative measurement of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen. | Myeloid to Erythroid Ratio Measurement | ||
NACLR | C106568 | Sodium Clearance | A measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute). | Sodium Clearance Measurement | ||
NACREAT | C79464 | Sodium/Creatinine | A relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen. | Sodium to Creatinine Ratio Measurement | ||
NAG | C79459 | N-Acetyl Glucosamide;N-Acetyl Glucosamine | A measurement of N-acetyl glucosamide (sugar derivative) in a biological specimen. | N-Acetyl Glucosamide Measurement | ||
NAGASE | C103419 | Beta-N-acetyl-D-glucosaminidase;N-acetyl-beta-D-glucosaminidase | A measurement of the N-acetyl-beta-D-glucosaminidase (enzyme) in a biological specimen. | N-acetyl-beta-D-glucosaminidase Measurement | ||
NAGASECR | C163470 | N-acetyl-B-D-glucosaminidase/Creatinine | A relative measurement (ratio or percentage) of the N-acetyl-beta-D-glucosaminidase to creatinine in a biological specimen. | N-acetyl-Beta-D-glucosaminidase to Creatinine Ratio Measurement | ||
NAGASEXR | C165975 | N-acetyl-beta-D-glucosaminidase Excretion Rate;NAGASE Excretion Rate | A measurement of the amount of N-acetyl-beta-D-glucosaminidase being excreted in a biological specimen over a defined amount of time (e.g. one hour). | N-acetyl-beta-D-glucosaminidase Excretion Rate | ||
NAGCREAT | C79460 | N-Acetyl Glucosamide/Creatinine | A relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen. | N-Acetyl Glucosamide to Creatinine Ratio Measurement | ||
NAK | C122137 | Sodium/Potassium | A relative measurement (ratio or percentage) of the sodium to potassium in a biological specimen. | Sodium to Potassium Ratio Measurement | ||
NALORPHN | C184592 | Allorphine;Antorphine;N-allylnormorphine;Nalorphine | A measurement of the nalorphine in a biological specimen. | Nalorphine Measurement | ||
NANDRLN | C75377 | Nandrolone;Norandrostenolone;Nortestosterone | A measurement of the nandrolone in a biological specimen. | Nandrolone Measurement | ||
NAPHYRON | C184553 | Naphyrone | A measurement of the naphyrone in a biological specimen. | Naphyrone Measurement | ||
NCCPTN | C154744 | Nociceptin;Orphanin FQ | A measurement of the nociceptin in a biological specimen. | Nociceptin Measurement | ||
NCLOSTBL | C184593 | Norclostebol | A measurement of the norclostebol in a biological specimen. | Norclostebol Measurement | ||
NCTD5P | C79437 | 5 Prime Nucleotidase;5'-Ribonucleotide Phosphohydrolase | A measurement of the 5'-nucleotidase in a biological specimen. | 5 Prime Nucleotidase Measurement | ||
NCTMPRT | C198286 | Nicotinamide Phosphoribosyltransferase;Visfatin | A measurement of the nicotinamide phosphoribosyltransferase in a biological specimen. | Nicotinamide Phosphoribosyltransferase Measurement | ||
NDMOLZPN | C177967 | Desmethylolanzapine;DMO;N-Desmethylolanzapine;Norolanzapine | A measurement of the N-desmethylolanzapine in a biological specimen. | N-Desmethylolanzapine Measurement | ||
NDMTASE | C163471 | N-Demethylase | A measurement of the N-Demethylase in a biological specimen. | N-Demethylase Measurement | ||
NDSMT | C181403 | N-Desmethyltramadol;N-DSMT | A measurement of the N-desmethyltramadol in a biological specimen. | N-Desmethyltramadol Measurement | ||
NEOPTERN | C80199 | Neopterin | A measurement of the neopterin in a biological specimen. | Neopterin Measurement | ||
NEPHRIN | C184645 | Nephrin;NPHS1 Adhesion Molecule, Nephrin | A measurement of the nephrin in a biological specimen. | Nephrin Measurement | ||
NEUMYLLY | C181450 | Neutrophilic Myelocytes/Lymphocytes | A relative measurement (ratio or percentage) of the neutrophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). | Neutrophilic Myelocytes to Lymphocytes Ratio Measurement | ||
NEUT | C63321 | Neutrophils | A measurement of the neutrophils in a biological specimen. | Absolute Neutrophil Count | ||
NEUTAGR | C116200 | Agranular Neutrophils | A measurement of the agranular neutrophils in a biological specimen. | Agranular Neutrophils Measurement | ||
NEUTB | C64830 | Neutrophils Band Form | A measurement of the banded neutrophils in a biological specimen. | Neutrophil Band Form Count | ||
NEUTBCE | C187701 | Neutrophils Band Form/Total Cells | A relative measurement (ratio or percentage) of the banded neutrophils to total cells in a biological specimen. | Neutrophil Band Form to Total Cell Ratio Measurement | ||
NEUTBLE | C64831 | Neutrophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen. | Neutrophil Band Form to Leukocyte Ratio | ||
NEUTBNE | C120642 | Neutrophils Band Form/ Neutrophils | A relative measurement (ratio or percentage) of banded neutrophils to total neutrophils in a biological specimen. | Neutrophils Band Form to Neutrophils Ratio Measurement | ||
NEUTCE | C98763 | Neutrophils/Total Cells | A relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen). | Neutrophil to Total Cell Ratio Measurement | ||
NEUTCYBS | C111166 | Cytoplasmic Basophilia Neutrophil | A measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content. | Cytoplasmic Basophilia Neutrophil Count | ||
NEUTGT | C96651 | Giant Neutrophils | A measurement of the giant neutrophils in a biological specimen. | Giant Neutrophil Count | ||
NEUTHYGR | C116201 | Hypogranular Neutrophils | A measurement of the hypogranular neutrophils in a biological specimen. | Hypogranular Neutrophil Measurement | ||
NEUTIM | C96678 | Immature Neutrophils | A measurement of the total immature neutrophils in a biological specimen. | Immature Neutrophil Count | ||
NEUTIMLE | C100442 | Immature Neutrophils/Leukocytes | A relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen. | Immature Neutrophils to Leukocytes Ratio Measurement | ||
NEUTLE | C64827 | Neutrophils/Leukocytes | A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen. | Neutrophil to Leukocyte Ratio Measurement | ||
NEUTLS | C116202 | Left Shift Neutrophils | An observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen. | Left Shift Neutrophil Measurement | ||
NEUTLY | C141271 | Neutrophils/Lymphocytes | A relative measurement (ratio) of the neutrophils to lymphocytes in a biological specimen. | Neutrophil to Lymphocyte Ratio Measurement | ||
NEUTMM | C84822 | Neutrophilic Metamyelocytes | A measurement of the neutrophilic metamyelocytes in a biological specimen. | Neutrophilic Metamyelocyte Count | ||
NEUTMMCE | C189509 | Neutrophilic Metamyelocytes/Total Cells | A relative measurement (ratio or percentage) of the neutrophilic metamyelocytes to total cells in a biological specimen. | Neutrophilic Metamyelocyte to Total Cell Ratio Measurement | ||
NEUTMY | C84823 | Neutrophilic Myelocytes | A measurement of the neutrophilic myelocytes in a biological specimen. | Neutrophilic Myelocyte Count | ||
NEUTNSQE | C135438 | Neutrophils/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the neutrophils to non-squamous epithelial cells in a biological specimen. | Neutrophils to Non-Squamous Epithelial Cells Ratio Measurement | ||
NEUTPPH | C187823 | Neutrophils with Pseudo Pelger-Huet Nucleus;Pseudo Pelger-Huet Neutrophils | A measurement of the neutrophils with a Pelger-Huet-like nucleus (hyposegmented) in a biological specimen. | Pseudo Pelger-Huet Neutrophil Count | ||
NEUTSG | C81997 | Neutrophils, Segmented | A measurement of the segmented neutrophils in a biological specimen. | Segmented Neutrophil Count | ||
NEUTSGB | C154755 | Neutrophils, Segmented + Band Form | A measurement of the segmented and band form neutrophils in a biological specimen. | Segmented and Band Form Neutrophils Measurement | ||
NEUTSGBP | C154756 | Neutrophils, Seg + Band Form + Precursor;Neutrophils, Segmented + Band Form + Precursors | A measurement of the segmented and band form neutrophils, metamyelocytes, myelocytes, promyelocytes, and myeloblasts in a biological specimen. | Segmented, Band Form and Precursor Neutrophils Measurement | ||
NEUTSGCE | C187679 | Neutrophils, Segmented/Total Cells | A relative measurement (ratio or percentage) of segmented neutrophils to total cells in a biological specimen. | Segmented Neutrophil to Total Cell Ratio Measurement | ||
NEUTSGLE | C82045 | Neutrophils, Segmented/Leukocytes | A relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen. | Segmented Neutrophil to Leukocyte Ratio Measurement | ||
NEUTSGNE | C120643 | Neutrophils, Segmented/Neutrophils | A relative measurement (ratio or percentage) of segmented neutrophils to total neutrophils in a biological specimen. | Segmented Neutrophils to Neutrophils Ratio Measurement | ||
NEUTTOXC | C132376 | Neutrophilic Toxic Change | A measurement of any type of toxic change in cells of the neutrophilic lineage in a biological specimen. | Neutrophilic Toxic Change Assessment | ||
NEUTVAC | C74628 | Vacuolated Neutrophils | A measurement of the neutrophils containing small vacuoles in a biological specimen. | Vacuolated Neutrophil Count | ||
NFHP | C172501 | Phosphorylated Neurofilament Heavy Chain | A measurement of the phosphorylated neurofilament heavy chain in a biological specimen. | Phosphorylated Neurofilament Heavy Chain Measurement | ||
NFLP | C142285 | NEFL;Neurofilament Light Chain Protein;Neurofilament Light Polypeptide;NF-L;Protein Phosphatase 1, Regulatory Subunit 110 | A measurement of the neurofilament light chain protein in a biological specimen. | Neurofilament Light Chain Protein Measurement | ||
NGF | C135439 | Nerve Growth Factor | A measurement of the total nerve growth factor in a biological specimen. | Nerve Growth Factor Measurement | ||
NGFA | C198287 | Nerve Growth Factor Alpha | A measurement of the nerve growth factor alpha in a biological specimen. | Nerve Growth Factor Alpha Measurement | ||
NGFB | C198210 | Nerve Growth Factor Beta | A measurement of the nerve growth factor beta in a biological specimen. | Nerve Growth Factor Beta Measurement | ||
NGFG | C198288 | Nerve Growth Factor Gamma | A measurement of the nerve growth factor gamma in a biological specimen. | Nerve Growth Factor Gamma Measurement | ||
NHDLLDL | C186085 | Non-HDL Cholesterol/LDL Cholesterol | A relative measurement (ratio or percentage) of the non-HDL cholesterol to LDL cholesterol in a biological specimen. | Non-HDL Cholesterol to LDL Cholesterol Ratio Measurement | ||
NHMCE | C147401 | Nonhematic Cells | A measurement of the cells of nonhematopoietic origin in a biological specimen. | Nonhematic Cells Count | ||
NHMCELE | C147402 | Nonhematic Cells/Leukocytes | A relative measurement (ratio) of the nonhematic cells to total leukocytes in a biological specimen. | Nonhematic Cells to Leukocytes Ratio Measurement | ||
NHYDCDN | C177952 | Norhydrocodone | A measurement of the norhydrocodone in a biological specimen. | Norhydrocodone Measurement | ||
NICOTINE | C147403 | Nicotine | A measurement of the nicotine in a biological specimen. | Nicotine Measurement | ||
NITRATE | C161352 | Nitrate;Nitric Acid | A measurement of the nitrate in a biological specimen. | Nitrate Measurement | ||
NITRICOX | C112360 | Nitric Oxide;NO | A measurement of the nitric oxide in a biological specimen. | Nitric Oxide Measurement | ||
NITRITE | C64810 | Nitrite | A measurement of the nitrite in a biological specimen. | Nitrite Measurement | ||
NKCE | C98762 | Natural Killer Cells | A measurement of the total natural killer cells in a biological specimen. | Natural Killer Cell Count | ||
NKCEFUNC | C116203 | Natural Killer Cell Activity;Natural Killer Cell Function | A measurement of the natural killer cell function in a biological specimen. | Natural Killer Cell Activity Measurement | ||
NKINA | C163473 | Neurokinin A;NKA;Substance K | A measurement of the neurokinin A in a biological specimen. | Neurokinin A Measurement | ||
NKLY | C181258 | Natural Killer Cells/Lymphocytes;NK Cells/Lym | A relative measurement (ratio or percentage) of the natural killer cells to lymphocytes in a biological specimen. | Natural Killer Cells to Lymphocytes Ratio Measurement | ||
NMH | C147404 | N-methylhistamine | A measurement of the N-methylhistamine in a biological specimen. | N-methylhistamine Measurement | ||
NMP22 | C156509 | Nuclear Matrix Protein 22;Nuclear Mitotic Apparatus Protein 1;NUMA1 | A measurement of the nuclear matrix protein 22 in a biological specimen. | Nuclear Matrix Protein 22 Measurement | ||
NOHDLHDL | C120644 | Non-HDL Cholesterol/HDL Cholesterol | A relative measurement (ratio or percentage) of non-high density lipoprotein cholesterol to high density lipoprotein cholesterol in a biological specimen. | Non-HDL Cholesterol to HDL Cholesterol Ratio Measurement | ||
NONHDL | C116204 | Non-HDL Cholesterol;Non-High Density Lipoprotein | A measurement of the non-high density lipoprotein cholesterol in a biological specimen. | Non-High Density Lipoprotein Cholesterol Measurement | ||
NORDOXPN | C191286 | Nordoxepin | A measurement of the nordoxepin present in a biological specimen. | Nordoxepin Measurement | ||
NOREPEXR | C163472 | Norepinephrine Excretion Rate | A measurement of the amount of norepinephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Norepinephrine Excretion Rate | ||
NOREPIN | C74868 | Noradrenaline;Norepinephrine | A measurement of the norepinephrine hormone in a biological specimen. | Noradrenaline Measurement | ||
NORMBASO | C147405 | Basophilic Normoblast | A measurement of the basophilic normoblasts in a biological specimen taken from a non-human organism. | Basophilic Normoblast Count | ||
NORMEEXR | C163474 | Normetanephrine Excretion Rate | A measurement of the amount of normetanephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Normetanephrine Excretion Rate | ||
NORMETA | C122138 | Normetanephrine | A measurement of the normetanephrine in a biological specimen. | Normetanephrine Measurement | ||
NORMETFR | C186086 | Normetanephrine, Free | A measurement of the free normetanephrine in a biological specimen. | Free Normetanephrine Measurement | ||
NORNCTN | C147406 | Nornicotine | A measurement of the nornicotine in a biological specimen. | Nornicotine Measurement | ||
NORTRPTL | C186087 | Nortriptyline | A measurement of the nortriptyline in a biological specimen. | Nortriptyline Measurement | ||
NOXYCDN | C177953 | Noroxycodone | A measurement of the noroxycodone in a biological specimen. | Noroxycodone Measurement | ||
NPAP | C100434 | Non-Prostatic Acid Phosphatase | A measurement of the non-prostatic acid phosphatase in a biological specimen. | Non-Prostatic Acid Phosphatase Measurement | ||
NPCRATE | C191295 | Normalized Protein Catabolic Rate;Normalized Protein Catabolism Rate;NPCR;nPCR | A calculated measurement of the normalized protein catabolism rate in a biological specimen used to assess dietary protein intake in dialysis patients. | Normalized Protein Catabolism Rate | ||
NPY | C74892 | Neuropeptide Y | A measurement of the neuropeptide Y in a biological specimen. | Neuropeptide Y Measurement | ||
NRDZPM | C139076 | Desmethyldiazepam;N-Desmethyldiazepam;Nordazepam;Nordiazepam | A measurement of the nordazepam present in a biological specimen. | Nordazepam Measurement | ||
NRENDRLN | C184594 | Norethandrolone | A measurement of the norethandrolone in a biological specimen. | Norethandrolone Measurement | ||
NRP1 | C165977 | BDCA4;CD304;Neuropilin-1;NP1;NRP;VEGF165R | A measurement of the neuropilin-1 in a biological specimen. | Neuropilin-1 Measurement | ||
NRPROPOX | C186088 | Norpropoxyphene | A measurement of the norpropoxyphene in a biological specimen. | Norpropoxyphene Measurement | ||
NSE | C116205 | Enolase 2;Gamma-enolase;Neuron Specific Enolase | A measurement of the neuron specific enolase in a biological specimen. | Neuron Specific Enolase Measurement | ||
NSPMTSPM | C142286 | Normal Sperm/Total Sperm;Sperm Morphology | A measurement (ratio or percentage) of the normal spermatozoa to total spermatozoa in a biological specimen. | Normal Sperm to Total Sperm Ratio Measurement | ||
NTELOCRT | C120645 | N-telopeptide/Creatinine | A relative measurement (ratio or percentage) of the N-telopeptide to creatinine in a biological specimen. | N-telopeptide to Creatinine Ratio Measurement | ||
NTELOP | C74743 | N-telopeptide | A measurement of the N-telopeptide in a biological specimen. | N-Telopeptide Measurement | ||
NTENS | C163475 | Neurotensin;NTS | A measurement of the neurotensin in a biological specimen. | Neurotensin Measurement | ||
NTRLFAT | C147407 | Neutral Fats | A measurement of the total neutral fats in a biological specimen. | Neutral Fats Measurement | ||
NTRZPM | C184629 | Nitrazepam | A measurement of the nitrazepam in a biological specimen. | Nitrazepam Measurement | ||
NTXI | C82039 | Type I Collagen N-Telopeptides;Type I Collagen X-Linked N-Telopeptides | A measurement of the type I collagen cross-linked N-telopeptides in a biological specimen. | Type I Collagen N-Telopeptide Measurement | ||
NTXICRT | C147408 | T1 Collagen X-link N-Telopeptides/Creat;Type I Collagen X-linked N-Telopeptides/Creatinine | A relative measurement (ratio or percentage) of the type 1 collagen cross-linked N-telopeptides to creatinine in a biological specimen. | Type 1 Collagen X-link N-Telopeptides to Creatinine Ratio Measurement | ||
NTXII | C82041 | Type II Collagen N-Telopeptides;Type II Collagen X-Linked N-Telopeptides | A measurement of the type II collagen cross-linked N-telopeptides in a biological specimen. | Type II Collagen N-Telopeptide Measurement | ||
NTZPMAOM | C186089 | Nitrazepam and/or Metabolites | A measurement of the nitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both nitrazepam and its metabolites. | Nitrazepam and/or Metabolites Measurement | ||
NUCCE | C150841 | Nucleated Cells | A measurement of the nucleated cells in a biological specimen. | Nucleated Cell Count | ||
NUCSWELL | C114213 | Nuclear Swelling | A measurement of the expansion of the nucleus of the cells in a biological specimen. | Nuclear Swelling Measurement | ||
O2CT | C111284 | Oxygen Content | A measurement of the amount of oxygen content in a biological specimen. | Oxygen Measurement | ||
OAS1 | C163476 | 2-5-Oligoadenylate Synthase 1 | A measurement of the 2-5-oligoadenylate synthase 1 in a biological specimen. | 2-5-Oligoadenylate Synthase 1 Measurement | ||
OAS2 | C163477 | 2-5-Oligoadenylate Synthase 2 | A measurement of the 2-5-oligoadenylate synthase 2 in a biological specimen. | 2-5-Oligoadenylate Synthase 2 Measurement | ||
OAS3 | C163478 | 2-5-Oligoadenylate Synthase 3 | A measurement of the 2-5-oligoadenylate synthase 3 in a biological specimen. | 2-5-Oligoadenylate Synthase 3 Measurement | ||
OCCBLD | C74686 | Occult Blood | A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination. | Occult Blood Measurement | ||
ODMTASE | C163479 | O-Demethylase | A measurement of the O-Demethylase in a biological specimen. | O-Demethylase Measurement | ||
ODSMT | C181402 | Desmetramadol;O-Desmethyltramadol;O-DSMT | A measurement of the O-desmethyltramadol in a biological specimen. | O-Desmethyltramadol Measurement | ||
OH8DXG2 | C174309 | 8-Hydroxy-2'-Deoxyguanosine;8-oxo-dG | A measurement of the 8-hydroxy-2'-deoxyguanosine in a biological specimen. | 8-Hydroxy-2'-Deoxyguanosine Measurement | ||
OH9RS | C177970 | 9-Hydroxyrisperidone;Paliperidone | A measurement of the 9-hydroxyrisperidone in a biological specimen. | 9-Hydroxyrisperidone Measurement | ||
OHDG8 | C172492 | 8-Hydroxydeoxyguanosine;8-OHdG | A measurement of the 8-hydroxydeoxyguanosine in a biological specimen. | 8-Hydroxydeoxyguanosine Measurement | ||
OHF6B | C150833 | 6 Beta-Hydrocortisol;6 Beta-Hydroxycortisol;6 beta-OHF | A measurement of 6 beta-hydroxycortisol in a biological specimen. | 6 Beta-Hydroxycortisol Measurement | ||
OLANZAPN | C177966 | Olanzapine | A measurement of the olanzapine in a biological specimen. | Olanzapine Measurement | ||
OLIGBAND | C122139 | Oligoclonal Bands | A measurement of the oligoclonal bands in a biological specimen. | Oligoclonal Bands Measurement | ||
OPG | C116206 | OCIF;Osteoclastogenesis Inhibitory Factor;Osteoprotegerin;TNFRS11B;Tumor Necrosis Factor Receptor Superfamily Member 11b | A measurement of the osteoprotegerin in a biological specimen. | Osteoprotegerin Measurement | ||
OPIATE | C74796 | Opiate | A measurement of any opiate class drug present in a biological specimen. | Opiate Measurement | ||
OPN | C124349 | Osteopontin | A measurement of the osteopontin in a biological specimen. | Osteopontin Measurement | ||
OPNCRT | C177962 | Osteopontin/Creatinine | A relative measurement (ratio or percentage) of the osteopontin to creatinine in a biological specimen. | Osteopontin to Creatinine Ratio Measurement | ||
ORNITHIN | C122140 | Ornithine | A measurement of the ornithine in a biological specimen. | Ornithine Measurement | ||
OSM | C132377 | Oncostatin M | A measurement of the oncostatin M in a biological specimen. | Oncostatin M Measurement | ||
OSMLTY | C74801 | Osmolality | A measurement of the osmoles of solute per unit of biological specimen. | Osmolality Measurement | ||
OSMRTY | C74802 | Osmolarity | A measurement of the osmoles of solute per liter of solution. | Osmolarity Measurement | ||
OSTEOC | C74744 | Osteocalcin | A measurement of the osteocalcin in a biological specimen. | Osteocalcin Measurement | ||
OVALCY | C142287 | Ovalocytes | A measurement of the ovalocytes (oval shaped cell with rounded ends and a long axis less than twice its short axis) in a biological specimen. | Ovalocyte Count | ||
OXACREAT | C117983 | Oxalate/Creatinine | A relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen. | Oxalate to Creatinine Ratio Measurement | ||
OXAEXR | C163480 | Oxalate Excretion Rate | A measurement of the amount of oxalate being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Oxalate Excretion Rate | ||
OXALATE | C92250 | Ethanedioate;Oxalate | A measurement of the oxalate in a biological specimen. | Oxalate Measurement | ||
OXANDRLN | C75381 | Ossandrolone;Oxandrolone | A measurement of the oxandrolone in a biological specimen. | Oxandrolone Measurement | ||
OXMORPHN | C147409 | Oxymorphone | A measurement of the Oxymorphone in a biological specimen. | Oxymorphone Measurement | ||
OXMSTRN | C184595 | Oxymesterone | A measurement of the oxymesterone in a biological specimen. | Oxymesterone Measurement | ||
OXMTHLN | C75388 | Oxymethalone;Oxymethenolone;Oxymetholone | A measurement of the oxymetholone in a biological specimen. | Oxymetholone Measurement | ||
OXYCAP | C96614 | Oxygen Capacity | A measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood. | Oxygen Capacity Measurement | ||
OXYCDN | C74884 | Oxycodone;Oxycontin | A measurement of the oxycodone present in a biological specimen. | Oxycodone Measurement | ||
OXYSAT | C60832 | Oxygen Saturation | A measurement of the oxygen-hemoglobin saturation of a volume of blood. | Oxygen Saturation Measurement | ||
OXYTOCIN | C74869 | Oxytocin;Oxytoxin | A measurement of the oxytocin hormone in a biological specimen. | Oxytocin Measurement | ||
OXZPM | C75375 | Oxazepam | A measurement of the oxazepam present in a biological specimen. | Oxazepam Measurement | ||
P1NP | C96625 | Amino-terminal propeptide of type 1 procollagen;P1NP Aminoterm Type 1;Procollagen 1 N-Terminal Propeptide | A measurement of the procollagen 1 N-terminal propeptide in a biological specimen. | Procollagen 1 N-Terminal Propeptide Measurement | ||
P3NP | C128973 | Procollagen 3 N-Terminal Propeptide | A measurement of the procollagen 3 N-terminal propeptide in a biological specimen. | Procollagen 3 N-Terminal Propeptide Measurement | ||
P50OXYGN | C102279 | P50 Oxygen | A measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen. | P50 Oxygen Measurement | ||
PABA | C186090 | Para-Aminobenzoate;Para-Aminobenzoic Acid | A measurement of the para-aminobenzoate in a biological specimen. | Para-Aminobenzoate Measurement | ||
PAF | C111292 | Platelet Activating Factor | A measurement of the platelet activating factor in a biological specimen. | Platelet Activating Factor Measurement | ||
PAHPP | C189315 | 4-Aminohippurate;P-Amino Hippuric Acid;P-Aminohippurate;PAH;Para Aminohippurate;Para Aminohippuric Acid;Para-Amino Hippuric Acid;Para-Aminohippurate | A measurement of the para aminohippurate in a biological specimen. | Para Aminohippurate Measurement | ||
PAHPPCLR | C189530 | 4-Aminohippurate Clearance;P-Amino Hippuric Acid Clearance;P-Aminohippurate Clearance;PAH Clearance;Para Aminohippurate Clearance;Para Aminohippuric Acid Clearance;Para-Amino Hippuric Acid Clearance;Para-Aminohippurate Clearance | A measurement of the volume of serum or plasma that would be cleared of para aminohippurate by excretion of urine for a specified unit of time (e.g. one minute). | Para Aminohippurate Clearance Measurement | ||
PAI1 | C82030 | Plasminogen Activator Inhibitor-1 | A measurement of the plasminogen activator inhibitor-1 in a biological specimen. | Plasminogen Activator Inhibitor-1 Measurement | ||
PAI1AG | C81989 | Plasminogen Activator Inhibitor-1 AG | A measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen. | Plasminogen Activator Inhibitor-1 Antigen Measurement | ||
PAP | C80204 | Prostatic Acid Phosphatase | A measurement of the prostatic acid phosphatase in a biological specimen. | Prostatic Acid Phosphatase Measurement | ||
PAPPA | C82031 | Pregnancy-Associated Plasma Protein-A | A measurement of the pregnancy-associated plasma protein-A in a biological specimen. | Pregnancy-Associated Plasma Protein-A Measurement | ||
PAPPEN | C74616 | Pappenheimer Bodies | A measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen. | Pappenheimer Body Count | ||
PARALD | C184630 | Paraldehyde | A measurement of the paraldehyde in a biological specimen. | Paraldehyde Measurement | ||
PARICEAB | C116207 | Anti-Parietal Cell Antibody;Parietal Cell Antibody | A measurement of the parietal cell antibody in a biological specimen. | Parietal Cell Antibody Measurement | ||
PAROXET | C147410 | Paroxetine | A measurement of the paroxetine present in a biological specimen. | Paroxetine Measurement | ||
PB223C | C184559 | PB-22 3-carboxyindole | A measurement of the synthetic cannabinoid metabolite PB-22 3-carboxyindole in a biological specimen. | PB-22 3-carboxyindole Measurement | ||
PB225F3C | C184560 | 5-fluoro PB-22 3-carboxyindole | A measurement of the synthetic cannabinoid metabolite 5-fluoro PB-22 3-carboxyindole in a biological specimen. | 5-fluoro PB-22 3-carboxyindole Measurement | ||
PBG | C156539 | Porphobilinogen | A measurement of the porphobilinogen in a biological specimen. | Porphobilinogen Measurement | ||
PBGCREAT | C156540 | Porphobilinogen/Creatinine | A relative measurement (ratio or percentage) of the porphobilinogen to creatinine in a biological specimen. | Porphobilinogen to Creatinine Ratio Measurement | ||
PC3MPSAM | C132378 | PCA3 mRNA/PSA mRNA | A relative measurement (ratio) of the prostate cancer antigen 3 mRNA to prostate specific antigen mRNA in a biological specimen. | PCA3 mRNA to PSA mRNA Ratio Measurement | ||
PCA3MRNA | C132379 | Prostate Cancer Antigen 3 mRNA | A measurement of the prostate cancer antigen 3 mRNA in a biological specimen. | Prostate Cancer Antigen 3 mRNA Measurement | ||
PCDW | C111294 | Platelet Component Distribution Width | A measurement of a marker of platelet shape change in a biological specimen. | Platelet Component Distribution Width Measurement | ||
PCHLRPZN | C177983 | Prochlorperazine | A measurement of the prochlorperazine in a biological specimen. | Prochlorperazine Measurement | ||
PCNAG | C120646 | Cyclin;Proliferating Cell Nuclear Antigen | A measurement of the proliferating cell nuclear antigen in a biological specimen. | Proliferating Cell Nuclear Antigen Measurement | ||
PCO2 | C82625 | Partial Pressure Carbon Dioxide | A measurement of the pressure of carbon dioxide in a biological specimen. | Partial Pressure of Carbon Dioxide Measurement | ||
PCO2ADJT | C147411 | Partial Pressure Carbon Dioxide Adj Temp | A measurement of the pressure of carbon dioxide, which has been adjusted for body temperature, in a biological specimen. | Partial Pressure of Carbon Dioxide Adjusted for Body Temperature Measurement | ||
PCP | C74694 | Phencyclidine;Phenylcyclohexylpiperidine | A measurement of the phencyclidine present in a biological specimen. | Phencyclidine Measurement | ||
PCSK9 | C120647 | Proprotein Convertase Subtilisin/Kexin 9 | A measurement of the proprotein convertase subtilisin/kexin type 9 in a biological specimen. | Proprotein Convertase Subtilisin/Kexin Type 9 Measurement | ||
PCSK9FR | C186091 | Proprotein Convertase Subtilisin/Kexin Type 9;Prprot Cnvrtase Subtilisin-Kexin 9, Free | A measurement of the free proprotein convertase subtilisin/kexin type 9 in a biological specimen. | Free Proprotein Convertase Subtilisin/Kexin Type 9 Measurement | ||
PCT | C103430 | Procalcitonin | A measurement of the procalcitonin in a biological specimen. | Procalcitonin Measurement | ||
PD1S | C172505 | Soluble CD279;Soluble PD-1;Soluble PD1;Soluble Programmed Cell Death Protein 1;Soluble Programmed Death-1 | A measurement of the soluble programmed death-1 protein in a biological specimen. | Soluble Programmed Death-1 Measurement | ||
PDGFAA | C163481 | PDGF Isoform AA;Platelet Derived Growth Factor IsoformAA;Platelet Derived Growth Factor-AA Isoform | A measurement of the platelet derived growth factor isoform AA in a biological specimen. | Platelet Derived Growth Factor Isoform AA Measurement | ||
PDGFAB | C116208 | PDGF Isoform AB;Platelet Derived Growth Factor IsoformAB;Platelet Derived Growth Factor-AB Isoform | A measurement of the platelet derived growth factor isoform AB in a biological specimen. | Platelet Derived Growth Factor Isoform AB Measurement | ||
PDL1S | C172503 | Soluble CD274;Soluble PD-L1;Soluble PDL1;Soluble Programmed Death Ligand 1 | A measurement of the soluble programmed death ligand 1 in a biological specimen. | Soluble Programmed Death Ligand 1 Measurement | ||
PDW | C81962 | Platelet Distribution Width | A measurement of the range of platelet sizes in a biological specimen. | Platelet Distribution Width | ||
PECAM1 | C135472 | CD31;CD31 Antigen;PECAM;PECAM-1;PECAM1;Platelet And Endothelial Cell Adhesion Molecule 1;Platelet Endo Cell Adhesion Molecule 1;Platelet Endothelial Adhesion Molecule | A measurement of the platelet and endothelial cell adhesion molecule 1 in a biological specimen. | Platelet Endothelial Cell Adhesion Molecule 1 Measurement | ||
PELGERH | C74617 | Pelger Huet Anomaly;Pelger-Huet Cells;PHA | A measurement of the Pelger-Huet Anomaly (nuclei of granulocytes appear rod-like, bilobed, peanut, or dumbbell shaped) in a biological specimen. | Pelger Huet Anomaly Measurement | ||
PEMAB | C81988 | Pemphigoid Antibodies | A measurement of the pemphigoid antibodies in a biological specimen. | Pemphigoid Antibody Measurement | ||
PEMOLINE | C184631 | Pemoline | A measurement of the pemoline in a biological specimen. | Pemoline Measurement | ||
PENDRN | C184561 | Pentedrone | A measurement of the pentedrone in a biological specimen. | Pentedrone Measurement | ||
PENTYLN | C184562 | Pentylone | A measurement of the pentylone in a biological specimen. | Pentylone Measurement | ||
PEPSNG | C100122 | Pepsinogen | A measurement of the pepsinogen in a biological specimen. | Pepsinogen Measurement | ||
PEPSNGA | C100469 | Pepsinogen A;PGA | A measurement of the pepsinogen A in a biological specimen. | Pepsinogen A Measurement | ||
PEPSNGC | C100470 | Pepsinogen C;PGC | A measurement of the pepsinogen C in a biological specimen. | Pepsinogen C Measurement | ||
PEPSNGI | C100467 | Pepsinogen I;PGI | A measurement of the pepsinogen I in a biological specimen. | Pepsinogen I Measurement | ||
PEPSNGII | C100468 | Pepsinogen II;PGII | A measurement of the pepsinogen II in a biological specimen. | Pepsinogen II Measurement | ||
PERCECE | C127632 | Proliferating Erythroid/Total Cells | A relative measurement (ratio or percentage) of the proliferating erythroid cells to total cells in a biological specimen. | Proliferating Erythroid Cell to Total Cell Ratio Measurement | ||
PERIOSTN | C112395 | OSF2;Osteoblast Specific Factor 2;Periostin;POSTN | A measurement of the periostin in a biological specimen. | Periostin Measurement | ||
PERPHNZN | C177988 | Perphenazine | A measurement of the perphenazine in a biological specimen. | Perphenazine Measurement | ||
PF2AI8CR | C119291 | 8-Iso-PGF2alpha/Creatinine | A relative measurement (ratio or percentage) of the prostaglandin F2 alpha isoform 8 to creatinine in a biological specimen. | 8-Iso-Prostaglandin F2 Alpha to Creatinine Ratio Measurement | ||
PF4HCIAB | C147412 | Platelet Factor 4 Heparin Complex Induced Antibody;Platelet Fctr 4 Heparin Cmplx Induced Ab | A measurement of the platelet factor 4 heparin complex induced antibody in a biological specimen. | Platelet Factor 4-Heparin Complex Induced Antibody Measurement | ||
PFCT | C111295 | PFCT;Platelet Function Closure Time | A measurement of the platelet function closure time in a biological specimen. | Platelet Function Closure Time Measurement | ||
PG | C103343 | Prostaglandin | A measurement of the total prostaglandin in a biological specimen. | Prostaglandin Measurement | ||
PGAG | C165978 | Platelet-Granulocyte Agg;Platelet-Granulocyte Aggregates | A measurement of the aggregates composed of platelets and granulocytes in a biological specimen. | Platelet-Granulocyte Aggregate Measurement | ||
PGD2 | C103431 | Prostaglandin D2 | A measurement of the prostaglandin D2 in a biological specimen. | Prostaglandin D2 Measurement | ||
PGD2R2 | C189515 | Prostaglandin D2 Receptor 2 | A measurement of the prostaglandin D2 receptor 2 in a biological specimen. | Prostaglandin D2 Receptor 2 Measurement | ||
PGD2S | C103432 | Beta-Trace Protein;Prostaglandin D2 Synthase | A measurement of the prostaglandin D2 synthase in a biological specimen. | Prostaglandin D2 Synthase Measurement | ||
PGE1 | C103434 | Prostaglandin E1 | A measurement of the prostaglandin E1 in a biological specimen. | Prostaglandin E1 Measurement | ||
PGE2 | C103435 | Prostaglandin E2 | A measurement of the prostaglandin E2 in a biological specimen. | Prostaglandin E2 Measurement | ||
PGES | C103433 | Prostaglandin E Synthase | A measurement of the prostaglandin E synthase in a biological specimen. | Prostaglandin E Synthase Measurement | ||
PGF1A | C103436 | Prostaglandin F1 Alpha | A measurement of the prostaglandin F1 alpha in a biological specimen. | Prostaglandin F1 Alpha Measurement | ||
PGF2A | C103437 | Prostaglandin F2 Alpha | A measurement of the prostaglandin F2 alpha in a biological specimen. | Prostaglandin F2 Alpha Measurement | ||
PGF2AI8 | C119292 | 8-Iso-Prostaglandin F2 Alpha | A measurement of the prostaglandin F2 alpha isoform 8 in a biological specimen. | 8-Iso-Prostaglandin F2 Alpha Measurement | ||
PH | C45997 | pH | The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid. | pH | ||
PHADJT | C161367 | pH Adjusted for Body Temp | A measurement of pH, which has been adjusted for body temperature, in a biological specimen. | pH Adjusted for Body Temperature Measurement | ||
PHE | C81280 | Phenylalanine | A measurement of the phenylalanine in a biological specimen. | Phenylalanine Measurement | ||
PHENTHZ | C74695 | Dibenzothiazine;Phenothiazine | A measurement of the phenothiazine present in a biological specimen. | Phenothiazine Measurement | ||
PHENYTN | C147413 | Phenytoin | A measurement of the phenytoin in a biological specimen. | Phenytoin Measurement | ||
PHETYR | C81281 | Phenylalanine/Tyrosine | A relative measurement (ratio) of the phenylalanine to tyrosine in a biological specimen. | Phenylalanine to Tyrosine Ratio Measurement | ||
PHNBRBTL | C75368 | Phenobarbital | A measurement of the phenobarbital present in a biological specimen. | Phenobarbital Measurement | ||
PHNDMTZN | C184597 | Phendimetrazine | A measurement of the phendimetrazine in a biological specimen. | Phendimetrazine Measurement | ||
PHNKET | C147414 | Phenyl Ketones;Phenylketones | A measurement of the total phenylketones in a biological specimen | Phenylketone Measurement | ||
PHNMTZN | C184574 | Phenmetrazine | A measurement of the phenmetrazine in a biological specimen. | Phenmetrazine Measurement | ||
PHNZCN | C184573 | Phenazocine | A measurement of the phenazocine in a biological specimen. | Phenazocine Measurement | ||
PHOS | C64857 | Inorganic Phosphate;Phosphate;Phosphorus | A measurement of the phosphate in a biological specimen. | Phosphate Measurement | ||
PHOSCLR | C106553 | Phosphate Clearance | A measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute). | Phosphate Clearance Measurement | ||
PHOSCRT | C79461 | Phosphate/Creatinine | A relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen. | Phosphate to Creatinine Ratio Measurement | ||
PHOSEXR | C150821 | Phosphorus Excretion Rate | A measurement of the amount of phosphorus being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Phosphorus Excretion Rate | ||
PHOSLPD | C96623 | Phospholipid | A measurement of the phospholipids in a biological specimen. | Phospholipid Measurement | ||
PHTRMN | C174299 | Phentermine;Phenyl-tertiary-butylamine | A measurement of the phentermine in a biological specimen. | Phentermine Measurement | ||
PICP | C82033 | Procollagen Type I Carboxy Term Peptide | A measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen. | Procollagen Type I Carboxy Terminal Peptide Measurement | ||
PIMOZIDE | C177987 | Pimozide | A measurement of the pimozide in a biological specimen. | Pimozide Measurement | ||
PIPRDROL | C184633 | Pipradrol | A measurement of the pipradrol in a biological specimen. | Pipradrol Measurement | ||
PIVKAII | C150846 | DCP;Des-Gammacarboxyprothrombin;PIVKA-II;Protein Induced by Vitamin K Absence-II;Protein Induced by Vitamin K Absence/Antagonist-II | A measurement of the protein induced by vitamin K absence-II in a biological specimen. | Protein Induced by Vitamin K Absence-II Measurement | ||
PKM | C156530 | Pyruvate Kinase Muscle Isozyme | A measurement of the total pyruvate kinase muscle isozymes (M1 and M2) in a biological specimen. | Pyruvate Kinase Muscle Isozyme Measurement | ||
PKM1 | C156532 | Pyruvate Kinase Isozyme M1 | A measurement of the pyruvate kinase isozyme M1 in a biological specimen. | Pyruvate Kinase Isozyme M1 Measurement | ||
PKM2 | C156531 | Pyruvate Kinase Isozyme M2 | A measurement of the pyruvate kinase isozyme M2 in a biological specimen. | Pyruvate Kinase Isozyme M2 Measurement | ||
PLA2 | C181405 | Phospholipase A2 | A measurement of the total phospholipase A2 in a biological specimen. | Phospholipase A2 Measurement | ||
PLAGGCVT | C114210 | Platelet Aggregation Curve Type | The classification of the curve pattern that is formed as a result of platelet aggregation. | Platelet Aggregometry Curve Type | ||
PLAGMAMP | C114211 | Platelet Aggregation Mean Amplitude | An average of the measurements of the magnitude of the platelet aggregation in a biological specimen. | Platelet Aggregometry Mean Amplitude | ||
PLAGMCVT | C114212 | Platelet Aggregation Mean Curve Type | The classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements. | Platelet Aggregometry Mean Curve Type | ||
PLAT | C51951 | Platelets | A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. | Platelet Count | ||
PLATAGGR | C103427 | Platelet Aggregation;Platelet Function | A measurement of the association of platelets to one another via adhesion molecules in a biological sample. | Platelet Aggregation Measurement | ||
PLATAGRN | C147415 | Platelets, Agranular | A measurement of the agranular platelets in a biological specimen. | Agranular Platelets Count | ||
PLATBIZ | C154733 | Bizarre Platelets | A measurement of the bizarre platelets (large with abnormal morphology and shape) in a biological specimen. | Bizarre Platelet Count | ||
PLATCLMP | C96624 | Platelet Clumps;PLT Clumps | A measurement of the platelet clumps in a biological specimen. | Platelet Clumps Count | ||
PLATEST | C135440 | Platelets, Estimated | An estimated measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. | Estimated Platelets Measurement | ||
PLATGNT | C74728 | Giant Platelets | A measurement of the giant (larger than 7um in diameter) platelets in a biological specimen. | Giant Platelet Count | ||
PLATHCT | C100424 | Platelet Hematocrit;Thrombocytocrit | A relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets. | Platelet Hematocrit Measurement | ||
PLATIM | C154723 | Immature Platelets;Reticulated Platelets | A measurement of the immature platelets in a biological specimen. | Immature Platelet Count | ||
PLATLRG | C74729 | Large Platelets | A measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen. | Large Platelet Count | ||
PLATSAT | C116209 | Platelet Satellitism | An examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen. | Platelet Satellitism Assessment | ||
PLCGF | C163482 | PGF;PIGF;Placental Growth Factor;PLGF | A measurement of the placental growth factor in a biological specimen. | Placental Growth Factor Measurement | ||
PLG | C127633 | Plasminogen | A measurement of the plasminogen (antigen) in a biological specimen. | Plasminogen Measurement | ||
PLP | C158237 | Active Vitamin B6;Pyridoxal Phosphate | A measurement of the pyridoxal phosphate in a biological specimen. | Pyridoxal Phosphate Measurement | ||
PLSCR1 | C163483 | Phospholipid Scramblase 1 | A measurement of the phospholipid scramblase 1 in a biological specimen. | Phospholipid Scramblase 1 Measurement | ||
PLSIMCCE | C147416 | Immature Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the immature plasma cells (plasmacytes) to total cells in a biological specimen. | Immature Plasma Cells to Total Cells Ratio Measurement | ||
PLSIMCE | C96679 | Immature Plasma Cells | A measurement of the immature plasma cells in a biological specimen. | Immature Plasma Cell Count | ||
PLSIMCLY | C96680 | Immature Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen. | Immature Plasma Cell to Lymphocyte Ratio Measurement | ||
PLSMCE | C74661 | Mature Plasma Cells;Plasmacytes;Plasmocytes | A measurement of the mature plasma cells (plasmacytes) in a biological specimen. | Mature Plasma Cell Count | ||
PLSMCECE | C98869 | Mature Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). | Mature Plasma Cell to Total Cell Ratio Measurement | ||
PLSMCELY | C74911 | Mature Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen. | Mature Plasma Cell to Lymphocyte Ratio Measurement | ||
PLSNCE | C172494 | Monoclonal Plasma Cells;Monotypic Plasma Cells;Neoplastic Plasma Cells | A measurement of the neoplastic plasma cells in a biological specimen. | Neoplastic Plasma Cell Count | ||
PLSPCE | C74619 | Plasmablast;Precursor Plasma Cells | A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. | Precursor Plasma Cell Count | ||
PLSPCELY | C74650 | Precursor Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen. | Precursor Plasma Cell to Lymphocyte Ratio Measurement | ||
PLSTCE | C128974 | Total Plasma Cells | A measurement of the total plasma cells in a biological specimen. | Plasma Cell Count | ||
PLSTCECE | C187987 | Total Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. | Plasma Cell to Total Cell Ratio Measurement | ||
PLSTCELE | C128975 | Total Plasma Cells/Leukocytes | A relative measurement (ratio or percentage) of the total plasma cells to leukocytes in a biological specimen. | Plasma Cells to Leukocytes Ratio Measurement | ||
PLSTCELY | C189499 | Total Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the total plasma cells to lymphocytes in a biological specimen. | Plasma Cell to Lymphocyte Ratio Measurement | ||
PLTAGAMP | C111293 | Platelet Aggregation Amplitude | A measurement of the magnitude of the platelet aggregation in a biological specimen. | Platelet Aggregation Amplitude Measurement | ||
PLTIMPLT | C170580 | Immature Platelet Fraction;Immature Platelets/Total Platelets;IPF;Reticulated Platelets/Total Platelets | A relative measurement (ratio or percentage) of immature platelets to total platelets in a biological specimen. | Immature Platelets to Total Platelets Ratio Measurement | ||
PLTLPLT | C161353 | Large Platelets/Total Platelets;Platelet Large Cell Ratio;PLCR | A relative measurement (ratio or percentage) of large platelets to total platelets in a biological specimen. | Large Platelets to Total Platelets Ratio Measurement | ||
PLTMORPH | C111296 | Platelet Morphology | An examination or assessment of the form and structure of platelets. | Platelet Morphology Measurement | ||
PMDW | C132380 | Platelet Mass Distribution Width | A measurement which represents the variation defined by two standard deviations of the platelet dry mass distribution in a biological specimen. | Platelet Mass Distribution Width | ||
PMYCECE | C127634 | Proliferating Myeloid Cells/Total Cells | A relative measurement (ratio or percentage) of the proliferating myeloid cells to total cells in a biological specimen. | Proliferating Myeloid Cell to Total Cell Ratio Measurement | ||
PNCTPP | C80201 | Pancreatic Polypeptide | A measurement of the pancreatic polypeptide in a biological specimen. | Pancreatic Polypeptide Measurement | ||
PNTBRBTL | C75367 | Pentobarbital | A measurement of the pentobarbital present in a biological specimen. | Pentobarbital Measurement | ||
PNTZOCIN | C184632 | Pentazocine | A measurement of the pentazocine in a biological specimen. | Pentazocine Measurement | ||
PO2 | C71251 | PaO2;Partial Pressure Oxygen;Po2;pO2 | A measurement of the pressure of oxygen in a biological specimen. | Partial Pressure of Oxygen Measurement | ||
PO2ADJT | C147417 | Partial Pressure Oxygen Adj for Temp | A measurement of the pressure of oxygen, which has been adjusted for body temperature, in a biological specimen. | Partial Pressure of Oxygen Adjusted for Body Temperature Measurement | ||
PO2FIO2 | C119293 | PAO2/FIO2;PP Arterial O2/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. | Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement | ||
POIKILO | C79602 | Poikilocytes | A measurement of the odd-shaped erythrocytes in a whole blood specimen. | Poikilocyte Measurement | ||
POIKRBC | C74649 | Poikilocytes/Erythrocytes | A relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen. | Poikilocyte to Erythrocyte Ratio Measurement | ||
POLYCHR | C64803 | Polychromasia | A measurement of the blue-staining characteristic of newly generated erythrocytes. | Polychromasia | ||
POLYERY | C147418 | Polychromatophilic Erythroblast | A measurement of the polychromatophilic erythroblasts in a biological specimen taken from a non-human organism. | Polychromatophilic Erythroblast Count | ||
POLYNORM | C147419 | Polychromatophilic Normoblast | A measurement of the polychromatophilic normoblasts in a biological specimen taken from a non-human organism. | Polychromatophilic Normoblast Count | ||
PORPH | C120648 | Porphyrin | A measurement of the total porphyrin in a biological specimen. | Porphyrin Measurement | ||
PPA | C174297 | Beta-Hydroxyamphetamine;Norephedrine;Phenylpropanolamine | A measurement of the phenylpropanolamine in a biological specimen. | Phenylpropanolamine Measurement | ||
PPI | C161358 | Inorganic Pyrophosphate | A measurement of the inorganic pyrophosphate in a biological specimen. | Inorganic Pyrophosphate Measurement | ||
PPIA | C187819 | Cyclophilin A;CYPA;Peptidylprolyl Isomerase A;Rotamase A | A measurement of the peptidylprolyl isomerase A in a biological specimen. | Peptidylprolyl Isomerase A Measurement | ||
PPTDCALB | C147420 | Phosphatidylcholine/Albumin | A relative measurement (ratio or percentage) of the phosphatidylcholine to albumin in a biological specimen. | Phosphatidylcholine to Albumin Ratio Measurement | ||
PPTDETH | C187820 | PEth;Phosphatidylethanol | A measurement of the total phosphatidylethanol in a biological specimen. | Phosphatidylethanol Measurement | ||
PRAB | C116210 | Panel Reactive Antibody;Percent Reactive Antibody;PRA Score | A measurement of the panel reactive antibody that is achieved by mixing and assessing the reactivity between the recipient's immune cells and the donor's human leukocyte antigen, in which anti-HLA class I and class II antibody specificities are measured separately in a biological specimen. | Panel Reactive Antibody Test | ||
PRABC | C132381 | Calculated Panel Reactive Antibody | A measurement of the calculated panel reactive antibody, which is based on the number/type of unacceptable HLA antigens to which an organ recipient has been sensitized, and which algorithmically estimates the level of sensitization in the recipient. The CPRA is computed from HLA antigen frequencies in a given donor population using both anti-HLA class I and class II antibody specificities; it also represents the percentage of actual organ donors that express one or more unacceptable HLA antigens to which a recipient may react adversely. | Calculated Panel Reactive Antibody Measurement | ||
PRCTC | C132382 | Prostate Circulating Tumor Cells | A measurement of the prostate circulating tumor cells in a biological specimen. | Circulating Prostate Tumor Cell Count | ||
PREALB | C100435 | Prealbumin;Thyroxine-binding Prealbumin;Transthyretin | A measurement of the prealbumin in a biological specimen. | Prealbumin Measurement | ||
PREGBLN | C184642 | Pregabalin | A measurement of the pregabalin in a biological specimen. | Pregabalin Measurement | ||
PRGNENLN | C147421 | Pregnenolone | A measurement of the pregnenolone in a biological specimen. | Pregnenolone Measurement | ||
PRGNNDL | C186092 | Pregnanediol | A measurement of the pregnanediol in a biological specimen. | Pregnanediol Measurement | ||
PRINSINS | C111299 | Proinsulin/Insulin Ratio | A relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen. | Proinsulin to Insulin Ratio Measurement | ||
PRLYMLE | C64829 | Prolymphocytes/Leukocytes | A relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen. | Prolymphocyte to Leukocyte Ratio | ||
PRMPNL | C184596 | Perampanel | A measurement of the perampanel in a biological specimen. | Perampanel Measurement | ||
PRO | C122141 | Proline | A measurement of the proline in a biological specimen. | Proline Measurement | ||
PROAP | C198289 | Cytosol Aminopeptidase V;Proline Aminopeptidase;Proline Iminopeptidase;Prolyl Aminopeptidase | A measurement of the proline aminopeptidase in a biological specimen. | Proline Aminopeptidase Measurement | ||
PROC6 | C165979 | C-terminal Pro-Peptide of the Alpha 3 Type VI Collagen Chain;Endotrophin;Pro-C6 | A measurement of the pro-C6 in a biological specimen. | Pro-C6 Measurement | ||
PRODINEA | C184567 | Alphaprodine | A measurement of the alphaprodine in a biological specimen. | Alphaprodine Measurement | ||
PROGEST | C74791 | Progesterone | A measurement of the progesterone hormone in a biological specimen. | Progesterone Measurement | ||
PROGESTR | C117846 | NR3C3;PGR;PgR;PR;Progesterone Receptor | A measurement of the progesterone receptor protein in a biological specimen. | Progesterone Receptor Measurement | ||
PROGRP | C156523 | Pro-gastrin Releasing Peptide;proGRP | A measurement of the pro-gastrin releasing peptide in a biological specimen. | Pro-gastrin Releasing Peptide Measurement | ||
PROINSUL | C81967 | Proinsulin | A measurement of the proinsulin in a biological specimen. | Proinsulin Measurement | ||
PROLCTN | C74870 | Prolactin | A measurement of the prolactin hormone in a biological specimen. | Prolactin Measurement | ||
PROLYM | C74620 | Prolymphocytes | A measurement of the prolymphocytes in a biological specimen. | Prolymphocyte Count | ||
PROLYMLY | C74651 | Prolymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen. | Prolymphocyte to Lymphocyte Ratio Measurement | ||
PROMONCE | C187678 | Promonocytes/Total Cells | A relative measurement (ratio or percentage) of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen). | Promonocyte to Total Cell Ratio Measurement | ||
PROMONLE | C74652 | Promonocytes/Leukocytes | A relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen. | Promonocyte to Lymphocyte Ratio Measurement | ||
PROMONO | C74621 | Promonocytes | A measurement of the promonocytes in a biological specimen. | Promonocyte Count | ||
PROMY | C74622 | Promyelocytes | A measurement of the promyelocytes (immature myelocytes) in a biological specimen. | Promyelocyte Count | ||
PROMYB | C117847 | Promyeloblasts | A measurement of the promyeloblasts in a biological specimen. | Promyeloblasts Measurement | ||
PROMYCE | C98773 | Promyelocytes/Total Cells | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). | Promyelocyte to Total Cell Ratio Measurement | ||
PROMYLE | C74653 | Promyelocytes/Leukocytes | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen. | Promyelocyte to Lymphocyte Ratio Measurement | ||
PROPOX | C74885 | Propoxyphene | A measurement of the propoxyphene present in a biological specimen. | Propoxyphene Measurement | ||
PRORUB | C128976 | Basophilic Erythroblast;Basophilic Normoblast;Prorubricyte | A measurement of the prorubricytes in a biological specimen. | Prorubricyte Count | ||
PRORUBCE | C128977 | Prorubricyte/Total Cells | A relative measurement (ratio or percentage) of the prorubricytes to total cells in a biological specimen. | Prorubricyte to Total Cell Ratio Measurement | ||
PROT | C64858 | Protein | A measurement of the total protein in a biological specimen. | Total Protein Measurement | ||
PROTCRT | C79463 | Protein/Creatinine | A relative measurement (ratio or percentage) of the total protein to creatinine in a biological specimen. | Protein to Creatinine Ratio Measurement | ||
PROTEXR | C150822 | Protein Excretion Rate | A measurement of the amount of total protein being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Protein Excretion Rate | ||
PROTOSML | C92240 | Protein/Osmolality;Protein/Osmolality Ratio | A relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen. | Protein to Osmolality Ratio Measurement | ||
PROTPATN | C147422 | Protein Pattern | A measurement of the protein band pattern in a biological specimen. | Protein Pattern Measurement | ||
PROTRPTL | C191287 | Protriptyline | A measurement of the protriptyline present in a biological specimen. | Protriptyline Measurement | ||
PROTS | C100436 | Protein S | A measurement of the total protein S in a biological specimen. | Protein S Measurement | ||
PROTSFR | C122142 | Protein S, Free | A measurement of the unbound protein S in a biological specimen. | Free Protein S Measurement | ||
PRSTNZL | C184598 | Prostanozol | A measurement of the prostanozol in a biological specimen. | Prostanozol Measurement | ||
PRTN3AB | C120649 | Proteinase 3 Antibody | A measurement of the proteinase 3 antibody in a biological specimen. | Proteinase 3 Antibody Measurement | ||
PRZPM | C139080 | Prazepam | A measurement of the prazepam present in a biological specimen. | Prazepam Measurement | ||
PSA | C17634 | Prostate Specific Antigen | A measurement of the total prostate specific antigen in a biological specimen. | Prostate Specific Antigen Measurement | ||
PSAF | C132383 | Prostate Specific Antigen, Free | A measurement of the unbound prostate-specific antigen in a biological specimen. | Free Prostate Specific Antigen Measurement | ||
PSAFPSAT | C132384 | PSA, Free/PSA | A relative measurement (percentage) of the free prostate specific antigen to total prostate specific antigen in a biological specimen. | Free PSA to Total PSA Ratio Measurement | ||
PSAMRNA | C132385 | Prostate Specific Antigen mRNA | A measurement of the prostate-specific antigen mRNA in a biological specimen. | Prostate Specific Antigen mRNA Measurement | ||
PSDEPHD | C74696 | Pseudoephedrine | A measurement of the pseudoephedrine present in a biological specimen. | Pseudoephedrine Measurement | ||
PSDGLSRF | C147423 | Phosphatidylglycerol/Lung Surfactant;Phosphatidylglycerol/Pulmonary Surfactant | A relative measurement (ratio) of the phosphatidylglycerol to total lung surfactant in a biological specimen. | Phosphatidylglycerol to Lung Surfactant Ratio Measurement | ||
PSELECT | C117850 | GMP-140;P-Selectin | A measurement of total P-selectin in a biological specimen. | P-Selectin Measurement | ||
PSELECTS | C120650 | Soluble P-Selectin | A measurement of the soluble P-selectin in a biological specimen. | Soluble P-Selectin Measurement | ||
PSIGAAB | C122143 | Phosphatidylserine IgA Antibody | A measurement of the phosphatidylserine IgA antibody in a biological specimen. | Phosphatidylserine Antibody IgA Measurement | ||
PSIGGAB | C122144 | Phosphatidylserine IgG Antibody | A measurement of the phosphatidylserine IgG antibody in a biological specimen. | Phosphatidylserine Antibody IgG Measurement | ||
PSIGMAB | C122145 | Phosphatidylserine IgM Antibody | A measurement of the phosphatidylserine IgM antibody in a biological specimen. | Phosphatidylserine Antibody IgM Measurement | ||
PSLCYBN | C75356 | Magic Mushrooms;Psilocybin;Psilocybine | A measurement of the psilocybin in a biological specimen. | Psilocybine Measurement | ||
PSP100AB | C120651 | P100 Polymyositis-scleroderma Autoag Ab | A measurement of the p100 polymyositis-scleroderma overlap syndrome-associated autoantigen antibody in a biological specimen. | P100 Polymyositis-scleroderma Autoantigen Antibody Measurement | ||
PT | C62656 | Prothrombin Time | A blood clotting measurement that evaluates the extrinsic pathway of coagulation. | Prothrombin Time | ||
PTA | C98774 | Factor II Activity;Prothrombin Activity | A measurement of the biological activity of coagulation factor prothrombin in a biological specimen. | Prothrombin Activity Measurement | ||
PTAC | C170591 | Prothrombin Time Actual/Control | A relative measurement (ratio or percentage) of the prothrombin time in a subject's specimen when compared to a control specimen. | Prothrombin Time Actual to Control Ratio Measurement | ||
PTAUAB42 | C176312 | Phosphorylated Tau Prot/Amyloid Beta1-42;Phosphorylated Tau Protein/Amyloid Beta 1-42 | A relative measurement (ratio) of the phosphorylated Tau protein to amyloid beta 1-42 in a biological specimen. | Phosphorylated Tau Protein to Amyloid Beta1-42 Ratio Measurement | ||
PTF1 | C189514 | Prothrombin Fragment 1 | A measurement of the prothrombin fragment 1 in a biological specimen. | Prothrombin Fragment 1 Measurement | ||
PTF1_2 | C82034 | Prothrombin Fragments 1 + 2 | A measurement of the prothrombin fragments 1 and 2 in a biological specimen. | Prothrombin Fragments 1 and 2 Measurement | ||
PTF2 | C189513 | Prothrombin Fragment 2 | A measurement of the prothrombin fragment 2 in a biological specimen. | Prothrombin Fragment 2 Measurement | ||
PTHCT | C81964 | Parathyrin Hormone, C-Terminal;Parathyroid Hormone, C-Terminal | A measurement of the C-terminal fragment of parathyroid hormone in a biological specimen. | C-Terminal Parathyroid Hormone Measurement | ||
PTHFG | C74784 | Parathyrin Hormone, Fragmented;Parathyroid Hormone, Fragmented | A measurement of the fragmented parathyroid hormone in a biological specimen. | Fragmented Parathyroid Hormone Measurement | ||
PTHI | C74789 | Parathyrin, Intact;Parathyroid Hormone, Intact | A measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen. | Intact Parathyroid Hormone Measurement | ||
PTHMM | C81965 | Parathyrin Hormone, Mid-Molecule;Parathyroid Hormone, Mid-Molecule | A measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen. | Mid-Molecule Parathyroid Hormone Measurement | ||
PTHNT | C81966 | Parathyrin Hormone, N-Terminal;Parathyroid Hormone, N-Terminal | A measurement of the N-terminal fragment of parathyroid hormone in a biological specimen. | N-Terminal Parathyroid Hormone Measurement | ||
PTHRP | C117851 | Parathyrin Hormone-related Protein;Parathyroid Hormone-related Peptide;Parathyroid Hormone-related Protein | A measurement of parathyroid hormone-related protein in a biological specimen. | Parathyroid Hormone-related Protein Measurement | ||
PTHW | C103451 | Parathyrin Hormone, Whole;Parathyroid Hormone, Whole | A measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen. | Whole Parathyroid Hormone Measurement | ||
PTSAAC | C147424 | Protein S Activity Actual/Control;Protein S Activity Actual/Normal;Protein S Activity Actual/Protein S Activity Control | A relative measurement (ratio or percentage) of the biological activity of protein S in a subject's specimen when compared to the same activity in a control specimen. | Protein S Activity Actual to Control Ratio Measurement | ||
PTSAC | C170593 | Protein S Actual/Control | A relative measurement (ratio or percentage) of the protein S in a subject's specimen when compared to a control specimen. | Protein S Actual to Control Ratio Measurement | ||
PTSFAAC | C147425 | Protein S Free Activity Actual/Control;Protein S Free Activity Actual/Normal;Protein S Free Activity Actual/Protein S Free Activity Control | A relative measurement (ratio or percentage) of the biological activity of free protein S in a subject's specimen when compared to the same activity in a control specimen. | Free Protein S Activity Actual to Control Ratio Measurement | ||
PTSFAC | C170596 | Protein S, Free Actual/Control | A relative measurement (ratio or percentage) of the free protein S in a subject's specimen when compared to a control specimen. | Free Protein S Actual to Control Ratio Measurement | ||
PTT | C178140 | Partial Thromboplastin Time | A measurement of the length of time that it takes for clotting to occur when no activating reagents are added to a biological specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. | Partial Thromboplastin Time | ||
PTTSTND | C187818 | Partial Thromboplastin Time/Standard Thromboplastin Time;PTT/Standard;PTT/Standard PTT | A relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time. | Partial Thromboplastin Time to Standard Thromboplastin Time Ratio Measurement | ||
PUS | C161359 | Pus | A measurement of the pus in a biological specimen. | Pus Measurement | ||
PYDCREAT | C147426 | Pyridinoline/Creatinine | A relative measurement (ratio or percentage) of the pyridinoline to creatinine in a biological specimen. | Pyridinoline to Creatinine Ratio Measurement | ||
PYK | C156470 | PK;Pyruvate Kinase | A measurement of the total pyruvate kinase in a biological specimen. | Pyruvate Kinase Measurement | ||
PYKCE | C189346 | Karyopyknotic Cells;Pyknotic Cells | A measurement of the pyknotic cells in a biological specimen. | Pyknotic Cell Count | ||
PYOCYTES | C156524 | Pyocytes | A measurement of the pyocytes in a biological specimen. | Pyocytes Measurement | ||
PYRIDNLN | C80211 | Pyridinoline | A measurement of the pyridinoline in a biological specimen. | Pyridinoline Measurement | ||
PYROVLRN | C184643 | Pyrovalerone | A measurement of the pyrovalerone in a biological specimen. | Pyrovalerone Measurement | ||
PYRUVATE | C147427 | Pyruvate;Pyruvic Acid | A measurement of the pyruvate in a biological specimen. | Pyruvate Measurement | ||
PYY | C80202 | Peptide Tyrosine Tyrosine;Peptide YY | A measurement of the peptide YY in a biological specimen. | Peptide YY Measurement | ||
QUETIAPN | C177965 | Quetiapine | A measurement of the quetiapine in a biological specimen. | Quetiapine Measurement | ||
QUZPM | C184634 | Quazepam | A measurement of the quazepam in a biological specimen. | Quazepam Measurement | ||
RAGE | C165980 | Advanced Glycosylation End-Product Specific Receptor;AGER;Receptor Advanced Glycation Endproducts | A measurement of the receptor advanced glycation endproducts in a biological specimen. | Receptor Advanced Glycation Endproducts Measurement | ||
RANKL | C117852 | Receptor Activator Nuclear KappaB Ligand;Receptor Activator of Nuclear Kappa-B Ligand | A measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen. | Receptor Activator Nuclear KappaB Ligand Measurement | ||
RANTES | C81957 | Chemokine Ligand 5;Reg upon Act Normal T-cell Exprd Secrtd | A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen. | Reg upon Act Normal T-cell Exprd Secrtd Measurement | ||
RBC | C51946 | Erythrocytes;Red Blood Cells | A measurement of the total erythrocytes in a biological specimen. | Erythrocyte Count | ||
RBCAGGLU | C111197 | Autoagglutination;Erythrocyte Agglutination;RBC Agglutination | A measurement of the erythrocyte agglutination in a biological specimen. | Erythrocyte Agglutination Measurement | ||
RBCCLMP | C92245 | Erythrocyte Cell Clumps;RBC Aggregates;RBC Clumps;Red Blood Cell Clumps | A measurement of red blood cell clumps in a biological specimen. | Erythrocyte Cell Clumps Measurement | ||
RBCDIPOP | C117853 | Dimorphic Erythrocyte Population;Dimorphic RBC Population | Examination of a biological specimen to detect the presence of dimorphic erythrocyte population. | Dimorphic Erythrocyte Population | ||
RBCDYRBC | C150839 | Dysmorphic Erythrocytes/Erythrocytes | A measurement (ratio or percentage) of dysmorphic erythrocytes to total erythrocytes in a biological specimen. | Dysmorphic Erythrocytes to Erythrocytes Ratio Measurement | ||
RBCDYSM | C135441 | Dysmorphic Erythrocytes | A measurement of the dysmorphic erythrocytes in a biological specimen. | Dysmorphic Erythrocyte Count | ||
RBCFRAG | C116212 | Erythrocyte Fragment;RBC Fragment | A measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen. | Erythrocyte Fragment Measurement | ||
RBCGHOST | C96605 | Erythrocyte Ghosts;RBC Ghosts | A measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen. | Erythrocyte Ghost Count | ||
RBCMORPH | C92296 | Erythrocyte Cell Morphology;RBC Morphology;Red Blood Cell Morphology | An examination or assessment of the form and structure of red blood cells. | Erythrocyte Cell Morphology | ||
RBCNUC | C74705 | Nucleated Erythrocytes;Nucleated Red Blood Cells | A measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen. | Nucleated Red Blood Cell Count | ||
RBCNUCLE | C82046 | Nucleated Erythrocytes/Leukocytes | A relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen. | Nucleated Erythrocyte to Leukocyte Ratio Measurement | ||
RBCNURBC | C74647 | Nucleated Erythrocytes/Erythrocytes;Nucleated Red Blood Cells/Erythrocytes | A relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen. | Nucleated Red Blood Cell to Erythrocyte Ratio Measurement | ||
RBP | C100437 | Retinol Binding Protein | A measurement of the total retinol binding protein in a biological specimen. | Retinol Binding Protein Measurement | ||
RBP1 | C189526 | Retinol Binding Protein 1 | A measurement of the retinol binding protein 1 in a biological specimen. | Retinol Binding Protein 1 Measurement | ||
RBP2 | C189525 | Retinol Binding Protein 2 | A measurement of the retinol binding protein 2 in a biological specimen. | Retinol Binding Protein 2 Measurement | ||
RBP3 | C189524 | Retinol Binding Protein 3 | A measurement of the retinol binding protein 3 in a biological specimen. | Retinol Binding Protein 3 Measurement | ||
RBP4 | C189523 | Retinol Binding Protein 4 | A measurement of the retinol binding protein 4 in a biological specimen. | Retinol Binding Protein 4 Measurement | ||
RBPCREAT | C154729 | Retinol Binding Protein/Creatinine | A relative measurement (ratio or percentage) of the retinol binding protein to creatinine in a biological specimen. | Retinol Binding Protein to Creatinine Ratio Measurement | ||
RDCSUB | C147428 | Reducing Substances | A measurement of the reducing substances (e.g., sugars, glutathione, creatinine, uric acid, and ascorbic acid) in a biological specimen. | Reducing Substance Measurement | ||
RDCSUG | C147429 | Reducing Sugars | A measurement of the reducing sugars in a biological specimen. | Reducing Sugar Measurement | ||
RDW | C64800 | Erythrocytes Distribution Width;RDW-CV;Red Blood Cell Distribution Width;Red Cell Volume Distribution Width | A relative measurement (ratio or percentage) of the standard deviation of the red blood cell volume to the mean distribution of the red blood cell volume in a biological specimen. | Erythrocyte Distribution Width Measurement | ||
RDWR | C139074 | RDWr;Ret Volume Distribution Width;Reticulocyte Volume Distribution Width | A relative measurement (ratio or percentage) of the standard deviation of the reticulocyte volume to the mean distribution of the reticulocyte volume in a biological specimen. | Reticulocyte Volume Distribution Width | ||
RDWRCV | C139072 | RDWr-CV;Red Cell Volume Distribution Width Coefficient of Variation in Reticulocytes;Ret RDW Coefficient of Variation;Reticulocyte Volume Distribution Width Coefficient of Variation | A measurement of the volume dispersion within a reticulocyte population, calculated as the standard deviation of the mean reticulocyte volume divided by the mean reticulocyte volume, multiplied by 100 to convert to a percentage. | Reticulocyte Volume Distribution Width Coefficient of Variation | ||
RDWRSD | C139073 | RDWr-SD;Red Cell Volume Distribution Width Standard Deviation in Reticulocytes;Ret RDW Standard Deviation;Reticulocyte Volume Distribution Width Standard Deviation | A measurement of the volume dispersion within a reticulocyte population, calculated as the width of the distribution curve at the 20 percent frequency level. | Reticulocyte Volume Distribution Width Standard Deviation | ||
RDWSD | C139071 | RDW Standard Deviation;RDW-SD;Red Cell Volume Distribution Width Standard Deviation | A measurement of the volume dispersion within an erythrocyte population, calculated as the width of the distribution curve at the 20 percent frequency level. | Red Cell Volume Distribution Width Standard Deviation | ||
RENIN | C74893 | Active Renin;Angiotensinogenase;Direct Renin;Renin | A measurement of the renin in a biological specimen. | Renin Measurement | ||
RENINA | C111305 | Renin Activity | A measurement of the renin activity in a biological specimen. | Renin Activity Measurement | ||
RESISTIN | C80205 | Resistin | A measurement of the resistin in a biological specimen. | Resistin Measurement | ||
RETCRRBC | C102274 | HCT Corrected Reticulocytes/Erythrocytes | A relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen. | Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement | ||
RETI | C51947 | Reticulocytes | A measurement of the reticulocytes in a biological specimen. | Reticulocyte Count | ||
RETICE | C187680 | Reticulocytes/Total Cells | A relative measurement (ratio or percentage) of reticulocytes to total cells in a biological specimen. | Reticulocyte to Total Cell Ratio Measurement | ||
RETICH | C98776 | CHr;Ret. Corpuscular Hemoglobin Content;Reticulocyte Cellular Hemoglobin Content | A measurement of the average total amount of hemoglobin per reticulocyte. | Reticulocyte Corpuscular Hemoglobin Content | ||
RETIH | C116188 | High Absorption Reticulocytes | A measurement of the high absorption reticulocytes in a biological specimen. | High Absorption Reticulocyte Measurement | ||
RETIHCR | C102273 | Hematocrit Corrected Reticulocytes | A measurement of the hematocrit corrected reticulocytes in a biological specimen. | Hematocrit Corrected Reticulocyte Count | ||
RETIHRTC | C116189 | High Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen. | High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
RETIL | C116190 | Low Absorption Reticulocytes | A measurement of the low absorption reticulocytes in a biological specimen. | Low Absorption Reticulocyte Measurement | ||
RETILRTC | C116191 | Low Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen. | Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
RETIM | C116192 | Medium Absorption Reticulocytes | A measurement of the medium absorption reticulocytes in a biological specimen. | Medium Absorption Reticulocyte Measurement | ||
RETIMRTC | C116193 | Medium Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen. | Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
RETINOAC | C187824 | Retinoate;Retinoic Acid | A measurement of the retinoic acid in a biological specimen. | Retinoic Acid Measurement | ||
RETIRBC | C64828 | Reticulocytes/Erythrocytes | A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen. | Reticulocyte to Erythrocyte Ratio | ||
RETPALM | C135442 | Retinol Palmitate;Retinyl Palmitate;Vitamin A Palmitate | A measurement of the endogenous retinyl palmitate vitamin A in a biological specimen. | Retinyl Palmitate Measurement | ||
RF | C74717 | Rheumatoid Factor | A measurement of the rheumatoid factor antibody in a biological specimen. | Rheumatoid Factor Measurement | ||
RFIGAAB | C120652 | Rheumatoid Factor IgA Antibody | A measurement of the rheumatoid factor IgA antibody in a biological specimen. | Rheumatoid Factor Antibody IgA Measurement | ||
RFIGGAB | C120653 | Rheumatoid Factor IgG Antibody | A measurement of the rheumatoid factor IgG antibody in a biological specimen. | Rheumatoid Factor Antibody IgG Measurement | ||
RFIGMAB | C120654 | Rheumatoid Factor IgM Antibody | A measurement of the rheumatoid factor IgM antibody in a biological specimen. | Rheumatoid Factor Antibody IgM Measurement | ||
RH | C92948 | Rh Factor | A measurement of non-specified Rhesus factor antigen(s) in a biological specimen. | Rh Factor Measurement | ||
RHD | C125948 | RhD Factor | A measurement of the Rhesus factor D antigen in a biological specimen. | RhD Factor Measurement | ||
RITALAC | C170582 | Ritalinic Acid | A measurement of the ritalinic acid in a biological specimen. | Ritalinic Acid Measurement | ||
RLP | C120655 | RLP Cholesterol | A measurement of the cholesterol remnant-like particles in a biological specimen. | Remnant-like Particle Cholesterol Measurement | ||
RMNTLP | C120656 | Remnant Lipoprotein | A measurement of the remnant lipoproteins in a biological specimen. | Remnant Lipoprotein Measurement | ||
RNA | C132301 | Ribonucleic Acid | A measurement of a targeted ribonucleic acid (RNA) in a biological specimen. | Ribonucleic Acid Measurement | ||
RNP70AB | C120657 | Ribonucleoprotein-70 Antibody;snRNP70 Antibody | A measurement of the small nuclear ribonucleoprotein 70 antibody in a biological specimen. | Ribonucleoprotein-70 Antibody Measurement | ||
RNPAB | C100457 | Ribonucleoprotein Antibody;Ribonucleoprotein Extractable Nuclear Antibody;RNP Antibody | A measurement of the total ribonucleoprotein antibodies in a biological specimen. | Ribonucleoprotein Antibody Measurement | ||
RNPSMAB | C120658 | Ribonucleoprotein Smith Complex Antibody | A measurement of the ribonucleoprotein Smith complex antibody in a biological specimen. | Ribonucleoprotein Smith Complex Antibody Measurement | ||
ROM | C122146 | Reactive Oxygen Metabolite | A measurement of the reactive oxygen metabolite in a biological specimen. | Reactive Oxygen Metabolite Measurement | ||
ROULEAUX | C74624 | Rouleaux Formation | A measurement of the stacking red blood cells in a biological specimen. | Rouleaux Formation Count | ||
ROUNDCE | C142288 | Round Cells | A measurement of the round cells (round shaped cells mainly comprised of white blood cells and immature spermatogenic cells) in a biological specimen. | Round Cell Count | ||
RP3IGGAB | C122147 | RNA Polymerase III IgG Antibody | A measurement of the RNA polymerase III IgG antibody in a biological specimen. | RNA Polymerase III IgG Antibody Measurement | ||
RPA1 | C142289 | Renal Papillary Antigen 1 | A measurement of the renal papillary antigen 1 in a biological specimen. | Renal Papillary Antigen 1 Measurement | ||
RPPAB | C120659 | Ribosomal P Protein Antibody | A measurement of the total ribosomal P protein antibody in a biological specimen. | Ribosomal P Protein Antibody Measurement | ||
RPTLAAC | C147430 | Reptilase Activity Actual/Control;Reptilase Activity Actual/Normal;Reptilase Activity Actual/Reptilase Activity Control | A relative measurement (ratio or percentage) of the biological activity of reptilase dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Reptilase Activity Actual to Control Ratio Measurement | ||
RPTLTIME | C96628 | Reptilase Time | A measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase. | Reptilase Time Measurement | ||
RSAD2 | C163484 | Cytomegalovirus-Induced Gene 5 Protein;Radical S-adenosyl Methionine Domain-Containing Protein 2 | A measurement of the cytomegalovirus-induced gene 5 protein in a biological specimen. | Cytomegalovirus-Induced Gene 5 Protein Measurement | ||
RSOH9RS | C177971 | Risperidone+9-Hydroxyrisperidone;Risperidone+Paliperidone | A measurement of the risperidone and 9-hydroxyrisperidone in a biological specimen. | Risperidone and 9-Hydroxyrisperidone Measurement | ||
RSPDN | C177969 | Risperidone | A measurement of the risperidone in a biological specimen. | Risperidone Measurement | ||
RT3 | C81968 | Triiodothyronine, Reverse | A measurement of the reverse triiodothyronine in a biological specimen. | Reverse Triiodothyronine Measurement | ||
RUB | C128978 | Polychromatophilic Erythroblast;Polychromatophilic Normoblast;Rubricyte | A measurement of the rubricytes in a biological specimen. | Rubricyte Count | ||
RUBCE | C129006 | Rubricyte/Total Cells | A relative measurement (ratio or percentage) of the rubricytes to total cells in a biological specimen. | Rubricyte to Total Cell Ratio Measurement | ||
S100A8 | C154730 | S100 Calcium Binding Protein A8 | A measurement of the S100 calcium binding protein A8 in a biological specimen. | S100 Calcium Binding Protein A8 Measurement | ||
S100B | C127635 | S100 Calcium-Binding Protein B | A measure of the S100 calcium-binding protein B in a biological specimen. | S100 Calcium-Binding Protein B Measurement | ||
S6PHS | C165981 | Phos-S6 Ribosomal Protein;Phosphorylated S6 protein of the 40S ribosomal subunit | A measurement of the phosphorylated S6 protein of the 40S ribosomal subunit in a biological specimen. | Phosphorylated 40S Ribosomal Protein S6 Measurement | ||
SAA1 | C165982 | PIG4;SAA1;Serum Amyloid A-1 Protein;Serum Amyloid A1 | A measurement of the serum amyloid A1 in a biological specimen. | Serum Amyloid A1 Measurement | ||
SAAG | C186093 | SAAG;Serum-Ascites Albumin Gradient | A measurement of the serum-ascites albumin gradient, calculated by subtracting the amount of albumin in ascites fluid from the albumin in serum. | Serum-Ascites Albumin Gradient Measurement | ||
SAHOMC | C172516 | S-adenosyl-L-homocysteine;S-Adenosylhomocysteine;SAH | A measurement of the S-adenosylhomocysteine in a biological specimen. | S-Adenosylhomocysteine Measurement | ||
SALCYLT | C147431 | Salicylates | A measurement of the salicylates in a biological specimen. | Salicylates Measurement | ||
SAMETH | C172515 | S-adenosyl-L-methionine;S-Adenosylmethionine;SAM-e;SAMe;SAMMY | A measurement of the S-adenosylmethionine in a biological specimen. | S-Adenosylmethionine Measurement | ||
SAO2FIO2 | C174311 | Oxygen Saturation/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. | Oxygen Saturation/Fraction Inspired O2 | ||
SARCOSIN | C154760 | N-Methylglycine;Sarcosine | A measurement of the sarcosine in a biological specimen. | Sarcosine Measurement | ||
SBUTRMN | C184635 | Sibutramine | A measurement of the sibutramine in a biological specimen. | Sibutramine Measurement | ||
SCBRBTL | C75369 | Secobarbital | A measurement of the secobarbital present in a biological specimen. | Secobarbital Measurement | ||
SCCAG | C120660 | Squamous Cell Carcinoma Antigen | A measurement of the squamous cell carcinoma antigen in a biological specimen. | Squamous Cell Carcinoma Antigen Measurement | ||
SCF | C82035 | KIT Ligand;Stem Cell Factor | A measurement of the stem cell factor in a biological specimen. | Stem Cell Factor Measurement | ||
SCHISRBC | C186094 | Schistocytes/Erythrocytes | A relative measure (ratio or percentage) of schistocytes to erythrocytes in a biological specimen. | Schistocyte to Erythrocyte Ratio Measurement | ||
SCHISTO | C74706 | Schistocytes | A measurement of the schistocytes (fragmented red blood cells) in a biological specimen. | Schistocyte Count | ||
SCKCERBC | C74656 | Sickle Cells/Erythrocytes | A relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen. | Sickle Cell to Erythrocyte Ratio Measurement | ||
SCKLCE | C74626 | Drepanocytes;Sickle Cells | A measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen. | Sickle Cell Count | ||
SCL70AB | C100458 | Scl-70 Antibody;Scleroderma-70 Antibody | A measurement of the total Scl-70 antibody in a biological specimen. | Scl-70 Antibody Measurement | ||
SCL70GAB | C122148 | Scl-70 IgG Antibody;Scleroderma-70 IgG Antibody | A measurement of the Scl-70 IgG antibody in a biological specimen. | Scl-70 IgG Antibody Measurement | ||
SCN | C154745 | Thiocyanate | A measurement of the thiocyanate in a biological specimen. | Thiocyanate Measurement | ||
SCNYLACT | C186095 | Succinylacetone | A measurement of the succinylacetone in a biological specimen. | Succinylacetone Measurement | ||
SDH | C79465 | Sorbitol Dehydrogenase | A measurement of the sorbitol dehydrogenase in a biological specimen. | Sorbitol Dehydrogenase Measurement | ||
SDMA | C158232 | N,N'-dimethylarginine;Symmetric Dimethylarginine | A measurement of the symmetric dimethylarginine in a biological specimen. | Symmetric Dimethylarginine Measurement | ||
SE | C187825 | Selenium | A measurement of the selenium in a biological specimen. | Selenium Measurement | ||
SECRETIN | C74871 | Secretin | A measurement of the secretin hormone in a biological specimen. | Secretin Measurement | ||
SEDEXAM | C105744 | Microscopic Sediment Analysis;Sediment Analysis;Sediment Examination | An observation, assessment or examination of the sediment in a biological specimen. | Sediment Analysis | ||
SER | C122149 | Serine | A measurement of the serine in a biological specimen. | Serine Measurement | ||
SERTRAL | C147432 | Sertraline | A measurement of the sertraline present in a biological specimen. | Sertraline Measurement | ||
SERTRALN | C187817 | Norsertraline | A measurement of the norsertraline in a biological specimen. | Norsertraline Measurement | ||
SEZCE | C74625 | Sezary Cells | A measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen. | Sezary Cell Count | ||
SEZCELE | C158231 | Sezary Cells/Leukocytes | A relative measurement (ratio or percentage) of the Sezary cells to all leukocytes in a biological specimen. | Sezary Cells to Leukocytes Ratio Measurement | ||
SEZCELY | C74655 | Sezary Cells/Lymphocytes | A relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen. | Sezary Cell to Lymphocyte Ratio Measurement | ||
SFTPD | C111322 | SP-D;Surfactant Protein D | A measurement of the surfactant protein D in a biological specimen. | Surfactant Protein D Measurement | ||
SH2D1A | C165983 | DSHP;Duncan Disease SH2-Protein;EBVS;IMD5;LYP;MTCP1;SAP;SAP/SH2D1A;SH2 Domain Containing 1A Protein;XLP;XLPD;XLPD1 | A measurement of the SH2 domain containing 1A protein in a biological specimen. | SH2 Domain Containing 1A Protein Measurement | ||
SHBG | C74745 | Sex Hormone Binding Globulin;Sex Hormone Binding Protein | A measurement of the sex hormone binding (globulin) protein in a biological specimen. | Sex Hormone Binding Protein Measurement | ||
SHH | C177989 | Sonic Hedgehog | A measurement of the sonic hedgehog protein in a biological specimen. | Sonic Hedgehog Measurement | ||
SICAM1 | C132386 | Soluble Intercell Adhesion Molecule 1 | A measurement of the soluble intercellular adhesion molecule 1 in a biological specimen. | Soluble Intercellular Adhesion Molecule 1 Measurement | ||
SICAM4 | C186096 | Soluble Intercell Adhesion Molecule 4;Soluble Intercellular Adhesion Molecule 4 | A measurement of the soluble intercellular adhesion molecule 4 in a biological specimen. | Soluble Intercellular Adhesion Molecule 4 Measurement | ||
SIXMAM | C74876 | 6-Monoacetylmorphine | A measurement of the 6-monoacetylmorphine present in a biological specimen. | 6-Monoacetylmorphine Measurement | ||
SJSA52AB | C120661 | Sjogrens SS-A52 Antibody | A measurement of the Sjogrens SS-A52 antibody in a biological specimen. | Sjogrens SS-A52 Antibody Measurement | ||
SJSA60AB | C120662 | Sjogrens SS-A60 Antibody | A measurement of the Sjogrens SS-A60 antibody in a biological specimen. | Sjogrens SS-A60 Antibody Measurement | ||
SJSSAAB | C92236 | Ro Antibody;Sjogrens SS-A Antibody | A measurement of the Sjogrens SS-A antibody in a biological specimen. | Sjogren's SS-A Antibody Measurement | ||
SJSSBAB | C92237 | La Antibody;Sjogrens SS-B Antibody | A measurement of the Sjogrens SS-B antibody in a biological specimen. | Sjogren's SS-B Antibody Measurement | ||
SLAIGGAB | C122150 | Soluble Liver Antigen IgG Antibody | A measurement of the soluble liver antigen IgG antibody in a biological specimen. | Soluble Liver Antigen IgG Antibody Measurement | ||
SLTFRNRC | C100438 | Soluble Transferrin Receptor | A measurement of the soluble transferrin receptor in a biological specimen. | Soluble Transferrin Receptor Measurement | ||
SLXAG | C114223 | Sialyl Lewis X Antigen;Sialyl Lex;Sialyl SSEA-1 Antigen;Sialyl-CD15;SLeX | A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen. | Sialyl SSEA-1 Antigen Measurement | ||
SMDGCE | C74627 | Basket Cells;Gumprecht Shadow Cells;Shadow Cells;Smudge Cells | A measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen. | Smudge Cell Count | ||
SMDGCELE | C119294 | Basket Cells/Leukocytes;Gumprecht Shadow Cells/Leukocytes;Shadow Cells/Leukocytes;Smudge Cells/Leukocytes | A relative measurement (ratio or percentage) of smudge cells to leukocytes in a biological specimen. | Smudge Cells to Leukocytes Ratio Measurement | ||
SMRP | C189495 | Soluble Mesothelin Related Peptides;Soluble Mesothelin Related Proteins | A measurement of the soluble mesothelin related peptides in a biological specimen. | Soluble Mesothelin Related Peptides Measurement | ||
SMTHAB | C92281 | Smith Antibody;Smith Extractable Nuclear Antibody | A measurement of the total Smith antibodies in a biological specimen. | Smith Antibody Measurement | ||
SMUSCAB | C111317 | Anti-Smooth Muscle Antibody;Smooth Muscle Antibody | A measurement of the total smooth muscle antibody in a biological specimen. | Smooth Muscle Antibody Measurement | ||
SMUSCGAB | C122151 | Actin IgG Antibody;Smooth Muscle IgG Antibody | A measurement of the smooth muscle IgG antibody in a biological specimen. | Smooth Muscle IgG Antibody Measurement | ||
SO2 | C114224 | Sulfur Dioxide | A measurement of the sulfur dioxide in a biological specimen. | Sulfur Dioxide Measurement | ||
SODIUM | C64809 | Sodium | A measurement of the sodium in a biological specimen. | Sodium Measurement | ||
SODMEXR | C150823 | Sodium Excretion Rate | A measurement of the amount of sodium being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Sodium Excretion Rate | ||
SOMATRO | C80360 | Growth Hormone;Somatotrophin;Somatotropin | A measurement of the somatotrophin (growth) hormone in a biological specimen. | Somatotrophin Measurement | ||
SOST | C117857 | Sclerostin | A measurement of the sclerostin in a biological specimen. | Sclerostin Measurement | ||
SPERM | C74663 | Spermatozoa | A measurement of the spermatozoa cells present in a biological specimen. | Spermatozoa Cell Count | ||
SPERMMTL | C102281 | Sperm Motility | A measurement of the sperm capable of forward, progressive movement in a semen specimen. | Sperm Motility Measurement | ||
SPERMP | C161366 | Spermatozoa, Progressive | A measurement of the progressive spermatozoa (motile in a forward direction) in a biological specimen. | Progressive Spermatozoa Measurement | ||
SPGRAV | C64832 | Specific Gravity | A ratio of the density of a fluid to the density of water. | Specific Gravity | ||
SPHERO | C74707 | Spherocytes | A measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen. | Spherocyte Count | ||
SPLA2II | C120663 | Type II Secretory Phospholipase A2 | A measurement of the type II secretory phospholipase A2 in a biological specimen. | Type II Secretory Phospholipase A2 Measurement | ||
SPMAGGLU | C142290 | Sperm Agglutination | A measurement of the motile spermatozoa agglutination in a biological specimen. | Sperm Agglutination Measurement | ||
SPMAGGR | C142291 | Sperm Aggregation | A measurement of the immotile spermatozoa aggregation in a biological specimen. | Sperm Aggregation Measurement | ||
SPMMSPM | C147433 | Motile Sperm/Total Sperm | A relative measurement (ratio or percentage) of the motile sperm to total sperm in a biological specimen. | Motile Sperm to Total Sperm Ratio Measurement | ||
SPMPSPM | C161365 | Spermatozoa, Progressive/Spermatozoa | A relative measurement (ratio or percentage) of the progressive spermatozoa to total spermatozoa in a biological specimen. | Progressive Spermatozoa to Total Spermatozoa Ratio Measurement | ||
SPWEIGHT | C106569 | Specimen Weight | A measurement of the weight of a biological specimen. | Specimen Weight Measurement | ||
SRPNA12 | C198290 | OL-64;Serpin A12;Serpin Family A Member 12;Vaspin;Visceral Adipose Tissue-Derived Serpin | A measurement of the serpin A12 in a biological specimen. | Serpin A12 Measurement | ||
SRTONIN | C74872 | Serotonin | A measurement of the serotonin hormone in a biological specimen. | Serotonin Measurement | ||
SSTR2 | C165984 | Somatostatin Receptor Type 2;SRIF-1 | A measurement of the somatostatin receptor type 2 in a biological specimen. | Somatostatin Receptor Type 2 Measurement | ||
STAT3 | C156469 | Signal Transducer and Activator of Transcription 3;STAT3 | A measurement of the STAT3 (signal transducer and activator of transcription 3) in a biological specimen. | STAT3 Measurement | ||
STAT3P | C156521 | Phosphorylated STAT3;pSTAT3 | A measurement of the phosphorylated STAT3 (signal transducer and activator of transcription 3) in a biological specimen. | Phosphorylated STAT3 Measurement | ||
STAT3PS3 | C156522 | Phosphorylated STAT3/STAT3;pSTAT3/STAT3 | A relative measurement (ratio or percentage) of the phosphorylated STAT3 to total STAT3 in a biological specimen. | Phosphorylated STAT3 to STAT3 Ratio Measurement | ||
STBSEXCS | C154721 | Standard Base Excess | A calculated measurement of the amount of acid required to return blood with hemoglobin at 5g/dL, which is used as a surrogate for extracellular fluid, to a normal pH under standard conditions. | Standard Base Excess Measurement | ||
STIPBASO | C96567 | Basophilic Stippling | A measurement of the basophilic stippling in a biological specimen. | Basophilic Stippling Measurement | ||
STNBLN | C184600 | Deacetylanatrofin;Stenbolone | A measurement of the stenbolone in a biological specimen. | Stenbolone Measurement | ||
STNZLL | C184599 | Stanozolol | A measurement of the stanozolol in a biological specimen. | Stanozolol Measurement | ||
STOMCY | C74708 | Stomatocytes | A measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen. | Stomatocyte Count | ||
STROPONI | C135443 | Skeletal Troponin I;sTnl | A measurement of the total skeletal troponin I in a biological specimen. | Skeletal Troponin I Measurement | ||
STS | C177993 | Steroid Sulfatase;Steryl-sulfatase | A measurement of the steroid sulfatase in a biological specimen. | Steroid Sulfatase Measurement | ||
SUFNTNL | C184575 | Sufentanil | A measurement of the sufentanil in a biological specimen. | Sufentanil Measurement | ||
SULFATE | C122153 | Sulfate;Sulphate | A measurement of the sulfate in a biological specimen. | Sulfate Measurement | ||
SVCAM1 | C92533 | Soluble Vasc Cell Adhesion Molecule 1 | A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen. | Soluble Vascular Cell Adhesion Molecule 1 | ||
SYNVCY | C191298 | Synoviocytes;Total Synoviocytes | A measurement of the total synoviocytes in a biological specimen. | Synoviocytes Cell Count | ||
SYNVCYLE | C191297 | Synoviocytes/Leukocytes;Total Synoviocytes/Leukocytes | A relative measurement (ratio or percentage) of the synoviocytes to all leukocytes in a biological specimen. | Synoviocytes to Leukocytes Ratio Measurement | ||
T3 | C74747 | Total T3;Triiodothyronine | A measurement of the total (free and bound) triiodothyronine in a biological specimen. | Triiodothyronine Measurement | ||
T3FR | C74787 | Free T3;Triiodothyronine, Free | A measurement of the free triiodothyronine in a biological specimen. | Free Triiodothyronine Measurement | ||
T3UP | C74748 | T3RU;T3U;Triiodothyronine Uptake | A measurement of the binding of triiodothyronine to thyroxine binding globulin protein in a biological specimen. | Triiodothyronine Uptake Measurement | ||
T4 | C74794 | Thyroxine;Total T4 | A measurement of the total (free and bound) thyroxine in a biological specimen. | Total Thyroxine Measurement | ||
T4FR | C74786 | Free T4;Thyroxine, Free | A measurement of the free thyroxine in a biological specimen. | Free Thyroxine Measurement | ||
T4FRIDX | C170598 | Thyroxine, Free Index | A measurement of the thyroid status in a biological specimen. This is calculated by a mathematical formula that takes into account the total thyroxine and unbound thyroxine binding globulins. | Free Thyroxine Index | ||
T4FRIND | C120664 | Thyroxine, Free, Indirect | An indirect measurement of the free thyroxine in a biological specimen. | Indirect Free Thyroxine Measurement | ||
TAP1 | C163486 | Antigen Peptide Transporter 1;Peptide Transporter TAP1 | A measurement of the peptide transporter TAP1 in a biological specimen. | Peptide Transporter TAP1 Measurement | ||
TAT | C106574 | Thrombin/Antithrombin;Thrombin/Antithrombin III | A relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample. | Thrombin to Antithrombin Ratio Measurement | ||
TATC | C161371 | TAT;Thrombin Antithrombin Complex;Thrombin Antithrombin Complex Antigen | A measurement of the thrombin-antithrombin complexes in a biological specimen. | Thrombin Antithrombin Complex Measurement | ||
TAU181P | C187821 | Phosphorylated Tau 181;Phosphorylated Tau Protein 181 | A measurement of the phosphorylated Tau protein 181 in a biological specimen. | Phosphorylated Tau Protein 181 Measurement | ||
TAURCRT | C158223 | Taurine/Creatinine | A relative measurement (ratio) of the taurine to the creatinine in a biological specimen. | Taurine to Creatinine Ratio Measurement | ||
TAURINE | C122154 | Tauric Acid;Taurine | A measurement of the taurine in a biological specimen. | Taurine Measurement | ||
TBG | C74746 | Thyroxine Binding Globulin | A measurement of the thyroxine binding globulin protein in a biological specimen. | Thyroxine Binding Globulin Protein Measurement | ||
TBP | C189496 | TATA Box Binding Protein;TATA-Binding Protein | A measurement of the TATA-box binding protein in a biological specimen. | TATA Box Binding Protein Measurement | ||
TCDCA | C176306 | Taurochenodeoxycholate;Taurochenodeoxycholic Acid | A measurement of the taurochenodeoxycholate in a biological specimen. | Taurochenodeoxycholate Measurement | ||
TCHT | C176301 | Taurocholate;Taurocholic Acid | A measurement of the taurocholate in a biological specimen. | Taurocholate Measurement | ||
TDTAG | C117859 | Terminal Deoxynucleotidyl Transferase Ag;Terminal Deoxynucleotidyl Transferase Antigen | A measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen. | Terminal Deoxynucleotidyl Transferase Antigen Measurement | ||
TEARDCY | C64801 | Dacryocytes;Tear Shaped Erythrocytes;Teardrop Cells | A measurement of dacryocytes in a biological specimen. | Dacryocyte Analysis | ||
TESTOS | C74793 | Testosterone;Total Testosterone | A measurement of the total (free and bound) testosterone in a biological specimen. | Total Testosterone Measurement | ||
TESTOSBA | C117860 | Bioavailable Testosterone | A measurement of bioavailable testosterone in a biological specimen. | Bioavailable Testosterone Measurement | ||
TESTOSFR | C74785 | Testosterone, Free | A measurement of the free testosterone in a biological specimen. | Free Testosterone Measurement | ||
TESTOSWB | C147434 | Testosterone, Weakly Bound | A measurement of the weakly bound testosterone (testosterone bound to albumin) in a biological specimen. | Weakly Bound Testosterone Measurement | ||
TFERRIN | C82037 | Transferrin | A measurement of the total transferrin in a biological specimen. | Transferrin Measurement | ||
TFRRNSAT | C98792 | Iron Binding Capacity Saturation;Iron Saturation;Iron to TIBC;Transferrin Saturation | A measurement of the iron bound to transferrin in a biological specimen. | Transferrin Saturation Measurement | ||
TGFA | C165985 | Transforming Growth Factor Alpha | A measurement of the transforming growth factor alpha in a biological specimen. | Transforming Growth Factor Alpha Measurement | ||
TGFB | C122155 | Transforming Growth Factor Beta | A measurement of the total transforming growth factor beta in a biological specimen. | Transforming Growth Factor Beta Measurement | ||
TGFB1 | C117861 | Transforming Growth Factor Beta 1 | A measurement of the transforming growth factor beta 1 in a biological specimen. | Transforming Growth Factor Beta 1 Measurement | ||
TGFB2 | C165986 | G-TSF;LDS4;TGF-beta2;Transforming Growth Factor Beta 2 | A measurement of the transforming growth factor beta 2 in a biological specimen. | Transforming Growth Factor Beta 2 Measurement | ||
TGFB3 | C165987 | ARVD;ARVD1;LDS5;RNHF;TGF-beta3;Transforming Growth Factor Beta 3 | A measurement of the transforming growth factor beta 3 in a biological specimen. | Transforming Growth Factor Beta 3 Measurement | ||
TGLOB | C103446 | TG;Thyroglobulin | A measurement of the thyroglobulin in a biological specimen. | Thyroglobulin Measurement | ||
TGLOBRR | C147435 | Thyroglobulin Recovery Rate | A measurement of the thyroglobulin recovery rate in a biological specimen obtained by measuring the thyroglobulin concentration before and after a known amount of thyroglobulin has been added to the specimen. | Thyroglobulin Recovery Rate | ||
THBD | C135444 | BDCA3;Thrombomodulin | A measurement of the thrombomodulin in a biological specimen. | Thrombomodulin Measurement | ||
THC | C147436 | Delta-9-Tetrahydrocannabinol;Tetrahydrocannabinol;THC | A measurement of the tetrahydrocannabinol in a biological specimen. | Tetrahydrocannabinol Measurement | ||
THCCOOH | C142293 | 11-Nor-Delta9-THC-9-Carboxylic Acid;THC-COOH | A measurement of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid present in a biological specimen. | 11-Nor-Delta9-THC-9-Carboxylic Acid Measurement | ||
THDCSL5A | C186097 | 5-Alpha Tetrahydrocortisol | A measurement of the 5-alpha tetrahydrocortisol in a biological specimen. | 5-Alpha Tetrahydrocortisol Measurement | ||
THEBAINE | C184577 | Thebaine | A measurement of the thebaine in a biological specimen. | Thebaine Measurement | ||
THEOPHYL | C105445 | Theophylline | A measurement of the Theophylline present in a biological specimen. | Theophylline Measurement | ||
THGSTNON | C184602 | Tetrahydrogestrinone | A measurement of the tetrahydrogestrinone in a biological specimen. | Tetrahydrogestrinone Measurement | ||
THIOPNTL | C184604 | Thiopental | A measurement of the thiopental in a biological specimen. | Thiopental Measurement | ||
THIORDZN | C177978 | Thioridazine | A measurement of the thioridazine in a biological specimen. | Thioridazine Measurement | ||
THIOTHXN | C177976 | Thiothixene | A measurement of the thiothixene in a biological specimen. | Thiothixene Measurement | ||
THMBAAC | C147437 | Thrombin Activity Actual/Control;Thrombin Activity Actual/Normal;Thrombin Activity Actual/Thrombin Activity Control | A relative measurement (ratio or percentage) of the biological activity of thrombin dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Thrombin Activity Actual to Control Ratio Measurement | ||
THMYLL | C184603 | Thiamylal | A measurement of the thiamylal in a biological specimen. | Thiamylal Measurement | ||
THR | C122156 | Threonine | A measurement of the threonine in a biological specimen. | Threonine Measurement | ||
THRCREAT | C158224 | Threonine/Creatinine | A relative measurement (ratio) of the threonine to the creatinine in a biological specimen. | Threonine to Creatinine Ratio Measurement | ||
THRMPTN | C74873 | Thrombopoietin | A measurement of the thrombopoietin hormone in a biological specimen. | Thrombopoietin Measurement | ||
THROMNUC | C111283 | Nucleated Thrombocytes;Thrombocytes | A measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates. | Nucleated Thrombocyte Count | ||
THYAB | C81990 | Thyroid Antibodies | A measurement of the thyroid antibodies in a biological specimen. | Thyroid Antibody Measurement | ||
THYATAB | C81992 | Thyroid Antithyroglobulin Antibodies | A measurement of the thyroid antithyroglobulin antibodies in a biological specimen. | Thyroid Antithyroglobulin Antibody Measurement | ||
THYPXD | C96639 | Thyroid Peroxidase;Thyroperoxidase | A measurement of the thyroperoxidase in a biological specimen. | Thyroperoxidase Measurement | ||
THYPXDAB | C96638 | Thyroid Antimicrosomal Antibody;Thyroperoxidase Antibody | A measurement of the thyroperoxidase antibody in a biological specimen. | Thyroperoxidase Antibody Measurement | ||
TIMM10 | C163487 | Translocase Inner Mitochondrial Membr 10;Translocase of Inner Mitochondrial Membrane 10 | A measurement of the translocase of inner mitochondrial membrane 10 in a biological specimen. | Translocase Inner Mitochondrial Membrane 10 Measurement | ||
TIMP1 | C82036 | Tissue Inhibitor of Metalloproteinase 1 | A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen. | Tissue Inhibitor of Metalloproteinase 1 Measurement | ||
TIMP1CRE | C106575 | TIMP1/Creatinine;Tissue Inhibitor of Metalloproteinase 1/Creatinine | A relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample. | Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement | ||
TIMP3 | C165988 | HSMRK222;K222;K222TA2;Metalloproteinase Inhibitor 3;SFD;Tissue Inhibitor of Metalloproteinase 3 | A measurement of the tissue inhibitor of metalloproteinase 3 in a biological specimen. | Tissue Inhibitor of Metalloproteinase 3 Measurement | ||
TK | C120665 | Thymidine Kinase | A measurement of the total thymidine kinase in a biological specimen. | Thymidine Kinase Measurement | ||
TK1 | C135445 | Thymidine Kinase 1;Thymidine Kinase, Cytosolic | A measurement of the thymidine kinase 1 in a biological specimen. | Thymidine Kinase 1 Measurement | ||
TK2 | C135446 | Thymidine Kinase 2;Thymidine Kinase, Mitochondrial | A measurement of the thymidine kinase 2 in a biological specimen. | Thymidine Kinase 2 Measurement | ||
TKG | C132387 | T-Kininogen | A measurement of the total T-kininogen in a biological specimen. | T-Kininogen Measurement | ||
TLCHT | C176309 | Taurolithocholate;Taurolithocholic Acid | A measurement of the taurolithocholate in a biological specimen. | Taurolithocholate Measurement | ||
TLYCE | C122157 | T-Cell Lymphocytes;T-Cells;T-Lymphocytes | A measurement of the total thymocyte-derived lymphocytes in a biological specimen. | T-Lymphocyte Count | ||
TLYMXM | C128979 | T-lymphocyte Crossmatch | A measurement to determine human leukocyte antigens (HLA) histocompatibility between the recipient and the donor by examining the presence or absence of the recipient's anti-HLA antibody reactivity towards HLA antigens expressed on the donor T-lymphocytes. | T-lymphocyte Crossmatch Measurement | ||
TMEPRDN | C184563 | Trimeperidine | A measurement of the trimeperidine in a biological specimen. | Trimeperidine Measurement | ||
TMZPM | C75376 | Temazepam | A measurement of the temazepam present in a biological specimen. | Temazepam Measurement | ||
TNF | C74751 | Tumor Necrosis Factor;Tumor Necrosis Factor alpha | A measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen. | Tumor Necrosis Factor Measurement | ||
TNF10 | C165989 | APO2L;CD253;TL2;TNF-Related Apoptosis-Inducing Ligand;TNFSF10;TNLG6A;TRAIL | A measurement of the total tumor necrosis factor superfamily member 10 in a biological specimen. | TNF Superfamily Member 10 Measurement | ||
TNF10R3 | C198291 | CD263;DcR1;TNF Receptor Superfamily Member 10c;TNF-Related Apoptosis-Inducing Ligand Receptor 3;TRAIL Receptor 3;TRAILR3 | A measurement of the TNF receptor superfamily member 10c in a biological specimen. | Tumor Necrosis Factor Receptor Superfamily Member 10c Measurement | ||
TNF12 | C165990 | APO3L;DR3LG;TNF Superfamily Member 12;TNLG4A;TWEAK | A measurement of the total tumor necrosis factor superfamily member 12 in a biological specimen. | TNF Superfamily Member 12 Measurement | ||
TNF12EXR | C156525 | TNF Superfamily Member 12 Excretion Rate;TWEAK Excretion Rate | A measurement of the amount of TNF superfamily member 12 being excreted in a biological specimen over a defined period of time (e.g. one hour). | TNF Superfamily Member 12 Excretion Rate | ||
TNF12S | C156526 | Soluble TNF Superfamily Member 12;Soluble TNFSF12 | A measurement of soluble tumor necrosis factor superfamily member 12 in a biological specimen. | Soluble TNF Superfamily Member 12 Measurement | ||
TNF5S | C174308 | Soluble CD154;Soluble CD40 Ligand;Soluble CD40L;Soluble CD40LG;Soluble gp39;Soluble T-BAM;Soluble TNF Superfamily Member 5;Soluble TNFSF5;Soluble TRAP | A measurement of the soluble tumor necrosis factor superfamily member 5 in a biological specimen. | Soluble TNF Superfamily Member 5 Measurement | ||
TNFAPI | C117862 | TNF-a Production Inhibition;TNF-a Production Inhibitory Activity | A measurement of TNF-a production inhibitory activity in a biological specimen. | TNF-a Production Inhibitory Activity Measurement | ||
TNFR1 | C120666 | CD120a;Tumor Necrosis Factor Receptor 1 | A measurement of the tumor necrosis factor receptor 1 (CD120a) in a biological specimen. | Tumor Necrosis Factor Receptor 1 Measurement | ||
TNFR1B | C165991 | CD120b;p75;p75TNFR;TBPII;TNF Receptor 1B;TNF-R-II;TNF-R75;TNFBR;TNFR1B;TNFR2;TNFR80;Tumor Necrosis Factor Receptor 2 | A measurement of the tumor necrosis factor receptor superfamily member 1B in a biological specimen. | TNF Receptor 1B Measurement | ||
TNFR5S | C174312 | Soluble B-cell Surface Antigen CD40;Soluble Bp50;Soluble CD40;Soluble CDW40;Soluble p50;Soluble TNF Receptor Superfamily Mem 5;Soluble TNF Receptor Superfamily Member 5;Soluble TNFRSF5;Soluble Tumor Necrosis Factor Receptor Superfamily, Member 5 | A measurement of the soluble tumor necrosis factor receptor superfamily member 5 (CD40) in a biological specimen. | Soluble TNF Receptor Superfamily Member 5 Measurement | ||
TNFSR | C117749 | Soluble Tumor Necrosis Factor Receptor | A measurement of the total soluble tumor necrosis factor receptor in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Measurement | ||
TNFSR1 | C117863 | Soluble TNF Receptor Type I | A measurement of the soluble tumor necrosis factor receptor type I in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Type I Measurement | ||
TNFSR2 | C117864 | Soluble CD120b;Soluble TNF Receptor 1B;Soluble TNF Receptor Type II;Soluble TNFR1B | A measurement of the soluble tumor necrosis factor receptor type II in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Type II Measurement | ||
TOMREG2 | C187827 | Tomoregulin-2;Transmembrane Protein With EGF-Like And Two Follistatin-Like Domains 2 | A measurement of the tomoregulin-2 in a biological specimen. | Tomoregulin-2 Measurement | ||
TOXGRAN | C96641 | Toxic Granulation | A measurement of the toxic granulation in granulocytic blood cells. | Toxic Granulation Measurement | ||
TOXVAC | C127813 | Toxic Vacuolation | A measurement of the toxic vacuolation in any of the granulocytic blood cells. | Toxic Vacuolation Assessment | ||
TPAAG | C81993 | Tissue Plasminogen Activator Antigen | A measurement of the tissue plasminogen activator antigen in a biological specimen. | Tissue Plasminogen Activator Antigen Measurement | ||
TPAG | C163488 | Tissue Polypeptide Antigen;TPA | A measurement of the tissue polypeptide antigen in a biological specimen. | Tissue Polypeptide Antigen Measurement | ||
TPNTDL | C184576 | Tapentadol | A measurement of the tapentadol in a biological specimen. | Tapentadol Measurement | ||
TPRONP | C84811 | Non-Phosphorylated Tau Protein | A measurement of the non-phosphorylated Tau protein in a biological specimen. | Nonphosphorylated Tau Protein Measurement | ||
TPROT | C84810 | Tau Protein;Total Tau Protein | A measurement of the total Tau protein in a biological specimen. | Tau Protein Measurement | ||
TPROTFR | C163489 | Tau Protein, Free | A measurement of the free tau protein in a biological specimen. | Free Tau Protein Measurement | ||
TPROTP | C84812 | Phosphorylated Tau Protein | A measurement of the phosphorylated Tau protein in a biological specimen. | Phosphorylated Tau Protein Measurement | ||
TRACP5B | C117865 | Tartrate-Resistant Acid Phosphatase 5b;TRAP5B | A measurement of tartrate-resistant acid phosphatase 5b in a biological specimen. | Tartrate-Resistant Acid Phosphatase 5b Measurement | ||
TRAMADOL | C161376 | Tramadol | A measurement of the tramadol present in a biological specimen. | Tramadol Measurement | ||
TRANK1 | C163490 | TPR and Ankyrin Repeat-Containing Protein 1;TPR-Ankyrin Repeat-Containing Protein 1 | A measurement of the TPR-ankyrin repeat-containing protein 1 in a biological specimen. | TPR-Ankyrin Repeat-containing Protein 1 Measurement | ||
TRAP | C80208 | Total Radical-Trap Antioxidant Potential | A measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension. | Total Radical-Trap Antioxidant Potential Measurement | ||
TRCYANDP | C100420 | Tricyclic Antidepressants | A measurement of tricyclic antidepressants in a biological specimen. | Tricyclic Antidepressant Measurement | ||
TRGTCE | C96636 | Codocytes;Target Cells | A measurement of the target cells in a biological specimen. | Target Cell Count | ||
TRH | C74874 | Thyrotropin Releasing Factor;Thyrotropin Releasing Hormone | A measurement of the thyrotropin releasing hormone in a biological specimen. | Thyrotropin Releasing Hormone Measurement | ||
TRICH | C92238 | Trichomonas | Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. | Trichomonas Screening | ||
TRIFLPZN | C177982 | Trifluoperazine | A measurement of the trifluoperazine in a biological specimen. | Trifluoperazine Measurement | ||
TRIG | C64812 | Triglycerides | A measurement of the triglycerides in a biological specimen. | Triglyceride Measurement | ||
TRIGHDL | C121183 | Triglycerides/HDL Cholesterol | A relative measurement (ratio or percentage) of the triglycerides to high density lipoprotein cholesterol in a biological specimen. | Triglycerides to HDL Cholesterol Ratio Measurement | ||
TRIM21 | C163491 | E3 Ubiquitin-Protein Ligase TRIM21;Ro(SS-A);Sjogren Syndrome Type A Antigen;Tripartite Motif Containing Protein 21 | A measurement of the tripartite motif containing protein 21 in a biological specimen. | Tripartite Motif Containing Protein 21 Measurement | ||
TRIM33 | C187799 | E3 Ubiquitin-Protein Ligase TRIM33;Tripartite Motif Containing 33 | A measurement of the E3 ubiquitin-protein ligase TRIM33 in a biological specimen. | E3 Ubiquitin-Protein Ligase TRIM33 Measurement | ||
TRIM38 | C163492 | Tripartite Motif Containing Protein 38 | A measurement of the tripartite motif containing protein 38 in a biological specimen. | Tripartite Motif Containing Protein 38 Measurement | ||
TRNBLN | C184605 | 17beta-Trenbolone;Trenbolone;Trienbolone | A measurement of the trenbolone in a biological specimen. | Trenbolone Measurement | ||
TROPONI | C74749 | Troponin I | A measurement of the actin binding troponin in a biological specimen. | Troponin I Measurement | ||
TROPONI1 | C135447 | Slow-Twitch Skeletal Muscle Troponin I;ssTnI;Troponin I Type 1 | A measurement of the troponin I type 1 (slow twitch skeletal muscle) in a biological specimen. | Troponin I Type 1 Measurement | ||
TROPONI2 | C127636 | Fast-Twitch Skeletal Muscle Troponin I;fsTnI;Troponin I Type 2 | A measurement of the troponin I type 2 (fast twitch skeletal muscle) in a biological specimen. | Troponin I Type 2 Measurement | ||
TROPONI3 | C135448 | Cardiac Troponin I;cTnI;TNNC1;Troponin I Type 3 | A measurement of the troponin I type 3 (cardiac muscle) in a biological specimen. | Troponin I Type 3 Measurement | ||
TROPONIN | C111327 | Troponin | A measurement of the total troponin in a biological specimen. | Troponin Measurement | ||
TROPONT | C74750 | Troponin T | A measurement of the tropomyosin binding troponin in a biological specimen. | Troponin T Measurement | ||
TRP | C154739 | Tryptophan | A measurement of the tryptophan in a biological specimen. | Tryptophan Measurement | ||
TRP1TRG1 | C135449 | Trypsin 1 and Trypsinogen 1 | A measurement of the trypsin 1 and trypsinogen 1 in a biological specimen. | Trypsin 1 and Trypsinogen 1 Measurement | ||
TRPCRT | C163493 | Tryptophan/Creatinine | A relative measurement (ratio or percentage) of the tryptophan to creatinine in a biological specimen. | Tryptophan to Creatinine Ratio Measurement | ||
TRPTRG | C135450 | Trypsin and Trypsinogen | A measurement of the total trypsin and total trypsinogen in a biological specimen. | Trypsin and Trypsinogen Measurement | ||
TRYPSIN | C163494 | Trypsin | A measurement of the trypsin in a biological specimen. | Trypsin Measurement | ||
TRYPTASE | C92292 | Tryptase | A measurement of the tryptase in a biological specimen. | Tryptase Measurement | ||
TRZDN | C187828 | Trazodone | A measurement of the trazodone in a biological specimen. | Trazodone Measurement | ||
TRZLM | C181451 | Triazolam | A measurement of the triazolam in a biological specimen. | Triazolam Measurement | ||
TSH | C64813 | Thyroid Stimulating Hormone;Thyrotropin | A measurement of the thyrotropin in a biological specimen. | Thyrotropin Measurement | ||
TSHRAB | C122158 | Thyroid Stimulating Hormone Receptor Antibody;Thyrotropin Receptor Antibody | A measurement of the thyrotropin receptor antibody in a biological specimen. | Thyroid Stimulating Hormone Receptor Antibody Measurement | ||
TSHT4FR | C181446 | Thyroid Stimulating Hormone/Free T4;Thyrotropin/Thyroxine, Free | A relative measurement (ratio) of the thyrotropin to free thyroxine in a biological specimen. | Thyrotropin to Free Thyroxine Ratio Measurement | ||
TSI | C147438 | Thyroid Stimulating Immunoglobulin | A measurement of the thyroid stimulating immunoglobulin in a biological specimen. | Thyroid Stimulating Immunoglobulin Measurement | ||
TSIAC | C161368 | Thyroid Stimulating Immunoglobulin Actual/Control;Thyroid Stimulating Immunoglobulin Actual/Normal;TSI Actual/Control | A relative measurement (ratio or percentage) of the thyroid stimulating immunoglobulin in a subject's specimen when compared to a control specimen. | Thyroid Stimulating Immunoglobulin Actual to Control Ratio Measurement | ||
TSLP | C184511 | Thymic Stromal Lymphopoietin | A measurement of the thymic stromal lymphopoietin in a biological specimen. | Thymic Stromal Lymphopoietin Measurement | ||
TSP1 | C163495 | THBS1;Thrombospondin 1 | A measurement of the thrombospondin 1 in a biological specimen. | Thrombospondin 1 Measurement | ||
TST4OH | C181429 | 4-Hydroxytestosterone | A measurement of the 4-hydroxytestosterone in a biological specimen. | 4-Hydroxytestosterone Measurement | ||
TSTFTSTT | C147439 | Testosterone, Free/Testosterone | A relative measurement (ratio or percentage) of the amount of the bioavailable testosterone compared to total testosterone in a biological specimen. | Free Testosterone to Testosterone Ratio Measurement | ||
TSTFWTST | C147440 | Testosterone Free+Weakly Bound/Testost;Testosterone, Free and Weakly Bound/Testosterone | A relative measurement (ratio or percentage) of the free and weakly bound testosterone to total testosterone in a biological specimen. | Free Testosterone and Weakly Bound to Total Testosterone Ratio Measurement | ||
TSTLCTN | C184601 | Testolactone | A measurement of the testolactone in a biological specimen. | Testolactone Measurement | ||
TSTSFRPT | C128980 | Testosterone, Free/Total Protein | A relative measurement (ratio or percentage) of free testosterone to total proteins in a biological specimen. | Free Testosterone to Total Protein Ratio Measurement | ||
TT | C80365 | Thrombin Time | A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI) | Thrombin Time | ||
TTAC | C161370 | Thrombin Time Actual/Control | A relative measurement (ratio or percentage) of the thrombin time in a subject's specimen when compared to a control specimen. | Thrombin Time Actual to Control Ratio Measurement | ||
TTGIGAAB | C147441 | Tissue Transglutaminase IgA Antibody | A measurement of the tissue transglutaminase IgA antibody in a biological specimen. | Tissue Transglutaminase IgA Antibody Measurement | ||
TTGIGGAB | C163496 | Tissue Transglutaminase IgG Antibody | A measurement of the tissue transglutaminase IgG antibody in a biological specimen. | Tissue Transglutaminase IgG Antibody Measurement | ||
TTGIGMAB | C147442 | Tissue Transglutaminase IgM Antibody | A measurement of the tissue transglutaminase IgM antibody in a biological specimen. | Tissue Transglutaminase IgM Antibody Measurement | ||
TUDCA | C176303 | Tauroursodeoxycholate;Tauroursodeoxycholic Acid | A measurement of the tauroursodeoxycholate in a biological specimen. | Tauroursodeoxycholate Measurement | ||
TURB | C74723 | Turbidity | A measurement of the opacity of a biological specimen. | Turbidity Measurement | ||
TXB2 | C103445 | Thromboxane B2 | A measurement of the thromboxane B2 in a biological specimen. | Thromboxane B2 Measurement | ||
TXB2_D11 | C103344 | 11-Dehydro-Thromboxane B2 | A measurement of the 11-dehydro-thromboxane B2 in a biological specimen. | 11-Dehydro-Thromboxane B2 Measurement | ||
TXB2D11R | C163497 | 11-Dehydro-Thromboxane B2 Excretion Rate | A measurement of the amount of 11-dehydro-thromboxane B2 being excreted in a biological specimen over a defined amount of time (e.g. one hour). | 11-Dehydro-Thromboxane B2 Excretion Rate | ||
TYR | C122159 | Tyrosine | A measurement of the tyrosine in a biological specimen. | Tyrosine Measurement | ||
U47700 | C184564 | Pink;Pinky;U-47700;U4;U47700 | A measurement of the synthetic cannabinoid U-47700 in a biological specimen. | U-47700 Measurement | ||
UBQN | C147443 | Ubiquitin Protein | A measurement of the total ubiquitin protein in a biological specimen. | Ubiquitin Protein Measurement | ||
UCHL1 | C189529 | Ubiquitin C-Terminal Hydrolase L1;Ubiquitin Carboxy-Terminal Hydrolase L1;UCH-L1 | A measurement of the ubiquitin C-terminal hydrolase L1 in a biological specimen. | Ubiquitin C-Terminal Hydrolase L1 Measurement | ||
UDCA | C176298 | Ursodeoxycholate;Ursodeoxycholic Acid;Ursodiol | A measurement of the ursodeoxycholate in a biological specimen. | Ursodeoxycholate Measurement | ||
UDCACM | C176238 | Ursodeoxycholate Compounds;Ursodeoxycholic Acid Compounds | A measurement of the ursodeoxycholic acid, glycoursodeoxycholic acid, tauroursodeoxycholic acid, and epimerized ursodeoxycholic acid in a biological specimen. | Ursodeoxycholate Compounds Measurement | ||
UNSPCE | C112241 | Unspecified Cells | A measurement of the cells not otherwise identified or specified in a biological specimen. | Count of Unspecified Cells | ||
UNSPCECE | C114225 | Unspecified Cells/Total Cells | A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen. | Unspecified Cells to Total Cell Ratio Measurement | ||
UNSPCELE | C161364 | Unspecified Cells/Leukocytes | A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to leukocytes in a biological specimen. | Unspecified Cells to Leukocytes Ratio Measurement | ||
UPA | C181447 | uPA;Urokinase Plasminogen Activator | A measurement of the urokinase plasminogen activator in a biological specimen. | Urokinase Plasminogen Activator Measurement | ||
UR144 | C184565 | UR-144;UR144 | A measurement of the synthetic cannabinoid UR-144 in a biological specimen. | UR-144 Measurement | ||
URATE | C64814 | Urate;Uric Acid | A measurement of the urate in a biological specimen. | Urate Measurement | ||
URATECRT | C117866 | Urate/Creatinine | A relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen. | Urate to Creatinine Ratio Measurement | ||
URATEEXR | C163498 | Urate Excretion Rate | A measurement of the amount of urate being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Urate Excretion Rate | ||
UREA | C64815 | Urea | A measurement of the urea in a biological specimen. | Urea Measurement | ||
UREACRT | C96645 | Urea/Creatinine | A relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen. | Urea to Creatinine Ratio Measurement | ||
UREAKTV | C191294 | Urea Distribution Volume Ratio;Urea Kt/V | A calculated measurement of the urea distribution volume (ratio) in a biological specimen used to quantify adequacy of dialysis treatment. | Urea Distribution Volume Ratio | ||
UREAN | C125949 | Urea Nitrogen | A measurement of the urea nitrogen in a biological specimen. | Urea Nitrogen Measurement | ||
UREANCRT | C125950 | Urea Nitrogen/Creatinine | A relative measurement (ratio or percentage) of the urea nitrogen to creatinine in a biological specimen. | Urea Nitrogen to Creatinine Ratio Measurement | ||
UREANEXR | C163499 | Urea Nitrogen Excretion Rate | A measurement of the amount of urea nitrogen being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Urea Nitrogen Excretion Rate | ||
UROBIL | C64816 | Urobilinogen | A measurement of the urobilinogen in a biological specimen. | Urobilinogen Measurement | ||
UROTHCE | C163500 | Urothelial Cells | A measurement of urothelial cells in a biological specimen. | Urothelial Cell Count | ||
URR | C191296 | Urea Reduction Ratio | A calculated measurement (ratio or percentage) of the proportionate reduction in urea nitrogen over the course of dialysis in a biological specimen. | Urea Reduction Ratio | ||
V25HD2 | C156528 | 25-Hydroxycalciferol;25-Hydroxyergocalciferol;25-Hydroxyvitamin D2;Ercalcidiol | A measurement of the 25-Hydroxyvitamin D2 in a biological specimen. | 25-Hydroxyvitamin D2 Measurement | ||
V25HD3 | C156529 | 25-Hydroxycholecalciferol;25-Hydroxyvitamin D;25-Hydroxyvitamin D3;Calcidiol;Calcifediol;Inactive Vitamin D | A measurement of the 25-Hydroxyvitamin D3 in a biological specimen. | 25-Hydroxyvitamin D3 Measurement | ||
VAL | C122160 | Valine | A measurement of the valine in a biological specimen. | Valine Measurement | ||
VALPRATE | C181410 | Valproate;Valproic Acid | A measurement of the valproate in a biological specimen. | Valproate Measurement | ||
VAPOB | C184517 | VLDL Apolipoprotein B | A measurement of the apolipoprotein B in the very low density lipoprotein fraction of a biological specimen. | VLDL Apolipoprotein B Measurement | ||
VBCE | C130166 | Viable Cells | A measurement of the viable cells in a biological specimen. | Viable Cell Count | ||
VCAM1 | C82042 | Vascular Cell Adhesion Molecule 1 | A measurement of the vascular cell adhesion molecule 1 in a biological specimen. | Vascular Cell Adhesion Molecule 1 Measurement | ||
VEGF | C92514 | Vascular Endothelial Growth Factor | A measurement of the vascular endothelial growth factor in a biological specimen. | Vascular Endothelial Growth Factor Measurement | ||
VEGFA | C132389 | Vascular Endothelial Growth Factor A | A measurement of the vascular endothelial growth factor A in a biological specimen. | Vascular Endothelial Growth Factor A Measurement | ||
VEGFC | C163501 | Vascular Endothelial Growth Factor C | A measurement of the vascular endothelial growth factor C in a biological specimen. | Vascular Endothelial Growth Factor C Measurement | ||
VEGFD | C172496 | FIGF;Vascular Endothelial Growth Factor D | A measurement of the vascular endothelial growth factor D in a biological specimen. | Vascular Endothelial Growth Factor D Measurement | ||
VEGFR1S | C165992 | Soluble Vasc Endoth Growth Factor Rec1;Soluble Vascular Endothelial Growth Factor Receptor 1 | A measurement of the soluble vascular endothelial growth factor receptor 1 in a biological specimen. | Soluble Vascular Endothelial Growth Factor Receptor Type 1 Measurement | ||
VEGFR2 | C156527 | Vasc Endothelial Growth Factor Rec 2;Vascular Endothelial Growth Factor Receptor 2 | A measurement of the vascular endothelial growth factor receptor 2 in a biological specimen. | Vascular Endothelial Growth Factor Receptor 2 Measurement | ||
VEGFR2S | C165993 | Soluble Vasc Endoth Growth Factor Rec2;Soluble Vascular Endothelial Growth Factor Receptor 2 | A measurement of the soluble vascular endothelial growth factor receptor 2 in a biological specimen. | Soluble Vascular Endothelial Growth Factor Receptor Type 2 Measurement | ||
VEGFR3S | C165994 | Soluble Vasc Endoth Growth Factor Rec3;Soluble Vascular Endothelial Growth Factor Receptor 3 | A measurement of the soluble vascular endothelial growth factor receptor 3 in a biological specimen. | Soluble Vascular Endothelial Growth Factor Receptor Type 3 Measurement | ||
VENLAFAX | C147444 | Venlafaxine | A measurement of the venlafaxine present in a biological specimen. | Venlafaxine Measurement | ||
VINBRBTL | C184606 | Vinbarbital | A measurement of the vinbarbital in a biological specimen. | Vinbarbital Measurement | ||
VIP | C163502 | Vasoactive Intestinal Polypeptide;VIP | A measurement of vasoactive intestinal polypeptide in a biological specimen. | Vasoactive Intestinal Polypeptide Measurement | ||
VISC | C75912 | Visc;Viscosity | The resistance of a liquid to sheer forces and flow. (NCI) | Viscosity | ||
VITA | C74895 | Retinol;Vitamin A | A measurement of the Vitamin A in a biological specimen. | Vitamin A Measurement | ||
VITB1 | C74896 | Thiamine;Vitamin B1 | A measurement of the thiamine in a biological specimen. | Vitamin B1 Measurement | ||
VITB12 | C64817 | Cobalamin;Vitamin B12 | A measurement of the Vitamin B12 in a biological specimen. | Vitamin B12 Measurement | ||
VITB17 | C74897 | Amygdalin;Vitamin B17 | A measurement of the Vitamin B17 in a biological specimen. | Vitamin B17 Measurement | ||
VITB2 | C74898 | Riboflavin;Vitamin B2 | A measurement of the riboflavin in a biological specimen. | Vitamin B2 Measurement | ||
VITB3 | C74899 | Niacin;Vitamin B3 | A measurement of the niacin in a biological specimen. | Vitamin B3 Measurement | ||
VITB5 | C74900 | Pantothenic Acid;Vitamin B5 | A measurement of the Vitamin B5 in a biological specimen. | Vitamin B5 Measurement | ||
VITB6 | C74901 | Pyridoxine;Vitamin B6 | A measurement of the Vitamin B6 in a biological specimen. | Vitamin B6 Measurement | ||
VITB7 | C74902 | Biotin;Vitamin B7 | A measurement of the Vitamin B7 in a biological specimen. | Vitamin B7 Measurement | ||
VITB9 | C74676 | Folate;Folic Acid;Vitamin B9 | A measurement of the folic acid in a biological specimen. | Folic Acid Measurement | ||
VITC | C74903 | Ascorbate;Ascorbic Acid;Vitamin C | A measurement of the Vitamin C in a biological specimen. | Vitamin C Measurement | ||
VITD2 | C74904 | Calciferol;Ergocalciferol;Viosterol;Vitamin D2 | A measurement of the Vitamin D2 in a biological specimen. | Vitamin D2 Measurement | ||
VITD23 | C179751 | Calciferol + Cholecalciferol;Vitamin D2 + Vitamin D3 | A measurement of the vitamin D2 and vitamin D3 in a biological specimen. | Vitamin D2 and Vitamin D3 Measurement | ||
VITD23OH | C147445 | Vitamin D + Metabolites;Vitamin D2 + Vitamin D3 + 25-Hydroxy Vitamin D2 + 25-Hydroxy Vitamin D3;Vitamin D2 D3 25-OH | A measurement of the vitamin D2, vitamin D3 and their metabolites in a biological specimen. | Vitamin D2 and Vitamin D3 and 25-Hydroxy Vitamin D2 and 25-Hydroxy Vitamin D3 Measurement | ||
VITD3 | C74905 | Calciol;Cholecalciferol;Colecalciferol;Vitamin D;Vitamin D3 | A measurement of the Vitamin D3 in a biological specimen. | Vitamin D3 Measurement | ||
VITDBP | C172506 | DBP;GC Vitamin D Binding Protein;VDBP;Vitamin D Binding Protein | A measurement of the vitamin D binding protein in a biological specimen. | Vitamin D Binding Protein Measurement | ||
VITE | C74906 | Vitamin E | A measurement of the Vitamin E in a biological specimen. | Vitamin E Measurement | ||
VITECHOL | C103448 | Vitamin E/Cholesterol | A relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen. | Vitamin E to Cholesterol Ratio Measurement | ||
VITK | C74907 | Naphthoquinone;Vitamin K | A measurement of the total Vitamin K in a biological specimen. | Vitamin K Measurement | ||
VITK1 | C103449 | Phylloquinone;Phytomenadione;Vitamin K1 | A measurement of the Vitamin K1 in a biological specimen. | Vitamin K1 Measurement | ||
VLDL | C105589 | VLDL Cholesterol | A measurement of the very low density lipoprotein cholesterol in a biological specimen. | Very Low Density Lipoprotein Cholesterol Measurement | ||
VLDL1 | C120667 | VLDL Cholesterol Subtype 1 | A measurement of the very low density lipoprotein cholesterol subtype 1 in a biological specimen. | VLDL Cholesterol Subtype 1 Measurement | ||
VLDL2 | C120668 | VLDL Cholesterol Subtype 2 | A measurement of the very low density lipoprotein cholesterol subtype 2 in a biological specimen. | VLDL Cholesterol Subtype 2 Measurement | ||
VLDL3 | C120669 | VLDL Cholesterol Subtype 3 | A measurement of the very low density lipoprotein cholesterol subtype 3 in a biological specimen. | VLDL Cholesterol Subtype 3 Measurement | ||
VLDLPSZ | C103450 | VLDL Particle Size | A measurement of the average particle size of very-low-density lipoprotein in a biological specimen. | VLDL Particle Size Measurement | ||
VLDLT | C174303 | VLDL Triglyceride | A measurement of the very low density lipoprotein triglyceride in a biological specimen. | VLDL Triglyceride Measurement | ||
VLDLTCT | C174301 | VLDL Trig + Chylomicron Trig;VLDL Triglyceride + Chylomicron Triglyceride | A measurement of the very low density lipoprotein triglyceride and chylomicron triglyceride in a biological specimen. | VLDL Triglyceride and Chylomicron Triglyceride Measurement | ||
VLZDN | C187829 | Vilazodone | A measurement of the vilazodone in a biological specimen. | Vilazodone Measurement | ||
VMA | C74875 | Vanillyl Mandelic Acid;Vanillylmandelate;Vanilmandelic Acid | A measurement of the vanillyl mandelic acid metabolite in a biological specimen. | Vanillyl Mandelic Acid Measurement | ||
VMAEXR | C163503 | Vanillyl Mandelic Acid Excretion Rate | A measurement of the amount of vanillyl mandelic acid being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Vanillyl Mandelic Acid Excretion Rate | ||
VOLUME | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
VRTOXTN | C187832 | Vortioxetine | A measurement of the vortioxetine in a biological specimen. | Vortioxetine Measurement | ||
VTD2125 | C179752 | 1,25-Dihydroxycalciferol;1,25-Dihydroxyergocalciferol;1,25-Dihydroxyvitamin D2;Ercalcitriol | A measurement of the 1,25-dihydroxyvitamin D2 in a biological specimen. | 1,25-Dihydroxyvitamin D2 Measurement | ||
VTD23125 | C179753 | 1,25-Di(OH)vitamin D2 + 1,25-Di(OH)vitamin D3;1,25-Dihydroxyvitamin D2 + 1,25-Dihydroxyvitamin D3;1,25-DihydroxyvitD2+1,25-DihydroxyvitD3 | A measurement of the 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in a biological specimen. | 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 Measurement | ||
VTD2D3IT | C147446 | 25-Hydroxyvit D2 + 25-Hydroxyvit D3 | A measurement of the total inactive vitamin D2 and vitamin D3 in a biological specimen. | 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Measurement | ||
VTD3125 | C179754 | 1,25-Dihydroxycholecalciferol;1,25-Dihydroxyvitamin D;1,25-Dihydroxyvitamin D3;Calcitriol | A measurement of the 1,25-dihydroxyvitamin D3 in a biological specimen. | 1,25-Dihydroxyvitamin D3 Measurement | ||
VTD32425 | C156511 | 24,25-Dihydroxycholecalciferol;24,25-Dihydroxyvitamin D;24,25-Dihydroxyvitamin D3 | A measurement of the 24,25-dihydroxyvitamin D3 in a biological specimen. | 24,25-Dihydroxyvitamin D3 Measurement | ||
VTRNCTN | C165995 | V75;Vitronectin;VN;VNT;VTN | A measurement of the vitronectin in a biological specimen. | Vitronectin Measurement | ||
VWFAAC | C147447 | von Will Factor Act Actual/Control;von Willebrand Factor Activity Actual/Normal;von Willebrand Factor Activity Actual/von Willebrand Factor Activity Control | A relative measurement (ratio or percentage) of the biological activity of the von Willebrand factor dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | von Willebrand Factor Activity Actual to Control Ratio Measurement | ||
VWFAC | C170597 | von Will Factor Actual/Control;von Willebrand Factor Actual/Control;von Willebrand Factor Actual/Normal;von Willebrand Factor Actual/von Willebrand Factor Control | A relative measurement (ratio or percentage) of the von Willebrand factor in a subject's specimen when compared to a control specimen. | von Willebrand Factor Actual to Control Ratio Measurement | ||
WBC | C51948 | Leukocytes;White Blood Cells | A measurement of the leukocytes in a biological specimen. | Leukocyte Count | ||
WBCCE | C135451 | Leukocytes/Total Cells;WBC/Total Cells | A relative measurement (ratio or percentage) of the leukocytes to total cells in a biological specimen. | Leukocytes to Total Cells Ratio Measurement | ||
WBCCLMP | C92246 | Leukocyte Cell Clumps;WBC Clumps;White Blood Cell Clumps | A measurement of white blood cell clumps in a biological specimen. | Leukocyte Cell Clumps Measurement | ||
WBCDIFF | C98493 | Leukocyte Cell Differential;Leukocyte Cell Fraction;Leukocyte Diff | An overall assessment of the leukocyte subtype distribution in a biological specimen. | Differential Leukocyte Count | ||
WBCMORPH | C92297 | Leukocyte Cell Morphology;WBC Morphology;White Blood Cell Morphology | An examination or assessment of the form and structure of white blood cells. | Leukocyte Cell Morphology | ||
WDR26 | C127637 | CDW2;Macrophage Inflammatory Protein-2;MIP2;WD Repeat-Containing Protein 26 | A measurement of the WD repeat-containing protein 26 in a biological specimen. | WD Repeat-Containing Protein 26 Measurement | ||
XLSXLSD | C186098 | Xylose/Xylose Dose | A relative measurement (percentage) of the xylose in a biological specimen to an administered dose of xylose. | Xylose to Xylose Dose Ratio Measurement | ||
XNTHCHR | C147449 | Xanthochromia | A measurement of the yellowish appearance of a biological specimen due to the presence of bilirubin produced by the degradation of heme from erythrocytes that have entered the biological specimen. | Xanthochromia Measurement | ||
XYLOSE | C186099 | Xylose | A measurement of the xylose in a biological specimen. | Xylose Measurement | ||
YEAST | C74664 | Yeast Cells | A measurement of the yeast cells present in a biological specimen. | Yeast Cell Measurement | ||
YEASTBUD | C106504 | Budding Yeast;Yeast Budding | A measurement of the budding yeast present in a biological specimen. | Budding Yeast Measurement | ||
YEASTHYP | C92239 | Yeast Hyphae | A measurement of the yeast hyphae present in a biological specimen. | Yeast Hyphae Screening | ||
YKL40P | C142294 | Chitinase-3-Like Protein 1;YKL-40 Protein | A measurement of the YKL-40 protein in a biological specimen. | YKL-40 Protein Measurement | ||
ZALEPLON | C184636 | Zaleplon | A measurement of the zaleplon in a biological specimen. | Zaleplon Measurement | ||
ZINC | C80210 | Zinc | A measurement of the zinc in a biological specimen. | Zinc Measurement | ||
ZIPRASDN | C177986 | Ziprasidone | A measurement of the ziprasidone in a biological specimen. | Ziprasidone Measurement | ||
ZOLPIDEM | C184637 | Zolpidem | A measurement of the zolpidem in a biological specimen. | Zolpidem Measurement | ||
ZOPCLN | C184638 | Zopiclone | A measurement of the zopiclone in a biological specimen. | Zopiclone Measurement | ||
ZPP | C147452 | Zinc Protoporphyrin | A measurement of the zinc protoporphyrin (zinc bound protoporphyrin) in a biological specimen. | Zinc Protoporphyrin Measurement | ||
Back to top | ||||||
CL.C67154.LBTEST | Laboratory Test Name
(LBTEST) | text
Extensible: Yes | C67154 | Laboratory Test Name | Terminology used for laboratory test names of the CDISC Study Data Tabulation Model. | CDISC SDTM Laboratory Test Name Terminology |
1,25-Dihydroxyvitamin D2 | C179752 | 1,25-Dihydroxycalciferol;1,25-Dihydroxyergocalciferol;1,25-Dihydroxyvitamin D2;Ercalcitriol | A measurement of the 1,25-dihydroxyvitamin D2 in a biological specimen. | 1,25-Dihydroxyvitamin D2 Measurement | ||
1,25-Dihydroxyvitamin D3 | C179754 | 1,25-Dihydroxycholecalciferol;1,25-Dihydroxyvitamin D;1,25-Dihydroxyvitamin D3;Calcitriol | A measurement of the 1,25-dihydroxyvitamin D3 in a biological specimen. | 1,25-Dihydroxyvitamin D3 Measurement | ||
1,25-DihydroxyvitD2+1,25-DihydroxyvitD3 | C179753 | 1,25-Di(OH)vitamin D2 + 1,25-Di(OH)vitamin D3;1,25-Dihydroxyvitamin D2 + 1,25-Dihydroxyvitamin D3;1,25-DihydroxyvitD2+1,25-DihydroxyvitD3 | A measurement of the 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in a biological specimen. | 1,25-Dihydroxyvitamin D2 and 1,25-Dihydroxyvitamin D3 Measurement | ||
1,3-Beta-D-Glucan | C132370 | 1,3-Beta-D-Glucan | A measurement of the 1,3-beta-D-glucan in a biological specimen. | 1,3-Beta-D-Glucan Measurement | ||
1,5-Anhydroglucitol | C124334 | 1,5-Anhydroglucitol | A measurement of the 1,5-anhydroglucitol in a biological specimen. | 1,5-Anhydroglucitol Measurement | ||
1-Hydroxymidazolam | C154732 | 1'-Hydroxymidazolam;1-Hydroxymidazolam;Alpha-Hydroxymidazolam | A measurement of the 1-Hydroxymidazolam present in a biological specimen. | 1-Hydroxymidazolam Measurement | ||
11-Dehydro-Thromboxane B2 Excretion Rate | C163497 | 11-Dehydro-Thromboxane B2 Excretion Rate | A measurement of the amount of 11-dehydro-thromboxane B2 being excreted in a biological specimen over a defined amount of time (e.g. one hour). | 11-Dehydro-Thromboxane B2 Excretion Rate | ||
11-Dehydro-Thromboxane B2 | C103344 | 11-Dehydro-Thromboxane B2 | A measurement of the 11-dehydro-thromboxane B2 in a biological specimen. | 11-Dehydro-Thromboxane B2 Measurement | ||
11-Deoxycorticosteroids | C186042 | 11-Deoxycorticoids;11-Deoxycorticosteroid;11-Deoxycorticosteroids | A measurement of the total 11-deoxycorticosteroids in a biological specimen. | 11-Deoxycorticosteroid Measurement | ||
11-Deoxycorticosterone | C186045 | 11-Deoxycorticosterone;21-Hydroxyprogesterone;Cortexone;Deoxycortone;Desoxycortone | A measurement of the 11-deoxycorticosterone in a biological specimen. | 11-Deoxycorticosterone Measurement | ||
11-Deoxycortisol | C186043 | 11-Deoxycortisol | A measurement of the 11-deoxycortisol in a biological specimen. | 11-Deoxycortisol Measurement | ||
11-Hydroxyandrostenedione | C186063 | 11-Hydroxyandrostenedione | A measurement of the 11-hydroxyandrostenedione in a biological specimen. | 11-Hydroxyandrostenedione Measurement | ||
11-Hydroxyandrosterone | C186064 | 11-Hydroxyandrosterone | A measurement of the 11-hydroxyandrosterone in a biological specimen. | 11-Hydroxyandrosterone Measurement | ||
11-Hydroxyetiocholanolone | C186069 | 11-Hydroxyetiocholanolone | A measurement of the 11-hydroxyetiocholanolone in a biological specimen. | 11-Hydroxyetiocholanolone Measurement | ||
11-Ketoandrosterone | C186073 | 11-Ketoandrosterone | A measurement of the 11-ketoandrosterone in a biological specimen. | 11-Ketoandrosterone Measurement | ||
11-Ketoetiocholanolone | C186074 | 11-Ketoetiocholanolone | A measurement of the 11-ketoetiocholanolone in a biological specimen. | 11-Ketoetiocholanolone Measurement | ||
11-Nor-Delta9-THC-9-Carboxylic Acid | C142293 | 11-Nor-Delta9-THC-9-Carboxylic Acid;THC-COOH | A measurement of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid present in a biological specimen. | 11-Nor-Delta9-THC-9-Carboxylic Acid Measurement | ||
17-Hydroxycorticosteroids | C186065 | 17-Hydroxycorticoid;17-Hydroxycorticosteroid;17-Hydroxycorticosteroids | A measurement of the 17-hydroxycorticosteroids in a biological specimen. | 17-Hydroxycorticosteroid Measurement | ||
17-Hydroxypregnenolone | C186070 | 17-Hydroxypregnenolone | A measurement of the 17-hydroxypregnenolone in a biological specimen. | 17-Hydroxypregnenolone Measurement | ||
17-Hydroxyprogesterone | C147370 | 17-Hydroxyprogesterone;17-OHP | A measurement of the 17-Hydroxyprogesterone in a biological specimen. | 17-Hydroxyprogesterone Measurement | ||
17-Ketogenic steroids | C186075 | 17-Ketogenic steroids | A measurement of the total 17-ketogenic steroids in a biological specimen. | 17-Ketogenic Steroid Measurement | ||
17-Ketosteroids | C186076 | 17-Ketosteroids | A measurement of the total 17-ketosteroids in a biological specimen. | 17-Ketosteroid Measurement | ||
18-Hydroxycorticosterone | C186067 | 18-Hydroxycorticosterone | A measurement of the 18-hydroxycorticosterone in a biological specimen. | 18-Hydroxycorticosterone Measurement | ||
18-Hydroxycortisol | C186066 | 18-Hydroxycortisol | A measurement of the 18-hydroxycortisol in a biological specimen. | 18-Hydroxycortisol Measurement | ||
18-Hydroxydeoxycorticosterone | C186068 | 18-Hydroxydeoxycorticosterone | A measurement of the 18-hydroxydeoxycorticosterone in a biological specimen. | 18-Hydroxydeoxycorticosterone Measurement | ||
2-5-Oligoadenylate Synthase 1 | C163476 | 2-5-Oligoadenylate Synthase 1 | A measurement of the 2-5-oligoadenylate synthase 1 in a biological specimen. | 2-5-Oligoadenylate Synthase 1 Measurement | ||
2-5-Oligoadenylate Synthase 2 | C163477 | 2-5-Oligoadenylate Synthase 2 | A measurement of the 2-5-oligoadenylate synthase 2 in a biological specimen. | 2-5-Oligoadenylate Synthase 2 Measurement | ||
2-5-Oligoadenylate Synthase 3 | C163478 | 2-5-Oligoadenylate Synthase 3 | A measurement of the 2-5-oligoadenylate synthase 3 in a biological specimen. | 2-5-Oligoadenylate Synthase 3 Measurement | ||
2-Hydroxyglutarate | C191293 | 2-Hydroxyglutarate;2-Hydroxyglutaric Acid;Alpha-Hydroxyglutaric Acid | A measurement of the 2-hydroxyglutarate in a biological specimen. | 2-Hydroxyglutarate Measurement | ||
2-Methylcitrate | C177957 | 2-Methylcitrate;2-Methylcitric Acid;MCA;Methylcitrate;Methylcitric Acid | A measurement of the 2-methylcitrate in a biological specimen. | 2-Methylcitrate Measurement | ||
20(S)-Hydroxycholesterol | C181420 | 20(S)-Hydroxycholesterol;20-Alpha-Hydroxycholesterol | A measurement of the 20(S)-hydroxycholesterol in a biological specimen. | 20(S)-Hydroxycholesterol Measurement | ||
21-Deoxycorticosterone | C186046 | 21-Deoxycorticosterone | A measurement of the 21-deoxycorticosterone in a biological specimen. | 21-Deoxycorticosterone Measurement | ||
21-Deoxycortisol | C186044 | 21-Deoxycortisol | A measurement of the 21-deoxycortisol in a biological specimen. | 21-Deoxycortisol Measurement | ||
22(R)-Hydroxycholesterol | C181421 | 22(R)-Hydroxycholesterol | A measurement of the 22(R)-hydroxycholesterol in a biological specimen. | 22(R)-Hydroxycholesterol Measurement | ||
22(S)-Hydroxycholesterol | C181422 | 22(S)-Hydroxycholesterol | A measurement of the 22(S)-hydroxycholesterol in a biological specimen. | 22(S)-Hydroxycholesterol Measurement | ||
24(R)-Hydroxycholesterol | C181424 | 24(R)-Hydroxycholesterol | A measurement of the 24(R)-hydroxycholesterol in a biological specimen. | 24(R)-Hydroxycholesterol Measurement | ||
24(S),25-Epoxycholesterol | C181423 | 24(S),25-Epoxycholesterol | A measurement of the 24(S),25-epoxycholesterol in a biological specimen. | 24(S),25-Epoxycholesterol Measurement | ||
24(S)-Hydroxycholesterol | C181425 | 24(S)-Hydroxycholesterol | A measurement of the 24(S)-hydroxycholesterol in a biological specimen. | 24(S)-Hydroxycholesterol Measurement | ||
24,25-Dihydroxyvitamin D3 | C156511 | 24,25-Dihydroxycholecalciferol;24,25-Dihydroxyvitamin D;24,25-Dihydroxyvitamin D3 | A measurement of the 24,25-dihydroxyvitamin D3 in a biological specimen. | 24,25-Dihydroxyvitamin D3 Measurement | ||
25-Hydroxycholesterol | C181426 | 25-Hydroxycholesterol | A measurement of the 25-hydroxycholesterol in a biological specimen. | 25-Hydroxycholesterol Measurement | ||
25-Hydroxyvit D2 + 25-Hydroxyvit D3 | C147446 | 25-Hydroxyvit D2 + 25-Hydroxyvit D3 | A measurement of the total inactive vitamin D2 and vitamin D3 in a biological specimen. | 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Measurement | ||
25-Hydroxyvitamin D2 | C156528 | 25-Hydroxycalciferol;25-Hydroxyergocalciferol;25-Hydroxyvitamin D2;Ercalcidiol | A measurement of the 25-Hydroxyvitamin D2 in a biological specimen. | 25-Hydroxyvitamin D2 Measurement | ||
25-Hydroxyvitamin D3 | C156529 | 25-Hydroxycholecalciferol;25-Hydroxyvitamin D;25-Hydroxyvitamin D3;Calcidiol;Calcifediol;Inactive Vitamin D | A measurement of the 25-Hydroxyvitamin D3 in a biological specimen. | 25-Hydroxyvitamin D3 Measurement | ||
27-Hydroxycholesterol | C181427 | 27-Hydroxycholesterol | A measurement of the 27-hydroxycholesterol in a biological specimen. | 27-Hydroxycholesterol Measurement | ||
3,4-Dihydroxyphenylacetic Acid | C103345 | 3,4-Dihydroxyphenylacetic Acid | A measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen. | 3,4-Dihydroxyphenylacetic Acid Measurement | ||
3,4-Dihydroxyphenylglycol | C101017 | 3,4-Dihydroxyphenylglycol;3.4 Dihydroxyphenylglycol | A measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen. | 3,4-Dihydroxyphenylglycol Measurement | ||
3,4-methylenedioxy-N-ethylamphetamine | C174295 | 3,4-methylenedioxy-N-ethylamphetamine;Eve;MDE | A measurement of the 3,4-methylenedioxy-N-ethylamphetamine in a biological specimen. | 3,4-methylenedioxy-N-ethylamphetamine Measurement | ||
3,4-methylenedioxyamphetamine | C174294 | 3,4-methylenedioxyamphetamine | A measurement of the 3,4-methylenedioxyamphetamine in a biological specimen. | 3,4-methylenedioxyamphetamine Measurement | ||
3,4-methylenedioxymethamphetamine | C75359 | 3,4-methylenedioxymethamphetamine;Ecstasy | A measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen. | 3,4-Methylenedioxymethamphetamine Measurement | ||
3-Alpha-Androstanediol Glucuronide | C186027 | 3-Alpha-Androstanediol Glucuronide | A measurement of the 3-alpha-androstanediol glucuronide in a biological specimen. | 3-Alpha-Androstanediol Glucuronide Measurement | ||
3-Methoxytyramine | C186082 | 3-Methoxytyramine | A measurement of the total 3-methoxytyramine in a biological specimen. | Total 3-Methoxytyramine Measurement | ||
3-Methoxytyramine, Free | C186083 | 3-Methoxytyramine, Free | A measurement of the free 3-methoxytyramine in a biological specimen. | Free 3-Methoxytyramine Measurement | ||
3-Methylfentanyl | C184525 | 3-Methylfentanyl | A measurement of the 3-methylfentanyl in a biological specimen. | 3-Methylfentanyl Measurement | ||
3beta-Hydroxy-5-Cholestenoic Acid | C181428 | 3-HCOA;3-Hydroxy-5-cholestenoic acid;3beta-Hydroxy-5-Cholestenoic Acid | A measurement of the 3beta-hydroxy-5-cholestenoic acid in a biological specimen. | 3beta-Hydroxy-5-Cholestenoic Acid Measurement | ||
4-Beta-Hydroxycholesterol | C156514 | 4-Beta-Hydroxycholesterol | A measurement of the 4-beta-hydroxycholesterol in a biological specimen. | 4-Beta-Hydroxycholesterol Measurement | ||
4-Hydroxymidazolam | C154731 | 4-Hydroxymidazolam | A measurement of the 4-hydroxymidazolam present in a biological specimen. | 4-Hydroxymidazolam Measurement | ||
4-Hydroxynonenal | C187788 | 4-HNE;4-hydroxy-2-nonenal;4-Hydroxynonenal;HNE | A measurement of the 4-hydroxynonenal in a biological specimen. | 4-Hydroxynonenal Measurement | ||
4-Hydroxytestosterone | C181429 | 4-Hydroxytestosterone | A measurement of the 4-hydroxytestosterone in a biological specimen. | 4-Hydroxytestosterone Measurement | ||
5 Prime Nucleotidase | C79437 | 5 Prime Nucleotidase;5'-Ribonucleotide Phosphohydrolase | A measurement of the 5'-nucleotidase in a biological specimen. | 5 Prime Nucleotidase Measurement | ||
5-Alpha Tetrahydrocortisol | C186097 | 5-Alpha Tetrahydrocortisol | A measurement of the 5-alpha tetrahydrocortisol in a biological specimen. | 5-Alpha Tetrahydrocortisol Measurement | ||
5-fluoro PB-22 3-carboxyindole | C184560 | 5-fluoro PB-22 3-carboxyindole | A measurement of the synthetic cannabinoid metabolite 5-fluoro PB-22 3-carboxyindole in a biological specimen. | 5-fluoro PB-22 3-carboxyindole Measurement | ||
5-Hydroxyindoleacetic Acid | C112217 | 5-Hydroxyindoleacetate;5-Hydroxyindoleacetic Acid | A measurement of 5-hydroxyindoleacetic acid in a biological specimen. | 5-Hydroxyindoleacetic Acid Measurement | ||
5-Hydroxyindoleacetic Acid/Creatinine | C170578 | 5-Hydroxyindoleacetic Acid/Creatinine | A relative measurement (ratio or percentage) of the 5-hydroxyindoleacetic acid to creatinine in a biological specimen. | 5-Hydroxyindoleacetic Acid to Creatinine Ratio Measurement | ||
5-HydroxyindoleaceticAcid Excretion Rate | C163454 | 5-Hydroxyindoleacetic Acid Excretion Rate;5-HydroxyindoleaceticAcid Excretion Rate | A measurement of the amount of 5-hydroxyindoleacetic acid being excreted in a biological specimen over a defined amount of time (e.g. one hour). | 5-Hydroxyindoleacetic Acid Excretion Rate | ||
6 Beta-Hydroxycortisol | C150833 | 6 Beta-Hydrocortisol;6 Beta-Hydroxycortisol;6 beta-OHF | A measurement of 6 beta-hydroxycortisol in a biological specimen. | 6 Beta-Hydroxycortisol Measurement | ||
6-Monoacetylmorphine | C74876 | 6-Monoacetylmorphine | A measurement of the 6-monoacetylmorphine present in a biological specimen. | 6-Monoacetylmorphine Measurement | ||
6a OH-tetrahydro-11-DeH-Corticosterone | C186058 | 6-Alpha Hydroxytetrahydro-11-Dehydrocorticosterone;6a OH-tetrahydro-11-DeH-Corticosterone | A measurement of the 6-alpha hydroxytetrahydro-11-dehydrocorticosterone in a biological specimen. | 6a OH-tetrahydro-11-DeH-Corticosterone Measurement | ||
6a OH-tetrahydro-11-Deoxycortisol | C186059 | 6-Alpha Hydroxytetrahydro-11-Deoxycortisol;6a OH-tetrahydro-11-Deoxycortisol | A measurement of the 6-alpha hydroxytetrahydro-11-deoxycortisol in a biological specimen. | 6a OH-tetrahydro-11-Deoxycortisol Measurement | ||
7-alpha-Hydroxy-4-cholesten-3-one | C172524 | 7-Alpha hydroxy-4-cholesten-3-one;7-alpha-Hydroxy-4-cholesten-3-one | A measurement of the 7-alpha-hydroxy-4-cholesten-3-one in a biological specimen. | 7-alpha-Hydroxy-4-cholesten-3-one Measurement | ||
7-Ketocholesterol | C181434 | 7-Ketocholesterol;7-Oxocholesterol | A measurement of the 7-ketocholesterol in a biological specimen. | 7-Ketocholesterol Measurement | ||
7alpha,25-Dihydroxycholesterol | C181430 | 7alpha,25-Dihydroxycholesterol | A measurement of the 7alpha,25-dihydroxycholesterol in a biological specimen. | 7alpha,25-Dihydroxycholesterol Measurement | ||
7alpha,27-Dihydroxycholesterol | C181431 | 7alpha,27-Dihydroxycholesterol | A measurement of the 7alpha,27-dihydroxycholesterol in a biological specimen. | 7alpha,27-Dihydroxycholesterol Measurement | ||
7alpha-Hydroxycholesterol | C181432 | 7alpha-Hydroxycholesterol | A measurement of the 7alpha-hydroxycholesterol in a biological specimen. | 7alpha-Hydroxycholesterol Measurement | ||
7beta-Hydroxycholesterol | C181433 | 7beta-Hydroxycholesterol | A measurement of the 7beta-hydroxycholesterol in a biological specimen. | 7beta-Hydroxycholesterol Measurement | ||
8-Hydroxy-2'-Deoxyguanosine | C174309 | 8-Hydroxy-2'-Deoxyguanosine;8-oxo-dG | A measurement of the 8-hydroxy-2'-deoxyguanosine in a biological specimen. | 8-Hydroxy-2'-Deoxyguanosine Measurement | ||
8-Hydroxydeoxyguanosine | C172492 | 8-Hydroxydeoxyguanosine;8-OHdG | A measurement of the 8-hydroxydeoxyguanosine in a biological specimen. | 8-Hydroxydeoxyguanosine Measurement | ||
8-Iso-PGF2alpha/Creatinine | C119291 | 8-Iso-PGF2alpha/Creatinine | A relative measurement (ratio or percentage) of the prostaglandin F2 alpha isoform 8 to creatinine in a biological specimen. | 8-Iso-Prostaglandin F2 Alpha to Creatinine Ratio Measurement | ||
8-Iso-Prostaglandin F2 Alpha | C119292 | 8-Iso-Prostaglandin F2 Alpha | A measurement of the prostaglandin F2 alpha isoform 8 in a biological specimen. | 8-Iso-Prostaglandin F2 Alpha Measurement | ||
9-Hydroxyrisperidone | C177970 | 9-Hydroxyrisperidone;Paliperidone | A measurement of the 9-hydroxyrisperidone in a biological specimen. | 9-Hydroxyrisperidone Measurement | ||
A Fetoprotein L3/A Fetoprotein | C96565 | A Fetoprotein L3/A Fetoprotein | A relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen. | Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement | ||
A Proliferation-Inducing Ligand | C111123 | A Proliferation-Inducing Ligand;CD256;TNFSF13;Tumor Necrosis Factor Ligand Superfamily Member 13 | A measurement of the a proliferation-inducing ligand in a biological specimen. | A Proliferation-Inducing Ligand Measurement | ||
AB-FUBINACA | C184526 | AB-FUBINACA | A measurement of the synthetic cannabinoid AB-FUBINACA in a biological specimen. | AB-FUBINACA Measurement | ||
AB-PINACA | C184527 | AB-PINACA | A measurement of the synthetic cannabinoid AB-PINACA in a biological specimen. | AB-PINACA Measurement | ||
Abnormal Cells | C111124 | Abnormal Cells | A measurement of the abnormal cells in a biological specimen. | Abnormal Cell Count | ||
Abnormal Cells/Leukocytes | C150834 | Abnormal Cells/Leukocytes | A relative measurement (ratio or percentage) of abnormal cells to leukocytes in a biological specimen. | Abnormal Cells to Leukocytes Ratio Measurement | ||
Abnormal Cells/Total Cells | C150835 | Abnormal Cells/Total Cells | A relative measurement (ratio or percentage) of abnormal cells to total cells in a biological specimen. | Abnormal Cells to Total Cells Ratio Measurement | ||
ABO A1 Subtype | C135397 | ABO A1 Subtype | The characterization of the ABO blood group A1 subtype in an individual. (NCI) | ABO A1 Subtype Determination | ||
ABO Blood Group | C125939 | ABO Blood Group | The characterization of the blood type of an individual by testing for the presence of A antigen and B antigen on the surface of red blood cells. | ABO Blood Group Determination | ||
Acanthocytes | C74699 | Acanthocytes | A measurement of the acanthocytes in a biological specimen. | Acanthocyte Count | ||
Acanthocytes/Erythrocytes | C74633 | Acanthocytes/Erythrocytes | A relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen. | Acanthocyte to Erythrocyte Ratio Measurement | ||
Acetaminophen | C135398 | Acetaminophen;Paracetamol | A measurement of the acetaminophen in a biological specimen. | Acetaminophen Measurement | ||
Acetaminophen-Cysteine Adduct | C172525 | Acetaminophen Protein Adduct;Acetaminophen-Cysteine Adduct;APAP-CYS;APAP-Protein | A measurement of the acetaminophen-cysteine adducts in a biological specimen. | Acetaminophen-Cysteine Adduct Measurement | ||
Acetoacetic Acid Excretion Rate | C189521 | Acetoacetate Excretion Rate;Acetoacetic Acid Excretion Rate | A measurement of the amount of acetoacetic acid being excreted in a biological specimen over a defined period of time (e.g. one hour). | Acetoacetic Acid Excretion Rate Measurement | ||
Acetoacetic Acid | C92247 | Acetoacetate;Acetoacetic Acid | A measurement of the acetoacetic acid in a biological specimen. | Acetoacetic Acid Measurement | ||
Acetone | C147288 | Acetone | A measurement of the acetone in a biological specimen. | Acetone Measurement | ||
Acetylcholine Receptor Antibody | C96559 | Acetylcholine Receptor Antibody | A measurement of the acetylcholine receptor antibody in a biological specimen. | Acetylcholine Receptor Antibody Measurement | ||
Acetylcholine | C74838 | Acetylcholine | A measurement of the acetylcholine hormone in a biological specimen. | Acetylcholine Measurement | ||
Acetylcholinesterase | C96560 | Acetylcholinesterase | A measurement of the acetylcholinesterase in a biological specimen. | Acetylcholinesterase Measurement | ||
Acetylfentanyl | C184528 | Acetyl Fentanyl;Acetylfentanyl | A measurement of the acetylfentanyl in a biological specimen. | Acetylfentanyl Measurement | ||
ACH Receptor Modulatn Ab/ACH Receptor Ab | C147297 | ACH Receptor Modulation Antibody/ACH Receptor Antibody;ACH Receptor Modulatn Ab/ACH Receptor Ab | A relative measurement (ratio or percentage) of the acetylcholine receptor modulation antibody to the total acetylcholine receptor antibodies in a biological specimen. | Acetylcholine Receptor Modulation Antibody to Acetylcholine Receptor Antibody Ratio Measurement | ||
Acid Alpha-Glucosidase | C189502 | Acid Alpha-Glucosidase;Acid Maltase;Alpha-1,4-glucosidase | A measurement of the acid alpha-glucosidase in a biological specimen. | Acid Alpha-Glucosidase Measurement | ||
Acid Labile Subunit | C163419 | Acid Labile Subunit;ALS;IGFALS;Insulin Like Growth Factor Binding Protein Acid Labile Subunit | A measurement of the acid labile subunit in a biological specimen. | Acid Labile Subunit Measurement | ||
Acid Phosphatase | C80163 | Acid Phosphatase | A measurement of the acid phosphatase in a biological specimen. | Acid Phosphatase Measurement | ||
Acid Sphingomyelinase | C189522 | Acid Sphingomyelinase | A measurement of the acid sphingomyelinase in a biological specimen. | Sphingomyelin Phosphodiesterase Measurement | ||
Activated Coagulation Time | C103348 | Activated Clotting Time;Activated Coagulation Time | A measurement of the inhibition of blood coagulation in response to anticoagulant therapies. | Activated Coagulation Time | ||
Activated Partial Thromboplastin Time | C38462 | Activated Partial Thromboplastin Time | A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a biological specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. | Activated Partial Thromboplastin Time | ||
Activated Protein C Resistance | C100471 | Activated Protein C Resistance;Factor V Leiden Screen | A measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen. | Activated Protein C Resistance Measurement | ||
Activated PTT/Standard | C98862 | Activated Partial Thromboplastin Time/Standard Thromboplastin Time;Activated PTT/Standard;Activated PTT/Standard PTT | A relative measurement (ratio or percentage) of the subject's activated partial thromboplastin time to a standard or control partial thromboplastin time. | Activated PTT/Standard Ratio Measurement | ||
Active Ghrelin | C112219 | Active Ghrelin | A measurement of active ghrelin in a biological specimen. | Active Ghrelin Measurement | ||
Acyl Coenzyme A Oxidase | C92286 | Acyl CoA Oxidase;Acyl Coenzyme A Oxidase;Fatty Acyl Coenzyme A Oxidase | A measurement of the acyl coenzyme A oxidase in a biological specimen. | Acyl Coenzyme A Oxidase Measurement | ||
Acylcarnitine | C156535 | Acylcarnitine | A measurement of the acylcarnitine in a biological specimen. | Acylcarnitine Measurement | ||
Acylcarnitine/Carnitine, Free | C147289 | Acylcarnitine/Carnitine, Free | A relative measurement (ratio or percentage) of the acylcarnitine to free carnitine in a biological specimen. | Acylcarnitine to Free Carnitine Ratio Measurement | ||
Acylglycine | C156534 | Acylglycine | A measurement of the acylglycine in a biological specimen. | Acylglycine Measurement | ||
ADAM Metallopeptidase Domain 8 | C147290 | A Disintegrin And Metalloproteinase Domain 8;ADAM Metallopeptidase Domain 8;CD156a Antigen | A measurement of the ADAM metallopeptidase domain 8 protein in a biological specimen. | ADAM Metallopeptidase Domain 8 Measurement | ||
ADAMTS13 Activity | C187830 | A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 13 Activity;ADAM Metallopeptidase With Thrombospondin Type 1 Motif 13 Activity;ADAMTS13 Activity;von Willebrand Coagulation Factor Cleaving Protease ADAMTS13 Activity | A measurement of the biological activity of von Willebrand coagulation factor cleaving protease, ADAMTS13, in a biological specimen. | von Willebrand Coagulation Factor Cleaving Protease Activity Measurement | ||
ADAMTS13 | C187684 | A Disintegrin-Like And Metalloprotease (Reprolysin Type) With Thrombospondin Type 1 Motif, 13;ADAM Metallopeptidase With Thrombospondin Type 1 Motif 13;von Willebrand Coagulation Factor Cleaving Protease ADAMTS13 | A measurement of the von Willebrand coagulation factor cleaving protease, ADAMTS13, in a biological specimen. | von Willebrand Coagulation Factor Cleaving Protease Measurement | ||
ADB-PINACA | C184529 | ADB-PINACA | A measurement of the synthetic cannabinoid ADB-PINACA in a biological specimen. | ADB-PINACA Measurement | ||
Adenosine Diphosphate | C102257 | Adenosine Diphosphate | A measurement of the adenosine diphosphate in a biological specimen. | Adenosine Diphosphate Measurement | ||
Adenosine Triphosphate | C147307 | Adenosine Triphosphate | A measurement of the adenosine triphosphate in a biological specimen. | Adenosine Triphosphate Measurement | ||
Adiponectin | C74839 | Adiponectin | A measurement of the total adiponectin hormone in a biological specimen. | Adiponectin Measurement | ||
Adiponectin, High Molecular Weight | C132363 | Adiponectin, High Molecular Weight | A measurement of the high molecular weight adiponectin hormone in a biological specimen. | High Molecular Weight Adiponectin Measurement | ||
Adrenocorticotropic Hormone | C74780 | Adrenocorticotropic Hormone;Corticotropin | A measurement of the adrenocorticotropic hormone in a biological specimen. | Adrenocorticotropic Hormone Measurement | ||
Aggrecan Chondroitin Sulfate Epitope 846 | C112220 | 846-Epitope;Aggrecan Chondroitin Sulfate Epitope 846;Chondroitin Sulfate Epitope 846;Chondroitin Sulfate Proteoglycan 1 Epitope 846;CS846 | A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen. | Aggrecan Chondroitin Sulfate Epitope 846 Measurement | ||
Agranular Neutrophils | C116200 | Agranular Neutrophils | A measurement of the agranular neutrophils in a biological specimen. | Agranular Neutrophils Measurement | ||
Alanine Aminopeptidase | C100430 | Alanine Aminopeptidase | A measurement of the alanine aminopeptidase in a biological specimen. | Alanine Aminopeptidase Measurement | ||
Alanine Aminotransferase | C64433 | Alanine Aminotransferase;SGPT | A measurement of the alanine aminotransferase in a biological specimen. | Alanine Aminotransferase Measurement | ||
Alanine | C122091 | Alanine | A measurement of the alanine in a biological specimen. | Alanine Measurement | ||
Albumin Clearance | C147293 | Albumin Clearance | A measurement of the albumin clearance in a biological specimen. | Albumin Clearance | ||
Albumin Excretion Rate | C150814 | Albumin Excretion Rate | A measurement of the amount of albumin excreted in a biological specimen over a defined period of time (e.g. one hour). | Albumin Excretion Rate | ||
Albumin Index | C154734 | Albumin Index | A relative measurement (ratio) of the albumin in cerebrospinal fluid to albumin in serum or plasma in a biological specimen. | Albumin Index | ||
Albumin | C64431 | Albumin;Microalbumin | A measurement of the albumin protein in a biological specimen. | Albumin Measurement | ||
Albumin/Creatinine | C74761 | Albumin/Creatinine;Microalbumin/Creatinine Ratio | A relative measurement (ratio) of the albumin to the creatinine in a biological specimen. | Albumin To Creatinine Protein Ratio Measurement | ||
Albumin/Globulin | C74894 | Albumin/Globulin | The ratio of albumin to globulin in a biological specimen. | Albumin to Globulin Ratio Measurement | ||
Albumin/Total Protein | C103453 | Albumin/Total Protein | A relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen. | Albumin to Total Protein Ratio Measurement | ||
Aldolase | C74731 | Aldolase | A measurement of the aldolase enzyme in a biological specimen. | Aldolase Measurement | ||
Aldosterone | C74841 | Aldosterone | A measurement of the aldosterone hormone in a biological specimen. | Aldosterone Measurement | ||
Aldosterone/Renin Activity | C124338 | Aldosterone/Renin Activity | A relative measurement (ratio) of the aldosterone to renin activity in a biological specimen. | Aldosterone to Renin Activity Ratio Measurement | ||
Aldrin Epoxidase | C154743 | Aldrin Epoxidase | A measurement of the aldrin epoxidase in a biological specimen. | Aldrin Epoxidase Measurement | ||
Alfentanil | C184566 | Alfentanil | A measurement of the alfentanil in a biological specimen. | Alfentanil Measurement | ||
Alk Phos, Bone/Total Alk Phos | C147294 | Alk Phos, Bone/Total Alk Phos;Alkaline Phosphatase, Bone/Total Alkaline Phosphatase | A relative measurement (ratio or percentage) of the bone specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. | Bone Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement | ||
Alk Phos, Intestinal/Total Alk Phos | C147295 | Alk Phos, Intestinal/Total Alk Phos;Alkaline Phosphatase, Intestinal/Total Alkaline Phosphatase | A relative measurement (ratio or percentage) of the intestinal specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. | Intestinal Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement | ||
Alk Phos, Liver + Bone/Total Alk Phos | C189497 | Alk Phos, Liver + Bone/Total Alk Phos | A relative measurement (ratio or percentage) of the liver and bone specific alkaline phosphatase isoforms to total alkaline phosphatase in a biological specimen. | Liver and Bone Specific Alkaline Phosphatase Isoform to Alkaline Phosphatase Ratio Measurement | ||
Alk Phos, Liver/Total Alk Phos | C147296 | Alk Phos, Liver/Total Alk Phos;Alkaline Phosphatase, Liver/Total Alkaline Phosphatase | A relative measurement (ratio or percentage) of the liver specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. | Liver Alkaline Phosphatase to Total Alkaline Phosphatase Ratio Measurement | ||
Alk Phos, Placental/Total Alk Phos | C184508 | Alk Phos, Placental/Total Alk Phos;Alkaline Phosphatase, Placental/Total Alkaline Phosphatase | A relative measurement (ratio or percentage) of the placental specific alkaline phosphatase isoform to total alkaline phosphatase in a biological specimen. | Placental Alkaline Phosphatase to Total Alkaline Phosphatase Measurement | ||
Alkaline Phosphatase Excretion Rate | C165942 | Alkaline Phosphatase Excretion Rate | A measurement of the amount of alkaline phosphatase being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Alkaline Phosphatase Excretion Rate | ||
Alkaline Phosphatase Isoenzyme | C139091 | Alkaline Phosphatase Isoenzyme | A measurement of the alkaline phosphatase isoenzyme in a biological specimen. | Alkaline Phosphatase Isoenzyme Measurement | ||
Alkaline Phosphatase | C64432 | Alkaline Phosphatase | A measurement of the alkaline phosphatase in a biological specimen. | Alkaline Phosphatase Measurement | ||
Alkaline Phosphatase/Creatinine | C79438 | Alkaline Phosphatase/Creatinine | A relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen. | Alkaline Phosphatase to Creatinine Ratio Measurement | ||
Alloisoleucine | C154762 | Alloisoleucine | A measurement of the alloisoleucine in a biological specimen. | Alloisoleucine Measurement | ||
Alpha Cortol | C186032 | Alpha Cortol;alpha-Cortol | A measurement of the alpha cortol in a biological specimen. | Alpha Cortol Measurement | ||
Alpha Cortolone | C186033 | Alpha Cortolone;alpha-Cortolone | A measurement of the alpha cortolone in a biological specimen. | Alpha Cortolone Measurement | ||
Alpha Fetoprotein Adj for Body Weight | C147291 | Alpha Fetoprotein Adj for Body Weight | A measurement of alpha fetoprotein, which has been adjusted for body weight, in a biological specimen. | Alpha Fetoprotein Adjusted for Body Weight Measurement | ||
Alpha Fetoprotein L1 | C96562 | Alpha Fetoprotein L1 | A measurement of the alpha fetoprotein L1 in a biological specimen. | Alpha Fetoprotein L1 Measurement | ||
Alpha Fetoprotein L2 | C96563 | Alpha Fetoprotein L2 | A measurement of the alpha fetoprotein L2 in a biological specimen. | Alpha Fetoprotein L2 Measurement | ||
Alpha Fetoprotein L3 | C96564 | Alpha Fetoprotein L3 | A measurement of the alpha fetoprotein L3 in a biological specimen. | Alpha Fetoprotein L3 Measurement | ||
Alpha Fetoprotein | C74732 | Alpha Fetoprotein;Alpha-1-Fetoprotein | A measurement of the alpha fetoprotein in a biological specimen. | Alpha-fetoprotein Measurement | ||
Alpha Globulin | C163445 | Alpha Globulin | A measurement of the total alpha globulins in a biological specimen. | Alpha Globulin Measurement | ||
Alpha Glutathione-S-Transferase | C79433 | Alpha Glutathione-S-Transferase | A measurement of the alpha form of glutathione S-transferase in a biological specimen. | Alpha Glutathione-S-Transferase Measurement | ||
Alpha Hydroxybutyrate Dehydrogenase | C111126 | Alpha Hydroxybutyrate Dehydrogenase | A measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen. | Alpha Hydroxybutyrate Dehydrogenase Measurement | ||
Alpha Melanocyte Stimulating Hormone | C187789 | Alpha Melanocyte Stimulating Hormone;Alpha-MSH | A measurement of the alpha melanocyte stimulating hormone in a biological specimen. | Alpha Melanocyte Stimulating Hormone Measurement | ||
Alpha Synuclein Protein | C142272 | Alpha Synuclein Protein | A measurement of the alpha synuclein protein in a biological specimen. | Alpha Synuclein Protein Measurement | ||
Alpha Tocopherol | C103349 | Alpha Tocopherol | A measurement of the alpha tocopherol in a biological specimen. | Alpha Tocopherol Measurement | ||
Alpha Tocopherol/Vitamin E | C103350 | Alpha Tocopherol/Vitamin E | A relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen. | Alpha Tocopherol to Vitamin E Ratio Measurement | ||
Alpha-1 Acid Glycoprotein | C100429 | Alpha-1 Acid Glycoprotein | A measurement of the alpha-1 acid glycoprotein in a biological specimen. | Alpha-1 Acid Glycoprotein Measurement | ||
Alpha-1 Antitrypsin Z-Polymer | C189527 | AAT Z-Polymer;Alpha-1 Antitrypsin Z-Polymer | A measurement of the polymers of Z-variant alpha-1 antitrypsin in a biological specimen. | Alpha-1 Antitrypsin Z-Polymer Measurement | ||
Alpha-1 Antitrypsin | C80167 | Alpha-1 Antitrypsin;Serum Trypsin Inhibitor | A measurement of the alpha-1 antitrypsin in a biological specimen. | Alpha-1 Antitrypsin Measurement | ||
Alpha-1 Antitrypsin, Functional | C181404 | Alpha-1 Antitrypsin, Functional | A measurement of the functional alpha-1 antitrypsin in a biological specimen. | Functional Alpha-1 Antitrypsin Measurement | ||
Alpha-1 Globulin | C92252 | A1-Globulin;Alpha-1 Globulin | A measurement of the proteins contributing to the alpha 1 fraction in a biological specimen. | Alpha-1 Globulin Measurement | ||
Alpha-1 Globulin/Total Protein | C92253 | Alpha-1 Globulin/Total Protein | A relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen. | Alpha-1 Globulin to Total Protein Ratio Measurement | ||
Alpha-1 Microglobulin Excretion Rate | C186022 | Alpha-1 Microglobulin Excretion Rate | A measurement of the amount of alpha-1 microglobulin being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Alpha-1 Microglobulin Excretion Rate Measurement | ||
Alpha-1 Microglobulin | C100461 | Alpha-1 Microglobulin;Protein HC | A measurement of the alpha-1 microglobulin in a biological specimen. | Alpha-1 Microglobulin Measurement | ||
Alpha-1 Microglobulin/Creatinine | C100462 | Alpha-1 Microglobulin/Creatinine | A relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen. | Alpha-1 Microglobulin to Creatinine Ratio Measurement | ||
Alpha-2 Antiplasmin Activity | C122094 | Alpha-2 Antiplasmin Activity | A measurement of the alpha-2 antiplasmin activity in a biological specimen. | Alpha-2 Antiplasmin Activity Measurement | ||
Alpha-2 Antiplasmin | C103351 | Alpha-2 Antiplasmin;Alpha-2 Plasmin Inhibitor | A measurement of the alpha-2 antiplasmin in a biological specimen. | Alpha-2 Antiplasmin Measurement | ||
Alpha-2 Globulin | C92254 | A2-Globulin;Alpha-2 Globulin | A measurement of the proteins contributing to the alpha 2 fraction in a biological specimen. | Alpha-2 Globulin Measurement | ||
Alpha-2 Globulin/Total Protein | C92255 | Alpha-2 Globulin/Total Protein | A relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen. | Alpha-2 Globulin to Total Protein Ratio Measurement | ||
Alpha-2 Macroglobulin | C80168 | Alpha-2 Macroglobulin | A measurement of the alpha-2 macroglobulin in a biological specimen. | Alpha-2 Macroglobulin Measurement | ||
Alpha-Aminoadipic Acid | C154761 | Alpha-Aminoadipate;Alpha-Aminoadipic Acid | A measurement of the alpha-aminoadipic acid in a biological specimen. | Alpha-Aminoadipic Acid Measurement | ||
Alpha-Aminobutyric Acid | C154759 | Alpha-aminobutyrate;Alpha-Aminobutyric Acid;Homoalanine | A measurement of the alpha-aminobutyric acid in a biological specimen. | Alpha-Aminobutyric Acid Measurement | ||
Alpha-GST Excretion Rate | C119278 | Alpha-GST Excretion Rate | A measurement of the amount of Alpha Glutathione-S-Transferase being excreted in a biological specimen over a defined period of time (e.g. one hour). | Alpha-GST Excretion Rate | ||
Alpha-Hydroxyalprazolam | C177954 | Alpha-Hydroxyalprazolam | A measurement of the alpha-hydroxyalprazolam in a biological specimen. | Alpha-Hydroxyalprazolam Measurement | ||
Alpha-Hydroxytriazolam | C181418 | Alpha-Hydroxytriazolam | A measurement of the alpha-hydroxytriazolam a biological specimen. | Alpha-Hydroxytriazolam Measurement | ||
Alpha-Methylacyl Coenzyme A Racemase | C132364 | Alpha-Methylacyl Coenzyme A Racemase | A measurement of the alpha-methylacyl coenzyme A racemase in a biological specimen. | Alpha-Methylacyl Coenzyme A Racemase Measurement | ||
Alpha-Methylfentanyl | C184537 | Alpha-Methylfentanyl | A measurement of the alpha-methylfentanyl in a biological specimen. | Alpha-Methylfentanyl Measurement | ||
Alpha-Methylphenethylamine | C75347 | Alpha-Methylphenethylamine;Amphetamine | A measurement of the alpha-methylphenethylamine in a biological specimen. | Amphetamine Measurement | ||
Alpha-N-acetylglucosaminidase | C147299 | Alpha-N-acetylglucosaminidase | A measurement of the alpha-N-acetylglucosaminidase in a biological specimen. | Alpha-N-acetylglucosaminidase Measurement | ||
Alpha-Smooth Muscle Actin | C163422 | Alpha-Actin 2;Alpha-SMA;Alpha-Smooth Muscle Actin | A measurement of the alpha-smooth muscle actin in a biological specimen. | Alpha-Smooth Muscle Actin Measurement | ||
Alphaprodine | C184567 | Alphaprodine | A measurement of the alphaprodine in a biological specimen. | Alphaprodine Measurement | ||
Alprazolam | C75370 | Alprazolam | A measurement of the alprazolam present in a biological specimen. | Alprazolam Measurement | ||
ALT/AST | C106498 | ALT/AST | A relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample. | Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement | ||
Aluminum | C111127 | Al;Aluminum | A measurement of aluminum in a biological specimen. | Aluminum Measurement | ||
AM-2201 | C184539 | AM-2201;AM2201 | A measurement of the synthetic cannabinoid AM-2201 in a biological specimen. | AM-2201 Measurement | ||
AM694 N-5-hydroxypentyl | C184538 | AM694 N-5-hydroxypentyl | A measurement of the synthetic cannabinoid metabolite AM694 N-5-hydroxypentyl in a biological specimen. | AM694 N-5-hydroxypentyl Measurement | ||
AMACR mRNA | C132365 | AMACR mRNA | A measurement of the alpha-methylacyl coenzyme A racemase mRNA in a biological specimen. | Alpha-Methylacyl Coenzyme A Racemase mRNA Measurement | ||
American Cockroach Antigen IgA Antibody | C130137 | American Cockroach Antigen IgA Antibody | A measurement of the Periplaneta americana antigen IgA antibody in a biological specimen. | American Cockroach Antigen IgA Antibody Measurement | ||
American Cockroach Antigen IgE Antibody | C130136 | American Cockroach Antigen IgE Antibody | A measurement of the Periplaneta americana antigen IgE antibody in a biological specimen. | American Cockroach Antigen IgE Antibody Measurement | ||
American Cockroach Antigen IgG Antibody | C130138 | American Cockroach Antigen IgG Antibody | A measurement of the Periplaneta americana antigen IgG antibody in a biological specimen. | American Cockroach Antigen IgG Antibody Measurement | ||
American Cockroach Antigen IgG4 Antibody | C130139 | American Cockroach Antigen IgG4 Antibody | A measurement of the Periplaneta americana antigen IgG4 antibody in a biological specimen. | American Cockroach Antigen IgG4 Antibody Measurement | ||
American Cockroach IgE AB RAST Score | C165933 | American Cockroach IgE AB RAST Score | A classification of the amount of Periplaneta americana antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | American Cockroach IgE Antibody RAST Score Measurement | ||
American Cockroach IgG AB RAST Score | C165918 | American Cockroach IgG AB RAST Score | A classification of the amount of Periplaneta americana antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | American Cockroach IgG Antibody RAST Score Measurement | ||
Amino Acids | C81183 | AA;Amino Acids | A measurement of the total amino acids in a biological specimen. | Amino Acid Measurement | ||
Amitriptyline | C186023 | Amitriptyline | A measurement of the amitriptyline in a biological specimen. | Amitriptyline Measurement | ||
Ammonia | C74799 | Ammonia;NH3 | A measurement of the ammonia in a biological specimen. | Ammonia Measurement | ||
Ammonium Biurate Crystals | C105590 | Acid Ammonium Urate Crystals;Ammonium Biurate Crystals;Ammonium Urate Crystals | A measurement of the ammonium biurate crystals present in a biological specimen. | Ammonium Biurate Crystals Measurement | ||
Ammonium Oxalate Crystals | C74759 | Ammonium Oxalate Crystals | A measurement of the ammonium oxalate crystals present in a urine specimen. | Urine Ammonium Oxalate Crystal Measurement | ||
Ammonium | C186024 | Ammonium;Ammonium Ion;NH4+ | A measurement of the ammonium ion (NH4+) in a biological specimen. | Ammonium Measurement | ||
Ammonium/Creatinine | C186025 | Ammonium/Creatinine | A relative measurement (ratio) of ammonium to creatinine in a biological specimen. | Ammonium to Creatinine Ratio Measurement | ||
Amobarbital | C75363 | Amobarbital | A measurement of the amobarbital present in a biological specimen. | Amobarbital Measurement | ||
Amorphous Crystals | C74665 | Amorphous Crystals | A measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen. | Amorphous Crystal Measurement | ||
Amorphous Phosphate Crystals | C92243 | Amorphous Phosphate Crystals | A measurement of the amorphous phosphate crystals in a biological specimen. | Amorphous Phosphate Crystals Measurement | ||
Amorphous Sediment | C74666 | Amorphous Debris;Amorphous Sediment | A measurement of the amorphous sediment present in a biological specimen. | Amorphous Sediment Measurement | ||
Amorphous Urate Crystals | C92244 | Amorphous Urate Crystals | A measurement of the amorphous urate crystals in a biological specimen. | Amorphous Urate Crystals Measurement | ||
Amphetamine | C74687 | Amphetamine | A measurement of any amphetamine class drug present in a biological specimen. | Amphetamine Drug Class Measurement | ||
Amylase | C64434 | Amylase | A measurement of the total enzyme amylase in a biological specimen. | Amylase Measurement | ||
Amylase, Pancreatic | C98767 | Amylase, Pancreatic;Pancreatic Amylase Isoenzyme | A measurement of the pancreatic enzyme amylase in a biological specimen. | Pancreatic Amylase Measurement | ||
Amylase, Salivary | C98780 | Amylase, Salivary;Salivary Amylase Isoenzyme | A measurement of the salivary enzyme amylase in a biological specimen. | Salivary Amylase Measurement | ||
Amyloid A | C125940 | Amyloid A | A measurement of the total amyloid A in a biological specimen. | Amyloid A Measurement | ||
Amyloid Alpha Precursor Protein | C119268 | Amyloid Alpha Precursor Protein | A measurement of the amyloid alpha precursor protein present in a biological specimen. | Amyloid Alpha Precursor Protein Measurement | ||
Amyloid Beta 1-38 | C103352 | Amyloid Beta 1-38;Amyloid Beta 38;Amyloid Beta 38 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen. | Amyloid Beta 1-38 Measurement | ||
Amyloid Beta 1-40 | C103353 | Amyloid Beta 1-40;Amyloid Beta 40;Amyloid Beta 40 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen. | Amyloid Beta 1-40 Measurement | ||
Amyloid Beta 1-41 | C184518 | Amyloid Beta 1-41;Amyloid Beta 41;Amyloid Beta 41 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 41 in a biological specimen. | Amyloid Beta 1-41 Measurement | ||
Amyloid Beta 1-42 | C84809 | Amyloid Beta 1-42;Amyloid Beta 42;Amyloid Beta 42 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen. | Beta Amyloid 42 Measurement | ||
Amyloid Beta Precursor Protein | C105438 | Amyloid Beta Precursor;Amyloid Beta Precursor Protein;Amyloid Precursor Beta;Amyloid Precursor Protein | A measurement of the amyloid beta precursor protein present in a biological specimen. | Amyloid Beta Precursor Protein Measurement | ||
Amyloid P | C81998 | Amyloid P;Amyloid P Component;SAP;Serum Amyloid P Component | A measurement of the total amyloid P in a biological specimen. | Amyloid P Measurement | ||
Amyloid, Beta | C81999 | Amyloid, Beta;Beta Amyloid | A measurement of the total amyloid beta in a biological specimen. | Beta Amyloid Measurement | ||
Anabasine | C147298 | Anabasine | A measurement of the anabasine in a biological specimen. | Anabasine Measurement | ||
Androstenediol | C74842 | Androstenediol | A measurement of the androstenediol metabolite in a biological specimen. | Androstenediol Metabolite Measurement | ||
Androstenedione | C74843 | 4-Androstenedione;Androstenedione | A measurement of the androstenedione hormone in a biological specimen. | Androstenedione Measurement | ||
Androsterone | C186026 | Androsterone | A measurement of the androsterone in a biological specimen. | Androsterone Measurement | ||
Angiopoietin 1 | C111128 | Angiopoietin 1 | A measurement of angiopoietin 1 in a biological specimen. | Angiopoietin 1 Measurement | ||
Angiopoietin 2 | C163421 | ANG2;Angiopoietin 2 | A measurement of angiopoietin 2 in a biological specimen. | Angiopoietin 2 Measurement | ||
Angiotensin Converting Enzyme | C80169 | Angiotensin Converting Enzyme | A measurement of the angiotensin converting enzyme in a biological specimen. | Angiotensin Converting Enzyme Measurement | ||
Angiotensin I | C74844 | Angiotensin I | A measurement of the angiotensin I hormone in a biological specimen. | Angiotensin I Measurement | ||
Angiotensin II | C74845 | Angiotensin II | A measurement of the angiotensin II hormone in a biological specimen. | Angiotensin II Measurement | ||
Angiotensinogen | C74846 | Angiotensin Precursor;Angiotensinogen | A measurement of the angiotensinogen hormone in a biological specimen. | Angiotensinogen Measurement | ||
Anileridine | C184568 | Anileridine | A measurement of the anileridine in a biological specimen. | Anileridine Measurement | ||
Animal Mix Antigen IgE Antibody | C130112 | Animal Mix Antigen IgE Antibody | A measurement of the animal mix antigen IgE antibody in a biological specimen. | Animal Mix Antigen IgE Antibody Measurement | ||
Animal Mix Antigen IgG Antibody | C130113 | Animal Mix Antigen IgG Antibody | A measurement of the animal mix antigen IgG antibody in a biological specimen. | Animal Mix Antigen IgG Antibody Measurement | ||
Animal Mix IgE AB RAST Score | C165927 | Animal Mix IgE AB RAST Score | A classification of the amount of animal mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Animal Mix IgE Antibody RAST Score Measurement | ||
Animal Mix IgG AB RAST Score | C165908 | Animal Mix IgG AB RAST Score | A classification of the amount of animal mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Animal Mix IgG Antibody RAST Score Measurement | ||
Anion Gap 3 | C147303 | Anion Gap 3 | A computed estimate of the unmeasured anions (computed as sodium minus the chloride and bicarbonate) in a biological specimen. | Anion Gap 3 Measurement | ||
Anion Gap 4 | C147304 | Anion Gap 4 | A computed estimate of the unmeasured anions (computed as the difference between the sum of serum sodium + serum potassium and the sum of the serum bicarbonate+ chloride) in a biological specimen. | Anion Gap 4 Measurement | ||
Anion Gap | C74685 | Anion Gap | A computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen. | Anion Gap Measurement | ||
Anisochromia | C161354 | Anisochromia | A measurement of the color variation of erythrocytes in a biological specimen. | Anisochromia Measurement | ||
Anisocytes | C74797 | Anisocytes;Anisocytosis | A measurement of the variability in the size of the red blood cells in a whole blood specimen. | Anisocyte Measurement | ||
Anti-DNA Antibodies | C81973 | Anti-DNA Antibodies;Anti-ds-DNA Antibodies | A measurement of the anti-DNA antibodies in a biological specimen. | Anti-DNA Antibody Measurement | ||
Anti-Double Stranded DNA IgG | C154769 | Anti-Double Stranded DNA IgG | A measurement of the double stranded DNA IgG antibody in a biological specimen. | Anti-Double Stranded DNA IgG Measurement | ||
Anti-Double Stranded DNA | C74913 | Anti-Double Stranded DNA | A measurement of the anti-double stranded DNA antibody in a biological specimen. | Anti-Double Stranded DNA Measurement | ||
Anti-Factor Xa Activity | C98706 | Anti-Factor Xa Activity | A measurement of the ability of antithrombin to inactivate activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen. | Anti-Factor Xa Activity Measurement | ||
Anti-Mullerian Hormone | C120625 | Anti-Mullerian Hormone | A measurement of the anti-Mullerian hormone in a biological specimen. | Anti-Mullerian Hormone Measurement | ||
Anti-Neutrophil Antibody | C176313 | Anti-Neutrophil Antibody | A measurement of the total anti-neutrophil antibody in a biological specimen. | Anti-Neutrophil Antibody Measurement | ||
Anti-Neutrophil Cytoplasmic Antibody | C120626 | Anti-Neutrophil Cytoplasmic Antibody | A measurement of the anti-neutrophil cytoplasmic antibody in a biological specimen. | Anti-Neutrophil Cytoplasmic Antibody Measurement | ||
Anti-Neutrophil Cytoplasmic IgG Antibody | C163420 | Anti-Neutrophil Cytoplasmic IgG Antibody | A measurement of the anti-neutrophil cytoplasmic IgG antibody in a biological specimen. | Anti-Neutrophil Cytoplasmic IgG Antibody Measurement | ||
Anti-Nucleosome Antibody | C120627 | Anti-Nucleosome Antibody | A measurement of the anti-nucleosome antibody in a biological specimen. | Anti-Nucleosome Antibody Measurement | ||
Anti-Phospholipid IgG Antibody | C124335 | Anti-Phospholipid IgG Antibody | A measurement of the antiphospholipid IgG antibody in a biological specimen. | Anti-Phospholipid IgG Antibody Measurement | ||
Anti-Phospholipid IgM Antibody | C124336 | Anti-Phospholipid IgM Antibody | A measurement of the antiphospholipid IgM antibody in a biological specimen. | Anti-Phospholipid IgM Antibody Measurement | ||
Anti-Single Stranded DNA IgG | C92269 | Anti-Single Stranded DNA IgG | A measurement of the anti-single stranded DNA IgG antibody in a biological specimen. | Anti-Single Stranded DNA IgG Measurement | ||
Antidepressants | C74691 | Antidepressants | A measurement of any antidepressant class drug present in a biological specimen. | Antidepressant Measurement | ||
Antidiuretic Hormone | C74847 | Antidiuretic Hormone;Vasopressin | A measurement of the antidiuretic hormone in a biological specimen. | Antidiuretic Hormone Measurement | ||
Antiglobulin Test, Direct | C81974 | Antiglobulin Test Polyspecific, Direct;Antiglobulin Test, Direct;Direct Coombs Test | A measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo. | Direct Antiglobulin Test | ||
Antiglobulin Test, Indirect | C91372 | Antiglobulin Test, Indirect;Indirect Coombs Test | A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen. | Indirect Antiglobulin Test | ||
Antimitochondrial Antibodies | C81975 | Antimitochondrial Antibodies;Mitochondrial Antibody | A measurement of the antimitochondrial antibodies in a biological specimen. | Antimitochondrial Antibody Measurement | ||
Antinuclear Antibodies | C74916 | Antinuclear Antibodies | A measurement of the total antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen. | Antinuclear Antibody Measurement | ||
Antinuclear IgG Antibody | C122093 | Antinuclear IgG Antibody | A measurement of the antinuclear IgG antibody in a biological specimen. | Antinuclear IgG Antibody Measurement | ||
Antiphospholipid Antibodies | C102258 | Antiphospholipid Antibodies | A measurement of the total antiphospholipid antibodies in a biological specimen. | Antiphospholipid Antibody Measurement | ||
Antithrombin Activity Actual/Control | C147306 | Antithrombin Activity Actual/Antithrombin Activity Control;Antithrombin Activity Actual/Control;Antithrombin Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of antithrombin in a subject's specimen when compared to the same activity in a control specimen. | Antithrombin Activity Actual to Control Ratio Measurement | ||
Antithrombin Activity | C81958 | Antithrombin Activity;Antithrombin III Activity | A measurement of the antithrombin activity in a biological specimen. | Antithrombin Activity Measurement | ||
Antithrombin Actual/Control | C170592 | Antithrombin Actual/Control;Antithrombin Actual/Normal | A relative measurement (ratio or percentage) of the Antithrombin in a subject's specimen when compared to a control specimen. | Antithrombin Actual to Control Ratio Measurement | ||
Antithrombin Antigen | C81977 | Antithrombin;Antithrombin Antigen;Antithrombin III;Antithrombin III Antigen | A measurement of the antithrombin antigen in a biological specimen. | Antithrombin Antigen Measurement | ||
Apolipoprotein A | C124337 | Apolipoprotein A | A measurement of the total apolipoprotein A in a biological specimen. | Apolipoprotein A Measurement | ||
Apolipoprotein A/Apolipoprotein B | C158222 | Apolipoprotein A/Apolipoprotein B | A relative measurement (ratio) of the total apolipoprotein A to apolipoprotein B in a biological specimen. | Apolipoprotein A to Apolipoprotein B Ratio Measurement | ||
Apolipoprotein A1 | C74733 | Apolipoprotein A1 | A measurement of the apolipoprotein A1 in a biological specimen. | Apolipoprotein A1 Measurement | ||
Apolipoprotein A1/Apolipoprotein B | C147292 | Apolipoprotein A1/Apolipoprotein B | A relative measurement (ratio or percentage) of the Apolipoprotein A1 to Apolipoprotein B in a biological specimen. | Apolipoprotein A1 to Apolipoprotein B Ratio Measurement | ||
Apolipoprotein A4 | C103354 | Apolipoprotein A4 | A measurement of the apolipoprotein A4 in a biological specimen. | Apolipoprotein A4 Measurement | ||
Apolipoprotein A5 | C103355 | Apolipoprotein A5 | A measurement of the apolipoprotein A5 in a biological specimen. | Apolipoprotein A5 Measurement | ||
Apolipoprotein AII | C82000 | Apolipoprotein AII | A measurement of the apolipoprotein AII in a biological specimen. | Apolipoprotein AII Measurement | ||
Apolipoprotein B | C74734 | Apolipoprotein B | A measurement of the total apolipoprotein B in a biological specimen. | Apolipoprotein B Measurement | ||
Apolipoprotein B/Apolipoprotein A1 | C103356 | Apolipoprotein B/Apolipoprotein A1 | A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen. | Apolipoprotein B to Apolipoprotein A1 Ratio Measurement | ||
Apolipoprotein B100 | C120628 | Apolipoprotein B100 | A measurement of the apolipoprotein B100 in a biological specimen. | Apolipoprotein B100 Measurement | ||
Apolipoprotein B48 | C120629 | Apolipoprotein B48 | A measurement of the apolipoprotein B48 in a biological specimen. | Apolipoprotein B48 Measurement | ||
Apolipoprotein C2 | C100427 | Apolipoprotein C2;Apolipoprotein CII | A measurement of the apolipoprotein C2 in a biological specimen. | Apolipoprotein C2 Measurement | ||
Apolipoprotein CI | C120630 | Apolipoprotein CI | A measurement of the apolipoprotein CI in a biological specimen. | Apolipoprotein CI Measurement | ||
Apolipoprotein CIII | C82001 | Apolipoprotein CIII | A measurement of the apolipoprotein CIII in a biological specimen. | Apolipoprotein CIII Measurement | ||
Apolipoprotein D | C198281 | Apolipoprotein D | A measurement of the apolipoprotein D in a biological specimen. | Apolipoprotein D Measurement | ||
Apolipoprotein E | C82002 | Apolipoprotein E | A measurement of the apolipoprotein E in a biological specimen. | Apolipoprotein E Measurement | ||
Apolipoprotein E4 | C92293 | Apolipoprotein E4 | A measurement of the apolipoprotein E4 in a biological specimen. | Apolipoprotein E4 Measurement | ||
Apolipoprotein H | C82003 | Apolipoprotein H | A measurement of the apolipoprotein H in a biological specimen. | Apolipoprotein H Measurement | ||
Apolipoprotein J | C100428 | Apolipoprotein J;Clusterin | A measurement of the apolipoprotein J in a biological specimen. | Apolipoprotein J Measurement | ||
Apolipoprotein J/Creatinine | C111130 | Apolipoprotein J/Creatinine;Clusterin/Creatinine | A relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen. | Apolipoprotein J to Creatinine Ratio Measurement | ||
Aprobarbital | C184578 | Aprobarbital | A measurement of the aprobarbital in a biological specimen. | Aprobarbital Measurement | ||
APTT-LA Actual/Control | C161369 | APTT-LA Actual/Control;Lupus Anticoagulant Sensitive APTT Actual/Control | A relative measurement (ratio or percentage) of the Lupus anticoagulant sensitive APTT in a subject's specimen when compared to a control specimen. | APTT-LA Actual to Control Ratio Measurement | ||
APTT-LA Screen to Confirm Pct Difference | C161372 | APTT-LA Screen to Confirm Percent Difference;PTT-LA Screen to Confirm Pct Difference | A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen aPTT - Confirm aPTT)/Screen aPTT]x100. | APTT-LA Screen to Confirm Percent Difference | ||
Arachidonate 5-Lipoxygenase | C184519 | 5-Lipoxygenase;5-LO;5-LOX;ALOX5;Arachidonate 5-Lipoxygenase | A measurement of the arachidonate 5-lipoxygenase in a biological specimen. | Arachidonate 5-Lipoxygenase Measurement | ||
Arachidonic Acid | C102259 | Arachidonic Acid | A measurement of the arachidonic acid present in a biological specimen. | Arachidonic Acid Measurement | ||
Arachis hypogaea Antigen IgE Antibody | C147276 | Arachis hypogaea Antigen IgE Antibody;Peanut Antigen IgE Antibody | A measurement of the Arachis hypogaea antigen IgE antibody in a biological specimen. | Arachis hypogaea Antigen IgE Antibody Measurement | ||
Arachis hypogaea IgE AB RAST Score | C165934 | Arachis hypogaea IgE AB RAST Score | A classification of the amount of Arachis hypogaea antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Arachis hypogaea IgE Antibody RAST Score Measurement | ||
Arginine | C122095 | Arginine | A measurement of the arginine in a biological specimen. | Arginine Measurement | ||
Argininosuccinic Acid | C154763 | Argininosuccinate;Argininosuccinic Acid | A measurement of the argininosuccinic acid in a biological specimen. | Argininosuccinic Acid Measurement | ||
Aripiprazole | C177974 | Aripiprazole | A measurement of the aripiprazole in a biological specimen. | Aripiprazole Measurement | ||
Arsenic | C147305 | Arsenic;As | A measurement of the arsenic in a biological specimen. | Arsenic Measurement | ||
Asenapine | C177985 | Asenapine | A measurement of the asenapine in a biological specimen. | Asenapine Measurement | ||
Asparagine | C122096 | Asparagine | A measurement of the asparagine in a biological specimen. | Asparagine Measurement | ||
Aspartate Aminotransferase Antigen | C81978 | Aspartate Aminotransferase Antigen;SGOT Antigen | A measurement of the aspartate aminotransferase antigen in a biological specimen. | Aspartate Aminotransferase Antigen Measurement | ||
Aspartate Aminotransferase | C64467 | Aspartate Aminotransferase;SGOT | A measurement of the aspartate aminotransferase in a biological specimen. | Aspartate Aminotransferase Measurement | ||
Aspartate Aminotransferase/Creatinine | C117830 | Aspartate Aminotransferase/Creatinine | A relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen. | Aspartate Aminotransferase to Creatinine Ratio Measurement | ||
Aspartic Acid | C122097 | Aspartate;Aspartic Acid | A measurement of the aspartic acid in a biological specimen. | Aspartic Acid Measurement | ||
AST to Platelet Ratio Index | C156512 | APRI Score;AST to Platelet Ratio Index | A calculation that indicates the likely presence of liver cirrhosis and fibrosis, measured as the relative measurement of aspartate aminotransferase (AST) to AST upper limit of normal, divided by the platelet count, and multiplied by 100. | Aspartate Aminotransferase to Platelet Ratio Index | ||
AST/ALT | C176297 | AST/ALT | A relative measurement (ratio or percentage) of the aspartate aminotransferase (AST) to alanine aminotransferase (ALT) present in a sample. | Aspartate Aminotransferase to Alanine Aminotransferase Ratio Measurement | ||
AST/Creatine Kinase | C158225 | Aspartate Aminotransferase/CPK;Aspartate Aminotransferase/Creatine Kinase;AST/Creatine Kinase | A relative measurement (ratio) of the aspartate aminotransferase to creatine kinase in a biological specimen. | Aspartate Aminotransferase to Creatine Kinase Ratio Measurement | ||
Asymmetric Dimethylarginine | C158233 | Asymmetric Dimethylarginine;N,N-dimethylarginine | A measurement of asymmetric dimethylarginine in a biological specimen. | Asymmetric Dimethylarginine Measurement | ||
Atherogenic Index of Plasma | C154726 | AIP;Atherogenic Index;Atherogenic Index of Plasma | A measurement of the base 10 logarithm of the ratio of molar concentration of plasma triglyceride to high density lipoprotein cholesterol in a biological specimen. | Atherogenic Index of Plasma | ||
Atrial Natriuretic Peptide | C74886 | Atrial Natriuretic Peptide;Atriopeptin | A measurement of the atrial natriuretic peptide in a biological specimen. | Atrial Natriuretic Peptide Measurement | ||
Atypical Lymphocytes/Lymphocytes | C74654 | Atypical Lymphocytes/Lymphocytes;Lymphocytes Atypical/Lymphocytes;Reactive Lymphocytes/Lymphocytes;Variant Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the atypical lymphocytes to all lymphocytes in a biological specimen. | Reactive Lymphocyte to Lymphocyte Ratio Measurement | ||
Auer Rods | C74657 | Auer Rods | A measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen. | Auer Rod Measurement | ||
AXL Receptor Tyrosine Kinase | C165943 | ARK;AXL Receptor Tyrosine Kinase;JTK11;Tyro7;UFO | A measurement of the AXL receptor tyrosine kinase in a biological specimen. | AXL Receptor Tyrosine Kinase Measurement | ||
Azurophilic Granules | C116185 | Azurophilic Granulation;Azurophilic Granules | An observation of azurophilic granules in a biological specimen. | Azurophilic Granule Measurement | ||
B-Cell Activating Factor | C111135 | B-Cell Activating Factor | A measurement of the B-cell activating factor in a biological specimen. | B-Cell Activating Factor Measurement | ||
B-lymphocyte Crossmatch | C128951 | B-lymphocyte Crossmatch | A measurement to determine human leukocyte antigens (HLA) histocompatibility between the recipient and the donor by examining the presence or absence of the recipient's anti-HLA antibody reactivity towards HLA antigens expressed on the donor B-lymphocytes. | B-lymphocyte Crossmatch Measurement | ||
B-Lymphocytes | C174314 | B-Cell Lymphocytes;B-Cells;B-Lymphocytes | A measurement of the B-lymphocytes in a biological specimen. | B-Lymphocyte Count | ||
B-Lymphocytes/Leukocytes | C174316 | B-Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the B-lymphocytes to leukocytes in a biological specimen. | B-Lymphocyte to Leukocyte Ratio Measurement | ||
B-Lymphocytes/Lymphocytes | C174315 | B-Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the B-lymphocytes to total lymphocytes in a biological specimen. | B-Lymphocyte to Lymphocyte Ratio Measurement | ||
B-Lymphocytes/Total Cells | C174317 | B-Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the B-lymphocytes to total cells in a biological specimen. | B-Lymphocyte to Total Cells Ratio Measurement | ||
Bacteria | C64469 | Bacteria | A measurement of the bacteria in a biological specimen. | Bacterial Count | ||
Bacterial Casts | C74762 | Bacterial Casts | A measurement of the bacterial casts present in a biological specimen. | Bacterial Cast Measurement | ||
Bactericidal/Permeability-Inc Protein Ab | C120631 | Bactericidal/Permeability-Inc Protein Ab;BPI Auto-antibody | A measurement of the bactericidal/permeability-increasing protein antibody in a biological specimen. | Bactericidal/Permeability-Increasing Protein Antibody Measurement | ||
Barbital | C184608 | Barbital | A measurement of the barbital in a biological specimen. | Barbital Measurement | ||
Barbiturates | C74688 | Barbiturates | A measurement of any barbiturate class drug present in a biological specimen. | Barbiturate Drug Class Measurement | ||
Base Deficit | C147309 | Base Deficit | A measurement of the amount of alkali required to return a biological specimen to a normal pH under standard conditions. | Base Deficit | ||
Base Excess | C119270 | Actual Base Excess;Base Excess | A calculated measurement of the amount of acid required to return blood to a normal pH under standard conditions. | Base Excess Measurement | ||
Basophilic Erythroblast | C147311 | Basophilic Erythroblast | A measurement of the basophilic erythroblasts in a biological specimen taken from a non-human organism. | Basophilic Erythroblast Count | ||
Basophilic Metamyelocytes | C135399 | Basophilic Metamyelocytes | A measurement of the basophilic metamyelocytes in a biological specimen. | Basophilic Metamyelocyte Count | ||
Basophilic Myelocytes | C135400 | Basophilic Myelocytes | A measurement of the basophilic myelocytes in a biological specimen. | Basophilic Myelocyte Count | ||
Basophilic Myelocytes/Lymphocytes | C181448 | Basophilic Myelocytes/Lymphocytes | A relative measurement (ratio or percentage) of the basophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). | Basophilic Myelocytes to Lymphocytes Ratio Measurement | ||
Basophilic Normoblast | C147405 | Basophilic Normoblast | A measurement of the basophilic normoblasts in a biological specimen taken from a non-human organism. | Basophilic Normoblast Count | ||
Basophilic Stippling | C96567 | Basophilic Stippling | A measurement of the basophilic stippling in a biological specimen. | Basophilic Stippling Measurement | ||
Basophils Band Form | C130154 | Basophils Band Form | A measurement of the banded basophils in a biological specimen. | Basophil Band Form Count | ||
Basophils Band Form/Leukocytes | C130155 | Basophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded basophils to leukocytes in a biological specimen. | Basophil Band Form to Leukocytes Ratio Measurement | ||
Basophils | C64470 | Basophils | A measurement of the basophils in a biological specimen. | Absolute Basophil Count | ||
Basophils, Segmented | C135401 | Basophils, Segmented | A measurement of the segmented basophils in a biological specimen. | Segmented Basophil Count | ||
Basophils/Leukocytes | C64471 | Basophils/Leukocytes | A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen. | Basophil to Leukocyte Ratio | ||
Basophils/Total Cells | C98865 | Basophils/Total Cells | A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). | Basophil to Total Cell Ratio Measurement | ||
Bee Mix Antigen IgE Antibody | C130116 | Bee Mix Antigen IgE Antibody | A measurement of the bee mix antigen IgE antibody in a biological specimen. | Bee Mix Antigen IgE Antibody Measurement | ||
Bee Mix Antigen IgG Antibody | C130117 | Bee Mix Antigen IgG Antibody | A measurement of the bee mix antigen IgG antibody in a biological specimen. | Bee Mix Antigen IgG Antibody Measurement | ||
Bee Mix Antigen IgG4 Antibody | C130118 | Bee Mix Antigen IgG4 Antibody | A measurement of the bee mix antigen IgG4 antibody in a biological specimen. | Bee Mix Antigen IgG4 Antibody Measurement | ||
Bee Mix IgE AB RAST Score | C165929 | Bee Mix IgE AB RAST Score | A classification of the amount of bee mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Bee Mix IgE Antibody RAST Score Measurement | ||
Bee Mix IgG AB RAST Score | C165910 | Bee Mix IgG AB RAST Score | A classification of the amount of bee mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Bee Mix IgG Antibody RAST Score Measurement | ||
Bence-Jones Protein | C111136 | Bence-Jones Protein | A measurement of the total Bence-Jones protein in a biological specimen. | Bence-Jones Protein Measurement | ||
Benzodiazepine | C74692 | Benzodiazepine | A measurement of any benzodiazepine class drug present in a biological specimen. | Benzodiazepine Measurement | ||
Benzoylecgonine | C75350 | Benzoylecgonine | A measurement of the benzoylecgonine in a biological specimen. | Benzoylecgonine Measurement | ||
Benzylpiperazine | C184554 | 1-benzylpiperazine;Benzylpiperazine;N-benzylpiperazine | A measurement of the benzylpiperazine in a biological specimen. | Benzylpiperazine Measurement | ||
Bermuda Grass Pollen IgA | C130069 | Bermuda Grass Pollen IgA | A measurement of the Cynodon dactylon pollen antigen IgA antibody in a biological specimen. | Bermuda Grass Pollen IgA Measurement | ||
Bermuda Grass Pollen IgE AB RAST Score | C165875 | Bermuda Grass Pollen IgE AB RAST Score | A classification of the amount of Cynodon dactylon pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Bermuda Grass Pollen IgE Antibody RAST Score Measurement | ||
Bermuda Grass Pollen IgE | C130068 | Bermuda Grass Pollen IgE | A measurement of the Cynodon dactylon pollen antigen IgE antibody in a biological specimen. | Bermuda Grass Pollen IgE Measurement | ||
Bermuda Grass Pollen IgG AB RAST Score | C165897 | Bermuda Grass Pollen IgG AB RAST Score | A classification of the amount of Cynodon dactylon pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Bermuda Grass Pollen IgG Antibody RAST Score Measurement | ||
Bermuda Grass Pollen IgG | C130070 | Bermuda Grass Pollen IgG | A measurement of the Cynodon dactylon pollen antigen IgG antibody in a biological specimen. | Bermuda Grass Pollen IgG Measurement | ||
Bermuda Grass Pollen IgG4 | C130071 | Bermuda Grass Pollen IgG4 | A measurement of the Cynodon dactylon pollen antigen IgG4 antibody in a biological specimen. | Bermuda Grass Pollen IgG4 Measurement | ||
Beta Alanine | C154764 | Beta Alanine | A measurement of the beta alanine in a biological specimen. | Beta Alanine Measurement | ||
Beta Carotene | C100472 | b-Carotene;Beta Carotene;Beta Carotin | A measurement of the beta carotene in a biological specimen. | Beta Carotene Measurement | ||
Beta Catenin | C103357 | Beta Catenin | A measurement of the beta catenin in a biological specimen. | Beta Catenin Measurement | ||
Beta Globulin | C92256 | Beta Globulin | A measurement of the proteins contributing to the beta fraction in a biological specimen. | Beta Globulin Measurement | ||
Beta Globulin/Total Protein | C92294 | Beta Globulin/Total Protein | A relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen. | Beta Globulin to Total Protein Ratio Measurement | ||
Beta+Gamma Tocopherol | C172497 | Beta and Gamma Tocopherol;Beta+Gamma Tocopherol | A measurement of the beta and gamma tocopherol in a biological specimen. | Beta and Gamma Tocopherol Measurement | ||
Beta-1 Globulin | C119274 | Beta-1 Globulin | A measurement of the beta-1 globulin in a biological specimen. | Beta-1 Globulin Measurement | ||
Beta-1 Globulin/Beta Protein | C142277 | Beta-1 Globulin/Beta Protein | A relative measurement (ratio or percentage) of the beta-1-fraction proteins to the total beta protein fraction in a biological specimen. | Beta-1 Globulin to Total Beta Protein Ratio Measurement | ||
Beta-1 Globulin/Total Protein | C119275 | Beta-1 Globulin/Total Protein | A relative measurement (ratio or percentage) of beta-1-fraction proteins to total proteins in a biological specimen. | Beta-1 Globulin to Total Protein Ratio Measurement | ||
Beta-1B Glycoprotein | C127607 | Beta-1B Glycoprotein;Hemopexin;HPX | A measurement of the beta-1B glycoprotein in a biological specimen. | Beta-1B Glycoprotein Measurement | ||
Beta-2 Globulin | C119276 | Beta-2 Globulin | A measurement of the beta-2 globulin in a biological specimen. | Beta-2 Globulin Measurement | ||
Beta-2 Globulin/Total Protein | C119277 | Beta-2 Globulin/Total Protein | A relative measurement (ratio or percentage) of beta-2-fraction proteins to total proteins in a biological specimen. | Beta-2 Globulin to Total Protein Ratio Measurement | ||
Beta-2 Glycoprotein 1 IgA Antibody | C147308 | Beta-2 Glycoprotein 1 IgA Antibody | A measurement of the beta-2 glycoprotein 1 IgG antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgA Antibody Measurement | ||
Beta-2 Glycoprotein 1 IgG Antibody | C103358 | Beta-2 Glycoprotein 1 IgG Antibody | A measurement of the Beta-2 glycoprotein 1 IgG antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgG Antibody Measurement | ||
Beta-2 Glycoprotein 1 IgM Antibody | C103359 | Beta-2 Glycoprotein 1 IgM Antibody | A measurement of the Beta-2 glycoprotein 1 IgM antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgM Antibody Measurement | ||
Beta-2 Glycoprotein Antibody | C81979 | Beta-2 Glycoprotein Antibody | A measurement of the beta-2 glycoprotein antibody in a biological specimen. | Beta-2 Glycoprotein Antibody Measurement | ||
Beta-2 Microglobulin | C81980 | Beta-2 Microglobulin | A measurement of the beta-2 microglobulin in a biological specimen. | Beta-2 Microglobulin Measurement | ||
Beta-2 Microglobulin/Creatinine | C127608 | Beta-2 Microglobulin/Creatinine | A relative measurement (ratio) of the beta-2 microglobulin to creatinine in a biological specimen. | Beta-2 Microglobulin to Creatinine Ratio Measurement | ||
Beta-Actin | C184510 | Actin Beta;B-Actin;Beta-Actin | A measurement of the beta-actin in a biological specimen. | Beta-Actin Measurement | ||
Beta-Aminobutyric Acid | C154765 | BABA;Beta-aminobutyrate;Beta-Aminobutyric Acid | A measurement of the beta-aminobutyric acid in a biological specimen. | Beta-Aminobutyric Acid Measurement | ||
Beta-cell Function | C123455 | Beta-cell Function | A measurement of the beta cell function (insulin production and secretion) in a biological specimen. | Beta-Cell Function Measurement | ||
Beta-defensin 2 | C122102 | Beta-defensin 2 | A measurement of the beta-defensin 2 in a biological specimen. | Beta-defensin 2 Measurement | ||
Beta-Hydroxybutyrate Excretion Rate | C189520 | 3-Hydroxybutyrate Excretion Rate;B-Hydroxybutyrate Excretion Rate;Beta-Hydroxybutyrate Excretion Rate;BHB Excretion Rate | A measurement of the amount of beta-Hydroxybutyrate being excreted in a biological specimen over a defined period of time (e.g. one hour). | Beta-Hydroxybutyrate Excretion Rate Measurement | ||
Beta-Hydroxybutyrate | C96568 | 3-Hydroxybutyrate;B-Hydroxybutyrate;Beta-Hydroxybutyrate;Beta-Hydroxybutyric Acid;BHB | A measurement of the total Beta-hydroxybutyrate in a biological specimen. | Beta-Hydroxybutyrate Measurement | ||
Beta-Hydroxybutyrate/Acetoacetate | C186028 | Beta-Hydroxybutyrate/Acetoacetate | A relative measurement (ratio) of the beta-hydroxybutyrate to acetoacetate in a biological specimen. | Beta-Hydroxybutyrate to Acetoacetate Ratio Measurement | ||
Beta-Hydroxythiofentanyl | C184530 | Beta-Hydroxythiofentanyl | A measurement of the beta-hydroxythiofentanyl in a biological specimen. | Beta-Hydroxythiofentanyl Measurement | ||
Betaines | C172517 | Betaines | A measurement of the betaine class compounds in a biological specimen. | Betaines Measurement | ||
Bicarbonate | C74667 | Bicarbonate;HCO3 | A measurement of the bicarbonate in a biological specimen. | Bicarbonate Measurement | ||
Bile Acid | C74800 | Bile Acid;Bile Acids;Bile Salt;Bile Salts | A measurement of the total bile acids in a biological specimen. | Bile Acid Measurement | ||
Bilirubin Crystals | C74668 | Bilirubin Crystals | A measurement of the bilirubin crystals present in a biological specimen. | Bilirubin Crystal Measurement | ||
Bilirubin | C38037 | Bilirubin;Total Bilirubin | A measurement of the total bilirubin in a biological specimen. | Total Bilirubin Measurement | ||
Bioavailable Testosterone | C117860 | Bioavailable Testosterone | A measurement of bioavailable testosterone in a biological specimen. | Bioavailable Testosterone Measurement | ||
Birch Pollen IgA | C130073 | Birch Pollen IgA | A measurement of the Betula pollen antigen IgA antibody in a biological specimen. | Birch Pollen IgA Measurement | ||
Birch Pollen IgE AB RAST Score | C165876 | Birch Pollen IgE AB RAST Score | A classification of the amount of Betula pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Birch Pollen IgE Antibody RAST Score Measurement | ||
Birch Pollen IgE | C130072 | Birch Pollen IgE | A measurement of the Betula pollen antigen IgE antibody in a biological specimen. | Birch Pollen IgE Measurement | ||
Birch Pollen IgG AB RAST Score | C165898 | Birch Pollen IgG AB RAST Score | A classification of the amount of Betula pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Birch Pollen IgG Antibody RAST Score Measurement | ||
Birch Pollen IgG | C130074 | Birch Pollen IgG | A measurement of the Betula pollen antigen IgG antibody in a biological specimen. | Birch Pollen IgG Measurement | ||
Birch Pollen IgG4 | C130075 | Birch Pollen IgG4 | A measurement of the Betula pollen antigen IgG4 antibody in a biological specimen. | Birch Pollen IgG4 Measurement | ||
Bite Cells | C74700 | Bite Cells | A measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen. | Bite Cell Count | ||
Bite Cells/Erythrocytes | C74634 | Bite Cells/Erythrocytes | A relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen. | Bite Cell to Erythrocyte Ratio Measurement | ||
Bizarre Platelets | C154733 | Bizarre Platelets | A measurement of the bizarre platelets (large with abnormal morphology and shape) in a biological specimen. | Bizarre Platelet Count | ||
Blasts | C74605 | Blasts | A measurement of the blast cells in a biological specimen. | Blast Count | ||
Blasts/Leukocytes | C64487 | Blasts/Leukocytes | A relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen. | Blast to Leukocyte Ratio | ||
Blasts/Nucleated Cells | C147312 | Blasts/Nucleated Cells | A relative measurement (ratio or percentage) of the blasts to the total nucleated cells in a biological specimen. | Blasts to Nucleated Cells Ratio Measurement | ||
Blasts/Total Cells | C150836 | Blasts/Total Cells | A relative measurement (ratio or percentage) of the blasts to total cells in a biological specimen. | Blasts to Total Cells Ratio Measurement | ||
Bleeding Time | C89775 | Bleeding Time;Clotting Time Homeostasis | A measurement of the time from the start to cessation of an induced bleed. | Bleeding Time | ||
Blister Cell | C127609 | Blister Cell | A measurement of the blister cells in a biological specimen. | Blister Cell Count | ||
Bolasterone | C184579 | Bolasterone | A measurement of the bolasterone in a biological specimen. | Bolasterone Measurement | ||
Boldenone | C75380 | Boldenone | A measurement of the boldenone in a biological specimen. | Boldenone Measurement | ||
Bone Specific Alkaline Phosphatase | C92287 | Bone Specific Alkaline Phosphatase | A measurement of the bone specific alkaline phosphatase isoform in a biological specimen. | Bone Specific Alkaline Phosphatase Measurement | ||
Boxelder Pollen IgE AB RAST Score | C165940 | Boxelder Pollen IgE AB RAST Score | A classification of the amount of Acer negundo pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Boxelder Pollen IgE Antibody RAST Score Measurement | ||
Boxelder Pollen IgE Antibody | C147284 | Boxelder Pollen IgE Antibody | A measurement of the Acer negundo pollen antigen IgE antibody in a biological specimen. | Boxelder Pollen IgE Antibody Measurement | ||
Brain Natriuretic Peptide | C74735 | B-Type Natriuretic Peptide;Brain Natriuretic Peptide | A measurement of the brain (B-type) natriuretic peptide in a biological specimen. | Brain Natriuretic Peptide Measurement | ||
Brain-Derived Neurotrophic Factor | C82004 | Brain-Derived Neurotrophic Factor | A measurement of the brain-derived neurotrophic factor in a biological specimen. | Brain-Derived Neurotrophic Factor Measurement | ||
Brexpiprazole | C177973 | Brexpiprazole | A measurement of the brexpiprazole in a biological specimen. | Brexpiprazole Measurement | ||
Brivaracetam | C184639 | Brivaracetam | A measurement of the brivaracetam in a biological specimen. | Brivaracetam Measurement | ||
Broad Casts | C96588 | Broad Casts | A measurement of the broad casts in a biological specimen. | Broad Casts Measurement | ||
Bromazepam | C184609 | Bromazepam | A measurement of the bromazepam in a biological specimen. | Bromazepam Measurement | ||
Bruton's Tyrosine Kinase | C165772 | Agammaglobulinemia Tyrosine Kinase;ATK;B-cell Progenitor Kinase;Bruton Tyrosine Kinase;Bruton's Tyrosine Kinase;Tyrosine-protein kinase BTK | A measurement of the Bruton's tyrosine kinase in a biological specimen. | Bruton's Tyrosine Kinase Measurement | ||
Bruton's Tyrosine Kinase, Free | C165944 | Bruton's Tyrosine Kinase, Free | A measurement of the free Bruton's tyrosine kinase in a biological specimen. | Free Bruton's Tyrosine Kinase Measurement | ||
Bufotenine | C184531 | Bufotenine | A measurement of the bufotenine in a biological specimen. | Bufotenine Measurement | ||
Buprenorphine | C75352 | Buprenorphine | A measurement of the buprenorphine drug present in a biological specimen. | Buprenorphine Measurement | ||
Burr Cells | C74701 | Burr Cells;Echinocytes | A measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen. | Burr Cell Count | ||
Butabarbital | C75364 | Butabarbital | A measurement of the butabarbital in a biological specimen. | Butabarbital Measurement | ||
Butalbital | C75365 | Butalbital | A measurement of the butalbital present in a biological specimen. | Butalbital Measurement | ||
Butorphanol | C184610 | Butorphanol | A measurement of the butorphanol in a biological specimen. | Butorphanol Measurement | ||
Butylone | C184532 | Butylone | A measurement of the butylone in a biological specimen. | Butylone Measurement | ||
Butyrylcholinesterase | C111142 | Acylcholine Acylhydrolase;Butyrylcholinesterase;Non-neuronal Cholinesterase;Plasma Cholinesterase;Pseudocholinesterase | A measurement of the total butyrylcholinesterase in a biological specimen. | Butyrylcholinesterase Measurement | ||
Butyrylfentanyl | C184533 | Butyrfentanyl;Butyryl Fentanyl;Butyrylfentanyl | A measurement of the butyrylfentanyl in a biological specimen. | Butyrylfentanyl Measurement | ||
C Reactive Protein | C64548 | C Reactive Protein | A measurement of the C reactive protein in a biological specimen. | C-Reactive Protein Measurement | ||
C-C Chemokine Receptor Type 5 | C122103 | C-C Chemokine Receptor Type 5;CD195 | A measurement of the CCR5, chemokine (C-C motif) receptor type 5, in a biological specimen. | C-C Chemokine Receptor Type 5 Measurement | ||
C-Peptide Excretion Rate | C187796 | C-Peptide Excretion Rate | A measurement of the amount of C-peptide being excreted in a biological specimen over a defined amount of time (e.g. one hour). | C-Peptide Excretion Rate | ||
C-peptide | C74736 | C-peptide | A measurement of the C (connecting) peptide of insulin in a biological specimen. | C-peptide Measurement | ||
C-peptide/Creatinine | C150837 | C-peptide/Creatinine | A relative measurement (ratio or percentage) of the C-peptide to creatinine in a biological specimen. | C-peptide to Creatinine Ratio Measurement | ||
Cabot Rings | C74702 | Cabot Rings | A measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen. | Cabot Ring Count | ||
Caffeine | C75346 | Caffeine | A measurement of the caffeine in a biological specimen. | Caffeine Measurement | ||
Calbindin | C125942 | Calbindin | A measurement of the total calbindin in a biological specimen. | Calbindin Measurement | ||
Calcitonin | C74848 | Calcitonin | A measurement of the calcitonin hormone in a biological specimen. | Calcitonin Measurement | ||
Calcitriol | C74849 | Calcitriol | A measurement of the calcitriol hormone in a biological specimen. | Calcitriol Measurement | ||
Calcium - Phosphorus Product | C103360 | Calcium - Phosphorus Product | A measurement of the product of the calcium and phosphate measurements in a biological specimen. | Calcium and Phosphorus Product Measurement | ||
Calcium Carbonate Crystals | C74669 | Calcium Carbonate Crystals | A measurement of the calcium carbonate crystals present in a biological specimen. | Calcium Carbonate Crystal Measurement | ||
Calcium Clearance | C96589 | Calcium Clearance | A measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute). | Calcium Clearance Measurement | ||
Calcium Corrected for Albumin | C154753 | Calcium Corrected for Albumin | A measurement of calcium, which has been corrected for albumin, in a biological specimen. | Albumin Corrected Calcium Measurement | ||
Calcium Corrected for Total Protein | C147314 | Calcium Corrected for Total Protein | A measurement of calcium, which has been corrected for total protein, in a biological specimen. | Calcium Corrected for Total Protein Measurement | ||
Calcium Corrected | C119272 | Calcium Corrected | A measurement of calcium, which has been corrected using an unspecified protein, in a biological specimen. | Calcium Corrected Measurement | ||
Calcium Excretion Rate | C150815 | Calcium Excretion Rate | A measurement of the amount of calcium being excreted in a biological specimen over a defined period of time (e.g. one hour). | Calcium Excretion Rate | ||
Calcium Oxalate Crystals | C74670 | Calcium Oxalate Crystals | A measurement of the calcium oxalate crystals present in a biological specimen. | Calcium Oxalate Crystal Measurement | ||
Calcium Oxalate Excretion Rate | C187793 | Calcium Oxalate Excretion Rate | A measurement of the amount of calcium oxalate being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Calcium Oxalate Excretion Rate | ||
Calcium Phosphate Crystals | C74671 | Calcium Phosphate Crystals | A measurement of the calcium phosphate crystals present in a biological specimen. | Calcium Phosphate Crystal Measurement | ||
Calcium Sulfate Crystals | C124340 | Calcium Sulfate Crystals | A measurement of the calcium sulfate crystals present in a biological specimen. | Calcium Sulfate Crystals Measurement | ||
Calcium Sulphate | C96590 | Calcium Sulphate | A measurement of the calcium sulphate in a biological specimen. | Calcium Sulphate Measurement | ||
Calcium | C64488 | Calcium | A measurement of the calcium in a biological specimen. | Calcium Measurement | ||
Calcium, Ionized pH Adjusted | C125941 | Calcium, Ionized pH Adjusted | A measurement of the pH adjusted ionized calcium in a biological specimen. | Ionized pH Adjusted Calcium Measurement | ||
Calcium, Ionized | C81948 | Calcium, Ionized | A measurement of the ionized calcium in a biological specimen. | Ionized Calcium Measurement | ||
Calcium/Creatinine | C79439 | Calcium/Creatinine | A relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen. | Calcium to Creatinine Ratio Measurement | ||
Calcium/Phosphorus | C139087 | Calcium/Phosphate;Calcium/Phosphorus | A relative measurement (ratio) of the calcium to phosphorus in a biological specimen. | Calcium to Phosphorus Ratio Measurement | ||
Calculated Panel Reactive Antibody | C132381 | Calculated Panel Reactive Antibody | A measurement of the calculated panel reactive antibody, which is based on the number/type of unacceptable HLA antigens to which an organ recipient has been sensitized, and which algorithmically estimates the level of sensitization in the recipient. The CPRA is computed from HLA antigen frequencies in a given donor population using both anti-HLA class I and class II antibody specificities; it also represents the percentage of actual organ donors that express one or more unacceptable HLA antigens to which a recipient may react adversely. | Calculated Panel Reactive Antibody Measurement | ||
Calprotectin | C82005 | Calprotectin | A measurement of the calprotectin in a biological specimen. | Calprotectin Measurement | ||
Cancer Antigen 1 | C103361 | Cancer Antigen 1 | A measurement of the cancer antigen 1 in a biological specimen. | Cancer Antigen 1 Measurement | ||
Cancer Antigen 125 | C79089 | CA125;CA125AG;Cancer Antigen 125;Carbohydrate Antigen 125;MUC16;Mucin-16;Mucin-16, Cell Surface Associated | A measurement of the cancer antigen 125 in a biological specimen. | CA-125 Measurement | ||
Cancer Antigen 15-3 | C103362 | Cancer Antigen 15-3;Carbohydrate Antigen 15-3 | A measurement of the cancer antigen 15-3 in a biological specimen. | Cancer Antigen 15-3 Measurement | ||
Cancer Antigen 19-9 | C81982 | Cancer Antigen 19-9;Carbohydrate Antigen 19-9 | A measurement of the cancer antigen 19-9 in a biological specimen. | Cancer Antigen 19-9 Measurement | ||
Cancer Antigen 242 | C172526 | Cancer Antigen 242;Carbohydrate Antigen 242 | A measurement of the cancer antigen 242 in a biological specimen. | Cancer Antigen 242 Measurement | ||
Cancer Antigen 27-29 | C111143 | Cancer Antigen 27-29 | A measurement of the cancer antigen 27-29 in a biological specimen. | Cancer Antigen 27-29 Measurement | ||
Cancer Antigen 50 | C187794 | CA50;Cancer Antigen 50;Carbohydrate Antigen 50 | A measurement of the cancer antigen 50 in a biological specimen. | Cancer Antigen 50 Measurement | ||
Cancer Antigen 72-4 | C106505 | CA 72-4;Cancer Antigen 72-4;Carbohydrate Antigen 72-4 | A measurement of the cancer antigen 72-4 in a biological specimen. | Cancer Antigen 72-4 Measurement | ||
Cannabinoid Metabolites | C165946 | Cannabinoid Metabolites;Cannabis Metabolites;Marijuana Metabolites | A measurement of any cannabinoid drug class metabolite(s) present in a biological specimen. | Cannabinoid Metabolite Measurement | ||
Cannabinoids | C74689 | Cannabinoids | A measurement of any cannabinoid class drug present in a biological specimen. | Cannabinoid Drug Class Measurement | ||
Cannabinoids, Synthetic | C135402 | Cannabinoids, Synthetic | A measurement of any synthetic cannabinoid class drug present in a biological specimen. | Synthetic Cannabinoid Measurement | ||
Carb-Deficient Transferrin/Transferrin | C125943 | Carb-Deficient Transferrin/Transferrin | A relative measurement (ratio or percentage) of the carbohydrate-deficient transferrin to total transferrin in a biological specimen. | Carbohydrate-Deficient Transferrin to Transferrin Ratio Measurement | ||
Carbamazepine | C147322 | Carbamazepine | A measurement of the carbamazepine in a biological specimen. | Carbamazepine Measurement | ||
Carbohydrate-Deficient Transferrin | C101016 | Carbohydrate-Deficient Transferrin | A measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen. | Carbohydrate-Deficient Transferrin Measurement | ||
Carbon Dioxide | C64545 | Carbon Dioxide | A measurement of the carbon dioxide gas in a biological specimen. | Carbon Dioxide Measurement | ||
Carbon Monoxide | C139084 | Carbon Monoxide | A measurement of the carbon monoxide in a biological specimen. | Carbon Monoxide Measurement | ||
Carbonic Anhydrase 9 | C172510 | CA9;CAIX;Carbonic Anhydrase 9 | A measurement of the carbonic anhydrase 9 in a biological specimen. | Carbonic Anhydrase 9 Measurement | ||
Carboxyhemoglobin | C96591 | Carboxyhemoglobin | A measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen. | Carboxyhemoglobin Measurement | ||
Carboxyhemoglobin/Total Hemoglobin | C147355 | Carboxyhemoglobin/Total Hemoglobin | A relative measurement (ratio or percentage) of the amount of carboxyhemoglobin compared to total hemoglobin in a biological specimen. | Carboxyhemoglobin to Total Hemoglobin Ratio Measurement | ||
Carboxypeptidase B2 | C165953 | Carboxypeptidase B2;CPU;PCPB;TAFI | A measurement of the carboxypeptidase B2 in a biological specimen. | Carboxypeptidase B2 Measurement | ||
Carcinoembryonic Antigen | C81983 | Carcinoembryonic Antigen | A measurement of the carcinoembryonic antigen in a biological specimen. | Carcinoembryonic Antigen Measurement | ||
Cardiolipin IgA Antibody | C122112 | Cardiolipin IgA Antibody | A measurement of the cardiolipin IgA antibody in a biological specimen. | Cardiolipin IgA Antibody Measurement | ||
Cardiolipin IgG Antibody | C111144 | Anti-Cardiolipin IgG Antibody;Cardiolipin IgG Antibody | A measurement of the cardiolipin IgG antibody in a biological specimen. | Cardiolipin IgG Antibody Measurement | ||
Cardiolipin IgM Antibody | C103363 | Cardiolipin IgM Antibody | A measurement of the cardiolipin IgM antibodies in a biological specimen. | Cardiolipin IgM Antibody Measurement | ||
Cariprazine | C177975 | Cariprazine | A measurement of the cariprazine in a biological specimen. | Cariprazine Measurement | ||
Carisoprodol | C184611 | Carisoprodol | A measurement of the carisoprodol in a biological specimen. | Carisoprodol Measurement | ||
Carnitine Acetyl Transferase | C92288 | Carnitine Acetyl Transferase | A measurement of the carnitine acetyl transferase in a biological specimen. | Carnitine Acetyl Transferase Measurement | ||
Carnitine Esters | C147323 | Carnitine Esters | A measurement of the total carnitine esters in a biological specimen. | Carnitine Ester Measurement | ||
Carnitine Excretion Rate | C163424 | Carnitine Excretion Rate | A measurement of the amount of carnitine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Carnitine Excretion Rate | ||
Carnitine | C74682 | Carnitine | A measurement of the total carnitine in a biological specimen. | Total Carnitine Measurement | ||
Carnitine, Free | C74677 | Carnitine, Free | A measurement of the free carnitine in a biological specimen. | Free Carnitine Measurement | ||
Carotene | C186034 | Carotene | A measurement of the total carotenes in a biological specimen. | Carotene Measurement | ||
Cartilage Oligomeric Matrix Protein | C111145 | Cartilage Oligomeric Matrix Protein | A measurement of the cartilage oligomeric matrix protein in a biological specimen. | Cartilage Oligomeric Matrix Protein Measurement | ||
Casein | C198282 | Casein | A measurement of the casein in a biological specimen. | Casein Measurement | ||
Cashew Antigen IgE Antibody | C177958 | Anacardium occidentale Nut Antigen IgE Antibody;Cashew Antigen IgE Antibody | A measurement of the cashew antigen IgE antibody in a biological specimen. | Cashew Antigen IgE Antibody Measurement | ||
Casts | C74763 | Casts | A statement that indicates casts were looked for in a biological specimen. | Cast Present Or Absent | ||
Cat Dander Antigen IgA Antibody | C130126 | Cat Dander Antigen IgA Antibody | A measurement of the Felis catus dander antigen IgA antibody in a biological specimen. | Cat Dander Antigen IgA Antibody Measurement | ||
Cat Dander Antigen IgE Antibody | C130124 | Cat Dander Antigen IgE Antibody | A measurement of the Felis catus dander antigen IgE antibody in a biological specimen. | Cat Dander Antigen IgE Antibody Measurement | ||
Cat Dander Antigen IgG Antibody | C130125 | Cat Dander Antigen IgG Antibody | A measurement of the Felis catus dander antigen IgG antibody in a biological specimen. | Cat Dander Antigen IgG Antibody Measurement | ||
Cat Dander Antigen IgG4 Antibody | C130127 | Cat Dander Antigen IgG4 Antibody | A measurement of the Felis catus dander antigen IgG4 antibody in a biological specimen. | Cat Dander Antigen IgG4 Antibody Measurement | ||
Cat Dander IgE AB RAST Score | C165877 | Cat Dander IgE AB RAST Score | A classification of the amount of Felis catus dander antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Cat Dander IgE Antibody RAST Score Measurement | ||
Cat Dander IgG AB RAST Score | C165914 | Cat Dander IgG AB RAST Score | A classification of the amount of Felis cattus dander IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Cat Dander IgG Antibody RAST Score Measurement | ||
Catecholamines | C186037 | Catecholamines | A measurement of the total catecholamines in a biological specimen. | Catecholamine Measurement | ||
Cathepsin Antibody | C120634 | Cathepsin Antibody | A measurement of the total cathepsin antibody in a biological specimen. | Cathepsin Antibody Measurement | ||
Cathinone | C184534 | Cathinone | A measurement of the cathinone in a biological specimen. | Cathinone Measurement | ||
CEA Cell Adhesion Molecule 1 | C172511 | BGP;Biliary Glycoprotein;Carcinoembryonic Antigen Cell Adhesion Molecule 1;CD66a;CEA Cell Adhesion Molecule 1;CEA Related Cell Adhesion Molecule 1 | A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 1 in a biological specimen. | CEA Cell Adhesion Molecule 1 Measurement | ||
CEA Cell Adhesion Molecule 5 | C191212 | Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5;CD66e;CEA Cell Adhesion Molecule 5 | A measurement of the carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. | CEA Cell Adhesion Molecule 5 Measurement | ||
Cell Morphology | C17768 | Cell Morphology | An examination or assessment of the form and structure of cells. | Cellular Morphology | ||
Cells | C48938 | Cells | A measurement of the total cells in a biological specimen. | Cell Count | ||
Cellular Casts | C74764 | Cellular Casts | A measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen. | Cellular Cast Measurement | ||
Cellularity | C111153 | Cellularity;Cellularity Grade | A measurement of the degree, quality or condition of cells in a biological specimen. | Cellularity Measurement | ||
Centromere B Antibodies | C111154 | Centromere B Antibodies | A measurement of centromere B antibodies in a biological specimen. | Centromere B Antibody Measurement | ||
Centromere IgG Antibody | C122111 | Centromere IgG Antibody;Centromere Protein B | A measurement of the centromere IgG antibody in a biological specimen. | Centromere IgG Antibody Measurement | ||
Ceruloplasmin | C100432 | Caeruloplasmin;Ceruloplasmin | A measurement of ceruloplasmin in a biological specimen. | Ceruloplasmin Measurement | ||
Chemokine (C-C Motif) Ligand 12 | C130156 | Chemokine (C-C Motif) Ligand 12;Monocyte Chemotactic Protein 5 | A measurement of the CCL12, chemokine (C-C motif) ligand 12, in a biological specimen. | Chemokine (C-C Motif) Ligand 12 Measurement | ||
Chemokine (C-C Motif) Ligand 13 | C165947 | C-C Motif Chemokine Ligand 13;Chemokine (C-C Motif) Ligand 13;CKb10;MCP-4;NCC1;SCYA13;SCYL1 | A measurement of the CCL13, chemokine (C-C motif) ligand 13, in a biological specimen. | Chemokine (C-C Motif) Ligand 13 Measurement | ||
Chemokine (C-C Motif) Ligand 16 | C165948 | Chemokine (C-C Motif) Ligand 16;CKb12;HCC-4;ILINCK;LCC-1;LEC;LMC;Mtn-1;NCC4;SCYA16;SCYL4 | A measurement of the CCL16, chemokine (C-C motif) ligand 16, in a biological specimen. | Chemokine (C-C Motif) Ligand 16 Measurement | ||
Chemokine (C-C Motif) Ligand 17 | C112236 | ABCD-2;Chemokine (C-C Motif) Ligand 17;SCYA17;TARC;Thymus and Activation Regulated Chemokine | A measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen. | Chemokine (C-C Motif) Ligand 17 Measurement | ||
Chemokine (C-C Motif) Ligand 18 | C112237 | AMAC-1;AMAC1;Chemokine (C-C Motif) Ligand 18;CKB7;DC-CK1;DCCK1;Macrophage inflammatory protein-4;MIP4;PARC;Pulmonary and Activation-Regulated Chemokine;SCYA18 | A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen. | Chemokine (C-C Motif) Ligand 18 Measurement | ||
Chemokine (C-C Motif) Ligand 19 | C130157 | Chemokine (C-C Motif) Ligand 19;Macrophage Inflammatory Protein 3 Beta;MIP3B | A measurement of the CCL19, chemokine (C-C motif) ligand 19, in a biological specimen. | Chemokine (C-C Motif) Ligand 19 Measurement | ||
Chemokine (C-C Motif) Ligand 2 Excr Rate | C156520 | Chemokine (C-C Motif) Ligand 2 Excr Rate;Chemokine (C-C Motif) Ligand 2 Excretion Rate;MCP1 Excretion Rate | A measurement of the amount of chemokine (C-C Motif) ligand 2 being excreted in a biological specimen over a defined period of time (e.g. one hour). | Chemokine (C-C Motif) Ligand 2 Excretion Rate | ||
Chemokine (C-C Motif) Ligand 20 | C161362 | CCL20;Chemokine (C-C Motif) Ligand 20;LARC;Liver Activation Regulated Chemokine;Macrophage Inflammatory Protein-3 Alpha;MIP3A | A measurement of the chemokine (C-C motif) ligand 20 in a biological specimen. | Chemokine (C-C Motif) Ligand 20 Measurement | ||
Chemokine (C-C Motif) Ligand 21 | C147315 | 6Ckine;Chemokine (C-C Motif) Ligand 21;Secondary Lymphoid Tissue Chemokine | A measurement of the CCL21, chemokine (C-C motif) ligand 21, in a biological specimen. | Chemokine (C-C Motif) Ligand 21 Measurement | ||
Chemokine (C-C Motif) Ligand 23 | C165949 | Chemokine (C-C Motif) Ligand 23;CK-BETA-8;Ckb-8-1;CKb8;Hmrp-2a;MIP3;MPIF-1;SCYA23 | A measurement of the CCL23, chemokine (C-C motif) ligand 23, in a biological specimen. | Chemokine (C-C Motif) Ligand 23 Measurement | ||
Chemokine (C-C Motif) Ligand 25 | C165950 | Chemokine (C-C Motif) Ligand 25;Ckb15;SCYA25;TECK | A measurement of the CCL25, chemokine (C-C motif) ligand 25, in a biological specimen. | Chemokine (C-C Motif) Ligand 25 Measurement | ||
Chemokine (C-C Motif) Ligand 7 | C130158 | Chemokine (C-C Motif) Ligand 7;MCP3;Monocyte Chemotactic Protein 3 | A measurement of the CCL7, chemokine (C-C motif) ligand 7, in a biological specimen. | Chemokine (C-C Motif) Ligand 7 Measurement | ||
Chemokine (C-C Motif) Ligand 8 | C165951 | Chemokine (C-C Motif) Ligand 8;HC14;MCP2;SCYA10;SCYA8 | A measurement of the CCL8, chemokine (C-C motif) ligand 8, in a biological specimen. | Chemokine (C-C Motif) Ligand 8 Measurement | ||
Chemokine (C-X-C Motif) Ligand 1 | C128952 | Chemokine (C-X-C Motif) Ligand 1;GRO Alpha;GRO/KC;Melanoma Growth Stimulating Activity, Alpha | A measurement of the CXCL1, chemokine (C-X-C motif) ligand 1, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 1 Measurement | ||
Chemokine (C-X-C Motif) Ligand 10 | C112238 | Chemokine (C-X-C Motif) Ligand 10;Interferon Gamma-induced Protein 10;Interferon-inducible Protein-10;IP-10;Small-inducible Cytokine B10 | A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 10 Measurement | ||
Chemokine (C-X-C Motif) Ligand 11 | C161360 | Chemokine (C-X-C Motif) Ligand 11;I-TAC;IFN-inducible T Cell Alpha Chemoattractant;ITAC | A measurement of the chemokine (C-X-C motif) ligand 11 in a biological specimen. | Chemokine (C-X-C Motif) Ligand 11 Measurement | ||
Chemokine (C-X-C Motif) Ligand 12 | C165954 | Chemokine (C-X-C Motif) Ligand 12;IRH;PBSF;SCYB12;SDF1;SDF1A;SDF1B;Stromal Cell-Derived Factor-1 Alpha;Stromal Cell-Derived Factor-1 Beta;TLSF;TPAR1 | A measurement of the CXCL12, chemokine (C-X-C motif) ligand 12, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 12 Measurement | ||
Chemokine (C-X-C Motif) Ligand 13 | C147328 | B Lymphocyte Chemoattractant;Chemokine (C-X-C Motif) Ligand 13 | A measurement of the CXCL13, chemokine (C-X-C motif) ligand 13, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 13 Measurement | ||
Chemokine (C-X-C Motif) Ligand 2 | C186039 | Chemokine (C-X-C Motif) Ligand 2;GRO Beta;GRO2;MIP2-Alpha | A measurement of the CXCL2, chemokine (C-X-C motif) ligand 2, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 2 Measurement | ||
Chemokine (C-X-C Motif) Ligand 3 | C147329 | Chemokine (C-X-C Motif) Ligand 3;GRO Gamma;Macrophage Inflammatory Protein 2-Beta;MIP2 Beta;MIP2B | A measurement of the CXCL3, chemokine (C-X-C motif) ligand 3, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 3 Measurement | ||
Chemokine (C-X-C Motif) Ligand 4 | C147330 | Chemokine (C-X-C Motif) Ligand 4;Oncostatin A;Platelet Factor 4;PLF4 | A measurement of the CXCL4, chemokine (C-X-C motif) ligand 4, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 4 Measurement | ||
Chemokine (C-X-C Motif) Ligand 6 | C130159 | Chemokine (C-X-C Motif) Ligand 6;GCP2;Granulocyte Chemotactic Protein 2 | A measurement of the CXCL6, chemokine (C-X-C motif) ligand 6, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 6 Measurement | ||
Chemokine (C-X-C Motif) Ligand 7 | C165955 | B-TG1;Beta-TG;Chemokine (C-X-C Motif) Ligand 7;CTAP-III;CTAP3;CTAPIII;LA-PF4;LDGF;MDGF;NAP-2;Neutrophil-Activating Peptide 2;PBP;PPBP;Pro-Platelet Basic Protein;SCYB7;TC1;TC2;TGB;TGB1;THBGB;THBGB1 | A measurement of the pro-platelet basic protein in a biological specimen. | Chemokine (C-X-C Motif) Ligand 7 Measurement | ||
Chemokine (C-X-C Motif) Ligand 9 | C165956 | Chemokine (C-X-C Motif) Ligand 9;CMK;crg-10;Humig;MIG;SCYB9 | A measurement of the CXCL9, chemokine (C-X-C motif) ligand 9, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 9 Measurement | ||
Chemokine (C-X-C Motif) Receptor 3 | C100431 | CD183;Chemokine (C-X-C Motif) Receptor 3;CXCR3;GPR9 | A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen. | Chemokine Receptor CXCR3 Measurement | ||
Chemokine (C-X-C Motif) Receptor 4 | C187797 | CD184;Chemokine (C-X-C Motif) Receptor 4;LPS-Associated Protein 3;Stromal Cell-Derived Factor 1 Receptor | A measurement of the CXCR4, chemokine (C-X-C motif) receptor 4, in a biological specimen. | C-X-C Chemokine Receptor Type 4 Measurement | ||
Chemokine (C-X3-C Motif) Ligand 1 | C161361 | Chemokine (C-X3-C motif) Ligand 1;Fractalkine;Neurotactin | A measurement of the chemokine (C-X3-C motif) ligand 1 in a biological specimen. | Chemokine (C-X3-C Motif) Ligand 1 Measurement | ||
Chenodeoxycholate Compounds | C176239 | Chenodeoxycholate Compounds;Chenodeoxycholic Acid Compounds | A measurement of the chenodeoxycholic acid, glycochenodeoxycholic acid, and taurochenodeoxycholic acid in a biological specimen. | Chenodeoxycholate Compounds Measurement | ||
Chenodeoxycholate | C172498 | Chenic Acid;Chenocholic Acid;Chenodeoxycholate;Chenodeoxycholic Acid | A measurement of the chenodeoxycholate in a biological specimen. | Chenodeoxycholate Measurement | ||
Chitotriosidase | C187795 | Chitinase 1;Chitotriosidase;Chitotriosidase-1 | A measurement of the chitotriosidase-1 in a biological specimen. | Chitotriosidase-1 Measurement | ||
Chloral Hydrate | C184612 | Chloral Hydrate;Mickey Finn;Trichloroacetaldehyde Monohydrate | A measurement of the chloral hydrate in a biological specimen. | Chloral Hydrate Measurement | ||
Chlordiazepoxide | C75371 | Chlordiazepoxide | A measurement of the chlordiazepoxide present in a biological specimen. | Chlordiazepoxide Measurement | ||
Chloride Clearance | C106509 | Chloride Clearance | A measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute). | Chloride Clearance Measurement | ||
Chloride Excretion Rate | C150816 | Chloride Excretion Rate | A measurement of the amount of chloride being excreted in a biological specimen over a defined period of time (e.g. one hour). | Chloride Excretion Rate | ||
Chloride | C64495 | Chloride | A measurement of the chloride in a biological specimen. | Chloride Measurement | ||
Chloride/Creatinine | C79440 | Chloride/Creatinine | A relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen. | Chloride to Creatinine Ratio Measurement | ||
Chlorphentermine | C184580 | Chlorphentermine | A measurement of the chlorphentermine in a biological specimen. | Chlorphentermine Measurement | ||
Chlorpromazine | C177968 | Chlorpromazine | A measurement of the chlorpromazine in a biological specimen. | Chlorpromazine Measurement | ||
Cholate Compounds | C176232 | Cholate Compounds;Cholic Acid Compounds | A measurement of the cholic acid, glycocholic acid, hyocholic acid, and taurocholic acid in a biological specimen. | Cholate Compounds Measurement | ||
Cholate | C172499 | Cholate;Cholic Acid | A measurement of the cholate in a biological specimen. | Cholate Measurement | ||
Cholecystokinin | C74850 | Cholecystokinin;Pancreozymin | A measurement of the cholecystokinin hormone in a biological specimen. | Cholecystokinin Measurement | ||
Cholestanol | C181435 | 5alpha-Cholestanol;Beta-Cholestanol;Cholestanol;Dehydrocholesterol;Zymostanol | A measurement of the cholestanol in a biological specimen. | Cholestanol Measurement | ||
Cholesterol Crystals | C74672 | Cholesterol Crystals | A measurement of the cholesterol crystals present in a biological specimen. | Cholesterol Crystal Measurement | ||
Cholesterol Sulfate | C181436 | Cholesterol Sulfate | A measurement of the cholesterol sulfate in a biological specimen. | Cholesterol Sulfate Measurement | ||
Cholesterol | C105586 | Cholesterol;Total Cholesterol | A measurement of the cholesterol in a biological specimen. | Cholesterol Measurement | ||
Cholesterol/HDL-Cholesterol | C80171 | Cholesterol/HDL-Cholesterol | A relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen. | Cholesterol to HDL-Cholesterol Ratio Measurement | ||
Cholesteryl Ester Transfer Protein Act | C103380 | Cholesteryl Ester Transfer Protein Act | A measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen. | Cholesteryl Ester Transfer Protein Activity Measurement | ||
Cholesteryl Ester Transfer Protein | C120632 | Cholesteryl Ester Transfer Protein | A measurement of the cholesteryl ester transfer protein in a biological specimen. | Cholesteryl Ester Transfer Protein Measurement | ||
Cholinesterase | C92289 | Cholinesterase | A measurement of the cholinesterase in a biological specimen. | Cholinesterase Measurement | ||
Choriogonadotropin Adj for Maternal Wt | C161374 | Choriogonadotropin Adj for Maternal Wt;Choriogonadotropin Adjusted for Maternal Weight | A measurement of choriogonadotropin, which has been adjusted for maternal body weight, in a biological specimen. | Choriogonadotropin Adjusted for Maternal Weight Measurement | ||
Choriogonadotropin Beta | C64851 | Choriogonadotropin Beta;Pregnancy Test | A measurement of the Choriogonadotropin Beta in a biological specimen. | Choriogonadotropin Beta Measurement | ||
Choriogonadotropin Beta, Free | C147360 | Choriogonadotropin Beta, Free | A measurement of the free choriogonadotropin beta in a biological specimen. | Free Choriogonadotropin Beta Measurement | ||
Choriogonadotropin | C147128 | Choriogonadotropin | A measurement of the total choriogonadotropin in a biological specimen. | Choriogonadotropin Measurement | ||
Choriogonadotropin, Intact | C147361 | Choriogonadotropin, Intact | A measurement of the intact choriogonadotropin in a biological specimen. | Intact Choriogonadotropin Measurement | ||
Chromatin Antibodies | C147318 | Chromatin Antibodies | A measurement of the chromatin antibodies in a biological specimen. | Chromatin Antibody Measurement | ||
Chromogranin A | C122108 | Chromogranin A | A measurement of the chromogranin A in a biological specimen. | Chromogranin A Measurement | ||
Chylomicron Triglyceride | C174302 | Chylomicron Triglyceride | A measurement of the chylomicron triglyceride in a biological specimen. | Chylomicron Triglyceride Measurement | ||
Chylomicrons | C120633 | Chylomicrons | A measurement of the chylomicrons in a biological specimen. | Chylomicrons Measurement | ||
Chymotrypsin | C111159 | Chymotrypsin | A measurement of the total chymotrypsin in a biological specimen. | Chymotrypsin Measurement | ||
Circulating Endothelial Cells | C96592 | Circulating Endothelial Cells | A measurement of the circulating endothelial cells in a biological specimen. | Circulating Endothelial Cell Count | ||
Circulating Immune Complexes | C127611 | Circulating Immune Complexes | A measurement of the circulating immune complexes in a biological specimen. | Circulating Immune Complex Measurement | ||
Circulating Tumor Cells | C96593 | Circulating Tumor Cells | A measurement of the circulating tumor cells in a biological specimen. | Circulating Tumor Cell Count | ||
Circulating Tumor Cells, Apoptotic | C186036 | Circulating Tumor Cells, Apoptotic | A measurement of the apoptotic circulating tumor cells in a biological specimen. | Apoptotic Circulating Tumor Cell Count | ||
Circulating Tumor Cells, Traditional | C186038 | Circulating Tumor Cells, Traditional | A measurement of the traditional circulating tumor cells in a biological specimen. | Traditional Circulating Tumor Cell Count | ||
Citalopram | C147327 | Citalopram | A measurement of the citalopram present in a biological specimen. | Citalopram Measurement | ||
Citrate Excretion Rate | C163425 | Citrate Excretion Rate | A measurement of the amount of citrate being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Citrate Excretion Rate | ||
Citrate | C92248 | Citrate;Citric Acid | A measurement of the citrate in a biological specimen. | Citrate Measurement | ||
Citrate/Creatinine | C122110 | Citrate/Creatinine;Citric Acid/Creatinine | A relative measurement (ratio or percentage) of the citrate to creatinine in a biological specimen. | Citrate to Creatinine Ratio Measurement | ||
Citrulline | C122109 | Citrulline | A measurement of the citrulline in a biological specimen. | Citrulline Measurement | ||
Citrulline/Creatinine | C189500 | Citrulline/Creatinine | A relative measurement (ratio or percentage) of the citrulline to creatinine in a biological specimen. | Citrulline to Creatinine Ratio Measurement | ||
CK, Macromolecular Type 1/Total CK | C147319 | CK, Macromolecular Type 1/Total CK;Creatine Kinase, Macromolecular Type 1/Total Creatine Kinase | A relative measurement (ratio or percentage) of the macromolecular type 1 creatine kinase to total creatine kinase in a biological specimen. | Macromolecular Type 1 Creatine Kinase to Total Creatine Kinase Ratio Measurement | ||
CK, Macromolecular Type 2/Total CK | C147320 | CK, Macromolecular Type 2/Total CK;Creatine Kinase, Macromolecular Type 2/Total Creatine Kinase | A relative measurement (ratio or percentage) of the macromolecular type 2 creatine kinase to total creatine kinase in a biological specimen. | Macromolecular Type 2 Creatine Kinase to Total Creatine Kinase Ratio Measurement | ||
Clarity | C96594 | Clarity | A measurement of the transparency of a biological specimen. | Clarity Measurement | ||
Clobazam | C184613 | Clobazam;cloBAZam | A measurement of the clobazam in a biological specimen. | Clobazam Measurement | ||
Clonazepam and/or Metabolites | C186031 | Clonazepam and/or Metabolites | A measurement of the clonazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both clonazepam and its metabolites. | Clonazepam and/or Metabolites Measurement | ||
Clonazepam | C139082 | Clonazepam | A measurement of the clonazepam present in a biological specimen. | Clonazepam Measurement | ||
Clorazepate | C139077 | Clorazepate | A measurement of the clorazepate present in a biological specimen. | Clorazepate Measurement | ||
Clostebol | C184581 | Clostebol | A measurement of the clostebol in a biological specimen. | Clostebol Measurement | ||
Clot Lysis Time | C187805 | Clot Lysis Time;ECLT;ELT;Euglobulin Clot Lysis Time;Euglobulin Lysis Time | A measurement of the amount of time it takes for dissolution of a fibrin clot in a biological specimen. | Euglobulin Clot Lysis Time | ||
Clot Retraction Time | C181437 | Clot Retraction Time | A measurement of the amount of time it takes for a clot to retract, or pull away from, the wall of a glass collection container. | Clot Retraction Time Measurement | ||
Clot Retraction | C181438 | Clot Retraction;Clot Retraction, Qualitative | A qualitative assessment of clot retraction in a biological specimen. | Qualitative Clot Retraction Measurement | ||
Clue Cells | C102261 | Clue Cells | A measurement of the clue cells in a biological specimen. | Clue Cell Count | ||
Coagulation Index | C112239 | CI;Coagulation Index | A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation. | Coagulation Index Measurement | ||
Cocaethylene | C156510 | Cocaethylene;Cocaine Ethyl | A measurement of the cocaethylene present in a biological specimen. | Cocaethylene Measurement | ||
Cocaine Amphetamine-Reg Transcript Prot | C142273 | CART;Cocaine Amphetamine-Reg Transcript Prot;Cocaine and Amphetamine-Regulated Transcript Protein | A measurement of the cocaine and amphetamine-regulated transcript protein in a biological specimen. | Cocaine Amphetamine-Regulated Transcript Protein Measurement | ||
Cocaine and/or Metabolites | C172490 | Cocaine and/or Metabolites | A measurement of the cocaine and/or its metabolite(s) present in a biological specimen, for an assay that can measure both cocaine and its metabolites. | Cocaine And/Or Metabolites Measurement | ||
Cocaine Benzoylecgonine Ecgonine | C142274 | Cocaine Benzoylecgonine Ecgonine | A measurement of the cocaine, benzoylecgonine, and/or ecgonine in a biological specimen. | Cocaine, Benzoylecgonine, and/or Ecgonine Measurement | ||
Cocaine Metabolites | C172491 | Cocaine Metabolites | A measurement of any cocaine drug class metabolite(s) present in a biological specimen. | Cocaine Metabolites Measurement | ||
Cocaine | C74690 | Cocaine | A measurement of the cocaine present in a biological specimen. | Cocaine Measurement | ||
Codeine | C74877 | Codeine | A measurement of the codeine present in a biological specimen. | Codeine Measurement | ||
Coefficient of Fat Absorption | C176311 | Coefficient of Fat Absorption | A measurement of the coefficient of fat absorption in a biological specimen. | Coefficient of Fat Absorption Measurement | ||
Coefficient of Nitrogen Absorption | C176310 | Coefficient of Nitrogen Absorption | A measurement of the coefficient of nitrogen absorption in a biological specimen. | Coefficient of Nitrogen Absorption Measurement | ||
Collagen III Neo-Peptide C3M | C165945 | Collagen III Neo-Peptide C3M | A measurement of the collagen III neo-peptide C3M in a biological specimen. | Collagen III Neo-Peptide C3M Measurement | ||
Collagen Type IV | C103383 | Collagen Type IV | A measurement of the collagen type IV in a biological specimen. | Collagen Type IV Measurement | ||
Color | C64546 | Color | A measurement of the color of a biological specimen. | Color Assessment | ||
Columnar Epi Cells/Non-Squam Epi Cells | C135405 | Columnar Epi Cells/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the columnar epithelial cells to non-squamous epithelial cells in a biological specimen. | Columnar Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement | ||
Common Ragweed Pollen IgE AB RAST Score | C165941 | Common Ragweed Pollen IgE AB RAST Score | A classification of the amount of Ambrosia artemisiifolia pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Common Ragweed Pollen IgE Antibody RAST Score Measurement | ||
Common Ragweed Pollen IgE Antibody | C147285 | Common Ragweed Pollen IgE Antibody | A measurement of the Ambrosia elatior pollen antigen IgE antibody in a biological specimen. | Common Ragweed Pollen IgE Antibody Measurement | ||
Complement Ba | C135403 | Ba Fragment of Complement Factor B;Ba Fragment of Factor B;Complement Ba | A measurement of the Ba fragment of complement factor B in a biological specimen. | Complement Ba Measurement | ||
Complement Bb | C80172 | Bb Fragment of Complement Factor B;Bb Fragment of Factor B;Complement Bb | A measurement of the Bb fragment of complement factor B in a biological specimen. | Complement Bb Measurement | ||
Complement C1 Esterase Inhibitor | C147313 | Complement C1 Esterase Inhibitor | A measurement of the complement C1 esterase inhibitor in a biological specimen. | Complement C1 Esterase Inhibitor Measurement | ||
Complement C1q Antibody | C80173 | Complement C1q Antibody | A measurement of the complement C1q antibody in a biological specimen. | Complement C1q Antibody Measurement | ||
Complement C1q | C186029 | Complement C1q | A measurement of the complement C1q in a biological specimen. | Complement C1q Measurement | ||
Complement C3 | C80174 | Complement C3 | A measurement of the complement C3 in a biological specimen. | Complement C3 Measurement | ||
Complement C3a DesArg | C163423 | Acylation-Stimulating Protein;ASP;Complement C3a DesArg | A measurement of the complement C3a DesArg in a biological specimen. | Complement C3a DesArg Measurement | ||
Complement C3a | C80175 | Complement C3a | A measurement of the complement C3a in a biological specimen. | Complement C3a Measurement | ||
Complement C3b | C80176 | Complement C3b | A measurement of the complement C3b in a biological specimen. | Complement C3b Measurement | ||
Complement C3c | C184521 | Complement C3c | A measurement of the complement C3c in a biological specimen. | Complement C3c Measurement | ||
Complement C3d Antibody | C119271 | Complement C3d Antibody | A measurement of the complement C3d antibody in a biological specimen. | Complement C3d Antibody Measurement | ||
Complement C4 | C80177 | Complement C4 | A measurement of the complement C4 in a biological specimen. | Complement C4 Measurement | ||
Complement C4a | C80178 | Complement C4a | A measurement of the complement C4a in a biological specimen. | Complement C4a Measurement | ||
Complement C4d | C127610 | Complement C4d | A measurement of the complement C4d in a biological specimen. | Complement C4d Measurement | ||
Complement C5 | C160935 | Complement C5 | A measurement of the total complement C5 in a biological specimen. | Complement C5 Measurement | ||
Complement C5, Free | C161357 | Complement C5, Free | A measurement of the free complement C5 in a biological specimen. | Free Complement C5 Measurement | ||
Complement C5a | C80179 | Complement C5a | A measurement of the complement C5a in a biological specimen. | Complement C5a Measurement | ||
Complement C5b-9 | C158235 | Complement C5b-9 | A measurement of the complement C5b-9 in a biological specimen. | Complement C5b-9 Measurement | ||
Complement CH100 | C147317 | CH100;Complement CH100;Total Hemolytic Complement CH100 | A measurement of the complement required to lyse 100 percent of red blood cells in a biological specimen. | Complement CH100 Measurement | ||
Complement CH50 | C100423 | CH50;Complement CH50;Total Hemolytic Complement CH50 | A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen. | CH50 Measurement | ||
Complement Total | C80160 | Complement Total;Total Hemolytic Complement | A measurement of the total complement in a biological specimen. | Complement Measurement | ||
Connective Tissue Growth Factor | C189504 | Cellular Communication Network Factor 2;CN2;Connective Tissue Growth Factor;IGFBP8 | A measurement of the connective tissue growth factor in a biological specimen. | Connective Tissue Growth Factor Measurement | ||
Consistency | C95110 | Consistency | A description about the firmness or make-up of an entity. | Consistency | ||
Copeptin | C127612 | Copeptin | A measurement of the copeptin in a biological specimen. | Copeptin Measurement | ||
Copper | C111161 | Copper;Cu | A measurement of copper in a biological specimen. | Copper Measurement | ||
Corpuscular Hemoglobin Content | C139066 | Cellular Hemoglobin Content;CH;Corpuscular Hemoglobin Content | A measurement of the mean erythrocyte hemoglobin content within an individual erythrocyte, calculated as the product of cell volume and cell hemoglobin concentration. | Corpuscular Hemoglobin Content | ||
Corpuscular HGB Conc Distribution Width | C139068 | Corpuscular Hemoglobin Concentration Distribution Width;Corpuscular HGB Conc Distribution Width | A measurement of the standard deviation of hemoglobin concentrations in erythrocytes in a biological specimen, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content. | Corpuscular Hemoglobin Concentration Distribution Width | ||
Corpuscular HGB Concentration Mean | C139067 | Corpuscular HGB Concentration Mean | A direct measurement of the concentration of hemoglobin within individual erythrocytes in a biological specimen, reported as a mean. | Corpuscular Hemoglobin Concentration Mean | ||
Corticosterone | C79434 | Corticosterone | A measurement of corticosterone in a biological specimen. | Corticosterone Measurement | ||
Corticosterone/Creatinine | C106511 | Corticosterone/Creatinine | A relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample. | Corticosterone to Creatinine Ratio Measurement | ||
Corticotropin Releasing Hormone | C74851 | Corticotropin Releasing Factor;Corticotropin Releasing Hormone | A measurement of the corticotropin releasing hormone in a biological specimen. | Corticotropin Releasing Hormone Measurement | ||
Cortisol | C74781 | Cortisol;Total Cortisol | A measurement of the cortisol in a biological specimen. | Cortisol Measurement | ||
Cortisol, Free Excretion Rate | C163427 | Cortisol, Free Excretion Rate | A measurement of the amount of free cortisol being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Free Cortisol Excretion Rate | ||
Cortisol, Free | C88113 | Cortisol, Free | A measurement of the free, unbound cortisol in a biological specimen. | Free Cortisol Measurement | ||
Cortisol/Creatinine | C106512 | Cortisol/Creatinine | A relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample. | Cortisol to Creatinine Ratio Measurement | ||
Cotinine | C92249 | Cotinine | A measurement of the cotinine in a biological specimen. | Cotinine Measurement | ||
Cow Milk Protein Antigen IgE Antibody | C147280 | Cow Milk Protein Antigen IgE Antibody | A measurement of the cow milk protein antigen IgE antibody in a biological specimen. | Cow Milk Protein Antigen IgE Antibody Measurement | ||
Cow Milk Protein IgE AB RAST Score | C165938 | Cow Milk Protein IgE AB RAST Score | A classification of the amount of cow milk protein IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Cow Milk Protein IgE Antibody RAST Score Measurement | ||
Creatine Kinase BB | C64490 | Creatine Kinase BB | A measurement of the homozygous B-type creatine kinase in a biological specimen. | Creatine Kinase BB Measurement | ||
Creatine Kinase BB/Total Creatine Kinase | C79466 | Creatine Kinase BB/Total Creatine Kinase | A relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase BB to Total Creatine Kinase Ratio Measurement | ||
Creatine Kinase MB | C64491 | Creatine Kinase MB | A measurement of the heterozygous MB-type creatine kinase in a biological specimen. | Creatine Kinase MB Measurement | ||
Creatine Kinase MB/Total Creatine Kinase | C79441 | Creatine Kinase MB/Total Creatine Kinase | A relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase MB to Total Creatine Kinase Ratio Measurement | ||
Creatine Kinase MM | C64494 | Creatine Kinase MM | A measurement of the homozygous M-type creatine kinase in a biological specimen. | Creatine Kinase MM Measurement | ||
Creatine Kinase MM/Total Creatine Kinase | C79442 | Creatine Kinase MM/Total Creatine Kinase | A relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase MM to Total Creatine Kinase Ratio Measurement | ||
Creatine Kinase | C64489 | CPK;Creatine Kinase;Creatine Phosphokinase | A measurement of the total creatine kinase in a biological specimen. | Creatine Kinase Measurement | ||
Creatinine Clearance Adjusted for BSA | C147324 | Creatinine Clearance Adjusted for BSA | A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body surface area. | Creatinine Clearance Adjusted for BSA | ||
Creatinine Clearance | C25747 | Creatinine Clearance | A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). | Creatinine Clearance | ||
Creatinine Clearance, Estimated | C150847 | Creatinine Clearance, Estimated | An estimate of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). | Estimated Creatinine Clearance | ||
Creatinine Excretion Rate | C150817 | Creatinine Excretion Rate | A measurement of the amount of creatinine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Creatinine Excretion Rate | ||
Creatinine | C64547 | Creatinine | A measurement of the creatinine in a biological specimen. | Creatinine Measurement | ||
Crenated Cells | C74703 | Crenated Cells | A measurement of the crenated cells in a biological specimen. | Crenated Cell Measurement | ||
Cryofibrinogen | C147326 | Cryofibrinogen | A measurement of the cryofibrinogen in a biological specimen. | Cryofibrinogen Measurement | ||
Cryoglobulin Volume/Serum Volume | C147325 | Cryoglobulin Volume/Serum Volume | A relative measurement (ratio or percentage) of the volume of cryoglobulin to total serum volume in a biological specimen. | Cryoglobulin Volume to Serum Volume Ratio Measurement | ||
Cryoglobulin | C111164 | Cryoglobulin | A measurement of cryoglobulin in a biological specimen. | Cryoglobulin Measurement | ||
Crystals | C74673 | Crystals | A statement that indicates crystals were looked for in a biological specimen. | Crystal Present Or Absent | ||
CSF IgG Index | C154735 | CSF IgG Index;CSF Index;IgG Index | A relative measurement (ratio) of the IgG to albumin in cerebrospinal fluid to the IgG to albumin in serum. | IgG Index | ||
Cyclic Adenosine 3,5-Monophosphate | C124339 | Cyclic Adenosine 3,5-Monophosphate | A measurement of cyclic adenosine 3,5-monophosphate in a biological specimen. | Cyclic Adenosine 3,5-Monophosphate Measurement | ||
Cyclic Adenosine Monophosphate/Creat | C186030 | Cyclic Adenosine 3,5-Monophosphate/Creatinine;Cyclic Adenosine Monophosphate/Creat;Cyclic Adenosine Monophosphate/Creatinine | A relative measurement (ratio) of the cyclic adenosine 3,5-monophosphate to creatinine in a biological specimen. | Cyclic Adenosine 3,5 Monophosphate to Creatinine Ratio Measurement | ||
Cyclic Citrullinated Peptide Antibody | C96595 | Cyclic Citrullinated Peptide Antibody | A measurement of the cyclic citrullinated peptide antibody in a biological specimen. | Cyclic Citrullinated Peptide Antibody Measurement | ||
Cyclic Citrullinated Peptide IgG Ab | C147316 | Cyclic Citrullinated Peptide IgG Ab;Cyclic Citrullinated Peptide IgG Antibody | A measurement of the cyclic citrullinated peptide IgG antibody in a biological specimen. | Cyclic Citrullinated Peptide IgG Antibody Measurement | ||
Cyclic Guanosine Monophosphate | C111165 | Cyclic Guanosine Monophosphate | A measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen. | Cyclic Guanosine Monophosphate Measurement | ||
Cylindroid Casts | C150838 | Cylindroid Casts;Cylindroid Pseudocasts | A measurement of cylindroid casts (casts with a tapering end) in a biological specimen. | Cylindroid Cast Measurement | ||
Cystathionine Beta-Synthase | C172520 | Cystathionine Beta-Synthase | A measurement of the cystathionine beta-synthase in a biological specimen. | Cystathionine Beta-Synthase Measurement | ||
Cystathionine | C147331 | Cystathionine | A measurement of the cystathionine in a biological specimen. | Cystathionine Measurement | ||
Cystatin C | C92290 | Cystatin C | A measurement of the cystatin C in a biological specimen. | Cystatin C Measurement | ||
Cystatin C/Creatinine | C106513 | Cystatin C/Creatinine | A relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample. | Cystatin C to Creatinine Ratio Measurement | ||
Cysteine | C172518 | Cysteine | A measurement of the cysteine in a biological specimen. | Cysteine Measurement | ||
Cysteinyl Leukotriene Receptor 1 | C189517 | CysLTR1;Cysteinyl Leukotriene Receptor 1 | A measurement of the cysteinyl leukotriene receptor 1 in a biological specimen. | Cysteinyl Leukotriene Receptor 1 Measurement | ||
Cystine Crystals | C74674 | Cystine Crystals | A measurement of the cystine crystals present in a biological specimen. | Cystine Crystal Measurement | ||
Cystine | C105441 | Cystine | A measurement of the cystine in a biological specimen. | Cystine Measurement | ||
Cytidine-Uridine Monophosphate Kinase 2 | C163426 | Cytidine-Uridine Monophosphate Kinase 2;Cytidine/Uridine Monophosphate Kinase 2 | A measurement of the cytidine-uridine monophosphate kinase 2 in a biological specimen. | Cytidine-Uridine Monophosphate Kinase 2 Measurement | ||
Cytochrome P450 2C9 | C161355 | Cytochrome P450 2C9 | A measurement of the cytochrome P450 2C9 enzyme in a biological specimen. | Cytochrome P450 2C9 Measurement | ||
Cytokeratin 18 Fragment | C130160 | Cytokeratin 18 Fragment | A measurement of the cytokeratin 18 fragment in a biological specimen. | Cytokeratin 18 Fragment Measurement | ||
Cytokeratin 19 Fragment 21-1 | C106514 | CYFRA21-1;Cytokeratin 19 Fragment 21-1 | A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen. | Cytokeratin 19 Fragment 21-1 Measurement | ||
Cytomegalovirus-Induced Gene 5 Protein | C163484 | Cytomegalovirus-Induced Gene 5 Protein;Radical S-adenosyl Methionine Domain-Containing Protein 2 | A measurement of the cytomegalovirus-induced gene 5 protein in a biological specimen. | Cytomegalovirus-Induced Gene 5 Protein Measurement | ||
Cytoplasmic Basophilia Neutrophil | C111166 | Cytoplasmic Basophilia Neutrophil | A measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content. | Cytoplasmic Basophilia Neutrophil Count | ||
D-Dimer | C82621 | D-Dimer | A measurement of the d-dimers in a biological specimen. | D-Dimer Measurement | ||
D-Norpseudoephedrine | C174298 | (+)-Norpseudoephedrine;Cathine;D-Norpseudoephedrine | A measurement of the D-norpseudoephedrine in a biological specimen. | D-Norpseudoephedrine Measurement | ||
D. farinae Antigen IgE Antibody | C130132 | American House Dust Mite IgE Antibody;D. farinae Antigen IgE Antibody;Dermatophagoides farinae IgE Antibody | A measurement of the Dermatophagoides farinae antigen IgE antibody in a biological specimen. | Dermatophagoides farinae Antigen IgE Antibody Measurement | ||
D. farinae Antigen IgG Antibody | C130133 | American House Dust Mite IgG Antibody;D. farinae Antigen IgG Antibody;Dermatophagoides farinae IgG Antibody | A measurement of the Dermatophagoides farinae antigen IgG antibody in a biological specimen. | Dermatophagoides farinae Antigen IgG Antibody Measurement | ||
D. farinae Antigen IgG4 Antibody | C165894 | American House Dust Mite IgG4 Antibody;D. farinae Antigen IgG4 Antibody;Dermatophagoides farinae IgG4 Antibody | A measurement of the Dermatophagoides farinae antigen IgG4 antibody in a biological specimen. | Dermatophagoides farinae Antigen IgG4 Antibody Measurement | ||
D. farinae IgE AB RAST Score | C165879 | American House Dust Mite IgE Antibody RAST Score;D. farinae IgE AB RAST Score;Dermatophagoides farinae IgE Antibody RAST Score | A classification of the amount of Dermatophagoides farinae IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dermatophagoides farinae IgE Antibody RAST Score Measurement | ||
D. farinae IgG AB RAST Score | C165916 | American House Dust Mite IgG Antibody RAST Score;D. farinae IgG AB RAST Score | A classification of the amount of D. farinae antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dermatophagoides farinae IgG Antibody RAST Score Measurement | ||
D. pteronyssinus Antigen IgE Antibody | C130134 | D. pteronyssinus Antigen IgE Antibody;Dermatophagoides pteronyssinus IgE Antibody;European House Dust Mite IgE Antibody | A measurement of the Dermatophagoides pteronyssinus antigen IgE antibody in a biological specimen. | Dermatophagoides pteronyssinus Antigen IgE Antibody Measurement | ||
D. pteronyssinus Antigen IgG Antibody | C130135 | D. pteronyssinus Antigen IgG Antibody;Dermatophagoides pteronyssinus IgG Antibody;European House Dust Mite IgG Antibody | A measurement of the Dermatophagoides pteronyssinus antigen IgG antibody in a biological specimen. | Dermatophagoides pteronyssinus Antigen IgG Antibody Measurement | ||
D. pteronyssinus Antigen IgG4 Antibody | C165896 | D. pteronyssinus Antigen IgG4 Antibody;Dermatophagoides pteronyssinus IgG4 Antibody;European House Dust Mite IgG4 Antibody | A measurement of the Dermatophagoides pteronyssinus antigen IgG4 antibody in a biological specimen. | Dermatophagoides pteronyssinus Antigen IgG4 Antibody Measurement | ||
D. pteronyssinus IgE AB RAST Score | C165880 | D. pteronyssinus IgE AB RAST Score;Dermatophagoides pteronyssinus IgE Antibody RAST Score;European House Dust Mite IgE Antibody RAST Score | A classification of the amount of Dermatophagoides pteronyssinus antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dermatophagoides pteronyssinus IgE Antibody RAST Score Measurement | ||
D. pteronyssinus IgG AB RAST Score | C165917 | D. pteronyssinus Antigen IgG AB RAST Score;Dermatophagoides pteronyssinus IgG Antibody;European House Dust Mite IgG Antibody | A classification of the amount of D. pteronyssinus antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dermatophagoides pteronyssinus IgG Antibody RAST Score Measurement | ||
Dacryocytes | C64801 | Dacryocytes;Tear Shaped Erythrocytes;Teardrop Cells | A measurement of dacryocytes in a biological specimen. | Dacryocyte Analysis | ||
Dairy Mix Antigen IgG Antibody | C130119 | Dairy Mix Antigen IgG Antibody | A measurement of the dairy mix antigen IgG antibody in a biological specimen. | Dairy Mix Antigen IgG Antibody Measurement | ||
Dairy Mix IgG AB RAST Score | C165911 | Dairy Mix IgG AB RAST Score | A classification of the amount of dairy mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dairy Mix IgG Antibody RAST Score Measurement | ||
DEAD Box Protein 58 | C163428 | DEAD Box Protein 58;DExD/H-Box Helicase 58;Probable ATP-Dependent RNA Helicase DDX58 | A measurement of the DEAD box protein 58 in a biological specimen. | DEAD Box Protein 58 Measurement | ||
Decanoylcarnitine | C156536 | C10;Decanoylcarnitine | A measurement of the decanoylcarnitine in a biological specimen. | Decanoylcarnitine Measurement | ||
Decorin | C172512 | DCN;Decorin | A measurement of the decorin in a biological specimen. | Decorin Measurement | ||
Degenerated Leukocytes | C111190 | Degenerated Leukocytes;Degenerated WBC;Degenerated White Blood Cells | A measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen. | Degenerated Leukocyte Count | ||
Dehydroepiandrosterone Sulfate | C96629 | Dehydroepiandrosterone Sulfate;DHEA Sulfate;DHEA-S;sDHEA | A measurement of the sulfated Dehydroepiandrosterone in a biological specimen. | Sulfated DHEA Measurement | ||
Dehydroepiandrosterone | C74852 | Dehydroepiandrosterone;Dehydroisoandrosterone | A measurement of the dehydroepiandrosterone hormone in a biological specimen. | Dehydroepiandrosterone Measurement | ||
Delta Aminolevulinate | C156537 | 5-Aminolevulinic Acid;5ALA;dALA;Delta Aminolevulinate;Delta Aminolevulinic Acid | A measurement of the delta aminolevulinic acid in a biological specimen. | Delta Aminolevulinate Measurement | ||
Delta Aminolevulinate/Creatinine | C156538 | Delta Aminolevulinate/Creatinine | A relative measurement (ratio or percentage) of the delta aminolevulinate to creatinine in a biological specimen. | Delta Aminolevulinate to Creatinine Ratio Measurement | ||
Density | C45781 | Density | A measurement of the compactness of a biological specimen expressed in mass per unit volume. | Density | ||
Deoxycholate | C172500 | Deoxycholate;Deoxycholic Acid | A measurement of the deoxycholate in a biological specimen. | Deoxycholate Measurement | ||
Deoxyhemoglobin | C124343 | Deoxyhemoglobin | A measurement of the deoxyhemoglobin, hemoglobin without oxygen, in a biological specimen. | Deoxyhemoglobin Measurement | ||
Deoxypyridinoline | C79443 | Deoxypyridinoline | A measurement of the deoxypyridinoline in a biological specimen. | Deoxypyridinoline Measurement | ||
Deoxypyridinoline/Creatinine | C79444 | Deoxypyridinoline/Creatinine | A relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen. | Deoxypyridinoline to Creatinine Ratio Measurement | ||
Deoxyribonucleic Acid | C135409 | Deoxyribonucleic Acid | A measurement of a targeted deoxyribonucleic acid (DNA) in a biological specimen. | Deoxyribonucleic Acid Measurement | ||
Desipramine | C186040 | Desipramine | A measurement of the desipramine in a biological specimen. | Desipramine Measurement | ||
Desmethylcitalopram | C189494 | Desmethyl Citalopram;Desmethylcitalopram;Norcitalopram | A measurement of the desmethylcitalopram in a biological specimen. | Desmethylcitalopram Measurement | ||
Desmoglein 1 Antibody | C122114 | Desmoglein 1 Antibody | A measurement of the desmoglein 1 antibody in a biological specimen. | Desmoglein 1 Antibody Measurement | ||
Desmoglein 3 Antibody | C122115 | Desmoglein 3 Antibody | A measurement of the desmoglein 3 antibody in a biological specimen. | Desmoglein 3 Antibody Measurement | ||
Desomorphine | C184535 | Desomorphine | A measurement of the desomorphine in a biological specimen. | Desomorphine Measurement | ||
Desoxymethyltestosterone | C184582 | Desoxymethyltestosterone | A measurement of the desoxymethyltestosterone in a biological specimen. | Desoxymethyltestosterone Measurement | ||
Desvenlafaxine | C147333 | Desvenlafaxine;O-Desmethylvenlafaxine | A measurement of the desvenlafaxine present in a biological specimen. | Desvenlafaxine Measurement | ||
Dextroamphetamine | C102262 | d-amphetamine;Dextroamphetamine | A measurement of the dextroamphetamine in a biological specimen. | Dextroamphetamine Measurement | ||
Di-Desmethylcitalopram | C189655 | Di-Desmethylcitalopram | A measurement of the di-desmethylcitalopram in a biological specimen. | Di-Desmethylcitalopram Measurement | ||
Diazepam | C75372 | Diazepam | A measurement of the diazepam present in a biological specimen. | Diazepam Measurement | ||
Dicalcium Phosphate Crystals | C135407 | Dicalcium Phosphate Crystals | A measurement of dicalcium phosphate crystals in a biological specimen. | Dicalcium Phosphate Crystals Measurement | ||
Dickkopf WNT Signaling Path Inhibitor 1 | C165957 | Dickkopf WNT Signaling Pathway Inhibitor 1;DKK-1;SK | A measurement of the dickkopf WNT signaling pathway inhibitor 1 in a biological specimen. | Dickkopf WNT Signaling Path Inhibitor 1 Measurement | ||
Diethylpropion | C184614 | Diethylpropion | A measurement of the diethylpropion in a biological specimen. | Diethylpropion Measurement | ||
Dihydrocodeine | C74878 | Dihydrocodeine | A measurement of the dihydrocodeine present in a biological specimen. | Dihydrocodeine Measurement | ||
Dihydrotestosterone | C74853 | Androstanalone;Androstanolone;Dihydrotestosterone | A measurement of the dihydrotestosterone hormone in a biological specimen. | Dihydrotestosterone Measurement | ||
Dilute Russell's Viper Venom Time Ratio | C103386 | Dilute Russell's Viper Venom Time Ratio;Lupus Anticoagulant Ratio | A relative measurement of the dilute Russell's viper venom time in a subject sample to a control sample. | Dilute Russell's Viper Venom Time to Control Ratio Measurement | ||
Dilute Russell's Viper Venom Time | C96696 | Dilute Russell's Viper Venom Time;Lupus Anticoagulant Test | A measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom. | Dilute Russell's Viper Venom Time Measurement | ||
Dimethylglycine | C172519 | Dimethylglycine | A measurement of the dimethylglycine in a biological specimen. | Dimethylglycine Measurement | ||
Dimorphic Erythrocyte Population | C117853 | Dimorphic Erythrocyte Population;Dimorphic RBC Population | Examination of a biological specimen to detect the presence of dimorphic erythrocyte population. | Dimorphic Erythrocyte Population | ||
Dipeptidyl Peptidase-4 | C177992 | Dipeptidyl Peptidase-4 | A measurement of the dipeptidyl peptidase-4 in a biological specimen. | Dipeptidyl Peptidase-4 Measurement | ||
Diphenoxylate | C184569 | Diphenoxylate | A measurement of the diphenoxylate in a biological specimen. | Diphenoxylate Measurement | ||
Dipipanone | C184540 | Dipipanone | A measurement of the dipipanone in a biological specimen. | Dipipanone Measurement | ||
Direct Bilirubin | C64481 | Direct Bilirubin | A measurement of the conjugated or water-soluble bilirubin in a biological specimen. | Direct Bilirubin Measurement | ||
Direct Bilirubin/Bilirubin | C158226 | Direct Bilirubin/Bilirubin | A relative measurement (ratio or percentage) of the direct bilirubin to total bilirubin in a biological specimen. | Direct Bilirubin to Bilirubin Ratio Measurement | ||
DNA Fragmentation Index | C135408 | DNA Fragmentation Index | A measurement of the deoxyribonucleic acid fragmentation within the nucleated cells of a biological specimen. | DNA Fragmentation Index | ||
DNase-B Antibody | C100463 | Anti-Dnase B;DNase-B Antibody | A measurement of Dnase-B antibody in a biological specimen. | DNase-B Antibody Measurement | ||
Dog Dander Antigen IgA Antibody | C130130 | Dog Dander Antigen IgA Antibody | A measurement of the Canis lupus dander antigen IgA antibody in a biological specimen. | Dog Dander Antigen IgA Antibody Measurement | ||
Dog Dander Antigen IgE Antibody | C130128 | Dog Dander Antigen IgE Antibody | A measurement of the Canis lupus dander antigen IgE antibody in a biological specimen. | Dog Dander Antigen IgE Antibody Measurement | ||
Dog Dander Antigen IgG Antibody | C130129 | Dog Dander Antigen IgG Antibody | A measurement of the Canis lupus dander antigen IgG antibody in a biological specimen. | Dog Dander Antigen IgG Antibody Measurement | ||
Dog Dander Antigen IgG4 Antibody | C130131 | Dog Dander Antigen IgG4 Antibody | A measurement of the Canis lupus dander antigen IgG4 antibody in a biological specimen. | Dog Dander Antigen IgG4 Antibody Measurement | ||
Dog Dander IgE AB RAST Score | C165932 | Dog Dander IgE AB RAST Score | A classification of the amount of canis lupus dander IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dog Dander IgE Antibody RAST Score Measurement | ||
Dog Dander IgG AB RAST Score | C165915 | Dog Dander IgG AB RAST Score | A classification of the amount of Canis lupus IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Dog Dander IgG Antibody RAST Score Measurement | ||
Dohle Bodies | C74610 | Dohle Bodies | A measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen. | Dohle Body Measurement | ||
Dopamine Excretion Rate | C163429 | Dopamine Excretion Rate | A measurement of the amount of dopamine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Dopamine Excretion Rate | ||
Dopamine | C74854 | Dopamine | A measurement of the dopamine hormone in a biological specimen. | Dopamine Measurement | ||
Doxepin and/or Metabolites | C186041 | Doxepin and/or Metabolites | A measurement of the doxepin and/or its metabolite(s) present in a biological specimen, for an assay that can measure both doxepin and its metabolites. | Doxepin And/Or Metabolites Measurement | ||
Doxepin | C191285 | Doxepin | A measurement of the doxepin present in a biological specimen. | Doxepin Measurement | ||
Drostanolone | C184583 | Dromostanolone;Drostanolone;Medrosteron;Medrotestron;Metholone | A measurement of the drostanolone in a biological specimen. | Drostanolone Measurement | ||
Drug Crystals | C156533 | Drug Crystals | A measurement of the drug crystals in a biological specimen. | Drug Crystal Measurement | ||
Drug Screen | C78139 | Drug Screen | An indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen. | Drug Test | ||
dRVVT Screen to Confirm Pct Difference | C161373 | dRVVT Screen to Confirm Pct Difference;dRVVT Screen to Confirm Percent Difference | A measurement to confirm the presence of Lupus anticoagulants, calculated as [(Screen dRVVT - Confirm dRVVT)/Screen dRVVT]x100. | dRVVT Screen to Confirm Percent Difference | ||
DRVVT Screen to Confirm Ratio | C163430 | DRVVT Screen to Confirm Ratio | A relative measurement (ratio) of the dilute Russell's viper venom time without the presence of excess phospholipid to the dRVVT in the presence of excess phospholipid. | Dilute Russell's Viper Venom Time to Confirm Ratio Measurement | ||
DTPA Clearance | C100441 | DTPA Clearance | A measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) by excretion of urine for a specified unit of time (e.g. one minute). | Diethylene Triamine Pentaacetic Acid Clearance | ||
Duloxetine | C187798 | Duloxetine | A measurement of the duloxetine in a biological specimen. | Duloxetine Measurement | ||
Dysmorphic Erythrocytes | C135441 | Dysmorphic Erythrocytes | A measurement of the dysmorphic erythrocytes in a biological specimen. | Dysmorphic Erythrocyte Count | ||
Dysmorphic Erythrocytes/Erythrocytes | C150839 | Dysmorphic Erythrocytes/Erythrocytes | A measurement (ratio or percentage) of dysmorphic erythrocytes to total erythrocytes in a biological specimen. | Dysmorphic Erythrocytes to Erythrocytes Ratio Measurement | ||
E-Selectin | C154736 | E-Selectin | A measurement of total E-selectin in a biological specimen. | E-selectin Measurement | ||
E3 Ubiquitin-Protein Ligase TRIM33 | C187799 | E3 Ubiquitin-Protein Ligase TRIM33;Tripartite Motif Containing 33 | A measurement of the E3 ubiquitin-protein ligase TRIM33 in a biological specimen. | E3 Ubiquitin-Protein Ligase TRIM33 Measurement | ||
Ecarin Clotting Time | C100422 | Ecarin Clotting Time | A measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin. | Ecarin Clotting Time Measurement | ||
Eccentrocytes | C96598 | Eccentrocytes | A measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen. | Eccentrocyte Count | ||
EDDP | C75353 | 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine;EDDP | A measurement of the methadone metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine present in a biological specimen. | EDDP Measurement | ||
EDTA Clearance | C100440 | EDTA Clearance | A measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) by excretion of urine for a specified unit of time (e.g. one minute). | EDTA Clearance | ||
Egg White Antigen IgE Antibody | C147281 | Egg White Antigen IgE Antibody | A measurement of the egg white antigen IgE antibody in a biological specimen. | Egg White Antigen IgE Antibody Measurement | ||
Egg White IgE AB RAST Score | C165939 | Egg White IgE AB RAST Score | A classification of the amount of egg white antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Egg White IgE Antibody RAST Score Measurement | ||
Elliptocytes | C64549 | Elliptocytes | A measurement of the elliptocytes (elliptically shaped cell with blunt ends and a long axis twice the length of its short axis) in a biological specimen. | Elliptocyte Count | ||
Endogenous Thrombin Potential | C102266 | Endogenous Thrombin Potential | A measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample. | Endogenous Thrombin Potential Measurement | ||
Endomysial Antibody | C163432 | Endomysial Antibody;Endomysium Antibody | A measurement of the endomysial antibody in a biological specimen. | Endomysial Antibody Measurement | ||
Endomysial IgA Antibody | C147334 | Endomysial IgA Antibody;Endomysium IgA Antibody | A measurement of the endomysial IgA antibody in a biological specimen. | Endomysial IgA Antibody Measurement | ||
Endostatin | C172509 | Collagen Type XVIII Alpha 1 Chain;Endostatin | A measurement of the endostatin in a biological specimen. | Endostatin Measurement | ||
Endothelin-1 | C82008 | Endothelin-1 | A measurement of the endothelin-1 in a biological specimen. | Endothelin-1 Measurement | ||
Endothelin-3 | C187800 | Endothelin-3;ET-3 | A measurement of the endothelin-3 in a biological specimen. | Endothelin-3 Measurement | ||
English Plantain Pollen IgA | C130085 | English Plantain Pollen IgA | A measurement of the Plantagio lanceolata pollen antigen IgA antibody in a biological specimen. | English Plantain Pollen IgA Measurement | ||
English Plantain Pollen IgE | C130084 | English Plantain Pollen IgE | A measurement of the Plantagio lanceolata pollen antigen IgE antibody in a biological specimen. | English Plantain Pollen IgE Measurement | ||
English Plantain Pollen IgG | C130086 | English Plantain Pollen IgG | A measurement of the Plantagio lanceolata pollen antigen IgG antibody in a biological specimen. | English Plantain Pollen IgG Measurement | ||
English Plantain Pollen IgG4 | C130087 | English Plantain Pollen IgG4 | A measurement of the Plantagio lanceolata pollen antigen IgG4 antibody in a biological specimen. | English Plantain Pollen IgG4 Measurement | ||
EnglishPlantain Pollen IgE AB RAST Score | C165887 | English Plantain Pollen IgE AB RAST Score;EnglishPlantain Pollen IgE AB RAST Score | A classification of the amount of Plantagio lanceolata pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | English Plantain Pollen IgE Antibody RAST Score Measurement | ||
EnglishPlantain Pollen IgG AB RAST Score | C165901 | English Plantain Pollen IgG AB RAST Score;EnglishPlantain Pollen IgG AB RAST Score | A classification of the amount of Plantagio lanceolata pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | English Plantain Pollen IgG Antibody RAST Score Measurement | ||
Eosinophil-Derived Neurotoxin | C184644 | Eosinophil Protein-X;Eosinophil-Derived Neurotoxin;RAF3;Ribonuclease A Family Member 2 | A measurement of the eosinophil-derived neurotoxin in a biological specimen. | Eosinophil-Derived Neurotoxin Measurement | ||
Eosinophilic Metamyelocytes | C84819 | Eosinophilic Metamyelocytes | A measurement of the eosinphilic metamyelocytes in a biological specimen. | Eosinophilic Metamyelocyte Count | ||
Eosinophilic Myelocytes | C84821 | Eosinophilic Myelocytes | A measurement of the eosinophilic myelocytes in a biological specimen. | Eosinophilic Myelocyte Count | ||
Eosinophilic Myelocytes/Lymphocytes | C181449 | Eosinophilic Myelocytes/Lymphocytes | A relative measurement (ratio or percentage) of the eosinophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). | Eosinophilic Myelocytes to Lymphocytes Ratio Measurement | ||
Eosinophils Band Form | C114216 | Eosinophils Band Form | A measurement of the banded eosinophils in a biological specimen. | Eosinophil Band Form Count | ||
Eosinophils Band Form/Leukocytes | C114217 | Eosinophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen. | Eosinophil Band Form to Leukocyte Ratio | ||
Eosinophils | C64550 | Eosinophils | A measurement of the eosinophils in a biological specimen. | Eosinophil Count | ||
Eosinophils, Segmented | C135412 | Eosinophils, Segmented | A measurement of the segmented eosinophils in a biological specimen. | Segmented Eosinophil Count | ||
Eosinophils/Leukocytes | C64604 | Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. | Eosinophil to Leukocyte Ratio | ||
Eosinophils/Non-Squam Epi Cells | C135411 | Eosinophils/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the eosinophils to non-squamous epithelial cells in a biological specimen. | Eosinophils to Non-Squamous Epithelial Cells Ratio Measurement | ||
Eosinophils/Nucleated Cells | C150840 | Eosinophils/Nucleated Cells | A relative measurement (ratio or percentage) of eosinophils to nucleated cells in a biological specimen. | Eosinophils to Nucleated Cells Ratio Measurement | ||
Eosinophils/Total Cells | C98720 | Eosinophils/Total Cells | A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). | Eosinophils to Total Cell Ratio Measurement | ||
Eotaxin-1 | C81952 | Chemokine Ligand 11;Eotaxin-1 | A measurement of the eotaxin-1 in a biological specimen. | Eotaxin-1 Measurement | ||
Eotaxin-2 | C81953 | Chemokine Ligand 24;Eotaxin-2 | A measurement of the eotaxin-2 in a biological specimen. | Eotaxin-2 Measurement | ||
Eotaxin-3 | C81954 | CCL26;Chemokine (C-C Motif) Ligand 26;Chemokine Ligand 26;Eotaxin-3 | A measurement of the eotaxin-3 in a biological specimen. | Eotaxin-3 Measurement | ||
Ephedrine | C174296 | Ephedrine | A measurement of the ephedrine in a biological specimen. | Ephedrine Measurement | ||
Epi Cells/Non-Squam Epi Cells | C135414 | Epi Cells/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the epithelial cells to non-squamous epithelial cells in a biological specimen. | Epithelial Cells to Non-Squamous Epithelial Cells Ratio Measurement | ||
Epidermal Growth Factor Receptor | C112273 | Epidermal Growth Factor Receptor;ERBB1;HER1 | A measurement of the epidermal growth factor receptor in a biological specimen. | Epidermal Growth Factor Receptor Measurement | ||
Epidermal Growth Factor Receptor, Free | C181452 | Epidermal Growth Factor Receptor, Free | A measurement of the free (unbound) epidermal growth factor receptor in a biological specimen. | Free Epidermal Growth Factor Receptor Measurement | ||
Epidermal Growth Factor | C82009 | Epidermal Growth Factor | A measurement of the epidermal growth factor in a biological specimen. | Epidermal Growth Factor Measurement | ||
Epimerized Ursodeoxycholate | C176304 | Epimerized Ursodeoxycholate;Epimerized Ursodeoxycholic Acid | A measurement of the epimerized ursodeoxycholate in a biological specimen. | Epimerized Ursodeoxycholate Measurement | ||
Epinephrine Excretion Rate | C163433 | Epinephrine Excretion Rate | A measurement of the amount of epinephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Epinephrine Excretion Rate | ||
Epinephrine | C79445 | Adrenaline;Epinephrine | A measurement of the epinephrine hormone in a biological specimen. | Epinephrine Measurement | ||
Epith Neutrophil-Activating Peptide 78 | C82010 | Epith Neutrophil-Activating Peptide 78 | A measurement of the epithelial neutrophil-activating peptide in a biological specimen. | Epithelial Neutrophil-Activating Peptide 78 Measurement | ||
Epithelial Casts | C74779 | Epithelial Casts | A measurement of the epithelial cell casts present in a biological specimen. | Epithelial-Cast Measurement | ||
Epithelial Cell Clumps | C187801 | Epithelial Cell Clumps | A measurement of the epithelial cell clumps in a biological specimen. | Epithelial Cell Clumps Measurement | ||
Epithelial Cells | C64605 | Epithelial Cells | A measurement of the epithelial cells in a biological specimen. | Epithelial Cell Count | ||
Epithelial Cells/Total Cells | C130161 | Epithelial Cells/Total Cells | A relative measurement (ratio or percentage) of the epithelial cells to total cells in a biological specimen. | Epithelial Cells to Total Cells Ratio Measurement | ||
Epithelial Stromal Interaction Protein 1 | C163434 | BRESI1;Epithelial Stromal Interaction Protein 1 | A measurement of the epithelial stromal interaction protein 1 in a biological specimen. | Epithelial Stromal Interaction 1 Measurement | ||
Ery. Mean Corpuscular Hemoglobin | C64797 | Ery. Mean Corpuscular Hemoglobin | A measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen, calculated as the product of hemoglobin times ten, divided by the number of erythrocytes. | Erythrocyte Mean Corpuscular Hemoglobin | ||
Ery. Mean Corpuscular HGB Concentration | C64798 | Ery. Mean Corpuscular HGB Concentration | An indirect measurement of the average concentration of hemoglobin per erythrocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit. | Erythrocyte Mean Corpuscular Hemoglobin Concentration | ||
Ery. Mean Corpuscular Volume | C64799 | Ery. Mean Corpuscular Volume;Erythrocytes Mean Corpuscular Volume;RBC Mean Corpuscular Volume | A measurement of the mean cellular volume per erythrocyte in a biological specimen. | Erythrocyte Mean Corpuscular Volume | ||
Erythrocyte Agglutination | C111197 | Autoagglutination;Erythrocyte Agglutination;RBC Agglutination | A measurement of the erythrocyte agglutination in a biological specimen. | Erythrocyte Agglutination Measurement | ||
Erythrocyte Cell Clumps | C92245 | Erythrocyte Cell Clumps;RBC Aggregates;RBC Clumps;Red Blood Cell Clumps | A measurement of red blood cell clumps in a biological specimen. | Erythrocyte Cell Clumps Measurement | ||
Erythrocyte Cell Morphology | C92296 | Erythrocyte Cell Morphology;RBC Morphology;Red Blood Cell Morphology | An examination or assessment of the form and structure of red blood cells. | Erythrocyte Cell Morphology | ||
Erythrocyte Fragment | C116212 | Erythrocyte Fragment;RBC Fragment | A measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen. | Erythrocyte Fragment Measurement | ||
Erythrocyte Ghosts | C96605 | Erythrocyte Ghosts;RBC Ghosts | A measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen. | Erythrocyte Ghost Count | ||
Erythrocyte Inclusion Bodies | C161375 | Erythrocyte Inclusion Bodies | A measurement of the erythrocyte inclusion bodies in a biological specimen. | Erythrocyte Inclusion Bodies Measurement | ||
Erythrocyte Protoporphyrin, Free | C147339 | Erythrocyte Protoporphyrin, Free | A measurement of the free erythrocyte protoporphyrin (zinc bound plus unbound protoporphyrin) in a biological specimen. | Free Erythrocyte Protoporphyrin Measurement | ||
Erythrocyte Sedimentation Rate | C74611 | Biernacki Reaction;Erythrocyte Sedimentation Rate | The distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour). | Erythrocyte Sedimentation Rate Measurement | ||
Erythrocytes Distribution Width | C64800 | Erythrocytes Distribution Width;RDW-CV;Red Blood Cell Distribution Width;Red Cell Volume Distribution Width | A relative measurement (ratio or percentage) of the standard deviation of the red blood cell volume to the mean distribution of the red blood cell volume in a biological specimen. | Erythrocyte Distribution Width Measurement | ||
Erythrocytes | C51946 | Erythrocytes;Red Blood Cells | A measurement of the total erythrocytes in a biological specimen. | Erythrocyte Count | ||
Erythroferrone | C186047 | Erythroferrone | A measurement of the erythroferrone in a biological specimen. | Erythroferrone Measurement | ||
Erythroid Cells/Nucleated Cells | C154720 | Erythroid Cells/Nucleated Cells | A relative measurement (ratio or percentage) of the erythroid cells to total nucleated cells in a biological specimen. | Erythroid Cells to Nucleated Cells Ratio Measurement | ||
Erythroid Cells/Total Cells | C154719 | Erythroid Cells/Total Cells | A relative measurement (ratio or percentage) of the erythroid cells to total cells in a biological specimen. | Erythroid Cells to Total Cells Ratio Measurement | ||
Erythroid Maturation Index | C135415 | Erythroid Maturation Index | A relative measurement (ratio) of the sum of erythroid maturation phase cells (pool) to the sum of erythroid proliferative phase cells (pool) in a biological specimen. | Erythroid Maturation Index | ||
Erythroid Maturation Pool | C135416 | Erythroid Maturation Pool | A measurement of the erythroid maturation phase cells (polychromatic rubricytes, normochromic rubricytes, and metarubricytes) in a biological specimen. | Erythroid Maturation Pool Count | ||
Erythroid Precursor Cells | C187802 | Erythroid Precursor Cells;Erythroid Precursors | A measurement of the erythroid precursors in a biological specimen. | Erythroid Precursor Cell Count | ||
Erythroid Precursor Cells/Total Cells | C187803 | Erythroid Precursor Cells/Total Cells;Erythroid Precursors/Total Cells | A relative measurement (ratio or percentage) of the erythroid precursors to total cells in a biological specimen. | Erythroid Precursor Cells to Total Cells Ratio Measurement | ||
Erythroid Proliferation Index | C135417 | Erythroid Proliferation Index | A relative measurement (ratio) of the sum of erythroid proliferative phase cells (pool) to the sum of erythroid maturation phase cells (pool) in a biological specimen. | Erythroid Proliferation Index | ||
Erythroid Proliferation Pool | C135418 | Erythroid Proliferation Pool | A measurement of the erythroid proliferative phase cells (rubriblasts, prorubricytes, and basophilic rubricytes) in a biological specimen. | Erythroid Proliferation Pool Count | ||
Erythropoietin | C74855 | Erythropoietin;Hematopoietin | A measurement of the erythropoietin hormone in a biological specimen. | Erythropoietin Measurement | ||
Escitalopram | C187804 | Escitalopram | A measurement of the escitalopram in a biological specimen. | Escitalopram Measurement | ||
Estazolam | C184615 | Estazolam | A measurement of the estazolam in a biological specimen. | Estazolam Measurement | ||
Estradiol | C74782 | Estradiol;Oestradiol | A measurement of the estradiol in a biological specimen. | Estradiol Measurement | ||
Estradiol, Free | C150842 | Estradiol, Free | A measurement of the unbound estradiol in a biological specimen. | Free Estradiol Measurement | ||
Estradiol, Free/Estradiol | C150843 | Estradiol, Free/Estradiol | A relative measurement (ratio or percentage) of unbound estradiol to total estradiol in a biological specimen. | Free Estradiol to Estradiol Ratio Measurement | ||
Estriol | C74856 | Estriol;Oestriol | A measurement of the estriol hormone in a biological specimen. | Estriol Measurement | ||
Estriol, Free | C81963 | Estriol, Free;Unconjugated Estriol | A measurement of the free estriol in a biological specimen. | Free Estriol Measurement | ||
Estrogen Receptor | C112274 | ER;ESR;Estrogen Receptor;Oestrogen Receptor | A measurement of estrogen receptor protein in a biological specimen. | Estrogen Receptor Measurement | ||
Estrogen | C147335 | Estrogen;Oestrogen | A measurement of the estrogen hormone in a biological specimen. | Estrogen Measurement | ||
Estrone Sulfate | C163431 | E1S;Estrone 3-Sulfate;Estrone Sulfate | A measurement of the estrone sulfate in a biological specimen. | Estrone Sulfate Measurement | ||
Estrone | C74857 | Estrone;Oestrone | A measurement of the estrone hormone in a biological specimen. | Estrone Measurement | ||
Ethanol | C74693 | Alcohol;Ethanol | A measurement of the ethanol present in a biological specimen. | Ethanol Measurement | ||
Ethchlorvynol | C184616 | Ethchlorvynol | A measurement of the ethchlorvynol in a biological specimen. | Ethchlorvynol Measurement | ||
Ethinamate | C184617 | Ethinamate | A measurement of the ethinamate in a biological specimen. | Ethinamate Measurement | ||
Ethyl Glucuronide Ethyl Sulfate | C170583 | Ethyl Glucuronide Ethyl Sulfate | A measurement of the ethyl glucuronide and/or ethyl sulfate in a biological specimen. | Ethyl Glucuronide And Ethyl Sulfate Measurement | ||
Ethyl Glucuronide | C170584 | Ethyl Glucuronide | A measurement of the ethyl glucuronide in a biological specimen. | Ethyl Glucuronide Measurement | ||
Ethyl Sulfate | C170585 | Ethyl Sulfate | A measurement of the ethyl sulfate in a biological specimen. | Ethyl Sulfate Measurement | ||
Ethylamphetamine | C184555 | Ethylamphetamine;Etilamfetamine;N-Ethylamphetamine | A measurement of the ethylamphetamine in a biological specimen. | Ethylamphetamine Measurement | ||
Ethylestrenol | C184584 | Ethylestrenol | A measurement of the ethylestrenol in a biological specimen. | Ethylestrenol Measurement | ||
Ethylmorphine | C184570 | Ethylmorphine | A measurement of the ethylmorphine in a biological specimen. | Ethylmorphine Measurement | ||
ETP Area Under Curve | C102263 | Endogenous Thrombin Potential Area Under Curve;ETP Area Under Curve | A measurement of the area under the thrombin generation curve. | Endogenous Thrombin Potential Area Under Curve Measurement | ||
ETP Lag Time Relative | C102265 | Endogenous Thrombin Potential Lag Time Relative;ETP Lag Time Relative | A relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. | Endogenous Thrombin Potential Lag Time Relative Measurement | ||
ETP Lag Time | C102264 | Endogenous Thrombin Potential Lag Time;ETP Lag Time | A measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. | Endogenous Thrombin Potential Lag Time Measurement | ||
ETP Peak Height Relative | C102268 | Endogenous Thrombin Potential Peak Height Relative;ETP Peak Height Relative | A relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test. | Endogenous Thrombin Potential Peak Height Relative Measurement | ||
ETP Peak Height | C102267 | Endogenous Thrombin Potential Peak Height;ETP Peak Height | A measurement of the maximum concentration of thrombin generated during a thrombin generation test. | Endogenous Thrombin Potential Peak Height Measurement | ||
ETP Time to Peak Relative | C102270 | Endogenous Thrombin Potential Time to Peak Relative;ETP Time to Peak Relative | A relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin. | Endogenous Thrombin Potential Time to Peak Relative Measurement | ||
ETP Time to Peak | C102269 | Endogenous Thrombin Potential Time to Peak;ETP Time to Peak | A measurement of the time it takes to generate the maximum concentration of thrombin. | Endogenous Thrombin Potential Time to Peak Measurement | ||
Extracell Newly Ident RAGE Bind Protein | C82011 | Extracell Newly Ident RAGE Bind Protein;S100 Calcium Binding Protein A12 | A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen. | Extracell Newly Ident RAGE Bind Protein Measurement | ||
Extractable Nuclear Antigen Antibody | C92270 | Anti-ENA;Extractable Nuclear Antigen Antibody | A measurement of the extractable nuclear antigen antibody in a biological specimen. | Extractable Nuclear Antigen Antibody Measurement | ||
Ezogabine | C184640 | Ezogabine | A measurement of the ezogabine in a biological specimen. | Ezogabine Measurement | ||
F2-Isoprostane | C80180 | F2-Isoprostane | A measurement of the F2-isoprostane in a biological specimen. | F2 Isoprostane Measurement | ||
Factor II | C96626 | Factor II;Prothrombin | A measurement of the coagulation factor II in a biological specimen. | Prothrombin Measurement | ||
Factor III | C81959 | Factor III;Tissue Factor, CD142 | A measurement of the coagulation factor III in a biological specimen. | Factor III Measurement | ||
Factor IX Activity Actual/Control | C170588 | Factor IX Activity Actual/Control;Factor IX Activity Actual/Factor IX Activity Control;Factor IX Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor IX dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor IX Activity Actual to Control Ratio Measurement | ||
Factor IX Activity | C103395 | Christmas Factor Activity;Factor IX Activity | A measurement of the biological activity of coagulation factor IX in a biological specimen. | Factor IX Activity Measurement | ||
Factor IX | C98725 | Christmas Factor;Factor IX | A measurement of the coagulation factor IX in a biological specimen. | Factor IX Measurement | ||
Factor V Activity Actual/Control | C170587 | Factor V Activity Actual/Control;Factor V Activity Actual/Factor V Activity Control;Factor V Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor V dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor V Activity Actual to Control Ratio Measurement | ||
Factor V Activity | C103396 | Factor V Activity;Labile Factor Activity | A measurement of the biological activity of coagulation factor V in a biological specimen. | Factor V Activity Measurement | ||
Factor V Leiden | C102271 | Factor V Leiden | A measurement of the coagulation factor V Leiden in a biological specimen. | Factor V Leiden Measurement | ||
Factor V | C98726 | Factor V;Labile Factor | A measurement of the coagulation factor V in a biological specimen. | Factor V Measurement | ||
Factor VII Activity Actual/Control | C170589 | Factor VII Activity Actual/Control;Factor VII Activity Actual/Factor VII Activity Control;Factor VII Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor VII dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor VII Activity Actual to Control Ratio Measurement | ||
Factor VII Activity | C103397 | Factor VII Activity;Proconvertin Activity;Stable Factor Activity | A measurement of the biological activity of coagulation factor VII in a biological specimen. | Factor VII Activity Measurement | ||
Factor VII | C81960 | Factor VII;Proconvertin;Stable Factor | A measurement of the coagulation factor VII in a biological specimen. | Factor VII Measurement | ||
Factor VIIa Activity | C103398 | Factor VIIa Activity | A measurement of the biological activity of coagulation factor VIIa in a biological specimen. | Factor VIIa Activity Measurement | ||
Factor VIII Activity Actual/Control | C147345 | Factor VIII Activity Actual/Control;Factor VIII Activity Actual/Factor VIII Activity Control;Factor VIII Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor VIII dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor VIII Activity Actual to Control Ratio Measurement | ||
Factor VIII Activity | C103399 | Anti-hemophilic Factor Activity;Factor VIII Activity;Factor VIII:C | A measurement of the biological activity of coagulation factor VIII in a biological specimen. | Factor VIII Activity Measurement | ||
Factor VIII Inhibitor | C154752 | Factor VIII Inhibitor | A measurement of the factor VIII Inhibitor in a biological specimen. | Factor VIII Inhibitor Measurement | ||
Factor VIII | C81961 | Anti-hemophilic Factor;Factor VIII | A measurement of the coagulation factor VIII in a biological specimen. | Factor VIII Measurement | ||
Factor X Activity Actual/Control | C170586 | Factor X Activity Actual/Control;Factor X Activity Actual/Factor X Activity Control;Factor X Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor X dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor X Activity Actual/Control Ratio Measurement | ||
Factor X Activity | C122118 | Factor X Activity | A measurement of the biological activity of coagulation factor X in a biological specimen. | Factor X Activity Measurement | ||
Factor X Actual/Control | C170590 | Factor X Actual/Control;Factor X Actual/Normal | A relative measurement (ratio or percentage) of the factor X in a subject's specimen when compared to a control specimen. | Factor X Actual to Control Ratio Measurement | ||
Factor X | C98727 | Factor X | A measurement of the coagulation factor X in a biological specimen. | Factor X Measurement | ||
Factor XI Activity | C163436 | Factor XI Activity | A measurement of the biological activity of coagulation factor XI in a biological specimen. | Factor XI Activity Measurement | ||
Factor XI | C163435 | Factor XI | A measurement of the factor XI in a biological specimen. | Factor XI Measurement | ||
Factor XII Activity | C163438 | Factor XII Activity | A measurement of the biological activity of coagulation factor XII in a biological specimen. | Factor XII Activity Measurement | ||
Factor XII | C163437 | Factor XII | A measurement of the factor XII in a biological specimen. | Factor XII Measurement | ||
Factor XIII Activity | C174313 | Factor XIII Activity | A measurement of the biological activity of coagulation factor XIII in a biological specimen. | Factor XIII Activity Measurement | ||
Factor XIII | C112277 | Factor XIII;Fibrin Stabilizing Factor | A measurement of the coagulation factor XIII in a biological specimen. | Factor XIII Measurement | ||
Factor XIV Activity Actual/Control | C147346 | Factor XIV Activity Actual/Control;Factor XIV Activity Actual/Factor XIV Activity Control;Factor XIV Activity Actual/Normal | A relative measurement (ratio or percentage) of the biological activity of factor XIV dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Factor XIV Activity Actual to Control Ratio Measurement | ||
Factor XIV Activity | C105442 | Factor XIV Activity;Protein C Activity;Protein C Function | A measurement of the biological activity of coagulation factor XIV in a biological specimen. | Factor XIV Activity Measurement | ||
Factor XIV Actual/Control | C170594 | Factor XIV Actual/Control;Protein C Actual/Control | A relative measurement (ratio or percentage) of the factor XIV in a subject's specimen when compared to a control specimen. | Factor XIV Actual to Control Ratio Measurement | ||
Factor XIV | C102272 | Autoprothrombin IIA;Factor XIV;Protein C;Protein C Antigen | A measurement of the coagulation factor XIV in a biological specimen. | Factor XIV Measurement | ||
Fas Cell Surface Death Receptor | C165960 | ALPS1A;APT1;CD95;Fas Cell Surface Death Receptor;FAS1;FASTM;TNF Receptor Superfamily Member 6;TNFRSF6 | A measurement of the Fas cell surface death receptor in a biological specimen. | Fas Cell Surface Death Receptor Measurement | ||
Fat Bodies, Oval | C81947 | Fat Bodies, Oval | A measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen. | Oval Fat Body Measurement | ||
Fat Droplet | C98728 | Fat Droplet | A measurement of the triglyceride aggregates within a biological specimen. | Fat Droplet Measurement | ||
Fat | C96648 | Fat | A measurement of the fat in a biological specimen. | Fat Measurement | ||
Fat/Total Solids | C187806 | Fat/Total Solids | A relative measurement (ratio or percentage) of the fat to total solid material in a biological specimen (for example a stool specimen). | Fats to Total Solids Ratio Measurement | ||
Fatty Acid Binding Protein 1 | C82012 | FABP1;Fatty Acid Binding Protein 1;L-FABP;L-Type Fatty Acid-Binding Protein;Liver Fatty Acid-Binding Protein | A measurement of the fatty acid binding protein 1 in a biological specimen. | Fatty Acid Binding Protein 1 Measurement | ||
Fatty Acid Binding Protein 3 | C106521 | Fatty Acid Binding Protein 3 | A measurement of the fatty acid binding protein 3 in a biological specimen. | Fatty Acid Binding Protein 3 Measurement | ||
Fatty Acids, Very Long Chain | C147337 | Fatty Acids, Very Long Chain | A measurement of the very long chain fatty acids (containing 22 or more carbon atoms) in a biological specimen. | Very Long Chain Fatty Acids Measurement | ||
Fatty Casts | C74766 | Fatty Casts | A measurement of the fatty casts present in a biological specimen. | Fatty Cast Measurement | ||
Fatty Liver Index | C156516 | Fatty Liver Index;FLI | A calculation that indicates the likely presence of fatty liver disease, taking into account waist circumference, body mass index, triglyceride concentrations, and gamma-glutamyltransferase activity. (Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006 Nov 2;6:33.) | Fatty Liver Index | ||
Fencamfamin | C184618 | Fencamfamin;Fencamfamine | A measurement of the fencamfamin in a biological specimen. | Fencamfamin Measurement | ||
Fenfluramine | C184619 | Fenfluramine | A measurement of the fenfluramine in a biological specimen. | Fenfluramine Measurement | ||
Fenproporex | C184620 | Fenproporex | A measurement of the fenproporex in a biological specimen. | Fenproporex Measurement | ||
Fentanyl | C147338 | Fentanyl | A measurement of the fentanyl in a biological specimen. | Fentanyl Measurement | ||
Ferritin Heavy Chain | C172521 | Apoferritin;Ferritin Heavy Chain;FTH;FTH1 | A measurement of the ferritin heavy chain in a biological specimen. | Ferritin Heavy Chain Measurement | ||
Ferritin Light Chain | C172522 | Ferritin Light Chain;FTL;L Apoferritin | A measurement of the ferritin light chain in a biological specimen. | Ferritin Light Chain Measurement | ||
Ferritin | C74737 | Ferritin | A measurement of the ferritin in a biological specimen. | Ferritin Measurement | ||
Fibrin Degradation Products | C82013 | Fibrin Degradation Products | A measurement of the fibrin degradation products in a biological specimen. | Fibrin Degradation Products Measurement | ||
Fibrin Monomer | C189498 | Fibrin Monomer;Soluble Fibrin Monomer | A measurement of the fibrin monomer in a biological specimen. | Fibrin Monomer Measurement | ||
Fibrinogen | C64606 | Fibrinogen;Fibrinogen Antigen | A measurement of the total fibrinogen (functional and non-functional) in a biological specimen. | Fibrinogen Measurement | ||
Fibrinogen, Functional | C139075 | Fibrinogen, Functional | A measurement of the functional fibrinogen (fibrinogen that is capable of being converted to fibrin) in a biological specimen. | Functional Fibrinogen Measurement | ||
Fibroblast Growth Factor 19 | C154727 | FGF 19;Fibroblast Growth Factor 19 | A measurement of the fibroblast growth factor 19 in a biological specimen. | Fibroblast Growth Factor 19 Measurement | ||
Fibroblast Growth Factor 21 | C112280 | FGF 21;Fibroblast Growth Factor 21 | A measurement of the fibroblast growth factor 21 in a biological specimen. | Fibroblast Growth Factor 21 Measurement | ||
Fibroblast Growth Factor 23 | C96650 | Fibroblast Growth Factor 23;Phosphatonin | A measurement of the total fibroblast growth factor 23 in a biological specimen. | Fibroblast Growth Factor 23 Measurement | ||
Fibroblast Growth Factor 23, C-Terminal | C135419 | Fibroblast Growth Factor 23, C-Terminal | A measurement of the C-terminal fibroblast growth factor 23 in a biological specimen. | C-Terminal Fibroblast Growth Factor 23 Measurement | ||
Fibroblast Growth Factor 23, Intact | C135420 | Fibroblast Growth Factor 23, Intact | A measurement of the intact fibroblast growth factor 23 in a biological specimen. | Intact Fibroblast Growth Factor 23 Measurement | ||
Fibroblast Growth Factor 9 | C130162 | FGF 9;Fibroblast Growth Factor 9 | A measurement of the fibroblast growth factor 9 in a biological specimen. | Fibroblast Growth Factor 9 Measurement | ||
Fibroblast Growth Factor Basic Form | C82014 | FGF2;Fibroblast Growth Factor Basic Form | A measurement of the basic form of fibroblast growth factor in a biological specimen. | Fibroblast Growth Factor Basic Form Measurement | ||
Fibronectin, Cellular | C172507 | Fibronectin, Cellular;Insoluble Fibronectin | A measurement of the cellular fibronectin in a biological specimen. | Cellular Fibronectin Measurement | ||
Fibronectin, Fetal | C92786 | Fibronectin, Fetal | A measurement of the fetal isoform of fibronectin in a biological specimen | Fetal Fibronectin Test | ||
Fibronectin, Maternal + Fetal | C177951 | Fibronectin, Maternal + Fetal | A measurement of the maternal plasma fibronectin and fetal fibronectin in a biological specimen. | Maternal and Fetal Fibronectin Measurement | ||
Fibronectin, Plasma | C172508 | Fibronectin, Plasma;Soluble Fibronectin | A measurement of the plasma fibronectin in a biological specimen. | Plasma Fibronectin Measurement | ||
FibroTest Score | C105443 | FibroSURE Score;FibroTest Score | A biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taking into account the age and gender of the patient. | FibroTest Score Measurement | ||
Ficolin-3 | C198283 | FCN3;Ficolin-3 | A measurement of the ficolin-3 in a biological specimen. | Ficolin-3 Measurement | ||
Fluid Output | C171455 | Fluid Output | A measurement of the total volume of fluid discharged over a set period of time. | Fluid Output | ||
Fluid Output, Estimated | C171508 | Fluid Output, Estimated | An estimate of the total volume of fluid discharged over a set period of time. | Estimated Fluid Output | ||
Flunitrazepam and/or Metabolites | C186048 | Flunitrazepam and/or Metabolites | A measurement of the flunitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flunitrazepam and its metabolites. | Flunitrazepam and/or Metabolites Measurement | ||
Flunitrazepam | C139081 | Flunitrazepam | A measurement of the flunitrazepam present in a biological specimen. | Flunitrazepam Measurement | ||
Fluoride | C122120 | Fluoride | A measurement of the fluoride in a biological specimen. | Fluoride Measurement | ||
Fluoxetine | C158219 | Fluoxetine | A measurement of the fluoxetine drug present in a biological specimen. | Fluoxetine Measurement | ||
Fluoxymesterone | C184585 | Fluoxymesterone | A measurement of the fluoxymesterone in a biological specimen. | Fluoxymesterone Measurement | ||
Fluphenazine | C177980 | Fluphenazine | A measurement of the fluphenazine in a biological specimen. | Fluphenazine Measurement | ||
Flurazepam and/or Metabolites | C186051 | Flurazepam and/or Metabolites | A measurement of the flurazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both flurazepam and its metabolites. | Flurazepam and/or Metabolites Measurement | ||
Flurazepam | C75373 | Flurazepam | A measurement of the flurazepam present in a biological specimen. | Flurazepam Measurement | ||
Fluvoxamine | C147340 | Fluvoxamine | A measurement of the fluvoxamine present in a biological specimen. | Fluvoxamine Measurement | ||
FMS-like Receptor Tyrosine Kinase 3 | C174307 | CD135;FMS-like Receptor Tyrosine Kinase 3 | A measurement of the FMS-like receptor tyrosine kinase 3 in a biological specimen. | FMS-like Receptor Tyrosine Kinase 3 Measurement | ||
FMS-like Tyrosine Kinase 3 Ligand | C174306 | FMS-like Tyrosine Kinase 3 Ligand | A measurement of the FMS-like tyrosine kinase 3 ligand in a biological specimen. | FMS-like Tyrosine Kinase 3 Ligand Measurement | ||
Folate Hydrolase mRNA | C132367 | Folate Hydrolase mRNA | A measurement of the folate hydrolase mRNA in a biological specimen. | Folate Hydrolase mRNA Measurement | ||
Follicle Stimulating Hormone | C74783 | Follicle Stimulating Hormone | A measurement of the follicle stimulating hormone (FSH) in a biological specimen. | Follicle Stimulating Hormone Measurement | ||
Fraction of Inspired Oxygen | C38082 | Fraction of Inspired Oxygen | A measurement of the volumetric fraction of oxygen in the inhaled gas. | Fraction of Inspired Oxygen | ||
Fractional Calcium Excretion | C114219 | Fractional Calcium Excretion | A measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine. | Fractional Excretion of Calcium | ||
Fractional Chloride Excretion | C114220 | Fractional Chloride Excretion | A measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine. | Fractional Excretion of Chloride | ||
Fractional Iron Absorption | C161349 | Fractional Iron Absorption | A relative measurement (ratio or percentage) of the iron absorbed into tissue or cells to the total available iron. | Fractional Iron Absorption | ||
Fractional Magnesium Excretion | C122119 | Fractional Magnesium Excretion | A measurement of the fractional excretion of magnesium that is computed based upon the concentrations of magnesium and creatinine in both blood and urine. | Fractional Excretion of Magnesium | ||
Fractional Phosphorus Excretion | C114221 | Fractional Inorganic Phosphate Excretion;Fractional Phosphorus Excretion | A measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine. | Fractional Excretion of Phosphate | ||
Fractional Potassium Excretion | C114222 | Fractional Potassium Excretion | A measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine. | Fractional Excretion of Potassium | ||
Fractional Sodium Excretion | C107435 | Fractional Sodium Excretion | A measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine. | Fractional Excretion of Sodium | ||
Free Androgen Index | C124341 | Free Androgen Index | A measurement of the androgen status in a biological specimen. This is calculated by a mathematical formula that takes into account the total testosterone level, sex hormone binding globulin, and a constant. | Free Androgen Index | ||
Free Fatty Acid | C80200 | Free Fatty Acid;Non-Esterified Fatty Acid, Free | A measurement of the total non-esterified fatty acids in a biological specimen. | Non-esterified Fatty Acids Measurement | ||
Free Fatty Acid, Saturated | C80206 | Free Fatty Acid, Saturated;Non-esterified Fatty Acid, Saturated | A measurement of the saturated non-esterified fatty acids in a biological specimen. | Saturated Non-esterified Fatty Acids Measurement | ||
Free Fatty Acid, Unsaturated | C80209 | Free Fatty Acid, Unsaturated;Non-esterified Fatty Acid, Unsaturated | A measurement of the unsaturated non-esterified fatty acids in a biological specimen. | Unsaturated Non-esterified Fatty Acids Measurement | ||
Free Glycerol | C100448 | Free Glycerin;Free Glycerol | A measurement of the amount of unbound glycerol in a biological specimen. | Free Glycerol Measurement | ||
Fructosamine Corrected for Total Protein | C161350 | Fructosamine Corrected for Total Protein | A measurement of fructosamine, which has been corrected for total protein, in a biological specimen. | Fructosamine Corrected for Total Protein Measurement | ||
Fructosamine | C74678 | Fructosamine;Glycated Serum Protein | A measurement of the fructosamine in a biological specimen. | Fructosamine Measurement | ||
Fructose | C147342 | Fructose | A measurement of the fructose in a biological specimen. | Fructose Measurement | ||
Fungi | C154813 | Fungi;Fungus | A measurement of the fungi in a biological specimen. | Fungi Measurement | ||
Fungi, Filamentous | C147343 | Fungi, Filamentous | A measurement of the filamentous fungi in a biological specimen. | Filamentous Fungi Count | ||
Fungi, Yeast-Like | C147344 | Fungi, Yeast-Like | A measurement of the yeast-like fungi in a biological specimen. | Yeast-Like Fungi Count | ||
Furanylfentanyl | C184541 | Furanyl Fentanyl;Furanylfentanyl | A measurement of the furanylfentanyl in a biological specimen. | Furanylfentanyl Measurement | ||
Furazabol | C184586 | Furazabol | A measurement of the furazabol in a biological specimen. | Furazabol Measurement | ||
G6PD-Deficient Erythrocytes | C132368 | G6PD-Deficient Erythrocytes | A measurement of the glucose-6-phosphate dehydrogenase deficient erythrocytes in a biological specimen. | G6PD-Deficient Erythrocytes Count | ||
G6PD-Deficient Erythrocytes/Erythrocytes | C132369 | G6PD-Deficient Erythrocytes/Erythrocytes | A relative measurement (ratio or percentage) of G6PD-deficient erythrocytes to total erythrocytes in a biological specimen. | G6PD-Deficient Erythrocytes to Erythrocytes Ratio Measurement | ||
Galactose Elimination Capacity | C124342 | Galactose Elimination Capacity | A liver function test that measures galactose elimination capacity in a biological specimen. | Galactose Elimination Capacity | ||
Galactose Mutarotase | C163439 | Galactose Mutarotase | A measurement of the galactose mutarotase in a biological specimen. | Galactose Mutarotase Measurement | ||
Galactose | C81308 | Galactose | A measurement of the galactose in a biological specimen. | Galactose Measurement | ||
Galactose-1-Phos Uridylyltransferase | C81251 | G1PUT;Galactose 1 Phosphate Uridyl Transferase;Galactose-1-Phos Uridylyltransferase;Galactose-1-Phosphate Uridylyltransferase;GALT | A measurement of the galactose-1-phosphate uridyltransferase in a biological specimen. | Galactose-1-Phosphate Uridyltransferase Measurement | ||
Galactose-1-Phosphate | C186052 | Galactose-1-Phosphate | A measurement of the galactose-1-phosphate in a biological specimen. | Galactose-1-Phosphate Measurement | ||
Galactose-Deficient IgA1 | C165961 | Galactose-Deficient IgA1;Gd-IgA1 | A measurement of the galactose-deficient IgA1 in a biological specimen. | Galactose-Deficient IgA1 Measurement | ||
Galanin | C80182 | Galanin | A measurement of the galanin in a biological specimen. | Galanin Measurement | ||
Galectin-3 Binding Protein | C186053 | Galectin-3 Binding Protein;LGALS3BP;M2BP;Mac-2 Binding Protein | A measurement of the galectin-3 binding protein in a biological specimen. | Galectin-3 Binding Protein Measurement | ||
Galectin-3 | C172493 | Galactose-Specific Lectin 3;Galectin-3;GALIG;MAC-2 | A measurement of the galectin-3 in a biological specimen. | Galectin-3 Measurement | ||
Gamma Globulin | C92257 | Gamma Globulin | A measurement of the proteins contributing to the gamma fraction in a biological specimen. | Gamma Globulin Measurement | ||
Gamma Globulin/Total Protein | C92295 | Gamma Globulin/Total Protein | A relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen. | Gamma Globulin to Total Protein Ratio Measurement | ||
Gamma Glutamyl Transferase | C64847 | Gamma Glutamyl Transferase | A measurement of the gamma glutamyl transferase in a biological specimen. | Gamma Glutamyl Transpeptidase Measurement | ||
Gamma Glutamyl Transferase/Creatinine | C79446 | Gamma Glutamyl Transferase/Creatinine | A relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen. | Gamma Glutamyl Transferase to Creatinine Ratio Measurement | ||
Gamma Tocopherol | C116211 | Gamma Tocopherol | A measurement of the gamma tocopherol in a biological specimen. | Gamma Tocopherol Measurement | ||
Gamma-Aminobutyric Acid | C154766 | GABA;Gamma-aminobutyrate;Gamma-Aminobutyric Acid | A measurement of the gamma-aminobutyric acid in a biological specimen. | Gamma-Aminobutyric Acid Measurement | ||
Gamma-Hydroxybutyrate | C75357 | 4-Hydroxybutanoic Acid;Gamma-Hydroxybutyrate;Gamma-Hydroxybutyric Acid | A measurement of the gamma-hydroxybutyrate in a biological specimen. | Gamma-Hydroxybutyrate Measurement | ||
GammaGlutamyl Transferase Excretion Rate | C165962 | Gamma Glutamyl Transferase Excretion Rate | A measurement of the amount of gamma glutamyl transferase being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Gamma Glutamyl Transferase Excretion Rate | ||
Ganglioside GM3 | C184516 | Ganglioside GM3;Monosialodihexosylganglioside | A measurement of the ganglioside GM3 in a biological specimen. | Ganglioside GM3 Measurement | ||
Gastrin | C74858 | Gastrin | A measurement of the gastrin hormone in a biological specimen. | Gastrin Measurement | ||
German Cockroach Antigen IgA Antibody | C130141 | German Cockroach Antigen IgA Antibody | A measurement of the Blattella germanica antigen IgA antibody in a biological specimen. | German Cockroach Antigen IgA Antibody Measurement | ||
German Cockroach Antigen IgE Antibody | C130140 | German Cockroach Antigen IgE Antibody | A measurement of the Blattella germanica antigen IgE antibody in a biological specimen. | German Cockroach Antigen IgE Antibody Measurement | ||
German Cockroach Antigen IgG Antibody | C130142 | German Cockroach Antigen IgG Antibody | A measurement of the Blattella germanica antigen IgG antibody in a biological specimen. | German Cockroach Antigen IgG Antibody Measurement | ||
German Cockroach Antigen IgG4 Antibody | C130143 | German Cockroach Antigen IgG4 Antibody | A measurement of the Blattella germanica antigen IgG4 antibody in a biological specimen. | German Cockroach Antigen IgG4 Antibody Measurement | ||
German Cockroach IgE AB RAST Score | C165878 | German Cockroach IgE AB RAST Score | A classification of the amount of Blattella germanica antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | German Cockroach IgE Antibody RAST Score Measurement | ||
German Cockroach IgG AB RAST Score | C165919 | German Cockroach IgG AB RAST Score | A classification of the amount of Blattella germanica antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | German Cockroach IgG Antibody RAST Score Measurement | ||
GFR from B-2 Microglobulin Adj for BSA | C100450 | GFR from B-2 Microglobulin Adj for BSA | A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area. | Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement | ||
GFR from Beta-Trace Protein Adj for BSA | C100449 | GFR from Beta-Trace Protein Adj for BSA | A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area. | Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement | ||
GFR from Creat and UreaN Adj BSA | C163442 | GFR from Creat and UreaN Adj BSA;GFR from Creatinine and Urea Nitrogen Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on creatinine and urea nitrogen. | Glomerular Filtration Rate from Creatinine and Urea Nitrogen Adjusted for Body Surface Area Measurement | ||
GFR from Creat,UreaN,Alb Adj BSA | C163443 | GFR from Creat,UreaN,Alb Adj BSA;GFR from Creatinine, Urea Nitrogen and Albumin Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on creatinine, urea nitrogen, and albumin. | Glomerular Filtration Rate from Creatinine, Urea Nitrogen, and Albumin Adjusted for Body Surface Area Measurement | ||
GFR from Creatinine Adjusted for BSA | C98735 | GFR from Creatinine Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on creatinine. | Glomerular Filtration Rate from Creatinine Adjusted for BSA | ||
GFR from Cystatin C Adjusted for BSA | C98736 | GFR from Cystatin C Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on cystatin C. | Glomerular Filtration Rate from Cystatin C Adjusted for BSA | ||
GFR from Cystatin C and Creat Adj BSA | C127614 | GFR from Cystatin C and Creat Adj BSA | An estimation of the glomerular filtration rate adjusted for body surface area based on cystatin C and creatinine. | Glomeluar Filtration Rate from Cystatin C and Creatinine Adjusted for BSA | ||
Ghrelin | C112286 | Ghrelin;Growth Hormone Secretagogue Receptor Ligand;Motilin-related Peptide;Total Ghrelin | A measurement of total ghrelin in a biological specimen. | Ghrelin Measurement | ||
Giant Neutrophils | C96651 | Giant Neutrophils | A measurement of the giant neutrophils in a biological specimen. | Giant Neutrophil Count | ||
Giant Platelets | C74728 | Giant Platelets | A measurement of the giant (larger than 7um in diameter) platelets in a biological specimen. | Giant Platelet Count | ||
Gliadin Antibody | C147347 | Gliadin Antibody | A measurement of the total gliadin antibodies in a biological specimen. | Gliadin Antibody Measurement | ||
Gliadin IgA Antibody | C147348 | Gliadin IgA Antibody | A measurement of the gliadin IgA antibody in a biological specimen. | Gliadin IgA Antibody Measurement | ||
Gliadin IgG Antibody | C147349 | Gliadin IgG Antibody | A measurement of the gliadin IgG antibody in a biological specimen. | Gliadin IgG Antibody Measurement | ||
Glial Fibrillary Acidic Protein | C189528 | Glial Fibrillary Acidic Protein | A measurement of the glial fibrillary acidic protein in a biological specimen. | Glial Fibrillary Acidic Protein Measurement | ||
Glitter Cells | C150844 | Glitter Cells | A measurement of the glitter cells in a biological specimen. | Glitter Cell Count | ||
Globulin | C74738 | Globulin | A measurement of the globulin protein in a biological specimen. | Globulin Protein Measurement | ||
Globulin/Creatinine | C142276 | Globulin/Creatinine | A relative measurement (ratio or percentage) of the globulin to creatinine in a biological specimen. | Globulin to Creatinine Ratio Measurement | ||
Glomerular Filtration Rate Adj for BSA | C98734 | Glomerular Filtration Rate Adj for BSA | A measurement of the glomerular filtration rate adjusted for body surface area. | Glomerular Filtration Rate Adjusted for BSA | ||
Glomerular Filtration Rate | C90505 | Glomerular Filtration Rate | A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time. | Glomerular Filtration Rate | ||
Glomerular Filtration Rate, Estimated | C110935 | Glomerular Filtration Rate, Estimated | A kidney function test that estimates the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time. | Estimated Glomerular Filtration Rate | ||
Glucagon | C74859 | Glucagon | A measurement of the glucagon hormone in a biological specimen. | Glucagon Measurement | ||
Glucagon-Like Peptide-1 | C80183 | Glucagon-Like Peptide-1;Total Glucagon-Like Peptide-1 | A measurement of the total glucagon-like peptide-1 in a biological specimen. | Glucagon-like Peptide-1 Measurement | ||
Glucagon-Like Peptide-1, Active Form | C80164 | Glucagon-Like Peptide-1, Active Form | A measurement of the active form of glucagon-like peptide-1 in a biological specimen. | Active Glucagon-like Peptide-1 Measurement | ||
Glucagon-Like Peptide-1, Inactive Form | C154768 | Glucagon-Like Peptide-1, Inactive Form | A measurement of the inactive form of glucagon-like peptide-1 in a biological specimen. | Inactive Glucagon-Like Peptide-1 Measurement | ||
Glucopsychosine | C184523 | Glucopsychosine;Glucosylsphingosine;Lyso-GL1 | A measurement of the glucopsychosine in a biological specimen. | Glucopsychosine Measurement | ||
Glucose Clearance | C96652 | Glucose Clearance | A measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute). | Glucose Clearance Measurement | ||
Glucose Excretion Rate | C150818 | Glucose Excretion Rate | A measurement of the amount of glucose being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Glucose Excretion Rate | ||
Glucose Management Indicator | C174310 | Glucose Management Indicator | An approximate measure (expressed as a % or mmol/mol) of an individual's expected hemoglobin A1c/hemoglobin level, based on the mean glucose measured over a period of at least 10 days by continuous glucose monitoring. | Glucose Management Indicator | ||
Glucose | C105585 | Glucose | A measurement of the glucose in a biological specimen. | Glucose Measurement | ||
Glucose, Estimated Average | C142275 | EAG;Estimated Average Glucose;Glucose, Estimated;Glucose, Estimated Average | A computed estimate of the blood glucose based on the value of the glycated hemoglobin | Estimated Average Glucose Measurement | ||
Glucose, Radiolabeled/Glucose | C186054 | Glucose, Enriched/Glucose;Glucose, Radiolabeled/Glucose | A relative measurement (ratio or percentage) of radiolabeled glucose to total glucose in a biological specimen. | Radiolabeled Glucose to Glucose Ratio Measurement | ||
Glucose-6-Phosphate Dehydrogenase Act | C139065 | Glucose-6-Phosphate Dehydrogenase Act | A measurement of the biological activity of glucose-6-phosphate dehydrogenase in a biological specimen. | Glucose-6-Phosphate Dehydrogenase Activity | ||
Glucose-6-Phosphate Dehydrogenase | C80184 | Glucose-6-Phosphate Dehydrogenase | A measurement of the glucose-6-phosphate dehydrogenase in a biological specimen. | Glucose-6-Phosphate Dehydrogenase Measurement | ||
Glucose-dep Insulinotropic Pep, Intact | C106537 | Glucose-dep Insulinotropic Pep, Intact;Intact Gastric Inhibitory Polypeptide;Intact GIP;Intact Glucose-dependent Insulinotropic Peptide | A measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen. | Intact Glucose-dependent Insulinotropic Peptide Measurement | ||
Glucose/Creatinine | C79447 | Glucose/Creatinine | A relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen. | Glucose to Creatinine Ratio Measurement | ||
Glucosylceramidase Beta | C184520 | Beta-Glucocerebrosidase;GBA;Glucocerebrosidase Beta;Glucosylceramidase;Glucosylceramidase Beta | A measurement of the glucosylceramidase beta in a biological specimen. | Glucosylceramidase Beta Measurement | ||
Glucosylceramide | C184522 | GL1;Glucocerebroside;Glucosylceramide | A measurement of the glucosylceramide in a biological specimen. | Glucosylceramide Measurement | ||
Glucuronidase, Alpha | C80165 | Glucuronidase, Alpha | A measurement of the alpha glucuronidase in a biological specimen. | Alpha Glucuronidase Measurement | ||
Glucuronidase, Beta | C80170 | Glucuronidase, Beta | A measurement of the beta glucuronidase in a biological specimen. | Beta Glucuronidase Measurement | ||
Glutamate Dehydrogenase | C79448 | Glutamate Dehydrogenase | A measurement of the glutamate dehydrogenase in a biological specimen. | Glutamate Dehydrogenase Measurement | ||
Glutamate | C74739 | Glutamate;Glutamic Acid | A measurement of the glutamate in a biological specimen. | Glutamate Measurement | ||
Glutamic Acid Decarboxylase 1 | C82015 | Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 67 | A measurement of the glutamic acid decarboxylase 1 in a biological specimen. | Glutamic Acid Decarboxylase 1 Measurement | ||
Glutamic Acid Decarboxylase 2 Antibody | C82017 | Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase 65 Antibody | A measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen. | Glutamic Acid Decarboxylase 2 Antibody Measurement | ||
Glutamic Acid Decarboxylase 2 | C82016 | Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 65 | A measurement of the glutamic acid decarboxylase 2 in a biological specimen. | Glutamic Acid Decarboxylase 2 Measurement | ||
Glutamic Acid Decarboxylase Antibody | C96653 | GAD Antibody;Glutamic Acid Decarboxylase Antibody | A measurement of the glutamic acid decarboxylase antibody in a biological specimen. | Glutamic Acid Decarboxylase Antibody Measurement | ||
Glutamine | C122121 | Glutamine | A measurement of the glutamine in a biological specimen. | Glutamine Measurement | ||
Glutathione S-Transferase, Alpha/Creat | C80166 | Glutathione S-Transferase, Alpha/Creat | A relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen. | Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
Glutathione S-Transferase, Pi | C80203 | Glutathione S-Transferase, Pi | A measurement of the Pi glutathione-s-transferase in a biological specimen. | Pi Glutathione S-Transferase Measurement | ||
Glutathione S-Transferase, Theta | C80207 | Glutathione S-Transferase, Theta | A measurement of the theta glutathione-s-transferase in a biological specimen. | Theta Glutathione S-Transferase Measurement | ||
Glutathione S-Transferase, Total | C80185 | Glutathione S-Transferase, Total | A measurement of the total glutathione-s-transferase in a biological specimen. | Glutathione-S-Transferase Measurement | ||
Glutathione S-Transferase, Y1 | C163449 | Glutathione S-Transferase, Y1 | A measurement of the Y1 subunit of glutathione-s-transferase in a biological specimen. | Glutathione S-Transferase Y1 Subunit Measurement | ||
Glutathione-S-Transferase/Creatinine | C79435 | Glutathione-S-Transferase/Creatinine | A relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen. | Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
Glutethimide | C184571 | Glutethimide | A measurement of the glutethimide in a biological specimen. | Glutethimide Measurement | ||
Glycated Albumin | C122092 | Glycated Albumin | A measurement of the glycated albumin present in a biological specimen. | Glycated Albumin Measurement | ||
Glycated Albumin/Albumin | C158228 | Glycated Albumin/Albumin;Glycosylated Albumin/Albumin | A relative measurement (ratio or percentage) of the glycated albumin to total albumin in a biological specimen. | Glycated Albumin to Albumin Ratio Measurement | ||
Glycated Ferritin | C186049 | Glycated Ferritin | A measurement of the glycated ferritin in a biological specimen. | Glycated Ferritin Measurement | ||
Glycated Ferritin/Ferritin | C186050 | Glycated Ferritin/Ferritin | A relative measurement (ratio or percentage) of the glycated ferritin to total ferritin in a biological specimen. | Glycated Ferritin to Ferritin Ratio Measurement | ||
Glyceraldehyde-3-Phosphate Dehydrogenase | C184524 | GAPDH;Glyceraldehyde 3 Phosphate Dehydrogenase;Glyceraldehyde-3-Phosphate Dehydrogenase | A measurement of the glyceraldehyde-3-phosphate dehydrogenase in a biological specimen. | Glyceraldehyde-3-Phosphate Dehydrogenase Measurement | ||
Glycerol | C132371 | Glycerol | A measurement of the total glycerol in a biological specimen. | Glycerol Measurement | ||
Glycine max Antigen IgE Antibody | C147278 | Glycine max Antigen IgE Antibody;Soybean Antigen IgE Antibody | A measurement of the Glycine max antigen IgE antibody in a biological specimen. | Glycine max Antigen IgE Antibody Measurement | ||
Glycine max IgE AB RAST Score | C165936 | Glycine max IgE AB RAST Score | A classification of the amount of Glycine max antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Glycine max IgE Antibody RAST Score Measurement | ||
Glycine | C122122 | Glycine | A measurement of the glycine in a biological specimen. | Glycine Measurement | ||
Glycine/Creatinine | C158221 | Glycine/Creatinine | A relative measurement (ratio) of the glycine to the creatinine in a biological specimen. | Glycine to Creatinine Ratio Measurement | ||
Glycochenodeoxycholate | C176305 | Glycochenodeoxycholate;Glycochenodeoxycholic Acid | A measurement of the glycochenodeoxycholate in a biological specimen. | Glycochenodeoxycholate Measurement | ||
Glycocholate | C176299 | Cholylglycine;Glycocholate;Glycocholic Acid | A measurement of the glycocholate in a biological specimen. | Glycocholate Measurement | ||
Glycogen Phosphorylase Isoenzyme BB | C198284 | Glycogen Phosphorylase Isoenzyme BB | A measurement of the glycogen phosphorylase isoenzyme BB in a biological specimen. | Glycogen Phosphorylase Isoenzyme BB Measurement | ||
Glycolithocholate | C176308 | Glycolithocholate;Glycolithocholic Acid | A measurement of the glycolithocholate in a biological specimen. | Glycolithocholate Measurement | ||
Glycoursodeoxycholate | C176302 | Glycoursodeoxycholate;Glycoursodeoxycholic Acid | A measurement of the glycoursodeoxycholate in a biological specimen. | Glycoursodeoxycholate Measurement | ||
Glycylproline Dipeptidyl Aminopeptidase | C187807 | Glycylproline Dipeptidyl Aminopeptidase;GPDA | A measurement of the glycylproline dipeptidyl aminopeptidase in a biological specimen. | Glycylproline Dipeptidyl Aminopeptidase Measurement | ||
Gold | C80186 | Gold | A measurement of the gold in a biological specimen. | Gold Measurement | ||
Gonadotropin Releasing Hormone | C74860 | Gonadotropin Releasing Hormone;Luteinising Hormone Releasing Hormone | A measurement of the gonadotropin releasing hormone in a biological specimen. | Gonadotropin Releasing Hormone Measurement | ||
Granular Casts | C74768 | Granular Casts | A measurement of the granular (coarse and fine) casts present in a biological specimen. | Granular Cast Measurement | ||
Granular Coarse Casts | C74765 | Granular Coarse Casts | A measurement of the coarse granular casts present in a biological specimen. | Coarse Granular Cast Measurement | ||
Granular Fine Casts | C74769 | Granular Fine Casts | A measurement of the fine granular casts present in a biological specimen. | Granular Fine Cast Measurement | ||
Granulin | C165963 | Granulin | A measurement of the granulin in a biological specimen. | Granulin Measurement | ||
Granulocyte Colony Stimulating Factor | C82018 | Granulocyte Colony Stimulating Factor | A measurement of the granulocyte colony stimulating factor in a biological specimen. | Granulocyte Colony Stimulating Factor Measurement | ||
Granulocyte Macrophage Colony Stm Factor | C82019 | Granulocyte Macrophage Colony Stm Factor | A measurement of the granulocyte macrophage colony stimulating factor in a biological specimen. | Granulocyte Macrophage Colony Stm Factor Measurement | ||
Granulocytes Band Form | C186055 | Banded Granulocytes;Granulocytes Band Form | A measurement of the banded granulocytes in a biological specimen. | Granulocytes Band Form Count | ||
Granulocytes Band Form/Total Cells | C127615 | Granulocytes Band Form/Total Cells | A relative measurement (ratio or percentage) of the banded granulocytes to total cells in a biological specimen. | Band Form Granulocyte to Total Cell Ratio Measurement | ||
Granulocytes Segmented | C186056 | Granulocytes Segmented | A measurement of the segmented granulocytes in a biological specimen. | Segmented Granulocyte Count | ||
Granulocytes Segmented/Total Cells | C127616 | Granulocytes Segmented/Total Cells | A relative measurement (ratio or percentage) of the segmented granulocytes to total cells in a biological specimen. | Segmented Granulocyte to Total Cell Ratio Measurement | ||
Granulocytes | C96654 | Granulocytes;Polymorphonuclear Leukocytes | A measurement of the granulocytes in a biological specimen. | Granulocyte Count | ||
Granulocytes/Leukocytes | C147351 | Granulocytes/Leukocytes;Polymorphonuclear Leukocytes/Leukocytes | A relative measurement (ratio or percentage) of the granulocytes to total leukocytes in a biological specimen. | Granulocytes to Leukocytes Ratio Measurement | ||
Granulocytes/Total Cells | C98866 | Granulocytes/Total Cells | A relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen). | Granulocyte to Total Cell Ratio Measurement | ||
Grass Mix Pollen Antigen IgA Antibody | C130105 | Grass Mix Pollen Antigen IgA Antibody | A measurement of the grass mix pollen antigen IgA antibody in a biological specimen. | Grass Mix Pollen Antigen IgA Antibody Measurement | ||
Grass Mix Pollen Antigen IgE Antibody | C130103 | Grass Mix Pollen Antigen IgE Antibody | A measurement of the grass mix pollen antigen IgE antibody in a biological specimen. | Grass Mix Pollen Antigen IgE Antibody Measurement | ||
Grass Mix Pollen Antigen IgG Antibody | C130104 | Grass Mix Pollen Antigen IgG Antibody | A measurement of the grass mix pollen antigen IgG antibody in a biological specimen. | Grass Mix Pollen Antigen IgG Antibody Measurement | ||
Grass Mix Pollen IgE AB RAST Score | C165924 | Grass Mix Pollen IgE AB RAST Score | A classification of the amount of grass mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Grass Mix Pollen IgE Antibody RAST Score Measurement | ||
Grass Mix Pollen IgG AB RAST Score | C165905 | Grass Mix Pollen IgG AB RAST Score | A classification of the amount of tree grass pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Grass Mix Pollen IgG Antibody RAST Score Measurement | ||
Growth Differentiation Factor 11 | C135422 | BMP-11;Bone Morphogenetic Protein 11;Growth Differentiation Factor 11 | A measurement of the growth differentiation factor 11 in a biological specimen. | Growth Differentiation Factor 11 Measurement | ||
Growth Differentiation Factor 15 | C181406 | GDF-15;Growth Differentiation Factor 15;Macrophage Inhibitory Cytokine-1;MIC-1 | A measurement of the growth differentiation factor 15 in a biological specimen. | Growth Differentiation Factor 15 Measurement | ||
Growth Differentiation Factor 8 | C135423 | Growth Differentiation Factor 8;Myostatin | A measurement of the growth differentiation factor 8 in a biological specimen. | Growth Differentiation Factor 8 Measurement | ||
Growth Hormone Binding Protein | C163444 | GH Binding Protein;Growth Hormone Binding Protein;Somatotropin Receptor | A measurement of the growth hormone binding protein in a biological specimen. | Growth Hormone Binding Protein Measurement | ||
Growth Hormone Inhibiting Hormone | C74861 | Growth Hormone Inhibiting Hormone;Somatostatin | A measurement of the growth hormone inhibiting hormone in a biological specimen. | Growth Hormone Inhibiting Hormone Measurement | ||
Growth Hormone Releasing Hormone | C74862 | Growth Hormone Releasing Hormone;Somatocrinin | A measurement of the growth hormone releasing hormone in a biological specimen. | Growth Hormone Releasing Hormone Measurement | ||
Growth Regulated Oncogene | C186057 | Growth Regulated Oncogene | A measurement of the total growth regulated oncogene proteins in a biological specimen. | Growth Regulated Oncogene Measurement | ||
Guanine Deaminase | C150845 | Guanase;Guanine Aminohydrolase;Guanine Deaminase | A measurement of the guanine deaminase in a biological specimen. | Guanine Deaminase Measurement | ||
Guanylate Binding Protein 1 | C163440 | Guanylate Binding Protein 1 | A measurement of the guanylate binding protein 1 in a biological specimen. | Guanylate Binding Protein 1 Measurement | ||
Guanylate Binding Protein 2 | C163441 | Guanylate Binding Protein 2 | A measurement of the guanylate binding protein 2 in a biological specimen. | Guanylate Binding Protein 2 Measurement | ||
Hairy Cells | C74604 | Hairy Cells | A measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen. | Hairy Cell Count | ||
Hairy Cells/Leukocytes | C135428 | Hairy Cells/Leukocytes | A relative measurement (ratio or percentage) of the hairy cells (B-cell lymphocytes with hairy projections from the cytoplasm) to all leukocytes in a biological specimen. | Hairy Cells to Leukocytes Ratio Measurement | ||
Hairy Cells/Lymphocytes | C74640 | Hairy Cells/Lymphocytes | A relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen . | Hairy Cell to Lymphocyte Ratio Measurement | ||
Hairy Cells/Total Cells | C135427 | Hairy Cells/Total Cells | A relative measurement (ratio or percentage) of the hairy cells to total cells in a biological specimen. | Hairy Cells to Total Cells Ratio Measurement | ||
Halazepam | C139078 | Halazepam | A measurement of the halazepam present in a biological specimen. | Halazepam Measurement | ||
Hallucinogen | C75343 | Hallucinogen | A measurement of any hallucinogenic class drug present in a biological specimen. | Hallucinogen Measurement | ||
Haloperidol | C177964 | Haloperidol | A measurement of the haloperidol in a biological specimen. | Haloperidol Measurement | ||
Haptoglobin | C74740 | Haptoglobin | A measurement of the haptoglobin protein in a biological specimen. | Haptoglobin Protein Measurement | ||
Hazelnut Antigen IgE Antibody | C177960 | Corylus Species Nut Antigen IgE Antibody;Hazelnut Antigen IgE Antibody | A measurement of the hazelnut antigen IgE antibody in a biological specimen. | Hazelnut Antigen IgE Antibody Measurement | ||
HCT Corrected Reticulocytes/Erythrocytes | C102274 | HCT Corrected Reticulocytes/Erythrocytes | A relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen. | Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement | ||
HDL Cholesterol | C105587 | HDL Cholesterol | A measurement of the high density lipoprotein cholesterol in a biological specimen. | High Density Lipoprotein Cholesterol Measurement | ||
HDL Cholesterol/LDL Cholesterol | C100425 | HDL Cholesterol/LDL Cholesterol | A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen. | HDL Cholesterol to LDL Cholesterol Ratio Measurement | ||
HDL Cholesterol/Total Cholesterol | C147362 | HDL Cholesterol/Total Cholesterol | A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to total cholesterol in a biological specimen. | HDL Cholesterol to Total Cholesterol Ratio Measurement | ||
HDL Particle Size | C103402 | HDL Particle Size | A measurement of the average particle size of high-density lipoprotein in a biological specimen. | HDL Particle Size Measurement | ||
HDL Phospholipid | C156513 | HDL Phospholipid;HDL-PL | A measurement of the high density lipoprotein phospholipid in a biological specimen. | HDL Phospholipid Measurement | ||
HDL-Cholesterol Subclass 2 | C80187 | HDL-Cholesterol Subclass 2 | A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen. | HDL-Cholesterol Subclass 2 Measurement | ||
HDL-Cholesterol Subclass 3 | C80188 | HDL-Cholesterol Subclass 3 | A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen. | HDL-Cholesterol Subclass 3 Measurement | ||
Heat Shock Protein 70 | C147368 | Heat Shock Protein 70 | A measurement of the heat shock protein 70 in a biological specimen. | Heat Shock Protein 70 Measurement | ||
Heat Shock Protein 90 Alpha | C147369 | Heat Shock Protein 90 Alpha | A measurement of the heat shock protein 90 alpha in a biological specimen. | Heat Shock Protein 90 Alpha Measurement | ||
Hect Domain and RLD 5 | C163453 | E3 ISG15--Protein Ligase HERC5;HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 5;Hect Domain and RLD 5 | A measurement of the hect domain and RLD 5 in a biological specimen. | Hect Domain and RLD 5 Measurement | ||
Heinz Bodies | C74709 | Heinz Bodies;Heinz-Erhlich Bodies | A measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen. | Heinz-Ehrlich Body Measurement | ||
Heinz Bodies/Erythrocytes | C111206 | Heinz Bodies/Erythrocytes | A relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen. | Heinz Body to Erythrocyte Ratio Measurement | ||
Helicase MOV-10 Protein | C165966 | Helicase MOV-10 Protein;Moloney Leukemia Virus 10 Protein | A measurement of helicase MOV-10 protein in a biological specimen. | Helicase MOV-10 Protein Measurement | ||
Helmet Cells | C74658 | Helmet Cells | A measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen. | Helmet Cell Count | ||
Hematocrit Corrected Reticulocytes | C102273 | Hematocrit Corrected Reticulocytes | A measurement of the hematocrit corrected reticulocytes in a biological specimen. | Hematocrit Corrected Reticulocyte Count | ||
Hematocrit | C64796 | Erythrocyte Volume Fraction;EVF;Hematocrit;Packed Cell Volume;PCV | The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes). | Hematocrit Measurement | ||
Hemoglobin A | C92258 | Hemoglobin A | A measurement of the hemoglobin A in a biological specimen. | Hemoglobin A Measurement | ||
Hemoglobin A/Total Hemoglobin | C81276 | Hemoglobin A/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin A to total hemoglobin in a biological specimen. | Hemoglobin A to Total Hemoglobin Ratio Measurement | ||
Hemoglobin A1/Total Hemoglobin | C147363 | Hemoglobin A1/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin A1 to total hemoglobin in a biological specimen. | Hemoglobin A1 to Total Hemoglobin Ratio Measurement | ||
Hemoglobin A1A | C163450 | Glycated Hemoglobin 1A;Glycosylated Hemoglobin 1A;Hemoglobin A1A | A measurement of the glycosylated hemoglobin A1A in a biological specimen. | Hemoglobin A1A Measurement | ||
Hemoglobin A1B | C163451 | Glycated Hemoglobin 1B;Glycosylated Hemoglobin 1B;Hemoglobin A1B | A measurement of the glycosylated hemoglobin A1B in a biological specimen. | Hemoglobin A1B Measurement | ||
Hemoglobin A1C | C64849 | Glycated Hemoglobin;Glycosylated Hemoglobin A1C;HbA1c;Hemoglobin A1C | A measurement of the glycosylated hemoglobin A1C in a biological specimen. | Glycosylated Hemoglobin Measurement | ||
Hemoglobin A1C/Hemoglobin | C111207 | Hemoglobin A1C/Hemoglobin | A relative measurement (ratio or percentage) of the glycosylated hemoglobin to total hemoglobin in a biological specimen. | Hemoglobin A1C to Hemoglobin Ratio Measurement | ||
Hemoglobin A2 Prime/Total Hemoglobin | C147353 | Hemoglobin A2 Prime/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin A2 prime to total hemoglobin in a biological specimen. | Hemoglobin A2 Prime to Total Hemoglobin Ratio Measurement | ||
Hemoglobin A2 | C92259 | Hemoglobin A2 | A measurement of the hemoglobin A2 in a biological specimen. | Hemoglobin A2 Measurement | ||
Hemoglobin A2/Total Hemoglobin | C81277 | Hemoglobin A2/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin A2 to total hemoglobin in a biological specimen. | Hemoglobin A2 to Total Hemoglobin Ratio Measurement | ||
Hemoglobin B | C92260 | Hemoglobin B | A measurement of the hemoglobin B in a biological specimen. | Hemoglobin B Measurement | ||
Hemoglobin Barts/Total Hemoglobin | C147354 | Hemoglobin Barts/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin Barts to total hemoglobin in a biological specimen. | Hemoglobin Barts to Total Hemoglobin Ratio Measurement | ||
Hemoglobin C Crystals | C112288 | Hemoglobin C Crystals | A measurement of hemoglobin C crystals in a biological specimen. | Hemoglobin C Crystals Measurement | ||
Hemoglobin C | C92261 | Hemoglobin C | A measurement of the hemoglobin C in a biological specimen. | Hemoglobin C Measurement | ||
Hemoglobin C/Total Hemoglobin | C81278 | Hemoglobin C/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin C to total hemoglobin in a biological specimen. | Hemoglobin C to Total Hemoglobin Ratio Measurement | ||
Hemoglobin Casts | C156515 | Hemoglobin Casts | A measurement of the hemoglobin casts present in a biological specimen. | Hemoglobin Cast Measurement | ||
Hemoglobin D/Total Hemoglobin | C147364 | Hemoglobin D/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin D to total hemoglobin in a biological specimen. | Hemoglobin D to Total Hemoglobin Ratio Measurement | ||
Hemoglobin Distribution Width | C106525 | Hemoglobin Concentration Distribution Width;Hemoglobin Distribution Width | A measurement of the distribution of the hemoglobin concentration in red blood cells. | Hemoglobin Distribution Width Measurement | ||
Hemoglobin E/Total Hemoglobin | C147365 | Hemoglobin E/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin E to total hemoglobin in a biological specimen. | Hemoglobin E to Total Hemoglobin Ratio Measurement | ||
Hemoglobin F | C92262 | Fetal Hemoglobin;Hemoglobin F | A measurement of the hemoglobin F in a biological specimen. | Hemoglobin F Measurement | ||
Hemoglobin F/Total Hemoglobin | C147366 | Hemoglobin F/Total Hemoglobin | A relative measurement (ratio or percentage) of the fetal hemoglobin (hemoglobin F) to total hemoglobin in a biological specimen. | Hemoglobin F to Total Hemoglobin Ratio Measurement | ||
Hemoglobin Fraction Pattern | C161363 | Hemoglobin Fraction Pattern | A description of the hemoglobin fraction pattern in a biological specimen. | Hemoglobin Fraction Pattern | ||
Hemoglobin G Coushatta/Total Hemoglobin | C147356 | Hemoglobin G Coushatta/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin G Coushatta to total hemoglobin in a biological specimen. | Hemoglobin G Coushatta to Total Hemoglobin Ratio Measurement | ||
Hemoglobin H Inclusion Bodies | C158234 | HBH Inclusion Bodies;Hemoglobin H Inclusion Bodies;HGH Inclusion Bodies | A measurement of the hemoglobin H inclusion bodies in a biological specimen. | Hemoglobin H Inclusion Bodies Measurement | ||
Hemoglobin Lepore/Total Hemoglobin | C147357 | Hemoglobin Lepore/Total Hemoglobin | A relative measurement (ratio or percentage) of the Lepore hemoglobin to total hemoglobin in a biological specimen. | Hemoglobin Lepore to Total Hemoglobin Ratio Measurement | ||
Hemoglobin O-Arab/Total Hemoglobin | C147358 | Hemoglobin O-Arab/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin O-Arab to total hemoglobin in a biological specimen. | Hemoglobin O-Arab to Total Hemoglobin Ratio Measurement | ||
Hemoglobin S | C122123 | Hemoglobin S;Sickle Hemoglobin | A measurement of the hemoglobin S in a biological specimen. | Hemoglobin S Measurement | ||
Hemoglobin S/Total Hemoglobin | C81279 | Hemoglobin S/Total Hemoglobin | A relative measurement (ratio or percentage) of the hemoglobin S to total hemoglobin in a biological specimen. | Hemoglobin S to Total Hemoglobin Ratio Measurement | ||
Hemoglobin Tetramer | C135425 | Hemoglobin Tetramer | A measurement of the hemoglobin tetramer in a biological specimen. | Hemoglobin Tetramer Measurement | ||
Hemoglobin Variants | C103845 | Hemoglobin Variants | A statement that indicates a defined set of hemoglobin variants were looked for in a biological specimen. | Hemoglobin Variant Measurement | ||
Hemoglobin | C64848 | Hemoglobin;Hemoglobin Monomer | A measurement of the total erythrocyte associated hemoglobin in a biological specimen. | Hemoglobin Measurement | ||
Hemoglobin, Free | C127617 | Hemoglobin, Free | A measurement of the hemoglobin external to erythrocytes in a biological specimen. | Free Hemoglobin Measurement | ||
Hemolytic Index | C111208 | Hemolysis;Hemolytic Index | A measurement of the destruction of red blood cells in a biological specimen. | Hemolytic Index | ||
Hemosiderin | C96659 | Hemosiderin | A measurement of the hemosiderin complex in a biological specimen. | Hemosiderin Measurement | ||
Heparin | C165967 | Heparin | A measurement of the heparin in a biological specimen. | Heparin Measurement | ||
Hepatocyte Growth Factor Receptor | C172514 | c-Met;Hepatocyte Growth Factor Receptor;MET Proto-Oncogene, Receptor Tyrosine Kinase;Tyrosine-Protein Kinase Met | A measurement of the hepatocyte growth factor receptor in a biological specimen. | Hepatocyte Growth Factor Receptor Measurement | ||
Hepatocyte Growth Factor Receptor, Free | C181453 | Hepatocyte Growth Factor Receptor, Free | A measurement of the free (unbound) hepatocyte growth factor receptor in a biological specimen. | Free Hepatocyte Growth Factor Receptor Measurement | ||
Hepatocyte Growth Factor | C135426 | Hepatocyte Growth Factor | A measurement of the hepatocyte growth factor in a biological specimen. | Hepatocyte Growth Factor Measurement | ||
Hepcidin | C174387 | Hepcidin | A measurement of the total hepcidin in a biological specimen. | Hepcidin Measurement | ||
Heterophils | C116186 | Heterophils | A measurement of heterophils (granular leukocytes) in a biological specimen from avian species. | Heterophil Measurement | ||
Heterophils/Leukocytes | C116187 | Heterophils/Leukocytes | A relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species. | Heterophils to Leukocytes Ratio Measurement | ||
Hexokinase | C96668 | Hexokinase | A measurement of the hexokinase in a biological specimen. | Hexokinase Measurement | ||
Hexosaminidase A | C181411 | Beta-Hexosaminidase Subunit Alpha;Beta-N-Acetylhexosaminidase Subunit Alpha;Hexosaminidase A;Hexosaminidase Subunit A;Hexosaminidase Subunit Alpha;N-Acetyl-Beta-Glucosaminidase Subunit Alpha | A measurement of the hexosaminidase A in a biological specimen. | Hexosaminidase A Measurement | ||
High Absorption Retic/Reticulocytes | C116189 | High Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen. | High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
High Absorption Reticulocytes | C116188 | High Absorption Reticulocytes | A measurement of the high absorption reticulocytes in a biological specimen. | High Absorption Reticulocyte Measurement | ||
Hippuric Acid Crystals | C74754 | Hippurate Crystals;Hippuric Acid Crystals | A measurement of the hippuric acid crystals present in a biological specimen. | Hippuric Acid Crystal Measurement | ||
Histamine | C80189 | Histamine | A measurement of the histamine in a biological specimen. | Histamine Measurement | ||
Histidine | C122124 | Histidine | A measurement of the histidine in a biological specimen. | Histidine Measurement | ||
Histone 1 Antibody | C112293 | Histone 1 Antibody | A measurement of the total histone 1 antibodies in a biological specimen. | Histone 1 Antibody Measurement | ||
Histone 2A Antibody | C112294 | Histone 2A Antibody | A measurement of the total histone 2A antibodies in a biological specimen. | Histone 2A Antibody Measurement | ||
Histone 2B Antibody | C112295 | Histone 2B Antibody | A measurement of the total histone 2B antibodies in a biological specimen. | Histone 2B Antibody Measurement | ||
Histone 3 Antibody | C112296 | Histone 3 Antibody | A measurement of the total histone 3 antibodies in a biological specimen. | Histone 3 Antibody Measurement | ||
Histone 4 Antibody | C112297 | Histone 4 Antibody | A measurement of the total histone 4 antibodies in a biological specimen. | Histone 4 Antibody Measurement | ||
Histone Antibodies | C111209 | Anti-Histone Antibodies;Histone Antibodies | A measurement of histone antibodies in a biological specimen. | Histone Antibody Measurement | ||
HLA A03 Antigen | C181440 | HLA A03 Antigen;HLA-A03 Antigen | A measurement of the HLA A03 antigen in a biological specimen. | HLA A03 Histocompatibility Antigen Measurement | ||
HLA A2 Antigen | C181441 | HLA A2 Antigen;HLA-A2 Antigen | A measurement of the HLA A2 antigen in a biological specimen. | HLA A2 Histocompatibility Antigen Measurement | ||
HLA A24 Antigen | C181442 | HLA A24 Antigen;HLA-A24 Antigen | A measurement of the HLA A24 antigen in a biological specimen. | HLA A24 Histocompatibility Antigen Measurement | ||
HLA A3 Antigen | C181443 | HLA A3 Antigen;HLA-A3 Antigen | A measurement of the HLA A3 antigen in a biological specimen. | HLA A3 Histocompatibility Antigen Measurement | ||
HLA Class I Antibody | C128964 | HLA Class I Antibody | A measurement of the human leukocyte antigen (HLA) antibody class I in a biological specimen. | HLA Class I Antibody Measurement | ||
HLA Class I Panel Reactive Antibody | C128967 | HLA Class I Panel Reactive Antibody | A measurement of the panel reactive antibody (the reactivity between host immune cells and donor) human leukocyte antigen class I in a biological specimen. | HLA Class I Panel Reactive Antibody Measurement | ||
HLA Class IA Antigen | C154746 | HLA Class IA Antigen | A measurement of the HLA class IA antigen in a biological specimen. | HLA Class IA Histocompatibility Antigen Measurement | ||
HLA Class IB Antigen | C154747 | HLA Class IB Antigen | A measurement of the HLA class IB antigen in a biological specimen. | HLA Class IB Histocompatibility Antigen Measurement | ||
HLA Class IC Antigen | C154748 | HLA Class IC Antigen | A measurement of the HLA class IC antigen in a biological specimen. | HLA Class IC Histocompatibility Antigen Measurement | ||
HLA Class II Antibody | C128965 | HLA Class II Antibody | A measurement of the human leukocyte antigen (HLA) antibody class II in a biological specimen. | HLA Class II Antibody Measurement | ||
HLA Class II Panel Reactive Antibody | C128966 | HLA Class II Panel Reactive Antibody | A measurement of the panel reactive antibody (the reactivity between host immune cells and donor) human leukocyte antigen class II in a biological specimen. | HLA Class II Panel Reactive Antibody Measurement | ||
HLA Cw Antigen | C181439 | HLA Cw Antigen;HLA-Cw Antigen | A measurement of the HLA Cw antigen in a biological specimen. | HLA Cw Histocompatibility Antigen Measurement | ||
HLA DP Alpha1 Antigen | C181417 | HLA DP Alpha1 Antigen;HLA-DP Alpha1 Antigen | A measurement of the HLA DP alpha1 antigen in a biological specimen. | HLA DP Alpha1 Histocompatibility Antigen Measurement | ||
HLA DP Beta Antigen | C181444 | HLA DP Beta Antigen;HLA-DP Beta Antigen | A measurement of the total HLA DP beta antigen in a biological specimen. | HLA DP Beta Histocompatibility Antigen Measurement | ||
HLA DP Beta1 Antigen | C154751 | HLA DP Beta1 Antigen | A measurement of the HLA DP beta1 antigen in a biological specimen. | HLA DP Beta1 Histocompatibility Antigen Measurement | ||
HLA DQ Alpha1 Antigen | C181416 | HLA DQ Alpha1 Antigen;HLA-DQ Alpha1 Antigen | A measurement of the HLA DQ alpha1 antigen in a biological specimen. | HLA DQ Alpha1 Histocompatibility Antigen Measurement | ||
HLA DQ Beta1 Antigen | C154750 | HLA DQ Beta1 Antigen | A measurement of the HLA DQ beta1 antigen in a biological specimen. | HLA DQ Beta1 Histocompatibility Antigen Measurement | ||
HLA DQ2 Antigen | C186061 | HLA DQ2 Antigen;HLA-DQ2 Antigen | A measurement of the HLA DQ2 antigen in a biological specimen. | HLA DQ2 Antigen Measurement | ||
HLA DQ8 Antigen | C186062 | HLA DQ8 Antigen;HLA-DQ8 Antigen | A measurement of the HLA DQ8 antigen in a biological specimen. | HLA DQ8 Antigen Measurement | ||
HLA DR Antigen | C176962 | HLA DR Antigen;HLA-DR Antigen | A measurement of the total HLA DR antigen in a biological specimen. | HLA DR Histocompatibility Antigen Measurement | ||
HLA DR Beta Antigen | C181192 | HLA DR Beta Antigen;HLA-DR Beta Antigen | A measurement of the total HLA DR beta antigen in a biological specimen. | HLA DR Beta Histocompatibility Antigen Measurement | ||
HLA DR Beta1 Antigen | C154749 | HLA DR Beta1 Antigen | A measurement of the HLA DR beta1 antigen in a biological specimen. | HLA DR Beta1 Histocompatibility Antigen Measurement | ||
HLA DR Beta2 Antigen | C181415 | HLA DR Beta2 Antigen;HLA-DR Beta2 Antigen | A measurement of the HLA DR beta2 antigen in a biological specimen. | HLA DR Beta 2 Histocompatibility Antigen Measurement | ||
HLA DR Beta3 Antigen | C181412 | HLA DR Beta3 Antigen;HLA-DR Beta3 Antigen | A measurement of the HLA DR beta3 antigen in a biological specimen. | HLA DR Beta 3 Histocompatibility Antigen Measurement | ||
HLA DR Beta4 Antigen | C181413 | HLA DR Beta4 Antigen;HLA-DR Beta4 Antigen | A measurement of the HLA DR beta4 antigen in a biological specimen. | HLA DR Beta 4 Histocompatibility Antigen Measurement | ||
HLA DR Beta5 Antigen | C181414 | HLA DR Beta5 Antigen;HLA-DR Beta5 Antigen | A measurement of the HLA DR beta5 antigen in a biological specimen. | HLA DR Beta 5 Histocompatibility Antigen Measurement | ||
HLA Mismatch Count | C128933 | HLA Mismatch Count | A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigens (HLA). | HLA Mismatch Count | ||
HLA-A Antigen Type | C128955 | HLA-A Antigen Type | The identification of the type of human leukocyte antigen, class I, group A (HLA-A), in a biological specimen. | HLA-A Antigen Type | ||
HLA-A Mismatch Count | C128956 | HLA-A Mismatch Count | A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class I, group A (HLA-A). | HLA-A Mismatch Count | ||
HLA-A2 Antibody | C128954 | HLA-A2 Antibody | A measurement of the human leukocyte antigen A2 (HLA-A2) antibody in a biological specimen. | HLA-A2 Antibody Measurement | ||
HLA-A23 Antibody | C128953 | HLA-A23 Antibody | A measurement of the human leukocyte antigen A23 (HLA-A23) antibody in a biological specimen. | HLA-A23 Antibody Measurement | ||
HLA-B Antigen Type | C128957 | HLA-B Antigen Type | The identification of the type of human leukocyte antigen, class I, group B (HLA-B), in a biological specimen. | HLA-B Antigen Type | ||
HLA-B Mismatch Count | C128958 | HLA-B Mismatch Count | A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class I, group B (HLA-B). | HLA-B Mismatch Count | ||
HLA-B27 Antigen | C100460 | HLA-B27 Antigen;Human Leukocyte Antigen B27 | A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen. | HLA-B27 Antigen Measurement | ||
HLA-DR Antigen Type | C128962 | HLA-DR Antigen Type | The identification of the type of human leukocyte antigen, class II, antigen-D-related (HLA-DR), in a biological specimen. | HLA-DR Antigen Type | ||
HLA-DR Mismatch Count | C128963 | HLA-DR Mismatch Count | A measurement to determine the number of mismatches between the recipient and the donor for the human leukocyte antigen, class II, antigen-D-related (HLA-DR). | HLA-DR Mismatch Count | ||
HLA-DR51 Antibody | C128959 | HLA-DR51 Antibody | A measurement of the human leukocyte antigen DR51 (HLA-DR51) antibody in a biological specimen. | HLA-DR51 Antibody Measurement | ||
HLA-DR51 Antigen Type | C189510 | HLA-DR51 Antigen Type | The identification of the type of human leukocyte antigen, class II, antigen-D-related 51 (HLA-DR51), in a biological specimen. | HLA-DR51 Antigen Measurement | ||
HLA-DR52 Antibody | C128960 | HLA-DR52 Antibody | A measurement of the human leukocyte antigen DR52 (HLA-DR52) antibody in a biological specimen. | HLA-DR52 Antibody Measurement | ||
HLA-DR52 Antigen Type | C189511 | HLA-DR52 Antigen Type | The identification of the type of human leukocyte antigen, class II, antigen-D-related 52 (HLA-DR52), in a biological specimen. | HLA-DR52 Antigen Measurement | ||
HLA-DR53 Antibody | C128961 | HLA-DR53 Antibody | A measurement of the human leukocyte antigen DR53 (HLA-DR53) antibody in a biological specimen. | HLA-DR53 Antibody Measurement | ||
HLA-DR53 Antigen Type | C189512 | HLA-DR53 Antigen Type | The identification of the type of human leukocyte antigen, class II, antigen-D-related 53 (HLA-DR53), in a biological specimen. | HLA-DR53 Antigen Measurement | ||
Homocitrulline | C154758 | Homocitrulline | A measurement of the homocitrulline in a biological specimen. | Homocitrulline Measurement | ||
Homocysteine | C74741 | Homocysteine | A measurement of the homocysteine amino acid in a biological specimen. | Homocysteine Acid Measurement | ||
Homovanillic Acid | C74863 | Homovanillic Acid | A measurement of the homovanillic acid metabolite in a biological specimen. | Homovanillic Acid Measurement | ||
Howell-Jolly Bodies | C74704 | Howell-Jolly Bodies | A measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen. | Howell-Jolly Body Measurement | ||
Human Albumin Antibody | C103405 | Human Albumin Antibody | A measurement of the human albumin antibody in a biological specimen. | Human Albumin Antibody Measurement | ||
Human Anti-Human Antibody | C165965 | Human Anti-Human Antibody | A measurement of the total human anti-human antibody in a biological specimen. | Human Anti-Human Antibody Measurement | ||
Human Anti-Mouse Antibody | C103406 | HAMA;Human Anti-Mouse Antibody | A measurement of the human anti-mouse antibody in a biological specimen. | Human Anti-Mouse Antibody Measurement | ||
Human Anti-Sheep IgE Antibody | C98740 | Human Anti-Sheep IgE Antibody | A measurement of the human anti-sheep IgE antibodies in a biological specimen. | Human Anti-Sheep IgE Antibody Measurement | ||
Human Anti-Sheep IgG Antibody | C98741 | Human Anti-Sheep IgG Antibody | A measurement of the human anti-sheep IgG antibodies in a biological specimen. | Human Anti-Sheep IgG Antibody Measurement | ||
Human Anti-Sheep IgM Antibody | C98742 | Human Anti-Sheep IgM Antibody | A measurement of the human anti-sheep IgM antibodies in a biological specimen. | Human Anti-Sheep IgM Antibody Measurement | ||
Human Epidermal Growth Factor Receptor 2 | C112312 | ERBB2;HER2/NEU;Human Epidermal Growth Factor Receptor 2 | A measurement of HER2 protein in a biological specimen. | Human Epidermal Growth Factor Receptor 2 Measurement | ||
Human Epididymis Protein 4 | C163452 | Human Epididymis Protein 4 | A measurement of the human epididymis protein 4 in a biological specimen. | Human Epididymis Protein 4 Measurement | ||
Huntingtin Protein | C142279 | Huntingtin Protein;Total Huntingtin Protein | A measurement of the total huntingtin protein in a biological specimen. | Huntingtin Protein Measurement | ||
Huntingtin Protein, Mutant | C142280 | Huntingtin Protein, Mutant | A measurement of the mutant huntingtin protein in a biological specimen. | Mutant Huntingtin Protein Measurement | ||
Huntingtin Protein, Wild Type | C191292 | Huntingtin Protein, Wild Type | A measurement of the wild type huntingtin protein in a biological specimen. | Wild Type Huntingtin Protein Measurement | ||
Hyaline Casts | C74770 | Hyaline Casts | A measurement of the hyaline casts present in a biological specimen. | Hyaline Cast Measurement | ||
Hyalogranular Casts | C174305 | Hyalogranular Casts | A measurement of the hyalogranular casts in a biological specimen. | Hyalogranular Casts | ||
Hyaluronic Acid | C112319 | Hyaluronic Acid | A measurement of hyaluronic acid in a biological specimen. | Hyaluronic Acid Measurement | ||
Hydrocodone | C74879 | Hydrocodone | A measurement of the hydrocodone present in a biological specimen. | Hydrocodone Measurement | ||
Hydrogen | C102275 | Hydrogen | A measurement of the hydrogen in a biological specimen. | Hydrogen Measurement | ||
Hydrogen+Methane | C186060 | H+CH4;Hydrogen+Methane | A measurement of the hydrogen and methane in a biological specimen. | Hydrogen and Methane Measurement | ||
Hydromorphone | C74880 | Hydromorphone | A measurement of the hydromorphone present in a biological specimen. | Hydromorphone Measurement | ||
Hydroxyalprazolam | C147352 | Hydroxyalprazolam | A measurement of the total hydroxyalprazolam present in a biological specimen. | Hydroxyalprazolam Measurement | ||
Hydroxyethylflurazepam | C181419 | 2-Hydroxyethylflurazepam;Hydroxyethylflurazepam | A measurement of the hydroxyethylflurazepam a biological specimen. | Hydroxyethylflurazepam Measurement | ||
Hydroxylysine | C154767 | Hydroxylysine | A measurement of the hydroxylysine in a biological specimen. | Hydroxylysine Measurement | ||
Hydroxyproline | C80190 | Hydroxyproline | A measurement of the total hydroxyproline in a biological specimen. | Hydroxyproline Measurement | ||
Hyocholate | C176300 | Hyocholate;Hyocholic Acid | A measurement of the hyocholate in a biological specimen. | Hyocholate Measurement | ||
Hyperchromia | C96669 | Hyperchromia;Hyperchromic Erythrocytes | A measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration. | Hyperchromia Measurement | ||
Hyperchromic Erythrocytes/Erythrocytes | C181408 | Hyperchromic Erythrocytes/Erythrocytes | A relative measurement (ratio or percentage) of the hyperchromic erythrocytes to total erythrocytes in a biological specimen. | Hyperchromic Erythrocytes to Erythrocytes Ratio Measurement | ||
Hypersegmented Cells | C74612 | Hypersegmented Cells | A measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen. | Hypersegmented Neutrophil Measurement | ||
Hypochromia | C64802 | Hypochromia;Hypochromic Erythrocytes | An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level. | Hypochromia | ||
Hypochromic Erythrocytes/Erythrocytes | C181409 | Hypochromic Erythrocytes/Erythrocytes | A relative measurement (ratio or percentage) of the hypochromic erythrocytes to total erythrocytes in a biological specimen. | Hypochromic Erythrocytes to Erythrocytes Ratio Measurement | ||
Hypogranular Neutrophils | C116201 | Hypogranular Neutrophils | A measurement of the hypogranular neutrophils in a biological specimen. | Hypogranular Neutrophil Measurement | ||
Hypoxanthine-Guanine PRT | C187809 | Hypoxanthine-Guanine Phosphoribosyltransferase;Hypoxanthine-Guanine PRT | A measurement of the hypoxanthine-guanine phosphoribosyltransferase in a biological specimen. | Hypoxanthine-Guanine Phosphoribosyltransferase Measurement | ||
Icteric Index | C111232 | Icteric Index;Icterus | A measurement of the yellow color of a biological specimen, due to the presence of bile pigments. | Icteric Index | ||
IDL Apolipoprotein B | C184514 | IDL Apolipoprotein B | A measurement of the apolipoprotein B in the intermediate density lipoprotein fraction of a biological specimen. | IDL Apolipoprotein B Measurement | ||
IDL Cholesterol | C112325 | IDL Cholesterol;Intermediate Density Lipoprotein | A measurement of the intermediate density lipoprotein in a biological specimen. | Intermediate Density Lipoprotein Cholesterol Measurement | ||
IDL Cholesterol/LDL Cholesterol | C187810 | IDL Cholesterol/LDL Cholesterol | A relative measurement (ratio) of the amount of intermediate density lipoprotein cholesterol compared to low density lipoprotein cholesterol in a biological specimen. | IDL Cholesterol to LDL Cholesterol Ratio Measurement | ||
IDL Particles | C116197 | IDL Particles;Intermediate Density Lipoproteins Particles | A measurement of the concentration of IDL particles in a biological specimen. | IDL Particles Measurement | ||
IDL Triglyceride | C189507 | IDL Triglyceride | A measurement of the intermediate density lipoprotein triglyceride in a biological specimen. | IDL Triglyceride Measurement | ||
IDL+VLDL Cholesterol Subtype 3 | C147371 | IDL Cholesterol and VLDL Cholesterol Subtype 3;IDL+VLDL Cholesterol Subtype 3 | A measurement of the intermediate density lipoprotein cholesterol and the very low density lipoprotein cholesterol subtype 3 in a biological specimen. | IDL Cholesterol and VLDL Cholesterol Subtype 3 Measurement | ||
IgG Clearance | C147373 | IgG Clearance | A measurement of the IgG clearance in a biological specimen. | IgG Clearance | ||
IgG Clearance/Albumin Clearance | C147374 | IgG Clearance/Albumin Clearance | A relative measurement (ratio) of the IgG clearance to albumin clearance in a biological specimen. | IgG Clearance to Albumin Clearance Ratio Measurement | ||
IgG IgM IgA Total | C111233 | IgG IgM IgA Total | A measurement of the total IgG, IgM, and IgA in a biological specimen. | IgG IgM IgA Total Measurement | ||
IgG Synthesis Rate | C147375 | IgG Synthesis Rate | A measurement of the IgG synthesis rate in a biological specimen. | IgG Synthesis Rate | ||
Iloperidone | C177984 | Iloperidone | A measurement of the iloperidone in a biological specimen. | Iloperidone Measurement | ||
Imipramine | C186071 | Imipramine | A measurement of the imipramine in a biological specimen. | Imipramine Measurement | ||
Immature Basophils | C96670 | Immature Basophils | A measurement of the immature basophils in a biological specimen. | Immature Basophil Count | ||
Immature Basophils/Leukocytes | C96671 | Immature Basophils/Leukocytes | A relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen. | Immature Basophil to Leukocyte Ratio Measurement | ||
Immature Cells | C96672 | Immature Cells | A measurement of the total immature cells in a blood specimen. | Immature Cell Count | ||
Immature Cells/Total Cells | C111234 | Immature Cells/Total Cells | A relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen. | Immature Cell to Total Cell Ratio Measurement | ||
Immature Eosinophils | C96673 | Immature Eosinophils | A measurement of the immature eosinophils in a biological specimen. | Immature Eosinophil Count | ||
Immature Eosinophils/Leukocytes | C96674 | Immature Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen. | Immature Eosinophil to Leukocyte Ratio Measurement | ||
Immature Granulocytes | C96675 | Immature Granulocytes | A measurement of the total immature granulocytes in a biological specimen. | Immature Granulocyte Count | ||
Immature Granulocytes/Leukocytes | C100445 | Immature Granulocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen). | Immature Granulocytes to Leukocytes Ratio Measurement | ||
Immature Leukocytes | C127625 | Immature Leukocytes | A measurement of the immature leukocytes in a biological specimen. | Immature Leukocyte Count | ||
Immature Leukocytes/Leukocytes | C127626 | Immature Leukocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature leukocytes to leukocytes in a biological specimen. | Immature Leukocyte to Leukocytes Ratio Measurement | ||
Immature Lymphocytes | C100444 | Immature Lymphocytes | A measurement of the immature lymphocytes in a biological specimen. | Immature Lymphocytes Measurement | ||
Immature Lymphocytes/Leukocytes | C100443 | Immature Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen. | Immature Lymphocytes to Leukocytes Ratio Measurement | ||
Immature Monocytes | C96676 | Immature Monocytes | A measurement of the immature monocytes in a biological specimen. | Immature Monocyte Count | ||
Immature Monocytes/Leukocytes | C96677 | Immature Monocytes/Leukocytes | A relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen. | Immature Monocyte to Leukocyte Ratio Measurement | ||
Immature Neutrophils | C96678 | Immature Neutrophils | A measurement of the total immature neutrophils in a biological specimen. | Immature Neutrophil Count | ||
Immature Neutrophils/Leukocytes | C100442 | Immature Neutrophils/Leukocytes | A relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen. | Immature Neutrophils to Leukocytes Ratio Measurement | ||
Immature Plasma Cells | C96679 | Immature Plasma Cells | A measurement of the immature plasma cells in a biological specimen. | Immature Plasma Cell Count | ||
Immature Plasma Cells/Lymphocytes | C96680 | Immature Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen. | Immature Plasma Cell to Lymphocyte Ratio Measurement | ||
Immature Plasma Cells/Total Cells | C147416 | Immature Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the immature plasma cells (plasmacytes) to total cells in a biological specimen. | Immature Plasma Cells to Total Cells Ratio Measurement | ||
Immature Platelets | C154723 | Immature Platelets;Reticulated Platelets | A measurement of the immature platelets in a biological specimen. | Immature Platelet Count | ||
Immature Platelets/Total Platelets | C170580 | Immature Platelet Fraction;Immature Platelets/Total Platelets;IPF;Reticulated Platelets/Total Platelets | A relative measurement (ratio or percentage) of immature platelets to total platelets in a biological specimen. | Immature Platelets to Total Platelets Ratio Measurement | ||
Immature Reticulocyte Fraction | C102276 | Immature Reticulocyte Fraction | A measurement of the immature reticulocyte fraction present in a biological specimen. | Immature Reticulocyte Fraction Measurement | ||
Immunoblasts | C103407 | Immunoblastic Lymphocytes;Immunoblasts | A measurement of the immunoblasts in a biological specimen. | Immunoblast Count | ||
Immunoblasts/Lymphocytes | C106535 | Immunoblasts/Lymphocytes;Lymphocytes, Immunoblastic/Lymphocytes | A relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample. | Immunoblasts to Lymphocytes Ratio Measurement | ||
Immunoglobulin A | C81969 | Immunoglobulin A | A measurement of the total immunoglobulin A in a biological specimen. | Immunoglobulin A Measurement | ||
Immunoglobulin A/Complement C3 | C184515 | IgA/C3;IgA/Complement C3;Immunoglobulin A/Complement C3 | A relative measurement (ratio) of the immunoglobulin A to complement C3 in a biological specimen. | Immunoglobulin A to Complement C3 Measurement | ||
Immunoglobulin D | C98745 | Immunoglobulin D | A measurement of the Immunoglobulin D in a biological specimen. | Immunoglobulin D Measurement | ||
Immunoglobulin E | C81970 | Immunoglobulin E | A measurement of the Immunoglobulin E in a biological specimen. | Immunoglobulin E Measurement | ||
Immunoglobulin G Subclass 1 | C122127 | Immunoglobulin G Subclass 1 | A measurement of the immunoglobulin G subclass 1 in a biological specimen. | Immunoglobulin G Subclass 1 Measurement | ||
Immunoglobulin G Subclass 2 | C122128 | Immunoglobulin G Subclass 2 | A measurement of the immunoglobulin G subclass 2 in a biological specimen. | Immunoglobulin G Subclass 2 Measurement | ||
Immunoglobulin G Subclass 3 | C122129 | Immunoglobulin G Subclass 3 | A measurement of the immunoglobulin G subclass 3 in a biological specimen. | Immunoglobulin G Subclass 3 Measurement | ||
Immunoglobulin G Subclass 4 | C122130 | Immunoglobulin G Subclass 4 | A measurement of the immunoglobulin G subclass 4 in a biological specimen. | Immunoglobulin G Subclass 4 Measurement | ||
Immunoglobulin G | C81971 | Immunoglobulin G | A measurement of the total immunoglobulin G in a biological specimen. | Immunoglobulin G Measurement | ||
Immunoglobulin G/Albumin | C147372 | IgG/Albumin;Immunoglobulin G/Albumin | A relative measurement (ratio or percentage) of the immunoglobulin G to albumin in a biological specimen. | Immunoglobulin G to Albumin Ratio Measurement | ||
Immunoglobulin G/Creatinine | C119285 | Immunoglobulin G/Creatinine | A relative measurement (ratio or percentage) of the immunoglobulin G to creatinine in a biological specimen. | Immunoglobulin G to Creatinine Ratio Measurement | ||
Immunoglobulin Heavy Constant Gamma 2 | C154737 | Immunoglobulin Heavy Constant Gamma 2 | A measurement of the immunoglobulin heavy constant gamma 2 in a biological specimen. | Immunoglobulin Heavy Constant Gamma 2 Measurement | ||
Immunoglobulin Heavy Constant Gamma 4 | C154738 | Immunoglobulin Heavy Constant Gamma 4 | A measurement of the immunoglobulin heavy constant gamma 4 in a biological specimen. | Immunoglobulin Heavy Constant Gamma 4 Measurement | ||
Immunoglobulin Light Chains | C147376 | Immunoglobulin Light Chains | A measurement of the total immunoglobulin (kappa and lambda) light chains in a biological specimen. | Immunoglobulin Light Chain Measurement | ||
Immunoglobulin Light Chains, Free | C156517 | Immunoglobulin Light Chains, Free | A measurement of the total free immunoglobulin (kappa and lambda) light chains in a biological specimen. | Free Immunoglobulin Light Chain Measurement | ||
Immunoglobulin M | C81972 | Immunoglobulin M | A measurement of the total immunoglobulin M in a biological specimen. | Immunoglobulin M Measurement | ||
Immunoglobulin | C81869 | Immunoglobulin | A measurement of the total immunoglobulin in a biological specimen. | Immunoglobulin Measurement | ||
Inclusion Bodies | C116184 | Inclusion Bodies | A measurement of the inclusion bodies in a biological specimen. | Inclusion Body Measurement | ||
Indican | C82044 | Indican | A measurement of the indican present in a biological specimen. | Indican Measurement | ||
Indirect Bilirubin | C64483 | Indirect Bilirubin | A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen. | Indirect Bilirubin Measurement | ||
Indocyanine Green Clearance | C184513 | Indocyanine Green Clearance | A measurement of the volume of serum or plasma that would be cleared of indocyanine green by excretion for a specified unit of time (e.g. one minute). | Indocyanine Green Clearance Measurement | ||
Indocyanine Green | C184512 | Indocyanine Green | A measurement of the indocyanine green in a biological specimen. | Indocyanine Green Measurement | ||
Industrial Mix Antigen IgE Antibody | C130114 | Industrial Mix Antigen IgE Antibody | A measurement of the industrial mix antigen IgE antibody in a biological specimen. | Industrial Mix Antigen IgE Antibody Measurement | ||
Industrial Mix Antigen IgG Antibody | C130115 | Industrial Mix Antigen IgG Antibody | A measurement of the industrial mix antigen IgG antibody in a biological specimen. | Industrial Mix Antigen IgG Antibody Measurement | ||
Industrial Mix IgE AB RAST Score | C165928 | Industrial Mix IgE AB RAST Score | A classification of the amount of industrial mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Industrial Mix IgE Antibody RAST Score Measurement | ||
Industrial Mix IgG AB RAST Score | C165909 | Industrial Mix IgG AB RAST Score | A classification of the amount of industrial mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Industrial Mix IgG Antibody RAST Score Measurement | ||
Inhibin A | C82020 | Inhibin A | A measurement of the inhibin A in a biological specimen. | Inhibin A Measurement | ||
Inhibin B | C96681 | Inhibin B | A measurement of the inhibin B in a biological specimen. | Inhibin B Measurement | ||
Inorganic Pyrophosphate | C161358 | Inorganic Pyrophosphate | A measurement of the inorganic pyrophosphate in a biological specimen. | Inorganic Pyrophosphate Measurement | ||
Insulin Antibody | C119287 | Insulin Antibody | A measurement of the antibody to insulin in a biological specimen. | Insulin Antibody Measurement | ||
Insulin Autoantibody | C119286 | Insulin Autoantibody | A measurement of the antibody to endogenous insulin in a biological specimen. | Insulin Autoantibody Measurement | ||
Insulin Resistance | C123458 | Insulin Resistance | A measurement of the insulin resistance (a cell's inability to respond to insulin) in a biological specimen. | Insulin Resistance Measurement | ||
Insulin Sensitivity | C123459 | Insulin Sensitivity | A measurement of the insulin sensitivity (cells are stimulated by lower than normal insulin levels) in a biological specimen. | Insulin Sensitivity Measurement | ||
Insulin | C74788 | Insulin | A measurement of the insulin in a biological specimen. | Insulin Measurement | ||
Insulin, Free | C147377 | Insulin, Free | A measurement of the free insulin in a biological specimen. | Free Insulin Measurement | ||
Insulin, Intact | C186072 | Insulin, Intact | A measurement of the intact insulin in a biological specimen. | Intact Insulin Measurement | ||
Insulin-Like Growth Factor Binding Prot1 | C128968 | Insulin-Like Growth Factor Binding Prot1;Insulin-Like Growth Factor Binding Protein 1 | A measurement of the total insulin-like growth factor binding protein 1 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 1 Measurement | ||
Insulin-Like Growth Factor Binding Prot2 | C128969 | Insulin-Like Growth Factor Binding Prot2;Insulin-Like Growth Factor Binding Protein 2 | A measurement of the insulin-like growth factor binding protein 2 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 2 Measurement | ||
Insulin-Like Growth Factor Binding Prot3 | C112322 | Insulin-Like Growth Factor Binding Prot3;Insulin-Like Growth Factor Binding Protein 3 | A measurement of the insulin-like growth factor binding protein 3 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 3 Measurement | ||
Insulin-Like Growth Factor Binding Prot7 | C165969 | AGM;FSTL2;IBP-7;IGFBP-7;IGFBP-7v;IGFBPRP1;Insulin-Like Growth Factor Binding Prot7;Insulin-like Growth Factor Binding Protein 7;MAC25;PSF;RAMSVPS;TAF | A measurement of the insulin-like growth factor binding protein 7 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 7 Measurement | ||
Insulin-like Growth Factor-1 | C74864 | Insulin-like Growth Factor-1 | A measurement of the insulin-like growth factor-1 in a biological specimen. | Insulin Like Growth Factor-1 Measurement | ||
Insulin-like Growth Factor-2 | C74865 | Insulin-like Growth Factor-2 | A measurement of the insulin-like growth factor-2 in a biological specimen. | Insulin Like Growth Factor-2 Measurement | ||
Insulinoma-Associated Protein 2 Antibody | C119284 | Insulinoma-Associated Protein 2 Antibody | A measurement of the insulinoma-associated protein 2 antibody in a biological specimen. | Insulinoma-Associated Protein 2 Antibody Measurement | ||
Intercellular Adhesion Molecule 1 | C124345 | CD54;Intercellular Adhesion Molecule 1 | A measurement of the intercellular adhesion molecule 1 in a biological specimen. | Intercellular Adhesion Molecule 1 Measurement | ||
Intercellular Adhesion Molecule 3 | C165968 | Intercellular Adhesion Molecule 3 | A measurement of the intercellular adhesion molecule 3 in a biological specimen. | Intercellular Adhesion Molecule 3 Measurement | ||
Intercellular Adhesion Molecule | C124344 | Intercellular Adhesion Molecule | A measurement of the total intercellular adhesion molecule in a biological specimen. | Intercellular Adhesion Molecule Measurement | ||
Interferon Alpha Type 2 | C184646 | Interferon Alpha Type 2 | A measurement of the interferon alpha type 2 in a biological specimen. | Interferon Alpha Type 2 Measurement | ||
Interferon Alpha | C81994 | Interferon Alpha | A measurement of the total interferon alpha in a biological specimen. | Interferon Alpha Measurement | ||
Interferon Alpha-Inducible Protein 27 | C163455 | Interferon Alpha-Induced Protein 27;Interferon Alpha-Inducible Protein 27 | A measurement of the interferon alpha-inducible protein 27 in a biological specimen. | Interferon Alpha-Inducible Protein 27 Measurement | ||
Interferon Alpha-Inducible Protein 6 | C163458 | Interferon Alpha-Inducible Protein 6 | A measurement of the interferon alpha-inducible protein 6 in a biological specimen. | Interferon Alpha-Inducible Protein 6 Measurement | ||
Interferon Beta | C81995 | Interferon Beta | A measurement of the interferon beta in a biological specimen. | Interferon Beta Measurement | ||
Interferon Gamma | C81996 | Interferon Gamma | A measurement of the interferon gamma in a biological specimen. | Interferon Gamma Measurement | ||
Interferon-Induced 56 kDa Protein | C163459 | Interferon-Induced 56 kDa Protein;Interferon-Induced Protein With Tetratricopeptide Repeats 1 | A measurement of the interferon-induced 56 KDa protein in a biological specimen. | Interferon-Induced 56 kDa Protein Measurement | ||
Interferon-Induced 60 kDa Protein | C163460 | Interferon-Induced 60 kDa Protein;Interferon-Induced Protein With Tetratricopeptide Repeats 3 | A measurement of the interferon-induced 60 KDa protein in a biological specimen. | Interferon-Induced 60 kDa Protein Measurement | ||
Interferon-Induced Protein 44 | C163456 | Interferon-Induced Protein 44 | A measurement of the interferon-induced protein 44 in a biological specimen. | Interferon-Induced Protein 44 Measurement | ||
Interferon-Induced Protein 44-Like | C163457 | Interferon-Induced Protein 44-Like | A measurement of the interferon-induced protein 44-like in a biological specimen. | Interferon-Induced Protein 44-Like Measurement | ||
Interferon-Induced Protein p78 | C163469 | Interferon-Induced GTP-Binding Protein Mx1;Interferon-Induced Protein p78 | A measurement of the interferon-induced protein P78 in a biological specimen. | Interferon-Induced Protein p78 Measurement | ||
Interleukin 1 Alpha | C122131 | Interleukin 1 Alpha | A measurement of interleukin 1 alpha in a biological specimen. | Interleukin 1 Alpha Measurement | ||
Interleukin 1 Beta | C112323 | IL-1B;IL1Beta;Interleukin 1 Beta;Interleukin 1B | A measurement of interleukin 1 beta in a biological specimen. | Interleukin 1 Beta Measurement | ||
Interleukin 1 Excretion Rate | C156518 | Interleukin 1 Excretion Rate | A measurement of the amount of interleukin 1 being excreted in a biological specimen over a defined period of time (e.g. one hour). | Interleukin 1 Excretion Rate | ||
Interleukin 1 Receptor Antagonist | C112324 | IL-1RA;Interleukin 1 Receptor Antagonist | A measurement of the interleukin 1 receptor antagonist in a biological specimen. | Interleukin 1 Receptor Antagonist Measurement | ||
Interleukin 1 Receptor Type 2 | C165970 | CD121b;CDw121b;IL-1R-2;IL-1RT2;IL1R2c;IL1RB;Interleukin 1 Receptor Type 2 | A measurement of the interleukin 1 receptor type 2 in a biological specimen. | Interleukin 1 Receptor Type 2 Measurement | ||
Interleukin 1 Receptor-Like 1 | C142281 | Interleukin 1 Receptor-Like 1;Protein ST2;sST2 | A measurement of the interleukin 1 receptor-like 1 in a biological specimen. | Interleukin 1 Receptor-Like 1 Measurement | ||
Interleukin 1 | C74805 | Interleukin 1 | A measurement of the interleukin 1 in a biological specimen. | Interleukin 1 Measurement | ||
Interleukin 10 | C74806 | Interleukin 10 | A measurement of the interleukin 10 in a biological specimen. | Interleukin 10 Measurement | ||
Interleukin 11 | C74807 | Interleukin 11 | A measurement of the interleukin 11 in a biological specimen. | Interleukin 11 Measurement | ||
Interleukin 12 Beta | C127623 | Interleukin 12 Beta;Interleukin 12 Beta Subunit;Interleukin 12 p40;Interleukin 12 p40 Subunit | A measurement of p40 subunit of Interleukin 12 in a biological specimen. | Interleukin 12 Beta Measurement | ||
Interleukin 12 | C74808 | Interleukin 12;Interleukin 12 p70 | A measurement of the interleukin 12 in a biological specimen. | Interleukin 12 Measurement | ||
Interleukin 12+23 p40 | C128970 | Interleukin 12+23 p40 | A measurement of the p40 subunit of the interleukins 12 and 23 in a biological specimen. | Interleukin 12+23 p40 Measurement | ||
Interleukin 13 | C74809 | Interleukin 13 | A measurement of the interleukin 13 in a biological specimen. | Interleukin 13 Measurement | ||
Interleukin 14 | C74810 | Interleukin 14 | A measurement of the interleukin 14 in a biological specimen. | Interleukin 14 Measurement | ||
Interleukin 15 | C74811 | Interleukin 15 | A measurement of the interleukin 15 in a biological specimen. | Interleukin 15 Measurement | ||
Interleukin 16 | C74812 | Interleukin 16 | A measurement of the interleukin 16 in a biological specimen. | Interleukin 16 Measurement | ||
Interleukin 17 | C74813 | IL-17A;Interleukin 17;Interleukin 17A | A measurement of the interleukin 17 in a biological specimen. | Interleukin 17 Measurement | ||
Interleukin 18 Binding Protein | C172513 | Interleukin 18 Binding Protein | A measurement of the interleukin 18 binding protein in a biological specimen. | Interleukin 18 Binding Protein Measurement | ||
Interleukin 18 Excretion Rate | C156519 | Interleukin 18 Excretion Rate | A measurement of the amount of interleukin 18 being excreted in a biological specimen over a defined period of time (e.g. one hour). | Interleukin 18 Excretion Rate | ||
Interleukin 18 | C74814 | Interleukin 18 | A measurement of the interleukin 18 in a biological specimen. | Interleukin 18 Measurement | ||
Interleukin 19 | C74815 | Interleukin 19 | A measurement of the interleukin 19 in a biological specimen. | Interleukin 19 Measurement | ||
Interleukin 2 Receptor Subunit Alpha | C142282 | CD25;IL-2Ra;Interleukin 2 Receptor Subunit Alpha | A measurement of the interleukin 2 receptor subunit alpha in a biological specimen. | Interleukin 2 Receptor Subunit Alpha Measurement | ||
Interleukin 2 Receptor Subunit Beta | C142283 | IL-2Rb;Interleukin 2 Receptor Subunit Beta | A measurement of the interleukin 2 receptor subunit beta in a biological specimen. | Interleukin 2 Receptor Subunit Beta Measurement | ||
Interleukin 2 Receptor | C158147 | Interleukin 2 Receptor | A measurement of the interleukin 2 receptor in a biological specimen. | Interleukin 2 Receptor Measurement | ||
Interleukin 2 | C74816 | Interleukin 2 | A measurement of the interleukin 2 in a biological specimen. | Interleukin 2 Measurement | ||
Interleukin 20 | C74817 | Interleukin 20 | A measurement of the interleukin 20 in a biological specimen. | Interleukin 20 Measurement | ||
Interleukin 21 | C74818 | Interleukin 21 | A measurement of the interleukin 21 in a biological specimen. | Interleukin 21 Measurement | ||
Interleukin 22 | C74819 | Interleukin 22 | A measurement of the interleukin 22 in a biological specimen. | Interleukin 22 Measurement | ||
Interleukin 23 | C74820 | Interleukin 23;Interleukin 23 p59 | A measurement of the interleukin 23 in a biological specimen. | Interleukin 23 Measurement | ||
Interleukin 24 | C74821 | Interleukin 24 | A measurement of the interleukin 24 in a biological specimen. | Interleukin 24 Measurement | ||
Interleukin 25 | C74822 | Interleukin 25 | A measurement of the interleukin 25 in a biological specimen. | Interleukin 25 Measurement | ||
Interleukin 26 | C74823 | Interleukin 26 | A measurement of the interleukin 26 in a biological specimen. | Interleukin 26 Measurement | ||
Interleukin 27 | C74824 | Interleukin 27 | A measurement of the interleukin 27 in a biological specimen. | Interleukin 27 Measurement | ||
Interleukin 28 | C74825 | Interleukin 28 | A measurement of the interleukin 28 in a biological specimen. | Interleukin 28 Measurement | ||
Interleukin 29 | C74826 | Interleukin 29 | A measurement of the interleukin 29 in a biological specimen. | Interleukin 29 Measurement | ||
Interleukin 3 | C74827 | Interleukin 3 | A measurement of the interleukin 3 in a biological specimen. | Interleukin 3 Measurement | ||
Interleukin 30 | C74828 | Interleukin 30 | A measurement of the interleukin 30 in a biological specimen. | Interleukin 30 Measurement | ||
Interleukin 31 | C74829 | Interleukin 31 | A measurement of the interleukin 31 in a biological specimen. | Interleukin 31 Measurement | ||
Interleukin 32 | C74830 | Interleukin 32 | A measurement of the interleukin 32 in a biological specimen. | Interleukin 32 Measurement | ||
Interleukin 33 | C74831 | Interleukin 33 | A measurement of the interleukin 33 in a biological specimen. | Interleukin 33 Measurement | ||
Interleukin 4 | C74832 | Interleukin 4 | A measurement of the interleukin 4 in a biological specimen. | Interleukin 4 Measurement | ||
Interleukin 5 | C74833 | Interleukin 5 | A measurement of the interleukin 5 in a biological specimen. | Interleukin 5 Measurement | ||
Interleukin 6 | C74834 | Interleukin 6 | A measurement of the interleukin 6 in a biological specimen. | Interleukin 6 Measurement | ||
Interleukin 7 | C74835 | Interleukin 7 | A measurement of the interleukin 7 in a biological specimen. | Interleukin 7 Measurement | ||
Interleukin 8 | C74836 | Interleukin 8 | A measurement of the interleukin 8 in a biological specimen. | Interleukin 8 Measurement | ||
Interleukin 9 | C74837 | Interleukin 9 | A measurement of the interleukin 9 in a biological specimen. | Interleukin 9 Measurement | ||
Intestinal Specific Alkaline Phosphatase | C119266 | Intestinal Specific Alkaline Phosphatase | A measurement of the intestinal specific alkaline phosphatase isoform in a biological specimen. | Intestinal Specific Alkaline Phosphatase Measurement | ||
Inulin Clearance | C98748 | Inulin Clearance | A measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute). | Inulin Clearance | ||
Inulin | C125945 | Inulin | A measurement of the inulin in a biological specimen. | Inulin Measurement | ||
Iodine | C181193 | Iodine | A measurement of the total iodine in a biological specimen. | Iodine Measurement | ||
Iodine, Free | C181445 | Iodine, Free | A measurement of the free (unbound) iodine in a biological specimen. | Free Iodine Measurement | ||
Iohexol Clearance | C100439 | Iohexol Clearance | A measurement of the volume of serum or plasma that would be cleared of Iohexol by excretion of urine for a specified unit of time (e.g. one minute). | Iohexol Clearance | ||
Iohexol | C125946 | Iohexol | A measurement of iohexol in a biological specimen. | Iohexol Measurement | ||
Iothalamate Clearance Adjusted for BSA | C98750 | Iothalamate Clearance Adjusted for BSA | A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body surface area. | Iothalamate Clearance Adjusted for BSA | ||
Iothalamate Clearance | C98749 | Iothalamate Clearance | A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute). | Iothalamate Clearance | ||
Iron Excretion Rate | C150819 | Iron Excretion Rate | A measurement of the amount of iron being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Iron Excretion Rate | ||
Iron | C74679 | FE;Iron | A measurement of the iron in a biological specimen. | Iron Measurement | ||
Islet Amyloid Polypeptide | C127622 | Amylin;Islet Amyloid Polypeptide | A measurement of the islet amyloid polypeptide in a biological specimen. | Islet Amyloid Polypeptide Measurement | ||
Islet Cell 512 Antibody | C81985 | IA-2 Antibody;ICA-512 Antibody;Islet Antigen 2 Autoantibody;Islet Cell 512 Antibody;Islet Cell Antigen 512 Autoantibody | A measurement of the islet cell 512 antibody in a biological specimen. | Islet Cell 512 Antibody Measurement | ||
Islet Cell 512 Antigen | C81986 | Islet Cell 512 Antigen | A measurement of the islet cell 512 antigen in a biological specimen. | Islet Cell 512 Antigen Measurement | ||
Islet Cell Antibody | C154725 | Islet Cell Antibody | A measurement of the total islet cell antibodies in a biological specimen. | Islet Cell Antibody Measurement | ||
Islet Cell Cytoplasmic IgG Antibody | C122126 | Islet Cell Cytoplasmic IgG Antibody | A measurement of the islet cell cytoplasmic IgG antibody in a biological specimen. | Islet Cell Cytoplasmic IgG Antibody Measurement | ||
Islet Neogenesis Assoc Protein Antibody | C81987 | Islet Neogenesis Assoc Protein Antibody | A measurement of the islet neogenesis associated protein antibody in a biological specimen. | Islet Neogenesis Associated Protein Antibody Measurement | ||
Isoleucine | C103410 | Isoleucine | A measurement of the isoleucine in a biological specimen. | Isoleucine Measurement | ||
Jo-1 Antibody | C100459 | Jo-1 Antibody | A measurement of the Jo-1 antibody in a biological specimen. | Jo-1 Antibody Measurement | ||
Johnson Grass Pollen IgG4 Antibody | C165895 | Johnson Grass Pollen IgG4 Antibody | A measurement of the Sorghum halepense pollen IgG4 antibody in a biological specimen. | Johnson Grass Pollen IgG4 Antibody Measurement | ||
JWH-018 | C184542 | JWH-018;JWH018 | A measurement of the synthetic cannabinoid JWH-018 in a biological specimen. | JWH-018 Measurement | ||
JWH-073 | C184543 | JWH-073;JWH073 | A measurement of the synthetic cannabinoid JWH-073 in a biological specimen. | JWH-073 Measurement | ||
JWH-081 | C184546 | JWH-081;JWH081 | A measurement of the synthetic cannabinoid JWH-081 in a biological specimen. | JWH-081 Measurement | ||
JWH-122 | C184547 | JWH-122;JWH122 | A measurement of the synthetic cannabinoid JWH-122 in a biological specimen. | JWH-122 Measurement | ||
JWH-200 | C184544 | JWH-200;JWH200 | A measurement of the synthetic cannabinoid JWH-200 in a biological specimen. | JWH-200 Measurement | ||
JWH-250 | C184545 | JWH-250;JWH250 | A measurement of the synthetic cannabinoid JWH-250 in a biological specimen. | JWH-250 Measurement | ||
JWH-398 | C184548 | JWH-398;JWH398 | A measurement of the synthetic cannabinoid JWH-398 in a biological specimen. | JWH-398 Measurement | ||
Kallikrein-2 | C132374 | Kallikrein-2 | A measurement of the kallikrein-2 in a biological specimen. | Kallikrein-2 Measurement | ||
Kappa Light Chain | C147379 | Kappa Light Chain | A measurement of the total kappa light chains in a biological specimen. | Kappa Light Chain Measurement | ||
Kappa Light Chain, Free | C98730 | Bence-Jones, Kappa;Kappa Light Chain, Free | A measurement of the free kappa light chain in a biological specimen. | Free Kappa Light Chain Measurement | ||
Kappa Light Chain/Lambda Light Chain | C161351 | Kappa Lambda Ratio;Kappa Light Chain/Lambda Light Chain | A relative measurement (ratio) of the total kappa light chain to total lambda light chain in a biological specimen. | Kappa Light Chain to Lambda Light Chain Ratio Measurement | ||
Kappa Lt Chain,Free/Lambda Lt Chain,Free | C98731 | Kappa Lt Chain,Free/Lambda Lt Chain,Free | A relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen. | Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement | ||
Keratocyte | C147380 | Keratocyte | A measurement of the keratocytes in a biological specimen. | Keratocyte Count | ||
Ketamine | C184587 | Ketamine | A measurement of the ketamine in a biological specimen. | Ketamine Measurement | ||
Ketobemidone | C184549 | Ketobemidone | A measurement of the ketobemidone in a biological specimen. | Ketobemidone Measurement | ||
Ketone Bodies Excretion Rate | C189519 | Ketone Bodies Excretion Rate | A measurement of the amount of ketone bodies being excreted in a biological specimen over a defined period of time (e.g. one hour). | Ketone Bodies Excretion Rate Measurement | ||
Ketone Bodies | C111239 | Ketone Bodies | A measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen. | Ketone Body Measurement | ||
Ketones | C64854 | Ketones | A measurement of the ketones in a biological specimen. | Ketone Measurement | ||
Keyhole Limpet Hemocyanin IgG Antibody | C132372 | Keyhole Limpet Hemocyanin IgG Antibody | A measurement of the keyhole limpet hemocyanin IgG antibody in a biological specimen. | Keyhole Limpet Hemocyanin IgG Antibody Measurement | ||
Keyhole Limpet Hemocyanin IgM Antibody | C132373 | Keyhole Limpet Hemocyanin IgM Antibody | A measurement of the keyhole limpet hemocyanin IgM antibody in a biological specimen. | Keyhole Limpet Hemocyanin IgM Antibody Measurement | ||
Ki-67 | C123557 | Ki-67;KI67;MKI67;pKi-67 | A measurement of the Ki-67 protein in a biological specimen. | Ki67 Measurement | ||
Kidney Injury Molecule-1 Excretion Rate | C163462 | Kidney Injury Molecule-1 Excretion Rate | A measurement of the amount of kidney injury molecule-1 being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Kidney Injury Molecule-1 Excretion Rate | ||
Kidney Injury Molecule-1 | C100433 | Hepatitis A Virus Cellular Receptor 1;Kidney Injury Molecule-1;KIM-1 | A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen. | Kidney Injury Molecule-1 Measurement | ||
Kidney Injury Molecule-1/Creatinine | C177955 | Kidney Injury Molecule-1/Creatinine | A relative measurement (ratio or percentage) of the kidney injury molecule-1 to creatinine in a biological specimen. | Kidney Injury Molecule-1/Creatinine Ratio Measurement | ||
Klotho | C127624 | Klotho | A measurement of the total klotho protein in a biological specimen. | Klotho Protein Measurement | ||
Krebs von den Lungen-6 | C154724 | KL-6;Krebs von den Lungen-6 Antigen | A measurement of the Krebs von den Lungen-6 in a biological specimen. | Krebs von den Lungen-6 Measurement | ||
Kurloff Cells | C96682 | Kurloff Cells | A measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family. | Kurloff Cells Measurement | ||
Kynurenine | C154740 | Kynurenine | A measurement of the kynurenine in a biological specimen. | Kynurenine Measurement | ||
Lacosamide | C184641 | Lacosamide | A measurement of the lacosamide in a biological specimen. | Lacosamide Measurement | ||
Lactate Dehydrogenase Excretion Rate | C165972 | Lactate Dehydrogenase Excretion Rate | A measurement of the amount of lactate dehydrogenase being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Lactate Dehydrogenase Excretion Rate | ||
Lactate Dehydrogenase | C64855 | Lactate Dehydrogenase | A measurement of the lactate dehydrogenase in a biological specimen. | Lactate Dehydrogenase Measurement | ||
Lactate Dehydrogenase/Creatinine | C79449 | Lactate Dehydrogenase/Creatinine | A relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen. | Lactate Dehydrogenase to Creatinine Ratio Measurement | ||
Lactic Acid | C79450 | 2-hydroxypropanoic acid;Lactate;Lactic Acid | A measurement of the lactic acid in a biological specimen. | Lactic Acid Measurement | ||
Lactoferrin Antibody | C120639 | Lactoferrin Antibody | A measurement of the lactoferrin antibody in a biological specimen. | Lactoferrin Antibody Measurement | ||
Lactoferrin | C82021 | Lactoferrin;Lactotransferrin | A measurement of the lactoferrin in a biological specimen. | Lactoferrin Measurement | ||
Lactose | C186077 | Lactose | A measurement of the lactose in a biological specimen. | Lactose Measurement | ||
Lactulose | C154741 | Lactulose | A measurement of the lactulose in a biological specimen. | Lactulose Measurement | ||
Lambda Light Chain | C147384 | Lambda Light Chain | A measurement of the total lambda light chains in a biological specimen. | Lambda Light Chain Measurement | ||
Lambda Light Chain, Free | C98732 | Bence-Jones, Lambda;Lambda Light Chain, Free | A measurement of the free lambda light chain in a biological specimen. | Free Lambda Light Chain Measurement | ||
LAMP2/GAPDH | C191289 | LAMP2/GAPDH;Lysosomal Associated Membrane Protein 2/Glyceraldehyde-3-Phosphate Dehydrogenase | A relative measurement (ratio) of the lysosomal associated membrane protein 2 to glyceraldehyde-3-phosphate dehydrogenase in a biological specimen. | Lysosomal Associated Membrane Protein 2 to Glyceraldehyde-3-Phosphate Dehydrogenase Ratio Measurement | ||
Large Lymphocytes | C158236 | Large Lymphocytes | A measurement of the large lymphocytes (approximately between 10 um and 20 um in diameter) in a biological specimen. | Large Lymphocyte Count | ||
Large Platelets | C74729 | Large Platelets | A measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen. | Large Platelet Count | ||
Large Platelets/Total Platelets | C161353 | Large Platelets/Total Platelets;Platelet Large Cell Ratio;PLCR | A relative measurement (ratio or percentage) of large platelets to total platelets in a biological specimen. | Large Platelets to Total Platelets Ratio Measurement | ||
Large Unstained Cells | C74659 | Large Unstained Cells | A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen. | Large Unstained Cell Count | ||
Large Unstained Cells/Leukocytes | C79467 | Large Unstained Cells/Leukocytes | A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen. | Large Unstained Cells to Leukocytes Ratio Measurement | ||
LDH Isoenzyme 1 | C74887 | LDH Isoenzyme 1 | A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 1 Measurement | ||
LDH Isoenzyme 1/LDH | C79451 | LDH Isoenzyme 1/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 1 to LDH Ratio Measurement | ||
LDH Isoenzyme 2 | C74888 | LDH Isoenzyme 2 | A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 2 Measurement | ||
LDH Isoenzyme 2/LDH | C79452 | LDH Isoenzyme 2/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 2 to LDH Ratio Measurement | ||
LDH Isoenzyme 3 | C74889 | LDH Isoenzyme 3 | A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 3 Measurement | ||
LDH Isoenzyme 3/LDH | C79453 | LDH Isoenzyme 3/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 3 to LDH Ratio Measurement | ||
LDH Isoenzyme 4 | C74890 | LDH Isoenzyme 4 | A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 4 Measurement | ||
LDH Isoenzyme 4/LDH | C79454 | LDH Isoenzyme 4/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 4 to LDH Ratio Measurement | ||
LDH Isoenzyme 5 | C74891 | LDH Isoenzyme 5 | A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 5 Measurement | ||
LDH Isoenzyme 5/LDH | C79455 | LDH Isoenzyme 5/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 5 to LDH Ratio Measurement | ||
LDL Apolipoprotein B | C189508 | LDL Apolipoprotein B | A measurement of the apolipoprotein B in the low density lipoprotein fraction of a biological specimen. | LDL Fraction Apoliprotein B Measurement | ||
LDL Cholesterol | C105588 | LDL Cholesterol | A measurement of the low density lipoprotein cholesterol in a biological specimen. | Low Density Lipoprotein Cholesterol Measurement | ||
LDL Cholesterol/HDL Cholesterol | C121182 | LDL Cholesterol/HDL Cholesterol | A relative measurement (ratio) of the low density lipoprotein cholesterol to high density lipoprotein cholesterol in a biological specimen. | LDL Cholesterol to HDL Cholesterol Ratio Measurement | ||
LDL Particle Size | C103412 | LDL Particle Size | A measurement of the average particle size of low-density lipoprotein in a biological specimen. | LDL Particle Size Measurement | ||
LDL Particles | C120636 | LDL Particles | A measurement of the concentration of the total LDL particles in a biological specimen. | LDL Particles Measurement | ||
LDL Subtype Pattern | C120637 | LDL Subtype Pattern | A description of the low density lipoprotein particle pattern (an interpretation of the amounts of LDL particles based on size and density) in a biological specimen. | LDL Subtype Pattern | ||
LDL Triglyceride | C189506 | LDL Triglyceride | A measurement of the low density lipoprotein triglyceride in a biological specimen. | LDL Triglyceride Measurement | ||
Lead | C147382 | Lead;Pb | A measurement of the lead in a biological specimen. | Lead Measurement | ||
Lecithin/Sphingomyelin | C147381 | Lecithin/Sphingomyelin;LS Ratio | A relative measurement (ratio) of the lecithin to sphingomyelin in a biological specimen. | Lecithin to Sphingomyelin Ratio Measurement | ||
Lectin-Like Oxidized LDL Receptor-1 | C198285 | Lectin-Like Oxidized LDL Receptor-1;LOX-1 | A measurement of the lectin-like oxidized LDL Receptor-1 in a biological specimen. | Lectin-Like Oxidized LDL Receptor-1 Measurement | ||
Left Shift Neutrophils | C116202 | Left Shift Neutrophils | An observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen. | Left Shift Neutrophil Measurement | ||
Leptin | C74866 | Leptin | A measurement of the leptin hormone in a biological specimen. | Leptin Measurement | ||
Leptocytes | C174293 | Leptocytes | A measurement of the leptocytes in a biological specimen. | Leptocyte Measurement | ||
Leucine Aminopeptidase | C122132 | Cytosol Aminopeptidase;LAP3;Leucine Aminopeptidase;Leucine Aminopeptidase 3;Leucyl Aminopeptidase | A measurement of the total leucine aminopeptidase present in a biological specimen. | Leucine Aminopeptidase Measurement | ||
Leucine Crystals | C74680 | Leucine Crystals | A measurement of the leucine crystals present in a biological specimen. | Leucine Crystal Measurement | ||
Leucine Rich Alpha-2-Glycoprotein 1 | C165973 | HMFT1766;Leucine Rich Alpha-2-Glycoprotein 1 | A measurement of the leucine rich alpha-2-glycoprotein 1 in a biological specimen. | Leucine Rich Alpha-2-Glycoprotein 1 Measurement | ||
Leucine | C122133 | Leucine | A measurement of the leucine in a biological specimen. | Leucine Measurement | ||
Leukemia Inhibitory Factor | C130163 | Leukemia Inhibitory Factor | A measurement of leukemia inhibitory factor in a biological specimen. | Leukemia Inhibitory Factor Measurement | ||
Leukemic Blasts | C74630 | Leukemic Blasts | A measurement of the leukemic blasts (lymphoblasts and/or myeloblasts that remain in an immature state even when outside the bone marrow) in a biological specimen. | Leukemic Blast Count | ||
Leukemic Blasts/Lymphocytes | C74641 | Leukemic Blasts/Lymphocytes | A relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts and/or myeloblasts) to mature lymphocytes in a biological specimen. | Leukemic Blast to Lymphocyte Ratio Measurement | ||
Leukemic Cells | C116195 | Leukemic Cells;Residual Leukemic Cells | A measurement of the leukemic cells in a biological specimen. | Leukemic Cells Measurement | ||
Leukocyte Cell Clumps | C92246 | Leukocyte Cell Clumps;WBC Clumps;White Blood Cell Clumps | A measurement of white blood cell clumps in a biological specimen. | Leukocyte Cell Clumps Measurement | ||
Leukocyte Cell Differential | C98493 | Leukocyte Cell Differential;Leukocyte Cell Fraction;Leukocyte Diff | An overall assessment of the leukocyte subtype distribution in a biological specimen. | Differential Leukocyte Count | ||
Leukocyte Cell Morphology | C92297 | Leukocyte Cell Morphology;WBC Morphology;White Blood Cell Morphology | An examination or assessment of the form and structure of white blood cells. | Leukocyte Cell Morphology | ||
Leukocyte Esterase | C64856 | Leukocyte Esterase | A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen. | Leukocyte Esterase Measurement | ||
Leukocytes | C51948 | Leukocytes;White Blood Cells | A measurement of the leukocytes in a biological specimen. | Leukocyte Count | ||
Leukocytes/Total Cells | C135451 | Leukocytes/Total Cells;WBC/Total Cells | A relative measurement (ratio or percentage) of the leukocytes to total cells in a biological specimen. | Leukocytes to Total Cells Ratio Measurement | ||
Leukotriene B4 | C103413 | Leukotriene B4 | A measurement of the leukotriene B4 in a biological specimen. | Leukotriene B4 Measurement | ||
Leukotriene C4 Synthase | C189516 | Leukotriene C4 Synthase | A measurement of the leukotriene C4 synthase in a biological specimen. | Leukotriene C4 Synthase Measurement | ||
Leukotriene D4 | C103414 | Leukotriene D4 | A measurement of the leukotriene D4 in a biological specimen. | Leukotriene D4 Measurement | ||
Leukotriene E4 | C103415 | Leukotriene E4 | A measurement of the leukotriene E4 in a biological specimen. | Leukotriene E4 Measurement | ||
Leuks Corrected for Nucl Erythrocytes | C147383 | Leukocytes Corrected for Nucleated Erythrocytes;Leuks Corrected for Nucl Erythrocytes | A measurement of the leukocytes corrected for nucleated erythrocytes in a biological specimen. | Leukocytes Corrected for Nucleated Erythrocytes Count | ||
Levetiracetam | C147386 | Levetiracetam | A measurement of the levetiracetam in a biological specimen. | Levetiracetam Measurement | ||
Levorphanol | C184572 | Levorphanol | A measurement of the levorphanol in a biological specimen. | Levorphanol Measurement | ||
Lipase | C117748 | Lipase;Total Lipase;Triacylglycerol Lipase | A measurement of the total triacylglycerol lipase in a biological specimen. | Lipase Measurement | ||
Lipase, Gastric | C117840 | Gastric Triacylglycerol Lipase;Lipase, Gastric;LIPF | A measurement of the gastric triacylglycerol lipase in a biological specimen. | Gastric Lipase Measurement | ||
Lipase, Hepatic | C187808 | Hepatic Triacylglycerol Lipase;Lipase, Hepatic;LIPH | A measurement of the hepatic triacylglycerol lipase in a biological specimen. | Hepatic Triacylglycerol Lipase Measurement | ||
Lipase, Lysosomal Acid | C117842 | Acid Cholesteryl Ester Hydrolase;LAL;LIPA;Lipase, Lysosomal Acid;Lysosomal Lipase | A measurement of the lysosomal acid lipase in a biological specimen. | Lysosomal Acid Lipase Measurement | ||
Lipase, Pancreatic | C117841 | Lipase, Pancreatic;Pancreatic Triacylglycerol Lipase;PNLIP | A measurement of the pancreatic triacylglycerol lipase in a biological specimen. | Pancreatic Lipase Measurement | ||
Lipemic Index | C111242 | Lipemia;Lipemic Index | A measurement of the abnormally high concentration of lipid in a biological specimen. | Lipemic Index | ||
Lipid | C74949 | Lipid;Total Lipid | A measurement of the total lipids (cholesterol, lipoproteins, and triglycerides) in a biological specimen. | Lipid Measurement | ||
Lipoarabinomannan | C125947 | Lipoarabinomannan | A measurement of the lipoarabinomannan in a biological specimen. | Lipoarabinomannan Measurement | ||
Lipocalin-2 | C106539 | Lipocalin-2;Neutrophil Gelatinase-Associated Lipocalin;NGAL;Oncogene 24p3 | A measurement of lipocalin-2 in a biological specimen. | Lipocalin-2 Measurement | ||
Lipocalin-2/Creatinine | C106540 | Lipocalin-2/Creatinine;Neutrophil Gelatinase-Associated Lipocalin/Creatinine;NGAL/Creatinine | A relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample. | Lipocalin-2 to Creatinine Ratio Measurement | ||
Lipoprotein Associated Phospholipase A2 | C120638 | Lipoprotein Associated Phospholipase A2 | A measurement of the lipoprotein associated phospholipase A2 in a biological specimen. | Lipoprotein Associated Phospholipase A2 Measurement | ||
Lipoprotein Lipase | C174291 | Lipoprotein Lipase | A measurement of the lipoprotein lipase in a biological specimen. | Lipoprotein Lipase Measurement | ||
Lipoprotein-a | C82022 | Lipoprotein-a | A measurement of the lipoprotein-a in a biological specimen. | Lipoprotein a Measurement | ||
Liquefaction Time | C142284 | Liquefaction Time | A measurement of the time it takes for a gelatinous or semi-solid substance to change to a liquid. | Liquefaction Time Measurement | ||
Lithium | C189505 | Lithium | A measurement of the lithium in a biological specimen. | Lithium Measurement | ||
Lithocholate Compounds | C176240 | Lithocholate Compounds;Lithocholic Acid Compounds | A measurement of the lithocholic acid, glycolithocholic acid, and taurolithocholic acid in a biological specimen. | Lithocholate Compounds Measurement | ||
Lithocholate | C176307 | Lithocholate;Lithocholic Acid | A measurement of the lithocholate in a biological specimen. | Lithocholate Measurement | ||
Liver Fibrosis Score | C147385 | Liver Fibrosis Score | A scoring system that evaluates liver pathology through the assessment of multiple blood test parameters, taking into account additional demographic factors such as the age and/or gender of the subject. | Liver Fibrosis Score | ||
Liver Kidney Microsomal Type 1 Antibody | C96683 | Liver Kidney Microsomal Type 1 Antibody;LKM-1 | A measurement of the liver kidney microsomal type 1 antibody in a biological specimen. | Liver Kidney Microsomal Type 1 Antibody Measurement | ||
Liver Kidney Microsomal Type 1 IgA Ab | C100456 | Liver Kidney Microsomal Type 1 IgA Ab | A measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgA Antibody Measurement | ||
Liver Kidney Microsomal Type 1 IgG Ab | C100454 | Liver Kidney Microsomal Type 1 IgG Ab | A measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgG Antibody Measurement | ||
Liver Kidney Microsomal Type 1 IgM Ab | C100455 | Liver Kidney Microsomal Type 1 IgM Ab | A measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgM Antibody Measurement | ||
Liver Specific Alkaline Phosphatase | C119267 | Liver Specific Alkaline Phosphatase | A measurement of the liver specific alkaline phosphatase isoform in a biological specimen. | Liver Specific Alkaline Phosphatase Measurement | ||
Loprazolam | C184621 | Loprazolam | A measurement of the loprazolam in a biological specimen. | Loprazolam Measurement | ||
Lorazepam | C75374 | Lorazepam | A measurement of the lorazepam present in a biological specimen. | Lorazepam Measurement | ||
Lormetazepam | C184622 | Lormetazepam | A measurement of the lormetazepam in a biological specimen. | Lormetazepam Measurement | ||
Low Absorption Retic/Reticulocytes | C116191 | Low Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen. | Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
Low Absorption Reticulocytes | C116190 | Low Absorption Reticulocytes | A measurement of the low absorption reticulocytes in a biological specimen. | Low Absorption Reticulocyte Measurement | ||
Loxapine | C177977 | Loxapine | A measurement of the loxapine in a biological specimen. | Loxapine Measurement | ||
Lupus Anticoagulant Sensitive APTT | C102277 | APTT-LA;Lupus Anticoagulant Sensitive APTT | A measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen. | Lupus Anticoagulant Sensitive APTT Measurement | ||
Lurasidone | C177963 | Lurasidone | A measurement of the lurasidone in a biological specimen. | Lurasidone Measurement | ||
Luteinizing Hormone | C74790 | Luteinizing Hormone;Lutropin | A measurement of the luteinizing hormone in a biological specimen. | Luteinizing Hormone Measurement | ||
Lymphoblasts | C102278 | Lymphoblasts;Lymphoid Blasts | A measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen. | Lymphoblast Count | ||
Lymphoblasts/Leukocytes | C105444 | Lymphoblasts/Leukocytes | A relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen. | Lymphoblast to Leukocyte Ratio Measurement | ||
Lymphoblasts/Lymphocytes | C189503 | Lymphoblasts/Lymphocytes | A relative measurement (ratio or percentage) of the lymphoblasts to lymphocytes in a biological specimen. | Lymphoblast to Lymphocyte Ratio Measurement | ||
Lymphocyte Antigen 6E | C163463 | Lymphocyte Antigen 6 Family Member E;Lymphocyte Antigen 6E | A measurement of the lymphocyte antigen 6E in a biological specimen. | Lymphocyte Antigen 6E Measurement | ||
Lymphocytes Activated | C119289 | Lymphocytes Activated | A measurement of the total activated lymphocytes in a biological specimen. | Activated Lymphocytes Measurement | ||
Lymphocytes Atypical | C64818 | Lymphocytes Atypical;Lymphocytes, Variant;Reactive Lymphocytes | A measurement of the atypical lymphocytes in a biological specimen. | Atypical Lymphocyte Count | ||
Lymphocytes Atypical/Leukocytes | C64819 | Lymphocytes Atypical/Leukocytes;Lymphocytes, Variant/Leukocytes;Reactive Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen. | Atypical Lymphocyte to Leukocyte Ratio Measurement | ||
Lymphocytes | C51949 | Lymphocytes | A measurement of the lymphocytes in a biological specimen. | Lymphocyte Count | ||
Lymphocytes, Clefted | C147387 | Lymphocytes, Clefted | A measurement of the clefted lymphocytes in a biological specimen. | Clefted Lymphocytes Count | ||
Lymphocytes, Clefted/Leukocytes | C147388 | Lymphocytes, Clefted/Leukocytes | A relative measurement (ratio or percentage) of the clefted lymphocytes to total leukocytes in a biological specimen. | Clefted Lymphocytes to Leukocytes Ratio Measurement | ||
Lymphocytes/Leukocytes | C64820 | Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. | Lymphocyte to Leukocyte Ratio | ||
Lymphocytes/Neutrophils | C186079 | Lymphocytes/Neutrophils | A relative measurement (ratio) of lymphocytes to neutrophils in a biological specimen. | Lymphocyte to Neutrophil Ratio Measurement | ||
Lymphocytes/Non-Squam Epi Cells | C135430 | Lymphocytes/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the lymphocytes to non-squamous epithelial cells in a biological specimen. | Lymphocytes to Non-Squamous Epithelial Cells Ratio Measurement | ||
Lymphocytes/Total Cells | C98751 | Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). | Lymphocyte to Total Cell Ratio Measurement | ||
Lymphoid Cells | C139064 | Lymphoid Cells | A measurement of the total lymphoid lineage cells in a biological specimen. | Lymphoid Cell Count | ||
Lymphoma Cells | C74613 | Lymphoma Cells | A measurement of the malignant lymphocytes in a biological specimen. | Lymphoma Cell Count | ||
Lymphoma Cells/Leukocytes | C147389 | Lymphoma Cells/Leukocytes | A relative measurement (ratio or percentage) of the malignant lymphocytes to all leukocytes in a biological specimen. | Lymphoma Cells to Leukocytes Ratio Measurement | ||
Lymphoma Cells/Lymphocytes | C74910 | Lymphoma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen. | Lymphoma Cell to Lymphocyte Ratio Measurement | ||
Lymphoma Cells/Total Cells | C186078 | Lymphoma Cells/Total Cells | A relative measurement (ratio or percentage) of the lymphoma cells to total cells in a biological specimen. | Lymphoma Cell to Total Cell Ratio Measurement | ||
Lymphotactin | C81955 | Chemokine Ligand 1;Lymphotactin | A measurement of the lymphotactin in a biological specimen. | Lymphotactin Measurement | ||
Lymphotoxin Alpha | C132375 | Lymphotoxin Alpha;TNF-beta;Tumor Necrosis Factor Beta | A measurement of the lymphotoxin alpha in a biological specimen. | Lymphotoxin Alpha Measurement | ||
Lysergic Acid Diethylamide | C75354 | Acid;Lysergate Diethylamide;Lysergic Acid Diethylamide | A measurement of the lysergic acid diethylamine (LSD) in a biological specimen. | Lysergide Measurement | ||
Lysine | C122134 | Lysine | A measurement of the lysine in a biological specimen. | Lysine Measurement | ||
Lysosomal Associated Membrane Protein 2 | C191288 | CD107b;Lysosomal Associated Membrane Protein 2;Lysosomal Membrane Associated Protein 2;Lysosome-Associated Membrane Protein 2 | A measurement of the lysosomal associated membrane protein 2 present in a biological specimen. | Lysosome-Associated Membrane Protein 2 Measurement | ||
Lysozyme | C120640 | Lysozyme | A measurement of lysozyme in a biological specimen. | Lysozyme Measurement | ||
MAB-CHMINACA | C184550 | MAB-CHMINACA | A measurement of the synthetic cannabinoid MAB-CHMINACA in a biological specimen. | MAB-CHMINACA Measurement | ||
Macroamylase | C111243 | Macroamylase | A measurement of macroamylase in a biological specimen. | Macroamylase Measurement | ||
Macrocytes | C64821 | Macrocytes | A measurement of the macrocytes in a biological specimen. | Macrocyte Count | ||
Macrophage Colony Stimulating Factor | C80191 | Macrophage Colony Stimulating Factor | A measurement of the macrophage colony stimulating factor in a biological specimen. | Macrophage Colony Stimulating Factor Measurement | ||
Macrophage Inflammatory Protein 1 Alpha | C82023 | Chemokine Ligand 3;Macrophage Inflammatory Protein 1 Alpha | A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen. | Macrophage Inflammatory Protein 1 Alpha Measurement | ||
Macrophage Inflammatory Protein 1 Beta | C82024 | Chemokine Ligand 4;Macrophage Inflammatory Protein 1 Beta | A measurement of the macrophage inflammatory protein 1 beta in a biological specimen. | Macrophage Inflammatory Protein 1 Beta Measurement | ||
Macrophage Inflammatory Protein 1 Gamma | C130164 | Macrophage Inflammatory Protein 1 Gamma | A measurement of the macrophage inflammatory protein 1 gamma in a biological specimen. | Macrophage Inflammatory Protein 1 Gamma Measurement | ||
Macrophage Inflammatory Protein 1 | C163464 | Macrophage Inflammatory Protein 1 | A measurement of total macrophage inflammatory protein 1 in a biological specimen. | Macrophage Inflammatory Protein 1 Measurement | ||
Macrophage Migration Inhibitory Factor | C163466 | Macrophage Migration Inhibitory Factor;MIF | A measurement of the macrophage migration inhibitory factor in a biological specimen. | Macrophage Migration Inhibitory Factor Measurement | ||
Macrophage-Derived Chemokine | C81956 | C-C Motif Chemokine Ligand 22;CCL22;Chemokine (C-C Motif) Ligand 22;Chemokine Ligand 22;Macrophage-Derived Chemokine | A measurement of the macrophage-derived chemokine in a biological specimen. | Macrophage-Derived Chemokine Measurement | ||
Macrophages | C74798 | Macrophages | A measurement of the macrophages in a biological specimen. | Macrophage Count | ||
Macrophages/Leukocytes | C123460 | Macrophages/Leukocytes | A relative measurement (ratio or percentage) of the macrophages to leukocytes in a biological specimen. | Macrophage to Leukocyte Ratio | ||
Macrophages/Non-Squam Epi Cells | C135431 | Macrophages/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the macrophages to non-squamous epithelial cells in a biological specimen. | Macrophages to Non-Squamous Epithelial Cells Ratio Measurement | ||
Macrophages/Total Cells | C111244 | Macrophages/Total Cells | A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. | Macrophage to Total Cell Ratio Measurement | ||
Macroscopic Blood | C147390 | Macroscopic Blood;Visible Blood | A measurement of the blood in body products such as a urine or stool sample, and visibly detectable on gross examination. | Macroscopic Blood Measurement | ||
Magnesium | C64840 | Magnesium | A measurement of the magnesium in a biological specimen. | Magnesium Measurement | ||
Magnesium, Ionized | C175951 | Magnesium, Ionized | A measurement of the ionized magnesium in a biological specimen. | Ionized Magnesium Measurement | ||
Magnesium/Creatinine | C79456 | Magnesium/Creatinine | A relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen. | Magnesium to Creatinine Ratio Measurement | ||
Malignant Cells, NOS | C74660 | Malignant Cells, NOS | A measurement of the malignant cells of all types in a biological specimen. | Malignant Cell Count | ||
Malignant Cells, NOS/Blood Cells | C74643 | Malignant Cells, NOS/Blood Cells | A relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen. | Malignant Cell to Blood Cell Ratio Measurement | ||
Malondialdehyde | C187811 | Malondialdehyde;MDA | A measurement of the malondialdehyde in a biological specimen. | Malondialdehyde Measurement | ||
Mannitol | C154742 | Mannitol | A measurement of the mannitol in a biological specimen. | Mannitol Measurement | ||
Mast Cells | C111246 | Mast Cells;Mastocytes | A measurement of the mast cells in a biological specimen. | Mast Cell Count | ||
Mast Cells/Leukocytes | C187812 | Mast Cells/Leukocytes | A relative measurement (ratio or percentage) of mast cells to total leukocytes in a biological specimen. | Mast Cells to Leukocytes Ratio Measurement | ||
Mast Cells/Total Cells | C111247 | Mast Cells/Total Cells | A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. | Mast Cell to Total Cell Ratio Measurement | ||
Matrix Metalloproteinase 1 | C80192 | Interstitial Collagenase;Matrix Metalloproteinase 1 | A measurement of the matrix metalloproteinase 1 in a biological specimen. | Matrix Metalloproteinase 1 Measurement | ||
Matrix Metalloproteinase 2 | C80193 | Gelatinase A;Matrix Metalloproteinase 2 | A measurement of the matrix metalloproteinase 2 in a biological specimen. | Matrix Metalloproteinase 2 Measurement | ||
Matrix Metalloproteinase 3 | C80194 | Matrix Metalloproteinase 3;Stromelysin 1 | A measurement of the matrix metalloproteinase 3 in a biological specimen. | Matrix Metalloproteinase 3 Measurement | ||
Matrix Metalloproteinase 7 | C80195 | Matrilysin;Matrix Metalloproteinase 7 | A measurement of the matrix metalloproteinase 7 in a biological specimen. | Matrix Metalloproteinase 7 Measurement | ||
Matrix Metalloproteinase 8 | C80196 | Matrix Metalloproteinase 8;Neutrophil Collagenase | A measurement of the matrix metalloproteinase 8 in a biological specimen. | Matrix Metalloproteinase 8 Measurement | ||
Matrix Metalloproteinase 9 | C80197 | Gelatinase B;Matrix Metalloproteinase 9 | A measurement of the matrix metalloproteinase 9 in a biological specimen. | Matrix Metalloproteinase 9 Measurement | ||
Mature Plasma Cells | C74661 | Mature Plasma Cells;Plasmacytes;Plasmocytes | A measurement of the mature plasma cells (plasmacytes) in a biological specimen. | Mature Plasma Cell Count | ||
Mature Plasma Cells/Lymphocytes | C74911 | Mature Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen. | Mature Plasma Cell to Lymphocyte Ratio Measurement | ||
Mature Plasma Cells/Total Cells | C98869 | Mature Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). | Mature Plasma Cell to Total Cell Ratio Measurement | ||
Maturing Erythroid Cells/Total Cells | C127628 | Erythroid Precursors/Total Cells;Maturing Erythroid Cells/Total Cells;Maturing Erythroid/Total Cells;Total Erythroid Precursors/Total Cells | A relative measurement (ratio or percentage) of the maturing erythroid cells to total cells in a biological specimen. | Maturing Erythroid Cell to Total Cell Ratio Measurement | ||
Maturing Myeloid Cells/Total Cells | C127629 | Maturing Myeloid/Total Cells | A relative measurement (ratio or percentage) of the maturing myeloid cells to total cells in a biological specimen. | Maturing Myeloid Cell to Total Cell Ratio Measurement | ||
May-Hegglin Anomaly | C74614 | May-Hegglin Anomaly | A measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes. | May-Hegglin Anomaly Measurement | ||
Mazindol | C184623 | Mazindol | A measurement of the mazindol in a biological specimen. | Mazindol Measurement | ||
MCV Reticulocytes | C114215 | MCV Reticulocytes;MCVr;Mean Corpuscular Volume Reticulocytes | A measurement of the mean volume of reticulocytes in a biological specimen. | Reticulocyte Mean Corpuscular Volume | ||
Mean Platelet Component | C96686 | Mean Platelet Component | A measurement of the mean platelet component (platelet activity) in a blood specimen. | Mean Platelet Component Measurement | ||
Mean Platelet Dry Mass | C114214 | Mean Platelet Dry Mass | A measurement of the mean platelet dry mass in a biological specimen. | Mean Platelet Dry Mass | ||
Mean Platelet Volume | C74730 | Mean Platelet Volume | A measurement of the average size of the platelets present in a blood sample. | Mean Platelet Volume Measurement | ||
Meconium | C147391 | Meconium | A measurement of the meconium in a biological specimen. | Meconium Measurement | ||
Medazepam | C139079 | Medazepam | A measurement of the medazepam present in a biological specimen. | Medazepam Measurement | ||
Medium Absorption Retic/Reticulocytes | C116193 | Medium Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen. | Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
Medium Absorption Reticulocytes | C116192 | Medium Absorption Reticulocytes | A measurement of the medium absorption reticulocytes in a biological specimen. | Medium Absorption Reticulocyte Measurement | ||
Mefenorex | C184624 | Mefenorex | A measurement of the mefenorex in a biological specimen. | Mefenorex Measurement | ||
Megakaryoblasts | C98752 | Megakaryoblasts | A measurement of the megakaryoblasts in a biological specimen. | Megakaryoblast Cell Count | ||
Megakaryoblasts/Leukocytes | C187813 | Megakaryoblasts/Leukocytes | A relative measurement (ratio or percentage) of megakaryoblasts to total leukocytes in a biological specimen. | Megakaryoblasts to Leukocytes Ratio Measurement | ||
Megakaryoblasts/Total Cells | C98753 | Megakaryoblasts/Total Cells | A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryoblast to Total Cell Ratio Measurement | ||
Megakaryocyte and Megakaryoblast Morph | C135432 | Megakaryocyte and Megakaryoblast Morph;Megakaryocyte and Megakaryoblast Morphology | An examination or assessment of the form and structure of megakaryoblasts and megakaryocytes. | Megakaryocyte and Megakaryoblast Morphology Assessment | ||
Megakaryocytes | C96688 | Megakaryocytes | A measurement of the megakaryocytes per unit of a biological specimen. | Megakaryocyte Count | ||
Megakaryocytes/Leukocytes | C154722 | Megakaryocytes/Leukocytes | A relative measurement (ratio or percentage) of the megakaryocytes to leukocytes in a biological specimen. | Megakaryocytes to Leukocytes Ratio Measurement | ||
Megakaryocytes/Total Cells | C98867 | Megakaryocytes/Total Cells | A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryocyte to Total Cell Ratio Measurement | ||
Melatonin | C74867 | Melatonin | A measurement of the melatonin hormone in a biological specimen. | Melatonin Measurement | ||
Meningeal Cells | C111250 | Meningeal Cells | A measurement of the mengingeal cells in a biological specimen. | Meningeal Cell Count | ||
Meningeal Cells/Total Cells | C111251 | Meningeal Cells/Total Cells | A relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen. | Meningeal Cell to Total Cell Ratio Measurement | ||
Meperidine | C147392 | Meperidine | A measurement of the meperidine in a biological specimen. | Meperidine Measurement | ||
Mephedrone | C184551 | Mephedrone | A measurement of the mephedrone in a biological specimen. | Mephedrone Measurement | ||
Meprobamate | C184625 | Meprobamate | A measurement of the meprobamate in a biological specimen. | Meprobamate Measurement | ||
Mercury | C147393 | Hg;Mercury | A measurement of the mercury in a biological specimen. | Mercury Measurement | ||
Mescaline | C75355 | 3,4,5-trimethoxyphenethylamine;Mescaline | A measurement of the mescaline in a biological specimen. | Mescaline Measurement | ||
Mesoridazine | C177979 | Mesoridazine | A measurement of the mesoridazine in a biological specimen. | Mesoridazine Measurement | ||
Mesothelial Cells | C147398 | Mesothelial Cells | A measurement of the mesothelial cells in a biological specimen. | Mesothelial Cells Count | ||
Mesothelial Cells/Leukocytes | C147399 | Mesothelial Cells/Leukocytes | A relative measurement (ratio or percentage) of the mesothelial cells to total leukocytes in a biological specimen. | Mesothelial Cells to Leukocytes Ratio Measurement | ||
Mesterolone | C184588 | Mesterelone;Mesterolone | A measurement of the mesterolone in a biological specimen. | Mesterolone Measurement | ||
Metamyelocytes | C74615 | Metamyelocytes | A measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen. | Metamyelocyte Count | ||
Metamyelocytes/Leukocytes | C74645 | Metamyelocytes/Leukocytes | A relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen. | Metamyelocyte to Leukocyte Ratio Measurement | ||
Metamyelocytes/Total Cells | C98754 | Metamyelocytes/Total Cells | A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). | Metamyelocyte to Total Cell Ratio Measurement | ||
Metanephrine Excretion Rate | C163468 | Metanephrine Excretion Rate | A measurement of the amount of metanephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Metanephrine Excretion Rate | ||
Metanephrine | C116198 | Metadrenaline;Metanephrine | A measurement of the metanephrine in a biological specimen. | Metanephrine Measurement | ||
Metanephrine+Normetanephrine Excr Rate | C177991 | Metanephrine+Normetanephrine Excr Rate;Metanephrine+Normetanephrine Excretion Rate | A measurement of the amount of metanephrine and normetanephrine being excreted in a biological specimen over a defined amount of time (e.g., one hour). | Metanephrine and Normetanephrine Excretion Rate | ||
Metanephrine+Normetanephrine | C177990 | Metanephrine+Normetanephrine | A measurement of the metanephrine and normetanephrine in a biological specimen. | Metanephrine and Normetanephrine Measurement | ||
Metanephrine, Free | C147400 | Metanephrine, Free | A measurement of the free metanephrine in a biological specimen. | Free Metanephrine Measurement | ||
Metarubricyte | C128972 | Acidophilic Erythroblast;Metarubricyte;Orthochromatophilic Normoblast;Orthochromic Erythroblast;Orthochromic Normoblast | A measurement of the metarubricytes in a biological specimen. | Metarubricyte Count | ||
Metarubricyte/Total Cells | C128971 | Metarubricyte/Total Cells | A relative measurement (ratio or percentage) of the metarubricytes to total cells in a biological specimen. | Metarubricyte to Total Cell Ratio Measurement | ||
Metarubricytes/Leukocytes | C165974 | Metarubricytes/Leukocytes | A relative measurement (ratio or percentage) of the metarubricytes to leukocytes in a biological specimen. | Metarubricyte to Leukocyte Ratio Measurement | ||
Methadone | C74881 | Methadone | A measurement of the methadone present in a biological specimen. | Methadone Measurement | ||
Methamphetamine | C75348 | Methamphetamine | A measurement of the methamphetamine drug present in a biological specimen. | Methamphetamine Measurement | ||
Methane | C186080 | CH4;Methane | A measurement of the methane in a biological specimen. | Methane Measurement | ||
Methanol | C147394 | Methanol | A measurement of the methanol in a biological specimen. | Methanol Measurement | ||
Methaqualone | C74882 | Methaqualone | A measurement of the methaqualone present in a biological specimen. | Methaqualone Measurement | ||
Methasterone | C184589 | Methasterone | A measurement of the methasterone in a biological specimen. | Methasterone Measurement | ||
Methcathinone | C184552 | Ephedrone;Methcathinone | A measurement of the methcathinone in a biological specimen. | Methcathinone Measurement | ||
Methemoglobin | C96689 | Methemoglobin | A measurement of the methemoglobin in a biological specimen. | Methemoglobin Measurement | ||
Methemoglobin/Total Hemoglobin | C147367 | FMET HB;Fractionated Methemoglobin;Methemoglobin/Total Hemoglobin | A relative measurement (ratio or percentage) of the amount of methemoglobin compared to total hemoglobin in a biological specimen. | Methemoglobin to Total Hemoglobin Ratio Measurement | ||
Methionine | C122238 | Methionine | A measurement of the methionine in a biological specimen. | Methionine Measurement | ||
Methohexital | C184626 | Methohexital | A measurement of the methohexital in a biological specimen. | Methohexital Measurement | ||
Methylmalonic Acid | C96690 | Methylmalonate;Methylmalonic Acid | A measurement of the methylmalonic acid in a biological specimen. | Methylmalonic Acid Measurement | ||
Methylphenidate | C170581 | Methylphenidate | A measurement of the methylphenidate in a biological specimen. | Methylphenidate Measurement | ||
Methylphenobarbital | C75366 | Mephobarbital;Methylphenobarbital | A measurement of the methylphenobarbital in a biological specimen. | Mephobarbital Measurement | ||
Methyltestosterone | C184590 | Methyltestosterone | A measurement of the methyltestosterone in a biological specimen. | Methyltestosterone Measurement | ||
Methyltransferase | C187814 | Methyltransferase | A measurement of the total methyltransferase in a biological specimen. | Methyltransferase Measurement | ||
Methyprylon | C184591 | Methyprylon | A measurement of the methyprylon in a biological specimen. | Methyprylon Measurement | ||
MHC Class I Chain Related Protein A | C172502 | MHC Class I Chain Related Protein A | A measurement of the MHC class I chain related protein A in a biological specimen. | MHC Class I Chain Related Protein A Measurement | ||
Microcytes | C64822 | Microcytes | A measurement of the microcytes in a biological specimen. | Microcyte Count | ||
Mid Cell Fraction | C116199 | Mid Cell Fraction;Mid Cells | A measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen. | Mid Cell Fraction Measurement | ||
Mid-Reg Pro-Atrial Natriuretic Peptide | C172523 | Mid-Reg Pro-Atrial Natriuretic Peptide;Mid-Regional Pro-Atrial Natriuretic Peptide;MR-proANP;MRproANP | A measurement of the mid-regional pro-atrial natriuretic peptide in a biological specimen. | Mid-Regional Pro-Atrial Natriuretic Peptide Measurement | ||
Midazolam | C139083 | Midazolam | A measurement of the midazolam present in a biological specimen. | Midazolam Measurement | ||
Milnacipran | C187815 | Milnacipran | A measurement of the milnacipran in a biological specimen. | Milnacipran Measurement | ||
Mitochondrial M2 Antibody | C147395 | Mitochondrial M2 Antibody | A measurement of the mitochondrial antibodies of M2 specificity in a biological specimen. | Mitochondrial M2 Antibody Measurement | ||
Mitochondrial M2 IgG Antibody | C163465 | Mitochondrial M2 IgG Antibody | A measurement of the mitochondrial IgG antibodies of M2 specificity in a biological specimen. | Mitochondrial M2 IgG Antibody Measurement | ||
Mixed Antigen IgE AB RAST Score | C165922 | Mixed Antigen IgE Antibody RAST Score | A classification of the amount of mixed antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mixed Antigen IgE Antibody RAST Score Measurement | ||
Mixed Antigen IgE Antibody | C130100 | Mixed Antigen IgE Antibody | A measurement of the mixed antigen IgE antibody in a biological specimen. | Mixed Antigen IgE Antibody Measurement | ||
Mixed Casts | C74771 | Mixed Casts | A measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen. | Mixed Cast Count | ||
Mixed Lymphocyte Reaction | C16790 | Mixed Leukocyte Reaction;Mixed Lymphocyte Reaction | A measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals. | Mixed Lymphocyte Reaction Test | ||
Modafinil | C184628 | Modafinil | A measurement of the modafinil in a biological specimen. | Modafinil Measurement | ||
Mold Mix Antigen IgA Antibody | C130111 | Mold Mix Antigen IgA Antibody | A measurement of the mold mix antigen IgA antibody in a biological specimen. | Mold Mix Antigen IgA Antibody Measurement | ||
Mold Mix Antigen IgE Antibody | C130109 | Mold Mix Antigen IgE Antibody | A measurement of the mold mix antigen IgE antibody in a biological specimen. | Mold Mix Antigen IgE Antibody Measurement | ||
Mold Mix Antigen IgG Antibody | C130110 | Mold Mix Antigen IgG Antibody | A measurement of the mold mix antigen IgG antibody in a biological specimen. | Mold Mix Antigen IgG Antibody Measurement | ||
Mold Mix IgE AB RAST Score | C165926 | Mold Mix IgE AB RAST Score | A classification of the amount of mold mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mold Mix IgE Antibody RAST Score Measurement | ||
Mold Mix IgG AB RAST Score | C165907 | Mold Mix IgG AB RAST Score | A classification of the amount of mold mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mold Mix IgG Antibody RAST Score Measurement | ||
Molindone | C177981 | Molindone | A measurement of the molindone in a biological specimen. | Molindone Measurement | ||
Monoblasts | C74631 | Monoblasts | A measurement of the monoblast cells in a biological specimen. | Monoblast Count | ||
Monoblasts/Leukocytes | C74646 | Monoblasts/Leukocytes | A relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen. | Monoblast to Leukocyte Ratio Measurement | ||
Monoblasts/Total Cells | C187677 | Monoblasts/Total Cells | A relative measurement (ratio or percentage) of the monoblasts to total cells in a biological specimen. | Monoblast to Total Cell Ratio Measurement | ||
Monoclonal Prot Immunoglobulin Isotype | C186081 | Immunoglobulin Immunofixation Interpretation;Monoclonal Prot Immunoglobulin Isotype;Monoclonal Protein Immunoglobulin Class;Monoclonal Protein Immunoglobulin Isotype | The identification of the monoclonal protein immunoglobulin isotype in a biological specimen. | Monoclonal Protein Immunoglobulin Isotype Determination | ||
Monoclonal Protein Excretion Rate | C163467 | M Protein Excretion Rate;M-Spike Protein Excretion Rate;Monoclonal Protein Excretion Rate;Monoclonal Protein Spike Excretion Rate;Myeloma Protein Excretion Rate | A measurement of the amount of Monoclonal Protein being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Monoclonal Protein Excretion Rate | ||
Monoclonal Protein Region | C158218 | Monoclonal Protein Band Region;Monoclonal Protein Region;Monoclonal Protein Spike Region | The identification of the protein zone (e.g., alpha-1 globulin, beta globulin, etc.) within which the monoclonal protein is observed. | Monoclonal Protein Spike Region Identification | ||
Monoclonal Protein | C92291 | Abnormal Gamma Protein Band;M Protein;M-Spike Paraprotein;M-Spike Protein;Monoclonal Immunoglobulin Protein;Monoclonal Protein;Monoclonal Protein Spike;Myeloma Protein;Paraprotein | A measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen. | Monoclonal Protein Measurement | ||
Monoclonal Protein/Total Protein | C147397 | M Protein/Total Protein;M-Spike Protein/Total Protein;Monoclonal Protein Spike/Total Protein;Monoclonal Protein/Total Protein;Myeloma Protein/Total Protein | A relative measurement (ratio or percentage) of the monoclonal protein to total protein in a biological specimen. | Monoclonal Protein to Total Protein Ratio Measurement | ||
Monocyte Chemotactic Protein 1 | C82025 | CCL2;Chemokine (C-C Motif) Ligand 2;Monocyte Chemotactic Protein 1 | A measurement of the monocyte chemotactic protein 1 in a biological specimen. | Monocyte Chemotactic Protein 1 Measurement | ||
Monocytes and Macrophages/Leukocytes | C147396 | Monocytes and Macrophages/Leukocytes | A relative measurement (ratio or percentage) of the monocytes and macrophages to total leukocytes in a biological specimen. | Monocytes and Macrophages to Leukocytes Ratio Measurement | ||
Monocytes | C64823 | Monocytes | A measurement of the monocytes in a biological specimen. | Monocyte Count | ||
Monocytes/Leukocytes | C64824 | Monocytes/Leukocytes | A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. | Monocyte to Leukocyte Ratio | ||
Monocytes/Macrocytes | C106544 | Monocytes/Macrocytes | A relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample. | Monocytes to Macrocytes Ratio Measurement | ||
Monocytes/Non-Squam Epi Cells | C135433 | Monocytes/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the monocytes to non-squamous epithelial cells in a biological specimen. | Monocytes to Non-Squamous Epithelial Cells Ratio Measurement | ||
Monocytes/Total Cells | C98872 | Monocytes/Total Cells | A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). | Monocytes to Total Cell Ratio Measurement | ||
Monocytoid Cells | C111276 | Monocytoid Cells | A measurement of the monocytoid cells in a biological specimen. | Monocytoid Cell Count | ||
Monocytoid Cells/Leukocytes | C120641 | Monocytoid Cells/Leukocytes | A relative measurement (ratio or percentage) of the monocytoid cells to leukocytes in a biological specimen. | Monocytoid Cells to Leukocytes Ratio Measurement | ||
Monocytoid Cells/Total Cells | C111277 | Monocytoid Cells/Total Cells | A relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen. | Monocytoid Cell to Total Cell Ratio Measurement | ||
Monomethylarginine | C181407 | Monomethylarginine;Tilarginine | A measurement of the monomethylarginine in a biological specimen. | Monomethylarginine Measurement | ||
Mononuclear Cells Atypical | C187790 | Mononuclear Cells Atypical | A measurement of the atypical mononuclear cells in a biological specimen. | Atypical Mononuclear Cell Count | ||
Mononuclear Cells Atypical/Leukocytes | C187791 | Mononuclear Cells Atypical/Leukocytes | A relative measurement (ratio or percentage) of the atypical mononuclear cells to leukocytes in a biological specimen. | Atypical Mononuclear Cells to Leukocytes Ratio Measurement | ||
Mononuclear Cells | C154757 | Mononuclear Cells;Mononucleated Cells | A measurement of the mononuclear cells in a biological specimen. | Mononuclear Cell Count | ||
Monosodium Urate Crystals | C74681 | Monosodium Urate Crystals;Sodium Urate Crystals | A measurement of the monosodium urate crystals present in a biological specimen. | Monosodium Urate Crystal Measurement | ||
Morphine | C74883 | Morphine | A measurement of the morphine present in a biological specimen. | Morphine Measurement | ||
Motile Sperm/Total Sperm | C147433 | Motile Sperm/Total Sperm | A relative measurement (ratio or percentage) of the motile sperm to total sperm in a biological specimen. | Motile Sperm to Total Sperm Ratio Measurement | ||
Mu Glutathione-S-Transferase | C79457 | Mu Glutathione-S-Transferase | A measurement of the mu form of glutathione S-transferase in a biological specimen. | Mu Glutathione-S-Transferase Measurement | ||
Mu Glutathione-S-Transferase/Creatinine | C79458 | Mu Glutathione-S-Transferase/Creatinine | A relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen. | Mu Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
Mucous Threads | C74721 | Mucous Threads | A measurement of the mucous threads present in a biological specimen. | Mucous Thread Measurement | ||
Murinoglobulin | C127630 | Murinoglobulin | A measurement of the murinoglobulin in a biological specimen. | Murinoglobulin Measurement | ||
Myelin Antibodies | C103418 | Myelin Antibodies | A measurement of the myelin antibodies in a biological specimen. | Myelin Antibodies Measurement | ||
Myelin Basic Protein | C122135 | Myelin Basic Protein | A measurement of the myelin basic protein in a biological specimen. | Myelin Basic Protein Measurement | ||
Myeloblasts | C74632 | Myeloblasts;Myeloid Blasts | A measurement of the myeloblast cells in a biological specimen. | Myeloblast Count | ||
Myeloblasts/Leukocytes | C64825 | Myeloblasts/Leukocytes | A relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen. | Myeloblast to Leukocyte Ratio | ||
Myeloblasts/Total Cells | C98761 | Myeloblasts/Total Cells | A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). | Myeloblast to Total Cell Ratio Measurement | ||
Myelocytes | C74662 | Myelocytes | A measurement of the myelocytes in a biological specimen. | Myelocyte Count | ||
Myelocytes/Leukocytes | C64826 | Myelocytes/Leukocytes | A relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen. | Myelocyte to Leukocyte Ratio | ||
Myelocytes/Total Cells | C98868 | Myelocytes/Total Cells | A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). | Myelocyte to Total Cell Ratio Measurement | ||
Myeloid Maturation Index | C135434 | Myeloid Maturation Index | A relative measurement (ratio) of the sum of myeloid maturation phase cells (pool) to the sum of myeloid proliferative phase cells (pool) in a biological specimen. | Myeloid Maturation Index | ||
Myeloid Maturation Pool | C135435 | Myeloid Maturation Pool | A measurement of the myeloid maturation phase cells (metamyelocytes, band neutrophils, and segmented neutrophils) in a biological specimen. | Myeloid Maturation Pool Count | ||
Myeloid Progenitor Cells | C130165 | Myeloid Progenitor Cells | A measurement of the myeloid progenitor cells in a biological specimen. | Myeloid Progenitor Cell Count | ||
Myeloid Progenitor Cells/Total Cells | C186084 | Myeloid Progenitor Cells/Total Cells | A relative measurement (ratio or percentage) of the myeloid progenitor cells to total cells in a biological specimen. | Myeloid Progenitor Cell to Total Cell Ratio Measurement | ||
Myeloid Proliferation Index | C135436 | Myeloid Proliferation Index | A relative measurement (ratio) of the sum of myeloid proliferative phase cells (pool) to the sum of myeloid maturation phase cells (pool) in a biological specimen. | Myeloid Proliferation Index | ||
Myeloid Proliferation Pool | C135437 | Myeloid Proliferation Pool | A measurement of the myeloid proliferative phase cells (myeloblasts, promyelocytes, and myelocytes) in a biological specimen. | Myeloid Proliferation Pool Count | ||
Myeloid/Erythroid Ratio | C92242 | Myeloid/Erythroid Ratio | A relative measurement of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen. | Myeloid to Erythroid Ratio Measurement | ||
Myeloperoxidase Antibody | C92280 | Myeloperoxidase Antibody | A measurement of the myeloperoxidase antibody in a biological specimen. | Myeloperoxidase Antibody Measurement | ||
Myeloperoxidase Index | C119290 | Myeloperoxidase Index | The mean peroxidase activity index or staining intensity of the neutrophil population relative to the archetype. | Neutrophil Myeloperoxidase Index | ||
Myeloperoxidase | C80198 | Myeloperoxidase | A measurement of the myeloperoxidase in a biological specimen. | Myeloperoxidase Measurement | ||
Myoglobin | C79436 | Myoglobin | A measurement of myoglobin in a biological specimen. | Myoglobin Measurement | ||
Myoglobin/Creatinine | C106546 | Myoglobin/Creatinine | A relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample. | Myoglobin to Creatinine Ratio Measurement | ||
Myosin Light Chain 3 | C106547 | Cardiac myosin light chain 1;Myosin light chain 1, slow-twitch muscle B/ventricular isoform;Myosin Light Chain 3 | A measurement of myosin light chain 3 in a biological specimen. | Myosin Light Chain 3 Measurement | ||
N,N-Dimethyltryptamine | C184536 | Dimethyltryptamine;DMT;N,N-Dimethyltryptamine | A measurement of the N,N-dimethyltryptamine in a biological specimen. | N,N-Dimethyltryptamine Measurement | ||
N-Acetyl Glucosamide | C79459 | N-Acetyl Glucosamide;N-Acetyl Glucosamine | A measurement of N-acetyl glucosamide (sugar derivative) in a biological specimen. | N-Acetyl Glucosamide Measurement | ||
N-Acetyl Glucosamide/Creatinine | C79460 | N-Acetyl Glucosamide/Creatinine | A relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen. | N-Acetyl Glucosamide to Creatinine Ratio Measurement | ||
N-acetyl-B-D-glucosaminidase/Creatinine | C163470 | N-acetyl-B-D-glucosaminidase/Creatinine | A relative measurement (ratio or percentage) of the N-acetyl-beta-D-glucosaminidase to creatinine in a biological specimen. | N-acetyl-Beta-D-glucosaminidase to Creatinine Ratio Measurement | ||
N-acetyl-beta-D-glucosaminidase | C103419 | Beta-N-acetyl-D-glucosaminidase;N-acetyl-beta-D-glucosaminidase | A measurement of the N-acetyl-beta-D-glucosaminidase (enzyme) in a biological specimen. | N-acetyl-beta-D-glucosaminidase Measurement | ||
N-Demethylase | C163471 | N-Demethylase | A measurement of the N-Demethylase in a biological specimen. | N-Demethylase Measurement | ||
N-Desmethylolanzapine | C177967 | Desmethylolanzapine;DMO;N-Desmethylolanzapine;Norolanzapine | A measurement of the N-desmethylolanzapine in a biological specimen. | N-Desmethylolanzapine Measurement | ||
N-Desmethyltramadol | C181403 | N-Desmethyltramadol;N-DSMT | A measurement of the N-desmethyltramadol in a biological specimen. | N-Desmethyltramadol Measurement | ||
N-methylhistamine | C147404 | N-methylhistamine | A measurement of the N-methylhistamine in a biological specimen. | N-methylhistamine Measurement | ||
N-telopeptide | C74743 | N-telopeptide | A measurement of the N-telopeptide in a biological specimen. | N-Telopeptide Measurement | ||
N-telopeptide/Creatinine | C120645 | N-telopeptide/Creatinine | A relative measurement (ratio or percentage) of the N-telopeptide to creatinine in a biological specimen. | N-telopeptide to Creatinine Ratio Measurement | ||
N-Terminal ProA-type Natriuretic Peptide | C139088 | N-terminal pro-Atrial Natriuretic Peptide;N-Terminal ProA-type Natriuretic Peptide;NT proANP II | A measurement of the N-terminal proA-type natriuretic peptide in a biological specimen. | N-Terminal ProA-type Natriuretic Peptide Measurement | ||
N-Terminal ProB-type Natriuretic Peptide | C96610 | N-terminal pro-Brain Natriuretic Peptide;N-Terminal ProB-type Natriuretic Peptide;NT proBNP II | A measurement of the N-terminal proB-type natriuretic peptide in a biological specimen. | N-Terminal ProB-type Natriuretic Peptide Measurement | ||
NAGASE Excretion Rate | C165975 | N-acetyl-beta-D-glucosaminidase Excretion Rate;NAGASE Excretion Rate | A measurement of the amount of N-acetyl-beta-D-glucosaminidase being excreted in a biological specimen over a defined amount of time (e.g. one hour). | N-acetyl-beta-D-glucosaminidase Excretion Rate | ||
Nalorphine | C184592 | Allorphine;Antorphine;N-allylnormorphine;Nalorphine | A measurement of the nalorphine in a biological specimen. | Nalorphine Measurement | ||
Nandrolone | C75377 | Nandrolone;Norandrostenolone;Nortestosterone | A measurement of the nandrolone in a biological specimen. | Nandrolone Measurement | ||
Naphyrone | C184553 | Naphyrone | A measurement of the naphyrone in a biological specimen. | Naphyrone Measurement | ||
Natural Killer Cell Function | C116203 | Natural Killer Cell Activity;Natural Killer Cell Function | A measurement of the natural killer cell function in a biological specimen. | Natural Killer Cell Activity Measurement | ||
Natural Killer Cells | C98762 | Natural Killer Cells | A measurement of the total natural killer cells in a biological specimen. | Natural Killer Cell Count | ||
Neoplastic Plasma Cells | C172494 | Monoclonal Plasma Cells;Monotypic Plasma Cells;Neoplastic Plasma Cells | A measurement of the neoplastic plasma cells in a biological specimen. | Neoplastic Plasma Cell Count | ||
Neopterin | C80199 | Neopterin | A measurement of the neopterin in a biological specimen. | Neopterin Measurement | ||
Nephrin | C184645 | Nephrin;NPHS1 Adhesion Molecule, Nephrin | A measurement of the nephrin in a biological specimen. | Nephrin Measurement | ||
Nerve Growth Factor Alpha | C198287 | Nerve Growth Factor Alpha | A measurement of the nerve growth factor alpha in a biological specimen. | Nerve Growth Factor Alpha Measurement | ||
Nerve Growth Factor Beta | C198210 | Nerve Growth Factor Beta | A measurement of the nerve growth factor beta in a biological specimen. | Nerve Growth Factor Beta Measurement | ||
Nerve Growth Factor Gamma | C198288 | Nerve Growth Factor Gamma | A measurement of the nerve growth factor gamma in a biological specimen. | Nerve Growth Factor Gamma Measurement | ||
Nerve Growth Factor | C135439 | Nerve Growth Factor | A measurement of the total nerve growth factor in a biological specimen. | Nerve Growth Factor Measurement | ||
Neurofilament Light Chain Protein | C142285 | NEFL;Neurofilament Light Chain Protein;Neurofilament Light Polypeptide;NF-L;Protein Phosphatase 1, Regulatory Subunit 110 | A measurement of the neurofilament light chain protein in a biological specimen. | Neurofilament Light Chain Protein Measurement | ||
Neurokinin A | C163473 | Neurokinin A;NKA;Substance K | A measurement of the neurokinin A in a biological specimen. | Neurokinin A Measurement | ||
Neuron Specific Enolase | C116205 | Enolase 2;Gamma-enolase;Neuron Specific Enolase | A measurement of the neuron specific enolase in a biological specimen. | Neuron Specific Enolase Measurement | ||
Neuropeptide Y | C74892 | Neuropeptide Y | A measurement of the neuropeptide Y in a biological specimen. | Neuropeptide Y Measurement | ||
Neuropilin-1 | C165977 | BDCA4;CD304;Neuropilin-1;NP1;NRP;VEGF165R | A measurement of the neuropilin-1 in a biological specimen. | Neuropilin-1 Measurement | ||
Neurotensin | C163475 | Neurotensin;NTS | A measurement of the neurotensin in a biological specimen. | Neurotensin Measurement | ||
Neutral Fats | C147407 | Neutral Fats | A measurement of the total neutral fats in a biological specimen. | Neutral Fats Measurement | ||
Neutrophil Cytoplasmic Ab, Atypical | C147300 | Anti-Neutrophil Cytoplasmic Antibody, Atypical;Neutrophil Cytoplasmic Ab, Atypical | A measurement of the atypical (cytoplasmic staining usually uniform and no interlobular accentuation) neutrophil cytoplasmic antibodies in a biological specimen. | Atypical Neutrophil Cytoplasmic Antibody Measurement | ||
Neutrophil Cytoplasmic Ab, Classic | C147301 | Anti-Neutrophil Cytoplasmic Antibody, Classic;Neutrophil Cytoplasmic Ab, Classic | A measurement of the classic (cytoplasmic granular fluorescence with central interlobular accentuation) neutrophil cytoplasmic antibodies in a biological specimen. | Classic Neutrophil Cytoplasmic Antibody Measurement | ||
Neutrophil Cytoplasmic Ab, Perinuclear | C147302 | Anti-Neutrophil Cytoplasmic Antibody, Perinuclear;Neutrophil Cytoplasmic Ab, Perinuclear | A measurement of the perinuclear (perinuclear staining without nuclear extension) neutrophil cytoplasmic antibodies in a biological specimen. | Perinuclear Neutrophil Cytoplasmic Antibody Measurement | ||
Neutrophil Elastase | C82026 | Neutrophil Elastase | A measurement of the neutrophil elastase in a biological specimen. | Neutrophil Elastase Measurement | ||
Neutrophil Elastase, Polymorphonuclear | C82027 | Neutrophil Elastase, Polymorphonuclear | A measurement of the polymorphonuclear neutrophil elastase in a biological specimen. | Polymorphonuclear Neutrophil Elastase Measurement | ||
Neutrophilic Metamyelocytes | C84822 | Neutrophilic Metamyelocytes | A measurement of the neutrophilic metamyelocytes in a biological specimen. | Neutrophilic Metamyelocyte Count | ||
Neutrophilic Metamyelocytes/Total Cells | C189509 | Neutrophilic Metamyelocytes/Total Cells | A relative measurement (ratio or percentage) of the neutrophilic metamyelocytes to total cells in a biological specimen. | Neutrophilic Metamyelocyte to Total Cell Ratio Measurement | ||
Neutrophilic Myelocytes | C84823 | Neutrophilic Myelocytes | A measurement of the neutrophilic myelocytes in a biological specimen. | Neutrophilic Myelocyte Count | ||
Neutrophilic Myelocytes/Lymphocytes | C181450 | Neutrophilic Myelocytes/Lymphocytes | A relative measurement (ratio or percentage) of the neutrophilic myelocytes to lymphocytes in a biological specimen (for example a bone marrow specimen). | Neutrophilic Myelocytes to Lymphocytes Ratio Measurement | ||
Neutrophilic Toxic Change | C132376 | Neutrophilic Toxic Change | A measurement of any type of toxic change in cells of the neutrophilic lineage in a biological specimen. | Neutrophilic Toxic Change Assessment | ||
Neutrophils Band Form | C64830 | Neutrophils Band Form | A measurement of the banded neutrophils in a biological specimen. | Neutrophil Band Form Count | ||
Neutrophils Band Form/ Neutrophils | C120642 | Neutrophils Band Form/ Neutrophils | A relative measurement (ratio or percentage) of banded neutrophils to total neutrophils in a biological specimen. | Neutrophils Band Form to Neutrophils Ratio Measurement | ||
Neutrophils Band Form/Leukocytes | C64831 | Neutrophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen. | Neutrophil Band Form to Leukocyte Ratio | ||
Neutrophils Band Form/Total Cells | C187701 | Neutrophils Band Form/Total Cells | A relative measurement (ratio or percentage) of the banded neutrophils to total cells in a biological specimen. | Neutrophil Band Form to Total Cell Ratio Measurement | ||
Neutrophils | C63321 | Neutrophils | A measurement of the neutrophils in a biological specimen. | Absolute Neutrophil Count | ||
Neutrophils, Seg + Band Form + Precursor | C154756 | Neutrophils, Seg + Band Form + Precursor;Neutrophils, Segmented + Band Form + Precursors | A measurement of the segmented and band form neutrophils, metamyelocytes, myelocytes, promyelocytes, and myeloblasts in a biological specimen. | Segmented, Band Form and Precursor Neutrophils Measurement | ||
Neutrophils, Segmented + Band Form | C154755 | Neutrophils, Segmented + Band Form | A measurement of the segmented and band form neutrophils in a biological specimen. | Segmented and Band Form Neutrophils Measurement | ||
Neutrophils, Segmented | C81997 | Neutrophils, Segmented | A measurement of the segmented neutrophils in a biological specimen. | Segmented Neutrophil Count | ||
Neutrophils, Segmented/Leukocytes | C82045 | Neutrophils, Segmented/Leukocytes | A relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen. | Segmented Neutrophil to Leukocyte Ratio Measurement | ||
Neutrophils, Segmented/Neutrophils | C120643 | Neutrophils, Segmented/Neutrophils | A relative measurement (ratio or percentage) of segmented neutrophils to total neutrophils in a biological specimen. | Segmented Neutrophils to Neutrophils Ratio Measurement | ||
Neutrophils, Segmented/Total Cells | C187679 | Neutrophils, Segmented/Total Cells | A relative measurement (ratio or percentage) of segmented neutrophils to total cells in a biological specimen. | Segmented Neutrophil to Total Cell Ratio Measurement | ||
Neutrophils/Leukocytes | C64827 | Neutrophils/Leukocytes | A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen. | Neutrophil to Leukocyte Ratio Measurement | ||
Neutrophils/Lymphocytes | C141271 | Neutrophils/Lymphocytes | A relative measurement (ratio) of the neutrophils to lymphocytes in a biological specimen. | Neutrophil to Lymphocyte Ratio Measurement | ||
Neutrophils/Non-Squam Epi Cells | C135438 | Neutrophils/Non-Squam Epi Cells | A relative measurement (ratio or percentage) of the neutrophils to non-squamous epithelial cells in a biological specimen. | Neutrophils to Non-Squamous Epithelial Cells Ratio Measurement | ||
Neutrophils/Total Cells | C98763 | Neutrophils/Total Cells | A relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen). | Neutrophil to Total Cell Ratio Measurement | ||
Niacin | C74899 | Niacin;Vitamin B3 | A measurement of the niacin in a biological specimen. | Vitamin B3 Measurement | ||
Nicomorphine | C184556 | Nicomorphine | A measurement of the nicomorphine in a biological specimen. | Nicomorphine Measurement | ||
Nicotinamide Phosphoribosyltransferase | C198286 | Nicotinamide Phosphoribosyltransferase;Visfatin | A measurement of the nicotinamide phosphoribosyltransferase in a biological specimen. | Nicotinamide Phosphoribosyltransferase Measurement | ||
Nicotine | C147403 | Nicotine | A measurement of the nicotine in a biological specimen. | Nicotine Measurement | ||
Nitrate | C161352 | Nitrate;Nitric Acid | A measurement of the nitrate in a biological specimen. | Nitrate Measurement | ||
Nitrazepam and/or Metabolites | C186089 | Nitrazepam and/or Metabolites | A measurement of the nitrazepam and/or its metabolite(s) present in a biological specimen, for an assay that can measure both nitrazepam and its metabolites. | Nitrazepam and/or Metabolites Measurement | ||
Nitrazepam | C184629 | Nitrazepam | A measurement of the nitrazepam in a biological specimen. | Nitrazepam Measurement | ||
Nitric Oxide | C112360 | Nitric Oxide;NO | A measurement of the nitric oxide in a biological specimen. | Nitric Oxide Measurement | ||
Nitrite | C64810 | Nitrite | A measurement of the nitrite in a biological specimen. | Nitrite Measurement | ||
NK Cells/Lym | C181258 | Natural Killer Cells/Lymphocytes;NK Cells/Lym | A relative measurement (ratio or percentage) of the natural killer cells to lymphocytes in a biological specimen. | Natural Killer Cells to Lymphocytes Ratio Measurement | ||
Nociceptin | C154744 | Nociceptin;Orphanin FQ | A measurement of the nociceptin in a biological specimen. | Nociceptin Measurement | ||
Non-HDL Cholesterol | C116204 | Non-HDL Cholesterol;Non-High Density Lipoprotein | A measurement of the non-high density lipoprotein cholesterol in a biological specimen. | Non-High Density Lipoprotein Cholesterol Measurement | ||
Non-HDL Cholesterol/HDL Cholesterol | C120644 | Non-HDL Cholesterol/HDL Cholesterol | A relative measurement (ratio or percentage) of non-high density lipoprotein cholesterol to high density lipoprotein cholesterol in a biological specimen. | Non-HDL Cholesterol to HDL Cholesterol Ratio Measurement | ||
Non-HDL Cholesterol/LDL Cholesterol | C186085 | Non-HDL Cholesterol/LDL Cholesterol | A relative measurement (ratio or percentage) of the non-HDL cholesterol to LDL cholesterol in a biological specimen. | Non-HDL Cholesterol to LDL Cholesterol Ratio Measurement | ||
Non-Phosphorylated Tau Protein | C84811 | Non-Phosphorylated Tau Protein | A measurement of the non-phosphorylated Tau protein in a biological specimen. | Nonphosphorylated Tau Protein Measurement | ||
Non-Prostatic Acid Phosphatase | C100434 | Non-Prostatic Acid Phosphatase | A measurement of the non-prostatic acid phosphatase in a biological specimen. | Non-Prostatic Acid Phosphatase Measurement | ||
Non-Squamous Epithelial Cells | C135413 | Non-Squamous Epithelial Cells | A measurement of the non-squamous epithelial cells in a biological specimen. | Non-Squamous Epithelial Cell Count | ||
Nonhematic Cells | C147401 | Nonhematic Cells | A measurement of the cells of nonhematopoietic origin in a biological specimen. | Nonhematic Cells Count | ||
Nonhematic Cells/Leukocytes | C147402 | Nonhematic Cells/Leukocytes | A relative measurement (ratio) of the nonhematic cells to total leukocytes in a biological specimen. | Nonhematic Cells to Leukocytes Ratio Measurement | ||
Norclostebol | C184593 | Norclostebol | A measurement of the norclostebol in a biological specimen. | Norclostebol Measurement | ||
Nordazepam | C139076 | Desmethyldiazepam;N-Desmethyldiazepam;Nordazepam;Nordiazepam | A measurement of the nordazepam present in a biological specimen. | Nordazepam Measurement | ||
Nordoxepin | C191286 | Nordoxepin | A measurement of the nordoxepin present in a biological specimen. | Nordoxepin Measurement | ||
Norepinephrine Excretion Rate | C163472 | Norepinephrine Excretion Rate | A measurement of the amount of norepinephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Norepinephrine Excretion Rate | ||
Norepinephrine | C74868 | Noradrenaline;Norepinephrine | A measurement of the norepinephrine hormone in a biological specimen. | Noradrenaline Measurement | ||
Norethandrolone | C184594 | Norethandrolone | A measurement of the norethandrolone in a biological specimen. | Norethandrolone Measurement | ||
Norfluoxetine | C187816 | Norfluoxetine | A measurement of the norfluoxetine in a biological specimen. | Norfluoxetine Measurement | ||
Norhydrocodone | C177952 | Norhydrocodone | A measurement of the norhydrocodone in a biological specimen. | Norhydrocodone Measurement | ||
Normal Sperm/Total Sperm | C142286 | Normal Sperm/Total Sperm;Sperm Morphology | A measurement (ratio or percentage) of the normal spermatozoa to total spermatozoa in a biological specimen. | Normal Sperm to Total Sperm Ratio Measurement | ||
Normalized Protein Catabolism Rate | C191295 | Normalized Protein Catabolic Rate;Normalized Protein Catabolism Rate;NPCR;nPCR | A calculated measurement of the normalized protein catabolism rate in a biological specimen used to assess dietary protein intake in dialysis patients. | Normalized Protein Catabolism Rate | ||
Normetanephrine Excretion Rate | C163474 | Normetanephrine Excretion Rate | A measurement of the amount of normetanephrine being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Normetanephrine Excretion Rate | ||
Normetanephrine | C122138 | Normetanephrine | A measurement of the normetanephrine in a biological specimen. | Normetanephrine Measurement | ||
Normetanephrine, Free | C186086 | Normetanephrine, Free | A measurement of the free normetanephrine in a biological specimen. | Free Normetanephrine Measurement | ||
Normoblasts | C189501 | Normoblasts | A measurement of the normoblasts in a biological specimen. | Normoblast Count | ||
Normoblasts/Total Cells | C98764 | Normoblasts/Total Cells | A relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Normoblast to Total Cell Ratio Measurement | ||
Normorphine | C184557 | Normorphine | A measurement of the normorphine in a biological specimen. | Normorphine Measurement | ||
Nornicotine | C147406 | Nornicotine | A measurement of the nornicotine in a biological specimen. | Nornicotine Measurement | ||
Noroxycodone | C177953 | Noroxycodone | A measurement of the noroxycodone in a biological specimen. | Noroxycodone Measurement | ||
Norpropoxyphene | C186088 | Norpropoxyphene | A measurement of the norpropoxyphene in a biological specimen. | Norpropoxyphene Measurement | ||
Norsertraline | C187817 | Norsertraline | A measurement of the norsertraline in a biological specimen. | Norsertraline Measurement | ||
Nortriptyline | C186087 | Nortriptyline | A measurement of the nortriptyline in a biological specimen. | Nortriptyline Measurement | ||
Nuclear Matrix Protein 22 | C156509 | Nuclear Matrix Protein 22;Nuclear Mitotic Apparatus Protein 1;NUMA1 | A measurement of the nuclear matrix protein 22 in a biological specimen. | Nuclear Matrix Protein 22 Measurement | ||
Nuclear Swelling | C114213 | Nuclear Swelling | A measurement of the expansion of the nucleus of the cells in a biological specimen. | Nuclear Swelling Measurement | ||
Nucleated Cells | C150841 | Nucleated Cells | A measurement of the nucleated cells in a biological specimen. | Nucleated Cell Count | ||
Nucleated Erythrocytes | C74705 | Nucleated Erythrocytes;Nucleated Red Blood Cells | A measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen. | Nucleated Red Blood Cell Count | ||
Nucleated Erythrocytes/Erythrocytes | C74647 | Nucleated Erythrocytes/Erythrocytes;Nucleated Red Blood Cells/Erythrocytes | A relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen. | Nucleated Red Blood Cell to Erythrocyte Ratio Measurement | ||
Nucleated Erythrocytes/Leukocytes | C82046 | Nucleated Erythrocytes/Leukocytes | A relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen. | Nucleated Erythrocyte to Leukocyte Ratio Measurement | ||
Nut Mix Antigen IgE Antibody | C130122 | Nut Mix Antigen IgE Antibody | A measurement of the nut mix antigen IgE antibody in a biological specimen. | Nut Mix Antigen IgE Antibody Measurement | ||
Nut Mix Antigen IgG Antibody | C130123 | Nut Mix Antigen IgG Antibody | A measurement of the nut mix antigen IgG antibody in a biological specimen. | Nut Mix Antigen IgG Antibody Measurement | ||
Nut Mix IgE AB RAST Score | C165931 | Nut Mix IgE AB RAST Score | A classification of the amount of nut mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Nut Mix IgE Antibody RAST Score Measurement | ||
Nut Mix IgG AB RAST Score | C165913 | Nut Mix IgG AB RAST Score | A classification of the amount of nut mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Nut Mix IgG Antibody RAST Score Measurement | ||
O-Demethylase | C163479 | O-Demethylase | A measurement of the O-Demethylase in a biological specimen. | O-Demethylase Measurement | ||
O-Desmethyltramadol | C181402 | Desmetramadol;O-Desmethyltramadol;O-DSMT | A measurement of the O-desmethyltramadol in a biological specimen. | O-Desmethyltramadol Measurement | ||
Occult Blood | C74686 | Occult Blood | A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination. | Occult Blood Measurement | ||
Olanzapine | C177966 | Olanzapine | A measurement of the olanzapine in a biological specimen. | Olanzapine Measurement | ||
Oligoclonal Bands | C122139 | Oligoclonal Bands | A measurement of the oligoclonal bands in a biological specimen. | Oligoclonal Bands Measurement | ||
Olive Tree Pollen IgE AB RAST Score | C165885 | Olive Tree Pollen IgE AB RAST Score | A classification of the amount of Olea europaea pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Olive Tree Pollen IgE Antibody RAST Score Measurement | ||
Olive Tree Pollen IgE Antibody | C165884 | Olive Tree Pollen IgE Antibody | A measurement of the Olea europaea pollen antigen IgE antibody in a biological specimen. | Olive Tree Pollen IgE Antibody Measurement | ||
Oncostatin M | C132377 | Oncostatin M | A measurement of the oncostatin M in a biological specimen. | Oncostatin M Measurement | ||
Opiate | C74796 | Opiate | A measurement of any opiate class drug present in a biological specimen. | Opiate Measurement | ||
Orchard Grass Pollen IgA | C130081 | Cocksfoot Grass Pollen IgA;Orchard Grass Pollen IgA | A measurement of the Dactylis glomerata pollen antigen IgA antibody in a biological specimen. | Orchard Grass Pollen IgA Measurement | ||
Orchard Grass Pollen IgE AB RAST Score | C165883 | Orchard Grass Pollen IgE AB RAST Score | A classification of the amount of Dactylis glomerata pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Orchard Grass Pollen IgE Antibody RAST Score Measurement | ||
Orchard Grass Pollen IgE | C130080 | Cocksfoot Grass Pollen IgE;Orchard Grass Pollen IgE | A measurement of the Dactylis glomerata pollen antigen IgE antibody in a biological specimen. | Orchard Grass Pollen IgE Measurement | ||
Orchard Grass Pollen IgG AB RAST Score | C165900 | Cocksfoot Grass Pollen IgG RAST Score;Orchard Grass Pollen IgG AB RAST Score | A classification of the amount of Dactylis glomerata pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Orchard Grass Pollen IgG Antibody RAST Score Measurement | ||
Orchard Grass Pollen IgG | C130082 | Cocksfoot Grass Pollen IgG;Orchard Grass Pollen IgG | A measurement of the Dactylis glomerata pollen antigen IgG antibody in a biological specimen. | Orchard Grass Pollen IgG Measurement | ||
Orchard Grass Pollen IgG4 | C130083 | Cocksfoot Grass Pollen IgG4;Orchard Grass Pollen IgG4 | A measurement of the Dactylis glomerata pollen antigen IgG4 antibody in a biological specimen. | Orchard Grass Pollen IgG4 Measurement | ||
Ornithine | C122140 | Ornithine | A measurement of the ornithine in a biological specimen. | Ornithine Measurement | ||
Osmolality | C74801 | Osmolality | A measurement of the osmoles of solute per unit of biological specimen. | Osmolality Measurement | ||
Osmolarity | C74802 | Osmolarity | A measurement of the osmoles of solute per liter of solution. | Osmolarity Measurement | ||
Osteocalcin | C74744 | Osteocalcin | A measurement of the osteocalcin in a biological specimen. | Osteocalcin Measurement | ||
Osteopontin | C124349 | Osteopontin | A measurement of the osteopontin in a biological specimen. | Osteopontin Measurement | ||
Osteopontin/Creatinine | C177962 | Osteopontin/Creatinine | A relative measurement (ratio or percentage) of the osteopontin to creatinine in a biological specimen. | Osteopontin to Creatinine Ratio Measurement | ||
Osteoprotegerin | C116206 | OCIF;Osteoclastogenesis Inhibitory Factor;Osteoprotegerin;TNFRS11B;Tumor Necrosis Factor Receptor Superfamily Member 11b | A measurement of the osteoprotegerin in a biological specimen. | Osteoprotegerin Measurement | ||
Ovalocytes | C142287 | Ovalocytes | A measurement of the ovalocytes (oval shaped cell with rounded ends and a long axis less than twice its short axis) in a biological specimen. | Ovalocyte Count | ||
Oxalate Excretion Rate | C163480 | Oxalate Excretion Rate | A measurement of the amount of oxalate being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Oxalate Excretion Rate | ||
Oxalate | C92250 | Ethanedioate;Oxalate | A measurement of the oxalate in a biological specimen. | Oxalate Measurement | ||
Oxalate/Creatinine | C117983 | Oxalate/Creatinine | A relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen. | Oxalate to Creatinine Ratio Measurement | ||
Oxandrolone | C75381 | Ossandrolone;Oxandrolone | A measurement of the oxandrolone in a biological specimen. | Oxandrolone Measurement | ||
Oxazepam | C75375 | Oxazepam | A measurement of the oxazepam present in a biological specimen. | Oxazepam Measurement | ||
Oxidized LDL Cholesterol Antibody | C119288 | Oxidized LDL Cholesterol Antibody | A measurement of the total oxidized low density lipoprotein cholesterol antibody in a biological specimen. | Oxidized LDL Cholesterol Antibody Measurement | ||
Oxidized LDL Cholesterol | C120635 | Oxidized LDL Cholesterol | A measurement of the oxidized low density lipoprotein cholesterol in a biological specimen. | Oxidized LDL Cholesterol Measurement | ||
Oxycodone | C74884 | Oxycodone;Oxycontin | A measurement of the oxycodone present in a biological specimen. | Oxycodone Measurement | ||
Oxygen Capacity | C96614 | Oxygen Capacity | A measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood. | Oxygen Capacity Measurement | ||
Oxygen Content | C111284 | Oxygen Content | A measurement of the amount of oxygen content in a biological specimen. | Oxygen Measurement | ||
Oxygen Saturation | C60832 | Oxygen Saturation | A measurement of the oxygen-hemoglobin saturation of a volume of blood. | Oxygen Saturation Measurement | ||
Oxygen Saturation/Fraction Inspired O2 | C174311 | Oxygen Saturation/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. | Oxygen Saturation/Fraction Inspired O2 | ||
Oxyhemoglobin | C96616 | Oxyhemoglobin | A measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen. | Oxyhemoglobin Measurement | ||
Oxyhemoglobin/Total Hemoglobin | C147359 | FO2 Hb;Fractioned Oxyhemoglobin;Oxyhemoglobin/Total Hemoglobin | A relative measurement (ratio or percentage) of the amount of oxyhemoglobin compared to total hemoglobin in a biological specimen. | Oxyhemoglobin to Total Hemoglobin Ratio Measurement | ||
Oxymesterone | C184595 | Oxymesterone | A measurement of the oxymesterone in a biological specimen. | Oxymesterone Measurement | ||
Oxymetholone | C75388 | Oxymethalone;Oxymethenolone;Oxymetholone | A measurement of the oxymetholone in a biological specimen. | Oxymetholone Measurement | ||
Oxymorphone | C147409 | Oxymorphone | A measurement of the Oxymorphone in a biological specimen. | Oxymorphone Measurement | ||
Oxytocin | C74869 | Oxytocin;Oxytoxin | A measurement of the oxytocin hormone in a biological specimen. | Oxytocin Measurement | ||
P-Selectin | C117850 | GMP-140;P-Selectin | A measurement of total P-selectin in a biological specimen. | P-Selectin Measurement | ||
P100 Polymyositis-scleroderma Autoag Ab | C120651 | P100 Polymyositis-scleroderma Autoag Ab | A measurement of the p100 polymyositis-scleroderma overlap syndrome-associated autoantigen antibody in a biological specimen. | P100 Polymyositis-scleroderma Autoantigen Antibody Measurement | ||
P50 Oxygen | C102279 | P50 Oxygen | A measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen. | P50 Oxygen Measurement | ||
Pancreatic Elastase 1 | C82028 | Pancreatic Elastase 1 | A measurement of the pancreatic elastase 1 in a biological specimen. | Pancreatic Elastase Measurement | ||
Pancreatic Elastase 1, Polymorphonuclear | C82029 | Pancreatic Elastase 1, Polymorphonuclear | A measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen. | Polymorphonuclear Pancreatic Elastase Measurement | ||
Pancreatic Polypeptide | C80201 | Pancreatic Polypeptide | A measurement of the pancreatic polypeptide in a biological specimen. | Pancreatic Polypeptide Measurement | ||
Panel Reactive Antibody | C116210 | Panel Reactive Antibody;Percent Reactive Antibody;PRA Score | A measurement of the panel reactive antibody that is achieved by mixing and assessing the reactivity between the recipient's immune cells and the donor's human leukocyte antigen, in which anti-HLA class I and class II antibody specificities are measured separately in a biological specimen. | Panel Reactive Antibody Test | ||
Pappenheimer Bodies | C74616 | Pappenheimer Bodies | A measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen. | Pappenheimer Body Count | ||
Para Aminohippurate Clearance | C189530 | 4-Aminohippurate Clearance;P-Amino Hippuric Acid Clearance;P-Aminohippurate Clearance;PAH Clearance;Para Aminohippurate Clearance;Para Aminohippuric Acid Clearance;Para-Amino Hippuric Acid Clearance;Para-Aminohippurate Clearance | A measurement of the volume of serum or plasma that would be cleared of para aminohippurate by excretion of urine for a specified unit of time (e.g. one minute). | Para Aminohippurate Clearance Measurement | ||
Para Aminohippurate | C189315 | 4-Aminohippurate;P-Amino Hippuric Acid;P-Aminohippurate;PAH;Para Aminohippurate;Para Aminohippuric Acid;Para-Amino Hippuric Acid;Para-Aminohippurate | A measurement of the para aminohippurate in a biological specimen. | Para Aminohippurate Measurement | ||
Para-Aminobenzoate | C186090 | Para-Aminobenzoate;Para-Aminobenzoic Acid | A measurement of the para-aminobenzoate in a biological specimen. | Para-Aminobenzoate Measurement | ||
Para-Fluorofentanyl | C184558 | Para-Fluorofentanyl | A measurement of the para-fluorofentanyl in a biological specimen. | Para-Fluorofentanyl Measurement | ||
Paraldehyde | C184630 | Paraldehyde | A measurement of the paraldehyde in a biological specimen. | Paraldehyde Measurement | ||
Parathyroid Hormone, C-Terminal | C81964 | Parathyrin Hormone, C-Terminal;Parathyroid Hormone, C-Terminal | A measurement of the C-terminal fragment of parathyroid hormone in a biological specimen. | C-Terminal Parathyroid Hormone Measurement | ||
Parathyroid Hormone, Fragmented | C74784 | Parathyrin Hormone, Fragmented;Parathyroid Hormone, Fragmented | A measurement of the fragmented parathyroid hormone in a biological specimen. | Fragmented Parathyroid Hormone Measurement | ||
Parathyroid Hormone, Intact | C74789 | Parathyrin, Intact;Parathyroid Hormone, Intact | A measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen. | Intact Parathyroid Hormone Measurement | ||
Parathyroid Hormone, Mid-Molecule | C81965 | Parathyrin Hormone, Mid-Molecule;Parathyroid Hormone, Mid-Molecule | A measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen. | Mid-Molecule Parathyroid Hormone Measurement | ||
Parathyroid Hormone, N-Terminal | C81966 | Parathyrin Hormone, N-Terminal;Parathyroid Hormone, N-Terminal | A measurement of the N-terminal fragment of parathyroid hormone in a biological specimen. | N-Terminal Parathyroid Hormone Measurement | ||
Parathyroid Hormone, Whole | C103451 | Parathyrin Hormone, Whole;Parathyroid Hormone, Whole | A measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen. | Whole Parathyroid Hormone Measurement | ||
Parathyroid Hormone-related Protein | C117851 | Parathyrin Hormone-related Protein;Parathyroid Hormone-related Peptide;Parathyroid Hormone-related Protein | A measurement of parathyroid hormone-related protein in a biological specimen. | Parathyroid Hormone-related Protein Measurement | ||
Parietal Cell Antibody | C116207 | Anti-Parietal Cell Antibody;Parietal Cell Antibody | A measurement of the parietal cell antibody in a biological specimen. | Parietal Cell Antibody Measurement | ||
Paroxetine | C147410 | Paroxetine | A measurement of the paroxetine present in a biological specimen. | Paroxetine Measurement | ||
Partial Pressure Carbon Dioxide Adj Temp | C147411 | Partial Pressure Carbon Dioxide Adj Temp | A measurement of the pressure of carbon dioxide, which has been adjusted for body temperature, in a biological specimen. | Partial Pressure of Carbon Dioxide Adjusted for Body Temperature Measurement | ||
Partial Pressure Carbon Dioxide | C82625 | Partial Pressure Carbon Dioxide | A measurement of the pressure of carbon dioxide in a biological specimen. | Partial Pressure of Carbon Dioxide Measurement | ||
Partial Pressure Oxygen Adj for Temp | C147417 | Partial Pressure Oxygen Adj for Temp | A measurement of the pressure of oxygen, which has been adjusted for body temperature, in a biological specimen. | Partial Pressure of Oxygen Adjusted for Body Temperature Measurement | ||
Partial Pressure Oxygen | C71251 | PaO2;Partial Pressure Oxygen;Po2;pO2 | A measurement of the pressure of oxygen in a biological specimen. | Partial Pressure of Oxygen Measurement | ||
Partial Thromboplastin Time | C178140 | Partial Thromboplastin Time | A measurement of the length of time that it takes for clotting to occur when no activating reagents are added to a biological specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. | Partial Thromboplastin Time | ||
Pathologic Casts | C186035 | Non-Hyalin Casts;Non-Hyaline Casts;Pathologic Casts | A measurement of the pathologic (non-hyaline) casts present in a biological specimen. | Pathologic Cast Measurement | ||
PB-22 3-carboxyindole | C184559 | PB-22 3-carboxyindole | A measurement of the synthetic cannabinoid metabolite PB-22 3-carboxyindole in a biological specimen. | PB-22 3-carboxyindole Measurement | ||
PCA3 mRNA/PSA mRNA | C132378 | PCA3 mRNA/PSA mRNA | A relative measurement (ratio) of the prostate cancer antigen 3 mRNA to prostate specific antigen mRNA in a biological specimen. | PCA3 mRNA to PSA mRNA Ratio Measurement | ||
Pelger Huet Anomaly | C74617 | Pelger Huet Anomaly;Pelger-Huet Cells;PHA | A measurement of the Pelger-Huet Anomaly (nuclei of granulocytes appear rod-like, bilobed, peanut, or dumbbell shaped) in a biological specimen. | Pelger Huet Anomaly Measurement | ||
Pemoline | C184631 | Pemoline | A measurement of the pemoline in a biological specimen. | Pemoline Measurement | ||
Pemphigoid Antibodies | C81988 | Pemphigoid Antibodies | A measurement of the pemphigoid antibodies in a biological specimen. | Pemphigoid Antibody Measurement | ||
Pentazocine | C184632 | Pentazocine | A measurement of the pentazocine in a biological specimen. | Pentazocine Measurement | ||
Pentedrone | C184561 | Pentedrone | A measurement of the pentedrone in a biological specimen. | Pentedrone Measurement | ||
Pentobarbital | C75367 | Pentobarbital | A measurement of the pentobarbital present in a biological specimen. | Pentobarbital Measurement | ||
Pentylone | C184562 | Pentylone | A measurement of the pentylone in a biological specimen. | Pentylone Measurement | ||
Pepsinogen A | C100469 | Pepsinogen A;PGA | A measurement of the pepsinogen A in a biological specimen. | Pepsinogen A Measurement | ||
Pepsinogen C | C100470 | Pepsinogen C;PGC | A measurement of the pepsinogen C in a biological specimen. | Pepsinogen C Measurement | ||
Pepsinogen I | C100467 | Pepsinogen I;PGI | A measurement of the pepsinogen I in a biological specimen. | Pepsinogen I Measurement | ||
Pepsinogen II | C100468 | Pepsinogen II;PGII | A measurement of the pepsinogen II in a biological specimen. | Pepsinogen II Measurement | ||
Pepsinogen | C100122 | Pepsinogen | A measurement of the pepsinogen in a biological specimen. | Pepsinogen Measurement | ||
Peptide Transporter TAP1 | C163486 | Antigen Peptide Transporter 1;Peptide Transporter TAP1 | A measurement of the peptide transporter TAP1 in a biological specimen. | Peptide Transporter TAP1 Measurement | ||
Peptide YY | C80202 | Peptide Tyrosine Tyrosine;Peptide YY | A measurement of the peptide YY in a biological specimen. | Peptide YY Measurement | ||
Peptidylprolyl Isomerase A | C187819 | Cyclophilin A;CYPA;Peptidylprolyl Isomerase A;Rotamase A | A measurement of the peptidylprolyl isomerase A in a biological specimen. | Peptidylprolyl Isomerase A Measurement | ||
Perampanel | C184596 | Perampanel | A measurement of the perampanel in a biological specimen. | Perampanel Measurement | ||
Periostin | C112395 | OSF2;Osteoblast Specific Factor 2;Periostin;POSTN | A measurement of the periostin in a biological specimen. | Periostin Measurement | ||
Perphenazine | C177988 | Perphenazine | A measurement of the perphenazine in a biological specimen. | Perphenazine Measurement | ||
pH Adjusted for Body Temp | C161367 | pH Adjusted for Body Temp | A measurement of pH, which has been adjusted for body temperature, in a biological specimen. | pH Adjusted for Body Temperature Measurement | ||
pH | C45997 | pH | The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid. | pH | ||
Phenazocine | C184573 | Phenazocine | A measurement of the phenazocine in a biological specimen. | Phenazocine Measurement | ||
Phencyclidine | C74694 | Phencyclidine;Phenylcyclohexylpiperidine | A measurement of the phencyclidine present in a biological specimen. | Phencyclidine Measurement | ||
Phendimetrazine | C184597 | Phendimetrazine | A measurement of the phendimetrazine in a biological specimen. | Phendimetrazine Measurement | ||
Phenmetrazine | C184574 | Phenmetrazine | A measurement of the phenmetrazine in a biological specimen. | Phenmetrazine Measurement | ||
Phenobarbital | C75368 | Phenobarbital | A measurement of the phenobarbital present in a biological specimen. | Phenobarbital Measurement | ||
Phenothiazine | C74695 | Dibenzothiazine;Phenothiazine | A measurement of the phenothiazine present in a biological specimen. | Phenothiazine Measurement | ||
Phentermine | C174299 | Phentermine;Phenyl-tertiary-butylamine | A measurement of the phentermine in a biological specimen. | Phentermine Measurement | ||
Phenylalanine | C81280 | Phenylalanine | A measurement of the phenylalanine in a biological specimen. | Phenylalanine Measurement | ||
Phenylalanine/Tyrosine | C81281 | Phenylalanine/Tyrosine | A relative measurement (ratio) of the phenylalanine to tyrosine in a biological specimen. | Phenylalanine to Tyrosine Ratio Measurement | ||
Phenylketones | C147414 | Phenyl Ketones;Phenylketones | A measurement of the total phenylketones in a biological specimen | Phenylketone Measurement | ||
Phenylpropanolamine | C174297 | Beta-Hydroxyamphetamine;Norephedrine;Phenylpropanolamine | A measurement of the phenylpropanolamine in a biological specimen. | Phenylpropanolamine Measurement | ||
Phenytoin | C147413 | Phenytoin | A measurement of the phenytoin in a biological specimen. | Phenytoin Measurement | ||
Phos-S6 Ribosomal Protein | C165981 | Phos-S6 Ribosomal Protein;Phosphorylated S6 protein of the 40S ribosomal subunit | A measurement of the phosphorylated S6 protein of the 40S ribosomal subunit in a biological specimen. | Phosphorylated 40S Ribosomal Protein S6 Measurement | ||
Phosphate Clearance | C106553 | Phosphate Clearance | A measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute). | Phosphate Clearance Measurement | ||
Phosphate Crystals | C174304 | Phosphate Crystals | A measurement of the total phosphate crystals in a biological specimen. | Phosphate Crystals Measurement | ||
Phosphate | C64857 | Inorganic Phosphate;Phosphate;Phosphorus | A measurement of the phosphate in a biological specimen. | Phosphate Measurement | ||
Phosphate/Creatinine | C79461 | Phosphate/Creatinine | A relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen. | Phosphate to Creatinine Ratio Measurement | ||
Phosphatidylcholine/Albumin | C147420 | Phosphatidylcholine/Albumin | A relative measurement (ratio or percentage) of the phosphatidylcholine to albumin in a biological specimen. | Phosphatidylcholine to Albumin Ratio Measurement | ||
Phosphatidylethanol | C187820 | PEth;Phosphatidylethanol | A measurement of the total phosphatidylethanol in a biological specimen. | Phosphatidylethanol Measurement | ||
Phosphatidylglycerol/Lung Surfactant | C147423 | Phosphatidylglycerol/Lung Surfactant;Phosphatidylglycerol/Pulmonary Surfactant | A relative measurement (ratio) of the phosphatidylglycerol to total lung surfactant in a biological specimen. | Phosphatidylglycerol to Lung Surfactant Ratio Measurement | ||
Phosphatidylserine IgA Antibody | C122143 | Phosphatidylserine IgA Antibody | A measurement of the phosphatidylserine IgA antibody in a biological specimen. | Phosphatidylserine Antibody IgA Measurement | ||
Phosphatidylserine IgG Antibody | C122144 | Phosphatidylserine IgG Antibody | A measurement of the phosphatidylserine IgG antibody in a biological specimen. | Phosphatidylserine Antibody IgG Measurement | ||
Phosphatidylserine IgM Antibody | C122145 | Phosphatidylserine IgM Antibody | A measurement of the phosphatidylserine IgM antibody in a biological specimen. | Phosphatidylserine Antibody IgM Measurement | ||
Phospholipase A2 | C181405 | Phospholipase A2 | A measurement of the total phospholipase A2 in a biological specimen. | Phospholipase A2 Measurement | ||
Phospholipid Scramblase 1 | C163483 | Phospholipid Scramblase 1 | A measurement of the phospholipid scramblase 1 in a biological specimen. | Phospholipid Scramblase 1 Measurement | ||
Phospholipid | C96623 | Phospholipid | A measurement of the phospholipids in a biological specimen. | Phospholipid Measurement | ||
Phosphorus Excretion Rate | C150821 | Phosphorus Excretion Rate | A measurement of the amount of phosphorus being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Phosphorus Excretion Rate | ||
Phosphorylated Neurofilament Heavy Chain | C172501 | Phosphorylated Neurofilament Heavy Chain | A measurement of the phosphorylated neurofilament heavy chain in a biological specimen. | Phosphorylated Neurofilament Heavy Chain Measurement | ||
Phosphorylated STAT3 | C156521 | Phosphorylated STAT3;pSTAT3 | A measurement of the phosphorylated STAT3 (signal transducer and activator of transcription 3) in a biological specimen. | Phosphorylated STAT3 Measurement | ||
Phosphorylated STAT3/STAT3 | C156522 | Phosphorylated STAT3/STAT3;pSTAT3/STAT3 | A relative measurement (ratio or percentage) of the phosphorylated STAT3 to total STAT3 in a biological specimen. | Phosphorylated STAT3 to STAT3 Ratio Measurement | ||
Phosphorylated Tau Prot/Amyloid Beta1-42 | C176312 | Phosphorylated Tau Prot/Amyloid Beta1-42;Phosphorylated Tau Protein/Amyloid Beta 1-42 | A relative measurement (ratio) of the phosphorylated Tau protein to amyloid beta 1-42 in a biological specimen. | Phosphorylated Tau Protein to Amyloid Beta1-42 Ratio Measurement | ||
Phosphorylated Tau Protein 181 | C187821 | Phosphorylated Tau 181;Phosphorylated Tau Protein 181 | A measurement of the phosphorylated Tau protein 181 in a biological specimen. | Phosphorylated Tau Protein 181 Measurement | ||
Phosphorylated Tau Protein | C84812 | Phosphorylated Tau Protein | A measurement of the phosphorylated Tau protein in a biological specimen. | Phosphorylated Tau Protein Measurement | ||
Pi-GST Excretion Rate | C119279 | Pi-GST Excretion Rate | A measurement of the amount of Pi Glutathione-S-Transferase being excreted in a biological specimen over a defined period of time (e.g. one hour). | Pi-GST Excretion Rate | ||
Pigment Casts | C189518 | Pigment Casts;Pigmented Casts | A measurement of the pigment casts present in a biological specimen. | Pigment Cast Measurement | ||
Pimozide | C177987 | Pimozide | A measurement of the pimozide in a biological specimen. | Pimozide Measurement | ||
Pipradrol | C184633 | Pipradrol | A measurement of the pipradrol in a biological specimen. | Pipradrol Measurement | ||
Placental Growth Factor | C163482 | PGF;PIGF;Placental Growth Factor;PLGF | A measurement of the placental growth factor in a biological specimen. | Placental Growth Factor Measurement | ||
Placental Specific Alkaline Phosphatase | C184509 | Placental Specific Alkaline Phosphatase | A measurement of the placental specific alkaline phosphatase isoform in a biological specimen. | Placental Specific Alkaline Phosphatase Measurement | ||
Plasma Equivalent Glucose Distribution | C163447 | Plasma Equivalent Glucose Distribution | A measurement of the plasma equivalent glucose distribution in a biological specimen. | Plasma Equivalent Glucose Distribution Measurement | ||
Plasma Equivalent Glucose | C163446 | Plasma Equivalent Glucose | A measurement of the plasma equivalent glucose in a biological specimen. | Plasma Equivalent Glucose Measurement | ||
Plasmacytoid Lymphocytes | C74618 | Plasmacytoid Lymphocytes;Plymphocytes | A measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen. | Plasmacytoid Lymphocyte Count | ||
Plasmacytoid Lymphocytes/Leukocytes | C158229 | Plasmacytoid Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes to all leukocytes in a biological specimen. | Plasmacytoid Lymphocytes to Leukocytes Ratio Measurement | ||
Plasmacytoid Lymphocytes/Lymphocytes | C74648 | Plasmacytoid Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen. | Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement | ||
Plasminogen Activator Inhibitor-1 AG | C81989 | Plasminogen Activator Inhibitor-1 AG | A measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen. | Plasminogen Activator Inhibitor-1 Antigen Measurement | ||
Plasminogen Activator Inhibitor-1 | C82030 | Plasminogen Activator Inhibitor-1 | A measurement of the plasminogen activator inhibitor-1 in a biological specimen. | Plasminogen Activator Inhibitor-1 Measurement | ||
Plasminogen | C127633 | Plasminogen | A measurement of the plasminogen (antigen) in a biological specimen. | Plasminogen Measurement | ||
Platelet Activating Factor | C111292 | Platelet Activating Factor | A measurement of the platelet activating factor in a biological specimen. | Platelet Activating Factor Measurement | ||
Platelet Aggregation Amplitude | C111293 | Platelet Aggregation Amplitude | A measurement of the magnitude of the platelet aggregation in a biological specimen. | Platelet Aggregation Amplitude Measurement | ||
Platelet Aggregation Curve Type | C114210 | Platelet Aggregation Curve Type | The classification of the curve pattern that is formed as a result of platelet aggregation. | Platelet Aggregometry Curve Type | ||
Platelet Aggregation Mean Amplitude | C114211 | Platelet Aggregation Mean Amplitude | An average of the measurements of the magnitude of the platelet aggregation in a biological specimen. | Platelet Aggregometry Mean Amplitude | ||
Platelet Aggregation Mean Curve Type | C114212 | Platelet Aggregation Mean Curve Type | The classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements. | Platelet Aggregometry Mean Curve Type | ||
Platelet Aggregation | C103427 | Platelet Aggregation;Platelet Function | A measurement of the association of platelets to one another via adhesion molecules in a biological sample. | Platelet Aggregation Measurement | ||
Platelet Clumps | C96624 | Platelet Clumps;PLT Clumps | A measurement of the platelet clumps in a biological specimen. | Platelet Clumps Count | ||
Platelet Component Distribution Width | C111294 | Platelet Component Distribution Width | A measurement of a marker of platelet shape change in a biological specimen. | Platelet Component Distribution Width Measurement | ||
Platelet Derived Growth Factor IsoformAA | C163481 | PDGF Isoform AA;Platelet Derived Growth Factor IsoformAA;Platelet Derived Growth Factor-AA Isoform | A measurement of the platelet derived growth factor isoform AA in a biological specimen. | Platelet Derived Growth Factor Isoform AA Measurement | ||
Platelet Derived Growth Factor IsoformAB | C116208 | PDGF Isoform AB;Platelet Derived Growth Factor IsoformAB;Platelet Derived Growth Factor-AB Isoform | A measurement of the platelet derived growth factor isoform AB in a biological specimen. | Platelet Derived Growth Factor Isoform AB Measurement | ||
Platelet Distribution Width | C81962 | Platelet Distribution Width | A measurement of the range of platelet sizes in a biological specimen. | Platelet Distribution Width | ||
Platelet Endothelial Adhesion Molecule 1 | C135472 | CD31;CD31 Antigen;PECAM;PECAM-1;PECAM1;Platelet And Endothelial Cell Adhesion Molecule 1;Platelet Endo Cell Adhesion Molecule 1;Platelet Endothelial Adhesion Molecule | A measurement of the platelet and endothelial cell adhesion molecule 1 in a biological specimen. | Platelet Endothelial Cell Adhesion Molecule 1 Measurement | ||
Platelet Fctr 4 Heparin Cmplx Induced Ab | C147412 | Platelet Factor 4 Heparin Complex Induced Antibody;Platelet Fctr 4 Heparin Cmplx Induced Ab | A measurement of the platelet factor 4 heparin complex induced antibody in a biological specimen. | Platelet Factor 4-Heparin Complex Induced Antibody Measurement | ||
Platelet Function Closure Time | C111295 | PFCT;Platelet Function Closure Time | A measurement of the platelet function closure time in a biological specimen. | Platelet Function Closure Time Measurement | ||
Platelet Hematocrit | C100424 | Platelet Hematocrit;Thrombocytocrit | A relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets. | Platelet Hematocrit Measurement | ||
Platelet Mass Distribution Width | C132380 | Platelet Mass Distribution Width | A measurement which represents the variation defined by two standard deviations of the platelet dry mass distribution in a biological specimen. | Platelet Mass Distribution Width | ||
Platelet Morphology | C111296 | Platelet Morphology | An examination or assessment of the form and structure of platelets. | Platelet Morphology Measurement | ||
Platelet Satellitism | C116209 | Platelet Satellitism | An examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen. | Platelet Satellitism Assessment | ||
Platelet-Granulocyte Agg | C165978 | Platelet-Granulocyte Agg;Platelet-Granulocyte Aggregates | A measurement of the aggregates composed of platelets and granulocytes in a biological specimen. | Platelet-Granulocyte Aggregate Measurement | ||
Platelets | C51951 | Platelets | A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. | Platelet Count | ||
Platelets, Agranular | C147415 | Platelets, Agranular | A measurement of the agranular platelets in a biological specimen. | Agranular Platelets Count | ||
Platelets, Estimated | C135440 | Platelets, Estimated | An estimated measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. | Estimated Platelets Measurement | ||
Poikilocytes | C79602 | Poikilocytes | A measurement of the odd-shaped erythrocytes in a whole blood specimen. | Poikilocyte Measurement | ||
Poikilocytes/Erythrocytes | C74649 | Poikilocytes/Erythrocytes | A relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen. | Poikilocyte to Erythrocyte Ratio Measurement | ||
Polychromasia | C64803 | Polychromasia | A measurement of the blue-staining characteristic of newly generated erythrocytes. | Polychromasia | ||
Polychromatophilic Erythroblast | C147418 | Polychromatophilic Erythroblast | A measurement of the polychromatophilic erythroblasts in a biological specimen taken from a non-human organism. | Polychromatophilic Erythroblast Count | ||
Polychromatophilic Normoblast | C147419 | Polychromatophilic Normoblast | A measurement of the polychromatophilic normoblasts in a biological specimen taken from a non-human organism. | Polychromatophilic Normoblast Count | ||
Porphobilinogen | C156539 | Porphobilinogen | A measurement of the porphobilinogen in a biological specimen. | Porphobilinogen Measurement | ||
Porphobilinogen/Creatinine | C156540 | Porphobilinogen/Creatinine | A relative measurement (ratio or percentage) of the porphobilinogen to creatinine in a biological specimen. | Porphobilinogen to Creatinine Ratio Measurement | ||
Porphyrin | C120648 | Porphyrin | A measurement of the total porphyrin in a biological specimen. | Porphyrin Measurement | ||
Potassium Clearance | C106560 | Potassium Clearance | A measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute). | Potassium Clearance Measurement | ||
Potassium Excretion Rate | C150820 | Potassium Excretion Rate | A measurement of the amount of potassium being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Potassium Excretion Rate | ||
Potassium | C64853 | Potassium | A measurement of the potassium in a biological specimen. | Potassium Measurement | ||
Potassium/Creatinine | C79462 | Potassium/Creatinine | A relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen. | Potassium to Creatinine Ratio Measurement | ||
PP Arterial O2/Fraction Inspired O2 | C119293 | PAO2/FIO2;PP Arterial O2/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. | Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement | ||
Prazepam | C139080 | Prazepam | A measurement of the prazepam present in a biological specimen. | Prazepam Measurement | ||
Prealbumin | C100435 | Prealbumin;Thyroxine-binding Prealbumin;Transthyretin | A measurement of the prealbumin in a biological specimen. | Prealbumin Measurement | ||
Precursor Plasma Cells | C74619 | Plasmablast;Precursor Plasma Cells | A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. | Precursor Plasma Cell Count | ||
Precursor Plasma Cells/Lymphocytes | C74650 | Precursor Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen. | Precursor Plasma Cell to Lymphocyte Ratio Measurement | ||
Pregabalin | C184642 | Pregabalin | A measurement of the pregabalin in a biological specimen. | Pregabalin Measurement | ||
Pregnancy-Associated Plasma Protein-A | C82031 | Pregnancy-Associated Plasma Protein-A | A measurement of the pregnancy-associated plasma protein-A in a biological specimen. | Pregnancy-Associated Plasma Protein-A Measurement | ||
Pregnanediol | C186092 | Pregnanediol | A measurement of the pregnanediol in a biological specimen. | Pregnanediol Measurement | ||
Pregnenolone | C147421 | Pregnenolone | A measurement of the pregnenolone in a biological specimen. | Pregnenolone Measurement | ||
Pro-C6 | C165979 | C-terminal Pro-Peptide of the Alpha 3 Type VI Collagen Chain;Endotrophin;Pro-C6 | A measurement of the pro-C6 in a biological specimen. | Pro-C6 Measurement | ||
Pro-gastrin Releasing Peptide | C156523 | Pro-gastrin Releasing Peptide;proGRP | A measurement of the pro-gastrin releasing peptide in a biological specimen. | Pro-gastrin Releasing Peptide Measurement | ||
ProB-type Natriuretic Peptide | C82032 | Pro-Brain Natriuretic Peptide;ProB-type Natriuretic Peptide;proBNP | A measurement of the proB-type natriuretic peptide in a biological specimen. | ProB-Type Natriuretic Peptide Measurement | ||
Procalcitonin | C103430 | Procalcitonin | A measurement of the procalcitonin in a biological specimen. | Procalcitonin Measurement | ||
Prochlorperazine | C177983 | Prochlorperazine | A measurement of the prochlorperazine in a biological specimen. | Prochlorperazine Measurement | ||
Procollagen 1 N-Terminal Propeptide | C96625 | Amino-terminal propeptide of type 1 procollagen;P1NP Aminoterm Type 1;Procollagen 1 N-Terminal Propeptide | A measurement of the procollagen 1 N-terminal propeptide in a biological specimen. | Procollagen 1 N-Terminal Propeptide Measurement | ||
Procollagen 3 N-Terminal Propeptide | C128973 | Procollagen 3 N-Terminal Propeptide | A measurement of the procollagen 3 N-terminal propeptide in a biological specimen. | Procollagen 3 N-Terminal Propeptide Measurement | ||
Procollagen Type I Carboxy Term Peptide | C82033 | Procollagen Type I Carboxy Term Peptide | A measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen. | Procollagen Type I Carboxy Terminal Peptide Measurement | ||
Progesterone Receptor | C117846 | NR3C3;PGR;PgR;PR;Progesterone Receptor | A measurement of the progesterone receptor protein in a biological specimen. | Progesterone Receptor Measurement | ||
Progesterone | C74791 | Progesterone | A measurement of the progesterone hormone in a biological specimen. | Progesterone Measurement | ||
Progranulin | C165964 | Progranulin | A measurement of the progranulin in a biological specimen. | Progranulin Measurement | ||
Proinsulin | C81967 | Proinsulin | A measurement of the proinsulin in a biological specimen. | Proinsulin Measurement | ||
Proinsulin/Insulin Ratio | C111299 | Proinsulin/Insulin Ratio | A relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen. | Proinsulin to Insulin Ratio Measurement | ||
Prolactin | C74870 | Prolactin | A measurement of the prolactin hormone in a biological specimen. | Prolactin Measurement | ||
Proliferating Cell Nuclear Antigen | C120646 | Cyclin;Proliferating Cell Nuclear Antigen | A measurement of the proliferating cell nuclear antigen in a biological specimen. | Proliferating Cell Nuclear Antigen Measurement | ||
Proliferating Erythroid/Total Cells | C127632 | Proliferating Erythroid/Total Cells | A relative measurement (ratio or percentage) of the proliferating erythroid cells to total cells in a biological specimen. | Proliferating Erythroid Cell to Total Cell Ratio Measurement | ||
Proliferating Myeloid Cells/Total Cells | C127634 | Proliferating Myeloid Cells/Total Cells | A relative measurement (ratio or percentage) of the proliferating myeloid cells to total cells in a biological specimen. | Proliferating Myeloid Cell to Total Cell Ratio Measurement | ||
Proline Aminopeptidase | C198289 | Cytosol Aminopeptidase V;Proline Aminopeptidase;Proline Iminopeptidase;Prolyl Aminopeptidase | A measurement of the proline aminopeptidase in a biological specimen. | Proline Aminopeptidase Measurement | ||
Proline | C122141 | Proline | A measurement of the proline in a biological specimen. | Proline Measurement | ||
Prolymphocytes | C74620 | Prolymphocytes | A measurement of the prolymphocytes in a biological specimen. | Prolymphocyte Count | ||
Prolymphocytes/Leukocytes | C64829 | Prolymphocytes/Leukocytes | A relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen. | Prolymphocyte to Leukocyte Ratio | ||
Prolymphocytes/Lymphocytes | C74651 | Prolymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen. | Prolymphocyte to Lymphocyte Ratio Measurement | ||
Promonocytes | C74621 | Promonocytes | A measurement of the promonocytes in a biological specimen. | Promonocyte Count | ||
Promonocytes/Leukocytes | C74652 | Promonocytes/Leukocytes | A relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen. | Promonocyte to Lymphocyte Ratio Measurement | ||
Promonocytes/Total Cells | C187678 | Promonocytes/Total Cells | A relative measurement (ratio or percentage) of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen). | Promonocyte to Total Cell Ratio Measurement | ||
Promyeloblasts | C117847 | Promyeloblasts | A measurement of the promyeloblasts in a biological specimen. | Promyeloblasts Measurement | ||
Promyelocytes | C74622 | Promyelocytes | A measurement of the promyelocytes (immature myelocytes) in a biological specimen. | Promyelocyte Count | ||
Promyelocytes/Leukocytes | C74653 | Promyelocytes/Leukocytes | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen. | Promyelocyte to Lymphocyte Ratio Measurement | ||
Promyelocytes/Total Cells | C98773 | Promyelocytes/Total Cells | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). | Promyelocyte to Total Cell Ratio Measurement | ||
Propoxyphene | C74885 | Propoxyphene | A measurement of the propoxyphene present in a biological specimen. | Propoxyphene Measurement | ||
Proprotein Convertase Subtilisin/Kexin 9 | C120647 | Proprotein Convertase Subtilisin/Kexin 9 | A measurement of the proprotein convertase subtilisin/kexin type 9 in a biological specimen. | Proprotein Convertase Subtilisin/Kexin Type 9 Measurement | ||
Prorubricyte | C128976 | Basophilic Erythroblast;Basophilic Normoblast;Prorubricyte | A measurement of the prorubricytes in a biological specimen. | Prorubricyte Count | ||
Prorubricyte/Total Cells | C128977 | Prorubricyte/Total Cells | A relative measurement (ratio or percentage) of the prorubricytes to total cells in a biological specimen. | Prorubricyte to Total Cell Ratio Measurement | ||
Prostaglandin D2 Receptor 2 | C189515 | Prostaglandin D2 Receptor 2 | A measurement of the prostaglandin D2 receptor 2 in a biological specimen. | Prostaglandin D2 Receptor 2 Measurement | ||
Prostaglandin D2 Synthase | C103432 | Beta-Trace Protein;Prostaglandin D2 Synthase | A measurement of the prostaglandin D2 synthase in a biological specimen. | Prostaglandin D2 Synthase Measurement | ||
Prostaglandin D2 | C103431 | Prostaglandin D2 | A measurement of the prostaglandin D2 in a biological specimen. | Prostaglandin D2 Measurement | ||
Prostaglandin E Synthase | C103433 | Prostaglandin E Synthase | A measurement of the prostaglandin E synthase in a biological specimen. | Prostaglandin E Synthase Measurement | ||
Prostaglandin E1 | C103434 | Prostaglandin E1 | A measurement of the prostaglandin E1 in a biological specimen. | Prostaglandin E1 Measurement | ||
Prostaglandin E2 | C103435 | Prostaglandin E2 | A measurement of the prostaglandin E2 in a biological specimen. | Prostaglandin E2 Measurement | ||
Prostaglandin F1 Alpha | C103436 | Prostaglandin F1 Alpha | A measurement of the prostaglandin F1 alpha in a biological specimen. | Prostaglandin F1 Alpha Measurement | ||
Prostaglandin F2 Alpha | C103437 | Prostaglandin F2 Alpha | A measurement of the prostaglandin F2 alpha in a biological specimen. | Prostaglandin F2 Alpha Measurement | ||
Prostaglandin | C103343 | Prostaglandin | A measurement of the total prostaglandin in a biological specimen. | Prostaglandin Measurement | ||
Prostanozol | C184598 | Prostanozol | A measurement of the prostanozol in a biological specimen. | Prostanozol Measurement | ||
Prostate Cancer Antigen 3 mRNA | C132379 | Prostate Cancer Antigen 3 mRNA | A measurement of the prostate cancer antigen 3 mRNA in a biological specimen. | Prostate Cancer Antigen 3 mRNA Measurement | ||
Prostate Circulating Tumor Cells | C132382 | Prostate Circulating Tumor Cells | A measurement of the prostate circulating tumor cells in a biological specimen. | Circulating Prostate Tumor Cell Count | ||
Prostate Specific Antigen mRNA | C132385 | Prostate Specific Antigen mRNA | A measurement of the prostate-specific antigen mRNA in a biological specimen. | Prostate Specific Antigen mRNA Measurement | ||
Prostate Specific Antigen | C17634 | Prostate Specific Antigen | A measurement of the total prostate specific antigen in a biological specimen. | Prostate Specific Antigen Measurement | ||
Prostate Specific Antigen, Free | C132383 | Prostate Specific Antigen, Free | A measurement of the unbound prostate-specific antigen in a biological specimen. | Free Prostate Specific Antigen Measurement | ||
Prostatic Acid Phosphatase | C80204 | Prostatic Acid Phosphatase | A measurement of the prostatic acid phosphatase in a biological specimen. | Prostatic Acid Phosphatase Measurement | ||
Protein Excretion Rate | C150822 | Protein Excretion Rate | A measurement of the amount of total protein being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Protein Excretion Rate | ||
Protein Induced by Vitamin K Absence-II | C150846 | DCP;Des-Gammacarboxyprothrombin;PIVKA-II;Protein Induced by Vitamin K Absence-II;Protein Induced by Vitamin K Absence/Antagonist-II | A measurement of the protein induced by vitamin K absence-II in a biological specimen. | Protein Induced by Vitamin K Absence-II Measurement | ||
Protein Pattern | C147422 | Protein Pattern | A measurement of the protein band pattern in a biological specimen. | Protein Pattern Measurement | ||
Protein S Activity Actual/Control | C147424 | Protein S Activity Actual/Control;Protein S Activity Actual/Normal;Protein S Activity Actual/Protein S Activity Control | A relative measurement (ratio or percentage) of the biological activity of protein S in a subject's specimen when compared to the same activity in a control specimen. | Protein S Activity Actual to Control Ratio Measurement | ||
Protein S Actual/Control | C170593 | Protein S Actual/Control | A relative measurement (ratio or percentage) of the protein S in a subject's specimen when compared to a control specimen. | Protein S Actual to Control Ratio Measurement | ||
Protein S Free Activity Actual/Control | C147425 | Protein S Free Activity Actual/Control;Protein S Free Activity Actual/Normal;Protein S Free Activity Actual/Protein S Free Activity Control | A relative measurement (ratio or percentage) of the biological activity of free protein S in a subject's specimen when compared to the same activity in a control specimen. | Free Protein S Activity Actual to Control Ratio Measurement | ||
Protein S | C100436 | Protein S | A measurement of the total protein S in a biological specimen. | Protein S Measurement | ||
Protein S, Free Actual/Control | C170596 | Protein S, Free Actual/Control | A relative measurement (ratio or percentage) of the free protein S in a subject's specimen when compared to a control specimen. | Free Protein S Actual to Control Ratio Measurement | ||
Protein S, Free | C122142 | Protein S, Free | A measurement of the unbound protein S in a biological specimen. | Free Protein S Measurement | ||
Protein | C64858 | Protein | A measurement of the total protein in a biological specimen. | Total Protein Measurement | ||
Protein/Creatinine | C79463 | Protein/Creatinine | A relative measurement (ratio or percentage) of the total protein to creatinine in a biological specimen. | Protein to Creatinine Ratio Measurement | ||
Protein/Osmolality | C92240 | Protein/Osmolality;Protein/Osmolality Ratio | A relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen. | Protein to Osmolality Ratio Measurement | ||
Proteinase 3 Antibody | C120649 | Proteinase 3 Antibody | A measurement of the proteinase 3 antibody in a biological specimen. | Proteinase 3 Antibody Measurement | ||
Prothrombin Activity | C98774 | Factor II Activity;Prothrombin Activity | A measurement of the biological activity of coagulation factor prothrombin in a biological specimen. | Prothrombin Activity Measurement | ||
Prothrombin Fragment 1 | C189514 | Prothrombin Fragment 1 | A measurement of the prothrombin fragment 1 in a biological specimen. | Prothrombin Fragment 1 Measurement | ||
Prothrombin Fragment 2 | C189513 | Prothrombin Fragment 2 | A measurement of the prothrombin fragment 2 in a biological specimen. | Prothrombin Fragment 2 Measurement | ||
Prothrombin Fragments 1 + 2 | C82034 | Prothrombin Fragments 1 + 2 | A measurement of the prothrombin fragments 1 and 2 in a biological specimen. | Prothrombin Fragments 1 and 2 Measurement | ||
Prothrombin Intl. Normalized Ratio | C64805 | Prothrombin Intl. Normalized Ratio | A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test. | International Normalized Ratio of Prothrombin Time | ||
Prothrombin Time Actual/Control | C170591 | Prothrombin Time Actual/Control | A relative measurement (ratio or percentage) of the prothrombin time in a subject's specimen when compared to a control specimen. | Prothrombin Time Actual to Control Ratio Measurement | ||
Prothrombin Time | C62656 | Prothrombin Time | A blood clotting measurement that evaluates the extrinsic pathway of coagulation. | Prothrombin Time | ||
Protoporphyrin, Free | C147341 | Protoporphyrin, Free | A measurement of the free protoporphyrin (unbound to iron in hemoglobin) in a biological specimen. | Free Protoporphyrin Measurement | ||
Protriptyline | C191287 | Protriptyline | A measurement of the protriptyline present in a biological specimen. | Protriptyline Measurement | ||
Prprot Cnvrtase Subtilisin-Kexin 9, Free | C186091 | Proprotein Convertase Subtilisin/Kexin Type 9;Prprot Cnvrtase Subtilisin-Kexin 9, Free | A measurement of the free proprotein convertase subtilisin/kexin type 9 in a biological specimen. | Free Proprotein Convertase Subtilisin/Kexin Type 9 Measurement | ||
PSA, Free/PSA | C132384 | PSA, Free/PSA | A relative measurement (percentage) of the free prostate specific antigen to total prostate specific antigen in a biological specimen. | Free PSA to Total PSA Ratio Measurement | ||
Pseudo Pelger-Huet Neutrophils | C187823 | Neutrophils with Pseudo Pelger-Huet Nucleus;Pseudo Pelger-Huet Neutrophils | A measurement of the neutrophils with a Pelger-Huet-like nucleus (hyposegmented) in a biological specimen. | Pseudo Pelger-Huet Neutrophil Count | ||
Pseudo-Eosinophils | C165958 | Pseudo-Eosinophils | A measurement of the pseudo-eosinophils in a biological specimen. | Pseudo-Eosinophil Count | ||
Pseudo-Eosinophils/Leukocytes | C165959 | Pseudo-Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of the pseudo-eosinophils to the leukocytes in a biological specimen. | Pseudo-Eosinophils to Leukocyte Ratio Measurement | ||
Pseudoephedrine | C74696 | Pseudoephedrine | A measurement of the pseudoephedrine present in a biological specimen. | Pseudoephedrine Measurement | ||
Psilocybin | C75356 | Magic Mushrooms;Psilocybin;Psilocybine | A measurement of the psilocybin in a biological specimen. | Psilocybine Measurement | ||
PTT/Standard | C187818 | Partial Thromboplastin Time/Standard Thromboplastin Time;PTT/Standard;PTT/Standard PTT | A relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time. | Partial Thromboplastin Time to Standard Thromboplastin Time Ratio Measurement | ||
Pus | C161359 | Pus | A measurement of the pus in a biological specimen. | Pus Measurement | ||
Pyknotic Cells | C189346 | Karyopyknotic Cells;Pyknotic Cells | A measurement of the pyknotic cells in a biological specimen. | Pyknotic Cell Count | ||
Pyocytes | C156524 | Pyocytes | A measurement of the pyocytes in a biological specimen. | Pyocytes Measurement | ||
Pyridinoline | C80211 | Pyridinoline | A measurement of the pyridinoline in a biological specimen. | Pyridinoline Measurement | ||
Pyridinoline/Creatinine | C147426 | Pyridinoline/Creatinine | A relative measurement (ratio or percentage) of the pyridinoline to creatinine in a biological specimen. | Pyridinoline to Creatinine Ratio Measurement | ||
Pyridoxal Phosphate | C158237 | Active Vitamin B6;Pyridoxal Phosphate | A measurement of the pyridoxal phosphate in a biological specimen. | Pyridoxal Phosphate Measurement | ||
Pyrovalerone | C184643 | Pyrovalerone | A measurement of the pyrovalerone in a biological specimen. | Pyrovalerone Measurement | ||
Pyruvate Kinase Isozyme M1 | C156532 | Pyruvate Kinase Isozyme M1 | A measurement of the pyruvate kinase isozyme M1 in a biological specimen. | Pyruvate Kinase Isozyme M1 Measurement | ||
Pyruvate Kinase Isozyme M2 | C156531 | Pyruvate Kinase Isozyme M2 | A measurement of the pyruvate kinase isozyme M2 in a biological specimen. | Pyruvate Kinase Isozyme M2 Measurement | ||
Pyruvate Kinase Muscle Isozyme | C156530 | Pyruvate Kinase Muscle Isozyme | A measurement of the total pyruvate kinase muscle isozymes (M1 and M2) in a biological specimen. | Pyruvate Kinase Muscle Isozyme Measurement | ||
Pyruvate Kinase | C156470 | PK;Pyruvate Kinase | A measurement of the total pyruvate kinase in a biological specimen. | Pyruvate Kinase Measurement | ||
Pyruvate | C147427 | Pyruvate;Pyruvic Acid | A measurement of the pyruvate in a biological specimen. | Pyruvate Measurement | ||
Quazepam | C184634 | Quazepam | A measurement of the quazepam in a biological specimen. | Quazepam Measurement | ||
Quetiapine | C177965 | Quetiapine | A measurement of the quetiapine in a biological specimen. | Quetiapine Measurement | ||
RBC Casts | C74772 | Erythrocyte Casts;RBC Casts | A measurement of the red blood cell casts present in a biological specimen. | Red Blood Cell Cast Measurement | ||
RDW Standard Deviation | C139071 | RDW Standard Deviation;RDW-SD;Red Cell Volume Distribution Width Standard Deviation | A measurement of the volume dispersion within an erythrocyte population, calculated as the width of the distribution curve at the 20 percent frequency level. | Red Cell Volume Distribution Width Standard Deviation | ||
Reactive Oxygen Metabolite | C122146 | Reactive Oxygen Metabolite | A measurement of the reactive oxygen metabolite in a biological specimen. | Reactive Oxygen Metabolite Measurement | ||
Receptor Activator Nuclear KappaB Ligand | C117852 | Receptor Activator Nuclear KappaB Ligand;Receptor Activator of Nuclear Kappa-B Ligand | A measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen. | Receptor Activator Nuclear KappaB Ligand Measurement | ||
Receptor Advanced Glycation Endproducts | C165980 | Advanced Glycosylation End-Product Specific Receptor;AGER;Receptor Advanced Glycation Endproducts | A measurement of the receptor advanced glycation endproducts in a biological specimen. | Receptor Advanced Glycation Endproducts Measurement | ||
Reducing Substances | C147428 | Reducing Substances | A measurement of the reducing substances (e.g., sugars, glutathione, creatinine, uric acid, and ascorbic acid) in a biological specimen. | Reducing Substance Measurement | ||
Reducing Sugars | C147429 | Reducing Sugars | A measurement of the reducing sugars in a biological specimen. | Reducing Sugar Measurement | ||
Reg upon Act Normal T-cell Exprd Secrtd | C81957 | Chemokine Ligand 5;Reg upon Act Normal T-cell Exprd Secrtd | A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen. | Reg upon Act Normal T-cell Exprd Secrtd Measurement | ||
Remnant Lipoprotein | C120656 | Remnant Lipoprotein | A measurement of the remnant lipoproteins in a biological specimen. | Remnant Lipoprotein Measurement | ||
Renal Epithelial Casts | C174229 | Renal Epithelial Casts | A measurement of the renal epithelial cell casts in a biological specimen. | Renal Epithelial Casts Measurement | ||
Renal Epithelial Cells | C170595 | Renal Epithelial Cells | A measurement of the renal epithelial cells in a biological specimen. | Renal Epithelial Cells Measurement | ||
Renal Papillary Antigen 1 | C142289 | Renal Papillary Antigen 1 | A measurement of the renal papillary antigen 1 in a biological specimen. | Renal Papillary Antigen 1 Measurement | ||
Renal Tubular Epithelial Casts | C174292 | Renal Tubular Epithelial Casts | A measurement of the renal tubular epithelial cell casts in a biological specimen. | Renal Tubular Epithelial Casts Measurement | ||
Renin Activity | C111305 | Renin Activity | A measurement of the renin activity in a biological specimen. | Renin Activity Measurement | ||
Renin | C74893 | Active Renin;Angiotensinogenase;Direct Renin;Renin | A measurement of the renin in a biological specimen. | Renin Measurement | ||
Reptilase Activity Actual/Control | C147430 | Reptilase Activity Actual/Control;Reptilase Activity Actual/Normal;Reptilase Activity Actual/Reptilase Activity Control | A relative measurement (ratio or percentage) of the biological activity of reptilase dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Reptilase Activity Actual to Control Ratio Measurement | ||
Reptilase Time | C96628 | Reptilase Time | A measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase. | Reptilase Time Measurement | ||
Resistin | C80205 | Resistin | A measurement of the resistin in a biological specimen. | Resistin Measurement | ||
Ret Corpuscular HGB Conc Distr Width | C139069 | Ret Corpuscular HGB Conc Distr Width;Reticulocyte Corpuscular Hemoglobin Distribution Width | A measurement of the standard deviation of hemoglobin concentrations in reticulocytes in a biological specimen, calculated as the standard deviation of hemoglobin content divided by the mean hemoglobin content. | Reticulocyte Corpuscular Hemoglobin Distribution Width | ||
Ret Hemoglobin Distribution Width | C139070 | Ret Hemoglobin Distribution Width;Reticulocyte Hemoglobin Concentration Distribution Width | A measurement of the distribution of the hemoglobin concentration in reticulocytes. | Reticulocyte Hemoglobin Distribution Width | ||
Ret RDW Coefficient of Variation | C139072 | RDWr-CV;Red Cell Volume Distribution Width Coefficient of Variation in Reticulocytes;Ret RDW Coefficient of Variation;Reticulocyte Volume Distribution Width Coefficient of Variation | A measurement of the volume dispersion within a reticulocyte population, calculated as the standard deviation of the mean reticulocyte volume divided by the mean reticulocyte volume, multiplied by 100 to convert to a percentage. | Reticulocyte Volume Distribution Width Coefficient of Variation | ||
Ret RDW Standard Deviation | C139073 | RDWr-SD;Red Cell Volume Distribution Width Standard Deviation in Reticulocytes;Ret RDW Standard Deviation;Reticulocyte Volume Distribution Width Standard Deviation | A measurement of the volume dispersion within a reticulocyte population, calculated as the width of the distribution curve at the 20 percent frequency level. | Reticulocyte Volume Distribution Width Standard Deviation | ||
Ret Volume Distribution Width | C139074 | RDWr;Ret Volume Distribution Width;Reticulocyte Volume Distribution Width | A relative measurement (ratio or percentage) of the standard deviation of the reticulocyte volume to the mean distribution of the reticulocyte volume in a biological specimen. | Reticulocyte Volume Distribution Width | ||
Ret. Corpuscular Hemoglobin Content | C98776 | CHr;Ret. Corpuscular Hemoglobin Content;Reticulocyte Cellular Hemoglobin Content | A measurement of the average total amount of hemoglobin per reticulocyte. | Reticulocyte Corpuscular Hemoglobin Content | ||
Ret. Corpuscular HGB Concentration Mean | C138970 | Ret. Corpuscular HGB Concentration Mean;Reticulocyte Corpuscular Hemoglobin Concentration Mean | An indirect measurement of the average concentration of hemoglobin per reticulocyte in a biological specimen, calculated as the ratio of hemoglobin to hematocrit. | Reticulocyte Corpuscular Hemoglobin Concentration Mean | ||
Reticulocytes | C51947 | Reticulocytes | A measurement of the reticulocytes in a biological specimen. | Reticulocyte Count | ||
Reticulocytes/Erythrocytes | C64828 | Reticulocytes/Erythrocytes | A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen. | Reticulocyte to Erythrocyte Ratio | ||
Reticulocytes/Total Cells | C187680 | Reticulocytes/Total Cells | A relative measurement (ratio or percentage) of reticulocytes to total cells in a biological specimen. | Reticulocyte to Total Cell Ratio Measurement | ||
Retinoic Acid | C187824 | Retinoate;Retinoic Acid | A measurement of the retinoic acid in a biological specimen. | Retinoic Acid Measurement | ||
Retinol Binding Protein 1 | C189526 | Retinol Binding Protein 1 | A measurement of the retinol binding protein 1 in a biological specimen. | Retinol Binding Protein 1 Measurement | ||
Retinol Binding Protein 2 | C189525 | Retinol Binding Protein 2 | A measurement of the retinol binding protein 2 in a biological specimen. | Retinol Binding Protein 2 Measurement | ||
Retinol Binding Protein 3 | C189524 | Retinol Binding Protein 3 | A measurement of the retinol binding protein 3 in a biological specimen. | Retinol Binding Protein 3 Measurement | ||
Retinol Binding Protein 4 | C189523 | Retinol Binding Protein 4 | A measurement of the retinol binding protein 4 in a biological specimen. | Retinol Binding Protein 4 Measurement | ||
Retinol Binding Protein | C100437 | Retinol Binding Protein | A measurement of the total retinol binding protein in a biological specimen. | Retinol Binding Protein Measurement | ||
Retinol Binding Protein/Creatinine | C154729 | Retinol Binding Protein/Creatinine | A relative measurement (ratio or percentage) of the retinol binding protein to creatinine in a biological specimen. | Retinol Binding Protein to Creatinine Ratio Measurement | ||
Retinyl Palmitate | C135442 | Retinol Palmitate;Retinyl Palmitate;Vitamin A Palmitate | A measurement of the endogenous retinyl palmitate vitamin A in a biological specimen. | Retinyl Palmitate Measurement | ||
Rh Factor | C92948 | Rh Factor | A measurement of non-specified Rhesus factor antigen(s) in a biological specimen. | Rh Factor Measurement | ||
RhD Factor | C125948 | RhD Factor | A measurement of the Rhesus factor D antigen in a biological specimen. | RhD Factor Measurement | ||
Rheumatoid Factor IgA Antibody | C120652 | Rheumatoid Factor IgA Antibody | A measurement of the rheumatoid factor IgA antibody in a biological specimen. | Rheumatoid Factor Antibody IgA Measurement | ||
Rheumatoid Factor IgG Antibody | C120653 | Rheumatoid Factor IgG Antibody | A measurement of the rheumatoid factor IgG antibody in a biological specimen. | Rheumatoid Factor Antibody IgG Measurement | ||
Rheumatoid Factor IgM Antibody | C120654 | Rheumatoid Factor IgM Antibody | A measurement of the rheumatoid factor IgM antibody in a biological specimen. | Rheumatoid Factor Antibody IgM Measurement | ||
Rheumatoid Factor | C74717 | Rheumatoid Factor | A measurement of the rheumatoid factor antibody in a biological specimen. | Rheumatoid Factor Measurement | ||
Riboflavin | C74898 | Riboflavin;Vitamin B2 | A measurement of the riboflavin in a biological specimen. | Vitamin B2 Measurement | ||
Ribonucleic Acid | C132301 | Ribonucleic Acid | A measurement of a targeted ribonucleic acid (RNA) in a biological specimen. | Ribonucleic Acid Measurement | ||
Ribonucleoprotein Antibody | C100457 | Ribonucleoprotein Antibody;Ribonucleoprotein Extractable Nuclear Antibody;RNP Antibody | A measurement of the total ribonucleoprotein antibodies in a biological specimen. | Ribonucleoprotein Antibody Measurement | ||
Ribonucleoprotein Smith Complex Antibody | C120658 | Ribonucleoprotein Smith Complex Antibody | A measurement of the ribonucleoprotein Smith complex antibody in a biological specimen. | Ribonucleoprotein Smith Complex Antibody Measurement | ||
Ribonucleoprotein-70 Antibody | C120657 | Ribonucleoprotein-70 Antibody;snRNP70 Antibody | A measurement of the small nuclear ribonucleoprotein 70 antibody in a biological specimen. | Ribonucleoprotein-70 Antibody Measurement | ||
Ribosomal P Protein Antibody | C120659 | Ribosomal P Protein Antibody | A measurement of the total ribosomal P protein antibody in a biological specimen. | Ribosomal P Protein Antibody Measurement | ||
Ringed Sideroblasts | C100419 | Ringed Sideroblasts | A measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen. | Ring Sideroblast Measurement | ||
Risperidone | C177969 | Risperidone | A measurement of the risperidone in a biological specimen. | Risperidone Measurement | ||
Risperidone+9-Hydroxyrisperidone | C177971 | Risperidone+9-Hydroxyrisperidone;Risperidone+Paliperidone | A measurement of the risperidone and 9-hydroxyrisperidone in a biological specimen. | Risperidone and 9-Hydroxyrisperidone Measurement | ||
Ritalinic Acid | C170582 | Ritalinic Acid | A measurement of the ritalinic acid in a biological specimen. | Ritalinic Acid Measurement | ||
RLP Cholesterol | C120655 | RLP Cholesterol | A measurement of the cholesterol remnant-like particles in a biological specimen. | Remnant-like Particle Cholesterol Measurement | ||
RNA Polymerase III IgG Antibody | C122147 | RNA Polymerase III IgG Antibody | A measurement of the RNA polymerase III IgG antibody in a biological specimen. | RNA Polymerase III IgG Antibody Measurement | ||
Rouleaux Formation | C74624 | Rouleaux Formation | A measurement of the stacking red blood cells in a biological specimen. | Rouleaux Formation Count | ||
Round Cells | C142288 | Round Cells | A measurement of the round cells (round shaped cells mainly comprised of white blood cells and immature spermatogenic cells) in a biological specimen. | Round Cell Count | ||
Round Epithelial Cells | C74698 | Round Epithelial Cells | A measurement of the round epithelial cells present in a biological specimen. | Round Epithelial Cell Count | ||
Rubriblast | C100446 | Proerythroblast;Pronormoblast;Rubriblast | A measurement of the rubriblasts in a biological specimen. | Proerythroblast Measurement | ||
Rubriblast/Total Cells | C98870 | Proerythroblast/Total Cells;Pronormoblasts/Total Cells;Rubriblast/Total Cells | A relative measurement (ratio or percentage) of the rubriblasts to total cells in a biological specimen (for example a bone marrow specimen). | Pronormoblast to Total Cell Ratio Measurement | ||
Rubricyte | C128978 | Polychromatophilic Erythroblast;Polychromatophilic Normoblast;Rubricyte | A measurement of the rubricytes in a biological specimen. | Rubricyte Count | ||
Rubricyte/Total Cells | C129006 | Rubricyte/Total Cells | A relative measurement (ratio or percentage) of the rubricytes to total cells in a biological specimen. | Rubricyte to Total Cell Ratio Measurement | ||
Russian Thistle Pollen IgE AB RAST Score | C165889 | Russian Thistle Pollen IgE AB RAST Score | A classification of the amount of Salsola tragus pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Russian Thistle Pollen IgE Antibody RAST Score Measurement | ||
Russian Thistle Pollen IgE Antibody | C165888 | Russian Thistle Pollen IgE Antibody | A measurement of the Salsola tragus pollen antigen IgE antibody in a biological specimen. | Russian Thistle Pollen IgE Antibody Measurement | ||
S-Adenosylhomocysteine | C172516 | S-adenosyl-L-homocysteine;S-Adenosylhomocysteine;SAH | A measurement of the S-adenosylhomocysteine in a biological specimen. | S-Adenosylhomocysteine Measurement | ||
S-Adenosylmethionine | C172515 | S-adenosyl-L-methionine;S-Adenosylmethionine;SAM-e;SAMe;SAMMY | A measurement of the S-adenosylmethionine in a biological specimen. | S-Adenosylmethionine Measurement | ||
S100 Calcium Binding Protein A8 | C154730 | S100 Calcium Binding Protein A8 | A measurement of the S100 calcium binding protein A8 in a biological specimen. | S100 Calcium Binding Protein A8 Measurement | ||
S100 Calcium-Binding Protein B | C127635 | S100 Calcium-Binding Protein B | A measure of the S100 calcium-binding protein B in a biological specimen. | S100 Calcium-Binding Protein B Measurement | ||
Salicylates | C147431 | Salicylates | A measurement of the salicylates in a biological specimen. | Salicylates Measurement | ||
Sarcosine | C154760 | N-Methylglycine;Sarcosine | A measurement of the sarcosine in a biological specimen. | Sarcosine Measurement | ||
Schistocytes | C74706 | Schistocytes | A measurement of the schistocytes (fragmented red blood cells) in a biological specimen. | Schistocyte Count | ||
Schistocytes/Erythrocytes | C186094 | Schistocytes/Erythrocytes | A relative measure (ratio or percentage) of schistocytes to erythrocytes in a biological specimen. | Schistocyte to Erythrocyte Ratio Measurement | ||
Scl-70 Antibody | C100458 | Scl-70 Antibody;Scleroderma-70 Antibody | A measurement of the total Scl-70 antibody in a biological specimen. | Scl-70 Antibody Measurement | ||
Scl-70 IgG Antibody | C122148 | Scl-70 IgG Antibody;Scleroderma-70 IgG Antibody | A measurement of the Scl-70 IgG antibody in a biological specimen. | Scl-70 IgG Antibody Measurement | ||
Sclerostin | C117857 | Sclerostin | A measurement of the sclerostin in a biological specimen. | Sclerostin Measurement | ||
Secobarbital | C75369 | Secobarbital | A measurement of the secobarbital present in a biological specimen. | Secobarbital Measurement | ||
Secretin | C74871 | Secretin | A measurement of the secretin hormone in a biological specimen. | Secretin Measurement | ||
Sediment Examination | C105744 | Microscopic Sediment Analysis;Sediment Analysis;Sediment Examination | An observation, assessment or examination of the sediment in a biological specimen. | Sediment Analysis | ||
Selenium | C187825 | Selenium | A measurement of the selenium in a biological specimen. | Selenium Measurement | ||
Serine | C122149 | Serine | A measurement of the serine in a biological specimen. | Serine Measurement | ||
Serotonin | C74872 | Serotonin | A measurement of the serotonin hormone in a biological specimen. | Serotonin Measurement | ||
Serpin A12 | C198290 | OL-64;Serpin A12;Serpin Family A Member 12;Vaspin;Visceral Adipose Tissue-Derived Serpin | A measurement of the serpin A12 in a biological specimen. | Serpin A12 Measurement | ||
Sertraline | C147432 | Sertraline | A measurement of the sertraline present in a biological specimen. | Sertraline Measurement | ||
Serum Amyloid A1 | C165982 | PIG4;SAA1;Serum Amyloid A-1 Protein;Serum Amyloid A1 | A measurement of the serum amyloid A1 in a biological specimen. | Serum Amyloid A1 Measurement | ||
Serum-Ascites Albumin Gradient | C186093 | SAAG;Serum-Ascites Albumin Gradient | A measurement of the serum-ascites albumin gradient, calculated by subtracting the amount of albumin in ascites fluid from the albumin in serum. | Serum-Ascites Albumin Gradient Measurement | ||
Sex Hormone Binding Globulin | C74745 | Sex Hormone Binding Globulin;Sex Hormone Binding Protein | A measurement of the sex hormone binding (globulin) protein in a biological specimen. | Sex Hormone Binding Protein Measurement | ||
Sezary Cells | C74625 | Sezary Cells | A measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen. | Sezary Cell Count | ||
Sezary Cells/Leukocytes | C158231 | Sezary Cells/Leukocytes | A relative measurement (ratio or percentage) of the Sezary cells to all leukocytes in a biological specimen. | Sezary Cells to Leukocytes Ratio Measurement | ||
Sezary Cells/Lymphocytes | C74655 | Sezary Cells/Lymphocytes | A relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen. | Sezary Cell to Lymphocyte Ratio Measurement | ||
SH2 Domain Containing 1A Protein | C165983 | DSHP;Duncan Disease SH2-Protein;EBVS;IMD5;LYP;MTCP1;SAP;SAP/SH2D1A;SH2 Domain Containing 1A Protein;XLP;XLPD;XLPD1 | A measurement of the SH2 domain containing 1A protein in a biological specimen. | SH2 Domain Containing 1A Protein Measurement | ||
Shellfish Mix Antigen IgE Antibody | C130120 | Shellfish Mix Antigen IgE Antibody | A measurement of the shellfish mix antigen IgE antibody in a biological specimen. | Shellfish Mix Antigen IgE Antibody Measurement | ||
Shellfish Mix Antigen IgG Antibody | C130121 | Shellfish Mix Antigen IgG Antibody | A measurement of the shellfish mix antigen IgG antibody in a biological specimen. | Shellfish Mix Antigen IgG Antibody Measurement | ||
Shellfish Mix IgE AB RAST Score | C165930 | Shellfish Mix IgE AB RAST Score | A classification of the amount of shellfish mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Shellfish Mix IgE Antibody RAST Score Measurement | ||
Shellfish Mix IgG AB RAST Score | C165912 | Shellfish Mix IgG AB RAST Score | A classification of the amount of shellfish mix IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Shellfish Mix IgG Antibody RAST Score Measurement | ||
Sialyl SSEA-1 Antigen | C114223 | Sialyl Lewis X Antigen;Sialyl Lex;Sialyl SSEA-1 Antigen;Sialyl-CD15;SLeX | A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen. | Sialyl SSEA-1 Antigen Measurement | ||
Sibutramine | C184635 | Sibutramine | A measurement of the sibutramine in a biological specimen. | Sibutramine Measurement | ||
Sickle Cells | C74626 | Drepanocytes;Sickle Cells | A measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen. | Sickle Cell Count | ||
Sickle Cells/Erythrocytes | C74656 | Sickle Cells/Erythrocytes | A relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen. | Sickle Cell to Erythrocyte Ratio Measurement | ||
Sideroblast | C100418 | Sideroblast | A measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen. | Sideroblast Measurement | ||
Silver Birch Pollen IgA | C130077 | Silver Birch Pollen IgA | A measurement of the Betula verrucosa pollen antigen IgA antibody in a biological specimen. | Silver Birch Pollen IgA Measurement | ||
Silver Birch Pollen IgE AB RAST Score | C165921 | Silver Birch Pollen IgE AB RAST Score | A classification of the amount of Betula pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Silver Birch Pollen IgE Antibody RAST Score Measurement | ||
Silver Birch Pollen IgE | C130076 | Silver Birch Pollen IgE | A measurement of the Betula verrucosa pollen antigen IgE antibody in a biological specimen. | Silver Birch Pollen IgE Measurement | ||
Silver Birch Pollen IgG AB RAST Score | C165899 | Silver Birch Pollen IgG AB RAST Score | A classification of the amount of Betula verrucosa pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Silver Birch Pollen IgG Antibody RAST Score Measurement | ||
Silver Birch Pollen IgG | C130078 | Silver Birch Pollen IgG | A measurement of the Betula verrucosa pollen antigen IgG antibody in a biological specimen. | Silver Birch Pollen IgG Measurement | ||
Silver Birch Pollen IgG4 | C130079 | Silver Birch Pollen IgG4 | A measurement of the Betula verrucosa pollen antigen IgG4 antibody in a biological specimen. | Silver Birch Pollen IgG4 Measurement | ||
Sjogrens SS-A Antibody | C92236 | Ro Antibody;Sjogrens SS-A Antibody | A measurement of the Sjogrens SS-A antibody in a biological specimen. | Sjogren's SS-A Antibody Measurement | ||
Sjogrens SS-A52 Antibody | C120661 | Sjogrens SS-A52 Antibody | A measurement of the Sjogrens SS-A52 antibody in a biological specimen. | Sjogrens SS-A52 Antibody Measurement | ||
Sjogrens SS-A60 Antibody | C120662 | Sjogrens SS-A60 Antibody | A measurement of the Sjogrens SS-A60 antibody in a biological specimen. | Sjogrens SS-A60 Antibody Measurement | ||
Sjogrens SS-B Antibody | C92237 | La Antibody;Sjogrens SS-B Antibody | A measurement of the Sjogrens SS-B antibody in a biological specimen. | Sjogren's SS-B Antibody Measurement | ||
Skeletal Troponin I | C135443 | Skeletal Troponin I;sTnl | A measurement of the total skeletal troponin I in a biological specimen. | Skeletal Troponin I Measurement | ||
Smith Antibody | C92281 | Smith Antibody;Smith Extractable Nuclear Antibody | A measurement of the total Smith antibodies in a biological specimen. | Smith Antibody Measurement | ||
Smooth Muscle Antibody | C111317 | Anti-Smooth Muscle Antibody;Smooth Muscle Antibody | A measurement of the total smooth muscle antibody in a biological specimen. | Smooth Muscle Antibody Measurement | ||
Smooth Muscle IgG Antibody | C122151 | Actin IgG Antibody;Smooth Muscle IgG Antibody | A measurement of the smooth muscle IgG antibody in a biological specimen. | Smooth Muscle IgG Antibody Measurement | ||
Smudge Cells | C74627 | Basket Cells;Gumprecht Shadow Cells;Shadow Cells;Smudge Cells | A measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen. | Smudge Cell Count | ||
Smudge Cells/Leukocytes | C119294 | Basket Cells/Leukocytes;Gumprecht Shadow Cells/Leukocytes;Shadow Cells/Leukocytes;Smudge Cells/Leukocytes | A relative measurement (ratio or percentage) of smudge cells to leukocytes in a biological specimen. | Smudge Cells to Leukocytes Ratio Measurement | ||
Sodium Clearance | C106568 | Sodium Clearance | A measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute). | Sodium Clearance Measurement | ||
Sodium Excretion Rate | C150823 | Sodium Excretion Rate | A measurement of the amount of sodium being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Sodium Excretion Rate | ||
Sodium | C64809 | Sodium | A measurement of the sodium in a biological specimen. | Sodium Measurement | ||
Sodium/Creatinine | C79464 | Sodium/Creatinine | A relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen. | Sodium to Creatinine Ratio Measurement | ||
Sodium/Potassium | C122137 | Sodium/Potassium | A relative measurement (ratio or percentage) of the sodium to potassium in a biological specimen. | Sodium to Potassium Ratio Measurement | ||
Soluble B Cell Maturation Antigen | C170577 | Soluble B Cell Maturation Antigen;Soluble BCM;Soluble BCMA;Soluble CD269;Soluble TNF Receptor Superfamily Member 17;Soluble TNFRSF13A | A measurement of the soluble B cell maturation antigen in a biological specimen. | Soluble B Cell Maturation Antigen Measurement | ||
Soluble CD163 | C154728 | Soluble CD163 | A measurement of the soluble CD163 in a biological specimen. | Soluble CD163 Measurement | ||
Soluble CD38 | C187826 | Cyclic ADP Ribose Hydrolase;Soluble CD38 | A measurement of the soluble CD38 protein in a biological specimen. | Soluble CD38 Measurement | ||
Soluble CEA Cell Adhesion Molecule 5 | C191290 | Soluble Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5;Soluble CD66e;Soluble CEA Cell Adhesion Molecule 5 | A measurement of the soluble carcinoembryonic antigen (CEA) cell adhesion molecule 5 in a biological specimen. | Soluble CEA Cell Adhesion Molecule 5 Measurement | ||
Soluble Complement C5b-9 | C170579 | sC5b-9;Smac;Soluble Complement C5b-9;Soluble MAC;Soluble Membrane Attack Complex;TCC;Terminal Complement Complex | A measurement of the soluble complement C5b-9 in a biological specimen. | Soluble Complement C5b-9 Measurement | ||
Soluble E-Selectin | C119273 | sE-selectin;Soluble E-Selectin | A measurement of the soluble E-Selectin in a biological specimen. | Soluble E-Selectin Measurement | ||
Soluble HER2 | C112291 | HER2 Antigen;HER2/NEU Antigen;HER2/NEU Shed Antigen;Soluble HER2;Soluble HER2/NEU | A measurement of the soluble HER2 protein in a biological specimen. | Soluble HER2 Antigen Measurement | ||
Soluble Immunoglobulin | C117835 | Soluble Immunoglobulin | A measurement of the soluble total immunoglobulin in a biological specimen. | Soluble Immunoglobulin Measurement | ||
Soluble Intercell Adhesion Molecule 1 | C132386 | Soluble Intercell Adhesion Molecule 1 | A measurement of the soluble intercellular adhesion molecule 1 in a biological specimen. | Soluble Intercellular Adhesion Molecule 1 Measurement | ||
Soluble Intercell Adhesion Molecule 4 | C186096 | Soluble Intercell Adhesion Molecule 4;Soluble Intercellular Adhesion Molecule 4 | A measurement of the soluble intercellular adhesion molecule 4 in a biological specimen. | Soluble Intercellular Adhesion Molecule 4 Measurement | ||
Soluble Interleukin 2 Receptor | C158220 | sCD25;Soluble CD25;Soluble IL-2Ra;Soluble Interleukin 2 Receptor;Soluble Interleukin 2 Receptor Subunit Alpha | A measurement of the soluble interleukin 2 receptor in a biological specimen. | Soluble Interleukin 2 Receptor Measurement | ||
Soluble Interleukin 6 Receptor | C117837 | Soluble Interleukin 6 Receptor | A measurement of the soluble interleukin 6 receptor in a biological specimen. | Soluble Interleukin 6 Receptor Measurement | ||
Soluble Interleukin-1 Receptor Type I | C117836 | Soluble Interleukin-1 Receptor Type I | A measurement of the soluble interleukin-1 receptor type I in a biological specimen. | Soluble Interleukin-1 Receptor Type I Measurement | ||
Soluble Kidney Injury Molecule-1 | C165971 | Soluble Hepatitis A Virus Cellular Receptor 1;Soluble Kidney Injury Molecule-1;Soluble KIM-1 | A measurement of the soluble kidney injury molecule-1 in a biological specimen. | Soluble Kidney Injury Molecule-1 Measurement | ||
Soluble L-Selectin | C172495 | sL-Selectin;Soluble CD62L;Soluble L-Selectin | A measurement of the soluble L-selectin in a biological specimen. | Soluble L-Selectin Measurement | ||
Soluble Liver Antigen IgG Antibody | C122150 | Soluble Liver Antigen IgG Antibody | A measurement of the soluble liver antigen IgG antibody in a biological specimen. | Soluble Liver Antigen IgG Antibody Measurement | ||
Soluble Lymphocyte Activation Gene-3 | C172504 | Soluble CD223 Antigen;Soluble LAG-3;Soluble Lymphocyte Activation Gene 3 Protein;Soluble Lymphocyte Activation Gene-3 | A measurement of the soluble lymphocyte activation gene-3 protein in a biological specimen. | Soluble Lymphocyte Activation Gene-3 Measurement | ||
Soluble Mesothelin Related Peptides | C189495 | Soluble Mesothelin Related Peptides;Soluble Mesothelin Related Proteins | A measurement of the soluble mesothelin related peptides in a biological specimen. | Soluble Mesothelin Related Peptides Measurement | ||
Soluble P-Selectin | C120650 | Soluble P-Selectin | A measurement of the soluble P-selectin in a biological specimen. | Soluble P-Selectin Measurement | ||
Soluble Programmed Death Ligand 1 | C172503 | Soluble CD274;Soluble PD-L1;Soluble PDL1;Soluble Programmed Death Ligand 1 | A measurement of the soluble programmed death ligand 1 in a biological specimen. | Soluble Programmed Death Ligand 1 Measurement | ||
Soluble Programmed Death-1 | C172505 | Soluble CD279;Soluble PD-1;Soluble PD1;Soluble Programmed Cell Death Protein 1;Soluble Programmed Death-1 | A measurement of the soluble programmed death-1 protein in a biological specimen. | Soluble Programmed Death-1 Measurement | ||
Soluble TNF Receptor Superfamily Mem 5 | C174312 | Soluble B-cell Surface Antigen CD40;Soluble Bp50;Soluble CD40;Soluble CDW40;Soluble p50;Soluble TNF Receptor Superfamily Mem 5;Soluble TNF Receptor Superfamily Member 5;Soluble TNFRSF5;Soluble Tumor Necrosis Factor Receptor Superfamily, Member 5 | A measurement of the soluble tumor necrosis factor receptor superfamily member 5 (CD40) in a biological specimen. | Soluble TNF Receptor Superfamily Member 5 Measurement | ||
Soluble TNF Receptor Type I | C117863 | Soluble TNF Receptor Type I | A measurement of the soluble tumor necrosis factor receptor type I in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Type I Measurement | ||
Soluble TNF Receptor Type II | C117864 | Soluble CD120b;Soluble TNF Receptor 1B;Soluble TNF Receptor Type II;Soluble TNFR1B | A measurement of the soluble tumor necrosis factor receptor type II in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Type II Measurement | ||
Soluble TNF Superfamily Member 12 | C156526 | Soluble TNF Superfamily Member 12;Soluble TNFSF12 | A measurement of soluble tumor necrosis factor superfamily member 12 in a biological specimen. | Soluble TNF Superfamily Member 12 Measurement | ||
Soluble TNF Superfamily Member 5 | C174308 | Soluble CD154;Soluble CD40 Ligand;Soluble CD40L;Soluble CD40LG;Soluble gp39;Soluble T-BAM;Soluble TNF Superfamily Member 5;Soluble TNFSF5;Soluble TRAP | A measurement of the soluble tumor necrosis factor superfamily member 5 in a biological specimen. | Soluble TNF Superfamily Member 5 Measurement | ||
Soluble Transferrin Receptor | C100438 | Soluble Transferrin Receptor | A measurement of the soluble transferrin receptor in a biological specimen. | Soluble Transferrin Receptor Measurement | ||
Soluble Tumor Necrosis Factor Receptor | C117749 | Soluble Tumor Necrosis Factor Receptor | A measurement of the total soluble tumor necrosis factor receptor in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Measurement | ||
Soluble Vasc Cell Adhesion Molecule 1 | C92533 | Soluble Vasc Cell Adhesion Molecule 1 | A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen. | Soluble Vascular Cell Adhesion Molecule 1 | ||
Soluble Vasc Endoth Growth Factor Rec1 | C165992 | Soluble Vasc Endoth Growth Factor Rec1;Soluble Vascular Endothelial Growth Factor Receptor 1 | A measurement of the soluble vascular endothelial growth factor receptor 1 in a biological specimen. | Soluble Vascular Endothelial Growth Factor Receptor Type 1 Measurement | ||
Soluble Vasc Endoth Growth Factor Rec2 | C165993 | Soluble Vasc Endoth Growth Factor Rec2;Soluble Vascular Endothelial Growth Factor Receptor 2 | A measurement of the soluble vascular endothelial growth factor receptor 2 in a biological specimen. | Soluble Vascular Endothelial Growth Factor Receptor Type 2 Measurement | ||
Soluble Vasc Endoth Growth Factor Rec3 | C165994 | Soluble Vasc Endoth Growth Factor Rec3;Soluble Vascular Endothelial Growth Factor Receptor 3 | A measurement of the soluble vascular endothelial growth factor receptor 3 in a biological specimen. | Soluble Vascular Endothelial Growth Factor Receptor Type 3 Measurement | ||
Somatostatin Receptor Type 2 | C165984 | Somatostatin Receptor Type 2;SRIF-1 | A measurement of the somatostatin receptor type 2 in a biological specimen. | Somatostatin Receptor Type 2 Measurement | ||
Somatotrophin | C80360 | Growth Hormone;Somatotrophin;Somatotropin | A measurement of the somatotrophin (growth) hormone in a biological specimen. | Somatotrophin Measurement | ||
Sonic Hedgehog | C177989 | Sonic Hedgehog | A measurement of the sonic hedgehog protein in a biological specimen. | Sonic Hedgehog Measurement | ||
Sorbitol Dehydrogenase | C79465 | Sorbitol Dehydrogenase | A measurement of the sorbitol dehydrogenase in a biological specimen. | Sorbitol Dehydrogenase Measurement | ||
Specific Gravity | C64832 | Specific Gravity | A ratio of the density of a fluid to the density of water. | Specific Gravity | ||
Specimen Appearance | C179695 | Specimen Appearance | The outward or visible aspect of a specimen. | Specimen Appearance Assessment | ||
Specimen Weight | C106569 | Specimen Weight | A measurement of the weight of a biological specimen. | Specimen Weight Measurement | ||
Sperm Agglutination | C142290 | Sperm Agglutination | A measurement of the motile spermatozoa agglutination in a biological specimen. | Sperm Agglutination Measurement | ||
Sperm Aggregation | C142291 | Sperm Aggregation | A measurement of the immotile spermatozoa aggregation in a biological specimen. | Sperm Aggregation Measurement | ||
Sperm Motility | C102281 | Sperm Motility | A measurement of the sperm capable of forward, progressive movement in a semen specimen. | Sperm Motility Measurement | ||
Spermatozoa | C74663 | Spermatozoa | A measurement of the spermatozoa cells present in a biological specimen. | Spermatozoa Cell Count | ||
Spermatozoa, Progressive | C161366 | Spermatozoa, Progressive | A measurement of the progressive spermatozoa (motile in a forward direction) in a biological specimen. | Progressive Spermatozoa Measurement | ||
Spermatozoa, Progressive/Spermatozoa | C161365 | Spermatozoa, Progressive/Spermatozoa | A relative measurement (ratio or percentage) of the progressive spermatozoa to total spermatozoa in a biological specimen. | Progressive Spermatozoa to Total Spermatozoa Ratio Measurement | ||
Spherocytes | C74707 | Spherocytes | A measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen. | Spherocyte Count | ||
Squamous Cell Carcinoma Antigen | C120660 | Squamous Cell Carcinoma Antigen | A measurement of the squamous cell carcinoma antigen in a biological specimen. | Squamous Cell Carcinoma Antigen Measurement | ||
Squamous Epithelial Cells | C74773 | Squamous Cells;Squamous Epithelial Cells | A measurement of the squamous epithelial cells present in a biological specimen. | Squamous Epithelial Cell Count | ||
Squamous Epithelial Cells/Total Cells | C132366 | Squamous Epithelial Cells/Total Cells | A relative measurement (ratio or percentage) of the squamous epithelial cells to total cells in a biological specimen. | Squamous Epithelial Cells to Total Cells Ratio Measurement | ||
Squamous Transitional Epithelial Cells | C74774 | Squamous Transitional Epithelial Cells | A measurement of the squamous transitional epithelial cells present in a biological specimen. | Squamous Transitional Epithelial Cell Count | ||
Standard Base Excess | C154721 | Standard Base Excess | A calculated measurement of the amount of acid required to return blood with hemoglobin at 5g/dL, which is used as a surrogate for extracellular fluid, to a normal pH under standard conditions. | Standard Base Excess Measurement | ||
Stanozolol | C184599 | Stanozolol | A measurement of the stanozolol in a biological specimen. | Stanozolol Measurement | ||
Starch Crystals | C81951 | Starch Crystals;Starch Granules | A measurement of the starch crystals in a biological specimen. | Starch Crystal Measurement | ||
STAT3 | C156469 | Signal Transducer and Activator of Transcription 3;STAT3 | A measurement of the STAT3 (signal transducer and activator of transcription 3) in a biological specimen. | STAT3 Measurement | ||
Stem Cell Factor | C82035 | KIT Ligand;Stem Cell Factor | A measurement of the stem cell factor in a biological specimen. | Stem Cell Factor Measurement | ||
Stenbolone | C184600 | Deacetylanatrofin;Stenbolone | A measurement of the stenbolone in a biological specimen. | Stenbolone Measurement | ||
Steroid Sulfatase | C177993 | Steroid Sulfatase;Steryl-sulfatase | A measurement of the steroid sulfatase in a biological specimen. | Steroid Sulfatase Measurement | ||
Stomatocytes | C74708 | Stomatocytes | A measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen. | Stomatocyte Count | ||
Succinylacetone | C186095 | Succinylacetone | A measurement of the succinylacetone in a biological specimen. | Succinylacetone Measurement | ||
Sufentanil | C184575 | Sufentanil | A measurement of the sufentanil in a biological specimen. | Sufentanil Measurement | ||
Sulfa Crystals | C74755 | Sulfa Crystals;Sulfonamide Crystals | A measurement of the sulfa crystals present in a biological specimen. | Sulfa Crystal Measurement | ||
Sulfate | C122153 | Sulfate;Sulphate | A measurement of the sulfate in a biological specimen. | Sulfate Measurement | ||
Sulfur Dioxide | C114224 | Sulfur Dioxide | A measurement of the sulfur dioxide in a biological specimen. | Sulfur Dioxide Measurement | ||
Surfactant Protein D | C111322 | SP-D;Surfactant Protein D | A measurement of the surfactant protein D in a biological specimen. | Surfactant Protein D Measurement | ||
Symmetric Dimethylarginine | C158232 | N,N'-dimethylarginine;Symmetric Dimethylarginine | A measurement of the symmetric dimethylarginine in a biological specimen. | Symmetric Dimethylarginine Measurement | ||
Synoviocytes | C191298 | Synoviocytes;Total Synoviocytes | A measurement of the total synoviocytes in a biological specimen. | Synoviocytes Cell Count | ||
Synoviocytes/Leukocytes | C191297 | Synoviocytes/Leukocytes;Total Synoviocytes/Leukocytes | A relative measurement (ratio or percentage) of the synoviocytes to all leukocytes in a biological specimen. | Synoviocytes to Leukocytes Ratio Measurement | ||
T-Kininogen | C132387 | T-Kininogen | A measurement of the total T-kininogen in a biological specimen. | T-Kininogen Measurement | ||
T-lymphocyte Crossmatch | C128979 | T-lymphocyte Crossmatch | A measurement to determine human leukocyte antigens (HLA) histocompatibility between the recipient and the donor by examining the presence or absence of the recipient's anti-HLA antibody reactivity towards HLA antigens expressed on the donor T-lymphocytes. | T-lymphocyte Crossmatch Measurement | ||
T-Lymphocytes | C122157 | T-Cell Lymphocytes;T-Cells;T-Lymphocytes | A measurement of the total thymocyte-derived lymphocytes in a biological specimen. | T-Lymphocyte Count | ||
T1 Collagen X-link N-Telopeptides/Creat | C147408 | T1 Collagen X-link N-Telopeptides/Creat;Type I Collagen X-linked N-Telopeptides/Creatinine | A relative measurement (ratio or percentage) of the type 1 collagen cross-linked N-telopeptides to creatinine in a biological specimen. | Type 1 Collagen X-link N-Telopeptides to Creatinine Ratio Measurement | ||
Tapentadol | C184576 | Tapentadol | A measurement of the tapentadol in a biological specimen. | Tapentadol Measurement | ||
Target Cells | C96636 | Codocytes;Target Cells | A measurement of the target cells in a biological specimen. | Target Cell Count | ||
Tartrate-Resistant Acid Phosphatase 5b | C117865 | Tartrate-Resistant Acid Phosphatase 5b;TRAP5B | A measurement of tartrate-resistant acid phosphatase 5b in a biological specimen. | Tartrate-Resistant Acid Phosphatase 5b Measurement | ||
TATA Box Binding Protein | C189496 | TATA Box Binding Protein;TATA-Binding Protein | A measurement of the TATA-box binding protein in a biological specimen. | TATA Box Binding Protein Measurement | ||
Tau Protein | C84810 | Tau Protein;Total Tau Protein | A measurement of the total Tau protein in a biological specimen. | Tau Protein Measurement | ||
Tau Protein, Free | C163489 | Tau Protein, Free | A measurement of the free tau protein in a biological specimen. | Free Tau Protein Measurement | ||
Taurine | C122154 | Tauric Acid;Taurine | A measurement of the taurine in a biological specimen. | Taurine Measurement | ||
Taurine/Creatinine | C158223 | Taurine/Creatinine | A relative measurement (ratio) of the taurine to the creatinine in a biological specimen. | Taurine to Creatinine Ratio Measurement | ||
Taurochenodeoxycholate | C176306 | Taurochenodeoxycholate;Taurochenodeoxycholic Acid | A measurement of the taurochenodeoxycholate in a biological specimen. | Taurochenodeoxycholate Measurement | ||
Taurocholate | C176301 | Taurocholate;Taurocholic Acid | A measurement of the taurocholate in a biological specimen. | Taurocholate Measurement | ||
Taurolithocholate | C176309 | Taurolithocholate;Taurolithocholic Acid | A measurement of the taurolithocholate in a biological specimen. | Taurolithocholate Measurement | ||
Tauroursodeoxycholate | C176303 | Tauroursodeoxycholate;Tauroursodeoxycholic Acid | A measurement of the tauroursodeoxycholate in a biological specimen. | Tauroursodeoxycholate Measurement | ||
Temazepam | C75376 | Temazepam | A measurement of the temazepam present in a biological specimen. | Temazepam Measurement | ||
Terminal Deoxynucleotidyl Transferase Ag | C117859 | Terminal Deoxynucleotidyl Transferase Ag;Terminal Deoxynucleotidyl Transferase Antigen | A measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen. | Terminal Deoxynucleotidyl Transferase Antigen Measurement | ||
Testolactone | C184601 | Testolactone | A measurement of the testolactone in a biological specimen. | Testolactone Measurement | ||
Testosterone Free+Weakly Bound/Testost | C147440 | Testosterone Free+Weakly Bound/Testost;Testosterone, Free and Weakly Bound/Testosterone | A relative measurement (ratio or percentage) of the free and weakly bound testosterone to total testosterone in a biological specimen. | Free Testosterone and Weakly Bound to Total Testosterone Ratio Measurement | ||
Testosterone | C74793 | Testosterone;Total Testosterone | A measurement of the total (free and bound) testosterone in a biological specimen. | Total Testosterone Measurement | ||
Testosterone, Free | C74785 | Testosterone, Free | A measurement of the free testosterone in a biological specimen. | Free Testosterone Measurement | ||
Testosterone, Free/Testosterone | C147439 | Testosterone, Free/Testosterone | A relative measurement (ratio or percentage) of the amount of the bioavailable testosterone compared to total testosterone in a biological specimen. | Free Testosterone to Testosterone Ratio Measurement | ||
Testosterone, Free/Total Protein | C128980 | Testosterone, Free/Total Protein | A relative measurement (ratio or percentage) of free testosterone to total proteins in a biological specimen. | Free Testosterone to Total Protein Ratio Measurement | ||
Testosterone, Weakly Bound | C147434 | Testosterone, Weakly Bound | A measurement of the weakly bound testosterone (testosterone bound to albumin) in a biological specimen. | Weakly Bound Testosterone Measurement | ||
Tetrahydrocannabinol | C147436 | Delta-9-Tetrahydrocannabinol;Tetrahydrocannabinol;THC | A measurement of the tetrahydrocannabinol in a biological specimen. | Tetrahydrocannabinol Measurement | ||
Tetrahydrogestrinone | C184602 | Tetrahydrogestrinone | A measurement of the tetrahydrogestrinone in a biological specimen. | Tetrahydrogestrinone Measurement | ||
Thebaine | C184577 | Thebaine | A measurement of the thebaine in a biological specimen. | Thebaine Measurement | ||
Theophylline | C105445 | Theophylline | A measurement of the Theophylline present in a biological specimen. | Theophylline Measurement | ||
Thiamine | C74896 | Thiamine;Vitamin B1 | A measurement of the thiamine in a biological specimen. | Vitamin B1 Measurement | ||
Thiamylal | C184603 | Thiamylal | A measurement of the thiamylal in a biological specimen. | Thiamylal Measurement | ||
Thiocyanate | C154745 | Thiocyanate | A measurement of the thiocyanate in a biological specimen. | Thiocyanate Measurement | ||
Thiopental | C184604 | Thiopental | A measurement of the thiopental in a biological specimen. | Thiopental Measurement | ||
Thioridazine | C177978 | Thioridazine | A measurement of the thioridazine in a biological specimen. | Thioridazine Measurement | ||
Thiothixene | C177976 | Thiothixene | A measurement of the thiothixene in a biological specimen. | Thiothixene Measurement | ||
Threonine | C122156 | Threonine | A measurement of the threonine in a biological specimen. | Threonine Measurement | ||
Threonine/Creatinine | C158224 | Threonine/Creatinine | A relative measurement (ratio) of the threonine to the creatinine in a biological specimen. | Threonine to Creatinine Ratio Measurement | ||
Thrombin Activity Actual/Control | C147437 | Thrombin Activity Actual/Control;Thrombin Activity Actual/Normal;Thrombin Activity Actual/Thrombin Activity Control | A relative measurement (ratio or percentage) of the biological activity of thrombin dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | Thrombin Activity Actual to Control Ratio Measurement | ||
Thrombin Antithrombin Complex | C161371 | TAT;Thrombin Antithrombin Complex;Thrombin Antithrombin Complex Antigen | A measurement of the thrombin-antithrombin complexes in a biological specimen. | Thrombin Antithrombin Complex Measurement | ||
Thrombin Time Actual/Control | C161370 | Thrombin Time Actual/Control | A relative measurement (ratio or percentage) of the thrombin time in a subject's specimen when compared to a control specimen. | Thrombin Time Actual to Control Ratio Measurement | ||
Thrombin Time | C80365 | Thrombin Time | A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI) | Thrombin Time | ||
Thrombin/Antithrombin | C106574 | Thrombin/Antithrombin;Thrombin/Antithrombin III | A relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample. | Thrombin to Antithrombin Ratio Measurement | ||
Thrombocytes | C111283 | Nucleated Thrombocytes;Thrombocytes | A measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates. | Nucleated Thrombocyte Count | ||
Thrombomodulin | C135444 | BDCA3;Thrombomodulin | A measurement of the thrombomodulin in a biological specimen. | Thrombomodulin Measurement | ||
Thrombopoietin | C74873 | Thrombopoietin | A measurement of the thrombopoietin hormone in a biological specimen. | Thrombopoietin Measurement | ||
Thrombospondin 1 | C163495 | THBS1;Thrombospondin 1 | A measurement of the thrombospondin 1 in a biological specimen. | Thrombospondin 1 Measurement | ||
Thromboxane B2 | C103445 | Thromboxane B2 | A measurement of the thromboxane B2 in a biological specimen. | Thromboxane B2 Measurement | ||
Thymic Stromal Lymphopoietin | C184511 | Thymic Stromal Lymphopoietin | A measurement of the thymic stromal lymphopoietin in a biological specimen. | Thymic Stromal Lymphopoietin Measurement | ||
Thymidine Kinase 1 | C135445 | Thymidine Kinase 1;Thymidine Kinase, Cytosolic | A measurement of the thymidine kinase 1 in a biological specimen. | Thymidine Kinase 1 Measurement | ||
Thymidine Kinase 2 | C135446 | Thymidine Kinase 2;Thymidine Kinase, Mitochondrial | A measurement of the thymidine kinase 2 in a biological specimen. | Thymidine Kinase 2 Measurement | ||
Thymidine Kinase | C120665 | Thymidine Kinase | A measurement of the total thymidine kinase in a biological specimen. | Thymidine Kinase Measurement | ||
Thyroglobulin Recovery Rate | C147435 | Thyroglobulin Recovery Rate | A measurement of the thyroglobulin recovery rate in a biological specimen obtained by measuring the thyroglobulin concentration before and after a known amount of thyroglobulin has been added to the specimen. | Thyroglobulin Recovery Rate | ||
Thyroglobulin | C103446 | TG;Thyroglobulin | A measurement of the thyroglobulin in a biological specimen. | Thyroglobulin Measurement | ||
Thyroid Antibodies | C81990 | Thyroid Antibodies | A measurement of the thyroid antibodies in a biological specimen. | Thyroid Antibody Measurement | ||
Thyroid Antithyroglobulin Antibodies | C81992 | Thyroid Antithyroglobulin Antibodies | A measurement of the thyroid antithyroglobulin antibodies in a biological specimen. | Thyroid Antithyroglobulin Antibody Measurement | ||
Thyroid Stimulating Immunoglobulin | C147438 | Thyroid Stimulating Immunoglobulin | A measurement of the thyroid stimulating immunoglobulin in a biological specimen. | Thyroid Stimulating Immunoglobulin Measurement | ||
Thyroperoxidase Antibody | C96638 | Thyroid Antimicrosomal Antibody;Thyroperoxidase Antibody | A measurement of the thyroperoxidase antibody in a biological specimen. | Thyroperoxidase Antibody Measurement | ||
Thyroperoxidase | C96639 | Thyroid Peroxidase;Thyroperoxidase | A measurement of the thyroperoxidase in a biological specimen. | Thyroperoxidase Measurement | ||
Thyrotropin Receptor Antibody | C122158 | Thyroid Stimulating Hormone Receptor Antibody;Thyrotropin Receptor Antibody | A measurement of the thyrotropin receptor antibody in a biological specimen. | Thyroid Stimulating Hormone Receptor Antibody Measurement | ||
Thyrotropin Releasing Hormone | C74874 | Thyrotropin Releasing Factor;Thyrotropin Releasing Hormone | A measurement of the thyrotropin releasing hormone in a biological specimen. | Thyrotropin Releasing Hormone Measurement | ||
Thyrotropin | C64813 | Thyroid Stimulating Hormone;Thyrotropin | A measurement of the thyrotropin in a biological specimen. | Thyrotropin Measurement | ||
Thyrotropin/Thyroxine, Free | C181446 | Thyroid Stimulating Hormone/Free T4;Thyrotropin/Thyroxine, Free | A relative measurement (ratio) of the thyrotropin to free thyroxine in a biological specimen. | Thyrotropin to Free Thyroxine Ratio Measurement | ||
Thyroxine Binding Globulin | C74746 | Thyroxine Binding Globulin | A measurement of the thyroxine binding globulin protein in a biological specimen. | Thyroxine Binding Globulin Protein Measurement | ||
Thyroxine | C74794 | Thyroxine;Total T4 | A measurement of the total (free and bound) thyroxine in a biological specimen. | Total Thyroxine Measurement | ||
Thyroxine, Free Index | C170598 | Thyroxine, Free Index | A measurement of the thyroid status in a biological specimen. This is calculated by a mathematical formula that takes into account the total thyroxine and unbound thyroxine binding globulins. | Free Thyroxine Index | ||
Thyroxine, Free | C74786 | Free T4;Thyroxine, Free | A measurement of the free thyroxine in a biological specimen. | Free Thyroxine Measurement | ||
Thyroxine, Free, Indirect | C120664 | Thyroxine, Free, Indirect | An indirect measurement of the free thyroxine in a biological specimen. | Indirect Free Thyroxine Measurement | ||
Timothy Grass Pollen IgA | C130089 | Timothy Grass Pollen IgA | A measurement of the Phleum pratense pollen antigen IgA antibody in a biological specimen. | Timothy Grass Pollen IgA Measurement | ||
Timothy Grass Pollen IgE AB RAST Score | C165890 | Timothy Grass Pollen IgE AB RAST Score | A classification of the amount of Phleum pratense pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Timothy Grass Pollen IgE Antibody RAST Score Measurement | ||
Timothy Grass Pollen IgE | C130088 | Timothy Grass Pollen IgE | A measurement of the Phleum pratense pollen antigen IgE antibody in a biological specimen. | Timothy Grass Pollen IgE Measurement | ||
Timothy Grass Pollen IgG AB RAST Score | C165902 | Timothy Grass Pollen IgG AB RAST Score | A classification of the amount of Phleum pratense pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Timothy Grass Pollen IgG Antibody RAST Score Measurement | ||
Timothy Grass Pollen IgG | C130090 | Timothy Grass Pollen IgG | A measurement of the Phleum pratense pollen antigen IgG antibody in a biological specimen. | Timothy Grass Pollen IgG Measurement | ||
Timothy Grass Pollen IgG4 | C130091 | Timothy Grass Pollen IgG4 | A measurement of the Phleum pratense pollen antigen IgG4 antibody in a biological specimen. | Timothy Grass Pollen IgG4 Measurement | ||
TIMP1/Creatinine | C106575 | TIMP1/Creatinine;Tissue Inhibitor of Metalloproteinase 1/Creatinine | A relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample. | Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement | ||
Tissue Inhibitor of Metalloproteinase 1 | C82036 | Tissue Inhibitor of Metalloproteinase 1 | A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen. | Tissue Inhibitor of Metalloproteinase 1 Measurement | ||
Tissue Inhibitor of Metalloproteinase 3 | C165988 | HSMRK222;K222;K222TA2;Metalloproteinase Inhibitor 3;SFD;Tissue Inhibitor of Metalloproteinase 3 | A measurement of the tissue inhibitor of metalloproteinase 3 in a biological specimen. | Tissue Inhibitor of Metalloproteinase 3 Measurement | ||
Tissue Plasminogen Activator Antigen | C81993 | Tissue Plasminogen Activator Antigen | A measurement of the tissue plasminogen activator antigen in a biological specimen. | Tissue Plasminogen Activator Antigen Measurement | ||
Tissue Polypeptide Antigen | C163488 | Tissue Polypeptide Antigen;TPA | A measurement of the tissue polypeptide antigen in a biological specimen. | Tissue Polypeptide Antigen Measurement | ||
Tissue Transglutaminase IgA Antibody | C147441 | Tissue Transglutaminase IgA Antibody | A measurement of the tissue transglutaminase IgA antibody in a biological specimen. | Tissue Transglutaminase IgA Antibody Measurement | ||
Tissue Transglutaminase IgG Antibody | C163496 | Tissue Transglutaminase IgG Antibody | A measurement of the tissue transglutaminase IgG antibody in a biological specimen. | Tissue Transglutaminase IgG Antibody Measurement | ||
Tissue Transglutaminase IgM Antibody | C147442 | Tissue Transglutaminase IgM Antibody | A measurement of the tissue transglutaminase IgM antibody in a biological specimen. | Tissue Transglutaminase IgM Antibody Measurement | ||
TNF Receptor 1B | C165991 | CD120b;p75;p75TNFR;TBPII;TNF Receptor 1B;TNF-R-II;TNF-R75;TNFBR;TNFR1B;TNFR2;TNFR80;Tumor Necrosis Factor Receptor 2 | A measurement of the tumor necrosis factor receptor superfamily member 1B in a biological specimen. | TNF Receptor 1B Measurement | ||
TNF Receptor Superfamily Member 10c | C198291 | CD263;DcR1;TNF Receptor Superfamily Member 10c;TNF-Related Apoptosis-Inducing Ligand Receptor 3;TRAIL Receptor 3;TRAILR3 | A measurement of the TNF receptor superfamily member 10c in a biological specimen. | Tumor Necrosis Factor Receptor Superfamily Member 10c Measurement | ||
TNF Superfamily Member 10 | C165989 | APO2L;CD253;TL2;TNF-Related Apoptosis-Inducing Ligand;TNFSF10;TNLG6A;TRAIL | A measurement of the total tumor necrosis factor superfamily member 10 in a biological specimen. | TNF Superfamily Member 10 Measurement | ||
TNF Superfamily Member 12 Excretion Rate | C156525 | TNF Superfamily Member 12 Excretion Rate;TWEAK Excretion Rate | A measurement of the amount of TNF superfamily member 12 being excreted in a biological specimen over a defined period of time (e.g. one hour). | TNF Superfamily Member 12 Excretion Rate | ||
TNF Superfamily Member 12 | C165990 | APO3L;DR3LG;TNF Superfamily Member 12;TNLG4A;TWEAK | A measurement of the total tumor necrosis factor superfamily member 12 in a biological specimen. | TNF Superfamily Member 12 Measurement | ||
TNF-a Production Inhibition | C117862 | TNF-a Production Inhibition;TNF-a Production Inhibitory Activity | A measurement of TNF-a production inhibitory activity in a biological specimen. | TNF-a Production Inhibitory Activity Measurement | ||
Tomoregulin-2 | C187827 | Tomoregulin-2;Transmembrane Protein With EGF-Like And Two Follistatin-Like Domains 2 | A measurement of the tomoregulin-2 in a biological specimen. | Tomoregulin-2 Measurement | ||
Total Amyloid Precursor Protein | C119269 | Total Amyloid Precursor Protein | A measurement of the total amyloid precursor protein present in a biological specimen. | Total Amyloid Precursor Protein Measurement | ||
Total Iron Binding Capacity | C74718 | Total Iron Binding Capacity | A measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen. | Total Iron Binding Capacity | ||
Total Plasma Cells | C128974 | Total Plasma Cells | A measurement of the total plasma cells in a biological specimen. | Plasma Cell Count | ||
Total Plasma Cells/Leukocytes | C128975 | Total Plasma Cells/Leukocytes | A relative measurement (ratio or percentage) of the total plasma cells to leukocytes in a biological specimen. | Plasma Cells to Leukocytes Ratio Measurement | ||
Total Plasma Cells/Lymphocytes | C189499 | Total Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the total plasma cells to lymphocytes in a biological specimen. | Plasma Cell to Lymphocyte Ratio Measurement | ||
Total Plasma Cells/Total Cells | C187987 | Total Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the total plasma cells to total cells in a biological specimen. | Plasma Cell to Total Cell Ratio Measurement | ||
Total Radical-Trap Antioxidant Potential | C80208 | Total Radical-Trap Antioxidant Potential | A measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension. | Total Radical-Trap Antioxidant Potential Measurement | ||
Toxic Granulation | C96641 | Toxic Granulation | A measurement of the toxic granulation in granulocytic blood cells. | Toxic Granulation Measurement | ||
Toxic Vacuolation | C127813 | Toxic Vacuolation | A measurement of the toxic vacuolation in any of the granulocytic blood cells. | Toxic Vacuolation Assessment | ||
TPR-Ankyrin Repeat-Containing Protein 1 | C163490 | TPR and Ankyrin Repeat-Containing Protein 1;TPR-Ankyrin Repeat-Containing Protein 1 | A measurement of the TPR-ankyrin repeat-containing protein 1 in a biological specimen. | TPR-Ankyrin Repeat-containing Protein 1 Measurement | ||
Tramadol | C161376 | Tramadol | A measurement of the tramadol present in a biological specimen. | Tramadol Measurement | ||
Transferrin Saturation | C98792 | Iron Binding Capacity Saturation;Iron Saturation;Iron to TIBC;Transferrin Saturation | A measurement of the iron bound to transferrin in a biological specimen. | Transferrin Saturation Measurement | ||
Transferrin | C82037 | Transferrin | A measurement of the total transferrin in a biological specimen. | Transferrin Measurement | ||
Transforming Growth Factor Alpha | C165985 | Transforming Growth Factor Alpha | A measurement of the transforming growth factor alpha in a biological specimen. | Transforming Growth Factor Alpha Measurement | ||
Transforming Growth Factor Beta 1 | C117861 | Transforming Growth Factor Beta 1 | A measurement of the transforming growth factor beta 1 in a biological specimen. | Transforming Growth Factor Beta 1 Measurement | ||
Transforming Growth Factor Beta 2 | C165986 | G-TSF;LDS4;TGF-beta2;Transforming Growth Factor Beta 2 | A measurement of the transforming growth factor beta 2 in a biological specimen. | Transforming Growth Factor Beta 2 Measurement | ||
Transforming Growth Factor Beta 3 | C165987 | ARVD;ARVD1;LDS5;RNHF;TGF-beta3;Transforming Growth Factor Beta 3 | A measurement of the transforming growth factor beta 3 in a biological specimen. | Transforming Growth Factor Beta 3 Measurement | ||
Transforming Growth Factor Beta | C122155 | Transforming Growth Factor Beta | A measurement of the total transforming growth factor beta in a biological specimen. | Transforming Growth Factor Beta Measurement | ||
Transitional Epithelial Cells | C92251 | Transitional Epithelial Cells | A measurement of the transitional epithelial cells present in a biological specimen. | Transitional Epithelial Cells Measurement | ||
Translocase Inner Mitochondrial Membr 10 | C163487 | Translocase Inner Mitochondrial Membr 10;Translocase of Inner Mitochondrial Membrane 10 | A measurement of the translocase of inner mitochondrial membrane 10 in a biological specimen. | Translocase Inner Mitochondrial Membrane 10 Measurement | ||
Trazodone | C187828 | Trazodone | A measurement of the trazodone in a biological specimen. | Trazodone Measurement | ||
Tree Mix Pollen Antigen IgE Antibody | C130101 | Tree Mix Pollen Antigen IgE Antibody | A measurement of the tree mix pollen antigen IgE antibody in a biological specimen. | Tree Mix Pollen Antigen IgE Antibody Measurement | ||
Tree Mix Pollen Antigen IgG Antibody | C130102 | Tree Mix Pollen Antigen IgG Antibody | A measurement of the tree mix pollen antigen IgG antibody in a biological specimen. | Tree Mix Pollen Antigen IgG Antibody Measurement | ||
Tree Mix Pollen IgE AB RAST Score | C165923 | Tree Mix Pollen IgE AB RAST Score | A classification of the amount of tree mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Tree Mix Pollen IgE Antibody RAST Score Measurement | ||
Tree Mix Pollen IgG AB RAST Score | C165904 | Tree Mix Pollen IgG AB RAST Score | A classification of the amount of tree mix pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Tree Mix Pollen IgG Antibody RAST Score Measurement | ||
Trenbolone | C184605 | 17beta-Trenbolone;Trenbolone;Trienbolone | A measurement of the trenbolone in a biological specimen. | Trenbolone Measurement | ||
Triazolam | C181451 | Triazolam | A measurement of the triazolam in a biological specimen. | Triazolam Measurement | ||
Trichomonas | C92238 | Trichomonas | Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. | Trichomonas Screening | ||
Tricyclic Antidepressants | C100420 | Tricyclic Antidepressants | A measurement of tricyclic antidepressants in a biological specimen. | Tricyclic Antidepressant Measurement | ||
Trifluoperazine | C177982 | Trifluoperazine | A measurement of the trifluoperazine in a biological specimen. | Trifluoperazine Measurement | ||
Triglycerides | C64812 | Triglycerides | A measurement of the triglycerides in a biological specimen. | Triglyceride Measurement | ||
Triglycerides/HDL Cholesterol | C121183 | Triglycerides/HDL Cholesterol | A relative measurement (ratio or percentage) of the triglycerides to high density lipoprotein cholesterol in a biological specimen. | Triglycerides to HDL Cholesterol Ratio Measurement | ||
Triiodothyronine Uptake | C74748 | T3RU;T3U;Triiodothyronine Uptake | A measurement of the binding of triiodothyronine to thyroxine binding globulin protein in a biological specimen. | Triiodothyronine Uptake Measurement | ||
Triiodothyronine | C74747 | Total T3;Triiodothyronine | A measurement of the total (free and bound) triiodothyronine in a biological specimen. | Triiodothyronine Measurement | ||
Triiodothyronine, Free | C74787 | Free T3;Triiodothyronine, Free | A measurement of the free triiodothyronine in a biological specimen. | Free Triiodothyronine Measurement | ||
Triiodothyronine, Reverse | C81968 | Triiodothyronine, Reverse | A measurement of the reverse triiodothyronine in a biological specimen. | Reverse Triiodothyronine Measurement | ||
Trimeperidine | C184563 | Trimeperidine | A measurement of the trimeperidine in a biological specimen. | Trimeperidine Measurement | ||
Tripartite Motif Containing Protein 21 | C163491 | E3 Ubiquitin-Protein Ligase TRIM21;Ro(SS-A);Sjogren Syndrome Type A Antigen;Tripartite Motif Containing Protein 21 | A measurement of the tripartite motif containing protein 21 in a biological specimen. | Tripartite Motif Containing Protein 21 Measurement | ||
Tripartite Motif Containing Protein 38 | C163492 | Tripartite Motif Containing Protein 38 | A measurement of the tripartite motif containing protein 38 in a biological specimen. | Tripartite Motif Containing Protein 38 Measurement | ||
Triple Phosphate Crystals | C74756 | Ammonium Magnesium Phosphate Crystals;Struvite Crystals;Triple Phosphate Crystals | A measurement of the triple phosphate crystals present in a biological specimen. | Triple Phosphate Crystal Measurement | ||
Triticum aestivum Antigen IgE Antibody | C147277 | Bread Wheat Antigen IgE Antibody;Triticum aestivum Antigen IgE Antibody | A measurement of the Triticum aestivum antigen IgE antibody in a biological specimen. | Triticum aestivum Antigen IgE Antibody Measurement | ||
Triticum aestivum IgE AB RAST Score | C165935 | Triticum aestivum IgE AB RAST Score | A classification of the amount of Triticum aestivum antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Triticum aestivum IgE Antibody RAST Score Measurement | ||
Triticum Species Antigen IgE Antibody | C177959 | Triticum Species Antigen IgE Antibody;Wheat Antigen IgE Antibody | A measurement of any of the Triticum species of wheat antigen IgE antibody in a biological specimen. | Triticum Species Antigen IgE Antibody Measurement | ||
Troponin I Type 1 | C135447 | Slow-Twitch Skeletal Muscle Troponin I;ssTnI;Troponin I Type 1 | A measurement of the troponin I type 1 (slow twitch skeletal muscle) in a biological specimen. | Troponin I Type 1 Measurement | ||
Troponin I Type 2 | C127636 | Fast-Twitch Skeletal Muscle Troponin I;fsTnI;Troponin I Type 2 | A measurement of the troponin I type 2 (fast twitch skeletal muscle) in a biological specimen. | Troponin I Type 2 Measurement | ||
Troponin I Type 3 | C135448 | Cardiac Troponin I;cTnI;TNNC1;Troponin I Type 3 | A measurement of the troponin I type 3 (cardiac muscle) in a biological specimen. | Troponin I Type 3 Measurement | ||
Troponin I | C74749 | Troponin I | A measurement of the actin binding troponin in a biological specimen. | Troponin I Measurement | ||
Troponin T | C74750 | Troponin T | A measurement of the tropomyosin binding troponin in a biological specimen. | Troponin T Measurement | ||
Troponin | C111327 | Troponin | A measurement of the total troponin in a biological specimen. | Troponin Measurement | ||
Trypsin 1 and Trypsinogen 1 | C135449 | Trypsin 1 and Trypsinogen 1 | A measurement of the trypsin 1 and trypsinogen 1 in a biological specimen. | Trypsin 1 and Trypsinogen 1 Measurement | ||
Trypsin and Trypsinogen | C135450 | Trypsin and Trypsinogen | A measurement of the total trypsin and total trypsinogen in a biological specimen. | Trypsin and Trypsinogen Measurement | ||
Trypsin | C163494 | Trypsin | A measurement of the trypsin in a biological specimen. | Trypsin Measurement | ||
Tryptase | C92292 | Tryptase | A measurement of the tryptase in a biological specimen. | Tryptase Measurement | ||
Tryptophan | C154739 | Tryptophan | A measurement of the tryptophan in a biological specimen. | Tryptophan Measurement | ||
Tryptophan/Creatinine | C163493 | Tryptophan/Creatinine | A relative measurement (ratio or percentage) of the tryptophan to creatinine in a biological specimen. | Tryptophan to Creatinine Ratio Measurement | ||
TSI Actual/Control | C161368 | Thyroid Stimulating Immunoglobulin Actual/Control;Thyroid Stimulating Immunoglobulin Actual/Normal;TSI Actual/Control | A relative measurement (ratio or percentage) of the thyroid stimulating immunoglobulin in a subject's specimen when compared to a control specimen. | Thyroid Stimulating Immunoglobulin Actual to Control Ratio Measurement | ||
Tubular Epithelial Cells | C74775 | Renal Tubular Epithelial Cells;Tubular Epithelial Cells | A measurement of the tubular epithelial cells present in a biological specimen. | Tubular Epithelial Cell Count | ||
Tumor Necrosis Factor Receptor 1 | C120666 | CD120a;Tumor Necrosis Factor Receptor 1 | A measurement of the tumor necrosis factor receptor 1 (CD120a) in a biological specimen. | Tumor Necrosis Factor Receptor 1 Measurement | ||
Tumor Necrosis Factor | C74751 | Tumor Necrosis Factor;Tumor Necrosis Factor alpha | A measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen. | Tumor Necrosis Factor Measurement | ||
Turbidity | C74723 | Turbidity | A measurement of the opacity of a biological specimen. | Turbidity Measurement | ||
Type I Collagen C-Telopeptides Beta | C187792 | Beta Isomer of C-Terminal Telopeptide of Type I Collagen;Type I Collagen C-Telopeptides Beta | A measurement of the beta isomer of type I collagen cross-linked C-telopeptides in a biological specimen. | Beta Isomer of C-Terminal Telopeptide of Type I Collagen Measurement | ||
Type I Collagen C-Telopeptides | C82038 | C-Terminal Telopeptide of Type I Collagen;Type I Collagen C-Telopeptides;Type I Collagen X-linked C-telopeptide | A measurement of the type I collagen cross-linked C-telopeptides in a biological specimen. | Type I Collagen C-Telopeptide Measurement | ||
Type I Collagen C-Telopeptides/Creat | C127613 | Type I Collagen C-Telopeptides/Creat;Type I Collagen X-Linked C-Telopeptides/Creatinine | A relative measurement (ratio or percentage) of the type I collagen cross-linked C-telopeptides to creatinine in a biological specimen. | Type I Collagen C-Telopeptide to Creatinine Ratio Measurement | ||
Type I Collagen N-Telopeptides | C82039 | Type I Collagen N-Telopeptides;Type I Collagen X-Linked N-Telopeptides | A measurement of the type I collagen cross-linked N-telopeptides in a biological specimen. | Type I Collagen N-Telopeptide Measurement | ||
Type I Myeloblasts | C92283 | Type I Myeloblasts | A measurement of type I myeloblast cells per unit of a biological specimen. | Type I Myeloblasts Measurement | ||
Type II Collagen C-Telopeptides | C82040 | Type II Collagen C-Telopeptides;Type II Collagen X-Linked C-Telopeptides | A measurement of the type II collagen cross-linked C-telopeptides in a biological specimen. | Type II Collagen C-Telopeptide Measurement | ||
Type II Collagen C-Telopeptides/Creat | C122113 | Type II Collagen C-Telopeptides/Creat;Type II Collagen X-Linked C-Telopeptides/Creatinine | A relative measurement (ratio or percentage) of the type II collagen cross-linked C-telopeptides to creatinine in a biological specimen. | Type II Collagen C-Telopeptides to Creatinine Ratio Measurement | ||
Type II Collagen N-Telopeptides | C82041 | Type II Collagen N-Telopeptides;Type II Collagen X-Linked N-Telopeptides | A measurement of the type II collagen cross-linked N-telopeptides in a biological specimen. | Type II Collagen N-Telopeptide Measurement | ||
Type II Myeloblasts | C92284 | Type II Myeloblasts | A measurement of type II myeloblast cells per unit of a biological specimen. | Type II Myeloblasts Measurement | ||
Type II Secretory Phospholipase A2 | C120663 | Type II Secretory Phospholipase A2 | A measurement of the type II secretory phospholipase A2 in a biological specimen. | Type II Secretory Phospholipase A2 Measurement | ||
Type III Myeloblasts | C92285 | Type III Myeloblasts | A measurement of type III myeloblast cells per unit of a biological specimen. | Type III Myeloblasts Measurement | ||
Tyrosine Crystals | C74683 | Tyrosine Crystals | A measurement of the tyrosine crystals present in a biological specimen. | Tyrosine Crystal Measurement | ||
Tyrosine | C122159 | Tyrosine | A measurement of the tyrosine in a biological specimen. | Tyrosine Measurement | ||
U-47700 | C184564 | Pink;Pinky;U-47700;U4;U47700 | A measurement of the synthetic cannabinoid U-47700 in a biological specimen. | U-47700 Measurement | ||
Ubiquinone 10 | C147321 | Coenzyme Q10;Ubiquinone 10 | A measurement of the ubiquinone 10 in a biological specimen. | Ubiquinone 10 Measurement | ||
Ubiquitin C-Terminal Hydrolase L1 | C189529 | Ubiquitin C-Terminal Hydrolase L1;Ubiquitin Carboxy-Terminal Hydrolase L1;UCH-L1 | A measurement of the ubiquitin C-terminal hydrolase L1 in a biological specimen. | Ubiquitin C-Terminal Hydrolase L1 Measurement | ||
Ubiquitin Protein | C147443 | Ubiquitin Protein | A measurement of the total ubiquitin protein in a biological specimen. | Ubiquitin Protein Measurement | ||
Ubiquitin-Like Protein ISG15 | C163461 | ISG15 Ubiquitin-Like Modifier;Ubiquitin-Like Protein ISG15 | A measurement of the ubiquitin-like protein ISG15 in a biological specimen. | Ubiquitin-Like Protein ISG15 Measurement | ||
Unclassified Casts | C74776 | Unclassified Casts | A measurement of the unclassifiable casts present in a biological specimen. | Unclassified Cast Measurement | ||
Unclassified Crystals | C74757 | Unclassified Crystals | A measurement of the unclassifiable crystals present in a biological specimen. | Unclassified Crystal Measurement | ||
Unsaturated Iron Binding Capacity | C74719 | Unsaturated Iron Binding Capacity | A measurement of the binding capacity of unsaturated iron in a biological specimen. | Unsaturated Iron Binding Capacity Measurement | ||
Unspecified Cells | C112241 | Unspecified Cells | A measurement of the cells not otherwise identified or specified in a biological specimen. | Count of Unspecified Cells | ||
Unspecified Cells/Leukocytes | C161364 | Unspecified Cells/Leukocytes | A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to leukocytes in a biological specimen. | Unspecified Cells to Leukocytes Ratio Measurement | ||
Unspecified Cells/Total Cells | C114225 | Unspecified Cells/Total Cells | A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen. | Unspecified Cells to Total Cell Ratio Measurement | ||
UR-144 | C184565 | UR-144;UR144 | A measurement of the synthetic cannabinoid UR-144 in a biological specimen. | UR-144 Measurement | ||
Urate Excretion Rate | C163498 | Urate Excretion Rate | A measurement of the amount of urate being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Urate Excretion Rate | ||
Urate | C64814 | Urate;Uric Acid | A measurement of the urate in a biological specimen. | Urate Measurement | ||
Urate/Creatinine | C117866 | Urate/Creatinine | A relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen. | Urate to Creatinine Ratio Measurement | ||
Urea Distribution Volume Ratio | C191294 | Urea Distribution Volume Ratio;Urea Kt/V | A calculated measurement of the urea distribution volume (ratio) in a biological specimen used to quantify adequacy of dialysis treatment. | Urea Distribution Volume Ratio | ||
Urea Nitrogen Excretion Rate | C163499 | Urea Nitrogen Excretion Rate | A measurement of the amount of urea nitrogen being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Urea Nitrogen Excretion Rate | ||
Urea Nitrogen | C125949 | Urea Nitrogen | A measurement of the urea nitrogen in a biological specimen. | Urea Nitrogen Measurement | ||
Urea Nitrogen/Creatinine | C125950 | Urea Nitrogen/Creatinine | A relative measurement (ratio or percentage) of the urea nitrogen to creatinine in a biological specimen. | Urea Nitrogen to Creatinine Ratio Measurement | ||
Urea Reduction Ratio | C191296 | Urea Reduction Ratio | A calculated measurement (ratio or percentage) of the proportionate reduction in urea nitrogen over the course of dialysis in a biological specimen. | Urea Reduction Ratio | ||
Urea | C64815 | Urea | A measurement of the urea in a biological specimen. | Urea Measurement | ||
Urea/Creatinine | C96645 | Urea/Creatinine | A relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen. | Urea to Creatinine Ratio Measurement | ||
Uric Acid Crystals | C74684 | Uric Acid Crystals | A measurement of the uric acid crystals (including acid urate and urate crystals) present in a biological specimen. | Uric Acid Crystal Measurement | ||
Urine Conductivity | C102282 | Urine Conductivity | A measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine. | Urine Conductivity | ||
Urobilinogen | C64816 | Urobilinogen | A measurement of the urobilinogen in a biological specimen. | Urobilinogen Measurement | ||
Urokinase Plasminogen Activator | C181447 | uPA;Urokinase Plasminogen Activator | A measurement of the urokinase plasminogen activator in a biological specimen. | Urokinase Plasminogen Activator Measurement | ||
Urothelial Cells | C163500 | Urothelial Cells | A measurement of urothelial cells in a biological specimen. | Urothelial Cell Count | ||
Ursodeoxycholate Compounds | C176238 | Ursodeoxycholate Compounds;Ursodeoxycholic Acid Compounds | A measurement of the ursodeoxycholic acid, glycoursodeoxycholic acid, tauroursodeoxycholic acid, and epimerized ursodeoxycholic acid in a biological specimen. | Ursodeoxycholate Compounds Measurement | ||
Ursodeoxycholate | C176298 | Ursodeoxycholate;Ursodeoxycholic Acid;Ursodiol | A measurement of the ursodeoxycholate in a biological specimen. | Ursodeoxycholate Measurement | ||
Vacuolated Lymphocytes | C111329 | Vacuolated Lymphocytes | A measurement of the vacuolated lymphocytes in a biological specimen. | Vacuolated Lymphocyte Count | ||
Vacuolated Lymphocytes/Leukocytes | C127627 | Vacuolated Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the vacuolated lymphocytes to leukocytes in a biological specimen. | Vacuolated Lymphocyte to Leukocyte Ratio Measurement | ||
Vacuolated Neutrophils | C74628 | Vacuolated Neutrophils | A measurement of the neutrophils containing small vacuoles in a biological specimen. | Vacuolated Neutrophil Count | ||
Valerylfentanyl | C184607 | Valeryl Fentanyl;Valerylfentanyl | A measurement of the valerylfentanyl in a biological specimen. | Valerylfentanyl Measurement | ||
Valine | C122160 | Valine | A measurement of the valine in a biological specimen. | Valine Measurement | ||
Valproate | C181410 | Valproate;Valproic Acid | A measurement of the valproate in a biological specimen. | Valproate Measurement | ||
Vanillyl Mandelic Acid Excretion Rate | C163503 | Vanillyl Mandelic Acid Excretion Rate | A measurement of the amount of vanillyl mandelic acid being excreted in a biological specimen over a defined amount of time (e.g. one hour). | Vanillyl Mandelic Acid Excretion Rate | ||
Vanillyl Mandelic Acid | C74875 | Vanillyl Mandelic Acid;Vanillylmandelate;Vanilmandelic Acid | A measurement of the vanillyl mandelic acid metabolite in a biological specimen. | Vanillyl Mandelic Acid Measurement | ||
Vasc Endothelial Growth Factor Rec 2 | C156527 | Vasc Endothelial Growth Factor Rec 2;Vascular Endothelial Growth Factor Receptor 2 | A measurement of the vascular endothelial growth factor receptor 2 in a biological specimen. | Vascular Endothelial Growth Factor Receptor 2 Measurement | ||
Vascular Cell Adhesion Molecule 1 | C82042 | Vascular Cell Adhesion Molecule 1 | A measurement of the vascular cell adhesion molecule 1 in a biological specimen. | Vascular Cell Adhesion Molecule 1 Measurement | ||
Vascular Endothelial Growth Factor A | C132389 | Vascular Endothelial Growth Factor A | A measurement of the vascular endothelial growth factor A in a biological specimen. | Vascular Endothelial Growth Factor A Measurement | ||
Vascular Endothelial Growth Factor C | C163501 | Vascular Endothelial Growth Factor C | A measurement of the vascular endothelial growth factor C in a biological specimen. | Vascular Endothelial Growth Factor C Measurement | ||
Vascular Endothelial Growth Factor D | C172496 | FIGF;Vascular Endothelial Growth Factor D | A measurement of the vascular endothelial growth factor D in a biological specimen. | Vascular Endothelial Growth Factor D Measurement | ||
Vascular Endothelial Growth Factor | C92514 | Vascular Endothelial Growth Factor | A measurement of the vascular endothelial growth factor in a biological specimen. | Vascular Endothelial Growth Factor Measurement | ||
Vasoactive Intestinal Polypeptide | C163502 | Vasoactive Intestinal Polypeptide;VIP | A measurement of vasoactive intestinal polypeptide in a biological specimen. | Vasoactive Intestinal Polypeptide Measurement | ||
Venlafaxine | C147444 | Venlafaxine | A measurement of the venlafaxine present in a biological specimen. | Venlafaxine Measurement | ||
Viable Cells | C130166 | Viable Cells | A measurement of the viable cells in a biological specimen. | Viable Cell Count | ||
Vilazodone | C187829 | Vilazodone | A measurement of the vilazodone in a biological specimen. | Vilazodone Measurement | ||
Vinbarbital | C184606 | Vinbarbital | A measurement of the vinbarbital in a biological specimen. | Vinbarbital Measurement | ||
Viscosity | C75912 | Visc;Viscosity | The resistance of a liquid to sheer forces and flow. (NCI) | Viscosity | ||
Vitamin A | C74895 | Retinol;Vitamin A | A measurement of the Vitamin A in a biological specimen. | Vitamin A Measurement | ||
Vitamin B12 | C64817 | Cobalamin;Vitamin B12 | A measurement of the Vitamin B12 in a biological specimen. | Vitamin B12 Measurement | ||
Vitamin B17 | C74897 | Amygdalin;Vitamin B17 | A measurement of the Vitamin B17 in a biological specimen. | Vitamin B17 Measurement | ||
Vitamin B5 | C74900 | Pantothenic Acid;Vitamin B5 | A measurement of the Vitamin B5 in a biological specimen. | Vitamin B5 Measurement | ||
Vitamin B6 | C74901 | Pyridoxine;Vitamin B6 | A measurement of the Vitamin B6 in a biological specimen. | Vitamin B6 Measurement | ||
Vitamin B7 | C74902 | Biotin;Vitamin B7 | A measurement of the Vitamin B7 in a biological specimen. | Vitamin B7 Measurement | ||
Vitamin B9 | C74676 | Folate;Folic Acid;Vitamin B9 | A measurement of the folic acid in a biological specimen. | Folic Acid Measurement | ||
Vitamin C | C74903 | Ascorbate;Ascorbic Acid;Vitamin C | A measurement of the Vitamin C in a biological specimen. | Vitamin C Measurement | ||
Vitamin D Binding Protein | C172506 | DBP;GC Vitamin D Binding Protein;VDBP;Vitamin D Binding Protein | A measurement of the vitamin D binding protein in a biological specimen. | Vitamin D Binding Protein Measurement | ||
Vitamin D2 + Vitamin D3 | C179751 | Calciferol + Cholecalciferol;Vitamin D2 + Vitamin D3 | A measurement of the vitamin D2 and vitamin D3 in a biological specimen. | Vitamin D2 and Vitamin D3 Measurement | ||
Vitamin D2 D3 25-OH | C147445 | Vitamin D + Metabolites;Vitamin D2 + Vitamin D3 + 25-Hydroxy Vitamin D2 + 25-Hydroxy Vitamin D3;Vitamin D2 D3 25-OH | A measurement of the vitamin D2, vitamin D3 and their metabolites in a biological specimen. | Vitamin D2 and Vitamin D3 and 25-Hydroxy Vitamin D2 and 25-Hydroxy Vitamin D3 Measurement | ||
Vitamin D2 | C74904 | Calciferol;Ergocalciferol;Viosterol;Vitamin D2 | A measurement of the Vitamin D2 in a biological specimen. | Vitamin D2 Measurement | ||
Vitamin D3 | C74905 | Calciol;Cholecalciferol;Colecalciferol;Vitamin D;Vitamin D3 | A measurement of the Vitamin D3 in a biological specimen. | Vitamin D3 Measurement | ||
Vitamin E | C74906 | Vitamin E | A measurement of the Vitamin E in a biological specimen. | Vitamin E Measurement | ||
Vitamin E/Cholesterol | C103448 | Vitamin E/Cholesterol | A relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen. | Vitamin E to Cholesterol Ratio Measurement | ||
Vitamin K | C74907 | Naphthoquinone;Vitamin K | A measurement of the total Vitamin K in a biological specimen. | Vitamin K Measurement | ||
Vitamin K1 | C103449 | Phylloquinone;Phytomenadione;Vitamin K1 | A measurement of the Vitamin K1 in a biological specimen. | Vitamin K1 Measurement | ||
Vitronectin | C165995 | V75;Vitronectin;VN;VNT;VTN | A measurement of the vitronectin in a biological specimen. | Vitronectin Measurement | ||
VLDL Apolipoprotein B | C184517 | VLDL Apolipoprotein B | A measurement of the apolipoprotein B in the very low density lipoprotein fraction of a biological specimen. | VLDL Apolipoprotein B Measurement | ||
VLDL Cholesterol Subtype 1 | C120667 | VLDL Cholesterol Subtype 1 | A measurement of the very low density lipoprotein cholesterol subtype 1 in a biological specimen. | VLDL Cholesterol Subtype 1 Measurement | ||
VLDL Cholesterol Subtype 2 | C120668 | VLDL Cholesterol Subtype 2 | A measurement of the very low density lipoprotein cholesterol subtype 2 in a biological specimen. | VLDL Cholesterol Subtype 2 Measurement | ||
VLDL Cholesterol Subtype 3 | C120669 | VLDL Cholesterol Subtype 3 | A measurement of the very low density lipoprotein cholesterol subtype 3 in a biological specimen. | VLDL Cholesterol Subtype 3 Measurement | ||
VLDL Cholesterol | C105589 | VLDL Cholesterol | A measurement of the very low density lipoprotein cholesterol in a biological specimen. | Very Low Density Lipoprotein Cholesterol Measurement | ||
VLDL Particle Size | C103450 | VLDL Particle Size | A measurement of the average particle size of very-low-density lipoprotein in a biological specimen. | VLDL Particle Size Measurement | ||
VLDL Trig + Chylomicron Trig | C174301 | VLDL Trig + Chylomicron Trig;VLDL Triglyceride + Chylomicron Triglyceride | A measurement of the very low density lipoprotein triglyceride and chylomicron triglyceride in a biological specimen. | VLDL Triglyceride and Chylomicron Triglyceride Measurement | ||
VLDL Triglyceride | C174303 | VLDL Triglyceride | A measurement of the very low density lipoprotein triglyceride in a biological specimen. | VLDL Triglyceride Measurement | ||
Volume | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
von Will Factor Act Actual/Control | C147447 | von Will Factor Act Actual/Control;von Willebrand Factor Activity Actual/Normal;von Willebrand Factor Activity Actual/von Willebrand Factor Activity Control | A relative measurement (ratio or percentage) of the biological activity of the von Willebrand factor dependent coagulation in a subject's specimen when compared to the same activity in a control specimen. | von Willebrand Factor Activity Actual to Control Ratio Measurement | ||
von Will Factor Actual/Control | C170597 | von Will Factor Actual/Control;von Willebrand Factor Actual/Control;von Willebrand Factor Actual/Normal;von Willebrand Factor Actual/von Willebrand Factor Control | A relative measurement (ratio or percentage) of the von Willebrand factor in a subject's specimen when compared to a control specimen. | von Willebrand Factor Actual to Control Ratio Measurement | ||
von Willebrand Factor Activity | C122117 | von Willebrand Factor Activity | A measurement of the biological activity of von Willebrand coagulation factor in a biological specimen. | von Willebrand Factor Activity Measurement | ||
von Willebrand Factor Multimers | C147336 | von Willebrand Factor Multimers | A measurement of the von Willebrand Factor multimers (an aggregate of multiple von Willebrand factor antigens that are held together with non-covalent bonds) in a biological specimen. | von Willebrand Factor Multimers Measurement | ||
von Willebrand Factor | C98799 | von Willebrand Factor;von Willebrand Factor Antigen | A measurement of the von Willebrand coagulation factor in a biological specimen. | von Willebrand Factor Measurement | ||
Vortioxetine | C187832 | Vortioxetine | A measurement of the vortioxetine in a biological specimen. | Vortioxetine Measurement | ||
Walnut Antigen IgE Antibody | C177961 | Juglans Species Nut Antigen IgE Antibody;Walnut Antigen IgE Antibody | A measurement of the walnut antigen IgE antibody in a biological specimen. | Walnut Antigen IgE Antibody Measurement | ||
Waxy Casts | C74777 | Waxy Casts | A measurement of the waxy casts present in a biological specimen. | Waxy Cell Cast Measurement | ||
WBC Casts | C74778 | WBC Casts | A measurement of the white blood cell casts present in a biological specimen. | White Blood Cell Cast Measurement | ||
WD Repeat-Containing Protein 26 | C127637 | CDW2;Macrophage Inflammatory Protein-2;MIP2;WD Repeat-Containing Protein 26 | A measurement of the WD repeat-containing protein 26 in a biological specimen. | WD Repeat-Containing Protein 26 Measurement | ||
Weed Mix Pollen Antigen IgA Antibody | C130108 | Weed Mix Pollen Antigen IgA Antibody | A measurement of the weed mix pollen antigen IgA antibody in a biological specimen. | Weed Mix Pollen Antigen IgA Antibody Measurement | ||
Weed Mix Pollen Antigen IgE Antibody | C130106 | Weed Mix Pollen Antigen IgE Antibody | A measurement of the weed mix pollen antigen IgE antibody in a biological specimen. | Weed Mix Pollen Antigen IgE Antibody Measurement | ||
Weed Mix Pollen Antigen IgG Antibody | C130107 | Weed Mix Pollen Antigen IgG Antibody | A measurement of the weed mix pollen antigen IgG antibody in a biological specimen. | Weed Mix Pollen Antigen IgG Antibody Measurement | ||
Weed Mix Pollen IgE AB RAST Score | C165925 | Weed Mix Pollen IgE AB RAST Score | A classification of the amount of weed mix pollen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Weed Mix Pollen IgE Antibody RAST Score Measurement | ||
Weed Mix Pollen IgG AB RAST Score | C165906 | Weed Mix Pollen IgG AB RAST Score | A classification of the amount of weed mix pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Weed Mix Pollen IgG Antibody RAST Score Measurement | ||
Western Ragweed Pollen IgA | C130093 | Western Ragweed Pollen IgA | A measurement of the Ambrosia psilostachya pollen antigen IgA antibody in a biological specimen. | Western Ragweed Pollen IgA Measurement | ||
Western Ragweed Pollen IgE AB RAST Score | C165891 | Western Ragweed Pollen IgE AB RAST Score | A classification of the amount of Ambrosia psilostachya pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Western Ragweed Pollen IgE Antibody RAST Score Measurement | ||
Western Ragweed Pollen IgE | C130092 | Western Ragweed Pollen IgE | A measurement of the Ambrosia psilostachya pollen antigen IgE antibody in a biological specimen. | Western Ragweed Pollen IgE Measurement | ||
Western Ragweed Pollen IgG AB RAST Score | C165903 | Western Ragweed Pollen IgG AB RAST Score | A classification of the amount of Ambrosia psilostachya pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Western Ragweed Pollen IgG Antibody RAST Score Measurement | ||
Western Ragweed Pollen IgG | C130094 | Western Ragweed Pollen IgG | A measurement of the Ambrosia psilostachya pollen antigen IgG antibody in a biological specimen. | Western Ragweed Pollen IgG Measurement | ||
Western Ragweed Pollen IgG4 | C130095 | Western Ragweed Pollen IgG4 | A measurement of the Ambrosia psilostachya pollen antigen IgG4 antibody in a biological specimen. | Western Ragweed Pollen IgG4 Measurement | ||
White Elm Pollen IgE AB RAST Score | C165882 | White Elm Pollen IgE AB RAST Score | A classification of the amount of Ulmus americana pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | White Elm Pollen IgE Antibody RAST Score Measurement | ||
White Elm Pollen IgE Antibody | C165881 | White Elm Pollen IgE Antibody | A measurement of the Ulmus americana pollen antigen IgE antibody in a biological specimen. | White Elm Pollen IgE Antibody Measurement | ||
White Elm Pollen IgG AB RAST Score | C165920 | White Elm Pollen IgG AB RAST Score | A classification of the amount of Ulmus americana pollen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | White Elm Pollen IgG Antibody RAST Score Measurement | ||
White Elm Pollen IgG Antibody | C147283 | White Elm Pollen IgG Antibody | A measurement of the Ulmus americana pollen antigen IgG antibody in a biological specimen. | White Elm Pollen IgG Antibody Measurement | ||
White Oak Pollen IgE AB RAST Score | C165886 | White Oak Pollen IgE AB RAST Score | A classification of the amount of Quercus alba pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | White Oak Pollen IgE Antibody RAST Score Measurement | ||
White Oak Pollen IgE Antibody | C147282 | White Oak Pollen IgE Antibody | A measurement of the Quercus alba pollen antigen IgE antibody in a biological specimen. | White Oak Pollen IgE Antibody Measurement | ||
Whole Blood Equivalent Glucose | C176296 | Whole Blood Equivalent Glucose | A measurement of the whole blood equivalent glucose in a biological specimen. | Whole Blood Equivalent Glucose Measurement | ||
Wild Rye Pollen IgE AB RAST Score | C165893 | Wild Rye Pollen IgE AB RAST Score | A classification of the amount of Elymus tricoides pollen antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Wild Rye Pollen IgE Antibody RAST Score Measurement | ||
Wild Rye Pollen IgE Antibody | C165892 | Wild Rye Pollen IgE Antibody | A measurement of the Elymus tricoides pollen antigen IgE antibody in a biological specimen. | Wild Rye Pollen IgE Antibody Measurement | ||
Xanthochromia | C147449 | Xanthochromia | A measurement of the yellowish appearance of a biological specimen due to the presence of bilirubin produced by the degradation of heme from erythrocytes that have entered the biological specimen. | Xanthochromia Measurement | ||
Xylose | C186099 | Xylose | A measurement of the xylose in a biological specimen. | Xylose Measurement | ||
Xylose/Xylose Dose | C186098 | Xylose/Xylose Dose | A relative measurement (percentage) of the xylose in a biological specimen to an administered dose of xylose. | Xylose to Xylose Dose Ratio Measurement | ||
Yeast Budding | C106504 | Budding Yeast;Yeast Budding | A measurement of the budding yeast present in a biological specimen. | Budding Yeast Measurement | ||
Yeast Cells | C74664 | Yeast Cells | A measurement of the yeast cells present in a biological specimen. | Yeast Cell Measurement | ||
Yeast Hyphae | C92239 | Yeast Hyphae | A measurement of the yeast hyphae present in a biological specimen. | Yeast Hyphae Screening | ||
YKL-40 Protein | C142294 | Chitinase-3-Like Protein 1;YKL-40 Protein | A measurement of the YKL-40 protein in a biological specimen. | YKL-40 Protein Measurement | ||
Zaleplon | C184636 | Zaleplon | A measurement of the zaleplon in a biological specimen. | Zaleplon Measurement | ||
Zea mays Antigen IgE Antibody | C147279 | Corn Antigen IgE Antibody;Zea mays Antigen IgE Antibody | A measurement of the Zea mays antigen IgE antibody in a biological specimen. | Zea mays Antigen IgE Antibody Measurement | ||
Zea mays IgE AB RAST Score | C165937 | Zea mays IgE AB RAST Score | A classification of the amount of Zea mays IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Zea mays IgE Antibody RAST Score Measurement | ||
Zinc Protoporphyrin | C147452 | Zinc Protoporphyrin | A measurement of the zinc protoporphyrin (zinc bound protoporphyrin) in a biological specimen. | Zinc Protoporphyrin Measurement | ||
Zinc | C80210 | Zinc | A measurement of the zinc in a biological specimen. | Zinc Measurement | ||
Ziprasidone | C177986 | Ziprasidone | A measurement of the ziprasidone in a biological specimen. | Ziprasidone Measurement | ||
Zolpidem | C184637 | Zolpidem | A measurement of the zolpidem in a biological specimen. | Zolpidem Measurement | ||
Zopiclone | C184638 | Zopiclone | A measurement of the zopiclone in a biological specimen. | Zopiclone Measurement | ||
Back to top | ||||||
CL.C102580.LBSTRESC | Laboratory Test Standard Character Result
(LBSTRESC) | text
Extensible: Yes | C102580 | Laboratory Test Standard Character Result | Terminology relevant to the standardized results, in character format, for laboratory tests. | CDISC SDTM Laboratory Test Standard Character Result Terminology |
ABNORMAL | C25401 | Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm. (NCI) | Abnormal | |||
ABSENT | C48190 | Not existing in a specified place at a specified time. (NCI) | Absent | |||
BORDERLINE | C14157 | Straddling the dividing line between two categories. | Borderline | |||
DETECTED | C191719 | A finding indicating that an entity or characteristic is perceived, discerned, or discovered. | Detected Finding | |||
INDETERMINATE | C48658 | Inconclusive | Cannot distinguish between two or more possible values in the current context. (NCI) | Indeterminate | ||
NEGATIVE | C38757 | An indication of a negative finding for a test or assessment, such as for a disease, condition, analyte, or microorganism. | Negative Finding | |||
NORMAL | C14165 | Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI) | Normal | |||
NOT DETECTED | C191300 | A finding indicating that an entity or characteristic is not perceived, discerned, or discovered. | Not Detected | |||
POSITIVE | C38758 | An indication of an affirmative finding for a test or assessment, such as for a disease, condition, analyte, or microorganism. | Positive Finding | |||
PRESENT | C25626 | Being or existing in a specified place or at the specified time. (NCI) | Present | |||
STRONGLY POSITIVE | C191301 | A positive finding that is strong in intensity, power, or magnitude. | Strongly Positive | |||
TOO NUMEROUS TO COUNT | C191303 | TNTC | A subjective finding indicating the presence of entities that are deemed too numerous to accurately quantify. | Too Numerous to Count | ||
TRACE | C80218 | A barely detectable amount. | Trace | |||
WEAKLY POSITIVE | C191302 | A positive finding that is weak in intensity, power, or magnitude. | Weakly Positive | |||
Back to top | ||||||
CL.C138215.LPPSS1TC | Lansky Play-Performance Status Scale Clinical Classification Test Code
(LPPSS1TC) | text
Extensible: No | C138215 | Lansky Play-Performance Status Scale Clinical Classification Test Code | Lansky Play-Performance Status Scale test code. | CDISC Clinical Classification LPSS Test Code Terminology |
LPPSS101 | C138364 | LPPSS1-Lansky Play-Performance Status | Lansky Play-Performance Status Scale - Lansky play-performance status. | LPSS - Lansky Play-Performance Status | ||
Back to top | ||||||
CL.C138214.LPPSS1TN | Lansky Play-Performance Status Scale Clinical Classification Test Name
(LPPSS1TN) | text
Extensible: No | C138214 | Lansky Play-Performance Status Scale Clinical Classification Test Name | Lansky Play-Performance Status Scale test name. | CDISC Clinical Classification LPSS Test Name Terminology |
LPPSS1-Lansky Play-Performance Status | C138364 | LPPSS1-Lansky Play-Performance Status | Lansky Play-Performance Status Scale - Lansky play-performance status. | LPSS - Lansky Play-Performance Status | ||
Back to top | ||||||
CL.C99073.LAT | Laterality
(LAT) | text
Extensible: Yes | C99073 | Laterality | CDISC terminology for anatomical location or specimen further detailing the side(s) of interest. | CDISC SDTM Laterality Terminology |
BILATERAL | C13332 | Affecting both sides of the body, or a pair of organs. | Bilateral | |||
CONTRALATERAL | C25307 | Having to do with the opposite side of the body, in relation to a pre-existing reference point. | Contralateral | |||
IPSILATERAL | C25308 | Having to do with the same side of the body, in relation to a pre-existing reference point. | Ipsilateral | |||
LATERAL | C25230 | Situated at or extending to the side. | Lateral | |||
LEFT | C25229 | Being or located on or directed toward the side of the body to the west when facing north. | Left | |||
RIGHT | C25228 | Being or located on or directed toward the side of the body to the east when facing north. | Right | |||
UNILATERAL | C28012 | Affecting one side of the body or one of a pair of organs. | Unilateral | |||
Back to top | ||||||
CL.C101862.LEADABN | Lead Abnormality
(LEADABN) | text
Extensible: Yes | C101862 | Lead Abnormality | Terminology related to the complications of cardiac lead systems. | CDISC SDTM Lead Abnormality Terminology |
CONDUCTOR FAILURE | C99924 | Conductor failure manifests by high lead impedance either absolutely (above manufacturer's product specifications) or by a significant increase from previously stable chronic values. | Cardiac Device Conductor Failure | |||
DEFIBRILLATION ISSUES | C99922 | The cardiac lead is not performing as expected with issues such as oversensing with or without shock or ATP, or failed shocks or inadequate DFT safety margins defibrillation activity. | Cardiac Defibrillator Issue | |||
EXTRACARDIAC STIMULATION | C99951 | This manifests as stimulation by the lead of non-cardiac structures such as the diaphragm, chest wall, or pectoral muscle. | Extracardiac Stimulation | |||
FAILED TO SHOCK WITH INADEQUATE DFT SAFETY MARGIN | C99954 | The cardiac lead failed to administer a shock and had an inadequate defibrillator threshold safety margin. | Failure to Shock with Inadequate Defibrillator Threshold Safety Margin | |||
FAILURE TO CAPTURE WITH ACCEPTABLE SAFETY MARGIN | C99953 | Failure to capture manifests as a high pacing threshold that results in either intermittent failure to capture at maximal programmed output or excessive battery drain leading to premature battery exhaustion. | Failure to Capture with Acceptable Safety Margin | |||
FAILURE TO PACE | C99528 | Failure to pace manifests as absence of pacemaker stimulation artifacts on electrocardiographic recordings despite rates below pacemaker programmed rate. | Failure of Cardiac Pacemaker to Pace | |||
INSULATION FAILURE | C99932 | Insulation failure manifests as low lead impedance either absolutely (below manufacturer's product specifications) or by a significant decrease from previously stable chronic values. | Cardiac Lead Insulation Failure | |||
LEAD DISLODGEMENT REQUIRING REPOSITION/REOPERATION | C100034 | The movement (macroscopic or microscopic) of an existing lead within the heart or vascular tree away from the original implantation site. | Cardiac Lead Dislodgement Requiring Reposition/Reoperation | |||
OVERSENSING WITH SHOCK OR ATP | C99927 | This manifests as sensing of non-cardiac depolarization signals that met arrhythmia detection criteria and elicited programmed tachyarrhythmia therapy. | Cardiac Device Oversensing with Shock or Anti-Tachycardia Pacing | |||
OVERSENSING WITHOUT SHOCK OR ATP | C99928 | This manifests as sensing of non-cardiac depolarization signals that did not meet arrhythmia detection criteria and do not elicit programmed tachyarrhythmia therapy. | Cardiac Device Oversensing without Shock or Anti-Tachycardia Pacing | |||
OVERSENSING | C99926 | Oversensing manifests as sensing of electrical signals not related to cardiac depolarization of the lead chamber that cannot be resolved acceptably by device reprogramming. | Cardiac Device Oversensing | |||
SET SCREW PROBLEM | C99929 | The pacing and/or sensing problem associated with high impedance due to a poor connection between a lead and generator caused by a loose set screw. | Cardiac Device Set Screw Problem | |||
UNDERSENSING | C99930 | Undersensing manifests as failure to sense appropriate cardiac depolarizations that cannot be resolved with reprogramming. | Cardiac Device Undersensing | |||
Back to top | ||||||
CL.C101867.LEADSTAT | Lead Status
(LEADSTAT) | text
Extensible: Yes | C101867 | Lead Status | The status of the lead. | CDISC SDTM Lead Status Terminology |
ABANDONED | C99906 | The lead has been left in situ but is not in use. | Abandoned Lead | |||
EXTRACTED | C102283 | The lead has been removed from the body. | Extracted Lead | |||
REUSED | C102284 | The lead has been left in situ and reused. | Reused Lead | |||
Back to top | ||||||
CL.C101868.LVEFMRE | Left Ventricular Ejection Fraction Measurement Result
(LVEFMRE) | text
Extensible: Yes | C101868 | Left Ventricular Ejection Fraction Measurement Result | Terminology for results of left ventricular ejection fraction assessments. | CDISC SDTM Left Ventricular Ejection Fraction Measurement Result Terminology |
HYPERDYNAMIC | C99512 | A pathologically high percentage of blood that is forced from the heart ventricle to produce cardiac output. This is often the result of ventricular dilation due to hypertrophic cardiomyopathy. Quantitatively, the ejection fraction is considered higher than 70%. | Hyperdynamic Ventricular Ejection Fraction | |||
MILD DYSFUNCTION | C99507 | Slightly less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 40% to 49%. | Mildly Abnormal Ejection Fraction | |||
MODERATE DYSFUNCTION | C99508 | Moderately less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 30% to 39%. | Moderately Abnormal Ejection Fraction | |||
NORMAL EJECTION FRACTION | C99513 | The usual amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 50% to 70%. | Normal Ventricular Ejection Fraction | |||
SEVERE DYSFUNCTION | C99509 | Severely less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered less than 30%. | Severely Abnormal Ventricular Ejection Fraction | |||
Back to top | ||||||
CL.C101861.LSNCMPX | Lesion Complexity
(LSNCMPX) | text
Extensible: No | C101861 | Lesion Complexity | Terminology related to the risk of percutaneous coronary intervention for a particular lesion. | CDISC SDTM Lesion Complexity Terminology |
ACC/AHA LESION COMPLEXITY SCORE A | C100037 | Low Risk | Discrete (less than 10 mm length) and concentric and readily accessible and non-angulated segment less than 45 degrees and smooth contour and little or no calcification and less than totally occlusive and not ostial in location and no major branch involvement and absence of thrombus. | American College of Cardiology/American Heart Association Lesion Complexity Score A | ||
ACC/AHA LESION COMPLEXITY SCORE B | C100038 | Medium Risk | Tubular (10-20 mm length) or eccentric or moderate tortuosity of proximal segment or moderately angulated segment, 45-90 degrees or irregular contour or moderate to heavy calcification or ostial in location or bifurcation lesions requiring double guidewires or some thrombus present or total occlusion less than3 months old. | American College of Cardiology/American Heart Association Lesion Complexity Score B | ||
ACC/AHA LESION COMPLEXITY SCORE C | C100039 | High Risk | Diffuse (length greater than 2cm) or excessive tortuosity of proximal segment or extremely angulated segments greater than 90 degrees or total occlusions greater than 3 months old and/or bridging collaterals or inability to protect major side branches or degenerated vein grafts with friable lesions. | American College of Cardiology/American Heart Association Lesion Complexity Score C | ||
Back to top | ||||||
CL.C135690.LEC01TC | Life Events Checklist for DSM-5 Standard Version Questionnaire Test Code
(LEC01TC) | text
Extensible: No | C135690 | Life Events Checklist for DSM-5 Standard Version Questionnaire Test Code | Life Events Checklist for DSM-5 Standard Version test code. | CDISC Questionnaire LEC-5 Standard Version Test Code Terminology |
LEC0101A | C135820 | LEC01-Natural Disaster: Happened | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Happened to me. | LEC-5 Standard Version - Natural Disaster: Happened | ||
LEC0101B | C135821 | LEC01-Natural Disaster: Witnessed | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Witnessed it. | LEC-5 Standard Version - Natural Disaster: Witnessed | ||
LEC0101C | C135822 | LEC01-Natural Disaster: Learned | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Learned about it. | LEC-5 Standard Version - Natural Disaster: Learned | ||
LEC0101D | C135823 | LEC01-Natural Disaster: Job | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Part of my job. | LEC-5 Standard Version - Natural Disaster: Job | ||
LEC0101E | C135824 | LEC01-Natural Disaster: Not Sure | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Not sure. | LEC-5 Standard Version - Natural Disaster: Not Sure | ||
LEC0101F | C135825 | LEC01-Natural Disaster: Not Apply | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Doesn't apply. | LEC-5 Standard Version - Natural Disaster: Not Apply | ||
LEC0102A | C135826 | LEC01-Fire or Explosion: Happened | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Happened to me. | LEC-5 Standard Version - Fire or Explosion: Happened | ||
LEC0102B | C135827 | LEC01-Fire or Explosion: Witnessed | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Witnessed it. | LEC-5 Standard Version - Fire or Explosion: Witnessed | ||
LEC0102C | C135828 | LEC01-Fire or Explosion: Learned | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Learned about it. | LEC-5 Standard Version - Fire or Explosion: Learned | ||
LEC0102D | C135829 | LEC01-Fire or Explosion: Job | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Part of my job. | LEC-5 Standard Version - Fire or Explosion: Job | ||
LEC0102E | C135830 | LEC01-Fire or Explosion: Not Sure | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Not sure. | LEC-5 Standard Version - Fire or Explosion: Not Sure | ||
LEC0102F | C135831 | LEC01-Fire or Explosion: Not Apply | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Doesn't apply. | LEC-5 Standard Version - Fire or Explosion: Not Apply | ||
LEC0103A | C135832 | LEC01-Transportation Accident: Happened | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Happened to me. | LEC-5 Standard Version - Transportation Accident: Happened | ||
LEC0103B | C135833 | LEC01-Transportation Accident: Witnessed | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Witnessed it. | LEC-5 Standard Version - Transportation Accident: Witnessed | ||
LEC0103C | C135834 | LEC01-Transportation Accident: Learned | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Learned about it. | LEC-5 Standard Version - Transportation Accident: Learned | ||
LEC0103D | C135835 | LEC01-Transportation Accident: Job | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Part of my job. | LEC-5 Standard Version - Transportation Accident: Job | ||
LEC0103E | C135836 | LEC01-Transportation Accident: Not Sure | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Not sure. | LEC-5 Standard Version - Transportation Accident: Not Sure | ||
LEC0103F | C135837 | LEC01-Transportation Accident: Not Apply | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Doesn't apply. | LEC-5 Standard Version - Transportation Accident: Not Apply | ||
LEC0104A | C135838 | LEC01-Serious Accident: Happened | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Happened to me. | LEC-5 Standard Version - Serious Accident: Happened | ||
LEC0104B | C135839 | LEC01-Serious Accident: Witnessed | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Witnessed it. | LEC-5 Standard Version - Serious Accident: Witnessed | ||
LEC0104C | C135840 | LEC01-Serious Accident: Learned | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Learned about it. | LEC-5 Standard Version - Serious Accident: Learned | ||
LEC0104D | C135841 | LEC01-Serious Accident: Job | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Part of my job. | LEC-5 Standard Version - Serious Accident: Job | ||
LEC0104E | C135842 | LEC01-Serious Accident: Not Sure | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Not sure. | LEC-5 Standard Version - Serious Accident: Not Sure | ||
LEC0104F | C135843 | LEC01-Serious Accident: Not Apply | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Doesn't apply. | LEC-5 Standard Version - Serious Accident: Not Apply | ||
LEC0105A | C135844 | LEC01-Toxic Substance: Happened | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Happened to me. | LEC-5 Standard Version - Toxic Substance: Happened | ||
LEC0105B | C135845 | LEC01-Toxic Substance: Witnessed | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Witnessed it. | LEC-5 Standard Version - Toxic Substance: Witnessed | ||
LEC0105C | C135846 | LEC01-Toxic Substance: Learned | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Learned about it. | LEC-5 Standard Version - Toxic Substance: Learned | ||
LEC0105D | C135847 | LEC01-Toxic Substance: Job | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Part of my job. | LEC-5 Standard Version - Toxic Substance: Job | ||
LEC0105E | C135848 | LEC01-Toxic Substance: Not Sure | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Not sure. | LEC-5 Standard Version - Toxic Substance: Not Sure | ||
LEC0105F | C135849 | LEC01-Toxic Substance: Not Apply | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Doesn't apply. | LEC-5 Standard Version - Toxic Substance: Not Apply | ||
LEC0106A | C135850 | LEC01-Physical Assault: Happened | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Happened to me. | LEC-5 Standard Version - Physical Assault: Happened | ||
LEC0106B | C135851 | LEC01-Physical Assault: Witnessed | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Witnessed it. | LEC-5 Standard Version - Physical Assault: Witnessed | ||
LEC0106C | C135852 | LEC01-Physical Assault: Learned | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Learned about it. | LEC-5 Standard Version - Physical Assault: Learned | ||
LEC0106D | C135853 | LEC01-Physical Assault: Job | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Part of my job. | LEC-5 Standard Version - Physical Assault: Job | ||
LEC0106E | C135854 | LEC01-Physical Assault: Not Sure | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Not sure. | LEC-5 Standard Version - Physical Assault: Not Sure | ||
LEC0106F | C135855 | LEC01-Physical Assault: Not Apply | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Doesn't apply. | LEC-5 Standard Version - Physical Assault: Not Apply | ||
LEC0107A | C135856 | LEC01-Assault With a Weapon: Happened | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Happened to me. | LEC-5 Standard Version - Assault With a Weapon: Happened | ||
LEC0107B | C135857 | LEC01-Assault With a Weapon: Witnessed | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Witnessed it. | LEC-5 Standard Version - Assault With a Weapon: Witnessed | ||
LEC0107C | C135858 | LEC01-Assault With a Weapon: Learned | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Learned about it. | LEC-5 Standard Version - Assault With a Weapon: Learned | ||
LEC0107D | C135859 | LEC01-Assault With a Weapon: Job | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Part of my job. | LEC-5 Standard Version - Assault With a Weapon: Job | ||
LEC0107E | C135860 | LEC01-Assault With a Weapon: Not Sure | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Not sure. | LEC-5 Standard Version - Assault With a Weapon: Not Sure | ||
LEC0107F | C135861 | LEC01-Assault With a Weapon: Not Apply | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Doesn't apply. | LEC-5 Standard Version - Assault With a Weapon: Not Apply | ||
LEC0108A | C135862 | LEC01-Sexual Assault: Happened | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Happened to me. | LEC-5 Standard Version - Sexual Assault: Happened | ||
LEC0108B | C135863 | LEC01-Sexual Assault: Witnessed | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Witnessed it. | LEC-5 Standard Version - Sexual Assault: Witnessed | ||
LEC0108C | C135864 | LEC01-Sexual Assault: Learned | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Learned about it. | LEC-5 Standard Version - Sexual Assault: Learned | ||
LEC0108D | C135865 | LEC01-Sexual Assault: Job | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Part of my job. | LEC-5 Standard Version - Sexual Assault: Job | ||
LEC0108E | C135866 | LEC01-Sexual Assault: Not Sure | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Not sure. | LEC-5 Standard Version - Sexual Assault: Not Sure | ||
LEC0108F | C135867 | LEC01-Sexual Assault: Not Apply | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Doesn't apply. | LEC-5 Standard Version - Sexual Assault: Not Apply | ||
LEC0109A | C135868 | LEC01-Unwanted Sex Experience: Happened | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Happened to me. | LEC-5 Standard Version - Unwanted Sex Experience: Happened | ||
LEC0109B | C135869 | LEC01-Unwanted Sex Experience: Witnessed | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Witnessed it. | LEC-5 Standard Version - Unwanted Sex Experience: Witnessed | ||
LEC0109C | C135870 | LEC01-Unwanted Sex Experience: Learned | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Learned about it. | LEC-5 Standard Version - Unwanted Sex Experience: Learned | ||
LEC0109D | C135871 | LEC01-Unwanted Sex Experience: Job | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Part of my job. | LEC-5 Standard Version - Unwanted Sex Experience: Job | ||
LEC0109E | C135872 | LEC01-Unwanted Sex Experience: Not Sure | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Not sure. | LEC-5 Standard Version - Unwanted Sex Experience: Not Sure | ||
LEC0109F | C135873 | LEC01-Unwanted Sex Experience: Not Apply | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Doesn't apply. | LEC-5 Standard Version - Unwanted Sex Experience: Not Apply | ||
LEC0110A | C135874 | LEC01-Combat/Exp to War-Zone: Happened | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Happened to me. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Happened | ||
LEC0110B | C135875 | LEC01-Combat/Exp to War-Zone: Witnessed | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Witnessed it. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Witnessed | ||
LEC0110C | C135876 | LEC01-Combat/Exp to War-Zone: Learned | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Learned about it. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Learned | ||
LEC0110D | C135877 | LEC01-Combat/Exp to War-Zone: Job | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Part of my job. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Job | ||
LEC0110E | C135878 | LEC01-Combat/Exp to War-Zone: Not Sure | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Not sure. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Not Sure | ||
LEC0110F | C135879 | LEC01-Combat/Exp to War-Zone: Not Apply | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Doesn't apply. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Not Apply | ||
LEC0111A | C135880 | LEC01-Captivity: Happened | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Happened to me. | LEC-5 Standard Version - Captivity: Happened | ||
LEC0111B | C135881 | LEC01-Captivity: Witnessed | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Witnessed it. | LEC-5 Standard Version - Captivity: Witnessed | ||
LEC0111C | C135882 | LEC01-Captivity: Learned | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Learned about it. | LEC-5 Standard Version - Captivity: Learned | ||
LEC0111D | C135883 | LEC01-Captivity: Job | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Part of my job. | LEC-5 Standard Version - Captivity: Job | ||
LEC0111E | C135884 | LEC01-Captivity: Not Sure | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Not sure. | LEC-5 Standard Version - Captivity: Not Sure | ||
LEC0111F | C135885 | LEC01-Captivity: Not Apply | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Doesn't apply. | LEC-5 Standard Version - Captivity: Not Apply | ||
LEC0112A | C135886 | LEC01-Life-threatening Illness: Happened | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Happened to me. | LEC-5 Standard Version - Life-threatening Illness: Happened | ||
LEC0112B | C135887 | LEC01-Life-threatening Illness: Witness | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Witnessed it. | LEC-5 Standard Version - Life-threatening Illness: Witnessed | ||
LEC0112C | C135888 | LEC01-Life-threatening Illness: Learned | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Learned about it. | LEC-5 Standard Version - Life-threatening Illness: Learned | ||
LEC0112D | C135889 | LEC01-Life-threatening Illness: Job | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Part of my job. | LEC-5 Standard Version - Life-threatening Illness: Job | ||
LEC0112E | C135890 | LEC01-Life-threatening Illness: Not Sure | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Not sure. | LEC-5 Standard Version - Life-threatening Illness: Not Sure | ||
LEC0112F | C135891 | LEC01-Life-threatening Illness: No Apply | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Doesn't apply. | LEC-5 Standard Version - Life-threatening Illness: Not Apply | ||
LEC0113A | C135892 | LEC01-Severe Human Suffering: Happened | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Happened to me. | LEC-5 Standard Version - Severe Human Suffering: Happened | ||
LEC0113B | C135893 | LEC01-Severe Human Suffering: Witnessed | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Witnessed it. | LEC-5 Standard Version - Severe Human Suffering: Witnessed | ||
LEC0113C | C135894 | LEC01-Severe Human Suffering: Learned | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Learned about it. | LEC-5 Standard Version - Severe Human Suffering: Learned | ||
LEC0113D | C135895 | LEC01-Severe Human Suffering: Job | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Part of my job. | LEC-5 Standard Version - Severe Human Suffering: Job | ||
LEC0113E | C135896 | LEC01-Severe Human Suffering: Not Sure | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Not sure. | LEC-5 Standard Version - Severe Human Suffering: Not Sure | ||
LEC0113F | C135897 | LEC01-Severe Human Suffering: Not Apply | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Doesn't apply. | LEC-5 Standard Version - Severe Human Suffering: Not Apply | ||
LEC0114A | C135898 | LEC01-Sudden Violent Death: Happened | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Happened to me. | LEC-5 Standard Version - Sudden Violent Death: Happened | ||
LEC0114B | C135899 | LEC01-Sudden Violent Death: Witnessed | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Witnessed it. | LEC-5 Standard Version - Sudden Violent Death: Witnessed | ||
LEC0114C | C135900 | LEC01-Sudden Violent Death: Learned | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Learned about it. | LEC-5 Standard Version - Sudden Violent Death: Learned | ||
LEC0114D | C135901 | LEC01-Sudden Violent Death: Job | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Part of my job. | LEC-5 Standard Version - Sudden Violent Death: Job | ||
LEC0114E | C135902 | LEC01-Sudden Violent Death: Not Sure | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Not sure. | LEC-5 Standard Version - Sudden Violent Death: Not Sure | ||
LEC0114F | C135903 | LEC01-Sudden Violent Death: Not Apply | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Doesn't apply. | LEC-5 Standard Version - Sudden Violent Death: Not Apply | ||
LEC0115A | C135904 | LEC01-Sudden Accidental Death: Happened | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Happened to me. | LEC-5 Standard Version - Sudden Accidental Death: Happened | ||
LEC0115B | C135905 | LEC01-Sudden Accidental Death: Witnessed | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Witnessed it. | LEC-5 Standard Version - Sudden Accidental Death: Witnessed | ||
LEC0115C | C135906 | LEC01-Sudden Accidental Death: Learned | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Learned about it. | LEC-5 Standard Version - Sudden Accidental Death: Learned | ||
LEC0115D | C135907 | LEC01-Sudden Accidental Death: Job | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Part of my job. | LEC-5 Standard Version - Sudden Accidental Death: Job | ||
LEC0115E | C135908 | LEC01-Sudden Accidental Death: Not Sure | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Not sure. | LEC-5 Standard Version - Sudden Accidental Death: Not Sure | ||
LEC0115F | C135909 | LEC01-Sudden Accidental Death: Not Apply | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Doesn't apply. | LEC-5 Standard Version - Sudden Accidental Death: Not Apply | ||
LEC0116A | C135910 | LEC01-Serious Injury Caused: Happened | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Happened to me. | LEC-5 Standard Version - Serious Injury Caused: Happened | ||
LEC0116B | C135911 | LEC01-Serious Injury Caused: Witnessed | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Witnessed it. | LEC-5 Standard Version - Serious Injury Caused: Witnessed | ||
LEC0116C | C135912 | LEC01-Serious Injury Caused: Learned | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Learned about it. | LEC-5 Standard Version - Serious Injury Caused: Learned | ||
LEC0116D | C135913 | LEC01-Serious Injury Caused: Job | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Part of my job. | LEC-5 Standard Version - Serious Injury Caused: Job | ||
LEC0116E | C135914 | LEC01-Serious Injury Caused: Not Sure | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Not sure. | LEC-5 Standard Version - Serious Injury Caused: Not Sure | ||
LEC0116F | C135915 | LEC01-Serious Injury Caused: Not Apply | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Doesn't apply. | LEC-5 Standard Version - Serious Injury Caused: Not Apply | ||
LEC0117A | C135916 | LEC01-Other Stressful Event: Happened | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Happened to me. | LEC-5 Standard Version - Other Stressful Event: Happened | ||
LEC0117B | C135917 | LEC01-Other Stressful Event: Witnessed | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Witnessed it. | LEC-5 Standard Version - Other Stressful Event: Witnessed | ||
LEC0117C | C135918 | LEC01-Other Stressful Event: Learned | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Learned about it. | LEC-5 Standard Version - Other Stressful Event: Learned | ||
LEC0117D | C135919 | LEC01-Other Stressful Event: Job | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Part of my job. | LEC-5 Standard Version - Other Stressful Event: Job | ||
LEC0117E | C135920 | LEC01-Other Stressful Event: Not Sure | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Not sure. | LEC-5 Standard Version - Other Stressful Event: Not Sure | ||
LEC0117F | C135921 | LEC01-Other Stressful Event: Not Apply | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Doesn't apply. | LEC-5 Standard Version - Other Stressful Event: Not Apply | ||
Back to top | ||||||
CL.C135689.LEC01TN | Life Events Checklist for DSM-5 Standard Version Questionnaire Test Name
(LEC01TN) | text
Extensible: No | C135689 | Life Events Checklist for DSM-5 Standard Version Questionnaire Test Name | Life Events Checklist for DSM-5 Standard Version test name. | CDISC Questionnaire LEC-5 Standard Version Test Name Terminology |
LEC01-Assault With a Weapon: Happened | C135856 | LEC01-Assault With a Weapon: Happened | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Happened to me. | LEC-5 Standard Version - Assault With a Weapon: Happened | ||
LEC01-Assault With a Weapon: Job | C135859 | LEC01-Assault With a Weapon: Job | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Part of my job. | LEC-5 Standard Version - Assault With a Weapon: Job | ||
LEC01-Assault With a Weapon: Learned | C135858 | LEC01-Assault With a Weapon: Learned | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Learned about it. | LEC-5 Standard Version - Assault With a Weapon: Learned | ||
LEC01-Assault With a Weapon: Not Apply | C135861 | LEC01-Assault With a Weapon: Not Apply | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Doesn't apply. | LEC-5 Standard Version - Assault With a Weapon: Not Apply | ||
LEC01-Assault With a Weapon: Not Sure | C135860 | LEC01-Assault With a Weapon: Not Sure | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Not sure. | LEC-5 Standard Version - Assault With a Weapon: Not Sure | ||
LEC01-Assault With a Weapon: Witnessed | C135857 | LEC01-Assault With a Weapon: Witnessed | Life Events Checklist for DSM-5, Standard Version - Assault with a weapon (for example, being shot, stabbed, threatened with a knife, gun, bomb): Witnessed it. | LEC-5 Standard Version - Assault With a Weapon: Witnessed | ||
LEC01-Captivity: Happened | C135880 | LEC01-Captivity: Happened | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Happened to me. | LEC-5 Standard Version - Captivity: Happened | ||
LEC01-Captivity: Job | C135883 | LEC01-Captivity: Job | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Part of my job. | LEC-5 Standard Version - Captivity: Job | ||
LEC01-Captivity: Learned | C135882 | LEC01-Captivity: Learned | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Learned about it. | LEC-5 Standard Version - Captivity: Learned | ||
LEC01-Captivity: Not Apply | C135885 | LEC01-Captivity: Not Apply | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Doesn't apply. | LEC-5 Standard Version - Captivity: Not Apply | ||
LEC01-Captivity: Not Sure | C135884 | LEC01-Captivity: Not Sure | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Not sure. | LEC-5 Standard Version - Captivity: Not Sure | ||
LEC01-Captivity: Witnessed | C135881 | LEC01-Captivity: Witnessed | Life Events Checklist for DSM-5, Standard Version - Captivity (for example, being kidnapped, abducted, held hostage, prisoner of war): Witnessed it. | LEC-5 Standard Version - Captivity: Witnessed | ||
LEC01-Combat/Exp to War-Zone: Happened | C135874 | LEC01-Combat/Exp to War-Zone: Happened | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Happened to me. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Happened | ||
LEC01-Combat/Exp to War-Zone: Job | C135877 | LEC01-Combat/Exp to War-Zone: Job | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Part of my job. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Job | ||
LEC01-Combat/Exp to War-Zone: Learned | C135876 | LEC01-Combat/Exp to War-Zone: Learned | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Learned about it. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Learned | ||
LEC01-Combat/Exp to War-Zone: Not Apply | C135879 | LEC01-Combat/Exp to War-Zone: Not Apply | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Doesn't apply. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Not Apply | ||
LEC01-Combat/Exp to War-Zone: Not Sure | C135878 | LEC01-Combat/Exp to War-Zone: Not Sure | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Not sure. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Not Sure | ||
LEC01-Combat/Exp to War-Zone: Witnessed | C135875 | LEC01-Combat/Exp to War-Zone: Witnessed | Life Events Checklist for DSM-5, Standard Version - Combat or exposure to a war-zone (in the military or as a civilian): Witnessed it. | LEC-5 Standard Version - Combat or Exposure to War-Zone: Witnessed | ||
LEC01-Fire or Explosion: Happened | C135826 | LEC01-Fire or Explosion: Happened | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Happened to me. | LEC-5 Standard Version - Fire or Explosion: Happened | ||
LEC01-Fire or Explosion: Job | C135829 | LEC01-Fire or Explosion: Job | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Part of my job. | LEC-5 Standard Version - Fire or Explosion: Job | ||
LEC01-Fire or Explosion: Learned | C135828 | LEC01-Fire or Explosion: Learned | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Learned about it. | LEC-5 Standard Version - Fire or Explosion: Learned | ||
LEC01-Fire or Explosion: Not Apply | C135831 | LEC01-Fire or Explosion: Not Apply | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Doesn't apply. | LEC-5 Standard Version - Fire or Explosion: Not Apply | ||
LEC01-Fire or Explosion: Not Sure | C135830 | LEC01-Fire or Explosion: Not Sure | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Not sure. | LEC-5 Standard Version - Fire or Explosion: Not Sure | ||
LEC01-Fire or Explosion: Witnessed | C135827 | LEC01-Fire or Explosion: Witnessed | Life Events Checklist for DSM-5, Standard Version - Fire or explosion: Witnessed it. | LEC-5 Standard Version - Fire or Explosion: Witnessed | ||
LEC01-Life-threatening Illness: Happened | C135886 | LEC01-Life-threatening Illness: Happened | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Happened to me. | LEC-5 Standard Version - Life-threatening Illness: Happened | ||
LEC01-Life-threatening Illness: Job | C135889 | LEC01-Life-threatening Illness: Job | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Part of my job. | LEC-5 Standard Version - Life-threatening Illness: Job | ||
LEC01-Life-threatening Illness: Learned | C135888 | LEC01-Life-threatening Illness: Learned | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Learned about it. | LEC-5 Standard Version - Life-threatening Illness: Learned | ||
LEC01-Life-threatening Illness: No Apply | C135891 | LEC01-Life-threatening Illness: No Apply | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Doesn't apply. | LEC-5 Standard Version - Life-threatening Illness: Not Apply | ||
LEC01-Life-threatening Illness: Not Sure | C135890 | LEC01-Life-threatening Illness: Not Sure | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Not sure. | LEC-5 Standard Version - Life-threatening Illness: Not Sure | ||
LEC01-Life-threatening Illness: Witness | C135887 | LEC01-Life-threatening Illness: Witness | Life Events Checklist for DSM-5, Standard Version - Life-threatening illness or injury: Witnessed it. | LEC-5 Standard Version - Life-threatening Illness: Witnessed | ||
LEC01-Natural Disaster: Happened | C135820 | LEC01-Natural Disaster: Happened | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Happened to me. | LEC-5 Standard Version - Natural Disaster: Happened | ||
LEC01-Natural Disaster: Job | C135823 | LEC01-Natural Disaster: Job | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Part of my job. | LEC-5 Standard Version - Natural Disaster: Job | ||
LEC01-Natural Disaster: Learned | C135822 | LEC01-Natural Disaster: Learned | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Learned about it. | LEC-5 Standard Version - Natural Disaster: Learned | ||
LEC01-Natural Disaster: Not Apply | C135825 | LEC01-Natural Disaster: Not Apply | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Doesn't apply. | LEC-5 Standard Version - Natural Disaster: Not Apply | ||
LEC01-Natural Disaster: Not Sure | C135824 | LEC01-Natural Disaster: Not Sure | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Not sure. | LEC-5 Standard Version - Natural Disaster: Not Sure | ||
LEC01-Natural Disaster: Witnessed | C135821 | LEC01-Natural Disaster: Witnessed | Life Events Checklist for DSM-5, Standard Version - Natural disaster (for example, flood, hurricane, tornado, earthquake): Witnessed it. | LEC-5 Standard Version - Natural Disaster: Witnessed | ||
LEC01-Other Stressful Event: Happened | C135916 | LEC01-Other Stressful Event: Happened | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Happened to me. | LEC-5 Standard Version - Other Stressful Event: Happened | ||
LEC01-Other Stressful Event: Job | C135919 | LEC01-Other Stressful Event: Job | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Part of my job. | LEC-5 Standard Version - Other Stressful Event: Job | ||
LEC01-Other Stressful Event: Learned | C135918 | LEC01-Other Stressful Event: Learned | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Learned about it. | LEC-5 Standard Version - Other Stressful Event: Learned | ||
LEC01-Other Stressful Event: Not Apply | C135921 | LEC01-Other Stressful Event: Not Apply | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Doesn't apply. | LEC-5 Standard Version - Other Stressful Event: Not Apply | ||
LEC01-Other Stressful Event: Not Sure | C135920 | LEC01-Other Stressful Event: Not Sure | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Not sure. | LEC-5 Standard Version - Other Stressful Event: Not Sure | ||
LEC01-Other Stressful Event: Witnessed | C135917 | LEC01-Other Stressful Event: Witnessed | Life Events Checklist for DSM-5, Standard Version - Any other very stressful event or experience: Witnessed it. | LEC-5 Standard Version - Other Stressful Event: Witnessed | ||
LEC01-Physical Assault: Happened | C135850 | LEC01-Physical Assault: Happened | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Happened to me. | LEC-5 Standard Version - Physical Assault: Happened | ||
LEC01-Physical Assault: Job | C135853 | LEC01-Physical Assault: Job | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Part of my job. | LEC-5 Standard Version - Physical Assault: Job | ||
LEC01-Physical Assault: Learned | C135852 | LEC01-Physical Assault: Learned | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Learned about it. | LEC-5 Standard Version - Physical Assault: Learned | ||
LEC01-Physical Assault: Not Apply | C135855 | LEC01-Physical Assault: Not Apply | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Doesn't apply. | LEC-5 Standard Version - Physical Assault: Not Apply | ||
LEC01-Physical Assault: Not Sure | C135854 | LEC01-Physical Assault: Not Sure | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Not sure. | LEC-5 Standard Version - Physical Assault: Not Sure | ||
LEC01-Physical Assault: Witnessed | C135851 | LEC01-Physical Assault: Witnessed | Life Events Checklist for DSM-5, Standard Version - Physical assault (for example, being attacked, hit, slapped, kicked, beaten up): Witnessed it. | LEC-5 Standard Version - Physical Assault: Witnessed | ||
LEC01-Serious Accident: Happened | C135838 | LEC01-Serious Accident: Happened | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Happened to me. | LEC-5 Standard Version - Serious Accident: Happened | ||
LEC01-Serious Accident: Job | C135841 | LEC01-Serious Accident: Job | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Part of my job. | LEC-5 Standard Version - Serious Accident: Job | ||
LEC01-Serious Accident: Learned | C135840 | LEC01-Serious Accident: Learned | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Learned about it. | LEC-5 Standard Version - Serious Accident: Learned | ||
LEC01-Serious Accident: Not Apply | C135843 | LEC01-Serious Accident: Not Apply | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Doesn't apply. | LEC-5 Standard Version - Serious Accident: Not Apply | ||
LEC01-Serious Accident: Not Sure | C135842 | LEC01-Serious Accident: Not Sure | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Not sure. | LEC-5 Standard Version - Serious Accident: Not Sure | ||
LEC01-Serious Accident: Witnessed | C135839 | LEC01-Serious Accident: Witnessed | Life Events Checklist for DSM-5, Standard Version - Serious accident at work, home, or during recreational activity: Witnessed it. | LEC-5 Standard Version - Serious Accident: Witnessed | ||
LEC01-Serious Injury Caused: Happened | C135910 | LEC01-Serious Injury Caused: Happened | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Happened to me. | LEC-5 Standard Version - Serious Injury Caused: Happened | ||
LEC01-Serious Injury Caused: Job | C135913 | LEC01-Serious Injury Caused: Job | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Part of my job. | LEC-5 Standard Version - Serious Injury Caused: Job | ||
LEC01-Serious Injury Caused: Learned | C135912 | LEC01-Serious Injury Caused: Learned | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Learned about it. | LEC-5 Standard Version - Serious Injury Caused: Learned | ||
LEC01-Serious Injury Caused: Not Apply | C135915 | LEC01-Serious Injury Caused: Not Apply | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Doesn't apply. | LEC-5 Standard Version - Serious Injury Caused: Not Apply | ||
LEC01-Serious Injury Caused: Not Sure | C135914 | LEC01-Serious Injury Caused: Not Sure | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Not sure. | LEC-5 Standard Version - Serious Injury Caused: Not Sure | ||
LEC01-Serious Injury Caused: Witnessed | C135911 | LEC01-Serious Injury Caused: Witnessed | Life Events Checklist for DSM-5, Standard Version - Serious injury, harm, or death you caused to someone else: Witnessed it. | LEC-5 Standard Version - Serious Injury Caused: Witnessed | ||
LEC01-Severe Human Suffering: Happened | C135892 | LEC01-Severe Human Suffering: Happened | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Happened to me. | LEC-5 Standard Version - Severe Human Suffering: Happened | ||
LEC01-Severe Human Suffering: Job | C135895 | LEC01-Severe Human Suffering: Job | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Part of my job. | LEC-5 Standard Version - Severe Human Suffering: Job | ||
LEC01-Severe Human Suffering: Learned | C135894 | LEC01-Severe Human Suffering: Learned | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Learned about it. | LEC-5 Standard Version - Severe Human Suffering: Learned | ||
LEC01-Severe Human Suffering: Not Apply | C135897 | LEC01-Severe Human Suffering: Not Apply | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Doesn't apply. | LEC-5 Standard Version - Severe Human Suffering: Not Apply | ||
LEC01-Severe Human Suffering: Not Sure | C135896 | LEC01-Severe Human Suffering: Not Sure | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Not sure. | LEC-5 Standard Version - Severe Human Suffering: Not Sure | ||
LEC01-Severe Human Suffering: Witnessed | C135893 | LEC01-Severe Human Suffering: Witnessed | Life Events Checklist for DSM-5, Standard Version - Severe human suffering: Witnessed it. | LEC-5 Standard Version - Severe Human Suffering: Witnessed | ||
LEC01-Sexual Assault: Happened | C135862 | LEC01-Sexual Assault: Happened | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Happened to me. | LEC-5 Standard Version - Sexual Assault: Happened | ||
LEC01-Sexual Assault: Job | C135865 | LEC01-Sexual Assault: Job | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Part of my job. | LEC-5 Standard Version - Sexual Assault: Job | ||
LEC01-Sexual Assault: Learned | C135864 | LEC01-Sexual Assault: Learned | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Learned about it. | LEC-5 Standard Version - Sexual Assault: Learned | ||
LEC01-Sexual Assault: Not Apply | C135867 | LEC01-Sexual Assault: Not Apply | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Doesn't apply. | LEC-5 Standard Version - Sexual Assault: Not Apply | ||
LEC01-Sexual Assault: Not Sure | C135866 | LEC01-Sexual Assault: Not Sure | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Not sure. | LEC-5 Standard Version - Sexual Assault: Not Sure | ||
LEC01-Sexual Assault: Witnessed | C135863 | LEC01-Sexual Assault: Witnessed | Life Events Checklist for DSM-5, Standard Version - Sexual assault (rape, attempted rape, made to perform any type of sexual act through force or threat of harm): Witnessed it. | LEC-5 Standard Version - Sexual Assault: Witnessed | ||
LEC01-Sudden Accidental Death: Happened | C135904 | LEC01-Sudden Accidental Death: Happened | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Happened to me. | LEC-5 Standard Version - Sudden Accidental Death: Happened | ||
LEC01-Sudden Accidental Death: Job | C135907 | LEC01-Sudden Accidental Death: Job | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Part of my job. | LEC-5 Standard Version - Sudden Accidental Death: Job | ||
LEC01-Sudden Accidental Death: Learned | C135906 | LEC01-Sudden Accidental Death: Learned | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Learned about it. | LEC-5 Standard Version - Sudden Accidental Death: Learned | ||
LEC01-Sudden Accidental Death: Not Apply | C135909 | LEC01-Sudden Accidental Death: Not Apply | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Doesn't apply. | LEC-5 Standard Version - Sudden Accidental Death: Not Apply | ||
LEC01-Sudden Accidental Death: Not Sure | C135908 | LEC01-Sudden Accidental Death: Not Sure | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Not sure. | LEC-5 Standard Version - Sudden Accidental Death: Not Sure | ||
LEC01-Sudden Accidental Death: Witnessed | C135905 | LEC01-Sudden Accidental Death: Witnessed | Life Events Checklist for DSM-5, Standard Version - Sudden accidental death: Witnessed it. | LEC-5 Standard Version - Sudden Accidental Death: Witnessed | ||
LEC01-Sudden Violent Death: Happened | C135898 | LEC01-Sudden Violent Death: Happened | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Happened to me. | LEC-5 Standard Version - Sudden Violent Death: Happened | ||
LEC01-Sudden Violent Death: Job | C135901 | LEC01-Sudden Violent Death: Job | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Part of my job. | LEC-5 Standard Version - Sudden Violent Death: Job | ||
LEC01-Sudden Violent Death: Learned | C135900 | LEC01-Sudden Violent Death: Learned | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Learned about it. | LEC-5 Standard Version - Sudden Violent Death: Learned | ||
LEC01-Sudden Violent Death: Not Apply | C135903 | LEC01-Sudden Violent Death: Not Apply | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Doesn't apply. | LEC-5 Standard Version - Sudden Violent Death: Not Apply | ||
LEC01-Sudden Violent Death: Not Sure | C135902 | LEC01-Sudden Violent Death: Not Sure | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Not sure. | LEC-5 Standard Version - Sudden Violent Death: Not Sure | ||
LEC01-Sudden Violent Death: Witnessed | C135899 | LEC01-Sudden Violent Death: Witnessed | Life Events Checklist for DSM-5, Standard Version - Sudden violent death (for example, homicide, suicide): Witnessed it. | LEC-5 Standard Version - Sudden Violent Death: Witnessed | ||
LEC01-Toxic Substance: Happened | C135844 | LEC01-Toxic Substance: Happened | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Happened to me. | LEC-5 Standard Version - Toxic Substance: Happened | ||
LEC01-Toxic Substance: Job | C135847 | LEC01-Toxic Substance: Job | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Part of my job. | LEC-5 Standard Version - Toxic Substance: Job | ||
LEC01-Toxic Substance: Learned | C135846 | LEC01-Toxic Substance: Learned | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Learned about it. | LEC-5 Standard Version - Toxic Substance: Learned | ||
LEC01-Toxic Substance: Not Apply | C135849 | LEC01-Toxic Substance: Not Apply | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Doesn't apply. | LEC-5 Standard Version - Toxic Substance: Not Apply | ||
LEC01-Toxic Substance: Not Sure | C135848 | LEC01-Toxic Substance: Not Sure | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Not sure. | LEC-5 Standard Version - Toxic Substance: Not Sure | ||
LEC01-Toxic Substance: Witnessed | C135845 | LEC01-Toxic Substance: Witnessed | Life Events Checklist for DSM-5, Standard Version - Exposure to toxic substance (for example, dangerous chemicals, radiation): Witnessed it. | LEC-5 Standard Version - Toxic Substance: Witnessed | ||
LEC01-Transportation Accident: Happened | C135832 | LEC01-Transportation Accident: Happened | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Happened to me. | LEC-5 Standard Version - Transportation Accident: Happened | ||
LEC01-Transportation Accident: Job | C135835 | LEC01-Transportation Accident: Job | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Part of my job. | LEC-5 Standard Version - Transportation Accident: Job | ||
LEC01-Transportation Accident: Learned | C135834 | LEC01-Transportation Accident: Learned | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Learned about it. | LEC-5 Standard Version - Transportation Accident: Learned | ||
LEC01-Transportation Accident: Not Apply | C135837 | LEC01-Transportation Accident: Not Apply | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Doesn't apply. | LEC-5 Standard Version - Transportation Accident: Not Apply | ||
LEC01-Transportation Accident: Not Sure | C135836 | LEC01-Transportation Accident: Not Sure | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Not sure. | LEC-5 Standard Version - Transportation Accident: Not Sure | ||
LEC01-Transportation Accident: Witnessed | C135833 | LEC01-Transportation Accident: Witnessed | Life Events Checklist for DSM-5, Standard Version - Transportation accident (for example, car accident, boat accident, train wreck, plane crash): Witnessed it. | LEC-5 Standard Version - Transportation Accident: Witnessed | ||
LEC01-Unwanted Sex Experience: Happened | C135868 | LEC01-Unwanted Sex Experience: Happened | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Happened to me. | LEC-5 Standard Version - Unwanted Sex Experience: Happened | ||
LEC01-Unwanted Sex Experience: Job | C135871 | LEC01-Unwanted Sex Experience: Job | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Part of my job. | LEC-5 Standard Version - Unwanted Sex Experience: Job | ||
LEC01-Unwanted Sex Experience: Learned | C135870 | LEC01-Unwanted Sex Experience: Learned | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Learned about it. | LEC-5 Standard Version - Unwanted Sex Experience: Learned | ||
LEC01-Unwanted Sex Experience: Not Apply | C135873 | LEC01-Unwanted Sex Experience: Not Apply | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Doesn't apply. | LEC-5 Standard Version - Unwanted Sex Experience: Not Apply | ||
LEC01-Unwanted Sex Experience: Not Sure | C135872 | LEC01-Unwanted Sex Experience: Not Sure | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Not sure. | LEC-5 Standard Version - Unwanted Sex Experience: Not Sure | ||
LEC01-Unwanted Sex Experience: Witnessed | C135869 | LEC01-Unwanted Sex Experience: Witnessed | Life Events Checklist for DSM-5, Standard Version - Other unwanted or uncomfortable sexual experience: Witnessed it. | LEC-5 Standard Version - Unwanted Sex Experience: Witnessed | ||
Back to top | ||||||
CL.C101851.GRSTNLOC | Location of Most Severe Stenosis Within a Graft
(GRSTNLOC) | text
Extensible: No | C101851 | Location of Most Severe Stenosis Within a Graft | Terminology used to describe the part of the graft that is most severely stenotic. | CDISC SDTM Location of Most Severe Stenosis Within a Graft Terminology |
AORTIC ANASTOMOSIS OF THE GRAFT | C99915 | The connection where the graft joins the aorta usually less than or equal to 3 mm from insertion point. | Aortic Anastomosis of Graft | |||
BODY OF THE GRAFT | C99918 | The portion of the graft that lies between its anastomoses. | Body of Graft | |||
CORONARY ANASTOMOSIS OF THE GRAFT | C80476 | Coronary Graft Anastomoses | The connection where the graft joins the coronary artery usually less than or equal to 3 mm from insertion point. | Coronary Graft Anastomoses | ||
Back to top | ||||||
CL.C154687.LUFATSCD | Lung Cancer Findings About Test Code
(LUFATSCD) | text
Extensible: Yes | C154687 | Lung Cancer Findings About Test Code | Terminology relevant to the test codes that describe findings about a lung cancer event or intervention. | CDISC SDTM Lung Cancer Findings About Test Code Terminology |
ORCANIND | C154860 | Origin of Cancer Known Ind;Origin of Cancer Known Indicator | An indication as to whether the primary site of cancer is known. | Cancer Primary Site Known Indicator | ||
RESCTIND | C154861 | Resected Tumor Ind;Resected Tumor Indicator | An indication as to whether the tumor has been resected. | Tumor Resected Indicator | ||
Back to top | ||||||
CL.C154688.LUFATS | Lung Cancer Findings About Test Name
(LUFATS) | text
Extensible: Yes | C154688 | Lung Cancer Findings About Test Name | Terminology relevant to the test names that describe findings about a lung cancer event or intervention. | CDISC SDTM Lung Cancer Findings About Test Name Terminology |
Origin of Cancer Known Ind | C154860 | Origin of Cancer Known Ind;Origin of Cancer Known Indicator | An indication as to whether the primary site of cancer is known. | Cancer Primary Site Known Indicator | ||
Resected Tumor Ind | C154861 | Resected Tumor Ind;Resected Tumor Indicator | An indication as to whether the tumor has been resected. | Tumor Resected Indicator | ||
Back to top | ||||||
CL.C132320.MRFATSCD | Malaria Findings About Test Code
(MRFATSCD) | text
Extensible: Yes | C132320 | Malaria Findings About Test Code | Terminology relevant to the test codes that describe findings about a malaria event or intervention. | CDISC SDTM Malaria Findings About Test Code Terminology |
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
SEV | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C132319.MRFATS | Malaria Findings About Test Name
(MRFATS) | text
Extensible: Yes | C132319 | Malaria Findings About Test Name | Terminology relevant to the test names that describe findings about a malaria event or intervention. | CDISC SDTM Malaria Findings About Test Name Terminology |
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Severity/Intensity | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C76348.MARISTAT | Marital Status Response
(MARISTAT) | text
Extensible: Yes | C76348 | Marital Status Response | A terminology codelist relevant to a person's current conjugal status. | CDISC SDTM Marital Status Terminology |
ANNULLED | C76240 | Marriage contract has been declared null and to not have existed. (HL7) | Annulled | |||
DIVORCED | C51776 | Marriage contract has been declared dissolved and inactive. (HL7) | Divorced | |||
DOMESTIC PARTNER | C53262 | Domestic Partner | Person declares that a domestic partnership relationship exists. (HL7) | Domestic Partnership | ||
INTERLOCUTORY | C76241 | Temporary order issued during the course of litigation. (HL7) | Interlocutory Marital Status | |||
LEGALLY SEPARATED | C51777 | A person living apart from his/her spouse by legal arrangement. (HL7) | Legally Separated | |||
MARRIED | C51773 | A current marriage contract is active. (HL7) | Married | |||
NEVER MARRIED | C51774 | No marriage contract has ever been entered. (HL7) | Never Married | |||
POLYGAMOUS | C76242 | More than 1 current spouse. (HL7) | Polygamous | |||
SEPARATED | C156541 | A person who is separated from their spouse, whether or not there is a legal arrangement. | Separated | |||
WIDOWED | C51775 | The spouse has died. (HL7) | Widowed | |||
Back to top | ||||||
CL.C115406.MPAI1TC | Mayo-Portland Adaptability Inventory-4 Questionnaire Test Code
(MPAI1TC) | text
Extensible: No | C115406 | Mayo-Portland Adaptability Inventory-4 Questionnaire Test Code | Mayo-Portland Adaptability Inventory-4 test code. | CDISC Questionnaire MPAI-4 Test Code Terminology |
MPAI101 | C115851 | MPAI1-Mobility | Mayo-Portland Adaptability Inventory-4 - Problems walking or moving; balance problems that interfere with moving about. | MPAI-4 - Abilities: Mobility | ||
MPAI102 | C115852 | MPAI1-Use of Hands | Mayo-Portland Adaptability Inventory-4 - Impaired strength or coordination in one or both hands. | MPAI-4 - Abilities: Use of Hands | ||
MPAI103 | C115853 | MPAI1-Vision | Mayo-Portland Adaptability Inventory-4 - Problems seeing; double vision; eye, brain, or nerve injuries that interfere with seeing. | MPAI-4 - Abilities: Vision | ||
MPAI104 | C115854 | MPAI1-Audition | Mayo-Portland Adaptability Inventory-4 - Problems hearing; ringing in the ears. | MPAI-4 - Abilities: Audition | ||
MPAI105 | C115855 | MPAI1-Dizziness | Mayo-Portland Adaptability Inventory-4 - Feeling unsteady, dizzy, light-headed. | MPAI-4 - Abilities: Dizziness | ||
MPAI106 | C115856 | MPAI1-Motor Speech | Mayo-Portland Adaptability Inventory-4 - Abnormal clearness or rate of speech; stuttering. | MPAI-4 - Abilities: Motor Speech | ||
MPAI107A | C115857 | MPAI1-Verbal Communication | Mayo-Portland Adaptability Inventory-4 - Problems expressing or understanding language. | MPAI-4 - Abilities: Verbal Communication | ||
MPAI107B | C115858 | MPAI1-Nonverbal Communication | Mayo-Portland Adaptability Inventory-4 - Restricted or unusual gestures or facial expressions; talking too much or not enough; missing nonverbal cues from others. | MPAI-4 - Abilities: Nonverbal Communication | ||
MPAI108 | C115859 | MPAI1-Attention/Concentration | Mayo-Portland Adaptability Inventory-4 - Problems ignoring distractions, shifting attention, keeping more than one thing in mind at a time. | MPAI-4 - Abilities: Attention or Concentration | ||
MPAI109 | C115860 | MPAI1-Memory | Mayo-Portland Adaptability Inventory-4 - Problems learning and recalling new information. | MPAI-4 - Abilities: Memory | ||
MPAI110 | C115861 | MPAI1-Fund of Information | Mayo-Portland Adaptability Inventory-4 - Problems remembering information learned in school or on the job; difficulty remembering information about self and family from years ago. | MPAI-4 - Abilities: Fund of Information | ||
MPAI111 | C115862 | MPAI1-Novel Problem-Solving | Mayo-Portland Adaptability Inventory-4 - Problems thinking up solutions or picking the best solution to new problems. | MPAI-4 - Abilities: Novel Problem-Solving | ||
MPAI112 | C115863 | MPAI1-Visuospatial Abilities | Mayo-Portland Adaptability Inventory-4 - Problems drawing, assembling things, route-finding, being visually aware on both the left and right sides. | MPAI-4 - Abilities: Visuospatial Abilities | ||
MPAI113 | C115864 | MPAI1-Anxiety | Mayo-Portland Adaptability Inventory-4 - Tense, nervous, fearful, phobias, nightmares, flashbacks of stressful events. | MPAI-4 - Adjustment: Anxiety | ||
MPAI114 | C115865 | MPAI1-Depression | Mayo-Portland Adaptability Inventory-4 - Sad, blue, hopeless, poor appetite, poor sleep, worry, self-criticism. | MPAI-4 - Adjustment: Depression | ||
MPAI115 | C115866 | MPAI1-Irritablity, Anger, Aggression | Mayo-Portland Adaptability Inventory-4 - Verbal or physical expressions of anger. | MPAI-4 - Adjustment: Irritability, Anger, Aggression | ||
MPAI116 | C115867 | MPAI1-Pain and Headache | Mayo-Portland Adaptability Inventory-4 - Verbal and nonverbal expressions of pain; activities limited by pain. | MPAI-4 - Adjustment: Pain and Headache | ||
MPAI117 | C115868 | MPAI1-Fatigue | Mayo-Portland Adaptability Inventory-4 - Feeling tired; lack of energy; tiring easily. | MPAI-4 - Adjustment: Fatigue | ||
MPAI118 | C115869 | MPAI1-Sensitivity to Mild Symptoms | Mayo-Portland Adaptability Inventory-4 - Focusing on thinking, physical or emotional problems attributed to brain injury; rate only how concern or worry about these symptoms affects current functioning over and above the effects of the symptoms themselves. | MPAI-4 - Adjustment: Sensitivity to Mild Symptoms | ||
MPAI119 | C115870 | MPAI1-Inappropriate Social Interaction | Mayo-Portland Adaptability Inventory-4 - Acting childish, silly, rude, behavior not fitting for time and place. | MPAI-4 - Adjustment: Inappropriate Social Interaction | ||
MPAI120 | C115871 | MPAI1-Impaired Self-Awareness | Mayo-Portland Adaptability Inventory-4 - Lack of recognition of personal limitations and disabilities and how they interfere with everyday activities and work or school. | MPAI-4 - Adjustment: Impaired Self-Awareness | ||
MPAI121 | C115872 | MPAI1-Family/Significant Relationships | Mayo-Portland Adaptability Inventory-4 - Interactions with close others; describe stress within the family or those closest to the person with brain injury; 'family functioning' means cooperating to accomplish those tasks that need to be done to keep the household running. | MPAI-4 - Adjustment: Family or Significant Relationships | ||
MPAI122 | C115873 | MPAI1-Initiation | Mayo-Portland Adaptability Inventory-4 - Problems getting started on activities without prompting. | MPAI-4 - Participation: Initiation | ||
MPAI123 | C115874 | MPAI1-Social Contact-Friends/Coworkers | Mayo-Portland Adaptability Inventory-4 - Social contact with friends, work associates, and other people who are not family, significant others, or professionals. | MPAI-4 - Participation: Social Contact with Fiends, Work Associates and Others | ||
MPAI124 | C115875 | MPAI1-Leisure and Recreation Activities | Mayo-Portland Adaptability Inventory-4 - Leisure and recreational activities. | MPAI-4 - Participation: Leisure and Recreational Activities | ||
MPAI125 | C115876 | MPAI1-Self-Care | Mayo-Portland Adaptability Inventory-4 - Eating, dressing, bathing, hygiene. | MPAI-4 - Participation: Self-Care | ||
MPAI126 | C115877 | MPAI1-Residence | Mayo-Portland Adaptability Inventory-4 - Responsibilities of independent living and homemaking (such as meal preparation, home repairs and maintenance, personal health maintenance beyond basic hygiene including medication management) but not including managing money. | MPAI-4 - Participation: Residence | ||
MPAI127 | C115878 | MPAI1-Transportation | Mayo-Portland Adaptability Inventory-4 - Transportation. | MPAI-4 - Participation: Transportation | ||
MPAI128A | C115879 | MPAI1-Paid Employment | Mayo-Portland Adaptability Inventory-4 - Hours per week at paid employment when primary desired social role is paid employment. 'Support' means special help from another person with responsibilities (such as, a job coach or shadow, tutor, helper) or reduced responsibilities. Modifications to the physical environment that facilitate employment are not considered as support. | MPAI-4 - Participation: Paid Employment | ||
MPAI128B | C115880 | MPAI1-Other Employment | Mayo-Portland Adaptability Inventory-4 - Hours per week involved in constructive, role-appropriate activity other than paid employment when primary desired social role is not paid employment. 'Support' means special help from another person with responsibilities (such as, a job coach or shadow, tutor, helper) or reduced responsibilities. Modifications to the physical environment that facilitate employment are not considered as support. | MPAI-4 - Participation: Other Employment | ||
MPAI128C | C115881 | MPAI1-Other Employment-Social Role | Mayo-Portland Adaptability Inventory-4 - Primary social role when paid employment is not primary desired social role. | MPAI-4 - Participation: Other Employment-Social Role | ||
MPAI129 | C115882 | MPAI1-Managing Money and Finances | Mayo-Portland Adaptability Inventory-4 - Shopping, keeping a check book or other bank account, managing personal income and investments. | MPAI-4 - Participation: Managing Money and Finances | ||
MPAI130A | C115883 | MPAI1-Alcohol Use-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury use of alcoholic beverages. | MPAI-4 - Alcohol Use Pre-Injury | ||
MPAI130B | C115884 | MPAI1-Alcohol Use-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury use of alcoholic beverages. | MPAI-4 - Alcohol Use Post-Injury | ||
MPAI131A | C115885 | MPAI1-Drug Use-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury use of illegal drugs or abuse of prescription drugs. | MPAI-4 - Drug Use Pre-Injury | ||
MPAI131B | C115886 | MPAI1-Drug Use-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury use of illegal drugs or abuse of prescription drugs. | MPAI-4 - Drug Use Post-Injury | ||
MPAI132A | C115887 | MPAI1-Psychotic Symptoms-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury hallucinations, delusions, other persistent severely distorted perceptions of reality. | MPAI-4 - Psychotic Symptoms Pre-Injury | ||
MPAI132B | C115888 | MPAI1-Psychotic Symptoms-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury hallucinations, delusions, other persistent severely distorted perceptions of reality. | MPAI-4 - Psychotic Symptoms Post-Injury | ||
MPAI133A | C115889 | MPAI1-Law Violations-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury history before and after injury. | MPAI-4 - Law Violations Pre-Injury | ||
MPAI133B | C115890 | MPAI1-Law Violations-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury history before and after injury. | MPAI-4 - Law Violations Post-Injury | ||
MPAI134A | C115891 | MPAI1-Other Physical Cond-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury physical disability due to medical conditions other than brain injury, such as, spinal cord injury, amputation. | MPAI-4 - Other Condition Causing Physical Impairment Pre-Injury | ||
MPAI134B | C115892 | MPAI1-Other Physical Cond-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury physical disability due to medical conditions other than brain injury, such as, spinal cord injury, amputation. | MPAI-4 - Other Condition Causing Physical Impairment Post-Injury | ||
MPAI135A | C115893 | MPAI1-Other Cognitive Cond-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury cognitive disability due to nonpsychiatric medical conditions other than brain injury, such as, dementia, stroke, developmental disability. | MPAI-4 - Other Condition Causing Cognitive Impairment Pre-Injury | ||
MPAI135B | C115894 | MPAI1-Other Cognitive Cond-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury cognitive disability due to nonpsychiatric medical conditions other than brain injury, such as, dementia, stroke, developmental disability. | MPAI-4 - Other Condition Causing Cognitive Impairment Post-Injury | ||
Back to top | ||||||
CL.C115405.MPAI1TN | Mayo-Portland Adaptability Inventory-4 Questionnaire Test Name
(MPAI1TN) | text
Extensible: No | C115405 | Mayo-Portland Adaptability Inventory-4 Questionnaire Test Name | Mayo-Portland Adaptability Inventory-4 test name. | CDISC Questionnaire MPAI-4 Test Name Terminology |
MPAI1-Alcohol Use-Post-Injury | C115884 | MPAI1-Alcohol Use-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury use of alcoholic beverages. | MPAI-4 - Alcohol Use Post-Injury | ||
MPAI1-Alcohol Use-Pre-Injury | C115883 | MPAI1-Alcohol Use-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury use of alcoholic beverages. | MPAI-4 - Alcohol Use Pre-Injury | ||
MPAI1-Anxiety | C115864 | MPAI1-Anxiety | Mayo-Portland Adaptability Inventory-4 - Tense, nervous, fearful, phobias, nightmares, flashbacks of stressful events. | MPAI-4 - Adjustment: Anxiety | ||
MPAI1-Attention/Concentration | C115859 | MPAI1-Attention/Concentration | Mayo-Portland Adaptability Inventory-4 - Problems ignoring distractions, shifting attention, keeping more than one thing in mind at a time. | MPAI-4 - Abilities: Attention or Concentration | ||
MPAI1-Audition | C115854 | MPAI1-Audition | Mayo-Portland Adaptability Inventory-4 - Problems hearing; ringing in the ears. | MPAI-4 - Abilities: Audition | ||
MPAI1-Depression | C115865 | MPAI1-Depression | Mayo-Portland Adaptability Inventory-4 - Sad, blue, hopeless, poor appetite, poor sleep, worry, self-criticism. | MPAI-4 - Adjustment: Depression | ||
MPAI1-Dizziness | C115855 | MPAI1-Dizziness | Mayo-Portland Adaptability Inventory-4 - Feeling unsteady, dizzy, light-headed. | MPAI-4 - Abilities: Dizziness | ||
MPAI1-Drug Use-Post-Injury | C115886 | MPAI1-Drug Use-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury use of illegal drugs or abuse of prescription drugs. | MPAI-4 - Drug Use Post-Injury | ||
MPAI1-Drug Use-Pre-Injury | C115885 | MPAI1-Drug Use-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury use of illegal drugs or abuse of prescription drugs. | MPAI-4 - Drug Use Pre-Injury | ||
MPAI1-Family/Significant Relationships | C115872 | MPAI1-Family/Significant Relationships | Mayo-Portland Adaptability Inventory-4 - Interactions with close others; describe stress within the family or those closest to the person with brain injury; 'family functioning' means cooperating to accomplish those tasks that need to be done to keep the household running. | MPAI-4 - Adjustment: Family or Significant Relationships | ||
MPAI1-Fatigue | C115868 | MPAI1-Fatigue | Mayo-Portland Adaptability Inventory-4 - Feeling tired; lack of energy; tiring easily. | MPAI-4 - Adjustment: Fatigue | ||
MPAI1-Fund of Information | C115861 | MPAI1-Fund of Information | Mayo-Portland Adaptability Inventory-4 - Problems remembering information learned in school or on the job; difficulty remembering information about self and family from years ago. | MPAI-4 - Abilities: Fund of Information | ||
MPAI1-Impaired Self-Awareness | C115871 | MPAI1-Impaired Self-Awareness | Mayo-Portland Adaptability Inventory-4 - Lack of recognition of personal limitations and disabilities and how they interfere with everyday activities and work or school. | MPAI-4 - Adjustment: Impaired Self-Awareness | ||
MPAI1-Inappropriate Social Interaction | C115870 | MPAI1-Inappropriate Social Interaction | Mayo-Portland Adaptability Inventory-4 - Acting childish, silly, rude, behavior not fitting for time and place. | MPAI-4 - Adjustment: Inappropriate Social Interaction | ||
MPAI1-Initiation | C115873 | MPAI1-Initiation | Mayo-Portland Adaptability Inventory-4 - Problems getting started on activities without prompting. | MPAI-4 - Participation: Initiation | ||
MPAI1-Irritablity, Anger, Aggression | C115866 | MPAI1-Irritablity, Anger, Aggression | Mayo-Portland Adaptability Inventory-4 - Verbal or physical expressions of anger. | MPAI-4 - Adjustment: Irritability, Anger, Aggression | ||
MPAI1-Law Violations-Post-Injury | C115890 | MPAI1-Law Violations-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury history before and after injury. | MPAI-4 - Law Violations Post-Injury | ||
MPAI1-Law Violations-Pre-Injury | C115889 | MPAI1-Law Violations-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury history before and after injury. | MPAI-4 - Law Violations Pre-Injury | ||
MPAI1-Leisure and Recreation Activities | C115875 | MPAI1-Leisure and Recreation Activities | Mayo-Portland Adaptability Inventory-4 - Leisure and recreational activities. | MPAI-4 - Participation: Leisure and Recreational Activities | ||
MPAI1-Managing Money and Finances | C115882 | MPAI1-Managing Money and Finances | Mayo-Portland Adaptability Inventory-4 - Shopping, keeping a check book or other bank account, managing personal income and investments. | MPAI-4 - Participation: Managing Money and Finances | ||
MPAI1-Memory | C115860 | MPAI1-Memory | Mayo-Portland Adaptability Inventory-4 - Problems learning and recalling new information. | MPAI-4 - Abilities: Memory | ||
MPAI1-Mobility | C115851 | MPAI1-Mobility | Mayo-Portland Adaptability Inventory-4 - Problems walking or moving; balance problems that interfere with moving about. | MPAI-4 - Abilities: Mobility | ||
MPAI1-Motor Speech | C115856 | MPAI1-Motor Speech | Mayo-Portland Adaptability Inventory-4 - Abnormal clearness or rate of speech; stuttering. | MPAI-4 - Abilities: Motor Speech | ||
MPAI1-Nonverbal Communication | C115858 | MPAI1-Nonverbal Communication | Mayo-Portland Adaptability Inventory-4 - Restricted or unusual gestures or facial expressions; talking too much or not enough; missing nonverbal cues from others. | MPAI-4 - Abilities: Nonverbal Communication | ||
MPAI1-Novel Problem-Solving | C115862 | MPAI1-Novel Problem-Solving | Mayo-Portland Adaptability Inventory-4 - Problems thinking up solutions or picking the best solution to new problems. | MPAI-4 - Abilities: Novel Problem-Solving | ||
MPAI1-Other Cognitive Cond-Post-Injury | C115894 | MPAI1-Other Cognitive Cond-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury cognitive disability due to nonpsychiatric medical conditions other than brain injury, such as, dementia, stroke, developmental disability. | MPAI-4 - Other Condition Causing Cognitive Impairment Post-Injury | ||
MPAI1-Other Cognitive Cond-Pre-Injury | C115893 | MPAI1-Other Cognitive Cond-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury cognitive disability due to nonpsychiatric medical conditions other than brain injury, such as, dementia, stroke, developmental disability. | MPAI-4 - Other Condition Causing Cognitive Impairment Pre-Injury | ||
MPAI1-Other Employment | C115880 | MPAI1-Other Employment | Mayo-Portland Adaptability Inventory-4 - Hours per week involved in constructive, role-appropriate activity other than paid employment when primary desired social role is not paid employment. 'Support' means special help from another person with responsibilities (such as, a job coach or shadow, tutor, helper) or reduced responsibilities. Modifications to the physical environment that facilitate employment are not considered as support. | MPAI-4 - Participation: Other Employment | ||
MPAI1-Other Employment-Social Role | C115881 | MPAI1-Other Employment-Social Role | Mayo-Portland Adaptability Inventory-4 - Primary social role when paid employment is not primary desired social role. | MPAI-4 - Participation: Other Employment-Social Role | ||
MPAI1-Other Physical Cond-Post-Injury | C115892 | MPAI1-Other Physical Cond-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury physical disability due to medical conditions other than brain injury, such as, spinal cord injury, amputation. | MPAI-4 - Other Condition Causing Physical Impairment Post-Injury | ||
MPAI1-Other Physical Cond-Pre-Injury | C115891 | MPAI1-Other Physical Cond-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury physical disability due to medical conditions other than brain injury, such as, spinal cord injury, amputation. | MPAI-4 - Other Condition Causing Physical Impairment Pre-Injury | ||
MPAI1-Paid Employment | C115879 | MPAI1-Paid Employment | Mayo-Portland Adaptability Inventory-4 - Hours per week at paid employment when primary desired social role is paid employment. 'Support' means special help from another person with responsibilities (such as, a job coach or shadow, tutor, helper) or reduced responsibilities. Modifications to the physical environment that facilitate employment are not considered as support. | MPAI-4 - Participation: Paid Employment | ||
MPAI1-Pain and Headache | C115867 | MPAI1-Pain and Headache | Mayo-Portland Adaptability Inventory-4 - Verbal and nonverbal expressions of pain; activities limited by pain. | MPAI-4 - Adjustment: Pain and Headache | ||
MPAI1-Psychotic Symptoms-Post-Injury | C115888 | MPAI1-Psychotic Symptoms-Post-Injury | Mayo-Portland Adaptability Inventory-4 - Post-injury hallucinations, delusions, other persistent severely distorted perceptions of reality. | MPAI-4 - Psychotic Symptoms Post-Injury | ||
MPAI1-Psychotic Symptoms-Pre-Injury | C115887 | MPAI1-Psychotic Symptoms-Pre-Injury | Mayo-Portland Adaptability Inventory-4 - Pre-injury hallucinations, delusions, other persistent severely distorted perceptions of reality. | MPAI-4 - Psychotic Symptoms Pre-Injury | ||
MPAI1-Residence | C115877 | MPAI1-Residence | Mayo-Portland Adaptability Inventory-4 - Responsibilities of independent living and homemaking (such as meal preparation, home repairs and maintenance, personal health maintenance beyond basic hygiene including medication management) but not including managing money. | MPAI-4 - Participation: Residence | ||
MPAI1-Self-Care | C115876 | MPAI1-Self-Care | Mayo-Portland Adaptability Inventory-4 - Eating, dressing, bathing, hygiene. | MPAI-4 - Participation: Self-Care | ||
MPAI1-Sensitivity to Mild Symptoms | C115869 | MPAI1-Sensitivity to Mild Symptoms | Mayo-Portland Adaptability Inventory-4 - Focusing on thinking, physical or emotional problems attributed to brain injury; rate only how concern or worry about these symptoms affects current functioning over and above the effects of the symptoms themselves. | MPAI-4 - Adjustment: Sensitivity to Mild Symptoms | ||
MPAI1-Social Contact-Friends/Coworkers | C115874 | MPAI1-Social Contact-Friends/Coworkers | Mayo-Portland Adaptability Inventory-4 - Social contact with friends, work associates, and other people who are not family, significant others, or professionals. | MPAI-4 - Participation: Social Contact with Fiends, Work Associates and Others | ||
MPAI1-Transportation | C115878 | MPAI1-Transportation | Mayo-Portland Adaptability Inventory-4 - Transportation. | MPAI-4 - Participation: Transportation | ||
MPAI1-Use of Hands | C115852 | MPAI1-Use of Hands | Mayo-Portland Adaptability Inventory-4 - Impaired strength or coordination in one or both hands. | MPAI-4 - Abilities: Use of Hands | ||
MPAI1-Verbal Communication | C115857 | MPAI1-Verbal Communication | Mayo-Portland Adaptability Inventory-4 - Problems expressing or understanding language. | MPAI-4 - Abilities: Verbal Communication | ||
MPAI1-Vision | C115853 | MPAI1-Vision | Mayo-Portland Adaptability Inventory-4 - Problems seeing; double vision; eye, brain, or nerve injuries that interfere with seeing. | MPAI-4 - Abilities: Vision | ||
MPAI1-Visuospatial Abilities | C115863 | MPAI1-Visuospatial Abilities | Mayo-Portland Adaptability Inventory-4 - Problems drawing, assembling things, route-finding, being visually aware on both the left and right sides. | MPAI-4 - Abilities: Visuospatial Abilities | ||
Back to top | ||||||
CL.C101845.MCRCSPTM | Mechanical Circulatory Support Placement Timing
(MCRCSPTM) | text
Extensible: No | C101845 | Mechanical Circulatory Support Placement Timing | A terminology codelist to describe the timing of mechanical circulatory support placement. | CDISC SDTM Mechanical Circulatory Support Placement Timing Terminology |
IN PLACE AT START OF PROCEDURE | C99981 | In Place at Start of Procedure | Mechanical Circulatory Support was in place at the start of the procedure. | Mechanical Circulatory Support in Place at Start of Procedure | ||
INSERTED DURING A NON-PERCUTANEOUS CORONARY INTERVENTION PROCEDURE | C99962 | Inserted during a Non PCI Procedure | Mechanical Circulatory Support was inserted during a non-Percutaneous Coronary Intervention (PCI) procedure. | Inserted During a Non-Percutaneous Coronary Intervention | ||
INSERTED DURING PROCEDURE AND AFTER PERCUTANEOUS CORONARY INTERVENTION STARTED | C99964 | Inserted during Procedure and after PCI Started | Mechanical Circulatory Support was inserted during the procedure after Percutaneous Coronary Intervention (PCI) started. | Inserted During Procedure and After Percutaneous Coronary Intervention Began | ||
INSERTED DURING PROCEDURE BUT PRIOR TO PERCUTANEOUS CORONARY INTERVENTION | C99963 | Inserted during Procedure but Prior to PCI | Mechanical Circulatory Support was inserted during the procedure prior to percutaneous coronary intervention (PCI). | Inserted During a Procedure but Prior to Percutaneous Coronary Intervention | ||
Back to top | ||||||
CL.C96777.MEDEVAL | Medical Evaluator Identifier
(MEDEVAL) | text
Extensible: Yes | C96777 | Medical Evaluator Identifier | A terminology codelist containing identifiers used to uniquely distinguish multiple evaluators with the same role. | CDISC SDTM Medical Evaluator Identifier Terminology |
ADJUDICATOR 1 | C150867 | An adjudicator performing the assessment who is given the designation of one. | Adjudicator 1 | |||
ADJUDICATOR 2 | C150868 | An adjudicator performing the assessment who is given the designation of two. | Adjudicator 2 | |||
ADJUDICATOR 3 | C150869 | An adjudicator performing the assessment who is given the designation of three. | Adjudicator 3 | |||
CARDIOLOGIST 1 | C187876 | A cardiologist performing the assessment who is given the designation of one. | Cardiologist 1 | |||
CARDIOLOGIST 2 | C189588 | A cardiologist performing the assessment who is given the designation of two. | Cardiologist 2 | |||
CERTIFIED ASSESSOR 1 | C189587 | A certified assessor performing the assessment who is given the designation of one. | Certified Assessor 1 | |||
CLINICAL PATHOLOGIST 1 | C187877 | A clinical pathologist performing the assessment who is given the designation of one. | Clinical Pathologist 1 | |||
CLINICAL PATHOLOGIST 2 | C189589 | A clinical pathologist performing the assessment who is given the designation of two. | Clinical Pathologist 2 | |||
DERMATOLOGIST 1 | C187878 | A dermatologist performing the assessment who is given the designation of one. | Dermatologist 1 | |||
DERMATOLOGIST 2 | C189590 | A dermatologist performing the assessment who is given the designation of two. | Dermatologist 2 | |||
DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN 1 | C187879 | A developmental behavioral pediatrician performing the assessment who is given the designation of one. | Developmental Behavioral Pediatrician 1 | |||
DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN 2 | C189591 | A developmental behavioral pediatrician performing the assessment who is given the designation of two. | Developmental Behavioral Pediatrician 2 | |||
DEVELOPMENTAL PSYCHOLOGIST 1 | C187880 | A developmental psychologist performing the assessment who is given the designation of one. | Developmental Psychologist 1 | |||
DEVELOPMENTAL PSYCHOLOGIST 2 | C189592 | A developmental psychologist performing the assessment who is given the designation of two. | Developmental Psychologist 2 | |||
ENDOCRINOLOGIST 1 | C187881 | An endocrinologist performing the assessment who is given the designation of one. | Endocrinologist 1 | |||
ENDOCRINOLOGIST 2 | C189593 | An endocrinologist performing the assessment who is given the designation of two. | Endocrinologist 2 | |||
FORENSIC PATHOLOGIST 1 | C187882 | A forensic pathologist performing the assessment who is given the designation of one. | Forensic Pathologist 1 | |||
FORENSIC PATHOLOGIST 2 | C189594 | A forensic pathologist performing the assessment who is given the designation of two. | Forensic Pathologist 2 | |||
HEMATOLOGIST 1 | C187883 | A hematologist performing the assessment who is given the designation of one. | Hematologist 1 | |||
HEMATOLOGIST 2 | C189595 | A hematologist performing the assessment who is given the designation of two. | Hematologist 2 | |||
INTERNIST 1 | C187884 | An internist performing the assessment who is given the designation of one. | Internist 1 | |||
INTERNIST 2 | C189596 | An internist performing the assessment who is given the designation of two. | Internist 2 | |||
MICROSCOPIST 1 | C132421 | A microscopist performing the assessment who is given the designation of one. | Microscopist 1 | |||
MICROSCOPIST 2 | C132422 | A microscopist performing the assessment who is given the designation of two. | Microscopist 2 | |||
MICROSCOPIST 3 | C132423 | A microscopist performing the assessment who is given the designation of three. | Microscopist 3 | |||
NEUROLOGIST 1 | C96692 | A neurologist performing the assessment who is given the designation of one. | Neurologist 1 | |||
NEUROLOGIST 2 | C96606 | A neurologist performing the assessment who is given the designation of two. | Neurologist 2 | |||
NEUROONCOLOGIST 1 | C189584 | A neurooncologist performing the assessment who is given the designation of one. | Neuro-oncologist 1 | |||
NEURORADIOLOGIST 1 | C184676 | A neuroradiologist performing the assessment who is given the designation of one. | Neuroradiologist 1 | |||
NEURORADIOLOGIST 2 | C184677 | A neuroradiologist performing the assessment who is given the designation of two. | Neuroradiologist 2 | |||
NUCLEAR MEDICINE PHYSICIAN 1 | C189585 | A nuclear medicine physician performing the assessment who is given the designation of one. | Nuclear Medicine Physician 1 | |||
ONCOLOGIST 1 | C96611 | An oncologist performing the assessment who is given the designation of one. | Oncologist 1 | |||
ONCOLOGIST 2 | C96612 | An oncologist performing the assessment who is given the designation of two. | Oncologist 2 | |||
OPHTHALMOLOGIST 1 | C187885 | An ophthalmologist performing the assessment who is given the designation of one. | Ophthalmologist 1 | |||
OPHTHALMOLOGIST 2 | C189597 | An ophthalmologist performing the assessment who is given the designation of two. | Ophthalmologist 2 | |||
OPTOMETRIST 1 | C187886 | An optometrist performing the assessment who is given the designation of one. | Optometrist 1 | |||
OPTOMETRIST 2 | C189598 | An optometrist performing the assessment who is given the designation of two. | Optometrist 2 | |||
OTOLARYNGOLOGIST 1 | C187887 | A otolaryngologist performing the assessment who is given the designation of one. | Otolaryngologist 1 | |||
OTOLARYNGOLOGIST 2 | C189599 | A otolaryngologist performing the assessment who is given the designation of two. | Otolaryngologist 2 | |||
PATHOLOGIST 1 | C154836 | A pathologist performing the assessment who is given the designation of one. | Pathologist 1 | |||
PATHOLOGIST 2 | C154837 | A pathologist performing the assessment who is given the designation of two. | Pathologist 2 | |||
PEDIATRIC NEUROLOGIST 1 | C187888 | A pediatric neurologist performing the assessment who is given the designation of one. | Pediatric Neurologist 1 | |||
PEDIATRIC NEUROLOGIST 2 | C189600 | A pediatric neurologist performing the assessment who is given the designation of two. | Pediatric Neurologist 2 | |||
PHARMACOKINETICIST 1 | C189586 | A pharmacokineticist performing the assessment who is given the designation of one. | Pharmacokineticist 1 | |||
PHYSIOTHERAPIST 1 | C187889 | A physiotherapist performing the assessment who is given the designation of one. | Physiotherapist 1 | |||
PHYSIOTHERAPIST 2 | C189601 | A physiotherapist performing the assessment who is given the designation of two. | Physiotherapist 2 | |||
RADIOLOGIST 1 | C94530 | A radiologist performing the assessment who is given the designation of one. | Radiologist 1 | |||
RADIOLOGIST 2 | C94531 | A radiologist performing the assessment who is given the designation of two. | Radiologist 2 | |||
RADIOLOGIST 3 | C187890 | A radiologist performing the assessment who is given the designation of three. | Radiologist 3 | |||
RATER 1 | C132425 | A rater performing the assessment who is given the designation of one. | Rater 1 | |||
RATER 2 | C132426 | A rater performing the assessment who is given the designation of two. | Rater 2 | |||
READER 1 | C94532 | A reader performing the assessment who is given the designation of one. | Reader 1 | |||
READER 2 | C94533 | A reader performing the assessment who is given the designation of two. | Reader 2 | |||
READER 3 | C139209 | A reader performing the assessment who is given the designation of three. | Reader 3 | |||
UROLOGIST 1 | C187891 | An urologist performing the assessment who is given the designation of one. | Urologist 1 | |||
UROLOGIST 2 | C189602 | An urologist performing the assessment who is given the designation of two. | Urologist 2 | |||
Back to top | ||||||
CL.C124301.MHEDTTYP | Medical History Event Date Type
(MHEDTTYP) | text
Extensible: Yes | C124301 | Medical History Event Date Type | Terminology relevant to the classification of the medical condition or event by which MHSTDTC is defined. | CDISC SDTM Medical History Event Date Type Terminology |
DIAGNOSIS | C15220 | Diagnostic | The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results or summary of such an investigation. (NCI) | Diagnosis | ||
DISEASE RELAPSE | C38155 | Recurrent Disease | The return of a disease after a period of remission. | Recurrent Disease | ||
DISEASE TRANSFORMATION | C123583 | A conversion from one disease diagnosis to another, which may be considered a progression to a worsening state. | Disease Transformation | |||
EPISODE | C75539 | A noteworthy happening that is distinctive in a series of related events. | Episode | |||
EXACERBATION | C124138 | An increase in frequency and/or worsening of a symptom, condition, or disease. | Exacerbation | |||
FLARE | C113680 | Flare Episode | A sudden worsening of a disease, condition, or symptom. | Flare-up | ||
INITIAL DIAGNOSIS | C156813 | The first diagnosis of the disease. | Initial Diagnosis | |||
INITIAL DISEASE RELAPSE | C123399 | First Recurrence;Initial Recurrence | The first relapse of the disease. | First Relapse | ||
MOST RECENT DIAGNOSIS | C184685 | Current Diagnosis | The latest diagnosis of the disease. | Most Recent Diagnosis | ||
MOST RECENT EPISODE | C191305 | The latest occurrence of an episode. | Most Recent Episode | |||
PATHOLOGICAL DIAGNOSIS | C178004 | Diagnosis based on a pathological assessment. | Pathological Diagnosis | |||
PROGRESSION | C17747 | A disease, condition, or injury that is increasing in extent or severity. | Disease Progression | |||
RESTAGING | C132008 | A disease staging event that happens after the initial staging event. | Restaging | |||
STAGING | C15608 | The determination of the extent of disease within the context of the expected progression of the disease, and in accordance with pre-defined criteria. | Staging | |||
SYMPTOM ONSET | C124353 | The point at which the symptoms began or were first noted. | Symptom Onset | |||
Back to top | ||||||
CL.C185847.MPSTATRS | Menopause Status Response
(MPSTATRS) | text
Extensible: No | C185847 | Menopause Status Response | Terminology relevant to the responses for the status of a female with respect to menopause. | CDISC SDTM Menopause Status Response Terminology |
PERIMENOPAUSAL | C15692 | Menopause Transitional Phase | The 10 or so years immediately prior to menopause when the subject experiences symptoms of menopause. | Perimenopausal | ||
POSTMENOPAUSAL | C15421 | The period of time after menopause. | Postmenopausal | |||
PREMENOPAUSAL | C15491 | The period of time before perimenopause. | Premenopausal | |||
Back to top | ||||||
CL.C85492.METHOD | Method
(METHOD) | text
Extensible: Yes | C85492 | Method | Method is any technique or procedure (an action) that determines how an observation or clinical finding was made. | CDISC SDTM Method Terminology |
ACCELERATOR MASS SPECTROMETRY | C135452 | AMS | A type of mass spectrometry in which ions in the sample are accelerated to very high kinetic energies, thus allowing for the separation of rare isotopes from more abundant isotopes. (NCI) | Accelerator Mass Spectrometry | ||
ACID FAST STAIN | C23015 | A microscopy staining method used to examine a specimen for the presence of acid-fast microorganisms, specifically mycobacteria. | Acid Fast Bacillae Staining Method | |||
ACRIDINE ORANGE STAIN | C85554 | A microscopy staining method that utilizes acridine orange, a fluorescent cationic dye that is selective for nucleic acids, to determine the presence of viable cells or microorganisms in a sample. Acridine orange interacts with RNA and DNA and the lysosomal compartment of cells. | Acridine Orange Staining Method | |||
ACTIGRAPHY | C180883 | A method for continuous recording of body movement that uses an actimetry sensor worn by an individual to measure rest/activity (sleep/wake) cycles. | Actigraphy | |||
ACTIVITY TRACKING | C187892 | A method to track an individual's physical activity using an activity monitor or other tracking device. | Activity Tracking | |||
AGAR DILUTION | C85555 | A method to determine microbial susceptibility to antibiotics in which test bacteria is inoculated onto agar plates with serial dilutions of know quantities of antibiotics. The minimum inhibitory concentration of antibiotic is assessed. | Agar Dilution Method | |||
AGAR PROPORTION | C172558 | A method that is used to determine microbial susceptibility to antibiotics by evaluating the extent of growth of several dilutions of a standardized inoculum of microorganism in drug-free and drug-containing agar mediums. The number of colony-forming units grown are compared and expressed as a proportion. | Agar Proportion | |||
AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY | C130170 | A form of complement-dependent lymphocytotoxicity assay with the addition of anti-human globulin (AHG) which is a complement fixing antibody to human immunoglobulin. AHG binds to both complement proteins and non-complement-fixing antibodies. | AHG-enhanced Complement-dependent Lymphocytotoxicity Assay | |||
ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN | C92304 | A microscopy staining method that utilizes periodic acid, an oxoacid of iodine, Schiff reagent, the reaction product of fuchsine and sodium bisulfite, and Alcian blue, a water soluble copper phthalocyanine dye. This staining method is used to differentially stain glycoproteins. | Alcian Blue and Periodic Acid Schiff Staining Method | |||
ALCIAN BLUE STAIN | C92299 | A microscopy staining method that utilizes alcian blue, a cationic, water soluble copper-containing phthalocyanine dye to determine the presence of acid mucopolysaccharides and glycosaminoglycans. | Alcian Blue Staining Method | |||
AMSLER GRID | C123464 | A diagrammatic method to test visual acuity and presence of macular degeneration, which uses a uniform square grid of lines with a dot in the center. | Amsler Grid | |||
ANALYTICAL ULTRACENTRIFUGATION | C120681 | A high-speed centrifugation-based method that uses an optical detection system to monitor and record data during the centrifugation process. | Analytical Ultracentrifugation | |||
ANGIOGRAPHY | C20080 | The X-ray examination of blood vessels or chambers of the heart after introduction of a radiopaque substance. | X-ray Angiography | |||
ANTIBIOTIC AGAR SCREEN | C85557 | A method used to detect organisms that have resistance to a single concentration of antibiotics in an agar matrix. | Antibiotic Agar Screening Method | |||
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY ASSAY | C187893 | ADCC | An in vitro assay that is used to measure antibodies in a biological specimen capable of eliciting effector cell-mediated lysis of target cells. | Antibody Dependent Cellular Cytotoxicity Assay | ||
ANTIMICROBIAL COMBINATION TESTING | C85558 | A method to determine the microbial susceptibility to two or more antibiotics. Numerical result translated into indifference, antagonism, synergism, or additive. | Antimicrobial Combination Testing Method | |||
APPLANATION TONOMETRY | C120682 | A method in which a constant pressure is applied to a surface (e.g., the surface of the cornea or an artery), in order to flatten a prespecified area of the membrane, which is used to calculate pressure within an organ or tissue (e.g., intraocular or arterial pressure). | Applanation Tonometry | |||
ARTERIAL SPIN LABELING FUNCTIONAL MRI | C116450 | ASL fMRI | A noninvasive fMRI technique that uses arterial water as an endogenous tracer to measure cerebral blood flow by magnetically labeling the proton spins of the arterial water prior to reaching the imaged volume. | Arterial Spin Labeling Magnetic Resonance Imaging | ||
ATOMIC ABSORPTION SPECTROMETRY | C85574 | A spectrometric method that determines the type and concentration of metal elements in a sample, based upon the principle that each elemental metal absorbs a particular wavelength of ultraviolet light when exposed to heat. | Atomic Absorption Spectroscopy | |||
AUDIOMETRY | C38036 | Testing conducted utilizing a manual or microprocessor audiometer to test for hearing loss. | Audiometric Test | |||
AURAMINE STAIN | C102599 | Auramine O | A microscopy acid fast staining method that utilizes auramine O, a bright yellow ketonimine dye, which binds to the mycolic acid in the cell walls of acid fast microorganisms. | Auramine Staining Method | ||
AUSCULTATION | C85573 | Listening with a device, such as a stethoscope, to anatomical locations that produce audible sounds like the heart, lungs and abdomen. | Auscultation | |||
AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT | C166060 | Simple Western Assay | An automated Western Blot system that uses capillary electrophoresis to separate proteins, followed by western blot. | Automated Capillary Electrophoresis Western Blot | ||
AUTOMATED COUNT | C154794 | A technique to determine the number of entities, which is performed by a device. | Automated Count | |||
AUTOMATED MICROSCOPY | C198345 | Any type of computer-assisted microscopy. | Automated Microscopy | |||
AUTOREFRACTION | C176330 | An eye examination method in which a computer-controlled electronic optometer is used to automatically measure refractive error. | Autorefraction | |||
BAC ACGH | C116157 | BAC Array-based CGH;Bacterial Artificial Chromosome Array-based CGH;Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization | A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers, using bacterial artificial chromosome clones containing target DNA fragments for hybridization. | Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization | ||
BALLPOINT PEN TECHNIQUE | C150875 | A technique used to measure the skin induration diameter of intradermal tuberculin tests based on resistance to the movement of a ballpoint pen across the skin. | Ballpoint Pen Technique | |||
BETA LACTAMASE | C85576 | A test that detects beta lactamase produced by Staphylococcus species, Haemophilus species, Moraxella catarrhalis, and Neisseria gonorrhoeae. | Beta Lactamase Screening Method | |||
BIOIMPEDANCE SPECTROSCOPY | C172556 | A type of spectroscopy that measures resistance to electrical current at a given body location, to assess tissue composition and fluid levels. | Bioimpedance Spectroscopy | |||
BIOPSY | C15189 | The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis. | Biopsy | |||
BIURET REACTION METHOD | C198346 | Biuret Reagent Test;Piotrowski's Test | A chemical technique where an alkaline solution is treated with Biuret reagent containing copper (II) ions that form complexes with peptide bonds in the solution and create a color change that is proportional in intensity to the number of peptide bonds. | Biuret Reaction Method | ||
BLOOD OXYGEN LEVEL-DEPENDENT FUNCTIONAL MRI | C49099 | Blood Oxygen Level-Dependent fMRI;BOLD fMRI | A functional magnetic resonance imaging technique that uses the difference between the magnetic signals of hemoglobin when it is carrying oxygen (oxyhemoglobin) and when it is not carrying oxygen (deoxyhemoglobin) to detect metabolic activity, and hence neurologic activity, in the brain. (NCI) | Blood Oxygen Level-Dependent Functional MRI | ||
BRDU CELLULAR PROLIFERATION ASSAY | C163545 | A type of cellular proliferation assay in which bromodeoxyuridine is used as a substitute for thymidine in the DNA of replicating cells. | BrdU Cellular Proliferation Assay | |||
CALCOFLUOR WHITE STAIN | C85577 | A microscopy staining method that utilizes calcofluor, a fluorescent dye that preferentially stains chitin and cellulose on the cell walls of fungi, parasites, and some cysts of the Pneumocystis genus. | Calcofluor White Staining Method | |||
CALCULATION | C54125 | The procedure or activity of determining a result by mathematical or logical methods. (NCI) | Calculation | |||
CALIPER MEASUREMENT METHOD | C176470 | A measurement methodology in which a caliper device is used for measuring the length of dimension, consisting of two hinged legs (that may be inturned or outturned) usually, but not always, attached to a ruled scale, dial, or digital display. | Vernier Caliper Measurement Method | |||
CAPILLARY ELECTROPHORESIS | C17637 | An electrophoresis procedure, in which a sample is introduced into a capillary tube and the components are separated by the application of high voltage. (NCI) | Capillary Electrophoresis | |||
CARDIAC THERMODILUTION | C150870 | A technique for calculating cardiac output in which a catheter (e.g., Swan-Ganz) is inserted into the pulmonary artery through a peripheral vein to measure the change in right ventricular outflow blood temperature after a cold saline solution is injected into the right atrium from a proximal catheter port. | Cardiac Output Thermodilution Method | |||
CARDIFF ACUITY CARDS | C191331 | A diagrammatic method to test visual acuity that uses a set of cards with familiar pictures placed in either the top or bottom half of the card, and which is used for those individuals who are unable to provide a verbal response to questions, including infants, toddlers, and other non-verbal individuals. | Cardiff Acuity Cards | |||
CELL BASED BIOASSAY | C150876 | An in vitro assay that utilizes live cells to measure the biological activity or potency of a drug, substance, or organism. | Cell Based Bioassay | |||
CELL CYTOTOXICITY NEUTRALIZATION ASSAY | C172559 | CCNA | An assay that is used to detect the presence of a toxin in a biological sample by inoculating two sets of tissue cell cultures, one prepared with anti-toxin and one prepared without anti-toxin, followed by assessment for cytopathic effect. | Cell Cytotoxicity Neutralization Assay | ||
CELL OF ORIGIN ASSAY | C158248 | COO Assay | An assay that utilizes gene expression profiling of RNA extracted from formalin-fixed, paraffin-embedded tissue biopsies, in order to determine the cell of origin of the tumor. | Cell-of-Origin Assay | ||
CELL-BASED TRANSDUCTION INHIBITION ASSAY | C198347 | A type of cell-based assay that measures the ability of a biological specimen to inhibit transduction of the target cell line (for example, antibody-dependent inhibition of recombinant adeno-associated virus vector transfection). | Cell-based Transduction Inhibition Assay | |||
CELLULAR PROLIFERATION ASSAY | C116553 | Any method to measure the number of dividing cells in a culture, or to measure the change in the proportion of cells that are dividing. | Cell Proliferation Assay | |||
CENTRIFUGATION | C16410 | Separating and isolating components of different density and size in a specimen using centrifugal force. | Centrifugation | |||
CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY | C172557 | Chemiluminescent Magnetic Microparticle Immunoassay;CMIA | A type of chemiluminescent immunoassay that uses paramagnetic microparticles bound to antigen or primary antibodies as a substrate for analyte binding prior to labeling with a luminescent compound. | Chemiluminescent Microparticle Immunoassay | ||
CHROMATOGRAPHY | C16431 | A technique for the separation of complex mixtures that relies on the differential affinities of substances for a gas or liquid mobile medium and for a stationary adsorbing medium through which they pass. | Chromatography | |||
CHROMOGENIC ASSAY | C166061 | An assay in which the reaction product produces a visible color change. | Chromogenic Assay | |||
CINEANGIOGRAPHY | C127679 | A type of angiography in which motion picture camera technology is used to record the passage of dye (usually fluorescent) through blood vessels and the heart. | Cineangiography | |||
CISH | C40960 | Chromogenic in Situ Hybridization | A laboratory procedure that combines the sequence-specific detection aspects of FISH with the simple detection methods of immunohistochemistry. Briefly, sequence-specific probes are hybridized to cells fixed on slides and the sequestered probe is visualized by a peroxidase reaction. It has the advantage of being a less costly assay that does not require fluorescence microscopy with results that are stable over time. | Chromogenic In Situ Hybridization | ||
CLAUSS METHOD | C142334 | An in vitro method to determine the plasma concentration of fibrin, based on the correlation of fibrinogen concentration with the clotting time of diluted plasma mixed with excess thrombin. The method is calibrated using a standard curve based on plasma with decreasing fibrinogen concentrations. | Clauss Method | |||
CLINICAL EVALUATION | C124351 | An appraisal of a patient's condition by a clinician that is based on a physical exam, medical history, patient's account of symptoms, laboratory assessments, and/or imaging analysis. | Clinical Evaluation | |||
CLIP SEQUENCING | C116152 | CLIP-Seq;Cross-linking Immunoprecipitation High-throughput Sequencing;HITS-CLIP | A molecular biology method combining crosslinking-immunoprecipitation and high-throughput sequencing techniques to detect and map RNA-protein interactions. | Cross-linking Immunoprecipitation High-throughput Sequencing | ||
CLIP | C111163 | Cross-Linking and Immunoprecipitation | A type of immunoprecipitation protocol that employs UV-light induced covalent cross-linking of molecules (for instance protein and RNA) prior to the immunoprecipitation and purification steps. | Cross-Linking and Immunoprecipitation | ||
CLOT DETECTION | C111095 | Any of several methods used to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI) | Clot Detection | |||
CO-OXIMETRY | C189603 | An invasive method that provides a direct measurement of fractional oxygen saturation in arterial blood by utilizing spectrophotometry. | CO-oximetry | |||
COLD PRECIPITATION | C181464 | A technique that potentially induces the formation of insoluble solids from solution by exposing the specimen to cold temperatures. | Cold Precipitation | |||
COLLOIDAL GOLD IMMUNOFILTRATION ASSAY | C191328 | A type of immunoassay in which a solution containing a target antigen is run through a membrane filter to which antibodies specific to the target antigen have been immobilized. Antibodies labeled with colloidal gold nanoparticles are then run through the membrane filter and are used for detection. | Colloidal Gold Immunofiltration Assay | |||
COLORIMETRY | C111096 | A method to measure the absorbance of visible wavelengths of light using a colorimeter. | Colorimetry | |||
COMPETITIVE DNA HYBRIDIZATION | C184683 | A hybridization method in which complementary single-stranded DNA from different sources compete to form complexes with target DNA sequences. | Competitive DNA Hybridization | |||
COMPETITIVE ELISA | C178028 | Competitive Enzyme-linked Immunosorbent Assay;Competitive Immunoassay;Inhibition ELISA | A type of enzyme-linked immunosorbent assay that uses a reference antigen to competitively bind labeled antibody against an antigen of interest. The strength of the signal interference caused by antibody bound to the reference antigen is used to determine the concentration of the antigen of interest. | Competitive Enzyme-linked Immunosorbent Assay | ||
COMPLEMENT FIXATION | C154799 | An in vitro immunoassay that detects the presence of a specific antibody utilizing complement-hemolytic activity. The complement binds to the antigen-antibody complexes in a biological specimen, leading to the reduction of hemolytic activity. | Complement Fixation Assay | |||
COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY | C130171 | A method that detects the presence and reaction of complement-fixing alloantibodies to donor lymphocytes, via the addition of complement proteins and lysis of the lymphocytes. | Complement-dependent Lymphocytotoxicity Assay | |||
COMPUTED TOMOGRAPHY PERFUSION | C116442 | CT Perfusion | A computed tomography imaging method used for the evaluation of tissue blood flow, where serial images are acquired after intravenous injection of a bolus of contrast agent, and software is used to analyze perfusion parameters and create color coded perfusion maps. | Computed Tomography Perfusion Imaging | ||
COMPUTERIZED CORNEAL TOPOGRAPHY | C172554 | Computer-Assisted Corneal Topography | A non-invasive, computer-assisted method of measuring the shape of the cornea of the eye. | Computerized Corneal Topography | ||
CONDITIONED PLAY AUDIOMETRY | C198348 | CPA | A type of conditioned audiometry to detect sound, where the child performs a motor activity in response to a specific auditory stimulus. | Conditioned Play Audiometry | ||
CONDITIONED-ORIENTATION REFLEX AUDIOMETRY | C198349 | COR Audiometry | A type of conditioned audiometry to detect and localize sound, where a delayed visual presentation is used to support a child's reflexive orientation response to an audio signal from one of multiple spatially separated sources. | Conditioned Orientation Reflex Audiometry | ||
CONFOCAL MICROSCOPY | C17753 | A system of (usually) epifluorescence light microscopy in which a fine laser beam of light is scanned over the object through the objective lens. This technique is particularly good at rejecting light from outside the plane of focus and so produces higher effective resolution than other microscopy techniques. | Confocal Microscopy | |||
CONGO RED STAIN | C154782 | A microscopy staining method that utilizes the Congo red stain, a benzidine derivative dye that stains amyloid and may also be used as a pH indicator. | Congo Red Staining Method | |||
CONTACT SPECULAR MICROSCOPY | C120683 | A type of specular microscopy in which the specular microscope makes contact with the cornea of the eye. | Contact Specular Microscopy | |||
CONTRAST ENHANCED CT SCAN | C137805 | Contrast Enhanced Computed Tomography;CT Scan With Contrast | A type of CT scan in which images are enhanced by the addition of contrast agents into the body. | Computed Tomography with Contrast | ||
CONTRAST ENHANCED MRI | C46087 | A technique that uses radiofrequency waves and a magnet to image the body. The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. (NCI) | Contrast-enhanced Magnetic Resonance Imaging | |||
CONTRAST ENHANCED PET SCAN | C172562 | PET Scan With Contrast | A type of PET scan in which images are enhanced by the addition of contrast agents into the body. | Contrast Enhanced PET Scan | ||
CONTRAST ENHANCED PET/CT SCAN | C142335 | An imaging technique that utilizes positron emission tomography and computed tomography in a single machine, in which images are enhanced by the addition of contrast agents into the body. | Contrast Enhanced PET-CT Scan | |||
CONTRAST ENHANCED SPIRAL CT SCAN | C172560 | Spiral CT Scan With Contrast | A type of spiral CT scan in which images are enhanced by the addition of contrast agents into the body. | Contrast Enhanced Spiral CT Scan | ||
CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY | C147464 | A type of transesophageal echocardiography in which images are enhanced by the addition of contrast agents into the body. | Transesophageal Echocardiography With Contrast | |||
CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY | C147465 | A type of transthoracic echocardiography in which images are enhanced by the addition of contrast agents into the body. | Transthoracic Echocardiography With Contrast | |||
CONTRAST ENHANCED X-RAY | C154783 | A type of X-ray in which images are enhanced by the addition of contrast agents into the body. | Contrast Enhanced X-ray | |||
CORONARY ANGIOGRAPHY | C100085 | A procedure in which the catheter is passed into the aortic root or other great vessels for the purpose of angiography of the native coronary arteries or bypass grafts supplying native coronary arteries. | Coronary Angiography | |||
COULOMETRIC TITRATION | C174335 | A titration method in which the titrating agent is generated electrochemically in solution and the magnitude and duration of the current are measured to determine the amount of the substance. | Coulometric Titration | |||
CRYOSCOPY | C122162 | A method for measuring the molar concentration of a substance in solution by determining the freezing point of the solution. | Cryoscopy | |||
CT SCAN WITHOUT CONTRAST | C137806 | A type of CT scan in which the images are not enhanced by the addition of contrast agents into the body. | Computed Tomography without Contrast | |||
CT SCAN | C17204 | CAT Scan;Computed Axial Tomography;Computed Tomography;Computerized Tomography;CT | An imaging technique for examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. | Computed Tomography | ||
CYSTOMETRY | C166062 | A method of bladder function testing in which pressure and volume are measured during the filling and voiding phases of micturition. | Cystometry | |||
CYSTOSCOPY | C16482 | Endoscopic examination of the urinary bladder or urethra. | Cystoscopy | |||
DARK FIELD MICROSCOPY | C85837 | A microscopic technique in which the light that does not come into contact with the structure or details of interest is subtracted from the ocular image. This yields an image in which the structure or details are alight while the areas where the structures or details are absent are dark. | Dark Field Microscopy | |||
DC SHEATH FLOW | C176328 | Sheath Flow DC Detection;Sheath Flow Direct Current Detection | A technique that utilizes hydrodynamic focusing to create a sheath flow in which the direct current impedance signal is measured. | Sheath Flow Direct Current Detection | ||
DIFFUSION TENSOR MRI | C64862 | Diffusion Tensor Imaging;DT-MRI;DTI | A type of MRI technique that maps the diffusion of water in three dimensions. | Diffusion Tensor Imaging | ||
DIFFUSION WEIGHTED MRI | C111116 | Diffusion Weighted Imaging;DW-MRI;DWI | A type of MRI technique in which diffusion-sensitizing gradients are applied to the imaging sequence. | Diffusion Weighted Imaging | ||
DIGITAL PCR ARRAY | C116158 | A technique used to deliver high-throughput digital PCR. The digital array partitions a sample premixed with PCR reagents into hundreds of individual PCR reactions, which allows the absolute quantification of target sequences and rare allele detection, as compared to conventional real-time quantitative PCR. | Digital Array | |||
DIGITAL PCR | C166063 | Digital Polymerase Chain Reaction;dPCR | A type of polymerase chain reaction technique in which the sample is fractionated, within which individual PCR reactions occur in each fraction. | Digital Polymerase Chain Reaction | ||
DIPSTICK MEASUREMENT METHOD | C178142 | A measurement methodology in which a dipstick device is used to detect the presence of an analyte in a liquid by producing a color change. | Dipstick Measurement Method | |||
DIRECT ELISA | C187894 | A type of enzyme-linked immunosorbent assay that uses a one-step process, where a labeled antibody binds the antigen of interest. | Direct Enzyme-linked Immunosorbent Assay | |||
DIRECT SEQUENCING | C116154 | A technique used to identify the sequence of individual nucleotides in a single strand of DNA fragment template which does not require subcloning and can be a plasmid insert, genomic DNA or a PCR product. | Direct Sequencing | |||
DISK DIFFUSION ZONE EDGE TEST | C181461 | A technique for microbial characterization that assesses the zone edge of susceptible bacteria isolates after disk diffusion with an antimicrobial agent. | Penicillin Zone Edge | |||
DISK DIFFUSION | C85595 | A method to determine microbial susceptibility to antibiotics in which filter paper disks containing known concentrations of antibiotics are placed on the agar surface that has been previously inoculated with the bacteria of interest. Microbial susceptibility is assessed by measuring the area around the disk that is free of microbial growth. | Disk Diffusion Method | |||
DNA MICROARRAY | C18158 | DNA Chip;Gene Chip;Gene Expression Array | An orderly array of DNA samples affixed to a support. The chip is used in various types of hybridization experiments. Used when a more specific microarray methodology is not specified. | DNA Microarray Chip | ||
DOPPLER ECHOCARDIOGRAPHY | C38634 | A type of echocardiography that uses sound waves applying the Doppler effect to measure characteristics of blood flow, such as direction, velocity, speed, and turbulence. | Doppler Echocardiography | |||
DOPPLER ULTRASOUND | C62781 | Diagnostic imaging that uses sound waves (ultrasound) applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow. | Doppler Ultrasound | |||
DOUBLE IMMUNODIFFUSION | C163546 | DID;Ouchterlony Double Immunodiffusion;Passive Double Immunodiffusion | A technique used to identify specific antibodies bound to an antigen by the appearance of a precipitation band (precipitin band) formed between wells in an agar gel plate as a result of the interaction of the antigen and antibodies at optimal concentration. | Double Immunodiffusion | ||
DROPLET DIGITAL PCR | C166064 | ddPCR | A type of digital polymerase chain reaction technique in which the sample is fractionated into thousands of tiny droplets using a water-oil emulsion droplet technology, within which individual PCR reactions occur in each droplet. | Droplet Digital PCR | ||
DUCTOGRAPHY | C123465 | Galactography | A type of mammography that uses contrast medium to visualize the ducts of the breast. | Ductography | ||
DUKE INCISION METHOD | C122163 | A method for assessing bleeding time in which a controlled incision is made on the ear or fingertip. | Duke Incision Method | |||
DXA SCAN | C48789 | DEXA Scan | A technique for measuring anatomical densities in which two X-ray beams at different energy levels are aimed at the anatomical location of interest and x-ray absorption is assessed. | Dual X-ray Absorptiometry | ||
DYNAMIC CONTRAST ENHANCED MRI | C62665 | A type of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties. | Dynamic Contrast-Enhanced Magnetic Resonance Imaging | |||
DYNAMIC LIGHT SCATTERING | C62329 | Photon Correlation Spectroscopy;Quasi-elastic Light Scattering | A type of spectroscopy that utilizes a laser beam to irradiate a sample containing particles in suspension, resulting in light scattering. | Photon Correlation Spectroscopy | ||
DYNAMIC SUSCEPTIBILITY-CONTRAST MRI | C116453 | DSC-MRI | A type of MRI that uses the transient signal reduction induced by the first pass of gadolinium chelate through the brain vessels to calculate cerebral blood flow maps, and to determine the ratio between the cerebral blood volume in the lesion and the cerebral blood volume in normal tissue. | Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging | ||
DYNAMOMETRY | C161407 | A technique that measures the torque, or force, of muscle contraction. | Dynamometry | |||
ECHOCARDIOGRAPHY | C16525 | A procedure that uses high-frequency sound waves (ultrasound) to create an image of the heart. | Echocardiography | |||
EEG | C38054 | ELECTROENCEPHALOGRAPHY | A technique used to capture and record spontaneous electrical activity of the brain by the application of electrodes to the scalp. | Electroencephalography | ||
EIA | C17455 | Enzyme Immunoassay | Any of several immunoassay methods that use an enzyme covalently linked to an antigen or antibody as a label; the most common types are enzyme-linked immunosorbent assay (ELISA) and enzyme-multiplied immunoassay technique (EMIT). | Enzyme Immunoassay | ||
ELASTOGRAPHY | C106517 | An ultrasound-based imaging technique used to examine the stiffness or elasticity of a tissue by applying mechanical compression or vibration to the tissue being imaged. (NCI) | Elastography | |||
ELECTRICAL IMPEDANCE MYOGRAPHY | C166065 | EIM | A non-invasive method of applying and measuring high-frequency, low-intensity electrical currents on the skin over localized muscle or muscle group of interest. | Electrical Impedance Myography | ||
ELECTROCHEMILUMINESCENCE IMMUNOASSAY | C111194 | A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution due to the formation of antigen-antibody complexes. | Electrochemiluminescence Immunoassay | |||
ELECTROCHEMILUMINESCENCE | C111193 | A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution. (NCI) | Electrochemiluminescence | |||
ELECTROGASTROGRAPHY | C150871 | A non-invasive technique that utilizes abdominal skin electrodes and computerized spectral analysis to assess gastric myoelectrical activity. | Electrogastrography | |||
ELECTROMYOGRAPHY | C38056 | EMG | A method to assess skeletal muscle function and nerve control, obtained by recording and studying the intrinsic electrical properties of the muscles. | Electromyography | ||
ELECTRONEUROGRAPHY | C154784 | A nerve conduction study technique where a brief electrical stimulation is delivered under the skin, and the resulting electrical activity is recorded to assess the conductivity of peripheral nerve impulses. | Electroneurography | |||
ELECTROPHORESIS | C16536 | The motion of charged particles in a colloid under the influence of an electric field; particles with a positive charge go to the cathode and negative to the anode. | Electrophoresis | |||
ELISA | C16553 | Enzyme-linked Immunosorbent Assay | A type of enzyme immunoassay in which an antigen or antibody is bound to a solid substrate (e.g., microplate or beads) and interacts with an enzyme-linked antibody or antigen in solution. | ELISA | ||
ELISPOT | C102632 | Enzyme-linked Immunosorbent Spot Assay | A highly sensitive immunoassay capable of detecting secreted materials from individuals cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way. | Enzyme-linked Immunosorbent Spot Assay | ||
ELLA | C147466 | Enzyme-Linked Lectin Assay | An enzyme immunoassay that utilizes enzyme-lectin conjugates to detect specific carbohydrate end groups on immobilized glycoproteins on microtiter plates. | Enzyme-Linked Lectin Assay | ||
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY | C16430 | ERCP | An imaging technique in which the bile ducts, pancreatic duct, and gallbladder are examined using a combination of endoscopy and fluoroscopy. | Endoscopic Retrograde Cholangiopancreatography | ||
ENDOSCOPIC ULTRASOUND | C46078 | An endoscopic technique using a specialized endoscope that transmits high frequency sound waves to generate ultrasound images. | Endoscopic Ultrasound | |||
ENDOSCOPY | C16546 | An examination of the body using an endoscope. | Endoscopic Procedure | |||
ENDPOINT DILUTION ASSAY | C120684 | An in vitro cell based assay in which plated host cells are inoculated with serial dilutions of an infective agent and observed for cytotoxic effects in order to calculate the titer. | Endpoint Dilution Assay | |||
ENZYMATIC COLORIMETRY | C111195 | A type of colorimetry that makes use of an enzymatic reaction to induce a color change. (NCI) | Enzymatic Colorimetry | |||
ENZYMATIC SPECTROPHOTOMETRY | C154785 | A spectrophotometry technique that measures the changes in the intensity of the light absorbed or scattered in response to an enzymatic reaction. | Enzymatic Spectrophotometry | |||
ENZYMATIC ULTRACENTRIFUGATION | C122164 | A high-speed centrifugation-based method that uses enzymatic catalytic reaction to quantify a substance. | Enzymatic Ultracentrifugation | |||
ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE | C111196 | EMIT | A type of homogenous immunoassay in which sample is applied to a reagent mixture of enzyme-labeled ligand, antibody, and substrate. Substrate binding to enzyme leads to inactivation and unlabeled-ligand in the sample can be quantified by colorimetric analysis. | Enzyme Multiplied Immunoassay Technique | ||
EPSILOMETER | C85596 | A method to determine microbial susceptibility to antibiotics in which a plastic strip impregnated with the antibiotic of interest is placed on an agar plate that has been inoculated with bacteria. The antibiotic diffuses from the strip producing a concentration gradient of drug on the agar. The point at which the elliptical shaped area of growth inhibition meets the strip is the minimum inhibitory concentration of the drug of interest. | Epsilometry | |||
ERGOSPIROMETRY | C172564 | Spiroergometry | An exercise testing method that continuously measures respiratory volume and frequency, oxygen intake, carbon-dioxide output, and heart rate during ergometer exercise to assess integrative cardiopulmonary, musculoskeletal, and metabolic response to physical stress. | Ergospirometry | ||
ETDRS EYE CHART | C117877 | A diagrammatic method to test visual acuity which incorporates the Bailey-Lovie layout in conjunction with Sloan optotypes. | Early Treatment of Diabetic Retinopathy Study Eye Chart | |||
FARNSWORTH-MUNSELL 100 HUE TEST | C130172 | A diagrammatic method to test color blindness or deficiencies, which uses 100 colors from the Munsell color system arranged in rows of four color families and containing 25 hues for each color. The subject must put the hues in order based on the anchor colors on the ends of each row. | Farnsworth-Munsell 100 Hue Test | |||
FARR ASSAY | C172551 | A type of radioimmunoprecipitation assay that uses ammonium sulfate to precipitate immune complexes formed with radiolabeled antigen. | Farr Assay | |||
FISH | C17563 | Fluorescence in Situ Hybridization | A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping. | Fluorescence In Situ Hybridization | ||
FLAME PHOTOMETRY | C106523 | A type of atomic spectroscopy that qualitatively or quantitatively measures select cations (particularly Na, K, Rb, Cs, Ca, Ba, Cu) by utilizing a low temperature flame capable of exciting a valence electron to an upper energy state which emits light at a wavelength unique to each cation as the electron returns to its ground state. (NCI) | Flame Photometry | |||
FLOCCULATION | C154798 | A method in which microscopic particles in suspension aggregate to form observable loosely clumped masses. | Flocculation Assay | |||
FLOCCULATION, CHARCOAL ENHANCED | C172553 | A type of flocculation method in which microscopic charcoal particles are used to enhance the visibility of aggregated masses in suspension. | Charcoal Enhanced Flocculation | |||
FLOW CYTOMETRY | C16585 | A technique for counting, examining or sorting microscopic particles suspended in a stream of fluid. The cells are placed in a fluid (with or without light-sensitive dye) and passed in a stream before a laser or other type of light. | Flow Cytometry | |||
FLOW MICROSCOPY | C112284 | A method of measuring the number of cells in a sample by placing the cells in a fluid and passing them, in a stream, through a special light microscope that can record and analyze images of the cells to determine the presence of foreign particles, cell counts, protein aggregates and morphology information. | Flow Microscopy | |||
FLUID ATTENUATED INVERSION RECOVERY MRI | C82392 | FLAIR MRI | A type of magnetic resonance imaging that uses an inversion recovery sequence with a long inversion time to null fluids present in the imaging area, improving clarity of the object of interest. | Fluid Attenuated Inversion Recovery | ||
FLUORESCEIN STAIN | C158242 | A microscopy staining method that utilizes an orange phthalic indicator dye, which emits green fluorescence in the presence of alkaline solutions. | Fluorescein Stain | |||
FLUORESCENCE ANGIOGRAPHY | C116569 | An examination technique that uses fluorescent dye and a specialized camera to inspect blood flow within vessels. | Fluorescence Angiography | |||
FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY | C158247 | FAVN | An immunofluorescence assay method that measures the level of virus-specific neutralizing antibodies in a specimen by the detection of fluorescence in susceptible cells incubated with serial dilutions of the specimen and fluorophore-conjugated virus. | Fluorescent Antibody Virus Neutralization Assay | ||
FLUORESCENT ENZYME IMMUNOASSAY | C142336 | FEIA | An assay technique that uses one or more antibodies to detect an analyte, where either the analyte or antibody is labelled with an enzyme. The binding of antibody to analyte is detected by the enzyme converting a substrate to a fluorescent product. | Fluorescent Enzyme Immunoassay | ||
FLUORESCENT IMMUNOASSAY | C17370 | Fluorescent Antibody Assay;Immunofluorescence Assay | A bioassay in which fluorescent-coupled antibodies or antigens are used to quantify or qualify a biological response to a stimulus. | Fluorescent Antibody Procedure | ||
FLUORESCENT LIFETIME IMAGING MICROSCOPY | C154786 | An imaging technique that produces spatially resolved images based on the differences in the excited state decay rates of fluorescent compounds in a sample. | Fluorescence Lifetime Imaging Microscopy | |||
FLUORESCENT MICROSCOPY | C16856 | Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. | Fluorescence Microscopy | |||
FLUORESCENT SPOT TEST | C132427 | A method to assess enzymatic activity in which a substrate reagent is incubated with a biological specimen and spotted on filter paper. The spots are then examined for fluorescence, which correlates with enzyme activity. | Fluorescent Spot Test | |||
FLUORIMETRY | C62322 | Fluorometry | An analytical method that utilizes ultraviolet light to excite the sample and detects the fluorescence emitted during the return of the sample to its ground state. (NCI) | Fluorimetry | ||
FLUOROSCOPY | C16588 | An imaging technique that produces real-time, moving images of tissues and deep structures of the body using the fluoroscope, a device that produces an image when X-rays strike a fluorescent screen. | Fluoroscopy | |||
FOCUS REDUCTION NEUTRALIZATION ASSAY | C191335 | Foci Reduction Neutralization Test;Focus Reduction Neutralization Test;FRNT | An assay that is used to determine whether neutralizing antibodies that are present in a biological specimen can block viral infection/proliferation ex vivo, by staining and counting the number of viral foci, which are detected with a colorimetric substrate, such as horseradish peroxidase or fluorescent labels. This assay typically uses live virus. | Focus Reduction Neutralization Assay | ||
FORCED OSCILLATION TECHNIQUE | C122165 | FOT | A non-invasive method to evaluate respiratory mechanical properties of the lung and airways using small-amplitude pressure oscillations superimposed on the normal, tidal breathing of a subject. | Forced Oscillation Technique | ||
FREEZING POINT DEPRESSION | C135453 | The addition of a solute to a solvent that results in a decrease in the temperature at which the solute-solvent mixture (solution) freezes. | Freezing Point Depression | |||
FUNCTIONAL MRI | C17958 | fMRI | A type of MRI that takes a series of images of an organ in quick succession and statistically analyzes the differences between the images. | Functional Magnetic Resonance Imaging | ||
FUNDUS PHOTOGRAPHY | C147467 | A method of capturing images of the vitreous, retina, choroid, and optic nerve using a fundus camera, a specialized low power microscope with an attached camera. | Eye Fundus Photography | |||
GC/FID | C135454 | Gas Chromatography/Flame Ionization Detector | An analytical technique where gas chromatography is coupled with flame ionization detection in order to separate, identify, and quantify substances in a sample. | Gas Chromatography and Flame Ionization Detection | ||
GC/MS | C111203 | Gas Chromatography/Mass Spectrometry | An analytical technique where gas chromatography is coupled with mass spectrometry in order to separate, identify, and quantify substances in a sample. (NCI) | Gas Chromatography Mass Spectrometry | ||
GC/MS-CI | C120686 | An analytical technique where gas chromatography is coupled with chemical ionization mass spectrometry in order to separate, identify, and quantify substances in a sample. | Gas Chromatography/Chemical Ionization Mass Spectrometry | |||
GC/MS-EI | C120687 | An analytical technique where gas chromatography is coupled with electron ionization mass spectrometry in order to separate, identify, and quantify substances in a sample. | Gas Chromatography/Electron Ionization Mass Spectrometry | |||
GC/MS/MS | C120685 | An analytical technique where gas chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. | Gas Chromatography/Tandem Mass Spectrometry | |||
GEL ELECTROPHORESIS | C18091 | A method of separating large molecules (such as DNA fragments or proteins) from a mixture of similar molecules by electrophoretic filtration through a gelatinous matrix. | Gel Electrophoresis | |||
GIEMSA STAIN | C85598 | A microscopy staining method that utilizes Giemsa, a mixture of ethylene blue and eosin, which forms purplish-black crystals when dried. This stain preferentially binds to the phosphate groups of DNA and aggregates at areas with an increase in adenine-thymine binding, thus leading to chromosomal staining patterns that lend themselves to g-banding analysis. Additionally Giemsa can be used as a differential stain to determine microbial cell adherence to human cells as well as in the diagnosis of malaria, spirochete, and protozoal infections. | Giemsa Staining Method | |||
GRADIENT DIFFUSION | C85599 | A method to determine microbial susceptibility to antibiotics in which an agar plate, which has a concentration gradient of the drug within the agar, is streaked with the microorganism of interest. Microbial susceptibility as well as minimum inhibitory concentration of antibiotic is assessed. | Gradient Diffusion Method | |||
GRAM STAIN | C23014 | A microscopy staining method for staining and identifying bacteria, based on the differential retention of a crystal violet-iodine complex within the cell membrane. Gram-positive organisms will appear blue-black or purple while Gram-negative organisms will appear red. | Gram Staining Method | |||
HAND-HELD DYNAMOMETRY | C186193 | A technique to assess isometric muscle strength using a hand-held dynamometer. | Hand-held Dynamometry | |||
HANSEL STAIN | C111205 | A microscopy staining method that uses Hansel reagent to differentiate eosinophils and neutrophils in a specimen. (NCI) | Hansel Staining Method | |||
HEMAGGLUTINATION ASSAY | C130173 | An in vitro assay that is used to determine the relative concentration of viruses, bacteria, or antibodies in which serial dilutions of solution containing virus, bacteria, or antibody are applied to red blood cells in culture to look for the presence of hemagglutination. | Hemagglutination Assay | |||
HEMAGGLUTINATION INHIBITION ASSAY | C120688 | An in vitro assay that is used to determine whether antibodies present in serum samples will inhibit hemagglutination in a cell culture plate containing red blood cells and a hemagglutinating agent. | Hemagglutination Inhibition Assay | |||
HEMATOXYLIN AND EOSIN STAIN | C23011 | H&E Stain | A microscopy staining method that utilizes two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen. | Hematoxylin and Eosin Staining Method | ||
HEMOCYTOMETRY | C120689 | A method that uses a thick glass slide containing a chamber with a defined volume, which is etched with a precisely ruled grid and is used to quantify cells or cell-sized particles in suspension. | Hemocytometry | |||
HEMOLYTIC COMPLEMENT ACTIVITY ASSAY | C70611 | A technique for measuring circulating complement in which biological specimens are added to antibody-coated erythrocytes and the percentage of cell lysis is measured. | Complement Hemolytic Activity Assay | |||
HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY | C95525 | An assay used to verify the presence of anti-HCV antibodies in a blood sample. Serum is incubated with a membrane strip on which four recombinant viral proteins are attached. The immunoblot is considered positive if two or more proteins react, and indeterminate if only one positive band is detected. (NCI) | Hepatitis C Virus Recombinant Immunoblot Assay | |||
HIGH LEVEL AMINOGLYCOSIDE SCREEN | C85556 | A method to determine microbial susceptibility to high concentrations of aminoglycoside antibiotics. | Aminoglycoside Screening Method | |||
HIGH RESOLUTION CT | C20644 | High Resolution Computed Tomography;HRCT | A type of computed tomography that utilizes narrow collimated light beams to take thin-slice, high-definition images. | High Resolution Computed Tomography | ||
HIGH RESOLUTION MELT ANALYSIS | C130174 | A reverse real-time polymerase chain reaction technique in which fluorescently labeled double-stranded DNA is slowly melted apart by increasing temperature. | High Resolution Melt Analysis | |||
HILLMEN COLOR CHART | C132428 | A visual color scale created by Hillman et al in 2004 to enable standardization of urine color in the assessment of hemoglobinuria. | Hillmen Color Chart | |||
HPLC | C16434 | High Performance Liquid Chromatography | Frequently referred to simply as HPLC, this form of column chromatography is used frequently in biochemistry. The analyte is forced through a column by liquid at high pressure, which decreases the time the separated components remain on the stationary phase. Less time on the column then translates to narrower peaks in the resulting chromatogram and thence to better selectivity and sensitivity. | High Performance Liquid Chromatography | ||
HPLC-EC | C198350 | High-Performance Liquid Chromatography with Electrochemical Detection;HPLC-ECD;HPLC-ED | An analytical technique where high performance liquid chromatography with an electrochemical detector is used to separate, identify, and quantify substances in a sample. | High-Performance Liquid Chromatography with Electrochemical Detection | ||
HPLC-FL | C120692 | An analytical technique where high performance liquid chromatography with a fluorescence detector is used to separate, identify, and quantify substances in a sample. | High-performance Liquid Chromatography-Fluorescence | |||
HPLC-UV | C120693 | An analytical technique where high performance liquid chromatography with an ultraviolet light detector is used to separate, identify, and quantify substances in a sample. | High-performance Liquid Chromatography-UV | |||
HPLC/IEX | C120690 | An analytical technique where high performance liquid chromatography is coupled to ion exchange chromatography in order to separate proteins based on net charge. | High-performance Liquid Chromatography/Ion-Exchange Chromatography | |||
HPLC/MS | C103513 | High Performance Liquid Chromatography/Mass Spectrometry | An analytical technique wherein high performance liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. | High Performance Liquid Chromatography Mass Spectrometry | ||
HPLC/MS/MS | C120691 | An analytical technique where high performance liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. | High-performance Liquid Chromatography/Tandem Mass Spectrometry | |||
ICC | C17731 | Immunocytochemistry | A method for the detection of proteins or antigens on samples of cells that are grown in monolayers or in suspension and deposited on slides, using antibodies or other biomolecules that bind the target and can be visualized through a chemical process. | Immunocytochemistry | ||
ICP-MS | C62328 | A mass spectrometry technique that uses inductively-coupled plasma generated from argon gas to atomize and ionize a sample. The resulting ions are separated and analyzed using a mass spectrometer. | Inductively-Coupled Plasma Mass Spectrometry | |||
IHC | C23020 | Immunohistochemistry | Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen. | Immunohistochemistry Staining Method | ||
IMMUNE REPERTOIRE DEEP SEQUENCING | C158249 | A DNA sequencing technique in which the full array of genes associated with immune cell markers are sequenced. | Immune Repertoire Deep Sequencing | |||
IMMUNO-PET SCAN | C163547 | An imaging technique that utilizes positron emission tomography following administration of labeled antibody to confer specificity in the image. | Immuno-Positron Emission Tomography Scan | |||
IMMUNOASSAY | C16714 | An immunological procedure involving the usage of enzyme-antibody or enzyme-antigen conjugates, antienzyme antibodies, or enzyme-antienzyme complexes. | Immunoenzyme Procedure | |||
IMMUNOBLOT | C17638 | A technique for analyzing or identifying proteins immobilized on a filter by complementary reaction with specific antibodies. (NCI) | Immunoblot Analysis | |||
IMMUNOCHEMILUMINOMETRIC ASSAY | C111235 | Chemiluminescence Immunoassay;Chemiluminescent Immunoassay;CLIA;ICMA | An immunoassay in which the antigen-antibody complex is quantified using light emission, which is generated from a chemical reaction. | Chemiluminescent Immunoassay | ||
IMMUNOCHROMATOGRAPHY | C154792 | ICA;Immunochromatography Assay | A type of chromatography assay in which an antibody-conjugate is passed over an immobilized antigen, or an antigen-conjugate is passed over an immobilized antibody, giving a visual indication of positive or negative result. | Immunochromatography | ||
IMMUNODIFFUSION | C158239 | A quantitative technique used to detect and estimate the concentration of an antigen by measuring the precipitation which is formed as a result of the interaction of the antigen and an antibody at optimal concentration. | Immunodiffusion | |||
IMMUNOFIXATION ELECTROPHORESIS | C54536 | IFE | An enhancement of immunoelectrophoresis in which a series of post-electrophoretic gel slabs are layered with cellulose-acetate gels saturated with specific antibodies. The resulting antigen-antibody complexes fixed on the second gel may then be stained, allowing sensitive and specific qualitative visual identification of proteins by electrophoretic position. | Immunofixation | ||
IMMUNOFLUORESCENT STAIN | C142337 | A microscopy staining method that utilizes immunofluorescent markers for use with histological applications of preserved cells. | Immunofluorescent Staining Method | |||
IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY | C142338 | An imaging technique in which fluorescently labeled cells are immunomagnetically selected and imaged by fluorescent microscopy. | Immunomagnetic Fluorescence Microscopy | |||
IMMUNOPRECIPITATION | C16724 | Antigen aggregation with antibody, in the right ratios, to cause precipitation. (NCI) | Immunoprecipitation | |||
IMMUNORADIOMETRIC ASSAY | C111236 | IRMA | An antibody-excess, non-competition radioimmunometric assay in which ligand is sandwiched between an immobilized antibody on a solid phase and a radiolabeled antibody raised against a different epitope of the ligand. | Immunoradiometric Assay | ||
IMMUNOTURBIDIMETRY | C106536 | Immunoturbidimetric Assay;Turbidimetric Immunoassay | A method that measures the absorbance of light from a sample which is used for quantifying an amount of analyte based on the level of turbidity produced by the formation and precipitation of an immune complex containing the analyte. (NCI) | Immunoturbidimetry | ||
IMPEDANCE CONDUCTIVITY | C154797 | A method that measures impedance of conductivity which corrects for the concentrations of conducting ions in the sample. | Impedance Conductivity | |||
IMPULSE OSCILLOMETRY | C122166 | IOS | A non-invasive method to measure pulmonary resistance and reactance, and the impedance of the respiratory system, using small pressure oscillation of a regular square wave of pressure 5 times per second. | Impulse Oscillometry | ||
IN SITU HYBRIDIZATION | C17562 | Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues. (NCI) | In Situ Hybridization | |||
IN VITRO GENE EXPRESSION ASSAY | C158251 | A method that detects gene transcription associated with an in vitro cellular stimulus, through detection of the resulting transcribed mRNA or translated protein. | In vitro Gene Expression Assay | |||
INCISION-INDUCED BLEEDING METHOD | C122039 | A method for assessing bleeding time in which a controlled incision is made in the dermis and the time to bleeding cessation is measured. | Incision-induced Bleeding Method | |||
INDIA INK STAIN | C85642 | A microscopy staining method that utilizes India Ink, a water soluble carbon-based black ink, to determine the presence of microorganisms that are surrounded by a gelatinous capsule. This is a negative staining method in which background is stained in black and the microbes and microscopic structures of interest remain white. | India Ink Staining Method | |||
INDIRECT BINDING ELECTROCHEMILUMINESCENCE IMMUNOASSAY | C178027 | A type of electrochemiluminescence immunoassay that utilizes primary and secondary antibodies in a two-step binding process. | Indirect Binding Electrochemiluminescence Immunoassay | |||
INDIRECT ELISA | C187895 | A type of enzyme-linked immunosorbent assay that uses a two-step process, where a primary antibody binds the antigen of interest and then a labeled secondary antibody binds to the primary antibody. | Indirect Enzyme-linked Immunosorbent Assay | |||
INDIRECT IMMUNOFLUORESCENCE | C176332 | Secondary Immunofluorescence | A fluorescent antibody technique in which a secondary fluorophore-conjugated antibody is used to detect a primary, unconjugated antibody directed against a target antigen. | Indirect Immunofluorescence | ||
INFRARED SPECTROMETRY | C85643 | A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that the atoms in a sample will vibrate or rotate at a specific frequency when exposed to infrared light. | Infrared Spectrometry | |||
INTERNATIONAL READING SPEED TEXT TEST | C178032 | IReST Test | A method for assessing reading performance based on a standardized set of ten equivalent paragraphs of text, based on everyday life reading demands with equivalent levels of difficulty. | International Reading Speed Text Test | ||
INTERRUPTER TECHNIQUE | C124352 | RINT | A non-invasive method of measuring airway resistance during which the subject breathes normally while airflow is interrupted at a predetermined rate and volume during the early exhalation phase. | Interrupter Technique | ||
INTRACELLULAR CYTOKINE STAIN FLOW CYTOMETRIC ASSAY | C178026 | ICS;Intracellular Cytokine Staining | A technique that is used with flow cytometry to measure cytokine production in isolated cells. Cells may be stimulated with an antigen or mitogen, and cytokine secretion may be blocked using protein transport inhibitors. The cells are then stained with fluorochrome labeled monoclonal antibodies that target surface markers, fixed and permeabilized, and stained with fluorochrome labeled anti-cytokine monoclonal antibodies prior to analysis by flow cytometry. | Intracellular Cytokine Stain Flow Cytometric Assay | ||
INTRAVASCULAR ULTRASOUND | C99535 | IVUS | An invasive procedure in which sound waves (called ultrasound) are bounced off of vascular tissues from within the vessel and the echoes produce a picture (sonogram). | Intravascular Ultrasound | ||
INTRAVENOUS PYELOGRAPHY | C20177 | IVP | An imaging technique in which X-ray images of the renal pelvis and urinary tract are obtained after intravenous injection of a radiopaque substance. | Intravenous Pyelography | ||
IODINE STAIN | C85649 | A microscopy staining method that utilizes Iodine, an element belonging to the halogen group, which specifically stains polysaccharides such as cellulose, chitin, glycogen, and starch a blue color. | Iodine Staining Method | |||
IRON HEMATOXYLIN STAIN | C85650 | A microscopy staining method that utilizes a mixture of iron and hematoxylin to visualize intracellular structures in a microscopic sample. In this dye system, iron acts as a mordant to hematoxylin rendering it insoluble, thereby allowing irreversible blue-black colored dyeing to the cell nucleus. | Iron Hematoxylin Staining Method | |||
ISHIHARA COLOR PLATES | C123466 | A diagrammatic method to test color blindness or deficiencies, which uses a circular form composed of multiple size circles in varying colors. A number or symbol is present in the middle and is composed of similar sized circles, which are a different color from those of the outer circular form. | Ishihara Color Plates | |||
ISOTHERMAL AMPLIFICATION | C184684 | A diverse group of nucleic acid amplification methods that are performed at a constant temperature and utilize a polymerase with strand-displacement activity. | Isothermal Amplification | |||
IVY INCISION METHOD | C122167 | A method for assessing bleeding time in which a controlled incision is made on the underside of the arm and blood is drawn off of the incision site with blotting paper every 30 seconds until bleeding stops. | Ivy Incision Method | |||
JAEGER EYE CHART | C130175 | A diagrammatic method to test visual acuity that uses paragraphs of text in differing font sizes to assess near vision. | Jaeger Eye Chart | |||
JAFFE REACTION | C120694 | A colorimetric method used to measure creatinine, in which color change is directly related to the amount of creatinine in an alkaline solution containing picric acid. | Jaffe Reaction | |||
KARYOTYPING | C16768 | The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell sample. | Karyotyping | |||
KINETIC CHROMOGENIC ASSAY | C142339 | A bioassay in which a biological specimen is incubated with a kinetic substrate, followed by optical assessment of color change. | Kinetic Chromogenic Assay | |||
KINETIC MICROPARTICLE IMMUNOASSAY | C111240 | A type of immunoassay in which the antigen of interest found in a biological specimen competes with a lattice of antigen-antibody complexes. Competing antigen inhibits lattice formation and decreases absorbance in proportion to the amount of antigen present in a biological specimen. (NCI) | Kinetic Microparticle Immunoassay | |||
KINYOUN STAIN | C85651 | A microscopy acid fast staining method that utilizes kinyoun carbol fuchsin, a dye containing basic fuchsin in solution with ethyl alcohol and aqueous phenol. This acid fast staining technique does not require heating during the primary staining step involving the carbol fuchsin. | Kinyoun Staining Method | |||
KLEIHAUER-BETKE | C161409 | A biospecimen collection and staining procedure in which maternal blood smear is prepared and stained using Shepard's staining method, followed by microscopic examination to identify fetal hemoglobin transference to the mother's bloodstream. | Kleihauer-Betke Staining Procedure | |||
KNEMOMETRY | C154787 | A technique which measures lower limb length using a knemometer, for the assessment of short-term growth and development in childhood. | Knemometry | |||
LAG AVIDITY EIA | C187896 | LAg-Avidity EIA;Limiting Antigen-Avidity Enzyme Immunoassay | An enzyme immunoassay technique that limits the amount of antigen available for binding in order to measure antibody avidity, with or without the use of a dissociation buffer. | Limiting Antigen-Avidity Enzyme Immunoassay | ||
LANDOLT RING | C142340 | A diagrammatic method to test visual acuity in which a symbol, in the shape of the letter C, is presented to the patient who must identify on which side of the symbol the gap is present. Both the size of the gap and the size of the symbol are reduced until the subject makes a predetermined rate of errors, thus ending the test. (NCI) | Landolt Ring | |||
LAPAROSCOPY | C16969 | A technique used to examine the abdominopelvic region with a laparoscope. | Laparoscopy | |||
LASER CAPTURE MICRODISSECTION | C19263 | Laser Microdissection;LCM;LMD | A technique used for the highly specific and selective capture and isolation of a cell population from a heterogeneous tissue section, cytological preparation, or live cell culture. This technique uses direct visualization of the cells via microscopy as well as a laser energy source for cutting and extraction of the cells. | Laser Capture Microdissection | ||
LC-FL | C122169 | An analytical technique where liquid chromatography with a fluorescence detector is used to separate, identify, and quantify substances in a sample. | Liquid Chromatography-Fluorescence | |||
LC/MS | C18475 | Liquid Chromatography/Mass Spectrometry | An analytical technique wherein liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. | Liquid Chromatography Mass Spectrometry | ||
LC/MS/MS | C122168 | An analytical technique where liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. | Liquid Chromatography/Tandem Mass Spectrometry | |||
LEAD CITRATE STAIN | C92301 | A microscopy staining method that utilizes lead citrate, a mixture of lead nitrate and sodium citrate, and has applications for electron microscopy staining. | Lead Citrate Staining Method | |||
LIGAND BINDING ASSAY | C178030 | An immunoassay that utilizes the interactions between two molecules, or the binding of molecules to antibodies, to detect and quantify analytes of interest. (NCI) | Ligand Binding Assay | |||
LIGHT MICROSCOPY | C17995 | Light microscopy is a technique for producing visible images of structures or details which are too small to be otherwise seen by the human eye. It involves passing light transmitted through or reflected from the subject through a series of lenses to be detected directly by the eye, imaged on a photographic plate, or captured digitally. | Light Microscopy | |||
LIGHT SCATTERING SPECTROSCOPY | C20059 | LiSSP | A type of spectroscopy that measures power spectral density of surface morphology by exploiting the tendency of light to disperse into a range of directions as a result of physical interaction. | Light-Scattering Spectroscopy | ||
LINE PROBE ASSAY | C102656 | LiPA;LPA | A microbial identification technique in which polymerase chain reaction is used to amplify specific nucleic acid sequences in a biospecimen. The product of this reaction is then applied to a nitrocellulose test strip containing complementary DNA probes. | Line Probe Assay | ||
LIPS | C187897 | Luciferase Immunoprecipitation System Assay | An immunoassay method that involves the binding of antibodies to luciferase-labeled antigen, precipitation of the antibody/antigen complex, and analysis of the precipitate through the light-producing interaction of luciferase and luciferin. | Luciferase Immunoprecipitation System Assay | ||
LIQUID SCINTILLATION COUNTING | C122170 | A method for measuring the amount of ionizing radiation in a liquid substance. Samples are mixed with a mixture of solvent, surfactant and scintillators that can convert beta particles into light energy, which can be measured. | Liquid Scintillation Counting | |||
LISSAMINE GREEN STAIN | C158241 | A microscopy staining method that utilizes a green, synthetically produced phenyl methane dye that preferentially stains degenerate and dead epithelial cells and stroma. | Lissamine Green Stain | |||
LOOP-MEDIATED ISOTHERMAL AMPLIFICATION | C102661 | LAMP | A type of nucleic acid amplification test in which sample DNA is exposed to a single temperature in the presence of multiple sets of primers and a polymerase with replication and high strand displacement activity. This test negates the need for thermal cyclers and may be a low cost alternative to PCR. | Loop-mediated Isothermal Amplification | ||
LUCIFERASE PROTEIN COMPLEMENTATION ASSAY | C198351 | LCA;Luciferase PCA | A cell-based assay that utilizes a luciferase complementation reporter mechanism to detect regulated protein-protein interactions in situ. | Luciferase Protein Complementation Assay | ||
LUXOL FAST BLUE AND CRESYL VIOLET STAIN | C92300 | A microscopy staining method that utilizes luxol fast blue, an alcohol soluble copper phthalocyanine dye, and cresyl violet, an organic compound that is commonly used as a counter stain, to determine the presence of myelin as well as helicobacter and campylobacter bacterial species. | Luxol Fast Blue and Cresyl Violet Staining Method | |||
LYMPHANGIOGRAPHY | C38069 | A type of angiographic procedure that allows for the examination of the lymph nodes and lymphatic vessels following the injection of a radiopaque substance. | Lymphangiography | |||
MACRO BROTH DILUTION | C85697 | A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a test tube. Each tube contains a known concentration of drug and is inoculated with a known quantity of bacteria. The tubes are incubated for a specified period of time and each is assessed for bacterial cell growth. The drug concentration in the first tube showing no growth is known as the MIC for that antibiotic. | Macro Broth Dilution Method | |||
MACROFLOCCULATION | C184678 | A type of flocculation method in which aggregates in suspension are detected with the naked eye. | Macroflocculation Assay | |||
MAGNETIC RESONANCE ANGIOGRAPHY | C114867 | MRA | A type of magnetic resonance imaging that is used to construct images of blood vessels. | MRI-Based Angiogram | ||
MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY | C113775 | MRCP | A type of magnetic resonance imaging that is used to construct images of the intrahepatic and extrahepatic bile ducts, the pancreatic duct, and the surrounding parenchyma. | Magnetic Resonance Cholangiopancreatography | ||
MAGNETIC RESONANCE ELASTOGRAPHY | C19338 | MRE | An imaging technique that combines MRI with ultrasound to assess the mechanical properties of tissues. An MRI machine captures a cross sectional image of the sound waves, produced by ultrasound techniques, which are then processed by computer to produce an image showing the hardness or elasticity of tissues within the cross section. | Magnetic Resonance Elastography | ||
MAGNETIC RESONANCE ENTEROGRAPHY | C176331 | MRE | A magnetic resonance imaging technique that allows for the visualization of the entire small bowel by imaging the abdomen and pelvis during the enteric phase of digestion following oral administration of large volumes of enteric contrast material for bowel distention, followed by intravenous administration of contrast agent. | Magnetic Resonance Enterography | ||
MAGNETOENCEPHALOGRAPHY | C16811 | MEG;MEG Scan | A non-invasive encephalographic technique used to measure the magnetic fields produced by electrical activity in the brain. | Magnetoencephalography | ||
MALDI | C48040 | Matrix-Assisted Laser Desorption Ionization Mass Spectrometry | A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample- matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. (CHI) | Matrix-Assisted Laser Desorption Ionization Mass Spectrometry | ||
MALDI-TOF | C19935 | Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry | In MALDI-TOF, a laser pulse is fired into a protein or peptide sample contained in a light-absorbing matrix. A small explosion vaporizes and ionizes the sample. In the presence of a high electric field, peptide ions are accelerated down an evacuated flight tube. Because large particles travel more slowly than small ones, the masses of the ionized particles are determined by measuring their arrival time at the end of the tube. | Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry | ||
MAMMOGRAPHY | C16818 | A type of radiography used specifically to examine breast tissue. The procedure utilizes a low-dose of x-rays or radiation to generate an image. | Mammography | |||
MANUAL CLOT DETECTION | C111245 | A clot detection method that uses a manual means (visual discernment) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI) | Manual Clot Detection | |||
MANUAL COUNT | C154795 | A technique to determine the number of entities, which is performed by visual inspection. | Manual Count | |||
MAPH | C116159 | Multiplex Amplifiable Probe Hybridization | A screening method used to determine changes in complex genomes. This method uses unique short probes which are quantitatively recovered and amplified after hybridization to genomic DNA. | Multiplex Amplifiable Probe Hybridization | ||
MASS CYTOMETRY | C187898 | Cytometry by Time-of-Flight;Time-of-Flight Cytometry;ToF Cytometry | A flow cytometry technique that utilizes mass spectrometry to detect antibodies labeled with heavy metal ion tags that are bound to antigens of interest on single cells. | Mass Cytometry | ||
MASS SPECTROMETRY | C17156 | MassSpec | An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. | Mass Spectrometry | ||
MECHANICAL CLOT DETECTION | C111249 | A clot detection method that uses a mechanical means (electromagnetic mechanical or electromechanical) to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI) | Mechanical Clot Detection | |||
MEDIASTINOSCOPY | C16829 | A technique used to examine the thorax with a mediastinoscope. | Mediastinoscopy | |||
METHYLATION-SENSITIVE QUANTITATIVE LOCKED NUCLEIC ACID PCR | C184682 | MS-qLNAPCR | A modified polymerase chain reaction (PCR) technique in which bisulphite-converted methylated CpG target sequences are amplified in the presence of locked nucleic acid (LNA) modified primers. | Methylation-Sensitive Quantitative Locked Nucleic Acid Polymerase Chain Reaction | ||
MICRO BROTH DILUTION | C85701 | A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a multi-well plate. Each well contains a known concentration of drug which is inoculated with a known quantity of bacteria. The plate is incubated for a specified period of time and each well is assessed for bacterial cell growth. The drug concentration in the first well showing no growth is known as the MIC for that antibiotic. | Micro Broth Dilution Method | |||
MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY | C142341 | Latex Agglutination;Latex Fixation | An immunoassay that involves coating microbeads of latex with antigens or antibodies, mixing them with a fluid specimen, and then observing for any agglutination. | Micro-Latex Particle-Mediated Immunoassay | ||
MICROARRAY | C44282 | A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array. The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues. | Microarray | |||
MICROBIAL BIOCHEMICAL IDENTIFICATION | C51955 | Any of a number of biochemical tests performed to identify the genus and/or species of a microorganism. These may include the assessment of gram reaction or metabolic characteristics. | Bacterial Typing Procedure | |||
MICROBIAL CONCENTRATION | C85702 | Any technique in which a sample is condensed in order to afford greater sensitivity for the detection of microorganisms. | Microbial Concentration Method | |||
MICROBIAL CULTURE | C25300 | Culture Procedure | Any method for growing microorganisms. | Microbial Culture Procedure | ||
MICROBIAL CULTURE, LIQUID | C102668 | A method for growing microorganisms in liquid culture media. | Microbial Liquid Culture | |||
MICROBIAL CULTURE, SOLID | C102669 | A method for growing microorganisms in solid culture media. | Microbial Solid Culture | |||
MICRODENSITOMETRY | C150872 | A technique for measuring microscopic optical density on exposed film or photographic images through the detection of faint spectral lines. | Microdensitometry | |||
MICROFLOCCULATION | C184679 | A type of flocculation method in which aggregates in suspension are detected microscopically. | Microflocculation Assay | |||
MICROFLUIDIC ELISA | C189604 | A type of enzyme-linked immunosorbent assay that utilizes microfluidic channels to simultaneously measure analytes of interest. | Microfluidic ELISA | |||
MICROFLUIDIC IMMUNOASSAY | C186194 | Any of a number of immunoassay-based techniques that use very small amounts (e.g., on a nanoliter scale) of biological fluids. | Microfluidic Immunoassay | |||
MICRONEUTRALIZATION ASSAY | C120695 | Virus Neutralization Assay;VNA | An assay that is used to determine whether neutralizing antibodies that are present in a biological specimen can block viral infection/proliferation ex vivo, by counting the number of living cells. This assay typically uses live virus. | Virus Neutralization Assay | ||
MICROPARTICLE ENZYME IMMUNOASSAY | C111252 | MEIA | An enzyme immunoassay that uses antigen-coated microparticles as a substrate for antibody binding. | Microparticle Enzyme Immunoassay | ||
MICROSCOPY | C16853 | The application of microscope magnification to the study of materials that cannot be properly seen by the unaided eye. (NCI) | Microscopy | |||
MIGET | C161408 | Multiple Inert Gas Elimination Technique | A technique that measures the pulmonary exchange of a set of inert gases dissolved together in saline (or dextrose) and infused intravenously. The measurements are then used to compute the distribution of ventilation/perfusion ratios that best describes the exchange of the gases simultaneously. (Wagner PD. The multiple inert gas elimination technique (MIGET). Intensive Care Med. 2008 Jun;34(6):994-1001.) | Multiple Inert Gas Elimination Technique | ||
MODIFIED ACID FAST STAIN | C85736 | A microscopy staining method, that does not utilize heat in the slide preparation, used to examine a specimen for the presence of acid-fast microorganisms, specifically nocardia. | Modified Acid Fast Staining Method | |||
MOUSE PROTECTION ASSAY | C166066 | MPA | An assay method that is used for the detection of neutralizing antibodies in subject's serum by determining the ability of the serum to prevent the death of mice that are exposed to a lethal dose of challenge agent. | Mouse Protection Assay | ||
MRI WITHOUT CONTRAST | C114184 | A technique that uses radiofrequency waves and a magnet to image the body, in which the images are not enhanced by the addition of contrast agents. | MRI Without Contrast | |||
MRI | C16809 | Magnetic Resonance Imaging | Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders. | Magnetic Resonance Imaging | ||
MRS | C29934 | Magnetic Resonance Spectroscopy | Magnetic resonance spectroscopy is a noninvasive imaging technique that operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution. (NCI) | Magnetic Resonance Spectroscopic Imaging | ||
MS/MS | C18142 | Tandem Mass Spectrometry | An analytical technique where mass spectrometry is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. | Tandem Mass Spectrometry | ||
MUGA | C38073 | Gated Heart Pool Scan;Radionuclide Ventriculogram Scan | A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles. | Multigated Acquisition Scan | ||
MULTI-SLICE SPIRAL CT | C106545 | Multi-Slice Spiral Computed Tomography | A type of spiral computed tomography that employs multiple rows of detectors, each capable of producing a simultaneous image (slice). (NCI) | Multi-slice Spiral Computed Tomography | ||
MULTIPLE BREATH WASHOUT | C130176 | A test of lung function in which changes in exhaled tracer gas concentration is analyzed for a specified number of tidal expirations, a defined period of time, or a defined index of expired gas volume. | Multiple Breath Washout | |||
MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING | C116160 | Multiple Complete Digestion | A DNA mapping technique based on complete restriction enzyme digestion of a set of overlapping clones that provides highly redundant coverage of the mapping target. | Multiple Complete Digest Restriction Fragment Mapping | ||
MULTIPLEX IMMUNOFLUORESCENCE | C181928 | Multiplex IF;Multiplexed Immunofluorescence;MxIF | A method that enables simultaneous measurement of multiple antigens on a single tissue section using immunofluorescence techniques. | Multiplexed Immunofluorescence | ||
MULTIPLEX IMMUNOHISTOCHEMISTRY | C181927 | Multiplex IHC;Multiplexed Immunohistochemistry;MxIHC | A method that enables simultaneous measurement of multiple antigens on a single tissue section using immunohistochemistry techniques. | Multiplexed Immunohistochemistry | ||
MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION | C116161 | MLPA | A type of high-throughput, multiplex PCR method that uses a single pair of PCR primers to amplify multiple targets and to determine changes in complex genomes. | Multiplex Ligation-dependent Probe Amplification | ||
MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY | C158250 | An assay technique that utilizes the polymerase chain reaction (PCR) method to amplify multiple DNA sequences in a single cycle, with the accumulation of amplification product being measured as the reaction progresses. | Multiplex Real-time Polymerase Chain Reaction Assay | |||
MULTIPLEXED BEAD BASED IMMUNOASSAY | C135455 | A type of solid-phase immunoassay that uses distinctly colored microbeads coated with one or more reagents, which may be antigens, antibodies, oligonucleotides, enzyme substrates, or receptors, for the simultaneous detection and measurement of one or many analytes within a single sample. | Multiplexed Bead Based Immunoassay | |||
MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS | C166067 | A type of digital gene expression analysis to detect or quantify targeted RNA transcripts using bar code indexing. | Multiplexed Digital Gene Expression Analysis | |||
MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY | C147468 | MOPA | An assay technique that measures the opsonophagocytic killing activity of antibodies against multiple serotypes in a single serum assay. | Multiplexed Opsonophagocytic Killing Assay | ||
MYELOPEROXIDASE STAIN | C158245 | MPO Stain | A microscopy staining method that utilizes hydrogen peroxide and a chromogenic electron donor to stain for the presence of myeloperoxidase. | Myeloperoxidase Stain | ||
NEPHELOMETRY | C111281 | A method to quantify the concentration of particulate matter suspended in a liquid or gas using a nephelometer. | Nephelometry | |||
NESTED POLYMERASE CHAIN REACTION | C127880 | Nested PCR | An assay technique that utilizes the polymerase chain reaction (PCR) method using two sets of primers, in two sequential runs of amplification, with the second set intended to amplify a target within the first run product. | Nested PCR | ||
NEURAMINIDASE INHIBITION ASSAY | C120696 | A type of enzyme-based assay that assesses neuraminidase activity in the presence of an enzyme inhibitor. | Neuraminidase Inhibition Assay | |||
NEXT GENERATION SEQUENCING | C101293 | Massively Parallel Sequencing | A type of sequencing technology that makes use of high-throughput parallel sequencing of multiple fragments of DNA or RNA. | Next Generation Sequencing | ||
NEXT GENERATION TARGETED SEQUENCING | C130177 | A type of next generation sequencing in which specific genes or portions of genes are targeted for sequencing using amplicon-based workflow. | Next Generation Targeted Sequencing | |||
NO INFORMATION | C53269 | NI | The value is exceptional (missing, omitted, incomplete, improper). No information as to the reason for being an exceptional value is provided. This is the most general exceptional value. It is also the default exceptional value. (ISO) | No Information Available | ||
NON-CONTACT SPECULAR MICROSCOPY | C120697 | A type of specular microscopy in which the specular microscope does not make contact with the cornea of the eye. | Non-Contact Specular Microscopy | |||
NON-INVASIVE DIELECTRIC SENSING | C166068 | A method in which the dielectric tissue properties are measured based on the emission and reflection of low-power electromagnetic signals in between two sensors attached to the body. | Non-Invasive Dielectric Sensing | |||
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY | C16810 | A type of spectroscopy that detects and measures the resonant spectra of molecular species in a tissue or sample. | Magnetic Resonance Spectroscopy | |||
NUCLEAR RADIOLOGY | C127514 | Any type of imaging method that uses radioactive materials. | Nuclear Radiology Imaging Procedure | |||
NUCLEIC ACID AMPLIFICATION TEST | C20055 | NAAT | Any of a number of molecular biological techniques that are used to copy nucleic acid sequences within a specimen, leading to an increase in the number of copies of that sequence of interest. These techniques may be used for detection of a particular gene or microorganism of interest. | Nucleic Acid Amplification Test | ||
NUCLEIC ACID BASED METHOD | C19770 | Molecular Analysis | Any laboratory methodology that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level. | Molecular Analysis | ||
NUCLEIC ACID HYBRIDIZATION | C16924 | A method in which single stranded nucleic acids are allowed to interact so that complexes, or hybrids, are formed by molecules with sufficiently similar, complementary sequences. By this means the degree of sequence identity can be assessed and specific sequences detected. (From Biology-online) | Nucleic Acid Hybridization | |||
NUCLEIC ACID SEQUENCING | C18881 | The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides. | Nucleic Acid Sequencing | |||
OBSERVATION | C25598 | Inspection;Visual Inspection | Observing a subject or material to gain information. | Observation | ||
OLIGO ACGH | C116156 | Oligonucleotide Array-based CGH;Oligonucleotide Array-based Comparative Genomic Hybridization | A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers in the genome, using oligonucleotides as targets for hybridization. | Oligonucleotide Array-based Comparative Genomic Hybridization | ||
OPHTHALMOSCOPY | C120698 | Fundoscopy | A technique used to examine the fundus and other anatomical structures of the eye with a magnifying instrument. | Ophthalmoscopy | ||
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY | C190550 | OCT-A;OCTA | An optical coherence tomography imaging method that utilizes motion contrast imaging to capture the patterns of moving red blood cell reflectance across time and create high-resolution, 3D angiograms of vascular networks. | Intravascular Optical Coherence Tomography | ||
OPTICAL COHERENCE TOMOGRAPHY | C20828 | OCT | Optical Coherence Tomography (OCT) combines the principles of ultrasound with the imaging performance of a microscope. OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. The frequencies and bandwidths of infrared light are orders of magnitude higher than medical ultrasound signals, resulting in greatly increased image resolution, 8-25 times greater than any existing modality. In addition to providing high-level resolutions for the evaluation of microanatomic structures OCT is also able to provide information regarding tissue composition. (NCI) | Optical Coherence Tomography | ||
OPTICAL DENSITY MEASUREMENT | C85776 | A quantification of the amount of light that is absorbed by or transmitted through a substance. | Optical Density Measurement | |||
OPTICAL MAPPING | C116162 | Optical Map | A technique used for constructing the ordered and high-resolution genome or chromosome sized restriction enzyme map of an organism from a single, stained DNA molecule, digested by the restriction enzyme and imaged by an optical microscope. | Optical Mapping | ||
ORCHIDOMETERY | C163548 | A method used to measure testicular volume by comparing the size of one's testicles to the beads in a orchidometer, which consists of a string of 12 numbered beads of increasing sizes of 1 to 6, 8, 10, 12, 15, 20, and 25mL. | Orchidometry | |||
OSCILLOMETRY | C154788 | A technique to measure a motion that repeats itself in a regular cycle around an equilibrium point or mean value. | Oscillometry | |||
PALM METHOD | C154793 | A method for estimating body surface area, in which the individual's hand, with or without digits, accounts for a small proportion of the total body surface. An individual's palm (not including fingers and wrist) accounts for about 0.5% of the individual's total body surface area. The entire palmar surface (including digits) accounts for about 1% of the individuals total body surface area. | Palm Method | |||
PALPATION | C16950 | A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient's body to examine the size, consistency, texture, location and tenderness of an organ or body part. | Palpation | |||
PANENDOSCOPY | C94528 | An endoscopic examination of the pharynx, larynx, trachea and esophagus. | Panendoscopy | |||
PAP STAIN | C128984 | Papanicolau Stain | A microscopy staining method that utilizes a mixture of dyes including hematoxylin, orange G (OG), and eosin azure, which contains variable portions of Eosin Y, light green SF yellowish, and Bismarck brown Y. This multichromatic staining method is used to differentially stain samples containing mixed cell populations. | Papanicolaou Staining Method | ||
PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY | C125952 | PENIA | A method to quantify the concentration of immunoaggregates suspended in a liquid or gas using a nephelometer. The immunoaggregates are target antigens agglutinated to antigen-specific antibody-coated polystyrene latex-enhanced particles. | Particle-Enhanced Nephelometric Immunoassay | ||
PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY | C125953 | PETIA | A method to quantify the opaqueness of a liquid using a turbidimeter, by measuring the decrease in light intensity due to the scattering effect of suspended immunoaggregates in a liquid sample. The immunoaggregates are target antigens agglutinated to antigen-specific antibody-coated polystyrene latex-enhanced particles. | Particle-Enhanced Turbidimetric Immunoassay | ||
PATHOLOGICAL EVALUATION | C125006 | An appraisal by a pathologist that is based on microscopic and macroscopic structural and functional changes that result from disease processes. | Pathologic Examination | |||
PEAK FLOWMETRY | C122171 | A method for measuring the flow of air through the bronchi upon expiration. | Peak Flowmetry | |||
PELLI-ROBSON EYE CHART | C117878 | A diagrammatic method to test visual acuity and contrast sensitivity, which uses large letters (at a 20/60 acuity) that decrease in contrast from right to left and top to bottom. | Pelli-Robson Contrast Sensitivity Eye Chart | |||
PERCUSSION | C62298 | A diagnostic test performed on a tooth by tapping on the crown with a dental instrument. | Dental Percussion | |||
PERFUSION MRI | C93243 | A type of contrast-enhanced magnetic resonance imaging technique that assesses the circulatory perfusion of an anatomical location. | Perfusion Magnetic Resonance Imaging | |||
PERIODIC ACID SCHIFF STAIN | C23019 | A microscopy staining method that utilizes Schiff's reagent, a solution composed of pararosanilin treated with sulfurous acid, which selectively reacts with and stains aldehydes pink to determine the presence of glycogen, mucin, mucoprotein, glycoprotein, as well as fungi. Periodic Acid Schiff staining is useful for outlining tissue structures such as basement membranes, capsules and blood vessels. | Periodic Acid Schiff Staining Method | |||
PERIPHERAL ANGIOGRAPHY | C117879 | A procedure in which the catheter is passed into a peripheral vessel (usually in the groin) for the purpose of angiography of the abdomen, hands, arms, feet and legs. | Peripheral Angiography | |||
PET SCAN WITHOUT CONTRAST | C191330 | A type of PET scan in which the images are not enhanced by the addition of contrast agents into the body. | PET SCAN Without Contrast | |||
PET SCAN | C17007 | An imaging technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance. A scanner reveals the tissue location of the metabolically-active substance administered. | Positron Emission Tomography | |||
PET/CT SCAN WITHOUT CONTRAST | C142342 | An imaging technique that utilizes positron emission tomography and computed tomography in a single machine, in which the images are not enhanced by the addition of contrast agents into the body. | PET-CT Scan Without Contrast | |||
PET/CT SCAN | C103512 | An imaging technique that utilizes positron emission tomography and computed tomography in a single machine. | Positron Emission Tomography and Computed Tomography Scan | |||
PET/MRI SCAN | C103514 | An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine. | Positron Emission Tomography and Magnetic Resonance Imaging | |||
PET/SPECT SCAN | C111297 | An imaging technique that utilizes positron emission tomography and single-photon emission computed tomography in a single machine. | Positron Emission Tomography and Single Photon Emission Computed Tomography Scan | |||
PH METER MEASUREMENT METHOD | C176471 | A measurement methodology in which a pH meter device is used for measuring the alkalinity or acidity of a liquid or semi-solid substance. | pH Meter Measurement Method | |||
PHASE CONTRAST MICROSCOPY | C16857 | A microscopic technique in which the amplitude shift that occurs when light passes through a specimen highlights structures or details within the specimen. | Phase-Contrast Microscopy | |||
PHASE-CONTRAST MRI | C135456 | PCMR | A type of MRI in which a phase shift between flowing tissue and static tissue is generated in order to determine the quantity and velocity of body fluid. | Phase-Contrast Magnetic Resonance Imaging | ||
PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY | C130178 | A type of solid-phase multiplex assay that uses microbeads coated with recombinant or purified antigens that will identify multiple antibodies. | Phenotypic Multiple Antigen Bead-based Multiplex Assay | |||
PHOROPTER | C120699 | An instrument composed of multiple lenses that refract the light going into the subject's eye, allowing the examiner to determine the refractive error of the eye. | Phoropter | |||
PHOTOGRAPHY | C94527 | The process by which an image is acquired by recording light emissions. | Photography | |||
PHOTOMETRIC CLOT DETECTION | C111291 | A clot detection method that uses a photometric means (measuring the absorbancy of monochromatic light) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI) | Photometric Clot Detection | |||
PHOTOMETRY | C65109 | Measurement of the properties of light, especially luminous intensity. (NCI) | Photometry | |||
PHYSICAL EXAMINATION | C20989 | Physical Exam | A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. | Physical Examination | ||
PINHOLE OCCLUSION | C184680 | A visual acuity method using a pinhole occluder device, which negates refractive error. | Pinhole Occlusion Method | |||
PLAQUE REDUCTION NEUTRALIZATION ASSAY | C172555 | Plaque Reduction Neutralization Test;PRNT | An assay that is used to determine whether neutralizing antibodies that are present in a biological specimen can block viral infection/proliferation ex vivo, by counting the number of cytolytic plaques. This assay typically uses live virus. | Plaque Reduction Neutralization Assay | ||
PLETHYSMOGRAPHY | C122173 | Body Box | A method used to measure changes in volume, pressure and resistance within an organ or whole body by means of a plethysmograph. | Plethysmography | ||
POLYGRAPHY | C166069 | A method of simultaneously recording variations in multiple physiological pulsations. | Polygraphy | |||
POLYMERASE CHAIN REACTION | C17003 | PCR | A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase. This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample. | Polymerase Chain Reaction | ||
POLYSOMNOGRAPHY | C114185 | PSG | A group of tests taken during sleep to capture and record brain wave changes, eye movements, breathing rate, blood pressure, heart rate, and the electrical activity of the heart and other muscles. | Polysomnography | ||
POPULATION SEQUENCING | C135457 | A process by which the individual genomes of most or all of an entire population of a species undergoes a large-scale comparison of the DNA sequences within that population, using probabilistic matching tools. | Population Sequencing | |||
POTENTIOMETRY | C142343 | Ion Selective Electrode Method;ISE Method | An electroanalytical technique in which the electrical potential of a solution is measured to determine the composition of the sample, by comparing the constant potential of the reference electrode with the actual potential of the indicator electrode. | Potentiometry | ||
PSEUDOVIRION-BASED NEUTRALIZATION ASSAY | C172552 | PBNA | An assay that is used to determine whether neutralizing antibodies that are present in a biological specimen can block pseudoviral infection ex vivo, by counting the number of infected cells. This assay uses a pseudovirus expressing a pathogenic virus antigen of interest. | Pseudovirion-Based Neutralization Assay | ||
PULMONARY ANGIOGRAPHY | C154789 | An x-ray imaging technique that involves visualization of the pulmonary vasculature after fluoroscopy-guided catheter placement and injection of an iodinated contrast medium into the pulmonary circulation. | Pulmonary Angiography | |||
PULSE OXIMETRY | C38085 | A non-invasive method that provides estimates of arterial hemoglobin oxygen saturation by utilizing selected wavelengths of light. | Pulse Oximetry | |||
PULSED-FIELD GEL ELECTROPHORESIS | C17426 | PFGE | An electrophoresis method used to separate proteins or high molecular weight linear DNA fragments that are greater than 50 kilobases (kb) in size. Fragments are separated by pulsing an electrical field across an agarose gel rather than applying the constant field used in conventional electrophoresis. | Pulsed-Field Gel Electrophoresis | ||
PUPILLOMETRY | C120700 | A technique used to measure the diameter of a single pupil in response to stimuli. | Monocular Pupillometry | |||
PYROSEQUENCING | C99481 | A DNA sequencing technique that is based on the detection of released pyrophosphate during DNA synthesis. | Pyrosequencing | |||
QUANTITATIVE COMPUTED TOMOGRAPHY | C161405 | QCT | A type of computed tomography in which a calibration standard derives quantitative tissue density values from radiodensity measurements. | Quantitative Computed Tomography | ||
QUANTITATIVE CORONARY ANGIOGRAPHY | C120701 | A type of angiographic procedure that allows for direct quantitative assessment of the native coronary arteries or bypass grafts supplying native coronary arteries. | Quantitative Coronary Angiography | |||
QUANTITATIVE METHYLATION-SPECIFIC PCR | C184681 | qMSP | A modified polymerase chain reaction (PCR) technique in which bisulphite-converted methylated DNA target sequences are amplified in the presence of an excess of unmethylated counterpart sequences. | Quantitative Methylation-Specific Polymerase Chain Reaction | ||
QUANTITATIVE PERIPHERAL ANGIOGRAPHY | C120702 | A type of angiographic procedure that allows for direct quantitative assessment of the vessels of the hands, arms, feet and legs. | Quantitative Peripheral Angiography | |||
QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION | C28408 | qRT-PCR;Real-Time Reverse Transcriptase PCR;rRT-PCR | A modified polymerase chain reaction (PCR) technique in which RNA sequences are reverse transcribed into complementary DNA (cDNA) transcripts by the enzyme reverse transcriptase. The cDNA is then amplified by a PCR reaction and quantified by comparing to a standard, using fluorescent probes. | Quantitative Reverse Transcriptase PCR | ||
QUANTITATIVE ULTRASOUND | C150873 | A type of ultrasound method in which the velocity and attenuation of ultrasonic sound waves are measured as they pass through tissue. | Quantitative Ultrasound | |||
RADIAL IMMUNODIFFUSION | C119296 | A quantitative technique used to detect and estimate the concentration of an antigen by measuring the diameter of the ring of precipitation (precipitin ring) which is formed as a result of the interaction of the antigen and an antibody at optimal concentration. (NCI) | Radial Immunodiffusion | |||
RADIATION DOSIMETRY | C15312 | Any of a number of techniques used to measure radiation exposure. | Radiation Dosimetry | |||
RADIOGRAPHY | C128940 | Radiographic Exam | A radiographic procedure using the emission of penetrating energy waves to form an image of the structure. | Radiographic Examination | ||
RADIOIMMUNOPRECIPITATION ASSAY | C172383 | RIPA | An immunoassay method that involves the binding of antibodies to radiolabeled antigen, precipitation of the antibody/antigen complex using a special reagent, and analysis of the precipitate. | Radioimmunoprecipitation Assay | ||
RAJI CELL EIA | C135458 | Raji Cell Enzyme Immunoassay | A type of complement receptor-dependent immune complex assay that uses Raji cells washed with anti-IgA, anti-IgG, anti-IgM, and anti-Ig (A+G+M) conjugated with an enzyme to detect the presence of circulating immune complexes in biologic fluids. (NCI) | Raji Cell Enzyme Immunoassay | ||
RAJI CELL RIA | C135459 | Raji Cell Radioimmunoassay | A type of complement receptor-dependent immune complex assay that uses radiolabeled anti-IgA, anti-IgG, or anti-IgM Raji cells to detect the presence of soluble immune complexes in biologic fluids. (NCI) | Raji Cell Radioimmunoassay | ||
RAPID IMMUNOASSAY | C178031 | Any of a number of immunoassay-based techniques that can be completed outside a laboratory in less than 30 minutes. | Rapid Immunoassay | |||
REAL-TIME POLYMERASE CHAIN REACTION ASSAY | C51962 | qPCR;Quantitative PCR;Real Time-PCR | A modified polymerase chain reaction (PCR) technique in which DNA amplification is detected and quantified as the PCR reaction progresses, through the use of fluorescent DNA probes in the reaction mixture. | Real Time PCR | ||
REBOUND TONOMETRY | C120703 | A method in which a probe is bounced off of the surface of the cornea, creating an induction current that is used to calculate intraocular pressure. | Rebound Tonometry | |||
REFLECTANCE SPECTROSCOPY | C19340 | The spectroscopic analysis of light reflected from a polished sample. | Reflectance or Transmission Spectroscopy | |||
REFRACTOMETRY | C111304 | A method to measure the refractive index (propensity for light to bend) of a sample. (NCI) | Refractometry | |||
REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS | C40211 | ROMA | A genomic microarray-based method that analyzes two restriction enzyme digested full genomes to identify regions in the genome that have undergone large scale variation. | Representational Oligonucleotide Microarray Analysis | ||
RESTING FUNCTIONAL MRI | C178024 | Resting fMRI | A type of functional magnetic resonance imaging that is performed on an organ in the absence of a stimulus or task. (NCI) | Resting Functional Magnetic Resonance Imaging | ||
RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS | C17633 | RFLP Analysis | A technique that analyzes restriction fragments of target DNA sequences to detect polymorphisms. | Restriction Fragment Length Polymorphism Analysis | ||
RETROGRADE PYELOGRAPHY | C28654 | An imaging technique in which X-ray images of the renal pelvis and urinary tract obtained after injection of a radiopaque substance into the ureter, usually done via a cystoscope. | Retrograde Pyelogram | |||
REVERSE TRANSCRIPTASE PCR | C18136 | Reverse Transcription Polymerase Chain Reaction;RT-PCR | A molecular biology technique used to recreate and amplify complementary DNA (cDNA) from total RNA or messenger RNA (mRNA), using reverse transcriptase and DNA polymerase. | Reverse Transcriptase-Polymerase Chain Reaction | ||
RIA | C17057 | Radioimmunoassay | Radioimmunoassay (RIA) is an immunological technique, which quantitatively determines antigen and antibody concentrations, using a radioactively labeled substance (radioligand), either directly or indirectly. | Radioimmunoassay | ||
RINNE TEST METHOD | C191334 | A technique that assesses auditory function by comparing sound conduction through air versus the mastoid bone, in which a vibrating tuning fork (at 512Hz) is placed on the mastoid bone and the subject indicates when they can no longer hear the vibration, at which point the still vibrating tuning fork is moved 1-2cm from the auditory canal and the subject again indicates when they can no longer hear the fork. | Rinne Test Method | |||
ROMANOWSKY STAIN | C158240 | A microscopy staining method that utilizes both cationic and anionic dyes (typically methylene blue and eosin Y, respectively) for the morphological assessment of cells in a biological specimen. | Romanowsky Stain | |||
ROTH 28 HUE TEST | C179765 | A standardized method of color vision testing that is a shortened version of the Farnsworth-Munsell 100-Hue test (FM100), using every third of the FM100's 85 color caps that are arranged in rows of four color families. | Roth-28 Hue Test | |||
RULER MEASUREMENT METHOD | C176469 | A measurement methodology in which a ruler device is used for measuring distance, consisting of an elongated piece of material marked with units of length. | Ruler Measurement Method | |||
RYAN BLUE STAIN | C85801 | A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. This staining technique substitutes aniline blue for the fast green counterstain of the original trichrome staining method and decreased levels of phosphotungstic acid in the reagent. | Ryan Blue Staining Method | |||
SANDWICH ELISA | C187899 | A type of enzyme-linked immunosorbent assay that uses separate capture and detection antibodies such that the antigen is bound between the two antibodies. | Sandwich Enzyme-linked Immunosorbent Assay | |||
SANGER SEQUENCING | C19641 | A DNA sequencing technique in which a mixture of deoxynucleosidetriphosphates (dNTPs) and chain-terminating dNTPs (which are radioactively or fluorescently labeled) are combined within the reaction mixture. Once the polymerase chain reaction is complete the DNA strands are separated by size and the labeled chain terminating dNTPs can be read in sequence by the investigator or a machine. | Dideoxy Chain Termination DNA Sequencing | |||
SCANNING ELECTRON MICROSCOPY | C16855 | An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through a specimen that has been coated with a heavy metal. | Scanning Electron Microscopy | |||
SCINTIGRAPHY | C62667 | An imaging technique that uses a small dose of a radioactive chemical (isotope) called a tracer that can detect sites of cancer growth, trauma, infection or degenerative disorders. The tracer, which is either injected into a vein or swallowed, travels through the bloodstream to the target organ, and emits gamma rays, which are detected by a gamma camera and analyzed by a computer to form an image of the target organ. (NCI) | Radionuclide Imaging | |||
SECONDARY ION MASS SPECTROMETRY | C154790 | An analytical technique in which a mass spectrometer is used to measure the atomic weight of sputtered ionized atoms (secondary ions) that are ejected from a solid surface after application of a beam of high energy primary ions. | Secondary Ion Mass Spectrometry | |||
SELF ASSESSMENT | C178029 | A technique in which one evaluates their own actions or performance. | Self Assessment | |||
SELF-REPORT | C74528 | An individual's perspective or subjective interpretation of an event or information. | Self-Report | |||
SEQUENCE SPECIFIC PRIMER POLYMERASE CHAIN REACTION | C130179 | PCR-SSP | A modified polymerase chain reaction (PCR) technique in which primer pair(s) are used to select a highly specific nucleotide sequence of interest, which will be the only sequence amplified. | Allele Specific Primer Polymerase Chain Reaction | ||
SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION | C130180 | SBT | A method that uses PCR amplification of specific nucleotides to produce templates and primers that are used to provide the entirety of the nucleotide sequence of a specific DNA strand, allowing for reliable and thorough genotyping of the allele in question. | Sequence-based Typing | ||
SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION | C130181 | PCR-SSOP | A modified polymerase chain reaction (PCR) technique that uses distinct probes, specifically synthesized according to the polymorphic region of the gene of interest, to detect nucleotide differences during genotype testing. | Sequence-specific Oligonucleotide Probe Polymerase Chain Reaction | ||
SEQUENCING | C116155 | A process to identify and determine the primary structure of, and the order of constituents in a biopolymer. Used when a more specific sequencing methodology is not specified. | Biopolymer Sequencing | |||
SESI-HRMS | C181462 | Secondary Electrospray Ionization High-resolution Mass Spectrometry | A method in which a nano-electrospray produces charging agents that collide with analyte molecules in gas-phase, creating an ionized vapor that is then analyzed via high resolution mass spectrometry. | Secondary Electrospray Ionization High-resolution Mass Spectrometry | ||
SICKLE CELL SOLUBILITY TEST | C166070 | A method of screening for sickle cell disease or trait in which sodium dithionite or a similar chemical is used to lyse red blood cells in a blood sample. This allows any hemoglobin S, which does not dissolve easily in plasma, to form crystals that visibly cloud the plasma. | Sickle Cell Solubility Test | |||
SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY | C130182 | A type of solid-phase multiplex assay that uses microbeads coated with a recombinant or purified antigen that will identify a single antibody. | Single Antigen Bead-based Multiplex Assay | |||
SINGLE-MOLECULE ARRAY | C161406 | SiMoA;Single Molecule Array Immunoassay | A type of enzyme-linked immunoassay in which single molecules can be detected through the use of femtomolar-sized reaction chambers and an excess of fluorescently labeled antibody-bound beads. | Single-Molecule Array | ||
SINGLE-SLICE SPIRAL CT | C106567 | Single-Slice Spiral Computed Tomography | A type of spiral computed tomography that employs only one detector and produces one image (slice). (NCI) | Single-slice Spiral Computed Tomography | ||
SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION | C130183 | PCR-SSCP | A modified polymerase chain reaction (PCR) technique followed by electrophoresis such that DNA molecular weights and three-dimensional structures are used to identify mutations. | Single-strand Conformation Polymerase Chain Reaction | ||
SISH | C142344 | Silver-Enhanced in Situ Hybridization | A type of in situ hybridization that uses a hybridization probe linked to an enzyme that elicits neutralization and deposition of silver onto the probe target site. | Silver-Enhanced in Situ Hybridization | ||
SIZE EXCLUSION CHROMATOGRAPHY | C16433 | Gel permeation or sieve chromatography that is performed on porous gels that separate solutes on the basis of size. | Gel Filtration Chromatography | |||
SLIT LAMP PHOTOGRAPHY | C158243 | Slit Lamp Biomicrography | A method of capturing images using a horizontally mounted microscope with an attached slit lamp. | Slit Lamp Photography | ||
SLIT LAMP | C75583 | Slit Lamp Biomicroscopy;Slit Lamp Examination | A method for examining the anterior segment of the eye using a slit lamp. | Slit-lamp Examination | ||
SLOAN LETTER EYE CHART 1.25% | C117880 | A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 1.25% contrast level. | Sloan Letter Eye Chart 1.25 Percent | |||
SLOAN LETTER EYE CHART 100% | C158246 | A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 100% contrast level. | Sloan Letter Eye Chart 100 Percent | |||
SLOAN LETTER EYE CHART 2.5% | C117881 | A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 2.5% contrast level. | Sloan Letter Eye Chart 2.5 Percent | |||
SMEAR | C65126 | The action of spreading a thin layer of material across a surface. | Smear | |||
SNELLEN EYE CHART | C123467 | A diagrammatic method to test visual acuity, which uses a chart containing 11 lines of Sloan optotypes in varying sizes with the largest located at the top of the chart and decreasing in size toward the bottom of the chart. | Snellen Eye Chart | |||
SNP ARRAY | C116151 | Genotype Chip;Single Nucleotide Polymorphism Array;SNP Genotyping;SNP Probe | A genomic microarray-based method able to detect single nucleotide polymorphisms. | Single Nucleotide Polymorphism Array | ||
SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY | C176329 | Cyanide-Free SLS Method;SLS Hemoglobin Detection Method | A hemoglobin estimation technique that utilizes sodium lauryl sulphate, a surfactant that lyses erythrocytes. The released hemoglobin converts to methemoglobin and forms a sodium lauryl sulphate-methemoglobin complex with a characteristic light absorbance spectrum, which is detected by photometry. | Sodium Lauryl Sulphate Method | ||
SPECT SCAN | C17203 | A type of tomography in which gamma photon-emitting radionuclides are administered to the patient and then detected by one or more gamma cameras rotated around the patient. From the series of two-dimensional images produced, a three-dimensional image can be created by computer reconstruction. | Single Photon Emission Computed Tomography | |||
SPECT/CT SCAN | C154791 | A dual-modality imaging technique that merges data from single-photon emission computed tomography (SPECT) and computed tomography (CT) to provide structural and functional information. | Single Photon Tomography and Computed Tomography Scan | |||
SPECTROPHOTOMETRY | C116701 | A technique used to calculate the transmittance of light through a material. | Spectrophotometry | |||
SPECULAR MICROSCOPY | C120542 | A noninvasive photographic technique used to visualize and examine the corneal endothelium, in which a source of light is projected onto the cornea and the subsequent image reflected from the optical interface between the corneal endothelium and the aqueous humor is captured. | Specular Microscopy | |||
SPIRAL CT SCAN WITHOUT CONTRAST | C172561 | A type of spiral CT scan in which the images are not enhanced by the addition of contrast agents into the body. | Spiral CT Scan Without Contrast | |||
SPIRAL CT | C20645 | Spiral Computed Tomography | A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. | Spiral CT | ||
SPIROMETRY | C85397 | A method used to measure the breathing capacity of the lung by means of a spirometer. | Spirometry | |||
STATIC PERIMETRY | C174334 | An eye examination technique that utilizes test objects with gradually increasing luminance that are positioned at fixed locations across the visual field to determine the threshold of visibility. | Static Perimetry | |||
STRESS ECHOCARDIOGRAPHY | C80407 | An echocardiographic technique in which an image of the heart is produced by ultrasonography under conditions (e.g., exercise, pharmacologic agents or pacing) intended to elicit signs and symptoms of myocardial ischemia. | Stress Echocardiography | |||
SURFACE PLASMON RESONANCE | C18117 | A quantum optical-electrical phenomena consisting of an alteration in light reflectance as a result of binding of molecules to a surface from which total internal reflection is occurring. | Surface Plasmon Resonance | |||
SUSCEPTIBILITY WEIGHTED MRI | C121377 | Susceptibility Weighted Imaging;SWI;SWI MRI;SWI-Phase | An MRI-based imaging technique that uses phase differences between tissues, due to differences in magnetic susceptibilities, to produce an enhanced contrast magnitude image. | Susceptibility Weighted Imaging | ||
SWEEP VISUAL EVOKED POTENTIAL | C191332 | Sweep VEP | A technique that measures an evoked potential caused by a visual stimulus and recorded by an electroencephalogram, and which is used for those individuals who are unable to provide a verbal response to questions, including infants, toddlers, and other non-verbal individuals. | Sweep Visual Evoked Potential | ||
SXA SCAN | C150874 | Single Energy X-Ray Absorptiometry | A technique for measuring anatomical densities in which a single X-ray beam, whose low and high energy is separated, is aimed at the anatomical location of interest and x-ray absorption is assessed. | Single Energy X-Ray Absorptiometry | ||
TARGETED GENOME SEQUENCING | C158253 | A DNA sequencing technique in which selected regions of an individual's genome are sequenced. | Targeted Genome Sequencing | |||
TARGETED TRANSCRIPTOME SEQUENCING | C158252 | Targeted RNA-Seq | An RNA sequencing technique in which selected RNA transcripts of an individual's genome are sequenced. | Targeted Transcriptome Sequencing | ||
TASK FUNCTIONAL MRI | C178023 | Task fMRI | A type of functional magnetic resonance imaging that images dynamic changes in brain tissue while the subject performs a task or experiences a sensory stimulus designed to target specific cognitive processes. | Task Functional Magnetic Resonance Imaging | ||
TELLER ACUITY CARDS | C142345 | A diagrammatic method to test visual acuity that uses a set of cards with parallel lines, used for those individuals who are unable to provide a verbal response to questions, including infants, toddlers, and other non verbal individuals. | Teller Acuity Cards | |||
TEMPLATE INCISION METHOD | C122174 | A method for assessing bleeding time in which two controlled incisions are made on the forearm using a template to guide placement of the scalpel or blade. | Template Incision Method | |||
TEST STRIP | C50322 | A piece of chemically treated medium designed to react in the presence of specific amounts of a trigger substance. | Test Strip Device | |||
THERMAL IONIZATION MASS SPECTROMETRY | C158244 | TIMS | A mass spectrometry method in which chemically purified samples are heated to create positively ionized atoms that are then accelerated by an electric field and mass separated by an electromagnet. | Thermal Ionization Mass Spectrometry | ||
THICK SMEAR | C85819 | A blood smear technique used to make a thick blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria. | Thick Smear Technique | |||
THIN SMEAR | C85820 | A blood smear technique used to make a thin blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria. | Thin Smear Technique | |||
TITRIMETRY | C181463 | A group of methods in which an analyte amount is determined based on its stoichiometric reaction with a reagent of established concentration that is introduced to a sample gradually until the analyte is consumed. (ScienceDirect) | Titrimetry | |||
TOLUIDINE BLUE STAIN | C92302 | A microscopy staining method that utilizes toluidine blue, a solution composed of tolonium chloride, to determine the presence of mast cells, lignin, proteoglycans and glycosaminoglycans. | Toluidine Blue Staining Method | |||
TONOMETRY | C120543 | A method in which pressure is applied to the surface of the cornea in order to flatten a prespecified area of the membrane. | Tonometry | |||
TOTAL BODY IRRADIATION | C15350 | TBI;Whole Body Irradiation | A procedure involving irradiation of the whole body. | Total-Body Irradiation | ||
TOTAL BODY RADIOGRAPHY | C96640 | A diagnostic radiologic test that involves the examination of the entire body in a single procedure. | Total Body Radiography | |||
TOURNIQUET TEST | C186195 | Hess;Rumpel-Leede | A method of assessing capillary fragility that is used in the diagnosis of hemorrhagic fevers. After taking a blood pressure measurement, the cuff is inflated to a point midway between the assessed systolic and diastolic pressures and maintained for five minutes; the cuff is then released and, after two minutes, the number of petechiae below the antecubital fossa are counted. | Tourniquet Test | ||
TOXIN NEUTRALIZATION ASSAY | C187900 | TNA | An in vitro assay to measure antibody in a biological specimen capable of protecting cells against the effect of a specific toxin. | Toxin Neutralization Assay | ||
TRANSABDOMINAL ULTRASOUND | C71375 | An ultrasound imaging technique in which the ultrasound probe is pressed against the skin of the abdomen in order to create an image of the abdominal organs. | Transabdominal Ultrasound | |||
TRANSCRIPTION-MEDIATED AMPLIFICATION | C122175 | A technique used to selectively replicate nucleic acid sequences from RNA templates using reverse transcriptase and RNA polymerase. | Transcription-mediated Amplification | |||
TRANSESOPHAGEAL ECHOCARDIOGRAPHY | C80405 | TEE | A cardiac ultrasound performed by passing a specialized probe containing a transducer into the patient's esophagus. | Transesophageal Echocardiography | ||
TRANSMISSION ELECTRON MICROSCOPY | C18216 | An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through the specimen. | Transmission Electron Microscopy | |||
TRANSTHORACIC ECHOCARDIOGRAPHY | C80404 | TTE | A non-invasive cardiac ultrasound performed by placing the transducer on the chest. | Transthoracic Echocardiography | ||
TRANSVAGINAL ULTRASOUND | C17644 | A technique in which sound waves are sent out by an ultrasound probe that has been inserted in the vagina and a computer uses the ultrasound echoes to create an image of the female reproductive organs. | Transvaginal Ultrasound | |||
TRICHROME STAIN | C23012 | A microscopy staining method that utilizes two or more colored, acidic dyes of contrasting colors. Masson trichrome is a mixture of three dyes including aniline blue, Beibrich scarlet and Weigert's iron hematoxylin. Other related, modified trichrome staining methods include Lillie's trichrome, Gomori's trichrome and Mallory's trichrome. | Trichrome Staining Method | |||
TRIPLE-PHASE MRI SCAN | C130184 | A type of magnetic resonance imaging (MRI) in which images are taken during three distinct timing points (phases) following the injection of contrast material: arterial, venous, and delayed. | Triple Phase MRI | |||
TRIPLE-PHASE SPIRAL CT SCAN | C19907 | Triple-Phase Spiral Computed Tomography | A type of computed tomography (CT) in which images are taken during three distinct timing points (phases) following the injection of contrast material: arterial, venous, and delayed. | Triple-Phase Spiral CT | ||
TRYPAN BLUE STAIN | C163743 | A microscopy staining method that utilizes trypan blue, an acid azo dye that can traverse the cell membrane of dead cells and is used to differentiate between living and dead cells. (NCI) | Trypan Blue Staining Method | |||
TURBIDIMETRY | C111328 | A method to quantify the opaqueness of a liquid using a turbidimeter, by measuring the decrease in light intensity due to the scattering effect of suspended particles in the liquid sample. | Turbidimetry | |||
TWO-COLOR MICROARRAY | C116153 | Dual-channel Microarray;Two-channel Expression Array;Two-channel Microarray;Two-color Microarray-based Gene Expression | A genomic microarray-based method using cDNA from two samples, labeled with two separate fluorophores/dyes at different emission wavelengths, and hybridized to a single microarray. The relative fluorescence intensity of each dye is being measured. | Two Color Microarray | ||
TYMPANOMETRY | C88505 | A technique that measures energy transmission through the middle ear using a tympanometer. | Tympanometry | |||
U-HPLC/MS/MS | C122176 | An analytical technique where ultra-high performance liquid chromatography is coupled to tandem mass spectrometry in order to separate, identify, and quantify substances in a sample. | Ultra High-performance Liquid Chromatography/Tandem Mass Spectrometry | |||
ULTRASONOGRAPHIC ELASTOGRAPHY | C172563 | A noninvasive technique that is used to measure organ or tissue stiffness. An ultrasound wave is passed into the organ or tissue from a small transducer on the end of an ultrasound probe which measures the velocity of the shear wave (in meters per second) as this wave passes through the organ or tissue. The shear wave velocity can then be converted into organ or tissue stiffness. This technique may be used as an alternative to organ or tissue biopsy. | Ultrasonographic Elastography | |||
ULTRASOUND | C17230 | A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer. | Ultrasound Imaging | |||
URANYL ACETATE STAIN | C92303 | A microscopy staining method that utilizes uranyl acetate, a water insoluble yellow crystalline solid, which is used as a negative stain in electron microscopy. | Uranyl Acetate Staining Method | |||
VAN DE KAMER TITRATION METHOD | C178025 | A chemical titration method described by van de Kamer, et al. in 1949 in which fecal fat is quantitatively measured by conversion of fecal lipids into fatty acids through saponification with ethanolic potassium hydroxide, release of the free fatty acids by the addition of hydrochloric acid and extraction into ether, and titration of the fatty acids against sodium hydroxide. (NCI) | Van de Kamer Titration Method | |||
VENTILATION PERFUSION LUNG SCAN | C38100 | VQ SCAN | A nuclear imaging test that uses radiopharmaceuticals to produce an image of the blood flow to the lungs. | Ventilation Perfusion Scanning | ||
VIRUS PLAQUE ASSAY | C174336 | An assay that is used to determine viral quantity by infecting monolayers of host cells with serially diluted virus, covering the monolayers with an immobilizing overlay after a period of incubation to restrict the spread of the virus to neighboring cells, and counting the resulting visible plaques of infected cells. | Virus Plaque Assay | |||
VISUAL ANALOG SCALE | C121547 | VAS | A psychometric response scale to assess subjective characteristics or symptoms, which relies upon a continuum of possible result values in between two fixed end-points. | Visual Analog Scale | ||
VISUAL REINFORCEMENT AUDIOMETRY | C198352 | Conditioned Visual Reinforcement Audiometry;VRA | A type of conditioned audiometry to detect sound, where a delayed visual presentation is used to support a child's reflexive orientation response to a audio signal from a single source. | Visual Reinforcement Audiometry | ||
WALLACE RULE OF NINES | C186196 | A method for estimating body surface area of second and third degree burns, based on assigned percentages for different regions of the body. | Wallace Rule of Nines | |||
WEBER GREEN STAIN | C85828 | A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. The staining method utilizes chromotrope 2R, a red acidic dye, the counterstain fast green, and phosphotungstic acid. | Weber Green Staining Method | |||
WEBER TEST METHOD | C191333 | A technique that assesses auditory function and/or type of hearing loss, in which a vibrating tuning fork (typically at 256Hz or 512Hz) is placed on top of the head or over the upper lip and the subject reporting whether sound is heard equally in both ears or whether the sound is louder in one ear. | Weber Test Method | |||
WESTERGREN | C154796 | A method that measures the sedimentation rate of an entity in an aqueous solution using a Westergren tube. | Westergren Tube Method | |||
WESTERN BLOT | C16357 | A method for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes. | Western Blotting | |||
WHOLE EXOME SEQUENCING | C101295 | WES | A DNA sequencing technique in which all of the exons of an individual's genome are sequenced. | Whole Exome Sequencing | ||
WHOLE GENOME SEQUENCING | C101294 | WGS | A DNA sequencing technique in which the entirety of the individual's genome is sequenced. | Whole Genome Sequencing | ||
WHOLE TRANSCRIPTOME SEQUENCING | C124261 | RNA-Seq;Whole Transcriptome Shotgun Sequencing;WTSS | An RNA sequencing technique in which all of the RNA transcripts of an individual's genome are sequenced. | Whole Transcriptome Sequencing | ||
WRIGHT STAIN | C85829 | A microscopy staining method that utilizes the Romanowsky stains, eosin and methylene blue, solubilized in methanol. In this staining protocol, methanol is also utilized as a fixative agent prior to staining. | Wright Staining Method | |||
WRIGHT-GIEMSA STAIN | C23041 | A microscopy staining method that is a combination of the Wright and Giemsa staining protocols and utilizes the Romanowsky stains, which are mixtures of eosin and thiazine dyes such as methylene blue. It produces darker blue and magenta shades than the giemsa stain alone, which may provide better contrast in microscopy. | Wright-Giemsa Staining Method | |||
X-RAY FLUORESCENCE SPECTROMETRY | C85830 | A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that each element emits fluorescent light of a particular wavelength when exposed to an X-ray. | X-Ray Fluorescence Spectrometry | |||
X-RAY WITHOUT CONTRAST | C191329 | A type of X-ray in which the images are not enhanced by the addition of contrast agents into the body. | X-Ray Without Contrast | |||
X-RAY | C38101 | Static X-Ray | A radiographic procedure using the emission of x-rays, a type of penetrating energy wave. | X-Ray Imaging | ||
ZIEHL NEELSEN ACID FAST STAIN | C85831 | A microscopy acid fast staining method that utilizes Ziehl-Neelsen carbol fuchsin, acid alcohol and methylene blue, to determine the presence of acid fast microorganisms. This acid fast staining technique requires heating during the primary staining step involving the carbol fuchsin. | Ziehl Neelsen Acid Fast Staining Method | |||
Back to top | ||||||
CL.C100152.MNSI1TC | Michigan Neuropathy Screening Instrument Questionnaire Test Code
(MNSI1TC) | text
Extensible: No | C100152 | Michigan Neuropathy Screening Instrument Questionnaire Test Code | Michigan Neuropathy Screening Instrument test code. | CDISC Questionnaire MNSI Test Code Terminology |
MNSI101 | C100587 | MNSI1-Are Your Legs and/or Feet Numb | Michigan Neuropathy Screening Instrument - History: Are your legs and/or feet numb? | MNSI - Legs and/or Feet Numb | ||
MNSI102 | C100588 | MNSI1-Ever Have Burning Pain Legs/Feet | Michigan Neuropathy Screening Instrument - History: Do you ever have any burning pain in your legs and/or feet? | MNSI - Burning Pain Legs/Feet | ||
MNSI103 | C100589 | MNSI1-Are Feet Too Sensitive to Touch | Michigan Neuropathy Screening Instrument - History: Are your feet too sensitive to touch? | MNSI - Feet Too Sensitive to Touch | ||
MNSI104 | C100590 | MNSI1-Get Muscle Cramps Legs/Feet | Michigan Neuropathy Screening Instrument - History: Do you get muscle cramps in your legs and/or feet? | MNSI - Muscle Cramps Legs/Feet | ||
MNSI105 | C100591 | MNSI1-Ever Prickling Feelings Legs/Feet | Michigan Neuropathy Screening Instrument - History: Do you ever have any prickling feelings in your legs or feet? | MNSI - Prickling Feelings Legs/Feet | ||
MNSI106 | C100592 | MNSI1-Hurt When Bed Covers Touch Skin | Michigan Neuropathy Screening Instrument - History: Does it hurt when the bed covers touch your skin? | MNSI - Hurt When Bed Covers Touch Skin | ||
MNSI107 | C100593 | MNSI1-Able to Tell Hot from Cold Water | Michigan Neuropathy Screening Instrument - History: When you get into the tub or shower, are you able to tell the hot water from the cold water? | MNSI - Able to Tell Hot from Cold Water | ||
MNSI108 | C100594 | MNSI1-Ever Had Open Sore on Foot | Michigan Neuropathy Screening Instrument - History: Have you ever had an open sore on your foot? | MNSI - Open Sore on Foot | ||
MNSI109 | C100595 | MNSI1-Doctor Says Diabetic Neuropathy | Michigan Neuropathy Screening Instrument - History: Has your doctor ever told you that you have diabetic neuropathy? | MNSI - Doctor Says Diabetic Neuropathy | ||
MNSI110 | C100596 | MNSI1-Feel Weak All Over Most Times | Michigan Neuropathy Screening Instrument - History: Do you feel weak all over most of the time? | MNSI - Feel Weak All Over Most Times | ||
MNSI111 | C100597 | MNSI1-Symptoms Worse at Night | Michigan Neuropathy Screening Instrument - History: Are your symptoms worse at night? | MNSI - Symptoms Worse at Night | ||
MNSI112 | C100598 | MNSI1-Legs Hurt When Walking | Michigan Neuropathy Screening Instrument - History: Do your legs hurt when you walk? | MNSI - Legs Hurt When Walking | ||
MNSI113 | C100599 | MNSI1-Able to Sense Feet When Walking | Michigan Neuropathy Screening Instrument - History: Are you able to sense your feet when you walk? | MNSI - Able to Sense Feet When Walking | ||
MNSI114 | C100600 | MNSI1-Skin So Dry That Feet Crack Open | Michigan Neuropathy Screening Instrument - History: Is the skin on your feet so dry that it cracks open? | MNSI - Skin So Dry That Feet Crack Open | ||
MNSI115 | C100601 | MNSI1-Ever Had Amputation | Michigan Neuropathy Screening Instrument - History: Have you ever had an amputation? | MNSI - Ever Had Amputation | ||
MNSI116 | C100602 | MNSI1-Total | Michigan Neuropathy Screening Instrument - History: Total. | MNSI - History Total | ||
MNSI117 | C100603 | MNSI1-Right Foot Appears Normal | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - normal. | MNSI - Right Foot Appears Normal | ||
MNSI118 | C100604 | MNSI1-Right Foot Deformities | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - deformities. | MNSI - Right Foot Deformities | ||
MNSI119 | C101019 | MNSI1-Right Foot Dry Skin, Callus | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - dry skin, callus. | MNSI - Right Foot Dry Skin, Callus | ||
MNSI120 | C100605 | MNSI1-Right Foot Infection | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - infection. | MNSI - Right Foot Infection | ||
MNSI121 | C100606 | MNSI1-Right Foot Fissure | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - fissure. | MNSI - Right Foot Fissure | ||
MNSI122 | C100607 | MNSI1-Right Foot Other Abnormal Specify | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - other, specify. | MNSI - Right Foot Other Abnormal Specify | ||
MNSI123 | C100608 | MNSI1-Left Foot Appears Normal | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - normal. | MNSI - Left Foot Appears Normal | ||
MNSI124 | C100609 | MNSI1-Left Foot Deformities | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - deformities. | MNSI - Left Foot Deformities | ||
MNSI125 | C101020 | MNSI1-Left Foot Dry Skin, Callus | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - dry skin, callus. | MNSI - Left Foot Dry Skin, Callus | ||
MNSI126 | C100610 | MNSI1-Left Foot Infection | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - infection. | MNSI - Left Foot Infection | ||
MNSI127 | C100611 | MNSI1-Left Foot Fissure | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - fissure. | MNSI - Left Foot Fissure | ||
MNSI128 | C100612 | MNSI1-Left Foot Other Abnormal Specify | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - other, specify. | MNSI - Left Foot Other Abnormal Specify | ||
MNSI129 | C100613 | MNSI1-Right Foot Ulceration | Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - ulceration. | MNSI - Right Foot Ulceration | ||
MNSI130 | C100614 | MNSI1-Left Foot Ulceration | Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - ulceration. | MNSI - Left Foot Ulceration | ||
MNSI131 | C100615 | MNSI1-Right Ankle Reflexes | Michigan Neuropathy Screening Instrument - Physical Assessment: Right ankle reflexes. | MNSI - Right Ankle Reflexes | ||
MNSI132 | C100616 | MNSI1-Left Ankle Reflexes | Michigan Neuropathy Screening Instrument - Physical Assessment: Left ankle reflexes. | MNSI - Left Ankle Reflexes | ||
MNSI133 | C100617 | MNSI1-Right Foot Vibration Great Toe | Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - vibration perception at great toe. | MNSI - Right Foot Vibration Great Toe | ||
MNSI134 | C100618 | MNSI1-Left Foot Vibration Great Toe | Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - vibration perception at great toe. | MNSI - Left Foot Vibration Great Toe | ||
MNSI135 | C100619 | MNSI1-Right Foot Monofilament | Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - monofilament. | MNSI - Right Foot Monofilament | ||
MNSI136 | C100620 | MNSI1-Left Foot Monofilament | Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - monofilament. | MNSI - Left Foot Monofilament | ||
MNSI137 | C100621 | MNSI1-Total Score | Michigan Neuropathy Screening Instrument - Physical Assessment: Total Score. | MNSI - Physical Assessment Total Score | ||
Back to top | ||||||
CL.C100151.MNSI1TN | Michigan Neuropathy Screening Instrument Questionnaire Test Name
(MNSI1TN) | text
Extensible: No | C100151 | Michigan Neuropathy Screening Instrument Questionnaire Test Name | Michigan Neuropathy Screening Instrument test name. | CDISC Questionnaire MNSI Test Name Terminology |
MNSI1-Able to Sense Feet When Walking | C100599 | MNSI1-Able to Sense Feet When Walking | Michigan Neuropathy Screening Instrument - History: Are you able to sense your feet when you walk? | MNSI - Able to Sense Feet When Walking | ||
MNSI1-Able to Tell Hot from Cold Water | C100593 | MNSI1-Able to Tell Hot from Cold Water | Michigan Neuropathy Screening Instrument - History: When you get into the tub or shower, are you able to tell the hot water from the cold water? | MNSI - Able to Tell Hot from Cold Water | ||
MNSI1-Are Feet Too Sensitive to Touch | C100589 | MNSI1-Are Feet Too Sensitive to Touch | Michigan Neuropathy Screening Instrument - History: Are your feet too sensitive to touch? | MNSI - Feet Too Sensitive to Touch | ||
MNSI1-Are Your Legs and/or Feet Numb | C100587 | MNSI1-Are Your Legs and/or Feet Numb | Michigan Neuropathy Screening Instrument - History: Are your legs and/or feet numb? | MNSI - Legs and/or Feet Numb | ||
MNSI1-Doctor Says Diabetic Neuropathy | C100595 | MNSI1-Doctor Says Diabetic Neuropathy | Michigan Neuropathy Screening Instrument - History: Has your doctor ever told you that you have diabetic neuropathy? | MNSI - Doctor Says Diabetic Neuropathy | ||
MNSI1-Ever Had Amputation | C100601 | MNSI1-Ever Had Amputation | Michigan Neuropathy Screening Instrument - History: Have you ever had an amputation? | MNSI - Ever Had Amputation | ||
MNSI1-Ever Had Open Sore on Foot | C100594 | MNSI1-Ever Had Open Sore on Foot | Michigan Neuropathy Screening Instrument - History: Have you ever had an open sore on your foot? | MNSI - Open Sore on Foot | ||
MNSI1-Ever Have Burning Pain Legs/Feet | C100588 | MNSI1-Ever Have Burning Pain Legs/Feet | Michigan Neuropathy Screening Instrument - History: Do you ever have any burning pain in your legs and/or feet? | MNSI - Burning Pain Legs/Feet | ||
MNSI1-Ever Prickling Feelings Legs/Feet | C100591 | MNSI1-Ever Prickling Feelings Legs/Feet | Michigan Neuropathy Screening Instrument - History: Do you ever have any prickling feelings in your legs or feet? | MNSI - Prickling Feelings Legs/Feet | ||
MNSI1-Feel Weak All Over Most Times | C100596 | MNSI1-Feel Weak All Over Most Times | Michigan Neuropathy Screening Instrument - History: Do you feel weak all over most of the time? | MNSI - Feel Weak All Over Most Times | ||
MNSI1-Get Muscle Cramps Legs/Feet | C100590 | MNSI1-Get Muscle Cramps Legs/Feet | Michigan Neuropathy Screening Instrument - History: Do you get muscle cramps in your legs and/or feet? | MNSI - Muscle Cramps Legs/Feet | ||
MNSI1-Hurt When Bed Covers Touch Skin | C100592 | MNSI1-Hurt When Bed Covers Touch Skin | Michigan Neuropathy Screening Instrument - History: Does it hurt when the bed covers touch your skin? | MNSI - Hurt When Bed Covers Touch Skin | ||
MNSI1-Left Ankle Reflexes | C100616 | MNSI1-Left Ankle Reflexes | Michigan Neuropathy Screening Instrument - Physical Assessment: Left ankle reflexes. | MNSI - Left Ankle Reflexes | ||
MNSI1-Left Foot Appears Normal | C100608 | MNSI1-Left Foot Appears Normal | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - normal. | MNSI - Left Foot Appears Normal | ||
MNSI1-Left Foot Deformities | C100609 | MNSI1-Left Foot Deformities | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - deformities. | MNSI - Left Foot Deformities | ||
MNSI1-Left Foot Dry Skin, Callus | C101020 | MNSI1-Left Foot Dry Skin, Callus | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - dry skin, callus. | MNSI - Left Foot Dry Skin, Callus | ||
MNSI1-Left Foot Fissure | C100611 | MNSI1-Left Foot Fissure | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - fissure. | MNSI - Left Foot Fissure | ||
MNSI1-Left Foot Infection | C100610 | MNSI1-Left Foot Infection | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - infection. | MNSI - Left Foot Infection | ||
MNSI1-Left Foot Monofilament | C100620 | MNSI1-Left Foot Monofilament | Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - monofilament. | MNSI - Left Foot Monofilament | ||
MNSI1-Left Foot Other Abnormal Specify | C100612 | MNSI1-Left Foot Other Abnormal Specify | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of left foot - other, specify. | MNSI - Left Foot Other Abnormal Specify | ||
MNSI1-Left Foot Ulceration | C100614 | MNSI1-Left Foot Ulceration | Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - ulceration. | MNSI - Left Foot Ulceration | ||
MNSI1-Left Foot Vibration Great Toe | C100618 | MNSI1-Left Foot Vibration Great Toe | Michigan Neuropathy Screening Instrument - Physical Assessment: Left foot - vibration perception at great toe. | MNSI - Left Foot Vibration Great Toe | ||
MNSI1-Legs Hurt When Walking | C100598 | MNSI1-Legs Hurt When Walking | Michigan Neuropathy Screening Instrument - History: Do your legs hurt when you walk? | MNSI - Legs Hurt When Walking | ||
MNSI1-Right Ankle Reflexes | C100615 | MNSI1-Right Ankle Reflexes | Michigan Neuropathy Screening Instrument - Physical Assessment: Right ankle reflexes. | MNSI - Right Ankle Reflexes | ||
MNSI1-Right Foot Appears Normal | C100603 | MNSI1-Right Foot Appears Normal | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - normal. | MNSI - Right Foot Appears Normal | ||
MNSI1-Right Foot Deformities | C100604 | MNSI1-Right Foot Deformities | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - deformities. | MNSI - Right Foot Deformities | ||
MNSI1-Right Foot Dry Skin, Callus | C101019 | MNSI1-Right Foot Dry Skin, Callus | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - dry skin, callus. | MNSI - Right Foot Dry Skin, Callus | ||
MNSI1-Right Foot Fissure | C100606 | MNSI1-Right Foot Fissure | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - fissure. | MNSI - Right Foot Fissure | ||
MNSI1-Right Foot Infection | C100605 | MNSI1-Right Foot Infection | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - infection. | MNSI - Right Foot Infection | ||
MNSI1-Right Foot Monofilament | C100619 | MNSI1-Right Foot Monofilament | Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - monofilament. | MNSI - Right Foot Monofilament | ||
MNSI1-Right Foot Other Abnormal Specify | C100607 | MNSI1-Right Foot Other Abnormal Specify | Michigan Neuropathy Screening Instrument - Physical Assessment: Appearance of right foot - other, specify. | MNSI - Right Foot Other Abnormal Specify | ||
MNSI1-Right Foot Ulceration | C100613 | MNSI1-Right Foot Ulceration | Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - ulceration. | MNSI - Right Foot Ulceration | ||
MNSI1-Right Foot Vibration Great Toe | C100617 | MNSI1-Right Foot Vibration Great Toe | Michigan Neuropathy Screening Instrument - Physical Assessment: Right foot - vibration perception at great toe. | MNSI - Right Foot Vibration Great Toe | ||
MNSI1-Skin So Dry That Feet Crack Open | C100600 | MNSI1-Skin So Dry That Feet Crack Open | Michigan Neuropathy Screening Instrument - History: Is the skin on your feet so dry that it cracks open? | MNSI - Skin So Dry That Feet Crack Open | ||
MNSI1-Symptoms Worse at Night | C100597 | MNSI1-Symptoms Worse at Night | Michigan Neuropathy Screening Instrument - History: Are your symptoms worse at night? | MNSI - Symptoms Worse at Night | ||
MNSI1-Total Score | C100621 | MNSI1-Total Score | Michigan Neuropathy Screening Instrument - Physical Assessment: Total Score. | MNSI - Physical Assessment Total Score | ||
MNSI1-Total | C100602 | MNSI1-Total | Michigan Neuropathy Screening Instrument - History: Total. | MNSI - History Total | ||
Back to top | ||||||
CL.C102581.MCIDCERT | Microbial Identification Certainty
(MCIDCERT) | text
Extensible: No | C102581 | Microbial Identification Certainty | Terminology relevant to the degree of certainty of the correctness of a microbial identification test result. | CDISC SDTM Microbial Identification Certainty Terminology |
DEFINITIVE | C62607 | Supplying or being a final or conclusive settlement or result. | Definitive | |||
PRESUMPTIVE | C102697 | Supplying or being a probable or reasonable settlement or result. | Presumptive | |||
Back to top | ||||||
CL.C174225.MBFTSDTL | Microbiology Findings Test Details
(MBFTSDTL) | text
Extensible: Yes | C174225 | Microbiology Findings Test Details | Terminology relevant to the additional descriptions of the test being performed to produce the microbiology finding. | CDISC SDTM Microbiology Findings Test Details Terminology |
CELL COUNT | C174332 | A measurement of the total cells of a pre-specified type in a specimen. | Specified Cell Count Test | |||
COLONY COUNT | C174333 | A measurement of the total number of microbial colonies of a pre-specified microorganism in a specimen. | Specified Colony Count Test | |||
DETECTION | C174330 | The determination of presence or absence of an entity in a specimen. | Biological Detection Test | |||
QUANTIFICATION CYCLE NUMBER | C161328 | Cp Number;Crossing point Number;Ct;Ct Number;Cycle Threshold;Cycle Threshold #;Cycle Threshold Number;Elbow Value;Take-off Point Number;Threshold Cycle;Threshold Cycle Number;TOP Number | The cycle number where the fluorescence of the target is detected above the background signal or a pre-set threshold. This value may be used for the computation of the concentration of a target in a polymerase chain reaction (PCR). | Threshold Cycle | ||
QUANTIFICATION | C48937 | The determination of the quantity of a pre-specified analyte in a specimen. | Quantitation | |||
VIRAL LOAD | C174331 | A measurement of the total number of viral particles of a pre-specified virus in a specimen. | Specified Viral Load Test | |||
Back to top | ||||||
CL.C128688.MSTESTCD | Microbiology Susceptibility Test Code
(MSTESTCD) | text
Extensible: Yes | C128688 | Microbiology Susceptibility Test Code | Terminology relevant to the test codes that define microorganism responses to antimicrobial agents. | CDISC SDTM Microbiology Susceptibility Test Code Terminology |
DIAZOINH | C147471 | Diameter of the Kill Zone;Diameter of the Zone of Inhibition | A measurement of the diameter of the circular region of bacteria growth inhibition that surrounds an antibiotic source on the surface of a cultured plate. | Antibiotic Susceptibility Zone Diameter | ||
FLMUTIND | C158255 | Flagged Mutations Present Indicator | An indication as to whether the pre-specified mutations of interest are present in the subject. | Flagged Mutations Present Indicator | ||
ICNETAS | C116255 | Inhibitory Concentration Net Assessment | An indication of reduced or increased susceptibility of a microbial organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug. | Inhibitory Concentration Net Assessment Measurement | ||
MEC50FCB | C139114 | Microbial EC50 Fold Change from Baseline | A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition of population growth or replication of a microbial organism. (NCI) | Microbial EC50 Fold Change from Baseline | ||
MEC50FCR | C139115 | Microbial EC50 Fold Change from Ref;Microbial EC50 Fold Change from Reference | A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. It is a ratio calculated by the EC50 Subject Result divided by the EC50 Reference Control Result. (NCI) | Microbial EC50 Fold Change from Reference | ||
MEC50R | C139116 | Microbial EC50 Reference Control Result | A reference control sample response based on the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. (NCI) | Microbial EC50 Reference Control Result | ||
MEC50S | C139117 | Microbial EC50 Subject Result | A measurement of titer of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. (NCI) | Microbial EC50 Subject Result | ||
MIC | C128985 | Minimum Inhibitory Concentration | A measurement that specifies the minimum concentration of the agent at which organism growth was inhibited. | Minimum Inhibitory Concentration Test | ||
MIC50FCB | C139118 | Microbial IC50 Fold Change from Baseline | A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the current IC50 Subject Result divided by the IC50 Subject Result from the baseline visit. | Microbial IC50 Fold Change from Baseline | ||
MIC50FCR | C139119 | Microbial IC50 Fold Change from Ref;Microbial IC50 Fold Change from Reference | A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the IC50 Subject Result divided by the IC50 Reference Control Result. | Microbial IC50 Fold Change from Reference | ||
MIC50R | C139120 | Microbial IC50 Reference Control Result | A reference control sample response based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. | Microbial IC50 Reference Control Result | ||
MIC50S | C139121 | Microbial IC50 Subject Result | A measurement of biological/biochemical reaction of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. | Microbial IC50 Subject Result | ||
MIC95FCB | C139122 | IC95 Fold Change from Baseline;Microbial IC95 Fold Change from Baseline | A fold change based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the current IC95 Subject Result divided by the IC95 Subject Result from the baseline visit. | Microbial IC95 Fold Change from Baseline | ||
MIC95FCR | C139123 | IC95 Fold Change from Reference;Microbial IC95 Fold Change from Ref | A fold change based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the IC95 Subject Result divided by the IC95 Reference Control Result. | Microbial IC95 Fold Change from Ref | ||
MIC95R | C139124 | IC95 Reference Control Result;Microbial IC95 Reference Control Result | A reference control sample response based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. | Microbial IC95 Reference Control Result | ||
MIC95S | C139125 | IC95 Subject Result;Microbial IC95 Subject Result | A measurement of biological/biochemical reaction of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. | Microbial IC95 Subject Result | ||
MICROSUS | C85540 | Microbial Susceptibility | A phenotypic or genotypic assessment of the response of the microbial organism to an antimicrobial agent. | Microbial Susceptibility Test | ||
SUSMUIND | C156550 | Susceptibility Score Mutations Indicator | An indication as to whether one or more scored mutations of interest that may confer susceptibility in the microorganism is present. | Susceptibility Score Mutations Indicator | ||
Back to top | ||||||
CL.C128687.MSTEST | Microbiology Susceptibility Test Name
(MSTEST) | text
Extensible: Yes | C128687 | Microbiology Susceptibility Test Name | Terminology relevant to the test names that define microorganism responses to antimicrobial agents. | CDISC SDTM Microbiology Susceptibility Test Name Terminology |
Diameter of the Zone of Inhibition | C147471 | Diameter of the Kill Zone;Diameter of the Zone of Inhibition | A measurement of the diameter of the circular region of bacteria growth inhibition that surrounds an antibiotic source on the surface of a cultured plate. | Antibiotic Susceptibility Zone Diameter | ||
Flagged Mutations Present Indicator | C158255 | Flagged Mutations Present Indicator | An indication as to whether the pre-specified mutations of interest are present in the subject. | Flagged Mutations Present Indicator | ||
Inhibitory Concentration Net Assessment | C116255 | Inhibitory Concentration Net Assessment | An indication of reduced or increased susceptibility of a microbial organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug. | Inhibitory Concentration Net Assessment Measurement | ||
Microbial EC50 Fold Change from Baseline | C139114 | Microbial EC50 Fold Change from Baseline | A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition of population growth or replication of a microbial organism. (NCI) | Microbial EC50 Fold Change from Baseline | ||
Microbial EC50 Fold Change from Ref | C139115 | Microbial EC50 Fold Change from Ref;Microbial EC50 Fold Change from Reference | A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. It is a ratio calculated by the EC50 Subject Result divided by the EC50 Reference Control Result. (NCI) | Microbial EC50 Fold Change from Reference | ||
Microbial EC50 Reference Control Result | C139116 | Microbial EC50 Reference Control Result | A reference control sample response based on the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. (NCI) | Microbial EC50 Reference Control Result | ||
Microbial EC50 Subject Result | C139117 | Microbial EC50 Subject Result | A measurement of titer of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 50 percent inhibition of the population growth or replication of a microbial organism. (NCI) | Microbial EC50 Subject Result | ||
Microbial IC50 Fold Change from Baseline | C139118 | Microbial IC50 Fold Change from Baseline | A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the current IC50 Subject Result divided by the IC50 Subject Result from the baseline visit. | Microbial IC50 Fold Change from Baseline | ||
Microbial IC50 Fold Change from Ref | C139119 | Microbial IC50 Fold Change from Ref;Microbial IC50 Fold Change from Reference | A fold change based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the IC50 Subject Result divided by the IC50 Reference Control Result. | Microbial IC50 Fold Change from Reference | ||
Microbial IC50 Reference Control Result | C139120 | Microbial IC50 Reference Control Result | A reference control sample response based on the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. | Microbial IC50 Reference Control Result | ||
Microbial IC50 Subject Result | C139121 | Microbial IC50 Subject Result | A measurement of biological/biochemical reaction of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 50 percent inhibition on the enzymatic activity of a microbial organism. | Microbial IC50 Subject Result | ||
Microbial IC95 Fold Change from Baseline | C139122 | IC95 Fold Change from Baseline;Microbial IC95 Fold Change from Baseline | A fold change based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the current IC95 Subject Result divided by the IC95 Subject Result from the baseline visit. | Microbial IC95 Fold Change from Baseline | ||
Microbial IC95 Fold Change from Ref | C139123 | IC95 Fold Change from Reference;Microbial IC95 Fold Change from Ref | A fold change based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. It is a ratio calculated by the IC95 Subject Result divided by the IC95 Reference Control Result. | Microbial IC95 Fold Change from Ref | ||
Microbial IC95 Reference Control Result | C139124 | IC95 Reference Control Result;Microbial IC95 Reference Control Result | A reference control sample response based on the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. | Microbial IC95 Reference Control Result | ||
Microbial IC95 Subject Result | C139125 | IC95 Subject Result;Microbial IC95 Subject Result | A measurement of biological/biochemical reaction of a microbial organism that has been exposed to the concentration of a specific drug expected to produce 95 percent inhibition on the enzymatic activity of a microbial organism. | Microbial IC95 Subject Result | ||
Microbial Susceptibility | C85540 | Microbial Susceptibility | A phenotypic or genotypic assessment of the response of the microbial organism to an antimicrobial agent. | Microbial Susceptibility Test | ||
Minimum Inhibitory Concentration | C128985 | Minimum Inhibitory Concentration | A measurement that specifies the minimum concentration of the agent at which organism growth was inhibited. | Minimum Inhibitory Concentration Test | ||
Susceptibility Score Mutations Indicator | C156550 | Susceptibility Score Mutations Indicator | An indication as to whether one or more scored mutations of interest that may confer susceptibility in the microorganism is present. | Susceptibility Score Mutations Indicator | ||
Back to top | ||||||
CL.C85495.MSRESCAT | Microbiology Susceptibility Testing Result Category
(MSRESCAT) | text
Extensible: No | C85495 | Microbiology Susceptibility Testing Result Category | Used to categorize the result of a finding in a standard format. | CDISC SDTM Microbiology Susceptibility Testing Result Category Terminology |
INDETERMINATE | C48658 | Inconclusive | Cannot distinguish between two or more possible values in the current context. (NCI) | Indeterminate | ||
INTERMEDIATE | C85560 | Intermediate | The growth of microorganisms may be inhibited by antimicrobials that approach usually attainable blood and tissue concentrations. The response rates may be lower than for susceptible isolates. This category also includes a buffer zone, which should prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations, especially for drugs with narrow pharmacotoxicity margins. | Antimicrobial Intermediate Susceptibility Result | ||
NONSUSCEPTIBLE | C85561 | Non Susceptible | A category used for microorganisms that have only a susceptible interpretive category, but not an intermediate or resistant interpretive category (i.e., susceptible-only interpretive category). This category may be applied to new antimicrobial agents for which no resistant microorganisms have been encountered at the time the initial interpretive criteria are determined. Microorganisms that test with an MIC above or a zone measurement below the susceptible interpretive criteria are designated as nonsusceptible. A designation of nonsusceptible does not necessarily mean that a resistance mechanism(s) exists in the microorganism. | Antimicrobial Nonsusceptibility Result | ||
NOT APPLICABLE | C48660 | NA;Not Applicable | Determination of a value is not relevant in the current context. (NCI) | Not Applicable | ||
NOT SUSCEPTIBLE | C186207 | The growth of the microorganism is intermediate or resistant to an antimicrobial. This category is used when describing isolates that are above the susceptible interpretive category breakpoint as defined by a standards organization, and, when the "intermediate" breakpoint and the "resistant" breakpoint are defined but not applied; or when "intermediate" and "resistant" interpretive categories are merged/combined. | Antimicrobial Not Susceptible Result | |||
RESISTANT | C85562 | Resistant | The growth of microorganisms are not inhibited by the usually achievable concentrations of the antimicrobial agent with normal dosages, and/or microorganisms demonstrate MICs or zone diameters that fall in the range where specific microbial resistance mechanisms (e.g. Beta-lactamases) are likely, and clinical efficacy of the agent against the microorganism has not been reliably shown in treatment studies. | Antimicrobial Resistance Result | ||
SUSCEPTIBLE | C85563 | Susceptible | The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection. | Antimicrobial Susceptibility Result | ||
SUSCEPTIBLE-DOSE DEPENDENT | C85559 | Susceptible-Dose Dependent | The growth of microorganisms may be inhibited when higher than normal dosages of an antimicrobial agent are used and maximal possible blood concentration of the antimicrobial agent is achieved. | Antimicrobial Dose Dependent Susceptibility Result | ||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C120527.MBTESTCD | Microbiology Test Code
(MBTESTCD) | text
Extensible: Yes | C120527 | Microbiology Test Code | Terminology relevant to the microbiology test codes of the CDISC Study Data Tabulation Model. | CDISC SDTM Microbiology Test Code Terminology |
ACBCM | C191309 | A. calcoaceticus-baumannii Complex;Acinetobacter calcoaceticus-baumannii Complex | A measurement of the Acinetobacter calcoaceticus-baumannii complex in a biological specimen. | Acinetobacter calcoaceticus/baumannii Complex Measurement | ||
ACBCMDNA | C191308 | A. calcoaceticus-baumannii Complex DNA;Acinetobacter calcoaceticus-baumannii Complex DNA | A measurement of Acinetobacter Calcoaceticus-Baumannii complex DNA in a biological specimen. | Acinetobacter calcoaceticus/baumannii Complex DNA Measurement | ||
ACINETOB | C179755 | Acinetobacter | A measurement of the organisms that are not assigned to the species level but are assigned to the Acinetobacter genus level in a biological specimen. | Acinetobacter Measurement | ||
ADENOVAB | C111125 | Adenovirus Antibody | A measurement of the adenovirus antibody in a biological specimen. | Adenovirus Antibody Measurement | ||
ADENOVAG | C154830 | Adenovirus Antigen | A measurement of the Adenovirus antigen in a biological specimen. | Adenovirus Antigen Measurement | ||
ADENOVIR | C171498 | Adenoviridae;Adenovirus | A measurement of the adenoviridae in a biological specimen. | Adenoviridae Measurement | ||
ADVIGGAB | C163529 | Adenovirus IgG Antibody | A measurement of the adenovirus IgG antibody in a biological specimen. | Adenovirus IgG Antibody Measurement | ||
ADVIGMAB | C163530 | Adenovirus IgM Antibody | A measurement of the adenovirus IgM antibody in a biological specimen. | Adenovirus IgM Antibody Measurement | ||
ADVNDNA | C191310 | Adenovirus DNA | A measurement of the DNA from any member of the family Adenoviridae in a biological specimen. | Adenovirus DNA Measurement | ||
ADVNUAC | C187838 | Adenovirus Nucleic Acid | A measurement of the nucleic acid from any member of the family Adenoviridae in a biological specimen. | Adenovirus Nucleic Acid Measurement | ||
AERBACT | C198301 | Aerobic Bacteria | A measurement of the aerobic bacteria in a biological specimen. | Aerobic Bacteria Measurement | ||
AFB | C128981 | Acid-Fast Bacilli | A measurement of any rod-shaped bacteria that resist decolorizing by acid after accepting an aqueous stain solution, due to the mycolic acids in their cell walls. | Acid-Fast Bacilli Measurement | ||
AFU | C187840 | Aspergillus fumigatus | A measurement of the Aspergillus fumigatus in a biological specimen. | Aspergillus fumigatus Measurement | ||
ANAPDNA | C187839 | Anaplasma DNA | A measurement of the DNA from any member of the genus Anaplasma in a biological specimen. | Anaplasma DNA Measurement | ||
ANAPLASM | C187668 | Anaplasma | A measurement of the organisms that are not assigned to the species level but are assigned to the Anaplasma genus level in a biological specimen. | Anaplasma Measurement | ||
ANARBACT | C198302 | Anaerobic Bacteria | A measurement of the anaerobic bacteria in a biological specimen. | Anaerobic Bacteria Measurement | ||
ANI | C187841 | Aspergillus niger | A measurement of the Aspergillus niger in a biological specimen. | Aspergillus niger Measurement | ||
ASCAB | C81976 | Anti-Saccharomyces cerevisiae Antibody;Baker's Yeast Antibody | A measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen. | Anti-Saccharomyces cerevisiae Antibody Measurement | ||
ASPAB | C166028 | Aspergillus Antibody | A measurement of the antibody to any member of the genus Aspergillus in a biological specimen. | Aspergillus Antibody Measurement | ||
ASPAG | C189540 | Aspergillus Antigen | A measurement of the antigen from any member of the genus Aspergillus in a biological specimen. | Aspergillus Antigen Measurement | ||
ASPDNA | C198303 | Aspergillus DNA | A measurement of the DNA from any member of the genus Aspergillus in a biological specimen. | Aspergillus DNA Measurement | ||
ASPERGIL | C172528 | Aspergillus | A measurement of the organisms that are not assigned to the species level but are assigned to the Aspergillus genus level in a biological specimen. | Aspergillus Measurement | ||
AXY | C172529 | Achromobacter xylosoxidans | A measurement of the Achromobacter xylosoxidans in a biological specimen. | Achromobacter xylosoxidans Measurement | ||
B19V | C156542 | Human Parvovirus B19 | A measurement of the Human Parvovirus B19 in a biological specimen. | Human Parvovirus B19 Measurement | ||
B19VDNA | C187856 | Human Parvovirus B19 DNA | A measurement of the Human Parvovirus B19 DNA in a biological specimen. | Human Parvovirus B19 DNA Measurement | ||
BABEDNA | C187842 | Babesia DNA | A measurement of the DNA from any member of the genus Babesia in a biological specimen. | Babesia DNA Measurement | ||
BACBLACT | C161400 | Bacterial Beta-lactamase | A measurement of the bacterial enzyme beta-lactamase in a biological specimen. | Bacterial Beta-lactamase Measurement | ||
BACILLE | C198304 | Bacilli/Leukocytes | A relative measurement (ratio or percentage) of the bacilli to leukocytes in a biological specimen. | Bacillus to Leukocyte Ratio Measurement | ||
BACILLI | C198305 | Bacilli;Rod-shaped Bacteria | A measurement of the rod-shaped bacilli in a biological specimen. | Bacillus Measurement | ||
BACLPSAG | C189546 | Bacterial Lipopolysaccharide Antigen | A measurement of the lipopolysaccharide antigen from bacteria in a biological specimen. | Bacterial Lipopolysaccharide Antigen Measurement | ||
BACT | C64469 | Bacteria | A measurement of the bacteria in a biological specimen. | Bacterial Count | ||
BAM | C172535 | Burkholderia ambifaria | A measurement of the Burkholderia ambifaria in a biological specimen. | Burkholderia ambifaria Measurement | ||
BAN | C172536 | Burkholderia anthina | A measurement of the Burkholderia anthina in a biological specimen. | Burkholderia anthina Measurement | ||
BBIGGMAB | C147310 | B. burgdorferi IgG and IgM Antibody;Borrelia burgdorferi IgG and IgM Antibody | A measurement of the Borrelia burgdorferi IgG and IgM antibodies in a biological specimen. | Borrelia burgdorferi IgG and IgM Antibody Measurement | ||
BBRAB | C122098 | Borrelia burgdorferi Antibody;Lyme Antibody | A measurement of the total Borrelia burgdorferi antibody in a biological specimen. | Borrelia Burgdorferi Antibody Measurement | ||
BBRIGAAB | C122099 | Borrelia burgdorferi IgA Antibody;Lyme IgA Antibody | A measurement of the Borrelia burgdorferi IgA antibody in a biological specimen. | Borrelia Burgdorferi IgA Antibody Measurement | ||
BBRIGGAB | C122100 | Borrelia burgdorferi IgG Antibody;Lyme IgG Antibody | A measurement of the Borrelia burgdorferi IgG antibody in a biological specimen. | Borrelia Burgdorferi IgG Antibody Measurement | ||
BBRIGMAB | C122101 | Borrelia burgdorferi IgM Antibody;Lyme IgM Antibody | A measurement of the Borrelia burgdorferi IgM antibody in a biological specimen. | Borrelia Burgdorferi IgM Antibody Measurement | ||
BCE | C172531 | Burkholderia cenocepacia | A measurement of the Burkholderia cenocepacia in a biological specimen. | Burkholderia cenocepacia Measurement | ||
BCEPACIA | C147456 | B. cepacia;Burkholderia cepacia;Pseudomonas cepacia | A measurement of the Burkholderia cepacia in a biological specimen. | Burkholderia cepacia Measurement | ||
BCTSILDS | C154820 | Bacterial Sialidase | A measurement of the bacterial sialidase enzyme in a biological specimen. | Bacterial Sialidase Measurement | ||
BDO | C172534 | Burkholderia dolosa | A measurement of the Burkholderia dolosa in a biological specimen. | Burkholderia dolosa Measurement | ||
BHODNA | C186145 | Blastocystis hominis DNA | A measurement of the Blastocystis hominis DNA in a biological specimen. | Blastocystis hominis DNA Measurement | ||
BLNBAC | C160937 | Beta-lactamase Negative Bacteria | A measurement of the beta-lactamase negative bacteria in a biological specimen. | Beta-lactamase Negative Bacteria Measurement | ||
BLPBAC | C160936 | Beta-lactamase Positive Bacteria | A measurement of the beta-lactamase positive bacteria in a biological specimen. | Beta-lactamase Positive Bacteria Measurement | ||
BMU | C172530 | Burkholderia multivorans | A measurement of the Burkholderia multivorans in a biological specimen. | Burkholderia multivorans Measurement | ||
BORRDNA | C187843 | Borrelia DNA | A measurement of the DNA from any member of the genus Borrelia in a biological specimen. | Borrelia DNA Measurement | ||
BPA | C178015 | Bordetella parapertussis | A measurement of the Bordetella parapertussis in a biological specimen. | Bordetella Parapertussis Measurement | ||
BPADNA | C186146 | Bordetella parapertussis DNA | A measurement of the Bordetella parapertussis DNA in a biological specimen. | Bordetella Parapertussis DNA Measurement | ||
BPE | C179756 | Bordetella pertussis | A measurement of the Bordetella pertussis in a biological specimen. | Bordetella pertussis Measurement | ||
BPEAG | C154832 | Bordetella pertussis Antigen | A measurement of the Bordetella pertussis antigen in a biological specimen. | Bordetella pertussis Antigen Measurement | ||
BPEDNA | C184667 | Bordetella pertussis DNA | A measurement of the Bordetella pertussis DNA in a biological specimen. | Bordetella pertussis DNA Measurement | ||
BPEF23AB | C163531 | Bordetella pertussis Serotype Fim 2/3 AB;Bordetella pertussis Serotype Fimbriae 2/3 Antibody | A measurement of the Bordetella pertussis serotypes fimbriae 2 and/or fimbriae 3 antibody in a biological specimen. | Bordetella pertussis Serotype Fimbrae 2/3 Antibody Measurement | ||
BPEFHAAB | C163532 | B. pertussis Filament Haemagglutinin AB;Bordetella pertussis FHA Antibody;Bordetella pertussis Filamentous Haemagglutinin Antibody | A measurement of the Bordetella pertussis filamentous haemagglutinin antibody in a biological specimen. | Bordetella pertussis Filament Haemagglutinin Antibody Measurement | ||
BPEPRNAB | C163533 | Bordetella pertussis Pertactin Antibody;Bordetella pertussis PRN Antibody | A measurement of the Bordetella pertussis pertactin antibody in a biological specimen. | Bordetella pertussis Pertactin Antibody Measurement | ||
BPETXNAB | C163534 | Bordetella pertussis Toxin Antibody | A measurement of the Bordetella pertussis toxin antibody in a biological specimen. | Bordetella pertussis Toxin Antibody Measurement | ||
BPY | C172537 | Burkholderia pyrrocinia | A measurement of the Burkholderia pyrrocinia in a biological specimen. | Burkholderia pyrrocinia Measurement | ||
BST | C172532 | Burkholderia stabilis | A measurement of the Burkholderia stabilis in a biological specimen. | Burkholderia stabilis Measurement | ||
BURKHOLD | C139113 | Burkholderia | A measurement of the organisms that are not assigned to the species level but are assigned to the Burkholderia genus level in a biological specimen. | Burkholderia Measurement | ||
BVI | C172533 | Burkholderia vietnamiensis | A measurement of the Burkholderia vietnamiensis in a biological specimen. | Burkholderia vietnamiensis Measurement | ||
C130096 | C130096 | Mucor racemosus IgE Antibody | A measurement of the Mucor racemosus IgE antibody in a biological specimen. | Mucor racemosus IgE Measurement | ||
C130097 | C130097 | Mucor racemosus IgA Antibody | A measurement of the Mucor racemosus IgA antibody in a biological specimen. | Mucor racemosus IgA Measurement | ||
C130098 | C130098 | Mucor racemosus IgG Antibody | A measurement of the Mucor racemosus IgG antibody in a biological specimen. | Mucor racemosus IgG Measurement | ||
C130099 | C130099 | Mucor racemosus IgG4 Antibody | A measurement of the Mucor racemosus IgG4 antibody in a biological specimen | Mucor racemosus IgG4 Measurement | ||
C130144 | C130144 | Aspergillus fumigatus IgE Antibody | A measurement of the Aspergillus fumigatus IgE antibody in a biological specimen. | Aspergillus fumigatus Antigen IgE Antibody Measurement | ||
C130145 | C130145 | Aspergillus fumigatus IgG Antibody | A measurement of the Aspergillus fumigatus IgG antibody in a biological specimen. | Aspergillus fumigatus Antigen IgG Antibody Measurement | ||
C130146 | C130146 | Penicillium chrysogenum IgE Antibody;Penicillium notatum IgE Antibody | A measurement of the Penicillium notatum IgE antibody in a biological specimen. | Penicillium notatum Antigen IgE Antibody Measurement | ||
C130147 | C130147 | Penicillium chrysogenum IgA Antibody;Penicillium notatum IgA Antibody | A measurement of the Penicillium notatum IgA antibody in a biological specimen. | Penicillium notatum Antigen IgA Antibody Measurement | ||
C130148 | C130148 | Penicillium chrysogenum IgG Antibody;Penicillium notatum IgG Antibody | A measurement of the Penicillium notatum IgG antibody in a biological specimen. | Penicillium notatum Antigen IgG Antibody Measurement | ||
C130149 | C130149 | Penicillium chrysogenum IgG4 Antibody;Penicillium notatum IgG4 Antibody | A measurement of the Penicillium notatum IgG4 antibody in a biological specimen. | Penicillium notatum Antigen IgG4 Antibody Measurement | ||
C130150 | C130150 | Alternaria alternata IgE Antibody;Alternaria tenuis IgE Antibody | A measurement of the Alternaria alternata IgE antibody in a biological specimen. | Alternaria tenuis alternata Antigen IgE Antibody Measurement | ||
C130151 | C130151 | Alternaria alternata IgA Antibody;Alternaria tenuis IgA Antibody | A measurement of the Alternaria alternata IgA antibody in a biological specimen. | Alternaria tenuis alternata Antigen IgA Antibody Measurement | ||
C130152 | C130152 | Alternaria alternata IgG Antibody;Alternaria tenuis IgG Antibody | A measurement of the Alternaria alternata IgG antibody in a biological specimen. | Alternaria tenuis alternata Antigen IgG Antibody Measurement | ||
C130153 | C130153 | Alternaria alternata IgG4 Antibody;Alternaria tenuis IgG4 Antibody | A measurement of the Alternaria alternata IgG4 antibody in a biological specimen. | Alternaria tenuis alternata Antigen IgG4 Antibody Measurement | ||
C142249 | C142249 | S. pneumonia Sero 1 IgG AB;Streptococcus pneumoniae Serotype 1 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 1 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 1 IgG Antibody Measurement | ||
C142250 | C142250 | S. pneumonia Sero 2 IgG AB;Streptococcus pneumoniae Serotype 2 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 2 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 2 IgG Antibody Measurement | ||
C142251 | C142251 | S. pneumonia Sero 3 IgG AB;Streptococcus pneumoniae Serotype 3 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 3 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 3 IgG Antibody Measurement | ||
C142252 | C142252 | S. pneumonia Sero 4 IgG AB;Streptococcus pneumoniae Serotype 4 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 4 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 4 IgG Antibody Measurement | ||
C142253 | C142253 | S. pneumonia Sero 5 IgG AB;Streptococcus pneumoniae Serotype 5 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 5 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 5 IgG Antibody Measurement | ||
C142254 | C142254 | S. pneumonia Sero 6B IgG AB;Streptococcus pneumoniae Serotype 6B IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 6B IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 6B IgG Antibody Measurement | ||
C142255 | C142255 | S. pneumonia Sero 7F IgG AB;Streptococcus pneumoniae Serotype 7F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 7F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 7F IgG Antibody Measurement | ||
C142256 | C142256 | S. pneumonia Sero 8 IgG AB;Streptococcus pneumoniae Serotype 8 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 8 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 8 IgG Antibody Measurement | ||
C142257 | C142257 | S. pneumonia Sero 9N IgG AB;Streptococcus pneumoniae Serotype 9N IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 9N IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 9N IgG Antibody Measurement | ||
C142258 | C142258 | S. pneumonia Sero 9V IgG AB;Streptococcus pneumoniae Serotype 9V IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 9V IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 9V IgG Antibody Measurement | ||
C142259 | C142259 | S. pneumonia Sero 10A IgG AB;Streptococcus pneumoniae Serotype 10A IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 10A IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 10A IgG Antibody Measurement | ||
C142260 | C142260 | S. pneumonia Sero 11A IgG AB;Streptococcus pneumoniae Serotype 11A IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 11A IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 11A IgG Antibody Measurement | ||
C142261 | C142261 | S. pneumonia Sero 12F IgG AB;Streptococcus pneumoniae Serotype 12F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 12F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 12F IgG Antibody Measurement | ||
C142262 | C142262 | S. pneumonia Sero 14 IgG AB;Streptococcus pneumoniae Serotype 14 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 14 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 14 IgG Antibody Measurement | ||
C142263 | C142263 | S. pneumonia Sero 15B IgG AB;Streptococcus pneumoniae Serotype 15B IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 15B IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 15B IgG Antibody Measurement | ||
C142264 | C142264 | S. pneumonia Sero 17F IgG AB;Streptococcus pneumoniae Serotype 17F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 17F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 17F IgG Antibody Measurement | ||
C142265 | C142265 | S. pneumonia Sero 18C IgG AB;Streptococcus pneumoniae Serotype 18C IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 18C IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 18C IgG Antibody Measurement | ||
C142266 | C142266 | S. pneumonia Sero 19F IgG AB;Streptococcus pneumoniae Serotype 19F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 19F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 19F IgG Antibody Measurement | ||
C142267 | C142267 | S. pneumonia Sero 19A IgG AB;Streptococcus pneumoniae Serotype 19A IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 19A IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 19A IgG Antibody Measurement | ||
C142268 | C142268 | S. pneumonia Sero 20 IgG AB;Streptococcus pneumoniae Serotype 20 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 20 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 20 IgG Antibody Measurement | ||
C142269 | C142269 | S. pneumonia Sero 22F IgG AB;Streptococcus pneumoniae Serotype 22F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 22F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 22F IgG Antibody Measurement | ||
C142270 | C142270 | S. pneumonia Sero 23F IgG AB;Streptococcus pneumoniae Serotype 23F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 23F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 23F IgG Antibody Measurement | ||
C142271 | C142271 | S. pneumonia Sero 33F IgG AB;Streptococcus pneumoniae Serotype 33F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 33F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 33F IgG Antibody Measurement | ||
C147286 | C147286 | Cladosporium herbarum IgE Antibody | A measurement of the Cladosporium herbarum antigen IgE antibody in a biological specimen. | Cladosporium herbarum IgE Antibody Measurement | ||
C150639 | C150639 | Clostridium difficile 027/NAP1/BI | A measurement of the 027/NAP1/BI strain of Clostridium difficile in a biological specimen. | Clostridium difficile 027/NAP1/BI Measurement | ||
C163521 | C163521 | HIV-2 Glycoprotein 36 Antibody;HIV-2 gp36 Antibody | A measurement of the HIV-2 glycoprotein 36 antibody in a biological specimen. | HIV-2 gp36 Antibody Measurement | ||
C163522 | C163522 | HIV-2 Glycoprotein140 Antibody;HIV-2 gp140 Antibody | A measurement of the amount of HIV-2 gp140 antibody in a biological specimen. | HIV-2 gp140 Antibody Measurement | ||
C163523 | C163523 | HIV-1 p31 Antibody;HIV-1 Protein 31 Antibody | A measurement of the amount of HIV-1 p31 antibody in a biological specimen. | HIV-1 p31 Antibody Measurement | ||
C163524 | C163524 | HIV-1 Glycoprotein 160 Antibody;HIV-1 gp160 Antibody | A measurement of the HIV-1 gp160 antibody in a biological specimen. | HIV-1 gp160 Antibody Measurement | ||
C163525 | C163525 | HIV-1 p24 Antibody;HIV-1 Protein 24 Antibody | A measurement of the HIV-1 p24 antibody in a biological specimen. | HIV-1 p24 Antibody Measurement | ||
C163526 | C163526 | HIV-1 Glycoprotein 41 Antibody;HIV-1 gp41 Antibody | A measurement of the HIV-1 gp41 antibody in a biological specimen. | HIV-1 gp41 Antibody Measurement | ||
C163527 | C163527 | Fusarium proliferatum IgE Antibody;Gibberella intermedia IgE Antibody | A measurement of the Fusarium proliferatum IgE antibody in a biological specimen. | Fusarium proliferatum IgE Antibody Measurement | ||
C163528 | C163528 | Malassezia IgE Antibody | A measurement of the IgE antibody to any member of the genus Malassezia in a biological specimen. | Malassezia Species IgE Antibody Measurement | ||
C166005 | C166005 | Norovirus Genogroup GII.4 IgG antibody;Norovirus GII.4 IgG antibody | A measurement of Norovirus genogroup II.4 IgG antibody in a biological specimen. | Norovirus Genogroup II.4 IgG Antibody Measurement | ||
C166006 | C166006 | Norovirus Genogroup GII.4 IgA antibody;Norovirus GII.4 IgA antibody | A measurement of Norovirus genogroup II.4 IgA antibody in a biological specimen. | Norovirus Genogroup II.4 IgA Antibody Measurement | ||
C166007 | C166007 | Norovirus Genogroup GII.4 IgM antibody;Norovirus GII.4 IgM antibody | A measurement of Norovirus genogroup II.4 IgM antibody in a biological specimen. | Norovirus Genogroup II.4 IgM Antibody Measurement | ||
C166008 | C166008 | V. chol/parahaemolyticus/vulnificus DNA;Vibrio cholerae/parahaemolyticus/vulnificus DNA | A measurement of the Vibrio cholerae and/or Vibrio parahaemolyticus and/or Vibrio vulnificus DNA in a biological specimen. | Vibrio cholerae, Vibrio parahaemolyticus, and/or Vibrio vulnificus DNA Measurement | ||
C166009 | C166009 | Invasion Plasmid Antigen H Gene;ipaH gene;Shigella species and/or Enteroinvasive Escherichia coli Invasion Plasmid Antigen H DNA;Shigella/EIEC ipaH DNA | A measurement of the invasion plasmid antigen H DNA from any members of the genus Shigella and/or enteroinvasive Escherichia coli in a biological specimen. | Shigella and/or Enteroinvasive Escherichia coli ipaH DNA Measurement | ||
C166010 | C166010 | Sapovirus Genogroups I/II/IV/V RNA | A measurement of the Sapovirus genogroups I, II, IV and/or V RNA in a biological specimen. | Sapovirus Genogroups I, II, IV, and/or V RNA Measurement | ||
C166011 | C166011 | Norovirus genogroup I and/or genogroup II RNA;Norovirus GI/GII RNA | A measurement of Norovirus genogroup I and/or II RNA in a biological specimen. | Norovirus Genogroup I and/or II RNA Measurement | ||
C166012 | C166012 | Enterotoxigenic Escherichia coli LtA/ST1a/ST1b DNA;ETEC LtA/ST1a/ST1b DNA | A measurement of the enterotoxigenic Escherichia coli LtA, ST1a and/or ST1b DNA in a biological specimen. | Enterotoxigenic Escherichia coli LtA, ST1a, and/or ST1b DNA Measurement | ||
C166013 | C166013 | Enteropathogenic Escherichia coli eae DNA;EPEC eae DNA | A measurement of the enteropathogenic Escherichia coli eae DNA in a biological specimen. | Enteropathogenic Escherichia coli eae DNA Measurement | ||
C166014 | C166014 | EAEC pAA Plasmid aggR/aatA DNA;Enteroaggregative Escherichia coli pAA Plasmid aggR/aatA DNA | A measurement of the enteroaggregative Escherichia coli pAA plasmid aggR and/or aatA DNA in a biological specimen. | Enteroaggregative Escherichia coli pAA Plasmid aggR and/or aatA DNA Measurement | ||
C166015 | C166015 | C. coli/jejuni/upsaliensis DNA;Campylobacter coli/jejuni/upsaliensis DNA | A measurement of the Campylobacter coli, Campylobacter jejuni and/or Campylobacter upsaliensis DNA in a biological specimen. | Campylobacter coli, Campylobacter jejuni and/or Campylobacter upsaliensis DNA Measurement | ||
C166016 | C166016 | Human astrovirus 1/2/3/4/5/6/7/8 RNA | A measurement of the Human astrovirus 1, 2, 3, 4, 5, 6, 7 and/or 8 RNA in a biological specimen. | Human astrovirus 1, 2, 3, 4, 5, 6, 7, and/or 8 RNA Measurement | ||
C166017 | C166017 | Human adenovirus 40/41 DNA;Human adenovirus F40/F41 DNA;Mastadenovirus 40/41 DNA | A measurement of the Human adenovirus type 40 and/or Human adenovirus type 41 DNA in a biological specimen. | Human adenovirus 40 and/or Human adenovirus 41 DNA Measurement | ||
C166018 | C166018 | Mucor racemosus IgG AB RAST Score | A classification of the amount of Mucor racemosus IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mucor racemosus IgG Antibody RAST Score Measurement | ||
C166019 | C166019 | A. fumigatus IgG AB RAST Score | A classification of the amount of A. fumigatus antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Aspergillus fumigatus IgG Antibody RAST Score Measurement | ||
C166020 | C166020 | P. notatum IgG AB RAST Score | A classification of the amount of P. notatum antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Penicillium notatum IgG Antibody RAST Score Measurement | ||
C166021 | C166021 | A. tenuis alternata IgG AB RAST Score | A classification of the amount of Alternaria alternata antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Alternaria alternata IgG Antibody RAST Score Measurement | ||
C166022 | C166022 | Mucor racemosus IgE RAST Score | A classification of the amount of Mucor racemosus antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mucor racemosus IgE Antibody RAST Score Measurement | ||
C166023 | C166023 | A. fumigatus IgE AB RAST Score | A classification of the amount of A. fumigatus antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Aspergillus fumigatus IgE Antibody RAST Score Measurement | ||
C166024 | C166024 | P. notatum IgE AB RAST Score | A classification of the amount of P. notatum antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Penicillium notatum IgE Antibody RAST Score Measurement | ||
C166025 | C166025 | A. tenuis alternata IgE AB RAST Score | A classification of the amount of Alternaria alternata antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Alternaria alternata IgE Antibody RAST Score Measurement | ||
C166026 | C166026 | Cladosporium herbarum IgE AB RAST Score | A classification of the amount of Cladosporium herbarum IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Cladosporium herbarum IgE Antibody RAST Score Measurement | ||
C166027 | C166027 | Penicillium chrysogenum IgE AB RAST Score;Penicilliumchrysogenum IgE AB RAST Score | A classification of the amount of Penicillium chrysogenum IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Penicillium chrysogenum IgE Antibody RAST Score Measurement | ||
C229ENC | C198306 | HCoV-229E Nucleic Acid;Human Coronavirus 229E Nucleic Acid | A measurement of the Human coronavirus 229E nucleic acid in a biological specimen. | Human Coronavirus 229E Nucleic Acid Measurement | ||
C229ERNA | C184652 | HCoV-229E RNA;Human Coronavirus 229E RNA | A measurement of the Human coronavirus 229E RNA in a biological specimen. | HCoV-229E RNA Measurement | ||
CAL | C161404 | Candida albicans;Candida stellatoidea | A measurement of the Candida albicans in a biological specimen. | Candida albicans Measurement | ||
CAMPYDNA | C186147 | Campylobacter DNA | A measurement of the DNA from any member of the genus Campylobacter in a biological specimen. | Campylobacter DNA Measurement | ||
CAMPYLOB | C189578 | Campylobacter | A measurement of the organisms that are not assigned to the species level but are assigned to the Campylobacter genus level in a biological specimen. | Campylobacter Measurement | ||
CANAG | C189541 | Candida Antigen | A measurement of the antigen from any member of the genus Candida in a biological specimen. | Candida Antigen Measurement | ||
CANDIDA | C179757 | Candida | A measurement of the organisms that are not assigned to the species level but are assigned to the Candida genus level in a biological specimen. | Candida Measurement | ||
CCADNA | C166029 | Cyclospora cayetanensis DNA | A measurement of the Cyclospora cayetanensis DNA in a biological specimen. | Cyclospora cayetanensis DNA Measurement | ||
CCO | C186148 | Campylobacter coli | A measurement of the Campylobacter coli in a biological specimen. | Campylobacter coli Measurement | ||
CDF | C150637 | Clostridium difficile | A measurement of the Clostridium difficile in a biological specimen. | Clostridium difficile Measurement | ||
CDFABTOX | C150858 | Clostridium difficile A/B Toxin | A measurement of the Clostridium difficile A and/or B toxin in a biological specimen. | Clostridium difficile A and/or B Toxin Measurement | ||
CDFATOX | C150863 | Clostridium difficile A Toxin | A measurement of the Clostridium difficile toxin A in a biological specimen. | Clostridium difficile A Toxin Measurement | ||
CDFBTOX | C150864 | Clostridium difficile B Toxin | A measurement of the Clostridium difficile toxin B in a biological specimen. | Clostridium difficile B Toxin Measurement | ||
CDFCDTD | C150866 | Clostridium difficile cdt DNA | A measurement of the Clostridium difficile binary toxin (cdt) DNA in a biological specimen. | Clostridium difficile cdt DNA Measurement | ||
CDFDNA | C198307 | Clostridium difficile DNA | A measurement of the Clostridium difficile DNA in a biological specimen. | Clostridium difficile DNA Measurement | ||
CDFGDH | C150857 | C. difficile Glutamate Dehydrogenase;Clostridium difficile Glutamate Dehydrogenase | A measurement of the Clostridium difficile glutamate dehydrogenase in a biological specimen. | C. difficile Glutamate Dehydrogenase Measurement | ||
CDFTCDAD | C150859 | Clostridium difficile tcdA DNA | A measurement of the Clostridium difficile toxin A (tcdA) DNA in a biological specimen. | Clostridium difficile tcdA DNA Measurement | ||
CDFTCDBD | C150860 | Clostridium difficile tcdB DNA | A measurement of the Clostridium difficile toxin B (tcdB) DNA in a biological specimen. | Clostridium difficile tcdB DNA Measurement | ||
CDFTCDCD | C150861 | Clostridium difficile tcdC DNA | A measurement of the Clostridium difficile regulatory protein (tcdC) DNA in a biological specimen. | Clostridium difficile tcdC DNA Measurement | ||
CDFTXN | C103381 | Clostridium difficile Toxin | A measurement of the Clostridium difficile toxin in a biological specimen. | Clostridium difficile Toxin Measurement | ||
CDITDAB | C163535 | Corynebacterium diphtheriae Toxoid Ab | A measurement of the Corynebacterium diphtheriae toxoid antibody in a biological specimen. | Corynebacterium diphtheriae Toxoid Antibody Measurement | ||
CDU | C189551 | Candida dubliniensis | A measurement of the Candida dubliniensis in a biological specimen. | Candida dubliniensis Measurement | ||
CGL | C187844 | Candida glabrata | A measurement of the Candida glabrata in a biological specimen. | Candida glabrata Measurement | ||
CHKAB | C135404 | Chikungunya Virus Antibody | A measurement of the Chikungunya virus antibody in a biological specimen. | Chikungunya Virus Antibody Measurement | ||
CHLAMYD | C172527 | Chlamydia | A measurement of the organisms that are not assigned to the species level but are assigned to the Chlamydia genus level in a biological specimen. | Chlamydia Measurement | ||
CIMAB | C166030 | Coccidioides immitis Antibody | A measurement of the Coccidioides immitis antibody in a biological specimen. | Coccidioides immitis Antibody Measurement | ||
CJE | C186149 | Campylobacter jejuni | A measurement of the Campylobacter jejuni in a biological specimen. | Campylobacter jejuni Measurement | ||
CKO | C187846 | Citrobacter koseri | A measurement of the Citrobacter koseri in a biological specimen. | Citrobacter koseri Measurement | ||
CMV | C184672 | Cytomegalovirus | A measurement of the organisms that are not assigned to the species level but are assigned to the Cytomegalovirus genus level in a biological specimen. | Cytomegalovirus Measurement | ||
CMVAG | C154828 | Cytomegalovirus Antigen | A measurement of the Cytomegalovirus antigen in a biological specimen. | Cytomegalovirus Antigen Measurement | ||
CMVDNA | C161394 | Cytomegalovirus DNA | A measurement of the Cytomegalovirus DNA in a biological specimen. | Cytomegalovirus DNA Measurement | ||
CMVIGGAB | C96596 | Cytomegalovirus IgG Antibody | A measurement of the cytomegalovirus IgG antibody in a biological specimen. | Cytomegalovirus IgG Antibody Measurement | ||
CMVIGMAB | C96597 | Cytomegalovirus IgM Antibody | A measurement of the cytomegalovirus IgM antibody in a biological specimen. | Cytomegalovirus IgM Antibody Measurement | ||
CMVP65AG | C170608 | Cytomegalovirus Phosphoprotein 65 Antigen;Cytomegalovirus pp65 Antigen | A measurement of the Cytomegalovirus phosphoprotein 65 (pp65) antigen in a biological specimen. | Cytomegalovirus pp65 Antigen Measurement | ||
CNEGADNA | C186150 | Cryptococcus neoformans/gattii DNA | A measurement of Cryptococcus neoformans and/or Cryptococcus gattii DNA in a biological specimen. | Cryptococcus neoformans and/or gattii DNA Measurement | ||
COCCAB | C111160 | Coccidioides Antibody | A measurement of the coccidioides antibody in a biological specimen. | Coccidioides Antibody Measurement | ||
COCCIGG | C166031 | Coccidioides IgG Antibody | A measurement of the IgG antibody from any member of the genus Coccidioides in a biological specimen. | Coccidioides IgG Antibody Measurement | ||
COCCIGM | C166032 | Coccidioides IgM Antibody | A measurement of the IgM antibody from any member of the genus Coccidioides in a biological specimen. | Coccidioides IgM Antibody Measurement | ||
CPAAG | C154831 | Cryptosporidium parvum Antigen | A measurement of the Cryptosporidium parvum antigen in a biological specimen. | Cryptosporidium parvum Antigen Measurement | ||
CPN | C178016 | Chlamydia pneumoniae | A measurement of the Chlamydia pneumoniae in a biological specimen. | Chlamydia Pneumoniae Measurement | ||
CPNDNA | C184657 | Chlamydia pneumoniae DNA | A measurement of the Chlamydia pneumoniae DNA in a biological specimen. | Chlamydia pneumoniae DNA Measurement | ||
CPNIGAAB | C92432 | Chlamydia pneumoniae IgA Antibody | A measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen. | Chlamydia pneumoniae IgA Antibody Measurement | ||
CPNIGGAB | C163536 | Chlamydia pneumoniae IgG Antibody;Chlamydophila pneumoniae IgG Antibody | A measurement of the Chlamydia pneumoniae IgG antibody in a biological specimen. | Chlamydia pneumoniae IgG Antibody Measurement | ||
CPNIGMAB | C92433 | Chlamydia pneumoniae IgM Antibody | A measurement of the Chlamydia pneumoniae IgM in a biological specimen. | Chlamydia pneumoniae IgM Antibody Measurement | ||
CPNNUAC | C198308 | Chlamydia pneumoniae Nucleic Acid | A measurement of the Chlamydia pneumoniae nucleic acid in a biological specimen. | Chlamydia pneumoniae Nucleic Acid Measurement | ||
CPSDNA | C189535 | Chlamydophila psittaci DNA | A measurement of the Chlamydophila psittaci DNA in a biological specimen. | Chlamydophila psittaci DNA Measurement | ||
CRA | C187845 | Acinetobacter, Carbapenem-resistant;Carbapenem Resistant Acinetobacter | A measurement of the organisms that are not assigned to the species level but are assigned to the Enterococcus genus level and are also carbapenem-resistant in a biological specimen. | Carbapenem-resistant Acinetobacter Measurement | ||
CRONAVIR | C171456 | Coronaviridae;Coronavirus | A measurement of the coronaviridae in a biological specimen. | Coronaviridae Measurement | ||
CRONRNA | C191311 | Coronavirus RNA | A measurement of the RNA from any member of the family Coronaviridae in a biological specimen. | Coronavirus RNA Measurement | ||
CRYPTCAG | C154829 | Cryptococcus Antigen | A measurement of the antigen from any member of the genus Cryptococcus in a biological specimen. | Cryptococcus Antigen Measurement | ||
CRYPTDNA | C166033 | Cryptosporidium DNA | A measurement of the DNA from any member of the genus Cryptosporidium in a biological specimen. | Cryptosporidium DNA Measurement | ||
CSPORAG | C166034 | Cryptosporidium Antigen | A measurement of the antigen from any member of the genus Cryptosporidium in a biological specimen. | Cryptosporidium Antigen Measurement | ||
CTBIGGAB | C116194 | Cholera Toxin B Subunit IgG Antibody | A measurement of the cholera toxin B subunit IgG antibody in a biological specimen. | Cholera Toxin B Subunit IgG Antibody Measurement | ||
CTETXNAB | C163537 | Clostridium tetani TeNT Antibody;Clostridium tetani Toxin Antibody;Tetanospasmin Antibody;Tetanus Neurotoxin Antibody | A measurement of the Clostridium tetani toxin antibody in a biological specimen. | Clostridium tetani Toxin Antibody Measurement | ||
CTR | C184659 | Chlamydia trachomatis | A measurement of the Chlamydia trachomatis in a biological specimen. | Chlamydia trachomatis Measurement | ||
CTRAG | C154835 | Chlamydia trachomatis Antigen | A measurement of the Chlamydia trachomatis antigen in a biological specimen. | Chlamydia trachomatis Antigen Measurement | ||
CTRDNA | C161392 | Chlamydia trachomatis DNA | A measurement of the Chlamydia trachomatis DNA in a biological specimen. | Chlamydia trachomatis DNA Measurement | ||
CTRIGAAB | C100464 | Chlamydia trachomatis IgA Antibody | A measurement of the Chlamydia trachomatis IgA antibody in a biological specimen. | Chlamydia trachomatis IgA Antibody Measurement | ||
CTRIGGAB | C100466 | Chlamydia trachomatis IgG Antibody | A measurement of the Chlamydia trachomatis IgG antibody in a biological specimen. | Chlamydia trachomatis IgG Antibody Measurement | ||
CTRIGMAB | C100465 | Chlamydia trachomatis IgM Antibody | A measurement of the Chlamydia trachomatis IgM antibody in a biological specimen. | Chlamydia trachomatis IgM Antibody Measurement | ||
CTRRNA | C186151 | Chlamydia trachomatis RNA | A measurement of the Chlamydia trachomatis RNA in a biological specimen. | Chlamydia Trachomatis RNA Measurement | ||
CTTIGGAB | C103382 | Clostridium tetani IgG Antibody | A measurement of the Clostridium tetani IgG antibody in a biological specimen. | Clostridium tetani IgG Antibody Measurement | ||
CTXIGGAB | C135406 | Clostridium tetani Toxoid IgG Antibody | A measurement of the Clostridium tetani toxoid IgG antibody in a biological specimen. | Clostridium tetani Toxoid IgG Antibody Measurement | ||
CURVBAC | C184671 | Curved Bacillus;Curved Rods | A measurement of the curved rod-shaped bacillus in a biological specimen. | Curved Bacillus Measurement | ||
DFRDNA | C186152 | Dientamoeba fragilis DNA | A measurement of the Dientamoeba fragilis DNA in a biological specimen. | Dientamoeba fragilis DNA Measurement | ||
DNV1RNA | C198309 | Dengue Virus 1 RNA | A measurement of the dengue virus 1 RNA in a biological specimen. | Dengue Virus 1 RNA Measurement | ||
DNV2RNA | C198310 | Dengue Virus 2 RNA | A measurement of the dengue virus 2 RNA in a biological specimen. | Dengue Virus 2 RNA Measurement | ||
DNV3RNA | C198311 | Dengue Virus 3 RNA | A measurement of the dengue virus 3 RNA in a biological specimen. | Dengue Virus 3 RNA Measurement | ||
DNV4RNA | C198312 | Dengue Virus 4 RNA | A measurement of the dengue virus 4 RNA in a biological specimen. | Dengue Virus 4 RNA Measurement | ||
DNVAB | C147332 | Dengue Virus Antibody | A measurement of the dengue virus antibody in a biological specimen. | Dengue Virus Antibody Measurement | ||
DNVIGGAB | C184649 | Dengue Virus IGG Antibody | A measurement of the dengue virus IgG antibody in a biological specimen. | Dengue Virus IgG Antibody Measurement | ||
DNVIGMAB | C184650 | Dengue Virus IGM Antibody | A measurement of the dengue virus IgM antibody in a biological specimen. | Dengue Virus IgM Antibody Measurement | ||
DNVNS1AG | C184648 | Dengue Virus Nonstructural Protein 1;Dengue Virus NS1 Antigen | A measurement of the dengue virus NS1 antigen in a biological specimen. | Dengue Virus NS1 Antigen Measurement | ||
DNVRNA | C198228 | Dengue Virus RNA | A measurement of the dengue virus RNA in a biological specimen. | Dengue Virus RNA Measurement | ||
DPTIGGAB | C103388 | Corynebacterium diphtheriae IgG Antibody;Diphtheria IgG Antibody | A measurement of the Corynebacterium diphtheriae IgG antibodies in a biological specimen. | Diphtheria IgG Antibody Measurement | ||
EBCIGGAB | C96600 | Epstein-Barr Capsid IgG Antibody | A measurement of the Epstein-Barr capsid IgG antibody in a biological specimen. | Epstein-Barr Capsid IgG Antibody Measurement | ||
EBCIGMAB | C96601 | Epstein-Barr Capsid IgM Antibody | A measurement of the Epstein-Barr capsid IgM antibody in a biological specimen. | Epstein-Barr Capsid IgM Antibody Measurement | ||
EBDNA | C166035 | Epstein-Barr DNA | A measurement of the Epstein-Barr virus DNA in a biological specimen. | Epstein-Barr DNA Measurement | ||
EBEAG | C96602 | Epstein-Barr Early Antigen | A measurement of the Epstein-Barr early antigen in a biological specimen. | Epstein-Barr Early Antigen Measurement | ||
EBEDIGAB | C122116 | Epstein-Barr Early D Antigen IgG Ab | A measurement of the Epstein-Barr early diffuse antigen IgG antibody in a biological specimen. | Epstein-Barr Early D Antigen IgG Antibody Measurement | ||
EBN1IGAB | C106518 | Epstein-Barr Nuclear Antigen 1 IgG Ab | A measurement of the Epstein-Barr nuclear antigen 1 IgG antibody in a biological specimen. | Epstein-Barr Nuclear Antigen 1 IgG Ab Measurement | ||
EBNAB | C96603 | Epstein-Barr Nuclear Antibody;Epstein-Barr Nuclear Antigen Antibody | A measurement of the Epstein-Barr nuclear antibody in a biological specimen. | Epstein-Barr Nuclear Antibody Measurement | ||
EBNAG | C96604 | Epstein-Barr Nuclear Antigen | A measurement of the Epstein-Barr nuclear antigen in a biological specimen. | Epstein-Barr Nuclear Antigen Measurement | ||
EBOIGMAB | C135410 | Ebola Virus IgM Antibody | A measurement of the Ebola virus IgM antibodies in a biological specimen. | Ebola Virus IgM Antibody Measurement | ||
EBOV | C184673 | Ebola Virus | A measurement of the Ebola virus in a biological specimen. | Ebola Virus Measurement | ||
EBV | C184675 | Epstein-Barr Virus | A measurement of the Epstein-Barr virus in a biological specimen. | Epstein-Barr Virus Measurement | ||
EBVINTP | C106519 | Epstein-Barr Virus Antibody Profile;Epstein-Barr Virus Infection Status;Epstein-Barr Virus Panel | An assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests. | Epstein-Barr Virus Infection Status | ||
EBVLMP1 | C187849 | Epstein-Barr Virus Latent Membrane Protein 1;Epstein-Barr Virus LMP1 | A measurement of the epstein-barr virus latent membrane protein 1 in a biological specimen. | Epstein-Barr Virus Latent Membrane Protein 1 Measurement | ||
ECL | C187979 | Enterobacter cloacae | A measurement of the Enterobacter cloacae in a biological specimen. | Enterobacter cloacae Measurement | ||
ECLCM | C191313 | Enterobacter cloacae Complex | A measurement of the Enterobacter cloacae complex in a biological specimen. | Enterobacter cloacae Complex Measurement | ||
ECLCMDNA | C191312 | Enterobacter cloacae Complex DNA | A measurement of the Enterobacter cloacae complex DNA in a biological specimen. | Enterobacter cloacae Complex DNA Measurement | ||
ECLSLTXN | C154818 | Escherichia coli Shiga-like Toxin | A measurement of the total Escherichia coli shiga-like toxin in a biological specimen. | Escherichia coli Shiga-like Toxin Measurement | ||
ECO | C172538 | Escherichia coli | A measurement of the Escherichia coli in a biological specimen. | Escherichia coli Measurement | ||
ECODNA | C191314 | Escherichia coli DNA | A measurement of the Escherichia coli DNA in a biological specimen. | Escherichia coli DNA Measurement | ||
ECOK1DNA | C186153 | Escherichia coli K1 DNA | A measurement of the Escherichia coli K1 DNA in a biological specimen. | Escherichia coli K1 DNA Measurement | ||
ECOOAG | C198313 | Escherichia coli O Antigen | A measurement of the Escherichia coli O antigen in a biological specimen. | Escherichia coli O Antigen Measurement | ||
ECVERTXN | C187850 | Escherichia coli Verotoxin | A measurement of the total Escherichia coli verotoxin in a biological specimen. | Escherichia coli Verotoxin Measurement | ||
EDI | C189543 | Entamoeba dispar | A measurement of the Entamoeba dispar in a biological specimen. | Entamoeba dispar Measurement | ||
EDIDNA | C189544 | Entamoeba dispar DNA | A measurement of the Entamoeba dispar DNA in a biological specimen. | Entamoeba dispar DNA Measurement | ||
EFA | C161396 | Streptococcus faecalis | A measurement of the Enterococcus faecalis in a biological specimen. | Enterococcus faecalis Measurement | ||
EFADNA | C189545 | Enterococcus faecalis DNA | A measurement of the Enterococcus faecalis DNA in a biological specimen. | Enterococcus faecalis DNA Measurement | ||
EFAM | C189538 | Enterococcus faecium | A measurement of the Enterococcus faecium in a biological specimen. | Enterococcus faecium Measurement | ||
EHIDNA | C166036 | Entamoeba histolytica DNA | A measurement of the Entamoeba histolytica DNA in a biological specimen. | Entamoeba histolytica DNA Measurement | ||
EHRLDNA | C187847 | Ehrlichia DNA | A measurement of the DNA from any member of the genus Ehrlichia in a biological specimen. | Ehrlichia DNA Measurement | ||
ENC1NAB | C181456 | Human Poliovirus 1 Neutralizing Antibody;Type 1 Poliovirus Neutralizing Antibody | A measurement of the Human poliovirus 1 neutralizing antibody in a biological specimen. | Human Poliovirus 1 Neutralizing Antibody Measurement | ||
ENC3NAB | C181457 | Human Poliovirus 3 Neutralizing Antibody;Type 3 Poliovirus Neutralizing Antibody | A measurement of the Human poliovirus 3 neutralizing antibody in a biological specimen. | Human Poliovirus 3 Neutralizing Antibody Measurement | ||
ENTEROBA | C179758 | Enterobacter | A measurement of the organisms that are not assigned to the species level but are assigned to the Enterobacter genus level in a biological specimen. | Enterobacter Measurement | ||
ENTEROCO | C187848 | Enterococcus | A measurement of the organisms that are not assigned to the species level but are assigned to the Enterococcus genus level in a biological specimen. | Enterococcus Measurement | ||
ENTEROVI | C172548 | Enterovirus | A measurement of the organisms that are not assigned to the species level but are assigned to the Enterovirus genus level in a biological specimen. | Enterovirus Measurement | ||
ENTRNA | C186154 | Enterovirus RNA | A measurement of the RNA from any member of the genus Enterovirus in a biological specimen. | Enterovirus RNA Measurement | ||
EO157AG | C198314 | Escherichia coli O157 Antigen | A measurement of the Escherichia coli O157 antigen in a biological specimen. | Escherichia coli O157 Antigen Measurement | ||
EO157DNA | C166037 | Escherichia coli O157 DNA | A measurement of the Escherichia coli O157 DNA in a biological specimen. | Escherichia coli O157 DNA Measurement | ||
FIRMBCRA | C189550 | Firmicutes/Bacteroidetes Ratio | A ratio measurement of the members from the phylum Firmicutes to the members from the phylum Bacteroidetes in a biological specimen. | Firmicutes to Bacteroidetes Ratio Measurement | ||
FLAGEL | C135421 | Flagellates | A measurement of the flagellates (protozoans that possess flagella) in a biological specimen. | Flagellates Measurement | ||
FNU | C189539 | Fusobacterium nucleatum | A measurement of the Fusobacterium nucleatum in a biological specimen. | Fusobacterium nucleatum Measurement | ||
FUNGI | C154813 | Fungi;Fungus | A measurement of the fungi in a biological specimen. | Fungi Measurement | ||
FUNGIFIL | C147343 | Fungi, Filamentous | A measurement of the filamentous fungi in a biological specimen. | Filamentous Fungi Count | ||
FUNGYLK | C147344 | Fungi, Yeast-Like | A measurement of the yeast-like fungi in a biological specimen. | Yeast-Like Fungi Count | ||
GAS | C189582 | Streptococcus Group A | A measurement of the Streptococcus group A in a biological specimen. | Group A Streptococcus Measurement | ||
GBS | C189583 | Streptococcus Group B | A measurement of the Streptococcus group B in a biological specimen. | Group B Streptococcus Measurement | ||
GIARDDNA | C186155 | Giardia DNA | A measurement of the DNA from any member of the genus Giardia in a biological specimen. | Giardia DNA Measurement | ||
GLAAG | C154822 | Giardia lamblia Antigen | A measurement of the Giardia lamblia antigen in a biological specimen. | Giardia lamblia Antigen Measurement | ||
GLACRAG | C189542 | Giardia lamblia/Cryptosporidium Antigen | A measurement of the antigen from Giardia lamblia and/or any member of the genus Cryptosporidium in a biological specimen. | Giardia lamblia/Cryptosporidium Antigen Measurement | ||
GLADNA | C166038 | Giardia duodenalis DNA;Giardia intestinalis DNA;Giardia lamblia DNA | A measurement of the Giardia lamblia DNA in a biological specimen. | Giardia lamblia DNA Measurement | ||
GLTAG | C154817 | Galactomannan Antigen | A measurement of the galactomannan antigen in a biological specimen. | Galactomannan Antigen Measurement | ||
GMNBAC | C154812 | Gram Negative Bacteria | A measurement of the gram negative bacteria in a biological specimen. | Gram Negative Bacteria Measurement | ||
GMNCOC | C161401 | Gram Negative Cocci | A measurement of the gram negative cocci-shaped bacteria in a biological specimen. | Gram Negative Cocci Measurement | ||
GMPBAC | C154811 | Gram Positive Bacteria | A measurement of the gram positive bacteria in a biological specimen. | Gram Positive Bacteria Measurement | ||
GVA | C161402 | Corynebacterium vaginalis;Gardnerella vaginalis | A measurement of the Gardnerella vaginalis in a biological specimen. | Gardnerella vaginalis Measurement | ||
HAAB | C92534 | Hepatitis A Virus Antibody | A measurement of the hepatitis A virus antibody in a biological specimen. | Hepatitis A Antibody Measurement | ||
HAEMINF | C147457 | H. influenzae;Haemophilus influenzae | A measurement of the Haemophilus influenza virus in a biological specimen. | Haemophilus influenzae Measurement | ||
HAEMOPH | C147458 | Haemophilus | A measurement of the organisms that are not assigned to the species level but are assigned to the Haemophilus genus level in a biological specimen. | Haemophilus Measurement | ||
HAIGGAB | C163538 | Hepatitis A Virus IgG Antibody | A measurement of hepatitis A virus IgG antibody in a biological specimen. | Hepatitis A Virus IgG Antibody Measurement | ||
HAIGMAB | C92271 | Hepatitis A Virus IgM Antibody | A measurement of hepatitis A virus IgM antibody in a biological specimen. | Hepatitis A Virus Antibody IgM Measurement | ||
HAVRNA | C187852 | Hepatitis A Virus RNA | A measurement of the hepatitis A virus RNA in a biological specimen. | Hepatitis A Virus RNA Measurement | ||
HBAB | C125944 | Hepatitis B Virus Antibody | A measurement of an unspecified hepatitis B antibody in a biological specimen. | Hepatitis B Virus Antibody Measurement | ||
HBCAB | C96660 | Hepatitis B Virus Core Antibody | A measurement of the hepatitis B virus core antibody in a biological specimen. | Hepatitis B Virus Core Antibody Measurement | ||
HBCAG | C166039 | Hepatitis B Virus Core Antigen | A measurement of the Hepatitis B virus core antigen in a biological specimen. | Hepatitis B Virus Core Antigen Measurement | ||
HBCIGGAB | C119280 | Hepatitis B Virus Core IgG Antibody | A measurement of the hepatitis B virus core IgG antibody in a biological specimen. | Hepatitis B Virus Core IgG Antibody Measurement | ||
HBCIGMAB | C96661 | Hepatitis B Virus Core IgM Antibody | A measurement of the hepatitis B virus core IgM antibody in a biological specimen. | Hepatitis B Virus Core IgM Antibody Measurement | ||
HBDNA | C103404 | Hepatitis B Virus DNA | A measurement of the Hepatitis B virus DNA in a biological specimen. | Hepatitis B DNA Measurement | ||
HBEAB | C96662 | Hepatitis B Virus e Antibody | A measurement of the hepatitis B e antibody in a biological specimen. | Hepatitis B Virus e Antibody Measurement | ||
HBEAG | C96663 | Hepatitis B Virus e Antigen | A measurement of the hepatitis B e antigen in a biological specimen. | Hepatitis B Virus e Antigen Measurement | ||
HBNUAC | C166040 | Hepatitis B Virus Nucleic Acid | A measurement of the hepatitis B virus nucleic acid in a biological specimen. | Hepatitis B Virus Nucleic Acid Measurement | ||
HBOVDNA | C184656 | Human bocavirus DNA | A measurement of the Human bocavirus DNA in a biological specimen. | Human Bocavirus DNA Measurement | ||
HBOVNUAC | C198315 | Human Bocavirus Nucleic Acid | A measurement of the Human bocavirus nucleic acid in a biological specimen. | Human Bocavirus Nucleic Acid Measurement | ||
HBRNA | C198316 | Hepatitis B Virus RNA | A measurement of the Hepatitis B virus RNA in a biological specimen. | Hepatitis B Virus RNA Measurement | ||
HBSAB | C74711 | Anti-HBs;HBsAb;Hepatitis B Virus Surface Antibody | A measurement of the hepatitis B virus surface antibody in a biological specimen. | Hepatitis B Surface Antibody Measurement | ||
HBSAG | C64850 | HBsAg;Hepatitis B Virus Surface Antigen | A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus. | Hepatitis B Virus Surface Antigen Measurement | ||
HBV | C189553 | Hepatitis B Virus | A measurement of the hepatitis B virus in a biological specimen. | Hepatitis B Virus Measurement | ||
HCAB | C92535 | Hepatitis C Virus Antibody | A measurement of the hepatitis C virus antibody in a biological specimen. | Hepatitis C Antibody Measurement | ||
HCAG | C116196 | Hepatitis C Virus Antigen | A measurement of the hepatitis C virus antigen in a biological specimen. | Hepatitis C Virus Antigen Measurement | ||
HCCAG | C135424 | Hepatitis C Virus Core Antigen | A measurement of the hepatitis C virus core antigen in a biological specimen. | Hepatitis C Virus Core Antigen Measurement | ||
HCNUAC | C166041 | Hepatitis C Virus Nucleic Acid | A measurement of the hepatitis C virus nucleic acid in a biological specimen. | Hepatitis C Virus Nucleic Acid Measurement | ||
HCOV229E | C178007 | Human Coronavirus 229E | A measurement of the Human coronavirus 229E in a biological specimen. | Human Coronavirus 229E Measurement | ||
HCOVHKU1 | C178008 | Human Coronavirus HKU1 | A measurement of the Human coronavirus HKU1 in a biological specimen. | Human Coronavirus HKU1 Measurement | ||
HCOVNL63 | C178009 | Human Coronavirus NL63 | A measurement of the Human coronavirus NL63 in a biological specimen. | Human Coronavirus NL63 Measurement | ||
HCOVOC43 | C178010 | Human Coronavirus OC43 | A measurement of the Human coronavirus OC43 in a biological specimen. | Human Coronavirus OC43 Measurement | ||
HCPAG | C154816 | Histoplasma capsulatum Antigen | A measurement of the Histoplasma capsulatum antigen in a biological specimen. | Histoplasma capsulatum Antigen Measurement | ||
HCRNA | C142330 | Hepatitis C Virus RNA | A measurement of the Hepatitis C virus RNA in a biological specimen. | Hepatitis C Virus RNA Measurement | ||
HCV | C189554 | Hepatitis C Virus | A measurement of the hepatitis C virus in a biological specimen. | Hepatitis C Virus Measurement | ||
HDAB | C96664 | Hepatitis D Virus Antibody;Hepatitis Delta Antibody | A measurement of the hepatitis D virus antibody in a biological specimen. | Hepatitis D Virus Antibody Measurement | ||
HDIGGAB | C119281 | Hepatitis D Virus IgG Antibody | A measurement of the hepatitis D virus IgG antibody in a biological specimen. | Hepatitis D Virus IgG Antibody Measurement | ||
HDIGMAB | C119282 | Hepatitis D Virus IgM Antibody | A measurement of the hepatitis D virus IgM antibody in a biological specimen. | Hepatitis D Virus IgM Antibody Measurement | ||
HDVRNA | C186156 | Hepatitis D Virus RNA | A measurement of the hepatitis D virus RNA in a biological specimen. | Hepatitis D Virus RNA Measurement | ||
HEAB | C119283 | Hepatitis E Virus Antibody | A measurement of the hepatitis E virus antibody in a biological specimen. | Hepatitis E Virus Antibody Measurement | ||
HEAG | C166042 | Hepatitis E Virus Antigen | A measurement of the Hepatitis E virus antigen in a biological specimen. | Hepatitis E Virus Antigen Measurement | ||
HEIGGAB | C106526 | Hepatitis E Virus IgG Antibody | A measurement of IgG antibody to the hepatitis E virus in a biological specimen. | Hepatitis E Virus IgG Antibody Measurement | ||
HEIGMAB | C96665 | Hepatitis E Virus IgM Antibody | A measurement of the hepatitis E virus IgM antibody in a biological specimen. | Hepatitis E Virus IgM Antibody Measurement | ||
HEMOZOIN | C187851 | Hemozoin | A measurement of hemozoin in a biological specimen. Hemozoin is a breakdown product of hemoglobin and iron-containing pigment that accumulates as cytoplasmic granules in blood-feeding parasites. | Hemozoin Measurement | ||
HERNA | C142331 | Hepatitis E Virus RNA | A measurement of the Hepatitis E virus RNA in a biological specimen. | Hepatitis E Virus RNA Measurement | ||
HHV6AB | C112292 | Human Herpesvirus 6 Antibody | A measurement of the human herpesvirus 6 antibody in a biological specimen. | Herpes Simplex Virus 6 Antibody Measurement | ||
HHV6DNA | C187855 | Human Herpesvirus 6 DNA | A measurement of the human herpesvirus 6 DNA in a biological specimen. | Human Herpesvirus 6 DNA Measurement | ||
HHV7DNA | C189549 | Human Herpesvirus 7 DNA | A measurement of the human herpesvirus 7 DNA in a biological specimen. | Human Herpesvirus 7 DNA Measurement | ||
HHV8 | C189316 | Human Herpes Virus 8 | A measurement of the human herpes virus 8 in a biological specimen. | Human Herpesvirus 8 Measurement | ||
HHV8DNA | C189552 | Human Herpesvirus 8 DNA | A measurement of the human herpesvirus 8 DNA in a biological specimen. | Human Herpesvirus 8 DNA Measurement | ||
HINDNA | C186157 | Haemophilus influenzae DNA | A measurement of the Haemophilus influenza virus DNA in a biological specimen. | Haemophilus influenzae DNA Measurement | ||
HIV | C161395 | Human Immunodeficiency Virus | A measurement of the Human Immunodeficiency Virus in a biological specimen. | Human Immunodeficiency Virus Measurement | ||
HIV124AG | C92265 | HIV-1 p24 Antigen | A measurement of the HIV-1 p24 antigen in a biological specimen. | HIV-1 p24 Antigen Measurement | ||
HIV12AB | C74714 | HIV-1/2 Antibody | A measurement of either the HIV-1 or HIV-2 virus antibody in a biological specimen. | HIV-1 HIV-2 Antibody Measurement | ||
HIV12AGB | C163539 | HIV-1/2 Antigen/Antibody | A measurement of the HIV-1/HIV-2 antigens and/or HIV-1/HIV-2 antibodies in a biological specimen (to be used when the antigen is not specified). | HIV-1/2 Antigen/Antibody Measurement | ||
HIV12P24 | C139085 | HIV-1/2 Antibody + HIV-1 p24 Antigen | A measurement of the antibody reaction of a biological specimen to either the HIV-1 or HIV-2 virus and the measurement of HIV-1 p24 antigen in a biological specimen. | HIV-1/2 Antibody and HIV-1 p24 Antigen Measurement | ||
HIV12RNA | C161393 | HIV-1/2 RNA | A measurement of the HIV-1 and/or HIV-2 RNA in a biological specimen. | HIV-1/2 RNA Measurement | ||
HIV1AB | C74713 | HIV-1 Antibody | A measurement of the HIV-1 virus antibody in a biological specimen. | HIV-1 Antibody Measurement | ||
HIV1AB24 | C166043 | HIV-1 Antibody + HIV-1 p24 Antigen | A measurement of the antibody reaction to the HIV-1 virus and the measurement of HIV-1 p24 antigen in a biological specimen. | HIV-1 Antibody and HIV-1 p24 Antigen Measurement | ||
HIV1AG | C154821 | HIV-1 Antigen | A measurement of the HIV-1 antigen in a biological specimen. | HIV-1 Antigen Measurement | ||
HIV1MONA | C92263 | HIV-1 Group M and O Nucleic Acid | A measurement of the HIV-1 group M and O nucleic acids in a biological specimen. | HIV-1 Group M and O Nucleic Acid Measurement | ||
HIV1OAB | C92264 | HIV-1 Group O Antibody | A measurement of the HIV-1 group O antibody in a biological specimen. | HIV-1 Group O Antibody Measurement | ||
HIV1RNA | C158238 | HIV-1 RNA | A measurement of the HIV-1 RNA in a biological specimen. | HIV-1 RNA Measurement | ||
HIV2AB | C74715 | HIV-2 Antibody | A measurement of the HIV-2 virus antibody in a biological specimen. | HIV-2 Antibody Measurement | ||
HIV2AB24 | C166044 | HIV-2 Antibody + HIV-1 p24 Antigen | A measurement of the antibody reaction to the HIV-2 virus and the measurement of HIV-1 p24 antigen in a biological specimen. | HIV-2 Antibody And HIV-1 p24 Antigen Measurement | ||
HIV2NUAC | C92266 | HIV-2 Nucleic Acid | A measurement of the HIV-2 nucleic acids in a biological specimen. | HIV-2 Nucleic Acid Measurement | ||
HIV2RNA | C166045 | HIV-2 RNA | A measurement of the HIV-2 RNA in a biological specimen. | HIV-2 RNA Measurement | ||
HIVAB | C106527 | HIV Antibody | A measurement of the HIV virus antibody in a biological specimen. | HIV Antibody Measurement | ||
HKU1NC | C198317 | HCoV-HKU1 Nucleic Acid;HCoV-HKU1 RNA;Human Coronavirus HKU1 Nucleic Acid | A measurement of the Human coronavirus HKU1 nucleic acid in a biological specimen. | Human Coronavirus HKU1 Nucleic Acid Measurement | ||
HKU1RNA | C184655 | HCoV-HKU1 RNA;Human Coronavirus HKU1 RNA | A measurement of the Human coronavirus HKU1 RNA in a biological specimen. | HCoV-HKU1 RNA Measurement | ||
HMPV | C178011 | Human Metapneumovirus | A measurement of the Human metapneumovirus in a biological specimen. | Human Metapneumovirus Measurement | ||
HMPVAG | C186158 | Human Metapneumovirus Antigen | A measurement of the Human metapneumovirus antigen in a biological specimen. | Human Metapneumovirus Antigen Measurement | ||
HMPVNUAC | C198318 | Human Metapneumovirus Nucleic Acid | A measurement of the Human metapneumovirus nucleic acid in a biological specimen. | Human Metapneumovirus Nucleic Acid Measurement | ||
HMPVRNA | C191315 | Human Metapneumovirus RNA | A measurement of the Human Metapneumovirus RNA in a biological specimen. | Human Metapneumovirus RNA Measurement | ||
HP1234RN | C186159 | Human Parainfluenza Virus 1/2/3/4 RNA | A measurement of the RNA from the Human Parainfluenza virus 1, 2, 3 and/or 4 in a biological specimen. | Human Parainfluenza Virus 1, 2, 3, and/or 4 RNA Measurement | ||
HP123AG | C186160 | Human Parainfluenza Virus 1/2/3 Antigen | A measurement of the Human Parainfluenza virus 1, 2, and/or 3 antigen in a biological specimen. | Human Parainfluenza Virus 1, 2, and/or 3 Antigen Measurement | ||
HP123RNA | C186161 | Human Parainfluenza Virus 1/2/3 RNA | A measurement of the RNA from the Human Parainfluenza virus 1, 2, and/or 3 in a biological specimen. | Human Parainfluenza Virus 1, 2, and/or 3 RNA Measurement | ||
HPADNA | C198319 | Haemophilus parahaemolyticus DNA | A measurement of the Haemophilus parahaemolyticus DNA in a biological specimen. | Haemophilus parahaemolyticus DNA Measurement | ||
HPIV1 | C186162 | Human Parainfluenza Virus 1 | A measurement of the Human parainfluenza virus 1 in a biological specimen. | Human Parainfluenza Virus 1 Measurement | ||
HPIV1AG | C154834 | Human Parainfluenza Virus 1 Antigen;Human Respirovirus 1 Antigen | A measurement of the Human parainfluenza virus 1 antigen in a biological specimen. | Human Parainfluenza Type 1 Antigen Measurement | ||
HPIV1NC | C198320 | Human Parainfluenza Virus 1 Nucleic Acid | A measurement of the Human parainfluenza virus 1 nucleic acid in a biological specimen. | Human Parainfluenza Virus 1 Nucleic Acid Measurement | ||
HPIV1RNA | C184662 | Human Parainfluenza Virus 1 RNA;Human Respirovirus 1 RNA | A measurement of the Human parainfluenza virus 1 RNA in a biological specimen. | Human Parainfluenza Virus 1 RNA Measurement | ||
HPIV2 | C178012 | Human Parainfluenza Virus 2 | A measurement of the Human parainfluenza virus 2 in a biological specimen. | Human Parainfluenza Virus 2 Measurement | ||
HPIV2AG | C186163 | Human Orthorubulavirus 2 Antigen;Human Parainfluenza Virus 2 Antigen | A measurement of the Human parainfluenza virus 2 antigen in a biological specimen. | Human Parainfluenza Virus 2 Antigen Measurement | ||
HPIV2NC | C198321 | Human Parainfluenza Virus 2 Nucleic Acid | A measurement of the Human parainfluenza virus 2 nucleic acid in a biological specimen. | Human Parainfluenza Virus 2 Nucleic Acid Measurement | ||
HPIV2RNA | C184663 | Human Orthorubulavirus 2 RNA;Human Parainfluenza Virus 2 RNA | A measurement of the Human parainfluenza virus 2 RNA in a biological specimen. | Human Parainfluenza Virus 2 RNA Measurement | ||
HPIV3 | C178013 | Human Parainfluenza Virus 3 | A measurement of the Human parainfluenza virus 3 in a biological specimen. | Human Parainfluenza Virus 3 Measurement | ||
HPIV3AG | C186164 | Human Parainfluenza Virus 3 Antigen;Human Respirovirus 3 Antigen | A measurement of the Human parainfluenza virus 3 antigen in a biological specimen. | Human Parainfluenza Virus 3 Antigen Measurement | ||
HPIV3NC | C198322 | Human Parainfluenza Virus 3 Nucleic Acid | A measurement of the Human parainfluenza virus 3 nucleic acid in a biological specimen. | Human Parainfluenza Virus 3 Nucleic Acid Measurement | ||
HPIV3RNA | C184664 | Human Parainfluenza Virus 3 RNA;Human Respirovirus 3 RNA | A measurement of the Human parainfluenza virus 3 RNA in a biological specimen. | Human Parainfluenza Virus 3 RNA Measurement | ||
HPIV4 | C178014 | Human Parainfluenza Virus 4 | A measurement of the Human parainfluenza virus 4 in a biological specimen. | Human Parainfluenza Virus 4 Measurement | ||
HPIV4BNC | C198323 | Human Parainfluenza Virus 4B Nucleic Acid | A measurement of the Human parainfluenza virus 4b nucleic acid in a biological specimen. | Human Parainfluenza Virus 4B Nucleic Acid Measurement | ||
HPIV4NC | C198324 | Human Parainfluenza Virus 4 Nucleic Acid | A measurement of the Human parainfluenza virus 4 nucleic acid in a biological specimen. | Human Parainfluenza Virus 4 Nucleic Acid Measurement | ||
HPIV4RNA | C184651 | Human Orthorubulavirus 4 RNA;Human Parainfluenza Virus 4 RNA | A measurement of the Human parainfluenza virus 4 RNA in a biological specimen. | Human Parainfluenza Virus 4 RNA Measurement | ||
HPIVAG | C154833 | Human Parainfluenza Antigen | A measurement of the Human Parainfluenza antigen in a biological specimen. | Human Parainfluenza Antigen Measurement | ||
HPIVRNA | C191316 | Human Parainfluenza virus RNA | A measurement of the Human parainfluenza virus RNA in a biological specimen. | Human Parainfluenza virus RNA Measurement | ||
HPLIGGAB | C103403 | Helicobacter pylori IgG Antibody | A measurement of the Helicobacter pylori IgG antibody in a biological specimen. | Helicobacter pylori IgG Antibody Measurement | ||
HPV11AB | C127618 | Human Papillomavirus 11 Antibody | A measurement of the human papillomavirus 11 antibody in a biological specimen. | Human Papillomavirus 11 Antibody Measurement | ||
HPV16AB | C127619 | Human Papillomavirus 16 Antibody | A measurement of the human papillomavirus 16 antibody in a biological specimen. | Human Papillomavirus 16 Antibody Measurement | ||
HPV18AB | C127620 | Human Papillomavirus 18 Antibody | A measurement of the human papillomavirus 18 antibody in a biological specimen. | Human Papillomavirus 18 Antibody Measurement | ||
HPV31 | C189566 | Human Papillomavirus Type 31 | A measurement of the Human papillomavirus type 31 in a biological specimen. | Human Papillomavirus Type 31 Measurement | ||
HPV33 | C189567 | Human Papillomavirus Type 33 | A measurement of the Human papillomavirus type 33 in a biological specimen. | Human Papillomavirus Type 33 Measurement | ||
HPV34 | C189556 | Human Papillomavirus Type 34 | A measurement of the Human papillomavirus type 34 in a biological specimen. | Human Papillomavirus Type 34 Measurement | ||
HPV35 | C189568 | Human Papillomavirus Type 35 | A measurement of the Human papillomavirus type 35 in a biological specimen. | Human Papillomavirus Type 35 Measurement | ||
HPV39 | C189569 | Human Papillomavirus Type 39 | A measurement of the Human papillomavirus type 39 in a biological specimen. | Human Papillomavirus Type 39 Measurement | ||
HPV40 | C189557 | Human Papillomavirus Type 40 | A measurement of the Human papillomavirus type 40 in a biological specimen. | Human Papillomavirus Type 40 Measurement | ||
HPV42 | C189558 | Human Papillomavirus Type 42 | A measurement of the Human papillomavirus type 42 in a biological specimen. | Human Papillomavirus Type 42 Measurement | ||
HPV43 | C189559 | Human Papillomavirus Type 43 | A measurement of the Human papillomavirus type 43 in a biological specimen. | Human Papillomavirus Type 43 Measurement | ||
HPV44 | C189560 | Human Papillomavirus Type 44 | A measurement of the Human papillomavirus type 44 in a biological specimen. | Human Papillomavirus Type 44 Measurement | ||
HPV45 | C189570 | Human Papillomavirus Type 45 | A measurement of the Human papillomavirus type 45 in a biological specimen. | Human Papillomavirus Type 45 Measurement | ||
HPV51 | C189571 | Human Papillomavirus Type 51 | A measurement of the Human papillomavirus type 51 in a biological specimen. | Human Papillomavirus Type 51 Measurement | ||
HPV52 | C189572 | Human Papillomavirus Type 52 | A measurement of the Human papillomavirus type 52 in a biological specimen. | Human Papillomavirus Type 52 Measurement | ||
HPV53 | C189561 | Human Papillomavirus Type 53 | A measurement of the Human papillomavirus type 53 in a biological specimen. | Human Papillomavirus Type 53 Measurement | ||
HPV54 | C189562 | Human Papillomavirus Type 54 | A measurement of the Human papillomavirus type 54 in a biological specimen. | Human Papillomavirus Type 54 Measurement | ||
HPV56 | C189573 | Human Papillomavirus Type 56 | A measurement of the Human papillomavirus type 56 in a biological specimen. | Human Papillomavirus Type 56 Measurement | ||
HPV58 | C189574 | Human Papillomavirus Type 58 | A measurement of the Human papillomavirus type 58 in a biological specimen. | Human Papillomavirus Type 58 Measurement | ||
HPV59 | C189575 | Human Papillomavirus Type 59 | A measurement of the Human papillomavirus type 59 in a biological specimen. | Human Papillomavirus Type 59 Measurement | ||
HPV66 | C189563 | Human Papillomavirus Type 66 | A measurement of the Human papillomavirus type 66 in a biological specimen. | Human Papillomavirus Type 66 Measurement | ||
HPV68 | C189576 | Human Papillomavirus Type 68 | A measurement of the Human papillomavirus type 68 in a biological specimen. | Human Papillomavirus Type 68 Measurement | ||
HPV69 | C189577 | Human Papillomavirus Type 69 | A measurement of the Human papillomavirus type 69 in a biological specimen. | Human Papillomavirus Type 69 Measurement | ||
HPV6AB | C127621 | Human Papillomavirus 6 Antibody | A measurement of the human papillomavirus 6 antibody in a biological specimen. | Human Papillomavirus 6 Antibody Measurement | ||
HPV70 | C189564 | Human Papillomavirus Type 70 | A measurement of the Human papillomavirus type 70 in a biological specimen. | Human Papillomavirus Type 70 Measurement | ||
HPV74 | C189565 | Human Papillomavirus Type 74 | A measurement of the Human papillomavirus type 74 in a biological specimen. | Human Papillomavirus Type 74 Measurement | ||
HPVE67MR | C186165 | Human Papillomavirus E6/E7 Messenger RNA;Human Papillomavirus E6/E7 mRNA | A measurement of the human papillomavirus E6 and/or E7 protein-making mRNA in a biological specimen. | Human Papillomavirus E6/E7 mRNA Measurement | ||
HPY | C189536 | Helicobacter pylori | A measurement of the Helicobacter pylori in a biological specimen. | Helicobacter pylori Measurement | ||
HPYAG | C154819 | Helicobacter pylori Antigen | A measurement of the Helicobacter pylori antigen in a biological specimen. | Helicobacter pylori Antigen Measurement | ||
HPYDNA | C184666 | Helicobacter pylori DNA | A measurement of the Helicobacter pylori DNA in a biological specimen. | Helicobacter pylori DNA Measurement | ||
HRVABC | C186166 | HRV A/B/C;Human rhinovirus;Human rhinovirus A/B/C | A measurement of the Human rhinovirus A, B and/or C in a biological specimen. | Human rhinovirus A, B, and/or C Measurement | ||
HRVABCAG | C186167 | HRV A/B/C Antigen;Human rhinovirus A/B/C Antigen;Human rhinovirus Antigen | A measurement of the Human rhinovirus A, B and/or C antigen in a biological specimen. | Human rhinovirus A, B, and/or C Antigen Measurement | ||
HS1 | C187853 | Herpes Simplex Virus 1 | A measurement of the herpes simplex virus 1 in a biological specimen. | Herpes Simplex Virus 1 Measurement | ||
HS12AG | C186168 | Herpes Simplex Virus 1/2 Antigen;HSV 1/2 Antigen | A measurement of the herpes simplex virus 1 and/or 2 antigen in a biological specimen. | Herpes Simplex Virus 1 and/or 2 Antigen Measurement | ||
HS12GGAB | C96697 | Herpes Simplex Virus 1/2 IgG Antibody;HSV-1/2 IgG Ab | A measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen. | Herpes Simplex Virus 1/2 IgG Antibody Measurement | ||
HS12GMAB | C96698 | Herpes Simplex Virus 1/2 IgM Antibody;HSV-1/2 IgM Ab | A measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen. | Herpes Simplex Virus 1/2 IgM Antibody Measurement | ||
HS1DNA | C186169 | Herpes Simplex Virus 1 DNA | A measurement of the herpes simplex virus 1 DNA in a biological specimen. | Herpes Simplex Virus 1 DNA Measurement | ||
HS1IGGAB | C96666 | Herpes Simplex Virus 1 IgG Antibody;HSV-1 IgG Antibody | A measurement of the herpes simplex virus 1 IgG antibody in a biological specimen. | Herpes Simplex Virus 1 IgG Antibody Measurement | ||
HS1IGMAB | C98738 | Herpes Simplex Virus 1 IgM Antibody | A measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen. | Herpes Simplex Virus 1 IgM Antibody Measurement | ||
HS2 | C187854 | Herpes Simplex Virus 2 | A measurement of the herpes simplex virus 2 in a biological specimen. | Herpes Simplex Virus 2 Measurement | ||
HS2DNA | C186170 | Herpes Simplex Virus 2 DNA | A measurement of the Herpes simplex virus 2 DNA in a biological specimen. | Herpes Simplex Virus 2 DNA Measurement | ||
HS2IGGAB | C96667 | Herpes Simplex Virus 2 IgG Antibody;HSV-2 IgG Antibody | A measurement of the herpes simplex virus 2 IgG antibody in a biological specimen. | Herpes Simplex Virus 2 IgG Antibody Measurement | ||
HS2IGMAB | C98739 | Herpes Simplex Virus 2 IgM Antibody | A measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen. | Herpes Simplex Virus 2 IgM Antibody Measurement | ||
HTLV12AB | C122125 | HTLV-1/2 Antibody;HTLV-I/II Antibody;Human T-cell Lymphotropic Virus 1/2 Antibody | A measurement of either the HTLV-1 or HTLV-2 virus antibody in a biological specimen. | HTLV-I HTLV-II Antibody Measurement | ||
HTPHAB | C81984 | Heterophile Antibodies | A measurement of the heterophile antibodies in a biological specimen. | Heterophile Antibody Measurement | ||
IAIGGAB | C103408 | Influenza A IgG Antibody | A measurement of the Influenza A IgG antibody in a biological specimen. | Influenza A IgG Antibody Measurement | ||
IBIGGAB | C103409 | Influenza B IgG Antibody | A measurement of the Influenza B IgG antibody in a biological specimen. | Influenza B IgG Antibody Measurement | ||
INFA | C187857 | Influenza A Virus | A measurement of the Influenza A virus an biological specimen. | Influenza A Virus Measurement | ||
INFAAG | C120677 | Influenza A Antigen | A measurement of the influenza A antigen in a biological specimen. | Influenza A Antigen Measurement | ||
INFAB | C184674 | Influenza A/B Virus | A measurement of the influenza A and/or B virus in a biological specimen. | Influenza A/B Virus Measurement | ||
INFABAG | C120678 | Influenza A/B Antigen | A measurement of the influenza A and/or B antigen in a biological specimen. | Influenza A/B Antigen Measurement | ||
INFANUAC | C198325 | Influenza A Nucleic Acid | A measurement of the Influenza A virus nucleic acid in an biological specimen. | Influenza A Nucleic Acid Measurement | ||
INFARNA | C191317 | Influenza A RNA | A measurement of the Influenza A virus RNA in a biological specimen. | Influenza A RNA Measurement | ||
INFB | C187858 | Influenza B Virus | A measurement of the Influenza B virus an biological specimen. | Influenza B Virus Measurement | ||
INFBAG | C120679 | Influenza B Antigen | A measurement of the influenza B antigen in a biological specimen. | Influenza B Antigen Measurement | ||
INFBNUAC | C198326 | Influenza B Nucleic Acid | A measurement of the Influenza B virus nucleic acid in an biological specimen. | Influenza B Nucleic Acid Measurement | ||
INFBRNA | C191318 | Influenza B RNA | A measurement of the Influenza B virus RNA in a biological specimen. | Influenza B RNA Measurement | ||
JCVAB | C112326 | JC Polyomavirus Antibody;JC Virus Antibody;JCV Antibody;John Cunningham Virus Antibody | A measurement of the JC virus antibody in a biological specimen. | JC Virus Antibody Measurement | ||
JCVDNA | C163540 | JC Polyomavirus DNA;JC Virus DNA;JCV DNA;John Cunningham Virus DNA | A measurement of the JC virus DNA in a biological specimen. | JC Virus DNA Measurement | ||
JEVAB | C147378 | Japanese Encephalitis Virus Antibody | A measurement of the Japanese encephalitis virus antibody in a biological specimen. | Japanese Encephalitis Virus Antibody Measurement | ||
KAE | C187859 | Klebsiella aerogenes | A measurement of the Klebsiella aerogenes in a biological specimen. | Klebsiella aerogenes Measurement | ||
KAEDNA | C191319 | Klebsiella aerogenes DNA | A measurement of the Klebsiella aerogenes DNA in a biological specimen. | Klebsiella aerogenes DNA Measurement | ||
KLEBSIEL | C172539 | Klebsiella | A measurement of the organisms that are not assigned to the species level but are assigned to the Klebsiella genus level in a biological specimen. | Klebsiella Measurement | ||
KOX | C191321 | Klebsiella oxytoca | A measurement of the Klebsiella oxytoca in a biological specimen. | Klebsiella oxytoca Measurement | ||
KOXDNA | C191320 | Klebsiella oxytoca DNA | A measurement of the Klebsiella oxytoca DNA in a biological specimen. | Klebsiella oxytoca DNA Measurement | ||
KPN | C187860 | Klebsiella pneumoniae | A measurement of the Klebsiella pneumoniae in a biological specimen. | Klebsiella pneumoniae Measurement | ||
KPNDNA | C191322 | Klebsiella pneumoniae DNA | A measurement of the Klebsiella pneumoniae DNA in a biological specimen. | Klebsiella pneumoniae DNA Measurement | ||
LCRDNA | C166046 | Lactobacillus crispatus DNA | A measurement of the Lactobacillus crispatus DNA in a biological specimen. | Lactobacillus crispatus DNA Measurement | ||
LLODNA | C187861 | Legionella longbeachae DNA | A measurement of the Legionella longbeachae DNA in a biological specimen. | Legionella longbeachae DNA Measurement | ||
LMO | C189534 | Listeria monocytogenes | A measurement of the Listeria monocytogenes in a biological specimen. | Listeria monocytogenes Measurement | ||
LPN | C186171 | Legionella pneumophila | A measurement of the Legionella pneumophila in a biological specimen. | Legionella pneumophila Measurement | ||
LPNAG | C92275 | Legionella pneumophila Antigen | A measurement of the Legionella pneumophila antigen in a biological specimen. | Legionella pneumophila Antigen Measurement | ||
LPNDNA | C186172 | Legionella pneumophila DNA | A measurement of the Legionella pneumophila DNA in a biological specimen. | Legionella pneumophila DNA Measurement | ||
LPNGMAB | C92277 | Legionella pneumophila IgG IgM Antibody | A measurement of the Legionella pneumophila IgG and IgM in a biological specimen. | Legionella pneumophila IgG IgM Antibody Measurement | ||
LPNIGGAB | C92276 | Legionella pneumophila IgG Antibody | A measurement of the Legionella pneumophila IgG antibody in a biological specimen. | Legionella pneumophila IgG Antibody Measurement | ||
LPNIGMAB | C92278 | Legionella pneumophila IgM Antibody | A measurement of the Legionella pneumophila IgM antibody in a biological specimen. | Legionella pneumophila IgM Antibody Measurement | ||
LPNS1AG | C154826 | Legionella pneumophila Serogroup 1 Antigen;Legionella pneumophila Sg 1 Antigen | A measurement of the Legionella pneumophila serogroup 1 antigen in a biological specimen. | Legionella pneumophila Serogroup 1 Antigen Measurement | ||
LSMDNA | C186173 | Listeria monocytogenes DNA | A measurement of the Listeria monocytogenes DNA in a biological specimen. | Listeria monocytogenes DNA Measurement | ||
MAB | C172543 | Mycobacterium abscessus | A measurement of the Mycobacterium abscessus in a biological specimen. | Mycobacterium abscessus Measurement | ||
MAVCM | C172540 | Mycobacterium avium Complex | A measurement of the group of bacterial species that can be assigned to the Mycobacterium avium complex in a biological specimen. | Mycobacterium avium Complex Measurement | ||
MCA | C187862 | Moraxella catarrhalis | A measurement of the Moraxella catarrhalis in a biological specimen. | Moraxella catarrhalis Measurement | ||
MCADNA | C191323 | Moraxella catarrhalis DNA | A measurement of the Moraxella catarrhalis DNA in a biological specimen. | Moraxella catarrhalis DNA Measurement | ||
MCH | C172544 | Mycobacterium chelonae | A measurement of the Mycobacterium chelonae in a biological specimen. | Mycobacterium chelonae Measurement | ||
MCORGIDN | C132416 | Microbial Organism Identification | The identification of the type of a microbial organism in a biological specimen. | Microoganism Identification | ||
MERSRNA | C171515 | MERS-CoV RNA | A measurement of the MERS-CoV RNA in a biological specimen. | MERS-CoV RNA Measurement | ||
MFILARIA | C117843 | Microfilaria | Presence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids. | Microfilaria Measurement | ||
MFO | C172545 | Mycobacterium fortuitum | A measurement of the Mycobacterium fortuitum in a biological specimen. | Mycobacterium fortuitum Measurement | ||
MGE | C166047 | Mycoplasma genitalium | A measurement of the Mycoplasma genitalium in a biological specimen. | Mycoplasma genitalium Measurement | ||
MGEDNA | C198327 | Mycoplasma genitalium DNA | A measurement of the Mycoplasma genitalium DNA in a biological specimen. | Mycoplasma genitalium DNA Measurement | ||
MHODNA | C198328 | Mycoplasma hominis DNA | A measurement of the Mycoplasma hominis DNA in a biological specimen. | Mycoplasma hominis DNA Measurement | ||
MKA | C172541 | Mycobacterium kansasii | A measurement of the Mycobacterium kansasii in a biological specimen. | Mycobacterium kansasii Measurement | ||
MMPIGGAB | C122136 | Mumps Virus IgG Antibody | A measurement of the mumps virus IgG antibody in a biological specimen. | Mumps Virus IgG Antibody Measurement | ||
MMPIGMAB | C163541 | Mumps Rubulavirus IgM Antibody;Mumps Virus IgM Antibody | A measurement of the Mumps rubulavirus IgM Antibody in a biological specimen. | Mumps Virus IgM Antibody Measurement | ||
MMPRNA | C189548 | Mumps rubulavirus RNA;Mumps Virus RNA | A measurement of the Mumps rubulavirus RNA in a biological specimen. | Mumps Virus RNA Measurement | ||
MORGANEL | C179759 | Morganella | A measurement of the organisms that are not assigned to the species level but are assigned to the Morganella genus level in a biological specimen. | Morganella Measurement | ||
MPN | C156543 | Mycoplasma pneumoniae | A measurement of the Mycoplasma pneumoniae in a biological specimen. | Mycoplasma pneumoniae Measurement | ||
MPNDNA | C184658 | Mycoplasma pneumoniae DNA | A measurement of the Mycoplasma pneumoniae DNA in a biological specimen. | Mycoplasma pneumoniae DNA Measurement | ||
MPNIGAAB | C163542 | Mycoplasma pneumoniae IgA Antibody | A measurement of the Mycoplasma pneumoniae IgA antibody in a biological specimen. | Mycoplasma pneumoniae IgA Antibody Measurement | ||
MPNIGMAB | C163543 | Mycoplasma pneumoniae IgM Antibody | A measurement of the Mycoplasma pneumoniae IgM antibody in a biological specimen. | Mycoplasma pneumoniae IgM Antibody Measurement | ||
MPNNUAC | C198329 | Mycoplasma pneumoniae Nucleic Acid | A measurement of the Mycoplasma pneumoniae nucleic acid in a biological specimen. | Mycoplasma pneumoniae Nucleic Acid Measurement | ||
MPPIGGAB | C166048 | Mycoplasma pneumophila IgG Antibody | A measurement of the Mycoplasma pneumophila IgG antibody in a biological specimen. | Mycoplasma pneumophila IgG Antibody Measurement | ||
MPPIGMAB | C166049 | Mycoplasma pneumophila IgM Antibody | A measurement of the Mycoplasma pneumophila IgM antibody in a biological specimen. | Mycoplasma pneumophila IgM Antibody Measurement | ||
MPXV | C198330 | Monkey Pox Virus;Monkeypox Virus | A measurement of the Monkeypox virus in a biological specimen. | Monkeypox Virus Measurement | ||
MPXVDNA | C198331 | Monkeypox Virus DNA | A measurement of the Monkeypox virus DNA in a biological specimen. | Monkeypox Virus DNA Measurement | ||
MRSA | C139110 | S. aureus, Methicillin-Resistant;Staphylococcus aureus, Methicillin-Resistant | A measurement of the methicillin-resistant strain of Staphylococcus aureus in a biological specimen. | Methicillin-resistant Staphylococcus aureus Measurement | ||
MSI | C172542 | Mycobacterium simiae | A measurement of the Mycobacterium simiae in a biological specimen. | Mycobacterium simiae Measurement | ||
MSSA | C139111 | S. aureus, Methicillin-Susceptible;Staphylococcus aureus, Methicillin-Susceptible | A measurement of the methicillin-susceptible strain of Staphylococcus aureus in a biological specimen. | Methicillin-susceptible Staphylococcus aureus Measurement | ||
MTB | C128982 | Mycobacterium tuberculosis | A measurement of the organisms that are assigned to the Mycobacterium tuberculosis species in a biological specimen. | Mycobacterium Tuberculosis Measurement | ||
MTBCMPLX | C128983 | Mycobacterium tuberculosis Complex | A measurement of the organisms assignable to the Mycobacterium tuberculosis complex in a biological specimen. | Mycobacterium tuberculosis Complex Measurement | ||
MTBIGAAB | C124346 | Mycobacterium tuberculosis IgA Antibody | A measurement of the Mycobacterium tuberculosis IgA antibodies in a biological specimen. | Mycobacterium tuberculosis IgA Antibody Measurement | ||
MTBIGEAB | C124347 | Mycobacterium tuberculosis IgE Antibody | A measurement of the Mycobacterium tuberculosis IgE antibodies in a biological specimen. | Mycobacterium tuberculosis IgE Antibody Measurement | ||
MTBIGGAB | C124348 | Mycobacterium tuberculosis IgG Antibody | A measurement of the Mycobacterium tuberculosis IgG antibodies in a biological specimen. | Mycobacterium tuberculosis IgG Antibody Measurement | ||
MTBRIR | C187868 | M. tuberculosis, Rifampin-resistant;Mycobacterium tuberculosis, Rifampin-resistant | A measurement of the organisms that are not assigned to the species level but are assigned to the Mycobacterium tuberculosis level and are also rifampin-resistant in a biological specimen. | Rifampin-resistant Mycobacterium Measurement | ||
MYCOBACT | C186174 | Mycobacterium | A measurement of the organisms that are not assigned to the species level but are assigned to the Mycobacterium genus level in a biological specimen. | Mycobacterium Measurement | ||
MYCOPLAS | C187863 | Mycoplasma | A measurement of the organisms that are not assigned to the species level but are assigned to the Mycoplasma genus level in a biological specimen. | Mycoplasma Measurement | ||
MYTBGIR | C92241 | M. tuberculosis IFN Gamma Response;Mycobacterium tuberculosis IFN Gamma Response | A measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection. | Mycobacterium tuberculosis Interferon Gamma Response | ||
MYTBNUAC | C92279 | Mycobacterium tuberculosis Nucleic Acid | A measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen. | Mycobacterium tuberculosis Nucleic Acid Measurement | ||
NCY | C187864 | Nocardia cyriacigeorgica | A measurement of the Nocardia cyriacigeorgica in a biological specimen. | Nocardia cyriacigeorgica Measurement | ||
NGO | C92298 | Neisseria gonorrhoeae | A measurement of the Neisseria gonorrhoeae in a biological specimen. | Neisseria gonorrhoeae Measurement | ||
NGOBLN | C161399 | N. gonorrhoeae, Beta-lactamase Negative | A measurement of the beta-lactamase negative strain of Neisseria gonorrhoeae in a biological specimen. | Neisseria gonorrhoeae, Beta-lactamase Negative Measurement | ||
NGOBLP | C161398 | N. gonorrhoeae, Beta-lactamase Positive | A measurement of the beta-lactamase positive strain of Neisseria gonorrhoeae in a biological specimen. | Neisseria gonorrhoeae, Beta-lactamase Positive Measurement | ||
NGODNA | C186175 | Neisseria gonorrhoeae DNA | A measurement of the Neisseria gonorrhoeae DNA in a biological specimen. | Neisseria gonorrhoeae DNA Measurement | ||
NGORNA | C186176 | Neisseria gonorrhoeae RNA | A measurement of the Neisseria gonorrhoeae RNA in a biological specimen. | Neisseria gonorrhoeae RNA Measurement | ||
NL63NC | C198332 | HCoV-NL63 Nucleic Acid;Human Coronavirus NL63 Nucleic Acid | A measurement of the Human coronavirus NL63 nucleic acid in a biological specimen. | Human Coronavirus NL63 Nucleic Acid Measurement | ||
NL63RNA | C184654 | HCoV-NL63 RNA;Human Coronavirus NL63 RNA | A measurement of the Human coronavirus NL63 RNA in a biological specimen. | HCoV-NL63 RNA Measurement | ||
NMEAAG | C198333 | Neisseria meningitidis A Antigen | A measurement of Neisseria meningitidis A antigen in a biological specimen. | Neisseria meningitidis A Antigen Measurement | ||
NMECAG | C198334 | Neisseria meningitidis C Antigen | A measurement of Neisseria meningitidis C antigen in a biological specimen. | Neisseria meningitidis C Antigen Measurement | ||
NMEDNA | C186177 | Neisseria meningitidis DNA | A measurement of Neisseria meningitidis DNA in a biological specimen. | Neisseria meningitidis DNA Measurement | ||
NOROVIRU | C189579 | Norovirus | A measurement of the organisms that are not assigned to the species level but are assigned to the Norovirus genus level in a biological specimen. | Norovirus Measurement | ||
NOVRNA | C166050 | Norwalk calicivirus RNA;Norwalk virus RNA | A measurement of the Norwalk virus RNA in a biological specimen. | Norwalk virus RNA Measurement | ||
NTBMYCO | C147459 | Non-tuberculous mycobacteria;Nontuberculous Mycobacteria;NTM | A measurement of the organisms that are assigned to the Mycobacterium genus but are not tuberculosis or leprosy-causing in a biological specimen. | Nontuberculous Mycobacteria Measurement | ||
NTMNUAC | C189533 | Nontuberculous Mycobacteria Nucleic Acid | A measurement of the nucleic acid from any nontuberculous member of the Mycobacterium genus in a biological specimen. | Nontuberculous Mycobacteria Nucleic Acid Measurement | ||
NVGIIRNA | C166051 | Human Calicivirus Genogroup 2 RNA;Norovirus Genogroup II RNA;Norovirus GII RNA | A measurement of Norovirus genogroup II RNA in a biological specimen. | Norovirus Genogroup II RNA Measurement | ||
NVGIRNA | C166052 | Human Calicivirus Genogroup 1 RNA;Norovirus Genogroup 1 RNA;Norovirus GI RNA | A measurement of Norovirus genogroup I RNA in a biological specimen. | Norovirus Genogroup I RNA Measurement | ||
NVRNA | C184668 | Norovirus RNA | A measurement of the RNA from any member of the genus Norovirus in a biological specimen. | Norovirus RNA Measurement | ||
OC43NC | C198335 | HCoV-OC43 Nucleic Acid;Human Coronavirus OC43 Nucleic Acid | A measurement of the Human coronavirus OC43 nucleic acid in a biological specimen. | Human Coronavirus OC43 Nucleic Acid Measurement | ||
OC43RNA | C184653 | HCoV-OC43 RNA;Human Coronavirus OC43 RNA | A measurement of the Human coronavirus OC43 RNA in a biological specimen. | HCoV-OC43 RNA Measurement | ||
OVAPARS | C100452 | Ova and Parasite | A measurement of the parasites and ova in a biological specimen. | Ova and Parasite Measurement | ||
PAE | C172546 | Pseudomonas aeruginosa | A measurement of the Pseudomonas aeruginosa in a biological specimen. | Pseudomonas aeruginosa Measurement | ||
PAEDNA | C191325 | Pseudomonas aeruginosa DNA | A measurement of the Pseudomonas aeruginosa DNA in a biological specimen. | Pseudomonas aeruginosa DNA Measurement | ||
PAERGMUC | C139108 | P. aeruginosa, Mucoid;Pseudomonas aeruginosa, Mucoid | A measurement of the mucoid strain of Pseudomonas aeruginosa in a biological specimen. | Mucoid Pseudomonas aeruginosa Measurement | ||
PAERGNMC | C139107 | P. aeruginosa, Non-Mucoid;Pseudomonas aeruginosa, Non-Mucoid | A measurement of the non-mucoid strain of Pseudomonas aeruginosa in a biological specimen. | Non-Mucoid Pseudomonas aeruginosa Measurement | ||
PAERGSCV | C139109 | P. aeruginosa, Small-colony Variant;Pseudomonas aeruginosa, SCV;Pseudomonas aeruginosa, Small-colony Variant | A measurement of the small-colony variant strain of Pseudomonas aeruginosa in a biological specimen. | Small-Colony Variant Pseudomonas aeruginosa Measurement | ||
PARECRNA | C186178 | Parechovirus RNA | A measurement of the RNA from any member of the genus Parechovirus in a biological specimen. | Parechovirus RNA Measurement | ||
PB19GGAB | C96617 | Parvovirus B19 IgG Antibody | A measurement of the Parvovirus B19 IgG antibody in a biological specimen. | Parvovirus B19 IgG Antibody Measurement | ||
PB19GMAB | C96618 | Parvovirus B19 IgM Antibody | A measurement of the Parvovirus B19 IgM antibody in a biological specimen. | Parvovirus B19 IgM Antibody Measurement | ||
PBI | C187866 | Prevotella bivia | A measurement of the Prevotella bivia in a biological specimen. | Prevotella bivia Measurement | ||
PJIAG | C186179 | Pneumocystis jiroveci Antigen | A measurement of the Pneumocystis jiroveci antigen in a biological specimen. | Pneumocystis jiroveci Antigen Measurement | ||
PJIDNA | C187865 | Pneumocystis jiroveci DNA | A measurement of the Pneumocystis jiroveci DNA in a biological specimen. | Pneumocystis jiroveci DNA Measurement | ||
PKNOWLA | C132417 | Plasmodium knowlesi, Asexual | A measurement of the Plasmodium knowlesi in an asexual replication stage in a biological specimen. | Asexual Plasmodium knowlesi Measurement | ||
PKNOWLS | C132418 | Plasmodium knowlesi, Sexual | A measurement of the Plasmodium knowlesi in a sexual replication stage in a biological specimen. | Sexual Plasmodium knowlesi Measurement | ||
PLSMDM | C100453 | Malaria;Plasmodium | Examination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus. | Plasmodium Measurement | ||
PMI | C179760 | Proteus mirabilis | A measurement of the Proteus mirabilis in a biological specimen. | Proteus mirabilis Measurement | ||
PROTDNA | C191324 | Proteus DNA;Proteus Species DNA;Proteus spp DNA | A measurement of the DNA from any member of the genus Proteus in a biological specimen. | Proteus DNA Measurement | ||
PROTOZOA | C117849 | Protozoa | A measurement of protozoa in a biological specimen. | Protozoa Measurement | ||
PSEUDOMO | C172384 | Pseudomonas | A measurement of the organisms that are not assigned to the species level but are assigned to the Pseudomonas genus level in a biological specimen. | Pseudomonas Measurement | ||
PSHDNA | C166053 | Plesiomonas shigelloides DNA | A measurement of the Plesiomonas shigelloides DNA in a biological specimen. | Plesiomonas shigelloides DNA Measurement | ||
RBOAG | C154815 | Measles Virus Antigen | A measurement of the Rubeola virus antigen in a biological specimen. | Rubeola Antigen Measurement | ||
RBOIGGAB | C112412 | Measles IgG Antibody;Rubeola IgG Antibody | A measurement of the Measles (Rubeola) virus IgG antibody in a biological specimen. | Rubeola IgG Antibody Measurement | ||
RBOIGMAB | C112413 | Measles IgM Antibody;Rubeola IgM Antibody | A measurement of the Measles (Rubeola) virus IgM antibody in a biological specimen. | Rubeola IgM Antibody Measurement | ||
REAAB | C74716 | Rapid Plasma Reagin;Reagin Antibody;RPR;VDRL;Venereal Disease Research Laboratory Test | A measurement of the non-specific Treponemal antibodies produced in response to cellular damage caused by Treponema pallidum (syphilis) in a biological specimen. | Rapid Plasma Reagin Measurement | ||
RICKDNA | C187867 | Rickettsia DNA | A measurement of the DNA from any member of the genus Rickettsia in a biological specimen. | Rickettsia DNA Measurement | ||
ROTAG | C154827 | Rotavirus Antigen | A measurement of the antigen from any member of the genus Rotavirus in a biological specimen. | Rotavirus Antigen Measurement | ||
ROTAVIRU | C172549 | Rotavirus | A measurement of the organisms that are not assigned to the species level but are assigned to the Rotavirus genus level in a biological specimen. | Rotavirus Measurement | ||
ROTRNA | C186180 | Rotavirus RNA | A measurement of the RNA from any member of the genus Rotavirus in a biological specimen. | Rotavirus RNA Measurement | ||
RROARNA | C166054 | Rotavirus A RNA;Rotavirus Group A RNA | A measurement of the Rotavirus A RNA in a biological specimen. | Rotavirus A RNA Measurement | ||
RSV | C171526 | Respiratory Syncytial Virus | A measurement of the respiratory syncytial virus in a biological specimen. | Respiratory Syncytial Virus Measurement | ||
RSVA | C184660 | Respiratory Syncytial Virus Type A | A measurement of the respiratory syncytial virus type A in a biological specimen. | Respiratory Syncytial Virus Type A Measurement | ||
RSVAG | C154823 | Respiratory Syncytial Virus Antigen;RSV Antigen | A measurement of the respiratory syncytial virus antigen in a biological specimen. | Respiratory Syncytial Virus Antigen Measurement | ||
RSVANUAC | C198336 | Respiratory Syncytial Virus Type A Nucleic Acid;RSV Type A Nucleic Acid | A measurement of the respiratory syncytial virus type A nucleic acid in a biological specimen. | Human Respiratory Syncytial Virus Type A Nucleic Acid Measurement | ||
RSVB | C184661 | Respiratory Syncytial Virus Type B | A measurement of the respiratory syncytial virus type B in a biological specimen. | Respiratory Syncytial Virus Type B Measurement | ||
RSVBNUAC | C198337 | Respiratory Syncytial Virus Type B Nucleic Acid;RSV Type B Nucleic Acid | A measurement of the respiratory syncytial virus type B nucleic acid in a biological specimen. | Human Respiratory Syncytial Virus Type B Nucleic Acid Measurement | ||
RSVRNA | C186181 | Respiratory Syncytial Virus RNA | A measurement of the respiratory syncytial virus RNA in a biological specimen. | Respiratory Syncytial Virus RNA Measurement | ||
RUBIGGAB | C103440 | Rubella IgG Antibody | A measurement of the Rubella IgG antibody in a biological specimen. | Rubella IgG Antibody Measurement | ||
RUBIGMAB | C163544 | Rubella IgM Antibody | A measurement of the Rubella IgM antibody in a biological specimen. | Rubella IgM Antibody Measurement | ||
RVENT | C179761 | Human rhinovirus/enterovirus | A measurement of the Human rhinovirus and/or Human enterovirus in a biological specimen. | Human Rhinovirus and/or Enterovirus Measurement | ||
RVENTRNA | C170609 | Human rhinovirus/enterovirus RNA | A measurement of RNA from any member of the Human Rhinovirus species and/or Human Enterovirus species in a biological specimen. | Human rhinovirus and/or enterovirus RNA Measurement | ||
SAG | C179762 | Streptococcus agalactiae | A measurement of the Streptococcus agalactiae in a biological specimen. | Streptococcus agalactiae Measurement | ||
SAGAG | C154824 | Streptococcus agalactiae Antigen;Streptococcus Group B Antigen | A measurement of the Streptococcus agalactiae antigen in a biological specimen. | Streptococcus agalactiae Antigen Measurement | ||
SAGDNA | C186182 | Streptococcus agalactiae DNA | A measurement of the Streptococcus agalactiae DNA in a biological specimen. | Streptococcus agalactiae DNA Measurement | ||
SALMOAG | C198338 | Salmonella Antigen | A measurement of the antigen from any member of the genus Salmonella in a biological specimen. | Salmonella Antigen Measurement | ||
SALMODNA | C186183 | Salmonella DNA | A measurement of the DNA from any member of the genus Salmonella in a biological specimen. | Salmonella DNA Measurement | ||
SALMONEL | C181460 | Salmonella | A measurement of the organisms that are not assigned to the species level but are assigned to the Salmonella genus level in a biological specimen. | Salmonella Measurement | ||
SAN | C187871 | Streptococcus anginosus | A measurement of the Streptococcus anginosus in a biological specimen. | Streptococcus anginosus Measurement | ||
SAR12AG | C174327 | SARS-CoV-1/SARS-CoV-2 Antigen | A measurement of the antigens from SARS-CoV-1 and/or SARS-CoV-2 in a biological specimen. | SARS-CoV-1/SARS-CoV-2 Antigen Measurement | ||
SAR2AB | C171439 | SARS-CoV-2 Antibody | A measurement of the SARS-CoV-2 antibody in a biological specimen. | Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Measurement | ||
SAR2AG | C176327 | SARS-CoV-2 Antigen | A measurement of the SARS-CoV-2 antigen in a biological specimen. | SARS-CoV-2 Antigen Measurement | ||
SAR2IGA | C171527 | SARS-CoV-2 IgA Antibody | A measurement of the SARS-CoV-2 IgA antibody in a biological specimen. | SARS-CoV-2 IgA Antibody Measurement | ||
SAR2IGAM | C174326 | SARS-CoV-2 IgA/IgM Antibody | A measurement of the SARS-CoV-2 IgA and/or IgM antibody in a biological specimen. | SARS-CoV-2 IgA/IgM Antibody Measurement | ||
SAR2IGG | C171528 | SARS-CoV-2 IgG Antibody | A measurement of the SARS-CoV-2 IgG antibody in a biological specimen. | SARS-CoV-2 IgG Antibody Measurement | ||
SAR2IGGM | C171529 | SARS-CoV-2 IgG/IgM Antibody | A measurement of the SARS-CoV-2 IgG and/or IgM antibody in a biological specimen. | SARS-CoV-2 IgG and/or IgM Antibody Measurement | ||
SAR2IGM | C171530 | SARS-CoV-2 IgM Antibody | A measurement of the SARS-CoV-2 IgM antibody in a biological specimen. | SARS-CoV-2 IgM Antibody Measurement | ||
SAR2IMAG | C174325 | SARS-CoV-2 IgM/IgA/IgG Antibody | A measurement of the SARS-CoV-2 IgM, IgA and/or IgG antibody in a biological specimen. | SARS-CoV-2 IgM/IgA/IgG Antibody Measurement | ||
SAR2NAB | C174329 | SARS-CoV-2 Neutralizing Antibody | A measurement of the SARS-CoV-2 neutralizing antibody in a biological specimen. | SARS-CoV-2 Neutralizing Antibody Measurement | ||
SAR2NPAB | C178005 | SARS-CoV-2 N Protein Antibody;SARS-CoV-2 Nucleocapsid Protein Antibody | A measurement of the SARS-CoV-2 nucleocapsid protein antibody in a biological specimen. | SARS-CoV-2 Nucleocapsid Protein Antibody Measurement | ||
SAR2NPAG | C189547 | SARS-CoV-2 N Protein Antigen | A measurement of the SARS-CoV-2 nucleocapsid protein antigen in a biological specimen. | SARS-CoV-2 Nucleocapsid Protein Antigen Measurement | ||
SAR2RNA | C171531 | SARS-CoV-2 RNA | A measurement of the SARS-CoV-2 RNA in a biological specimen. | SARS-CoV-2 RNA Measurement | ||
SAR2SPAB | C178006 | SARS-CoV-2 S Protein Antibody;SARS-CoV-2 Spike Protein Antibody | A measurement of the SARS-CoV-2 spike protein antibody in a biological specimen. | SARS-CoV-2 Spike Protein Antibody Measurement | ||
SAR2SRNA | C187869 | SARS-CoV-2 S Gene;SARS-CoV-2 S RNA;SARS-CoV-2 Spike RNA | A measurement of the SARS-CoV-2 S RNA in a biological specimen. | SARS-CoV-2 S RNA Measurement | ||
SARRMRNA | C174324 | SARS-related Coronavirus RNA/MERS RNA | A measurement of the SARS-related and/or MERS Coronavirus RNA which includes but not limited to SARS-CoV, SARS-CoV-2, other SARS-like Coronavirus, and/or MERS-CoV in a biological specimen. | SARS-related Coronavirus RNA/MERS RNA Measurement | ||
SARSCOV1 | C174328 | SARS-CoV;SARS-CoV-1;Severe Acute Respiratory Syndrome-Related Coronavirus | A measurement of the severe acute respiratory syndrome-related Coronavirus in a biological specimen. | Severe Acute Respiratory Syndrome-related Coronavirus Measurement | ||
SARSCOV2 | C171532 | SARS-CoV-2;Severe Acute Resp Syndrome Coronavirus 2;Severe Acute Respiratory Syndrome Coronavirus 2 | A measurement of the severe acute respiratory syndrome Coronavirus 2 in a biological specimen. | Severe Acute Respiratory Syndrome Coronavirus 2 Measurement | ||
SARSRRNA | C174323 | SARS-related Coronavirus RNA | A measurement of the SARS-related Coronavirus RNA including but not limited to SARS-CoV, SARS-CoV-2, and/or other SARS-like Coronavirus in a biological specimen. | SARS-related Coronavirus RNA Measurement | ||
SAUDNA | C186184 | Staphylococcus aureus DNA | A measurement of the Staphylococcus aureus DNA in a biological specimen. | Staphylococcus aureus DNA Measurement | ||
SAUREUS | C147460 | S. aureus;Staphylococcus aureus | A measurement of the Staphylococcus aureus in a biological specimen. | Staphylococcus aureus Measurement | ||
SENBODNA | C166055 | Salmonella enterica/bongori DNA | A measurement of the Salmonella enterica and/or Salmonella bongori DNA in a biological specimen. | Salmonella enterica and/or Salmonella bongori DNA Measurement | ||
SEP | C187870 | Staphylococcus epidermidis | A measurement of the Staphylococcus epidermidis in a biological specimen. | Staphylococcus epidermidis Measurement | ||
SERRATIA | C179763 | Serratia | A measurement of the organisms that are not assigned to the species level but are assigned to the Serratia genus level in a biological specimen. | Serratia Measurement | ||
SHA | C186185 | Staphylococcus haemolyticus | A measurement of the Staphylococcus haemolyticus in a biological specimen. | Staphylococcus haemolyticus Measurement | ||
SHIGAG | C198339 | Shigella Antigen | A measurement of the antigen from any member of the genus Shigella in a biological specimen. | Shigella Antigen Measurement | ||
SHIGATOX | C184669 | Shiga Toxin | A measurement of the shiga toxin in a biological specimen. | Shiga Toxin Measurement | ||
SHIGDNA | C184670 | Shigella DNA | A measurement of the DNA from any member of the genus Shigella in a biological specimen. | Shigella DNA Measurement | ||
SHIGEIEC | C186186 | Shigella/EIEC;Shigella/Enteroinvasive E. coli;Shigella/Enteroinvasive Escherichia coli | A measurement of the organisms that are not assigned to the species level but are assigned to the Shigella genus level and/or enteroinvasive Escherichia coli in a biological specimen. | Shigella and/or Enteroinvasive Escherichia coli DNA Measurement | ||
SHIGELLA | C181459 | Shigella | A measurement of the organisms that are not assigned to the species level but are assigned to the Shigella genus level in a biological specimen. | Shigella Measurement | ||
SMA | C198340 | Serratia marcescens | A measurement of the Serratia marcescens in a biological specimen. | Serratia marcescens Measurement | ||
SMAAB | C166056 | Schistosoma mansoni Antibody | A measurement of the Schistosoma mansoni antibody in a biological specimen. | Schistosoma mansoni Antibody Measurement | ||
SMADNA | C191326 | Serratia marcescens DNA | A measurement of the Serratia marcescens DNA in a biological specimen. | Serratia marcescens DNA Measurement | ||
SPN | C187872 | Streptococcus pneumoniae | A measurement of the Streptococcus pneumoniae in a biological specimen. | Streptococcus pneumoniae Measurement | ||
SPNAG | C122152 | Streptococcus pneumoniae Antigen | A measurement of the Streptococcus pneumoniae antigen in a biological specimen. | Streptococcus pneumoniae Antigen Measurement | ||
SPNDNA | C186187 | Streptococcus pneumoniae DNA | A measurement of Streptococcus pneumoniae DNA in a biological specimen. | Streptococcus pneumoniae DNA Measurement | ||
SPNIGGAB | C142232 | Streptococcus pneumoniae IgG Antibody | A measurement of the Streptococcus pneumoniae IgG antibody in a biological specimen. | Streptococcus pneumoniae IgG Antibody Measurement | ||
SPY | C187873 | Streptococcus pyogenes | A measurement of the Streptococcus pyogenes in a biological specimen. | Streptococcus pyogenes Measurement | ||
SPYAG | C154814 | Streptococcus pyogenes Antigen | A measurement of the Streptococcus pyogenes antigen in a biological specimen. | Streptococcus pyogenes Antigen Measurement | ||
SPYDNA | C191327 | Streptococcus pyogenes DNA | A measurement of the Streptococcus pyogenes DNA in a biological specimen. | Streptococcus pyogenes DNA Measurement | ||
SR2RDRPR | C186188 | SARS-CoV-2 RdRp Gene;SARS-CoV-2 RdRp RNA;SARS-CoV-2 RNA-dependent RNA Polymerase RNA | A measurement of the SARS-CoV-2 RdRp RNA in a biological specimen. | SARS-CoV-2 RdRp RNA Measurement | ||
SSA | C179764 | Staphylococcus saprophyticus | A measurement of the Staphylococcus saprophyticus in a biological specimen. | Staphylococcus saprophyticus Measurement | ||
STAPHCGN | C189581 | Staphylococcus, Coagulase Negative | A measurement of the coagulase negative Staphylococcus species in a biological specimen. | Coagulase Negative Staphylococcus Measurement | ||
STAPHCGP | C189580 | Staphylococcus, Coagulase Positive | A measurement of the coagulase positive Staphylococcus species in a biological specimen. | Coagulase Positive Staphylococcus Measurement | ||
STENMALT | C139112 | Stenotrophomonas maltophilia | A measurement of the organisms that are assigned to the Stenotrophomonas maltophilia species in a biological specimen. | Stenotrophomonas maltophilia Measurement | ||
STREPTOC | C187667 | Streptococcus | A measurement of the organisms that are not assigned to the species level but are assigned to the Streptococcus genus level in a biological specimen. | Streptococcus Measurement | ||
STRIGGAB | C117858 | Strongyloides IgG Antibody | A measurement of strongyloides IgG antibody in a biological specimen. | Strongyloides IgG Antibody Measurement | ||
STRPLOAB | C92282 | Antistreptolysin O;Streptolysin O Antibody | A measurement of Streptolysin O Antibody in a biological specimen. | Streptolysin O Antibody Measurement | ||
TGNIGGAB | C139089 | Toxoplasma gondii IgG Antibody | A measurement of the Toxoplasma gondii IgG antibody in a biological specimen. | Toxoplasma gondii IgG Antibody Measurement | ||
TGNIGMAB | C139090 | Toxoplasma gondii IgM Antibody | A measurement of the Toxoplasma gondii IgM antibody in a biological specimen. | Toxoplasma gondii IgM Antibody Measurement | ||
TGODNA | C184665 | Toxoplasma gondii DNA | A measurement of the Toxoplasma gondii DNA in a biological specimen. | Toxoplasma gondii DNA Measurement | ||
TGOGMAB | C166057 | Toxoplasma gondii IgG/IgM Antibody | A measurement of the Toxoplasma gondii IgG and/or IgM antibody in a biological specimen. | Toxoplasma gondii IgG and/or IgM Antibody Measurement | ||
TOXBPCDF | C150865 | Toxin B-Producing Clostridium difficile | A measurement of the toxin B-producing strain of Clostridium difficile in a biological specimen. | Toxin B-Producing Clostridium difficile Measurement | ||
TOXCDF | C150862 | Toxigenic Clostridium difficile | A measurement of the toxigenic strain of Clostridium difficile in a biological specimen. | Toxigenic Clostridium difficile Measurement | ||
TPA | C184647 | Treponema pallidum | A measurement of the Treponema pallidum in a biological specimen. | Treponema pallidum Measurement | ||
TPADNA | C198341 | Treponema pallidum DNA | A measurement of the Treponema pallidum DNA in a biological specimen. | Treponema pallidum DNA Measurement | ||
TPLAB | C132388 | Treponema pallidum Antibody | A measurement of the total Treponema pallidum antibody in a biological specimen. | Treponema pallidum Antibody Measurement | ||
TRICH | C92238 | Trichomonas | Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. | Trichomonas Screening | ||
TRICHRNA | C186189 | Trichomonas RNA | A measurement of the RNA from any member of the genus Trichomonas in a biological specimen. | Trichomonas RNA Measurement | ||
TVA | C161403 | Trichomonas vaginalis | A measurement of the Trichomonas vaginalis in a biological specimen. | Trichomonas vaginalis Measurement | ||
TVADNA | C186190 | Trichomonas vaginalis DNA | A measurement of the Trichomonas vaginalis DNA in a biological specimen. | Trichomonas vaginalis DNA Measurement | ||
UPA | C198342 | Ureaplasma parvum | A measurement of the Ureaplasma parvum in a biological specimen. | Ureaplasma parvum Measurement | ||
UPADNA | C198343 | Ureaplasma parvum DNA | A measurement of the Ureaplasma parvum DNA in a biological specimen. | Ureaplasma parvum DNA Measurement | ||
UREASE | C154825 | Urease | A measurement of the microbial urease enzyme in a biological specimen. | Urease Measurement | ||
UUR | C189537 | Ureaplasma urealyticum | A measurement of the Ureaplasma urealyticum in a biological specimen. | Ureaplasma urealyticum Measurement | ||
UURDNA | C198344 | Ureaplasma urealyticum DNA | A measurement of the Ureaplasma urealyticum DNA in a biological specimen. | Ureaplasma urealyticum DNA Measurement | ||
VACCINIA | C181458 | Vaccinia Virus | A measurement of the Vaccinia virus in a biological specimen. | Vaccinia Virus Measurement | ||
VCHDNA | C166058 | Vibrio cholerae DNA | A measurement of the Vibrio cholerae DNA in a biological specimen. | Vibrio cholerae DNA Measurement | ||
VPADNA | C187874 | Vibrio parahaemolyticus DNA | A measurement of the Vibrio parahaemolyticus DNA in a biological specimen. | Vibrio parahaemolyticus DNA Measurement | ||
VRE | C186191 | Enterococcus, Vancomycin-resistant | A measurement of the organisms that are vancomycin-resistant, and are not assigned to the species level but are assigned to the Enterococcus genus level in a biological specimen. | Vancomycin-resistant Enterococcus Measurement | ||
VZV | C189555 | Varicella Zoster Virus | A measurement of the varicella zoster virus in a biological specimen. | Varicella Zoster Virus Measurement | ||
VZVAB | C117867 | Varicella Zoster Virus Antibody | A measurement of the total varicella zoster virus antibody in a biological specimen. | Varicella Zoster Virus Antibody Measurement | ||
VZVDNA | C186192 | Varicella Zoster Virus DNA | A measurement of the Varicella Zoster virus DNA in a biological specimen. | Varicella Zoster Virus DNA Measurement | ||
VZVIGAAB | C98795 | Varicella Zoster Virus IgA Antibody | A measurement of the Varicella Zoster virus IgA antibodies in a biological specimen. | Varicella Zoster Virus IgA Antibody Measurement | ||
VZVIGGAB | C98796 | Varicella Zoster Virus IgG Antibody | A measurement of the Varicella Zoster virus IgG antibodies in a biological specimen. | Varicella Zoster Virus IgG Antibody Measurement | ||
VZVIGMAB | C98797 | Varicella Zoster Virus IgM Antibody | A measurement of the Varicella Zoster virus IgM antibodies in a biological specimen. | Varicella Zoster Virus IgM Antibody Measurement | ||
WNVAB | C147448 | West Nile Virus Antibody | A measurement of the west Nile virus antibody in a biological specimen. | West Nile Virus Antibody Measurement | ||
YEAST | C74664 | Yeast Cells | A measurement of the yeast cells present in a biological specimen. | Yeast Cell Measurement | ||
YEASTBUD | C106504 | Budding Yeast;Yeast Budding | A measurement of the budding yeast present in a biological specimen. | Budding Yeast Measurement | ||
YEASTHYP | C92239 | Yeast Hyphae | A measurement of the yeast hyphae present in a biological specimen. | Yeast Hyphae Screening | ||
YENDNA | C166059 | Yersinia enterocolitica DNA | A measurement of the Yersinia enterocolitica DNA in a biological specimen. | Yersinia enterocolitica DNA Measurement | ||
YERSINIA | C187875 | Yersinia | A measurement of the organisms that are not assigned to the species level but are assigned to the Yersinia genus level in a biological specimen. | Yersinia Measurement | ||
YFVAB | C147450 | Yellow Fever Virus Antibody | A measurement of the yellow fever virus antibody in a biological specimen. | Yellow Fever Virus Antibody Measurement | ||
ZEBOV | C132420 | Zaire Ebolavirus | A measurement of the Zaire ebolavirus present in a biological specimen. | Zaire Ebolavirus Measurement | ||
ZKVAB | C147451 | Zika Virus Antibody | A measurement of the Zika virus antibody in a biological specimen. | Zika Virus Antibody Measurement | ||
Back to top | ||||||
CL.C120528.MBTEST | Microbiology Test Name
(MBTEST) | text
Extensible: Yes | C120528 | Microbiology Test Name | Terminology relevant to the microbiology test names of the CDISC Study Data Tabulation Model. | CDISC SDTM Microbiology Test Name Terminology |
A. alternata IgE AB RAST Score | C166025 | A. tenuis alternata IgE AB RAST Score | A classification of the amount of Alternaria alternata antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Alternaria alternata IgE Antibody RAST Score Measurement | ||
A. alternata IgG AB RAST Score | C166021 | A. tenuis alternata IgG AB RAST Score | A classification of the amount of Alternaria alternata antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Alternaria alternata IgG Antibody RAST Score Measurement | ||
A. calcoaceticus-baumannii Complex DNA | C191308 | A. calcoaceticus-baumannii Complex DNA;Acinetobacter calcoaceticus-baumannii Complex DNA | A measurement of Acinetobacter Calcoaceticus-Baumannii complex DNA in a biological specimen. | Acinetobacter calcoaceticus/baumannii Complex DNA Measurement | ||
A. calcoaceticus-baumannii Complex | C191309 | A. calcoaceticus-baumannii Complex;Acinetobacter calcoaceticus-baumannii Complex | A measurement of the Acinetobacter calcoaceticus-baumannii complex in a biological specimen. | Acinetobacter calcoaceticus/baumannii Complex Measurement | ||
A. fumigatus IgE AB RAST Score | C166023 | A. fumigatus IgE AB RAST Score | A classification of the amount of A. fumigatus antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Aspergillus fumigatus IgE Antibody RAST Score Measurement | ||
A. fumigatus IgG AB RAST Score | C166019 | A. fumigatus IgG AB RAST Score | A classification of the amount of A. fumigatus antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Aspergillus fumigatus IgG Antibody RAST Score Measurement | ||
Achromobacter xylosoxidans | C172529 | Achromobacter xylosoxidans | A measurement of the Achromobacter xylosoxidans in a biological specimen. | Achromobacter xylosoxidans Measurement | ||
Acid-Fast Bacilli | C128981 | Acid-Fast Bacilli | A measurement of any rod-shaped bacteria that resist decolorizing by acid after accepting an aqueous stain solution, due to the mycolic acids in their cell walls. | Acid-Fast Bacilli Measurement | ||
Acinetobacter | C179755 | Acinetobacter | A measurement of the organisms that are not assigned to the species level but are assigned to the Acinetobacter genus level in a biological specimen. | Acinetobacter Measurement | ||
Acinetobacter, Carbapenem-resistant | C187845 | Acinetobacter, Carbapenem-resistant;Carbapenem Resistant Acinetobacter | A measurement of the organisms that are not assigned to the species level but are assigned to the Enterococcus genus level and are also carbapenem-resistant in a biological specimen. | Carbapenem-resistant Acinetobacter Measurement | ||
Adenoviridae | C171498 | Adenoviridae;Adenovirus | A measurement of the adenoviridae in a biological specimen. | Adenoviridae Measurement | ||
Adenovirus Antibody | C111125 | Adenovirus Antibody | A measurement of the adenovirus antibody in a biological specimen. | Adenovirus Antibody Measurement | ||
Adenovirus Antigen | C154830 | Adenovirus Antigen | A measurement of the Adenovirus antigen in a biological specimen. | Adenovirus Antigen Measurement | ||
Adenovirus DNA | C191310 | Adenovirus DNA | A measurement of the DNA from any member of the family Adenoviridae in a biological specimen. | Adenovirus DNA Measurement | ||
Adenovirus IgG Antibody | C163529 | Adenovirus IgG Antibody | A measurement of the adenovirus IgG antibody in a biological specimen. | Adenovirus IgG Antibody Measurement | ||
Adenovirus IgM Antibody | C163530 | Adenovirus IgM Antibody | A measurement of the adenovirus IgM antibody in a biological specimen. | Adenovirus IgM Antibody Measurement | ||
Adenovirus Nucleic Acid | C187838 | Adenovirus Nucleic Acid | A measurement of the nucleic acid from any member of the family Adenoviridae in a biological specimen. | Adenovirus Nucleic Acid Measurement | ||
Aerobic Bacteria | C198301 | Aerobic Bacteria | A measurement of the aerobic bacteria in a biological specimen. | Aerobic Bacteria Measurement | ||
Alternaria alternata IgA Antibody | C130151 | Alternaria alternata IgA Antibody;Alternaria tenuis IgA Antibody | A measurement of the Alternaria alternata IgA antibody in a biological specimen. | Alternaria tenuis alternata Antigen IgA Antibody Measurement | ||
Alternaria alternata IgE Antibody | C130150 | Alternaria alternata IgE Antibody;Alternaria tenuis IgE Antibody | A measurement of the Alternaria alternata IgE antibody in a biological specimen. | Alternaria tenuis alternata Antigen IgE Antibody Measurement | ||
Alternaria alternata IgG Antibody | C130152 | Alternaria alternata IgG Antibody;Alternaria tenuis IgG Antibody | A measurement of the Alternaria alternata IgG antibody in a biological specimen. | Alternaria tenuis alternata Antigen IgG Antibody Measurement | ||
Alternaria alternata IgG4 Antibody | C130153 | Alternaria alternata IgG4 Antibody;Alternaria tenuis IgG4 Antibody | A measurement of the Alternaria alternata IgG4 antibody in a biological specimen. | Alternaria tenuis alternata Antigen IgG4 Antibody Measurement | ||
Anaerobic Bacteria | C198302 | Anaerobic Bacteria | A measurement of the anaerobic bacteria in a biological specimen. | Anaerobic Bacteria Measurement | ||
Anaplasma DNA | C187839 | Anaplasma DNA | A measurement of the DNA from any member of the genus Anaplasma in a biological specimen. | Anaplasma DNA Measurement | ||
Anaplasma | C187668 | Anaplasma | A measurement of the organisms that are not assigned to the species level but are assigned to the Anaplasma genus level in a biological specimen. | Anaplasma Measurement | ||
Anti-Saccharomyces cerevisiae Antibody | C81976 | Anti-Saccharomyces cerevisiae Antibody;Baker's Yeast Antibody | A measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen. | Anti-Saccharomyces cerevisiae Antibody Measurement | ||
Aspergillus Antibody | C166028 | Aspergillus Antibody | A measurement of the antibody to any member of the genus Aspergillus in a biological specimen. | Aspergillus Antibody Measurement | ||
Aspergillus Antigen | C189540 | Aspergillus Antigen | A measurement of the antigen from any member of the genus Aspergillus in a biological specimen. | Aspergillus Antigen Measurement | ||
Aspergillus DNA | C198303 | Aspergillus DNA | A measurement of the DNA from any member of the genus Aspergillus in a biological specimen. | Aspergillus DNA Measurement | ||
Aspergillus fumigatus IgE Antibody | C130144 | Aspergillus fumigatus IgE Antibody | A measurement of the Aspergillus fumigatus IgE antibody in a biological specimen. | Aspergillus fumigatus Antigen IgE Antibody Measurement | ||
Aspergillus fumigatus IgG Antibody | C130145 | Aspergillus fumigatus IgG Antibody | A measurement of the Aspergillus fumigatus IgG antibody in a biological specimen. | Aspergillus fumigatus Antigen IgG Antibody Measurement | ||
Aspergillus fumigatus | C187840 | Aspergillus fumigatus | A measurement of the Aspergillus fumigatus in a biological specimen. | Aspergillus fumigatus Measurement | ||
Aspergillus niger | C187841 | Aspergillus niger | A measurement of the Aspergillus niger in a biological specimen. | Aspergillus niger Measurement | ||
Aspergillus | C172528 | Aspergillus | A measurement of the organisms that are not assigned to the species level but are assigned to the Aspergillus genus level in a biological specimen. | Aspergillus Measurement | ||
B. burgdorferi IgG and IgM Antibody | C147310 | B. burgdorferi IgG and IgM Antibody;Borrelia burgdorferi IgG and IgM Antibody | A measurement of the Borrelia burgdorferi IgG and IgM antibodies in a biological specimen. | Borrelia burgdorferi IgG and IgM Antibody Measurement | ||
B. pertussis Filament Haemagglutinin AB | C163532 | B. pertussis Filament Haemagglutinin AB;Bordetella pertussis FHA Antibody;Bordetella pertussis Filamentous Haemagglutinin Antibody | A measurement of the Bordetella pertussis filamentous haemagglutinin antibody in a biological specimen. | Bordetella pertussis Filament Haemagglutinin Antibody Measurement | ||
Babesia DNA | C187842 | Babesia DNA | A measurement of the DNA from any member of the genus Babesia in a biological specimen. | Babesia DNA Measurement | ||
Bacilli | C198305 | Bacilli;Rod-shaped Bacteria | A measurement of the rod-shaped bacilli in a biological specimen. | Bacillus Measurement | ||
Bacilli/Leukocytes | C198304 | Bacilli/Leukocytes | A relative measurement (ratio or percentage) of the bacilli to leukocytes in a biological specimen. | Bacillus to Leukocyte Ratio Measurement | ||
Bacteria | C64469 | Bacteria | A measurement of the bacteria in a biological specimen. | Bacterial Count | ||
Bacterial Beta-lactamase | C161400 | Bacterial Beta-lactamase | A measurement of the bacterial enzyme beta-lactamase in a biological specimen. | Bacterial Beta-lactamase Measurement | ||
Bacterial Lipopolysaccharide Antigen | C189546 | Bacterial Lipopolysaccharide Antigen | A measurement of the lipopolysaccharide antigen from bacteria in a biological specimen. | Bacterial Lipopolysaccharide Antigen Measurement | ||
Bacterial Sialidase | C154820 | Bacterial Sialidase | A measurement of the bacterial sialidase enzyme in a biological specimen. | Bacterial Sialidase Measurement | ||
Beta-lactamase Negative Bacteria | C160937 | Beta-lactamase Negative Bacteria | A measurement of the beta-lactamase negative bacteria in a biological specimen. | Beta-lactamase Negative Bacteria Measurement | ||
Beta-lactamase Positive Bacteria | C160936 | Beta-lactamase Positive Bacteria | A measurement of the beta-lactamase positive bacteria in a biological specimen. | Beta-lactamase Positive Bacteria Measurement | ||
Blastocystis hominis DNA | C186145 | Blastocystis hominis DNA | A measurement of the Blastocystis hominis DNA in a biological specimen. | Blastocystis hominis DNA Measurement | ||
Bordetella parapertussis DNA | C186146 | Bordetella parapertussis DNA | A measurement of the Bordetella parapertussis DNA in a biological specimen. | Bordetella Parapertussis DNA Measurement | ||
Bordetella parapertussis | C178015 | Bordetella parapertussis | A measurement of the Bordetella parapertussis in a biological specimen. | Bordetella Parapertussis Measurement | ||
Bordetella pertussis Antigen | C154832 | Bordetella pertussis Antigen | A measurement of the Bordetella pertussis antigen in a biological specimen. | Bordetella pertussis Antigen Measurement | ||
Bordetella pertussis DNA | C184667 | Bordetella pertussis DNA | A measurement of the Bordetella pertussis DNA in a biological specimen. | Bordetella pertussis DNA Measurement | ||
Bordetella pertussis Pertactin Antibody | C163533 | Bordetella pertussis Pertactin Antibody;Bordetella pertussis PRN Antibody | A measurement of the Bordetella pertussis pertactin antibody in a biological specimen. | Bordetella pertussis Pertactin Antibody Measurement | ||
Bordetella pertussis Serotype Fim 2/3 AB | C163531 | Bordetella pertussis Serotype Fim 2/3 AB;Bordetella pertussis Serotype Fimbriae 2/3 Antibody | A measurement of the Bordetella pertussis serotypes fimbriae 2 and/or fimbriae 3 antibody in a biological specimen. | Bordetella pertussis Serotype Fimbrae 2/3 Antibody Measurement | ||
Bordetella pertussis Toxin Antibody | C163534 | Bordetella pertussis Toxin Antibody | A measurement of the Bordetella pertussis toxin antibody in a biological specimen. | Bordetella pertussis Toxin Antibody Measurement | ||
Bordetella pertussis | C179756 | Bordetella pertussis | A measurement of the Bordetella pertussis in a biological specimen. | Bordetella pertussis Measurement | ||
Borrelia burgdorferi Antibody | C122098 | Borrelia burgdorferi Antibody;Lyme Antibody | A measurement of the total Borrelia burgdorferi antibody in a biological specimen. | Borrelia Burgdorferi Antibody Measurement | ||
Borrelia burgdorferi IgA Antibody | C122099 | Borrelia burgdorferi IgA Antibody;Lyme IgA Antibody | A measurement of the Borrelia burgdorferi IgA antibody in a biological specimen. | Borrelia Burgdorferi IgA Antibody Measurement | ||
Borrelia burgdorferi IgG Antibody | C122100 | Borrelia burgdorferi IgG Antibody;Lyme IgG Antibody | A measurement of the Borrelia burgdorferi IgG antibody in a biological specimen. | Borrelia Burgdorferi IgG Antibody Measurement | ||
Borrelia burgdorferi IgM Antibody | C122101 | Borrelia burgdorferi IgM Antibody;Lyme IgM Antibody | A measurement of the Borrelia burgdorferi IgM antibody in a biological specimen. | Borrelia Burgdorferi IgM Antibody Measurement | ||
Borrelia DNA | C187843 | Borrelia DNA | A measurement of the DNA from any member of the genus Borrelia in a biological specimen. | Borrelia DNA Measurement | ||
Burkholderia ambifaria | C172535 | Burkholderia ambifaria | A measurement of the Burkholderia ambifaria in a biological specimen. | Burkholderia ambifaria Measurement | ||
Burkholderia anthina | C172536 | Burkholderia anthina | A measurement of the Burkholderia anthina in a biological specimen. | Burkholderia anthina Measurement | ||
Burkholderia cenocepacia | C172531 | Burkholderia cenocepacia | A measurement of the Burkholderia cenocepacia in a biological specimen. | Burkholderia cenocepacia Measurement | ||
Burkholderia cepacia | C147456 | B. cepacia;Burkholderia cepacia;Pseudomonas cepacia | A measurement of the Burkholderia cepacia in a biological specimen. | Burkholderia cepacia Measurement | ||
Burkholderia dolosa | C172534 | Burkholderia dolosa | A measurement of the Burkholderia dolosa in a biological specimen. | Burkholderia dolosa Measurement | ||
Burkholderia multivorans | C172530 | Burkholderia multivorans | A measurement of the Burkholderia multivorans in a biological specimen. | Burkholderia multivorans Measurement | ||
Burkholderia pyrrocinia | C172537 | Burkholderia pyrrocinia | A measurement of the Burkholderia pyrrocinia in a biological specimen. | Burkholderia pyrrocinia Measurement | ||
Burkholderia stabilis | C172532 | Burkholderia stabilis | A measurement of the Burkholderia stabilis in a biological specimen. | Burkholderia stabilis Measurement | ||
Burkholderia vietnamiensis | C172533 | Burkholderia vietnamiensis | A measurement of the Burkholderia vietnamiensis in a biological specimen. | Burkholderia vietnamiensis Measurement | ||
Burkholderia | C139113 | Burkholderia | A measurement of the organisms that are not assigned to the species level but are assigned to the Burkholderia genus level in a biological specimen. | Burkholderia Measurement | ||
C. coli/jejuni/upsaliensis DNA | C166015 | C. coli/jejuni/upsaliensis DNA;Campylobacter coli/jejuni/upsaliensis DNA | A measurement of the Campylobacter coli, Campylobacter jejuni and/or Campylobacter upsaliensis DNA in a biological specimen. | Campylobacter coli, Campylobacter jejuni and/or Campylobacter upsaliensis DNA Measurement | ||
C. difficile Glutamate Dehydrogenase | C150857 | C. difficile Glutamate Dehydrogenase;Clostridium difficile Glutamate Dehydrogenase | A measurement of the Clostridium difficile glutamate dehydrogenase in a biological specimen. | C. difficile Glutamate Dehydrogenase Measurement | ||
Campylobacter coli | C186148 | Campylobacter coli | A measurement of the Campylobacter coli in a biological specimen. | Campylobacter coli Measurement | ||
Campylobacter DNA | C186147 | Campylobacter DNA | A measurement of the DNA from any member of the genus Campylobacter in a biological specimen. | Campylobacter DNA Measurement | ||
Campylobacter jejuni | C186149 | Campylobacter jejuni | A measurement of the Campylobacter jejuni in a biological specimen. | Campylobacter jejuni Measurement | ||
Campylobacter | C189578 | Campylobacter | A measurement of the organisms that are not assigned to the species level but are assigned to the Campylobacter genus level in a biological specimen. | Campylobacter Measurement | ||
Candida albicans | C161404 | Candida albicans;Candida stellatoidea | A measurement of the Candida albicans in a biological specimen. | Candida albicans Measurement | ||
Candida Antigen | C189541 | Candida Antigen | A measurement of the antigen from any member of the genus Candida in a biological specimen. | Candida Antigen Measurement | ||
Candida dubliniensis | C189551 | Candida dubliniensis | A measurement of the Candida dubliniensis in a biological specimen. | Candida dubliniensis Measurement | ||
Candida glabrata | C187844 | Candida glabrata | A measurement of the Candida glabrata in a biological specimen. | Candida glabrata Measurement | ||
Candida | C179757 | Candida | A measurement of the organisms that are not assigned to the species level but are assigned to the Candida genus level in a biological specimen. | Candida Measurement | ||
Chikungunya Virus Antibody | C135404 | Chikungunya Virus Antibody | A measurement of the Chikungunya virus antibody in a biological specimen. | Chikungunya Virus Antibody Measurement | ||
Chlamydia pneumoniae DNA | C184657 | Chlamydia pneumoniae DNA | A measurement of the Chlamydia pneumoniae DNA in a biological specimen. | Chlamydia pneumoniae DNA Measurement | ||
Chlamydia pneumoniae IgA Antibody | C92432 | Chlamydia pneumoniae IgA Antibody | A measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen. | Chlamydia pneumoniae IgA Antibody Measurement | ||
Chlamydia pneumoniae IgG Antibody | C163536 | Chlamydia pneumoniae IgG Antibody;Chlamydophila pneumoniae IgG Antibody | A measurement of the Chlamydia pneumoniae IgG antibody in a biological specimen. | Chlamydia pneumoniae IgG Antibody Measurement | ||
Chlamydia pneumoniae IgM Antibody | C92433 | Chlamydia pneumoniae IgM Antibody | A measurement of the Chlamydia pneumoniae IgM in a biological specimen. | Chlamydia pneumoniae IgM Antibody Measurement | ||
Chlamydia pneumoniae Nucleic Acid | C198308 | Chlamydia pneumoniae Nucleic Acid | A measurement of the Chlamydia pneumoniae nucleic acid in a biological specimen. | Chlamydia pneumoniae Nucleic Acid Measurement | ||
Chlamydia pneumoniae | C178016 | Chlamydia pneumoniae | A measurement of the Chlamydia pneumoniae in a biological specimen. | Chlamydia Pneumoniae Measurement | ||
Chlamydia trachomatis Antigen | C154835 | Chlamydia trachomatis Antigen | A measurement of the Chlamydia trachomatis antigen in a biological specimen. | Chlamydia trachomatis Antigen Measurement | ||
Chlamydia trachomatis DNA | C161392 | Chlamydia trachomatis DNA | A measurement of the Chlamydia trachomatis DNA in a biological specimen. | Chlamydia trachomatis DNA Measurement | ||
Chlamydia trachomatis IgA Antibody | C100464 | Chlamydia trachomatis IgA Antibody | A measurement of the Chlamydia trachomatis IgA antibody in a biological specimen. | Chlamydia trachomatis IgA Antibody Measurement | ||
Chlamydia trachomatis IgG Antibody | C100466 | Chlamydia trachomatis IgG Antibody | A measurement of the Chlamydia trachomatis IgG antibody in a biological specimen. | Chlamydia trachomatis IgG Antibody Measurement | ||
Chlamydia trachomatis IgM Antibody | C100465 | Chlamydia trachomatis IgM Antibody | A measurement of the Chlamydia trachomatis IgM antibody in a biological specimen. | Chlamydia trachomatis IgM Antibody Measurement | ||
Chlamydia trachomatis RNA | C186151 | Chlamydia trachomatis RNA | A measurement of the Chlamydia trachomatis RNA in a biological specimen. | Chlamydia Trachomatis RNA Measurement | ||
Chlamydia trachomatis | C184659 | Chlamydia trachomatis | A measurement of the Chlamydia trachomatis in a biological specimen. | Chlamydia trachomatis Measurement | ||
Chlamydia | C172527 | Chlamydia | A measurement of the organisms that are not assigned to the species level but are assigned to the Chlamydia genus level in a biological specimen. | Chlamydia Measurement | ||
Chlamydophila psittaci DNA | C189535 | Chlamydophila psittaci DNA | A measurement of the Chlamydophila psittaci DNA in a biological specimen. | Chlamydophila psittaci DNA Measurement | ||
Cholera Toxin B Subunit IgG Antibody | C116194 | Cholera Toxin B Subunit IgG Antibody | A measurement of the cholera toxin B subunit IgG antibody in a biological specimen. | Cholera Toxin B Subunit IgG Antibody Measurement | ||
Citrobacter koseri | C187846 | Citrobacter koseri | A measurement of the Citrobacter koseri in a biological specimen. | Citrobacter koseri Measurement | ||
Cladosporium herbarum IgE AB RAST Score | C166026 | Cladosporium herbarum IgE AB RAST Score | A classification of the amount of Cladosporium herbarum IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Cladosporium herbarum IgE Antibody RAST Score Measurement | ||
Cladosporium herbarum IgE Antibody | C147286 | Cladosporium herbarum IgE Antibody | A measurement of the Cladosporium herbarum antigen IgE antibody in a biological specimen. | Cladosporium herbarum IgE Antibody Measurement | ||
Clostridium difficile 027/NAP1/BI | C150639 | Clostridium difficile 027/NAP1/BI | A measurement of the 027/NAP1/BI strain of Clostridium difficile in a biological specimen. | Clostridium difficile 027/NAP1/BI Measurement | ||
Clostridium difficile A Toxin | C150863 | Clostridium difficile A Toxin | A measurement of the Clostridium difficile toxin A in a biological specimen. | Clostridium difficile A Toxin Measurement | ||
Clostridium difficile A/B Toxin | C150858 | Clostridium difficile A/B Toxin | A measurement of the Clostridium difficile A and/or B toxin in a biological specimen. | Clostridium difficile A and/or B Toxin Measurement | ||
Clostridium difficile B Toxin | C150864 | Clostridium difficile B Toxin | A measurement of the Clostridium difficile toxin B in a biological specimen. | Clostridium difficile B Toxin Measurement | ||
Clostridium difficile cdt DNA | C150866 | Clostridium difficile cdt DNA | A measurement of the Clostridium difficile binary toxin (cdt) DNA in a biological specimen. | Clostridium difficile cdt DNA Measurement | ||
Clostridium difficile DNA | C198307 | Clostridium difficile DNA | A measurement of the Clostridium difficile DNA in a biological specimen. | Clostridium difficile DNA Measurement | ||
Clostridium difficile tcdA DNA | C150859 | Clostridium difficile tcdA DNA | A measurement of the Clostridium difficile toxin A (tcdA) DNA in a biological specimen. | Clostridium difficile tcdA DNA Measurement | ||
Clostridium difficile tcdB DNA | C150860 | Clostridium difficile tcdB DNA | A measurement of the Clostridium difficile toxin B (tcdB) DNA in a biological specimen. | Clostridium difficile tcdB DNA Measurement | ||
Clostridium difficile tcdC DNA | C150861 | Clostridium difficile tcdC DNA | A measurement of the Clostridium difficile regulatory protein (tcdC) DNA in a biological specimen. | Clostridium difficile tcdC DNA Measurement | ||
Clostridium difficile Toxin | C103381 | Clostridium difficile Toxin | A measurement of the Clostridium difficile toxin in a biological specimen. | Clostridium difficile Toxin Measurement | ||
Clostridium difficile | C150637 | Clostridium difficile | A measurement of the Clostridium difficile in a biological specimen. | Clostridium difficile Measurement | ||
Clostridium tetani IgG Antibody | C103382 | Clostridium tetani IgG Antibody | A measurement of the Clostridium tetani IgG antibody in a biological specimen. | Clostridium tetani IgG Antibody Measurement | ||
Clostridium tetani Toxin Antibody | C163537 | Clostridium tetani TeNT Antibody;Clostridium tetani Toxin Antibody;Tetanospasmin Antibody;Tetanus Neurotoxin Antibody | A measurement of the Clostridium tetani toxin antibody in a biological specimen. | Clostridium tetani Toxin Antibody Measurement | ||
Clostridium tetani Toxoid IgG Antibody | C135406 | Clostridium tetani Toxoid IgG Antibody | A measurement of the Clostridium tetani toxoid IgG antibody in a biological specimen. | Clostridium tetani Toxoid IgG Antibody Measurement | ||
Coccidioides Antibody | C111160 | Coccidioides Antibody | A measurement of the coccidioides antibody in a biological specimen. | Coccidioides Antibody Measurement | ||
Coccidioides IgG Antibody | C166031 | Coccidioides IgG Antibody | A measurement of the IgG antibody from any member of the genus Coccidioides in a biological specimen. | Coccidioides IgG Antibody Measurement | ||
Coccidioides IgM Antibody | C166032 | Coccidioides IgM Antibody | A measurement of the IgM antibody from any member of the genus Coccidioides in a biological specimen. | Coccidioides IgM Antibody Measurement | ||
Coccidioides immitis Antibody | C166030 | Coccidioides immitis Antibody | A measurement of the Coccidioides immitis antibody in a biological specimen. | Coccidioides immitis Antibody Measurement | ||
Coronaviridae | C171456 | Coronaviridae;Coronavirus | A measurement of the coronaviridae in a biological specimen. | Coronaviridae Measurement | ||
Coronavirus RNA | C191311 | Coronavirus RNA | A measurement of the RNA from any member of the family Coronaviridae in a biological specimen. | Coronavirus RNA Measurement | ||
Corynebacterium diphtheriae Toxoid Ab | C163535 | Corynebacterium diphtheriae Toxoid Ab | A measurement of the Corynebacterium diphtheriae toxoid antibody in a biological specimen. | Corynebacterium diphtheriae Toxoid Antibody Measurement | ||
Cryptococcus Antigen | C154829 | Cryptococcus Antigen | A measurement of the antigen from any member of the genus Cryptococcus in a biological specimen. | Cryptococcus Antigen Measurement | ||
Cryptococcus neoformans/gattii DNA | C186150 | Cryptococcus neoformans/gattii DNA | A measurement of Cryptococcus neoformans and/or Cryptococcus gattii DNA in a biological specimen. | Cryptococcus neoformans and/or gattii DNA Measurement | ||
Cryptosporidium Antigen | C166034 | Cryptosporidium Antigen | A measurement of the antigen from any member of the genus Cryptosporidium in a biological specimen. | Cryptosporidium Antigen Measurement | ||
Cryptosporidium DNA | C166033 | Cryptosporidium DNA | A measurement of the DNA from any member of the genus Cryptosporidium in a biological specimen. | Cryptosporidium DNA Measurement | ||
Cryptosporidium parvum Antigen | C154831 | Cryptosporidium parvum Antigen | A measurement of the Cryptosporidium parvum antigen in a biological specimen. | Cryptosporidium parvum Antigen Measurement | ||
Curved Bacillus | C184671 | Curved Bacillus;Curved Rods | A measurement of the curved rod-shaped bacillus in a biological specimen. | Curved Bacillus Measurement | ||
Cyclospora cayetanensis DNA | C166029 | Cyclospora cayetanensis DNA | A measurement of the Cyclospora cayetanensis DNA in a biological specimen. | Cyclospora cayetanensis DNA Measurement | ||
Cytomegalovirus Antigen | C154828 | Cytomegalovirus Antigen | A measurement of the Cytomegalovirus antigen in a biological specimen. | Cytomegalovirus Antigen Measurement | ||
Cytomegalovirus DNA | C161394 | Cytomegalovirus DNA | A measurement of the Cytomegalovirus DNA in a biological specimen. | Cytomegalovirus DNA Measurement | ||
Cytomegalovirus IgG Antibody | C96596 | Cytomegalovirus IgG Antibody | A measurement of the cytomegalovirus IgG antibody in a biological specimen. | Cytomegalovirus IgG Antibody Measurement | ||
Cytomegalovirus IgM Antibody | C96597 | Cytomegalovirus IgM Antibody | A measurement of the cytomegalovirus IgM antibody in a biological specimen. | Cytomegalovirus IgM Antibody Measurement | ||
Cytomegalovirus pp65 Antigen | C170608 | Cytomegalovirus Phosphoprotein 65 Antigen;Cytomegalovirus pp65 Antigen | A measurement of the Cytomegalovirus phosphoprotein 65 (pp65) antigen in a biological specimen. | Cytomegalovirus pp65 Antigen Measurement | ||
Cytomegalovirus | C184672 | Cytomegalovirus | A measurement of the organisms that are not assigned to the species level but are assigned to the Cytomegalovirus genus level in a biological specimen. | Cytomegalovirus Measurement | ||
Dengue Virus 1 RNA | C198309 | Dengue Virus 1 RNA | A measurement of the dengue virus 1 RNA in a biological specimen. | Dengue Virus 1 RNA Measurement | ||
Dengue Virus 2 RNA | C198310 | Dengue Virus 2 RNA | A measurement of the dengue virus 2 RNA in a biological specimen. | Dengue Virus 2 RNA Measurement | ||
Dengue Virus 3 RNA | C198311 | Dengue Virus 3 RNA | A measurement of the dengue virus 3 RNA in a biological specimen. | Dengue Virus 3 RNA Measurement | ||
Dengue Virus 4 RNA | C198312 | Dengue Virus 4 RNA | A measurement of the dengue virus 4 RNA in a biological specimen. | Dengue Virus 4 RNA Measurement | ||
Dengue Virus Antibody | C147332 | Dengue Virus Antibody | A measurement of the dengue virus antibody in a biological specimen. | Dengue Virus Antibody Measurement | ||
Dengue Virus IGG Antibody | C184649 | Dengue Virus IGG Antibody | A measurement of the dengue virus IgG antibody in a biological specimen. | Dengue Virus IgG Antibody Measurement | ||
Dengue Virus IGM Antibody | C184650 | Dengue Virus IGM Antibody | A measurement of the dengue virus IgM antibody in a biological specimen. | Dengue Virus IgM Antibody Measurement | ||
Dengue Virus NS1 Antigen | C184648 | Dengue Virus Nonstructural Protein 1;Dengue Virus NS1 Antigen | A measurement of the dengue virus NS1 antigen in a biological specimen. | Dengue Virus NS1 Antigen Measurement | ||
Dengue Virus RNA | C198228 | Dengue Virus RNA | A measurement of the dengue virus RNA in a biological specimen. | Dengue Virus RNA Measurement | ||
Dientamoeba fragilis DNA | C186152 | Dientamoeba fragilis DNA | A measurement of the Dientamoeba fragilis DNA in a biological specimen. | Dientamoeba fragilis DNA Measurement | ||
Diphtheria IgG Antibody | C103388 | Corynebacterium diphtheriae IgG Antibody;Diphtheria IgG Antibody | A measurement of the Corynebacterium diphtheriae IgG antibodies in a biological specimen. | Diphtheria IgG Antibody Measurement | ||
EAEC pAA Plasmid aggR/aatA DNA | C166014 | EAEC pAA Plasmid aggR/aatA DNA;Enteroaggregative Escherichia coli pAA Plasmid aggR/aatA DNA | A measurement of the enteroaggregative Escherichia coli pAA plasmid aggR and/or aatA DNA in a biological specimen. | Enteroaggregative Escherichia coli pAA Plasmid aggR and/or aatA DNA Measurement | ||
Ebola Virus IgM Antibody | C135410 | Ebola Virus IgM Antibody | A measurement of the Ebola virus IgM antibodies in a biological specimen. | Ebola Virus IgM Antibody Measurement | ||
Ebola Virus | C184673 | Ebola Virus | A measurement of the Ebola virus in a biological specimen. | Ebola Virus Measurement | ||
EBV Profile Interpretation | C106519 | Epstein-Barr Virus Antibody Profile;Epstein-Barr Virus Infection Status;Epstein-Barr Virus Panel | An assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests. | Epstein-Barr Virus Infection Status | ||
Ehrlichia DNA | C187847 | Ehrlichia DNA | A measurement of the DNA from any member of the genus Ehrlichia in a biological specimen. | Ehrlichia DNA Measurement | ||
Entamoeba dispar DNA | C189544 | Entamoeba dispar DNA | A measurement of the Entamoeba dispar DNA in a biological specimen. | Entamoeba dispar DNA Measurement | ||
Entamoeba dispar | C189543 | Entamoeba dispar | A measurement of the Entamoeba dispar in a biological specimen. | Entamoeba dispar Measurement | ||
Entamoeba histolytica DNA | C166036 | Entamoeba histolytica DNA | A measurement of the Entamoeba histolytica DNA in a biological specimen. | Entamoeba histolytica DNA Measurement | ||
Enterobacter cloacae Complex DNA | C191312 | Enterobacter cloacae Complex DNA | A measurement of the Enterobacter cloacae complex DNA in a biological specimen. | Enterobacter cloacae Complex DNA Measurement | ||
Enterobacter cloacae Complex | C191313 | Enterobacter cloacae Complex | A measurement of the Enterobacter cloacae complex in a biological specimen. | Enterobacter cloacae Complex Measurement | ||
Enterobacter cloacae | C187979 | Enterobacter cloacae | A measurement of the Enterobacter cloacae in a biological specimen. | Enterobacter cloacae Measurement | ||
Enterobacter | C179758 | Enterobacter | A measurement of the organisms that are not assigned to the species level but are assigned to the Enterobacter genus level in a biological specimen. | Enterobacter Measurement | ||
Enterococcus faecalis DNA | C189545 | Enterococcus faecalis DNA | A measurement of the Enterococcus faecalis DNA in a biological specimen. | Enterococcus faecalis DNA Measurement | ||
Enterococcus faecalis | C161396 | Streptococcus faecalis | A measurement of the Enterococcus faecalis in a biological specimen. | Enterococcus faecalis Measurement | ||
Enterococcus faecium | C189538 | Enterococcus faecium | A measurement of the Enterococcus faecium in a biological specimen. | Enterococcus faecium Measurement | ||
Enterococcus | C187848 | Enterococcus | A measurement of the organisms that are not assigned to the species level but are assigned to the Enterococcus genus level in a biological specimen. | Enterococcus Measurement | ||
Enterococcus, Vancomycin-resistant | C186191 | Enterococcus, Vancomycin-resistant | A measurement of the organisms that are vancomycin-resistant, and are not assigned to the species level but are assigned to the Enterococcus genus level in a biological specimen. | Vancomycin-resistant Enterococcus Measurement | ||
Enterovirus RNA | C186154 | Enterovirus RNA | A measurement of the RNA from any member of the genus Enterovirus in a biological specimen. | Enterovirus RNA Measurement | ||
Enterovirus | C172548 | Enterovirus | A measurement of the organisms that are not assigned to the species level but are assigned to the Enterovirus genus level in a biological specimen. | Enterovirus Measurement | ||
EPEC eae DNA | C166013 | Enteropathogenic Escherichia coli eae DNA;EPEC eae DNA | A measurement of the enteropathogenic Escherichia coli eae DNA in a biological specimen. | Enteropathogenic Escherichia coli eae DNA Measurement | ||
Epstein-Barr Capsid IgG Antibody | C96600 | Epstein-Barr Capsid IgG Antibody | A measurement of the Epstein-Barr capsid IgG antibody in a biological specimen. | Epstein-Barr Capsid IgG Antibody Measurement | ||
Epstein-Barr Capsid IgM Antibody | C96601 | Epstein-Barr Capsid IgM Antibody | A measurement of the Epstein-Barr capsid IgM antibody in a biological specimen. | Epstein-Barr Capsid IgM Antibody Measurement | ||
Epstein-Barr DNA | C166035 | Epstein-Barr DNA | A measurement of the Epstein-Barr virus DNA in a biological specimen. | Epstein-Barr DNA Measurement | ||
Epstein-Barr Early Antigen | C96602 | Epstein-Barr Early Antigen | A measurement of the Epstein-Barr early antigen in a biological specimen. | Epstein-Barr Early Antigen Measurement | ||
Epstein-Barr Early D Antigen IgG Ab | C122116 | Epstein-Barr Early D Antigen IgG Ab | A measurement of the Epstein-Barr early diffuse antigen IgG antibody in a biological specimen. | Epstein-Barr Early D Antigen IgG Antibody Measurement | ||
Epstein-Barr Nuclear Antibody | C96603 | Epstein-Barr Nuclear Antibody;Epstein-Barr Nuclear Antigen Antibody | A measurement of the Epstein-Barr nuclear antibody in a biological specimen. | Epstein-Barr Nuclear Antibody Measurement | ||
Epstein-Barr Nuclear Antigen 1 IgG Ab | C106518 | Epstein-Barr Nuclear Antigen 1 IgG Ab | A measurement of the Epstein-Barr nuclear antigen 1 IgG antibody in a biological specimen. | Epstein-Barr Nuclear Antigen 1 IgG Ab Measurement | ||
Epstein-Barr Nuclear Antigen | C96604 | Epstein-Barr Nuclear Antigen | A measurement of the Epstein-Barr nuclear antigen in a biological specimen. | Epstein-Barr Nuclear Antigen Measurement | ||
Epstein-Barr Virus LMP1 | C187849 | Epstein-Barr Virus Latent Membrane Protein 1;Epstein-Barr Virus LMP1 | A measurement of the epstein-barr virus latent membrane protein 1 in a biological specimen. | Epstein-Barr Virus Latent Membrane Protein 1 Measurement | ||
Epstein-Barr Virus | C184675 | Epstein-Barr Virus | A measurement of the Epstein-Barr virus in a biological specimen. | Epstein-Barr Virus Measurement | ||
Escherichia coli DNA | C191314 | Escherichia coli DNA | A measurement of the Escherichia coli DNA in a biological specimen. | Escherichia coli DNA Measurement | ||
Escherichia coli K1 DNA | C186153 | Escherichia coli K1 DNA | A measurement of the Escherichia coli K1 DNA in a biological specimen. | Escherichia coli K1 DNA Measurement | ||
Escherichia coli O Antigen | C198313 | Escherichia coli O Antigen | A measurement of the Escherichia coli O antigen in a biological specimen. | Escherichia coli O Antigen Measurement | ||
Escherichia coli O157 Antigen | C198314 | Escherichia coli O157 Antigen | A measurement of the Escherichia coli O157 antigen in a biological specimen. | Escherichia coli O157 Antigen Measurement | ||
Escherichia coli O157 DNA | C166037 | Escherichia coli O157 DNA | A measurement of the Escherichia coli O157 DNA in a biological specimen. | Escherichia coli O157 DNA Measurement | ||
Escherichia coli Shiga-like Toxin | C154818 | Escherichia coli Shiga-like Toxin | A measurement of the total Escherichia coli shiga-like toxin in a biological specimen. | Escherichia coli Shiga-like Toxin Measurement | ||
Escherichia coli Verotoxin | C187850 | Escherichia coli Verotoxin | A measurement of the total Escherichia coli verotoxin in a biological specimen. | Escherichia coli Verotoxin Measurement | ||
Escherichia coli | C172538 | Escherichia coli | A measurement of the Escherichia coli in a biological specimen. | Escherichia coli Measurement | ||
ETEC LtA/ST1a/ST1b DNA | C166012 | Enterotoxigenic Escherichia coli LtA/ST1a/ST1b DNA;ETEC LtA/ST1a/ST1b DNA | A measurement of the enterotoxigenic Escherichia coli LtA, ST1a and/or ST1b DNA in a biological specimen. | Enterotoxigenic Escherichia coli LtA, ST1a, and/or ST1b DNA Measurement | ||
Firmicutes/Bacteroidetes Ratio | C189550 | Firmicutes/Bacteroidetes Ratio | A ratio measurement of the members from the phylum Firmicutes to the members from the phylum Bacteroidetes in a biological specimen. | Firmicutes to Bacteroidetes Ratio Measurement | ||
Flagellates | C135421 | Flagellates | A measurement of the flagellates (protozoans that possess flagella) in a biological specimen. | Flagellates Measurement | ||
Fungi | C154813 | Fungi;Fungus | A measurement of the fungi in a biological specimen. | Fungi Measurement | ||
Fungi, Filamentous | C147343 | Fungi, Filamentous | A measurement of the filamentous fungi in a biological specimen. | Filamentous Fungi Count | ||
Fungi, Yeast-Like | C147344 | Fungi, Yeast-Like | A measurement of the yeast-like fungi in a biological specimen. | Yeast-Like Fungi Count | ||
Fusarium proliferatum IgE Antibody | C163527 | Fusarium proliferatum IgE Antibody;Gibberella intermedia IgE Antibody | A measurement of the Fusarium proliferatum IgE antibody in a biological specimen. | Fusarium proliferatum IgE Antibody Measurement | ||
Fusobacterium nucleatum | C189539 | Fusobacterium nucleatum | A measurement of the Fusobacterium nucleatum in a biological specimen. | Fusobacterium nucleatum Measurement | ||
Galactomannan Antigen | C154817 | Galactomannan Antigen | A measurement of the galactomannan antigen in a biological specimen. | Galactomannan Antigen Measurement | ||
Gardnerella vaginalis | C161402 | Corynebacterium vaginalis;Gardnerella vaginalis | A measurement of the Gardnerella vaginalis in a biological specimen. | Gardnerella vaginalis Measurement | ||
Giardia DNA | C186155 | Giardia DNA | A measurement of the DNA from any member of the genus Giardia in a biological specimen. | Giardia DNA Measurement | ||
Giardia lamblia Antigen | C154822 | Giardia lamblia Antigen | A measurement of the Giardia lamblia antigen in a biological specimen. | Giardia lamblia Antigen Measurement | ||
Giardia lamblia DNA | C166038 | Giardia duodenalis DNA;Giardia intestinalis DNA;Giardia lamblia DNA | A measurement of the Giardia lamblia DNA in a biological specimen. | Giardia lamblia DNA Measurement | ||
Giardia lamblia/Cryptosporidium Antigen | C189542 | Giardia lamblia/Cryptosporidium Antigen | A measurement of the antigen from Giardia lamblia and/or any member of the genus Cryptosporidium in a biological specimen. | Giardia lamblia/Cryptosporidium Antigen Measurement | ||
Gram Negative Bacteria | C154812 | Gram Negative Bacteria | A measurement of the gram negative bacteria in a biological specimen. | Gram Negative Bacteria Measurement | ||
Gram Negative Cocci | C161401 | Gram Negative Cocci | A measurement of the gram negative cocci-shaped bacteria in a biological specimen. | Gram Negative Cocci Measurement | ||
Gram Positive Bacteria | C154811 | Gram Positive Bacteria | A measurement of the gram positive bacteria in a biological specimen. | Gram Positive Bacteria Measurement | ||
Haemophilus influenzae DNA | C186157 | Haemophilus influenzae DNA | A measurement of the Haemophilus influenza virus DNA in a biological specimen. | Haemophilus influenzae DNA Measurement | ||
Haemophilus influenzae | C147457 | H. influenzae;Haemophilus influenzae | A measurement of the Haemophilus influenza virus in a biological specimen. | Haemophilus influenzae Measurement | ||
Haemophilus parahaemolyticus DNA | C198319 | Haemophilus parahaemolyticus DNA | A measurement of the Haemophilus parahaemolyticus DNA in a biological specimen. | Haemophilus parahaemolyticus DNA Measurement | ||
Haemophilus | C147458 | Haemophilus | A measurement of the organisms that are not assigned to the species level but are assigned to the Haemophilus genus level in a biological specimen. | Haemophilus Measurement | ||
HCoV-229E Nucleic Acid | C198306 | HCoV-229E Nucleic Acid;Human Coronavirus 229E Nucleic Acid | A measurement of the Human coronavirus 229E nucleic acid in a biological specimen. | Human Coronavirus 229E Nucleic Acid Measurement | ||
HCoV-229E RNA | C184652 | HCoV-229E RNA;Human Coronavirus 229E RNA | A measurement of the Human coronavirus 229E RNA in a biological specimen. | HCoV-229E RNA Measurement | ||
HCoV-HKU1 Nucleic Acid | C198317 | HCoV-HKU1 Nucleic Acid;HCoV-HKU1 RNA;Human Coronavirus HKU1 Nucleic Acid | A measurement of the Human coronavirus HKU1 nucleic acid in a biological specimen. | Human Coronavirus HKU1 Nucleic Acid Measurement | ||
HCoV-HKU1 RNA | C184655 | HCoV-HKU1 RNA;Human Coronavirus HKU1 RNA | A measurement of the Human coronavirus HKU1 RNA in a biological specimen. | HCoV-HKU1 RNA Measurement | ||
HCoV-NL63 Nucleic Acid | C198332 | HCoV-NL63 Nucleic Acid;Human Coronavirus NL63 Nucleic Acid | A measurement of the Human coronavirus NL63 nucleic acid in a biological specimen. | Human Coronavirus NL63 Nucleic Acid Measurement | ||
HCoV-NL63 RNA | C184654 | HCoV-NL63 RNA;Human Coronavirus NL63 RNA | A measurement of the Human coronavirus NL63 RNA in a biological specimen. | HCoV-NL63 RNA Measurement | ||
HCoV-OC43 Nucleic Acid | C198335 | HCoV-OC43 Nucleic Acid;Human Coronavirus OC43 Nucleic Acid | A measurement of the Human coronavirus OC43 nucleic acid in a biological specimen. | Human Coronavirus OC43 Nucleic Acid Measurement | ||
HCoV-OC43 RNA | C184653 | HCoV-OC43 RNA;Human Coronavirus OC43 RNA | A measurement of the Human coronavirus OC43 RNA in a biological specimen. | HCoV-OC43 RNA Measurement | ||
Helicobacter pylori Antigen | C154819 | Helicobacter pylori Antigen | A measurement of the Helicobacter pylori antigen in a biological specimen. | Helicobacter pylori Antigen Measurement | ||
Helicobacter pylori DNA | C184666 | Helicobacter pylori DNA | A measurement of the Helicobacter pylori DNA in a biological specimen. | Helicobacter pylori DNA Measurement | ||
Helicobacter pylori IgG Antibody | C103403 | Helicobacter pylori IgG Antibody | A measurement of the Helicobacter pylori IgG antibody in a biological specimen. | Helicobacter pylori IgG Antibody Measurement | ||
Helicobacter pylori | C189536 | Helicobacter pylori | A measurement of the Helicobacter pylori in a biological specimen. | Helicobacter pylori Measurement | ||
Hemozoin | C187851 | Hemozoin | A measurement of hemozoin in a biological specimen. Hemozoin is a breakdown product of hemoglobin and iron-containing pigment that accumulates as cytoplasmic granules in blood-feeding parasites. | Hemozoin Measurement | ||
Hepatitis A Virus Antibody | C92534 | Hepatitis A Virus Antibody | A measurement of the hepatitis A virus antibody in a biological specimen. | Hepatitis A Antibody Measurement | ||
Hepatitis A Virus IgG Antibody | C163538 | Hepatitis A Virus IgG Antibody | A measurement of hepatitis A virus IgG antibody in a biological specimen. | Hepatitis A Virus IgG Antibody Measurement | ||
Hepatitis A Virus IgM Antibody | C92271 | Hepatitis A Virus IgM Antibody | A measurement of hepatitis A virus IgM antibody in a biological specimen. | Hepatitis A Virus Antibody IgM Measurement | ||
Hepatitis A Virus RNA | C187852 | Hepatitis A Virus RNA | A measurement of the hepatitis A virus RNA in a biological specimen. | Hepatitis A Virus RNA Measurement | ||
Hepatitis B Virus Antibody | C125944 | Hepatitis B Virus Antibody | A measurement of an unspecified hepatitis B antibody in a biological specimen. | Hepatitis B Virus Antibody Measurement | ||
Hepatitis B Virus Core Antibody | C96660 | Hepatitis B Virus Core Antibody | A measurement of the hepatitis B virus core antibody in a biological specimen. | Hepatitis B Virus Core Antibody Measurement | ||
Hepatitis B Virus Core Antigen | C166039 | Hepatitis B Virus Core Antigen | A measurement of the Hepatitis B virus core antigen in a biological specimen. | Hepatitis B Virus Core Antigen Measurement | ||
Hepatitis B Virus Core IgG Antibody | C119280 | Hepatitis B Virus Core IgG Antibody | A measurement of the hepatitis B virus core IgG antibody in a biological specimen. | Hepatitis B Virus Core IgG Antibody Measurement | ||
Hepatitis B Virus Core IgM Antibody | C96661 | Hepatitis B Virus Core IgM Antibody | A measurement of the hepatitis B virus core IgM antibody in a biological specimen. | Hepatitis B Virus Core IgM Antibody Measurement | ||
Hepatitis B Virus DNA | C103404 | Hepatitis B Virus DNA | A measurement of the Hepatitis B virus DNA in a biological specimen. | Hepatitis B DNA Measurement | ||
Hepatitis B Virus e Antibody | C96662 | Hepatitis B Virus e Antibody | A measurement of the hepatitis B e antibody in a biological specimen. | Hepatitis B Virus e Antibody Measurement | ||
Hepatitis B Virus e Antigen | C96663 | Hepatitis B Virus e Antigen | A measurement of the hepatitis B e antigen in a biological specimen. | Hepatitis B Virus e Antigen Measurement | ||
Hepatitis B Virus Nucleic Acid | C166040 | Hepatitis B Virus Nucleic Acid | A measurement of the hepatitis B virus nucleic acid in a biological specimen. | Hepatitis B Virus Nucleic Acid Measurement | ||
Hepatitis B Virus RNA | C198316 | Hepatitis B Virus RNA | A measurement of the Hepatitis B virus RNA in a biological specimen. | Hepatitis B Virus RNA Measurement | ||
Hepatitis B Virus Surface Antibody | C74711 | Anti-HBs;HBsAb;Hepatitis B Virus Surface Antibody | A measurement of the hepatitis B virus surface antibody in a biological specimen. | Hepatitis B Surface Antibody Measurement | ||
Hepatitis B Virus Surface Antigen | C64850 | HBsAg;Hepatitis B Virus Surface Antigen | A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus. | Hepatitis B Virus Surface Antigen Measurement | ||
Hepatitis B Virus | C189553 | Hepatitis B Virus | A measurement of the hepatitis B virus in a biological specimen. | Hepatitis B Virus Measurement | ||
Hepatitis C Virus Antibody | C92535 | Hepatitis C Virus Antibody | A measurement of the hepatitis C virus antibody in a biological specimen. | Hepatitis C Antibody Measurement | ||
Hepatitis C Virus Antigen | C116196 | Hepatitis C Virus Antigen | A measurement of the hepatitis C virus antigen in a biological specimen. | Hepatitis C Virus Antigen Measurement | ||
Hepatitis C Virus Core Antigen | C135424 | Hepatitis C Virus Core Antigen | A measurement of the hepatitis C virus core antigen in a biological specimen. | Hepatitis C Virus Core Antigen Measurement | ||
Hepatitis C Virus Nucleic Acid | C166041 | Hepatitis C Virus Nucleic Acid | A measurement of the hepatitis C virus nucleic acid in a biological specimen. | Hepatitis C Virus Nucleic Acid Measurement | ||
Hepatitis C Virus RNA | C142330 | Hepatitis C Virus RNA | A measurement of the Hepatitis C virus RNA in a biological specimen. | Hepatitis C Virus RNA Measurement | ||
Hepatitis C Virus | C189554 | Hepatitis C Virus | A measurement of the hepatitis C virus in a biological specimen. | Hepatitis C Virus Measurement | ||
Hepatitis D Virus Antibody | C96664 | Hepatitis D Virus Antibody;Hepatitis Delta Antibody | A measurement of the hepatitis D virus antibody in a biological specimen. | Hepatitis D Virus Antibody Measurement | ||
Hepatitis D Virus IgG Antibody | C119281 | Hepatitis D Virus IgG Antibody | A measurement of the hepatitis D virus IgG antibody in a biological specimen. | Hepatitis D Virus IgG Antibody Measurement | ||
Hepatitis D Virus IgM Antibody | C119282 | Hepatitis D Virus IgM Antibody | A measurement of the hepatitis D virus IgM antibody in a biological specimen. | Hepatitis D Virus IgM Antibody Measurement | ||
Hepatitis D Virus RNA | C186156 | Hepatitis D Virus RNA | A measurement of the hepatitis D virus RNA in a biological specimen. | Hepatitis D Virus RNA Measurement | ||
Hepatitis E Virus Antibody | C119283 | Hepatitis E Virus Antibody | A measurement of the hepatitis E virus antibody in a biological specimen. | Hepatitis E Virus Antibody Measurement | ||
Hepatitis E Virus Antigen | C166042 | Hepatitis E Virus Antigen | A measurement of the Hepatitis E virus antigen in a biological specimen. | Hepatitis E Virus Antigen Measurement | ||
Hepatitis E Virus IgG Antibody | C106526 | Hepatitis E Virus IgG Antibody | A measurement of IgG antibody to the hepatitis E virus in a biological specimen. | Hepatitis E Virus IgG Antibody Measurement | ||
Hepatitis E Virus IgM Antibody | C96665 | Hepatitis E Virus IgM Antibody | A measurement of the hepatitis E virus IgM antibody in a biological specimen. | Hepatitis E Virus IgM Antibody Measurement | ||
Hepatitis E Virus RNA | C142331 | Hepatitis E Virus RNA | A measurement of the Hepatitis E virus RNA in a biological specimen. | Hepatitis E Virus RNA Measurement | ||
Herpes Simplex Virus 1 DNA | C186169 | Herpes Simplex Virus 1 DNA | A measurement of the herpes simplex virus 1 DNA in a biological specimen. | Herpes Simplex Virus 1 DNA Measurement | ||
Herpes Simplex Virus 1 IgG Antibody | C96666 | Herpes Simplex Virus 1 IgG Antibody;HSV-1 IgG Antibody | A measurement of the herpes simplex virus 1 IgG antibody in a biological specimen. | Herpes Simplex Virus 1 IgG Antibody Measurement | ||
Herpes Simplex Virus 1 IgM Antibody | C98738 | Herpes Simplex Virus 1 IgM Antibody | A measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen. | Herpes Simplex Virus 1 IgM Antibody Measurement | ||
Herpes Simplex Virus 1 | C187853 | Herpes Simplex Virus 1 | A measurement of the herpes simplex virus 1 in a biological specimen. | Herpes Simplex Virus 1 Measurement | ||
Herpes Simplex Virus 1/2 Antigen | C186168 | Herpes Simplex Virus 1/2 Antigen;HSV 1/2 Antigen | A measurement of the herpes simplex virus 1 and/or 2 antigen in a biological specimen. | Herpes Simplex Virus 1 and/or 2 Antigen Measurement | ||
Herpes Simplex Virus 1/2 IgG Antibody | C96697 | Herpes Simplex Virus 1/2 IgG Antibody;HSV-1/2 IgG Ab | A measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen. | Herpes Simplex Virus 1/2 IgG Antibody Measurement | ||
Herpes Simplex Virus 1/2 IgM Antibody | C96698 | Herpes Simplex Virus 1/2 IgM Antibody;HSV-1/2 IgM Ab | A measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen. | Herpes Simplex Virus 1/2 IgM Antibody Measurement | ||
Herpes Simplex Virus 2 DNA | C186170 | Herpes Simplex Virus 2 DNA | A measurement of the Herpes simplex virus 2 DNA in a biological specimen. | Herpes Simplex Virus 2 DNA Measurement | ||
Herpes Simplex Virus 2 IgG Antibody | C96667 | Herpes Simplex Virus 2 IgG Antibody;HSV-2 IgG Antibody | A measurement of the herpes simplex virus 2 IgG antibody in a biological specimen. | Herpes Simplex Virus 2 IgG Antibody Measurement | ||
Herpes Simplex Virus 2 IgM Antibody | C98739 | Herpes Simplex Virus 2 IgM Antibody | A measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen. | Herpes Simplex Virus 2 IgM Antibody Measurement | ||
Herpes Simplex Virus 2 | C187854 | Herpes Simplex Virus 2 | A measurement of the herpes simplex virus 2 in a biological specimen. | Herpes Simplex Virus 2 Measurement | ||
Heterophile Antibodies | C81984 | Heterophile Antibodies | A measurement of the heterophile antibodies in a biological specimen. | Heterophile Antibody Measurement | ||
Histoplasma capsulatum Antigen | C154816 | Histoplasma capsulatum Antigen | A measurement of the Histoplasma capsulatum antigen in a biological specimen. | Histoplasma capsulatum Antigen Measurement | ||
HIV Antibody | C106527 | HIV Antibody | A measurement of the HIV virus antibody in a biological specimen. | HIV Antibody Measurement | ||
HIV-1 Antibody + HIV-1 p24 Antigen | C166043 | HIV-1 Antibody + HIV-1 p24 Antigen | A measurement of the antibody reaction to the HIV-1 virus and the measurement of HIV-1 p24 antigen in a biological specimen. | HIV-1 Antibody and HIV-1 p24 Antigen Measurement | ||
HIV-1 Antibody | C74713 | HIV-1 Antibody | A measurement of the HIV-1 virus antibody in a biological specimen. | HIV-1 Antibody Measurement | ||
HIV-1 Antigen | C154821 | HIV-1 Antigen | A measurement of the HIV-1 antigen in a biological specimen. | HIV-1 Antigen Measurement | ||
HIV-1 gp160 Antibody | C163524 | HIV-1 Glycoprotein 160 Antibody;HIV-1 gp160 Antibody | A measurement of the HIV-1 gp160 antibody in a biological specimen. | HIV-1 gp160 Antibody Measurement | ||
HIV-1 gp41 Antibody | C163526 | HIV-1 Glycoprotein 41 Antibody;HIV-1 gp41 Antibody | A measurement of the HIV-1 gp41 antibody in a biological specimen. | HIV-1 gp41 Antibody Measurement | ||
HIV-1 Group M and O Nucleic Acid | C92263 | HIV-1 Group M and O Nucleic Acid | A measurement of the HIV-1 group M and O nucleic acids in a biological specimen. | HIV-1 Group M and O Nucleic Acid Measurement | ||
HIV-1 Group O Antibody | C92264 | HIV-1 Group O Antibody | A measurement of the HIV-1 group O antibody in a biological specimen. | HIV-1 Group O Antibody Measurement | ||
HIV-1 p24 Antibody | C163525 | HIV-1 p24 Antibody;HIV-1 Protein 24 Antibody | A measurement of the HIV-1 p24 antibody in a biological specimen. | HIV-1 p24 Antibody Measurement | ||
HIV-1 p24 Antigen | C92265 | HIV-1 p24 Antigen | A measurement of the HIV-1 p24 antigen in a biological specimen. | HIV-1 p24 Antigen Measurement | ||
HIV-1 p31 Antibody | C163523 | HIV-1 p31 Antibody;HIV-1 Protein 31 Antibody | A measurement of the amount of HIV-1 p31 antibody in a biological specimen. | HIV-1 p31 Antibody Measurement | ||
HIV-1 RNA | C158238 | HIV-1 RNA | A measurement of the HIV-1 RNA in a biological specimen. | HIV-1 RNA Measurement | ||
HIV-1/2 Antibody + HIV-1 p24 Antigen | C139085 | HIV-1/2 Antibody + HIV-1 p24 Antigen | A measurement of the antibody reaction of a biological specimen to either the HIV-1 or HIV-2 virus and the measurement of HIV-1 p24 antigen in a biological specimen. | HIV-1/2 Antibody and HIV-1 p24 Antigen Measurement | ||
HIV-1/2 Antibody | C74714 | HIV-1/2 Antibody | A measurement of either the HIV-1 or HIV-2 virus antibody in a biological specimen. | HIV-1 HIV-2 Antibody Measurement | ||
HIV-1/2 Antigen/Antibody | C163539 | HIV-1/2 Antigen/Antibody | A measurement of the HIV-1/HIV-2 antigens and/or HIV-1/HIV-2 antibodies in a biological specimen (to be used when the antigen is not specified). | HIV-1/2 Antigen/Antibody Measurement | ||
HIV-1/2 RNA | C161393 | HIV-1/2 RNA | A measurement of the HIV-1 and/or HIV-2 RNA in a biological specimen. | HIV-1/2 RNA Measurement | ||
HIV-2 Antibody + HIV-1 p24 Antigen | C166044 | HIV-2 Antibody + HIV-1 p24 Antigen | A measurement of the antibody reaction to the HIV-2 virus and the measurement of HIV-1 p24 antigen in a biological specimen. | HIV-2 Antibody And HIV-1 p24 Antigen Measurement | ||
HIV-2 Antibody | C74715 | HIV-2 Antibody | A measurement of the HIV-2 virus antibody in a biological specimen. | HIV-2 Antibody Measurement | ||
HIV-2 gp140 Antibody | C163522 | HIV-2 Glycoprotein140 Antibody;HIV-2 gp140 Antibody | A measurement of the amount of HIV-2 gp140 antibody in a biological specimen. | HIV-2 gp140 Antibody Measurement | ||
HIV-2 gp36 Antibody | C163521 | HIV-2 Glycoprotein 36 Antibody;HIV-2 gp36 Antibody | A measurement of the HIV-2 glycoprotein 36 antibody in a biological specimen. | HIV-2 gp36 Antibody Measurement | ||
HIV-2 Nucleic Acid | C92266 | HIV-2 Nucleic Acid | A measurement of the HIV-2 nucleic acids in a biological specimen. | HIV-2 Nucleic Acid Measurement | ||
HIV-2 RNA | C166045 | HIV-2 RNA | A measurement of the HIV-2 RNA in a biological specimen. | HIV-2 RNA Measurement | ||
HTLV-1/2 Antibody | C122125 | HTLV-1/2 Antibody;HTLV-I/II Antibody;Human T-cell Lymphotropic Virus 1/2 Antibody | A measurement of either the HTLV-1 or HTLV-2 virus antibody in a biological specimen. | HTLV-I HTLV-II Antibody Measurement | ||
Human adenovirus 40/41 DNA | C166017 | Human adenovirus 40/41 DNA;Human adenovirus F40/F41 DNA;Mastadenovirus 40/41 DNA | A measurement of the Human adenovirus type 40 and/or Human adenovirus type 41 DNA in a biological specimen. | Human adenovirus 40 and/or Human adenovirus 41 DNA Measurement | ||
Human astrovirus 1/2/3/4/5/6/7/8 RNA | C166016 | Human astrovirus 1/2/3/4/5/6/7/8 RNA | A measurement of the Human astrovirus 1, 2, 3, 4, 5, 6, 7 and/or 8 RNA in a biological specimen. | Human astrovirus 1, 2, 3, 4, 5, 6, 7, and/or 8 RNA Measurement | ||
Human bocavirus DNA | C184656 | Human bocavirus DNA | A measurement of the Human bocavirus DNA in a biological specimen. | Human Bocavirus DNA Measurement | ||
Human Bocavirus Nucleic Acid | C198315 | Human Bocavirus Nucleic Acid | A measurement of the Human bocavirus nucleic acid in a biological specimen. | Human Bocavirus Nucleic Acid Measurement | ||
Human Coronavirus 229E | C178007 | Human Coronavirus 229E | A measurement of the Human coronavirus 229E in a biological specimen. | Human Coronavirus 229E Measurement | ||
Human Coronavirus HKU1 | C178008 | Human Coronavirus HKU1 | A measurement of the Human coronavirus HKU1 in a biological specimen. | Human Coronavirus HKU1 Measurement | ||
Human Coronavirus NL63 | C178009 | Human Coronavirus NL63 | A measurement of the Human coronavirus NL63 in a biological specimen. | Human Coronavirus NL63 Measurement | ||
Human Coronavirus OC43 | C178010 | Human Coronavirus OC43 | A measurement of the Human coronavirus OC43 in a biological specimen. | Human Coronavirus OC43 Measurement | ||
Human Herpes Virus 8 | C189316 | Human Herpes Virus 8 | A measurement of the human herpes virus 8 in a biological specimen. | Human Herpesvirus 8 Measurement | ||
Human Herpesvirus 6 Antibody | C112292 | Human Herpesvirus 6 Antibody | A measurement of the human herpesvirus 6 antibody in a biological specimen. | Herpes Simplex Virus 6 Antibody Measurement | ||
Human Herpesvirus 6 DNA | C187855 | Human Herpesvirus 6 DNA | A measurement of the human herpesvirus 6 DNA in a biological specimen. | Human Herpesvirus 6 DNA Measurement | ||
Human Herpesvirus 7 DNA | C189549 | Human Herpesvirus 7 DNA | A measurement of the human herpesvirus 7 DNA in a biological specimen. | Human Herpesvirus 7 DNA Measurement | ||
Human Herpesvirus 8 DNA | C189552 | Human Herpesvirus 8 DNA | A measurement of the human herpesvirus 8 DNA in a biological specimen. | Human Herpesvirus 8 DNA Measurement | ||
Human Immunodeficiency Virus | C161395 | Human Immunodeficiency Virus | A measurement of the Human Immunodeficiency Virus in a biological specimen. | Human Immunodeficiency Virus Measurement | ||
Human Metapneumovirus Antigen | C186158 | Human Metapneumovirus Antigen | A measurement of the Human metapneumovirus antigen in a biological specimen. | Human Metapneumovirus Antigen Measurement | ||
Human Metapneumovirus Nucleic Acid | C198318 | Human Metapneumovirus Nucleic Acid | A measurement of the Human metapneumovirus nucleic acid in a biological specimen. | Human Metapneumovirus Nucleic Acid Measurement | ||
Human Metapneumovirus RNA | C191315 | Human Metapneumovirus RNA | A measurement of the Human Metapneumovirus RNA in a biological specimen. | Human Metapneumovirus RNA Measurement | ||
Human Metapneumovirus | C178011 | Human Metapneumovirus | A measurement of the Human metapneumovirus in a biological specimen. | Human Metapneumovirus Measurement | ||
Human Papillomavirus 11 Antibody | C127618 | Human Papillomavirus 11 Antibody | A measurement of the human papillomavirus 11 antibody in a biological specimen. | Human Papillomavirus 11 Antibody Measurement | ||
Human Papillomavirus 16 Antibody | C127619 | Human Papillomavirus 16 Antibody | A measurement of the human papillomavirus 16 antibody in a biological specimen. | Human Papillomavirus 16 Antibody Measurement | ||
Human Papillomavirus 18 Antibody | C127620 | Human Papillomavirus 18 Antibody | A measurement of the human papillomavirus 18 antibody in a biological specimen. | Human Papillomavirus 18 Antibody Measurement | ||
Human Papillomavirus 6 Antibody | C127621 | Human Papillomavirus 6 Antibody | A measurement of the human papillomavirus 6 antibody in a biological specimen. | Human Papillomavirus 6 Antibody Measurement | ||
Human Papillomavirus E6/E7 mRNA | C186165 | Human Papillomavirus E6/E7 Messenger RNA;Human Papillomavirus E6/E7 mRNA | A measurement of the human papillomavirus E6 and/or E7 protein-making mRNA in a biological specimen. | Human Papillomavirus E6/E7 mRNA Measurement | ||
Human Papillomavirus Type 31 | C189566 | Human Papillomavirus Type 31 | A measurement of the Human papillomavirus type 31 in a biological specimen. | Human Papillomavirus Type 31 Measurement | ||
Human Papillomavirus Type 33 | C189567 | Human Papillomavirus Type 33 | A measurement of the Human papillomavirus type 33 in a biological specimen. | Human Papillomavirus Type 33 Measurement | ||
Human Papillomavirus Type 34 | C189556 | Human Papillomavirus Type 34 | A measurement of the Human papillomavirus type 34 in a biological specimen. | Human Papillomavirus Type 34 Measurement | ||
Human Papillomavirus Type 35 | C189568 | Human Papillomavirus Type 35 | A measurement of the Human papillomavirus type 35 in a biological specimen. | Human Papillomavirus Type 35 Measurement | ||
Human Papillomavirus Type 39 | C189569 | Human Papillomavirus Type 39 | A measurement of the Human papillomavirus type 39 in a biological specimen. | Human Papillomavirus Type 39 Measurement | ||
Human Papillomavirus Type 40 | C189557 | Human Papillomavirus Type 40 | A measurement of the Human papillomavirus type 40 in a biological specimen. | Human Papillomavirus Type 40 Measurement | ||
Human Papillomavirus Type 42 | C189558 | Human Papillomavirus Type 42 | A measurement of the Human papillomavirus type 42 in a biological specimen. | Human Papillomavirus Type 42 Measurement | ||
Human Papillomavirus Type 43 | C189559 | Human Papillomavirus Type 43 | A measurement of the Human papillomavirus type 43 in a biological specimen. | Human Papillomavirus Type 43 Measurement | ||
Human Papillomavirus Type 44 | C189560 | Human Papillomavirus Type 44 | A measurement of the Human papillomavirus type 44 in a biological specimen. | Human Papillomavirus Type 44 Measurement | ||
Human Papillomavirus Type 45 | C189570 | Human Papillomavirus Type 45 | A measurement of the Human papillomavirus type 45 in a biological specimen. | Human Papillomavirus Type 45 Measurement | ||
Human Papillomavirus Type 51 | C189571 | Human Papillomavirus Type 51 | A measurement of the Human papillomavirus type 51 in a biological specimen. | Human Papillomavirus Type 51 Measurement | ||
Human Papillomavirus Type 52 | C189572 | Human Papillomavirus Type 52 | A measurement of the Human papillomavirus type 52 in a biological specimen. | Human Papillomavirus Type 52 Measurement | ||
Human Papillomavirus Type 53 | C189561 | Human Papillomavirus Type 53 | A measurement of the Human papillomavirus type 53 in a biological specimen. | Human Papillomavirus Type 53 Measurement | ||
Human Papillomavirus Type 54 | C189562 | Human Papillomavirus Type 54 | A measurement of the Human papillomavirus type 54 in a biological specimen. | Human Papillomavirus Type 54 Measurement | ||
Human Papillomavirus Type 56 | C189573 | Human Papillomavirus Type 56 | A measurement of the Human papillomavirus type 56 in a biological specimen. | Human Papillomavirus Type 56 Measurement | ||
Human Papillomavirus Type 58 | C189574 | Human Papillomavirus Type 58 | A measurement of the Human papillomavirus type 58 in a biological specimen. | Human Papillomavirus Type 58 Measurement | ||
Human Papillomavirus Type 59 | C189575 | Human Papillomavirus Type 59 | A measurement of the Human papillomavirus type 59 in a biological specimen. | Human Papillomavirus Type 59 Measurement | ||
Human Papillomavirus Type 66 | C189563 | Human Papillomavirus Type 66 | A measurement of the Human papillomavirus type 66 in a biological specimen. | Human Papillomavirus Type 66 Measurement | ||
Human Papillomavirus Type 68 | C189576 | Human Papillomavirus Type 68 | A measurement of the Human papillomavirus type 68 in a biological specimen. | Human Papillomavirus Type 68 Measurement | ||
Human Papillomavirus Type 69 | C189577 | Human Papillomavirus Type 69 | A measurement of the Human papillomavirus type 69 in a biological specimen. | Human Papillomavirus Type 69 Measurement | ||
Human Papillomavirus Type 70 | C189564 | Human Papillomavirus Type 70 | A measurement of the Human papillomavirus type 70 in a biological specimen. | Human Papillomavirus Type 70 Measurement | ||
Human Papillomavirus Type 74 | C189565 | Human Papillomavirus Type 74 | A measurement of the Human papillomavirus type 74 in a biological specimen. | Human Papillomavirus Type 74 Measurement | ||
Human Parainfluenza Antigen | C154833 | Human Parainfluenza Antigen | A measurement of the Human Parainfluenza antigen in a biological specimen. | Human Parainfluenza Antigen Measurement | ||
Human Parainfluenza Virus 1 Antigen | C154834 | Human Parainfluenza Virus 1 Antigen;Human Respirovirus 1 Antigen | A measurement of the Human parainfluenza virus 1 antigen in a biological specimen. | Human Parainfluenza Type 1 Antigen Measurement | ||
Human Parainfluenza Virus 1 Nucleic Acid | C198320 | Human Parainfluenza Virus 1 Nucleic Acid | A measurement of the Human parainfluenza virus 1 nucleic acid in a biological specimen. | Human Parainfluenza Virus 1 Nucleic Acid Measurement | ||
Human Parainfluenza Virus 1 RNA | C184662 | Human Parainfluenza Virus 1 RNA;Human Respirovirus 1 RNA | A measurement of the Human parainfluenza virus 1 RNA in a biological specimen. | Human Parainfluenza Virus 1 RNA Measurement | ||
Human Parainfluenza Virus 1 | C186162 | Human Parainfluenza Virus 1 | A measurement of the Human parainfluenza virus 1 in a biological specimen. | Human Parainfluenza Virus 1 Measurement | ||
Human Parainfluenza Virus 1/2/3 Antigen | C186160 | Human Parainfluenza Virus 1/2/3 Antigen | A measurement of the Human Parainfluenza virus 1, 2, and/or 3 antigen in a biological specimen. | Human Parainfluenza Virus 1, 2, and/or 3 Antigen Measurement | ||
Human Parainfluenza Virus 1/2/3 RNA | C186161 | Human Parainfluenza Virus 1/2/3 RNA | A measurement of the RNA from the Human Parainfluenza virus 1, 2, and/or 3 in a biological specimen. | Human Parainfluenza Virus 1, 2, and/or 3 RNA Measurement | ||
Human Parainfluenza Virus 1/2/3/4 RNA | C186159 | Human Parainfluenza Virus 1/2/3/4 RNA | A measurement of the RNA from the Human Parainfluenza virus 1, 2, 3 and/or 4 in a biological specimen. | Human Parainfluenza Virus 1, 2, 3, and/or 4 RNA Measurement | ||
Human Parainfluenza Virus 2 Antigen | C186163 | Human Orthorubulavirus 2 Antigen;Human Parainfluenza Virus 2 Antigen | A measurement of the Human parainfluenza virus 2 antigen in a biological specimen. | Human Parainfluenza Virus 2 Antigen Measurement | ||
Human Parainfluenza Virus 2 Nucleic Acid | C198321 | Human Parainfluenza Virus 2 Nucleic Acid | A measurement of the Human parainfluenza virus 2 nucleic acid in a biological specimen. | Human Parainfluenza Virus 2 Nucleic Acid Measurement | ||
Human Parainfluenza Virus 2 RNA | C184663 | Human Orthorubulavirus 2 RNA;Human Parainfluenza Virus 2 RNA | A measurement of the Human parainfluenza virus 2 RNA in a biological specimen. | Human Parainfluenza Virus 2 RNA Measurement | ||
Human Parainfluenza Virus 2 | C178012 | Human Parainfluenza Virus 2 | A measurement of the Human parainfluenza virus 2 in a biological specimen. | Human Parainfluenza Virus 2 Measurement | ||
Human Parainfluenza Virus 3 Antigen | C186164 | Human Parainfluenza Virus 3 Antigen;Human Respirovirus 3 Antigen | A measurement of the Human parainfluenza virus 3 antigen in a biological specimen. | Human Parainfluenza Virus 3 Antigen Measurement | ||
Human Parainfluenza Virus 3 Nucleic Acid | C198322 | Human Parainfluenza Virus 3 Nucleic Acid | A measurement of the Human parainfluenza virus 3 nucleic acid in a biological specimen. | Human Parainfluenza Virus 3 Nucleic Acid Measurement | ||
Human Parainfluenza Virus 3 RNA | C184664 | Human Parainfluenza Virus 3 RNA;Human Respirovirus 3 RNA | A measurement of the Human parainfluenza virus 3 RNA in a biological specimen. | Human Parainfluenza Virus 3 RNA Measurement | ||
Human Parainfluenza Virus 3 | C178013 | Human Parainfluenza Virus 3 | A measurement of the Human parainfluenza virus 3 in a biological specimen. | Human Parainfluenza Virus 3 Measurement | ||
Human Parainfluenza Virus 4 Nucleic Acid | C198324 | Human Parainfluenza Virus 4 Nucleic Acid | A measurement of the Human parainfluenza virus 4 nucleic acid in a biological specimen. | Human Parainfluenza Virus 4 Nucleic Acid Measurement | ||
Human Parainfluenza Virus 4 RNA | C184651 | Human Orthorubulavirus 4 RNA;Human Parainfluenza Virus 4 RNA | A measurement of the Human parainfluenza virus 4 RNA in a biological specimen. | Human Parainfluenza Virus 4 RNA Measurement | ||
Human Parainfluenza Virus 4 | C178014 | Human Parainfluenza Virus 4 | A measurement of the Human parainfluenza virus 4 in a biological specimen. | Human Parainfluenza Virus 4 Measurement | ||
Human Parainfluenza Virus 4B Nucleic Acid | C198323 | Human Parainfluenza Virus 4B Nucleic Acid | A measurement of the Human parainfluenza virus 4b nucleic acid in a biological specimen. | Human Parainfluenza Virus 4B Nucleic Acid Measurement | ||
Human Parainfluenza virus RNA | C191316 | Human Parainfluenza virus RNA | A measurement of the Human parainfluenza virus RNA in a biological specimen. | Human Parainfluenza virus RNA Measurement | ||
Human Parvovirus B19 DNA | C187856 | Human Parvovirus B19 DNA | A measurement of the Human Parvovirus B19 DNA in a biological specimen. | Human Parvovirus B19 DNA Measurement | ||
Human Parvovirus B19 | C156542 | Human Parvovirus B19 | A measurement of the Human Parvovirus B19 in a biological specimen. | Human Parvovirus B19 Measurement | ||
Human Poliovirus 1 Neutralizing Antibody | C181456 | Human Poliovirus 1 Neutralizing Antibody;Type 1 Poliovirus Neutralizing Antibody | A measurement of the Human poliovirus 1 neutralizing antibody in a biological specimen. | Human Poliovirus 1 Neutralizing Antibody Measurement | ||
Human Poliovirus 3 Neutralizing Antibody | C181457 | Human Poliovirus 3 Neutralizing Antibody;Type 3 Poliovirus Neutralizing Antibody | A measurement of the Human poliovirus 3 neutralizing antibody in a biological specimen. | Human Poliovirus 3 Neutralizing Antibody Measurement | ||
Human rhinovirus A/B/C Antigen | C186167 | HRV A/B/C Antigen;Human rhinovirus A/B/C Antigen;Human rhinovirus Antigen | A measurement of the Human rhinovirus A, B and/or C antigen in a biological specimen. | Human rhinovirus A, B, and/or C Antigen Measurement | ||
Human rhinovirus A/B/C | C186166 | HRV A/B/C;Human rhinovirus;Human rhinovirus A/B/C | A measurement of the Human rhinovirus A, B and/or C in a biological specimen. | Human rhinovirus A, B, and/or C Measurement | ||
Human rhinovirus/enterovirus RNA | C170609 | Human rhinovirus/enterovirus RNA | A measurement of RNA from any member of the Human Rhinovirus species and/or Human Enterovirus species in a biological specimen. | Human rhinovirus and/or enterovirus RNA Measurement | ||
Human rhinovirus/enterovirus | C179761 | Human rhinovirus/enterovirus | A measurement of the Human rhinovirus and/or Human enterovirus in a biological specimen. | Human Rhinovirus and/or Enterovirus Measurement | ||
Influenza A Antigen | C120677 | Influenza A Antigen | A measurement of the influenza A antigen in a biological specimen. | Influenza A Antigen Measurement | ||
Influenza A IgG Antibody | C103408 | Influenza A IgG Antibody | A measurement of the Influenza A IgG antibody in a biological specimen. | Influenza A IgG Antibody Measurement | ||
Influenza A Nucleic Acid | C198325 | Influenza A Nucleic Acid | A measurement of the Influenza A virus nucleic acid in an biological specimen. | Influenza A Nucleic Acid Measurement | ||
Influenza A RNA | C191317 | Influenza A RNA | A measurement of the Influenza A virus RNA in a biological specimen. | Influenza A RNA Measurement | ||
Influenza A Virus | C187857 | Influenza A Virus | A measurement of the Influenza A virus an biological specimen. | Influenza A Virus Measurement | ||
Influenza A/B Antigen | C120678 | Influenza A/B Antigen | A measurement of the influenza A and/or B antigen in a biological specimen. | Influenza A/B Antigen Measurement | ||
Influenza A/B Virus | C184674 | Influenza A/B Virus | A measurement of the influenza A and/or B virus in a biological specimen. | Influenza A/B Virus Measurement | ||
Influenza B Antigen | C120679 | Influenza B Antigen | A measurement of the influenza B antigen in a biological specimen. | Influenza B Antigen Measurement | ||
Influenza B IgG Antibody | C103409 | Influenza B IgG Antibody | A measurement of the Influenza B IgG antibody in a biological specimen. | Influenza B IgG Antibody Measurement | ||
Influenza B Nucleic Acid | C198326 | Influenza B Nucleic Acid | A measurement of the Influenza B virus nucleic acid in an biological specimen. | Influenza B Nucleic Acid Measurement | ||
Influenza B RNA | C191318 | Influenza B RNA | A measurement of the Influenza B virus RNA in a biological specimen. | Influenza B RNA Measurement | ||
Influenza B Virus | C187858 | Influenza B Virus | A measurement of the Influenza B virus an biological specimen. | Influenza B Virus Measurement | ||
Japanese Encephalitis Virus Antibody | C147378 | Japanese Encephalitis Virus Antibody | A measurement of the Japanese encephalitis virus antibody in a biological specimen. | Japanese Encephalitis Virus Antibody Measurement | ||
JC Virus Antibody | C112326 | JC Polyomavirus Antibody;JC Virus Antibody;JCV Antibody;John Cunningham Virus Antibody | A measurement of the JC virus antibody in a biological specimen. | JC Virus Antibody Measurement | ||
JC Virus DNA | C163540 | JC Polyomavirus DNA;JC Virus DNA;JCV DNA;John Cunningham Virus DNA | A measurement of the JC virus DNA in a biological specimen. | JC Virus DNA Measurement | ||
Klebsiella aerogenes DNA | C191319 | Klebsiella aerogenes DNA | A measurement of the Klebsiella aerogenes DNA in a biological specimen. | Klebsiella aerogenes DNA Measurement | ||
Klebsiella aerogenes | C187859 | Klebsiella aerogenes | A measurement of the Klebsiella aerogenes in a biological specimen. | Klebsiella aerogenes Measurement | ||
Klebsiella oxytoca DNA | C191320 | Klebsiella oxytoca DNA | A measurement of the Klebsiella oxytoca DNA in a biological specimen. | Klebsiella oxytoca DNA Measurement | ||
Klebsiella oxytoca | C191321 | Klebsiella oxytoca | A measurement of the Klebsiella oxytoca in a biological specimen. | Klebsiella oxytoca Measurement | ||
Klebsiella pneumoniae DNA | C191322 | Klebsiella pneumoniae DNA | A measurement of the Klebsiella pneumoniae DNA in a biological specimen. | Klebsiella pneumoniae DNA Measurement | ||
Klebsiella pneumoniae | C187860 | Klebsiella pneumoniae | A measurement of the Klebsiella pneumoniae in a biological specimen. | Klebsiella pneumoniae Measurement | ||
Klebsiella | C172539 | Klebsiella | A measurement of the organisms that are not assigned to the species level but are assigned to the Klebsiella genus level in a biological specimen. | Klebsiella Measurement | ||
Lactobacillus crispatus DNA | C166046 | Lactobacillus crispatus DNA | A measurement of the Lactobacillus crispatus DNA in a biological specimen. | Lactobacillus crispatus DNA Measurement | ||
Legionella longbeachae DNA | C187861 | Legionella longbeachae DNA | A measurement of the Legionella longbeachae DNA in a biological specimen. | Legionella longbeachae DNA Measurement | ||
Legionella pneumophila Antigen | C92275 | Legionella pneumophila Antigen | A measurement of the Legionella pneumophila antigen in a biological specimen. | Legionella pneumophila Antigen Measurement | ||
Legionella pneumophila DNA | C186172 | Legionella pneumophila DNA | A measurement of the Legionella pneumophila DNA in a biological specimen. | Legionella pneumophila DNA Measurement | ||
Legionella pneumophila IgG Antibody | C92276 | Legionella pneumophila IgG Antibody | A measurement of the Legionella pneumophila IgG antibody in a biological specimen. | Legionella pneumophila IgG Antibody Measurement | ||
Legionella pneumophila IgG IgM Antibody | C92277 | Legionella pneumophila IgG IgM Antibody | A measurement of the Legionella pneumophila IgG and IgM in a biological specimen. | Legionella pneumophila IgG IgM Antibody Measurement | ||
Legionella pneumophila IgM Antibody | C92278 | Legionella pneumophila IgM Antibody | A measurement of the Legionella pneumophila IgM antibody in a biological specimen. | Legionella pneumophila IgM Antibody Measurement | ||
Legionella pneumophila Sg 1 Antigen | C154826 | Legionella pneumophila Serogroup 1 Antigen;Legionella pneumophila Sg 1 Antigen | A measurement of the Legionella pneumophila serogroup 1 antigen in a biological specimen. | Legionella pneumophila Serogroup 1 Antigen Measurement | ||
Legionella pneumophila | C186171 | Legionella pneumophila | A measurement of the Legionella pneumophila in a biological specimen. | Legionella pneumophila Measurement | ||
Listeria monocytogenes DNA | C186173 | Listeria monocytogenes DNA | A measurement of the Listeria monocytogenes DNA in a biological specimen. | Listeria monocytogenes DNA Measurement | ||
Listeria monocytogenes | C189534 | Listeria monocytogenes | A measurement of the Listeria monocytogenes in a biological specimen. | Listeria monocytogenes Measurement | ||
M. tuberculosis IFN Gamma Response | C92241 | M. tuberculosis IFN Gamma Response;Mycobacterium tuberculosis IFN Gamma Response | A measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection. | Mycobacterium tuberculosis Interferon Gamma Response | ||
M. tuberculosis, Rifampin-resistant | C187868 | M. tuberculosis, Rifampin-resistant;Mycobacterium tuberculosis, Rifampin-resistant | A measurement of the organisms that are not assigned to the species level but are assigned to the Mycobacterium tuberculosis level and are also rifampin-resistant in a biological specimen. | Rifampin-resistant Mycobacterium Measurement | ||
Malassezia IgE Antibody | C163528 | Malassezia IgE Antibody | A measurement of the IgE antibody to any member of the genus Malassezia in a biological specimen. | Malassezia Species IgE Antibody Measurement | ||
MERS-CoV RNA | C171515 | MERS-CoV RNA | A measurement of the MERS-CoV RNA in a biological specimen. | MERS-CoV RNA Measurement | ||
Microbial Organism Identification | C132416 | Microbial Organism Identification | The identification of the type of a microbial organism in a biological specimen. | Microoganism Identification | ||
Microfilaria | C117843 | Microfilaria | Presence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids. | Microfilaria Measurement | ||
Monkeypox Virus DNA | C198331 | Monkeypox Virus DNA | A measurement of the Monkeypox virus DNA in a biological specimen. | Monkeypox Virus DNA Measurement | ||
Monkeypox Virus | C198330 | Monkey Pox Virus;Monkeypox Virus | A measurement of the Monkeypox virus in a biological specimen. | Monkeypox Virus Measurement | ||
Moraxella catarrhalis DNA | C191323 | Moraxella catarrhalis DNA | A measurement of the Moraxella catarrhalis DNA in a biological specimen. | Moraxella catarrhalis DNA Measurement | ||
Moraxella catarrhalis | C187862 | Moraxella catarrhalis | A measurement of the Moraxella catarrhalis in a biological specimen. | Moraxella catarrhalis Measurement | ||
Morganella | C179759 | Morganella | A measurement of the organisms that are not assigned to the species level but are assigned to the Morganella genus level in a biological specimen. | Morganella Measurement | ||
Mucor racemosus IgA Antibody | C130097 | Mucor racemosus IgA Antibody | A measurement of the Mucor racemosus IgA antibody in a biological specimen. | Mucor racemosus IgA Measurement | ||
Mucor racemosus IgE AB RAST Score | C166022 | Mucor racemosus IgE RAST Score | A classification of the amount of Mucor racemosus antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mucor racemosus IgE Antibody RAST Score Measurement | ||
Mucor racemosus IgE Antibody | C130096 | Mucor racemosus IgE Antibody | A measurement of the Mucor racemosus IgE antibody in a biological specimen. | Mucor racemosus IgE Measurement | ||
Mucor racemosus IgG AB RAST Score | C166018 | Mucor racemosus IgG AB RAST Score | A classification of the amount of Mucor racemosus IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Mucor racemosus IgG Antibody RAST Score Measurement | ||
Mucor racemosus IgG Antibody | C130098 | Mucor racemosus IgG Antibody | A measurement of the Mucor racemosus IgG antibody in a biological specimen. | Mucor racemosus IgG Measurement | ||
Mucor racemosus IgG4 Antibody | C130099 | Mucor racemosus IgG4 Antibody | A measurement of the Mucor racemosus IgG4 antibody in a biological specimen | Mucor racemosus IgG4 Measurement | ||
Mumps Virus IgG Antibody | C122136 | Mumps Virus IgG Antibody | A measurement of the mumps virus IgG antibody in a biological specimen. | Mumps Virus IgG Antibody Measurement | ||
Mumps Virus IgM Antibody | C163541 | Mumps Rubulavirus IgM Antibody;Mumps Virus IgM Antibody | A measurement of the Mumps rubulavirus IgM Antibody in a biological specimen. | Mumps Virus IgM Antibody Measurement | ||
Mumps Virus RNA | C189548 | Mumps rubulavirus RNA;Mumps Virus RNA | A measurement of the Mumps rubulavirus RNA in a biological specimen. | Mumps Virus RNA Measurement | ||
Mycobacterium abscessus | C172543 | Mycobacterium abscessus | A measurement of the Mycobacterium abscessus in a biological specimen. | Mycobacterium abscessus Measurement | ||
Mycobacterium avium Complex | C172540 | Mycobacterium avium Complex | A measurement of the group of bacterial species that can be assigned to the Mycobacterium avium complex in a biological specimen. | Mycobacterium avium Complex Measurement | ||
Mycobacterium chelonae | C172544 | Mycobacterium chelonae | A measurement of the Mycobacterium chelonae in a biological specimen. | Mycobacterium chelonae Measurement | ||
Mycobacterium fortuitum | C172545 | Mycobacterium fortuitum | A measurement of the Mycobacterium fortuitum in a biological specimen. | Mycobacterium fortuitum Measurement | ||
Mycobacterium kansasii | C172541 | Mycobacterium kansasii | A measurement of the Mycobacterium kansasii in a biological specimen. | Mycobacterium kansasii Measurement | ||
Mycobacterium simiae | C172542 | Mycobacterium simiae | A measurement of the Mycobacterium simiae in a biological specimen. | Mycobacterium simiae Measurement | ||
Mycobacterium tuberculosis Complex | C128983 | Mycobacterium tuberculosis Complex | A measurement of the organisms assignable to the Mycobacterium tuberculosis complex in a biological specimen. | Mycobacterium tuberculosis Complex Measurement | ||
Mycobacterium tuberculosis IgA Antibody | C124346 | Mycobacterium tuberculosis IgA Antibody | A measurement of the Mycobacterium tuberculosis IgA antibodies in a biological specimen. | Mycobacterium tuberculosis IgA Antibody Measurement | ||
Mycobacterium tuberculosis IgE Antibody | C124347 | Mycobacterium tuberculosis IgE Antibody | A measurement of the Mycobacterium tuberculosis IgE antibodies in a biological specimen. | Mycobacterium tuberculosis IgE Antibody Measurement | ||
Mycobacterium tuberculosis IgG Antibody | C124348 | Mycobacterium tuberculosis IgG Antibody | A measurement of the Mycobacterium tuberculosis IgG antibodies in a biological specimen. | Mycobacterium tuberculosis IgG Antibody Measurement | ||
Mycobacterium tuberculosis Nucleic Acid | C92279 | Mycobacterium tuberculosis Nucleic Acid | A measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen. | Mycobacterium tuberculosis Nucleic Acid Measurement | ||
Mycobacterium tuberculosis | C128982 | Mycobacterium tuberculosis | A measurement of the organisms that are assigned to the Mycobacterium tuberculosis species in a biological specimen. | Mycobacterium Tuberculosis Measurement | ||
Mycobacterium | C186174 | Mycobacterium | A measurement of the organisms that are not assigned to the species level but are assigned to the Mycobacterium genus level in a biological specimen. | Mycobacterium Measurement | ||
Mycoplasma genitalium DNA | C198327 | Mycoplasma genitalium DNA | A measurement of the Mycoplasma genitalium DNA in a biological specimen. | Mycoplasma genitalium DNA Measurement | ||
Mycoplasma genitalium | C166047 | Mycoplasma genitalium | A measurement of the Mycoplasma genitalium in a biological specimen. | Mycoplasma genitalium Measurement | ||
Mycoplasma hominis DNA | C198328 | Mycoplasma hominis DNA | A measurement of the Mycoplasma hominis DNA in a biological specimen. | Mycoplasma hominis DNA Measurement | ||
Mycoplasma pneumoniae DNA | C184658 | Mycoplasma pneumoniae DNA | A measurement of the Mycoplasma pneumoniae DNA in a biological specimen. | Mycoplasma pneumoniae DNA Measurement | ||
Mycoplasma pneumoniae IgA Antibody | C163542 | Mycoplasma pneumoniae IgA Antibody | A measurement of the Mycoplasma pneumoniae IgA antibody in a biological specimen. | Mycoplasma pneumoniae IgA Antibody Measurement | ||
Mycoplasma pneumoniae IgM Antibody | C163543 | Mycoplasma pneumoniae IgM Antibody | A measurement of the Mycoplasma pneumoniae IgM antibody in a biological specimen. | Mycoplasma pneumoniae IgM Antibody Measurement | ||
Mycoplasma pneumoniae Nucleic Acid | C198329 | Mycoplasma pneumoniae Nucleic Acid | A measurement of the Mycoplasma pneumoniae nucleic acid in a biological specimen. | Mycoplasma pneumoniae Nucleic Acid Measurement | ||
Mycoplasma pneumoniae | C156543 | Mycoplasma pneumoniae | A measurement of the Mycoplasma pneumoniae in a biological specimen. | Mycoplasma pneumoniae Measurement | ||
Mycoplasma pneumophila IgG Antibody | C166048 | Mycoplasma pneumophila IgG Antibody | A measurement of the Mycoplasma pneumophila IgG antibody in a biological specimen. | Mycoplasma pneumophila IgG Antibody Measurement | ||
Mycoplasma pneumophila IgM Antibody | C166049 | Mycoplasma pneumophila IgM Antibody | A measurement of the Mycoplasma pneumophila IgM antibody in a biological specimen. | Mycoplasma pneumophila IgM Antibody Measurement | ||
Mycoplasma | C187863 | Mycoplasma | A measurement of the organisms that are not assigned to the species level but are assigned to the Mycoplasma genus level in a biological specimen. | Mycoplasma Measurement | ||
N. gonorrhoeae, Beta-lactamase Negative | C161399 | N. gonorrhoeae, Beta-lactamase Negative | A measurement of the beta-lactamase negative strain of Neisseria gonorrhoeae in a biological specimen. | Neisseria gonorrhoeae, Beta-lactamase Negative Measurement | ||
N. gonorrhoeae, Beta-lactamase Positive | C161398 | N. gonorrhoeae, Beta-lactamase Positive | A measurement of the beta-lactamase positive strain of Neisseria gonorrhoeae in a biological specimen. | Neisseria gonorrhoeae, Beta-lactamase Positive Measurement | ||
Neisseria gonorrhoeae DNA | C186175 | Neisseria gonorrhoeae DNA | A measurement of the Neisseria gonorrhoeae DNA in a biological specimen. | Neisseria gonorrhoeae DNA Measurement | ||
Neisseria gonorrhoeae RNA | C186176 | Neisseria gonorrhoeae RNA | A measurement of the Neisseria gonorrhoeae RNA in a biological specimen. | Neisseria gonorrhoeae RNA Measurement | ||
Neisseria gonorrhoeae | C92298 | Neisseria gonorrhoeae | A measurement of the Neisseria gonorrhoeae in a biological specimen. | Neisseria gonorrhoeae Measurement | ||
Neisseria meningitidis A Antigen | C198333 | Neisseria meningitidis A Antigen | A measurement of Neisseria meningitidis A antigen in a biological specimen. | Neisseria meningitidis A Antigen Measurement | ||
Neisseria meningitidis C Antigen | C198334 | Neisseria meningitidis C Antigen | A measurement of Neisseria meningitidis C antigen in a biological specimen. | Neisseria meningitidis C Antigen Measurement | ||
Neisseria meningitidis DNA | C186177 | Neisseria meningitidis DNA | A measurement of Neisseria meningitidis DNA in a biological specimen. | Neisseria meningitidis DNA Measurement | ||
Nocardia cyriacigeorgica | C187864 | Nocardia cyriacigeorgica | A measurement of the Nocardia cyriacigeorgica in a biological specimen. | Nocardia cyriacigeorgica Measurement | ||
Nontuberculous Mycobacteria Nucleic Acid | C189533 | Nontuberculous Mycobacteria Nucleic Acid | A measurement of the nucleic acid from any nontuberculous member of the Mycobacterium genus in a biological specimen. | Nontuberculous Mycobacteria Nucleic Acid Measurement | ||
Nontuberculous Mycobacteria | C147459 | Non-tuberculous mycobacteria;Nontuberculous Mycobacteria;NTM | A measurement of the organisms that are assigned to the Mycobacterium genus but are not tuberculosis or leprosy-causing in a biological specimen. | Nontuberculous Mycobacteria Measurement | ||
Norovirus Genogroup I RNA | C166052 | Human Calicivirus Genogroup 1 RNA;Norovirus Genogroup 1 RNA;Norovirus GI RNA | A measurement of Norovirus genogroup I RNA in a biological specimen. | Norovirus Genogroup I RNA Measurement | ||
Norovirus Genogroup I/II RNA | C166011 | Norovirus genogroup I and/or genogroup II RNA;Norovirus GI/GII RNA | A measurement of Norovirus genogroup I and/or II RNA in a biological specimen. | Norovirus Genogroup I and/or II RNA Measurement | ||
Norovirus Genogroup II RNA | C166051 | Human Calicivirus Genogroup 2 RNA;Norovirus Genogroup II RNA;Norovirus GII RNA | A measurement of Norovirus genogroup II RNA in a biological specimen. | Norovirus Genogroup II RNA Measurement | ||
Norovirus Genogroup II.4 IgA Antibody | C166006 | Norovirus Genogroup GII.4 IgA antibody;Norovirus GII.4 IgA antibody | A measurement of Norovirus genogroup II.4 IgA antibody in a biological specimen. | Norovirus Genogroup II.4 IgA Antibody Measurement | ||
Norovirus Genogroup II.4 IgG Antibody | C166005 | Norovirus Genogroup GII.4 IgG antibody;Norovirus GII.4 IgG antibody | A measurement of Norovirus genogroup II.4 IgG antibody in a biological specimen. | Norovirus Genogroup II.4 IgG Antibody Measurement | ||
Norovirus Genogroup II.4 IgM Antibody | C166007 | Norovirus Genogroup GII.4 IgM antibody;Norovirus GII.4 IgM antibody | A measurement of Norovirus genogroup II.4 IgM antibody in a biological specimen. | Norovirus Genogroup II.4 IgM Antibody Measurement | ||
Norovirus RNA | C184668 | Norovirus RNA | A measurement of the RNA from any member of the genus Norovirus in a biological specimen. | Norovirus RNA Measurement | ||
Norovirus | C189579 | Norovirus | A measurement of the organisms that are not assigned to the species level but are assigned to the Norovirus genus level in a biological specimen. | Norovirus Measurement | ||
Norwalk virus RNA | C166050 | Norwalk calicivirus RNA;Norwalk virus RNA | A measurement of the Norwalk virus RNA in a biological specimen. | Norwalk virus RNA Measurement | ||
Ova and Parasite | C100452 | Ova and Parasite | A measurement of the parasites and ova in a biological specimen. | Ova and Parasite Measurement | ||
P. aeruginosa, Mucoid | C139108 | P. aeruginosa, Mucoid;Pseudomonas aeruginosa, Mucoid | A measurement of the mucoid strain of Pseudomonas aeruginosa in a biological specimen. | Mucoid Pseudomonas aeruginosa Measurement | ||
P. aeruginosa, Non-mucoid | C139107 | P. aeruginosa, Non-Mucoid;Pseudomonas aeruginosa, Non-Mucoid | A measurement of the non-mucoid strain of Pseudomonas aeruginosa in a biological specimen. | Non-Mucoid Pseudomonas aeruginosa Measurement | ||
P. aeruginosa, Small-colony Variant | C139109 | P. aeruginosa, Small-colony Variant;Pseudomonas aeruginosa, SCV;Pseudomonas aeruginosa, Small-colony Variant | A measurement of the small-colony variant strain of Pseudomonas aeruginosa in a biological specimen. | Small-Colony Variant Pseudomonas aeruginosa Measurement | ||
P. notatum IgE AB RAST Score | C166024 | P. notatum IgE AB RAST Score | A classification of the amount of P. notatum antigen IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Penicillium notatum IgE Antibody RAST Score Measurement | ||
P. notatum IgG AB RAST Score | C166020 | P. notatum IgG AB RAST Score | A classification of the amount of P. notatum antigen IgG antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Penicillium notatum IgG Antibody RAST Score Measurement | ||
Parechovirus RNA | C186178 | Parechovirus RNA | A measurement of the RNA from any member of the genus Parechovirus in a biological specimen. | Parechovirus RNA Measurement | ||
Parvovirus B19 IgG Antibody | C96617 | Parvovirus B19 IgG Antibody | A measurement of the Parvovirus B19 IgG antibody in a biological specimen. | Parvovirus B19 IgG Antibody Measurement | ||
Parvovirus B19 IgM Antibody | C96618 | Parvovirus B19 IgM Antibody | A measurement of the Parvovirus B19 IgM antibody in a biological specimen. | Parvovirus B19 IgM Antibody Measurement | ||
Penicillium notatum IgA Antibody | C130147 | Penicillium chrysogenum IgA Antibody;Penicillium notatum IgA Antibody | A measurement of the Penicillium notatum IgA antibody in a biological specimen. | Penicillium notatum Antigen IgA Antibody Measurement | ||
Penicillium notatum IgE Antibody | C130146 | Penicillium chrysogenum IgE Antibody;Penicillium notatum IgE Antibody | A measurement of the Penicillium notatum IgE antibody in a biological specimen. | Penicillium notatum Antigen IgE Antibody Measurement | ||
Penicillium notatum IgG Antibody | C130148 | Penicillium chrysogenum IgG Antibody;Penicillium notatum IgG Antibody | A measurement of the Penicillium notatum IgG antibody in a biological specimen. | Penicillium notatum Antigen IgG Antibody Measurement | ||
Penicillium notatum IgG4 Antibody | C130149 | Penicillium chrysogenum IgG4 Antibody;Penicillium notatum IgG4 Antibody | A measurement of the Penicillium notatum IgG4 antibody in a biological specimen. | Penicillium notatum Antigen IgG4 Antibody Measurement | ||
Penicilliumchrysogenum IgE AB RAST Score | C166027 | Penicillium chrysogenum IgE AB RAST Score;Penicilliumchrysogenum IgE AB RAST Score | A classification of the amount of Penicillium chrysogenum IgE antibody, using the RAST (radioallergosorbent test) scoring system, in a biological specimen. | Penicillium chrysogenum IgE Antibody RAST Score Measurement | ||
Plasmodium knowlesi, Asexual | C132417 | Plasmodium knowlesi, Asexual | A measurement of the Plasmodium knowlesi in an asexual replication stage in a biological specimen. | Asexual Plasmodium knowlesi Measurement | ||
Plasmodium knowlesi, Sexual | C132418 | Plasmodium knowlesi, Sexual | A measurement of the Plasmodium knowlesi in a sexual replication stage in a biological specimen. | Sexual Plasmodium knowlesi Measurement | ||
Plasmodium | C100453 | Malaria;Plasmodium | Examination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus. | Plasmodium Measurement | ||
Plesiomonas shigelloides DNA | C166053 | Plesiomonas shigelloides DNA | A measurement of the Plesiomonas shigelloides DNA in a biological specimen. | Plesiomonas shigelloides DNA Measurement | ||
Pneumocystis jiroveci Antigen | C186179 | Pneumocystis jiroveci Antigen | A measurement of the Pneumocystis jiroveci antigen in a biological specimen. | Pneumocystis jiroveci Antigen Measurement | ||
Pneumocystis jiroveci DNA | C187865 | Pneumocystis jiroveci DNA | A measurement of the Pneumocystis jiroveci DNA in a biological specimen. | Pneumocystis jiroveci DNA Measurement | ||
Prevotella bivia | C187866 | Prevotella bivia | A measurement of the Prevotella bivia in a biological specimen. | Prevotella bivia Measurement | ||
Proteus DNA | C191324 | Proteus DNA;Proteus Species DNA;Proteus spp DNA | A measurement of the DNA from any member of the genus Proteus in a biological specimen. | Proteus DNA Measurement | ||
Proteus mirabilis | C179760 | Proteus mirabilis | A measurement of the Proteus mirabilis in a biological specimen. | Proteus mirabilis Measurement | ||
Protozoa | C117849 | Protozoa | A measurement of protozoa in a biological specimen. | Protozoa Measurement | ||
Pseudomonas aeruginosa DNA | C191325 | Pseudomonas aeruginosa DNA | A measurement of the Pseudomonas aeruginosa DNA in a biological specimen. | Pseudomonas aeruginosa DNA Measurement | ||
Pseudomonas aeruginosa | C172546 | Pseudomonas aeruginosa | A measurement of the Pseudomonas aeruginosa in a biological specimen. | Pseudomonas aeruginosa Measurement | ||
Pseudomonas | C172384 | Pseudomonas | A measurement of the organisms that are not assigned to the species level but are assigned to the Pseudomonas genus level in a biological specimen. | Pseudomonas Measurement | ||
Reagin Antibody | C74716 | Rapid Plasma Reagin;Reagin Antibody;RPR;VDRL;Venereal Disease Research Laboratory Test | A measurement of the non-specific Treponemal antibodies produced in response to cellular damage caused by Treponema pallidum (syphilis) in a biological specimen. | Rapid Plasma Reagin Measurement | ||
Respiratory Syncytial Virus Antigen | C154823 | Respiratory Syncytial Virus Antigen;RSV Antigen | A measurement of the respiratory syncytial virus antigen in a biological specimen. | Respiratory Syncytial Virus Antigen Measurement | ||
Respiratory Syncytial Virus RNA | C186181 | Respiratory Syncytial Virus RNA | A measurement of the respiratory syncytial virus RNA in a biological specimen. | Respiratory Syncytial Virus RNA Measurement | ||
Respiratory Syncytial Virus Type A | C184660 | Respiratory Syncytial Virus Type A | A measurement of the respiratory syncytial virus type A in a biological specimen. | Respiratory Syncytial Virus Type A Measurement | ||
Respiratory Syncytial Virus Type B | C184661 | Respiratory Syncytial Virus Type B | A measurement of the respiratory syncytial virus type B in a biological specimen. | Respiratory Syncytial Virus Type B Measurement | ||
Respiratory Syncytial Virus | C171526 | Respiratory Syncytial Virus | A measurement of the respiratory syncytial virus in a biological specimen. | Respiratory Syncytial Virus Measurement | ||
Rickettsia DNA | C187867 | Rickettsia DNA | A measurement of the DNA from any member of the genus Rickettsia in a biological specimen. | Rickettsia DNA Measurement | ||
Rotavirus A RNA | C166054 | Rotavirus A RNA;Rotavirus Group A RNA | A measurement of the Rotavirus A RNA in a biological specimen. | Rotavirus A RNA Measurement | ||
Rotavirus Antigen | C154827 | Rotavirus Antigen | A measurement of the antigen from any member of the genus Rotavirus in a biological specimen. | Rotavirus Antigen Measurement | ||
Rotavirus RNA | C186180 | Rotavirus RNA | A measurement of the RNA from any member of the genus Rotavirus in a biological specimen. | Rotavirus RNA Measurement | ||
Rotavirus | C172549 | Rotavirus | A measurement of the organisms that are not assigned to the species level but are assigned to the Rotavirus genus level in a biological specimen. | Rotavirus Measurement | ||
RSV Type A Nucleic Acid | C198336 | Respiratory Syncytial Virus Type A Nucleic Acid;RSV Type A Nucleic Acid | A measurement of the respiratory syncytial virus type A nucleic acid in a biological specimen. | Human Respiratory Syncytial Virus Type A Nucleic Acid Measurement | ||
RSV Type B Nucleic Acid | C198337 | Respiratory Syncytial Virus Type B Nucleic Acid;RSV Type B Nucleic Acid | A measurement of the respiratory syncytial virus type B nucleic acid in a biological specimen. | Human Respiratory Syncytial Virus Type B Nucleic Acid Measurement | ||
Rubella IgG Antibody | C103440 | Rubella IgG Antibody | A measurement of the Rubella IgG antibody in a biological specimen. | Rubella IgG Antibody Measurement | ||
Rubella IgM Antibody | C163544 | Rubella IgM Antibody | A measurement of the Rubella IgM antibody in a biological specimen. | Rubella IgM Antibody Measurement | ||
Rubeola Antigen | C154815 | Measles Virus Antigen | A measurement of the Rubeola virus antigen in a biological specimen. | Rubeola Antigen Measurement | ||
Rubeola IgG Antibody | C112412 | Measles IgG Antibody;Rubeola IgG Antibody | A measurement of the Measles (Rubeola) virus IgG antibody in a biological specimen. | Rubeola IgG Antibody Measurement | ||
Rubeola IgM Antibody | C112413 | Measles IgM Antibody;Rubeola IgM Antibody | A measurement of the Measles (Rubeola) virus IgM antibody in a biological specimen. | Rubeola IgM Antibody Measurement | ||
S. aureus, Methicillin-resistant | C139110 | S. aureus, Methicillin-Resistant;Staphylococcus aureus, Methicillin-Resistant | A measurement of the methicillin-resistant strain of Staphylococcus aureus in a biological specimen. | Methicillin-resistant Staphylococcus aureus Measurement | ||
S. aureus, Methicillin-susceptible | C139111 | S. aureus, Methicillin-Susceptible;Staphylococcus aureus, Methicillin-Susceptible | A measurement of the methicillin-susceptible strain of Staphylococcus aureus in a biological specimen. | Methicillin-susceptible Staphylococcus aureus Measurement | ||
S. pneumoniae Sero 1 IgG AB | C142249 | S. pneumonia Sero 1 IgG AB;Streptococcus pneumoniae Serotype 1 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 1 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 1 IgG Antibody Measurement | ||
S. pneumoniae Sero 10A IgG AB | C142259 | S. pneumonia Sero 10A IgG AB;Streptococcus pneumoniae Serotype 10A IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 10A IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 10A IgG Antibody Measurement | ||
S. pneumoniae Sero 11A IgG AB | C142260 | S. pneumonia Sero 11A IgG AB;Streptococcus pneumoniae Serotype 11A IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 11A IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 11A IgG Antibody Measurement | ||
S. pneumoniae Sero 12F IgG AB | C142261 | S. pneumonia Sero 12F IgG AB;Streptococcus pneumoniae Serotype 12F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 12F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 12F IgG Antibody Measurement | ||
S. pneumoniae Sero 14 IgG AB | C142262 | S. pneumonia Sero 14 IgG AB;Streptococcus pneumoniae Serotype 14 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 14 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 14 IgG Antibody Measurement | ||
S. pneumoniae Sero 15B IgG AB | C142263 | S. pneumonia Sero 15B IgG AB;Streptococcus pneumoniae Serotype 15B IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 15B IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 15B IgG Antibody Measurement | ||
S. pneumoniae Sero 17F IgG AB | C142264 | S. pneumonia Sero 17F IgG AB;Streptococcus pneumoniae Serotype 17F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 17F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 17F IgG Antibody Measurement | ||
S. pneumoniae Sero 18C IgG AB | C142265 | S. pneumonia Sero 18C IgG AB;Streptococcus pneumoniae Serotype 18C IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 18C IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 18C IgG Antibody Measurement | ||
S. pneumoniae Sero 19A IgG AB | C142267 | S. pneumonia Sero 19A IgG AB;Streptococcus pneumoniae Serotype 19A IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 19A IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 19A IgG Antibody Measurement | ||
S. pneumoniae Sero 19F IgG AB | C142266 | S. pneumonia Sero 19F IgG AB;Streptococcus pneumoniae Serotype 19F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 19F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 19F IgG Antibody Measurement | ||
S. pneumoniae Sero 2 IgG AB | C142250 | S. pneumonia Sero 2 IgG AB;Streptococcus pneumoniae Serotype 2 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 2 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 2 IgG Antibody Measurement | ||
S. pneumoniae Sero 20 IgG AB | C142268 | S. pneumonia Sero 20 IgG AB;Streptococcus pneumoniae Serotype 20 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 20 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 20 IgG Antibody Measurement | ||
S. pneumoniae Sero 22F IgG AB | C142269 | S. pneumonia Sero 22F IgG AB;Streptococcus pneumoniae Serotype 22F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 22F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 22F IgG Antibody Measurement | ||
S. pneumoniae Sero 23F IgG AB | C142270 | S. pneumonia Sero 23F IgG AB;Streptococcus pneumoniae Serotype 23F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 23F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 23F IgG Antibody Measurement | ||
S. pneumoniae Sero 3 IgG AB | C142251 | S. pneumonia Sero 3 IgG AB;Streptococcus pneumoniae Serotype 3 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 3 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 3 IgG Antibody Measurement | ||
S. pneumoniae Sero 33F IgG AB | C142271 | S. pneumonia Sero 33F IgG AB;Streptococcus pneumoniae Serotype 33F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 33F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 33F IgG Antibody Measurement | ||
S. pneumoniae Sero 4 IgG AB | C142252 | S. pneumonia Sero 4 IgG AB;Streptococcus pneumoniae Serotype 4 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 4 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 4 IgG Antibody Measurement | ||
S. pneumoniae Sero 5 IgG AB | C142253 | S. pneumonia Sero 5 IgG AB;Streptococcus pneumoniae Serotype 5 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 5 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 5 IgG Antibody Measurement | ||
S. pneumoniae Sero 6B IgG AB | C142254 | S. pneumonia Sero 6B IgG AB;Streptococcus pneumoniae Serotype 6B IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 6B IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 6B IgG Antibody Measurement | ||
S. pneumoniae Sero 7F IgG AB | C142255 | S. pneumonia Sero 7F IgG AB;Streptococcus pneumoniae Serotype 7F IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 7F IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 7F IgG Antibody Measurement | ||
S. pneumoniae Sero 8 IgG AB | C142256 | S. pneumonia Sero 8 IgG AB;Streptococcus pneumoniae Serotype 8 IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 8 IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 8 IgG Antibody Measurement | ||
S. pneumoniae Sero 9N IgG AB | C142257 | S. pneumonia Sero 9N IgG AB;Streptococcus pneumoniae Serotype 9N IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 9N IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 9N IgG Antibody Measurement | ||
S. pneumoniae Sero 9V IgG AB | C142258 | S. pneumonia Sero 9V IgG AB;Streptococcus pneumoniae Serotype 9V IgG Antibody | A measurement of the Streptococcus pneumoniae serotype 9V IgG antibody in a biological specimen. | Streptococcus pneumoniae Serotype 9V IgG Antibody Measurement | ||
Salmonella Antigen | C198338 | Salmonella Antigen | A measurement of the antigen from any member of the genus Salmonella in a biological specimen. | Salmonella Antigen Measurement | ||
Salmonella DNA | C186183 | Salmonella DNA | A measurement of the DNA from any member of the genus Salmonella in a biological specimen. | Salmonella DNA Measurement | ||
Salmonella enterica/bongori DNA | C166055 | Salmonella enterica/bongori DNA | A measurement of the Salmonella enterica and/or Salmonella bongori DNA in a biological specimen. | Salmonella enterica and/or Salmonella bongori DNA Measurement | ||
Salmonella | C181460 | Salmonella | A measurement of the organisms that are not assigned to the species level but are assigned to the Salmonella genus level in a biological specimen. | Salmonella Measurement | ||
Sapovirus Genogroups I/II/IV/V RNA | C166010 | Sapovirus Genogroups I/II/IV/V RNA | A measurement of the Sapovirus genogroups I, II, IV and/or V RNA in a biological specimen. | Sapovirus Genogroups I, II, IV, and/or V RNA Measurement | ||
SARS-CoV-1/SARS-CoV-2 Antigen | C174327 | SARS-CoV-1/SARS-CoV-2 Antigen | A measurement of the antigens from SARS-CoV-1 and/or SARS-CoV-2 in a biological specimen. | SARS-CoV-1/SARS-CoV-2 Antigen Measurement | ||
SARS-CoV-2 Antibody | C171439 | SARS-CoV-2 Antibody | A measurement of the SARS-CoV-2 antibody in a biological specimen. | Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Measurement | ||
SARS-CoV-2 Antigen | C176327 | SARS-CoV-2 Antigen | A measurement of the SARS-CoV-2 antigen in a biological specimen. | SARS-CoV-2 Antigen Measurement | ||
SARS-CoV-2 IgA Antibody | C171527 | SARS-CoV-2 IgA Antibody | A measurement of the SARS-CoV-2 IgA antibody in a biological specimen. | SARS-CoV-2 IgA Antibody Measurement | ||
SARS-CoV-2 IgA/IgM Antibody | C174326 | SARS-CoV-2 IgA/IgM Antibody | A measurement of the SARS-CoV-2 IgA and/or IgM antibody in a biological specimen. | SARS-CoV-2 IgA/IgM Antibody Measurement | ||
SARS-CoV-2 IgG Antibody | C171528 | SARS-CoV-2 IgG Antibody | A measurement of the SARS-CoV-2 IgG antibody in a biological specimen. | SARS-CoV-2 IgG Antibody Measurement | ||
SARS-CoV-2 IgG/IgM Antibody | C171529 | SARS-CoV-2 IgG/IgM Antibody | A measurement of the SARS-CoV-2 IgG and/or IgM antibody in a biological specimen. | SARS-CoV-2 IgG and/or IgM Antibody Measurement | ||
SARS-CoV-2 IgM Antibody | C171530 | SARS-CoV-2 IgM Antibody | A measurement of the SARS-CoV-2 IgM antibody in a biological specimen. | SARS-CoV-2 IgM Antibody Measurement | ||
SARS-CoV-2 IgM/IgA/IgG Antibody | C174325 | SARS-CoV-2 IgM/IgA/IgG Antibody | A measurement of the SARS-CoV-2 IgM, IgA and/or IgG antibody in a biological specimen. | SARS-CoV-2 IgM/IgA/IgG Antibody Measurement | ||
SARS-CoV-2 Neutralizing Antibody | C174329 | SARS-CoV-2 Neutralizing Antibody | A measurement of the SARS-CoV-2 neutralizing antibody in a biological specimen. | SARS-CoV-2 Neutralizing Antibody Measurement | ||
SARS-CoV-2 Nucleocapsid Protein Antibody | C178005 | SARS-CoV-2 N Protein Antibody;SARS-CoV-2 Nucleocapsid Protein Antibody | A measurement of the SARS-CoV-2 nucleocapsid protein antibody in a biological specimen. | SARS-CoV-2 Nucleocapsid Protein Antibody Measurement | ||
SARS-CoV-2 Nucleocapsid Protein Antigen | C189547 | SARS-CoV-2 N Protein Antigen | A measurement of the SARS-CoV-2 nucleocapsid protein antigen in a biological specimen. | SARS-CoV-2 Nucleocapsid Protein Antigen Measurement | ||
SARS-CoV-2 RdRp RNA | C186188 | SARS-CoV-2 RdRp Gene;SARS-CoV-2 RdRp RNA;SARS-CoV-2 RNA-dependent RNA Polymerase RNA | A measurement of the SARS-CoV-2 RdRp RNA in a biological specimen. | SARS-CoV-2 RdRp RNA Measurement | ||
SARS-CoV-2 RNA | C171531 | SARS-CoV-2 RNA | A measurement of the SARS-CoV-2 RNA in a biological specimen. | SARS-CoV-2 RNA Measurement | ||
SARS-CoV-2 S RNA | C187869 | SARS-CoV-2 S Gene;SARS-CoV-2 S RNA;SARS-CoV-2 Spike RNA | A measurement of the SARS-CoV-2 S RNA in a biological specimen. | SARS-CoV-2 S RNA Measurement | ||
SARS-CoV-2 Spike Protein Antibody | C178006 | SARS-CoV-2 S Protein Antibody;SARS-CoV-2 Spike Protein Antibody | A measurement of the SARS-CoV-2 spike protein antibody in a biological specimen. | SARS-CoV-2 Spike Protein Antibody Measurement | ||
SARS-related Coronavirus RNA | C174323 | SARS-related Coronavirus RNA | A measurement of the SARS-related Coronavirus RNA including but not limited to SARS-CoV, SARS-CoV-2, and/or other SARS-like Coronavirus in a biological specimen. | SARS-related Coronavirus RNA Measurement | ||
SARS-related Coronavirus RNA/MERS RNA | C174324 | SARS-related Coronavirus RNA/MERS RNA | A measurement of the SARS-related and/or MERS Coronavirus RNA which includes but not limited to SARS-CoV, SARS-CoV-2, other SARS-like Coronavirus, and/or MERS-CoV in a biological specimen. | SARS-related Coronavirus RNA/MERS RNA Measurement | ||
Schistosoma mansoni Antibody | C166056 | Schistosoma mansoni Antibody | A measurement of the Schistosoma mansoni antibody in a biological specimen. | Schistosoma mansoni Antibody Measurement | ||
Serratia marcescens DNA | C191326 | Serratia marcescens DNA | A measurement of the Serratia marcescens DNA in a biological specimen. | Serratia marcescens DNA Measurement | ||
Serratia marcescens | C198340 | Serratia marcescens | A measurement of the Serratia marcescens in a biological specimen. | Serratia marcescens Measurement | ||
Serratia | C179763 | Serratia | A measurement of the organisms that are not assigned to the species level but are assigned to the Serratia genus level in a biological specimen. | Serratia Measurement | ||
Severe Acute Resp Syndro-Rel Coronavirus | C174328 | SARS-CoV;SARS-CoV-1;Severe Acute Respiratory Syndrome-Related Coronavirus | A measurement of the severe acute respiratory syndrome-related Coronavirus in a biological specimen. | Severe Acute Respiratory Syndrome-related Coronavirus Measurement | ||
Severe Acute Resp Syndrome Coronavirus 2 | C171532 | SARS-CoV-2;Severe Acute Resp Syndrome Coronavirus 2;Severe Acute Respiratory Syndrome Coronavirus 2 | A measurement of the severe acute respiratory syndrome Coronavirus 2 in a biological specimen. | Severe Acute Respiratory Syndrome Coronavirus 2 Measurement | ||
Shiga Toxin | C184669 | Shiga Toxin | A measurement of the shiga toxin in a biological specimen. | Shiga Toxin Measurement | ||
Shigella Antigen | C198339 | Shigella Antigen | A measurement of the antigen from any member of the genus Shigella in a biological specimen. | Shigella Antigen Measurement | ||
Shigella DNA | C184670 | Shigella DNA | A measurement of the DNA from any member of the genus Shigella in a biological specimen. | Shigella DNA Measurement | ||
Shigella | C181459 | Shigella | A measurement of the organisms that are not assigned to the species level but are assigned to the Shigella genus level in a biological specimen. | Shigella Measurement | ||
Shigella/EIEC ipaH DNA | C166009 | Invasion Plasmid Antigen H Gene;ipaH gene;Shigella species and/or Enteroinvasive Escherichia coli Invasion Plasmid Antigen H DNA;Shigella/EIEC ipaH DNA | A measurement of the invasion plasmid antigen H DNA from any members of the genus Shigella and/or enteroinvasive Escherichia coli in a biological specimen. | Shigella and/or Enteroinvasive Escherichia coli ipaH DNA Measurement | ||
Shigella/EIEC | C186186 | Shigella/EIEC;Shigella/Enteroinvasive E. coli;Shigella/Enteroinvasive Escherichia coli | A measurement of the organisms that are not assigned to the species level but are assigned to the Shigella genus level and/or enteroinvasive Escherichia coli in a biological specimen. | Shigella and/or Enteroinvasive Escherichia coli DNA Measurement | ||
Staphylococcus aureus DNA | C186184 | Staphylococcus aureus DNA | A measurement of the Staphylococcus aureus DNA in a biological specimen. | Staphylococcus aureus DNA Measurement | ||
Staphylococcus aureus | C147460 | S. aureus;Staphylococcus aureus | A measurement of the Staphylococcus aureus in a biological specimen. | Staphylococcus aureus Measurement | ||
Staphylococcus epidermidis | C187870 | Staphylococcus epidermidis | A measurement of the Staphylococcus epidermidis in a biological specimen. | Staphylococcus epidermidis Measurement | ||
Staphylococcus haemolyticus | C186185 | Staphylococcus haemolyticus | A measurement of the Staphylococcus haemolyticus in a biological specimen. | Staphylococcus haemolyticus Measurement | ||
Staphylococcus saprophyticus | C179764 | Staphylococcus saprophyticus | A measurement of the Staphylococcus saprophyticus in a biological specimen. | Staphylococcus saprophyticus Measurement | ||
Staphylococcus, Coagulase Negative | C189581 | Staphylococcus, Coagulase Negative | A measurement of the coagulase negative Staphylococcus species in a biological specimen. | Coagulase Negative Staphylococcus Measurement | ||
Staphylococcus, Coagulase Positive | C189580 | Staphylococcus, Coagulase Positive | A measurement of the coagulase positive Staphylococcus species in a biological specimen. | Coagulase Positive Staphylococcus Measurement | ||
Stenotrophomonas maltophilia | C139112 | Stenotrophomonas maltophilia | A measurement of the organisms that are assigned to the Stenotrophomonas maltophilia species in a biological specimen. | Stenotrophomonas maltophilia Measurement | ||
Streptococcus agalactiae Antigen | C154824 | Streptococcus agalactiae Antigen;Streptococcus Group B Antigen | A measurement of the Streptococcus agalactiae antigen in a biological specimen. | Streptococcus agalactiae Antigen Measurement | ||
Streptococcus agalactiae DNA | C186182 | Streptococcus agalactiae DNA | A measurement of the Streptococcus agalactiae DNA in a biological specimen. | Streptococcus agalactiae DNA Measurement | ||
Streptococcus agalactiae | C179762 | Streptococcus agalactiae | A measurement of the Streptococcus agalactiae in a biological specimen. | Streptococcus agalactiae Measurement | ||
Streptococcus anginosus | C187871 | Streptococcus anginosus | A measurement of the Streptococcus anginosus in a biological specimen. | Streptococcus anginosus Measurement | ||
Streptococcus Group A | C189582 | Streptococcus Group A | A measurement of the Streptococcus group A in a biological specimen. | Group A Streptococcus Measurement | ||
Streptococcus Group B | C189583 | Streptococcus Group B | A measurement of the Streptococcus group B in a biological specimen. | Group B Streptococcus Measurement | ||
Streptococcus pneumoniae Antigen | C122152 | Streptococcus pneumoniae Antigen | A measurement of the Streptococcus pneumoniae antigen in a biological specimen. | Streptococcus pneumoniae Antigen Measurement | ||
Streptococcus pneumoniae DNA | C186187 | Streptococcus pneumoniae DNA | A measurement of Streptococcus pneumoniae DNA in a biological specimen. | Streptococcus pneumoniae DNA Measurement | ||
Streptococcus pneumoniae IgG Antibody | C142232 | Streptococcus pneumoniae IgG Antibody | A measurement of the Streptococcus pneumoniae IgG antibody in a biological specimen. | Streptococcus pneumoniae IgG Antibody Measurement | ||
Streptococcus pneumoniae | C187872 | Streptococcus pneumoniae | A measurement of the Streptococcus pneumoniae in a biological specimen. | Streptococcus pneumoniae Measurement | ||
Streptococcus pyogenes Antigen | C154814 | Streptococcus pyogenes Antigen | A measurement of the Streptococcus pyogenes antigen in a biological specimen. | Streptococcus pyogenes Antigen Measurement | ||
Streptococcus pyogenes DNA | C191327 | Streptococcus pyogenes DNA | A measurement of the Streptococcus pyogenes DNA in a biological specimen. | Streptococcus pyogenes DNA Measurement | ||
Streptococcus pyogenes | C187873 | Streptococcus pyogenes | A measurement of the Streptococcus pyogenes in a biological specimen. | Streptococcus pyogenes Measurement | ||
Streptococcus | C187667 | Streptococcus | A measurement of the organisms that are not assigned to the species level but are assigned to the Streptococcus genus level in a biological specimen. | Streptococcus Measurement | ||
Streptolysin O Antibody | C92282 | Antistreptolysin O;Streptolysin O Antibody | A measurement of Streptolysin O Antibody in a biological specimen. | Streptolysin O Antibody Measurement | ||
Strongyloides IgG Antibody | C117858 | Strongyloides IgG Antibody | A measurement of strongyloides IgG antibody in a biological specimen. | Strongyloides IgG Antibody Measurement | ||
Toxigenic Clostridium difficile | C150862 | Toxigenic Clostridium difficile | A measurement of the toxigenic strain of Clostridium difficile in a biological specimen. | Toxigenic Clostridium difficile Measurement | ||
Toxin B-Producing Clostridium difficile | C150865 | Toxin B-Producing Clostridium difficile | A measurement of the toxin B-producing strain of Clostridium difficile in a biological specimen. | Toxin B-Producing Clostridium difficile Measurement | ||
Toxoplasma gondii DNA | C184665 | Toxoplasma gondii DNA | A measurement of the Toxoplasma gondii DNA in a biological specimen. | Toxoplasma gondii DNA Measurement | ||
Toxoplasma gondii IgG Antibody | C139089 | Toxoplasma gondii IgG Antibody | A measurement of the Toxoplasma gondii IgG antibody in a biological specimen. | Toxoplasma gondii IgG Antibody Measurement | ||
Toxoplasma gondii IgG/IgM Antibody | C166057 | Toxoplasma gondii IgG/IgM Antibody | A measurement of the Toxoplasma gondii IgG and/or IgM antibody in a biological specimen. | Toxoplasma gondii IgG and/or IgM Antibody Measurement | ||
Toxoplasma gondii IgM Antibody | C139090 | Toxoplasma gondii IgM Antibody | A measurement of the Toxoplasma gondii IgM antibody in a biological specimen. | Toxoplasma gondii IgM Antibody Measurement | ||
Treponema pallidum Antibody | C132388 | Treponema pallidum Antibody | A measurement of the total Treponema pallidum antibody in a biological specimen. | Treponema pallidum Antibody Measurement | ||
Treponema pallidum DNA | C198341 | Treponema pallidum DNA | A measurement of the Treponema pallidum DNA in a biological specimen. | Treponema pallidum DNA Measurement | ||
Treponema pallidum | C184647 | Treponema pallidum | A measurement of the Treponema pallidum in a biological specimen. | Treponema pallidum Measurement | ||
Trichomonas RNA | C186189 | Trichomonas RNA | A measurement of the RNA from any member of the genus Trichomonas in a biological specimen. | Trichomonas RNA Measurement | ||
Trichomonas vaginalis DNA | C186190 | Trichomonas vaginalis DNA | A measurement of the Trichomonas vaginalis DNA in a biological specimen. | Trichomonas vaginalis DNA Measurement | ||
Trichomonas vaginalis | C161403 | Trichomonas vaginalis | A measurement of the Trichomonas vaginalis in a biological specimen. | Trichomonas vaginalis Measurement | ||
Trichomonas | C92238 | Trichomonas | Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. | Trichomonas Screening | ||
Ureaplasma parvum DNA | C198343 | Ureaplasma parvum DNA | A measurement of the Ureaplasma parvum DNA in a biological specimen. | Ureaplasma parvum DNA Measurement | ||
Ureaplasma parvum | C198342 | Ureaplasma parvum | A measurement of the Ureaplasma parvum in a biological specimen. | Ureaplasma parvum Measurement | ||
Ureaplasma urealyticum DNA | C198344 | Ureaplasma urealyticum DNA | A measurement of the Ureaplasma urealyticum DNA in a biological specimen. | Ureaplasma urealyticum DNA Measurement | ||
Ureaplasma urealyticum | C189537 | Ureaplasma urealyticum | A measurement of the Ureaplasma urealyticum in a biological specimen. | Ureaplasma urealyticum Measurement | ||
Urease | C154825 | Urease | A measurement of the microbial urease enzyme in a biological specimen. | Urease Measurement | ||
V. chol/parahaemolyticus/vulnificus DNA | C166008 | V. chol/parahaemolyticus/vulnificus DNA;Vibrio cholerae/parahaemolyticus/vulnificus DNA | A measurement of the Vibrio cholerae and/or Vibrio parahaemolyticus and/or Vibrio vulnificus DNA in a biological specimen. | Vibrio cholerae, Vibrio parahaemolyticus, and/or Vibrio vulnificus DNA Measurement | ||
Vaccinia Virus | C181458 | Vaccinia Virus | A measurement of the Vaccinia virus in a biological specimen. | Vaccinia Virus Measurement | ||
Varicella Zoster Virus Antibody | C117867 | Varicella Zoster Virus Antibody | A measurement of the total varicella zoster virus antibody in a biological specimen. | Varicella Zoster Virus Antibody Measurement | ||
Varicella Zoster Virus DNA | C186192 | Varicella Zoster Virus DNA | A measurement of the Varicella Zoster virus DNA in a biological specimen. | Varicella Zoster Virus DNA Measurement | ||
Varicella Zoster Virus IgA Antibody | C98795 | Varicella Zoster Virus IgA Antibody | A measurement of the Varicella Zoster virus IgA antibodies in a biological specimen. | Varicella Zoster Virus IgA Antibody Measurement | ||
Varicella Zoster Virus IgG Antibody | C98796 | Varicella Zoster Virus IgG Antibody | A measurement of the Varicella Zoster virus IgG antibodies in a biological specimen. | Varicella Zoster Virus IgG Antibody Measurement | ||
Varicella Zoster Virus IgM Antibody | C98797 | Varicella Zoster Virus IgM Antibody | A measurement of the Varicella Zoster virus IgM antibodies in a biological specimen. | Varicella Zoster Virus IgM Antibody Measurement | ||
Varicella Zoster Virus | C189555 | Varicella Zoster Virus | A measurement of the varicella zoster virus in a biological specimen. | Varicella Zoster Virus Measurement | ||
Vibrio cholerae DNA | C166058 | Vibrio cholerae DNA | A measurement of the Vibrio cholerae DNA in a biological specimen. | Vibrio cholerae DNA Measurement | ||
Vibrio parahaemolyticus DNA | C187874 | Vibrio parahaemolyticus DNA | A measurement of the Vibrio parahaemolyticus DNA in a biological specimen. | Vibrio parahaemolyticus DNA Measurement | ||
West Nile Virus Antibody | C147448 | West Nile Virus Antibody | A measurement of the west Nile virus antibody in a biological specimen. | West Nile Virus Antibody Measurement | ||
Yeast Budding | C106504 | Budding Yeast;Yeast Budding | A measurement of the budding yeast present in a biological specimen. | Budding Yeast Measurement | ||
Yeast Cells | C74664 | Yeast Cells | A measurement of the yeast cells present in a biological specimen. | Yeast Cell Measurement | ||
Yeast Hyphae | C92239 | Yeast Hyphae | A measurement of the yeast hyphae present in a biological specimen. | Yeast Hyphae Screening | ||
Yellow Fever Virus Antibody | C147450 | Yellow Fever Virus Antibody | A measurement of the yellow fever virus antibody in a biological specimen. | Yellow Fever Virus Antibody Measurement | ||
Yersinia enterocolitica DNA | C166059 | Yersinia enterocolitica DNA | A measurement of the Yersinia enterocolitica DNA in a biological specimen. | Yersinia enterocolitica DNA Measurement | ||
Yersinia | C187875 | Yersinia | A measurement of the organisms that are not assigned to the species level but are assigned to the Yersinia genus level in a biological specimen. | Yersinia Measurement | ||
Zaire Ebolavirus | C132420 | Zaire Ebolavirus | A measurement of the Zaire ebolavirus present in a biological specimen. | Zaire Ebolavirus Measurement | ||
Zika Virus Antibody | C147451 | Zika Virus Antibody | A measurement of the Zika virus antibody in a biological specimen. | Zika Virus Antibody Measurement | ||
Back to top | ||||||
CL.C85491.MICROORG | Microorganism
(MICROORG) | text
Extensible: Yes | C85491 | Microorganism | Microorganisms, bacteria, fungi and other organisms. | CDISC SDTM Microorganism Terminology |
ABIOTROPHIA DEFECTIVA | C86078 | Any bacterial organism that can be assigned to the species Abiotrophia defectiva. | Abiotrophia defectiva | |||
ABIOTROPHIA | C86077 | Any bacteria that is not assigned to the species level but can be assigned to the Abiotrophia genus level. | Abiotrophia | |||
ABSIDIA | C119580 | Any fungal organism that is not assigned to the species level but can be assigned to the Absidia genus level. | Absidia | |||
ACANTHAMOEBA ASTRONYXIS | C119297 | Any amoebic organism that can be assigned to the species Acanthamoeba astronyxis. | Acanthamoeba astronyxis | |||
ACANTHAMOEBA CASTELLANII | C119298 | Any amoebic organism that can be assigned to the species Acanthamoeba castellanii. | Acanthamoeba castellanii | |||
ACANTHAMOEBA CULBERTSONI | C119299 | Any amoebic organism that can be assigned to the species Acanthamoeba culbertsoni. | Acanthamoeba culbertsoni | |||
ACANTHAMOEBA GRIFFINI | C119300 | Any amoebic organism that can be assigned to the species Acanthamoeba griffini. | Acanthamoeba griffini | |||
ACANTHAMOEBA HATCHETTI | C119301 | Any amoebic organism that can be assigned to the species Acanthamoeba hatchetti. | Acanthamoeba hatchetti | |||
ACANTHAMOEBA LUGDUNENSIS | C119302 | Any amoebic organism that can be assigned to the species Acanthamoeba lugdunensis. | Acanthamoeba lugdunensis | |||
ACANTHAMOEBA PALESTINENSIS | C119303 | Any amoebic organism that can be assigned to the species Acanthamoeba palestinensis. | Acanthamoeba palestinensis | |||
ACANTHAMOEBA POLYPHAGA | C119304 | Any amoebic organism that can be assigned to the species Acanthamoeba polyphaga. | Acanthamoeba polyphaga | |||
ACANTHAMOEBA QUINA | C119305 | Any amoebic organism that can be assigned to the species Acanthamoeba quina. | Acanthamoeba quina | |||
ACANTHAMOEBA RHYSODES | C119306 | Any amoebic organism that can be assigned to the species Acanthamoeba rhysodes. | Acanthamoeba rhysodes | |||
ACANTHAMOEBA | C118934 | Any amoebic organism that is not assigned to the species level but can be assigned to the Acanthamoeba genus level. | Acanthamoeba | |||
ACHROMOBACTER DENITRIFICANS | C86080 | Alcaligenes denitrificans | Any bacterial organism that can be assigned to the species Achromobacter denitrificans. | Achromobacter denitrificans | ||
ACHROMOBACTER PIECHAUDII | C86081 | Any bacterial organism that can be assigned to the species Achromobacter piechaudii. | Achromobacter piechaudii | |||
ACHROMOBACTER RUHLANDII | C119307 | Alcaligenes ruhlandii;Hydrogenomonas ruhlandii;Pseudomonas ruhlandii | Any bacterial organism that can be assigned to the species Achromobacter ruhlandii. | Achromobacter ruhlandii | ||
ACHROMOBACTER XYLOSOXIDANS | C86082 | Alcaligenes xylosoxidans | Any bacterial organism that can be assigned to the species Achromobacter xylosoxidans. | Achromobacter xylosoxidans | ||
ACHROMOBACTER | C86079 | Any bacteria that is not assigned to the species level but can be assigned to the Achromobacter genus level. | Achromobacter | |||
ACID-FAST BACILLUS | C184694 | Any rod-shaped bacteria with the characteristic of acid fastness that resists decolorization by acids during staining. | Acid-fast Bacillus | |||
ACIDAMINOCOCCUS FERMENTANS | C86084 | Any bacterial organism that can be assigned to the species Acidaminococcus fermentans. | Acidaminococcus fermentans | |||
ACIDAMINOCOCCUS INTESTINI | C127680 | Any bacterial organism that can be assigned to the species Acidaminococcus intestini. | Acidaminococcus intestini | |||
ACIDAMINOCOCCUS | C86083 | Any bacteria that is not assigned to the species level but can be assigned to the Acidaminococcus genus level. | Acidaminococcus | |||
ACIDOVORAX DELAFIELDII | C86086 | Any bacterial organism that can be assigned to the species Acidovorax delafieldii. | Acidovorax delafieldii | |||
ACIDOVORAX FACILIS | C86087 | Any bacterial organism that can be assigned to the species Acidovorax facilis. | Acidovorax facilis | |||
ACIDOVORAX TEMPERANS | C86088 | Any bacterial organism that can be assigned to the species Acidovorax temperans. | Acidovorax temperans | |||
ACIDOVORAX | C86085 | Any bacteria that is not assigned to the species level but can be assigned to the Acidovorax genus level. | Acidovorax | |||
ACINETOBACTER ANITRATUS | C86089 | Acinetobacter baumannii;Acinetobacter calcoaceticus subsp. anitratus | Any bacterial organism that can be assigned to the species Acinetobacter anitratus. | Acinetobacter anitratus | ||
ACINETOBACTER CALCOACETICUS | C86090 | Any bacterial organism that can be assigned to the species Acinetobacter calcoaceticus. | Acinetobacter calcoaceticus | |||
ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEX | C86091 | Abc Complex;Acb Complex;Acinetobacter baumannii-calcoaceticus Complex | A bacterial species group that mainly includes Acinetobacter baumannii, Acinetobacter nosocomialis, Acinetobacter pittii, and Acinetobacter calcoaceticus, as well as those that are phenotypically or genetically similar to these species. | Acinetobacter calcoaceticus/baumannii Complex | ||
ACINETOBACTER HAEMOLYTICUS | C86092 | Any bacterial organism that can be assigned to the species Acinetobacter haemolyticus. | Acinetobacter haemolyticus | |||
ACINETOBACTER JOHNSONII | C86093 | Any bacterial organism that can be assigned to the species Acinetobacter johnsonii. | Acinetobacter johnsonii | |||
ACINETOBACTER JUNII | C86094 | Any bacterial organism that can be assigned to the species Acinetobacter junii. | Acinetobacter junii | |||
ACINETOBACTER LWOFFII | C86095 | Acinetobacter calcoaceticus subsp. lwoffii | Any bacterial organism that can be assigned to the species Acinetobacter lwoffii. | Acinetobacter lwoffii | ||
ACINETOBACTER PARVUS | C119308 | Acinetobacter sp. phenon 4 | Any bacterial organism that can be assigned to the species Acinetobacter parvus. | Acinetobacter parvus | ||
ACINETOBACTER PITTII | C184693 | Acinetobacter genomosp. 3;g-proteobacteria | Any bacterial organism that can be assigned to the species Acinetobacter pittii. | Acinetobacter pittii | ||
ACINETOBACTER RADIORESISTENS | C86096 | Any bacterial organism that can be assigned to the species Acinetobacter radioresistens. | Acinetobacter radioresistens | |||
ACINETOBACTER URSINGII | C119309 | Acinetobacter sp. phenon 1 | Any bacterial organism that can be assigned to the species Acinetobacter ursingii. | Acinetobacter ursingii | ||
ACINETOBACTER | C76200 | Any bacteria that is not assigned to the species level but can be assigned to the Acinetobacter genus level. | Acinetobacter | |||
ACREMONIUM ATROGRISEUM | C119310 | Gliomastix atrogriseum;Phaeoscopulariopsis atrogrisea | Any fungal organism that can be assigned to the species Acremonium atrogriseum. | Acremonium atrogriseum | ||
ACREMONIUM | C118935 | Any fungal organism that is not assigned to the species level but can be assigned to the Acremonium genus level. | Acremonium | |||
ACTINOBACILLUS ACTINOMYCETEMCOMITANS | C86098 | Any bacterial organism that can be assigned to the species Actinobacillus actinomycetemcomitans. | Actinobacillus actinomycetemcomitans | |||
ACTINOBACILLUS EQUULI | C86099 | Any bacterial organism that can be assigned to the species Actinobacillus equuli. | Actinobacillus equuli | |||
ACTINOBACILLUS LIGNIERESII | C86100 | Any bacterial organism that can be assigned to the species Actinobacillus ligniersii. | Actinobacillus lignieresii | |||
ACTINOBACILLUS PLEUROPNEUMONIAE | C86101 | Haemophilus pleuropneumoniae | Any bacterial organism that can be assigned to the species Actinobacillus pleuropneumoniae. | Actinobacillus pleuropneumoniae | ||
ACTINOBACILLUS SUIS | C86102 | Any bacterial organism that can be assigned to the species Actinobacillus suis. | Actinobacillus suis | |||
ACTINOBACILLUS UREAE | C86103 | Pasteurella ureae | Any bacterial organism that can be assigned to the species Actinobacillus ureae. | Actinobacillus ureae | ||
ACTINOBACILLUS | C86097 | Any bacteria that is not assigned to the species level but can be assigned to the Actinobacillus genus level. | Actinobacillus | |||
ACTINOBACULUM SCHAALII | C119311 | Any bacterial organism that can be assigned to the species Actinobaculum schaalii. | Actinobaculum schaalii | |||
ACTINOMADURA MADURAE | C86105 | Any bacterial organism that can be assigned to the species Actinomadura madurae. | Actinomadura madurae | |||
ACTINOMADURA PELLETIERI | C86106 | Any bacterial organism that can be assigned to the species Actinomadura pelletieri. | Actinomadura pelletieri | |||
ACTINOMADURA | C86104 | Any bacteria that is not assigned to the species level but can be assigned to the Actinomadura genus level. | Actinomadura | |||
ACTINOMYCES BOVIS | C86107 | Actinocladothrix bovis;Cladothrix bovis;Discomyces bovis;Nocardia bovis;Oospora bovis;Proactinomyces bovis;Sarcomyces bovis;Sphaerotilus bovis;Streptothrix bovis | Any bacterial organism that can be assigned to the species Actinomyces bovis. | Actinomyces bovis | ||
ACTINOMYCES EUROPAEUS | C119312 | Any bacterial organism that can be assigned to the species Actinomyces europaeus. | Actinomyces europaeus | |||
ACTINOMYCES ISRAELII | C86108 | Any bacterial organism that can be assigned to the species Actinomyces israelii. | Actinomyces israelii | |||
ACTINOMYCES MEYERII | C86109 | Any bacterial organism that can be assigned to the species Actinomyces meyerii. | Actinomyces meyerii | |||
ACTINOMYCES NAESLUNDII | C86110 | Any bacterial organism that can be assigned to the species Actinomyces naseslundii. | Actinomyces naeslundii | |||
ACTINOMYCES NEUII SUBSP. NEUII | C119313 | CDC coryneform group 1 | Any bacterial organism that can be assigned to the species Actinomyces neuii subspecies neuii. | Actinomyces neuii Subspecies neuii | ||
ACTINOMYCES NEUII | C86111 | Any bacterial organism that can be assigned to the species Actinomyces neuii. | Actinomyces neuii | |||
ACTINOMYCES ODONTOLYTICUS | C86112 | Any bacterial organism that can be assigned to the species Actinomyces odontolyticus. | Actinomyces odontolyticus | |||
ACTINOMYCES RADINGAE | C86113 | Any bacterial organism that can be assigned to the species Actinomyces radingae. | Actinomyces radingae | |||
ACTINOMYCES TURICENSIS | C86114 | Any bacterial organism that can be assigned to the species Actinomyces turicensis. | Actinomyces turicensis | |||
ACTINOMYCES VISCOSUS | C86115 | Any bacterial organism that can be assigned to the species Actinomyces viscosus. | Actinomyces viscosus | |||
ACTINOMYCES | C76201 | Any bacteria that is not assigned to the species level but can be assigned to the Actinomyces genus level. | Actinomyces | |||
ADENOVIRIDAE | C14179 | Adenovirus;ADV | Any viral organism that can be assigned to the family Adenoviridae. | Adenoviridae | ||
ADHERENT INVASIVE ESCHERICHIA COLI | C187901 | Adherent Invasive E. coli;AIEC | Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype adherent invasive. AIEC causes Crohn's disease and inflammatory bowel disease. | Adherent Invasive Escherichia coli | ||
AEROBIC GRAM-NEGATIVE BACILLUS | C86116 | Aerobic Gram-negative Rod | Any rod-shaped bacteria with an oxygen-based metabolism and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Aerobic Gram Negative Bacillus | ||
AEROBIC GRAM-NEGATIVE COCCOBACILLUS | C125954 | Any bacterial organism with an oxygen-based metabolism, and is intermediate in morphology between a spherical-shaped coccus and a rod-shaped bacillus that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. | Aerobic Gram-Negative Coccobacillus | |||
AEROBIC GRAM-NEGATIVE COCCUS | C86117 | Any spherical-shaped bacteria with an oxygen-based metabolism and a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Aerobic Gram Negative Coccus | |||
AEROBIC GRAM-POSITIVE BACILLUS | C86118 | Aerobic Gram-positive Rod | Any rod-shaped bacteria with an oxygen-based metabolism and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Aerobic Gram Positive Bacillus | ||
AEROBIC GRAM-POSITIVE COCCUS | C86119 | Any spherical-shaped bacteria with an oxygen-based metabolism and a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Aerobic Gram Positive Coccus | |||
AEROBIC STREPTOCOCCUS | C86120 | Any bacteria assigned to the genus Streptococcus that requires oxygen to grow or respirate. | Aerobic Streptococcus | |||
AEROCOCCACEAE | C85913 | Any bacteria that are not assigned to the species level but can be assigned to the Aerococcaceae family level. | Aerococcaceae | |||
AEROCOCCUS SANGUINICOLA | C119314 | Any bacterial organism that can be assigned to the species Aerococcus sanguinicola. | Aerococcus sanguinicola | |||
AEROCOCCUS URINAE | C86122 | Any bacterial organism that can be assigned to the species Aerococcus urinae. | Aerococcus urinae | |||
AEROCOCCUS VIRIDANS | C86123 | Any bacterial organism that can be assigned to the species Aerococcus viridans. | Aerococcus viridans | |||
AEROCOCCUS | C86121 | Any bacteria that is not assigned to the species level but can be assigned to the Aerococcus genus level. | Aerococcus | |||
AEROMONAS HYDROPHILA | C86125 | Any bacterial organism that can be assigned to the species Aeromonas hydrophila. | Aeromonas hydrophila | |||
AEROMONAS JANDAEI | C86126 | Any bacterial organism that can be assigned to the species Aeromonas jandaei. | Aeromonas jandaei | |||
AEROMONAS PUNCTATA | C86127 | Aeromonas caviae | Any bacterial organism that can be assigned to the species Aeromonas punctata. | Aeromonas punctata | ||
AEROMONAS SALMONICIDA | C86128 | Any bacterial organism that can be assigned to the species Aeromonas salmonicida. | Aeromonas salmonicida | |||
AEROMONAS SCHUBERTII | C86129 | Any bacterial organism that can be assigned to the species Aeromonas schubertii. | Aeromonas schubertii | |||
AEROMONAS SOBRIA | C86130 | Any bacterial organism that can be assigned to the species Aeromonas sobria. | Aeromonas sobria | |||
AEROMONAS VERONII | C86131 | Any bacterial organism that can be assigned to the species Aeromonas veronii. | Aeromonas veronii | |||
AEROMONAS | C86124 | Any bacteria that is not assigned to the species level but can be assigned to the Aeromonas genus level. | Aeromonas | |||
AGGREGATIBACTER ACTINOMYCETEMCOMITANS | C86133 | Haemophilus actinomycetemcomitans | Any bacterial organism that can be assigned to the species Aggregatibacter actinomycetemcomitans. | Aggregatibacter actinomycetemcomitans | ||
AGGREGATIBACTER APHROPHILUS | C86134 | Haemophilus aphrophilus;Haemophilus paraphrophilus | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus. | Aggregatibacter aphrophilus | ||
AGGREGATIBACTER APHROPHILUS, BETA-LACTAMASE NEGATIVE | C119315 | Haemophilus aphrophilus, Beta-lactamase Negative | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is beta-lactamase negative. | Aggregatibacter aphrophilus, Beta-lactamase Negative | ||
AGGREGATIBACTER APHROPHILUS, BETA-LACTAMASE POSITIVE | C119316 | Haemophilus aphrophilus, Beta-lactamase Positive | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is beta-lactamase positive. | Aggregatibacter aphrophilus, Beta-lactamase Positive | ||
AGGREGATIBACTER APHROPHILUS, PENICILLINASE NEGATIVE | C119317 | Haemophilus aphrophilus, Penicillinase Negative | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is penicillinase negative. | Aggregatibacter aphrophilus, Penicillinase Negative | ||
AGGREGATIBACTER APHROPHILUS, PENICILLINASE POSITIVE | C119318 | Haemophilus aphrophilus, Penicillinase Positive | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is penicillinase positive. | Aggregatibacter aphrophilus, Penicillinase Positive | ||
AGGREGATIBACTER SEGNIS | C86135 | Haemophilus segnis | Any bacterial organism that can be assigned to the species Aggregatibacter segnis. | Aggregatibacter segnis | ||
AGGREGATIBACTER | C86132 | Any bacteria that is not assigned to the species level but can be assigned to the Aggregatibacter genus level. | Aggregatibacter | |||
AGROBACTERIUM RADIOBACTER | C86137 | Any bacterial organism that can be assigned to the species Agrobacterium radiobacter. | Agrobacterium radiobacter | |||
AGROBACTERIUM TUMEFACIENS | C86138 | Rhizobium radiobacter | Any bacterial organism that can be assigned to the species Agrobacterium tumefaciens. | Agrobacterium tumefaciens | ||
AGROBACTERIUM | C86011 | Any bacteria that is not assigned to the species level but can be assigned to the Agrobacterium genus level. | Agrobacterium | |||
AJELLOMYCES CAPSULATUS | C77186 | Any fungal organism that can be assigned to the species Ajellomyces capsulatus. | Ajellomyces capsulatus | |||
ALCALIGENACEAE | C85914 | Any bacteria that are not assigned to the species level but can be assigned to the Alcaligenaceae family level. | Alcaligenaceae | |||
ALCALIGENES FAECALIS | C86140 | Alcaligenes odorans | Any bacterial organism that can be assigned to the species Alcaligenes faecalis. | Alcaligenes faecalis | ||
ALCALIGENES | C86012 | Any bacteria that is not assigned to the species level but can be assigned to the Alcaligenes genus level. | Alcaligenes | |||
ALISTIPES PUTREDINIS | C86871 | Bacteroides putredinis | Any bacterial organism that can be assigned to the species Alistipes putredinis. | Alistipes putredinis | ||
ALISTIPES SHAHII | C114246 | Any bacterial organism that can be assigned to the species Alistipes shahii. | Alistipes shahii | |||
ALISTIPES | C86870 | Any bacterial organism that is not assigned to the species level but can be assigned to the Alistipes genus level. | Alistipes | |||
ALKALIHALOBACILLUS CLAUSII | C184691 | Bacillus clausii | Any bacterial organism that can be assigned to the species Alkalihalobacillus clausii. | Alkalihalobacillus clausii | ||
ALPHACORONAVIRUS | C119319 | Coronavirus Group 1 | Any viral organism that is not assigned to the species level but can be assigned to the Alphacoronavirus genus level. | Alphacoronavirus | ||
ALPHAVIRUS | C112030 | Arboviruses Group A | Any viral organism that can be assigned to the genus Alphavirus. | Alphavirus | ||
ALTERNARIA ALTERNATA | C87529 | Alternaria tenuis | Any fungal organism that can be assigned to the species Alternaria alternata. | Alternaria alternata | ||
ALTERNARIA | C119320 | Any fungal organism that is not assigned to the species level but can be assigned to the Alternaria genus level. | Alternaria | |||
AMOEBA | C119581 | Ameba | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Amoeba genus level. | Amoeba | ||
ANAEROBIC BACTERIA | C119321 | Anaerobe | Any bacterial organism that does not require oxygen to grow or respirate and cannot be assigned to a specific genus or species. | Anaerobic Bacteria | ||
ANAEROBIC COCCUS | C119322 | Any spherical shaped bacterial organism that does not require oxygen to grow or respirate and cannot be assigned to a specific genus or species. | Anaerobic Coccus | |||
ANAEROBIC GRAM-NEGATIVE BACILLUS | C86142 | Anaerobic Gram-negative Rod | Any rod-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Anaerobic Gram Negative Bacillus | ||
ANAEROBIC GRAM-NEGATIVE BACTERIA | C119323 | Gram-negative Anaerobe | Any bacterial organism that does not require oxygen to grow or respirate, cannot be assigned to a specific genus or species, and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Anaerobic Gram-negative Bacteria | ||
ANAEROBIC GRAM-NEGATIVE COCCOBACILLUS | C125955 | Any bacterial organism that does not require oxygen to grow or respirate, and is intermediate in morphology between a spherical-shaped coccus and a rod-shaped bacillus that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. | Anaerobic Gram-Negative Coccobacillus | |||
ANAEROBIC GRAM-NEGATIVE COCCUS | C86143 | Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Anaerobic Gram Negative Coccus | |||
ANAEROBIC GRAM-POSITIVE BACILLUS | C86144 | Anaerobic Gram-positive Rod | Any rod-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Anaerobic Gram Positive Bacillus | ||
ANAEROBIC GRAM-POSITIVE BACTERIA | C120704 | Gram-positive Anaerobe | Any bacterial organism that does not require oxygen to grow or respirate, cannot be assigned to a specific genus or species, and has a cell wall that contains high levels of peptidoglycan and stains purple with the Gram staining technique. | Anaerobic Gram Positive Bacteria | ||
ANAEROBIC GRAM-POSITIVE COCCUS | C86145 | Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Anaerobic Gram Positive Coccus | |||
ANAEROBIC STREPTOCOCCUS | C86146 | Any bacteria assigned to the genus Streptococcus that does not require oxygen to grow or respirate. | Anaerobic Streptococcus | |||
ANAEROCOCCUS HYDROGENALIS | C86874 | Peptostreptococcus hydrogenalis | Any bacterial organism that can be assigned to the species Anaerococcus hydrogenalis. | Anaerococcus hydrogenalis | ||
ANAEROCOCCUS PREVOTII | C86875 | Micrococcus prevotii;Peptococcus prevotii;Peptostreptococcus prevotii | Any bacterial organism that can be assigned to the species Anaerococcus prevotii. | Anaerococcus prevotii | ||
ANAEROCOCCUS TETRADIUS | C86876 | Gaffkya anaerobia;Peptostreptotoccus tetradius | Any bacterial organism that can be assigned to the species Anaerococcus tetradius. | Anaerococcus tetradius | ||
ANAEROCOCCUS VAGINALIS | C86877 | Any bacterial organism that can be assigned to the species Anaerococcus vaginalis. | Anaerococcus vaginalis | |||
ANAEROCOCCUS | C86872 | Any bacteria that is not assigned to the species level but can be assigned to the Anaerococcus genus level. | Anaerococcus | |||
ANAPLASMA | C187902 | Any bacteria that is not assigned to the species level but can be assigned to the Anaplasma genus level. | Anaplasma | |||
ANCYLOSTOMA BRAZILIENSE | C122239 | Ancylostoma ceylanicum;Ancylostoma ceylonicum | Any nematode parasite that can be assigned to the species Ancylostoma braziliense. | Ancylostoma braziliense | ||
ANCYLOSTOMA CANINUM | C122240 | Dog Hookworm | Any nematode parasite that can be assigned to the species Ancylostoma caninum. | Ancylostoma caninum | ||
ANCYLOSTOMA DUODENALE | C122241 | European Hookworm;Old World Hookworm | Any nematode parasite that can be assigned to the species Ancylostoma duodenale. | Ancylostoma duodenale | ||
ANCYLOSTOMA | C120705 | Any nematode parasite that is not assigned to the species level but can be assigned to the Ancylostoma genus level. | Ancylostoma | |||
ANCYLOSTOMATOIDEA | C123646 | Hookworms | Any nematode parasite that can be assigned to the family of Ancylostomatoidea. | Ancylostomatoidea | ||
ANGIOSTRONGYLUS CANTONENSIS | C122242 | Rat Lungworm | Any nematode parasite that can be assigned to the species Angiostrongylus cantonensis. | Angiostrongylus cantonensis | ||
ANGIOSTRONGYLUS | C122042 | Any nematode parasite that is not assigned to the species level but can be assigned to the Angiostrongylus genus level. | Angiostrongylus | |||
ANISAKIS SIMPLEX | C122243 | Herring Worm | Any nematode parasite that can be assigned to the species Anisakis simplex. | Anisakis simplex | ||
ANISAKIS | C122043 | Any nematode parasite that is not assigned to the species level but can be assigned to the Anisakis genus level. | Anisakis | |||
APHTHOVIRUS | C112229 | Any viral organism that can be assigned to the genus Aphthovirus. | Aphthovirus | |||
APOPHYSOMYCES ELEGANS | C127681 | Any fungal organism that can be assigned to the species Apophysomyces elegans. | Apophysomyces elegans | |||
ARBOVIRUS | C112230 | Arthropod-borne Virus | A non-taxonomic grouping of viruses that are transmitted through an arthropod vector and replicate in a vertebrate host. | Arbovirus | ||
ARCANOBACTERIUM BERNARDIAE | C86148 | Any bacterial organism that can be assigned to the species Arcanobacterium bernardiae. | Arcanobacterium bernardiae | |||
ARCANOBACTERIUM HAEMOLYTICUM | C86149 | Corynebacterium haemolyticum;Corynebacterium haemolyticus | Any bacterial organism that can be assigned to the species Arcanobacterium haemolyticum. | Arcanobacterium haemolyticum | ||
ARCANOBACTERIUM | C86147 | Any bacteria that is not assigned to the species level but can be assigned to the Arcanobacterium genus level. | Arcanobacterium | |||
ARCOBACTER BUTZLERI | C86153 | Campylobacter butzleri | Any bacterial organism that can be assigned to the species Arcobacter butzleri. | Arcobacter butzleri | ||
ARCOBACTER CRYAEROPHILUS | C86154 | Campylobacter cryaerophilus | Any bacterial organism that can be assigned to the species Arcobacter cryaerophilus. | Arcobacter cryaerophilus | ||
ARCOBACTER | C86152 | Any bacteria that is not assigned to the species level but can be assigned to the Arcobacter genus level. | Arcobacter | |||
ARENAVIRUS | C14306 | Any viral organism that can be assigned to the genus Arenavirus. | Arenavirus | |||
ARTHRINIUM PHAEOSPERMUM | C127682 | Any fungal organism that can be assigned to the species Arthrinium phaeospermum. | Arthrinium phaeospermum | |||
ARTHROBACTER CUMMINSII | C114248 | Any bacterial organism that can be assigned to the species Arthrobacter cumminsii. | Arthrobacter cumminsii | |||
ARTHROBACTER | C86155 | Any bacteria that is not assigned to the species level but can be assigned to the Arthrobacter genus level. | Arthrobacter | |||
ARTHRODERMA FULVUM | C127683 | Microsporum fulvum | Any fungal organism that can be assigned to the species Arthroderma fulvum. | Arthroderma fulvum | ||
ARTHRODERMA OBTUSUM | C127684 | Microsporum nanum | Any fungal organism that can be assigned to the species Arthroderma obtusum. | Arthroderma obtusum | ||
ARTHRODERMA OTAE | C127685 | Microsporum canis;Nannizzia otae | Any fungal organism that can be assigned to the species Arthroderma otae. | Arthroderma otae | ||
ARTHRODERMA PERSICOLOR | C127686 | Trichophyton persicolor | Any fungal organism that can be assigned to the species Arthroderma persicolor. | Arthroderma persicolor | ||
ARTHRODERMA SIMII | C127687 | Trichophyton simii | Any fungal organism that can be assigned to the species Arthroderma simii. | Arthroderma simii | ||
ARTHROGRAPHIS | C139106 | Any fungal organism that is not assigned to the species level but can be assigned to the Arthrographis genus level. | Arthrographis | |||
ASCARIS LUMBRICOIDES | C122177 | Giant Roundworm | Any nematode parasite that can be assigned to the species Ascaris lumbricoides. | Ascaris lumbricoides | ||
ASPERGILLUS FLAVUS COMPLEX | C122244 | A non-taxonomic grouping of fungal species that are morphologically similar to the Aspergillus flavus species. | Aspergillus Flavus Complex | |||
ASPERGILLUS FLAVUS | C77181 | Any fungal organism that can be assigned to the species Aspergillus flavus. | Aspergillus flavus | |||
ASPERGILLUS FUMIGATUS COMPLEX | C122245 | A non-taxonomic grouping of fungal species that are morphologically similar to the Aspergillus fumigatus species. | Aspergillus Fumigatus Complex | |||
ASPERGILLUS FUMIGATUS | C77182 | Aspergillus fumigates | Any fungal organism that can be assigned to the species Aspergillus fumigatus. | Aspergillus fumigatus | ||
ASPERGILLUS NIGER | C121138 | Any fungal organism that can be assigned to the species Aspergillus niger. | Aspergillus niger | |||
ASPERGILLUS NIVEUS | C150877 | Any fungal organism that can be assigned to the species Aspergillus niveus. | Aspergillus niveus | |||
ASPERGILLUS OCHRACEUS | C87508 | Any fungal organism that can be assigned to the species Aspergillus ochraceus. | Aspergillus ochraceus | |||
ASPERGILLUS TERREUS | C87511 | Aspergillus terrestrius | Any fungal organism that can be assigned to the species Aspergillus terreus. | Aspergillus terreus | ||
ASPERGILLUS VERSICOLOR | C127688 | Sterigmatocystis versicolor | Any fungal organism that can be assigned to the species Aspergillus versicolor. | Aspergillus versicolor | ||
ASPERGILLUS | C77180 | Any fungal organism that is not assigned to the species level but can be assigned to the Aspergillus genus level. | Aspergillus | |||
ASTEROTREMELLA HUMICOLA | C127689 | Apiotrichum humicola;Azymoprocandida humicola;Candida humicola;Cryptococcus humicola;Mycotorula humicola;Torula humicola;Vanrija humicola;Vanrijia humicola | Any fungal organism that can be assigned to the species Asterotremella humicola. | Asterotremella humicola | ||
ASTROVIRIDAE | C112231 | Any viral organism that can be assigned to the family Astroviridae. | Astroviridae | |||
ATOPOBIUM MINUTUM | C86156 | Lactobacillus minutis;Lactobacillus minutus | Any bacterial organism that can be assigned to the species Atopobium minutum. | Atopobium minutum | ||
ATOPOBIUM PARVULUM | C86157 | Streptococcus parvulus | Any bacterial organism that can be assigned to the species Atopobium parvulum. | Atopobium parvulum | ||
ATOPOBIUM RIMAE | C114244 | Lactobacillus rimae | Any bacterial organism that can be assigned to the species Atopobium rimae. | Atopobium rimae | ||
ATOPOBIUM VAGINAE | C122178 | Any bacterial organism that can be assigned to the species Atopobium vaginae. | Atopobium vaginae | |||
AUREOBASIDIUM PULLULANS | C127690 | Aureobasidium pullulans var. pullulans | Any fungal organism that can be assigned to the species Aureobasidium pullulans. | Aureobasidium pullulans | ||
AVIBACTERIUM PARAGALLINARUM | C86158 | Haemophilus paragallinarum | Any bacterial organism that can be assigned to the species Avibacterium paragallinarum. | Avibacterium paragallinarum | ||
BABESIA DIVERGENS | C122179 | Any unicellular, eukaryotic organism that can be assigned to the species Babesia divergens. | Babesia divergens | |||
BABESIA MICROTI | C122180 | Any unicellular, eukaryotic organism that can be assigned to the species Babesia microti. | Babesia microti | |||
BABESIA | C122040 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Babesia genus level. | Babesia | |||
BACILLUS ALVEI | C86159 | Any bacterial organism that can be assigned to the species Bacillus alvei. | Bacillus alvei | |||
BACILLUS ANTHRACIS | C86160 | Any bacterial organism that can be assigned to the species Bacillus anthracis. | Bacillus anthracis | |||
BACILLUS CEREUS | C86161 | Any bacterial organism that can be assigned to the species Bacillus cereus. | Bacillus cereus | |||
BACILLUS LENTUS | C86162 | Any bacterial organism that can be assigned to the species Bacillus lentus. | Bacillus lentus | |||
BACILLUS LICHENIFORMIS | C86163 | Any bacterial organism that can be assigned to the species Bacillus licheniformis. | Bacillus licheniformis | |||
BACILLUS MEGATERIUM | C86164 | Any bacterial organism that can be assigned to the species Bacillus megaterium. | Bacillus megaterium | |||
BACILLUS MYCOIDES | C86165 | Any bacterial organism that can be assigned to the species Bacillus mycoides. | Bacillus mycoides | |||
BACILLUS POLYMYXA | C86166 | Any bacterial organism that can be assigned to the species Bacillus polymyxa. | Bacillus polymyxa | |||
BACILLUS PUMILUS | C122181 | Bacillus aminoglucosidicus | Any bacterial organism that can be assigned to the species Bacillus pumilus. | Bacillus pumilus | ||
BACILLUS SUBTILIS | C86167 | Any bacterial organism that can be assigned to the species Bacillus subtilis. | Bacillus subtilis | |||
BACILLUS | C76202 | Any bacteria that is not assigned to the species level but can be assigned to the Bacillus genus level. | Bacillus | |||
BACTERIA | C14187 | Bacterium;Eubacteria | Any organism assigned to the kingdom Bacteria. | Bacteria | ||
BACTEROIDES CACCAE | C86168 | Any bacterial organism that can be assigned to the species Bacteroides caccae. | Bacteroides caccae | |||
BACTEROIDES CAPILLOSUS | C86169 | Any bacterial organism that can be assigned to the species Bacteroides capillosus. | Bacteroides capillosus | |||
BACTEROIDES CELLULOSOLVENS | C86170 | Any bacterial organism that can be assigned to the species Bacteroides cellulosolvens. | Bacteroides cellulosolvens | |||
BACTEROIDES DOREI | C111133 | Any bacterial organism that can be assigned to the species Bacteroides dorei. | Bacteroides dorei | |||
BACTEROIDES EGGERTHII | C86171 | Any bacterial organism that can be assigned to the species Bacteroides eggerthii. | Bacteroides eggerthii | |||
BACTEROIDES FAECIS | C111134 | Any bacterial organism that can be assigned to the species Bacteroides faecis. | Bacteroides faecis | |||
BACTEROIDES FRAGILIS GROUP | C86173 | A non-taxonomic grouping of bacteria that belongs to the fragilis group of the genus Bacteroides. | Bacteroides fragilis Group | |||
BACTEROIDES FRAGILIS | C86172 | Any bacterial organism that can be assigned to the species Bacteroides fragilis. | Bacteroides fragilis | |||
BACTEROIDES INTESTINALIS | C119324 | Any bacterial organism that can be assigned to the species Bacteroides intestinalis. | Bacteroides intestinalis | |||
BACTEROIDES NORDII | C86174 | Any bacterial organism that can be assigned to the species Bacteroides nordii. | Bacteroides nordii | |||
BACTEROIDES OVATUS | C86175 | Any bacterial organism that can be assigned to the species Bacteroides ovatus. | Bacteroides ovatus | |||
BACTEROIDES PYOGENES | C86178 | Bacteroides tectum;Bacteroides tectus | Any bacterial organism that can be assigned to the species Bacteroides pyogenes. | Bacteroides tectus | ||
BACTEROIDES SALYERSIAE | C122182 | Any bacterial organism that can be assigned to the species Bacteroides salyersiae. | Bacteroides salyersiae | |||
BACTEROIDES STERCORIS | C86177 | Bacteroides fragilis subsp. A | Any bacterial organism that can be assigned to the species Bacteroides stercoris. | Bacteroides stercoris | ||
BACTEROIDES THETAIOTAOMICRON | C86179 | Any bacterial organism that can be assigned to the species Bacteroides thetaiotamicron. | Bacteroides thetaiotaomicron | |||
BACTEROIDES UNIFORMIS | C86180 | Any bacterial organism that can be assigned to the species Bacteroides uniformis. | Bacteroides uniformis | |||
BACTEROIDES VULGATUS | C86182 | Any bacterial organism that can be assigned to the species Bacteroides vulgatus. | Bacteroides vulgatus | |||
BACTEROIDES XYLANISOLVENS | C122183 | Any bacterial organism that can be assigned to the species Bacteroides xylanisolvens. | Bacteroides xylanisolvens | |||
BACTEROIDES | C76204 | Any bacteria that is not assigned to the species level but can be assigned to the Bacteroides genus level. | Bacteroides | |||
BALAMUTHIA MANDRILLARIS | C122184 | Any amoebic organism that can be assigned to the species Balamuthia mandrillaris. | Balamuthia mandrillaris | |||
BALAMUTHIA | C122041 | Any amoebic organism that is not assigned to the species level but can be assigned to the Balamuthia genus level. | Balamuthia | |||
BALANTIDIUM COLI | C122246 | Paramecium coli | Any unicellular, eukaryotic organism that can be assigned to the species Balantidium coli. | Balantidium coli | ||
BARMAH FOREST VIRUS | C112232 | Any viral organism that can be assigned to the species Barmah Forest virus. | Barmah Forest Virus | |||
BARTONELLA ELIZABETHAE | C86185 | Rochalimaea elizabethae | Any bacterial organism that can be assigned to the species Bartonella elizabethae. | Bartonella elizabethae | ||
BARTONELLA HENSELAE | C86186 | Rochalimaea henselae | Any bacterial organism that can be assigned to the species Bartonella henselae. | Bartonella henselae | ||
BARTONELLA QUINTANA | C86187 | Rochalimaea quintana | Any bacterial organism that can be assigned to the species Bartonella quintana. | Bartonella quintana | ||
BARTONELLA | C86184 | Any bacteria that is not assigned to the species level but can be assigned to the Bartonella genus level. | Bartonella | |||
BERGEYELLA ZOOHELCUM | C86189 | Weeksella zoohelcum | Any bacterial organism that can be assigned to the species Bergeyella zoohelcum. | Bergeyella zoohelcum | ||
BERGEYELLA | C86188 | Any bacteria that is not assigned to the species level but can be assigned to the Bergeyella genus level. | Bergeyella | |||
BETA STREPTOCOCCUS, GROUP A | C189614 | GAS;Streptococcus Group A | A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the A group. | Beta-Hemolytic Streptococcus Group A | ||
BETA STREPTOCOCCUS, GROUP B | C189615 | GBS;Streptococcus Group B | A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the B group. | Beta-Hemolytic Streptococcus Group B | ||
BETA STREPTOCOCCUS, GROUP C | C86191 | GCS;Streptococcus Group C | A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the C group. | Beta-Hemolytic Streptococcus Group C | ||
BETA STREPTOCOCCUS, GROUP F | C86192 | GFS;Streptococcus Group F | A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the F group. | Beta-Hemolytic Streptococcus Group F | ||
BETA STREPTOCOCCUS, GROUP G | C86193 | GGS;Streptococcus Group G | A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the G group. | Beta-Hemolytic Streptococcus Group G | ||
BETACORONAVIRUS | C113207 | Coronavirus Group 2 | Any viral organism that can be assigned to the genus Betacoronavirus. | Betacoronavirus | ||
BIFIDOBACTERIUM ADOLESCENTIS | C86195 | Any bacterial organism that can be assigned to the species Bifidobacterium adolescentis. | Bifidobacterium adolescentis | |||
BIFIDOBACTERIUM ANGULATUM | C86196 | Any bacterial organism that can be assigned to the species Bifidobacterium angulatum. | Bifidobacterium angulatum | |||
BIFIDOBACTERIUM ANIMALIS | C122247 | Any bacterial organism that can be assigned to the species Bifidobacterium animalis. | Bifidobacterium animalis | |||
BIFIDOBACTERIUM BIFIDUM | C86197 | Any bacterial organism that can be assigned to the species Bifidobacterium bifidum. | Bifidobacterium bifidum | |||
BIFIDOBACTERIUM BREVE | C122248 | Bifidobacterium parvulorum | Any bacterial organism that can be assigned to the species Bifidobacterium breve. | Bifidobacterium breve | ||
BIFIDOBACTERIUM DENTIUM | C86198 | Bifidobacterium appendicitis | Any bacterial organism that can be assigned to the species Bifidobacterium dentium. | Bifidobacterium dentium | ||
BIFIDOBACTERIUM LONGUM | C86199 | Any bacterial organism that can be assigned to the species Bifidobacterium longum. | Bifidobacterium longum | |||
BIFIDOBACTERIUM PSEUDOCATENULATUM | C122249 | Any bacterial organism that can be assigned to the species Bifidobacterium pseudocatenulatum. | Bifidobacterium pseudocatenulatum | |||
BIFIDOBACTERIUM | C86194 | Any bacteria that is not assigned to the species level but can be assigned to the Bifidobacterium genus level. | Bifidobacterium | |||
BILOPHILA WADSWORTHIA | C86201 | Any bacterial organism that can be assigned to the species Bilophila wadsworthia. | Bilophila wadsworthia | |||
BILOPHILA | C86200 | Any bacteria that is not assigned to the species level but can be assigned to the Bilophila genus level. | Bilophila | |||
BIPOLARIS | C122250 | Any fungal organism that is not assigned to the species level but can be assigned to the Bipolaris genus level. | Bipolaris | |||
BK POLYOMAVIRUS | C89820 | BK Virus | Any viral organism that can be assigned to the species BK polyomavirus. | BK Virus | ||
BLASTOCYSTIS HOMINIS | C122251 | Any unicellular, eukaryotic organism that can be assigned to the species Blastocystis hominis. | Blastocystis hominis | |||
BOCAPARVOVIRUS | C127691 | Bocavirus | Any viral organism that can be assigned to the genus Bocaparvovirus. | Bocaparvovirus | ||
BORDETELLA AVIUM | C86203 | Any bacterial organism that can be assigned to the species Bordetella avium. | Bordetella avium | |||
BORDETELLA BRONCHISEPTICA | C86204 | Bordetella bronchicanis | Any bacterial organism that can be assigned to the species Bordetella bronchiseptica. | Bordetella bronchiseptica | ||
BORDETELLA HINZII | C127692 | Any bacterial organism that can be assigned to the species Bordetella hinzii. | Bordetella hinzii | |||
BORDETELLA HOLMESII | C135460 | CDC Nonoxidizer Group 2 | Any bacterial organism that can be assigned to the species Bordetella holmesii. | Bordetella holmesii | ||
BORDETELLA PARAPERTUSSIS | C86205 | Any bacterial organism that can be assigned to the species Bordetella parapertussis. | Bordetella parapertussis | |||
BORDETELLA PERTUSSIS | C76205 | Any bacterial organism that can be assigned to the species Bordetella pertussis. | Bordetella pertussis | |||
BORDETELLA PETRII | C127693 | Any bacterial organism that can be assigned to the species Bordetella petrii. | Bordetella petrii | |||
BORDETELLA | C86202 | Any bacteria that is not assigned to the species level but can be assigned to the Bordetella genus level. | Bordetella | |||
BORRELIA BURGDORFERI | C76208 | Any bacterial organism that can be assigned to the species Borrelia burgdorferi. | Borrelia burgdorferi | |||
BORRELIA MIYAMOTOI | C122252 | Any bacterial organism that can be assigned to the species Borrelia miyamotoi. | Borrelia miyamotoi | |||
BORRELIA | C86206 | Any bacteria that is not assigned to the species level but can be assigned to the Borrelia genus level. | Borrelia | |||
BREVIBACILLUS LATEROSPORUS | C86208 | Any bacterial organism that can be assigned to the species Brevibacillus laterosporus. | Brevibacillus laterosporus | |||
BREVIBACILLUS | C86207 | Any bacteria that is not assigned to the species level but can be assigned to the Brevibacillus genus level. | Brevibacillus | |||
BREVIBACTERIUM CASEI | C86210 | Any bacterial organism that can be assigned to the species Brevibacterium casei. | Brevibacterium casei | |||
BREVIBACTERIUM EPIDERMIDIS | C86211 | Any bacterial organism that can be assigned to the species Brevibacterium epidermidis. | Brevibacterium epidermidis | |||
BREVIBACTERIUM | C86209 | Any bacteria that is not assigned to the species level but can be assigned to the Brevibacterium genus level. | Brevibacterium | |||
BREVUNDIMONAS DIMINUTA | C86213 | Pseudomonas diminuta | Any bacterial organism that can be assigned to the species Brevundimonas diminuta. | Brevundimonas diminuta | ||
BREVUNDIMONAS VESICULARIS | C86214 | Pseudomonas vesicularis | Any bacterial organism that can be assigned to the species Brevundimonas vesicularis. | Brevundimonas vesicularis | ||
BREVUNDIMONAS | C86212 | Any bacteria that is not assigned to the species level but can be assigned to the Brevundimonas genus level. | Brevundimonas | |||
BRUCELLA ABORTUS | C86216 | Any bacterial organism that can be assigned to the species Brucella abortus. | Brucella abortus | |||
BRUCELLA CANIS | C86217 | Any bacterial organism that can be assigned to the species Brucella canis. | Brucella canis | |||
BRUCELLA MELITENSIS | C86218 | Any bacterial organism that can be assigned to the species Brucella melitensis. | Brucella melitensis | |||
BRUCELLA SUIS | C86219 | Any bacterial organism that can be assigned to the species Brucella suis. | Brucella suis | |||
BRUCELLA | C86215 | Any bacteria that is not assigned to the species level but can be assigned to the Brucella genus level. | Brucella | |||
BUDVICIA AQUATICA | C86221 | Any bacterial organism that can be assigned to the species Budvicia aquatica. | Budvicia aquatica | |||
BUDVICIA | C86220 | Any bacteria that is not assigned to the species level but can be assigned to the Budvicia genus level. | Budvicia | |||
BURKHOLDERIA AMBIFARIA | C172567 | Burkholderia cepacia Complex Genomovar VII | Any bacterial organism that can be assigned to the species Burkholderia ambifaria. | Burkholderia ambifaria | ||
BURKHOLDERIA ANTHINA | C172566 | Any bacterial organism that can be assigned to the species Burkholderia anthina. | Burkholderia anthina | |||
BURKHOLDERIA CENOCEPACIA | C86223 | Any bacterial organism that can be assigned to the species Burkholderia cenocepacia. | Burkholderia cenocepacia | |||
BURKHOLDERIA CEPACIA COMPLEX | C86224 | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Burkholderia cepacia species. | Burkholderia cepacia Complex | |||
BURKHOLDERIA CEPACIA | C76376 | Pseudomonas cepacia | Any bacterial organism that can be assigned to the species Burkholderia cepacia. | Burkholderia cepacia | ||
BURKHOLDERIA DOLOSA | C172568 | Burkholderia cepacia Genomovar VI | Any bacterial organism that can be assigned to the species Burkholderia dolosa. | Burkholderia dolosa | ||
BURKHOLDERIA GLADIOLI | C86225 | Pseudomonas gladioli | Any bacterial organism that can be assigned to the species Burkholderia gladioli. | Burkholderia gladioli | ||
BURKHOLDERIA MALLEI | C86226 | Actinobacillus mallei | Any bacterial organism that can be assigned to the species Burkholderia mallei. | Burkholderia mallei | ||
BURKHOLDERIA MULTIVORANS | C172571 | Burkholderia cepacia Genomovar II | Any bacterial organism that can be assigned to the species Burkholderia multivorans. | Burkholderia multivorans | ||
BURKHOLDERIA PSEUDOMALLEI | C86227 | Burkholderia pseudomalle;Pseudomonas pseudomallei | Any bacterial organism that can be assigned to the species Burkholderia pseudomallei. | Burkholderia pseudomallei | ||
BURKHOLDERIA PYRROCINIA | C172565 | Pseudomonas pyrrocinia | Any bacterial organism that can be assigned to the species Burkholderia pyrrocinia. | Burkholderia pyrrocinia | ||
BURKHOLDERIA STABILIS | C172570 | Burkholderia cepacia Genomovar IV | Any bacterial organism that can be assigned to the species Burkholderia stabilis. | Burkholderia stabilis | ||
BURKHOLDERIA VIETNAMIENSIS | C172569 | Burkholderia cepacia Genomovar V | Any bacterial organism that can be assigned to the species Burkholderia vietnamiensis. | Burkholderia vietnamiensis | ||
BURKHOLDERIA | C86222 | Any bacteria that is not assigned to the species level but can be assigned to the Burkholderia genus level. | Burkholderia | |||
BUTTIAUXELLA AGRESTIS | C86229 | Any bacterial organism that can be assigned to the species Buttiauxella agrestis. | Buttiauxella agrestis | |||
BUTTIAUXELLA FERRAGUTIAE | C122253 | CDC Enteric Group 63 | Any bacterial organism that can be assigned to the species Buttiauxella ferragutiae. | Buttiauxella ferragutiae | ||
BUTTIAUXELLA GAVINIAE | C122254 | CDC Enteric Group 64 | Any bacterial organism that can be assigned to the species Buttiauxella gaviniae. | Buttiauxella gaviniae | ||
BUTTIAUXELLA NOACKIAE | C122255 | CDC Enteric Group 59 | Any bacterial organism that can be assigned to the species Buttiauxella noackiae. | Buttiauxella noackiae | ||
BUTTIAUXELLA | C86228 | Any bacteria that is not assigned to the species level but can be assigned to the Buttiauxella genus level. | Buttiauxella | |||
BYSSOCHLAMYS SPECTABILIS | C127694 | Paecilomyces spectabilis;Paecilomyces variotii;Talaromyces spectabilis | Any fungal organism that can be assigned to the species Byssochlamys spectabilis. | Byssochlamys spectabilis | ||
CALICIVIRIDAE | C14304 | Any viral organism that can be assigned to the family Caliciviridae. | Caliciviridae | |||
CALODIUM HEPATICUM | C122256 | Capillaria hepatica | Any nematode parasite that can be assigned to the species Calodium hepaticum. | Calodium hepaticum | ||
CAMPYLOBACTER COLI | C86230 | Any bacterial organism that can be assigned to the species Campylobacter coli. | Campylobacter coli | |||
CAMPYLOBACTER CONCISUS | C86231 | Any bacterial organism that can be assigned to the species Campylobacter concisus. | Campylobacter concisus | |||
CAMPYLOBACTER CURVUS | C86232 | Wolinella curva | Any bacterial organism that can be assigned to the species Campylobacter curvus. | Campylobacter curvus | ||
CAMPYLOBACTER FETUS | C86233 | Vibrio fetus | Any bacterial organism that can be assigned to the species Campylobacter fetus. | Campylobacter fetus | ||
CAMPYLOBACTER GRACILIS | C86234 | Bacteroides gracilis | Any bacterial organism that can be assigned to the species Campylobacter gracilis. | Campylobacter gracilis | ||
CAMPYLOBACTER JEJUNI | C86235 | Any bacterial organism that can be assigned to the species Campylobacter jejuni. | Campylobacter jejuni | |||
CAMPYLOBACTER LARI | C86236 | Campylobacter laridis | Any bacterial organism that can be assigned to the species Campylobacter lari. | Campylobacter lari | ||
CAMPYLOBACTER RECTUS | C86237 | Wolinella recta | Any bacterial organism that can be assigned to the species Campylobacter rectus. | Campylobacter rectus | ||
CAMPYLOBACTER UPSALIENSIS | C86238 | Any bacterial organism that can be assigned to the species Campylobacter upsaliensis. | Campylobacter upsaliensis | |||
CAMPYLOBACTER UREOLYTICUS | C86181 | Bacteroides corrodens;Bacteroides ureolyticus | Any bacterial organism that can be assigned to the species Campylobacter ureolyticus. | Bacteroides ureolyticus | ||
CAMPYLOBACTER | C76211 | Any bacteria that is not assigned to the species level but can be assigned to the Campylobacter genus level. | Campylobacter | |||
CANDIDA ALBICANS | C77170 | Candida stellatoidea | Any fungal organism that can be assigned to the species Candida albicans. | Candida albicans | ||
CANDIDA BOIDINII | C127695 | Hansenula alcolica | Any fungal organism that can be assigned to the species Candida boidinii. | Candida boidinii | ||
CANDIDA DUBLINIENSIS | C114255 | Any fungal organism that can be assigned to the species Candida dubliniensis. | Candida dubliniensis | |||
CANDIDA FAMATA | C127696 | Any fungal organism that can be assigned to the species Candida famata. | Candida famata | |||
CANDIDA GLABRATA | C77179 | Torulopsis glabrata | Any fungal organism that can be assigned to the species Candida glabrata. | Candida glabrata | ||
CANDIDA INCONSPICUA | C127697 | Torulopsis inconspicua | Any fungal organism that can be assigned to the species Candida inconspicua. | Candida inconspicua | ||
CANDIDA INTERMEDIA | C120706 | Blastodendrion intermedium;Blastodendrion intermedius;Cryptococcus intermedius;Kluyveromyces cellobiovorus;Mycotorula intermedia | Any fungal organism that can be assigned to the species Candida intermedia. | Candida intermedia | ||
CANDIDA ORTHOPSILOSIS | C114260 | Candida parapsilosis group II | Any fungal organism that can be assigned to the species Candida orthopsilosis. | Candida orthopsilosis | ||
CANDIDA PARAPSILOSIS | C77176 | Any fungal organism that can be assigned to the species Candida parapsilosis. | Candida parapsilosis | |||
CANDIDA PARARUGOSA | C114258 | Any fungal organism that can be assigned to the species Candida pararugosa. | Candida pararugosa | |||
CANDIDA RUGOSA | C114254 | Any fungal organism that can be assigned to the species Candida rugosa. | Candida rugosa | |||
CANDIDA SAKE | C127698 | Any fungal organism that can be assigned to the species Candida sake. | Candida sake | |||
CANDIDA TROPICALIS | C77177 | Any fungal organism that can be assigned to the species Candida tropicalis. | Candida tropicalis | |||
CANDIDA ZEYLANOIDES | C114261 | Candida krissii | Any fungal organism that can be assigned to the species Candida zeylanoides. | Candida zeylanoides | ||
CANDIDA | C77163 | Any fungal organism that is not assigned to the species level but can be assigned to the Candida genus level. | Candida | |||
CAPILLARIA PHILIPPINENSIS | C122257 | Paracapillaria philippinensis | Any nematode parasite that can be assigned to the species Capillaria philippinensis. | Capillaria philippinensis | ||
CAPILLARIA | C122044 | Hairworm | Any nematode parasite that is not assigned to the species level but can be assigned to the Capillaria genus level. | Capillaria | ||
CAPNOCYTOPHAGA CANIMORSUS | C86239 | Any bacterial organism that can be assigned to the species Capnocytophaga canimorsus. | Capnocytophaga canimorsus | |||
CAPNOCYTOPHAGA GINGIVALIS | C86240 | Any bacterial organism that can be assigned to the species Capnocytophaga gingivalis. | Capnocytophaga gingivalis | |||
CAPNOCYTOPHAGA OCHRACEA | C86241 | Any bacterial organism that can be assigned to the species Capnocytophaga ochracea. | Capnocytophaga ochracea | |||
CAPNOCYTOPHAGA SPUTIGENA | C86242 | Any bacterial organism that can be assigned to the species Capnocytophaga sputigena. | Capnocytophaga sputigena | |||
CAPNOCYTOPHAGA | C76269 | Any bacteria that is not assigned to the species level but can be assigned to the Capnocytophaga genus level. | Capnocytophaga | |||
CARBAPENEM RESISTANT ACINETOBACTER | C150879 | Any bacterial organism that can be assigned to the genus Acinetobacter and is resistant to the antibiotic carbapenem. | Carbapenem Resistant Acinetobacter | |||
CARDIOBACTERIUM HOMINIS | C86244 | Any bacterial organism that can be assigned to the species Cardiobacterium hominis. | Cardiobacterium hominis | |||
CARDIOBACTERIUM | C86243 | Any bacteria that is not assigned to the species level but can be assigned to the Cardiobacterium genus level. | Cardiobacterium | |||
CEDECEA DAVISAE | C86246 | Any bacterial organism that can be assigned to the species Cedecea davisae. | Cedecea davisae | |||
CEDECEA LAPAGEI | C86247 | Any bacterial organism that can be assigned to the species Cedecea lapagei. | Cedecea lapagei | |||
CEDECEA NETERI | C86248 | Cedecea Species 4 | Any bacterial organism that can be assigned to the species Cedecea neteri. | Cedecea neteri | ||
CEDECEA | C86245 | Any bacteria that is not assigned to the species level but can be assigned to the Cedecea genus level. | Cedecea | |||
CELLULOMONAS HOMINIS | C86250 | Any bacterial organism that can be assigned to the species Cellulomonas hominis. | Cellulomonas hominis | |||
CELLULOMONAS | C86249 | Any bacteria that is not assigned to the species level but can be assigned to the Cellulomonas genus level. | Cellulomonas | |||
CELLULOSIMICROBIUM CELLULANS | C86252 | Arthrobacter luteus;Cellulomonas cellulans;Nocardia cellulans;Oerskovia xanthineolytica | Any bacterial organism that can be assigned to the species Cellulosimicrobium cellulans. | Cellulosimicrobium cellulans | ||
CELLULOSIMICROBIUM | C86251 | Any bacteria that is not assigned to the species level but can be assigned to the Cellulosimicrobium genus level. | Cellulosimicrobium | |||
CESTODA | C122045 | Tapeworm | Any parasitic flatworm that is not assigned to the species level but can be assigned to the Cestoda class level. | Cestoda | ||
CHAETOMIUM | C122258 | Any fungal organism that is not assigned to the species level but can be assigned to the Chaetomium genus level. | Chaetomium | |||
CHIKUNGUNYA VIRUS | C125638 | Any viral organism that can be assigned to the species Chikungunya virus. | Chikungunya Virus | |||
CHILOMASTIX MESNILI | C122259 | Any unicellular, eukaryotic organism that can be assigned to the species Chilomastix mesnili. | Chilomastix mesnili | |||
CHLAMYDIA PNEUMONIAE | C76272 | Chlamydia pneumoniae;Chlamydophila pneumoniae | Any bacterial organism that can be assigned to the species Chlamydia pneumoniae. | Chlamydia pneumoniae | ||
CHLAMYDIA TRACHOMATIS | C86253 | Any bacterial organism that can be assigned to the species Chlamydia trachomatis. | Chlamydia trachomatis | |||
CHLAMYDIA | C76271 | Any bacteria that is not assigned to the species level but can be assigned to the Chlamydia genus level. | Chlamydia | |||
CHLAMYDOPHILA PSITTACI | C86255 | Chlamydia psittaci | Any bacterial organism that can be assigned to the species Chlamydophila psittaci. | Chlamydophila psittaci | ||
CHLAMYDOPHILA | C86254 | Any bacteria that is not assigned to the species level but can be assigned to the Chlamydophila genus level. | Chlamydophila | |||
CHROMOBACTERIUM VIOLACEUM | C86257 | Any bacterial organism that can be assigned to the species Chromobacterium violaceum. | Chromobacterium violaceum | |||
CHROMOBACTERIUM | C86256 | Any bacteria that is not assigned to the species level but can be assigned to the Chromobacterium genus level. | Chromobacterium | |||
CHRYSEOBACTERIUM GLEUM | C86259 | Flavobacterium gleum | Any bacterial organism that can be assigned to the species Chryseobacterium gleum. | Chryseobacterium gleum | ||
CHRYSEOBACTERIUM INDOLOGENES | C86260 | Flavobacterium indologenes | Any bacterial organism that can be assigned to the species Chryseobacterium indologenes. | Chryseobacterium indologenes | ||
CHRYSEOBACTERIUM | C86258 | Any bacteria that is not assigned to the species level but can be assigned to the Chryseobacterium genus level. | Chryseobacterium | |||
CHRYSEOMONAS | C86261 | Any bacteria that is not assigned to the species level but can be assigned to the Chryseomonas genus level. | Chryseomonas | |||
CHRYSOSPORIUM | C122260 | Any fungal organism that is not assigned to the species level but can be assigned to the Chrysosporium genus level. | Chrysosporium | |||
CITROBACTER AMALONATICUS | C86262 | Levinea amalonatica | Any bacterial organism that can be assigned to the species Citrobacter amalonaticus. | Citrobacter amalonaticus | ||
CITROBACTER BRAAKII | C86263 | Any bacterial organism that can be assigned to the species Citrobacter braakii. | Citrobacter braakii | |||
CITROBACTER FARMERI | C86264 | Citrobacter amalonaticus Biogroup 1 | Any bacterial organism that can be assigned to the species Citrobacter farmeri. | Citrobacter farmeri | ||
CITROBACTER FREUNDII COMPLEX | C86266 | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Citrobacter freundii species. | Citrobacter freundii Complex | |||
CITROBACTER FREUNDII | C86265 | Colobactrum freundii | Any bacterial organism that can be assigned to the species Citrobacter freundii. | Citrobacter freundii | ||
CITROBACTER KOSERI | C86267 | Citrobacter diversus | Any bacterial organism that can be assigned to the species Citrobacter koseri. | Citrobacter koseri | ||
CITROBACTER WERKMANII | C139100 | Citrobacter Genomospecies 7 | Any bacterial organism that can be assigned to the species Citrobacter werkmanii. | Citrobacter werkmanii | ||
CITROBACTER YOUNGAE | C86268 | Any bacterial organism that can be assigned to the species Citrobacter youngae. | Citrobacter youngae | |||
CITROBACTER | C76273 | Any bacteria that is not assigned to the species level but can be assigned to the Citrobacter genus level. | Citrobacter | |||
CLADOSPORIUM HERBARUM | C187903 | Byssus herbarum;Dematium herbarum | Any fungal organism that can be assigned to the species Cladosporium herbarum. | Cladosporium herbarum | ||
CLADOSPORIUM | C122261 | Any fungal organism that is not assigned to the species level but can be assigned to the Cladosporium genus level. | Cladosporium | |||
CLAVISPORA LUSITANIAE | C77174 | Candida lusitaniae | Any fungal organism that can be assigned to the species Clavispora lusitaniae. | Clavispora lusitaniae | ||
CLONORCHIS SINENSIS | C122262 | Oriental liver fluke | Any trematode parasite that can be assigned to the species Clonorchis sinensis. | Clonorchis sinensis | ||
CLOSTRIDIUM ACETOBUTYLICUM | C86269 | Any bacterial organism that can be assigned to the species Clostridium acetobutylicum. | Clostridium acetobutylicum | |||
CLOSTRIDIUM ALDENENSE | C122263 | Any bacterial organism that can be assigned to the species Clostridium aldenense. | Clostridium aldenense | |||
CLOSTRIDIUM BARATII | C86270 | Clostridium barati | Any bacterial organism that can be assigned to the species Clostridium baratii. | Clostridium baratii | ||
CLOSTRIDIUM BEIJERINCKII | C86271 | Any bacterial organism that can be assigned to the species Clostridium beijerinckii. | Clostridium beijerinckii | |||
CLOSTRIDIUM BIFERMENTANS | C86272 | Paraclostridium bifermentans | Any bacterial organism that can be assigned to the species Clostridium bifermentans. | Clostridium bifermentans | ||
CLOSTRIDIUM BOLTEAE | C114250 | Any bacterial organism that can be assigned to the species Clostridium bolteae. | Clostridium bolteae | |||
CLOSTRIDIUM BUTYRICUM | C86273 | Clostridium pseudotetanicum | Any bacterial organism that can be assigned to the species Clostridium butyricum. | Clostridium butyricum | ||
CLOSTRIDIUM CADAVERIS | C86274 | Any bacterial organism that can be assigned to the species Clostridium cadaveris. | Clostridium cadaveris | |||
CLOSTRIDIUM CELATUM | C86275 | Any bacterial organism that can be assigned to the species Clostridium celatum. | Clostridium celatum | |||
CLOSTRIDIUM CITRONIAE | C122264 | Any bacterial organism that can be assigned to the species Clostridium citroniae. | Clostridium citroniae | |||
CLOSTRIDIUM CLOSTRIDIOFORME | C86276 | Clostridium clostridiiforme | Any bacterial organism that can be assigned to the species Clostridium clostridioforme. | Clostridium clostridioforme | ||
CLOSTRIDIUM COCHLEARIUM | C86277 | Any bacterial organism that can be assigned to the species Clostridium cochlearium. | Clostridium cochlearium | |||
CLOSTRIDIUM COCLEATUM | C86278 | Any bacterial organism that can be assigned to the species Clostridium cocleatum. | Clostridium cocleatum | |||
CLOSTRIDIUM COLICANIS | C187904 | Any bacterial organism that can be assigned to the species Clostridium colicanis. | Clostridium colicanis | |||
CLOSTRIDIUM DIFFICILE | C76276 | Clostridioides difficile;Clostridium difficilis | Any bacterial organism that can be assigned to the species Clostridium difficile. | Clostridium difficile | ||
CLOSTRIDIUM FALLAX | C86279 | Clostridium pseudofallax | Any bacterial organism that can be assigned to the species Clostridium fallax. | Clostridium fallax | ||
CLOSTRIDIUM GLYCOLICUM | C86280 | Any bacterial organism that can be assigned to the species Clostridium glycolicum. | Clostridium glycolicum | |||
CLOSTRIDIUM HAEMOLYTICUM | C86281 | Any bacterial organism that can be assigned to the species Clostridium haemolyticum. | Clostridium haemolyticum | |||
CLOSTRIDIUM HATHEWAYI | C114251 | Any bacterial organism that can be assigned to the species Clostridium hathewayi. | Clostridium hathewayi | |||
CLOSTRIDIUM HISTOLYTICUM | C86282 | Any bacterial organism that can be assigned to the species Clostridium histolyticum. | Clostridium histolyticum | |||
CLOSTRIDIUM INNOCUUM | C86283 | Any bacterial organism that can be assigned to the species Clostridium innocuum. | Clostridium innocuum | |||
CLOSTRIDIUM LIMOSUM | C86284 | Any bacterial organism that can be assigned to the species Clostridium limosum. | Clostridium limosum | |||
CLOSTRIDIUM NOVYI | C86285 | Any bacterial organism that can be assigned to the species Clostridium novyi. | Clostridium novyi | |||
CLOSTRIDIUM OCEANICUM | C86286 | Any bacterial organism that can be assigned to the species Clostridium oceanicum. | Clostridium oceanicum | |||
CLOSTRIDIUM OROTICUM | C122265 | Zymobacterium oroticum | Any bacterial organism that can be assigned to the species Clostridium oroticum. | Clostridium oroticum | ||
CLOSTRIDIUM PARAPUTRIFICUM | C86287 | Any bacterial organism that can be assigned to the species Clostridium paraputrificum. | Clostridium paraputrificum | |||
CLOSTRIDIUM PERFRINGENS | C86288 | Clostridium welchii | Any bacterial organism that can be assigned to the species Clostridium perfringens. | Clostridium perfringens | ||
CLOSTRIDIUM PUTRIFICUM | C86289 | Clostridium lentoputrescens | Any bacterial organism that can be assigned to the species Clostridium putrificum. | Clostridium putrificum | ||
CLOSTRIDIUM RAMOSUM | C86290 | Actinomyces ramosus | Any bacterial organism that can be assigned to the species Clostridium ramosum. | Clostridium ramosum | ||
CLOSTRIDIUM RECTUM | C86291 | Any bacterial organism that can be assigned to the species Clostridium rectum. | Clostridium rectum | |||
CLOSTRIDIUM SARTAGOFORME | C119325 | Any bacterial organism that can be assigned to the species Clostridium sartagoforme. | Clostridium sartagoforme | |||
CLOSTRIDIUM SEPTICUM | C86292 | Any bacterial organism that can be assigned to the species Clostridium septicum. | Clostridium septicum | |||
CLOSTRIDIUM SORDELLII | C86293 | Paeniclostridium sordellii | Any bacterial organism that can be assigned to the species Clostridium sordellii. | Clostridium sordellii | ||
CLOSTRIDIUM SPIROFORME | C122266 | Any bacterial organism that can be assigned to the species Clostridium spiroforme. | Clostridium spiroforme | |||
CLOSTRIDIUM SPOROGENES | C86294 | Any bacterial organism that can be assigned to the species Clostridium sporogenes. | Clostridium sporogenes | |||
CLOSTRIDIUM SUBTERMINALE | C86295 | Any bacterial organism that can be assigned to the species Clostridium subterminale. | Clostridium subterminale | |||
CLOSTRIDIUM SYMBIOSUM | C86296 | Bacteroides symbiosus | Any bacterial organism that can be assigned to the species Clostridium symbiosum. | Clostridium symbiosum | ||
CLOSTRIDIUM TERTIUM | C86297 | Any bacterial organism that can be assigned to the species Clostridium tertium. | Clostridium tertium | |||
CLOSTRIDIUM TETANI | C86298 | Any bacterial organism that can be assigned to the species Clostridium tetani. | Clostridium tetani | |||
CLOSTRIDIUM TYROBUTYRICUM | C86299 | Any bacterial organism that can be assigned to the species Clostridium tyrobutyricum. | Clostridium tyrobutyricum | |||
CLOSTRIDIUM | C76275 | Any bacteria that is not assigned to the species level but can be assigned to the Clostridium genus level. | Clostridium | |||
COAGULASE NEGATIVE STAPHYLOCOCCUS | C62584 | Any bacteria assigned to the genus Staphylococcus that does not express the enzyme coagulase. | Coagulase-Negative Staphylococcus | |||
COAGULASE POSITIVE STAPHYLOCOCCUS | C62585 | Any bacteria assigned to the genus Staphylococcus that expresses the enzyme coagulase. | Coagulase-Positive Staphylococcus | |||
COCCIDIOIDES IMMITIS | C117354 | Ascomycete fungi | Any fungal organism that can be assigned to the species Coccidioides immitis. | Coccidioides immitis | ||
COCCIDIOIDES | C187905 | Any fungal organism that is not assigned to the species level but can be assigned to the Coccidioides genus level. | Coccidioides | |||
COLIFORM BACTERIA | C122046 | A non-taxonomic grouping of rod-shaped, gram-negative, non-spore forming bacteria that ferment lactose, producing acid and gas. | Coliform Bacteria | |||
COLIFORM BACTERIA, LACTOSE FERMENTING | C122267 | A non-taxonomic grouping of coliform bacteria that can ferment lactose. | Coliform Bacteria, Lactose Fermenting | |||
COLIFORM BACTERIA, NON-LACTOSE FERMENTING | C122268 | A non-taxonomic grouping of coliform bacteria that cannot ferment lactose. | Coliform Bacteria, Non-Lactose Fermenting | |||
COLLINSELLA AEROFACIENS | C86301 | Eubacterium aerofaciens | Any bacterial organism that can be assigned to the species Collinsella aerofaciens. | Collinsella aerofaciens | ||
COLLINSELLA INTESTINALIS | C86302 | Any bacterial organism that can be assigned to the species Collinsella intestinalis. | Collinsella intestinalis | |||
COLLINSELLA | C86300 | Any bacteria that is not assigned to the species level but can be assigned to the Collinsella genus level. | Collinsella | |||
COLORADO TICK FEVER VIRUS | C112240 | CTFV | Any viral organism that can be assigned to the species Colorado tick fever virus. | Colorado Tick Fever Virus | ||
COMAMONAS TERRIGENA | C86304 | Any bacterial organism that can be assigned to the species Comamonas terrigena. | Comamonas terrigena | |||
COMAMONAS TESTOSTERONI | C86305 | Pseudomonas testosteroni | Any bacterial organism that can be assigned to the species Comamonas testosteroni. | Comamonas testosteroni | ||
COMAMONAS | C86303 | Any bacteria that is not assigned to the species level but can be assigned to the Comamonas genus level. | Comamonas | |||
CONIOCHAETA | C123468 | Lecythophora | Any fungal organism that is not assigned to the species level but can be assigned to the Coniochaeta genus level. | Coniochaeta | ||
COPRINELLUS RADIANS | C127699 | Coprinus radians | Any fungal organism that can be assigned to the species Coprinellus radians. | Coprinellus radians | ||
CORONAVIRIDAE | C113205 | Any viral organism that can be assigned to the family Coronaviridae. | Coronaviridae | |||
CORYNEBACTERIUM ACCOLENS | C86306 | CDC Coryneform Group G-1 | Any bacterial organism that can be assigned to the species Corynebacterium accolens. | Corynebacterium accolens | ||
CORYNEBACTERIUM AFERMENTANS | C86307 | Corynebacterium ANF-1 | Any bacterial organism that can be assigned to the species Corynebacterium afermentans. | Corynebacterium afermentans | ||
CORYNEBACTERIUM AMYCOLATUM | C86308 | Any bacterial organism that can be assigned to the species Corynebacterium amycolatum. | Corynebacterium amycolatum | |||
CORYNEBACTERIUM ARGENTORATENSE | C86309 | Any bacterial organism that can be assigned to the species Corynebacterium argentoratense. | Corynebacterium argentoratense | |||
CORYNEBACTERIUM AURIMUCOSUM | C127700 | Corynebacterium nigricans | Any bacterial organism that can be assigned to the species Corynebacterium aurimucosum. | Corynebacterium aurimucosum | ||
CORYNEBACTERIUM AURIS | C86310 | Any bacterial organism that can be assigned to the species Corynebacterium auris. | Corynebacterium auris | |||
CORYNEBACTERIUM BOVIS | C86311 | Any bacterial organism that can be assigned to the species Corynebacterium bovis. | Corynebacterium bovis | |||
CORYNEBACTERIUM COYLEAE | C122269 | Any bacterial organism that can be assigned to the species Corynebacterium coyleae. | Corynebacterium coyleae | |||
CORYNEBACTERIUM DIPHTHERIAE TYPE GRAVIS | C122270 | Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae subspecies gravis. | Corynebacterium diphtheriae bv. gravis | |||
CORYNEBACTERIUM DIPHTHERIAE TYPE INTERMEDIUS | C122271 | Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae subspecies intermedius. | Corynebacterium diphtheriae bv. intermedius | |||
CORYNEBACTERIUM DIPHTHERIAE TYPE MITIS | C122272 | Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae subspecies mitis. | Corynebacterium diphtheriae bv. mitis | |||
CORYNEBACTERIUM DIPHTHERIAE VAR. BELFANTI | C122273 | Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae subspecies belfanti. | Corynebacterium diphtheriae bv. belfanti | |||
CORYNEBACTERIUM DIPHTHERIAE | C86312 | Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae. | Corynebacterium diphtheriae | |||
CORYNEBACTERIUM GENITALIUM | C86313 | Any bacterial organism that can be assigned to the species Corynebacterium genitalium. | Corynebacterium genitalium | |||
CORYNEBACTERIUM GLUCURONOLYTICUM | C86955 | Any bacterial organism that can be assigned to the species Corynebacterium glucuronolyticum. | Corynebacterium glucuronolyticum | |||
CORYNEBACTERIUM JEIKEIUM | C76307 | CDC Coryneform Group JK | Any bacterial organism that can be assigned to the species Corynebacterium jeikeium. | Corynebacterium jeikeium | ||
CORYNEBACTERIUM KUTSCHERI | C86314 | Any bacterial organism that can be assigned to the species Corynebacterium kutscheri. | Corynebacterium kutscheri | |||
CORYNEBACTERIUM MACGINLEYI | C86315 | Any bacterial organism that can be assigned to the species Corynebacterium macginleyi. | Corynebacterium macginleyi | |||
CORYNEBACTERIUM MATRUCHOTII | C86316 | Bacterionema matruchotii | Any bacterial organism that can be assigned to the species Corynebacterium matruchotii. | Corynebacterium matruchotii | ||
CORYNEBACTERIUM MINUTISSIMUM | C86317 | Any bacterial organism that can be assigned to the species Corynebacterium minutissimum. | Corynebacterium minutissimum | |||
CORYNEBACTERIUM MUCIFACIENS | C122274 | Any bacterial organism that can be assigned to the species Corynebacterium mucifaciens. | Corynebacterium mucifaciens | |||
CORYNEBACTERIUM PILOSUM | C86318 | Any bacterial organism that can be assigned to the species Corynebacterium pilosum. | Corynebacterium pilosum | |||
CORYNEBACTERIUM PROPINQUUM | C86319 | Any bacterial organism that can be assigned to the species Corynebacterium propinquum. | Corynebacterium propinquum | |||
CORYNEBACTERIUM PSEUDODIPHTHERITICUM | C86320 | Corynebacterium hofmannii | Any bacterial organism that can be assigned to the species Corynebacterium pseudodiphtheriticum. | Corynebacterium pseudodiphtheriticum | ||
CORYNEBACTERIUM PSEUDOTUBERCULOSIS | C86321 | Any bacterial organism that can be assigned to the species Corynebacterium pseudotuberculosis. | Corynebacterium pseudotuberculosis | |||
CORYNEBACTERIUM RENALE | C86322 | Any bacterial organism that can be assigned to the species Corynebacterium renale. | Corynebacterium renale | |||
CORYNEBACTERIUM SIMULANS | C122275 | Any bacterial organism that can be assigned to the species Corynebacterium simulans. | Corynebacterium simulans | |||
CORYNEBACTERIUM STRIATUM | C86323 | Any bacterial organism that can be assigned to the species Corynebacterium striatum. | Corynebacterium striatum | |||
CORYNEBACTERIUM TUBERCULOSTEARICUM | C114249 | Any bacterial organism that can be assigned to the species Corynebacterium tuberculostearicum. | Corynebacterium tuberculostearicum | |||
CORYNEBACTERIUM ULCERANS | C86324 | Any bacterial organism that can be assigned to the species Corynebacterium ulcerans. | Corynebacterium ulcerans | |||
CORYNEBACTERIUM UREALYTICUM | C86325 | CDC Coryneform Group D-2 | Any bacterial organism that can be assigned to the species Corynebacterium urealyticum. | Corynebacterium urealyticum | ||
CORYNEBACTERIUM XEROSIS | C86326 | Any bacterial organism that can be assigned to the species Corynebacterium xerosis. | Corynebacterium xerosis | |||
CORYNEBACTERIUM | C76308 | Any bacteria that is not assigned to the species level but can be assigned to the Corynebacterium genus level. | Corynebacterium | |||
CORYNEFORM GRAM-POSITIVE BACILLUS | C86327 | Coryneform Gram-positive Rod | Any bacteria whose shape is similar to those bacteria assigned to the Corynebacterium genus and have a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Coryneform Gram Positive Bacillus | ||
COXIELLA BURNETII | C86328 | Any bacterial organism that can be assigned to the species Coxiella burnetii. | Coxiella burnetii | |||
COXIELLA | C76309 | Any bacteria that is not assigned to the species level but can be assigned to the Coxiella genus level. | Coxiella | |||
COXSACKIE A VIRUS | C112242 | Coxsackie Virus A | Any viral organism that can be assigned to the Human Enterovirus A, B and/or C species and subtype Coxsackie A virus. | Coxsackie A Virus | ||
COXSACKIE B VIRUS | C112243 | Coxsackie Virus B | Any viral organism that can be assigned to the Human Enterovirus B species and subtype Coxsackie B virus. | Coxsackie B Virus | ||
CRONOBACTER SAKAZAKII | C86329 | Enterobacter sakazakii | Any bacterial organism that can be assigned to the species Cronobacter sakazakii. | Cronobacter sakazakii | ||
CRYPTOCOCCUS ALBIDUS VAR. ALBIDUS | C127701 | Any fungal organism that can be assigned to the species Cryptococcus albidus variant albidus. | Cryptococcus albidus Var. albidus | |||
CRYPTOCOCCUS ALBIDUS | C114267 | Rhodotorula albida;Torula albida;Torulopsis albida;Torulopsis nadaensis;Torulopsis neoformans var. albida | Any fungal organism that can be assigned to the species Cryptococcus albidus. | Cryptococcus albidus | ||
CRYPTOCOCCUS DIFFLUENS | C127702 | Cryptococcus albidus var. diffluens;Cryptococcus diffluens var. diffluens;Torulopsis diffluens | Any fungal organism that can be assigned to the species Cryptococcus diffluens. | Cryptococcus diffluens | ||
CRYPTOCOCCUS GATTII | C114268 | Cryptococcus bacillisporus | Any fungal organism that can be assigned to the species Cryptococcus gattii. | Cryptococcus gattii | ||
CRYPTOCOCCUS LAURENTII | C114269 | Any fungal organism that can be assigned to the species Cryptococcus laurentii. | Cryptococcus laurentii | |||
CRYPTOCOCCUS NEOFORMANS | C14195 | Blastomyces neoformans;Debaryomyces neoformans;Lipomyces neoformans;Saccharomyces neoformans;Torula neoformans;Torulopsis neoformans | Any fungal organism that can be assigned to the species Cryptococcus neoformans. | Cryptococcus neoformans | ||
CRYPTOCOCCUS RANDHAWII | C114266 | Any fungal organism that can be assigned to the species Cryptococcus randhawii. | Cryptococcus randhawii | |||
CRYPTOCOCCUS TERREUS | C127703 | Any fungal organism that can be assigned to the species Cryptococcus terreus. | Cryptococcus terreus | |||
CRYPTOCOCCUS | C77184 | Any fungal organism that is not assigned to the species level but can be assigned to the Cryptococcus genus level. | Cryptococcus | |||
CRYPTOSPORIDIUM PARVUM | C122276 | Any unicellular, eukaryotic organism that can be assigned to the species Cryptosporidium parvum. | Cryptosporidium parvum | |||
CRYPTOSPORIDIUM | C77214 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Cryptosporidium genus level. | Cryptosporidium | |||
CUPRIAVIDUS PAUCULUS | C86331 | CDC Group IVc-2;Ralstonia paucula;Wautersia paucula | Any bacterial organism that can be assigned to the species Cupriavidus pauculus. | Cupriavidus pauculus | ||
CUPRIAVIDUS | C86330 | Any bacteria that is not assigned to the species level but can be assigned to the Cupriavidus genus level. | Cupriavidus | |||
CURVED BACILLUS | C184698 | Curved Rods | Any rod-shaped bacteria that also appear curved. | Curved Bacillus | ||
CURVULARIA | C122277 | Any fungal organism that is not assigned to the species level but can be assigned to the Curvularia genus level. | Curvularia | |||
CYCLOSPORA CAYETANENSIS | C122278 | Cyclospora cayetanesis | Any unicellular, eukaryotic organism that can be assigned to the species Cyclospora cayetanensis. | Cyclospora cayetanensis | ||
CYCLOSPORA | C122047 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Cyclospora genus level. | Cyclospora | |||
CYSTOBASIDIUM MINUTUM | C127704 | Rhodotorula minuta;Torula minuta | Any fungal organism that can be assigned to the species Cystobasidium minutum. | Cystobasidium minutum | ||
CYSTOISOSPORA BELLI | C123647 | Isospora belli | Any unicellular, eukaryotic organism that can be assigned to the species Cystoisospora belli. | Cystoisospora belli | ||
CYTOMEGALOVIRUS | C14196 | Any viral organism that can be assigned to the genus Cytomegalovirus. | Cytomegalovirus | |||
DELFTIA ACIDOVORANS | C86333 | Comamonas acidovorans;Pseudomonas acidovorans | Any bacterial organism that can be assigned to the species Delftia acidovorans. | Delftia acidovorans | ||
DELFTIA | C86332 | Any bacteria that is not assigned to the species level but can be assigned to the Delftia genus level. | Delftia | |||
DELTACORONAVIRUS | C122279 | Coronavirus Group 3 | Any viral organism that can be assigned to the genus Deltacoronavirus. | Deltacoronavirus | ||
DELTARETROVIRUS | C14347 | Any viral organism that can be assigned to the genus Deltaretrovirus. | Deltaretrovirus | |||
DENGUE VIRUS 1 | C112266 | DEN-1;Dengue Virus Type 1;DENV-1 | Any viral organism that can be assigned to the Dengue virus serotype 1. | Dengue Virus 1 | ||
DENGUE VIRUS 2 | C112267 | DEN-2;Dengue Virus Type 2;DENV-2 | Any viral organism that can be assigned to the Dengue virus serotype 2. | Dengue Virus 2 | ||
DENGUE VIRUS 3 | C112268 | DEN-3;Dengue Virus Type 3;DENV-3 | Any viral organism that can be assigned to the Dengue virus serotype 3. | Dengue Virus 3 | ||
DENGUE VIRUS 4 | C112269 | DEN-4;Dengue Virus Type 4;DENV-4 | Any viral organism that can be assigned to the Dengue virus serotype 4. | Dengue Virus 4 | ||
DENGUE VIRUS | C112036 | Any viral organism that can be assigned to the species Dengue virus. | Dengue Virus | |||
DERMABACTER HOMINIS | C86335 | Any bacterial organism that can be assigned to the species Dermabacter hominis. | Dermabacter hominis | |||
DERMABACTER | C86334 | Any bacteria that is not assigned to the species level but can be assigned to the Dermabacter genus level. | Dermabacter | |||
DERMACOCCUS NISHINOMIYAENSIS | C86336 | Micrococcus nishinomiyaensis | Any bacterial organism that can be assigned to the species Dermacoccus nishinomiyaensis. | Dermacoccus nishinomiyaensis | ||
DERMATOPHILUS CONGOLENSIS | C86338 | Any bacterial organism that can be assigned to the species Dermatophilus congolensis. | Dermatophilus congolensis | |||
DERMATOPHILUS | C86337 | Any bacteria that is not assigned to the species level but can be assigned to the Dermatophilus genus level. | Dermatophilus | |||
DESULFOVIBRIO DESULFURICANS | C86340 | Any bacterial organism that can be assigned to the species Desulfovibrio desulfuricans. | Desulfovibrio desulfuricans | |||
DESULFOVIBRIO FAIRFIELDENSIS | C86341 | Any bacterial organism that can be assigned to the species Desulfovibrio fairfieldensis. | Desulfovibrio fairfieldensis | |||
DESULFOVIBRIO PIGER | C86342 | Desulfomonas pigra | Any bacterial organism that can be assigned to the species Desulfovibrio piger. | Desulfovibrio piger | ||
DESULFOVIBRIO | C86339 | Desulfomonas | Any bacteria that is not assigned to the species level but can be assigned to the Desulfovibrio genus level. | Desulfovibrio | ||
DIALISTER MICRAEROPHILUS | C122280 | Any bacterial organism that can be assigned to the species Dialister micraerophilus. | Dialister micraerophilus | |||
DIALISTER PNEUMOSINTES | C122281 | Bacillus pneumosintes;Bacteroides pneumosintes | Any bacterial organism that can be assigned to the species Dialister pneumosintes. | Dialister pneumosintes | ||
DICKEYA DADANTII | C127705 | Any bacterial organism that can be assigned to the species Dickeya dadantii. | Dickeya dadantii | |||
DIENTAMOEBA FRAGILIS | C122282 | Any unicellular, eukaryotic organism that can be assigned to the species Dientamoeba fragilis. | Dientamoeba fragilis | |||
DIFFUSELY ADHERING ESCHERICHIA COLI | C187906 | DAEC;Diffusely Adhering E. coli | Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype diffusely adhering. DAEC causes urinary tract infections (UTIs), pregnancy complications, and diarrhea in children of ages 18 months to 5 years. | Diffusely Adhering Escherichia coli | ||
DIPETALONEMA | C122283 | Any nematode parasite that is not assigned to the species level but can be assigned to the Dipetalonema genus level. | Dipetalonema | |||
DIPHTHEROID BACILLUS | C86343 | Any of a number of rod-shaped bacteria that resemble Corynebacterium diphtheriae, either in morphology or etiology. | Diptheroid Bacillus | |||
DIPHYLLOBOTHRIUM LATUM | C122284 | Broad Fish Tapeworm | Any cestode parasite that can be assigned to the species Diphyllobothrium latum. | Diphyllobothrium latum | ||
DIPYLIDIUM CANINUM | C122285 | Cucumber Tapeworm;Double-pore Tapeworm;Flea Tapeworm | Any cestode parasite that can be assigned to the species Dipylidium caninum. | Dipylidium caninum | ||
DOLOSIGRANULUM PIGRUM | C122286 | Any bacterial organism that can be assigned to the species Dolosigranulum pigrum. | Dolosigranulum pigrum | |||
DOREA | C122287 | Any bacterial organism that can be assigned to the genus Dorea. | Dorea | |||
DRACUNCULUS MEDINENSIS | C122288 | Guinea worm | Any nematode parasite that can be assigned to the species Dracunculus medinensis. | Dracunculus medinensis | ||
EBOLA VIRUS | C112271 | EBOV | Any viral organism that can be assigned to the genus Ebola virus. | Ebola Virus | ||
ECHINOCOCCUS GRANULOSUS | C122289 | Hydatid Worm;Hyper Tapeworm | Any cestode parasite that can be assigned to the species Echinococcus granulosus. | Echinococcus granulosus | ||
ECHINOCOCCUS MULTILOCULARIS | C122290 | Any cestode parasite that can be assigned to the species Echinococcus multilocularis. | Echinococcus multilocularis | |||
ECHINOCOCCUS VOGELI | C122291 | Any cestode parasite that can be assigned to the species Echinococcus vogeli. | Echinococcus vogeli | |||
ECHOVIRUS | C112272 | Any viral organism that can be assigned to the species Echovirus. | Echovirus | |||
EDWARDSIELLA HOSHINAE | C86345 | Any bacterial organism that can be assigned to the species Edwardsiella hoshinae. | Edwardsiella hoshinae | |||
EDWARDSIELLA ICTALURI | C86346 | Any bacterial organism that can be assigned to the species Edwardsiella ictaluri. | Edwardsiella ictaluri | |||
EDWARDSIELLA TARDA | C86347 | Any bacterial organism that can be assigned to the species Edwardsiella tarda. | Edwardsiella tarda | |||
EDWARDSIELLA | C86344 | Any bacteria that is not assigned to the species level but can be assigned to the Edwardsiella genus level. | Edwardsiella | |||
EGGERTHELLA LENTA | C86349 | Eubacterium lentum | Any bacterial organism that can be assigned to the species Eggerthella lenta. | Eggerthella lenta | ||
EGGERTHELLA | C86348 | Any bacteria that is not assigned to the species level but can be assigned to the Eggerthella genus level. | Eggerthella | |||
EHRLICHIA | C122292 | Cowdria;Kurlovia;Nicollea | Any bacterial organism that is not assigned to the species level but can be assigned to the Ehrlichia genus level. | Ehrlichia | ||
EIKENELLA CORRODENS | C86351 | Any bacterial organism that can be assigned to the species Eikenella corrodens. | Eikenella corrodens | |||
EIKENELLA | C86350 | Any bacteria that is not assigned to the species level but can be assigned to the Eikenella genus level. | Eikenella | |||
ELIZABETHKINGIA MENINGOCEPTICA | C86353 | Chryseobacterium meningosepticum;Flavobacterium meningosepticum | Any bacterial organism that can be assigned to the species Elizabethkingia meningoceptica. | Elizabethkingia meningoceptica | ||
ELIZABETHKINGIA | C86352 | Any bacteria that is not assigned to the species level but can be assigned to the Elizabethkingia genus level. | Elizabethkingia | |||
EMPEDOBACTER BREVIS | C86355 | Flavobacterium breve | Any bacterial organism that can be assigned to the species Empedobacter brevis. | Empedobacter brevis | ||
EMPEDOBACTER | C86354 | Any bacteria that is not assigned to the species level but can be assigned to the Empedobacter genus level. | Empedobacter | |||
ENCEPHALITOZOON | C122293 | Septata | Any fungal organism that is not assigned to the species level but can be assigned to the Encephalitozoon genus level. | Encephalitozoon | ||
ENDOLIMAX NANA | C122294 | Any unicellular, eukaryotic organism that can be assigned to the species Endolimax nana. | Endolimax nana | |||
ENTAMOEBA COLI | C122295 | Any unicellular, eukaryotic organism that can be assigned to the species Entamoeba coli. | Entamoeba coli | |||
ENTAMOEBA DISPAR | C187907 | Any amoebic organism that can be assigned to the species Entamoeba dispar. | Entamoeba dispar | |||
ENTAMOEBA HARTMANNI | C122296 | Any unicellular, eukaryotic organism that can be assigned to the species Entamoeba hartmanni. | Entamoeba hartmanni | |||
ENTAMOEBA HISTOLYTICA | C122297 | Any unicellular, eukaryotic organism that can be assigned to the species Entamoeba histolytica. | Entamoeba histolytica | |||
ENTAMOEBA POLECKI | C122298 | Any unicellular, eukaryotic organism that can be assigned to the species Entamoeba polecki. | Entamoeba polecki | |||
ENTAMOEBA | C122048 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Entamoeba genus level. | Entamoeba | |||
ENTERIC BACTERIA | C127706 | Any rod-shaped bacterial organism that does not require oxygen to grow or respirate, cannot be assigned to a specific genus or species, has a cell wall that stains Gram-negative, and that occurs normally or pathogenically in the intestinal tracts of animals. | Enteric Bacteria | |||
ENTEROAGGREGATIVE ESCHERICHIA COLI | C187908 | EAEC;Enteroaggregative E. coli | Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enteroaggregative. EAEC causes acute or persistent watery diarrhea prevalent in developing countries and in the immunocompromised host. | Enteroaggregative Escherichia coli | ||
ENTEROBACTER AEROGENES | C86356 | Aerobacter aerogenes;Klebsiella aerogenes | Any bacterial organism that can be assigned to the species Enterobacter aerogenes. | Enterobacter aerogenes | ||
ENTEROBACTER AMNIGENUS | C86357 | Enterobacter amnigenus I | Any bacterial organism that can be assigned to the species Enterobacter amnigenus. | Enterobacter amnigenus | ||
ENTEROBACTER ASBURIAE | C86358 | CDC Enteric Group 17 | Any bacterial organism that can be assigned to the species Enterobacter asburiae. | Enterobacter asburiae | ||
ENTEROBACTER CANCEROGENUS | C86359 | CDC Enteric Group 19;Enterobacter taylorae | Any bacterial organism that can be assigned to the species Enterobacter cancerogenus. | Enterobacter cancerogenus | ||
ENTEROBACTER CLOACAE COMPLEX | C122299 | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Enterobacter cloacae species. | Enterobacter cloacae Complex | |||
ENTEROBACTER CLOACAE | C86360 | Any bacterial organism that can be assigned to the species Enterobacter cloacae. | Enterobacter cloacae | |||
ENTEROBACTER GERGOVIAE | C86361 | Any bacterial organism that can be assigned to the species Enterobacter gergoviae. | Enterobacter gergoviae | |||
ENTEROBACTER HORMAECHEI | C86362 | CDC Enteric Group 75 | Any bacterial organism that can be assigned to the species Enterobacter hormaechei. | Enterobacter hormaechei | ||
ENTEROBACTER | C76310 | Any bacteria that is not assigned to the species level but can be assigned to the Enterobacter genus level. | Enterobacter | |||
ENTEROBACTERIACEAE | C85932 | Enterobacteraceae | Any bacteria that is not assigned to the species level but can be assigned to the Enterobacteriaceae family level. | Enterobacteriaceae | ||
ENTEROBIUS VERMICULARIS | C122300 | Any nematode parasite that can be assigned to the species Enterobius vermicularis. | Enterobius vermicularis | |||
ENTEROCOCCUS AVIUM | C86364 | Streptococcus avium | Any bacterial organism that can be assigned to the species Enterococcus avium. | Enterococcus avium | ||
ENTEROCOCCUS CASSELIFLAVUS | C86365 | Any bacterial organism that can be assigned to the species Enterococcus casseliflavus. | Enterococcus casseliflavus | |||
ENTEROCOCCUS DISPAR | C86366 | Any bacterial organism that can be assigned to the species Enterococcus dispar. | Enterococcus dispar | |||
ENTEROCOCCUS DURANS | C86367 | Streptococcus durans | Any bacterial organism that can be assigned to the species Enterococcus durans. | Enterococcus durans | ||
ENTEROCOCCUS FAECALIS | C86368 | Streptococcus faecalis | Any bacterial organism that can be assigned to the species Enterococcus faecalis. | Enterococcus faecalis | ||
ENTEROCOCCUS FAECIUM | C86369 | Streptococcus faecium | Any bacterial organism that can be assigned to the species Enterococcus faecium. | Enterococcus faecium | ||
ENTEROCOCCUS GALLINARUM | C86370 | Any bacterial organism that can be assigned to the species Enterococcus gallinarum. | Enterococcus gallinarum | |||
ENTEROCOCCUS HIRAE | C86371 | Any bacterial organism that can be assigned to the species Enterococcus hirae. | Enterococcus hirae | |||
ENTEROCOCCUS MALODORATUS | C86372 | Any bacterial organism that can be assigned to the species Enterococcus malodoratus. | Enterococcus malodoratus | |||
ENTEROCOCCUS MUNDTII | C86373 | Any bacterial organism that can be assigned to the species Enterococcus mundtii. | Enterococcus mundtii | |||
ENTEROCOCCUS PSEUDOAVIUM | C86374 | Any bacterial organism that can be assigned to the species Enterococcus pseudoavium. | Enterococcus pseudoavium | |||
ENTEROCOCCUS RAFFINOSUS | C86375 | Any bacterial organism that can be assigned to the species Enterococcus raffinosus. | Enterococcus raffinosus | |||
ENTEROCOCCUS SACCHAROLYTICUS | C122301 | Streptococcus saccharolyticus | Any bacterial organism that can be assigned to the species Enterococcus saccharolyticus. | Enterococcus saccharolyticus | ||
ENTEROCOCCUS THAILANDICUS | C114243 | Enterococcus sanguinicola | Any bacterial organism that can be assigned to the species Enterococcus thailandicus. | Enterococcus thailandicus | ||
ENTEROCOCCUS | C76311 | Any bacteria that is not assigned to the species level but can be assigned to the Enterococcus genus level. | Enterococcus | |||
ENTEROCYTOZOON | C122302 | Any fungal organism that is not assigned to the species level but can be assigned to the Enterocytozoon genus level. | Enterocytozoon | |||
ENTEROHEMORRHAGIC ESCHERICHIA COLI | C184688 | EHEC;Enterohemorrhagic E. coli | Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enterohemorrhagic. EHEC is a subset of STEC, produces shiga toxin, and causes hemorrhagic colitis associated with the hemolytic uremic syndrome. | Enterohemorrhagic Escherichia coli | ||
ENTEROINVASIVE ESCHERICHIA COLI | C187909 | EIEC;Enteroinvasive E. coli | Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enterohemorrhagic. EIEC causes dysentery identical to that caused by Shigella sonnei. | Enteroinvasive Escherichia coli | ||
ENTEROMONAS HOMINIS | C122303 | Any unicellular, eukaryotic organism that can be assigned to the species Enteromonas hominis. | Enteromonas hominis | |||
ENTEROPATHOGENIC ESCHERICHIA COLI | C184690 | Enteropathogenic E. coli;EPEC | Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enteropathogenic. EPEC causes acute and chronic watery diarrhea in infants and children. | Enteropathogenic Escherichia coli | ||
ENTEROTOXIGENIC ESCHERICHIA COLI | C187910 | Enterotoxigenic E. coli;ETEC | Any bacterial organism that can be assigned to the species Escherichia coli, and is considered as the pathotype enterotoxigenic. ETEC causes watery diarrhea in infants and travelers. | Enterotoxigenic Escherichia coli | ||
ENTEROVIRUS | C14203 | Any viral organism that can be assigned to the genus Enterovirus. | Enterovirus | |||
EPICOCCUM | C122304 | Any fungal organism that is not assigned to the species level but can be assigned to the Epicoccum genus level. | Epicoccum | |||
EPIDERMOPHYTON FLOCCOSUM | C127707 | Acrothecium floccosum;Epidermophyton floccosum var. nigricans | Any fungal organism that can be assigned to the species Epidermophyton floccosum. | Epidermophyton floccosum | ||
EPSTEIN-BARR VIRUS | C14204 | EBV;HHV-4;Human Gammaherpesvirus 4;Human Herpesvirus 4 | Any viral organism that can be assigned to the species Epstein-Barr virus. | Epstein-Barr Virus | ||
ERYSIPELOTHRIX RHUSIOPATHIAE | C86377 | Any bacterial organism that can be assigned to the species Erysipelothrix rhusiopathiae. | Erysipelothrix rhusiopathiae | |||
ERYSIPELOTHRIX | C86376 | Erysipelothrix insidiosa | Any bacteria that is not assigned to the species level but can be assigned to the Erysipelothrix genus level. | Erysipelothrix | ||
ESCHERICHIA ALBERTII | C86378 | Any bacterial organism that can be assigned to the species Escherichia albertii. | Escherichia albertii | |||
ESCHERICHIA BLATTAE | C86379 | Any bacterial organism that can be assigned to the species Escherichia blattae. | Escherichia blattae | |||
ESCHERICHIA COLI K1 | C186197 | Any bacterial organism that can be assigned to the species Escherichia coli and strain K1. | Escherichia coli Strain K1 | |||
ESCHERICHIA COLI O157 (NOT H7) | C198214 | Any bacterial organism that can be assigned to the species Escherichia coli and serogroup O157, but does not include the H7 serotype. | Escherichia coli Serogroup O157 Not Including H7 Serotype | |||
ESCHERICHIA COLI O157 | C86882 | Any bacterial organism that can be assigned to the species Escherichia coli and serogroup O157. | Escherichia coli strain O157 | |||
ESCHERICHIA COLI O157:H7 | C86883 | Any bacterial organism that can be assigned to the species Escherichia coli and serotype O157:H7. | Escherichia coli Serotype O157:H7 | |||
ESCHERICHIA COLI O26 | C86884 | Any bacterial organism that can be assigned to the species Escherichia coli and serogroup O26. | Escherichia coli Serogroup O26 | |||
Escherichia coli Serogroup O111 | C86881 | Any bacterial organism that can be assigned to the species Escherichia coli and serogroup O111. | Escherichia coli strain O111 | |||
ESCHERICHIA COLI | C14206 | E. coli | Any bacterial organism that can be assigned to the species Escherichia coli. | Escherichia coli | ||
ESCHERICHIA COLI, ESBL | C122305 | Escherichia coli, Extended-spectrum Beta-lactamases | Any bacterial organism that can be assigned to the species Escherichia coli and produces extended-spectrum beta-lactamases (ESBL). | Escherichia coli, Extended-spectrum Beta-lactamase Positive | ||
ESCHERICHIA FERGUSONII | C86380 | CDC Enteric Group 10 | Any bacterial organism that can be assigned to the species Escherichia fergusonii. | Escherichia fergusonii | ||
ESCHERICHIA HERMANNII | C86381 | CDC Enteric Group 11 | Any bacterial organism that can be assigned to the species Escherichia hermannii. | Escherichia hermannii | ||
ESCHERICHIA VULNERIS | C86382 | CDC Enteric Group 1 | Any bacterial organism that can be assigned to the species Escherichia vulneris. | Escherichia vulneris | ||
ESCHERICHIA | C77208 | Any bacteria that is not assigned to the species level but can be assigned to the Escherichia genus level. | Escherichia | |||
EUBACTERIUM ALACTOLYTICUM | C86384 | Any bacterial organism that can be assigned to the species Eubacterium adactolyticum. | Eubacterium alactolyticum | |||
EUBACTERIUM CONTORTUM | C86385 | Any bacterial organism that can be assigned to the species Eubacterium contortum. | Eubacterium contortum | |||
EUBACTERIUM LIMOSUM | C86386 | Any bacterial organism that can be assigned to the species Eubacterium limosum. | Eubacterium limosum | |||
EUBACTERIUM NODATUM | C86387 | Any bacterial organism that can be assigned to the species Eubacterium nodatum. | Eubacterium nodatum | |||
EUBACTERIUM RECTALE | C86388 | Any bacterial organism that can be assigned to the species Eubacterium rectale. | Eubacterium rectale | |||
EUBACTERIUM VENTRIOSUM | C86389 | Any bacterial organism that can be assigned to the species Eubacterium ventriosum. | Eubacterium ventriosum | |||
EUBACTERIUM | C86383 | Any bacteria that is not assigned to the species level but can be assigned to the Eubacterium genus level. | Eubacterium | |||
EUROTIUM HERBARIORUM | C127708 | Aspergillus glaucus;Aspergillus herbariorum | Any fungal organism that can be assigned to the species Eurotium herbariorum. | Eurotium herbariorum | ||
EWINGELLA AMERICANA | C86391 | Any bacterial organism that can be assigned to the species Ewingella americana. | Ewingella americana | |||
EWINGELLA | C86390 | Any bacteria that is not assigned to the species level but can be assigned to the Ewingella genus level. | Ewingella | |||
EXIGUOBACTERIUM ACETYLICUM | C86886 | Brevibacterium acetylicum | Any bacterial organism that can be assigned to the species Exiguobacterium acetylicum. | Exiguobacterium acetylicum | ||
EXIGUOBACTERIUM | C86885 | Any bacteria that is not assigned to the species level but can be assigned to the Exiguobacterium genus level. | Exiguobacterium | |||
EXOPHIALA DERMATITIDIS | C127709 | Wangiella dermatitidis | Any fungal organism that can be assigned to the species Exophiala dermatitidis. | Exophiala dermatitidis | ||
EXOPHIALA JEANSELMEI | C127710 | Phialophora jeanselmei;Pullularia jeanselmei;Torula jeanselmei | Any fungal organism that can be assigned to the species Exophiala jeanselmei. | Exophiala jeanselmei | ||
EXSEROHILUM | C122306 | Any fungal organism that is not assigned to the species level but can be assigned to the Exserohilum genus level. | Exserohilum | |||
FACKLAMIA HOMINIS | C122307 | Any bacterial organism that can be assigned to the species Facklamia hominis. | Facklamia hominis | |||
FACKLAMIA | C86392 | Any bacteria that is not assigned to the species level but can be assigned to the Facklamia genus level. | Facklamia | |||
FAECALIBACTERIUM PRAUSNITZII | C86394 | Fusobacterium prausnitzii | Any bacterial organism that can be assigned to the species Faecalibacterium prausnitzii. | Faecalibacterium prausnitzii | ||
FAECALIBACTERIUM | C86393 | Any bacteria that is not assigned to the species level but can be assigned to the Faecalibacterium genus level. | Faecalibacterium | |||
FASCIOLA HEPATICA | C122308 | Sheep liver fluke | Any trematode parasite that can be assigned to the species Fasciola hepatica. | Fasciola hepatica | ||
FASCIOLOPSIS BUSKI | C122309 | Any trematode parasite that can be assigned to the species Fasciolopsis buski. | Fasciolopsis buski | |||
FERMENTATIVE GRAM-NEGATIVE BACILLUS | C86395 | Fermentative Gram-negative Rod | Any rod-shaped, anaerobic bacteria that can convert carbohydrates into acids and alcohols and has a cell wall contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Fermentative Gram Negative Bacillus | ||
FILOBASIDIUM UNIGUTTULATUM | C114265 | Cryptococcus neoformans var. uniguttulatus;Cryptococcus uniguttulatus;Eutorulopsis uniguttulata | Any fungal organism that can be assigned to the species Filobasidium uniguttulatum. | Filobasidium uniguttulatum | ||
FILOVIRIDAE | C112031 | Filovirus | Any viral organism that can be assigned to the family Filoviridae. | Filoviridae | ||
FINEGOLDIA MAGNA | C86888 | Peptostreptococcus magnus | Any bacterial organism that can be assigned to the species Finegoldia magna. | Finegoldia magna | ||
FINEGOLDIA | C86887 | Any bacteria that is not assigned to the species level but can be assigned to the Finegoldia genus level. | Finegoldia | |||
FLAVIVIRUS | C14208 | Any viral organism that can be assigned to the genus Flavivirus. | Flavivirus | |||
FLAVOBACTERIUM | C76320 | Any bacteria that is not assigned to the species level but can be assigned to the Flavobacterium genus level. | Flavobacterium | |||
FLAVONIFRACTOR | C122310 | Any bacterial organism that is not assigned to the species level but can be assigned to the Flavonifractor genus level. | Flavonifractor | |||
FONSECAEA | C122311 | Any fungal organism that is not assigned to the species level but can be assigned to the Fonsecaea genus level. | Fonsecaea | |||
FRANCISELLA TULARENSIS | C86397 | Pasteurella tularensis | Any bacterial organism that can be assigned to the species Francisella tularensis. | Francisella tularensis | ||
FRANCISELLA | C86396 | Any bacteria that is not assigned to the species level but can be assigned to the Francisella genus level. | Francisella | |||
FUNGI | C14209 | Any organism assigned to the kingdom Fungi. | Fungus | |||
FUSARIUM CHLAMYDOSPORUM | C127711 | Any fungal organism that can be assigned to the species Fusarium chlamydosporum. | Fusarium chlamydosporum | |||
FUSARIUM INCARNATUM | C127712 | Fusarium pallidoroseum;Fusarium semitectum | Any fungal organism that can be assigned to the species Fusarium incarnatum. | Fusarium incarnatum | ||
FUSARIUM PROLIFERATUM | C187911 | Any fungal organism that can be assigned to the species Fusarium proliferatum. | Fusarium proliferatum | |||
FUSARIUM SOLANI | C128551 | Neocosmospora solani | Any fungal organism that can be assigned to the species Fusarium solani. | Fusarium solani | ||
FUSARIUM | C77185 | Any fungal organism that is not assigned to the species level but can be assigned to the Fusarium genus level. | Fusarium | |||
FUSOBACTERIUM GONIDIAFORMANS | C86398 | Any bacterial organism that can be assigned to the species Fusobacterium gonidiaformans. | Fusobacterium gonidiaformans | |||
FUSOBACTERIUM MORTIFERUM | C86399 | Any bacterial organism that can be assigned to the species Fusobacterium mortiferum. | Fusobacterium mortiferum | |||
FUSOBACTERIUM NAVIFORME | C114252 | Bacillus naviformis;Fusibacterium naviforme;Pseudobacterium naviformis;Ristella naviformis | Any bacterial organism that can be assigned to the species Fusobacterium naviforme. | Fusobacterium naviforme | ||
FUSOBACTERIUM NECROGENES | C86400 | Any bacterial organism that can be assigned to the species Fusobacterium necrogenes. | Fusobacterium necrogenes | |||
FUSOBACTERIUM NECROPHORUM | C86401 | Any bacterial organism that can be assigned to the species Fusobacterium necrophorum. | Fusobacterium necrophorum | |||
FUSOBACTERIUM NUCLEATUM | C86404 | Any bacterial organism that can be assigned to the species Fusobacterium nucleatum. | Fusobacterium nucleatum | |||
FUSOBACTERIUM PERIODONTICUM | C122312 | Any bacterial organism that can be assigned to the species Fusobacterium periodonticum. | Fusobacterium periodonticum | |||
FUSOBACTERIUM RUSSII | C86405 | Any bacterial organism that can be assigned to the species Fusobacterium russii. | Fusobacterium russii | |||
FUSOBACTERIUM ULCERANS | C86406 | Any bacterial organism that can be assigned to the species Fusobacterium ulcerans. | Fusobacterium ulcerans | |||
FUSOBACTERIUM VARIUM | C86407 | Fusobacterium necrophorum Biovar C;Fusobacterium pseudonecrophorum | Any bacterial organism that can be assigned to the species Fusobacterium varium. | Fusobacterium varium | ||
FUSOBACTERIUM | C76323 | Any bacteria that is not assigned to the species level but can be assigned to the Fusobacterium genus level. | Fusobacterium | |||
GAMMACORONAVIRUS | C122313 | Coronavirus group 3 | Any viral organism that is not assigned to the species level but can be assigned to the Gammacoronavirus genus level. | Gammacoronavirus | ||
GARDNERELLA VAGINALIS | C86410 | Corynebacterium vaginalis | Any bacterial organism that can be assigned to the species Gardnerella vaginalis. | Gardnerella vaginalis | ||
GARDNERELLA | C86409 | Any bacteria that is not assigned to the species level but can be assigned to the Gardnerella genus level. | Gardnerella | |||
GEMELLA BERGERI | C86890 | Any bacterial organism that can be assigned to the species Gemella bergeri. | Gemella bergeri | |||
GEMELLA HAEMOLYSANS | C86891 | Neisseria haemolysans | Any bacterial organism that can be assigned to the species Gemella haemolysans. | Gemella haemolysans | ||
GEMELLA MORBILLORUM | C86892 | Streptococcus morbillorum | Any bacterial organism that can be assigned to the species Gemella morbillorum. | Gemella morbillorum | ||
GEMELLA SANGUINIS | C86893 | Any bacterial organism that can be assigned to the species Gemella sanguinis. | Gemella sanguinis | |||
GEMELLA | C86889 | Any bacteria that is not assigned to the species level but can be assigned to the Gemella genus level. | Gemella | |||
GEOMYCES | C122314 | Any fungal organism that is not assigned to the species level but can be assigned to the Geomyces genus level. | Geomyces | |||
GEOTRICHUM KLEBAHNII | C127713 | Geotrichum penicillatum;Trichosporon penicillatum | Any fungal organism that can be assigned to the species Geotrichum klebahnii. | Geotrichum klebahnii | ||
GEOTRICHUM | C122315 | Any fungal organism that is not assigned to the species level but can be assigned to the Geotrichum genus level. | Geotrichum | |||
GIARDIA LAMBLIA | C122316 | Giardia duodenalis;Giardia intestinalis;Lamblia intestinalis | Any unicellular, eukaryotic organism that can be assigned to the species Giardia lamblia. | Giardia lamblia | ||
GIARDIA | C77213 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Giardia genus level. | Giardia | |||
GLIOCLADIUM | C122317 | Any fungal organism that is not assigned to the species level but can be assigned to the Gliocladium genus level. | Gliocladium | |||
GLOBICATELLA SANGUINIS | C86412 | Globicatella sanguis | Any bacterial organism that can be assigned to the species Globicatella sanguinis. | Globicatella sanguinis | ||
GLOBICATELLA SULFIDIFACIENS | C86413 | Any bacterial organism that can be assigned to the species Globicatella sulfidifaciens. | Globicatella sulfidifaciens | |||
GLOBICATELLA | C86411 | Any bacteria that is not assigned to the species level but can be assigned to the Globicatella genus level. | Globicatella | |||
GNATHOSTOMA SPINIGERUM | C122318 | Any nematode parasite that can be assigned to the species Gnathostoma spinigerum. | Gnathostoma spinigerum | |||
GNATHOSTOMA | C122023 | Any nematode parasite that is not assigned to the species level but can be assigned to the Gnathostoma genus level. | Gnathostoma | |||
GORDONIA AICHIENSIS | C86415 | Gordona aichiensis;Tsukamurella aichiensis | Any bacterial organism that can be assigned to the species Gordonia aichiensis. | Gordonia aichiensis | ||
GORDONIA BRONCHIALIS | C86416 | Gordona bronchialis;Rhodococcus bronchialis | Any bacterial organism that can be assigned to the species Gordonia bronchialis. | Gordonia bronchialis | ||
GORDONIA RUBRIPERTINCTA | C86417 | Gordona rubropertincta;Rhodococcus rubripertincta | Any bacterial organism that can be assigned to the species Gordonia rubripertincta. | Gordonia rubripertincta | ||
GORDONIA SPUTI | C86418 | Gordona sputi | Any bacterial organism that can be assigned to the species Gordonia sputi. | Gordonia sputi | ||
GORDONIA TERRAE | C86419 | Gordona terrae;Rhodococcus terrae | Any bacterial organism that can be assigned to the species Gordonia terrae. | Gordonia terrae | ||
GORDONIA | C86414 | Any bacteria that is not assigned to the species level but can be assigned to the Gordonia genus level. | Gordonia | |||
GRACILIBACILLUS | C86420 | Any bacteria that is not assigned to the species level but can be assigned to the Gracilibacillus genus level. | Gracilibacillus | |||
GRAM-NEGATIVE BACILLUS | C86421 | Gram Negative Rods | Any rod-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. | Gram Negative Bacillus | ||
GRAM-NEGATIVE COCCOBACILLUS | C122319 | Any bacteria intermediate in morphology between a spherical-shaped coccus and a rod-shaped bacillus that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. | Gram-Negative Coccobacillus | |||
GRAM-NEGATIVE COCCUS | C86422 | Any spherical-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. | Gram Negative Coccus | |||
GRAM-NEGATIVE DIPLOCOCCUS | C122320 | Any spherical-shaped bacteria in the form of two joined cells that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. | Gram-Negative Diplococcus | |||
GRAM-NEGATIVE MICROAEROPHILIC BACILLUS | C122321 | Any rod-shaped bacteria whose growth requires lower than atmospheric oxygen level and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Gram-Negative Microaerophilic Bacillus | |||
GRAM-NEGATIVE MICROAEROPHILIC COCCUS | C122322 | Any spherical-shaped bacteria whose growth requires lower than atmospheric oxygen level and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Gram-Negative Microaerophilic Coccus | |||
GRAM-NEGATIVE PLEOMORPHIC BACILLUS | C123469 | Any rod-shaped bacteria with the ability to alter its shape or size in response to stimuli and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Gram-Negative Pleomorphic Bacillus | |||
GRAM-POSITIVE BACILLUS | C62589 | Any rod-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Gram Positive Bacillus | |||
GRAM-POSITIVE COCCUS | C86424 | Any spherical-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Gram Positive Coccus | |||
GRAM-POSITIVE DIPLOCOCCUS | C123470 | Any spherical-shaped bacteria in the form of two joined cells and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Gram-Positive Diplococcus | |||
GRAM-POSITIVE MICROAEROPHILIC BACILLUS | C123471 | Any rod-shaped bacteria whose growth requires lower than atmospheric oxygen level and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Gram-Positive Microaerophilic Bacillus | |||
GRAM-POSITIVE MICROAEROPHILIC COCCUS | C123472 | Any spherical-shaped bacteria whose growth requires lower than atmospheric oxygen level and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Gram-Positive Microaerophilic Coccus | |||
GRANULICATELLA ADIACENS | C86426 | Abiotrophia adjacens;Streptococcus adjacens | Any bacterial organism that can be assigned to the species Granulicatella adiacens. | Granulicatella adiacens | ||
GRANULICATELLA ELEGANS | C111204 | Abiotrophia elegans | Any bacterial organism that can be assigned to the species Granulicatella elegans. | Granulicatella elegans | ||
GRANULICATELLA | C86425 | Any bacteria that is not assigned to the species level but can be assigned to the Granulicatella genus level. | Granulicatella | |||
GRIMONTIA HOLLISAE | C86427 | Vibrio hollisae | Any bacterial organism that can be assigned to the species Grimontia hollisae. | Grimontia hollisae | ||
GUEHOMYCES PULLULANS | C127714 | Basidiotrichosporon pullulans;Monilia pullulans;Oidium pullulans;Oospora pullulans;Trichosporon pullulans | Any fungal organism that can be assigned to the species Guehomyces pullulans. | Guehomyces pullulans | ||
HAEMOPHILUS AEGYPTIUS | C86428 | Any bacterial organism that can be assigned to the species Haemophilus aegyptius. | Haemophilus aegyptius | |||
HAEMOPHILUS HAEMOGLOBINOPHILUS | C86429 | Any bacterial organism that can be assigned to the species Haemophilus haemoglobinophilus. | Haemophilus haemoglobinophilus | |||
HAEMOPHILUS HAEMOLYTICUS | C86430 | Any bacterial organism that can be assigned to the species Haemophilus haemolyticus. | Haemophilus haemolyticus | |||
HAEMOPHILUS HAEMOLYTICUS, BETA-LACTAMASE NEGATIVE | C123473 | Any bacterial organism that can be assigned to the species Haemophilus haemolyticus and is beta-lactamase negative. | Haemophilus haemolyticus, Beta-Lactamase Negative | |||
HAEMOPHILUS HAEMOLYTICUS, BETA-LACTAMASE POSITIVE | C123474 | Any bacterial organism that can be assigned to the species Haemophilus haemolyticus and is beta-lactamase positive. | Haemophilus haemolyticus, Beta-Lactamase Positive | |||
HAEMOPHILUS HAEMOLYTICUS, PENICILLINASE NEGATIVE | C123475 | Any bacterial organism that can be assigned to the species Haemophilus haemolyticus and is penicillinase negative. | Haemophilus haemolyticus, Penicillinase Negative | |||
HAEMOPHILUS HAEMOLYTICUS, PENICILLINASE POSITIVE | C123476 | Any bacterial organism that can be assigned to the species Haemophilus haemolyticus and is penicillinase positive. | Haemophilus haemolyticus, Penicillinase Positive | |||
HAEMOPHILUS INFLUENZAE | C86431 | H-flu | Any bacterial organism that can be assigned to the species Haemophilus influenzae. | Haemophilus influenzae | ||
HAEMOPHILUS INFLUENZAE, BETA-LACTAMASE NEGATIVE | C123477 | Any bacterial organism that can be assigned to the species Haemophilus influenzae and is beta-lactamase negative. | Haemophilus influenzae, Beta-Lactamase Negative | |||
HAEMOPHILUS INFLUENZAE, BETA-LACTAMASE POSITIVE | C123478 | Any bacterial organism that can be assigned to the species Haemophilus influenzae and is beta-lactamase positive. | Haemophilus influenzae, Beta-Lactamase Positive | |||
HAEMOPHILUS INFLUENZAE, PENICILLINASE NEGATIVE | C123479 | Any bacterial organism that can be assigned to the species Haemophilus influenzae and is penicillinase negative. | Haemophilus influenzae, Penicillinase Negative | |||
HAEMOPHILUS INFLUENZAE, PENICILLINASE POSITIVE | C123480 | Any bacterial organism that can be assigned to the species Haemophilus influenzae and is penicillinase positive. | Haemophilus influenzae, Penicillinase Positive | |||
HAEMOPHILUS PARAHAEMOLYTICUS | C86432 | Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus. | Haemophilus parahaemolyticus | |||
HAEMOPHILUS PARAHAEMOLYTICUS, BETA-LACTAMASE NEGATIVE | C123481 | Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus and is beta-lactamase negative. | Haemophilus parahaemolyticus, Beta-Lactamase Negative | |||
HAEMOPHILUS PARAHAEMOLYTICUS, BETA-LACTAMASE POSITIVE | C123482 | Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus and is beta-lactamase positive. | Haemophilus parahaemolyticus, Beta-Lactamase Positive | |||
HAEMOPHILUS PARAHAEMOLYTICUS, PENICILLINASE NEGATIVE | C123483 | Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus and is penicillinase negative. | Haemophilus parahaemolyticus, Penicillinase Negative | |||
HAEMOPHILUS PARAHAEMOLYTICUS, PENICILLINASE POSITIVE | C123484 | Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus and is penicillinase positive. | Haemophilus parahaemolyticus, Penicillinase Positive | |||
HAEMOPHILUS PARAINFLUENZAE | C86433 | Hemophilus parainfluenzae | Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae. | Haemophilus parainfluenzae | ||
HAEMOPHILUS PARAINFLUENZAE, BETA-LACTAMASE NEGATIVE | C123485 | Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae and is beta-lactamase negative. | Haemophilus parainfluenzae, Beta-Lactamase Negative | |||
HAEMOPHILUS PARAINFLUENZAE, BETA-LACTAMASE POSITIVE | C123486 | Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae and is beta-lactamase positive. | Haemophilus parainfluenzae, Beta-Lactamase Positive | |||
HAEMOPHILUS PARAINFLUENZAE, PENICILLINASE NEGATIVE | C123487 | Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae and is penicillinase negative. | Haemophilus parainfluenzae, Penicillinase Negative | |||
HAEMOPHILUS PARAINFLUENZAE, PENICILLINASE POSITIVE | C123488 | Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae and is penicillinase positive. | Haemophilus parainfluenzae, Penicillinase Positive | |||
HAEMOPHILUS PARAPHROHAEMOLYTICUS | C127715 | Any bacterial organism that can be assigned to the species Haemophilus paraphrohaemolyticus. | Haemophilus paraphrohaemolyticus | |||
HAEMOPHILUS | C76324 | Any bacteria that is not assigned to the species level but can be assigned to the Haemophilus genus level. | Haemophilus | |||
HAFNIA ALVEI | C86435 | Enterobacter alvei | Any bacterial organism that can be assigned to the species Hafnia alvei. | Hafnia alvei | ||
HAFNIA | C86434 | Any bacteria that is not assigned to the species level but can be assigned to the Hafnia genus level. | Hafnia | |||
HALOBACILLUS | C86436 | Any bacteria that is not assigned to the species level but can be assigned to the Halobacillus genus level. | Halobacillus | |||
HANNAELLA LUTEOLA | C127716 | Chromotorula luteola;Cryptococcus luteolus;Hannaella luteolus;Rhodotorula luteola;Torula luteola;Torulopsis luteola | Any fungal organism that can be assigned to the species Hannaella luteola. | Hannaella luteola | ||
HANSENIASPORA GUILLIERMONDII | C127717 | Any fungal organism that can be assigned to the species Hanseniaspora guilliermondii. | Hanseniaspora guilliermondii | |||
HANSENIASPORA UVARUM | C127718 | Hanseniaspora apiculata;Kloeckera apiculata;Kloeckeraspora uvarum | Any fungal organism that can be assigned to the species Hanseniaspora uvarum. | Hanseniaspora uvarum | ||
HANSENIASPORA VALBYENSIS | C127719 | Any fungal organism that can be assigned to the species Hanseniaspora valbyensis. | Hanseniaspora valbyensis | |||
HANTAVIRUS | C14213 | Any viral organism that can be assigned to the genus Hantavirus. | Hantavirus | |||
HELCOCOCCUS KUNZII | C86878 | Any bacterial organism that can be assigned to the species Helcococcus kunzii. | Helcococcus kunzii | |||
HELCOCOCCUS PYOGENES | C86879 | Any bacterial organism that can be assigned to the species Helcococcus pyogenes. | Helcococcus pyogenes | |||
HELCOCOCCUS SUECIENSIS | C86880 | Any bacterial organism that can be assigned to the species Helcococcus sueciensis. | Helcococcus sueciensis | |||
HELCOCOCCUS | C86873 | Any bacteria that is not assigned to the species level but can be assigned to the Helcococcus genus level. | Helcococcus | |||
HELICOBACTER CINAEDI | C86437 | Campylobacter cinaedi | Any bacterial organism that can be assigned to the species Helicobacter cinaedi. | Helicobacter cinaedi | ||
HELICOBACTER FELIS | C14330 | Any bacterial organism that can be assigned to the species Helicobacter felis. | Helicobacter felis | |||
HELICOBACTER FENNELLIAE | C86438 | Campylobacter fennelliae | Any bacterial organism that can be assigned to the species Helicobacter fennelliae. | Helicobacter fennelliae | ||
HELICOBACTER MUSTELAE | C86439 | Campylobacter mustelae | Any bacterial organism that can be assigned to the species Helicobacter mustelae. | Helicobacter mustelae | ||
HELICOBACTER PYLORI | C14289 | Campylobacter pylori;H. pylori | Any bacterial organism that can be assigned to the species Helicobacter pylori. | Helicobacter pylori | ||
HELICOBACTER RAPPINI | C86440 | Flexispira rappini | Any bacterial organism that can be assigned to the species Helicobacter rappini. | Helicobacter rappini | ||
HELICOBACTER | C14296 | Any bacteria that is not assigned to the species level but can be assigned to the Helicobacter genus level. | Helicobacter | |||
HENDRA VIRUS | C112289 | Any viral organism that can be assigned to the species Hendra virus. | Hendra Virus | |||
HENIPAVIRUS | C112290 | Any viral organism that can be assigned to the genus Henipavirus. | Henipavirus | |||
HEPATITIS A VIRUS | C14325 | HAV | Any viral organism that can be assigned to the species Hepatitis A virus. | Hepatitis A Virus | ||
HEPATITIS B VIRUS | C14215 | HBV | Any viral organism that can be assigned to the species Hepatitis B virus. | Hepatitis B Virus | ||
HEPATITIS C VIRUS | C14312 | HCV | Any viral organism that can be assigned to the species Hepatitis C virus. | Hepatitis C Virus | ||
HEPATITIS D VIRUS | C93324 | HDV | Any viral organism that can be assigned to the species Hepatitis D virus. | Hepatitis D Virus | ||
HEPATITIS E VIRUS | C14295 | HEV | Any viral organism that can be assigned to the species Hepatitis E virus. | Hepatitis E Virus | ||
HEPATITIS G VIRUS | C14328 | GBV-C;HGV | Any viral organism that can be assigned to the species Hepatitis G virus. | GB virus C | ||
HERBASPIRILLUM HUTTIENSE | C127720 | Pseudomonas huttiensis | Any bacterial organism that can be assigned to the species Herbaspirillum huttiense. | Herbaspirillum huttiense | ||
HERPES SIMPLEX VIRUS 1 | C14311 | Herpes Simplex Virus Type 1;HHV-1;HSV-1;Human Alphaherpesvirus 1;Human Herpesvirus 1 | Any viral organism that can be assigned to the species herpes simplex virus 1. | Human Herpesvirus 1 | ||
HERPES SIMPLEX VIRUS 2 | C112313 | Herpes Simplex Virus Type 2;HHV-2;HSV-2;Human Alphaherpesvirus 2;Human Herpesvirus 2 | Any viral organism that can be assigned to the species herpes simplex virus 2. | Human Herpesvirus 2 | ||
HETEROPHYES HETEROPHYES | C123489 | Any trematode parasite that can be assigned to the species Heterophyes heterophyes. | Heterophyes heterophyes | |||
HISTOPHILUS SOMNI | C86441 | Haemophilus somnus | Any bacterial organism that can be assigned to the species Histophilus somni. | Histophilus somni | ||
HIV-1 GROUP O | C187912 | A non-taxonomic grouping of HIV-1 strains that are assigned to the O group. | HIV-1 Group O | |||
HOLDEMANIA FILIFORMIS | C86443 | Any bacterial organism that can be assigned to the species Holdemania filiformis. | Holdemania filiformis | |||
HOLDEMANIA | C86442 | Any bacteria that is not assigned to the species level but can be assigned to the Holdemania genus level. | Holdemania | |||
HORTAEA WERNECKII | C127721 | Any fungal organism that can be assigned to the species Hortaea werneckii. | Hortaea werneckii | |||
HUMAN BOCAVIRUS | C184695 | Any viral organism that can be assigned to the species Human bocavirus. | Human Bocavirus | |||
HUMAN CORONAVIRUS 229E | C178019 | Coronavirus 229E;HCoV-229E | Any viral organism that can be assigned to the species Human coronavirus 229E. | Human Coronavirus 229E | ||
HUMAN CORONAVIRUS HKU1 | C178020 | HCoV-HKU1 | Any viral organism that can be assigned to the species Human coronavirus HKU1. | Human Coronavirus HKU1 | ||
HUMAN CORONAVIRUS NL63 | C178021 | Coronavirus NL63;HCoV-NL63 | Any viral organism that can be assigned to the species Human coronavirus NL63. | Human Coronavirus NL63 | ||
HUMAN CORONAVIRUS OC43 | C178022 | HCoV-OC43 | Any viral organism that can be assigned to the species Human coronavirus OC43. | Human Coronavirus OC43 | ||
HUMAN CYTOMEGALOVIRUS | C112314 | HCMV;HHV-5;Human Betaherpesvirus 5;Human Herpesvirus 5 | Any viral organism that can be assigned to the species human cytomegalovirus. | Human Herpesvirus 5 | ||
HUMAN HERPESVIRUS 6 | C14218 | Herpes Simplex Virus 6;Herpes Virus 6;HHV-6;Human Betaherpesvirus 6 | Any viral organism that can be assigned to the species human herpesvirus 6. | Human Herpesvirus 6 | ||
HUMAN HERPESVIRUS 7 | C112315 | Herpes Simplex Virus 7;Herpes Virus 7;HHV-7;Human Betaherpesvirus 7 | Any viral organism that can be assigned to the species human herpesvirus 7. | Human Herpesvirus 7 | ||
HUMAN HERPESVIRUS 8 | C14327 | Herpes Virus 8;HHV-8;Human Gammaherpesvirus 8;Kaposi's Sarcoma-associated Herpesvirus;KSHV | Any viral organism that can be assigned to the species human herpesvirus 8. | Human Herpesvirus 8 | ||
HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE A | C189605 | HIV-1 Subtype A | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade A. | Human Immunodeficiency Virus 1 Subtype A | ||
HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE AE | C191336 | HIV-1 CRF01_AE;Human Immunodeficiency Virus 1 Circulating Recombinant Form AE | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major), and subtype/clade circulating recombinant form (CRF) AE. | Human Immunodeficiency Virus 1 Subtype AE | ||
HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE AG | C191337 | HIV-1 CRF02_AG;Human Immunodeficiency Virus 1 Circulating Recombinant Form AG | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major), and subtype/clade circulating recombinant form (CRF) AG. | Human Immunodeficiency Virus 1 Subtype AG | ||
HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE B | C189606 | HIV-1 Subtype B | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade B. | Human Immunodeficiency Virus 1 Subtype B | ||
HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C | C189607 | HIV-1 Subtype C | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade C. | Human Immunodeficiency Virus 1 Subtype C | ||
HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE D | C189608 | HIV-1 Subtype D | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade D. | Human Immunodeficiency Virus 1 Subtype D | ||
HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE F | C189609 | HIV-1 Subtype F | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade F. | Human Immunodeficiency Virus 1 Subtype F | ||
HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE G | C189610 | HIV-1 Subtype G | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1, group M (major) and subtype/clade G. | Human Immunodeficiency Virus 1 Subtype G | ||
HUMAN IMMUNODEFICIENCY VIRUS 1 | C14220 | HIV-1;LAV-1 | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1. | Human Immunodeficiency Virus 1 | ||
HUMAN IMMUNODEFICIENCY VIRUS 2 | C14221 | HIV-2;LAV-2 | Any viral organism that can be assigned to the species Human Immunodeficiency virus 2. | Human Immunodeficiency Virus 2 | ||
HUMAN IMMUNODEFICIENCY VIRUS | C14219 | HIV | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1 or 2. | Human Immunodeficiency Virus | ||
HUMAN METAPNEUMOVIRUS | C125640 | An viral species which can be assigned to the species Human metapneumovirus. | Human Metapneumovirus | |||
HUMAN PAPILLOMAVIRUS TYPE 11 | C99178 | HPV 11;Human papillomavirus 11 | Any viral organism that can be assigned to the Human papillomavirus virus type 11 serotype. | Human Papillomavirus-11 | ||
HUMAN PAPILLOMAVIRUS TYPE 16 | C14338 | HPV 16 | Any viral organism that can be assigned to the Human papillomavirus virus type 16 serotype. | Human Papillomavirus-16 | ||
HUMAN PAPILLOMAVIRUS TYPE 18 | C14377 | HPV 18 | Any viral organism that can be assigned to the Human papillomavirus virus type 18 serotype. | Human Papillomavirus-18 | ||
HUMAN PAPILLOMAVIRUS TYPE 31 | C102904 | HPV 31;Human papillomavirus 31 | Any viral organism that can be assigned to the Human papillomavirus virus type 31 serotype. | Human Papillomavirus-31 | ||
HUMAN PAPILLOMAVIRUS TYPE 33 | C102996 | HPV 33;Human papillomavirus 33 | Any viral organism that can be assigned to the Human papillomavirus virus type 33 serotype. | Human Papillomavirus-33 | ||
HUMAN PAPILLOMAVIRUS TYPE 34 | C186749 | HPV 34 | Any viral organism that can be assigned to the Human papillomavirus virus type 34 serotype. | Human Papillomavirus-34 | ||
HUMAN PAPILLOMAVIRUS TYPE 35 | C102997 | HPV 35;Human papillomavirus 35 | Any viral organism that can be assigned to the Human papillomavirus virus type 35 serotype. | Human Papillomavirus-35 | ||
HUMAN PAPILLOMAVIRUS TYPE 39 | C102998 | HPV 39;Human papillomavirus 39 | Any viral organism that can be assigned to the Human papillomavirus virus type 39 serotype. | Human Papillomavirus-39 | ||
HUMAN PAPILLOMAVIRUS TYPE 40 | C186750 | HPV 40;Human papillomavirus 40 | Any viral organism that can be assigned to the Human papillomavirus virus type 40 serotype. | Human Papillomavirus-40 | ||
HUMAN PAPILLOMAVIRUS TYPE 42 | C186751 | HPV 42;Human papillomavirus 42 | Any viral organism that can be assigned to the Human papillomavirus virus type 42 serotype. | Human Papillomavirus-42 | ||
HUMAN PAPILLOMAVIRUS TYPE 43 | C186752 | HPV 43;Human papillomavirus 43 | Any viral organism that can be assigned to the Human papillomavirus virus type 43 serotype. | Human Papillomavirus-43 | ||
HUMAN PAPILLOMAVIRUS TYPE 44 | C186753 | HPV 44;Human papillomavirus 44 | Any viral organism that can be assigned to the Human papillomavirus virus type 44 serotype. | Human Papillomavirus-44 | ||
HUMAN PAPILLOMAVIRUS TYPE 45 | C102999 | HPV 45;Human papillomavirus 45 | Any viral organism that can be assigned to the Human papillomavirus virus type 45 serotype. | Human Papillomavirus-45 | ||
HUMAN PAPILLOMAVIRUS TYPE 51 | C103000 | HPV 51;Human papillomavirus 51 | Any viral organism that can be assigned to the Human papillomavirus virus type 51 serotype. | Human Papillomavirus-51 | ||
HUMAN PAPILLOMAVIRUS TYPE 52 | C103001 | HPV 52;Human papillomavirus 52 | Any viral organism that can be assigned to the Human papillomavirus virus type 52 serotype. | Human Papillomavirus-52 | ||
HUMAN PAPILLOMAVIRUS TYPE 53 | C103002 | HPV 53 | Any viral organism that can be assigned to the Human papillomavirus virus type 53 serotype. | Human Papillomavirus-53 | ||
HUMAN PAPILLOMAVIRUS TYPE 54 | C186754 | HPV 54;Human papillomavirus 54 | Any viral organism that can be assigned to the Human papillomavirus virus type 54 serotype. | Human Papillomavirus-54 | ||
HUMAN PAPILLOMAVIRUS TYPE 56 | C103003 | HPV 56;Human papillomavirus 56 | Any viral organism that can be assigned to the Human papillomavirus virus type 56 serotype. | Human Papillomavirus-56 | ||
HUMAN PAPILLOMAVIRUS TYPE 58 | C103004 | HPV 58;Human papillomavirus 58 | Any viral organism that can be assigned to the Human papillomavirus virus type 58 serotype. | Human Papillomavirus-58 | ||
HUMAN PAPILLOMAVIRUS TYPE 59 | C103005 | HPV 59;Human papillomavirus 59 | Any viral organism that can be assigned to the Human papillomavirus virus type 59 serotype. | Human Papillomavirus-59 | ||
HUMAN PAPILLOMAVIRUS TYPE 6 | C14319 | HPV 6 | Any viral organism that can be assigned to the Human papillomavirus virus type 6 serotype. | Human Papillomavirus-6 | ||
HUMAN PAPILLOMAVIRUS TYPE 66 | C103006 | HPV 66;Human papillomavirus 66 | Any viral organism that can be assigned to the Human papillomavirus virus type 66 serotype. | Human Papillomavirus-66 | ||
HUMAN PAPILLOMAVIRUS TYPE 68 | C103007 | HPV 68;Human papillomavirus 68 | Any viral organism that can be assigned to the Human papillomavirus virus type 68 serotype. | Human Papillomavirus-68 | ||
HUMAN PAPILLOMAVIRUS TYPE 69 | C186755 | HPV 69;Human papillomavirus 69 | Any viral organism that can be assigned to the Human papillomavirus virus type 69 serotype. | Human Papillomavirus-69 | ||
HUMAN PAPILLOMAVIRUS TYPE 70 | C156055 | HPV 70 | Any viral organism that can be assigned to the Human papillomavirus virus type 70 serotype. | Human Papillomavirus-70 | ||
HUMAN PAPILLOMAVIRUS TYPE 74 | C186780 | HPV 74;Human papillomavirus 74 | Any viral organism that can be assigned to the Human papillomavirus virus type 74 serotype. | Human Papillomavirus-74 | ||
HUMAN PAPILLOMAVIRUS | C14226 | HPV;Human Papilloma Virus | Any viral organism in humans that can be assigned to the family Papillomaviridae. | Human Papillomavirus | ||
HUMAN PARAINFLUENZA VIRUS 1 | C14254 | HPIV-1;Human Parainfluenza Virus Type 1;Human Respirovirus 1 | Any viral organism that can be assigned to the species Human Parainfluenza virus 1. | Human Parainfluenza Virus 1 | ||
HUMAN PARAINFLUENZA VIRUS 2 | C112316 | HPIV-2;Human orthorubulavirus 2;Human Parainfluenza Virus Type 2;Human Rubulavirus 2 | Any viral organism that can be assigned to the species Human Parainfluenza virus 2. | Human Parainfluenza Virus 2 | ||
HUMAN PARAINFLUENZA VIRUS 3 | C112317 | HPIV-3;Human Parainfluenza Virus Type 3;Human Respirovirus 3 | Any viral organism that can be assigned to the species Human Parainfluenza virus 3. | Human Parainfluenza Virus 3 | ||
HUMAN PARAINFLUENZA VIRUS 4 | C112318 | HPIV Type 4;HPIV-4;Human orthorubulavirus 4;Human Parainfluenza Virus Type 4;Human Rubulavirus 4 | Any viral organism that can be assigned to the species Human Parainfluenza virus 4. | Human Parainfluenza Virus 4 | ||
HUMAN PARAINFLUENZA VIRUS 4B | C198353 | HPIV4b;Human Parainfluenza Virus Type 4b | Any viral organism that can be assigned to below the species level Human Parainfluenza virus 4b. | Human Parainfluenza Virus 4b | ||
HUMAN PARAINFLUENZA VIRUS | C125641 | Any viral organism that can be assigned to the species Human Parainfluenza virus 1, 2, 3 and/or 4. | Human Parainfluenza Virus | |||
HUMAN PARVOVIRUS B19 | C89772 | B19 Virus;Human Erythrovirus B19;Parvovirus B19 | Any viral organism that can be assigned to the species Human Parvovirus B19. | Parvovirus B19 | ||
HUMAN POLIOVIRUS 1 | C181465 | Human poliovirus type 1;NC Type 1 | Any viral organism that can be assigned to the Human poliovirus serotype 1. | Human Poliovirus Type 1 | ||
HUMAN POLIOVIRUS 3 | C181466 | ENC Type 3;Human poliovirus type 3 | Any viral organism that can be assigned to the Human poliovirus serotype 3. | Human Poliovirus Type 3 | ||
HUMAN RESPIRATORY SYNCYTIAL VIRUS | C14267 | hRSV;Human RSV;RSV | Any viral organism that can be assigned to the species Human Respiratory Syncitial virus. | Human Respiratory Syncytial Virus | ||
HUMAN T-LYMPHOTROPIC VIRUS 1 | C14223 | Adult T-cell Leukemia Lymphoma ATLL;Adult T-cell Lymphoma Virus Type 1;HTLV-1 | Any viral organism that can be assigned to the Human T-lymphotrophic virus serotype 1. | HTLV-1 | ||
HUMAN T-LYMPHOTROPIC VIRUS 2 | C14224 | HTLV-2;HTLV-II | Any viral organism that can be assigned to the Human T-lymphotrophic virus serotype 2. | HTLV-2 | ||
HYMENOLEPIS DIMINUTA | C124354 | Rat Tapeworm | Any cestode parasite that can be assigned to the species Hymenolepis diminuta. | Hymenolepis diminuta | ||
HYMENOLEPIS NANA | C122323 | Dwarf Tapeworm;Taenia nana;Vampirolepis nana | Any cestode parasite that can be assigned to the species Hymenolepis nana. | Hymenolepis nana | ||
INFLUENZA A VIRUS SUBTYPE H1N1 | C80445 | Any viral organism that can be assigned to the Influenza A species subtype H1N1. | Influenza A (H1N1) Virus | |||
INFLUENZA A VIRUS SUBTYPE H5N1 | C123490 | Any viral organism that can be assigned to the Influenza A species subtype H5N1. | Influenza A (H5N1) Virus | |||
INFLUENZA A VIRUS | C53454 | FLUAV;Influenza Virus Type A | Any viral organism that can be assigned to the species Influenza A virus. | Influenza A Virus | ||
INFLUENZA B VIRUS | C53468 | FLUBV;Influenza Virus Type B | Any viral organism that can be assigned to the species Influenza B virus. | Influenza B Virus | ||
INFLUENZA C VIRUS | C97157 | FLUCV;Influenza Virus Type C | Any viral organism that can be assigned to the species Influenza C virus. | Influenza C Virus | ||
INQUILINUS LIMOSUS | C86445 | Any bacterial organism that can be assigned to the species Inquilinus limosus. | Inquilinus limosus | |||
INQUILINUS | C86444 | Any bacteria that is not assigned to the species level but can be assigned to the Inquilinus genus level. | Inquilinus | |||
INTESTINIBACTER BARTLETTII | C122324 | Clostridium bartlettii | Any bacterial organism that can be assigned to the species Intestinibacter bartlettii. | Intestinibacter bartlettii | ||
IODAMOEBA BUTSCHLII | C123491 | Any amoebic organism that can be assigned to the species Iodamoeba butschlii. | Iodamoeba butschlii | |||
ISOSPORA | C122325 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Isospora genus level. | Isospora | |||
JAPANESE ENCEPHALITIS VIRUS | C187913 | JEV | Any viral organism that can be assigned to the species Japanese encephalitis virus. | Japanese Encephalitis Virus | ||
JC VIRUS | C14229 | Human polyomavirus (type JC);Polyomavirus hominis 2;polyomavirus JC | Any viral organism that can be assigned to the species JC polyomavirus. | JC Virus | ||
JEOTGALIBACILLUS | C86446 | Any bacteria that is not assigned to the species level but can be assigned to the Jeotgalibacillus genus level. | Jeotgalibacillus | |||
JOHNSONELLA IGNAVA | C86448 | Any bacterial organism that can be assigned to the species Johnsonella ignava. | Johnsonella ignava | |||
JOHNSONELLA | C86447 | Any bacteria that is not assigned to the species level but can be assigned to the Johnsonella genus level. | Johnsonella | |||
KERSTERSIA GYIORUM | C127722 | Any bacterial organism that can be assigned to the species Kerstersia gyiorum. | Kerstersia gyiorum | |||
KINGELLA DENITRIFICANS | C86450 | Any bacterial organism that can be assigned to the species Kingella denitrificans. | Kingella denitrificans | |||
KINGELLA KINGAE | C86451 | Moraxella kingae | Any bacterial organism that can be assigned to the species Kingella kingae. | Kingella kingae | ||
KINGELLA ORALIS | C86452 | Any bacterial organism that can be assigned to the species Kingella oralis. | Kingella oralis | |||
KINGELLA POTUS | C86453 | Any bacterial organism that can be assigned to the species Kingella potus. | Kingella potus | |||
KINGELLA | C86449 | Any bacteria that is not assigned to the species level but can be assigned to the Kingella genus level. | Kingella | |||
KLEBSIELLA AEROGENES | C187914 | Aerobacter aerogenes;Enterobacter aerogenes;Klebsiella mobilis | Any bacterial organism that can be assigned to the species Klebsiella aerogenes. | Klebsiella aerogenes | ||
KLEBSIELLA GRANULOMATIS | C86454 | Any bacterial organism that can be assigned to the species Klebsiella granulomatis. | Klebsiella granulomatis | |||
KLEBSIELLA OXYTOCA | C86455 | Any bacterial organism that can be assigned to the species Klebsiella oxytoca. | Klebsiella oxytoca | |||
KLEBSIELLA OXYTOCA, ESBL | C139102 | Klebsiella oxytoca, Extended-Spectrum Beta-Lactamases | Any bacterial organism that can be assigned to the species Klebsiella oxytoca and produces extended-spectrum beta-lactamases (ESBL). | Extended-spectrum Beta-lactamase Positive Klebsiella oxytoca | ||
KLEBSIELLA OZAENAE | C86456 | Klebsiella pneumoniae subsp. ozaenae | Any bacterial organism that can be assigned to the species Klebsiella ozaenae. | Klebsiella ozaenae | ||
KLEBSIELLA PNEUMONIAE | C86457 | Any bacterial organism that can be assigned to the species Klebsiella pneumoniae. | Klebsiella pneumoniae | |||
KLEBSIELLA PNEUMONIAE, ESBL | C139101 | Klebsiella pneumoniae, Extended-Spectrum Beta-Lactamases | Any bacterial organism that can be assigned to the species Klebsiella pneumoniae and produces extended-spectrum beta-lactamases (ESBL). | Extended-spectrum Beta-lactamase Positive Klebsiella pneumoniae | ||
KLEBSIELLA RHINOSCLEROMATIS | C86458 | Klebsiella pneumoniae subsp. rhinoscleromatis | Any bacterial organism that can be assigned to the species Klebsiella rhinoscleromatis. | Klebsiella rhinoscleromatis | ||
KLEBSIELLA SINGAPORENSIS | C86459 | Any bacterial organism that can be assigned to the species Klebsiella singaporensis. | Klebsiella singaporensis | |||
KLEBSIELLA VARIICOLA | C86460 | Any bacterial organism that can be assigned to the species Klebsiella variicola. | Klebsiella variicola | |||
KLEBSIELLA | C28165 | Any bacteria that is not assigned to the species level but can be assigned to the Klebsiella genus level. | Klebsiella | |||
KLOECKERA JAPONICA | C127723 | Any fungal organism that can be assigned to the species Kloeckera japonica. | Kloeckera japonica | |||
KLUYVERA ASCORBATA | C86462 | CDC Enteric Group 8 | Any bacterial organism that can be assigned to the species Kluyvera ascorbata. | Kluyvera ascorbata | ||
KLUYVERA CRYOCRESCENS | C86463 | Any bacterial organism that can be assigned to the species Kluyvera cryocrescens. | Kluyvera cryocrescens | |||
KLUYVERA GEORGIANA | C86464 | Any bacterial organism that can be assigned to the species Kluyvera georgiana. | Kluyvera georgiana | |||
KLUYVERA INTERMEDIA | C86465 | Enterobacter intermedium;Enterobacter intermedius;Kluyvera cochleae | Any bacterial organism that can be assigned to the species Kluyvera intermedia. | Kluyvera intermedia | ||
KLUYVERA | C86461 | Any bacteria that is not assigned to the species level but can be assigned to the Kluyvera genus level. | Kluyvera | |||
KLUYVEROMYCES LACTIS | C127724 | Candida sphaerica;Kluyveromyces drosophilarum;Kluyveromyces lactis var. drosophilarum;Kluyveromyces lactis var. lactis;Kluyveromyces marxianus lactis;Kluyveromyces marxianus var. drosophilarum;Kluyveromyces marxianus var. lactis | Any fungal organism that can be assigned to the species Kluyveromyces lactis. | Kluyveromyces lactis | ||
KLUYVEROMYCES MARXIANUS | C114256 | Candida pseudotropicalis;Kluyveromyces cicerisporus;Kluyveromyces fragilis | Any fungal organism that can be assigned to the species Kluyveromyces marxianus. | Kluyveromyces marxianus | ||
KNOELLIA | C86466 | Any bacteria that is not assigned to the species level but can be assigned to the Knoellia genus level. | Knoellia | |||
KOCURIA KRISTINAE | C86468 | Micrococcus kristinae | Any bacterial organism that can be assigned to the species Kocuria kristinae. | Kocuria kristinae | ||
KOCURIA RHIZOPHILA | C127307 | Any bacterial organism that can be assigned to the species Kocuria rhizophila. | Kocuria rhizophila | |||
KOCURIA ROSEA | C86469 | Any bacterial organism that can be assigned to the species Kocuria rosea. | Kocuria rosea | |||
KOCURIA VARIANS | C86470 | Any bacterial organism that can be assigned to the species Kocuria varians. | Kocuria varians | |||
KOCURIA | C86467 | Any bacteria that is not assigned to the species level but can be assigned to the Kocuria genus level. | Kocuria | |||
KODAMAEA OHMERI | C127725 | Candida guilliermondii var. membranifaciens;Pichia ohmeri;Yamadazyma ohmeri | Any fungal organism that can be assigned to the species Kodamaea ohmeri. | Kodamaea ohmeri | ||
KURTHIA | C86471 | Any bacteria that is not assigned to the species level but can be assigned to the Kurthia genus level. | Kurthia | |||
KYTOCOCCUS SEDENTARIUS | C86473 | Any bacterial organism that can be assigned to the species Kytococcus sedentarius. | Kytococcus sedentarius | |||
KYTOCOCCUS | C86472 | Any bacteria that is not assigned to the species level but can be assigned to the Kytococcus genus level. | Kytococcus | |||
LACTICASEIBACILLUS PARACASEI SUBSP. PARACASEI | C189611 | Lactobacillus paracasei paracasei | Any bacterial organism that can be assigned to Lacticaseibacillus paracasei subspecies paracasei. | Lactobacillus paracasei Subspecies paracasei | ||
LACTOBACILLUS ACIDOPHILUS | C86474 | Any bacterial organism that can be assigned to the species Lactobacillus acidophilus. | Lactobacillus acidophilus | |||
LACTOBACILLUS BREVIS | C86475 | Any bacterial organism that can be assigned to the species Lactobacillus brevis. | Lactobacillus brevis | |||
LACTOBACILLUS CASEI | C86476 | Any bacterial organism that can be assigned to the species Lactobacillus casei. | Lactobacillus casei | |||
LACTOBACILLUS CATENAFORMIS | C86477 | Lactobacillus catenaforme | Any bacterial organism that can be assigned to the species Lactobacillus catenaformis. | Lactobacillus catenaformis | ||
LACTOBACILLUS FERMENTUM | C86478 | Lactobacillus cellobiosus | Any bacterial organism that can be assigned to the species Lactobacillus fermentum. | Lactobacillus fermentum | ||
LACTOBACILLUS GALLINARUM | C86479 | Any bacterial organism that can be assigned to the species Lactobacillus gallinarum. | Lactobacillus gallinarum | |||
LACTOBACILLUS GASSERI | C123492 | Any bacterial organism that can be assigned to the species Lactobacillus gasseri. | Lactobacillus gasseri | |||
LACTOBACILLUS JENSENII | C86480 | Any bacterial organism that can be assigned to the species Lactobacillus jensenii. | Lactobacillus jensenii | |||
LACTOBACILLUS JOHNSONII | C86481 | Any bacterial organism that can be assigned to the species Lactobacillus johnsonii. | Lactobacillus johnsonii | |||
LACTOBACILLUS ORIS | C123493 | Any bacterial organism that can be assigned to the species Lactobacillus oris. | Lactobacillus oris | |||
LACTOBACILLUS PARACASEI | C123494 | Any bacterial organism that can be assigned to the species Lactobacillus paracasei. | Lactobacillus paracasei | |||
LACTOBACILLUS RHAMNOSUS | C123495 | Lactobacillus casei rhamnosus | Any bacterial organism that can be assigned to the species Lactobacillus rhamnosus. | Lactobacillus rhamnosus | ||
LACTOBACILLUS SALIVARIUS | C86482 | Any bacterial organism that can be assigned to the species Lactobacillus salivarius. | Lactobacillus salivarius | |||
LACTOBACILLUS VAGINALIS | C123496 | Any bacterial organism that can be assigned to the species Lactobacillus vaginalis. | Lactobacillus vaginalis | |||
LACTOBACILLUS | C76352 | Any bacteria that is not assigned to the species level but can be assigned to the Lactobacillus genus level. | Lactobacillus | |||
LACTOCOCCUS GARVIEAE | C86484 | Any bacterial organism that can be assigned to the species Lactococcus garvieae. | Lactococcus garvieae | |||
LACTOCOCCUS LACTIS SUBSP. CREMORIS | C86894 | Lactococcus cremoris;Streptococcus cremoris;Streptococcus hollandicus;Streptococcus lactis B | Any bacterial organism that can be assigned to Lactococcus lactis subspecies cremoris. | Lactococcus lactis subsp cremoris | ||
LACTOCOCCUS LACTIS SUBSP. LACTIS | C123497 | Lactobacillus xylosus;Streptococcus diacetilactis | Any bacterial organism that can be assigned to Lactococcus lactis subspecies lactis. | Lactococcus lactis subsp lactis | ||
LACTOCOCCUS LACTIS | C86485 | Any bacterial organism that can be assigned to the species Lactococcus lactis. | Lactococcus lactis | |||
LACTOCOCCUS | C86483 | Doederlein bacillus | Any bacteria that is not assigned to the species level but can be assigned to the Lactococcus genus level. | Lactococcus | ||
LECLERCIA ADECARBOXYLATA | C86487 | CDC Enteric Group 41 | Any bacterial organism that can be assigned to the species Leclercia adecarboxylata. | Leclercia adecarboxylata | ||
LECLERCIA | C86486 | Any bacteria that is not assigned to the species level but can be assigned to the Leclercia genus level. | Leclercia | |||
LEGIONELLA LONGBEACHAE | C86488 | Any bacterial organism that can be assigned to the species Legionella longbeachae. | Legionella longbeachae | |||
LEGIONELLA PNEUMOPHILA SEROGROUP 1 | C123498 | Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 1. | Legionella pneumophila Serogroup 1 | |||
LEGIONELLA PNEUMOPHILA SEROGROUP 2 | C123499 | Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 2. | Legionella pneumophila Serogroup 2 | |||
LEGIONELLA PNEUMOPHILA SEROGROUP 3 | C123500 | Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 3. | Legionella pneumophila Serogroup 3 | |||
LEGIONELLA PNEUMOPHILA SEROGROUP 4 | C123501 | Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 4. | Legionella pneumophila Serogroup 4 | |||
LEGIONELLA PNEUMOPHILA SEROGROUP 5 | C123502 | Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 5. | Legionella pneumophila Serogroup 5 | |||
LEGIONELLA PNEUMOPHILA SEROGROUP 6 | C123503 | Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 6. | Legionella pneumophila Serogroup 6 | |||
LEGIONELLA PNEUMOPHILA SEROGROUP 7 | C123504 | Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 7. | Legionella pneumophila Serogroup 7 | |||
LEGIONELLA PNEUMOPHILA SEROGROUP 8 | C123505 | Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 8. | Legionella pneumophila Serogroup 8 | |||
LEGIONELLA PNEUMOPHILA SEROGROUP 9 | C123506 | Any bacterial organism that can be assigned to the species Legionella pneumophila serogroup 9. | Legionella pneumophila Serogroup 9 | |||
LEGIONELLA PNEUMOPHILA | C86489 | Any bacterial organism that can be assigned to the species Legionella pneumophila. | Legionella pneumophila | |||
LEGIONELLA | C76353 | Any bacteria that is not assigned to the species level but can be assigned to the Legionella genus level. | Legionella | |||
LEIFSONIA AQUATICA | C86491 | Corynebacterium aquaticum | Any bacterial organism that can be assigned to the species Leifsonia aquatica. | Leifsonia aquatica | ||
LEIFSONIA | C86490 | Any bacteria that is not assigned to the species level but can be assigned to the Leifsonia genus level. | Leifsonia | |||
LEISHMANIA BRAZILIENSIS | C123507 | Leishmania brasiliensis;Leishmania viannia | Any unicellular, eukaryotic organism that can be assigned to the species Leishmania braziliensis. | Leishmania braziliensis | ||
LEISHMANIA DONOVANI | C123508 | Any unicellular, eukaryotic organism that can be assigned to the species Leishmania donovani. | Leishmania donovani | |||
LEISHMANIA INFANTUM | C123509 | Leishmania chagasi;Leishmania donovani infantum | Any unicellular, eukaryotic organism that can be assigned to the species Leishmania infantum. | Leishmania infantum | ||
LEISHMANIA MEXICANA | C123510 | Any unicellular, eukaryotic organism that can be assigned to the species Leishmania mexicana. | Leishmania mexicana | |||
LEISHMANIA TROPICA | C123511 | Leishmania tropica minor | Any unicellular, eukaryotic organism that can be assigned to the species Leishmania tropica. | Leishmania tropica | ||
LEMINORELLA GRIMONTII | C86493 | CDC Enteric Group 57 | Any bacterial organism that can be assigned to the species Leminorella grimontii. | Leminorella grimontii | ||
LEMINORELLA RICHARDII | C86494 | Any bacterial organism that can be assigned to the species Leminorella richardii. | Leminorella richardii | |||
LEMINORELLA | C86492 | Any bacteria that is not assigned to the species level but can be assigned to the Leminorella genus level. | Leminorella | |||
LENTIVIRUS | C14290 | Lentivirinae | Any viral organism that can be assigned to the genus Lentivirus. | Lentivirus | ||
LEPTOSPIRA | C76355 | Any bacteria that is not assigned to the species level but can be assigned to the Leptospira genus level. | Leptospira | |||
LEUCONOSTOC CITREUM | C86495 | Any bacterial organism that can be assigned to the species Leuconostoc citreum. | Leuconostoc citreum | |||
LEUCONOSTOC LACTIS | C86496 | Any bacterial organism that can be assigned to the species Leuconostoc lactis. | Leuconostoc lactis | |||
LEUCONOSTOC MESENTEROIDES | C86497 | Any bacterial organism that can be assigned to the species Leuconostoc mesenteroides. | Leuconostoc mesenteroides | |||
LEUCONOSTOC PSEUDOMESENTEROIDES | C86498 | Any bacterial organism that can be assigned to the species Leuconostoc pseudomesenteroides. | Leuconostoc pseudomesenteroides | |||
LEUCONOSTOC | C76357 | Any bacteria that is not assigned to the species level but can be assigned to the Leuconostoc genus level. | Leuconostoc | |||
LISTERIA GRAYI | C86499 | Any bacterial organism that can be assigned to the species Listeria grayi. | Listeria grayi | |||
LISTERIA INNOCUA | C86500 | Any bacterial organism that can be assigned to the species Listeria innocua. | Listeria innocua | |||
LISTERIA IVANOVII | C86501 | Listeria bulgarica;Listeria monocytogenes subsp. perhaemolytica;Listeria perhaemolytica | Any bacterial organism that can be assigned to the species Listeria ivanovii. | Listeria ivanovii | ||
LISTERIA MONOCYTOGENES | C86502 | Bacterium monocytogenes hominis;Corynebacterium infantisepticum;Corynebacterium parvulum;Listerella hepatolytica | Any bacterial organism that can be assigned to the species Listeria monocytogenes. | Listeria monocytogenes | ||
LISTERIA SEELIGERI | C86503 | Any bacterial organism that can be assigned to the species Listeria seeligeri. | Listeria seeligeri | |||
LISTERIA WELSHIMERI | C86504 | Any bacterial organism that can be assigned to the species Listeria welshimeri. | Listeria welshimeri | |||
LISTERIA | C76359 | Any bacteria that is not assigned to the species level but can be assigned to the Listeria genus level. | Listeria | |||
LOA LOA | C123512 | Eye Worm | Any nematode parasite that can be assigned to the species Loa loa. | Loa loa | ||
LOMENTOSPORA PROLIFICANS | C117362 | Scedosporium inflatum;Scedosporium prolificans | Any fungal organism that can be assigned to the species Lomentospora prolificans. | Scedosporium prolificans | ||
LYSINIBACILLUS | C127727 | Any bacteria that is not assigned to the species level but can be assigned to the Lysinibacillus genus level. | Lysinibacillus | |||
LYSSAVIRUS | C112330 | Any viral organism that can be assigned to the genus Lyssavirus. | Lyssavirus | |||
MACROCOCCUS CASEOLYTICUS | C86506 | Staphylococcus caseolyticus | Any bacterial organism that can be assigned to the species Macrococcus caseolyticus. | Macrococcus caseolyticus | ||
MACROCOCCUS | C86505 | Any bacteria that is not assigned to the species level but can be assigned to the Macrococcus genus level. | Macrococcus | |||
MADURELLA MYCETOMATIS | C127728 | Madurella ikedae;Madurella mycetomi;Streptotrix mycetomatis | Any fungal organism that can be assigned to the species Madurella mycetomatis. | Madurella mycetomatis | ||
MAGNUSIOMYCES CAPITATUS | C114263 | Blastoschizomyces capitatus;Dipodascus capitatus;Geotrichum capitatum;Saprochaete capitata;Trichosporon capitatum | Any fungal organism that can be assigned to the species Magnusiomyces capitatus. | Magnusiomyces capitatus | ||
MALASSEZIA FURFUR | C127729 | Pityrosporum orbiculare;Pityrosporum ovale;Saccharomyces ovalis | Any fungal organism that can be assigned to the species Malassezia furfur. | Malassezia furfur | ||
MALASSEZIA PACHYDERMATIS | C127730 | Pityrosporum pachydermatis | Any fungal organism that can be assigned to the species Malassezia pachydermatis. | Malassezia pachydermatis | ||
MALASSEZIA | C127292 | Any fungal organism that is not assigned to the species level but can be assigned to the Malassezia genus level. | Malassezia | |||
MANNHEIMIA HAEMOLYTICA | C86508 | Pasteurella haemolytica | Any bacterial organism that can be assigned to the species Mannheimia haemolytica. | Mannheimia haemolytica | ||
MANNHEIMIA | C86507 | Any bacteria that is not assigned to the species level but can be assigned to the Mannheimia genus level. | Mannheimia | |||
MANSONELLA OZZARDI | C122326 | Filaria ozzardi;Tetrapetalonema ozzardi | Any nematode parasite that can be assigned to the species Mansonella ozzardi. | Mansonella ozzardi | ||
MANSONELLA PERSTANS | C119326 | Dipetalonema perstans | Any nematode parasite that can be assigned to the species Mansonella perstans. | Mansonella perstans | ||
MANSONELLA STREPTOCERCA | C122327 | Dipetalonema streptocerca | Any nematode parasite that can be assigned to the species Mansonella streptocerca. | Mansonella streptocerca | ||
MARBURGVIRUS | C112331 | Any viral organism that can be assigned to the genus Marburgvirus. | Marburgvirus | |||
MEASLES MORBILLIVIRUS | C14237 | Measles Virus;Rougeole Virus;Rubeola Virus;SSPEV;Subacute Sclerosing Panencephalitis Virus | Any viral organism that can be assigned to the species Measles morbillivirus. | Measles morbillivirus | ||
MEGAMONAS FUNIFORMIS | C114247 | Any bacterial organism that can be assigned to the species Megamonas funiformis. | Megamonas funiformis | |||
MEGAMONAS HYPERMEGALE | C123513 | Bacteroides hypermegas;Megamonas hypermegas;Sphaerophorus hypermegas | Any bacterial organism that can be assigned to the species Megamonas hypermegale. | Megamonas hypermegale | ||
MEGAMONAS | C113447 | Any bacteria that is not assigned to the species level but can be assigned to the Megamonas genus level. | Megamonas | |||
MEGASPHAERA ELSDENII | C86896 | Peptostreptococcus elsdenii | Any bacterial organism that can be assigned to the species Megasphaera elsdenii. | Megasphaera elsdenii | ||
MEGASPHAERA | C86895 | Any bacteria that is not assigned to the species level but can be assigned to the Megasphaera genus level. | Megasphaera | |||
METAGONIMUS YOKOGAWAI | C123514 | Any trematode parasite that can be assigned to the species Metagonimus yokogawai. | Metagonimus yokogawai | |||
METAPNEUMOVIRUS | C125956 | Any viral organism that can be assigned to the genus Metapneumovirus. | Metapneumovirus | |||
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS | C123515 | MRSA | Any bacterial organism that can be assigned to the species Staphylococcus aureus and is resistant to methicillin. | Methicillin Resistant Staphylococcus Aureus | ||
METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS | C123516 | MSSA | Any bacterial organism that can be assigned to the species Staphylococcus aureus and is susceptible to methicillin. | Methicillin Susceptible Staphylococcus Aureus | ||
METHYLOBACTERIUM MESOPHILICUM | C86510 | Pseudomonas mesophilica | Any bacterial organism that can be assigned to the species Methylobacterium mesophilicum. | Methylobacterium mesophilicum | ||
METHYLOBACTERIUM | C76361 | Any bacteria that is not assigned to the species level but can be assigned to the Methylobacterium genus level. | Methylobacterium | |||
METSCHNIKOWIA PULCHERRIMA | C127731 | Candida pulcherrima | Any fungal organism that can be assigned to the species Metschnikowia pulcherrima. | Metschnikowia pulcherrima | ||
MEYEROZYMA GUILLIERMONDII | C77172 | Candida guilliermondii;Candida guilliermondii var. carpophila;Endomyces guilliermondii;Pichia guilliermondii;Yamadazyma guilliermondii | Any fungal organism that can be assigned to the species Meyerozyma guilliermondii. | Pichia guilliermondii | ||
MICROBACTERIUM PARAOXYDANS | C86512 | Any bacterial organism that can be assigned to the species Microbacterium paraoxydans. | Microbacterium paraoxydans | |||
MICROBACTERIUM | C85511 | Any bacteria that is not assigned to the species level but can be assigned to the Microbacterium genus level. | Microbacterium | |||
MICROCOCCUS LUTEUS | C86513 | Any bacterial organism that can be assigned to the species Micrococcus luteus. | Micrococcus luteus | |||
MICROCOCCUS LYLAE | C86514 | Any bacterial organism that can be assigned to the species Micrococcus lylae. | Micrococcus lylae | |||
MICROCOCCUS | C77086 | Any bacteria that is not assigned to the species level but can be assigned to the Micrococcus genus level. | Micrococcus | |||
MICROSPORIDIA | C123335 | Microspora;Microsporea;Microsporida | Any fungal organism that can be assigned to the phylum Microsporidia. | Microsporidia | ||
MICROSPORUM AUDOUINII | C127732 | Any fungal organism that can be assigned to the species Microsporum audouinii. | Microsporum audouinii | |||
MICROSPORUM DISTORTUM | C127733 | Microsporum canis var. distortum | Any fungal organism that can be assigned to the species Microsporum distortum. | Microsporum distortum | ||
MICROSPORUM EQUINUM | C127734 | Any fungal organism that can be assigned to the species Microsporum equinum. | Microsporum equinum | |||
MICROSPORUM FERRUGINEUM | C127735 | Any fungal organism that can be assigned to the species Microsporum ferrugineum. | Microsporum ferrugineum | |||
MICROSPORUM GYPSEUM | C127736 | Arthroderma gypseum;Gymnoascus gypseus;Nannizzia gypsea | Any fungal organism that can be assigned to the species Microsporum gypseum. | Microsporum gypseum | ||
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS | C171516 | MERS Virus;MERS-CoV;Middle East Respiratory Syndrome-related Coronavirus | Any viral organism that can be assigned to the species Middle East respiratory syndrome coronavirus. | Middle East Respiratory Syndrome Coronavirus | ||
MITSUOKELLA MULTACIDA | C86516 | Any bacterial organism that can be assigned to the species Mitsuokella multacida. | Mitsuokella multacida | |||
MITSUOKELLA | C86515 | Any bacteria that is not assigned to the species level but can be assigned to the Mitsuokella genus level. | Mitsuokella | |||
MIXED FLORA | C120707 | The presence of more than one fungal and/or bacterial organism in a culture. (NCI) | Mixed Flora | |||
MOBILUNCUS CURTISII | C86518 | Any bacterial organism that can be assigned to the species Mobiluncus curtisii. | Mobiluncus curtisii | |||
MOBILUNCUS MULIERIS | C86519 | Any bacterial organism that can be assigned to the species Mobiluncus mulieris. | Mobiluncus mulieris | |||
MOBILUNCUS | C86517 | Any bacteria that is not assigned to the species level but can be assigned to the Mobiluncus genus level. | Mobiluncus | |||
MOELLERELLA WISCONSENSIS | C86521 | CDC Enteric Group 46 | Any bacterial organism that can be assigned to the species Moellerella wisconsensis. | Moellerella wisconsensis | ||
MOELLERELLA | C86520 | Any bacteria that is not assigned to the species level but can be assigned to the Moellerella genus level. | Moellerella | |||
MOGIBACTERIUM TIMIDUM | C86899 | Eubacterium timidum | Any bacterial organism that can be assigned to the species Mogibacterium timidum. | Mogibacterium timidum | ||
MOGIBACTERIUM | C86898 | Any bacteria that is not assigned to the species level but can be assigned to the Mogibacterium genus level. | Mogibacterium | |||
MOLD | C28266 | Filamentous fungus;Mould | A non-taxonomic grouping of fungi that grow in the form of mycelium of hyphae (vegetative filaments). | Mold | ||
MOLLUSCIPOXVIRUS | C112356 | Molluscipox Virus | Any viral organism that can be assigned to the genus Molluscipoxvirus. | Molluscipoxvirus | ||
MOLLUSCUM CONTAGIOSUM VIRUS | C112357 | MCV;MOCV | Any viral organism that can be assigned to the species Molluscum contagiosum virus. | Molluscum Contagiosum Virus | ||
MONASCUS RUBER | C127737 | Any fungal organism that can be assigned to the species Monascus ruber. | Monascus ruber | |||
MONKEYPOX VIRUS | C187442 | Monkey Pox Virus | Any viral organism that can be assigned to the species Monkeypox virus. | Monkeypox Virus | ||
MORAXELLA ATLANTAE | C86523 | Any bacterial organism that can be assigned to the species Moraxella atlantae. | Moraxella atlantae | |||
MORAXELLA BOVIS | C86524 | Any bacterial organism that can be assigned to the species Moraxella bovis. | Moraxella bovis | |||
MORAXELLA CANIS | C86525 | Any bacterial organism that can be assigned to the species Moraxella canis. | Moraxella canis | |||
MORAXELLA CATARRHALIS | C76210 | Branhamella catarrhalis | Any bacterial organism that can be assigned to the species Moraxella catarrhalis. | Moraxella catarrhalis | ||
MORAXELLA CATARRHALIS, BETA-LACTAMASE NEGATIVE | C123517 | Any bacterial organism that can be assigned to the species Moraxella catarrhalis and is beta-lactamase negative. | Moraxella catarrhalis, Beta-Lactamase Negative | |||
MORAXELLA CATARRHALIS, BETA-LACTAMASE POSITIVE | C123518 | Any bacterial organism that can be assigned to the species Moraxella catarrhalis and is beta-lactamase positive. | Moraxella catarrhalis, Beta-Lactamase Positive | |||
MORAXELLA CATARRHALIS, PENICILLINASE NEGATIVE | C123519 | Any bacterial organism that can be assigned to the species Moraxella catarrhalis and is penicillinase negative. | Moraxella catarrhalis, Penicillinase Negative | |||
MORAXELLA CATARRHALIS, PENICILLINASE POSITIVE | C123520 | Any bacterial organism that can be assigned to the species Moraxella catarrhalis and is penicillinase positive. | Moraxella catarrhalis, Penicillinase Positive | |||
MORAXELLA LACUNATA | C86526 | Moraxella liquefaciens | Any bacterial organism that can be assigned to the species Moraxella lacunata. | Moraxella lacunata | ||
MORAXELLA LINCOLNII | C86527 | Any bacterial organism that can be assigned to the species Moraxella lincolnii. | Moraxella lincolnii | |||
MORAXELLA NONLIQUEFACIENS | C86528 | Any bacterial organism that can be assigned to the species Moraxella nonliquefaciens. | Moraxella nonliquefaciens | |||
MORAXELLA OBLONGA | C86529 | Any bacterial organism that can be assigned to the species Moraxella oblonga. | Moraxella oblonga | |||
MORAXELLA OSLOENSIS | C86530 | Any bacterial organism that can be assigned to the species Moraxella osloensis. | Moraxella osloensis | |||
MORAXELLA | C86009 | Branhamella | Any bacteria that is not assigned to the species level but can be assigned to the Moraxella genus level. | Moraxella | ||
MORBILLIVIRUS | C14309 | Any viral organism that can be assigned to the genus Morbillivirus. | Morbillivirus | |||
MORGANELLA MORGANII | C86015 | Proteus morganii | Any bacterial organism that can be assigned to the species Morganella morganii. | Morganella morganii | ||
MORGANELLA MORGANII, LYSINE-POSITIVE | C123521 | Any bacterial organism that can be assigned to the species Morganella morganii and is able to metabolize lysine. | Morganella morganii, Lysine-Positive | |||
MORGANELLA MORGANII, ORNITHINE-NEGATIVE | C123522 | Any bacterial organism that can be assigned to the species Morganella morganii and is unable to metabolize ornithine. | Morganella morganii, Ornithine-Negative | |||
MORGANELLA | C86531 | Any bacteria that is not assigned to the species level but can be assigned to the Morganella genus level. | Morganella | |||
MUCOR RACEMOSUS | C187915 | Any fungal organism that can be assigned to the species Mucor racemosus. | Mucor racemosus | |||
MUCOR RAMOSISSIMUS | C127738 | Any fungal organism that can be assigned to the species Mucor ramosissimus. | Mucor ramosissimus | |||
MUCOR | C120708 | Any fungal organism that is not assigned to the species level but can be assigned to the Mucor genus level. | Mucor | |||
MUMPS RUBULAVIRUS | C14245 | Mumps orthorubulavirus;Mumps Virus | Any viral organism that can be assigned to the species Mumps rubulavirus. | Mumps Virus | ||
MURINE LEUKEMIA VIRUS SUBTYPE MOLONEY | C14241 | M-MuLV;Moloney Murine Leukemia Virus M-MuLV;MoMuLV;Rat Moloney Murine Leukemia Virus MoMuLV | Any viral organism that can be assigned to the Murine leukaemia virus species subtype Moloney. | Moloney Leukemia Virus | ||
MURINE LEUKEMIA VIRUS | C14244 | Murine Leukemia Virus MLV;Murine Leukemia Virus MuLV | Any viral organism that can be assigned to the species Murine leukemia virus. | Mouse Leukemia Virus | ||
MYCOBACTERIUM ABSCESSUS COMPLEX | C174337 | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium abscessus species. This grouping may include but is not limited to: M. abscessus subsp. abscessus, M. abscessus subsp. massiliense, and M. abscessus subsp. bolletii. | Mycobacterium abscessus Complex | |||
MYCOBACTERIUM ABSCESSUS SUBSP. BOLLETII | C150883 | Mycobacterium bolletii | Any bacterial organism that can be assigned to the species Mycobacterium abscessus subspecies bolletii. | Mycobacterium abscessus Subspecies bolletii | ||
MYCOBACTERIUM ABSCESSUS SUBSP. MASSILIENSE | C150882 | Mycobacterium massiliense | Any bacterial organism that can be assigned to the species Mycobacterium abscessus subspecies massiliense. | Mycobacterium abscessus Subspecies massiliense | ||
MYCOBACTERIUM ABSCESSUS | C86533 | Mycobacterium chelonae subsp. abscessus | Any bacterial organism that can be assigned to the species Mycobacterium abscessus. | Mycobacterium abscessus | ||
MYCOBACTERIUM AFRICANUM | C85544 | Any bacterial organism that can be assigned to the species Mycobacterium africanum. | Mycobacterium africanum | |||
MYCOBACTERIUM AVIUM COMPLEX | C76368 | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium avium species. | Mycobacterium avium complex | |||
MYCOBACTERIUM AVIUM | C86535 | Any bacterial organism that can be assigned to the species Mycobacterium avium. | Mycobacterium avium | |||
MYCOBACTERIUM BOVIS BCG | C85546 | An attenuated form of Mycobacterium bovis that is used to generate the Bacillus Calmette-Guerin vaccine. | Mycobacterium bovis BCG | |||
MYCOBACTERIUM BOVIS | C85545 | Any bacterial organism that can be assigned to the species Mycobacterium bovis. | Mycobacterium bovis | |||
MYCOBACTERIUM CANETTII | C85547 | Any bacterial organism that can be assigned to the species Mycobacterium canettii. | Mycobacterium canetti | |||
MYCOBACTERIUM CHELONAE | C86536 | Mycobacterium chelonae subsp. chelonae | Any bacterial organism that can be assigned to the species Mycobacterium chelonae. | Mycobacterium chelonae | ||
MYCOBACTERIUM CHIMAERA | C174343 | Any bacterial organism that can be assigned to the species Mycobacterium chimaera. | Mycolicibacterium chimaera | |||
MYCOBACTERIUM FLAVESCENS | C86537 | Any bacterial organism that can be assigned to the species Mycobacterium flavescens. | Mycobacterium flavescens | |||
MYCOBACTERIUM FORTUITUM COMPLEX | C86539 | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium fortuitum species. | Mycobacterium fortuitum Complex | |||
MYCOBACTERIUM FORTUITUM | C86538 | Any bacterial organism that can be assigned to the species Mycobacterium fortuitum. | Mycobacterium fortuitum | |||
MYCOBACTERIUM GASTRI | C86540 | Any bacterial organism that can be assigned to the species Mycobacterium gastri. | Mycobacterium gastri | |||
MYCOBACTERIUM GORDONAE | C86541 | Mycobacterium aquae | Any bacterial organism that can be assigned to the species Mycobacterium gordonae. | Mycobacterium gordonae | ||
MYCOBACTERIUM HAEMOPHILUM | C86542 | Any bacterial organism that can be assigned to the species Mycobacterium haemophilum. | Mycobacterium haemophilum | |||
MYCOBACTERIUM INTRACELLULARE | C91843 | Any bacterial organism that can be assigned to the species Mycobacterium intracellulare. | Mycobacterium intracellulare | |||
MYCOBACTERIUM INTRACELLULARE/CHIMAERA GROUP | C174342 | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium intracellulare and Mycobacterium chimaera species. | Mycobacterium intracellulare and chimaera Group | |||
MYCOBACTERIUM KANSASII | C85543 | Any bacterial organism that can be assigned to the species Mycobacterium kansasii. | Mycobacterium kansasii | |||
MYCOBACTERIUM LEPRAE | C86544 | Any bacterial organism that can be assigned to the species Mycobacterium leprae. | Mycobacterium leprae | |||
MYCOBACTERIUM MALMOENSE | C150880 | Any bacterial organism that can be assigned to the species Mycobacterium malmoense. | Mycobacterium malmoense | |||
MYCOBACTERIUM MARINUM | C86545 | Mycobacterium balnei | Any bacterial organism that can be assigned to the species Mycobacterium marinum. | Mycobacterium marinum | ||
MYCOBACTERIUM MICROTI | C85548 | Any bacterial organism that can be assigned to the species Mycobacterium microti. | Mycobacterium microti | |||
MYCOBACTERIUM PEREGRINUM | C86546 | Any bacterial organism that can be assigned to the species Mycobacterium peregrinum. | Mycobacterium peregrinum | |||
MYCOBACTERIUM SCROFULACEUM | C86547 | Any bacterial organism that can be assigned to the species Mycobacterium scrofulaceum. | Mycobacterium scrofulaceum | |||
MYCOBACTERIUM SIMIAE | C86548 | Mycobacterium habana | Any bacterial organism that can be assigned to the species Mycobacterium simiae. | Mycobacterium simiae | ||
MYCOBACTERIUM SMEGMATIS | C86590 | Any bacterial organism that can be assigned to the species Mycobacterium smegmatis. | Mycobacterium smegmatis | |||
MYCOBACTERIUM SZULGAI | C86591 | Any bacterial organism that can be assigned to the species Mycobacterium szulgai. | Mycobacterium szulgai | |||
MYCOBACTERIUM TERRAE | C86592 | Any bacterial organism that can be assigned to the species Mycobacterium terrae. | Mycobacterium terrae | |||
MYCOBACTERIUM THERMORESISTIBILE | C86593 | Any bacterial organism that can be assigned to the species Mycobacterium thermoresistibile. | Mycobacterium thermoresistibile | |||
MYCOBACTERIUM TUBERCULOSIS COMPLEX | C86594 | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycobacterium tuberculosis species. | Mycobacterium tuberculosis Complex | |||
MYCOBACTERIUM TUBERCULOSIS | C76370 | Any bacterial organism that can be assigned to the species Mycobacterium tuberculosis. | Mycobacterium tuberculosis | |||
MYCOBACTERIUM ULCERANS | C86595 | Mycobacterium buruli | Any bacterial organism that can be assigned to the species Mycobacterium ulcerans. | Mycobacterium ulcerans | ||
MYCOBACTERIUM XENOPI | C150881 | Any bacterial organism that can be assigned to the species Mycobacterium xenopi. | Mycobacterium xenopi | |||
MYCOBACTERIUM | C76369 | Any bacteria that is not assigned to the species level but can be assigned to the Mycobacterium genus level. | Mycobacterium | |||
MYCOLICIBACTERIUM AUBAGNENSE | C174341 | Mycobacterium aubagnense | Any bacterial organism that can be assigned to the species Mycolicibacterium aubagnense. | Mycolicibacterium aubagnense | ||
MYCOLICIBACTERIUM MUCOGENICUM GROUP | C174338 | Mycobacterium mucogenicum Group | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Mycolicibacterium mucogenicum species. This group may include but is not limited to: M. mucogenicum, M. aubagnense, and M. phocaicum. | Mycolicibacterium mucogenicum Group | ||
MYCOLICIBACTERIUM MUCOGENICUM | C125636 | Mycobacterium mucogenicum | Any bacterial organism that can be assigned to the species Mycolicibacterium mucogenicum. | Mycobacterium mucogenicum | ||
MYCOLICIBACTERIUM PHOCAICUM | C174340 | Mycobacterium phocaicum | Any bacterial organism that can be assigned to the species Mycolicibacterium phocaicum. | Mycolicibacterium phocaicum | ||
MYCOPLASMA HOMINIS | C86597 | Any bacterial organism that can be assigned to the species Mycoplasma hominis. | Mycoplasma hominis | |||
MYCOPLASMA ORALE | C86598 | Any bacterial organism that can be assigned to the species Mycoplasma orale. | Mycoplasma orale | |||
MYCOPLASMA PNEUMONIAE | C86599 | Any bacterial organism that can be assigned to the species Mycoplasma pneumoniae. | Mycoplasma pneumoniae | |||
MYCOPLASMA | C73540 | Any bacteria that is not assigned to the species level but can be assigned to the Mycoplasma genus level. | Mycoplasma | |||
MYROIDES ODORATUS | C86954 | Flavobacterium odoratum | Any bacterial organism that can be assigned to the species Myroides odoratus. | Myroides odoratus | ||
MYROIDES | C86953 | Any bacteria that is not assigned to the species level but can be assigned to the Myroides genus level. | Myroides | |||
NAEGLERIA FOWLERI | C123523 | Any unicellular, eukaryotic organism that can be assigned to the species Naegleria fowleri. | Naegleria fowleri | |||
NAEGLERIA | C123422 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Naegleria genus level. | Naegleria | |||
NAIROVIRUS | C112358 | Any viral organism that can be assigned to the genus Nairovirus. | Nairovirus | |||
NECATOR AMERICANUS | C123524 | Any nematode parasite that can be assigned to the species Necator americanus. | Necator americanus | |||
NEISSERIA CANIS | C86600 | Any bacterial organism that can be assigned to the species Neisseria canis. | Neisseria canis | |||
NEISSERIA CINEREA | C86601 | Micrococcus cinereus | Any bacterial organism that can be assigned to the species Neisseria cinerea. | Neisseria cinerea | ||
NEISSERIA ELONGATA SUBSP. NITROREDUCENS | C123648 | CDC Group M-6 | Any bacterial organism that can be assigned to the species Neisseria elongata subspecies nitroreducens. | Neisseria elongata subsp nitroreducens | ||
NEISSERIA ELONGATA | C123423 | Any bacterial organism that can be assigned to the species Neisseria elongata. | Neisseria elongata | |||
NEISSERIA FLAVESCENS | C86602 | Any bacterial organism that can be assigned to the species Neisseria flavescens. | Neisseria flavescens | |||
NEISSERIA GONORRHOEAE | C86603 | Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae. | Neisseria gonorrhoeae | |||
NEISSERIA GONORRHOEAE, BETA-LACTAMASE NEGATIVE | C123525 | Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae and is beta-lactamase negative. | Neisseria gonorrhoeae, Beta-lactamase Negative | |||
NEISSERIA GONORRHOEAE, BETA-LACTAMASE POSITIVE | C123526 | Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae and is beta-lactamase positive. | Neisseria gonorrhoeae, Beta-lactamase Positive | |||
NEISSERIA GONORRHOEAE, PENICILLINASE NEGATIVE | C123527 | Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae and is penicillinase negative. | Neisseria gonorrhoeae, Penicillinase Negative | |||
NEISSERIA GONORRHOEAE, PENICILLINASE POSITIVE | C123528 | Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae and is penicillinase positive. | Neisseria gonorrhoeae, Penicillinase Positive | |||
NEISSERIA LACTAMICA | C86604 | Any bacterial organism that can be assigned to the species Neisseria lactamica. | Neisseria lactamica | |||
NEISSERIA MENINGITIDIS SEROGROUP B | C189612 | MenB;Neisseria meningitidis Group B | Any bacterial organism that can be assigned to the Neisseria meningitidis serogroup B. | Neisseria meningitidis Serogroup B | ||
NEISSERIA MENINGITIDIS | C86605 | Any bacterial organism that can be assigned to the species Neisseria meningitidis. | Neisseria meningitidis | |||
NEISSERIA MUCOSA | C86606 | Any bacterial organism that can be assigned to the species Neisseria mucosa. | Neisseria mucosa | |||
NEISSERIA POLYSACCHAREA | C86607 | Any bacterial organism that can be assigned to the species Neisseria polysaccharea. | Neisseria polysaccharea | |||
NEISSERIA SICCA | C86608 | Any bacterial organism that can be assigned to the species Neisseria sicca. | Neisseria sicca | |||
NEISSERIA SUBFLAVA | C86609 | Any bacterial organism that can be assigned to the species Neisseria subflava. | Neisseria subflava | |||
NEISSERIA WEAVERII | C86610 | CDC Group M-5 | Any bacterial organism that can be assigned to the species Neisseria weaverii. | Neisseria weaverii | ||
NEISSERIA | C76371 | Any bacteria that is not assigned to the species level but can be assigned to the Neisseria genus level. | Neisseria | |||
NEMATODA | C14248 | Roundworms | Any parasitic roundworm that is not assigned to the species level but can be assigned to the Nematoda phylum level. | Nematoda | ||
NEWCASTLE DISEASE VIRUS | C93023 | Avian Paramyxovirus Type 1;NDV | Any viral organism that can be assigned to the species Newcastle disease virus. | Newcastle Disease Virus | ||
NIGROSPORA | C123529 | Any fungal organism that is not assigned to the species level but can be assigned to the Nigrospora genus level. | Nigrospora | |||
NIPAH VIRUS | C112359 | NiV | Any viral organism that can be assigned to the species Nipah virus. | Nipah Virus | ||
NOCARDIA ASTEROIDES COMPLEX | C86612 | A non-taxonomic grouping of bacterial species that are phenotypically or genetically similar to the Nocardia asteroides species. | Nocardia asteroides Complex | |||
NOCARDIA ASTEROIDES | C86611 | Any bacterial organism that can be assigned to the species Nocardia asteroides. | Nocardia asteroides | |||
NOCARDIA BRASILIENSIS | C86613 | Any bacterial organism that can be assigned to the species Nocardia brasiliensis. | Nocardia brasiliensis | |||
NOCARDIA CYRIACIGEORGICA | C128543 | Any bacterial organism that can be assigned to the species Nocardia cyriacigeorgica. | Nocardia cyriacigeorgica | |||
NOCARDIA DASSONVILLEI | C86614 | Any bacterial organism that can be assigned to the species Nocardia dassonvillei. | Nocardia dassonvillei | |||
NOCARDIA FARCINICA | C86615 | Any bacterial organism that can be assigned to the species Nocardia farcinica. | Nocardia farcinica | |||
NOCARDIA NOVA | C86616 | Any bacterial organism that can be assigned to the species Nocardia nova. | Nocardia nova | |||
NOCARDIA OTITIDISCAVIARUM | C86617 | Nocardia caviae | Any bacterial organism that can be assigned to the species Nocardia otitidiscaviarum. | Nocardia otitidiscaviarum | ||
NOCARDIA | C76372 | Any bacteria that is not assigned to the species level but can be assigned to the Nocardia genus level. | Nocardia | |||
NON-FERMENTATIVE GRAM-NEGATIVE BACILLUS | C86618 | Non-fermentative Gram-negative Rod | Any rod-shaped, anaerobic bacteria that cannot convert carbohydrates into acids and alcohols and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Non-Fermentative Gram Negative Bacillus | ||
NORMAL FLORA | C125957 | The presence of microorganisms that normally reside at an anatomical site and that under normal circumstances do not cause disease. | Normal Flora | |||
NOROVIRUS GENOGROUP I | C184686 | Human calicivirus genogroup 1;Norovirus GI | Any viral organism that can be assigned to the Norovirus genogroup I. | Norovirus Genogroup I | ||
NOROVIRUS GENOGROUP II | C184687 | Norovirus GII | Any viral organism that can be assigned to the Norovirus genogroup II. | Norovirus Genogroup II | ||
NOROVIRUS GENOGROUP II.4 | C166071 | Norovirus Genogroup GII.4;Norovirus GII.4 | Any viral organism that can be assigned to the Norovirus genogroup II.4. | Norovirus Genogroup II.4 | ||
NOROVIRUS | C112362 | Norwalk-like virus;NoV | Any viral organism that can be assigned to the genus Norovirus. | Norovirus | ||
NORWALK VIRUS | C112363 | Norwalk calicivirus;NV | Any viral organism that can be assigned to the species Norwalk virus. | Norwalk Virus | ||
NOSEMA | C123530 | Any fungal organism that is not assigned to the species level but can be assigned to the Nosema genus level. | Nosema | |||
OCHROBACTRUM ANTHROPI | C86620 | Achromobacter subsp. Biotype 1 | Any bacterial organism that can be assigned to the species Ochrobactrum anthropi. | Ochrobactrum anthropi | ||
OCHROBACTRUM INTERMEDIUM | C86621 | Any bacterial organism that can be assigned to the species Ochrobactrum intermedium. | Ochrobactrum intermedium | |||
OCHROBACTRUM | C86619 | Any bacteria that is not assigned to the species level but can be assigned to the Ochrobactrum genus level. | Ochrobactrum | |||
ODORIBACTER SPLANCHNICUS | C86176 | Bacteroides splanchnicus | Any bacterial organism that can be assigned to the species Odoribacter splanchnicus. | Bacteroides splanchnicus | ||
OERSKOVIA TURBATA | C86623 | Any bacterial organism that can be assigned to the species Oerskovia turbata. | Oerskovia turbata | |||
OERSKOVIA | C86622 | Any bacteria that is not assigned to the species level but can be assigned to the Oerskovia genus level. | Oerskovia | |||
OIDIODENDRON | C123531 | Any fungal organism that is not assigned to the species level but can be assigned to the Oidiodendron genus level. | Oidiodendron | |||
OLIGELLA UREOLYTICA | C86625 | CDC Group Ive | Any bacterial organism that can be assigned to the species Oligella ureolytica. | Oligella ureolytica | ||
OLIGELLA URETHRALIS | C86626 | Any bacterial organism that can be assigned to the species Oligella urethralis. | Oligella urethralis | |||
OLIGELLA | C86624 | Any bacteria that is not assigned to the species level but can be assigned to the Oligella genus level. | Oligella | |||
OLSENELLA ULI | C86628 | Lactobacillus uli | Any bacterial organism that can be assigned to the species Olsenella uli. | Olsenella uli | ||
OLSENELLA | C86627 | Any bacteria that is not assigned to the species level but can be assigned to the Olsenella genus level. | Olsenella | |||
ONCHOCERCA VOLVULUS | C124355 | Any trematode parasite that can be assigned to the species Onchocerca volvulus. | Onchocerca volvulus | |||
OPISTHORCHIS FELINEUS | C124356 | Cat Liver Fluke | Any trematode parasite that can be assigned to the species Opisthorchis felineus. | Opisthorchis felineus | ||
ORBIVIRUS | C112365 | Any viral organism that can be assigned to the genus Orbivirus. | Orbivirus | |||
ORTHOBUNYAVIRUS | C112366 | Bunyavirus | Any viral organism that can be assigned to the genus Orthobunyavirus. | Orthobunyavirus | ||
ORTHOPOXVIRUS | C96524 | Any viral organism that can be assigned to the genus Orthopoxvirus. | Orthopoxvirus | |||
OXACILLIN RESISTANT STAPHYLOCOCCUS AUREUS | C147469 | ORSA | Any bacterial organism that can be assigned to the species Staphylococcus aureus and is resistant to the antibiotic oxacillin. | Oxacillin Resistant Staphylococcus aureus | ||
PAECILOMYCES | C123532 | Any fungal organism that is not assigned to the species level but can be assigned to the Paecilomyces genus level. | Paecilomyces | |||
PAENIBACILLUS GLUCANOLYTICUS | C123533 | Bacillus glucanolyticus | Any bacterial organism that can be assigned to the species Paenibacillus glucanolyticus. | Paenibacillus glucanolyticus | ||
PAENIBACILLUS PHOENICIS | C128544 | Any bacterial organism that can be assigned to the species Paenibacillus phoenicis. | Paenibacillus phoenicis | |||
PANDORAEA APISTA | C123534 | Any bacterial organism that can be assigned to the species Pandoraea apista. | Pandoraea apista | |||
PANDORAEA PNOMENUSA | C86630 | Any bacterial organism that can be assigned to the species Pandoraea pnomenusa. | Pandoraea pnomenusa | |||
PANDORAEA SPUTORUM | C119327 | Any bacterial organism that can be assigned to the species Pandoraea sputorum. | Pandoraea sputorum | |||
PANDORAEA | C86629 | Any bacteria that is not assigned to the species level but can be assigned to the Pandoraea genus level. | Pandoraea | |||
PANNONIBACTER PHRAGMITETUS | C119328 | Achromobacter group B;Achromobacter group E | Any bacterial organism that can be assigned to the species Pannonibacter phragmitetus. | Pannonibacter phragmitetus | ||
PANTOEA AGGLOMERANS | C86632 | Enterobacter agglomerans | Any bacterial organism that can be assigned to the species Pantoea agglomerans. | Pantoea agglomerans | ||
PANTOEA | C86631 | Any bacteria that is not assigned to the species level but can be assigned to the Pantoea genus level. | Pantoea | |||
PARABACTEROIDES DISTASONIS | C86634 | Bacteroides distasonis | Any bacterial organism that can be assigned to the species Parabacteroides distasonis. | Parabacteroides distasonis | ||
PARABACTEROIDES GOLDSTEINII | C123535 | Bacteroides goldsteinii | Any bacterial organism that can be assigned to the species Parabacteroides goldsteinii. | Parabacteroides goldsteinii | ||
PARABACTEROIDES JOHNSONII | C123536 | Any bacterial organism that can be assigned to the species Parabacteroides johnsonii. | Parabacteroides johnsonii | |||
PARABACTEROIDES MERDAE | C86635 | Bacteroides fragilis T4-1;Bacteroides merdae | Any bacterial organism that can be assigned to the species Parabacteroides merdae. | Parabacteroides merdae | ||
PARABACTEROIDES | C86633 | Any bacteria that is not assigned to the species level but can be assigned to the Parabacteroides genus level. | Parabacteroides | |||
PARACOCCUS YEEI | C123537 | CDC Group EO-2 | Any bacterial organism that can be assigned to the species Paracoccus yeei. | Paracoccus yeei | ||
PARAGONIMUS WESTERMANI | C123538 | Oriental Lung Fluke | Any trematode parasite that can be assigned to the species Paragonimus westermani. | Paragonimus westermani | ||
PARAPOXVIRUS | C112367 | Any viral organism that can be assigned to the genus Parapoxvirus. | Parapoxvirus | |||
PARECHOVIRUS | C186198 | Any viral organism that is not assigned to the species level but can be assigned to the Parechovirus genus level. | Parechovirus | |||
PARVIMONAS MICRA | C86901 | Micromonas micros;Peptostreptococcus micros | Any bacterial organism that can be assigned to the species Parvimonas micra. | Parvimonas micra | ||
PARVIMONAS | C86900 | Any bacteria that is not assigned to the species level but can be assigned to the Parvimonas genus level. | Parvimonas | |||
PASTEURELLA AEROGENES | C86637 | Any bacterial organism that can be assigned to the species Pasteurella aerogenes. | Pasteurella aerogenes | |||
PASTEURELLA BETTYAE | C86638 | Any bacterial organism that can be assigned to the species Pasteurella bettyae. | Pasteurella bettyae | |||
PASTEURELLA CANIS | C86639 | Pasteurella multocida Biotype 6 | Any bacterial organism that can be assigned to the species Pasteurella canis. | Pasteurella canis | ||
PASTEURELLA MULTOCIDA | C76373 | Pasteurella septica | Any bacterial organism that can be assigned to the species Pasteurella multocida. | Pasteurella multocida | ||
PASTEURELLA PNEUMOTROPICA | C86640 | Any bacterial organism that can be assigned to the species Pasteurella pneumotropica. | Pasteurella pneumotropica | |||
PASTEURELLA | C86636 | Any bacteria that is not assigned to the species level but can be assigned to the Pasteurella genus level. | Pasteurella | |||
PEDIOCOCCUS PENTOSACEUS | C123539 | Pediococcus hennebergii | Any bacterial organism that can be assigned to the species Pediococcus pentosaceus. | Pediococcus pentosaceus | ||
PEDIOCOCCUS | C86641 | Any bacteria that is not assigned to the species level but can be assigned to the Pediococcus genus level. | Pediococcus | |||
PENICILLIUM CHRYSOGENUM | C187916 | Penicillium notatum | Any fungal organism that can be assigned to the species Penicillium chrysogenum. | Penicillium chrysogenum | ||
PENICILLIUM | C123540 | Any fungal organism that is not assigned to the species level but can be assigned to the Penicillium genus level. | Penicillium | |||
PENTATRICHOMONAS HOMINIS | C123541 | Any unicellular, eukaryotic organism that can be assigned to the species Pentatrichomonas hominis. | Pentatrichomonas hominis | |||
PEPTOCOCCUS NIGER | C86643 | Micrococcus niger | Any bacterial organism that can be assigned to the species Peptococcus niger. | Peptococcus niger | ||
PEPTOCOCCUS | C86642 | Any bacteria that is not assigned to the species level but can be assigned to the Peptococcus genus level. | Peptococcus | |||
PEPTONIPHILUS ASACCHAROLYTICUS | C86903 | Peptococcus asaccharolyticus;Peptostreptococcus asaccharolyticus | Any bacterial organism that can be assigned to the species Peptoniphilus asaccharolyticus. | Peptoniphilus asaccharolyticus | ||
PEPTONIPHILUS HAREI | C114245 | Peptostreptococcus harei;Schleiferella harei | Any bacterial organism that can be assigned to the species Peptoniphilus harei. | Peptoniphilus harei | ||
PEPTONIPHILUS INDOLICUS | C86904 | Peptostreptococcus indolicus | Any bacterial organism that can be assigned to the species Peptoniphilus indolicus. | Peptoniphilus indolicus | ||
PEPTONIPHILUS | C86902 | Any bacteria that is not assigned to the species level but can be assigned to the Peptoniphilus genus level. | Peptoniphilus | |||
PEPTOSTREPTOCOCCUS ANAEROBIUS | C86645 | Any bacterial organism that can be assigned to the species Peptostreptococcus anaerobius. | Peptostreptococcus anaerobius | |||
PEPTOSTREPTOCOCCUS STOMATIS | C119329 | Any bacterial organism that can be assigned to the species Peptostreptococcus stomatis. | Peptostreptococcus stomatis | |||
PEPTOSTREPTOCOCCUS | C86644 | Any bacteria that is not assigned to the species level but can be assigned to the Peptostreptococcus genus level. | Peptostreptococcus | |||
PESTALOTIOPSIS | C123542 | Any fungal organism that is not assigned to the species level but can be assigned to the Pestalotiopsis genus level. | Pestalotiopsis | |||
PHIALOPHORA VERRUCOSA | C127739 | Any fungal organism that can be assigned to the species Phialophora verrucosa. | Phialophora verrucosa | |||
PHIALOPHORA | C123543 | Any fungal organism that is not assigned to the species level but can be assigned to the Phialophora genus level. | Phialophora | |||
PHLEBOVIRUS | C112397 | Any viral organism that can be assigned to the genus Phlebovirus. | Phlebovirus | |||
PHOTOBACTERIUM DAMSELAE | C86647 | Photobacterium damselae subsp. damselae;Vibrio damsela | Any bacterial organism that can be assigned to the species Photobacterium damselae. | Photobacterium damselae | ||
PHOTOBACTERIUM | C86646 | Any bacteria that is not assigned to the species level but can be assigned to the Photobacterium genus level. | Photobacterium | |||
PHOTORHABDUS LUMINESCENS | C86649 | Any bacterial organism that can be assigned to the species Photorhabdus luminescens. | Photorhabdus luminescens | |||
PHOTORHABDUS | C86648 | Any bacteria that is not assigned to the species level but can be assigned to the Photorhabdus genus level. | Photorhabdus | |||
PICHIA FERMENTANS | C127740 | Candida fimetaria;Candida lambica;Mycoderma lambica | Any fungal organism that can be assigned to the species Pichia fermentans. | Pichia fermentans | ||
PICHIA KLUYVERI | C114270 | Any fungal organism that can be assigned to the species Pichia kluyveri. | Pichia kluyveri | |||
PICHIA KUDRIAVZEVII | C77173 | Candida krusei;Issatchenkia orientalis | Any fungal organism that can be assigned to the species Pichia kudriavzevii. | Candida krusei | ||
PICHIA NORVEGENSIS | C114259 | Candida mycoderma var. annulata | Any fungal organism that can be assigned to the species Pichia norvegensis. | Pichia norvegensis | ||
PICHIA | C123544 | Hansenula | Any fungal organism that is not assigned to the species level but can be assigned to the Pichia genus level. | Pichia | ||
PIEDRAIA HORTAE | C127741 | Any fungal organism that can be assigned to the species Piedraia hortae. | Piedraia hortae | |||
PIEDRAIA | C123545 | Any fungal organism that is not assigned to the species level but can be assigned to the Piedraia genus level. | Piedraia | |||
PITHOMYCES | C123546 | Any fungal organism that is not assigned to the species level but can be assigned to the Pithomyces genus level. | Pithomyces | |||
PLANOCOCCUS | C86650 | Any bacteria that is not assigned to the species level but can be assigned to the Planococcus genus level. | Planococcus | |||
PLASMODIUM FALCIPARUM | C123547 | Any unicellular, eukaryotic organism that can be assigned to the species Plasmodium falciparum. | Plasmodium falciparum | |||
PLASMODIUM MALARIAE | C123548 | Any unicellular, eukaryotic organism that can be assigned to the species Plasmodium malariae. | Plasmodium malariae | |||
PLASMODIUM OVALE | C123549 | Any unicellular, eukaryotic organism that can be assigned to the species Plasmodium ovale. | Plasmodium ovale | |||
PLASMODIUM VIVAX | C123550 | Any unicellular, eukaryotic organism that can be assigned to the species Plasmodium vivax. | Plasmodium vivax | |||
PLEISTOPHORA | C124357 | Any fungal organism that is not assigned to the species level but can be assigned to the Pleistophora genus level. | Pleistophora | |||
PLESIOMONAS SHIGELLOIDES | C86652 | Aeromonas shigelloides | Any bacterial organism that can be assigned to the species Plesiomonas shigelloides. | Plesiomonas shigelloides | ||
PLESIOMONAS | C86651 | Any bacteria that is not assigned to the species level but can be assigned to the Plesiomonas genus level. | Plesiomonas | |||
PNEUMOCYSTIS CARINII | C127308 | Any fungal organism that can be assigned to the species Pneumocystis carinii. | Pneumocystis carinii | |||
PNEUMOCYSTIS JIROVECII | C117361 | Pneumocystis carinii f. sp. Hominis | Any fungal organism that can be assigned to the species Pneumocystis jirovecii. | Pneumocystis jirovecii | ||
PNEUMOCYSTIS | C124358 | Any fungal organism that is not assigned to the species level but can be assigned to the Pneumocystis genus level. | Pneumocystis | |||
PNEUMOVIRUS | C112398 | Any viral organism that can be assigned to the genus Pneumovirus. | Pneumovirus | |||
POLIOVIRUS | C14259 | ENC;Enterovirus C;Human enterovirus C | Any viral organism that can be assigned to the species Poliovirus. | Poliovirus | ||
POLYOMAVIRUS | C14260 | Any viral organism that can be assigned to the genus Polyomavirus. | Polyomavirus | |||
PORPHYROMONAS ASACCHAROLYTICA | C86654 | Bacteroides asaccharolyticus | Any bacterial organism that can be assigned to the species Porphyromonas asaccharolytica. | Porphyromonas asaccharolytica | ||
PORPHYROMONAS BENNONIS | C128546 | Any bacterial organism that can be assigned to the species Porphyromonas bennonis. | Porphyromonas bennonis | |||
PORPHYROMONAS CATONIAE | C86655 | Any bacterial organism that can be assigned to the species Porphyromonas catoniae. | Porphyromonas catoniae | |||
PORPHYROMONAS ENDODONTALIS | C86656 | Bacteroides endodontalis | Any bacterial organism that can be assigned to the species Porphyromonas endodontalis. | Porphyromonas endodontalis | ||
PORPHYROMONAS GINGIVALIS | C86657 | Bacteroides gingivalis | Any bacterial organism that can be assigned to the species Porphyromonas gingivalis. | Porphyromonas gingivalis | ||
PORPHYROMONAS LEVII | C86658 | Bacteroides levii;Bacteroides melaninogenicus subsp. levii | Any bacterial organism that can be assigned to the species Porphyromonas levii. | Porphyromonas levii | ||
PORPHYROMONAS SOMERAE | C86659 | Any bacterial organism that can be assigned to the species Porphyromonas somerae. | Porphyromonas somerae | |||
PORPHYROMONAS | C86653 | Any bacteria that is not assigned to the species level but can be assigned to the Porphyromonas genus level. | Porphyromonas | |||
PREVOTELLA AMNII | C124359 | Any bacterial organism that can be assigned to the species Prevotella amnii. | Prevotella amnii | |||
PREVOTELLA BARONIAE | C124360 | Prevotella Genomospecies E4 | Any bacterial organism that can be assigned to the species Prevotella baroniae. | Prevotella baroniae | ||
PREVOTELLA BERGENSIS | C119330 | Any bacterial organism that can be assigned to the species Prevotella bergensis. | Prevotella bergensis | |||
PREVOTELLA BIVIA | C86661 | Bacteroides bivia | Any bacterial organism that can be assigned to the species Prevotella bivia. | Prevotella bivia | ||
PREVOTELLA BREVIS | C86662 | Bacteroides ruminicola subsp. brevis;Bacteroides ruminicola subsp. brevus | Any bacterial organism that can be assigned to the species Prevotella brevis. | Prevotella brevis | ||
PREVOTELLA BUCCAE | C86663 | Bacteroides buccae | Any bacterial organism that can be assigned to the species Prevotella buccae. | Prevotella buccae | ||
PREVOTELLA BUCCALIS | C86664 | Any bacterial organism that can be assigned to the species Prevotella buccalis. | Prevotella buccalis | |||
PREVOTELLA CORPORIS | C86665 | Any bacterial organism that can be assigned to the species Prevotella corporis. | Prevotella corporis | |||
PREVOTELLA DENTALIS | C86666 | Any bacterial organism that can be assigned to the species Prevotella dentalis. | Prevotella dentalis | |||
PREVOTELLA DENTICOLA | C86667 | Bacteroides denticola | Any bacterial organism that can be assigned to the species Prevotella denticola. | Prevotella denticola | ||
PREVOTELLA DISIENS | C86668 | Bacteroides disiens | Any bacterial organism that can be assigned to the species Prevotella disiens. | Prevotella disiens | ||
PREVOTELLA HEPARINOLYTICA | C86669 | Bacteroides heparinolyticus | Any bacterial organism that can be assigned to the species Prevotella heparinolytica. | Prevotella heparinolytica | ||
PREVOTELLA HISTICOLA | C128545 | Any bacterial organism that can be assigned to the species Prevotella histicola. | Prevotella histicola | |||
PREVOTELLA INTERMEDIA | C86670 | Bacteroides intermedia | Any bacterial organism that can be assigned to the species Prevotella intermedia. | Prevotella intermedia | ||
PREVOTELLA INTERMEDIA/NIGRESCENS GROUP | C86671 | A non-taxonomic grouping of bacteria that belongs to the intermedia/nigrescens group of the genus Prevotella. | Prevotella intermedia/nigrescens Group | |||
PREVOTELLA LOESCHEII | C86672 | Any bacterial organism that can be assigned to the species Prevotella loescheii. | Prevotella loescheii | |||
PREVOTELLA MELANINOGENICA | C86673 | Bacteroides melaninogenicus | Any bacterial organism that can be assigned to the species Prevotella melaninogenica. | Prevotella melaninogenica | ||
PREVOTELLA NIGRESCENS | C86674 | Any bacterial organism that can be assigned to the species Prevotella nigrescens. | Prevotella nigrescens | |||
PREVOTELLA ORALIS | C86675 | Bacteroides oralis | Any bacterial organism that can be assigned to the species Prevotella oralis. | Prevotella oralis | ||
PREVOTELLA ORIS | C86676 | Bacteroides oris | Any bacterial organism that can be assigned to the species Prevotella oris. | Prevotella oris | ||
PREVOTELLA RUMINICOLA | C86677 | Bacteroides ruminicola | Any bacterial organism that can be assigned to the species Prevotella ruminicola. | Prevotella ruminicola | ||
PREVOTELLA TANNERAE | C86678 | Any bacterial organism that can be assigned to the species Prevotella tannerae. | Prevotella tannerae | |||
PREVOTELLA TIMONENSIS | C124361 | Any bacterial organism that can be assigned to the species Prevotella timonensis. | Prevotella timonensis | |||
PREVOTELLA VERORALIS | C86679 | Any bacterial organism that can be assigned to the species Prevotella veroralis. | Prevotella veroralis | |||
PREVOTELLA | C86660 | Any bacteria that is not assigned to the species level but can be assigned to the Prevotella genus level. | Prevotella | |||
PROPIONIBACTERIUM ACNES | C14378 | Bacillus acnes;Corynebacterium acnes;Corynebacterium parvum;Cutibacterium acnes | Any bacterial organism that can be assigned to the species Propionibacterium acnes. | Propionibacterium acnes | ||
PROPIONIBACTERIUM AVIDUM | C86681 | Any bacterial organism that can be assigned to the species Propionibacterium avidum. | Propionibacterium avidum | |||
PROPIONIBACTERIUM GRANULOSUM | C86682 | Corynebacterium granulosum | Any bacterial organism that can be assigned to the species Propionibacterium granulosum. | Propionibacterium granulosum | ||
PROPIONIBACTERIUM PROPIONICUM | C86683 | Actinomyces propionicus | Any bacterial organism that can be assigned to the species Propionibacterium propionicum. | Propionibacterium propionicum | ||
PROPIONIBACTERIUM | C86013 | Any bacteria that is not assigned to the species level but can be assigned to the Propionibacterium genus level. | Propionibacterium | |||
PROTEUS HAUSERI | C86684 | Any bacterial organism that can be assigned to the species Proteus hauseri. | Proteus hauseri | |||
PROTEUS INCONSTANS | C84582 | Providencia inconstans | Any bacterial organism that can be assigned to the species Proteus inconstans. | Proteus inconstans | ||
PROTEUS MIRABILIS | C86019 | Any bacterial organism that can be assigned to the species Proteus mirabilis. | Proteus mirabilis | |||
PROTEUS MYXOFACIENS | C86687 | Any bacterial organism that can be assigned to the species Proteus myxofaciens. | Proteus myxofaciens | |||
PROTEUS PENNERI | C86688 | Indole Negative Proteus vulgaris | Any bacterial organism that can be assigned to the species Proteus penneri. | Proteus penneri | ||
PROTEUS VULGARIS | C85250 | Any bacterial organism that can be assigned to the species Proteus vulgaris. | Proteus vulgaris | |||
PROTEUS | C76374 | Any bacteria that is not assigned to the species level but can be assigned to the Proteus genus level. | Proteus | |||
PROTOTHECA STAGNORUM | C124362 | Prototheca stagnora | Any algal organism that can be assigned to the species Prototheca stagnorum. | Prototheca stagnora | ||
PROTOTHECA WICKERHAMII | C114271 | Any algal organism that can be assigned to the species Prototheca wickerhamii. | Prototheca wickerhamii | |||
PROTOTHECA ZOPFII | C124363 | Any algal organism that can be assigned to the species Prototheca zopfii. | Prototheca zopfii | |||
PROVIDENCIA ALCALIFACIENS | C86691 | Any bacterial organism that can be assigned to the species Providencia alcalifaciens. | Providencia alcalifaciens | |||
PROVIDENCIA HEIMBACHAE | C86692 | Any bacterial organism that can be assigned to the species Providencia heimbachae. | Providencia heimbachae | |||
PROVIDENCIA RETTGERI | C86693 | Any bacterial organism that can be assigned to the species Providencia rettgeri. | Proteus rettgeri | |||
PROVIDENCIA RUSTIGIANII | C86694 | Providencia alcalifaciens Biogroup 3 | Any bacterial organism that can be assigned to the species Providencia rustigianii. | Providencia rustigianii | ||
PROVIDENCIA STUARTII | C86695 | Any bacterial organism that can be assigned to the species Providencia stuartii. | Providencia stuartii | |||
PROVIDENCIA STUARTII, UREA-POSITIVE | C124364 | Any bacterial organism that can be assigned to the species Providencia stuartii and is able to metabolize urea. | Urea-Positive Providencia stuartii | |||
PROVIDENCIA | C86690 | Any bacteria that is not assigned to the species level but can be assigned to the Providencia genus level. | Providencia | |||
PSEUDOCOWPOX VIRUS | C112401 | Paravaccinia virus;Pseudocowpoxvirus | Any viral organism that can be assigned to the species Pseudocowpox virus. | Pseudocowpox Virus | ||
PSEUDOMONAS AERUGINOSA | C86696 | Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa. | Pseudomonas aeruginosa | |||
PSEUDOMONAS AERUGINOSA, MUCOID | C139104 | Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa and the mucoid strain. | Mucoid Pseudomonas aeruginosa | |||
PSEUDOMONAS AERUGINOSA, NON-MUCOID | C139103 | Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa and the non-mucoid strain. | Non-Mucoid Pseudomonas aeruginosa | |||
PSEUDOMONAS AERUGINOSA, SMALL-COLONY VARIANT | C139105 | Pseudomonas aeruginosa SCV | Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa and the small-colony variant strain. | Small-Colony Variant Pseudomonas aeruginosa | ||
PSEUDOMONAS ALCALIGENES | C86697 | Any bacterial organism that can be assigned to the species Pseudomonas alcaligenes. | Pseudomonas alcaligenes | |||
PSEUDOMONAS CHLORORAPHIS | C86699 | Any bacterial organism that can be assigned to the species Pseudomonas chlororaphis. | Pseudomonas chlororaphis | |||
PSEUDOMONAS FLUORESCENS | C86700 | Bacterium fluorescen;Liquidomonas fluorescens | Any bacterial organism that can be assigned to the species Pseudomonas fluorescens. | Pseudomonas fluorescens | ||
PSEUDOMONAS FLUORESCENS/PUTIDA GROUP | C86962 | A non-taxonomic grouping of bacteria that belongs to the fluorescens/putida group of the genus Pseudomonas. | Pseudomonas fluorescens/putida Group | |||
PSEUDOMONAS LUTEOLA | C86701 | Chryseomonas luteola | Any bacterial organism that can be assigned to the species Pseudomonas luteola. | Pseudomonas luteola | ||
PSEUDOMONAS MENDOCINA | C86702 | Any bacterial organism that can be assigned to the species Pseudomonas mendocina. | Pseudomonas mendocina | |||
PSEUDOMONAS MOSSELII | C86703 | Any bacterial organism that can be assigned to the species Pseudomonas mosselii. | Pseudomonas mosselii | |||
PSEUDOMONAS NITROREDUCENS | C124365 | Pseudomonas azelaica | Any bacterial organism that can be assigned to the species Pseudomonas nitroreducens. | Pseudomonas nitroreducens | ||
PSEUDOMONAS ORYZIHABITANS | C76319 | Flavimonas oryzihabitans | Any bacterial organism that can be assigned to the species Pseudomonas oryzihabitans. | Pseudomonas oryzihabitans | ||
PSEUDOMONAS OTITIDIS | C128547 | Any bacterial organism that can be assigned to the species Pseudomonas otitidis. | Pseudomonas otitidis | |||
PSEUDOMONAS PSEUDOALCALIGENES | C86704 | Pseudomonas alcaligenes Biotype B | Any bacterial organism that can be assigned to the species Pseudomonas pseudoalcaligenes. | Pseudomonas pseudoalcaligenes | ||
PSEUDOMONAS PUTIDA | C86705 | Any bacterial organism that can be assigned to the species Pseudomonas putida. | Pseudomonas putida | |||
PSEUDOMONAS STUTZERI | C86706 | Any bacterial organism that can be assigned to the species Pseudomonas stutzeri. | Pseudomonas stutzeri | |||
PSEUDOMONAS | C76375 | Any bacteria that is not assigned to the species level but can be assigned to the Pseudomonas genus level. | Pseudomonas | |||
PSEUDOTERRANOVA DECIPIENS | C124366 | Codworm;Phocanema decipiens;Sealworm | Any nematode parasite that can be assigned to the species Pseudoterranova decipiens. | Pseudoterranova decipiens | ||
PSYCHROBACTER IMMOBILIS | C86708 | Any bacterial organism that can be assigned to the species Psychrobacter immobilis. | Psychrobacter immobilis | |||
PSYCHROBACTER PHENYLPYRUVICUS | C86709 | Moraxella phenylpyruvica | Any bacterial organism that can be assigned to the species Psychrobacter phenylpyruvicus. | Psychrobacter phenylpyruvicus | ||
PSYCHROBACTER | C86707 | Any bacteria that is not assigned to the species level but can be assigned to the Psychrobacter genus level. | Psychrobacter | |||
PURPUREOCILLIUM LILACINUM | C127742 | Paecilomyces lilacinus;Penicillium lilacinum;Purpureocillium lilacinus | Any fungal organism that can be assigned to the species Purpureocillium lilacinum. | Purpureocillium lilacinum | ||
PYRENOCHAETA | C124367 | Any fungal organism that is not assigned to the species level but can be assigned to the Pyrenochaeta genus level. | Pyrenochaeta | |||
RABIES VIRUS | C112405 | Any viral organism that can be assigned to the species Rabies virus. | Rabies Virus | |||
RAHNELLA AQUATILIS | C86711 | Any bacterial organism that can be assigned to the species Rahnella aquatilis. | Rahnella aquatilis | |||
RAHNELLA | C86710 | Any bacteria that is not assigned to the species level but can be assigned to the Rahnella genus level. | Rahnella | |||
RALSTONIA MANNITOLILYTICA | C111302 | Any bacterial organism that can be assigned to the species Ralstonia mannitolilytica. | Ralstonia mannitolilytica | |||
RALSTONIA PICKETTII BIOVARIANT 1 | C124368 | Pseudomonas Group CDC Va-1 | Any bacterial organism that can be assigned to the species Pseudomonas pickettii biovariant 1. | Ralstonia pickettii Biovariant 1 | ||
RALSTONIA PICKETTII | C86713 | Burkholderia pickettii;Pseudomonas pickettii | Any bacterial organism that can be assigned to the species Ralstonia pickettii. | Ralstonia pickettii | ||
RALSTONIA | C86712 | Any bacteria that is not assigned to the species level but can be assigned to the Ralstonia genus level. | Ralstonia | |||
RAOULTELLA ORNITHINOLYTICA | C86715 | Klebsiella ornithinolytica | Any bacterial organism that can be assigned to the species Raoultella ornithinolytica. | Raoultella ornithinolytica | ||
RAOULTELLA PLANTICOLA | C86716 | Any bacterial organism that can be assigned to the species Raoultella planticola. | Raoultella planticola | |||
RAOULTELLA TERRIGENA | C86717 | Klebsiella terrigena | Any bacterial organism that can be assigned to the species Raoultella terrigena. | Raoultella terrigena | ||
RAOULTELLA | C86714 | Any bacteria that is not assigned to the species level but can be assigned to the Raoultella genus level. | Raoultella | |||
RESPIRATORY SYNCYTIAL VIRUS TYPE A | C184696 | Respiratory Syncytial Virus Subsp. A;RSV Type A;RSV-A | Any viral organism that can be assigned to the species Human Respiratory Syncytial virus type A. | Human Respiratory Syncytial Virus Type A | ||
RESPIRATORY SYNCYTIAL VIRUS TYPE B | C184697 | Respiratory Syncytial Virus Subsp. B;RSV Type B;RSV-B | Any viral organism that can be assigned to the species Human Respiratory Syncytial virus type B. | Human Respiratory Syncytial Virus Type B | ||
RESPIROVIRUS | C14310 | Paramyxovirus | Any viral organism that can be assigned to the genus Paramyxovirus. | Paramyxovirus | ||
RETORTAMONAS INTESTINALIS | C124369 | Any unicellular, eukaryotic organism that can be assigned to the species Retortamonas intestinalis. | Retortamonas intestinalis | |||
RHINOVIRUS A | C112407 | Human Rhinovirus A | Any viral organism that can be assigned to the species Rhinovirus A. | Rhinovirus A | ||
RHINOVIRUS B | C112408 | Human Rhinovirus B | Any viral organism that can be assigned to the species Rhinovirus B. | Rhinovirus B | ||
RHINOVIRUS C | C112409 | Human Rhinovirus C | Any viral organism that can be assigned to the species Rhinovirus C. | Rhinovirus C | ||
RHIZOBIUM | C86718 | Any bacteria that is not assigned to the species level but can be assigned to the Rhizobium genus level. | Rhizobium | |||
RHIZOMUCOR PUSILLUS | C120709 | Mucor pusillus | Any fungal organism that can be assigned to the species Rhizomucor pusillus. | Rhizomucor pusillus | ||
RHIZOMUCOR | C120541 | Any fungal organism that is not assigned to the species level but can be assigned to the Rhizomucor genus level. | Rhizomucor | |||
RHIZOPUS ORYZAE | C127743 | Rhizopus arrhizus;Rhizopus chiuniang;Rhizopus formosaensis;Rhizopus hangchow;Rhizopus javanicus Y. Takeda;Rhizopus liquefaciens;Rhizopus peka;Rhizopus pseudochinensis;Rhizopus suinus;Rhizopus tamarii;Rhizopus thermosus;Rhizopus tritici | Any fungal organism that can be assigned to the species Rhizopus oryzae. | Rhizopus oryzae | ||
RHIZOPUS | C77196 | Any fungal organism that is not assigned to the species level but can be assigned to the Rhizopus genus level. | Rhizopus | |||
RHODOCOCCUS EQUI | C86719 | Corynebacterium equi | Any bacterial organism that can be assigned to the species Rhodococcus equi. | Rhodococcus equi | ||
RHODOCOCCUS | C76378 | Any bacteria that is not assigned to the species level but can be assigned to the Rhodococcus genus level. | Rhodococcus | |||
RHODOTORULA GLUTINIS | C114264 | Any fungal organism that can be assigned to the species Rhodotorula glutinis. | Rhodotorula glutinis | |||
RHODOTORULA MUCILAGINOSA | C86027 | Rhodotorula pilimanae;Rhodotorula rubra;Sporobolomyces albo-rubescens | Any fungal organism that can be assigned to the species Rhodotorula mucilaginosa. | Rhodotorula mucilaginosa | ||
RHODOTORULA | C124370 | Any fungal organism that is not assigned to the species level but can be assigned to the Rhodotorula genus level. | Rhodotorula | |||
RICKETTSIA AFRICAE | C86720 | Any bacterial organism that can be assigned to the species Rickettsia africae. | Rickettsia africae | |||
RICKETTSIA FELIS | C86721 | Any bacterial organism that can be assigned to the species Rickettsia felis. | Rickettsia felis | |||
RICKETTSIA JAPONICA | C86722 | Any bacterial organism that can be assigned to the species Rickettsia japonica. | Rickettsia japonica | |||
RICKETTSIA PROWAZEKII | C86723 | Any bacterial organism that can be assigned to the species Rickettsia prowazekii. | Rickettsia prowazekii | |||
RICKETTSIA RICKETTSII | C86724 | Any bacterial organism that can be assigned to the species Rickettsia rickettsii. | Rickettsia rickettsii | |||
RICKETTSIA TYPHI | C86725 | Any bacterial organism that can be assigned to the species Rickettsia typhi. | Rickettsia typhi | |||
RICKETTSIA | C76379 | Any bacteria that is not assigned to the species level but can be assigned to the Rickettsia genus level. | Rickettsia | |||
RIFAMPIN RESISTANT MYCOBACTERIUM TUBERCULOSIS | C187917 | Any bacterial organism that can be assigned to the species Mycobacterium tuberculosis and is resistant to the antibiotic rifampin. | Rifampin-Resistant Mycobacterium tuberculosis | |||
ROSEOLOVIRUS | C112410 | Any viral organism that can be assigned to the genus Roseolovirus. | Roseolovirus | |||
ROSEOMONAS GILARDII | C124371 | Any bacterial organism that can be assigned to the species Roseomonas gilardii. | Roseomonas gilardii | |||
ROSEOMONAS MUCOSA | C124372 | Any bacterial organism that can be assigned to the species Roseomonas mucosa. | Roseomonas mucosa | |||
ROSEOMONAS | C86726 | Any bacteria that is not assigned to the species level but can be assigned to the Roseomonas genus level. | Roseomonas | |||
ROSS RIVER VIRUS | C112411 | RRV | Any viral organism that can be assigned to the species Ross River virus. | Ross River Virus | ||
ROTAVIRUS | C77199 | Any viral organism that can be assigned to the genus Rotavirus. | Rotavirus | |||
ROTHIA DENTOCARIOSA | C86728 | Nocardia dentocariosa | Any bacterial organism that can be assigned to the species Rothia dentocariosa. | Rothia dentocariosa | ||
ROTHIA MUCILAGINOSA | C76382 | Stomatococcus mucilaginosus | Any bacterial organism that can be assigned to the species Rothia mucilaginosa. | Rothia mucilaginosa | ||
ROTHIA | C86727 | Stomatococcus | Any bacteria that is not assigned to the species level but can be assigned to the Rothia genus level. | Rothia | ||
RUBELLA VIRUS | C77198 | German Measles Virus | Any viral organism that can be assigned to the species Rubella virus. | Rubella Virus | ||
RUBIVIRUS | C112414 | Any viral organism that can be assigned to the genus Rubivirus. | Rubivirus | |||
RUBULAVIRUS | C14326 | Any viral organism that can be assigned to the genus Rubulavirus. | Rubulavirus | |||
RUMINOCOCCUS GNAVUS | C124373 | Any bacterial organism that can be assigned to the species Ruminococcus gnavus. | Ruminococcus gnavus | |||
RUMINOCOCCUS PRODUCTUS | C86730 | Peptostreptococcus productus | Any bacterial organism that can be assigned to the species Ruminococcus productus. | Ruminococcus productus | ||
RUMINOCOCCUS | C86729 | Any bacteria that is not assigned to the species level but can be assigned to the Ruminococcus genus level. | Ruminococcus | |||
SACCHAROMYCES CEREVISIAE | C14271 | Bakers Yeast;Brewers Yeast;Saccharomyces capensis;Saccharomyces italicus;Saccharomyces oviformis;Saccharomyces uvarum var. melibiosus | Any fungal organism that can be assigned to the species Saccharomyces cerevisiae. | Saccharomyces cerevisiae | ||
SALMONELLA BONGORI | C91842 | Any bacterial organism that can be assigned to the species Salmonella bongori. | Salmonella bongori | |||
SALMONELLA CHOLERAESUIS VAR. DECATUR | C124374 | Salmonella decatur | Any bacterial organism that can be assigned to the species Salmonella choleraesuis variant decatur. | Salmonella enterica Serotype choleraesuis var. decatur | ||
SALMONELLA ENTERICA SUBSP. ARIZONAE | C86910 | Arizona arizonae;Arizona hinshawii;Paracolobactrum arizonae;Salmonella arizonae | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies arizonae. | Salmonella enterica subsp arizonae | ||
SALMONELLA ENTERICA SUBSP. DIARIZONAE | C91844 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies diarizonae. | Salmonella enterica subsp diarizonae | |||
SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS | C124375 | Bacillus enteritidis;Salmonella enteritidis | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant enteritidis. | Salmonella enterica subsp. enterica Serovar enteritidis | ||
SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR GALLINARUM | C124376 | Salmonella gallinarum | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant gallinarum. | Salmonella enterica subsp. enterica Serovar gallinarum | ||
SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR PULLORUM | C124377 | Salmonella pullorum | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant pullorum. | Salmonella enterica subsp. enterica Serovar Pullorum | ||
SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI | C86926 | Bacillus typhi;Salmonella serotype typhi;Salmonella typhi | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant typhi. | Salmonella Serotype Typhi | ||
SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHISUIS | C124378 | Salmonella typhisuis | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica serovariant typhisuis. | Salmonella enterica subsp. enterica Serovar typhisuis | ||
SALMONELLA ENTERICA SUBSP. ENTERICA | C86913 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica. | Salmonella enterica subsp enterica | |||
SALMONELLA ENTERICA SUBSP. HOUTENAE | C91845 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies houtenae. | Salmonella enterica subsp houtenae | |||
SALMONELLA ENTERICA SUBSP. INDICA | C91846 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies indica. | Salmonella enterica subsp indica | |||
SALMONELLA ENTERICA SUBSP. SALAMAE | C91847 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies salamae. | Salmonella enterica subsp salamae | |||
SALMONELLA ENTERICA | C86731 | Any bacterial organism that can be assigned to the species Salmonella enterica. | Salmonella enterica | |||
SALMONELLA SEROTYPE CHOLERAESUIS | C86915 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Choleraesuis. | Salmonella Serotype Choleraesuis | |||
SALMONELLA SEROTYPE DUBLIN | C86918 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Dublin. | Salmonella Serotype Dublin | |||
SALMONELLA SEROTYPE ENTERITIDIS | C86919 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Enteritidis. | Salmonella Serotype Enteritidis | |||
SALMONELLA SEROTYPE GROUP A | C124379 | Any bacterial organism that can be assigned to the genus Salmonella and serotype group A. | Salmonella Serotype Group A | |||
SALMONELLA SEROTYPE GROUP B | C124380 | Any bacterial organism that can be assigned to the genus Salmonella and serotype group B. | Salmonella Serotype Group B | |||
SALMONELLA SEROTYPE GROUP C | C124381 | Any bacterial organism that can be assigned to the genus Salmonella and serotype group C. | Salmonella Serotype Group C | |||
SALMONELLA SEROTYPE GROUP C1 | C124382 | Any bacterial organism that can be assigned to the genus Salmonella and serotype group C1. | Salmonella Serotype Group C1 | |||
SALMONELLA SEROTYPE GROUP C2 | C124383 | Any bacterial organism that can be assigned to the genus Salmonella and serotype group C2. | Salmonella Serotype Group C2 | |||
SALMONELLA SEROTYPE NEWPORT | C86921 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Newport. | Salmonella Serotype Newport | |||
SALMONELLA SEROTYPE PARATYPHI A | C86922 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi A. | Salmonella Serotype Paratyphi A | |||
SALMONELLA SEROTYPE PARATYPHI B | C86924 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi B. | Salmonella Serotype Paratyphi B | |||
SALMONELLA SEROTYPE PARATYPHI C | C86925 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi C. | Salmonella Serotype Paratyphi C | |||
SALMONELLA SEROTYPE TYPHIMURIUM | C86927 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Typhimurium. | Salmonella Serotype Typhimurium | |||
SALMONELLA | C76380 | Any bacteria that is not assigned to the species level but can be assigned to the Salmonella genus level. | Salmonella | |||
SAPOVIRUS | C112029 | Any viral organism that can be assigned to the genus Sapovirus. | Sapovirus | |||
SAPPORO VIRUS | C112415 | Human Calicivirus Sapporo-like Virus;Human Calicivirus SLV | Any viral organism that can be assigned to the species Sapporo virus. | Sapporo Virus | ||
SARCINA VENTRICULI | C124384 | Zymosarcina ventriculi | Any bacterial organism that can be assigned to the species Sarcina ventriculi. | Sarcina ventriculi | ||
SARCOCYSTIS HOMINIS | C124385 | Any unicellular, eukaryotic organism that can be assigned to the species Sarcocystis hominis. | Sarcocystis hominis | |||
SARCOCYSTIS SUIHOMINIS | C124386 | Any unicellular, eukaryotic organism that can be assigned to the species Sarcocystis suihominis. | Sarcocystis suihominis | |||
SARCOCYSTIS | C124286 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Sarcocystis genus level. | Sarcocystis | |||
SCEDOSPORIUM BOYDII | C127744 | Allescheria boydii;Petriellidium boydii;Pseudallescheria boydii | Any fungal organism that can be assigned to the species Scedosporium boydii. | Scedosporium boydii | ||
SCHISTOSOMA CERCARIAE | C124387 | Any trematode parasite that can be assigned to the genus Schistosoma and is in the larval life stage. | Schistosoma Cercariae | |||
SCHISTOSOMA HAEMATOBIUM | C124388 | Any trematode parasite that can be assigned to the species Schistosoma haematobium. | Schistosoma haematobium | |||
SCHISTOSOMA INTERCALATUM | C124389 | Any trematode parasite that can be assigned to the species Schistosoma intercalatum. | Schistosoma intercalatum | |||
SCHISTOSOMA JAPONICUM | C124390 | Any trematode parasite that can be assigned to the species Schistosoma japonicum. | Schistosoma japonicum | |||
SCHISTOSOMA MANSONI | C124391 | Any trematode parasite that can be assigned to the species Schistosoma mansoni. | Schistosoma mansoni | |||
SCHISTOSOMA MEKONGI | C124392 | Any trematode parasite that can be assigned to the species Schistosoma mekongi. | Schistosoma mekongi | |||
SCHIZOPHYLLUM | C124393 | Any fungal organism that is not assigned to the species level but can be assigned to the Schizophyllum genus level. | Schizophyllum | |||
SCOLECOBASIDIUM TERREUM | C127745 | Any fungal organism that can be assigned to the species Scolecobasidium terreum. | Scolecobasidium terreum | |||
SCOPULARIOPSIS BREVICAULIS | C127746 | Microascus brevicaulis | Any fungal organism that can be assigned to the species Scopulariopsis brevicaulis. | Scopulariopsis brevicaulis | ||
SCOPULARIOPSIS | C124394 | Any fungal organism that is not assigned to the species level but can be assigned to the Scopulariopsis genus level. | Scopulariopsis | |||
SELENOMONAS NOXIA | C86733 | Any bacterial organism that can be assigned to the species Selenomonas noxia. | Selenomonas noxia | |||
SELENOMONAS SPUTIGENA | C86734 | Any bacterial organism that can be assigned to the species Selenomonas sputigena. | Selenomonas sputigena | |||
SELENOMONAS | C86732 | Any bacteria that is not assigned to the species level but can be assigned to the Selenomonas genus level. | Selenomonas | |||
SERRATIA FICARIA | C86736 | Any bacterial organism that can be assigned to the species Serratia ficaria. | Serratia ficaria | |||
SERRATIA FONTICOLA | C86737 | Any bacterial organism that can be assigned to the species Serratia fonticola. | Serratia fonticola | |||
SERRATIA LIQUEFACIENS GROUP | C124395 | A non-taxonomic grouping of bacteria that belongs to the liquefaciens group of the genus Serratia. | Serratia liquefaciens Group | |||
SERRATIA LIQUEFACIENS | C86738 | Enterobacter liquefaciens | Any bacterial organism that can be assigned to the species Serratia liquefaciens. | Serratia liquefaciens | ||
SERRATIA MARCESCENS | C14272 | Any bacterial organism that can be assigned to the species Serratia marcescens. | Serratia marcescens | |||
SERRATIA ODORIFERA BIOGROUP 1 | C124396 | Any bacterial organism that can be assigned to the species Serratia odorifera and biogroup 1. | Serratia odorifera Biogroup 1 | |||
SERRATIA ODORIFERA BIOGROUP 2 | C124397 | Any bacterial organism that can be assigned to the species Serratia odorifera and biogroup 2. | Serratia odorifera Biogroup 2 | |||
SERRATIA ODORIFERA | C86739 | Any bacterial organism that can be assigned to the species Serratia odorifera. | Serratia odorifera | |||
SERRATIA PLYMUTHICA | C86740 | Any bacterial organism that can be assigned to the species Serratia plymuthica. | Serratia plymuthica | |||
SERRATIA RUBIDAEA | C86741 | Serratia marinorubra | Any bacterial organism that can be assigned to the species Serratia rubidaea. | Serratia rubidaea | ||
SERRATIA | C86010 | Serratia | Any bacteria that is not assigned to the species level but can be assigned to the Serratia genus level. | Serratia | ||
SETOSPHAERIA ROSTRATA | C127747 | Exserohilum rostratum | Any fungal organism that can be assigned to the species Setosphaeria rostrata. | Setosphaeria rostrata | ||
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 | C169076 | 2019-nCoV;COVID-19 Virus;SARS Coronavirus 2;SARS-CoV-2;SARS2 | Any viral organism that can be assigned to the severe acute respiratory syndrome Coronavirus 2. | SARS Coronavirus 2 | ||
SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS | C112432 | HCoV-SARS;SARS;SARS-CoV;SARS-CoV-1;Severe Acute Respiratory Syndrome Coronavirus | Any viral organism that can be assigned to the species SARS coronavirus. | SARS Coronavirus | ||
SHEWANELLA ALGAE | C123551 | Any bacterial organism that can be assigned to the species Shewanella algae. | Shewanella algae | |||
SHEWANELLA PUTREFACIENS | C86743 | Alteromonas putrefaciens;Pseudomonas putrefaciens | Any bacterial organism that can be assigned to the species Shewanella putrefaciens. | Shewanella putrefaciens | ||
SHEWANELLA | C86742 | Any bacteria that is not assigned to the species level but can be assigned to the Shewanella genus level. | Shewanella | |||
SHIGA TOXIN-PRODUCING ESCHERICHIA COLI | C184689 | Shiga Toxin-producing E. coli;Shiga-like Toxin-producing E. coli;STEC | Any bacterial organism that can be assigned to the species Escherichia coli and produces shiga toxin (also called shiga-like toxin). | Shiga Toxin-producing Escherichia coli | ||
SHIGELLA BOYDII | C86744 | Any bacterial organism that can be assigned to the species Shigella boydii. | Shigella boydii | |||
SHIGELLA DYSENTERIAE | C86745 | Any bacterial organism that can be assigned to the species Shigella dysenteriae. | Shigella dysenteriae | |||
SHIGELLA FLEXNERI | C86746 | Any bacterial organism that can be assigned to the species Shigella flexneri. | Shigella flexneri | |||
SHIGELLA SONNEI | C86747 | Any bacterial organism that can be assigned to the species Shigella sonnei. | Shigella sonnei | |||
SHIGELLA | C76381 | Any bacteria that is not assigned to the species level but can be assigned to the Shigella genus level. | Shigella | |||
SIMPLEXVIRUS | C112419 | Human Herpes Simplex Virus | Any viral organism that can be assigned to the genus Simplexvirus. | Simplex Virus | ||
SLACKIA EXIGUA | C111313 | Eubacterium exiguum | Any bacterial organism that can be assigned to the species Slackia exigua. | Slackia exigua | ||
SOLOBACTERIUM MOOREI | C123552 | Any bacterial organism that can be assigned to the species Solobacterium moorei. | Solobacterium moorei | |||
SPHINGOBACTERIUM MIZUTAII | C86958 | Flavobacterium mizutae | Any bacterial organism that can be assigned to the species Sphingobacterium mizutaii. | Sphingobacterium mizutaii | ||
SPHINGOBACTERIUM MULTIVORUM | C86959 | CDC Group IIk-2 | Any bacterial organism that can be assigned to the species Sphingobacterium multivorum. | Sphingobacterium multivorum | ||
SPHINGOBACTERIUM SPIRITIVORUM | C86960 | Any bacterial organism that can be assigned to the species Sphingobacterium spiritivorum. | Sphingobacterium spiritivorum | |||
SPHINGOBACTERIUM THALPOPHILUM | C86961 | Flavobacterium thalpophilum | Any bacterial organism that can be assigned to the species Sphingobacterium thalpophilum. | Sphingobacterium thalpophilum | ||
SPHINGOBACTERIUM | C86957 | Any bacteria that is not assigned to the species level but can be assigned to the Sphingobacterium genus level. | Sphingobacterium | |||
SPHINGOMONAS PAUCIMOBILIS | C86749 | Pseudomonas paucimobilis | Any bacterial organism that can be assigned to the species Sphingomonas paucimobilis. | Sphingomonas paucimobilis | ||
SPHINGOMONAS | C86748 | Any bacteria that is not assigned to the species level but can be assigned to the Sphingomonas genus level. | Sphingomonas | |||
SPIRILLUM MINUS | C124399 | Any bacterial organism that can be assigned to the species Spirillum minus. | Spirillum minus | |||
SPIRILLUM | C124288 | Any bacterial organism that is not assigned to the species level but can be assigned to the Spirillum genus level. | Spirillum | |||
SPORIDIOBOLUS SALMONICOLOR | C127748 | Aessosporon salmonicolor;Sporobolomyces salmonicolor | Any fungal organism that can be assigned to the species Sporidiobolus salmonicolor. | Sporidiobolus salmonicolor | ||
SPOROTHRIX SCHENCKII | C127749 | Any fungal organism that can be assigned to the species Sporothrix schenckii. | Sporothrix schenckii | |||
STAPHYLOCOCCUS ARLETTAE | C86750 | Any bacterial organism that can be assigned to the species Staphylococcus arlettae. | Staphylococcus arlettae | |||
STAPHYLOCOCCUS AUREUS | C50921 | Staph. aureus | Any bacterial organism that can be assigned to the species Staphylococcus aureus. | Staphylococcus Aureus | ||
STAPHYLOCOCCUS AUREUS, BETA-LACTAMASE NEGATIVE | C124400 | Any bacterial organism that can be assigned to the species Staphylococcus aureus and is beta-lactamase negative. | Beta-Lactamase Negative Staphylococcus Aureus | |||
STAPHYLOCOCCUS AUREUS, BETA-LACTAMASE POSITIVE | C124401 | Any bacterial organism that can be assigned to the species Staphylococcus aureus and is beta-lactamase positive. | Beta-Lactamase Positive Staphylococcus Aureus | |||
STAPHYLOCOCCUS AUREUS, PENICILLINASE NEGATIVE | C124402 | Any bacterial organism that can be assigned to the species Staphylococcus aureus and is penicillinase negative. | Penicillinase Negative Staphylococcus Aureus | |||
STAPHYLOCOCCUS AUREUS, PENICILLINASE POSITIVE | C124403 | Any bacterial organism that can be assigned to the species Staphylococcus aureus and is penicillinase positive. | Penicillinase Positive Staphylococcus Aureus | |||
STAPHYLOCOCCUS AURICULARIS | C86751 | Any bacterial organism that can be assigned to the species Staphylococcus auricularis. | Staphylococcus auricularis | |||
STAPHYLOCOCCUS CAPITIS SUBSP. UREALYTICUS | C150878 | Any bacterial organism that can be assigned to the species Staphylococcus capitis subspecies urealyticus. | Staphylococcus capitis Subspecies urealyticus | |||
STAPHYLOCOCCUS CAPITIS | C86752 | Any bacterial organism that can be assigned to the species Staphylococcus capitis. | Staphylococcus capitis | |||
STAPHYLOCOCCUS CAPRAE | C86753 | Any bacterial organism that can be assigned to the species Staphylococcus caprae. | Staphylococcus caprae | |||
STAPHYLOCOCCUS CARNOSUS | C86754 | Any bacterial organism that can be assigned to the species Staphylococcus carnosus. | Staphylococcus carnosus | |||
STAPHYLOCOCCUS CHROMOGENES | C86755 | Any bacterial organism that can be assigned to the species Staphylococcus chromogenes. | Staphylococcus chromogenes | |||
STAPHYLOCOCCUS COHNII SUBSP. UREALYTICUS | C124404 | Any bacterial organism that can be assigned to the species Staphylococcus cohnii subspecies urealyticus. | Staphylococcus cohnii subsp. urealyticus | |||
STAPHYLOCOCCUS COHNII | C86756 | Any bacterial organism that can be assigned to the species Staphylococcus cohnii. | Staphylococcus cohnii | |||
STAPHYLOCOCCUS EPIDERMIDIS | C86757 | Staphylococcus albus | Any bacterial organism that can be assigned to the species Staphylococcus epidermidis. | Staphylococcus epidermidis | ||
STAPHYLOCOCCUS EQUORUM | C86758 | Any bacterial organism that can be assigned to the species Staphylococcus equorum. | Staphylococcus equorum | |||
STAPHYLOCOCCUS FELIS | C86759 | Any bacterial organism that can be assigned to the species Staphylococcus felis. | Staphylococcus felis | |||
STAPHYLOCOCCUS GALLINARUM | C86760 | Any bacterial organism that can be assigned to the species Staphylococcus gallinarum. | Staphylococcus gallinarum | |||
STAPHYLOCOCCUS HAEMOLYTICUS | C86761 | Staph. haemolyticus | Any bacterial organism that can be assigned to the species Staphylococcus haemolyticus. | Staphylococcus haemolyticus | ||
STAPHYLOCOCCUS HOMINIS | C86762 | Coagulase Negative Staphylococcus hominis | Any bacterial organism that can be assigned to the species Staphylococcus hominis. | Staphylococcus hominis | ||
STAPHYLOCOCCUS HYICUS | C86763 | Any bacterial organism that can be assigned to the species Staphylococcus hyicus. | Staphylococcus hyicus | |||
STAPHYLOCOCCUS INTERMEDIUS | C86764 | Any bacterial organism that can be assigned to the species Staphylococcus intermedius. | Staphylococcus intermedius | |||
STAPHYLOCOCCUS KLOOSII | C86765 | Any bacterial organism that can be assigned to the species Staphylococcus kloosii. | Staphylococcus kloosii | |||
STAPHYLOCOCCUS LENTUS | C86766 | Any bacterial organism that can be assigned to the species Staphylococcus lentus. | Staphylococcus lentus | |||
STAPHYLOCOCCUS LUGDUNENSIS | C86767 | Any bacterial organism that can be assigned to the species Staphylococcus lugdunensis. | Staphylococcus lugdunensis | |||
STAPHYLOCOCCUS PASTEURI | C86768 | Any bacterial organism that can be assigned to the species Staphylococcus pasteuri. | Staphylococcus pasteuri | |||
STAPHYLOCOCCUS PETTENKOFERI | C128548 | Any bacterial organism that can be assigned to the species Staphylococcus pettenkoferi. | Staphylococcus pettenkoferi | |||
STAPHYLOCOCCUS SACCHAROLYTICUS | C86769 | Peptococcus saccharolyticus | Any bacterial organism that can be assigned to the species Staphylococcus saccharolyticus. | Staphylococcus saccharolyticus | ||
STAPHYLOCOCCUS SAPROPHYTICUS | C86770 | Any bacterial organism that can be assigned to the species Staphylococcus saprophyticus. | Staphylococcus saprophyticus | |||
STAPHYLOCOCCUS SCHLEIFERI SUBSP. COAGULANS | C124405 | Any bacterial organism that can be assigned to the species Staphylococcus schleiferi subspecies coagulans. | Staphylococcus schleiferi subsp. coagulans | |||
STAPHYLOCOCCUS SCHLEIFERI | C86771 | Any bacterial organism that can be assigned to the species Staphylococcus schleiferi. | Staphylococcus schleiferi | |||
STAPHYLOCOCCUS SCIURI | C86772 | Any bacterial organism that can be assigned to the species Staphylococcus sciuri. | Staphylococcus sciuri | |||
STAPHYLOCOCCUS SIMULANS | C86773 | Any bacterial organism that can be assigned to the species Staphylococcus simulans. | Staphylococcus simulans | |||
STAPHYLOCOCCUS SUCCINUS | C124406 | Any bacterial organism that can be assigned to the species Staphylococcus succinus. | Staphylococcus succinus | |||
STAPHYLOCOCCUS WARNERI | C86774 | Any bacterial organism that can be assigned to the species Staphylococcus warneri. | Staphylococcus warneri | |||
STAPHYLOCOCCUS XYLOSUS | C86775 | Any bacterial organism that can be assigned to the species Staphylococcus xylosus. | Staphylococcus xylosus | |||
STAPHYLOCOCCUS | C62583 | Any bacteria that is not assigned to the species level but can be assigned to the Staphylococcus genus level. | Staphylococcus | |||
STEMPHYLIUM | C124407 | Any fungal organism that is not assigned to the species level but can be assigned to the Stemphylium genus level. | Stemphylium | |||
STENOTROPHOMONAS ACIDAMINIPHILA | C189613 | Any bacterial organism that can be assigned to the species Stenotrophomonas acidaminiphila. | Stenotrophomonas acidaminiphila | |||
STENOTROPHOMONAS MALTOPHILIA | C76377 | Pseudomonas maltophilia;Xanthomonas maltophilia | Any bacterial organism that can be assigned to the species Stenotrophomonas maltophilia. | Stenotrophomonas maltophilia | ||
STENOTROPHOMONAS | C86776 | Stenotrophomonas | Any bacteria that is not assigned to the species level but can be assigned to the Stenotrophomonas genus level. | Stenotrophomonas | ||
STREPTOBACILLUS MONILIFORMIS | C86778 | Haverhillia multiformis | Any bacterial organism that can be assigned to the species Streptobacillus moniliformis. | Streptobacillus moniliformis | ||
STREPTOBACILLUS | C86777 | Any bacteria that is not assigned to the species level but can be assigned to the Streptobacillus genus level. | Streptobacillus | |||
STREPTOCOCCACEAE | C85967 | Any bacteria that are not assigned to the species level but can be assigned to the Streptococcaceae family level. | Streptococcaceae | |||
STREPTOCOCCUS ACIDOMINIMUS | C86779 | Any bacterial organism that can be assigned to the species Streptococcus acidominimus. | Streptococcus acidominimus | |||
STREPTOCOCCUS AGALACTIAE | C86780 | STREPT. GP B(AGALACT) | Any bacterial organism that can be assigned to the species Streptococcus agalactiae. | Streptococcus agalactiae | ||
STREPTOCOCCUS ALACTOLYTICUS | C86781 | Any bacterial organism that can be assigned to the species Streptococcus alactolyticus. | Streptococcus alactolyticus | |||
STREPTOCOCCUS ALPHA-HEMOLYTIC | C86141 | A bacteria that is assigned to the genus Streptococcus that is able to reduce the iron content in hemoglobin in red blood cells, thus producing green-colored colonies on blood agar plates. | Alpha-Hemolytic Streptococcus | |||
STREPTOCOCCUS ANGINOSUS GROUP | C86783 | A non-taxonomic grouping of bacteria that belongs to the anginosus group of the genus Streptococcus. | Streptococcus anginosus Group | |||
STREPTOCOCCUS ANGINOSUS | C86782 | Any bacterial organism that can be assigned to the species Streptococcus anginosus. | Streptococcus anginosus | |||
STREPTOCOCCUS BETA-HEMOLYTIC | C86190 | A bacteria that is assigned to the genus Streptococcus that is able to facilitate the complete rupturing of red blood cells, thus producing wide, clear, zones around colonies on blood agar plates. | Beta-Hemolytic Streptococcus | |||
STREPTOCOCCUS BOVIS GROUP | C86785 | A non-taxonomic grouping of bacteria that belongs to the bovis group of the genus Streptococcus. | Streptococcus bovis Group | |||
STREPTOCOCCUS BOVIS | C86784 | Any bacterial organism that can be assigned to the species Streptococcus bovis. | Streptococcus bovis | |||
STREPTOCOCCUS CANIS | C86786 | Any bacterial organism that can be assigned to the species Streptococcus canis. | Streptococcus canis | |||
STREPTOCOCCUS CONSTELLATUS | C86787 | Any bacterial organism that can be assigned to the species Streptococcus constellatus. | Streptococcus constellatus | |||
STREPTOCOCCUS CRISTATUS | C86788 | Any bacterial organism that can be assigned to the species Streptococcus cristatus. | Streptococcus cristatus | |||
STREPTOCOCCUS DYSGALACTIAE SUBSP. DYSGALACTIAE | C91848 | Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies dysgalactiae. | Streptococcus dysgalactiae subsp dysgalactiae | |||
STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILIS | C86906 | Streptococcus equisimilis | Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies equisimilis. | Streptococcus dysgalactiae subsp equisimilis | ||
STREPTOCOCCUS DYSGALACTIAE | C86905 | Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae. | Streptococcus dysgalactiae | |||
STREPTOCOCCUS EQUI SUBSP. ZOOEPIDEMICUS | C124408 | Any bacterial organism that can be assigned to the species Streptococcus equi subspecies zooepidemicus. | Streptococcus equi subsp. zooepidemicus | |||
STREPTOCOCCUS EQUI | C86789 | Any bacterial organism that can be assigned to the species Streptococcus equi. | Streptococcus equi | |||
STREPTOCOCCUS EQUINUS | C86790 | Any bacterial organism that can be assigned to the species Streptococcus equinus. | Streptococcus equinus | |||
STREPTOCOCCUS GALLOLYTICUS | C86791 | Any bacterial organism that can be assigned to the species Streptococcus gallolyticus. | Streptococcus gallolyticus | |||
STREPTOCOCCUS GAMMA-HEMOLYTIC | C86408 | Non-Hemolytic Streptococcus | A bacteria that is assigned to the genus Streptococcus that is unable to facilitate red blood cell lysis. | Gamma-Hemolytic Streptococcus | ||
STREPTOCOCCUS GORDONII | C86792 | Any bacterial organism that can be assigned to the species Streptococcus gordonii. | Streptococcus gordonii | |||
STREPTOCOCCUS INFANTARIUS | C86793 | Any bacterial organism that can be assigned to the species Streptococcus infantarius. | Streptococcus infantarius | |||
STREPTOCOCCUS INTERMEDIUS | C86794 | Any bacterial organism that can be assigned to the species Streptococcus intermedius. | Streptococcus intermedius | |||
STREPTOCOCCUS LUTETIENSIS | C124409 | Any bacterial organism that can be assigned to the species Streptococcus lutetiensis. | Streptococcus lutetiensis | |||
STREPTOCOCCUS MASSILIENSIS | C124410 | Any bacterial organism that can be assigned to the species Streptococcus massiliensis. | Streptococcus massiliensis | |||
STREPTOCOCCUS MILLERI GROUP | C86796 | A non-taxonomic grouping of bacteria that belongs to the milleri group of the genus Streptococcus. | Streptococcus milleri Group | |||
STREPTOCOCCUS MILLERI | C86795 | Streptococcus milleri I | Any bacterial organism that can be assigned to the species Streptococcus milleri. | Streptococcus milleri | ||
STREPTOCOCCUS MITIS GROUP | C86797 | A non-taxonomic grouping of bacteria that belongs to the mitis group of the genus Streptococcus. | Streptococcus mitis Group | |||
STREPTOCOCCUS MITIS | C89774 | Any bacterial organism that can be assigned to the species Streptococcus mitis. | Streptococcus mitis | |||
STREPTOCOCCUS MUTANS GROUP | C86798 | A non-taxonomic grouping of bacteria that belongs to the mutans group of the genus Streptococcus. | Streptococcus mutans Group | |||
STREPTOCOCCUS MUTANS | C124411 | Any bacterial organism that can be assigned to the species Streptococcus mutans. | Streptococcus mutans | |||
STREPTOCOCCUS NUTRITIONALLY VARIANT | C123554 | Nutritionally Variant Streptococci;NVS | Any bacterial organism that can be assigned to a nutritionally variant group in the genus Streptococcus. | Nutritionally Variant Streptococcus | ||
STREPTOCOCCUS ORALIS | C86799 | Any bacterial organism that can be assigned to the species Streptococcus oralis. | Streptococcus oralis | |||
STREPTOCOCCUS PARASANGUINIS | C86800 | Streptococcus parasanguis | Any bacterial organism that can be assigned to the species Streptococcus parasanguinis. | Streptococcus parasanguinis | ||
STREPTOCOCCUS PASTEURIANUS | C187918 | Streptococcus gallolyticus subsp. pasteurianus | Any bacterial organism that can be assigned to the species Streptococcus pasteurianus. | Streptococcus pasteurianus | ||
STREPTOCOCCUS PLURANIMALIUM | C124412 | Any bacterial organism that can be assigned to the species Streptococcus pluranimalium. | Streptococcus pluranimalium | |||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 1 | C187919 | Streptococcus pneumoniae US Serotype 1 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 1. | Streptococcus pneumoniae Danish Serotype 1 | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 10A | C187920 | Streptococcus pneumoniae US Serotype 34 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 10A. | Streptococcus pneumoniae Danish Serotype 10A | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 11A | C187921 | Streptococcus pneumoniae US Serotype 43 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 11A. | Streptococcus pneumoniae Danish Serotype 11A | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 12F | C187922 | Streptococcus pneumoniae US Serotype 12 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 12F. | Streptococcus pneumoniae Danish Serotype 12F | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 14 | C187923 | Streptococcus pneumoniae US Serotype 14 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 14. | Streptococcus pneumoniae Danish Serotype 14 | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 15B | C187924 | Streptococcus pneumoniae US Serotype 54 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 15B. | Streptococcus pneumoniae Danish Serotype 15B | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 17F | C187925 | Streptococcus pneumoniae US Serotype 17 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 17F. | Streptococcus pneumoniae Danish Serotype 17F | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 18C | C187926 | Streptococcus pneumoniae US Serotype 56 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 18C. | Streptococcus pneumoniae Danish Serotype 18C | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 19A | C187927 | Streptococcus pneumoniae US Serotype 57 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 19A. | Streptococcus pneumoniae Danish Serotype 19A | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 19F | C187928 | Streptococcus pneumoniae US Serotype 19 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 19F. | Streptococcus pneumoniae Danish Serotype 19F | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 2 | C187929 | Streptococcus pneumoniae US Serotype 2 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 2. | Streptococcus pneumoniae Danish Serotype 2 | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 20A | C187930 | Streptococcus pneumoniae US Serotype 20 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 20A. | Streptococcus pneumoniae Danish Serotype 20A | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 22F | C187931 | Streptococcus pneumoniae US Serotype 22 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 22F. | Streptococcus pneumoniae Danish Serotype 22F | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 23F | C187932 | Streptococcus pneumoniae US Serotype 23 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 23F. | Streptococcus pneumoniae Danish Serotype 23F | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 3 | C187933 | Streptococcus pneumoniae US Serotype 3 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 3. | Streptococcus pneumoniae Danish Serotype 3 | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 33F | C187934 | Streptococcus pneumoniae US Serotype 70 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 33F. | Streptococcus pneumoniae Danish Serotype 33F | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 4 | C187935 | Streptococcus pneumoniae US Serotype 4 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 4. | Streptococcus pneumoniae Danish Serotype 4 | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 5 | C187936 | Streptococcus pneumoniae US Serotype 5 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 5. | Streptococcus pneumoniae Danish Serotype 5 | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 6B | C187937 | Streptococcus pneumoniae US Serotype 26 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 6B. | Streptococcus pneumoniae Danish Serotype 6B | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 7F | C187938 | Streptococcus pneumoniae US Serotype 51 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 7F. | Streptococcus pneumoniae Danish Serotype 7F | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 8 | C187939 | Streptococcus pneumoniae US Serotype 8 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 8. | Streptococcus pneumoniae Danish Serotype 8 | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 9N | C187940 | Streptococcus pneumoniae US Serotype 9 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 9N. | Streptococcus pneumoniae Danish Serotype 9N | ||
STREPTOCOCCUS PNEUMONIAE DANISH SEROTYPE 9V | C187941 | Streptococcus pneumoniae US Serotype 68 | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae Danish serotype 9V. | Streptococcus pneumoniae Danish Serotype 9V | ||
STREPTOCOCCUS PNEUMONIAE | C76384 | Diplococcus pneumoniae | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae. | Streptococcus pneumoniae | ||
STREPTOCOCCUS PORCINUS | C86802 | Any bacterial organism that can be assigned to the species Streptococcus porcinus. | Streptococcus porcinus | |||
STREPTOCOCCUS PYOGENES | C86803 | Group A Beta-hemolytic Streptococcus pyogenes;Micrococcus scarlatinae;Streptococcus erysipelatos;Streptococcus hemolyticus;Streptococcus scarlatinae | Any bacterial organism that can be assigned to the species Streptococcus pyogenes. | Streptococcus pyogenes | ||
STREPTOCOCCUS SALIVARIUS GROUP | C86805 | A non-taxonomic grouping of bacteria that belongs to the salivarius group of the genus Streptococcus. | Streptococcus salivarius Group | |||
STREPTOCOCCUS SALIVARIUS | C86804 | Any bacterial organism that can be assigned to the species Streptococcus salivarius. | Streptococcus salivarius | |||
STREPTOCOCCUS SANGUINIS | C86806 | Streptococcus sanguis | Any bacterial organism that can be assigned to the species Streptococcus sanguinis. | Streptococcus sanguinis | ||
STREPTOCOCCUS SUIS SEROTYPE 2 | C128552 | Streptococcus Group R | Any bacterial organism that can be assigned to the species Streptococcus suis serotype 2. | Streptococcus suis serotype 2 | ||
STREPTOCOCCUS SUIS | C86807 | Any bacterial organism that can be assigned to the species Streptococcus suis. | Streptococcus suis | |||
STREPTOCOCCUS THERMOPHILUS | C86808 | Any bacterial organism that can be assigned to the species Streptococcus thermophilus. | Streptococcus thermophilus | |||
STREPTOCOCCUS UBERIS | C86809 | Any bacterial organism that can be assigned to the species Streptococcus uberis. | Streptococcus uberis | |||
STREPTOCOCCUS URINALIS | C128549 | Any bacterial organism that can be assigned to the species Streptococcus urinalis. | Streptococcus urinalis | |||
STREPTOCOCCUS VESTIBULARIS | C86810 | Any bacterial organism that can be assigned to the species Streptococcus vestibularis. | Streptococcus vestibularis | |||
STREPTOCOCCUS VIRIDANS GROUP | C86811 | A non-taxonomic grouping of species within the Streptococcus genus that are alpha-hemolytic and do not express Lancefield antigens. | Streptococcus viridans Group | |||
STREPTOCOCCUS VIRIDANS | C124413 | Any bacterial organism that can be assigned to the species Streptococcus viridans. | Streptococcus viridans | |||
STREPTOCOCCUS | C76383 | Streptococci sp. | Any bacteria that is not assigned to the species level but can be assigned to the Streptococcus genus level. | Streptococcus | ||
STREPTOMYCES ALBUS | C86812 | Any bacterial organism that can be assigned to the species Streptomyces albus. | Streptomyces albus | |||
STREPTOMYCES GRISEUS | C86813 | Any bacterial organism that can be assigned to the species Streptomyces griseus. | Streptomyces griseus | |||
STREPTOMYCES PARAGUAYENSIS | C125958 | Any bacterial organism that can be assigned to the species Streptomyces paraguayensis. | Streptomyces paraguayensis | |||
STREPTOMYCES SOMALIENSIS | C86814 | Any bacterial organism that can be assigned to the species Streptomyces somaliensis. | Streptomyces somaliensis | |||
STREPTOMYCES | C14278 | Any bacteria that is not assigned to the species level but can be assigned to the Streptomyces genus level. | Streptomyces | |||
STRONGYLOIDES STERCORALIS | C125643 | Any nematode parasite that can be assigned to the species Strongyloides stercoralis. | Strongyloides stercoralis | |||
STRONGYLOIDES | C125924 | Any nematode parasite that is not assigned to the species level but can be assigned to the Strongyloides genus level. | Strongyloides | |||
SUTTERELLA | C86956 | Any bacteria that is not assigned to the species level but can be assigned to the Sutterella genus level. | Sutterella | |||
SUTTONELLA INDOLOGENES | C86816 | Kingella indologenes | Any bacterial organism that can be assigned to the species Suttonella indologenes. | Suttonella indologenes | ||
SUTTONELLA | C86815 | Any bacteria that is not assigned to the species level but can be assigned to the Suttonella genus level. | Suttonella | |||
SYNCEPHALASTRUM | C125959 | Any fungal organism that is not assigned to the species level but can be assigned to the Syncephalastrum genus level. | Syncephalastrum | |||
TAENIA SAGINATA | C125960 | Beef Tapeworm | Any cestode parasite that can be assigned to the species Taenia saginata. | Taenia saginata | ||
TAENIA SOLIUM | C125961 | Cysticercus cellulosae;Pork Tapeworm | Any cestode parasite that can be assigned to the species Taenia solium. | Taenia solium | ||
TAENIA | C125925 | Any cestode parasite that is not assigned to the species level but can be assigned to the Taenia genus level. | Taenia | |||
TATLOCKIA MICDADEI | C86817 | Legionella micdadei | Any bacterial organism that can be assigned to the species Legionella micdadei. | Tatlockia micdadei | ||
TATUMELLA PTYSEOS | C86819 | CDC Group EF-9 | Any bacterial organism that can be assigned to the species Tatumella ptyseos. | Tatumella ptyseos | ||
TATUMELLA | C86818 | Any bacteria that is not assigned to the species level but can be assigned to the Tatumella genus level. | Tatumella | |||
TETRAGENOCOCCUS SOLITARIUS | C86821 | Enterococcus solitarius | Any bacterial organism that can be assigned to the species Tetragenococcus solitarius. | Tetragenococcus solitarius | ||
TETRAGENOCOCCUS | C86820 | Any bacteria that is not assigned to the species level but can be assigned to the Tetragenococcus genus level. | Tetragenococcus | |||
TICK-BORNE ENCEPHALITIS VIRUS | C112422 | FSME virus;TBEV | Any viral organism that can be assigned to the species Tick-borne encephalitis virus. | Tick-Borne Encephalitis Virus | ||
TISSIERELLA PRAEACUTA | C86908 | Any bacterial organism that can be assigned to the species Tissierella praeacuta. | Tissierella praeacuta | |||
TISSIERELLA | C86907 | Any bacteria that is not assigned to the species level but can be assigned to the Tissierella genus level. | Tissierella | |||
TORULASPORA DELBRUECKII | C125962 | Any fungal organism that can be assigned to the species Torulaspora delbrueckii. | Torulaspora delbrueckii | |||
TOXOCARA CANIS | C125963 | Dog Roundworm | Any nematode parasite that can be assigned to the species Toxocara canis. | Toxocara canis | ||
TOXOCARA CATI | C125964 | Cat Roundworm;Feline Roundworm | Any nematode parasite that can be assigned to the species Toxocara cati. | Toxocara cati | ||
TOXOCARA | C125927 | Any nematode parasite that is not assigned to the species level but can be assigned to the Toxocara genus level. | Toxocara | |||
TOXOPLASMA GONDII | C125644 | Any unicellular, eukaryotic organism that can be assigned to the species Toxoplasma gondii. | Toxoplasma gondii | |||
TOXOPLASMA | C75538 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Toxoplasma genus level. | Toxoplasma | |||
TRABULSIELLA GUAMENSIS | C86823 | CDC Enteric Group 90 | Any bacterial organism that can be assigned to the species Trabulsiella guamensis. | Trabulsiella guamensis | ||
TRABULSIELLA | C86822 | Any bacteria that is not assigned to the species level but can be assigned to the Trabulsiella genus level. | Trabulsiella | |||
TREMATODA | C123338 | Any parasitic flatworm that is not assigned to the species level but can be assigned to the Trematoda class level. | Trematoda | |||
TREMATOSPHAERIA GRISEA | C127750 | Madurella grisea | Any fungal organism that can be assigned to the species Trematosphaeria grisea. | Trematosphaeria grisea | ||
TREPONEMA PALLIDUM SUBSP. ENDEMICUM | C91850 | Any bacterial organism that can be assigned to the species Treponema pallidum subspecies endemicum. | Treponema pallidum subsp endemicum | |||
TREPONEMA PALLIDUM SUBSP. PALLIDUM | C91849 | Any bacterial organism that can be assigned to the species Treponema pallidum subspecies pallidum. | Treponema pallidum subsp pallidum | |||
TREPONEMA PALLIDUM SUBSP. PERTENUE | C86909 | Treponema pertenue | Any bacterial organism that can be assigned to the species Treponema pallidum and subspecies pertenue. | Treponema pallidum subsp pertenue | ||
TREPONEMA PALLIDUM | C86825 | Any bacterial organism that can be assigned to the species Treponema pallidum. | Treponema pallidum | |||
TREPONEMA | C76385 | Any bacteria that is not assigned to the species level but can be assigned to the Treponema genus level. | Treponema | |||
TRICHINELLA SPIRALIS | C125965 | Any nematode parasite that can be assigned to the species Trichinella spiralis. | Trichinella spiralis | |||
TRICHINELLA | C125928 | Any nematode parasite that is not assigned to the species level but can be assigned to the Trichinella genus level. | Trichinella | |||
TRICHODERMA | C125966 | Any fungal organism that is not assigned to the species level but can be assigned to the Trichoderma genus level. | Trichoderma | |||
TRICHOMONAS VAGINALIS | C125967 | Any unicellular, eukaryotic organism that can be assigned to the species Trichomonas vaginalis. | Trichomonas vaginalis | |||
TRICHOMONAS | C89825 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Trichomonas genus level. | Trichomonas | |||
TRICHOMONASCUS CIFERRII | C127751 | Candida ciferrii;Stephanoascus ciferrii | Any fungal organism that can be assigned to the species Trichomonascus ciferrii. | Trichomonascus ciferrii | ||
TRICHOPHYTON EQUINUM | C127752 | Any fungal organism that can be assigned to the species Trichophyton equinum. | Trichophyton equinum | |||
TRICHOPHYTON MENTAGROPHYTES | C127753 | Microsporum mentagrophytes | Any fungal organism that can be assigned to the species Trichophyton mentagrophytes. | Trichophyton mentagrophytes | ||
TRICHOPHYTON RUBRUM | C127754 | Epidermophyton rubrum;Trichophyton fischeri;Trichophyton kanei;Trichophyton megninii;Trichophyton raubitschekii | Any fungal organism that can be assigned to the species Trichophyton rubrum. | Trichophyton rubrum | ||
TRICHOPHYTON SCHOENLEINII | C127755 | Any fungal organism that can be assigned to the species Trichophyton schoenleinii. | Trichophyton schoenleinii | |||
TRICHOPHYTON SOUDANENSE | C127756 | Any fungal organism that can be assigned to the species Trichophyton soudanense. | Trichophyton soudanense | |||
TRICHOPHYTON TONSURANS | C127757 | Any fungal organism that can be assigned to the species Trichophyton tonsurans. | Trichophyton tonsurans | |||
TRICHOPHYTON VERRUCOSUM | C127758 | Any fungal organism that can be assigned to the species Trichophyton verrucosum. | Trichophyton verrucosum | |||
TRICHOPHYTON VIOLACEUM | C127759 | Any fungal organism that can be assigned to the species Trichophyton violaceum. | Trichophyton violaceum | |||
TRICHOPHYTON YAOUNDEI | C127760 | Any fungal organism that can be assigned to the species Trichophyton yaoundei. | Trichophyton yaoundei | |||
TRICHOSPORON ASAHII | C114272 | Any fungal organism that can be assigned to the species Trichosporon asahii. | Trichosporon asahii | |||
TRICHOSPORON BEIGELII | C127761 | Any fungal organism that can be assigned to the species Trichosporon beigelii. | Trichosporon beigelii | |||
TRICHOSPORON MUCOIDES | C128550 | Any fungal organism that can be assigned to the species Trichosporon mucoides. | Trichosporon mucoides | |||
TRICHOSPORON | C114129 | Any fungal organism that is not assigned to the species level but can be assigned to the Trichosporon genus level. | Trichosporon | |||
TRICHOSTRONGYLUS AXEI | C125968 | Any nematode parasite that can be assigned to the species Trichostrongylus axei. | Trichostrongylus axei | |||
TRICHOSTRONGYLUS COLUBRIFORMIS | C125969 | Any nematode parasite that can be assigned to the species Trichostrongylus colubriformis. | Trichostrongylus colubriformis | |||
TRICHOSTRONGYLUS ORIENTALIS | C125970 | Any nematode parasite that can be assigned to the species Trichostrongylus orientalis. | Trichostrongylus orientalis | |||
TRICHOSTRONGYLUS PROBOLURUS | C125971 | Any nematode parasite that can be assigned to the species Trichostrongylus probolurus. | Trichostrongylus probolurus | |||
TRICHOSTRONGYLUS VITRINUS | C125972 | Any nematode parasite that can be assigned to the species Trichostrongylus vitrinus. | Trichostrongylus vitrinus | |||
TRICHOSTRONGYLUS | C125930 | Any nematode parasite that is not assigned to the species level but can be assigned to the Trichostrongylus genus level. | Trichostrongylus | |||
TRICHURIS TRICHIURA | C125973 | Human Whipworm | Any nematode parasite that can be assigned to the species Trichuris trichiura. | Trichuris trichiura | ||
TRICHURIS | C125929 | Any nematode parasite that is not assigned to the species level but can be assigned to the Trichuris genus level. | Trichuris | |||
TRITIRACHIUM | C125974 | Any fungal organism that is not assigned to the species level but can be assigned to the Tritirachium genus level. | Tritirachium | |||
TROPHERYMA WHIPPLEI | C86827 | Any bacterial organism that can be assigned to the species Tropheryma whipplei. | Tropheryma whipplei | |||
TROPHERYMA | C86826 | Any bacteria that is not assigned to the species level but can be assigned to the Tropheryma genus level. | Tropheryma | |||
TRUEPERELLA PYOGENES | C86150 | Actinomyces pyogenes;Arcanobacterium pyogenes;Corynebacterium pyogenes | Any bacterial organism that can be assigned to the species Trueperella pyogenes. | Arcanobacterium pyogenes | ||
TRYPANOSOMA BRUCEI GAMBIENSE | C125975 | Any unicellular, eukaryotic organism that can be assigned to the species Trypanosoma brucei subspecies gambiense. | Trypanosoma brucei gambiense | |||
TRYPANOSOMA BRUCEI RHODESIENSE | C125976 | Any unicellular, eukaryotic organism that can be assigned to the species Trypanosoma brucei subspecies rhodesiense. | Trypanosoma brucei rhodesiense | |||
TRYPANOSOMA CRUZI | C125977 | Any unicellular, eukaryotic organism that can be assigned to the species Trypanosoma cruzi. | Trypanosoma cruzi | |||
TSUKAMURELLA PAUROMETABOLUM | C86829 | Gordona aurantiaca | Any bacterial organism that can be assigned to the species Tsukamurella paurometabolum. | Tsukamurella paurometabolum | ||
TSUKAMURELLA PULMONIS | C114253 | Any bacterial organism that can be assigned to the species Tsukamurella pulmonis. | Tsukamurella pulmonis | |||
TSUKAMURELLA | C86828 | Any bacteria that is not assigned to the species level but can be assigned to the Tsukamurella genus level. | Tsukamurella | |||
TURICELLA OTITIDIS | C86831 | Rhodococcus aurantiazus | Any bacterial organism that can be assigned to the species Turicella otitidis. | Turicella otitidis | ||
TURICELLA | C86830 | Any bacteria that is not assigned to the species level but can be assigned to the Turicella genus level. | Turicella | |||
ULOCLADIUM | C125978 | Any fungal organism that is not assigned to the species level but can be assigned to the Ulocladium genus level. | Ulocladium | |||
UREAPLASMA PARVUM | C198354 | Ureaplasma urealyticum biovar 1 | Any bacterial organism that can be assigned to the species Ureaplasma parvum. | Ureaplasma parvum | ||
UREAPLASMA UREALYTICUM | C86833 | T-mycoplasma | Any bacterial organism that can be assigned to the species Ureaplasma urealyticum. | Ureaplasma urealyticum | ||
UREAPLASMA | C86832 | Any bacteria that is not assigned to the species level but can be assigned to the Ureaplasma genus level. | Ureaplasma | |||
USTILAGO | C125979 | Any fungal organism that is not assigned to the species level but can be assigned to the Ustilago genus level. | Ustilago | |||
VACCINIA VIRUS | C14281 | VV | Any viral organism that can be assigned to the species Vaccinia virus. | Vaccinia Virus | ||
VAGOCOCCUS | C86834 | Any bacteria that is not assigned to the species level but can be assigned to the Vagococcus genus level. | Vagococcus | |||
VANCOMYCIN RESISTANT ENTEROCOCCUS | C76312 | VRE | Any bacterial organism that can be assigned to the genus Enterococcus and is resistant to the antibiotic vancomycin. | Vancomycin Resistant Enterococcus | ||
VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS | C125980 | VRSA | Any bacterial organism that can be assigned to the species Staphylococcus aureus and is resistant to the antibiotic vancomycin. | Vancomycin Resistant Staphylococcus Aureus | ||
VANCOMYCIN SUSCEPTIBLE ENTEROCOCCUS | C125981 | VSE | Any bacterial organism that can be assigned to the genus Enterococcus and is susceptible to the antibiotic vancomycin. | Vancomycin Susceptible Enterococcus | ||
VARIBACULUM CAMBRIENSE | C86836 | Any bacterial organism that can be assigned to the species Varibaculum cambriense. | Varibaculum cambriense | |||
VARIBACULUM | C86835 | Any bacteria that is not assigned to the species level but can be assigned to the Varibaculum genus level. | Varibaculum | |||
VARICELLA ZOSTER VIRUS | C71091 | HHV-3;Human Alphaherpesvirus 3;Human Herpesvirus 3;Varicella Zoster Virus;VZV | Any viral organism that can be assigned to the species varicella zoster virus. | Varicella Zoster Virus | ||
VARICELLOVIRUS | C112426 | Varicellavirus | Any viral organism that can be assigned to the genus Varicellovirus. | Varicellovirus | ||
VARIOLA VIRUS | C96527 | Smallpox Virus;Variola Virus VAR | Any viral organism that can be assigned to the species Variola virus. | Variola Virus | ||
VEILLONELLA ATYPICA | C125982 | Veillonella parvula subsp. atypica | Any bacterial organism that can be assigned to the species Veillonella atypica. | Veillonella atypica | ||
VEILLONELLA DISPAR | C86838 | Any bacterial organism that can be assigned to the species Veillonella dispar. | Veillonella dispar | |||
VEILLONELLA PARVULA | C86839 | Any bacterial organism that can be assigned to the species Veillonella parvula. | Veillonella parvula | |||
VEILLONELLA | C86837 | Any bacteria that is not assigned to the species level but can be assigned to the Veillonella genus level. | Veillonella | |||
VEROTOXIN-PRODUCING ESCHERICHIA COLI | C187942 | Verotoxin-producing E. coli;VETC | Any bacterial organism that can be assigned to the species Escherichia coli and produces verotoxin. | Verotoxin-producing Escherichia coli | ||
VERTICILLIUM | C125983 | Any fungal organism that is not assigned to the species level but can be assigned to the Verticillium genus level. | Verticillium | |||
VIBRIO ALGINOLYTICUS | C86840 | Any bacterial organism that can be assigned to the species Vibrio alginolyticus. | Vibrio alginolyticus | |||
VIBRIO CHOLERAE | C86841 | Vibrio comma | Any bacterial organism that can be assigned to the species Vibrio cholerae. | Vibrio cholerae | ||
VIBRIO FLUVIALIS | C86842 | Any bacterial organism that can be assigned to the species Vibrio fluvialis. | Vibrio fluvialis | |||
VIBRIO FURNISSII | C86843 | Any bacterial organism that can be assigned to the species Vibrio furnissii. | Vibrio furnissii | |||
VIBRIO METSCHNIKOVII | C86844 | CDC Enteric Group 16 | Any bacterial organism that can be assigned to the species Vibrio metschnikovii. | Vibrio metschnikovii | ||
VIBRIO MIMICUS | C86845 | Any bacterial organism that can be assigned to the species Vibrio mimicus. | Vibrio mimicus | |||
VIBRIO PARAHAEMOLYTICUS | C86846 | Any bacterial organism that can be assigned to the species Vibrio parahaemolyticus. | Vibrio parahaemolyticus | |||
VIBRIO VULNIFICUS | C86847 | Beneckea vulnifica | Any bacterial organism that can be assigned to the species Vibrio vulnificus. | Vibrio vulnificus | ||
VIBRIO | C76386 | Any bacteria that is not assigned to the species level but can be assigned to the Vibrio genus level. | Vibrio | |||
VORTICELLA | C125984 | Any unicellular, eukaryotic organism that is not assigned to the species level but can be assigned to the Vorticella genus level. | Vorticella | |||
WAUTERSIELLA FALSENII | C111334 | Any bacterial organism that can be assigned to the species Wautersiella falsenii. | Wautersiella falsenii | |||
WEEKSELLA VIROSA | C86849 | Any bacterial organism that can be assigned to the species Weeksella virosa. | Weeksella virosa | |||
WEEKSELLA | C86848 | Any bacteria that is not assigned to the species level but can be assigned to the Weeksella genus level. | Weeksella | |||
WEISSELLA CIBARIA | C184692 | Weissella kimchii | Any bacterial organism that can be assigned to the species Weissella cibaria. | Weissella cibaria | ||
WEST NILE VIRUS | C71877 | WNV | Any viral organism that can be assigned to the species West Nile virus. | West Nile Virus | ||
WICKERHAMOMYCES ANOMALUS | C114262 | Candida pelliculosa;Hansenula anomala;Pichia anomala | Any fungal organism that can be assigned to the species Wickerhamomyces anomalus. | Wickerhamomyces anomalus | ||
WOLINELLA SUCCINOGENES | C86851 | Any bacterial organism that can be assigned to the species Wolinella succinogenes. | Wolinella succinogenes | |||
WOLINELLA | C86850 | Any bacteria that is not assigned to the species level but can be assigned to the Wolinella genus level. | Wolinella | |||
WUCHERERIA BANCROFTI | C122328 | Filaria bancrofti | Any nematode parasite that can be assigned to the species Wuchereria bancrofti. | Wuchereria bancrofti | ||
WUCHERERIA | C122013 | Any nematode parasite that is not assigned to the species level but can be assigned to the Wuchereria genus level. | Wuchereria | |||
XANTHOMONAS | C86018 | Any bacterial organism that is not assigned to the species level but can be assigned to the Xanthomonas genus level. | Xanthomonas | |||
YARROWIA LIPOLYTICA | C114257 | Candida lipolytica;Mycotorula lipolytica | Any fungal organism that can be assigned to the species Yarrowia lipolytica. | Yarrowia lipolytica | ||
YEAST | C14286 | Any of various single-celled ascomycetes, basidiomycetes and imperfect fungi with little or no mycelium development that asexually reproduce by budding. They ferment sugars to produce alcohol and carbon dioxide. | Yeast | |||
YELLOW FEVER VIRUS | C97156 | Flavivirus febricis;YFV | Any viral organism that can be assigned to the species Yellow fever virus. | Yellow Fever Virus | ||
YERSINIA ALDOVAE | C86853 | Any bacterial organism that can be assigned to the species Yersinia aldovae. | Yersinia aldovae | |||
YERSINIA BERCOVIERI | C86854 | Yersinia enterocolitica Biogroup 3B | Any bacterial organism that can be assigned to the species Yersinia bercovieri. | Yersinia bercovieri | ||
YERSINIA ENTEROCOLITICA | C86855 | Pasteurella enterocolitica | Any bacterial organism that can be assigned to the species Yersinia enterocolitica. | Yersinia enterocolitica | ||
YERSINIA FREDERIKSENII | C86856 | Any bacterial organism that can be assigned to the species Yersinia frederiksenii. | Yersinia frederiksenii | |||
YERSINIA INTERMEDIA | C86857 | Any bacterial organism that can be assigned to the species Yersinia intermedia. | Yersinia intermedia | |||
YERSINIA KRISTENSENII | C86858 | Any bacterial organism that can be assigned to the species Yersinia kristensenii. | Yersinia kristensenii | |||
YERSINIA MOLLARETII | C86859 | Yersinia enterocolitica Biogroup 3A | Any bacterial organism that can be assigned to the species Yersinia mollaretii. | Yersinia mollaretii | ||
YERSINIA PESTIS | C86860 | Pasteurella pestis | Any bacterial organism that can be assigned to the species Yersinia pestis. | Yersinia pestis | ||
YERSINIA PSEUDOTUBERCULOSIS | C86861 | Pasteurella pseudotuberculosis | Any bacterial organism that can be assigned to the species Yersinia pseudotuberculosis. | Yersinia pseudotuberculosis | ||
YERSINIA ROHDEI | C86862 | Any bacterial organism that can be assigned to the species Yersinia rohdei. | Yersinia rohdei | |||
YERSINIA RUCKERI | C86863 | Any bacterial organism that can be assigned to the species Yersinia ruckeri. | Yersinia ruckeri | |||
YERSINIA | C86852 | Any bacteria that is not assigned to the species level but can be assigned to the Yersinia genus level. | Yersinia | |||
YOKENELLA REGENSBURGEI | C86865 | CDC Enteric Group 45 | Any bacterial organism that can be assigned to the species Yokenella regensburgei. | Yokenella regensburgei | ||
YOKENELLA | C86864 | Any bacteria that is not assigned to the species level but can be assigned to the Yokenella genus level. | Yokenella | |||
ZIKA VIRUS | C128553 | Any viral organism that can be assigned to the species Zika virus. | Zika Virus | |||
ZIMMERMANNELLA ALBA | C86867 | Any bacterial organism that can be assigned to the species Zimmermannella alba. | Zimmermannella alba | |||
ZIMMERMANNELLA BIFIDA | C86868 | Any bacterial organism that can be assigned to the species Zimmermannella bifida. | Zimmermannella bifida | |||
ZIMMERMANNELLA | C86866 | Any bacteria that is not assigned to the species level but can be assigned to the Zimmermannella genus level. | Zimmermannella | |||
Back to top | ||||||
CL.C125922.MIFTSDTL | Microscopic Findings Test Details
(MIFTSDTL) | text
Extensible: Yes | C125922 | Microscopic Findings Test Details | Terminology relevant to the additional descriptions of the test being performed to produce the microscopic result. | CDISC SDTM Microscopic Findings Test Detail Terminology |
AJCC TUMOR GRADE | C135461 | A grading system developed by the American Joint Committee on Cancer (AJCC) and assigned based on the degree of cellular differentiation within a tumor sample. | AJCC Tumor Grade | |||
ALLRED PROPORTION POSITIVE SCORE | C125985 | A score developed by Allred et al. (1998) and assigned based on the percent positivity of cells for a particular protein (Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 Feb;11(2):155-68). | Allred Proportion Positive Score | |||
ALLRED STAINING INTENSITY SCORE | C125986 | A score developed by Allred et al. (1998) and assigned based on the average staining intensity of cells for a particular protein (Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 Feb;11(2):155-68). | Allred Average Staining Intensity Score | |||
ALLRED TOTAL SCORE | C125987 | The histopathological evaluation of staining in tissue based on the Allred scoring system (Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998 Feb;11(2):155-68). | Allred Total Score | |||
BANFF QUANTITATIVE CRITERIA SCORE RENAL | C135462 | A score originally developed by Solez et al. (1993) and assigned based on the histologic evaluation of kidney allograft biopsies according to the Banff Working Classification of Renal Allograft Pathology. | Banff Renal Quantitative Criteria Score | |||
BATTS-LUDWIG FIBROSIS SCORE | C119570 | Batts-Ludwig Fibrosis Score | The histopathological evaluation of the liver based on the Batts-Ludwig scoring system. | Batts-Ludwig Fibrosis Score | ||
BAUERMEISTER SCORE | C154808 | A score based on the Bauermeister scale, a 6-point grading system used to rate the extent of myelofibrosis, based on the amount of reticulin and collagen fibers present in the bone marrow. (Bauermeister DE. Quantitation of bone marrow reticulin-a normal range. Am J Clin Pathol. 1971 Jul;56(1):24-31.) | Bauermeister Score | |||
CAP TUMOR REGRESSION GRADE | C181467 | College of American Pathology Tumor Regression Grade | A grading system developed by the College of American Pathology to assess a decrease in tumor size or extent in the body. (College of American Pathology) | College of American Pathology Tumor Regression Grade | ||
CHALKLEY SCORE | C158254 | A microscopic measurement of the volumetric or area ratios of components (e.g. blood vessel-, macrophage-, or lymphatic vessel density) of tissues or organs. (Chalkley HW. Method for the quantitative morphological analysis of tissues. J Natl Cancer Inst; 4: 47-52) | Chalkley Score | |||
ENHANCED LIVER FIBROSIS SCORE | C132429 | ELF | The histopathological evaluation of the liver based on the enhanced liver fibrosis scoring system. | Enhanced Liver Fibrosis Score | ||
EUROPEAN CONSENSUS SCORE | C154809 | A score based on the European Consensus scale, a 4-point grading system for the qualitative and quantitative evaluation of bone marrow fibrosis. (Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005 Aug;90(8):1128-32.) | European Consensus Score For Bone Marrow Fibrosis | |||
EVANS TUMOR REGRESSION GRADE 1992 | C181469 | A grading system developed by Evans et al (1992) to assess a decrease in tumor size or extent in the body. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. (1992) 127:1335-9.) | Evans et al Tumor Regression Grade (1992) | |||
FIGO TUMOR GRADE | C187943 | A tumor histopathologic grading system developed by Bhatla et al (2018) for uterine and cervical cancers. (Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet 2018;143(Suppl 2):22-36.) | FIGO Tumor Grade | |||
FUHRMAN NUCLEAR GRADE | C62411 | Fuhrman Tumor Grade | A tumor grading system developed by Fuhrman et al (1982) that evaluates nuclear grade, based on nuclear size, irregularity and nucleolar prominence, in renal cell carcinomas. (Fuhrman SA, Lasky SA, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982 Oct;6(7):655-63.) | Fuhrman Nuclear Grade | ||
GHAS SCORE | C178033 | Global Histologic Disease Activity Score | A score originally developed by D'Haens et al. (1998) and assigned based on the histologic evaluation of acute and chronic inflammatory changes, epithelial damage, and the extent of inflammation in Crohn's disease mucosal biopsy specimens, according to the Global Histologic Disease Activity Score. (G R D'Haens, K Geboes, M Peeters, F Baert, F Penninckx, P Rutgeerts. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998 Feb;114(2):262-7). | Global Histologic Disease Activity Score | ||
GLEASON PRIMARY SCORE | C48603 | The most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. (Gleason, D. F. (1977). The Veteran's Administration Cooperative Urologic Research Group: histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum, M. Urologic Pathology: The Prostate. Philadelphia: Lea and Febiger. pp. 171-198.) | Primary Gleason Pattern | |||
GLEASON SECONDARY SCORE | C48604 | The second most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. (Gleason, D. F. (1977). The Veteran's Administration Cooperative Urologic Research Group: histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum, M. Urologic Pathology: The Prostate. Philadelphia: Lea and Febiger. pp. 171-198.) | Secondary Gleason Pattern | |||
GLEASON TOTAL SUM | C48602 | The sum of the primary and secondary Gleason scores. If three patterns are identified, it is the sum of the primary pattern score and the score of the least well-differentiated pattern. (Gleason, D. F. (1977). The Veteran's Administration Cooperative Urologic Research Group: histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum, M. Urologic Pathology: The Prostate. Philadelphia: Lea and Febiger. pp. 171-198.) | Total Gleason Score for Prostate Cancer | |||
H SCORE STAINING INTENSITY 0 | C181473 | A measurement of the amount or proportion of cells that have a staining intensity of 0, based on the H Score scoring system, in a biological specimen. (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). | H Score Staining Intensity 0 | |||
H SCORE STAINING INTENSITY 1+ | C181474 | A measurement of the amount or proportion of cells that have a staining intensity of 1+, based on the H Score scoring system, in a biological specimen. (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). | H Score Staining Intensity 1+ | |||
H SCORE STAINING INTENSITY 2+ | C181475 | A measurement of the amount or proportion of cells that have a staining intensity of 2+, based on the H Score scoring system, in a biological specimen. (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). | H Score Staining Intensity 2+ | |||
H SCORE STAINING INTENSITY 3+ | C181476 | A measurement of the amount or proportion of cells that have a staining intensity of 3+, based on the H Score scoring system, in a biological specimen. (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). | H Score Staining Intensity 3+ | |||
H SCORE TOTAL SCORE | C125988 | The histopathological evaluation of staining in tissue based on the H Score scoring system (McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716-721). | H Score Total Score | |||
HARTMAN TUMOR REGRESSION GRADE 2012 | C181470 | A grading system developed by Hartman et al (2012) to assess a decrease in tumor size or extent in the body. (Hartman DJ, Krasinskas AM. Assessing treatment effect in pancreatic cancer. Arch Pathol Lab Med. (2012) 136:100-9.) | Hartman et al Tumor Regression Grade (2012) | |||
IARC AND WHO CLASSIFICATION OF NEUROENDOCRINE NEOPLASMS 2018 | C189619 | A classification for grading and staging of neuroendocrine neoplasms published by the World Health Organization (WHO) in 2018. (Rindi, G., Klimstra, D.S., Abedi-Ardekani, B. et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31, 1770-1786 (2018).) | IARC and WHO Classification of Tumors of Neuroendocrine Neoplasms 2018 | |||
IDWORAK TUMOR REGRESSION GRADE 1997 | C181471 | A grading system developed by Dworak et al (1997) to assess a decrease in tumor size or extent in the body. (Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. (1997) 12:19-23.) | iDworak et al Tumor Regression Grade (1997) | |||
ISHAK FIBROSIS SCORE | C95149 | Ishak Fibrosis Score | The histopathological evaluation of the liver based on the Ishak scoring system. | Ishak Score | ||
ISUP GLEASON GRADE GROUP | C142346 | A grading system for prostatic adenocarcinoma based on cellular differentiation patterns and Gleason primary and secondary scores (Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016 Feb;40(2):244-52.) | International Society of Urological Pathology Gleason Grade Group | |||
JASS RECTAL CANCER PROGNOSTIC CLASSIFICATION 1987 | C187944 | A classification system for rectal cancer prognosis based on four histomorphologic parameters. (JR Jass, SB Love, JM Northover. A new prognostic classification of rectal cancer. Lancet 1987 Jun 6;1(8545):1303-6.) | JASS Rectal Cancer Prognostic Classification 1987 | |||
KNODELL FIBROSIS SCORE | C119571 | Knodell Fibrosis Score | The histopathological evaluation of the liver based on the Knodell scoring system. | Knodell Fibrosis Score | ||
MD ANDERSON TUMOR REGRESSION GRADE 2012 | C181468 | A grading system developed by Chatterjee et al (2012) to assess a decrease in tumor size or extent in the body. (Chatterjee D, Katz MH, Rashid A, Wolff RA, Wang H, Lee JE, et al. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer. (2012) 118:3182-90.) | MD Anderson Tumor Regression Grade (2012) | |||
METAVIR FIBROSIS SCORE | C119572 | Metavir Fibrosis Score | The histopathological evaluation of the liver based on the Meta-analysis of Histological Data in Viral Hepatitis (Metavir) scoring system. | METAVIR Fibrosis Score | ||
METMAB SCORE | C174344 | The histopathological evaluation of MET (Hepatocyte Growth Factor Receptor) staining in tissue based on the METMAB scoring system (Koeppen H, Yu W, Zha J, et al. Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib +/- Onartuzumab in Advanced Non-Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit. Clin Cancer Res. 2014 September 1; 20(17): 4488-4498.) | METMAB Score | |||
NAFLD ACTIVITY SCORE | C181472 | NAS;Non-Alcoholic Fatty Liver Disease Activity Score | The histopathological evaluation of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) based on the NAFLD activity scoring system (NAS). (Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun;41(6):1313-21.) | Non-Alcoholic Fatty Liver Disease Activity Score | ||
NOTTINGHAM HISTOLOGIC GRADE | C138986 | Elston-Ellis modification of Scarff-Bloom-Richardson Grading System | A histologic grading system developed by Elston and Ellis as a modification of the Scarff-Bloom-Richardson grading system, based on tubule formation, nuclear pleomorphism, and mitotic counts of invasive adenocarcinomas. (CW Ellston, O Ellis. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991 Nov;19(5):403-10.) | Nottingham Grade | ||
PERCENT POSITIVE CELL | C70460 | A measurement of the proportion of cells that are positive for a given protein. | Percent of Positive Cells | |||
POSITIVE CELL COUNT | C156548 | A measurement of the total number of cells that stain positively in a biological specimen. | Positive Cell Count | |||
PROLIFERATIVE INDEX | C28042 | Cell Proliferation Index | An assessment of the amount or extent of proliferating cells in a biological specimen. | Proliferative Index | ||
RECEPTOR OVERALL STATUS | C125989 | An assessment of the status of a biological specimen with regards to a given receptor. | Receptor Overall Status | |||
RHI SCORE | C178034 | Robarts Histopathology Index Score | A score developed by Mosli et al. (2017) and assigned based on the histologic evaluation of disease activity in ulcerative colitis. (Mahmoud H Mosli, Brian G Feagan, Guangyong Zou, et al. Development and validation of a histological index for UC. Gut. 2017 Jan;66(1):50-58.) | Robarts Histopathology Index Score | ||
SCHEUER FIBROSIS SCORE | C119573 | Scheuer Fibrosis Score | The histopathological evaluation of the liver based on the Scheuer scoring system. | Scheuer Fibrosis Score | ||
STAINING INTENSITY 0 | C186199 | A measurement of the amount or proportion of tissue or cells that have a staining intensity of 0. | Staining Intensity 0 | |||
STAINING INTENSITY 1+ | C186200 | A measurement of the amount or proportion of tissue or cells that have a staining intensity of 1+. | Staining Intensity 1+ | |||
STAINING INTENSITY 2+ | C186201 | A measurement of the amount or proportion of tissue or cells that have a staining intensity of 2+. | Staining Intensity 2+ | |||
STAINING INTENSITY 3+ | C186202 | A measurement of the amount or proportion of tissue or cells that have a staining intensity of 3+. | Staining Intensity 3+ | |||
STAINING INTENSITY | C127762 | The degree or magnitude of staining within a biological specimen. | Staining Intensity | |||
TUMOR PROPORTION SCORE | C154810 | The percentage of viable tumor cells with partial or complete cell membrane staining. | Tumor Proportion Score | |||
WHO CLASSIFICATION OF TUMORS OF ENDOCRINE ORGANS 2017 | C189617 | A classification for grading and staging of tumors of endocrine organs published by the World Health Organization (WHO) in 2017. (Lloyd RV, Osamura R, Kloppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs. 4th ed. Lyon: IARC Press; 2017.) | WHO Classification of Tumors of Endocrine Organs 2017 | |||
WHO CLASSIFICATION OF TUMORS OF THE DIGESTIVE SYSTEM 2010 | C189616 | A classification for grading and staging of tumors of the digestive system published by the World Health Organization (WHO) in 2010. (Bosman F, Carneiro F: World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System., Lyon: IARC Press, 2010.) | WHO Classification of Tumors of the Digestive System 2010 | |||
WHO CLASSIFICATION OF TUMORS OF THE DIGESTIVE SYSTEM 2019 | C189618 | A classification for grading and staging of tumors of the digestive system published by the World Health Organization (WHO) in 2019. (Iris D Nagtegaal, Robert D Odze, David Klimstra, Valerie Paradis, Massimo Rugge, Peter Schirmacher, Kay M Washington, Fatima Carneiro, Ian A Cree, and the WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020 Jan; 76(2): 182-188.) | WHO Classification of Tumors of the Digestive System 2019 | |||
WHO/ISUP NUCLEAR GRADE | C187945 | WHO/ISUP Tumor Grade | A tumor grading system developed by the members of the ISUP Renal Tumor Panel (2013) that evaluates nuclear grade in renal cell carcinomas. (Delahunt B., Cheville J.C., Martignoni G., Humphrey P.A., Magi-Galluzzi C., McKenney J., Egevad L., Algaba F., Moch H., Grignon D.J., Montironi R., Srigley J.R., Members of the ISUP Renal Tumor Panel. International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37:1490-1504.) | WHO/ISUP Fuhrman Nuclear Grade | ||
Back to top | ||||||
CL.C150770.MMS2TC | Mini-Mental State Examination 2 Standard Version Functional Test Test Code
(MMS2TC) | text
Extensible: No | C150770 | Mini-Mental State Examination 2 Standard Version Functional Test Test Code | Mini-Mental State Examination 2 Standard Version test code. | CDISC Functional Test MMSE-2 Standard Version Test Code Terminology |
MMS201A | C150994 | MMS2-Repeat Word 1 | Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 1. | MMSE-2 Standard Version - Repeat Word 1 | ||
MMS201B | C150995 | MMS2-Repeat Word 2 | Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 2. | MMSE-2 Standard Version - Repeat Word 2 | ||
MMS201C | C150996 | MMS2-Repeat Word 3 | Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 3. | MMSE-2 Standard Version - Repeat Word 3 | ||
MMS202A | C150997 | MMS2-What Is the Year | Mini-Mental State Examination 2 Standard Version - What is the year? | MMSE-2 Standard Version - What Is the Year | ||
MMS202B | C150998 | MMS2-What Is the Season | Mini-Mental State Examination 2 Standard Version - What is the season? | MMSE-2 Standard Version - What Is the Season | ||
MMS202C | C150999 | MMS2-What Is the Month of Year | Mini-Mental State Examination 2 Standard Version - What is the month of the year? | MMSE-2 Standard Version - What Is the Month of Year | ||
MMS202D | C151000 | MMS2-What Is the Day of Week | Mini-Mental State Examination 2 Standard Version - What is the day of the week? | MMSE-2 Standard Version - What Is the Day of Week | ||
MMS202E | C151001 | MMS2-What Is the Date | Mini-Mental State Examination 2 Standard Version - What is the date? | MMSE-2 Standard Version - What Is the Date | ||
MMS203A | C151002 | MMS2-What Is the State | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the state (or province)? | MMSE-2 Standard Version - What Is the State | ||
MMS203B | C151003 | MMS2-What Is the County | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the county (or city/town)? | MMSE-2 Standard Version - What Is the County | ||
MMS203C | C151004 | MMS2-What Is the City/Town | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the city/town (or part of city/neighborhood)? | MMSE-2 Standard Version - What Is the City/Town | ||
MMS203D | C151005 | MMS2-What Is the Building | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the building (name or type)? | MMSE-2 Standard Version - What Is the Building | ||
MMS203E | C151006 | MMS2-What Is the Floor | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the floor of the building (room number or address)? | MMSE-2 Standard Version - What Is the Floor | ||
MMS204A | C151007 | MMS2-Recall Word 1 | Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 1? | MMSE-2 Standard Version - Recall Word 1 | ||
MMS204B | C151008 | MMS2-Recall Word 2 | Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 2? | MMSE-2 Standard Version - Recall Word 2 | ||
MMS204C | C151009 | MMS2-Recall Word 3 | Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 3? | MMSE-2 Standard Version - Recall Word 3 | ||
MMS205A | C151010 | MMS2-What is 100 Take Away 7 | Mini-Mental State Examination 2 Standard Version - What is 100 take away 7 [93]? | MMSE-2 Standard Version - What is 100 Take Away 7 | ||
MMS205B | C151011 | MMS2-Keep Subtracting 7 Step 2 | Mini-Mental State Examination 2 Standard Version - Keep going [86]. | MMSE-2 Standard Version - Keep Subtracting 7 Step 2 | ||
MMS205C | C151012 | MMS2-Keep Subtracting 7 Step 3 | Mini-Mental State Examination 2 Standard Version - Keep going [79]. | MMSE-2 Standard Version - Keep Subtracting 7 Step 3 | ||
MMS205D | C151013 | MMS2-Keep Subtracting 7 Step 4 | Mini-Mental State Examination 2 Standard Version - Keep going [72]. | MMSE-2 Standard Version - Keep Subtracting 7 Step 4 | ||
MMS205E | C151014 | MMS2-Keep Subtracting 7 Step 5 | Mini-Mental State Examination 2 Standard Version - Keep going [65]. | MMSE-2 Standard Version - Keep Subtracting 7 Step 5 | ||
MMS206A | C151015 | MMS2-Naming Object 1 | Mini-Mental State Examination 2 Standard Version - What is this: Object 1? | MMSE-2 Standard Version - Naming Object 1 | ||
MMS206B | C151016 | MMS2-Naming Object 2 | Mini-Mental State Examination 2 Standard Version - What is this: Object 2? | MMSE-2 Standard Version - Naming Object 2 | ||
MMS207 | C151017 | MMS2-Repeat What I Say | Mini-Mental State Examination 2 Standard Version - Now I am going to ask you to repeat what I say. Ready? "It is a lovely, sunny day but too warm." Now you say that. | MMSE-2 Standard Version - Repeat What I Say | ||
MMS208A | C151018 | MMS2-Point to the Circle | Mini-Mental State Examination 2 Standard Version - Look at these pictures and point to the circle. | MMSE-2 Standard Version - Point to the Circle | ||
MMS208B | C151019 | MMS2-Point to the Square | Mini-Mental State Examination 2 Standard Version - Then point to the square. | MMSE-2 Standard Version - Point to the Square | ||
MMS208C | C151020 | MMS2-Point to the Triangle | Mini-Mental State Examination 2 Standard Version - Then point to the triangle. | MMSE-2 Standard Version - Point to the Triangle | ||
MMS209 | C151021 | MMS2-Do What This Says to Do | Mini-Mental State Examination 2 Standard Version - Please do what this says to do. | MMSE-2 Standard Version - Do What This Says to Do | ||
MMS210 | C151022 | MMS2-Write a Sentence | Mini-Mental State Examination 2 Standard Version - Please write a sentence. | MMSE-2 Standard Version - Write a Sentence | ||
MMS211 | C151023 | MMS2-Copy This Design | Mini-Mental State Examination 2 Standard Version - Please copy this design. | MMSE-2 Standard Version - Copy This Design | ||
MMS212 | C151024 | MMS2-BV Total Raw Score | Mini-Mental State Examination 2 Standard Version - BV (Brief Version) total raw score. | MMSE-2 Standard Version - BV Total Raw Score | ||
MMS213 | C151025 | MMS2-SV Total Raw Score | Mini-Mental State Examination 2 Standard Version - SV (Standard Version) total raw score. | MMSE-2 Standard Version - SV Total Raw Score | ||
MMS214 | C151026 | MMS2-Level of Consciousness | Mini-Mental State Examination 2 Standard Version - Assessment of level of consciousness. | MMSE-2 Standard Version - Level of Consciousness | ||
Back to top | ||||||
CL.C150769.MMS2TN | Mini-Mental State Examination 2 Standard Version Functional Test Test Name
(MMS2TN) | text
Extensible: No | C150769 | Mini-Mental State Examination 2 Standard Version Functional Test Test Name | Mini-Mental State Examination 2 Standard Version test name. | CDISC Functional Test MMSE-2 Standard Version Test Name Terminology |
MMS2-BV Total Raw Score | C151024 | MMS2-BV Total Raw Score | Mini-Mental State Examination 2 Standard Version - BV (Brief Version) total raw score. | MMSE-2 Standard Version - BV Total Raw Score | ||
MMS2-Copy This Design | C151023 | MMS2-Copy This Design | Mini-Mental State Examination 2 Standard Version - Please copy this design. | MMSE-2 Standard Version - Copy This Design | ||
MMS2-Do What This Says to Do | C151021 | MMS2-Do What This Says to Do | Mini-Mental State Examination 2 Standard Version - Please do what this says to do. | MMSE-2 Standard Version - Do What This Says to Do | ||
MMS2-Keep Subtracting 7 Step 2 | C151011 | MMS2-Keep Subtracting 7 Step 2 | Mini-Mental State Examination 2 Standard Version - Keep going [86]. | MMSE-2 Standard Version - Keep Subtracting 7 Step 2 | ||
MMS2-Keep Subtracting 7 Step 3 | C151012 | MMS2-Keep Subtracting 7 Step 3 | Mini-Mental State Examination 2 Standard Version - Keep going [79]. | MMSE-2 Standard Version - Keep Subtracting 7 Step 3 | ||
MMS2-Keep Subtracting 7 Step 4 | C151013 | MMS2-Keep Subtracting 7 Step 4 | Mini-Mental State Examination 2 Standard Version - Keep going [72]. | MMSE-2 Standard Version - Keep Subtracting 7 Step 4 | ||
MMS2-Keep Subtracting 7 Step 5 | C151014 | MMS2-Keep Subtracting 7 Step 5 | Mini-Mental State Examination 2 Standard Version - Keep going [65]. | MMSE-2 Standard Version - Keep Subtracting 7 Step 5 | ||
MMS2-Level of Consciousness | C151026 | MMS2-Level of Consciousness | Mini-Mental State Examination 2 Standard Version - Assessment of level of consciousness. | MMSE-2 Standard Version - Level of Consciousness | ||
MMS2-Naming Object 1 | C151015 | MMS2-Naming Object 1 | Mini-Mental State Examination 2 Standard Version - What is this: Object 1? | MMSE-2 Standard Version - Naming Object 1 | ||
MMS2-Naming Object 2 | C151016 | MMS2-Naming Object 2 | Mini-Mental State Examination 2 Standard Version - What is this: Object 2? | MMSE-2 Standard Version - Naming Object 2 | ||
MMS2-Point to the Circle | C151018 | MMS2-Point to the Circle | Mini-Mental State Examination 2 Standard Version - Look at these pictures and point to the circle. | MMSE-2 Standard Version - Point to the Circle | ||
MMS2-Point to the Square | C151019 | MMS2-Point to the Square | Mini-Mental State Examination 2 Standard Version - Then point to the square. | MMSE-2 Standard Version - Point to the Square | ||
MMS2-Point to the Triangle | C151020 | MMS2-Point to the Triangle | Mini-Mental State Examination 2 Standard Version - Then point to the triangle. | MMSE-2 Standard Version - Point to the Triangle | ||
MMS2-Recall Word 1 | C151007 | MMS2-Recall Word 1 | Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 1? | MMSE-2 Standard Version - Recall Word 1 | ||
MMS2-Recall Word 2 | C151008 | MMS2-Recall Word 2 | Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 2? | MMSE-2 Standard Version - Recall Word 2 | ||
MMS2-Recall Word 3 | C151009 | MMS2-Recall Word 3 | Mini-Mental State Examination 2 Standard Version - What were those three words I asked you to remember: Word 3? | MMSE-2 Standard Version - Recall Word 3 | ||
MMS2-Repeat What I Say | C151017 | MMS2-Repeat What I Say | Mini-Mental State Examination 2 Standard Version - Now I am going to ask you to repeat what I say. Ready? "It is a lovely, sunny day but too warm." Now you say that. | MMSE-2 Standard Version - Repeat What I Say | ||
MMS2-Repeat Word 1 | C150994 | MMS2-Repeat Word 1 | Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 1. | MMSE-2 Standard Version - Repeat Word 1 | ||
MMS2-Repeat Word 2 | C150995 | MMS2-Repeat Word 2 | Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 2. | MMSE-2 Standard Version - Repeat Word 2 | ||
MMS2-Repeat Word 3 | C150996 | MMS2-Repeat Word 3 | Mini-Mental State Examination 2 Standard Version - Now repeat those words back to me: Word 3. | MMSE-2 Standard Version - Repeat Word 3 | ||
MMS2-SV Total Raw Score | C151025 | MMS2-SV Total Raw Score | Mini-Mental State Examination 2 Standard Version - SV (Standard Version) total raw score. | MMSE-2 Standard Version - SV Total Raw Score | ||
MMS2-What is 100 Take Away 7 | C151010 | MMS2-What is 100 Take Away 7 | Mini-Mental State Examination 2 Standard Version - What is 100 take away 7 [93]? | MMSE-2 Standard Version - What is 100 Take Away 7 | ||
MMS2-What Is the Building | C151005 | MMS2-What Is the Building | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the building (name or type)? | MMSE-2 Standard Version - What Is the Building | ||
MMS2-What Is the City/Town | C151004 | MMS2-What Is the City/Town | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the city/town (or part of city/neighborhood)? | MMSE-2 Standard Version - What Is the City/Town | ||
MMS2-What Is the County | C151003 | MMS2-What Is the County | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the county (or city/town)? | MMSE-2 Standard Version - What Is the County | ||
MMS2-What Is the Date | C151001 | MMS2-What Is the Date | Mini-Mental State Examination 2 Standard Version - What is the date? | MMSE-2 Standard Version - What Is the Date | ||
MMS2-What Is the Day of Week | C151000 | MMS2-What Is the Day of Week | Mini-Mental State Examination 2 Standard Version - What is the day of the week? | MMSE-2 Standard Version - What Is the Day of Week | ||
MMS2-What Is the Floor | C151006 | MMS2-What Is the Floor | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the floor of the building (room number or address)? | MMSE-2 Standard Version - What Is the Floor | ||
MMS2-What Is the Month of Year | C150999 | MMS2-What Is the Month of Year | Mini-Mental State Examination 2 Standard Version - What is the month of the year? | MMSE-2 Standard Version - What Is the Month of Year | ||
MMS2-What Is the Season | C150998 | MMS2-What Is the Season | Mini-Mental State Examination 2 Standard Version - What is the season? | MMSE-2 Standard Version - What Is the Season | ||
MMS2-What Is the State | C151002 | MMS2-What Is the State | Mini-Mental State Examination 2 Standard Version - Where are we now? What is the state (or province)? | MMSE-2 Standard Version - What Is the State | ||
MMS2-What Is the Year | C150997 | MMS2-What Is the Year | Mini-Mental State Examination 2 Standard Version - What is the year? | MMSE-2 Standard Version - What Is the Year | ||
MMS2-Write a Sentence | C151022 | MMS2-Write a Sentence | Mini-Mental State Examination 2 Standard Version - Please write a sentence. | MMSE-2 Standard Version - Write a Sentence | ||
Back to top | ||||||
CL.C100142.MMS1TC | Mini-Mental State Examination Functional Test Test Code
(MMS1TC) | text
Extensible: No | C100142 | Mini-Mental State Examination Functional Test Test Code | Mini-Mental State Examination test code. | CDISC Functional Test MMSE Test Code Terminology |
MMS101A | C100543 | MMS1-What Is the Year | Mini-Mental State Examination - What is the year? | MMSE - What Is the Year | ||
MMS101B | C100544 | MMS1-What Is the Season | Mini-Mental State Examination - What is the season? | MMSE - What Is the Season | ||
MMS101C | C100547 | MMS1-What Is the Month of Year | Mini-Mental State Examination - What is the month of the year? | MMSE - What Is the Month of Year | ||
MMS101D | C100546 | MMS1-What Is the Day of Week | Mini-Mental State Examination - What is the day of the week? | MMSE - What Is the Day of Week | ||
MMS101E | C100545 | MMS1-What Is the Date | Mini-Mental State Examination - What is the date? | MMSE - What Is the Date | ||
MMS102A | C100549 | MMS1-What Is the State | Mini-Mental State Examination - Where are we now? What is the state (province)? | MMSE - What Is the State | ||
MMS102B | C100550 | MMS1-What Is the County | Mini-Mental State Examination - Where are we now? What is the county (or city/town)? | MMSE - What Is the County | ||
MMS102C | C100551 | MMS1-What Is the City/Town | Mini-Mental State Examination - Where are we now? What is the city/town (or part of city/neighborhood)? | MMSE - What Is the City or Town | ||
MMS102D | C100552 | MMS1-What Is the Building | Mini-Mental State Examination - Where are we now? What is the building (name or type)? | MMSE - What Is the Building | ||
MMS102E | C100553 | MMS1-What Is the Floor | Mini-Mental State Examination - Where are we now? What is the floor of the building (room number or address)? | MMSE - What Is the Floor | ||
MMS103A | C100555 | MMS1-Repeat Word 1 | Mini-Mental State Examination - Now repeat those words back to me: Word 1. | MMSE - Repeat Word 1 | ||
MMS103B | C100556 | MMS1-Repeat Word 2 | Mini-Mental State Examination - Now repeat those words back to me: Word 2. | MMSE - Repeat Word 2 | ||
MMS103C | C100557 | MMS1-Repeat Word 3 | Mini-Mental State Examination - Now repeat those words back to me: Word 3. | MMSE - Repeat Word 3 | ||
MMS104 | C100570 | MMS1-Attention and Calculation Subtotal | Mini-Mental State Examination - Attention and calculation subtotal. | MMSE - Attention and Calculation Subtotal | ||
MMS104AA | C100559 | MMS1-What is 100 Take Away 7 | Mini-Mental State Examination - What is 100 take away 7 [93]? | MMSE - What is 100 Take Away 7 | ||
MMS104AB | C100560 | MMS1-Keep Subtracting 7 Step 2 | Mini-Mental State Examination - Keep going [86]. | MMSE - Keep Subtracting 7 Step 2 | ||
MMS104AC | C100561 | MMS1-Keep Subtracting 7 Step 3 | Mini-Mental State Examination - Keep going [79]. | MMSE - Keep Subtracting 7 Step 3 | ||
MMS104AD | C100562 | MMS1-Keep Subtracting 7 Step 4 | Mini-Mental State Examination - Keep going [72]. | MMSE - Keep Subtracting 7 Step 4 | ||
MMS104AE | C100563 | MMS1-Keep Subtracting 7 Step 5 | Mini-Mental State Examination - Keep going [65]. | MMSE - Keep Subtracting 7 Step 5 | ||
MMS104BA | C100565 | MMS1-Spell Backward Letter 1 | Mini-Mental State Examination - Spell backward, letter 1. | MMSE - Spell Backward Letter 1 | ||
MMS104BB | C100566 | MMS1-Spell Backward Letter 2 | Mini-Mental State Examination - Spell backward, letter 2. | MMSE - Spell Backward Letter 2 | ||
MMS104BC | C100567 | MMS1-Spell Backward Letter 3 | Mini-Mental State Examination - Spell backward, letter 3. | MMSE - Spell Backward Letter 3 | ||
MMS104BD | C100568 | MMS1-Spell Backward Letter 4 | Mini-Mental State Examination - Spell backward, letter 4. | MMSE - Spell Backward Letter 4 | ||
MMS104BE | C100569 | MMS1-Spell Backward Letter 5 | Mini-Mental State Examination - Spell backward, letter 5. | MMSE - Spell Backward Letter 5 | ||
MMS105A | C100572 | MMS1-Recall Word 1 | Mini-Mental State Examination - What were those three words I asked you to remember: Word 1? | MMSE - Recall Word 1 | ||
MMS105B | C100573 | MMS1-Recall Word 2 | Mini-Mental State Examination - What were those three words I asked you to remember: Word 2? | MMSE - Recall Word 2 | ||
MMS105C | C100574 | MMS1-Recall Word 3 | Mini-Mental State Examination - What were those three words I asked you to remember: Word 3? | MMSE - Recall Word 3 | ||
MMS106A | C100576 | MMS1-Naming Object 1 | Mini-Mental State Examination - What is this: Object 1? | MMSE - Naming Object 1 | ||
MMS106B | C100577 | MMS1-Naming Object 2 | Mini-Mental State Examination - What is this: Object 2? | MMSE - Naming Object 2 | ||
MMS107 | C100578 | MMS1-Repeat What I Say | Mini-Mental State Examination - Now I am going to ask you to repeat what I say. Ready? "No ifs, ands, or buts." Now you say that. | MMSE - Repeat What I Say | ||
MMS108A | C100580 | MMS1-Take in Right Hand | Mini-Mental State Examination - Listen carefully because I am going to ask you to do something. Take this paper in your right hand. | MMSE - Take in Right Hand | ||
MMS108B | C100581 | MMS1-Fold in Half | Mini-Mental State Examination - Fold it in half. | MMSE - Fold in Half | ||
MMS108C | C100582 | MMS1-Put on Floor (or Table) | Mini-Mental State Examination - And put it on the floor (or table). | MMSE - Put on Floor or Table | ||
MMS109 | C100583 | MMS1-Read This and Do What It Says | Mini-Mental State Examination - Please read this and do what it says. | MMSE - Read This and Do What It Says | ||
MMS110 | C100584 | MMS1-Write a Sentence | Mini-Mental State Examination - Please write a sentence. | MMSE - Write a Sentence | ||
MMS111 | C100585 | MMS1-Copy This Design | Mini-Mental State Examination - Please copy this design. | MMSE - Copy This Design | ||
MMS112 | C100586 | MMS1-Total Score | Mini-Mental State Examination - Total score. | MMSE - Total Score | ||
MMS113 | C136234 | MMS1-Level of Consciousness | Mini-Mental State Examination - Assessment of level of consciousness. | MMSE - Level of Consciousness | ||
Back to top | ||||||
CL.C100141.MMS1TN | Mini-Mental State Examination Functional Test Test Name
(MMS1TN) | text
Extensible: No | C100141 | Mini-Mental State Examination Functional Test Test Name | Mini-Mental State Examination test name. | CDISC Functional Test MMSE Test Name Terminology |
MMS1-Attention and Calculation Subtotal | C100570 | MMS1-Attention and Calculation Subtotal | Mini-Mental State Examination - Attention and calculation subtotal. | MMSE - Attention and Calculation Subtotal | ||
MMS1-Copy This Design | C100585 | MMS1-Copy This Design | Mini-Mental State Examination - Please copy this design. | MMSE - Copy This Design | ||
MMS1-Fold in Half | C100581 | MMS1-Fold in Half | Mini-Mental State Examination - Fold it in half. | MMSE - Fold in Half | ||
MMS1-Keep Subtracting 7 Step 2 | C100560 | MMS1-Keep Subtracting 7 Step 2 | Mini-Mental State Examination - Keep going [86]. | MMSE - Keep Subtracting 7 Step 2 | ||
MMS1-Keep Subtracting 7 Step 3 | C100561 | MMS1-Keep Subtracting 7 Step 3 | Mini-Mental State Examination - Keep going [79]. | MMSE - Keep Subtracting 7 Step 3 | ||
MMS1-Keep Subtracting 7 Step 4 | C100562 | MMS1-Keep Subtracting 7 Step 4 | Mini-Mental State Examination - Keep going [72]. | MMSE - Keep Subtracting 7 Step 4 | ||
MMS1-Keep Subtracting 7 Step 5 | C100563 | MMS1-Keep Subtracting 7 Step 5 | Mini-Mental State Examination - Keep going [65]. | MMSE - Keep Subtracting 7 Step 5 | ||
MMS1-Level of Consciousness | C136234 | MMS1-Level of Consciousness | Mini-Mental State Examination - Assessment of level of consciousness. | MMSE - Level of Consciousness | ||
MMS1-Naming Object 1 | C100576 | MMS1-Naming Object 1 | Mini-Mental State Examination - What is this: Object 1? | MMSE - Naming Object 1 | ||
MMS1-Naming Object 2 | C100577 | MMS1-Naming Object 2 | Mini-Mental State Examination - What is this: Object 2? | MMSE - Naming Object 2 | ||
MMS1-Put on Floor (or Table) | C100582 | MMS1-Put on Floor (or Table) | Mini-Mental State Examination - And put it on the floor (or table). | MMSE - Put on Floor or Table | ||
MMS1-Read This and Do What It Says | C100583 | MMS1-Read This and Do What It Says | Mini-Mental State Examination - Please read this and do what it says. | MMSE - Read This and Do What It Says | ||
MMS1-Recall Word 1 | C100572 | MMS1-Recall Word 1 | Mini-Mental State Examination - What were those three words I asked you to remember: Word 1? | MMSE - Recall Word 1 | ||
MMS1-Recall Word 2 | C100573 | MMS1-Recall Word 2 | Mini-Mental State Examination - What were those three words I asked you to remember: Word 2? | MMSE - Recall Word 2 | ||
MMS1-Recall Word 3 | C100574 | MMS1-Recall Word 3 | Mini-Mental State Examination - What were those three words I asked you to remember: Word 3? | MMSE - Recall Word 3 | ||
MMS1-Repeat What I Say | C100578 | MMS1-Repeat What I Say | Mini-Mental State Examination - Now I am going to ask you to repeat what I say. Ready? "No ifs, ands, or buts." Now you say that. | MMSE - Repeat What I Say | ||
MMS1-Repeat Word 1 | C100555 | MMS1-Repeat Word 1 | Mini-Mental State Examination - Now repeat those words back to me: Word 1. | MMSE - Repeat Word 1 | ||
MMS1-Repeat Word 2 | C100556 | MMS1-Repeat Word 2 | Mini-Mental State Examination - Now repeat those words back to me: Word 2. | MMSE - Repeat Word 2 | ||
MMS1-Repeat Word 3 | C100557 | MMS1-Repeat Word 3 | Mini-Mental State Examination - Now repeat those words back to me: Word 3. | MMSE - Repeat Word 3 | ||
MMS1-Spell Backward Letter 1 | C100565 | MMS1-Spell Backward Letter 1 | Mini-Mental State Examination - Spell backward, letter 1. | MMSE - Spell Backward Letter 1 | ||
MMS1-Spell Backward Letter 2 | C100566 | MMS1-Spell Backward Letter 2 | Mini-Mental State Examination - Spell backward, letter 2. | MMSE - Spell Backward Letter 2 | ||
MMS1-Spell Backward Letter 3 | C100567 | MMS1-Spell Backward Letter 3 | Mini-Mental State Examination - Spell backward, letter 3. | MMSE - Spell Backward Letter 3 | ||
MMS1-Spell Backward Letter 4 | C100568 | MMS1-Spell Backward Letter 4 | Mini-Mental State Examination - Spell backward, letter 4. | MMSE - Spell Backward Letter 4 | ||
MMS1-Spell Backward Letter 5 | C100569 | MMS1-Spell Backward Letter 5 | Mini-Mental State Examination - Spell backward, letter 5. | MMSE - Spell Backward Letter 5 | ||
MMS1-Take in Right Hand | C100580 | MMS1-Take in Right Hand | Mini-Mental State Examination - Listen carefully because I am going to ask you to do something. Take this paper in your right hand. | MMSE - Take in Right Hand | ||
MMS1-Total Score | C100586 | MMS1-Total Score | Mini-Mental State Examination - Total score. | MMSE - Total Score | ||
MMS1-What is 100 Take Away 7 | C100559 | MMS1-What is 100 Take Away 7 | Mini-Mental State Examination - What is 100 take away 7 [93]? | MMSE - What is 100 Take Away 7 | ||
MMS1-What Is the Building | C100552 | MMS1-What Is the Building | Mini-Mental State Examination - Where are we now? What is the building (name or type)? | MMSE - What Is the Building | ||
MMS1-What Is the City/Town | C100551 | MMS1-What Is the City/Town | Mini-Mental State Examination - Where are we now? What is the city/town (or part of city/neighborhood)? | MMSE - What Is the City or Town | ||
MMS1-What Is the County | C100550 | MMS1-What Is the County | Mini-Mental State Examination - Where are we now? What is the county (or city/town)? | MMSE - What Is the County | ||
MMS1-What Is the Date | C100545 | MMS1-What Is the Date | Mini-Mental State Examination - What is the date? | MMSE - What Is the Date | ||
MMS1-What Is the Day of Week | C100546 | MMS1-What Is the Day of Week | Mini-Mental State Examination - What is the day of the week? | MMSE - What Is the Day of Week | ||
MMS1-What Is the Floor | C100553 | MMS1-What Is the Floor | Mini-Mental State Examination - Where are we now? What is the floor of the building (room number or address)? | MMSE - What Is the Floor | ||
MMS1-What Is the Month of Year | C100547 | MMS1-What Is the Month of Year | Mini-Mental State Examination - What is the month of the year? | MMSE - What Is the Month of Year | ||
MMS1-What Is the Season | C100544 | MMS1-What Is the Season | Mini-Mental State Examination - What is the season? | MMSE - What Is the Season | ||
MMS1-What Is the State | C100549 | MMS1-What Is the State | Mini-Mental State Examination - Where are we now? What is the state (province)? | MMSE - What Is the State | ||
MMS1-What Is the Year | C100543 | MMS1-What Is the Year | Mini-Mental State Examination - What is the year? | MMSE - What Is the Year | ||
MMS1-Write a Sentence | C100584 | MMS1-Write a Sentence | Mini-Mental State Examination - Please write a sentence. | MMSE - Write a Sentence | ||
Back to top | ||||||
CL.C181165.MODDLV | Mode of Delivery
(MODDLV) | text
Extensible: Yes | C181165 | Mode of Delivery | A terminology codelist relevant to the mode of delivery of a fetus or neonate. | CDISC SDTM Mode of Delivery Terminology |
BREECH EXTRACTION | C114136 | The delivery of a breech-presenting fetus, which is manually pulled through the birth canal. | Breech Extraction | |||
CESAREAN SECTION | C46088 | C-Section;Cesarean Delivery | Surgical delivery of one or more intrauterine fetuses though an abdominal incision. | Cesarean Section | ||
DELIVERY BY DESTRUCTIVE OPERATION | C114143 | Extraction of a fetus through the cervix using destructive surgical techniques. | Delivery by Destructive Operation | |||
VAGINAL ASSISTED DELIVERY | C81301 | Operative Vaginal Delivery | Birth of the fetus through the vagina with the application of vacuum or forceps or any other instrument. | Vaginal Assisted Delivery | ||
VAGINAL BIRTH AFTER CESAREAN DELIVERY | C81302 | A vaginal birth in a woman with one or more previous cesarean births. (reVITALize) | Vaginal Birth after Cesarean Delivery | |||
VAGINAL DELIVERY | C81303 | Birth of the fetus through the vagina. | Vaginal Delivery | |||
Back to top | ||||||
CL.C127265.MODTRN | Mode of Disease Transmission
(MODTRN) | text
Extensible: Yes | C127265 | Mode of Disease Transmission | The terminology relevant to the mechanism by which a disease is transmitted. | CDISC SDTM Mode of Disease Transmission Terminology |
BLOOD TRANSFUSION | C15192 | The infusion of whole blood or a blood component into the bloodstream. | Blood Transfusion | |||
BREASTFEEDING | C25596 | The nursing of an infant at the female's breast. | Breast Feeding | |||
HORIZONTAL TRANSMISSION | C127773 | The transmission of a disease from one individual to another within the same species. | Horizontal Transmission | |||
INJECTION NEEDLE REUSE | C156549 | The use of injection needles that have been previously used. | Injection Needle Reuse | |||
INTRAUTERINE EXPOSURE | C154864 | The exposure to agents that occurs as a result of in utero development. | Intrauterine Exposure | |||
LABOR AND DELIVERY | C92934 | The process by which a mammal gives birth. | Labor and Delivery Process | |||
OCCUPATIONAL EXPOSURE | C16929 | The exposure to agents that occurs as a result of one's occupation. | Occupational Exposure | |||
OPPOSITE-SEX SEXUAL CONTACT | C154862 | Heterosexual Contact | Sexual contact with a member of the opposite sex. | Heterosexual Contact | ||
PERINATAL EXPOSURE | C19942 | The exposure to agents that occurs transplacentally or during the labor and delivery process. | Perinatal Exposure | |||
SAME-SEX SEXUAL CONTACT | C154863 | Homosexual Contact | Sexual contact with a member of the same sex. | Homosexual Contact | ||
SEXUAL CONTACT | C154689 | Sexual interaction between individuals. | Sexual Contact | |||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
VERTICAL TRANSMISSION | C98977 | The transmission of a disease from the mother to the fetus or newborn. | Maternal Transmission | |||
Back to top | ||||||
CL.C171445.CNTMODE | Mode of Subject Contact
(CNTMODE) | text
Extensible: Yes | C171445 | Mode of Subject Contact | Terminology relevant to the means by which interaction occurs between the subject and person or entity. | CDISC SDTM Mode of Subject Contact Terminology |
IN PERSON | C175574 | In-Person | An interaction that takes place in the physical presence of someone else. | In Person | ||
IVRS | C177933 | Interactive Voice Response System | A type of automated system in which individuals can access information menus containing pre-recorded or dynamically generated information with voice prompts, without the need for an agent or operator. | Interactive Voice Response System | ||
REMOTE AUDIO VIDEO | C171525 | A form of remote communication by audio video technology. | Audio-Videoconferencing | |||
REMOTE AUDIO | C171524 | A form of remote communication by audio technology. | Audioconferencing | |||
SHIPMENT CONFIRMED BY SIGNATURE | C171533 | Receipt of shipped material was confirmed by signature. | Shipment Confirmed by Signature | |||
TELEPHONE CALL | C171537 | Communication by way of telephone. | Telephone Call | |||
Back to top | ||||||
CL.C120991.MELD01TC | Model for End Stage Liver Disease Clinical Classification Test Code
(MELD01TC) | text
Extensible: No | C120991 | Model for End Stage Liver Disease Clinical Classification Test Code | Model for End Stage Liver Disease test code. | CDISC Clinical Classification MELD Test Code Terminology |
MELD0101 | C121076 | MELD01-Score | Model for End Stage Liver Disease - MELD score. | MELD - Score | ||
Back to top | ||||||
CL.C120990.MELD01TN | Model for End Stage Liver Disease Clinical Classification Test Name
(MELD01TN) | text
Extensible: No | C120990 | Model for End Stage Liver Disease Clinical Classification Test Name | Model for End Stage Liver Disease test name. | CDISC Clinical Classification MELD Test Name Terminology |
MELD01-Score | C121076 | MELD01-Score | Model for End Stage Liver Disease - MELD score. | MELD - Score | ||
Back to top | ||||||
CL.C113858.MFIS01TC | Modified Fatigue Impact Scale Questionnaire Test Code
(MFIS01TC) | text
Extensible: No | C113858 | Modified Fatigue Impact Scale Questionnaire Test Code | Modified Fatigue Impact Scale test code. | CDISC Questionnaire Modified Fatigue Impact Scale Test Code Terminology |
MFIS0101 | C113967 | MFIS01-I Have Been Less Alert | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less alert. | MFIS - Have Been Less Alert | ||
MFIS0102 | C113968 | MFIS01-Have Difficulty Paying Attention | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty paying attention for long periods of time. | MFIS - Have Difficulty Paying Attention for Long Time | ||
MFIS0103 | C113969 | MFIS01-Have Been Unable to Think Clearly | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been unable to think clearly. | MFIS - Unable to Think Clearly | ||
MFIS0104 | C113970 | MFIS01-Been Clumsy and Uncoordinated | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been clumsy and uncoordinated. | MFIS - Have Been Clumsy and Uncoordinated | ||
MFIS0105 | C113971 | MFIS01-I Have Been Forgetful | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been forgetful. | MFIS - Have Been Forgetful | ||
MFIS0106 | C113972 | MFIS01-Pace Myself in Physical Activity | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had to pace myself in my physical activities. | MFIS - Pace Myself in Physical Activities | ||
MFIS0107 | C113973 | MFIS01-Less Motivated, Physical Effort | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to do anything that requires physical effort. | MFIS - Less Motivated to Do Anything That Requires Physical Effort | ||
MFIS0108 | C113974 | MFIS01-Less Motivated, Social Activity | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to participate in social activities. | MFIS - Less Motivated to Participate in Social Activities | ||
MFIS0109 | C113975 | MFIS01-Limited in Ability Away From Home | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been limited in my ability to do things away from home. | MFIS - Limited in My Abilities to Do Things Away From Home | ||
MFIS0110 | C113976 | MFIS01-Trouble Maintain Physical Effort | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble maintaining physical effort for long periods. | MFIS - Have Trouble Maintain Physical Effort | ||
MFIS0111 | C113977 | MFIS01-Have Difficulty Making Decisions | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty making decisions. | MFIS - Have Difficulty Making Decisions | ||
MFIS0112 | C113978 | MFIS01-Less Motivated, Thinking | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to do anything that requires thinking. | MFIS - Less Motivated to Do Anything That Requires Thinking | ||
MFIS0113 | C113979 | MFIS01-My Muscles Have Felt Weak | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks my muscles have felt weak. | MFIS - Muscles Have Felt Weak | ||
MFIS0114 | C113980 | MFIS01-Been Physically Uncomfortable | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been physically uncomfortable. | MFIS - Been Physically Uncomfortable | ||
MFIS0115 | C113981 | MFIS01-Trouble Finishing Thinking Tasks | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble finishing tasks that require thinking. | MFIS - Have Trouble Finishing Tasks That Require Thinking | ||
MFIS0116 | C113982 | MFIS01-Difficulty Organizing My Thoughts | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty organizing my thoughts when doing things at home or at work. | MFIS - Difficulty Organizing My Thoughts | ||
MFIS0117 | C113983 | MFIS01-Less Able Complete Physical Tasks | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less able to complete tasks that require physical effort. | MFIS - Less Able to Complete Tasks That Require Physical Effort | ||
MFIS0118 | C113984 | MFIS01-My Thinking Has Been Slowed Down | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks my thinking has been slowed down. | MFIS - My Thinking Has Been Slowed Down | ||
MFIS0119 | C113985 | MFIS01-I Have Had Trouble Concentrating | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble concentrating. | MFIS - Have Trouble Concentrating | ||
MFIS0120 | C113986 | MFIS01-Have Limited My Physical Activity | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have limited my physical activities. | MFIS - Have Limited My Physical Activities | ||
MFIS0121 | C113987 | MFIS01-Need to Rest More Often or Longer | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have needed to rest more often or for longer periods. | MFIS - Need to Rest More Often or Longer | ||
Back to top | ||||||
CL.C113857.MFIS01TN | Modified Fatigue Impact Scale Questionnaire Test Name
(MFIS01TN) | text
Extensible: No | C113857 | Modified Fatigue Impact Scale Questionnaire Test Name | Modified Fatigue Impact Scale test name. | CDISC Questionnaire Modified Fatigue Impact Scale Test Name Terminology |
MFIS01-Been Clumsy and Uncoordinated | C113970 | MFIS01-Been Clumsy and Uncoordinated | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been clumsy and uncoordinated. | MFIS - Have Been Clumsy and Uncoordinated | ||
MFIS01-Been Physically Uncomfortable | C113980 | MFIS01-Been Physically Uncomfortable | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been physically uncomfortable. | MFIS - Been Physically Uncomfortable | ||
MFIS01-Difficulty Organizing My Thoughts | C113982 | MFIS01-Difficulty Organizing My Thoughts | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty organizing my thoughts when doing things at home or at work. | MFIS - Difficulty Organizing My Thoughts | ||
MFIS01-Have Been Unable to Think Clearly | C113969 | MFIS01-Have Been Unable to Think Clearly | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been unable to think clearly. | MFIS - Unable to Think Clearly | ||
MFIS01-Have Difficulty Making Decisions | C113977 | MFIS01-Have Difficulty Making Decisions | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty making decisions. | MFIS - Have Difficulty Making Decisions | ||
MFIS01-Have Difficulty Paying Attention | C113968 | MFIS01-Have Difficulty Paying Attention | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had difficulty paying attention for long periods of time. | MFIS - Have Difficulty Paying Attention for Long Time | ||
MFIS01-Have Limited My Physical Activity | C113986 | MFIS01-Have Limited My Physical Activity | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have limited my physical activities. | MFIS - Have Limited My Physical Activities | ||
MFIS01-I Have Been Forgetful | C113971 | MFIS01-I Have Been Forgetful | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been forgetful. | MFIS - Have Been Forgetful | ||
MFIS01-I Have Been Less Alert | C113967 | MFIS01-I Have Been Less Alert | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less alert. | MFIS - Have Been Less Alert | ||
MFIS01-I Have Had Trouble Concentrating | C113985 | MFIS01-I Have Had Trouble Concentrating | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble concentrating. | MFIS - Have Trouble Concentrating | ||
MFIS01-Less Able Complete Physical Tasks | C113983 | MFIS01-Less Able Complete Physical Tasks | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less able to complete tasks that require physical effort. | MFIS - Less Able to Complete Tasks That Require Physical Effort | ||
MFIS01-Less Motivated, Physical Effort | C113973 | MFIS01-Less Motivated, Physical Effort | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to do anything that requires physical effort. | MFIS - Less Motivated to Do Anything That Requires Physical Effort | ||
MFIS01-Less Motivated, Social Activity | C113974 | MFIS01-Less Motivated, Social Activity | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to participate in social activities. | MFIS - Less Motivated to Participate in Social Activities | ||
MFIS01-Less Motivated, Thinking | C113978 | MFIS01-Less Motivated, Thinking | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been less motivated to do anything that requires thinking. | MFIS - Less Motivated to Do Anything That Requires Thinking | ||
MFIS01-Limited in Ability Away From Home | C113975 | MFIS01-Limited in Ability Away From Home | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have been limited in my ability to do things away from home. | MFIS - Limited in My Abilities to Do Things Away From Home | ||
MFIS01-My Muscles Have Felt Weak | C113979 | MFIS01-My Muscles Have Felt Weak | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks my muscles have felt weak. | MFIS - Muscles Have Felt Weak | ||
MFIS01-My Thinking Has Been Slowed Down | C113984 | MFIS01-My Thinking Has Been Slowed Down | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks my thinking has been slowed down. | MFIS - My Thinking Has Been Slowed Down | ||
MFIS01-Need to Rest More Often or Longer | C113987 | MFIS01-Need to Rest More Often or Longer | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have needed to rest more often or for longer periods. | MFIS - Need to Rest More Often or Longer | ||
MFIS01-Pace Myself in Physical Activity | C113972 | MFIS01-Pace Myself in Physical Activity | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had to pace myself in my physical activities. | MFIS - Pace Myself in Physical Activities | ||
MFIS01-Trouble Finishing Thinking Tasks | C113981 | MFIS01-Trouble Finishing Thinking Tasks | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble finishing tasks that require thinking. | MFIS - Have Trouble Finishing Tasks That Require Thinking | ||
MFIS01-Trouble Maintain Physical Effort | C113976 | MFIS01-Trouble Maintain Physical Effort | Modified Fatigue Impact Scale - Because of my fatigue during the past 4 weeks I have had trouble maintaining physical effort for long periods. | MFIS - Have Trouble Maintain Physical Effort | ||
Back to top | ||||||
CL.C112445.MHIS01TC | Modified Hachinski Ischemic Scale-NACC Version Questionnaire Test Code
(MHIS01TC) | text
Extensible: No | C112445 | Modified Hachinski Ischemic Scale-NACC Version Questionnaire Test Code | Modified Hachinski Ischemic Scale-NACC Version test code. | CDISC Questionnaire MHIS-NACC Test Code Terminology |
MHIS0101 | C112618 | MHIS01-Abrupt Onset | Modified Hachinski Ischemic Scale-NACC Version - Abrupt onset (re: cognitive status). | MHIS-NACC - Abrupt Onset | ||
MHIS0102 | C112619 | MHIS01-Stepwise Deterioration | Modified Hachinski Ischemic Scale-NACC Version - Stepwise deterioration (re: cognitive status). | MHIS-NACC - Stepwise Deterioration | ||
MHIS0103 | C112813 | MHIS01- Somatic Complaints | Modified Hachinski Ischemic Scale-NACC Version - Somatic complaints. | MHIS-NACC - Somatic Complaints | ||
MHIS0104 | C112620 | MHIS01-Emotional Incontinence | Modified Hachinski Ischemic Scale-NACC Version - Emotional incontinence. | MHIS-NACC - Emotional Incontinence | ||
MHIS0105 | C112621 | MHIS01-History or Presence Hypertension | Modified Hachinski Ischemic Scale-NACC Version - History or presence of hypertension. | MHIS-NACC - History or Presence of Hypertension | ||
MHIS0106 | C112622 | MHIS01-History of Stroke | Modified Hachinski Ischemic Scale-NACC Version - History of stroke. | MHIS-NACC - History of Stroke | ||
MHIS0107 | C112623 | MHIS01-Focal Neurological Symptoms | Modified Hachinski Ischemic Scale-NACC Version - Focal neurological symptoms. | MHIS-NACC - Focal Neurological Symptoms | ||
MHIS0108 | C112624 | MHIS01-Focal Neurological Signs | Modified Hachinski Ischemic Scale-NACC Version - Focal neurological signs. | MHIS-NACC - Focal Neurological Signs | ||
MHIS0109 | C112625 | MHIS01-Total Score | Modified Hachinski Ischemic Scale-NACC Version - Sum all circled answers for a total score. | MHIS-NACC - Total Score | ||
Back to top | ||||||
CL.C112444.MHIS01TN | Modified Hachinski Ischemic Scale-NACC Version Questionnaire Test Name
(MHIS01TN) | text
Extensible: No | C112444 | Modified Hachinski Ischemic Scale-NACC Version Questionnaire Test Name | Modified Hachinski Ischemic Scale-NACC Version test name. | CDISC Questionnaire MHIS-NACC Test Name Terminology |
MHIS01- Somatic Complaints | C112813 | MHIS01- Somatic Complaints | Modified Hachinski Ischemic Scale-NACC Version - Somatic complaints. | MHIS-NACC - Somatic Complaints | ||
MHIS01-Abrupt Onset | C112618 | MHIS01-Abrupt Onset | Modified Hachinski Ischemic Scale-NACC Version - Abrupt onset (re: cognitive status). | MHIS-NACC - Abrupt Onset | ||
MHIS01-Emotional Incontinence | C112620 | MHIS01-Emotional Incontinence | Modified Hachinski Ischemic Scale-NACC Version - Emotional incontinence. | MHIS-NACC - Emotional Incontinence | ||
MHIS01-Focal Neurological Signs | C112624 | MHIS01-Focal Neurological Signs | Modified Hachinski Ischemic Scale-NACC Version - Focal neurological signs. | MHIS-NACC - Focal Neurological Signs | ||
MHIS01-Focal Neurological Symptoms | C112623 | MHIS01-Focal Neurological Symptoms | Modified Hachinski Ischemic Scale-NACC Version - Focal neurological symptoms. | MHIS-NACC - Focal Neurological Symptoms | ||
MHIS01-History of Stroke | C112622 | MHIS01-History of Stroke | Modified Hachinski Ischemic Scale-NACC Version - History of stroke. | MHIS-NACC - History of Stroke | ||
MHIS01-History or Presence Hypertension | C112621 | MHIS01-History or Presence Hypertension | Modified Hachinski Ischemic Scale-NACC Version - History or presence of hypertension. | MHIS-NACC - History or Presence of Hypertension | ||
MHIS01-Stepwise Deterioration | C112619 | MHIS01-Stepwise Deterioration | Modified Hachinski Ischemic Scale-NACC Version - Stepwise deterioration (re: cognitive status). | MHIS-NACC - Stepwise Deterioration | ||
MHIS01-Total Score | C112625 | MHIS01-Total Score | Modified Hachinski Ischemic Scale-NACC Version - Sum all circled answers for a total score. | MHIS-NACC - Total Score | ||
Back to top | ||||||
CL.C106669.MMRC01TC | Modified Medical Research Council Dyspnea Scale Questionnaire Test Code
(MMRC01TC) | text
Extensible: No | C106669 | Modified Medical Research Council Dyspnea Scale Questionnaire Test Code | Modified Medical Research Council Dyspnea Scale test code. | CDISC Questionnaire MMRC Test Code Terminology |
MMRC0101 | C106852 | MMRC01-Description of Breathlessness | Modified Medical Research Council Dyspnea Scale - Description of breathlessness. | MMRC - Description of Level of Breathlessness | ||
Back to top | ||||||
CL.C106668.MMRC01TN | Modified Medical Research Council Dyspnea Scale Questionnaire Test Name
(MMRC01TN) | text
Extensible: No | C106668 | Modified Medical Research Council Dyspnea Scale Questionnaire Test Name | Modified Medical Research Council Dyspnea Scale test name. | CDISC Questionnaire MMRC Test Name Terminology |
MMRC01-Description of Breathlessness | C106852 | MMRC01-Description of Breathlessness | Modified Medical Research Council Dyspnea Scale - Description of breathlessness. | MMRC - Description of Level of Breathlessness | ||
Back to top | ||||||
CL.C111348.MRS01TC | Modified Rankin Scale Questionnaire Test Code
(MRS01TC) | text
Extensible: No | C111348 | Modified Rankin Scale Questionnaire Test Code | Modified Rankin Scale test code. | CDISC Questionnaire MRS Test Code Terminology |
MRS0101 | C111520 | MRS01-Modified Rankin Scale Score | Modified Rankin Scale - Modified Rankin Scale Score. | MRS - Modified Rankin Scale Score | ||
Back to top | ||||||
CL.C111347.MRS01TN | Modified Rankin Scale Questionnaire Test Name
(MRS01TN) | text
Extensible: No | C111347 | Modified Rankin Scale Questionnaire Test Name | Modified Rankin Scale test name. | CDISC Questionnaire MRS Test Name Terminology |
MRS01-Modified Rankin Scale Score | C111520 | MRS01-Modified Rankin Scale Score | Modified Rankin Scale - Modified Rankin Scale Score. | MRS - Modified Rankin Scale Score | ||
Back to top | ||||||
CL.C190893.MVAI101OR | Modified Van Assche Index Clinical Classification ORRES for MVAI101 TN/TC
(MVAI101OR) | text
Extensible: No | C190893 | Modified Van Assche Index Clinical Classification ORRES for MVAI101 TN/TC | Modified Van Assche Index original result for MVAI101 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI101 Original Response Terminology |
Absent | C190988 | MVAI101-Absent | Modified Van Assche Index original result for MVAI101-Absent. | Modified Van Assche Index MVAI101 Original Result - Absent | ||
Horseshoe configuration | C190990 | MVAI101-Horseshoe configuration | Modified Van Assche Index original result for MVAI101-Horseshoe configuration. | Modified Van Assche Index MVAI101 Original Result - Horseshoe Configuration | ||
Infralevatoric | C190989 | MVAI101-Infralevatoric | Modified Van Assche Index original result for MVAI101-Infralevatoric. | Modified Van Assche Index MVAI101 Original Result - Infralevatoric | ||
Supralevatoric | C190991 | MVAI101-Supralevatoric | Modified Van Assche Index original result for MVAI101-Supralevatoric. | Modified Van Assche Index MVAI101 Original Result - Supralevatoric | ||
Back to top | ||||||
CL.C190895.MVAI102OR | Modified Van Assche Index Clinical Classification ORRES for MVAI102 TN/TC
(MVAI102OR) | text
Extensible: No | C190895 | Modified Van Assche Index Clinical Classification ORRES for MVAI102 TN/TC | Modified Van Assche Index original result for MVAI102 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI102 Original Response Terminology |
Absent | C190996 | MVAI102-Absent | Modified Van Assche Index original result for MVAI102-Absent. | Modified Van Assche Index MVAI102 Original Result - Absent | ||
Mild | C190997 | MVAI102-Mild | Modified Van Assche Index original result for MVAI102-Mild. | Modified Van Assche Index MVAI102 Original Result - Mild | ||
Pronounced | C190998 | MVAI102-Pronounced | Modified Van Assche Index original result for MVAI102-Pronounced. | Modified Van Assche Index MVAI102 Original Result - Pronounced | ||
Back to top | ||||||
CL.C190897.MVAI103OR | Modified Van Assche Index Clinical Classification ORRES for MVAI103 TN/TC
(MVAI103OR) | text
Extensible: No | C190897 | Modified Van Assche Index Clinical Classification ORRES for MVAI103 TN/TC | Modified Van Assche Index original result for MVAI103 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI103 Original Response Terminology |
Increased signal intensity | C191004 | MVAI103-Increased signal intensity | Modified Van Assche Index original result for MVAI103-Increased signal intensity. | Modified Van Assche Index MVAI103 Original Result - Increased Signal Intensity | ||
Normal | C191002 | MVAI103-Normal | Modified Van Assche Index original result for MVAI103-Normal. | Modified Van Assche Index MVAI103 Original Result - Normal | ||
Thickened | C191003 | MVAI103-Thickened | Modified Van Assche Index original result for MVAI103-Thickened. | Modified Van Assche Index MVAI103 Original Result - Thickened | ||
Back to top | ||||||
CL.C190899.MVAI104OR | Modified Van Assche Index Clinical Classification ORRES for MVAI104 TN/TC
(MVAI104OR) | text
Extensible: No | C190899 | Modified Van Assche Index Clinical Classification ORRES for MVAI104 TN/TC | Modified Van Assche Index original result for MVAI104 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI104 Original Response Terminology |
Absent | C191008 | MVAI104-Absent | Modified Van Assche Index original result for MVAI104-Absent. | Modified Van Assche Index MVAI104 Original Result - Absent | ||
Collection - large | C191013 | MVAI104-Collection - large | Modified Van Assche Index original result for MVAI104-Collection - large. | Modified Van Assche Index MVAI104 Original Result - Collection - Large | ||
Collection - medium | C191012 | MVAI104-Collection - medium | Modified Van Assche Index original result for MVAI104-Collection - medium. | Modified Van Assche Index MVAI104 Original Result - Collection - Medium | ||
Collection - small | C191011 | MVAI104-Collection - small | Modified Van Assche Index original result for MVAI104-Collection - small. | Modified Van Assche Index MVAI104 Original Result - Collection - Small | ||
Diffuse | C191009 | MVAI104-Diffuse | Modified Van Assche Index original result for MVAI104-Diffuse. | Modified Van Assche Index MVAI104 Original Result - Diffuse | ||
Focal | C191010 | MVAI104-Focal | Modified Van Assche Index original result for MVAI104-Focal. | Modified Van Assche Index MVAI104 Original Result - Focal | ||
Back to top | ||||||
CL.C190901.MVAI105OR | Modified Van Assche Index Clinical Classification ORRES for MVAI105 TN/TC
(MVAI105OR) | text
Extensible: No | C190901 | Modified Van Assche Index Clinical Classification ORRES for MVAI105 TN/TC | Modified Van Assche Index original result for MVAI105 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI105 Original Response Terminology |
Fibrous | C191020 | MVAI105-Fibrous | Modified Van Assche Index original result for MVAI105-Fibrous. | Modified Van Assche Index MVAI105 Original Result - Fibrous | ||
Fluid/pus | C191022 | MVAI105-Fluid/pus | Modified Van Assche Index original result for MVAI105-Fluid/pus. | Modified Van Assche Index MVAI105 Original Result - Fluid/Pus | ||
Granulation tissue | C191021 | MVAI105-Granulation tissue | Modified Van Assche Index original result for MVAI105-Granulation tissue. | Modified Van Assche Index MVAI105 Original Result - Granulation Tissue | ||
Back to top | ||||||
CL.C190894.MVAI101STR | Modified Van Assche Index Clinical Classification STRESC for MVAI101 TN/TC
(MVAI101STR) | text
Extensible: No | C190894 | Modified Van Assche Index Clinical Classification STRESC for MVAI101 TN/TC | Modified Van Assche Index standardized character result for MVAI101 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI101 Standardized Character Response Terminology |
0 | C190992 | MVAI101-0 | Modified Van Assche Index standardized character result for MVAI101-Absent. | Modified Van Assche Index MVAI101 Standardized Character Result 0 | ||
1 | C190993 | MVAI101-1 | Modified Van Assche Index standardized character result for MVAI101-Infralevatoric. | Modified Van Assche Index MVAI101 Standardized Character Result 1 | ||
2 | C190994 | MVAI101-2 | Modified Van Assche Index standardized character result for MVAI101-Horseshoe configuration. | Modified Van Assche Index MVAI101 Standardized Character Result 2 | ||
3 | C190995 | MVAI101-3 | Modified Van Assche Index standardized character result for MVAI101-Supralevatoric. | Modified Van Assche Index MVAI101 Standardized Character Result 3 | ||
Back to top | ||||||
CL.C190896.MVAI102STR | Modified Van Assche Index Clinical Classification STRESC for MVAI102 TN/TC
(MVAI102STR) | text
Extensible: No | C190896 | Modified Van Assche Index Clinical Classification STRESC for MVAI102 TN/TC | Modified Van Assche Index standardized character result for MVAI102 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI102 Standardized Character Response Terminology |
0 | C190999 | MVAI102-0 | Modified Van Assche Index standardized character result for MVAI102-Absent. | Modified Van Assche Index MVAI102 Standardized Character Result 0 | ||
1 | C191000 | MVAI102-1 | Modified Van Assche Index standardized character result for MVAI102-Mild. | Modified Van Assche Index MVAI102 Standardized Character Result 1 | ||
2 | C191001 | MVAI102-2 | Modified Van Assche Index standardized character result for MVAI102-Pronounced. | Modified Van Assche Index MVAI102 Standardized Character Result 2 | ||
Back to top | ||||||
CL.C190898.MVAI103STR | Modified Van Assche Index Clinical Classification STRESC for MVAI103 TN/TC
(MVAI103STR) | text
Extensible: No | C190898 | Modified Van Assche Index Clinical Classification STRESC for MVAI103 TN/TC | Modified Van Assche Index standardized character result for MVAI103 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI103 Standardized Character Response Terminology |
0 | C191005 | MVAI103-0 | Modified Van Assche Index standardized character result for MVAI103-Normal. | Modified Van Assche Index MVAI103 Standardized Character Result 0 | ||
1 | C191006 | MVAI103-1 | Modified Van Assche Index standardized character result for MVAI103-Thickened. | Modified Van Assche Index MVAI103 Standardized Character Result 1 | ||
2 | C191007 | MVAI103-2 | Modified Van Assche Index standardized character result for MVAI103-Increased signal intensity. | Modified Van Assche Index MVAI103 Standardized Character Result 2 | ||
Back to top | ||||||
CL.C190900.MVAI104STR | Modified Van Assche Index Clinical Classification STRESC for MVAI104 TN/TC
(MVAI104STR) | text
Extensible: No | C190900 | Modified Van Assche Index Clinical Classification STRESC for MVAI104 TN/TC | Modified Van Assche Index standardized character result for MVAI104 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI104 Standardized Character Response Terminology |
0 | C191014 | MVAI104-0 | Modified Van Assche Index standardized character result for MVAI104-Absent. | Modified Van Assche Index MVAI104 Standardized Character Result 0 | ||
1 | C191015 | MVAI104-1 | Modified Van Assche Index standardized character result for MVAI104-Diffuse. | Modified Van Assche Index MVAI104 Standardized Character Result 1 | ||
2 | C191016 | MVAI104-2 | Modified Van Assche Index standardized character result for MVAI104-Focal. | Modified Van Assche Index MVAI104 Standardized Character Result 2 | ||
3 | C191017 | MVAI104-3 | Modified Van Assche Index standardized character result for MVAI104-Collection - small. | Modified Van Assche Index MVAI104 Standardized Character Result 3 | ||
4 | C191018 | MVAI104-4 | Modified Van Assche Index standardized character result for MVAI104-Collection - medium. | Modified Van Assche Index MVAI104 Standardized Character Result 4 | ||
5 | C191019 | MVAI104-5 | Modified Van Assche Index standardized character result for MVAI104-Collection - large. | Modified Van Assche Index MVAI104 Standardized Character Result 5 | ||
Back to top | ||||||
CL.C190902.MVAI105STR | Modified Van Assche Index Clinical Classification STRESC for MVAI105 TN/TC
(MVAI105STR) | text
Extensible: No | C190902 | Modified Van Assche Index Clinical Classification STRESC for MVAI105 TN/TC | Modified Van Assche Index standardized character result for MVAI105 test and test code. | CDISC Clinical Classification Modified Van Assche Index MVAI105 Standardized Character Response Terminology |
0 | C191023 | MVAI105-0 | Modified Van Assche Index standardized character result for MVAI105-Fibrous. | Modified Van Assche Index MVAI105 Standardized Character Result 0 | ||
1 | C191024 | MVAI105-1 | Modified Van Assche Index standardized character result for MVAI105-Granulation tissue. | Modified Van Assche Index MVAI105 Standardized Character Result 1 | ||
2 | C191025 | MVAI105-2 | Modified Van Assche Index standardized character result for MVAI105-Fluid/pus. | Modified Van Assche Index MVAI105 Standardized Character Result 2 | ||
Back to top | ||||||
CL.C190930.MVAI1TC | Modified Van Assche Index Clinical Classification Test Code
(MVAI1TC) | text
Extensible: No | C190930 | Modified Van Assche Index Clinical Classification Test Code | Modified Van Assche Index test code. | CDISC Clinical Classification Modified Van Assche Index Test Code Terminology |
MVAI101 | C191060 | MVAI1-Extension | Modified Van Assche Index - Extension. | MVAI - Extension | ||
MVAI102 | C191061 | MVAI1-Hyperintensity T2-weighted Images | Modified Van Assche Index - Hyperintensity T2-weighted images. | MVAI - Hyperintensity T2-weighted Images | ||
MVAI103 | C191062 | MVAI1-Rectal Wall Involvement | Modified Van Assche Index - Rectal wall involvement. | MVAI - Rectal Wall Involvement | ||
MVAI104 | C191063 | MVAI1-Inflammatory Mass | Modified Van Assche Index - Inflammatory mass. | MVAI - Inflammatory Mass | ||
MVAI105 | C191064 | MVAI1-Dominant Feature | Modified Van Assche Index - Dominant feature. | MVAI - Dominant Feature | ||
MVAI106 | C191065 | MVAI1-Total Score | Modified Van Assche Index - Total score. | MVAI - Total Score | ||
Back to top | ||||||
CL.C190929.MVAI1TN | Modified Van Assche Index Clinical Classification Test Name
(MVAI1TN) | text
Extensible: No | C190929 | Modified Van Assche Index Clinical Classification Test Name | Modified Van Assche Index test name. | CDISC Clinical Classification Modified Van Assche Index Test Name Terminology |
MVAI1-Dominant Feature | C191064 | MVAI1-Dominant Feature | Modified Van Assche Index - Dominant feature. | MVAI - Dominant Feature | ||
MVAI1-Extension | C191060 | MVAI1-Extension | Modified Van Assche Index - Extension. | MVAI - Extension | ||
MVAI1-Hyperintensity T2-weighted Images | C191061 | MVAI1-Hyperintensity T2-weighted Images | Modified Van Assche Index - Hyperintensity T2-weighted images. | MVAI - Hyperintensity T2-weighted Images | ||
MVAI1-Inflammatory Mass | C191063 | MVAI1-Inflammatory Mass | Modified Van Assche Index - Inflammatory mass. | MVAI - Inflammatory Mass | ||
MVAI1-Rectal Wall Involvement | C191062 | MVAI1-Rectal Wall Involvement | Modified Van Assche Index - Rectal wall involvement. | MVAI - Rectal Wall Involvement | ||
MVAI1-Total Score | C191065 | MVAI1-Total Score | Modified Van Assche Index - Total score. | MVAI - Total Score | ||
Back to top | ||||||
CL.C190928.MCHR01TC | Montreal Classification for Crohn's Disease Clinical Classification Test Code
(MCHR01TC) | text
Extensible: No | C190928 | Montreal Classification for Crohn's Disease Clinical Classification Test Code | Montreal Classification for Crohn's Disease test code. | CDISC Clinical Classification Montreal Classification for Crohn's Disease Test Code Terminology |
MCHR0101 | C191057 | MCHR01-Age at Diagnosis | Montreal Classification for Crohn's Disease - Age at diagnosis (A). | Montreal Classification - Age at Diagnosis | ||
MCHR0102 | C191058 | MCHR01-Location | Montreal Classification for Crohn's Disease - Location (L). | Montreal Classification - Location | ||
MCHR0103 | C191059 | MCHR01-Behavior | Montreal Classification for Crohn's Disease - Behavior (B). | Montreal Classification - Behavior | ||
Back to top | ||||||
CL.C190927.MCHR01TN | Montreal Classification for Crohn's Disease Clinical Classification Test Name
(MCHR01TN) | text
Extensible: No | C190927 | Montreal Classification for Crohn's Disease Clinical Classification Test Name | Montreal Classification for Crohn's Disease test name. | CDISC Clinical Classification Montreal Classification for Crohn's Disease Test Name Terminology |
MCHR01-Age at Diagnosis | C191057 | MCHR01-Age at Diagnosis | Montreal Classification for Crohn's Disease - Age at diagnosis (A). | Montreal Classification - Age at Diagnosis | ||
MCHR01-Behavior | C191059 | MCHR01-Behavior | Montreal Classification for Crohn's Disease - Behavior (B). | Montreal Classification - Behavior | ||
MCHR01-Location | C191058 | MCHR01-Location | Montreal Classification for Crohn's Disease - Location (L). | Montreal Classification - Location | ||
Back to top | ||||||
CL.C100140.UPD2TC | Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire Test Code
(UPD2TC) | text
Extensible: No | C100140 | Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire Test Code | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale test code. | CDISC Questionnaire MDS-UPDRS Test Code Terminology |
UPD2101 | C100473 | UPD2-Cognitive Impairment | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you had problems remembering things, following conversations, paying attention, thinking clearly, or finding your way around the house or in town? | MDS-UPDRS - Cognitive Impairment | ||
UPD2102 | C100474 | UPD2-Hallucinations and Psychosis | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you seen, heard, smelled or felt things that were not really there? | MDS-UPDRS - Hallucinations and Psychosis | ||
UPD2103 | C100475 | UPD2-Depressed Mood | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you felt low, sad, hopeless or unable to enjoy things? If yes, was this feeling for longer than one day at a time? Did it make it difficult for you carry out your usual activities or to be with people? | MDS-UPDRS - Depressed Mood | ||
UPD2104 | C100476 | UPD2-Anxious Mood | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you felt nervous, worried or tense? If yes, was this feeling for longer than one day at a time? Did it make it difficult for you to follow your usual activities or to be with other people? | MDS-UPDRS - Anxious Mood | ||
UPD2105 | C100477 | UPD2-Apathy | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you felt indifferent to doing activities or being with people? | MDS-UPDRS - Apathy | ||
UPD2106 | C100478 | UPD2-Ftrs Dopa Dysregulation Synd | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had unusually strong urges that are hard to control? Do you feel driven to do or think about something and find it hard to stop? | MDS-UPDRS - Features of Dopamine Dysregulation Syndrome | ||
UPD2107 | C100479 | UPD2-Sleep Problems | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble going to sleep at night or staying asleep through the night? | MDS-UPDRS - Sleep Problems | ||
UPD2108 | C100480 | UPD2-Daytime Sleepiness | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble staying awake during the daytime? | MDS-UPDRS - Daytime Sleepiness | ||
UPD2109 | C100481 | UPD2-Pain and other Sensations | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had uncomfortable feelings in your body like pain, aches tingling or cramps? | MDS-UPDRS - Pain and Other Sensations | ||
UPD2110 | C100482 | UPD2-Urinary Problems | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble with urine control? | MDS-UPDRS - Urinary Problems | ||
UPD2111 | C100483 | UPD2-Constipation Problems | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you had constipation troubles that cause you difficulty moving your bowels? | MDS-UPDRS - Constipation Problems | ||
UPD2112 | C100484 | UPD2-Lightheadedness on Standing | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you felt faint, dizzy or foggy when you stand up after sitting or lying down? | MDS-UPDRS - Lightheadedness on Standing | ||
UPD2113 | C100485 | UPD2-Fatigue | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually felt fatigued? | MDS-UPDRS - Fatigue | ||
UPD2201 | C100486 | UPD2-Speech | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had problems with your speech? | MDS-UPDRS - Speech | ||
UPD2202 | C100487 | UPD2-Saliva and Drooling | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had too much saliva during when you are awake or when you sleep? | MDS-UPDRS - Saliva and Drooling | ||
UPD2203 | C100488 | UPD2-Chewing and Swallowing | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems swallowing pills or eating meals? | MDS-UPDRS - Chewing and Swallowing | ||
UPD2204 | C100489 | UPD2-Eating Tasks | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had troubles handling your food and using eating utensils? | MDS-UPDRS - Eating Tasks | ||
UPD2205 | C100490 | UPD2-Dressing | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems dressing? | MDS-UPDRS - Dressing | ||
UPD2206 | C100491 | UPD2-Hygiene | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually been slow or do you need help with washing, bathing, shaving, brushing teeth, combing your hair or with other personal hygiene? | MDS-UPDRS - Hygiene | ||
UPD2207 | C100492 | UPD2-Handwriting | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have people usually had trouble reading your handwriting? | MDS-UPDRS - Handwriting | ||
UPD2208 | C100493 | UPD2-Doing Hobbies/Other Activities | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had trouble doing your hobbies or other things that you like to do? | MDS-UPDRS - Doing Hobbies and Other Activities | ||
UPD2209 | C100494 | UPD2-Turning in Bed | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, do you usually have trouble turning over in bed? | MDS-UPDRS - Turning in Bed | ||
UPD2210 | C100495 | UPD2-Tremor | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had shaking or tremor? | MDS-UPDRS - Tremor | ||
UPD2211 | C101018 | UPD2-Get Out of Bed/Car/Deep Chair | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had trouble getting out of bed, a car seat, or a deep chair? | MDS-UPDRS - Get Out of Bed, Car, or Deep Chair | ||
UPD2212 | C100496 | UPD2-Walking and Balance | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems with balance and walking? | MDS-UPDRS - Walking and Balance | ||
UPD2213 | C100497 | UPD2-Freezing | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, on your usual day when walking, do you suddenly stop or freeze as if your feet are stuck to the floor? | MDS-UPDRS - Freezing | ||
UPD2301 | C100502 | UPD2-Speech Problems | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Speech Problems. | MDS-UPDRS - Speech Problems | ||
UPD2302 | C100503 | UPD2-Facial Expression | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Facial Expression. | MDS-UPDRS - Facial Expression | ||
UPD2303A | C100504 | UPD2-Rigidity Neck | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Neck. | MDS-UPDRS - Rigidity Neck | ||
UPD2303B | C100505 | UPD2-Rigidity RT Upper Extremity | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Right Upper Extremity. | MDS-UPDRS - Rigidity Right Upper Extremity | ||
UPD2303C | C100506 | UPD2-Rigidity Left Upper Extremity | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Left Upper Extremity. | MDS-UPDRS - Rigidity Left Upper Extremity | ||
UPD2303D | C100507 | UPD2-Rigidity RT Lower Extremity | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Right Lower Extremity. | MDS-UPDRS - Rigidity Right Lower Extremity | ||
UPD2303E | C100508 | UPD2-Rigidity Left Lower Extremity | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Left Lower Extremity. | MDS-UPDRS - Rigidity Left Lower Extremity | ||
UPD2304A | C100509 | UPD2-Right Finger Tapping | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Finger Tapping. | MDS-UPDRS - Right Finger Tapping | ||
UPD2304B | C100510 | UPD2-Left Finger Tapping | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Finger Tapping. | MDS-UPDRS - Left Finger Tapping | ||
UPD2305A | C100511 | UPD2-Right Hand Movements | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Hand Movements. | MDS-UPDRS - Right Hand Movements | ||
UPD2305B | C100512 | UPD2-Left Hand Movements | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Hand Movements. | MDS-UPDRS - Left Hand Movements | ||
UPD2306A | C100513 | UPD2-Pron/Sup Movement of RT Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Pronation-Supination Movements of Right Hand. | MDS-UPDRS - Pronanation-Supination Movement of Right Hand | ||
UPD2306B | C100514 | UPD2-Pron/Sup Movement of Left Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Pronation-Supination Movements of Left Hand. | MDS-UPDRS - Pronanation-Supination Movement of Left Hand | ||
UPD2307A | C100515 | UPD2-Right Toe Tapping | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Toe Tapping. | MDS-UPDRS - Right Toe Tapping | ||
UPD2307B | C100516 | UPD2-Left Toe Tapping | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Toe Tapping. | MDS-UPDRS - Left Toe Tapping | ||
UPD2308A | C100517 | UPD2-Right Leg Agility | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Leg Agility. | MDS-UPDRS - Right Leg Agility | ||
UPD2308B | C100518 | UPD2-Left Leg Agility | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Leg Agility. | MDS-UPDRS - Left Leg Agility | ||
UPD2309 | C100519 | UPD2-Arising from Chair | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Arising from Chair. | MDS-UPDRS - Arising from Chair | ||
UPD2310 | C100520 | UPD2-Gait | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Gait. | MDS-UPDRS - Gait | ||
UPD2311 | C100521 | UPD2-Freezing of Gait | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Freezing of Gait. | MDS-UPDRS - Freezing of Gait | ||
UPD2312 | C100522 | UPD2-Postural Stability | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Stability. | MDS-UPDRS - Postural Stability | ||
UPD2313 | C100523 | UPD2-Posture | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Posture. | MDS-UPDRS - Posture | ||
UPD2314 | C100524 | UPD2-Body Bradykinesia | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Global Spontaneity of Movement (Body Bradykinesia). | MDS-UPDRS - Body Bradykinesia | ||
UPD2315A | C100525 | UPD2-Postural Tremor of Right Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Tremor of the Right Hand. | MDS-UPDRS - Postural Tremor of Right Hand | ||
UPD2315B | C113882 | UPD2-Postural Tremor of Left Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Tremor of the Left Hand. | MDS-UPDRS - Postural Tremor of Left Hand | ||
UPD2316A | C113883 | UPD2-Kinetic Tremor of Right Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Kinetic Tremor of the Right Hand. | MDS-UPDRS - Kinetic Tremor of Right Hand | ||
UPD2316B | C100526 | UPD2-Kinetic Tremor of Left Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Kinetic Tremor of the Left Hand. | MDS-UPDRS - Kinetic Tremor of Left Hand | ||
UPD2317A | C100527 | UPD2-Rest Tremor Amplitude RUE | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Right Upper Extremity. | MDS-UPDRS - Rest Tremor Amplitude Right Upper Extremity | ||
UPD2317B | C100528 | UPD2-Rest Tremor Amplitude LUE | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Left Upper Extremity. | MDS-UPDRS - Rest Tremor Amplitude Left Upper Extremity | ||
UPD2317C | C100529 | UPD2-Rest Tremor Amplitude RLE | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Right Lower Extremity. | MDS-UPDRS - Rest Tremor Amplitude Right Lower Extremity | ||
UPD2317D | C100530 | UPD2-Rest Tremor Amplitude LLE | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Left Lower Extremity. | MDS-UPDRS - Rest Tremor Amplitude Left Lower Extremity | ||
UPD2317E | C100531 | UPD2-Rest Tremor Amplitude Lip/Jaw | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Lip/Jaw. | MDS-UPDRS - Rest Tremor Amplitude Lip or Jaw | ||
UPD2318 | C100532 | UPD2-Consistency of Rest Tremor | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Consistency of Rest Tremor. | MDS-UPDRS - Consistency of Rest Tremor | ||
UPD23A | C100498 | UPD2-Medication for PD | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Is the patient on medication for treating the symptoms of Parkinson's Disease? | MDS-UPDRS - Medication for Parkinson's Disease | ||
UPD23B | C100499 | UPD2-Clinical State on Meds | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - If the patient is receiving medication for treating the symptoms of Parkinson's Disease, mark the patient's clinical state. | MDS-UPDRS - Clinical State on Medication | ||
UPD23C | C100500 | UPD2-Taking Levodopa | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Is the patient on Levodopa? | MDS-UPDRS - Taking Levodopa | ||
UPD23C1 | C100501 | UPD2-Minutes Since Levodopa Dose | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Minutes since last Levodopa dose. | MDS-UPDRS - Minutes Since Levodopa Dose | ||
UPD2401 | C100536 | UPD2-Time Spent with Dyskinesias | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Time Spent with Dyskinesias. | MDS-UPDRS - Time Spent with Dyskinesias | ||
UPD2402 | C100537 | UPD2-Functional Impact Dyskinesias | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Functional Impact of Dyskinesias. | MDS-UPDRS - Functional Impact of Dyskinesias | ||
UPD2403 | C100538 | UPD2-Time Spent in the Off State | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Time Spent in the Off State. | MDS-UPDRS - Time Spent in the Off State | ||
UPD2404 | C100539 | UPD2-Functional Impact Fluctuations | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Functional Impact of Fluctuations. | MDS-UPDRS - Functional Impact of Fluctuations | ||
UPD2405 | C100540 | UPD2-Complexity Motor Fluctuations | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Complexity of Motor Fluctuations. | MDS-UPDRS - Complexity of Motor Fluctuations | ||
UPD2406 | C100541 | UPD2-Painful Off-state Dystonia | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Painful Off-state Dystonia. | MDS-UPDRS - Painful Off-state Dystonia | ||
UPD2DA | C100533 | UPD2-Dyskinesias During Exam | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Were dyskinesias (chorea or dystonia) present during examination? | MDS-UPDRS - Dyskinesias During Exam | ||
UPD2DB | C100534 | UPD2-Movements Interfere Ratings | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - If yes, did these movements interfere with your ratings? | MDS-UPDRS - Movements Interfere with Ratings | ||
UPD2HY | C100535 | UPD2-Hoehn and Yahr Stage | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Hoehn and Yahr Stage. | MDS-UPDRS - Hoehn and Yahr Stage | ||
Back to top | ||||||
CL.C100139.UPD2TN | Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire Test Name
(UPD2TN) | text
Extensible: No | C100139 | Movement Disorder Society Unified Parkinson's Disease Rating Scale Questionnaire Test Name | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale test name. | CDISC Questionnaire MDS-UPDRS Test Name Terminology |
UPD2-Anxious Mood | C100476 | UPD2-Anxious Mood | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you felt nervous, worried or tense? If yes, was this feeling for longer than one day at a time? Did it make it difficult for you to follow your usual activities or to be with other people? | MDS-UPDRS - Anxious Mood | ||
UPD2-Apathy | C100477 | UPD2-Apathy | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you felt indifferent to doing activities or being with people? | MDS-UPDRS - Apathy | ||
UPD2-Arising from Chair | C100519 | UPD2-Arising from Chair | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Arising from Chair. | MDS-UPDRS - Arising from Chair | ||
UPD2-Body Bradykinesia | C100524 | UPD2-Body Bradykinesia | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Global Spontaneity of Movement (Body Bradykinesia). | MDS-UPDRS - Body Bradykinesia | ||
UPD2-Chewing and Swallowing | C100488 | UPD2-Chewing and Swallowing | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems swallowing pills or eating meals? | MDS-UPDRS - Chewing and Swallowing | ||
UPD2-Clinical State on Meds | C100499 | UPD2-Clinical State on Meds | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - If the patient is receiving medication for treating the symptoms of Parkinson's Disease, mark the patient's clinical state. | MDS-UPDRS - Clinical State on Medication | ||
UPD2-Cognitive Impairment | C100473 | UPD2-Cognitive Impairment | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you had problems remembering things, following conversations, paying attention, thinking clearly, or finding your way around the house or in town? | MDS-UPDRS - Cognitive Impairment | ||
UPD2-Complexity Motor Fluctuations | C100540 | UPD2-Complexity Motor Fluctuations | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Complexity of Motor Fluctuations. | MDS-UPDRS - Complexity of Motor Fluctuations | ||
UPD2-Consistency of Rest Tremor | C100532 | UPD2-Consistency of Rest Tremor | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Consistency of Rest Tremor. | MDS-UPDRS - Consistency of Rest Tremor | ||
UPD2-Constipation Problems | C100483 | UPD2-Constipation Problems | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you had constipation troubles that cause you difficulty moving your bowels? | MDS-UPDRS - Constipation Problems | ||
UPD2-Daytime Sleepiness | C100480 | UPD2-Daytime Sleepiness | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble staying awake during the daytime? | MDS-UPDRS - Daytime Sleepiness | ||
UPD2-Depressed Mood | C100475 | UPD2-Depressed Mood | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you felt low, sad, hopeless or unable to enjoy things? If yes, was this feeling for longer than one day at a time? Did it make it difficult for you carry out your usual activities or to be with people? | MDS-UPDRS - Depressed Mood | ||
UPD2-Doing Hobbies/Other Activities | C100493 | UPD2-Doing Hobbies/Other Activities | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had trouble doing your hobbies or other things that you like to do? | MDS-UPDRS - Doing Hobbies and Other Activities | ||
UPD2-Dressing | C100490 | UPD2-Dressing | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems dressing? | MDS-UPDRS - Dressing | ||
UPD2-Dyskinesias During Exam | C100533 | UPD2-Dyskinesias During Exam | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Were dyskinesias (chorea or dystonia) present during examination? | MDS-UPDRS - Dyskinesias During Exam | ||
UPD2-Eating Tasks | C100489 | UPD2-Eating Tasks | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had troubles handling your food and using eating utensils? | MDS-UPDRS - Eating Tasks | ||
UPD2-Facial Expression | C100503 | UPD2-Facial Expression | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Facial Expression. | MDS-UPDRS - Facial Expression | ||
UPD2-Fatigue | C100485 | UPD2-Fatigue | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually felt fatigued? | MDS-UPDRS - Fatigue | ||
UPD2-Freezing of Gait | C100521 | UPD2-Freezing of Gait | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Freezing of Gait. | MDS-UPDRS - Freezing of Gait | ||
UPD2-Freezing | C100497 | UPD2-Freezing | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, on your usual day when walking, do you suddenly stop or freeze as if your feet are stuck to the floor? | MDS-UPDRS - Freezing | ||
UPD2-Ftrs Dopa Dysregulation Synd | C100478 | UPD2-Ftrs Dopa Dysregulation Synd | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had unusually strong urges that are hard to control? Do you feel driven to do or think about something and find it hard to stop? | MDS-UPDRS - Features of Dopamine Dysregulation Syndrome | ||
UPD2-Functional Impact Dyskinesias | C100537 | UPD2-Functional Impact Dyskinesias | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Functional Impact of Dyskinesias. | MDS-UPDRS - Functional Impact of Dyskinesias | ||
UPD2-Functional Impact Fluctuations | C100539 | UPD2-Functional Impact Fluctuations | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Functional Impact of Fluctuations. | MDS-UPDRS - Functional Impact of Fluctuations | ||
UPD2-Gait | C100520 | UPD2-Gait | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Gait. | MDS-UPDRS - Gait | ||
UPD2-Get Out of Bed/Car/Deep Chair | C101018 | UPD2-Get Out of Bed/Car/Deep Chair | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had trouble getting out of bed, a car seat, or a deep chair? | MDS-UPDRS - Get Out of Bed, Car, or Deep Chair | ||
UPD2-Hallucinations and Psychosis | C100474 | UPD2-Hallucinations and Psychosis | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week have you seen, heard, smelled or felt things that were not really there? | MDS-UPDRS - Hallucinations and Psychosis | ||
UPD2-Handwriting | C100492 | UPD2-Handwriting | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have people usually had trouble reading your handwriting? | MDS-UPDRS - Handwriting | ||
UPD2-Hoehn and Yahr Stage | C100535 | UPD2-Hoehn and Yahr Stage | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Hoehn and Yahr Stage. | MDS-UPDRS - Hoehn and Yahr Stage | ||
UPD2-Hygiene | C100491 | UPD2-Hygiene | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually been slow or do you need help with washing, bathing, shaving, brushing teeth, combing your hair or with other personal hygiene? | MDS-UPDRS - Hygiene | ||
UPD2-Kinetic Tremor of Left Hand | C100526 | UPD2-Kinetic Tremor of Left Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Kinetic Tremor of the Left Hand. | MDS-UPDRS - Kinetic Tremor of Left Hand | ||
UPD2-Kinetic Tremor of Right Hand | C113883 | UPD2-Kinetic Tremor of Right Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Kinetic Tremor of the Right Hand. | MDS-UPDRS - Kinetic Tremor of Right Hand | ||
UPD2-Left Finger Tapping | C100510 | UPD2-Left Finger Tapping | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Finger Tapping. | MDS-UPDRS - Left Finger Tapping | ||
UPD2-Left Hand Movements | C100512 | UPD2-Left Hand Movements | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Hand Movements. | MDS-UPDRS - Left Hand Movements | ||
UPD2-Left Leg Agility | C100518 | UPD2-Left Leg Agility | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Leg Agility. | MDS-UPDRS - Left Leg Agility | ||
UPD2-Left Toe Tapping | C100516 | UPD2-Left Toe Tapping | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Left Toe Tapping. | MDS-UPDRS - Left Toe Tapping | ||
UPD2-Lightheadedness on Standing | C100484 | UPD2-Lightheadedness on Standing | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you felt faint, dizzy or foggy when you stand up after sitting or lying down? | MDS-UPDRS - Lightheadedness on Standing | ||
UPD2-Medication for PD | C100498 | UPD2-Medication for PD | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Is the patient on medication for treating the symptoms of Parkinson's Disease? | MDS-UPDRS - Medication for Parkinson's Disease | ||
UPD2-Minutes Since Levodopa Dose | C100501 | UPD2-Minutes Since Levodopa Dose | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Minutes since last Levodopa dose. | MDS-UPDRS - Minutes Since Levodopa Dose | ||
UPD2-Movements Interfere Ratings | C100534 | UPD2-Movements Interfere Ratings | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - If yes, did these movements interfere with your ratings? | MDS-UPDRS - Movements Interfere with Ratings | ||
UPD2-Pain and other Sensations | C100481 | UPD2-Pain and other Sensations | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had uncomfortable feelings in your body like pain, aches tingling or cramps? | MDS-UPDRS - Pain and Other Sensations | ||
UPD2-Painful Off-state Dystonia | C100541 | UPD2-Painful Off-state Dystonia | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Painful Off-state Dystonia. | MDS-UPDRS - Painful Off-state Dystonia | ||
UPD2-Postural Stability | C100522 | UPD2-Postural Stability | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Stability. | MDS-UPDRS - Postural Stability | ||
UPD2-Postural Tremor of Left Hand | C113882 | UPD2-Postural Tremor of Left Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Tremor of the Left Hand. | MDS-UPDRS - Postural Tremor of Left Hand | ||
UPD2-Postural Tremor of Right Hand | C100525 | UPD2-Postural Tremor of Right Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Postural Tremor of the Right Hand. | MDS-UPDRS - Postural Tremor of Right Hand | ||
UPD2-Posture | C100523 | UPD2-Posture | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Posture. | MDS-UPDRS - Posture | ||
UPD2-Pron/Sup Movement of Left Hand | C100514 | UPD2-Pron/Sup Movement of Left Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Pronation-Supination Movements of Left Hand. | MDS-UPDRS - Pronanation-Supination Movement of Left Hand | ||
UPD2-Pron/Sup Movement of RT Hand | C100513 | UPD2-Pron/Sup Movement of RT Hand | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Pronation-Supination Movements of Right Hand. | MDS-UPDRS - Pronanation-Supination Movement of Right Hand | ||
UPD2-Rest Tremor Amplitude Lip/Jaw | C100531 | UPD2-Rest Tremor Amplitude Lip/Jaw | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Lip/Jaw. | MDS-UPDRS - Rest Tremor Amplitude Lip or Jaw | ||
UPD2-Rest Tremor Amplitude LLE | C100530 | UPD2-Rest Tremor Amplitude LLE | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Left Lower Extremity. | MDS-UPDRS - Rest Tremor Amplitude Left Lower Extremity | ||
UPD2-Rest Tremor Amplitude LUE | C100528 | UPD2-Rest Tremor Amplitude LUE | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Left Upper Extremity. | MDS-UPDRS - Rest Tremor Amplitude Left Upper Extremity | ||
UPD2-Rest Tremor Amplitude RLE | C100529 | UPD2-Rest Tremor Amplitude RLE | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Right Lower Extremity. | MDS-UPDRS - Rest Tremor Amplitude Right Lower Extremity | ||
UPD2-Rest Tremor Amplitude RUE | C100527 | UPD2-Rest Tremor Amplitude RUE | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rest Tremor Amplitude Right Upper Extremity. | MDS-UPDRS - Rest Tremor Amplitude Right Upper Extremity | ||
UPD2-Right Finger Tapping | C100509 | UPD2-Right Finger Tapping | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Finger Tapping. | MDS-UPDRS - Right Finger Tapping | ||
UPD2-Right Hand Movements | C100511 | UPD2-Right Hand Movements | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Hand Movements. | MDS-UPDRS - Right Hand Movements | ||
UPD2-Right Leg Agility | C100517 | UPD2-Right Leg Agility | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Leg Agility. | MDS-UPDRS - Right Leg Agility | ||
UPD2-Right Toe Tapping | C100515 | UPD2-Right Toe Tapping | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Right Toe Tapping. | MDS-UPDRS - Right Toe Tapping | ||
UPD2-Rigidity Left Lower Extremity | C100508 | UPD2-Rigidity Left Lower Extremity | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Left Lower Extremity. | MDS-UPDRS - Rigidity Left Lower Extremity | ||
UPD2-Rigidity Left Upper Extremity | C100506 | UPD2-Rigidity Left Upper Extremity | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Left Upper Extremity. | MDS-UPDRS - Rigidity Left Upper Extremity | ||
UPD2-Rigidity Neck | C100504 | UPD2-Rigidity Neck | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Neck. | MDS-UPDRS - Rigidity Neck | ||
UPD2-Rigidity RT Lower Extremity | C100507 | UPD2-Rigidity RT Lower Extremity | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Right Lower Extremity. | MDS-UPDRS - Rigidity Right Lower Extremity | ||
UPD2-Rigidity RT Upper Extremity | C100505 | UPD2-Rigidity RT Upper Extremity | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Rigidity Right Upper Extremity. | MDS-UPDRS - Rigidity Right Upper Extremity | ||
UPD2-Saliva and Drooling | C100487 | UPD2-Saliva and Drooling | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had too much saliva during when you are awake or when you sleep? | MDS-UPDRS - Saliva and Drooling | ||
UPD2-Sleep Problems | C100479 | UPD2-Sleep Problems | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble going to sleep at night or staying asleep through the night? | MDS-UPDRS - Sleep Problems | ||
UPD2-Speech Problems | C100502 | UPD2-Speech Problems | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Speech Problems. | MDS-UPDRS - Speech Problems | ||
UPD2-Speech | C100486 | UPD2-Speech | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had problems with your speech? | MDS-UPDRS - Speech | ||
UPD2-Taking Levodopa | C100500 | UPD2-Taking Levodopa | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Is the patient on Levodopa? | MDS-UPDRS - Taking Levodopa | ||
UPD2-Time Spent in the Off State | C100538 | UPD2-Time Spent in the Off State | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Time Spent in the Off State. | MDS-UPDRS - Time Spent in the Off State | ||
UPD2-Time Spent with Dyskinesias | C100536 | UPD2-Time Spent with Dyskinesias | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Time Spent with Dyskinesias. | MDS-UPDRS - Time Spent with Dyskinesias | ||
UPD2-Tremor | C100495 | UPD2-Tremor | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had shaking or tremor? | MDS-UPDRS - Tremor | ||
UPD2-Turning in Bed | C100494 | UPD2-Turning in Bed | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, do you usually have trouble turning over in bed? | MDS-UPDRS - Turning in Bed | ||
UPD2-Urinary Problems | C100482 | UPD2-Urinary Problems | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you had trouble with urine control? | MDS-UPDRS - Urinary Problems | ||
UPD2-Walking and Balance | C100496 | UPD2-Walking and Balance | The Movement Disorder Society version of the Unified Parkinson's Disease Rating Scale - Over the past week, have you usually had problems with balance and walking? | MDS-UPDRS - Walking and Balance | ||
Back to top | ||||||
CL.C117741.MSFATSCD | Multiple Sclerosis Findings About Test Code
(MSFATSCD) | text
Extensible: Yes | C117741 | Multiple Sclerosis Findings About Test Code | Terminology relevant to the test codes that describe multiple sclerosis findings. | CDISC SDTM Multiple Sclerosis Findings About Test Code Terminology |
DXCRITMT | C117883 | Diagnostic Criteria Met | A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. | Which Diagnostic Criteria Met | ||
LOCONSET | C117884 | Localization of Onset | The anatomical location of the beginning or early stages of a disease. | Location of Disease Onset | ||
OUNIMULT | C117885 | Onset Unifocal or Multifocal | A categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease. | Focality of Disease Onset | ||
Back to top | ||||||
CL.C117740.MSFATS | Multiple Sclerosis Findings About Test Name
(MSFATS) | text
Extensible: Yes | C117740 | Multiple Sclerosis Findings About Test Name | Terminology relevant to the test names that describe multiple sclerosis findings. | CDISC SDTM Multiple Sclerosis Findings About Test Name Terminology |
Diagnostic Criteria Met | C117883 | Diagnostic Criteria Met | A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. | Which Diagnostic Criteria Met | ||
Localization of Onset | C117884 | Localization of Onset | The anatomical location of the beginning or early stages of a disease. | Location of Disease Onset | ||
Onset Unifocal or Multifocal | C117885 | Onset Unifocal or Multifocal | A categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease. | Focality of Disease Onset | ||
Back to top | ||||||
CL.C113860.MSQL1TC | Multiple Sclerosis Quality of Life-54 Instrument Questionnaire Test Code
(MSQL1TC) | text
Extensible: No | C113860 | Multiple Sclerosis Quality of Life-54 Instrument Questionnaire Test Code | Multiple Sclerosis Quality of Life-54 Instrument test code. | CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Code Terminology |
MSQL101 | C113988 | MSQL1-Would You Say Your Health Is | Multiple Sclerosis Quality of Life-54 Instrument - In general, would you say your health is: | MSQOL-54 - Would You Say Your Health Is | ||
MSQL102 | C113989 | MSQL1-Health Now Compared to 1 Year Ago | Multiple Sclerosis Quality of Life-54 Instrument - Compared to one year ago, how would you rate your health in general now? | MSQOL-54 - Health Now Compared to One Year Ago | ||
MSQL103 | C113990 | MSQL1-Health Limit Vigorous Activities | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | MSQOL-54 - Health Limit Vigorous Activities | ||
MSQL104 | C113991 | MSQL1-Health Limit Moderate Activities | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | MSQOL-54 - Health Limit Moderate Activities | ||
MSQL105 | C113992 | MSQL1-Health Limit Carrying Groceries | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Lifting or carrying groceries. | MSQOL-54 - Health Limit Lifting or Carrying Groceries | ||
MSQL106 | C113993 | MSQL1-Health Limit Climb Several Flights | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Climbing several flights of stairs. | MSQOL-54 - Health Limit Climbing Several Stairs | ||
MSQL107 | C113994 | MSQL1-Health Limit Climb One Flight | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Climbing one flight of stairs. | MSQOL-54 - Health Limit Climbing One Stair | ||
MSQL108 | C113995 | MSQL1-Health Limit Bending or Kneeling | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Bending, kneeling, or stooping. | MSQOL-54 - Health Limit Bending, Kneeling or Stooping | ||
MSQL109 | C113996 | MSQL1-Health Limit Walk More Than Mile | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking more than a mile. | MSQOL-54 - Health Limit Walking More than A Mile | ||
MSQL110 | C113997 | MSQL1-Health Limit Walk Several Blocks | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking several blocks. | MSQOL-54 - Health Limit Walking Several Blocks | ||
MSQL111 | C113998 | MSQL1-Health Limit Walk One Block | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking one block. | MSQOL-54 - Health Limit Walking One Block | ||
MSQL112 | C113999 | MSQL1-Health Limit Bathing/Dressing Self | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Bathing and dressing yourself. | MSQOL-54 - Health Limit Bathing and Dressing Yourself | ||
MSQL113 | C114000 | MSQL1-Phys Health: Cut Work Time | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Cut down on the amount of time you could spend on work or other activities. | MSQOL-54 - Physical Health Cut Down Time on Work | ||
MSQL114 | C114001 | MSQL1-Phys Health: Accomplish Less | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. | MSQOL-54 - Physical Health Accomplish Less | ||
MSQL115 | C114002 | MSQL1-Phys Health: Limit Kind of Work | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. | MSQOL-54 - Physical Health Limited in the Kind of Work | ||
MSQL116 | C114003 | MSQL1-Phys Health: Difficulty Performing | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Had difficulty performing the work or other activities. | MSQOL-54 - Physical Health Difficulty Perform Work | ||
MSQL117 | C114004 | MSQL1-Emotional Problem: Cut Work Time | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Cut down on the amount of time you could spend on work or other activities. | MSQOL-54 - Emotional Problem Cut Down Time on Work | ||
MSQL118 | C114005 | MSQL1-Emotional Problem: Accomplish Less | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Accomplished less than you would like. | MSQOL-54 - Emotional Problem Accomplish Less | ||
MSQL119 | C114006 | MSQL1-Emotional Problem: Less Careful | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Didn't do work or other activities as carefully as usual. | MSQOL-54 - Emotional Problem Did Not Do Work Carefully | ||
MSQL120 | C114007 | MSQL1-Extent Interfered Social Activity | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | MSQOL-54 - Extend Physical Health or Emotional Problem Interfere With Social Activities | ||
MSQL121 | C114008 | MSQL1-How Much Bodily Pain Have You Had | Multiple Sclerosis Quality of Life-54 Instrument - How much bodily pain have you had during the past 4 weeks? | MSQOL-54 - Bodily Pain | ||
MSQL122 | C114009 | MSQL1-Did Pain Interfere With Your Work | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much did pain interfere with your normal work? | MSQOL-54 - Pain Interfere With Normal Work | ||
MSQL123 | C114010 | MSQL1-Did You Feel Full of Pep | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel full of pep? | MSQOL-54 - Feel Full of Pep | ||
MSQL124 | C114011 | MSQL1-Have Been a Very Nervous Person | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you been a very nervous person? | MSQOL-54 - Been a Nervous Person | ||
MSQL125 | C114012 | MSQL1-Have Felt So Down in the Dumps | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt so down in the dumps that nothing could cheer you up? | MSQOL-54 - Felt So Down Nothing Could Cheer You Up | ||
MSQL126 | C114013 | MSQL1-Have You Felt Calm and Peaceful | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt calm and peaceful? | MSQOL-54 - Felt Calm and Peaceful | ||
MSQL127 | C114014 | MSQL1-Did You Have a Lot of Energy | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you have a lot of energy? | MSQOL-54 - Have a Lot of Energy | ||
MSQL128 | C114015 | MSQL1-Have Felt Downhearted and Blue | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt downhearted and blue? | MSQOL-54 - Felt Downhearted and Blue | ||
MSQL129 | C114016 | MSQL1-Did You Feel Worn Out | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel worn out? | MSQOL-54 - Feel Worn Out | ||
MSQL130 | C114017 | MSQL1-Have You Been a Happy Person | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you been a happy person? | MSQOL-54 - Been a Happy Person | ||
MSQL131 | C114018 | MSQL1-Did You Feel Tired | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel tired? | MSQOL-54 - Feel Tired | ||
MSQL132 | C114019 | MSQL1-Did You Feel Rested on Waking | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel rested on waking in the morning? | MSQOL-54 - Feel Rested Waking in the Morning | ||
MSQL133 | C114020 | MSQL1-Amt Time Interfere Social Activity | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities? | MSQOL-54 - Time Physical Health or Emotional Problem Interfere With Social Activities | ||
MSQL134 | C114021 | MSQL1-Get Sick Easier Than Other People | Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I seem to get sick a little easier than other people. | MSQOL-54 - Get Sick Easier Than Other | ||
MSQL135 | C114022 | MSQL1-I Am as Healthy as Anybody I Know | Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I am as healthy as anybody I know. | MSQOL-54 - As Healthy as Anybody | ||
MSQL136 | C114023 | MSQL1-I Expect My Health to Get Worse | Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I expect my health to get worse. | MSQOL-54 - Expect Health to Get Worse | ||
MSQL137 | C114024 | MSQL1-My Health Is Excellent | Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: My health is excellent. | MSQOL-54 - Health is Excellent | ||
MSQL138 | C114025 | MSQL1-Discouraged by Health Problems | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Were you discouraged by your health problems? | MSQOL-54 - Discouraged by Health Problem | ||
MSQL139 | C114026 | MSQL1-Were Frustrated About Your Health | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Were you frustrated about your health? | MSQOL-54 - Frustrated With Health | ||
MSQL140 | C114027 | MSQL1-Was Health a Worry in Your Life | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Was your health a worry in your life? | MSQOL-54 - Health a Worry in Life | ||
MSQL141 | C114028 | MSQL1-Weighed Down by Health Problems | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel weighed down by your health problems? | MSQOL-54 - Feel Weighed Down by Health Problem | ||
MSQL142 | C114029 | MSQL1-Difficulty Concentrating/Thinking | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you had difficulty concentrating and thinking? | MSQOL-54 - Difficulty Concentrating and Thinking | ||
MSQL143 | C114030 | MSQL1-Trouble Keep Attention for Long | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you have trouble keeping your attention on an activity for long? | MSQOL-54 - Trouble Keep Attention for Long | ||
MSQL144 | C114031 | MSQL1-Have Had Trouble With Your Memory | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you had trouble with your memory? | MSQOL-54 - Trouble With Memory | ||
MSQL145 | C114032 | MSQL1-Others Notice Your Memory Trouble | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have others, such as family members or friends, noticed that you have trouble with your memory or problems with your concentration? | MSQOL-54 - Others Notice Your Problems With Memory or Concentration | ||
MSQL146 | C114033 | MSQL1-Lack of Sexual Interest | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Lack of sexual interest. | MSQOL-54 - Lack of Sexual Interest | ||
MSQL147M | C114034 | MSQL1-Difficult Getting/Keeping Erection | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Difficulty getting or keeping an erection. | MSQOL-54 - Difficulty Keeping an Erection | ||
MSQL147W | C114035 | MSQL1-Inadequate Lubrication | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Inadequate lubrication. | MSQOL-54 - Inadequate Lubrication | ||
MSQL148 | C114036 | MSQL1-Difficulty Having Orgasm | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Difficulty having orgasm. | MSQOL-54 - Difficulty Having Orgasm | ||
MSQL149 | C114037 | MSQL1-Ability to Satisfy Sexual Partner | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Ability to satisfy sexual partner. | MSQOL-54 - Ability to Satisfy Sexual Partner | ||
MSQL150 | C114038 | MSQL1-Satisfied With Sexual Function | Multiple Sclerosis Quality of Life-54 Instrument - Overall, how satisfied were you with your sexual function during the past 4 weeks? | MSQOL-54 - Satisfied With Sexual Function | ||
MSQL151 | C114039 | MSQL1-Bowel/Bladder Interfered Activity | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, to what extent have problems with your bowel or bladder function interfered with your normal social activities with family, friends, neighbors, or groups? | MSQOL-54 - Bowel or Bladder Function Interfere With Social Activities | ||
MSQL152 | C114040 | MSQL1-Pain Interfere Enjoyment of Life | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much did pain interfere with your enjoyment of life? | MSQOL-54 - Pain Interfere Enjoyment of Life | ||
MSQL153 | C114041 | MSQL1-Rate Your Own Quality-of-Life | Multiple Sclerosis Quality of Life-54 Instrument - Overall, how would you rate your own quality-of-life? | MSQOL-54 - Rate Your Own Quality of Life | ||
MSQL154 | C114042 | MSQL1-Describe How Feel About Your Life | Multiple Sclerosis Quality of Life-54 Instrument - Which best describes how you feel about your life as a whole? | MSQOL-54 - Describe How You Feel About Your Life | ||
Back to top | ||||||
CL.C113859.MSQL1TN | Multiple Sclerosis Quality of Life-54 Instrument Questionnaire Test Name
(MSQL1TN) | text
Extensible: No | C113859 | Multiple Sclerosis Quality of Life-54 Instrument Questionnaire Test Name | Multiple Sclerosis Quality of Life-54 Instrument test name. | CDISC Questionnaire Multiple Sclerosis Quality of Life-54 Instrument Test Name Terminology |
MSQL1-Ability to Satisfy Sexual Partner | C114037 | MSQL1-Ability to Satisfy Sexual Partner | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Ability to satisfy sexual partner. | MSQOL-54 - Ability to Satisfy Sexual Partner | ||
MSQL1-Amt Time Interfere Social Activity | C114020 | MSQL1-Amt Time Interfere Social Activity | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities? | MSQOL-54 - Time Physical Health or Emotional Problem Interfere With Social Activities | ||
MSQL1-Bowel/Bladder Interfered Activity | C114039 | MSQL1-Bowel/Bladder Interfered Activity | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, to what extent have problems with your bowel or bladder function interfered with your normal social activities with family, friends, neighbors, or groups? | MSQOL-54 - Bowel or Bladder Function Interfere With Social Activities | ||
MSQL1-Describe How Feel About Your Life | C114042 | MSQL1-Describe How Feel About Your Life | Multiple Sclerosis Quality of Life-54 Instrument - Which best describes how you feel about your life as a whole? | MSQOL-54 - Describe How You Feel About Your Life | ||
MSQL1-Did Pain Interfere With Your Work | C114009 | MSQL1-Did Pain Interfere With Your Work | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much did pain interfere with your normal work? | MSQOL-54 - Pain Interfere With Normal Work | ||
MSQL1-Did You Feel Full of Pep | C114010 | MSQL1-Did You Feel Full of Pep | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel full of pep? | MSQOL-54 - Feel Full of Pep | ||
MSQL1-Did You Feel Rested on Waking | C114019 | MSQL1-Did You Feel Rested on Waking | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel rested on waking in the morning? | MSQOL-54 - Feel Rested Waking in the Morning | ||
MSQL1-Did You Feel Tired | C114018 | MSQL1-Did You Feel Tired | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel tired? | MSQOL-54 - Feel Tired | ||
MSQL1-Did You Feel Worn Out | C114016 | MSQL1-Did You Feel Worn Out | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel worn out? | MSQOL-54 - Feel Worn Out | ||
MSQL1-Did You Have a Lot of Energy | C114014 | MSQL1-Did You Have a Lot of Energy | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you have a lot of energy? | MSQOL-54 - Have a Lot of Energy | ||
MSQL1-Difficult Getting/Keeping Erection | C114034 | MSQL1-Difficult Getting/Keeping Erection | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Difficulty getting or keeping an erection. | MSQOL-54 - Difficulty Keeping an Erection | ||
MSQL1-Difficulty Concentrating/Thinking | C114029 | MSQL1-Difficulty Concentrating/Thinking | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you had difficulty concentrating and thinking? | MSQOL-54 - Difficulty Concentrating and Thinking | ||
MSQL1-Difficulty Having Orgasm | C114036 | MSQL1-Difficulty Having Orgasm | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Difficulty having orgasm. | MSQOL-54 - Difficulty Having Orgasm | ||
MSQL1-Discouraged by Health Problems | C114025 | MSQL1-Discouraged by Health Problems | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Were you discouraged by your health problems? | MSQOL-54 - Discouraged by Health Problem | ||
MSQL1-Emotional Problem: Accomplish Less | C114005 | MSQL1-Emotional Problem: Accomplish Less | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Accomplished less than you would like. | MSQOL-54 - Emotional Problem Accomplish Less | ||
MSQL1-Emotional Problem: Cut Work Time | C114004 | MSQL1-Emotional Problem: Cut Work Time | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Cut down on the amount of time you could spend on work or other activities. | MSQOL-54 - Emotional Problem Cut Down Time on Work | ||
MSQL1-Emotional Problem: Less Careful | C114006 | MSQL1-Emotional Problem: Less Careful | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Didn't do work or other activities as carefully as usual. | MSQOL-54 - Emotional Problem Did Not Do Work Carefully | ||
MSQL1-Extent Interfered Social Activity | C114007 | MSQL1-Extent Interfered Social Activity | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | MSQOL-54 - Extend Physical Health or Emotional Problem Interfere With Social Activities | ||
MSQL1-Get Sick Easier Than Other People | C114021 | MSQL1-Get Sick Easier Than Other People | Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I seem to get sick a little easier than other people. | MSQOL-54 - Get Sick Easier Than Other | ||
MSQL1-Have Been a Very Nervous Person | C114011 | MSQL1-Have Been a Very Nervous Person | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you been a very nervous person? | MSQOL-54 - Been a Nervous Person | ||
MSQL1-Have Felt Downhearted and Blue | C114015 | MSQL1-Have Felt Downhearted and Blue | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt downhearted and blue? | MSQOL-54 - Felt Downhearted and Blue | ||
MSQL1-Have Felt So Down in the Dumps | C114012 | MSQL1-Have Felt So Down in the Dumps | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt so down in the dumps that nothing could cheer you up? | MSQOL-54 - Felt So Down Nothing Could Cheer You Up | ||
MSQL1-Have Had Trouble With Your Memory | C114031 | MSQL1-Have Had Trouble With Your Memory | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you had trouble with your memory? | MSQOL-54 - Trouble With Memory | ||
MSQL1-Have You Been a Happy Person | C114017 | MSQL1-Have You Been a Happy Person | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you been a happy person? | MSQOL-54 - Been a Happy Person | ||
MSQL1-Have You Felt Calm and Peaceful | C114013 | MSQL1-Have You Felt Calm and Peaceful | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have you felt calm and peaceful? | MSQOL-54 - Felt Calm and Peaceful | ||
MSQL1-Health Limit Bathing/Dressing Self | C113999 | MSQL1-Health Limit Bathing/Dressing Self | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Bathing and dressing yourself. | MSQOL-54 - Health Limit Bathing and Dressing Yourself | ||
MSQL1-Health Limit Bending or Kneeling | C113995 | MSQL1-Health Limit Bending or Kneeling | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Bending, kneeling, or stooping. | MSQOL-54 - Health Limit Bending, Kneeling or Stooping | ||
MSQL1-Health Limit Carrying Groceries | C113992 | MSQL1-Health Limit Carrying Groceries | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Lifting or carrying groceries. | MSQOL-54 - Health Limit Lifting or Carrying Groceries | ||
MSQL1-Health Limit Climb One Flight | C113994 | MSQL1-Health Limit Climb One Flight | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Climbing one flight of stairs. | MSQOL-54 - Health Limit Climbing One Stair | ||
MSQL1-Health Limit Climb Several Flights | C113993 | MSQL1-Health Limit Climb Several Flights | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Climbing several flights of stairs. | MSQOL-54 - Health Limit Climbing Several Stairs | ||
MSQL1-Health Limit Moderate Activities | C113991 | MSQL1-Health Limit Moderate Activities | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | MSQOL-54 - Health Limit Moderate Activities | ||
MSQL1-Health Limit Vigorous Activities | C113990 | MSQL1-Health Limit Vigorous Activities | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | MSQOL-54 - Health Limit Vigorous Activities | ||
MSQL1-Health Limit Walk More Than Mile | C113996 | MSQL1-Health Limit Walk More Than Mile | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking more than a mile. | MSQOL-54 - Health Limit Walking More than A Mile | ||
MSQL1-Health Limit Walk One Block | C113998 | MSQL1-Health Limit Walk One Block | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking one block. | MSQOL-54 - Health Limit Walking One Block | ||
MSQL1-Health Limit Walk Several Blocks | C113997 | MSQL1-Health Limit Walk Several Blocks | Multiple Sclerosis Quality of Life-54 Instrument - Does your health limit you in these activities: Walking several blocks. | MSQOL-54 - Health Limit Walking Several Blocks | ||
MSQL1-Health Now Compared to 1 Year Ago | C113989 | MSQL1-Health Now Compared to 1 Year Ago | Multiple Sclerosis Quality of Life-54 Instrument - Compared to one year ago, how would you rate your health in general now? | MSQOL-54 - Health Now Compared to One Year Ago | ||
MSQL1-How Much Bodily Pain Have You Had | C114008 | MSQL1-How Much Bodily Pain Have You Had | Multiple Sclerosis Quality of Life-54 Instrument - How much bodily pain have you had during the past 4 weeks? | MSQOL-54 - Bodily Pain | ||
MSQL1-I Am as Healthy as Anybody I Know | C114022 | MSQL1-I Am as Healthy as Anybody I Know | Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I am as healthy as anybody I know. | MSQOL-54 - As Healthy as Anybody | ||
MSQL1-I Expect My Health to Get Worse | C114023 | MSQL1-I Expect My Health to Get Worse | Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: I expect my health to get worse. | MSQOL-54 - Expect Health to Get Worse | ||
MSQL1-Inadequate Lubrication | C114035 | MSQL1-Inadequate Lubrication | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Inadequate lubrication. | MSQOL-54 - Inadequate Lubrication | ||
MSQL1-Lack of Sexual Interest | C114033 | MSQL1-Lack of Sexual Interest | Multiple Sclerosis Quality of Life-54 Instrument - How much of a problem was each of the following for you during the past 4 weeks: Lack of sexual interest. | MSQOL-54 - Lack of Sexual Interest | ||
MSQL1-My Health Is Excellent | C114024 | MSQL1-My Health Is Excellent | Multiple Sclerosis Quality of Life-54 Instrument - How TRUE or FALSE is each of the following statements for you: My health is excellent. | MSQOL-54 - Health is Excellent | ||
MSQL1-Others Notice Your Memory Trouble | C114032 | MSQL1-Others Notice Your Memory Trouble | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Have others, such as family members or friends, noticed that you have trouble with your memory or problems with your concentration? | MSQOL-54 - Others Notice Your Problems With Memory or Concentration | ||
MSQL1-Pain Interfere Enjoyment of Life | C114040 | MSQL1-Pain Interfere Enjoyment of Life | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, how much did pain interfere with your enjoyment of life? | MSQOL-54 - Pain Interfere Enjoyment of Life | ||
MSQL1-Phys Health: Accomplish Less | C114001 | MSQL1-Phys Health: Accomplish Less | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. | MSQOL-54 - Physical Health Accomplish Less | ||
MSQL1-Phys Health: Cut Work Time | C114000 | MSQL1-Phys Health: Cut Work Time | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Cut down on the amount of time you could spend on work or other activities. | MSQOL-54 - Physical Health Cut Down Time on Work | ||
MSQL1-Phys Health: Difficulty Performing | C114003 | MSQL1-Phys Health: Difficulty Performing | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Had difficulty performing the work or other activities. | MSQOL-54 - Physical Health Difficulty Perform Work | ||
MSQL1-Phys Health: Limit Kind of Work | C114002 | MSQL1-Phys Health: Limit Kind of Work | Multiple Sclerosis Quality of Life-54 Instrument - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. | MSQOL-54 - Physical Health Limited in the Kind of Work | ||
MSQL1-Rate Your Own Quality-of-Life | C114041 | MSQL1-Rate Your Own Quality-of-Life | Multiple Sclerosis Quality of Life-54 Instrument - Overall, how would you rate your own quality-of-life? | MSQOL-54 - Rate Your Own Quality of Life | ||
MSQL1-Satisfied With Sexual Function | C114038 | MSQL1-Satisfied With Sexual Function | Multiple Sclerosis Quality of Life-54 Instrument - Overall, how satisfied were you with your sexual function during the past 4 weeks? | MSQOL-54 - Satisfied With Sexual Function | ||
MSQL1-Trouble Keep Attention for Long | C114030 | MSQL1-Trouble Keep Attention for Long | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you have trouble keeping your attention on an activity for long? | MSQOL-54 - Trouble Keep Attention for Long | ||
MSQL1-Was Health a Worry in Your Life | C114027 | MSQL1-Was Health a Worry in Your Life | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Was your health a worry in your life? | MSQOL-54 - Health a Worry in Life | ||
MSQL1-Weighed Down by Health Problems | C114028 | MSQL1-Weighed Down by Health Problems | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Did you feel weighed down by your health problems? | MSQOL-54 - Feel Weighed Down by Health Problem | ||
MSQL1-Were Frustrated About Your Health | C114026 | MSQL1-Were Frustrated About Your Health | Multiple Sclerosis Quality of Life-54 Instrument - How much of the time during the past 4 weeks: Were you frustrated about your health? | MSQOL-54 - Frustrated With Health | ||
MSQL1-Would You Say Your Health Is | C113988 | MSQL1-Would You Say Your Health Is | Multiple Sclerosis Quality of Life-54 Instrument - In general, would you say your health is: | MSQOL-54 - Would You Say Your Health Is | ||
Back to top | ||||||
CL.C127269.MUSCTSCD | Musculoskeletal System Finding Test Code
(MUSCTSCD) | text
Extensible: Yes | C127269 | Musculoskeletal System Finding Test Code | A terminology codelist to describe the test code for a physiological examination of the musculoskeletal system. | CDISC SDTM Musculoskeletal System Finding Test Code Terminology |
ALPHANGL | C191306 | Alpha Angle;Alpha Angle of the Hip | A measurement of the angle between the line from the center of the femoral head to the center of the femoral neck at its narrowest point and the line from the center of the femoral head to a point where the distance from the bone to the center of the head is greater than the radius of the cartilage-covered femoral head. | Alpha Angle of the Hip | ||
AREA | C25244 | Area | The extent of a 2-dimensional surface enclosed within a boundary. (NCI) | Area | ||
ASMMASS | C178018 | Appendicular Skeletal Muscle Mass;ASMM | A measurement of the mass of the muscles of the arms and legs. | Appendicular Skeletal Muscle Mass | ||
BETAANGL | C191307 | Beta Angle;Beta Angle of the Hip | A measurement of the angle formed by the cartilaginous roof to the vertical cortex of the ilium. | Beta Angle of the Hip | ||
BMC | C147472 | Bone Mass;Bone Mineral Content;Bone Mineral Mass | An assessment of the quantity of minerals within a specific bone(s) or segments. | Bone Mineral Content | ||
BMD | C61545 | Bone Mineral Density | A measurement of the amount of minerals contained in a specified volume or area of bone(s) or segments. | Bone Mineral Density Test | ||
BMDT | C147473 | Bone Mineral Density T-Score | The standard deviation of the subject's bone mineral density score in comparison to the normal bone mineral density of a healthy 30-year old adult. | Bone Mineral Density T-Score | ||
BMDZ | C139217 | Bone Mineral Density Z-Score | A statistical score representing the number of standard deviations above or below what is expected for an individual's bone mineral density based on his age, sex, weight, and race. | Bone Mineral Density Z-Score | ||
BMMTABDT | C139223 | Brooke mMRC MMT Score, Abduction;Brooke Modified Medical Research Council Manual Muscle Test Score, Abduction | The numerical value that represents the result of a clinical assessment of muscle strength and function during abduction that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Abduction | ||
BMMTDORS | C139225 | Brooke mMRC MMT Score, Dorsiflexion;Brooke Modified Medical Research Council Manual Muscle Test Score, Dorsiflexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during dorsiflexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Dorsiflexion | ||
BMMTEVE | C139227 | Brooke mMRC MMT Score, Eversion;Brooke Modified Medical Research Council Manual Muscle Test Score, Eversion | The numerical value that represents the result of a clinical assessment of muscle strength and function during eversion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Eversion | ||
BMMTEXT | C139220 | Brooke mMRC MMT Score, Extension;Brooke Modified Medical Research Council Manual Muscle Test Score, Extension | The numerical value that represents the result of a clinical assessment of muscle strength and function during extension that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Extension | ||
BMMTFLX | C139222 | Brooke mMRC MMT Score, Flexion;Brooke Modified Medical Research Council Manual Muscle Test Score, Flexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during flexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Flexion | ||
BMMTINV | C139226 | Brooke mMRC MMT Score, Inversion;Brooke Modified Medical Research Council Manual Muscle Test Score, Inversion | The numerical value that represents the result of a clinical assessment of muscle strength and function during inversion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Inversion | ||
BMMTLR | C139224 | Brooke mMRC MMT Score, Lat. Rotat.;Brooke Modified Medical Research Council Manual Muscle Test Score, Lateral Rotation | The numerical value that represents the result of a clinical assessment of muscle strength and function during lateral rotation that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Lateral Rotation | ||
BMMTPF | C139221 | Brooke mMRC MMT Score, Plantar Flex;Brooke Modified Medical Research Council Manual Muscle Test Score, Plantar Flexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during plantar flexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Plantar Flexion | ||
BODYFATP | C139218 | Body Fat Percentage | The amount of an individual's total body mass that is fat, expressed as a percent. | Body Fat Percentage | ||
ENDURM | C181501 | Muscle Endurance | A measurement of a muscle's ability to perform repetitive contractions against a force. | Muscle Endurance Measurement | ||
FATMASS | C158256 | Fat Mass | A measurement of the fat weight associated with a body part or whole body. | Fat Mass | ||
FOCLOIND | C154909 | Fontanelle Closure Indicator | An indication as to whether the fontanelle is closed. | Fontanelle Closure Indicator | ||
GPBAEST | C181502 | Greulich and Pyle Bone Age Estimation;Greulich and Pyle Skeletal Maturity Estimation | An estimated assessment of an individual's skeletal maturity (bone age) based on comparison of standard radiographic images of the bones of the hand and wrist. (Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. The American Journal of the Medical Sciences. 1959;238(3):393.) | Greulich and Pyle Bone Age Estimation | ||
GRIPSTR | C139210 | Grip Strength | An assessment of muscle strength that measures that force with which one holds or grasps. | Grip Strength | ||
ISOMSABD | C181496 | Isometric Muscle Strength, Abduction | An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part away from the midline of the body. | Isometric Muscle Strength, Abduction | ||
ISOMSADD | C181500 | Isometric Muscle Strength, Adduction | An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part toward the midline of the body. | Isometric Muscle Strength, Adduction | ||
ISOMSDOR | C181497 | Isometric Muscle Strength, Dorsiflexion | An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part bending upwards towards the dorsal surface of the body. | Isometric Muscle Strength, Dorsiflexion | ||
ISOMSER | C181499 | Isometric Muscle Strength, Extern Rotat;Isometric Muscle Strength, External Rotation | An assessment of muscle strength that measures the force produced by static muscle contraction during the rotational movement of a body part outward, away from the body. | Isometric Muscle Strength, External Rotation | ||
ISOMSEXT | C139215 | Isometric Muscle Strength, Extension | An assessment of muscle strength that measures the force produced by static muscle contraction during the straightening (unbending) movement between body parts. (NCI) | Isometric Muscle Strength, Extension | ||
ISOMSFL | C139216 | Isometric Muscle Strength, Flexion | An assessment of muscle strength that measures the force produced by static muscle contraction during the bending movement between body parts. (NCI) | Isometric Muscle Strength, Flexion | ||
ISOMSIR | C181498 | Isometric Muscle Strength, Intern Rotat;Isometric Muscle Strength, Internal Rotation | An assessment of muscle strength that measures the force produced by static muscle contraction during the rotational movement of a body part inward, toward the body. | Isometric Muscle Strength, Internal Rotation | ||
LEANMASS | C158257 | Lean Mass | A measurement of the weight of a body part or whole body, minus the weight of the fat associated with that body part or whole body. | Lean Mass | ||
MKEXAM | C167264 | Musculoskeletal System Examination | An observation, assessment or examination of the musculoskeletal system. | Musculoskeletal Examination | ||
MMTABDT | C139231 | Medical Research Council Manual Muscle Test Score, Abduction;MRC MMT Score, Abduction | The numerical value that represents the result of a clinical assessment of muscle strength and function during abduction that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Abduction | ||
MMTDORS | C139233 | Medical Research Council Manual Muscle Test Score, Dorsiflexion;MRC MMT Score, Dorsiflexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during dorsiflexion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Dorsiflexion | ||
MMTEVE | C139235 | Medical Research Council Manual Muscle Test Score, Eversion;MRC MMT Score, Eversion | The numerical value that represents the result of a clinical assessment of muscle strength and function during eversion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Eversion | ||
MMTEXT | C139228 | Medical Research Council Manual Muscle Test Score, Extension;MRC MMT Score, Extension | The numerical value that represents the result of a clinical assessment of muscle strength and function during extension that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Extension | ||
MMTFLX | C139230 | Medical Research Council Manual Muscle Test Score, Flexion;MRC MMT Score, Flexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during flexion that is based on the Medical Research Council Manual Muscle. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Flexion | ||
MMTINV | C139234 | Medical Research Council Manual Muscle Test Score, Inversion;MRC MMT Score, Inversion | The numerical value that represents the result of a clinical assessment of muscle strength and function during inversion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Inversion | ||
MMTLR | C139232 | Medical Research Council Manual Muscle Test Score, Lateral Rotation;MRC MMT Score, Lat. Rotat. | The numerical value that represents the result of a clinical assessment of muscle strength and function during lateral rotation that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Lateral Rotation | ||
MMTPF | C139229 | Medical Research Council Manual Muscle Test Score, Plantar Flexion;MRC MMT Score, Plantar Flex | The numerical value that represents the result of a clinical assessment of muscle strength and function during plantar flexion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Plantar Flexion | ||
PINCHSTR | C139211 | Pinch Strength | An assessment of hand muscle strength that measures the force with which an individual can squeeze or compress an object using his thumb and one or multiple fingers from the same hand. | Pinch Strength | ||
ROMABDT | C139212 | Range of Motion, Abduction | An assessment of joint flexibility that measures the movement of a body part pulling away from the midline of the body, in number of degrees. (NCI) | Range of Motion, Abduction | ||
ROMDORFL | C139214 | Range of Motion, Dorsiflexion | An assessment of joint flexibility that measures the movement of a body part bending towards its dorsal surface, in number of degrees. (NCI) | Range of Motion, Dorsiflexion | ||
ROMEXT | C139213 | Range of Motion, Extension | An assessment of joint flexibility that measures the straightening (unbending) movement between body parts, in number of degrees. (NCI) | Range of Motion, Extension | ||
SGBESCR | C128986 | Sharp/Genant Bone Erosion Score | The numerical value that represents the result of a clinical assessment of bone erosion based on the Genant modification of the Sharp Joint Erosion Assessment (Genant HK. Methods of assessing radiographic change in rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):35-47). | Sharp Genant Bone Erosion Score | ||
SGJSNSCR | C128987 | Sharp/Genant JSN Score | The numerical value that represents the result of a clinical assessment of joint space narrowing based on the Genant modification of the Sharp Joint Space Narrowing Assessment (Genant HK. Methods of assessing radiographic change in rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):35-47). | Sharp Genant Joint Space Narrowing Score | ||
SMMASS | C178017 | Skeletal Muscle Mass | A measurement of the total mass of the skeletal muscle. | Skeletal Muscle Mass | ||
SVBESCR | C128988 | Sharp/Van der Heijde Bone Erosion Score | The numerical value that represents the result of a clinical assessment of bone erosion based on the Van der Heijde modification of the Sharp Joint Erosion Assessment (Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8). | Sharp van der Heijde Bone Erosion Score | ||
SVJSNSCR | C128989 | Sharp/Van der Heijde JSN Score | The numerical value that represents the result of a clinical assessment of joint space narrowing based on the Van der Heijde modification of the Sharp Joint Space Narrowing Assessment (Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8). | Sharp van der Heijde Joint Space Narrowing Score | ||
SWLLIND | C127774 | Swollen Indicator | An indication as to whether there are symptoms of swelling. | Swollen Indicator | ||
TNDRIND | C127775 | Tenderness Indicator | An indication as to whether there are symptoms of tenderness. | Tenderness Indicator | ||
Back to top | ||||||
CL.C127270.MUSCTS | Musculoskeletal System Finding Test Name
(MUSCTS) | text
Extensible: Yes | C127270 | Musculoskeletal System Finding Test Name | A terminology codelist to describe the test name for a physiological examination of the musculoskeletal system. | CDISC SDTM Musculoskeletal System Finding Test Name Terminology |
Alpha Angle | C191306 | Alpha Angle;Alpha Angle of the Hip | A measurement of the angle between the line from the center of the femoral head to the center of the femoral neck at its narrowest point and the line from the center of the femoral head to a point where the distance from the bone to the center of the head is greater than the radius of the cartilage-covered femoral head. | Alpha Angle of the Hip | ||
Appendicular Skeletal Muscle Mass | C178018 | Appendicular Skeletal Muscle Mass;ASMM | A measurement of the mass of the muscles of the arms and legs. | Appendicular Skeletal Muscle Mass | ||
Area | C25244 | Area | The extent of a 2-dimensional surface enclosed within a boundary. (NCI) | Area | ||
Beta Angle | C191307 | Beta Angle;Beta Angle of the Hip | A measurement of the angle formed by the cartilaginous roof to the vertical cortex of the ilium. | Beta Angle of the Hip | ||
Body Fat Percentage | C139218 | Body Fat Percentage | The amount of an individual's total body mass that is fat, expressed as a percent. | Body Fat Percentage | ||
Bone Mineral Content | C147472 | Bone Mass;Bone Mineral Content;Bone Mineral Mass | An assessment of the quantity of minerals within a specific bone(s) or segments. | Bone Mineral Content | ||
Bone Mineral Density T-Score | C147473 | Bone Mineral Density T-Score | The standard deviation of the subject's bone mineral density score in comparison to the normal bone mineral density of a healthy 30-year old adult. | Bone Mineral Density T-Score | ||
Bone Mineral Density Z-Score | C139217 | Bone Mineral Density Z-Score | A statistical score representing the number of standard deviations above or below what is expected for an individual's bone mineral density based on his age, sex, weight, and race. | Bone Mineral Density Z-Score | ||
Bone Mineral Density | C61545 | Bone Mineral Density | A measurement of the amount of minerals contained in a specified volume or area of bone(s) or segments. | Bone Mineral Density Test | ||
Brooke mMRC MMT Score, Abduction | C139223 | Brooke mMRC MMT Score, Abduction;Brooke Modified Medical Research Council Manual Muscle Test Score, Abduction | The numerical value that represents the result of a clinical assessment of muscle strength and function during abduction that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Abduction | ||
Brooke mMRC MMT Score, Dorsiflexion | C139225 | Brooke mMRC MMT Score, Dorsiflexion;Brooke Modified Medical Research Council Manual Muscle Test Score, Dorsiflexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during dorsiflexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Dorsiflexion | ||
Brooke mMRC MMT Score, Eversion | C139227 | Brooke mMRC MMT Score, Eversion;Brooke Modified Medical Research Council Manual Muscle Test Score, Eversion | The numerical value that represents the result of a clinical assessment of muscle strength and function during eversion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Eversion | ||
Brooke mMRC MMT Score, Extension | C139220 | Brooke mMRC MMT Score, Extension;Brooke Modified Medical Research Council Manual Muscle Test Score, Extension | The numerical value that represents the result of a clinical assessment of muscle strength and function during extension that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Extension | ||
Brooke mMRC MMT Score, Flexion | C139222 | Brooke mMRC MMT Score, Flexion;Brooke Modified Medical Research Council Manual Muscle Test Score, Flexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during flexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Flexion | ||
Brooke mMRC MMT Score, Inversion | C139226 | Brooke mMRC MMT Score, Inversion;Brooke Modified Medical Research Council Manual Muscle Test Score, Inversion | The numerical value that represents the result of a clinical assessment of muscle strength and function during inversion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Inversion | ||
Brooke mMRC MMT Score, Lat. Rotat. | C139224 | Brooke mMRC MMT Score, Lat. Rotat.;Brooke Modified Medical Research Council Manual Muscle Test Score, Lateral Rotation | The numerical value that represents the result of a clinical assessment of muscle strength and function during lateral rotation that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Lateral Rotation | ||
Brooke mMRC MMT Score, Plantar Flex | C139221 | Brooke mMRC MMT Score, Plantar Flex;Brooke Modified Medical Research Council Manual Muscle Test Score, Plantar Flexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during plantar flexion that is based on the Brooke Modified Medical Research Council Manual Muscle Test. (Brooke MH, Griggs RC, Mendell JR, Fenichel GM, et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981 May-Jun;4(3):186-97. doi:10.1002/mus.880040304). | Brooke Modified Medical Research Council Manual Muscle Test Score, Plantar Flexion | ||
Fat Mass | C158256 | Fat Mass | A measurement of the fat weight associated with a body part or whole body. | Fat Mass | ||
Fontanelle Closure Indicator | C154909 | Fontanelle Closure Indicator | An indication as to whether the fontanelle is closed. | Fontanelle Closure Indicator | ||
Greulich and Pyle Bone Age Estimation | C181502 | Greulich and Pyle Bone Age Estimation;Greulich and Pyle Skeletal Maturity Estimation | An estimated assessment of an individual's skeletal maturity (bone age) based on comparison of standard radiographic images of the bones of the hand and wrist. (Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. The American Journal of the Medical Sciences. 1959;238(3):393.) | Greulich and Pyle Bone Age Estimation | ||
Grip Strength | C139210 | Grip Strength | An assessment of muscle strength that measures that force with which one holds or grasps. | Grip Strength | ||
Isometric Muscle Strength, Abduction | C181496 | Isometric Muscle Strength, Abduction | An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part away from the midline of the body. | Isometric Muscle Strength, Abduction | ||
Isometric Muscle Strength, Adduction | C181500 | Isometric Muscle Strength, Adduction | An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part toward the midline of the body. | Isometric Muscle Strength, Adduction | ||
Isometric Muscle Strength, Dorsiflexion | C181497 | Isometric Muscle Strength, Dorsiflexion | An assessment of muscle strength that measures the force produced by static muscle contraction during the movement of a body part bending upwards towards the dorsal surface of the body. | Isometric Muscle Strength, Dorsiflexion | ||
Isometric Muscle Strength, Extension | C139215 | Isometric Muscle Strength, Extension | An assessment of muscle strength that measures the force produced by static muscle contraction during the straightening (unbending) movement between body parts. (NCI) | Isometric Muscle Strength, Extension | ||
Isometric Muscle Strength, Extern Rotat | C181499 | Isometric Muscle Strength, Extern Rotat;Isometric Muscle Strength, External Rotation | An assessment of muscle strength that measures the force produced by static muscle contraction during the rotational movement of a body part outward, away from the body. | Isometric Muscle Strength, External Rotation | ||
Isometric Muscle Strength, Flexion | C139216 | Isometric Muscle Strength, Flexion | An assessment of muscle strength that measures the force produced by static muscle contraction during the bending movement between body parts. (NCI) | Isometric Muscle Strength, Flexion | ||
Isometric Muscle Strength, Intern Rotat | C181498 | Isometric Muscle Strength, Intern Rotat;Isometric Muscle Strength, Internal Rotation | An assessment of muscle strength that measures the force produced by static muscle contraction during the rotational movement of a body part inward, toward the body. | Isometric Muscle Strength, Internal Rotation | ||
Lean Mass | C158257 | Lean Mass | A measurement of the weight of a body part or whole body, minus the weight of the fat associated with that body part or whole body. | Lean Mass | ||
MRC MMT Score, Abduction | C139231 | Medical Research Council Manual Muscle Test Score, Abduction;MRC MMT Score, Abduction | The numerical value that represents the result of a clinical assessment of muscle strength and function during abduction that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Abduction | ||
MRC MMT Score, Dorsiflexion | C139233 | Medical Research Council Manual Muscle Test Score, Dorsiflexion;MRC MMT Score, Dorsiflexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during dorsiflexion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Dorsiflexion | ||
MRC MMT Score, Eversion | C139235 | Medical Research Council Manual Muscle Test Score, Eversion;MRC MMT Score, Eversion | The numerical value that represents the result of a clinical assessment of muscle strength and function during eversion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Eversion | ||
MRC MMT Score, Extension | C139228 | Medical Research Council Manual Muscle Test Score, Extension;MRC MMT Score, Extension | The numerical value that represents the result of a clinical assessment of muscle strength and function during extension that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Extension | ||
MRC MMT Score, Flexion | C139230 | Medical Research Council Manual Muscle Test Score, Flexion;MRC MMT Score, Flexion | The numerical value that represents the result of a clinical assessment of muscle strength and function during flexion that is based on the Medical Research Council Manual Muscle. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Flexion | ||
MRC MMT Score, Inversion | C139234 | Medical Research Council Manual Muscle Test Score, Inversion;MRC MMT Score, Inversion | The numerical value that represents the result of a clinical assessment of muscle strength and function during inversion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Inversion | ||
MRC MMT Score, Lat. Rotat. | C139232 | Medical Research Council Manual Muscle Test Score, Lateral Rotation;MRC MMT Score, Lat. Rotat. | The numerical value that represents the result of a clinical assessment of muscle strength and function during lateral rotation that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Lateral Rotation | ||
MRC MMT Score, Plantar Flex | C139229 | Medical Research Council Manual Muscle Test Score, Plantar Flexion;MRC MMT Score, Plantar Flex | The numerical value that represents the result of a clinical assessment of muscle strength and function during plantar flexion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2). | Medical Research Council Manual Muscle Test Score, Plantar Flexion | ||
Muscle Endurance | C181501 | Muscle Endurance | A measurement of a muscle's ability to perform repetitive contractions against a force. | Muscle Endurance Measurement | ||
Musculoskeletal System Examination | C167264 | Musculoskeletal System Examination | An observation, assessment or examination of the musculoskeletal system. | Musculoskeletal Examination | ||
Pinch Strength | C139211 | Pinch Strength | An assessment of hand muscle strength that measures the force with which an individual can squeeze or compress an object using his thumb and one or multiple fingers from the same hand. | Pinch Strength | ||
Range of Motion, Abduction | C139212 | Range of Motion, Abduction | An assessment of joint flexibility that measures the movement of a body part pulling away from the midline of the body, in number of degrees. (NCI) | Range of Motion, Abduction | ||
Range of Motion, Dorsiflexion | C139214 | Range of Motion, Dorsiflexion | An assessment of joint flexibility that measures the movement of a body part bending towards its dorsal surface, in number of degrees. (NCI) | Range of Motion, Dorsiflexion | ||
Range of Motion, Extension | C139213 | Range of Motion, Extension | An assessment of joint flexibility that measures the straightening (unbending) movement between body parts, in number of degrees. (NCI) | Range of Motion, Extension | ||
Sharp/Genant Bone Erosion Score | C128986 | Sharp/Genant Bone Erosion Score | The numerical value that represents the result of a clinical assessment of bone erosion based on the Genant modification of the Sharp Joint Erosion Assessment (Genant HK. Methods of assessing radiographic change in rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):35-47). | Sharp Genant Bone Erosion Score | ||
Sharp/Genant JSN Score | C128987 | Sharp/Genant JSN Score | The numerical value that represents the result of a clinical assessment of joint space narrowing based on the Genant modification of the Sharp Joint Space Narrowing Assessment (Genant HK. Methods of assessing radiographic change in rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):35-47). | Sharp Genant Joint Space Narrowing Score | ||
Sharp/Van der Heijde Bone Erosion Score | C128988 | Sharp/Van der Heijde Bone Erosion Score | The numerical value that represents the result of a clinical assessment of bone erosion based on the Van der Heijde modification of the Sharp Joint Erosion Assessment (Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8). | Sharp van der Heijde Bone Erosion Score | ||
Sharp/Van der Heijde JSN Score | C128989 | Sharp/Van der Heijde JSN Score | The numerical value that represents the result of a clinical assessment of joint space narrowing based on the Van der Heijde modification of the Sharp Joint Space Narrowing Assessment (Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8). | Sharp van der Heijde Joint Space Narrowing Score | ||
Skeletal Muscle Mass | C178017 | Skeletal Muscle Mass | A measurement of the total mass of the skeletal muscle. | Skeletal Muscle Mass | ||
Swollen Indicator | C127774 | Swollen Indicator | An indication as to whether there are symptoms of swelling. | Swollen Indicator | ||
Tenderness Indicator | C127775 | Tenderness Indicator | An indication as to whether there are symptoms of tenderness. | Tenderness Indicator | ||
Back to top | ||||||
CL.C129092.FAC028TC | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire Test Code
(FAC028TC) | text
Extensible: No | C129092 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire Test Code | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 test code. | CDISC Questionnaire NCCN-FACT FBLSI-18 Version 2 Test Code Terminology |
FAC02801 | C129170 | FAC028-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have pain. | NCCN-FACT FBLSI-18 Version 2 - I Have Pain | ||
FAC02802 | C129171 | FAC028-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am losing weight. | NCCN-FACT FBLSI-18 Version 2 - I Am Losing Weight | ||
FAC02803 | C129172 | FAC028-Have Trouble Controlling My Urine | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have trouble controlling my urine. | NCCN-FACT FBLSI-18 Version 2 - Have Trouble Controlling My Urine | ||
FAC02804 | C129173 | FAC028-I Feel Weak All Over | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel weak all over. | NCCN-FACT FBLSI-18 Version 2 - I Feel Weak All Over | ||
FAC02805 | C129174 | FAC028-I Feel Light-headed | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel light-headed (dizzy). | NCCN-FACT FBLSI-18 Version 2 - I Feel Light-headed | ||
FAC02806 | C129175 | FAC028-Trouble Meeting Needs of Family | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. | NCCN-FACT FBLSI-18 Version 2 - Trouble Meeting Needs of Family | ||
FAC02807 | C129176 | FAC028-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have a good appetite. | NCCN-FACT FBLSI-18 Version 2 - I Have a Good Appetite | ||
FAC02808 | C129177 | FAC028-Able to Have/Maintain Erection | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - (For men only) I am able to have and maintain an erection. | NCCN-FACT FBLSI-18 Version 2 - Able to Have, Maintain Erection | ||
FAC02809 | C129178 | FAC028-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am sleeping well. | NCCN-FACT FBLSI-18 Version 2 - I Am Sleeping Well | ||
FAC02810 | C129179 | FAC028-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I worry that my condition will get worse. | NCCN-FACT FBLSI-18 Version 2 - Worry My Condition Will Get Worse | ||
FAC02811 | C129180 | FAC028-I Feel Sad | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel sad. | NCCN-FACT FBLSI-18 Version 2 - I Feel Sad | ||
FAC02812 | C129181 | FAC028-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have nausea. | NCCN-FACT FBLSI-18 Version 2 - I Have Nausea | ||
FAC02813 | C129182 | FAC028-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have a lack of energy. | NCCN-FACT FBLSI-18 Version 2 - I Have a Lack of Energy | ||
FAC02814 | C129183 | FAC028-I Feel Ill | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel ill. | NCCN-FACT FBLSI-18 Version 2 - I Feel Ill | ||
FAC02815 | C129184 | FAC028-I Have Control of My Bowels | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have control of my bowels. | NCCN-FACT FBLSI-18 Version 2 - I Have Control of My Bowels | ||
FAC02816 | C129185 | FAC028-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FBLSI-18 Version 2 - Bothered by Treatment Side Effect | ||
FAC02817 | C129186 | FAC028-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am able to enjoy life. | NCCN-FACT FBLSI-18 Version 2 - I Am Able to Enjoy Life | ||
FAC02818 | C129187 | FAC028-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FBLSI-18 Version 2 - Content With Quality of My Life | ||
Back to top | ||||||
CL.C129091.FAC028TN | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire Test Name
(FAC028TN) | text
Extensible: No | C129091 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 Questionnaire Test Name | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 test name. | CDISC Questionnaire NCCN-FACT FBLSI-18 Version 2 Test Name Terminology |
FAC028-Able to Have/Maintain Erection | C129177 | FAC028-Able to Have/Maintain Erection | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - (For men only) I am able to have and maintain an erection. | NCCN-FACT FBLSI-18 Version 2 - Able to Have, Maintain Erection | ||
FAC028-Bothered by Treatment Side Effect | C129185 | FAC028-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FBLSI-18 Version 2 - Bothered by Treatment Side Effect | ||
FAC028-Content With Quality of My Life | C129187 | FAC028-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FBLSI-18 Version 2 - Content With Quality of My Life | ||
FAC028-Have Trouble Controlling My Urine | C129172 | FAC028-Have Trouble Controlling My Urine | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have trouble controlling my urine. | NCCN-FACT FBLSI-18 Version 2 - Have Trouble Controlling My Urine | ||
FAC028-I Am Able to Enjoy Life | C129186 | FAC028-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am able to enjoy life. | NCCN-FACT FBLSI-18 Version 2 - I Am Able to Enjoy Life | ||
FAC028-I Am Losing Weight | C129171 | FAC028-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am losing weight. | NCCN-FACT FBLSI-18 Version 2 - I Am Losing Weight | ||
FAC028-I Am Sleeping Well | C129178 | FAC028-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I am sleeping well. | NCCN-FACT FBLSI-18 Version 2 - I Am Sleeping Well | ||
FAC028-I Feel Ill | C129183 | FAC028-I Feel Ill | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel ill. | NCCN-FACT FBLSI-18 Version 2 - I Feel Ill | ||
FAC028-I Feel Light-headed | C129174 | FAC028-I Feel Light-headed | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel light-headed (dizzy). | NCCN-FACT FBLSI-18 Version 2 - I Feel Light-headed | ||
FAC028-I Feel Sad | C129180 | FAC028-I Feel Sad | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel sad. | NCCN-FACT FBLSI-18 Version 2 - I Feel Sad | ||
FAC028-I Feel Weak All Over | C129173 | FAC028-I Feel Weak All Over | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I feel weak all over. | NCCN-FACT FBLSI-18 Version 2 - I Feel Weak All Over | ||
FAC028-I Have a Good Appetite | C129176 | FAC028-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have a good appetite. | NCCN-FACT FBLSI-18 Version 2 - I Have a Good Appetite | ||
FAC028-I Have a Lack of Energy | C129182 | FAC028-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have a lack of energy. | NCCN-FACT FBLSI-18 Version 2 - I Have a Lack of Energy | ||
FAC028-I Have Control of My Bowels | C129184 | FAC028-I Have Control of My Bowels | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have control of my bowels. | NCCN-FACT FBLSI-18 Version 2 - I Have Control of My Bowels | ||
FAC028-I Have Nausea | C129181 | FAC028-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have nausea. | NCCN-FACT FBLSI-18 Version 2 - I Have Nausea | ||
FAC028-I Have Pain | C129170 | FAC028-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I have pain. | NCCN-FACT FBLSI-18 Version 2 - I Have Pain | ||
FAC028-Trouble Meeting Needs of Family | C129175 | FAC028-Trouble Meeting Needs of Family | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. | NCCN-FACT FBLSI-18 Version 2 - Trouble Meeting Needs of Family | ||
FAC028-Worry My Condition Will Get Worse | C129179 | FAC028-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Bladder Symptom Index-18 Version 2 - I worry that my condition will get worse. | NCCN-FACT FBLSI-18 Version 2 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C150786.FAC030TC | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire Test Code
(FAC030TC) | text
Extensible: No | C150786 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire Test Code | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 test code. | CDISC Questionnaire NCCN-FACT FBRSI-24 Version 2 Test Code Terminology |
FAC03001 | C151280 | FAC030-I Get Headaches | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I get headaches. | NCCN-FACT FBRSI-24 Version 2 - I Get Headaches | ||
FAC03002 | C151281 | FAC030-I Have Trouble With Coordination | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have trouble with coordination. | NCCN-FACT FBRSI-24 Version 2 - I Have Trouble With Coordination | ||
FAC03003 | C151282 | FAC030-I Have Had Seizures | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have had seizures (convulsions). | NCCN-FACT FBRSI-24 Version 2 - I Have Had Seizures | ||
FAC03004 | C151283 | FAC030-I Need Help in Caring for Myself | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I need help in caring for myself (bathing, dressing, eating, etc.). | NCCN-FACT FBRSI-24 Version 2 - I Need Help in Caring for Myself | ||
FAC03005 | C151284 | FAC030-Have Weakness in My Arms or Legs | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have weakness in my arms or legs. | NCCN-FACT FBRSI-24 Version 2 - Have Weakness in My Arms or Legs | ||
FAC03006 | C151285 | FAC030-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am losing weight. | NCCN-FACT FBRSI-24 Version 2 - I Am Losing Weight | ||
FAC03007 | C151286 | FAC030-Trouble Meeting Needs of Family | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. | NCCN-FACT FBRSI-24 Version 2 - Trouble Meeting Needs of Family | ||
FAC03008 | C151287 | FAC030-Difficulty Expressing My Thoughts | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have difficulty expressing my thoughts. | NCCN-FACT FBRSI-24 Version 2 - Difficulty Expressing My Thoughts | ||
FAC03009 | C151288 | FAC030-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am sleeping well. | NCCN-FACT FBRSI-24 Version 2 - I Am Sleeping Well | ||
FAC03010 | C151289 | FAC030-I Am Able to Concentrate | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to concentrate. | NCCN-FACT FBRSI-24 Version 2 - I Am Able to Concentrate | ||
FAC03011 | C151290 | FAC030-I Can Remember New Things | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I can remember new things. | NCCN-FACT FBRSI-24 Version 2 - I Can Remember New Things | ||
FAC03012 | C151291 | FAC030-Able to Find the Right Words | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to find the right word(s) to say what I mean. | NCCN-FACT FBRSI-24 Version 2 - Able to Find the Right Words | ||
FAC03013 | C151292 | FAC030-Bothered by Change in Personality | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am bothered by the change in my personality. | NCCN-FACT FBRSI-24 Version 2 - Bothered by Change in Personality | ||
FAC03014 | C151293 | FAC030-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I worry that my condition will get worse. | NCCN-FACT FBRSI-24 Version 2 - Worry My Condition Will Get Worse | ||
FAC03015 | C151294 | FAC030-I Am Afraid of Having a Seizure | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am afraid of having a seizure (convulsion). | NCCN-FACT FBRSI-24 Version 2 - I Am Afraid of Having a Seizure | ||
FAC03016 | C151295 | FAC030-Frustrated I Cannot Do Things | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I get frustrated that I cannot do things I used to. | NCCN-FACT FBRSI-24 Version 2 - Frustrated I Cannot Do Things | ||
FAC03017 | C151296 | FAC030-Losing Hope Against Illness | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am losing hope in the fight against my illness. | NCCN-FACT FBRSI-24 Version 2 - Losing Hope Against Illness | ||
FAC03018 | C151297 | FAC030-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have a lack of energy. | NCCN-FACT FBRSI-24 Version 2 - I Have a Lack of Energy | ||
FAC03019 | C151298 | FAC030-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have nausea. | NCCN-FACT FBRSI-24 Version 2 - I Have Nausea | ||
FAC03020 | C151299 | FAC030-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FBRSI-24 Version 2 - Bothered by Treatment Side Effect | ||
FAC03021 | C151300 | FAC030-I Feel Fatigued | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I feel fatigued. | NCCN-FACT FBRSI-24 Version 2 - I Feel Fatigued | ||
FAC03022 | C151301 | FAC030-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have a good appetite. | NCCN-FACT FBRSI-24 Version 2 - I Have a Good Appetite | ||
FAC03023 | C151302 | FAC030-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to enjoy life. | NCCN-FACT FBRSI-24 Version 2 - I Am Able to Enjoy Life | ||
FAC03024 | C151303 | FAC030-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FBRSI-24 Version 2 - Content With Quality of My Life | ||
Back to top | ||||||
CL.C150785.FAC030TN | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire Test Name
(FAC030TN) | text
Extensible: No | C150785 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 Questionnaire Test Name | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 test name. | CDISC Questionnaire NCCN-FACT FBRSI-24 Version 2 Test Name Terminology |
FAC030-Able to Find the Right Words | C151291 | FAC030-Able to Find the Right Words | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to find the right word(s) to say what I mean. | NCCN-FACT FBRSI-24 Version 2 - Able to Find the Right Words | ||
FAC030-Bothered by Change in Personality | C151292 | FAC030-Bothered by Change in Personality | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am bothered by the change in my personality. | NCCN-FACT FBRSI-24 Version 2 - Bothered by Change in Personality | ||
FAC030-Bothered by Treatment Side Effect | C151299 | FAC030-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FBRSI-24 Version 2 - Bothered by Treatment Side Effect | ||
FAC030-Content With Quality of My Life | C151303 | FAC030-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FBRSI-24 Version 2 - Content With Quality of My Life | ||
FAC030-Difficulty Expressing My Thoughts | C151287 | FAC030-Difficulty Expressing My Thoughts | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have difficulty expressing my thoughts. | NCCN-FACT FBRSI-24 Version 2 - Difficulty Expressing My Thoughts | ||
FAC030-Frustrated I Cannot Do Things | C151295 | FAC030-Frustrated I Cannot Do Things | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I get frustrated that I cannot do things I used to. | NCCN-FACT FBRSI-24 Version 2 - Frustrated I Cannot Do Things | ||
FAC030-Have Weakness in My Arms or Legs | C151284 | FAC030-Have Weakness in My Arms or Legs | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have weakness in my arms or legs. | NCCN-FACT FBRSI-24 Version 2 - Have Weakness in My Arms or Legs | ||
FAC030-I Am Able to Concentrate | C151289 | FAC030-I Am Able to Concentrate | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to concentrate. | NCCN-FACT FBRSI-24 Version 2 - I Am Able to Concentrate | ||
FAC030-I Am Able to Enjoy Life | C151302 | FAC030-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am able to enjoy life. | NCCN-FACT FBRSI-24 Version 2 - I Am Able to Enjoy Life | ||
FAC030-I Am Afraid of Having a Seizure | C151294 | FAC030-I Am Afraid of Having a Seizure | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am afraid of having a seizure (convulsion). | NCCN-FACT FBRSI-24 Version 2 - I Am Afraid of Having a Seizure | ||
FAC030-I Am Losing Weight | C151285 | FAC030-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am losing weight. | NCCN-FACT FBRSI-24 Version 2 - I Am Losing Weight | ||
FAC030-I Am Sleeping Well | C151288 | FAC030-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am sleeping well. | NCCN-FACT FBRSI-24 Version 2 - I Am Sleeping Well | ||
FAC030-I Can Remember New Things | C151290 | FAC030-I Can Remember New Things | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I can remember new things. | NCCN-FACT FBRSI-24 Version 2 - I Can Remember New Things | ||
FAC030-I Feel Fatigued | C151300 | FAC030-I Feel Fatigued | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I feel fatigued. | NCCN-FACT FBRSI-24 Version 2 - I Feel Fatigued | ||
FAC030-I Get Headaches | C151280 | FAC030-I Get Headaches | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I get headaches. | NCCN-FACT FBRSI-24 Version 2 - I Get Headaches | ||
FAC030-I Have a Good Appetite | C151301 | FAC030-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have a good appetite. | NCCN-FACT FBRSI-24 Version 2 - I Have a Good Appetite | ||
FAC030-I Have a Lack of Energy | C151297 | FAC030-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have a lack of energy. | NCCN-FACT FBRSI-24 Version 2 - I Have a Lack of Energy | ||
FAC030-I Have Had Seizures | C151282 | FAC030-I Have Had Seizures | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have had seizures (convulsions). | NCCN-FACT FBRSI-24 Version 2 - I Have Had Seizures | ||
FAC030-I Have Nausea | C151298 | FAC030-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have nausea. | NCCN-FACT FBRSI-24 Version 2 - I Have Nausea | ||
FAC030-I Have Trouble With Coordination | C151281 | FAC030-I Have Trouble With Coordination | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I have trouble with coordination. | NCCN-FACT FBRSI-24 Version 2 - I Have Trouble With Coordination | ||
FAC030-I Need Help in Caring for Myself | C151283 | FAC030-I Need Help in Caring for Myself | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I need help in caring for myself (bathing, dressing, eating, etc.). | NCCN-FACT FBRSI-24 Version 2 - I Need Help in Caring for Myself | ||
FAC030-Losing Hope Against Illness | C151296 | FAC030-Losing Hope Against Illness | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I am losing hope in the fight against my illness. | NCCN-FACT FBRSI-24 Version 2 - Losing Hope Against Illness | ||
FAC030-Trouble Meeting Needs of Family | C151286 | FAC030-Trouble Meeting Needs of Family | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. | NCCN-FACT FBRSI-24 Version 2 - Trouble Meeting Needs of Family | ||
FAC030-Worry My Condition Will Get Worse | C151293 | FAC030-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Brain Symptom Index-24 Version 2 - I worry that my condition will get worse. | NCCN-FACT FBRSI-24 Version 2 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C150788.FAC036TC | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire Test Code
(FAC036TC) | text
Extensible: No | C150788 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire Test Code | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 test code. | CDISC Questionnaire NCCN-FACT FHNSI-22 Version 2 Test Code Terminology |
FAC03601 | C151304 | FAC036-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have pain. | NCCN-FACT FHNSI-22 Version 2 - I Have Pain | ||
FAC03602 | C151305 | FAC036-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am losing weight. | NCCN-FACT FHNSI-22 Version 2 - I Am Losing Weight | ||
FAC03603 | C151306 | FAC036-I Have Trouble Breathing | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have trouble breathing. | NCCN-FACT FHNSI-22 Version 2 - I Have Trouble Breathing | ||
FAC03604 | C151307 | FAC036-I Feel Ill | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I feel ill. | NCCN-FACT FHNSI-22 Version 2 - I Feel Ill | ||
FAC03605 | C151308 | FAC036-Pain in My Mouth, Throat or Neck | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have pain in my mouth, throat or neck. | NCCN-FACT FHNSI-22 Version 2 - Pain in My Mouth, Throat or Neck | ||
FAC03606 | C151309 | FAC036-Trouble Meeting Needs of Family | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. | NCCN-FACT FHNSI-22 Version 2 - Trouble Meeting Needs of Family | ||
FAC03607 | C151310 | FAC036-Can Swallow Naturally and Easily | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I can swallow naturally and easily. | NCCN-FACT FHNSI-22 Version 2 - Can Swallow Naturally and Easily | ||
FAC03608 | C151311 | FAC036-Able to Eat the Foods That I Like | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to eat the foods that I like. | NCCN-FACT FHNSI-22 Version 2 - Able to Eat the Foods That I Like | ||
FAC03609 | C151312 | FAC036-Able to Communicate With Others | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to communicate with others. | NCCN-FACT FHNSI-22 Version 2 - Able to Communicate With Others | ||
FAC03610 | C151313 | FAC036-I Can Eat Solid Foods | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I can eat solid foods. | NCCN-FACT FHNSI-22 Version 2 - I Can Eat Solid Foods | ||
FAC03611 | C151314 | FAC036-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am sleeping well. | NCCN-FACT FHNSI-22 Version 2 - I Am Sleeping Well | ||
FAC03612 | C151315 | FAC036-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I worry that my condition will get worse. | NCCN-FACT FHNSI-22 Version 2 - Worry My Condition Will Get Worse | ||
FAC03613 | C151316 | FAC036-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have a lack of energy. | NCCN-FACT FHNSI-22 Version 2 - I Have a Lack of Energy | ||
FAC03614 | C151317 | FAC036-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have nausea. | NCCN-FACT FHNSI-22 Version 2 - I Have Nausea | ||
FAC03615 | C151318 | FAC036-Had Change in the Way Food Tastes | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have had a change in the way food tastes. | NCCN-FACT FHNSI-22 Version 2 - Had Change in the Way Food Tastes | ||
FAC03616 | C151319 | FAC036-I Have Mouth Sores | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have mouth sores. | NCCN-FACT FHNSI-22 Version 2 - I Have Mouth Sores | ||
FAC03617 | C151320 | FAC036-I Am Bothered by Hair Loss | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am bothered by hair loss. | NCCN-FACT FHNSI-22 Version 2 - I Am Bothered by Hair Loss | ||
FAC03618 | C151321 | FAC036-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FHNSI-22 Version 2 - Bothered by Treatment Side Effect | ||
FAC03619 | C151322 | FAC036-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have a good appetite. | NCCN-FACT FHNSI-22 Version 2 - I Have a Good Appetite | ||
FAC03620 | C151323 | FAC036-I Am Able to Work | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to work (include work at home). | NCCN-FACT FHNSI-22 Version 2 - I Am Able to Work | ||
FAC03621 | C151324 | FAC036-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to enjoy life. | NCCN-FACT FHNSI-22 Version 2 - I Am Able to Enjoy Life | ||
FAC03622 | C151325 | FAC036-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FHNSI-22 Version 2 - Content With Quality of My Life | ||
Back to top | ||||||
CL.C150787.FAC036TN | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire Test Name
(FAC036TN) | text
Extensible: No | C150787 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 Questionnaire Test Name | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 test name. | CDISC Questionnaire NCCN-FACT FHNSI-22 Version 2 Test Name Terminology |
FAC036-Able to Communicate With Others | C151312 | FAC036-Able to Communicate With Others | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to communicate with others. | NCCN-FACT FHNSI-22 Version 2 - Able to Communicate With Others | ||
FAC036-Able to Eat the Foods That I Like | C151311 | FAC036-Able to Eat the Foods That I Like | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to eat the foods that I like. | NCCN-FACT FHNSI-22 Version 2 - Able to Eat the Foods That I Like | ||
FAC036-Bothered by Treatment Side Effect | C151321 | FAC036-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FHNSI-22 Version 2 - Bothered by Treatment Side Effect | ||
FAC036-Can Swallow Naturally and Easily | C151310 | FAC036-Can Swallow Naturally and Easily | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I can swallow naturally and easily. | NCCN-FACT FHNSI-22 Version 2 - Can Swallow Naturally and Easily | ||
FAC036-Content With Quality of My Life | C151325 | FAC036-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FHNSI-22 Version 2 - Content With Quality of My Life | ||
FAC036-Had Change in the Way Food Tastes | C151318 | FAC036-Had Change in the Way Food Tastes | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have had a change in the way food tastes. | NCCN-FACT FHNSI-22 Version 2 - Had Change in the Way Food Tastes | ||
FAC036-I Am Able to Enjoy Life | C151324 | FAC036-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to enjoy life. | NCCN-FACT FHNSI-22 Version 2 - I Am Able to Enjoy Life | ||
FAC036-I Am Able to Work | C151323 | FAC036-I Am Able to Work | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am able to work (include work at home). | NCCN-FACT FHNSI-22 Version 2 - I Am Able to Work | ||
FAC036-I Am Bothered by Hair Loss | C151320 | FAC036-I Am Bothered by Hair Loss | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am bothered by hair loss. | NCCN-FACT FHNSI-22 Version 2 - I Am Bothered by Hair Loss | ||
FAC036-I Am Losing Weight | C151305 | FAC036-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am losing weight. | NCCN-FACT FHNSI-22 Version 2 - I Am Losing Weight | ||
FAC036-I Am Sleeping Well | C151314 | FAC036-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I am sleeping well. | NCCN-FACT FHNSI-22 Version 2 - I Am Sleeping Well | ||
FAC036-I Can Eat Solid Foods | C151313 | FAC036-I Can Eat Solid Foods | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I can eat solid foods. | NCCN-FACT FHNSI-22 Version 2 - I Can Eat Solid Foods | ||
FAC036-I Feel Ill | C151307 | FAC036-I Feel Ill | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I feel ill. | NCCN-FACT FHNSI-22 Version 2 - I Feel Ill | ||
FAC036-I Have a Good Appetite | C151322 | FAC036-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have a good appetite. | NCCN-FACT FHNSI-22 Version 2 - I Have a Good Appetite | ||
FAC036-I Have a Lack of Energy | C151316 | FAC036-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have a lack of energy. | NCCN-FACT FHNSI-22 Version 2 - I Have a Lack of Energy | ||
FAC036-I Have Mouth Sores | C151319 | FAC036-I Have Mouth Sores | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have mouth sores. | NCCN-FACT FHNSI-22 Version 2 - I Have Mouth Sores | ||
FAC036-I Have Nausea | C151317 | FAC036-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have nausea. | NCCN-FACT FHNSI-22 Version 2 - I Have Nausea | ||
FAC036-I Have Pain | C151304 | FAC036-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have pain. | NCCN-FACT FHNSI-22 Version 2 - I Have Pain | ||
FAC036-I Have Trouble Breathing | C151306 | FAC036-I Have Trouble Breathing | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have trouble breathing. | NCCN-FACT FHNSI-22 Version 2 - I Have Trouble Breathing | ||
FAC036-Pain in My Mouth, Throat or Neck | C151308 | FAC036-Pain in My Mouth, Throat or Neck | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I have pain in my mouth, throat or neck. | NCCN-FACT FHNSI-22 Version 2 - Pain in My Mouth, Throat or Neck | ||
FAC036-Trouble Meeting Needs of Family | C151309 | FAC036-Trouble Meeting Needs of Family | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - Because of my physical condition, I have trouble meeting the needs of my family. | NCCN-FACT FHNSI-22 Version 2 - Trouble Meeting Needs of Family | ||
FAC036-Worry My Condition Will Get Worse | C151315 | FAC036-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Head & Neck Symptom Index-22 Version 2 - I worry that my condition will get worse. | NCCN-FACT FHNSI-22 Version 2 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C129090.FAC042TC | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire Test Code
(FAC042TC) | text
Extensible: No | C129090 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire Test Code | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 test code. | CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Code Terminology |
FAC04201 | C129151 | FAC042-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a lack of energy. | NCCN-FACT FKSI-19 Version 2 - I Have a Lack of Energy | ||
FAC04202 | C129152 | FAC042-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have pain. | NCCN-FACT FKSI-19 Version 2 - I Have Pain | ||
FAC04203 | C129153 | FAC042-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am losing weight. | NCCN-FACT FKSI-19 Version 2 - I Am Losing Weight | ||
FAC04204 | C129154 | FAC042-I Feel Fatigued | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I feel fatigued. | NCCN-FACT FKSI-19 Version 2 - I Feel Fatigued | ||
FAC04205 | C129155 | FAC042-I Have Been Short of Breath | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have been short of breath. | NCCN-FACT FKSI-19 Version 2 - I Have Been Short of Breath | ||
FAC04206 | C129156 | FAC042-I Am Bothered by Fevers | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am bothered by fevers (episodes of high body temperature). | NCCN-FACT FKSI-19 Version 2 - I Am Bothered by Fevers | ||
FAC04207 | C129157 | FAC042-I Have Bone Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have bone pain. | NCCN-FACT FKSI-19 Version 2 - I Have Bone Pain | ||
FAC04208 | C129158 | FAC042-I Have Been Coughing | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have been coughing. | NCCN-FACT FKSI-19 Version 2 - I Have Been Coughing | ||
FAC04209 | C129159 | FAC042-I Feel Weak All Over | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I feel weak all over. | NCCN-FACT FKSI-19 Version 2 - I Feel Weak All Over | ||
FAC04210 | C129160 | FAC042-I Have Had Blood in My Urine | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have had blood in my urine. | NCCN-FACT FKSI-19 Version 2 - I Have Had Blood in My Urine | ||
FAC04211 | C129161 | FAC042-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a good appetite. | NCCN-FACT FKSI-19 Version 2 - I Have a Good Appetite | ||
FAC04212 | C129162 | FAC042-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am sleeping well. | NCCN-FACT FKSI-19 Version 2 - I Am Sleeping Well | ||
FAC04213 | C129163 | FAC042-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I worry that my condition will get worse. | NCCN-FACT FKSI-19 Version 2 - Worry My Condition Will Get Worse | ||
FAC04214 | C129164 | FAC042-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have nausea. | NCCN-FACT FKSI-19 Version 2 - I Have Nausea | ||
FAC04215 | C129165 | FAC042-I Have Diarrhea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have diarrhea (diarrhoea). | NCCN-FACT FKSI-19 Version 2 - I Have Diarrhea | ||
FAC04216 | C129166 | FAC042-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FKSI-19 Version 2 - Bothered by Treatment Side Effect | ||
FAC04217 | C129167 | FAC042-I Am Able to Work | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am able to work (include work at home). | NCCN-FACT FKSI-19 Version 2 - I Am Able to Work | ||
FAC04218 | C129168 | FAC042-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am able to enjoy life. | NCCN-FACT FKSI-19 Version 2 - I Am Able to Enjoy Life | ||
FAC04219 | C129169 | FAC042-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FKSI-19 Version 2 - Content With Quality of My Life | ||
Back to top | ||||||
CL.C129089.FAC042TN | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire Test Name
(FAC042TN) | text
Extensible: No | C129089 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 Questionnaire Test Name | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 test name. | CDISC Questionnaire NCCN-FACT FKSI-19 Version 2 Test Name Terminology |
FAC042-Bothered by Treatment Side Effect | C129166 | FAC042-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FKSI-19 Version 2 - Bothered by Treatment Side Effect | ||
FAC042-Content With Quality of My Life | C129169 | FAC042-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FKSI-19 Version 2 - Content With Quality of My Life | ||
FAC042-I Am Able to Enjoy Life | C129168 | FAC042-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am able to enjoy life. | NCCN-FACT FKSI-19 Version 2 - I Am Able to Enjoy Life | ||
FAC042-I Am Able to Work | C129167 | FAC042-I Am Able to Work | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am able to work (include work at home). | NCCN-FACT FKSI-19 Version 2 - I Am Able to Work | ||
FAC042-I Am Bothered by Fevers | C129156 | FAC042-I Am Bothered by Fevers | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am bothered by fevers (episodes of high body temperature). | NCCN-FACT FKSI-19 Version 2 - I Am Bothered by Fevers | ||
FAC042-I Am Losing Weight | C129153 | FAC042-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am losing weight. | NCCN-FACT FKSI-19 Version 2 - I Am Losing Weight | ||
FAC042-I Am Sleeping Well | C129162 | FAC042-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I am sleeping well. | NCCN-FACT FKSI-19 Version 2 - I Am Sleeping Well | ||
FAC042-I Feel Fatigued | C129154 | FAC042-I Feel Fatigued | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I feel fatigued. | NCCN-FACT FKSI-19 Version 2 - I Feel Fatigued | ||
FAC042-I Feel Weak All Over | C129159 | FAC042-I Feel Weak All Over | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I feel weak all over. | NCCN-FACT FKSI-19 Version 2 - I Feel Weak All Over | ||
FAC042-I Have a Good Appetite | C129161 | FAC042-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a good appetite. | NCCN-FACT FKSI-19 Version 2 - I Have a Good Appetite | ||
FAC042-I Have a Lack of Energy | C129151 | FAC042-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have a lack of energy. | NCCN-FACT FKSI-19 Version 2 - I Have a Lack of Energy | ||
FAC042-I Have Been Coughing | C129158 | FAC042-I Have Been Coughing | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have been coughing. | NCCN-FACT FKSI-19 Version 2 - I Have Been Coughing | ||
FAC042-I Have Been Short of Breath | C129155 | FAC042-I Have Been Short of Breath | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have been short of breath. | NCCN-FACT FKSI-19 Version 2 - I Have Been Short of Breath | ||
FAC042-I Have Bone Pain | C129157 | FAC042-I Have Bone Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have bone pain. | NCCN-FACT FKSI-19 Version 2 - I Have Bone Pain | ||
FAC042-I Have Diarrhea | C129165 | FAC042-I Have Diarrhea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have diarrhea (diarrhoea). | NCCN-FACT FKSI-19 Version 2 - I Have Diarrhea | ||
FAC042-I Have Had Blood in My Urine | C129160 | FAC042-I Have Had Blood in My Urine | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have had blood in my urine. | NCCN-FACT FKSI-19 Version 2 - I Have Had Blood in My Urine | ||
FAC042-I Have Nausea | C129164 | FAC042-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have nausea. | NCCN-FACT FKSI-19 Version 2 - I Have Nausea | ||
FAC042-I Have Pain | C129152 | FAC042-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I have pain. | NCCN-FACT FKSI-19 Version 2 - I Have Pain | ||
FAC042-Worry My Condition Will Get Worse | C129163 | FAC042-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Kidney Symptom Index-19 Version 2 - I worry that my condition will get worse. | NCCN-FACT FKSI-19 Version 2 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C129098.FAC050TC | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire Test Code
(FAC050TC) | text
Extensible: No | C129098 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire Test Code | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 test code. | CDISC Questionnaire NCCN-FACT FOSI-18 Version 2 Test Code Terminology |
FAC05001 | C129233 | FAC050-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have a lack of energy. | NCCN-FACT FOSI-18 Version 2 - I Have a Lack of Energy | ||
FAC05002 | C129234 | FAC050-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have pain. | NCCN-FACT FOSI-18 Version 2 - I Have Pain | ||
FAC05003 | C129235 | FAC050-I Feel Ill | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I feel ill. | NCCN-FACT FOSI-18 Version 2 - I Feel Ill | ||
FAC05004 | C129236 | FAC050-I Have Cramps in My Stomach Area | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have cramps in my stomach area. | NCCN-FACT FOSI-18 Version 2 - I Have Cramps in My Stomach Area | ||
FAC05005 | C129237 | FAC050-I Feel Fatigued | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I feel fatigued. | NCCN-FACT FOSI-18 Version 2 - I Feel Fatigued | ||
FAC05006 | C129238 | FAC050-I Am Bothered by Constipation | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by constipation. | NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Constipation | ||
FAC05007 | C129239 | FAC050-I Have Swelling in Stomach Area | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have swelling in my stomach area. | NCCN-FACT FOSI-18 Version 2 - I Have Swelling in Stomach Area | ||
FAC05008 | C129240 | FAC050-I Have Control of My Bowels | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have control of my bowels. | NCCN-FACT FOSI-18 Version 2 - I Have Control of My Bowels | ||
FAC05009 | C129241 | FAC050-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am sleeping well. | NCCN-FACT FOSI-18 Version 2 - I Am Sleeping Well | ||
FAC05010 | C129242 | FAC050-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I worry that my condition will get worse. | NCCN-FACT FOSI-18 Version 2 - Worry My Condition Will Get Worse | ||
FAC05011 | C129243 | FAC050-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have nausea. | NCCN-FACT FOSI-18 Version 2 - I Have Nausea | ||
FAC05012 | C129244 | FAC050-I Am Bothered by Hair Loss | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by hair loss. | NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Hair Loss | ||
FAC05013 | C129245 | FAC050-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FOSI-18 Version 2 - Bothered by Treatment Side Effect | ||
FAC05014 | C129246 | FAC050-I Have Been Vomiting | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have been vomiting. | NCCN-FACT FOSI-18 Version 2 - I Have Been Vomiting | ||
FAC05015 | C129247 | FAC050-I Am Bothered by Skin Problems | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by skin problems. | NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Skin Problems | ||
FAC05016 | C129248 | FAC050-I Am Able to Get Around by Myself | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am able to get around by myself. | NCCN-FACT FOSI-18 Version 2 - I Am Able to Get Around by Myself | ||
FAC05017 | C129249 | FAC050-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am able to enjoy life. | NCCN-FACT FOSI-18 Version 2 - I Am Able to Enjoy Life | ||
FAC05018 | C129250 | FAC050-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FOSI-18 Version 2 - Content With Quality of My Life | ||
Back to top | ||||||
CL.C129097.FAC050TN | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire Test Name
(FAC050TN) | text
Extensible: No | C129097 | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 Questionnaire Test Name | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 test name. | CDISC Questionnaire NCCN-FACT FOSI-18 Version 2 Test Name Terminology |
FAC050-Bothered by Treatment Side Effect | C129245 | FAC050-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT FOSI-18 Version 2 - Bothered by Treatment Side Effect | ||
FAC050-Content With Quality of My Life | C129250 | FAC050-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am content with the quality of my life right now. | NCCN-FACT FOSI-18 Version 2 - Content With Quality of My Life | ||
FAC050-I Am Able to Enjoy Life | C129249 | FAC050-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am able to enjoy life. | NCCN-FACT FOSI-18 Version 2 - I Am Able to Enjoy Life | ||
FAC050-I Am Able to Get Around by Myself | C129248 | FAC050-I Am Able to Get Around by Myself | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am able to get around by myself. | NCCN-FACT FOSI-18 Version 2 - I Am Able to Get Around by Myself | ||
FAC050-I Am Bothered by Constipation | C129238 | FAC050-I Am Bothered by Constipation | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by constipation. | NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Constipation | ||
FAC050-I Am Bothered by Hair Loss | C129244 | FAC050-I Am Bothered by Hair Loss | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by hair loss. | NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Hair Loss | ||
FAC050-I Am Bothered by Skin Problems | C129247 | FAC050-I Am Bothered by Skin Problems | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am bothered by skin problems. | NCCN-FACT FOSI-18 Version 2 - I Am Bothered by Skin Problems | ||
FAC050-I Am Sleeping Well | C129241 | FAC050-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I am sleeping well. | NCCN-FACT FOSI-18 Version 2 - I Am Sleeping Well | ||
FAC050-I Feel Fatigued | C129237 | FAC050-I Feel Fatigued | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I feel fatigued. | NCCN-FACT FOSI-18 Version 2 - I Feel Fatigued | ||
FAC050-I Feel Ill | C129235 | FAC050-I Feel Ill | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I feel ill. | NCCN-FACT FOSI-18 Version 2 - I Feel Ill | ||
FAC050-I Have a Lack of Energy | C129233 | FAC050-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have a lack of energy. | NCCN-FACT FOSI-18 Version 2 - I Have a Lack of Energy | ||
FAC050-I Have Been Vomiting | C129246 | FAC050-I Have Been Vomiting | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have been vomiting. | NCCN-FACT FOSI-18 Version 2 - I Have Been Vomiting | ||
FAC050-I Have Control of My Bowels | C129240 | FAC050-I Have Control of My Bowels | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have control of my bowels. | NCCN-FACT FOSI-18 Version 2 - I Have Control of My Bowels | ||
FAC050-I Have Cramps in My Stomach Area | C129236 | FAC050-I Have Cramps in My Stomach Area | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have cramps in my stomach area. | NCCN-FACT FOSI-18 Version 2 - I Have Cramps in My Stomach Area | ||
FAC050-I Have Nausea | C129243 | FAC050-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have nausea. | NCCN-FACT FOSI-18 Version 2 - I Have Nausea | ||
FAC050-I Have Pain | C129234 | FAC050-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have pain. | NCCN-FACT FOSI-18 Version 2 - I Have Pain | ||
FAC050-I Have Swelling in Stomach Area | C129239 | FAC050-I Have Swelling in Stomach Area | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I have swelling in my stomach area. | NCCN-FACT FOSI-18 Version 2 - I Have Swelling in Stomach Area | ||
FAC050-Worry My Condition Will Get Worse | C129242 | FAC050-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Ovarian Symptom Index-18 Version 2 - I worry that my condition will get worse. | NCCN-FACT FOSI-18 Version 2 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C171355.NEWS1TC | National Early Warning Score 2 Clinical Classification Test Code
(NEWS1TC) | text
Extensible: No | C171355 | National Early Warning Score 2 Clinical Classification Test Code | National Early Warning Score 2 test code. | CDISC Clinical Classification NEWS2 Test Code Terminology |
NEWS101 | C171358 | NEWS1-Respirations | National Early Warning Score 2 - Respirations. | NEWS2 - Respirations | ||
NEWS102 | C171359 | NEWS1-Oxygen Saturation SpO2 Scale 1 | National Early Warning Score 2 - SpO2 Scale 1 oxygen saturation. | NEWS2 - Oxygen Saturation SpO2 Scale 1 | ||
NEWS103 | C171360 | NEWS1-Oxygen Saturation SpO2 Scale 2 | National Early Warning Score 2 - SpO2 Scale 2 oxygen saturation. | NEWS2 - Oxygen Saturation SpO2 Scale 2 | ||
NEWS104 | C171361 | NEWS1-Air or Oxygen | National Early Warning Score 2 - Air or oxygen? | NEWS2 - Air or Oxygen | ||
NEWS104A | C171362 | NEWS1-Air or Oxygen: Device | National Early Warning Score 2 - Air or oxygen: Device. | NEWS2 - Air or Oxygen: Device | ||
NEWS105 | C171363 | NEWS1-Systolic Blood Pressure | National Early Warning Score 2 - Blood pressure. Score uses systolic BP only. | NEWS2 - Systolic Blood Pressure | ||
NEWS106 | C171364 | NEWS1-Pulse | National Early Warning Score 2 - Pulse. | NEWS2 - Pulse | ||
NEWS107 | C171365 | NEWS1-Consciousness | National Early Warning Score 2 - Consciousness. | NEWS2 - Consciousness | ||
NEWS108 | C171366 | NEWS1-Temperature | National Early Warning Score 2 - Temperature. | NEWS2 - Temperature | ||
NEWS109 | C171367 | NEWS1-NEWS Total | National Early Warning Score 2 - NEWS total. | NEWS2 - NEWS Total | ||
NEWS110 | C171368 | NEWS1-Monitoring Frequency | National Early Warning Score 2 - Monitoring frequency. | NEWS2 - Monitoring Frequency | ||
NEWS111 | C171369 | NEWS1-Escalation of Care | National Early Warning Score 2 - Escalation of care. | NEWS2 - Escalation of Care | ||
Back to top | ||||||
CL.C171354.NEWS1TN | National Early Warning Score 2 Clinical Classification Test Name
(NEWS1TN) | text
Extensible: No | C171354 | National Early Warning Score 2 Clinical Classification Test Name | National Early Warning Score 2 test name. | CDISC Clinical Classification NEWS2 Test Name Terminology |
NEWS1-Air or Oxygen | C171361 | NEWS1-Air or Oxygen | National Early Warning Score 2 - Air or oxygen? | NEWS2 - Air or Oxygen | ||
NEWS1-Air or Oxygen: Device | C171362 | NEWS1-Air or Oxygen: Device | National Early Warning Score 2 - Air or oxygen: Device. | NEWS2 - Air or Oxygen: Device | ||
NEWS1-Consciousness | C171365 | NEWS1-Consciousness | National Early Warning Score 2 - Consciousness. | NEWS2 - Consciousness | ||
NEWS1-Escalation of Care | C171369 | NEWS1-Escalation of Care | National Early Warning Score 2 - Escalation of care. | NEWS2 - Escalation of Care | ||
NEWS1-Monitoring Frequency | C171368 | NEWS1-Monitoring Frequency | National Early Warning Score 2 - Monitoring frequency. | NEWS2 - Monitoring Frequency | ||
NEWS1-NEWS Total | C171367 | NEWS1-NEWS Total | National Early Warning Score 2 - NEWS total. | NEWS2 - NEWS Total | ||
NEWS1-Oxygen Saturation SpO2 Scale 1 | C171359 | NEWS1-Oxygen Saturation SpO2 Scale 1 | National Early Warning Score 2 - SpO2 Scale 1 oxygen saturation. | NEWS2 - Oxygen Saturation SpO2 Scale 1 | ||
NEWS1-Oxygen Saturation SpO2 Scale 2 | C171360 | NEWS1-Oxygen Saturation SpO2 Scale 2 | National Early Warning Score 2 - SpO2 Scale 2 oxygen saturation. | NEWS2 - Oxygen Saturation SpO2 Scale 2 | ||
NEWS1-Pulse | C171364 | NEWS1-Pulse | National Early Warning Score 2 - Pulse. | NEWS2 - Pulse | ||
NEWS1-Respirations | C171358 | NEWS1-Respirations | National Early Warning Score 2 - Respirations. | NEWS2 - Respirations | ||
NEWS1-Systolic Blood Pressure | C171363 | NEWS1-Systolic Blood Pressure | National Early Warning Score 2 - Blood pressure. Score uses systolic BP only. | NEWS2 - Systolic Blood Pressure | ||
NEWS1-Temperature | C171366 | NEWS1-Temperature | National Early Warning Score 2 - Temperature. | NEWS2 - Temperature | ||
Back to top | ||||||
CL.C112453.VFQ1TC | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format Questionnaire Test Code
(VFQ1TC) | text
Extensible: No | C112453 | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format Questionnaire Test Code | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format test code. | CDISC Questionnaire VFQ25-Interviewer Administered Format Test Code Terminology |
VFQ101 | C112729 | VFQ1-Your Overall Health Is | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: In general, would you say your overall health is: | VFQ25-Interviewer Administered Format - Overall Health | ||
VFQ102 | C112730 | VFQ1-Eyesight Using Both Eyes Is | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind? | VFQ25-Interviewer Administered Format - Eyesight Using Both Eyes | ||
VFQ103 | C112731 | VFQ1-How Often You Worry About Eyesight | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: How much of the time do you worry about your eyesight? | VFQ25-Interviewer Administered Format - Time Spent Worry About Eyesight | ||
VFQ104 | C112732 | VFQ1-How Much Pain in and Around Eyes | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: How much pain or discomfort have you had in and around your eyes (for example, burning, itching, or aching)? Would you say it is: | VFQ25-Interviewer Administered Format - Pain or Discomfort You Had in and Around Eyes | ||
VFQ105 | C112733 | VFQ1-Difficulty Reading Newspapers | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have reading ordinary print in newspapers? Would you say you have: | VFQ25-Interviewer Administered Format - Difficulty Reading Ordinary Print in Newspapers | ||
VFQ106 | C112734 | VFQ1-Difficulty Doing Work/Hobbies | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools? Would you say: | VFQ25-Interviewer Administered Format - Difficulty Doing Work or Hobbies | ||
VFQ107 | C112735 | VFQ1-Difficulty Finding on Crowded Shelf | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have finding something on a crowded shelf? | VFQ25-Interviewer Administered Format - Difficulty Finding Something On a Shelf | ||
VFQ108 | C112736 | VFQ1-Difficulty Reading Street Signs | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have reading street signs or the names of stores? | VFQ25-Interviewer Administered Format - Difficulty Reading Street Signs | ||
VFQ109 | C112737 | VFQ1-Difficulty Going Down Step at Night | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night? | VFQ25-Interviewer Administered Format - Difficulty Going Down Steps at Night | ||
VFQ110 | C112738 | VFQ1-Difficulty Noticing Objects to Side | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have noticing objects off to the side while you are walking along? | VFQ25-Interviewer Administered Format - Difficulty Noticing Objects Off to the Side While Walking | ||
VFQ111 | C112739 | VFQ1-Difficulty Seeing How People React | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have seeing how people react to things you say? | VFQ25-Interviewer Administered Format - Difficulty Seeing How People React | ||
VFQ112 | C112740 | VFQ1-Difficulty Picking Out Own Clothes | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have picking out and matching your own clothes? | VFQ25-Interviewer Administered Format - Difficulty Picking Out and Matching Own Clothes | ||
VFQ113 | C112741 | VFQ1-Difficulty Visiting With People | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants? | VFQ25-Interviewer Administered Format - Difficulty Visiting People | ||
VFQ114 | C112742 | VFQ1-Difficulty Going Out to See Movies | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events? | VFQ25-Interviewer Administered Format - Difficulty Going Out to See Movies | ||
VFQ115 | C112743 | VFQ1-Are You Currently Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Are you currently driving, at least once in a while? | VFQ25-Interviewer Administered Format - Are You Currently Driving | ||
VFQ115A | C112744 | VFQ1-Never Driven or Given Up Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If no, Have you never driven a car or have you given up driving? | VFQ25-Interviewer Administered Format - Never Driven or Given Up Driving | ||
VFQ115B | C112745 | VFQ1-Main Reason You Gave Up Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If gave up driving: Was that mainly because of your eyesight, mainly for some other reason, or because of both your eyesight and other reasons? | VFQ25-Interviewer Administered Format - Main Reason You Gave Up Driving | ||
VFQ115C | C112746 | VFQ1-Difficulty Driving During Daytime | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If currently driving: How much difficulty do you have driving during the daytime in familiar places? Would you say you have: | VFQ25-Interviewer Administered Format - Difficulty Driving During Daytime | ||
VFQ116 | C112747 | VFQ1-Difficulty Driving at Night | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have driving at night? Would you say you have: | VFQ25-Interviewer Administered Format - Difficulty Driving at Night | ||
VFQ116A | C112748 | VFQ1-Driving in Difficult Conditions | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have driving in difficult conditions, such as in bad weather, during rush hour, on the freeway, or in city traffic? Would you say you have: | VFQ25-Interviewer Administered Format - Driving in Difficult Condition | ||
VFQ117 | C112749 | VFQ1-Accomplish Less Than You Would Like | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Do you accomplish less than you would like because of your vision? | VFQ25-Interviewer Administered Format - Accomplish Less Because of Vision | ||
VFQ118 | C112750 | VFQ1-Limited in How Long You Can Work | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Are you limited in how long you can work or do other activities because of your vision? | VFQ25-Interviewer Administered Format - Limited in How Long You Can Work Because of Vision | ||
VFQ119 | C112751 | VFQ1-Eye Pain Keep From Doing What Like | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: How much does pain or discomfort in or around your eyes, for example, burning, itching, or aching, keep you from doing what you'd like to be doing? Would you say: | VFQ25-Interviewer Administered Format - Pain in Eyes Keep You From Doing What You Like | ||
VFQ120 | C112752 | VFQ1-I Stay Home Most of the Time | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I stay home most of the time because of my eyesight. | VFQ25-Interviewer Administered Format - Stay Home Because of Eyesight | ||
VFQ121 | C112753 | VFQ1-I Feel Frustrated a Lot of the Time | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I feel frustrated a lot of the time because of my eyesight. | VFQ25-Interviewer Administered Format - Feel Frustrated Because of Eyesight | ||
VFQ122 | C112754 | VFQ1-Much Less Control Over What I Do | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I have much less control over what I do, because of my eyesight. | VFQ25-Interviewer Administered Format - Have Less Control Because of Eyesight | ||
VFQ123 | C112755 | VFQ1-Rely Too Much on What Others Tell | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Because of my eyesight, I have to rely too much on what other people tell me. | VFQ25-Interviewer Administered Format - Have to Rely On Other People Because of Eyesight | ||
VFQ124 | C112756 | VFQ1-I Need a Lot of Help From Others | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I need a lot of help from others because of my eyesight. | VFQ25-Interviewer Administered Format - Need Help From Others Because of Eyesight | ||
VFQ125 | C112757 | VFQ1-Worry I'll Do Embarrassing Things | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I worry about doing things that will embarrass myself or others, because of my eyesight. | VFQ25-Interviewer Administered Format - Worry About Embarrass Myself or Others Because of Eyesight | ||
VFQ1A01 | C112758 | VFQ1-Rate Your Overall Health | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health: How would you rate your overall health, on a scale where zero is as bad as death and 10 is best possible health? | VFQ25-Interviewer Administered Format - Rate Your Overall Health | ||
VFQ1A02 | C112759 | VFQ1-Rate Your Eyesight Now | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Vision: How would you rate your eyesight now (with glasses or contact lens on, if you wear them), on a scale of from 0 to 10, where zero means the worst possible eyesight, as bad or worse than being blind, and 10 means the best possible eyesight? | VFQ25-Interviewer Administered Format - Rate Your Eyesight Now | ||
VFQ1A03 | C112760 | VFQ1-Difficulty Reading Small Print | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Wearing glasses, how much difficulty do you have reading the small print in a telephone book, on a medicine bottle, or on legal forms? Would you say: | VFQ25-Interviewer Administered Format - Difficulty Reading Small Print | ||
VFQ1A04 | C112761 | VFQ1-Difficulty Figure Out Bill Accuracy | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have figuring out whether bills you receive are accurate? | VFQ25-Interviewer Administered Format - Difficulty Figure Out Bill Accuracy | ||
VFQ1A05 | C112762 | VFQ1-Difficulty Shaving or Styling Hair | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have doing things like shaving, styling your hair, or putting on makeup? | VFQ25-Interviewer Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup | ||
VFQ1A06 | C112763 | VFQ1-Difficulty Recognizing People | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have recognizing people you know from across a room? | VFQ25-Interviewer Administered Format - Difficulty Recognizing People You Know | ||
VFQ1A07 | C112764 | VFQ1-Difficulty Taking Part in Sports | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have taking part in active sports or other outdoor activities that you enjoy (like golf, bowling, jogging, or walking)? | VFQ25-Interviewer Administered Format - Difficulty Taking Part in Sports or Outdoor Activities | ||
VFQ1A08 | C112765 | VFQ1-Difficulty Seeing Programs on TV | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have seeing and enjoying programs on TV? | VFQ25-Interviewer Administered Format - Difficulty Seeing and Enjoying Programs on TV | ||
VFQ1A09 | C112766 | VFQ1-Difficulty Entertaining Friends | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Social Function: Because of your eyesight, how much difficulty do you have entertaining friends and family in your home? | VFQ25-Interviewer Administered Format - Difficulty Entertaining Friends and Family in Home | ||
VFQ1A11A | C112767 | VFQ1-Do You Have More Help From Others | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Role Limitations: Do you have more help from others because of your vision? | VFQ25-Interviewer Administered Format - Do You Have More Help From Others | ||
VFQ1A11B | C112768 | VFQ1-Limited in Kinds of Things Can Do | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Role Limitations: Are you limited in the kinds of things you can do because of your vision? | VFQ25-Interviewer Administered Format - Limited in Kinds of Things Can Do | ||
VFQ1A12 | C112769 | VFQ1-Often Irritable Because Eyesight | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Well-Being/Distress: I am often irritable because of my eyesight. | VFQ25-Interviewer Administered Format - Often Irritable Because of Eyesight | ||
VFQ1A13 | C112770 | VFQ1-I Don't Go Out of My Home Alone | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Dependency: I don't go out of my home alone, because of my eyesight. | VFQ25-Interviewer Administered Format - Don't Go Out of Home Alone Because of Eyesight | ||
Back to top | ||||||
CL.C112452.VFQ1TN | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format Questionnaire Test Name
(VFQ1TN) | text
Extensible: No | C112452 | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format Questionnaire Test Name | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format test name. | CDISC Questionnaire VFQ25-Interviewer Administered Format Test Name Terminology |
VFQ1-Accomplish Less Than You Would Like | C112749 | VFQ1-Accomplish Less Than You Would Like | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Do you accomplish less than you would like because of your vision? | VFQ25-Interviewer Administered Format - Accomplish Less Because of Vision | ||
VFQ1-Are You Currently Driving | C112743 | VFQ1-Are You Currently Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Are you currently driving, at least once in a while? | VFQ25-Interviewer Administered Format - Are You Currently Driving | ||
VFQ1-Difficulty Doing Work/Hobbies | C112734 | VFQ1-Difficulty Doing Work/Hobbies | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools? Would you say: | VFQ25-Interviewer Administered Format - Difficulty Doing Work or Hobbies | ||
VFQ1-Difficulty Driving at Night | C112747 | VFQ1-Difficulty Driving at Night | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have driving at night? Would you say you have: | VFQ25-Interviewer Administered Format - Difficulty Driving at Night | ||
VFQ1-Difficulty Driving During Daytime | C112746 | VFQ1-Difficulty Driving During Daytime | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If currently driving: How much difficulty do you have driving during the daytime in familiar places? Would you say you have: | VFQ25-Interviewer Administered Format - Difficulty Driving During Daytime | ||
VFQ1-Difficulty Entertaining Friends | C112766 | VFQ1-Difficulty Entertaining Friends | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Social Function: Because of your eyesight, how much difficulty do you have entertaining friends and family in your home? | VFQ25-Interviewer Administered Format - Difficulty Entertaining Friends and Family in Home | ||
VFQ1-Difficulty Figure Out Bill Accuracy | C112761 | VFQ1-Difficulty Figure Out Bill Accuracy | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have figuring out whether bills you receive are accurate? | VFQ25-Interviewer Administered Format - Difficulty Figure Out Bill Accuracy | ||
VFQ1-Difficulty Finding on Crowded Shelf | C112735 | VFQ1-Difficulty Finding on Crowded Shelf | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have finding something on a crowded shelf? | VFQ25-Interviewer Administered Format - Difficulty Finding Something On a Shelf | ||
VFQ1-Difficulty Going Down Step at Night | C112737 | VFQ1-Difficulty Going Down Step at Night | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night? | VFQ25-Interviewer Administered Format - Difficulty Going Down Steps at Night | ||
VFQ1-Difficulty Going Out to See Movies | C112742 | VFQ1-Difficulty Going Out to See Movies | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events? | VFQ25-Interviewer Administered Format - Difficulty Going Out to See Movies | ||
VFQ1-Difficulty Noticing Objects to Side | C112738 | VFQ1-Difficulty Noticing Objects to Side | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have noticing objects off to the side while you are walking along? | VFQ25-Interviewer Administered Format - Difficulty Noticing Objects Off to the Side While Walking | ||
VFQ1-Difficulty Picking Out Own Clothes | C112740 | VFQ1-Difficulty Picking Out Own Clothes | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have picking out and matching your own clothes? | VFQ25-Interviewer Administered Format - Difficulty Picking Out and Matching Own Clothes | ||
VFQ1-Difficulty Reading Newspapers | C112733 | VFQ1-Difficulty Reading Newspapers | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have reading ordinary print in newspapers? Would you say you have: | VFQ25-Interviewer Administered Format - Difficulty Reading Ordinary Print in Newspapers | ||
VFQ1-Difficulty Reading Small Print | C112760 | VFQ1-Difficulty Reading Small Print | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Wearing glasses, how much difficulty do you have reading the small print in a telephone book, on a medicine bottle, or on legal forms? Would you say: | VFQ25-Interviewer Administered Format - Difficulty Reading Small Print | ||
VFQ1-Difficulty Reading Street Signs | C112736 | VFQ1-Difficulty Reading Street Signs | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have reading street signs or the names of stores? | VFQ25-Interviewer Administered Format - Difficulty Reading Street Signs | ||
VFQ1-Difficulty Recognizing People | C112763 | VFQ1-Difficulty Recognizing People | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have recognizing people you know from across a room? | VFQ25-Interviewer Administered Format - Difficulty Recognizing People You Know | ||
VFQ1-Difficulty Seeing How People React | C112739 | VFQ1-Difficulty Seeing How People React | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have seeing how people react to things you say? | VFQ25-Interviewer Administered Format - Difficulty Seeing How People React | ||
VFQ1-Difficulty Seeing Programs on TV | C112765 | VFQ1-Difficulty Seeing Programs on TV | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have seeing and enjoying programs on TV? | VFQ25-Interviewer Administered Format - Difficulty Seeing and Enjoying Programs on TV | ||
VFQ1-Difficulty Shaving or Styling Hair | C112762 | VFQ1-Difficulty Shaving or Styling Hair | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have doing things like shaving, styling your hair, or putting on makeup? | VFQ25-Interviewer Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup | ||
VFQ1-Difficulty Taking Part in Sports | C112764 | VFQ1-Difficulty Taking Part in Sports | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have taking part in active sports or other outdoor activities that you enjoy (like golf, bowling, jogging, or walking)? | VFQ25-Interviewer Administered Format - Difficulty Taking Part in Sports or Outdoor Activities | ||
VFQ1-Difficulty Visiting With People | C112741 | VFQ1-Difficulty Visiting With People | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants? | VFQ25-Interviewer Administered Format - Difficulty Visiting People | ||
VFQ1-Do You Have More Help From Others | C112767 | VFQ1-Do You Have More Help From Others | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Role Limitations: Do you have more help from others because of your vision? | VFQ25-Interviewer Administered Format - Do You Have More Help From Others | ||
VFQ1-Driving in Difficult Conditions | C112748 | VFQ1-Driving in Difficult Conditions | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: How much difficulty do you have driving in difficult conditions, such as in bad weather, during rush hour, on the freeway, or in city traffic? Would you say you have: | VFQ25-Interviewer Administered Format - Driving in Difficult Condition | ||
VFQ1-Eye Pain Keep From Doing What Like | C112751 | VFQ1-Eye Pain Keep From Doing What Like | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: How much does pain or discomfort in or around your eyes, for example, burning, itching, or aching, keep you from doing what you'd like to be doing? Would you say: | VFQ25-Interviewer Administered Format - Pain in Eyes Keep You From Doing What You Like | ||
VFQ1-Eyesight Using Both Eyes Is | C112730 | VFQ1-Eyesight Using Both Eyes Is | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind? | VFQ25-Interviewer Administered Format - Eyesight Using Both Eyes | ||
VFQ1-How Much Pain in and Around Eyes | C112732 | VFQ1-How Much Pain in and Around Eyes | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: How much pain or discomfort have you had in and around your eyes (for example, burning, itching, or aching)? Would you say it is: | VFQ25-Interviewer Administered Format - Pain or Discomfort You Had in and Around Eyes | ||
VFQ1-How Often You Worry About Eyesight | C112731 | VFQ1-How Often You Worry About Eyesight | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: How much of the time do you worry about your eyesight? | VFQ25-Interviewer Administered Format - Time Spent Worry About Eyesight | ||
VFQ1-I Don't Go Out of My Home Alone | C112770 | VFQ1-I Don't Go Out of My Home Alone | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Dependency: I don't go out of my home alone, because of my eyesight. | VFQ25-Interviewer Administered Format - Don't Go Out of Home Alone Because of Eyesight | ||
VFQ1-I Feel Frustrated a Lot of the Time | C112753 | VFQ1-I Feel Frustrated a Lot of the Time | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I feel frustrated a lot of the time because of my eyesight. | VFQ25-Interviewer Administered Format - Feel Frustrated Because of Eyesight | ||
VFQ1-I Need a Lot of Help From Others | C112756 | VFQ1-I Need a Lot of Help From Others | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I need a lot of help from others because of my eyesight. | VFQ25-Interviewer Administered Format - Need Help From Others Because of Eyesight | ||
VFQ1-I Stay Home Most of the Time | C112752 | VFQ1-I Stay Home Most of the Time | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I stay home most of the time because of my eyesight. | VFQ25-Interviewer Administered Format - Stay Home Because of Eyesight | ||
VFQ1-Limited in How Long You Can Work | C112750 | VFQ1-Limited in How Long You Can Work | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Are you limited in how long you can work or do other activities because of your vision? | VFQ25-Interviewer Administered Format - Limited in How Long You Can Work Because of Vision | ||
VFQ1-Limited in Kinds of Things Can Do | C112768 | VFQ1-Limited in Kinds of Things Can Do | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Role Limitations: Are you limited in the kinds of things you can do because of your vision? | VFQ25-Interviewer Administered Format - Limited in Kinds of Things Can Do | ||
VFQ1-Main Reason You Gave Up Driving | C112745 | VFQ1-Main Reason You Gave Up Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If gave up driving: Was that mainly because of your eyesight, mainly for some other reason, or because of both your eyesight and other reasons? | VFQ25-Interviewer Administered Format - Main Reason You Gave Up Driving | ||
VFQ1-Much Less Control Over What I Do | C112754 | VFQ1-Much Less Control Over What I Do | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I have much less control over what I do, because of my eyesight. | VFQ25-Interviewer Administered Format - Have Less Control Because of Eyesight | ||
VFQ1-Never Driven or Given Up Driving | C112744 | VFQ1-Never Driven or Given Up Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Difficulty With Activities: If no, Have you never driven a car or have you given up driving? | VFQ25-Interviewer Administered Format - Never Driven or Given Up Driving | ||
VFQ1-Often Irritable Because Eyesight | C112769 | VFQ1-Often Irritable Because Eyesight | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Well-Being/Distress: I am often irritable because of my eyesight. | VFQ25-Interviewer Administered Format - Often Irritable Because of Eyesight | ||
VFQ1-Rate Your Eyesight Now | C112759 | VFQ1-Rate Your Eyesight Now | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Vision: How would you rate your eyesight now (with glasses or contact lens on, if you wear them), on a scale of from 0 to 10, where zero means the worst possible eyesight, as bad or worse than being blind, and 10 means the best possible eyesight? | VFQ25-Interviewer Administered Format - Rate Your Eyesight Now | ||
VFQ1-Rate Your Overall Health | C112758 | VFQ1-Rate Your Overall Health | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health: How would you rate your overall health, on a scale where zero is as bad as death and 10 is best possible health? | VFQ25-Interviewer Administered Format - Rate Your Overall Health | ||
VFQ1-Rely Too Much on What Others Tell | C112755 | VFQ1-Rely Too Much on What Others Tell | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: Because of my eyesight, I have to rely too much on what other people tell me. | VFQ25-Interviewer Administered Format - Have to Rely On Other People Because of Eyesight | ||
VFQ1-Worry I'll Do Embarrassing Things | C112757 | VFQ1-Worry I'll Do Embarrassing Things | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - Responses to Vision Problems: I worry about doing things that will embarrass myself or others, because of my eyesight. | VFQ25-Interviewer Administered Format - Worry About Embarrass Myself or Others Because of Eyesight | ||
VFQ1-Your Overall Health Is | C112729 | VFQ1-Your Overall Health Is | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Interviewer-Administered Format - General Health and Vision: In general, would you say your overall health is: | VFQ25-Interviewer Administered Format - Overall Health | ||
Back to top | ||||||
CL.C112455.VFQ2TC | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format Questionnaire Test Code
(VFQ2TC) | text
Extensible: No | C112455 | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format Questionnaire Test Code | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format test code. | CDISC Questionnaire VFQ25-Self Administered Format Test Code Terminology |
VFQ201 | C112771 | VFQ2-Your Overall Health Is | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: In general, would you say your overall health is: | VFQ25-Self Administered Format - Overall Health | ||
VFQ202 | C112772 | VFQ2-Eyesight Using Both Eyes Is | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind? | VFQ25-Self Administered Format - Eyesight Using Both Eyes | ||
VFQ203 | C112773 | VFQ2-How Often You Worry About Eyesight | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: How much of the time do you worry about your eyesight? | VFQ25-Self Administered Format - Time Spent Worry About Eyesight | ||
VFQ204 | C112774 | VFQ2-How Much Pain in and Around Eyes | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: How much pain or discomfort have you had in and around your eyes (for example, burning, itching, or aching)? Would you say it is: | VFQ25-Self Administered Format - Pain or Discomfort You Had in and Around Eyes | ||
VFQ205 | C112775 | VFQ2-Difficulty Reading Newspapers | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have reading ordinary print in newspapers? Would you say you have: | VFQ25-Self Administered Format - Difficulty Reading Ordinary Print in Newspapers | ||
VFQ206 | C112776 | VFQ2-Difficulty Doing Work/Hobbies | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools? Would you say: | VFQ25-Self Administered Format - Difficulty Doing Work or Hobbies | ||
VFQ207 | C112777 | VFQ2-Difficulty Finding on Crowded Shelf | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have finding something on a crowded shelf? | VFQ25-Self Administered Format - Difficulty Finding Something On a Shelf | ||
VFQ208 | C112778 | VFQ2-Difficulty Reading Street Signs | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have reading street signs or the names of stores? | VFQ25-Self Administered Format - Difficulty Reading Street Signs | ||
VFQ209 | C112779 | VFQ2-Difficulty Going Down Step at Night | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night? | VFQ25-Self Administered Format - Difficulty Going Down Steps at Night | ||
VFQ210 | C112780 | VFQ2-Difficulty Noticing Objects to Side | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have noticing objects off to the side while you are walking along? | VFQ25-Self Administered Format - Difficulty Noticing Objects Off to the Side While Walking | ||
VFQ211 | C112781 | VFQ2-Difficulty Seeing How People React | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have seeing how people react to things you say? | VFQ25-Self Administered Format - Difficulty Seeing How People React | ||
VFQ212 | C112782 | VFQ2-Difficulty Picking Out Own Clothes | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have picking out and matching your own clothes? | VFQ25-Self Administered Format - Difficulty Picking Out and Matching Own Clothes | ||
VFQ213 | C112783 | VFQ2-Difficulty Visiting With People | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants? | VFQ25-Self Administered Format - Difficulty Visiting People | ||
VFQ214 | C112784 | VFQ2-Difficulty Going Out to See Movies | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events? | VFQ25-Self Administered Format - Difficulty Going Out to See Movies | ||
VFQ215 | C112785 | VFQ2-Are You Currently Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Are you currently driving, at least once in a while? | VFQ25-Self Administered Format - Are You Currently Driving | ||
VFQ215A | C112786 | VFQ2-Never Driven or Given Up Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If no: Have you never driven a car or have you given up driving? | VFQ25-Self Administered Format - Never Driven or Given Up Driving | ||
VFQ215B | C112787 | VFQ2-Main Reason You Gave Up Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If you gave up driving: Was that mainly because of your eyesight, mainly for some other reason, or because of both your eyesight and other reasons? | VFQ25-Self Administered Format - Main Reason You Gave Up Driving | ||
VFQ215C | C112788 | VFQ2-Difficulty Driving During Daytime | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If currently driving: How much difficulty do you have driving during the daytime in familiar places? Would you say you have: | VFQ25-Self Administered Format - Difficulty Driving During Daytime | ||
VFQ216 | C112789 | VFQ2-Difficulty Driving at Night | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have driving at night? Would you say you have: | VFQ25-Self Administered Format - Difficulty Driving at Night | ||
VFQ216A | C112790 | VFQ2-Driving in Difficult Conditions | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have driving in difficult conditions, such as in bad weather, during rush hour, on the freeway, or in city traffic? Would you say you have: | VFQ25-Self Administered Format - Driving in Difficult Condition | ||
VFQ217 | C112791 | VFQ2-Accomplish Less Than You Would Like | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Do you accomplish less than you would like because of your vision? | VFQ25-Self Administered Format - Accomplish Less Because of Vision | ||
VFQ218 | C112792 | VFQ2-Limited in How Long You Can Work | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Are you limited in how long you can work or do other activities because of your vision? | VFQ25-Self Administered Format - Limited in How Long You Can Work Because of Vision | ||
VFQ219 | C112793 | VFQ2-Eye Pain Keep From Doing What Like | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: How much does pain or discomfort in or around your eyes, for example, burning, itching, or aching, keep you from doing what you'd like to be doing? Would you say: | VFQ25-Self Administered Format - Pain in Eyes Keep You From Doing What You Like | ||
VFQ220 | C112794 | VFQ2-I Stay Home Most of the Time | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I stay home most of the time because of my eyesight. | VFQ25-Self Administered Format - Stay Home Because of Eyesight | ||
VFQ221 | C112795 | VFQ2-I Feel Frustrated a Lot of the Time | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I feel frustrated a lot of the time because of my eyesight. | VFQ25-Self Administered Format - Feel Frustrated Because of Eyesight | ||
VFQ222 | C112796 | VFQ2-Much Less Control Over What I Do | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I have much less control over what I do, because of my eyesight. | VFQ25-Self Administered Format - Have Less Control Because of Eyesight | ||
VFQ223 | C112797 | VFQ2-Rely Too Much on What Others Tell | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Because of my eyesight, I have to rely too much on what other people tell me. | VFQ25-Self Administered Format - Have to Rely On Other People Because of Eyesight | ||
VFQ224 | C112798 | VFQ2-I Need a Lot of Help From Others | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I need a lot of help from others because of my eyesight. | VFQ25-Self Administered Format - Need Help From Others Because of Eyesight | ||
VFQ225 | C112799 | VFQ2-Worry I'll Do Embarrassing Things | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I worry about doing things that will embarrass myself or others, because of my eyesight. | VFQ25-Self Administered Format - Worry About Embarrass Myself or Others Because of Eyesight | ||
VFQ2A01 | C112800 | VFQ2-Rate Your Overall Health | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health: How would you rate your overall health, on a scale where zero is as bad as death and 10 is best possible health? | VFQ25-Self Administered Format - Rate Your Overall Health | ||
VFQ2A02 | C112801 | VFQ2-Rate Your Eyesight Now | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Vision: How would you rate your eyesight now (with glasses or contact lens on, if you wear them), on a scale of from 0 to 10, where zero means the worst possible eyesight, as bad or worse than being blind, and 10 means the best possible eyesight? | VFQ25-Self Administered Format - Rate Your Eyesight Now | ||
VFQ2A03 | C112802 | VFQ2-Difficulty Reading Small Print | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Wearing glasses, how much difficulty do you have reading the small print in a telephone book, on a medicine bottle, or on legal forms? Would you say: | VFQ25-Self Administered Format - Difficulty Reading Small Print | ||
VFQ2A04 | C112803 | VFQ2-Difficulty Figure Out Bill Accuracy | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have figuring out whether bills you receive are accurate? | VFQ25-Self Administered Format - Difficulty Figure Out Bill Accuracy | ||
VFQ2A05 | C112804 | VFQ2-Difficulty Shaving or Styling Hair | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have doing things like shaving, styling your hair, or putting on makeup? | VFQ25-Self Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup | ||
VFQ2A06 | C112805 | VFQ2-Difficulty Recognizing People | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have recognizing people you know from across a room? | VFQ25-Self Administered Format - Difficulty Recognizing People You Know | ||
VFQ2A07 | C112806 | VFQ2-Difficulty Taking Part in Sports | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have taking part in active sports or other outdoor activities that you enjoy (like golf, bowling, jogging, or walking)? | VFQ25-Self Administered Format - Difficulty Taking Part in Sports or Outdoor Activities | ||
VFQ2A08 | C112807 | VFQ2-Difficulty Seeing Programs on TV | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have seeing and enjoying programs on TV? | VFQ25-Self Administered Format - Difficulty Seeing and Enjoying Programs on TV | ||
VFQ2A09 | C112808 | VFQ2-Difficulty Entertaining Friends | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Social Function: Because of your eyesight, how much difficulty do you have entertaining friends and family in your home? | VFQ25-Self Administered Format - Difficulty Entertaining Friends and Family in Home | ||
VFQ2A11A | C112809 | VFQ2-Do You Have More Help From Others | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Role Limitations: Do you have more help from others because of your vision? | VFQ25-Self Administered Format - Do You Have More Help From Others | ||
VFQ2A11B | C112810 | VFQ2-Limited in Kinds of Things Can Do | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Role Limitations: Are you limited in the kinds of things you can do because of your vision? | VFQ25-Self Administered Format - Limited in Kinds of Things Can Do | ||
VFQ2A12 | C112811 | VFQ2-Often Irritable Because Eyesight | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Well-Being/Distress: I am often irritable because of my eyesight. | VFQ25-Self Administered Format - Often Irritable Because of Eyesight | ||
VFQ2A13 | C112812 | VFQ2-I Don't Go Out of My Home Alone | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Dependency: I don't go out of my home alone, because of my eyesight. | VFQ25-Self Administered Format - Don't Go Out of Home Alone Because of Eyesight | ||
Back to top | ||||||
CL.C112454.VFQ2TN | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format Questionnaire Test Name
(VFQ2TN) | text
Extensible: No | C112454 | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format Questionnaire Test Name | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format test name. | CDISC Questionnaire VFQ25-Self Administered Format Test Name Terminology |
VFQ2-Accomplish Less Than You Would Like | C112791 | VFQ2-Accomplish Less Than You Would Like | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Do you accomplish less than you would like because of your vision? | VFQ25-Self Administered Format - Accomplish Less Because of Vision | ||
VFQ2-Are You Currently Driving | C112785 | VFQ2-Are You Currently Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Are you currently driving, at least once in a while? | VFQ25-Self Administered Format - Are You Currently Driving | ||
VFQ2-Difficulty Doing Work/Hobbies | C112776 | VFQ2-Difficulty Doing Work/Hobbies | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools? Would you say: | VFQ25-Self Administered Format - Difficulty Doing Work or Hobbies | ||
VFQ2-Difficulty Driving at Night | C112789 | VFQ2-Difficulty Driving at Night | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have driving at night? Would you say you have: | VFQ25-Self Administered Format - Difficulty Driving at Night | ||
VFQ2-Difficulty Driving During Daytime | C112788 | VFQ2-Difficulty Driving During Daytime | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If currently driving: How much difficulty do you have driving during the daytime in familiar places? Would you say you have: | VFQ25-Self Administered Format - Difficulty Driving During Daytime | ||
VFQ2-Difficulty Entertaining Friends | C112808 | VFQ2-Difficulty Entertaining Friends | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Social Function: Because of your eyesight, how much difficulty do you have entertaining friends and family in your home? | VFQ25-Self Administered Format - Difficulty Entertaining Friends and Family in Home | ||
VFQ2-Difficulty Figure Out Bill Accuracy | C112803 | VFQ2-Difficulty Figure Out Bill Accuracy | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have figuring out whether bills you receive are accurate? | VFQ25-Self Administered Format - Difficulty Figure Out Bill Accuracy | ||
VFQ2-Difficulty Finding on Crowded Shelf | C112777 | VFQ2-Difficulty Finding on Crowded Shelf | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have finding something on a crowded shelf? | VFQ25-Self Administered Format - Difficulty Finding Something On a Shelf | ||
VFQ2-Difficulty Going Down Step at Night | C112779 | VFQ2-Difficulty Going Down Step at Night | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night? | VFQ25-Self Administered Format - Difficulty Going Down Steps at Night | ||
VFQ2-Difficulty Going Out to See Movies | C112784 | VFQ2-Difficulty Going Out to See Movies | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events? | VFQ25-Self Administered Format - Difficulty Going Out to See Movies | ||
VFQ2-Difficulty Noticing Objects to Side | C112780 | VFQ2-Difficulty Noticing Objects to Side | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have noticing objects off to the side while you are walking along? | VFQ25-Self Administered Format - Difficulty Noticing Objects Off to the Side While Walking | ||
VFQ2-Difficulty Picking Out Own Clothes | C112782 | VFQ2-Difficulty Picking Out Own Clothes | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have picking out and matching your own clothes? | VFQ25-Self Administered Format - Difficulty Picking Out and Matching Own Clothes | ||
VFQ2-Difficulty Reading Newspapers | C112775 | VFQ2-Difficulty Reading Newspapers | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have reading ordinary print in newspapers? Would you say you have: | VFQ25-Self Administered Format - Difficulty Reading Ordinary Print in Newspapers | ||
VFQ2-Difficulty Reading Small Print | C112802 | VFQ2-Difficulty Reading Small Print | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Wearing glasses, how much difficulty do you have reading the small print in a telephone book, on a medicine bottle, or on legal forms? Would you say: | VFQ25-Self Administered Format - Difficulty Reading Small Print | ||
VFQ2-Difficulty Reading Street Signs | C112778 | VFQ2-Difficulty Reading Street Signs | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have reading street signs or the names of stores? | VFQ25-Self Administered Format - Difficulty Reading Street Signs | ||
VFQ2-Difficulty Recognizing People | C112805 | VFQ2-Difficulty Recognizing People | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have recognizing people you know from across a room? | VFQ25-Self Administered Format - Difficulty Recognizing People You Know | ||
VFQ2-Difficulty Seeing How People React | C112781 | VFQ2-Difficulty Seeing How People React | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have seeing how people react to things you say? | VFQ25-Self Administered Format - Difficulty Seeing How People React | ||
VFQ2-Difficulty Seeing Programs on TV | C112807 | VFQ2-Difficulty Seeing Programs on TV | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have seeing and enjoying programs on TV? | VFQ25-Self Administered Format - Difficulty Seeing and Enjoying Programs on TV | ||
VFQ2-Difficulty Shaving or Styling Hair | C112804 | VFQ2-Difficulty Shaving or Styling Hair | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Near Vision: Because of your eyesight, how much difficulty do you have doing things like shaving, styling your hair, or putting on makeup? | VFQ25-Self Administered Format - Difficulty Shaving or Styling Hair or Putting On Makeup | ||
VFQ2-Difficulty Taking Part in Sports | C112806 | VFQ2-Difficulty Taking Part in Sports | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Distance Vision: Because of your eyesight, how much difficulty do you have taking part in active sports or other outdoor activities that you enjoy (like golf, bowling, jogging, or walking)? | VFQ25-Self Administered Format - Difficulty Taking Part in Sports or Outdoor Activities | ||
VFQ2-Difficulty Visiting With People | C112783 | VFQ2-Difficulty Visiting With People | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: Because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants? | VFQ25-Self Administered Format - Difficulty Visiting People | ||
VFQ2-Do You Have More Help From Others | C112809 | VFQ2-Do You Have More Help From Others | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Role Limitations: Do you have more help from others because of your vision? | VFQ25-Self Administered Format - Do You Have More Help From Others | ||
VFQ2-Driving in Difficult Conditions | C112790 | VFQ2-Driving in Difficult Conditions | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: How much difficulty do you have driving in difficult conditions, such as in bad weather, during rush hour, on the freeway, or in city traffic? Would you say you have: | VFQ25-Self Administered Format - Driving in Difficult Condition | ||
VFQ2-Eye Pain Keep From Doing What Like | C112793 | VFQ2-Eye Pain Keep From Doing What Like | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: How much does pain or discomfort in or around your eyes, for example, burning, itching, or aching, keep you from doing what you'd like to be doing? Would you say: | VFQ25-Self Administered Format - Pain in Eyes Keep You From Doing What You Like | ||
VFQ2-Eyesight Using Both Eyes Is | C112772 | VFQ2-Eyesight Using Both Eyes Is | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: At the present time, would you say your eyesight using both eyes (with glasses or contact lenses, if you wear them) is excellent, good, fair, poor, or very poor or are you completely blind? | VFQ25-Self Administered Format - Eyesight Using Both Eyes | ||
VFQ2-How Much Pain in and Around Eyes | C112774 | VFQ2-How Much Pain in and Around Eyes | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: How much pain or discomfort have you had in and around your eyes (for example, burning, itching, or aching)? Would you say it is: | VFQ25-Self Administered Format - Pain or Discomfort You Had in and Around Eyes | ||
VFQ2-How Often You Worry About Eyesight | C112773 | VFQ2-How Often You Worry About Eyesight | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: How much of the time do you worry about your eyesight? | VFQ25-Self Administered Format - Time Spent Worry About Eyesight | ||
VFQ2-I Don't Go Out of My Home Alone | C112812 | VFQ2-I Don't Go Out of My Home Alone | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Dependency: I don't go out of my home alone, because of my eyesight. | VFQ25-Self Administered Format - Don't Go Out of Home Alone Because of Eyesight | ||
VFQ2-I Feel Frustrated a Lot of the Time | C112795 | VFQ2-I Feel Frustrated a Lot of the Time | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I feel frustrated a lot of the time because of my eyesight. | VFQ25-Self Administered Format - Feel Frustrated Because of Eyesight | ||
VFQ2-I Need a Lot of Help From Others | C112798 | VFQ2-I Need a Lot of Help From Others | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I need a lot of help from others because of my eyesight. | VFQ25-Self Administered Format - Need Help From Others Because of Eyesight | ||
VFQ2-I Stay Home Most of the Time | C112794 | VFQ2-I Stay Home Most of the Time | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I stay home most of the time because of my eyesight. | VFQ25-Self Administered Format - Stay Home Because of Eyesight | ||
VFQ2-Limited in How Long You Can Work | C112792 | VFQ2-Limited in How Long You Can Work | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Are you limited in how long you can work or do other activities because of your vision? | VFQ25-Self Administered Format - Limited in How Long You Can Work Because of Vision | ||
VFQ2-Limited in Kinds of Things Can Do | C112810 | VFQ2-Limited in Kinds of Things Can Do | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Role Limitations: Are you limited in the kinds of things you can do because of your vision? | VFQ25-Self Administered Format - Limited in Kinds of Things Can Do | ||
VFQ2-Main Reason You Gave Up Driving | C112787 | VFQ2-Main Reason You Gave Up Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If you gave up driving: Was that mainly because of your eyesight, mainly for some other reason, or because of both your eyesight and other reasons? | VFQ25-Self Administered Format - Main Reason You Gave Up Driving | ||
VFQ2-Much Less Control Over What I Do | C112796 | VFQ2-Much Less Control Over What I Do | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I have much less control over what I do, because of my eyesight. | VFQ25-Self Administered Format - Have Less Control Because of Eyesight | ||
VFQ2-Never Driven or Given Up Driving | C112786 | VFQ2-Never Driven or Given Up Driving | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Difficulty With Activities: If no: Have you never driven a car or have you given up driving? | VFQ25-Self Administered Format - Never Driven or Given Up Driving | ||
VFQ2-Often Irritable Because Eyesight | C112811 | VFQ2-Often Irritable Because Eyesight | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Well-Being/Distress: I am often irritable because of my eyesight. | VFQ25-Self Administered Format - Often Irritable Because of Eyesight | ||
VFQ2-Rate Your Eyesight Now | C112801 | VFQ2-Rate Your Eyesight Now | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Vision: How would you rate your eyesight now (with glasses or contact lens on, if you wear them), on a scale of from 0 to 10, where zero means the worst possible eyesight, as bad or worse than being blind, and 10 means the best possible eyesight? | VFQ25-Self Administered Format - Rate Your Eyesight Now | ||
VFQ2-Rate Your Overall Health | C112800 | VFQ2-Rate Your Overall Health | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health: How would you rate your overall health, on a scale where zero is as bad as death and 10 is best possible health? | VFQ25-Self Administered Format - Rate Your Overall Health | ||
VFQ2-Rely Too Much on What Others Tell | C112797 | VFQ2-Rely Too Much on What Others Tell | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: Because of my eyesight, I have to rely too much on what other people tell me. | VFQ25-Self Administered Format - Have to Rely On Other People Because of Eyesight | ||
VFQ2-Worry I'll Do Embarrassing Things | C112799 | VFQ2-Worry I'll Do Embarrassing Things | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - Responses to Vision Problems: I worry about doing things that will embarrass myself or others, because of my eyesight. | VFQ25-Self Administered Format - Worry About Embarrass Myself or Others Because of Eyesight | ||
VFQ2-Your Overall Health Is | C112771 | VFQ2-Your Overall Health Is | National Eye Institute Visual Functioning Questionnaire - 25 Version 2000 Self-Administered Format - General Health and Vision: In general, would you say your overall health is: | VFQ25-Self Administered Format - Overall Health | ||
Back to top | ||||||
CL.C120993.NSA01TC | Negative Symptom Assessment-16 Clinical Classification Test Code
(NSA01TC) | text
Extensible: No | C120993 | Negative Symptom Assessment-16 Clinical Classification Test Code | Negative Symptom Assessment-16 test code. | CDISC Clinical Classification NSA-16 Test Code Terminology |
NSA0101 | C121077 | NSA01-Prolonged Time to Respond | Negative Symptom Assessment-16 - Prolonged time to respond. | NSA-16 - Prolonged Time to Respond | ||
NSA0102 | C121078 | NSA01-Restricted Speech Quantity | Negative Symptom Assessment-16 - Restricted speech quantity. | NSA-16 - Restricted Speech Quantity | ||
NSA0103 | C121079 | NSA01-Impoverished Speech Content | Negative Symptom Assessment-16 - Impoverished speech content. | NSA-16 - Impoverished Speech Content | ||
NSA0104 | C121080 | NSA01-Inarticulate Speech | Negative Symptom Assessment-16 - Inarticulate speech. | NSA-16 - Inarticulate Speech | ||
NSA0105 | C121081 | NSA01-Emotion: Reduced Range | Negative Symptom Assessment-16 - Emotion: Reduced range. | NSA-16 - Emotion: Reduced Range | ||
NSA0106 | C121082 | NSA01-Affect Reduce Modulation Intensity | Negative Symptom Assessment-16 - Affect: Reduced modulation of intensity. | NSA-16 - Affect: Reduce Modulation Intensity | ||
NSA0107 | C121083 | NSA01-Affect: Reduced Display on Demand | Negative Symptom Assessment-16 - Affect: Reduced display on demand. | NSA-16 - Affect: Reduced Display on Demand | ||
NSA0108 | C121084 | NSA01-Reduced Social Drive | Negative Symptom Assessment-16 - Reduced social drive. | NSA-16 - Reduced Social Drive | ||
NSA0109 | C121085 | NSA01-Poor Rapport With Interviewer | Negative Symptom Assessment-16 - Poor rapport with interviewer. | NSA-16 - Poor Rapport With Interviewer | ||
NSA0110 | C121086 | NSA01-Interest Emotional/Phys Intimacy | Negative Symptom Assessment-16 - Interest in emotional and physical intimacy. | NSA-16 - Interest in Emotional and Physical Intimacy | ||
NSA0111 | C121087 | NSA01-Poor Grooming and Hygiene | Negative Symptom Assessment-16 - Poor grooming and hygiene. | NSA-16 - Poor Grooming and Hygiene | ||
NSA0112 | C121088 | NSA01-Reduced Sense of Purpose | Negative Symptom Assessment-16 - Reduced sense of purpose. | NSA-16 - Reduced Sense of Purpose | ||
NSA0113 | C121089 | NSA01-Reduced Interests | Negative Symptom Assessment-16 - Reduced interests. | NSA-16 - Reduced Interests | ||
NSA0114 | C121090 | NSA01-Reduced Daily Activity | Negative Symptom Assessment-16 - Reduced daily activity. | NSA-16 - Reduced Daily Activity | ||
NSA0115 | C121091 | NSA01-Reduced Expressive Gestures | Negative Symptom Assessment-16 - Reduced expressive gestures. | NSA-16 - Reduced Expressive Gestures | ||
NSA0116 | C121092 | NSA01-Slowed Movements | Negative Symptom Assessment-16 - Slowed movements. | NSA-16 - Slowed Movements | ||
NSA0117 | C121093 | NSA01-Global Negative Symptoms Rating | Negative Symptom Assessment-16 - Global negative symptoms rating. | NSA-16 - Global Negative Symptoms Rating | ||
NSA0118 | C121094 | NSA01-Global Neg Symptom Rating-Severity | Negative Symptom Assessment-16 - Global negative symptoms rating - severity. | NSA-16 - Global Negative Symptoms Rating-Severity | ||
NSA0119 | C121095 | NSA01-Global Level of Functioning | Negative Symptom Assessment-16 - Global level of functioning. | NSA-16 - Global Level of Functioning | ||
Back to top | ||||||
CL.C120992.NSA01TN | Negative Symptom Assessment-16 Clinical Classification Test Name
(NSA01TN) | text
Extensible: No | C120992 | Negative Symptom Assessment-16 Clinical Classification Test Name | Negative Symptom Assessment-16 test name. | CDISC Clinical Classification NSA-16 Test Name Terminology |
NSA01-Affect Reduce Modulation Intensity | C121082 | NSA01-Affect Reduce Modulation Intensity | Negative Symptom Assessment-16 - Affect: Reduced modulation of intensity. | NSA-16 - Affect: Reduce Modulation Intensity | ||
NSA01-Affect: Reduced Display on Demand | C121083 | NSA01-Affect: Reduced Display on Demand | Negative Symptom Assessment-16 - Affect: Reduced display on demand. | NSA-16 - Affect: Reduced Display on Demand | ||
NSA01-Emotion: Reduced Range | C121081 | NSA01-Emotion: Reduced Range | Negative Symptom Assessment-16 - Emotion: Reduced range. | NSA-16 - Emotion: Reduced Range | ||
NSA01-Global Level of Functioning | C121095 | NSA01-Global Level of Functioning | Negative Symptom Assessment-16 - Global level of functioning. | NSA-16 - Global Level of Functioning | ||
NSA01-Global Neg Symptom Rating-Severity | C121094 | NSA01-Global Neg Symptom Rating-Severity | Negative Symptom Assessment-16 - Global negative symptoms rating - severity. | NSA-16 - Global Negative Symptoms Rating-Severity | ||
NSA01-Global Negative Symptoms Rating | C121093 | NSA01-Global Negative Symptoms Rating | Negative Symptom Assessment-16 - Global negative symptoms rating. | NSA-16 - Global Negative Symptoms Rating | ||
NSA01-Impoverished Speech Content | C121079 | NSA01-Impoverished Speech Content | Negative Symptom Assessment-16 - Impoverished speech content. | NSA-16 - Impoverished Speech Content | ||
NSA01-Inarticulate Speech | C121080 | NSA01-Inarticulate Speech | Negative Symptom Assessment-16 - Inarticulate speech. | NSA-16 - Inarticulate Speech | ||
NSA01-Interest Emotional/Phys Intimacy | C121086 | NSA01-Interest Emotional/Phys Intimacy | Negative Symptom Assessment-16 - Interest in emotional and physical intimacy. | NSA-16 - Interest in Emotional and Physical Intimacy | ||
NSA01-Poor Grooming and Hygiene | C121087 | NSA01-Poor Grooming and Hygiene | Negative Symptom Assessment-16 - Poor grooming and hygiene. | NSA-16 - Poor Grooming and Hygiene | ||
NSA01-Poor Rapport With Interviewer | C121085 | NSA01-Poor Rapport With Interviewer | Negative Symptom Assessment-16 - Poor rapport with interviewer. | NSA-16 - Poor Rapport With Interviewer | ||
NSA01-Prolonged Time to Respond | C121077 | NSA01-Prolonged Time to Respond | Negative Symptom Assessment-16 - Prolonged time to respond. | NSA-16 - Prolonged Time to Respond | ||
NSA01-Reduced Daily Activity | C121090 | NSA01-Reduced Daily Activity | Negative Symptom Assessment-16 - Reduced daily activity. | NSA-16 - Reduced Daily Activity | ||
NSA01-Reduced Expressive Gestures | C121091 | NSA01-Reduced Expressive Gestures | Negative Symptom Assessment-16 - Reduced expressive gestures. | NSA-16 - Reduced Expressive Gestures | ||
NSA01-Reduced Interests | C121089 | NSA01-Reduced Interests | Negative Symptom Assessment-16 - Reduced interests. | NSA-16 - Reduced Interests | ||
NSA01-Reduced Sense of Purpose | C121088 | NSA01-Reduced Sense of Purpose | Negative Symptom Assessment-16 - Reduced sense of purpose. | NSA-16 - Reduced Sense of Purpose | ||
NSA01-Reduced Social Drive | C121084 | NSA01-Reduced Social Drive | Negative Symptom Assessment-16 - Reduced social drive. | NSA-16 - Reduced Social Drive | ||
NSA01-Restricted Speech Quantity | C121078 | NSA01-Restricted Speech Quantity | Negative Symptom Assessment-16 - Restricted speech quantity. | NSA-16 - Restricted Speech Quantity | ||
NSA01-Slowed Movements | C121092 | NSA01-Slowed Movements | Negative Symptom Assessment-16 - Slowed movements. | NSA-16 - Slowed Movements | ||
Back to top | ||||||
CL.C116104.NVTESTCD | Nervous System Findings Test Code
(NVTESTCD) | text
Extensible: Yes | C116104 | Nervous System Findings Test Code | Terminology relevant to the test codes that describe nervous system physiology findings. | CDISC SDTM Nervous System Physiology Test Code Terminology |
ABRIAL | C181572 | ABR Wave I, Absolute Latency;Auditory Brainstem Response Wave I, Absolute Latency | A measurement of the absolute latency of the auditory brainstem response wave I of the auditory evoked potential waveform. | Auditory Brainstem Response Wave I, Absolute Latency | ||
ABRVA | C181574 | ABR Wave V, Amplitude;Auditory Brainstem Response Wave V, Amplitude | A measurement of the magnitude, or height, of the auditory brainstem response wave V of the auditory evoked potential waveform. | Auditory Brainstem Response Wave V, Amplitude | ||
ABRVAL | C181573 | ABR Wave V, Absolute Latency;Auditory Brainstem Response Wave V, Absolute Latency | A measurement of the absolute latency of the auditory brainstem response wave V of the auditory evoked potential waveform. | Auditory Brainstem Response Wave V, Absolute Latency | ||
ABRVP | C181575 | ABR Wave V, Presence;Auditory Brainstem Response Wave V, Presence | An assessment of the presence of the auditory brainstem response wave V of the auditory evoked potential waveform. | Auditory Brainstem Response Wave V, Presence | ||
ATNRFX | C81324 | Asymmetric Tonic Neck Reflex;ATNR | An involuntary, primal response in the neonate in which the arm extends to follow the infant's gaze, while the opposing arm and leg flex inward. | Tonic Neck Reflex | ||
BLDFLRT | C94866 | Blood Flow Rate | The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. | Blood Flow Rate | ||
BRADYKIN | C187952 | Bradykinesia | An evaluation of bradykinesia (slow movement). | Bradykinesia Evaluation | ||
BSI | C114183 | Boundary Shift Integral | A measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time. | Boundary Shift Integral | ||
CTNPCTN | C158260 | Creatine+Phosphocreatine | A measurement of the creatine plus phosphocreatine in a biological specimen. | Creatine and Phosphocreatine Measurement | ||
DYSESTHE | C187956 | Dysesthesia | An evaluation of dysesthesia (distortion of a sense resulting in an abnormal and unpleasant sensation, usually described as burning, tingling, or numbness). | Dysesthesia Evaluation | ||
DYSTONIA | C187957 | Dystonia | An evaluation of dystonia (a movement disorder characterized by sustained or intermittent muscle contractions, resulting in abnormal movements and/or postures). | Dystonia Evaluation | ||
FCGPCPC | C158259 | Choline, Free + Glycerophosphorylcholine + Phosphorylcholine;Choline, Free+GPC+PCh | A measurement of the free choline plus glycerophosphorylcholine (GCP) plus phosphorylcholine (PCh) in a biological specimen. | Free Choline and Glycerophosphorylcholine and Phosphorylcholine Measurement | ||
GLMC4GLM | C187954 | Glutamate C4 Enriched/Glutamate | A relative measurement (ratio or percentage) of the C4 enriched glutamate to total glutamate in a biological specimen. | C4 Enriched Glutamate to Total Glutamate Ratio Measurement | ||
GLN | C122121 | Glutamine | A measurement of the glutamine in a biological specimen. | Glutamine Measurement | ||
GLNC4GLN | C187955 | Glutamine C4 Enriched/Glutamine | A relative measurement (ratio or percentage) of the C4 enriched glutamine to total glutamine in a biological specimen. | C4 Enriched Glutamine to Total Glutamine Ratio Measurement | ||
GLNTRFX | C191341 | Galant Reflex | An involuntary, primal response in the neonate in which a finger is run down one side of the spine and the neonate laterally flexes toward that side. | Galant Reflex | ||
GLUTAM | C74739 | Glutamate;Glutamic Acid | A measurement of the glutamate in a biological specimen. | Glutamate Measurement | ||
GLX | C156563 | Glutamate and Glutamine | A measurement of the glutamate and glutamine in a biological specimen. | Glutamate and Glutamine Measurement | ||
GLXC3GLX | C187953 | Glutamate and Glutamine C3 Enriched/Glutamate and Glutamine;Glutamate and Glutamine C3 Enriched/GLX | A relative measurement (ratio or percentage) of the C3 enriched glutamate and glutamine to total glutamate and glutamine in a biological specimen. | C3 Enriched Glutamate and Glutamine to Total Glutamate and Glutamine Ratio Measurement | ||
GPCPC | C158261 | Glycerophosphorylcholine + Phosphorylcholine;GPC+PCh | A measurement of the glycerophosphorylcholine (GPC) plus phosphorylcholine (PC) in a biological specimen. | Glycerophosphorylcholine and Phosphorylcholine Measurement | ||
GRAESTHE | C187958 | Graphesthesia | An evaluation of graphesthesia (the ability to recognize symbols when they're traced on the skin). | Graphesthesia Evaluation | ||
INOSM | C156562 | mI;Myo-Inositol | A measurement of the myo-inositol in a biological specimen. | Myo-Inositol Measurement | ||
MORORFX | C81311 | Moro Reflex | An involuntary, primal response in the neonate to loud noise or the feeling of falling. The response is characterized by the infant's arms symmetrically spreading out to the side and then back to the midline, and involuntarily flexing the fingers and toes. | Moro Reflex | ||
MUSCRIG | C187959 | Muscular Rigidity | An evaluation of muscular rigidity (an involuntary, persistent state of firm, tense muscles with marked resistance to passive movement). | Muscular Rigidity Evaluation | ||
N145LAT | C117886 | N145 Latency | An assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform. | N145 Latency | ||
N1SLPDUR | C154868 | N1 Sleep Duration;Stage 1 Sleep Duration | The length of time of N1 sleep. | N1 Sleep Phase Duration | ||
N1SLPTST | C156555 | N1 Sleep/Total Sleep Time | A relative measurement (percentage) of the N1 sleep time to total sleep time. | N1 Sleep to Total Sleep Time Ratio Measurement | ||
N2SLPDUR | C154869 | N2 Sleep Duration;Stage 2 Sleep Duration | The length of time of N2 sleep. | N2 Sleep Phase Duration | ||
N2SLPTST | C156556 | N2 Sleep/Total Sleep Time | A relative measurement (percentage) of the N2 sleep time to total sleep time. | N2 Sleep to Total Sleep Time Ratio Measurement | ||
N3SLPDUR | C154870 | N3 Sleep Duration;Stage 3 Sleep Duration | The length of time of N3 sleep. | N3 Sleep Phase Duration | ||
N3SLPTST | C156557 | N3 Sleep/Total Sleep Time | A relative measurement (percentage) of the N3 sleep time to total sleep time. | N3 Sleep to Total Sleep Time Ratio Measurement | ||
N75LAT | C130185 | N1 Latency;N75 Latency | An assessment of the latency of the N75 or N1 wave of the visual evoked potential assessment waveform. | N75 Latency | ||
NAA | C156561 | N-Acetyl Aspartate | A measurement of the N-acetyl aspartate in a biological specimen. | N-Acetyl Aspartate Measurement | ||
NAANAAG | C158258 | N-acetylaspartate + N-acetyl-aspartylglutamate;NAA+NAAG | A measurement of the N-acetylaspartate plus N-acetyl-aspartylglutamate in a biological specimen. | N-acetylaspartate and N-acetyl-aspartylglutamate Measurement | ||
NVEXAM | C81313 | Nervous System Examination | An observation, assessment or examination of the nervous system. | Neurologic Examination | ||
P100AMP | C117887 | P100 Amplitude | The magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak. | N75 to P100 Peak to Peak Amplitude | ||
P100LAT | C117888 | P100 Latency | An assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform. | P100 Latency | ||
PEAKRA | C156559 | Peak Response Amplitude | The maximum height change between the wave and the equilibrium point of a stimulus-response waveform. | Peak Response Amplitude | ||
PEAKRAL | C156560 | Peak Response Amplitude Latency | A measurement of the time interval between a stimulus and the maximal response. | Peak Response Amplitude Latency | ||
PLMGRRFX | C81254 | Palmar Grasp Reflex | An involuntary, primal response in the neonate to grasp the fingers when their palm is touched. This reflex is present until six months of age. | Grasp Reflex | ||
PLTGRRFX | C110939 | Plantar Grasp Reflex | An involuntary, primal response in the neonate that is characterized by flexion of the toes when the sole of the foot is stroked. | Plantar Grasp Reflex | ||
REMDUR | C154871 | REM Duration | The total amount of time an individual spends in rapid eye movement (REM) sleep. | Rapid Eye Movement Sleep Phase Duration | ||
REMLAT | C154872 | REM Latency | The time between the onset of sleep and the onset of the first rapid eye movement (REM) cycle. | Rapid Eye Movement Sleep Phase Latency | ||
REMTST | C156558 | REM/Total Sleep Time | A relative measurement (percentage) of the rapid eye movement (REM) sleep time to total sleep time. | REM to Total Sleep Time Ratio Measurement | ||
ROOTRFX | C81320 | Rooting Reflex | An involuntary, primal response in the neonate to search for the nipple when the cheek is touched. | Rooting Reflex | ||
SE | C156553 | Sleep Efficiency | A relative measurement (percentage) of the total sleep time (N1 sleep + N2 sleep + N3 sleep + REM sleep) to the total time spent in bed. | Sleep Efficiency | ||
SKNCUDNC | C154866 | Skin Conductance | The degree to which the skin can conduct electricity. | Skin Conductance | ||
SOL | C154867 | Sleep Onset Latency | The duration of time between when the lights are turned off and when the individual falls asleep. | Sleep Onset Latency | ||
STEPRFX | C81322 | Stepping Reflex | An involuntary, primal response in the neonate to take brisk steps when the feet are placed on a surface whilst in a supported standing position. | Step Reflex | ||
SUCKRFX | C81323 | Sucking Reflex | An involuntary, primal response in the neonate when a nipple is placed on an infant's lips. | Sucking Reflex | ||
SUV | C69310 | Standard Uptake Value | The ratio between the tissue radioactivity concentration at a point in time C(T) and the injected dose of radioactivity per kilogram of the patient's body weight. | Standardized Uptake Value | ||
SUVR | C116141 | Standard Uptake Value Ratio | The ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region. | Standard Uptake Value Ratio | ||
THICK | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
TREMOR | C187960 | Tremor | An evaluation of tremor (the shaking movement of the whole body or just a certain part of it, often caused by problems of the neurons responsible for muscle action). | Tremor Evaluation | ||
TST | C156552 | Total Sleep Time | The total amount of sleep time from sleep onset to sleep offset, determined by summing the N1 sleep, N2 sleep, N3 sleep, and REM sleep durations. | Total Sleep Time | ||
VOLUME | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
WASO | C156554 | Awake After Sleep Onset;Wake After Sleep Onset;Wake Time After Sleep Onset | A measurement of the sum of durations of wakefulness episodes throughout the night, not including the wakefulness before sleep onset. | Wake After Sleep Onset | ||
Back to top | ||||||
CL.C116103.NVTEST | Nervous System Findings Test Name
(NVTEST) | text
Extensible: Yes | C116103 | Nervous System Findings Test Name | Terminology relevant to the test names that describe nervous system physiology findings. | CDISC SDTM Nervous System Physiology Test Name Terminology |
ABR Wave I, Absolute Latency | C181572 | ABR Wave I, Absolute Latency;Auditory Brainstem Response Wave I, Absolute Latency | A measurement of the absolute latency of the auditory brainstem response wave I of the auditory evoked potential waveform. | Auditory Brainstem Response Wave I, Absolute Latency | ||
ABR Wave V, Absolute Latency | C181573 | ABR Wave V, Absolute Latency;Auditory Brainstem Response Wave V, Absolute Latency | A measurement of the absolute latency of the auditory brainstem response wave V of the auditory evoked potential waveform. | Auditory Brainstem Response Wave V, Absolute Latency | ||
ABR Wave V, Amplitude | C181574 | ABR Wave V, Amplitude;Auditory Brainstem Response Wave V, Amplitude | A measurement of the magnitude, or height, of the auditory brainstem response wave V of the auditory evoked potential waveform. | Auditory Brainstem Response Wave V, Amplitude | ||
ABR Wave V, Presence | C181575 | ABR Wave V, Presence;Auditory Brainstem Response Wave V, Presence | An assessment of the presence of the auditory brainstem response wave V of the auditory evoked potential waveform. | Auditory Brainstem Response Wave V, Presence | ||
Asymmetric Tonic Neck Reflex | C81324 | Asymmetric Tonic Neck Reflex;ATNR | An involuntary, primal response in the neonate in which the arm extends to follow the infant's gaze, while the opposing arm and leg flex inward. | Tonic Neck Reflex | ||
Blood Flow Rate | C94866 | Blood Flow Rate | The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. | Blood Flow Rate | ||
Boundary Shift Integral | C114183 | Boundary Shift Integral | A measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time. | Boundary Shift Integral | ||
Bradykinesia | C187952 | Bradykinesia | An evaluation of bradykinesia (slow movement). | Bradykinesia Evaluation | ||
Choline, Free+GPC+PCh | C158259 | Choline, Free + Glycerophosphorylcholine + Phosphorylcholine;Choline, Free+GPC+PCh | A measurement of the free choline plus glycerophosphorylcholine (GCP) plus phosphorylcholine (PCh) in a biological specimen. | Free Choline and Glycerophosphorylcholine and Phosphorylcholine Measurement | ||
Creatine+Phosphocreatine | C158260 | Creatine+Phosphocreatine | A measurement of the creatine plus phosphocreatine in a biological specimen. | Creatine and Phosphocreatine Measurement | ||
Dysesthesia | C187956 | Dysesthesia | An evaluation of dysesthesia (distortion of a sense resulting in an abnormal and unpleasant sensation, usually described as burning, tingling, or numbness). | Dysesthesia Evaluation | ||
Dystonia | C187957 | Dystonia | An evaluation of dystonia (a movement disorder characterized by sustained or intermittent muscle contractions, resulting in abnormal movements and/or postures). | Dystonia Evaluation | ||
Galant Reflex | C191341 | Galant Reflex | An involuntary, primal response in the neonate in which a finger is run down one side of the spine and the neonate laterally flexes toward that side. | Galant Reflex | ||
Glutamate and Glutamine C3 Enriched/GLX | C187953 | Glutamate and Glutamine C3 Enriched/Glutamate and Glutamine;Glutamate and Glutamine C3 Enriched/GLX | A relative measurement (ratio or percentage) of the C3 enriched glutamate and glutamine to total glutamate and glutamine in a biological specimen. | C3 Enriched Glutamate and Glutamine to Total Glutamate and Glutamine Ratio Measurement | ||
Glutamate and Glutamine | C156563 | Glutamate and Glutamine | A measurement of the glutamate and glutamine in a biological specimen. | Glutamate and Glutamine Measurement | ||
Glutamate C4 Enriched/Glutamate | C187954 | Glutamate C4 Enriched/Glutamate | A relative measurement (ratio or percentage) of the C4 enriched glutamate to total glutamate in a biological specimen. | C4 Enriched Glutamate to Total Glutamate Ratio Measurement | ||
Glutamate | C74739 | Glutamate;Glutamic Acid | A measurement of the glutamate in a biological specimen. | Glutamate Measurement | ||
Glutamine C4 Enriched/Glutamine | C187955 | Glutamine C4 Enriched/Glutamine | A relative measurement (ratio or percentage) of the C4 enriched glutamine to total glutamine in a biological specimen. | C4 Enriched Glutamine to Total Glutamine Ratio Measurement | ||
Glutamine | C122121 | Glutamine | A measurement of the glutamine in a biological specimen. | Glutamine Measurement | ||
GPC+PCh | C158261 | Glycerophosphorylcholine + Phosphorylcholine;GPC+PCh | A measurement of the glycerophosphorylcholine (GPC) plus phosphorylcholine (PC) in a biological specimen. | Glycerophosphorylcholine and Phosphorylcholine Measurement | ||
Graphesthesia | C187958 | Graphesthesia | An evaluation of graphesthesia (the ability to recognize symbols when they're traced on the skin). | Graphesthesia Evaluation | ||
Moro Reflex | C81311 | Moro Reflex | An involuntary, primal response in the neonate to loud noise or the feeling of falling. The response is characterized by the infant's arms symmetrically spreading out to the side and then back to the midline, and involuntarily flexing the fingers and toes. | Moro Reflex | ||
Muscular Rigidity | C187959 | Muscular Rigidity | An evaluation of muscular rigidity (an involuntary, persistent state of firm, tense muscles with marked resistance to passive movement). | Muscular Rigidity Evaluation | ||
Myo-Inositol | C156562 | mI;Myo-Inositol | A measurement of the myo-inositol in a biological specimen. | Myo-Inositol Measurement | ||
N-Acetyl Aspartate | C156561 | N-Acetyl Aspartate | A measurement of the N-acetyl aspartate in a biological specimen. | N-Acetyl Aspartate Measurement | ||
N1 Sleep Duration | C154868 | N1 Sleep Duration;Stage 1 Sleep Duration | The length of time of N1 sleep. | N1 Sleep Phase Duration | ||
N1 Sleep/Total Sleep Time | C156555 | N1 Sleep/Total Sleep Time | A relative measurement (percentage) of the N1 sleep time to total sleep time. | N1 Sleep to Total Sleep Time Ratio Measurement | ||
N145 Latency | C117886 | N145 Latency | An assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform. | N145 Latency | ||
N2 Sleep Duration | C154869 | N2 Sleep Duration;Stage 2 Sleep Duration | The length of time of N2 sleep. | N2 Sleep Phase Duration | ||
N2 Sleep/Total Sleep Time | C156556 | N2 Sleep/Total Sleep Time | A relative measurement (percentage) of the N2 sleep time to total sleep time. | N2 Sleep to Total Sleep Time Ratio Measurement | ||
N3 Sleep Duration | C154870 | N3 Sleep Duration;Stage 3 Sleep Duration | The length of time of N3 sleep. | N3 Sleep Phase Duration | ||
N3 Sleep/Total Sleep Time | C156557 | N3 Sleep/Total Sleep Time | A relative measurement (percentage) of the N3 sleep time to total sleep time. | N3 Sleep to Total Sleep Time Ratio Measurement | ||
N75 Latency | C130185 | N1 Latency;N75 Latency | An assessment of the latency of the N75 or N1 wave of the visual evoked potential assessment waveform. | N75 Latency | ||
NAA+NAAG | C158258 | N-acetylaspartate + N-acetyl-aspartylglutamate;NAA+NAAG | A measurement of the N-acetylaspartate plus N-acetyl-aspartylglutamate in a biological specimen. | N-acetylaspartate and N-acetyl-aspartylglutamate Measurement | ||
Nervous System Examination | C81313 | Nervous System Examination | An observation, assessment or examination of the nervous system. | Neurologic Examination | ||
P100 Amplitude | C117887 | P100 Amplitude | The magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak. | N75 to P100 Peak to Peak Amplitude | ||
P100 Latency | C117888 | P100 Latency | An assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform. | P100 Latency | ||
Palmar Grasp Reflex | C81254 | Palmar Grasp Reflex | An involuntary, primal response in the neonate to grasp the fingers when their palm is touched. This reflex is present until six months of age. | Grasp Reflex | ||
Peak Response Amplitude Latency | C156560 | Peak Response Amplitude Latency | A measurement of the time interval between a stimulus and the maximal response. | Peak Response Amplitude Latency | ||
Peak Response Amplitude | C156559 | Peak Response Amplitude | The maximum height change between the wave and the equilibrium point of a stimulus-response waveform. | Peak Response Amplitude | ||
Plantar Grasp Reflex | C110939 | Plantar Grasp Reflex | An involuntary, primal response in the neonate that is characterized by flexion of the toes when the sole of the foot is stroked. | Plantar Grasp Reflex | ||
REM Duration | C154871 | REM Duration | The total amount of time an individual spends in rapid eye movement (REM) sleep. | Rapid Eye Movement Sleep Phase Duration | ||
REM Latency | C154872 | REM Latency | The time between the onset of sleep and the onset of the first rapid eye movement (REM) cycle. | Rapid Eye Movement Sleep Phase Latency | ||
REM/Total Sleep Time | C156558 | REM/Total Sleep Time | A relative measurement (percentage) of the rapid eye movement (REM) sleep time to total sleep time. | REM to Total Sleep Time Ratio Measurement | ||
Rooting Reflex | C81320 | Rooting Reflex | An involuntary, primal response in the neonate to search for the nipple when the cheek is touched. | Rooting Reflex | ||
Skin Conductance | C154866 | Skin Conductance | The degree to which the skin can conduct electricity. | Skin Conductance | ||
Sleep Efficiency | C156553 | Sleep Efficiency | A relative measurement (percentage) of the total sleep time (N1 sleep + N2 sleep + N3 sleep + REM sleep) to the total time spent in bed. | Sleep Efficiency | ||
Sleep Onset Latency | C154867 | Sleep Onset Latency | The duration of time between when the lights are turned off and when the individual falls asleep. | Sleep Onset Latency | ||
Standard Uptake Value Ratio | C116141 | Standard Uptake Value Ratio | The ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region. | Standard Uptake Value Ratio | ||
Standard Uptake Value | C69310 | Standard Uptake Value | The ratio between the tissue radioactivity concentration at a point in time C(T) and the injected dose of radioactivity per kilogram of the patient's body weight. | Standardized Uptake Value | ||
Stepping Reflex | C81322 | Stepping Reflex | An involuntary, primal response in the neonate to take brisk steps when the feet are placed on a surface whilst in a supported standing position. | Step Reflex | ||
Sucking Reflex | C81323 | Sucking Reflex | An involuntary, primal response in the neonate when a nipple is placed on an infant's lips. | Sucking Reflex | ||
Thickness | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
Total Sleep Time | C156552 | Total Sleep Time | The total amount of sleep time from sleep onset to sleep offset, determined by summing the N1 sleep, N2 sleep, N3 sleep, and REM sleep durations. | Total Sleep Time | ||
Tremor | C187960 | Tremor | An evaluation of tremor (the shaking movement of the whole body or just a certain part of it, often caused by problems of the neurons responsible for muscle action). | Tremor Evaluation | ||
Volume | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
Wake After Sleep Onset | C156554 | Awake After Sleep Onset;Wake After Sleep Onset;Wake Time After Sleep Onset | A measurement of the sum of durations of wakefulness episodes throughout the night, not including the wakefulness before sleep onset. | Wake After Sleep Onset | ||
Back to top | ||||||
CL.C103473.NPS01TC | Neuropathic Pain Scale Questionnaire Test Code
(NPS01TC) | text
Extensible: No | C103473 | Neuropathic Pain Scale Questionnaire Test Code | Neuropathic Pain Scale test code. | CDISC Questionnaire NPS Test Code Terminology |
NPS0101 | C103638 | NPS01-Tell Us How Intense Your Pain Is | Neuropathic Pain Scale - Please use the scale below to tell us how intense your pain is. | NPS - Tell Us How Intense Your Pain Is | ||
NPS0102 | C103639 | NPS01-Tell Us How Sharp Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how sharp your pain feels. Words used to describe 'sharp' feelings include 'like a knife,' 'like a spike,' 'jabbing,' or 'like jolts.' | NPS - Tell Us How Sharp Your Pain Feels | ||
NPS0103 | C103640 | NPS01-Tell Us How Hot Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how hot your pain feels. Words used to describe very hot pain include 'burning' and 'on fire.' | NPS - Tell Us How Hot Your Pain Feels | ||
NPS0104 | C103641 | NPS01-Tell Us How Dull Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how dull your pain feels. Words used to describe very dull pain include 'like a dull toothache,' 'dull pain,' and 'like a bruise.' | NPS - Tell Us How Dull Your Pain Feels | ||
NPS0105 | C103642 | NPS01-Tell Us How Cold Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how cold your pain feels. Words used to describe very cold pain included 'like ice' and 'freezing.' | NPS - Tell Us How Cold Your Pain Feels | ||
NPS0106 | C103643 | NPS01-Sensitiv Skin to Light Touch/Cloth | Neuropathic Pain Scale - Please use the scale below to tell us how sensitive your skin is to light touch or clothing. Words used to describe sensitive skin include 'like sunburned skin,' and 'raw skin.' | NPS - Tell Us How Sensitive Your Skin is to Light Touch or Clothing | ||
NPS0107 | C103644 | NPS01-Tell Us How Itchy Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how itchy your pain feels. Words used to describe itchy pain include 'like poison oak' and 'like a mosquito bite.' | NPS - Tell Us How Itchy Your Pain Feels | ||
NPS0108 | C103645 | NPS01-Describe Time Quality Of Your Pain | Neuropathic Pain Scale - Which of the following best describes the time quality of your pain? Please check only one answer. | NPS - Describe the Time Quality Of Your Pain | ||
NPS0108A | C103646 | NPS01-Describe the Background Pain | Neuropathic Pain Scale - I feel a background pain all of the time and occasional flare-ups (break-through pain) some of the time. Describe the background pain. | NPS - Describe the Background Pain | ||
NPS0108B | C103647 | NPS01-Describe the Flare-up Pain | Neuropathic Pain Scale - I feel a background pain all of the time and occasional flare-ups (break-through pain) some of the time. Describe the flare-up (break-through) pain. | NPS - Describe the Flare-up Pain | ||
NPS0108C | C103648 | NPS01-Describe Single Type Pain All Time | Neuropathic Pain Scale - I feel a single type of pain all the time. Describe this pain. | NPS - Describe the Single Type of Pain All Time | ||
NPS0108D | C103649 | NPS01-Describe the Occasional Pain | Neuropathic Pain Scale - I fee a single type of pain only sometimes. Other times, I am pain free. Describe the occasional pain. | NPS - Describe the Occasional Pain | ||
NPS0109 | C103650 | NPS01-Tell How Unpleasant Your Pain Feel | Neuropathic Pain Scale - Now that you have told us the different physical aspects of your pain, the different types of sensations, we want you to tell us overall how unpleasant your pain is to you. Words used to describe very unpleasant pain include 'miserable' and intolerable.' Remember, pain can have a low intensity, buy still feel extremely unpleasant, and some kinds of pain can have a high intensity but be very tolerable. With this scale, please tell us how unpleasant your pain feels. | NPS - Tell Us Overall How Unpleasant Your Pain is to You | ||
NPS0110A | C103651 | NPS01-How Intense is Your Deep Pain | Neuropathic Pain Scale - Lastly, we want you to give us an estimate of the severity of your deep versus surface pain. We want your to rate each location of pain separately. We realize that it can be difficult to make these estimates, and most likely it will be a 'best guess,' but please give us your best estimate. How intense is your deep pain? | NPS - How Intense is Your Deep Pain | ||
NPS0110B | C103652 | NPS01-How Intense is Your Surface Pain | Neuropathic Pain Scale - Lastly, we want you to give us an estimate of the severity of your deep versus surface pain. We want your to rate each location of pain separately. We realize that it can be difficult to make these estimates, and most likely it will be a 'best guess,' but please give us your best estimate. How intense is your surface pain? | NPS - How Intense is Your Surface Pain | ||
Back to top | ||||||
CL.C103472.NPS01TN | Neuropathic Pain Scale Questionnaire Test Name
(NPS01TN) | text
Extensible: No | C103472 | Neuropathic Pain Scale Questionnaire Test Name | Neuropathic Pain Scale test name. | CDISC Questionnaire NPS Test Name Terminology |
NPS01-Describe Single Type Pain All Time | C103648 | NPS01-Describe Single Type Pain All Time | Neuropathic Pain Scale - I feel a single type of pain all the time. Describe this pain. | NPS - Describe the Single Type of Pain All Time | ||
NPS01-Describe the Background Pain | C103646 | NPS01-Describe the Background Pain | Neuropathic Pain Scale - I feel a background pain all of the time and occasional flare-ups (break-through pain) some of the time. Describe the background pain. | NPS - Describe the Background Pain | ||
NPS01-Describe the Flare-up Pain | C103647 | NPS01-Describe the Flare-up Pain | Neuropathic Pain Scale - I feel a background pain all of the time and occasional flare-ups (break-through pain) some of the time. Describe the flare-up (break-through) pain. | NPS - Describe the Flare-up Pain | ||
NPS01-Describe the Occasional Pain | C103649 | NPS01-Describe the Occasional Pain | Neuropathic Pain Scale - I fee a single type of pain only sometimes. Other times, I am pain free. Describe the occasional pain. | NPS - Describe the Occasional Pain | ||
NPS01-Describe Time Quality Of Your Pain | C103645 | NPS01-Describe Time Quality Of Your Pain | Neuropathic Pain Scale - Which of the following best describes the time quality of your pain? Please check only one answer. | NPS - Describe the Time Quality Of Your Pain | ||
NPS01-How Intense is Your Deep Pain | C103651 | NPS01-How Intense is Your Deep Pain | Neuropathic Pain Scale - Lastly, we want you to give us an estimate of the severity of your deep versus surface pain. We want your to rate each location of pain separately. We realize that it can be difficult to make these estimates, and most likely it will be a 'best guess,' but please give us your best estimate. How intense is your deep pain? | NPS - How Intense is Your Deep Pain | ||
NPS01-How Intense is Your Surface Pain | C103652 | NPS01-How Intense is Your Surface Pain | Neuropathic Pain Scale - Lastly, we want you to give us an estimate of the severity of your deep versus surface pain. We want your to rate each location of pain separately. We realize that it can be difficult to make these estimates, and most likely it will be a 'best guess,' but please give us your best estimate. How intense is your surface pain? | NPS - How Intense is Your Surface Pain | ||
NPS01-Sensitiv Skin to Light Touch/Cloth | C103643 | NPS01-Sensitiv Skin to Light Touch/Cloth | Neuropathic Pain Scale - Please use the scale below to tell us how sensitive your skin is to light touch or clothing. Words used to describe sensitive skin include 'like sunburned skin,' and 'raw skin.' | NPS - Tell Us How Sensitive Your Skin is to Light Touch or Clothing | ||
NPS01-Tell How Unpleasant Your Pain Feel | C103650 | NPS01-Tell How Unpleasant Your Pain Feel | Neuropathic Pain Scale - Now that you have told us the different physical aspects of your pain, the different types of sensations, we want you to tell us overall how unpleasant your pain is to you. Words used to describe very unpleasant pain include 'miserable' and intolerable.' Remember, pain can have a low intensity, buy still feel extremely unpleasant, and some kinds of pain can have a high intensity but be very tolerable. With this scale, please tell us how unpleasant your pain feels. | NPS - Tell Us Overall How Unpleasant Your Pain is to You | ||
NPS01-Tell Us How Cold Your Pain Feels | C103642 | NPS01-Tell Us How Cold Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how cold your pain feels. Words used to describe very cold pain included 'like ice' and 'freezing.' | NPS - Tell Us How Cold Your Pain Feels | ||
NPS01-Tell Us How Dull Your Pain Feels | C103641 | NPS01-Tell Us How Dull Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how dull your pain feels. Words used to describe very dull pain include 'like a dull toothache,' 'dull pain,' and 'like a bruise.' | NPS - Tell Us How Dull Your Pain Feels | ||
NPS01-Tell Us How Hot Your Pain Feels | C103640 | NPS01-Tell Us How Hot Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how hot your pain feels. Words used to describe very hot pain include 'burning' and 'on fire.' | NPS - Tell Us How Hot Your Pain Feels | ||
NPS01-Tell Us How Intense Your Pain Is | C103638 | NPS01-Tell Us How Intense Your Pain Is | Neuropathic Pain Scale - Please use the scale below to tell us how intense your pain is. | NPS - Tell Us How Intense Your Pain Is | ||
NPS01-Tell Us How Itchy Your Pain Feels | C103644 | NPS01-Tell Us How Itchy Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how itchy your pain feels. Words used to describe itchy pain include 'like poison oak' and 'like a mosquito bite.' | NPS - Tell Us How Itchy Your Pain Feels | ||
NPS01-Tell Us How Sharp Your Pain Feels | C103639 | NPS01-Tell Us How Sharp Your Pain Feels | Neuropathic Pain Scale - Please use the scale below to tell us how sharp your pain feels. Words used to describe 'sharp' feelings include 'like a knife,' 'like a spike,' 'jabbing,' or 'like jolts.' | NPS - Tell Us How Sharp Your Pain Feels | ||
Back to top | ||||||
CL.C100144.NPI1TC | Neuropsychiatric Inventory Questionnaire Test Code
(NPI1TC) | text
Extensible: No | C100144 | Neuropsychiatric Inventory Questionnaire Test Code | The Neuropsychiatric Inventory test code. | CDISC Questionnaire NPI Test Code Terminology |
NPI1A | C100622 | NPI1-Beliefs Untrue | Neuropsychiatric Inventory - Does the patient have beliefs that you know are not true? (for example, insisting that people are trying to harm him/her or steal from him/her)? Has he/she said that family members are not who they say they are or that the house is not their home? I'm not asking about mere suspiciousness; I am interested if the patient is convinced that these things are happening to him/her. | NPI - Have Beliefs That You Know are Not True | ||
NPI1A01 | C100623 | NPI1-In Danger | Neuropsychiatric Inventory - Does the patient believe that he/she is in danger - that others are planning to hurt him/her? | NPI - He/She is in Danger | ||
NPI1A02 | C100624 | NPI1-Others Are Stealing | Neuropsychiatric Inventory - Does the patient believe that others are stealing from him/her? | NPI - Others are Stealing From Him/Her | ||
NPI1A03 | C100625 | NPI1-Spouse Having Affair | Neuropsychiatric Inventory - Does the patient believe that his/her spouse is having an affair? | NPI - His/Her Spouse is Having an Affair | ||
NPI1A04 | C100626 | NPI1-Unwelcome Guests in House | Neuropsychiatric Inventory - Does the patient believe that unwelcome guests are living in his/her house? | NPI - Unwelcome Guests are Living in His/Her House | ||
NPI1A05 | C100627 | NPI1-People Not Who They Claim | Neuropsychiatric Inventory - Does the patient believe that his/her spouse or others are not who they claim to be? | NPI - His/Her Spouse or Others Are Not Who They Claim To Be | ||
NPI1A06 | C100628 | NPI1-House Not Their Home | Neuropsychiatric Inventory - Does the patient believe that his/her house is not his/her home? | NPI - His/Her House Is Not His/Her Home | ||
NPI1A07 | C100629 | NPI1-Family Plans to Abandon | Neuropsychiatric Inventory - Does the patient believe that family members plan to abandon him/her? | NPI - Family Members Plan to Abandon Him/Her | ||
NPI1A08 | C100630 | NPI1-TV/Magazine Figures Present | Neuropsychiatric Inventory - Does the patient believe that television or magazine figures are actually present in the home? (Does he/she try to talk or interact with them?) | NPI - Television or Magazine Figures Are Actually Present In the Home | ||
NPI1A09 | C100631 | NPI1-Other Unusual Beliefs | Neuropsychiatric Inventory - Does the patient believe any other unusual things that I haven't asked about? | NPI - Any Other Unusual Things That I Haven't Asked About | ||
NPI1A10 | C103602 | NPI1-Delusions Frequency | Neuropsychiatric Inventory - Frequency of the delusions. | NPI - Delusions Frequency | ||
NPI1A11 | C103603 | NPI1-Delusions Severity | Neuropsychiatric Inventory - Severity of the delusions. | NPI - Delusions Severity | ||
NPI1A12 | C103604 | NPI1-Delusions Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Delusions Distress | ||
NPI1AFS | C112469 | NPI1-Delusions FxS Score | Neuropsychiatric Inventory - Delusions: (frequency score x severity score). | NPI - Delusions FxS Score | ||
NPI1B | C100632 | NPI1-False Visions or Voices | Neuropsychiatric Inventory - Does the patient have hallucinations such as seeing false visions or hearing false voices? Does he/she seem to see, hear or experience things that are not present? By this question we do not mean just mistaken beliefs such as stating that someone who has died is still alive; rather we are asking if the patient actually has abnormal experiences of sounds or visions. | NPI - Hallucinations Such as Seeing False Visions or Hearing False Voices | ||
NPI1B01 | C100633 | NPI1-Hearing Voices | Neuropsychiatric Inventory - Does the patient describe hearing voices or act as if he/she hears voices? | NPI - Describe Hearing Voices or Act as if He/She Hears Voices | ||
NPI1B02 | C100634 | NPI1-Talk to People Not There | Neuropsychiatric Inventory - Does the patient talk to people who are not there? | NPI - Talk to People Who Are Not There | ||
NPI1B03 | C100635 | NPI1-See Things Not Seen by Others | Neuropsychiatric Inventory - Does the patient describe seeing things not seen by others or behave as if he/she is seeing things not seen by others (people, animals, lights, etc.)? | NPI - Describe Seeing Things Not Seen by Others | ||
NPI1B04 | C100636 | NPI1-Smell Odors Others Do Not Smell | Neuropsychiatric Inventory - Does the patient report smelling odors not smelled by others? | NPI - Report Smelling Odors Not Smelled by Others | ||
NPI1B05 | C100637 | NPI1-Feel Things on Skin | Neuropsychiatric Inventory - Does the patient describe feeling things on his/her skin or otherwise appear to be feeling things crawling or touching him/her? | NPI - Describe Feeling Things on His/Her Skin | ||
NPI1B06 | C100638 | NPI1-Taste without Known Cause | Neuropsychiatric Inventory - Does the patient describe tastes that are without any known cause? | NPI - Describe Tastes That Are Without Any Known Cause | ||
NPI1B07 | C100639 | NPI1-Other Unusual Sensory Experience | Neuropsychiatric Inventory - Does the patient describe any other unusual sensory experiences? | NPI - Describe Any Other Unusual Sensory Experiences | ||
NPI1B08 | C103605 | NPI1-Hallucinations Frequency | Neuropsychiatric Inventory - Frequency of the hallucinations. | NPI - Hallucinations Frequency | ||
NPI1B09 | C103606 | NPI1-Hallucinations Severity | Neuropsychiatric Inventory - Severity of the hallucinations. | NPI - Hallucinations Severity | ||
NPI1B10 | C103607 | NPI1-Hallucinations Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Hallucinations Distress | ||
NPI1BFS | C112470 | NPI1-Hallucinations FxS Score | Neuropsychiatric Inventory - Hallucinations: (frequency score x severity score). | NPI - Hallucinations FxS Score | ||
NPI1C | C100640 | NPI1-Refuse to Cooperate | Neuropsychiatric Inventory - Does the patient have periods when he/she refuses to cooperate or won't let people help him/her? Is he/she hard to handle? | NPI - Periods When He/She Refuses to Cooperate | ||
NPI1C01 | C100641 | NPI1-Get Upset with Caregiver | Neuropsychiatric Inventory - Does the patient get upset with those trying to care for him/her or resist activities such as bathing or changing clothes? | NPI - Get Upset with Those Trying to Care for Him/Her | ||
NPI1C02 | C100642 | NPI1-Stubborn | Neuropsychiatric Inventory - Is the patient stubborn, having to have things his/her way? | NPI - Stubborn | ||
NPI1C03 | C100643 | NPI1-Uncooperative | Neuropsychiatric Inventory - Is the patient uncooperative, resistive to help from others? | NPI - Uncooperative | ||
NPI1C04 | C100644 | NPI1-Other Behaviors Hard to Handle | Neuropsychiatric Inventory - Does the patient have any other behaviors that make him/her hard to handle? | NPI - Any Other Behaviors That Make Him/Her Hard to Handle | ||
NPI1C05 | C100645 | NPI1-Shout or Curse Angrily | Neuropsychiatric Inventory - Does the patient shout or curse angrily? | NPI - Shout or Curse Angrily | ||
NPI1C06 | C100646 | NPI1-Slam, Kick or Throw Things | Neuropsychiatric Inventory - Does the patient slam doors, kick furniture, throw things? | NPI - Slam doors, Kick Furniture, Throw Things | ||
NPI1C07 | C100647 | NPI1-Hurt or Hit Others | Neuropsychiatric Inventory - Does the patient attempt to hurt or hit others? | NPI - Attempt to Hurt or Hit Others | ||
NPI1C08 | C100648 | NPI1-Other Aggressive Behavior | Neuropsychiatric Inventory - Does the patient have any other aggressive or agitated behaviors? | NPI - Any Other Aggressive or Agitated Behaviors | ||
NPI1C09 | C103608 | NPI1-Agitation/Aggression Frequency | Neuropsychiatric Inventory - Frequency of the agitation/aggression. | NPI - Agitation/Aggression Frequency | ||
NPI1C10 | C103609 | NPI1-Agitation/Aggression Severity | Neuropsychiatric Inventory - Severity of the agitation/aggression. | NPI - Agitation/Aggression Severity | ||
NPI1C11 | C103610 | NPI1-Agitation/Aggression Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Agitation/Aggression Distress | ||
NPI1CFS | C112471 | NPI1-Agitation/Aggression FxS Score | Neuropsychiatric Inventory - Agitation/Aggression: (frequency score x severity score). | NPI - Agitation/Aggression FxS Score | ||
NPI1D | C100649 | NPI1-Sad or Depressed | Neuropsychiatric Inventory - Does the patient seem sad or depressed? Does he/she say that he/she feels sad or depressed? | NPI - Seem Sad or Depressed | ||
NPI1D01 | C100650 | NPI1-Tearfulness or Sobbing | Neuropsychiatric Inventory - Does the patient have periods of tearfulness or sobbing that seem to indicate sadness? | NPI - Periods of Tearfulness or Sobbing | ||
NPI1D02 | C100651 | NPI1-Say or Act in Low Spirits | Neuropsychiatric Inventory - Does the patient say, or act as if he/she is sad or in low spirits? | NPI - Say, or Act as if He/She is Sad or in Low Spirits | ||
NPI1D03 | C100652 | NPI1-Feel Like a Failure | Neuropsychiatric Inventory - Does the patient put him/herself down or say that he/she feels like a failure? | NPI - Put Him/Herself Down or Say That He/She Feels Like a Failure | ||
NPI1D04 | C100653 | NPI1-Bad Person | Neuropsychiatric Inventory - Does the patient say that he/she is a bad person or deserves to be punished? | NPI - Say That He/She is a Bad Person | ||
NPI1D05 | C100654 | NPI1-Discouraged | Neuropsychiatric Inventory - Does the patient seem very discouraged or say that he/she has no future? | NPI - Seem Very Discouraged | ||
NPI1D06 | C100655 | NPI1-Burden to Family | Neuropsychiatric Inventory - Does the patient say he/she is a burden to the family or that the family would be better off without him/her? | NPI - Say He/She is a Burden to the Family | ||
NPI1D07 | C100656 | NPI1-Wish for Death | Neuropsychiatric Inventory - Does the patient express a wish for death or talk about killing himself/herself? | NPI - Express a Wish for Death | ||
NPI1D08 | C100657 | NPI1-Other Signs of Depression | Neuropsychiatric Inventory - Does the patient show any other signs of depression or sadness? | NPI - Show Any Other Signs of Depression or Sadness | ||
NPI1D09 | C103611 | NPI1-Depression/Dysphoria Frequency | Neuropsychiatric Inventory - Frequency of the depression/dysphoria. | NPI - Depression/Dysphoria Frequency | ||
NPI1D10 | C103612 | NPI1-Depression/Dysphoria Severity | Neuropsychiatric Inventory - Severity of the depression/dysphoria. | NPI - Depression/Dysphoria Severity | ||
NPI1D11 | C103613 | NPI1-Depression/Dysphoria Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Depression/Dysphoria Distress | ||
NPI1DFS | C112472 | NPI1-Depression/Dysphoria FxS Score | Neuropsychiatric Inventory - Depression/Dysphoria: (frequency score x severity score). | NPI - Depression/Dysphoria FxS Score | ||
NPI1DIST | C112482 | NPI1-NPI Total Distress Score | Neuropsychiatric Inventory - Sub-total of distress score. | NPI - NPI Total Distress Score | ||
NPI1E | C100658 | NPI1-Nervous or Worried | Neuropsychiatric Inventory - Is the patient very nervous, worried, or frightened for no apparent reason? Does he/she seem very tense or fidgety? Is the patient afraid to be apart from you? | NPI - Very Nervous, Worried, or Frightened for No Apparent Reason | ||
NPI1E01 | C100659 | NPI1-Worried about Planned Event | Neuropsychiatric Inventory - Does the patient say that he/she is worried about planned events? | NPI - Say That He/She is Worried About Planned Events | ||
NPI1E02 | C100660 | NPI1-Shaky or Unable to Relax | Neuropsychiatric Inventory - Does the patient have periods of feeling shaky, unable to relax, or feeling excessively tense? | NPI - Periods of Feeling Shaky, Unable to Relax, or Feeling Excessively Tense | ||
NPI1E03 | C100661 | NPI1-Short of Breath, Gasp, Sigh | Neuropsychiatric Inventory - Does the patient have periods of (or complain of) shortness of breath, gasping, or sighing for no apparent reason other than nervousness? | NPI - Periods of Shortness of Breath, Gasping, or Sighing for No Apparent Reason | ||
NPI1E04 | C100662 | NPI1-Butterflies or Racing Heart | Neuropsychiatric Inventory - Does the patient complain of butterflies in his/her stomach, or of racing or pounding of the heart in association with nervousness? (Symptoms not explained by ill health). | NPI - Complain of Butterflies, Racing or Pounding Heart | ||
NPI1E05 | C100663 | NPI1-Avoid Places or Situations | Neuropsychiatric Inventory - Does the patient avoid certain places or situations that make him/her more nervous such as riding in the car, meeting with friends, or being in crowds? | NPI - Avoid Certain Places or Situations That Make Him/Her More Nervous | ||
NPI1E06 | C100664 | NPI1-Nervous when Separated | Neuropsychiatric Inventory - Does the patient become nervous and upset when separated from you (or his/her caregiver)? (Does he/she cling to you to keep from being separated?). | NPI - Become Nervous and Upset When Separated From You | ||
NPI1E07 | C100665 | NPI1-Other Signs of Anxiety | Neuropsychiatric Inventory - Does the patient show any other signs of anxiety? | NPI - Show Any Other Signs of Anxiety | ||
NPI1E08 | C103614 | NPI1-Anxiety Frequency | Neuropsychiatric Inventory - Frequency of the anxiety. | NPI - Anxiety Frequency | ||
NPI1E09 | C103615 | NPI1-Anxiety Severity | Neuropsychiatric Inventory - Severity of the anxiety. | NPI - Anxiety Severity | ||
NPI1E10 | C103616 | NPI1-Anxiety Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Anxiety Distress | ||
NPI1EFS | C112473 | NPI1-Anxiety FxS Score | Neuropsychiatric Inventory - Anxiety: (frequency score x severity score). | NPI - Anxiety FxS Score | ||
NPI1F | C100666 | NPI1-Too Cheerful or Happy | Neuropsychiatric Inventory - Does the patient seem too cheerful or too happy for no reason? I don't mean the normal happiness that comes from seeing friends, receiving presents, or spending time with family members. I am asking if the patient has a persistent and abnormally good mood or finds humor where others do not. | NPI - Seem Too Cheerful or Too Happy for No Reason | ||
NPI1F01 | C100667 | NPI1-Feel Good or Too Happy | Neuropsychiatric Inventory - Does the patient appear to feel good or to be too happy, different from his/her usual self? | NPI - Appear to Feel Good or to Be Too Happy | ||
NPI1F02 | C100668 | NPI1-Humor Others Do Not Find Funny | Neuropsychiatric Inventory - Does the patient find humor and laugh at things that others do not find funny? | NPI - Fine Humor and Laugh at Things That Others Do Not Find Funny | ||
NPI1F03 | C100669 | NPI1-Childish Sense of Humor | Neuropsychiatric Inventory - Does the patient seem to have a childish sense of humor with a tendency to giggle or laugh inappropriately (such as when something unfortunate happens to others)? | NPI - Seem to Have a Childish Sense of Humor | ||
NPI1F04 | C100670 | NPI1-Jokes Others Do Not Find Funny | Neuropsychiatric Inventory - Does the patient tell jokes or make remarks that are not funny to others but seem funny to him/her? | NPI - Tell Jokes or Make Remarks That are Not Funny to Others | ||
NPI1F05 | C100671 | NPI1-Childish Pranks | Neuropsychiatric Inventory - Does he/she play childish pranks such as pinching or playing "keep away" for the fun of it? | NPI - Play Childish Pranks | ||
NPI1F06 | C100672 | NPI1-Talk Big | Neuropsychiatric Inventory - Does the patient "talk big" or claim to have more abilities or wealth than is true? | NPI - Talk Big or Claim to Have More Abilities or Wealth Than is True | ||
NPI1F07 | C100673 | NPI1-Other Signs of Feeling Too Happy | Neuropsychiatric Inventory - Does the patient show any other signs of feeling too good or being too happy? | NPI - Show Any Other Signs of Feeling Too Good or Being Too Happy | ||
NPI1F08 | C103617 | NPI1-Elation/Euphoria Frequency | Neuropsychiatric Inventory - Frequency of the elation/euphoria. | NPI - Elation/Euphoria Frequency | ||
NPI1F09 | C103618 | NPI1-Elation/Euphoria Severity | Neuropsychiatric Inventory - Severity of the elation/euphoria. | NPI - Elation/Euphoria Severity | ||
NPI1F10 | C103619 | NPI1-Elation/Euphoria Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Elation/Euphoria Distress | ||
NPI1FFS | C112474 | NPI1-Elation/Euphoria FxS Score | Neuropsychiatric Inventory - Elation/Euphoria: (frequency score x severity score). | NPI - Elation/Euphoria FxS Score | ||
NPI1G | C100674 | NPI1-Lost Interest in World | Neuropsychiatric Inventory - Has the patient lost interest in the world around him/her? Has he/she lost interest in doing things or does he/she lack motivation for starting new activities? Is he/she more difficult to engage in conversation or in doing chores? Is the patient apathetic or indifferent? | NPI - Lost Interest in the World Around Him/Her | ||
NPI1G01 | C100675 | NPI1-Less Spontaneous or Active | Neuropsychiatric Inventory - Does the patient seem less spontaneous and less active than usual? | NPI - Seem Less Spontaneous and Less Active Than Usual | ||
NPI1G02 | C100676 | NPI1-Less Likely Initiate Conversation | Neuropsychiatric Inventory - Is the patient less likely to initiate a conversation? | NPI - Less Likely Initiate to Initiate a Conversation | ||
NPI1G03 | C100677 | NPI1-Less Affectionate | Neuropsychiatric Inventory - Is the patient less affectionate or lacking in emotions when compared to his/her usual self? | NPI - Less Affectionate or Lacking in Emotions | ||
NPI1G04 | C100678 | NPI1-Contribute Less to Chores | Neuropsychiatric Inventory - Does the patient contribute less to household chores? | NPI - Contribute Less to Household Chores | ||
NPI1G05 | C100679 | NPI1-Less Interest in Activities | Neuropsychiatric Inventory - Does the patient seem less interested in the activities and plans of others? | NPI - Less Interested in the Activities and Plans of Others | ||
NPI1G06 | C100680 | NPI1-Lost Interest in Friends | Neuropsychiatric Inventory - Has the patient lost interest in friends and family members? | NPI - Lost Interest in Friends and Family Members | ||
NPI1G07 | C100681 | NPI1-Less Enthusiastic | Neuropsychiatric Inventory - Is the patient less enthusiastic about his/her usual interests? | NPI - Less Enthusiastic About His/Her Usual Interests | ||
NPI1G08 | C100682 | NPI1-Other Signs of Not Caring | Neuropsychiatric Inventory - Does the patient show any other signs that he/she doesn't care about doing new things? | NPI - Show Any Other Signs That He/She Doesn't Care About Doing New Things | ||
NPI1G09 | C103620 | NPI1-Apathy/Indifference Frequency | Neuropsychiatric Inventory - Frequency of the apathy/indifference. | NPI - Apathy/Indifference Frequency | ||
NPI1G10 | C103621 | NPI1-Apathy/Indifference Severity | Neuropsychiatric Inventory - Severity of the apathy/indifference. | NPI - Apathy/Indifference Severity | ||
NPI1G11 | C103622 | NPI1-Apathy/Indifference Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Apathy/Indifference Distress | ||
NPI1GFS | C112475 | NPI1-Apathy/Indifference FxS Score | Neuropsychiatric Inventory - Apathy/Indifference: (frequency score x severity score). | NPI - Apathy/Indifference FxS Score | ||
NPI1H | C100683 | NPI1-Act Impulsively | Neuropsychiatric Inventory - Does the patient seem to act impulsively without thinking? Does he/she do or say things that are not usually done or said in public? Does he/she do things that are embarrassing to you or others? | NPI - Seem to Act Impulsively Without Thinking | ||
NPI1H01 | C100684 | NPI1-Act Impulsively without Care | Neuropsychiatric Inventory - Does the patient act impulsively without appearing to consider the consequences? | NPI - Act Impulsively without Appearing to Consider the Consequences | ||
NPI1H02 | C100685 | NPI1-Talk to Strangers | Neuropsychiatric Inventory - Does the patient talk to total strangers as if he/she knew them? | NPI - Talk to Total Strangers as if He/She Knew Them | ||
NPI1H03 | C100686 | NPI1-Say Insensitive Things | Neuropsychiatric Inventory - Does the patient say things to people that are insensitive or hurt their feelings? | NPI - Say Things to People that are Insensitive | ||
NPI1H04 | C100687 | NPI1-Make Crude Remarks | Neuropsychiatric Inventory - Does the patient say crude things or make sexual remarks that he/she would not usually have said? | NPI - Say Crude Things or Make Sexual Remarks | ||
NPI1H05 | C100688 | NPI1-Talk Openly about Private Matters | Neuropsychiatric Inventory - Does the patient talk openly about very personal or private matters not usually discussed in public? | NPI - Talk Openly About Very Personal or Private Matters | ||
NPI1H06 | C100689 | NPI1-Take Liberties or Touch Others | Neuropsychiatric Inventory - Does the patient take liberties or touch or hug others in a way that is out of character for him/her? | NPI - Take Liberties or Touch or Hug Others | ||
NPI1H07 | C100690 | NPI1-Other Signs of Impulses | Neuropsychiatric Inventory - Does the patient show any other signs of loss of control of his/her impulses? | NPI - Show Any Other Signs of Loss of Control of His/Her Impulses | ||
NPI1H08 | C103623 | NPI1-Disinhibition Frequency | Neuropsychiatric Inventory - Frequency of the disinhibition. | NPI - Disinhibition Frequency | ||
NPI1H09 | C103624 | NPI1-Disinhibition Severity | Neuropsychiatric Inventory - Severity of the disinhibition. | NPI - Disinhibition Severity | ||
NPI1H10 | C103625 | NPI1-Disinhibition Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Disinhibition Distress | ||
NPI1HFS | C112476 | NPI1-Disinhibition FxS Score | Neuropsychiatric Inventory - Disinhibition: (frequency score x severity score). | NPI - Disinhibition FxS Score | ||
NPI1I | C100691 | NPI1-Irritated and Easily Disturbed | Neuropsychiatric Inventory - Does the patient get irritated and easily disturbed? Are his/her moods very changeable? Is he/she abnormally impatient? We do not mean frustration over memory loss or inability to perform usual tasks; we are interested to know if the patient has abnormal irritability, impatience, or rapid emotional changes different from his/her usual self. | NPI - Get Irritated and Easily Disturbed | ||
NPI1I01 | C100692 | NPI1-Bad Temper | Neuropsychiatric Inventory - Does the patient have a bad temper, flying "off the handle" easily over little things? | NPI - Bad Temper, Flying 'Off the Handle' Easily Over Little Things | ||
NPI1I02 | C100693 | NPI1-Rapidly Change Moods | Neuropsychiatric Inventory - Does the patient rapidly change moods from one to another, being fine one minute and angry the next? | NPI - Rapidly Change Moods From One to Another | ||
NPI1I03 | C100694 | NPI1-Sudden Anger | Neuropsychiatric Inventory - Does the patient have sudden flashes of anger? | NPI - Sudden Flares of Anger | ||
NPI1I04 | C100695 | NPI1-Impatient | Neuropsychiatric Inventory - Is the patient impatient, having trouble coping with delays or waiting for planned activities? | NPI - Impatient, Having Trouble Coping with Delays | ||
NPI1I05 | C100696 | NPI1-Cranky and Irritable | Neuropsychiatric Inventory - Is the patient cranky and irritable? | NPI - Cranky and Irritable | ||
NPI1I06 | C100697 | NPI1-Argumentative | Neuropsychiatric Inventory - Is the patient argumentative and difficult to get along with? | NPI - Argumentative and Difficult to Get Along With | ||
NPI1I07 | C100698 | NPI1-Other Signs of Irritability | Neuropsychiatric Inventory - Does the patient show any other signs of irritability? | NPI - Show Any Other Signs of Irritability | ||
NPI1I08 | C103626 | NPI1-Irritability/Lability Frequency | Neuropsychiatric Inventory - Frequency of the irritability/lability. | NPI - Irritability/Lability Frequency | ||
NPI1I09 | C103627 | NPI1-Irritability/Lability Severity | Neuropsychiatric Inventory - Severity of the irritability/lability. | NPI - Irritability/Lability Severity | ||
NPI1I10 | C103628 | NPI1-Irritability/Lability Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Irritability/Lability Distress | ||
NPI1IFS | C112477 | NPI1-Irritability/Lability FxS Score | Neuropsychiatric Inventory - Irritability/Lability: (frequency score x severity score). | NPI - Irritability/Lability FxS Score | ||
NPI1J | C100699 | NPI1-Do Things Repeatedly | Neuropsychiatric Inventory - Does the patient pace, do things over and over such as opening closets or drawers, or repeatedly pick at things or wind string or threads? | NPI - Pace, Do Things Over and Over, Repeatedly Pick at Things | ||
NPI1J01 | C100700 | NPI1-Pace | Neuropsychiatric Inventory - Does the patient pace around the house without apparent purpose? | NPI - Pace Around the House Without Apparent Purpose | ||
NPI1J02 | C100701 | NPI1-Rummage Around and Unpack | Neuropsychiatric Inventory - Does the patient rummage around opening and unpacking drawers or closets? | NPI - Rummage Around Opening and Unpacking Drawers or Closets | ||
NPI1J03 | C100702 | NPI1-Repeatedly Change Clothing | Neuropsychiatric Inventory - Does the patient repeatedly put on and take off clothing? | NPI - Repeatedly Put On and Take Off Clothing | ||
NPI1J04 | C100703 | NPI1-Repetitive Activities or Habits | Neuropsychiatric Inventory - Does the patient have repetitive activities or "habits" that he/she performs over and over? | NPI - Repetitive Activities or 'Habits' | ||
NPI1J05 | C100704 | NPI1-Repetitive Activities | Neuropsychiatric Inventory - Does the patient engage in repetitive activities such as handling buttons, picking, wrapping string, etc.? | NPI - Engage in Repetitive Activities | ||
NPI1J06 | C100705 | NPI1-Fidget Excessively | Neuropsychiatric Inventory - Does the patient fidget excessively, seem unable to sit still, or bounce his/her feet or tap his/her fingers a lot? | NPI - Fidget Excessively, Seem Unable to Sit Still | ||
NPI1J07 | C100706 | NPI1-Other Repetitive Activities | Neuropsychiatric Inventory - Does the patient do any other activities over and over? | NPI - Do Any Other Activities Over and Over | ||
NPI1J08 | C103629 | NPI1-Aberrant Motor Behavior Frequency | Neuropsychiatric Inventory - Frequency of the aberrant motor behavior. | NPI - Aberrant Motor Behavior Frequency | ||
NPI1J09 | C103630 | NPI1-Aberrant Motor Behavior Severity | Neuropsychiatric Inventory - Severity of the aberrant motor behavior. | NPI - Aberrant Motor Behavior Severity | ||
NPI1J10 | C103631 | NPI1-Aberrant Motor Behavior Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Aberrant Motor Behavior Distress | ||
NPI1JFS | C112478 | NPI1-Aberrant Motor Behavior FxS Score | Neuropsychiatric Inventory - Aberrant Motor Behavior: (frequency score x severity score). | NPI - Aberrant Motor Behavior FxS Score | ||
NPI1K | C100707 | NPI1-Difficulty Sleeping | Neuropsychiatric Inventory - Does the patient have difficulty sleeping (do not count as present if the patient simply gets up once or twice per night to go the bathroom and falls back asleep immediately)? Is he/she up at night? Does he/she wander at night, get dressed, or disturb your sleep? | NPI - Difficulty Sleeping | ||
NPI1K01 | C100708 | NPI1-Difficulty Falling Asleep | Neuropsychiatric Inventory - Does the patient have difficulty falling asleep? | NPI - Difficulty Falling Asleep | ||
NPI1K02 | C100709 | NPI1-Get Up during Night | Neuropsychiatric Inventory - Does the patient get up during the night (do not count if the patient gets up once or twice per night only to go to the bathroom and falls back asleep immediately)? | NPI - Get Up During the Night | ||
NPI1K03 | C100710 | NPI1-Wander or Pace at Night | Neuropsychiatric Inventory - Does the patient wander, pace or get involved in inappropriate activities at night? | NPI - Wander, Pace or Get Involved in Inappropriate Activities at Night | ||
NPI1K04 | C100711 | NPI1-Awaken Caregiver during Night | Neuropsychiatric Inventory - Does the patient awaken you during the night? | NPI - Awaken You During the Night | ||
NPI1K05 | C100712 | NPI1-Wake at Night and Think Morning | Neuropsychiatric Inventory - Does the patient wake up at night, dress, and plan to go out thinking that it is morning and time to start the day? | NPI - Wake Up at Night, Dress, and Plan to Go Out | ||
NPI1K06 | C100713 | NPI1-Awaken Too Early in Morning | Neuropsychiatric Inventory - Does the patient awaken too early in the morning (earlier than was his/her habit)? | NPI - Awaken Too Early in Morning | ||
NPI1K07 | C100714 | NPI1-Excessive Sleep during Day | Neuropsychiatric Inventory - Does the patient sleep excessively during the day? | NPI - Sleep Excessively During the Day | ||
NPI1K08 | C100715 | NPI1-Other Nighttime Behaviors | Neuropsychiatric Inventory - Does the patient have any other nighttime behaviors that bother you that we haven't talked about? | NPI - Any Other Nighttime Behaviors That Bother You | ||
NPI1K09 | C103632 | NPI1-Sleep/Nighttime Behavior Frequency | Neuropsychiatric Inventory - Frequency of the nighttime behavior. | NPI - Sleep and Nighttime Behavior Disorders Frequency | ||
NPI1K10 | C103633 | NPI1-Sleep/Nighttime Behavior Severity | Neuropsychiatric Inventory - Severity of the nighttime behavior. | NPI - Sleep and Nighttime Behavior Disorders Severity | ||
NPI1K11 | C103634 | NPI1-Sleep/Nighttime Behavior Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Sleep and Nighttime Behavior Disorders Distress | ||
NPI1KFS | C112479 | NPI1-Sleep/Night Behav Disord FxS Score | Neuropsychiatric Inventory - Sleep and Nighttime Behavior Disorders: (frequency score x severity score). | NPI - Sleep/Night Behavior Disorder FxS Score | ||
NPI1L | C100716 | NPI1-Change in Appetite or Weight | Neuropsychiatric Inventory - Has he/she had any change in appetite, weight, or eating habits (count as NA if the patient is incapacitated and has to be fed)? Has there been any change in the type of food he/she prefers? | NPI - Change in Appetite, Weight, or Eating Habits | ||
NPI1L01 | C100717 | NPI1-Loss of Appetite | Neuropsychiatric Inventory - Has he/she had a loss of appetite? | NPI - Loss of Appetite | ||
NPI1L02 | C100718 | NPI1-Increase in Appetite | Neuropsychiatric Inventory - Has he/she had an increase in appetite? | NPI - Increase in Appetite | ||
NPI1L03 | C100719 | NPI1-Weight Loss | Neuropsychiatric Inventory - Has he/she had a loss of weight? | NPI - Loss of Weight | ||
NPI1L04 | C100720 | NPI1-Weight Gain | Neuropsychiatric Inventory - Has he/she gained weight? | NPI - Gained Weight | ||
NPI1L05 | C100721 | NPI1-Change in Eating Behavior | Neuropsychiatric Inventory - Has he/she had a change in eating behavior such as putting too much food in his/her mouth at once? | NPI - Change in Eating Behavior | ||
NPI1L06 | C100722 | NPI1-Change in Kind of Food | Neuropsychiatric Inventory - Has he/she had a change in the kind of food he/she likes such as eating too many sweets or other specific types of food? | NPI - Change in Kind of Food He/She Likes | ||
NPI1L07 | C100723 | NPI1-Develop Eating Behaviors | Neuropsychiatric Inventory - Has he/she developed eating behaviors such as eating exactly the same types of food each day or eating the food in exactly the same order? | NPI - Developed Eating Behaviors Such as Eating Exactly the Same Types of Food | ||
NPI1L08 | C100724 | NPI1-Other Changes in Eating | Neuropsychiatric Inventory - Have there been any other changes in appetite or eating that I haven't asked about? | NPI - Any Other Changes in Appetite or Eating | ||
NPI1L09 | C103635 | NPI1-Appetite/Eating Disorder Frequency | Neuropsychiatric Inventory - Frequency of the changes in eating habits or appetite. | NPI - Appetite and Eating Disorders Frequency | ||
NPI1L10 | C103636 | NPI1-Appetite/Eating Disorder Severity | Neuropsychiatric Inventory - Severity of the changes in eating habits or appetite. | NPI - Appetite and Eating Disorders Severity | ||
NPI1L11 | C103637 | NPI1-Appetite/Eating Disorder Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Appetite and Eating Disorders Distress | ||
NPI1LFS | C112480 | NPI1-Appetite/Eating Disorders FxS Score | Neuropsychiatric Inventory - Appetite and Eating Disorders: (frequency score x severity score). | NPI - Appetite/Eating Disorders FxS Score | ||
NPI1TOT | C112481 | NPI1-NPI Total Score | Neuropsychiatric Inventory - Total of (Frequency Sub-total) x (Severity Sub-total). | NPI - NPI Total Score | ||
Back to top | ||||||
CL.C100143.NPI1TN | Neuropsychiatric Inventory Questionnaire Test Name
(NPI1TN) | text
Extensible: No | C100143 | Neuropsychiatric Inventory Questionnaire Test Name | The Neuropsychiatric Inventory test name. | CDISC Questionnaire NPI Test Name Terminology |
NPI1-Aberrant Motor Behavior Distress | C103631 | NPI1-Aberrant Motor Behavior Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Aberrant Motor Behavior Distress | ||
NPI1-Aberrant Motor Behavior Frequency | C103629 | NPI1-Aberrant Motor Behavior Frequency | Neuropsychiatric Inventory - Frequency of the aberrant motor behavior. | NPI - Aberrant Motor Behavior Frequency | ||
NPI1-Aberrant Motor Behavior FxS Score | C112478 | NPI1-Aberrant Motor Behavior FxS Score | Neuropsychiatric Inventory - Aberrant Motor Behavior: (frequency score x severity score). | NPI - Aberrant Motor Behavior FxS Score | ||
NPI1-Aberrant Motor Behavior Severity | C103630 | NPI1-Aberrant Motor Behavior Severity | Neuropsychiatric Inventory - Severity of the aberrant motor behavior. | NPI - Aberrant Motor Behavior Severity | ||
NPI1-Act Impulsively without Care | C100684 | NPI1-Act Impulsively without Care | Neuropsychiatric Inventory - Does the patient act impulsively without appearing to consider the consequences? | NPI - Act Impulsively without Appearing to Consider the Consequences | ||
NPI1-Act Impulsively | C100683 | NPI1-Act Impulsively | Neuropsychiatric Inventory - Does the patient seem to act impulsively without thinking? Does he/she do or say things that are not usually done or said in public? Does he/she do things that are embarrassing to you or others? | NPI - Seem to Act Impulsively Without Thinking | ||
NPI1-Agitation/Aggression Distress | C103610 | NPI1-Agitation/Aggression Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Agitation/Aggression Distress | ||
NPI1-Agitation/Aggression Frequency | C103608 | NPI1-Agitation/Aggression Frequency | Neuropsychiatric Inventory - Frequency of the agitation/aggression. | NPI - Agitation/Aggression Frequency | ||
NPI1-Agitation/Aggression FxS Score | C112471 | NPI1-Agitation/Aggression FxS Score | Neuropsychiatric Inventory - Agitation/Aggression: (frequency score x severity score). | NPI - Agitation/Aggression FxS Score | ||
NPI1-Agitation/Aggression Severity | C103609 | NPI1-Agitation/Aggression Severity | Neuropsychiatric Inventory - Severity of the agitation/aggression. | NPI - Agitation/Aggression Severity | ||
NPI1-Anxiety Distress | C103616 | NPI1-Anxiety Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Anxiety Distress | ||
NPI1-Anxiety Frequency | C103614 | NPI1-Anxiety Frequency | Neuropsychiatric Inventory - Frequency of the anxiety. | NPI - Anxiety Frequency | ||
NPI1-Anxiety FxS Score | C112473 | NPI1-Anxiety FxS Score | Neuropsychiatric Inventory - Anxiety: (frequency score x severity score). | NPI - Anxiety FxS Score | ||
NPI1-Anxiety Severity | C103615 | NPI1-Anxiety Severity | Neuropsychiatric Inventory - Severity of the anxiety. | NPI - Anxiety Severity | ||
NPI1-Apathy/Indifference Distress | C103622 | NPI1-Apathy/Indifference Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Apathy/Indifference Distress | ||
NPI1-Apathy/Indifference Frequency | C103620 | NPI1-Apathy/Indifference Frequency | Neuropsychiatric Inventory - Frequency of the apathy/indifference. | NPI - Apathy/Indifference Frequency | ||
NPI1-Apathy/Indifference FxS Score | C112475 | NPI1-Apathy/Indifference FxS Score | Neuropsychiatric Inventory - Apathy/Indifference: (frequency score x severity score). | NPI - Apathy/Indifference FxS Score | ||
NPI1-Apathy/Indifference Severity | C103621 | NPI1-Apathy/Indifference Severity | Neuropsychiatric Inventory - Severity of the apathy/indifference. | NPI - Apathy/Indifference Severity | ||
NPI1-Appetite/Eating Disorder Distress | C103637 | NPI1-Appetite/Eating Disorder Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Appetite and Eating Disorders Distress | ||
NPI1-Appetite/Eating Disorder Frequency | C103635 | NPI1-Appetite/Eating Disorder Frequency | Neuropsychiatric Inventory - Frequency of the changes in eating habits or appetite. | NPI - Appetite and Eating Disorders Frequency | ||
NPI1-Appetite/Eating Disorder Severity | C103636 | NPI1-Appetite/Eating Disorder Severity | Neuropsychiatric Inventory - Severity of the changes in eating habits or appetite. | NPI - Appetite and Eating Disorders Severity | ||
NPI1-Appetite/Eating Disorders FxS Score | C112480 | NPI1-Appetite/Eating Disorders FxS Score | Neuropsychiatric Inventory - Appetite and Eating Disorders: (frequency score x severity score). | NPI - Appetite/Eating Disorders FxS Score | ||
NPI1-Argumentative | C100697 | NPI1-Argumentative | Neuropsychiatric Inventory - Is the patient argumentative and difficult to get along with? | NPI - Argumentative and Difficult to Get Along With | ||
NPI1-Avoid Places or Situations | C100663 | NPI1-Avoid Places or Situations | Neuropsychiatric Inventory - Does the patient avoid certain places or situations that make him/her more nervous such as riding in the car, meeting with friends, or being in crowds? | NPI - Avoid Certain Places or Situations That Make Him/Her More Nervous | ||
NPI1-Awaken Caregiver during Night | C100711 | NPI1-Awaken Caregiver during Night | Neuropsychiatric Inventory - Does the patient awaken you during the night? | NPI - Awaken You During the Night | ||
NPI1-Awaken Too Early in Morning | C100713 | NPI1-Awaken Too Early in Morning | Neuropsychiatric Inventory - Does the patient awaken too early in the morning (earlier than was his/her habit)? | NPI - Awaken Too Early in Morning | ||
NPI1-Bad Person | C100653 | NPI1-Bad Person | Neuropsychiatric Inventory - Does the patient say that he/she is a bad person or deserves to be punished? | NPI - Say That He/She is a Bad Person | ||
NPI1-Bad Temper | C100692 | NPI1-Bad Temper | Neuropsychiatric Inventory - Does the patient have a bad temper, flying "off the handle" easily over little things? | NPI - Bad Temper, Flying 'Off the Handle' Easily Over Little Things | ||
NPI1-Beliefs Untrue | C100622 | NPI1-Beliefs Untrue | Neuropsychiatric Inventory - Does the patient have beliefs that you know are not true? (for example, insisting that people are trying to harm him/her or steal from him/her)? Has he/she said that family members are not who they say they are or that the house is not their home? I'm not asking about mere suspiciousness; I am interested if the patient is convinced that these things are happening to him/her. | NPI - Have Beliefs That You Know are Not True | ||
NPI1-Burden to Family | C100655 | NPI1-Burden to Family | Neuropsychiatric Inventory - Does the patient say he/she is a burden to the family or that the family would be better off without him/her? | NPI - Say He/She is a Burden to the Family | ||
NPI1-Butterflies or Racing Heart | C100662 | NPI1-Butterflies or Racing Heart | Neuropsychiatric Inventory - Does the patient complain of butterflies in his/her stomach, or of racing or pounding of the heart in association with nervousness? (Symptoms not explained by ill health). | NPI - Complain of Butterflies, Racing or Pounding Heart | ||
NPI1-Change in Appetite or Weight | C100716 | NPI1-Change in Appetite or Weight | Neuropsychiatric Inventory - Has he/she had any change in appetite, weight, or eating habits (count as NA if the patient is incapacitated and has to be fed)? Has there been any change in the type of food he/she prefers? | NPI - Change in Appetite, Weight, or Eating Habits | ||
NPI1-Change in Eating Behavior | C100721 | NPI1-Change in Eating Behavior | Neuropsychiatric Inventory - Has he/she had a change in eating behavior such as putting too much food in his/her mouth at once? | NPI - Change in Eating Behavior | ||
NPI1-Change in Kind of Food | C100722 | NPI1-Change in Kind of Food | Neuropsychiatric Inventory - Has he/she had a change in the kind of food he/she likes such as eating too many sweets or other specific types of food? | NPI - Change in Kind of Food He/She Likes | ||
NPI1-Childish Pranks | C100671 | NPI1-Childish Pranks | Neuropsychiatric Inventory - Does he/she play childish pranks such as pinching or playing "keep away" for the fun of it? | NPI - Play Childish Pranks | ||
NPI1-Childish Sense of Humor | C100669 | NPI1-Childish Sense of Humor | Neuropsychiatric Inventory - Does the patient seem to have a childish sense of humor with a tendency to giggle or laugh inappropriately (such as when something unfortunate happens to others)? | NPI - Seem to Have a Childish Sense of Humor | ||
NPI1-Contribute Less to Chores | C100678 | NPI1-Contribute Less to Chores | Neuropsychiatric Inventory - Does the patient contribute less to household chores? | NPI - Contribute Less to Household Chores | ||
NPI1-Cranky and Irritable | C100696 | NPI1-Cranky and Irritable | Neuropsychiatric Inventory - Is the patient cranky and irritable? | NPI - Cranky and Irritable | ||
NPI1-Delusions Distress | C103604 | NPI1-Delusions Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Delusions Distress | ||
NPI1-Delusions Frequency | C103602 | NPI1-Delusions Frequency | Neuropsychiatric Inventory - Frequency of the delusions. | NPI - Delusions Frequency | ||
NPI1-Delusions FxS Score | C112469 | NPI1-Delusions FxS Score | Neuropsychiatric Inventory - Delusions: (frequency score x severity score). | NPI - Delusions FxS Score | ||
NPI1-Delusions Severity | C103603 | NPI1-Delusions Severity | Neuropsychiatric Inventory - Severity of the delusions. | NPI - Delusions Severity | ||
NPI1-Depression/Dysphoria Distress | C103613 | NPI1-Depression/Dysphoria Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Depression/Dysphoria Distress | ||
NPI1-Depression/Dysphoria Frequency | C103611 | NPI1-Depression/Dysphoria Frequency | Neuropsychiatric Inventory - Frequency of the depression/dysphoria. | NPI - Depression/Dysphoria Frequency | ||
NPI1-Depression/Dysphoria FxS Score | C112472 | NPI1-Depression/Dysphoria FxS Score | Neuropsychiatric Inventory - Depression/Dysphoria: (frequency score x severity score). | NPI - Depression/Dysphoria FxS Score | ||
NPI1-Depression/Dysphoria Severity | C103612 | NPI1-Depression/Dysphoria Severity | Neuropsychiatric Inventory - Severity of the depression/dysphoria. | NPI - Depression/Dysphoria Severity | ||
NPI1-Develop Eating Behaviors | C100723 | NPI1-Develop Eating Behaviors | Neuropsychiatric Inventory - Has he/she developed eating behaviors such as eating exactly the same types of food each day or eating the food in exactly the same order? | NPI - Developed Eating Behaviors Such as Eating Exactly the Same Types of Food | ||
NPI1-Difficulty Falling Asleep | C100708 | NPI1-Difficulty Falling Asleep | Neuropsychiatric Inventory - Does the patient have difficulty falling asleep? | NPI - Difficulty Falling Asleep | ||
NPI1-Difficulty Sleeping | C100707 | NPI1-Difficulty Sleeping | Neuropsychiatric Inventory - Does the patient have difficulty sleeping (do not count as present if the patient simply gets up once or twice per night to go the bathroom and falls back asleep immediately)? Is he/she up at night? Does he/she wander at night, get dressed, or disturb your sleep? | NPI - Difficulty Sleeping | ||
NPI1-Discouraged | C100654 | NPI1-Discouraged | Neuropsychiatric Inventory - Does the patient seem very discouraged or say that he/she has no future? | NPI - Seem Very Discouraged | ||
NPI1-Disinhibition Distress | C103625 | NPI1-Disinhibition Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Disinhibition Distress | ||
NPI1-Disinhibition Frequency | C103623 | NPI1-Disinhibition Frequency | Neuropsychiatric Inventory - Frequency of the disinhibition. | NPI - Disinhibition Frequency | ||
NPI1-Disinhibition FxS Score | C112476 | NPI1-Disinhibition FxS Score | Neuropsychiatric Inventory - Disinhibition: (frequency score x severity score). | NPI - Disinhibition FxS Score | ||
NPI1-Disinhibition Severity | C103624 | NPI1-Disinhibition Severity | Neuropsychiatric Inventory - Severity of the disinhibition. | NPI - Disinhibition Severity | ||
NPI1-Do Things Repeatedly | C100699 | NPI1-Do Things Repeatedly | Neuropsychiatric Inventory - Does the patient pace, do things over and over such as opening closets or drawers, or repeatedly pick at things or wind string or threads? | NPI - Pace, Do Things Over and Over, Repeatedly Pick at Things | ||
NPI1-Elation/Euphoria Distress | C103619 | NPI1-Elation/Euphoria Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Elation/Euphoria Distress | ||
NPI1-Elation/Euphoria Frequency | C103617 | NPI1-Elation/Euphoria Frequency | Neuropsychiatric Inventory - Frequency of the elation/euphoria. | NPI - Elation/Euphoria Frequency | ||
NPI1-Elation/Euphoria FxS Score | C112474 | NPI1-Elation/Euphoria FxS Score | Neuropsychiatric Inventory - Elation/Euphoria: (frequency score x severity score). | NPI - Elation/Euphoria FxS Score | ||
NPI1-Elation/Euphoria Severity | C103618 | NPI1-Elation/Euphoria Severity | Neuropsychiatric Inventory - Severity of the elation/euphoria. | NPI - Elation/Euphoria Severity | ||
NPI1-Excessive Sleep during Day | C100714 | NPI1-Excessive Sleep during Day | Neuropsychiatric Inventory - Does the patient sleep excessively during the day? | NPI - Sleep Excessively During the Day | ||
NPI1-False Visions or Voices | C100632 | NPI1-False Visions or Voices | Neuropsychiatric Inventory - Does the patient have hallucinations such as seeing false visions or hearing false voices? Does he/she seem to see, hear or experience things that are not present? By this question we do not mean just mistaken beliefs such as stating that someone who has died is still alive; rather we are asking if the patient actually has abnormal experiences of sounds or visions. | NPI - Hallucinations Such as Seeing False Visions or Hearing False Voices | ||
NPI1-Family Plans to Abandon | C100629 | NPI1-Family Plans to Abandon | Neuropsychiatric Inventory - Does the patient believe that family members plan to abandon him/her? | NPI - Family Members Plan to Abandon Him/Her | ||
NPI1-Feel Good or Too Happy | C100667 | NPI1-Feel Good or Too Happy | Neuropsychiatric Inventory - Does the patient appear to feel good or to be too happy, different from his/her usual self? | NPI - Appear to Feel Good or to Be Too Happy | ||
NPI1-Feel Like a Failure | C100652 | NPI1-Feel Like a Failure | Neuropsychiatric Inventory - Does the patient put him/herself down or say that he/she feels like a failure? | NPI - Put Him/Herself Down or Say That He/She Feels Like a Failure | ||
NPI1-Feel Things on Skin | C100637 | NPI1-Feel Things on Skin | Neuropsychiatric Inventory - Does the patient describe feeling things on his/her skin or otherwise appear to be feeling things crawling or touching him/her? | NPI - Describe Feeling Things on His/Her Skin | ||
NPI1-Fidget Excessively | C100705 | NPI1-Fidget Excessively | Neuropsychiatric Inventory - Does the patient fidget excessively, seem unable to sit still, or bounce his/her feet or tap his/her fingers a lot? | NPI - Fidget Excessively, Seem Unable to Sit Still | ||
NPI1-Get Up during Night | C100709 | NPI1-Get Up during Night | Neuropsychiatric Inventory - Does the patient get up during the night (do not count if the patient gets up once or twice per night only to go to the bathroom and falls back asleep immediately)? | NPI - Get Up During the Night | ||
NPI1-Get Upset with Caregiver | C100641 | NPI1-Get Upset with Caregiver | Neuropsychiatric Inventory - Does the patient get upset with those trying to care for him/her or resist activities such as bathing or changing clothes? | NPI - Get Upset with Those Trying to Care for Him/Her | ||
NPI1-Hallucinations Distress | C103607 | NPI1-Hallucinations Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Hallucinations Distress | ||
NPI1-Hallucinations Frequency | C103605 | NPI1-Hallucinations Frequency | Neuropsychiatric Inventory - Frequency of the hallucinations. | NPI - Hallucinations Frequency | ||
NPI1-Hallucinations FxS Score | C112470 | NPI1-Hallucinations FxS Score | Neuropsychiatric Inventory - Hallucinations: (frequency score x severity score). | NPI - Hallucinations FxS Score | ||
NPI1-Hallucinations Severity | C103606 | NPI1-Hallucinations Severity | Neuropsychiatric Inventory - Severity of the hallucinations. | NPI - Hallucinations Severity | ||
NPI1-Hearing Voices | C100633 | NPI1-Hearing Voices | Neuropsychiatric Inventory - Does the patient describe hearing voices or act as if he/she hears voices? | NPI - Describe Hearing Voices or Act as if He/She Hears Voices | ||
NPI1-House Not Their Home | C100628 | NPI1-House Not Their Home | Neuropsychiatric Inventory - Does the patient believe that his/her house is not his/her home? | NPI - His/Her House Is Not His/Her Home | ||
NPI1-Humor Others Do Not Find Funny | C100668 | NPI1-Humor Others Do Not Find Funny | Neuropsychiatric Inventory - Does the patient find humor and laugh at things that others do not find funny? | NPI - Fine Humor and Laugh at Things That Others Do Not Find Funny | ||
NPI1-Hurt or Hit Others | C100647 | NPI1-Hurt or Hit Others | Neuropsychiatric Inventory - Does the patient attempt to hurt or hit others? | NPI - Attempt to Hurt or Hit Others | ||
NPI1-Impatient | C100695 | NPI1-Impatient | Neuropsychiatric Inventory - Is the patient impatient, having trouble coping with delays or waiting for planned activities? | NPI - Impatient, Having Trouble Coping with Delays | ||
NPI1-In Danger | C100623 | NPI1-In Danger | Neuropsychiatric Inventory - Does the patient believe that he/she is in danger - that others are planning to hurt him/her? | NPI - He/She is in Danger | ||
NPI1-Increase in Appetite | C100718 | NPI1-Increase in Appetite | Neuropsychiatric Inventory - Has he/she had an increase in appetite? | NPI - Increase in Appetite | ||
NPI1-Irritability/Lability Distress | C103628 | NPI1-Irritability/Lability Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Irritability/Lability Distress | ||
NPI1-Irritability/Lability Frequency | C103626 | NPI1-Irritability/Lability Frequency | Neuropsychiatric Inventory - Frequency of the irritability/lability. | NPI - Irritability/Lability Frequency | ||
NPI1-Irritability/Lability FxS Score | C112477 | NPI1-Irritability/Lability FxS Score | Neuropsychiatric Inventory - Irritability/Lability: (frequency score x severity score). | NPI - Irritability/Lability FxS Score | ||
NPI1-Irritability/Lability Severity | C103627 | NPI1-Irritability/Lability Severity | Neuropsychiatric Inventory - Severity of the irritability/lability. | NPI - Irritability/Lability Severity | ||
NPI1-Irritated and Easily Disturbed | C100691 | NPI1-Irritated and Easily Disturbed | Neuropsychiatric Inventory - Does the patient get irritated and easily disturbed? Are his/her moods very changeable? Is he/she abnormally impatient? We do not mean frustration over memory loss or inability to perform usual tasks; we are interested to know if the patient has abnormal irritability, impatience, or rapid emotional changes different from his/her usual self. | NPI - Get Irritated and Easily Disturbed | ||
NPI1-Jokes Others Do Not Find Funny | C100670 | NPI1-Jokes Others Do Not Find Funny | Neuropsychiatric Inventory - Does the patient tell jokes or make remarks that are not funny to others but seem funny to him/her? | NPI - Tell Jokes or Make Remarks That are Not Funny to Others | ||
NPI1-Less Affectionate | C100677 | NPI1-Less Affectionate | Neuropsychiatric Inventory - Is the patient less affectionate or lacking in emotions when compared to his/her usual self? | NPI - Less Affectionate or Lacking in Emotions | ||
NPI1-Less Enthusiastic | C100681 | NPI1-Less Enthusiastic | Neuropsychiatric Inventory - Is the patient less enthusiastic about his/her usual interests? | NPI - Less Enthusiastic About His/Her Usual Interests | ||
NPI1-Less Interest in Activities | C100679 | NPI1-Less Interest in Activities | Neuropsychiatric Inventory - Does the patient seem less interested in the activities and plans of others? | NPI - Less Interested in the Activities and Plans of Others | ||
NPI1-Less Likely Initiate Conversation | C100676 | NPI1-Less Likely Initiate Conversation | Neuropsychiatric Inventory - Is the patient less likely to initiate a conversation? | NPI - Less Likely Initiate to Initiate a Conversation | ||
NPI1-Less Spontaneous or Active | C100675 | NPI1-Less Spontaneous or Active | Neuropsychiatric Inventory - Does the patient seem less spontaneous and less active than usual? | NPI - Seem Less Spontaneous and Less Active Than Usual | ||
NPI1-Loss of Appetite | C100717 | NPI1-Loss of Appetite | Neuropsychiatric Inventory - Has he/she had a loss of appetite? | NPI - Loss of Appetite | ||
NPI1-Lost Interest in Friends | C100680 | NPI1-Lost Interest in Friends | Neuropsychiatric Inventory - Has the patient lost interest in friends and family members? | NPI - Lost Interest in Friends and Family Members | ||
NPI1-Lost Interest in World | C100674 | NPI1-Lost Interest in World | Neuropsychiatric Inventory - Has the patient lost interest in the world around him/her? Has he/she lost interest in doing things or does he/she lack motivation for starting new activities? Is he/she more difficult to engage in conversation or in doing chores? Is the patient apathetic or indifferent? | NPI - Lost Interest in the World Around Him/Her | ||
NPI1-Make Crude Remarks | C100687 | NPI1-Make Crude Remarks | Neuropsychiatric Inventory - Does the patient say crude things or make sexual remarks that he/she would not usually have said? | NPI - Say Crude Things or Make Sexual Remarks | ||
NPI1-Nervous or Worried | C100658 | NPI1-Nervous or Worried | Neuropsychiatric Inventory - Is the patient very nervous, worried, or frightened for no apparent reason? Does he/she seem very tense or fidgety? Is the patient afraid to be apart from you? | NPI - Very Nervous, Worried, or Frightened for No Apparent Reason | ||
NPI1-Nervous when Separated | C100664 | NPI1-Nervous when Separated | Neuropsychiatric Inventory - Does the patient become nervous and upset when separated from you (or his/her caregiver)? (Does he/she cling to you to keep from being separated?). | NPI - Become Nervous and Upset When Separated From You | ||
NPI1-NPI Total Distress Score | C112482 | NPI1-NPI Total Distress Score | Neuropsychiatric Inventory - Sub-total of distress score. | NPI - NPI Total Distress Score | ||
NPI1-NPI Total Score | C112481 | NPI1-NPI Total Score | Neuropsychiatric Inventory - Total of (Frequency Sub-total) x (Severity Sub-total). | NPI - NPI Total Score | ||
NPI1-Other Aggressive Behavior | C100648 | NPI1-Other Aggressive Behavior | Neuropsychiatric Inventory - Does the patient have any other aggressive or agitated behaviors? | NPI - Any Other Aggressive or Agitated Behaviors | ||
NPI1-Other Behaviors Hard to Handle | C100644 | NPI1-Other Behaviors Hard to Handle | Neuropsychiatric Inventory - Does the patient have any other behaviors that make him/her hard to handle? | NPI - Any Other Behaviors That Make Him/Her Hard to Handle | ||
NPI1-Other Changes in Eating | C100724 | NPI1-Other Changes in Eating | Neuropsychiatric Inventory - Have there been any other changes in appetite or eating that I haven't asked about? | NPI - Any Other Changes in Appetite or Eating | ||
NPI1-Other Nighttime Behaviors | C100715 | NPI1-Other Nighttime Behaviors | Neuropsychiatric Inventory - Does the patient have any other nighttime behaviors that bother you that we haven't talked about? | NPI - Any Other Nighttime Behaviors That Bother You | ||
NPI1-Other Repetitive Activities | C100706 | NPI1-Other Repetitive Activities | Neuropsychiatric Inventory - Does the patient do any other activities over and over? | NPI - Do Any Other Activities Over and Over | ||
NPI1-Other Signs of Anxiety | C100665 | NPI1-Other Signs of Anxiety | Neuropsychiatric Inventory - Does the patient show any other signs of anxiety? | NPI - Show Any Other Signs of Anxiety | ||
NPI1-Other Signs of Depression | C100657 | NPI1-Other Signs of Depression | Neuropsychiatric Inventory - Does the patient show any other signs of depression or sadness? | NPI - Show Any Other Signs of Depression or Sadness | ||
NPI1-Other Signs of Feeling Too Happy | C100673 | NPI1-Other Signs of Feeling Too Happy | Neuropsychiatric Inventory - Does the patient show any other signs of feeling too good or being too happy? | NPI - Show Any Other Signs of Feeling Too Good or Being Too Happy | ||
NPI1-Other Signs of Impulses | C100690 | NPI1-Other Signs of Impulses | Neuropsychiatric Inventory - Does the patient show any other signs of loss of control of his/her impulses? | NPI - Show Any Other Signs of Loss of Control of His/Her Impulses | ||
NPI1-Other Signs of Irritability | C100698 | NPI1-Other Signs of Irritability | Neuropsychiatric Inventory - Does the patient show any other signs of irritability? | NPI - Show Any Other Signs of Irritability | ||
NPI1-Other Signs of Not Caring | C100682 | NPI1-Other Signs of Not Caring | Neuropsychiatric Inventory - Does the patient show any other signs that he/she doesn't care about doing new things? | NPI - Show Any Other Signs That He/She Doesn't Care About Doing New Things | ||
NPI1-Other Unusual Beliefs | C100631 | NPI1-Other Unusual Beliefs | Neuropsychiatric Inventory - Does the patient believe any other unusual things that I haven't asked about? | NPI - Any Other Unusual Things That I Haven't Asked About | ||
NPI1-Other Unusual Sensory Experience | C100639 | NPI1-Other Unusual Sensory Experience | Neuropsychiatric Inventory - Does the patient describe any other unusual sensory experiences? | NPI - Describe Any Other Unusual Sensory Experiences | ||
NPI1-Others Are Stealing | C100624 | NPI1-Others Are Stealing | Neuropsychiatric Inventory - Does the patient believe that others are stealing from him/her? | NPI - Others are Stealing From Him/Her | ||
NPI1-Pace | C100700 | NPI1-Pace | Neuropsychiatric Inventory - Does the patient pace around the house without apparent purpose? | NPI - Pace Around the House Without Apparent Purpose | ||
NPI1-People Not Who They Claim | C100627 | NPI1-People Not Who They Claim | Neuropsychiatric Inventory - Does the patient believe that his/her spouse or others are not who they claim to be? | NPI - His/Her Spouse or Others Are Not Who They Claim To Be | ||
NPI1-Rapidly Change Moods | C100693 | NPI1-Rapidly Change Moods | Neuropsychiatric Inventory - Does the patient rapidly change moods from one to another, being fine one minute and angry the next? | NPI - Rapidly Change Moods From One to Another | ||
NPI1-Refuse to Cooperate | C100640 | NPI1-Refuse to Cooperate | Neuropsychiatric Inventory - Does the patient have periods when he/she refuses to cooperate or won't let people help him/her? Is he/she hard to handle? | NPI - Periods When He/She Refuses to Cooperate | ||
NPI1-Repeatedly Change Clothing | C100702 | NPI1-Repeatedly Change Clothing | Neuropsychiatric Inventory - Does the patient repeatedly put on and take off clothing? | NPI - Repeatedly Put On and Take Off Clothing | ||
NPI1-Repetitive Activities or Habits | C100703 | NPI1-Repetitive Activities or Habits | Neuropsychiatric Inventory - Does the patient have repetitive activities or "habits" that he/she performs over and over? | NPI - Repetitive Activities or 'Habits' | ||
NPI1-Repetitive Activities | C100704 | NPI1-Repetitive Activities | Neuropsychiatric Inventory - Does the patient engage in repetitive activities such as handling buttons, picking, wrapping string, etc.? | NPI - Engage in Repetitive Activities | ||
NPI1-Rummage Around and Unpack | C100701 | NPI1-Rummage Around and Unpack | Neuropsychiatric Inventory - Does the patient rummage around opening and unpacking drawers or closets? | NPI - Rummage Around Opening and Unpacking Drawers or Closets | ||
NPI1-Sad or Depressed | C100649 | NPI1-Sad or Depressed | Neuropsychiatric Inventory - Does the patient seem sad or depressed? Does he/she say that he/she feels sad or depressed? | NPI - Seem Sad or Depressed | ||
NPI1-Say Insensitive Things | C100686 | NPI1-Say Insensitive Things | Neuropsychiatric Inventory - Does the patient say things to people that are insensitive or hurt their feelings? | NPI - Say Things to People that are Insensitive | ||
NPI1-Say or Act in Low Spirits | C100651 | NPI1-Say or Act in Low Spirits | Neuropsychiatric Inventory - Does the patient say, or act as if he/she is sad or in low spirits? | NPI - Say, or Act as if He/She is Sad or in Low Spirits | ||
NPI1-See Things Not Seen by Others | C100635 | NPI1-See Things Not Seen by Others | Neuropsychiatric Inventory - Does the patient describe seeing things not seen by others or behave as if he/she is seeing things not seen by others (people, animals, lights, etc.)? | NPI - Describe Seeing Things Not Seen by Others | ||
NPI1-Shaky or Unable to Relax | C100660 | NPI1-Shaky or Unable to Relax | Neuropsychiatric Inventory - Does the patient have periods of feeling shaky, unable to relax, or feeling excessively tense? | NPI - Periods of Feeling Shaky, Unable to Relax, or Feeling Excessively Tense | ||
NPI1-Short of Breath, Gasp, Sigh | C100661 | NPI1-Short of Breath, Gasp, Sigh | Neuropsychiatric Inventory - Does the patient have periods of (or complain of) shortness of breath, gasping, or sighing for no apparent reason other than nervousness? | NPI - Periods of Shortness of Breath, Gasping, or Sighing for No Apparent Reason | ||
NPI1-Shout or Curse Angrily | C100645 | NPI1-Shout or Curse Angrily | Neuropsychiatric Inventory - Does the patient shout or curse angrily? | NPI - Shout or Curse Angrily | ||
NPI1-Slam, Kick or Throw Things | C100646 | NPI1-Slam, Kick or Throw Things | Neuropsychiatric Inventory - Does the patient slam doors, kick furniture, throw things? | NPI - Slam doors, Kick Furniture, Throw Things | ||
NPI1-Sleep/Night Behav Disord FxS Score | C112479 | NPI1-Sleep/Night Behav Disord FxS Score | Neuropsychiatric Inventory - Sleep and Nighttime Behavior Disorders: (frequency score x severity score). | NPI - Sleep/Night Behavior Disorder FxS Score | ||
NPI1-Sleep/Nighttime Behavior Distress | C103634 | NPI1-Sleep/Nighttime Behavior Distress | Neuropsychiatric Inventory - How emotionally distressing do you find this behavior? | NPI - Sleep and Nighttime Behavior Disorders Distress | ||
NPI1-Sleep/Nighttime Behavior Frequency | C103632 | NPI1-Sleep/Nighttime Behavior Frequency | Neuropsychiatric Inventory - Frequency of the nighttime behavior. | NPI - Sleep and Nighttime Behavior Disorders Frequency | ||
NPI1-Sleep/Nighttime Behavior Severity | C103633 | NPI1-Sleep/Nighttime Behavior Severity | Neuropsychiatric Inventory - Severity of the nighttime behavior. | NPI - Sleep and Nighttime Behavior Disorders Severity | ||
NPI1-Smell Odors Others Do Not Smell | C100636 | NPI1-Smell Odors Others Do Not Smell | Neuropsychiatric Inventory - Does the patient report smelling odors not smelled by others? | NPI - Report Smelling Odors Not Smelled by Others | ||
NPI1-Spouse Having Affair | C100625 | NPI1-Spouse Having Affair | Neuropsychiatric Inventory - Does the patient believe that his/her spouse is having an affair? | NPI - His/Her Spouse is Having an Affair | ||
NPI1-Stubborn | C100642 | NPI1-Stubborn | Neuropsychiatric Inventory - Is the patient stubborn, having to have things his/her way? | NPI - Stubborn | ||
NPI1-Sudden Anger | C100694 | NPI1-Sudden Anger | Neuropsychiatric Inventory - Does the patient have sudden flashes of anger? | NPI - Sudden Flares of Anger | ||
NPI1-Take Liberties or Touch Others | C100689 | NPI1-Take Liberties or Touch Others | Neuropsychiatric Inventory - Does the patient take liberties or touch or hug others in a way that is out of character for him/her? | NPI - Take Liberties or Touch or Hug Others | ||
NPI1-Talk Big | C100672 | NPI1-Talk Big | Neuropsychiatric Inventory - Does the patient "talk big" or claim to have more abilities or wealth than is true? | NPI - Talk Big or Claim to Have More Abilities or Wealth Than is True | ||
NPI1-Talk Openly about Private Matters | C100688 | NPI1-Talk Openly about Private Matters | Neuropsychiatric Inventory - Does the patient talk openly about very personal or private matters not usually discussed in public? | NPI - Talk Openly About Very Personal or Private Matters | ||
NPI1-Talk to People Not There | C100634 | NPI1-Talk to People Not There | Neuropsychiatric Inventory - Does the patient talk to people who are not there? | NPI - Talk to People Who Are Not There | ||
NPI1-Talk to Strangers | C100685 | NPI1-Talk to Strangers | Neuropsychiatric Inventory - Does the patient talk to total strangers as if he/she knew them? | NPI - Talk to Total Strangers as if He/She Knew Them | ||
NPI1-Taste without Known Cause | C100638 | NPI1-Taste without Known Cause | Neuropsychiatric Inventory - Does the patient describe tastes that are without any known cause? | NPI - Describe Tastes That Are Without Any Known Cause | ||
NPI1-Tearfulness or Sobbing | C100650 | NPI1-Tearfulness or Sobbing | Neuropsychiatric Inventory - Does the patient have periods of tearfulness or sobbing that seem to indicate sadness? | NPI - Periods of Tearfulness or Sobbing | ||
NPI1-Too Cheerful or Happy | C100666 | NPI1-Too Cheerful or Happy | Neuropsychiatric Inventory - Does the patient seem too cheerful or too happy for no reason? I don't mean the normal happiness that comes from seeing friends, receiving presents, or spending time with family members. I am asking if the patient has a persistent and abnormally good mood or finds humor where others do not. | NPI - Seem Too Cheerful or Too Happy for No Reason | ||
NPI1-TV/Magazine Figures Present | C100630 | NPI1-TV/Magazine Figures Present | Neuropsychiatric Inventory - Does the patient believe that television or magazine figures are actually present in the home? (Does he/she try to talk or interact with them?) | NPI - Television or Magazine Figures Are Actually Present In the Home | ||
NPI1-Uncooperative | C100643 | NPI1-Uncooperative | Neuropsychiatric Inventory - Is the patient uncooperative, resistive to help from others? | NPI - Uncooperative | ||
NPI1-Unwelcome Guests in House | C100626 | NPI1-Unwelcome Guests in House | Neuropsychiatric Inventory - Does the patient believe that unwelcome guests are living in his/her house? | NPI - Unwelcome Guests are Living in His/Her House | ||
NPI1-Wake at Night and Think Morning | C100712 | NPI1-Wake at Night and Think Morning | Neuropsychiatric Inventory - Does the patient wake up at night, dress, and plan to go out thinking that it is morning and time to start the day? | NPI - Wake Up at Night, Dress, and Plan to Go Out | ||
NPI1-Wander or Pace at Night | C100710 | NPI1-Wander or Pace at Night | Neuropsychiatric Inventory - Does the patient wander, pace or get involved in inappropriate activities at night? | NPI - Wander, Pace or Get Involved in Inappropriate Activities at Night | ||
NPI1-Weight Gain | C100720 | NPI1-Weight Gain | Neuropsychiatric Inventory - Has he/she gained weight? | NPI - Gained Weight | ||
NPI1-Weight Loss | C100719 | NPI1-Weight Loss | Neuropsychiatric Inventory - Has he/she had a loss of weight? | NPI - Loss of Weight | ||
NPI1-Wish for Death | C100656 | NPI1-Wish for Death | Neuropsychiatric Inventory - Does the patient express a wish for death or talk about killing himself/herself? | NPI - Express a Wish for Death | ||
NPI1-Worried about Planned Event | C100659 | NPI1-Worried about Planned Event | Neuropsychiatric Inventory - Does the patient say that he/she is worried about planned events? | NPI - Say That He/She is Worried About Planned Events | ||
Back to top | ||||||
CL.C78738.NCF | Never/Current/Former Classification
(NCF) | text
Extensible: No | C78738 | Never/Current/Former Classification | A classification of usage or experience that falls into three categories; never, current, or former. | CDISC SDTM Never/Current/Former Classification Terminology |
CURRENT | C25471 | Occurring in or belonging to the present time. (NCI) | Current | |||
FORMER | C25627 | Previous | Occurring prior to something else. (NCI) | Previous | ||
NEVER | C70543 | Not ever; at no time in the past. | Never | |||
Back to top | ||||||
CL.C101839.NYHAC | New York Heart Association Classification
(NYHAC) | text
Extensible: No | C101839 | New York Heart Association Classification | A terminology codelist based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. | CDISC SDTM New York Heart Association Class Responses Terminology |
NYHA CLASS I | C66904 | New York Heart Association Class I | Without limitations of physical activity. Ordinary physical activity does not cause undue fatigue, palpitations, or dyspnea. | New York Heart Association Class I | ||
NYHA CLASS II | C66905 | New York Heart Association Class II | Slight limitation of physical activity. The patient is comfortable at rest. Ordinary physical activity results in fatigue, palpitations, or dyspnea. | New York Heart Association Class II | ||
NYHA CLASS III | C66907 | New York Heart Association Class III | Marked limitation of physical activity. The patient is comfortable at rest. Less than ordinary activity causes fatigue, palpitations, or dyspnea. | New York Heart Association Class III | ||
NYHA CLASS IV | C66908 | New York Heart Association Class IV | Inability to carry on any physical activity without discomfort. Heart failure symptoms are present even at rest or with minimal exertion. | New York Heart Association Class IV | ||
Back to top | ||||||
CL.C115392.NHPT01TC | Nine-Hole Peg Test Functional Test Test Code
(NHPT01TC) | text
Extensible: No | C115392 | Nine-Hole Peg Test Functional Test Test Code | Nine-Hole Peg Test test code. | CDISC Functional Test NHPT Test Code Terminology |
NHPT0101 | C115807 | NHPT01-Time to Complete 9-Hole Peg Test | Nine-Hole Peg Test - Time in seconds to complete 9-Hole Peg Test. | NHPT - Time to Complete 9-Hole Peg Test | ||
NHPT0102 | C115808 | NHPT01-More Than Two Attempts | Nine-Hole Peg Test - Did it take more than two attempts to get two successful trials? | NHPT - More Than Two Attempts | ||
Back to top | ||||||
CL.C115391.NHPT01TN | Nine-Hole Peg Test Functional Test Test Name
(NHPT01TN) | text
Extensible: No | C115391 | Nine-Hole Peg Test Functional Test Test Name | Nine-Hole Peg Test test name. | CDISC Functional Test NHPT Test Name Terminology |
NHPT01-More Than Two Attempts | C115808 | NHPT01-More Than Two Attempts | Nine-Hole Peg Test - Did it take more than two attempts to get two successful trials? | NHPT - More Than Two Attempts | ||
NHPT01-Time to Complete 9-Hole Peg Test | C115807 | NHPT01-Time to Complete 9-Hole Peg Test | Nine-Hole Peg Test - Time in seconds to complete 9-Hole Peg Test. | NHPT - Time to Complete 9-Hole Peg Test | ||
Back to top | ||||||
CL.C66742.NY | No Yes Response
(NY) | text
Extensible: No | C66742 | No Yes Response | A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable. | CDISC SDTM Yes No Unknown or Not Applicable Response Terminology |
N | C49487 | No | The non-affirmative response to a question. (NCI) | No | ||
NA | C48660 | NA;Not Applicable | Determination of a value is not relevant in the current context. (NCI) | Not Applicable | ||
U | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Y | C49488 | Yes | The affirmative response to a question. (NCI) | Yes | ||
Back to top | ||||||
CL.C179590.OIPRM | Non-host Organism Identifier Parameters
(OIPRM) | text
Extensible: Yes | C179590 | Non-host Organism Identifier Parameters | Parameters used to describe the levels of taxonomic and non-taxonomic nomenclature of a microorganism. | CDISC SDTM Non-host Organism Identifiers Parameter Long Name Terminology |
Clade | C179767 | Clade | A taxonomic parameter for the specification of clade of the organism. | Clade | ||
Genotype | C179768 | Genotype | A non-taxonomic parameter that can specify the genotype of the organism. | Organism by Genotype | ||
Geographical Origin | C179769 | Geographical Origin | A non-taxonomic parameter that can specify the geographic location where the organism was identified, collected or came from. | Organism by Geographic Origin | ||
Group | C179770 | Group | A non-taxonomic parameter that can specify the group of the organism. | Organism by Group | ||
Isolate | C179771 | Isolate | A non-taxonomic parameter that can specify the isolate of the organism. | Organism Isolate | ||
Lineage | C179772 | Lineage | A taxonomic parameter for the specification of lineage of the organism. | Organism Lineage | ||
NCBI GenBank ID | C43685 | GenBank ID;NCBI GenBank ID | The accession number for a gene within the National Center for Biotechnology Information (NCBI) GenBank database. | GenBank Accession Number | ||
NCBI Taxonomy ID | C179773 | NCBI Taxonomy ID | The taxonomy identifier for an organism within the National Center for Biotechnology Information (NCBI) Taxonomy database. | NCBI Taxonomy Identifier | ||
Pathotype | C187964 | Pathotype | A non-taxonomic parameter that can specify the pathotype of the organism, which is classified based on its resulting pathogenicity on a specified host. | Pathotype | ||
Pseudotype Viral Backbone | C179774 | Pseudotype Viral Backbone | A non-taxonomic parameter that can specify the pseudotype viral backbone of the engineered virus. | Organism Pseudotype Viral Backbone | ||
Species | C45293 | Species | A taxonomic parameter for the specification of species of the organism. | Species | ||
Spoligotype | C187963 | Spacer Oligonucleotide Type;Spoligotype | A non-taxonomic parameter that can specify the spoligotype of a microorganism. A spoligotype is obtained from reading of the unique spacer sequences in a highly conserved region in the genetic material of the microorganism. | Spoligotype | ||
Strain | C14419 | Strain;Strain Number | A non-taxonomic parameter that can specify the strain of the organism. | Organism Strain | ||
Subtype | C179775 | Subtype | A non-taxonomic parameter that can specify the subtype of the organism. | Organism by Subtype | ||
Type | C179776 | Type | A non-taxonomic parameter that can specify the type of the organism. | Organism by Type | ||
Year of Collection | C179777 | Year of Collection | A non-taxonomic parameter that can specify the year when the organism was collected or isolated. | Organism by Year Collected | ||
Back to top | ||||||
CL.C179591.OIPRMCD | Non-host Organism Identifier Parameters Code
(OIPRMCD) | text
Extensible: Yes | C179591 | Non-host Organism Identifier Parameters Code | Parameter codes used to describe the levels of taxonomic and non-taxonomic nomenclature of a microorganism. | CDISC SDTM Non-host Organism Identifiers Parameter Code Terminology |
CLADE | C179767 | Clade | A taxonomic parameter for the specification of clade of the organism. | Clade | ||
GENOTYPE | C179768 | Genotype | A non-taxonomic parameter that can specify the genotype of the organism. | Organism by Genotype | ||
GEOORIG | C179769 | Geographical Origin | A non-taxonomic parameter that can specify the geographic location where the organism was identified, collected or came from. | Organism by Geographic Origin | ||
GROUP | C179770 | Group | A non-taxonomic parameter that can specify the group of the organism. | Organism by Group | ||
ISOLATE | C179771 | Isolate | A non-taxonomic parameter that can specify the isolate of the organism. | Organism Isolate | ||
LINEAGE | C179772 | Lineage | A taxonomic parameter for the specification of lineage of the organism. | Organism Lineage | ||
NCBIGBID | C43685 | GenBank ID;NCBI GenBank ID | The accession number for a gene within the National Center for Biotechnology Information (NCBI) GenBank database. | GenBank Accession Number | ||
NCBITXID | C179773 | NCBI Taxonomy ID | The taxonomy identifier for an organism within the National Center for Biotechnology Information (NCBI) Taxonomy database. | NCBI Taxonomy Identifier | ||
PATHOTYP | C187964 | Pathotype | A non-taxonomic parameter that can specify the pathotype of the organism, which is classified based on its resulting pathogenicity on a specified host. | Pathotype | ||
PSDOBACK | C179774 | Pseudotype Viral Backbone | A non-taxonomic parameter that can specify the pseudotype viral backbone of the engineered virus. | Organism Pseudotype Viral Backbone | ||
SPECIES | C45293 | Species | A taxonomic parameter for the specification of species of the organism. | Species | ||
SPOLIGO | C187963 | Spacer Oligonucleotide Type;Spoligotype | A non-taxonomic parameter that can specify the spoligotype of a microorganism. A spoligotype is obtained from reading of the unique spacer sequences in a highly conserved region in the genetic material of the microorganism. | Spoligotype | ||
STRAIN | C14419 | Strain;Strain Number | A non-taxonomic parameter that can specify the strain of the organism. | Organism Strain | ||
SUBTYPE | C179775 | Subtype | A non-taxonomic parameter that can specify the subtype of the organism. | Organism by Subtype | ||
TYPE | C179776 | Type | A non-taxonomic parameter that can specify the type of the organism. | Organism by Type | ||
YEARCOLL | C179777 | Year of Collection | A non-taxonomic parameter that can specify the year when the organism was collected or isolated. | Organism by Year Collected | ||
Back to top | ||||||
CL.C154455.NSCLC1TC | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 Questionnaire Test Code
(NSCLC1TC) | text
Extensible: No | C154455 | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 Questionnaire Test Code | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 test code. | CDISC Questionnaire NSCLC-SAQ Version 1.0 Test Code Terminology |
NSCLC101 | C155621 | NSCLC1-Rate Coughing at Worst | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate your coughing at its worst over the last 7 days? | NSCLC-SAQ Version 1.0 - Rate Coughing at Worst | ||
NSCLC102 | C155622 | NSCLC1-Rate Worst Pain in Chest | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate the worst pain in your chest over the last 7 days? | NSCLC-SAQ Version 1.0 - Rate Worst Pain in Chest | ||
NSCLC103 | C155623 | NSCLC1-Rate Worst Pain Other Than Chest | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate the worst pain in areas other than your chest over the last 7 days? | NSCLC-SAQ Version 1.0 - Rate Worst Pain Other Than Chest | ||
NSCLC104 | C155624 | NSCLC1-Short of Breath Usual Activities | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you feel short of breath during usual activities over the last 7 days? | NSCLC-SAQ Version 1.0 - Short of Breath Usual Activities | ||
NSCLC105 | C155625 | NSCLC1-How Often Low Energy | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you have low energy over the last 7 days? | NSCLC-SAQ Version 1.0 - How Often Low Energy | ||
NSCLC106 | C155626 | NSCLC1-How Often Tire Easily | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you tire easily over the last 7 days? | NSCLC-SAQ Version 1.0 - How Often Tire Easily | ||
NSCLC107 | C155627 | NSCLC1-How Often Poor Appetite | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you have a poor appetite over the last 7 days? | NSCLC-SAQ Version 1.0 - How Often Poor Appetite | ||
NSCLC108 | C176206 | NSCLC1-Cough Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Cough domain subscore. | NSCLC-SAQ Version 1.0 - Cough Domain Subscore | ||
NSCLC109 | C176207 | NSCLC1-Fatigue Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Fatigue domain subscore. | NSCLC-SAQ Version 1.0 - Fatigue Domain Subscore | ||
NSCLC110 | C176208 | NSCLC1-Pain Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Pain domain subscore. | NSCLC-SAQ Version 1.0 - Pain Domain Subscore | ||
NSCLC111 | C176209 | NSCLC1-Dyspnea Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Dyspnea domain subscore. | NSCLC-SAQ Version 1.0 - Dyspnea Domain Subscore | ||
NSCLC112 | C176210 | NSCLC1-Appetite Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Appetite domain subscore. | NSCLC-SAQ Version 1.0 - Appetite Domain Subscore | ||
NSCLC113 | C155628 | NSCLC1-Total Score | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Total score. | NSCLC-SAQ Version 1.0 - Total Score | ||
Back to top | ||||||
CL.C154454.NSCLC1TN | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 Questionnaire Test Name
(NSCLC1TN) | text
Extensible: No | C154454 | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 Questionnaire Test Name | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 test name. | CDISC Questionnaire NSCLC-SAQ Version 1.0 Test Name Terminology |
NSCLC1-Appetite Domain Subscore | C176210 | NSCLC1-Appetite Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Appetite domain subscore. | NSCLC-SAQ Version 1.0 - Appetite Domain Subscore | ||
NSCLC1-Cough Domain Subscore | C176206 | NSCLC1-Cough Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Cough domain subscore. | NSCLC-SAQ Version 1.0 - Cough Domain Subscore | ||
NSCLC1-Dyspnea Domain Subscore | C176209 | NSCLC1-Dyspnea Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Dyspnea domain subscore. | NSCLC-SAQ Version 1.0 - Dyspnea Domain Subscore | ||
NSCLC1-Fatigue Domain Subscore | C176207 | NSCLC1-Fatigue Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Fatigue domain subscore. | NSCLC-SAQ Version 1.0 - Fatigue Domain Subscore | ||
NSCLC1-How Often Low Energy | C155625 | NSCLC1-How Often Low Energy | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you have low energy over the last 7 days? | NSCLC-SAQ Version 1.0 - How Often Low Energy | ||
NSCLC1-How Often Poor Appetite | C155627 | NSCLC1-How Often Poor Appetite | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you have a poor appetite over the last 7 days? | NSCLC-SAQ Version 1.0 - How Often Poor Appetite | ||
NSCLC1-How Often Tire Easily | C155626 | NSCLC1-How Often Tire Easily | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you tire easily over the last 7 days? | NSCLC-SAQ Version 1.0 - How Often Tire Easily | ||
NSCLC1-Pain Domain Subscore | C176208 | NSCLC1-Pain Domain Subscore | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Pain domain subscore. | NSCLC-SAQ Version 1.0 - Pain Domain Subscore | ||
NSCLC1-Rate Coughing at Worst | C155621 | NSCLC1-Rate Coughing at Worst | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate your coughing at its worst over the last 7 days? | NSCLC-SAQ Version 1.0 - Rate Coughing at Worst | ||
NSCLC1-Rate Worst Pain in Chest | C155622 | NSCLC1-Rate Worst Pain in Chest | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate the worst pain in your chest over the last 7 days? | NSCLC-SAQ Version 1.0 - Rate Worst Pain in Chest | ||
NSCLC1-Rate Worst Pain Other Than Chest | C155623 | NSCLC1-Rate Worst Pain Other Than Chest | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How would you rate the worst pain in areas other than your chest over the last 7 days? | NSCLC-SAQ Version 1.0 - Rate Worst Pain Other Than Chest | ||
NSCLC1-Short of Breath Usual Activities | C155624 | NSCLC1-Short of Breath Usual Activities | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - How often did you feel short of breath during usual activities over the last 7 days? | NSCLC-SAQ Version 1.0 - Short of Breath Usual Activities | ||
NSCLC1-Total Score | C155628 | NSCLC1-Total Score | Non-Small Cell Lung Cancer Symptom Assessment Questionnaire v1.0 - Total score. | NSCLC-SAQ Version 1.0 - Total Score | ||
Back to top | ||||||
CL.C101855.NSYSPCID | Non-system Reason for PCI Delay
(NSYSPCID) | text
Extensible: No | C101855 | Non-system Reason for PCI Delay | A terminology codelist that contains reasons for non-system PCI delay. | CDISC SDTM Non-system Reason for PCI Delay Terminology |
CARDIAC ARREST BEFORE PCI | C99920 | Cardiac arrest which occurs before a percutaneous coronary intervention can take place. | Cardiac Arrest Prior to Percutaneous Coronary Intervention | |||
DIFFICULT VASCULAR ACCESS | C99945 | Access to the subject's vasculature is troublesome or formidable. | Difficult Vascular Access | |||
DIFFICULTY CROSSING THE CULPRIT LESION DURING THE PCI PROCEDURE | C99946 | Placement of intracoronary devices across the coronary stenosis is troublesome or formidable. | Difficulty Crossing Culprit Lesion During Percutaneous Coronary Intervention | |||
ENDOTRACHEAL INTUBATION BEFORE PCI | C99950 | Intubation before PCI | Endotracheal intubation which occurs before a percutaneous coronary intervention can take place. | Endotracheal Intubation before Percutaneous Coronary Intervention | ||
OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
SUBJECT DELAY IN PROVIDING CONSENT | C100016 | Patient Delay in Providing Consent | The subject has not provided consent in a timely manner for the procedure to take place. | Subject Delay in Providing Consent | ||
Back to top | ||||||
CL.C101834.NORMABNM | Normal Abnormal Response
(NORMABNM) | text
Extensible: No | C101834 | Normal Abnormal Response | A terminology codelist to describe a normal or abnormal response. | CDISC SDTM Normal Abnormal Response Terminology |
ABNORMAL | C25401 | Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm. (NCI) | Abnormal | |||
INDETERMINATE | C48658 | Inconclusive | Cannot distinguish between two or more possible values in the current context. (NCI) | Indeterminate | ||
NORMAL | C14165 | Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI) | Normal | |||
NOT EVALUABLE | C62222 | Not Assessable;Not Evaluable | Unable to be evaluated. (NCI) | Unevaluable | ||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C132517.NSAA1TC | North Star Ambulatory Assessment Clinical Classification Test Code
(NSAA1TC) | text
Extensible: No | C132517 | North Star Ambulatory Assessment Clinical Classification Test Code | North Star Ambulatory Assessment test code. | CDISC Clinical Classification NSAA Test Code Terminology |
NSAA101 | C132536 | NSAA1-Stand | North Star Ambulatory Assessment - Can you stand up tall for me for as long as you can and as still as you can. | NSAA - Stand | ||
NSAA102 | C132537 | NSAA1-Walk | North Star Ambulatory Assessment - Can you walk from A to B (state to and where from) for me. | NSAA - Walk | ||
NSAA103 | C132538 | NSAA1-Stand Up From Chair | North Star Ambulatory Assessment - Stand up from the chair keeping your arms folded if you can. | NSAA - Stand Up From Chair | ||
NSAA104 | C132539 | NSAA1-Stand on One Leg - Right | North Star Ambulatory Assessment - Can you stand on your right leg for as long as you can? | NSAA - Stand on One Leg - Right | ||
NSAA105 | C132540 | NSAA1-Stand on One Leg - Left | North Star Ambulatory Assessment - Can you stand on your left leg for as long as you can? | NSAA - Stand on One Leg - Left | ||
NSAA106 | C132541 | NSAA1-Climb Box Step - Right | North Star Ambulatory Assessment - Can you step onto the top of the box using your right leg first? | NSAA - Climb Box Step - Right | ||
NSAA107 | C132542 | NSAA1-Climb Box Step - Left | North Star Ambulatory Assessment - Can you step onto the top of the box using your left leg first? | NSAA - Climb Box Step - Left | ||
NSAA108 | C132543 | NSAA1-Descend Box Step - Right | North Star Ambulatory Assessment - Can you step down from the box using your right leg first? | NSAA - Descend Box Step - Right | ||
NSAA109 | C132544 | NSAA1-Descend Box Step - Left | North Star Ambulatory Assessment - Can you step down from the box using your left leg first? | NSAA - Descend Box Step - Left | ||
NSAA110 | C132545 | NSAA1-Gets to Sitting | North Star Ambulatory Assessment - Can you get from lying to sitting? | NSAA - Gets to Sitting | ||
NSAA111 | C132546 | NSAA1-Rise From Floor | North Star Ambulatory Assessment - Get up from the floor using as little support as possible and as fast as you can (from supine). | NSAA - Rise From Floor | ||
NSAA111A | C132547 | NSAA1-Rise From Floor Time | North Star Ambulatory Assessment - Time to get up from the floor using as little support as possible and as fast as you can (from supine) (seconds). | NSAA - Rise From Floor Time | ||
NSAA112 | C132548 | NSAA1-Lifts Head | North Star Ambulatory Assessment - Lift your head to look at your toes keeping your arms folded. | NSAA - Lifts Head | ||
NSAA113 | C132549 | NSAA1-Stands on Heels | North Star Ambulatory Assessment - Can you stand on your heels? | NSAA - Stands on Heels | ||
NSAA114 | C132550 | NSAA1-Jump | North Star Ambulatory Assessment - How high can you jump? | NSAA - Jump | ||
NSAA115 | C132551 | NSAA1-Hop Right Leg | North Star Ambulatory Assessment - Can you hop on your right leg? | NSAA - Hop Right Leg | ||
NSAA116 | C132552 | NSAA1-Hop Left Leg | North Star Ambulatory Assessment - Can you hop on your left leg? | NSAA - Hop Left Leg | ||
NSAA117 | C132553 | NSAA1-Run (10m) | North Star Ambulatory Assessment - Run as fast as you can to...(give point). | NSAA - Run (10m) | ||
NSAA117A | C132554 | NSAA1-Run (10m) Time | North Star Ambulatory Assessment - Time to run as fast as you can (seconds). | NSAA - Run (10m) Time | ||
NSAA118 | C132555 | NSAA1-Total | North Star Ambulatory Assessment - Total. | NSAA - Total | ||
Back to top | ||||||
CL.C132516.NSAA1TN | North Star Ambulatory Assessment Clinical Classification Test Name
(NSAA1TN) | text
Extensible: No | C132516 | North Star Ambulatory Assessment Clinical Classification Test Name | North Star Ambulatory Assessment test name. | CDISC Clinical Classification NSAA Test Name Terminology |
NSAA1-Climb Box Step - Left | C132542 | NSAA1-Climb Box Step - Left | North Star Ambulatory Assessment - Can you step onto the top of the box using your left leg first? | NSAA - Climb Box Step - Left | ||
NSAA1-Climb Box Step - Right | C132541 | NSAA1-Climb Box Step - Right | North Star Ambulatory Assessment - Can you step onto the top of the box using your right leg first? | NSAA - Climb Box Step - Right | ||
NSAA1-Descend Box Step - Left | C132544 | NSAA1-Descend Box Step - Left | North Star Ambulatory Assessment - Can you step down from the box using your left leg first? | NSAA - Descend Box Step - Left | ||
NSAA1-Descend Box Step - Right | C132543 | NSAA1-Descend Box Step - Right | North Star Ambulatory Assessment - Can you step down from the box using your right leg first? | NSAA - Descend Box Step - Right | ||
NSAA1-Gets to Sitting | C132545 | NSAA1-Gets to Sitting | North Star Ambulatory Assessment - Can you get from lying to sitting? | NSAA - Gets to Sitting | ||
NSAA1-Hop Left Leg | C132552 | NSAA1-Hop Left Leg | North Star Ambulatory Assessment - Can you hop on your left leg? | NSAA - Hop Left Leg | ||
NSAA1-Hop Right Leg | C132551 | NSAA1-Hop Right Leg | North Star Ambulatory Assessment - Can you hop on your right leg? | NSAA - Hop Right Leg | ||
NSAA1-Jump | C132550 | NSAA1-Jump | North Star Ambulatory Assessment - How high can you jump? | NSAA - Jump | ||
NSAA1-Lifts Head | C132548 | NSAA1-Lifts Head | North Star Ambulatory Assessment - Lift your head to look at your toes keeping your arms folded. | NSAA - Lifts Head | ||
NSAA1-Rise From Floor Time | C132547 | NSAA1-Rise From Floor Time | North Star Ambulatory Assessment - Time to get up from the floor using as little support as possible and as fast as you can (from supine) (seconds). | NSAA - Rise From Floor Time | ||
NSAA1-Rise From Floor | C132546 | NSAA1-Rise From Floor | North Star Ambulatory Assessment - Get up from the floor using as little support as possible and as fast as you can (from supine). | NSAA - Rise From Floor | ||
NSAA1-Run (10m) Time | C132554 | NSAA1-Run (10m) Time | North Star Ambulatory Assessment - Time to run as fast as you can (seconds). | NSAA - Run (10m) Time | ||
NSAA1-Run (10m) | C132553 | NSAA1-Run (10m) | North Star Ambulatory Assessment - Run as fast as you can to...(give point). | NSAA - Run (10m) | ||
NSAA1-Stand on One Leg - Left | C132540 | NSAA1-Stand on One Leg - Left | North Star Ambulatory Assessment - Can you stand on your left leg for as long as you can? | NSAA - Stand on One Leg - Left | ||
NSAA1-Stand on One Leg - Right | C132539 | NSAA1-Stand on One Leg - Right | North Star Ambulatory Assessment - Can you stand on your right leg for as long as you can? | NSAA - Stand on One Leg - Right | ||
NSAA1-Stand Up From Chair | C132538 | NSAA1-Stand Up From Chair | North Star Ambulatory Assessment - Stand up from the chair keeping your arms folded if you can. | NSAA - Stand Up From Chair | ||
NSAA1-Stand | C132536 | NSAA1-Stand | North Star Ambulatory Assessment - Can you stand up tall for me for as long as you can and as still as you can. | NSAA - Stand | ||
NSAA1-Stands on Heels | C132549 | NSAA1-Stands on Heels | North Star Ambulatory Assessment - Can you stand on your heels? | NSAA - Stands on Heels | ||
NSAA1-Total | C132555 | NSAA1-Total | North Star Ambulatory Assessment - Total. | NSAA - Total | ||
NSAA1-Walk | C132537 | NSAA1-Walk | North Star Ambulatory Assessment - Can you walk from A to B (state to and where from) for me. | NSAA - Walk | ||
Back to top | ||||||
CL.C66789.ND | Not Done
(ND) | text
Extensible: No | C66789 | Not Done | Indicates a task, process or examination that has either not been initiated or completed. (NCI) | CDISC SDTM Not Done Terminology |
NOT DONE | C49484 | Indicates a task, process or examination that has either not been initiated or completed. (NCI) | Not Done | |||
Back to top | ||||||
CL.C154685.NTFATSCD | Nutrition Findings About Test Code
(NTFATSCD) | text
Extensible: Yes | C154685 | Nutrition Findings About Test Code | Terminology relevant to the test codes that describe findings about a nutrition event or intervention. | CDISC SDTM Nutrition Findings About Test Code Terminology |
EVENTFRQ | C25515 | Event Frequency | The number of times an event occurs within a given time period. | Temporal Frequency | ||
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
SEV | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C154686.NTFATS | Nutrition Findings About Test Name
(NTFATS) | text
Extensible: Yes | C154686 | Nutrition Findings About Test Name | Terminology relevant to the test names that describe findings about a nutrition event or intervention. | CDISC SDTM Nutrition Findings About Test Name Terminology |
Event Frequency | C25515 | Event Frequency | The number of times an event occurs within a given time period. | Temporal Frequency | ||
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Severity/Intensity | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C127258.OBSSBSR | Observational Study Biospecimen Retention
(OBSSBSR) | text
Extensible: Yes | C127258 | Observational Study Biospecimen Retention | The terminology relevant to whether biospecimens were retained and contain DNA within an observational study. | CDISC SDTM Observational Study Biospecimen Retention Terminology |
SAMPLES NOT RETAINED | C127776 | An indication that no biospecimen samples were retained. | Biospecimens Not Retained | |||
SAMPLES WITH DNA RETAINED | C127777 | An indication that the retained biospecimens contain DNA. | Retained Specimens Contain DNA | |||
SAMPLES WITHOUT DNA RETAINED | C127778 | An indication that the retained biospecimens do not contain DNA. | Retained Specimens Do Not Contain DNA | |||
Back to top | ||||||
CL.C127259.OBSSMO | Observational Study Model
(OBSSMO) | text
Extensible: Yes | C127259 | Observational Study Model | The terminology relevant to the trial design for observational studies. | CDISC SDTM Observational Study Model Terminology |
CASE CONTROL | C15197 | A study that compares groups of people with generally similar characteristics, those with the condition under study (case) and those without the condition under study (control). | Case-Control Study | |||
CASE CROSSOVER | C127779 | A study in which the subject characteristics of the case, immediately prior to disease onset (sometimes called the hazard period), are compared to characteristics of same case at a prior time (i.e., control period). (ClinicalTrials.gov) | Observational Case-Crossover Study | |||
CASE ONLY | C15362 | A study in which the subject with the condition under study (the case) is compared against a theoretical/historical model of distribution that serves as a control. | Case Study | |||
COHORT | C15208 | A study in which subjects are grouped based on a predefined personal or administrative characteristic. | Cohort Study | |||
ECOLOGIC OR COMMUNITY | C127780 | A study in which geographically distinct study populations are compared with respect to a particular outcome. | Ecologic or Community Based Study | |||
FAMILY BASED | C15407 | A study in which related or non-related family members are compared with respect to a particular outcome. | Family Study | |||
Back to top | ||||||
CL.C127260.OBSSSM | Observational Study Sampling Method
(OBSSSM) | text
Extensible: Yes | C127260 | Observational Study Sampling Method | The terminology relevant to the method by which the study population is selected in an observational study. | CDISC SDTM Observational Study Sampling Method Terminology |
NON-PROBABILITY SAMPLE | C127781 | A non-random process used to select a study population in which the participants have been selected based on convenience or with a particular purpose in mind. | Non-Probability Sampling Method | |||
PROBABILITY SAMPLE | C71517 | An exclusively random process to guarantee that each participant or population has specified chance of selection, such as simple random sampling, systematic sampling, stratified random sampling, cluster sampling, and consecutive patient sampling. (clinicaltrials.gov) | Equal Probability Sampling Method | |||
Back to top | ||||||
CL.C127261.OBSSTP | Observational Study Time Perspective
(OBSSTP) | text
Extensible: Yes | C127261 | Observational Study Time Perspective | The terminology relevant to the temporal relationship between the observation period and time of subject enrollment in an observational study. | CDISC SDTM Observational Study Time Perspective Terminology |
CROSS SECTIONAL | C53310 | Studies in which observations or measurements made at a single point in time, usually at subject enrollment. (clinicaltrials.gov) | Cross-Sectional Study | |||
PROSPECTIVE | C15273 | Studies that look forward using periodic observations collected predominantly following subject enrollment. (clinicaltrials.gov) | Longitudinal Study | |||
RETROSPECTIVE | C53312 | Studies that look back using observations collected predominantly prior to subject selection and enrollment. (clinicaltrials.gov) | Retrospective Study | |||
Back to top | ||||||
CL.C96785.ONCRSR | Oncology Response Assessment Result
(ONCRSR) | text
Extensible: Yes | C96785 | Oncology Response Assessment Result | Terminology for oncology studies relevant to the result of response to treatment or therapy assessment within the disease response and clinical classification domain. | CDISC SDTM Tumor Response Result Terminology |
ABSENT MORPHOLOGIC RESPONSE | C123571 | The absence of change in the overall attenuation of the metastasis and in the peripheral rim, suggesting a lack of response to treatment. | Absent Morphologic Response | |||
CA125 50% RESPONSE | C123572 | Cancer Antigen 125 50% Response | The amount of cancer antigen 125 is reduced by 50% from protocol-defined baseline value(s). | CA125 50% Response | ||
CA125 75% RESPONSE | C123573 | Cancer Antigen 125 75% Response | The amount of cancer antigen 125 is reduced by 75% from protocol-defined baseline value(s). | CA125 75% Response | ||
cCR | C123574 | Clinical Complete Remission;Clinical Complete Response | The disappearance of all signs of cancer based on physical exam, such as palpation. | Clinical Complete Response | ||
CHR | C123575 | Complete Hematologic Remission;Complete Hematologic Response | The disappearance of cancer in response to treatment, including platelet and white blood cell counts returning to normal levels, a non-palpable spleen, and no immature white blood cells present in the blood unless it is a regenerating marrow following treatment. | Complete Hematologic Response | ||
CLINICAL RELAPSE | C191345 | The return of a disease after a period of remission, as determined by clinical signs and symptoms. | Clinical Relapse | |||
CMR | C123407 | Complete Metabolic Response | The disappearance of metabolic tumor activity in all relevant lesions. | Tumor Complete Metabolic Response | ||
cPR | C123576 | Clinical Partial Remission;Clinical Partial Response | A decrease in the size and the extent of tissue involvement by cancer, based on physical exam, such as palpation. | Clinical Partial Response | ||
CR | C4870 | Complete Remission;Complete Response | The disappearance of all signs of cancer in response to treatment. (NCI) | Complete Remission | ||
CR-CT | C123577 | Complete Remission, CT-Based;Complete Response, CT-Based | The disappearance of all signs of cancer, based on CT scan and criteria-defined assessments. | Complete Response by Computed Tomography | ||
CRi | C103385 | Complete Remission with Incomplete Blood Count Recovery;Complete Response with Incomplete Bone Marrow Recovery | The disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia. | Complete Response with Incomplete Bone Marrow Recovery | ||
CYTOGENETIC CR | C123578 | CCgR;CCyR;Complete Cytogenetic Response;CRc;Cytogenetic Complete Remission;Cytogenetic Complete Response | The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment. | Cytogenetic Complete Response | ||
CYTOGENETIC MINIMAL RESPONSE | C123579 | Minimal CgR | A minimal decrease in abnormal karyotype, based on pre-defined thresholds. | Cytogenetic Minimal Response | ||
CYTOGENETIC MINOR RESPONSE | C123580 | Minor CgR | A minor decrease in abnormal karyotype, based on pre-defined thresholds. | Cytogenetic Minor Response | ||
CYTOGENETIC NO RESPONSE | C123581 | No CgR;No Cytogenetic Response | No change in abnormal karyotype, based on pre-defined thresholds. | Cytogenetic No Response | ||
CYTOGENETIC PR | C123582 | Cytogenetic Partial Response;Partial CgR | A partial decrease in abnormal karyotype, based on pre-defined thresholds. | Cytogenetic Partial Response | ||
DECREASED | C25640 | Reduced | Made less in size, amount, degree, or extent. | Reduced | ||
DISEASE TRANSFORMATION | C123583 | A conversion from one disease diagnosis to another, which may be considered a progression to a worsening state. | Disease Transformation | |||
EQUIVOCAL | C86071 | Open to question. | Equivocal | |||
FAVORABLE RESPONSE | C123584 | No new lesions(s) and a decrease in lesion size, or a reduction in central necrosis or attenuation in one or more enhancing lesions, based on pre-defined thresholds. | Favorable Response | |||
HI-E | C123585 | Hematologic Improvement-Erythroid Response | An improvement in erythrocyte count as a response to treatment. | Hematologic Improvement-Erythroid Response | ||
HI-N | C123586 | Hematologic Improvement-Neutrophil Response | An improvement of neutrophil count as a response to treatment. | Hematologic Improvement-Neutrophil Response | ||
HI-P | C123587 | Hematologic Improvement-Platelet Response | An improvement of platelet count as a response to treatment. | Hematologic Improvement-Platelet Response | ||
iCPD | C142356 | Radiographic progression which has been confirmed by additional imaging showing worsening of initial progression. | iRECIST Confirmed Progressive Disease | |||
iCR | C142357 | The disappearance of all signs of cancer following an initial apparent radiographic progression. | iRECIST Complete Response | |||
IMMUNOPHENOTYPIC CR | C123588 | Immunophenotypic Complete Response | The disappearance of all signs of cancer, supported by the absence of phenotypically aberrant plasma cells (clonal) in bone marrow. (Rajkumar SV, Harousseau J, Durie B et al, Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. Blood. 2011; 117(18):4691-4695) | Immunophenotypic Complete Response | ||
IMPROVED | C125459 | Better | A subjective response indicating that something has improved or gotten better. | Improved | ||
INCREASED | C25533 | A process of becoming larger, more intense, more extensive, more numerous, more important, or more likely. | Increase | |||
INDETERMINATE RESPONSE | C123589 | A response that is neither favorable nor unfavorable. | Indeterminate Response | |||
INDETERMINATE | C48658 | Inconclusive | Cannot distinguish between two or more possible values in the current context. (NCI) | Indeterminate | ||
iPR | C142358 | A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer following an initial apparent radiographic progression. | iRECIST Partial Response | |||
iSD | C142359 | Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries following an initial apparent radiographic progression. | iRECIST Stable Disease | |||
iUPD | C142360 | Apparent radiographic progression which requires confirmation, per criteria, with additional imaging. | iRECIST Unconfirmed Progressive Disease | |||
MAJOR PATHOLOGIC RESPONSE | C123590 | A major decrease in signs of cancer, supported by pathological examination and based on pre-defined thresholds. | Major Pathologic Response | |||
mCR | C123591 | Marrow Complete Remission;Marrow Complete Response | A decrease in the number of bone marrow plasma cells to protocol-defined level(s). | Marrow Complete Response | ||
MINOR PATHOLOGIC RESPONSE | C123592 | A minor decrease in signs of cancer, supported by pathological examination and based on pre-defined thresholds. | Minor Pathologic Response | |||
MOLECULAR CR | C123593 | CMR;Complete Molecular Response;Molecular Complete Remission;Molecular Complete Response | The disappearance of all signs of cancer, supported by molecular analysis. | Molecular Complete Response | ||
MOLECULAR MAJOR RESPONSE | C123594 | Major Molecular Response;MMolR;MMR | A decrease in signs of cancer, supported by molecular analysis. | Molecular Major Response | ||
MORPHOLOGIC CR | C123595 | Morphologic Complete Remission;Morphologic Complete Response | The disappearance of all signs of cancer, supported by morphological analysis. | Morphologic Complete Response | ||
MORPHOLOGIC CRi | C123596 | Morphologic Complete Remission with Incomplete Blood Count Recovery;Morphologic Complete Remission with Incomplete Bone Marrow Recovery | The disappearance of all cells with morphologic characteristics of cancer, accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia. | Morphologic Complete Remission with Incomplete Blood Count Recovery | ||
MORPHOLOGIC LEUKEMIA-FREE STATE | C123597 | NEL;No Evidence of Leukemia | The disappearance of all cells with morphologic characteristics of leukemia, accompanied by bone marrow recovery, in response to treatment. Hematologic recovery is not required. Leukemia free state can be a hypocellular marrow. | Morphologic Leukemia-Free State | ||
MR | C123598 | Minimal Response;Minor Response | A finding that refers to hematologic and solid malignancies and indicates that there is a minor improvement in the measures of disease burden, meeting a predetermined threshold, but not meeting partial response criteria. | Minimal Response | ||
MRD RELAPSE | C124430 | Minimal Residual Disease Relapse;MRD Reappearance;Relapse from MRD Negative | Presence of residual disease based on pre-defined thresholds and return of quantifiable minimal residual disease positivity after a period of minimal residual disease negativity. | Measurable Residual Disease Relapse | ||
NE | C62222 | Not Assessable;Not Evaluable | Unable to be evaluated. (NCI) | Unevaluable | ||
NED | C40413 | No Evidence of Disease | An absence of detectable disease. | No Evidence of Disease | ||
NEGATIVE | C38757 | An indication of a negative finding for a test or assessment, such as for a disease, condition, analyte, or microorganism. | Negative Finding | |||
NON-CR/NON-PD | C96700 | Non Complete Response/Non Progressive Disease | Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247.) | Non Complete Response/Non Progressive Disease | ||
NON-iCR/NON-iUPD | C142361 | Persistence of one or more non-target lesion(s) without unequivocal progression following an initial apparent radiographic progression. | Non iRECIST Complete Response-Non iRECIST Unconfirmed Progressive Disease | |||
NON-PD | C123599 | Non Progressive Disease | Following a previous assessment of progressive disease unconfirmed (PDu) of non-target lesion(s), the subsequent required assessment does not confirm progressive disease. | Non Progressive Disease | ||
NON-QUANTIFIABLE MRD POSITIVITY | C124431 | Non-Quantifiable Minimal Residual Disease Positivity | Presence of non-quantifiable minimal residual disease based on laboratory techniques. | Non-Quantifiable Measurable Residual Disease Positivity | ||
NONE BEYOND PHYSIOLOGIC REPLACEMENT DOSE | C161412 | An indication that the subject's steroid dose is the same as their physiologic replacement dose. | No Steroid Use Beyond Physiologic Replacement Dose | |||
NOT ALL EVALUATED | C103424 | Not All Evaluated | Not all target lesions were assessed. Or not all non-target lesions were assessed. | Not All Lesions Evaluated | ||
nPR | C70633 | Nodular Partial Response | Remission with remaining lymphoid nodules reflecting residual disease. | Nodular Partial Remission | ||
NR | C123600 | No Response | No apparent change or worsening in lesion staging classification. | No Response | ||
OPTIMAL MORPHOLOGIC RESPONSE | C123601 | Hypo-attenuation of the metastases which may appear pseudocystic, perfectly homogeneous, and devoid of a recognizable peripheral rim. | Optimal Morphologic Response | |||
PARTIAL MORPHOLOGIC RESPONSE | C123602 | Mixed attenuation and some homogeneity of the metastases with a partially resolved peripheral rim. | Partial Morphologic Response | |||
pCR | C123603 | Complete Pathological Response;Pathologic Complete Remission;Pathologic Complete Response | The disappearance of all signs of cancer, supported by pathological examination. | Pathologic Complete Response | ||
PD FROM PR | C123604 | Progression from PR;Progressive Disease from Partial Response | Disease progression occurring after a partial response. | Progression from Partial Response | ||
PD | C35571 | Disease Progression;Progressive Disease | A disease process that is increasing in extent or severity. (NCI) | Progressive Disease | ||
PD-CT | C123606 | Progressive Disease, CT-Based | There is an increase in the size and extent of tissue involvement by cancer, based on CT scan and criteria-defined assessments. | Progressive Disease by Computed Tomography | ||
PD/RELAPSE AFTER HI | C123605 | Progression or Relapse After Hematologic Improvement | Disease progression or the return of a disease after a period of remission, occurring after a hematologic improvement. | Progression or Relapse After Hematologic Improvement | ||
PDu | C123607 | PD Unconfirmed;Unconfirmed Progressive Disease | A disease process that is increasing in scope or severity but the criteria for progressive disease is not met. | Unconfirmed Progressive Disease | ||
PMD | C123608 | Progressive Metabolic Disease | An increase of metabolic tumor activity in all relevant lesions, based on pre-defined thresholds, or the development of new lesions. | Progressive Metabolic Disease | ||
PMR | C123609 | Partial Metabolic Response | A decrease of metabolic tumor activity in all relevant lesions, based on a pre-defined threshold. | Partial Metabolic Response | ||
POSITIVE | C38758 | An indication of an affirmative finding for a test or assessment, such as for a disease, condition, analyte, or microorganism. | Positive Finding | |||
PR WITH LYMPHOCYTOSIS | C128998 | Partial Response with Lymphocytosis;PR-L;PRL | A decrease in the size and the extent of tissue involvement by cancer, accompanied by an increase in blood lymphocyte count above a predetermined threshold. | Partial Response with Lymphocytosis | ||
PR | C18058 | Partial Remission;Partial Response | A finding indicating that there is a decrease based on a predetermined threshold in the size and the extent of tissue involvement by cancer. | Partial Remission | ||
PR-CT | C123610 | Partial Remission, CT-Based;Partial Response, CT-Based | A decrease in the size and extent of tissue involvement by cancer, based on CT scan and criteria-defined assessments. | Partial Response by Computed Tomography | ||
PSA PROGRESSION | C123611 | Prostate Specific Antigen Progression | The amount of prostate specific antigen is increased, based on pre-defined thresholds. | PSA Progression | ||
PSEUDOPROGRESSION | C98298 | Apparent increase in lesion burden, not proven to be disease progression. | Pseudoprogression | |||
PSEUDORESPONSE | C131142 | Apparent decrease in lesion burden, not proven to be favorable treatment response. | Pseudoresponse | |||
QUANTIFIABLE MRD POSITIVITY | C124432 | Quantifiable Minimal Residual Disease Positivity | Presence of quantifiable minimal residual disease based on laboratory techniques. | Quantifiable Measurable Residual Disease Positivity | ||
RELAPSED DISEASE FROM CR OR PR | C123613 | Relapsed Disease From Complete Response or Partial Response | The return of a disease after a period of complete remission or partial remission. | Relapsed Disease From Complete or Partial Response | ||
RELAPSED DISEASE FROM CR | C123612 | Relapse from CR;Relapsed Disease From Complete Response | The return of a disease after a period of complete remission. | Relapsed Disease From Complete Response | ||
RELAPSED DISEASE | C38155 | Recurrent Disease | The return of a disease after a period of remission. | Recurrent Disease | ||
sCR | C123614 | Stringent Complete Remission;Stringent Complete Response | The confirmed disappearance of all signs of cancer, and absence of molecular or cytogenetic marker of disease, in response to treatment with additional biochemical, immunological and histopathological analyses to verify the CR. | Stringent Complete Response | ||
SD | C18213 | Stable Disease | Cancer that is neither decreasing nor increasing in extent or severity based on predetermined boundaries. (NCI) | Stable Disease | ||
SD-CT | C123615 | Stable Disease, CT-Based | The size and extent of tissue involvement by cancer is neither decreasing nor increasing, based on CT scan and criteria-defined assessments. | Stable Disease by Computed Tomography | ||
SMD | C123616 | NMR;No Metabolic Response;Stable Metabolic Disease | The absence of change or mild changes of metabolic tumor activity in all relevant lesions based on a pre-defined threshold. | Stable Metabolic Disease | ||
STABLE | C30103 | Subject to little fluctuation; showing little if any change. (NCI) | Stable | |||
TREATMENT FAILURE | C48226 | The lack of expected or desired effect related to a therapy. (NCI) | Lack of Efficacy | |||
UNEQUIVOCAL | C123645 | Leaving no doubt; not open to question. (NCI) | Unequivocal | |||
UNFAVORABLE RESPONSE | C123617 | An increase in lesion size, based on a pre-defined threshold, or the development of new lesion(s), marked central fill-in of a lesion, or new enhancement of a previously homogeneously hypoattenuating nonenhancing mass. | Unfavorable Response | |||
VGPR | C123618 | Very Good Partial Remission;Very Good Partial Response | Partial response with additional serum and urine M-protein reduction, but not meeting complete response. | Very Good Partial Response | ||
WORSENED | C71686 | In a declining condition or state. | Worse | |||
Back to top | ||||||
CL.C96782.ONCRTSCD | Oncology Response Assessment Test Code
(ONCRTSCD) | text
Extensible: Yes | C96782 | Oncology Response Assessment Test Code | Terminology for oncology studies relevant to the test codes that describe an assessment of response to treatment or therapy within the disease response and clinical classification domain. | CDISC SDTM Tumor Response Assessment Test Code Terminology |
ANATRESP | C156564 | Anatomic Response | An assessment of the anatomic response (based on changes in size of anatomic structures) of the disease to the therapy. | Anatomic Response | ||
BESTRESP | C94536 | Best Overall Response;Best Response | An assessment of the most clinically favorable overall response of the disease to the therapy. | Best Overall Response | ||
BMIVLIND | C135477 | Bone Marrow Involvement Indicator | An indication as to whether disease is present in the bone marrow. | Bone Marrow Disease Involvement Indicator | ||
BMRRESP | C173307 | Bone Marrow Response | An assessment of the disease response to therapy within the bone marrow. | Bone Marrow Response | ||
BONERESP | C132455 | Bone Response | An assessment of the bone response of the disease to the therapy. | Bone Response | ||
CLINRESP | C123619 | Clinical Response | An assessment of the clinical response of the disease to the therapy. | Clinical Response | ||
CPRFSTAT | C135478 | Clinical Performance Status | An assessment of the clinical performance, measured by a rating or scale, as a condition of disease response to therapy. (NCI) | Clinical Performance Status | ||
CYTORESP | C123620 | Cytogenetic Response | An assessment of the cytogenetic response of the disease to the therapy. | Cytogenetic Response | ||
DRCRIND | C123621 | Disease Recurrence Indicator | An indication as to whether disease recurrence occurred. | Disease Recurrence Indicator | ||
HEMARESP | C123622 | Hematologic Response | An assessment of the hematologic response of the disease to the therapy. | Hematologic Response | ||
LIVRRESP | C135479 | Liver Response | An assessment of the disease response to therapy within the liver. | Disease Response in Liver | ||
METBRESP | C123623 | Metabolic Response | An assessment of the metabolic response of the disease to the therapy. | Metabolic Response | ||
METSIND | C132456 | Metastatic Indicator | An indication as to whether disease metastasis has occurred. | Metastatic Disease Indicator | ||
MJPTHIND | C172576 | Major Pathological Response Indicator | An indication as to whether major pathological response occurred. | Major Pathological Response Indicator | ||
MNPTHIND | C172577 | Minor Pathological Response Indicator | An indication as to whether minor pathological response occurred. | Minor Pathological Response Indicator | ||
MOLRESP | C123624 | Molecular Response | An assessment of the molecular response of the disease to the therapy. | Molecular Response | ||
MRDIND | C172578 | Minimal Residual Disease Indicator;MRD Indicator | An indication as to whether the subject has minimal residual disease. | Measurable Residual Disease Indicator | ||
MRDRESP | C124433 | Minimal Residual Disease Response;MRD Response | An assessment of the minimal residual disease response of the disease to the therapy. | Measurable Residual Disease Response | ||
MRPHRESP | C123625 | Morphologic Response | An assessment of the morphologic response of the disease to the therapy. | Morphologic Response | ||
NEWLIND | C142362 | New Lesion Indicator | An indication as to whether new lesions are present, in comparison to a previous timepoint. | New Lesion Indicator | ||
NEWLPROG | C103420 | New Lesion Progression | An assessment of the equivocality of disease progression based on a newly identified lesion. | New Lesion Progression | ||
NEWLWIND | C142363 | New Lesion Worsening Indicator | An indication as to whether the previously identified new lesions are showing signs of worsening. | New Lesion Worsening Indicator | ||
NTERESP | C135480 | Non-Target Enhancing Response | An assessment of the response to the therapy of the non-target enhancing disease. (NCI) | Non-Target Enhancing Lesion Response | ||
NTLWIND | C142364 | Non-Target Lesion Worsening Indicator | An indication as to whether non-target lesions, which have previously shown progression, are showing additional signs of worsening. | Non-Target Lesion Worsening Indicator | ||
NTNERESP | C135481 | Non-Target Non-Enhancing Response | An assessment of the response to the therapy of the non-target non-enhancing disease. (NCI) | Non-Target Non-Enhancing Lesion Response | ||
NTRGRESP | C94535 | Non-target Response | An assessment of the response of a non-target lesion(s) to the therapy. | Response in Non-Target Lesion | ||
OVRLRESP | C96613 | Overall Response | An assessment of the overall response of the disease to the therapy. (NCI) | Overall Response | ||
PATHRESP | C123626 | Pathologic Response | An assessment of the pathologic response of the disease to the therapy. | Pathologic Response | ||
RDIORESP | C123627 | Radiologic Response | An assessment of the radiologic response of the disease to the therapy. | Radiologic Response | ||
SFTSRESP | C132457 | Soft Tissue Response | An assessment of the soft tissue response of the disease to the therapy. | Soft Tissue Response | ||
SPLNRESP | C135482 | Spleen Response | An assessment of the disease response to therapy within the spleen. | Disease Response in Spleen | ||
STRUSTAT | C135483 | Steroid Use Status | An assessment of steroid usage as a condition of disease response to therapy. (NCI) | Steroid Use Status | ||
SYMPTDTR | C124434 | Symptomatic Deterioration | A global deterioration of health status providing evidence of disease progression not covered by disease response criteria (eg. RECIST). | Symptomatic Deterioration | ||
TMRESP | C132458 | Tumor Marker Response | An assessment of disease response to therapy based on tumor marker measurement. | Tumor Marker Response | ||
TRGRESP | C94534 | Target Response | An assessment of the response of a target lesion(s) to the therapy. | Response in Target Lesion | ||
Back to top | ||||||
CL.C96781.ONCRTS | Oncology Response Assessment Test Name
(ONCRTS) | text
Extensible: Yes | C96781 | Oncology Response Assessment Test Name | Terminology for oncology studies relevant to the test names that describe an assessment of response to treatment or therapy within the disease response and clinical classification domain. | CDISC SDTM Tumor Response Assessment Test Name Terminology |
Anatomic Response | C156564 | Anatomic Response | An assessment of the anatomic response (based on changes in size of anatomic structures) of the disease to the therapy. | Anatomic Response | ||
Best Overall Response | C94536 | Best Overall Response;Best Response | An assessment of the most clinically favorable overall response of the disease to the therapy. | Best Overall Response | ||
Bone Marrow Involvement Indicator | C135477 | Bone Marrow Involvement Indicator | An indication as to whether disease is present in the bone marrow. | Bone Marrow Disease Involvement Indicator | ||
Bone Marrow Response | C173307 | Bone Marrow Response | An assessment of the disease response to therapy within the bone marrow. | Bone Marrow Response | ||
Bone Response | C132455 | Bone Response | An assessment of the bone response of the disease to the therapy. | Bone Response | ||
Clinical Performance Status | C135478 | Clinical Performance Status | An assessment of the clinical performance, measured by a rating or scale, as a condition of disease response to therapy. (NCI) | Clinical Performance Status | ||
Clinical Response | C123619 | Clinical Response | An assessment of the clinical response of the disease to the therapy. | Clinical Response | ||
Cytogenetic Response | C123620 | Cytogenetic Response | An assessment of the cytogenetic response of the disease to the therapy. | Cytogenetic Response | ||
Disease Recurrence Indicator | C123621 | Disease Recurrence Indicator | An indication as to whether disease recurrence occurred. | Disease Recurrence Indicator | ||
Hematologic Response | C123622 | Hematologic Response | An assessment of the hematologic response of the disease to the therapy. | Hematologic Response | ||
Liver Response | C135479 | Liver Response | An assessment of the disease response to therapy within the liver. | Disease Response in Liver | ||
Major Pathological Response Indicator | C172576 | Major Pathological Response Indicator | An indication as to whether major pathological response occurred. | Major Pathological Response Indicator | ||
Metabolic Response | C123623 | Metabolic Response | An assessment of the metabolic response of the disease to the therapy. | Metabolic Response | ||
Metastatic Indicator | C132456 | Metastatic Indicator | An indication as to whether disease metastasis has occurred. | Metastatic Disease Indicator | ||
Minimal Residual Disease Indicator | C172578 | Minimal Residual Disease Indicator;MRD Indicator | An indication as to whether the subject has minimal residual disease. | Measurable Residual Disease Indicator | ||
Minimal Residual Disease Response | C124433 | Minimal Residual Disease Response;MRD Response | An assessment of the minimal residual disease response of the disease to the therapy. | Measurable Residual Disease Response | ||
Minor Pathological Response Indicator | C172577 | Minor Pathological Response Indicator | An indication as to whether minor pathological response occurred. | Minor Pathological Response Indicator | ||
Molecular Response | C123624 | Molecular Response | An assessment of the molecular response of the disease to the therapy. | Molecular Response | ||
Morphologic Response | C123625 | Morphologic Response | An assessment of the morphologic response of the disease to the therapy. | Morphologic Response | ||
New Lesion Indicator | C142362 | New Lesion Indicator | An indication as to whether new lesions are present, in comparison to a previous timepoint. | New Lesion Indicator | ||
New Lesion Progression | C103420 | New Lesion Progression | An assessment of the equivocality of disease progression based on a newly identified lesion. | New Lesion Progression | ||
New Lesion Worsening Indicator | C142363 | New Lesion Worsening Indicator | An indication as to whether the previously identified new lesions are showing signs of worsening. | New Lesion Worsening Indicator | ||
Non-Target Enhancing Response | C135480 | Non-Target Enhancing Response | An assessment of the response to the therapy of the non-target enhancing disease. (NCI) | Non-Target Enhancing Lesion Response | ||
Non-Target Lesion Worsening Indicator | C142364 | Non-Target Lesion Worsening Indicator | An indication as to whether non-target lesions, which have previously shown progression, are showing additional signs of worsening. | Non-Target Lesion Worsening Indicator | ||
Non-Target Non-Enhancing Response | C135481 | Non-Target Non-Enhancing Response | An assessment of the response to the therapy of the non-target non-enhancing disease. (NCI) | Non-Target Non-Enhancing Lesion Response | ||
Non-target Response | C94535 | Non-target Response | An assessment of the response of a non-target lesion(s) to the therapy. | Response in Non-Target Lesion | ||
Overall Response | C96613 | Overall Response | An assessment of the overall response of the disease to the therapy. (NCI) | Overall Response | ||
Pathologic Response | C123626 | Pathologic Response | An assessment of the pathologic response of the disease to the therapy. | Pathologic Response | ||
Radiologic Response | C123627 | Radiologic Response | An assessment of the radiologic response of the disease to the therapy. | Radiologic Response | ||
Soft Tissue Response | C132457 | Soft Tissue Response | An assessment of the soft tissue response of the disease to the therapy. | Soft Tissue Response | ||
Spleen Response | C135482 | Spleen Response | An assessment of the disease response to therapy within the spleen. | Disease Response in Spleen | ||
Steroid Use Status | C135483 | Steroid Use Status | An assessment of steroid usage as a condition of disease response to therapy. (NCI) | Steroid Use Status | ||
Symptomatic Deterioration | C124434 | Symptomatic Deterioration | A global deterioration of health status providing evidence of disease progression not covered by disease response criteria (eg. RECIST). | Symptomatic Deterioration | ||
Target Response | C94534 | Target Response | An assessment of the response of a target lesion(s) to the therapy. | Response in Target Lesion | ||
Tumor Marker Response | C132458 | Tumor Marker Response | An assessment of disease response to therapy based on tumor marker measurement. | Tumor Marker Response | ||
Back to top | ||||||
CL.C117743.OETESTCD | Ophthalmic Exam Test Code
(OETESTCD) | text
Extensible: Yes | C117743 | Ophthalmic Exam Test Code | Terminology relevant to the test codes that describe findings from ophthalmic examinations. | CDISC SDTM Ophthalmic Exam Test Code Terminology |
ASTAXIS | C117889 | Astigmatism Axis | A measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian. | Astigmatism Axis | ||
CELLDENS | C120538 | Cell Density | A measurement of the number of cells contained in a unit of volume or area. | Cell Density | ||
CELLDMAX | C120710 | Cell Density, Maximum | The maximum number in a group of values that represent the cell density. | Maximum Cell Density | ||
CELLDMIN | C120711 | Cell Density, Minimum | The minimum number in a group of values that represent the cell density. | Minimum Cell Density | ||
CELLDMN | C120712 | Cell Density, Mean | The mean number in a group of values that represent the cell density. | Mean Cell Density | ||
CELLDSD | C120713 | Cell Density, Standard Deviation | The standard deviation in a group of values that represent the cell density. | Standard Deviation of Cell Density | ||
CLDISIND | C181511 | Corrective Lens for Distance Indicator | An indication as to whether an eye lens(es) is worn by the subject to correct for distance. | Corrective Lens for Distance Indicator | ||
CLDISTYP | C181512 | Corrective Lens Type for Distance | A description of the type of eye lens(es) worn by the subject to correct for distance. | Corrective Lens Type for Distance | ||
COLOR | C37927 | Color | The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) | Color | ||
CUPDISC | C120714 | Cup to Disc Ratio | The ratio of the diameter of the optic cup compared to the diameter of the optic disc. (NCI) | Optic Cup to Disc Ratio | ||
DBMACEGR | C187961 | Diabetic Macular Edema Grade | The position on a scale to assess diabetic macular edema. | Diabetic Macular Edema Grade | ||
DBRETGR | C187962 | Diabetic Retinopathy Grade | The position on a scale to assess diabetic retinopathy. | Diabetic Retinopathy Grade | ||
DIAMETER | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
DIAMMIN | C120715 | Diameter, Minimum | The minimum number in a group of values that represent the diameter of an object. | Minimum Diameter | ||
DIAMMN | C120716 | Diameter, Mean | The mean number in a group of values that represent the diameter of an object. | Mean Diameter | ||
DIAMSD | C120717 | Diameter, Standard Deviation | The standard deviation in a group of values that represent the diameter of an object. | Standard Deviation of Diameter | ||
EDEMA | C178049 | Edema | An evaluation of edema (an excessive amount of watery fluid) in a biological specimen or location. | Edema Evaluation | ||
EYDCOMGR | C147474 | Eye Drop Comfort Grade | The position on a scale to assess the degree of comfort associated with the administration of an eye drop. | Eye Drop Comfort Grade | ||
HYPERGR | C132432 | Hyperemia Grade | The position on a scale to assess hyperemia. | Hyperemia Grade | ||
HYPERMIA | C178048 | Hyperemia | An evaluation of hyperemia (an increased amount of blood) in a biological specimen or location. | Hyperemia Evaluation | ||
INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
IOP | C87143 | Intraocular Pressure | The fluid pressure within the eye. | Intraocular Pressure | ||
LDIAM | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
LENSSTAT | C120718 | Lens Status | The condition or state of the lens of the eye. (NCI) | Lens Status | ||
LOGSCORE | C117890 | Log Score | A number or range of numeric values on the log scale that measures performance, function, quality, or ability. | Log Score | ||
MLD | C189626 | Margin Limbal Distance | A measurement of the distance from the inferior limbus to the central upper-eyelid margin, with the patient's gaze pointed upward. | Margin Limbal Distance | ||
MNARS | C142233 | Minimum Angle of Resolution | The smallest angle of separation that allows an image-forming device, including the retina, to distinguish two objects as distinct entities. | Minimum Angle of Resolution | ||
MNARSLOG | C142351 | Minimum Angle of Resolution, Log10 | The base-10 logarithm of the minimum angle of resolution achieved by an individual during testing. | Log10 Minimum Angle of Resolution | ||
MRD1 | C189624 | Margin Reflex Distance 1;Margin to Reflex Distance 1;Marginal Reflex Distance 1 | A measurement of the distance between the corneal light reflex to the central upper-eyelid margin, with the patient's gaze in the primary position (i.e., straight ahead). | Margin Reflex Distance 1 | ||
MRD2 | C189625 | Margin Reflex Distance 2;Margin to Reflex Distance 2;Marginal Reflex Distance 2 | A measurement of the distance between the corneal light reflex to central lower-eyelid margin, with the patient's gaze in the primary position (i.e., straight ahead). | Margin Reflex Distance 2 | ||
NRPNTACC | C142352 | Near-Point Accommodation | The minimum distance from the retina that an object remains in clear focus. | Near-Point Accommodation | ||
NUMCHRRD | C142353 | Number of Characters Read | The integer that describes the number of characters read by the subject during an eye chart assessment. | Number of Characters Read | ||
NUMCHRUR | C142354 | Number of Characters Unread | The integer that describes the number of characters not able to be read by the subject during an eye chart assessment. | Number of Characters Unread | ||
NUMLCOR | C117891 | Number of Letters Correct | The integer that describes the number of letters correctly identified by the subject during an eye chart assessment. | Number of Correct Eye Chart Letters | ||
NUMLINRD | C139242 | Number of Lines Read | The integer that describes the number of lines read by the subject during an eye chart assessment. | Number of Eye Chart Lines Read | ||
NUMLINUR | C142355 | Number of Lines Unread | The integer that describes the number of lines not able to be read by the subject during an eye chart assessment. | Number of Lines Unread | ||
OEEXAM | C38060 | Ophthalmic Examination | An observation, assessment or examination of the eye. | Eye Examination | ||
OPACITY | C189623 | Opacity | An assessment of the degree of opaqueness or the lack of transparency. | Opacity Measurement | ||
REACTIV | C25637 | Reactivity | A description of the action in response to some kind of stimulus. | Reaction | ||
RECYLDR | C117892 | Cylindrical Refraction Error;Cylindrical Refractive Error | A measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI) | Cylindrical Refractive Error | ||
RESPHERE | C117893 | Spherical Refraction Error;Spherical Refractive Error | A measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI) | Spherical Refractive Error | ||
SHAPE | C25677 | Shape | The spatial arrangement of something as distinct from its substance. (NCI) | Shape | ||
SUBECADT | C147475 | Subject to Eye Chart Actual Distance | The actual distance between the subject and the eye chart during an eye assessment. | Actual Subject to Eye Chart Distance | ||
SUBECPDT | C147476 | Subject to Eye Chart Planned Distance | The planned distance between the subject and the eye chart during an eye assessment. | Planned Subject to Eye Chart Distance | ||
TEARSCR | C172574 | Tear Secretion | A measurement of the amount of tear production in a subject. | Tear Secretion Amount | ||
TEARSCRR | C172575 | Tear Secretion Rate | A measurement of the amount of tears being secreted over a defined amount of time (e.g. 5 minutes). | Tear Secretion Rate | ||
THICK | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
THICKMAX | C120719 | Thickness, Maximum | The maximum number in a group of values that represent the thickness of an object. | Maximum Thickness | ||
THICKMIN | C120720 | Thickness, Minimum | The minimum number in a group of values that represent the thickness of an object. | Minimum Thickness | ||
THICKMN | C120721 | Thickness, Mean | The mean number in a group of values that represent the thickness of an object. | Mean Thickness | ||
THICKSD | C120722 | Thickness, Standard Deviation | The standard deviation in a group of values that represent the thickness of an object. | Standard Deviation of Thickness | ||
VACGRFRQ | C147477 | Visual Acuity Card Grating Frequency | A measurement of the number of horizontal or vertical lines within a pre-determined unit of length on a visual acuity card. | Acuity Card Grating Frequency | ||
Back to top | ||||||
CL.C117742.OETEST | Ophthalmic Exam Test Name
(OETEST) | text
Extensible: Yes | C117742 | Ophthalmic Exam Test Name | Terminology relevant to the test names that describe findings from ophthalmic examinations. | CDISC SDTM Ophthalmic Exam Test Name Terminology |
Astigmatism Axis | C117889 | Astigmatism Axis | A measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian. | Astigmatism Axis | ||
Cell Density | C120538 | Cell Density | A measurement of the number of cells contained in a unit of volume or area. | Cell Density | ||
Cell Density, Maximum | C120710 | Cell Density, Maximum | The maximum number in a group of values that represent the cell density. | Maximum Cell Density | ||
Cell Density, Mean | C120712 | Cell Density, Mean | The mean number in a group of values that represent the cell density. | Mean Cell Density | ||
Cell Density, Minimum | C120711 | Cell Density, Minimum | The minimum number in a group of values that represent the cell density. | Minimum Cell Density | ||
Cell Density, Standard Deviation | C120713 | Cell Density, Standard Deviation | The standard deviation in a group of values that represent the cell density. | Standard Deviation of Cell Density | ||
Color | C37927 | Color | The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) | Color | ||
Corrective Lens for Distance Indicator | C181511 | Corrective Lens for Distance Indicator | An indication as to whether an eye lens(es) is worn by the subject to correct for distance. | Corrective Lens for Distance Indicator | ||
Corrective Lens Type for Distance | C181512 | Corrective Lens Type for Distance | A description of the type of eye lens(es) worn by the subject to correct for distance. | Corrective Lens Type for Distance | ||
Cup to Disc Ratio | C120714 | Cup to Disc Ratio | The ratio of the diameter of the optic cup compared to the diameter of the optic disc. (NCI) | Optic Cup to Disc Ratio | ||
Cylindrical Refraction Error | C117892 | Cylindrical Refraction Error;Cylindrical Refractive Error | A measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI) | Cylindrical Refractive Error | ||
Diabetic Macular Edema Grade | C187961 | Diabetic Macular Edema Grade | The position on a scale to assess diabetic macular edema. | Diabetic Macular Edema Grade | ||
Diabetic Retinopathy Grade | C187962 | Diabetic Retinopathy Grade | The position on a scale to assess diabetic retinopathy. | Diabetic Retinopathy Grade | ||
Diameter | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
Diameter, Mean | C120716 | Diameter, Mean | The mean number in a group of values that represent the diameter of an object. | Mean Diameter | ||
Diameter, Minimum | C120715 | Diameter, Minimum | The minimum number in a group of values that represent the diameter of an object. | Minimum Diameter | ||
Diameter, Standard Deviation | C120717 | Diameter, Standard Deviation | The standard deviation in a group of values that represent the diameter of an object. | Standard Deviation of Diameter | ||
Edema | C178049 | Edema | An evaluation of edema (an excessive amount of watery fluid) in a biological specimen or location. | Edema Evaluation | ||
Eye Drop Comfort Grade | C147474 | Eye Drop Comfort Grade | The position on a scale to assess the degree of comfort associated with the administration of an eye drop. | Eye Drop Comfort Grade | ||
Hyperemia Grade | C132432 | Hyperemia Grade | The position on a scale to assess hyperemia. | Hyperemia Grade | ||
Hyperemia | C178048 | Hyperemia | An evaluation of hyperemia (an increased amount of blood) in a biological specimen or location. | Hyperemia Evaluation | ||
Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
Intraocular Pressure | C87143 | Intraocular Pressure | The fluid pressure within the eye. | Intraocular Pressure | ||
Lens Status | C120718 | Lens Status | The condition or state of the lens of the eye. (NCI) | Lens Status | ||
Log Score | C117890 | Log Score | A number or range of numeric values on the log scale that measures performance, function, quality, or ability. | Log Score | ||
Longest Diameter | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
Margin Limbal Distance | C189626 | Margin Limbal Distance | A measurement of the distance from the inferior limbus to the central upper-eyelid margin, with the patient's gaze pointed upward. | Margin Limbal Distance | ||
Margin Reflex Distance 1 | C189624 | Margin Reflex Distance 1;Margin to Reflex Distance 1;Marginal Reflex Distance 1 | A measurement of the distance between the corneal light reflex to the central upper-eyelid margin, with the patient's gaze in the primary position (i.e., straight ahead). | Margin Reflex Distance 1 | ||
Margin Reflex Distance 2 | C189625 | Margin Reflex Distance 2;Margin to Reflex Distance 2;Marginal Reflex Distance 2 | A measurement of the distance between the corneal light reflex to central lower-eyelid margin, with the patient's gaze in the primary position (i.e., straight ahead). | Margin Reflex Distance 2 | ||
Minimum Angle of Resolution | C142233 | Minimum Angle of Resolution | The smallest angle of separation that allows an image-forming device, including the retina, to distinguish two objects as distinct entities. | Minimum Angle of Resolution | ||
Minimum Angle of Resolution, Log10 | C142351 | Minimum Angle of Resolution, Log10 | The base-10 logarithm of the minimum angle of resolution achieved by an individual during testing. | Log10 Minimum Angle of Resolution | ||
Near-Point Accommodation | C142352 | Near-Point Accommodation | The minimum distance from the retina that an object remains in clear focus. | Near-Point Accommodation | ||
Number of Characters Read | C142353 | Number of Characters Read | The integer that describes the number of characters read by the subject during an eye chart assessment. | Number of Characters Read | ||
Number of Characters Unread | C142354 | Number of Characters Unread | The integer that describes the number of characters not able to be read by the subject during an eye chart assessment. | Number of Characters Unread | ||
Number of Letters Correct | C117891 | Number of Letters Correct | The integer that describes the number of letters correctly identified by the subject during an eye chart assessment. | Number of Correct Eye Chart Letters | ||
Number of Lines Read | C139242 | Number of Lines Read | The integer that describes the number of lines read by the subject during an eye chart assessment. | Number of Eye Chart Lines Read | ||
Number of Lines Unread | C142355 | Number of Lines Unread | The integer that describes the number of lines not able to be read by the subject during an eye chart assessment. | Number of Lines Unread | ||
Opacity | C189623 | Opacity | An assessment of the degree of opaqueness or the lack of transparency. | Opacity Measurement | ||
Ophthalmic Examination | C38060 | Ophthalmic Examination | An observation, assessment or examination of the eye. | Eye Examination | ||
Reactivity | C25637 | Reactivity | A description of the action in response to some kind of stimulus. | Reaction | ||
Shape | C25677 | Shape | The spatial arrangement of something as distinct from its substance. (NCI) | Shape | ||
Spherical Refractive Error | C117893 | Spherical Refraction Error;Spherical Refractive Error | A measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI) | Spherical Refractive Error | ||
Subject to Eye Chart Actual Distance | C147475 | Subject to Eye Chart Actual Distance | The actual distance between the subject and the eye chart during an eye assessment. | Actual Subject to Eye Chart Distance | ||
Subject to Eye Chart Planned Distance | C147476 | Subject to Eye Chart Planned Distance | The planned distance between the subject and the eye chart during an eye assessment. | Planned Subject to Eye Chart Distance | ||
Tear Secretion Rate | C172575 | Tear Secretion Rate | A measurement of the amount of tears being secreted over a defined amount of time (e.g. 5 minutes). | Tear Secretion Rate | ||
Tear Secretion | C172574 | Tear Secretion | A measurement of the amount of tear production in a subject. | Tear Secretion Amount | ||
Thickness | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
Thickness, Maximum | C120719 | Thickness, Maximum | The maximum number in a group of values that represent the thickness of an object. | Maximum Thickness | ||
Thickness, Mean | C120721 | Thickness, Mean | The mean number in a group of values that represent the thickness of an object. | Mean Thickness | ||
Thickness, Minimum | C120720 | Thickness, Minimum | The minimum number in a group of values that represent the thickness of an object. | Minimum Thickness | ||
Thickness, Standard Deviation | C120722 | Thickness, Standard Deviation | The standard deviation in a group of values that represent the thickness of an object. | Standard Deviation of Thickness | ||
Visual Acuity Card Grating Frequency | C147477 | Visual Acuity Card Grating Frequency | A measurement of the number of horizontal or vertical lines within a pre-determined unit of length on a visual acuity card. | Acuity Card Grating Frequency | ||
Back to top | ||||||
CL.C119013.OEFOCUS | Ophthalmic Focus of Study Specific Interest
(OEFOCUS) | text
Extensible: No | C119013 | Ophthalmic Focus of Study Specific Interest | Terminology relevant to the identification of a focus of ophthalmic observations. | CDISC SDTM Ophthalmic Focus of Study Specific Interest Terminology |
OD | C119333 | The eye positioned in the right orbit, Oculus Dexter. | Right Eye | |||
OS | C119334 | The eye positioned in the left orbit, Oculus Sinister. | Left Eye | |||
OU | C119335 | Of or pertaining to both the left and right eyes, Oculus Uterque. | Both Eyes | |||
Back to top | ||||||
CL.C150811.OTHEVENT | Other Disposition Event Response
(OTHEVENT) | text
Extensible: Yes | C150811 | Other Disposition Event Response | A terminology codelist relevant to other important events that occur during a trial but are not driven by protocol requirements. | CDISC SDTM Other Disposition Event Response Terminology |
SITE TRANSFER | C186208 | The study subject has been assigned to a different study site. | Study Site Transfer | |||
TREATMENT UNBLINDED | C142742 | A study event during which the treatment assignment is made known to the subject, investigator, and/or other trial personnel. | Unblinding | |||
WITHDRAWAL OF CONSENT FROM PROTOCOL-SPECIFIED ACTIVITY | C170610 | The subject or parent/guardian withdraws their consent for the subject to participate in certain protocol-specified study activities, but does not withdraw consent from participation in the study as a whole. | Withdrawal of Consent From Protocol-Specified Activity | |||
Back to top | ||||||
CL.C66768.OUT | Outcome of Event
(OUT) | text
Extensible: No | C66768 | Outcome of Event | A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI) | CDISC SDTM Adverse Event Outcome Terminology |
FATAL | C48275 | 5;FATAL;Grade 5 | The termination of life as a result of an adverse event. (NCI) | Death Related to Adverse Event | ||
NOT RECOVERED/NOT RESOLVED | C49494 | One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI) | Not Recovered from Adverse Event | |||
RECOVERED/RESOLVED WITH SEQUELAE | C49495 | One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI) | Recovered from Adverse Event with Sequelae | |||
RECOVERED/RESOLVED | C49498 | One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI) | Recovered from Adverse Event | |||
RECOVERING/RESOLVING | C49496 | One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI) | Recovering or Resolving | |||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C115394.PASAT1TC | Paced Auditory Serial Addition Test Functional Test Test Code
(PASAT1TC) | text
Extensible: No | C115394 | Paced Auditory Serial Addition Test Functional Test Test Code | Paced Auditory Serial Addition Test test code. | CDISC Functional Test PASAT Test Code Terminology |
PASAT101 | C115809 | PASAT1-Total Correct | Paced Auditory Serial Addition Test - Total correct. | PASAT - Total Correct | ||
PASAT102 | C115810 | PASAT1-Percent Correct | Paced Auditory Serial Addition Test - Percent correct. | PASAT - Percent Correct | ||
PASAT103 | C115811 | PASAT1-More Than One Attempt | Paced Auditory Serial Addition Test - Did it take more than one attempt to get one successful trial? | PASAT - More Than One Attempt | ||
PASAT104 | C115812 | PASAT1-Total Correct in First Half | Paced Auditory Serial Addition Test - Total correct in first half. | PASAT - Total Correct in First Half | ||
PASAT105 | C115813 | PASAT1-Total Correct in Second Half | Paced Auditory Serial Addition Test - Total correct in second half. | PASAT - Total Correct in Second Half | ||
PASAT106 | C115814 | PASAT1-Total Commission Errors | Paced Auditory Serial Addition Test - Total commission errors. | PASAT - Total Commission Errors | ||
PASAT107 | C115815 | PASAT1-Total Omission Errors | Paced Auditory Serial Addition Test - Total omission errors. | PASAT - Total Omission Errors | ||
Back to top | ||||||
CL.C115393.PASAT1TN | Paced Auditory Serial Addition Test Functional Test Test Name
(PASAT1TN) | text
Extensible: No | C115393 | Paced Auditory Serial Addition Test Functional Test Test Name | Paced Auditory Serial Addition Test test name. | CDISC Functional Test PASAT Test Name Terminology |
PASAT1-More Than One Attempt | C115811 | PASAT1-More Than One Attempt | Paced Auditory Serial Addition Test - Did it take more than one attempt to get one successful trial? | PASAT - More Than One Attempt | ||
PASAT1-Percent Correct | C115810 | PASAT1-Percent Correct | Paced Auditory Serial Addition Test - Percent correct. | PASAT - Percent Correct | ||
PASAT1-Total Commission Errors | C115814 | PASAT1-Total Commission Errors | Paced Auditory Serial Addition Test - Total commission errors. | PASAT - Total Commission Errors | ||
PASAT1-Total Correct in First Half | C115812 | PASAT1-Total Correct in First Half | Paced Auditory Serial Addition Test - Total correct in first half. | PASAT - Total Correct in First Half | ||
PASAT1-Total Correct in Second Half | C115813 | PASAT1-Total Correct in Second Half | Paced Auditory Serial Addition Test - Total correct in second half. | PASAT - Total Correct in Second Half | ||
PASAT1-Total Correct | C115809 | PASAT1-Total Correct | Paced Auditory Serial Addition Test - Total correct. | PASAT - Total Correct | ||
PASAT1-Total Omission Errors | C115815 | PASAT1-Total Omission Errors | Paced Auditory Serial Addition Test - Total omission errors. | PASAT - Total Omission Errors | ||
Back to top | ||||||
CL.C150772.PTAP1TC | Paced Tapping Functional Test Test Code
(PTAP1TC) | text
Extensible: No | C150772 | Paced Tapping Functional Test Test Code | Paced Tapping test code. | CDISC Functional Test Paced Tapping Test Code Terminology |
PTAP101 | C151027 | PTAP1-Total Trials Expected | Paced Tapping - Total number of trials expected to be administered in the task. | Paced Tapping - Total Trials Expected | ||
PTAP102 | C151028 | PTAP1-Total Trials Administered | Paced Tapping - Total number of trials actually administered in the task. | Paced Tapping - Total Trials Administered | ||
PTAP103 | C151029 | PTAP1-Total Trials Completed | Paced Tapping - Total number of trials actually completed in the task. | Paced Tapping - Total Trials Completed | ||
PTAP104 | C151030 | PTAP1-Total Interval Tone Admin All | Paced Tapping - Total number of intertap intervals across all 4 toned tapping phases of each trial administered. | Paced Tapping - Total Interval Tone Admin All | ||
PTAP105 | C151031 | PTAP1-Total Interval Tone Trim All | Paced Tapping - Total number of intertap intervals across the 4 toned tapping phases of each trial, that were trimmed before analysis. | Paced Tapping - Total Interval Tone Trim All | ||
PTAP105A | C151032 | PTAP1-Minimum Interval Tone All | Paced Tapping - The minimum intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Minimum Interval Tone All | ||
PTAP105B | C151033 | PTAP1-Maximum Interval Tone All | Paced Tapping - The maximum intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Maximum Interval Tone All | ||
PTAP105C | C151034 | PTAP1-Mean Interval Tone All | Paced Tapping - The mean intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Mean Interval Tone All | ||
PTAP105D | C151035 | PTAP1-Median Interval Tone All | Paced Tapping - The median intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Median Interval Tone All | ||
PTAP105E | C151036 | PTAP1-Variance Interval Tone All | Paced Tapping - The variance of the intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Variance Interval Tone All | ||
PTAP105F | C151037 | PTAP1-Deviation Interval Tone All | Paced Tapping - The standard deviation of the intertap intervals within the tone-paced tapping phase across all trials. | Paced Tapping - Deviation Interval Tone All | ||
PTAP105G | C151038 | PTAP1-Reciprocal Interval Tone All | Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the tone-paced tapping phase across all trials. | Paced Tapping - Reciprocal Interval Tone All | ||
PTAP105H | C151039 | PTAP1-Avg Sign Dev Interval Tone All | Paced Tapping - The average signed deviation of the intertap intervals within the tone-paced tapping phase across all trials. | Paced Tapping - Avg Sign Dev Interval Tone All | ||
PTAP106 | C151040 | PTAP1-Total Interval Self Admin All | Paced Tapping - Total number of interlap intervals across all 4 trials administered (self-paced tapping phases). | Paced Tapping - Total Interval Self Admin All | ||
PTAP107 | C151041 | PTAP1-Total Interval Self Trim All | Paced Tapping - Total number of intertap intervals across all 4 trials that were trimmed before analysis (self-paced tapping phases). | Paced Tapping - Total Interval Self Trim All | ||
PTAP107A | C151042 | PTAP1-Minimum Interval Self All | Paced Tapping - The minimum intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Minimum Interval Self All | ||
PTAP107B | C151043 | PTAP1-Maximum Interval Self All | Paced Tapping - The maximum intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Maximum Interval Self All | ||
PTAP107C | C151044 | PTAP1-Mean Interval Self All | Paced Tapping - The mean intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Mean Interval Self All | ||
PTAP107D | C151045 | PTAP1-Median Interval Self All | Paced Tapping - The median intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Median Interval Self All | ||
PTAP107E | C151046 | PTAP1-Variance Interval Self All | Paced Tapping - The variance of the intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Variance Interval Self All | ||
PTAP107F | C151047 | PTAP1-Deviation Interval Self All | Paced Tapping - The standard deviation of the intertap intervals within the self-paced tapping phase across all trials. | Paced Tapping - Deviation Interval Self All | ||
PTAP107G | C151048 | PTAP1-Reciprocal Interval Self All | Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the self-paced tapping phase across all trials. | Paced Tapping - Reciprocal Interval Self All | ||
PTAP107H | C151049 | PTAP1-Avg Sign Dev Interval Self All | Paced Tapping - The average signed deviation of the intertap intervals within the self-paced tapping phase across all trials. | Paced Tapping - Avg Sign Dev Interval Self All | ||
PTAP108 | C151050 | PTAP1-Trials Expected in Trial | Paced Tapping - Number of trials expected to be administered in Trial n. | Paced Tapping - Trials Expected in Trial | ||
PTAP109 | C151051 | PTAP1-Trials Administered in Trial | Paced Tapping - Number of trials actually administered in Trial n. | Paced Tapping - Trials Administered in Trial | ||
PTAP110 | C151052 | PTAP1-Trials Completed in Trial | Paced Tapping - Number of trials actually completed in Trial n. | Paced Tapping - Trials Completed in Trial | ||
PTAP111 | C151053 | PTAP1-Num Intervals Expected Tone Trial | Paced Tapping - Total number of intertap intervals expected for the tone-tapping phase of Trial n. | Paced Tapping - Num Intervals Expected Tone Trial | ||
PTAP112 | C151054 | PTAP1-Num Intervals Trim Tone Trial | Paced Tapping - Total number of intertap intervals within the tone-tapping phase of Trial n, that were trimmed before analysis. | Paced Tapping - Num Intervals Trim Tone Trial | ||
PTAP112A | C151055 | PTAP1-Minimum Interval Tone Trial | Paced Tapping - The minimum intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Minimum Interval Tone Trial | ||
PTAP112B | C151056 | PTAP1-Maximum Interval Tone Trial | Paced Tapping - The maximum intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Maximum Interval Tone Trial | ||
PTAP112C | C151057 | PTAP1-Mean Interval Tone Trial | Paced Tapping - The mean intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Mean Interval Tone Trial | ||
PTAP112D | C151058 | PTAP1-Median Interval Tone Trial | Paced Tapping - The median intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Median Interval Tone Trial | ||
PTAP112E | C151059 | PTAP1-Variance Interval Tone Trial | Paced Tapping - The variance of the intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Variance Interval Tone Trial | ||
PTAP112F | C151060 | PTAP1-Deviation Interval Tone Trial | Paced Tapping - The standard deviation of the intertap intervals within the tone-tapping phase of Trial n. | Paced Tapping - Deviation Interval Tone Trial | ||
PTAP112G | C151061 | PTAP1-Reciprocal Interval ToneTrial | Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the tone-tapping phase of Trial n. | Paced Tapping - Reciprocal Interval ToneTrial | ||
PTAP112H | C151062 | PTAP1-Avg Sign Dev Interval Tone Trial | Paced Tapping - The average signed deviation of the intertap intervals within the tone-tapping phase of Trial n. | Paced Tapping - Avg Sign Dev Interval Tone Trial | ||
PTAP113 | C151063 | PTAP1-Num Intervals Expected Self Trial | Paced Tapping - Total number of intertap intervals expected for the self-paced tapping phase of Trial n. | Paced Tapping - Num Intervals Expected Self Trial | ||
PTAP114 | C151064 | PTAP1-Num Intervals Trim Self Trial | Paced Tapping - Total number of intertap intervals within the self-paced tapping phase of Trial n, that were trimmed before analysis. | Paced Tapping - Num Intervals Trim Self Trial | ||
PTAP114A | C151065 | PTAP1-Minimum Interval Self Trial | Paced Tapping - The minimum intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Minimum Interval Self Trial | ||
PTAP114B | C151066 | PTAP1-Maximum Interval Self Trial | Paced Tapping - The maximum intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Maximum Interval Self Trial | ||
PTAP114C | C151067 | PTAP1-Mean Interval Self Trial | Paced Tapping - The mean intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Mean Interval Self Trial | ||
PTAP114D | C151068 | PTAP1-Median Interval Self Trial | Paced Tapping - The median intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Median Interval Self Trial | ||
PTAP114E | C151069 | PTAP1-Variance Interval Self Trial | Paced Tapping - The variance of the intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Variance Interval Self Trial | ||
PTAP114F | C151070 | PTAP1-Deviation Interval Self Trial | Paced Tapping - The standard deviation of the intertap intervals within the self-paced tapping phase of Trial n. | Paced Tapping - Deviation Interval Self Trial | ||
PTAP114G | C151071 | PTAP1-Reciprocal Interval Self Trial | Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the self-paced tapping phase of Trial n. | Paced Tapping - Reciprocal Interval Self Trial | ||
PTAP114H | C151072 | PTAP1-Avg Sign Dev Interval Self Trial | Paced Tapping - The average signed deviation of the intertap intervals within the self-paced tapping phase of Trial n. | Paced Tapping - Avg Sign Dev Interval Self Trial | ||
Back to top | ||||||
CL.C150771.PTAP1TN | Paced Tapping Functional Test Test Name
(PTAP1TN) | text
Extensible: No | C150771 | Paced Tapping Functional Test Test Name | Paced Tapping test name. | CDISC Functional Test Paced Tapping Test Name Terminology |
PTAP1-Avg Sign Dev Interval Self All | C151049 | PTAP1-Avg Sign Dev Interval Self All | Paced Tapping - The average signed deviation of the intertap intervals within the self-paced tapping phase across all trials. | Paced Tapping - Avg Sign Dev Interval Self All | ||
PTAP1-Avg Sign Dev Interval Self Trial | C151072 | PTAP1-Avg Sign Dev Interval Self Trial | Paced Tapping - The average signed deviation of the intertap intervals within the self-paced tapping phase of Trial n. | Paced Tapping - Avg Sign Dev Interval Self Trial | ||
PTAP1-Avg Sign Dev Interval Tone All | C151039 | PTAP1-Avg Sign Dev Interval Tone All | Paced Tapping - The average signed deviation of the intertap intervals within the tone-paced tapping phase across all trials. | Paced Tapping - Avg Sign Dev Interval Tone All | ||
PTAP1-Avg Sign Dev Interval Tone Trial | C151062 | PTAP1-Avg Sign Dev Interval Tone Trial | Paced Tapping - The average signed deviation of the intertap intervals within the tone-tapping phase of Trial n. | Paced Tapping - Avg Sign Dev Interval Tone Trial | ||
PTAP1-Deviation Interval Self All | C151047 | PTAP1-Deviation Interval Self All | Paced Tapping - The standard deviation of the intertap intervals within the self-paced tapping phase across all trials. | Paced Tapping - Deviation Interval Self All | ||
PTAP1-Deviation Interval Self Trial | C151070 | PTAP1-Deviation Interval Self Trial | Paced Tapping - The standard deviation of the intertap intervals within the self-paced tapping phase of Trial n. | Paced Tapping - Deviation Interval Self Trial | ||
PTAP1-Deviation Interval Tone All | C151037 | PTAP1-Deviation Interval Tone All | Paced Tapping - The standard deviation of the intertap intervals within the tone-paced tapping phase across all trials. | Paced Tapping - Deviation Interval Tone All | ||
PTAP1-Deviation Interval Tone Trial | C151060 | PTAP1-Deviation Interval Tone Trial | Paced Tapping - The standard deviation of the intertap intervals within the tone-tapping phase of Trial n. | Paced Tapping - Deviation Interval Tone Trial | ||
PTAP1-Maximum Interval Self All | C151043 | PTAP1-Maximum Interval Self All | Paced Tapping - The maximum intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Maximum Interval Self All | ||
PTAP1-Maximum Interval Self Trial | C151066 | PTAP1-Maximum Interval Self Trial | Paced Tapping - The maximum intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Maximum Interval Self Trial | ||
PTAP1-Maximum Interval Tone All | C151033 | PTAP1-Maximum Interval Tone All | Paced Tapping - The maximum intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Maximum Interval Tone All | ||
PTAP1-Maximum Interval Tone Trial | C151056 | PTAP1-Maximum Interval Tone Trial | Paced Tapping - The maximum intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Maximum Interval Tone Trial | ||
PTAP1-Mean Interval Self All | C151044 | PTAP1-Mean Interval Self All | Paced Tapping - The mean intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Mean Interval Self All | ||
PTAP1-Mean Interval Self Trial | C151067 | PTAP1-Mean Interval Self Trial | Paced Tapping - The mean intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Mean Interval Self Trial | ||
PTAP1-Mean Interval Tone All | C151034 | PTAP1-Mean Interval Tone All | Paced Tapping - The mean intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Mean Interval Tone All | ||
PTAP1-Mean Interval Tone Trial | C151057 | PTAP1-Mean Interval Tone Trial | Paced Tapping - The mean intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Mean Interval Tone Trial | ||
PTAP1-Median Interval Self All | C151045 | PTAP1-Median Interval Self All | Paced Tapping - The median intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Median Interval Self All | ||
PTAP1-Median Interval Self Trial | C151068 | PTAP1-Median Interval Self Trial | Paced Tapping - The median intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Median Interval Self Trial | ||
PTAP1-Median Interval Tone All | C151035 | PTAP1-Median Interval Tone All | Paced Tapping - The median intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Median Interval Tone All | ||
PTAP1-Median Interval Tone Trial | C151058 | PTAP1-Median Interval Tone Trial | Paced Tapping - The median intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Median Interval Tone Trial | ||
PTAP1-Minimum Interval Self All | C151042 | PTAP1-Minimum Interval Self All | Paced Tapping - The minimum intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Minimum Interval Self All | ||
PTAP1-Minimum Interval Self Trial | C151065 | PTAP1-Minimum Interval Self Trial | Paced Tapping - The minimum intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Minimum Interval Self Trial | ||
PTAP1-Minimum Interval Tone All | C151032 | PTAP1-Minimum Interval Tone All | Paced Tapping - The minimum intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Minimum Interval Tone All | ||
PTAP1-Minimum Interval Tone Trial | C151055 | PTAP1-Minimum Interval Tone Trial | Paced Tapping - The minimum intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Minimum Interval Tone Trial | ||
PTAP1-Num Intervals Expected Self Trial | C151063 | PTAP1-Num Intervals Expected Self Trial | Paced Tapping - Total number of intertap intervals expected for the self-paced tapping phase of Trial n. | Paced Tapping - Num Intervals Expected Self Trial | ||
PTAP1-Num Intervals Expected Tone Trial | C151053 | PTAP1-Num Intervals Expected Tone Trial | Paced Tapping - Total number of intertap intervals expected for the tone-tapping phase of Trial n. | Paced Tapping - Num Intervals Expected Tone Trial | ||
PTAP1-Num Intervals Trim Self Trial | C151064 | PTAP1-Num Intervals Trim Self Trial | Paced Tapping - Total number of intertap intervals within the self-paced tapping phase of Trial n, that were trimmed before analysis. | Paced Tapping - Num Intervals Trim Self Trial | ||
PTAP1-Num Intervals Trim Tone Trial | C151054 | PTAP1-Num Intervals Trim Tone Trial | Paced Tapping - Total number of intertap intervals within the tone-tapping phase of Trial n, that were trimmed before analysis. | Paced Tapping - Num Intervals Trim Tone Trial | ||
PTAP1-Reciprocal Interval Self All | C151048 | PTAP1-Reciprocal Interval Self All | Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the self-paced tapping phase across all trials. | Paced Tapping - Reciprocal Interval Self All | ||
PTAP1-Reciprocal Interval Self Trial | C151071 | PTAP1-Reciprocal Interval Self Trial | Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the self-paced tapping phase of Trial n. | Paced Tapping - Reciprocal Interval Self Trial | ||
PTAP1-Reciprocal Interval Tone All | C151038 | PTAP1-Reciprocal Interval Tone All | Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the tone-paced tapping phase across all trials. | Paced Tapping - Reciprocal Interval Tone All | ||
PTAP1-Reciprocal Interval ToneTrial | C151061 | PTAP1-Reciprocal Interval ToneTrial | Paced Tapping - The reciprocal of the standard deviation of the intertap intervals within the tone-tapping phase of Trial n. | Paced Tapping - Reciprocal Interval ToneTrial | ||
PTAP1-Total Interval Self Admin All | C151040 | PTAP1-Total Interval Self Admin All | Paced Tapping - Total number of interlap intervals across all 4 trials administered (self-paced tapping phases). | Paced Tapping - Total Interval Self Admin All | ||
PTAP1-Total Interval Self Trim All | C151041 | PTAP1-Total Interval Self Trim All | Paced Tapping - Total number of intertap intervals across all 4 trials that were trimmed before analysis (self-paced tapping phases). | Paced Tapping - Total Interval Self Trim All | ||
PTAP1-Total Interval Tone Admin All | C151030 | PTAP1-Total Interval Tone Admin All | Paced Tapping - Total number of intertap intervals across all 4 toned tapping phases of each trial administered. | Paced Tapping - Total Interval Tone Admin All | ||
PTAP1-Total Interval Tone Trim All | C151031 | PTAP1-Total Interval Tone Trim All | Paced Tapping - Total number of intertap intervals across the 4 toned tapping phases of each trial, that were trimmed before analysis. | Paced Tapping - Total Interval Tone Trim All | ||
PTAP1-Total Trials Administered | C151028 | PTAP1-Total Trials Administered | Paced Tapping - Total number of trials actually administered in the task. | Paced Tapping - Total Trials Administered | ||
PTAP1-Total Trials Completed | C151029 | PTAP1-Total Trials Completed | Paced Tapping - Total number of trials actually completed in the task. | Paced Tapping - Total Trials Completed | ||
PTAP1-Total Trials Expected | C151027 | PTAP1-Total Trials Expected | Paced Tapping - Total number of trials expected to be administered in the task. | Paced Tapping - Total Trials Expected | ||
PTAP1-Trials Administered in Trial | C151051 | PTAP1-Trials Administered in Trial | Paced Tapping - Number of trials actually administered in Trial n. | Paced Tapping - Trials Administered in Trial | ||
PTAP1-Trials Completed in Trial | C151052 | PTAP1-Trials Completed in Trial | Paced Tapping - Number of trials actually completed in Trial n. | Paced Tapping - Trials Completed in Trial | ||
PTAP1-Trials Expected in Trial | C151050 | PTAP1-Trials Expected in Trial | Paced Tapping - Number of trials expected to be administered in Trial n. | Paced Tapping - Trials Expected in Trial | ||
PTAP1-Variance Interval Self All | C151046 | PTAP1-Variance Interval Self All | Paced Tapping - The variance of the intertap interval within the self-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Variance Interval Self All | ||
PTAP1-Variance Interval Self Trial | C151069 | PTAP1-Variance Interval Self Trial | Paced Tapping - The variance of the intertap interval within the self-paced tapping phase of Trial n (in milliseconds). | Paced Tapping - Variance Interval Self Trial | ||
PTAP1-Variance Interval Tone All | C151036 | PTAP1-Variance Interval Tone All | Paced Tapping - The variance of the intertap interval within the tone-paced tapping phase across all trials (in milliseconds). | Paced Tapping - Variance Interval Tone All | ||
PTAP1-Variance Interval Tone Trial | C151059 | PTAP1-Variance Interval Tone Trial | Paced Tapping - The variance of the intertap interval within the tone-tapping phase of Trial n (in milliseconds). | Paced Tapping - Variance Interval Tone Trial | ||
Back to top | ||||||
CL.C105134.PI01TC | Pain Intensity Questionnaire Test Code
(PI01TC) | text
Extensible: No | C105134 | Pain Intensity Questionnaire Test Code | Pain Intensity test code. | CDISC Questionnaire PI v1 Test Code Terminology |
PI0101 | C105261 | PI01-Pain Intensity | Pain Intensity - Pain intensity for various time periods of evaluation. | PI - Pain Intensity For Various Time Periods of Evaluation | ||
PI0102 | C105262 | PI01-Average Pain Intensity | Pain Intensity - Average pain intensity for various time periods of evaluation. | PI - Average Pain Intensity For Various Time Periods of Evaluation | ||
PI0103 | C105263 | PI01-Minimum Pain Intensity | Pain Intensity - Minimum pain intensity for various time periods of evaluation. | PI - Minimum Pain Intensity For Various Time Periods of Evaluation | ||
PI0104 | C105264 | PI01-Maximum Pain Intensity | Pain Intensity - Maximum pain intensity for various time periods of evaluation. | PI - Maximum Pain Intensity For Various Time Periods of Evaluation | ||
PI0105 | C105265 | PI01-Least Pain Intensity | Pain Intensity - Least pain intensity for various time periods of evaluation. | PI - Least Pain Intensity For Various Time Periods of Evaluation | ||
PI0106 | C105266 | PI01-Worst Pain Intensity | Pain Intensity - Worst pain intensity for various time periods of evaluation. | PI - Worst Pain Intensity For Various Time Periods of Evaluation | ||
Back to top | ||||||
CL.C105133.PI01TN | Pain Intensity Questionnaire Test Name
(PI01TN) | text
Extensible: No | C105133 | Pain Intensity Questionnaire Test Name | Pain Intensity test name. | CDISC Questionnaire PI v1 Test Name Terminology |
PI01-Average Pain Intensity | C105262 | PI01-Average Pain Intensity | Pain Intensity - Average pain intensity for various time periods of evaluation. | PI - Average Pain Intensity For Various Time Periods of Evaluation | ||
PI01-Least Pain Intensity | C105265 | PI01-Least Pain Intensity | Pain Intensity - Least pain intensity for various time periods of evaluation. | PI - Least Pain Intensity For Various Time Periods of Evaluation | ||
PI01-Maximum Pain Intensity | C105264 | PI01-Maximum Pain Intensity | Pain Intensity - Maximum pain intensity for various time periods of evaluation. | PI - Maximum Pain Intensity For Various Time Periods of Evaluation | ||
PI01-Minimum Pain Intensity | C105263 | PI01-Minimum Pain Intensity | Pain Intensity - Minimum pain intensity for various time periods of evaluation. | PI - Minimum Pain Intensity For Various Time Periods of Evaluation | ||
PI01-Pain Intensity | C105261 | PI01-Pain Intensity | Pain Intensity - Pain intensity for various time periods of evaluation. | PI - Pain Intensity For Various Time Periods of Evaluation | ||
PI01-Worst Pain Intensity | C105266 | PI01-Worst Pain Intensity | Pain Intensity - Worst pain intensity for various time periods of evaluation. | PI - Worst Pain Intensity For Various Time Periods of Evaluation | ||
Back to top | ||||||
CL.C105136.PR01TC | Pain Relief Questionnaire Test Code
(PR01TC) | text
Extensible: No | C105136 | Pain Relief Questionnaire Test Code | Pain Relief test code. | CDISC Questionnaire PR v1 Test Code Terminology |
PR0101 | C105267 | PR01-Pain Relief | Pain Relief - Pain relief for various time periods of evaluation. | PR - Pain Relief For Various Time Periods of Evaluation | ||
PR0102 | C105268 | PR01-Average Pain Relief | Pain Relief - Average pain relief for various time periods of evaluation. | PR - Average Pain Relief For Various Time Periods of Evaluation | ||
PR0103 | C105269 | PR01-Minimum Pain Relief | Pain Relief - Minimum pain relief for various time periods of evaluation. | PR - Minimum Pain Relief For Various Time Periods of Evaluation | ||
PR0104 | C105270 | PR01-Maximum Pain Relief | Pain Relief - Maximum pain relief for various time periods of evaluation. | PR - Maximum Pain Relief For Various Time Periods of Evaluation | ||
PR0105 | C105271 | PR01-Least Pain Relief | Pain Relief - Least pain relief for various time periods of evaluation. | PR - Least Pain Relief For Various Time Periods of Evaluation | ||
PR0106 | C105272 | PR01-Worst Pain Relief | Pain Relief - Worst pain relief for various time periods of evaluation. | PR - Worst Pain Relief For Various Time Periods of Evaluation | ||
PR0107 | C105273 | PR01-Starting Pain at Least 1/2 Gone | Pain Relief - Starting pain at least 1/2 Gone? | PR - Starting Pain Half Gone | ||
PR0108 | C105274 | PR01-Was there Perceptible Pain Relief | Pain Relief - Was there perceptible pain relief? | PR - Was There Perceptible Pain Relief | ||
PR0109 | C105275 | PR01-Time to Perceptible Pain Relief | Pain Relief - Time to perceptible pain relief. | PR - Time to Perceptible Pain Relief | ||
PR0110 | C105276 | PR01-Was there Meaningful Pain Relief | Pain Relief - Was there meaningful pain relief? | PR - Was There Meaningful Pain Relief | ||
PR0111 | C105277 | PR01-Time to Meaningful Pain Relief | Pain Relief - Time to meaningful pain relief. | PR - Time to Meaningful Pain Relief | ||
Back to top | ||||||
CL.C105135.PR01TN | Pain Relief Questionnaire Test Name
(PR01TN) | text
Extensible: No | C105135 | Pain Relief Questionnaire Test Name | Pain Relief test name. | CDISC Questionnaire PR v1 Test Name Terminology |
PR01-Average Pain Relief | C105268 | PR01-Average Pain Relief | Pain Relief - Average pain relief for various time periods of evaluation. | PR - Average Pain Relief For Various Time Periods of Evaluation | ||
PR01-Least Pain Relief | C105271 | PR01-Least Pain Relief | Pain Relief - Least pain relief for various time periods of evaluation. | PR - Least Pain Relief For Various Time Periods of Evaluation | ||
PR01-Maximum Pain Relief | C105270 | PR01-Maximum Pain Relief | Pain Relief - Maximum pain relief for various time periods of evaluation. | PR - Maximum Pain Relief For Various Time Periods of Evaluation | ||
PR01-Minimum Pain Relief | C105269 | PR01-Minimum Pain Relief | Pain Relief - Minimum pain relief for various time periods of evaluation. | PR - Minimum Pain Relief For Various Time Periods of Evaluation | ||
PR01-Pain Relief | C105267 | PR01-Pain Relief | Pain Relief - Pain relief for various time periods of evaluation. | PR - Pain Relief For Various Time Periods of Evaluation | ||
PR01-Starting Pain at Least 1/2 Gone | C105273 | PR01-Starting Pain at Least 1/2 Gone | Pain Relief - Starting pain at least 1/2 Gone? | PR - Starting Pain Half Gone | ||
PR01-Time to Meaningful Pain Relief | C105277 | PR01-Time to Meaningful Pain Relief | Pain Relief - Time to meaningful pain relief. | PR - Time to Meaningful Pain Relief | ||
PR01-Time to Perceptible Pain Relief | C105275 | PR01-Time to Perceptible Pain Relief | Pain Relief - Time to perceptible pain relief. | PR - Time to Perceptible Pain Relief | ||
PR01-Was there Meaningful Pain Relief | C105276 | PR01-Was there Meaningful Pain Relief | Pain Relief - Was there meaningful pain relief? | PR - Was There Meaningful Pain Relief | ||
PR01-Was there Perceptible Pain Relief | C105274 | PR01-Was there Perceptible Pain Relief | Pain Relief - Was there perceptible pain relief? | PR - Was There Perceptible Pain Relief | ||
PR01-Worst Pain Relief | C105272 | PR01-Worst Pain Relief | Pain Relief - Worst pain relief for various time periods of evaluation. | PR - Worst Pain Relief For Various Time Periods of Evaluation | ||
Back to top | ||||||
CL.C179592.PAFATSCD | Pancreatic Cancer Findings About Test Code
(PAFATSCD) | text
Extensible: Yes | C179592 | Pancreatic Cancer Findings About Test Code | Terminology relevant to the test codes that describe findings about an pancreatic cancer event or intervention. | CDISC SDTM Pancreatic Cancer Findings About Test Code Terminology |
PRYSTUOG | C179451 | Primary Site of Tumor Origin | The anatomical location of the primary tumor site of disease. | Primary Tumor Site | ||
Back to top | ||||||
CL.C179593.PAFATS | Pancreatic Cancer Findings About Test Name
(PAFATS) | text
Extensible: Yes | C179593 | Pancreatic Cancer Findings About Test Name | Terminology relevant to the test names that describe findings about an pancreatic cancer event or intervention. | CDISC SDTM Pancreatic Cancer Findings About Test Name Terminology |
Primary Site of Tumor Origin | C179451 | Primary Site of Tumor Origin | The anatomical location of the primary tumor site of disease. | Primary Tumor Site | ||
Back to top | ||||||
CL.C112447.PDDS01TC | Patient Determined Disease Steps Questionnaire Test Code
(PDDS01TC) | text
Extensible: No | C112447 | Patient Determined Disease Steps Questionnaire Test Code | Patient Determined Disease Steps test code. | CDISC Questionnaire PDDS Test Code Terminology |
PDDS0101 | C112626 | PDDS01-Category Describing Situation | Patient Determined Disease Steps - This scale focuses mainly on how well you walk. You might not find a description that reflects your condition exactly, but please mark the one category that describes your situation the closest. | PDDS - Category Describing Situation | ||
Back to top | ||||||
CL.C112446.PDDS01TN | Patient Determined Disease Steps Questionnaire Test Name
(PDDS01TN) | text
Extensible: No | C112446 | Patient Determined Disease Steps Questionnaire Test Name | Patient Determined Disease Steps test name. | CDISC Questionnaire PDDS Test Name Terminology |
PDDS01-Category Describing Situation | C112626 | PDDS01-Category Describing Situation | Patient Determined Disease Steps - This scale focuses mainly on how well you walk. You might not find a description that reflects your condition exactly, but please mark the one category that describes your situation the closest. | PDDS - Category Describing Situation | ||
Back to top | ||||||
CL.C135688.PGI01TC | Patient Global Impression Generic Modification Version Questionnaire Test Code
(PGI01TC) | text
Extensible: No | C135688 | Patient Global Impression Generic Modification Version Questionnaire Test Code | Patient Global Impression Generic Modification Version test code. | CDISC Questionnaire PGI Generic Modification Version Test Code Terminology |
PGI0101 | C135817 | PGI01-Severity | Patient Global Impression - Considering all the ways your condition impacts you, how severe is your condition at this time? | PGI Generic Modification Version - Severity | ||
PGI0102 | C135818 | PGI01-Change | Patient Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition changed? | PGI Generic Modification Version - Change | ||
PGI0103 | C135819 | PGI01-Improvement | Patient Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition improved? | PGI Generic Modification Version - Improvement | ||
Back to top | ||||||
CL.C135687.PGI01TN | Patient Global Impression Generic Modification Version Questionnaire Test Name
(PGI01TN) | text
Extensible: No | C135687 | Patient Global Impression Generic Modification Version Questionnaire Test Name | Patient Global Impression Generic Modification Version test name. | CDISC Questionnaire PGI Generic Modification Version Test Name Terminology |
PGI01-Change | C135818 | PGI01-Change | Patient Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition changed? | PGI Generic Modification Version - Change | ||
PGI01-Improvement | C135819 | PGI01-Improvement | Patient Global Impression - Compared to <previously assessed protocol specified time point> how much has your condition improved? | PGI Generic Modification Version - Improvement | ||
PGI01-Severity | C135817 | PGI01-Severity | Patient Global Impression - Considering all the ways your condition impacts you, how severe is your condition at this time? | PGI Generic Modification Version - Severity | ||
Back to top | ||||||
CL.C103483.PHQ02TC | Patient Health Questionnaire - 15 Item Questionnaire Test Code
(PHQ02TC) | text
Extensible: No | C103483 | Patient Health Questionnaire - 15 Item Questionnaire Test Code | Patient Health Questionnaire - 15 test code. | CDISC Questionnaire PHQ-15 Test Code Terminology |
PHQ0201 | C103715 | PHQ02-Stomach Pain | Patient Health Questionnaire - 15 - Stomach pain. | PHQ-15 - Stomach Pain | ||
PHQ0202 | C103716 | PHQ02-Back Pain | Patient Health Questionnaire - 15 - Back pain. | PHQ-15 - Back Pain | ||
PHQ0203 | C103717 | PHQ02-Pain In Your Arms, Legs, or Joints | Patient Health Questionnaire - 15 - Pain in your arms, legs, or joints (knees, hips, etc.). | PHQ-15 - Pain In Your Arms, Legs, or Joints | ||
PHQ0204 | C103718 | PHQ02-Menstrual Cramp/Problem Periods | Patient Health Questionnaire - 15 - Menstrual cramps or other problems with your periods [Women only]. | PHQ-15 - Menstrual Cramp or Other Problems with Your Periods | ||
PHQ0205 | C103719 | PHQ02-Headaches | Patient Health Questionnaire - 15 - Headaches. | PHQ-15 - Headaches | ||
PHQ0206 | C103720 | PHQ02-Chest Pain | Patient Health Questionnaire - 15 - Chest pain. | PHQ-15 - Chest Pain | ||
PHQ0207 | C103721 | PHQ02-Dizziness | Patient Health Questionnaire - 15 - Dizziness. | PHQ-15 - Dizziness | ||
PHQ0208 | C103722 | PHQ02-Fainting Spells | Patient Health Questionnaire - 15 - Fainting spells. | PHQ-15 - Fainting Spells | ||
PHQ0209 | C103723 | PHQ02-Feeling Your Heart Pound or Race | Patient Health Questionnaire - 15 - Feeling your heart pound or race. | PHQ-15 - Feeling Your Heart Pound or Race | ||
PHQ0210 | C103724 | PHQ02-Shortness of Breath | Patient Health Questionnaire - 15 - Shortness of breath. | PHQ-15 - Shortness of Breath | ||
PHQ0211 | C103725 | PHQ02-Pain/Problems During Intercourse | Patient Health Questionnaire - 15 - Pain or problems during sexual intercourse. | PHQ-15 - Pain or Problems During Sexual Intercourse | ||
PHQ0212 | C103726 | PHQ02-Constipation/Loose Bowels/Diarrhea | Patient Health Questionnaire - 15 - Constipation, loose bowels, or diarrhea. | PHQ-15 - Constipation, Loose Bowels, or Diarrhea | ||
PHQ0213 | C103727 | PHQ02-Nausea, Gas, or Indigestion | Patient Health Questionnaire - 15 - Nausea, gas, or indigestion. | PHQ-15 - Nausea, Gas, or Indigestion | ||
PHQ0214 | C103728 | PHQ02-Feeling Tired or Having Low Energy | Patient Health Questionnaire - 15 - Feeling tired or having low energy. | PHQ-15 - Feeling Tired or Having Low Energy | ||
PHQ0215 | C103729 | PHQ02-Trouble Sleeping | Patient Health Questionnaire - 15 - Trouble sleeping. | PHQ-15 - Trouble Sleeping | ||
PHQ0216 | C124782 | PHQ02-Total Score | Patient Health Questionnaire - 15 - Total score. | PHQ-15 - Total Score | ||
Back to top | ||||||
CL.C103482.PHQ02TN | Patient Health Questionnaire - 15 Item Questionnaire Test Name
(PHQ02TN) | text
Extensible: No | C103482 | Patient Health Questionnaire - 15 Item Questionnaire Test Name | Patient Health Questionnaire - 15 test name. | CDISC Questionnaire PHQ-15 Test Name Terminology |
PHQ02-Back Pain | C103716 | PHQ02-Back Pain | Patient Health Questionnaire - 15 - Back pain. | PHQ-15 - Back Pain | ||
PHQ02-Chest Pain | C103720 | PHQ02-Chest Pain | Patient Health Questionnaire - 15 - Chest pain. | PHQ-15 - Chest Pain | ||
PHQ02-Constipation/Loose Bowels/Diarrhea | C103726 | PHQ02-Constipation/Loose Bowels/Diarrhea | Patient Health Questionnaire - 15 - Constipation, loose bowels, or diarrhea. | PHQ-15 - Constipation, Loose Bowels, or Diarrhea | ||
PHQ02-Dizziness | C103721 | PHQ02-Dizziness | Patient Health Questionnaire - 15 - Dizziness. | PHQ-15 - Dizziness | ||
PHQ02-Fainting Spells | C103722 | PHQ02-Fainting Spells | Patient Health Questionnaire - 15 - Fainting spells. | PHQ-15 - Fainting Spells | ||
PHQ02-Feeling Tired or Having Low Energy | C103728 | PHQ02-Feeling Tired or Having Low Energy | Patient Health Questionnaire - 15 - Feeling tired or having low energy. | PHQ-15 - Feeling Tired or Having Low Energy | ||
PHQ02-Feeling Your Heart Pound or Race | C103723 | PHQ02-Feeling Your Heart Pound or Race | Patient Health Questionnaire - 15 - Feeling your heart pound or race. | PHQ-15 - Feeling Your Heart Pound or Race | ||
PHQ02-Headaches | C103719 | PHQ02-Headaches | Patient Health Questionnaire - 15 - Headaches. | PHQ-15 - Headaches | ||
PHQ02-Menstrual Cramp/Problem Periods | C103718 | PHQ02-Menstrual Cramp/Problem Periods | Patient Health Questionnaire - 15 - Menstrual cramps or other problems with your periods [Women only]. | PHQ-15 - Menstrual Cramp or Other Problems with Your Periods | ||
PHQ02-Nausea, Gas, or Indigestion | C103727 | PHQ02-Nausea, Gas, or Indigestion | Patient Health Questionnaire - 15 - Nausea, gas, or indigestion. | PHQ-15 - Nausea, Gas, or Indigestion | ||
PHQ02-Pain In Your Arms, Legs, or Joints | C103717 | PHQ02-Pain In Your Arms, Legs, or Joints | Patient Health Questionnaire - 15 - Pain in your arms, legs, or joints (knees, hips, etc.). | PHQ-15 - Pain In Your Arms, Legs, or Joints | ||
PHQ02-Pain/Problems During Intercourse | C103725 | PHQ02-Pain/Problems During Intercourse | Patient Health Questionnaire - 15 - Pain or problems during sexual intercourse. | PHQ-15 - Pain or Problems During Sexual Intercourse | ||
PHQ02-Shortness of Breath | C103724 | PHQ02-Shortness of Breath | Patient Health Questionnaire - 15 - Shortness of breath. | PHQ-15 - Shortness of Breath | ||
PHQ02-Stomach Pain | C103715 | PHQ02-Stomach Pain | Patient Health Questionnaire - 15 - Stomach pain. | PHQ-15 - Stomach Pain | ||
PHQ02-Total Score | C124782 | PHQ02-Total Score | Patient Health Questionnaire - 15 - Total score. | PHQ-15 - Total Score | ||
PHQ02-Trouble Sleeping | C103729 | PHQ02-Trouble Sleeping | Patient Health Questionnaire - 15 - Trouble sleeping. | PHQ-15 - Trouble Sleeping | ||
Back to top | ||||||
CL.C157727.PHQ04TC | Patient Health Questionnaire - 2 Item Questionnaire Test Code
(PHQ04TC) | text
Extensible: No | C157727 | Patient Health Questionnaire - 2 Item Questionnaire Test Code | Patient Health Questionnaire - 2 test code. | CDISC Questionnaire PHQ-2 Test Code Terminology |
PHQ0401 | C157729 | PHQ04-Little Interest/Pleasure in Things | The Patient Health Questionnaire-2 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Little interest or pleasure in doing things. | PHQ-2 - Little Interest or Pleasure in Doing Things | ||
PHQ0402 | C157730 | PHQ04-Feeling Down Depressed or Hopeless | The Patient Health Questionnaire-2 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling down, depressed or hopeless. | PHQ-2 - Feeling Down, Depressed or Hopeless | ||
Back to top | ||||||
CL.C157726.PHQ04TN | Patient Health Questionnaire - 2 Item Questionnaire Test Name
(PHQ04TN) | text
Extensible: No | C157726 | Patient Health Questionnaire - 2 Item Questionnaire Test Name | Patient Health Questionnaire - 2 test name. | CDISC Questionnaire PHQ-2 Test Name Terminology |
PHQ04-Feeling Down Depressed or Hopeless | C157730 | PHQ04-Feeling Down Depressed or Hopeless | The Patient Health Questionnaire-2 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling down, depressed or hopeless. | PHQ-2 - Feeling Down, Depressed or Hopeless | ||
PHQ04-Little Interest/Pleasure in Things | C157729 | PHQ04-Little Interest/Pleasure in Things | The Patient Health Questionnaire-2 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Little interest or pleasure in doing things. | PHQ-2 - Little Interest or Pleasure in Doing Things | ||
Back to top | ||||||
CL.C190940.PHQ05TC | Patient Health Questionnaire - 8 Questionnaire Test Code
(PHQ05TC) | text
Extensible: No | C190940 | Patient Health Questionnaire - 8 Questionnaire Test Code | Patient Health Questionnaire - 8 test code. | CDISC Questionnaire Patient Health Questionnaire - 8 Item Test Code Terminology |
PHQ0501 | C191154 | PHQ05-Little Interest/Pleasure in Things | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Little interest or pleasure in doing things. | PHQ-8 - Little Interest or Pleasure in Things | ||
PHQ0502 | C191155 | PHQ05-Feeling Down Depressed or Hopeless | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling down, depressed, or hopeless. | PHQ-8 - Feeling Down Depressed or Hopeless | ||
PHQ0503 | C191156 | PHQ05-Trouble Falling or Staying Asleep | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Trouble falling or staying asleep, or sleeping too much. | PHQ-8 - Trouble Falling or Staying Asleep | ||
PHQ0504 | C191157 | PHQ05-Feeling Tired or Little Energy | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling tired or having little energy. | PHQ-8 - Feeling Tired or Little Energy | ||
PHQ0505 | C191158 | PHQ05-Poor Appetite or Overeating | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Poor appetite or overeating. | PHQ-8 - Poor Appetite or Overeating | ||
PHQ0506 | C191159 | PHQ05-Feeling Bad About Yourself | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling bad about yourself--or that you are a failure or have let yourself or your family down. | PHQ-8 - Feeling Bad About Yourself | ||
PHQ0507 | C191160 | PHQ05-Trouble Concentrating on Things | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Trouble concentrating on things, such as reading the newspaper or watching television. | PHQ-8 - Trouble Concentrating on Things | ||
PHQ0508 | C191161 | PHQ05-Moving Slowly or Fidgety/Restless | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Moving or speaking so slowly that other people could have noticed? Or the opposite -- being so fidgety or restless that you have been moving around a lot more than usual. | PHQ-8 - Moving Slowly or Fidgety or Restless | ||
PHQ0509 | C191162 | PHQ05-Total Score | Patient Health Questionnaire - 8 - Total Score. | PHQ-8 - Total Score | ||
Back to top | ||||||
CL.C190939.PHQ05TN | Patient Health Questionnaire - 8 Questionnaire Test Name
(PHQ05TN) | text
Extensible: No | C190939 | Patient Health Questionnaire - 8 Questionnaire Test Name | Patient Health Questionnaire - 8 test name. | CDISC Questionnaire Patient Health Questionnaire - 8 Item Test Name Terminology |
PHQ05-Feeling Bad About Yourself | C191159 | PHQ05-Feeling Bad About Yourself | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling bad about yourself--or that you are a failure or have let yourself or your family down. | PHQ-8 - Feeling Bad About Yourself | ||
PHQ05-Feeling Down Depressed or Hopeless | C191155 | PHQ05-Feeling Down Depressed or Hopeless | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling down, depressed, or hopeless. | PHQ-8 - Feeling Down Depressed or Hopeless | ||
PHQ05-Feeling Tired or Little Energy | C191157 | PHQ05-Feeling Tired or Little Energy | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Feeling tired or having little energy. | PHQ-8 - Feeling Tired or Little Energy | ||
PHQ05-Little Interest/Pleasure in Things | C191154 | PHQ05-Little Interest/Pleasure in Things | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Little interest or pleasure in doing things. | PHQ-8 - Little Interest or Pleasure in Things | ||
PHQ05-Moving Slowly or Fidgety/Restless | C191161 | PHQ05-Moving Slowly or Fidgety/Restless | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Moving or speaking so slowly that other people could have noticed? Or the opposite -- being so fidgety or restless that you have been moving around a lot more than usual. | PHQ-8 - Moving Slowly or Fidgety or Restless | ||
PHQ05-Poor Appetite or Overeating | C191158 | PHQ05-Poor Appetite or Overeating | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Poor appetite or overeating. | PHQ-8 - Poor Appetite or Overeating | ||
PHQ05-Total Score | C191162 | PHQ05-Total Score | Patient Health Questionnaire - 8 - Total Score. | PHQ-8 - Total Score | ||
PHQ05-Trouble Concentrating on Things | C191160 | PHQ05-Trouble Concentrating on Things | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Trouble concentrating on things, such as reading the newspaper or watching television. | PHQ-8 - Trouble Concentrating on Things | ||
PHQ05-Trouble Falling or Staying Asleep | C191156 | PHQ05-Trouble Falling or Staying Asleep | Patient Health Questionnaire - 8 - Over the past 2 weeks, how often have you been bothered by any of the following problems? Trouble falling or staying asleep, or sleeping too much. | PHQ-8 - Trouble Falling or Staying Asleep | ||
Back to top | ||||||
CL.C103481.PHQ01TC | Patient Health Questionnaire - 9 Item Questionnaire Test Code
(PHQ01TC) | text
Extensible: No | C103481 | Patient Health Questionnaire - 9 Item Questionnaire Test Code | Patient Health Questionnaire - 9 test code. | CDISC Questionnaire PHQ-9 Test Code Terminology |
PHQ0101 | C103705 | PHQ01-Little Interest/Pleasure in Things | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Little interest or pleasure in doing things. | PHQ-9 - Little Interest or Pleasure in Doing Things | ||
PHQ0102 | C103706 | PHQ01-Feeling Down Depressed or Hopeless | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling down, depressed, or hopeless. | PHQ-9 - Feeling Down, Depressed, or Hopeless | ||
PHQ0103 | C103707 | PHQ01-Trouble Falling or Staying Asleep | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Trouble falling or staying asleep, or sleeping too much. | PHQ-9 - Trouble Falling or Staying Asleep, or Sleeping Too Much | ||
PHQ0104 | C103708 | PHQ01-Feeling Tired or Little Energy | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling tired or having little energy. | PHQ-9 - Feeling Tired or Having Little Energy | ||
PHQ0105 | C103709 | PHQ01-Poor Appetite or Overeating | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Poor appetite or overeating. | PHQ-9 - Poor Appetite or Overeating | ||
PHQ0106 | C103710 | PHQ01-Feeling Bad About Yourself | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling bad about yourself - or that you are a failure or have let yourself or your family down. | PHQ-9 - Feeling Bad About Yourself | ||
PHQ0107 | C103711 | PHQ01-Trouble Concentrating on Things | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Trouble concentrating on things, such as reading the newspaper or watching television. | PHQ-9 - Trouble Concentrating on Things | ||
PHQ0108 | C103712 | PHQ01-Moving Slowly or Fidgety/Restless | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Moving or speaking so slowly that other people could have noticed? Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual. | PHQ-9 - Moving or Speaking Slowly or the Opposite being Fidgety or Restless | ||
PHQ0109 | C103713 | PHQ01-Thoughts You Be Better Off Dead | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Thoughts that you would be better off dead or of hurting yourself in some way. | PHQ-9 - Thoughts That You Would be Better Off Dead | ||
PHQ0110 | C103714 | PHQ01-Difficult to Work/Take Care Things | Patient Health Questionnaire - 9 - If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? | PHQ-9 - How Difficult have Problems Made it for You to Work, Take Care of Things, or Get Along with Other People | ||
PHQ0111 | C113887 | PHQ01-Total Score | Patient Health Questionnaire - 9 - Total score. | PHQ-9 - Total Score | ||
Back to top | ||||||
CL.C103480.PHQ01TN | Patient Health Questionnaire - 9 Item Questionnaire Test Name
(PHQ01TN) | text
Extensible: No | C103480 | Patient Health Questionnaire - 9 Item Questionnaire Test Name | Patient Health Questionnaire - 9 test name. | CDISC Questionnaire PHQ-9 Test Name Terminology |
PHQ01-Difficult to Work/Take Care Things | C103714 | PHQ01-Difficult to Work/Take Care Things | Patient Health Questionnaire - 9 - If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? | PHQ-9 - How Difficult have Problems Made it for You to Work, Take Care of Things, or Get Along with Other People | ||
PHQ01-Feeling Bad About Yourself | C103710 | PHQ01-Feeling Bad About Yourself | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling bad about yourself - or that you are a failure or have let yourself or your family down. | PHQ-9 - Feeling Bad About Yourself | ||
PHQ01-Feeling Down Depressed or Hopeless | C103706 | PHQ01-Feeling Down Depressed or Hopeless | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling down, depressed, or hopeless. | PHQ-9 - Feeling Down, Depressed, or Hopeless | ||
PHQ01-Feeling Tired or Little Energy | C103708 | PHQ01-Feeling Tired or Little Energy | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Feeling tired or having little energy. | PHQ-9 - Feeling Tired or Having Little Energy | ||
PHQ01-Little Interest/Pleasure in Things | C103705 | PHQ01-Little Interest/Pleasure in Things | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Little interest or pleasure in doing things. | PHQ-9 - Little Interest or Pleasure in Doing Things | ||
PHQ01-Moving Slowly or Fidgety/Restless | C103712 | PHQ01-Moving Slowly or Fidgety/Restless | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Moving or speaking so slowly that other people could have noticed? Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual. | PHQ-9 - Moving or Speaking Slowly or the Opposite being Fidgety or Restless | ||
PHQ01-Poor Appetite or Overeating | C103709 | PHQ01-Poor Appetite or Overeating | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Poor appetite or overeating. | PHQ-9 - Poor Appetite or Overeating | ||
PHQ01-Thoughts You Be Better Off Dead | C103713 | PHQ01-Thoughts You Be Better Off Dead | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Thoughts that you would be better off dead or of hurting yourself in some way. | PHQ-9 - Thoughts That You Would be Better Off Dead | ||
PHQ01-Total Score | C113887 | PHQ01-Total Score | Patient Health Questionnaire - 9 - Total score. | PHQ-9 - Total Score | ||
PHQ01-Trouble Concentrating on Things | C103711 | PHQ01-Trouble Concentrating on Things | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Trouble concentrating on things, such as reading the newspaper or watching television. | PHQ-9 - Trouble Concentrating on Things | ||
PHQ01-Trouble Falling or Staying Asleep | C103707 | PHQ01-Trouble Falling or Staying Asleep | Patient Health Questionnaire - 9 - Over the last 2 weeks, how often have you been bothered by: Trouble falling or staying asleep, or sleeping too much. | PHQ-9 - Trouble Falling or Staying Asleep, or Sleeping Too Much | ||
Back to top | ||||||
CL.C125749.PHQ03TC | Patient Health Questionnaire Screener Version Questionnaire Test Code
(PHQ03TC) | text
Extensible: No | C125749 | Patient Health Questionnaire Screener Version Questionnaire Test Code | Patient Health Questionnaire Screener Version test code. | CDISC Questionnaire PHQ Screener Version Test Code Terminology |
PHQ0301A | C125829 | PHQ03-Stomach Pain | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by stomach pain? | PHQ Screener Version - Stomach Pain | ||
PHQ0301B | C125830 | PHQ03-Back Pain | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by back pain? | PHQ Screener Version - Back Pain | ||
PHQ0301C | C125831 | PHQ03-Pain in Your Arms/Legs/Joints | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by pain in your arms, legs, or joints (knees, hips, etc.)? | PHQ Screener Version - Pain in Arms, Legs, Joints | ||
PHQ0301D | C125832 | PHQ03-Menstrual Cramp/Problem | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by menstrual cramps or other problems with your periods? | PHQ Screener Version - Menstrual Cramp or Other Problem | ||
PHQ0301E | C125833 | PHQ03-Pain/Problems During Intercourse | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by pain or problems during sexual intercourse? | PHQ Screener Version - Pain During Intercourse | ||
PHQ0301F | C125834 | PHQ03-Headaches | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by headaches? | PHQ Screener Version - Headaches | ||
PHQ0301G | C125835 | PHQ03-Chest Pain | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by chest pain? | PHQ Screener Version - Chest Pain | ||
PHQ0301H | C125836 | PHQ03-Dizziness | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by dizziness? | PHQ Screener Version - Dizziness | ||
PHQ0301I | C125837 | PHQ03-Fainting Spells | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by fainting spells? | PHQ Screener Version - Fainting Spells | ||
PHQ0301J | C125838 | PHQ03-Feeling Your Heart Pound/Race | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by feeling your heart pound/race? | PHQ Screener Version - Feeling Your Heart Pound or Race | ||
PHQ0301K | C125839 | PHQ03-Shortness of Breath | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by shortness of breath? | PHQ Screener Version - Shortness of Breath | ||
PHQ0301L | C125840 | PHQ03-Constipation/Diarrhea | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by constipation, loose bowels, or diarrhea? | PHQ Screener Version - Constipation or Diarrhea | ||
PHQ0301M | C125841 | PHQ03-Nausea/Gas/Indigestion | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by nausea, gas, indigestion? | PHQ Screener Version - Nausea, Gas or Indigestion | ||
PHQ0302A | C125842 | PHQ03-Little Interest in Doing Things | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by little interest or pleasure in doing things? | PHQ Screener Version - Little Interest in Doing Things | ||
PHQ0302B | C125843 | PHQ03-Feeling Down/Depressed | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling down, depressed, or hopeless? | PHQ Screener Version - Feeling Down or Depressed | ||
PHQ0302C | C125844 | PHQ03-Last 2 Week Trouble Falling Asleep | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by trouble falling or staying asleep, or sleeping too much? | PHQ Screener Version - Last 2 Weeks, Trouble Falling or Staying Asleep | ||
PHQ0302D | C125845 | PHQ03-Feeling Tired/Little Energy | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling tired or having little energy? | PHQ Screener Version - Feeling Tired or Little Energy | ||
PHQ0302E | C125846 | PHQ03-Poor Appetite or Overeating | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by poor appetite or overeating? | PHQ Screener Version - Poor Appetite or Overeating | ||
PHQ0302F | C125847 | PHQ03-Feeling Bad About Yourself | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling bad about yourself - or that you are a failure or have let yourself or your family down? | PHQ Screener Version - Feeling Bad About Yourself | ||
PHQ0302G | C125848 | PHQ03-Last 2 Week Trouble Concentrating | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by trouble concentrating on things, such as reading the newspaper or watching television? | PHQ Screener Version - Last 2 Weeks, Trouble Concentrating | ||
PHQ0302H | C125849 | PHQ03-Moving Slowly/Fidgety/Restless | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by moving or speaking so slowly that other people could have noticed? Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual? | PHQ Screener Version - Moving Slowly or Moving More | ||
PHQ0302I | C125850 | PHQ03-Thoughts Be Better Off Dead | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by thoughts that you would be better off dead or of hurting yourself in some way? | PHQ Screener Version - Thoughts Be Better Off Dead | ||
PHQ0303A | C125851 | PHQ03-Anxiety Attack | Patient Health Questionnaire Screener Version - In the last 4 weeks, have you had an anxiety attack - suddenly feeling fear or panic? | PHQ Screener Version - Anxiety Attack | ||
PHQ0303B | C125852 | PHQ03-Anxiety Attack Happened Before | Patient Health Questionnaire Screener Version - Has this ever happened before? | PHQ Screener Version - Anxiety Attack Happened Before | ||
PHQ0303C | C125853 | PHQ03-Anxiety Attacks Come Suddenly | Patient Health Questionnaire Screener Version - Do some of these attacks come suddenly out of the blue - that is, in situations where you don't expect to be nervous or uncomfortable? | PHQ Screener Version - Anxiety Attacks Come Suddenly | ||
PHQ0303D | C125854 | PHQ03-Anxiety Attacks Bother a Lot | Patient Health Questionnaire Screener Version - Do these attacks bother you a lot or are you worried about having another attack? | PHQ Screener Version - Anxiety Attacks Bother a Lot | ||
PHQ0304A | C125855 | PHQ03-Anxiety Attack Short of Breath | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Were you short of breath? | PHQ Screener Version - Anxiety Attack Short of Breath | ||
PHQ0304B | C125856 | PHQ03-Anxiety Attack Heart Race/Pound | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did your heart race, pound, or skip? | PHQ Screener Version - Anxiety Attack Heart Race or Pound | ||
PHQ0304C | C125857 | PHQ03-Anxiety Attack Chest Pain | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have chest pain or pressure? | PHQ Screener Version - Anxiety Attack Chest Pain | ||
PHQ0304D | C125858 | PHQ03-Anxiety Attack Sweat | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you sweat? | PHQ Screener Version - Anxiety Attack Sweat | ||
PHQ0304E | C125859 | PHQ03-Anxiety Attack Choking | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you feel as if you were choking? | PHQ Screener Version - Anxiety Attack Choking | ||
PHQ0304F | C125860 | PHQ03-Anxiety Attack Hot Flash/Chill | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have hot flashes or chills? | PHQ Screener Version - Anxiety Attack Hot Flash or Chill | ||
PHQ0304G | C125861 | PHQ03-Anxiety Attack Nausea/Diarrhea | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have nausea or an upset stomach, or the feeling that you were going to have diarrhea? | PHQ Screener Version - Anxiety Attack Nausea or Diarrhea | ||
PHQ0304H | C125862 | PHQ03-Anxiety Attack Dizzy/Faint | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you feel dizzy, unsteady, or faint? | PHQ Screener Version - Anxiety Attack Dizzy or Faint | ||
PHQ0304I | C125863 | PHQ03-Anxiety Attack Tingling/Numbness | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have tingling or numbness in parts of your body? | PHQ Screener Version - Anxiety Attack Tingling or Numbness | ||
PHQ0304J | C125864 | PHQ03-Anxiety Attack Tremble/Shake | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you tremble or shake? | PHQ Screener Version - Anxiety Attack Tremble or Shake | ||
PHQ0304K | C125865 | PHQ03-Anxiety Attack Afraid You Dying | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Were you afraid you were dying? | PHQ Screener Version - Anxiety Attack Afraid You Were Dying | ||
PHQ0305A | C125866 | PHQ03-Feeling Nervous/Anxious | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by feeling nervous, anxious, on edge, or worrying a lot about different things? | PHQ Screener Version - Feeling Nervous or Anxious | ||
PHQ0305B | C125867 | PHQ03-Feeling Restless | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by feeling restless so that it is hard to sit still? | PHQ Screener Version - Feeling Restless | ||
PHQ0305C | C125868 | PHQ03-Getting Tired Easily | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by getting tired very easily? | PHQ Screener Version - Getting Tired Easily | ||
PHQ0305D | C125869 | PHQ03-Muscle Tension/Aches/Soreness | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by muscle tension, aches, or soreness? | PHQ Screener Version - Muscle Tension | ||
PHQ0305E | C125870 | PHQ03-Last 4 Week Trouble Falling Asleep | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by trouble falling asleep or staying asleep? | PHQ Screener Version - Last 4 Weeks, Trouble Falling or Staying Asleep | ||
PHQ0305F | C125871 | PHQ03-Last 4 Week Trouble Concentrating | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by trouble concentrating on things, such as reading a book or watching TV? | PHQ Screener Version - Last 4 Weeks, Trouble Concentrating | ||
PHQ0305G | C125872 | PHQ03-Becoming Easily Annoyed | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by becoming easily annoyed or irritable? | PHQ Screener Version - Becoming Easily Annoyed | ||
PHQ0306A | C125873 | PHQ03-No Control What/How Much Eat | Patient Health Questionnaire Screener Version - Do you often feel that you can't control what or how much you eat? | PHQ Screener Version - No Control What or How Much Eat | ||
PHQ0306B | C125874 | PHQ03-Eat 2-Hours Large Amount Food | Patient Health Questionnaire Screener Version - Do you often eat, within any 2 - hour period, what most people would regard as an unusually large amount of food? | PHQ Screener Version - Often Eat Large Amount Food | ||
PHQ0306C | C125875 | PHQ03-Eat a Lot Twice Week | Patient Health Questionnaire Screener Version - Has this been as often, on average, as twice a week for the last 3 months? | PHQ Screener Version - Eat a Lot Twice Week | ||
PHQ0307A | C125876 | PHQ03-Made Yourself Vomit | Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Made yourself vomit? | PHQ Screener Version - Avoid Gaining Weight, Made Yourself Vomit | ||
PHQ0307B | C125877 | PHQ03-Took Twice Dose of Laxatives | Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Took more than twice the recommended dose of laxatives to avoid gaining weight? | PHQ Screener Version - Avoid Gaining Weight, Took Twice Dose of Laxatives | ||
PHQ0307C | C125878 | PHQ03-Fasted at Least 24 Hours | Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Fasted - not eaten anything at all for at least 24 hours to avoid gaining weight? | PHQ Screener Version - Avoid Gaining Weight, Fasted at Least 24 Hours | ||
PHQ0307D | C125879 | PHQ03-Exercised Avoid Gaining Weight | Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Exercised for more than an hour specifically to avoid gaining weight after binge eating? | PHQ Screener Version - Avoid Gaining Weight, Exercise | ||
PHQ0308 | C125880 | PHQ03-Avoid Gaining Weight Twice Week | Patient Health Questionnaire Screener Version - If you checked "YES" to any of these ways of avoiding gaining weight, were any as often, on average, as twice a week? | PHQ Screener Version - Avoid Gaining Weight Twice Week | ||
PHQ0309 | C125881 | PHQ03-Drink Alcohol | Patient Health Questionnaire Screener Version - Do you ever drink alcohol (including beer or wine)? | PHQ Screener Version - Drink Alcohol | ||
PHQ0310A | C125882 | PHQ03-Drank Alcohol With Health Problem | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drank alcohol even though a doctor suggested that you stop drinking because of a problem with your health? | PHQ Screener Version - Drank Alcohol With Health Problem | ||
PHQ0310B | C125883 | PHQ03-Alcohol at Work/School | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drank alcohol, were high from alcohol, or hung over while you were working, or going to school, or taking care of children or other responsibilities? | PHQ Screener Version - Drank Alcohol at Work or School | ||
PHQ0310C | C125884 | PHQ03-Missed Work Because of Drinking | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You missed or were late for work, school, or other activities because you were drinking or hung over? | PHQ Screener Version - Missed Work Because of Drinking | ||
PHQ0310D | C125885 | PHQ03-Problem With People While Drinking | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You had a problem getting along with other people while you were drinking? | PHQ Screener Version - Problem Getting Along With People While Drinking | ||
PHQ0310E | C125886 | PHQ03-Drove After Several Drinks | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drove a car after having several drinks or after drinking too much? | PHQ Screener Version - Drove Car After Several Drinks | ||
PHQ0311 | C125887 | PHQ03-Problems Made It Difficult to Work | Patient Health Questionnaire Screener Version - If you checked off any problems on this questionnaire, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? | PHQ Screener Version - Problems Made It Difficult to Work | ||
Back to top | ||||||
CL.C125748.PHQ03TN | Patient Health Questionnaire Screener Version Questionnaire Test Name
(PHQ03TN) | text
Extensible: No | C125748 | Patient Health Questionnaire Screener Version Questionnaire Test Name | Patient Health Questionnaire Screener Version test name. | CDISC Questionnaire PHQ Screener Version Test Name Terminology |
PHQ03-Alcohol at Work/School | C125883 | PHQ03-Alcohol at Work/School | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drank alcohol, were high from alcohol, or hung over while you were working, or going to school, or taking care of children or other responsibilities? | PHQ Screener Version - Drank Alcohol at Work or School | ||
PHQ03-Anxiety Attack Afraid You Dying | C125865 | PHQ03-Anxiety Attack Afraid You Dying | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Were you afraid you were dying? | PHQ Screener Version - Anxiety Attack Afraid You Were Dying | ||
PHQ03-Anxiety Attack Chest Pain | C125857 | PHQ03-Anxiety Attack Chest Pain | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have chest pain or pressure? | PHQ Screener Version - Anxiety Attack Chest Pain | ||
PHQ03-Anxiety Attack Choking | C125859 | PHQ03-Anxiety Attack Choking | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you feel as if you were choking? | PHQ Screener Version - Anxiety Attack Choking | ||
PHQ03-Anxiety Attack Dizzy/Faint | C125862 | PHQ03-Anxiety Attack Dizzy/Faint | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you feel dizzy, unsteady, or faint? | PHQ Screener Version - Anxiety Attack Dizzy or Faint | ||
PHQ03-Anxiety Attack Happened Before | C125852 | PHQ03-Anxiety Attack Happened Before | Patient Health Questionnaire Screener Version - Has this ever happened before? | PHQ Screener Version - Anxiety Attack Happened Before | ||
PHQ03-Anxiety Attack Heart Race/Pound | C125856 | PHQ03-Anxiety Attack Heart Race/Pound | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did your heart race, pound, or skip? | PHQ Screener Version - Anxiety Attack Heart Race or Pound | ||
PHQ03-Anxiety Attack Hot Flash/Chill | C125860 | PHQ03-Anxiety Attack Hot Flash/Chill | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have hot flashes or chills? | PHQ Screener Version - Anxiety Attack Hot Flash or Chill | ||
PHQ03-Anxiety Attack Nausea/Diarrhea | C125861 | PHQ03-Anxiety Attack Nausea/Diarrhea | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have nausea or an upset stomach, or the feeling that you were going to have diarrhea? | PHQ Screener Version - Anxiety Attack Nausea or Diarrhea | ||
PHQ03-Anxiety Attack Short of Breath | C125855 | PHQ03-Anxiety Attack Short of Breath | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Were you short of breath? | PHQ Screener Version - Anxiety Attack Short of Breath | ||
PHQ03-Anxiety Attack Sweat | C125858 | PHQ03-Anxiety Attack Sweat | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you sweat? | PHQ Screener Version - Anxiety Attack Sweat | ||
PHQ03-Anxiety Attack Tingling/Numbness | C125863 | PHQ03-Anxiety Attack Tingling/Numbness | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you have tingling or numbness in parts of your body? | PHQ Screener Version - Anxiety Attack Tingling or Numbness | ||
PHQ03-Anxiety Attack Tremble/Shake | C125864 | PHQ03-Anxiety Attack Tremble/Shake | Patient Health Questionnaire Screener Version - Think about your last bad anxiety attack. Did you tremble or shake? | PHQ Screener Version - Anxiety Attack Tremble or Shake | ||
PHQ03-Anxiety Attack | C125851 | PHQ03-Anxiety Attack | Patient Health Questionnaire Screener Version - In the last 4 weeks, have you had an anxiety attack - suddenly feeling fear or panic? | PHQ Screener Version - Anxiety Attack | ||
PHQ03-Anxiety Attacks Bother a Lot | C125854 | PHQ03-Anxiety Attacks Bother a Lot | Patient Health Questionnaire Screener Version - Do these attacks bother you a lot or are you worried about having another attack? | PHQ Screener Version - Anxiety Attacks Bother a Lot | ||
PHQ03-Anxiety Attacks Come Suddenly | C125853 | PHQ03-Anxiety Attacks Come Suddenly | Patient Health Questionnaire Screener Version - Do some of these attacks come suddenly out of the blue - that is, in situations where you don't expect to be nervous or uncomfortable? | PHQ Screener Version - Anxiety Attacks Come Suddenly | ||
PHQ03-Avoid Gaining Weight Twice Week | C125880 | PHQ03-Avoid Gaining Weight Twice Week | Patient Health Questionnaire Screener Version - If you checked "YES" to any of these ways of avoiding gaining weight, were any as often, on average, as twice a week? | PHQ Screener Version - Avoid Gaining Weight Twice Week | ||
PHQ03-Back Pain | C125830 | PHQ03-Back Pain | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by back pain? | PHQ Screener Version - Back Pain | ||
PHQ03-Becoming Easily Annoyed | C125872 | PHQ03-Becoming Easily Annoyed | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by becoming easily annoyed or irritable? | PHQ Screener Version - Becoming Easily Annoyed | ||
PHQ03-Chest Pain | C125835 | PHQ03-Chest Pain | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by chest pain? | PHQ Screener Version - Chest Pain | ||
PHQ03-Constipation/Diarrhea | C125840 | PHQ03-Constipation/Diarrhea | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by constipation, loose bowels, or diarrhea? | PHQ Screener Version - Constipation or Diarrhea | ||
PHQ03-Dizziness | C125836 | PHQ03-Dizziness | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by dizziness? | PHQ Screener Version - Dizziness | ||
PHQ03-Drank Alcohol With Health Problem | C125882 | PHQ03-Drank Alcohol With Health Problem | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drank alcohol even though a doctor suggested that you stop drinking because of a problem with your health? | PHQ Screener Version - Drank Alcohol With Health Problem | ||
PHQ03-Drink Alcohol | C125881 | PHQ03-Drink Alcohol | Patient Health Questionnaire Screener Version - Do you ever drink alcohol (including beer or wine)? | PHQ Screener Version - Drink Alcohol | ||
PHQ03-Drove After Several Drinks | C125886 | PHQ03-Drove After Several Drinks | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You drove a car after having several drinks or after drinking too much? | PHQ Screener Version - Drove Car After Several Drinks | ||
PHQ03-Eat 2-Hours Large Amount Food | C125874 | PHQ03-Eat 2-Hours Large Amount Food | Patient Health Questionnaire Screener Version - Do you often eat, within any 2 - hour period, what most people would regard as an unusually large amount of food? | PHQ Screener Version - Often Eat Large Amount Food | ||
PHQ03-Eat a Lot Twice Week | C125875 | PHQ03-Eat a Lot Twice Week | Patient Health Questionnaire Screener Version - Has this been as often, on average, as twice a week for the last 3 months? | PHQ Screener Version - Eat a Lot Twice Week | ||
PHQ03-Exercised Avoid Gaining Weight | C125879 | PHQ03-Exercised Avoid Gaining Weight | Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Exercised for more than an hour specifically to avoid gaining weight after binge eating? | PHQ Screener Version - Avoid Gaining Weight, Exercise | ||
PHQ03-Fainting Spells | C125837 | PHQ03-Fainting Spells | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by fainting spells? | PHQ Screener Version - Fainting Spells | ||
PHQ03-Fasted at Least 24 Hours | C125878 | PHQ03-Fasted at Least 24 Hours | Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Fasted - not eaten anything at all for at least 24 hours to avoid gaining weight? | PHQ Screener Version - Avoid Gaining Weight, Fasted at Least 24 Hours | ||
PHQ03-Feeling Bad About Yourself | C125847 | PHQ03-Feeling Bad About Yourself | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling bad about yourself - or that you are a failure or have let yourself or your family down? | PHQ Screener Version - Feeling Bad About Yourself | ||
PHQ03-Feeling Down/Depressed | C125843 | PHQ03-Feeling Down/Depressed | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling down, depressed, or hopeless? | PHQ Screener Version - Feeling Down or Depressed | ||
PHQ03-Feeling Nervous/Anxious | C125866 | PHQ03-Feeling Nervous/Anxious | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by feeling nervous, anxious, on edge, or worrying a lot about different things? | PHQ Screener Version - Feeling Nervous or Anxious | ||
PHQ03-Feeling Restless | C125867 | PHQ03-Feeling Restless | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by feeling restless so that it is hard to sit still? | PHQ Screener Version - Feeling Restless | ||
PHQ03-Feeling Tired/Little Energy | C125845 | PHQ03-Feeling Tired/Little Energy | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by feeling tired or having little energy? | PHQ Screener Version - Feeling Tired or Little Energy | ||
PHQ03-Feeling Your Heart Pound/Race | C125838 | PHQ03-Feeling Your Heart Pound/Race | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by feeling your heart pound/race? | PHQ Screener Version - Feeling Your Heart Pound or Race | ||
PHQ03-Getting Tired Easily | C125868 | PHQ03-Getting Tired Easily | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by getting tired very easily? | PHQ Screener Version - Getting Tired Easily | ||
PHQ03-Headaches | C125834 | PHQ03-Headaches | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by headaches? | PHQ Screener Version - Headaches | ||
PHQ03-Last 2 Week Trouble Concentrating | C125848 | PHQ03-Last 2 Week Trouble Concentrating | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by trouble concentrating on things, such as reading the newspaper or watching television? | PHQ Screener Version - Last 2 Weeks, Trouble Concentrating | ||
PHQ03-Last 2 Week Trouble Falling Asleep | C125844 | PHQ03-Last 2 Week Trouble Falling Asleep | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by trouble falling or staying asleep, or sleeping too much? | PHQ Screener Version - Last 2 Weeks, Trouble Falling or Staying Asleep | ||
PHQ03-Last 4 Week Trouble Concentrating | C125871 | PHQ03-Last 4 Week Trouble Concentrating | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by trouble concentrating on things, such as reading a book or watching TV? | PHQ Screener Version - Last 4 Weeks, Trouble Concentrating | ||
PHQ03-Last 4 Week Trouble Falling Asleep | C125870 | PHQ03-Last 4 Week Trouble Falling Asleep | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by trouble falling asleep or staying asleep? | PHQ Screener Version - Last 4 Weeks, Trouble Falling or Staying Asleep | ||
PHQ03-Little Interest in Doing Things | C125842 | PHQ03-Little Interest in Doing Things | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by little interest or pleasure in doing things? | PHQ Screener Version - Little Interest in Doing Things | ||
PHQ03-Made Yourself Vomit | C125876 | PHQ03-Made Yourself Vomit | Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Made yourself vomit? | PHQ Screener Version - Avoid Gaining Weight, Made Yourself Vomit | ||
PHQ03-Menstrual Cramp/Problem | C125832 | PHQ03-Menstrual Cramp/Problem | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by menstrual cramps or other problems with your periods? | PHQ Screener Version - Menstrual Cramp or Other Problem | ||
PHQ03-Missed Work Because of Drinking | C125884 | PHQ03-Missed Work Because of Drinking | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You missed or were late for work, school, or other activities because you were drinking or hung over? | PHQ Screener Version - Missed Work Because of Drinking | ||
PHQ03-Moving Slowly/Fidgety/Restless | C125849 | PHQ03-Moving Slowly/Fidgety/Restless | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by moving or speaking so slowly that other people could have noticed? Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual? | PHQ Screener Version - Moving Slowly or Moving More | ||
PHQ03-Muscle Tension/Aches/Soreness | C125869 | PHQ03-Muscle Tension/Aches/Soreness | Patient Health Questionnaire Screener Version - Over the last 4 weeks, how often have you been bothered by muscle tension, aches, or soreness? | PHQ Screener Version - Muscle Tension | ||
PHQ03-Nausea/Gas/Indigestion | C125841 | PHQ03-Nausea/Gas/Indigestion | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by nausea, gas, indigestion? | PHQ Screener Version - Nausea, Gas or Indigestion | ||
PHQ03-No Control What/How Much Eat | C125873 | PHQ03-No Control What/How Much Eat | Patient Health Questionnaire Screener Version - Do you often feel that you can't control what or how much you eat? | PHQ Screener Version - No Control What or How Much Eat | ||
PHQ03-Pain in Your Arms/Legs/Joints | C125831 | PHQ03-Pain in Your Arms/Legs/Joints | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by pain in your arms, legs, or joints (knees, hips, etc.)? | PHQ Screener Version - Pain in Arms, Legs, Joints | ||
PHQ03-Pain/Problems During Intercourse | C125833 | PHQ03-Pain/Problems During Intercourse | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by pain or problems during sexual intercourse? | PHQ Screener Version - Pain During Intercourse | ||
PHQ03-Poor Appetite or Overeating | C125846 | PHQ03-Poor Appetite or Overeating | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by poor appetite or overeating? | PHQ Screener Version - Poor Appetite or Overeating | ||
PHQ03-Problem With People While Drinking | C125885 | PHQ03-Problem With People While Drinking | Patient Health Questionnaire Screener Version - Have any of the following happened to you more than once in the last 6 months: You had a problem getting along with other people while you were drinking? | PHQ Screener Version - Problem Getting Along With People While Drinking | ||
PHQ03-Problems Made It Difficult to Work | C125887 | PHQ03-Problems Made It Difficult to Work | Patient Health Questionnaire Screener Version - If you checked off any problems on this questionnaire, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people? | PHQ Screener Version - Problems Made It Difficult to Work | ||
PHQ03-Shortness of Breath | C125839 | PHQ03-Shortness of Breath | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by shortness of breath? | PHQ Screener Version - Shortness of Breath | ||
PHQ03-Stomach Pain | C125829 | PHQ03-Stomach Pain | Patient Health Questionnaire Screener Version - During the last 4 weeks, how much have you been bothered by stomach pain? | PHQ Screener Version - Stomach Pain | ||
PHQ03-Thoughts Be Better Off Dead | C125850 | PHQ03-Thoughts Be Better Off Dead | Patient Health Questionnaire Screener Version - Over the last 2 weeks, how often have you been bothered by thoughts that you would be better off dead or of hurting yourself in some way? | PHQ Screener Version - Thoughts Be Better Off Dead | ||
PHQ03-Took Twice Dose of Laxatives | C125877 | PHQ03-Took Twice Dose of Laxatives | Patient Health Questionnaire Screener Version - In the last 3 months have you often done any of the following in order to avoid gaining weight: Took more than twice the recommended dose of laxatives to avoid gaining weight? | PHQ Screener Version - Avoid Gaining Weight, Took Twice Dose of Laxatives | ||
Back to top | ||||||
CL.C179942.PT01TC | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Questionnaire Test Code
(PT01TC) | text
Extensible: No | C179942 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Questionnaire Test Code | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 test code. | CDISC Questionnaire PRO-CTCAE Version 1.0 Test Code Terminology |
PT01001A | C180044 | PT01-Dry Mouth Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dry mouth at its worst? | PRO-CTCAE V1.0 - Dry Mouth Severity | ||
PT01002A | C180045 | PT01-Difficulty Swallowing Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your difficulty swallowing at its worst? | PRO-CTCAE V1.0 - Difficulty Swallowing Severity | ||
PT01003A | C180046 | PT01-Mouth/Throat Sores Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your mouth or throat sores at their worst? | PRO-CTCAE V1.0 - Mouth/Throat Sores Severity | ||
PT01003B | C180047 | PT01-Mouth/Throat Sores Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did mouth or throat sores interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Mouth/Throat Sores Interference | ||
PT01004A | C180048 | PT01-Cracking Corners of Mouth Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of skin cracking at the corners of your mouth at its worst? | PRO-CTCAE V1.0 - Cracking Corners of Mouth Severity | ||
PT01005A | C180049 | PT01-Voice Quality Changes Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any voice changes? | PRO-CTCAE V1.0 - Voice Quality Changes Presence | ||
PT01006A | C180050 | PT01-Hoarseness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hoarse voice at its worst? | PRO-CTCAE V1.0 - Hoarseness Severity | ||
PT01007A | C180051 | PT01-Taste Changes Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with tasting food or drink at their worst? | PRO-CTCAE V1.0 - Taste Changes Severity | ||
PT01008A | C180052 | PT01-Decreased Appetite Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your decreased appetite at its worst? | PRO-CTCAE V1.0 - Decreased Appetite Severity | ||
PT01008B | C180053 | PT01-Decreased Appetite Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did decreased appetite interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Decreased Appetite Interference | ||
PT01009A | C180054 | PT01-Nausea Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have nausea? | PRO-CTCAE V1.0 - Nausea Frequency | ||
PT01009B | C180055 | PT01-Nausea Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your nausea at its worst? | PRO-CTCAE V1.0 - Nausea Severity | ||
PT01010A | C180056 | PT01-Vomiting Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have vomiting? | PRO-CTCAE V1.0 - Vomiting Frequency | ||
PT01010B | C180057 | PT01-Vomiting Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your vomiting at its worst? | PRO-CTCAE V1.0 - Vomiting Severity | ||
PT01011A | C180058 | PT01-Heartburn Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have heartburn? | PRO-CTCAE V1.0 - Heartburn Frequency | ||
PT01011B | C180059 | PT01-Heartburn Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your heartburn at its worst? | PRO-CTCAE V1.0 - Heartburn Severity | ||
PT01012A | C180060 | PT01-Gas Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any increased passing of gas (flatulence)? | PRO-CTCAE V1.0 - Gas Presence | ||
PT01013A | C180061 | PT01-Bloating Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have bloating of the abdomen (belly)? | PRO-CTCAE V1.0 - Bloating Frequency | ||
PT01013B | C180062 | PT01-Bloating Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your bloating of the abdomen (belly) at its worst? | PRO-CTCAE V1.0 - Bloating Severity | ||
PT01014A | C180063 | PT01-Hiccups Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have hiccups? | PRO-CTCAE V1.0 - Hiccups Frequency | ||
PT01014B | C180064 | PT01-Hiccups Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hiccups at their worst? | PRO-CTCAE V1.0 - Hiccups Severity | ||
PT01015A | C180065 | PT01-Constipation Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your constipation at its worst? | PRO-CTCAE V1.0 - Constipation Severity | ||
PT01016A | C180066 | PT01-Diarrhea Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have loose or watery stools (diarrhea/diarrhoea)? | PRO-CTCAE V1.0 - Diarrhea Frequency | ||
PT01017A | C180067 | PT01-Abdominal Pain Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have pain in the abdomen (belly area)? | PRO-CTCAE V1.0 - Abdominal Pain Frequency | ||
PT01017B | C180068 | PT01-Abdominal Pain Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain in the abdomen (belly area) at its worst? | PRO-CTCAE V1.0 - Abdominal Pain Severity | ||
PT01017C | C180069 | PT01-Abdominal Pain Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did pain in the abdomen (belly area) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Abdominal Pain Interference | ||
PT01018A | C180070 | PT01-Fecal Incontinence Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you lose control of bowel movements? | PRO-CTCAE V1.0 - Fecal Incontinence Frequency | ||
PT01018B | C180071 | PT01-Fecal Incontinence Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did loss of control of bowel movements interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Fecal Incontinence Interference | ||
PT01019A | C180072 | PT01-Shortness of Breath Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your shortness of breath at its worst? | PRO-CTCAE V1.0 - Shortness of Breath Severity | ||
PT01019B | C180073 | PT01-Shortness of Breath Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did your shortness of breath interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Shortness of Breath Interference | ||
PT01020A | C180074 | PT01-Cough Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your cough at its worst? | PRO-CTCAE V1.0 - Cough Severity | ||
PT01020B | C180075 | PT01-Cough Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did cough interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Cough Interference | ||
PT01021A | C180076 | PT01-Wheezing Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your wheezing (whistling noise in the chest with breathing) at its worst? | PRO-CTCAE V1.0 - Wheezing Severity | ||
PT01022A | C180077 | PT01-Swelling Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have arm or leg swelling? | PRO-CTCAE V1.0 - Swelling Frequency | ||
PT01022B | C180078 | PT01-Swelling Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your arm or leg swelling at its worst? | PRO-CTCAE V1.0 - Swelling Severity | ||
PT01022C | C180079 | PT01-Swelling Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did arm or leg swelling interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Swelling Interference | ||
PT01023A | C180080 | PT01-Heart Palpitations Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel a pounding or racing heartbeat (palpitations)? | PRO-CTCAE V1.0 - Heart Palpitations Frequency | ||
PT01023B | C180081 | PT01-Heart Palpitations Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pounding or racing heartbeat (palpitations) at its worst? | PRO-CTCAE V1.0 - Heart Palpitations Severity | ||
PT01024A | C180082 | PT01-Rash Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any rash? | PRO-CTCAE V1.0 - Rash Presence | ||
PT01025A | C180083 | PT01-Skin Dryness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dry skin at its worst? | PRO-CTCAE V1.0 - Skin Dryness Severity | ||
PT01026A | C180084 | PT01-Acne Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your acne or pimples on the face or chest at its worst? | PRO-CTCAE V1.0 - Acne Severity | ||
PT01027A | C180085 | PT01-Hair Loss Amount | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any hair loss? | PRO-CTCAE V1.0 - Hair Loss Amount | ||
PT01028A | C180086 | PT01-Itching Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your itchy skin at its worst? | PRO-CTCAE V1.0 - Itching Severity | ||
PT01029A | C180087 | PT01-Hives Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any hives (itchy red bumps on the skin)? | PRO-CTCAE V1.0 - Hives Presence | ||
PT01030A | C180088 | PT01-Hand-Foot Syndrome Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hand-foot syndrome (a rash of the hands or feet that can cause cracking, peeling, redness or pain) at its worst? | PRO-CTCAE V1.0 - Hand-Foot Syndrome Severity | ||
PT01031A | C180089 | PT01-Nail Loss Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you lose any fingernails or toenails? | PRO-CTCAE V1.0 - Nail Loss Presence | ||
PT01032A | C180090 | PT01-Nail Ridging Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any ridges or bumps on your fingernails or toenails? | PRO-CTCAE V1.0 - Nail Ridging Presence | ||
PT01033A | C180091 | PT01-Nail Discoloration Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any change in the color of your fingernails or toenails? | PRO-CTCAE V1.0 - Nail Discoloration Presence | ||
PT01034A | C180092 | PT01-Sensitivity to Sunlight Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any increased skin sensitivity to sunlight? | PRO-CTCAE V1.0 - Sensitivity to Sunlight Presence | ||
PT01035A | C180093 | PT01-Bed/Pressure Sores Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any bed sores? | PRO-CTCAE V1.0 - Bed/Pressure Sores Presence | ||
PT01036A | C180094 | PT01-Radiation Skin Reaction Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your skin burns from radiation at their worst? | PRO-CTCAE V1.0 - Radiation Skin Reaction Severity | ||
PT01037A | C180095 | PT01-Skin Darkening Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any unusual darkening of the skin? | PRO-CTCAE V1.0 - Skin Darkening Presence | ||
PT01038A | C180096 | PT01-Stretch Marks Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any stretch marks? | PRO-CTCAE V1.0 - Stretch Marks Presence | ||
PT01039A | C180097 | PT01-Numbness & Tingling Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your numbness or tingling in your hands or feet at its worst? | PRO-CTCAE V1.0 - Numbness & Tingling Severity | ||
PT01039B | C180098 | PT01-Numbness & Tingling Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did numbness or tingling in your hands or feet interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Numbness & Tingling Interference | ||
PT01040A | C180099 | PT01-Dizziness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dizziness at its worst? | PRO-CTCAE V1.0 - Dizziness Severity | ||
PT01040B | C180100 | PT01-Dizziness Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did dizziness interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Dizziness Interference | ||
PT01041A | C180101 | PT01-Blurred Vision Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your blurry vision at its worst? | PRO-CTCAE V1.0 - Blurred Vision Severity | ||
PT01041B | C180102 | PT01-Blurred Vision Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did blurry vision interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Blurred Vision Interference | ||
PT01042A | C180103 | PT01-Flashing Lights in Eyes Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any flashing lights in front of your eyes? | PRO-CTCAE V1.0 - Flashing Lights in Eyes Presence | ||
PT01043A | C180104 | PT01-Visual Floaters Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any spots or lines (floaters) that drift in front of your eyes? | PRO-CTCAE V1.0 - Visual Floaters Presence | ||
PT01044A | C180105 | PT01-Watery Eyes Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your watery eyes (tearing) at their worst? | PRO-CTCAE V1.0 - Watery Eyes Severity | ||
PT01044B | C180106 | PT01-Watery Eyes Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did watery eyes (tearing) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Watery Eyes Interference | ||
PT01045A | C180107 | PT01-Ringing in Ears Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of ringing in your ears at its worst? | PRO-CTCAE V1.0 - Ringing in Ears Severity | ||
PT01046A | C180108 | PT01-Concentration Problems Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with concentration at their worst? | PRO-CTCAE V1.0 - Concentration Problems Severity | ||
PT01046B | C180109 | PT01-Concentration Problems Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did problems with concentration interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Concentration Problems Interference | ||
PT01047A | C180110 | PT01-Memory Problems Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with memory at their worst? | PRO-CTCAE V1.0 - Memory Problems Severity | ||
PT01047B | C180111 | PT01-Memory Problems Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did problems with memory interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Memory Problems Interference | ||
PT01048A | C180112 | PT01-General Pain Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have pain? | PRO-CTCAE V1.0 - General Pain Frequency | ||
PT01048B | C180113 | PT01-General Pain Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain at its worst? | PRO-CTCAE V1.0 - General Pain Severity | ||
PT01048C | C180114 | PT01-General Pain Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did pain interfere with your usual or daily activities? | PRO-CTCAE V1.0 - General Pain Interference | ||
PT01049A | C180115 | PT01-Headache Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have a headache? | PRO-CTCAE V1.0 - Headache Frequency | ||
PT01049B | C180116 | PT01-Headache Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your headache at its worst? | PRO-CTCAE V1.0 - Headache Severity | ||
PT01049C | C180117 | PT01-Headache Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did your headache interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Headache Interference | ||
PT01050A | C180118 | PT01-Muscle Pain Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have aching muscles? | PRO-CTCAE V1.0 - Muscle Pain Frequency | ||
PT01050B | C180119 | PT01-Muscle Pain Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your aching muscles at their worst? | PRO-CTCAE V1.0 - Muscle Pain Severity | ||
PT01050C | C180120 | PT01-Muscle Pain Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did aching muscles interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Muscle Pain Interference | ||
PT01051A | C180121 | PT01-Joint Pain Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have aching joints (such as elbows, knees, shoulders)? | PRO-CTCAE V1.0 - Joint Pain Frequency | ||
PT01051B | C180122 | PT01-Joint Pain Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your aching joints (such as elbows, knees, shoulders) at their worst? | PRO-CTCAE V1.0 - Joint Pain Severity | ||
PT01051C | C180123 | PT01-Joint Pain Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did aching joints (such as elbows, knees, shoulders) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Joint Pain Interference | ||
PT01052A | C180124 | PT01-Insomnia Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your insomnia (including difficulty falling asleep, staying asleep, or waking up early) at its worst? | PRO-CTCAE V1.0 - Insomnia Severity | ||
PT01052B | C180125 | PT01-Insomnia Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did insomnia (including difficulty falling asleep, staying asleep, or waking up early) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Insomnia Interference | ||
PT01053A | C180126 | PT01-Fatigue Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your fatigue, tiredness, or lack of energy at its worst? | PRO-CTCAE V1.0 - Fatigue Severity | ||
PT01053B | C180127 | PT01-Fatigue Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did fatigue, tiredness, or lack of energy interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Fatigue Interference | ||
PT01054A | C180128 | PT01-Anxious Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel anxiety? | PRO-CTCAE V1.0 - Anxious Frequency | ||
PT01054B | C180129 | PT01-Anxious Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your anxiety at its worst? | PRO-CTCAE V1.0 - Anxious Severity | ||
PT01054C | C180130 | PT01-Anxious Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did anxiety interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Anxious Interference | ||
PT01055A | C180131 | PT01-Discouraged Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel that nothing could cheer you up? | PRO-CTCAE V1.0 - Discouraged Frequency | ||
PT01055B | C180132 | PT01-Discouraged Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your feelings that nothing could cheer you up at their worst? | PRO-CTCAE V1.0 - Discouraged Severity | ||
PT01055C | C180133 | PT01-Discouraged Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did feeling that nothing could cheer you up interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Discouraged Interference | ||
PT01056A | C180134 | PT01-Sad Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have sad or unhappy feelings? | PRO-CTCAE V1.0 - Sad Frequency | ||
PT01056B | C180135 | PT01-Sad Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your sad or unhappy feelings at their worst? | PRO-CTCAE V1.0 - Sad Severity | ||
PT01056C | C180136 | PT01-Sad Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did sad or unhappy feelings interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Sad Interference | ||
PT01057A | C180137 | PT01-Irregular Menstrual Period Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any irregular menstrual periods? | PRO-CTCAE V1.0 - Irregular Menstrual Period Presence | ||
PT01058A | C180138 | PT01-Missed Menstrual Period Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you miss an expected menstrual period? | PRO-CTCAE V1.0 - Missed Menstrual Period Presence | ||
PT01059A | C180139 | PT01-Vaginal Discharge Amount | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any unusual vaginal discharge? | PRO-CTCAE V1.0 - Vaginal Discharge Amount | ||
PT01060A | C180140 | PT01-Vaginal Dryness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your vaginal dryness at its worst? | PRO-CTCAE V1.0 - Vaginal Dryness Severity | ||
PT01061A | C180141 | PT01-Painful Urination Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain or burning with urination at its worst? | PRO-CTCAE V1.0 - Painful Urination Severity | ||
PT01062A | C180142 | PT01-Urinary Urgency Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel an urge to urinate all of a sudden? | PRO-CTCAE V1.0 - Urinary Urgency Frequency | ||
PT01062B | C180143 | PT01-Urinary Urgency Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did sudden urges to urinate interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Urinary Urgency Interference | ||
PT01063A | C180144 | PT01-Urinary Frequency Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, were there times when you had to urinate frequently? | PRO-CTCAE V1.0 - Urinary Frequency Frequency | ||
PT01063B | C180145 | PT01-Urinary Frequency Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did frequent urination interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Urinary Frequency Interference | ||
PT01064A | C180146 | PT01-Urine Color Change Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any urine color change? | PRO-CTCAE V1.0 - Urine Color Change Presence | ||
PT01065A | C180147 | PT01-Urinary Incontinence Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have loss of control of urine (leakage)? | PRO-CTCAE V1.0 - Urinary Incontinence Frequency | ||
PT01065B | C180148 | PT01-Urinary Incontinence Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did loss of control of urine (leakage) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Urinary Incontinence Interference | ||
PT01066A | C180149 | PT01-Achieve&Maintain Erection Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your difficulty getting or keeping an erection at its worst? | PRO-CTCAE V1.0 - Achieve&Maintain Erection Severity | ||
PT01067A | C180150 | PT01-Ejaculation Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have ejaculation problems? | PRO-CTCAE V1.0 - Ejaculation Frequency | ||
PT01068A | C180151 | PT01-Decreased Libido Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your decreased sexual interest at its worst? | PRO-CTCAE V1.0 - Decreased Libido Severity | ||
PT01069A | C180152 | PT01-Delayed Orgasm Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you feel that it took too long to have an orgasm or climax? | PRO-CTCAE V1.0 - Delayed Orgasm Presence | ||
PT01070A | C180153 | PT01-Unable to Have Orgasm Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, were you unable to have an orgasm or climax? | PRO-CTCAE V1.0 - Unable to Have Orgasm Presence | ||
PT01071A | C180154 | PT01-Pain w/Sexual Intercourse Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain during vaginal sex at its worst? | PRO-CTCAE V1.0 - Pain w/Sexual Intercourse Severity | ||
PT01072A | C180155 | PT01-Breast Swelling&Tenderness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your breast area enlargement or tenderness at its worst? | PRO-CTCAE V1.0 - Breast Swelling&Tenderness Severity | ||
PT01073A | C180156 | PT01-Bruising Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you bruise easily (black and blue marks)? | PRO-CTCAE V1.0 - Bruising Presence | ||
PT01074A | C180157 | PT01-Chills Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have shivering or shaking chills? | PRO-CTCAE V1.0 - Chills Frequency | ||
PT01074B | C180158 | PT01-Chills Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your shivering or shaking chills at their worst? | PRO-CTCAE V1.0 - Chills Severity | ||
PT01075A | C180159 | PT01-Increased Sweating Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have unexpected or excessive sweating during the day or nighttime (not related to hot flashes/flushes)? | PRO-CTCAE V1.0 - Increased Sweating Frequency | ||
PT01075B | C180160 | PT01-Increased Sweating Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your unexpected or excessive sweating during the day or nighttime (not related to hot flashes/flushes) at its worst? | PRO-CTCAE V1.0 - Increased Sweating Severity | ||
PT01076A | C180161 | PT01-Decreased Sweating Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have an unexpected decrease in sweating? | PRO-CTCAE V1.0 - Decreased Sweating Presence | ||
PT01077A | C180162 | PT01-Hot Flashes Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have hot flashes/flushes? | PRO-CTCAE V1.0 - Hot Flashes Frequency | ||
PT01077B | C180163 | PT01-Hot Flashes Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hot flashes/flushes at their worst? | PRO-CTCAE V1.0 - Hot Flashes Severity | ||
PT01078A | C180164 | PT01-Nosebleed Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have nosebleeds? | PRO-CTCAE V1.0 - Nosebleed Frequency | ||
PT01078B | C180165 | PT01-Nosebleed Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your nosebleeds at their worst? | PRO-CTCAE V1.0 - Nosebleed Severity | ||
PT01079A | C180166 | PT01-Pain&Swelling at Inj Site Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any pain, swelling, or redness at a site of drug injection or IV? | PRO-CTCAE V1.0 - Pain&Swelling at Inj Site Presence | ||
PT01080A | C180167 | PT01-Body Odor Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your body odor at its worst? | PRO-CTCAE V1.0 - Body Odor Severity | ||
PT01081 | C180168 | PT01-Any Other Symptoms Reported | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Do you have any other symptoms that you wish to report? | PRO-CTCAE V1.0 - Any Other Symptoms Reported | ||
PT01082A | C180169 | PT01-Other Symptom 1 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 1? | PRO-CTCAE V1.0 - Other Symptom 1 | ||
PT01082B | C180170 | PT01-Other Symptom 1 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 1 at its worst? | PRO-CTCAE V1.0 - Other Symptom 1 Severity | ||
PT01083A | C180171 | PT01-Other Symptom 2 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 2? | PRO-CTCAE V1.0 - Other Symptom 2 | ||
PT01083B | C180172 | PT01-Other Symptom 2 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 2 at its worst? | PRO-CTCAE V1.0 - Other Symptom 2 Severity | ||
PT01084A | C180173 | PT01-Other Symptom 3 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 3? | PRO-CTCAE V1.0 - Other Symptom 3 | ||
PT01084B | C180174 | PT01-Other Symptom 3 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 3 at its worst? | PRO-CTCAE V1.0 - Other Symptom 3 Severity | ||
PT01085A | C180175 | PT01-Other Symptom 4 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 4? | PRO-CTCAE V1.0 - Other Symptom 4 | ||
PT01085B | C180176 | PT01-Other Symptom 4 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 4 at its worst? | PRO-CTCAE V1.0 - Other Symptom 4 Severity | ||
PT01086A | C180177 | PT01-Other Symptom 5 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 5? | PRO-CTCAE V1.0 - Other Symptom 5 | ||
PT01086B | C180178 | PT01-Other Symptom 5 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 5 at its worst? | PRO-CTCAE V1.0 - Other Symptom 5 Severity | ||
PT01087A | C180179 | PT01-Other Symptom 6 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 6? | PRO-CTCAE V1.0 - Other Symptom 6 | ||
PT01087B | C180180 | PT01-Other Symptom 6 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 6 at its worst? | PRO-CTCAE V1.0 - Other Symptom 6 Severity | ||
PT01088A | C180181 | PT01-Other Symptom 7 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 7? | PRO-CTCAE V1.0 - Other Symptom 7 | ||
PT01088B | C180182 | PT01-Other Symptom 7 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 7 at its worst? | PRO-CTCAE V1.0 - Other Symptom 7 Severity | ||
PT01089A | C180183 | PT01-Other Symptom 8 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 8? | PRO-CTCAE V1.0 - Other Symptom 8 | ||
PT01089B | C180184 | PT01-Other Symptom 8 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 8 at its worst? | PRO-CTCAE V1.0 - Other Symptom 8 Severity | ||
PT01090A | C180185 | PT01-Other Symptom 9 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 9? | PRO-CTCAE V1.0 - Other Symptom 9 | ||
PT01090B | C180186 | PT01-Other Symptom 9 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 9 at its worst? | PRO-CTCAE V1.0 - Other Symptom 9 Severity | ||
PT01091A | C180187 | PT01-Other Symptom 10 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 10? | PRO-CTCAE V1.0 - Other Symptom 10 | ||
PT01091B | C180188 | PT01-Other Symptom 10 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 10 at its worst? | PRO-CTCAE V1.0 - Other Symptom 10 Severity | ||
Back to top | ||||||
CL.C179941.PT01TN | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Questionnaire Test Name
(PT01TN) | text
Extensible: No | C179941 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 Questionnaire Test Name | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 test name. | CDISC Questionnaire PRO-CTCAE Version 1.0 Test Name Terminology |
PT01-Abdominal Pain Frequency | C180067 | PT01-Abdominal Pain Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have pain in the abdomen (belly area)? | PRO-CTCAE V1.0 - Abdominal Pain Frequency | ||
PT01-Abdominal Pain Interference | C180069 | PT01-Abdominal Pain Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did pain in the abdomen (belly area) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Abdominal Pain Interference | ||
PT01-Abdominal Pain Severity | C180068 | PT01-Abdominal Pain Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain in the abdomen (belly area) at its worst? | PRO-CTCAE V1.0 - Abdominal Pain Severity | ||
PT01-Achieve&Maintain Erection Severity | C180149 | PT01-Achieve&Maintain Erection Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your difficulty getting or keeping an erection at its worst? | PRO-CTCAE V1.0 - Achieve&Maintain Erection Severity | ||
PT01-Acne Severity | C180084 | PT01-Acne Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your acne or pimples on the face or chest at its worst? | PRO-CTCAE V1.0 - Acne Severity | ||
PT01-Anxious Frequency | C180128 | PT01-Anxious Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel anxiety? | PRO-CTCAE V1.0 - Anxious Frequency | ||
PT01-Anxious Interference | C180130 | PT01-Anxious Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did anxiety interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Anxious Interference | ||
PT01-Anxious Severity | C180129 | PT01-Anxious Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your anxiety at its worst? | PRO-CTCAE V1.0 - Anxious Severity | ||
PT01-Any Other Symptoms Reported | C180168 | PT01-Any Other Symptoms Reported | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Do you have any other symptoms that you wish to report? | PRO-CTCAE V1.0 - Any Other Symptoms Reported | ||
PT01-Bed/Pressure Sores Presence | C180093 | PT01-Bed/Pressure Sores Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any bed sores? | PRO-CTCAE V1.0 - Bed/Pressure Sores Presence | ||
PT01-Bloating Frequency | C180061 | PT01-Bloating Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have bloating of the abdomen (belly)? | PRO-CTCAE V1.0 - Bloating Frequency | ||
PT01-Bloating Severity | C180062 | PT01-Bloating Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your bloating of the abdomen (belly) at its worst? | PRO-CTCAE V1.0 - Bloating Severity | ||
PT01-Blurred Vision Interference | C180102 | PT01-Blurred Vision Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did blurry vision interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Blurred Vision Interference | ||
PT01-Blurred Vision Severity | C180101 | PT01-Blurred Vision Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your blurry vision at its worst? | PRO-CTCAE V1.0 - Blurred Vision Severity | ||
PT01-Body Odor Severity | C180167 | PT01-Body Odor Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your body odor at its worst? | PRO-CTCAE V1.0 - Body Odor Severity | ||
PT01-Breast Swelling&Tenderness Severity | C180155 | PT01-Breast Swelling&Tenderness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your breast area enlargement or tenderness at its worst? | PRO-CTCAE V1.0 - Breast Swelling&Tenderness Severity | ||
PT01-Bruising Presence | C180156 | PT01-Bruising Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you bruise easily (black and blue marks)? | PRO-CTCAE V1.0 - Bruising Presence | ||
PT01-Chills Frequency | C180157 | PT01-Chills Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have shivering or shaking chills? | PRO-CTCAE V1.0 - Chills Frequency | ||
PT01-Chills Severity | C180158 | PT01-Chills Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your shivering or shaking chills at their worst? | PRO-CTCAE V1.0 - Chills Severity | ||
PT01-Concentration Problems Interference | C180109 | PT01-Concentration Problems Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did problems with concentration interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Concentration Problems Interference | ||
PT01-Concentration Problems Severity | C180108 | PT01-Concentration Problems Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with concentration at their worst? | PRO-CTCAE V1.0 - Concentration Problems Severity | ||
PT01-Constipation Severity | C180065 | PT01-Constipation Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your constipation at its worst? | PRO-CTCAE V1.0 - Constipation Severity | ||
PT01-Cough Interference | C180075 | PT01-Cough Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did cough interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Cough Interference | ||
PT01-Cough Severity | C180074 | PT01-Cough Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your cough at its worst? | PRO-CTCAE V1.0 - Cough Severity | ||
PT01-Cracking Corners of Mouth Severity | C180048 | PT01-Cracking Corners of Mouth Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of skin cracking at the corners of your mouth at its worst? | PRO-CTCAE V1.0 - Cracking Corners of Mouth Severity | ||
PT01-Decreased Appetite Interference | C180053 | PT01-Decreased Appetite Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did decreased appetite interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Decreased Appetite Interference | ||
PT01-Decreased Appetite Severity | C180052 | PT01-Decreased Appetite Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your decreased appetite at its worst? | PRO-CTCAE V1.0 - Decreased Appetite Severity | ||
PT01-Decreased Libido Severity | C180151 | PT01-Decreased Libido Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your decreased sexual interest at its worst? | PRO-CTCAE V1.0 - Decreased Libido Severity | ||
PT01-Decreased Sweating Presence | C180161 | PT01-Decreased Sweating Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have an unexpected decrease in sweating? | PRO-CTCAE V1.0 - Decreased Sweating Presence | ||
PT01-Delayed Orgasm Presence | C180152 | PT01-Delayed Orgasm Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you feel that it took too long to have an orgasm or climax? | PRO-CTCAE V1.0 - Delayed Orgasm Presence | ||
PT01-Diarrhea Frequency | C180066 | PT01-Diarrhea Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have loose or watery stools (diarrhea/diarrhoea)? | PRO-CTCAE V1.0 - Diarrhea Frequency | ||
PT01-Difficulty Swallowing Severity | C180045 | PT01-Difficulty Swallowing Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your difficulty swallowing at its worst? | PRO-CTCAE V1.0 - Difficulty Swallowing Severity | ||
PT01-Discouraged Frequency | C180131 | PT01-Discouraged Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel that nothing could cheer you up? | PRO-CTCAE V1.0 - Discouraged Frequency | ||
PT01-Discouraged Interference | C180133 | PT01-Discouraged Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did feeling that nothing could cheer you up interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Discouraged Interference | ||
PT01-Discouraged Severity | C180132 | PT01-Discouraged Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your feelings that nothing could cheer you up at their worst? | PRO-CTCAE V1.0 - Discouraged Severity | ||
PT01-Dizziness Interference | C180100 | PT01-Dizziness Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did dizziness interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Dizziness Interference | ||
PT01-Dizziness Severity | C180099 | PT01-Dizziness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dizziness at its worst? | PRO-CTCAE V1.0 - Dizziness Severity | ||
PT01-Dry Mouth Severity | C180044 | PT01-Dry Mouth Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dry mouth at its worst? | PRO-CTCAE V1.0 - Dry Mouth Severity | ||
PT01-Ejaculation Frequency | C180150 | PT01-Ejaculation Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have ejaculation problems? | PRO-CTCAE V1.0 - Ejaculation Frequency | ||
PT01-Fatigue Interference | C180127 | PT01-Fatigue Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did fatigue, tiredness, or lack of energy interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Fatigue Interference | ||
PT01-Fatigue Severity | C180126 | PT01-Fatigue Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your fatigue, tiredness, or lack of energy at its worst? | PRO-CTCAE V1.0 - Fatigue Severity | ||
PT01-Fecal Incontinence Frequency | C180070 | PT01-Fecal Incontinence Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you lose control of bowel movements? | PRO-CTCAE V1.0 - Fecal Incontinence Frequency | ||
PT01-Fecal Incontinence Interference | C180071 | PT01-Fecal Incontinence Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did loss of control of bowel movements interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Fecal Incontinence Interference | ||
PT01-Flashing Lights in Eyes Presence | C180103 | PT01-Flashing Lights in Eyes Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any flashing lights in front of your eyes? | PRO-CTCAE V1.0 - Flashing Lights in Eyes Presence | ||
PT01-Gas Presence | C180060 | PT01-Gas Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any increased passing of gas (flatulence)? | PRO-CTCAE V1.0 - Gas Presence | ||
PT01-General Pain Frequency | C180112 | PT01-General Pain Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have pain? | PRO-CTCAE V1.0 - General Pain Frequency | ||
PT01-General Pain Interference | C180114 | PT01-General Pain Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did pain interfere with your usual or daily activities? | PRO-CTCAE V1.0 - General Pain Interference | ||
PT01-General Pain Severity | C180113 | PT01-General Pain Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain at its worst? | PRO-CTCAE V1.0 - General Pain Severity | ||
PT01-Hair Loss Amount | C180085 | PT01-Hair Loss Amount | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any hair loss? | PRO-CTCAE V1.0 - Hair Loss Amount | ||
PT01-Hand-Foot Syndrome Severity | C180088 | PT01-Hand-Foot Syndrome Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hand-foot syndrome (a rash of the hands or feet that can cause cracking, peeling, redness or pain) at its worst? | PRO-CTCAE V1.0 - Hand-Foot Syndrome Severity | ||
PT01-Headache Frequency | C180115 | PT01-Headache Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have a headache? | PRO-CTCAE V1.0 - Headache Frequency | ||
PT01-Headache Interference | C180117 | PT01-Headache Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did your headache interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Headache Interference | ||
PT01-Headache Severity | C180116 | PT01-Headache Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your headache at its worst? | PRO-CTCAE V1.0 - Headache Severity | ||
PT01-Heart Palpitations Frequency | C180080 | PT01-Heart Palpitations Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel a pounding or racing heartbeat (palpitations)? | PRO-CTCAE V1.0 - Heart Palpitations Frequency | ||
PT01-Heart Palpitations Severity | C180081 | PT01-Heart Palpitations Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pounding or racing heartbeat (palpitations) at its worst? | PRO-CTCAE V1.0 - Heart Palpitations Severity | ||
PT01-Heartburn Frequency | C180058 | PT01-Heartburn Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have heartburn? | PRO-CTCAE V1.0 - Heartburn Frequency | ||
PT01-Heartburn Severity | C180059 | PT01-Heartburn Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your heartburn at its worst? | PRO-CTCAE V1.0 - Heartburn Severity | ||
PT01-Hiccups Frequency | C180063 | PT01-Hiccups Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have hiccups? | PRO-CTCAE V1.0 - Hiccups Frequency | ||
PT01-Hiccups Severity | C180064 | PT01-Hiccups Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hiccups at their worst? | PRO-CTCAE V1.0 - Hiccups Severity | ||
PT01-Hives Presence | C180087 | PT01-Hives Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any hives (itchy red bumps on the skin)? | PRO-CTCAE V1.0 - Hives Presence | ||
PT01-Hoarseness Severity | C180050 | PT01-Hoarseness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hoarse voice at its worst? | PRO-CTCAE V1.0 - Hoarseness Severity | ||
PT01-Hot Flashes Frequency | C180162 | PT01-Hot Flashes Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have hot flashes/flushes? | PRO-CTCAE V1.0 - Hot Flashes Frequency | ||
PT01-Hot Flashes Severity | C180163 | PT01-Hot Flashes Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your hot flashes/flushes at their worst? | PRO-CTCAE V1.0 - Hot Flashes Severity | ||
PT01-Increased Sweating Frequency | C180159 | PT01-Increased Sweating Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have unexpected or excessive sweating during the day or nighttime (not related to hot flashes/flushes)? | PRO-CTCAE V1.0 - Increased Sweating Frequency | ||
PT01-Increased Sweating Severity | C180160 | PT01-Increased Sweating Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your unexpected or excessive sweating during the day or nighttime (not related to hot flashes/flushes) at its worst? | PRO-CTCAE V1.0 - Increased Sweating Severity | ||
PT01-Insomnia Interference | C180125 | PT01-Insomnia Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did insomnia (including difficulty falling asleep, staying asleep, or waking up early) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Insomnia Interference | ||
PT01-Insomnia Severity | C180124 | PT01-Insomnia Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your insomnia (including difficulty falling asleep, staying asleep, or waking up early) at its worst? | PRO-CTCAE V1.0 - Insomnia Severity | ||
PT01-Irregular Menstrual Period Presence | C180137 | PT01-Irregular Menstrual Period Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any irregular menstrual periods? | PRO-CTCAE V1.0 - Irregular Menstrual Period Presence | ||
PT01-Itching Severity | C180086 | PT01-Itching Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your itchy skin at its worst? | PRO-CTCAE V1.0 - Itching Severity | ||
PT01-Joint Pain Frequency | C180121 | PT01-Joint Pain Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have aching joints (such as elbows, knees, shoulders)? | PRO-CTCAE V1.0 - Joint Pain Frequency | ||
PT01-Joint Pain Interference | C180123 | PT01-Joint Pain Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did aching joints (such as elbows, knees, shoulders) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Joint Pain Interference | ||
PT01-Joint Pain Severity | C180122 | PT01-Joint Pain Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your aching joints (such as elbows, knees, shoulders) at their worst? | PRO-CTCAE V1.0 - Joint Pain Severity | ||
PT01-Memory Problems Interference | C180111 | PT01-Memory Problems Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did problems with memory interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Memory Problems Interference | ||
PT01-Memory Problems Severity | C180110 | PT01-Memory Problems Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with memory at their worst? | PRO-CTCAE V1.0 - Memory Problems Severity | ||
PT01-Missed Menstrual Period Presence | C180138 | PT01-Missed Menstrual Period Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you miss an expected menstrual period? | PRO-CTCAE V1.0 - Missed Menstrual Period Presence | ||
PT01-Mouth/Throat Sores Interference | C180047 | PT01-Mouth/Throat Sores Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did mouth or throat sores interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Mouth/Throat Sores Interference | ||
PT01-Mouth/Throat Sores Severity | C180046 | PT01-Mouth/Throat Sores Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your mouth or throat sores at their worst? | PRO-CTCAE V1.0 - Mouth/Throat Sores Severity | ||
PT01-Muscle Pain Frequency | C180118 | PT01-Muscle Pain Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have aching muscles? | PRO-CTCAE V1.0 - Muscle Pain Frequency | ||
PT01-Muscle Pain Interference | C180120 | PT01-Muscle Pain Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did aching muscles interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Muscle Pain Interference | ||
PT01-Muscle Pain Severity | C180119 | PT01-Muscle Pain Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your aching muscles at their worst? | PRO-CTCAE V1.0 - Muscle Pain Severity | ||
PT01-Nail Discoloration Presence | C180091 | PT01-Nail Discoloration Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any change in the color of your fingernails or toenails? | PRO-CTCAE V1.0 - Nail Discoloration Presence | ||
PT01-Nail Loss Presence | C180089 | PT01-Nail Loss Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you lose any fingernails or toenails? | PRO-CTCAE V1.0 - Nail Loss Presence | ||
PT01-Nail Ridging Presence | C180090 | PT01-Nail Ridging Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any ridges or bumps on your fingernails or toenails? | PRO-CTCAE V1.0 - Nail Ridging Presence | ||
PT01-Nausea Frequency | C180054 | PT01-Nausea Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have nausea? | PRO-CTCAE V1.0 - Nausea Frequency | ||
PT01-Nausea Severity | C180055 | PT01-Nausea Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your nausea at its worst? | PRO-CTCAE V1.0 - Nausea Severity | ||
PT01-Nosebleed Frequency | C180164 | PT01-Nosebleed Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have nosebleeds? | PRO-CTCAE V1.0 - Nosebleed Frequency | ||
PT01-Nosebleed Severity | C180165 | PT01-Nosebleed Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your nosebleeds at their worst? | PRO-CTCAE V1.0 - Nosebleed Severity | ||
PT01-Numbness & Tingling Interference | C180098 | PT01-Numbness & Tingling Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did numbness or tingling in your hands or feet interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Numbness & Tingling Interference | ||
PT01-Numbness & Tingling Severity | C180097 | PT01-Numbness & Tingling Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your numbness or tingling in your hands or feet at its worst? | PRO-CTCAE V1.0 - Numbness & Tingling Severity | ||
PT01-Other Symptom 1 Severity | C180170 | PT01-Other Symptom 1 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 1 at its worst? | PRO-CTCAE V1.0 - Other Symptom 1 Severity | ||
PT01-Other Symptom 1 | C180169 | PT01-Other Symptom 1 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 1? | PRO-CTCAE V1.0 - Other Symptom 1 | ||
PT01-Other Symptom 10 Severity | C180188 | PT01-Other Symptom 10 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 10 at its worst? | PRO-CTCAE V1.0 - Other Symptom 10 Severity | ||
PT01-Other Symptom 10 | C180187 | PT01-Other Symptom 10 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 10? | PRO-CTCAE V1.0 - Other Symptom 10 | ||
PT01-Other Symptom 2 Severity | C180172 | PT01-Other Symptom 2 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 2 at its worst? | PRO-CTCAE V1.0 - Other Symptom 2 Severity | ||
PT01-Other Symptom 2 | C180171 | PT01-Other Symptom 2 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 2? | PRO-CTCAE V1.0 - Other Symptom 2 | ||
PT01-Other Symptom 3 Severity | C180174 | PT01-Other Symptom 3 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 3 at its worst? | PRO-CTCAE V1.0 - Other Symptom 3 Severity | ||
PT01-Other Symptom 3 | C180173 | PT01-Other Symptom 3 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 3? | PRO-CTCAE V1.0 - Other Symptom 3 | ||
PT01-Other Symptom 4 Severity | C180176 | PT01-Other Symptom 4 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 4 at its worst? | PRO-CTCAE V1.0 - Other Symptom 4 Severity | ||
PT01-Other Symptom 4 | C180175 | PT01-Other Symptom 4 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 4? | PRO-CTCAE V1.0 - Other Symptom 4 | ||
PT01-Other Symptom 5 Severity | C180178 | PT01-Other Symptom 5 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 5 at its worst? | PRO-CTCAE V1.0 - Other Symptom 5 Severity | ||
PT01-Other Symptom 5 | C180177 | PT01-Other Symptom 5 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 5? | PRO-CTCAE V1.0 - Other Symptom 5 | ||
PT01-Other Symptom 6 Severity | C180180 | PT01-Other Symptom 6 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 6 at its worst? | PRO-CTCAE V1.0 - Other Symptom 6 Severity | ||
PT01-Other Symptom 6 | C180179 | PT01-Other Symptom 6 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 6? | PRO-CTCAE V1.0 - Other Symptom 6 | ||
PT01-Other Symptom 7 Severity | C180182 | PT01-Other Symptom 7 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 7 at its worst? | PRO-CTCAE V1.0 - Other Symptom 7 Severity | ||
PT01-Other Symptom 7 | C180181 | PT01-Other Symptom 7 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 7? | PRO-CTCAE V1.0 - Other Symptom 7 | ||
PT01-Other Symptom 8 Severity | C180184 | PT01-Other Symptom 8 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 8 at its worst? | PRO-CTCAE V1.0 - Other Symptom 8 Severity | ||
PT01-Other Symptom 8 | C180183 | PT01-Other Symptom 8 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 8? | PRO-CTCAE V1.0 - Other Symptom 8 | ||
PT01-Other Symptom 9 Severity | C180186 | PT01-Other Symptom 9 Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of this symptom 9 at its worst? | PRO-CTCAE V1.0 - Other Symptom 9 Severity | ||
PT01-Other Symptom 9 | C180185 | PT01-Other Symptom 9 | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - Other symptom term 9? | PRO-CTCAE V1.0 - Other Symptom 9 | ||
PT01-Pain w/Sexual Intercourse Severity | C180154 | PT01-Pain w/Sexual Intercourse Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain during vaginal sex at its worst? | PRO-CTCAE V1.0 - Pain w/Sexual Intercourse Severity | ||
PT01-Pain&Swelling at Inj Site Presence | C180166 | PT01-Pain&Swelling at Inj Site Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any pain, swelling, or redness at a site of drug injection or IV? | PRO-CTCAE V1.0 - Pain&Swelling at Inj Site Presence | ||
PT01-Painful Urination Severity | C180141 | PT01-Painful Urination Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your pain or burning with urination at its worst? | PRO-CTCAE V1.0 - Painful Urination Severity | ||
PT01-Radiation Skin Reaction Severity | C180094 | PT01-Radiation Skin Reaction Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your skin burns from radiation at their worst? | PRO-CTCAE V1.0 - Radiation Skin Reaction Severity | ||
PT01-Rash Presence | C180082 | PT01-Rash Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any rash? | PRO-CTCAE V1.0 - Rash Presence | ||
PT01-Ringing in Ears Severity | C180107 | PT01-Ringing in Ears Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of ringing in your ears at its worst? | PRO-CTCAE V1.0 - Ringing in Ears Severity | ||
PT01-Sad Frequency | C180134 | PT01-Sad Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have sad or unhappy feelings? | PRO-CTCAE V1.0 - Sad Frequency | ||
PT01-Sad Interference | C180136 | PT01-Sad Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did sad or unhappy feelings interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Sad Interference | ||
PT01-Sad Severity | C180135 | PT01-Sad Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your sad or unhappy feelings at their worst? | PRO-CTCAE V1.0 - Sad Severity | ||
PT01-Sensitivity to Sunlight Presence | C180092 | PT01-Sensitivity to Sunlight Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any increased skin sensitivity to sunlight? | PRO-CTCAE V1.0 - Sensitivity to Sunlight Presence | ||
PT01-Shortness of Breath Interference | C180073 | PT01-Shortness of Breath Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did your shortness of breath interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Shortness of Breath Interference | ||
PT01-Shortness of Breath Severity | C180072 | PT01-Shortness of Breath Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your shortness of breath at its worst? | PRO-CTCAE V1.0 - Shortness of Breath Severity | ||
PT01-Skin Darkening Presence | C180095 | PT01-Skin Darkening Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any unusual darkening of the skin? | PRO-CTCAE V1.0 - Skin Darkening Presence | ||
PT01-Skin Dryness Severity | C180083 | PT01-Skin Dryness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your dry skin at its worst? | PRO-CTCAE V1.0 - Skin Dryness Severity | ||
PT01-Stretch Marks Presence | C180096 | PT01-Stretch Marks Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any stretch marks? | PRO-CTCAE V1.0 - Stretch Marks Presence | ||
PT01-Swelling Frequency | C180077 | PT01-Swelling Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have arm or leg swelling? | PRO-CTCAE V1.0 - Swelling Frequency | ||
PT01-Swelling Interference | C180079 | PT01-Swelling Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did arm or leg swelling interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Swelling Interference | ||
PT01-Swelling Severity | C180078 | PT01-Swelling Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your arm or leg swelling at its worst? | PRO-CTCAE V1.0 - Swelling Severity | ||
PT01-Taste Changes Severity | C180051 | PT01-Taste Changes Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your problems with tasting food or drink at their worst? | PRO-CTCAE V1.0 - Taste Changes Severity | ||
PT01-Unable to Have Orgasm Presence | C180153 | PT01-Unable to Have Orgasm Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, were you unable to have an orgasm or climax? | PRO-CTCAE V1.0 - Unable to Have Orgasm Presence | ||
PT01-Urinary Frequency Frequency | C180144 | PT01-Urinary Frequency Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, were there times when you had to urinate frequently? | PRO-CTCAE V1.0 - Urinary Frequency Frequency | ||
PT01-Urinary Frequency Interference | C180145 | PT01-Urinary Frequency Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did frequent urination interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Urinary Frequency Interference | ||
PT01-Urinary Incontinence Frequency | C180147 | PT01-Urinary Incontinence Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have loss of control of urine (leakage)? | PRO-CTCAE V1.0 - Urinary Incontinence Frequency | ||
PT01-Urinary Incontinence Interference | C180148 | PT01-Urinary Incontinence Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did loss of control of urine (leakage) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Urinary Incontinence Interference | ||
PT01-Urinary Urgency Frequency | C180142 | PT01-Urinary Urgency Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you feel an urge to urinate all of a sudden? | PRO-CTCAE V1.0 - Urinary Urgency Frequency | ||
PT01-Urinary Urgency Interference | C180143 | PT01-Urinary Urgency Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did sudden urges to urinate interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Urinary Urgency Interference | ||
PT01-Urine Color Change Presence | C180146 | PT01-Urine Color Change Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any urine color change? | PRO-CTCAE V1.0 - Urine Color Change Presence | ||
PT01-Vaginal Discharge Amount | C180139 | PT01-Vaginal Discharge Amount | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any unusual vaginal discharge? | PRO-CTCAE V1.0 - Vaginal Discharge Amount | ||
PT01-Vaginal Dryness Severity | C180140 | PT01-Vaginal Dryness Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your vaginal dryness at its worst? | PRO-CTCAE V1.0 - Vaginal Dryness Severity | ||
PT01-Visual Floaters Presence | C180104 | PT01-Visual Floaters Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any spots or lines (floaters) that drift in front of your eyes? | PRO-CTCAE V1.0 - Visual Floaters Presence | ||
PT01-Voice Quality Changes Presence | C180049 | PT01-Voice Quality Changes Presence | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, did you have any voice changes? | PRO-CTCAE V1.0 - Voice Quality Changes Presence | ||
PT01-Vomiting Frequency | C180056 | PT01-Vomiting Frequency | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how often did you have vomiting? | PRO-CTCAE V1.0 - Vomiting Frequency | ||
PT01-Vomiting Severity | C180057 | PT01-Vomiting Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your vomiting at its worst? | PRO-CTCAE V1.0 - Vomiting Severity | ||
PT01-Watery Eyes Interference | C180106 | PT01-Watery Eyes Interference | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, how much did watery eyes (tearing) interfere with your usual or daily activities? | PRO-CTCAE V1.0 - Watery Eyes Interference | ||
PT01-Watery Eyes Severity | C180105 | PT01-Watery Eyes Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your watery eyes (tearing) at their worst? | PRO-CTCAE V1.0 - Watery Eyes Severity | ||
PT01-Wheezing Severity | C180076 | PT01-Wheezing Severity | Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events Item Library Version 1.0 - In the last 7 days, what was the severity of your wheezing (whistling noise in the chest with breathing) at its worst? | PRO-CTCAE V1.0 - Wheezing Severity | ||
Back to top | ||||||
CL.C190865.PDFATSCD | Pediatric Findings About Test Code
(PDFATSCD) | text
Extensible: Yes | C190865 | Pediatric Findings About Test Code | Terminology relevant to the test codes that describe findings about a pediatric event or intervention. | CDISC SDTM Pediatric Findings About Test Code Terminology |
DCHOLEST | C184466 | Dietary Cholesterol | A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. | Dietary Cholesterol Measurement | ||
DFATT | C172460 | Dietary Fat, Total | A determination of the total fat in a nutritional product or meal, or a portion thereof. | Total Dietary Fat Measurement | ||
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Back to top | ||||||
CL.C190864.PDFATS | Pediatric Findings About Test Name
(PDFATS) | text
Extensible: Yes | C190864 | Pediatric Findings About Test Name | Terminology relevant to the test names that describe findings about a pediatric event or intervention. | CDISC SDTM Pediatric Findings About Test Name Terminology |
Dietary Cholesterol | C184466 | Dietary Cholesterol | A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. | Dietary Cholesterol Measurement | ||
Dietary Fat, Total | C172460 | Dietary Fat, Total | A determination of the total fat in a nutritional product or meal, or a portion thereof. | Total Dietary Fat Measurement | ||
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Back to top | ||||||
CL.C147546.FAC099TC | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire Test Code
(FAC099TC) | text
Extensible: No | C147546 | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire Test Code | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue test code. | CDISC Questionnaire Peds-FACIT-F Test Code Terminology |
FAC09901 | C147686 | FAC099-I Feel Tired | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I feel tired. | Peds-FACIT-F - I Feel Tired | ||
FAC09902 | C147687 | FAC099-I Have Energy | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I have energy (or strength). | Peds-FACIT-F - I Have Energy | ||
FAC09903 | C147688 | FAC099-Could Do My Usual Things at Home | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I could do my usual things at home. | Peds-FACIT-F - Could Do My Usual Things at Home | ||
FAC09904 | C147689 | FAC099-Trouble Starting Things | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I had trouble starting things because I was too tired. | Peds-FACIT-F - Trouble Starting Things | ||
FAC09905 | C147690 | FAC099-Trouble Finishing Things | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I had trouble finishing things because I was too tired. | Peds-FACIT-F - Trouble Finishing Things | ||
FAC09906 | C147691 | FAC099-I Needed to Sleep During the Day | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I needed to sleep during the day. | Peds-FACIT-F - I Needed to Sleep During the Day | ||
FAC09907 | C147692 | FAC099-Upset by Being Too Tired | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I got upset by being too tired to do things I wanted to do. | Peds-FACIT-F - Upset by Being Too Tired | ||
FAC09908 | C147693 | FAC099-Hard for Me to Play With Friends | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made it hard for me to play or go out with my friends as much as I'd like. | Peds-FACIT-F - Hard for Me to Play With Friends | ||
FAC09909 | C147694 | FAC099-Needed Help Doing Usual Things | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I needed help doing my usual things at home. | Peds-FACIT-F - Needed Help Doing Usual Things | ||
FAC09910 | C147695 | FAC099-I Feel Weak | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I feel weak. | Peds-FACIT-F - I Feel Weak | ||
FAC09911 | C147696 | FAC099-I Was Too Tired to Eat | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I was too tired to eat. | Peds-FACIT-F - I Was Too Tired to Eat | ||
FAC09912 | C147697 | FAC099-Being Tired Made Me Sad | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made me sad. | Peds-FACIT-F - Being Tired Made Me Sad | ||
FAC09913 | C147698 | FAC099-Being Tired Made Me Mad | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made me mad (angry). | Peds-FACIT-F - Being Tired Made Me Mad | ||
Back to top | ||||||
CL.C147545.FAC099TN | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire Test Name
(FAC099TN) | text
Extensible: No | C147545 | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue Questionnaire Test Name | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue test name. | CDISC Questionnaire Peds-FACIT-F Test Name Terminology |
FAC099-Being Tired Made Me Mad | C147698 | FAC099-Being Tired Made Me Mad | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made me mad (angry). | Peds-FACIT-F - Being Tired Made Me Mad | ||
FAC099-Being Tired Made Me Sad | C147697 | FAC099-Being Tired Made Me Sad | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made me sad. | Peds-FACIT-F - Being Tired Made Me Sad | ||
FAC099-Could Do My Usual Things at Home | C147688 | FAC099-Could Do My Usual Things at Home | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I could do my usual things at home. | Peds-FACIT-F - Could Do My Usual Things at Home | ||
FAC099-Hard for Me to Play With Friends | C147693 | FAC099-Hard for Me to Play With Friends | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - Being tired made it hard for me to play or go out with my friends as much as I'd like. | Peds-FACIT-F - Hard for Me to Play With Friends | ||
FAC099-I Feel Tired | C147686 | FAC099-I Feel Tired | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I feel tired. | Peds-FACIT-F - I Feel Tired | ||
FAC099-I Feel Weak | C147695 | FAC099-I Feel Weak | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I feel weak. | Peds-FACIT-F - I Feel Weak | ||
FAC099-I Have Energy | C147687 | FAC099-I Have Energy | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I have energy (or strength). | Peds-FACIT-F - I Have Energy | ||
FAC099-I Needed to Sleep During the Day | C147691 | FAC099-I Needed to Sleep During the Day | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I needed to sleep during the day. | Peds-FACIT-F - I Needed to Sleep During the Day | ||
FAC099-I Was Too Tired to Eat | C147696 | FAC099-I Was Too Tired to Eat | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I was too tired to eat. | Peds-FACIT-F - I Was Too Tired to Eat | ||
FAC099-Needed Help Doing Usual Things | C147694 | FAC099-Needed Help Doing Usual Things | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I needed help doing my usual things at home. | Peds-FACIT-F - Needed Help Doing Usual Things | ||
FAC099-Trouble Finishing Things | C147690 | FAC099-Trouble Finishing Things | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I had trouble finishing things because I was too tired. | Peds-FACIT-F - Trouble Finishing Things | ||
FAC099-Trouble Starting Things | C147689 | FAC099-Trouble Starting Things | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I had trouble starting things because I was too tired. | Peds-FACIT-F - Trouble Starting Things | ||
FAC099-Upset by Being Too Tired | C147692 | FAC099-Upset by Being Too Tired | Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue - I got upset by being too tired to do things I wanted to do. | Peds-FACIT-F - Upset by Being Too Tired | ||
Back to top | ||||||
CL.C135696.PODCI2TC | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire Test Code
(PODCI2TC) | text
Extensible: No | C135696 | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire Test Code | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version test code. | CDISC Questionnaire PODCI Adolescent Parent-Reported Version Test Code Terminology |
PODCI201 | C136034 | PODCI2-Lift Heavy Books | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Lift heavy books? | PODCI Adolescent Parent-Reported Version - Lift Heavy Books | ||
PODCI202 | C136035 | PODCI2-Pour a Half Gallon of Milk | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Pour a half gallon of milk? | PODCI Adolescent Parent-Reported Version - Pour a Half Gallon of Milk | ||
PODCI203 | C136036 | PODCI2-Open a Jar Been Opened Before | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Open a jar that has been opened before? | PODCI Adolescent Parent-Reported Version - Open a Jar Been Opened Before | ||
PODCI204 | C136037 | PODCI2-Use a Fork and Spoon | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Use a fork and spoon? | PODCI Adolescent Parent-Reported Version - Use a Fork and Spoon | ||
PODCI205 | C136038 | PODCI2-Comb His/Her Hair | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Comb his/her hair? | PODCI Adolescent Parent-Reported Version - Comb His or Her Hair | ||
PODCI206 | C136039 | PODCI2-Button Buttons | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Button buttons? | PODCI Adolescent Parent-Reported Version - Button Buttons | ||
PODCI207 | C136040 | PODCI2-Put on His/Her Coat | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Put on his/her coat? | PODCI Adolescent Parent-Reported Version - Put on His or Her Coat | ||
PODCI208 | C136041 | PODCI2-Write With a Pencil | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Write with a pencil? | PODCI Adolescent Parent-Reported Version - Write With a Pencil | ||
PODCI209 | C136042 | PODCI2-Miss School Because of Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - On average, over the last 12 months, how often did your child miss school (camp, etc.) because of his/her health? | PODCI Adolescent Parent-Reported Version - Miss School Because of Health | ||
PODCI210 | C136043 | PODCI2-How He/She Looks | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: How he/she looks? | PODCI Adolescent Parent-Reported Version - How He or She Looks | ||
PODCI211 | C136044 | PODCI2-His/Her Body | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her body? | PODCI Adolescent Parent-Reported Version - His or Her Body | ||
PODCI212 | C136045 | PODCI2-What Clothes/Shoes He/She Wear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: What clothes or shoes he/she can wear? | PODCI Adolescent Parent-Reported Version - What Clothes or Shoes He or She Wear | ||
PODCI213 | C136046 | PODCI2-Ability Do Same Things Friends Do | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her ability to do the same things his/her friends do? | PODCI Adolescent Parent-Reported Version - Ability Do Same Things Friends Do | ||
PODCI214 | C136047 | PODCI2-His/Her Health in General | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her health in general? | PODCI Adolescent Parent-Reported Version - His or Her Health in General | ||
PODCI215 | C136048 | PODCI2-Feel Sick and Tired | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Did your child feel sick and tired? | PODCI Adolescent Parent-Reported Version - Feel Sick and Tired | ||
PODCI216 | C136049 | PODCI2-Full of Pep and Energy | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Were your child full of pep and energy? | PODCI Adolescent Parent-Reported Version - Full of Pep and Energy | ||
PODCI217 | C136050 | PODCI2-Pain/Discom Inter With Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your child's activities? | PODCI Adolescent Parent-Reported Version - Pain or Discomfort Interfere With Activities | ||
PODCI218 | C136051 | PODCI2-Run Short Distances | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Run short distances? | PODCI Adolescent Parent-Reported Version - Run Short Distances | ||
PODCI219 | C136052 | PODCI2-Bicycle or Tricycle | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Bicycle or tricycle? | PODCI Adolescent Parent-Reported Version - Bicycle or Tricycle | ||
PODCI220 | C136053 | PODCI2-Climb Three Flights of Stairs | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Climb three flights of stairs? | PODCI Adolescent Parent-Reported Version - Climb Three Flights of Stairs | ||
PODCI221 | C136054 | PODCI2-Climb One Flight of Stairs | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Climb one flight of stairs? | PODCI Adolescent Parent-Reported Version - Climb One Flight of Stairs | ||
PODCI222 | C136055 | PODCI2-Walk More Than a Mile | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk more than a mile? | PODCI Adolescent Parent-Reported Version - Walk More Than a Mile | ||
PODCI223 | C136056 | PODCI2-Walk Three Blocks | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk three blocks? | PODCI Adolescent Parent-Reported Version - Walk Three Blocks | ||
PODCI224 | C136057 | PODCI2-Walk One Block | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk one block? | PODCI Adolescent Parent-Reported Version - Walk One Block | ||
PODCI225 | C136058 | PODCI2-Get On and Off a Bus | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a bus? | PODCI Adolescent Parent-Reported Version - Get On and Off a Bus | ||
PODCI226 | C136059 | PODCI2-Need Help Walking and Climbing | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child need help from another person for walking and climbing? | PODCI Adolescent Parent-Reported Version - Need Help Walking and Climbing | ||
PODCI227 | C136060 | PODCI2-Use Assistive Devices for Walking | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? | PODCI Adolescent Parent-Reported Version - Use Assistive Devices for Walking | ||
PODCI228 | C136061 | PODCI2-Stand Washing Hands at a Sink | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Stand while washing his/her hands and face at a sink? | PODCI Adolescent Parent-Reported Version - Stand Washing Hands at a Sink | ||
PODCI229 | C136062 | PODCI2-Sit in Chair Without Holding On | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Sit in a regular chair without holding on? | PODCI Adolescent Parent-Reported Version - Sit in Chair Without Holding On | ||
PODCI230 | C136063 | PODCI2-Get On and Off a Toilet or Chair | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a toilet or chair? | PODCI Adolescent Parent-Reported Version - Get On and Off a Toilet or Chair | ||
PODCI231 | C136064 | PODCI2-Get In and Out of Bed | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get in and out of bed? | PODCI Adolescent Parent-Reported Version - Get In and Out of Bed | ||
PODCI232 | C136065 | PODCI2-Turn Door Knobs | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Turn door knobs? | PODCI Adolescent Parent-Reported Version - Turn Door Knobs | ||
PODCI233 | C136066 | PODCI2-Bend Over and Pick Up Something | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Bend over from a standing position and pick up something off the floor? | PODCI Adolescent Parent-Reported Version - Bend Over and Pick Up Something | ||
PODCI234 | C136067 | PODCI2-Need Help Sitting and Standing | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child need help from another person for sitting and standing? | PODCI Adolescent Parent-Reported Version - Need Help Sitting and Standing | ||
PODCI235 | C136068 | PODCI2-Use Assistive Devices for Sitting | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? | PODCI Adolescent Parent-Reported Version - Use Assistive Devices for Sitting | ||
PODCI236 | C136069 | PODCI2-Participate in Outdoor Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in recreational outdoor activities with other children the same age (For example: bicycling, skating, hiking, jogging)? | PODCI Adolescent Parent-Reported Version - Participate in Outdoor Activities | ||
PODCI237 | C136070 | PODCI2-Outdoor Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Pain | ||
PODCI238 | C136071 | PODCI2-Outdoor Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Health | ||
PODCI239 | C136072 | PODCI2-Outdoor Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Instructions | ||
PODCI240 | C136073 | PODCI2-Outdoor Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Fear | ||
PODCI241 | C136074 | PODCI2-Outdoor Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Dislike | ||
PODCI242 | C136075 | PODCI2-Outdoor Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Too young? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Too Young | ||
PODCI243 | C136076 | PODCI2-Outdoor Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Activity not in season? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Season | ||
PODCI244 | C136077 | PODCI2-Participate in Pickup Games | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in pickup games or sports with other children the same age (For example: tag, dodge ball, basketball, softball, soccer, catch, jump rope, touch football, hop scotch)? | PODCI Adolescent Parent-Reported Version - Participate in Pickup Games | ||
PODCI245 | C136078 | PODCI2-Games Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Games Limited by: Pain | ||
PODCI246 | C136079 | PODCI2-Games Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Games Limited by: Health | ||
PODCI247 | C136080 | PODCI2-Games Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Games Limited by: Instructions | ||
PODCI248 | C136081 | PODCI2-Games Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Games Limited by: Fear | ||
PODCI249 | C136082 | PODCI2-Games Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Dislike of pickup games or sports? | PODCI Adolescent Parent-Reported Version - Games Limited by: Dislike | ||
PODCI250 | C136083 | PODCI2-Games Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Too young? | PODCI Adolescent Parent-Reported Version - Games Limited by: Too Young | ||
PODCI251 | C136084 | PODCI2-Games Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Activity not in season? | PODCI Adolescent Parent-Reported Version - Games Limited by: Season | ||
PODCI252 | C136085 | PODCI2-Participate in Competitive Sports | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in competitive level sports with other children the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? | PODCI Adolescent Parent-Reported Version - Participate in Competitive Sports | ||
PODCI253 | C136086 | PODCI2-Comp Sports Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Pain | ||
PODCI254 | C136087 | PODCI2-Comp Sports Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Health | ||
PODCI255 | C136088 | PODCI2-Comp Sports Limited by: Instruct | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Instructions | ||
PODCI256 | C136089 | PODCI2-Comp Sports Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Fear | ||
PODCI257 | C136090 | PODCI2-Comp Sports Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Dislike of pickup games or sports? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Dislike | ||
PODCI258 | C136091 | PODCI2-Comp Sports Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Too young? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Too Young | ||
PODCI259 | C136092 | PODCI2-Comp Sports Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Activity not in season? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Season | ||
PODCI260 | C136093 | PODCI2-Get Together With Friends | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often in the last week did your child get together and do things with friends? | PODCI Adolescent Parent-Reported Version - Get Together With Friends | ||
PODCI261 | C136094 | PODCI2-Friends Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Pain | ||
PODCI262 | C136095 | PODCI2-Friends Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Health | ||
PODCI263 | C136096 | PODCI2-Friends Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Instructions | ||
PODCI264 | C136097 | PODCI2-Friends Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Fear | ||
PODCI265 | C136098 | PODCI2-Friends Limited by: Not Around | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Friends not around? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Not Around | ||
PODCI266 | C136099 | PODCI2-Participate in Gym/Recess | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often in the last week did your child participate in gym/recess? | PODCI Adolescent Parent-Reported Version - Participate in Gym or Recess | ||
PODCI267 | C136100 | PODCI2-Gym Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Pain | ||
PODCI268 | C136101 | PODCI2-Gym Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Health | ||
PODCI269 | C136102 | PODCI2-Gym Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Instructions | ||
PODCI270 | C136103 | PODCI2-Gym Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Fear | ||
PODCI271 | C136104 | PODCI2-Gym Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Dislike of gym/recess? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Dislike | ||
PODCI272 | C136105 | PODCI2-Gym Limited by: Not in Session | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: School not in session? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Not in Session | ||
PODCI273 | C136106 | PODCI2-Gym Limited by: Not Attend School | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Does not attend school? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Not Attend School | ||
PODCI274 | C136107 | PODCI2-Easy to Make Friends | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Is it easy or hard for your child to make friends with children his/her own age? | PODCI Adolescent Parent-Reported Version - Easy to Make Friends | ||
PODCI275 | C136108 | PODCI2-Pain During the Last Week | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How much pain has your child had during the last week? | PODCI Adolescent Parent-Reported Version - Pain During the Last Week | ||
PODCI276 | C136109 | PODCI2-Pain Interfere With Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much did pain interfere with your child's normal activities (including at home, outside of the home, and at school)? | PODCI Adolescent Parent-Reported Version - Pain Interfere With Activities | ||
PODCI277 | C136110 | PODCI2-Have Pain Relief | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To have pain relief. | PODCI Adolescent Parent-Reported Version - Have Pain Relief | ||
PODCI278 | C136111 | PODCI2-Look Better | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To look better. | PODCI Adolescent Parent-Reported Version - Look Better | ||
PODCI279 | C136112 | PODCI2-Feel Better | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To feel better about himself/herself. | PODCI Adolescent Parent-Reported Version - Feel Better | ||
PODCI280 | C136113 | PODCI2-Sleep More Comfortably | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To sleep more comfortably. | PODCI Adolescent Parent-Reported Version - Sleep More Comfortably | ||
PODCI281 | C136114 | PODCI2-Able to Do Activities at Home | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do activities at home. | PODCI Adolescent Parent-Reported Version - Able to Do Activities at Home | ||
PODCI282 | C136115 | PODCI2-Able to Do More at School | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more at school. | PODCI Adolescent Parent-Reported Version - Able to Do More at School | ||
PODCI283 | C136116 | PODCI2-Able to Do More Play | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more play or recreational activities. | PODCI Adolescent Parent-Reported Version - Able to Do More Play | ||
PODCI284 | C136117 | PODCI2-Able to Do More Sports | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more sports. | PODCI Adolescent Parent-Reported Version - Able to Do More Sports | ||
PODCI285 | C136118 | PODCI2-Free From Pain as Adult | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be free from pain or disability as an adult. | PODCI Adolescent Parent-Reported Version - Free From Pain as Adult | ||
PODCI286 | C136119 | PODCI2-Spend Rest of Life With Condition | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If your child had to spend the rest of his/her life with his/her bone and muscle condition as it is right now, how would you feel about it? | PODCI Adolescent Parent-Reported Version - Spend Rest of Life With Condition | ||
PODCI287 | C136120 | PODCI2-Up Extremity/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Upper extremity and physical function core scale. | PODCI Adolescent Parent-Reported Version - Upper Extremity and Physical Function Scale | ||
PODCI288 | C136121 | PODCI2-Transfer/Basic Mobility Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Transfer and basic mobility core scale. | PODCI Adolescent Parent-Reported Version - Transfer and Basic Mobility Scale | ||
PODCI289 | C136122 | PODCI2-Sports/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Sports and physical functioning core scale. | PODCI Adolescent Parent-Reported Version - Sports and Physical Function Scale | ||
PODCI290 | C136123 | PODCI2-Pain/Comfort Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Pain/comfort core scale. | PODCI Adolescent Parent-Reported Version - Pain or Comfort Scale | ||
PODCI291 | C136124 | PODCI2-Happiness Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Happiness core scale. | PODCI Adolescent Parent-Reported Version - Happiness Scale | ||
PODCI292 | C136125 | PODCI2-Global Functioning Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Global functioning scale. | PODCI Adolescent Parent-Reported Version - Global Functioning Scale | ||
Back to top | ||||||
CL.C135695.PODCI2TN | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire Test Name
(PODCI2TN) | text
Extensible: No | C135695 | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version Questionnaire Test Name | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported Version test name. | CDISC Questionnaire PODCI Adolescent Parent-Reported Version Test Name Terminology |
PODCI2-Ability Do Same Things Friends Do | C136046 | PODCI2-Ability Do Same Things Friends Do | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her ability to do the same things his/her friends do? | PODCI Adolescent Parent-Reported Version - Ability Do Same Things Friends Do | ||
PODCI2-Able to Do Activities at Home | C136114 | PODCI2-Able to Do Activities at Home | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do activities at home. | PODCI Adolescent Parent-Reported Version - Able to Do Activities at Home | ||
PODCI2-Able to Do More at School | C136115 | PODCI2-Able to Do More at School | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more at school. | PODCI Adolescent Parent-Reported Version - Able to Do More at School | ||
PODCI2-Able to Do More Play | C136116 | PODCI2-Able to Do More Play | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more play or recreational activities. | PODCI Adolescent Parent-Reported Version - Able to Do More Play | ||
PODCI2-Able to Do More Sports | C136117 | PODCI2-Able to Do More Sports | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more sports. | PODCI Adolescent Parent-Reported Version - Able to Do More Sports | ||
PODCI2-Bend Over and Pick Up Something | C136066 | PODCI2-Bend Over and Pick Up Something | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Bend over from a standing position and pick up something off the floor? | PODCI Adolescent Parent-Reported Version - Bend Over and Pick Up Something | ||
PODCI2-Bicycle or Tricycle | C136052 | PODCI2-Bicycle or Tricycle | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Bicycle or tricycle? | PODCI Adolescent Parent-Reported Version - Bicycle or Tricycle | ||
PODCI2-Button Buttons | C136039 | PODCI2-Button Buttons | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Button buttons? | PODCI Adolescent Parent-Reported Version - Button Buttons | ||
PODCI2-Climb One Flight of Stairs | C136054 | PODCI2-Climb One Flight of Stairs | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Climb one flight of stairs? | PODCI Adolescent Parent-Reported Version - Climb One Flight of Stairs | ||
PODCI2-Climb Three Flights of Stairs | C136053 | PODCI2-Climb Three Flights of Stairs | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Climb three flights of stairs? | PODCI Adolescent Parent-Reported Version - Climb Three Flights of Stairs | ||
PODCI2-Comb His/Her Hair | C136038 | PODCI2-Comb His/Her Hair | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Comb his/her hair? | PODCI Adolescent Parent-Reported Version - Comb His or Her Hair | ||
PODCI2-Comp Sports Limited by: Dislike | C136090 | PODCI2-Comp Sports Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Dislike of pickup games or sports? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Dislike | ||
PODCI2-Comp Sports Limited by: Fear | C136089 | PODCI2-Comp Sports Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Fear | ||
PODCI2-Comp Sports Limited by: Health | C136087 | PODCI2-Comp Sports Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Health | ||
PODCI2-Comp Sports Limited by: Instruct | C136088 | PODCI2-Comp Sports Limited by: Instruct | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Instructions | ||
PODCI2-Comp Sports Limited by: Pain | C136086 | PODCI2-Comp Sports Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Pain | ||
PODCI2-Comp Sports Limited by: Season | C136092 | PODCI2-Comp Sports Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Activity not in season? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Season | ||
PODCI2-Comp Sports Limited by: Too Young | C136091 | PODCI2-Comp Sports Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Too young? | PODCI Adolescent Parent-Reported Version - Competitive Sports Limited by: Too Young | ||
PODCI2-Easy to Make Friends | C136107 | PODCI2-Easy to Make Friends | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Is it easy or hard for your child to make friends with children his/her own age? | PODCI Adolescent Parent-Reported Version - Easy to Make Friends | ||
PODCI2-Feel Better | C136112 | PODCI2-Feel Better | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To feel better about himself/herself. | PODCI Adolescent Parent-Reported Version - Feel Better | ||
PODCI2-Feel Sick and Tired | C136048 | PODCI2-Feel Sick and Tired | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Did your child feel sick and tired? | PODCI Adolescent Parent-Reported Version - Feel Sick and Tired | ||
PODCI2-Free From Pain as Adult | C136118 | PODCI2-Free From Pain as Adult | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To be free from pain or disability as an adult. | PODCI Adolescent Parent-Reported Version - Free From Pain as Adult | ||
PODCI2-Friends Limited by: Fear | C136097 | PODCI2-Friends Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Fear | ||
PODCI2-Friends Limited by: Health | C136095 | PODCI2-Friends Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Health | ||
PODCI2-Friends Limited by: Instructions | C136096 | PODCI2-Friends Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Instructions | ||
PODCI2-Friends Limited by: Not Around | C136098 | PODCI2-Friends Limited by: Not Around | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Friends not around? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Not Around | ||
PODCI2-Friends Limited by: Pain | C136094 | PODCI2-Friends Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Friends Limited by: Pain | ||
PODCI2-Full of Pep and Energy | C136049 | PODCI2-Full of Pep and Energy | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Were your child full of pep and energy? | PODCI Adolescent Parent-Reported Version - Full of Pep and Energy | ||
PODCI2-Games Limited by: Dislike | C136082 | PODCI2-Games Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Dislike of pickup games or sports? | PODCI Adolescent Parent-Reported Version - Games Limited by: Dislike | ||
PODCI2-Games Limited by: Fear | C136081 | PODCI2-Games Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Games Limited by: Fear | ||
PODCI2-Games Limited by: Health | C136079 | PODCI2-Games Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Games Limited by: Health | ||
PODCI2-Games Limited by: Instructions | C136080 | PODCI2-Games Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Games Limited by: Instructions | ||
PODCI2-Games Limited by: Pain | C136078 | PODCI2-Games Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Games Limited by: Pain | ||
PODCI2-Games Limited by: Season | C136084 | PODCI2-Games Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Activity not in season? | PODCI Adolescent Parent-Reported Version - Games Limited by: Season | ||
PODCI2-Games Limited by: Too Young | C136083 | PODCI2-Games Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Too young? | PODCI Adolescent Parent-Reported Version - Games Limited by: Too Young | ||
PODCI2-Get In and Out of Bed | C136064 | PODCI2-Get In and Out of Bed | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get in and out of bed? | PODCI Adolescent Parent-Reported Version - Get In and Out of Bed | ||
PODCI2-Get On and Off a Bus | C136058 | PODCI2-Get On and Off a Bus | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a bus? | PODCI Adolescent Parent-Reported Version - Get On and Off a Bus | ||
PODCI2-Get On and Off a Toilet or Chair | C136063 | PODCI2-Get On and Off a Toilet or Chair | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a toilet or chair? | PODCI Adolescent Parent-Reported Version - Get On and Off a Toilet or Chair | ||
PODCI2-Get Together With Friends | C136093 | PODCI2-Get Together With Friends | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often in the last week did your child get together and do things with friends? | PODCI Adolescent Parent-Reported Version - Get Together With Friends | ||
PODCI2-Global Functioning Scale | C136125 | PODCI2-Global Functioning Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Global functioning scale. | PODCI Adolescent Parent-Reported Version - Global Functioning Scale | ||
PODCI2-Gym Limited by: Dislike | C136104 | PODCI2-Gym Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Dislike of gym/recess? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Dislike | ||
PODCI2-Gym Limited by: Fear | C136103 | PODCI2-Gym Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Fear | ||
PODCI2-Gym Limited by: Health | C136101 | PODCI2-Gym Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Health | ||
PODCI2-Gym Limited by: Instructions | C136102 | PODCI2-Gym Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Instructions | ||
PODCI2-Gym Limited by: Not Attend School | C136106 | PODCI2-Gym Limited by: Not Attend School | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Does not attend school? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Not Attend School | ||
PODCI2-Gym Limited by: Not in Session | C136105 | PODCI2-Gym Limited by: Not in Session | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: School not in session? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Not in Session | ||
PODCI2-Gym Limited by: Pain | C136100 | PODCI2-Gym Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Gym Limited by: Pain | ||
PODCI2-Happiness Scale | C136124 | PODCI2-Happiness Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Happiness core scale. | PODCI Adolescent Parent-Reported Version - Happiness Scale | ||
PODCI2-Have Pain Relief | C136110 | PODCI2-Have Pain Relief | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To have pain relief. | PODCI Adolescent Parent-Reported Version - Have Pain Relief | ||
PODCI2-His/Her Body | C136044 | PODCI2-His/Her Body | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her body? | PODCI Adolescent Parent-Reported Version - His or Her Body | ||
PODCI2-His/Her Health in General | C136047 | PODCI2-His/Her Health in General | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: His/her health in general? | PODCI Adolescent Parent-Reported Version - His or Her Health in General | ||
PODCI2-How He/She Looks | C136043 | PODCI2-How He/She Looks | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: How he/she looks? | PODCI Adolescent Parent-Reported Version - How He or She Looks | ||
PODCI2-Lift Heavy Books | C136034 | PODCI2-Lift Heavy Books | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Lift heavy books? | PODCI Adolescent Parent-Reported Version - Lift Heavy Books | ||
PODCI2-Look Better | C136111 | PODCI2-Look Better | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To look better. | PODCI Adolescent Parent-Reported Version - Look Better | ||
PODCI2-Miss School Because of Health | C136042 | PODCI2-Miss School Because of Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - On average, over the last 12 months, how often did your child miss school (camp, etc.) because of his/her health? | PODCI Adolescent Parent-Reported Version - Miss School Because of Health | ||
PODCI2-Need Help Sitting and Standing | C136067 | PODCI2-Need Help Sitting and Standing | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child need help from another person for sitting and standing? | PODCI Adolescent Parent-Reported Version - Need Help Sitting and Standing | ||
PODCI2-Need Help Walking and Climbing | C136059 | PODCI2-Need Help Walking and Climbing | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child need help from another person for walking and climbing? | PODCI Adolescent Parent-Reported Version - Need Help Walking and Climbing | ||
PODCI2-Open a Jar Been Opened Before | C136036 | PODCI2-Open a Jar Been Opened Before | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Open a jar that has been opened before? | PODCI Adolescent Parent-Reported Version - Open a Jar Been Opened Before | ||
PODCI2-Outdoor Limited by: Dislike | C136074 | PODCI2-Outdoor Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Dislike | ||
PODCI2-Outdoor Limited by: Fear | C136073 | PODCI2-Outdoor Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Fear | ||
PODCI2-Outdoor Limited by: Health | C136071 | PODCI2-Outdoor Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: General health? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Health | ||
PODCI2-Outdoor Limited by: Instructions | C136072 | PODCI2-Outdoor Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Instructions | ||
PODCI2-Outdoor Limited by: Pain | C136070 | PODCI2-Outdoor Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Pain? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Pain | ||
PODCI2-Outdoor Limited by: Season | C136076 | PODCI2-Outdoor Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Activity not in season? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Season | ||
PODCI2-Outdoor Limited by: Too Young | C136075 | PODCI2-Outdoor Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Too young? | PODCI Adolescent Parent-Reported Version - Outdoor Limited by: Too Young | ||
PODCI2-Pain During the Last Week | C136108 | PODCI2-Pain During the Last Week | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How much pain has your child had during the last week? | PODCI Adolescent Parent-Reported Version - Pain During the Last Week | ||
PODCI2-Pain Interfere With Activities | C136109 | PODCI2-Pain Interfere With Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much did pain interfere with your child's normal activities (including at home, outside of the home, and at school)? | PODCI Adolescent Parent-Reported Version - Pain Interfere With Activities | ||
PODCI2-Pain/Comfort Scale | C136123 | PODCI2-Pain/Comfort Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Pain/comfort core scale. | PODCI Adolescent Parent-Reported Version - Pain or Comfort Scale | ||
PODCI2-Pain/Discom Inter With Activities | C136050 | PODCI2-Pain/Discom Inter With Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your child's activities? | PODCI Adolescent Parent-Reported Version - Pain or Discomfort Interfere With Activities | ||
PODCI2-Participate in Competitive Sports | C136085 | PODCI2-Participate in Competitive Sports | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in competitive level sports with other children the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? | PODCI Adolescent Parent-Reported Version - Participate in Competitive Sports | ||
PODCI2-Participate in Gym/Recess | C136099 | PODCI2-Participate in Gym/Recess | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often in the last week did your child participate in gym/recess? | PODCI Adolescent Parent-Reported Version - Participate in Gym or Recess | ||
PODCI2-Participate in Outdoor Activities | C136069 | PODCI2-Participate in Outdoor Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in recreational outdoor activities with other children the same age (For example: bicycling, skating, hiking, jogging)? | PODCI Adolescent Parent-Reported Version - Participate in Outdoor Activities | ||
PODCI2-Participate in Pickup Games | C136077 | PODCI2-Participate in Pickup Games | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Can your child participate in pickup games or sports with other children the same age (For example: tag, dodge ball, basketball, softball, soccer, catch, jump rope, touch football, hop scotch)? | PODCI Adolescent Parent-Reported Version - Participate in Pickup Games | ||
PODCI2-Pour a Half Gallon of Milk | C136035 | PODCI2-Pour a Half Gallon of Milk | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Pour a half gallon of milk? | PODCI Adolescent Parent-Reported Version - Pour a Half Gallon of Milk | ||
PODCI2-Put on His/Her Coat | C136040 | PODCI2-Put on His/Her Coat | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Put on his/her coat? | PODCI Adolescent Parent-Reported Version - Put on His or Her Coat | ||
PODCI2-Run Short Distances | C136051 | PODCI2-Run Short Distances | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Run short distances? | PODCI Adolescent Parent-Reported Version - Run Short Distances | ||
PODCI2-Sit in Chair Without Holding On | C136062 | PODCI2-Sit in Chair Without Holding On | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Sit in a regular chair without holding on? | PODCI Adolescent Parent-Reported Version - Sit in Chair Without Holding On | ||
PODCI2-Sleep More Comfortably | C136113 | PODCI2-Sleep More Comfortably | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - As a result of my child's treatment, I expect my child: To sleep more comfortably. | PODCI Adolescent Parent-Reported Version - Sleep More Comfortably | ||
PODCI2-Spend Rest of Life With Condition | C136119 | PODCI2-Spend Rest of Life With Condition | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - If your child had to spend the rest of his/her life with his/her bone and muscle condition as it is right now, how would you feel about it? | PODCI Adolescent Parent-Reported Version - Spend Rest of Life With Condition | ||
PODCI2-Sports/Phys Function Scale | C136122 | PODCI2-Sports/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Sports and physical functioning core scale. | PODCI Adolescent Parent-Reported Version - Sports and Physical Function Scale | ||
PODCI2-Stand Washing Hands at a Sink | C136061 | PODCI2-Stand Washing Hands at a Sink | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Stand while washing his/her hands and face at a sink? | PODCI Adolescent Parent-Reported Version - Stand Washing Hands at a Sink | ||
PODCI2-Transfer/Basic Mobility Scale | C136121 | PODCI2-Transfer/Basic Mobility Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Transfer and basic mobility core scale. | PODCI Adolescent Parent-Reported Version - Transfer and Basic Mobility Scale | ||
PODCI2-Turn Door Knobs | C136065 | PODCI2-Turn Door Knobs | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Turn door knobs? | PODCI Adolescent Parent-Reported Version - Turn Door Knobs | ||
PODCI2-Up Extremity/Phys Function Scale | C136120 | PODCI2-Up Extremity/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - Upper extremity and physical function core scale. | PODCI Adolescent Parent-Reported Version - Upper Extremity and Physical Function Scale | ||
PODCI2-Use a Fork and Spoon | C136037 | PODCI2-Use a Fork and Spoon | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Use a fork and spoon? | PODCI Adolescent Parent-Reported Version - Use a Fork and Spoon | ||
PODCI2-Use Assistive Devices for Sitting | C136068 | PODCI2-Use Assistive Devices for Sitting | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? | PODCI Adolescent Parent-Reported Version - Use Assistive Devices for Sitting | ||
PODCI2-Use Assistive Devices for Walking | C136060 | PODCI2-Use Assistive Devices for Walking | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? | PODCI Adolescent Parent-Reported Version - Use Assistive Devices for Walking | ||
PODCI2-Walk More Than a Mile | C136055 | PODCI2-Walk More Than a Mile | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk more than a mile? | PODCI Adolescent Parent-Reported Version - Walk More Than a Mile | ||
PODCI2-Walk One Block | C136057 | PODCI2-Walk One Block | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk one block? | PODCI Adolescent Parent-Reported Version - Walk One Block | ||
PODCI2-Walk Three Blocks | C136056 | PODCI2-Walk Three Blocks | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, has it been easy or hard for your child to: Walk three blocks? | PODCI Adolescent Parent-Reported Version - Walk Three Blocks | ||
PODCI2-What Clothes/Shoes He/She Wear | C136045 | PODCI2-What Clothes/Shoes He/She Wear | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, how happy has your child been with: What clothes or shoes he/she can wear? | PODCI Adolescent Parent-Reported Version - What Clothes or Shoes He or She Wear | ||
PODCI2-Write With a Pencil | C136041 | PODCI2-Write With a Pencil | Pediatric Outcomes Data Collection Instrument, Adolescent Parent-Reported - During the last week, was it easy or hard for your child to: Write with a pencil? | PODCI Adolescent Parent-Reported Version - Write With a Pencil | ||
Back to top | ||||||
CL.C135698.PODCI3TC | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire Test Code
(PODCI3TC) | text
Extensible: No | C135698 | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire Test Code | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version test code. | CDISC Questionnaire PODCI Adolescent Self-Reported Version Test Code Terminology |
PODCI301 | C136126 | PODCI3-Lift Heavy Books | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Lift heavy books? | PODCI Adolescent Self-Reported Version - Lift Heavy Books | ||
PODCI302 | C136127 | PODCI3-Pour a Half Gallon of Milk | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Pour a half gallon of milk? | PODCI Adolescent Self-Reported Version - Pour a Half Gallon of Milk | ||
PODCI303 | C136128 | PODCI3-Open a Jar Been Opened Before | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Open a jar that has been opened before? | PODCI Adolescent Self-Reported Version - Open a Jar Been Opened Before | ||
PODCI304 | C136129 | PODCI3-Use a Fork and Spoon | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Use a fork and spoon? | PODCI Adolescent Self-Reported Version - Use a Fork and Spoon | ||
PODCI305 | C136130 | PODCI3-Comb Your Hair | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Comb your hair? | PODCI Adolescent Self-Reported Version - Comb Your Hair | ||
PODCI306 | C136131 | PODCI3-Button Buttons | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Button buttons? | PODCI Adolescent Self-Reported Version - Button Buttons | ||
PODCI307 | C136132 | PODCI3-Put on Your Coat | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Put on your coat? | PODCI Adolescent Self-Reported Version - Put on Your Coat | ||
PODCI308 | C136133 | PODCI3-Write With a Pencil | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Write with a pencil? | PODCI Adolescent Self-Reported Version - Write With a Pencil | ||
PODCI309 | C136134 | PODCI3-Miss School Because of Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - On average, over the last 12 months, how often did you miss school (camp, etc.) because of your health? | PODCI Adolescent Self-Reported Version - Miss School Because of Health | ||
PODCI310 | C136135 | PODCI3-How You Look | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: How you look? | PODCI Adolescent Self-Reported Version - How You Look | ||
PODCI311 | C136136 | PODCI3-Your Body | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your body? | PODCI Adolescent Self-Reported Version - Your Body | ||
PODCI312 | C136137 | PODCI3-What Clothes/Shoes You Can Wear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: What clothes or shoes you can wear? | PODCI Adolescent Self-Reported Version - What Clothes or Shoes You Can Wear | ||
PODCI313 | C136138 | PODCI3-Ability Do Same Things Friends Do | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your ability to do the same things your friends do? | PODCI Adolescent Self-Reported Version - Ability Do Same Things Friends Do | ||
PODCI314 | C136139 | PODCI3-Your Health in General | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your health in general? | PODCI Adolescent Self-Reported Version - Your Health in General | ||
PODCI315 | C136140 | PODCI3-Feel Sick and Tired | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Did you feel sick and tired? | PODCI Adolescent Self-Reported Version - Feel Sick and Tired | ||
PODCI316 | C136141 | PODCI3-Full of Pep and Energy | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Were you full of pep and energy? | PODCI Adolescent Self-Reported Version - Full of Pep and Energy | ||
PODCI317 | C136142 | PODCI3-Pain/Discom Inter With Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your activities? | PODCI Adolescent Self-Reported Version - Pain or Discomfort Interfere With Activities | ||
PODCI318 | C136143 | PODCI3-Run Short Distances | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Run short distances? | PODCI Adolescent Self-Reported Version - Run Short Distances | ||
PODCI319 | C136144 | PODCI3-Bicycle or Tricycle | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Bicycle or tricycle? | PODCI Adolescent Self-Reported Version - Bicycle or Tricycle | ||
PODCI320 | C136145 | PODCI3-Climb Three Flights of Stairs | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Climb three flights of stairs? | PODCI Adolescent Self-Reported Version - Climb Three Flights of Stairs | ||
PODCI321 | C136146 | PODCI3-Climb One Flight of Stairs | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Climb one flight of stairs? | PODCI Adolescent Self-Reported Version - Climb One Flight of Stairs | ||
PODCI322 | C136147 | PODCI3-Walk More Than a Mile | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk more than a mile? | PODCI Adolescent Self-Reported Version - Walk More Than a Mile | ||
PODCI323 | C136148 | PODCI3-Walk Three Blocks | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk three blocks? | PODCI Adolescent Self-Reported Version - Walk Three Blocks | ||
PODCI324 | C136149 | PODCI3-Walk One Block | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk one block? | PODCI Adolescent Self-Reported Version - Walk One Block | ||
PODCI325 | C136150 | PODCI3-Get On and Off a Bus | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get on and off a bus? | PODCI Adolescent Self-Reported Version - Get On and Off a Bus | ||
PODCI326 | C136151 | PODCI3-Need Help Walking and Climbing | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you need help from another person for walking and climbing? | PODCI Adolescent Self-Reported Version - Need Help Walking and Climbing | ||
PODCI327 | C136152 | PODCI3-Use Assistive Devices for Walking | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? | PODCI Adolescent Self-Reported Version - Use Assistive Devices for Walking | ||
PODCI328 | C136153 | PODCI3-Stand Washing Hands at a Sink | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Stand while washing your hands and face at a sink? | PODCI Adolescent Self-Reported Version - Stand Washing Hands at a Sink | ||
PODCI329 | C136154 | PODCI3-Sit in Chair Without Holding On | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Sit in a regular chair without holding on? | PODCI Adolescent Self-Reported Version - Sit in Chair Without Holding On | ||
PODCI330 | C136155 | PODCI3-Get On and Off a Toilet or Chair | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get on and off a toilet or chair? | PODCI Adolescent Self-Reported Version - Get On and Off a Toilet or Chair | ||
PODCI331 | C136156 | PODCI3-Get In and Out of Bed | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get in and out of bed? | PODCI Adolescent Self-Reported Version - Get In and Out of Bed | ||
PODCI332 | C136157 | PODCI3-Turn Door Knobs | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Turn door knobs? | PODCI Adolescent Self-Reported Version - Turn Door Knobs | ||
PODCI333 | C136158 | PODCI3-Bend Over and Pick Up Something | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Bend over from a standing position and pick up something off the floor? | PODCI Adolescent Self-Reported Version - Bend Over and Pick Up Something | ||
PODCI334 | C136159 | PODCI3-Need Help Sitting and Standing | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you need help from another person for sitting and standing? | PODCI Adolescent Self-Reported Version - Need Help Sitting and Standing | ||
PODCI335 | C136160 | PODCI3-Use Assistive Devices for Sitting | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? | PODCI Adolescent Self-Reported Version - Use Assistive Devices for Sitting | ||
PODCI336 | C136161 | PODCI3-Participate in Outdoor Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in recreational outdoor activities with other kids the same age (For example: bicycling, skating, hiking, jogging)? | PODCI Adolescent Self-Reported Version - Participate in Outdoor Activities | ||
PODCI337 | C136162 | PODCI3-Outdoor Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Pain | ||
PODCI338 | C136163 | PODCI3-Outdoor Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Health | ||
PODCI339 | C136164 | PODCI3-Outdoor Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Instructions | ||
PODCI340 | C136165 | PODCI3-Outdoor Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Fear | ||
PODCI341 | C136166 | PODCI3-Outdoor Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Dislike of recreational outdoor activities? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Dislike | ||
PODCI342 | C136167 | PODCI3-Outdoor Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Activity not in season? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Season | ||
PODCI343 | C136168 | PODCI3-Participate in Pickup Games | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in pickup games or sports with other kids the same age (For example: tag, dodge ball, basketball, softball, soccer, catch, jump rope, touch football, hop scotch)? | PODCI Adolescent Self-Reported Version - Participate in Pickup Games | ||
PODCI344 | C136169 | PODCI3-Games Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Games Limited by: Pain | ||
PODCI345 | C136170 | PODCI3-Games Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Games Limited by: Health | ||
PODCI346 | C136171 | PODCI3-Games Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Games Limited by: Instructions | ||
PODCI347 | C136172 | PODCI3-Games Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Games Limited by: Fear | ||
PODCI348 | C136173 | PODCI3-Games Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Dislike of pickup games or sports? | PODCI Adolescent Self-Reported Version - Games Limited by: Dislike | ||
PODCI349 | C136174 | PODCI3-Games Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Activity not in season? | PODCI Adolescent Self-Reported Version - Games Limited by: Season | ||
PODCI350 | C136175 | PODCI3-Participate in Competitive Sports | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in competitive level sports with other kids the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? | PODCI Adolescent Self-Reported Version - Participate in Competitive Sports | ||
PODCI351 | C136176 | PODCI3-Comp Sports Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Pain | ||
PODCI352 | C136177 | PODCI3-Comp Sports Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Health | ||
PODCI353 | C136178 | PODCI3-Comp Sports Limited by: Instruct | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Instructions | ||
PODCI354 | C136179 | PODCI3-Comp Sports Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Fear | ||
PODCI355 | C136180 | PODCI3-Comp Sports Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Dislike of pickup games or sports? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Dislike | ||
PODCI356 | C136181 | PODCI3-Comp Sports Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Activity not in season? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Season | ||
PODCI357 | C136182 | PODCI3-Get Together With Friends | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often in the last week did you get together and do things with friends? | PODCI Adolescent Self-Reported Version - Get Together With Friends | ||
PODCI358 | C136183 | PODCI3-Friends Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Friends Limited by: Pain | ||
PODCI359 | C136184 | PODCI3-Friends Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Friends Limited by: Health | ||
PODCI360 | C136185 | PODCI3-Friends Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Friends Limited by: Instructions | ||
PODCI361 | C136186 | PODCI3-Friends Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Friends Limited by: Fear | ||
PODCI362 | C136187 | PODCI3-Friends Limited by: Not Around | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Friends not around? | PODCI Adolescent Self-Reported Version - Friends Limited by: Not Around | ||
PODCI363 | C136188 | PODCI3-Participate in Gym/Recess | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often in the last week did you participate in gym/recess? | PODCI Adolescent Self-Reported Version - Participate in Gym or Recess | ||
PODCI364 | C136189 | PODCI3-Gym Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Gym Limited by: Pain | ||
PODCI365 | C136190 | PODCI3-Gym Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Gym Limited by: Health | ||
PODCI366 | C136191 | PODCI3-Gym Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Gym Limited by: Instructions | ||
PODCI367 | C136192 | PODCI3-Gym Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Gym Limited by: Fear | ||
PODCI368 | C136193 | PODCI3-Gym Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Dislike of gym/recess? | PODCI Adolescent Self-Reported Version - Gym Limited by: Dislike | ||
PODCI369 | C136194 | PODCI3-Gym Limited by: Not in Session | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: School not in session? | PODCI Adolescent Self-Reported Version - Gym Limited by: Not in Session | ||
PODCI370 | C136195 | PODCI3-Gym Limited by: Not Attend School | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: I don't attend school? | PODCI Adolescent Self-Reported Version - Gym Limited by: Not Attend School | ||
PODCI371 | C136196 | PODCI3-Easy to Make Friends | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Is it easy or hard for you to make friends with kids your own age? | PODCI Adolescent Self-Reported Version - Easy to Make Friends | ||
PODCI372 | C136197 | PODCI3-Pain During the Last Week | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How much pain have you had during the last week? | PODCI Adolescent Self-Reported Version - Pain During the Last Week | ||
PODCI373 | C136198 | PODCI3-Pain Interfere With Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much did pain interfere with your normal activities (including at home, outside of the home, and at school)? | PODCI Adolescent Self-Reported Version - Pain Interfere With Activities | ||
PODCI374 | C136199 | PODCI3-Have Pain Relief | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To have pain relief. | PODCI Adolescent Self-Reported Version - Have Pain Relief | ||
PODCI375 | C136200 | PODCI3-Look Better | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To look better. | PODCI Adolescent Self-Reported Version - Look Better | ||
PODCI376 | C136201 | PODCI3-Feel Better | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To feel better about myself. | PODCI Adolescent Self-Reported Version - Feel Better | ||
PODCI377 | C136202 | PODCI3-Sleep More Comfortably | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To sleep more comfortably. | PODCI Adolescent Self-Reported Version - Sleep More Comfortably | ||
PODCI378 | C136203 | PODCI3-Able to Do Activities at Home | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do activities at home. | PODCI Adolescent Self-Reported Version - Able to Do Activities at Home | ||
PODCI379 | C136204 | PODCI3-Able to Do More at School | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more at school. | PODCI Adolescent Self-Reported Version - Able to Do More at School | ||
PODCI380 | C136205 | PODCI3-Able to Do More Play | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more play or recreational activities. | PODCI Adolescent Self-Reported Version - Able to Do More Play | ||
PODCI381 | C136206 | PODCI3-Able to Do More Sports | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more sports. | PODCI Adolescent Self-Reported Version - Able to Do More Sports | ||
PODCI382 | C136207 | PODCI3-Free From Pain as Adult | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be free from pain or disability as an adult. | PODCI Adolescent Self-Reported Version - Free From Pain as Adult | ||
PODCI383 | C136208 | PODCI3-Spend Rest of Life With Condition | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you had to spend the rest of your life with your bone and muscle condition as it is right now, how would you feel about it? | PODCI Adolescent Self-Reported Version - Spend Rest of Life With Condition | ||
PODCI384 | C136209 | PODCI3-Up Extremity/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Upper extremity and physical function core scale. | PODCI Adolescent Self-Reported Version - Upper Extremity and Physical Function Scale | ||
PODCI385 | C136210 | PODCI3-Transfer/Basic Mobility Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Transfer and basic mobility core scale. | PODCI Adolescent Self-Reported Version - Transfer and Basic Mobility Scale | ||
PODCI386 | C136211 | PODCI3-Sports/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Sports and physical functioning core scale. | PODCI Adolescent Self-Reported Version - Sports and Physical Function Scale | ||
PODCI387 | C136212 | PODCI3-Pain/Comfort Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Pain/comfort core scale. | PODCI Adolescent Self-Reported Version - Pain or Comfort Scale | ||
PODCI388 | C136213 | PODCI3-Happiness Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Happiness core scale. | PODCI Adolescent Self-Reported Version - Happiness Scale | ||
PODCI389 | C136214 | PODCI3-Global Functioning Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Global functioning scale. | PODCI Adolescent Self-Reported Version - Global Functioning Scale | ||
Back to top | ||||||
CL.C135697.PODCI3TN | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire Test Name
(PODCI3TN) | text
Extensible: No | C135697 | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version Questionnaire Test Name | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported Version test name. | CDISC Questionnaire PODCI Adolescent Self-Reported Version Test Name Terminology |
PODCI3-Ability Do Same Things Friends Do | C136138 | PODCI3-Ability Do Same Things Friends Do | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your ability to do the same things your friends do? | PODCI Adolescent Self-Reported Version - Ability Do Same Things Friends Do | ||
PODCI3-Able to Do Activities at Home | C136203 | PODCI3-Able to Do Activities at Home | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do activities at home. | PODCI Adolescent Self-Reported Version - Able to Do Activities at Home | ||
PODCI3-Able to Do More at School | C136204 | PODCI3-Able to Do More at School | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more at school. | PODCI Adolescent Self-Reported Version - Able to Do More at School | ||
PODCI3-Able to Do More Play | C136205 | PODCI3-Able to Do More Play | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more play or recreational activities. | PODCI Adolescent Self-Reported Version - Able to Do More Play | ||
PODCI3-Able to Do More Sports | C136206 | PODCI3-Able to Do More Sports | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be able to do more sports. | PODCI Adolescent Self-Reported Version - Able to Do More Sports | ||
PODCI3-Bend Over and Pick Up Something | C136158 | PODCI3-Bend Over and Pick Up Something | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Bend over from a standing position and pick up something off the floor? | PODCI Adolescent Self-Reported Version - Bend Over and Pick Up Something | ||
PODCI3-Bicycle or Tricycle | C136144 | PODCI3-Bicycle or Tricycle | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Bicycle or tricycle? | PODCI Adolescent Self-Reported Version - Bicycle or Tricycle | ||
PODCI3-Button Buttons | C136131 | PODCI3-Button Buttons | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Button buttons? | PODCI Adolescent Self-Reported Version - Button Buttons | ||
PODCI3-Climb One Flight of Stairs | C136146 | PODCI3-Climb One Flight of Stairs | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Climb one flight of stairs? | PODCI Adolescent Self-Reported Version - Climb One Flight of Stairs | ||
PODCI3-Climb Three Flights of Stairs | C136145 | PODCI3-Climb Three Flights of Stairs | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Climb three flights of stairs? | PODCI Adolescent Self-Reported Version - Climb Three Flights of Stairs | ||
PODCI3-Comb Your Hair | C136130 | PODCI3-Comb Your Hair | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Comb your hair? | PODCI Adolescent Self-Reported Version - Comb Your Hair | ||
PODCI3-Comp Sports Limited by: Dislike | C136180 | PODCI3-Comp Sports Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Dislike of pickup games or sports? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Dislike | ||
PODCI3-Comp Sports Limited by: Fear | C136179 | PODCI3-Comp Sports Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Fear | ||
PODCI3-Comp Sports Limited by: Health | C136177 | PODCI3-Comp Sports Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Health | ||
PODCI3-Comp Sports Limited by: Instruct | C136178 | PODCI3-Comp Sports Limited by: Instruct | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Instructions | ||
PODCI3-Comp Sports Limited by: Pain | C136176 | PODCI3-Comp Sports Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Pain | ||
PODCI3-Comp Sports Limited by: Season | C136181 | PODCI3-Comp Sports Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 50 above, was your activity limited by: Activity not in season? | PODCI Adolescent Self-Reported Version - Competitive Sports Limited by: Season | ||
PODCI3-Easy to Make Friends | C136196 | PODCI3-Easy to Make Friends | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Is it easy or hard for you to make friends with kids your own age? | PODCI Adolescent Self-Reported Version - Easy to Make Friends | ||
PODCI3-Feel Better | C136201 | PODCI3-Feel Better | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To feel better about myself. | PODCI Adolescent Self-Reported Version - Feel Better | ||
PODCI3-Feel Sick and Tired | C136140 | PODCI3-Feel Sick and Tired | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Did you feel sick and tired? | PODCI Adolescent Self-Reported Version - Feel Sick and Tired | ||
PODCI3-Free From Pain as Adult | C136207 | PODCI3-Free From Pain as Adult | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To be free from pain or disability as an adult. | PODCI Adolescent Self-Reported Version - Free From Pain as Adult | ||
PODCI3-Friends Limited by: Fear | C136186 | PODCI3-Friends Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Friends Limited by: Fear | ||
PODCI3-Friends Limited by: Health | C136184 | PODCI3-Friends Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Friends Limited by: Health | ||
PODCI3-Friends Limited by: Instructions | C136185 | PODCI3-Friends Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Friends Limited by: Instructions | ||
PODCI3-Friends Limited by: Not Around | C136187 | PODCI3-Friends Limited by: Not Around | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Friends not around? | PODCI Adolescent Self-Reported Version - Friends Limited by: Not Around | ||
PODCI3-Friends Limited by: Pain | C136183 | PODCI3-Friends Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 57 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Friends Limited by: Pain | ||
PODCI3-Full of Pep and Energy | C136141 | PODCI3-Full of Pep and Energy | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Were you full of pep and energy? | PODCI Adolescent Self-Reported Version - Full of Pep and Energy | ||
PODCI3-Games Limited by: Dislike | C136173 | PODCI3-Games Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Dislike of pickup games or sports? | PODCI Adolescent Self-Reported Version - Games Limited by: Dislike | ||
PODCI3-Games Limited by: Fear | C136172 | PODCI3-Games Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Games Limited by: Fear | ||
PODCI3-Games Limited by: Health | C136170 | PODCI3-Games Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Games Limited by: Health | ||
PODCI3-Games Limited by: Instructions | C136171 | PODCI3-Games Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Games Limited by: Instructions | ||
PODCI3-Games Limited by: Pain | C136169 | PODCI3-Games Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Games Limited by: Pain | ||
PODCI3-Games Limited by: Season | C136174 | PODCI3-Games Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 43 above, was your activity limited by: Activity not in season? | PODCI Adolescent Self-Reported Version - Games Limited by: Season | ||
PODCI3-Get In and Out of Bed | C136156 | PODCI3-Get In and Out of Bed | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get in and out of bed? | PODCI Adolescent Self-Reported Version - Get In and Out of Bed | ||
PODCI3-Get On and Off a Bus | C136150 | PODCI3-Get On and Off a Bus | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get on and off a bus? | PODCI Adolescent Self-Reported Version - Get On and Off a Bus | ||
PODCI3-Get On and Off a Toilet or Chair | C136155 | PODCI3-Get On and Off a Toilet or Chair | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Get on and off a toilet or chair? | PODCI Adolescent Self-Reported Version - Get On and Off a Toilet or Chair | ||
PODCI3-Get Together With Friends | C136182 | PODCI3-Get Together With Friends | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often in the last week did you get together and do things with friends? | PODCI Adolescent Self-Reported Version - Get Together With Friends | ||
PODCI3-Global Functioning Scale | C136214 | PODCI3-Global Functioning Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Global functioning scale. | PODCI Adolescent Self-Reported Version - Global Functioning Scale | ||
PODCI3-Gym Limited by: Dislike | C136193 | PODCI3-Gym Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Dislike of gym/recess? | PODCI Adolescent Self-Reported Version - Gym Limited by: Dislike | ||
PODCI3-Gym Limited by: Fear | C136192 | PODCI3-Gym Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Gym Limited by: Fear | ||
PODCI3-Gym Limited by: Health | C136190 | PODCI3-Gym Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Gym Limited by: Health | ||
PODCI3-Gym Limited by: Instructions | C136191 | PODCI3-Gym Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Gym Limited by: Instructions | ||
PODCI3-Gym Limited by: Not Attend School | C136195 | PODCI3-Gym Limited by: Not Attend School | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: I don't attend school? | PODCI Adolescent Self-Reported Version - Gym Limited by: Not Attend School | ||
PODCI3-Gym Limited by: Not in Session | C136194 | PODCI3-Gym Limited by: Not in Session | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: School not in session? | PODCI Adolescent Self-Reported Version - Gym Limited by: Not in Session | ||
PODCI3-Gym Limited by: Pain | C136189 | PODCI3-Gym Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "sometimes" or "never or rarely" to Question 63 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Gym Limited by: Pain | ||
PODCI3-Happiness Scale | C136213 | PODCI3-Happiness Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Happiness core scale. | PODCI Adolescent Self-Reported Version - Happiness Scale | ||
PODCI3-Have Pain Relief | C136199 | PODCI3-Have Pain Relief | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To have pain relief. | PODCI Adolescent Self-Reported Version - Have Pain Relief | ||
PODCI3-How You Look | C136135 | PODCI3-How You Look | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: How you look? | PODCI Adolescent Self-Reported Version - How You Look | ||
PODCI3-Lift Heavy Books | C136126 | PODCI3-Lift Heavy Books | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Lift heavy books? | PODCI Adolescent Self-Reported Version - Lift Heavy Books | ||
PODCI3-Look Better | C136200 | PODCI3-Look Better | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To look better. | PODCI Adolescent Self-Reported Version - Look Better | ||
PODCI3-Miss School Because of Health | C136134 | PODCI3-Miss School Because of Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - On average, over the last 12 months, how often did you miss school (camp, etc.) because of your health? | PODCI Adolescent Self-Reported Version - Miss School Because of Health | ||
PODCI3-Need Help Sitting and Standing | C136159 | PODCI3-Need Help Sitting and Standing | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you need help from another person for sitting and standing? | PODCI Adolescent Self-Reported Version - Need Help Sitting and Standing | ||
PODCI3-Need Help Walking and Climbing | C136151 | PODCI3-Need Help Walking and Climbing | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you need help from another person for walking and climbing? | PODCI Adolescent Self-Reported Version - Need Help Walking and Climbing | ||
PODCI3-Open a Jar Been Opened Before | C136128 | PODCI3-Open a Jar Been Opened Before | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Open a jar that has been opened before? | PODCI Adolescent Self-Reported Version - Open a Jar Been Opened Before | ||
PODCI3-Outdoor Limited by: Dislike | C136166 | PODCI3-Outdoor Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Dislike of recreational outdoor activities? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Dislike | ||
PODCI3-Outdoor Limited by: Fear | C136165 | PODCI3-Outdoor Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Fear the other kids won't like you? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Fear | ||
PODCI3-Outdoor Limited by: Health | C136163 | PODCI3-Outdoor Limited by: Health | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: General health? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Health | ||
PODCI3-Outdoor Limited by: Instructions | C136164 | PODCI3-Outdoor Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Doctor or parent instructions? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Instructions | ||
PODCI3-Outdoor Limited by: Pain | C136162 | PODCI3-Outdoor Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Pain? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Pain | ||
PODCI3-Outdoor Limited by: Season | C136167 | PODCI3-Outdoor Limited by: Season | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you answered "no" to Question 36 above, was your activity limited by: Activity not in season? | PODCI Adolescent Self-Reported Version - Outdoor Limited by: Season | ||
PODCI3-Pain During the Last Week | C136197 | PODCI3-Pain During the Last Week | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How much pain have you had during the last week? | PODCI Adolescent Self-Reported Version - Pain During the Last Week | ||
PODCI3-Pain Interfere With Activities | C136198 | PODCI3-Pain Interfere With Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much did pain interfere with your normal activities (including at home, outside of the home, and at school)? | PODCI Adolescent Self-Reported Version - Pain Interfere With Activities | ||
PODCI3-Pain/Comfort Scale | C136212 | PODCI3-Pain/Comfort Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Pain/comfort core scale. | PODCI Adolescent Self-Reported Version - Pain or Comfort Scale | ||
PODCI3-Pain/Discom Inter With Activities | C136142 | PODCI3-Pain/Discom Inter With Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your activities? | PODCI Adolescent Self-Reported Version - Pain or Discomfort Interfere With Activities | ||
PODCI3-Participate in Competitive Sports | C136175 | PODCI3-Participate in Competitive Sports | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in competitive level sports with other kids the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? | PODCI Adolescent Self-Reported Version - Participate in Competitive Sports | ||
PODCI3-Participate in Gym/Recess | C136188 | PODCI3-Participate in Gym/Recess | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often in the last week did you participate in gym/recess? | PODCI Adolescent Self-Reported Version - Participate in Gym or Recess | ||
PODCI3-Participate in Outdoor Activities | C136161 | PODCI3-Participate in Outdoor Activities | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in recreational outdoor activities with other kids the same age (For example: bicycling, skating, hiking, jogging)? | PODCI Adolescent Self-Reported Version - Participate in Outdoor Activities | ||
PODCI3-Participate in Pickup Games | C136168 | PODCI3-Participate in Pickup Games | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Can you participate in pickup games or sports with other kids the same age (For example: tag, dodge ball, basketball, softball, soccer, catch, jump rope, touch football, hop scotch)? | PODCI Adolescent Self-Reported Version - Participate in Pickup Games | ||
PODCI3-Pour a Half Gallon of Milk | C136127 | PODCI3-Pour a Half Gallon of Milk | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Pour a half gallon of milk? | PODCI Adolescent Self-Reported Version - Pour a Half Gallon of Milk | ||
PODCI3-Put on Your Coat | C136132 | PODCI3-Put on Your Coat | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Put on your coat? | PODCI Adolescent Self-Reported Version - Put on Your Coat | ||
PODCI3-Run Short Distances | C136143 | PODCI3-Run Short Distances | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Run short distances? | PODCI Adolescent Self-Reported Version - Run Short Distances | ||
PODCI3-Sit in Chair Without Holding On | C136154 | PODCI3-Sit in Chair Without Holding On | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Sit in a regular chair without holding on? | PODCI Adolescent Self-Reported Version - Sit in Chair Without Holding On | ||
PODCI3-Sleep More Comfortably | C136202 | PODCI3-Sleep More Comfortably | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - As a result of my treatment, I expect: To sleep more comfortably. | PODCI Adolescent Self-Reported Version - Sleep More Comfortably | ||
PODCI3-Spend Rest of Life With Condition | C136208 | PODCI3-Spend Rest of Life With Condition | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - If you had to spend the rest of your life with your bone and muscle condition as it is right now, how would you feel about it? | PODCI Adolescent Self-Reported Version - Spend Rest of Life With Condition | ||
PODCI3-Sports/Phys Function Scale | C136211 | PODCI3-Sports/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Sports and physical functioning core scale. | PODCI Adolescent Self-Reported Version - Sports and Physical Function Scale | ||
PODCI3-Stand Washing Hands at a Sink | C136153 | PODCI3-Stand Washing Hands at a Sink | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Stand while washing your hands and face at a sink? | PODCI Adolescent Self-Reported Version - Stand Washing Hands at a Sink | ||
PODCI3-Transfer/Basic Mobility Scale | C136210 | PODCI3-Transfer/Basic Mobility Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Transfer and basic mobility core scale. | PODCI Adolescent Self-Reported Version - Transfer and Basic Mobility Scale | ||
PODCI3-Turn Door Knobs | C136157 | PODCI3-Turn Door Knobs | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Turn door knobs? | PODCI Adolescent Self-Reported Version - Turn Door Knobs | ||
PODCI3-Up Extremity/Phys Function Scale | C136209 | PODCI3-Up Extremity/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - Upper extremity and physical function core scale. | PODCI Adolescent Self-Reported Version - Upper Extremity and Physical Function Scale | ||
PODCI3-Use a Fork and Spoon | C136129 | PODCI3-Use a Fork and Spoon | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Use a fork and spoon? | PODCI Adolescent Self-Reported Version - Use a Fork and Spoon | ||
PODCI3-Use Assistive Devices for Sitting | C136160 | PODCI3-Use Assistive Devices for Sitting | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? | PODCI Adolescent Self-Reported Version - Use Assistive Devices for Sitting | ||
PODCI3-Use Assistive Devices for Walking | C136152 | PODCI3-Use Assistive Devices for Walking | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - How often do you use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? | PODCI Adolescent Self-Reported Version - Use Assistive Devices for Walking | ||
PODCI3-Walk More Than a Mile | C136147 | PODCI3-Walk More Than a Mile | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk more than a mile? | PODCI Adolescent Self-Reported Version - Walk More Than a Mile | ||
PODCI3-Walk One Block | C136149 | PODCI3-Walk One Block | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk one block? | PODCI Adolescent Self-Reported Version - Walk One Block | ||
PODCI3-Walk Three Blocks | C136148 | PODCI3-Walk Three Blocks | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, has it been easy or hard for you to: Walk three blocks? | PODCI Adolescent Self-Reported Version - Walk Three Blocks | ||
PODCI3-What Clothes/Shoes You Can Wear | C136137 | PODCI3-What Clothes/Shoes You Can Wear | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: What clothes or shoes you can wear? | PODCI Adolescent Self-Reported Version - What Clothes or Shoes You Can Wear | ||
PODCI3-Write With a Pencil | C136133 | PODCI3-Write With a Pencil | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, was it easy or hard for you to: Write with a pencil? | PODCI Adolescent Self-Reported Version - Write With a Pencil | ||
PODCI3-Your Body | C136136 | PODCI3-Your Body | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your body? | PODCI Adolescent Self-Reported Version - Your Body | ||
PODCI3-Your Health in General | C136139 | PODCI3-Your Health in General | Pediatric Outcomes Data Collection Instrument, Adolescent Self-Reported - During the last week, how happy have you been with: Your health in general? | PODCI Adolescent Self-Reported Version - Your Health in General | ||
Back to top | ||||||
CL.C135694.PODCI1TC | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire Test Code
(PODCI1TC) | text
Extensible: No | C135694 | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire Test Code | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version test code. | CDISC Questionnaire PODCI Pediatric Parent-Reported Version Test Code Terminology |
PODCI101 | C135942 | PODCI1-Lift Heavy Books | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Lift heavy books? | PODCI Pediatric Parent-Reported Version - Lift Heavy Books | ||
PODCI102 | C135943 | PODCI1-Pour a Half Gallon of Milk | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Pour a half gallon of milk? | PODCI Pediatric Parent-Reported Version - Pour a Half Gallon of Milk | ||
PODCI103 | C135944 | PODCI1-Open a Jar Been Opened Before | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Open a jar that has been opened before? | PODCI Pediatric Parent-Reported Version - Open a Jar Been Opened Before | ||
PODCI104 | C135945 | PODCI1-Use a Fork and Spoon | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Use a fork and spoon? | PODCI Pediatric Parent-Reported Version - Use a Fork and Spoon | ||
PODCI105 | C135946 | PODCI1-Comb His/Her Hair | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Comb his/her hair? | PODCI Pediatric Parent-Reported Version - Comb His or Her Hair | ||
PODCI106 | C135947 | PODCI1-Button Buttons | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Button buttons? | PODCI Pediatric Parent-Reported Version - Button Buttons | ||
PODCI107 | C135948 | PODCI1-Put on His/Her Coat | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Put on his/her coat? | PODCI Pediatric Parent-Reported Version - Put on His or Her Coat | ||
PODCI108 | C135949 | PODCI1-Write With a Pencil | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Write with a pencil? | PODCI Pediatric Parent-Reported Version - Write With a Pencil | ||
PODCI109 | C135950 | PODCI1-Miss School Because of Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - On average, over the last 12 months, how often did your child miss school (preschool, day care, camp, etc.) because of his/her health? | PODCI Pediatric Parent-Reported Version - Miss School Because of Health | ||
PODCI110 | C135951 | PODCI1-How He/She Looks | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: How he/she looks? | PODCI Pediatric Parent-Reported Version - How He or She Looks | ||
PODCI111 | C135952 | PODCI1-His/Her Body | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her body? | PODCI Pediatric Parent-Reported Version - His or Her Body | ||
PODCI112 | C135953 | PODCI1-What Clothes/Shoes He/She Wear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: What clothes or shoes he/she can wear? | PODCI Pediatric Parent-Reported Version - What Clothes or Shoes He or She Wear | ||
PODCI113 | C135954 | PODCI1-Ability Do Same Things Friends Do | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her ability to do the same things his/her friends do? | PODCI Pediatric Parent-Reported Version - Ability Do Same Things Friends Do | ||
PODCI114 | C135955 | PODCI1-His/Her Health in General | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her health in general? | PODCI Pediatric Parent-Reported Version - His or Her Health in General | ||
PODCI115 | C135956 | PODCI1-Feel Sick and Tired | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Did your child feel sick and tired? | PODCI Pediatric Parent-Reported Version - Feel Sick and Tired | ||
PODCI116 | C135957 | PODCI1-Full of Pep and Energy | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Were your child full of pep and energy? | PODCI Pediatric Parent-Reported Version - Full of Pep and Energy | ||
PODCI117 | C135958 | PODCI1-Pain/Discom Inter With Activities | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your child's activities? | PODCI Pediatric Parent-Reported Version - Pain or Discomfort Interfere With Activities | ||
PODCI118 | C135959 | PODCI1-Run Short Distances | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Run short distances? | PODCI Pediatric Parent-Reported Version - Run Short Distances | ||
PODCI119 | C135960 | PODCI1-Bicycle or Tricycle | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Bicycle or tricycle? | PODCI Pediatric Parent-Reported Version - Bicycle or Tricycle | ||
PODCI120 | C135961 | PODCI1-Climb Three Flights of Stairs | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Climb three flights of stairs? | PODCI Pediatric Parent-Reported Version - Climb Three Flights of Stairs | ||
PODCI121 | C135962 | PODCI1-Climb One Flight of Stairs | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Climb one flight of stairs? | PODCI Pediatric Parent-Reported Version - Climb One Flight of Stairs | ||
PODCI122 | C135963 | PODCI1-Walk More Than a Mile | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk more than a mile? | PODCI Pediatric Parent-Reported Version - Walk More Than a Mile | ||
PODCI123 | C135964 | PODCI1-Walk Three Blocks | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk three blocks? | PODCI Pediatric Parent-Reported Version - Walk Three Blocks | ||
PODCI124 | C135965 | PODCI1-Walk One Block | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk one block? | PODCI Pediatric Parent-Reported Version - Walk One Block | ||
PODCI125 | C135966 | PODCI1-Get On and Off a Bus | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a bus? | PODCI Pediatric Parent-Reported Version - Get On and Off a Bus | ||
PODCI126 | C135967 | PODCI1-Need Help Walking and Climbing | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child need help from another person for walking and climbing? | PODCI Pediatric Parent-Reported Version - Need Help Walking and Climbing | ||
PODCI127 | C135968 | PODCI1-Use Assistive Devices for Walking | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? | PODCI Pediatric Parent-Reported Version - Use Assistive Devices for Walking | ||
PODCI128 | C135969 | PODCI1-Stand Washing Hands at a Sink | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Stand while washing his/her hands and face at a sink? | PODCI Pediatric Parent-Reported Version - Stand Washing Hands at a Sink | ||
PODCI129 | C135970 | PODCI1-Sit in Chair Without Holding On | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Sit in a regular chair without holding on? | PODCI Pediatric Parent-Reported Version - Sit in Chair Without Holding On | ||
PODCI130 | C135971 | PODCI1-Get On and Off a Toilet or Chair | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a toilet or chair? | PODCI Pediatric Parent-Reported Version - Get On and Off a Toilet or Chair | ||
PODCI131 | C135972 | PODCI1-Get In and Out of Bed | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get in and out of bed? | PODCI Pediatric Parent-Reported Version - Get In and Out of Bed | ||
PODCI132 | C135973 | PODCI1-Turn Door Knobs | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Turn door knobs? | PODCI Pediatric Parent-Reported Version - Turn Door Knobs | ||
PODCI133 | C135974 | PODCI1-Bend Over and Pick Up Something | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Bend over from a standing position and pick up something off the floor? | PODCI Pediatric Parent-Reported Version - Bend Over and Pick Up Something | ||
PODCI134 | C135975 | PODCI1-Need Help Sitting and Standing | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child need help from another person for sitting and standing? | PODCI Pediatric Parent-Reported Version - Need Help Sitting and Standing | ||
PODCI135 | C135976 | PODCI1-Use Assistive Devices for Sitting | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? | PODCI Pediatric Parent-Reported Version - Use Assistive Devices for Sitting | ||
PODCI136 | C135977 | PODCI1-Participate in Outdoor Activities | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in recreational outdoor activities with other children the same age (For example: bicycling, tricycling, skating, hiking, jogging)? | PODCI Pediatric Parent-Reported Version - Participate in Outdoor Activities | ||
PODCI137 | C135978 | PODCI1-Outdoor Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Pain | ||
PODCI138 | C135979 | PODCI1-Outdoor Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Health | ||
PODCI139 | C135980 | PODCI1-Outdoor Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Instructions | ||
PODCI140 | C135981 | PODCI1-Outdoor Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Fear | ||
PODCI141 | C135982 | PODCI1-Outdoor Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Dislike | ||
PODCI142 | C135983 | PODCI1-Outdoor Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Too young? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Too Young | ||
PODCI143 | C135984 | PODCI1-Outdoor Limited by: Season | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Activity not in season? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Season | ||
PODCI144 | C135985 | PODCI1-Participate in Pickup Games | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in pickup games or sports with other children the same age (For example: tag, dodge ball, basketball, soccer, catch, jump rope, touch football, hop scotch)? | PODCI Pediatric Parent-Reported Version - Participate in Pickup Games | ||
PODCI145 | C135986 | PODCI1-Games Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Games Limited by: Pain | ||
PODCI146 | C135987 | PODCI1-Games Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Games Limited by: Health | ||
PODCI147 | C135988 | PODCI1-Games Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Games Limited by: Instructions | ||
PODCI148 | C135989 | PODCI1-Games Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Games Limited by: Fear | ||
PODCI149 | C135990 | PODCI1-Games Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Dislike of pickup games or sports? | PODCI Pediatric Parent-Reported Version - Games Limited by: Dislike | ||
PODCI150 | C135991 | PODCI1-Games Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Too young? | PODCI Pediatric Parent-Reported Version - Games Limited by: Too Young | ||
PODCI151 | C135992 | PODCI1-Games Limited by: Season | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Activity not in season? | PODCI Pediatric Parent-Reported Version - Games Limited by: Season | ||
PODCI152 | C135993 | PODCI1-Participate in Competitive Sports | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in competitive level sports with other children the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? | PODCI Pediatric Parent-Reported Version - Participate in Competitive Sports | ||
PODCI153 | C135994 | PODCI1-Comp Sports Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Pain | ||
PODCI154 | C135995 | PODCI1-Comp Sports Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Health | ||
PODCI155 | C135996 | PODCI1-Comp Sports Limited by: Instruct | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Instruction | ||
PODCI156 | C135997 | PODCI1-Comp Sports Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Fear | ||
PODCI157 | C135998 | PODCI1-Comp Sports Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Dislike of pickup games or sports? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Dislike | ||
PODCI158 | C135999 | PODCI1-Comp Sports Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Too young? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Too Young | ||
PODCI159 | C136000 | PODCI1-Comp Sports Limited by: Season | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Activity not in season? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Season | ||
PODCI160 | C136001 | PODCI1-Get Together With Friends | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often in the last week did your child get together and do things with friends? | PODCI Pediatric Parent-Reported Version - Get Together With Friends | ||
PODCI161 | C136002 | PODCI1-Friends Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Pain | ||
PODCI162 | C136003 | PODCI1-Friends Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Health | ||
PODCI163 | C136004 | PODCI1-Friends Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Instructions | ||
PODCI164 | C136005 | PODCI1-Friends Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Fear | ||
PODCI165 | C136006 | PODCI1-Friends Limited by: Not Around | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Friends not around? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Not Around | ||
PODCI166 | C136007 | PODCI1-Participate in Gym/Recess | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often in the last week did your child participate in gym/recess? | PODCI Pediatric Parent-Reported Version - Participate in Gym or Recess | ||
PODCI167 | C136008 | PODCI1-Gym Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Pain | ||
PODCI168 | C136009 | PODCI1-Gym Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Health | ||
PODCI169 | C136010 | PODCI1-Gym Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Instructions | ||
PODCI170 | C136011 | PODCI1-Gym Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Fear | ||
PODCI171 | C136012 | PODCI1-Gym Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Dislike of gym/recess? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Dislike | ||
PODCI172 | C136013 | PODCI1-Gym Limited by: Not in Session | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: School not in session? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Not in Session | ||
PODCI173 | C136014 | PODCI1-Gym Limited by: Not Attend School | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Does not attend school? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Not Attend School | ||
PODCI174 | C136015 | PODCI1-Easy to Make Friends | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Is it easy or hard for your child to make friends with children his/her own age? | PODCI Pediatric Parent-Reported Version - Easy to Make Friends | ||
PODCI175 | C136016 | PODCI1-Pain During the Last Week | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How much pain has your child had during the last week? | PODCI Pediatric Parent-Reported Version - Pain During the Last Week | ||
PODCI176 | C136017 | PODCI1-Pain Interfere With Activities | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much did pain interfere with your child's normal activities (including at home, outside of the home, and at school)? | PODCI Pediatric Parent-Reported Version - Pain Interfere With Activities | ||
PODCI177 | C136018 | PODCI1-Have Pain Relief | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To have pain relief. | PODCI Pediatric Parent-Reported Version - Have Pain Relief | ||
PODCI178 | C136019 | PODCI1-Look Better | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To look better. | PODCI Pediatric Parent-Reported Version - Look Better | ||
PODCI179 | C136020 | PODCI1-Feel Better | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To feel better about himself/herself. | PODCI Pediatric Parent-Reported Version - Feel Better | ||
PODCI180 | C136021 | PODCI1-Sleep More Comfortably | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To sleep more comfortably. | PODCI Pediatric Parent-Reported Version - Sleep More Comfortably | ||
PODCI181 | C136022 | PODCI1-Able to Do Activities at Home | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do activities at home. | PODCI Pediatric Parent-Reported Version - Able to Do Activities at Home | ||
PODCI182 | C136023 | PODCI1-Able to Do More at School | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more at school. | PODCI Pediatric Parent-Reported Version - Able to Do More at School | ||
PODCI183 | C136024 | PODCI1-Able to Do More Play | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more play or recreational activities (biking, walking, doing things with friends). | PODCI Pediatric Parent-Reported Version - Able to Do More Play | ||
PODCI184 | C136025 | PODCI1-Able to Do More Sports | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more sports. | PODCI Pediatric Parent-Reported Version - Able to Do More Sports | ||
PODCI185 | C136026 | PODCI1-Free From Pain as Adult | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be free from pain or disability as an adult. | PODCI Pediatric Parent-Reported Version - Free From Pain as Adult | ||
PODCI186 | C136027 | PODCI1-Spend Rest of Life With Condition | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If your child had to spend the rest of his/her life with his/her bone and muscle condition as it is right now, how would you feel about it? | PODCI Pediatric Parent-Reported Version - Spend Rest of Life With Condition | ||
PODCI187 | C136028 | PODCI1-Up Extremity/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Upper extremity and physical function core scale. | PODCI Pediatric Parent-Reported Version - Upper Extremity and Physical Function Scale | ||
PODCI188 | C136029 | PODCI1-Transfer/Basic Mobility Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Transfer and basic mobility core scale. | PODCI Pediatric Parent-Reported Version - Transfer and Basic Mobility Scale | ||
PODCI189 | C136030 | PODCI1-Sports/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Sports and physical functioning core scale. | PODCI Pediatric Parent-Reported Version - Sports and Physical Function Scale | ||
PODCI190 | C136031 | PODCI1-Pain/Comfort Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Pain/comfort core scale. | PODCI Pediatric Parent-Reported Version - Pain or Comfort Scale | ||
PODCI191 | C136032 | PODCI1-Happiness Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Happiness core scale. | PODCI Pediatric Parent-Reported Version - Happiness Scale | ||
PODCI192 | C136033 | PODCI1-Global Functioning Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Global functioning scale. | PODCI Pediatric Parent-Reported Version - Global Functioning Scale | ||
Back to top | ||||||
CL.C135693.PODCI1TN | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire Test Name
(PODCI1TN) | text
Extensible: No | C135693 | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version Questionnaire Test Name | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported Version test name. | CDISC Questionnaire PODCI Pediatric Parent-Reported Version Test Name Terminology |
PODCI1-Ability Do Same Things Friends Do | C135954 | PODCI1-Ability Do Same Things Friends Do | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her ability to do the same things his/her friends do? | PODCI Pediatric Parent-Reported Version - Ability Do Same Things Friends Do | ||
PODCI1-Able to Do Activities at Home | C136022 | PODCI1-Able to Do Activities at Home | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do activities at home. | PODCI Pediatric Parent-Reported Version - Able to Do Activities at Home | ||
PODCI1-Able to Do More at School | C136023 | PODCI1-Able to Do More at School | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more at school. | PODCI Pediatric Parent-Reported Version - Able to Do More at School | ||
PODCI1-Able to Do More Play | C136024 | PODCI1-Able to Do More Play | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more play or recreational activities (biking, walking, doing things with friends). | PODCI Pediatric Parent-Reported Version - Able to Do More Play | ||
PODCI1-Able to Do More Sports | C136025 | PODCI1-Able to Do More Sports | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be able to do more sports. | PODCI Pediatric Parent-Reported Version - Able to Do More Sports | ||
PODCI1-Bend Over and Pick Up Something | C135974 | PODCI1-Bend Over and Pick Up Something | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Bend over from a standing position and pick up something off the floor? | PODCI Pediatric Parent-Reported Version - Bend Over and Pick Up Something | ||
PODCI1-Bicycle or Tricycle | C135960 | PODCI1-Bicycle or Tricycle | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Bicycle or tricycle? | PODCI Pediatric Parent-Reported Version - Bicycle or Tricycle | ||
PODCI1-Button Buttons | C135947 | PODCI1-Button Buttons | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Button buttons? | PODCI Pediatric Parent-Reported Version - Button Buttons | ||
PODCI1-Climb One Flight of Stairs | C135962 | PODCI1-Climb One Flight of Stairs | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Climb one flight of stairs? | PODCI Pediatric Parent-Reported Version - Climb One Flight of Stairs | ||
PODCI1-Climb Three Flights of Stairs | C135961 | PODCI1-Climb Three Flights of Stairs | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Climb three flights of stairs? | PODCI Pediatric Parent-Reported Version - Climb Three Flights of Stairs | ||
PODCI1-Comb His/Her Hair | C135946 | PODCI1-Comb His/Her Hair | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Comb his/her hair? | PODCI Pediatric Parent-Reported Version - Comb His or Her Hair | ||
PODCI1-Comp Sports Limited by: Dislike | C135998 | PODCI1-Comp Sports Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Dislike of pickup games or sports? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Dislike | ||
PODCI1-Comp Sports Limited by: Fear | C135997 | PODCI1-Comp Sports Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Fear | ||
PODCI1-Comp Sports Limited by: Health | C135995 | PODCI1-Comp Sports Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Health | ||
PODCI1-Comp Sports Limited by: Instruct | C135996 | PODCI1-Comp Sports Limited by: Instruct | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Instruction | ||
PODCI1-Comp Sports Limited by: Pain | C135994 | PODCI1-Comp Sports Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Pain | ||
PODCI1-Comp Sports Limited by: Season | C136000 | PODCI1-Comp Sports Limited by: Season | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Activity not in season? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Season | ||
PODCI1-Comp Sports Limited by: Too Young | C135999 | PODCI1-Comp Sports Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 52 above, was your child's activity limited by: Too young? | PODCI Pediatric Parent-Reported Version - Competitive Sports Limited by: Too Young | ||
PODCI1-Easy to Make Friends | C136015 | PODCI1-Easy to Make Friends | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Is it easy or hard for your child to make friends with children his/her own age? | PODCI Pediatric Parent-Reported Version - Easy to Make Friends | ||
PODCI1-Feel Better | C136020 | PODCI1-Feel Better | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To feel better about himself/herself. | PODCI Pediatric Parent-Reported Version - Feel Better | ||
PODCI1-Feel Sick and Tired | C135956 | PODCI1-Feel Sick and Tired | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Did your child feel sick and tired? | PODCI Pediatric Parent-Reported Version - Feel Sick and Tired | ||
PODCI1-Free From Pain as Adult | C136026 | PODCI1-Free From Pain as Adult | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To be free from pain or disability as an adult. | PODCI Pediatric Parent-Reported Version - Free From Pain as Adult | ||
PODCI1-Friends Limited by: Fear | C136005 | PODCI1-Friends Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Fear | ||
PODCI1-Friends Limited by: Health | C136003 | PODCI1-Friends Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Health | ||
PODCI1-Friends Limited by: Instructions | C136004 | PODCI1-Friends Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Instructions | ||
PODCI1-Friends Limited by: Not Around | C136006 | PODCI1-Friends Limited by: Not Around | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Friends not around? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Not Around | ||
PODCI1-Friends Limited by: Pain | C136002 | PODCI1-Friends Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 60 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Friends Limited by: Pain | ||
PODCI1-Full of Pep and Energy | C135957 | PODCI1-Full of Pep and Energy | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Were your child full of pep and energy? | PODCI Pediatric Parent-Reported Version - Full of Pep and Energy | ||
PODCI1-Games Limited by: Dislike | C135990 | PODCI1-Games Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Dislike of pickup games or sports? | PODCI Pediatric Parent-Reported Version - Games Limited by: Dislike | ||
PODCI1-Games Limited by: Fear | C135989 | PODCI1-Games Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Games Limited by: Fear | ||
PODCI1-Games Limited by: Health | C135987 | PODCI1-Games Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Games Limited by: Health | ||
PODCI1-Games Limited by: Instructions | C135988 | PODCI1-Games Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Games Limited by: Instructions | ||
PODCI1-Games Limited by: Pain | C135986 | PODCI1-Games Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Games Limited by: Pain | ||
PODCI1-Games Limited by: Season | C135992 | PODCI1-Games Limited by: Season | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Activity not in season? | PODCI Pediatric Parent-Reported Version - Games Limited by: Season | ||
PODCI1-Games Limited by: Too Young | C135991 | PODCI1-Games Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 44 above, was your child's activity limited by: Too young? | PODCI Pediatric Parent-Reported Version - Games Limited by: Too Young | ||
PODCI1-Get In and Out of Bed | C135972 | PODCI1-Get In and Out of Bed | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get in and out of bed? | PODCI Pediatric Parent-Reported Version - Get In and Out of Bed | ||
PODCI1-Get On and Off a Bus | C135966 | PODCI1-Get On and Off a Bus | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a bus? | PODCI Pediatric Parent-Reported Version - Get On and Off a Bus | ||
PODCI1-Get On and Off a Toilet or Chair | C135971 | PODCI1-Get On and Off a Toilet or Chair | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Get on and off a toilet or chair? | PODCI Pediatric Parent-Reported Version - Get On and Off a Toilet or Chair | ||
PODCI1-Get Together With Friends | C136001 | PODCI1-Get Together With Friends | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often in the last week did your child get together and do things with friends? | PODCI Pediatric Parent-Reported Version - Get Together With Friends | ||
PODCI1-Global Functioning Scale | C136033 | PODCI1-Global Functioning Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Global functioning scale. | PODCI Pediatric Parent-Reported Version - Global Functioning Scale | ||
PODCI1-Gym Limited by: Dislike | C136012 | PODCI1-Gym Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Dislike of gym/recess? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Dislike | ||
PODCI1-Gym Limited by: Fear | C136011 | PODCI1-Gym Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Fear | ||
PODCI1-Gym Limited by: Health | C136009 | PODCI1-Gym Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Health | ||
PODCI1-Gym Limited by: Instructions | C136010 | PODCI1-Gym Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Instructions | ||
PODCI1-Gym Limited by: Not Attend School | C136014 | PODCI1-Gym Limited by: Not Attend School | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Does not attend school? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Not Attend School | ||
PODCI1-Gym Limited by: Not in Session | C136013 | PODCI1-Gym Limited by: Not in Session | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: School not in session? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Not in Session | ||
PODCI1-Gym Limited by: Pain | C136008 | PODCI1-Gym Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "sometimes" or "never or rarely" to Question 66 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Gym Limited by: Pain | ||
PODCI1-Happiness Scale | C136032 | PODCI1-Happiness Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Happiness core scale. | PODCI Pediatric Parent-Reported Version - Happiness Scale | ||
PODCI1-Have Pain Relief | C136018 | PODCI1-Have Pain Relief | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To have pain relief. | PODCI Pediatric Parent-Reported Version - Have Pain Relief | ||
PODCI1-His/Her Body | C135952 | PODCI1-His/Her Body | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her body? | PODCI Pediatric Parent-Reported Version - His or Her Body | ||
PODCI1-His/Her Health in General | C135955 | PODCI1-His/Her Health in General | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: His/her health in general? | PODCI Pediatric Parent-Reported Version - His or Her Health in General | ||
PODCI1-How He/She Looks | C135951 | PODCI1-How He/She Looks | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: How he/she looks? | PODCI Pediatric Parent-Reported Version - How He or She Looks | ||
PODCI1-Lift Heavy Books | C135942 | PODCI1-Lift Heavy Books | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Lift heavy books? | PODCI Pediatric Parent-Reported Version - Lift Heavy Books | ||
PODCI1-Look Better | C136019 | PODCI1-Look Better | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To look better. | PODCI Pediatric Parent-Reported Version - Look Better | ||
PODCI1-Miss School Because of Health | C135950 | PODCI1-Miss School Because of Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - On average, over the last 12 months, how often did your child miss school (preschool, day care, camp, etc.) because of his/her health? | PODCI Pediatric Parent-Reported Version - Miss School Because of Health | ||
PODCI1-Need Help Sitting and Standing | C135975 | PODCI1-Need Help Sitting and Standing | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child need help from another person for sitting and standing? | PODCI Pediatric Parent-Reported Version - Need Help Sitting and Standing | ||
PODCI1-Need Help Walking and Climbing | C135967 | PODCI1-Need Help Walking and Climbing | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child need help from another person for walking and climbing? | PODCI Pediatric Parent-Reported Version - Need Help Walking and Climbing | ||
PODCI1-Open a Jar Been Opened Before | C135944 | PODCI1-Open a Jar Been Opened Before | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Open a jar that has been opened before? | PODCI Pediatric Parent-Reported Version - Open a Jar Been Opened Before | ||
PODCI1-Outdoor Limited by: Dislike | C135982 | PODCI1-Outdoor Limited by: Dislike | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Dislike of recreational outdoor activities? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Dislike | ||
PODCI1-Outdoor Limited by: Fear | C135981 | PODCI1-Outdoor Limited by: Fear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Fear the other kids won't like him/her? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Fear | ||
PODCI1-Outdoor Limited by: Health | C135979 | PODCI1-Outdoor Limited by: Health | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: General health? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Health | ||
PODCI1-Outdoor Limited by: Instructions | C135980 | PODCI1-Outdoor Limited by: Instructions | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Doctor or parent instructions? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Instructions | ||
PODCI1-Outdoor Limited by: Pain | C135978 | PODCI1-Outdoor Limited by: Pain | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Pain? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Pain | ||
PODCI1-Outdoor Limited by: Season | C135984 | PODCI1-Outdoor Limited by: Season | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Activity not in season? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Season | ||
PODCI1-Outdoor Limited by: Too Young | C135983 | PODCI1-Outdoor Limited by: Too Young | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If you answered "no" to Question 36 above, was your child's activity limited by: Too young? | PODCI Pediatric Parent-Reported Version - Outdoor Limited by: Too Young | ||
PODCI1-Pain During the Last Week | C136016 | PODCI1-Pain During the Last Week | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How much pain has your child had during the last week? | PODCI Pediatric Parent-Reported Version - Pain During the Last Week | ||
PODCI1-Pain Interfere With Activities | C136017 | PODCI1-Pain Interfere With Activities | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much did pain interfere with your child's normal activities (including at home, outside of the home, and at school)? | PODCI Pediatric Parent-Reported Version - Pain Interfere With Activities | ||
PODCI1-Pain/Comfort Scale | C136031 | PODCI1-Pain/Comfort Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Pain/comfort core scale. | PODCI Pediatric Parent-Reported Version - Pain or Comfort Scale | ||
PODCI1-Pain/Discom Inter With Activities | C135958 | PODCI1-Pain/Discom Inter With Activities | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how much of the time: Did pain or discomfort interfere with your child's activities? | PODCI Pediatric Parent-Reported Version - Pain or Discomfort Interfere With Activities | ||
PODCI1-Participate in Competitive Sports | C135993 | PODCI1-Participate in Competitive Sports | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in competitive level sports with other children the same age (For example: hockey, basketball, soccer, football, baseball, swimming, running [track or cross country], gymnastics, or dance)? | PODCI Pediatric Parent-Reported Version - Participate in Competitive Sports | ||
PODCI1-Participate in Gym/Recess | C136007 | PODCI1-Participate in Gym/Recess | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often in the last week did your child participate in gym/recess? | PODCI Pediatric Parent-Reported Version - Participate in Gym or Recess | ||
PODCI1-Participate in Outdoor Activities | C135977 | PODCI1-Participate in Outdoor Activities | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in recreational outdoor activities with other children the same age (For example: bicycling, tricycling, skating, hiking, jogging)? | PODCI Pediatric Parent-Reported Version - Participate in Outdoor Activities | ||
PODCI1-Participate in Pickup Games | C135985 | PODCI1-Participate in Pickup Games | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Can your child participate in pickup games or sports with other children the same age (For example: tag, dodge ball, basketball, soccer, catch, jump rope, touch football, hop scotch)? | PODCI Pediatric Parent-Reported Version - Participate in Pickup Games | ||
PODCI1-Pour a Half Gallon of Milk | C135943 | PODCI1-Pour a Half Gallon of Milk | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Pour a half gallon of milk? | PODCI Pediatric Parent-Reported Version - Pour a Half Gallon of Milk | ||
PODCI1-Put on His/Her Coat | C135948 | PODCI1-Put on His/Her Coat | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Put on his/her coat? | PODCI Pediatric Parent-Reported Version - Put on His or Her Coat | ||
PODCI1-Run Short Distances | C135959 | PODCI1-Run Short Distances | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Run short distances? | PODCI Pediatric Parent-Reported Version - Run Short Distances | ||
PODCI1-Sit in Chair Without Holding On | C135970 | PODCI1-Sit in Chair Without Holding On | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Sit in a regular chair without holding on? | PODCI Pediatric Parent-Reported Version - Sit in Chair Without Holding On | ||
PODCI1-Sleep More Comfortably | C136021 | PODCI1-Sleep More Comfortably | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - As a result of my child's treatment, I expect my child: To sleep more comfortably. | PODCI Pediatric Parent-Reported Version - Sleep More Comfortably | ||
PODCI1-Spend Rest of Life With Condition | C136027 | PODCI1-Spend Rest of Life With Condition | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - If your child had to spend the rest of his/her life with his/her bone and muscle condition as it is right now, how would you feel about it? | PODCI Pediatric Parent-Reported Version - Spend Rest of Life With Condition | ||
PODCI1-Sports/Phys Function Scale | C136030 | PODCI1-Sports/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Sports and physical functioning core scale. | PODCI Pediatric Parent-Reported Version - Sports and Physical Function Scale | ||
PODCI1-Stand Washing Hands at a Sink | C135969 | PODCI1-Stand Washing Hands at a Sink | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Stand while washing his/her hands and face at a sink? | PODCI Pediatric Parent-Reported Version - Stand Washing Hands at a Sink | ||
PODCI1-Transfer/Basic Mobility Scale | C136029 | PODCI1-Transfer/Basic Mobility Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Transfer and basic mobility core scale. | PODCI Pediatric Parent-Reported Version - Transfer and Basic Mobility Scale | ||
PODCI1-Turn Door Knobs | C135973 | PODCI1-Turn Door Knobs | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Turn door knobs? | PODCI Pediatric Parent-Reported Version - Turn Door Knobs | ||
PODCI1-Up Extremity/Phys Function Scale | C136028 | PODCI1-Up Extremity/Phys Function Scale | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - Upper extremity and physical function core scale. | PODCI Pediatric Parent-Reported Version - Upper Extremity and Physical Function Scale | ||
PODCI1-Use a Fork and Spoon | C135945 | PODCI1-Use a Fork and Spoon | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Use a fork and spoon? | PODCI Pediatric Parent-Reported Version - Use a Fork and Spoon | ||
PODCI1-Use Assistive Devices for Sitting | C135976 | PODCI1-Use Assistive Devices for Sitting | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for sitting and standing? | PODCI Pediatric Parent-Reported Version - Use Assistive Devices for Sitting | ||
PODCI1-Use Assistive Devices for Walking | C135968 | PODCI1-Use Assistive Devices for Walking | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - How often does your child use assistive devices (such as braces, crutches, or wheelchair) for walking and climbing? | PODCI Pediatric Parent-Reported Version - Use Assistive Devices for Walking | ||
PODCI1-Walk More Than a Mile | C135963 | PODCI1-Walk More Than a Mile | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk more than a mile? | PODCI Pediatric Parent-Reported Version - Walk More Than a Mile | ||
PODCI1-Walk One Block | C135965 | PODCI1-Walk One Block | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk one block? | PODCI Pediatric Parent-Reported Version - Walk One Block | ||
PODCI1-Walk Three Blocks | C135964 | PODCI1-Walk Three Blocks | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, has it been easy or hard for your child to: Walk three blocks? | PODCI Pediatric Parent-Reported Version - Walk Three Blocks | ||
PODCI1-What Clothes/Shoes He/She Wear | C135953 | PODCI1-What Clothes/Shoes He/She Wear | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, how happy has your child been with: What clothes or shoes he/she can wear? | PODCI Pediatric Parent-Reported Version - What Clothes or Shoes He or She Wear | ||
PODCI1-Write With a Pencil | C135949 | PODCI1-Write With a Pencil | Pediatric Outcomes Data Collection Instrument, Pediatric Parent-Reported - During the last week, was it easy or hard for your child to: Write with a pencil? | PODCI Pediatric Parent-Reported Version - Write With a Pencil | ||
Back to top | ||||||
CL.C138231.PQL15TC | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report Questionnaire Test Code
(PQL15TC) | text
Extensible: No | C138231 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child Test Code Terminology |
PQL1501 | C138515 | PQL15-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Breathe | ||
PQL1502 | C138516 | PQL15-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Sick Easily | ||
PQL1503 | C138517 | PQL15-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Sores and/or Rashes | ||
PQL1504 | C138518 | PQL15-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Legs Hurt | ||
PQL1505 | C138519 | PQL15-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Feel Tired | ||
PQL1506 | C138520 | PQL15-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Back Feels Stiff | ||
PQL1507 | C138521 | PQL15-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Wake Up Tired | ||
PQL1508 | C138522 | PQL15-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hands Are Weak | ||
PQL1509 | C138523 | PQL15-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Use Bathroom | ||
PQL1510 | C138524 | PQL15-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Gain or Lose Weight | ||
PQL1511 | C138525 | PQL15-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Use Hands | ||
PQL1512 | C138526 | PQL15-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Swallow Food | ||
PQL1513 | C138527 | PQL15-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Long Time to Bathe or Shower | ||
PQL1514 | C138528 | PQL15-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Hurt Accidentally | ||
PQL1515 | C138529 | PQL15-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Take Long Time to Eat | ||
PQL1516 | C138530 | PQL15-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Turn During Night | ||
PQL1517 | C138531 | PQL15-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Go Places With Equipment | ||
PQL1518 | C138532 | PQL15-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Tell Doctors and Nurses How Feel | ||
PQL1519 | C138533 | PQL15-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Ask Doctors and Nurses Questions | ||
PQL1520 | C138534 | PQL15-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Explain Illness to People | ||
PQL1521 | C138535 | PQL15-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard for Family to Plan Activities | ||
PQL1522 | C138536 | PQL15-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard for Family to Rest | ||
PQL1523 | C138537 | PQL15-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Money Problem in Our Family | ||
PQL1524 | C138538 | PQL15-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Family Has Lot of Problems | ||
PQL1525 | C138539 | PQL15-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138230.PQL15TN | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report Questionnaire Test Name
(PQL15TN) | text
Extensible: No | C138230 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child Test Name Terminology |
PQL15-Back Feels Stiff | C138520 | PQL15-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Back Feels Stiff | ||
PQL15-Do Not Have Equipment Need | C138539 | PQL15-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Do Not Have Equipment Need | ||
PQL15-Family Has Lot of Problems | C138538 | PQL15-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Family Has Lot of Problems | ||
PQL15-Feel Tired | C138519 | PQL15-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Feel Tired | ||
PQL15-Get Hurt Accidentally | C138528 | PQL15-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Hurt Accidentally | ||
PQL15-Get Sick Easily | C138516 | PQL15-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Sick Easily | ||
PQL15-Get Sores and/or Rashes | C138517 | PQL15-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Get Sores and/or Rashes | ||
PQL15-Hands Are Weak | C138522 | PQL15-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hands Are Weak | ||
PQL15-Hard Ask Doctors/Nurses Questions | C138533 | PQL15-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Ask Doctors and Nurses Questions | ||
PQL15-Hard Explain Illness to People | C138534 | PQL15-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Explain Illness to People | ||
PQL15-Hard for Family to Plan Activities | C138535 | PQL15-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard for Family to Plan Activities | ||
PQL15-Hard for Family to Rest | C138536 | PQL15-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard for Family to Rest | ||
PQL15-Hard Tell Doctors/Nurses How Feel | C138532 | PQL15-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard Tell Doctors and Nurses How Feel | ||
PQL15-Hard to Breathe | C138515 | PQL15-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Breathe | ||
PQL15-Hard to Gain/Lose Weight | C138524 | PQL15-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Gain or Lose Weight | ||
PQL15-Hard to Go Places With Equipment | C138531 | PQL15-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Go Places With Equipment | ||
PQL15-Hard to Swallow Food | C138526 | PQL15-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Swallow Food | ||
PQL15-Hard to Turn During Night | C138530 | PQL15-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Turn During Night | ||
PQL15-Hard to Use Bathroom | C138523 | PQL15-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Use Bathroom | ||
PQL15-Hard to Use Hands | C138525 | PQL15-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Hard to Use Hands | ||
PQL15-Legs Hurt | C138518 | PQL15-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Legs Hurt | ||
PQL15-Long Time to Bathe/Shower | C138527 | PQL15-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Long Time to Bathe or Shower | ||
PQL15-Money Problem in Our Family | C138537 | PQL15-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Money Problem in Our Family | ||
PQL15-Take Long Time to Eat | C138529 | PQL15-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Take Long Time to Eat | ||
PQL15-Wake Up Tired | C138521 | PQL15-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Child - Wake Up Tired | ||
Back to top | ||||||
CL.C138227.PQL14TC | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Questionnaire Test Code
(PQL14TC) | text
Extensible: No | C138227 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child test code. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Child Report Test Code Terminology |
PQL1401 | C138465 | PQL14-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Breathe | ||
PQL1402 | C138466 | PQL14-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Sick Easily | ||
PQL1403 | C138467 | PQL14-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Sores and/or Rashes | ||
PQL1404 | C138468 | PQL14-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Legs Hurt | ||
PQL1405 | C138469 | PQL14-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Feel Tired | ||
PQL1406 | C138470 | PQL14-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Back Feels Stiff | ||
PQL1407 | C138471 | PQL14-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Wake Up Tired | ||
PQL1408 | C138472 | PQL14-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hands Are Weak | ||
PQL1409 | C138473 | PQL14-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Use Bathroom | ||
PQL1410 | C138474 | PQL14-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Gain or Lose Weight | ||
PQL1411 | C138475 | PQL14-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Use Hands | ||
PQL1412 | C138476 | PQL14-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Swallow Food | ||
PQL1413 | C138477 | PQL14-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Long Time to Bathe or Shower | ||
PQL1414 | C138478 | PQL14-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Hurt Accidentally | ||
PQL1415 | C138479 | PQL14-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Take Long Time to Eat | ||
PQL1416 | C138480 | PQL14-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Turn During Night | ||
PQL1417 | C138481 | PQL14-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Go Places With Equipment | ||
PQL1418 | C138482 | PQL14-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Tell Doctors and Nurses How Feel | ||
PQL1419 | C138483 | PQL14-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Ask Doctors and Nurses Questions | ||
PQL1420 | C138484 | PQL14-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Explain Illness to People | ||
PQL1421 | C138485 | PQL14-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard for Family to Plan Activities | ||
PQL1422 | C138486 | PQL14-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard for Family to Rest | ||
PQL1423 | C138487 | PQL14-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Money Problem in Our Family | ||
PQL1424 | C138488 | PQL14-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Family Has Lot of Problems | ||
PQL1425 | C138489 | PQL14-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138226.PQL14TN | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Questionnaire Test Name
(PQL14TN) | text
Extensible: No | C138226 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child test name. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Child Report Test Name Terminology |
PQL14-Back Feels Stiff | C138470 | PQL14-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Back Feels Stiff | ||
PQL14-Do Not Have Equipment Need | C138489 | PQL14-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Do Not Have Equipment Need | ||
PQL14-Family Has Lot of Problems | C138488 | PQL14-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Family Has Lot of Problems | ||
PQL14-Feel Tired | C138469 | PQL14-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Feel Tired | ||
PQL14-Get Hurt Accidentally | C138478 | PQL14-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Hurt Accidentally | ||
PQL14-Get Sick Easily | C138466 | PQL14-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Sick Easily | ||
PQL14-Get Sores and/or Rashes | C138467 | PQL14-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Get Sores and/or Rashes | ||
PQL14-Hands Are Weak | C138472 | PQL14-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hands Are Weak | ||
PQL14-Hard Ask Doctors/Nurses Questions | C138483 | PQL14-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Ask Doctors and Nurses Questions | ||
PQL14-Hard Explain Illness to People | C138484 | PQL14-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Explain Illness to People | ||
PQL14-Hard for Family to Plan Activities | C138485 | PQL14-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard for Family to Plan Activities | ||
PQL14-Hard for Family to Rest | C138486 | PQL14-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard for Family to Rest | ||
PQL14-Hard Tell Doctors/Nurses How Feel | C138482 | PQL14-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard Tell Doctors and Nurses How Feel | ||
PQL14-Hard to Breathe | C138465 | PQL14-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Breathe | ||
PQL14-Hard to Gain/Lose Weight | C138474 | PQL14-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Gain or Lose Weight | ||
PQL14-Hard to Go Places With Equipment | C138481 | PQL14-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Go Places With Equipment | ||
PQL14-Hard to Swallow Food | C138476 | PQL14-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Swallow Food | ||
PQL14-Hard to Turn During Night | C138480 | PQL14-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Turn During Night | ||
PQL14-Hard to Use Bathroom | C138473 | PQL14-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Use Bathroom | ||
PQL14-Hard to Use Hands | C138475 | PQL14-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Hard to Use Hands | ||
PQL14-Legs Hurt | C138468 | PQL14-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Legs Hurt | ||
PQL14-Long Time to Bathe/Shower | C138477 | PQL14-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Long Time to Bathe or Shower | ||
PQL14-Money Problem in Our Family | C138487 | PQL14-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Money Problem in Our Family | ||
PQL14-Take Long Time to Eat | C138479 | PQL14-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Take Long Time to Eat | ||
PQL14-Wake Up Tired | C138471 | PQL14-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Child - In the past 7 days, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Child Report - Wake Up Tired | ||
Back to top | ||||||
CL.C138233.PQL13TC | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report Questionnaire Test Code
(PQL13TC) | text
Extensible: No | C138233 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen Test Code Terminology |
PQL1301 | C138540 | PQL13-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Breathe | ||
PQL1302 | C138541 | PQL13-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Sick Easily | ||
PQL1303 | C138542 | PQL13-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Sores and/or Rashes | ||
PQL1304 | C138543 | PQL13-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Legs Hurt | ||
PQL1305 | C138544 | PQL13-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Feel Tired | ||
PQL1306 | C138545 | PQL13-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Back Feels Stiff | ||
PQL1307 | C138546 | PQL13-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Wake Up Tired | ||
PQL1308 | C138547 | PQL13-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hands Are Weak | ||
PQL1309 | C138548 | PQL13-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Use Bathroom | ||
PQL1310 | C138549 | PQL13-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Gain or Lose Weight | ||
PQL1311 | C138550 | PQL13-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Use Hands | ||
PQL1312 | C138551 | PQL13-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Swallow Food | ||
PQL1313 | C138552 | PQL13-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Long Time to Bathe or Shower | ||
PQL1314 | C138553 | PQL13-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Hurt Accidentally | ||
PQL1315 | C138554 | PQL13-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Take Long Time to Eat | ||
PQL1316 | C138555 | PQL13-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Turn During Night | ||
PQL1317 | C138556 | PQL13-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Go Places With Equipment | ||
PQL1318 | C138557 | PQL13-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Tell Doctors and Nurses How Feel | ||
PQL1319 | C138558 | PQL13-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Ask Doctors and Nurses Questions | ||
PQL1320 | C138559 | PQL13-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Explain Illness to People | ||
PQL1321 | C138560 | PQL13-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard for Family to Plan Activities | ||
PQL1322 | C138561 | PQL13-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard for Family to Rest | ||
PQL1323 | C138562 | PQL13-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Money Problem in Our Family | ||
PQL1324 | C138563 | PQL13-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Family Has Lot of Problems | ||
PQL1325 | C138564 | PQL13-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138232.PQL13TN | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report Questionnaire Test Name
(PQL13TN) | text
Extensible: No | C138232 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen Test Name Terminology |
PQL13-Back Feels Stiff | C138545 | PQL13-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Back Feels Stiff | ||
PQL13-Do Not Have Equipment Need | C138564 | PQL13-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Do Not Have Equipment Need | ||
PQL13-Family Has Lot of Problems | C138563 | PQL13-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Family Has Lot of Problems | ||
PQL13-Feel Tired | C138544 | PQL13-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Feel Tired | ||
PQL13-Get Hurt Accidentally | C138553 | PQL13-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Hurt Accidentally | ||
PQL13-Get Sick Easily | C138541 | PQL13-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Sick Easily | ||
PQL13-Get Sores and/or Rashes | C138542 | PQL13-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Get Sores and/or Rashes | ||
PQL13-Hands Are Weak | C138547 | PQL13-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hands Are Weak | ||
PQL13-Hard Ask Doctors/Nurses Questions | C138558 | PQL13-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Ask Doctors and Nurses Questions | ||
PQL13-Hard Explain Illness to People | C138559 | PQL13-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Explain Illness to People | ||
PQL13-Hard for Family to Plan Activities | C138560 | PQL13-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard for Family to Plan Activities | ||
PQL13-Hard for Family to Rest | C138561 | PQL13-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard for Family to Rest | ||
PQL13-Hard Tell Doctors/Nurses How Feel | C138557 | PQL13-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard Tell Doctors and Nurses How Feel | ||
PQL13-Hard to Breathe | C138540 | PQL13-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Breathe | ||
PQL13-Hard to Gain/Lose Weight | C138549 | PQL13-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Gain or Lose Weight | ||
PQL13-Hard to Go Places With Equipment | C138556 | PQL13-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Go Places With Equipment | ||
PQL13-Hard to Swallow Food | C138551 | PQL13-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Swallow Food | ||
PQL13-Hard to Turn During Night | C138555 | PQL13-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Turn During Night | ||
PQL13-Hard to Use Bathroom | C138548 | PQL13-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Use Bathroom | ||
PQL13-Hard to Use Hands | C138550 | PQL13-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Hard to Use Hands | ||
PQL13-Legs Hurt | C138543 | PQL13-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Legs Hurt | ||
PQL13-Long Time to Bathe/Shower | C138552 | PQL13-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Long Time to Bathe or Shower | ||
PQL13-Money Problem in Our Family | C138562 | PQL13-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Money Problem in Our Family | ||
PQL13-Take Long Time to Eat | C138554 | PQL13-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Take Long Time to Eat | ||
PQL13-Wake Up Tired | C138546 | PQL13-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Parent Report - In the past 7 days, how much of a problem has this been for your teen: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Teen - Wake Up Tired | ||
Back to top | ||||||
CL.C138239.PQL12TC | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Questionnaire Test Code
(PQL12TC) | text
Extensible: No | C138239 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen test code. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Teen Report Test Code Terminology |
PQL1201 | C138615 | PQL12-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Breathe | ||
PQL1202 | C138616 | PQL12-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Sick Easily | ||
PQL1203 | C138617 | PQL12-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Sores and/or Rashes | ||
PQL1204 | C138618 | PQL12-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Legs Hurt | ||
PQL1205 | C138619 | PQL12-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Feel Tired | ||
PQL1206 | C138620 | PQL12-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Back Feels Stiff | ||
PQL1207 | C138621 | PQL12-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Wake Up Tired | ||
PQL1208 | C138622 | PQL12-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hands Are Weak | ||
PQL1209 | C138623 | PQL12-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Use Bathroom | ||
PQL1210 | C138624 | PQL12-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Gain or Lose Weight | ||
PQL1211 | C138625 | PQL12-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Use Hands | ||
PQL1212 | C138626 | PQL12-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Swallow Food | ||
PQL1213 | C138627 | PQL12-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Long Time to Bathe or Shower | ||
PQL1214 | C138628 | PQL12-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Hurt Accidentally | ||
PQL1215 | C138629 | PQL12-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Take Long Time to Eat | ||
PQL1216 | C138630 | PQL12-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Turn During Night | ||
PQL1217 | C138631 | PQL12-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Go Places With Equipment | ||
PQL1218 | C138632 | PQL12-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Tell Doctors and Nurses How Feel | ||
PQL1219 | C138633 | PQL12-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Ask Doctors and Nurses Questions | ||
PQL1220 | C138634 | PQL12-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Explain Illness to People | ||
PQL1221 | C138635 | PQL12-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard for Family to Plan Activities | ||
PQL1222 | C138636 | PQL12-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard for Family to Rest | ||
PQL1223 | C138637 | PQL12-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Money Problem in Our Family | ||
PQL1224 | C138638 | PQL12-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Family Has Lot of Problems | ||
PQL1225 | C138639 | PQL12-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138238.PQL12TN | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Questionnaire Test Name
(PQL12TN) | text
Extensible: No | C138238 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen test name. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Teen Report Test Name Terminology |
PQL12-Back Feels Stiff | C138620 | PQL12-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Back Feels Stiff | ||
PQL12-Do Not Have Equipment Need | C138639 | PQL12-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Do Not Have Equipment Need | ||
PQL12-Family Has Lot of Problems | C138638 | PQL12-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Family Has Lot of Problems | ||
PQL12-Feel Tired | C138619 | PQL12-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Feel Tired | ||
PQL12-Get Hurt Accidentally | C138628 | PQL12-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Hurt Accidentally | ||
PQL12-Get Sick Easily | C138616 | PQL12-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Sick Easily | ||
PQL12-Get Sores and/or Rashes | C138617 | PQL12-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Get Sores and/or Rashes | ||
PQL12-Hands Are Weak | C138622 | PQL12-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hands Are Weak | ||
PQL12-Hard Ask Doctors/Nurses Questions | C138633 | PQL12-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Ask Doctors and Nurses Questions | ||
PQL12-Hard Explain Illness to People | C138634 | PQL12-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Explain Illness to People | ||
PQL12-Hard for Family to Plan Activities | C138635 | PQL12-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard for Family to Plan Activities | ||
PQL12-Hard for Family to Rest | C138636 | PQL12-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard for Family to Rest | ||
PQL12-Hard Tell Doctors/Nurses How Feel | C138632 | PQL12-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard Tell Doctors and Nurses How Feel | ||
PQL12-Hard to Breathe | C138615 | PQL12-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Breathe | ||
PQL12-Hard to Gain/Lose Weight | C138624 | PQL12-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Gain or Lose Weight | ||
PQL12-Hard to Go Places With Equipment | C138631 | PQL12-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Go Places With Equipment | ||
PQL12-Hard to Swallow Food | C138626 | PQL12-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Swallow Food | ||
PQL12-Hard to Turn During Night | C138630 | PQL12-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Turn During Night | ||
PQL12-Hard to Use Bathroom | C138623 | PQL12-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Use Bathroom | ||
PQL12-Hard to Use Hands | C138625 | PQL12-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Hard to Use Hands | ||
PQL12-Legs Hurt | C138618 | PQL12-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Legs Hurt | ||
PQL12-Long Time to Bathe/Shower | C138627 | PQL12-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Long Time to Bathe or Shower | ||
PQL12-Money Problem in Our Family | C138637 | PQL12-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Money Problem in Our Family | ||
PQL12-Take Long Time to Eat | C138629 | PQL12-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Take Long Time to Eat | ||
PQL12-Wake Up Tired | C138621 | PQL12-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Teen - In the past 7 days, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Teen Report - Wake Up Tired | ||
Back to top | ||||||
CL.C138229.PQL18TC | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report Questionnaire Test Code
(PQL18TC) | text
Extensible: No | C138229 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler Test Code Terminology |
PQL1801 | C138490 | PQL18-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Breathe | ||
PQL1802 | C138491 | PQL18-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Sick Easily | ||
PQL1803 | C138492 | PQL18-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Sores and/or Rashes | ||
PQL1804 | C138493 | PQL18-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Legs Hurt | ||
PQL1805 | C138494 | PQL18-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Feel Tired | ||
PQL1806 | C138495 | PQL18-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Back Feels Stiff | ||
PQL1807 | C138496 | PQL18-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Wake Up Tired | ||
PQL1808 | C138497 | PQL18-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hands Are Weak | ||
PQL1809 | C138498 | PQL18-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Use Bathroom | ||
PQL1810 | C138499 | PQL18-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Gain or Lose Weight | ||
PQL1811 | C138500 | PQL18-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Use Hands | ||
PQL1812 | C138501 | PQL18-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Swallow Food | ||
PQL1813 | C138502 | PQL18-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Long Time to Bathe or Shower | ||
PQL1814 | C138503 | PQL18-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Hurt Accidentally | ||
PQL1815 | C138504 | PQL18-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Take Long Time to Eat | ||
PQL1816 | C138505 | PQL18-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Turn During Night | ||
PQL1817 | C138506 | PQL18-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Go Places With Equipment | ||
PQL1818 | C138507 | PQL18-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Tell Doctors and Nurses How Feel | ||
PQL1819 | C138508 | PQL18-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Ask Doctors and Nurses Questions | ||
PQL1820 | C138509 | PQL18-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Explain Illness to People | ||
PQL1821 | C138510 | PQL18-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard for Family to Plan Activities | ||
PQL1822 | C138511 | PQL18-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard for Family to Rest | ||
PQL1823 | C138512 | PQL18-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Money Problem in Our Family | ||
PQL1824 | C138513 | PQL18-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Family Has Lot of Problems | ||
PQL1825 | C138514 | PQL18-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138228.PQL18TN | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report Questionnaire Test Name
(PQL18TN) | text
Extensible: No | C138228 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler Test Name Terminology |
PQL18-Back Feels Stiff | C138495 | PQL18-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Back Feels Stiff | ||
PQL18-Do Not Have Equipment Need | C138514 | PQL18-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Do Not Have Equipment Need | ||
PQL18-Family Has Lot of Problems | C138513 | PQL18-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Family Has Lot of Problems | ||
PQL18-Feel Tired | C138494 | PQL18-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Feel Tired | ||
PQL18-Get Hurt Accidentally | C138503 | PQL18-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Hurt Accidentally | ||
PQL18-Get Sick Easily | C138491 | PQL18-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Sick Easily | ||
PQL18-Get Sores and/or Rashes | C138492 | PQL18-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Get Sores and/or Rashes | ||
PQL18-Hands Are Weak | C138497 | PQL18-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hands Are Weak | ||
PQL18-Hard Ask Doctors/Nurses Questions | C138508 | PQL18-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Ask Doctors and Nurses Questions | ||
PQL18-Hard Explain Illness to People | C138509 | PQL18-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Explain Illness to People | ||
PQL18-Hard for Family to Plan Activities | C138510 | PQL18-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard for Family to Plan Activities | ||
PQL18-Hard for Family to Rest | C138511 | PQL18-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard for Family to Rest | ||
PQL18-Hard Tell Doctors/Nurses How Feel | C138507 | PQL18-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard Tell Doctors and Nurses How Feel | ||
PQL18-Hard to Breathe | C138490 | PQL18-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Breathe | ||
PQL18-Hard to Gain/Lose Weight | C138499 | PQL18-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Gain or Lose Weight | ||
PQL18-Hard to Go Places With Equipment | C138506 | PQL18-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Go Places With Equipment | ||
PQL18-Hard to Swallow Food | C138501 | PQL18-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Swallow Food | ||
PQL18-Hard to Turn During Night | C138505 | PQL18-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Turn During Night | ||
PQL18-Hard to Use Bathroom | C138498 | PQL18-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Use Bathroom | ||
PQL18-Hard to Use Hands | C138500 | PQL18-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Hard to Use Hands | ||
PQL18-Legs Hurt | C138493 | PQL18-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Legs Hurt | ||
PQL18-Long Time to Bathe/Shower | C138502 | PQL18-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Long Time to Bathe or Shower | ||
PQL18-Money Problem in Our Family | C138512 | PQL18-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Money Problem in Our Family | ||
PQL18-Take Long Time to Eat | C138504 | PQL18-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Take Long Time to Eat | ||
PQL18-Wake Up Tired | C138496 | PQL18-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Toddler Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent of Toddler - Wake Up Tired | ||
Back to top | ||||||
CL.C138235.PQL11TC | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report Questionnaire Test Code
(PQL11TC) | text
Extensible: No | C138235 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults Test Code Terminology |
PQL1101 | C138565 | PQL11-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Breathe | ||
PQL1102 | C138566 | PQL11-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Sick Easily | ||
PQL1103 | C138567 | PQL11-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Sores and/or Rashes | ||
PQL1104 | C138568 | PQL11-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Legs Hurt | ||
PQL1105 | C138569 | PQL11-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Feel Tired | ||
PQL1106 | C138570 | PQL11-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Back Feels Stiff | ||
PQL1107 | C138571 | PQL11-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Wake Up Tired | ||
PQL1108 | C138572 | PQL11-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hands Are Weak | ||
PQL1109 | C138573 | PQL11-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Use Bathroom | ||
PQL1110 | C138574 | PQL11-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Gain or Lose Weight | ||
PQL1111 | C138575 | PQL11-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Use Hands | ||
PQL1112 | C138576 | PQL11-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Swallow Food | ||
PQL1113 | C138577 | PQL11-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Long Time to Bathe or Shower | ||
PQL1114 | C138578 | PQL11-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Hurt Accidentally | ||
PQL1115 | C138579 | PQL11-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Take Long Time to Eat | ||
PQL1116 | C138580 | PQL11-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Turn During Night | ||
PQL1117 | C138581 | PQL11-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Go Places With Equipment | ||
PQL1118 | C138582 | PQL11-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Tell Doctors and Nurses How Feel | ||
PQL1119 | C138583 | PQL11-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Ask Doctors and Nurses Questions | ||
PQL1120 | C138584 | PQL11-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Explain Illness to People | ||
PQL1121 | C138585 | PQL11-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard for Family to Plan Activities | ||
PQL1122 | C138586 | PQL11-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard for Family to Rest | ||
PQL1123 | C138587 | PQL11-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Money Problem in Our Family | ||
PQL1124 | C138588 | PQL11-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Family Has Lot of Problems | ||
PQL1125 | C138589 | PQL11-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138234.PQL11TN | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report Questionnaire Test Name
(PQL11TN) | text
Extensible: No | C138234 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults Test Name Terminology |
PQL11-Back Feels Stiff | C138570 | PQL11-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Back Feels Stiff | ||
PQL11-Do Not Have Equipment Need | C138589 | PQL11-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Do Not Have Equipment Need | ||
PQL11-Family Has Lot of Problems | C138588 | PQL11-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Family Has Lot of Problems | ||
PQL11-Feel Tired | C138569 | PQL11-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Feel Tired | ||
PQL11-Get Hurt Accidentally | C138578 | PQL11-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Hurt Accidentally | ||
PQL11-Get Sick Easily | C138566 | PQL11-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Sick Easily | ||
PQL11-Get Sores and/or Rashes | C138567 | PQL11-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Get Sores and/or Rashes | ||
PQL11-Hands Are Weak | C138572 | PQL11-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hands Are Weak | ||
PQL11-Hard Ask Doctors/Nurses Questions | C138583 | PQL11-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Ask Doctors and Nurses Questions | ||
PQL11-Hard Explain Illness to People | C138584 | PQL11-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Explain Illness to People | ||
PQL11-Hard for Family to Plan Activities | C138585 | PQL11-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard for Family to Plan Activities | ||
PQL11-Hard for Family to Rest | C138586 | PQL11-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard for Family to Rest | ||
PQL11-Hard Tell Doctors/Nurses How Feel | C138582 | PQL11-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard Tell Doctors and Nurses How Feel | ||
PQL11-Hard to Breathe | C138565 | PQL11-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Breathe | ||
PQL11-Hard to Gain/Lose Weight | C138574 | PQL11-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Gain or Lose Weight | ||
PQL11-Hard to Go Places With Equipment | C138581 | PQL11-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Go Places With Equipment | ||
PQL11-Hard to Swallow Food | C138576 | PQL11-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Swallow Food | ||
PQL11-Hard to Turn During Night | C138580 | PQL11-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Turn During Night | ||
PQL11-Hard to Use Bathroom | C138573 | PQL11-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Use Bathroom | ||
PQL11-Hard to Use Hands | C138575 | PQL11-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Hard to Use Hands | ||
PQL11-Legs Hurt | C138568 | PQL11-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Legs Hurt | ||
PQL11-Long Time to Bathe/Shower | C138577 | PQL11-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Long Time to Bathe or Shower | ||
PQL11-Money Problem in Our Family | C138587 | PQL11-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Money Problem in Our Family | ||
PQL11-Take Long Time to Eat | C138579 | PQL11-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Take Long Time to Eat | ||
PQL11-Wake Up Tired | C138571 | PQL11-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Adults - Wake Up Tired | ||
Back to top | ||||||
CL.C138241.PQL10TC | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Questionnaire Test Code
(PQL10TC) | text
Extensible: No | C138241 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult test code. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report Test Code Terminology |
PQL1001 | C138640 | PQL10-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Breathe | ||
PQL1002 | C138641 | PQL10-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Sick Easily | ||
PQL1003 | C138642 | PQL10-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Sores and/or Rashes | ||
PQL1004 | C138643 | PQL10-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Legs Hurt | ||
PQL1005 | C138644 | PQL10-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Feel Tired | ||
PQL1006 | C138645 | PQL10-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Back Feels Stiff | ||
PQL1007 | C138646 | PQL10-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Wake Up Tired | ||
PQL1008 | C138647 | PQL10-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hands Are Weak | ||
PQL1009 | C138648 | PQL10-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Use Bathroom | ||
PQL1010 | C138649 | PQL10-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Gain or Lose Weight | ||
PQL1011 | C138650 | PQL10-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Use Hands | ||
PQL1012 | C138651 | PQL10-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Swallow Food | ||
PQL1013 | C138652 | PQL10-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Long Time to Bathe or Shower | ||
PQL1014 | C138653 | PQL10-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Hurt Accidentally | ||
PQL1015 | C138654 | PQL10-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Take Long Time to Eat | ||
PQL1016 | C138655 | PQL10-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Turn During Night | ||
PQL1017 | C138656 | PQL10-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Go Places With Equipment | ||
PQL1018 | C138657 | PQL10-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Tell Doctors and Nurses How Feel | ||
PQL1019 | C138658 | PQL10-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Ask Doctors and Nurses Questions | ||
PQL1020 | C138659 | PQL10-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Explain Illness to People | ||
PQL1021 | C138660 | PQL10-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard for Family to Plan Activities | ||
PQL1022 | C138661 | PQL10-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard for Family to Rest | ||
PQL1023 | C138662 | PQL10-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Money Problem in Our Family | ||
PQL1024 | C138663 | PQL10-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Family Has Lot of Problems | ||
PQL1025 | C138664 | PQL10-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138240.PQL10TN | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Questionnaire Test Name
(PQL10TN) | text
Extensible: No | C138240 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult test name. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report Test Name Terminology |
PQL10-Back Feels Stiff | C138645 | PQL10-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Back Feels Stiff | ||
PQL10-Do Not Have Equipment Need | C138664 | PQL10-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Do Not Have Equipment Need | ||
PQL10-Family Has Lot of Problems | C138663 | PQL10-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Family Has Lot of Problems | ||
PQL10-Feel Tired | C138644 | PQL10-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Feel Tired | ||
PQL10-Get Hurt Accidentally | C138653 | PQL10-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Hurt Accidentally | ||
PQL10-Get Sick Easily | C138641 | PQL10-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Sick Easily | ||
PQL10-Get Sores and/or Rashes | C138642 | PQL10-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Get Sores and/or Rashes | ||
PQL10-Hands Are Weak | C138647 | PQL10-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hands Are Weak | ||
PQL10-Hard Ask Doctors/Nurses Questions | C138658 | PQL10-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Ask Doctors and Nurses Questions | ||
PQL10-Hard Explain Illness to People | C138659 | PQL10-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Explain Illness to People | ||
PQL10-Hard for Family to Plan Activities | C138660 | PQL10-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard for Family to Plan Activities | ||
PQL10-Hard for Family to Rest | C138661 | PQL10-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard for Family to Rest | ||
PQL10-Hard Tell Doctors/Nurses How Feel | C138657 | PQL10-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard Tell Doctors and Nurses How Feel | ||
PQL10-Hard to Breathe | C138640 | PQL10-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Breathe | ||
PQL10-Hard to Gain/Lose Weight | C138649 | PQL10-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Gain or Lose Weight | ||
PQL10-Hard to Go Places With Equipment | C138656 | PQL10-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Go Places With Equipment | ||
PQL10-Hard to Swallow Food | C138651 | PQL10-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Swallow Food | ||
PQL10-Hard to Turn During Night | C138655 | PQL10-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Turn During Night | ||
PQL10-Hard to Use Bathroom | C138648 | PQL10-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Use Bathroom | ||
PQL10-Hard to Use Hands | C138650 | PQL10-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Hard to Use Hands | ||
PQL10-Legs Hurt | C138643 | PQL10-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Legs Hurt | ||
PQL10-Long Time to Bathe/Shower | C138652 | PQL10-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Long Time to Bathe or Shower | ||
PQL10-Money Problem in Our Family | C138662 | PQL10-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Money Problem in Our Family | ||
PQL10-Take Long Time to Eat | C138654 | PQL10-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Take Long Time to Eat | ||
PQL10-Wake Up Tired | C138646 | PQL10-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Adult - In the past 7 days, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Young Adult Report - Wake Up Tired | ||
Back to top | ||||||
CL.C138237.PQL17TC | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report Questionnaire Test Code
(PQL17TC) | text
Extensible: No | C138237 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child Test Code Terminology |
PQL1701 | C138590 | PQL17-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Breathe | ||
PQL1702 | C138591 | PQL17-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Sick Easily | ||
PQL1703 | C138592 | PQL17-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Sores and/or Rashes | ||
PQL1704 | C138593 | PQL17-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Legs Hurt | ||
PQL1705 | C138594 | PQL17-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Feel Tired | ||
PQL1706 | C138595 | PQL17-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Back Feels Stiff | ||
PQL1707 | C138596 | PQL17-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Wake Up Tired | ||
PQL1708 | C138597 | PQL17-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hands Are Weak | ||
PQL1709 | C138598 | PQL17-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Use Bathroom | ||
PQL1710 | C138599 | PQL17-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Gain or Lose Weight | ||
PQL1711 | C138600 | PQL17-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Use Hands | ||
PQL1712 | C138601 | PQL17-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Swallow Food | ||
PQL1713 | C138602 | PQL17-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Long Time to Bathe or Shower | ||
PQL1714 | C138603 | PQL17-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Hurt Accidentally | ||
PQL1715 | C138604 | PQL17-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Take Long Time to Eat | ||
PQL1716 | C138605 | PQL17-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Turn During Night | ||
PQL1717 | C138606 | PQL17-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Go Places With Equipment | ||
PQL1718 | C138607 | PQL17-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Tell Doctors and Nurses How Feel | ||
PQL1719 | C138608 | PQL17-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Ask Doctors and Nurses Questions | ||
PQL1720 | C138609 | PQL17-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Explain Illness to People | ||
PQL1721 | C138610 | PQL17-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard for Family to Plan Activities | ||
PQL1722 | C138611 | PQL17-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard for Family to Rest | ||
PQL1723 | C138612 | PQL17-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Money Problem in Our Family | ||
PQL1724 | C138613 | PQL17-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Family Has Lot of Problems | ||
PQL1725 | C138614 | PQL17-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138236.PQL17TN | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report Questionnaire Test Name
(PQL17TN) | text
Extensible: No | C138236 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child Test Name Terminology |
PQL17-Back Feels Stiff | C138595 | PQL17-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Back Feels Stiff | ||
PQL17-Do Not Have Equipment Need | C138614 | PQL17-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Do Not Have Equipment Need | ||
PQL17-Family Has Lot of Problems | C138613 | PQL17-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Family Has Lot of Problems | ||
PQL17-Feel Tired | C138594 | PQL17-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Feel Tired | ||
PQL17-Get Hurt Accidentally | C138603 | PQL17-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Hurt Accidentally | ||
PQL17-Get Sick Easily | C138591 | PQL17-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Sick Easily | ||
PQL17-Get Sores and/or Rashes | C138592 | PQL17-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Get Sores and/or Rashes | ||
PQL17-Hands Are Weak | C138597 | PQL17-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hands Are Weak | ||
PQL17-Hard Ask Doctors/Nurses Questions | C138608 | PQL17-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Ask Doctors and Nurses Questions | ||
PQL17-Hard Explain Illness to People | C138609 | PQL17-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Explain Illness to People | ||
PQL17-Hard for Family to Plan Activities | C138610 | PQL17-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard for Family to Plan Activities | ||
PQL17-Hard for Family to Rest | C138611 | PQL17-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard for Family to Rest | ||
PQL17-Hard Tell Doctors/Nurses How Feel | C138607 | PQL17-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard Tell Doctors and Nurses How Feel | ||
PQL17-Hard to Breathe | C138590 | PQL17-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Breathe | ||
PQL17-Hard to Gain/Lose Weight | C138599 | PQL17-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Gain or Lose Weight | ||
PQL17-Hard to Go Places With Equipment | C138606 | PQL17-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Go Places With Equipment | ||
PQL17-Hard to Swallow Food | C138601 | PQL17-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Swallow Food | ||
PQL17-Hard to Turn During Night | C138605 | PQL17-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Turn During Night | ||
PQL17-Hard to Use Bathroom | C138598 | PQL17-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Use Bathroom | ||
PQL17-Hard to Use Hands | C138600 | PQL17-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Hard to Use Hands | ||
PQL17-Legs Hurt | C138593 | PQL17-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Legs Hurt | ||
PQL17-Long Time to Bathe/Shower | C138602 | PQL17-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Long Time to Bathe or Shower | ||
PQL17-Money Problem in Our Family | C138612 | PQL17-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Money Problem in Our Family | ||
PQL17-Take Long Time to Eat | C138604 | PQL17-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Take Long Time to Eat | ||
PQL17-Wake Up Tired | C138596 | PQL17-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Parent Report - In the past 7 days, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Parent Report for Young Child - Wake Up Tired | ||
Back to top | ||||||
CL.C138243.PQL16TC | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Questionnaire Test Code
(PQL16TC) | text
Extensible: No | C138243 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child test code. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report Test Code Terminology |
PQL1601 | C138665 | PQL16-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Breathe | ||
PQL1602 | C138666 | PQL16-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Sick Easily | ||
PQL1603 | C138667 | PQL16-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Sores and/or Rashes | ||
PQL1604 | C138668 | PQL16-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Legs Hurt | ||
PQL1605 | C138669 | PQL16-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I feel tired. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Feel Tired | ||
PQL1606 | C138670 | PQL16-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Back Feels Stiff | ||
PQL1607 | C138671 | PQL16-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I wake up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Wake Up Tired | ||
PQL1608 | C138672 | PQL16-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hands Are Weak | ||
PQL1609 | C138673 | PQL16-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Use Bathroom | ||
PQL1610 | C138674 | PQL16-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Gain or Lose Weight | ||
PQL1611 | C138675 | PQL16-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use my hands. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Use Hands | ||
PQL1612 | C138676 | PQL16-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Swallow Food | ||
PQL1613 | C138677 | PQL16-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Long Time to Bathe or Shower | ||
PQL1614 | C138678 | PQL16-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Hurt Accidentally | ||
PQL1615 | C138679 | PQL16-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I take a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Take Long Time to Eat | ||
PQL1616 | C138680 | PQL16-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Turn During Night | ||
PQL1617 | C138681 | PQL16-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Go Places With Equipment | ||
Back to top | ||||||
CL.C138242.PQL16TN | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Questionnaire Test Name
(PQL16TN) | text
Extensible: No | C138242 | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child test name. | CDISC Questionnaire PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report Test Name Terminology |
PQL16-Back Feels Stiff | C138670 | PQL16-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My back feels stiff. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Back Feels Stiff | ||
PQL16-Feel Tired | C138669 | PQL16-Feel Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I feel tired. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Feel Tired | ||
PQL16-Get Hurt Accidentally | C138678 | PQL16-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get hurt accidentally. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Hurt Accidentally | ||
PQL16-Get Sick Easily | C138666 | PQL16-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sick easily. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Sick Easily | ||
PQL16-Get Sores and/or Rashes | C138667 | PQL16-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Get Sores and/or Rashes | ||
PQL16-Hands Are Weak | C138672 | PQL16-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My hands are weak. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hands Are Weak | ||
PQL16-Hard to Breathe | C138665 | PQL16-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to breathe. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Breathe | ||
PQL16-Hard to Gain/Lose Weight | C138674 | PQL16-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Gain or Lose Weight | ||
PQL16-Hard to Go Places With Equipment | C138681 | PQL16-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Go Places With Equipment | ||
PQL16-Hard to Swallow Food | C138676 | PQL16-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to swallow food. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Swallow Food | ||
PQL16-Hard to Turn During Night | C138680 | PQL16-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Turn During Night | ||
PQL16-Hard to Use Bathroom | C138673 | PQL16-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Use Bathroom | ||
PQL16-Hard to Use Hands | C138675 | PQL16-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use my hands. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Hard to Use Hands | ||
PQL16-Legs Hurt | C138668 | PQL16-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: My legs hurt. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Legs Hurt | ||
PQL16-Long Time to Bathe/Shower | C138677 | PQL16-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Long Time to Bathe or Shower | ||
PQL16-Take Long Time to Eat | C138679 | PQL16-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I take a long time to eat. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Take Long Time to Eat | ||
PQL16-Wake Up Tired | C138671 | PQL16-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Acute Version 3 Young Child - Think about how you have been doing for the past 7 days. Please listen carefully to each sentence and tell me how much of a problem this is for you: I wake up tired. | PedsQL Neuromuscular Module Acute Version 3.0 Young Child Report - Wake Up Tired | ||
Back to top | ||||||
CL.C138249.PQL06TC | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report Questionnaire Test Code
(PQL06TC) | text
Extensible: No | C138249 | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Child Test Code Terminology |
PQL0601 | C138732 | PQL06-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Breathe | ||
PQL0602 | C138733 | PQL06-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Sick Easily | ||
PQL0603 | C138734 | PQL06-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Sores and/or Rashes | ||
PQL0604 | C138735 | PQL06-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Legs Hurt | ||
PQL0605 | C138736 | PQL06-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Feel Tired | ||
PQL0606 | C138737 | PQL06-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Back Feels Stiff | ||
PQL0607 | C138738 | PQL06-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Wake Up Tired | ||
PQL0608 | C138739 | PQL06-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hands Are Weak | ||
PQL0609 | C138740 | PQL06-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Use Bathroom | ||
PQL0610 | C138741 | PQL06-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Gain or Lose Weight | ||
PQL0611 | C138742 | PQL06-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Use Hands | ||
PQL0612 | C138743 | PQL06-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Swallow Food | ||
PQL0613 | C138744 | PQL06-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Long Time to Bathe or Shower | ||
PQL0614 | C138745 | PQL06-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Hurt Accidentally | ||
PQL0615 | C138746 | PQL06-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Take Long Time to Eat | ||
PQL0616 | C138747 | PQL06-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Turn During Night | ||
PQL0617 | C138748 | PQL06-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Go Places With Equipment | ||
PQL0618 | C138749 | PQL06-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Tell Doctors and Nurses How Feel | ||
PQL0619 | C138750 | PQL06-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Ask Doctors and Nurses Questions | ||
PQL0620 | C138751 | PQL06-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Explain Illness to People | ||
PQL0621 | C138752 | PQL06-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard for Family to Plan Activities | ||
PQL0622 | C138753 | PQL06-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard for Family to Rest | ||
PQL0623 | C138754 | PQL06-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Money Problem in Our Family | ||
PQL0624 | C138755 | PQL06-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Family Has Lot of Problems | ||
PQL0625 | C138756 | PQL06-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138248.PQL06TN | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report Questionnaire Test Name
(PQL06TN) | text
Extensible: No | C138248 | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Child Test Name Terminology |
PQL06-Back Feels Stiff | C138737 | PQL06-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Back Feels Stiff | ||
PQL06-Do Not Have Equipment Need | C138756 | PQL06-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Do Not Have Equipment Need | ||
PQL06-Family Has Lot of Problems | C138755 | PQL06-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Family Has Lot of Problems | ||
PQL06-Feel Tired | C138736 | PQL06-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Feel Tired | ||
PQL06-Get Hurt Accidentally | C138745 | PQL06-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Hurt Accidentally | ||
PQL06-Get Sick Easily | C138733 | PQL06-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Sick Easily | ||
PQL06-Get Sores and/or Rashes | C138734 | PQL06-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Get Sores and/or Rashes | ||
PQL06-Hands Are Weak | C138739 | PQL06-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hands Are Weak | ||
PQL06-Hard Ask Doctors/Nurses Questions | C138750 | PQL06-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Ask Doctors and Nurses Questions | ||
PQL06-Hard Explain Illness to People | C138751 | PQL06-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Explain Illness to People | ||
PQL06-Hard for Family to Plan Activities | C138752 | PQL06-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard for Family to Plan Activities | ||
PQL06-Hard for Family to Rest | C138753 | PQL06-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard for Family to Rest | ||
PQL06-Hard Tell Doctors/Nurses How Feel | C138749 | PQL06-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard Tell Doctors and Nurses How Feel | ||
PQL06-Hard to Breathe | C138732 | PQL06-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Breathe | ||
PQL06-Hard to Gain/Lose Weight | C138741 | PQL06-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Gain or Lose Weight | ||
PQL06-Hard to Go Places With Equipment | C138748 | PQL06-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Go Places With Equipment | ||
PQL06-Hard to Swallow Food | C138743 | PQL06-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Swallow Food | ||
PQL06-Hard to Turn During Night | C138747 | PQL06-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Turn During Night | ||
PQL06-Hard to Use Bathroom | C138740 | PQL06-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Use Bathroom | ||
PQL06-Hard to Use Hands | C138742 | PQL06-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Hard to Use Hands | ||
PQL06-Legs Hurt | C138735 | PQL06-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Legs Hurt | ||
PQL06-Long Time to Bathe/Shower | C138744 | PQL06-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Long Time to Bathe or Shower | ||
PQL06-Money Problem in Our Family | C138754 | PQL06-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Money Problem in Our Family | ||
PQL06-Take Long Time to Eat | C138746 | PQL06-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Take Long Time to Eat | ||
PQL06-Wake Up Tired | C138738 | PQL06-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Child Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Child - Wake Up Tired | ||
Back to top | ||||||
CL.C138245.PQL05TC | Pediatric Quality of Life Neuromuscular Module Version 3 Child Questionnaire Test Code
(PQL05TC) | text
Extensible: No | C138245 | Pediatric Quality of Life Neuromuscular Module Version 3 Child Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Version 3 Child test code. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Child Report Test Code Terminology |
PQL0501 | C138682 | PQL05-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Breathe | ||
PQL0502 | C138683 | PQL05-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Version 3.0 Child Report - Get Sick Easily | ||
PQL0503 | C138684 | PQL05-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Child Report - Get Sores and/or Rashes | ||
PQL0504 | C138685 | PQL05-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Version 3.0 Child Report - Legs Hurt | ||
PQL0505 | C138686 | PQL05-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Version 3.0 Child Report - Feel Tired | ||
PQL0506 | C138687 | PQL05-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Child Report - Back Feels Stiff | ||
PQL0507 | C138688 | PQL05-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Version 3.0 Child Report - Wake Up Tired | ||
PQL0508 | C138689 | PQL05-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hands Are Weak | ||
PQL0509 | C138690 | PQL05-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Use Bathroom | ||
PQL0510 | C138691 | PQL05-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Gain or Lose Weight | ||
PQL0511 | C138692 | PQL05-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Use Hands | ||
PQL0512 | C138693 | PQL05-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Swallow Food | ||
PQL0513 | C138694 | PQL05-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Child Report - Long Time to Bathe or Shower | ||
PQL0514 | C138695 | PQL05-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Child Report - Get Hurt Accidentally | ||
PQL0515 | C138696 | PQL05-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Child Report - Take Long Time to Eat | ||
PQL0516 | C138697 | PQL05-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Turn During Night | ||
PQL0517 | C138698 | PQL05-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Go Places With Equipment | ||
PQL0518 | C138699 | PQL05-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Tell Doctors and Nurses How Feel | ||
PQL0519 | C138700 | PQL05-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Ask Doctors and Nurses Questions | ||
PQL0520 | C138701 | PQL05-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Explain Illness to People | ||
PQL0521 | C138702 | PQL05-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard for Family to Plan Activities | ||
PQL0522 | C138703 | PQL05-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard for Family to Rest | ||
PQL0523 | C138704 | PQL05-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Child Report - Money Problem in Our Family | ||
PQL0524 | C138705 | PQL05-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Child Report - Family Has Lot of Problems | ||
PQL0525 | C138706 | PQL05-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Version 3.0 Child Report - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138244.PQL05TN | Pediatric Quality of Life Neuromuscular Module Version 3 Child Questionnaire Test Name
(PQL05TN) | text
Extensible: No | C138244 | Pediatric Quality of Life Neuromuscular Module Version 3 Child Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Version 3 Child test name. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Child Report Test Name Terminology |
PQL05-Back Feels Stiff | C138687 | PQL05-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Child Report - Back Feels Stiff | ||
PQL05-Do Not Have Equipment Need | C138706 | PQL05-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Version 3.0 Child Report - Do Not Have Equipment Need | ||
PQL05-Family Has Lot of Problems | C138705 | PQL05-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Child Report - Family Has Lot of Problems | ||
PQL05-Feel Tired | C138686 | PQL05-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Version 3.0 Child Report - Feel Tired | ||
PQL05-Get Hurt Accidentally | C138695 | PQL05-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Child Report - Get Hurt Accidentally | ||
PQL05-Get Sick Easily | C138683 | PQL05-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Version 3.0 Child Report - Get Sick Easily | ||
PQL05-Get Sores and/or Rashes | C138684 | PQL05-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Child Report - Get Sores and/or Rashes | ||
PQL05-Hands Are Weak | C138689 | PQL05-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hands Are Weak | ||
PQL05-Hard Ask Doctors/Nurses Questions | C138700 | PQL05-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Ask Doctors and Nurses Questions | ||
PQL05-Hard Explain Illness to People | C138701 | PQL05-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Explain Illness to People | ||
PQL05-Hard for Family to Plan Activities | C138702 | PQL05-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard for Family to Plan Activities | ||
PQL05-Hard for Family to Rest | C138703 | PQL05-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard for Family to Rest | ||
PQL05-Hard Tell Doctors/Nurses How Feel | C138699 | PQL05-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard Tell Doctors and Nurses How Feel | ||
PQL05-Hard to Breathe | C138682 | PQL05-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Breathe | ||
PQL05-Hard to Gain/Lose Weight | C138691 | PQL05-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Gain or Lose Weight | ||
PQL05-Hard to Go Places With Equipment | C138698 | PQL05-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Go Places With Equipment | ||
PQL05-Hard to Swallow Food | C138693 | PQL05-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Swallow Food | ||
PQL05-Hard to Turn During Night | C138697 | PQL05-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Turn During Night | ||
PQL05-Hard to Use Bathroom | C138690 | PQL05-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Use Bathroom | ||
PQL05-Hard to Use Hands | C138692 | PQL05-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Version 3.0 Child Report - Hard to Use Hands | ||
PQL05-Legs Hurt | C138685 | PQL05-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Version 3.0 Child Report - Legs Hurt | ||
PQL05-Long Time to Bathe/Shower | C138694 | PQL05-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Child Report - Long Time to Bathe or Shower | ||
PQL05-Money Problem in Our Family | C138704 | PQL05-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Child Report - Money Problem in Our Family | ||
PQL05-Take Long Time to Eat | C138696 | PQL05-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Child Report - Take Long Time to Eat | ||
PQL05-Wake Up Tired | C138688 | PQL05-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Child - In the past one month, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Version 3.0 Child Report - Wake Up Tired | ||
Back to top | ||||||
CL.C138251.PQL04TC | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report Questionnaire Test Code
(PQL04TC) | text
Extensible: No | C138251 | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen Test Code Terminology |
PQL0401 | C138757 | PQL04-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Breathe | ||
PQL0402 | C138758 | PQL04-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Sick Easily | ||
PQL0403 | C138759 | PQL04-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Sores and/or Rashes | ||
PQL0404 | C138760 | PQL04-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Legs Hurt | ||
PQL0405 | C138761 | PQL04-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Feel Tired | ||
PQL0406 | C138762 | PQL04-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Back Feels Stiff | ||
PQL0407 | C138763 | PQL04-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Wake Up Tired | ||
PQL0408 | C138764 | PQL04-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hands Are Weak | ||
PQL0409 | C138765 | PQL04-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Use Bathroom | ||
PQL0410 | C138766 | PQL04-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Gain or Lose Weight | ||
PQL0411 | C138767 | PQL04-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Use Hands | ||
PQL0412 | C138768 | PQL04-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Swallow Food | ||
PQL0413 | C138769 | PQL04-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Long Time to Bathe or Shower | ||
PQL0414 | C138770 | PQL04-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Hurt Accidentally | ||
PQL0415 | C138771 | PQL04-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Take Long Time to Eat | ||
PQL0416 | C138772 | PQL04-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Turn During Night | ||
PQL0417 | C138773 | PQL04-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Go Places With Equipment | ||
PQL0418 | C138774 | PQL04-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Tell Doctors and Nurses How Feel | ||
PQL0419 | C138775 | PQL04-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Ask Doctors and Nurses Questions | ||
PQL0420 | C138776 | PQL04-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Explain Illness to People | ||
PQL0421 | C138777 | PQL04-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard for Family to Plan Activities | ||
PQL0422 | C138778 | PQL04-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard for Family to Rest | ||
PQL0423 | C138779 | PQL04-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Money Problem in Our Family | ||
PQL0424 | C138780 | PQL04-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Family Has Lot of Problems | ||
PQL0425 | C138781 | PQL04-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138250.PQL04TN | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report Questionnaire Test Name
(PQL04TN) | text
Extensible: No | C138250 | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen Test Name Terminology |
PQL04-Back Feels Stiff | C138762 | PQL04-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Back Feels Stiff | ||
PQL04-Do Not Have Equipment Need | C138781 | PQL04-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Do Not Have Equipment Need | ||
PQL04-Family Has Lot of Problems | C138780 | PQL04-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Family Has Lot of Problems | ||
PQL04-Feel Tired | C138761 | PQL04-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Feel Tired | ||
PQL04-Get Hurt Accidentally | C138770 | PQL04-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Hurt Accidentally | ||
PQL04-Get Sick Easily | C138758 | PQL04-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Sick Easily | ||
PQL04-Get Sores and/or Rashes | C138759 | PQL04-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Get Sores and/or Rashes | ||
PQL04-Hands Are Weak | C138764 | PQL04-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hands Are Weak | ||
PQL04-Hard Ask Doctors/Nurses Questions | C138775 | PQL04-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Ask Doctors and Nurses Questions | ||
PQL04-Hard Explain Illness to People | C138776 | PQL04-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Explain Illness to People | ||
PQL04-Hard for Family to Plan Activities | C138777 | PQL04-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard for Family to Plan Activities | ||
PQL04-Hard for Family to Rest | C138778 | PQL04-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard for Family to Rest | ||
PQL04-Hard Tell Doctors/Nurses How Feel | C138774 | PQL04-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard Tell Doctors and Nurses How Feel | ||
PQL04-Hard to Breathe | C138757 | PQL04-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Breathe | ||
PQL04-Hard to Gain/Lose Weight | C138766 | PQL04-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Gain or Lose Weight | ||
PQL04-Hard to Go Places With Equipment | C138773 | PQL04-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Go Places With Equipment | ||
PQL04-Hard to Swallow Food | C138768 | PQL04-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Swallow Food | ||
PQL04-Hard to Turn During Night | C138772 | PQL04-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Turn During Night | ||
PQL04-Hard to Use Bathroom | C138765 | PQL04-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Use Bathroom | ||
PQL04-Hard to Use Hands | C138767 | PQL04-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Hard to Use Hands | ||
PQL04-Legs Hurt | C138760 | PQL04-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Legs Hurt | ||
PQL04-Long Time to Bathe/Shower | C138769 | PQL04-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Long Time to Bathe or Shower | ||
PQL04-Money Problem in Our Family | C138779 | PQL04-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Money Problem in Our Family | ||
PQL04-Take Long Time to Eat | C138771 | PQL04-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Take Long Time to Eat | ||
PQL04-Wake Up Tired | C138763 | PQL04-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Parent Report - In the past one month, how much of a problem has this been for your teen: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Teen - Wake Up Tired | ||
Back to top | ||||||
CL.C138257.PQL03TC | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Questionnaire Test Code
(PQL03TC) | text
Extensible: No | C138257 | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Version 3 Teen test code. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Teen Report Test Code Terminology |
PQL0301 | C138832 | PQL03-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Breathe | ||
PQL0302 | C138833 | PQL03-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Sick Easily | ||
PQL0303 | C138834 | PQL03-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Sores and/or Rashes | ||
PQL0304 | C138835 | PQL03-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Legs Hurt | ||
PQL0305 | C138836 | PQL03-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Feel Tired | ||
PQL0306 | C138837 | PQL03-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Back Feels Stiff | ||
PQL0307 | C138838 | PQL03-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Wake Up Tired | ||
PQL0308 | C138839 | PQL03-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hands Are Weak | ||
PQL0309 | C138840 | PQL03-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Use Bathroom | ||
PQL0310 | C138841 | PQL03-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Gain or Lose Weight | ||
PQL0311 | C138842 | PQL03-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Use Hands | ||
PQL0312 | C138843 | PQL03-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Swallow Food | ||
PQL0313 | C138844 | PQL03-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Long Time to Bathe or Shower | ||
PQL0314 | C138845 | PQL03-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Hurt Accidentally | ||
PQL0315 | C138846 | PQL03-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Take Long Time to Eat | ||
PQL0316 | C138847 | PQL03-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Turn During Night | ||
PQL0317 | C138848 | PQL03-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Go Places With Equipment | ||
PQL0318 | C138849 | PQL03-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Tell Doctors and Nurses How Feel | ||
PQL0319 | C138850 | PQL03-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Ask Doctors and Nurses Questions | ||
PQL0320 | C138851 | PQL03-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Explain Illness to People | ||
PQL0321 | C138852 | PQL03-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard for Family to Plan Activities | ||
PQL0322 | C138853 | PQL03-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard for Family to Rest | ||
PQL0323 | C138854 | PQL03-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Money Problem in Our Family | ||
PQL0324 | C138855 | PQL03-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Family Has Lot of Problems | ||
PQL0325 | C138856 | PQL03-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138256.PQL03TN | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Questionnaire Test Name
(PQL03TN) | text
Extensible: No | C138256 | Pediatric Quality of Life Neuromuscular Module Version 3 Teen Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Version 3 Teen test name. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Teen Report Test Name Terminology |
PQL03-Back Feels Stiff | C138837 | PQL03-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Back Feels Stiff | ||
PQL03-Do Not Have Equipment Need | C138856 | PQL03-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Do Not Have Equipment Need | ||
PQL03-Family Has Lot of Problems | C138855 | PQL03-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Family Has Lot of Problems | ||
PQL03-Feel Tired | C138836 | PQL03-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Feel Tired | ||
PQL03-Get Hurt Accidentally | C138845 | PQL03-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Hurt Accidentally | ||
PQL03-Get Sick Easily | C138833 | PQL03-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Sick Easily | ||
PQL03-Get Sores and/or Rashes | C138834 | PQL03-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Get Sores and/or Rashes | ||
PQL03-Hands Are Weak | C138839 | PQL03-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hands Are Weak | ||
PQL03-Hard Ask Doctors/Nurses Questions | C138850 | PQL03-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Ask Doctors and Nurses Questions | ||
PQL03-Hard Explain Illness to People | C138851 | PQL03-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Explain Illness to People | ||
PQL03-Hard for Family to Plan Activities | C138852 | PQL03-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard for Family to Plan Activities | ||
PQL03-Hard for Family to Rest | C138853 | PQL03-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard for Family to Rest | ||
PQL03-Hard Tell Doctors/Nurses How Feel | C138849 | PQL03-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard Tell Doctors and Nurses How Feel | ||
PQL03-Hard to Breathe | C138832 | PQL03-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Breathe | ||
PQL03-Hard to Gain/Lose Weight | C138841 | PQL03-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Gain or Lose Weight | ||
PQL03-Hard to Go Places With Equipment | C138848 | PQL03-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Go Places With Equipment | ||
PQL03-Hard to Swallow Food | C138843 | PQL03-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Swallow Food | ||
PQL03-Hard to Turn During Night | C138847 | PQL03-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Turn During Night | ||
PQL03-Hard to Use Bathroom | C138840 | PQL03-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Use Bathroom | ||
PQL03-Hard to Use Hands | C138842 | PQL03-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Hard to Use Hands | ||
PQL03-Legs Hurt | C138835 | PQL03-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Legs Hurt | ||
PQL03-Long Time to Bathe/Shower | C138844 | PQL03-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Long Time to Bathe or Shower | ||
PQL03-Money Problem in Our Family | C138854 | PQL03-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Money Problem in Our Family | ||
PQL03-Take Long Time to Eat | C138846 | PQL03-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Take Long Time to Eat | ||
PQL03-Wake Up Tired | C138838 | PQL03-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Teen - In the past one month, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Version 3.0 Teen Report - Wake Up Tired | ||
Back to top | ||||||
CL.C138247.PQL09TC | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report Questionnaire Test Code
(PQL09TC) | text
Extensible: No | C138247 | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent of Toddler Test Code Terminology |
PQL0901 | C138707 | PQL09-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Breathe | ||
PQL0902 | C138708 | PQL09-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Sick Easily | ||
PQL0903 | C138709 | PQL09-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Sores and/or Rashes | ||
PQL0904 | C138710 | PQL09-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Legs Hurt | ||
PQL0905 | C138711 | PQL09-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Feel Tired | ||
PQL0906 | C138712 | PQL09-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Back Feels Stiff | ||
PQL0907 | C138713 | PQL09-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Wake Up Tired | ||
PQL0908 | C138714 | PQL09-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hands Are Weak | ||
PQL0909 | C138715 | PQL09-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Use Bathroom | ||
PQL0910 | C138716 | PQL09-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Gain or Lose Weight | ||
PQL0911 | C138717 | PQL09-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Use Hands | ||
PQL0912 | C138718 | PQL09-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Swallow Food | ||
PQL0913 | C138719 | PQL09-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Long Time to Bathe or Shower | ||
PQL0914 | C138720 | PQL09-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Hurt Accidentally | ||
PQL0915 | C138721 | PQL09-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Take Long Time to Eat | ||
PQL0916 | C138722 | PQL09-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Turn During Night | ||
PQL0917 | C138723 | PQL09-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Go Places With Equipment | ||
PQL0918 | C138724 | PQL09-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Tell Doctors and Nurses How Feel | ||
PQL0919 | C138725 | PQL09-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Ask Doctors and Nurses Questions | ||
PQL0920 | C138726 | PQL09-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Explain Illness to People | ||
PQL0921 | C138727 | PQL09-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard for Family to Plan Activities | ||
PQL0922 | C138728 | PQL09-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard for Family to Rest | ||
PQL0923 | C138729 | PQL09-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Money Problem in Our Family | ||
PQL0924 | C138730 | PQL09-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Family Has Lot of Problems | ||
PQL0925 | C138731 | PQL09-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138246.PQL09TN | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report Questionnaire Test Name
(PQL09TN) | text
Extensible: No | C138246 | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent of Toddler Test Name Terminology |
PQL09-Back Feels Stiff | C138712 | PQL09-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Back Feels Stiff | ||
PQL09-Do Not Have Equipment Need | C138731 | PQL09-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Do Not Have Equipment Need | ||
PQL09-Family Has Lot of Problems | C138730 | PQL09-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Family Has Lot of Problems | ||
PQL09-Feel Tired | C138711 | PQL09-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Feel Tired | ||
PQL09-Get Hurt Accidentally | C138720 | PQL09-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Hurt Accidentally | ||
PQL09-Get Sick Easily | C138708 | PQL09-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Sick Easily | ||
PQL09-Get Sores and/or Rashes | C138709 | PQL09-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Get Sores and/or Rashes | ||
PQL09-Hands Are Weak | C138714 | PQL09-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hands Are Weak | ||
PQL09-Hard Ask Doctors/Nurses Questions | C138725 | PQL09-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Ask Doctors and Nurses Questions | ||
PQL09-Hard Explain Illness to People | C138726 | PQL09-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Explain Illness to People | ||
PQL09-Hard for Family to Plan Activities | C138727 | PQL09-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard for Family to Plan Activities | ||
PQL09-Hard for Family to Rest | C138728 | PQL09-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard for Family to Rest | ||
PQL09-Hard Tell Doctors/Nurses How Feel | C138724 | PQL09-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard Tell Doctors and Nurses How Feel | ||
PQL09-Hard to Breathe | C138707 | PQL09-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Breathe | ||
PQL09-Hard to Gain/Lose Weight | C138716 | PQL09-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Gain or Lose Weight | ||
PQL09-Hard to Go Places With Equipment | C138723 | PQL09-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Go Places With Equipment | ||
PQL09-Hard to Swallow Food | C138718 | PQL09-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Swallow Food | ||
PQL09-Hard to Turn During Night | C138722 | PQL09-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Turn During Night | ||
PQL09-Hard to Use Bathroom | C138715 | PQL09-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Use Bathroom | ||
PQL09-Hard to Use Hands | C138717 | PQL09-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Hard to Use Hands | ||
PQL09-Legs Hurt | C138710 | PQL09-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Legs Hurt | ||
PQL09-Long Time to Bathe/Shower | C138719 | PQL09-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Long Time to Bathe or Shower | ||
PQL09-Money Problem in Our Family | C138729 | PQL09-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Money Problem in Our Family | ||
PQL09-Take Long Time to Eat | C138721 | PQL09-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Take Long Time to Eat | ||
PQL09-Wake Up Tired | C138713 | PQL09-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Toddler Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent of Toddler - Wake Up Tired | ||
Back to top | ||||||
CL.C138253.PQL02TC | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report Questionnaire Test Code
(PQL02TC) | text
Extensible: No | C138253 | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report Test Code Terminology |
PQL0201 | C138782 | PQL02-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Breathe | ||
PQL0202 | C138783 | PQL02-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Sick Easily | ||
PQL0203 | C138784 | PQL02-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Sores and/or Rashes | ||
PQL0204 | C138785 | PQL02-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Legs Hurt | ||
PQL0205 | C138786 | PQL02-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Feel Tired | ||
PQL0206 | C138787 | PQL02-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Back Feels Stiff | ||
PQL0207 | C138788 | PQL02-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Wake Up Tired | ||
PQL0208 | C138789 | PQL02-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hands Are Weak | ||
PQL0209 | C138790 | PQL02-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Use Bathroom | ||
PQL0210 | C138791 | PQL02-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Gain or Lose Weight | ||
PQL0211 | C138792 | PQL02-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Use Hands | ||
PQL0212 | C138793 | PQL02-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Swallow Food | ||
PQL0213 | C138794 | PQL02-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Long Time to Bathe or Shower | ||
PQL0214 | C138795 | PQL02-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Hurt Accidentally | ||
PQL0215 | C138796 | PQL02-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Take Long Time to Eat | ||
PQL0216 | C138797 | PQL02-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Turn During Night | ||
PQL0217 | C138798 | PQL02-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Go Places With Equipment | ||
PQL0218 | C138799 | PQL02-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Tell Doctors and Nurses How Feel | ||
PQL0219 | C138800 | PQL02-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Ask Doctors and Nurses Questions | ||
PQL0220 | C138801 | PQL02-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Explain Illness to People | ||
PQL0221 | C138802 | PQL02-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard for Family to Plan Activities | ||
PQL0222 | C138803 | PQL02-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard for Family to Rest | ||
PQL0223 | C138804 | PQL02-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Money Problem in Our Family | ||
PQL0224 | C138805 | PQL02-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Family Has Lot of Problems | ||
PQL0225 | C138806 | PQL02-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138252.PQL02TN | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report Questionnaire Test Name
(PQL02TN) | text
Extensible: No | C138252 | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report Test Name Terminology |
PQL02-Back Feels Stiff | C138787 | PQL02-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Back Feels Stiff | ||
PQL02-Do Not Have Equipment Need | C138806 | PQL02-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Do Not Have Equipment Need | ||
PQL02-Family Has Lot of Problems | C138805 | PQL02-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Family Has Lot of Problems | ||
PQL02-Feel Tired | C138786 | PQL02-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Feel Tired | ||
PQL02-Get Hurt Accidentally | C138795 | PQL02-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Hurt Accidentally | ||
PQL02-Get Sick Easily | C138783 | PQL02-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Sick Easily | ||
PQL02-Get Sores and/or Rashes | C138784 | PQL02-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Get Sores and/or Rashes | ||
PQL02-Hands Are Weak | C138789 | PQL02-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hands Are Weak | ||
PQL02-Hard Ask Doctors/Nurses Questions | C138800 | PQL02-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Ask Doctors and Nurses Questions | ||
PQL02-Hard Explain Illness to People | C138801 | PQL02-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Explain Illness to People | ||
PQL02-Hard for Family to Plan Activities | C138802 | PQL02-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard for Family to Plan Activities | ||
PQL02-Hard for Family to Rest | C138803 | PQL02-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard for Family to Rest | ||
PQL02-Hard Tell Doctors/Nurses How Feel | C138799 | PQL02-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard Tell Doctors and Nurses How Feel | ||
PQL02-Hard to Breathe | C138782 | PQL02-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Breathe | ||
PQL02-Hard to Gain/Lose Weight | C138791 | PQL02-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Gain or Lose Weight | ||
PQL02-Hard to Go Places With Equipment | C138798 | PQL02-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Go Places With Equipment | ||
PQL02-Hard to Swallow Food | C138793 | PQL02-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Swallow Food | ||
PQL02-Hard to Turn During Night | C138797 | PQL02-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Turn During Night | ||
PQL02-Hard to Use Bathroom | C138790 | PQL02-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Use Bathroom | ||
PQL02-Hard to Use Hands | C138792 | PQL02-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Hard to Use Hands | ||
PQL02-Legs Hurt | C138785 | PQL02-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Legs Hurt | ||
PQL02-Long Time to Bathe/Shower | C138794 | PQL02-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Long Time to Bathe or Shower | ||
PQL02-Money Problem in Our Family | C138804 | PQL02-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Money Problem in Our Family | ||
PQL02-Take Long Time to Eat | C138796 | PQL02-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Take Long Time to Eat | ||
PQL02-Wake Up Tired | C138788 | PQL02-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Adults Report - Wake Up Tired | ||
Back to top | ||||||
CL.C138259.PQL01TC | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Questionnaire Test Code
(PQL01TC) | text
Extensible: No | C138259 | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult test code. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Young Adult Report Test Code Terminology |
PQL0101 | C138857 | PQL01-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Breathe | ||
PQL0102 | C138858 | PQL01-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Sick Easily | ||
PQL0103 | C138859 | PQL01-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Sores and/or Rashes | ||
PQL0104 | C138860 | PQL01-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Legs Hurt | ||
PQL0105 | C138861 | PQL01-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Feel Tired | ||
PQL0106 | C138862 | PQL01-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Back Feels Stiff | ||
PQL0107 | C138863 | PQL01-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Wake Up Tired | ||
PQL0108 | C138864 | PQL01-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hands Are Weak | ||
PQL0109 | C138865 | PQL01-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Use Bathroom | ||
PQL0110 | C138866 | PQL01-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Gain or Lose Weight | ||
PQL0111 | C138867 | PQL01-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Use Hands | ||
PQL0112 | C138868 | PQL01-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Swallow Food | ||
PQL0113 | C138869 | PQL01-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Long Time to Bathe or Shower | ||
PQL0114 | C138870 | PQL01-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Hurt Accidentally | ||
PQL0115 | C138871 | PQL01-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Take Long Time to Eat | ||
PQL0116 | C138872 | PQL01-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Turn During Night | ||
PQL0117 | C138873 | PQL01-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Go Places With Equipment | ||
PQL0118 | C138874 | PQL01-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Tell Doctors and Nurses How Feel | ||
PQL0119 | C138875 | PQL01-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Ask Doctors and Nurses Questions | ||
PQL0120 | C138876 | PQL01-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Explain Illness to People | ||
PQL0121 | C138877 | PQL01-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard for Family to Plan Activities | ||
PQL0122 | C138878 | PQL01-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard for Family to Rest | ||
PQL0123 | C138879 | PQL01-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Money Problem in Our Family | ||
PQL0124 | C138880 | PQL01-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Family Has Lot of Problems | ||
PQL0125 | C138881 | PQL01-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138258.PQL01TN | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Questionnaire Test Name
(PQL01TN) | text
Extensible: No | C138258 | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult test name. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Young Adult Report Test Name Terminology |
PQL01-Back Feels Stiff | C138862 | PQL01-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Back Feels Stiff | ||
PQL01-Do Not Have Equipment Need | C138881 | PQL01-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I do not have the equipment I need. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Do Not Have Equipment Need | ||
PQL01-Family Has Lot of Problems | C138880 | PQL01-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I think my family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Family Has Lot of Problems | ||
PQL01-Feel Tired | C138861 | PQL01-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I feel tired. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Feel Tired | ||
PQL01-Get Hurt Accidentally | C138870 | PQL01-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Hurt Accidentally | ||
PQL01-Get Sick Easily | C138858 | PQL01-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get sick easily. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Sick Easily | ||
PQL01-Get Sores and/or Rashes | C138859 | PQL01-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Get Sores and/or Rashes | ||
PQL01-Hands Are Weak | C138864 | PQL01-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My hands are weak. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hands Are Weak | ||
PQL01-Hard Ask Doctors/Nurses Questions | C138875 | PQL01-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Ask Doctors and Nurses Questions | ||
PQL01-Hard Explain Illness to People | C138876 | PQL01-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to explain my illness to other people. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Explain Illness to People | ||
PQL01-Hard for Family to Plan Activities | C138877 | PQL01-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for my family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard for Family to Plan Activities | ||
PQL01-Hard for Family to Rest | C138878 | PQL01-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for my family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard for Family to Rest | ||
PQL01-Hard Tell Doctors/Nurses How Feel | C138874 | PQL01-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to tell the doctors and nurses how I feel. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard Tell Doctors and Nurses How Feel | ||
PQL01-Hard to Breathe | C138857 | PQL01-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to breathe. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Breathe | ||
PQL01-Hard to Gain/Lose Weight | C138866 | PQL01-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Gain or Lose Weight | ||
PQL01-Hard to Go Places With Equipment | C138873 | PQL01-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Go Places With Equipment | ||
PQL01-Hard to Swallow Food | C138868 | PQL01-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to swallow food. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Swallow Food | ||
PQL01-Hard to Turn During Night | C138872 | PQL01-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Turn During Night | ||
PQL01-Hard to Use Bathroom | C138865 | PQL01-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Use Bathroom | ||
PQL01-Hard to Use Hands | C138867 | PQL01-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It is hard to use my hands. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Hard to Use Hands | ||
PQL01-Legs Hurt | C138860 | PQL01-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: My legs hurt. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Legs Hurt | ||
PQL01-Long Time to Bathe/Shower | C138869 | PQL01-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Long Time to Bathe or Shower | ||
PQL01-Money Problem in Our Family | C138879 | PQL01-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Money Problem in Our Family | ||
PQL01-Take Long Time to Eat | C138871 | PQL01-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I take a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Take Long Time to Eat | ||
PQL01-Wake Up Tired | C138863 | PQL01-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Adult - In the past one month, how much of a problem has this been for you: I wake up tired. | PedsQL Neuromuscular Module Version 3.0 Young Adult Report - Wake Up Tired | ||
Back to top | ||||||
CL.C138255.PQL08TC | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report Questionnaire Test Code
(PQL08TC) | text
Extensible: No | C138255 | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report test code. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child Test Code Terminology |
PQL0801 | C138807 | PQL08-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Breathe | ||
PQL0802 | C138808 | PQL08-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Sick Easily | ||
PQL0803 | C138809 | PQL08-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Sores and/or Rashes | ||
PQL0804 | C138810 | PQL08-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Legs Hurt | ||
PQL0805 | C138811 | PQL08-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Feel Tired | ||
PQL0806 | C138812 | PQL08-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Back Feels Stiff | ||
PQL0807 | C138813 | PQL08-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Wake Up Tired | ||
PQL0808 | C138814 | PQL08-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hands Are Weak | ||
PQL0809 | C138815 | PQL08-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Use Bathroom | ||
PQL0810 | C138816 | PQL08-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Gain or Lose Weight | ||
PQL0811 | C138817 | PQL08-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Use Hands | ||
PQL0812 | C138818 | PQL08-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Swallow Food | ||
PQL0813 | C138819 | PQL08-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Long Time to Bathe or Shower | ||
PQL0814 | C138820 | PQL08-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Hurt Accidentally | ||
PQL0815 | C138821 | PQL08-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Take Long Time to Eat | ||
PQL0816 | C138822 | PQL08-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Turn During Night | ||
PQL0817 | C138823 | PQL08-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Go Places With Equipment | ||
PQL0818 | C138824 | PQL08-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Tell Doctors and Nurses How Feel | ||
PQL0819 | C138825 | PQL08-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Ask Doctors and Nurses Questions | ||
PQL0820 | C138826 | PQL08-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Explain Illness to People | ||
PQL0821 | C138827 | PQL08-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard for Family to Plan Activities | ||
PQL0822 | C138828 | PQL08-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard for Family to Rest | ||
PQL0823 | C138829 | PQL08-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Money Problem in Our Family | ||
PQL0824 | C138830 | PQL08-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Family Has Lot of Problems | ||
PQL0825 | C138831 | PQL08-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Do Not Have Equipment Need | ||
Back to top | ||||||
CL.C138254.PQL08TN | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report Questionnaire Test Name
(PQL08TN) | text
Extensible: No | C138254 | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report test name. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child Test Name Terminology |
PQL08-Back Feels Stiff | C138812 | PQL08-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Back Feels Stiff | ||
PQL08-Do Not Have Equipment Need | C138831 | PQL08-Do Not Have Equipment Need | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child does not have the equipment he or she needs. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Do Not Have Equipment Need | ||
PQL08-Family Has Lot of Problems | C138830 | PQL08-Family Has Lot of Problems | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: I think our family has a lot of problems. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Family Has Lot of Problems | ||
PQL08-Feel Tired | C138811 | PQL08-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child feels tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Feel Tired | ||
PQL08-Get Hurt Accidentally | C138820 | PQL08-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Hurt Accidentally | ||
PQL08-Get Sick Easily | C138808 | PQL08-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sick easily. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Sick Easily | ||
PQL08-Get Sores and/or Rashes | C138809 | PQL08-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child gets sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Get Sores and/or Rashes | ||
PQL08-Hands Are Weak | C138814 | PQL08-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's hands are weak. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hands Are Weak | ||
PQL08-Hard Ask Doctors/Nurses Questions | C138825 | PQL08-Hard Ask Doctors/Nurses Questions | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to ask the doctors and nurses questions. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Ask Doctors and Nurses Questions | ||
PQL08-Hard Explain Illness to People | C138826 | PQL08-Hard Explain Illness to People | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to explain his or her illness to other people. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Explain Illness to People | ||
PQL08-Hard for Family to Plan Activities | C138827 | PQL08-Hard for Family to Plan Activities | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to plan activities like vacations. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard for Family to Plan Activities | ||
PQL08-Hard for Family to Rest | C138828 | PQL08-Hard for Family to Rest | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for our family to get enough rest. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard for Family to Rest | ||
PQL08-Hard Tell Doctors/Nurses How Feel | C138824 | PQL08-Hard Tell Doctors/Nurses How Feel | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to tell the doctors and nurses how he or she feels. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard Tell Doctors and Nurses How Feel | ||
PQL08-Hard to Breathe | C138807 | PQL08-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to breathe. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Breathe | ||
PQL08-Hard to Gain/Lose Weight | C138816 | PQL08-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to gain or lose weight when he or she wants to. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Gain or Lose Weight | ||
PQL08-Hard to Go Places With Equipment | C138823 | PQL08-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to go places with his or her equipment. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Go Places With Equipment | ||
PQL08-Hard to Swallow Food | C138818 | PQL08-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to swallow food. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Swallow Food | ||
PQL08-Hard to Turn During Night | C138822 | PQL08-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to turn him or herself during the night. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Turn During Night | ||
PQL08-Hard to Use Bathroom | C138815 | PQL08-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Use Bathroom | ||
PQL08-Hard to Use Hands | C138817 | PQL08-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It is hard for my child to use his or her hands. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Hard to Use Hands | ||
PQL08-Legs Hurt | C138810 | PQL08-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child's legs hurt. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Legs Hurt | ||
PQL08-Long Time to Bathe/Shower | C138819 | PQL08-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: It takes my child a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Long Time to Bathe or Shower | ||
PQL08-Money Problem in Our Family | C138829 | PQL08-Money Problem in Our Family | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: I think money is a problem in our family. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Money Problem in Our Family | ||
PQL08-Take Long Time to Eat | C138821 | PQL08-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child takes a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Take Long Time to Eat | ||
PQL08-Wake Up Tired | C138813 | PQL08-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Parent Report - In the past one month, how much of a problem has this been for your child: My child wakes up tired. | PedsQL Neuromuscular Module Version 3.0 Parent Report for Young Child - Wake Up Tired | ||
Back to top | ||||||
CL.C138261.PQL07TC | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Questionnaire Test Code
(PQL07TC) | text
Extensible: No | C138261 | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Questionnaire Test Code | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child test code. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Young Child Report Test Code Terminology |
PQL0701 | C138882 | PQL07-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to breathe. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Breathe | ||
PQL0702 | C138883 | PQL07-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sick easily. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Sick Easily | ||
PQL0703 | C138884 | PQL07-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Sores and/or Rashes | ||
PQL0704 | C138885 | PQL07-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My legs hurt. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Legs Hurt | ||
PQL0705 | C138886 | PQL07-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I feel tired. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Feel Tired | ||
PQL0706 | C138887 | PQL07-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Back Feels Stiff | ||
PQL0707 | C138888 | PQL07-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I wake up tired. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Wake Up Tired | ||
PQL0708 | C138889 | PQL07-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My hands are weak. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hands Are Weak | ||
PQL0709 | C138890 | PQL07-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Use Bathroom | ||
PQL0710 | C138891 | PQL07-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Gain or Lose Weight | ||
PQL0711 | C138892 | PQL07-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use my hands. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Use Hands | ||
PQL0712 | C138893 | PQL07-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to swallow food. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Swallow Food | ||
PQL0713 | C138894 | PQL07-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Long Time to Bathe or Shower | ||
PQL0714 | C138895 | PQL07-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Hurt Accidentally | ||
PQL0715 | C138896 | PQL07-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I take a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Take Long Time to Eat | ||
PQL0716 | C138897 | PQL07-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Turn During Night | ||
PQL0717 | C138898 | PQL07-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Go Places With Equipment | ||
Back to top | ||||||
CL.C138260.PQL07TN | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Questionnaire Test Name
(PQL07TN) | text
Extensible: No | C138260 | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child Questionnaire Test Name | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child test name. | CDISC Questionnaire PedsQL Neuromuscular Module Version 3.0 Young Child Report Test Name Terminology |
PQL07-Back Feels Stiff | C138887 | PQL07-Back Feels Stiff | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My back feels stiff. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Back Feels Stiff | ||
PQL07-Feel Tired | C138886 | PQL07-Feel Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I feel tired. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Feel Tired | ||
PQL07-Get Hurt Accidentally | C138895 | PQL07-Get Hurt Accidentally | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get hurt accidentally. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Hurt Accidentally | ||
PQL07-Get Sick Easily | C138883 | PQL07-Get Sick Easily | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sick easily. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Sick Easily | ||
PQL07-Get Sores and/or Rashes | C138884 | PQL07-Get Sores and/or Rashes | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I get sores and/or rashes. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Get Sores and/or Rashes | ||
PQL07-Hands Are Weak | C138889 | PQL07-Hands Are Weak | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My hands are weak. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hands Are Weak | ||
PQL07-Hard to Breathe | C138882 | PQL07-Hard to Breathe | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to breathe. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Breathe | ||
PQL07-Hard to Gain/Lose Weight | C138891 | PQL07-Hard to Gain/Lose Weight | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to gain or lose weight when I want to. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Gain or Lose Weight | ||
PQL07-Hard to Go Places With Equipment | C138898 | PQL07-Hard to Go Places With Equipment | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard for me to go places with my equipment. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Go Places With Equipment | ||
PQL07-Hard to Swallow Food | C138893 | PQL07-Hard to Swallow Food | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to swallow food. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Swallow Food | ||
PQL07-Hard to Turn During Night | C138897 | PQL07-Hard to Turn During Night | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to turn myself during the night. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Turn During Night | ||
PQL07-Hard to Use Bathroom | C138890 | PQL07-Hard to Use Bathroom | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use the bathroom. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Use Bathroom | ||
PQL07-Hard to Use Hands | C138892 | PQL07-Hard to Use Hands | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It is hard to use my hands. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Hard to Use Hands | ||
PQL07-Legs Hurt | C138885 | PQL07-Legs Hurt | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: My legs hurt. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Legs Hurt | ||
PQL07-Long Time to Bathe/Shower | C138894 | PQL07-Long Time to Bathe/Shower | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: It takes me a long time to bathe or shower. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Long Time to Bathe or Shower | ||
PQL07-Take Long Time to Eat | C138896 | PQL07-Take Long Time to Eat | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I take a long time to eat. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Take Long Time to Eat | ||
PQL07-Wake Up Tired | C138888 | PQL07-Wake Up Tired | Pediatric Quality of Life Neuromuscular Module Version 3 Young Child - Think about how you have been doing for the last few weeks. Please listen carefully to each sentence and tell me how much of a problem this is for you: I wake up tired. | PedsQL Neuromuscular Module Version 3.0 Young Child Report - Wake Up Tired | ||
Back to top | ||||||
CL.C138217.PUL01TC | Performance of the Upper Limb Module for DMD Version 1.2 Functional Test Test Code
(PUL01TC) | text
Extensible: No | C138217 | Performance of the Upper Limb Module for DMD Version 1.2 Functional Test Test Code | Performance of the Upper Limb Module for DMD Version 1.2 test code. | CDISC Functional Test PUL 1.2 Test Code Terminology |
PUL0101 | C138365 | PUL01-Preferred Arm | Performance of the Upper Limb Module for DMD Version 1.2 - Preferred arm. | PUL 1.2 - Preferred Arm | ||
PUL0102 | C138366 | PUL01-Elbow Contractures | Performance of the Upper Limb Module for DMD Version 1.2 - Elbow contractures of the preferred arm. | PUL 1.2 - Elbow Contractures | ||
PUL0103 | C138393 | PUL01-High Level Shoulder Dimension | Performance of the Upper Limb Module for DMD Version 1.2 - High level shoulder dimension score. | PUL 1.2 - High Level Shoulder Dimension | ||
PUL0104 | C138394 | PUL01-Mid Level Elbow Dimension | Performance of the Upper Limb Module for DMD Version 1.2 - Mid level elbow dimension score. | PUL 1.2 - Mid Level Elbow Dimension | ||
PUL0105 | C138395 | PUL01-Distal Wrist/Hand Dimension | Performance of the Upper Limb Module for DMD Version 1.2 - Distal wrist and hand dimension score. | PUL 1.2 - Distal Wrist or Hand Dimension | ||
PUL0106 | C138396 | PUL01-Total Score | Performance of the Upper Limb Module for DMD Version 1.2 - Total Score. | PUL 1.2 - Total Score | ||
PUL01A | C138367 | PUL01-Entry Item | Performance of the Upper Limb Module for DMD Version 1.2 - Entry item. | PUL 1.2 - Entry Item | ||
PUL01B | C138368 | PUL01-Shoulder Abduction to Shldr Hgt | Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder abduction to shoulder height. | PUL 1.2 - Shoulder Abduction to Height | ||
PUL01C | C138369 | PUL01-Shoulder Abduction Above Shldr Hgt | Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder abduction above shoulder height. | PUL 1.2 - Shoulder Abduction Above Height | ||
PUL01D | C138370 | PUL01-Shoulder Flexion to Shldr Height | Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder flexion to shoulder height. | PUL 1.2 - Shoulder Flexion to Height | ||
PUL01E | C138371 | PUL01-Shoulder Flexion Above Shldr Hgt | Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder flexion above shoulder height. | PUL 1.2 - Shoulder Flexion Above Height | ||
PUL01F | C138372 | PUL01-Hand(s) to Mouth | Performance of the Upper Limb Module for DMD Version 1.2 - Hand(s) to mouth. | PUL 1.2 - Hand(s) to Mouth | ||
PUL01G | C138373 | PUL01-Hand(s) to Table From Lap | Performance of the Upper Limb Module for DMD Version 1.2 - Hand(s) to table from lap. | PUL 1.2 - Hand(s) to Table From Lap | ||
PUL01H | C138374 | PUL01-Move Weight on Table | Performance of the Upper Limb Module for DMD Version 1.2 - Move weight on table. | PUL 1.2 - Move Weight on Table | ||
PUL01I | C138375 | PUL01-Lifting Light Cans | Performance of the Upper Limb Module for DMD Version 1.2 - Lifting light cans. | PUL 1.2 - Lifting Light Cans | ||
PUL01I1 | C138376 | PUL01-Lifting Light Cans Time | Performance of the Upper Limb Module for DMD Version 1.2 - Lifting light cans, time. | PUL 1.2 - Lifting Light Cans Time | ||
PUL01J | C138377 | PUL01-Lifting Heavy Cans | Performance of the Upper Limb Module for DMD Version 1.2 - Lifting heavy cans. | PUL 1.2 - Lifting Heavy Cans | ||
PUL01J1 | C138378 | PUL01-Lifting Heavy Cans Time | Performance of the Upper Limb Module for DMD Version 1.2 - Lifting heavy cans, time. | PUL 1.2 - Lifting Heavy Cans Time | ||
PUL01K | C138379 | PUL01-Stacking Light Cans | Performance of the Upper Limb Module for DMD Version 1.2 - Stacking light cans. | PUL 1.2 - Stacking Light Cans | ||
PUL01K1 | C138380 | PUL01-Stacking Light Cans Time | Performance of the Upper Limb Module for DMD Version 1.2 - Stacking light cans, time. | PUL 1.2 - Stacking Light Cans Time | ||
PUL01L | C138381 | PUL01-Stacking Heavy Cans | Performance of the Upper Limb Module for DMD Version 1.2 - Stacking heavy cans. | PUL 1.2 - Stacking Heavy Cans | ||
PUL01L1 | C138382 | PUL01-Stacking Heavy Cans Time | Performance of the Upper Limb Module for DMD Version 1.2 - Stacking heavy cans, time. | PUL 1.2 - Stacking Heavy Cans Time | ||
PUL01M | C138383 | PUL01-Remove Lid From Container | Performance of the Upper Limb Module for DMD Version 1.2 - Remove lid from container. | PUL 1.2 - Remove Lid From Container | ||
PUL01N | C138384 | PUL01-Tearing Paper | Performance of the Upper Limb Module for DMD Version 1.2 - Tearing paper. | PUL 1.2 - Tearing Paper | ||
PUL01O | C138385 | PUL01-Tracing Path | Performance of the Upper Limb Module for DMD Version 1.2 - Tracing path. | PUL 1.2 - Tracing Path | ||
PUL01P | C138386 | PUL01-Push on The Light | Performance of the Upper Limb Module for DMD Version 1.2 - Push on the light. | PUL 1.2 - Push on The Light | ||
PUL01Q | C138387 | PUL01-Supination | Performance of the Upper Limb Module for DMD Version 1.2 - Supination. | PUL 1.2 - Supination | ||
PUL01R | C138388 | PUL01-Picking Up Coins | Performance of the Upper Limb Module for DMD Version 1.2 - Picking up coins. | PUL 1.2 - Picking Up Coins | ||
PUL01S | C138389 | PUL01-Placing Finger on Number Diagram | Performance of the Upper Limb Module for DMD Version 1.2 - Placing finger on number diagram. | PUL 1.2 - Placing Finger on Number Diagram | ||
PUL01T | C138390 | PUL01-Finger Pinch Grip | Performance of the Upper Limb Module for DMD Version 1.2 - Finger pinch grip. | PUL 1.2 - Finger Pinch Grip | ||
PUL01U | C138391 | PUL01-3 Point Grip | Performance of the Upper Limb Module for DMD Version 1.2 - 3 point grip. | PUL 1.2 - 3 Point Grip | ||
PUL01V | C138392 | PUL01-Thumb (Key) Grip | Performance of the Upper Limb Module for DMD Version 1.2 - Thumb (key) grip. | PUL 1.2 - Thumb (Key) Grip | ||
Back to top | ||||||
CL.C138216.PUL01TN | Performance of the Upper Limb Module for DMD Version 1.2 Functional Test Test Name
(PUL01TN) | text
Extensible: No | C138216 | Performance of the Upper Limb Module for DMD Version 1.2 Functional Test Test Name | Performance of the Upper Limb Module for DMD Version 1.2 test name. | CDISC Functional Test PUL 1.2 Test Name Terminology |
PUL01-3 Point Grip | C138391 | PUL01-3 Point Grip | Performance of the Upper Limb Module for DMD Version 1.2 - 3 point grip. | PUL 1.2 - 3 Point Grip | ||
PUL01-Distal Wrist/Hand Dimension | C138395 | PUL01-Distal Wrist/Hand Dimension | Performance of the Upper Limb Module for DMD Version 1.2 - Distal wrist and hand dimension score. | PUL 1.2 - Distal Wrist or Hand Dimension | ||
PUL01-Elbow Contractures | C138366 | PUL01-Elbow Contractures | Performance of the Upper Limb Module for DMD Version 1.2 - Elbow contractures of the preferred arm. | PUL 1.2 - Elbow Contractures | ||
PUL01-Entry Item | C138367 | PUL01-Entry Item | Performance of the Upper Limb Module for DMD Version 1.2 - Entry item. | PUL 1.2 - Entry Item | ||
PUL01-Finger Pinch Grip | C138390 | PUL01-Finger Pinch Grip | Performance of the Upper Limb Module for DMD Version 1.2 - Finger pinch grip. | PUL 1.2 - Finger Pinch Grip | ||
PUL01-Hand(s) to Mouth | C138372 | PUL01-Hand(s) to Mouth | Performance of the Upper Limb Module for DMD Version 1.2 - Hand(s) to mouth. | PUL 1.2 - Hand(s) to Mouth | ||
PUL01-Hand(s) to Table From Lap | C138373 | PUL01-Hand(s) to Table From Lap | Performance of the Upper Limb Module for DMD Version 1.2 - Hand(s) to table from lap. | PUL 1.2 - Hand(s) to Table From Lap | ||
PUL01-High Level Shoulder Dimension | C138393 | PUL01-High Level Shoulder Dimension | Performance of the Upper Limb Module for DMD Version 1.2 - High level shoulder dimension score. | PUL 1.2 - High Level Shoulder Dimension | ||
PUL01-Lifting Heavy Cans Time | C138378 | PUL01-Lifting Heavy Cans Time | Performance of the Upper Limb Module for DMD Version 1.2 - Lifting heavy cans, time. | PUL 1.2 - Lifting Heavy Cans Time | ||
PUL01-Lifting Heavy Cans | C138377 | PUL01-Lifting Heavy Cans | Performance of the Upper Limb Module for DMD Version 1.2 - Lifting heavy cans. | PUL 1.2 - Lifting Heavy Cans | ||
PUL01-Lifting Light Cans Time | C138376 | PUL01-Lifting Light Cans Time | Performance of the Upper Limb Module for DMD Version 1.2 - Lifting light cans, time. | PUL 1.2 - Lifting Light Cans Time | ||
PUL01-Lifting Light Cans | C138375 | PUL01-Lifting Light Cans | Performance of the Upper Limb Module for DMD Version 1.2 - Lifting light cans. | PUL 1.2 - Lifting Light Cans | ||
PUL01-Mid Level Elbow Dimension | C138394 | PUL01-Mid Level Elbow Dimension | Performance of the Upper Limb Module for DMD Version 1.2 - Mid level elbow dimension score. | PUL 1.2 - Mid Level Elbow Dimension | ||
PUL01-Move Weight on Table | C138374 | PUL01-Move Weight on Table | Performance of the Upper Limb Module for DMD Version 1.2 - Move weight on table. | PUL 1.2 - Move Weight on Table | ||
PUL01-Picking Up Coins | C138388 | PUL01-Picking Up Coins | Performance of the Upper Limb Module for DMD Version 1.2 - Picking up coins. | PUL 1.2 - Picking Up Coins | ||
PUL01-Placing Finger on Number Diagram | C138389 | PUL01-Placing Finger on Number Diagram | Performance of the Upper Limb Module for DMD Version 1.2 - Placing finger on number diagram. | PUL 1.2 - Placing Finger on Number Diagram | ||
PUL01-Preferred Arm | C138365 | PUL01-Preferred Arm | Performance of the Upper Limb Module for DMD Version 1.2 - Preferred arm. | PUL 1.2 - Preferred Arm | ||
PUL01-Push on The Light | C138386 | PUL01-Push on The Light | Performance of the Upper Limb Module for DMD Version 1.2 - Push on the light. | PUL 1.2 - Push on The Light | ||
PUL01-Remove Lid From Container | C138383 | PUL01-Remove Lid From Container | Performance of the Upper Limb Module for DMD Version 1.2 - Remove lid from container. | PUL 1.2 - Remove Lid From Container | ||
PUL01-Shoulder Abduction Above Shldr Hgt | C138369 | PUL01-Shoulder Abduction Above Shldr Hgt | Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder abduction above shoulder height. | PUL 1.2 - Shoulder Abduction Above Height | ||
PUL01-Shoulder Abduction to Shldr Hgt | C138368 | PUL01-Shoulder Abduction to Shldr Hgt | Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder abduction to shoulder height. | PUL 1.2 - Shoulder Abduction to Height | ||
PUL01-Shoulder Flexion Above Shldr Hgt | C138371 | PUL01-Shoulder Flexion Above Shldr Hgt | Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder flexion above shoulder height. | PUL 1.2 - Shoulder Flexion Above Height | ||
PUL01-Shoulder Flexion to Shldr Height | C138370 | PUL01-Shoulder Flexion to Shldr Height | Performance of the Upper Limb Module for DMD Version 1.2 - Shoulder flexion to shoulder height. | PUL 1.2 - Shoulder Flexion to Height | ||
PUL01-Stacking Heavy Cans Time | C138382 | PUL01-Stacking Heavy Cans Time | Performance of the Upper Limb Module for DMD Version 1.2 - Stacking heavy cans, time. | PUL 1.2 - Stacking Heavy Cans Time | ||
PUL01-Stacking Heavy Cans | C138381 | PUL01-Stacking Heavy Cans | Performance of the Upper Limb Module for DMD Version 1.2 - Stacking heavy cans. | PUL 1.2 - Stacking Heavy Cans | ||
PUL01-Stacking Light Cans Time | C138380 | PUL01-Stacking Light Cans Time | Performance of the Upper Limb Module for DMD Version 1.2 - Stacking light cans, time. | PUL 1.2 - Stacking Light Cans Time | ||
PUL01-Stacking Light Cans | C138379 | PUL01-Stacking Light Cans | Performance of the Upper Limb Module for DMD Version 1.2 - Stacking light cans. | PUL 1.2 - Stacking Light Cans | ||
PUL01-Supination | C138387 | PUL01-Supination | Performance of the Upper Limb Module for DMD Version 1.2 - Supination. | PUL 1.2 - Supination | ||
PUL01-Tearing Paper | C138384 | PUL01-Tearing Paper | Performance of the Upper Limb Module for DMD Version 1.2 - Tearing paper. | PUL 1.2 - Tearing Paper | ||
PUL01-Thumb (Key) Grip | C138392 | PUL01-Thumb (Key) Grip | Performance of the Upper Limb Module for DMD Version 1.2 - Thumb (key) grip. | PUL 1.2 - Thumb (Key) Grip | ||
PUL01-Total Score | C138396 | PUL01-Total Score | Performance of the Upper Limb Module for DMD Version 1.2 - Total Score. | PUL 1.2 - Total Score | ||
PUL01-Tracing Path | C138385 | PUL01-Tracing Path | Performance of the Upper Limb Module for DMD Version 1.2 - Tracing path. | PUL 1.2 - Tracing Path | ||
Back to top | ||||||
CL.C138219.PUL02TC | Performance of the Upper Limb Module for DMD Version 2.0 Functional Test Test Code
(PUL02TC) | text
Extensible: No | C138219 | Performance of the Upper Limb Module for DMD Version 2.0 Functional Test Test Code | Performance of the Upper Limb Module for DMD Version 2.0 test code. | CDISC Functional Test PUL 2.0 Test Code Terminology |
PUL0201 | C138398 | PUL02-Shoulder Abduction Arms Above Head | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder abduction both arms above head. | PUL 2.0 - Shoulder Abduction Arms Above Head | ||
PUL0202 | C138399 | PUL02-Raise Both Arms to Shoulder Height | Performance of the Upper Limb Module for DMD Version 2.0 - Raise both arms to shoulder height (elbows at shoulder height). | PUL 2.0 - Raise Both Arms to Shoulder Height | ||
PUL0203 | C138400 | PUL02-Flexion Shoulder Height No Weights | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion to shoulder height (no weights). | PUL 2.0 - Flexion Shoulder Height No Weights | ||
PUL0204 | C138401 | PUL02-Flexion to Shoulder Height 500g | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion to shoulder height with 500g weight. | PUL 2.0 - Flexion to Shoulder Height 500g | ||
PUL0205 | C138402 | PUL02-Flexion Above Shoulder Height 500g | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion above shoulder height with 500g weight. | PUL 2.0 - Flexion Above Shoulder Height 500g | ||
PUL0206 | C138403 | PUL02-Flexion Above Shoulder Height 1kg | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion above shoulder with 1 kg weight. | PUL 2.0 - Flexion Above Shoulder Height 1kg | ||
PUL0207 | C138404 | PUL02-Hand(s) to Mouth | Performance of the Upper Limb Module for DMD Version 2.0 - Hand(s) to mouth. | PUL 2.0 - Hand(s) to Mouth | ||
PUL0208 | C138405 | PUL02-Hands to Table From Lap | Performance of the Upper Limb Module for DMD Version 2.0 - Hands to table from lap. | PUL 2.0 - Hands to Table From Lap | ||
PUL0209 | C138406 | PUL02-Move Weight on Table 100g | Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 100g. | PUL 2.0 - Move Weight On Table 100g | ||
PUL0210 | C138407 | PUL02-Move Weight on Table 500g | Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 500g. | PUL 2.0 - Move Weight On Table 500g | ||
PUL0211 | C138408 | PUL02-Move Weight on Table 1kg | Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 1kg. | PUL 2.0 - Move Weight On Table 1kg | ||
PUL0212 | C138409 | PUL02-Lift Heavy Can Diagonally | Performance of the Upper Limb Module for DMD Version 2.0 - Lift heavy can diagonally. | PUL 2.0 - Lift Heavy Can Diagonally | ||
PUL0213 | C138410 | PUL02-Stack of Three Cans | Performance of the Upper Limb Module for DMD Version 2.0 - Stack of three cans. | PUL 2.0 - Stack of Three Cans | ||
PUL0214 | C138411 | PUL02-Stack of Five Cans | Performance of the Upper Limb Module for DMD Version 2.0 - Stack of five cans. | PUL 2.0 - Stack of Five Cans | ||
PUL0215 | C138412 | PUL02-Remove Lid From Container | Performance of the Upper Limb Module for DMD Version 2.0 - Remove lid from container. | PUL 2.0 - Remove Lid From Container | ||
PUL0216 | C138413 | PUL02-Tearing Paper | Performance of the Upper Limb Module for DMD Version 2.0 - Tearing paper. | PUL 2.0 - Tearing Paper | ||
PUL0217 | C138414 | PUL02-Tracing Path | Performance of the Upper Limb Module for DMD Version 2.0 - Tracing path. | PUL 2.0 - Tracing Path | ||
PUL0218 | C138415 | PUL02-Push on Light | Performance of the Upper Limb Module for DMD Version 2.0 - Push on light. | PUL 2.0 - Push on Light | ||
PUL0219 | C138416 | PUL02-Supination | Performance of the Upper Limb Module for DMD Version 2.0 - Supination. | PUL 2.0 - Supination | ||
PUL0220 | C138417 | PUL02-Picking Up Coins | Performance of the Upper Limb Module for DMD Version 2.0 - Picking up coins. | PUL 2.0 - Picking Up Coins | ||
PUL0221 | C138418 | PUL02-Placing Finger on Number Diagram | Performance of the Upper Limb Module for DMD Version 2.0 - Placing finger on number diagram. | PUL 2.0 - Placing Finger on Number Diagram | ||
PUL0222 | C138419 | PUL02-Pick Up 10g Weight Finger Pinch | Performance of the Upper Limb Module for DMD Version 2.0 - Pick up 10g weight finger pinch. | PUL 2.0 - Pick Up 10g Weight Finger Pinch | ||
PUL0223 | C138420 | PUL02-Preferred Arm | Performance of the Upper Limb Module for DMD Version 2.0 - Preferred arm. | PUL 2.0 - Preferred Arm | ||
PUL0224 | C138421 | PUL02-Right Elbow Extension ROM | Performance of the Upper Limb Module for DMD Version 2.0 - Right elbow extension ROM. | PUL 2.0 - Right Elbow Extension ROM | ||
PUL0225 | C138422 | PUL02-Left Elbow Extension ROM | Performance of the Upper Limb Module for DMD Version 2.0 - Left elbow extension ROM. | PUL 2.0 - Left Elbow Extension ROM | ||
PUL0226 | C138423 | PUL02-Right Available Supination ROM | Performance of the Upper Limb Module for DMD Version 2.0 - Right available supination ROM. | PUL 2.0 - Right Available Supination ROM | ||
PUL0227 | C138424 | PUL02-Left Available Supination ROM | Performance of the Upper Limb Module for DMD Version 2.0 - Left available supination ROM. | PUL 2.0 - Left Available Supination ROM | ||
PUL0228 | C138425 | PUL02-High Level Shoulder Dimension | Performance of the Upper Limb Module for DMD Version 2.0 - High level shoulder dimension score. | PUL 2.0 - High Level Shoulder Dimension | ||
PUL0229 | C138426 | PUL02-Mid Level Elbow Dimension | Performance of the Upper Limb Module for DMD Version 2.0 - Mid level elbow dimension score. | PUL 2.0 - Mid Level Elbow Dimension | ||
PUL0230 | C138427 | PUL02-Distal Wrist/Hand Dimension | Performance of the Upper Limb Module for DMD Version 2.0 - Distal wrist and hand dimension score. | PUL 2.0 - Distal Wrist or Hand Dimension | ||
PUL0231 | C138428 | PUL02-Total Score | Performance of the Upper Limb Module for DMD Version 2.0 - Total score. | PUL 2.0 - Total Score | ||
PUL02A | C138397 | PUL02-Entry Item | Performance of the Upper Limb Module for DMD Version 2.0 - Entry item. | PUL 2.0 - Entry Item | ||
Back to top | ||||||
CL.C138218.PUL02TN | Performance of the Upper Limb Module for DMD Version 2.0 Functional Test Test Name
(PUL02TN) | text
Extensible: No | C138218 | Performance of the Upper Limb Module for DMD Version 2.0 Functional Test Test Name | Performance of the Upper Limb Module for DMD Version 2.0 test name. | CDISC Functional Test PUL 2.0 Test Name Terminology |
PUL02-Distal Wrist/Hand Dimension | C138427 | PUL02-Distal Wrist/Hand Dimension | Performance of the Upper Limb Module for DMD Version 2.0 - Distal wrist and hand dimension score. | PUL 2.0 - Distal Wrist or Hand Dimension | ||
PUL02-Entry Item | C138397 | PUL02-Entry Item | Performance of the Upper Limb Module for DMD Version 2.0 - Entry item. | PUL 2.0 - Entry Item | ||
PUL02-Flexion Above Shoulder Height 1kg | C138403 | PUL02-Flexion Above Shoulder Height 1kg | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion above shoulder with 1 kg weight. | PUL 2.0 - Flexion Above Shoulder Height 1kg | ||
PUL02-Flexion Above Shoulder Height 500g | C138402 | PUL02-Flexion Above Shoulder Height 500g | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion above shoulder height with 500g weight. | PUL 2.0 - Flexion Above Shoulder Height 500g | ||
PUL02-Flexion Shoulder Height No Weights | C138400 | PUL02-Flexion Shoulder Height No Weights | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion to shoulder height (no weights). | PUL 2.0 - Flexion Shoulder Height No Weights | ||
PUL02-Flexion to Shoulder Height 500g | C138401 | PUL02-Flexion to Shoulder Height 500g | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder flexion to shoulder height with 500g weight. | PUL 2.0 - Flexion to Shoulder Height 500g | ||
PUL02-Hand(s) to Mouth | C138404 | PUL02-Hand(s) to Mouth | Performance of the Upper Limb Module for DMD Version 2.0 - Hand(s) to mouth. | PUL 2.0 - Hand(s) to Mouth | ||
PUL02-Hands to Table From Lap | C138405 | PUL02-Hands to Table From Lap | Performance of the Upper Limb Module for DMD Version 2.0 - Hands to table from lap. | PUL 2.0 - Hands to Table From Lap | ||
PUL02-High Level Shoulder Dimension | C138425 | PUL02-High Level Shoulder Dimension | Performance of the Upper Limb Module for DMD Version 2.0 - High level shoulder dimension score. | PUL 2.0 - High Level Shoulder Dimension | ||
PUL02-Left Available Supination ROM | C138424 | PUL02-Left Available Supination ROM | Performance of the Upper Limb Module for DMD Version 2.0 - Left available supination ROM. | PUL 2.0 - Left Available Supination ROM | ||
PUL02-Left Elbow Extension ROM | C138422 | PUL02-Left Elbow Extension ROM | Performance of the Upper Limb Module for DMD Version 2.0 - Left elbow extension ROM. | PUL 2.0 - Left Elbow Extension ROM | ||
PUL02-Lift Heavy Can Diagonally | C138409 | PUL02-Lift Heavy Can Diagonally | Performance of the Upper Limb Module for DMD Version 2.0 - Lift heavy can diagonally. | PUL 2.0 - Lift Heavy Can Diagonally | ||
PUL02-Mid Level Elbow Dimension | C138426 | PUL02-Mid Level Elbow Dimension | Performance of the Upper Limb Module for DMD Version 2.0 - Mid level elbow dimension score. | PUL 2.0 - Mid Level Elbow Dimension | ||
PUL02-Move Weight on Table 100g | C138406 | PUL02-Move Weight on Table 100g | Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 100g. | PUL 2.0 - Move Weight On Table 100g | ||
PUL02-Move Weight on Table 1kg | C138408 | PUL02-Move Weight on Table 1kg | Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 1kg. | PUL 2.0 - Move Weight On Table 1kg | ||
PUL02-Move Weight on Table 500g | C138407 | PUL02-Move Weight on Table 500g | Performance of the Upper Limb Module for DMD Version 2.0 - Move weight on table 500g. | PUL 2.0 - Move Weight On Table 500g | ||
PUL02-Pick Up 10g Weight Finger Pinch | C138419 | PUL02-Pick Up 10g Weight Finger Pinch | Performance of the Upper Limb Module for DMD Version 2.0 - Pick up 10g weight finger pinch. | PUL 2.0 - Pick Up 10g Weight Finger Pinch | ||
PUL02-Picking Up Coins | C138417 | PUL02-Picking Up Coins | Performance of the Upper Limb Module for DMD Version 2.0 - Picking up coins. | PUL 2.0 - Picking Up Coins | ||
PUL02-Placing Finger on Number Diagram | C138418 | PUL02-Placing Finger on Number Diagram | Performance of the Upper Limb Module for DMD Version 2.0 - Placing finger on number diagram. | PUL 2.0 - Placing Finger on Number Diagram | ||
PUL02-Preferred Arm | C138420 | PUL02-Preferred Arm | Performance of the Upper Limb Module for DMD Version 2.0 - Preferred arm. | PUL 2.0 - Preferred Arm | ||
PUL02-Push on Light | C138415 | PUL02-Push on Light | Performance of the Upper Limb Module for DMD Version 2.0 - Push on light. | PUL 2.0 - Push on Light | ||
PUL02-Raise Both Arms to Shoulder Height | C138399 | PUL02-Raise Both Arms to Shoulder Height | Performance of the Upper Limb Module for DMD Version 2.0 - Raise both arms to shoulder height (elbows at shoulder height). | PUL 2.0 - Raise Both Arms to Shoulder Height | ||
PUL02-Remove Lid From Container | C138412 | PUL02-Remove Lid From Container | Performance of the Upper Limb Module for DMD Version 2.0 - Remove lid from container. | PUL 2.0 - Remove Lid From Container | ||
PUL02-Right Available Supination ROM | C138423 | PUL02-Right Available Supination ROM | Performance of the Upper Limb Module for DMD Version 2.0 - Right available supination ROM. | PUL 2.0 - Right Available Supination ROM | ||
PUL02-Right Elbow Extension ROM | C138421 | PUL02-Right Elbow Extension ROM | Performance of the Upper Limb Module for DMD Version 2.0 - Right elbow extension ROM. | PUL 2.0 - Right Elbow Extension ROM | ||
PUL02-Shoulder Abduction Arms Above Head | C138398 | PUL02-Shoulder Abduction Arms Above Head | Performance of the Upper Limb Module for DMD Version 2.0 - Shoulder abduction both arms above head. | PUL 2.0 - Shoulder Abduction Arms Above Head | ||
PUL02-Stack of Five Cans | C138411 | PUL02-Stack of Five Cans | Performance of the Upper Limb Module for DMD Version 2.0 - Stack of five cans. | PUL 2.0 - Stack of Five Cans | ||
PUL02-Stack of Three Cans | C138410 | PUL02-Stack of Three Cans | Performance of the Upper Limb Module for DMD Version 2.0 - Stack of three cans. | PUL 2.0 - Stack of Three Cans | ||
PUL02-Supination | C138416 | PUL02-Supination | Performance of the Upper Limb Module for DMD Version 2.0 - Supination. | PUL 2.0 - Supination | ||
PUL02-Tearing Paper | C138413 | PUL02-Tearing Paper | Performance of the Upper Limb Module for DMD Version 2.0 - Tearing paper. | PUL 2.0 - Tearing Paper | ||
PUL02-Total Score | C138428 | PUL02-Total Score | Performance of the Upper Limb Module for DMD Version 2.0 - Total score. | PUL 2.0 - Total Score | ||
PUL02-Tracing Path | C138414 | PUL02-Tracing Path | Performance of the Upper Limb Module for DMD Version 2.0 - Tracing path. | PUL 2.0 - Tracing Path | ||
Back to top | ||||||
CL.C66726.FRM | Pharmaceutical Dosage Form
(FRM) | text
Extensible: Yes | C66726 | Pharmaceutical Dosage Form | The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug. | CDISC SDTM Pharmaceutical Dosage Form Terminology |
AEROSOL | C42887 | aer | A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). | Aerosol Dosage Form | ||
AEROSOL, FOAM | C42888 | A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. | Aerosol Foam Dosage Form | |||
AEROSOL, METERED | C42960 | A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI) | Metered Aerosol Dosage Form | |||
AEROSOL, POWDER | C42971 | A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI) | Powder Aerosol Dosage Form | |||
AEROSOL, SPRAY | C42889 | An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI) | Aerosol Spray Dosage Form | |||
BAR, CHEWABLE | C42892 | A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI) | Chewable Bar Dosage Form | |||
BEAD | C42890 | A solid dosage form in the shape of a small ball. (NCI) | Bead Dosage Form | |||
BEAD, IMPLANT, EXTENDED RELEASE | C43451 | A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI) | Extended Release Bead Implant Dosage Form | |||
BLOCK | C42891 | Solid dosage form, usually in the shape of a square or rectangle. (NCI) | Block Dosage Form | |||
CAPLET | C97197 | A solid dosage form in which a tablet has been compacted into capsule shape. | Caplet Dosage Form | |||
CAPSULE | C25158 | cap | A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI) | Capsule Dosage Form | ||
CAPSULE, COATED PELLETS | C42896 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or 'shell' made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI) | Coated Pellet in Capsule Dosage Form | |||
CAPSULE, COATED | C42895 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. | Coated Capsule Dosage Form | |||
CAPSULE, COATED, EXTENDED RELEASE | C42917 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. | Extended Release Coated Capsule Dosage Form | |||
CAPSULE, DELAYED RELEASE PELLETS | C42904 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. | Delayed Release Pellet in Capsule Dosage Form | |||
CAPSULE, DELAYED RELEASE | C42902 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI) | Delayed Release Capsule Dosage Form | |||
CAPSULE, EXTENDED RELEASE | C42916 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI) | Extended Release Capsule Dosage Form | |||
CAPSULE, FILM COATED, EXTENDED RELEASE | C42928 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or 'shell' made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. | Extended Release Film Coated Capsule Dosage Form | |||
CAPSULE, GELATIN COATED | C42936 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI) | Gelatin Coated Capsule Dosage Form | |||
CAPSULE, HARD, EXTENDED RELEASE | C158214 | A capsule, covered with a rigid outer shell, that is designed to release active and/or inert ingredient(s) at a controlled, prolonged rate so as to reduce dosing frequency. | Extended Release Capsule, Hard Dosage Form | |||
CAPSULE, IMMEDIATE RELEASE | C142247 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container, which is designed to release its active and/or inert ingredient(s) immediately upon administration. | Immediate Release Capsule Dosage Form | |||
CAPSULE, LIQUID FILLED | C42954 | A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI) | Liquid Filled Capsule Dosage Form | |||
CAPSULE, SOFTGEL | C184506 | A capsule, covered with a soft gelatin shell and containing a liquid, suspension, or semisolid, that is designed to release active and/or inert ingredient(s). | Capsule Softgel Pharmaceutical Dosage Form | |||
CAPSULE, SOFTGEL, EXTENDED RELEASE | C158215 | A capsule, covered with a soft gelatin shell and containing a liquid, suspension, or semisolid, that is designed to release active and/or inert ingredient(s) at a controlled, prolonged rate so as to reduce dosing frequency. | Extended Release Capsule, Softgel Dosage Form | |||
CEMENT | C45414 | A substance that serves to produce solid union between two surfaces. (NCI) | Cement Dosage Form | |||
CIGARETTE | C42678 | A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances. | Cigarette Dosage Form | |||
CLOTH | C60884 | A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. | Cloth Dosage Form | |||
CONCENTRATE | C60891 | A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI) | Concentrated Dosage Form | |||
CONE | C42900 | A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI) | Cone Dosage Form | |||
CORE, EXTENDED RELEASE | C42919 | An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI) | Extended Release Core Dosage Form | |||
CREAM | C28944 | A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI) | Cream Dosage Form | |||
CREAM, AUGMENTED | C60897 | A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. | Augmented Cream Dosage Form | |||
CRYSTAL | C42901 | A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice. | Crystal Dosage Form | |||
CULTURE | C45415 | The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI) | Culture Dosage Form | |||
DEPOT | C106178 | Depot Extended Release Dosage Form | Parenteral sustained-release systems of microparticles, implants, or biodegradable polymer-excipients designed to release their active pharmaceutical ingredient over a prolonged period of time. | Extended Release Depot Dosage Form | ||
DIAPHRAGM | C47890 | A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI) | Vaginal Diaphragm Dosage Form | |||
DISC | C43525 | A circular plate-like organ or structure. | Disc Dosage Form | |||
DOUCHE | C42679 | A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI) | Douche Dosage Form | |||
DRESSING | C42763 | The application of various materials for protecting a wound. | Dressing Dosage Form | |||
DRUG DELIVERY SYSTEM | C17423 | Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. | Drug Delivery System | |||
ELIXIR | C42912 | A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI) | Elixir Dosage Form | |||
EMULSION | C42913 | A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI) | Emulsion Dosage Form | |||
ENEMA | C42915 | A rectal preparation for therapeutic, diagnostic, or nutritive purposes. (NCI) | Enema Dosage Form | |||
EXTRACT | C42929 | A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI) | Extract Dosage Form | |||
FIBER, EXTENDED RELEASE | C60926 | A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. | Extended Release Fiber Dosage Form | |||
FILM | C42932 | A thin layer or coating. (NCI) | Film Dosage Form | |||
FILM, EXTENDED RELEASE | C42920 | A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI) | Extended Release Film Dosage Form | |||
FILM, SOLUBLE | C42984 | A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI) | Soluble Film Dosage Form | |||
FOR SOLUTION | C60927 | A product, usually a solid, intended for solution prior to administration. | Dosage Form for Solution | |||
FOR SUSPENSION | C60928 | A product, usually a solid, intended for suspension prior to administration. | Dosage Form for Suspension | |||
FOR SUSPENSION, EXTENDED RELEASE | C60929 | A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. | Extended Release Dosage Form for Suspension | |||
GAS | C42933 | Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI) | Gas Dosage Form | |||
GEL | C42934 | A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. | Gel Dosage Form | |||
GEL, CHEWABLE | C134876 | Gummie;Gummy | A formed or molded oral gel dosage form that maintains its shape, is elastic, and yields to mastication. (NCI) | Chewable Gel Dosage Form | ||
GEL, DENTIFRICE | C42906 | A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI) | Dentifrice Gel Dosage Form | |||
GEL, METERED | C60930 | A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. | Metered Gel Dosage Form | |||
GENERATOR | C48193 | An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI) | Generator Dosage Form | |||
GLOBULE | C42937 | Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI) | Globule Dosage Form | |||
GRAFT | C45416 | A slip of skin or of other tissue for implantation. (NCI) | Graft Dosage Form | |||
GRANULE | C42938 | A small particle or grain. (NCI) | Granule Dosage Form | |||
GRANULE, COATED | C148551 | A small medicinal particle or grain that is covered in a designated coating. | Coated Granule Dosage Form | |||
GRANULE, DELAYED RELEASE | C42903 | A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI) | Delayed Release Granule Dosage Form | |||
GRANULE, EFFERVESCENT | C42909 | A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI) | Effervescent Granule Dosage Form | |||
GRANULE, FOR SOLUTION | C42939 | A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI) | Granule for Solution Dosage Form | |||
GRANULE, FOR SUSPENSION | C42940 | A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI) | Granule for Suspension Dosage Form | |||
GRANULE, FOR SUSPENSION, EXTENDED RELEASE | C42921 | A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI) | Extended Release Granule for Suspension Dosage Form | |||
GUM | C42941 | A mucilaginous excretion from various plants. (NCI) | Gum Dosage Form | |||
GUM, CHEWING | C42894 | A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI) | Chewing Gum Dosage Form | |||
GUM, RESIN | C42978 | Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI) | Resin Gum Dosage Form | |||
IMPLANT | C42942 | A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI) | Implant Dosage Form | |||
INHALANT | C42944 | A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI) | Inhalant Dosage Form | |||
INHALATION VAPOR, CAPSULE | C149582 | Capsule for Inhalation | Solid preparation consisting of a capsule formulation intended for generation of vapor to be inhaled to obtain a local effect. The vapor is usually generated by adding the whole capsule or the capsule contents to hot water. (EDQM) | Inhalation Vapor, Capsule Dosage Form | ||
INJECTABLE, LIPOSOMAL | C60931 | An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). | Liposomal Injection Dosage Form | |||
INJECTION | C42946 | A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI) | Injectable Dosage Form | |||
INJECTION, EMULSION | C42914 | An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally. | Emulsion for Injection Dosage Form | |||
INJECTION, LIPID COMPLEX | C42950 | A substance composed of complexed active and/or inert ingredient(s) with natural or synthetic lipids that is intended for injection. (NCI) | Injectable Lipid Complex Dosage Form | |||
INJECTION, POWDER, FOR SOLUTION | C42974 | A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI) | Powder for Injectable Solution Dosage Form | |||
INJECTION, POWDER, FOR SUSPENSION | C42976 | A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI) | Powder for Injectable Suspension Dosage Form | |||
INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE | C42977 | A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). | Powder for Injectable Extended Release Suspension Dosage Form | |||
INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION | C42959 | A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI) | Lyophilized Powder for Injectable Liposomal Suspension Dosage Form | |||
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | C42957 | A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI) | Lyophilized Powder for Injectable Solution Dosage Form | |||
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION | C42958 | A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures. | Lyophilized Powder for Injectable Suspension Dosage Form | |||
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE | C42956 | A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI) | Lyophilized Powder for Extended Release Injectable Suspension Dosage Form | |||
INJECTION, SOLUTION | C42945 | A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI) | Injectable Solution Dosage Form | |||
INJECTION, SOLUTION, CONCENTRATE | C42899 | A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI) | Concentrated Injectable Solution Dosage Form | |||
INJECTION, SUSPENSION | C42995 | A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI) | Injectable Suspension Dosage Form | |||
INJECTION, SUSPENSION, EXTENDED RELEASE | C42926 | A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) | Injectable Extended Release Suspension Dosage Form | |||
INJECTION, SUSPENSION, LIPOSOMAL | C42951 | A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI) | Injectable Liposomal Suspension Dosage Form | |||
INJECTION, SUSPENSION, SONICATED | C42988 | A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI) | Injectable Sonicated Suspension Dosage Form | |||
INSERT | C60933 | A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. | Insert Dosage Form | |||
INSERT, EXTENDED RELEASE | C42922 | A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI) | Extended Release Insert Dosage Form | |||
INTRAUTERINE DEVICE | C47915 | A device inserted and left in the uterus to prevent effective conception. (NCI) | Intrauterine Device Dosage Form | |||
IRRIGANT | C42947 | A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI) | Irrigant Dosage Form | |||
JELLY | C42948 | A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI) | Jelly Dosage Form | |||
KIT | C47916 | A packaged collection of related material. (NCI) | Kit Dosage Form | |||
LINER, DENTAL | C45413 | A material applied to the inside of the dental cavity, for protection or insulation of the surface. | Dental Liner Dosage Form | |||
LINIMENT | C42949 | A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI) | Liniment Dosage Form | |||
LIPSTICK | C42952 | A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI) | Lipstick Dosage Form | |||
LIQUID | C42953 | A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. | Liquid Dosage Form | |||
LIQUID, EXTENDED RELEASE | C60934 | A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. | Extended Release Liquid Dosage Form | |||
LOTION | C29167 | An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. | Lotion Dosage Form | |||
LOTION, AUGMENTED | C60957 | A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. | Augmented Lotion Dosage Form | |||
LOTION/SHAMPOO | C60958 | A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. | Lotion Shampoo Dosage Form | |||
LOZENGE | C42955 | A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick. | Lozenge Dosage Form | |||
MOUTHWASH | C29269 | An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI) | Mouthwash Dosage Form | |||
NOT APPLICABLE | C48624 | The use of a dosage form term is not relevant or appropriate. (NCI) | Dosage Form Not Applicable | |||
OIL | C42965 | An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI) | Oil Dosage Form | |||
OINTMENT | C42966 | oint | A suspension or emulsion, semisolid (1) dosage form, usually containing less than 20 percent water and volatiles (2) and greater than 50 percent hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. | Ointment Dosage Form | ||
OINTMENT, AUGMENTED | C60984 | An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. | Augmented Ointment Dosage Form | |||
PACKING | C47887 | A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin. | Packing Dosage Form | |||
PASTE | C42967 | A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI) | Paste Dosage Form | |||
PASTE, DENTIFRICE | C42907 | A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI) | Dentifrice Paste Dosage Form | |||
PASTILLE | C60985 | An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. | Pastille Dosage Form | |||
PATCH | C42968 | A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms Extended Release Film and System. | Patch Dosage Form | |||
PATCH, EXTENDED RELEASE | C42923 | A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) | Extended Release Patch Dosage Form | |||
PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED | C42911 | A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) | Electrically Controlled Extended Release Patch Dosage Form | |||
PELLET | C42969 | A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI) | Pellet Dosage Form | |||
PELLET, IMPLANTABLE | C42943 | A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. | Implantable Pellet Dosage Form | |||
PELLETS, COATED, EXTENDED RELEASE | C42918 | A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI) | Extended Release Coated Pellet Dosage Form | |||
PILL | C25394 | A dose of medicine in the form of a small pellet. (NCI) | Pill Dosage Form | |||
PLASTER | C42970 | Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. | Plaster Dosage Form | |||
POULTICE | C47913 | A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI) | Poultice Dosage Form | |||
POWDER | C42972 | An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI) | Powder Dosage Form | |||
POWDER, DENTIFRICE | C42908 | A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI) | Dentifrice Powder Dosage Form | |||
POWDER, FOR SOLUTION | C42973 | An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI) | Powder for Solution Dosage Form | |||
POWDER, FOR SUSPENSION | C42975 | An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI) | Powder for Suspension Dosage Form | |||
POWDER, LYOPHILIZED | C87541 | An intimate mixture of dry, finely divided drugs and/or chemicals that is lyophilized. | Lyophilized Powder Dosage Form | |||
POWDER, METERED | C42961 | A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI) | Metered Powder Dosage Form | |||
RING | C60988 | A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. | Ring Dosage Form | |||
RINSE | C42979 | A liquid used to cleanse by flushing. (NCI) | Rinse Dosage Form | |||
SALVE | C42980 | A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI) | Salve Dosage Form | |||
SHAMPOO | C42981 | A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI) | Shampoo Dosage Form | |||
SHAMPOO, SUSPENSION | C42982 | A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI) | Shampoo Suspension Dosage Form | |||
SOAP | C42983 | Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI) | Soap Dosage Form | |||
SOLID | C45235 | A substance having definite shape and volume manufactured for the administration of active and/or inert ingredient(s). Solids may include, but are not limited to, tablets, capsules, powders, granules, and certain suppositories. | Solid Dosage Form | |||
SOLUTION | C42986 | A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. | Solution Dosage Form | |||
SOLUTION, CONCENTRATE | C42898 | A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI) | Concentrated Solution Dosage Form | |||
SOLUTION, FOR SLUSH | C42987 | A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI) | Solution for Slush Dosage Form | |||
SOLUTION, GEL FORMING / DROPS | C60994 | A solution, which after usually being administered in a drop-wise fashion, forms a gel. | Gel Forming Drop Solution Dosage Form | |||
SOLUTION, GEL FORMING, EXTENDED RELEASE | C42935 | A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency. | Extended Release Gel Forming Solution Dosage Form | |||
SOLUTION/ DROPS | C60992 | A solution which is usually administered in a drop-wise fashion. | Drop Solution Dosage Form | |||
SPONGE | C47912 | A porous, interlacing, absorbent material that contains a drug. It is typically used for applying or introducing medication, or for cleansing. A sponge usually retains its shape. | Sponge Dosage Form | |||
SPRAY | C42989 | A liquid minutely divided as by a jet of air or steam. (NCI) | Spray Dosage Form | |||
SPRAY, METERED | C42962 | A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI) | Metered Spray Dosage Form | |||
SPRAY, SUSPENSION | C42990 | A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI) | Spray Suspension Dosage Form | |||
STICK | C42991 | A dosage form prepared in a relatively long and slender often cylindrical form. (NCI) | Stick Dosage Form | |||
STRIP | C47914 | A long narrow piece of material. | Strip Dosage Form | |||
SUPPOSITORY | C42993 | supp | A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. | Suppository Dosage Form | ||
SUPPOSITORY, EXTENDED RELEASE | C42924 | A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI) | Extended Release Suppository Dosage Form | |||
SUSPENSION | C42994 | Ready to Use Suspension;susp | A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. | Suspension Dosage Form | ||
SUSPENSION, EXTENDED RELEASE | C42925 | A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) | Extended Release Suspension Dosage Form | |||
SUSPENSION/DROPS | C60995 | A suspension which is usually administered in a dropwise fashion. | Drop Suspension Dosage Form | |||
SUTURE | C47889 | A strand or fiber used to hold wound edges in apposition during healing. (NCI) | Suture Dosage Form | |||
SWAB | C47898 | A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing. | Swab Dosage Form | |||
SYRUP | C42996 | An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions. (NCI) | Syrup Dosage Form | |||
TABLET | C42998 | tab | A solid dosage form containing medicinal substances with or without suitable diluents. (NCI) | Tablet Dosage Form | ||
TABLET, CHEWABLE | C42893 | A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI) | Chewable Tablet Dosage Form | |||
TABLET, COATED PARTICLES | C60997 | A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. | Tablet Coated Particle Dosage Form | |||
TABLET, COATED | C42897 | A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI) | Coated Tablet Dosage Form | |||
TABLET, DELAYED RELEASE PARTICLES | C42997 | A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI) | Delayed Release Particle Tablet Dosage Form | |||
TABLET, DELAYED RELEASE | C42905 | Tablet, Gastro-Resistant | A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI) | Delayed Release Tablet Dosage Form | ||
TABLET, EFFERVESCENT | C42910 | A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration. | Effervescent Tablet Dosage Form | |||
TABLET, EXTENDED RELEASE | C42927 | Tablet, Prolonged Release | A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI) | Extended Release Tablet Dosage Form | ||
TABLET, FILM COATED | C42931 | A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI) | Film Coated Tablet Dosage Form | |||
TABLET, FILM COATED, EXTENDED RELEASE | C42930 | A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. | Film Coated Extended Release Tablet Dosage Form | |||
TABLET, FOR SOLUTION | C61004 | A tablet that forms a solution when placed in a liquid. | Tablet for Solution Dosage Form | |||
TABLET, FOR SUSPENSION | C61005 | A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet). | Tablet for Suspension Dosage Form | |||
TABLET, IMMEDIATE RELEASE | C142248 | A solid dosage form containing medicinal substances with or without suitable diluents, which is designed to release its active and/or inert ingredient(s) immediately upon administration. | Immediate Release Tablet Dosage Form | |||
TABLET, IMMEDIATE RELEASE, SOLID DISPERSION | C162112 | A solid dosage form containing one or more active pharmaceutical ingredient which can be dispersed in a carrier at solid state, and immediately released upon administration. (NCI) | Solid Dispersion Immediate Release Tablet Dosage Form | |||
TABLET, MODIFIED RELEASE | C170453 | A solid dosage form exhibiting an altered inherent rate of release of active and/or inert ingredient(s). | Modified Release Tablet Dosage Form | |||
TABLET, MODIFIED RELEASE, LONG DURATION | C170573 | A solid dosage form exhibiting an altered inherent rate of release of active and/or inert ingredient(s) that is classified as long. | Long Modified Release Tablet Dosage Form | |||
TABLET, MODIFIED RELEASE, SHORT DURATION | C170574 | A solid dosage form exhibiting an altered inherent rate of release of active and/or inert ingredient(s) that is classified as short. | Short Modified Release Tablet Dosage Form | |||
TABLET, MULTILAYER | C42964 | A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI) | Multilayered Tablet Dosage Form | |||
TABLET, MULTILAYER, EXTENDED RELEASE | C42963 | A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI) | Multilayered Extended Release Tablet Dosage Form | |||
TABLET, ORALLY DISINTEGRATING | C42999 | A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue. (NCI) | Orally Disintegrating Tablet Dosage Form | |||
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | C61006 | A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. | Orally Disintegrating Delayed Release Tablet Dosage Form | |||
TABLET, SOLUBLE | C42985 | A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI) | Soluble Tablet Dosage Form | |||
TABLET, SUGAR COATED | C42992 | A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI) | Sugar Coated Tablet Dosage Form | |||
TAMPON | C47892 | A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI) | Tampon Dosage Form | |||
TAPE | C47897 | A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI) | Tape Dosage Form | |||
TINCTURE | C43000 | An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances. (NCI) | Tincture Dosage Form | |||
TROCHE | C43001 | A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients. (NCI) | Troche Dosage Form | |||
UNASSIGNED | C43002 | A dosage form has yet to be assigned. (NCI) | Unassigned Dosage Form | |||
UNKNOWN | C150001 | The type of pharmaceutical dose form is unknown, or has unspecified or variable physical characteristics. (EDQM) | Unknown Dosage Form Category | |||
VAGINAL RING | C91199 | A ring composed of active and/or inert ingredient(s), intended for administration in or around the vagina. | Vaginal Ring Dosage Form | |||
WAFER | C43003 | A thin slice of material containing a medicinal agent. (NCI) | Wafer Dosage Form | |||
Back to top | ||||||
CL.C95121.PHSPRPCD | Physical Properties Test Code
(PHSPRPCD) | text
Extensible: Yes | C95121 | Physical Properties Test Code | Terminology relevant to the test codes that describe the physical characteristics of an entity. | CDISC SDTM Physical Properties Test Code Terminology |
COLOR | C37927 | Color | The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) | Color | ||
CONSIST | C95110 | Consistency | A description about the firmness or make-up of an entity. | Consistency | ||
DEPTH | C25333 | Depth | The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) | Depth | ||
DESCR | C25365 | Description | A written or verbal account, representation, statement, or explanation of something. (NCI) | Description | ||
DIAMETER | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
HAIRCOV | C95109 | Hair Cover | A description of the quantity or quality of the hair or fur covering a biological entity. (NCI) | Hair or Fur Cover | ||
LENGTH | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
SHAPE | C25677 | Shape | The spatial arrangement of something as distinct from its substance. (NCI) | Shape | ||
ULCER | C25757 | Ulceration | The formation or development of an ulcer. (NCI) | Ulceration | ||
WIDTH | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
Back to top | ||||||
CL.C95120.PHSPRP | Physical Properties Test Name
(PHSPRP) | text
Extensible: Yes | C95120 | Physical Properties Test Name | Terminology relevant to the test names that describe the physical characteristics of an entity. | CDISC SDTM Physical Properties Test Name Terminology |
Color | C37927 | Color | The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) | Color | ||
Consistency | C95110 | Consistency | A description about the firmness or make-up of an entity. | Consistency | ||
Depth | C25333 | Depth | The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) | Depth | ||
Description | C25365 | Description | A written or verbal account, representation, statement, or explanation of something. (NCI) | Description | ||
Diameter | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
Hair Cover | C95109 | Hair Cover | A description of the quantity or quality of the hair or fur covering a biological entity. (NCI) | Hair or Fur Cover | ||
Length | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
Shape | C25677 | Shape | The spatial arrangement of something as distinct from its substance. (NCI) | Shape | ||
Ulceration | C25757 | Ulceration | The formation or development of an ulcer. (NCI) | Ulceration | ||
Width | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
Back to top | ||||||
CL.C172330.PKANMET | PK Analytical Method
(PKANMET) | text
Extensible: Yes | C172330 | PK Analytical Method | Terminology relevant to the formula or analysis method associated with a pharmacokinetic parameter calculation. | CDISC SDTM PK Analytical Method Terminology |
LIN-LOG TRAPEZOIDAL METHOD | C172579 | Linear-Logarithmic Trapezoidal Method | An AUC calculation method that utilizes the linear trapezoidal interpolation rule up to the maximum concentration (Cmax) and Logarithmic trapezoidal interpolation for the remainder of the concentration curve. | Linear-Logarithmic Trapezoidal Method | ||
LINEAR TRAPEZOIDAL - LOG INTERPOLATION METHOD | C172582 | Linear Trapezoidal - Logarithmic Interpolation Method | An AUC calculation method that utilizes the linear trapezoidal interpolation rule for the entire concentration curve, except when partial areas are selected with no measured endpoint, then logarithmic interpolation is used to calculate the missing data. | Linear Trapezoidal - Log Interpolation Method | ||
LINEAR TRAPEZOIDAL METHOD | C172580 | An AUC calculation method that utilizes the linear trapezoidal interpolation rule for the entire concentration curve. | Linear Trapezoidal Method | |||
LINEAR UP LOG DOWN METHOD | C172581 | An AUC calculation method that utilizes linear trapezoidal interpolation between two points any time the measured concentration increases and logarithmic trapezoidal interpolation between two points any time the concentration decreases over the entire concentration curve. | Linear Up Log Down Method | |||
Back to top | ||||||
CL.C85493.PKPARM | PK Parameters
(PKPARM) | text
Extensible: Yes | C85493 | PK Parameters | Parameters used to describe the time-concentration curve. | CDISC SDTM Pharmacokinetic Parameter Long Name Terminology |
Absolute Bioavailability | C154838 | Absolute Bioavailability | The fraction of the treatment dose that reaches the systemic circulation; this is the ratio of the amount of drug in the system (area under the curve) after extravascular administration of a test formulation divided by the drug in the system (area under the curve) after IV administration. | Absolute Bioavailability | ||
Accum Ratio AUC Infinity Obs | C170611 | Accum Ratio AUC Infinity Obs | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration during the initial dosing interval. | Accumulation Ratio AUC Infinity Observed | ||
Accum Ratio AUC Infinity Pred | C170612 | Accum Ratio AUC Infinity Pred | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration during the initial dosing interval. | Accumulation Ratio AUC Infinity Predicted | ||
Accum Ratio AUC T1 to T2 norm by dose | C132436 | Accum Ratio AUC T1 to T2 norm by dose | The area under the curve from T1 to T2 at steady state divided by the area under the curve from T1 to T2 during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio AUC T1 to T2 Normalized by Dose | ||
Accum Ratio AUC to Last Nonzero Conc | C139129 | Accum Ratio AUC to Last Nonzero Conc | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the area under the curve from the time of dosing to the last measurable concentration during the initial dosing interval. | Accumulation Ratio AUC to Last Nonzero Concentration | ||
Accum Ratio AUCIFO Norm by Dose | C170613 | Accum Ratio AUCIFO Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio AUC Infinity Observed Normalized by Dose | ||
Accum Ratio AUCIFP Norm by Dose | C170614 | Accum Ratio AUCIFP Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio AUC Infinity Predicted Normalized by Dose | ||
Accum Ratio AUCTAU norm by dose | C132435 | Accum Ratio AUCTAU norm by dose | The area under the curve (AUCTAU) at steady state divided by the area under the curve (AUCTAU) over the initial dosing interval, each divided by the associated dose. | Accumulation Ratio AUC Over Dosing Interval Normalized by Dose | ||
Accum Ratio Cmax norm by dose | C132437 | Accum Ratio Cmax norm by dose | The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio Cmax Normalized by Dose | ||
Accum Ratio Cmin norm by dose | C132438 | Accum Ratio Cmin norm by dose | The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio Cmin Normalized by Dose | ||
Accum Ratio Ctrough norm by dose | C132439 | Accum Ratio Ctrough norm by dose | The trough concentration at steady state divided by the trough concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio Ctrough Normalized by Dose | ||
Accumulation Index using Lambda z | C114234 | Accumulation Index using Lambda z | Predicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data. | Accumulation Index using Lambda z | ||
Accumulation Ratio AUC from T1 to T2 | C122329 | Accumulation Ratio AUC from T1 to T2 | The area under the curve from T1 to T2 at steady state divided by the area under the curve from T1 to T2 during the initial dosing interval. | Accumulation Ratio Area Under the Curve from T1 to T2 | ||
Accumulation Ratio AUCTAU | C102356 | Accumulation Ratio AUCTAU | The area under the curve over the dosing interval at steady state divided by the area under the curve over the initial dosing interval. | Accumulation Ratio Area Under the Curve | ||
Accumulation Ratio Cmax | C102357 | Accumulation Ratio Cmax | The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval. | Accumulation Ratio Cmax | ||
Accumulation Ratio Cmin | C102358 | Accumulation Ratio Cmin | The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval. | Accumulation Ratio Cmin | ||
Accumulation Ratio Ctrough | C102426 | Accumulation Ratio Ctrough | The trough concentration at steady state divided by the trough concentration during the initial dosing interval. | Accumulation Ratio Ctrough | ||
Amt of Analyte at Steady State | C181513 | Amt of Analyte at Steady State | The amount of analyte in the body at steady state. | Amount of Analyte at Steady State | ||
Amt of Analyte at Time T | C181514 | Amt of Analyte at Time T | The amount of analyte in the body at any time t. | Amount of Analyte at Time T | ||
Amt Rec from T1 to T2 Norm by BMI | C102360 | Amt Rec from T1 to T2 Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index. | Amount Recovered from T1 to T2 Normalized by Body Mass Index | ||
Amt Rec from T1 to T2 Norm by SA | C102361 | Amt Rec from T1 to T2 Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area. | Amount Recovered from T1 to T2 Normalized by Surface Area | ||
Amt Rec from T1 to T2 Norm by WT | C102362 | Amt Rec from T1 to T2 Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight. | Amount Recovered from T1 to T2 Normalized by Weight | ||
Amt Rec from T1 to T2 | C102359 | Amt Rec from T1 to T2 | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2. | Amount Recovered from T1 to T2 | ||
Amt Rec Infinity Obs Norm by BMI | C112223 | Amt Rec Infinity Obs Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Amount Recovered Infinity Observed Normalized by Body Mass Index | ||
Amt Rec Infinity Obs Norm by SA | C112224 | Amt Rec Infinity Obs Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Amount Recovered Infinity Observed Normalized by Surface Area | ||
Amt Rec Infinity Obs Norm by WT | C112225 | Amt Rec Infinity Obs Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | Amount Recovered Infinity Observed Normalized by Weight | ||
Amt Rec Infinity Obs | C112032 | Amt Rec Infinity Obs | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Amount Recovered Infinity Observed | ||
Amt Rec Infinity Pred Norm by BMI | C112226 | Amt Rec Infinity Pred Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Amount Recovered Infinity Predicted Normalized by Body Mass Index | ||
Amt Rec Infinity Pred Norm by SA | C112227 | Amt Rec Infinity Pred Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Amount Recovered Infinity Predicted Normalized by Surface Area | ||
Amt Rec Infinity Pred Norm by WT | C112228 | Amt Rec Infinity Pred Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Amount Recovered Infinity Predicted Normalized by Weight | ||
Amt Rec Infinity Pred | C112033 | Amt Rec Infinity Pred | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Amount Recovered Infinity Predicted | ||
Amt Rec Over Dosing Interval Norm by BMI | C102364 | Amt Rec Over Dosing Interval Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index. | Amount Recovered Over Dosing Interval Normalized by Body Mass Index | ||
Amt Rec Over Dosing Interval Norm by SA | C102365 | Amt Rec Over Dosing Interval Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area. | Amount Recovered Over Dosing Interval Normalized by Surface Area | ||
Amt Rec Over Dosing Interval Norm by WT | C102366 | Amt Rec Over Dosing Interval Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight. | Amount Recovered Over Dosing Interval Normalized by Weight | ||
Amt Rec Over Dosing Interval | C102363 | Amt Rec Over Dosing Interval | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU). | Amount Recovered Over Dosing Interval | ||
Amt Rec to Last Nonzero Conc | C174346 | Amt Rec to Last Nonzero Conc | The cumulative amount recovered from the specimen type specified in PPSPEC, from the time of dosing to the last non-zero concentration. | Amount Recovered to Last Nonzero Concentration | ||
Apparent CL for Unbound Drug | C154844 | Apparent CL for Unbound Drug | The total apparent clearance of the unbound fraction of drug, adjusted for bioavailability. | Apparent Clearance for Unbound Drug | ||
AUC %Back Extrapolation Obs | C85763 | AUC %Back Extrapolation Obs | Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the observed value of the last non-zero concentration. | Observed Area Under the Curve Percent Back Extrapolation | ||
AUC %Back Extrapolation Pred | C85787 | AUC %Back Extrapolation Pred | Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the predicted value of the last non-zero concentration. | Predicted Area Under the Curve Percent Back Extrapolation | ||
AUC %Extrapolation Obs | C85764 | AUC %Extrapolation Obs | The area under the curve (AUC) from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. | Observed Area Under the Curve Percent Extrapolation | ||
AUC %Extrapolation Pred | C85788 | AUC %Extrapolation Pred | The area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. | Predicted Area Under the Curve Percent Extrapolation | ||
AUC All Norm by BMI | C92362 | AUC All Norm by BMI | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Body Mass Index | ||
AUC All Norm by Dose | C92306 | AUC All Norm by Dose | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Dose | ||
AUC All Norm by SA | C92307 | AUC All Norm by SA | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Surface Area | ||
AUC All Norm by WT | C92308 | AUC All Norm by WT | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Weight | ||
AUC All | C85564 | AUC All | The area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not. | Area Under the Curve All | ||
AUC from T1 to T2 Norm by BMI | C92312 | AUC from T1 to T2 Norm by BMI | The area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index. | AUC from T1 to T2 Normalized by Body Mass Index | ||
AUC from T1 to T2 Norm by Dose | C92313 | AUC from T1 to T2 Norm by Dose | The area under the curve (AUC) over the interval from T1 to T2 divided by the dose. | AUC from T1 to T2 Normalized by Dose | ||
AUC from T1 to T2 Norm by SA | C92314 | AUC from T1 to T2 Norm by SA | The area under the curve (AUC) over the interval from T1 to T2 divided by the surface area. | AUC from T1 to T2 Normalized by Surface Area | ||
AUC from T1 to T2 Norm by WT | C92315 | AUC from T1 to T2 Norm by WT | The area under the curve (AUC) over the interval from T1 to T2 divided by the weight. | AUC from T1 to T2 Normalized by Weight | ||
AUC from T1 to T2 | C85566 | AUC from T1 to T2 | The area under the curve (AUC) over the interval from T1 to T2. | Area Under the Curve from T1 to T2 | ||
AUC Infinity Obs LN Transformed | C161413 | AUC Infinity Obs LN Transformed | The natural log transformed area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Natural Log Transformed Observed Area Under the Curve Infinity | ||
AUC Infinity Obs Norm by BMI | C92316 | AUC Infinity Obs Norm by BMI | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | AUC Infinity Observed Normalized by Body Mass Index | ||
AUC Infinity Obs Norm by Dose | C96695 | AUC Infinity Obs Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. | AUC Infinity Observed Normalized by Dose | ||
AUC Infinity Obs Norm by Dose/WT | C174345 | AUC Infinity Obs Norm by Dose/WT | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the body weight-adjusted dose. | AUC Infinity Observed Normalized by Weight-Adjusted Dose | ||
AUC Infinity Obs Norm by SA | C92317 | AUC Infinity Obs Norm by SA | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | AUC Infinity Observed Normalized by Surface Area | ||
AUC Infinity Obs Norm by WT | C92318 | AUC Infinity Obs Norm by WT | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | AUC Infinity Observed Normalized by Weight | ||
AUC Infinity Obs | C85761 | AUC Infinity Obs | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Area Under the Curve Infinity | ||
AUC Infinity Obs, Unbound Drug | C154845 | AUC Infinity Obs, Unbound Drug | The portion of observed AUC to infinity, represented by the unbound fraction of drug. | Observed Area Under the Curve Infinity of Unbound Drug | ||
AUC Infinity Pred Norm by BMI | C92319 | AUC Infinity Pred Norm by BMI | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | AUC Infinity Predicted Normalized by Body Mass Index | ||
AUC Infinity Pred Norm by Dose | C85786 | AUC Infinity Pred Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Predicted Area Under the Curve Infinity by Dose | ||
AUC Infinity Pred Norm by SA | C92320 | AUC Infinity Pred Norm by SA | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | AUC Infinity Predicted Normalized by Surface Area | ||
AUC Infinity Pred Norm by WT | C92321 | AUC Infinity Pred Norm by WT | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | AUC Infinity Predicted Normalized by Weight | ||
AUC Infinity Pred | C85785 | AUC Infinity Pred | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Area Under the Curve Infinity | ||
AUC Infinity Pred, Unbound Drug | C154846 | AUC Infinity Pred, Unbound Drug | The portion of predicted AUC to infinity, represented by the unbound fraction of drug. | Predicted Area Under the Curve Infinity of Unbound Drug | ||
AUC Over Dosing Interval Norm by BMI | C92322 | AUC Over Dosing Interval Norm by BMI | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index. | AUC Over Dosing Interval Normalized by Body Mass Index | ||
AUC Over Dosing Interval Norm by Dose | C92323 | AUC Over Dosing Interval Norm by Dose | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose. | AUC Over Dosing Interval Normalized by Dose | ||
AUC Over Dosing Interval Norm by SA | C92324 | AUC Over Dosing Interval Norm by SA | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area. | AUC Over Dosing Interval Normalized by Surface Area | ||
AUC Over Dosing Interval Norm by WT | C92325 | AUC Over Dosing Interval Norm by WT | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight. | AUC Over Dosing Interval Normalized by Weight | ||
AUC Over Dosing Interval | C85567 | AUC Over Dosing Interval | The area under the curve (AUC) for the defined interval between doses (TAU). | Area Under the Curve Over Dosing Interval | ||
AUC to Last Nonzero Conc LN Transformed | C161414 | AUC to Last Nonzero Conc LN Transformed | The natural log transformed area under the curve (AUC) from the time of dosing to the last measurable concentration. | Natural Log Transformed Area Under the Curve From Dosing to Last Concentration | ||
AUC to Last Nonzero Conc Norm by BMI | C92309 | AUC to Last Nonzero Conc Norm by BMI | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index. | AUC Dosing to Last Concentration Normalized by Body Mass Index | ||
AUC to Last Nonzero Conc Norm by Dose | C92310 | AUC to Last Nonzero Conc Norm by Dose | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose. | AUC Dosing to Last Concentration Normalized by Dose | ||
AUC to Last Nonzero Conc Norm by SA | C92311 | AUC to Last Nonzero Conc Norm by SA | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area. | AUC Dosing to Last Concentration Normalized by Surface Area | ||
AUC to Last Nonzero Conc Norm by WT | C92305 | AUC to Last Nonzero Conc Norm by WT | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight. | AUC Dosing to Last Concentration Normalized by Weight | ||
AUC to Last Nonzero Conc | C85565 | AUC to Last Nonzero Conc | The area under the curve (AUC) from the time of dosing to the last measurable concentration. | Area Under the Curve From Dosing to Last Concentration | ||
AUC to Last Nonzero Conc, Unbound Drug | C154847 | AUC to Last Nonzero Conc, Unbound Drug | The portion of the area under the curve (AUC) from the time of dosing to the last measurable concentration, represented by the unbound fraction of drug. | Area Under the Curve From Dosing to Last Concentration of Unbound Drug | ||
AUCIFPDW Norm by Dose/WT | C174349 | AUC Infinity Pred Norm by Dose per Body Weight;AUCIFPDW Norm by Dose/WT | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the body weight-adjusted dose. | AUC Infinity Predicted Normalized by Weight-Adjusted Dose | ||
AUCINT Norm by Dose/WT | C174348 | AUC from T1 to T2 Norm by Dose per Body Weight;AUCINT Norm by Dose/kg WT | The area under the curve (AUC) over the interval from T1 to T2 divided by the body weight-adjusted dose. | AUC from T1 to T2 Normalized by Weight-Adjusted Dose | ||
AUCLST Norm by Dose/WT | C174347 | AUC to Last Nonzero Conc Norm by Dose per Body Weight;AUCLST Norm by Dose/WT | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body weight-adjusted dose. | AUC Dosing From Dosing to Last Concentration Normalized by Weight-Adjusted Dose | ||
AUCTAU Norm by Dose/WT | C174350 | AUC Over Dosing Interval Norm by Dose per Body Weight;AUCTAU Norm by Dose/WT | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body weight-adjusted dose. | AUC Over Dosing Interval Normalized by Weight-Adjusted Dose | ||
AUMC % Extrapolation Obs | C85766 | AUMC % Extrapolation Obs | The area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. | Observed Area Under the First Moment Curve Percent Extrapolation | ||
AUMC % Extrapolation Pred | C85790 | AUMC % Extrapolation Pred | The area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. | Predicted Area Under the First Moment Curve Percent Extrapolation | ||
AUMC Infinity Obs Norm by BMI | C92330 | AUMC Infinity Obs Norm by BMI | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | AUMC Infinity Observed Normalized by Body Mass Index | ||
AUMC Infinity Obs Norm by Dose | C92331 | AUMC Infinity Obs Norm by Dose | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. | AUMC Infinity Observed Normalized by Dose | ||
AUMC Infinity Obs Norm by SA | C92332 | AUMC Infinity Obs Norm by SA | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | AUMC Infinity Observed Normalized by Surface Area | ||
AUMC Infinity Obs Norm by WT | C92333 | AUMC Infinity Obs Norm by WT | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | AUMC Infinity Observed Normalized by Weight | ||
AUMC Infinity Obs | C85765 | AUMC Infinity Obs | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Area Under the First Moment Curve Infinity | ||
AUMC Infinity Pred Norm by BMI | C92334 | AUMC Infinity Pred Norm by BMI | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | AUMC Infinity Predicted Normalized by Body Mass Index | ||
AUMC Infinity Pred Norm by Dose | C92335 | AUMC Infinity Pred Norm by Dose | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. | AUMC Infinity Predicted Normalized by Dose | ||
AUMC Infinity Pred Norm by SA | C92336 | AUMC Infinity Pred Norm by SA | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | AUMC Infinity Predicted Normalized by Surface Area | ||
AUMC Infinity Pred Norm by WT | C92337 | AUMC Infinity Pred Norm by WT | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | AUMC Infinity Predicted Normalized by Weight | ||
AUMC Infinity Pred | C85789 | AUMC Infinity Pred | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Area Under the First Moment Curve Infinity | ||
AUMC Over Dosing Interval Norm by BMI | C92338 | AUMC Over Dosing Interval Norm by BMI | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index. | AUMC Over Dosing Interval Normalized by Body Mass Index | ||
AUMC Over Dosing Interval Norm by Dose | C92339 | AUMC Over Dosing Interval Norm by Dose | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose. | AUMC Over Dosing Interval Normalized by Dose | ||
AUMC Over Dosing Interval Norm by SA | C92340 | AUMC Over Dosing Interval Norm by SA | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area. | AUMC Over Dosing Interval Normalized by Surface Area | ||
AUMC Over Dosing Interval Norm by WT | C92341 | AUMC Over Dosing Interval Norm by WT | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight. | AUMC Over Dosing Interval Normalized by Weight | ||
AUMC Over Dosing Interval | C85570 | AUMC Over Dosing Interval | The area under the first moment curve (AUMC) for the defined interval between doses (TAU). | Area Under the First Moment Curve Over Dosing Interval | ||
AUMC to Last Nonzero Conc Norm by BMI | C92326 | AUMC to Last Nonzero Conc Norm by BMI | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index. | AUMC Dosing to Last Concentration Normalized by Body Mass Index | ||
AUMC to Last Nonzero Conc Norm by Dose | C92327 | AUMC to Last Nonzero Conc Norm by Dose | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose. | AUMC Dosing to Last Concentration Normalized by Dose | ||
AUMC to Last Nonzero Conc Norm by SA | C92328 | AUMC to Last Nonzero Conc Norm by SA | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area. | AUMC Dosing to Last Concentration Normalized by Surface Area | ||
AUMC to Last Nonzero Conc Norm by WT | C92329 | AUMC to Last Nonzero Conc Norm by WT | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight. | AUMC Dosing to Last Concentration Normalized by Weight | ||
AUMC to Last Nonzero Conc | C85569 | AUMC to Last Nonzero Conc | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration. | Area Under the First Moment Curve From Dosing to Last Concentration | ||
AURC % Extrapolation Obs | C85768 | AURC % Extrapolation Obs | The area under the excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the excretion rate curve extrapolated to infinity. | Observed Area Under the Excretion Rate Curve Percent Extrapolation | ||
AURC % Extrapolation Pred | C85792 | AURC % Extrapolation Pred | The area under the excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the excretion rate curve extrapolated to infinity. | Predicted Area Under the Excretion Rate Curve Percent Extrapolation | ||
AURC All Norm by BMI | C92342 | AURC All Norm by BMI | The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index. | AURC All Normalized by Body Mass Index | ||
AURC All Norm by Dose | C92343 | AURC All Norm by Dose | The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose. | AURC All Normalized by Dose | ||
AURC All Norm by SA | C92344 | AURC All Norm by SA | The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area. | AURC All Normalized by Surface Area | ||
AURC All Norm by WT | C92345 | AURC All Norm by WT | The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight. | AURC All Normalized by Weight | ||
AURC All | C85841 | AURC All | The area under the excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not. | Area Under Excretion Rate Curve All | ||
AURC Dosing to Last Conc Norm by BMI | C92346 | AURC to Last Nonzero Rate Norm by BMI | The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index. | AURC Dosing to Last Concentration Normalized by Body Mass Index | ||
AURC Dosing to Last Conc Norm by Dose | C92347 | AURC to Last Nonzero Rate Norm by Dose | The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose. | AURC Dosing to Last Concentration Normalized by Dose | ||
AURC Dosing to Last Conc Norm by SA | C92348 | AURC to Last Nonzero Rate Norm by SA | The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area. | AURC Dosing to Last Concentration Normalized by Surface Area | ||
AURC Dosing to Last Conc Norm by WT | C92349 | AURC to Last Nonzero Rate Norm by WT | The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight. | AURC Dosing to Last Concentration Normalized by Weight | ||
AURC from T1 to T2 Norm by BMI | C92350 | AURC from T1 to T2 Norm by BMI | The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index. | AURC from T1 to T2 Normalized by Body Mass Index | ||
AURC from T1 to T2 Norm by Dose | C92351 | AURC from T1 to T2 Norm by Dose | The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose. | AURC from T1 to T2 Normalized by Dose | ||
AURC from T1 to T2 Norm by SA | C92352 | AURC from T1 to T2 Norm by SA | The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area. | AURC from T1 to T2 Normalized by Surface Area | ||
AURC from T1 to T2 Norm by WT | C92353 | AURC from T1 to T2 Norm by WT | The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight. | AURC from T1 to T2 Normalized by Weight | ||
AURC from T1 to T2 | C85572 | AURC from T1 to T2 | The area under the excretion rate curve (AURC) over the interval from T1 to T2. | Area Under the Excretion Rate Curve from T1 to T2 | ||
AURC Infinity Obs Norm by BMI | C92354 | AURC Infinity Obs Norm by BMI | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index. | AURC Infinity Observed Normalized by Body Mass Index | ||
AURC Infinity Obs Norm by Dose | C92355 | AURC Infinity Obs Norm by Dose | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose. | AURC Infinity Observed Normalized by Dose | ||
AURC Infinity Obs Norm by SA | C92356 | AURC Infinity Obs Norm by SA | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area. | AURC Infinity Observed Normalized by Surface Area | ||
AURC Infinity Obs Norm by WT | C92357 | AURC Infinity Obs Norm by WT | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight. | AURC Infinity Observed Normalized by Weight | ||
AURC Infinity Obs | C85767 | AURC Infinity Obs | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate. | Observed Area Under the Excretion Rate Curve infinity | ||
AURC Infinity Pred Norm by BMI | C92358 | AURC Infinity Pred Norm by BMI | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the body mass index. | AURC Infinity Predicted Normalized by Body Mass Index | ||
AURC Infinity Pred Norm by Dose | C92359 | AURC Infinity Pred Norm by Dose | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the dose. | AURC Infinity Predicted Normalized by Dose | ||
AURC Infinity Pred Norm by SA | C92360 | AURC Infinity Pred Norm by SA | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the surface area. | AURC Infinity Predicted Normalized by Surface Area | ||
AURC Infinity Pred Norm by WT | C92361 | AURC Infinity Pred Norm by WT | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the weight. | AURC Infinity Predicted Normalized by Weight | ||
AURC Infinity Pred | C85791 | AURC Infinity Pred | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate. | Predicted Area Under the Excretion Rate Curve Infinity | ||
AURC to Last Nonzero Rate | C85571 | AURC to Last Nonzero Rate | The area under the excretion rate curve (AURC) from time zero to the time of the last measurable concentration. | Area Under the Excretion Rate Curve From Dosing to Last Concentration | ||
Average Conc from T1 to T2 Norm by BMI | C132440 | Average Conc from T1 to T2 Norm by BMI | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the body mass index. | Average Concentration from T1 to T2 Normalized by Body Mass Index | ||
Average Conc from T1 to T2 Norm by Dose | C132441 | Average Conc from T1 to T2 Norm by Dose | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the dose. | Average Concentration from T1 to T2 Normalized by Dose | ||
Average Conc from T1 to T2 Norm by SA | C132442 | Average Conc from T1 to T2 Norm by SA | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the surface area. | Average Concentration from T1 to T2 Normalized by Surface Area | ||
Average Conc from T1 to T2 Norm by WT | C132443 | Average Conc from T1 to T2 Norm by WT | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the weight. | Average Concentration from T1 to T2 Normalized by Weight | ||
Average Conc from T1 to T2 | C132302 | Average Conc from T1 to T2 | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval. | Average Concentration from T1 to T2 | ||
Average Conc Norm by BMI | C92367 | Average Conc Norm by BMI | AUCTAU divided by TAU and then divided by the body mass index. | Average Concentration Normalized by Body Mass Index | ||
Average Conc Norm by Dose | C92368 | Average Conc Norm by Dose | AUCTAU divided by TAU and then divided by the dose. | Average Concentration Normalized by Dose | ||
Average Conc Norm by SA | C92369 | Average Conc Norm by SA | AUCTAU divided by TAU and then divided by the surface area. | Average Concentration Normalized by Surface Area | ||
Average Conc Norm by WT | C92370 | Average Conc Norm by WT | AUCTAU divided by TAU and then divided by the weight. | Average Concentration Normalized by Weight | ||
Average Concentration Norm by Dose/WT | C174351 | Average Concentration Norm by Dose/WT | AUCTAU divided by TAU divided by the body weight-adjusted dose. | Average Concentration Normalized by Weight-Adjusted Dose | ||
Average Concentration | C85575 | Average Concentration | AUCTAU divided by TAU. | Average Concentration | ||
Average of Conc Trough | C181516 | Average of Conc Trough | The arithmetic average of two or more trough concentrations. | Average of Trough Concentration | ||
CAVGINT Norm by Dose/WT | C174352 | Average Conc from T1 to T2 Norm by Dose per Body Weight;CAVGINT Norm by Dose/WT | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval divided by the body weight-adjusted dose. | Average Concentration from T1 to T2 Normalized by Weight-Adjusted Dose | ||
Conc by BMI | C102367 | Conc by BMI | The concentration divided by body mass index. | Concentration Divided by Body Mass Index | ||
Conc by Dose | C102368 | Conc by Dose | The concentration divided by dose. | Concentration Divided by Dose | ||
Conc by SA | C102369 | Conc by SA | The concentration divided by surface area. | Concentration Divided by Surface Area | ||
Conc by WT | C102370 | Conc by WT | The concentration divided by weight. | Concentration Divided by Weight | ||
Conc Trough by BMI | C102395 | Conc Trough by BMI | The trough concentration divided by body mass index. | Trough Concentration Divided by Body Mass Index | ||
Conc Trough by Dose | C102396 | Conc Trough by Dose | The trough concentration divided by dose. | Trough Concentration Divided by Dose | ||
Conc Trough by SA | C102397 | Conc Trough by SA | The trough concentration divided by surface area. | Trough Concentration Divided by Surface Area | ||
Conc Trough by WT | C102398 | Conc Trough by WT | The trough concentration divided by weight. | Trough Concentration Divided by Weight | ||
Conc Trough | C102394 | Conc Trough | Concentration at end of dosing interval. | Trough Concentration | ||
Concentration at End Infusion | C181515 | Concentration at End Infusion | The observed concentration at the end of the infusion. | Concentration at End Infusion | ||
Concentration at Half Tmax | C135489 | Concentration at Half Tmax | The concentration that occurs at the midpoint time between dosing time and Tmax. | Concentration at Half Tmax | ||
Correlation Between TimeX and Log ConcY | C85821 | Correlation Between TimeX and Log ConcY | The correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z. | Time and Log Concentration Correlation | ||
Dosing Interval | C176355 | Dosing Interval | The duration of time between two doses. | Dosing Interval | ||
Effective Half-Life | C95007 | Effective Half-Life | The drug half-life that quantifies the accumulation ratio of a drug following multiple dosing. | Effective Half-life | ||
Excret Rate from T1 to T2 Norm by BMI | C105450 | Excret Rate from T1 to T2 Norm by BMI | The excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by BMI | ||
Excret Rate from T1 to T2 Norm by Dose | C105451 | Excret Rate from T1 to T2 Norm by Dose | The excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by Dose | ||
Excret Rate from T1 to T2 Norm by SA | C105452 | Excret Rate from T1 to T2 Norm by SA | The excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by SA | ||
Excret Rate from T1 to T2 Norm by WT | C105453 | Excret Rate from T1 to T2 Norm by WT | The excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by WT | ||
Excret Rate from T1 to T2 | C105449 | Excret Rate from T1 to T2 | The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 | ||
Fluctuation% | C85581 | Fluctuation% | The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau. | Concentration Variability Between Dose Time and Tau | ||
Fract Excr from T1 to T2 | C156576 | Fract Excr from T1 to T2 | The fraction of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. | Fractional Excretion from T1 to T2 | ||
Fraction Bound | C154840 | Fraction Bound | The percent or ratio of bound substance concentration to the total concentration. | Fraction Bound | ||
Fraction of the Dose Metabolized | C184704 | Fraction of the Dose Metabolized | The fraction of the bioavailable dose which has been metabolized. | Fraction of the Dose Metabolized | ||
Fraction Unbound | C135490 | Fraction Unbound | The percent or ratio of free substance concentration to the total concentration. (NCI) | Fraction Unbound | ||
Half Tmax | C135491 | Half Tmax | The midpoint time between dosing time and Tmax. | Half Tmax | ||
Half-Life Distribution | C172583 | Half-Life Distribution | Half-life calculated from the distributional phase. | Half-Life Distribution | ||
Half-Life Lambda z | C85818 | Half-Life Lambda z | Terminal half-life. | Terminal Half Life | ||
Half-Life TAU | C147483 | Half-Life TAU | Half-life calculated within a dosing interval. | Half-Life TAU | ||
Hemodialysis Clearance | C112287 | Hemodialysis Clearance | The clearance of a substance from the blood during a hemodialysis session. | Hemodialysis Clearance | ||
Hemodialysis Extraction Ratio | C116213 | Hemodialysis Extraction Ratio | The fractional content of a substance removed from the blood during a hemodialysis session. | Hemodialysis Extraction Ratio | ||
Initial Conc Norm by BMI | C92383 | Initial Conc Norm by BMI | Initial concentration divided by the body mass index. Given only for bolus IV models. | Initial Concentration Normalized by Body Mass Index | ||
Initial Conc Norm by Dose | C92384 | Initial Conc Norm by Dose | Initial concentration divided by the dose. Given only for bolus IV models. | Initial Concentration Normalized by Dose | ||
Initial Conc Norm by SA | C92385 | Initial Conc Norm by SA | Initial concentration divided by the surface area. Given only for bolus IV models. | Initial Concentration Normalized by Surface Area | ||
Initial Conc Norm by WT | C92386 | Initial Conc Norm by WT | Initial concentration divided by the weight. Given only for bolus IV models. | Initial Concentration Normalized by Weight | ||
Initial Conc | C85644 | Initial Conc | Initial concentration. Given only for bolus IV models. | Initial Concentration | ||
K Slope of Distribution | C172584 | K Slope of Distribution | The distribution rate constant. | K Slope of Distribution | ||
Lambda z Lower Limit TAU | C147479 | Lambda z Lower Limit TAU | The lower limit on time for values to be included in the calculation of Lambda z, calculated within a dosing interval. | Lambda z Lower Limit TAU | ||
Lambda z Lower Limit | C85653 | Lambda z Lower Limit | The lower limit on time for values to be included in the calculation of Lambda z. | Lambda Z Time Lower Limit | ||
Lambda z Span | C135492 | Lambda z Span | The interval of time covered by the data points used in the terminal disposition phase regression analysis, divided by half life. This yields the terminal disposition phase duration expressed as the number of half lives. | Lambda Z Span | ||
Lambda z TAU | C147481 | Lambda z TAU | The first order rate constant associated with the terminal (log-linear) portion of the curve, calculated within a dosing interval. | Lambda z TAU | ||
Lambda z Upper Limit TAU | C147482 | Lambda z Upper Limit TAU | The upper limit on time for values to be included in the calculation of Lambda z, calculated within a dosing interval. | Lambda z Upper Limit TAU | ||
Lambda z Upper Limit | C85654 | Lambda z Upper Limit | The upper limit on time for values to be included in the calculation of Lambda z. | Lambda Z Time Upper Limit | ||
Lambda z | C85652 | Lambda z | The first order rate constant associated with the terminal (log-linear) portion of the curve. | Lambda Z | ||
Last Meas Excretion Rate Norm by BMI | C92391 | Last Meas Excretion Rate Norm by BMI | The last measurable (positive) excretion rate divided by the body mass index. | Last Measurable Excretion Rate Normalized by Body Mass Index | ||
Last Meas Excretion Rate Norm by Dose | C92392 | Last Meas Excretion Rate Norm by Dose | The last measurable (positive) excretion rate divided by the dose. | Last Measurable Excretion Rate Normalized by Dose | ||
Last Meas Excretion Rate Norm by SA | C92393 | Last Meas Excretion Rate Norm by SA | The last measurable (positive) excretion rate divided by the surface area. | Last Measurable Excretion Rate Normalized by Surface Area | ||
Last Meas Excretion Rate Norm by WT | C92394 | Last Meas Excretion Rate Norm by WT | The last measurable (positive) excretion rate divided by the weight. | Last Measurable Excretion Rate Normalized by Weight | ||
Last Meas Excretion Rate | C85656 | Last Meas Excretion Rate | The last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC. | Last Measurable Observed Excretion Rate | ||
Last Nonzero Conc Norm by BMI | C92387 | Last Nonzero Conc Norm by BMI | The concentration corresponding to Tlast divided by the body mass index. | Last Concentration Normalized by Body Mass Index | ||
Last Nonzero Conc Norm by Dose | C92388 | Last Nonzero Conc Norm by Dose | The concentration corresponding to Tlast divided by the dose. | Last Concentration Normalized by Dose | ||
Last Nonzero Conc Norm by SA | C92389 | Last Nonzero Conc Norm by SA | The concentration corresponding to Tlast divided by the surface area. | Last Concentration Normalized by Surface Area | ||
Last Nonzero Conc Norm by WT | C92390 | Last Nonzero Conc Norm by WT | The concentration corresponding to Tlast divided by the weight. | Last Concentration Normalized by Weight | ||
Last Nonzero Conc | C85655 | Last Nonzero Conc | The concentration corresponding to Tlast. | Last Concentration | ||
Max Conc LN Transformed | C161415 | Max Conc LN Transformed | The natural log transformed maximum concentration occurring at Tmax. | Natural Log Transformed Cmax | ||
Max Conc Norm by BMI | C92371 | Max Conc Norm by BMI | The maximum concentration occurring at Tmax, divided by the body mass index. | Maximum Concentration Normalized by Body Mass Index | ||
Max Conc Norm by Dose | C85698 | Max Conc Norm by Dose | The maximum concentration occurring at Tmax, divided by the dose. | Maximum Concentration Dose Normalized | ||
Max Conc Norm by Dose/WT | C174353 | Max Conc Norm by Dose/WT | The maximum concentration occurring at Tmax divided by the body weight-adjusted dose. | Maximum Concentration Normalized by Weight-Adjusted Dose | ||
Max Conc Norm by SA | C92372 | Max Conc Norm by SA | The maximum concentration occurring at Tmax, divided by the surface area. | Maximum Concentration Normalized by Surface Area | ||
Max Conc Norm by WT | C92373 | Max Conc Norm by WT | The maximum concentration occurring at Tmax, divided by the weight. | Maximum Concentration Normalized by Weight | ||
Max Conc | C70918 | Max Conc | The maximum concentration occurring at Tmax. | Cmax | ||
Max Conc, Unbound Drug | C154848 | Max Conc, Unbound Drug | The maximum concentration represented by the unbound fraction of drug, occurring at Tmax. | Maximum Concentration of Unbound Drug | ||
Max Excretion Rate Norm by BMI | C92395 | Max Excretion Rate Norm by BMI | The maximum excretion rate divided by the body mass index. | Maximum Observed Excretion Rate Normalized by Body Mass Index | ||
Max Excretion Rate Norm by Dose | C92396 | Max Excretion Rate Norm by Dose | The maximum excretion rate divided by the dose. | Maximum Observed Excretion Rate Normalized by Dose | ||
Max Excretion Rate Norm by SA | C92397 | Max Excretion Rate Norm by SA | The maximum excretion rate divided by the surface area. | Maximum Observed Excretion Rate Normalized by Surface Area | ||
Max Excretion Rate Norm by WT | C92398 | Max Excretion Rate Norm by WT | The maximum excretion rate divided by the weight. | Maximum Observed Excretion Rate Normalized by Weight | ||
Max Excretion Rate | C85699 | Max Excretion Rate | The maximum excretion rate determined for the specimen type specified in PPSPEC. | Maximum Observed Excretion Rate | ||
Mean Absorption Time | C120723 | Mean Absorption Time | Mean absorption time of a substance administered by extravascular dosing. | Mean Absorption Time | ||
Midpoint of Interval of Last Nonzero ER | C85580 | Midpoint of Interval of Last Nonzero ER | The midpoint of collection interval associated with last measurable excretion rate. | Collection Interval Midpoint | ||
Midpoint of Interval of Maximum ER | C85823 | Midpoint of Interval of Maximum ER | The midpoint of collection interval associated with the maximum excretion rate. | Time of Maximum Observed Excretion Rate | ||
Min Conc Norm by BMI | C92374 | Min Conc Norm by BMI | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index. | Minimum Concentration Normalized by Body Mass Index | ||
Min Conc Norm by Dose | C92375 | Min Conc Norm by Dose | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose. | Minimum Concentration Normalized by Dose | ||
Min Conc Norm by Dose/WT | C174354 | Min Conc Norm by Dose/WT | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body weight-adjusted dose. | Minimum Concentration Normalized by Weight-Adjusted Dose | ||
Min Conc Norm by SA | C92376 | Min Conc Norm by SA | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area. | Minimum Concentration Normalized by Surface Area | ||
Min Conc Norm by WT | C92377 | Min Conc Norm by WT | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight. | Minimum Concentration Normalized by Weight | ||
Min Conc | C85579 | Min Conc | The minimum concentration between dose time and dose time plus Tau (at Tmin). | Cmin | ||
MRT Extravasc Infinity Obs | C120724 | MRT Extravasc Infinity Obs | The mean residence time (MRT) extrapolated to infinity for a substance administered by extravascular dosing, calculated using the observed value of the last non-zero concentration. Extravascular MRT includes Mean Absorption Time (MAT). | Mean Residence Time Infinity Observed by Extravascular Dose | ||
MRT Extravasc Infinity Pred | C120725 | MRT Extravasc Infinity Pred | The mean residence time (MRT) extrapolated to infinity for a substance administered by extravascular dosing, calculated using the predicted value of the last non-zero concentration. Extravascular MRT includes Mean Absorption Time (MAT). | Mean Residence Time Infinity Predicted by Extravascular Dose | ||
MRT Extravasc to Last Nonzero Conc | C120726 | MRT Extravasc to Last Nonzero Conc | Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration for a substance administered by extravascular dosing. Extravascular MRT includes Mean Absorption Time (MAT). | Mean Residence Time to Last Nonzero Concentration by Extravascular Dose | ||
MRT IV Bolus Infinity Obs | C121134 | MRT IV Bolus Infinity Obs | The mean residence time (MRT) extrapolated to infinity for a substance administered by intravascular bolus dosing, calculated using the observed value of the last non-zero concentration. | Mean Residence Time Infinity Observed by Intravascular Bolus Dose | ||
MRT IV Bolus Infinity Pred | C121136 | MRT IV Bolus Infinity Pred | The mean residence time (MRT) extrapolated to infinity for a substance administered by intravascular bolus dosing, calculated using the predicted value of the last non-zero concentration. | Mean Residence Time Infinity Predicted by Intravascular Bolus Dose | ||
MRT IV Bolus to Last Nonzero Conc | C121137 | MRT IV Bolus to Last Nonzero Conc | Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration, for a substance administered by intravascular bolus dosing. | Mean Residence Time to Last Nonzero Concentration by Intravascular Bolus Dose | ||
MRT IV Cont Inf Infinity Obs | C181517 | MRT IV Cont Inf Infinity Obs | The mean residence time (MRT) extrapolated to infinity for a substance administered by constant rate of continuous intravascular infusion, calculated using the observed value of the last non-zero concentration. | Mean Residence Time Intravenous Continuous Infusion Infinity Observed | ||
MRT IV Cont Inf Infinity Pred | C181518 | MRT IV Cont Inf Infinity Pred | The mean residence time (MRT) extrapolated to infinity for a substance administered by constant rate of continuous intravascular infusion, calculated using the predicted value of the last non-zero concentration. | Mean Residence Time Intravenous Continuous Infusion Infinity Predicted | ||
MRT IV Cont Inf to Last Nonzero Conc | C181519 | MRT IV Cont Inf to Last Nonzero Conc | Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration, for a substance administered by constant rate of continuous intravascular infusion. | Mean Residence Time Intravenous Continuous Infusion to Last Nonzero Concentration | ||
Nonrenal CL Norm by BMI | C105454 | Nonrenal CL Norm by BMI | The total clearance of a substance from the blood minus the renal clearance divided by the body mass index. | Nonrenal Clearance Normalized by BMI | ||
Nonrenal CL Norm by Dose | C105455 | Nonrenal CL Norm by Dose | The total clearance of a substance from the blood minus the renal clearance divided by the dose. | Nonrenal Clearance Normalized by Dose | ||
Nonrenal CL Norm by SA | C105456 | Nonrenal CL Norm by SA | The total clearance of a substance from the blood minus the renal clearance divided by the surface area. | Nonrenal Clearance Normalized by SA | ||
Nonrenal CL Norm by WT | C105457 | Nonrenal CL Norm by WT | The total clearance of a substance from the blood minus the renal clearance divided by the weight. | Nonrenal Clearance Normalized by WT | ||
Nonrenal CL | C102376 | Nonrenal CL | The total clearance of a substance from the blood less the renal clearance. | Nonrenal Clearance | ||
Number of Points for Lambda z TAU | C147480 | Number of Points for Lambda z TAU | The number of time points used in computing Lambda z determined in a dosing interval. | Number of Points for Lambda z TAU | ||
Number of Points for Lambda z | C85816 | Number of Points for Lambda z | The number of time points used in computing Lambda z. | Sum of Lambda Z Timepoints | ||
Pct Rec from T1 to T2 Norm by BMI | C102383 | Pct Rec from T1 to T2 Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index. | Percent Recovered from T1 to T2 Normalized by Body Mass Index | ||
Pct Rec from T1 to T2 Norm by SA | C102384 | Pct Rec from T1 to T2 Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area. | Percent Recovered from T1 to T2 Normalized by Surface Area | ||
Pct Rec from T1 to T2 Norm by WT | C102385 | Pct Rec from T1 to T2 Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight. | Percent Recovered from T1 to T2 Normalized by Weight | ||
Pct Rec from T1 to T2 | C102382 | Pct Rec from T1 to T2 | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. | Percent Recovered from T1 to T2 | ||
Pct Rec Infinity Obs Norm by BMI | C112389 | Pct Rec Infinity Obs Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Percent Recovered Infinity Observed Normalized by Body Mass Index | ||
Pct Rec Infinity Obs Norm by SA | C112390 | Pct Rec Infinity Obs Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Percent Recovered Infinity Observed Normalized by Surface Area | ||
Pct Rec Infinity Obs Norm by WT | C112391 | Pct Rec Infinity Obs Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | Percent Recovered Infinity Observed Normalized by Weight | ||
Pct Rec Infinity Obs | C112034 | Pct Rec Infinity Obs | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Percent Recovered Infinity Observed | ||
Pct Rec Infinity Pred Norm by BMI | C112392 | Pct Rec Infinity Pred Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Percent Recovered Infinity Predicted Normalized by Body Mass Index | ||
Pct Rec Infinity Pred Norm by SA | C112393 | Pct Rec Infinity Pred Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Percent Recovered Infinity Predicted Normalized by Surface Area | ||
Pct Rec Infinity Pred Norm by WT | C112394 | Pct Rec Infinity Pred Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Percent Recovered Infinity Predicted Normalized by Weight | ||
Pct Rec Infinity Pred | C112035 | Pct Rec Infinity Pred | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Percent Recovered Infinity Predicted | ||
Pct Rec Over Dosing Interval Norm by BMI | C102387 | Pct Rec Over Dosing Interval Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index. | Percent Recovered Over Dosing Interval Normalized by Body Mass Index | ||
Pct Rec Over Dosing Interval Norm by SA | C102388 | Pct Rec Over Dosing Interval Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area. | Percent Recovered Over Dosing Interval Normalized by Surface Area | ||
Pct Rec Over Dosing Interval Norm by WT | C102389 | Pct Rec Over Dosing Interval Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight. | Percent Recovered Over Dosing Interval Normalized by Weight | ||
Pct Rec Over Dosing Interval | C102386 | Pct Rec Over Dosing Interval | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU). | Percent Recovered Over Dosing Interval | ||
Pct Rec to Last Nonzero Conc | C166075 | Pct Rec to Last Nonzero Conc | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, from the time of dosing to the last non-zero concentration. | Percent Recovered To Last Nonzero Concentration | ||
Peak Trough Ratio | C102381 | Peak Trough Ratio | The maximum concentration during a dosing interval divided by the concentration at the end of the dosing interval. | Peak Trough Ratio | ||
R Squared Adjusted | C85553 | R Squared Adjusted | The goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z. | Adjusted R Squared | ||
R Squared | C85542 | R Squared | The goodness of fit statistic for the terminal elimination phase. | R Squared | ||
Ratio Amt Rec from T1 to T2 | C176347 | Ratio Amt Rec from T1 to T2 | The ratio of two amount recovered from T1 to T2 values. | Ratio Amount Recovered from T1 to T2 | ||
Ratio Amt Rec Infinity Obs | C176354 | Ratio Amt Rec Infinity Obs | The ratio of two amount recovered infinity observed values. | Ratio Amount Recovered Infinity Observed | ||
Ratio AUC All | C176344 | Ratio AUC All | The ratio of two AUC All values. | AUC All Ratio | ||
Ratio AUC from T1 to T2 Norm by Dose | C176349 | Ratio AUC from T1 to T2 Norm by Dose | The ratio of two AUC from T1 to T2 normalized by dose values. | Ratio AUC from T1 to T2 Normalized by Dose | ||
Ratio AUC from T1 to T2 | C176236 | Ratio AUC from T1 to T2 | The ratio of two AUC from T1 to T2 values. | Ratio AUC From T1 to T2 | ||
Ratio AUC Infinity Obs Norm by Dose | C176348 | Ratio AUC Infinity Obs Norm by Dose | The ratio of two AUC infinity observed normalized by dose values. | Ratio AUC Infinity Observed Normalized by Dose | ||
Ratio AUC Infinity Obs | C156578 | Ratio AUC Infinity Obs | The ratio of two AUC infinity observed values. | Area Under the Curve Ratio Infinity Observed | ||
Ratio AUC Infinity Pred | C156577 | Ratio AUC Infinity Pred | The ratio of two AUC infinity predicted values. | Area Under the Curve Ratio Infinity Predicted | ||
Ratio AUC Over Dosing Interval | C176351 | Ratio AUC Over Dosing Interval | The ratio of two AUCTAU values. | Ratio AUC Over Dosing Interval | ||
Ratio AUC to Last Nonzero Conc | C176237 | Ratio AUC to Last Nonzero Conc | The ratio of two AUC to last nonzero concentration values. | Ratio AUC to Last Nonzero Concentration | ||
Ratio AUC | C156471 | Ratio AUC | The ratio of two AUC values. | Area Under the Curve Ratio | ||
Ratio Average Concentration | C176345 | Ratio Average Concentration | The ratio of two average concentration values. | Average Concentration Ratio | ||
Ratio CMAX | C156579 | Ratio CMAX | The ratio of two Cmax values. | Cmax to Cmax Ratio Measurement | ||
Ratio Conc Trough | C176353 | Ratio Conc Trough | The ratio of two CTROUGH values. | Ratio Concentration Trough | ||
Ratio Concentration | C176235 | Ratio Concentration | The ratio of two concentration values. | Concentration Ratio | ||
Ratio Max Conc Norm by Dose | C176352 | Ratio Max Conc Norm by Dose | The ratio of two maximum concentration normalized by dose values. | Ratio Maximum Concentration Normalized by Dose | ||
Ratio Min Conc | C176346 | Ratio Min Conc | The ratio of two cmin values. | Minimum Concentration Ratio | ||
Ratio of CMAX to CMIN | C156580 | Ratio of CMAX to CMIN | The ratio of Cmax value to Cmin value. | Cmax to Cmin Ratio Measurement | ||
RatioAUC to Last Nonzero Conc NormByDose | C176350 | Ratio AUC to Last Nonzero Conc Norm by Dose | The ratio of two AUC to last nonzero concentration normalized by dose values. | Ratio AUC to Last Nonzero Concentration Normalized by Dose | ||
Relative Bioavailability | C154839 | Relative Bioavailability | The fraction of the treatment dose that reaches the systemic circulation relative to a reference route or reference formulation. The ratio of the amount of drug in the system (area under the curve) after administration of a test formulation divided by the drug in the system after a non-IV administration of a reference formulation and/or reference route. | Relative Bioavailability | ||
Renal CL as Pct CL EV | C154849 | Renal CL as Pct CL EV | The portion of total clearance attributed to the kidneys expressed as a percentage, following extravascular administration. | Renal Clearance to Total Clearance Ratio Measurement After Oral Dosing | ||
Renal CL as Pct CL IV | C154850 | Renal CL as Pct CL IV | The portion of total clearance attributed to the kidneys expressed as a percentage, following intravenous administration. | Renal Clearance to Total Clearance Ratio Measurement After Intravenous Dosing | ||
Renal CL for Dose Int Norm by BMI | C122334 | Renal CL for Dose Int Norm by BMI | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the body mass index. | Renal Clearance for Dose Interval Normalized by Body Mass Index | ||
Renal CL for Dose Int Norm by Dose | C122335 | Renal CL for Dose Int Norm by Dose | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the dose. | Renal Clearance for Dose Interval Normalized by Dose | ||
Renal CL for Dose Int Norm by SA | C122336 | Renal CL for Dose Int Norm by SA | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the surface area. | Renal Clearance for Dose Interval Normalized by Surface Area | ||
Renal CL for Dose Int Norm by WT | C122337 | Renal CL for Dose Int Norm by WT | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the weight. | Renal Clearance for Dose Interval Normalized by Weight | ||
Renal CL for Dose Int | C122050 | Renal CL for Dose Int | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU. | Renal Clearance for Dose Interval | ||
Renal CL for Unbound Drug | C154843 | Renal CL for Unbound Drug | The unbound fraction of drug within the portion of total clearance attributed to the kidneys. | Renal Clearance for Unbound Drug | ||
Renal CL from T1 to T2 Norm by BMI | C122330 | Renal CL from T1 to T2 Norm by BMI | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the body mass index. | Renal Clearance from T1 to T2 Normalized by Body Mass Index | ||
Renal CL from T1 to T2 Norm by Dose | C122331 | Renal CL from T1 to T2 Norm by Dose | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the dose. | Renal Clearance from T1 to T2 Normalized by Dose | ||
Renal CL from T1 to T2 Norm by SA | C122332 | Renal CL from T1 to T2 Norm by SA | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the surface area. | Renal Clearance from T1 to T2 Normalized by Surface Area | ||
Renal CL from T1 to T2 Norm by WT | C122333 | Renal CL from T1 to T2 Norm by WT | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the weight. | Renal Clearance from T1 to T2 Normalized by Weight | ||
Renal CL from T1 to T2 | C122049 | Renal CL from T1 to T2 | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2. | Renal Clearance from T1 to T2 | ||
Renal CL Norm by BMI | C105458 | Renal CL Norm by BMI | The clearance of a substance from the blood by the kidneys divided by the body mass index. | Renal Clearance Normalized by BMI | ||
Renal CL Norm by Dose | C105459 | Renal CL Norm by Dose | The clearance of a substance from the blood by the kidneys divided by the dose. | Renal Clearance Normalized by Dose | ||
Renal CL Norm by SA | C105460 | Renal CL Norm by SA | The clearance of a substance from the blood by the kidneys divided by the surface area. | Renal Clearance Normalized by SA | ||
Renal CL Norm by WT | C105461 | Renal CL Norm by WT | The clearance of a substance from the blood by the kidneys divided by the weight. | Renal Clearance Normalized by WT | ||
Renal CL | C75913 | Renal CL | The clearance of a substance from the blood by the kidneys. | Renal Clearance | ||
Stationarity Ratio AUC | C122338 | Stationarity Ratio AUC | The area under the curve (AUCTAU) at steady state divided by the area under the curve extrapolated to infinity for the initial dosing interval. | Stationarity Ratio Area Under the Curve | ||
Sum of Urine Vol | C85817 | Sum of Urine Vol | The sum of urine volumes that are used for PK parameters. | Sum Urine Volume | ||
Swing | C161416 | Swing | The difference between Cmax and Cmin standardized to Cmin within a dosing interval. | PK Swing | ||
Time of CMAX | C70919 | Time of CMAX | The time of maximum observed concentration sampled during a dosing interval. | Tmax | ||
Time of CMIN Observation | C85825 | Time of CMIN Observation | The time of minimum concentration sampled during a dosing interval. | Tmin | ||
Time of Last Nonzero Conc | C85822 | Time of Last Nonzero Conc | The time of the last measurable (positive) concentration. | Time of Last Nonzero Concentration | ||
Time Until First Nonzero Conc | C85824 | Time Until First Nonzero Conc | The time prior to the first measurable (non-zero) concentration. | Time until First Nonzero Concentration | ||
Total CL by F for Dose Int Norm by BMI | C114227 | Total CL by F for Dose Int Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Body Mass Index | ||
Total CL by F for Dose Int Norm by Dose | C114226 | Total CL by F for Dose Int Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Dose | ||
Total CL by F for Dose Int Norm by SA | C114228 | Total CL by F for Dose Int Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Surface Area | ||
Total CL by F for Dose Int Norm by WT | C114229 | Total CL by F for Dose Int Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight | ||
Total CL by F for Dose Int | C114121 | Total CL by F for Dose Int | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. | Total Body Clearance by Fraction of Dose for Dose Interval | ||
Total CL for Dose Int Norm by BMI | C114231 | Total CL for Dose Int Norm by BMI | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index. | Total Body Clearance for Dose Interval Normalized by Body Mass Index | ||
Total CL for Dose Int Norm by Dose | C114230 | Total CL for Dose Int Norm by Dose | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose. | Total Body Clearance for Dose Interval Normalized by Dose | ||
Total CL for Dose Int Norm by SA | C114232 | Total CL for Dose Int Norm by SA | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area. | Total Body Clearance for Dose Interval Normalized by Surface Area | ||
Total CL for Dose Int Norm by WT | C114233 | Total CL for Dose Int Norm by WT | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight. | Total Body Clearance for Dose Interval Normalized by Weight | ||
Total CL for Dose Int | C114122 | Total CL for Dose Int | The total body clearance for intravascular administration, calculated using AUCTAU. | Total Body Clearance for Dose Interval | ||
Total CL Obs by F Norm by BMI | C92399 | Total CL Obs by F Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Total Clearance Observed by Fraction Dose Normalized by Body Mass Index | ||
Total CL Obs by F Norm by Dose | C92400 | Total CL Obs by F Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. | Total Clearance Observed by Fraction Dose Normalized by Dose | ||
Total CL Obs by F Norm by SA | C92401 | Total CL Obs by F Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Total Clearance Observed by Fraction Dose Normalized by Surface Area | ||
Total CL Obs by F Norm by WT | C92402 | Total CL Obs by F Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. | Total Clearance Observed by Fraction Dose Normalized by Weight | ||
Total CL Obs by F | C85772 | Total CL Obs by F | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. | Observed Total Body Clearance by Fraction of Dose Absorbed | ||
Total CL Obs for Unbound Drug | C154842 | Total CL Obs for Unbound Drug | The total body clearance for intravascular administration divided by the fraction of drug unbound, calculated using the observed value of the last non-zero concentration. | Total Clearance Observed for Unbound Drug | ||
Total CL Obs Norm by BMI | C92403 | Total CL Obs Norm by BMI | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Total Clearance Observed Normalized by Body Mass Index | ||
Total CL Obs Norm by Dose | C92404 | Total CL Obs Norm by Dose | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. | Total Clearance Observed Normalized by Dose | ||
Total CL Obs Norm by SA | C92405 | Total CL Obs Norm by SA | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Total Clearance Observed Normalized by Surface Area | ||
Total CL Obs Norm by WT | C92406 | Total CL Obs Norm by WT | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. | Total Clearance Observed Normalized by Weight | ||
Total CL Obs | C85773 | Total CL Obs | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration. | Observed Total Body Clearance Rate | ||
Total CL Pred by F Norm by BMI | C92417 | Total CL Pred by F Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by body mass index. | Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index | ||
Total CL Pred by F Norm by Dose | C92418 | Total CL Pred by F Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Total Clearance Predicted by Fraction Dose Normalized by Dose | ||
Total CL Pred by F Norm by SA | C92419 | Total CL Pred by F Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Total Clearance Predicted by Fraction Dose Normalized by Surface Area | ||
Total CL Pred by F Norm by WT | C92420 | Total CL Pred by F Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Total Clearance Predicted by Fraction Dose Normalized by Weight | ||
Total CL Pred by F | C85796 | Total CL Pred by F | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. | Predicted Total Body Clearance by Fraction of Dose Absorbed | ||
Total CL Pred for Unbound Drug | C154841 | Total CL Pred for Unbound Drug | The total body clearance for intravascular administration divided by the fraction of drug unbound, calculated using the predicted value of the last non-zero concentration. | Total Clearance Predicted for Unbound Drug | ||
Total CL Pred Norm by BMI | C92421 | Total CL Pred Norm by BMI | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Total Clearance Predicted Normalized by Body Mass Index | ||
Total CL Pred Norm by Dose | C92422 | Total CL Pred Norm by Dose | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Total Clearance Predicted Normalized by Dose | ||
Total CL Pred Norm by SA | C92423 | Total CL Pred Norm by SA | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Total Clearance Predicted Normalized by Surface Area | ||
Total CL Pred Norm by WT | C92424 | Total CL Pred Norm by WT | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Total Clearance Predicted Normalized by Weight | ||
Total CL Pred | C85797 | Total CL Pred | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration. | Predicted Total Body Clearance Rate | ||
Trough Peak Ratio | C122339 | Trough Peak Ratio | The concentration at the start of a dosing interval divided by the maximum concentration during the dosing interval. | Trough Peak Ratio | ||
Vol Dist Initial Norm by BMI | C102372 | Vol Dist Initial Norm by BMI | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index. | Initial Volume of Distribution Normalized by Body Mass Index | ||
Vol Dist Initial Norm by Dose | C102373 | Vol Dist Initial Norm by Dose | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose. | Initial Volume of Distribution Normalized by Dose | ||
Vol Dist Initial Norm by SA | C102374 | Vol Dist Initial Norm by SA | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area. | Initial Volume of Distribution Normalized by Surface Area | ||
Vol Dist Initial Norm by WT | C102375 | Vol Dist Initial Norm by WT | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight. | Initial Volume of Distribution Normalized by Weight | ||
Vol Dist Initial | C102371 | Vol Dist Initial | The initial volume of distribution for a substance administered by bolus intravascular dosing. | Initial Volume of Distribution | ||
Vol Dist Steady State Obs by B | C156574 | Vol Dist Steady State Obs by B | The volume of distribution at steady state based on the observed CLST for a substance administered, divided by the fraction of bound drug. | Volume of Distribution Steady State Observed by Bound Drug | ||
Vol Dist Steady State Obs by F | C156570 | Vol Dist Steady State Obs by F | The volume of distribution at steady state based on the observed CLST for a substance administered by extravascular dosing, divided by the fraction of dose absorbed. | Volume of Distribution Steady State Observed by Fraction of Dose Absorbed | ||
Vol Dist Steady State Obs by UB | C156572 | Vol Dist Steady State Obs by UB | The volume of distribution at steady state based on the observed CLST for a substance administered, divided by the fraction of unbound drug. | Volume of Distribution Steady State Observed by Unbound Drug | ||
Vol Dist Steady State Obs Norm by BMI | C102377 | Vol Dist Steady State Obs Norm by BMI | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index. | Observed Steady State Volume of Distribution Normalized by Body Mass Index | ||
Vol Dist Steady State Obs Norm by Dose | C102378 | Vol Dist Steady State Obs Norm by Dose | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose. | Observed Steady State Volume of Distribution Normalized by Dose | ||
Vol Dist Steady State Obs Norm by SA | C102379 | Vol Dist Steady State Obs Norm by SA | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area. | Observed Steady State Volume of Distribution Normalized by Surface Area | ||
Vol Dist Steady State Obs Norm by WT | C102380 | Vol Dist Steady State Obs Norm by WT | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight. | Observed Steady State Volume of Distribution Normalized by Weight | ||
Vol Dist Steady State Obs | C85770 | Vol Dist Steady State Obs | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing. | Observed Steady State Volume of Distribution | ||
Vol Dist Steady State Pred by B | C156575 | Vol Dist Steady State Pred by B | The volume of distribution at steady state based on the predicted CLST for a substance administered, divided by the fraction of bound drug. | Volume of Distribution Steady State Predicted by Bound Drug | ||
Vol Dist Steady State Pred by F | C156571 | Vol Dist Steady State Pred by F | The volume of distribution at steady state based on the predicted CLST for a substance administered by extravascular dosing, divided by the fraction of dose absorbed. | Volume of Distribution Steady State Predicted by Fraction of Dose Absorbed | ||
Vol Dist Steady State Pred by UB | C156573 | Vol Dist Steady State Pred by UB | The volume of distribution at steady state based on the predicted CLST for a substance administered, divided by the fraction of unbound drug. | Volume of Distribution Steady State Predicted by Unbound Drug | ||
Vol Dist Steady State Pred Norm by BMI | C102390 | Vol Dist Steady State Pred Norm by BMI | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index. | Predicted Steady State Volume of Distribution Normalized by Body Mass Index | ||
Vol Dist Steady State Pred Norm by Dose | C102391 | Vol Dist Steady State Pred Norm by Dose | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose. | Predicted Steady State Volume of Distribution Normalized by Dose | ||
Vol Dist Steady State Pred Norm by SA | C102392 | Vol Dist Steady State Pred Norm by SA | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area. | Predicted Steady State Volume of Distribution Normalized by Surface Area | ||
Vol Dist Steady State Pred Norm by WT | C102393 | Vol Dist Steady State Pred Norm by WT | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight. | Predicted Steady State Volume of Distribution Normalized by Weight | ||
Vol Dist Steady State Pred | C85794 | Vol Dist Steady State Pred | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing. | Predicted Steady State Volume of Distribution | ||
Vz for Dose Int by F Norm by BMI | C111365 | Vz for Dose Int by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. | Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index | ||
Vz for Dose Int by F Norm by Dose | C111366 | Vz for Dose Int by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. | Volume of Distribution for Dosing Interval by Fraction Normalized by Dose | ||
Vz for Dose Int by F Norm by SA | C111367 | Vz for Dose Int by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. | Volume of Distribution for Dosing Interval by Fraction Normalized by Surface Area | ||
Vz for Dose Int by F Norm by WT | C111368 | Vz for Dose Int by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. | Volume of Distribution for Dosing Interval by Fraction Normalized by Weight | ||
Vz for Dose Int by F | C111364 | Vz for Dose Int by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. | Volume of Distribution for Dosing Interval by Fraction | ||
Vz for Dose Int Norm by BMI | C111369 | Vz for Dose Int Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index. | Volume of Distribution for Dosing Interval Normalized by Body Mass Index | ||
Vz for Dose Int Norm by Dose | C111370 | Vz for Dose Int Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose. | Volume of Distribution for Dosing Interval Normalized by Dose | ||
Vz for Dose Int Norm by SA | C111371 | Vz for Dose Int Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area. | Volume of Distribution for Dosing Interval Normalized by Surface Area | ||
Vz for Dose Int Norm by WT | C111372 | Vz for Dose Int Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight. | Volume of Distribution for Dosing Interval Normalized by Weight | ||
Vz for Dose Int | C111333 | Vz for Dose Int | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU. | Volume of Distribution for Dosing Interval | ||
Vz Obs by F for UB | C156581 | Vz Obs by F for UB | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration and corrected for unbound drug. | Observed Volume of Distribution of Absorbed Fraction for Unbound Drug | ||
Vz Obs by F Norm by BMI | C92410 | Vz Obs by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution of Fraction Dose Observed Normalized by Body Mass Index | ||
Vz Obs by F Norm by Dose | C102729 | Vz Obs by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. | Volume of Distribution of Fraction Dose Observed Normalized by Dose | ||
Vz Obs by F Norm by SA | C92411 | Vz Obs by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Volume of Distribution of Fraction Dose Observed Normalized by Surface Area | ||
Vz Obs by F Norm by WT | C92412 | Vz Obs by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. | Volume of Distribution of Fraction Dose Observed Normalized by Weight | ||
Vz Obs by F | C85775 | Vz Obs by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. | Observed Volume of Distribution of Absorbed Fraction | ||
Vz Obs for UB | C158265 | Vz Obs for UB | The volume of distribution associated with the terminal slope following administration, calculated using the observed value of the last non-zero concentration and corrected for unbound drug. | Volume of Distribution Observed for Unbound Drug | ||
Vz Obs Norm by BMI | C92407 | Vz Obs Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution Observed Normalized by Body Mass Index | ||
Vz Obs Norm by Dose | C102683 | Vz Obs Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. | Observed Volume of Distribution Normalized by Dose | ||
Vz Obs Norm by SA | C92408 | Vz Obs Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Volume of Distribution Observed Normalized by Surface Area | ||
Vz Obs Norm by WT | C92409 | Vz Obs Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. | Volume of Distribution Observed Normalized by Weight | ||
Vz Obs | C85774 | Vz Obs | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration. | Observed Volume of Distribution | ||
Vz Pred by F for UB | C158267 | Vz Pred by F for UB | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value at the time of the last non-zero concentration and corrected for unbound drug. | Volume of Distribution of Fraction Dose Predicted Corrected for Unbound Drug | ||
Vz Pred by F Norm by BMI | C92428 | Vz Pred by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution of Fraction Dose Predicted Normalized by Body Mass Index | ||
Vz Pred by F Norm by Dose | C102730 | Vz Pred by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Volume of Distribution of Fraction Dose Predicted Normalized by Dose | ||
Vz Pred by F Norm by SA | C92429 | Vz Pred by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Volume of Distribution of Fraction Dose Predicted Normalized by Surface Area | ||
Vz Pred by F Norm by WT | C92430 | Vz Pred by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Volume of Distribution of Fraction Dose Predicted Normalized by Weight | ||
Vz Pred by F | C85799 | Vz Pred by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. | Predicted Volume of Distribution of Absorbed Fraction | ||
Vz Pred for UB | C158266 | Vz Pred for UB | The volume of distribution associated with the terminal slope following administration, calculated using the predicted value at the time of the last non-zero concentration and corrected for unbound drug. | Volume of Distribution Predicted for Unbound Drug | ||
Vz Pred Norm by BMI | C92425 | Vz Pred Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution Predicted Normalized by Body Mass Index | ||
Vz Pred Norm by Dose | C102696 | Vz Pred Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Predicted Volume of Distribution Normalized by Dose | ||
Vz Pred Norm by SA | C92426 | Vz Pred Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Volume of Distribution Predicted Normalized by Surface Area | ||
Vz Pred Norm by WT | C92427 | Vz Pred Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Volume of Distribution Predicted Normalized by Weight | ||
Vz Pred | C85798 | Vz Pred | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration. | Predicted Volume of Distribution | ||
Back to top | ||||||
CL.C85839.PKPARMCD | PK Parameters Code
(PKPARMCD) | text
Extensible: Yes | C85839 | PK Parameters Code | Parameter codes used to describe the time-concentration curve. | CDISC SDTM Pharmacokinetic Parameter Short Name Terminology |
AILAMZ | C114234 | Accumulation Index using Lambda z | Predicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data. | Accumulation Index using Lambda z | ||
AMSS | C181513 | Amt of Analyte at Steady State | The amount of analyte in the body at steady state. | Amount of Analyte at Steady State | ||
AMTT | C181514 | Amt of Analyte at Time T | The amount of analyte in the body at any time t. | Amount of Analyte at Time T | ||
ARAUC | C102356 | Accumulation Ratio AUCTAU | The area under the curve over the dosing interval at steady state divided by the area under the curve over the initial dosing interval. | Accumulation Ratio Area Under the Curve | ||
ARAUCD | C132435 | Accum Ratio AUCTAU norm by dose | The area under the curve (AUCTAU) at steady state divided by the area under the curve (AUCTAU) over the initial dosing interval, each divided by the associated dose. | Accumulation Ratio AUC Over Dosing Interval Normalized by Dose | ||
ARAUCIFO | C170611 | Accum Ratio AUC Infinity Obs | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration during the initial dosing interval. | Accumulation Ratio AUC Infinity Observed | ||
ARAUCIFP | C170612 | Accum Ratio AUC Infinity Pred | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration during the initial dosing interval. | Accumulation Ratio AUC Infinity Predicted | ||
ARAUCIND | C132436 | Accum Ratio AUC T1 to T2 norm by dose | The area under the curve from T1 to T2 at steady state divided by the area under the curve from T1 to T2 during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio AUC T1 to T2 Normalized by Dose | ||
ARAUCINT | C122329 | Accumulation Ratio AUC from T1 to T2 | The area under the curve from T1 to T2 at steady state divided by the area under the curve from T1 to T2 during the initial dosing interval. | Accumulation Ratio Area Under the Curve from T1 to T2 | ||
ARAUCIOD | C170613 | Accum Ratio AUCIFO Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio AUC Infinity Observed Normalized by Dose | ||
ARAUCIPD | C170614 | Accum Ratio AUCIFP Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio AUC Infinity Predicted Normalized by Dose | ||
ARAUCLST | C139129 | Accum Ratio AUC to Last Nonzero Conc | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the area under the curve from the time of dosing to the last measurable concentration during the initial dosing interval. | Accumulation Ratio AUC to Last Nonzero Concentration | ||
ARCMAX | C102357 | Accumulation Ratio Cmax | The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval. | Accumulation Ratio Cmax | ||
ARCMAXD | C132437 | Accum Ratio Cmax norm by dose | The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio Cmax Normalized by Dose | ||
ARCMIN | C102358 | Accumulation Ratio Cmin | The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval. | Accumulation Ratio Cmin | ||
ARCMIND | C132438 | Accum Ratio Cmin norm by dose | The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio Cmin Normalized by Dose | ||
ARCTROUD | C132439 | Accum Ratio Ctrough norm by dose | The trough concentration at steady state divided by the trough concentration during the initial dosing interval, each divided by the associated dose. | Accumulation Ratio Ctrough Normalized by Dose | ||
ARCTROUG | C102426 | Accumulation Ratio Ctrough | The trough concentration at steady state divided by the trough concentration during the initial dosing interval. | Accumulation Ratio Ctrough | ||
AUCALL | C85564 | AUC All | The area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not. | Area Under the Curve All | ||
AUCALLB | C92362 | AUC All Norm by BMI | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Body Mass Index | ||
AUCALLD | C92306 | AUC All Norm by Dose | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Dose | ||
AUCALLS | C92307 | AUC All Norm by SA | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Surface Area | ||
AUCALLW | C92308 | AUC All Norm by WT | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Weight | ||
AUCIFO | C85761 | AUC Infinity Obs | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Area Under the Curve Infinity | ||
AUCIFOB | C92316 | AUC Infinity Obs Norm by BMI | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | AUC Infinity Observed Normalized by Body Mass Index | ||
AUCIFOD | C96695 | AUC Infinity Obs Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. | AUC Infinity Observed Normalized by Dose | ||
AUCIFODW | C174345 | AUC Infinity Obs Norm by Dose/WT | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration divided by the body weight-adjusted dose. | AUC Infinity Observed Normalized by Weight-Adjusted Dose | ||
AUCIFOLN | C161413 | AUC Infinity Obs LN Transformed | The natural log transformed area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Natural Log Transformed Observed Area Under the Curve Infinity | ||
AUCIFOS | C92317 | AUC Infinity Obs Norm by SA | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | AUC Infinity Observed Normalized by Surface Area | ||
AUCIFOUB | C154845 | AUC Infinity Obs, Unbound Drug | The portion of observed AUC to infinity, represented by the unbound fraction of drug. | Observed Area Under the Curve Infinity of Unbound Drug | ||
AUCIFOW | C92318 | AUC Infinity Obs Norm by WT | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | AUC Infinity Observed Normalized by Weight | ||
AUCIFP | C85785 | AUC Infinity Pred | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Area Under the Curve Infinity | ||
AUCIFPB | C92319 | AUC Infinity Pred Norm by BMI | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | AUC Infinity Predicted Normalized by Body Mass Index | ||
AUCIFPD | C85786 | AUC Infinity Pred Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Predicted Area Under the Curve Infinity by Dose | ||
AUCIFPDW | C174349 | AUC Infinity Pred Norm by Dose per Body Weight;AUCIFPDW Norm by Dose/WT | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration divided by the body weight-adjusted dose. | AUC Infinity Predicted Normalized by Weight-Adjusted Dose | ||
AUCIFPS | C92320 | AUC Infinity Pred Norm by SA | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | AUC Infinity Predicted Normalized by Surface Area | ||
AUCIFPUB | C154846 | AUC Infinity Pred, Unbound Drug | The portion of predicted AUC to infinity, represented by the unbound fraction of drug. | Predicted Area Under the Curve Infinity of Unbound Drug | ||
AUCIFPW | C92321 | AUC Infinity Pred Norm by WT | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | AUC Infinity Predicted Normalized by Weight | ||
AUCINT | C85566 | AUC from T1 to T2 | The area under the curve (AUC) over the interval from T1 to T2. | Area Under the Curve from T1 to T2 | ||
AUCINTB | C92312 | AUC from T1 to T2 Norm by BMI | The area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index. | AUC from T1 to T2 Normalized by Body Mass Index | ||
AUCINTD | C92313 | AUC from T1 to T2 Norm by Dose | The area under the curve (AUC) over the interval from T1 to T2 divided by the dose. | AUC from T1 to T2 Normalized by Dose | ||
AUCINTDW | C174348 | AUC from T1 to T2 Norm by Dose per Body Weight;AUCINT Norm by Dose/kg WT | The area under the curve (AUC) over the interval from T1 to T2 divided by the body weight-adjusted dose. | AUC from T1 to T2 Normalized by Weight-Adjusted Dose | ||
AUCINTS | C92314 | AUC from T1 to T2 Norm by SA | The area under the curve (AUC) over the interval from T1 to T2 divided by the surface area. | AUC from T1 to T2 Normalized by Surface Area | ||
AUCINTW | C92315 | AUC from T1 to T2 Norm by WT | The area under the curve (AUC) over the interval from T1 to T2 divided by the weight. | AUC from T1 to T2 Normalized by Weight | ||
AUCLST | C85565 | AUC to Last Nonzero Conc | The area under the curve (AUC) from the time of dosing to the last measurable concentration. | Area Under the Curve From Dosing to Last Concentration | ||
AUCLSTB | C92309 | AUC to Last Nonzero Conc Norm by BMI | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index. | AUC Dosing to Last Concentration Normalized by Body Mass Index | ||
AUCLSTD | C92310 | AUC to Last Nonzero Conc Norm by Dose | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose. | AUC Dosing to Last Concentration Normalized by Dose | ||
AUCLSTDW | C174347 | AUC to Last Nonzero Conc Norm by Dose per Body Weight;AUCLST Norm by Dose/WT | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body weight-adjusted dose. | AUC Dosing From Dosing to Last Concentration Normalized by Weight-Adjusted Dose | ||
AUCLSTLN | C161414 | AUC to Last Nonzero Conc LN Transformed | The natural log transformed area under the curve (AUC) from the time of dosing to the last measurable concentration. | Natural Log Transformed Area Under the Curve From Dosing to Last Concentration | ||
AUCLSTS | C92311 | AUC to Last Nonzero Conc Norm by SA | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area. | AUC Dosing to Last Concentration Normalized by Surface Area | ||
AUCLSTUB | C154847 | AUC to Last Nonzero Conc, Unbound Drug | The portion of the area under the curve (AUC) from the time of dosing to the last measurable concentration, represented by the unbound fraction of drug. | Area Under the Curve From Dosing to Last Concentration of Unbound Drug | ||
AUCLSTW | C92305 | AUC to Last Nonzero Conc Norm by WT | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight. | AUC Dosing to Last Concentration Normalized by Weight | ||
AUCPBEO | C85763 | AUC %Back Extrapolation Obs | Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the observed value of the last non-zero concentration. | Observed Area Under the Curve Percent Back Extrapolation | ||
AUCPBEP | C85787 | AUC %Back Extrapolation Pred | Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the predicted value of the last non-zero concentration. | Predicted Area Under the Curve Percent Back Extrapolation | ||
AUCPEO | C85764 | AUC %Extrapolation Obs | The area under the curve (AUC) from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. | Observed Area Under the Curve Percent Extrapolation | ||
AUCPEP | C85788 | AUC %Extrapolation Pred | The area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. | Predicted Area Under the Curve Percent Extrapolation | ||
AUCTAU | C85567 | AUC Over Dosing Interval | The area under the curve (AUC) for the defined interval between doses (TAU). | Area Under the Curve Over Dosing Interval | ||
AUCTAUB | C92322 | AUC Over Dosing Interval Norm by BMI | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index. | AUC Over Dosing Interval Normalized by Body Mass Index | ||
AUCTAUD | C92323 | AUC Over Dosing Interval Norm by Dose | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose. | AUC Over Dosing Interval Normalized by Dose | ||
AUCTAUDW | C174350 | AUC Over Dosing Interval Norm by Dose per Body Weight;AUCTAU Norm by Dose/WT | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body weight-adjusted dose. | AUC Over Dosing Interval Normalized by Weight-Adjusted Dose | ||
AUCTAUS | C92324 | AUC Over Dosing Interval Norm by SA | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area. | AUC Over Dosing Interval Normalized by Surface Area | ||
AUCTAUW | C92325 | AUC Over Dosing Interval Norm by WT | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight. | AUC Over Dosing Interval Normalized by Weight | ||
AUMCIFO | C85765 | AUMC Infinity Obs | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Area Under the First Moment Curve Infinity | ||
AUMCIFOB | C92330 | AUMC Infinity Obs Norm by BMI | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | AUMC Infinity Observed Normalized by Body Mass Index | ||
AUMCIFOD | C92331 | AUMC Infinity Obs Norm by Dose | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. | AUMC Infinity Observed Normalized by Dose | ||
AUMCIFOS | C92332 | AUMC Infinity Obs Norm by SA | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | AUMC Infinity Observed Normalized by Surface Area | ||
AUMCIFOW | C92333 | AUMC Infinity Obs Norm by WT | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | AUMC Infinity Observed Normalized by Weight | ||
AUMCIFP | C85789 | AUMC Infinity Pred | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Area Under the First Moment Curve Infinity | ||
AUMCIFPB | C92334 | AUMC Infinity Pred Norm by BMI | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | AUMC Infinity Predicted Normalized by Body Mass Index | ||
AUMCIFPD | C92335 | AUMC Infinity Pred Norm by Dose | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. | AUMC Infinity Predicted Normalized by Dose | ||
AUMCIFPS | C92336 | AUMC Infinity Pred Norm by SA | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | AUMC Infinity Predicted Normalized by Surface Area | ||
AUMCIFPW | C92337 | AUMC Infinity Pred Norm by WT | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | AUMC Infinity Predicted Normalized by Weight | ||
AUMCLST | C85569 | AUMC to Last Nonzero Conc | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration. | Area Under the First Moment Curve From Dosing to Last Concentration | ||
AUMCLSTB | C92326 | AUMC to Last Nonzero Conc Norm by BMI | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index. | AUMC Dosing to Last Concentration Normalized by Body Mass Index | ||
AUMCLSTD | C92327 | AUMC to Last Nonzero Conc Norm by Dose | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose. | AUMC Dosing to Last Concentration Normalized by Dose | ||
AUMCLSTS | C92328 | AUMC to Last Nonzero Conc Norm by SA | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area. | AUMC Dosing to Last Concentration Normalized by Surface Area | ||
AUMCLSTW | C92329 | AUMC to Last Nonzero Conc Norm by WT | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight. | AUMC Dosing to Last Concentration Normalized by Weight | ||
AUMCPEO | C85766 | AUMC % Extrapolation Obs | The area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. | Observed Area Under the First Moment Curve Percent Extrapolation | ||
AUMCPEP | C85790 | AUMC % Extrapolation Pred | The area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. | Predicted Area Under the First Moment Curve Percent Extrapolation | ||
AUMCTAU | C85570 | AUMC Over Dosing Interval | The area under the first moment curve (AUMC) for the defined interval between doses (TAU). | Area Under the First Moment Curve Over Dosing Interval | ||
AUMCTAUB | C92338 | AUMC Over Dosing Interval Norm by BMI | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index. | AUMC Over Dosing Interval Normalized by Body Mass Index | ||
AUMCTAUD | C92339 | AUMC Over Dosing Interval Norm by Dose | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose. | AUMC Over Dosing Interval Normalized by Dose | ||
AUMCTAUS | C92340 | AUMC Over Dosing Interval Norm by SA | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area. | AUMC Over Dosing Interval Normalized by Surface Area | ||
AUMCTAUW | C92341 | AUMC Over Dosing Interval Norm by WT | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight. | AUMC Over Dosing Interval Normalized by Weight | ||
AURCALL | C85841 | AURC All | The area under the excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not. | Area Under Excretion Rate Curve All | ||
AURCALLB | C92342 | AURC All Norm by BMI | The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index. | AURC All Normalized by Body Mass Index | ||
AURCALLD | C92343 | AURC All Norm by Dose | The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose. | AURC All Normalized by Dose | ||
AURCALLS | C92344 | AURC All Norm by SA | The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area. | AURC All Normalized by Surface Area | ||
AURCALLW | C92345 | AURC All Norm by WT | The area under the excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight. | AURC All Normalized by Weight | ||
AURCIFO | C85767 | AURC Infinity Obs | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate. | Observed Area Under the Excretion Rate Curve infinity | ||
AURCIFOB | C92354 | AURC Infinity Obs Norm by BMI | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index. | AURC Infinity Observed Normalized by Body Mass Index | ||
AURCIFOD | C92355 | AURC Infinity Obs Norm by Dose | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose. | AURC Infinity Observed Normalized by Dose | ||
AURCIFOS | C92356 | AURC Infinity Obs Norm by SA | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area. | AURC Infinity Observed Normalized by Surface Area | ||
AURCIFOW | C92357 | AURC Infinity Obs Norm by WT | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight. | AURC Infinity Observed Normalized by Weight | ||
AURCIFP | C85791 | AURC Infinity Pred | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate. | Predicted Area Under the Excretion Rate Curve Infinity | ||
AURCIFPB | C92358 | AURC Infinity Pred Norm by BMI | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the body mass index. | AURC Infinity Predicted Normalized by Body Mass Index | ||
AURCIFPD | C92359 | AURC Infinity Pred Norm by Dose | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the dose. | AURC Infinity Predicted Normalized by Dose | ||
AURCIFPS | C92360 | AURC Infinity Pred Norm by SA | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the surface area. | AURC Infinity Predicted Normalized by Surface Area | ||
AURCIFPW | C92361 | AURC Infinity Pred Norm by WT | The area under the excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divided by the weight. | AURC Infinity Predicted Normalized by Weight | ||
AURCINT | C85572 | AURC from T1 to T2 | The area under the excretion rate curve (AURC) over the interval from T1 to T2. | Area Under the Excretion Rate Curve from T1 to T2 | ||
AURCINTB | C92350 | AURC from T1 to T2 Norm by BMI | The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index. | AURC from T1 to T2 Normalized by Body Mass Index | ||
AURCINTD | C92351 | AURC from T1 to T2 Norm by Dose | The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose. | AURC from T1 to T2 Normalized by Dose | ||
AURCINTS | C92352 | AURC from T1 to T2 Norm by SA | The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area. | AURC from T1 to T2 Normalized by Surface Area | ||
AURCINTW | C92353 | AURC from T1 to T2 Norm by WT | The area under the excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight. | AURC from T1 to T2 Normalized by Weight | ||
AURCLST | C85571 | AURC to Last Nonzero Rate | The area under the excretion rate curve (AURC) from time zero to the time of the last measurable concentration. | Area Under the Excretion Rate Curve From Dosing to Last Concentration | ||
AURCLSTB | C92346 | AURC to Last Nonzero Rate Norm by BMI | The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index. | AURC Dosing to Last Concentration Normalized by Body Mass Index | ||
AURCLSTD | C92347 | AURC to Last Nonzero Rate Norm by Dose | The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose. | AURC Dosing to Last Concentration Normalized by Dose | ||
AURCLSTS | C92348 | AURC to Last Nonzero Rate Norm by SA | The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area. | AURC Dosing to Last Concentration Normalized by Surface Area | ||
AURCLSTW | C92349 | AURC to Last Nonzero Rate Norm by WT | The area under the excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight. | AURC Dosing to Last Concentration Normalized by Weight | ||
AURCPEO | C85768 | AURC % Extrapolation Obs | The area under the excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the excretion rate curve extrapolated to infinity. | Observed Area Under the Excretion Rate Curve Percent Extrapolation | ||
AURCPEP | C85792 | AURC % Extrapolation Pred | The area under the excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the excretion rate curve extrapolated to infinity. | Predicted Area Under the Excretion Rate Curve Percent Extrapolation | ||
C0 | C85644 | Initial Conc | Initial concentration. Given only for bolus IV models. | Initial Concentration | ||
C0B | C92383 | Initial Conc Norm by BMI | Initial concentration divided by the body mass index. Given only for bolus IV models. | Initial Concentration Normalized by Body Mass Index | ||
C0D | C92384 | Initial Conc Norm by Dose | Initial concentration divided by the dose. Given only for bolus IV models. | Initial Concentration Normalized by Dose | ||
C0S | C92385 | Initial Conc Norm by SA | Initial concentration divided by the surface area. Given only for bolus IV models. | Initial Concentration Normalized by Surface Area | ||
C0W | C92386 | Initial Conc Norm by WT | Initial concentration divided by the weight. Given only for bolus IV models. | Initial Concentration Normalized by Weight | ||
CAVG | C85575 | Average Concentration | AUCTAU divided by TAU. | Average Concentration | ||
CAVGB | C92367 | Average Conc Norm by BMI | AUCTAU divided by TAU and then divided by the body mass index. | Average Concentration Normalized by Body Mass Index | ||
CAVGD | C92368 | Average Conc Norm by Dose | AUCTAU divided by TAU and then divided by the dose. | Average Concentration Normalized by Dose | ||
CAVGDW | C174351 | Average Concentration Norm by Dose/WT | AUCTAU divided by TAU divided by the body weight-adjusted dose. | Average Concentration Normalized by Weight-Adjusted Dose | ||
CAVGINT | C132302 | Average Conc from T1 to T2 | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval. | Average Concentration from T1 to T2 | ||
CAVGINTB | C132440 | Average Conc from T1 to T2 Norm by BMI | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the body mass index. | Average Concentration from T1 to T2 Normalized by Body Mass Index | ||
CAVGINTD | C132441 | Average Conc from T1 to T2 Norm by Dose | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the dose. | Average Concentration from T1 to T2 Normalized by Dose | ||
CAVGINTS | C132442 | Average Conc from T1 to T2 Norm by SA | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the surface area. | Average Concentration from T1 to T2 Normalized by Surface Area | ||
CAVGINTW | C132443 | Average Conc from T1 to T2 Norm by WT | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval and then divided by the weight. | Average Concentration from T1 to T2 Normalized by Weight | ||
CAVGS | C92369 | Average Conc Norm by SA | AUCTAU divided by TAU and then divided by the surface area. | Average Concentration Normalized by Surface Area | ||
CAVGTR | C181516 | Average of Conc Trough | The arithmetic average of two or more trough concentrations. | Average of Trough Concentration | ||
CAVGW | C92370 | Average Conc Norm by WT | AUCTAU divided by TAU and then divided by the weight. | Average Concentration Normalized by Weight | ||
CAVINTDW | C174352 | Average Conc from T1 to T2 Norm by Dose per Body Weight;CAVGINT Norm by Dose/WT | The area under the curve over the interval from T1 to T2 (AUCINT) divided by the length of the interval divided by the body weight-adjusted dose. | Average Concentration from T1 to T2 Normalized by Weight-Adjusted Dose | ||
CHTMAX | C135489 | Concentration at Half Tmax | The concentration that occurs at the midpoint time between dosing time and Tmax. | Concentration at Half Tmax | ||
CLFO | C85772 | Total CL Obs by F | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. | Observed Total Body Clearance by Fraction of Dose Absorbed | ||
CLFOB | C92399 | Total CL Obs by F Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Total Clearance Observed by Fraction Dose Normalized by Body Mass Index | ||
CLFOD | C92400 | Total CL Obs by F Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. | Total Clearance Observed by Fraction Dose Normalized by Dose | ||
CLFOS | C92401 | Total CL Obs by F Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Total Clearance Observed by Fraction Dose Normalized by Surface Area | ||
CLFOW | C92402 | Total CL Obs by F Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. | Total Clearance Observed by Fraction Dose Normalized by Weight | ||
CLFP | C85796 | Total CL Pred by F | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. | Predicted Total Body Clearance by Fraction of Dose Absorbed | ||
CLFPB | C92417 | Total CL Pred by F Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by body mass index. | Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index | ||
CLFPD | C92418 | Total CL Pred by F Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Total Clearance Predicted by Fraction Dose Normalized by Dose | ||
CLFPS | C92419 | Total CL Pred by F Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Total Clearance Predicted by Fraction Dose Normalized by Surface Area | ||
CLFPW | C92420 | Total CL Pred by F Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Total Clearance Predicted by Fraction Dose Normalized by Weight | ||
CLFTAU | C114121 | Total CL by F for Dose Int | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. | Total Body Clearance by Fraction of Dose for Dose Interval | ||
CLFTAUB | C114227 | Total CL by F for Dose Int Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Body Mass Index | ||
CLFTAUD | C114226 | Total CL by F for Dose Int Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Dose | ||
CLFTAUS | C114228 | Total CL by F for Dose Int Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Surface Area | ||
CLFTAUW | C114229 | Total CL by F for Dose Int Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight | ||
CLFUB | C154844 | Apparent CL for Unbound Drug | The total apparent clearance of the unbound fraction of drug, adjusted for bioavailability. | Apparent Clearance for Unbound Drug | ||
CLO | C85773 | Total CL Obs | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration. | Observed Total Body Clearance Rate | ||
CLOB | C92403 | Total CL Obs Norm by BMI | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Total Clearance Observed Normalized by Body Mass Index | ||
CLOD | C92404 | Total CL Obs Norm by Dose | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. | Total Clearance Observed Normalized by Dose | ||
CLOS | C92405 | Total CL Obs Norm by SA | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Total Clearance Observed Normalized by Surface Area | ||
CLOUB | C154842 | Total CL Obs for Unbound Drug | The total body clearance for intravascular administration divided by the fraction of drug unbound, calculated using the observed value of the last non-zero concentration. | Total Clearance Observed for Unbound Drug | ||
CLOW | C92406 | Total CL Obs Norm by WT | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. | Total Clearance Observed Normalized by Weight | ||
CLP | C85797 | Total CL Pred | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration. | Predicted Total Body Clearance Rate | ||
CLPB | C92421 | Total CL Pred Norm by BMI | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Total Clearance Predicted Normalized by Body Mass Index | ||
CLPD | C92422 | Total CL Pred Norm by Dose | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Total Clearance Predicted Normalized by Dose | ||
CLPS | C92423 | Total CL Pred Norm by SA | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Total Clearance Predicted Normalized by Surface Area | ||
CLPUB | C154841 | Total CL Pred for Unbound Drug | The total body clearance for intravascular administration divided by the fraction of drug unbound, calculated using the predicted value of the last non-zero concentration. | Total Clearance Predicted for Unbound Drug | ||
CLPW | C92424 | Total CL Pred Norm by WT | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Total Clearance Predicted Normalized by Weight | ||
CLRPCLEV | C154849 | Renal CL as Pct CL EV | The portion of total clearance attributed to the kidneys expressed as a percentage, following extravascular administration. | Renal Clearance to Total Clearance Ratio Measurement After Oral Dosing | ||
CLRPCLIV | C154850 | Renal CL as Pct CL IV | The portion of total clearance attributed to the kidneys expressed as a percentage, following intravenous administration. | Renal Clearance to Total Clearance Ratio Measurement After Intravenous Dosing | ||
CLST | C85655 | Last Nonzero Conc | The concentration corresponding to Tlast. | Last Concentration | ||
CLSTB | C92387 | Last Nonzero Conc Norm by BMI | The concentration corresponding to Tlast divided by the body mass index. | Last Concentration Normalized by Body Mass Index | ||
CLSTD | C92388 | Last Nonzero Conc Norm by Dose | The concentration corresponding to Tlast divided by the dose. | Last Concentration Normalized by Dose | ||
CLSTS | C92389 | Last Nonzero Conc Norm by SA | The concentration corresponding to Tlast divided by the surface area. | Last Concentration Normalized by Surface Area | ||
CLSTW | C92390 | Last Nonzero Conc Norm by WT | The concentration corresponding to Tlast divided by the weight. | Last Concentration Normalized by Weight | ||
CLTAU | C114122 | Total CL for Dose Int | The total body clearance for intravascular administration, calculated using AUCTAU. | Total Body Clearance for Dose Interval | ||
CLTAUB | C114231 | Total CL for Dose Int Norm by BMI | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index. | Total Body Clearance for Dose Interval Normalized by Body Mass Index | ||
CLTAUD | C114230 | Total CL for Dose Int Norm by Dose | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose. | Total Body Clearance for Dose Interval Normalized by Dose | ||
CLTAUS | C114232 | Total CL for Dose Int Norm by SA | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area. | Total Body Clearance for Dose Interval Normalized by Surface Area | ||
CLTAUW | C114233 | Total CL for Dose Int Norm by WT | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight. | Total Body Clearance for Dose Interval Normalized by Weight | ||
CMAX | C70918 | Max Conc | The maximum concentration occurring at Tmax. | Cmax | ||
CMAXB | C92371 | Max Conc Norm by BMI | The maximum concentration occurring at Tmax, divided by the body mass index. | Maximum Concentration Normalized by Body Mass Index | ||
CMAXD | C85698 | Max Conc Norm by Dose | The maximum concentration occurring at Tmax, divided by the dose. | Maximum Concentration Dose Normalized | ||
CMAXDW | C174353 | Max Conc Norm by Dose/WT | The maximum concentration occurring at Tmax divided by the body weight-adjusted dose. | Maximum Concentration Normalized by Weight-Adjusted Dose | ||
CMAXLN | C161415 | Max Conc LN Transformed | The natural log transformed maximum concentration occurring at Tmax. | Natural Log Transformed Cmax | ||
CMAXS | C92372 | Max Conc Norm by SA | The maximum concentration occurring at Tmax, divided by the surface area. | Maximum Concentration Normalized by Surface Area | ||
CMAXUB | C154848 | Max Conc, Unbound Drug | The maximum concentration represented by the unbound fraction of drug, occurring at Tmax. | Maximum Concentration of Unbound Drug | ||
CMAXW | C92373 | Max Conc Norm by WT | The maximum concentration occurring at Tmax, divided by the weight. | Maximum Concentration Normalized by Weight | ||
CMIN | C85579 | Min Conc | The minimum concentration between dose time and dose time plus Tau (at Tmin). | Cmin | ||
CMINB | C92374 | Min Conc Norm by BMI | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index. | Minimum Concentration Normalized by Body Mass Index | ||
CMIND | C92375 | Min Conc Norm by Dose | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose. | Minimum Concentration Normalized by Dose | ||
CMINDW | C174354 | Min Conc Norm by Dose/WT | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body weight-adjusted dose. | Minimum Concentration Normalized by Weight-Adjusted Dose | ||
CMINS | C92376 | Min Conc Norm by SA | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area. | Minimum Concentration Normalized by Surface Area | ||
CMINW | C92377 | Min Conc Norm by WT | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight. | Minimum Concentration Normalized by Weight | ||
CONCB | C102367 | Conc by BMI | The concentration divided by body mass index. | Concentration Divided by Body Mass Index | ||
CONCD | C102368 | Conc by Dose | The concentration divided by dose. | Concentration Divided by Dose | ||
CONCEINF | C181515 | Concentration at End Infusion | The observed concentration at the end of the infusion. | Concentration at End Infusion | ||
CONCS | C102369 | Conc by SA | The concentration divided by surface area. | Concentration Divided by Surface Area | ||
CONCW | C102370 | Conc by WT | The concentration divided by weight. | Concentration Divided by Weight | ||
CORRXY | C85821 | Correlation Between TimeX and Log ConcY | The correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z. | Time and Log Concentration Correlation | ||
CTROUGH | C102394 | Conc Trough | Concentration at end of dosing interval. | Trough Concentration | ||
CTROUGHB | C102395 | Conc Trough by BMI | The trough concentration divided by body mass index. | Trough Concentration Divided by Body Mass Index | ||
CTROUGHD | C102396 | Conc Trough by Dose | The trough concentration divided by dose. | Trough Concentration Divided by Dose | ||
CTROUGHS | C102397 | Conc Trough by SA | The trough concentration divided by surface area. | Trough Concentration Divided by Surface Area | ||
CTROUGHW | C102398 | Conc Trough by WT | The trough concentration divided by weight. | Trough Concentration Divided by Weight | ||
DISTHL | C172583 | Half-Life Distribution | Half-life calculated from the distributional phase. | Half-Life Distribution | ||
EFFHL | C95007 | Effective Half-Life | The drug half-life that quantifies the accumulation ratio of a drug following multiple dosing. | Effective Half-life | ||
ERINT | C105449 | Excret Rate from T1 to T2 | The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 | ||
ERINTB | C105450 | Excret Rate from T1 to T2 Norm by BMI | The excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by BMI | ||
ERINTD | C105451 | Excret Rate from T1 to T2 Norm by Dose | The excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by Dose | ||
ERINTS | C105452 | Excret Rate from T1 to T2 Norm by SA | The excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by SA | ||
ERINTW | C105453 | Excret Rate from T1 to T2 Norm by WT | The excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by WT | ||
ERLST | C85656 | Last Meas Excretion Rate | The last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC. | Last Measurable Observed Excretion Rate | ||
ERLSTB | C92391 | Last Meas Excretion Rate Norm by BMI | The last measurable (positive) excretion rate divided by the body mass index. | Last Measurable Excretion Rate Normalized by Body Mass Index | ||
ERLSTD | C92392 | Last Meas Excretion Rate Norm by Dose | The last measurable (positive) excretion rate divided by the dose. | Last Measurable Excretion Rate Normalized by Dose | ||
ERLSTS | C92393 | Last Meas Excretion Rate Norm by SA | The last measurable (positive) excretion rate divided by the surface area. | Last Measurable Excretion Rate Normalized by Surface Area | ||
ERLSTW | C92394 | Last Meas Excretion Rate Norm by WT | The last measurable (positive) excretion rate divided by the weight. | Last Measurable Excretion Rate Normalized by Weight | ||
ERMAX | C85699 | Max Excretion Rate | The maximum excretion rate determined for the specimen type specified in PPSPEC. | Maximum Observed Excretion Rate | ||
ERMAXB | C92395 | Max Excretion Rate Norm by BMI | The maximum excretion rate divided by the body mass index. | Maximum Observed Excretion Rate Normalized by Body Mass Index | ||
ERMAXD | C92396 | Max Excretion Rate Norm by Dose | The maximum excretion rate divided by the dose. | Maximum Observed Excretion Rate Normalized by Dose | ||
ERMAXS | C92397 | Max Excretion Rate Norm by SA | The maximum excretion rate divided by the surface area. | Maximum Observed Excretion Rate Normalized by Surface Area | ||
ERMAXW | C92398 | Max Excretion Rate Norm by WT | The maximum excretion rate divided by the weight. | Maximum Observed Excretion Rate Normalized by Weight | ||
ERTLST | C85580 | Midpoint of Interval of Last Nonzero ER | The midpoint of collection interval associated with last measurable excretion rate. | Collection Interval Midpoint | ||
ERTMAX | C85823 | Midpoint of Interval of Maximum ER | The midpoint of collection interval associated with the maximum excretion rate. | Time of Maximum Observed Excretion Rate | ||
FABS | C154838 | Absolute Bioavailability | The fraction of the treatment dose that reaches the systemic circulation; this is the ratio of the amount of drug in the system (area under the curve) after extravascular administration of a test formulation divided by the drug in the system (area under the curve) after IV administration. | Absolute Bioavailability | ||
FB | C154840 | Fraction Bound | The percent or ratio of bound substance concentration to the total concentration. | Fraction Bound | ||
FLUCP | C85581 | Fluctuation% | The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau. | Concentration Variability Between Dose Time and Tau | ||
FM | C184704 | Fraction of the Dose Metabolized | The fraction of the bioavailable dose which has been metabolized. | Fraction of the Dose Metabolized | ||
FREL | C154839 | Relative Bioavailability | The fraction of the treatment dose that reaches the systemic circulation relative to a reference route or reference formulation. The ratio of the amount of drug in the system (area under the curve) after administration of a test formulation divided by the drug in the system after a non-IV administration of a reference formulation and/or reference route. | Relative Bioavailability | ||
FREXINT | C156576 | Fract Excr from T1 to T2 | The fraction of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. | Fractional Excretion from T1 to T2 | ||
FU | C135490 | Fraction Unbound | The percent or ratio of free substance concentration to the total concentration. (NCI) | Fraction Unbound | ||
HDCL | C112287 | Hemodialysis Clearance | The clearance of a substance from the blood during a hemodialysis session. | Hemodialysis Clearance | ||
HDER | C116213 | Hemodialysis Extraction Ratio | The fractional content of a substance removed from the blood during a hemodialysis session. | Hemodialysis Extraction Ratio | ||
HTMAX | C135491 | Half Tmax | The midpoint time between dosing time and Tmax. | Half Tmax | ||
KDIST | C172584 | K Slope of Distribution | The distribution rate constant. | K Slope of Distribution | ||
LAMZ | C85652 | Lambda z | The first order rate constant associated with the terminal (log-linear) portion of the curve. | Lambda Z | ||
LAMZHL | C85818 | Half-Life Lambda z | Terminal half-life. | Terminal Half Life | ||
LAMZLL | C85653 | Lambda z Lower Limit | The lower limit on time for values to be included in the calculation of Lambda z. | Lambda Z Time Lower Limit | ||
LAMZLTAU | C147479 | Lambda z Lower Limit TAU | The lower limit on time for values to be included in the calculation of Lambda z, calculated within a dosing interval. | Lambda z Lower Limit TAU | ||
LAMZNPT | C85816 | Number of Points for Lambda z | The number of time points used in computing Lambda z. | Sum of Lambda Z Timepoints | ||
LAMZNTAU | C147480 | Number of Points for Lambda z TAU | The number of time points used in computing Lambda z determined in a dosing interval. | Number of Points for Lambda z TAU | ||
LAMZSPN | C135492 | Lambda z Span | The interval of time covered by the data points used in the terminal disposition phase regression analysis, divided by half life. This yields the terminal disposition phase duration expressed as the number of half lives. | Lambda Z Span | ||
LAMZTAU | C147481 | Lambda z TAU | The first order rate constant associated with the terminal (log-linear) portion of the curve, calculated within a dosing interval. | Lambda z TAU | ||
LAMZUL | C85654 | Lambda z Upper Limit | The upper limit on time for values to be included in the calculation of Lambda z. | Lambda Z Time Upper Limit | ||
LAMZUTAU | C147482 | Lambda z Upper Limit TAU | The upper limit on time for values to be included in the calculation of Lambda z, calculated within a dosing interval. | Lambda z Upper Limit TAU | ||
MAT | C120723 | Mean Absorption Time | Mean absorption time of a substance administered by extravascular dosing. | Mean Absorption Time | ||
MRTEVIFO | C120724 | MRT Extravasc Infinity Obs | The mean residence time (MRT) extrapolated to infinity for a substance administered by extravascular dosing, calculated using the observed value of the last non-zero concentration. Extravascular MRT includes Mean Absorption Time (MAT). | Mean Residence Time Infinity Observed by Extravascular Dose | ||
MRTEVIFP | C120725 | MRT Extravasc Infinity Pred | The mean residence time (MRT) extrapolated to infinity for a substance administered by extravascular dosing, calculated using the predicted value of the last non-zero concentration. Extravascular MRT includes Mean Absorption Time (MAT). | Mean Residence Time Infinity Predicted by Extravascular Dose | ||
MRTEVLST | C120726 | MRT Extravasc to Last Nonzero Conc | Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration for a substance administered by extravascular dosing. Extravascular MRT includes Mean Absorption Time (MAT). | Mean Residence Time to Last Nonzero Concentration by Extravascular Dose | ||
MRTIBIFO | C121134 | MRT IV Bolus Infinity Obs | The mean residence time (MRT) extrapolated to infinity for a substance administered by intravascular bolus dosing, calculated using the observed value of the last non-zero concentration. | Mean Residence Time Infinity Observed by Intravascular Bolus Dose | ||
MRTIBIFP | C121136 | MRT IV Bolus Infinity Pred | The mean residence time (MRT) extrapolated to infinity for a substance administered by intravascular bolus dosing, calculated using the predicted value of the last non-zero concentration. | Mean Residence Time Infinity Predicted by Intravascular Bolus Dose | ||
MRTIBLST | C121137 | MRT IV Bolus to Last Nonzero Conc | Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration, for a substance administered by intravascular bolus dosing. | Mean Residence Time to Last Nonzero Concentration by Intravascular Bolus Dose | ||
MRTICIFO | C181517 | MRT IV Cont Inf Infinity Obs | The mean residence time (MRT) extrapolated to infinity for a substance administered by constant rate of continuous intravascular infusion, calculated using the observed value of the last non-zero concentration. | Mean Residence Time Intravenous Continuous Infusion Infinity Observed | ||
MRTICIFP | C181518 | MRT IV Cont Inf Infinity Pred | The mean residence time (MRT) extrapolated to infinity for a substance administered by constant rate of continuous intravascular infusion, calculated using the predicted value of the last non-zero concentration. | Mean Residence Time Intravenous Continuous Infusion Infinity Predicted | ||
MRTICLST | C181519 | MRT IV Cont Inf to Last Nonzero Conc | Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration, for a substance administered by constant rate of continuous intravascular infusion. | Mean Residence Time Intravenous Continuous Infusion to Last Nonzero Concentration | ||
NRENALCL | C102376 | Nonrenal CL | The total clearance of a substance from the blood less the renal clearance. | Nonrenal Clearance | ||
NRENLCLB | C105454 | Nonrenal CL Norm by BMI | The total clearance of a substance from the blood minus the renal clearance divided by the body mass index. | Nonrenal Clearance Normalized by BMI | ||
NRENLCLD | C105455 | Nonrenal CL Norm by Dose | The total clearance of a substance from the blood minus the renal clearance divided by the dose. | Nonrenal Clearance Normalized by Dose | ||
NRENLCLS | C105456 | Nonrenal CL Norm by SA | The total clearance of a substance from the blood minus the renal clearance divided by the surface area. | Nonrenal Clearance Normalized by SA | ||
NRENLCLW | C105457 | Nonrenal CL Norm by WT | The total clearance of a substance from the blood minus the renal clearance divided by the weight. | Nonrenal Clearance Normalized by WT | ||
PTROUGHR | C102381 | Peak Trough Ratio | The maximum concentration during a dosing interval divided by the concentration at the end of the dosing interval. | Peak Trough Ratio | ||
R2 | C85542 | R Squared | The goodness of fit statistic for the terminal elimination phase. | R Squared | ||
R2ADJ | C85553 | R Squared Adjusted | The goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z. | Adjusted R Squared | ||
RAAUC | C156471 | Ratio AUC | The ratio of two AUC values. | Area Under the Curve Ratio | ||
RAAUCALL | C176344 | Ratio AUC All | The ratio of two AUC All values. | AUC All Ratio | ||
RAAUCIFO | C156578 | Ratio AUC Infinity Obs | The ratio of two AUC infinity observed values. | Area Under the Curve Ratio Infinity Observed | ||
RAAUCIFP | C156577 | Ratio AUC Infinity Pred | The ratio of two AUC infinity predicted values. | Area Under the Curve Ratio Infinity Predicted | ||
RAAUCIND | C176349 | Ratio AUC from T1 to T2 Norm by Dose | The ratio of two AUC from T1 to T2 normalized by dose values. | Ratio AUC from T1 to T2 Normalized by Dose | ||
RAAUCINT | C176236 | Ratio AUC from T1 to T2 | The ratio of two AUC from T1 to T2 values. | Ratio AUC From T1 to T2 | ||
RAAUCIOD | C176348 | Ratio AUC Infinity Obs Norm by Dose | The ratio of two AUC infinity observed normalized by dose values. | Ratio AUC Infinity Observed Normalized by Dose | ||
RAAUCLSD | C176350 | Ratio AUC to Last Nonzero Conc Norm by Dose | The ratio of two AUC to last nonzero concentration normalized by dose values. | Ratio AUC to Last Nonzero Concentration Normalized by Dose | ||
RAAUCLST | C176237 | Ratio AUC to Last Nonzero Conc | The ratio of two AUC to last nonzero concentration values. | Ratio AUC to Last Nonzero Concentration | ||
RAAUCTAU | C176351 | Ratio AUC Over Dosing Interval | The ratio of two AUCTAU values. | Ratio AUC Over Dosing Interval | ||
RACAVG | C176345 | Ratio Average Concentration | The ratio of two average concentration values. | Average Concentration Ratio | ||
RACMAX | C156579 | Ratio CMAX | The ratio of two Cmax values. | Cmax to Cmax Ratio Measurement | ||
RACMAXD | C176352 | Ratio Max Conc Norm by Dose | The ratio of two maximum concentration normalized by dose values. | Ratio Maximum Concentration Normalized by Dose | ||
RACMIN | C176346 | Ratio Min Conc | The ratio of two cmin values. | Minimum Concentration Ratio | ||
RACONC | C176235 | Ratio Concentration | The ratio of two concentration values. | Concentration Ratio | ||
RACTRGH | C176353 | Ratio Conc Trough | The ratio of two CTROUGH values. | Ratio Concentration Trough | ||
RAMAXMIN | C156580 | Ratio of CMAX to CMIN | The ratio of Cmax value to Cmin value. | Cmax to Cmin Ratio Measurement | ||
RARECIFO | C176354 | Ratio Amt Rec Infinity Obs | The ratio of two amount recovered infinity observed values. | Ratio Amount Recovered Infinity Observed | ||
RARECINT | C176347 | Ratio Amt Rec from T1 to T2 | The ratio of two amount recovered from T1 to T2 values. | Ratio Amount Recovered from T1 to T2 | ||
RCAMIFO | C112032 | Amt Rec Infinity Obs | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Amount Recovered Infinity Observed | ||
RCAMIFOB | C112223 | Amt Rec Infinity Obs Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Amount Recovered Infinity Observed Normalized by Body Mass Index | ||
RCAMIFOS | C112224 | Amt Rec Infinity Obs Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Amount Recovered Infinity Observed Normalized by Surface Area | ||
RCAMIFOW | C112225 | Amt Rec Infinity Obs Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | Amount Recovered Infinity Observed Normalized by Weight | ||
RCAMIFP | C112033 | Amt Rec Infinity Pred | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Amount Recovered Infinity Predicted | ||
RCAMIFPB | C112226 | Amt Rec Infinity Pred Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Amount Recovered Infinity Predicted Normalized by Body Mass Index | ||
RCAMIFPS | C112227 | Amt Rec Infinity Pred Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Amount Recovered Infinity Predicted Normalized by Surface Area | ||
RCAMIFPW | C112228 | Amt Rec Infinity Pred Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Amount Recovered Infinity Predicted Normalized by Weight | ||
RCAMINT | C102359 | Amt Rec from T1 to T2 | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2. | Amount Recovered from T1 to T2 | ||
RCAMINTB | C102360 | Amt Rec from T1 to T2 Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index. | Amount Recovered from T1 to T2 Normalized by Body Mass Index | ||
RCAMINTS | C102361 | Amt Rec from T1 to T2 Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area. | Amount Recovered from T1 to T2 Normalized by Surface Area | ||
RCAMINTW | C102362 | Amt Rec from T1 to T2 Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight. | Amount Recovered from T1 to T2 Normalized by Weight | ||
RCAMLST | C174346 | Amt Rec to Last Nonzero Conc | The cumulative amount recovered from the specimen type specified in PPSPEC, from the time of dosing to the last non-zero concentration. | Amount Recovered to Last Nonzero Concentration | ||
RCAMTAU | C102363 | Amt Rec Over Dosing Interval | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU). | Amount Recovered Over Dosing Interval | ||
RCAMTAUB | C102364 | Amt Rec Over Dosing Interval Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index. | Amount Recovered Over Dosing Interval Normalized by Body Mass Index | ||
RCAMTAUS | C102365 | Amt Rec Over Dosing Interval Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area. | Amount Recovered Over Dosing Interval Normalized by Surface Area | ||
RCAMTAUW | C102366 | Amt Rec Over Dosing Interval Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight. | Amount Recovered Over Dosing Interval Normalized by Weight | ||
RCPCIFO | C112034 | Pct Rec Infinity Obs | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Percent Recovered Infinity Observed | ||
RCPCIFOB | C112389 | Pct Rec Infinity Obs Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Percent Recovered Infinity Observed Normalized by Body Mass Index | ||
RCPCIFOS | C112390 | Pct Rec Infinity Obs Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Percent Recovered Infinity Observed Normalized by Surface Area | ||
RCPCIFOW | C112391 | Pct Rec Infinity Obs Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | Percent Recovered Infinity Observed Normalized by Weight | ||
RCPCIFP | C112035 | Pct Rec Infinity Pred | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Percent Recovered Infinity Predicted | ||
RCPCIFPB | C112392 | Pct Rec Infinity Pred Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Percent Recovered Infinity Predicted Normalized by Body Mass Index | ||
RCPCIFPS | C112393 | Pct Rec Infinity Pred Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Percent Recovered Infinity Predicted Normalized by Surface Area | ||
RCPCIFPW | C112394 | Pct Rec Infinity Pred Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Percent Recovered Infinity Predicted Normalized by Weight | ||
RCPCINT | C102382 | Pct Rec from T1 to T2 | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. | Percent Recovered from T1 to T2 | ||
RCPCINTB | C102383 | Pct Rec from T1 to T2 Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index. | Percent Recovered from T1 to T2 Normalized by Body Mass Index | ||
RCPCINTS | C102384 | Pct Rec from T1 to T2 Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area. | Percent Recovered from T1 to T2 Normalized by Surface Area | ||
RCPCINTW | C102385 | Pct Rec from T1 to T2 Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight. | Percent Recovered from T1 to T2 Normalized by Weight | ||
RCPCLST | C166075 | Pct Rec to Last Nonzero Conc | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, from the time of dosing to the last non-zero concentration. | Percent Recovered To Last Nonzero Concentration | ||
RCPCTAU | C102386 | Pct Rec Over Dosing Interval | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU). | Percent Recovered Over Dosing Interval | ||
RCPCTAUB | C102387 | Pct Rec Over Dosing Interval Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index. | Percent Recovered Over Dosing Interval Normalized by Body Mass Index | ||
RCPCTAUS | C102388 | Pct Rec Over Dosing Interval Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area. | Percent Recovered Over Dosing Interval Normalized by Surface Area | ||
RCPCTAUW | C102389 | Pct Rec Over Dosing Interval Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight. | Percent Recovered Over Dosing Interval Normalized by Weight | ||
RENALCL | C75913 | Renal CL | The clearance of a substance from the blood by the kidneys. | Renal Clearance | ||
RENALCLB | C105458 | Renal CL Norm by BMI | The clearance of a substance from the blood by the kidneys divided by the body mass index. | Renal Clearance Normalized by BMI | ||
RENALCLD | C105459 | Renal CL Norm by Dose | The clearance of a substance from the blood by the kidneys divided by the dose. | Renal Clearance Normalized by Dose | ||
RENALCLS | C105460 | Renal CL Norm by SA | The clearance of a substance from the blood by the kidneys divided by the surface area. | Renal Clearance Normalized by SA | ||
RENALCLW | C105461 | Renal CL Norm by WT | The clearance of a substance from the blood by the kidneys divided by the weight. | Renal Clearance Normalized by WT | ||
RENCLTAU | C122050 | Renal CL for Dose Int | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU. | Renal Clearance for Dose Interval | ||
RNCLINT | C122049 | Renal CL from T1 to T2 | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2. | Renal Clearance from T1 to T2 | ||
RNCLINTB | C122330 | Renal CL from T1 to T2 Norm by BMI | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the body mass index. | Renal Clearance from T1 to T2 Normalized by Body Mass Index | ||
RNCLINTD | C122331 | Renal CL from T1 to T2 Norm by Dose | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the dose. | Renal Clearance from T1 to T2 Normalized by Dose | ||
RNCLINTS | C122332 | Renal CL from T1 to T2 Norm by SA | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the surface area. | Renal Clearance from T1 to T2 Normalized by Surface Area | ||
RNCLINTW | C122333 | Renal CL from T1 to T2 Norm by WT | The clearance of a substance from the blood by the kidneys over the interval from T1 to T2 divided by the weight. | Renal Clearance from T1 to T2 Normalized by Weight | ||
RNCLTAUB | C122334 | Renal CL for Dose Int Norm by BMI | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the body mass index. | Renal Clearance for Dose Interval Normalized by Body Mass Index | ||
RNCLTAUD | C122335 | Renal CL for Dose Int Norm by Dose | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the dose. | Renal Clearance for Dose Interval Normalized by Dose | ||
RNCLTAUS | C122336 | Renal CL for Dose Int Norm by SA | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the surface area. | Renal Clearance for Dose Interval Normalized by Surface Area | ||
RNCLTAUW | C122337 | Renal CL for Dose Int Norm by WT | The clearance of a substance from the blood by the kidneys, calculated using AUCTAU, divided by the weight. | Renal Clearance for Dose Interval Normalized by Weight | ||
RNCLUB | C154843 | Renal CL for Unbound Drug | The unbound fraction of drug within the portion of total clearance attributed to the kidneys. | Renal Clearance for Unbound Drug | ||
SRAUC | C122338 | Stationarity Ratio AUC | The area under the curve (AUCTAU) at steady state divided by the area under the curve extrapolated to infinity for the initial dosing interval. | Stationarity Ratio Area Under the Curve | ||
SWING | C161416 | Swing | The difference between Cmax and Cmin standardized to Cmin within a dosing interval. | PK Swing | ||
TAU | C176355 | Dosing Interval | The duration of time between two doses. | Dosing Interval | ||
TAUHL | C147483 | Half-Life TAU | Half-life calculated within a dosing interval. | Half-Life TAU | ||
TLAG | C85824 | Time Until First Nonzero Conc | The time prior to the first measurable (non-zero) concentration. | Time until First Nonzero Concentration | ||
TLST | C85822 | Time of Last Nonzero Conc | The time of the last measurable (positive) concentration. | Time of Last Nonzero Concentration | ||
TMAX | C70919 | Time of CMAX | The time of maximum observed concentration sampled during a dosing interval. | Tmax | ||
TMIN | C85825 | Time of CMIN Observation | The time of minimum concentration sampled during a dosing interval. | Tmin | ||
TROUGHPR | C122339 | Trough Peak Ratio | The concentration at the start of a dosing interval divided by the maximum concentration during the dosing interval. | Trough Peak Ratio | ||
V0 | C102371 | Vol Dist Initial | The initial volume of distribution for a substance administered by bolus intravascular dosing. | Initial Volume of Distribution | ||
V0B | C102372 | Vol Dist Initial Norm by BMI | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index. | Initial Volume of Distribution Normalized by Body Mass Index | ||
V0D | C102373 | Vol Dist Initial Norm by Dose | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose. | Initial Volume of Distribution Normalized by Dose | ||
V0S | C102374 | Vol Dist Initial Norm by SA | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area. | Initial Volume of Distribution Normalized by Surface Area | ||
V0W | C102375 | Vol Dist Initial Norm by WT | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight. | Initial Volume of Distribution Normalized by Weight | ||
VOLPK | C85817 | Sum of Urine Vol | The sum of urine volumes that are used for PK parameters. | Sum Urine Volume | ||
VSSO | C85770 | Vol Dist Steady State Obs | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing. | Observed Steady State Volume of Distribution | ||
VSSOB | C102377 | Vol Dist Steady State Obs Norm by BMI | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index. | Observed Steady State Volume of Distribution Normalized by Body Mass Index | ||
VSSOBD | C156574 | Vol Dist Steady State Obs by B | The volume of distribution at steady state based on the observed CLST for a substance administered, divided by the fraction of bound drug. | Volume of Distribution Steady State Observed by Bound Drug | ||
VSSOD | C102378 | Vol Dist Steady State Obs Norm by Dose | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose. | Observed Steady State Volume of Distribution Normalized by Dose | ||
VSSOF | C156570 | Vol Dist Steady State Obs by F | The volume of distribution at steady state based on the observed CLST for a substance administered by extravascular dosing, divided by the fraction of dose absorbed. | Volume of Distribution Steady State Observed by Fraction of Dose Absorbed | ||
VSSOS | C102379 | Vol Dist Steady State Obs Norm by SA | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area. | Observed Steady State Volume of Distribution Normalized by Surface Area | ||
VSSOUB | C156572 | Vol Dist Steady State Obs by UB | The volume of distribution at steady state based on the observed CLST for a substance administered, divided by the fraction of unbound drug. | Volume of Distribution Steady State Observed by Unbound Drug | ||
VSSOW | C102380 | Vol Dist Steady State Obs Norm by WT | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight. | Observed Steady State Volume of Distribution Normalized by Weight | ||
VSSP | C85794 | Vol Dist Steady State Pred | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing. | Predicted Steady State Volume of Distribution | ||
VSSPB | C102390 | Vol Dist Steady State Pred Norm by BMI | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index. | Predicted Steady State Volume of Distribution Normalized by Body Mass Index | ||
VSSPBD | C156575 | Vol Dist Steady State Pred by B | The volume of distribution at steady state based on the predicted CLST for a substance administered, divided by the fraction of bound drug. | Volume of Distribution Steady State Predicted by Bound Drug | ||
VSSPD | C102391 | Vol Dist Steady State Pred Norm by Dose | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose. | Predicted Steady State Volume of Distribution Normalized by Dose | ||
VSSPF | C156571 | Vol Dist Steady State Pred by F | The volume of distribution at steady state based on the predicted CLST for a substance administered by extravascular dosing, divided by the fraction of dose absorbed. | Volume of Distribution Steady State Predicted by Fraction of Dose Absorbed | ||
VSSPS | C102392 | Vol Dist Steady State Pred Norm by SA | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area. | Predicted Steady State Volume of Distribution Normalized by Surface Area | ||
VSSPUB | C156573 | Vol Dist Steady State Pred by UB | The volume of distribution at steady state based on the predicted CLST for a substance administered, divided by the fraction of unbound drug. | Volume of Distribution Steady State Predicted by Unbound Drug | ||
VSSPW | C102393 | Vol Dist Steady State Pred Norm by WT | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight. | Predicted Steady State Volume of Distribution Normalized by Weight | ||
VZFO | C85775 | Vz Obs by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. | Observed Volume of Distribution of Absorbed Fraction | ||
VZFOB | C92410 | Vz Obs by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution of Fraction Dose Observed Normalized by Body Mass Index | ||
VZFOD | C102729 | Vz Obs by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. | Volume of Distribution of Fraction Dose Observed Normalized by Dose | ||
VZFOS | C92411 | Vz Obs by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Volume of Distribution of Fraction Dose Observed Normalized by Surface Area | ||
VZFOUB | C156581 | Vz Obs by F for UB | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration and corrected for unbound drug. | Observed Volume of Distribution of Absorbed Fraction for Unbound Drug | ||
VZFOW | C92412 | Vz Obs by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. | Volume of Distribution of Fraction Dose Observed Normalized by Weight | ||
VZFP | C85799 | Vz Pred by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. | Predicted Volume of Distribution of Absorbed Fraction | ||
VZFPB | C92428 | Vz Pred by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution of Fraction Dose Predicted Normalized by Body Mass Index | ||
VZFPD | C102730 | Vz Pred by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Volume of Distribution of Fraction Dose Predicted Normalized by Dose | ||
VZFPS | C92429 | Vz Pred by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Volume of Distribution of Fraction Dose Predicted Normalized by Surface Area | ||
VZFPUB | C158267 | Vz Pred by F for UB | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value at the time of the last non-zero concentration and corrected for unbound drug. | Volume of Distribution of Fraction Dose Predicted Corrected for Unbound Drug | ||
VZFPW | C92430 | Vz Pred by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Volume of Distribution of Fraction Dose Predicted Normalized by Weight | ||
VZFTAU | C111364 | Vz for Dose Int by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. | Volume of Distribution for Dosing Interval by Fraction | ||
VZFTAUB | C111365 | Vz for Dose Int by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. | Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index | ||
VZFTAUD | C111366 | Vz for Dose Int by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. | Volume of Distribution for Dosing Interval by Fraction Normalized by Dose | ||
VZFTAUS | C111367 | Vz for Dose Int by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. | Volume of Distribution for Dosing Interval by Fraction Normalized by Surface Area | ||
VZFTAUW | C111368 | Vz for Dose Int by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. | Volume of Distribution for Dosing Interval by Fraction Normalized by Weight | ||
VZO | C85774 | Vz Obs | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration. | Observed Volume of Distribution | ||
VZOB | C92407 | Vz Obs Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution Observed Normalized by Body Mass Index | ||
VZOD | C102683 | Vz Obs Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. | Observed Volume of Distribution Normalized by Dose | ||
VZOS | C92408 | Vz Obs Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Volume of Distribution Observed Normalized by Surface Area | ||
VZOUB | C158265 | Vz Obs for UB | The volume of distribution associated with the terminal slope following administration, calculated using the observed value of the last non-zero concentration and corrected for unbound drug. | Volume of Distribution Observed for Unbound Drug | ||
VZOW | C92409 | Vz Obs Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. | Volume of Distribution Observed Normalized by Weight | ||
VZP | C85798 | Vz Pred | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration. | Predicted Volume of Distribution | ||
VZPB | C92425 | Vz Pred Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution Predicted Normalized by Body Mass Index | ||
VZPD | C102696 | Vz Pred Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Predicted Volume of Distribution Normalized by Dose | ||
VZPS | C92426 | Vz Pred Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Volume of Distribution Predicted Normalized by Surface Area | ||
VZPUB | C158266 | Vz Pred for UB | The volume of distribution associated with the terminal slope following administration, calculated using the predicted value at the time of the last non-zero concentration and corrected for unbound drug. | Volume of Distribution Predicted for Unbound Drug | ||
VZPW | C92427 | Vz Pred Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Volume of Distribution Predicted Normalized by Weight | ||
VZTAU | C111333 | Vz for Dose Int | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU. | Volume of Distribution for Dosing Interval | ||
VZTAUB | C111369 | Vz for Dose Int Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index. | Volume of Distribution for Dosing Interval Normalized by Body Mass Index | ||
VZTAUD | C111370 | Vz for Dose Int Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose. | Volume of Distribution for Dosing Interval Normalized by Dose | ||
VZTAUS | C111371 | Vz for Dose Int Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area. | Volume of Distribution for Dosing Interval Normalized by Surface Area | ||
VZTAUW | C111372 | Vz for Dose Int Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight. | Volume of Distribution for Dosing Interval Normalized by Weight | ||
Back to top | ||||||
CL.C85494.PKUNIT | PK Units of Measure
(PKUNIT) | text
Extensible: Yes | C85494 | PK Units of Measure | Units of measure for pharmacokinetic data and parameters. | CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology |
% | C25613 | Percentage | One hundred times the quotient of one quantity divided by another, with the same units of measurement. | Percentage | ||
%/g | C181520 | Percentage of the administered dose recovered per gram of matrix or tissue, normalized by the sample weight. | Percent Administered Dose Recovered Per Gram | |||
(Bq/g)/(kBq/kg) | C163549 | (Bq/g)/(Bq/g);(Bq/g)/(kBq/kg) | Becquerel per gram, divided by dose per kilogram body weight or Becquerel per gram, divided by dose per gram body weight. | Becquerel per Gram per Kilobecquerel per Kilogram | ||
(Bq/mL)/(kBq/kg) | C163550 | (Bq/mL)/(Bq/g);(Bq/mL)/(kBq/kg) | Becquerel per milliliter, divided by dose per kilogram body weight or Becquerel per milliliter, divided by dose per gram body weight. | Becquerel per Milliliter per Kilobecquerel per Kilogram | ||
(h*Bq/g)/(kBq/kg) | C163551 | (h*Bq/g)/(Bq/g);(h*Bq/g)/(kBq/kg) | Hours times Becquerel per gram (area under the curve), divided by dose per kilogram body weight or hours times Becquerel per gram (area under the curve), divided by dose per gram body weight. | Hour Times Becquerel per Gram per Kilobecquerel per Kilogram | ||
(h*Bq/mL)/(kBq/kg) | C163552 | (h*Bq/mL)/(Bq/g);(h*Bq/mL)/(kBq/kg) | Hours times Becquerel per milliliter (area under the curve), divided by dose per kilogram body weight or hours times Becquerel per milliliter (area under the curve), divided by dose per gram body weight. | Hour Times Becquerel per Milliliter per Kilobecquerel per Kilogram | ||
(L/day)/(kg/m2) | C120727 | Liters per day (flow rate), divided by kilograms per meter squared (body mass index). | Liter per Day per Kilogram per Meter Squared | |||
(L/day)/(mg/day) | C120728 | (L/day)/(mg/day);(mL/day)/(ug/day) | Liters per day (flow rate), divided by milligrams per day (daily dose) or milliliters per day (flow rate), divided by micrograms per day (daily dose). | Liter per Day per Milligram per Day | ||
(L/day)/(mg/kg) | C120729 | (L/day)/(mg/kg);(mL/day)/(ug/kg) | Liters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Day per Milligram per Kilogram | ||
(L/day)/(mg/kg/day) | C120730 | (L/day)/(mg/kg/day);(mL/day)/(ug/kg/day) | Liters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Day per Milligram per Kilogram per Day | ||
(L/day)/(mg/m2) | C120731 | (L/day)/(mg/m2);(mL/day)/(ug/m2) | Liters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Day per Milligram per Meter Squared | ||
(L/day)/(mg/m2/day) | C120732 | (L/day)/(mg/m2/day);(mL/day)/(ug/m2/day) | Liters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Day per Milligram per Meter Squared per Day | ||
(L/day)/(ug/day) | C120733 | Liters per day (flow rate), divided by micrograms per day (daily dose). | Liter per Day per Microgram per Day | |||
(L/day)/(ug/kg) | C120734 | Liters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Day per Microgram per Kilogram | |||
(L/day)/(ug/kg/day) | C120735 | Liters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Day per Microgram per Kilogram per Day | |||
(L/day)/(ug/m2) | C120736 | Liters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Day per Microgram per Meter Squared | |||
(L/day)/(ug/m2/day) | C120737 | Liters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Day per Microgram per Meter Squared per Day | |||
(L/day)/g | C85657 | (L/day)/g;(mL/day)/mg | Liters per day (flow rate), divided by grams (weight) or milliliters per day (flow rate), divided by milligrams (dose). | Liter per Gram per Day | ||
(L/day)/kg | C73755 | (L/day)/kg;(mL/day)/g;mL/g/day | Milliliters per gram per day or liters per day (flow rate), divided by kilograms (weight) or milliliters per day (flow rate), divided by grams (weight). | Milliliter per Gram per Day | ||
(L/day)/m2 | C120738 | Liters per day (flow rate), divided by meters squared (surface area). | Liter per Day per Meter Squared | |||
(L/day)/mg | C85672 | (L/day)/mg;(mL/day)/ug | Liters per day (flow rate), divided by milligrams (dose) or milliliters per day (flow rate), divided by micrograms (dose). | Liter per Milligram per Day | ||
(L/day)/ug | C85665 | Liters per day (flow rate), divided by micrograms (dose). | Liter per Microgram per Day | |||
(L/h)/(kg/m2) | C120739 | Liters per hour (flow rate), divided by kilograms per meter squared (body mass index). | Liter per Hour per Kilogram per Meter Squared | |||
(L/h)/(mg/day) | C120740 | (L/h)/(mg/day);(mL/h)/(ug/day) | Liters per hour (flow rate), divided by milligrams per day (daily dose) or milliliters per hour (flow rate), divided by micrograms per day (daily dose). | Liter per Hour per Milligram per Day | ||
(L/h)/(mg/kg) | C120741 | (L/h)/(mg/kg);(mL/h)/(ug/kg) | Liters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Hour per Milligram per Kilogram | ||
(L/h)/(mg/kg/day) | C120742 | (L/h)/(mg/kg/day);(mL/h)/(ug/kg/day) | Liters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Hour per Milligram per Kilogram per Day | ||
(L/h)/(mg/m2) | C120743 | (L/h)/(mg/m2);(mL/h)/(ug/m2) | Liters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Hour per Milligram per Meter Squared | ||
(L/h)/(mg/m2/day) | C120744 | (L/h)/(mg/m2/day);(mL/h)/(ug/m2/day) | Liters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Hour per Milligram per Meter Squared per Day | ||
(L/h)/(ug/day) | C120745 | Liters per hour (flow rate), divided by micrograms per day (daily dose). | Liter per Hour per Microgram per Day | |||
(L/h)/(ug/kg) | C120746 | Liters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Hour per Microgram per Kilogram | |||
(L/h)/(ug/kg/day) | C120747 | Liters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Hour per Microgram per Kilogram per Day | |||
(L/h)/(ug/m2) | C120748 | Liters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Hour per Microgram per Meter Squared | |||
(L/h)/(ug/m2/day) | C120749 | Liters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Hour per Microgram per Meter Squared per Day | |||
(L/h)/g | C85658 | (L/h)/g;(mL/h)/mg | Liters per hour (flow rate), divided by grams (weight) or milliliters per hour (flow rate), divided by milligrams (dose). | Liter per Gram per Hour | ||
(L/h)/kg | C73756 | (L/h)/kg;(mL/h)/g;mL/g/h | Milliliters per gram per hour or liters per hour (flow rate), divided by kilograms (weight) or milliliters per hour (flow rate), divided by grams (weight). | Milliliter per Gram per Hour | ||
(L/h)/m2 | C105494 | (L/h)/m2;L/h/m2 | Liters per hour (flow rate), divided by meters squared (surface area). | Liter Per Hour Per Square Meter | ||
(L/h)/mg | C85673 | (L/h)/mg;(mL/h)/ug | Liters per hour (flow rate), divided by milligrams (dose) or milliliters per hour (flow rate), divided by micrograms (dose). | Liter per Milligram per Hour | ||
(L/h)/ug | C85662 | Liters per hour (flow rate), divided by micrograms (dose). | Liter per Microgram per Hour | |||
(L/min)/(kg/m2) | C120750 | Liters per minute (flow rate), divided by kilograms per meter squared (body mass index). | Liter per Minute per Kilogram per Meter Squared | |||
(L/min)/(mg/day) | C120751 | (L/min)/(mg/day);(mL/min)/(ug/day) | Liters per minute (flow rate), divided by milligrams per day (daily dose) or milliliters per minute (flow rate), divided by micrograms per day (daily dose). | Liter per Minute per Milligram per Day | ||
(L/min)/(mg/kg) | C120752 | (L/min)/(mg/kg);(mL/min)/(ug/kg) | Liters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Minute per Milligram per Kilogram | ||
(L/min)/(mg/kg/day) | C120753 | (L/min)/(mg/kg/day);(mL/min)/(ug/kg/day) | Liters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Minute per Milligram per Kilogram per Day | ||
(L/min)/(mg/m2) | C120754 | (L/min)/(mg/m2);(mL/min)/(ug/m2) | Liters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Minute per Milligram per Meter Squared | ||
(L/min)/(mg/m2/day) | C120755 | (L/min)/(mg/m2/day);(mL/min)/(ug/m2/day) | Liters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Minute per Milligram per Meter Squared per Day | ||
(L/min)/(ug/day) | C120756 | Liters per minute (flow rate), divided by micrograms per day (daily dose). | Liter per Minute per Microgram per Day | |||
(L/min)/(ug/kg) | C120757 | Liters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Minute per Microgram per Kilogram | |||
(L/min)/(ug/kg/day) | C120758 | Liters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Minute per Microgram per Kilogram per Day | |||
(L/min)/(ug/m2) | C120759 | Liters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Minute per Microgram per Meter Squared | |||
(L/min)/(ug/m2/day) | C120760 | Liters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Minute per Microgram per Meter Squared per Day | |||
(L/min)/g | C85659 | (L/min)/g;(mL/min)/mg | Liters per minute (flow rate), divided by grams (weight) or milliliters per minute (flow rate), divided by milligrams (dose). | Liter per Gram per Minute | ||
(L/min)/kg | C73757 | (L/min)/kg;(mL/min)/g;mL/g/min | Milliliters per gram per minute or liters per minute (flow rate), divided by kilograms (weight) or milliliters per minute (flow rate), divided by grams (weight). | Milliliter per Gram per Minute | ||
(L/min)/m2 | C105496 | (L/min)/m2;L/min/m2 | Liters per minute (flow rate), divided by meters squared (surface area). | Liter Per Minute Per Square Meter | ||
(L/min)/mg | C85674 | (L/min)/mg;(mL/min)/ug | Liters per minute (flow rate), divided by milligrams (dose) or milliliters per minute (flow rate), divided by micrograms (dose). | Liter per Milligram per Minute | ||
(L/min)/ug | C85666 | Liters per minute (flow rate), divided by micrograms (dose). | Liter per Microgram per Minute | |||
(mL/day)/(kg/m2) | C120761 | Milliliters per day (flow rate), divided by kilograms per meter squared (body mass index). | Milliliter per Day per Kilogram per Meter Squared | |||
(mL/day)/(mg/day) | C120762 | Milliliters per day (flow rate), divided by milligrams per day (daily dose). | Milliliter per Day per Milligram per Day | |||
(mL/day)/(mg/kg) | C120763 | Milliliters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight). | Milliliter per Day per Milligram per Kilogram | |||
(mL/day)/(mg/kg/day) | C120764 | Milliliters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Milliliter per Day per Milligram per Kilogram per Day | |||
(mL/day)/(mg/m2) | C120765 | Milliliters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area). | Milliliter per Day per Milligram per Meter Squared | |||
(mL/day)/(mg/m2/day) | C120766 | Milliliters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milliliter per Day per Milligram per Meter Squared per Day | |||
(mL/day)/kg | C73758 | (mL/day)/kg;mL/kg/day | Milliliters per kilogram per day or milliliters per day (flow rate), divided by kilograms (weight). | Milliliter per Kilogram per Day | ||
(mL/day)/m2 | C120773 | Milliliters per day (flow rate), divided by meters squared (surface area). | Milliliter per Day per Meter Squared | |||
(mL/h)/(kg/m2) | C120776 | Milliliters per hour (flow rate), divided by kilograms per meter squared (body mass index). | Milliliter per Hour per Kilogram per Meter Squared | |||
(mL/h)/(mg/day) | C120777 | Milliliters per hour (flow rate), divided by milligrams per day (daily dose). | Milliliter per Hour per Milligram per Day | |||
(mL/h)/(mg/kg) | C120778 | Milliliters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight). | Milliliter per Hour per Milligram per Kilogram | |||
(mL/h)/(mg/kg/day) | C120779 | Milliliters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Milliliter per Hour per Milligram per Kilogram per Day | |||
(mL/h)/(mg/m2) | C120780 | Milliliters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area). | Milliliter per Hour per Milligram per Meter Squared | |||
(mL/h)/(mg/m2/day) | C120781 | Milliliters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milliliter per Hour per Milligram per Meter Squared per Day | |||
(mL/h)/kg | C73759 | (mL/h)/kg;mL/kg/h | Milliliters per kilogram per hour or milliliters per hour (flow rate), divided by kilograms (weight). | Milliliter per Kilogram per Hour | ||
(mL/h)/m2 | C120788 | Milliliters per hour (flow rate), divided by meters squared (surface area). | Milliliter per Hour per Meter Squared | |||
(mL/min)/(kg/m2) | C120791 | Milliliters per minute (flow rate), divided by kilograms per meter squared (body mass index). | Milliliter per Minute per Kilogram per Meter Squared | |||
(mL/min)/(mg/day) | C120792 | Milliliters per minute (flow rate), divided by milligrams per day (daily dose). | Milliliter per Minute per Milligram per Day | |||
(mL/min)/(mg/kg) | C120793 | Milliliters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight). | Milliliter per Minute per Milligram per Kilogram | |||
(mL/min)/(mg/kg/day) | C120794 | Milliliters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Milliliter per Minute per Milligram per Kilogram per Day | |||
(mL/min)/(mg/m2) | C120795 | Milliliters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area). | Milliliter per Minute per Milligram per Meter Squared | |||
(mL/min)/(mg/m2/day) | C120796 | Milliliters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milliliter per Minute per Milligram per Meter Squared per Day | |||
(mL/min)/kg | C73760 | (mL/min)/kg;mL/kg/min | Milliliters per kilogram per minute or milliliters per minute (flow rate), divided by kilograms (weight). | Milliliter per Kilogram per Minute | ||
(mL/min)/m2 | C120803 | Milliliters per minute (flow rate), divided by meters squared (surface area). | Milliliter per Minute per Meter Squared | |||
/day | C25473 | /day;Daily;Per Day | A rate of occurrences within a period of time equal to one day. | Daily | ||
/h | C66966 | Per Hour | A rate of occurrences within a period of time equal to one hour. | Per Hour | ||
/min | C66967 | A rate of occurrences within a period of time equal to one minute. | Per Minute | |||
Bq | C42562 | Becquerel | A unit of activity of a radionuclide, equal to one nuclear disintegration or other nuclear transition from a particular energy state occurring in an amount of a radionuclide during one second-long time interval.(NCI) | Becquerel | ||
Bq/g | C70522 | Becquerel per Gram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one gram.(NCI) | Becquerel per Gram | ||
Bq/kg | C70521 | Becquerel per Kilogram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one kilogram.(NCI) | Becquerel per Kilogram | ||
Bq/L | C71165 | Becquerel per Liter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one liter.(NCI) | Becquerel per Liter | ||
Bq/mg | C70524 | Becquerel per Milligram;kBq/g;Kilobecquerel per Gram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one milligram.(NCI) | Becquerel per Milligram | ||
Bq/mL | C71167 | Becquerel per Milliliter;kBq/L;Kilobecquerel per Liter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one milliliter or one kilobecquerel per liter.(NCI) | Becquerel per Milliliter | ||
Bq/ug | C70523 | Becquerel per Microgram;Bq/mcg;Bq/ug;kBq/mg;Kilobecquerel per Milligram;MBq/g;Megabecquerel per Gram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one microgram, or equal to activity of one kilobecquerel of the sample with total mass of one milligram. | Becquerel per Microgram | ||
Bq/uL | C71166 | Becquerel per Microliter;kBq/mL;Kilobecquerel per Milliliter;MBq/L;Megabecquerel per Liter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one millionth of a liter.(NCI) | Becquerel per Microliter | ||
copies/mL | C100900 | A unit of concentration expressed as a number of copies per unit volume equal to one milliliter. | Copies per Milliliter | |||
copies/ug | C126079 | A unit of concentration expressed as a number of copies per unit volume equal to one microgram. | Copies per Microgram | |||
copies/uL | C116237 | A unit of concentration expressed as a number of copies per unit volume equal to one microliter. | Copies per Microliter | |||
day | C25301 | A unit of measurement of time equal to 24 hours. | Day | |||
day*fg/mL | C85583 | Days times femtograms per milliliter (area under the curve). | Day Times Femtogram per Milliliter | |||
day*fg/mL/(kg/m2) | C111167 | Days times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Femtogram per Milliliter per Kilogram per Meter Squared | |||
day*fg/mL/(mg/g) | C117894 | Days times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Femtogram Per Milliliter Per Milligram Per Gram | |||
day*fg/mL/(mg/g/day) | C117895 | Days times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Femtogram Per Milliliter Per Milligram Per Gram Per Day | |||
day*fg/mL/g | C112244 | day*fg/mL/g;day*pg/mL/kg | Days times picograms per milliliter (area under the curve), divided by kilograms (weight) or days times femtograms per milliliter (area under the curve), divided by grams (weight). | Day Times Femtogram Per Milliliter Per Gram | ||
day*fg/mL/kg | C112245 | Days times femtograms per milliliter (area under the curve), divided by kilograms (weight). | Day Times Femtogram Per Milliliter Per Kilogram | |||
day*fg/mL/m2 | C111168 | Days times femtograms per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Femtogram per Milliliter per Meter Squared | |||
day*g/mL | C85584 | Days times grams per milliliter (area under the curve). | Day Times Gram per Milliliter | |||
day*g/mL/(kg/m2) | C111169 | Days times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Gram per Milliliter per Kilogram per Meter Squared | |||
day*g/mL/(mg/g) | C117896 | Days times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times gram Per Milliliter Per Milligram Per Gram | |||
day*g/mL/(mg/g/day) | C117897 | Days times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times gram Per Milliliter Per Milligram Per Gram Per Day | |||
day*g/mL/g | C112246 | Days times grams per milliliter (area under the curve), divided by grams (weight). | Day Times Gram Per Milliliter Per Gram | |||
day*g/mL/kg | C112247 | day*g/mL/kg;day*mg/mL/g;day*ng/mL/ug;day*ug/mL/mg | Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). | Day Times Gram Per Milliliter Per Kilogram | ||
day*g/mL/m2 | C111170 | Days times grams per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Gram per Milliliter per Meter Squared | |||
day*mg/mL | C85588 | Days times milligrams per milliliter (area under the curve). | Day Times Milligram per Milliliter | |||
day*mg/mL/(kg/m2) | C111175 | Days times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Milligram per Milliliter per Kilogram per Meter Squared | |||
day*mg/mL/(mg/g) | C117898 | Days times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Milligram Per Milliliter Per Milligram Per Gram | |||
day*mg/mL/(mg/g/day) | C117899 | Days times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Milligram Per Milliliter Per Milligram Per Gram Per Day | |||
day*mg/mL/m2 | C111176 | Days times milligrams per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Milligram per Milliliter per Meter Squared | |||
day*mmol/L | C85587 | Days times millimoles per liter (area under the curve). | Day Times Micromole per Milliliter | |||
day*mmol/L/(kg/m2) | C111177 | Days times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Millimole per Liter per Kilogram per Meter Squared | |||
day*mmol/L/(mg/g) | C117900 | Days times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Millimole Per Liter Per Milligram Per Gram | |||
day*mmol/L/(mg/g/day) | C117901 | Days times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Millimole Per Liter Per Milligram Per Gram Per Day | |||
day*mmol/L/g | C112254 | day*mmol/L/g;day*mol/L/kg | Days times moles per liter (area under the curve), divided by kilograms (weight) or days times millimoles per liter (area under the curve), divided by grams (weight). | Day Times Millimole Per Liter Per Gram | ||
day*mmol/L/m2 | C111178 | Days times millimoles per liter (area under the curve), divided by meters squared (surface area). | Day Times Millimole per Liter per Meter Squared | |||
day*mol/L | C85589 | Days times moles per liter (area under the curve). | Day Times Millimole per Milliliter | |||
day*mol/L/(kg/m2) | C111179 | Days times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Mole per Liter per Kilogram per Meter Squared | |||
day*mol/L/(mg/g) | C117902 | Days times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times mole Per Liter Per Milligram Per Gram | |||
day*mol/L/(mg/g/day) | C117903 | Days times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times mole Per Liter Per Milligram Per Gram Per Day | |||
day*mol/L/g | C112256 | Days times moles per liter (area under the curve), divided by grams (weight). | Day Times Mole Per Liter Per Gram | |||
day*mol/L/m2 | C111180 | Days times moles per liter (area under the curve), divided by meters squared (surface area). | Day Times Mole per Liter per Meter Squared | |||
day*ng/mL | C85591 | Days times nanograms per milliliter (area under the curve). | Day Times Nanogram per Milliliter | |||
day*ng/mL/(kg/m2) | C111181 | Days times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Nanogram per Milliliter per Kilogram per Meter Squared | |||
day*ng/mL/(mg/g) | C117904 | Days times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Nanogram Per Milliliter Per Milligram Per Gram | |||
day*ng/mL/(mg/g/day) | C117905 | Days times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Nanogram Per Milliliter Per Milligram Per Gram Per Day | |||
day*ng/mL/kg | C112259 | day*ng/mL/kg;day*pg/mL/g | Days times nanograms per milliliter (area under the curve), divided by kilograms (weight) or days times picograms per milliliter (area under the curve), divided by grams (weight). | Day Times Nanogram Per Milliliter Per Kilogram | ||
day*ng/mL/m2 | C111182 | Days times nanograms per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Nanogram per Milliliter per Meter Squared | |||
day*nmol/L | C85594 | Days times nanomoles per liter (area under the curve). | Day Times Picomole per Milliliter | |||
day*nmol/L/(kg/m2) | C111183 | Days times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Nanomole per Liter per Kilogram per Meter Squared | |||
day*nmol/L/(mg/g) | C117906 | Days times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Nanomole Per Liter Per Milligram Per Gram | |||
day*nmol/L/(mg/g/day) | C117907 | Days times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Nanomole Per Liter Per Milligram Per Gram Per Day | |||
day*nmol/L/kg | C112261 | day*nmol/L/kg;day*pmol/L/g | Days times nanomoles per liter (area under the curve), divided by kilograms (weight) or days times picomoles per liter (area under the curve), divided by grams (weight). | Day Times Nanomole Per Liter Per Kilogram | ||
day*nmol/L/m2 | C111184 | Days times nanomoles per liter (area under the curve), divided by meters squared (surface area). | Day Times Nanomole per Liter per Meter Squared | |||
day*pg/mL | C85593 | Days times picograms per milliliter (area under the curve). | Day Times Picogram per Milliliter | |||
day*pg/mL/(kg/m2) | C111185 | Days times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Picogram per Milliliter per Kilogram per Meter Squared | |||
day*pg/mL/(mg/g) | C117908 | Days times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Picogram Per Milliliter Per Milligram Per Gram | |||
day*pg/mL/(mg/g/day) | C117909 | Days times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Picogram Per Milliliter Per Milligram Per Gram Per Day | |||
day*pg/mL/m2 | C111186 | Days times picograms per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Picogram per Milliliter per Meter Squared | |||
day*pmol/L | C111187 | Days times picomoles per liter (area under the curve). | Day Times Picomole per Liter | |||
day*pmol/L/(kg/m2) | C111188 | Days times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Picomole per Liter per Kilogram per Meter Squared | |||
day*pmol/L/(mg/g) | C117910 | Days times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Picomole Per Liter Per Milligram Per Gram | |||
day*pmol/L/(mg/g/day) | C117911 | Days times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Picomole Per Liter Per Milligram Per Gram Per Day | |||
day*pmol/L/kg | C112265 | Days times picomoles per liter (area under the curve), divided by kilograms (weight). | Day Times Picomole Per Liter Per Kilogram | |||
day*pmol/L/m2 | C111189 | Days times picomoles per liter (area under the curve), divided by meters squared (surface area). | Day Times Picomole per Liter per Meter Squared | |||
day*ug/mL | C85586 | Days times micrograms per milliliter (area under the curve). | Day Times Microgram per Milliliter | |||
day*ug/mL/(kg/m2) | C111171 | Days times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Microgram per Milliliter per Kilogram per Meter Squared | |||
day*ug/mL/(mg/g) | C117912 | Days times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Microgram Per Milliliter Per Milligram Per Gram | |||
day*ug/mL/(mg/g/day) | C117913 | Days times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Microgram Per Milliliter Per Milligram Per Gram Per Day | |||
day*ug/mL/(mg/kg) | C132444 | Days times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Day Times Microgram per Milliliter Times Kilogram per Milligram | |||
day*ug/mL/g | C112248 | day*mg/mL/kg;day*ug/mL/g | Days times milligrams per milliliter (area under the curve), divided by kilograms (weight) or days times micrograms per milliliter (area under the curve), divided by grams (weight). | Day Times Microgram Per Milliliter Per Gram | ||
day*ug/mL/kg | C112249 | day*ng/mL/g;day*ug/mL/kg | Days times micrograms per milliliter (area under the curve), divided by kilograms (weight) or days times nanograms per milliliter (area under the curve), divided by grams (weight). | Day Times Microgram Per Milliliter Per Kilogram | ||
day*ug/mL/m2 | C111172 | Days times micrograms per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Microgram per Milliliter per Meter Squared | |||
day*umol/L | C85592 | Days times micromoles per liter (area under the curve). | Day Times Nanomole per Milliliter | |||
day*umol/L/(kg/m2) | C111173 | Days times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Micromole per Liter per Kilogram per Meter Squared | |||
day*umol/L/(mg/g) | C117914 | Days times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Micromole Per Liter Per Milligram Per Gram | |||
day*umol/L/(mg/g/day) | C117915 | Days times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Micromole Per Liter Per Milligram Per Gram Per Day | |||
day*umol/L/g | C112250 | day*mmol/L/kg;day*umol/L/g | Days times millimoles per liter (area under the curve), divided by kilograms (weight) or days times micromoles per liter (area under the curve), divided by grams (weight). | Day Times Micromole Per Liter Per Gram | ||
day*umol/L/kg | C112251 | day*nmol/L/g;day*umol/L/kg | Days times micromoles per liter (area under the curve), divided by kilograms (weight) or days times nanomoles per liter (area under the curve), divided by grams (weight). | Day Times Micromole Per Liter Per Kilogram | ||
day*umol/L/m2 | C111174 | Days times micromoles per liter (area under the curve), divided by meters squared (surface area). | Day Times Micromole per Liter per Meter Squared | |||
DNA copies/ug | C170632 | A unit of measurement equal to the number of deoxyribonucleic acid (DNA) copies per unit of mass equal to one microgram. | DNA Copies Per Microgram | |||
fg/mL | C85597 | fg/mL;pg/L | A unit of concentration or mass density equal to one femtogram of substance per milliliter of solution or one picogram of substance per liter of solution. | Femtogram per Milliliter | ||
fg/mL/(kg/m2) | C119336 | Femtograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Femtogram per Milliliter per Kilogram per Meter Squared | |||
fg/mL/(mg/day) | C119337 | Femtograms per milliliter (concentration), divided by milligrams per day (daily dose). | Femtogram per Milliliter per Milligram per Day | |||
fg/mL/(mg/kg) | C119338 | Femtograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Femtogram per Milliliter per Milligram per Kilogram | |||
fg/mL/(mg/kg/day) | C119339 | Femtograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Femtogram per Milliliter per Milligram per Kilogram per Day | |||
fg/mL/(mg/m2) | C119340 | Femtograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area). | Femtogram per Milliliter per Milligram per Meter Squared | |||
fg/mL/(mg/m2/day) | C119341 | Femtograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Femtogram per Milliliter per Milligram per Meter Squared per Day | |||
fg/mL/(ug/day) | C119342 | fg/mL/(ug/day);pg/mL/(mg/day) | Picograms per milliliter (concentration), divided by milligrams per day (daily dose) or femtograms per milliliter (concentration), divided by micrograms per day (daily dose). | Femtogram per Milliliter per Microgram per Day | ||
fg/mL/(ug/m2) | C119345 | fg/mL/(ug/m2);pg/mL/(mg/m2) | Picograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Femtogram per Milliliter per Microgram per Meter Squared | ||
fg/mL/(ug/m2/day) | C119346 | fg/mL/(ug/m2/day);pg/mL/(mg/m2/day) | Picograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Femtogram per Milliliter per Microgram per Meter Squared per Day | ||
fg/mL/g | C119347 | fg/mL/g;pg/mL/kg | Picograms per milliliter (concentration), divided by kilograms (weight) or femtograms per milliliter (concentration), divided by grams (weight). | Femtogram per Milliliter per Gram | ||
fg/mL/kg | C119348 | Femtograms per milliliter (concentration), divided by kilograms (weight). | Femtogram per Milliliter per Kilogram | |||
fg/mL/m2 | C119349 | Femtograms per milliliter (concentration), divided by meters squared (surface area). | Femtogram per Milliliter per Meter Squared | |||
fg/mL/ug | C119351 | fg/mL/ug;ng/mL/g;pg/mL/mg;ug/mL/kg | Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). | Femtogram per Milliliter per Microgram | ||
fraction of 1 | C105484 | Proportion of 1 | A unit for expressing a percentage as a decimal whereby the total value is measured as a fraction of the numeric 1. | Fraction of 1 | ||
g | C48155 | Gram | A unit of mass equal to one thousandth (1E-3) of a kilogram, the kilogram being the base unit of mass in the International System of Units (SI). | Gram | ||
g/day | C67372 | g/24h | A unit of mass flow rate equal to one gram per day. | Gram per 24 Hours | ||
g/h | C85601 | A unit of mass flow rate or dose administration rate equal to one gram per hour. | Gram per Hour | |||
g/min | C85602 | A unit of mass flow rate or dose administration rate equal to one gram per minute. | Gram per Minute | |||
g/mL | C64566 | g/mL;Gram per Milliliter;gram/mL;kg/L;Kilogram per Liter;mg/uL | A unit of concentration or mass density equal to one gram of substance per milliliter of solution or one kilogram of substance per liter of solution. | Kilogram per Liter | ||
g/mL/(kg/m2) | C119352 | Grams per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Gram per Milliliter per Kilogram per Meter Squared | |||
g/mL/(mg/day) | C119353 | g/mL/(mg/day);mg/mL/(ug/day) | Grams per milliliter (concentration), divided by milligrams per day (daily dose) or milligrams per milliliter (concentration), divided by micrograms per day (daily dose). | Gram per Milliliter per Milligram per Day | ||
g/mL/(mg/kg) | C105462 | g/mL/(mg/kg);mg/mL/(ug/kg) | Grams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Gram Per Milliliter Per Milligram Per Kilogram | ||
g/mL/(mg/kg/day) | C105463 | g/mL/(mg/kg/day);mg/mL/(ug/kg/day) | Grams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Gram Per Milliliter Per Milligram Per Kilogram Per Day | ||
g/mL/(mg/m2) | C119354 | g/mL/(mg/m2);mg/mL/(ug/m2) | Grams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Gram per Milliliter per Milligram per Meter Squared | ||
g/mL/(mg/m2/day) | C119355 | g/mL/(mg/m2/day);mg/mL/(ug/m2/day) | Grams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Gram per Milliliter per Milligram per Meter Squared per Day | ||
g/mL/(ug/day) | C119356 | Grams per milliliter (concentration), divided by micrograms per day (daily dose). | Gram per Milliliter per Microgram per Day | |||
g/mL/(ug/kg) | C119357 | Grams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Gram per Milliliter per Microgram per Kilogram | |||
g/mL/(ug/kg/day) | C119358 | Grams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Gram per Milliliter per Microgram per Kilogram per Day | |||
g/mL/(ug/m2) | C119359 | Grams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by body weight). | Gram per Milliliter per Microgram per Meter Squared | |||
g/mL/(ug/m2/day) | C119360 | Grams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Gram per Milliliter per Microgram per Meter Squared per Day | |||
g/mL/g | C119361 | g/mL/g;mg/mL/mg;ug/mL/ug | Grams per milliliter (concentration), divided by grams (weight) or milligrams per milliliter (concentration), divided by milligrams (dose) or micrograms per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Gram | ||
g/mL/m2 | C119363 | Grams per milliliter (concentration), divided by meters squared (surface area). | Gram per Milliliter per Meter Squared | |||
g/mL/mg | C119364 | g/mL/mg;mg/mL/ug | Grams per milliliter (concentration), divided by milligrams (dose) or milligrams per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Milligram | ||
g/mL/ug | C119365 | Grams per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Microgram | |||
GBq | C70513 | Gigabecquerel | A unit of radioactivity equal to one billion nuclear disintegrations or other nuclear transformations per second, or to 1E9 Becquerels. (NCI) | Gigabecquerel | ||
GBq/g | C70525 | GBq/g;Gigabecquerel per Gram;kBq/ug;Kilobecquerel per Microgram;MBq/mg;Megabecquerel per Milligram | A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one gram, or equal to activity of one megabecquerel of the sample with total mass of one milligram. | Gigabecquerel per Gram | ||
GBq/mg | C70527 | Gigabecquerel per Milligram;MBq/mcg;MBq/ug;Megabecquerel per Microgram | A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one milligram.(NCI) | Gigabecquerel per Milligram | ||
GBq/nL | C163553 | Gigabecquerel per nanoliter. | Gigabecquerel/nL | |||
GBq/ug | C70526 | GBq/mcg;Gigabecquerel per Microgram;MBq/ng;Megabecquerel per nanogram | A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one microgram.(NCI) | Gigabecquerel per Microgram | ||
GBq/uL | C73562 | Gigabecquerel per microliter. | Gigabecquerel per Microliter | |||
h | C25529 | h;Hours;hr | A unit of measurement of time equal to 60 minutes. | Hour | ||
h*Bq/g | C163554 | Hours times Becquerel per gram (area under the curve). | Hour Times Becquerel per Gram | |||
h*Bq/mL | C163555 | Hours times Becquerel per milliliter (area under the curve). | Hour Times Becquerel per milliliter | |||
h*DNA copies/ug | C172585 | Hours times DNA copies per microgram (area under the curve). | Hours Times DNA Copies Per Microgram | |||
h*fg/mL | C85611 | Hours times femtograms per milliliter (area under the curve). | Hour Times Femtogram per Milliliter | |||
h*fg/mL/(kg/m2) | C111210 | Hours times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Femtogram per Milliliter per Kilogram per Meter Squared | |||
h*fg/mL/(mg/g) | C117916 | Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Femtogram Per Milliliter Per Milligram Per Gram | |||
h*fg/mL/(mg/g/day) | C117917 | Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Femtogram Per Milliliter Per Milligram Per Gram Per Day | |||
h*fg/mL/kg | C112299 | Hours times femtograms per milliliter (area under the curve), divided by kilograms (weight). | Hour Times Femtogram Per Milliliter Per Kilogram | |||
h*fg/mL/m2 | C111211 | Hours times femtograms per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Femtogram per Milliliter per Meter Squared | |||
h*g/mL | C85613 | h*kg/L;h*mg/uL | Hours times grams per milliliter (area under the curve). | Hour Times Gram per Milliliter | ||
h*g/mL/(kg/m2) | C111212 | Hours times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Gram per Milliliter per Kilogram per Meter Squared | |||
h*g/mL/(mg/g) | C117918 | Hours times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times gram Per Milliliter Per Milligram Per Gram | |||
h*g/mL/(mg/g/day) | C117919 | Hours times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times gram Per Milliliter Per Milligram Per Gram Per Day | |||
h*g/mL/(mg/kg) | C105464 | Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Gram Per Milliliter Per Milligram Per Kilogram | |||
h*g/mL/(mg/kg/day) | C105465 | Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Gram Per Milliliter Per Milligram Per Kilogram Per Day | |||
h*g/mL/g | C112300 | Hours times grams per milliliter (area under the curve), divided by grams (weight). | Hour Times Gram Per Milliliter Per Gram | |||
h*g/mL/m2 | C111213 | Hours times grams per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Gram per Milliliter per Meter Squared | |||
h*mg/mL | C85621 | Hours times milligrams per milliliter (area under the curve). | Hour Times Milligram per Milliliter | |||
h*mg/mL/(kg/m2) | C111218 | Hours times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Milligram per Milliliter per Kilogram per Meter Squared | |||
h*mg/mL/(mg/g) | C117920 | Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Gram | |||
h*mg/mL/(mg/g/day) | C117921 | Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Gram Per Day | |||
h*mg/mL/(mg/kg) | C105468 | Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Kilogram | |||
h*mg/mL/(mg/kg/day) | C105469 | Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Kilogram Per Day | |||
h*mg/mL/m2 | C111219 | Hours times milligrams per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Milligram per Milliliter per Meter Squared | |||
h*mIU/mL | C181522 | mIU*h/mL | Hours times milli international unit per milliliter (area under the curve). | Hour Times Milli-international Unit per Milliliter | ||
h*mmol/L | C85618 | Hours times millimoles per liter (area under the curve). | Hour Times Micromole per Milliliter | |||
h*mmol/L/(kg/m2) | C111220 | Hours times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Millimole per Liter per Kilogram per Meter Squared | |||
h*mmol/L/(mg/g) | C117922 | Hours times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Millimole Per Liter Per Milligram Per Gram | |||
h*mmol/L/(mg/g/day) | C117923 | Hours times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Millimole Per Liter Per Milligram Per Gram Per Day | |||
h*mmol/L/g | C106530 | h*mmol/L/g;h*mol/L/kg | Hours times moles per liter (area under the curve), divided by kilograms (weight) or hours times millimoles per liter (area under the curve), divided by grams (weight). | Hour times Millimole Per Liter Per Gram | ||
h*mmol/L/kg | C112307 | h*mmol/L/kg;h*nmol/L/mg;h*pmol/L/ug;h*umol/L/g | Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). | Hour Times Millimole Per Liter Per Kilogram | ||
h*mmol/L/m2 | C111221 | Hours times millimoles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Millimole per Liter per Meter Squared | |||
h*mol/L | C85622 | Hours times moles per liter (area under the curve). | Hour Times Millimole per Milliliter | |||
h*mol/L/(kg/m2) | C111222 | Hours times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Mole per Liter per Kilogram per Meter Squared | |||
h*mol/L/(mg/g) | C117924 | Hours times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times mole Per Liter Per Milligram Per Gram | |||
h*mol/L/(mg/g/day) | C117925 | Hours times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times mole Per Liter Per Milligram Per Gram Per Day | |||
h*mol/L/g | C106531 | h*mmol/L/mg;h*mol/L/g;h*umol/L/ug | Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). | Hour times Mole Per Liter Per Gram | ||
h*mol/L/m2 | C111223 | Hours times moles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Mole per Liter per Meter Squared | |||
h*ng/mL | C85624 | h*ug/L | Hours times nanograms per milliliter (area under the curve). | Hour Times Nanogram per Milliliter | ||
h*ng/mL/(kg/m2) | C111224 | Hours times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Nanogram per Milliliter per Kilogram per Meter Squared | |||
h*ng/mL/(mg/cm2) | C172589 | Hour times nanograms per milliliter (area under the curve), divided by milligrams per centimeter squared (body mass index). | Hours Times Nanogram Per Milliliter Per Milligram Per Square Centimeter | |||
h*ng/mL/(mg/cm2/day) | C174356 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per centimeter squared per day (daily dose normalized by surface area). | Hour Times Nanogram Per Milliliter Per Milligram Per Centimeter Squared Per Day | |||
h*ng/mL/(mg/g) | C117926 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Nanogram Per Milliliter Per Milligram Per Gram | |||
h*ng/mL/(mg/g/day) | C117927 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Nanogram Per Milliliter Per Milligram Per Gram Per Day | |||
h*ng/mL/(mg/kg) | C85628 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Nanogram per Milliliter per Milligram per Kilogram | |||
h*ng/mL/(mg/kg/day) | C105470 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Nanogram Per Milliliter Per Milligram Per Kilogram Per Day | |||
h*ng/mL/(mg/m2) | C85629 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per meter squared (dose normalized by surface area). | Hour Times Nanogram per Milliliter per Milligram per Meter Squared | |||
h*ng/mL/g | C85625 | h*ng/mL/g;h*pg/mL/mg;h*ug/mL/kg | Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight) or hours times nanograms per milliliter (area under the curve), divided by grams (weight) or hours times picograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Nanogram per Milliliter per Gram | ||
h*ng/mL/kg | C85626 | h*ng/mL/kg;h*pg/mL/g | Hours times nanograms per milliliter (area under the curve), divided by kilograms (weight) or hours times picograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Nanogram per Milliliter per Kilogram | ||
h*ng/mL/m2 | C111225 | Hours times nanograms per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Nanogram per Milliliter per Meter Squared | |||
h*ng/mL/mg | C85627 | h*mg/mL/kg;h*ng/mL/mg;h*ug/mL/g | Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight) or hours times micrograms per milliliter (area under the curve), divided by grams (weight) or hours times nanograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Nanogram per Milliliter per Milligram | ||
h*ngEq/mL | C166076 | Hours times nanogram equivalents per milliliter (area under the curve obtained based on radioactivity measurements). | Hour Times Nanogram Equivalents Per Milliliter | |||
h*ngEq/mL/mgEq | C166077 | Hours times nanogram equivalents per milliliter (area under the curve obtained based on radioactivity measurements), divided by milligram equivalents (radiolabeled dose). | Hour Times Nanogram Equivalents Per Milliliter Per Milligram Equivalents | |||
h*nmol/L | C85640 | Hours times nanomoles per liter (area under the curve). | Hour Times Picomole per Milliliter | |||
h*nmol/L/(kg/m2) | C111226 | Hours times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Nanomole per Liter per Kilogram per Meter Squared | |||
h*nmol/L/(mg/g) | C117928 | Hours times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Nanomole Per Liter Per Milligram Per Gram | |||
h*nmol/L/(mg/g/day) | C117929 | Hours times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Nanomole Per Liter Per Milligram Per Gram Per Day | |||
h*nmol/L/(mg/kg) | C132445 | Hours times nanomoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Nanomole per Liter per Milligram per Kilogram | |||
h*nmol/L/m2 | C111227 | Hours times nanomoles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Nanomole per Liter per Meter Squared | |||
h*pg/mL | C85635 | Hours times picograms per milliliter (area under the curve). | Hour Times Picogram per Milliliter | |||
h*pg/mL/(kg/m2) | C111228 | Hours times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Picogram per Milliliter per Kilogram per Meter Squared | |||
h*pg/mL/(mg/g) | C117930 | Hours times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Gram | |||
h*pg/mL/(mg/g/day) | C117931 | Hours times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Gram Per Day | |||
h*pg/mL/(mg/kg) | C105471 | Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Kilogram | |||
h*pg/mL/(mg/kg/day) | C105472 | Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Kilogram Per Day | |||
h*pg/mL/kg | C85636 | h*fg/mL/g;h*pg/mL/kg | Hours times picograms per milliliter (area under the curve), divided by kilograms (weight) or hours times femtograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Picogram per Milliliter per Kilogram | ||
h*pg/mL/m2 | C111229 | Hours times picograms per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Picogram per Milliliter per Meter Squared | |||
h*pgEq/mL | C166078 | h*ngEq/L | Hours times picogram equivalents per milliliter (area under the curve obtained based on radioactivity measurements). | Hour Times Picogram Equivalents Per Milliliter | ||
h*pgEq/mL/mgEq | C166079 | Hours times picogram equivalents per milliliter (area under the curve obtained based on radioactivity measurements), divided by milligram equivalents (radiolabeled dose). | Hour Times Picogram Equivalents Per Milliliter Per Milligram Equivalents | |||
h*pmol/L | C85612 | Hours times picomoles per liter (area under the curve). | Hour Times Femtomole per Milliliter | |||
h*pmol/L/(kg/m2) | C111230 | Hours times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Picomole per Liter per Kilogram per Meter Squared | |||
h*pmol/L/(mg/g) | C117932 | Hours times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Picomole Per Liter Per Milligram Per Gram | |||
h*pmol/L/(mg/g/day) | C117933 | Hours times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Picomole Per Liter Per Milligram Per Gram Per Day | |||
h*pmol/L/(mg/kg) | C174355 | Hours times picomoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Picomole Per Liter Per Milligram Per Kilogram | |||
h*pmol/L/g | C106532 | h*nmol/L/kg;h*pmol/L/g | Hours times nanomoles per liter (area under the curve), divided by kilograms (weight) or hours times picomoles per liter (area under the curve), divided by grams (weight). | Hour times Picomole Per Liter Per Gram | ||
h*pmol/L/kg | C112311 | Hours times picomoles per liter (area under the curve), divided by kilograms (weight). | Hour Times Picomole Per Liter Per Kilogram | |||
h*pmol/L/m2 | C111231 | Hours times picomoles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Picomole per Liter per Meter Squared | |||
h*ug/g | C176356 | h*mg/kg;h*ng/mg | Hours times micrograms per gram (area under the curve). | Hour Times Microgram Per Gram | ||
h*ug/mL | C85615 | h*mg/L | Hours times micrograms per milliliter (area under the curve). | Hour Times Microgram per Milliliter | ||
h*ug/mL/(kg/m2) | C111214 | Hours times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Microgram per Milliliter per Kilogram per Meter Squared | |||
h*ug/mL/(mg/g) | C117934 | Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Gram | |||
h*ug/mL/(mg/g/day) | C117935 | Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Gram Per Day | |||
h*ug/mL/(mg/kg) | C105466 | Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Kilogram | |||
h*ug/mL/(mg/kg/day) | C105467 | h*ng/mL/(ug/kg/day);h*ug/mL/(mg/kg/day) | Hour times nanograms per milliliter (area under the curve), divided by micrograms per kilogram per day (daily dose normalized by body weight), or hour times micrograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Kilogram Per Day | ||
h*ug/mL/m2 | C111215 | Hours times micrograms per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Microgram per Milliliter per Meter Squared | |||
h*ug/mL/mg | C85617 | h*g/mL/kg;h*mg/mL/g;h*ug/mL/mg | Hours times grams per milliliter (area under the curve), divided by kilograms (weight) or hours times milligrams per milliliter (area under the curve), divided by grams (weight) or hours times micrograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Microgram per Milliliter per Milligram | ||
h*ugEq/mL | C166080 | Hours times microgram equivalents per milliliter (area under the curve obtained based on radioactivity measurements). | Hour Times Microgram Equivalents Per Milliliter | |||
h*ugEq/mL/mgEq | C166081 | Hours times microgram equivalents per milliliter (area under the curve obtained based on radioactivity measurements ), divided by milligram equivalents (radiolabeled dose). | Hour Times Microgram Equivalents Per Milliliter Per Milligram Equivalents | |||
h*uIU/mL | C181521 | uIU*h/mL | Hours times micro international unit per milliliter (area under the curve). | Hour Times Micro-international Unit per Milliliter | ||
h*umol/L | C85632 | Hours times micromoles per liter (area under the curve). | Hour Times Nanomole per Milliliter | |||
h*umol/L/(kg/m2) | C111216 | Hours times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Micromole per Liter per Kilogram per Meter Squared | |||
h*umol/L/(mg/g) | C117936 | Hours times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Micromole Per Liter Per Milligram Per Gram | |||
h*umol/L/(mg/g/day) | C117937 | Hours times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Micromole Per Liter Per Milligram Per Gram Per Day | |||
h*umol/L/(mg/kg) | C132446 | Hours times micromoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Micromole per Liter per Milligram per Kilogram | |||
h*umol/L/kg | C112304 | h*nmol/L/g;h*umol/L/kg | Hours times micromoles per liter (area under the curve), divided by kilograms (weight) or hours times nanomoles per liter (area under the curve), divided by grams (weight). | Hour Times Micromole Per Liter Per Kilogram | ||
h*umol/L/m2 | C111217 | Hours times micromoles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Micromole per Liter per Meter Squared | |||
h2*DNA copies/ug | C172586 | h*h*DNA copies/ug | Hours squared times DNA copies per microgram (area under the moment curve). | Hours Squared Time DNA Copies Per Microgram | ||
h2*mg/mL | C85606 | h*h*mg/mL;h2*g/L;h2*ug/uL;h^2*mg/mL;mg*h2/mL | Hours squared times milligrams per milliliter. | Hour Squared Times Milligram per Milliliter | ||
h2*mmol/L | C85605 | Hours squared times millimoles per liter (area under the moment curve). | Hour Squared Times Micromole per Milliliter | |||
h2*mol/L | C85607 | Hours squared times moles per liter (area under the moment curve). | Hour Squared Times Millimole per Milliliter | |||
h2*ng/mL | C85608 | h*h*ng/mL;h2*ug/L;h^2*ng/mL;ng*h2/mL | Hours squared times nanograms per milliliter. | Hour Squared Times Nanogram per Milliliter | ||
h2*nmol/L | C85610 | Hours squared times nanomoles per liter (area under the moment curve). | Hour Squared Times Picomole per Milliliter | |||
h2*pg/mL | C85609 | h*h*pg/mL;h2*ng/L;h^2*pg/mL;pg*h2/mL | Hours squared times picogram per milliliter. | Hour Squared Times Picogram per Milliliter | ||
h2*pmol/L | C106529 | Hours squared times picomoles per liter (area under the moment curve). | Hour Squared Times Picomole Per Liter | |||
h2*ug/mL | C85604 | h*h*ug/mL;h2*mcg/mL;h2*mg/L;h^2*ug/mL;ug*h2/mL | Hours squared times micrograms per milliliter. | Hour Squared Times Microgram per Milliliter | ||
h2*umol/L | C106528 | Hours squared times micromoles per liter (area under the moment curve). | Hour Squared Times Micromole Per Liter | |||
IU | C48579 | IE;International Unit | The unitage assigned by the WHO (World Health Organization) to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization, to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.(NCI) | International Unit | ||
IU/day | C85645 | A unit of substance (biologic activity) flow rate equal to one international unit per day. | International Unit per Day | |||
IU/h | C85646 | IU/h | A unit of substance (biologic activity) flow rate equal to one international unit per hour. | International Unit per Hour | ||
IU/min | C85647 | IU/min | A unit of substance (biologic activity) flow rate equal to one international unit per minute. | International Unit per Minute | ||
IU/mL | C67377 | IE/mL;International Unit per Milliliter;Kilo International Unit per Liter;kIU/L | A unit of concentration (biologic activity) equal to one international unit of substance per milliliter of solution. | International Unit per Milliliter | ||
IU/mL/(kg/m2) | C119366 | International units per milliliter (concentration), divided by kilograms per meter squared (body mass index). | International Unit per Milliliter per Kilogram per Meter Squared | |||
IU/mL/(mg/day) | C119367 | IU/mL/(mg/day);mIU/mL/(ug/day) | International units per milliliter (concentration), divided by milligrams per day (daily dose) or milli-international units per milliliter (concentration), divided by micrograms per day (daily dose). | International Unit per Milliliter per Milligram per Day | ||
IU/mL/(mg/kg) | C119368 | IU/mL/(mg/kg);mIU/mL/(ug/kg) | International units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | International Unit per Milliliter per Milligram per Kilogram | ||
IU/mL/(mg/kg/day) | C119369 | IU/mL/(mg/kg/day);mIU/mL/(ug/kg/day) | International units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | International Unit per Milliliter per Milligram per Kilogram per Day | ||
IU/mL/(mg/m2) | C119370 | IU/mL/(mg/m2);mIU/mL/(ug/m2) | International units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | International Unit per Milliliter per Milligram per Meter Squared | ||
IU/mL/(mg/m2/day) | C119371 | IU/mL/(mg/m2/day);mIU/mL/(ug/m2/day) | International units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | International Unit per Milliliter per Milligram per Meter Squared per Day | ||
IU/mL/(ug/day) | C119372 | International units per milliliter (concentration), divided by micrograms per day (daily dose). | International Unit per Milliliter per Microgram per Day | |||
IU/mL/(ug/kg) | C119373 | International units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | International Unit per Milliliter per Microgram per Kilogram | |||
IU/mL/(ug/kg/day) | C119374 | International units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | International Unit per Milliliter per Microgram per Kilogram per Day | |||
IU/mL/(ug/m2) | C119375 | International units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | International Unit per Milliliter per Microgram per Meter Squared | |||
IU/mL/(ug/m2/day) | C119376 | International units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | International Unit per Milliliter per Microgram per Meter Squared per Day | |||
IU/mL/g | C119377 | IU/mL/g;mIU/mL/mg;uIU/mL/ug | International units per milliliter (concentration), divided by grams (weight) or milli-international units per milliliter (concentration), divided by milligrams (dose) or micro-international units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Gram | ||
IU/mL/kg | C119378 | IU/mL/kg;mIU/mL/g;uIU/mL/mg | International units per milliliter (concentration), divided by kilograms (weight) or milli-international units per milliliter (concentration), divided by grams (weight) or micro-international units per milliliter (concentration), divided by milligrams (dose). | International Unit per Milliliter per Kilogram | ||
IU/mL/m2 | C119379 | International units per milliliter (concentration), divided by meters squared (surface area). | International Unit per Milliliter per Meter Squared | |||
IU/mL/mg | C119380 | IU/mL/mg;mIU/mL/ug | International units per milliliter (concentration), divided by milligrams (dose) or milli-international units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Milligram | ||
IU/mL/ug | C119381 | International units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Microgram | |||
kBq | C70511 | Kilobecquerel | A unit of radioactivity equal to one thousand nuclear disintegrations or other nuclear transformations per second, or to 1E3 Becquerels. (NCI) | Kilobecquerel | ||
kBq/uL | C71168 | GBq/L;Gigabecquerel per Liter;Kilobecquerel per Microliter;MBq/mL;Megabecquerel per Milliliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousand Becquerels per unit volume equal to one millionth of a liter.(NCI) | Kilobecquerel per Microliter | ||
L | C48505 | Liter | A unit of volume equal to one thousandth (1E-3) of a cubic meter, the cubic meter being the standard derived unit of volume in the International System of Units (SI). | Liter | ||
L/(kg/m2) | C120806 | Liters (volume), divided by kilograms per meter squared (body mass index). | Liter per Kilogram per Meter Squared | |||
L/(mg/day) | C123561 | mL/(ug/day) | Liters (volume), divided by milligrams per day (daily dose). | Liter Divided by Milligram Per Day | ||
L/(mg/kg) | C120807 | Liters (volume), divided by milligrams per kilogram (dose normalized by body weight). | Liter per Milligram per Kilogram | |||
L/(mg/kg/day) | C120808 | L/(mg/kg/day);mL/(ug/kg/day) | Liters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Milligram per Kilogram per Day | ||
L/(mg/m2) | C123562 | mL/(ug/m2) | Liters (volume), divided by milligrams per meter squared (dose normalized by surface area). | Liter Divided by Milligram per Meter Squared | ||
L/(mg/m2/day) | C120809 | L/(mg/m2/day);mL/(ug/m2/day) | Liters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Milligram per Meter Squared per Day | ||
L/(ug/day) | C123563 | Liters (volume), divided by micrograms per day (daily dose). | Liter Divided by Microgram per Day | |||
L/(ug/kg) | C120810 | Liters (volume), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Microgram per Kilogram | |||
L/(ug/kg/day) | C120811 | Liters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Microgram per Kilogram per Day | |||
L/(ug/m2) | C120812 | Liters (volume), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Microgram per Meter Squared | |||
L/(ug/m2/day) | C120813 | Liters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Microgram per Meter Squared per Day | |||
L/day | C69110 | A unit of flow rate equal to one liter per day. | Liter per Day | |||
L/g | C42577 | mL/mg | Liters (volume), divided by grams (weight) or milliliters (volume), divided by milligrams (dose). | Cubic Meter per Kilogram | ||
L/h | C69160 | A unit of flow rate equal to one liter per hour. | Liter per Hour | |||
L/kg | C73725 | L/kg;mL/g | Liters (volume) divided by kilograms (weight) or milliliters (volume), divided by grams (weight). | Liter per Kilogram | ||
L/m2 | C120814 | Liters (volume), divided by meters squared (surface area). | Liter per Meter Squared | |||
L/mg | C124417 | L/mg;mL/ug | Liters (volume), divided by milligrams (dose) or milliliters (volume), divided by micrograms (dose). | Liter per Milligram | ||
L/min | C67388 | A unit of flow rate equal to one liter per minute. | Liter per Minute | |||
L/ug | C120815 | Liters (volume), divided by micrograms (dose). | Liter per Microgram | |||
MBq | C70512 | Megabecquerel | A unit of radioactivity equal to one million nuclear disintegrations or other nuclear transformations per second, or to 1E6 Becquerels. (NCI) | Megabecquerel | ||
MBq/uL | C71169 | GBq/mL;Gigabecquerel per Milliliter;MBq/uL;Megabecquerel per Microliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one million Becquerels per unit volume equal to one millionth of a liter, or defined as a concentration of a radionuclide with an activity equal to one billion Becquerels per unit volume equal to one thousandth of a liter. | Megabecquerel per Microliter | ||
mg | C28253 | Milligram | A unit of mass equal to one thousandth (1E-3) of a gram. | Milligram | ||
mg/day | C67399 | A unit of mass flow rate equal to one milligram per day. | Milligram per 24 Hours | |||
mg/dL | C67015 | mg%;Milligram per Deciliter | A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.(NCI) | Milligram per Deciliter | ||
mg/h | C66969 | A unit of mass flow rate equal to one milligram per hour. | Milligram per Hour | |||
mg/kg | C67401 | Milligram per Kilogram;Nanogram per Milligram;ng/mg;ug/g | Milligrams (weight), divided by kilograms (weight) or nanograms (weight) per milligrams (weight). | Milligram per Kilogram | ||
mg/kg/day | C66976 | Milligram per Kilogram per Day | A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to twenty-four hours. (NCI) | Milligram per Kilogram per Day | ||
mg/min | C73742 | A unit of mass flow rate equal to one milligram per minute. | Milligram per Minute | |||
mg/mL | C42576 | g/L;Gram per Liter;kg/m3;Kilogram per Cubic Meter;mg/mL;Microgram per Microliter;Milligram per Milliliter;ug/uL | A unit of concentration or mass density equal to one milligram of substance per milliliter of solution or one gram of substance per liter of solution. | Kilogram per Cubic Meter | ||
mg/mL/(kg/m2) | C119382 | Milligrams per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Milligram per Milliliter per Kilogram per Meter Squared | |||
mg/mL/(mg/day) | C119383 | mg/mL/(mg/day);ug/mL/(ug/day) | Milligrams per milliliter (concentration), divided by milligrams per day (daily dose) or micrograms per milliliter (concentration), divided by micrograms per day (daily dose). | Milligram per Milliliter per Milligram per Day | ||
mg/mL/(mg/kg) | C105475 | mg/mL/(mg/kg);ug/mL/(ug/kg) | Milligrams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Milligram Per Milliliter Per Milligram Per Kilogram | ||
mg/mL/(mg/kg/day) | C105476 | mg/mL/(mg/kg/day);ug/mL/(ug/kg/day) | Milligrams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Milligram Per Milliliter Per Milligram Per Kilogram Per Day | ||
mg/mL/(mg/m2) | C119384 | mg/mL/(mg/m2);ug/mL/(ug/m2) | Milligrams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Milligram per Milliliter per Milligram per Meter Squared | ||
mg/mL/(mg/m2/day) | C119385 | mg/mL/(mg/m2/day);ug/mL/(ug/m2/day) | Milligrams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Milligram per Milliliter per Milligram per Meter Squared per Day | ||
mg/mL/m2 | C119393 | Milligrams per milliliter (concentration), divided by meters squared (surface area). | Milligram per Milliliter per Meter Squared | |||
mgEq | C156468 | Milligram Equivalent | A unit of relative amount of substance equal to one thousandth of a gram of an equivalent weight. | Milligram Equivalent | ||
min | C48154 | Minute | A unit of measurement of time equal to 60 seconds. | Minute | ||
min*fg/mL | C85724 | Minutes times femtograms per milliliter (area under the curve). | Minute Times Femtogram per Milliliter | |||
min*fg/mL/(kg/m2) | C111254 | Minutes times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Femtogram per Milliliter per Kilogram per Meter Squared | |||
min*fg/mL/(mg/g) | C117938 | Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Femtogram Per Milliliter Per Milligram Per Gram | |||
min*fg/mL/(mg/g/day) | C117939 | Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Femtogram Per Milliliter Per Milligram Per Gram Per Day | |||
min*fg/mL/g | C112334 | min*fg/mL/g;min*pg/mL/kg | Minutes times picograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times femtograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Femtogram Per Milliliter Per Gram | ||
min*fg/mL/kg | C112335 | Minutes times femtograms per milliliter (area under the curve), divided by kilograms (weight). | Minute Times Femtogram Per Milliliter Per Kilogram | |||
min*fg/mL/m2 | C111255 | Minutes times femtograms per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Femtogram per Milliliter per Meter Squared | |||
min*g/mL | C85725 | Minutes times grams per milliliter (area under the curve). | Minute Times Gram per Milliliter | |||
min*g/mL/(kg/m2) | C111256 | Minutes times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Gram per Milliliter per Kilogram per Meter Squared | |||
min*g/mL/(mg/g) | C117940 | Minutes times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times gram Per Milliliter Per Milligram Per Gram | |||
min*g/mL/(mg/g/day) | C117941 | Minutes times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times gram Per Milliliter Per Milligram Per Gram Per Day | |||
min*g/mL/g | C112336 | Minutes times grams per milliliter (area under the curve), divided by grams (weight). | Minute Times Gram Per Milliliter Per Gram | |||
min*g/mL/kg | C112337 | min*g/mL/kg;min*mg/mL/g | Minutes times grams per milliliter (area under the curve), divided by kilograms (weight) or minutes times milligrams per milliliter (area under the curve), divided by grams (weight). | Minute Times Gram Per Milliliter Per Kilogram | ||
min*g/mL/m2 | C111257 | Minutes times grams per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Gram per Milliliter per Meter Squared | |||
min*mg/mL | C85729 | Minutes times milligrams per milliliter (area under the curve). | Minute Times Milligram per Milliliter | |||
min*mg/mL/(kg/m2) | C111262 | Minutes times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Milligram per Milliliter per Kilogram per Meter Squared | |||
min*mg/mL/(mg/g) | C117942 | Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Milligram Per Milliliter Per Milligram Per Gram | |||
min*mg/mL/(mg/g/day) | C117943 | Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Milligram Per Milliliter Per Milligram Per Gram Per Day | |||
min*mg/mL/m2 | C111263 | Minutes times milligrams per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Milligram per Milliliter per Meter Squared | |||
min*mmol/L | C85728 | Minutes times millimoles per liter (area under the curve). | Minute Times Micromole per Milliliter | |||
min*mmol/L/(kg/m2) | C111264 | Minutes times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Millimole per Liter per Kilogram per Meter Squared | |||
min*mmol/L/(mg/g) | C117944 | Minutes times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Millimole Per Liter Per Milligram Per Gram | |||
min*mmol/L/(mg/g/day) | C117945 | Minutes times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Millimole Per Liter Per Milligram Per Gram Per Day | |||
min*mmol/L/g | C112344 | min*mmol/L/g;min*mol/L/kg | Minutes times moles per liter (area under the curve), divided by kilograms (weight) or minutes times millimoles per liter (area under the curve), divided by grams (weight). | Minute Times Millimole Per Liter Per Gram | ||
min*mmol/L/m2 | C111265 | Minutes times millimoles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Millimole per Liter per Meter Squared | |||
min*mol/L | C85730 | Minutes times moles per liter (area under the curve). | Minute Times Millimole per Milliliter | |||
min*mol/L/(kg/m2) | C111266 | Minutes times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Mole per Liter per Kilogram per Meter Squared | |||
min*mol/L/(mg/g) | C117946 | Minutes times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times mole Per Liter Per Milligram Per Gram | |||
min*mol/L/(mg/g/day) | C117947 | Minutes times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times mole Per Liter Per Milligram Per Gram Per Day | |||
min*mol/L/g | C112346 | Minutes times moles per liter (area under the curve), divided by grams (weight). | Minute Times Mole Per Liter Per Gram | |||
min*mol/L/m2 | C111267 | Minutes times moles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Mole per Liter per Meter Squared | |||
min*ng/mL | C85732 | Minutes times nanograms per milliliter (area under the curve). | Minute Times Nanogram per Milliliter | |||
min*ng/mL/(kg/m2) | C111268 | Minutes times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Nanogram per Milliliter per Kilogram per Meter Squared | |||
min*ng/mL/(mg/g) | C117948 | Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Nanogram Per Milliliter Per Milligram Per Gram | |||
min*ng/mL/(mg/g/day) | C117949 | Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Nanogram Per Milliliter Per Milligram Per Gram Per Day | |||
min*ng/mL/kg | C112349 | min*ng/mL/kg;min*pg/mL/g | Minutes times nanograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times picograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Nanogram Per Milliliter Per Kilogram | ||
min*ng/mL/m2 | C111269 | Minutes times nanograms per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Nanogram per Milliliter per Meter Squared | |||
min*nmol/L | C85735 | Minutes times nanomoles per liter (area under the curve). | Minute Times Picomole per Milliliter | |||
min*nmol/L/(kg/m2) | C111270 | Minutes times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Nanomole per Liter per Kilogram per Meter Squared | |||
min*nmol/L/(mg/g) | C117950 | Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Nanomole Per Liter Per Milligram Per Gram | |||
min*nmol/L/(mg/g/day) | C117951 | Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Nanomole Per Liter Per Milligram Per Gram Per Day | |||
min*nmol/L/kg | C112351 | min*nmol/L/kg;min*pmol/L/g | Minutes times nanomoles per liter (area under the curve), divided by kilograms (weight) or minutes times picomoles per liter (area under the curve), divided by grams (weight). | Minute Times Nanomole Per Liter Per Kilogram | ||
min*nmol/L/m2 | C111271 | Minutes times nanomoles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Nanomole per Liter per Meter Squared | |||
min*pg/mL | C85734 | Minutes times picograms per milliliter (area under the curve). | Minute Times Picogram per Milliliter | |||
min*pg/mL/(kg/m2) | C111272 | Minutes times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Picogram per Milliliter per Kilogram per Meter Squared | |||
min*pg/mL/(mg/g) | C117952 | Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Picogram Per Milliliter Per Milligram Per Gram | |||
min*pg/mL/(mg/g/day) | C117953 | Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Picogram Per Milliliter Per Milligram Per Gram Per Day | |||
min*pg/mL/m2 | C111273 | Minutes times picograms per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Picogram per Milliliter per Meter Squared | |||
min*pmol/L | C106543 | Minutes times picomoles per liter (area under the curve). | Minute Times Picomole Per Liter | |||
min*pmol/L/(kg/m2) | C111274 | Minutes times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Picomole per Liter per Kilogram per Meter Squared | |||
min*pmol/L/(mg/g) | C117954 | Minutes times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Picomole Per Liter Per Milligram Per Gram | |||
min*pmol/L/(mg/g/day) | C117955 | Minutes times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Picomole Per Liter Per Milligram Per Gram Per Day | |||
min*pmol/L/kg | C112355 | Minutes times picomoles per liter (area under the curve), divided by kilograms (weight). | Minute Times Picomole Per Liter Per Kilogram | |||
min*pmol/L/m2 | C111275 | Minutes times picomoles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Picomole per Liter per Meter Squared | |||
min*ug/mL | C85727 | Minutes times micrograms per milliliter (area under the curve). | Minute Times Microgram per Milliliter | |||
min*ug/mL/(kg/m2) | C111258 | Minutes times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Microgram per Milliliter per Kilogram per Meter Squared | |||
min*ug/mL/(mg/g) | C117956 | Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Microgram Per Milliliter Per Milligram Per Gram | |||
min*ug/mL/(mg/g/day) | C117957 | Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Microgram Per Milliliter Per Milligram Per Gram Per Day | |||
min*ug/mL/g | C112338 | min*mg/mL/kg;min*ug/mL/g | Minutes times milligrams per milliliter (area under the curve), divided by kilograms (weight) or minutes times micrograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Microgram Per Milliliter Per Gram | ||
min*ug/mL/kg | C112339 | min*ng/mL/g;min*ug/mL/kg | Minutes times micrograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times nanograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Microgram Per Milliliter Per Kilogram | ||
min*ug/mL/m2 | C111259 | Minutes times micrograms per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Microgram per Milliliter per Meter Squared | |||
min*umol/L | C85733 | Minutes times micromoles per liter (area under the curve). | Minute Times Nanomole per Milliliter | |||
min*umol/L/(kg/m2) | C111260 | Minutes times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Micromole per Liter per Kilogram per Meter Squared | |||
min*umol/L/(mg/g) | C117958 | Minutes times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Micromole Per Liter Per Milligram Per Gram | |||
min*umol/L/(mg/g/day) | C117959 | Minutes times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Micromole Per Liter Per Milligram Per Gram Per Day | |||
min*umol/L/g | C112340 | min*mmol/L/kg;min*umol/L/g | Minutes times millimoles per liter (area under the curve), divided by kilograms (weight) or minutes times micromoles per liter (area under the curve), divided by grams (weight). | Minute Times Micromole Per Liter Per Gram | ||
min*umol/L/kg | C112341 | min*nmol/L/g;min*umol/L/kg | Minutes times micromoles per liter (area under the curve), divided by kilograms (weight) or minutes times nanomoles per liter (area under the curve), divided by grams (weight). | Minute Times Micromole Per Liter Per Kilogram | ||
min*umol/L/m2 | C111261 | Minutes times micromoles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Micromole per Liter per Meter Squared | |||
mIU/mL | C67376 | IE/L;International Unit per Liter;IU/L;mIU/mL | A unit of concentration (biologic activity) equal to one milli-international unit of substance per milliliter of solution or one international unit of substance per liter of solution. | International Unit per Liter | ||
mIU/mL/(kg/m2) | C119396 | Milli-international units per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Milli-International Unit per Milliliter per Kilogram per Meter Squared | |||
mIU/mL/(mg/day) | C119397 | mIU/mL/(mg/day);uIU/mL/(ug/day) | Milli-international units per milliliter (concentration), divided by milligrams per day (daily dose) or micro-international units per milliliter (concentration), divided by micrograms per day (daily dose). | Milli-International Unit per Milliliter per Milligram per Day | ||
mIU/mL/(mg/kg) | C119398 | mIU/mL/(mg/kg);uIU/mL/(ug/kg) | Milli-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Milli-International Unit per Milliliter per Milligram per Kilogram | ||
mIU/mL/(mg/kg/day) | C119399 | mIU/mL/(mg/kg/day);uIU/mL/(ug/kg/day) | Milli-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Milli-International Unit per Milliliter per Milligram per Kilogram per Day | ||
mIU/mL/(mg/m2) | C119400 | mIU/mL/(mg/m2);uIU/mL/(ug/m2) | Milli-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Milli-International Unit per Milliliter per Milligram per Meter Squared | ||
mIU/mL/(mg/m2/day) | C119401 | mIU/mL/(mg/m2/day);uIU/mL/(ug/m2/day) | Milli-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Milli-International Unit per Milliliter per Milligram per Meter Squared per Day | ||
mIU/mL/kg | C119408 | mIU/mL/kg;uIU/mL/g | Milli-international units per milliliter (concentration), divided by kilograms (weight) or micro-international units per milliliter (concentration), divided by grams (weight). | Milli-International Unit per Milliliter per Kilogram | ||
mIU/mL/m2 | C119409 | Milli-international units per milliliter (concentration), divided by meters squared (surface area). | Milli-International Unit per Milliliter per Meter Squared | |||
mL | C28254 | cm3;Milliliter | A unit of volume equal to one thousandth (1E-3) of a liter. | Milliliter | ||
mL/(kg/m2) | C120816 | Milliliters (volume), divided by kilograms per meter squared (body mass index). | Milliliter per Kilogram per Meter Squared | |||
mL/(mg/day) | C120817 | Milliliters (volume), divided by milligrams per day (daily dose). | Milliliter per Milligram per Day | |||
mL/(mg/kg) | C120818 | Milliliters (volume), divided by milligrams per kilogram (dose normalized by body weight). | Milliliter per Milligram per Kilogram | |||
mL/(mg/kg/day) | C120819 | Milliliters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Milliliter per Milligram per Kilogram per Day | |||
mL/(mg/m2) | C120820 | Milliliters (volume), divided by milligrams per meter squared (dose normalized by surface area). | Milliliter per Milligram per Meter Squared | |||
mL/(mg/m2/day) | C120821 | Milliliters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milliliter per Milligram per Meter Squared per Day | |||
mL/(ug/kg) | C120822 | Milliliters (volume), divided by micrograms per kilogram (dose normalized by body weight). | Milliliter per Microgram per Kilogram | |||
mL/day | C67410 | mL/24h | A unit of flow rate equal to one milliliter per day. | Milliliter per 24 Hours | ||
mL/h | C66962 | cc/hr;cm3/h | A unit of flow rate equal to one milliliter per hour. | Milliliter per Hour | ||
mL/kg | C67411 | Milliliters (volume) divided by kilograms (weight). | Milliliter per Kilogram | |||
mL/m2 | C73761 | Milliliters (volume) divided by meters squared (surface area). | Milliliter per Square Meter | |||
mL/min | C64777 | A unit of flow rate equal to one milliliter per minute. | Milliliter per Minute | |||
mmol | C48513 | Millimole | A unit of amount of substance equal to one thousandth (1E-3) of a mole. | Millimole | ||
mmol/h | C85720 | A unit of substance flow rate equal to one millimole per hour. | Millimole per Hour | |||
mmol/L | C64387 | mcmol/mL;Micromole per Milliliter;Millimole per Liter;mmol/L;mol/m3;Mole per Cubic Meter;nmol/uL;umol/mL | A unit of concentration (molarity unit) equal to one millimole of solute per liter of solution. | Millimole per Liter | ||
mmol/L/(kg/m2) | C119412 | Millimoles per liter (concentration), divided by kilograms per meter squared (body mass index). | Millimole per Liter per Kilogram per Meter Squared | |||
mmol/L/(mg/day) | C119413 | mmol/L/(mg/day);umol/L/(ug/day) | Millimoles per liter (concentration), divided by milligrams per day (daily dose) or micromoles per liter (concentration), divided by micrograms per day (daily dose). | Millimole per Liter per Milligram per Day | ||
mmol/L/(mg/kg) | C119414 | mmol/L/(mg/kg);umol/L/(ug/kg) | Millimoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Millimole per Liter per Milligram per Kilogram | ||
mmol/L/(mg/kg/day) | C119415 | mmol/L/(mg/kg/day);umol/L/(ug/kg/day) | Millimoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Millimole per Liter per Milligram per Kilogram per Day | ||
mmol/L/(mg/m2) | C119416 | mmol/L/(mg/m2);umol/L/(ug/m2) | Millimoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Millimole per Liter per Milligram per Meter Squared | ||
mmol/L/(mg/m2/day) | C119417 | mmol/L/(mg/m2/day);umol/L/(ug/m2/day) | Millimoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Millimole per Liter per Milligram per Meter Squared per Day | ||
mmol/L/(ug/day) | C119418 | mmol/L/(ug/day);mol/L/(mg/day) | Moles per liter (concentration), divided by milligrams per day (daily dose) or millimoles per liter (concentration), divided by micrograms per day (daily dose). | Millimole per Liter per Microgram per Day | ||
mmol/L/(ug/kg) | C119419 | mmol/L/(ug/kg);mol/L/(mg/kg) | Moles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Millimole per Liter per Microgram per Kilogram | ||
mmol/L/(ug/kg/day) | C119420 | mmol/L/(ug/kg/day);mol/L/(mg/kg/day) | Moles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Millimole per Liter per Microgram per Kilogram per Day | ||
mmol/L/(ug/m2) | C119421 | mmol/L/(ug/m2);mol/L/(mg/m2) | Moles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Millimole per Liter per Microgram per Meter Squared | ||
mmol/L/(ug/m2/day) | C119422 | mmol/L/(ug/m2/day);mol/L/(mg/m2/day) | Moles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Millimole per Liter per Microgram per Meter Squared per Day | ||
mmol/L/g | C119423 | mmol/L/g;mol/L/kg;nmol/L/ug;umol/L/mg | Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Gram | ||
mmol/L/m2 | C119425 | Millimoles per liter (concentration), divided by meters squared (surface area). | Millimole per Liter per Meter Squared | |||
mmol/L/mg | C119426 | mmol/L/mg;mol/L/g;umol/L/ug | Moles per liter (concentration), divided by grams (weight) or millimoles per liter (concentration), divided by milligrams (dose) or micromoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Milligram | ||
mmol/L/ug | C119427 | mmol/L/ug;mol/L/mg | Moles per liter (concentration), divided by milligrams (dose) or millimoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Microgram | ||
mmol/min | C85722 | A unit of substance flow rate equal to one millimole per minute. | Millimole per Minute | |||
mol | C42539 | Mole | The base unit of amount of substance in the International System of Units (SI). It is equal to the same number of elementary units as there are atoms in 0.012 kg of carbon-12. | Mole | ||
mol/day | C85737 | A unit of substance flow rate equal to one mole per day. | Mole per Day | |||
mol/h | C85738 | A unit of substance flow rate equal to one mole per hour. | Mole per Hour | |||
mol/L | C48555 | mmol/mL;mol/L;Mole per Liter | A unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI) | Mole per Liter | ||
mol/L/(kg/m2) | C119428 | Moles per liter (concentration), divided by kilograms per meter squared (body mass index). | Mole per Liter per Kilogram per Meter Squared | |||
mol/L/(ug/day) | C119434 | Moles per liter (concentration), divided by micrograms per day (daily dose). | Mole per Liter per Microgram per Day | |||
mol/L/(ug/kg) | C119435 | Moles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Mole per Liter per Microgram per Kilogram | |||
mol/L/(ug/kg/day) | C119436 | Moles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Mole per Liter per Microgram per Kilogram per Day | |||
mol/L/(ug/m2) | C119437 | Moles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Mole per Liter per Microgram per Meter Squared | |||
mol/L/(ug/m2/day) | C119438 | Moles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Mole per Liter per Microgram per Meter Squared per Day | |||
mol/L/m2 | C119441 | Moles per liter (concentration), divided by meters squared (surface area). | Mole per Liter per Meter Squared | |||
mol/L/ug | C119443 | Moles per liter (concentration), divided by micrograms (dose). | Mole per Liter per Microgram | |||
mol/min | C85739 | A unit of substance flow rate equal to one mole per minute. | Mole per Minute | |||
ng | C48516 | Nanogram | A unit of mass equal to one billionth (1E-9) of a gram. | Nanogram | ||
ng/day | C85741 | A unit of mass flow rate equal to one nanogram per day. | Nanogram per Day | |||
ng/h | C85742 | A unit of mass flow rate equal to one nanogram per hour. | Nanogram per Hour | |||
ng/kg/min | C85743 | Nanograms per kilogram per minute. | Nanogram per Kilogram per Minute | |||
ng/min | C85749 | A unit of mass flow rate equal to one nanogram per minute. | Nanogram per Minute | |||
ng/mL | C67306 | mcg/L;mg/m3;Microgram per Liter;Milligram per Cubic Meter;Nanogram per Milliliter;ng/mL;ug/L | A unit of concentration or mass density equal to one nanogram of substance per milliliter of solution or one microgram of substance per liter of solution. | Microgram per Liter | ||
ng/mL/(kg/m2) | C119444 | Nanograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Nanogram per Milliliter per Kilogram per Meter Squared | |||
ng/mL/(mg/cm2) | C172588 | Nanograms per milliliter (concentration), divided by milligrams per centimeter squared (body mass index). | Nanogram Per Milliliter Per Milligram Per Square Centimeter | |||
ng/mL/(mg/day) | C119445 | ng/mL/(mg/day);pg/mL/(ug/day) | Nanograms per milliliter (concentration), divided by milligrams per day (daily dose) or picograms per milliliter (concentration), divided by micrograms per day (daily dose). | Nanogram per Milliliter per Milligram per Day | ||
ng/mL/(mg/kg) | C105477 | ng/mL/(mg/kg);pg/mL/(ug/kg) | Nanograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Nanogram Per Milliliter Per Milligram Per Kilogram | ||
ng/mL/(mg/kg/day) | C105478 | ng/mL/(mg/kg/day);pg/mL/(ug/kg/day) | Nanograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Nanogram Per Milliliter Per Milligram Per Kilogram Per Day | ||
ng/mL/(mg/m2) | C119446 | ng/mL/(mg/m2);pg/mL/(ug/m2) | Nanograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanogram per Milliliter per Milligram per Meter Squared | ||
ng/mL/(mg/m2/day) | C119447 | ng/mL/(mg/m2/day);pg/mL/(ug/m2/day) | Nanograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanogram per Milliliter per Milligram per Meter Squared per Day | ||
ng/mL/(ug/day) | C119448 | ng/mL/(ug/day);ug/mL/(mg/day) | Micrograms per milliliter (concentration), divided by milligrams per day (daily dose) or nanograms per milliliter (concentration), divided by micrograms per day (daily dose). | Nanogram per Milliliter per Microgram per Day | ||
ng/mL/(ug/m2) | C119451 | ng/mL/(ug/m2);ug/mL/(mg/m2) | Micrograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanogram per Milliliter per Microgram per Meter Squared | ||
ng/mL/(ug/m2/day) | C119452 | ng/mL/(ug/m2/day);ug/mL/(mg/m2/day) | Micrograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanogram per Milliliter per Microgram per Meter Squared per Day | ||
ng/mL/kg | C85746 | fg/mL/mg;ng/mL/kg;pg/mL/g | Nanograms per milliliter (concentration), divided by kilograms (weight) or picograms per milliliter (concentration), divided by grams (weight) or femtograms per milliliter (concentration), divided by milligrams (dose). | Nanogram per Milliliter per Kilogram | ||
ng/mL/m2 | C119454 | Nanograms per milliliter (concentration), divided by meters squared (surface area). | Nanogram per Milliliter per Meter Squared | |||
ng/mL/mg | C85747 | mg/mL/kg;ng/mL/mg;pg/mL/ug;ug/mL/g | Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). | Nanogram per Milliliter per Milligram | ||
ngEq | C184705 | Nanogram Equivalent | A unit of relative amount of substance equal to one billionth of a gram of an equivalent weight. | Nanogram Equivalents | ||
ngEq/g | C166082 | Nanogram equivalents of a radiolabeled substance per gram of matrix or tissue. | Nanogram Equivalents Per Gram | |||
ngEq/mL | C122230 | ngEq/mL;ugEq/L | A concentration unit measured as the number of microgram equivalents of solute per liter of solution, or as the number of nanogram equivalents of solute per milliliter of solution. | Microgram Equivalent per Liter | ||
ngEq/mL/mgEq | C166083 | Nanogram equivalents of a radiolabeled substance per milliliter, divided by milligram equivalents (radiolabeled dose). | Nanogram Equivalents Per Milliliter Per Milligram Equivalents | |||
nmol | C48517 | Nanomole | A unit of amount of substance equal to one billionth (1E-9) of a mole. (NCI) | Nanomole | ||
nmol/day | C85751 | A unit of substance flow rate equal to one nanomole per day. | Nanomole per Day | |||
nmol/g | C85752 | nmol/g;pmol/mg;umol/kg | Nanomoles per gram. | Nanomole per Gram | ||
nmol/h | C85753 | A unit of substance flow rate equal to one nanomole per hour. | Nanomole per Hour | |||
nmol/kg | C85754 | nmol/kg;pmol/g | Nanomoles (amount), divided by kilograms (weight) or picomoles per gram. | Nanomole per Kilogram | ||
nmol/L | C67432 | Nanomole per Liter;pmol/mL | A unit of concentration (molarity unit) equal to one nanomole of solute per liter of solution. | Nanomole per Liter | ||
nmol/L/(kg/m2) | C119456 | Nanomoles per liter (concentration), divided by kilograms per meter squared (body mass index). | Nanomole per Liter per Kilogram per Meter Squared | |||
nmol/L/(mg/day) | C119457 | nmol/L/(mg/day);pmol/L/(ug/day) | Nanomoles per liter (concentration), divided by milligrams per day (daily dose) or picomoles per liter (concentration), divided by micrograms per day (daily dose). | Nanomole per Liter per Milligram per Day | ||
nmol/L/(mg/kg) | C119458 | nmol/L/(mg/kg);pmol/L/(ug/kg) | Nanomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Nanomole per Liter per Milligram per Kilogram | ||
nmol/L/(mg/kg/day) | C119459 | nmol/L/(mg/kg/day);pmol/L/(ug/kg/day) | Nanomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Nanomole per Liter per Milligram per Kilogram per Day | ||
nmol/L/(mg/m2) | C119460 | nmol/L/(mg/m2);pmol/L/(ug/m2) | Nanomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanomole per Liter per Milligram per Meter Squared | ||
nmol/L/(mg/m2/day) | C119461 | nmol/L/(mg/m2/day);pmol/L/(ug/m2/day) | Nanomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanomole per Liter per Milligram per Meter Squared per Day | ||
nmol/L/(ug/day) | C119462 | nmol/L/(ug/day);umol/L/(mg/day) | Micromoles per liter (concentration), divided by milligrams per day (daily dose) or nanomoles per liter (concentration), divided by micrograms per day (daily dose). | Nanomole per Liter per Microgram per Day | ||
nmol/L/(ug/kg) | C119463 | nmol/L/(ug/kg);umol/L/(mg/kg) | Micromoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Nanomole per Liter per Microgram per Kilogram | ||
nmol/L/(ug/kg/day) | C119464 | nmol/L/(ug/kg/day);umol/L/(mg/kg/day) | Micromoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Nanomole per Liter per Microgram per Kilogram per Day | ||
nmol/L/(ug/m2) | C119465 | nmol/L/(ug/m2);umol/L/(mg/m2) | Micromoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanomole per Liter per Microgram per Meter Squared | ||
nmol/L/(ug/m2/day) | C119466 | nmol/L/(ug/m2/day);umol/L/(mg/m2/day) | Micromoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanomole per Liter per Microgram per Meter Squared per Day | ||
nmol/L/g | C119467 | nmol/L/g;pmol/L/mg;umol/L/kg | Micromoles per liter (concentration), divided by kilograms (weight) or nanomoles per liter (concentration), divided by grams (weight) or picomoles per liter (concentration), divided by milligrams (dose). | Nanomole per Liter per Gram | ||
nmol/L/kg | C119468 | nmol/L/kg;pmol/L/g | Nanomoles per liter (concentration), divided by kilograms (weight) or picomoles per liter (concentration), divided by grams (weight). | Nanomole per Liter per Kilogram | ||
nmol/L/m2 | C119469 | Nanomoles per liter (concentration), divided by meters squared (surface area). | Nanomole per Liter per Meter Squared | |||
nmol/min | C85758 | A unit of substance flow rate equal to one nanomole per minute. | Nanomole per Minute | |||
pg/day | C85778 | A unit of mass flow rate equal to one picogram per day. | Picogram per Day | |||
pg/h | C85779 | A unit of mass flow rate equal to one picogram per hour. | Picogram per Hour | |||
pg/mg | C67396 | mcg/kg;Microgram per Kilogram;ng/g;pg/mg;ug/kg | A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) | Microgram per Kilogram | ||
pg/min | C85782 | A unit of mass flow rate equal to one picogram per minute. | Picogram per Minute | |||
pg/mL | C67327 | Microgram per Cubic Meter;ng/L;pg/mL;ug/m3 | A unit of concentration or mass density equal to one picogram of substance per milliliter of solution or one nanogram of substance per liter of solution. | Nanogram per Liter | ||
pg/mL/(kg/m2) | C119472 | Picograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Picogram per Milliliter per Kilogram per Meter Squared | |||
pg/mL/(mg/kg) | C105479 | fg/mL/(ug/kg);pg/mL/(mg/kg) | Picograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Picogram Per Milliliter Per Milligram Per Kilogram | ||
pg/mL/(mg/kg/day) | C105480 | fg/mL/(ug/kg/day);pg/mL/(mg/kg/day) | Picograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Picogram Per Milliliter Per Milligram Per Kilogram Per Day | ||
pg/mL/m2 | C119483 | Picograms per milliliter (concentration), divided by meters squared (surface area). | Picogram per Milliliter per Meter Squared | |||
pgEq/g | C166084 | Picogram equivalents of a radiolabeled substance per gram of matrix or tissue. | Picogram Equivalents Per Gram | |||
pgEq/mL | C166085 | ngEq/L | Picogram equivalents of a radiolabeled substance per milliliter of matrix or fluid. | Picogram Equivalents Per Milliliter | ||
pgEq/mL/mgEq | C166086 | Picogram equivalents of a radiolabeled substance per milliliter, divided by milligram equivalents (radiolabeled dose). | Picogram Equivalents Per Milliliter Per Milligram Equivalents | |||
pmol | C65045 | Picomole | A unit of amount of substance equal to a trillionth (1E-12) of a mole. (NCI) | Picomole | ||
pmol/L | C67434 | Femtomole per Milliliter;fmol/mL;Picomole per Liter | A unit of concentration (molarity unit) equal to one picomole of solute per liter of solution. | Picomole per Liter | ||
pmol/L/(kg/m2) | C119485 | Picomoles per liter (concentration), divided by kilograms per meter squared (body mass index). | Picomole per Liter per Kilogram per Meter Squared | |||
pmol/L/(mg/day) | C119486 | Picomoles per liter (concentration), divided by milligrams per day (daily dose). | Picomole per Liter per Milligram per Day | |||
pmol/L/(mg/kg) | C119487 | Picomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Picomole per Liter per Milligram per Kilogram | |||
pmol/L/(mg/kg/day) | C119488 | Picomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Picomole per Liter per Milligram per Kilogram per Day | |||
pmol/L/(mg/m2) | C119489 | Picomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area). | Picomole per Liter per Milligram per Meter Squared | |||
pmol/L/(mg/m2/day) | C119490 | Picomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Picomole per Liter per Milligram per Meter Squared per Day | |||
pmol/L/kg | C119497 | Picomoles per liter (concentration), divided by kilograms (weight). | Picomole per Liter per Kilogram | |||
pmol/L/m2 | C119498 | Picomoles per liter (concentration), divided by meters squared (surface area). | Picomole per Liter per Meter Squared | |||
pmol/L/ug | C85784 | mmol/L/kg;nmol/L/mg;pmol/L/ug;umol/L/g | Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). | Picomole per Liter per Microgram | ||
RATIO | C44256 | The quotient of one quantity divided by another, with the same units of measurement. | Ratio | |||
U/L | C67456 | mU/mL;Unit per Liter | A unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance. | Unit per Liter | ||
ug | C48152 | mcg;Microgram | A unit of mass equal to one millionth (1E-6) of a gram. | Microgram | ||
ug/day | C71205 | mcg/day | A unit of mass flow rate equal to one microgram per day. | Microgram per Day | ||
ug/dL | C67305 | Microgram per Deciliter | A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one microgram occupies the volume one deciliter. (NCI) | Microgram per Deciliter | ||
ug/h | C67394 | mcg/h | A unit of mass flow rate equal to one microgram per hour. | Microgram per Hour | ||
ug/min | C71211 | mcg/min | A unit of mass flow rate equal to one microgram per minute. | Microgram per Minute | ||
ug/mL | C64572 | g/m3;Gram per Cubic Meter;mcg/mL;mg/L;Microgram per Milliliter;Milligram per Liter;ng/uL;ug/mL | A unit of concentration or mass density equal to one microgram of substance per milliliter of solution or one milligram of substance per liter of solution. | Microgram per Milliliter | ||
ug/mL/(kg/m2) | C119500 | Micrograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Microgram per Milliliter per Kilogram per Meter Squared | |||
ug/mL/(mg/kg) | C105473 | ng/mL/(ug/kg);ug/mL/(mg/kg) | Micrograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Microgram Per Milliliter Per Milligram Per Kilogram | ||
ug/mL/(mg/kg/day) | C105474 | ng/mL/(ug/kg/day);ug/mL/(mg/kg/day) | Micrograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Microgram Per Milliliter Per Milligram Per Kilogram Per Day | ||
ug/mL/m2 | C119511 | Micrograms per milliliter (concentration), divided by meters squared (surface area). | Microgram per Milliliter per Meter Squared | |||
ug/mL/mg | C85710 | g/mL/kg;mg/mL/g;ng/mL/ug;ug/mL/mg | Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). | Milligram per Liter per Milligram | ||
ugEq | C105497 | Microgram Equivalent | A unit of relative amount of substance equal to one millionth of a gram of an equivalent weight. | Microgram Equivalent | ||
ugEq/g | C166087 | Microgram equivalents of a radiolabeled substance per gram of matrix or tissue. | Microgram Equivalents Per Gram | |||
ugEq/mL | C172587 | mgEq/L;ngEq/uL | A concentration unit measured as a number of microgram equivalent of solute per milliliter of solution. | Microgram Equivalents Per Milliliter | ||
ugEq/mL/mgEq | C166088 | Microgram equivalents of a radiolabeled substance per milliliter, divided by milligram equivalents (radiolabeled dose). | Microgram Equivalents Per Milliliter Per Milligram Equivalents | |||
uIU/mL | C67405 | mcIU/mL;Micro-International Unit per milliliter;mIE/L;mIU/L;uIU/mL | A unit of concentration (biologic activity) equal to one micro-international unit of substance per milliliter of solution or one milli-international unit of substance per liter of solution. | Microinternational Unit per Milliliter | ||
uIU/mL/(kg/m2) | C119513 | Micro-international units per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Micro-International Units per Milliliter per Kilogram per Meter Squared | |||
uIU/mL/(mg/day) | C119514 | Micro-international units per milliliter (concentration), divided by milligrams per day (daily dose). | Micro-International Units per Milliliter per Milligram per Day | |||
uIU/mL/(mg/kg) | C119515 | Micro-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Micro-International Units per Milliliter per Milligram per Kilogram | |||
uIU/mL/(mg/kg/day) | C119516 | Micro-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Micro-International Units per Milliliter per Milligram per Kilogram per Day | |||
uIU/mL/(mg/m2) | C119517 | Micro-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area). | Micro-International Units per Milliliter per Milligram per Meter Squared | |||
uIU/mL/(mg/m2/day) | C119518 | Micro-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Micro-International Units per Milliliter per Milligram per Meter Squared per Day | |||
uIU/mL/kg | C119525 | Micro-international units per milliliter (concentration), divided by kilograms (weight). | Micro-International Units per Milliliter per Kilogram | |||
uIU/mL/m2 | C119526 | Micro-international units per milliliter (concentration), divided by meters squared (surface area). | Micro-International Units per Milliliter per Meter Squared | |||
umol | C48509 | mcmol;Micromole | A unit of amount of substance equal to one millionth (1E-6) of a mole. (NCI) | Micromole | ||
umol/day | C67406 | mcmol/day | A unit of substance flow rate equal to one micromole per day. | Micromole per 24 Hours | ||
umol/h | C85707 | A unit of substance flow rate equal to one micromole per hour. | Micromole per Hour | |||
umol/L | C48508 | nmol/mL | A unit of concentration (molarity unit) equal to one micromole of solute per liter of solution. | Micromole per Liter | ||
umol/L/(kg/m2) | C119529 | Micromoles per liter (concentration), divided by kilograms per meter squared (body mass index). | Micromole per Liter per Kilogram per Meter Squared | |||
umol/L/m2 | C119542 | Micromoles per liter (concentration), divided by meters squared (surface area). | Micromole per Liter per Meter Squared | |||
umol/min | C85708 | mcmol/min | A unit of substance flow rate equal to one micromole per minute. | Micromole per Minute | ||
vg/dose | C124471 | Vector Genomes/dose;Vector Genomic Copies/dose;VGC/dose | A unit for cloning vector amount expressed as the number of vector genomes per dose. | Vector Genomes per Dose | ||
vg/kg | C163566 | Vector Genomes per Kilogram;Vector Genomic Copies/kg;VGC/kg | A unit for the vector amount expressed as the number of vector genomes per kilogram of body weight. | Vector Genomes per Kilogram | ||
vg/mL | C124472 | Vector Genomes/mL;Vector Genomic Copies/mL;VGC/mL | A unit for cloning vector concentration expressed as the number of vector genomes per milliliter. | Vector Genomes per Milliliter | ||
Back to top | ||||||
CL.C128685.PKUDMG | PK Units of Measure - Dose mg
(PKUDMG) | text
Extensible: Yes | C128685 | PK Units of Measure - Dose mg | Units of measure for pharmacokinetic parameters normalized by dose amount in milligrams. | CDISC SDTM PK Unit of Measure Milligram Dose Terminology |
(L/day)/(mg/day) | C120728 | (L/day)/(mg/day);(mL/day)/(ug/day) | Liters per day (flow rate), divided by milligrams per day (daily dose) or milliliters per day (flow rate), divided by micrograms per day (daily dose). | Liter per Day per Milligram per Day | ||
(L/day)/(mg/kg) | C120729 | (L/day)/(mg/kg);(mL/day)/(ug/kg) | Liters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Day per Milligram per Kilogram | ||
(L/day)/(mg/kg/day) | C120730 | (L/day)/(mg/kg/day);(mL/day)/(ug/kg/day) | Liters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Day per Milligram per Kilogram per Day | ||
(L/day)/(mg/m2) | C120731 | (L/day)/(mg/m2);(mL/day)/(ug/m2) | Liters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Day per Milligram per Meter Squared | ||
(L/day)/(mg/m2/day) | C120732 | (L/day)/(mg/m2/day);(mL/day)/(ug/m2/day) | Liters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Day per Milligram per Meter Squared per Day | ||
(L/day)/mg | C85672 | (L/day)/mg;(mL/day)/ug | Liters per day (flow rate), divided by milligrams (dose) or milliliters per day (flow rate), divided by micrograms (dose). | Liter per Milligram per Day | ||
(L/h)/(mg/day) | C120740 | (L/h)/(mg/day);(mL/h)/(ug/day) | Liters per hour (flow rate), divided by milligrams per day (daily dose) or milliliters per hour (flow rate), divided by micrograms per day (daily dose). | Liter per Hour per Milligram per Day | ||
(L/h)/(mg/kg) | C120741 | (L/h)/(mg/kg);(mL/h)/(ug/kg) | Liters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Hour per Milligram per Kilogram | ||
(L/h)/(mg/kg/day) | C120742 | (L/h)/(mg/kg/day);(mL/h)/(ug/kg/day) | Liters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Hour per Milligram per Kilogram per Day | ||
(L/h)/(mg/m2) | C120743 | (L/h)/(mg/m2);(mL/h)/(ug/m2) | Liters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Hour per Milligram per Meter Squared | ||
(L/h)/(mg/m2/day) | C120744 | (L/h)/(mg/m2/day);(mL/h)/(ug/m2/day) | Liters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Hour per Milligram per Meter Squared per Day | ||
(L/h)/mg | C85673 | (L/h)/mg;(mL/h)/ug | Liters per hour (flow rate), divided by milligrams (dose) or milliliters per hour (flow rate), divided by micrograms (dose). | Liter per Milligram per Hour | ||
(L/min)/(mg/day) | C120751 | (L/min)/(mg/day);(mL/min)/(ug/day) | Liters per minute (flow rate), divided by milligrams per day (daily dose) or milliliters per minute (flow rate), divided by micrograms per day (daily dose). | Liter per Minute per Milligram per Day | ||
(L/min)/(mg/kg) | C120752 | (L/min)/(mg/kg);(mL/min)/(ug/kg) | Liters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Minute per Milligram per Kilogram | ||
(L/min)/(mg/kg/day) | C120753 | (L/min)/(mg/kg/day);(mL/min)/(ug/kg/day) | Liters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Minute per Milligram per Kilogram per Day | ||
(L/min)/(mg/m2) | C120754 | (L/min)/(mg/m2);(mL/min)/(ug/m2) | Liters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Minute per Milligram per Meter Squared | ||
(L/min)/(mg/m2/day) | C120755 | (L/min)/(mg/m2/day);(mL/min)/(ug/m2/day) | Liters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Minute per Milligram per Meter Squared per Day | ||
(L/min)/mg | C85674 | (L/min)/mg;(mL/min)/ug | Liters per minute (flow rate), divided by milligrams (dose) or milliliters per minute (flow rate), divided by micrograms (dose). | Liter per Milligram per Minute | ||
(mL/day)/(mg/day) | C120762 | Milliliters per day (flow rate), divided by milligrams per day (daily dose). | Milliliter per Day per Milligram per Day | |||
(mL/day)/(mg/kg) | C120763 | Milliliters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight). | Milliliter per Day per Milligram per Kilogram | |||
(mL/day)/(mg/kg/day) | C120764 | Milliliters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Milliliter per Day per Milligram per Kilogram per Day | |||
(mL/day)/(mg/m2) | C120765 | Milliliters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area). | Milliliter per Day per Milligram per Meter Squared | |||
(mL/day)/(mg/m2/day) | C120766 | Milliliters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milliliter per Day per Milligram per Meter Squared per Day | |||
(mL/day)/mg | C85657 | (L/day)/g;(mL/day)/mg | Liters per day (flow rate), divided by grams (weight) or milliliters per day (flow rate), divided by milligrams (dose). | Liter per Gram per Day | ||
(mL/h)/(mg/day) | C120777 | Milliliters per hour (flow rate), divided by milligrams per day (daily dose). | Milliliter per Hour per Milligram per Day | |||
(mL/h)/(mg/kg) | C120778 | Milliliters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight). | Milliliter per Hour per Milligram per Kilogram | |||
(mL/h)/(mg/kg/day) | C120779 | Milliliters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Milliliter per Hour per Milligram per Kilogram per Day | |||
(mL/h)/(mg/m2) | C120780 | Milliliters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area). | Milliliter per Hour per Milligram per Meter Squared | |||
(mL/h)/(mg/m2/day) | C120781 | Milliliters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milliliter per Hour per Milligram per Meter Squared per Day | |||
(mL/h)/mg | C85658 | (L/h)/g;(mL/h)/mg | Liters per hour (flow rate), divided by grams (weight) or milliliters per hour (flow rate), divided by milligrams (dose). | Liter per Gram per Hour | ||
(mL/min)/(mg/day) | C120792 | Milliliters per minute (flow rate), divided by milligrams per day (daily dose). | Milliliter per Minute per Milligram per Day | |||
(mL/min)/(mg/kg) | C120793 | Milliliters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight). | Milliliter per Minute per Milligram per Kilogram | |||
(mL/min)/(mg/kg/day) | C120794 | Milliliters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Milliliter per Minute per Milligram per Kilogram per Day | |||
(mL/min)/(mg/m2) | C120795 | Milliliters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area). | Milliliter per Minute per Milligram per Meter Squared | |||
(mL/min)/(mg/m2/day) | C120796 | Milliliters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milliliter per Minute per Milligram per Meter Squared per Day | |||
(mL/min)/mg | C85659 | (L/min)/g;(mL/min)/mg | Liters per minute (flow rate), divided by grams (weight) or milliliters per minute (flow rate), divided by milligrams (dose). | Liter per Gram per Minute | ||
day*ug/mL/(mg/kg) | C132444 | Days times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Day Times Microgram per Milliliter Times Kilogram per Milligram | |||
day*ug/mL/mg | C112247 | day*g/mL/kg;day*mg/mL/g;day*ng/mL/ug;day*ug/mL/mg | Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). | Day Times Gram Per Milliliter Per Kilogram | ||
fg/mL/(mg/day) | C119337 | Femtograms per milliliter (concentration), divided by milligrams per day (daily dose). | Femtogram per Milliliter per Milligram per Day | |||
fg/mL/(mg/kg) | C119338 | Femtograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Femtogram per Milliliter per Milligram per Kilogram | |||
fg/mL/(mg/kg/day) | C119339 | Femtograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Femtogram per Milliliter per Milligram per Kilogram per Day | |||
fg/mL/(mg/m2) | C119340 | Femtograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area). | Femtogram per Milliliter per Milligram per Meter Squared | |||
fg/mL/(mg/m2/day) | C119341 | Femtograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Femtogram per Milliliter per Milligram per Meter Squared per Day | |||
fg/mL/mg | C85746 | fg/mL/mg;ng/mL/kg;pg/mL/g | Nanograms per milliliter (concentration), divided by kilograms (weight) or picograms per milliliter (concentration), divided by grams (weight) or femtograms per milliliter (concentration), divided by milligrams (dose). | Nanogram per Milliliter per Kilogram | ||
g/mL/(mg/day) | C119353 | g/mL/(mg/day);mg/mL/(ug/day) | Grams per milliliter (concentration), divided by milligrams per day (daily dose) or milligrams per milliliter (concentration), divided by micrograms per day (daily dose). | Gram per Milliliter per Milligram per Day | ||
g/mL/(mg/kg) | C105462 | g/mL/(mg/kg);mg/mL/(ug/kg) | Grams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Gram Per Milliliter Per Milligram Per Kilogram | ||
g/mL/(mg/kg/day) | C105463 | g/mL/(mg/kg/day);mg/mL/(ug/kg/day) | Grams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Gram Per Milliliter Per Milligram Per Kilogram Per Day | ||
g/mL/(mg/m2) | C119354 | g/mL/(mg/m2);mg/mL/(ug/m2) | Grams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Gram per Milliliter per Milligram per Meter Squared | ||
g/mL/(mg/m2/day) | C119355 | g/mL/(mg/m2/day);mg/mL/(ug/m2/day) | Grams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Gram per Milliliter per Milligram per Meter Squared per Day | ||
g/mL/mg | C119364 | g/mL/mg;mg/mL/ug | Grams per milliliter (concentration), divided by milligrams (dose) or milligrams per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Milligram | ||
h*g/mL/(mg/kg) | C105464 | Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Gram Per Milliliter Per Milligram Per Kilogram | |||
h*g/mL/(mg/kg/day) | C105465 | Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Gram Per Milliliter Per Milligram Per Kilogram Per Day | |||
h*mg/mL/(mg/kg) | C105468 | Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Kilogram | |||
h*mg/mL/(mg/kg/day) | C105469 | Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Kilogram Per Day | |||
h*mmol/L/mg | C106531 | h*mmol/L/mg;h*mol/L/g;h*umol/L/ug | Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). | Hour times Mole Per Liter Per Gram | ||
h*ng/mL/(mg/cm2/day) | C174356 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per centimeter squared per day (daily dose normalized by surface area). | Hour Times Nanogram Per Milliliter Per Milligram Per Centimeter Squared Per Day | |||
h*ng/mL/(mg/kg) | C85628 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Nanogram per Milliliter per Milligram per Kilogram | |||
h*ng/mL/(mg/kg/day) | C105470 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Nanogram Per Milliliter Per Milligram Per Kilogram Per Day | |||
h*ng/mL/(mg/m2) | C85629 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per meter squared (dose normalized by surface area). | Hour Times Nanogram per Milliliter per Milligram per Meter Squared | |||
h*ng/mL/mg | C85627 | h*mg/mL/kg;h*ng/mL/mg;h*ug/mL/g | Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight) or hours times micrograms per milliliter (area under the curve), divided by grams (weight) or hours times nanograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Nanogram per Milliliter per Milligram | ||
h*nmol/L/(mg/kg) | C132445 | Hours times nanomoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Nanomole per Liter per Milligram per Kilogram | |||
h*nmol/L/mg | C112307 | h*mmol/L/kg;h*nmol/L/mg;h*pmol/L/ug;h*umol/L/g | Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). | Hour Times Millimole Per Liter Per Kilogram | ||
h*pg/mL/(mg/kg) | C105471 | Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Kilogram | |||
h*pg/mL/(mg/kg/day) | C105472 | Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Kilogram Per Day | |||
h*pg/mL/mg | C85625 | h*ng/mL/g;h*pg/mL/mg;h*ug/mL/kg | Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight) or hours times nanograms per milliliter (area under the curve), divided by grams (weight) or hours times picograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Nanogram per Milliliter per Gram | ||
h*pmol/L/(mg/kg) | C174355 | Hours times picomoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Picomole Per Liter Per Milligram Per Kilogram | |||
h*ug/mL/(mg/kg) | C105466 | Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Kilogram | |||
h*ug/mL/(mg/kg/day) | C105467 | h*ng/mL/(ug/kg/day);h*ug/mL/(mg/kg/day) | Hour times nanograms per milliliter (area under the curve), divided by micrograms per kilogram per day (daily dose normalized by body weight), or hour times micrograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Kilogram Per Day | ||
h*ug/mL/mg | C85617 | h*g/mL/kg;h*mg/mL/g;h*ug/mL/mg | Hours times grams per milliliter (area under the curve), divided by kilograms (weight) or hours times milligrams per milliliter (area under the curve), divided by grams (weight) or hours times micrograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Microgram per Milliliter per Milligram | ||
h*umol/L/(mg/kg) | C132446 | Hours times micromoles per liter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Micromole per Liter per Milligram per Kilogram | |||
IU/mL/(mg/day) | C119367 | IU/mL/(mg/day);mIU/mL/(ug/day) | International units per milliliter (concentration), divided by milligrams per day (daily dose) or milli-international units per milliliter (concentration), divided by micrograms per day (daily dose). | International Unit per Milliliter per Milligram per Day | ||
IU/mL/(mg/kg) | C119368 | IU/mL/(mg/kg);mIU/mL/(ug/kg) | International units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | International Unit per Milliliter per Milligram per Kilogram | ||
IU/mL/(mg/kg/day) | C119369 | IU/mL/(mg/kg/day);mIU/mL/(ug/kg/day) | International units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | International Unit per Milliliter per Milligram per Kilogram per Day | ||
IU/mL/(mg/m2) | C119370 | IU/mL/(mg/m2);mIU/mL/(ug/m2) | International units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | International Unit per Milliliter per Milligram per Meter Squared | ||
IU/mL/(mg/m2/day) | C119371 | IU/mL/(mg/m2/day);mIU/mL/(ug/m2/day) | International units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | International Unit per Milliliter per Milligram per Meter Squared per Day | ||
IU/mL/mg | C119380 | IU/mL/mg;mIU/mL/ug | International units per milliliter (concentration), divided by milligrams (dose) or milli-international units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Milligram | ||
L/(mg/kg) | C120807 | Liters (volume), divided by milligrams per kilogram (dose normalized by body weight). | Liter per Milligram per Kilogram | |||
L/(mg/kg/day) | C120808 | L/(mg/kg/day);mL/(ug/kg/day) | Liters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Milligram per Kilogram per Day | ||
L/(mg/m2/day) | C120809 | L/(mg/m2/day);mL/(ug/m2/day) | Liters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Milligram per Meter Squared per Day | ||
L/mg | C124417 | L/mg;mL/ug | Liters (volume), divided by milligrams (dose) or milliliters (volume), divided by micrograms (dose). | Liter per Milligram | ||
mg/mL/(mg/day) | C119383 | mg/mL/(mg/day);ug/mL/(ug/day) | Milligrams per milliliter (concentration), divided by milligrams per day (daily dose) or micrograms per milliliter (concentration), divided by micrograms per day (daily dose). | Milligram per Milliliter per Milligram per Day | ||
mg/mL/(mg/kg) | C105475 | mg/mL/(mg/kg);ug/mL/(ug/kg) | Milligrams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Milligram Per Milliliter Per Milligram Per Kilogram | ||
mg/mL/(mg/kg/day) | C105476 | mg/mL/(mg/kg/day);ug/mL/(ug/kg/day) | Milligrams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Milligram Per Milliliter Per Milligram Per Kilogram Per Day | ||
mg/mL/(mg/m2) | C119384 | mg/mL/(mg/m2);ug/mL/(ug/m2) | Milligrams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Milligram per Milliliter per Milligram per Meter Squared | ||
mg/mL/(mg/m2/day) | C119385 | mg/mL/(mg/m2/day);ug/mL/(ug/m2/day) | Milligrams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Milligram per Milliliter per Milligram per Meter Squared per Day | ||
mg/mL/mg | C119361 | g/mL/g;mg/mL/mg;ug/mL/ug | Grams per milliliter (concentration), divided by grams (weight) or milligrams per milliliter (concentration), divided by milligrams (dose) or micrograms per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Gram | ||
mIU/mL/(mg/day) | C119397 | mIU/mL/(mg/day);uIU/mL/(ug/day) | Milli-international units per milliliter (concentration), divided by milligrams per day (daily dose) or micro-international units per milliliter (concentration), divided by micrograms per day (daily dose). | Milli-International Unit per Milliliter per Milligram per Day | ||
mIU/mL/(mg/kg) | C119398 | mIU/mL/(mg/kg);uIU/mL/(ug/kg) | Milli-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Milli-International Unit per Milliliter per Milligram per Kilogram | ||
mIU/mL/(mg/kg/day) | C119399 | mIU/mL/(mg/kg/day);uIU/mL/(ug/kg/day) | Milli-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Milli-International Unit per Milliliter per Milligram per Kilogram per Day | ||
mIU/mL/(mg/m2) | C119400 | mIU/mL/(mg/m2);uIU/mL/(ug/m2) | Milli-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Milli-International Unit per Milliliter per Milligram per Meter Squared | ||
mIU/mL/(mg/m2/day) | C119401 | mIU/mL/(mg/m2/day);uIU/mL/(ug/m2/day) | Milli-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Milli-International Unit per Milliliter per Milligram per Meter Squared per Day | ||
mIU/mL/mg | C119377 | IU/mL/g;mIU/mL/mg;uIU/mL/ug | International units per milliliter (concentration), divided by grams (weight) or milli-international units per milliliter (concentration), divided by milligrams (dose) or micro-international units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Gram | ||
mL/(mg/day) | C120817 | Milliliters (volume), divided by milligrams per day (daily dose). | Milliliter per Milligram per Day | |||
mL/(mg/kg) | C120818 | Milliliters (volume), divided by milligrams per kilogram (dose normalized by body weight). | Milliliter per Milligram per Kilogram | |||
mL/(mg/kg/day) | C120819 | Milliliters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Milliliter per Milligram per Kilogram per Day | |||
mL/(mg/m2) | C120820 | Milliliters (volume), divided by milligrams per meter squared (dose normalized by surface area). | Milliliter per Milligram per Meter Squared | |||
mL/(mg/m2/day) | C120821 | Milliliters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milliliter per Milligram per Meter Squared per Day | |||
mmol/L/(mg/day) | C119413 | mmol/L/(mg/day);umol/L/(ug/day) | Millimoles per liter (concentration), divided by milligrams per day (daily dose) or micromoles per liter (concentration), divided by micrograms per day (daily dose). | Millimole per Liter per Milligram per Day | ||
mmol/L/(mg/kg) | C119414 | mmol/L/(mg/kg);umol/L/(ug/kg) | Millimoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Millimole per Liter per Milligram per Kilogram | ||
mmol/L/(mg/kg/day) | C119415 | mmol/L/(mg/kg/day);umol/L/(ug/kg/day) | Millimoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Millimole per Liter per Milligram per Kilogram per Day | ||
mmol/L/(mg/m2) | C119416 | mmol/L/(mg/m2);umol/L/(ug/m2) | Millimoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Millimole per Liter per Milligram per Meter Squared | ||
mmol/L/(mg/m2/day) | C119417 | mmol/L/(mg/m2/day);umol/L/(ug/m2/day) | Millimoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Millimole per Liter per Milligram per Meter Squared per Day | ||
mmol/L/mg | C119426 | mmol/L/mg;mol/L/g;umol/L/ug | Moles per liter (concentration), divided by grams (weight) or millimoles per liter (concentration), divided by milligrams (dose) or micromoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Milligram | ||
mol/L/(mg/day) | C119418 | mmol/L/(ug/day);mol/L/(mg/day) | Moles per liter (concentration), divided by milligrams per day (daily dose) or millimoles per liter (concentration), divided by micrograms per day (daily dose). | Millimole per Liter per Microgram per Day | ||
mol/L/(mg/kg) | C119419 | mmol/L/(ug/kg);mol/L/(mg/kg) | Moles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Millimole per Liter per Microgram per Kilogram | ||
mol/L/(mg/kg/day) | C119420 | mmol/L/(ug/kg/day);mol/L/(mg/kg/day) | Moles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Millimole per Liter per Microgram per Kilogram per Day | ||
mol/L/(mg/m2) | C119421 | mmol/L/(ug/m2);mol/L/(mg/m2) | Moles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Millimole per Liter per Microgram per Meter Squared | ||
mol/L/(mg/m2/day) | C119422 | mmol/L/(ug/m2/day);mol/L/(mg/m2/day) | Moles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Millimole per Liter per Microgram per Meter Squared per Day | ||
mol/L/mg | C119427 | mmol/L/ug;mol/L/mg | Moles per liter (concentration), divided by milligrams (dose) or millimoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Microgram | ||
ng/mg | C67401 | Milligram per Kilogram;Nanogram per Milligram;ng/mg;ug/g | Milligrams (weight), divided by kilograms (weight) or nanograms (weight) per milligrams (weight). | Milligram per Kilogram | ||
ng/mL/(mg/day) | C119445 | ng/mL/(mg/day);pg/mL/(ug/day) | Nanograms per milliliter (concentration), divided by milligrams per day (daily dose) or picograms per milliliter (concentration), divided by micrograms per day (daily dose). | Nanogram per Milliliter per Milligram per Day | ||
ng/mL/(mg/kg) | C105477 | ng/mL/(mg/kg);pg/mL/(ug/kg) | Nanograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Nanogram Per Milliliter Per Milligram Per Kilogram | ||
ng/mL/(mg/kg/day) | C105478 | ng/mL/(mg/kg/day);pg/mL/(ug/kg/day) | Nanograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Nanogram Per Milliliter Per Milligram Per Kilogram Per Day | ||
ng/mL/(mg/m2) | C119446 | ng/mL/(mg/m2);pg/mL/(ug/m2) | Nanograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanogram per Milliliter per Milligram per Meter Squared | ||
ng/mL/(mg/m2/day) | C119447 | ng/mL/(mg/m2/day);pg/mL/(ug/m2/day) | Nanograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanogram per Milliliter per Milligram per Meter Squared per Day | ||
ng/mL/mg | C85747 | mg/mL/kg;ng/mL/mg;pg/mL/ug;ug/mL/g | Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). | Nanogram per Milliliter per Milligram | ||
nmol/L/(mg/day) | C119457 | nmol/L/(mg/day);pmol/L/(ug/day) | Nanomoles per liter (concentration), divided by milligrams per day (daily dose) or picomoles per liter (concentration), divided by micrograms per day (daily dose). | Nanomole per Liter per Milligram per Day | ||
nmol/L/(mg/kg) | C119458 | nmol/L/(mg/kg);pmol/L/(ug/kg) | Nanomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Nanomole per Liter per Milligram per Kilogram | ||
nmol/L/(mg/kg/day) | C119459 | nmol/L/(mg/kg/day);pmol/L/(ug/kg/day) | Nanomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Nanomole per Liter per Milligram per Kilogram per Day | ||
nmol/L/(mg/m2) | C119460 | nmol/L/(mg/m2);pmol/L/(ug/m2) | Nanomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanomole per Liter per Milligram per Meter Squared | ||
nmol/L/(mg/m2/day) | C119461 | nmol/L/(mg/m2/day);pmol/L/(ug/m2/day) | Nanomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanomole per Liter per Milligram per Meter Squared per Day | ||
nmol/L/mg | C85784 | mmol/L/kg;nmol/L/mg;pmol/L/ug;umol/L/g | Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). | Picomole per Liter per Microgram | ||
pg/mg | C67396 | mcg/kg;Microgram per Kilogram;ng/g;pg/mg;ug/kg | A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) | Microgram per Kilogram | ||
pg/mL/(mg/day) | C119342 | fg/mL/(ug/day);pg/mL/(mg/day) | Picograms per milliliter (concentration), divided by milligrams per day (daily dose) or femtograms per milliliter (concentration), divided by micrograms per day (daily dose). | Femtogram per Milliliter per Microgram per Day | ||
pg/mL/(mg/kg) | C105479 | fg/mL/(ug/kg);pg/mL/(mg/kg) | Picograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Picogram Per Milliliter Per Milligram Per Kilogram | ||
pg/mL/(mg/kg/day) | C105480 | fg/mL/(ug/kg/day);pg/mL/(mg/kg/day) | Picograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Picogram Per Milliliter Per Milligram Per Kilogram Per Day | ||
pg/mL/(mg/m2) | C119345 | fg/mL/(ug/m2);pg/mL/(mg/m2) | Picograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Femtogram per Milliliter per Microgram per Meter Squared | ||
pg/mL/(mg/m2/day) | C119346 | fg/mL/(ug/m2/day);pg/mL/(mg/m2/day) | Picograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Femtogram per Milliliter per Microgram per Meter Squared per Day | ||
pg/mL/mg | C119351 | fg/mL/ug;ng/mL/g;pg/mL/mg;ug/mL/kg | Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). | Femtogram per Milliliter per Microgram | ||
pmol/L/(mg/day) | C119486 | Picomoles per liter (concentration), divided by milligrams per day (daily dose). | Picomole per Liter per Milligram per Day | |||
pmol/L/(mg/kg) | C119487 | Picomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Picomole per Liter per Milligram per Kilogram | |||
pmol/L/(mg/kg/day) | C119488 | Picomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Picomole per Liter per Milligram per Kilogram per Day | |||
pmol/L/(mg/m2) | C119489 | Picomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area). | Picomole per Liter per Milligram per Meter Squared | |||
pmol/L/(mg/m2/day) | C119490 | Picomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Picomole per Liter per Milligram per Meter Squared per Day | |||
pmol/L/mg | C119467 | nmol/L/g;pmol/L/mg;umol/L/kg | Micromoles per liter (concentration), divided by kilograms (weight) or nanomoles per liter (concentration), divided by grams (weight) or picomoles per liter (concentration), divided by milligrams (dose). | Nanomole per Liter per Gram | ||
ug/mg | C69104 | Gram per Kilogram;mg/g;Microgram per Milligram;Milligram per Gram;ug/mg | Grams (weight), divided by kilograms (weight) or micrograms (weight) per milligrams (weight). | Gram per Kilogram | ||
ug/mL/(mg/day) | C119448 | ng/mL/(ug/day);ug/mL/(mg/day) | Micrograms per milliliter (concentration), divided by milligrams per day (daily dose) or nanograms per milliliter (concentration), divided by micrograms per day (daily dose). | Nanogram per Milliliter per Microgram per Day | ||
ug/mL/(mg/kg) | C105473 | ng/mL/(ug/kg);ug/mL/(mg/kg) | Micrograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Microgram Per Milliliter Per Milligram Per Kilogram | ||
ug/mL/(mg/kg/day) | C105474 | ng/mL/(ug/kg/day);ug/mL/(mg/kg/day) | Micrograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Microgram Per Milliliter Per Milligram Per Kilogram Per Day | ||
ug/mL/(mg/m2) | C119451 | ng/mL/(ug/m2);ug/mL/(mg/m2) | Micrograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanogram per Milliliter per Microgram per Meter Squared | ||
ug/mL/(mg/m2/day) | C119452 | ng/mL/(ug/m2/day);ug/mL/(mg/m2/day) | Micrograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanogram per Milliliter per Microgram per Meter Squared per Day | ||
ug/mL/mg | C85710 | g/mL/kg;mg/mL/g;ng/mL/ug;ug/mL/mg | Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). | Milligram per Liter per Milligram | ||
uIU/mL/(mg/day) | C119514 | Micro-international units per milliliter (concentration), divided by milligrams per day (daily dose). | Micro-International Units per Milliliter per Milligram per Day | |||
uIU/mL/(mg/kg) | C119515 | Micro-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Micro-International Units per Milliliter per Milligram per Kilogram | |||
uIU/mL/(mg/kg/day) | C119516 | Micro-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Micro-International Units per Milliliter per Milligram per Kilogram per Day | |||
uIU/mL/(mg/m2) | C119517 | Micro-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area). | Micro-International Units per Milliliter per Milligram per Meter Squared | |||
uIU/mL/(mg/m2/day) | C119518 | Micro-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Micro-International Units per Milliliter per Milligram per Meter Squared per Day | |||
uIU/mL/mg | C119378 | IU/mL/kg;mIU/mL/g;uIU/mL/mg | International units per milliliter (concentration), divided by kilograms (weight) or milli-international units per milliliter (concentration), divided by grams (weight) or micro-international units per milliliter (concentration), divided by milligrams (dose). | International Unit per Milliliter per Kilogram | ||
umol/L/(mg/day) | C119462 | nmol/L/(ug/day);umol/L/(mg/day) | Micromoles per liter (concentration), divided by milligrams per day (daily dose) or nanomoles per liter (concentration), divided by micrograms per day (daily dose). | Nanomole per Liter per Microgram per Day | ||
umol/L/(mg/kg) | C119463 | nmol/L/(ug/kg);umol/L/(mg/kg) | Micromoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Nanomole per Liter per Microgram per Kilogram | ||
umol/L/(mg/kg/day) | C119464 | nmol/L/(ug/kg/day);umol/L/(mg/kg/day) | Micromoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Nanomole per Liter per Microgram per Kilogram per Day | ||
umol/L/(mg/m2) | C119465 | nmol/L/(ug/m2);umol/L/(mg/m2) | Micromoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanomole per Liter per Microgram per Meter Squared | ||
umol/L/(mg/m2/day) | C119466 | nmol/L/(ug/m2/day);umol/L/(mg/m2/day) | Micromoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanomole per Liter per Microgram per Meter Squared per Day | ||
umol/L/mg | C119423 | mmol/L/g;mol/L/kg;nmol/L/ug;umol/L/mg | Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Gram | ||
Back to top | ||||||
CL.C128686.PKUDUG | PK Units of Measure - Dose ug
(PKUDUG) | text
Extensible: Yes | C128686 | PK Units of Measure - Dose ug | Units of measure for pharmacokinetic parameters normalized by dose amount in micrograms. | CDISC SDTM PK Unit of Measure Microgram Dose Terminology |
(L/day)/(ug/day) | C120733 | Liters per day (flow rate), divided by micrograms per day (daily dose). | Liter per Day per Microgram per Day | |||
(L/day)/(ug/kg) | C120734 | Liters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Day per Microgram per Kilogram | |||
(L/day)/(ug/kg/day) | C120735 | Liters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Day per Microgram per Kilogram per Day | |||
(L/day)/(ug/m2) | C120736 | Liters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Day per Microgram per Meter Squared | |||
(L/day)/(ug/m2/day) | C120737 | Liters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Day per Microgram per Meter Squared per Day | |||
(L/day)/ug | C85665 | Liters per day (flow rate), divided by micrograms (dose). | Liter per Microgram per Day | |||
(L/h)/(ug/day) | C120745 | Liters per hour (flow rate), divided by micrograms per day (daily dose). | Liter per Hour per Microgram per Day | |||
(L/h)/(ug/kg) | C120746 | Liters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Hour per Microgram per Kilogram | |||
(L/h)/(ug/kg/day) | C120747 | Liters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Hour per Microgram per Kilogram per Day | |||
(L/h)/(ug/m2) | C120748 | Liters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Hour per Microgram per Meter Squared | |||
(L/h)/(ug/m2/day) | C120749 | Liters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Hour per Microgram per Meter Squared per Day | |||
(L/h)/ug | C85662 | Liters per hour (flow rate), divided by micrograms (dose). | Liter per Microgram per Hour | |||
(L/min)/(ug/day) | C120756 | Liters per minute (flow rate), divided by micrograms per day (daily dose). | Liter per Minute per Microgram per Day | |||
(L/min)/(ug/kg) | C120757 | Liters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Minute per Microgram per Kilogram | |||
(L/min)/(ug/kg/day) | C120758 | Liters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Minute per Microgram per Kilogram per Day | |||
(L/min)/(ug/m2) | C120759 | Liters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Minute per Microgram per Meter Squared | |||
(L/min)/(ug/m2/day) | C120760 | Liters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Minute per Microgram per Meter Squared per Day | |||
(L/min)/ug | C85666 | Liters per minute (flow rate), divided by micrograms (dose). | Liter per Microgram per Minute | |||
(mL/day)/(ug/day) | C120728 | (L/day)/(mg/day);(mL/day)/(ug/day) | Liters per day (flow rate), divided by milligrams per day (daily dose) or milliliters per day (flow rate), divided by micrograms per day (daily dose). | Liter per Day per Milligram per Day | ||
(mL/day)/(ug/kg) | C120729 | (L/day)/(mg/kg);(mL/day)/(ug/kg) | Liters per day (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Day per Milligram per Kilogram | ||
(mL/day)/(ug/kg/day) | C120730 | (L/day)/(mg/kg/day);(mL/day)/(ug/kg/day) | Liters per day (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per day (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Day per Milligram per Kilogram per Day | ||
(mL/day)/(ug/m2) | C120731 | (L/day)/(mg/m2);(mL/day)/(ug/m2) | Liters per day (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Day per Milligram per Meter Squared | ||
(mL/day)/(ug/m2/day) | C120732 | (L/day)/(mg/m2/day);(mL/day)/(ug/m2/day) | Liters per day (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per day (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Day per Milligram per Meter Squared per Day | ||
(mL/day)/ug | C85672 | (L/day)/mg;(mL/day)/ug | Liters per day (flow rate), divided by milligrams (dose) or milliliters per day (flow rate), divided by micrograms (dose). | Liter per Milligram per Day | ||
(mL/h)/(ug/day) | C120740 | (L/h)/(mg/day);(mL/h)/(ug/day) | Liters per hour (flow rate), divided by milligrams per day (daily dose) or milliliters per hour (flow rate), divided by micrograms per day (daily dose). | Liter per Hour per Milligram per Day | ||
(mL/h)/(ug/kg) | C120741 | (L/h)/(mg/kg);(mL/h)/(ug/kg) | Liters per hour (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Hour per Milligram per Kilogram | ||
(mL/h)/(ug/kg/day) | C120742 | (L/h)/(mg/kg/day);(mL/h)/(ug/kg/day) | Liters per hour (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per hour (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Hour per Milligram per Kilogram per Day | ||
(mL/h)/(ug/m2) | C120743 | (L/h)/(mg/m2);(mL/h)/(ug/m2) | Liters per hour (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Hour per Milligram per Meter Squared | ||
(mL/h)/(ug/m2/day) | C120744 | (L/h)/(mg/m2/day);(mL/h)/(ug/m2/day) | Liters per hour (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per hour (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Hour per Milligram per Meter Squared per Day | ||
(mL/h)/ug | C85673 | (L/h)/mg;(mL/h)/ug | Liters per hour (flow rate), divided by milligrams (dose) or milliliters per hour (flow rate), divided by micrograms (dose). | Liter per Milligram per Hour | ||
(mL/min)/(ug/day) | C120751 | (L/min)/(mg/day);(mL/min)/(ug/day) | Liters per minute (flow rate), divided by milligrams per day (daily dose) or milliliters per minute (flow rate), divided by micrograms per day (daily dose). | Liter per Minute per Milligram per Day | ||
(mL/min)/(ug/kg) | C120752 | (L/min)/(mg/kg);(mL/min)/(ug/kg) | Liters per minute (flow rate), divided by milligrams per kilogram (dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Minute per Milligram per Kilogram | ||
(mL/min)/(ug/kg/day) | C120753 | (L/min)/(mg/kg/day);(mL/min)/(ug/kg/day) | Liters per minute (flow rate), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters per minute (flow rate), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Minute per Milligram per Kilogram per Day | ||
(mL/min)/(ug/m2) | C120754 | (L/min)/(mg/m2);(mL/min)/(ug/m2) | Liters per minute (flow rate), divided by milligrams per meter squared (dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Minute per Milligram per Meter Squared | ||
(mL/min)/(ug/m2/day) | C120755 | (L/min)/(mg/m2/day);(mL/min)/(ug/m2/day) | Liters per minute (flow rate), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters per minute (flow rate), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Minute per Milligram per Meter Squared per Day | ||
(mL/min)/ug | C85674 | (L/min)/mg;(mL/min)/ug | Liters per minute (flow rate), divided by milligrams (dose) or milliliters per minute (flow rate), divided by micrograms (dose). | Liter per Milligram per Minute | ||
day*ng/mL/(mg/kg) | C198211 | Days times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Day Times Nanogram Per Milliliter Per Milligram Per Kilogram | |||
day*ng/mL/ug | C112247 | day*g/mL/kg;day*mg/mL/g;day*ng/mL/ug;day*ug/mL/mg | Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). | Day Times Gram Per Milliliter Per Kilogram | ||
fg/mL/(ug/day) | C119342 | fg/mL/(ug/day);pg/mL/(mg/day) | Picograms per milliliter (concentration), divided by milligrams per day (daily dose) or femtograms per milliliter (concentration), divided by micrograms per day (daily dose). | Femtogram per Milliliter per Microgram per Day | ||
fg/mL/(ug/kg) | C105479 | fg/mL/(ug/kg);pg/mL/(mg/kg) | Picograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Picogram Per Milliliter Per Milligram Per Kilogram | ||
fg/mL/(ug/kg/day) | C105480 | fg/mL/(ug/kg/day);pg/mL/(mg/kg/day) | Picograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or femtograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Picogram Per Milliliter Per Milligram Per Kilogram Per Day | ||
fg/mL/(ug/m2) | C119345 | fg/mL/(ug/m2);pg/mL/(mg/m2) | Picograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Femtogram per Milliliter per Microgram per Meter Squared | ||
fg/mL/(ug/m2/day) | C119346 | fg/mL/(ug/m2/day);pg/mL/(mg/m2/day) | Picograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or femtograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Femtogram per Milliliter per Microgram per Meter Squared per Day | ||
fg/mL/ug | C119351 | fg/mL/ug;ng/mL/g;pg/mL/mg;ug/mL/kg | Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). | Femtogram per Milliliter per Microgram | ||
g/mL/(ug/day) | C119356 | Grams per milliliter (concentration), divided by micrograms per day (daily dose). | Gram per Milliliter per Microgram per Day | |||
g/mL/(ug/kg) | C119357 | Grams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Gram per Milliliter per Microgram per Kilogram | |||
g/mL/(ug/kg/day) | C119358 | Grams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Gram per Milliliter per Microgram per Kilogram per Day | |||
g/mL/(ug/m2) | C119359 | Grams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by body weight). | Gram per Milliliter per Microgram per Meter Squared | |||
g/mL/(ug/m2/day) | C119360 | Grams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Gram per Milliliter per Microgram per Meter Squared per Day | |||
g/mL/ug | C119365 | Grams per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Microgram | |||
h*ng/mL/(ug/kg/day) | C105467 | h*ng/mL/(ug/kg/day);h*ug/mL/(mg/kg/day) | Hour times nanograms per milliliter (area under the curve), divided by micrograms per kilogram per day (daily dose normalized by body weight), or hour times micrograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Kilogram Per Day | ||
h*pmol/L/ug | C112307 | h*mmol/L/kg;h*nmol/L/mg;h*pmol/L/ug;h*umol/L/g | Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). | Hour Times Millimole Per Liter Per Kilogram | ||
h*umol/L/ug | C106531 | h*mmol/L/mg;h*mol/L/g;h*umol/L/ug | Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). | Hour times Mole Per Liter Per Gram | ||
IU/mL/(ug/day) | C119372 | International units per milliliter (concentration), divided by micrograms per day (daily dose). | International Unit per Milliliter per Microgram per Day | |||
IU/mL/(ug/kg) | C119373 | International units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | International Unit per Milliliter per Microgram per Kilogram | |||
IU/mL/(ug/kg/day) | C119374 | International units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | International Unit per Milliliter per Microgram per Kilogram per Day | |||
IU/mL/(ug/m2) | C119375 | International units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | International Unit per Milliliter per Microgram per Meter Squared | |||
IU/mL/(ug/m2/day) | C119376 | International units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | International Unit per Milliliter per Microgram per Meter Squared per Day | |||
IU/mL/ug | C119381 | International units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Microgram | |||
L/(ug/kg) | C120810 | Liters (volume), divided by micrograms per kilogram (dose normalized by body weight). | Liter per Microgram per Kilogram | |||
L/(ug/kg/day) | C120811 | Liters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Microgram per Kilogram per Day | |||
L/(ug/m2) | C120812 | Liters (volume), divided by micrograms per meter squared (dose normalized by surface area). | Liter per Microgram per Meter Squared | |||
L/(ug/m2/day) | C120813 | Liters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Microgram per Meter Squared per Day | |||
L/ug | C120815 | Liters (volume), divided by micrograms (dose). | Liter per Microgram | |||
mg/mL/(ug/day) | C119353 | g/mL/(mg/day);mg/mL/(ug/day) | Grams per milliliter (concentration), divided by milligrams per day (daily dose) or milligrams per milliliter (concentration), divided by micrograms per day (daily dose). | Gram per Milliliter per Milligram per Day | ||
mg/mL/(ug/kg) | C105462 | g/mL/(mg/kg);mg/mL/(ug/kg) | Grams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Gram Per Milliliter Per Milligram Per Kilogram | ||
mg/mL/(ug/kg/day) | C105463 | g/mL/(mg/kg/day);mg/mL/(ug/kg/day) | Grams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milligrams per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Gram Per Milliliter Per Milligram Per Kilogram Per Day | ||
mg/mL/(ug/m2) | C119354 | g/mL/(mg/m2);mg/mL/(ug/m2) | Grams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Gram per Milliliter per Milligram per Meter Squared | ||
mg/mL/(ug/m2/day) | C119355 | g/mL/(mg/m2/day);mg/mL/(ug/m2/day) | Grams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milligrams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Gram per Milliliter per Milligram per Meter Squared per Day | ||
mg/mL/ug | C119364 | g/mL/mg;mg/mL/ug | Grams per milliliter (concentration), divided by milligrams (dose) or milligrams per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Milligram | ||
mIU/mL/(ug/day) | C119367 | IU/mL/(mg/day);mIU/mL/(ug/day) | International units per milliliter (concentration), divided by milligrams per day (daily dose) or milli-international units per milliliter (concentration), divided by micrograms per day (daily dose). | International Unit per Milliliter per Milligram per Day | ||
mIU/mL/(ug/kg) | C119368 | IU/mL/(mg/kg);mIU/mL/(ug/kg) | International units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | International Unit per Milliliter per Milligram per Kilogram | ||
mIU/mL/(ug/kg/day) | C119369 | IU/mL/(mg/kg/day);mIU/mL/(ug/kg/day) | International units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milli-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | International Unit per Milliliter per Milligram per Kilogram per Day | ||
mIU/mL/(ug/m2) | C119370 | IU/mL/(mg/m2);mIU/mL/(ug/m2) | International units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | International Unit per Milliliter per Milligram per Meter Squared | ||
mIU/mL/(ug/m2/day) | C119371 | IU/mL/(mg/m2/day);mIU/mL/(ug/m2/day) | International units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milli-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | International Unit per Milliliter per Milligram per Meter Squared per Day | ||
mIU/mL/ug | C119380 | IU/mL/mg;mIU/mL/ug | International units per milliliter (concentration), divided by milligrams (dose) or milli-international units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Milligram | ||
mL/(ug/kg/day) | C120808 | L/(mg/kg/day);mL/(ug/kg/day) | Liters (volume), divided by milligrams per kilogram per day (daily dose normalized by body weight) or milliliters (volume), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Liter per Milligram per Kilogram per Day | ||
mL/(ug/m2/day) | C120809 | L/(mg/m2/day);mL/(ug/m2/day) | Liters (volume), divided by milligrams per meter squared per day (daily dose normalized by surface area) or milliliters (volume), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Liter per Milligram per Meter Squared per Day | ||
mmol/L/(ug/day) | C119418 | mmol/L/(ug/day);mol/L/(mg/day) | Moles per liter (concentration), divided by milligrams per day (daily dose) or millimoles per liter (concentration), divided by micrograms per day (daily dose). | Millimole per Liter per Microgram per Day | ||
mmol/L/(ug/kg) | C119419 | mmol/L/(ug/kg);mol/L/(mg/kg) | Moles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Millimole per Liter per Microgram per Kilogram | ||
mmol/L/(ug/kg/day) | C119420 | mmol/L/(ug/kg/day);mol/L/(mg/kg/day) | Moles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or millimoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Millimole per Liter per Microgram per Kilogram per Day | ||
mmol/L/(ug/m2) | C119421 | mmol/L/(ug/m2);mol/L/(mg/m2) | Moles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Millimole per Liter per Microgram per Meter Squared | ||
mmol/L/(ug/m2/day) | C119422 | mmol/L/(ug/m2/day);mol/L/(mg/m2/day) | Moles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or millimoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Millimole per Liter per Microgram per Meter Squared per Day | ||
mmol/L/ug | C119427 | mmol/L/ug;mol/L/mg | Moles per liter (concentration), divided by milligrams (dose) or millimoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Microgram | ||
mol/L/(ug/day) | C119434 | Moles per liter (concentration), divided by micrograms per day (daily dose). | Mole per Liter per Microgram per Day | |||
mol/L/(ug/kg) | C119435 | Moles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Mole per Liter per Microgram per Kilogram | |||
mol/L/(ug/kg/day) | C119436 | Moles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Mole per Liter per Microgram per Kilogram per Day | |||
mol/L/(ug/m2) | C119437 | Moles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Mole per Liter per Microgram per Meter Squared | |||
mol/L/(ug/m2/day) | C119438 | Moles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Mole per Liter per Microgram per Meter Squared per Day | |||
mol/L/ug | C119443 | Moles per liter (concentration), divided by micrograms (dose). | Mole per Liter per Microgram | |||
ng/mL/(ug/day) | C119448 | ng/mL/(ug/day);ug/mL/(mg/day) | Micrograms per milliliter (concentration), divided by milligrams per day (daily dose) or nanograms per milliliter (concentration), divided by micrograms per day (daily dose). | Nanogram per Milliliter per Microgram per Day | ||
ng/mL/(ug/kg) | C105473 | ng/mL/(ug/kg);ug/mL/(mg/kg) | Micrograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Microgram Per Milliliter Per Milligram Per Kilogram | ||
ng/mL/(ug/kg/day) | C105474 | ng/mL/(ug/kg/day);ug/mL/(mg/kg/day) | Micrograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Microgram Per Milliliter Per Milligram Per Kilogram Per Day | ||
ng/mL/(ug/m2) | C119451 | ng/mL/(ug/m2);ug/mL/(mg/m2) | Micrograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanogram per Milliliter per Microgram per Meter Squared | ||
ng/mL/(ug/m2/day) | C119452 | ng/mL/(ug/m2/day);ug/mL/(mg/m2/day) | Micrograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanogram per Milliliter per Microgram per Meter Squared per Day | ||
ng/mL/ug | C85710 | g/mL/kg;mg/mL/g;ng/mL/ug;ug/mL/mg | Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). | Milligram per Liter per Milligram | ||
nmol/L/(ug/day) | C119462 | nmol/L/(ug/day);umol/L/(mg/day) | Micromoles per liter (concentration), divided by milligrams per day (daily dose) or nanomoles per liter (concentration), divided by micrograms per day (daily dose). | Nanomole per Liter per Microgram per Day | ||
nmol/L/(ug/kg) | C119463 | nmol/L/(ug/kg);umol/L/(mg/kg) | Micromoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Nanomole per Liter per Microgram per Kilogram | ||
nmol/L/(ug/kg/day) | C119464 | nmol/L/(ug/kg/day);umol/L/(mg/kg/day) | Micromoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or nanomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Nanomole per Liter per Microgram per Kilogram per Day | ||
nmol/L/(ug/m2) | C119465 | nmol/L/(ug/m2);umol/L/(mg/m2) | Micromoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanomole per Liter per Microgram per Meter Squared | ||
nmol/L/(ug/m2/day) | C119466 | nmol/L/(ug/m2/day);umol/L/(mg/m2/day) | Micromoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or nanomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanomole per Liter per Microgram per Meter Squared per Day | ||
nmol/L/ug | C119423 | mmol/L/g;mol/L/kg;nmol/L/ug;umol/L/mg | Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Gram | ||
pg/mL/(ug/day) | C119445 | ng/mL/(mg/day);pg/mL/(ug/day) | Nanograms per milliliter (concentration), divided by milligrams per day (daily dose) or picograms per milliliter (concentration), divided by micrograms per day (daily dose). | Nanogram per Milliliter per Milligram per Day | ||
pg/mL/(ug/kg) | C105477 | ng/mL/(mg/kg);pg/mL/(ug/kg) | Nanograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Nanogram Per Milliliter Per Milligram Per Kilogram | ||
pg/mL/(ug/kg/day) | C105478 | ng/mL/(mg/kg/day);pg/mL/(ug/kg/day) | Nanograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Nanogram Per Milliliter Per Milligram Per Kilogram Per Day | ||
pg/mL/(ug/m2) | C119446 | ng/mL/(mg/m2);pg/mL/(ug/m2) | Nanograms per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanogram per Milliliter per Milligram per Meter Squared | ||
pg/mL/(ug/m2/day) | C119447 | ng/mL/(mg/m2/day);pg/mL/(ug/m2/day) | Nanograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanogram per Milliliter per Milligram per Meter Squared per Day | ||
pg/mL/ug | C85747 | mg/mL/kg;ng/mL/mg;pg/mL/ug;ug/mL/g | Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). | Nanogram per Milliliter per Milligram | ||
pmol/L/(ug/day) | C119457 | nmol/L/(mg/day);pmol/L/(ug/day) | Nanomoles per liter (concentration), divided by milligrams per day (daily dose) or picomoles per liter (concentration), divided by micrograms per day (daily dose). | Nanomole per Liter per Milligram per Day | ||
pmol/L/(ug/kg) | C119458 | nmol/L/(mg/kg);pmol/L/(ug/kg) | Nanomoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Nanomole per Liter per Milligram per Kilogram | ||
pmol/L/(ug/kg/day) | C119459 | nmol/L/(mg/kg/day);pmol/L/(ug/kg/day) | Nanomoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or picomoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Nanomole per Liter per Milligram per Kilogram per Day | ||
pmol/L/(ug/m2) | C119460 | nmol/L/(mg/m2);pmol/L/(ug/m2) | Nanomoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Nanomole per Liter per Milligram per Meter Squared | ||
pmol/L/(ug/m2/day) | C119461 | nmol/L/(mg/m2/day);pmol/L/(ug/m2/day) | Nanomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or picomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanomole per Liter per Milligram per Meter Squared per Day | ||
pmol/L/ug | C85784 | mmol/L/kg;nmol/L/mg;pmol/L/ug;umol/L/g | Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). | Picomole per Liter per Microgram | ||
ug/mL/(ug/day) | C119383 | mg/mL/(mg/day);ug/mL/(ug/day) | Milligrams per milliliter (concentration), divided by milligrams per day (daily dose) or micrograms per milliliter (concentration), divided by micrograms per day (daily dose). | Milligram per Milliliter per Milligram per Day | ||
ug/mL/(ug/kg) | C105475 | mg/mL/(mg/kg);ug/mL/(ug/kg) | Milligrams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Milligram Per Milliliter Per Milligram Per Kilogram | ||
ug/mL/(ug/kg/day) | C105476 | mg/mL/(mg/kg/day);ug/mL/(ug/kg/day) | Milligrams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micrograms per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Milligram Per Milliliter Per Milligram Per Kilogram Per Day | ||
ug/mL/(ug/m2) | C119384 | mg/mL/(mg/m2);ug/mL/(ug/m2) | Milligrams per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Milligram per Milliliter per Milligram per Meter Squared | ||
ug/mL/(ug/m2/day) | C119385 | mg/mL/(mg/m2/day);ug/mL/(ug/m2/day) | Milligrams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micrograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Milligram per Milliliter per Milligram per Meter Squared per Day | ||
ug/mL/ug | C119361 | g/mL/g;mg/mL/mg;ug/mL/ug | Grams per milliliter (concentration), divided by grams (weight) or milligrams per milliliter (concentration), divided by milligrams (dose) or micrograms per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Gram | ||
uIU/mL/(ug/day) | C119397 | mIU/mL/(mg/day);uIU/mL/(ug/day) | Milli-international units per milliliter (concentration), divided by milligrams per day (daily dose) or micro-international units per milliliter (concentration), divided by micrograms per day (daily dose). | Milli-International Unit per Milliliter per Milligram per Day | ||
uIU/mL/(ug/kg) | C119398 | mIU/mL/(mg/kg);uIU/mL/(ug/kg) | Milli-international units per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Milli-International Unit per Milliliter per Milligram per Kilogram | ||
uIU/mL/(ug/kg/day) | C119399 | mIU/mL/(mg/kg/day);uIU/mL/(ug/kg/day) | Milli-international units per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micro-international units per milliliter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Milli-International Unit per Milliliter per Milligram per Kilogram per Day | ||
uIU/mL/(ug/m2) | C119400 | mIU/mL/(mg/m2);uIU/mL/(ug/m2) | Milli-international units per milliliter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Milli-International Unit per Milliliter per Milligram per Meter Squared | ||
uIU/mL/(ug/m2/day) | C119401 | mIU/mL/(mg/m2/day);uIU/mL/(ug/m2/day) | Milli-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micro-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Milli-International Unit per Milliliter per Milligram per Meter Squared per Day | ||
uIU/mL/ug | C119377 | IU/mL/g;mIU/mL/mg;uIU/mL/ug | International units per milliliter (concentration), divided by grams (weight) or milli-international units per milliliter (concentration), divided by milligrams (dose) or micro-international units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Gram | ||
umol/L/(ug/day) | C119413 | mmol/L/(mg/day);umol/L/(ug/day) | Millimoles per liter (concentration), divided by milligrams per day (daily dose) or micromoles per liter (concentration), divided by micrograms per day (daily dose). | Millimole per Liter per Milligram per Day | ||
umol/L/(ug/kg) | C119414 | mmol/L/(mg/kg);umol/L/(ug/kg) | Millimoles per liter (concentration), divided by milligrams per kilogram (dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram (dose normalized by body weight). | Millimole per Liter per Milligram per Kilogram | ||
umol/L/(ug/kg/day) | C119415 | mmol/L/(mg/kg/day);umol/L/(ug/kg/day) | Millimoles per liter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight) or micromoles per liter (concentration), divided by micrograms per kilogram per day (daily dose normalized by body weight). | Millimole per Liter per Milligram per Kilogram per Day | ||
umol/L/(ug/m2) | C119416 | mmol/L/(mg/m2);umol/L/(ug/m2) | Millimoles per liter (concentration), divided by milligrams per meter squared (dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared (dose normalized by surface area). | Millimole per Liter per Milligram per Meter Squared | ||
umol/L/(ug/m2/day) | C119417 | mmol/L/(mg/m2/day);umol/L/(ug/m2/day) | Millimoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area) or micromoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Millimole per Liter per Milligram per Meter Squared per Day | ||
umol/L/ug | C119426 | mmol/L/mg;mol/L/g;umol/L/ug | Moles per liter (concentration), divided by grams (weight) or millimoles per liter (concentration), divided by milligrams (dose) or micromoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Milligram | ||
Back to top | ||||||
CL.C128684.PKUWG | PK Units of Measure - Weight g
(PKUWG) | text
Extensible: Yes | C128684 | PK Units of Measure - Weight g | Units of measure for pharmacokinetic parameters normalized by weight in grams. | CDISC SDTM PK Unit of Measure Gram Weight Terminology |
(L/day)/g | C85657 | (L/day)/g;(mL/day)/mg | Liters per day (flow rate), divided by grams (weight) or milliliters per day (flow rate), divided by milligrams (dose). | Liter per Gram per Day | ||
(L/h)/g | C85658 | (L/h)/g;(mL/h)/mg | Liters per hour (flow rate), divided by grams (weight) or milliliters per hour (flow rate), divided by milligrams (dose). | Liter per Gram per Hour | ||
(L/min)/g | C85659 | (L/min)/g;(mL/min)/mg | Liters per minute (flow rate), divided by grams (weight) or milliliters per minute (flow rate), divided by milligrams (dose). | Liter per Gram per Minute | ||
(mL/day)/g | C73755 | (L/day)/kg;(mL/day)/g;mL/g/day | Milliliters per gram per day or liters per day (flow rate), divided by kilograms (weight) or milliliters per day (flow rate), divided by grams (weight). | Milliliter per Gram per Day | ||
(mL/h)/g | C73756 | (L/h)/kg;(mL/h)/g;mL/g/h | Milliliters per gram per hour or liters per hour (flow rate), divided by kilograms (weight) or milliliters per hour (flow rate), divided by grams (weight). | Milliliter per Gram per Hour | ||
(mL/min)/g | C73757 | (L/min)/kg;(mL/min)/g;mL/g/min | Milliliters per gram per minute or liters per minute (flow rate), divided by kilograms (weight) or milliliters per minute (flow rate), divided by grams (weight). | Milliliter per Gram per Minute | ||
day*fg/mL/g | C112244 | day*fg/mL/g;day*pg/mL/kg | Days times picograms per milliliter (area under the curve), divided by kilograms (weight) or days times femtograms per milliliter (area under the curve), divided by grams (weight). | Day Times Femtogram Per Milliliter Per Gram | ||
day*g/mL/g | C112246 | Days times grams per milliliter (area under the curve), divided by grams (weight). | Day Times Gram Per Milliliter Per Gram | |||
day*mg/mL/g | C112247 | day*g/mL/kg;day*mg/mL/g;day*ng/mL/ug;day*ug/mL/mg | Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). | Day Times Gram Per Milliliter Per Kilogram | ||
day*mmol/L/g | C112254 | day*mmol/L/g;day*mol/L/kg | Days times moles per liter (area under the curve), divided by kilograms (weight) or days times millimoles per liter (area under the curve), divided by grams (weight). | Day Times Millimole Per Liter Per Gram | ||
day*mol/L/g | C112256 | Days times moles per liter (area under the curve), divided by grams (weight). | Day Times Mole Per Liter Per Gram | |||
day*ng/mL/g | C112249 | day*ng/mL/g;day*ug/mL/kg | Days times micrograms per milliliter (area under the curve), divided by kilograms (weight) or days times nanograms per milliliter (area under the curve), divided by grams (weight). | Day Times Microgram Per Milliliter Per Kilogram | ||
day*nmol/L/g | C112251 | day*nmol/L/g;day*umol/L/kg | Days times micromoles per liter (area under the curve), divided by kilograms (weight) or days times nanomoles per liter (area under the curve), divided by grams (weight). | Day Times Micromole Per Liter Per Kilogram | ||
day*pg/mL/g | C112259 | day*ng/mL/kg;day*pg/mL/g | Days times nanograms per milliliter (area under the curve), divided by kilograms (weight) or days times picograms per milliliter (area under the curve), divided by grams (weight). | Day Times Nanogram Per Milliliter Per Kilogram | ||
day*pmol/L/g | C112261 | day*nmol/L/kg;day*pmol/L/g | Days times nanomoles per liter (area under the curve), divided by kilograms (weight) or days times picomoles per liter (area under the curve), divided by grams (weight). | Day Times Nanomole Per Liter Per Kilogram | ||
day*ug/mL/g | C112248 | day*mg/mL/kg;day*ug/mL/g | Days times milligrams per milliliter (area under the curve), divided by kilograms (weight) or days times micrograms per milliliter (area under the curve), divided by grams (weight). | Day Times Microgram Per Milliliter Per Gram | ||
day*umol/L/g | C112250 | day*mmol/L/kg;day*umol/L/g | Days times millimoles per liter (area under the curve), divided by kilograms (weight) or days times micromoles per liter (area under the curve), divided by grams (weight). | Day Times Micromole Per Liter Per Gram | ||
fg/mL/g | C119347 | fg/mL/g;pg/mL/kg | Picograms per milliliter (concentration), divided by kilograms (weight) or femtograms per milliliter (concentration), divided by grams (weight). | Femtogram per Milliliter per Gram | ||
g/mL/g | C119361 | g/mL/g;mg/mL/mg;ug/mL/ug | Grams per milliliter (concentration), divided by grams (weight) or milligrams per milliliter (concentration), divided by milligrams (dose) or micrograms per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Gram | ||
h*fg/mL/g | C85636 | h*fg/mL/g;h*pg/mL/kg | Hours times picograms per milliliter (area under the curve), divided by kilograms (weight) or hours times femtograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Picogram per Milliliter per Kilogram | ||
h*g/mL/g | C112300 | Hours times grams per milliliter (area under the curve), divided by grams (weight). | Hour Times Gram Per Milliliter Per Gram | |||
h*mg/mL/g | C85617 | h*g/mL/kg;h*mg/mL/g;h*ug/mL/mg | Hours times grams per milliliter (area under the curve), divided by kilograms (weight) or hours times milligrams per milliliter (area under the curve), divided by grams (weight) or hours times micrograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Microgram per Milliliter per Milligram | ||
h*mmol/L/g | C106530 | h*mmol/L/g;h*mol/L/kg | Hours times moles per liter (area under the curve), divided by kilograms (weight) or hours times millimoles per liter (area under the curve), divided by grams (weight). | Hour times Millimole Per Liter Per Gram | ||
h*mol/L/g | C106531 | h*mmol/L/mg;h*mol/L/g;h*umol/L/ug | Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). | Hour times Mole Per Liter Per Gram | ||
h*ng/mL/g | C85625 | h*ng/mL/g;h*pg/mL/mg;h*ug/mL/kg | Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight) or hours times nanograms per milliliter (area under the curve), divided by grams (weight) or hours times picograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Nanogram per Milliliter per Gram | ||
h*nmol/L/g | C112304 | h*nmol/L/g;h*umol/L/kg | Hours times micromoles per liter (area under the curve), divided by kilograms (weight) or hours times nanomoles per liter (area under the curve), divided by grams (weight). | Hour Times Micromole Per Liter Per Kilogram | ||
h*pg/mL/g | C85626 | h*ng/mL/kg;h*pg/mL/g | Hours times nanograms per milliliter (area under the curve), divided by kilograms (weight) or hours times picograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Nanogram per Milliliter per Kilogram | ||
h*pmol/L/g | C106532 | h*nmol/L/kg;h*pmol/L/g | Hours times nanomoles per liter (area under the curve), divided by kilograms (weight) or hours times picomoles per liter (area under the curve), divided by grams (weight). | Hour times Picomole Per Liter Per Gram | ||
h*ug/mL/g | C85627 | h*mg/mL/kg;h*ng/mL/mg;h*ug/mL/g | Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight) or hours times micrograms per milliliter (area under the curve), divided by grams (weight) or hours times nanograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Nanogram per Milliliter per Milligram | ||
h*umol/L/g | C112307 | h*mmol/L/kg;h*nmol/L/mg;h*pmol/L/ug;h*umol/L/g | Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). | Hour Times Millimole Per Liter Per Kilogram | ||
IU/mL/g | C119377 | IU/mL/g;mIU/mL/mg;uIU/mL/ug | International units per milliliter (concentration), divided by grams (weight) or milli-international units per milliliter (concentration), divided by milligrams (dose) or micro-international units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Gram | ||
L/g | C42577 | mL/mg | Liters (volume), divided by grams (weight) or milliliters (volume), divided by milligrams (dose). | Cubic Meter per Kilogram | ||
mg/mL/g | C85710 | g/mL/kg;mg/mL/g;ng/mL/ug;ug/mL/mg | Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). | Milligram per Liter per Milligram | ||
min*fg/mL/g | C112334 | min*fg/mL/g;min*pg/mL/kg | Minutes times picograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times femtograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Femtogram Per Milliliter Per Gram | ||
min*g/mL/g | C112336 | Minutes times grams per milliliter (area under the curve), divided by grams (weight). | Minute Times Gram Per Milliliter Per Gram | |||
min*mg/mL/g | C112337 | min*g/mL/kg;min*mg/mL/g | Minutes times grams per milliliter (area under the curve), divided by kilograms (weight) or minutes times milligrams per milliliter (area under the curve), divided by grams (weight). | Minute Times Gram Per Milliliter Per Kilogram | ||
min*mmol/L/g | C112344 | min*mmol/L/g;min*mol/L/kg | Minutes times moles per liter (area under the curve), divided by kilograms (weight) or minutes times millimoles per liter (area under the curve), divided by grams (weight). | Minute Times Millimole Per Liter Per Gram | ||
min*mol/L/g | C112346 | Minutes times moles per liter (area under the curve), divided by grams (weight). | Minute Times Mole Per Liter Per Gram | |||
min*ng/mL/g | C112339 | min*ng/mL/g;min*ug/mL/kg | Minutes times micrograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times nanograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Microgram Per Milliliter Per Kilogram | ||
min*nmol/L/g | C112341 | min*nmol/L/g;min*umol/L/kg | Minutes times micromoles per liter (area under the curve), divided by kilograms (weight) or minutes times nanomoles per liter (area under the curve), divided by grams (weight). | Minute Times Micromole Per Liter Per Kilogram | ||
min*pg/mL/g | C112349 | min*ng/mL/kg;min*pg/mL/g | Minutes times nanograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times picograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Nanogram Per Milliliter Per Kilogram | ||
min*pmol/L/g | C112351 | min*nmol/L/kg;min*pmol/L/g | Minutes times nanomoles per liter (area under the curve), divided by kilograms (weight) or minutes times picomoles per liter (area under the curve), divided by grams (weight). | Minute Times Nanomole Per Liter Per Kilogram | ||
min*ug/mL/g | C112338 | min*mg/mL/kg;min*ug/mL/g | Minutes times milligrams per milliliter (area under the curve), divided by kilograms (weight) or minutes times micrograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Microgram Per Milliliter Per Gram | ||
min*umol/L/g | C112340 | min*mmol/L/kg;min*umol/L/g | Minutes times millimoles per liter (area under the curve), divided by kilograms (weight) or minutes times micromoles per liter (area under the curve), divided by grams (weight). | Minute Times Micromole Per Liter Per Gram | ||
mIU/mL/g | C119378 | IU/mL/kg;mIU/mL/g;uIU/mL/mg | International units per milliliter (concentration), divided by kilograms (weight) or milli-international units per milliliter (concentration), divided by grams (weight) or micro-international units per milliliter (concentration), divided by milligrams (dose). | International Unit per Milliliter per Kilogram | ||
mL/g | C73725 | L/kg;mL/g | Liters (volume) divided by kilograms (weight) or milliliters (volume), divided by grams (weight). | Liter per Kilogram | ||
mmol/L/g | C119423 | mmol/L/g;mol/L/kg;nmol/L/ug;umol/L/mg | Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Gram | ||
mol/L/g | C119426 | mmol/L/mg;mol/L/g;umol/L/ug | Moles per liter (concentration), divided by grams (weight) or millimoles per liter (concentration), divided by milligrams (dose) or micromoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Milligram | ||
ng/g | C67396 | mcg/kg;Microgram per Kilogram;ng/g;pg/mg;ug/kg | A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) | Microgram per Kilogram | ||
ng/mL/g | C119351 | fg/mL/ug;ng/mL/g;pg/mL/mg;ug/mL/kg | Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). | Femtogram per Milliliter per Microgram | ||
nmol/g | C85752 | nmol/g;pmol/mg;umol/kg | Nanomoles per gram. | Nanomole per Gram | ||
nmol/L/g | C119467 | nmol/L/g;pmol/L/mg;umol/L/kg | Micromoles per liter (concentration), divided by kilograms (weight) or nanomoles per liter (concentration), divided by grams (weight) or picomoles per liter (concentration), divided by milligrams (dose). | Nanomole per Liter per Gram | ||
pg/mL/g | C85746 | fg/mL/mg;ng/mL/kg;pg/mL/g | Nanograms per milliliter (concentration), divided by kilograms (weight) or picograms per milliliter (concentration), divided by grams (weight) or femtograms per milliliter (concentration), divided by milligrams (dose). | Nanogram per Milliliter per Kilogram | ||
pmol/L/g | C119468 | nmol/L/kg;pmol/L/g | Nanomoles per liter (concentration), divided by kilograms (weight) or picomoles per liter (concentration), divided by grams (weight). | Nanomole per Liter per Kilogram | ||
ug/mL/g | C85747 | mg/mL/kg;ng/mL/mg;pg/mL/ug;ug/mL/g | Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). | Nanogram per Milliliter per Milligram | ||
uIU/mL/g | C119408 | mIU/mL/kg;uIU/mL/g | Milli-international units per milliliter (concentration), divided by kilograms (weight) or micro-international units per milliliter (concentration), divided by grams (weight). | Milli-International Unit per Milliliter per Kilogram | ||
umol/L/g | C85784 | mmol/L/kg;nmol/L/mg;pmol/L/ug;umol/L/g | Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). | Picomole per Liter per Microgram | ||
Back to top | ||||||
CL.C128683.PKUWKG | PK Units of Measure - Weight kg
(PKUWKG) | text
Extensible: Yes | C128683 | PK Units of Measure - Weight kg | Units of measure for pharmacokinetic parameters normalized by weight in kilograms. | CDISC SDTM PK Unit of Measure Kilogram Weight Terminology |
(L/day)/kg | C73755 | (L/day)/kg;(mL/day)/g;mL/g/day | Milliliters per gram per day or liters per day (flow rate), divided by kilograms (weight) or milliliters per day (flow rate), divided by grams (weight). | Milliliter per Gram per Day | ||
(L/h)/kg | C73756 | (L/h)/kg;(mL/h)/g;mL/g/h | Milliliters per gram per hour or liters per hour (flow rate), divided by kilograms (weight) or milliliters per hour (flow rate), divided by grams (weight). | Milliliter per Gram per Hour | ||
(L/min)/kg | C73757 | (L/min)/kg;(mL/min)/g;mL/g/min | Milliliters per gram per minute or liters per minute (flow rate), divided by kilograms (weight) or milliliters per minute (flow rate), divided by grams (weight). | Milliliter per Gram per Minute | ||
(mL/day)/kg | C73758 | (mL/day)/kg;mL/kg/day | Milliliters per kilogram per day or milliliters per day (flow rate), divided by kilograms (weight). | Milliliter per Kilogram per Day | ||
(mL/h)/kg | C73759 | (mL/h)/kg;mL/kg/h | Milliliters per kilogram per hour or milliliters per hour (flow rate), divided by kilograms (weight). | Milliliter per Kilogram per Hour | ||
(mL/min)/kg | C73760 | (mL/min)/kg;mL/kg/min | Milliliters per kilogram per minute or milliliters per minute (flow rate), divided by kilograms (weight). | Milliliter per Kilogram per Minute | ||
day*g/mL/kg | C112247 | day*g/mL/kg;day*mg/mL/g;day*ng/mL/ug;day*ug/mL/mg | Days times grams per milliliter (area under the curve), divided by kilograms (weight); or days times milligrams per milliliter (area under the curve), divided by grams (weight); or days times micrograms per milliliter (area under the curve), divided by milligrams (dose); or days times nanograms per milliliter (area under the curve), divided by micrograms (dose). | Day Times Gram Per Milliliter Per Kilogram | ||
day*mg/mL/kg | C112248 | day*mg/mL/kg;day*ug/mL/g | Days times milligrams per milliliter (area under the curve), divided by kilograms (weight) or days times micrograms per milliliter (area under the curve), divided by grams (weight). | Day Times Microgram Per Milliliter Per Gram | ||
day*mmol/L/kg | C112250 | day*mmol/L/kg;day*umol/L/g | Days times millimoles per liter (area under the curve), divided by kilograms (weight) or days times micromoles per liter (area under the curve), divided by grams (weight). | Day Times Micromole Per Liter Per Gram | ||
day*mol/L/kg | C112254 | day*mmol/L/g;day*mol/L/kg | Days times moles per liter (area under the curve), divided by kilograms (weight) or days times millimoles per liter (area under the curve), divided by grams (weight). | Day Times Millimole Per Liter Per Gram | ||
day*ng/mL/kg | C112259 | day*ng/mL/kg;day*pg/mL/g | Days times nanograms per milliliter (area under the curve), divided by kilograms (weight) or days times picograms per milliliter (area under the curve), divided by grams (weight). | Day Times Nanogram Per Milliliter Per Kilogram | ||
day*nmol/L/kg | C112261 | day*nmol/L/kg;day*pmol/L/g | Days times nanomoles per liter (area under the curve), divided by kilograms (weight) or days times picomoles per liter (area under the curve), divided by grams (weight). | Day Times Nanomole Per Liter Per Kilogram | ||
day*pg/mL/kg | C112244 | day*fg/mL/g;day*pg/mL/kg | Days times picograms per milliliter (area under the curve), divided by kilograms (weight) or days times femtograms per milliliter (area under the curve), divided by grams (weight). | Day Times Femtogram Per Milliliter Per Gram | ||
day*pmol/L/kg | C112265 | Days times picomoles per liter (area under the curve), divided by kilograms (weight). | Day Times Picomole Per Liter Per Kilogram | |||
day*ug/mL/kg | C112249 | day*ng/mL/g;day*ug/mL/kg | Days times micrograms per milliliter (area under the curve), divided by kilograms (weight) or days times nanograms per milliliter (area under the curve), divided by grams (weight). | Day Times Microgram Per Milliliter Per Kilogram | ||
day*umol/L/kg | C112251 | day*nmol/L/g;day*umol/L/kg | Days times micromoles per liter (area under the curve), divided by kilograms (weight) or days times nanomoles per liter (area under the curve), divided by grams (weight). | Day Times Micromole Per Liter Per Kilogram | ||
fg/mL/kg | C119348 | Femtograms per milliliter (concentration), divided by kilograms (weight). | Femtogram per Milliliter per Kilogram | |||
g/mL/kg | C85710 | g/mL/kg;mg/mL/g;ng/mL/ug;ug/mL/mg | Grams per milliliter (concentration), divided by kilograms (weight) or milligrams per milliliter (concentration), divided by grams (weight) or micrograms per milliliter (concentration), divided by milligrams (dose) or nanograms per milliliter (concentration), divided by micrograms (dose). | Milligram per Liter per Milligram | ||
h*g/mL/kg | C85617 | h*g/mL/kg;h*mg/mL/g;h*ug/mL/mg | Hours times grams per milliliter (area under the curve), divided by kilograms (weight) or hours times milligrams per milliliter (area under the curve), divided by grams (weight) or hours times micrograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Microgram per Milliliter per Milligram | ||
h*mg/mL/kg | C85627 | h*mg/mL/kg;h*ng/mL/mg;h*ug/mL/g | Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight) or hours times micrograms per milliliter (area under the curve), divided by grams (weight) or hours times nanograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Nanogram per Milliliter per Milligram | ||
h*mmol/L/kg | C112307 | h*mmol/L/kg;h*nmol/L/mg;h*pmol/L/ug;h*umol/L/g | Hours times millimoles per liter (area under the curve), divided by kilograms (weight); or hours times micromoles per liter (area under the curve), divided by grams (weight); or hours times nanomoles per liter (area under the curve), divided by milligrams (dose); or hours times picomoles per liter (area under the curve), divided by micrograms (dose). | Hour Times Millimole Per Liter Per Kilogram | ||
h*mol/L/kg | C106530 | h*mmol/L/g;h*mol/L/kg | Hours times moles per liter (area under the curve), divided by kilograms (weight) or hours times millimoles per liter (area under the curve), divided by grams (weight). | Hour times Millimole Per Liter Per Gram | ||
h*ng/mL/kg | C85626 | h*ng/mL/kg;h*pg/mL/g | Hours times nanograms per milliliter (area under the curve), divided by kilograms (weight) or hours times picograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Nanogram per Milliliter per Kilogram | ||
h*nmol/L/kg | C106532 | h*nmol/L/kg;h*pmol/L/g | Hours times nanomoles per liter (area under the curve), divided by kilograms (weight) or hours times picomoles per liter (area under the curve), divided by grams (weight). | Hour times Picomole Per Liter Per Gram | ||
h*pg/mL/kg | C85636 | h*fg/mL/g;h*pg/mL/kg | Hours times picograms per milliliter (area under the curve), divided by kilograms (weight) or hours times femtograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Picogram per Milliliter per Kilogram | ||
h*pmol/L/kg | C112311 | Hours times picomoles per liter (area under the curve), divided by kilograms (weight). | Hour Times Picomole Per Liter Per Kilogram | |||
h*ug/mL/kg | C85625 | h*ng/mL/g;h*pg/mL/mg;h*ug/mL/kg | Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight) or hours times nanograms per milliliter (area under the curve), divided by grams (weight) or hours times picograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Nanogram per Milliliter per Gram | ||
h*umol/L/kg | C112304 | h*nmol/L/g;h*umol/L/kg | Hours times micromoles per liter (area under the curve), divided by kilograms (weight) or hours times nanomoles per liter (area under the curve), divided by grams (weight). | Hour Times Micromole Per Liter Per Kilogram | ||
IU/mL/kg | C119378 | IU/mL/kg;mIU/mL/g;uIU/mL/mg | International units per milliliter (concentration), divided by kilograms (weight) or milli-international units per milliliter (concentration), divided by grams (weight) or micro-international units per milliliter (concentration), divided by milligrams (dose). | International Unit per Milliliter per Kilogram | ||
L/kg | C73725 | L/kg;mL/g | Liters (volume) divided by kilograms (weight) or milliliters (volume), divided by grams (weight). | Liter per Kilogram | ||
mg/mL/kg | C85747 | mg/mL/kg;ng/mL/mg;pg/mL/ug;ug/mL/g | Milligrams per milliliter (concentration), divided by kilograms (weight) or micrograms per milliliter (concentration), divided by grams (weight) or nanograms per milliliter (concentration), divided by milligrams (dose) or picograms per milliliter (concentration), divided by micrograms (dose). | Nanogram per Milliliter per Milligram | ||
min*g/mL/kg | C112337 | min*g/mL/kg;min*mg/mL/g | Minutes times grams per milliliter (area under the curve), divided by kilograms (weight) or minutes times milligrams per milliliter (area under the curve), divided by grams (weight). | Minute Times Gram Per Milliliter Per Kilogram | ||
min*mg/mL/kg | C112338 | min*mg/mL/kg;min*ug/mL/g | Minutes times milligrams per milliliter (area under the curve), divided by kilograms (weight) or minutes times micrograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Microgram Per Milliliter Per Gram | ||
min*mmol/L/kg | C112340 | min*mmol/L/kg;min*umol/L/g | Minutes times millimoles per liter (area under the curve), divided by kilograms (weight) or minutes times micromoles per liter (area under the curve), divided by grams (weight). | Minute Times Micromole Per Liter Per Gram | ||
min*mol/L/kg | C112344 | min*mmol/L/g;min*mol/L/kg | Minutes times moles per liter (area under the curve), divided by kilograms (weight) or minutes times millimoles per liter (area under the curve), divided by grams (weight). | Minute Times Millimole Per Liter Per Gram | ||
min*ng/mL/kg | C112349 | min*ng/mL/kg;min*pg/mL/g | Minutes times nanograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times picograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Nanogram Per Milliliter Per Kilogram | ||
min*nmol/L/kg | C112351 | min*nmol/L/kg;min*pmol/L/g | Minutes times nanomoles per liter (area under the curve), divided by kilograms (weight) or minutes times picomoles per liter (area under the curve), divided by grams (weight). | Minute Times Nanomole Per Liter Per Kilogram | ||
min*pg/mL/kg | C112334 | min*fg/mL/g;min*pg/mL/kg | Minutes times picograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times femtograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Femtogram Per Milliliter Per Gram | ||
min*pmol/L/kg | C112355 | Minutes times picomoles per liter (area under the curve), divided by kilograms (weight). | Minute Times Picomole Per Liter Per Kilogram | |||
min*ug/mL/kg | C112339 | min*ng/mL/g;min*ug/mL/kg | Minutes times micrograms per milliliter (area under the curve), divided by kilograms (weight) or minutes times nanograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Microgram Per Milliliter Per Kilogram | ||
min*umol/L/kg | C112341 | min*nmol/L/g;min*umol/L/kg | Minutes times micromoles per liter (area under the curve), divided by kilograms (weight) or minutes times nanomoles per liter (area under the curve), divided by grams (weight). | Minute Times Micromole Per Liter Per Kilogram | ||
mIU/mL/kg | C119408 | mIU/mL/kg;uIU/mL/g | Milli-international units per milliliter (concentration), divided by kilograms (weight) or micro-international units per milliliter (concentration), divided by grams (weight). | Milli-International Unit per Milliliter per Kilogram | ||
mL/kg | C67411 | Milliliters (volume) divided by kilograms (weight). | Milliliter per Kilogram | |||
mmol/L/kg | C85784 | mmol/L/kg;nmol/L/mg;pmol/L/ug;umol/L/g | Millimoles per liter (concentration), divided by kilograms (weight) or micromoles per liter (concentration), divided by grams (weight) or nanomoles per liter (concentration), divided by milligrams (dose) or picomoles per liter (concentration), divided by micrograms (dose). | Picomole per Liter per Microgram | ||
mol/L/kg | C119423 | mmol/L/g;mol/L/kg;nmol/L/ug;umol/L/mg | Moles per liter (concentration), divided by kilograms (weight) or millimoles per liter (concentration), divided by grams (weight) or micromoles per liter (concentration), divided by milligrams (dose) or nanomoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Gram | ||
ng/kg/min | C85743 | Nanograms per kilogram per minute. | Nanogram per Kilogram per Minute | |||
ng/mL/kg | C85746 | fg/mL/mg;ng/mL/kg;pg/mL/g | Nanograms per milliliter (concentration), divided by kilograms (weight) or picograms per milliliter (concentration), divided by grams (weight) or femtograms per milliliter (concentration), divided by milligrams (dose). | Nanogram per Milliliter per Kilogram | ||
nmol/kg | C85754 | nmol/kg;pmol/g | Nanomoles (amount), divided by kilograms (weight) or picomoles per gram. | Nanomole per Kilogram | ||
nmol/L/kg | C119468 | nmol/L/kg;pmol/L/g | Nanomoles per liter (concentration), divided by kilograms (weight) or picomoles per liter (concentration), divided by grams (weight). | Nanomole per Liter per Kilogram | ||
pg/mL/kg | C119347 | fg/mL/g;pg/mL/kg | Picograms per milliliter (concentration), divided by kilograms (weight) or femtograms per milliliter (concentration), divided by grams (weight). | Femtogram per Milliliter per Gram | ||
pmol/L/kg | C119497 | Picomoles per liter (concentration), divided by kilograms (weight). | Picomole per Liter per Kilogram | |||
ug/mL/kg | C119351 | fg/mL/ug;ng/mL/g;pg/mL/mg;ug/mL/kg | Micrograms per milliliter (concentration), divided by kilograms (weight) or nanograms per milliliter (concentration), divided by grams (weight) or picograms per milliliter (concentration), divided by milligrams (dose) or femtograms per milliliter (concentration), divided by micrograms (dose). | Femtogram per Milliliter per Microgram | ||
uIU/mL/kg | C119525 | Micro-international units per milliliter (concentration), divided by kilograms (weight). | Micro-International Units per Milliliter per Kilogram | |||
umol/L/kg | C119467 | nmol/L/g;pmol/L/mg;umol/L/kg | Micromoles per liter (concentration), divided by kilograms (weight) or nanomoles per liter (concentration), divided by grams (weight) or picomoles per liter (concentration), divided by milligrams (dose). | Nanomole per Liter per Gram | ||
Back to top | ||||||
CL.C99075.PORTOT | Portion/Totality
(PORTOT) | text
Extensible: Yes | C99075 | Portion/Totality | Qualifier for anatomical location or specimen further detailing the portion or totality, which means arrangement of, or apportioning of an entity. | CDISC SDTM Portion/Totality Terminology |
ALL | C64916 | Being or representing the total number of individual entities. | All | |||
ENTIRE | C25326 | Whole | Being or representing the complete extent of a single entity. | Whole | ||
HEMI | C81009 | Of or pertaining to one half of a whole. | Half | |||
MULTIPLE | C17648 | More than one. (NCI) | Multiple | |||
PARTIAL | C25378 | Being or representing an incomplete extent of a single entity. | Partial | |||
SEGMENT | C45312 | One of the parts into which something is divided. | Segment | |||
SINGLE | C48440 | One. | Single | |||
Back to top | ||||||
CL.C71148.POSITION | Position
(POSITION) | text
Extensible: Yes | C71148 | Position | Terminology codelist used with Body Position within CDISC. | CDISC SDTM Body Position Terminology |
DECUBITUS | C77532 | Recumbent | Lying down. (NCI) | Recumbent Position | ||
FOWLERS | C62173 | Fowlers | A semi-sitting position whereby the head of an adjustable bed is elevated to the desired height, about 60-90 cm, to produce angulation of the body, usually 45 degrees to 60 degrees. Knees may or may not be bent. (NCI) | Fowler's Position | ||
LATERAL DECUBITUS | C100758 | Lateral Decubitus | Lying down on one side. | Lateral Decubitus Position | ||
LEFT LATERAL DECUBITUS | C62172 | Left lateral decubitus | A recumbent left lateral side position. (NCI) | Left Lateral Decubitus Position | ||
PRONE | C62165 | Prone | An anterior recumbent body position whereby the person lies on its stomach and faces downward. (NCI) | Prone Position | ||
REVERSE TRENDELENBURG | C62169 | Reverse Trendelenburg | A supine position with the person inclined at an angle of 45 degrees so that the head is higher than the pelvis. (NCI) | Reverse Trendelenburg | ||
RIGHT LATERAL DECUBITUS | C62171 | Right lateral decubitus | A recumbent right lateral side position. (NCI) | Right Lateral Decubitus Position | ||
SEMI-FOWLERS | C62174 | Semi-Fowlers | A semi-sitting or semi-reclined body position whereby the head is elevated on an angle of approximately 30 degrees. (NCI) | Semi-Fowler's Position | ||
SEMI-RECUMBENT | C111310 | Semi-Supine | A semi-sitting or semi-reclined body position in which the head is elevated above horizontal. (NCI) | Semi-Recumbent | ||
SITTING | C62122 | Sitting | The state or act of one who sits; the posture of one who occupies a seat. (NCI) | Sitting | ||
SITTING, LEGS DEPENDENT | C150885 | Sitting With Legs Dangling | A position where the legs of a subject dangle, or hang down, while sitting. | Sitting With Legs Dependent | ||
SLING | C92604 | Sling | A position in which the subject's body is supported by a sling. | Patient in Body Sling | ||
STANDING | C62166 | Orthostatic;Standing | The act of assuming or maintaining an erect upright position. (NCI) | Standing | ||
STANDING, BENT FORWARD | C174357 | A position where the subject is standing and bent forward at the waist. | Standing, Bent Forward | |||
SUPINE | C62167 | Supine | A posterior recumbent body position whereby the person lies on its back and faces upward. (NCI) | Supine Position | ||
TRENDELENBURG | C62168 | Trendelenburg | A supine position with the person inclined at an angle of 45 degrees so that the pelvis is higher than the head. (NCI) | Trendelenburg | ||
UNCONSTRAINED | C90480 | Unconstrained | The ability to move body parts and limbs without physical restriction. (NCI) | Unconstrained Body Movement | ||
Back to top | ||||||
CL.C124686.PANSS1TC | Positive and Negative Syndrome Scale Clinical Classification Test Code
(PANSS1TC) | text
Extensible: No | C124686 | Positive and Negative Syndrome Scale Clinical Classification Test Code | Positive and Negative Syndrome Scale test code. | CDISC Clinical Classification PANSS Test Code Terminology |
PANSS101 | C124747 | PANSS1-Delusions | Positive and Negative Syndrome Scale - Delusions. | PANSS - Delusions | ||
PANSS102 | C124748 | PANSS1-Conceptual Disorganization | Positive and Negative Syndrome Scale - Conceptual disorganization. | PANSS - Conceptual Disorganization | ||
PANSS103 | C124749 | PANSS1-Hallucinatory Behavior | Positive and Negative Syndrome Scale - Hallucinatory behavior. | PANSS - Hallucinatory Behavior | ||
PANSS104 | C124750 | PANSS1-Excitement | Positive and Negative Syndrome Scale - Excitement. | PANSS - Excitement | ||
PANSS105 | C124751 | PANSS1-Grandiosity | Positive and Negative Syndrome Scale - Grandiosity. | PANSS - Grandiosity | ||
PANSS106 | C124752 | PANSS1-Suspiciousness/Persecution | Positive and Negative Syndrome Scale - Suspiciousness/persecution. | PANSS - Suspiciousness or Persecution | ||
PANSS107 | C124753 | PANSS1-Hostility | Positive and Negative Syndrome Scale - Hostility. | PANSS - Hostility | ||
PANSS108 | C124754 | PANSS1-Blunted Affect | Positive and Negative Syndrome Scale - Blunted affect. | PANSS - Blunted Affect | ||
PANSS109 | C124755 | PANSS1-Emotional Withdrawal | Positive and Negative Syndrome Scale - Emotional withdrawal. | PANSS - Emotional Withdrawal | ||
PANSS110 | C124756 | PANSS1-Poor Rapport | Positive and Negative Syndrome Scale - Poor rapport. | PANSS - Poor Rapport | ||
PANSS111 | C124757 | PANSS1-Passive/Apathetic Social Withdraw | Positive and Negative Syndrome Scale - Passive/apathetic social withdrawal. | PANSS - Passive or Apathetic Social Withdrawal | ||
PANSS112 | C124758 | PANSS1-Difficulty in Abstract Thinking | Positive and Negative Syndrome Scale - Difficulty in abstract thinking. | PANSS - Difficulty in Abstract Thinking | ||
PANSS113 | C124759 | PANSS1-Lack of Spontaneity | Positive and Negative Syndrome Scale - Lack of spontaneity and flow of conversation. | PANSS - Lack of Spontaneity | ||
PANSS114 | C124760 | PANSS1-Stereotyped Thinking | Positive and Negative Syndrome Scale - Stereotyped thinking. | PANSS - Stereotyped Thinking | ||
PANSS115 | C124761 | PANSS1-Somatic Concern | Positive and Negative Syndrome Scale - Somatic concern. | PANSS - Somatic Concern | ||
PANSS116 | C124762 | PANSS1-Anxiety | Positive and Negative Syndrome Scale - Anxiety. | PANSS - Anxiety | ||
PANSS117 | C124763 | PANSS1-Guilt Feelings | Positive and Negative Syndrome Scale - Guilt feelings. | PANSS - Guilt Feelings | ||
PANSS118 | C124764 | PANSS1-Tension | Positive and Negative Syndrome Scale - Tension. | PANSS - Tension | ||
PANSS119 | C124765 | PANSS1-Mannerisms and Posturing | Positive and Negative Syndrome Scale - Mannerisms and posturing. | PANSS - Mannerisms and Posturing | ||
PANSS120 | C124766 | PANSS1-Depression | Positive and Negative Syndrome Scale - Depression. | PANSS - Depression | ||
PANSS121 | C124767 | PANSS1-Motor Retardation | Positive and Negative Syndrome Scale - Motor retardation. | PANSS - Motor Retardation | ||
PANSS122 | C124768 | PANSS1-Uncooperativeness | Positive and Negative Syndrome Scale - Uncooperativeness. | PANSS - Uncooperativeness | ||
PANSS123 | C124769 | PANSS1-Unusual Thought Content | Positive and Negative Syndrome Scale - Unusual thought content. | PANSS - Unusual Thought Content | ||
PANSS124 | C124770 | PANSS1-Disorientation | Positive and Negative Syndrome Scale - Disorientation. | PANSS - Disorientation | ||
PANSS125 | C124771 | PANSS1-Poor Attention | Positive and Negative Syndrome Scale - Poor attention. | PANSS - Poor Attention | ||
PANSS126 | C124772 | PANSS1-Lack of Judgment and Insight | Positive and Negative Syndrome Scale - Lack of judgment and insight. | PANSS - Lack of Judgement | ||
PANSS127 | C124773 | PANSS1-Disturbance of Volition | Positive and Negative Syndrome Scale - Disturbance of volition. | PANSS - Disturbance of Volition | ||
PANSS128 | C124774 | PANSS1-Poor Impulse Control | Positive and Negative Syndrome Scale - Poor impulse control. | PANSS - Poor Impulse Control | ||
PANSS129 | C124775 | PANSS1-Preoccupation | Positive and Negative Syndrome Scale - Preoccupation. | PANSS - Preoccupation | ||
PANSS130 | C124776 | PANSS1-Active Social Avoidance | Positive and Negative Syndrome Scale - Active social avoidance. | PANSS - Active Social Avoidance | ||
Back to top | ||||||
CL.C124685.PANSS1TN | Positive and Negative Syndrome Scale Clinical Classification Test Name
(PANSS1TN) | text
Extensible: No | C124685 | Positive and Negative Syndrome Scale Clinical Classification Test Name | Positive and Negative Syndrome Scale test name. | CDISC Clinical Classification PANSS Test Name Terminology |
PANSS1-Active Social Avoidance | C124776 | PANSS1-Active Social Avoidance | Positive and Negative Syndrome Scale - Active social avoidance. | PANSS - Active Social Avoidance | ||
PANSS1-Anxiety | C124762 | PANSS1-Anxiety | Positive and Negative Syndrome Scale - Anxiety. | PANSS - Anxiety | ||
PANSS1-Blunted Affect | C124754 | PANSS1-Blunted Affect | Positive and Negative Syndrome Scale - Blunted affect. | PANSS - Blunted Affect | ||
PANSS1-Conceptual Disorganization | C124748 | PANSS1-Conceptual Disorganization | Positive and Negative Syndrome Scale - Conceptual disorganization. | PANSS - Conceptual Disorganization | ||
PANSS1-Delusions | C124747 | PANSS1-Delusions | Positive and Negative Syndrome Scale - Delusions. | PANSS - Delusions | ||
PANSS1-Depression | C124766 | PANSS1-Depression | Positive and Negative Syndrome Scale - Depression. | PANSS - Depression | ||
PANSS1-Difficulty in Abstract Thinking | C124758 | PANSS1-Difficulty in Abstract Thinking | Positive and Negative Syndrome Scale - Difficulty in abstract thinking. | PANSS - Difficulty in Abstract Thinking | ||
PANSS1-Disorientation | C124770 | PANSS1-Disorientation | Positive and Negative Syndrome Scale - Disorientation. | PANSS - Disorientation | ||
PANSS1-Disturbance of Volition | C124773 | PANSS1-Disturbance of Volition | Positive and Negative Syndrome Scale - Disturbance of volition. | PANSS - Disturbance of Volition | ||
PANSS1-Emotional Withdrawal | C124755 | PANSS1-Emotional Withdrawal | Positive and Negative Syndrome Scale - Emotional withdrawal. | PANSS - Emotional Withdrawal | ||
PANSS1-Excitement | C124750 | PANSS1-Excitement | Positive and Negative Syndrome Scale - Excitement. | PANSS - Excitement | ||
PANSS1-Grandiosity | C124751 | PANSS1-Grandiosity | Positive and Negative Syndrome Scale - Grandiosity. | PANSS - Grandiosity | ||
PANSS1-Guilt Feelings | C124763 | PANSS1-Guilt Feelings | Positive and Negative Syndrome Scale - Guilt feelings. | PANSS - Guilt Feelings | ||
PANSS1-Hallucinatory Behavior | C124749 | PANSS1-Hallucinatory Behavior | Positive and Negative Syndrome Scale - Hallucinatory behavior. | PANSS - Hallucinatory Behavior | ||
PANSS1-Hostility | C124753 | PANSS1-Hostility | Positive and Negative Syndrome Scale - Hostility. | PANSS - Hostility | ||
PANSS1-Lack of Judgment and Insight | C124772 | PANSS1-Lack of Judgment and Insight | Positive and Negative Syndrome Scale - Lack of judgment and insight. | PANSS - Lack of Judgement | ||
PANSS1-Lack of Spontaneity | C124759 | PANSS1-Lack of Spontaneity | Positive and Negative Syndrome Scale - Lack of spontaneity and flow of conversation. | PANSS - Lack of Spontaneity | ||
PANSS1-Mannerisms and Posturing | C124765 | PANSS1-Mannerisms and Posturing | Positive and Negative Syndrome Scale - Mannerisms and posturing. | PANSS - Mannerisms and Posturing | ||
PANSS1-Motor Retardation | C124767 | PANSS1-Motor Retardation | Positive and Negative Syndrome Scale - Motor retardation. | PANSS - Motor Retardation | ||
PANSS1-Passive/Apathetic Social Withdraw | C124757 | PANSS1-Passive/Apathetic Social Withdraw | Positive and Negative Syndrome Scale - Passive/apathetic social withdrawal. | PANSS - Passive or Apathetic Social Withdrawal | ||
PANSS1-Poor Attention | C124771 | PANSS1-Poor Attention | Positive and Negative Syndrome Scale - Poor attention. | PANSS - Poor Attention | ||
PANSS1-Poor Impulse Control | C124774 | PANSS1-Poor Impulse Control | Positive and Negative Syndrome Scale - Poor impulse control. | PANSS - Poor Impulse Control | ||
PANSS1-Poor Rapport | C124756 | PANSS1-Poor Rapport | Positive and Negative Syndrome Scale - Poor rapport. | PANSS - Poor Rapport | ||
PANSS1-Preoccupation | C124775 | PANSS1-Preoccupation | Positive and Negative Syndrome Scale - Preoccupation. | PANSS - Preoccupation | ||
PANSS1-Somatic Concern | C124761 | PANSS1-Somatic Concern | Positive and Negative Syndrome Scale - Somatic concern. | PANSS - Somatic Concern | ||
PANSS1-Stereotyped Thinking | C124760 | PANSS1-Stereotyped Thinking | Positive and Negative Syndrome Scale - Stereotyped thinking. | PANSS - Stereotyped Thinking | ||
PANSS1-Suspiciousness/Persecution | C124752 | PANSS1-Suspiciousness/Persecution | Positive and Negative Syndrome Scale - Suspiciousness/persecution. | PANSS - Suspiciousness or Persecution | ||
PANSS1-Tension | C124764 | PANSS1-Tension | Positive and Negative Syndrome Scale - Tension. | PANSS - Tension | ||
PANSS1-Uncooperativeness | C124768 | PANSS1-Uncooperativeness | Positive and Negative Syndrome Scale - Uncooperativeness. | PANSS - Uncooperativeness | ||
PANSS1-Unusual Thought Content | C124769 | PANSS1-Unusual Thought Content | Positive and Negative Syndrome Scale - Unusual thought content. | PANSS - Unusual Thought Content | ||
Back to top | ||||||
CL.C102582.PRITBCON | Priority of Tuberculosis Contact
(PRITBCON) | text
Extensible: Yes | C102582 | Priority of Tuberculosis Contact | Terminology relevant to the prioritization of tuberculosis contacts. | CDISC SDTM Priority of Tuberculosis Contact Terminology |
HIGH-PRIORITY TUBERCULOSIS CONTACT | C102644 | An individual that has tested positive for pulmonary, laryngeal, or pleural tuberculosis and may or may not present with cavitary disease. | High-priority Tuberculosis Subject | |||
LOW-PRIORITY TUBERCULOSIS CONTACT | C102662 | An individual that has had limited exposure to an individual with tuberculosis and has a low probability of having had a recent infection. | Low-priority Tuberculosis Subject | |||
MEDIUM-PRIORITY TUBERCULOSIS CONTACT | C102665 | An individual that has tested negative for pulmonary, laryngeal, or pleural tuberculosis but has had a non-cavitary chest x-ray that is consistent with tuberculosis. | Medium-priority Tuberculosis Subject | |||
Back to top | ||||||
CL.C101858.PROCEDUR | Procedure
(PROCEDUR) | text
Extensible: Yes | C101858 | Procedure | A terminology codelist to describe any activity considered to be a therapeutic or diagnostic procedure. | CDISC SDTM Procedure Terminology |
3D CONFORMAL RADIATION THERAPY | C16035 | 3D CRT | A process by which a dose of radiation is automatically shaped to closely conform to the entire volume of the tumor, so that surrounding normal tissue is spared and treatment toxicity is decreased. (NCI) | 3-Dimensional Conformal Radiation Therapy | ||
ABLATION | C20985 | Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by surgery, chemical destruction, morbid process, or noxious substance. (NCI) | Ablation Therapy | |||
ABLATION, ACCESSORY PATHWAYS | C99907 | An invasive therapeutic procedure to destroy tissue in an accessory pathways in the atrioventricular conduction system that contributes to arrhythmia. | Ablation of Cardiac Accessory Pathway | |||
ABLATION, ATRIAL | C80432 | An invasive therapeutic procedure to destroy tissue in the cardiac atria that is the source of an arrhythmia. | Atrial Ablation | |||
ABLATION, AV NODE | C99908 | An invasive therapeutic procedure to destroy tissue in the AV-node that contributes to arrhythmia. | Ablation of Cardiac Atrioventricular Node | |||
ABLATION, CARDIAC | C100068 | Cardiac Ablation | An invasive therapeutic procedure to destroy tissue in the heart used to correct heart arrhythmias. | Cardiac Ablation | ||
ABLATION, CHEMICAL | C111157 | Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by chemical means. (NCI) | Chemical Ablation | |||
ABLATION, LASER | C111241 | Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by light amplification by stimulated emission of radiation. (NCI) | Laser Ablation | |||
ABLATION, VENTRICULAR | C80433 | An invasive therapeutic procedure to destroy tissue in the cardiac ventricles that is the source of an arrhythmia. | Ventricular Ablation | |||
AORTIC BALLOON VALVOTOMY | C99916 | Dilation of the valve between the left ventricle of the heart and the aorta by inflating a balloon. | Aortic Balloon Valvotomy | |||
AORTIC VALVE REPLACEMENT | C50815 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. aortic valve with a bioprosthetic, homograft, or autograft valve. | Aortic Valve Replacement | |||
ARTIFICIAL HEART IMPLANTATION | C172590 | Total Artificial Heart Implantation | Implantation of a prosthetic device into the body to replace the function of both cardiac ventricles and all four cardiac valves, typically as a bridge to transplantation. | Total Artificial Heart Implantation | ||
ATRIAL SEPTAL CLOSURE | C99939 | Repair of atrial septum. | Closure of Cardiac Atrial Septum | |||
BILEVEL POSITIVE AIRWAY PRESSURE VENTILATION | C124039 | BIPAP Ventilation;BPAP Ventilation | A type of non-invasive mechanical ventilation procedure that that uses bilevel positive airway pressure to support spontaneous breathing activity. | Biphasic Positive Airway Pressure | ||
BILOBECTOMY | C91828 | Right Lung Bilobectomy | Surgical removal of two lobes of the right lung. | Bilobectomy | ||
BIOPSY | C15189 | The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis. | Biopsy | |||
BIOPSY, CORE | C15680 | CNB;Core Needle Biopsy;Needle Biopsy | A type of biopsy in which a tissue sample is removed using a needle with a relatively large diameter. | Core Biopsy | ||
BIOPSY, EXCISIONAL | C15385 | A type of biopsy in which an entire lesion is removed for microscopic examination. | Excisional Biopsy | |||
BIOPSY, INCISIONAL | C15386 | A type of biopsy in which part of a lesion is removed for microscopic examination. | Incisional Biopsy | |||
BIOPSY, PUNCH | C28743 | A type of biopsy in which a disk of tissue is removed using a punch device. | Punch Biopsy | |||
BIVENTRICULAR DEFIBRILLATING CARDIAC PACEMAKER IMPLANTATION | C172595 | CRT-D Implantation | A surgical procedure in which a cardiac pacing device with a built-in cardioverter defibrillator is placed under the skin, with leads positioned in the right atrium and both ventricles. | Cardiac Resynchronization Therapy Defibrillator Implantation | ||
BLOOD ULTRAFILTRATION | C172593 | A mechanical fluid removal technique that involves the pressure-driven movement of plasma water and solutes from whole blood across a semipermeable membrane. | Blood Ultrafiltration | |||
BONE MARROW TRANSPLANT | C15194 | BMT | A therapeutic procedure to replace diseased or pathologic bone marrow with transplanted, healthy bone marrow cells. | Bone Marrow Transplantation | ||
BRACHYTHERAPY | C15195 | A type of radiation therapy in which radioactive material is placed inside the body, into a tumor or body cavity. | Brachytherapy | |||
BRACHYTHERAPY, INTERSTITIAL | C66891 | A type of brachytherapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into a tumor or body tissue. | Interstitial Radiation Therapy | |||
BRACHYTHERAPY, INTRACAVITARY | C28049 | A type of brachytherapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into a body cavity such as the chest cavity or the vagina. | Intracavitary Radiation Therapy | |||
CARDIAC ASSIST DEVICE | C170616 | Any of a number of implantable cardiac devices meant to aid the heart in carrying out its functions. | Cardiac Assist Device | |||
CARDIAC CATHETERIZATION | C38044 | A procedure in which a thin plastic tube (catheter) is inserted into an artery or vein in the arm or leg and then advanced into the chambers of the heart or into the coronary arteries. | Cardiac Catheterization | |||
CARDIAC RESYNCHRONIZATION THERAPY | C80436 | Biventricular Cardiac Pacemaker Procedure;CRT | An invasive procedure that includes an electronic device that stimulates both right and left cardiac ventricles to improve coordination of ventricular contraction. | Cardiac Resynchronization Therapy | ||
CARDIAC STENT PLACEMENT | C100080 | A procedure performed during a percutaneous coronary intervention in which a device is deployed into the lumen of a coronary artery to expand and support the vessel wall such that the vessel remains patent and blood flow is uninhibited. | Cardiac Stent Placement | |||
CARDIAC TRANSPLANT | C15246 | Heart Transplant | A surgical procedure in which a damaged heart is removed and replaced by another heart from a suitable donor. | Heart Transplantation | ||
CARDIOVERSION, CHEMICAL | C99937 | CHEMICAL CARDIOVERSION | The administration of pharmacologic agents to correct abnormal heart rhythm. | Chemical Cardioversion | ||
CARDIOVERSION, ELECTRICAL | C99948 | ELECTRICAL CARDIOVERSION | The administration of electric current to correct abnormal heart rhythm. | Electric Cardioversion | ||
CATARACT SURGERY | C157809 | A surgical procedure to remove the clouded lens from the eye, and oftentimes replace it with an artificial lens. | Cataract Surgery | |||
CHEMOTHERAPY | C15632 | The use of synthetic or naturally-occurring chemicals for the treatment of diseases. | Chemotherapy | |||
CHOLECYSTECTOMY | C51676 | Surgical removal of the gallbladder. | Cholecystectomy | |||
COLONOSCOPY | C16450 | Endoscopic examination of the luminal surface of the colon. | Colonoscopy | |||
CONTINUOUS POSITIVE AIRWAY PRESSURE VENTILATION | C124040 | CPAP Ventilation | A type of non-invasive mechanical ventilation procedure that uses continuous positive airway pressure to support spontaneous breathing activity. | Continuous Positive Airway Pressure | ||
CONTRAST ENHANCED ECG GATED MRI | C174358 | A type of ECG gated MRI in which the images are enhanced by the addition of contrast agents into the body. | Contrast Enhanced ECG Gated MRI | |||
CORONARY ARTERY BYPASS GRAFT | C51998 | Aortocoronary Bypass;CAB;CABG;Coronary Artery Bypass;Coronary Artery Bypass Graft;Coronary Artery Bypass Graft Surgery;Coronary Artery Bypass Grafting;Heart Bypass | A procedure performed to bypass partially or completely occluded coronary arteries with veins and/or arteries harvested from elsewhere in the body, thereby improving the blood supply to the coronary circulation supplying the myocardium (heart muscle). | Coronary Artery Bypass Surgery | ||
CRYOABLATION | C15215 | Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by freezing. (NCI) | Cryosurgery | |||
CRYOTHERAPY | C40030 | The therapeutic use of cold or refrigeration. | Cryotherapy | |||
CT SCAN | C17204 | CAT Scan;Computed Axial Tomography;Computed Tomography;Computerized Tomography;CT | An imaging technique for examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. | Computed Tomography | ||
CURETTAGE | C15216 | The removal of tissue with a curette (a spoon-shaped instrument with a sharp edge). | Curettage Procedure | |||
DIGITAL WIDE FIELD FUNDUS PHOTOGRAPHY | C166089 | A type of digital fundus photography that makes use of a significantly wider viewing angle than traditional fundus photography. | Digital Wide Field Fundus Photography | |||
ECG GATED MRI WITHOUT CONTRAST | C174359 | A type of ECG gated MRI in which the images are not enhanced by the addition of contrast agents into the body. | ECG Gated MRI Without Contrast | |||
ECG GATED MRI | C174231 | A type of magnetic resonance imaging in which data is acquired during a specified portion of the cardiac cycle, allowing for the collection of stop motion imaging of the heart. | ECG Gated MRI | |||
ELECTROCAUTERIZATION | C111192 | A procedure for destroying tissue using an electrical current. | Electrocauterization | |||
ENDARTERECTOMY | C52002 | Excision of an atheromatous plaque. (NCI) | Endarterectomy | |||
EXCISION | C15232 | The act of cutting out; the surgical removal of part or all of a structure or organ. (NCI) | Excision | |||
EXPLORATORY LAPAROTOMY | C51779 | Celiotomy | Creation of a surgical opening into the abdominal cavity for examination of the contents of the abdominal cavity as a means of diagnosis. | Exploratory Laparotomy | ||
EXTERNAL BEAM RADIATION THERAPY | C15751 | A type of radiation therapy in which high-energy beams are delivered to the tumor from outside of the body. | External Beam Radiation Therapy | |||
EXTRACORPOREAL CYTOKINE ADSORPTION HEMOFILTRATION | C187966 | The use of an adsorbing hemofilter in an external blood purification device to reduce cytokine levels in the blood. | Extracorporeal Cytokine Adsorption Hemofiltration | |||
EXTRACORPOREAL MEMBRANE OXYGENATION | C171507 | ECMO | A technique that utilizes a device to pump a patient's blood outside of the body, oxygenate it, and return it to the body. | Extracorporeal Membrane Oxygenation | ||
HEART VALVE PROCEDURE | C99546 | Heart Valve Surgery | Any surgical procedure performed for the purpose of repairing or replacing a degenerated, calcified, malformed, or dysfunctional heart valve. | Cardiac Valve Procedure | ||
HEMODIALYSIS | C15248 | A therapeutic procedure involving the extracorporeal removal of harmful waste and fluids from the blood using a dialysis machine. Following dialysis, the blood is returned to the body. | Hemodialysis | |||
HEMOFILTRATION | C172594 | A mechanical fluid removal technique that involves the pressure-driven movement of plasma water and solutes from whole blood through a system of extracorporeal filters, with simultaneous reinfusion of replacement fluid into the body to keep volume homeostasis. | Hemofiltration | |||
HIGH-DOSE RATE BRACHYTHERAPY | C15651 | A type of brachytherapy that targets a cancerous tissue with high doses of radiation through the use of inserted temporary implants. | High-Dose Rate Brachytherapy | |||
HIGH-FLOW NASAL CANNULA OXYGEN THERAPY | C171510 | HFNC Oxygen Therapy | The delivery of heated, humidified, oxygen-enriched gas via nasal cannula at flow rates greater than those typically delivered by standard-flow oxygen devices. | High-Flow Nasal Cannula Oxygen Therapy | ||
HOLTER CONTINUOUS ECG RECORDING | C38064 | An electrocardiographic method for collecting continuous ECG waveforms with a variable number of discrete leads with duration longer than the standard 10 second ECG. Holter recording may be performed in patients who are ambulatory, and may collect data for 24 hours or longer. | Holter Monitoring | |||
IMMUNOTHERAPY | C15262 | A therapy designed to induce changes in a patient's immune status. | Immunotherapy | |||
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | C80435 | Implantable Cardioverter Defibrillator Procedure | A procedure involving an electronic device implanted in the body that delivers electrical stimulation to the heart to treat tachycardia. It may also have the capability to treat bradycardia. | Implantable Cardioverter-Defibrillator Placement | ||
INFRARED PHOTO COAGULATION | C62730 | Infrared Coagulation | The use of an intense beam of light, such as a laser, to seal off blood vessels or destroy tissue. (NCI) | Infrared Photocoagulation Therapy | ||
INTENSITY-MODULATED RADIATION THERAPY | C16135 | An advanced form of 3-Dimensional Conformal Radiation Therapy (3D CRT) that involves the use of varying intensities of small radiation beams to produce dosage distributions that are more precise than those possible with 3D CRT. (NCI) | Intensity-Modulated Radiation Therapy | |||
INTRA-AORTIC BALLOON PUMP THERAPY | C172591 | A type of mechanical circulatory support procedure in which a balloon catheter inserted into the proximal descending aorta is inflated immediately after aortic valve closure in diastole and deflated just before aortic valve opening in systole, with the augmentation of coronary blood flow during diastole increasing coronary blood flow and systemic perfusion. | Intra-aortic Balloon Pump Counterpulsation | |||
LEAD | C99934 | Lead Procedure | A procedure involving one or more wires used for pacemaker or implantable defibrillator devices. | Cardiac Lead Procedure | ||
LEFT ATRIAL APPENDAGE OCCLUSION | C99965 | The therapeutic blockage of the muscular pouch in the left atrium. | Intentional Left Cardiac Atrial Appendage Occlusion Procedure | |||
LEFT COLECTOMY | C51624 | Surgical removal of the left portion of the colon. | Left Colectomy | |||
LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION | C172327 | LVAD Implantation;LVAD Insertion | A procedure involving the implantation of a mechanical cardiac pump which receives blood from the left ventricle and delivers it to the aorta. (NCI) | Left Ventricular Assist Device Insertion | ||
LEFT VENTRICULAR SYSTOLIC DYSFUNCTION EVALUATION | C99975 | An examination and assessment of the inability of the left ventricle to effectively pump blood to the body. | Left Cardiac Ventricular Systolic Dysfunction Evaluation | |||
LOBECTOMY | C15272 | Surgical removal of a lobe of an organ. | Lobectomy | |||
LOCAL IMMUNOTHERAPY | C156582 | Any immunotherapy that targets, or is restricted to, a specific anatomical location. | Local Immunotherapy Procedure | |||
LOW ANTERIOR RESECTION | C113716 | LAR;Lower Anterior Rectal Resection | Resection of the rectum through an incision in the lower abdomen. | Low Anterior Resection | ||
LOW-DOSE RATE BRACHYTHERAPY | C85254 | A type of brachytherapy that targets a cancerous tissue with low doses of radiation through the use of inserted temporary or permanent implants. | Low-Dose Rate Brachytherapy | |||
LUMPECTOMY | C15755 | Surgical removal of a discrete mass. | Lumpectomy | |||
LYMPHADENECTOMY | C15275 | Lymph Node Dissection;Lymph Node Excision | Surgical removal of the lymph node(s). | Lymphadenectomy | ||
MECHANICAL VENTILATION | C70909 | A procedure that mechanically assists or replaces spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs. | Mechanical Ventilation | |||
METASTASECTOMY | C94461 | Surgical removal of metastases. | Metastasectomy | |||
MICROWAVE THERAPY | C93351 | Microwave Thermotherapy | Any therapeutic procedure in which microwave irradiation is used for the purpose of heating and destroying targeted tissue. | Microwave Thermotherapy | ||
MITRAL BALLOON VALVOTOMY | C99987 | Dilation of the valve between the left atrium and the left ventricle of the heart by inflating a balloon. | Mitral Balloon Valvotomy | |||
MITRAL COMMISSUROTOMY | C99988 | Dilation of the valve between the left atrium and the left ventricle of the heart by use of a surgeon's finger or rigid instrument. | Mitral Commissurotomy | |||
MITRAL VALVE REPAIR | C80449 | Surgery performed for the purpose of reducing regurgitation of the mitral valve. | Mitral Valve Repair | |||
MITRAL VALVE REPLACEMENT | C50825 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. mitral valve with bioprosthetic, homograft or autograft valve. | Mitral Valve Replacement | |||
MODIFIED RADICAL MASTECTOMY | C15278 | Surgical removal of one or both breasts, including the areola, nipple, and the majority of the axillary lymph nodes, but sparing the pectoralis major muscle. | Modified Radical Mastectomy | |||
MOHS SURGERY | C28208 | A dermatologic procedure used to treat certain forms of skin cancer in which tissue is removed and immediately tested via frozen section; tissue continues to be removed until clear margins are achieved. | Mohs Surgery | |||
MRI | C16809 | Magnetic Resonance Imaging | Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders. | Magnetic Resonance Imaging | ||
MUGA | C38073 | Gated Heart Pool Scan;Radionuclide Ventriculogram Scan | A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles. | Multigated Acquisition Scan | ||
NON-CARDIOVASCULAR SURGERY | C99995 | An operative procedure that does not involve the heart or the blood vessels. | Non-Cardiovascular Surgery | |||
NON-INVASIVE MECHANICAL VENTILATION | C171457 | NIV;Non-Invasive Ventilation | A type of mechanical ventilation procedure that uses a non-invasive means, such as a face mask or nasal mask, to deliver oxygenated air into the lungs. | Non-Invasive Mechanical Ventilation | ||
PACEMAKER | C99998 | Pacemaker Procedure | A procedure involving an electronic device that delivers electrical stimulation to the heart to treat bradycardia. | Pacemaker Procedure | ||
PANCREATIC STENT PLACEMENT | C179785 | Placement of a stent within the pancreas. | Pancreatic Stent Placement | |||
PANCREATICODUODENECTOMY | C15356 | Kausch-Whipple Procedure;Pancreatoduodenectomy;Whipple Procedure | Surgical removal of the head of the pancreas, the first part of the small intestine (duodenum), the gallbladder and the bile duct. (Mayo Clinic) | Whipple Procedure | ||
PAP SMEAR | C17348 | A biospecimen collection and staining procedure in which secretions and superficial cells of the cervix are collected and stained with the Papanicolaou stain followed by microscopic examination to identify the presence of abnormal cells. | Pap Smear | |||
PARTIAL PANCREATECTOMY | C51666 | Surgical removal of part of the pancreas. | Partial Pancreatectomy | |||
PERCUTANEOUS CORONARY INTERVENTION | C99521 | PCI | A percutaneous coronary intervention (PCI) is the placement of an angioplasty guide wire, balloon, or other device (e.g. stent, atherectomy, brachytherapy, or thrombectomy catheter) into a native coronary artery or coronary artery bypass graft for the purpose of mechanical coronary revascularization. Examples of things not considered to be PCI procedures include intravascular ultrasound, measurements of coronary flow reserve, or measurements of fractional flow reserve. | Percutaneous Coronary Intervention | ||
PERCUTANEOUS MITRAL REPAIR | C100003 | Invasive procedure through a puncture in the skin, performed for the purpose of reducing regurgitation of the mitral valve. | Percutaneous Mitral Valve Repair | |||
PERCUTANEOUS VENTRICULAR ASSIST DEVICE PLACEMENT | C172592 | PVAD Insertion;PVAD Placement | A minimally invasive procedure in which a catheter is inserted into the femoral artery or vein in order to temporarily connect a mechanical circulatory support device that is worn outside the body to the circulatory system. | Percutaneous Ventricular Assist Device Placement | ||
PERICARDIAL STRIPPING | C100004 | Removal or resection of the pericardium. | Pericardial Stripping | |||
PERICARDIAL WINDOW | C51618 | A procedure in which an opening is made in the pericardium. | Pericardial Window Procedure | |||
PERICARDIOCENTESIS | C52010 | The aspiration of excess fluid between the pericardium and the heart. | Pericardiocentesis | |||
PERIPHERAL BLOOD STEM CELL TRANSPLANT | C15430 | A therapeutic procedure that involves the transplantation of stem cells harvested from the circulating blood of a patient or donor. | Peripheral Blood Stem Cell Transplantation | |||
PERIPHERAL VASCULAR INTERVENTION | C116150 | PVI | A peripheral vascular intervention is a catheter-based or open surgical procedure designed to improve arterial or venous blood flow or otherwise modify or revise vascular conduits. In general, the intention to perform percutaneous vascular intervention is denoted by the insertion of a guide wire into an artery or vein. For the sake of simplicity, this definition applies to the extracranial carotid artery and other non-cardiac arteries and veins, while it excludes the lymphatics and intracranial vessels. | Peripheral Vascular Intervention | ||
PHOTODYNAMIC THERAPY | C15300 | PDT | Use of light and photosensitizing agents to treat cancer and other conditions. | Photodynamic Therapy | ||
PHOTOTHERAPY | C15301 | The treatment of a disorder by exposure to light, including ultraviolet and infrared radiation. (Bartleby.com) | Phototherapy | |||
PHYSICAL EXAMINATION | C20989 | Physical Exam | A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. | Physical Examination | ||
PLEURECTOMY | C51651 | The surgical removal of all or part of the pleura. (NCI) | Pleurectomy | |||
PLEURODESIS | C66899 | A therapeutic surgical procedure in which the pleural space is surgically eliminated by the adherence of the visceral and parietal pleurae. (NCI) | Pleurodesis | |||
POLYPECTOMY | C25349 | Surgical removal of a polypoid lesion from the mucosal surface. | Polypectomy | |||
POSITIVE AIRWAY PRESSURE VENTILATION | C157960 | PAP Therapy | Any type of non-invasive mechanical ventilation procedure that uses positive airway pressure to support spontaneous breathing activity. | Positive Airway Pressure Therapies | ||
PULMONARY VALVE REPLACEMENT | C50817 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. pulmonary valve with bioprosthetic, homograft or autograft valve. | Pulmonary Valve Replacement | |||
PULMONIC VALVULOPLASTY | C100044 | Dilation of the valve between the right ventricle and the pulmonary artery of the heart by inflating a balloon. | Pulmonic Valvuloplasty | |||
RADICAL MASTECTOMY | C15279 | Surgical removal of one or both breasts, including the areola, nipple, axillary lymph nodes, and pectoral muscles. | Radical Mastectomy | |||
RADIOTHERAPY | C15313 | Radiation Therapy;Radiotherapy | Use of targeted or whole body radiation to treat a disease. | Radiation Therapy | ||
RE-EXCISION | C48600 | Surgical removal of a structure or organ, which was not completely removed in an earlier attempt. | Re-Excision | |||
RECONSTRUCTIVE SURGERY | C25351 | Surgical restoration of form and/or function of a body part. | Reconstructive Surgery | |||
RENAL REPLACEMENT THERAPY | C126400 | RRT | Any of the procedures used to supplement or substitute for the blood-filtering function of the kidneys. | Renal Replacement Therapy | ||
RIGHT COLECTOMY | C51623 | Surgical removal of the right portion of the colon. | Right Colectomy | |||
RIGHT VENTRICULAR ASSIST DEVICE IMPLANTATION | C172927 | RVAD Implantation;RVAD Insertion | A procedure involving the implantation of a mechanical pump which receives blood from the right ventricle and delivers it to the pulmonary artery. | Right Ventricular Assist Device Insertion | ||
SEGMENTECTOMY | C91061 | Segmental Resection | Surgical removal of a segment of an organ or partial resection of a gland. | Segmentectomy | ||
SENTINEL LYMPH NODE BIOPSY | C15667 | Surgical removal and examination of the lymph node which is first in receiving the lymphatic drainage of a specified anatomic location. | Sentinel Lymph Node Biopsy | |||
SEPTAL ABLATION | C80439 | A cardiac catheterization procedure to relieve symptoms in patients with severe obstructive hypertrophic cardiomyopathy. A catheter is used to inject alcohol into a septal artery supplying the heart muscle responsible for the obstruction, destroying the muscle tissue and relieving the obstruction. | Septal Ablation | |||
SHAVE EXCISION | C51885 | Surgical removal of thin slices of tissue from a structure or organ, done with a razor blade or scalpel. | Shave Excision | |||
SIGMOIDECTOMY | C91838 | Surgical removal of the sigmoid colon. | Sigmoidectomy | |||
SPECT/CT SCAN | C154791 | A dual-modality imaging technique that merges data from single-photon emission computed tomography (SPECT) and computed tomography (CT) to provide structural and functional information. | Single Photon Tomography and Computed Tomography Scan | |||
SUCTION BLISTER TECHNIQUE | C179786 | Suction Blistering | The creation of an artificially induced skin blister by the application of mechanical pressure to an area of skin, causing in vivo separation of the epidermis and dermis. | Suction Blister Technique | ||
SURGICAL MAZE | C100017 | Cox Maze | A cardiac procedure intended to inhibit atrial fibrillation, in which a series of incisions are made in the atria to block abnormal electrical circuits that contribute to atrial fibrillation. | Surgical Maze Procedure | ||
THORACENTESIS | C15392 | The removal of excess fluid via needle puncture from the thoracic cavity. | Thoracentesis | |||
THORACOSCOPIC WEDGE RESECTION | C154873 | TWR | A minimally invasive surgical procedure in which video-assisted thoracoscopy is used to remove of a wedge-shaped portion of tissue from a lung lobe. | Thorascopic Wedge Resection of the Lung | ||
TOTAL COLECTOMY | C51924 | Surgical removal of the entire colon. | Total Colectomy | |||
TOTAL PANCREATECTOMY | C15340 | Surgical removal of the entire pancreas. | Total Pancreatectomy | |||
TRACHEOSTOMY | C15341 | Tracheotomy | Creation of a surgical opening into the trachea. | Tracheotomy | ||
TRANSCATHETER AORTIC VALVE IMPLANT | C100022 | Transcatheter Aortic Valve Implantation | Use of a thin tube to deliver an artificial valve apparatus between the left ventricle of the heart and the aorta. | Transcatheter Aortic Valve Implantation | ||
TRANSTHORACIC ECHOCARDIOGRAPHY | C80404 | TTE | A non-invasive cardiac ultrasound performed by placing the transducer on the chest. | Transthoracic Echocardiography | ||
TRANSURETHRAL RESECTION OF BLADDER TUMOR | C116651 | TURBT | A surgical procedure in which a resectoscope is passed through the urethra into the bladder to diagnose and remove all or part of a bladder tumor. | Transurethral Resection of Bladder Tumor | ||
TRANSVERSE COLECTOMY | C51612 | Surgical removal of the transverse colon. | Transverse Colectomy | |||
TRICUSPID VALVE REPAIR | C99935 | Surgery performed for the purpose of reducing regurgitation of the cardiac valve between the right atrium and right ventricle. | Cardiac Tricuspid Valve Repair | |||
TRICUSPID VALVE REPLACEMENT | C50816 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. tricuspid valve with bioprosthetic, homograft or autograft valve. | Tricuspid Valve Replacement | |||
UMBILICAL CORD BLOOD TRANSPLANT | C15640 | A therapeutic procedure that involves the transplantation of hematopoietic stem cells collected from the umbilical cord or placenta. | Umbilical Cord Blood Transplantation | |||
VENTRICULAR ANEURYSM RESECTION | C80451 | Cardiac surgical procedure performed for the removal of an aneurysm from the ventricular wall. | Ventricular Aneurysm Resection | |||
VENTRICULAR SEPTAL CLOSURE | C99940 | Repair of ventricular septum. | Closure of Cardiac Ventricle Septum | |||
X-RAY | C38101 | Static X-Ray | A radiographic procedure using the emission of x-rays, a type of penetrating energy wave. | X-Ray Imaging | ||
Back to top | ||||||
CL.C101856.PRURGNCY | Procedure Urgency Status
(PRURGNCY) | text
Extensible: No | C101856 | Procedure Urgency Status | A terminology codelist that describes the degree of urgency for a procedure. | CDISC SDTM Procedure Urgency Status Terminology |
ELECTIVE | C51996 | Elective procedures can be deferred without increased risk of compromised outcome. Patient's clinical condition is currently stable and has been stable in the days/weeks prior. The clinical situation does not demand that the procedure take place at a specified time. | Elective Surgical Procedure | |||
EMERGENCY | C62648 | Emergency procedures must be performed as soon as possible because of substantial concerns that delay could lead to death. Clinical situation demands that procedure should be performed immediately or in next available room, even if it means another case must be rescheduled. | Emergency | |||
SALVAGE | C15359 | Performing a salvage procedure is the last resort. The clinical situation involves either ongoing life support measures, life support measures for more than 60 seconds during the prior 10 minutes, or unanticipated institution of extracorporeal circulatory support. | Salvage Therapy | |||
URGENT | C100031 | Deferring an urgent procedure increases risk of adverse outcome or clinical deterioration. Clinical situation warrants performing urgent procedures during the current episode of care to avoid compromising patient safety. | Urgent Procedure | |||
Back to top | ||||||
CL.C114118.PROTMLST | Protocol Milestone
(PROTMLST) | text
Extensible: Yes | C114118 | Protocol Milestone | A terminology codelist relevant to protocol-specified, point-in-time events during a study. | CDISC SDTM Protocol Milestone Terminology |
DECLINED TO CONTINUE INTO NEXT TRIAL ELEMENT | C186210 | An indication that the subject has declined to continue into a subsequent trial Element. | Declined to Continue Into Next Trial Element | |||
DECLINED TO CONTINUE INTO SURVIVAL FOLLOW-UP | C176358 | An indication that the subject has declined to continue into the survival follow-up phase of the trial. | Declined To Continue Into Survival Follow-Up | |||
ELIGIBILITY CRITERIA MET | C132447 | The subject has fulfilled the criteria needed to enter or continue in the study. | Eligibility Criteria Met By Subject | |||
ENTERED INTO TRIAL | C161417 | The subject has met eligibility criteria and is enrolled in the study. The subject may or may not subsequently be randomized. | Subject Entered Into Trial | |||
INFORMED ASSENT OBTAINED | C161418 | Informed Assent | Assent given by a minor or adult who is unable to give informed consent on their own behalf, to participate in a clinical trial. Assent must be accompanied by consent from a parent or legal guardian for full participation in the study. | Informed Assent | ||
INFORMED CONSENT OBTAINED | C16735 | Consent given by a subject, or in the case of an individual that can only give assent, by a parent or legal guardian, for the participation in a clinical study only after having achieved an understanding of both the relevant medical facts and the relevant risks involved. | Informed Consent | |||
OPTED TO CONTINUE INTO NEXT TRIAL ELEMENT | C186211 | An indication that the subject has opted to continue into a subsequent trial Element. | Opted to Continue Into Next Trial Element | |||
OPTED TO CONTINUE INTO SURVIVAL FOLLOW-UP | C176357 | An indication that the subject has opted to continue into the survival follow-up phase of the trial. | Opted To Continue Into Survival Follow-Up | |||
RANDOMIZED | C114209 | Participants are assigned to arms of a clinical trial by chance. | Subject is Randomized | |||
RE-RANDOMIZED | C186212 | Participants are re-assigned by chance to arms of a clinical trial. | Re-randomized | |||
Back to top | ||||||
CL.C190938.PASI05TC | Psoriasis Area and Severity Index Version Bozek Clinical Classification Test Code
(PASI05TC) | text
Extensible: No | C190938 | Psoriasis Area and Severity Index Version Bozek Clinical Classification Test Code | Psoriasis Area and Severity Index Version Bozek test code. | CDISC Clinical Classification Psoriasis Area and Severity Index Bozek Version Test Code Terminology |
PASI0501 | C191124 | PASI05-Head: Erythema/Redness | Psoriasis Area and Severity Index Version Bozek - Head: Erythema/Redness symptom score. | PASI Bozek Version - Head: Erythema/Redness | ||
PASI0502 | C191125 | PASI05-Head: Thickness/Induration | Psoriasis Area and Severity Index Version Bozek - Head: Thickness/Induration symptom score. | PASI Bozek Version - Head: Thickness/Induration | ||
PASI0503 | C191126 | PASI05-Head: Desquamation/Scaling | Psoriasis Area and Severity Index Version Bozek - Head: Desquamation/Scaling symptom score. | PASI Bozek Version - Head: Desquamation/Scaling | ||
PASI0504 | C191127 | PASI05-Head: Area Score | Psoriasis Area and Severity Index Version Bozek - Head: Area score. | PASI Bozek Version - Head: Area Score | ||
PASI0505 | C191128 | PASI05-Up Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Erythema/Redness symptom score. | PASI Bozek Version - Upper Extremities: Erythema/Redness | ||
PASI0506 | C191129 | PASI05-Up Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Thickness/Induration symptom score. | PASI Bozek Version - Upper Extremities: Thickness/Induration | ||
PASI0507 | C191130 | PASI05-Up Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Desquamation/Scaling symptom score. | PASI Bozek Version - Upper Extremities: Desquamation/Scaling | ||
PASI0508 | C191131 | PASI05-Up Extrem: Area Score | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Area score. | PASI Bozek Version - Upper Extremities: Area Score | ||
PASI0509 | C191132 | PASI05-Trunk: Erythema/Redness | Psoriasis Area and Severity Index Version Bozek - Trunk: Erythema/Redness symptom score. | PASI Bozek Version - Trunk: Erythema/Redness | ||
PASI0510 | C191133 | PASI05-Trunk: Thickness/Induration | Psoriasis Area and Severity Index Version Bozek - Trunk: Thickness/Induration symptom score. | PASI Bozek Version - Trunk: Thickness/Induration | ||
PASI0511 | C191134 | PASI05-Trunk: Desquamation/Scaling | Psoriasis Area and Severity Index Version Bozek - Trunk: Desquamation/Scaling symptom score. | PASI Bozek Version - Trunk: Desquamation/Scaling | ||
PASI0512 | C191135 | PASI05-Trunk: Area Score | Psoriasis Area and Severity Index Version Bozek - Trunk: Area score. | PASI Bozek Version - Trunk: Area Score | ||
PASI0513 | C191136 | PASI05-Low Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Erythema/Redness symptom score. | PASI Bozek Version - Lower Extremities: Erythema/Redness | ||
PASI0514 | C191137 | PASI05-Low Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Thickness/Induration symptom score. | PASI Bozek Version - Lower Extremities: Thickness/Induration | ||
PASI0515 | C191138 | PASI05-Low Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Desquamation/Scaling symptom score. | PASI Bozek Version - Lower Extremities: Desquamation/Scaling | ||
PASI0516 | C191139 | PASI05-Low Extrem: Area Score | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Area score. | PASI Bozek Version - Lower Extremities: Area Score | ||
PASI0517 | C191140 | PASI05-Head: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Bozek - Head: Sum of symptom scores. | PASI Bozek Version - Head: Sum of Symptom Scores | ||
PASI0518 | C191141 | PASI05-Head: Sum X Area | Psoriasis Area and Severity Index Version Bozek - Head: Sum of symptom scores x area score. | PASI Bozek Version - Head: Sum X Area | ||
PASI0519 | C191142 | PASI05-Head: Sum X Area X 0.1 | Psoriasis Area and Severity Index Version Bozek - Head: Sum x area x 0.1. | PASI Bozek Version - Head: Sum X Area X 0.1 | ||
PASI0520 | C191143 | PASI05-Up Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum of symptom scores. | PASI Bozek Version - Upper Extremities: Sum of Symptom Scores | ||
PASI0521 | C191144 | PASI05-Up Extrem: Sum X Area | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum of symptom scores x area score. | PASI Bozek Version - Upper Extremities: Sum X Area | ||
PASI0522 | C191145 | PASI05-Up Extrem: Sum X Area X 0.2 | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum x area x 0.2. | PASI Bozek Version - Upper Extremities: Sum X Area X 0.2 | ||
PASI0523 | C191146 | PASI05-Trunk: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Bozek - Trunk: Sum of symptom scores. | PASI Bozek Version - Trunk: Sum of Symptom Scores | ||
PASI0524 | C191147 | PASI05-Trunk: Sum X Area | Psoriasis Area and Severity Index Version Bozek - Trunk: Sum of symptom scores x area score. | PASI Bozek Version - Trunk: Sum X Area | ||
PASI0525 | C191148 | PASI05-Trunk: Sum X Area X 0.3 | Psoriasis Area and Severity Index Version Bozek - Trunk: Sum x area x 0.3. | PASI Bozek Version - Trunk: Sum X Area X 0.3 | ||
PASI0526 | C191149 | PASI05-Low Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum of symptom scores. | PASI Bozek Version - Lower Extremities: Sum of Symptom Scores | ||
PASI0527 | C191150 | PASI05-Low Extrem: Sum X Area | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum of symptom scores x area score. | PASI Bozek Version - Lower Extremities: Sum X Area | ||
PASI0528 | C191151 | PASI05-Low Extrem: Sum X Area X 0.4 | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum x area x 0.4. | PASI Bozek Version - Lower Extremities: Sum X Area X 0.4 | ||
PASI0529 | C191152 | PASI05-Total Sum | Psoriasis Area and Severity Index Version Bozek - Total sum. | PASI Bozek Version - Total Sum | ||
Back to top | ||||||
CL.C190937.PASI05TN | Psoriasis Area and Severity Index Version Bozek Clinical Classification Test Name
(PASI05TN) | text
Extensible: No | C190937 | Psoriasis Area and Severity Index Version Bozek Clinical Classification Test Name | Psoriasis Area and Severity Index Version Bozek test name. | CDISC Clinical Classification Psoriasis Area and Severity Index Bozek Version Test Name Terminology |
PASI05-Head: Area Score | C191127 | PASI05-Head: Area Score | Psoriasis Area and Severity Index Version Bozek - Head: Area score. | PASI Bozek Version - Head: Area Score | ||
PASI05-Head: Desquamation/Scaling | C191126 | PASI05-Head: Desquamation/Scaling | Psoriasis Area and Severity Index Version Bozek - Head: Desquamation/Scaling symptom score. | PASI Bozek Version - Head: Desquamation/Scaling | ||
PASI05-Head: Erythema/Redness | C191124 | PASI05-Head: Erythema/Redness | Psoriasis Area and Severity Index Version Bozek - Head: Erythema/Redness symptom score. | PASI Bozek Version - Head: Erythema/Redness | ||
PASI05-Head: Sum of Symptom Scores | C191140 | PASI05-Head: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Bozek - Head: Sum of symptom scores. | PASI Bozek Version - Head: Sum of Symptom Scores | ||
PASI05-Head: Sum X Area X 0.1 | C191142 | PASI05-Head: Sum X Area X 0.1 | Psoriasis Area and Severity Index Version Bozek - Head: Sum x area x 0.1. | PASI Bozek Version - Head: Sum X Area X 0.1 | ||
PASI05-Head: Sum X Area | C191141 | PASI05-Head: Sum X Area | Psoriasis Area and Severity Index Version Bozek - Head: Sum of symptom scores x area score. | PASI Bozek Version - Head: Sum X Area | ||
PASI05-Head: Thickness/Induration | C191125 | PASI05-Head: Thickness/Induration | Psoriasis Area and Severity Index Version Bozek - Head: Thickness/Induration symptom score. | PASI Bozek Version - Head: Thickness/Induration | ||
PASI05-Low Extrem: Area Score | C191139 | PASI05-Low Extrem: Area Score | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Area score. | PASI Bozek Version - Lower Extremities: Area Score | ||
PASI05-Low Extrem: Desquamation/Scaling | C191138 | PASI05-Low Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Desquamation/Scaling symptom score. | PASI Bozek Version - Lower Extremities: Desquamation/Scaling | ||
PASI05-Low Extrem: Erythema/Redness | C191136 | PASI05-Low Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Erythema/Redness symptom score. | PASI Bozek Version - Lower Extremities: Erythema/Redness | ||
PASI05-Low Extrem: Sum of Symptom Scores | C191149 | PASI05-Low Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum of symptom scores. | PASI Bozek Version - Lower Extremities: Sum of Symptom Scores | ||
PASI05-Low Extrem: Sum X Area X 0.4 | C191151 | PASI05-Low Extrem: Sum X Area X 0.4 | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum x area x 0.4. | PASI Bozek Version - Lower Extremities: Sum X Area X 0.4 | ||
PASI05-Low Extrem: Sum X Area | C191150 | PASI05-Low Extrem: Sum X Area | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Sum of symptom scores x area score. | PASI Bozek Version - Lower Extremities: Sum X Area | ||
PASI05-Low Extrem: Thickness/Induration | C191137 | PASI05-Low Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Bozek - Lower Extremities: Thickness/Induration symptom score. | PASI Bozek Version - Lower Extremities: Thickness/Induration | ||
PASI05-Total Sum | C191152 | PASI05-Total Sum | Psoriasis Area and Severity Index Version Bozek - Total sum. | PASI Bozek Version - Total Sum | ||
PASI05-Trunk: Area Score | C191135 | PASI05-Trunk: Area Score | Psoriasis Area and Severity Index Version Bozek - Trunk: Area score. | PASI Bozek Version - Trunk: Area Score | ||
PASI05-Trunk: Desquamation/Scaling | C191134 | PASI05-Trunk: Desquamation/Scaling | Psoriasis Area and Severity Index Version Bozek - Trunk: Desquamation/Scaling symptom score. | PASI Bozek Version - Trunk: Desquamation/Scaling | ||
PASI05-Trunk: Erythema/Redness | C191132 | PASI05-Trunk: Erythema/Redness | Psoriasis Area and Severity Index Version Bozek - Trunk: Erythema/Redness symptom score. | PASI Bozek Version - Trunk: Erythema/Redness | ||
PASI05-Trunk: Sum of Symptom Scores | C191146 | PASI05-Trunk: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Bozek - Trunk: Sum of symptom scores. | PASI Bozek Version - Trunk: Sum of Symptom Scores | ||
PASI05-Trunk: Sum X Area X 0.3 | C191148 | PASI05-Trunk: Sum X Area X 0.3 | Psoriasis Area and Severity Index Version Bozek - Trunk: Sum x area x 0.3. | PASI Bozek Version - Trunk: Sum X Area X 0.3 | ||
PASI05-Trunk: Sum X Area | C191147 | PASI05-Trunk: Sum X Area | Psoriasis Area and Severity Index Version Bozek - Trunk: Sum of symptom scores x area score. | PASI Bozek Version - Trunk: Sum X Area | ||
PASI05-Trunk: Thickness/Induration | C191133 | PASI05-Trunk: Thickness/Induration | Psoriasis Area and Severity Index Version Bozek - Trunk: Thickness/Induration symptom score. | PASI Bozek Version - Trunk: Thickness/Induration | ||
PASI05-Up Extrem: Area Score | C191131 | PASI05-Up Extrem: Area Score | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Area score. | PASI Bozek Version - Upper Extremities: Area Score | ||
PASI05-Up Extrem: Desquamation/Scaling | C191130 | PASI05-Up Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Desquamation/Scaling symptom score. | PASI Bozek Version - Upper Extremities: Desquamation/Scaling | ||
PASI05-Up Extrem: Erythema/Redness | C191128 | PASI05-Up Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Erythema/Redness symptom score. | PASI Bozek Version - Upper Extremities: Erythema/Redness | ||
PASI05-Up Extrem: Sum of Symptom Scores | C191143 | PASI05-Up Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum of symptom scores. | PASI Bozek Version - Upper Extremities: Sum of Symptom Scores | ||
PASI05-Up Extrem: Sum X Area X 0.2 | C191145 | PASI05-Up Extrem: Sum X Area X 0.2 | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum x area x 0.2. | PASI Bozek Version - Upper Extremities: Sum X Area X 0.2 | ||
PASI05-Up Extrem: Sum X Area | C191144 | PASI05-Up Extrem: Sum X Area | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Sum of symptom scores x area score. | PASI Bozek Version - Upper Extremities: Sum X Area | ||
PASI05-Up Extrem: Thickness/Induration | C191129 | PASI05-Up Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Bozek - Upper Extremities: Thickness/Induration symptom score. | PASI Bozek Version - Upper Extremities: Thickness/Induration | ||
Back to top | ||||||
CL.C190936.PASI04TC | Psoriasis Area and Severity Index Version EMA Clinical Classification Test Code
(PASI04TC) | text
Extensible: No | C190936 | Psoriasis Area and Severity Index Version EMA Clinical Classification Test Code | Psoriasis Area and Severity Index Version EMA test code. | CDISC Clinical Classification Psoriasis Area and Severity Index European Medical Agency Version Test Code Terminology |
PASI0401 | C191095 | PASI04-Head: Erythema/Redness | Psoriasis Area and Severity Index Version EMA - Head: Erythema/Redness symptom score. | PASI EMA Version - Head: Erythema/Redness | ||
PASI0402 | C191096 | PASI04-Head: Thickness/Induration | Psoriasis Area and Severity Index Version EMA - Head: Thickness/Induration symptom score. | PASI EMA Version - Head: Thickness/Induration | ||
PASI0403 | C191097 | PASI04-Head: Desquamation/Scaling | Psoriasis Area and Severity Index Version EMA - Head: Desquamation/Scaling symptom score. | PASI EMA Version - Head: Desquamation/Scaling | ||
PASI0404 | C191098 | PASI04-Head: Area Score | Psoriasis Area and Severity Index Version EMA - Head: Area score. | PASI EMA Version - Head: Area Score | ||
PASI0405 | C191099 | PASI04-Up Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Erythema/Redness symptom score. | PASI EMA Version - Upper Extremities: Erythema/Redness | ||
PASI0406 | C191100 | PASI04-Up Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Thickness/Induration symptom score. | PASI EMA Version - Upper Extremities: Thickness/Induration | ||
PASI0407 | C191101 | PASI04-Up Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Desquamation/Scaling symptom score. | PASI EMA Version - Upper Extremities: Desquamation/Scaling | ||
PASI0408 | C191102 | PASI04-Up Extrem: Area Score | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Area score. | PASI EMA Version - Upper Extremities: Area Score | ||
PASI0409 | C191103 | PASI04-Trunk: Erythema/Redness | Psoriasis Area and Severity Index Version EMA - Trunk: Erythema/Redness symptom score. | PASI EMA Version - Trunk: Erythema/Redness | ||
PASI0410 | C191104 | PASI04-Trunk: Thickness/Induration | Psoriasis Area and Severity Index Version EMA - Trunk: Thickness/Induration symptom score. | PASI EMA Version - Trunk: Thickness/Induration | ||
PASI0411 | C191105 | PASI04-Trunk: Desquamation/Scaling | Psoriasis Area and Severity Index Version EMA - Trunk: Desquamation/Scaling symptom score. | PASI EMA Version - Trunk: Desquamation/Scaling | ||
PASI0412 | C191106 | PASI04-Trunk: Area Score | Psoriasis Area and Severity Index Version EMA - Trunk: Area score. | PASI EMA Version - Trunk: Area Score | ||
PASI0413 | C191107 | PASI04-Low Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Erythema/Redness symptom score. | PASI EMA Version - Lower Extremities: Erythema/Redness | ||
PASI0414 | C191108 | PASI04-Low Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Thickness/Induration symptom score. | PASI EMA Version - Lower Extremities: Thickness/Induration | ||
PASI0415 | C191109 | PASI04-Low Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Desquamation/Scaling symptom score. | PASI EMA Version - Lower Extremities: Desquamation/Scaling | ||
PASI0416 | C191110 | PASI04-Low Extrem: Area Score | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Area score. | PASI EMA Version - Lower Extremities: Area Score | ||
PASI0417 | C191111 | PASI04-Head: Sum of Symptom Scores | Psoriasis Area and Severity Index Version EMA - Head: Sum of symptom scores. | PASI EMA Version - Head: Sum of Symptom Scores | ||
PASI0418 | C191112 | PASI04-Head: Sum X Area | Psoriasis Area and Severity Index Version EMA - Head: Sum of symptom scores x area score. | PASI EMA Version - Head: Sum X Area | ||
PASI0419 | C191113 | PASI04-Head: Sum X Area X 0.1 | Psoriasis Area and Severity Index Version EMA - Head: Sum x area x 0.1. | PASI EMA Version - Head: Sum X Area X 0.1 | ||
PASI0420 | C191114 | PASI04-Up Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum of symptom scores. | PASI EMA Version - Upper Extremities: Sum of Symptom Scores | ||
PASI0421 | C191115 | PASI04-Up Extrem: Sum X Area | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum of symptom scores x area score. | PASI EMA Version - Upper Extremities: Sum X Area | ||
PASI0422 | C191116 | PASI04-Up Extrem: Sum X Area X 0.2 | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum x area x 0.2. | PASI EMA Version - Upper Extremities: Sum X Area X 0.2 | ||
PASI0423 | C191117 | PASI04-Trunk: Sum of Symptom Scores | Psoriasis Area and Severity Index Version EMA - Trunk: Sum of symptom scores. | PASI EMA Version - Trunk: Sum of Symptom Scores | ||
PASI0424 | C191118 | PASI04-Trunk: Sum X Area | Psoriasis Area and Severity Index Version EMA - Trunk: Sum of symptom scores x area score. | PASI EMA Version - Trunk: Sum X Area | ||
PASI0425 | C191119 | PASI04-Trunk: Sum X Area X 0.3 | Psoriasis Area and Severity Index Version EMA - Trunk: Sum x area x 0.3. | PASI EMA Version - Trunk: Sum X Area X 0.3 | ||
PASI0426 | C191120 | PASI04-Low Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum of symptom scores. | PASI EMA Version - Lower Extremities: Sum of Symptom Scores | ||
PASI0427 | C191121 | PASI04-Low Extrem: Sum X Area | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum of symptom scores x area score. | PASI EMA Version - Lower Extremities: Sum X Area | ||
PASI0428 | C191122 | PASI04-Low Extrem: Sum X Area X 0.4 | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum x area x 0.4. | PASI EMA Version - Lower Extremities: Sum X Area X 0.4 | ||
PASI0429 | C191123 | PASI04-Total Sum | Psoriasis Area and Severity Index Version EMA - Total sum. | PASI EMA Version - Total Sum | ||
Back to top | ||||||
CL.C190935.PASI04TN | Psoriasis Area and Severity Index Version EMA Clinical Classification Test Name
(PASI04TN) | text
Extensible: No | C190935 | Psoriasis Area and Severity Index Version EMA Clinical Classification Test Name | Psoriasis Area and Severity Index Version EMA test name. | CDISC Clinical Classification Psoriasis Area and Severity Index European Medical Agency Version Test Name Terminology |
PASI04-Head: Area Score | C191098 | PASI04-Head: Area Score | Psoriasis Area and Severity Index Version EMA - Head: Area score. | PASI EMA Version - Head: Area Score | ||
PASI04-Head: Desquamation/Scaling | C191097 | PASI04-Head: Desquamation/Scaling | Psoriasis Area and Severity Index Version EMA - Head: Desquamation/Scaling symptom score. | PASI EMA Version - Head: Desquamation/Scaling | ||
PASI04-Head: Erythema/Redness | C191095 | PASI04-Head: Erythema/Redness | Psoriasis Area and Severity Index Version EMA - Head: Erythema/Redness symptom score. | PASI EMA Version - Head: Erythema/Redness | ||
PASI04-Head: Sum of Symptom Scores | C191111 | PASI04-Head: Sum of Symptom Scores | Psoriasis Area and Severity Index Version EMA - Head: Sum of symptom scores. | PASI EMA Version - Head: Sum of Symptom Scores | ||
PASI04-Head: Sum X Area X 0.1 | C191113 | PASI04-Head: Sum X Area X 0.1 | Psoriasis Area and Severity Index Version EMA - Head: Sum x area x 0.1. | PASI EMA Version - Head: Sum X Area X 0.1 | ||
PASI04-Head: Sum X Area | C191112 | PASI04-Head: Sum X Area | Psoriasis Area and Severity Index Version EMA - Head: Sum of symptom scores x area score. | PASI EMA Version - Head: Sum X Area | ||
PASI04-Head: Thickness/Induration | C191096 | PASI04-Head: Thickness/Induration | Psoriasis Area and Severity Index Version EMA - Head: Thickness/Induration symptom score. | PASI EMA Version - Head: Thickness/Induration | ||
PASI04-Low Extrem: Area Score | C191110 | PASI04-Low Extrem: Area Score | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Area score. | PASI EMA Version - Lower Extremities: Area Score | ||
PASI04-Low Extrem: Desquamation/Scaling | C191109 | PASI04-Low Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Desquamation/Scaling symptom score. | PASI EMA Version - Lower Extremities: Desquamation/Scaling | ||
PASI04-Low Extrem: Erythema/Redness | C191107 | PASI04-Low Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Erythema/Redness symptom score. | PASI EMA Version - Lower Extremities: Erythema/Redness | ||
PASI04-Low Extrem: Sum of Symptom Scores | C191120 | PASI04-Low Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum of symptom scores. | PASI EMA Version - Lower Extremities: Sum of Symptom Scores | ||
PASI04-Low Extrem: Sum X Area X 0.4 | C191122 | PASI04-Low Extrem: Sum X Area X 0.4 | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum x area x 0.4. | PASI EMA Version - Lower Extremities: Sum X Area X 0.4 | ||
PASI04-Low Extrem: Sum X Area | C191121 | PASI04-Low Extrem: Sum X Area | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Sum of symptom scores x area score. | PASI EMA Version - Lower Extremities: Sum X Area | ||
PASI04-Low Extrem: Thickness/Induration | C191108 | PASI04-Low Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version EMA - Lower Extremities: Thickness/Induration symptom score. | PASI EMA Version - Lower Extremities: Thickness/Induration | ||
PASI04-Total Sum | C191123 | PASI04-Total Sum | Psoriasis Area and Severity Index Version EMA - Total sum. | PASI EMA Version - Total Sum | ||
PASI04-Trunk: Area Score | C191106 | PASI04-Trunk: Area Score | Psoriasis Area and Severity Index Version EMA - Trunk: Area score. | PASI EMA Version - Trunk: Area Score | ||
PASI04-Trunk: Desquamation/Scaling | C191105 | PASI04-Trunk: Desquamation/Scaling | Psoriasis Area and Severity Index Version EMA - Trunk: Desquamation/Scaling symptom score. | PASI EMA Version - Trunk: Desquamation/Scaling | ||
PASI04-Trunk: Erythema/Redness | C191103 | PASI04-Trunk: Erythema/Redness | Psoriasis Area and Severity Index Version EMA - Trunk: Erythema/Redness symptom score. | PASI EMA Version - Trunk: Erythema/Redness | ||
PASI04-Trunk: Sum of Symptom Scores | C191117 | PASI04-Trunk: Sum of Symptom Scores | Psoriasis Area and Severity Index Version EMA - Trunk: Sum of symptom scores. | PASI EMA Version - Trunk: Sum of Symptom Scores | ||
PASI04-Trunk: Sum X Area X 0.3 | C191119 | PASI04-Trunk: Sum X Area X 0.3 | Psoriasis Area and Severity Index Version EMA - Trunk: Sum x area x 0.3. | PASI EMA Version - Trunk: Sum X Area X 0.3 | ||
PASI04-Trunk: Sum X Area | C191118 | PASI04-Trunk: Sum X Area | Psoriasis Area and Severity Index Version EMA - Trunk: Sum of symptom scores x area score. | PASI EMA Version - Trunk: Sum X Area | ||
PASI04-Trunk: Thickness/Induration | C191104 | PASI04-Trunk: Thickness/Induration | Psoriasis Area and Severity Index Version EMA - Trunk: Thickness/Induration symptom score. | PASI EMA Version - Trunk: Thickness/Induration | ||
PASI04-Up Extrem: Area Score | C191102 | PASI04-Up Extrem: Area Score | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Area score. | PASI EMA Version - Upper Extremities: Area Score | ||
PASI04-Up Extrem: Desquamation/Scaling | C191101 | PASI04-Up Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Desquamation/Scaling symptom score. | PASI EMA Version - Upper Extremities: Desquamation/Scaling | ||
PASI04-Up Extrem: Erythema/Redness | C191099 | PASI04-Up Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Erythema/Redness symptom score. | PASI EMA Version - Upper Extremities: Erythema/Redness | ||
PASI04-Up Extrem: Sum of Symptom Scores | C191114 | PASI04-Up Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum of symptom scores. | PASI EMA Version - Upper Extremities: Sum of Symptom Scores | ||
PASI04-Up Extrem: Sum X Area X 0.2 | C191116 | PASI04-Up Extrem: Sum X Area X 0.2 | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum x area x 0.2. | PASI EMA Version - Upper Extremities: Sum X Area X 0.2 | ||
PASI04-Up Extrem: Sum X Area | C191115 | PASI04-Up Extrem: Sum X Area | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Sum of symptom scores x area score. | PASI EMA Version - Upper Extremities: Sum X Area | ||
PASI04-Up Extrem: Thickness/Induration | C191100 | PASI04-Up Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version EMA - Upper Extremities: Thickness/Induration symptom score. | PASI EMA Version - Upper Extremities: Thickness/Induration | ||
Back to top | ||||||
CL.C179936.PASI02TC | Psoriasis Area and Severity Index Version Feldman Clinical Classification Test Code
(PASI02TC) | text
Extensible: No | C179936 | Psoriasis Area and Severity Index Version Feldman Clinical Classification Test Code | Psoriasis Area and Severity Index Version Feldman test code. | CDISC Clinical Classification PASI Feldman Version Test Code Terminology |
PASI0201 | C180218 | PASI02-Head: Erythema/Redness | Psoriasis Area and Severity Index Version Feldman - Head: Erythema/Redness symptom score. | PASI Feldman Version - Head: Erythema/Redness | ||
PASI0202 | C180219 | PASI02-Head: Thickness/Induration | Psoriasis Area and Severity Index Version Feldman - Head: Thickness/Induration symptom score. | PASI Feldman Version - Head: Thickness/Induration | ||
PASI0203 | C180220 | PASI02-Head: Desquamation/Scaling | Psoriasis Area and Severity Index Version Feldman - Head: Desquamation/Scaling symptom score. | PASI Feldman Version - Head: Desquamation/Scaling | ||
PASI0204 | C180221 | PASI02-Head: Area Score | Psoriasis Area and Severity Index Version Feldman - Head: Area score. | PASI Feldman Version - Head: Area Score | ||
PASI0205 | C180222 | PASI02-Up Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Erythema/Redness symptom score. | PASI Feldman Version - Upper Extremities: Erythema/Redness | ||
PASI0206 | C180223 | PASI02-Up Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Thickness/Induration symptom score. | PASI Feldman Version - Upper Extremities: Thickness/Induration | ||
PASI0207 | C180224 | PASI02-Up Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Desquamation/Scaling symptom score. | PASI Feldman Version - Upper Extremities: Desquamation/Scaling | ||
PASI0208 | C180225 | PASI02-Up Extrem: Area Score | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Area score. | PASI Feldman Version - Upper Extremities: Area Score | ||
PASI0209 | C180226 | PASI02-Trunk: Erythema/Redness | Psoriasis Area and Severity Index Version Feldman - Trunk: Erythema/Redness symptom score. | PASI Feldman Version - Trunk: Erythema/Redness | ||
PASI0210 | C180227 | PASI02-Trunk: Thickness/Induration | Psoriasis Area and Severity Index Version Feldman - Trunk: Thickness/Induration symptom score. | PASI Feldman Version - Trunk: Thickness/Induration | ||
PASI0211 | C180228 | PASI02-Trunk: Desquamation/Scaling | Psoriasis Area and Severity Index Version Feldman - Trunk: Desquamation/Scaling symptom score. | PASI Feldman Version - Trunk: Desquamation/Scaling | ||
PASI0212 | C180229 | PASI02-Trunk: Area Score | Psoriasis Area and Severity Index Version Feldman - Trunk: Area score. | PASI Feldman Version - Trunk: Area Score | ||
PASI0213 | C180230 | PASI02-Low Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Erythema/Redness symptom score. | PASI Feldman Version - Lower Extremities: Erythema/Redness | ||
PASI0214 | C180231 | PASI02-Low Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Thickness/Induration symptom score. | PASI Feldman Version - Lower Extremities: Thickness/Induration | ||
PASI0215 | C180232 | PASI02-Low Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Desquamation/Scaling symptom score. | PASI Feldman Version - Lower Extremities: Desquamation/Scaling | ||
PASI0216 | C180233 | PASI02-Low Extrem: Area Score | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Area score. | PASI Feldman Version - Lower Extremities: Area Score | ||
PASI0217 | C180234 | PASI02-Head: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Feldman - Head: Sum of symptom scores. | PASI Feldman Version - Head: Sum of Symptom Scores | ||
PASI0218 | C180235 | PASI02-Head: Sum X Area | Psoriasis Area and Severity Index Version Feldman - Head: Sum of symptom scores x area score. | PASI Feldman Version - Head: Sum X Area | ||
PASI0219 | C180236 | PASI02-Head: Sum X Area X 0.1 | Psoriasis Area and Severity Index Version Feldman - Head: Sum x area x 0.1. | PASI Feldman Version - Head: Sum X Area X 0.1 | ||
PASI0220 | C180237 | PASI02-Up Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum of symptom scores. | PASI Feldman Version - Upper Extremities: Sum of Symptom Scores | ||
PASI0221 | C180238 | PASI02-Up Extrem: Sum X Area | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum of symptom scores x area score. | PASI Feldman Version - Upper Extremities: Sum X Area | ||
PASI0222 | C180239 | PASI02-Up Extrem: Sum X Area X 0.2 | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum x area x 0.2. | PASI Feldman Version - Upper Extremities: Sum X Area X 0.2 | ||
PASI0223 | C180240 | PASI02-Trunk: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Feldman - Trunk: Sum of symptom scores. | PASI Feldman Version - Trunk: Sum of Symptom Scores | ||
PASI0224 | C180241 | PASI02-Trunk: Sum X Area | Psoriasis Area and Severity Index Version Feldman - Trunk: Sum of symptom scores x area score. | PASI Feldman Version - Trunk: Sum X Area | ||
PASI0225 | C180242 | PASI02-Trunk: Sum X Area X 0.3 | Psoriasis Area and Severity Index Version Feldman - Trunk: Sum x area x 0.3. | PASI Feldman Version - Trunk: Sum X Area X 0.3 | ||
PASI0226 | C180243 | PASI02-Low Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum of symptom scores. | PASI Feldman Version - Lower Extremities: Sum of Symptom Scores | ||
PASI0227 | C180244 | PASI02-Low Extrem: Sum X Area | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum of symptom scores x area score. | PASI Feldman Version - Lower Extremities: Sum X Area | ||
PASI0228 | C180245 | PASI02-Low Extrem: Sum X Area X 0.4 | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum x area x 0.4. | PASI Feldman Version - Lower Extremities: Sum X Area X 0.4 | ||
PASI0229 | C180246 | PASI02-Total Sum | Psoriasis Area and Severity Index Version Feldman - Total sum. | PASI Feldman Version - Total Sum | ||
Back to top | ||||||
CL.C179935.PASI02TN | Psoriasis Area and Severity Index Version Feldman Clinical Classification Test Name
(PASI02TN) | text
Extensible: No | C179935 | Psoriasis Area and Severity Index Version Feldman Clinical Classification Test Name | Psoriasis Area and Severity Index Version Feldman test name. | CDISC Clinical Classification PASI Feldman Version Test Name Terminology |
PASI02-Head: Area Score | C180221 | PASI02-Head: Area Score | Psoriasis Area and Severity Index Version Feldman - Head: Area score. | PASI Feldman Version - Head: Area Score | ||
PASI02-Head: Desquamation/Scaling | C180220 | PASI02-Head: Desquamation/Scaling | Psoriasis Area and Severity Index Version Feldman - Head: Desquamation/Scaling symptom score. | PASI Feldman Version - Head: Desquamation/Scaling | ||
PASI02-Head: Erythema/Redness | C180218 | PASI02-Head: Erythema/Redness | Psoriasis Area and Severity Index Version Feldman - Head: Erythema/Redness symptom score. | PASI Feldman Version - Head: Erythema/Redness | ||
PASI02-Head: Sum of Symptom Scores | C180234 | PASI02-Head: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Feldman - Head: Sum of symptom scores. | PASI Feldman Version - Head: Sum of Symptom Scores | ||
PASI02-Head: Sum X Area X 0.1 | C180236 | PASI02-Head: Sum X Area X 0.1 | Psoriasis Area and Severity Index Version Feldman - Head: Sum x area x 0.1. | PASI Feldman Version - Head: Sum X Area X 0.1 | ||
PASI02-Head: Sum X Area | C180235 | PASI02-Head: Sum X Area | Psoriasis Area and Severity Index Version Feldman - Head: Sum of symptom scores x area score. | PASI Feldman Version - Head: Sum X Area | ||
PASI02-Head: Thickness/Induration | C180219 | PASI02-Head: Thickness/Induration | Psoriasis Area and Severity Index Version Feldman - Head: Thickness/Induration symptom score. | PASI Feldman Version - Head: Thickness/Induration | ||
PASI02-Low Extrem: Area Score | C180233 | PASI02-Low Extrem: Area Score | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Area score. | PASI Feldman Version - Lower Extremities: Area Score | ||
PASI02-Low Extrem: Desquamation/Scaling | C180232 | PASI02-Low Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Desquamation/Scaling symptom score. | PASI Feldman Version - Lower Extremities: Desquamation/Scaling | ||
PASI02-Low Extrem: Erythema/Redness | C180230 | PASI02-Low Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Erythema/Redness symptom score. | PASI Feldman Version - Lower Extremities: Erythema/Redness | ||
PASI02-Low Extrem: Sum of Symptom Scores | C180243 | PASI02-Low Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum of symptom scores. | PASI Feldman Version - Lower Extremities: Sum of Symptom Scores | ||
PASI02-Low Extrem: Sum X Area X 0.4 | C180245 | PASI02-Low Extrem: Sum X Area X 0.4 | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum x area x 0.4. | PASI Feldman Version - Lower Extremities: Sum X Area X 0.4 | ||
PASI02-Low Extrem: Sum X Area | C180244 | PASI02-Low Extrem: Sum X Area | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Sum of symptom scores x area score. | PASI Feldman Version - Lower Extremities: Sum X Area | ||
PASI02-Low Extrem: Thickness/Induration | C180231 | PASI02-Low Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Feldman - Lower Extremities: Thickness/Induration symptom score. | PASI Feldman Version - Lower Extremities: Thickness/Induration | ||
PASI02-Total Sum | C180246 | PASI02-Total Sum | Psoriasis Area and Severity Index Version Feldman - Total sum. | PASI Feldman Version - Total Sum | ||
PASI02-Trunk: Area Score | C180229 | PASI02-Trunk: Area Score | Psoriasis Area and Severity Index Version Feldman - Trunk: Area score. | PASI Feldman Version - Trunk: Area Score | ||
PASI02-Trunk: Desquamation/Scaling | C180228 | PASI02-Trunk: Desquamation/Scaling | Psoriasis Area and Severity Index Version Feldman - Trunk: Desquamation/Scaling symptom score. | PASI Feldman Version - Trunk: Desquamation/Scaling | ||
PASI02-Trunk: Erythema/Redness | C180226 | PASI02-Trunk: Erythema/Redness | Psoriasis Area and Severity Index Version Feldman - Trunk: Erythema/Redness symptom score. | PASI Feldman Version - Trunk: Erythema/Redness | ||
PASI02-Trunk: Sum of Symptom Scores | C180240 | PASI02-Trunk: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Feldman - Trunk: Sum of symptom scores. | PASI Feldman Version - Trunk: Sum of Symptom Scores | ||
PASI02-Trunk: Sum X Area X 0.3 | C180242 | PASI02-Trunk: Sum X Area X 0.3 | Psoriasis Area and Severity Index Version Feldman - Trunk: Sum x area x 0.3. | PASI Feldman Version - Trunk: Sum X Area X 0.3 | ||
PASI02-Trunk: Sum X Area | C180241 | PASI02-Trunk: Sum X Area | Psoriasis Area and Severity Index Version Feldman - Trunk: Sum of symptom scores x area score. | PASI Feldman Version - Trunk: Sum X Area | ||
PASI02-Trunk: Thickness/Induration | C180227 | PASI02-Trunk: Thickness/Induration | Psoriasis Area and Severity Index Version Feldman - Trunk: Thickness/Induration symptom score. | PASI Feldman Version - Trunk: Thickness/Induration | ||
PASI02-Up Extrem: Area Score | C180225 | PASI02-Up Extrem: Area Score | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Area score. | PASI Feldman Version - Upper Extremities: Area Score | ||
PASI02-Up Extrem: Desquamation/Scaling | C180224 | PASI02-Up Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Desquamation/Scaling symptom score. | PASI Feldman Version - Upper Extremities: Desquamation/Scaling | ||
PASI02-Up Extrem: Erythema/Redness | C180222 | PASI02-Up Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Erythema/Redness symptom score. | PASI Feldman Version - Upper Extremities: Erythema/Redness | ||
PASI02-Up Extrem: Sum of Symptom Scores | C180237 | PASI02-Up Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum of symptom scores. | PASI Feldman Version - Upper Extremities: Sum of Symptom Scores | ||
PASI02-Up Extrem: Sum X Area X 0.2 | C180239 | PASI02-Up Extrem: Sum X Area X 0.2 | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum x area x 0.2. | PASI Feldman Version - Upper Extremities: Sum X Area X 0.2 | ||
PASI02-Up Extrem: Sum X Area | C180238 | PASI02-Up Extrem: Sum X Area | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Sum of symptom scores x area score. | PASI Feldman Version - Upper Extremities: Sum X Area | ||
PASI02-Up Extrem: Thickness/Induration | C180223 | PASI02-Up Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Feldman - Upper Extremities: Thickness/Induration symptom score. | PASI Feldman Version - Upper Extremities: Thickness/Induration | ||
Back to top | ||||||
CL.C190934.PASI03TC | Psoriasis Area and Severity Index Version Fredriksson Clinical Classification Test Code
(PASI03TC) | text
Extensible: No | C190934 | Psoriasis Area and Severity Index Version Fredriksson Clinical Classification Test Code | Psoriasis Area and Severity Index Version Fredriksson test code. | CDISC Clinical Classification Psoriasis Area and Severity Index Fredriksson Version Test Code Terminology |
PASI0301 | C191066 | PASI03-Head: Erythema/Redness | Psoriasis Area and Severity Index Version Fredriksson - Head: Erythema/Redness symptom score. | PASI Fredriksson Version - Head: Erythema/Redness | ||
PASI0302 | C191067 | PASI03-Head: Thickness/Induration | Psoriasis Area and Severity Index Version Fredriksson - Head: Thickness/Induration symptom score. | PASI Fredriksson Version - Head: Thickness/Induration | ||
PASI0303 | C191068 | PASI03-Head: Desquamation/Scaling | Psoriasis Area and Severity Index Version Fredriksson - Head: Desquamation/Scaling symptom score. | PASI Fredriksson Version - Head: Desquamation/Scaling | ||
PASI0304 | C191069 | PASI03-Head: Area Score | Psoriasis Area and Severity Index Version Fredriksson - Head: Area score. | PASI Fredriksson Version - Head: Area Score | ||
PASI0305 | C191070 | PASI03-Up Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Erythema/Redness symptom score. | PASI Fredriksson Version - Upper Extremities: Erythema/Redness | ||
PASI0306 | C191071 | PASI03-Up Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Thickness/Induration symptom score. | PASI Fredriksson Version - Upper Extremities: Thickness/Induration | ||
PASI0307 | C191072 | PASI03-Up Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Desquamation/Scaling symptom score. | PASI Fredriksson Version - Upper Extremities: Desquamation/Scaling | ||
PASI0308 | C191073 | PASI03-Up Extrem: Area Score | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Area score. | PASI Fredriksson Version - Upper Extremities: Area Score | ||
PASI0309 | C191074 | PASI03-Trunk: Erythema/Redness | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Erythema/Redness symptom score. | PASI Fredriksson Version - Trunk: Erythema/Redness | ||
PASI0310 | C191075 | PASI03-Trunk: Thickness/Induration | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Thickness/Induration symptom score. | PASI Fredriksson Version - Trunk: Thickness/Induration | ||
PASI0311 | C191076 | PASI03-Trunk: Desquamation/Scaling | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Desquamation/Scaling symptom score. | PASI Fredriksson Version - Trunk: Desquamation/Scaling | ||
PASI0312 | C191077 | PASI03-Trunk: Area Score | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Area score. | PASI Fredriksson Version - Trunk: Area Score | ||
PASI0313 | C191078 | PASI03-Low Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Erythema/Redness symptom score. | PASI Fredriksson Version - Lower Extremities: Erythema/Redness | ||
PASI0314 | C191079 | PASI03-Low Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Thickness/Induration symptom score. | PASI Fredriksson Version - Lower Extremities: Thickness/Induration | ||
PASI0315 | C191080 | PASI03-Low Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Desquamation/Scaling symptom score. | PASI Fredriksson Version - Lower Extremities: Desquamation/Scaling | ||
PASI0316 | C191081 | PASI03-Low Extrem: Area Score | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Area score. | PASI Fredriksson Version - Lower Extremities: Area Score | ||
PASI0317 | C191082 | PASI03-Head: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Fredriksson - Head: Sum of symptom scores. | PASI Fredriksson Version - Head: Sum of Symptom Scores | ||
PASI0318 | C191083 | PASI03-Head: Sum X Area | Psoriasis Area and Severity Index Version Fredriksson - Head: Sum of symptom scores x area score. | PASI Fredriksson Version - Head: Sum X Area | ||
PASI0319 | C191084 | PASI03-Head: Sum X Area X 0.1 | Psoriasis Area and Severity Index Version Fredriksson - Head: Sum x area x 0.1. | PASI Fredriksson Version - Head: Sum X Area X 0.1 | ||
PASI0320 | C191085 | PASI03-Up Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum of symptom scores. | PASI Fredriksson Version - Upper Extremities: Sum of Symptom Scores | ||
PASI0321 | C191086 | PASI03-Up Extrem: Sum X Area | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum of symptom scores x area score. | PASI Fredriksson Version - Upper Extremities: Sum X Area | ||
PASI0322 | C191087 | PASI03-Up Extrem: Sum X Area X 0.2 | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum x area x 0.2. | PASI Fredriksson Version - Upper Extremities: Sum X Area X 0.2 | ||
PASI0323 | C191088 | PASI03-Trunk: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum of symptom scores. | PASI Fredriksson Version - Trunk: Sum of Symptom Scores | ||
PASI0324 | C191089 | PASI03-Trunk: Sum X Area | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum of symptom scores x area score. | PASI Fredriksson Version - Trunk: Sum X Area | ||
PASI0325 | C191090 | PASI03-Trunk: Sum X Area X 0.3 | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum x area x 0.3. | PASI Fredriksson Version - Trunk: Sum X Area X 0.3 | ||
PASI0326 | C191091 | PASI03-Low Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum of symptom scores. | PASI Fredriksson Version - Lower Extremities: Sum of Symptom Scores | ||
PASI0327 | C191092 | PASI03-Low Extrem: Sum X Area | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum of symptom scores x area score. | PASI Fredriksson Version - Lower Extremities: Sum X Area | ||
PASI0328 | C191093 | PASI03-Low Extrem: Sum X Area X 0.4 | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum x area x 0.4. | PASI Fredriksson Version - Lower Extremities: Sum X Area X 0.4 | ||
PASI0329 | C191094 | PASI03-Total Sum | Psoriasis Area and Severity Index Version Fredriksson - Total sum. | PASI Fredriksson Version - Total Sum | ||
Back to top | ||||||
CL.C190933.PASI03TN | Psoriasis Area and Severity Index Version Fredriksson Clinical Classification Test Name
(PASI03TN) | text
Extensible: No | C190933 | Psoriasis Area and Severity Index Version Fredriksson Clinical Classification Test Name | Psoriasis Area and Severity Index Version Fredriksson test name. | CDISC Clinical Classification Psoriasis Area and Severity Index Fredriksson Version Test Name Terminology |
PASI03-Head: Area Score | C191069 | PASI03-Head: Area Score | Psoriasis Area and Severity Index Version Fredriksson - Head: Area score. | PASI Fredriksson Version - Head: Area Score | ||
PASI03-Head: Desquamation/Scaling | C191068 | PASI03-Head: Desquamation/Scaling | Psoriasis Area and Severity Index Version Fredriksson - Head: Desquamation/Scaling symptom score. | PASI Fredriksson Version - Head: Desquamation/Scaling | ||
PASI03-Head: Erythema/Redness | C191066 | PASI03-Head: Erythema/Redness | Psoriasis Area and Severity Index Version Fredriksson - Head: Erythema/Redness symptom score. | PASI Fredriksson Version - Head: Erythema/Redness | ||
PASI03-Head: Sum of Symptom Scores | C191082 | PASI03-Head: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Fredriksson - Head: Sum of symptom scores. | PASI Fredriksson Version - Head: Sum of Symptom Scores | ||
PASI03-Head: Sum X Area X 0.1 | C191084 | PASI03-Head: Sum X Area X 0.1 | Psoriasis Area and Severity Index Version Fredriksson - Head: Sum x area x 0.1. | PASI Fredriksson Version - Head: Sum X Area X 0.1 | ||
PASI03-Head: Sum X Area | C191083 | PASI03-Head: Sum X Area | Psoriasis Area and Severity Index Version Fredriksson - Head: Sum of symptom scores x area score. | PASI Fredriksson Version - Head: Sum X Area | ||
PASI03-Head: Thickness/Induration | C191067 | PASI03-Head: Thickness/Induration | Psoriasis Area and Severity Index Version Fredriksson - Head: Thickness/Induration symptom score. | PASI Fredriksson Version - Head: Thickness/Induration | ||
PASI03-Low Extrem: Area Score | C191081 | PASI03-Low Extrem: Area Score | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Area score. | PASI Fredriksson Version - Lower Extremities: Area Score | ||
PASI03-Low Extrem: Desquamation/Scaling | C191080 | PASI03-Low Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Desquamation/Scaling symptom score. | PASI Fredriksson Version - Lower Extremities: Desquamation/Scaling | ||
PASI03-Low Extrem: Erythema/Redness | C191078 | PASI03-Low Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Erythema/Redness symptom score. | PASI Fredriksson Version - Lower Extremities: Erythema/Redness | ||
PASI03-Low Extrem: Sum of Symptom Scores | C191091 | PASI03-Low Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum of symptom scores. | PASI Fredriksson Version - Lower Extremities: Sum of Symptom Scores | ||
PASI03-Low Extrem: Sum X Area X 0.4 | C191093 | PASI03-Low Extrem: Sum X Area X 0.4 | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum x area x 0.4. | PASI Fredriksson Version - Lower Extremities: Sum X Area X 0.4 | ||
PASI03-Low Extrem: Sum X Area | C191092 | PASI03-Low Extrem: Sum X Area | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Sum of symptom scores x area score. | PASI Fredriksson Version - Lower Extremities: Sum X Area | ||
PASI03-Low Extrem: Thickness/Induration | C191079 | PASI03-Low Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Fredriksson - Lower Extremities: Thickness/Induration symptom score. | PASI Fredriksson Version - Lower Extremities: Thickness/Induration | ||
PASI03-Total Sum | C191094 | PASI03-Total Sum | Psoriasis Area and Severity Index Version Fredriksson - Total sum. | PASI Fredriksson Version - Total Sum | ||
PASI03-Trunk: Area Score | C191077 | PASI03-Trunk: Area Score | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Area score. | PASI Fredriksson Version - Trunk: Area Score | ||
PASI03-Trunk: Desquamation/Scaling | C191076 | PASI03-Trunk: Desquamation/Scaling | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Desquamation/Scaling symptom score. | PASI Fredriksson Version - Trunk: Desquamation/Scaling | ||
PASI03-Trunk: Erythema/Redness | C191074 | PASI03-Trunk: Erythema/Redness | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Erythema/Redness symptom score. | PASI Fredriksson Version - Trunk: Erythema/Redness | ||
PASI03-Trunk: Sum of Symptom Scores | C191088 | PASI03-Trunk: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum of symptom scores. | PASI Fredriksson Version - Trunk: Sum of Symptom Scores | ||
PASI03-Trunk: Sum X Area X 0.3 | C191090 | PASI03-Trunk: Sum X Area X 0.3 | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum x area x 0.3. | PASI Fredriksson Version - Trunk: Sum X Area X 0.3 | ||
PASI03-Trunk: Sum X Area | C191089 | PASI03-Trunk: Sum X Area | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Sum of symptom scores x area score. | PASI Fredriksson Version - Trunk: Sum X Area | ||
PASI03-Trunk: Thickness/Induration | C191075 | PASI03-Trunk: Thickness/Induration | Psoriasis Area and Severity Index Version Fredriksson - Trunk: Thickness/Induration symptom score. | PASI Fredriksson Version - Trunk: Thickness/Induration | ||
PASI03-Up Extrem: Area Score | C191073 | PASI03-Up Extrem: Area Score | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Area score. | PASI Fredriksson Version - Upper Extremities: Area Score | ||
PASI03-Up Extrem: Desquamation/Scaling | C191072 | PASI03-Up Extrem: Desquamation/Scaling | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Desquamation/Scaling symptom score. | PASI Fredriksson Version - Upper Extremities: Desquamation/Scaling | ||
PASI03-Up Extrem: Erythema/Redness | C191070 | PASI03-Up Extrem: Erythema/Redness | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Erythema/Redness symptom score. | PASI Fredriksson Version - Upper Extremities: Erythema/Redness | ||
PASI03-Up Extrem: Sum of Symptom Scores | C191085 | PASI03-Up Extrem: Sum of Symptom Scores | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum of symptom scores. | PASI Fredriksson Version - Upper Extremities: Sum of Symptom Scores | ||
PASI03-Up Extrem: Sum X Area X 0.2 | C191087 | PASI03-Up Extrem: Sum X Area X 0.2 | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum x area x 0.2. | PASI Fredriksson Version - Upper Extremities: Sum X Area X 0.2 | ||
PASI03-Up Extrem: Sum X Area | C191086 | PASI03-Up Extrem: Sum X Area | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Sum of symptom scores x area score. | PASI Fredriksson Version - Upper Extremities: Sum X Area | ||
PASI03-Up Extrem: Thickness/Induration | C191071 | PASI03-Up Extrem: Thickness/Induration | Psoriasis Area and Severity Index Version Fredriksson - Upper Extremities: Thickness/Induration symptom score. | PASI Fredriksson Version - Upper Extremities: Thickness/Induration | ||
Back to top | ||||||
CL.C170447.PSFATSCD | Psoriasis Findings About Test Code
(PSFATSCD) | text
Extensible: Yes | C170447 | Psoriasis Findings About Test Code | Terminology relevant to the test codes that describe findings about a psoriasis event or intervention. | CDISC SDTM Psoriasis Findings About Test Code Terminology |
QOLIMP | C170617 | QOL Impact;Quality of Life Impact | The effect or consequence of an event or condition on an individual's sense of well-being and ability to enjoy life. | Quality of Life Impact | ||
SEV | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C170446.PSFATS | Psoriasis Findings About Test Name
(PSFATS) | text
Extensible: Yes | C170446 | Psoriasis Findings About Test Name | Terminology relevant to the test names that describe findings about a psoriasis event or intervention. | CDISC SDTM Psoriasis Findings About Test Name Terminology |
QOL Impact | C170617 | QOL Impact;Quality of Life Impact | The effect or consequence of an event or condition on an individual's sense of well-being and ability to enjoy life. | Quality of Life Impact | ||
Severity/Intensity | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Back to top | ||||||
CL.C158113.QRSMTHOD | QRS Method
(QRSMTHOD) | text
Extensible: Yes | C158113 | QRS Method | Terminology relevant to the technique or procedure used to determine how the response or result for an item in a questionnaire, rating, or scale was determined. | CDISC SDTM QRS Method Terminology |
LIKERT SCALE 3-POINT | C172597 | Likert Scale 3-Point | A questionnaire, rating and scale (QRS) data type using a 3-point Likert Scale. | Likert Scale 3-Point | ||
LIKERT SCALE 5-POINT | C172596 | Likert Scale 5-Point | A questionnaire, rating and scale (QRS) data type using a 5-point Likert Scale. | Likert Scale 5-Point | ||
LIKERT SCALE 7-POINT | C166090 | Likert Scale 7-Point | A questionnaire, rating and scale (QRS) data type using a 7-point Likert Scale. | Likert Scale 7-Point | ||
NUMERICAL RATING SCALE 11-POINT | C158270 | NRS 11-Point;Numeric Rating Scale 11-Point | A questionnaire, rating and scale (QRS) data type using a 11-point numerical rating scale (NRS). | Numerical Rating Scale 11-Point | ||
NUMERICAL RATING SCALE 21-POINT | C172598 | NRS 21-Point;Numeric Rating Scale 21-Point | A questionnaire, rating and scale (QRS) data type using a 21-point numerical rating scale (NRS). | Numerical Rating Scale 21-Point | ||
NUMERICAL RATING SCALE 5-POINT | C174360 | NRS 5-Point;Numeric Rating Scale 5-Point | A questionnaire, rating and scale (QRS) data type using a 5-point numerical rating scale (NRS). | Numerical Rating Scale 5-Point | ||
NUMERICAL RATING SCALE 6-POINT | C166091 | NRS 6-Point;Numeric Rating Scale 6-Point | A questionnaire, rating and scale (QRS) data type using a 6-point numerical rating scale (NRS). | Numerical Rating Scale 6-Point | ||
NUMERICAL RATING SCALE 7-POINT | C187967 | NRS 7-Point;Numeric Rating Scale 7-Point | A questionnaire, rating and scale (QRS) data type using a 7-point numerical rating scale (NRS). | Numerical Rating Scale 7-Point | ||
VERBAL RATING SCALE 4-POINT | C158271 | VRS 4-Point | A questionnaire, rating and scale (QRS) data type using a 4-point verbal rating scale (VRS). | Verbal Rating Scale 4-Point | ||
VERBAL RATING SCALE 5-POINT | C158272 | VRS 5-Point | A questionnaire, rating and scale (QRS) data type using a 5-point verbal rating scale (VRS). | Verbal Rating Scale 5-Point | ||
VERBAL RATING SCALE 6-POINT | C158273 | VRS 6-Point | A questionnaire, rating and scale (QRS) data type using a 6-point verbal rating scale (VRS). | Verbal Rating Scale 6-Point | ||
VISUAL ANALOG SCALE (0-100) | C187968 | VAS (0-100) | A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 0-100 scale with no units. | Visual Analog Scale (0-100) | ||
VISUAL ANALOG SCALE (1-10) | C179787 | VAS (1-10) | A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 1-10 scale with no units. | Visual Analog Scale (1-10) | ||
VISUAL ANALOG SCALE (1-100) | C179788 | VAS (1-100) | A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 1-100 scale with no units. | Visual Analog Scale (1-100) | ||
VISUAL ANALOG SCALE (1-50) | C179789 | VAS (1-50) | A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 1-50 scale with no units. | Visual Analog Scale (1-50) | ||
VISUAL ANALOG SCALE (10 CM) | C172599 | VAS (10 cm) | A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 10 cm scale. | Visual Analog Scale (10 cm) | ||
VISUAL ANALOG SCALE (100 MM) | C158268 | VAS (100 mm) | A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 100 mm scale. | Visual Analog Scale (100 mm) | ||
VISUAL ANALOG SCALE (50 MM) | C158269 | VAS (50 mm) | A questionnaire, rating and scale (QRS) data type using a visual analog scale (VAS) 50 mm scale. | Visual Analog Scale (50 mm) | ||
Back to top | ||||||
CL.C130267.QLES2TC | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form Test Code
(QLES2TC) | text
Extensible: No | C130267 | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form Test Code | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form test code. | CDISC Questionnaire Q-LES-Q-SF Test Code Terminology |
QLES201 | C130705 | QLES2-Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Physical health? | Q-LES-Q-SF - Physical Health | ||
QLES202 | C130706 | QLES2-Mood | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Mood? | Q-LES-Q-SF - Mood | ||
QLES203 | C130707 | QLES2-Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Work? | Q-LES-Q-SF - Work | ||
QLES204 | C130708 | QLES2-Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Household activities? | Q-LES-Q-SF - Household Activities | ||
QLES205 | C130709 | QLES2-Social Relationships | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Social relationships? | Q-LES-Q-SF - Social Relationships | ||
QLES206 | C130710 | QLES2-Family Relationships | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Family relationships? | Q-LES-Q-SF - Family Relationships | ||
QLES207 | C130711 | QLES2-Leisure Time Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Leisure time activities? | Q-LES-Q-SF - Leisure Time Activities | ||
QLES208 | C130712 | QLES2-Ability to Function in Daily Life | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to function in daily life? | Q-LES-Q-SF - Ability to Function in Daily Life | ||
QLES209 | C130713 | QLES2-Sex Drive, Interest, Performance | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Sexual drive, interest and/or performance? | Q-LES-Q-SF - Sex Drive, Interest, Performance | ||
QLES210 | C130714 | QLES2-Economic Status | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Economic status? | Q-LES-Q-SF - Economic Status | ||
QLES211 | C130715 | QLES2-Living/Housing Situation | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Living/housing situation? | Q-LES-Q-SF - Living or Housing Situation | ||
QLES212 | C130716 | QLES2-Ability to Get Around Physically | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to get around physically without feeling dizzy or unsteady or falling? | Q-LES-Q-SF - Ability to Get Around Physically | ||
QLES213 | C130717 | QLES2-Vision Ability to Do Work/Hobbies | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Your vision in terms of ability to do work or hobbies? | Q-LES-Q-SF - Vision Ability to Do Work or Hobbies | ||
QLES214 | C130718 | QLES2-Overall Sense of Well Being | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Overall sense of well being? | Q-LES-Q-SF - Overall Sense of Well Being | ||
QLES215 | C130719 | QLES2-Medication | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Medication? | Q-LES-Q-SF - Medication | ||
QLES216 | C130720 | QLES2-Rate Overall Life Satisfaction | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - How would you rate your overall life satisfaction and contentment during the past week? | Q-LES-Q-SF - Rate Overall Life Satisfaction | ||
Back to top | ||||||
CL.C130266.QLES2TN | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form Test Name
(QLES2TN) | text
Extensible: No | C130266 | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form Test Name | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form test name. | CDISC Questionnaire Q-LES-Q-SF Test Name Terminology |
QLES2-Ability to Function in Daily Life | C130712 | QLES2-Ability to Function in Daily Life | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to function in daily life? | Q-LES-Q-SF - Ability to Function in Daily Life | ||
QLES2-Ability to Get Around Physically | C130716 | QLES2-Ability to Get Around Physically | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to get around physically without feeling dizzy or unsteady or falling? | Q-LES-Q-SF - Ability to Get Around Physically | ||
QLES2-Economic Status | C130714 | QLES2-Economic Status | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Economic status? | Q-LES-Q-SF - Economic Status | ||
QLES2-Family Relationships | C130710 | QLES2-Family Relationships | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Family relationships? | Q-LES-Q-SF - Family Relationships | ||
QLES2-Household Activities | C130708 | QLES2-Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Household activities? | Q-LES-Q-SF - Household Activities | ||
QLES2-Leisure Time Activities | C130711 | QLES2-Leisure Time Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Leisure time activities? | Q-LES-Q-SF - Leisure Time Activities | ||
QLES2-Living/Housing Situation | C130715 | QLES2-Living/Housing Situation | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Living/housing situation? | Q-LES-Q-SF - Living or Housing Situation | ||
QLES2-Medication | C130719 | QLES2-Medication | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Medication? | Q-LES-Q-SF - Medication | ||
QLES2-Mood | C130706 | QLES2-Mood | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Mood? | Q-LES-Q-SF - Mood | ||
QLES2-Overall Sense of Well Being | C130718 | QLES2-Overall Sense of Well Being | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Overall sense of well being? | Q-LES-Q-SF - Overall Sense of Well Being | ||
QLES2-Physical Health | C130705 | QLES2-Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Physical health? | Q-LES-Q-SF - Physical Health | ||
QLES2-Rate Overall Life Satisfaction | C130720 | QLES2-Rate Overall Life Satisfaction | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - How would you rate your overall life satisfaction and contentment during the past week? | Q-LES-Q-SF - Rate Overall Life Satisfaction | ||
QLES2-Sex Drive, Interest, Performance | C130713 | QLES2-Sex Drive, Interest, Performance | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Sexual drive, interest and/or performance? | Q-LES-Q-SF - Sex Drive, Interest, Performance | ||
QLES2-Social Relationships | C130709 | QLES2-Social Relationships | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Social relationships? | Q-LES-Q-SF - Social Relationships | ||
QLES2-Vision Ability to Do Work/Hobbies | C130717 | QLES2-Vision Ability to Do Work/Hobbies | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Your vision in terms of ability to do work or hobbies? | Q-LES-Q-SF - Vision Ability to Do Work or Hobbies | ||
QLES2-Work | C130707 | QLES2-Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - Short Form - Taking everything into consideration, during the past week how satisfied have you been with your: Work? | Q-LES-Q-SF - Work | ||
Back to top | ||||||
CL.C130265.QLES1TC | Quality Of Life Enjoyment And Satisfaction Questionnaire Test Code
(QLES1TC) | text
Extensible: No | C130265 | Quality Of Life Enjoyment And Satisfaction Questionnaire Test Code | Quality Of Life Enjoyment And Satisfaction Questionnaire test code. | CDISC Questionnaire Q-LES-Q Test Code Terminology |
QLES101 | C130604 | QLES1-Free of Aches, Pains, Discomfort | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been completely free of aches, pains, or discomfort? | Q-LES-Q - Free of Aches, Pains, Discomfort | ||
QLES102 | C130605 | QLES1-Felt Rested | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt rested? | Q-LES-Q - Felt Rested | ||
QLES103 | C130606 | QLES1-Felt Energetic | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt energetic? | Q-LES-Q - Felt Energetic | ||
QLES104 | C130607 | QLES1-Felt in Excellent Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt in excellent physical health? | Q-LES-Q - Felt in Excellent Physical Health | ||
QLES105 | C130608 | QLES1-At Least Very Good Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt in at least very good physical health? | Q-LES-Q - At Least Very Good Physical Health | ||
QLES106 | C130609 | QLES1-Free of Worry of Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been free of worry about your physical health? | Q-LES-Q - Free of Worry of Physical Health | ||
QLES107 | C130610 | QLES1-Felt You Got Enough Sleep | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt you got enough sleep? | Q-LES-Q - Felt You Got Enough Sleep | ||
QLES108 | C130611 | QLES1-Be as Physically Active as Needed | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt able to be as physically active as needed? | Q-LES-Q - Be as Physically Active as Needed | ||
QLES109 | C130612 | QLES1-Felt Well Coordinated | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt well coordinated? | Q-LES-Q - Felt Well Coordinated | ||
QLES110 | C130613 | QLES1-Felt Memory Was Functioning Well | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt your memory was functioning well? | Q-LES-Q - Felt Memory Was Functioning Well | ||
QLES111 | C130614 | QLES1-Felt Good Physically | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt good physically? | Q-LES-Q - Felt Good Physically | ||
QLES112 | C130615 | QLES1-Felt Full of Pep and Vitality | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt full of pep and vitality? | Q-LES-Q - Felt Full of Pep and Vitality | ||
QLES113 | C130616 | QLES1-Free of Visual Problems | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been free of visual problems? | Q-LES-Q - Free of Visual Problems | ||
QLES114 | C130617 | QLES1-Felt Clearheaded | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt clearheaded? | Q-LES-Q - Felt Clearheaded | ||
QLES115 | C130618 | QLES1-Felt Satisfied With Your Life | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt satisfied with your life? | Q-LES-Q - Felt Satisfied With Your Life | ||
QLES116 | C130619 | QLES1-Felt Good About Your Appearance | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good about your appearance? | Q-LES-Q - Felt Good About Your Appearance | ||
QLES117 | C130620 | QLES1-Felt Happy or Cheerful | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt happy or cheerful? | Q-LES-Q - Felt Happy or Cheerful | ||
QLES118 | C130621 | QLES1-Felt Independent | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt independent? | Q-LES-Q - Felt Independent | ||
QLES119 | C130622 | QLES1-Felt Content | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt content? | Q-LES-Q - Felt Content | ||
QLES120 | C130623 | QLES1-Able to Communicate With Others | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to communicate with others? | Q-LES-Q - Able to Communicate With Others | ||
QLES121 | C130624 | QLES1-Taking Care of Your Appearance | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt interested in taking care of your appearance (hair, clothing) and personal hygiene (bathing, dressing)? | Q-LES-Q - Taking Care of Your Appearance | ||
QLES122 | C130625 | QLES1-Felt Able to Make Decisions | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to make decisions? | Q-LES-Q - Felt Able to Make Decisions | ||
QLES123 | C130626 | QLES1-Felt Relaxed | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt relaxed? | Q-LES-Q - Felt Relaxed | ||
QLES124 | C130627 | QLES1-Felt Good About Your Life | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good about your life? | Q-LES-Q - Felt Good About Your Life | ||
QLES125 | C130628 | QLES1-Able to Travel About When Needed | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to travel about to get things done when needed (walk, use car, bus, train, or whatever is available as needed)? | Q-LES-Q - Able to Travel About to Get Things Done When Needed | ||
QLES126 | C130629 | QLES1-Able to Deal With Life's Problems | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to deal with life's problems? | Q-LES-Q - Able to Deal With Life's Problems | ||
QLES127 | C130630 | QLES1-Able to Take Care of Yourself | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to take care of yourself? | Q-LES-Q - Able to Take Care of Yourself | ||
QLES128A | C130631 | QLES1-Have a Job | Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you have a job? | Q-LES-Q - Have a Job | ||
QLES128B | C130632 | QLES1-Work for Yourself | Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you work for yourself? | Q-LES-Q - Work for Yourself | ||
QLES128C | C130633 | QLES1-Do Volunteer Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you do volunteer work? | Q-LES-Q - Do Volunteer Work | ||
QLES128D | C130634 | QLES1-Reason for Not Working | Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason not having a job, working for yourself, and not doing volunteer work? | Q-LES-Q - Reason for Not Working | ||
QLES129 | C130635 | QLES1-Enjoyed Your Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Enjoyed your work? | Q-LES-Q - Enjoyed Your Work | ||
QLES130 | C130636 | QLES1-Solved Work Problem Without Stress | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Solved work problems or dealt with them without undue stress? | Q-LES-Q - Solved Work Problem Without Stress | ||
QLES131 | C130637 | QLES1-Thought Clearly About Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Thought clearly about work? | Q-LES-Q - Thought Clearly About Work | ||
QLES132 | C130638 | QLES1-Decisive About Work/Made Decisions | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been decisive about work, or made decisions when needed? | Q-LES-Q - Decisive About Work or Made Decisions | ||
QLES133 | C130639 | QLES1-Accomplished What You Wanted to Do | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Accomplished what you wanted to do? | Q-LES-Q - Accomplished What You Wanted to Do | ||
QLES134 | C130640 | QLES1-Pleased With Work Accomplishments | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been pleased with your work accomplishments? | Q-LES-Q - Pleased With Work Accomplishments | ||
QLES135 | C130641 | QLES1-Worked Well | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Worked well? | Q-LES-Q - Worked Well | ||
QLES136 | C130642 | QLES1-Been Interested in Your Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been interested in your work? | Q-LES-Q - Been Interested in Your Work | ||
QLES137 | C130643 | QLES1-Concentrated on Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Concentrated on work? | Q-LES-Q - Concentrated on Work | ||
QLES138 | C130644 | QLES1-Worked Carefully | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Worked carefully? | Q-LES-Q - Worked Carefully | ||
QLES139 | C130645 | QLES1-Kept Up With Expected Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Kept up with expected work? | Q-LES-Q - Kept Up With Expected Work | ||
QLES140 | C130646 | QLES1-Taken Care of Work by Yourself | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Taken care of work by yourself when it was necessary? | Q-LES-Q - Taken Care of Work by Yourself | ||
QLES141 | C130647 | QLES1-Communicated/Interacted With Ease | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Communicated and interacted with ease with others while working? | Q-LES-Q - Communicated and Interacted With Ease | ||
QLES142 | C130648 | QLES1-Responsible for Household | Quality Of Life Enjoyment And Satisfaction Questionnaire - Are you responsible for any household duties/housework/homemaker activities (e.g., cleaning, shopping, doing dishes, food shopping or preparation) for your-self or for other people? | Q-LES-Q - Responsible for Household | ||
QLES142A | C130649 | QLES1-Reason for No Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason for no household duties/housework/homemaker activities (e.g., cleaning, shopping doing dishes, food shopping or preparation) for your-self or for other people? | Q-LES-Q - Reason for No Household Activities | ||
QLES143 | C130650 | QLES1-Kept Room Clean to Satisfaction | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Kept your room/apartment/house cleaned to your satisfaction? | Q-LES-Q - Kept Room Clean to Satisfaction | ||
QLES144 | C130651 | QLES1-Paid Bills, Done Banking | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Paid the bills, done the banking to your satisfaction? | Q-LES-Q - Paid Bills, Done Banking | ||
QLES145 | C130652 | QLES1-Shopped for Food/Household Items | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Shopped for food or other household items to your satisfaction? | Q-LES-Q - Shopped for Food or Household Items | ||
QLES146 | C130653 | QLES1-Prepared Food or Obtained Food | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Prepared food or obtained food to your satisfaction? | Q-LES-Q - Prepared Food or Obtained Food | ||
QLES147 | C130654 | QLES1-Taken Care of Laundry/Cleaning | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Taken care of the laundry/cleaning to your satisfaction? | Q-LES-Q - Taken Care of Laundry or Cleaning | ||
QLES148 | C130655 | QLES1-Accomplish Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Had a feeling of accomplishment with regard to household activities? | Q-LES-Q - Accomplish Household Activities | ||
QLES149 | C130656 | QLES1-Thought Clearly Household Activ | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Concentrated and thought clearly about what household activities needed to be done? | Q-LES-Q - Thought Clearly Household Activities to be Done | ||
QLES150 | C130657 | QLES1-Solved House Problems w/o Stress | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Solved household problems or dealt with them without undue stress? | Q-LES-Q - Solved House Problems Without Stress | ||
QLES151 | C130658 | QLES1-Decisive Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been decisive or made decisions when needed with regard to household activities? | Q-LES-Q - Decisive With Regard to Household Activities | ||
QLES152 | C130659 | QLES1-Made Repairs Household Maintenance | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Made repairs or taken care of household maintenance as needed? | Q-LES-Q - Made Repairs or Household Maintenance | ||
QLES153 | C130660 | QLES1-Taken Courses/Going to Class | Quality Of Life Enjoyment And Satisfaction Questionnaire - Have you been taking any courses, going to class, or been involved in any type of course work, school or college studies during the past week? | Q-LES-Q - Taken Courses or Going to Class | ||
QLES153A | C130661 | QLES1-Reason for No Courses | Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason not taking any courses, going to class, or been involved in any type of course work, school or college studies during the past week. | Q-LES-Q - Reason for No Courses | ||
QLES154 | C130662 | QLES1-Enjoyed Course/Class Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Enjoyed the course/class work? | Q-LES-Q - Enjoyed Course or Class Work | ||
QLES155 | C130663 | QLES1-Looked Forward to Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Looked forward to getting to work on the course/class work? | Q-LES-Q - Looked Forward to Course Work | ||
QLES156 | C130664 | QLES1-Course/Class Work Without Stress | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Dealt with the course/class work without undue stress? | Q-LES-Q - Dealt With Course or Class Work Without Stress | ||
QLES157 | C130665 | QLES1-Thought Clearly About Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Thought clearly about the course/class work? | Q-LES-Q - Thought Clearly About Course Work | ||
QLES158 | C130666 | QLES1-Decisive About Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been decisive about the course/class work when needed? | Q-LES-Q - Decisive About Course Work | ||
QLES159 | C130667 | QLES1-Pleased With Course Accomplishment | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been pleased with your course/class work accomplishments? | Q-LES-Q - Pleased With Course Accomplishment | ||
QLES160 | C130668 | QLES1-Interested in Your Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been interested in your course/class work? | Q-LES-Q - Interested in Your Course Work | ||
QLES161 | C130669 | QLES1-Concentrated on Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Concentrated on the course/class work? | Q-LES-Q - Concentrated on Course Work | ||
QLES162 | C130670 | QLES1-Felt Good Doing Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good while doing your course/class work? | Q-LES-Q - Felt Good Doing Course Work | ||
QLES163 | C130671 | QLES1-Communicated With Ease at Course | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Communicated and interacted with ease with others at your course/class? | Q-LES-Q - Communicated With Ease at Course | ||
QLES164 | C130672 | QLES1-Use Time for a Leisure Activity | Quality Of Life Enjoyment And Satisfaction Questionnaire - When you had time, how often did you use that time for a leisure time activity? | Q-LES-Q - Use Time for a Leisure Activity | ||
QLES165 | C130673 | QLES1-Enjoy the Leisure Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you enjoy the leisure activities? | Q-LES-Q - Enjoy the Leisure Activities | ||
QLES166 | C130674 | QLES1-Look Forward to Leisure Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you look forward to the leisure activities before spending time at them? | Q-LES-Q - Look Forward to Leisure Activities | ||
QLES167 | C130675 | QLES1-Concentrate on Leisure Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you concentrate on the leisure activities and pay attention to them? | Q-LES-Q - Concentrate on Leisure Activities | ||
QLES168 | C130676 | QLES1-Solve or Deal Without Undue Stress | Quality Of Life Enjoyment And Satisfaction Questionnaire - If a problem arose in your leisure activities, how often did you solve it or deal with it without undue stress? | Q-LES-Q - Solve or Deal Without Undue Stress | ||
QLES169 | C130677 | QLES1-Leisure Activity Sustain Interest | Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did the leisure activities sustain your interest? | Q-LES-Q - Leisure Activity Sustain Interest | ||
QLES170 | C130678 | QLES1-Enjoyed Being With Friends | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Enjoyed talking with or being with friends or relatives? | Q-LES-Q - Enjoyed Being With Friends | ||
QLES171 | C130679 | QLES1-Getting Together With Friends | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Looked forward to getting together with friends or relatives? | Q-LES-Q - Getting Together With Friends | ||
QLES172 | C130680 | QLES1-Made Social Plans With Friends | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Made social plans with friends or relatives for future activities? | Q-LES-Q - Made Social Plans With Friends | ||
QLES173 | C130681 | QLES1-Enjoyed Talking With Co-workers | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Enjoyed talking with co-workers or neighbors? | Q-LES-Q - Enjoyed Talking With Co-workers | ||
QLES174 | C130682 | QLES1-Patient With Others | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Been patient with others when others were irritating in their actions or words? | Q-LES-Q - Patient With Others | ||
QLES175 | C130683 | QLES1-Interested in Problems of People | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Been interested in the problems of other people? | Q-LES-Q - Interested in Problems of People | ||
QLES176 | C130684 | QLES1-Felt Affection Toward People | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt affection toward one or more people? | Q-LES-Q - Felt Affection Toward People | ||
QLES177 | C130685 | QLES1-Gotten Along Well With People | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Gotten along well with other people? | Q-LES-Q - Gotten Along Well With People | ||
QLES178 | C130686 | QLES1-Joked or Laughed With Other People | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Joked or laughed with other people? | Q-LES-Q - Joked or Laughed With Other People | ||
QLES179 | C130687 | QLES1-Met Needs of Friends or Relatives | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt you met the needs of friends or relatives? | Q-LES-Q - Met Needs of Friends or Relatives | ||
QLES180 | C130688 | QLES1-Relationships Without Problems | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt your relationships with your friends or relatives were without major problems or conflicts? | Q-LES-Q - Relationships Without Problems | ||
QLES181 | C130689 | QLES1-Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Physical health? | Q-LES-Q - Physical Health | ||
QLES182 | C130690 | QLES1-Mood | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Mood? | Q-LES-Q - Mood | ||
QLES183 | C130691 | QLES1-Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Work? | Q-LES-Q - Work | ||
QLES184 | C130692 | QLES1-Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Household activities? | Q-LES-Q - Household Activities | ||
QLES185 | C130693 | QLES1-Social Relationships | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Social relationships? | Q-LES-Q - Social Relationships | ||
QLES186 | C130694 | QLES1-Family Relationships | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Family relationships? | Q-LES-Q - Family Relationships | ||
QLES187 | C130695 | QLES1-Leisure Time Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Leisure time activities? | Q-LES-Q - Leisure Time Activities | ||
QLES188 | C130696 | QLES1-Ability to Function in Daily Life | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to function in daily life? | Q-LES-Q - Ability to Function in Daily Life | ||
QLES189 | C130697 | QLES1-Sex Drive, Interest, Performance | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Sexual drive, interest and/or performance? | Q-LES-Q - Sex Drive, Interest, Performance | ||
QLES190 | C130698 | QLES1-Economic Status | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Economic status? | Q-LES-Q - Economic Status | ||
QLES191 | C130699 | QLES1-Living/Housing Situation | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Living/housing situation? | Q-LES-Q - Living or Housing Situation | ||
QLES192 | C130700 | QLES1-Ability to Get Around Physically | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to get around physically without feeling dizzy or unsteady or falling? | Q-LES-Q - Ability to Get Around Physically | ||
QLES193 | C130701 | QLES1-Vision Ability to Do Work/Hobbies | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: your vision in terms of ability to do work or hobbies? | Q-LES-Q - Vision Ability to Do Work or Hobbies | ||
QLES194 | C130702 | QLES1-Overall Sense of Well Being | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Overall sense of well being? | Q-LES-Q - Overall Sense of Well Being | ||
QLES195 | C130703 | QLES1-Medication | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Medication? | Q-LES-Q - Medication | ||
QLES196 | C130704 | QLES1-Rate Overall Life Satisfaction | Quality Of Life Enjoyment And Satisfaction Questionnaire - How would you rate your overall life satisfaction and contentment during the past week? | Q-LES-Q - Rate Overall Life Satisfaction | ||
Back to top | ||||||
CL.C130264.QLES1TN | Quality Of Life Enjoyment And Satisfaction Questionnaire Test Name
(QLES1TN) | text
Extensible: No | C130264 | Quality Of Life Enjoyment And Satisfaction Questionnaire Test Name | Quality Of Life Enjoyment And Satisfaction Questionnaire test name. | CDISC Questionnaire Q-LES-Q Test Name Terminology |
QLES1-Ability to Function in Daily Life | C130696 | QLES1-Ability to Function in Daily Life | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to function in daily life? | Q-LES-Q - Ability to Function in Daily Life | ||
QLES1-Ability to Get Around Physically | C130700 | QLES1-Ability to Get Around Physically | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Ability to get around physically without feeling dizzy or unsteady or falling? | Q-LES-Q - Ability to Get Around Physically | ||
QLES1-Able to Communicate With Others | C130623 | QLES1-Able to Communicate With Others | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to communicate with others? | Q-LES-Q - Able to Communicate With Others | ||
QLES1-Able to Deal With Life's Problems | C130629 | QLES1-Able to Deal With Life's Problems | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to deal with life's problems? | Q-LES-Q - Able to Deal With Life's Problems | ||
QLES1-Able to Take Care of Yourself | C130630 | QLES1-Able to Take Care of Yourself | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to take care of yourself? | Q-LES-Q - Able to Take Care of Yourself | ||
QLES1-Able to Travel About When Needed | C130628 | QLES1-Able to Travel About When Needed | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to travel about to get things done when needed (walk, use car, bus, train, or whatever is available as needed)? | Q-LES-Q - Able to Travel About to Get Things Done When Needed | ||
QLES1-Accomplish Household Activities | C130655 | QLES1-Accomplish Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Had a feeling of accomplishment with regard to household activities? | Q-LES-Q - Accomplish Household Activities | ||
QLES1-Accomplished What You Wanted to Do | C130639 | QLES1-Accomplished What You Wanted to Do | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Accomplished what you wanted to do? | Q-LES-Q - Accomplished What You Wanted to Do | ||
QLES1-At Least Very Good Physical Health | C130608 | QLES1-At Least Very Good Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt in at least very good physical health? | Q-LES-Q - At Least Very Good Physical Health | ||
QLES1-Be as Physically Active as Needed | C130611 | QLES1-Be as Physically Active as Needed | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt able to be as physically active as needed? | Q-LES-Q - Be as Physically Active as Needed | ||
QLES1-Been Interested in Your Work | C130642 | QLES1-Been Interested in Your Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been interested in your work? | Q-LES-Q - Been Interested in Your Work | ||
QLES1-Communicated With Ease at Course | C130671 | QLES1-Communicated With Ease at Course | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Communicated and interacted with ease with others at your course/class? | Q-LES-Q - Communicated With Ease at Course | ||
QLES1-Communicated/Interacted With Ease | C130647 | QLES1-Communicated/Interacted With Ease | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Communicated and interacted with ease with others while working? | Q-LES-Q - Communicated and Interacted With Ease | ||
QLES1-Concentrate on Leisure Activities | C130675 | QLES1-Concentrate on Leisure Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you concentrate on the leisure activities and pay attention to them? | Q-LES-Q - Concentrate on Leisure Activities | ||
QLES1-Concentrated on Course Work | C130669 | QLES1-Concentrated on Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Concentrated on the course/class work? | Q-LES-Q - Concentrated on Course Work | ||
QLES1-Concentrated on Work | C130643 | QLES1-Concentrated on Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Concentrated on work? | Q-LES-Q - Concentrated on Work | ||
QLES1-Course/Class Work Without Stress | C130664 | QLES1-Course/Class Work Without Stress | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Dealt with the course/class work without undue stress? | Q-LES-Q - Dealt With Course or Class Work Without Stress | ||
QLES1-Decisive About Course Work | C130666 | QLES1-Decisive About Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been decisive about the course/class work when needed? | Q-LES-Q - Decisive About Course Work | ||
QLES1-Decisive About Work/Made Decisions | C130638 | QLES1-Decisive About Work/Made Decisions | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been decisive about work, or made decisions when needed? | Q-LES-Q - Decisive About Work or Made Decisions | ||
QLES1-Decisive Household Activities | C130658 | QLES1-Decisive Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been decisive or made decisions when needed with regard to household activities? | Q-LES-Q - Decisive With Regard to Household Activities | ||
QLES1-Do Volunteer Work | C130633 | QLES1-Do Volunteer Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you do volunteer work? | Q-LES-Q - Do Volunteer Work | ||
QLES1-Economic Status | C130698 | QLES1-Economic Status | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Economic status? | Q-LES-Q - Economic Status | ||
QLES1-Enjoy the Leisure Activities | C130673 | QLES1-Enjoy the Leisure Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you enjoy the leisure activities? | Q-LES-Q - Enjoy the Leisure Activities | ||
QLES1-Enjoyed Being With Friends | C130678 | QLES1-Enjoyed Being With Friends | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Enjoyed talking with or being with friends or relatives? | Q-LES-Q - Enjoyed Being With Friends | ||
QLES1-Enjoyed Course/Class Work | C130662 | QLES1-Enjoyed Course/Class Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Enjoyed the course/class work? | Q-LES-Q - Enjoyed Course or Class Work | ||
QLES1-Enjoyed Talking With Co-workers | C130681 | QLES1-Enjoyed Talking With Co-workers | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Enjoyed talking with co-workers or neighbors? | Q-LES-Q - Enjoyed Talking With Co-workers | ||
QLES1-Enjoyed Your Work | C130635 | QLES1-Enjoyed Your Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Enjoyed your work? | Q-LES-Q - Enjoyed Your Work | ||
QLES1-Family Relationships | C130694 | QLES1-Family Relationships | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Family relationships? | Q-LES-Q - Family Relationships | ||
QLES1-Felt Able to Make Decisions | C130625 | QLES1-Felt Able to Make Decisions | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt able to make decisions? | Q-LES-Q - Felt Able to Make Decisions | ||
QLES1-Felt Affection Toward People | C130684 | QLES1-Felt Affection Toward People | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt affection toward one or more people? | Q-LES-Q - Felt Affection Toward People | ||
QLES1-Felt Clearheaded | C130617 | QLES1-Felt Clearheaded | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt clearheaded? | Q-LES-Q - Felt Clearheaded | ||
QLES1-Felt Content | C130622 | QLES1-Felt Content | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt content? | Q-LES-Q - Felt Content | ||
QLES1-Felt Energetic | C130606 | QLES1-Felt Energetic | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt energetic? | Q-LES-Q - Felt Energetic | ||
QLES1-Felt Full of Pep and Vitality | C130615 | QLES1-Felt Full of Pep and Vitality | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt full of pep and vitality? | Q-LES-Q - Felt Full of Pep and Vitality | ||
QLES1-Felt Good About Your Appearance | C130619 | QLES1-Felt Good About Your Appearance | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good about your appearance? | Q-LES-Q - Felt Good About Your Appearance | ||
QLES1-Felt Good About Your Life | C130627 | QLES1-Felt Good About Your Life | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good about your life? | Q-LES-Q - Felt Good About Your Life | ||
QLES1-Felt Good Doing Course Work | C130670 | QLES1-Felt Good Doing Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt good while doing your course/class work? | Q-LES-Q - Felt Good Doing Course Work | ||
QLES1-Felt Good Physically | C130614 | QLES1-Felt Good Physically | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt good physically? | Q-LES-Q - Felt Good Physically | ||
QLES1-Felt Happy or Cheerful | C130620 | QLES1-Felt Happy or Cheerful | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt happy or cheerful? | Q-LES-Q - Felt Happy or Cheerful | ||
QLES1-Felt in Excellent Physical Health | C130607 | QLES1-Felt in Excellent Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt in excellent physical health? | Q-LES-Q - Felt in Excellent Physical Health | ||
QLES1-Felt Independent | C130621 | QLES1-Felt Independent | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt independent? | Q-LES-Q - Felt Independent | ||
QLES1-Felt Memory Was Functioning Well | C130613 | QLES1-Felt Memory Was Functioning Well | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt your memory was functioning well? | Q-LES-Q - Felt Memory Was Functioning Well | ||
QLES1-Felt Relaxed | C130626 | QLES1-Felt Relaxed | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt relaxed? | Q-LES-Q - Felt Relaxed | ||
QLES1-Felt Rested | C130605 | QLES1-Felt Rested | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt rested? | Q-LES-Q - Felt Rested | ||
QLES1-Felt Satisfied With Your Life | C130618 | QLES1-Felt Satisfied With Your Life | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt satisfied with your life? | Q-LES-Q - Felt Satisfied With Your Life | ||
QLES1-Felt Well Coordinated | C130612 | QLES1-Felt Well Coordinated | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt well coordinated? | Q-LES-Q - Felt Well Coordinated | ||
QLES1-Felt You Got Enough Sleep | C130610 | QLES1-Felt You Got Enough Sleep | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Felt you got enough sleep? | Q-LES-Q - Felt You Got Enough Sleep | ||
QLES1-Free of Aches, Pains, Discomfort | C130604 | QLES1-Free of Aches, Pains, Discomfort | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been completely free of aches, pains, or discomfort? | Q-LES-Q - Free of Aches, Pains, Discomfort | ||
QLES1-Free of Visual Problems | C130616 | QLES1-Free of Visual Problems | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been free of visual problems? | Q-LES-Q - Free of Visual Problems | ||
QLES1-Free of Worry of Physical Health | C130609 | QLES1-Free of Worry of Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - With regard to your physical health, during the past week how much of the time have you: Been free of worry about your physical health? | Q-LES-Q - Free of Worry of Physical Health | ||
QLES1-Getting Together With Friends | C130679 | QLES1-Getting Together With Friends | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Looked forward to getting together with friends or relatives? | Q-LES-Q - Getting Together With Friends | ||
QLES1-Gotten Along Well With People | C130685 | QLES1-Gotten Along Well With People | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Gotten along well with other people? | Q-LES-Q - Gotten Along Well With People | ||
QLES1-Have a Job | C130631 | QLES1-Have a Job | Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you have a job? | Q-LES-Q - Have a Job | ||
QLES1-Household Activities | C130692 | QLES1-Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Household activities? | Q-LES-Q - Household Activities | ||
QLES1-Interested in Problems of People | C130683 | QLES1-Interested in Problems of People | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Been interested in the problems of other people? | Q-LES-Q - Interested in Problems of People | ||
QLES1-Interested in Your Course Work | C130668 | QLES1-Interested in Your Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been interested in your course/class work? | Q-LES-Q - Interested in Your Course Work | ||
QLES1-Joked or Laughed With Other People | C130686 | QLES1-Joked or Laughed With Other People | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Joked or laughed with other people? | Q-LES-Q - Joked or Laughed With Other People | ||
QLES1-Kept Room Clean to Satisfaction | C130650 | QLES1-Kept Room Clean to Satisfaction | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Kept your room/apartment/house cleaned to your satisfaction? | Q-LES-Q - Kept Room Clean to Satisfaction | ||
QLES1-Kept Up With Expected Work | C130645 | QLES1-Kept Up With Expected Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Kept up with expected work? | Q-LES-Q - Kept Up With Expected Work | ||
QLES1-Leisure Activity Sustain Interest | C130677 | QLES1-Leisure Activity Sustain Interest | Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did the leisure activities sustain your interest? | Q-LES-Q - Leisure Activity Sustain Interest | ||
QLES1-Leisure Time Activities | C130695 | QLES1-Leisure Time Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Leisure time activities? | Q-LES-Q - Leisure Time Activities | ||
QLES1-Living/Housing Situation | C130699 | QLES1-Living/Housing Situation | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Living/housing situation? | Q-LES-Q - Living or Housing Situation | ||
QLES1-Look Forward to Leisure Activities | C130674 | QLES1-Look Forward to Leisure Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - How often did you look forward to the leisure activities before spending time at them? | Q-LES-Q - Look Forward to Leisure Activities | ||
QLES1-Looked Forward to Course Work | C130663 | QLES1-Looked Forward to Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Looked forward to getting to work on the course/class work? | Q-LES-Q - Looked Forward to Course Work | ||
QLES1-Made Repairs Household Maintenance | C130659 | QLES1-Made Repairs Household Maintenance | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Made repairs or taken care of household maintenance as needed? | Q-LES-Q - Made Repairs or Household Maintenance | ||
QLES1-Made Social Plans With Friends | C130680 | QLES1-Made Social Plans With Friends | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Made social plans with friends or relatives for future activities? | Q-LES-Q - Made Social Plans With Friends | ||
QLES1-Medication | C130703 | QLES1-Medication | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Medication? | Q-LES-Q - Medication | ||
QLES1-Met Needs of Friends or Relatives | C130687 | QLES1-Met Needs of Friends or Relatives | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt you met the needs of friends or relatives? | Q-LES-Q - Met Needs of Friends or Relatives | ||
QLES1-Mood | C130690 | QLES1-Mood | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Mood? | Q-LES-Q - Mood | ||
QLES1-Overall Sense of Well Being | C130702 | QLES1-Overall Sense of Well Being | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Overall sense of well being? | Q-LES-Q - Overall Sense of Well Being | ||
QLES1-Paid Bills, Done Banking | C130651 | QLES1-Paid Bills, Done Banking | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Paid the bills, done the banking to your satisfaction? | Q-LES-Q - Paid Bills, Done Banking | ||
QLES1-Patient With Others | C130682 | QLES1-Patient With Others | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Been patient with others when others were irritating in their actions or words? | Q-LES-Q - Patient With Others | ||
QLES1-Physical Health | C130689 | QLES1-Physical Health | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Physical health? | Q-LES-Q - Physical Health | ||
QLES1-Pleased With Course Accomplishment | C130667 | QLES1-Pleased With Course Accomplishment | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Been pleased with your course/class work accomplishments? | Q-LES-Q - Pleased With Course Accomplishment | ||
QLES1-Pleased With Work Accomplishments | C130640 | QLES1-Pleased With Work Accomplishments | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Been pleased with your work accomplishments? | Q-LES-Q - Pleased With Work Accomplishments | ||
QLES1-Prepared Food or Obtained Food | C130653 | QLES1-Prepared Food or Obtained Food | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Prepared food or obtained food to your satisfaction? | Q-LES-Q - Prepared Food or Obtained Food | ||
QLES1-Rate Overall Life Satisfaction | C130704 | QLES1-Rate Overall Life Satisfaction | Quality Of Life Enjoyment And Satisfaction Questionnaire - How would you rate your overall life satisfaction and contentment during the past week? | Q-LES-Q - Rate Overall Life Satisfaction | ||
QLES1-Reason for No Courses | C130661 | QLES1-Reason for No Courses | Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason not taking any courses, going to class, or been involved in any type of course work, school or college studies during the past week. | Q-LES-Q - Reason for No Courses | ||
QLES1-Reason for No Household Activities | C130649 | QLES1-Reason for No Household Activities | Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason for no household duties/housework/homemaker activities (e.g., cleaning, shopping doing dishes, food shopping or preparation) for your-self or for other people? | Q-LES-Q - Reason for No Household Activities | ||
QLES1-Reason for Not Working | C130634 | QLES1-Reason for Not Working | Quality Of Life Enjoyment And Satisfaction Questionnaire - Reason not having a job, working for yourself, and not doing volunteer work? | Q-LES-Q - Reason for Not Working | ||
QLES1-Relationships Without Problems | C130688 | QLES1-Relationships Without Problems | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how often have you: Felt your relationships with your friends or relatives were without major problems or conflicts? | Q-LES-Q - Relationships Without Problems | ||
QLES1-Responsible for Household | C130648 | QLES1-Responsible for Household | Quality Of Life Enjoyment And Satisfaction Questionnaire - Are you responsible for any household duties/housework/homemaker activities (e.g., cleaning, shopping, doing dishes, food shopping or preparation) for your-self or for other people? | Q-LES-Q - Responsible for Household | ||
QLES1-Sex Drive, Interest, Performance | C130697 | QLES1-Sex Drive, Interest, Performance | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Sexual drive, interest and/or performance? | Q-LES-Q - Sex Drive, Interest, Performance | ||
QLES1-Shopped for Food/Household Items | C130652 | QLES1-Shopped for Food/Household Items | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Shopped for food or other household items to your satisfaction? | Q-LES-Q - Shopped for Food or Household Items | ||
QLES1-Social Relationships | C130693 | QLES1-Social Relationships | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Social relationships? | Q-LES-Q - Social Relationships | ||
QLES1-Solve or Deal Without Undue Stress | C130676 | QLES1-Solve or Deal Without Undue Stress | Quality Of Life Enjoyment And Satisfaction Questionnaire - If a problem arose in your leisure activities, how often did you solve it or deal with it without undue stress? | Q-LES-Q - Solve or Deal Without Undue Stress | ||
QLES1-Solved House Problems w/o Stress | C130657 | QLES1-Solved House Problems w/o Stress | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Solved household problems or dealt with them without undue stress? | Q-LES-Q - Solved House Problems Without Stress | ||
QLES1-Solved Work Problem Without Stress | C130636 | QLES1-Solved Work Problem Without Stress | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Solved work problems or dealt with them without undue stress? | Q-LES-Q - Solved Work Problem Without Stress | ||
QLES1-Taken Care of Laundry/Cleaning | C130654 | QLES1-Taken Care of Laundry/Cleaning | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Taken care of the laundry/cleaning to your satisfaction? | Q-LES-Q - Taken Care of Laundry or Cleaning | ||
QLES1-Taken Care of Work by Yourself | C130646 | QLES1-Taken Care of Work by Yourself | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Taken care of work by yourself when it was necessary? | Q-LES-Q - Taken Care of Work by Yourself | ||
QLES1-Taken Courses/Going to Class | C130660 | QLES1-Taken Courses/Going to Class | Quality Of Life Enjoyment And Satisfaction Questionnaire - Have you been taking any courses, going to class, or been involved in any type of course work, school or college studies during the past week? | Q-LES-Q - Taken Courses or Going to Class | ||
QLES1-Taking Care of Your Appearance | C130624 | QLES1-Taking Care of Your Appearance | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Felt interested in taking care of your appearance (hair, clothing) and personal hygiene (bathing, dressing)? | Q-LES-Q - Taking Care of Your Appearance | ||
QLES1-Thought Clearly About Course Work | C130665 | QLES1-Thought Clearly About Course Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week how much of the time have you: Thought clearly about the course/class work? | Q-LES-Q - Thought Clearly About Course Work | ||
QLES1-Thought Clearly About Work | C130637 | QLES1-Thought Clearly About Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Thought clearly about work? | Q-LES-Q - Thought Clearly About Work | ||
QLES1-Thought Clearly Household Activ | C130656 | QLES1-Thought Clearly Household Activ | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Concentrated and thought clearly about what household activities needed to be done? | Q-LES-Q - Thought Clearly Household Activities to be Done | ||
QLES1-Use Time for a Leisure Activity | C130672 | QLES1-Use Time for a Leisure Activity | Quality Of Life Enjoyment And Satisfaction Questionnaire - When you had time, how often did you use that time for a leisure time activity? | Q-LES-Q - Use Time for a Leisure Activity | ||
QLES1-Vision Ability to Do Work/Hobbies | C130701 | QLES1-Vision Ability to Do Work/Hobbies | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: your vision in terms of ability to do work or hobbies? | Q-LES-Q - Vision Ability to Do Work or Hobbies | ||
QLES1-Work for Yourself | C130632 | QLES1-Work for Yourself | Quality Of Life Enjoyment And Satisfaction Questionnaire - Do you work for yourself? | Q-LES-Q - Work for Yourself | ||
QLES1-Work | C130691 | QLES1-Work | Quality Of Life Enjoyment And Satisfaction Questionnaire - Taking everything into consideration, during the past week how satisfied have you been with your: Work? | Q-LES-Q - Work | ||
QLES1-Worked Carefully | C130644 | QLES1-Worked Carefully | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Worked carefully? | Q-LES-Q - Worked Carefully | ||
QLES1-Worked Well | C130641 | QLES1-Worked Well | Quality Of Life Enjoyment And Satisfaction Questionnaire - During the past week, how often have you: Worked well? | Q-LES-Q - Worked Well | ||
Back to top | ||||||
CL.C174052.IBDQ01TC | Quality of Life in Inflammatory Bowel Disease Questionnaire Test Code
(IBDQ01TC) | text
Extensible: No | C174052 | Quality of Life in Inflammatory Bowel Disease Questionnaire Test Code | Quality of Life in Inflammatory Bowel Disease Questionnaire test code. | CDISC Questionnaire IBDQ Test Code Terminology |
IBDQ0101 | C174071 | IBDQ01-How Frequent Bowel Movements | Quality of Life in Inflammatory Bowel Disease Questionnaire - How frequent have your bowel movements been during the last two weeks? | IBDQ - How Frequent Bowel Movements | ||
IBDQ0102 | C174072 | IBDQ01-Fatigue Been a Problem | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often has the feeling of fatigue or of being tired and worn out been a problem for you during the last 2 weeks? | IBDQ - Fatigue Been a Problem | ||
IBDQ0103 | C174073 | IBDQ01-Felt Frustrated | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt frustrated, impatient or restless? | IBDQ - Felt Frustrated | ||
IBDQ0104 | C174074 | IBDQ01-Unable to Attend School or Work | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been unable to attend school or do your work because of your bowel problem? | IBDQ - Unable to Attend School or Work | ||
IBDQ0105 | C174075 | IBDQ01-Bowel Movements Been Loose | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have your bowel movements been loose? | IBDQ - Bowel Movements Been Loose | ||
IBDQ0106 | C174076 | IBDQ01-How Much Energy Have You Had | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much energy have you had during the last 2 weeks? | IBDQ - How Much Energy Have You Had | ||
IBDQ0107 | C174077 | IBDQ01-Feel Worried About Surgery | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks did you feel worried about the possibility of needing to have surgery because of your bowel problem? | IBDQ - Feel Worried About Surgery | ||
IBDQ0108 | C174078 | IBDQ01-Delay/Cancel Social Engagement | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had to delay or cancel a social engagement because of your bowel problem? | IBDQ - Delay or Cancel Social Engagement | ||
IBDQ0109 | C174079 | IBDQ01-Troubled by Cramps in Abdomen | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled by cramps in your abdomen? | IBDQ - Troubled by Cramps in Abdomen | ||
IBDQ0110 | C174080 | IBDQ01-Felt Generally Unwell | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt generally unwell? | IBDQ - Felt Generally Unwell | ||
IBDQ0111 | C174081 | IBDQ01-Fear of Not Finding a Washroom | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled because of fear of not finding a washroom? | IBDQ - Fear of Not Finding a Washroom | ||
IBDQ0112 | C174082 | IBDQ01-Difficulty Doing Leisure/Sports | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much difficulty have you had, as a result of your bowel problems, doing leisure or sports activities you would have liked to have done during the last 2 weeks? | IBDQ - Difficulty Doing Leisure or Sports | ||
IBDQ0113 | C174083 | IBDQ01-Troubled by Pain in Abdomen | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled by pain in the abdomen? | IBDQ - Troubled by Pain in Abdomen | ||
IBDQ0114 | C174084 | IBDQ01-Problems Getting Sleep/Waking Up | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had problems getting a good night's sleep, or been troubled by waking up during the night? | IBDQ - Problems Getting Sleep or Waking Up | ||
IBDQ0115 | C174085 | IBDQ01-Felt Depressed or Discouraged | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt depressed or discouraged? | IBDQ - Felt Depressed or Discouraged | ||
IBDQ0116 | C174086 | IBDQ01-Avoid Events Where No Washroom | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had to avoid attending events where there was no washroom close at hand? | IBDQ - Avoid Events Where No Washroom | ||
IBDQ0117 | C174087 | IBDQ01-Problem Passing Large Amounts Gas | Quality of Life in Inflammatory Bowel Disease Questionnaire - Overall, in the last 2 weeks, how much of a problem have you had with passing large amounts of gas? | IBDQ - Problem Passing Large Amounts Gas | ||
IBDQ0118 | C174088 | IBDQ01-Problem Maintaining Weight | Quality of Life in Inflammatory Bowel Disease Questionnaire - Overall, in the last 2 weeks, how much of a problem have you had maintaining or getting to, the weight you would like to be at? | IBDQ - Problem Maintaining Weight | ||
IBDQ0119 | C174089 | IBDQ01-Felt Worried or Anxious | Quality of Life in Inflammatory Bowel Disease Questionnaire - In general, how often during the last 2 weeks have you felt worried or anxious? | IBDQ - Felt Worried or Anxious | ||
IBDQ0120 | C174090 | IBDQ01-Troubled by Abdominal Bloating | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 week have you been troubled by a feeling of abdominal bloating? | IBDQ - Troubled by Abdominal Bloating | ||
IBDQ0121 | C174091 | IBDQ01-Felt Relaxed and Free of Tension | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt relaxed and free of tension? | IBDQ - Felt Relaxed and Free of Tension | ||
IBDQ0122 | C174092 | IBDQ01-Problem With Rectal Bleeding | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you had a problem with rectal bleeding with your bowel movements? | IBDQ - Problem With Rectal Bleeding | ||
IBDQ0123 | C174093 | IBDQ01-Felt Embarrassed Bowel Problem | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt embarrassed as a result of your bowel problem? | IBDQ - Felt Embarrassed Bowel Problem | ||
IBDQ0124 | C174094 | IBDQ01-Go to Bathroom Bowels Empty | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by a feeling of having to go to the bathroom even though your bowels were empty? | IBDQ - Go to Bathroom Bowels Empty | ||
IBDQ0125 | C174095 | IBDQ01-Felt Tearful or Upset | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt tearful or upset? | IBDQ - Felt Tearful or Upset | ||
IBDQ0126 | C174096 | IBDQ01-Accidental Soiling of Underpants | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by accidental soiling of your underpants? | IBDQ - Accidental Soiling of Underpants | ||
IBDQ0127 | C174097 | IBDQ01-Felt Angry Bowel Problem | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt angry as a result of your bowel problem? | IBDQ - Felt Angry Bowel Problem | ||
IBDQ0128 | C174098 | IBDQ01-Limited Sexual Activity | Quality of Life in Inflammatory Bowel Disease Questionnaire - To what extent has your bowel problem limited sexual activity during the last 2 weeks? | IBDQ - Limited Sexual Activity | ||
IBDQ0129 | C174099 | IBDQ01-Nausea or Sick to Your Stomach | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by nausea or feeling sick to your stomach? | IBDQ - Nausea or Sick to Your Stomach | ||
IBDQ0130 | C174100 | IBDQ01-Felt Irritable | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt irritable? | IBDQ - Felt Irritable | ||
IBDQ0131 | C174101 | IBDQ01-Lack of Understanding From Others | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the past 2 weeks have you felt a lack of understanding from others? | IBDQ - Lack of Understanding From Others | ||
IBDQ0132 | C174102 | IBDQ01-Satisfied With Personal Life | Quality of Life in Inflammatory Bowel Disease Questionnaire - How satisfied, happy, or pleased have you been with your personal life during the past 2 weeks? | IBDQ - Satisfied With Personal Life | ||
Back to top | ||||||
CL.C174051.IBDQ01TN | Quality of Life in Inflammatory Bowel Disease Questionnaire Test Name
(IBDQ01TN) | text
Extensible: No | C174051 | Quality of Life in Inflammatory Bowel Disease Questionnaire Test Name | Quality of Life in Inflammatory Bowel Disease Questionnaire test name. | CDISC Questionnaire IBDQ Test Name Terminology |
IBDQ01-Accidental Soiling of Underpants | C174096 | IBDQ01-Accidental Soiling of Underpants | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by accidental soiling of your underpants? | IBDQ - Accidental Soiling of Underpants | ||
IBDQ01-Avoid Events Where No Washroom | C174086 | IBDQ01-Avoid Events Where No Washroom | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had to avoid attending events where there was no washroom close at hand? | IBDQ - Avoid Events Where No Washroom | ||
IBDQ01-Bowel Movements Been Loose | C174075 | IBDQ01-Bowel Movements Been Loose | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have your bowel movements been loose? | IBDQ - Bowel Movements Been Loose | ||
IBDQ01-Delay/Cancel Social Engagement | C174078 | IBDQ01-Delay/Cancel Social Engagement | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had to delay or cancel a social engagement because of your bowel problem? | IBDQ - Delay or Cancel Social Engagement | ||
IBDQ01-Difficulty Doing Leisure/Sports | C174082 | IBDQ01-Difficulty Doing Leisure/Sports | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much difficulty have you had, as a result of your bowel problems, doing leisure or sports activities you would have liked to have done during the last 2 weeks? | IBDQ - Difficulty Doing Leisure or Sports | ||
IBDQ01-Fatigue Been a Problem | C174072 | IBDQ01-Fatigue Been a Problem | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often has the feeling of fatigue or of being tired and worn out been a problem for you during the last 2 weeks? | IBDQ - Fatigue Been a Problem | ||
IBDQ01-Fear of Not Finding a Washroom | C174081 | IBDQ01-Fear of Not Finding a Washroom | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled because of fear of not finding a washroom? | IBDQ - Fear of Not Finding a Washroom | ||
IBDQ01-Feel Worried About Surgery | C174077 | IBDQ01-Feel Worried About Surgery | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks did you feel worried about the possibility of needing to have surgery because of your bowel problem? | IBDQ - Feel Worried About Surgery | ||
IBDQ01-Felt Angry Bowel Problem | C174097 | IBDQ01-Felt Angry Bowel Problem | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt angry as a result of your bowel problem? | IBDQ - Felt Angry Bowel Problem | ||
IBDQ01-Felt Depressed or Discouraged | C174085 | IBDQ01-Felt Depressed or Discouraged | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt depressed or discouraged? | IBDQ - Felt Depressed or Discouraged | ||
IBDQ01-Felt Embarrassed Bowel Problem | C174093 | IBDQ01-Felt Embarrassed Bowel Problem | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt embarrassed as a result of your bowel problem? | IBDQ - Felt Embarrassed Bowel Problem | ||
IBDQ01-Felt Frustrated | C174073 | IBDQ01-Felt Frustrated | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt frustrated, impatient or restless? | IBDQ - Felt Frustrated | ||
IBDQ01-Felt Generally Unwell | C174080 | IBDQ01-Felt Generally Unwell | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt generally unwell? | IBDQ - Felt Generally Unwell | ||
IBDQ01-Felt Irritable | C174100 | IBDQ01-Felt Irritable | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt irritable? | IBDQ - Felt Irritable | ||
IBDQ01-Felt Relaxed and Free of Tension | C174091 | IBDQ01-Felt Relaxed and Free of Tension | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you felt relaxed and free of tension? | IBDQ - Felt Relaxed and Free of Tension | ||
IBDQ01-Felt Tearful or Upset | C174095 | IBDQ01-Felt Tearful or Upset | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you felt tearful or upset? | IBDQ - Felt Tearful or Upset | ||
IBDQ01-Felt Worried or Anxious | C174089 | IBDQ01-Felt Worried or Anxious | Quality of Life in Inflammatory Bowel Disease Questionnaire - In general, how often during the last 2 weeks have you felt worried or anxious? | IBDQ - Felt Worried or Anxious | ||
IBDQ01-Go to Bathroom Bowels Empty | C174094 | IBDQ01-Go to Bathroom Bowels Empty | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by a feeling of having to go to the bathroom even though your bowels were empty? | IBDQ - Go to Bathroom Bowels Empty | ||
IBDQ01-How Frequent Bowel Movements | C174071 | IBDQ01-How Frequent Bowel Movements | Quality of Life in Inflammatory Bowel Disease Questionnaire - How frequent have your bowel movements been during the last two weeks? | IBDQ - How Frequent Bowel Movements | ||
IBDQ01-How Much Energy Have You Had | C174076 | IBDQ01-How Much Energy Have You Had | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much energy have you had during the last 2 weeks? | IBDQ - How Much Energy Have You Had | ||
IBDQ01-Lack of Understanding From Others | C174101 | IBDQ01-Lack of Understanding From Others | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the past 2 weeks have you felt a lack of understanding from others? | IBDQ - Lack of Understanding From Others | ||
IBDQ01-Limited Sexual Activity | C174098 | IBDQ01-Limited Sexual Activity | Quality of Life in Inflammatory Bowel Disease Questionnaire - To what extent has your bowel problem limited sexual activity during the last 2 weeks? | IBDQ - Limited Sexual Activity | ||
IBDQ01-Nausea or Sick to Your Stomach | C174099 | IBDQ01-Nausea or Sick to Your Stomach | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you been troubled by nausea or feeling sick to your stomach? | IBDQ - Nausea or Sick to Your Stomach | ||
IBDQ01-Problem Maintaining Weight | C174088 | IBDQ01-Problem Maintaining Weight | Quality of Life in Inflammatory Bowel Disease Questionnaire - Overall, in the last 2 weeks, how much of a problem have you had maintaining or getting to, the weight you would like to be at? | IBDQ - Problem Maintaining Weight | ||
IBDQ01-Problem Passing Large Amounts Gas | C174087 | IBDQ01-Problem Passing Large Amounts Gas | Quality of Life in Inflammatory Bowel Disease Questionnaire - Overall, in the last 2 weeks, how much of a problem have you had with passing large amounts of gas? | IBDQ - Problem Passing Large Amounts Gas | ||
IBDQ01-Problem With Rectal Bleeding | C174092 | IBDQ01-Problem With Rectal Bleeding | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 weeks have you had a problem with rectal bleeding with your bowel movements? | IBDQ - Problem With Rectal Bleeding | ||
IBDQ01-Problems Getting Sleep/Waking Up | C174084 | IBDQ01-Problems Getting Sleep/Waking Up | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you had problems getting a good night's sleep, or been troubled by waking up during the night? | IBDQ - Problems Getting Sleep or Waking Up | ||
IBDQ01-Satisfied With Personal Life | C174102 | IBDQ01-Satisfied With Personal Life | Quality of Life in Inflammatory Bowel Disease Questionnaire - How satisfied, happy, or pleased have you been with your personal life during the past 2 weeks? | IBDQ - Satisfied With Personal Life | ||
IBDQ01-Troubled by Abdominal Bloating | C174090 | IBDQ01-Troubled by Abdominal Bloating | Quality of Life in Inflammatory Bowel Disease Questionnaire - How much of the time during the last 2 week have you been troubled by a feeling of abdominal bloating? | IBDQ - Troubled by Abdominal Bloating | ||
IBDQ01-Troubled by Cramps in Abdomen | C174079 | IBDQ01-Troubled by Cramps in Abdomen | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled by cramps in your abdomen? | IBDQ - Troubled by Cramps in Abdomen | ||
IBDQ01-Troubled by Pain in Abdomen | C174083 | IBDQ01-Troubled by Pain in Abdomen | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been troubled by pain in the abdomen? | IBDQ - Troubled by Pain in Abdomen | ||
IBDQ01-Unable to Attend School or Work | C174074 | IBDQ01-Unable to Attend School or Work | Quality of Life in Inflammatory Bowel Disease Questionnaire - How often during the last 2 weeks have you been unable to attend school or do your work because of your bowel problem? | IBDQ - Unable to Attend School or Work | ||
Back to top | ||||||
CL.C130249.QIDSC1TC | Quick Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Code
(QIDSC1TC) | text
Extensible: No | C130249 | Quick Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Code | Quick Inventory of Depressive Symptomatology Clinician-Rated Version test code. | CDISC Clinical Classification QIDS-C Test Code Terminology |
QIDSC101 | C130394 | QIDSC1-Sleep Onset Insomnia | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sleep onset insomnia. | QIDS-C - Sleep Onset Insomnia | ||
QIDSC102 | C130395 | QIDSC1-Mid-Nocturnal Insomnia | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mid-nocturnal insomnia. | QIDS-C - Mid-Nocturnal Insomnia | ||
QIDSC103 | C130396 | QIDSC1-Early Morning Insomnia | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Early morning insomnia. | QIDS-C - Early Morning Insomnia | ||
QIDSC104 | C130397 | QIDSC1-Hypersomnia | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Hypersomnia. | QIDS-C - Hypersomnia | ||
QIDSC105 | C130398 | QIDSC1-Mood (Sad) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (sad). | QIDS-C - Mood (Sad) | ||
QIDSC106 | C130399 | QIDSC1-Appetite (Decreased) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (decreased). | QIDS-C - Appetite (Decreased) | ||
QIDSC107 | C130400 | QIDSC1-Appetite (Increased) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (increased). | QIDS-C - Appetite (Increased) | ||
QIDSC108 | C130401 | QIDSC1-Weight (Decrease) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (decrease) within the last two weeks. | QIDS-C - Weight (Decrease) | ||
QIDSC109 | C130402 | QIDSC1-Weight (Increase) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (increase) within the last two weeks. | QIDS-C - Weight (Increase) | ||
QIDSC110 | C130403 | QIDSC1-Concentration/Decision Making | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Concentration/decision making. | QIDS-C - Concentration or Decision Making | ||
QIDSC111 | C130404 | QIDSC1-Outlook (Self) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (self). | QIDS-C - Outlook (Self) | ||
QIDSC112 | C130405 | QIDSC1-Suicidal Ideation | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Suicidal ideation. | QIDS-C - Suicidal Ideation | ||
QIDSC113 | C130406 | QIDSC1-Involvement | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Involvement. | QIDS-C - Involvement | ||
QIDSC114 | C130407 | QIDSC1-Energy/Fatiguability | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Energy/fatiguability. | QIDS-C - Energy or Fatiguability | ||
QIDSC115 | C130408 | QIDSC1-Psychomotor Slowing | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor slowing. | QIDS-C - Psychomotor Slowing | ||
QIDSC116 | C130409 | QIDSC1-Psychomotor Agitation | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor agitation. | QIDS-C - Psychomotor Agitation | ||
QIDSC117 | C130410 | QIDSC1-Highest Score Sleep Items | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on any 1 of the 4 sleep items. | QIDS-C - Highest Score Sleep Items | ||
QIDSC118 | C130411 | QIDSC1-High Score Appetite/Weight Items | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on any 1 of the 4 appetite/weight change items. | QIDS-C - High Score Appetite or Weight Items | ||
QIDSC119 | C130412 | QIDSC1-Highest Score Psychomotor Items | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on either of the 2 psychomotor items. | QIDS-C - Highest Score Psychomotor Items | ||
QIDSC120 | C130413 | QIDSC1-Total Score | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Total score. | QIDS-C - Total Score | ||
Back to top | ||||||
CL.C130248.QIDSC1TN | Quick Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Name
(QIDSC1TN) | text
Extensible: No | C130248 | Quick Inventory of Depressive Symptomatology Clinician-Rated Version Clinical Classification Test Name | Quick Inventory of Depressive Symptomatology Clinician-Rated Version test name. | CDISC Clinical Classification QIDS-C Test Name Terminology |
QIDSC1-Appetite (Decreased) | C130399 | QIDSC1-Appetite (Decreased) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (decreased). | QIDS-C - Appetite (Decreased) | ||
QIDSC1-Appetite (Increased) | C130400 | QIDSC1-Appetite (Increased) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Appetite (increased). | QIDS-C - Appetite (Increased) | ||
QIDSC1-Concentration/Decision Making | C130403 | QIDSC1-Concentration/Decision Making | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Concentration/decision making. | QIDS-C - Concentration or Decision Making | ||
QIDSC1-Early Morning Insomnia | C130396 | QIDSC1-Early Morning Insomnia | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Early morning insomnia. | QIDS-C - Early Morning Insomnia | ||
QIDSC1-Energy/Fatiguability | C130407 | QIDSC1-Energy/Fatiguability | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Energy/fatiguability. | QIDS-C - Energy or Fatiguability | ||
QIDSC1-High Score Appetite/Weight Items | C130411 | QIDSC1-High Score Appetite/Weight Items | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on any 1 of the 4 appetite/weight change items. | QIDS-C - High Score Appetite or Weight Items | ||
QIDSC1-Highest Score Psychomotor Items | C130412 | QIDSC1-Highest Score Psychomotor Items | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on either of the 2 psychomotor items. | QIDS-C - Highest Score Psychomotor Items | ||
QIDSC1-Highest Score Sleep Items | C130410 | QIDSC1-Highest Score Sleep Items | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Enter the highest score on any 1 of the 4 sleep items. | QIDS-C - Highest Score Sleep Items | ||
QIDSC1-Hypersomnia | C130397 | QIDSC1-Hypersomnia | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Hypersomnia. | QIDS-C - Hypersomnia | ||
QIDSC1-Involvement | C130406 | QIDSC1-Involvement | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Involvement. | QIDS-C - Involvement | ||
QIDSC1-Mid-Nocturnal Insomnia | C130395 | QIDSC1-Mid-Nocturnal Insomnia | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mid-nocturnal insomnia. | QIDS-C - Mid-Nocturnal Insomnia | ||
QIDSC1-Mood (Sad) | C130398 | QIDSC1-Mood (Sad) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Mood (sad). | QIDS-C - Mood (Sad) | ||
QIDSC1-Outlook (Self) | C130404 | QIDSC1-Outlook (Self) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Outlook (self). | QIDS-C - Outlook (Self) | ||
QIDSC1-Psychomotor Agitation | C130409 | QIDSC1-Psychomotor Agitation | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor agitation. | QIDS-C - Psychomotor Agitation | ||
QIDSC1-Psychomotor Slowing | C130408 | QIDSC1-Psychomotor Slowing | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Psychomotor slowing. | QIDS-C - Psychomotor Slowing | ||
QIDSC1-Sleep Onset Insomnia | C130394 | QIDSC1-Sleep Onset Insomnia | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Sleep onset insomnia. | QIDS-C - Sleep Onset Insomnia | ||
QIDSC1-Suicidal Ideation | C130405 | QIDSC1-Suicidal Ideation | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Suicidal ideation. | QIDS-C - Suicidal Ideation | ||
QIDSC1-Total Score | C130413 | QIDSC1-Total Score | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Total score. | QIDS-C - Total Score | ||
QIDSC1-Weight (Decrease) | C130401 | QIDSC1-Weight (Decrease) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (decrease) within the last two weeks. | QIDS-C - Weight (Decrease) | ||
QIDSC1-Weight (Increase) | C130402 | QIDSC1-Weight (Increase) | Quick Inventory of Depressive Symptomatology - Clinician-Rated - Please circle one response to each item that best describes the patient for the last seven days: Weight (increase) within the last two weeks. | QIDS-C - Weight (Increase) | ||
Back to top | ||||||
CL.C130263.QIDSR1TC | Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Code
(QIDSR1TC) | text
Extensible: No | C130263 | Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Code | Quick Inventory of Depressive Symptomatology Self-Report Version test code. | CDISC Questionnaire QIDS-SR Test Code Terminology |
QIDSR101 | C130584 | QIDSR1-Falling Asleep | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Falling asleep. | QIDS-SR - Falling Asleep | ||
QIDSR102 | C130585 | QIDSR1-Sleep During the Night | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleep during the night. | QIDS-SR - Sleep During the Night | ||
QIDSR103 | C130586 | QIDSR1-Waking Up Too Early | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Waking up too early. | QIDS-SR - Waking Up Too Early | ||
QIDSR104 | C130587 | QIDSR1-Sleeping Too Much | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleeping too much. | QIDS-SR - Sleeping Too Much | ||
QIDSR105 | C130588 | QIDSR1-Feeling Sad | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling sad. | QIDS-SR - Feeling Sad | ||
QIDSR106 | C130589 | QIDSR1-Decreased Appetite | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Decreased appetite. | QIDS-SR - Decreased Appetite | ||
QIDSR107 | C130590 | QIDSR1-Increased Appetite | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Increased appetite. | QIDS-SR - Increased Appetite | ||
QIDSR108 | C130591 | QIDSR1-Decreased Weight | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Decreased weight. | QIDS-SR - Decreased Weight | ||
QIDSR109 | C130592 | QIDSR1-Increased Weight | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Increased weight. | QIDS-SR - Increased Weight | ||
QIDSR110 | C130593 | QIDSR1-Concentration/Decision Making | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Concentration/decision making. | QIDS-SR - Concentration or Decision Making | ||
QIDSR111 | C130594 | QIDSR1-View of Myself | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of myself. | QIDS-SR - View of Myself | ||
QIDSR112 | C130595 | QIDSR1-Thoughts of Death or Suicide | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Thoughts of death or suicide. | QIDS-SR - Thoughts of Death or Suicide | ||
QIDSR113 | C130596 | QIDSR1-General Interest | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: General interest. | QIDS-SR - General Interest | ||
QIDSR114 | C130597 | QIDSR1-Energy Level | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Energy level. | QIDS-SR - Energy Level | ||
QIDSR115 | C130598 | QIDSR1-Feeling Slowed Down | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling slowed down. | QIDS-SR - Feeling Slowed Down | ||
QIDSR116 | C130599 | QIDSR1-Feeling Restless | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling restless. | QIDS-SR - Feeling Restless | ||
QIDSR117 | C130600 | QIDSR1-Highest Score Sleep Items | Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on any 1 of the 4 sleep items. | QIDS-SR - Highest Score Sleep Items | ||
QIDSR118 | C130601 | QIDSR1-High Score Appetite/Weight Items | Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on any 1 of the 4 appetite/weight change items. | QIDS-SR - High Score Appetite or Weight Items | ||
QIDSR119 | C130602 | QIDSR1-Highest Score Psychomotor Items | Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on either of the 2 psychomotor items. | QIDS-SR - Highest Score Psychomotor Items | ||
QIDSR120 | C130603 | QIDSR1-Total Score | Quick Inventory of Depressive Symptomatology - Self-Report - Total score. | QIDS-SR - Total Score | ||
Back to top | ||||||
CL.C130262.QIDSR1TN | Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Name
(QIDSR1TN) | text
Extensible: No | C130262 | Quick Inventory of Depressive Symptomatology Self-Report Version Questionnaire Test Name | Quick Inventory of Depressive Symptomatology Self-Report Version test name. | CDISC Questionnaire QIDS-SR Test Name Terminology |
QIDSR1-Concentration/Decision Making | C130593 | QIDSR1-Concentration/Decision Making | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Concentration/decision making. | QIDS-SR - Concentration or Decision Making | ||
QIDSR1-Decreased Appetite | C130589 | QIDSR1-Decreased Appetite | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Decreased appetite. | QIDS-SR - Decreased Appetite | ||
QIDSR1-Decreased Weight | C130591 | QIDSR1-Decreased Weight | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Decreased weight. | QIDS-SR - Decreased Weight | ||
QIDSR1-Energy Level | C130597 | QIDSR1-Energy Level | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Energy level. | QIDS-SR - Energy Level | ||
QIDSR1-Falling Asleep | C130584 | QIDSR1-Falling Asleep | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Falling asleep. | QIDS-SR - Falling Asleep | ||
QIDSR1-Feeling Restless | C130599 | QIDSR1-Feeling Restless | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling restless. | QIDS-SR - Feeling Restless | ||
QIDSR1-Feeling Sad | C130588 | QIDSR1-Feeling Sad | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling sad. | QIDS-SR - Feeling Sad | ||
QIDSR1-Feeling Slowed Down | C130598 | QIDSR1-Feeling Slowed Down | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Feeling slowed down. | QIDS-SR - Feeling Slowed Down | ||
QIDSR1-General Interest | C130596 | QIDSR1-General Interest | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: General interest. | QIDS-SR - General Interest | ||
QIDSR1-High Score Appetite/Weight Items | C130601 | QIDSR1-High Score Appetite/Weight Items | Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on any 1 of the 4 appetite/weight change items. | QIDS-SR - High Score Appetite or Weight Items | ||
QIDSR1-Highest Score Psychomotor Items | C130602 | QIDSR1-Highest Score Psychomotor Items | Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on either of the 2 psychomotor items. | QIDS-SR - Highest Score Psychomotor Items | ||
QIDSR1-Highest Score Sleep Items | C130600 | QIDSR1-Highest Score Sleep Items | Quick Inventory of Depressive Symptomatology - Self-Report - Enter the highest score on any 1 of the 4 sleep items. | QIDS-SR - Highest Score Sleep Items | ||
QIDSR1-Increased Appetite | C130590 | QIDSR1-Increased Appetite | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Increased appetite. | QIDS-SR - Increased Appetite | ||
QIDSR1-Increased Weight | C130592 | QIDSR1-Increased Weight | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: within the last two weeks: Increased weight. | QIDS-SR - Increased Weight | ||
QIDSR1-Sleep During the Night | C130585 | QIDSR1-Sleep During the Night | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleep during the night. | QIDS-SR - Sleep During the Night | ||
QIDSR1-Sleeping Too Much | C130587 | QIDSR1-Sleeping Too Much | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Sleeping too much. | QIDS-SR - Sleeping Too Much | ||
QIDSR1-Thoughts of Death or Suicide | C130595 | QIDSR1-Thoughts of Death or Suicide | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Thoughts of death or suicide. | QIDS-SR - Thoughts of Death or Suicide | ||
QIDSR1-Total Score | C130603 | QIDSR1-Total Score | Quick Inventory of Depressive Symptomatology - Self-Report - Total score. | QIDS-SR - Total Score | ||
QIDSR1-View of Myself | C130594 | QIDSR1-View of Myself | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: View of myself. | QIDS-SR - View of Myself | ||
QIDSR1-Waking Up Too Early | C130586 | QIDSR1-Waking Up Too Early | Quick Inventory of Depressive Symptomatology - Self-Report - Please circle the one response to each item that best describes you for the past seven days: Waking up too early. | QIDS-SR - Waking Up Too Early | ||
Back to top | ||||||
CL.C74457.RACE | Race
(RACE) | text
Extensible: No | C74457 | Race | Terminology codelist used to identify the race of an individual within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model. | CDISC SDTM Race Terminology |
AMERICAN INDIAN OR ALASKA NATIVE | C41259 | A person having origins in any of the original peoples of North and South America (including Central America), and who maintains tribal affiliation or community attachment. (FDA) | American Indian or Alaska Native | |||
ASIAN | C41260 | A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. (FDA) | Asian | |||
BLACK OR AFRICAN AMERICAN | C16352 | A person having origins in any of the black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American." (FDA) | Black or African American | |||
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | C41219 | Denotes a person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. The term covers particularly people who identify themselves as part-Hawaiian, Native Hawaiian, Guamanian or Chamorro, Carolinian, Samoan, Chuu. (FDA) | Native Hawaiian or Other Pacific Islander | |||
NOT REPORTED | C43234 | Not reported | Not provided or available. | Not Reported | ||
OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
WHITE | C41261 | Denotes a person with European, Middle Eastern, or North African ancestral origin who identifies, or is identified, as White. (FDA) | White | |||
Back to top | ||||||
CL.C128689.RACEC | Race As Collected
(RACEC) | text
Extensible: Yes | C128689 | Race As Collected | A terminology codelist relevant to the race of an individual as collected on the case report form. | CDISC SDTM Collected Race Terminology |
ABORIGINAL AUSTRALIAN | C154875 | The native people of Australia. | Aboriginal Australian | |||
AFRICAN AMERICAN | C128937 | A person having origins in the original peoples of sub-Saharan Africa and the United States. | African American | |||
AFRICAN CARIBBEAN | C41226 | A person having origins in the original peoples of sub-Saharan Africa and the Caribbean. | African Caribbean | |||
AFRICAN | C42331 | A person having origins in any of the original peoples of sub-Saharan Africa. | African | |||
ALASKA NATIVE | C18237 | The native people of Alaska. | Alaska Native | |||
AMERICAN INDIAN OR ALASKA NATIVE | C41259 | A person having origins in any of the original peoples of North and South America (including Central America), and who maintains tribal affiliation or community attachment. (FDA) | American Indian or Alaska Native | |||
AMERICAN INDIAN | C43877 | The native people of North America. | American Indian | |||
ARAB | C43876 | A person having origins in any of the original peoples of the Arabian peninsula and surrounding territories in the Middle East and northern Africa. | Arab | |||
ASIAN AMERICAN | C16310 | A person having origins in the original peoples of Asia and the United States. | Asian American | |||
ASIAN INDIAN | C41262 | A person having origins in any of the original peoples of the Indian subcontinent. | Asian Indian | |||
ASIAN | C41260 | A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. (FDA) | Asian | |||
BAHAMIAN | C67271 | A person having origins in any of the original peoples of the Bahamas. | Bahamian | |||
BANGLADESHI | C43671 | A person having origins in any of the original peoples of Bangladesh. | Bangladeshi | |||
BARBADIAN | C43823 | A person having origins in any of the original peoples of Barbados. | Barbadian | |||
BHUTANESE | C43673 | A person having origins in any of the original peoples of Bhutan. | Bhutanese | |||
BLACK CENTRAL AMERICAN | C128991 | A person having origins in the original peoples of sub-Saharan Africa and Central America. | Black Central American | |||
BLACK OR AFRICAN AMERICAN | C16352 | A person having origins in any of the black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American." (FDA) | Black or African American | |||
BLACK SOUTH AMERICAN | C128992 | A person having origins in the original peoples of sub-Saharan Africa and South America. | Black South American | |||
BLACK | C128938 | A person having origins in the original peoples of sub-Saharan Africa or the Caribbean. | Black | |||
BOTSWANAN | C43830 | A person having origins in any of the original peoples of Botswana. | Botswanan | |||
BURMESE | C43674 | A person having origins in any of the original peoples of Myanmar (formerly Burma). | Burmese | |||
CAMBODIAN | C43399 | A person having origins in any of the original peoples of Cambodia (formerly Kampuchea). | Cambodian | |||
CARIBBEAN INDIAN | C77810 | The native people of the Caribbean. | Caribbean Indian | |||
CENTRAL AMERICAN INDIAN | C44950 | The native people of Central America. | Central American Indian | |||
CENTRAL ASIAN | C126534 | A person having origins in any of the original peoples of Central Asia. | Central Asian | |||
CHAMORRO | C43403 | The native people of the Mariana Islands, including the United States territories of Guam and the Commonwealth of the Northern Mariana Islands in Micronesia. | Chamorran | |||
CHINESE | C43391 | A person having origins in any of the original peoples of China. | Chinese | |||
DOMINICA ISLANDER | C43824 | A person having origins in any of the original peoples of Dominica. | Dominica Islander | |||
DOMINICAN | C67117 | A person having origins in any of the original peoples of the Dominican Republic. | Dominican | |||
EAST ASIAN | C161419 | A person having origins in any of the original peoples of East Asia. | East Asian | |||
EASTERN EUROPEAN | C77819 | A person having origins in any of the original peoples of Eastern Europe. | Eastern European | |||
ENGLISH | C43853 | A person having origins in any of the original peoples of England. | English | |||
ETHIOPIAN | C43831 | A person having origins in any of the original peoples of Ethiopia. | Ethiopian | |||
EUROPEAN | C43851 | A person having origins in any of the original peoples of Europe. | European | |||
FILIPINO | C43393 | A person having origins in any of the original peoples of the Philippines. | Filipino | |||
GREENLAND INUIT | C44265 | The native people of Greenland. | Greenland Eskimo | |||
GUAMANIAN OR CHAMORRO | C43837 | A person having origins in the original peoples of the United States territories of Guam and the Commonwealth of the Northern Mariana Islands in Micronesia. | Guamanian or Chamorro | |||
GUAMANIAN | C43404 | A person having origins in any of the original peoples of Guam. | Guamanian | |||
HAITIAN | C43825 | A person having origins in any of the original peoples of Haiti. | Haitian | |||
HMONG | C43398 | The native people originating in China around the Yellow River or Hoang Ho. | Hmong | |||
INDONESIAN | C43715 | A person having origins in any of the original peoples of Indonesia. | Indonesian | |||
INUPIAT INUIT | C44268 | The native people inhabiting the territory spanning the Norton Sound on the Bering Sea to the Canadian border. | Inupiat Eskimo | |||
IRISH | C43856 | A person having origins in any of the original peoples of Ireland. | Irish | |||
IWO JIMAN | C43718 | A person having origins in any of the original peoples of Iwo Jima. | Iwo Jiman | |||
JAMAICAN | C43826 | A person having origins in any of the original peoples of Jamaica. | Jamaican | |||
JAPANESE | C43392 | A person having origins in any of the original peoples of Japan. | Japanese | |||
KHOISAN | C154874 | The native people of the Western Cape in southern Africa. | Khoisan | |||
KOREAN | C43395 | A person having origins in any of the original peoples of North and South Korea. | Korean | |||
LAOTIAN | C43397 | A person having origins in any of the original peoples of Laos. | Laotian | |||
LATIN AMERICAN | C126531 | A person of Latin American descent. | Latin American | |||
LIBERIAN | C43832 | A person having origins in any of the original peoples of Liberia. | Liberian | |||
MALAGASY | C43722 | A person having origins in any of the original peoples of Madagascar. | Malagasy | |||
MALAYSIAN | C43716 | A person having origins in any of the original peoples of Malaysia. | Malaysian | |||
MALDIVIAN | C43719 | A person having origins in any of the original peoples of the Maldives. | Maldivian | |||
MAORI | C158274 | The native people of New Zealand. | Maori | |||
MEDITERRANEAN | C77811 | A person having origins in any of the original peoples of the countries surrounding the Mediterranean sea. | Mediterranean | |||
MELANESIAN | C43409 | A person having origins in any of the original peoples of Melanesia. | Melanesian | |||
MICRONESIAN | C43402 | A person having origins in any of the original peoples of Micronesia. | Micronesian | |||
MIDDLE EASTERN | C77820 | A person having origins in any of the original peoples of the Middle East. | Middle Eastern | |||
MONGOLIAN | C43864 | A person having origins in any of the original peoples of Mongolia. | Mongolian | |||
NAMIBIAN | C43833 | A person having origins in any of the original peoples of Namibia. | Namibian | |||
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | C41219 | Denotes a person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. The term covers particularly people who identify themselves as part-Hawaiian, Native Hawaiian, Guamanian or Chamorro, Carolinian, Samoan, Chuu. (FDA) | Native Hawaiian or Other Pacific Islander | |||
NATIVE HAWAIIAN | C43394 | A person having origins in any of the original peoples of Hawaii. (NCI) | Native Hawaiian | |||
NEPALESE | C43720 | A person having origins in any of the original peoples of Nepal. | Nepalese | |||
NIGERIAN | C43834 | A person having origins in any of the original peoples of Nigeria. | Nigerian | |||
NORTH AFRICAN | C77813 | A person having origins in any of the original peoples of North Africa. | North Coast of Africa | |||
NORTHERN EUROPEAN | C77814 | A person having origins in any of the original peoples of Northern Europe. | Northern European | |||
NOT REPORTED | C43234 | Not reported | Not provided or available. | Not Reported | ||
OKINAWAN | C43717 | A person having origins in any of the original peoples of Okinawa. | Okinawan | |||
OTHER PACIFIC ISLANDER | C107602 | A person having origins in the original peoples of the Pacific Islands, but not Guam, Hawaii, the Mariana Islands or Samoa. (NCI) | Other Pacific Islander | |||
OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
PAKISTANI | C43427 | A person having origins in any of the original peoples of Pakistan. | Pakistani | |||
POLYNESIAN | C43405 | A person having origins in any of the original peoples of Polynesia. | Polynesian | |||
RUSSIAN | C43860 | A person having origins in any of the original peoples of Russia. | Russian | |||
SAMOAN | C43407 | A person having origins in any of the original peoples of Samoa. (NCI) | Samoan | |||
SIBERIAN ESKIMO | C44269 | The native Yupik people inhabiting the coast of the Chukchi Peninsula in the far northeast of the Russian Federation and on St. Lawrence Island in Alaska. | Siberian Eskimo | |||
SINGAPOREAN | C43721 | A person having origins in any of the original peoples of Singapore. | Singaporean | |||
SOUTH AMERICAN INDIAN | C44953 | The native people of South America. | South American Indian | |||
SOUTH ASIAN | C41263 | A person having origins in any of the original peoples of the South Asia. | South Asian | |||
SOUTHEAST ASIAN | C126533 | A person having origins in any of the original peoples of Southeast Asia. | Southeast Asian | |||
SOUTHERN AFRICAN COLOURED | C156583 | A person whose ancestry is from one or more of the indigenous Southern African peoples and one or more of the naturalized racial groups of Southern Africa (typically Western European, South Asian, or Southeastern Asian). | Southern African Coloured | |||
SRI LANKAN | C43672 | A person having origins in any of the original peoples of Sri Lanka. | Sri Lankan | |||
TAIWANESE | C43675 | A person having origins in any of the original peoples of Taiwan. | Taiwanese | |||
THAI | C43400 | A person having origins in any of the original peoples of Thailand. | Thai | |||
TOBAGOAN | C43827 | A person having origins in any of the original peoples of Tobago. | Tobagoan | |||
TRINIDADIAN | C43828 | A person having origins in any of the original peoples of Trinidad. | Trinidadian | |||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
VIETNAMESE | C43396 | A person having origins in any of the original peoples of Viet Nam. | Vietnamese | |||
WEST ASIAN | C153343 | A person having origins in any of the original peoples of Western Asia. | Western Asian | |||
WEST INDIAN | C43829 | A person having origins in any of the original peoples of the West Indies. | West Indian | |||
WESTERN EUROPEAN | C77817 | A person having origins in any of the original peoples of Western Europe. | Western European | |||
WHITE CARIBBEAN | C77816 | A person having origins in the original peoples of Europe, the Middle East, or North Africa, and the Caribbean. | White Caribbean | |||
WHITE CENTRAL AMERICAN | C128993 | A person having origins in the original peoples of Europe, the Middle East, or North Africa, and Central America. | White Central American | |||
WHITE SOUTH AMERICAN | C128994 | A person having origins in the original peoples of Europe, the Middle East, or North Africa, and South America. | White South American | |||
WHITE | C41261 | Denotes a person with European, Middle Eastern, or North African ancestral origin who identifies, or is identified, as White. (FDA) | White | |||
YUPIK ESKIMO | C44270 | The native people inhabiting western, southwestern, and southcentral Alaska and the Russian Far East. | Yupik Eskimo | |||
ZAIREAN | C43835 | A person having origins in any of the original peoples of Zaire. | Zairean | |||
Back to top | ||||||
CL.C113862.R3601TC | RAND 36-Item Health Survey 1.0 Questionnaire Test Code
(R3601TC) | text
Extensible: No | C113862 | RAND 36-Item Health Survey 1.0 Questionnaire Test Code | RAND 36-Item Health Survey 1.0 test code. | CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Code Terminology |
R360101 | C114043 | R3601-Would You Say Your Health Is | RAND 36-Item Health Survey 1.0 - In general, would you say your health is: | RAND-36 - Rate Your Health | ||
R360102 | C114044 | R3601-Health Now Compared to 1 Year Ago | RAND 36-Item Health Survey 1.0 - Compared to one year ago, how would you rate your health in general now? | RAND-36 - Rate Your Health Compared to One Year Ago | ||
R360103 | C114045 | R3601-Health Limit Vigorous Activities | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | RAND-36 - Health Limit Vigorous Activities | ||
R360104 | C114046 | R3601-Health Limit Moderate Activities | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | RAND-36 - Health Limit Moderate Activities | ||
R360105 | C114047 | R3601-Health Limit Carrying Groceries | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Lifting or carrying groceries. | RAND-36 - Health Limit Lifting Groceries | ||
R360106 | C114048 | R3601-Health Limit Climb Several Flights | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Climbing several flights of stairs. | RAND-36 - Health Limit Climbing Several Flights | ||
R360107 | C114049 | R3601-Health Limit Climb One Flight | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Climbing one flight of stairs. | RAND-36 - Health Limit Climbing One Flight | ||
R360108 | C114050 | R3601-Health Limit Bending or Kneeling | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Bending, kneeling, or stooping. | RAND-36 - Health Limit Bending or Stooping | ||
R360109 | C114051 | R3601-Health Limit Walk More Than Mile | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking more than a mile. | RAND-36 - Health Limit Walking More Than A Mile | ||
R360110 | C114052 | R3601-Health Limit Walk Several Blocks | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking several blocks. | RAND-36 - Health Limit Walking Several Blocks | ||
R360111 | C114053 | R3601-Health Limit Walk One Block | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking one block. | RAND-36 - Health Limit Walking One Block | ||
R360112 | C114054 | R3601-Health Limit Bathing/Dressing Self | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Bathing or dressing yourself. | RAND-36 - Health Limit Bathing or Dressing | ||
R360113 | C114055 | R3601-Phys Health: Cut Work Time | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Cut down the amount of time you spent on work or other activities. | RAND-36 - Physical Health Cut Down Time Spent on Work | ||
R360114 | C114056 | R3601-Phys Health: Accomplish Less | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. | RAND-36 - Physical Health Accomplished Less | ||
R360115 | C114057 | R3601-Phys Health: Limit Kind of Work | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. | RAND-36 - Physical Health Limited in the Kind of Work | ||
R360116 | C114058 | R3601-Phys Health: Difficulty Performing | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Had difficulty performing the work or other activities. | RAND-36 - Physical Health Difficulty Performing Work | ||
R360117 | C114059 | R3601-Emotional Problem: Cut Work Time | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Cut down the amount of time you spent on work or other activities. | RAND-36 - Emotional Problem Cut Down Time Spent on Work | ||
R360118 | C114060 | R3601-Emotional Problem: Accomplish Less | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Accomplished less than you would like. | RAND-36 - Emotional Problem Accomplished Less | ||
R360119 | C114061 | R3601-Emotional Problem: Less Careful | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Didn't do work or other activities as carefully as usual. | RAND-36 - Emotional Problem Did Not Do Work as Carefully | ||
R360120 | C114062 | R3601-Extent Interfered Social Activity | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | RAND-36 - Extend Physical Health or Emotional Problems Interfere With Social Activities | ||
R360121 | C114063 | R3601-How Much Bodily Pain Have You Had | RAND 36-Item Health Survey 1.0 - How much bodily pain have you had during the past 4 weeks? | RAND-36 - Bodily Pain | ||
R360122 | C114064 | R3601-Did Pain Interfere With Your Work | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, how much did pain interfere with your normal work? | RAND-36 - Pain Interfere With Normal Work | ||
R360123 | C114065 | R3601-Did You Feel Full of Pep | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel full of pep? | RAND-36 - Feel Full of Pep | ||
R360124 | C114066 | R3601-Have Been a Very Nervous Person | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you been a very nervous person? | RAND-36 - Been a Nervous Person | ||
R360125 | C114067 | R3601-Have Felt So Down in the Dumps | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt so down in the dumps that nothing could cheer you up? | RAND-36 - Felt Nothing Could Cheer You Up | ||
R360126 | C114068 | R3601-Have You Felt Calm and Peaceful | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt calm and peaceful? | RAND-36 - Felt Calm and Peaceful | ||
R360127 | C114069 | R3601-Did You Have a Lot of Energy | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you have a lot of energy? | RAND-36 - Have a Lot of Energy | ||
R360128 | C114070 | R3601-Have Felt Downhearted and Blue | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt downhearted and blue? | RAND-36 - Felt Downhearted and Blue | ||
R360129 | C114071 | R3601-Did You Feel Worn Out | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel worn out? | RAND-36 - Feel Worn Out | ||
R360130 | C114072 | R3601-Have You Been a Happy Person | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you been a happy person? | RAND-36 - Been a Happy Person | ||
R360131 | C114073 | R3601-Did You Feel Tired | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel tired? | RAND-36 - Feel Tired | ||
R360132 | C114074 | R3601-Amt Time Interfere Social Activity | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities? | RAND-36 - Time Physical Health or Emotional Problems Interfere With Social Activities | ||
R360133 | C114075 | R3601-Get Sick Easier Than Other People | RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I seem to get sick a little easier than other people. | RAND-36 - Get Sick Easier Than Other | ||
R360134 | C114076 | R3601-I Am as Healthy as Anybody I Know | RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I am as healthy as anybody I know. | RAND-36 - As Healthy as Anybody | ||
R360135 | C114077 | R3601-I Expect My Health to Get Worse | RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I expect my health to get worse. | RAND-36 - Expect Health to Get Worse | ||
R360136 | C114078 | R3601-My Health Is Excellent | RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: My health is excellent. | RAND-36 - My Health is Excellent | ||
Back to top | ||||||
CL.C113861.R3601TN | RAND 36-Item Health Survey 1.0 Questionnaire Test Name
(R3601TN) | text
Extensible: No | C113861 | RAND 36-Item Health Survey 1.0 Questionnaire Test Name | RAND 36-Item Health Survey 1.0 test name. | CDISC Questionnaire RAND 36-Item Health Survey 1.0 Test Name Terminology |
R3601-Amt Time Interfere Social Activity | C114074 | R3601-Amt Time Interfere Social Activity | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities? | RAND-36 - Time Physical Health or Emotional Problems Interfere With Social Activities | ||
R3601-Did Pain Interfere With Your Work | C114064 | R3601-Did Pain Interfere With Your Work | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, how much did pain interfere with your normal work? | RAND-36 - Pain Interfere With Normal Work | ||
R3601-Did You Feel Full of Pep | C114065 | R3601-Did You Feel Full of Pep | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel full of pep? | RAND-36 - Feel Full of Pep | ||
R3601-Did You Feel Tired | C114073 | R3601-Did You Feel Tired | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel tired? | RAND-36 - Feel Tired | ||
R3601-Did You Feel Worn Out | C114071 | R3601-Did You Feel Worn Out | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you feel worn out? | RAND-36 - Feel Worn Out | ||
R3601-Did You Have a Lot of Energy | C114069 | R3601-Did You Have a Lot of Energy | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Did you have a lot of energy? | RAND-36 - Have a Lot of Energy | ||
R3601-Emotional Problem: Accomplish Less | C114060 | R3601-Emotional Problem: Accomplish Less | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Accomplished less than you would like. | RAND-36 - Emotional Problem Accomplished Less | ||
R3601-Emotional Problem: Cut Work Time | C114059 | R3601-Emotional Problem: Cut Work Time | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Cut down the amount of time you spent on work or other activities. | RAND-36 - Emotional Problem Cut Down Time Spent on Work | ||
R3601-Emotional Problem: Less Careful | C114061 | R3601-Emotional Problem: Less Careful | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems: Didn't do work or other activities as carefully as usual. | RAND-36 - Emotional Problem Did Not Do Work as Carefully | ||
R3601-Extent Interfered Social Activity | C114062 | R3601-Extent Interfered Social Activity | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | RAND-36 - Extend Physical Health or Emotional Problems Interfere With Social Activities | ||
R3601-Get Sick Easier Than Other People | C114075 | R3601-Get Sick Easier Than Other People | RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I seem to get sick a little easier than other people. | RAND-36 - Get Sick Easier Than Other | ||
R3601-Have Been a Very Nervous Person | C114066 | R3601-Have Been a Very Nervous Person | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you been a very nervous person? | RAND-36 - Been a Nervous Person | ||
R3601-Have Felt Downhearted and Blue | C114070 | R3601-Have Felt Downhearted and Blue | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt downhearted and blue? | RAND-36 - Felt Downhearted and Blue | ||
R3601-Have Felt So Down in the Dumps | C114067 | R3601-Have Felt So Down in the Dumps | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt so down in the dumps that nothing could cheer you up? | RAND-36 - Felt Nothing Could Cheer You Up | ||
R3601-Have You Been a Happy Person | C114072 | R3601-Have You Been a Happy Person | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you been a happy person? | RAND-36 - Been a Happy Person | ||
R3601-Have You Felt Calm and Peaceful | C114068 | R3601-Have You Felt Calm and Peaceful | RAND 36-Item Health Survey 1.0 - How much of the time during the past 4 weeks: Have you felt calm and peaceful? | RAND-36 - Felt Calm and Peaceful | ||
R3601-Health Limit Bathing/Dressing Self | C114054 | R3601-Health Limit Bathing/Dressing Self | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Bathing or dressing yourself. | RAND-36 - Health Limit Bathing or Dressing | ||
R3601-Health Limit Bending or Kneeling | C114050 | R3601-Health Limit Bending or Kneeling | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Bending, kneeling, or stooping. | RAND-36 - Health Limit Bending or Stooping | ||
R3601-Health Limit Carrying Groceries | C114047 | R3601-Health Limit Carrying Groceries | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Lifting or carrying groceries. | RAND-36 - Health Limit Lifting Groceries | ||
R3601-Health Limit Climb One Flight | C114049 | R3601-Health Limit Climb One Flight | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Climbing one flight of stairs. | RAND-36 - Health Limit Climbing One Flight | ||
R3601-Health Limit Climb Several Flights | C114048 | R3601-Health Limit Climb Several Flights | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Climbing several flights of stairs. | RAND-36 - Health Limit Climbing Several Flights | ||
R3601-Health Limit Moderate Activities | C114046 | R3601-Health Limit Moderate Activities | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | RAND-36 - Health Limit Moderate Activities | ||
R3601-Health Limit Vigorous Activities | C114045 | R3601-Health Limit Vigorous Activities | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | RAND-36 - Health Limit Vigorous Activities | ||
R3601-Health Limit Walk More Than Mile | C114051 | R3601-Health Limit Walk More Than Mile | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking more than a mile. | RAND-36 - Health Limit Walking More Than A Mile | ||
R3601-Health Limit Walk One Block | C114053 | R3601-Health Limit Walk One Block | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking one block. | RAND-36 - Health Limit Walking One Block | ||
R3601-Health Limit Walk Several Blocks | C114052 | R3601-Health Limit Walk Several Blocks | RAND 36-Item Health Survey 1.0 - Does your health now limit you in these activities: Walking several blocks. | RAND-36 - Health Limit Walking Several Blocks | ||
R3601-Health Now Compared to 1 Year Ago | C114044 | R3601-Health Now Compared to 1 Year Ago | RAND 36-Item Health Survey 1.0 - Compared to one year ago, how would you rate your health in general now? | RAND-36 - Rate Your Health Compared to One Year Ago | ||
R3601-How Much Bodily Pain Have You Had | C114063 | R3601-How Much Bodily Pain Have You Had | RAND 36-Item Health Survey 1.0 - How much bodily pain have you had during the past 4 weeks? | RAND-36 - Bodily Pain | ||
R3601-I Am as Healthy as Anybody I Know | C114076 | R3601-I Am as Healthy as Anybody I Know | RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I am as healthy as anybody I know. | RAND-36 - As Healthy as Anybody | ||
R3601-I Expect My Health to Get Worse | C114077 | R3601-I Expect My Health to Get Worse | RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: I expect my health to get worse. | RAND-36 - Expect Health to Get Worse | ||
R3601-My Health Is Excellent | C114078 | R3601-My Health Is Excellent | RAND 36-Item Health Survey 1.0 - How TRUE or FALSE is each of the following statements for you: My health is excellent. | RAND-36 - My Health is Excellent | ||
R3601-Phys Health: Accomplish Less | C114056 | R3601-Phys Health: Accomplish Less | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Accomplished less than you would like. | RAND-36 - Physical Health Accomplished Less | ||
R3601-Phys Health: Cut Work Time | C114055 | R3601-Phys Health: Cut Work Time | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Cut down the amount of time you spent on work or other activities. | RAND-36 - Physical Health Cut Down Time Spent on Work | ||
R3601-Phys Health: Difficulty Performing | C114058 | R3601-Phys Health: Difficulty Performing | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Had difficulty performing the work or other activities. | RAND-36 - Physical Health Difficulty Performing Work | ||
R3601-Phys Health: Limit Kind of Work | C114057 | R3601-Phys Health: Limit Kind of Work | RAND 36-Item Health Survey 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health: Were limited in the kind of work or other activities. | RAND-36 - Physical Health Limited in the Kind of Work | ||
R3601-Would You Say Your Health Is | C114043 | R3601-Would You Say Your Health Is | RAND 36-Item Health Survey 1.0 - In general, would you say your health is: | RAND-36 - Rate Your Health | ||
Back to top | ||||||
CL.C135700.RSSS01TC | RAND Social Support Survey Instrument Questionnaire Test Code
(RSSS01TC) | text
Extensible: No | C135700 | RAND Social Support Survey Instrument Questionnaire Test Code | RAND Social Support Survey Instrument test code. | CDISC Questionnaire RAND Social Support Survey Test Code Terminology |
RSSS0101 | C136215 | RSSS01-Count on to Listen to You | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone you can count on to listen to you when you need to talk. | RAND Social Support Survey - Count on to Listen to You | ||
RSSS0102 | C136216 | RSSS01-Give You Info to Help Understand | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to give you information to help you understand a situation. | RAND Social Support Survey - Give You Info to Help Understand | ||
RSSS0103 | C136217 | RSSS01-Give You Advice About a Crisis | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to give you good advice about a crisis. | RAND Social Support Survey - Give You Advice About a Crisis | ||
RSSS0104 | C136218 | RSSS01-Confide in/Talk to About Yourself | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to confide in or talk to about yourself or your problems. | RAND Social Support Survey - Confide in or Talk to About Yourself | ||
RSSS0105 | C136219 | RSSS01-Advice You Really Want | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone whose advice you really want. | RAND Social Support Survey - Advice You Really Want | ||
RSSS0106 | C136220 | RSSS01-Share Your Private Worries/Fears | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to share your most private worries and fears with. | RAND Social Support Survey - Share Your Private Worries and Fears | ||
RSSS0107 | C136221 | RSSS01-Turn to Suggestions Personal Prob | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to turn to for suggestions about how to deal with a personal problem. | RAND Social Support Survey - Suggestions to Deal With Personal Problem | ||
RSSS0108 | C136222 | RSSS01-Understands Your Problems | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who understands your problems. | RAND Social Support Survey - Understands Your Problems | ||
RSSS0109 | C136223 | RSSS01-Help If You Were Confined to Bed | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to help you if you were confined to bed. | RAND Social Support Survey - Help If You Were Confined to Bed | ||
RSSS0110 | C136224 | RSSS01-Take You to the Doctor If Needed | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to take you to the doctor if you needed it. | RAND Social Support Survey - Take You to the Doctor If Needed | ||
RSSS0111 | C136225 | RSSS01-Prepare Your Meals If Unable | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to prepare your meals if you were unable to do it yourself. | RAND Social Support Survey - Prepare Your Meals If Unable | ||
RSSS0112 | C136226 | RSSS01-Help With Daily Chores If Sick | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to help with daily chores if you were sick. | RAND Social Support Survey - Help With Daily Chores If Sick | ||
RSSS0113 | C136227 | RSSS01-Shows You Love and Affection | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who shows you love and affection. | RAND Social Support Survey - Shows You Love and Affection | ||
RSSS0114 | C136228 | RSSS01-Love and Make You Feel Wanted | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to love and make you feel wanted. | RAND Social Support Survey - Love and Make You Feel Wanted | ||
RSSS0115 | C136229 | RSSS01-Hugs You | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who hugs you. | RAND Social Support Survey - Hugs You | ||
RSSS0116 | C136230 | RSSS01-Have a Good Time With | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to have a good time with. | RAND Social Support Survey - Have a Good Time With | ||
RSSS0117 | C136231 | RSSS01-Get Together With for Relaxation | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to get together with for relaxation. | RAND Social Support Survey - Get Together With for Relaxation | ||
RSSS0118 | C136232 | RSSS01-Do Something Enjoyable With | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to do something enjoyable with. | RAND Social Support Survey - Do Something Enjoyable With | ||
RSSS0119 | C136233 | RSSS01-Help You Get Your Mind Off Things | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to do things with to help you get your mind off things. | RAND Social Support Survey - Help You Get Your Mind Off Things | ||
Back to top | ||||||
CL.C135699.RSSS01TN | RAND Social Support Survey Instrument Questionnaire Test Name
(RSSS01TN) | text
Extensible: No | C135699 | RAND Social Support Survey Instrument Questionnaire Test Name | RAND Social Support Survey Instrument test name. | CDISC Questionnaire RAND Social Support Survey Test Name Terminology |
RSSS01-Advice You Really Want | C136219 | RSSS01-Advice You Really Want | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone whose advice you really want. | RAND Social Support Survey - Advice You Really Want | ||
RSSS01-Confide in/Talk to About Yourself | C136218 | RSSS01-Confide in/Talk to About Yourself | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to confide in or talk to about yourself or your problems. | RAND Social Support Survey - Confide in or Talk to About Yourself | ||
RSSS01-Count on to Listen to You | C136215 | RSSS01-Count on to Listen to You | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone you can count on to listen to you when you need to talk. | RAND Social Support Survey - Count on to Listen to You | ||
RSSS01-Do Something Enjoyable With | C136232 | RSSS01-Do Something Enjoyable With | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to do something enjoyable with. | RAND Social Support Survey - Do Something Enjoyable With | ||
RSSS01-Get Together With for Relaxation | C136231 | RSSS01-Get Together With for Relaxation | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to get together with for relaxation. | RAND Social Support Survey - Get Together With for Relaxation | ||
RSSS01-Give You Advice About a Crisis | C136217 | RSSS01-Give You Advice About a Crisis | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to give you good advice about a crisis. | RAND Social Support Survey - Give You Advice About a Crisis | ||
RSSS01-Give You Info to Help Understand | C136216 | RSSS01-Give You Info to Help Understand | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to give you information to help you understand a situation. | RAND Social Support Survey - Give You Info to Help Understand | ||
RSSS01-Have a Good Time With | C136230 | RSSS01-Have a Good Time With | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to have a good time with. | RAND Social Support Survey - Have a Good Time With | ||
RSSS01-Help If You Were Confined to Bed | C136223 | RSSS01-Help If You Were Confined to Bed | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to help you if you were confined to bed. | RAND Social Support Survey - Help If You Were Confined to Bed | ||
RSSS01-Help With Daily Chores If Sick | C136226 | RSSS01-Help With Daily Chores If Sick | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to help with daily chores if you were sick. | RAND Social Support Survey - Help With Daily Chores If Sick | ||
RSSS01-Help You Get Your Mind Off Things | C136233 | RSSS01-Help You Get Your Mind Off Things | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to do things with to help you get your mind off things. | RAND Social Support Survey - Help You Get Your Mind Off Things | ||
RSSS01-Hugs You | C136229 | RSSS01-Hugs You | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who hugs you. | RAND Social Support Survey - Hugs You | ||
RSSS01-Love and Make You Feel Wanted | C136228 | RSSS01-Love and Make You Feel Wanted | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to love and make you feel wanted. | RAND Social Support Survey - Love and Make You Feel Wanted | ||
RSSS01-Prepare Your Meals If Unable | C136225 | RSSS01-Prepare Your Meals If Unable | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to prepare your meals if you were unable to do it yourself. | RAND Social Support Survey - Prepare Your Meals If Unable | ||
RSSS01-Share Your Private Worries/Fears | C136220 | RSSS01-Share Your Private Worries/Fears | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to share your most private worries and fears with. | RAND Social Support Survey - Share Your Private Worries and Fears | ||
RSSS01-Shows You Love and Affection | C136227 | RSSS01-Shows You Love and Affection | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who shows you love and affection. | RAND Social Support Survey - Shows You Love and Affection | ||
RSSS01-Take You to the Doctor If Needed | C136224 | RSSS01-Take You to the Doctor If Needed | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to take you to the doctor if you needed it. | RAND Social Support Survey - Take You to the Doctor If Needed | ||
RSSS01-Turn to Suggestions Personal Prob | C136221 | RSSS01-Turn to Suggestions Personal Prob | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone to turn to for suggestions about how to deal with a personal problem. | RAND Social Support Survey - Suggestions to Deal With Personal Problem | ||
RSSS01-Understands Your Problems | C136222 | RSSS01-Understands Your Problems | RAND Social Support Survey Instrument - How often is each of the following kinds of support available to you if you need it: Someone who understands your problems. | RAND Social Support Survey - Understands Your Problems | ||
Back to top | ||||||
CL.C101864.CSLVLNIM | Reason CS/LV Lead Not Implanted
(CSLVLNIM) | text
Extensible: No | C101864 | Reason CS/LV Lead Not Implanted | The reason that a Coronary Sinus Access or Left Ventricular (CS/LV) lead was not implanted. | CDISC SDTM Reason Coronary Sinus Access or Left Ventricular Lead Not Implanted Terminology |
COULD NOT OBTAIN ACCEPTABLE PACING THRESHOLDS | C100025 | The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain acceptable pacing thresholds. | Unable to Obtain Acceptable Pacing Thresholds | |||
LEAD POSITION RESULTS IN UNDESIRABLE STIMULATION OF THE DIAPHRAGM | C99933 | The coronary sinus/left ventricular lead was not implanted because the lead position resulted in undesirable stimulation of the diaphragm. | Cardiac Lead Position Results in Undesirable Stimulation of Diaphragm | |||
PREVIOUSLY IMPLANTED | C100007 | The coronary sinus/left ventricular lead was not implanted because a lead had been previously implanted. | Previously Implanted Cardiac Lead | |||
UNABLE TO OBTAIN SATISFACTORY CORONARY SINUS ACCESS | C100026 | The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory coronary sinus access. | Unable to Obtain Satisfactory Coronary Sinus Access | |||
UNABLE TO OBTAIN SATISFACTORY VASCULAR ACCESS | C100027 | The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory vascular access. | Unable to Obtain Satisfactory Vascular Access | |||
UNABLE TO POSITION LEAD DUE TO CORONARY SINUS DISSECTION | C100028 | The coronary sinus/left ventricular lead was not implanted because the coronary sinus was dissected. | Unable to Position Lead Due to Coronary Sinus Dissection | |||
UNABLE TO POSITION LEAD IN TRIBUTARY VEIN OF CORONARY SINUS | C100029 | The coronary sinus/left ventricular lead was not implanted because the operator was unable to position the lead in the tributary vein of the coronary sinus. | Unable to Position Lead In tributary Vein of Coronary Sinus | |||
Back to top | ||||||
CL.C102584.REASTRT | Reason For Treatment
(REASTRT) | text
Extensible: Yes | C102584 | Reason For Treatment | Terminology relevant to the reason the treatment was administered. | CDISC SDTM Reason For Treatment Terminology |
FAILURE AFTER FIRST TREATMENT | C102635 | A lack of response to the first cycle of therapy. | Failure After First Treatment | |||
FAILURE AFTER MULTIPLE TREATMENTS | C102636 | A lack of response to more than one cycle of therapy. | Failure After Multiple Treatments | |||
PREVIOUS PATIENT NONCOMPLIANCE | C102698 | A previous episode of failure by a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment. | Previous Patient Noncompliance | |||
RECURRENT DISEASE | C38155 | Recurrent Disease | The return of a disease after a period of remission. | Recurrent Disease | ||
Back to top | ||||||
CL.C102583.REASTINT | Reason for Treatment Interruption
(REASTINT) | text
Extensible: Yes | C102583 | Reason for Treatment Interruption | Terminology relevant to the reason the drug or therapy was temporarily ceased. | CDISC SDTM Reason for Treatment Interruption Terminology |
FORGOT TO TAKE MEDICATION DOSE | C102638 | A patient's failure to remember to take a dose of medication. | Forgot to Take Medication Dose | |||
INTOLERANCE | C71437 | An inability to absorb or metabolize certain substances in the normal way. | Intolerance | |||
MEDICATION MISPLACED | C102664 | Medications that were lost because they were put in the wrong place. | Medication Misplaced | |||
PATIENT NONCOMPLIANCE | C91752 | Failure of a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment. | Patient Noncompliance | |||
TREATMENT FAILURE | C48226 | The lack of expected or desired effect related to a therapy. (NCI) | Lack of Efficacy | |||
VACATION | C80227 | Leisure time away from work devoted to rest or pleasure. | Vacation | |||
Back to top | ||||||
CL.C78736.NRIND | Reference Range Indicator
(NRIND) | text
Extensible: Yes | C78736 | Reference Range Indicator | A description of the results relative to the normal or expected range of values. | CDISC SDTM Reference Range Indicator |
ABNORMAL | C78802 | Reported values outside the typical or expected range. (NCI) | Abnormal Reference Range | |||
HIGH | C78800 | Reported values above the typical or expected range. (NCI) | Value Above Reference Range | |||
LOW | C78801 | Reported values below the typical or expected range. (NCI) | Value Below Reference Range | |||
NORMAL | C78727 | Reported values within the typical or expected range. (NCI) | Normal Reference Range | |||
Back to top | ||||||
CL.C66728.STENRF | Relation to Reference Period
(STENRF) | text
Extensible: No | C66728 | Relation to Reference Period | The relative relationship of a timepoint to a reference timepoint. | CDISC SDTM Relation to Reference Period Terminology |
AFTER | C38008 | The time period following a point or another period of time. (NCI) | Post | |||
BEFORE | C25629 | Earlier in time or order. (NCI) | Prior | |||
BEFORE/DURING | C184710 | Before or at some point in a given period of time. | Before or During | |||
COINCIDENT | C25456 | Occurring or operating at the same time. | Concurrent | |||
DURING | C25490 | At some point in a given period of time. (NCI) | During | |||
DURING/AFTER | C49640 | Within a certain period of time or after a certain point or period in time. (NCI) | During or After | |||
ONGOING | C53279 | Continuous | Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI) | Continue | ||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C100130.RELSUB | Relationship to Subject
(RELSUB) | text
Extensible: Yes | C100130 | Relationship to Subject | The relationship of a person to a study subject. | CDISC SDTM Relationship to Subject Terminology |
ACCIDENTAL ASSOCIATE | C130052 | A person whose association to an individual is unintentional. | Accidental Association | |||
AUNT, BIOLOGICAL MATERNAL | C96575 | Biological Maternal Aunt | A female relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI) | Biological Maternal Aunt | ||
AUNT, BIOLOGICAL PATERNAL | C96581 | Biological Paternal Aunt | A female relative who is a sibling of the biological father, and who both share a common ancestor. (NCI) | Biological Paternal Aunt | ||
AUNT, BIOLOGICAL | C96569 | Biological Aunt | A female relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI) | Biological Aunt | ||
BIOLOGICALLY RELATED | C71384 | An individual that shares genetic makeup with another individual. | Biological Relative | |||
BIOLOGICALLY UNRELATED | C130053 | An individual that does not share any genetic makeup with another individual. | Biologically Unrelated | |||
BROTHER, BIOLOGICAL MATERNAL HALF | C96656 | Half-brother with Mother as Common Parent | A male who shares with his sibling the genetic makeup inherited from only the biological mother. | Half-brother with Mother as Common Parent | ||
BROTHER, BIOLOGICAL PATERNAL HALF | C96655 | Half-brother with Father as Common Parent | A male who shares with his sibling the genetic makeup inherited from only the biological father. | Half-brother with Father as Common Parent | ||
BROTHER, BIOLOGICAL | C96570 | Biological Brother | A male who shares with his sibling the genetic makeup inherited from one or both of their shared biological parents. | Biological Brother | ||
BROTHER, FULL | C111201 | A male who shares with his sibling the genetic makeup inherited from both of the biological parents. | Full Brother | |||
BROTHER, HALF | C71402 | Half Brother | A male who shares with his sibling the genetic makeup inherited from only one of the biological parents. | Half Brother | ||
CAREGIVER | C17445 | Caregiver;Caretaker | The primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI) | Caregiver | ||
CHILD | C150886 | A biological or non-biological first generation offspring, including but not limited to biological children (including those born outside of marriage), adopted children, step children, and foster children. (NCI) | Child Relation | |||
CHILD, BIOLOGICAL | C42708 | Biological Child | A son or daughter with genetic makeup inherited from the parent. | Offspring | ||
CLINICIAN | C85499 | Clinician | An individual, such as a physician, nurse practitioner or other health care professional, who takes responsibility for a subject's care. | Clinician | ||
COUSIN, BIOLOGICAL MATERNAL | C96576 | Biological Maternal Cousin | A relative who is the offspring of a sibling of the biological mother and share a common ancestor. | Biological Maternal Cousin | ||
COUSIN, BIOLOGICAL PATERNAL | C96582 | Biological Paternal Cousin | A relative who is the offspring of a sibling of the biological father and share a common ancestor. | Biological Paternal Cousin | ||
COUSIN, BIOLOGICAL | C96571 | Biological Cousin | A relative who is the offspring of a sibling of either of the biological parents, and who share a common ancestor. (NCI) | Biological Cousin | ||
DAUGHTER, BIOLOGICAL | C150887 | A female progeny with genetic makeup inherited from the parent. | Biological Daughter | |||
DOMESTIC PARTNER | C53262 | Domestic Partner | Person declares that a domestic partnership relationship exists. (HL7) | Domestic Partnership | ||
DONOR | C48284 | Donor | One that contributes something. (NCI) | Donor | ||
DONOR, BLOOD | C132448 | Someone from whom blood is removed for transplantation or other purpose. | Blood Donor | |||
DONOR, KIDNEY | C130054 | Someone from whom one or more kidneys are removed for transplantation or other purpose. | Kidney Donor | |||
DONOR, ORGAN | C100810 | Organ Donor | Someone from whom an organ is removed for transplantation or other purpose. | Organ Donor | ||
DONOR, TISSUE | C25168 | Tissue Donor | Someone from whom tissue is removed for transplantation or other purpose. | Tissue Donor | ||
EDUCATOR | C102873 | One who instructs or educates others. | Teacher | |||
FAMILY MEMBER | C41256 | Family Member | Any of the individuals who are descended from a common progenitor, related by marriage or other legal tie. | Family Member | ||
FATHER | C25174 | A male parent. | Father | |||
FATHER, BIOLOGICAL OF SUBJECT'S CHILD | C166092 | The biological father of the offspring of the female subject. | Biological Father of Subject's Child | |||
FATHER, BIOLOGICAL | C96572 | Biological Father | A male who contributes to the genetic makeup of his offspring through the fertilization of an ovum by his sperm. (NCI) | Biological Father | ||
FATHER, STEP | C154851 | A male who has acquired children through marriage. | Step Father | |||
FRIEND | C72884 | A person whom an individual knows, likes, and trusts. (NCI) | Friend | |||
GRANDCHILD, BIOLOGICAL | C100805 | Biological Grandchild | A biological child of an individual's biological child. | Biological Grandchild | ||
GRANDFATHER, BIOLOGICAL MATERNAL | C96577 | Biological Maternal Grandfather | A male relative who is the biological father of the biological mother. (NCI) | Biological Maternal Grandfather | ||
GRANDFATHER, BIOLOGICAL PATERNAL | C96583 | Biological Paternal Grandfather | A male relative who is the biological father of the biological father. (NCI) | Biological Paternal Grandfather | ||
GRANDFATHER, BIOLOGICAL | C96573 | Biological Grandfather | A male relative who is the biological father of either the biological mother or the biological father. (NCI) | Biological Grandfather | ||
GRANDMOTHER, BIOLOGICAL MATERNAL | C96578 | Biological Maternal Grandmother | A female relative who is the biological mother of the biological mother. (NCI) | Biological Maternal Grandmother | ||
GRANDMOTHER, BIOLOGICAL PATERNAL | C96584 | Biological Paternal Grandmother | A female relative who is the biological mother of the biological father. (NCI) | Biological Paternal Grandmother | ||
GRANDMOTHER, BIOLOGICAL | C96574 | Biological Grandmother | A female relative who is the biological mother of either the biological mother or the biological father. (NCI) | Biological Grandmother | ||
GRANDPARENT, BIOLOGICAL MATERNAL | C111248 | A relative who is the biological parent of the biological mother. | Maternal Biological Grandparent | |||
GRANDPARENT, BIOLOGICAL PATERNAL | C111286 | A relative who is the biological parent of the biological father. | Paternal Biological Grandparent | |||
GRANDPARENT, BIOLOGICAL | C100806 | Biological Grandparent | A biological parent of the biological father or biological mother. | Biological Grandparent | ||
HOUSEHOLD MEMBER | C132449 | An individual who is considered part of the social unit comprising one or more individuals living together (all of whom need not be related) in the same dwelling. | Household Member | |||
HUSBAND | C71588 | A male partner in marriage. (NCI) | Husband | |||
MOTHER | C25189 | A female parent. | Mother | |||
MOTHER, BIOLOGICAL OF SUBJECT'S CHILD | C166093 | The biological mother of the offspring of the male subject. | Biological Mother of Subject's Child | |||
MOTHER, BIOLOGICAL | C96580 | Biological Mother | A female who contributes to the genetic makeup of her offspring from the fertilization of her ovum. (NCI) | Biological Mother | ||
MOTHER, STEP | C132450 | A female who has acquired children through marriage. | Stepmother | |||
NURSE | C20821 | Nurse | A professional healthcare provider who has graduated from a nursing program. | Nurse | ||
PARENT | C42709 | A mother or a father. | Parent | |||
PREGNANCY PARTNER | C100811 | Pregnancy Partner | An individual who provides support to a pregnant individual. | Pregnancy Partner | ||
RELATIVE | C21480 | Any individual related biologically or legally to another individual. | Relative | |||
RELATIVE, BIOLOGICAL PATERNAL | C132451 | Any biological relative of an individual's biological father. | Biological Relative, Paternal | |||
RELATIVE, BIOLOGICAL, FIRST DEGREE | C161420 | Any individual related biologically to another individual and considered immediate family as in the case of a parent, sibling or child. (NCI) | First Degree Biological Relative | |||
RELATIVE, BIOLOGICAL, SECOND DEGREE | C161421 | Any individual related biologically to another individual and considered one degree removed from the immediate family as in the case of grandparents, aunts and uncles. (NCI) | Second Degree Biological Relative | |||
RELATIVE, FIRST DEGREE | C21481 | First Degree Relative | Any individual related biologically or legally to another individual and considered immediate family as in the case of a spouse, parent, sibling or child. | First Degree Relative | ||
RELATIVE, HOUSEHOLD | C127782 | Any individual related biologically or legally to another individual and residing in the same residence. | Household Relative | |||
RELATIVE, NON-HOUSEHOLD | C127783 | Any individual related biologically or legally to another individual and not residing in the same residence. | Non-household Relative | |||
RELATIVE, SECOND DEGREE | C19811 | Second Degree Relative | Any individual related biologically or legally to another individual and considered one degree removed from the immediate family as in the case of in-laws, grandparents, aunts and uncles. | Second Degree Relative | ||
RELATIVE, THIRD DEGREE | C100808 | Third Degree Relative | Any individual related biologically or legally to another individual and considered two degrees removed from the immediate family as in the case of cousins. | Third Degree Relative | ||
SCHOOLMATE | C127784 | Any individual with whom the subject attends or attended the same school. | Schoolmate | |||
SEXUAL PARTNER | C100812 | Sexual Partner | A person with whom one has had sexual relations. | Sexual Partner | ||
SIBLING | C25204 | A person's brother or sister. | Sibling | |||
SIBLING, BIOLOGICAL | C100809 | Biological Sibling | A person's brother or sister with whom they share a genetic makeup inherited from their shared biological parents. | Biological Sibling | ||
SIBLING, FULL | C71390 | A person's brother or sister with whom they share a genetic makeup inherited from both of their shared biological parents. | Full Sibling | |||
SIBLING, HALF | C71391 | A person's brother or sister with whom they share a genetic makeup inherited from one of their shared biological parents. | Half Sibling | |||
SISTER, BIOLOGICAL MATERNAL HALF | C96658 | Half-sister with Mother as Common Parent | A female who shares with her sibling the genetic makeup inherited from only the biological mother. | Half-sister with Mother as Common Parent | ||
SISTER, BIOLOGICAL PATERNAL HALF | C96657 | Half-sister with Father as Common Parent | A female who shares with her sibling the genetic makeup inherited from only the biological father. | Half-sister with Father as Common Parent | ||
SISTER, BIOLOGICAL | C96586 | Biological Sister | A female who shares with her sibling the genetic makeup inherited from one or both of their shared biological parents. | Biological Sister | ||
SISTER, FULL | C111202 | A female who shares with her sibling the genetic makeup inherited from both of the biological parents. | Full Sister | |||
SISTER, HALF | C71403 | Half Sister | A female who shares with her sibling the genetic makeup inherited from only one of the biological parents. | Half Sister | ||
SON, BIOLOGICAL | C150888 | A male progeny with genetic makeup inherited from the parent. | Biological Son | |||
SPOUSE | C62649 | Spouse | A person's partner in marriage. (NCI) | Spouse | ||
SUSPECTED SOURCE CASE | C132452 | An individual that is believed likely to have transmitted a disease to another individual. | Suspected Source Case | |||
TECHNICIAN | C63861 | Technician | A person skilled in the performance of the technical or procedural aspects of a profession. (NCI) | Technician | ||
TWIN | C73427 | Twin | Either of two offspring born from the same pregnancy. (NCI) | Twin | ||
TWIN, DIZYGOTIC | C73428 | Dizygotic Twin | Either of the two offspring resulting from two separately fertilized ovums during the same pregnancy. | Fraternal Twin | ||
TWIN, MONOZYGOTIC | C73429 | Monozygotic Twin | Either of the two offspring resulting from a shared ovum. (NCI) | Identical Twin | ||
UNCLE, BIOLOGICAL MATERNAL | C96579 | Biological Maternal Uncle | A male relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI) | Biological Maternal Uncle | ||
UNCLE, BIOLOGICAL PATERNAL | C96585 | Biological Paternal Uncle | A male relative who is a sibling of the biological father, and who both share a common ancestor. (NCI) | Biological Paternal Uncle | ||
UNCLE, BIOLOGICAL | C96587 | Biological Uncle | A male relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI) | Biological Uncle | ||
WIFE | C71587 | A female partner in marriage. | Wife | |||
Back to top | ||||||
CL.C78737.RELTYPE | Relationship Type
(RELTYPE) | text
Extensible: No | C78737 | Relationship Type | The description of relationship types between a record or set of records. | CDISC SDTM Relationship Type Terminology |
MANY | C170512 | A side of a dataset-to-dataset relationship that contains more than one element. | Many Relationship Type | |||
ONE | C66832 | A textual representation of the numeral 1. | One | |||
Back to top | ||||||
CL.C106479.RPTESTCD | Reproductive System Findings Test Code
(RPTESTCD) | text
Extensible: Yes | C106479 | Reproductive System Findings Test Code | A terminology codelist for the physiological test codes related to the male and female reproductive systems. | CDISC SDTM Reproductive System Findings Test Code Terminology |
ABORTN | C106550 | Number of Abortions | A measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy. | Number of Abortions | ||
ADLVRDTC | C178050 | Actual Date of Delivery | The date on which the delivery event occurred. | Actual Date of Delivery | ||
ADRNRAGE | C189362 | Adrenarche Age | The age at onset of adrenal androgen-mediated secondary sexual characteristics. | Adrenarche Age | ||
BCMETHOD | C106501 | Birth Control Method | The method by which conception or impregnation is prevented. | Birth Control Method | ||
BLDSPNUM | C181528 | Number of Continuous Days of Bleed/Spot | The number of days one has experienced continuous menstrual bleeding and/or spotting. | Number of Continuous Days of Menstrual Bleeding and/or Spotting | ||
BLEEDIND | C154889 | Abnormal Bleeding Indicator | An indication as to whether there is the presence of abnormal bleeding. | Abnormal Bleeding Indicator | ||
BLISTIND | C122195 | Blistering Indicator | An indication as to whether blistering occurred. | Blistering Indicator | ||
BRFENDTC | C189364 | Breastfeeding End Date | The date on which breastfeeding ended. | Breastfeeding End Date | ||
BRFSTDTC | C189363 | Breastfeeding Start Date | The date on which breastfeeding started. | Breastfeeding Start Date | ||
BRTHFTN | C139265 | Number Full Term Live Births | A measurement of the total number of live birth events at which the gestational age of the neonate is 39 weeks and 0 days through 40 weeks and 6 days. | Number of Full Term Live Births | ||
BRTHLVN | C178141 | Number of Live Births | A measurement of the total number of live-born offspring a female has delivered. | Number of Live Births | ||
BRTHN | C158275 | Number of Births | A measurement of the total number of birth events experienced by a female. | Number of Births | ||
BRTHPRN | C139266 | Number of Premature Live Births | A measurement of the total number of live birth events at which the gestational age of the neonate is less than 37 weeks and 0 days. | Number of Premature Live Births | ||
BRTHSTN | C139267 | Number of Stillbirths | A measurement of the total number of birth events at which the fetus is of at least 20 weeks gestation, or of a birth weight of at least 350 grams if the gestational age is unknown, which is born without signs of life at the time of delivery, and with an Apgar score of zero at both one and five minutes. | Number of Stillbirths | ||
BRTLVIND | C156589 | Live Birth Indicator | An indication as to whether the subject has ever delivered live-born offspring. | Live Birth Indicator | ||
BSBMPIND | C189352 | Bleed/Spot Between Menstrual Periods Ind;Bleeding or Spotting Between Menstrual Periods Indicator | An indication as to whether the individual has experienced bleeding or spotting between menstrual periods. | Bleeding or Spotting Between Menstrual Periods Indicator | ||
BTHGLIND | C154880 | Bartholin's Gland Abnormality Indicator | An indication as to whether the Bartholin's gland is abnormal. | Bartholin's Gland Abnormality Indicator | ||
CABNIND | C122187 | Congenital Abnormality Indicator | An indication as to whether any abnormality was present at birth or during the neonatal period. | Congenital Abnormality Indicator | ||
CHILDPOT | C106508 | Childbearing Potential | An indicator as to whether the female subject has the potential to become pregnant. (NCI) | Childbearing Potential | ||
CNDMIND | C181526 | Condom Use for Most Recent Sexual Intercourse Indicator;Condom Use Most Recent Sex Interc Ind | An indication as to whether a condom was used during the most recent occurrence of sexual intercourse. | Condom Use for Most Recent Sexual Intercourse Indicator | ||
CNDUFRQD | C181527 | Condom Use Frequency Desc;Condom Use Frequency Description | A description of the regularity with which a condom is used during sexual activity. | Condom Use Frequency | ||
CSRSCTN | C189358 | Number of C-Sections;Number of Cesarean Sections | A measurement of the total number of cesarean section delivery events experienced by the individual. | Number of Cesarean Sections | ||
DLVRMODE | C81179 | Mode of Delivery | Description of the method by which a fetus is delivered. | Delivery Procedure | ||
DSCHGIND | C154888 | Discharge Indicator | An indication as to whether there is the presence of discharge. | Discharge Indicator | ||
ECCHYIND | C154884 | Ecchymosis Indicator | An indication as to whether ecchymosis is present. | Ecchymosis Indicator | ||
ECTPREGN | C120832 | Number of Ectopic Pregnancies | A measurement of the total number of ectopic pregnancies experienced by a female subject. | Number of Ectopic Pregnancies | ||
EDCDTC | C120833 | Estimated Date of Conception | An approximate calculated date at which the conception event took place. | Estimated Date of Conception | ||
EDEMAIND | C154885 | Edema Indicator | An indication as to whether edema is present. | Edema Indicator | ||
EDLVRDTC | C81247 | Estimated Date of Delivery | An approximate calculation of the delivery date. | Expected Date of Confinement | ||
EGESTAGE | C122188 | Estimated Gestational Age | An approximate calculation of the gestational age of the fetus, neonate, or infant. | Estimated Gestational Age | ||
ENMPSDTC | C158276 | Est Next Menstrual Period Start Date;Estimated Next Menstrual Period Start Date | The approximate date of the first day of the next menstrual cycle. | Estimated Next Menstrual Period Start Date | ||
ERLYTRMN | C122189 | Number of Early Term Births | A measurement of the total number of birth events at which the gestational age of the neonate is 37 weeks and 0 days through 38 weeks and 6 days. | Number of Early Term Births | ||
ERYTHIND | C154877 | Erythema Indicator;Redness Indicator | An indication as to whether erythema is present. | Erythema Indicator | ||
FETLDTHN | C120834 | Number of Late Fetal Deaths | A measurement of the total number of fetal deaths (death of a fetus at 16 weeks, 0 days to 19 weeks, 6 days of gestation) experienced by a female subject. | Number of Late Fetal Deaths | ||
FMPSTDTC | C198357 | First Menstrual Period Start Date | The date of the first day of the first menstrual cycle. | First Menstrual Period Start Date | ||
FULLTRMN | C122190 | Number of Full Term Births | A measurement of the total number of birth events (both live and dead) at which the gestational age of the neonate is 39 weeks and 0 days through 40 weeks and 6 days. | Number of Full Term Births | ||
FUNDHT | C154876 | Fundal Height | A measurement of the distance between the pubic symphysis and the top of the palpable uterus. | Fundal Height | ||
GRAVIND | C73435 | Gravida;Gravida Indicator | An indication as to whether the subject is or has ever been pregnant. | Gravida | ||
HMPIND | C184708 | Has Menstrual Periods Indicator | An indication as to whether the subject experiences menstrual cycles. | Has Menstrual Periods Indicator | ||
HSPGCIND | C176360 | Hosp Due to Pregnancy Complication Ind;Hospitalized Due to Pregnancy Complication Indicator | An indication as to whether the individual was hospitalized due to a pregnancy complication. | Hospitalized Due to Pregnancy Complication Indicator | ||
INABOIND | C156588 | Induced Abortion Indicator | An indication as to whether the female subject has ever had an induced abortion procedure. | Induced Abortion Indicator | ||
INABORTN | C120835 | Number of Induced Abortions | A measurement of the total number of induced abortions experienced by a female subject. | Number of Induced Abortions | ||
INFRTIND | C189356 | Infertility Indicator | An indication as to whether the individual has experienced infertility. | Infertility Indicator | ||
INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
IRRMPIND | C189353 | Irregular Menstrual Periods Indicator | An indication as to whether the individual has experienced irregular menstrual periods. | Irregular Menstrual Periods Indicator | ||
LMPELTM | C191351 | Elapsed Time Since LMP | The interval of time since the individual's last menstrual period. | Elapsed Time Since Last Menstrual Period | ||
LMPSTDTC | C81257 | Last Menstrual Period Start Date | The date of the first day of the most recent menstrual cycle. | Last Menstrual Period | ||
MASSIND | C154886 | Mass Indicator | An indication as to whether a mass is present. | Mass Indicator | ||
MENARAGE | C19666 | Menarche Age | The age at which the first menstruation event occurred. (NCI) | Age at Menarche | ||
MENFDUR | C156586 | Menses Flow Duration | The length of time during which menses is expelled from the uterus. | Menses Duration | ||
MENFRD | C156585 | Menses Flow Rate Description | A subjective description of the menstrual flow rate during a menstrual cycle. | Menses Flow Rate Description | ||
MENOAGE | C106497 | Menopause Age | The age at which permanent cessation of menses occurred. (NCI) | Age at Menopause | ||
MENOSTAT | C106541 | Menopause Status | The status of a female with respect to menopause. | Menopause Status | ||
MENREG | C156587 | Menstrual Cycle Regularity | A description of how an individual's menstrual cycle conforms to a consistent temporal pattern. | Menstrual Cycle Regularity | ||
MENSDUR | C119549 | Menstrual Cycle Duration | The length of time of the menses cycle, measured from the beginning of one menstrual period to the beginning of the next. | Menstrual Cycle Duration | ||
MENSDURA | C189354 | Average Menstrual Cycle Duration;Average Menstrual Cycle Length | The average length of time of the menses cycle. | Average Menstrual Cycle Duration | ||
MRSXIDTC | C181524 | Date of Most Recent Sexual Intercourse | The date of the most recent occurrence of sexual intercourse. | Date of Last Sexual Intercourse | ||
MSCRGIND | C122191 | Miscarriage Indicator | An indication as to whether any pregnancies resulted in miscarriages. | Miscarriage Indicator | ||
MTENDIND | C154887 | Motion Tenderness Indicator | An indication as to whether there are symptoms of motion tenderness. | Motion Tenderness Indicator | ||
PARITY | C16955 | Parity | The number of pregnancies reaching 20 weeks and 0 days of gestation or beyond, regardless of the number of fetuses or outcomes. (NICHD) | Parity | ||
PCONFIND | C122192 | Pregnancy Confirmed Indicator | An indication as to whether the subject's pregnancy has been confirmed. | Pregnancy Confirmed Indicator | ||
PEELIND | C154883 | Peeling Indicator | An indication as to whether there is the presence of peeling. | Peeling Indicator | ||
PPRTIND | C198358 | Post-Partum Indicator | An indication as to whether the subject is in the stages of recovery post pregnancy and birth event. | Post-Partum Indicator | ||
PRDCEIND | C163557 | Products of Conception Examined Ind;Products of Conception Examined Indicator | An indication as to whether the products of conception have been examined. | Products of Conception Examined Indicator | ||
PREGIND | C139264 | Pregnant Indicator | An indication as to whether the subject or associated person is pregnant at the time the question is asked. | Pregnancy Indicator | ||
PREGNN | C106551 | Number of Pregnancies | A measurement of the total number of pregnancy events experienced by a female. | Number of Pregnancies | ||
PREGST | C106561 | Pregnant During the Study | An indicator as to whether a female is pregnant during the study period. (NCI) | Pregnant During the Study | ||
PREMBTHN | C122193 | Number of Premature Births | A measurement of the total number of birth events (both live and dead) at which the gestational age of the neonate is less than 37 weeks and 0 days. | Number of Premature Births | ||
PRGENDTC | C163558 | Date Pregnancy Ended | The date on which the pregnancy ended. | Pregnancy End Date | ||
PRGOUT | C90491 | Pregnancy Outcome | The end result of a pregnancy. | Pregnancy Outcome | ||
PRVPREGN | C120836 | Number of Previous Pregnancies | A measurement of the total number of pregnancy events experienced by the female subject prior to the current pregnancy. | Number of Previous Pregnancies | ||
PSUSPIND | C186213 | Pregnancy Suspected Indicator | An indication as to whether the subject or associated person suspects that they are pregnant at the time the question is asked. | Pregnancy Suspected Indicator | ||
PUSTIND | C154882 | Pustule Indicator | An indication as to whether a pustule is present. | Pustule Indicator | ||
RASHIND | C154878 | Rash Indicator | An indication as to whether rash is present. | Rash Indicator | ||
RPEXAM | C198359 | Reproductive System Examination | An observation, assessment or examination of the reproductive system. | Reproductive System Examination | ||
SCBFCIND | C189360 | Subj Currently Breastfeeding a Child Ind;Subject Currently Breastfeeding a Child Indicator | An indication as to whether the individual is currently breastfeeding a child. | Subject Currently Breastfeeding a Child Indicator | ||
SEXABDUR | C189357 | Duration of Sexual Abstinence | The length of time during which the individual abstained from sexual activity. | Duration of Sexual Abstinence | ||
SKGLAIND | C154879 | Skene's Gland Abnormality Indicator | An indication as to whether the Skene's gland is abnormal. | Skene's Gland Abnormality Indicator | ||
SPABORTN | C120837 | Number of Spontaneous Abortions | A measurement of the total number of spontaneous abortions (in which the fetus is less than 20 weeks gestational age) experienced by a female subject. | Number of Spontaneous Abortions | ||
SRGSTIND | C189355 | Surgically Sterile Indicator | An indication as to whether the individual has been surgically sterilized. | Individual Surgically Sterile Indicator | ||
STILBIND | C122194 | Stillbirth Indicator | An indication as to whether any pregnancies resulted in stillbirths. | Stillbirth Indicator | ||
THICK | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
THLARAGE | C189361 | Thelarche Age | The age at onset of breast development. | Thelarche Age | ||
TNDRIND | C127775 | Tenderness Indicator | An indication as to whether there are symptoms of tenderness. | Tenderness Indicator | ||
TRMPGCAT | C176361 | Term Pregnancy Category | A classification of the gestation duration of the pregnancy at the time of delivery. | Term Pregnancy Category | ||
TSXPARTN | C181525 | Total Number of Sexual Partners | The total number of individuals with whom one has engaged in sexual activity. | Total Number of Sexual Partners | ||
ULCERIND | C154881 | Ulcer Indicator | An indication as to whether an ulcer is present. | Ulcer Indicator | ||
VAGDLVN | C189359 | Number of Vaginal Deliveries | A measurement of the total number of vaginal delivery events experienced by the individual. | Number of Vaginal Deliveries | ||
VBSFRQD | C176359 | Vaginal Bleeding/Spotting Freq Desc;Vaginal Bleeding/Spotting Frequency Description | A description of the frequency at which vaginal bleeding and/or spotting has occurred. | Vaginal Bleeding and/or Spotting Frequency Description | ||
Back to top | ||||||
CL.C106478.RPTEST | Reproductive System Findings Test Name
(RPTEST) | text
Extensible: Yes | C106478 | Reproductive System Findings Test Name | A terminology codelist for the physiological test names related to the male and female reproductive systems. | CDISC SDTM Reproductive System Findings Test Name Terminology |
Abnormal Bleeding Indicator | C154889 | Abnormal Bleeding Indicator | An indication as to whether there is the presence of abnormal bleeding. | Abnormal Bleeding Indicator | ||
Actual Date of Delivery | C178050 | Actual Date of Delivery | The date on which the delivery event occurred. | Actual Date of Delivery | ||
Adrenarche Age | C189362 | Adrenarche Age | The age at onset of adrenal androgen-mediated secondary sexual characteristics. | Adrenarche Age | ||
Average Menstrual Cycle Duration | C189354 | Average Menstrual Cycle Duration;Average Menstrual Cycle Length | The average length of time of the menses cycle. | Average Menstrual Cycle Duration | ||
Bartholin's Gland Abnormality Indicator | C154880 | Bartholin's Gland Abnormality Indicator | An indication as to whether the Bartholin's gland is abnormal. | Bartholin's Gland Abnormality Indicator | ||
Birth Control Method | C106501 | Birth Control Method | The method by which conception or impregnation is prevented. | Birth Control Method | ||
Bleed/Spot Between Menstrual Periods Ind | C189352 | Bleed/Spot Between Menstrual Periods Ind;Bleeding or Spotting Between Menstrual Periods Indicator | An indication as to whether the individual has experienced bleeding or spotting between menstrual periods. | Bleeding or Spotting Between Menstrual Periods Indicator | ||
Blistering Indicator | C122195 | Blistering Indicator | An indication as to whether blistering occurred. | Blistering Indicator | ||
Breastfeeding End Date | C189364 | Breastfeeding End Date | The date on which breastfeeding ended. | Breastfeeding End Date | ||
Breastfeeding Start Date | C189363 | Breastfeeding Start Date | The date on which breastfeeding started. | Breastfeeding Start Date | ||
Childbearing Potential | C106508 | Childbearing Potential | An indicator as to whether the female subject has the potential to become pregnant. (NCI) | Childbearing Potential | ||
Condom Use Frequency Desc | C181527 | Condom Use Frequency Desc;Condom Use Frequency Description | A description of the regularity with which a condom is used during sexual activity. | Condom Use Frequency | ||
Condom Use Most Recent Sex Interc Ind | C181526 | Condom Use for Most Recent Sexual Intercourse Indicator;Condom Use Most Recent Sex Interc Ind | An indication as to whether a condom was used during the most recent occurrence of sexual intercourse. | Condom Use for Most Recent Sexual Intercourse Indicator | ||
Congenital Abnormality Indicator | C122187 | Congenital Abnormality Indicator | An indication as to whether any abnormality was present at birth or during the neonatal period. | Congenital Abnormality Indicator | ||
Date of Most Recent Sexual Intercourse | C181524 | Date of Most Recent Sexual Intercourse | The date of the most recent occurrence of sexual intercourse. | Date of Last Sexual Intercourse | ||
Date Pregnancy Ended | C163558 | Date Pregnancy Ended | The date on which the pregnancy ended. | Pregnancy End Date | ||
Discharge Indicator | C154888 | Discharge Indicator | An indication as to whether there is the presence of discharge. | Discharge Indicator | ||
Duration of Sexual Abstinence | C189357 | Duration of Sexual Abstinence | The length of time during which the individual abstained from sexual activity. | Duration of Sexual Abstinence | ||
Ecchymosis Indicator | C154884 | Ecchymosis Indicator | An indication as to whether ecchymosis is present. | Ecchymosis Indicator | ||
Edema Indicator | C154885 | Edema Indicator | An indication as to whether edema is present. | Edema Indicator | ||
Elapsed Time Since LMP | C191351 | Elapsed Time Since LMP | The interval of time since the individual's last menstrual period. | Elapsed Time Since Last Menstrual Period | ||
Erythema Indicator | C154877 | Erythema Indicator;Redness Indicator | An indication as to whether erythema is present. | Erythema Indicator | ||
Est Next Menstrual Period Start Date | C158276 | Est Next Menstrual Period Start Date;Estimated Next Menstrual Period Start Date | The approximate date of the first day of the next menstrual cycle. | Estimated Next Menstrual Period Start Date | ||
Estimated Date of Conception | C120833 | Estimated Date of Conception | An approximate calculated date at which the conception event took place. | Estimated Date of Conception | ||
Estimated Date of Delivery | C81247 | Estimated Date of Delivery | An approximate calculation of the delivery date. | Expected Date of Confinement | ||
Estimated Gestational Age | C122188 | Estimated Gestational Age | An approximate calculation of the gestational age of the fetus, neonate, or infant. | Estimated Gestational Age | ||
First Menstrual Period Start Date | C198357 | First Menstrual Period Start Date | The date of the first day of the first menstrual cycle. | First Menstrual Period Start Date | ||
Fundal Height | C154876 | Fundal Height | A measurement of the distance between the pubic symphysis and the top of the palpable uterus. | Fundal Height | ||
Gravida Indicator | C73435 | Gravida;Gravida Indicator | An indication as to whether the subject is or has ever been pregnant. | Gravida | ||
Has Menstrual Periods Indicator | C184708 | Has Menstrual Periods Indicator | An indication as to whether the subject experiences menstrual cycles. | Has Menstrual Periods Indicator | ||
Hosp Due to Pregnancy Complication Ind | C176360 | Hosp Due to Pregnancy Complication Ind;Hospitalized Due to Pregnancy Complication Indicator | An indication as to whether the individual was hospitalized due to a pregnancy complication. | Hospitalized Due to Pregnancy Complication Indicator | ||
Induced Abortion Indicator | C156588 | Induced Abortion Indicator | An indication as to whether the female subject has ever had an induced abortion procedure. | Induced Abortion Indicator | ||
Infertility Indicator | C189356 | Infertility Indicator | An indication as to whether the individual has experienced infertility. | Infertility Indicator | ||
Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
Irregular Menstrual Periods Indicator | C189353 | Irregular Menstrual Periods Indicator | An indication as to whether the individual has experienced irregular menstrual periods. | Irregular Menstrual Periods Indicator | ||
Last Menstrual Period Start Date | C81257 | Last Menstrual Period Start Date | The date of the first day of the most recent menstrual cycle. | Last Menstrual Period | ||
Live Birth Indicator | C156589 | Live Birth Indicator | An indication as to whether the subject has ever delivered live-born offspring. | Live Birth Indicator | ||
Mass Indicator | C154886 | Mass Indicator | An indication as to whether a mass is present. | Mass Indicator | ||
Menarche Age | C19666 | Menarche Age | The age at which the first menstruation event occurred. (NCI) | Age at Menarche | ||
Menopause Age | C106497 | Menopause Age | The age at which permanent cessation of menses occurred. (NCI) | Age at Menopause | ||
Menopause Status | C106541 | Menopause Status | The status of a female with respect to menopause. | Menopause Status | ||
Menses Flow Duration | C156586 | Menses Flow Duration | The length of time during which menses is expelled from the uterus. | Menses Duration | ||
Menses Flow Rate Description | C156585 | Menses Flow Rate Description | A subjective description of the menstrual flow rate during a menstrual cycle. | Menses Flow Rate Description | ||
Menstrual Cycle Duration | C119549 | Menstrual Cycle Duration | The length of time of the menses cycle, measured from the beginning of one menstrual period to the beginning of the next. | Menstrual Cycle Duration | ||
Menstrual Cycle Regularity | C156587 | Menstrual Cycle Regularity | A description of how an individual's menstrual cycle conforms to a consistent temporal pattern. | Menstrual Cycle Regularity | ||
Miscarriage Indicator | C122191 | Miscarriage Indicator | An indication as to whether any pregnancies resulted in miscarriages. | Miscarriage Indicator | ||
Mode of Delivery | C81179 | Mode of Delivery | Description of the method by which a fetus is delivered. | Delivery Procedure | ||
Motion Tenderness Indicator | C154887 | Motion Tenderness Indicator | An indication as to whether there are symptoms of motion tenderness. | Motion Tenderness Indicator | ||
Number Full Term Live Births | C139265 | Number Full Term Live Births | A measurement of the total number of live birth events at which the gestational age of the neonate is 39 weeks and 0 days through 40 weeks and 6 days. | Number of Full Term Live Births | ||
Number of Abortions | C106550 | Number of Abortions | A measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy. | Number of Abortions | ||
Number of Births | C158275 | Number of Births | A measurement of the total number of birth events experienced by a female. | Number of Births | ||
Number of Cesarean Sections | C189358 | Number of C-Sections;Number of Cesarean Sections | A measurement of the total number of cesarean section delivery events experienced by the individual. | Number of Cesarean Sections | ||
Number of Continuous Days of Bleed/Spot | C181528 | Number of Continuous Days of Bleed/Spot | The number of days one has experienced continuous menstrual bleeding and/or spotting. | Number of Continuous Days of Menstrual Bleeding and/or Spotting | ||
Number of Early Term Births | C122189 | Number of Early Term Births | A measurement of the total number of birth events at which the gestational age of the neonate is 37 weeks and 0 days through 38 weeks and 6 days. | Number of Early Term Births | ||
Number of Ectopic Pregnancies | C120832 | Number of Ectopic Pregnancies | A measurement of the total number of ectopic pregnancies experienced by a female subject. | Number of Ectopic Pregnancies | ||
Number of Full Term Births | C122190 | Number of Full Term Births | A measurement of the total number of birth events (both live and dead) at which the gestational age of the neonate is 39 weeks and 0 days through 40 weeks and 6 days. | Number of Full Term Births | ||
Number of Induced Abortions | C120835 | Number of Induced Abortions | A measurement of the total number of induced abortions experienced by a female subject. | Number of Induced Abortions | ||
Number of Late Fetal Deaths | C120834 | Number of Late Fetal Deaths | A measurement of the total number of fetal deaths (death of a fetus at 16 weeks, 0 days to 19 weeks, 6 days of gestation) experienced by a female subject. | Number of Late Fetal Deaths | ||
Number of Live Births | C178141 | Number of Live Births | A measurement of the total number of live-born offspring a female has delivered. | Number of Live Births | ||
Number of Pregnancies | C106551 | Number of Pregnancies | A measurement of the total number of pregnancy events experienced by a female. | Number of Pregnancies | ||
Number of Premature Births | C122193 | Number of Premature Births | A measurement of the total number of birth events (both live and dead) at which the gestational age of the neonate is less than 37 weeks and 0 days. | Number of Premature Births | ||
Number of Premature Live Births | C139266 | Number of Premature Live Births | A measurement of the total number of live birth events at which the gestational age of the neonate is less than 37 weeks and 0 days. | Number of Premature Live Births | ||
Number of Previous Pregnancies | C120836 | Number of Previous Pregnancies | A measurement of the total number of pregnancy events experienced by the female subject prior to the current pregnancy. | Number of Previous Pregnancies | ||
Number of Spontaneous Abortions | C120837 | Number of Spontaneous Abortions | A measurement of the total number of spontaneous abortions (in which the fetus is less than 20 weeks gestational age) experienced by a female subject. | Number of Spontaneous Abortions | ||
Number of Stillbirths | C139267 | Number of Stillbirths | A measurement of the total number of birth events at which the fetus is of at least 20 weeks gestation, or of a birth weight of at least 350 grams if the gestational age is unknown, which is born without signs of life at the time of delivery, and with an Apgar score of zero at both one and five minutes. | Number of Stillbirths | ||
Number of Vaginal Deliveries | C189359 | Number of Vaginal Deliveries | A measurement of the total number of vaginal delivery events experienced by the individual. | Number of Vaginal Deliveries | ||
Parity | C16955 | Parity | The number of pregnancies reaching 20 weeks and 0 days of gestation or beyond, regardless of the number of fetuses or outcomes. (NICHD) | Parity | ||
Peeling Indicator | C154883 | Peeling Indicator | An indication as to whether there is the presence of peeling. | Peeling Indicator | ||
Post-Partum Indicator | C198358 | Post-Partum Indicator | An indication as to whether the subject is in the stages of recovery post pregnancy and birth event. | Post-Partum Indicator | ||
Pregnancy Confirmed Indicator | C122192 | Pregnancy Confirmed Indicator | An indication as to whether the subject's pregnancy has been confirmed. | Pregnancy Confirmed Indicator | ||
Pregnancy Outcome | C90491 | Pregnancy Outcome | The end result of a pregnancy. | Pregnancy Outcome | ||
Pregnancy Suspected Indicator | C186213 | Pregnancy Suspected Indicator | An indication as to whether the subject or associated person suspects that they are pregnant at the time the question is asked. | Pregnancy Suspected Indicator | ||
Pregnant During the Study | C106561 | Pregnant During the Study | An indicator as to whether a female is pregnant during the study period. (NCI) | Pregnant During the Study | ||
Pregnant Indicator | C139264 | Pregnant Indicator | An indication as to whether the subject or associated person is pregnant at the time the question is asked. | Pregnancy Indicator | ||
Products of Conception Examined Ind | C163557 | Products of Conception Examined Ind;Products of Conception Examined Indicator | An indication as to whether the products of conception have been examined. | Products of Conception Examined Indicator | ||
Pustule Indicator | C154882 | Pustule Indicator | An indication as to whether a pustule is present. | Pustule Indicator | ||
Rash Indicator | C154878 | Rash Indicator | An indication as to whether rash is present. | Rash Indicator | ||
Reproductive System Examination | C198359 | Reproductive System Examination | An observation, assessment or examination of the reproductive system. | Reproductive System Examination | ||
Skene's Gland Abnormality Indicator | C154879 | Skene's Gland Abnormality Indicator | An indication as to whether the Skene's gland is abnormal. | Skene's Gland Abnormality Indicator | ||
Stillbirth Indicator | C122194 | Stillbirth Indicator | An indication as to whether any pregnancies resulted in stillbirths. | Stillbirth Indicator | ||
Subj Currently Breastfeeding a Child Ind | C189360 | Subj Currently Breastfeeding a Child Ind;Subject Currently Breastfeeding a Child Indicator | An indication as to whether the individual is currently breastfeeding a child. | Subject Currently Breastfeeding a Child Indicator | ||
Surgically Sterile Indicator | C189355 | Surgically Sterile Indicator | An indication as to whether the individual has been surgically sterilized. | Individual Surgically Sterile Indicator | ||
Tenderness Indicator | C127775 | Tenderness Indicator | An indication as to whether there are symptoms of tenderness. | Tenderness Indicator | ||
Term Pregnancy Category | C176361 | Term Pregnancy Category | A classification of the gestation duration of the pregnancy at the time of delivery. | Term Pregnancy Category | ||
Thelarche Age | C189361 | Thelarche Age | The age at onset of breast development. | Thelarche Age | ||
Thickness | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
Total Number of Sexual Partners | C181525 | Total Number of Sexual Partners | The total number of individuals with whom one has engaged in sexual activity. | Total Number of Sexual Partners | ||
Ulcer Indicator | C154881 | Ulcer Indicator | An indication as to whether an ulcer is present. | Ulcer Indicator | ||
Vaginal Bleeding/Spotting Freq Desc | C176359 | Vaginal Bleeding/Spotting Freq Desc;Vaginal Bleeding/Spotting Frequency Description | A description of the frequency at which vaginal bleeding and/or spotting has occurred. | Vaginal Bleeding and/or Spotting Frequency Description | ||
Back to top | ||||||
CL.C111106.RETESTCD | Respiratory Test Code
(RETESTCD) | text
Extensible: Yes | C111106 | Respiratory Test Code | A terminology codelist based on the test codes for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. | CDISC SDTM Respiratory Test Code Terminology |
ADDRELF | C189634 | Additional Disease-Related Findings | A determination of additional abnormalities and/or other observations that may be associated with the disease of interest, for which a targeted test has not been identified in the data. | Additional Disease-Related Findings | ||
AIRTRAP | C170620 | Air Trapping | A measurement of the gas retention in a specified intrapulmonary space at the end of exhalation. | Air Trapping Measurement | ||
ALVVOL | C156584 | Alveolar Volume;VA | The quantity of gas that enters the alveoli during inspiration. | Alveolar Volume | ||
AWVOL | C170457 | Airway Volume | The total volume of gas in a specified airway or set of airways at a specified point in time in the respiratory cycle. | Airway Volume | ||
AWVOLPP | C170621 | Percent Predicted Airway Volume | The total volume of gas in a specified airway or set of airways at a specified point in time in the respiratory cycle, expressed as a proportion of the predicted normal value. | Percent Predicted Airway Volume | ||
AWWVOL | C170619 | Airway Wall Volume | The volume of the entirety of the airway tissue in a specified intrapulmonary region. | Airway Wall Volume | ||
BLDFLRT | C94866 | Blood Flow Rate | The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. | Blood Flow Rate | ||
DLCO | C38083 | Diffusion Capacity of Lung for CO;TLCO;Transfer Factor of Lung for CO | The volume of the carbon monoxide that is transferred from inspired air into the pulmonary capillary blood. | Carbon Monoxide Diffusing Capability Test | ||
DLCOHC | C120825 | HGB Corrected DLCO | The diffusing capacity of the lungs for carbon monoxide adjusted for hemoglobin concentration. | Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide | ||
DLCOHCPP | C120826 | Percent Predicted HGB Corrected DLCO | The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the predicted normal value, adjusted for hemoglobin concentration. | Percent Predicted Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide | ||
DLCOHCVA | C120827 | HGB Corrected DLCO/VA | The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the alveolar volume, adjusted for hemoglobin concentration. | Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio | ||
DLCOHVAP | C120828 | Percent Predicted HGB Corrected DLCO/VA | The proportion of diffusing capacity of the lungs for carbon monoxide to the alveolar volume expressed as a proportion of the predicted normal value, adjusted for hemoglobin concentration. | Percent Predicted Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio | ||
DLCOM | C123564 | Mean Diffusion Capacity of Lung for CO | The mean volume of the carbon monoxide that is transferred from inspired air into the pulmonary capillary blood. | Mean Carbon Monoxide Diffusing Capability Test | ||
DLCOPP | C120829 | Percent Predicted DLCO | The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the predicted normal value. | Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide | ||
DLCOVA | C120830 | DLCO/VA | The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the alveolar volume. | Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio | ||
DLCOVAPP | C120831 | Percent Predicted DLCO/VA | The proportion of the diffusing capacity of the lungs for carbon monoxide to alveolar volume, expressed as a proportion of the predicted normal value. | Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio | ||
DOMLGPT | C189632 | Dominant Lung Pattern | A subjective assessment of the primary lung abnormality pattern, generally based on size, distribution, and/or amount. | Dominant Lung Pattern Assessment | ||
DOMLGPTD | C189633 | Dominant Lung Pattern Distribution | A subjective assessment of the distribution of the primary lung abnormality pattern. | Dominant Lung Pattern Distribution Assessment | ||
EFFIND | C161422 | Effusion Indicator | An indication as to whether effusion is present. | Effusion Indicator | ||
EFFVOL | C161424 | Effusion Volume | The amount of three dimensional space occupied by the effusion fluid. | Effusion Volume Measurement | ||
ELSTNCE | C135493 | Elastance | A measure of the resistance of a system to expand, i.e. the pressure change that is required to elicit a unit volume change in the lungs. Elastance is the reciprocal of compliance. | Elastance | ||
ERV | C111200 | Expiratory Reserve Volume | The maximum volume of air a subject can exhale from the lungs after a tidal exhalation. | Expiratory Reserve Volume | ||
ERVPP | C112375 | Percent Predicted ERV | The maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value. | Percent Predicted Expiratory Reserve Volume | ||
EV_05FVC | C139243 | Forced Expiratory Volume in 0.05 S/FVC;Forced Expiratory Volume in 0.05 Seconds over FVC | The ratio of the volume of gas that is forcibly exhaled during the first 0.05 seconds following maximal inhalation to that of the forced vital capacity. | Forced Expiratory Volume in 0.05 Second to FVC Ratio Measurement | ||
EV_1FVC | C139244 | Forced Expiratory Volume in 0.1 S/FVC;Forced Expiratory Volume in 0.1 Seconds over FVC | The ratio of the volume of gas that is forcibly exhaled during the first 0.1 seconds following maximal inhalation to that of the forced vital capacity. | Forced Expiratory Volume in 0.1 Second to FVC Ratio Measurement | ||
EV_2FVC | C139245 | Forced Expiratory Volume in 0.2 S/FVC;Forced Expiratory Volume in 0.2 Seconds over FVC | The ratio of the volume of gas that is forcibly exhaled during the first 0.2 seconds following maximal inhalation to that of the forced vital capacity. | Forced Expiratory Volume in 0.2 Second to FVC Ratio Measurement | ||
EVC | C147484 | Expiratory Vital Capacity | The maximum volume of air an individual can exhale from the point of maximal inhalation. | Expiratory Vital Capacity | ||
EXPRELTM | C120931 | Expiration Relaxation Time | The time required to exhale 63.2% of the total expiratory volume, as measured from the start of exhalation. | Expiration Relaxation Time | ||
FEF2575 | C119545 | Forced Expiratory Flow 25-75% | The mean forced expiratory flow rate at 25-75% of the forced vital capacity. (NCI) | Forced Expiratory Flow at 25-75 Percent | ||
FEF2575P | C119546 | Percent Predicted FEF25-75 | The mean forced expiratory flow rate at 25-75% of the forced vital capacity as a proportion of the predicted normal value. (NCI) | Percent Predicted Forced Expiratory Flow at 25-75 Percent | ||
FEF50 | C139253 | Forced Expiratory Flow 50% | The mean forced expiratory flow rate at 50% of the forced vital capacity. (NCI) | Forced Expiratory Flow at 50 Percent Forced Vital Capacity | ||
FEF_05 | C139250 | Forced Expiratory Flow in 0.05 Second | The forced expiratory flow rate during the first 0.05 second of a forced exhalation. | Forced Expiratory Flow in 0.05 Second | ||
FEF_1 | C139251 | Forced Expiratory Flow in 0.1 Second | The forced expiratory flow rate during the first 0.1 second of a forced exhalation. | Forced Expiratory Flow in 0.1 Second | ||
FEF_2 | C139252 | Forced Expiratory Flow in 0.2 Second | The forced expiratory flow rate during the first 0.2 second of a forced exhalation. | Forced Expiratory Flow in 0.2 Second | ||
FEV1 | C38084 | Forced Expiratory Volume in 1 Second | The volume of air that can be forcibly exhaled during the first second following maximal inhalation. | Forced Expiratory Volume in 1 Second | ||
FEV1FVC | C111359 | FEV1/FVC | A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the largest observed expired volume during a forced vital capacity maneuver. | Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio Measurement | ||
FEV1FVC6 | C123565 | FEV1/FVC6 | A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the observed expired volume during the first six seconds of a forced vital capacity maneuver. | Forced Expiratory Volume in 1 Second to Forced Vital Capacity in 6 Seconds | ||
FEV1FVCP | C112377 | Percent Predicted FEV1/FVC | The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 1 Second Divided by Forced Vital Capacity | ||
FEV1PP | C112376 | Percent Predicted FEV1 | Forced expiratory volume in one second as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 1 Second | ||
FEV1REV | C112285 | FEV1 Reversibility | The change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value. | Forced Expiratory Volume in 1 Second Reversibility | ||
FEV1SVC | C170626 | FEV1/SVC | A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the largest observed expired volume during a slow vital capacity maneuver. | Forced Expiratory Volume in 1 Second to Slow Vital Capacity Ratio Measurement | ||
FEV3 | C132453 | Forced Expiratory Volume in 3 Seconds | The volume of air that can be forcibly exhaled during the first three seconds following maximal inhalation. | Forced Expiratory Volume in 3 Seconds | ||
FEV3FVC | C170625 | FEV3/FVC | A relative measurement (ratio or percentage) of the forced expiratory volume during the first three seconds of exhalation to the largest observed expired volume during a forced vital capacity maneuver. | Forced Expiratory Volume in 3 Seconds to Forced Vital Capacity Ratio Measurement | ||
FEV3PP | C170627 | Percent Predicted FEV3 | Forced expiratory volume in three seconds as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 3 Seconds | ||
FEV6 | C47843 | Forced Expiratory Volume in 6 Seconds | The volume of air that can be forcibly exhaled during the first six seconds following maximal inhalation. | Forced Expiratory Volume in 6 Seconds | ||
FEV6PP | C112378 | Percent Predicted FEV6 | Forced expiratory volume in six seconds as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 6 Seconds | ||
FEV_05 | C139246 | Forced Expiratory Volume in 0.05 Second | The volume of air that can be forcibly exhaled during the first 0.05 second following maximal inhalation. | Forced Expiratory Volume in 0.05 Second | ||
FEV_1 | C139247 | Forced Expiratory Volume in 0.1 Second | The volume of air that can be forcibly exhaled during the first 0.1 second following maximal inhalation. | Forced Expiratory Volume in 0.1 Second | ||
FEV_2 | C139248 | Forced Expiratory Volume in 0.2 Second | The volume of air that can be forcibly exhaled during the first 0.2 second following maximal inhalation. | Forced Expiratory Volume in 0.2 Second | ||
FEV_5 | C139262 | Forced Expiratory Volume in 0.5 Second | The volume of air that can be forcibly exhaled during the first half second following maximal inhalation. | Forced Expiratory Volume in 0.5 Second | ||
FEV_75 | C174362 | Forced Expiratory Volume in 0.75 Second | The volume of air that can be forcibly exhaled during the first 0.75 second following maximal inhalation. | Forced Expiratory Volume in 0.75 Second | ||
FEV_PEF | C139249 | FEV at PEF;Forced Expiratory Volume at Peak Expiratory Flow | The volume of gas that is forcibly exhaled at the peak of expiratory flow. | Forced Expiratory Volume at Peak Expiratory Flow | ||
FIF25 | C124418 | Forced Inspiratory Flow at 25% | The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 25 percent of the total volume of air has been inhaled. | Forced Inspiratory Flow at 25% | ||
FIF50 | C124419 | Forced Inspiratory Flow at 50% | The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 50 percent of the total volume of air has been inhaled. | Forced Inspiratory Flow at 50% | ||
FIF75 | C124420 | Forced Inspiratory Flow at 75% | The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 75 percent of the total volume of air has been inhaled. | Forced Inspiratory Flow at 75% | ||
FIFMAX | C112333 | Maximum Forced Inspiratory Flow | The fastest rate of inspired air achieved during a forced inspiration maneuver. | Maximum Forced Inspiratory Flow | ||
FIFMAXPP | C112379 | Percent Predicted FIFmax | The fastest rate of inspired air achieved during a forced inspiration maneuver expressed as a percentage of the expected result value for healthy individuals with similar characteristics. | Percent Predicted Forced Inspiratory Flow Maximum | ||
FIO2 | C38082 | Fraction of Inspired Oxygen | A measurement of the volumetric fraction of oxygen in the inhaled gas. | Fraction of Inspired Oxygen | ||
FIV1 | C111360 | Forced Inspiratory Volume in 1 Second | The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation. | Forced Inspiratory Volume in 1 Second | ||
FIV1PP | C112380 | Percent Predicted FIV1 | The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value. | Percent Predicted Forced Inspiratory Volume in 1 Second | ||
FIVC | C139263 | Forced Inspiratory Vital Capacity | The difference in lung volume between maximal expiration to residual volume followed immediately by full inspiration to total lung capacity during forceful inhalation. | Forced Inspiratory Vital Capacity | ||
FRC | C89800 | Functional Residual Capacity | The volume of air remaining in the lungs after a normal exhalation. (NCI) | Functional Residual Capacity | ||
FRCPP | C126052 | Percent Predicted FRC | The functional residual capacity as a proportion of the predicted normal value. | Percent Predicted Functional Residual Capacity | ||
FVC | C111361 | Forced Vital Capacity | The volume of air that can be forcibly exhaled following maximal inhalation. | Forced Vital Capacity | ||
FVC6 | C124421 | Forced Vital Capacity in 6 Seconds | The volume of air that can be forcibly exhaled during the first six seconds following maximal inhalation. | Forced Vital Capacity in 6 Seconds | ||
FVCPP | C112381 | Percent Predicted Forced Vital Capacity | Forced vital capacity as a proportion of the predicted normal value. | Percent Predicted Forced Vital Capacity | ||
GAW | C124422 | Airway Conductance | The instantaneous rate of air flow in the airway, expressed as the pressure difference between any given part of the airway and the alveoli; it is the reciprocal of airway resistance (Raw). | Airway Conductance | ||
IC | C111362 | Inspiratory Capacity | The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV). | Inspiratory Capacity | ||
ICPP | C112382 | Percent Predicted Inspiratory Capacity | The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value. | Percent Predicted Inspiratory Capacity | ||
ICREV | C112321 | IC Reversibility | The change in IC following administration of a bronchodilator relative to the pre-treatment IC value. | Inspiratory Capacity Reversibility | ||
INERTANC | C139254 | Inertance | The measure of the force of the column of air in the conducting airways. | Pulmonary Inertance | ||
INFLTIND | C171512 | Infiltrates Indicator | An indication as to whether infiltrates have occurred. | Infiltrates Indicator | ||
INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
IRV | C111237 | Inspiratory Reserve Volume | The maximum volume of air a subject can inhale into the lungs after a tidal inhalation. | Inspiratory Reserve Volume | ||
IRVPP | C112383 | Percent Predicted IRV | The maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value. | Percent Predicted Inspiratory Reserve Volume | ||
IVC | C124423 | Inspiratory Vital Capacity | The maximum volume of air an individual can inhale from the point of maximal exhalation. | Inspiratory Vital Capacity | ||
IVCPP | C124424 | Percent Predicted IVC | The maximum volume of air an individual can inhale from the point of maximal exhalation as a percentage of the predicted normal value. | Percent Predicted Inspiratory Vital Capacity | ||
LCI | C124425 | Lung Clearance Index | A representative measurement of the number of times the volume of air in the lung at the start of the washout (the Functional Residual Capacity) must be recycled to eliminate the tracer to the pre-defined endpoint. | Lung Clearance Index | ||
LOBVOL | C174232 | Lobar Volume | The total volume of gas in a lobe of the lung at a specified point in time during the respiratory cycle. | Lobar Volume | ||
LOBVOLPP | C174361 | Percent Predicted Lobar Volume | The total volume of gas in a lobe of the lung at a specified point in time during the respiratory cycle, as a proportion of the predicted normal value. | Percent Predicted Lobar Volume | ||
MALEVDES | C161312 | Malignancy Evidence Description | The basis for the determination that a malignancy is present. | Evidence of Malignant Disease Description | ||
MALIND | C161423 | Malignancy Indicator | An indication as to whether a malignancy is present. | Malignant Disease Indicator | ||
MEP | C135494 | Maximal Expiratory Pressure | The greatest amount of pressure that can be generated by exhaling against a mouthpiece, which is a measure of the strength of respiratory muscles. (NCI) | Maximal Expiratory Pressure | ||
MEPPP | C135495 | Percent Predicted MEP | The greatest amount of pressure that can be generated by exhaling against a mouthpiece, which is a measure of the strength of respiratory muscles expressed as a proportion of the predicted normal value. (NCI) | Percent Predicted Maximal Expiratory Pressure | ||
MIP | C135496 | Maximal Inspiratory Pressure;Negative Inspiratory Force;NIF | The greatest amount of pressure that can be generated during inhalation against a fully occluded airway, which is used to measure the strength of respiratory muscles. (NCI) | Maximal Inspiratory Pressure | ||
MIPPP | C135497 | Percent Predicted MIP | The greatest amount of pressure that can be generated during inhalation against a fully occluded airway, which is used to measure the strength of respiratory muscles expressed as a proportion of the predicted normal value. (NCI) | Percent Predicted Maximal Inspiratory Pressure | ||
OI | C189635 | Oxygenation Index | A measurement of the efficiency of oxygen exchange by the lungs, which is calculated by multiplying the fraction of inspired oxygen (FiO2) (in %) to mean airway pressure (Mpaw), and dividing by pressure of arterial oxygen (PaO2). | Oxygenation Index | ||
OXYPULSE | C123566 | Oxygen Pulse | The volume of oxygen per heartbeat consumed by the body while at rest. | Oxygen Pulse | ||
PCF | C135498 | Peak Cough Flow | The maximum rate of air flow expelled through the mouth, endotracheal, or tracheostomy tube during a cough. (NCI) | Peak Cough Flow | ||
PEF | C41372 | Peak Expiratory Flow | The maximum rate of exhalation. | Peak Expiratory Flow | ||
PEFPP | C112384 | Percent Predicted Peak Expiratory Flow | The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Peak Expiratory Flow | ||
PEFREV | C112368 | PEF Reversibility | The change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value. | Peak Expiratory Flow Reversibility | ||
PEFTIME | C139259 | Peak Expiratory Flow Time | The time from the start of the test until the subject reaches his maximum expiratory gas flow rate. | Peak Expiratory Flow Time | ||
PIF | C120939 | Peak Inspiratory Flow | The maximum rate of inhalation. | Peak Inspiratory Flow Rate | ||
PLMXRS | C123567 | Pulmonary Reactance | A measurement of the ability of the lung to store energy, which is required for passive expiration. | Pulmonary Reactance | ||
PNEUMIND | C171521 | Pneumonia Indicator | An indication as to whether pneumonia has occurred. | Pneumonia Indicator | ||
PNIF | C119547 | Peak Nasal Inspiratory Flow | The maximal flow achieved during the maximally forced inspiration through the nose initiated at maximum exhalation. (NCI) | Peak Nasal Inspiratory Flow | ||
PO2FIO2 | C119293 | PAO2/FIO2;PP Arterial O2/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. | Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement | ||
QUASCOMP | C139255 | Quasi-Static Compliance | The static elastic recoil pressure of the lungs at a given lung volume. | Quasi-Static Compliance | ||
RAW | C120927 | Airway Resistance | A measurement of respiratory tract resistance to airflow during inspiration and expiration. | Airway Resistance | ||
RAWPP | C170623 | Percent Predicted Airway Resistance | A measurement of respiratory tract resistance to airflow during inspiration and expiration, as a proportion of the predicted normal value. | Percent Predicted Airway Resistance | ||
REEXAM | C198356 | Respiratory System Examination | An observation, assessment or examination of the respiratory system. | Respiratory System Examination | ||
RELSZCHG | C163556 | Relative Size Change | An assessment of the size difference in comparison to a baseline or previous value. | Relative Size Change | ||
RER | C123568 | Respiratory Exchange Ratio | The ratio between the amount of carbon dioxide produced and oxygen consumed in one breath. | Respiratory Exchange Ratio | ||
RRS | C122185 | Total Respiratory System Resistance | A calculated value based on all factors that influence the flow of gas from the airway opening to the alveoli, including airway resistance, and tissue resistance of the lung and chest wall. (NCI) | Total Respiratory System Resistance | ||
RV | C89836 | Residual Volume | The volume of air remaining in the lungs after maximum exhalation. | Residual Volume | ||
RVPP | C112385 | Percent Predicted Residual Volume | The volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value. | Percent Predicted Residual Volume | ||
SALKA | C139256 | Salazar-Knowles Equation Parameter A | A representation of the exponential function described by the Salazar-Knowles equation, and an estimation of a subject's inspiratory capacity. | Salazar-Knowles Equation Parameter A | ||
SALKB | C139257 | Salazar-Knowles Equation Parameter B | The difference between the volume at total lung capacity and the hypothesized volume at a transpulmonary pressure of zero. | Salazar-Knowles Equation Parameter B | ||
SALKK | C139258 | Salazar-Knowles Equation, K | The reflection of the curvature of the upper portion of the deflationary limb of the pressure-volume curve. | Salazar-Knowles Equation, K Parameter | ||
SAO2FIO2 | C174311 | Oxygen Saturation/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. | Oxygen Saturation/Fraction Inspired O2 | ||
SAWVOL | C170618 | Specific Airway Volume | A parameter used in functional respiratory imaging, derived by dividing the airway volume of a specified intrapulmonary region by the total volume of the same specified intrapulmonary region. | Specific Airway Volume | ||
SAWVOLPP | C170622 | Percent Predicted Specific Airway Volume | A parameter used in functional respiratory imaging, derived by dividing the airway volume of a specified intrapulmonary region by the total volume of the same specified intrapulmonary region, expressed as a proportion of the predicted normal value. | Percent Predicted Specific Airway Volume | ||
SGAW | C122186 | Specific Airway Conductance | A measurement of the airway conductance relative to lung volume. (NCI) | Specific Airway Conductance | ||
SRAW | C123569 | Specific Airway Resistance | A measurement used to describe airway behavior irrespective of lung volume; it is calculated as airway resistance (Raw) multiplied by functional residual capacity (FRC). | Specific Airway Resistance | ||
SRAWPP | C170624 | Percent Predicted Sp Airway Resistance;Percent Predicted Specific Airway Resistance | A measurement used to describe airway behavior irrespective of lung volume; it is calculated as airway resistance (Raw) multiplied by functional residual capacity (FRC), as a proportion of the predicted normal value. | Percent Predicted Specific Airway Resistance | ||
SVC | C111315 | Slow Vital Capacity | The maximum volume of air that can be exhaled after slow maximum inhalation. | Slow Vital Capacity | ||
SVCPP | C112386 | Percent Predicted Slow Vital Capacity | The maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Slow Vital Capacity | ||
TGV | C124426 | Thoracic Gas Volume | The absolute volume of air contained in the thoracic cavity at any given point in time and at any level of alveolar pressure. | Thoracic Gas Volume | ||
TLC | C111325 | Total Lung Capacity | The total volume of air in the lungs after maximum inhalation. | Total Lung Capacity | ||
TLCPP | C112388 | Percent Predicted Total Lung Capacity | The total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Total Lung Capacity | ||
TSUELAS | C139260 | Tissue Elastance | A measurement of the reflection of energy conservation within a given tissue. | Tissue Elastance | ||
TSUHYS | C139261 | Tissue Hysteresivity | The energy dissipated relative to the elastic energy stored in the tissue in a P-V cycle. (Fredberg JJ, Stamenovic D. On the imperfect elasticity of lung tissue. J Appl Physiol (1985). 1989 Dec;67(6):2408-19). | Tissue Hysteresivity Measurement | ||
TV | C111324 | Tidal Volume | The volume of air moved into and out of the lungs during breathing at rest. | Tidal Volume | ||
TVPP | C112387 | Percent Predicted Tidal Volume | The volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value. | Percent Predicted Tidal Volume | ||
VO2 | C123570 | Oxygen Consumption | The rate at which oxygen is absorbed and utilized by any given tissue in the body. | Oxygen Consumption | ||
VO2MAX | C178242 | Maximal Oxygen Consumption | The maximum rate of oxygen utilization at which oxygen uptake no longer increases and beyond which no level of effort can raise it. | Maximal Oxygen Uptake | ||
VO2MAXE | C174363 | Estimated Maximal Aerobic Capacity;Maximal Oxygen Consumption, Estimated | The predicted maximum rate of oxygen uptake that is derived from physiological responses to submaximal exercise performance and is used as a measure of cardiorespiratory fitness. | Maximal Oxygen Consumption, Estimated | ||
Back to top | ||||||
CL.C111107.RETEST | Respiratory Test Name
(RETEST) | text
Extensible: Yes | C111107 | Respiratory Test Name | A terminology codelist based on the test names for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. | CDISC SDTM Respiratory Test Name Terminology |
Additional Disease-Related Findings | C189634 | Additional Disease-Related Findings | A determination of additional abnormalities and/or other observations that may be associated with the disease of interest, for which a targeted test has not been identified in the data. | Additional Disease-Related Findings | ||
Air Trapping | C170620 | Air Trapping | A measurement of the gas retention in a specified intrapulmonary space at the end of exhalation. | Air Trapping Measurement | ||
Airway Conductance | C124422 | Airway Conductance | The instantaneous rate of air flow in the airway, expressed as the pressure difference between any given part of the airway and the alveoli; it is the reciprocal of airway resistance (Raw). | Airway Conductance | ||
Airway Resistance | C120927 | Airway Resistance | A measurement of respiratory tract resistance to airflow during inspiration and expiration. | Airway Resistance | ||
Airway Volume | C170457 | Airway Volume | The total volume of gas in a specified airway or set of airways at a specified point in time in the respiratory cycle. | Airway Volume | ||
Airway Wall Volume | C170619 | Airway Wall Volume | The volume of the entirety of the airway tissue in a specified intrapulmonary region. | Airway Wall Volume | ||
Alveolar Volume | C156584 | Alveolar Volume;VA | The quantity of gas that enters the alveoli during inspiration. | Alveolar Volume | ||
Blood Flow Rate | C94866 | Blood Flow Rate | The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. | Blood Flow Rate | ||
Diffusion Capacity of Lung for CO | C38083 | Diffusion Capacity of Lung for CO;TLCO;Transfer Factor of Lung for CO | The volume of the carbon monoxide that is transferred from inspired air into the pulmonary capillary blood. | Carbon Monoxide Diffusing Capability Test | ||
DLCO/VA | C120830 | DLCO/VA | The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the alveolar volume. | Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio | ||
Dominant Lung Pattern Distribution | C189633 | Dominant Lung Pattern Distribution | A subjective assessment of the distribution of the primary lung abnormality pattern. | Dominant Lung Pattern Distribution Assessment | ||
Dominant Lung Pattern | C189632 | Dominant Lung Pattern | A subjective assessment of the primary lung abnormality pattern, generally based on size, distribution, and/or amount. | Dominant Lung Pattern Assessment | ||
Effusion Indicator | C161422 | Effusion Indicator | An indication as to whether effusion is present. | Effusion Indicator | ||
Effusion Volume | C161424 | Effusion Volume | The amount of three dimensional space occupied by the effusion fluid. | Effusion Volume Measurement | ||
Elastance | C135493 | Elastance | A measure of the resistance of a system to expand, i.e. the pressure change that is required to elicit a unit volume change in the lungs. Elastance is the reciprocal of compliance. | Elastance | ||
Expiration Relaxation Time | C120931 | Expiration Relaxation Time | The time required to exhale 63.2% of the total expiratory volume, as measured from the start of exhalation. | Expiration Relaxation Time | ||
Expiratory Reserve Volume | C111200 | Expiratory Reserve Volume | The maximum volume of air a subject can exhale from the lungs after a tidal exhalation. | Expiratory Reserve Volume | ||
Expiratory Vital Capacity | C147484 | Expiratory Vital Capacity | The maximum volume of air an individual can exhale from the point of maximal inhalation. | Expiratory Vital Capacity | ||
FEV at PEF | C139249 | FEV at PEF;Forced Expiratory Volume at Peak Expiratory Flow | The volume of gas that is forcibly exhaled at the peak of expiratory flow. | Forced Expiratory Volume at Peak Expiratory Flow | ||
FEV1 Reversibility | C112285 | FEV1 Reversibility | The change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value. | Forced Expiratory Volume in 1 Second Reversibility | ||
FEV1/FVC | C111359 | FEV1/FVC | A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the largest observed expired volume during a forced vital capacity maneuver. | Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio Measurement | ||
FEV1/FVC6 | C123565 | FEV1/FVC6 | A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the observed expired volume during the first six seconds of a forced vital capacity maneuver. | Forced Expiratory Volume in 1 Second to Forced Vital Capacity in 6 Seconds | ||
FEV1/SVC | C170626 | FEV1/SVC | A relative measurement (ratio or percentage) of the forced expiratory volume during the first second of exhalation to the largest observed expired volume during a slow vital capacity maneuver. | Forced Expiratory Volume in 1 Second to Slow Vital Capacity Ratio Measurement | ||
FEV3/FVC | C170625 | FEV3/FVC | A relative measurement (ratio or percentage) of the forced expiratory volume during the first three seconds of exhalation to the largest observed expired volume during a forced vital capacity maneuver. | Forced Expiratory Volume in 3 Seconds to Forced Vital Capacity Ratio Measurement | ||
Forced Expiratory Flow 25-75% | C119545 | Forced Expiratory Flow 25-75% | The mean forced expiratory flow rate at 25-75% of the forced vital capacity. (NCI) | Forced Expiratory Flow at 25-75 Percent | ||
Forced Expiratory Flow 50% | C139253 | Forced Expiratory Flow 50% | The mean forced expiratory flow rate at 50% of the forced vital capacity. (NCI) | Forced Expiratory Flow at 50 Percent Forced Vital Capacity | ||
Forced Expiratory Flow in 0.05 Second | C139250 | Forced Expiratory Flow in 0.05 Second | The forced expiratory flow rate during the first 0.05 second of a forced exhalation. | Forced Expiratory Flow in 0.05 Second | ||
Forced Expiratory Flow in 0.1 Second | C139251 | Forced Expiratory Flow in 0.1 Second | The forced expiratory flow rate during the first 0.1 second of a forced exhalation. | Forced Expiratory Flow in 0.1 Second | ||
Forced Expiratory Flow in 0.2 Second | C139252 | Forced Expiratory Flow in 0.2 Second | The forced expiratory flow rate during the first 0.2 second of a forced exhalation. | Forced Expiratory Flow in 0.2 Second | ||
Forced Expiratory Volume in 0.05 S/FVC | C139243 | Forced Expiratory Volume in 0.05 S/FVC;Forced Expiratory Volume in 0.05 Seconds over FVC | The ratio of the volume of gas that is forcibly exhaled during the first 0.05 seconds following maximal inhalation to that of the forced vital capacity. | Forced Expiratory Volume in 0.05 Second to FVC Ratio Measurement | ||
Forced Expiratory Volume in 0.05 Second | C139246 | Forced Expiratory Volume in 0.05 Second | The volume of air that can be forcibly exhaled during the first 0.05 second following maximal inhalation. | Forced Expiratory Volume in 0.05 Second | ||
Forced Expiratory Volume in 0.1 S/FVC | C139244 | Forced Expiratory Volume in 0.1 S/FVC;Forced Expiratory Volume in 0.1 Seconds over FVC | The ratio of the volume of gas that is forcibly exhaled during the first 0.1 seconds following maximal inhalation to that of the forced vital capacity. | Forced Expiratory Volume in 0.1 Second to FVC Ratio Measurement | ||
Forced Expiratory Volume in 0.1 Second | C139247 | Forced Expiratory Volume in 0.1 Second | The volume of air that can be forcibly exhaled during the first 0.1 second following maximal inhalation. | Forced Expiratory Volume in 0.1 Second | ||
Forced Expiratory Volume in 0.2 S/FVC | C139245 | Forced Expiratory Volume in 0.2 S/FVC;Forced Expiratory Volume in 0.2 Seconds over FVC | The ratio of the volume of gas that is forcibly exhaled during the first 0.2 seconds following maximal inhalation to that of the forced vital capacity. | Forced Expiratory Volume in 0.2 Second to FVC Ratio Measurement | ||
Forced Expiratory Volume in 0.2 Second | C139248 | Forced Expiratory Volume in 0.2 Second | The volume of air that can be forcibly exhaled during the first 0.2 second following maximal inhalation. | Forced Expiratory Volume in 0.2 Second | ||
Forced Expiratory Volume in 0.5 Second | C139262 | Forced Expiratory Volume in 0.5 Second | The volume of air that can be forcibly exhaled during the first half second following maximal inhalation. | Forced Expiratory Volume in 0.5 Second | ||
Forced Expiratory Volume in 0.75 Second | C174362 | Forced Expiratory Volume in 0.75 Second | The volume of air that can be forcibly exhaled during the first 0.75 second following maximal inhalation. | Forced Expiratory Volume in 0.75 Second | ||
Forced Expiratory Volume in 1 Second | C38084 | Forced Expiratory Volume in 1 Second | The volume of air that can be forcibly exhaled during the first second following maximal inhalation. | Forced Expiratory Volume in 1 Second | ||
Forced Expiratory Volume in 3 Seconds | C132453 | Forced Expiratory Volume in 3 Seconds | The volume of air that can be forcibly exhaled during the first three seconds following maximal inhalation. | Forced Expiratory Volume in 3 Seconds | ||
Forced Expiratory Volume in 6 Seconds | C47843 | Forced Expiratory Volume in 6 Seconds | The volume of air that can be forcibly exhaled during the first six seconds following maximal inhalation. | Forced Expiratory Volume in 6 Seconds | ||
Forced Inspiratory Flow at 25% | C124418 | Forced Inspiratory Flow at 25% | The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 25 percent of the total volume of air has been inhaled. | Forced Inspiratory Flow at 25% | ||
Forced Inspiratory Flow at 50% | C124419 | Forced Inspiratory Flow at 50% | The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 50 percent of the total volume of air has been inhaled. | Forced Inspiratory Flow at 50% | ||
Forced Inspiratory Flow at 75% | C124420 | Forced Inspiratory Flow at 75% | The forced inspiratory flow rate at the point on the inspiratory flow-volume curve where 75 percent of the total volume of air has been inhaled. | Forced Inspiratory Flow at 75% | ||
Forced Inspiratory Vital Capacity | C139263 | Forced Inspiratory Vital Capacity | The difference in lung volume between maximal expiration to residual volume followed immediately by full inspiration to total lung capacity during forceful inhalation. | Forced Inspiratory Vital Capacity | ||
Forced Inspiratory Volume in 1 Second | C111360 | Forced Inspiratory Volume in 1 Second | The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation. | Forced Inspiratory Volume in 1 Second | ||
Forced Vital Capacity in 6 Seconds | C124421 | Forced Vital Capacity in 6 Seconds | The volume of air that can be forcibly exhaled during the first six seconds following maximal inhalation. | Forced Vital Capacity in 6 Seconds | ||
Forced Vital Capacity | C111361 | Forced Vital Capacity | The volume of air that can be forcibly exhaled following maximal inhalation. | Forced Vital Capacity | ||
Fraction of Inspired Oxygen | C38082 | Fraction of Inspired Oxygen | A measurement of the volumetric fraction of oxygen in the inhaled gas. | Fraction of Inspired Oxygen | ||
Functional Residual Capacity | C89800 | Functional Residual Capacity | The volume of air remaining in the lungs after a normal exhalation. (NCI) | Functional Residual Capacity | ||
HGB Corrected DLCO | C120825 | HGB Corrected DLCO | The diffusing capacity of the lungs for carbon monoxide adjusted for hemoglobin concentration. | Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide | ||
HGB Corrected DLCO/VA | C120827 | HGB Corrected DLCO/VA | The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the alveolar volume, adjusted for hemoglobin concentration. | Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio | ||
IC Reversibility | C112321 | IC Reversibility | The change in IC following administration of a bronchodilator relative to the pre-treatment IC value. | Inspiratory Capacity Reversibility | ||
Inertance | C139254 | Inertance | The measure of the force of the column of air in the conducting airways. | Pulmonary Inertance | ||
Infiltrates Indicator | C171512 | Infiltrates Indicator | An indication as to whether infiltrates have occurred. | Infiltrates Indicator | ||
Inspiratory Capacity | C111362 | Inspiratory Capacity | The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV). | Inspiratory Capacity | ||
Inspiratory Reserve Volume | C111237 | Inspiratory Reserve Volume | The maximum volume of air a subject can inhale into the lungs after a tidal inhalation. | Inspiratory Reserve Volume | ||
Inspiratory Vital Capacity | C124423 | Inspiratory Vital Capacity | The maximum volume of air an individual can inhale from the point of maximal exhalation. | Inspiratory Vital Capacity | ||
Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
Lobar Volume | C174232 | Lobar Volume | The total volume of gas in a lobe of the lung at a specified point in time during the respiratory cycle. | Lobar Volume | ||
Lung Clearance Index | C124425 | Lung Clearance Index | A representative measurement of the number of times the volume of air in the lung at the start of the washout (the Functional Residual Capacity) must be recycled to eliminate the tracer to the pre-defined endpoint. | Lung Clearance Index | ||
Malignancy Evidence Description | C161312 | Malignancy Evidence Description | The basis for the determination that a malignancy is present. | Evidence of Malignant Disease Description | ||
Malignancy Indicator | C161423 | Malignancy Indicator | An indication as to whether a malignancy is present. | Malignant Disease Indicator | ||
Maximal Expiratory Pressure | C135494 | Maximal Expiratory Pressure | The greatest amount of pressure that can be generated by exhaling against a mouthpiece, which is a measure of the strength of respiratory muscles. (NCI) | Maximal Expiratory Pressure | ||
Maximal Inspiratory Pressure | C135496 | Maximal Inspiratory Pressure;Negative Inspiratory Force;NIF | The greatest amount of pressure that can be generated during inhalation against a fully occluded airway, which is used to measure the strength of respiratory muscles. (NCI) | Maximal Inspiratory Pressure | ||
Maximal Oxygen Consumption | C178242 | Maximal Oxygen Consumption | The maximum rate of oxygen utilization at which oxygen uptake no longer increases and beyond which no level of effort can raise it. | Maximal Oxygen Uptake | ||
Maximal Oxygen Consumption, Estimated | C174363 | Estimated Maximal Aerobic Capacity;Maximal Oxygen Consumption, Estimated | The predicted maximum rate of oxygen uptake that is derived from physiological responses to submaximal exercise performance and is used as a measure of cardiorespiratory fitness. | Maximal Oxygen Consumption, Estimated | ||
Maximum Forced Inspiratory Flow | C112333 | Maximum Forced Inspiratory Flow | The fastest rate of inspired air achieved during a forced inspiration maneuver. | Maximum Forced Inspiratory Flow | ||
Mean Diffusion Capacity of Lung for CO | C123564 | Mean Diffusion Capacity of Lung for CO | The mean volume of the carbon monoxide that is transferred from inspired air into the pulmonary capillary blood. | Mean Carbon Monoxide Diffusing Capability Test | ||
Oxygen Consumption | C123570 | Oxygen Consumption | The rate at which oxygen is absorbed and utilized by any given tissue in the body. | Oxygen Consumption | ||
Oxygen Pulse | C123566 | Oxygen Pulse | The volume of oxygen per heartbeat consumed by the body while at rest. | Oxygen Pulse | ||
Oxygen Saturation/Fraction Inspired O2 | C174311 | Oxygen Saturation/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. | Oxygen Saturation/Fraction Inspired O2 | ||
Oxygenation Index | C189635 | Oxygenation Index | A measurement of the efficiency of oxygen exchange by the lungs, which is calculated by multiplying the fraction of inspired oxygen (FiO2) (in %) to mean airway pressure (Mpaw), and dividing by pressure of arterial oxygen (PaO2). | Oxygenation Index | ||
Peak Cough Flow | C135498 | Peak Cough Flow | The maximum rate of air flow expelled through the mouth, endotracheal, or tracheostomy tube during a cough. (NCI) | Peak Cough Flow | ||
Peak Expiratory Flow Time | C139259 | Peak Expiratory Flow Time | The time from the start of the test until the subject reaches his maximum expiratory gas flow rate. | Peak Expiratory Flow Time | ||
Peak Expiratory Flow | C41372 | Peak Expiratory Flow | The maximum rate of exhalation. | Peak Expiratory Flow | ||
Peak Inspiratory Flow | C120939 | Peak Inspiratory Flow | The maximum rate of inhalation. | Peak Inspiratory Flow Rate | ||
Peak Nasal Inspiratory Flow | C119547 | Peak Nasal Inspiratory Flow | The maximal flow achieved during the maximally forced inspiration through the nose initiated at maximum exhalation. (NCI) | Peak Nasal Inspiratory Flow | ||
PEF Reversibility | C112368 | PEF Reversibility | The change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value. | Peak Expiratory Flow Reversibility | ||
Percent Predicted Airway Resistance | C170623 | Percent Predicted Airway Resistance | A measurement of respiratory tract resistance to airflow during inspiration and expiration, as a proportion of the predicted normal value. | Percent Predicted Airway Resistance | ||
Percent Predicted Airway Volume | C170621 | Percent Predicted Airway Volume | The total volume of gas in a specified airway or set of airways at a specified point in time in the respiratory cycle, expressed as a proportion of the predicted normal value. | Percent Predicted Airway Volume | ||
Percent Predicted DLCO | C120829 | Percent Predicted DLCO | The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the predicted normal value. | Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide | ||
Percent Predicted DLCO/VA | C120831 | Percent Predicted DLCO/VA | The proportion of the diffusing capacity of the lungs for carbon monoxide to alveolar volume, expressed as a proportion of the predicted normal value. | Percent Predicted Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio | ||
Percent Predicted ERV | C112375 | Percent Predicted ERV | The maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value. | Percent Predicted Expiratory Reserve Volume | ||
Percent Predicted FEF25-75 | C119546 | Percent Predicted FEF25-75 | The mean forced expiratory flow rate at 25-75% of the forced vital capacity as a proportion of the predicted normal value. (NCI) | Percent Predicted Forced Expiratory Flow at 25-75 Percent | ||
Percent Predicted FEV1 | C112376 | Percent Predicted FEV1 | Forced expiratory volume in one second as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 1 Second | ||
Percent Predicted FEV1/FVC | C112377 | Percent Predicted FEV1/FVC | The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 1 Second Divided by Forced Vital Capacity | ||
Percent Predicted FEV3 | C170627 | Percent Predicted FEV3 | Forced expiratory volume in three seconds as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 3 Seconds | ||
Percent Predicted FEV6 | C112378 | Percent Predicted FEV6 | Forced expiratory volume in six seconds as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 6 Seconds | ||
Percent Predicted FIFmax | C112379 | Percent Predicted FIFmax | The fastest rate of inspired air achieved during a forced inspiration maneuver expressed as a percentage of the expected result value for healthy individuals with similar characteristics. | Percent Predicted Forced Inspiratory Flow Maximum | ||
Percent Predicted FIV1 | C112380 | Percent Predicted FIV1 | The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value. | Percent Predicted Forced Inspiratory Volume in 1 Second | ||
Percent Predicted Forced Vital Capacity | C112381 | Percent Predicted Forced Vital Capacity | Forced vital capacity as a proportion of the predicted normal value. | Percent Predicted Forced Vital Capacity | ||
Percent Predicted FRC | C126052 | Percent Predicted FRC | The functional residual capacity as a proportion of the predicted normal value. | Percent Predicted Functional Residual Capacity | ||
Percent Predicted HGB Corrected DLCO | C120826 | Percent Predicted HGB Corrected DLCO | The diffusing capacity of the lungs for carbon monoxide expressed as a proportion of the predicted normal value, adjusted for hemoglobin concentration. | Percent Predicted Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide | ||
Percent Predicted HGB Corrected DLCO/VA | C120828 | Percent Predicted HGB Corrected DLCO/VA | The proportion of diffusing capacity of the lungs for carbon monoxide to the alveolar volume expressed as a proportion of the predicted normal value, adjusted for hemoglobin concentration. | Percent Predicted Hemoglobin Corrected Diffusion Capacity of the Lung for Carbon Monoxide/Alveolar Volume Ratio | ||
Percent Predicted Inspiratory Capacity | C112382 | Percent Predicted Inspiratory Capacity | The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value. | Percent Predicted Inspiratory Capacity | ||
Percent Predicted IRV | C112383 | Percent Predicted IRV | The maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value. | Percent Predicted Inspiratory Reserve Volume | ||
Percent Predicted IVC | C124424 | Percent Predicted IVC | The maximum volume of air an individual can inhale from the point of maximal exhalation as a percentage of the predicted normal value. | Percent Predicted Inspiratory Vital Capacity | ||
Percent Predicted Lobar Volume | C174361 | Percent Predicted Lobar Volume | The total volume of gas in a lobe of the lung at a specified point in time during the respiratory cycle, as a proportion of the predicted normal value. | Percent Predicted Lobar Volume | ||
Percent Predicted MEP | C135495 | Percent Predicted MEP | The greatest amount of pressure that can be generated by exhaling against a mouthpiece, which is a measure of the strength of respiratory muscles expressed as a proportion of the predicted normal value. (NCI) | Percent Predicted Maximal Expiratory Pressure | ||
Percent Predicted MIP | C135497 | Percent Predicted MIP | The greatest amount of pressure that can be generated during inhalation against a fully occluded airway, which is used to measure the strength of respiratory muscles expressed as a proportion of the predicted normal value. (NCI) | Percent Predicted Maximal Inspiratory Pressure | ||
Percent Predicted Peak Expiratory Flow | C112384 | Percent Predicted Peak Expiratory Flow | The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Peak Expiratory Flow | ||
Percent Predicted Residual Volume | C112385 | Percent Predicted Residual Volume | The volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value. | Percent Predicted Residual Volume | ||
Percent Predicted Slow Vital Capacity | C112386 | Percent Predicted Slow Vital Capacity | The maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Slow Vital Capacity | ||
Percent Predicted Sp Airway Resistance | C170624 | Percent Predicted Sp Airway Resistance;Percent Predicted Specific Airway Resistance | A measurement used to describe airway behavior irrespective of lung volume; it is calculated as airway resistance (Raw) multiplied by functional residual capacity (FRC), as a proportion of the predicted normal value. | Percent Predicted Specific Airway Resistance | ||
Percent Predicted Specific Airway Volume | C170622 | Percent Predicted Specific Airway Volume | A parameter used in functional respiratory imaging, derived by dividing the airway volume of a specified intrapulmonary region by the total volume of the same specified intrapulmonary region, expressed as a proportion of the predicted normal value. | Percent Predicted Specific Airway Volume | ||
Percent Predicted Tidal Volume | C112387 | Percent Predicted Tidal Volume | The volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value. | Percent Predicted Tidal Volume | ||
Percent Predicted Total Lung Capacity | C112388 | Percent Predicted Total Lung Capacity | The total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Total Lung Capacity | ||
Pneumonia Indicator | C171521 | Pneumonia Indicator | An indication as to whether pneumonia has occurred. | Pneumonia Indicator | ||
PP Arterial O2/Fraction Inspired O2 | C119293 | PAO2/FIO2;PP Arterial O2/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. | Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement | ||
Pulmonary Reactance | C123567 | Pulmonary Reactance | A measurement of the ability of the lung to store energy, which is required for passive expiration. | Pulmonary Reactance | ||
Quasi-Static Compliance | C139255 | Quasi-Static Compliance | The static elastic recoil pressure of the lungs at a given lung volume. | Quasi-Static Compliance | ||
Relative Size Change | C163556 | Relative Size Change | An assessment of the size difference in comparison to a baseline or previous value. | Relative Size Change | ||
Residual Volume | C89836 | Residual Volume | The volume of air remaining in the lungs after maximum exhalation. | Residual Volume | ||
Respiratory Exchange Ratio | C123568 | Respiratory Exchange Ratio | The ratio between the amount of carbon dioxide produced and oxygen consumed in one breath. | Respiratory Exchange Ratio | ||
Respiratory System Examination | C198356 | Respiratory System Examination | An observation, assessment or examination of the respiratory system. | Respiratory System Examination | ||
Salazar-Knowles Equation Parameter A | C139256 | Salazar-Knowles Equation Parameter A | A representation of the exponential function described by the Salazar-Knowles equation, and an estimation of a subject's inspiratory capacity. | Salazar-Knowles Equation Parameter A | ||
Salazar-Knowles Equation Parameter B | C139257 | Salazar-Knowles Equation Parameter B | The difference between the volume at total lung capacity and the hypothesized volume at a transpulmonary pressure of zero. | Salazar-Knowles Equation Parameter B | ||
Salazar-Knowles Equation, K | C139258 | Salazar-Knowles Equation, K | The reflection of the curvature of the upper portion of the deflationary limb of the pressure-volume curve. | Salazar-Knowles Equation, K Parameter | ||
Slow Vital Capacity | C111315 | Slow Vital Capacity | The maximum volume of air that can be exhaled after slow maximum inhalation. | Slow Vital Capacity | ||
Specific Airway Conductance | C122186 | Specific Airway Conductance | A measurement of the airway conductance relative to lung volume. (NCI) | Specific Airway Conductance | ||
Specific Airway Resistance | C123569 | Specific Airway Resistance | A measurement used to describe airway behavior irrespective of lung volume; it is calculated as airway resistance (Raw) multiplied by functional residual capacity (FRC). | Specific Airway Resistance | ||
Specific Airway Volume | C170618 | Specific Airway Volume | A parameter used in functional respiratory imaging, derived by dividing the airway volume of a specified intrapulmonary region by the total volume of the same specified intrapulmonary region. | Specific Airway Volume | ||
Thoracic Gas Volume | C124426 | Thoracic Gas Volume | The absolute volume of air contained in the thoracic cavity at any given point in time and at any level of alveolar pressure. | Thoracic Gas Volume | ||
Tidal Volume | C111324 | Tidal Volume | The volume of air moved into and out of the lungs during breathing at rest. | Tidal Volume | ||
Tissue Elastance | C139260 | Tissue Elastance | A measurement of the reflection of energy conservation within a given tissue. | Tissue Elastance | ||
Tissue Hysteresivity | C139261 | Tissue Hysteresivity | The energy dissipated relative to the elastic energy stored in the tissue in a P-V cycle. (Fredberg JJ, Stamenovic D. On the imperfect elasticity of lung tissue. J Appl Physiol (1985). 1989 Dec;67(6):2408-19). | Tissue Hysteresivity Measurement | ||
Total Lung Capacity | C111325 | Total Lung Capacity | The total volume of air in the lungs after maximum inhalation. | Total Lung Capacity | ||
Total Respiratory System Resistance | C122185 | Total Respiratory System Resistance | A calculated value based on all factors that influence the flow of gas from the airway opening to the alveoli, including airway resistance, and tissue resistance of the lung and chest wall. (NCI) | Total Respiratory System Resistance | ||
Back to top | ||||||
CL.C177910.RSLSCLRS | Result Scale Response
(RSLSCLRS) | text
Extensible: Yes | C177910 | Result Scale Response | Terminology relevant to the values that classifies the scale of the original result value with respect to whether the result is, for example, ordinal, nominal, quantitative, or narrative. | CDISC SDTM Result Scale Response Terminology |
NARRATIVE | C80446 | Nar | A textual description of the particulars of an act, occurrence, or course of events. | Narrative | ||
NOMINAL | C47798 | Nom | A scale or classification with no inherent order to the values, which uses named categories or labels. | Nominal Scale | ||
ORDINAL | C47797 | Ord | A scale that uses an ordered set of values where the difference between successive designations may not be constant. | Ordinal Scale | ||
QUANTITATIVE | C70766 | Qn | A numeric measure of a physical attribute of an entity or substance. | Quantitative Concept | ||
Back to top | ||||||
CL.C179588.RESTYPRS | Result Type Response
(RESTYPRS) | text
Extensible: Yes | C179588 | Result Type Response | Terminology relevant to the values that describe the result type. | CDISC SDTM Result Type Response Terminology |
APPEARANCE | C25377 | Aper | The outward or visible aspect of an entity. | Appearance | ||
ARBITRARY CONCENTRATION | C179790 | ACnc | The quantity of a specified substance, which is subject to individual judgment, preference, or predetermined reference, in a unit volume or weight of another substance. | Arbitrary Concentration | ||
AREIC VOLUME RATE | C179791 | ArVRat | The volume consumed, produced, excreted, or otherwise changed per area per unit of time. | Areic Volume Rate | ||
CATALYTIC CONCENTRATION | C179792 | CCnc | The quantity of a specified substance, which is based on catalytic activity, in a unit volume or weight of another substance. | Catalytic Concentration | ||
CATALYTIC CONTENT | C179793 | CCnt | The total amount of catalytic activity for a substance contained within an entity. | Catalytic Content | ||
CATALYTIC DECIMAL FRACTION | C189628 | CFr.DF;Decimal Catalytic Fraction | The catalytic activity of a component substance to the catalytic activity of the whole represented as a decimal between 0 and 1. | Catalytic Decimal Fraction | ||
CATALYTIC FRACTION | C179794 | CFr | The catalytic activity of a component substance to the catalytic activity of the whole. | Catalytic Fraction | ||
CATALYTIC SUBSTANCE | C191346 | CSub;Enzymatic Activity/Substance | The enzymatic activity of a specified component divided by the number of molar entities. | Catalytic Substance Activity | ||
ENTITIC MASS | C179795 | EntMass | The weight of a specified component divided by the number of entities. | Entitic Mass | ||
ENTITIC SUBSTANCE | C191349 | Entitic Substance Amount;EntSub | The molar amount of a specified component divided by the number of entities. | Entitic Substance | ||
ENTITIC VOLUME | C179796 | EntVol | The volume of a specified component divided by the number of entities. | Entitic Volume | ||
FLUORESCENCE INTENSITY | C184706 | Fluorescent Intensity | The degree or magnitude of fluorescent light emission. | Fluorescence Intensity | ||
IMPRESSION | C131082 | Imp | A diagnostic statement that is an interpretation or abstraction of an observation(s). | Impression | ||
LOG SUBSTANCE CONCENTRATION | C179797 | LsCnc | The quantity, expressed as the log of the moles, of a specified substance in a unit volume or weight of another substance. | Log Substance Concentration | ||
MASS CONCENTRATION | C179798 | MCnc | The quantity, expressed as a weight, of a specified substance in a unit volume or weight of another substance. | Mass Concentration | ||
MASS CONTENT | C191347 | The weight of a component substance per unit weight of a sample. | Mass Content | |||
MASS DECIMAL FRACTION | C189627 | MFr.DF | The weight of a component substance to the weight of the whole represented as a decimal between 0 and 1. | Mass Decimal Fraction | ||
MASS FRACTION | C67470 | MFr | The weight of a component substance to the weight of the whole. | Mass Fraction | ||
MASS RATE | C179799 | MRat | The weight consumed, produced, excreted, or otherwise changed per unit of time. | Mass Rate | ||
MASS RATIO | C179800 | MRto | The quotient of the weight of one substance divided by the weight of another substance. | Mass Ratio | ||
MORPHOLOGY | C17943 | Morph | A statement about the form and/or structure of a target entity. | Morphology | ||
MULTIPLE OF THE MEDIAN | C179801 | MoM | The individual test result relative to the median value of a reference set of test results. | Multiple of the Median | ||
NUMBER AERIC | C179802 | Naric | The number of specified entities per unit of area. | Number Aeric | ||
NUMBER CONCENTRATION | C179803 | NCnc | The number of specified entities in a unit volume or weight of a substance. | Number Concentration | ||
NUMBER FRACTION | C179804 | NFr | The number of component entities to the total number of entities. | Number Fraction | ||
NUMBER | C25463 | Count;Num;Number Count | An absolute count of the number of entities. | Count | ||
ODDS RATIO | C16932 | OR | The ratio of the probability of an event occurring in one group to the probability of it occurring in another group, or to a sample-based estimate of that ratio. | Odds Ratio | ||
OSMOLARITY | C179805 | Osmol | The number of solute particles per liter of solution. | Osmolarity | ||
PARTIAL PRESSURE | C75755 | PPres | The pressure exerted by a single component of a mixture of gases. | Partial Pressure | ||
PERCENT DIFFERENCE | C179806 | PctDiff | The difference between two numbers divided by the average of the two numbers, multiplied by 100. | Percent Difference | ||
PERCENTILE | C48919 | Centile;Prctl | Any of the 99 intermediate points that divide an ordered set of scores into 100 parts, each of which contains one-hundredth of the total. | Percentile | ||
PRESENCE OR IDENTITY | C179807 | Prid | An indication of the presence of an entity which, if present, is identified. | Presence and Identity | ||
PRESENCE OR THRESHOLD | C179808 | PrThr | An indication of the presence of an entity which, if present, is in an amount above a predetermined threshold. | Presence and Threshold | ||
QUINTILE | C189631 | Quintile | Any of the 4 intermediate points that divide an ordered set of scores into 5 parts, each of which contains one-twentieth of the total. | Quintile | ||
RATIO | C179809 | Ratio | The relationship in quantity, amount, or size between two entities or activities. | Ratio Result Type | ||
RELATIVE ARBITRARY CONCENTRATION | C191348 | RelACnc | The quantity of a specified substance, which is subject to individual judgment, preference, or predetermined reference, in a unit volume or weight of another substance, relative to a comparator. | Relative Arbitrary Concentration | ||
RELATIVE CATALYTIC CONCENTRATION | C179810 | RelCCnc | The quantity of a specified substance, which is based on catalytic activity, in a unit volume or weight of another substance, relative to a comparator. | Relative Catalytic Concentration | ||
RELATIVE DENSITY | C179811 | Rden | The density of a specified substance, relative to a comparator. | Relative Density | ||
RELATIVE MASS CONCENTRATION | C179812 | RelMCnc | The quantity, expressed as a weight, of a specified substance in a unit volume or weight of another substance, relative to a comparator. | Relative Mass Concentration | ||
RELATIVE TIME | C179813 | RelTime | The time of a specified activity, relative to a comparator. | Relative Time | ||
SATURATION FRACTION | C189630 | SatFr | The degree or extent to which something is dissolved, absorbed, or bound compared with the maximum physical limit under defined conditions. | Saturation Fraction | ||
SCORE | C25338 | Score | A number or range of numeric values that assess and order a result or response for purposes of comparison. | Score | ||
SUBSTANCE CONCENTRATION | C179814 | Molar Concentration;SCnc | The quantity, expressed in moles, of a specified substance in a unit volume or weight of another substance. | Molar Concentration | ||
SUBSTANCE FRACTION | C179815 | Molar Fraction;SFr | The molar amount of a component substance to the molar amount of the whole. | Molar Fraction | ||
SUBSTANCE RATE | C179816 | Molar Rate;SRat | The molar amount of substance consumed, produced, excreted, or otherwise changed per unit of time. | Molar Rate | ||
SUBSTANCE RATIO | C81268 | Molar Ratio;SRto | The quotient of the molar amount of one substance, divided by the molar amount of another substance. | Molar Ratio | ||
TIME RATIO | C179712 | TRto | The quotient of one activity time interval divided by another activity time interval. | Time Ratio | ||
TIME | C25330 | Duration;Time;Time Duration | The length of time during which something continues. | Duration | ||
TITER | C67454 | Titr;Titre | Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent. | Titer | ||
TYPE | C25284 | Type | An identifiable class based on common distinguishable qualities. | Type | ||
VELOCITY | C179817 | Vel | The speed of an entity in a given direction. | Velocity | ||
VISCOSITY | C75912 | Visc;Viscosity | The resistance of a liquid to sheer forces and flow. (NCI) | Viscosity | ||
VOLUME DECIMAL FRACTION | C189629 | VFr.DF | Quotient of the volume of a component substance to the sum of the volumes of all component substances represented as a decimal between 0 and 1. | Volume Decimal Fraction | ||
VOLUME FRACTION | C67469 | VFr | Quotient of the volume of a component substance to the sum of the volumes of all component substances. | Volume Fraction | ||
VOLUME RATE | C75761 | VRat | The volume consumed, produced, excreted, or otherwise changed per unit of time. | Volume Rate | ||
VOLUME | C25335 | Vol | The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI) | Volume | ||
Z SCORE | C68741 | ZScore | The number of positive or negative standard deviations of a measured value from the mean of its population. | Z-Score | ||
Back to top | ||||||
CL.C103465.FIQR01TC | Revised Fibromyalgia Impact Questionnaire Questionnaire Test Code
(FIQR01TC) | text
Extensible: No | C103465 | Revised Fibromyalgia Impact Questionnaire Questionnaire Test Code | Revised Fibromyalgia Impact Questionnaire test code. | CDISC Questionnaire FIQR Test Code Terminology |
FIQR0101 | C103544 | FIQR01-Brush or Comb Your Hair | Revised Fibromyalgia Impact Questionnaire - Brush or comb your hair. | FIQR - Brush or Comb Your Hair | ||
FIQR0102 | C103545 | FIQR01-Walk Continuously for 20 Minutes | Revised Fibromyalgia Impact Questionnaire - Walk continuously for 20 minutes. | FIQR - Walk Continuously for 20 Minutes | ||
FIQR0103 | C103546 | FIQR01-Prepare a Homemade Meal | Revised Fibromyalgia Impact Questionnaire - Prepare a homemade meal. | FIQR - Prepare a Homemade Meal | ||
FIQR0104 | C103547 | FIQR01-Vacuum Scrub or Sweep Floors | Revised Fibromyalgia Impact Questionnaire - Vacuum, scrub or sweep floors. | FIQR - Vacuum Scrub or Sweep Floors | ||
FIQR0105 | C103548 | FIQR01-Lift/Carry Bag Full of Groceries | Revised Fibromyalgia Impact Questionnaire - Lift and carry a bag full of groceries. | FIQR - Lift and Carry a Bag Full of Groceries | ||
FIQR0106 | C103549 | FIQR01-Climb One Flight of Stairs | Revised Fibromyalgia Impact Questionnaire - Climb one flight of stairs. | FIQR - Climb One Flight of Stairs | ||
FIQR0107 | C103550 | FIQR01-Change Bed Sheets | Revised Fibromyalgia Impact Questionnaire - Change bed sheets. | FIQR - Change Bed Sheets | ||
FIQR0108 | C103551 | FIQR01-Sit in a Chair for 45 Minutes | Revised Fibromyalgia Impact Questionnaire - Sit in a chair for 45 minutes. | FIQR - Sit in a Chair for 45 Minutes | ||
FIQR0109 | C103552 | FIQR01-Go Shopping for Groceries | Revised Fibromyalgia Impact Questionnaire - Go shopping for groceries. | FIQR - Go Shopping for Groceries | ||
FIQR0110 | C103553 | FIQR01-Fibromyalgia Prevented Goals | Revised Fibromyalgia Impact Questionnaire - Fibromyalgia prevented me from accomplishing goals for the week. | FIQR - Fibromyalgia Prevented Me from Accomplishing Goals for the Week | ||
FIQR0111 | C103554 | FIQR01-Overwhelmed by Fibromyalgia | Revised Fibromyalgia Impact Questionnaire - I was completely overwhelmed by my fibromyalgia symptoms. | FIQR - I was Completely Overwhelmed by My Fibromyalgia Symptoms | ||
FIQR0112 | C103555 | FIQR01-Pain | Revised Fibromyalgia Impact Questionnaire - Please rate your level of pain. | FIQR - Pain | ||
FIQR0113 | C103556 | FIQR01-Energy | Revised Fibromyalgia Impact Questionnaire - Please rate your level of energy. | FIQR - Energy | ||
FIQR0114 | C103557 | FIQR01-Stiffness | Revised Fibromyalgia Impact Questionnaire - Please rate your level of stiffness. | FIQR - Stiffness | ||
FIQR0115 | C103558 | FIQR01-Your Sleep | Revised Fibromyalgia Impact Questionnaire - Please rate the quality of your sleep. | FIQR - Your Sleep | ||
FIQR0116 | C103559 | FIQR01-Depression | Revised Fibromyalgia Impact Questionnaire - Please rate your level of depression. | FIQR - Depression | ||
FIQR0117 | C103560 | FIQR01-Memory Problems | Revised Fibromyalgia Impact Questionnaire - Please rate your level of memory problems. | FIQR - Memory Problems | ||
FIQR0118 | C103561 | FIQR01-Anxiety | Revised Fibromyalgia Impact Questionnaire - Please rate your level of anxiety. | FIQR - Anxiety | ||
FIQR0119 | C103562 | FIQR01-Tenderness to Touch | Revised Fibromyalgia Impact Questionnaire - Please rate your level of tenderness to touch. | FIQR - Tenderness to Touch | ||
FIQR0120 | C103563 | FIQR01-Balance Problems | Revised Fibromyalgia Impact Questionnaire - Please rate your level of balance problems. | FIQR - Balance Problems | ||
FIQR0121 | C103564 | FIQR01-Sensitivity Noise/Light/Odor/Cold | Revised Fibromyalgia Impact Questionnaire - Please rate your level of sensitivity to loud noises, bright lights, odors and cold. | FIQR - Sensitivity to Loud Noises, Bright Lights, Odors and Cold | ||
FIQR0122 | C118107 | FIQR01-Activities Sub-Total | Revised Fibromyalgia Impact Questionnaire - Sub-total for activities subcategory. | FIQR - Activities Sub-Total | ||
FIQR0123 | C118108 | FIQR01-Overall Impact Sub-Total | Revised Fibromyalgia Impact Questionnaire - Sub-total for overall impact subcategory. | FIQR - Overall Impact Sub-Total | ||
FIQR0124 | C118109 | FIQR01-Symptoms Sub-Total | Revised Fibromyalgia Impact Questionnaire - Sub-total for symptoms subcategory. | FIQR - Symptoms Sub-Total | ||
FIQR0125 | C118110 | FIQR01-FIQR Total | Revised Fibromyalgia Impact Questionnaire - FIQR total. | FIQR - FIQR Total | ||
Back to top | ||||||
CL.C103464.FIQR01TN | Revised Fibromyalgia Impact Questionnaire Questionnaire Test Name
(FIQR01TN) | text
Extensible: No | C103464 | Revised Fibromyalgia Impact Questionnaire Questionnaire Test Name | Revised Fibromyalgia Impact Questionnaire test name. | CDISC Questionnaire FIQR Test Name Terminology |
FIQR01-Activities Sub-Total | C118107 | FIQR01-Activities Sub-Total | Revised Fibromyalgia Impact Questionnaire - Sub-total for activities subcategory. | FIQR - Activities Sub-Total | ||
FIQR01-Anxiety | C103561 | FIQR01-Anxiety | Revised Fibromyalgia Impact Questionnaire - Please rate your level of anxiety. | FIQR - Anxiety | ||
FIQR01-Balance Problems | C103563 | FIQR01-Balance Problems | Revised Fibromyalgia Impact Questionnaire - Please rate your level of balance problems. | FIQR - Balance Problems | ||
FIQR01-Brush or Comb Your Hair | C103544 | FIQR01-Brush or Comb Your Hair | Revised Fibromyalgia Impact Questionnaire - Brush or comb your hair. | FIQR - Brush or Comb Your Hair | ||
FIQR01-Change Bed Sheets | C103550 | FIQR01-Change Bed Sheets | Revised Fibromyalgia Impact Questionnaire - Change bed sheets. | FIQR - Change Bed Sheets | ||
FIQR01-Climb One Flight of Stairs | C103549 | FIQR01-Climb One Flight of Stairs | Revised Fibromyalgia Impact Questionnaire - Climb one flight of stairs. | FIQR - Climb One Flight of Stairs | ||
FIQR01-Depression | C103559 | FIQR01-Depression | Revised Fibromyalgia Impact Questionnaire - Please rate your level of depression. | FIQR - Depression | ||
FIQR01-Energy | C103556 | FIQR01-Energy | Revised Fibromyalgia Impact Questionnaire - Please rate your level of energy. | FIQR - Energy | ||
FIQR01-Fibromyalgia Prevented Goals | C103553 | FIQR01-Fibromyalgia Prevented Goals | Revised Fibromyalgia Impact Questionnaire - Fibromyalgia prevented me from accomplishing goals for the week. | FIQR - Fibromyalgia Prevented Me from Accomplishing Goals for the Week | ||
FIQR01-FIQR Total | C118110 | FIQR01-FIQR Total | Revised Fibromyalgia Impact Questionnaire - FIQR total. | FIQR - FIQR Total | ||
FIQR01-Go Shopping for Groceries | C103552 | FIQR01-Go Shopping for Groceries | Revised Fibromyalgia Impact Questionnaire - Go shopping for groceries. | FIQR - Go Shopping for Groceries | ||
FIQR01-Lift/Carry Bag Full of Groceries | C103548 | FIQR01-Lift/Carry Bag Full of Groceries | Revised Fibromyalgia Impact Questionnaire - Lift and carry a bag full of groceries. | FIQR - Lift and Carry a Bag Full of Groceries | ||
FIQR01-Memory Problems | C103560 | FIQR01-Memory Problems | Revised Fibromyalgia Impact Questionnaire - Please rate your level of memory problems. | FIQR - Memory Problems | ||
FIQR01-Overall Impact Sub-Total | C118108 | FIQR01-Overall Impact Sub-Total | Revised Fibromyalgia Impact Questionnaire - Sub-total for overall impact subcategory. | FIQR - Overall Impact Sub-Total | ||
FIQR01-Overwhelmed by Fibromyalgia | C103554 | FIQR01-Overwhelmed by Fibromyalgia | Revised Fibromyalgia Impact Questionnaire - I was completely overwhelmed by my fibromyalgia symptoms. | FIQR - I was Completely Overwhelmed by My Fibromyalgia Symptoms | ||
FIQR01-Pain | C103555 | FIQR01-Pain | Revised Fibromyalgia Impact Questionnaire - Please rate your level of pain. | FIQR - Pain | ||
FIQR01-Prepare a Homemade Meal | C103546 | FIQR01-Prepare a Homemade Meal | Revised Fibromyalgia Impact Questionnaire - Prepare a homemade meal. | FIQR - Prepare a Homemade Meal | ||
FIQR01-Sensitivity Noise/Light/Odor/Cold | C103564 | FIQR01-Sensitivity Noise/Light/Odor/Cold | Revised Fibromyalgia Impact Questionnaire - Please rate your level of sensitivity to loud noises, bright lights, odors and cold. | FIQR - Sensitivity to Loud Noises, Bright Lights, Odors and Cold | ||
FIQR01-Sit in a Chair for 45 Minutes | C103551 | FIQR01-Sit in a Chair for 45 Minutes | Revised Fibromyalgia Impact Questionnaire - Sit in a chair for 45 minutes. | FIQR - Sit in a Chair for 45 Minutes | ||
FIQR01-Stiffness | C103557 | FIQR01-Stiffness | Revised Fibromyalgia Impact Questionnaire - Please rate your level of stiffness. | FIQR - Stiffness | ||
FIQR01-Symptoms Sub-Total | C118109 | FIQR01-Symptoms Sub-Total | Revised Fibromyalgia Impact Questionnaire - Sub-total for symptoms subcategory. | FIQR - Symptoms Sub-Total | ||
FIQR01-Tenderness to Touch | C103562 | FIQR01-Tenderness to Touch | Revised Fibromyalgia Impact Questionnaire - Please rate your level of tenderness to touch. | FIQR - Tenderness to Touch | ||
FIQR01-Vacuum Scrub or Sweep Floors | C103547 | FIQR01-Vacuum Scrub or Sweep Floors | Revised Fibromyalgia Impact Questionnaire - Vacuum, scrub or sweep floors. | FIQR - Vacuum Scrub or Sweep Floors | ||
FIQR01-Walk Continuously for 20 Minutes | C103545 | FIQR01-Walk Continuously for 20 Minutes | Revised Fibromyalgia Impact Questionnaire - Walk continuously for 20 minutes. | FIQR - Walk Continuously for 20 Minutes | ||
FIQR01-Your Sleep | C103558 | FIQR01-Your Sleep | Revised Fibromyalgia Impact Questionnaire - Please rate the quality of your sleep. | FIQR - Your Sleep | ||
Back to top | ||||||
CL.C123655.AVL02TC | Rey Auditory Verbal Learning Test Functional Test Test Code
(AVL02TC) | text
Extensible: No | C123655 | Rey Auditory Verbal Learning Test Functional Test Test Code | Rey Auditory Verbal Learning Test test code. | CDISC Functional Test AVLT-REY Test Code Terminology |
AVL0201 | C123683 | AVL02-List A Word 1 | Auditory Verbal Learning Test - List A, Word 1. | AVLT-REY - List A Word 1 | ||
AVL0202 | C123684 | AVL02-List A Word 2 | Auditory Verbal Learning Test - List A, Word 2. | AVLT-REY - List A Word 2 | ||
AVL0203 | C123685 | AVL02-List A Word 3 | Auditory Verbal Learning Test - List A, Word 3. | AVLT-REY - List A Word 3 | ||
AVL0204 | C123686 | AVL02-List A Word 4 | Auditory Verbal Learning Test - List A, Word 4. | AVLT-REY - List A Word 4 | ||
AVL0205 | C123687 | AVL02-List A Word 5 | Auditory Verbal Learning Test - List A, Word 5. | AVLT-REY - List A Word 5 | ||
AVL0206 | C123688 | AVL02-List A Word 6 | Auditory Verbal Learning Test - List A, Word 6. | AVLT-REY - List A Word 6 | ||
AVL0207 | C123689 | AVL02-List A Word 7 | Auditory Verbal Learning Test - List A, Word 7. | AVLT-REY - List A Word 7 | ||
AVL0208 | C123690 | AVL02-List A Word 8 | Auditory Verbal Learning Test - List A, Word 8. | AVLT-REY - List A Word 8 | ||
AVL0209 | C123691 | AVL02-List A Word 9 | Auditory Verbal Learning Test - List A, Word 9. | AVLT-REY - List A Word 9 | ||
AVL0210 | C123692 | AVL02-List A Word 10 | Auditory Verbal Learning Test - List A, Word 10. | AVLT-REY - List A Word 10 | ||
AVL0211 | C123693 | AVL02-List A Word 11 | Auditory Verbal Learning Test - List A, Word 11. | AVLT-REY - List A Word 11 | ||
AVL0212 | C123694 | AVL02-List A Word 12 | Auditory Verbal Learning Test - List A, Word 12. | AVLT-REY - List A Word 12 | ||
AVL0213 | C123695 | AVL02-List A Word 13 | Auditory Verbal Learning Test - List A, Word 13. | AVLT-REY - List A Word 13 | ||
AVL0214 | C123696 | AVL02-List A Word 14 | Auditory Verbal Learning Test - List A, Word 14. | AVLT-REY - List A Word 14 | ||
AVL0215 | C123697 | AVL02-List A Word 15 | Auditory Verbal Learning Test - List A, Word 15. | AVLT-REY - List A Word 15 | ||
AVL0216 | C123698 | AVL02-List A Total | Auditory Verbal Learning Test - The number of List A words recalled from a trial. | AVLT-REY - List A Total | ||
AVL0217 | C123699 | AVL02-List A Intrusions | Auditory Verbal Learning Test - The number of List A intrusions while recalling from a trial. | AVLT-REY - List A Intrusions | ||
AVL0218 | C123700 | AVL02-List B Word 1 | Auditory Verbal Learning Test - List B, Word 1. | AVLT-REY - List B Word 1 | ||
AVL0219 | C123701 | AVL02-List B Word 2 | Auditory Verbal Learning Test - List B, Word 2. | AVLT-REY - List B Word 2 | ||
AVL0220 | C123702 | AVL02-List B Word 3 | Auditory Verbal Learning Test - List B, Word 3. | AVLT-REY - List B Word 3 | ||
AVL0221 | C123703 | AVL02-List B Word 4 | Auditory Verbal Learning Test - List B, Word 4. | AVLT-REY - List B Word 4 | ||
AVL0222 | C123704 | AVL02-List B Word 5 | Auditory Verbal Learning Test - List B, Word 5. | AVLT-REY - List B Word 5 | ||
AVL0223 | C123705 | AVL02-List B Word 6 | Auditory Verbal Learning Test - List B, Word 6. | AVLT-REY - List B Word 6 | ||
AVL0224 | C123706 | AVL02-List B Word 7 | Auditory Verbal Learning Test - List B, Word 7. | AVLT-REY - List B Word 7 | ||
AVL0225 | C123707 | AVL02-List B Word 8 | Auditory Verbal Learning Test - List B, Word 8. | AVLT-REY - List B Word 8 | ||
AVL0226 | C123708 | AVL02-List B Word 9 | Auditory Verbal Learning Test - List B, Word 9. | AVLT-REY - List B Word 9 | ||
AVL0227 | C123709 | AVL02-List B Word 10 | Auditory Verbal Learning Test - List B, Word 10. | AVLT-REY - List B Word 10 | ||
AVL0228 | C123710 | AVL02-List B Word 11 | Auditory Verbal Learning Test - List B, Word 11. | AVLT-REY - List B Word 11 | ||
AVL0229 | C123711 | AVL02-List B Word 12 | Auditory Verbal Learning Test - List B, Word 12. | AVLT-REY - List B Word 12 | ||
AVL0230 | C123712 | AVL02-List B Word 13 | Auditory Verbal Learning Test - List B, Word 13. | AVLT-REY - List B Word 13 | ||
AVL0231 | C123713 | AVL02-List B Word 14 | Auditory Verbal Learning Test - List B, Word 14. | AVLT-REY - List B Word 14 | ||
AVL0232 | C123714 | AVL02-List B Word 15 | Auditory Verbal Learning Test - List B, Word 15. | AVLT-REY - List B Word 15 | ||
AVL0233 | C123715 | AVL02- List B Total | Auditory Verbal Learning Test - The number of words recalled from List B trial. | AVLT-REY - List B Total | ||
AVL0234 | C123716 | AVL02-List B Intrusions | Auditory Verbal Learning Test - The number of intrusions while recalling from List B trial. | AVLT-REY - List B Intrusions | ||
AVL0235 | C123717 | AVL02-Recognition Total | Auditory Verbal Learning Test - The number of words correct on recognition test. | AVLT-REY - Recognition Total | ||
AVL0236 | C123718 | AVL02-Recognition Intrusions | Auditory Verbal Learning Test - The number of intrusions on recognition test. | AVLT-REY - Recognition Intrusions | ||
Back to top | ||||||
CL.C123654.AVL02TN | Rey Auditory Verbal Learning Test Functional Test Test Name
(AVL02TN) | text
Extensible: No | C123654 | Rey Auditory Verbal Learning Test Functional Test Test Name | Rey Auditory Verbal Learning Test test name. | CDISC Functional Test AVLT-REY Test Name Terminology |
AVL02- List B Total | C123715 | AVL02- List B Total | Auditory Verbal Learning Test - The number of words recalled from List B trial. | AVLT-REY - List B Total | ||
AVL02-List A Intrusions | C123699 | AVL02-List A Intrusions | Auditory Verbal Learning Test - The number of List A intrusions while recalling from a trial. | AVLT-REY - List A Intrusions | ||
AVL02-List A Total | C123698 | AVL02-List A Total | Auditory Verbal Learning Test - The number of List A words recalled from a trial. | AVLT-REY - List A Total | ||
AVL02-List A Word 1 | C123683 | AVL02-List A Word 1 | Auditory Verbal Learning Test - List A, Word 1. | AVLT-REY - List A Word 1 | ||
AVL02-List A Word 10 | C123692 | AVL02-List A Word 10 | Auditory Verbal Learning Test - List A, Word 10. | AVLT-REY - List A Word 10 | ||
AVL02-List A Word 11 | C123693 | AVL02-List A Word 11 | Auditory Verbal Learning Test - List A, Word 11. | AVLT-REY - List A Word 11 | ||
AVL02-List A Word 12 | C123694 | AVL02-List A Word 12 | Auditory Verbal Learning Test - List A, Word 12. | AVLT-REY - List A Word 12 | ||
AVL02-List A Word 13 | C123695 | AVL02-List A Word 13 | Auditory Verbal Learning Test - List A, Word 13. | AVLT-REY - List A Word 13 | ||
AVL02-List A Word 14 | C123696 | AVL02-List A Word 14 | Auditory Verbal Learning Test - List A, Word 14. | AVLT-REY - List A Word 14 | ||
AVL02-List A Word 15 | C123697 | AVL02-List A Word 15 | Auditory Verbal Learning Test - List A, Word 15. | AVLT-REY - List A Word 15 | ||
AVL02-List A Word 2 | C123684 | AVL02-List A Word 2 | Auditory Verbal Learning Test - List A, Word 2. | AVLT-REY - List A Word 2 | ||
AVL02-List A Word 3 | C123685 | AVL02-List A Word 3 | Auditory Verbal Learning Test - List A, Word 3. | AVLT-REY - List A Word 3 | ||
AVL02-List A Word 4 | C123686 | AVL02-List A Word 4 | Auditory Verbal Learning Test - List A, Word 4. | AVLT-REY - List A Word 4 | ||
AVL02-List A Word 5 | C123687 | AVL02-List A Word 5 | Auditory Verbal Learning Test - List A, Word 5. | AVLT-REY - List A Word 5 | ||
AVL02-List A Word 6 | C123688 | AVL02-List A Word 6 | Auditory Verbal Learning Test - List A, Word 6. | AVLT-REY - List A Word 6 | ||
AVL02-List A Word 7 | C123689 | AVL02-List A Word 7 | Auditory Verbal Learning Test - List A, Word 7. | AVLT-REY - List A Word 7 | ||
AVL02-List A Word 8 | C123690 | AVL02-List A Word 8 | Auditory Verbal Learning Test - List A, Word 8. | AVLT-REY - List A Word 8 | ||
AVL02-List A Word 9 | C123691 | AVL02-List A Word 9 | Auditory Verbal Learning Test - List A, Word 9. | AVLT-REY - List A Word 9 | ||
AVL02-List B Intrusions | C123716 | AVL02-List B Intrusions | Auditory Verbal Learning Test - The number of intrusions while recalling from List B trial. | AVLT-REY - List B Intrusions | ||
AVL02-List B Word 1 | C123700 | AVL02-List B Word 1 | Auditory Verbal Learning Test - List B, Word 1. | AVLT-REY - List B Word 1 | ||
AVL02-List B Word 10 | C123709 | AVL02-List B Word 10 | Auditory Verbal Learning Test - List B, Word 10. | AVLT-REY - List B Word 10 | ||
AVL02-List B Word 11 | C123710 | AVL02-List B Word 11 | Auditory Verbal Learning Test - List B, Word 11. | AVLT-REY - List B Word 11 | ||
AVL02-List B Word 12 | C123711 | AVL02-List B Word 12 | Auditory Verbal Learning Test - List B, Word 12. | AVLT-REY - List B Word 12 | ||
AVL02-List B Word 13 | C123712 | AVL02-List B Word 13 | Auditory Verbal Learning Test - List B, Word 13. | AVLT-REY - List B Word 13 | ||
AVL02-List B Word 14 | C123713 | AVL02-List B Word 14 | Auditory Verbal Learning Test - List B, Word 14. | AVLT-REY - List B Word 14 | ||
AVL02-List B Word 15 | C123714 | AVL02-List B Word 15 | Auditory Verbal Learning Test - List B, Word 15. | AVLT-REY - List B Word 15 | ||
AVL02-List B Word 2 | C123701 | AVL02-List B Word 2 | Auditory Verbal Learning Test - List B, Word 2. | AVLT-REY - List B Word 2 | ||
AVL02-List B Word 3 | C123702 | AVL02-List B Word 3 | Auditory Verbal Learning Test - List B, Word 3. | AVLT-REY - List B Word 3 | ||
AVL02-List B Word 4 | C123703 | AVL02-List B Word 4 | Auditory Verbal Learning Test - List B, Word 4. | AVLT-REY - List B Word 4 | ||
AVL02-List B Word 5 | C123704 | AVL02-List B Word 5 | Auditory Verbal Learning Test - List B, Word 5. | AVLT-REY - List B Word 5 | ||
AVL02-List B Word 6 | C123705 | AVL02-List B Word 6 | Auditory Verbal Learning Test - List B, Word 6. | AVLT-REY - List B Word 6 | ||
AVL02-List B Word 7 | C123706 | AVL02-List B Word 7 | Auditory Verbal Learning Test - List B, Word 7. | AVLT-REY - List B Word 7 | ||
AVL02-List B Word 8 | C123707 | AVL02-List B Word 8 | Auditory Verbal Learning Test - List B, Word 8. | AVLT-REY - List B Word 8 | ||
AVL02-List B Word 9 | C123708 | AVL02-List B Word 9 | Auditory Verbal Learning Test - List B, Word 9. | AVLT-REY - List B Word 9 | ||
AVL02-Recognition Intrusions | C123718 | AVL02-Recognition Intrusions | Auditory Verbal Learning Test - The number of intrusions on recognition test. | AVLT-REY - Recognition Intrusions | ||
AVL02-Recognition Total | C123717 | AVL02-Recognition Total | Auditory Verbal Learning Test - The number of words correct on recognition test. | AVLT-REY - Recognition Total | ||
Back to top | ||||||
CL.C124672.RCVD01TC | Reynolds Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Code
(RCVD01TC) | text
Extensible: No | C124672 | Reynolds Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Code | Reynolds Cardiovascular Disease 10-Year Risk Score test code. | CDISC Clinical Classification Reynolds CVD 10-Year Risk Score Test Code Terminology |
RCVD0101 | C124723 | RCVD01-Reynolds CVD 10-Year Risk Score | Reynolds Cardiovascular Disease 10-Year Risk Score - Cardiovascular disease 10-year risk score. | Reynolds CVD 10-Year Risk Score - Risk Score | ||
Back to top | ||||||
CL.C124671.RCVD01TN | Reynolds Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Name
(RCVD01TN) | text
Extensible: No | C124671 | Reynolds Cardiovascular Disease 10-Year Risk Score Clinical Classification Test Name | Reynolds Cardiovascular Disease 10-Year Risk Score test name. | CDISC Clinical Classification Reynolds CVD 10-Year Risk Score Test Name Terminology |
RCVD01-Reynolds CVD 10-Year Risk Score | C124723 | RCVD01-Reynolds CVD 10-Year Risk Score | Reynolds Cardiovascular Disease 10-Year Risk Score - Cardiovascular disease 10-year risk score. | Reynolds CVD 10-Year Risk Score - Risk Score | ||
Back to top | ||||||
CL.C171409.RASS01TC | Richmond Agitation-Sedation Scale Clinical Classification Test Code
(RASS01TC) | text
Extensible: No | C171409 | Richmond Agitation-Sedation Scale Clinical Classification Test Code | Richmond Agitation-Sedation Scale test code. | CDISC Clinical Classification RASS Test Code Terminology |
RASS0101 | C171419 | RASS01-Score | Richmond Agitation-Sedation Scale - Score. | RASS - Score | ||
Back to top | ||||||
CL.C171408.RASS01TN | Richmond Agitation-Sedation Scale Clinical Classification Test Name
(RASS01TN) | text
Extensible: No | C171408 | Richmond Agitation-Sedation Scale Clinical Classification Test Name | Richmond Agitation-Sedation Scale test name. | CDISC Clinical Classification RASS Test Name Terminology |
RASS01-Score | C171419 | RASS01-Score | Richmond Agitation-Sedation Scale - Score. | RASS - Score | ||
Back to top | ||||||
CL.C171413.SAS01TC | Riker Sedation-Agitation Scale Clinical Classification Test Code
(SAS01TC) | text
Extensible: No | C171413 | Riker Sedation-Agitation Scale Clinical Classification Test Code | Riker Sedation-Agitation Scale test code. | CDISC Clinical Classification SAS Test Code Terminology |
SAS0101 | C171420 | SAS01-Score | Riker Sedation-Agitation Scale - Score. | SAS - Score | ||
Back to top | ||||||
CL.C171412.SAS01TN | Riker Sedation-Agitation Scale Clinical Classification Test Name
(SAS01TN) | text
Extensible: No | C171412 | Riker Sedation-Agitation Scale Clinical Classification Test Name | Riker Sedation-Agitation Scale test name. | CDISC Clinical Classification SAS Test Name Terminology |
SAS01-Score | C171420 | SAS01-Score | Riker Sedation-Agitation Scale - Score. | SAS - Score | ||
Back to top | ||||||
CL.C141659.RISEF1TC | Rising From Floor Functional Test Test Code
(RISEF1TC) | text
Extensible: No | C141659 | Rising From Floor Functional Test Test Code | Rising From Floor test code. | CDISC Functional Test Rising From Floor Test Code Terminology |
RISEF101 | C174105 | RISEF1-Was Rising From Floor Performed | Rising From Floor - Was Rising From Floor performed? | Rising From Floor - Was Rising From Floor Performed | ||
RISEF102 | C141702 | RISEF1-Time to Rise From Floor | Rising From Floor - If yes, time taken to rise from floor. | Rising From Floor - Time to Rise From Floor | ||
RISEF103 | C151073 | RISEF1-Wear Orthoses | Rising From Floor - If yes, did subject wear orthoses? | Rising From Floor - Wear Orthoses | ||
RISEF104 | C141703 | RISEF1-Test Grade | Rising From Floor - Test grade. | Rising From Floor - Test Grade | ||
Back to top | ||||||
CL.C141658.RISEF1TN | Rising From Floor Functional Test Test Name
(RISEF1TN) | text
Extensible: No | C141658 | Rising From Floor Functional Test Test Name | Rising From Floor test name. | CDISC Functional Test Rising From Floor Test Name Terminology |
RISEF1-Test Grade | C141703 | RISEF1-Test Grade | Rising From Floor - Test grade. | Rising From Floor - Test Grade | ||
RISEF1-Time to Rise From Floor | C141702 | RISEF1-Time to Rise From Floor | Rising From Floor - If yes, time taken to rise from floor. | Rising From Floor - Time to Rise From Floor | ||
RISEF1-Was Rising From Floor Performed | C174105 | RISEF1-Was Rising From Floor Performed | Rising From Floor - Was Rising From Floor performed? | Rising From Floor - Was Rising From Floor Performed | ||
RISEF1-Wear Orthoses | C151073 | RISEF1-Wear Orthoses | Rising From Floor - If yes, did subject wear orthoses? | Rising From Floor - Wear Orthoses | ||
Back to top | ||||||
CL.C101848.RSKASMT | Risk Assessment
(RSKASMT) | text
Extensible: No | C101848 | Risk Assessment | A terminology codelist to describe the risk of a disease, disorder or abnormal condition. | CDISC SDTM Risk Assessment Terminology |
HIGH RISK | C102401 | The potential future harm that may arise from some present action or attribute or condition is almost certain. | High Risk | |||
INTERMEDIATE RISK | C102402 | The potential future harm that may arise from some present action or attribute or condition is moderate. | Intermediate Risk | |||
LOW RISK | C102403 | The potential future harm that may arise from some present action or attribute or condition is small. | Low Risk | |||
MINIMAL RISK | C139268 | The potential future harm that may arise from some present action or attribute or condition is minimal. | Minimal Risk | |||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C119072.RPQ01TC | Rivermead Post Concussion Symptoms Questionnaire Questionnaire Test Code
(RPQ01TC) | text
Extensible: No | C119072 | Rivermead Post Concussion Symptoms Questionnaire Questionnaire Test Code | Rivermead Post Concussion Symptoms Questionnaire test code. | CDISC Questionnaire RPQ Test Code Terminology |
RPQ0101 | C119175 | RPQ01-Headaches | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Headaches. | RPQ - Headaches | ||
RPQ0102 | C119176 | RPQ01-Feelings of Dizziness | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feelings of dizziness. | RPQ - Feelings of Dizziness | ||
RPQ0103 | C119177 | RPQ01-Nausea and/or Vomiting | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Nausea and/or vomiting. | RPQ - Nausea and/or Vomiting | ||
RPQ0104 | C119178 | RPQ01-Noise Sensitivity/Loud Noise | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Noise sensitivity, easily upset by loud noise. | RPQ - Noise Sensitivity | ||
RPQ0105 | C119179 | RPQ01-Sleep Disturbance | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Sleep disturbance. | RPQ - Sleep Disturbance | ||
RPQ0106 | C119180 | RPQ01-Fatigue, Tiring More Easily | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Fatigue, tiring more easily. | RPQ - Fatigue, Tiring More Easily | ||
RPQ0107 | C119181 | RPQ01-Being Irritable, Easily Angered | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Being irritable, easily angered. | RPQ - Being Irritable, Easily Angered | ||
RPQ0108 | C119182 | RPQ01-Feeling Depressed or Tearful | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feeling depressed or tearful. | RPQ - Feeling Depressed or Tearful | ||
RPQ0109 | C119183 | RPQ01-Feeling Frustrated or Impatient | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feeling frustrated or impatient. | RPQ - Feeling Frustrated or Impatient | ||
RPQ0110 | C119184 | RPQ01-Forgetfulness, Poor Memory | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Forgetfulness, poor memory. | RPQ - Forgetfulness, Poor Memory | ||
RPQ0111 | C119185 | RPQ01-Poor Concentration | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Poor concentration. | RPQ - Poor Concentration | ||
RPQ0112 | C119186 | RPQ01-Taking Longer to Think | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Taking longer to think. | RPQ - Taking Longer to Think | ||
RPQ0113 | C119187 | RPQ01-Blurred Vision | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Blurred vision. | RPQ - Blurred Vision | ||
RPQ0114 | C119188 | RPQ01-Light Sensitivity/Bright Light | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Light sensitivity, easily upset by bright light. | RPQ - Light Sensitivity | ||
RPQ0115 | C119189 | RPQ01-Double Vision | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Double vision. | RPQ - Double Vision | ||
RPQ0116 | C119190 | RPQ01-Restlessness | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Restlessness. | RPQ - Restlessness | ||
RPQ0117A | C119191 | RPQ01-Any Other Difficulties 1 (Text) | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 1? (Text). | RPQ - Any Other Difficulties 1 (Text) | ||
RPQ0117B | C119192 | RPQ01-Any Other Difficulties 1 | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 1? | RPQ - Any Other Difficulties 1 (number) | ||
RPQ0118A | C119193 | RPQ01-Any Other Difficulties 2 (Text) | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 2? (Text). | RPQ - Any Other Difficulties 2 (Text) | ||
RPQ0118B | C119194 | RPQ01-Any Other Difficulties 2 | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 2? | RPQ - Any Other Difficulties 2 (Number) | ||
Back to top | ||||||
CL.C119071.RPQ01TN | Rivermead Post Concussion Symptoms Questionnaire Questionnaire Test Name
(RPQ01TN) | text
Extensible: No | C119071 | Rivermead Post Concussion Symptoms Questionnaire Questionnaire Test Name | Rivermead Post Concussion Symptoms Questionnaire test name. | CDISC Questionnaire RPQ Test Name Terminology |
RPQ01-Any Other Difficulties 1 (Text) | C119191 | RPQ01-Any Other Difficulties 1 (Text) | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 1? (Text). | RPQ - Any Other Difficulties 1 (Text) | ||
RPQ01-Any Other Difficulties 1 | C119192 | RPQ01-Any Other Difficulties 1 | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 1? | RPQ - Any Other Difficulties 1 (number) | ||
RPQ01-Any Other Difficulties 2 (Text) | C119193 | RPQ01-Any Other Difficulties 2 (Text) | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 2? (Text). | RPQ - Any Other Difficulties 2 (Text) | ||
RPQ01-Any Other Difficulties 2 | C119194 | RPQ01-Any Other Difficulties 2 | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, are you experiencing any other difficulties 2? | RPQ - Any Other Difficulties 2 (Number) | ||
RPQ01-Being Irritable, Easily Angered | C119181 | RPQ01-Being Irritable, Easily Angered | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Being irritable, easily angered. | RPQ - Being Irritable, Easily Angered | ||
RPQ01-Blurred Vision | C119187 | RPQ01-Blurred Vision | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Blurred vision. | RPQ - Blurred Vision | ||
RPQ01-Double Vision | C119189 | RPQ01-Double Vision | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Double vision. | RPQ - Double Vision | ||
RPQ01-Fatigue, Tiring More Easily | C119180 | RPQ01-Fatigue, Tiring More Easily | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Fatigue, tiring more easily. | RPQ - Fatigue, Tiring More Easily | ||
RPQ01-Feeling Depressed or Tearful | C119182 | RPQ01-Feeling Depressed or Tearful | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feeling depressed or tearful. | RPQ - Feeling Depressed or Tearful | ||
RPQ01-Feeling Frustrated or Impatient | C119183 | RPQ01-Feeling Frustrated or Impatient | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feeling frustrated or impatient. | RPQ - Feeling Frustrated or Impatient | ||
RPQ01-Feelings of Dizziness | C119176 | RPQ01-Feelings of Dizziness | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Feelings of dizziness. | RPQ - Feelings of Dizziness | ||
RPQ01-Forgetfulness, Poor Memory | C119184 | RPQ01-Forgetfulness, Poor Memory | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Forgetfulness, poor memory. | RPQ - Forgetfulness, Poor Memory | ||
RPQ01-Headaches | C119175 | RPQ01-Headaches | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Headaches. | RPQ - Headaches | ||
RPQ01-Light Sensitivity/Bright Light | C119188 | RPQ01-Light Sensitivity/Bright Light | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Light sensitivity, easily upset by bright light. | RPQ - Light Sensitivity | ||
RPQ01-Nausea and/or Vomiting | C119177 | RPQ01-Nausea and/or Vomiting | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Nausea and/or vomiting. | RPQ - Nausea and/or Vomiting | ||
RPQ01-Noise Sensitivity/Loud Noise | C119178 | RPQ01-Noise Sensitivity/Loud Noise | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Noise sensitivity, easily upset by loud noise. | RPQ - Noise Sensitivity | ||
RPQ01-Poor Concentration | C119185 | RPQ01-Poor Concentration | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Poor concentration. | RPQ - Poor Concentration | ||
RPQ01-Restlessness | C119190 | RPQ01-Restlessness | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Restlessness. | RPQ - Restlessness | ||
RPQ01-Sleep Disturbance | C119179 | RPQ01-Sleep Disturbance | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Sleep disturbance. | RPQ - Sleep Disturbance | ||
RPQ01-Taking Longer to Think | C119186 | RPQ01-Taking Longer to Think | Rivermead Post Concussion Symptoms Questionnaire - Compared with before the accident, do you now suffer from: Taking longer to think. | RPQ - Taking Longer to Think | ||
Back to top | ||||||
CL.C166190.ROCK01TC | Rockport One Mile Walk Test Version 1.0 Functional Test Test Code
(ROCK01TC) | text
Extensible: No | C166190 | Rockport One Mile Walk Test Version 1.0 Functional Test Test Code | Rockport One Mile Walk Test Version 1.0 test code. | CDISC Functional Test RFWT Version 1 Test Code Terminology |
ROCK0101 | C166338 | ROCK01-Time To Complete One Mile Walk | Rockport One Mile Walk Test - Time to complete one-mile walk. | RFWT Version 1 - Time To Complete One Mile Walk | ||
Back to top | ||||||
CL.C166189.ROCK01TN | Rockport One Mile Walk Test Version 1.0 Functional Test Test Name
(ROCK01TN) | text
Extensible: No | C166189 | Rockport One Mile Walk Test Version 1.0 Functional Test Test Name | Rockport One Mile Walk Test Version 1.0 test name. | CDISC Functional Test RFWT Version 1 Test Name Terminology |
ROCK01-Time To Complete One Mile Walk | C166338 | ROCK01-Time To Complete One Mile Walk | Rockport One Mile Walk Test - Time to complete one-mile walk. | RFWT Version 1 - Time To Complete One Mile Walk | ||
Back to top | ||||||
CL.C100166.RDQ01TC | Roland Morris Disability Questionnaire Questionnaire Test Code
(RDQ01TC) | text
Extensible: No | C100166 | Roland Morris Disability Questionnaire Questionnaire Test Code | Roland Morris Disability Questionnaire test code. | CDISC Questionnaire RDQ Test Code Terminology |
RDQ0101 | C100780 | RDQ01-Stay at Home | Roland Morris Disability Questionnaire - I stay at home most of the time because of my back. | RDQ - Stay at Home | ||
RDQ0102 | C100781 | RDQ01-Change Position Frequently | Roland Morris Disability Questionnaire - I change position frequently to try and get my back comfortable. | RDQ - Change Position Frequently | ||
RDQ0103 | C100782 | RDQ01-Walk More Slowly | Roland Morris Disability Questionnaire - I walk more slowly than usual because of my back. | RDQ - Walk More Slowly | ||
RDQ0104 | C100783 | RDQ01-Not Do Any Usual Jobs | Roland Morris Disability Questionnaire - Because of my back, I am not doing any of the jobs that I usually do around the house. | RDQ - Not Do Any Usual House Jobs | ||
RDQ0105 | C100784 | RDQ01-Use Handrail to Get Upstairs | Roland Morris Disability Questionnaire - Because of my back, I use a handrail to get upstairs. | RDQ - Use Handrail to Get Upstairs | ||
RDQ0106 | C100785 | RDQ01-Lie Down to Rest More Often | Roland Morris Disability Questionnaire - Because of my back, I lie down to rest more often. | RDQ - Lie Down to Rest More Often | ||
RDQ0107 | C100786 | RDQ01-Hold on to Get Out of a Chair | Roland Morris Disability Questionnaire - Because of my back, I have to hold on to something to get out of an easy chair. | RDQ - Hold on to Get Out of a Chair | ||
RDQ0108 | C100787 | RDQ01-Get Other People to Do Things | Roland Morris Disability Questionnaire - Because of my back, I try to get other people to do things for me. | RDQ - Get Other People to Do Things | ||
RDQ0109 | C100788 | RDQ01-Get Dressed More Slowly | Roland Morris Disability Questionnaire - I get dressed more slowly then usual because of my back. | RDQ - Get Dressed More Slowly | ||
RDQ0110 | C100789 | RDQ01-Only Stand for Short Periods | Roland Morris Disability Questionnaire - I only stand for short periods of time because of my back. | RDQ - Only Stand for Short Periods | ||
RDQ0111 | C100790 | RDQ01-Try Not to Bend or Kneel | Roland Morris Disability Questionnaire - Because of my back, I try not to bend or kneel down. | RDQ - Try Not to Bend or Kneel | ||
RDQ0112 | C100791 | RDQ01-Difficult to Get Out of a Chair | Roland Morris Disability Questionnaire - I find it difficult to get out of a chair because of my back. | RDQ - Difficult to Get Out of a Chair | ||
RDQ0113 | C100792 | RDQ01-Painful Almost All the Time | Roland Morris Disability Questionnaire - My back is painful almost all the time. | RDQ - Painful Almost All the Time | ||
RDQ0114 | C100793 | RDQ01-Difficult to Turn Over in Bed | Roland Morris Disability Questionnaire - I find it difficult to turn over in bed because of my back. | RDQ - Difficult to Turn Over in Bed | ||
RDQ0115 | C100794 | RDQ01-Appetite is Not Very Good | Roland Morris Disability Questionnaire - My appetite is not very good because of my back pain. | RDQ - Appetite is Not Very Good | ||
RDQ0116 | C100795 | RDQ01-Trouble Putting on Socks/Stockings | Roland Morris Disability Questionnaire - I have trouble putting on my socks (or stockings) because of the pain in my back. | RDQ - Trouble Putting on Socks or Stockings | ||
RDQ0117 | C100796 | RDQ01-Only Walk Short Distances | Roland Morris Disability Questionnaire - I only walk short distances because of my back. | RDQ - Only Walk Short Distances | ||
RDQ0118 | C100797 | RDQ01-Sleep Less Well | Roland Morris Disability Questionnaire - I sleep less well because of my back. | RDQ - Sleep Less Well | ||
RDQ0119 | C100798 | RDQ01-Get Dressed With Help | Roland Morris Disability Questionnaire - Because of my back pain, I get dressed with help from someone else. | RDQ - Get Dressed With Help | ||
RDQ0120 | C100799 | RDQ01-Sit Down Most of the Day | Roland Morris Disability Questionnaire - I sit down for most of the day because of my back. | RDQ - Sit Down Most of the Day | ||
RDQ0121 | C100800 | RDQ01-Avoid Heavy Jobs | Roland Morris Disability Questionnaire - I avoid heavy jobs around the house because of my back. | RDQ - Avoid Heavy Jobs | ||
RDQ0122 | C100801 | RDQ01-More Irritable With People | Roland Morris Disability Questionnaire - Because of my back pain, I am more irritable and bad tempered with people than usual. | RDQ - More Irritable With People | ||
RDQ0123 | C100802 | RDQ01-Go Upstairs More Slowly | Roland Morris Disability Questionnaire - Because of my back, I go upstairs more slowly than usual. | RDQ - Go Upstairs More Slowly | ||
RDQ0124 | C100803 | RDQ01-Stay in Bed | Roland Morris Disability Questionnaire - I stay in bed most of the time because of my back. | RDQ - Stay in Bed | ||
RDQ0125 | C100804 | RDQ01-RDQ Total Score | Roland Morris Disability Questionnaire - RDQ total derived score. | RDQ - Total Derived Score | ||
Back to top | ||||||
CL.C100165.RDQ01TN | Roland Morris Disability Questionnaire Questionnaire Test Name
(RDQ01TN) | text
Extensible: No | C100165 | Roland Morris Disability Questionnaire Questionnaire Test Name | Roland Morris Disability Questionnaire test name. | CDISC Questionnaire RDQ Test Name Terminology |
RDQ01-Appetite is Not Very Good | C100794 | RDQ01-Appetite is Not Very Good | Roland Morris Disability Questionnaire - My appetite is not very good because of my back pain. | RDQ - Appetite is Not Very Good | ||
RDQ01-Avoid Heavy Jobs | C100800 | RDQ01-Avoid Heavy Jobs | Roland Morris Disability Questionnaire - I avoid heavy jobs around the house because of my back. | RDQ - Avoid Heavy Jobs | ||
RDQ01-Change Position Frequently | C100781 | RDQ01-Change Position Frequently | Roland Morris Disability Questionnaire - I change position frequently to try and get my back comfortable. | RDQ - Change Position Frequently | ||
RDQ01-Difficult to Get Out of a Chair | C100791 | RDQ01-Difficult to Get Out of a Chair | Roland Morris Disability Questionnaire - I find it difficult to get out of a chair because of my back. | RDQ - Difficult to Get Out of a Chair | ||
RDQ01-Difficult to Turn Over in Bed | C100793 | RDQ01-Difficult to Turn Over in Bed | Roland Morris Disability Questionnaire - I find it difficult to turn over in bed because of my back. | RDQ - Difficult to Turn Over in Bed | ||
RDQ01-Get Dressed More Slowly | C100788 | RDQ01-Get Dressed More Slowly | Roland Morris Disability Questionnaire - I get dressed more slowly then usual because of my back. | RDQ - Get Dressed More Slowly | ||
RDQ01-Get Dressed With Help | C100798 | RDQ01-Get Dressed With Help | Roland Morris Disability Questionnaire - Because of my back pain, I get dressed with help from someone else. | RDQ - Get Dressed With Help | ||
RDQ01-Get Other People to Do Things | C100787 | RDQ01-Get Other People to Do Things | Roland Morris Disability Questionnaire - Because of my back, I try to get other people to do things for me. | RDQ - Get Other People to Do Things | ||
RDQ01-Go Upstairs More Slowly | C100802 | RDQ01-Go Upstairs More Slowly | Roland Morris Disability Questionnaire - Because of my back, I go upstairs more slowly than usual. | RDQ - Go Upstairs More Slowly | ||
RDQ01-Hold on to Get Out of a Chair | C100786 | RDQ01-Hold on to Get Out of a Chair | Roland Morris Disability Questionnaire - Because of my back, I have to hold on to something to get out of an easy chair. | RDQ - Hold on to Get Out of a Chair | ||
RDQ01-Lie Down to Rest More Often | C100785 | RDQ01-Lie Down to Rest More Often | Roland Morris Disability Questionnaire - Because of my back, I lie down to rest more often. | RDQ - Lie Down to Rest More Often | ||
RDQ01-More Irritable With People | C100801 | RDQ01-More Irritable With People | Roland Morris Disability Questionnaire - Because of my back pain, I am more irritable and bad tempered with people than usual. | RDQ - More Irritable With People | ||
RDQ01-Not Do Any Usual Jobs | C100783 | RDQ01-Not Do Any Usual Jobs | Roland Morris Disability Questionnaire - Because of my back, I am not doing any of the jobs that I usually do around the house. | RDQ - Not Do Any Usual House Jobs | ||
RDQ01-Only Stand for Short Periods | C100789 | RDQ01-Only Stand for Short Periods | Roland Morris Disability Questionnaire - I only stand for short periods of time because of my back. | RDQ - Only Stand for Short Periods | ||
RDQ01-Only Walk Short Distances | C100796 | RDQ01-Only Walk Short Distances | Roland Morris Disability Questionnaire - I only walk short distances because of my back. | RDQ - Only Walk Short Distances | ||
RDQ01-Painful Almost All the Time | C100792 | RDQ01-Painful Almost All the Time | Roland Morris Disability Questionnaire - My back is painful almost all the time. | RDQ - Painful Almost All the Time | ||
RDQ01-RDQ Total Score | C100804 | RDQ01-RDQ Total Score | Roland Morris Disability Questionnaire - RDQ total derived score. | RDQ - Total Derived Score | ||
RDQ01-Sit Down Most of the Day | C100799 | RDQ01-Sit Down Most of the Day | Roland Morris Disability Questionnaire - I sit down for most of the day because of my back. | RDQ - Sit Down Most of the Day | ||
RDQ01-Sleep Less Well | C100797 | RDQ01-Sleep Less Well | Roland Morris Disability Questionnaire - I sleep less well because of my back. | RDQ - Sleep Less Well | ||
RDQ01-Stay at Home | C100780 | RDQ01-Stay at Home | Roland Morris Disability Questionnaire - I stay at home most of the time because of my back. | RDQ - Stay at Home | ||
RDQ01-Stay in Bed | C100803 | RDQ01-Stay in Bed | Roland Morris Disability Questionnaire - I stay in bed most of the time because of my back. | RDQ - Stay in Bed | ||
RDQ01-Trouble Putting on Socks/Stockings | C100795 | RDQ01-Trouble Putting on Socks/Stockings | Roland Morris Disability Questionnaire - I have trouble putting on my socks (or stockings) because of the pain in my back. | RDQ - Trouble Putting on Socks or Stockings | ||
RDQ01-Try Not to Bend or Kneel | C100790 | RDQ01-Try Not to Bend or Kneel | Roland Morris Disability Questionnaire - Because of my back, I try not to bend or kneel down. | RDQ - Try Not to Bend or Kneel | ||
RDQ01-Use Handrail to Get Upstairs | C100784 | RDQ01-Use Handrail to Get Upstairs | Roland Morris Disability Questionnaire - Because of my back, I use a handrail to get upstairs. | RDQ - Use Handrail to Get Upstairs | ||
RDQ01-Walk More Slowly | C100782 | RDQ01-Walk More Slowly | Roland Morris Disability Questionnaire - I walk more slowly than usual because of my back. | RDQ - Walk More Slowly | ||
Back to top | ||||||
CL.C66729.ROUTE | Route of Administration Response
(ROUTE) | text
Extensible: Yes | C66729 | Route of Administration Response | A terminology codelist relevant to the course by which a substance is administered in order to reach the site of action in the body. | CDISC SDTM Route of Administration Terminology |
AURICULAR (OTIC) | C38192 | Administration to or by way of the ear. (FDA) | Auricular Route of Administration | |||
BUCCAL | C38193 | Administration directed toward the cheek, generally from within the mouth. (FDA) | Buccal Route of Administration | |||
CONJUNCTIVAL | C38194 | Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball. (FDA) | Conjunctival Route of Administration | |||
CUTANEOUS | C38675 | Administration to the skin. (FDA) | Cutaneous Route of Administration | |||
DENTAL | C38197 | Administration to a tooth or teeth. (FDA) | Dental Route of Administration | |||
DIETARY | C78373 | Administration by way of food or water. | Dietary Route of Administration | |||
ELECTRO-OSMOSIS | C38633 | Administration of through the diffusion of substance through a membrane in an electric field. (FDA) | Electro-osmosis Route of Administration | |||
ENDOCERVICAL | C38205 | Intracervical Route of Administration | Administration within the canal of the cervix uteri. Synonymous with the term intracervical. (FDA) | Endocervical Route of Administration | ||
ENDOSINUSIAL | C38206 | Administration within the nasal sinuses of the head. (FDA) | Endosinusial Route of Administration | |||
ENDOTRACHEAL | C38208 | Intratracheal Route of Administration | Administration directly into the trachea. Synonymous with the term intratracheal. (FDA) | Endotracheal Route of Administration | ||
ENTERAL | C38209 | Administration directly into the intestines. (FDA) | Enteral Route of Administration | |||
EPIDURAL | C38210 | Administration upon or over the dura mater. (FDA) | Epidural Route of Administration | |||
EXTRA-AMNIOTIC | C38211 | Administration to the outside of the membrane enveloping the fetus. (FDA) | Extraamniotic Route of Administration | |||
EXTRACORPOREAL | C38212 | Administration outside of the body. (FDA) | Extracorporeal Circulation Route of Administration | |||
HEMODIALYSIS | C38200 | Administration through hemodialysate fluid. (FDA) | Administration via Hemodialysis | |||
INFILTRATION | C38215 | Administration that results in substances passing into tissue spaces or into cells. (FDA) | Infiltration Route of Administration | |||
INTERSTITIAL | C38219 | Administration to or in the interstices of a tissue. (FDA) | Interstitial Route of Administration | |||
INTRA-ABDOMINAL | C38220 | Administration within the abdomen. (FDA) | Intraabdominal Route of Administration | |||
INTRA-AMNIOTIC | C38221 | Administration within the amnion. (FDA) | Intraamniotic Route of Administration | |||
INTRA-ARTERIAL | C38222 | Administration within an artery or arteries. (FDA) | Intraarterial Route of Administration | |||
INTRA-ARTICULAR | C38223 | Administration within a joint. (FDA) | Intraarticular Route of Administration | |||
INTRABILIARY | C38224 | Administration within the bile, bile ducts or gallbladder. (FDA) | Intrabiliary Route of Administration | |||
INTRABRONCHIAL | C38225 | Administration within a bronchus. (FDA) | Intrabronchial Route of Administration | |||
INTRABURSAL | C38226 | Administration within a bursa. (FDA) | Intrabursal Route of Administration | |||
INTRACAMERAL | C64984 | Administration by injection directly into the anterior chamber of the eye. | Intracameral Route of Administration | |||
INTRACARDIAC | C38227 | Administration within the heart. (FDA) | Intracardiac Route of Administration | |||
INTRACARTILAGINOUS | C38228 | Administration within a cartilage; endochondral. (FDA) | Intracartilaginous Route of Administration | |||
INTRACAUDAL | C38229 | Administration within the cauda equina. (FDA) | Intracaudal Route of Administration | |||
INTRACAVERNOUS | C38230 | Administration within a pathologic cavity, such as occurs in the lung in tuberculosis. (FDA) | Intracavernous Route of Administration | |||
INTRACAVITARY | C38231 | Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound. (FDA) | Intracavitary Route of Administration | |||
INTRACEREBRAL | C38232 | Administration within the cerebrum. (FDA) | Intracerebral Route of Administration | |||
INTRACISTERNAL | C38233 | Administration within the cisterna magna cerebellomedularis. (FDA) | Intracisternal Route of Administration | |||
INTRACOCHLEAR | C184707 | Administration within the cochlea. | Intracochlear Route of Administration | |||
INTRACORNEAL | C38234 | Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye). (FDA) | Intracorneal Route of Administration | |||
INTRACORONAL, DENTAL | C38217 | Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck. (FDA) | Intracoronal Dental Route of Administration | |||
INTRACORONARY | C38218 | Administration within the coronary arteries. (FDA) | Intracoronary Route of Administration | |||
INTRACORPORUS CAVERNOSUM | C38235 | Administration within the dilatable spaces of the corporus cavernosa of the penis. (FDA) | Intracorporus Cavernosum Route of Administration | |||
INTRADERMAL | C38238 | Administration within the dermis. (FDA) | Intradermal Route of Administration | |||
INTRADISCAL | C38239 | Administration within a disc. (FDA) | Intradiscal Route of Administration | |||
INTRADUCTAL | C38240 | Administration within the duct of a gland. (FDA) | Intraductal Route of Administration | |||
INTRADUODENAL | C38241 | Administration within the duodenum. (FDA) | Intraduodenal Route of Administration | |||
INTRADURAL | C38242 | Administration within or beneath the dura. (FDA) | Intradural Route of Administration | |||
INTRAEPIDERMAL | C38243 | Administration within the epidermis. (FDA) | Intraepidermal Route of Administration | |||
INTRAESOPHAGEAL | C38245 | Administration within the esophagus. (FDA) | Intraesophageal Route of Administration | |||
INTRAGASTRIC | C38246 | Administration within the stomach. (FDA) | Intragastric Route of Administration | |||
INTRAGINGIVAL | C38247 | Administration within the gingivae. (FDA) | Intragingival Route of Administration | |||
INTRAHEPATIC | C38248 | Administration into the liver. | Intrahepatic Route of Administration | |||
INTRAILEAL | C38249 | Administration within the distal portion of the small intestine, from the jejunum to the cecum. (FDA) | Intraileal Route of Administration | |||
INTRAJEJUNAL | C102399 | Administration into the jejunum. | Intrajejunal Route of Administration | |||
INTRALESIONAL | C38250 | Administration within or introduced directly into a localized lesion. (FDA) | Intralesional Route of Administration | |||
INTRALUMINAL | C38251 | Administration within the lumen of a tube. (FDA) | Intraluminal Route of Administration | |||
INTRALYMPHATIC | C38252 | Administration within the lymph. (FDA) | Intralymphatic Route of Administration | |||
INTRAMAMMARY | C79137 | Administration of a drug into mammary tissue. | Intramammary Route of Administration | |||
INTRAMANDIBULAR | C156590 | Administration within the mandible. | Intramandibular Route of Administration | |||
INTRAMEDULLARY | C38253 | Administration within the marrow cavity of a bone. (FDA) | Intramedullary Route of Administration | |||
INTRAMENINGEAL | C38254 | Administration within the meninges (the three membranes that envelope the brain and spinal cord). (FDA) | Intrameningeal Route of Administration | |||
INTRAMUSCULAR | C28161 | Administration within a muscle. (FDA) | Intramuscular Route of Administration | |||
INTRANODAL | C79141 | Administration within a lymph node. | Intranodal Route of Administration | |||
INTRAOCULAR | C38255 | Administration within the eye. (FDA) | Intraocular Route of Administration | |||
INTRAOSSEOUS | C64987 | Administration within the marrow of the bone. | Intraosseous Route of Administration | |||
INTRAOVARIAN | C38256 | Administration within the ovary. (FDA) | Intraovarian Route of Administration | |||
INTRAPALATAL | C102400 | Administration into the palate. | Intrapalatal Route of Administration | |||
INTRAPARENCHYMAL | C119548 | Administration within or into the parenchyma of a targeted organ. | Intraparenchymal Route of Administration | |||
INTRAPERICARDIAL | C38257 | Administration within the pericardium. (FDA) | Intrapericardial Route of Administration | |||
INTRAPERITONEAL | C38258 | Administration within the peritoneal cavity. (FDA) | Intraperitoneal Route of Administration | |||
INTRAPLEURAL | C38259 | Administration within the pleura. (FDA) | Intrapleural Route of Administration | |||
INTRAPROSTATIC | C38260 | Administration within the prostate gland. (FDA) | Intraprostatic Route of Administration | |||
INTRAPULMONARY | C38261 | Administration within the lungs or its bronchi. (FDA) | Intrapulmonary Route of Administration | |||
INTRARUMINAL | C79139 | Administration of a drug into the rumen of an animal. | Intraruminal Route of Administration | |||
INTRASINAL | C38262 | Administration within the nasal or periorbital sinuses. (FDA) | Intrasinal Route of Administration | |||
INTRASPINAL | C38263 | Administration within the vertebral column. (FDA) | Intraspinal Route of Administration | |||
INTRASTOMAL | C65138 | Administration into a stoma. | Administration via Stoma | |||
INTRASURGICAL SITE | C142365 | Administration within the site of surgery. | Intrasurgical Site Route of Administration | |||
INTRASYNOVIAL | C38264 | Administration within the synovial cavity of a joint. (FDA) | Intrasynovial Route of Administration | |||
INTRATENDINOUS | C38265 | Administration within a tendon. (FDA) | Intratendinous Route of Administration | |||
INTRATESTICULAR | C38266 | Administration within the testicle. (FDA) | Intratesticular Route of Administration | |||
INTRATHALAMIC | C128995 | Administration within the thalamus. | Intrathalamic Route of Administration | |||
INTRATHECAL | C38267 | Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles. (FDA) | Intrathecal Route of Administration | |||
INTRATHORACIC | C38207 | Administration within the thorax (internal to the ribs); synonymous with the term endothoracic. (FDA) | Endothoracic Route of Administration | |||
INTRATUBULAR | C38268 | Administration within the tubules of an organ. (FDA) | Intratubular Route of Administration | |||
INTRATUMOR | C38269 | Intratumor Route of Administration | Administration within a tumor. (FDA) | Intratumoral Route of Administration | ||
INTRATYMPANIC | C38270 | Administration within the auris media. (FDA) | Intratympanic Route of Administration | |||
INTRAUTERINE | C38272 | Administration within the uterus. (FDA) | Intrauterine Route of Administration | |||
INTRAVAGINAL | C128996 | Administration within the vagina. | Intravaginal Route of Administration | |||
INTRAVASCULAR | C38273 | Administration within a vessel or vessels. (FDA) | Intravascular Route of Administration | |||
INTRAVENOUS BOLUS | C38274 | Administration within or into a vein or veins all at once. (FDA) | Intravenous Bolus | |||
INTRAVENOUS DRIP | C38279 | Administration within or into a vein or veins over a sustained period of time. (FDA) | Intravenous Drip | |||
INTRAVENOUS | C38276 | Administration within or into a vein or veins. (FDA) | Intravenous Route of Administration | |||
INTRAVENTRICULAR | C38277 | Administration within a ventricle. (FDA) | Intraventricular Route of Administration | |||
INTRAVESICAL | C38278 | Administration within the bladder. (FDA) | Intravesical Route of Administration | |||
INTRAVITREAL | C38280 | Administration within the vitreous body of the eye. (FDA) | Intravitreal Route of Administration | |||
IONTOPHORESIS | C38203 | Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body. (FDA) | Iontophoresis Route of Administration | |||
IRRIGATION | C38281 | Administration to bathe or flush open wounds or body cavities. (FDA) | Irrigation Route of Administration | |||
LARYNGEAL | C38282 | Administration directly upon the larynx. (FDA) | Laryngeal Route of Administration | |||
MICRODIALYSIS | C150889 | Administration through microdialysate fluid. | Microdialysis Route of Administration | |||
NASAL | C38284 | Intranasal Route of Administration | Administration to the nose; administered by way of the nose. (FDA) | Nasal Route of Administration | ||
NASODUODENAL | C188189 | Administration through the nose and into the duodenum, usually by means of a tube. | Nasoduodenal Route of Administration | |||
NASOGASTRIC | C38285 | Administration through the nose and into the stomach, usually by means of a tube. (FDA) | Nasogastric Route of Administration | |||
NASOJEJUNAL | C191350 | Administration through the nose and into the jejunum, usually by means of a tube. | Nasojejunal Route of Administration | |||
NOT APPLICABLE | C48623 | Routes of administration are not applicable. (FDA) | Route of Administration Not Applicable | |||
OCCLUSIVE DRESSING TECHNIQUE | C38286 | Administration by the topical route which is then covered by a dressing which occludes the area. (FDA) | Occlusive Dressing Technique | |||
OPHTHALMIC | C38287 | Administration to the external eye. (FDA) | Ophthalmic Route of Administration | |||
ORAL GAVAGE | C78374 | Administration through the mouth and into the stomach, usually by means of a tube. (NCI) | Oral Gavage Route of Administration | |||
ORAL | C38288 | Intraoral Route of Administration;PO | Administration to or by way of the mouth. (FDA) | Oral Route of Administration | ||
OROGASTRIC | C188195 | Administration through the mouth and into the stomach, usually by means of a tube. | Orogastric Route of Administration | |||
OROMUCOSAL | C64906 | Administration across the mucosa of the oral cavity. | Oromucosal Route of Administration | |||
OROPHARYNGEAL | C38289 | Administration directly to the mouth and pharynx. (FDA) | Oropharyngeal Route of Administration | |||
PARENTERAL | C38291 | Administration by injection, infusion, or implantation. (FDA) | Parenteral Route of Administration | |||
PERCUTANEOUS | C38676 | Administration through the skin. (FDA) | Percutaneous Route of Administration | |||
PERIARTICULAR | C38292 | Administration around a joint. (FDA) | Periarticular Route of Administration | |||
PERIDURAL | C38677 | Administration to the outside of the dura mater of the spinal cord. (FDA) | Peridural Route of Administration | |||
PERINEURAL | C38293 | Administration surrounding a nerve or nerves. (FDA) | Perineural Route of Administration | |||
PERIODONTAL | C38294 | Administration around a tooth. (FDA) | Periodontal Route of Administration | |||
PERIVENOUS | C112396 | Administration into the area surrounding a vein. (NCI) | Perivenous Route of Administration | |||
PHARYNGEAL | C172600 | Administration directly upon the pharynx. | Pharyngeal Route of Administration | |||
RECTAL | C38295 | Administration to the rectum. (FDA) | Rectal Route of Administration | |||
RESPIRATORY (INHALATION) | C38216 | Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect. (FDA) | Inhalation Route of Administration | |||
RETROBULBAR | C38296 | Administration behind the pons or behind the eyeball. (FDA) | Retrobulbar Route of Administration | |||
SOFT TISSUE | C38198 | Administration into any soft tissue. (FDA) | Soft Tissue Route of Administration | |||
SUBARACHNOID | C38297 | Administration beneath the arachnoid. (FDA) | Subarachnoid Route of Administration | |||
SUBCONJUNCTIVAL | C38298 | Administration beneath the conjunctiva. (FDA) | Subconjunctival Route of Administration | |||
SUBCUTANEOUS | C38299 | SC;Subdermal Route of Administration | Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL. (FDA) | Subcutaneous Route of Administration | ||
SUBDURAL | C181523 | Administration between the dura mater and the arachnoid mater. | Subdural Route of Administration | |||
SUBLINGUAL | C38300 | Administration beneath the tongue. (FDA) | Sublingual Route of Administration | |||
SUBMUCOSAL | C38301 | Administration beneath the mucous membrane. (FDA) | Submucosal Route of Administration | |||
SUBRETINAL | C79143 | Administration beneath the retina. | Subretinal Route of Administration | |||
SUBTENON | C94636 | Administration by injection through the membrane covering the muscles and nerves at the back of the eyeball. | Subtenon Route of Administration | |||
SUPRACHOROIDAL | C128997 | Administration above the choroid. | Suprachoroidal Route of Administration | |||
TOPICAL | C38304 | TOP | Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL. (FDA) | Topical Route of Administration | ||
TRANSDERMAL | C38305 | Administration through the dermal layer of the skin to the systemic circulation by diffusion. (FDA) | Transdermal Route of Administration | |||
TRANSMAMMARY | C111326 | Administration by ingestion of colostrum or breast milk. | Transmammary Route of Administration | |||
TRANSMUCOSAL | C38283 | Administration across the mucosa. (FDA) | Mucosal Route of Administration | |||
TRANSPLACENTAL | C38307 | Administration through or across the placenta. (FDA) | Transplacental Route of Administration | |||
TRANSTRACHEAL | C38308 | Administration through the wall of the trachea. (FDA) | Transtracheal Route of Administration | |||
TRANSTYMPANIC | C38309 | Administration across or through the tympanic cavity. (FDA) | Transtympanic Route of Administration | |||
UNASSIGNED | C38310 | Route of administration has not yet been assigned. (FDA) | Unassigned Route of Administration | |||
UNKNOWN | C38311 | Route of administration is unknown. (FDA) | Unknown Route of Administration | |||
URETERAL | C38312 | Administration into the ureter. (FDA) | Ureteral Route of Administration | |||
URETHRAL | C38271 | Administration into the urethra. (FDA) | Intraurethral Route of Administration | |||
VAGINAL | C38313 | Administration into the vagina. (FDA) | Vaginal Route of Administration | |||
Back to top | ||||||
CL.C190903.RUTG0101OR | Rutgeerts Score Clinical Classification ORRES for RUTG0101 TN/TC
(RUTG0101OR) | text
Extensible: No | C190903 | Rutgeerts Score Clinical Classification ORRES for RUTG0101 TN/TC | Rutgeerts Score original result for RUTG0101 test and test code. | CDISC Clinical Classification Rutgeerts Score RUTG0101 Original Response Terminology |
<5 aphthous lesions | C191027 | RUTG0101-<5 aphthous lesions | Rutgeerts Score original result for RUTG0101-Less than 5 aphthous lesions. | Rutgeerts Score RUTG0101 Original Result - Less Than 5 Aphthous Lesions | ||
>5 aphthous lesions with normal mucosa between the lesions, or skip areas of larger lesions or lesions confined to the ileocolonic anastomosis (i.e., <1 cm in length) | C191028 | RUTG0101->5 aphthous lesions with normal mucosa between the lesions, or skip areas of larger lesions or lesions confined to the ileocolonic anastomosis (i.e., <1 cm in length) | Rutgeerts Score original result for RUTG0101-Greater than 5 aphthous lesions with normal mucosa between the lesions, or skip areas of larger lesions or lesions confined to the ileocolonic anastomosis (i.e., less than 1 cm in length). | Rutgeerts Score RUTG0101 Original Result - Greater Than 5 Aphthous Lesions With Normal Mucosa Between the Lesions, or Skip Areas of Larger Lesions or Lesions Confined to the Ileocolonic Anastomosis (i.e., Less Than 1 cm in Length) | ||
diffuse aphthous ileitis with diffusely inflamed mucosa | C191029 | RUTG0101-diffuse aphthous ileitis with diffusely inflamed mucosa | Rutgeerts Score original result for RUTG0101-Diffuse aphthous ileitis with diffusely inflamed mucosa. | Rutgeerts Score RUTG0101 Original Result - Diffuse Aphthous Ileitis With Diffusely Inflamed Mucosa | ||
diffuse inflammation with already larger ulcers, nodules, and/or narrowing | C191030 | RUTG0101-diffuse inflammation with already larger ulcers, nodules, and/or narrowing | Rutgeerts Score original result for RUTG0101-Diffuse inflammation with already larger ulcers, nodules, and/or narrowing. | Rutgeerts Score RUTG0101 Original Result - Diffuse Inflammation With Already Larger Ulcers, Nodules, and/or Narrowing | ||
no lesions | C191026 | RUTG0101-no lesions | Rutgeerts Score original result for RUTG0101-No lesions. | Rutgeerts Score RUTG0101 Original Result - No Lesions | ||
Back to top | ||||||
CL.C190904.RUTG0101STR | Rutgeerts Score Clinical Classification STRESC for RUTG0101 TN/TC
(RUTG0101STR) | text
Extensible: No | C190904 | Rutgeerts Score Clinical Classification STRESC for RUTG0101 TN/TC | Rutgeerts Score standardized character result for RUTG0101 test and test code. | CDISC Clinical Classification Rutgeerts Score RUTG0101 Standardized Character Response Terminology |
i0 | C191031 | RUTG0101-i0 | Rutgeerts Score standardized character result for RUTG0101-No lesions. | Rutgeerts Score RUTG0101 Standardized Character Result i0 | ||
i1 | C191032 | RUTG0101-i1 | Rutgeerts Score standardized character result for RUTG0101-Less than 5 aphthous lesions. | Rutgeerts Score RUTG0101 Standardized Character Result i1 | ||
i2 | C191033 | RUTG0101-i2 | Rutgeerts Score standardized character result for RUTG0101-Greater than 5 aphthous lesions with normal mucosa between the lesions, or skip areas of larger lesions or lesions confined to the ileocolonic anastomosis (i.e., less than 1 cm in length). | Rutgeerts Score RUTG0101 Standardized Character Result i2 | ||
i3 | C191034 | RUTG0101-i3 | Rutgeerts Score standardized character result for RUTG0101-Diffuse aphthous ileitis with diffusely inflamed mucosa. | Rutgeerts Score RUTG0101 Standardized Character Result i3 | ||
i4 | C191035 | RUTG0101-i4 | Rutgeerts Score standardized character result for RUTG0101-Diffuse inflammation with already larger ulcers, nodules, and/or narrowing. | Rutgeerts Score RUTG0101 Standardized Character Result i4 | ||
Back to top | ||||||
CL.C190932.RUTG01TC | Rutgeerts Score Clinical Classification Test Code
(RUTG01TC) | text
Extensible: No | C190932 | Rutgeerts Score Clinical Classification Test Code | Rutgeerts Score test code. | CDISC Clinical Classification Rutgeerts Score Test Code Terminology |
RUTG0101 | C191153 | RUTG01-Rutgeerts Score | Rutgeerts Score - Rutgeerts score. | Rutgeerts Score - Rutgeerts Score | ||
Back to top | ||||||
CL.C190931.RUTG01TN | Rutgeerts Score Clinical Classification Test Name
(RUTG01TN) | text
Extensible: No | C190931 | Rutgeerts Score Clinical Classification Test Name | Rutgeerts Score test name. | CDISC Clinical Classification Rutgeerts Score Test Name Terminology |
RUTG01-Rutgeerts Score | C191153 | RUTG01-Rutgeerts Score | Rutgeerts Score - Rutgeerts score. | Rutgeerts Score - Rutgeerts Score | ||
Back to top | ||||||
CL.C115408.SWLS01TC | Satisfaction With Life Scale Questionnaire Test Code
(SWLS01TC) | text
Extensible: No | C115408 | Satisfaction With Life Scale Questionnaire Test Code | Satisfaction With Life Scale test code. | CDISC Questionnaire SWLS Test Code Terminology |
SWLS0101 | C115895 | SWLS01-My Life is Close to Ideal | Satisfaction With Life Scale - In most ways my life is close to ideal. | SWLS - My Life is Close to Ideal | ||
SWLS0102 | C115896 | SWLS01-My Life Conditions are Excellent | Satisfaction With Life Scale - The conditions of my life are excellent. | SWLS - Life Conditions are Excellent | ||
SWLS0103 | C115897 | SWLS01-I Am Satisfied with My Life | Satisfaction With Life Scale - I am satisfied with my life. | SWLS - Satisfied with My Life | ||
SWLS0104 | C115898 | SWLS01-Have Gotten Important Things | Satisfaction With Life Scale - So far I have gotten the important things I want in life. | SWLS - Have Gotten Important Things | ||
SWLS0105 | C115899 | SWLS01-Live Life Over Change Nothing | Satisfaction With Life Scale - If I could live my life over, I would change almost nothing. | SWLS - Live Life Over Change Nothing | ||
Back to top | ||||||
CL.C115407.SWLS01TN | Satisfaction With Life Scale Questionnaire Test Name
(SWLS01TN) | text
Extensible: No | C115407 | Satisfaction With Life Scale Questionnaire Test Name | Satisfaction With Life Scale test name. | CDISC Questionnaire SWLS Test Name Terminology |
SWLS01-Have Gotten Important Things | C115898 | SWLS01-Have Gotten Important Things | Satisfaction With Life Scale - So far I have gotten the important things I want in life. | SWLS - Have Gotten Important Things | ||
SWLS01-I Am Satisfied with My Life | C115897 | SWLS01-I Am Satisfied with My Life | Satisfaction With Life Scale - I am satisfied with my life. | SWLS - Satisfied with My Life | ||
SWLS01-Live Life Over Change Nothing | C115899 | SWLS01-Live Life Over Change Nothing | Satisfaction With Life Scale - If I could live my life over, I would change almost nothing. | SWLS - Live Life Over Change Nothing | ||
SWLS01-My Life Conditions are Excellent | C115896 | SWLS01-My Life Conditions are Excellent | Satisfaction With Life Scale - The conditions of my life are excellent. | SWLS - Life Conditions are Excellent | ||
SWLS01-My Life is Close to Ideal | C115895 | SWLS01-My Life is Close to Ideal | Satisfaction With Life Scale - In most ways my life is close to ideal. | SWLS - My Life is Close to Ideal | ||
Back to top | ||||||
CL.C124302.SZFATSCD | Schizophrenia Findings About Test Code
(SZFATSCD) | text
Extensible: Yes | C124302 | Schizophrenia Findings About Test Code | Terminology relevant to the test codes that describe findings about a schizophrenia event or intervention. | CDISC SDTM Schizophrenia Findings About Test Code Terminology |
ACUTSTRS | C124437 | Most Severe Acute Stressor | The agent, stimulus, activity, or event that causes stress with an acute frequency, which has the highest level of severity. | Most Severe Acute Stressor | ||
AGEEPSD1 | C124438 | Age At First Episode | The age at which the first episode occurred. | Age at First Episode | ||
AGEHOSP1 | C124439 | Age At First Hospitalization | The age at which the first hospitalization event occurred. | Age at First Hospitalization | ||
AGETRT1 | C124440 | Age At First Treatment | The age at which the first treatment for the condition occurred. | Age at First Treatment | ||
CHRNSTRS | C124441 | Most Severe Chronic Stressor | The agent, stimulus, activity, or event that causes stress with a chronic frequency, which has the highest level of severity. | Most Severe Chronic Stressor | ||
CLININD | C124442 | Clinic Stay Indicator | An indication as to whether the subject was admitted to a healthcare clinic. | Clinic Stay Indicator | ||
EPSDNUM | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
HOSPNUM | C124443 | Number Of Hospitalizations | The total number of hospitalization events that have occurred for the condition. | Number of Hospitalizations | ||
LONGCRSE | C35461 | Longitudinal Course | A description of the series of events, including signs and symptoms, that define the course of a chronic disease over time. | Clinical Course of Disease | ||
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
TRTSETT | C124444 | Treatment Environmental Setting;Treatment Setting | The surroundings or environment within which the subject receives therapeutic treatment for the condition. | Treatment Environmental Setting | ||
Back to top | ||||||
CL.C124303.SZFATS | Schizophrenia Findings About Test Name
(SZFATS) | text
Extensible: Yes | C124303 | Schizophrenia Findings About Test Name | Terminology relevant to the test names that describe findings about a schizophrenia event or intervention. | CDISC SDTM Schizophrenia Findings About Test Name Terminology |
Age At First Episode | C124438 | Age At First Episode | The age at which the first episode occurred. | Age at First Episode | ||
Age At First Hospitalization | C124439 | Age At First Hospitalization | The age at which the first hospitalization event occurred. | Age at First Hospitalization | ||
Age At First Treatment | C124440 | Age At First Treatment | The age at which the first treatment for the condition occurred. | Age at First Treatment | ||
Clinic Stay Indicator | C124442 | Clinic Stay Indicator | An indication as to whether the subject was admitted to a healthcare clinic. | Clinic Stay Indicator | ||
Longitudinal Course | C35461 | Longitudinal Course | A description of the series of events, including signs and symptoms, that define the course of a chronic disease over time. | Clinical Course of Disease | ||
Most Severe Acute Stressor | C124437 | Most Severe Acute Stressor | The agent, stimulus, activity, or event that causes stress with an acute frequency, which has the highest level of severity. | Most Severe Acute Stressor | ||
Most Severe Chronic Stressor | C124441 | Most Severe Chronic Stressor | The agent, stimulus, activity, or event that causes stress with a chronic frequency, which has the highest level of severity. | Most Severe Chronic Stressor | ||
Number of Episodes | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
Number Of Hospitalizations | C124443 | Number Of Hospitalizations | The total number of hospitalization events that have occurred for the condition. | Number of Hospitalizations | ||
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Treatment Setting | C124444 | Treatment Environmental Setting;Treatment Setting | The surroundings or environment within which the subject receives therapeutic treatment for the condition. | Treatment Environmental Setting | ||
Back to top | ||||||
CL.C100160.SOAPR1TC | Screener and Opioid Assessment for Patients with Pain - Revised Questionnaire Test Code
(SOAPR1TC) | text
Extensible: No | C100160 | Screener and Opioid Assessment for Patients with Pain - Revised Questionnaire Test Code | Screener and Opioid Assessment for Patients with Pain - Revised test code. | CDISC Questionnaire SOAPP-R Test Code Terminology |
SOAPR101 | C100870 | SOAPR1-How Often Mood Swings | Screener and Opioid Assessment for Patients with Pain - Revised - How often do you have mood swings? | SOAPP-R - How Often Mood Swings | ||
SOAPR102 | C100871 | SOAPR1-Need Higher Doses of Medication | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt a need for higher doses of medication to treat your pain? | SOAPP-R - Need Higher Doses of Medication | ||
SOAPR103 | C100872 | SOAPR1-Felt Impatient With Doctors | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt impatient with your doctors? | SOAPP-R - Felt Impatient With Doctors | ||
SOAPR104 | C100873 | SOAPR1-Felt That Things Are Overwhelming | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt that things are just too overwhelming that you can't handle them? | SOAPP-R - Felt That Things Are Overwhelming | ||
SOAPR105 | C100874 | SOAPR1-How Often Tension at Home | Screener and Opioid Assessment for Patients with Pain - Revised - How often is there tension in the home? | SOAPP-R - How Often Tension at Home | ||
SOAPR106 | C100875 | SOAPR1-How Often Counted Pain Pills | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you counted pain pills to see how many are remaining? | SOAPP-R - How Often Counted Pain Pills | ||
SOAPR107 | C100876 | SOAPR1-Concerned People Will Judge You | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been concerned that people will judge you for taking pain medication? | SOAPP-R - Concerned People Will Judge You | ||
SOAPR108 | C100877 | SOAPR1-How Often Feel Bored | Screener and Opioid Assessment for Patients with Pain - Revised - How often do you feel bored? | SOAPP-R - How Often Feel Bored | ||
SOAPR109 | C100878 | SOAPR1-How Often Taken More Pain Med | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you taken more pain medication than you were supposed to? | SOAPP-R - How Often Taken More Pain Medication | ||
SOAPR110 | C100879 | SOAPR1-Worried About Being Left Alone | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you worried about being left alone? | SOAPP-R - Worried About Being Left Alone | ||
SOAPR111 | C100880 | SOAPR1-Felt Craving for Medication | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt a craving for medication? | SOAPP-R - Felt Craving for Medication | ||
SOAPR112 | C100881 | SOAPR1-Expressed Concern Over Med Use | Screener and Opioid Assessment for Patients with Pain - Revised - How often have others expressed concern over your use of medication? | SOAPP-R - Others Expressed Concern Over Medication Use | ||
SOAPR113 | C100882 | SOAPR1-How Often Friends Had Problem | Screener and Opioid Assessment for Patients with Pain - Revised - How often have any of your close friends had a problem with alcohol or drugs? | SOAPP-R - How Often Friends Had Problem | ||
SOAPR114 | C100883 | SOAPR1-Others Told You Bad Temper | Screener and Opioid Assessment for Patients with Pain - Revised - How often have others told you that you had a bad temper? | SOAPP-R - Others Told You Bad Temper | ||
SOAPR115 | C100884 | SOAPR1-Felt Consumed to Get Pain Med | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt consumed by the need to get pain medication? | SOAPP-R - Felt Consumed to Get Pain Medication | ||
SOAPR116 | C100885 | SOAPR1-Run Out of Pain Med Early | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you run out of pain medication early? | SOAPP-R - Run Out of Pain Medication Early | ||
SOAPR117 | C100886 | SOAPR1-Kept From What You Deserve | Screener and Opioid Assessment for Patients with Pain - Revised - How often have others kept you from getting what you deserve? | SOAPP-R - Others Kept You From what You Deserve | ||
SOAPR118 | C100887 | SOAPR1-Legal Problems or Arrested | Screener and Opioid Assessment for Patients with Pain - Revised - How often, in your lifetime, have you had legal problems or been arrested? | SOAPP-R - Legal Problems or Arrested | ||
SOAPR119 | C100888 | SOAPR1-Attended AA or NA Meeting | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you attended an AA or NA meeting? | SOAPP-R - Attended AA or NA Meeting | ||
SOAPR120 | C100889 | SOAPR1-Argument Someone Got Hurt | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been in an argument that was so out of control that someone got hurt? | SOAPP-R - Argument Where Someone Got Hurt | ||
SOAPR121 | C100890 | SOAPR1-How Often Sexually Abused | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been sexually abused? | SOAPP-R - How Often Sexually Abused | ||
SOAPR122 | C100891 | SOAPR1-Suggested Drug or Alcohol Problem | Screener and Opioid Assessment for Patients with Pain - Revised - How often have others suggested that you have a drug or alcohol problem? | SOAPP-R - Others Suggested Drug or Alcohol Problem | ||
SOAPR123 | C100892 | SOAPR1-How Often Borrowed Pain Meds | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you had to borrow pain medications from your family or friends? | SOAPP-R - How Often Borrowed Pain Medication | ||
SOAPR124 | C100893 | SOAPR1-Treated for Alcohol or Drug Prob | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been treated for an alcohol or drug problem? | SOAPP-R - Treated for Alcohol or Drug Problem | ||
SOAPR125 | C100894 | SOAPR1-Any Additional Information | Screener and Opioid Assessment for Patients with Pain - Revised - Please include any additional information you wish about the above answers. | SOAPP-R - Any Additional Information | ||
SOAPR126 | C100895 | SOAPR1-Score | Screener and Opioid Assessment for Patients with Pain - Revised - Score. | SOAPP-R - Score | ||
Back to top | ||||||
CL.C100159.SOAPR1TN | Screener and Opioid Assessment for Patients with Pain - Revised Questionnaire Test Name
(SOAPR1TN) | text
Extensible: No | C100159 | Screener and Opioid Assessment for Patients with Pain - Revised Questionnaire Test Name | Screener and Opioid Assessment for Patients with Pain - Revised test name. | CDISC Questionnaire SOAPP-R Test Name Terminology |
SOAPR1-Any Additional Information | C100894 | SOAPR1-Any Additional Information | Screener and Opioid Assessment for Patients with Pain - Revised - Please include any additional information you wish about the above answers. | SOAPP-R - Any Additional Information | ||
SOAPR1-Argument Someone Got Hurt | C100889 | SOAPR1-Argument Someone Got Hurt | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been in an argument that was so out of control that someone got hurt? | SOAPP-R - Argument Where Someone Got Hurt | ||
SOAPR1-Attended AA or NA Meeting | C100888 | SOAPR1-Attended AA or NA Meeting | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you attended an AA or NA meeting? | SOAPP-R - Attended AA or NA Meeting | ||
SOAPR1-Concerned People Will Judge You | C100876 | SOAPR1-Concerned People Will Judge You | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been concerned that people will judge you for taking pain medication? | SOAPP-R - Concerned People Will Judge You | ||
SOAPR1-Expressed Concern Over Med Use | C100881 | SOAPR1-Expressed Concern Over Med Use | Screener and Opioid Assessment for Patients with Pain - Revised - How often have others expressed concern over your use of medication? | SOAPP-R - Others Expressed Concern Over Medication Use | ||
SOAPR1-Felt Consumed to Get Pain Med | C100884 | SOAPR1-Felt Consumed to Get Pain Med | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt consumed by the need to get pain medication? | SOAPP-R - Felt Consumed to Get Pain Medication | ||
SOAPR1-Felt Craving for Medication | C100880 | SOAPR1-Felt Craving for Medication | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt a craving for medication? | SOAPP-R - Felt Craving for Medication | ||
SOAPR1-Felt Impatient With Doctors | C100872 | SOAPR1-Felt Impatient With Doctors | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt impatient with your doctors? | SOAPP-R - Felt Impatient With Doctors | ||
SOAPR1-Felt That Things Are Overwhelming | C100873 | SOAPR1-Felt That Things Are Overwhelming | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt that things are just too overwhelming that you can't handle them? | SOAPP-R - Felt That Things Are Overwhelming | ||
SOAPR1-How Often Borrowed Pain Meds | C100892 | SOAPR1-How Often Borrowed Pain Meds | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you had to borrow pain medications from your family or friends? | SOAPP-R - How Often Borrowed Pain Medication | ||
SOAPR1-How Often Counted Pain Pills | C100875 | SOAPR1-How Often Counted Pain Pills | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you counted pain pills to see how many are remaining? | SOAPP-R - How Often Counted Pain Pills | ||
SOAPR1-How Often Feel Bored | C100877 | SOAPR1-How Often Feel Bored | Screener and Opioid Assessment for Patients with Pain - Revised - How often do you feel bored? | SOAPP-R - How Often Feel Bored | ||
SOAPR1-How Often Friends Had Problem | C100882 | SOAPR1-How Often Friends Had Problem | Screener and Opioid Assessment for Patients with Pain - Revised - How often have any of your close friends had a problem with alcohol or drugs? | SOAPP-R - How Often Friends Had Problem | ||
SOAPR1-How Often Mood Swings | C100870 | SOAPR1-How Often Mood Swings | Screener and Opioid Assessment for Patients with Pain - Revised - How often do you have mood swings? | SOAPP-R - How Often Mood Swings | ||
SOAPR1-How Often Sexually Abused | C100890 | SOAPR1-How Often Sexually Abused | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been sexually abused? | SOAPP-R - How Often Sexually Abused | ||
SOAPR1-How Often Taken More Pain Med | C100878 | SOAPR1-How Often Taken More Pain Med | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you taken more pain medication than you were supposed to? | SOAPP-R - How Often Taken More Pain Medication | ||
SOAPR1-How Often Tension at Home | C100874 | SOAPR1-How Often Tension at Home | Screener and Opioid Assessment for Patients with Pain - Revised - How often is there tension in the home? | SOAPP-R - How Often Tension at Home | ||
SOAPR1-Kept From What You Deserve | C100886 | SOAPR1-Kept From What You Deserve | Screener and Opioid Assessment for Patients with Pain - Revised - How often have others kept you from getting what you deserve? | SOAPP-R - Others Kept You From what You Deserve | ||
SOAPR1-Legal Problems or Arrested | C100887 | SOAPR1-Legal Problems or Arrested | Screener and Opioid Assessment for Patients with Pain - Revised - How often, in your lifetime, have you had legal problems or been arrested? | SOAPP-R - Legal Problems or Arrested | ||
SOAPR1-Need Higher Doses of Medication | C100871 | SOAPR1-Need Higher Doses of Medication | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you felt a need for higher doses of medication to treat your pain? | SOAPP-R - Need Higher Doses of Medication | ||
SOAPR1-Others Told You Bad Temper | C100883 | SOAPR1-Others Told You Bad Temper | Screener and Opioid Assessment for Patients with Pain - Revised - How often have others told you that you had a bad temper? | SOAPP-R - Others Told You Bad Temper | ||
SOAPR1-Run Out of Pain Med Early | C100885 | SOAPR1-Run Out of Pain Med Early | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you run out of pain medication early? | SOAPP-R - Run Out of Pain Medication Early | ||
SOAPR1-Score | C100895 | SOAPR1-Score | Screener and Opioid Assessment for Patients with Pain - Revised - Score. | SOAPP-R - Score | ||
SOAPR1-Suggested Drug or Alcohol Problem | C100891 | SOAPR1-Suggested Drug or Alcohol Problem | Screener and Opioid Assessment for Patients with Pain - Revised - How often have others suggested that you have a drug or alcohol problem? | SOAPP-R - Others Suggested Drug or Alcohol Problem | ||
SOAPR1-Treated for Alcohol or Drug Prob | C100893 | SOAPR1-Treated for Alcohol or Drug Prob | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you been treated for an alcohol or drug problem? | SOAPP-R - Treated for Alcohol or Drug Problem | ||
SOAPR1-Worried About Being Left Alone | C100879 | SOAPR1-Worried About Being Left Alone | Screener and Opioid Assessment for Patients with Pain - Revised - How often have you worried about being left alone? | SOAPP-R - Worried About Being Left Alone | ||
Back to top | ||||||
CL.C116108.DTHDXCD | SDTM Death Diagnosis and Details Test Code
(DTHDXCD) | text
Extensible: Yes | C116108 | SDTM Death Diagnosis and Details Test Code | Terminology relevant to the test codes that describe the death diagnosis and related details. | CDISC SDTM Death Diagnosis Test Code Terminology |
AGEDTH | C135383 | Age at Death | The age at which death occurred. (NCI) | Age at Death | ||
AUTOPIND | C135384 | Autopsy Indicator | An indication as to whether an autopsy was performed. (NCI) | Autopsy Indicator | ||
DTHCOIND | C135385 | Death Certificate Obtained Indicator | An indication as to whether a death certificate was obtained. (NCI) | Death Certification Indicator | ||
DTHEXIND | C184505 | Death Expected Indicator | An indication as to whether the death was expected. | Death Expected Indicator | ||
DTHWIND | C170571 | Death Witnessed Indicator | An indication as to whether the death event was witnessed by another individual. | Death Witnessed Indicator | ||
HMROIND | C135386 | Hospital Medical Record Obtained Ind;Hospital Medical Record Obtained Indicator | An indication as to whether a hospital medical record was obtained. | Hospital Medical Record Indicator | ||
HSDTHIND | C198258 | Hospitalized at Time of Death Indicator | An indication as to whether the subject was hospitalized at the time of death. | Hospitalized at Time of Death Indicator | ||
INFOSCOD | C176287 | Information Source for Cause of Death | The person or authoritative source that provided the cause of death. | Information Source for Cause of Death | ||
LOCDTH | C124331 | Location of Death | The physical location at which the subject ceased to live. | Location of Death | ||
PRCDTH | C99531 | Primary Cause of Death | The primary significant event which ultimately led to death. | Primary Cause of Death | ||
SDTHIND | C174284 | Sudden Death Indicator | An indication as to whether death was unexpected or occurred without warning. | Sudden Death Indicator | ||
SECDTH | C116142 | Secondary Cause of Death | The secondary significant event which ultimately led to death. | Secondary Cause of Death | ||
Back to top | ||||||
CL.C116107.DTHDX | SDTM Death Diagnosis and Details Test Name
(DTHDX) | text
Extensible: Yes | C116107 | SDTM Death Diagnosis and Details Test Name | Terminology relevant to the test codes that describe the death diagnosis and related details. | CDISC SDTM Death Diagnosis Test Name Terminology |
Age at Death | C135383 | Age at Death | The age at which death occurred. (NCI) | Age at Death | ||
Autopsy Indicator | C135384 | Autopsy Indicator | An indication as to whether an autopsy was performed. (NCI) | Autopsy Indicator | ||
Death Certificate Obtained Indicator | C135385 | Death Certificate Obtained Indicator | An indication as to whether a death certificate was obtained. (NCI) | Death Certification Indicator | ||
Death Expected Indicator | C184505 | Death Expected Indicator | An indication as to whether the death was expected. | Death Expected Indicator | ||
Death Witnessed Indicator | C170571 | Death Witnessed Indicator | An indication as to whether the death event was witnessed by another individual. | Death Witnessed Indicator | ||
Hospital Medical Record Obtained Ind | C135386 | Hospital Medical Record Obtained Ind;Hospital Medical Record Obtained Indicator | An indication as to whether a hospital medical record was obtained. | Hospital Medical Record Indicator | ||
Hospitalized at Time of Death Indicator | C198258 | Hospitalized at Time of Death Indicator | An indication as to whether the subject was hospitalized at the time of death. | Hospitalized at Time of Death Indicator | ||
Information Source for Cause of Death | C176287 | Information Source for Cause of Death | The person or authoritative source that provided the cause of death. | Information Source for Cause of Death | ||
Location of Death | C124331 | Location of Death | The physical location at which the subject ceased to live. | Location of Death | ||
Primary Cause of Death | C99531 | Primary Cause of Death | The primary significant event which ultimately led to death. | Primary Cause of Death | ||
Secondary Cause of Death | C116142 | Secondary Cause of Death | The secondary significant event which ultimately led to death. | Secondary Cause of Death | ||
Sudden Death Indicator | C174284 | Sudden Death Indicator | An indication as to whether death was unexpected or occurred without warning. | Sudden Death Indicator | ||
Back to top | ||||||
CL.C66734.DOMAIN | SDTM Domain Abbreviation
(DOMAIN) | text
Extensible: Yes | C66734 | SDTM Domain Abbreviation | A unique, 2-character domain code used in the regulatory submission process. The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary) | CDISC SDTM Submission Domain Abbreviation Terminology |
AE | C49562 | Adverse Events | An events domain that contains data describing untoward medical occurrences in a patient or subjects that are administered a pharmaceutical product and which may not necessarily have a causal relationship with the treatment. | Adverse Event Domain | ||
AG | C117755 | Procedure Agents | An interventions domain that contains the agents administered to the subject as part of a procedure or assessment, as opposed to drugs, medications and therapies administered with therapeutic intent. | Procedure Agents Domain | ||
BE | C111138 | Biospecimen Events | An events domain that documents actions taken that affect or may affect a specimen (e.g., specimen collection, freezing and thawing, aliquoting, transportation). | Biospecimen Events Domain | ||
BS | C111137 | Biospecimen Findings | A findings domain that contains data related to biospecimen characteristics. | Biospecimen Domain | ||
CE | C85441 | Clinical Events | An events domain that contains clinical events of interest that would not be classified as adverse events. | Clinical Events Domain | ||
CM | C49568 | Concomitant/Prior Medications | An interventions domain that contains concomitant and prior medications used by the subject, such as those given on an as needed basis or condition-appropriate medications. | Concomitant Medication Domain | ||
CO | C49569 | Comments | A special-purpose domain that contains comments that may be collected alongside other data. | Comment Domain | ||
CP | C181319 | Cell Phenotype Findings | A findings domain that contains data related to the characterization of cell phenotype, lineage, and function based on expression of specific markers in single cell or particle suspensions. | Cell Phenotype Findings Domain | ||
CV | C102605 | Cardiovascular System Findings | A findings domain that contains physiological and morphological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels. | Cardiovascular System Findings Domain | ||
DA | C49578 | Product Accountability | A findings domain that contains the accountability of study product, such as information on the receipt, dispensing, return, and packaging. | Product Accountability Domain | ||
DD | C95087 | Death Details;Death Diagnosis and Details | A findings domain that contains the diagnosis of the cause of death for a subject. | Death Diagnosis Domain | ||
DE | C102616 | Device Events | An events domain that contains data for device-related events. | Device Events Domain | ||
DI | C102618 | Device Identifiers | A special-purpose domain containing information that identifies a specific device unit. | Device Identifiers Domain | ||
DM | C49572 | Demographics | A special-purpose domain that includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjects. | Demographics Domain | ||
DO | C102619 | Device Properties | A findings domain that contains the device characteristics that do not vary over the course of the study. | Device Properties Domain | ||
DR | C102620 | Device-Subject Relationships | A special-purpose domain that contains the linkage of each subject to the device(s) to which they may have been exposed during the study. | Device to Subject Relationship Domain | ||
DS | C49576 | Disposition | An events domain that contains information encompassing and representing data related to subject disposition. | Disposition Domain | ||
DT | C102621 | Device Tracking and Disposition | A events domain that contains the logistics and disposition information specific to a given device. | Device Tracking and Disposition Domain | ||
DU | C102622 | Device In-Use | A findings domain that contains the measurements and settings that are intentionally set on a device when it is in use. These are characteristics that exist for the device, and have a specific setting for a use instance. | Device-In-Use Domain | ||
DV | C49585 | Protocol Deviations | An events domain that contains protocol violations and deviations during the course of the study. | Protocol Deviations Domain | ||
DX | C102617 | Device Exposure | An interventions domain that contains a subject's exposure to a medical device under study. | Device Exposure Domain | ||
EC | C117466 | Exposure as Collected | An interventions domain that contains information about protocol-specified study treatment administrations, as collected. | Exposure as Collected Domain | ||
ED | C102630 | Endocrine System Findings | A findings domain that contains physiological and morphological findings related to the endocrine system, including the glands and cells that make hormones that are released directly into the blood and travel to tissues and organs all over the body. | Endocrine System Findings Domain | ||
EG | C49626 | ECG Test Results | A findings domain that contains ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived. | Electrocardiogram Domain | ||
EX | C49587 | Exposure | An interventions domain that contains the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject. | Exposure Domain | ||
FA | C85442 | Findings About Events or Interventions | A findings domain that contains the findings about an event or intervention that cannot be represented within an events or interventions domain record or as a supplemental qualifier. | Findings About Events or Interventions Domain | ||
FT | C117756 | Functional Tests | A findings domain that contains data for named, stand-alone, task-based evaluations designed to provide an assessment of mobility, dexterity, or cognitive ability. | Functional Tests Domain | ||
GF | C181320 | Genomics Findings | A findings domain that contains data related to the structure, function, evolution, mapping, and editing of subject and non-host organism genomic material of interest. This domain includes but is not limited to assessments and results for genetic variation and transcription, and summary measures derived from these assessments. The GF domain is used for findings from characteristics assessed from nucleic acids and may include subsequent inferences and/or predictions about related proteins/amino acids. | Genomics Findings Domain | ||
GI | C102640 | Gastrointestinal System Findings | A findings domain that contains physiological and morphological findings related to the gastrointestinal system, including the esophagus, stomach, small and large intestine, anus, liver, biliary tract and pancreas. | Digestive System Findings Domain | ||
HM | C102641 | Hematopoietic System Findings | A findings domain that contains physiological and morphological findings related to the hematopoietic system, including the bone marrow and lymph nodes involved in the production of blood. | Hematopoietic System Findings Domain | ||
HO | C117757 | Healthcare Encounters | A events domain that contains data for inpatient and outpatient healthcare events (e.g., hospitalization, nursing home stay, rehabilitation facility stay, ambulatory surgery). | Healthcare Encounters Domain | ||
IE | C61536 | Inclusion/Exclusion Criteria Not Met | A findings domain that contains those criteria that cause the subject to be in violation of the inclusion/exclusion criteria. | Inclusion Exclusion Criteria Not Met Domain | ||
IG | C102651 | Integumentary System Findings | A findings domain that contains physiological and morphological findings related to the integumentary system, including the epidermis, dermis, and all of their derivatives including hairs, nails, sudoriferous glands, and sebaceous glands. | Integumentary System Findings Domain | ||
IS | C112320 | Immunogenicity Specimen Assessments | A findings domain for assessments of antigen induced humoral or cell-mediated immune response in the subject. | Immunogenicity Specimen Assessments Domain | ||
LB | C49592 | Laboratory Test Results | A findings domain that contains laboratory test data such as hematology, clinical chemistry and urinalysis. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains. | Laboratory Data Domain | ||
MB | C49602 | Microbiology Specimen | A findings domain that represents non-host organisms identified including bacteria, viruses, parasites, protozoa and fungi. | Microbiology Specimen Domain | ||
MH | C49603 | Medical History | An events domain that contains data that includes the subject's prior medical history at the start of the trial. | Medical History Domain | ||
MI | C95095 | Microscopic Findings | A findings domain that contains histopathology findings and microscopic evaluations. | Microscopic Findings Domain | ||
MK | C102674 | Musculoskeletal System Findings | A findings domain that contains physiological and morphological findings related to the system of muscles, tendons, ligaments, bones, joints, and associated tissues. | Musculoskeletal Findings, Connective and Soft Tissue Findings Domain | ||
ML | C49604 | Meal Data | An interventions domain that contains information describing a subject's food product consumption. | Meal Data Domain | ||
MS | C61531 | Microbiology Susceptibility | A findings domain that represents drug susceptibility testing results only. This includes phenotypic testing (where drug is added directly to a culture of organisms) and genotypic tests that provide results in terms of susceptible or resistant. Drug susceptibility testing may occur on a wide variety of non-host organisms, including bacteria, viruses, fungi, protozoa and parasites. | Microbiology Susceptibility Domain | ||
NV | C102677 | Nervous System Findings | A findings domain that contains physiological and morphological findings related to the nervous system, including the brain, spinal cord, the cranial and spinal nerves, autonomic ganglia and plexuses. | Nervous System Findings Domain | ||
OE | C147180 | Ophthalmic Examinations | A findings domain that contains tests that measure a person's ocular health and visual status, to detect abnormalities in the components of the visual system, and to determine how well the person can see. | Ophthalmic Examinations Domain | ||
OI | C161329 | Non-host Organism Identifiers | A special-purpose domain containing information that identifies levels of taxonomic nomenclature of microbes or parasites that have been either experimentally determined in the course of a study or are previously known, as in the case of lab strains used as reference in the study. | Non-host Organism Identifiers Domain | ||
PC | C49606 | Pharmacokinetics Concentrations | A findings domain that contains concentrations of drugs or metabolites in fluids or tissues as a function of time. | Pharmacokinetic Concentration Domain | ||
PE | C49608 | Physical Examination | A findings domain that contains findings observed during a physical examination where the body is evaluated by inspection, palpation, percussion, and auscultation. | Physical Exam Domain | ||
POOLDEF | C147181 | Pool Definition | A dataset that identifies individual subjects included in a pool of subjects for which a single observation record (pool level) is captured. | Pool Definition Dataset | ||
PP | C49607 | Pharmacokinetics Parameters | A findings domain that contains pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data. | Pharmacokinetic Parameters Domain | ||
PR | C102700 | Procedures | An interventions domain that contains interventional activity intended to have diagnostic, preventive, therapeutic, or palliative effects. | Procedure Domain | ||
QS | C49609 | Questionnaires | A findings domain that contains data for named, stand-alone instruments designed to provide an assessment of a concept. Questionnaires have a defined standard structure, format, and content; consist of conceptually related items that are typically scored; and have documented methods for administration and analysis. | Questionnaire Domain | ||
RE | C95098 | Respiratory System Findings | A findings domain that contains physiological and morphological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. | Respiratory Domain | ||
RELREC | C147182 | Related Records | A dataset used to describe relationships between records for a subject within or across domains, and relationships of records across datasets. | Related Records Dataset | ||
RELSPEC | C181321 | Related Specimens | A dataset used to represent relationships between specimens. | Related Specimens Dataset | ||
RELSUB | C147183 | Related Subjects | A dataset used to represent relationships between study subjects. | Related Subjects Dataset | ||
RP | C102707 | Reproductive System Findings | A findings domain that contains physiological and morphological findings related to the male and female reproductive systems. | Reproductive System Findings Domain | ||
RS | C107097 | Disease Response and Clin Classification | A findings domain for the assessment of disease response to therapy, or clinical classification based on published criteria. | Disease Response Domain | ||
SA | C177945 | Serious Adverse Events | An events domain that contains data describing untoward medical occurrences considered serious (SAE) in a patient or subjects that are administered a pharmaceutical product and which may not necessarily have a causal relationship with the treatment. | Serious Adverse Events Domain | ||
SC | C49610 | Subject Characteristics | A findings domain that contains subject-related data not collected in other domains. | Subject Characteristics Domain | ||
SE | C49616 | Subject Elements | A special-purpose domain that contains the actual order of elements followed by the subject, together with the start date/time and end date/time for each element. | Subject Element Domain | ||
SM | C147184 | Subject Disease Milestones | A special-purpose domain that is designed to record the timing, for each subject, of disease milestones that have been defined in the Trial Disease Milestones (TM) domain. | Subject Disease Milestones Domain | ||
SR | C112420 | Skin Response | A findings about domain for submitting dermal responses to antigens. | Skin Response Domain | ||
SS | C117655 | Subject Status | A findings domain that contains the subject's status that is evaluated periodically to determine if it has changed. | Subject Status Domain | ||
SU | C49615 | Substance Use | An interventions domain that contains substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use. | Substance Use Domain | ||
SV | C49617 | Subject Visits | A special-purpose domain that contains information for each subject's actual and planned visits and contact events. | Subject Visits Domain | ||
TA | C49618 | Trial Arms | A trial design domain that contains each planned arm in the trial. | Trial Arms Domain | ||
TD | C117699 | Trial Disease Assessments | A trial design domain that provides information on the protocol-specified disease assessment schedule, to be used for comparison with the actual occurrence of the efficacy assessments in order to determine whether there was good compliance with the schedule. | Trial Disease Assessments Domain | ||
TE | C49619 | Trial Elements | A trial design domain that contains the element code that is unique for each element, the element description, and the rules for starting and ending an element. | Trial Elements Domain | ||
TI | C49620 | Trial Inclusion/Exclusion Criteria | A trial design domain that contains one record for each of the inclusion and exclusion criteria for the trial. This domain is not subject oriented. | Trial Inclusion and Exclusion Criteria Domain | ||
TM | C147270 | Trial Disease Milestones | A trial design domain that is used to describe disease milestones, which are observations or activities anticipated to occur in the course of the disease under study, and which trigger the collection of data. | Trial Disease Milestones Domain | ||
TR | C106578 | Tumor/Lesion Results | A findings domain that represents quantitative measurements and/or qualitative assessments of the tumors, lesions, or locations of interest identified in the Tumor/Lesion Identification (TU) domain. | Tumor Results Domain | ||
TS | C53483 | Trial Summary | A trial design domain that contains one record for each trial summary characteristic. This domain is not subject oriented. | Trial Summary Domain | ||
TU | C106577 | Tumor/Lesion Identification | A findings domain that represents data that uniquely identifies tumors, lesions, or locations of interest under study. | Tumor Identifier Domain | ||
TV | C49621 | Trial Visits | A trial design domain that contains the planned order and number of visits in the study within each arm. | Trial Visits Domain | ||
UR | C102726 | Urinary System Findings | A findings domain that contains physiological and morphological findings related to the urinary tract, including the organs involved in the creation and excretion of urine such as the kidneys, ureters, bladder and urethra. | Urinary System Findings Domain | ||
VS | C49622 | Vital Signs | A findings domain that contains measurements including but not limited to blood pressure, temperature, respiration, body surface area, body mass index, height and weight. | Vital Signs Domain | ||
Back to top | ||||||
CL.C132263.MITSCD | SDTM Microscopic Findings Test Code
(MITSCD) | text
Extensible: Yes | C132263 | SDTM Microscopic Findings Test Code | Terminology for the test codes concerned with the clinical findings from a specimen that are visible by microscopic analysis. | CDISC SDTM Microscopic Findings Test Code Terminology |
ABNCE | C111124 | Abnormal Cells | A measurement of the abnormal cells in a biological specimen. | Abnormal Cell Count | ||
ACDOBOD | C181485 | Acidophil Bodies;Acidophil Body | An evaluation of acidophil bodies in a biological specimen. | Acidophil Body Assessment | ||
ALK | C154805 | ALK Protein | A measurement of the ALK receptor tyrosine kinase in a biological specimen. | ALK Protein Measurement | ||
AMACR | C132364 | Alpha-Methylacyl Coenzyme A Racemase | A measurement of the alpha-methylacyl coenzyme A racemase in a biological specimen. | Alpha-Methylacyl Coenzyme A Racemase Measurement | ||
APOCE | C181495 | Apoptotic Cells | A measurement of the apoptotic cells in a biological specimen. | Apoptotic Cell Count | ||
APOCECE | C181494 | Apoptotic Cells/Total Cells | A relative measurement (ratio or percentage) of the apoptotic cells to total cells in a biological specimen. | Apoptotic Cell to Total Cell Count | ||
ARCHCHG | C178037 | Architectural Changes | An evaluation of tissue architectural changes in a biological specimen. | Architectural Changes Assessment | ||
ARTLRHYT | C135463 | Arteriolar Hyaline Thickening | An evaluation of the arteriolar hyaline thickening of vessels in a biological specimen. | Arteriolar Hyaline Thickening Assessment | ||
ARV7 | C184703 | Androgen Receptor Variant 7;AR-V7 | A measurement of the androgen receptor variant 7 in a biological specimen. | Androgen Receptor Variant 7 Measurement | ||
BANFRDX | C135464 | Banff Diagnostic Category Renal | The histologic evaluation and diagnosis of the type of renal allograft rejection based on kidney biopsies and the Banff Working Classification from the Banff Foundation for Allograft Pathology. (NCI) | Banff Renal Diagnostic Category Assessment | ||
BASOCE | C98865 | Basophils/Total Cells | A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). | Basophil to Total Cell Ratio Measurement | ||
BD1 | C156546 | Beta-defensin 1 | A measurement of the beta-defensin 1 in a biological specimen. | Beta-defensin 1 Measurement | ||
BD2 | C122102 | Beta-defensin 2 | A measurement of the beta-defensin 2 in a biological specimen. | Beta-defensin 2 Measurement | ||
BDKRB1 | C139099 | BK-1 Receptor;Bradykinin Receptor B1 | A measurement of the bradykinin receptor B1 in a biological specimen. | Bradykinin Receptor B1 Measurement | ||
BIAFFNUM | C178041 | Number of Biopsy Specimens Affected | The total number of biopsy specimens in which a finding has been observed. | Number of Biopsy Specimens Affected | ||
BLASTCE | C150836 | Blasts/Total Cells | A relative measurement (ratio or percentage) of the blasts to total cells in a biological specimen. | Blasts to Total Cells Ratio Measurement | ||
BLDVESD | C156545 | Blood Vessel Density | An evaluation of the blood vessel density in a biological specimen. | Blood Vessel Density | ||
BLSTMBCE | C98761 | Myeloblasts/Total Cells | A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). | Myeloblast to Total Cell Ratio Measurement | ||
BLSTMKCE | C98753 | Megakaryoblasts/Total Cells | A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryoblast to Total Cell Ratio Measurement | ||
BRCA1 | C123555 | Breast Cancer Type 1 Susceptibility Prot | A measurement of BRCA1 protein in a biological specimen. | Breast Cancer Type 1 Susceptibility Protein Measurement | ||
CD20 | C103368 | CD20;CD20 Expressing Cells | A count of the CD20 expressing cells per unit in a biological specimen. | CD20 Expressing Cell Measurement | ||
CD3 | C103809 | CD3;CD3 Expressing Cells | A count of the CD3 expressing cells per unit in a biological specimen. | CD3 Expressing Cell Count | ||
CD4 | C103810 | CD4;CD4 Expressing Cells | A count of the CD4 expressing cells per unit in a biological specimen. | CD4 Expressing Cell Count | ||
CD56 | C103370 | CD56;CD56 Expressing Cells | A count of the CD56 expressing cells per unit of a biological specimen. | CD56 Expressing Cell Measurement | ||
CD68 | C156544 | CD68;CD68 Expressing Cells | A count of the CD68 expressing cells per unit in a biological specimen. | CD68 Expressing Cell Count | ||
CD8 | C103811 | CD8;CD8 Expressing Cells | A count of the CD8 expressing cells per unit in a biological specimen. | CD8 Expressing Cell Count | ||
CDX2AG | C139098 | CDX2 Antigen | A measurement of the CDX2 antigen in a biological specimen. | CDX2 Antigen Measurement | ||
CEDISTR | C187946 | Cell Distribution | An interpretive assessment of the proportion of various cell types in a biological specimen. | Cell Distribution Measurement | ||
CELLDIFF | C132430 | Cellular Differentiation | An evaluation of cellular maturity and specialization in a biological specimen. | Cellular Differentiation Assessment | ||
CELLULAR | C111153 | Cellularity;Cellularity Grade | A measurement of the degree, quality or condition of cells in a biological specimen. | Cellularity Measurement | ||
CHINFINL | C178042 | Chronic Inflammatory Infiltrate | An evaluation of chronic inflammatory infiltrate in a biological specimen. | Chronic Inflammatory Infiltrate Assessment | ||
CORBIOMN | C139092 | Number of Malignant Biopsy Cores | A measurement of the total number of core biopsies that contain malignant tissue. (NCI) | Number of Malignant Biopsy Cores | ||
CRYPABSC | C176336 | Crypt Abscess | An evaluation of crypt abscess in a biological specimen. | Crypt Abscess Assessment | ||
CRYPARCD | C176337 | Crypt Architectural Damage | An evaluation of the extent of the architectural damage to the crypts in a biological specimen. | Crypt Architectural Damage Assessment | ||
CRYPTTS | C176335 | Cryptitis | An evaluation of cryptitis in a biological specimen. | Cryptitis Assessment | ||
CY16 | C127763 | Cytokeratin 16 | A measurement of the cytokeratin 16 in a biological specimen. | Cytokeratin 16 Measurement | ||
CYEXAM | C18280 | Cytogenetic Examination | An assessment by microscopic analysis of chromosomal and subchromosomal structure and function. | Cytogenetic Analysis | ||
DCLAMP | C127764 | Dendritic Cell-Lysosomal-Assoc Memb Prot | A measurement of the dendritic cell-lysosomal-associated membrane protein in a biological specimen. | Dendritic Cell Lysosomal-Associated Membrane Protein Measurement | ||
DIAGNOS | C15220 | Diagnostic | The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results or summary of such an investigation. (NCI) | Diagnosis | ||
EGFR | C112273 | Epidermal Growth Factor Receptor;ERBB1;HER1 | A measurement of the epidermal growth factor receptor in a biological specimen. | Epidermal Growth Factor Receptor Measurement | ||
EGFRVP | C154806 | EGFR Variant Protein | A measurement of the EGFR protein with a specified variation(s) (mutations, deletions, insertions, etc.) in a biological specimen. | EGFR Variant Protein Measurement | ||
EMVI | C184699 | Extramural Venous Invasion | An evaluation of extramural venous invasion in a biological specimen. | Extramural Venous Invasion Assessment | ||
EOSCE | C98720 | Eosinophils/Total Cells | A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). | Eosinophils to Total Cell Ratio Measurement | ||
EPIDMG | C178036 | Epithelial Damage | An evaluation of epithelial damage in a biological specimen. | Epithelial Damage Assessment | ||
EPITHINT | C176338 | Epithelial Integrity | An evaluation of the integrity of the epithelium in a biological specimen. | Epithelial Integrity Assessment | ||
ERLIERLT | C156547 | Epi RBM Lngth, Intact/Epi RBM Lngth, Tot;Epithelial RBM Length, Intact/Epithelial RBM Length, Total | A relative measurement (ratio or percentage) of the intact epithelial reticular basement membrane length to the total epithelial reticular basement membrane length in a biological specimen. | Intact Epithelial Reticular Basement Membrane Length to Total Epithelial Reticular Basement Membrane Length Ratio Measurement | ||
EROULC | C178045 | Erosion and/or Ulceration | An evaluation of the erosion and/or ulceration in a biological specimen. | Erosion and/or Ulceration Assessment | ||
ESTRCPT | C112274 | ER;ESR;Estrogen Receptor;Oestrogen Receptor | A measurement of estrogen receptor protein in a biological specimen. | Estrogen Receptor Measurement | ||
FIBROSIS | C127765 | Fibrosis | An evaluation of fibrosis in a biological specimen. | Fibrosis Assessment | ||
FOLH1 | C132431 | Folate Hydrolase 1 | A measurement of the folate hydrolase 1 in a biological specimen. | Folate Hydrolase 1 Measurement | ||
FOXP3 | C166072 | AIID;DIETER;Forkhead Box P3;Forkhead Box Protein 3;IPEX;JM2;PIDX;SCURFIN;XPID | A measurement of the forkhead box protein 3 in a biological specimen. | Forkhead Box Protein P3 Measurement | ||
GHISTXQL | C147493 | General Histopathologic Examination, Qualitative;General Histopathological Exam, Qual | A qualitative microscopic examination of tissue sections to determine the presence of pathologic finding(s). This term is intended to be used for non-targeted examinations. | Qualitative Histopathologic Examination | ||
GLOMLTIS | C135465 | Glomerulitis | An evaluation of glomerulitis in a biological specimen. | Glomerulitis Assessment | ||
GLOMPATH | C135466 | Glomerulopathy | An evaluation of glomerulopathy in a biological specimen. | Glomerulopathy Assessment | ||
GOBCE | C189621 | Goblet Cells | A measurement of the goblet cells in a biological specimen. | Goblet Cell Count | ||
GOBCEPIC | C189622 | Goblet Cells/Epithelial Cells | A relative measurement (ratio or percentage) of the goblet cells to total epithelial cells in a biological specimen. | Goblet Cell to Epithelial Cell Ratio Measurement | ||
GRNLMA | C176334 | Granuloma | An evaluation of granuloma(s) in a biological specimen. | Granuloma Assessment | ||
GZMB | C166073 | C11;CCPI;CGL1;CSPB;CTLA1;CTSGL1;Granzyme B;HLP;SECT | A measurement of the granzyme B in a biological specimen. | Granzyme B Measurement | ||
HEPBLLN | C181484 | Ballooning Degeneration;Hepatocellular Ballooning | An evaluation of hepatocellular ballooning in a biological specimen. | Hepatocellular Ballooning Assessment | ||
HER2 | C112312 | ERBB2;HER2/NEU;Human Epidermal Growth Factor Receptor 2 | A measurement of HER2 protein in a biological specimen. | Human Epidermal Growth Factor Receptor 2 Measurement | ||
HGFR | C172514 | c-Met;Hepatocyte Growth Factor Receptor;MET Proto-Oncogene, Receptor Tyrosine Kinase;Tyrosine-Protein Kinase Met | A measurement of the hepatocyte growth factor receptor in a biological specimen. | Hepatocyte Growth Factor Receptor Measurement | ||
HISTTYPC | C154802 | Histologic Type of Cancer | The determination of the histologic type of cancer in a biological specimen. | Histologic Type of Cancer | ||
HMCEADI | C191338 | Hematopoietic Cells/Adipocytes;Hematopoietic Cells/Fat Cells;Hematopoietic Cells/Lipocytes | A relative measurement (ratio) of the hematopoietic cells to adipocytes in a biological specimen. | Hematopoietic Cells to Adipocytes Ratio Measurement | ||
ICAM1 | C124345 | CD54;Intercellular Adhesion Molecule 1 | A measurement of the intercellular adhesion molecule 1 in a biological specimen. | Intercellular Adhesion Molecule 1 Measurement | ||
IENFDEN | C142347 | Intraepidermal Nerve Fiber Density | A measurement of the intraepidermal nerve fiber density in a biological specimen. | Intraepidermal Nerve Fiber Density | ||
IEPINEOA | C181490 | Epithelial Neoplasia;Intraepithelial Neoplasia | An evaluation of intraepithelial neoplasia in a biological specimen. | Intraepithelial Neoplasia Assessment | ||
INTMART | C135467 | Intimal Arteritis | An evaluation of intimal arteritis in a biological specimen. | Intimal Arteritis Assessment | ||
INTSFBRO | C135468 | Interstitial Fibrosis | An evaluation of interstitial fibrosis in a biological specimen. | Interstitial Fibrosis Assessment | ||
IRON | C74679 | FE;Iron | A measurement of the iron in a biological specimen. | Iron Measurement | ||
KI67 | C123557 | Ki-67;KI67;MKI67;pKi-67 | A measurement of the Ki-67 protein in a biological specimen. | Ki67 Measurement | ||
LCN2 | C106539 | Lipocalin-2;Neutrophil Gelatinase-Associated Lipocalin;NGAL;Oncogene 24p3 | A measurement of lipocalin-2 in a biological specimen. | Lipocalin-2 Measurement | ||
LFA1 | C176341 | Lymphocyte Function-Associated Antigen 1 | A measurement of the lymphocyte function-associated antigen 1 in a biological specimen. | Lymphocyte Function-Associated Antigen 1 Measurement | ||
LNEXCPSD | C184702 | Lymph Node Extracapsular Spread | An evaluation of lymph node extracapsular spread by the tumor in a biological specimen. | Lymph Node Extracapsular Spread Assessment | ||
LNININD | C181493 | Lymph Node Involvement Indicator | An indication as to whether cancer is present in the lymph nodes. | Lymph Node Involvement Indicator | ||
LNINNUM | C189620 | Number of Lymph Nodes Involved;Number of Lymph Nodes Positive for Neoplastic Cells | A measurement of the total number of lymph nodes that contain neoplastic cells. | Number of Lymph Nodes Involved With Neoplastic Cells | ||
LNSTATE | C124448 | Lymph Node State | A condition or state of a lymph node at a particular time. | Lymph Node State | ||
LOBLINF | C181480 | Lobular Inflammation | An evaluation of lobular inflammation in a biological specimen. | Lobular Inflammation Assessment | ||
LPGNLMLG | C181482 | Large Lipogranuloma | An evaluation of large lipogranuloma in a biological specimen. | Large Lipogranuloma Assessment | ||
LYEPIENT | C178035 | Epithelial Lymphocytes/Enterocytes;Intraepithelial Lymphocytes/Enterocytes | A relative measurement (ratio or percentage) of the lymphocytes to enterocytes within the epithelium of a biological specimen. | Intraepithelial Lymphocytes to Enterocytes Ratio Measurement | ||
LYMCE | C98751 | Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). | Lymphocyte to Total Cell Ratio Measurement | ||
LYMMCE | C74613 | Lymphoma Cells | A measurement of the malignant lymphocytes in a biological specimen. | Lymphoma Cell Count | ||
LYMMCECE | C186078 | Lymphoma Cells/Total Cells | A relative measurement (ratio or percentage) of the lymphoma cells to total cells in a biological specimen. | Lymphoma Cell to Total Cell Ratio Measurement | ||
LYMPAGG | C187947 | Lymphoid Aggregates | A measurement of the lymphoid aggregates in a biological specimen. | Lymphoid Aggregates Measurement | ||
LYMPHINV | C127766 | Lymphatic Invasion | An evaluation of lymphatic invasion in a biological specimen. | Lymphatic Invasion Assessment | ||
MALLBOD | C181488 | Mallory Body;Mallory Hyaline;Mallory's Hyaline;Mallory-Denk Body | An evaluation of Mallory bodies in a biological specimen. | Mallory Body Assessment | ||
MASTCECE | C111247 | Mast Cells/Total Cells | A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. | Mast Cell to Total Cell Ratio Measurement | ||
MCGNLM | C181481 | Microgranuloma | An evaluation of microgranuloma in a biological specimen. | Microgranuloma Assessment | ||
MCINTINF | C135469 | Mononuc Cell Interstitial Inflammation | An evaluation of mononuclear cell interstitial inflammation in a biological specimen. | Mononuclear Cell Interstitial Inflammation Assessment | ||
MEGAMITC | C181487 | Megamitochondria | An evaluation of megamitochondria in a biological specimen. | Megamitochondria Assessment | ||
MERCECE | C127628 | Erythroid Precursors/Total Cells;Maturing Erythroid Cells/Total Cells;Maturing Erythroid/Total Cells;Total Erythroid Precursors/Total Cells | A relative measurement (ratio or percentage) of the maturing erythroid cells to total cells in a biological specimen. | Maturing Erythroid Cell to Total Cell Ratio Measurement | ||
METAMYCE | C98754 | Metamyelocytes/Total Cells | A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). | Metamyelocyte to Total Cell Ratio Measurement | ||
MIEXAM | C90424 | Microscopic Examination | An assessment by microscope (e.g., light, electron, confocal, etc.). | Microscopic Examination | ||
MITOFIG | C135470 | Mitotic Figure;Mitotic Figures | A measurement of the cells containing mitotic figures in a biological specimen. | Mitotic Figure Assessment | ||
MITOSCR | C138982 | Mitotic Count Score;Mitotic Score | An evaluation of the mitotic score in a biological specimen. | Mitotic Rate Score | ||
MLH1 | C139094 | MutL Homolog 1 | A measurement of the MLH1 mismatch repair protein in a biological specimen. | MutL Homolog 1 Measurement | ||
MLH3 | C186203 | MutL Homolog 3 | A measurement of the MLH3 mismatch repair protein in a biological specimen. | MutL Homolog 3 Measurement | ||
MMRPINTP | C139093 | Mismatch Repair Proteins Interpretation | The determination of the meaning of protein expression assessments across multiple mismatch repair proteins. | Mismatch Repair Proteins Interpretation | ||
MMRPROT | C185932 | Mismatch Repair Proteins;MMR Proteins | An evaluation of the mismatch repair proteins in a biological specimen. | Mismatch Repair Protein Measurement | ||
MNC | C154757 | Mononuclear Cells;Mononucleated Cells | A measurement of the mononuclear cells in a biological specimen. | Mononuclear Cell Count | ||
MNCINLLP | C178038 | Infilt of Mono Cells in Lamina Propria;Infiltration of Mononuclear Cells in Lamina Propria | An evaluation of infiltration of mononuclear cells in the lamina propria in a biological specimen. | Infiltration of Mononuclear Cells in Lamina Propria Assessment | ||
MONOBLCE | C187677 | Monoblasts/Total Cells | A relative measurement (ratio or percentage) of the monoblasts to total cells in a biological specimen. | Monoblast to Total Cell Ratio Measurement | ||
MONOCE | C98872 | Monocytes/Total Cells | A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). | Monocytes to Total Cell Ratio Measurement | ||
MPHGPIG | C181486 | Macrophage, Pigmented;Pigmented Macrophage | An evaluation of pigmented macrophages in a biological specimen. | Pigmented Macrophage Assessment | ||
MSH2 | C139095 | MutS Homolog 2 | A measurement of the MSH2 mismatch repair protein in a biological specimen. | MutS Homolog 2 Measurement | ||
MSH3 | C186204 | MutS Homolog 3 | A measurement of the MSH3 mismatch repair protein in a biological specimen. | MutS Homolog 3 Measurement | ||
MSH6 | C139096 | MutS Homolog 6 | A measurement of the MSH6 mismatch repair protein in a biological specimen. | MutS Homolog 6 Measurement | ||
MSNGMTRX | C135471 | Mesangial Matrix | An evaluation of mesangial matrix in a biological specimen. | Mesangial Matrix Assessment | ||
MVSTS | C181479 | Microvesicular Steatosis | An evaluation of microvesicular steatosis in a biological specimen. | Microvesicular Steatosis Assessment | ||
MYCYCE | C98868 | Myelocytes/Total Cells | A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). | Myelocyte to Total Cell Ratio Measurement | ||
MYFIBROS | C154803 | Myelofibrosis | An evaluation of myelofibrosis in a biological specimen. | Myelofibrosis Assessment | ||
NCRPLEOM | C181492 | Nuclear Pleomorphism | An evaluation of nuclear pleomorphism in a biological specimen. | Nuclear Pleomorphism Assessment | ||
NEOCE | C154801 | Neoplastic Cells | A measurement of the neoplastic cells in a biological specimen. | Tumor Cell Count | ||
NEOCECE | C123556 | Cancer Cellularity;Neoplastic Cells/Total Cells;Tumor Cells/Total Cells | A relative measurement (ratio or percentage) of the neoplastic cells to total cells in a biological specimen. | Cancer Cellularity Measurement | ||
NEUTBCE | C187701 | Neutrophils Band Form/Total Cells | A relative measurement (ratio or percentage) of the banded neutrophils to total cells in a biological specimen. | Neutrophil Band Form to Total Cell Ratio Measurement | ||
NEUTEPI | C178044 | Neutrophils in Epithelium | An evaluation of neutrophils in the epithelium in a biological specimen. | Neutrophils in Epithelium Assessment | ||
NEUTLP | C178043 | Lamina Propria Neutrophils;Neutrophils in Lamina Propria | An evaluation of neutrophils in the lamina propria in a biological specimen. | Neutrophils in Lamina Propria Assessment | ||
NEUTSGCE | C187679 | Neutrophils, Segmented/Total Cells | A relative measurement (ratio or percentage) of segmented neutrophils to total cells in a biological specimen. | Segmented Neutrophil to Total Cell Ratio Measurement | ||
NKX2_1 | C123558 | NK2 Homeobox 1;TEBP;Thyroid Transcription Factor 1;TTF1 | A measurement of NK2 homeobox 1 protein in a biological specimen. | NK2 Homeobox 1 Measurement | ||
NORMCECE | C127767 | Normal Cells/Total Cells | A relative measurement (ratio or percentage) of the normal cells to total cells in a biological specimen. | Normal Cell to Total Cell Ratio Measurement | ||
NT5E | C181656 | 5'-NT;5'-Nucleotidase;5'-Nucleotidase Ecto;CD73;E5NT;Ecto-5'-Nucleotidase | A measurement of ecto-5'-nucleotidase in a biological specimen. | Ecto-5'-Nucleotidase Measurement | ||
NUCLGLCG | C181489 | Glycogenated Nuclei;Nuclei, Glycogenated | An evaluation of glycogenated nuclei in a biological specimen. | Glycogenated Nuclei Assessment | ||
OVLTGRD | C18000 | Histologic Grade;Overall Tumor Grade;Tumor Grade | An assigned tumor grade based on a defined scoring system. | Histologic Grade | ||
P16INK4A | C179766 | CDK4I;Cyclin Dependent Kinase Inhibitor 2A p16;p16;p16 Inhibitors of CDK4;p16-INK4a | A measurement of the p16-INK4A in a biological specimen. | p16-INK4A Measurement | ||
P53 | C186205 | Tumor Protein p53 | A measurement of the tumor protein p53 in a biological specimen. | Cellular Tumor Antigen p53 Measurement | ||
PAP | C80204 | Prostatic Acid Phosphatase | A measurement of the prostatic acid phosphatase in a biological specimen. | Prostatic Acid Phosphatase Measurement | ||
PAX3FKHR | C142348 | PAX3-FKHR Fusion Protein | A measurement of the PAX3-FKHR fusion protein in a biological specimen. | PAX3-FKHR Fusion Protein Measurement | ||
PCTISCA | C123559 | Percentage of In situ Carcinoma | A relative measurement (percentage) of in situ component present in a carcinoma compared to the entire malignant cellular proliferation. (NCI) | Percentage of in situ Carcinoma | ||
PDL1 | C154807 | CD274;PD-L1;Programmed Cell Death 1 Ligand 1;Programmed Death Ligand 1 | A measurement of the programmed death ligand 1 in a biological specimen. | Programmed Death Ligand 1 Measurement | ||
PECAM1 | C135472 | CD31;CD31 Antigen;PECAM;PECAM-1;PECAM1;Platelet And Endothelial Cell Adhesion Molecule 1;Platelet Endo Cell Adhesion Molecule 1;Platelet Endothelial Adhesion Molecule | A measurement of the platelet and endothelial cell adhesion molecule 1 in a biological specimen. | Platelet Endothelial Cell Adhesion Molecule 1 Measurement | ||
PLSTCECE | C98869 | Mature Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). | Mature Plasma Cell to Total Cell Ratio Measurement | ||
PMLIGCE | C184700 | Precancerous Cells;Premalignant Lesions | An evaluation of premalignant cells in a biological specimen. | Premalignant Cell Count | ||
PMLIGCEM | C184701 | Premalignant Cell Morphology | An examination or assessment of the form and structure of premalignant cells. | Premalignant Cell Morphology Assessment | ||
PMNEPI | C178040 | Polymorphonuclear Cells in Epithelium | An evaluation of polymorphonuclear cells in the epithelium in a biological specimen. | Polymorphonuclear Cells in Epithelium Assessment | ||
PMNINLLP | C178039 | Infilt of PMN Cells in Lamina Propria;Infiltration of Polymorphonuclear Cells in Lamina Propria | An evaluation of infiltration of polymorphonuclear cells in the lamina propria in a biological specimen. | Infiltration of Polymorphonuclear Cells in Lamina Propria Assessment | ||
PMS1 | C186206 | PMS1 Homolog 1 | A measurement of the PMS1 mismatch repair protein in a biological specimen. | PMS1 Homolog 1 Measurement | ||
PMS2 | C139097 | PMS1 Homolog 2 | A measurement of the PMS2 mismatch repair protein in a biological specimen. | PMS1 Homolog 2 Measurement | ||
PMYCECE | C127634 | Proliferating Myeloid Cells/Total Cells | A relative measurement (ratio or percentage) of the proliferating myeloid cells to total cells in a biological specimen. | Proliferating Myeloid Cell to Total Cell Ratio Measurement | ||
PNLINV | C127768 | Perineural Invasion | An evaluation of perineural invasion in a biological specimen. | Perineural Invasion Assessment | ||
PNTHCEMP | C176339 | Paneth Cell Metaplasia | An evaluation of paneth cell metaplasia in a biological specimen. | Paneth Cell Metaplasia Assessment | ||
PORTINF | C181483 | Portal Inflammation | An evaluation of portal inflammation in a biological specimen. | Portal Inflammation Assessment | ||
PROGESTR | C117846 | NR3C3;PGR;PgR;PR;Progesterone Receptor | A measurement of the progesterone receptor protein in a biological specimen. | Progesterone Receptor Measurement | ||
PROMONCE | C187678 | Promonocytes/Total Cells | A relative measurement (ratio or percentage) of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen). | Promonocyte to Total Cell Ratio Measurement | ||
PROMYCE | C98773 | Promyelocytes/Total Cells | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). | Promyelocyte to Total Cell Ratio Measurement | ||
PTBCPLTS | C135473 | Peritubular Capillaritis | An evaluation of peritubular capillaritis in a biological specimen. | Peritubular Capillaritis Assessment | ||
PTEN | C147470 | Phosphatase and Tensin Homolog | A measurement of the phosphatase and tensin homolog in a biological specimen. | Phosphatase and Tensin Homolog Measurement | ||
PYKCE | C189346 | Karyopyknotic Cells;Pyknotic Cells | A measurement of the pyknotic cells in a biological specimen. | Pyknotic Cell Count | ||
PYSACMSB | C178047 | Polysaccharides and Mucosubstances | A measurement of the polysaccharides and mucosubstances in a biological specimen. | Polysaccharides and Mucosubstances Measurement | ||
RETICE | C187680 | Reticulocytes/Total Cells | A relative measurement (ratio or percentage) of reticulocytes to total cells in a biological specimen. | Reticulocyte to Total Cell Ratio Measurement | ||
ROS1 | C154804 | ROS Proto-oncogene 1 Protein;ROS1 Protein | A measurement of the ROS proto-oncogene 1 protein in a biological specimen. | ROS1 Protein Measurement | ||
S100A7 | C127769 | S100 Calcium Binding Protein A7 | A measurement of the S100 calcium binding protein A7 in a biological specimen. | S100 Calcium Binding Protein A7 Measurement | ||
SGMGIREG | C177569 | Surgical Margin Involvement Region | The anatomical region or plane containing neoplastic tissue that has been left outside the boundary of a resected specimen within the patient. | Anatomic Site for Involved Surgical Margin | ||
SGMGSTAT | C123560 | Surgical Margins Status | The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. (NCI) | Surgical Margins Status | ||
SMUSCAB | C111317 | Anti-Smooth Muscle Antibody;Smooth Muscle Antibody | A measurement of the total smooth muscle antibody in a biological specimen. | Smooth Muscle Antibody Measurement | ||
STRMCECE | C127770 | Stromal Cells/Total Cells | A relative measurement (ratio or percentage) of the stromal cells to total cells in a biological specimen. | Stromal Cell to Total Cell Ratio Measurement | ||
STSEXT | C181477 | Steatosis Extent;Steatosis Grade | An evaluation of the amount or degree of steatosis (fatty tissue) in a biological specimen. | Steatosis Extent | ||
STSLOC | C181478 | Steatosis Location | An evaluation of the predominant distribution pattern of steatosis (fatty tissue) in a biological specimen. | Steatosis Location | ||
TBLFRM | C181491 | Tubule Formation | An evaluation of tubule formation in a biological specimen. | Tubule Formation Assessment | ||
TGFB1 | C117861 | Transforming Growth Factor Beta 1 | A measurement of the transforming growth factor beta 1 in a biological specimen. | Transforming Growth Factor Beta 1 Measurement | ||
THICK | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
TISABNUM | C176340 | Number of Abnormal Tissue Samples | The total number of tissue samples in which a pathological abnormality has been observed. | Number of Abnormal Tissue Samples | ||
TMBRDCFG | C187951 | Invasive Margin;Tumor Border Configuration;Tumor Margin Configuration | An evaluation of the morphologic appearance at the point where the tumor meets adjacent, non-tumor tissue. | Tumor Margin Configuration Assessment | ||
TMDIFF | C187949 | Tumor Differentiation | An evaluation of the tissue architecture of the tumor in comparison to the non-pathological tissue the tumor arose from. | Tumor Differentiation Assessment | ||
TMINLPTN | C187950 | Tumor Infiltration Pattern | An evaluation of the tumor infiltration pattern in a biological specimen. | Tumor Infiltration Pattern Assessment | ||
TRCETMCE | C154800 | Transitional Cells/Tumor Cells | A relative measurement (ratio or percentage) of the transitional cells to the tumor cells in a biological specimen. | Transitional Cell to Tumor Cell Ratio Measurement | ||
TUBATRO | C135474 | Tubular Atrophy | An evaluation of tubular atrophy in a biological specimen. | Tubular Atrophy Assessment | ||
TUBULTIS | C135475 | Tubulitis | An evaluation of tubulitis in a biological specimen. | Tubulitis Assessment | ||
TUMRGR | C178046 | Tumor Regression | An evaluation of tumor regression in a biological specimen. | Tumor Regression Assessment | ||
ULCER | C176333 | Ulceration | An evaluation of ulceration in a biological specimen. | Ulceration Assessment | ||
VASINV | C127772 | Vascular Invasion | An evaluation of vascular invasion in a biological specimen. | Vascular Invasion Assessment | ||
VFBINTMT | C135476 | Vascular Fibrous Intimal Thickening | An evaluation of the fibrointimal thickening of vessels in a biological specimen. | Vascular Fibrous Intimal Thickening Assessment | ||
Back to top | ||||||
CL.C132262.MITS | SDTM Microscopic Findings Test Name
(MITS) | text
Extensible: Yes | C132262 | SDTM Microscopic Findings Test Name | Terminology for the test names concerned with the clinical findings from a specimen that are visible by microscopic analysis. | CDISC SDTM Microscopic Findings Test Name Terminology |
Abnormal Cells | C111124 | Abnormal Cells | A measurement of the abnormal cells in a biological specimen. | Abnormal Cell Count | ||
Acidophil Body | C181485 | Acidophil Bodies;Acidophil Body | An evaluation of acidophil bodies in a biological specimen. | Acidophil Body Assessment | ||
ALK Protein | C154805 | ALK Protein | A measurement of the ALK receptor tyrosine kinase in a biological specimen. | ALK Protein Measurement | ||
Alpha-Methylacyl Coenzyme A Racemase | C132364 | Alpha-Methylacyl Coenzyme A Racemase | A measurement of the alpha-methylacyl coenzyme A racemase in a biological specimen. | Alpha-Methylacyl Coenzyme A Racemase Measurement | ||
Androgen Receptor Variant 7 | C184703 | Androgen Receptor Variant 7;AR-V7 | A measurement of the androgen receptor variant 7 in a biological specimen. | Androgen Receptor Variant 7 Measurement | ||
Apoptotic Cells | C181495 | Apoptotic Cells | A measurement of the apoptotic cells in a biological specimen. | Apoptotic Cell Count | ||
Apoptotic Cells/Total Cells | C181494 | Apoptotic Cells/Total Cells | A relative measurement (ratio or percentage) of the apoptotic cells to total cells in a biological specimen. | Apoptotic Cell to Total Cell Count | ||
Architectural Changes | C178037 | Architectural Changes | An evaluation of tissue architectural changes in a biological specimen. | Architectural Changes Assessment | ||
Arteriolar Hyaline Thickening | C135463 | Arteriolar Hyaline Thickening | An evaluation of the arteriolar hyaline thickening of vessels in a biological specimen. | Arteriolar Hyaline Thickening Assessment | ||
Banff Diagnostic Category Renal | C135464 | Banff Diagnostic Category Renal | The histologic evaluation and diagnosis of the type of renal allograft rejection based on kidney biopsies and the Banff Working Classification from the Banff Foundation for Allograft Pathology. (NCI) | Banff Renal Diagnostic Category Assessment | ||
Basophils/Total Cells | C98865 | Basophils/Total Cells | A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). | Basophil to Total Cell Ratio Measurement | ||
Beta-defensin 1 | C156546 | Beta-defensin 1 | A measurement of the beta-defensin 1 in a biological specimen. | Beta-defensin 1 Measurement | ||
Beta-defensin 2 | C122102 | Beta-defensin 2 | A measurement of the beta-defensin 2 in a biological specimen. | Beta-defensin 2 Measurement | ||
Blasts/Total Cells | C150836 | Blasts/Total Cells | A relative measurement (ratio or percentage) of the blasts to total cells in a biological specimen. | Blasts to Total Cells Ratio Measurement | ||
Blood Vessel Density | C156545 | Blood Vessel Density | An evaluation of the blood vessel density in a biological specimen. | Blood Vessel Density | ||
Bradykinin Receptor B1 | C139099 | BK-1 Receptor;Bradykinin Receptor B1 | A measurement of the bradykinin receptor B1 in a biological specimen. | Bradykinin Receptor B1 Measurement | ||
Breast Cancer Type 1 Susceptibility Prot | C123555 | Breast Cancer Type 1 Susceptibility Prot | A measurement of BRCA1 protein in a biological specimen. | Breast Cancer Type 1 Susceptibility Protein Measurement | ||
CD20 | C103368 | CD20;CD20 Expressing Cells | A count of the CD20 expressing cells per unit in a biological specimen. | CD20 Expressing Cell Measurement | ||
CD3 | C103809 | CD3;CD3 Expressing Cells | A count of the CD3 expressing cells per unit in a biological specimen. | CD3 Expressing Cell Count | ||
CD4 | C103810 | CD4;CD4 Expressing Cells | A count of the CD4 expressing cells per unit in a biological specimen. | CD4 Expressing Cell Count | ||
CD56 | C103370 | CD56;CD56 Expressing Cells | A count of the CD56 expressing cells per unit of a biological specimen. | CD56 Expressing Cell Measurement | ||
CD68 | C156544 | CD68;CD68 Expressing Cells | A count of the CD68 expressing cells per unit in a biological specimen. | CD68 Expressing Cell Count | ||
CD8 | C103811 | CD8;CD8 Expressing Cells | A count of the CD8 expressing cells per unit in a biological specimen. | CD8 Expressing Cell Count | ||
CDX2 Antigen | C139098 | CDX2 Antigen | A measurement of the CDX2 antigen in a biological specimen. | CDX2 Antigen Measurement | ||
Cell Distribution | C187946 | Cell Distribution | An interpretive assessment of the proportion of various cell types in a biological specimen. | Cell Distribution Measurement | ||
Cellular Differentiation | C132430 | Cellular Differentiation | An evaluation of cellular maturity and specialization in a biological specimen. | Cellular Differentiation Assessment | ||
Cellularity | C111153 | Cellularity;Cellularity Grade | A measurement of the degree, quality or condition of cells in a biological specimen. | Cellularity Measurement | ||
Chronic Inflammatory Infiltrate | C178042 | Chronic Inflammatory Infiltrate | An evaluation of chronic inflammatory infiltrate in a biological specimen. | Chronic Inflammatory Infiltrate Assessment | ||
Crypt Abscess | C176336 | Crypt Abscess | An evaluation of crypt abscess in a biological specimen. | Crypt Abscess Assessment | ||
Crypt Architectural Damage | C176337 | Crypt Architectural Damage | An evaluation of the extent of the architectural damage to the crypts in a biological specimen. | Crypt Architectural Damage Assessment | ||
Cryptitis | C176335 | Cryptitis | An evaluation of cryptitis in a biological specimen. | Cryptitis Assessment | ||
Cytogenetic Examination | C18280 | Cytogenetic Examination | An assessment by microscopic analysis of chromosomal and subchromosomal structure and function. | Cytogenetic Analysis | ||
Cytokeratin 16 | C127763 | Cytokeratin 16 | A measurement of the cytokeratin 16 in a biological specimen. | Cytokeratin 16 Measurement | ||
Dendritic Cell-Lysosomal-Assoc Memb Prot | C127764 | Dendritic Cell-Lysosomal-Assoc Memb Prot | A measurement of the dendritic cell-lysosomal-associated membrane protein in a biological specimen. | Dendritic Cell Lysosomal-Associated Membrane Protein Measurement | ||
Diagnosis | C15220 | Diagnostic | The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results or summary of such an investigation. (NCI) | Diagnosis | ||
Ecto-5'-Nucleotidase | C181656 | 5'-NT;5'-Nucleotidase;5'-Nucleotidase Ecto;CD73;E5NT;Ecto-5'-Nucleotidase | A measurement of ecto-5'-nucleotidase in a biological specimen. | Ecto-5'-Nucleotidase Measurement | ||
EGFR Variant Protein | C154806 | EGFR Variant Protein | A measurement of the EGFR protein with a specified variation(s) (mutations, deletions, insertions, etc.) in a biological specimen. | EGFR Variant Protein Measurement | ||
Eosinophils/Total Cells | C98720 | Eosinophils/Total Cells | A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). | Eosinophils to Total Cell Ratio Measurement | ||
Epi RBM Lngth, Intact/Epi RBM Lngth, Tot | C156547 | Epi RBM Lngth, Intact/Epi RBM Lngth, Tot;Epithelial RBM Length, Intact/Epithelial RBM Length, Total | A relative measurement (ratio or percentage) of the intact epithelial reticular basement membrane length to the total epithelial reticular basement membrane length in a biological specimen. | Intact Epithelial Reticular Basement Membrane Length to Total Epithelial Reticular Basement Membrane Length Ratio Measurement | ||
Epidermal Growth Factor Receptor | C112273 | Epidermal Growth Factor Receptor;ERBB1;HER1 | A measurement of the epidermal growth factor receptor in a biological specimen. | Epidermal Growth Factor Receptor Measurement | ||
Epithelial Damage | C178036 | Epithelial Damage | An evaluation of epithelial damage in a biological specimen. | Epithelial Damage Assessment | ||
Epithelial Integrity | C176338 | Epithelial Integrity | An evaluation of the integrity of the epithelium in a biological specimen. | Epithelial Integrity Assessment | ||
Erosion and/or Ulceration | C178045 | Erosion and/or Ulceration | An evaluation of the erosion and/or ulceration in a biological specimen. | Erosion and/or Ulceration Assessment | ||
Estrogen Receptor | C112274 | ER;ESR;Estrogen Receptor;Oestrogen Receptor | A measurement of estrogen receptor protein in a biological specimen. | Estrogen Receptor Measurement | ||
Extramural Venous Invasion | C184699 | Extramural Venous Invasion | An evaluation of extramural venous invasion in a biological specimen. | Extramural Venous Invasion Assessment | ||
Fibrosis | C127765 | Fibrosis | An evaluation of fibrosis in a biological specimen. | Fibrosis Assessment | ||
Folate Hydrolase 1 | C132431 | Folate Hydrolase 1 | A measurement of the folate hydrolase 1 in a biological specimen. | Folate Hydrolase 1 Measurement | ||
Forkhead Box Protein 3 | C166072 | AIID;DIETER;Forkhead Box P3;Forkhead Box Protein 3;IPEX;JM2;PIDX;SCURFIN;XPID | A measurement of the forkhead box protein 3 in a biological specimen. | Forkhead Box Protein P3 Measurement | ||
General Histopathologic Exam, Qual | C147493 | General Histopathologic Examination, Qualitative;General Histopathological Exam, Qual | A qualitative microscopic examination of tissue sections to determine the presence of pathologic finding(s). This term is intended to be used for non-targeted examinations. | Qualitative Histopathologic Examination | ||
Glomerulitis | C135465 | Glomerulitis | An evaluation of glomerulitis in a biological specimen. | Glomerulitis Assessment | ||
Glomerulopathy | C135466 | Glomerulopathy | An evaluation of glomerulopathy in a biological specimen. | Glomerulopathy Assessment | ||
Goblet Cells | C189621 | Goblet Cells | A measurement of the goblet cells in a biological specimen. | Goblet Cell Count | ||
Goblet Cells/Epithelial Cells | C189622 | Goblet Cells/Epithelial Cells | A relative measurement (ratio or percentage) of the goblet cells to total epithelial cells in a biological specimen. | Goblet Cell to Epithelial Cell Ratio Measurement | ||
Granuloma | C176334 | Granuloma | An evaluation of granuloma(s) in a biological specimen. | Granuloma Assessment | ||
Granzyme B | C166073 | C11;CCPI;CGL1;CSPB;CTLA1;CTSGL1;Granzyme B;HLP;SECT | A measurement of the granzyme B in a biological specimen. | Granzyme B Measurement | ||
Hematopoietic Cells/Adipocytes | C191338 | Hematopoietic Cells/Adipocytes;Hematopoietic Cells/Fat Cells;Hematopoietic Cells/Lipocytes | A relative measurement (ratio) of the hematopoietic cells to adipocytes in a biological specimen. | Hematopoietic Cells to Adipocytes Ratio Measurement | ||
Hepatocellular Ballooning | C181484 | Ballooning Degeneration;Hepatocellular Ballooning | An evaluation of hepatocellular ballooning in a biological specimen. | Hepatocellular Ballooning Assessment | ||
Hepatocyte Growth Factor Receptor | C172514 | c-Met;Hepatocyte Growth Factor Receptor;MET Proto-Oncogene, Receptor Tyrosine Kinase;Tyrosine-Protein Kinase Met | A measurement of the hepatocyte growth factor receptor in a biological specimen. | Hepatocyte Growth Factor Receptor Measurement | ||
Histologic Type of Cancer | C154802 | Histologic Type of Cancer | The determination of the histologic type of cancer in a biological specimen. | Histologic Type of Cancer | ||
Human Epidermal Growth Factor Receptor 2 | C112312 | ERBB2;HER2/NEU;Human Epidermal Growth Factor Receptor 2 | A measurement of HER2 protein in a biological specimen. | Human Epidermal Growth Factor Receptor 2 Measurement | ||
Infilt of Mono Cells in Lamina Propria | C178038 | Infilt of Mono Cells in Lamina Propria;Infiltration of Mononuclear Cells in Lamina Propria | An evaluation of infiltration of mononuclear cells in the lamina propria in a biological specimen. | Infiltration of Mononuclear Cells in Lamina Propria Assessment | ||
Infilt of PMN Cells in Lamina Propria | C178039 | Infilt of PMN Cells in Lamina Propria;Infiltration of Polymorphonuclear Cells in Lamina Propria | An evaluation of infiltration of polymorphonuclear cells in the lamina propria in a biological specimen. | Infiltration of Polymorphonuclear Cells in Lamina Propria Assessment | ||
Intercellular Adhesion Molecule 1 | C124345 | CD54;Intercellular Adhesion Molecule 1 | A measurement of the intercellular adhesion molecule 1 in a biological specimen. | Intercellular Adhesion Molecule 1 Measurement | ||
Interstitial Fibrosis | C135468 | Interstitial Fibrosis | An evaluation of interstitial fibrosis in a biological specimen. | Interstitial Fibrosis Assessment | ||
Intimal Arteritis | C135467 | Intimal Arteritis | An evaluation of intimal arteritis in a biological specimen. | Intimal Arteritis Assessment | ||
Intraepidermal Nerve Fiber Density | C142347 | Intraepidermal Nerve Fiber Density | A measurement of the intraepidermal nerve fiber density in a biological specimen. | Intraepidermal Nerve Fiber Density | ||
Intraepithelial Lymphocytes/Enterocytes | C178035 | Epithelial Lymphocytes/Enterocytes;Intraepithelial Lymphocytes/Enterocytes | A relative measurement (ratio or percentage) of the lymphocytes to enterocytes within the epithelium of a biological specimen. | Intraepithelial Lymphocytes to Enterocytes Ratio Measurement | ||
Intraepithelial Neoplasia | C181490 | Epithelial Neoplasia;Intraepithelial Neoplasia | An evaluation of intraepithelial neoplasia in a biological specimen. | Intraepithelial Neoplasia Assessment | ||
Iron | C74679 | FE;Iron | A measurement of the iron in a biological specimen. | Iron Measurement | ||
Ki-67 | C123557 | Ki-67;KI67;MKI67;pKi-67 | A measurement of the Ki-67 protein in a biological specimen. | Ki67 Measurement | ||
Large Lipogranuloma | C181482 | Large Lipogranuloma | An evaluation of large lipogranuloma in a biological specimen. | Large Lipogranuloma Assessment | ||
Lipocalin-2 | C106539 | Lipocalin-2;Neutrophil Gelatinase-Associated Lipocalin;NGAL;Oncogene 24p3 | A measurement of lipocalin-2 in a biological specimen. | Lipocalin-2 Measurement | ||
Lobular Inflammation | C181480 | Lobular Inflammation | An evaluation of lobular inflammation in a biological specimen. | Lobular Inflammation Assessment | ||
Lymph Node Extracapsular Spread | C184702 | Lymph Node Extracapsular Spread | An evaluation of lymph node extracapsular spread by the tumor in a biological specimen. | Lymph Node Extracapsular Spread Assessment | ||
Lymph Node Involvement Indicator | C181493 | Lymph Node Involvement Indicator | An indication as to whether cancer is present in the lymph nodes. | Lymph Node Involvement Indicator | ||
Lymph Node State | C124448 | Lymph Node State | A condition or state of a lymph node at a particular time. | Lymph Node State | ||
Lymphatic Invasion | C127766 | Lymphatic Invasion | An evaluation of lymphatic invasion in a biological specimen. | Lymphatic Invasion Assessment | ||
Lymphocyte Function-Associated Antigen 1 | C176341 | Lymphocyte Function-Associated Antigen 1 | A measurement of the lymphocyte function-associated antigen 1 in a biological specimen. | Lymphocyte Function-Associated Antigen 1 Measurement | ||
Lymphocytes/Total Cells | C98751 | Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). | Lymphocyte to Total Cell Ratio Measurement | ||
Lymphoid Aggregates | C187947 | Lymphoid Aggregates | A measurement of the lymphoid aggregates in a biological specimen. | Lymphoid Aggregates Measurement | ||
Lymphoma Cells | C74613 | Lymphoma Cells | A measurement of the malignant lymphocytes in a biological specimen. | Lymphoma Cell Count | ||
Lymphoma Cells/Total Cells | C186078 | Lymphoma Cells/Total Cells | A relative measurement (ratio or percentage) of the lymphoma cells to total cells in a biological specimen. | Lymphoma Cell to Total Cell Ratio Measurement | ||
Macrophage, Pigmented | C181486 | Macrophage, Pigmented;Pigmented Macrophage | An evaluation of pigmented macrophages in a biological specimen. | Pigmented Macrophage Assessment | ||
Mallory Body | C181488 | Mallory Body;Mallory Hyaline;Mallory's Hyaline;Mallory-Denk Body | An evaluation of Mallory bodies in a biological specimen. | Mallory Body Assessment | ||
Mast Cells/Total Cells | C111247 | Mast Cells/Total Cells | A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. | Mast Cell to Total Cell Ratio Measurement | ||
Maturing Erythroid/Total Cells | C127628 | Erythroid Precursors/Total Cells;Maturing Erythroid Cells/Total Cells;Maturing Erythroid/Total Cells;Total Erythroid Precursors/Total Cells | A relative measurement (ratio or percentage) of the maturing erythroid cells to total cells in a biological specimen. | Maturing Erythroid Cell to Total Cell Ratio Measurement | ||
Megakaryoblasts/Total Cells | C98753 | Megakaryoblasts/Total Cells | A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryoblast to Total Cell Ratio Measurement | ||
Megamitochondria | C181487 | Megamitochondria | An evaluation of megamitochondria in a biological specimen. | Megamitochondria Assessment | ||
Mesangial Matrix | C135471 | Mesangial Matrix | An evaluation of mesangial matrix in a biological specimen. | Mesangial Matrix Assessment | ||
Metamyelocytes/Total Cells | C98754 | Metamyelocytes/Total Cells | A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). | Metamyelocyte to Total Cell Ratio Measurement | ||
Microgranuloma | C181481 | Microgranuloma | An evaluation of microgranuloma in a biological specimen. | Microgranuloma Assessment | ||
Microscopic Examination | C90424 | Microscopic Examination | An assessment by microscope (e.g., light, electron, confocal, etc.). | Microscopic Examination | ||
Microvesicular Steatosis | C181479 | Microvesicular Steatosis | An evaluation of microvesicular steatosis in a biological specimen. | Microvesicular Steatosis Assessment | ||
Mismatch Repair Proteins Interpretation | C139093 | Mismatch Repair Proteins Interpretation | The determination of the meaning of protein expression assessments across multiple mismatch repair proteins. | Mismatch Repair Proteins Interpretation | ||
Mitotic Figure | C135470 | Mitotic Figure;Mitotic Figures | A measurement of the cells containing mitotic figures in a biological specimen. | Mitotic Figure Assessment | ||
Mitotic Score | C138982 | Mitotic Count Score;Mitotic Score | An evaluation of the mitotic score in a biological specimen. | Mitotic Rate Score | ||
MMR Proteins | C185932 | Mismatch Repair Proteins;MMR Proteins | An evaluation of the mismatch repair proteins in a biological specimen. | Mismatch Repair Protein Measurement | ||
Monoblasts/Total Cells | C187677 | Monoblasts/Total Cells | A relative measurement (ratio or percentage) of the monoblasts to total cells in a biological specimen. | Monoblast to Total Cell Ratio Measurement | ||
Monocytes/Total Cells | C98872 | Monocytes/Total Cells | A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). | Monocytes to Total Cell Ratio Measurement | ||
Mononuc Cell Interstitial Inflammation | C135469 | Mononuc Cell Interstitial Inflammation | An evaluation of mononuclear cell interstitial inflammation in a biological specimen. | Mononuclear Cell Interstitial Inflammation Assessment | ||
Mononuclear Cells | C154757 | Mononuclear Cells;Mononucleated Cells | A measurement of the mononuclear cells in a biological specimen. | Mononuclear Cell Count | ||
MutL Homolog 1 | C139094 | MutL Homolog 1 | A measurement of the MLH1 mismatch repair protein in a biological specimen. | MutL Homolog 1 Measurement | ||
MutL Homolog 3 | C186203 | MutL Homolog 3 | A measurement of the MLH3 mismatch repair protein in a biological specimen. | MutL Homolog 3 Measurement | ||
MutS Homolog 2 | C139095 | MutS Homolog 2 | A measurement of the MSH2 mismatch repair protein in a biological specimen. | MutS Homolog 2 Measurement | ||
MutS Homolog 3 | C186204 | MutS Homolog 3 | A measurement of the MSH3 mismatch repair protein in a biological specimen. | MutS Homolog 3 Measurement | ||
MutS Homolog 6 | C139096 | MutS Homolog 6 | A measurement of the MSH6 mismatch repair protein in a biological specimen. | MutS Homolog 6 Measurement | ||
Myeloblasts/Total Cells | C98761 | Myeloblasts/Total Cells | A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). | Myeloblast to Total Cell Ratio Measurement | ||
Myelocytes/Total Cells | C98868 | Myelocytes/Total Cells | A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). | Myelocyte to Total Cell Ratio Measurement | ||
Myelofibrosis | C154803 | Myelofibrosis | An evaluation of myelofibrosis in a biological specimen. | Myelofibrosis Assessment | ||
Neoplastic Cells | C154801 | Neoplastic Cells | A measurement of the neoplastic cells in a biological specimen. | Tumor Cell Count | ||
Neoplastic Cells/Total Cells | C123556 | Cancer Cellularity;Neoplastic Cells/Total Cells;Tumor Cells/Total Cells | A relative measurement (ratio or percentage) of the neoplastic cells to total cells in a biological specimen. | Cancer Cellularity Measurement | ||
Neutrophils Band Form/Total Cells | C187701 | Neutrophils Band Form/Total Cells | A relative measurement (ratio or percentage) of the banded neutrophils to total cells in a biological specimen. | Neutrophil Band Form to Total Cell Ratio Measurement | ||
Neutrophils in Epithelium | C178044 | Neutrophils in Epithelium | An evaluation of neutrophils in the epithelium in a biological specimen. | Neutrophils in Epithelium Assessment | ||
Neutrophils in Lamina Propria | C178043 | Lamina Propria Neutrophils;Neutrophils in Lamina Propria | An evaluation of neutrophils in the lamina propria in a biological specimen. | Neutrophils in Lamina Propria Assessment | ||
Neutrophils, Segmented/Total Cells | C187679 | Neutrophils, Segmented/Total Cells | A relative measurement (ratio or percentage) of segmented neutrophils to total cells in a biological specimen. | Segmented Neutrophil to Total Cell Ratio Measurement | ||
NK2 Homeobox 1 | C123558 | NK2 Homeobox 1;TEBP;Thyroid Transcription Factor 1;TTF1 | A measurement of NK2 homeobox 1 protein in a biological specimen. | NK2 Homeobox 1 Measurement | ||
Normal Cells/Total Cells | C127767 | Normal Cells/Total Cells | A relative measurement (ratio or percentage) of the normal cells to total cells in a biological specimen. | Normal Cell to Total Cell Ratio Measurement | ||
Nuclear Pleomorphism | C181492 | Nuclear Pleomorphism | An evaluation of nuclear pleomorphism in a biological specimen. | Nuclear Pleomorphism Assessment | ||
Nuclei, Glycogenated | C181489 | Glycogenated Nuclei;Nuclei, Glycogenated | An evaluation of glycogenated nuclei in a biological specimen. | Glycogenated Nuclei Assessment | ||
Number of Abnormal Tissue Samples | C176340 | Number of Abnormal Tissue Samples | The total number of tissue samples in which a pathological abnormality has been observed. | Number of Abnormal Tissue Samples | ||
Number of Biopsy Specimens Affected | C178041 | Number of Biopsy Specimens Affected | The total number of biopsy specimens in which a finding has been observed. | Number of Biopsy Specimens Affected | ||
Number of Lymph Nodes Involved | C189620 | Number of Lymph Nodes Involved;Number of Lymph Nodes Positive for Neoplastic Cells | A measurement of the total number of lymph nodes that contain neoplastic cells. | Number of Lymph Nodes Involved With Neoplastic Cells | ||
Number of Malignant Biopsy Cores | C139092 | Number of Malignant Biopsy Cores | A measurement of the total number of core biopsies that contain malignant tissue. (NCI) | Number of Malignant Biopsy Cores | ||
Overall Tumor Grade | C18000 | Histologic Grade;Overall Tumor Grade;Tumor Grade | An assigned tumor grade based on a defined scoring system. | Histologic Grade | ||
p16-INK4A | C179766 | CDK4I;Cyclin Dependent Kinase Inhibitor 2A p16;p16;p16 Inhibitors of CDK4;p16-INK4a | A measurement of the p16-INK4A in a biological specimen. | p16-INK4A Measurement | ||
Paneth Cell Metaplasia | C176339 | Paneth Cell Metaplasia | An evaluation of paneth cell metaplasia in a biological specimen. | Paneth Cell Metaplasia Assessment | ||
PAX3-FKHR Fusion Protein | C142348 | PAX3-FKHR Fusion Protein | A measurement of the PAX3-FKHR fusion protein in a biological specimen. | PAX3-FKHR Fusion Protein Measurement | ||
Percentage of In situ Carcinoma | C123559 | Percentage of In situ Carcinoma | A relative measurement (percentage) of in situ component present in a carcinoma compared to the entire malignant cellular proliferation. (NCI) | Percentage of in situ Carcinoma | ||
Perineural Invasion | C127768 | Perineural Invasion | An evaluation of perineural invasion in a biological specimen. | Perineural Invasion Assessment | ||
Peritubular Capillaritis | C135473 | Peritubular Capillaritis | An evaluation of peritubular capillaritis in a biological specimen. | Peritubular Capillaritis Assessment | ||
Phosphatase and Tensin Homolog | C147470 | Phosphatase and Tensin Homolog | A measurement of the phosphatase and tensin homolog in a biological specimen. | Phosphatase and Tensin Homolog Measurement | ||
Platelet Endo Cell Adhesion Molecule 1 | C135472 | CD31;CD31 Antigen;PECAM;PECAM-1;PECAM1;Platelet And Endothelial Cell Adhesion Molecule 1;Platelet Endo Cell Adhesion Molecule 1;Platelet Endothelial Adhesion Molecule | A measurement of the platelet and endothelial cell adhesion molecule 1 in a biological specimen. | Platelet Endothelial Cell Adhesion Molecule 1 Measurement | ||
PMS1 Homolog 1 | C186206 | PMS1 Homolog 1 | A measurement of the PMS1 mismatch repair protein in a biological specimen. | PMS1 Homolog 1 Measurement | ||
PMS1 Homolog 2 | C139097 | PMS1 Homolog 2 | A measurement of the PMS2 mismatch repair protein in a biological specimen. | PMS1 Homolog 2 Measurement | ||
Polymorphonuclear Cells in Epithelium | C178040 | Polymorphonuclear Cells in Epithelium | An evaluation of polymorphonuclear cells in the epithelium in a biological specimen. | Polymorphonuclear Cells in Epithelium Assessment | ||
Polysaccharides and Mucosubstances | C178047 | Polysaccharides and Mucosubstances | A measurement of the polysaccharides and mucosubstances in a biological specimen. | Polysaccharides and Mucosubstances Measurement | ||
Portal Inflammation | C181483 | Portal Inflammation | An evaluation of portal inflammation in a biological specimen. | Portal Inflammation Assessment | ||
Premalignant Cell Morphology | C184701 | Premalignant Cell Morphology | An examination or assessment of the form and structure of premalignant cells. | Premalignant Cell Morphology Assessment | ||
Premalignant Cells | C184700 | Precancerous Cells;Premalignant Lesions | An evaluation of premalignant cells in a biological specimen. | Premalignant Cell Count | ||
Progesterone Receptor | C117846 | NR3C3;PGR;PgR;PR;Progesterone Receptor | A measurement of the progesterone receptor protein in a biological specimen. | Progesterone Receptor Measurement | ||
Programmed Death Ligand 1 | C154807 | CD274;PD-L1;Programmed Cell Death 1 Ligand 1;Programmed Death Ligand 1 | A measurement of the programmed death ligand 1 in a biological specimen. | Programmed Death Ligand 1 Measurement | ||
Proliferating Myeloid Cells/Total Cells | C127634 | Proliferating Myeloid Cells/Total Cells | A relative measurement (ratio or percentage) of the proliferating myeloid cells to total cells in a biological specimen. | Proliferating Myeloid Cell to Total Cell Ratio Measurement | ||
Promonocytes/Total Cells | C187678 | Promonocytes/Total Cells | A relative measurement (ratio or percentage) of the promonocytes to total cells in a biological specimen (for example a bone marrow specimen). | Promonocyte to Total Cell Ratio Measurement | ||
Promyelocytes/Total Cells | C98773 | Promyelocytes/Total Cells | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). | Promyelocyte to Total Cell Ratio Measurement | ||
Prostatic Acid Phosphatase | C80204 | Prostatic Acid Phosphatase | A measurement of the prostatic acid phosphatase in a biological specimen. | Prostatic Acid Phosphatase Measurement | ||
Pyknotic Cells | C189346 | Karyopyknotic Cells;Pyknotic Cells | A measurement of the pyknotic cells in a biological specimen. | Pyknotic Cell Count | ||
Reticulocytes/Total Cells | C187680 | Reticulocytes/Total Cells | A relative measurement (ratio or percentage) of reticulocytes to total cells in a biological specimen. | Reticulocyte to Total Cell Ratio Measurement | ||
ROS1 Protein | C154804 | ROS Proto-oncogene 1 Protein;ROS1 Protein | A measurement of the ROS proto-oncogene 1 protein in a biological specimen. | ROS1 Protein Measurement | ||
S100 Calcium Binding Protein A7 | C127769 | S100 Calcium Binding Protein A7 | A measurement of the S100 calcium binding protein A7 in a biological specimen. | S100 Calcium Binding Protein A7 Measurement | ||
Smooth Muscle Antibody | C111317 | Anti-Smooth Muscle Antibody;Smooth Muscle Antibody | A measurement of the total smooth muscle antibody in a biological specimen. | Smooth Muscle Antibody Measurement | ||
Steatosis Extent | C181477 | Steatosis Extent;Steatosis Grade | An evaluation of the amount or degree of steatosis (fatty tissue) in a biological specimen. | Steatosis Extent | ||
Steatosis Location | C181478 | Steatosis Location | An evaluation of the predominant distribution pattern of steatosis (fatty tissue) in a biological specimen. | Steatosis Location | ||
Stromal Cells/Total Cells | C127770 | Stromal Cells/Total Cells | A relative measurement (ratio or percentage) of the stromal cells to total cells in a biological specimen. | Stromal Cell to Total Cell Ratio Measurement | ||
Surgical Margin Involvement Region | C177569 | Surgical Margin Involvement Region | The anatomical region or plane containing neoplastic tissue that has been left outside the boundary of a resected specimen within the patient. | Anatomic Site for Involved Surgical Margin | ||
Surgical Margins Status | C123560 | Surgical Margins Status | The determination of the presence of actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. (NCI) | Surgical Margins Status | ||
Thickness | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
Total Plasma Cells/Total Cells | C98869 | Mature Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). | Mature Plasma Cell to Total Cell Ratio Measurement | ||
Transforming Growth Factor Beta 1 | C117861 | Transforming Growth Factor Beta 1 | A measurement of the transforming growth factor beta 1 in a biological specimen. | Transforming Growth Factor Beta 1 Measurement | ||
Transitional Cells/Tumor Cells | C154800 | Transitional Cells/Tumor Cells | A relative measurement (ratio or percentage) of the transitional cells to the tumor cells in a biological specimen. | Transitional Cell to Tumor Cell Ratio Measurement | ||
Tubular Atrophy | C135474 | Tubular Atrophy | An evaluation of tubular atrophy in a biological specimen. | Tubular Atrophy Assessment | ||
Tubule Formation | C181491 | Tubule Formation | An evaluation of tubule formation in a biological specimen. | Tubule Formation Assessment | ||
Tubulitis | C135475 | Tubulitis | An evaluation of tubulitis in a biological specimen. | Tubulitis Assessment | ||
Tumor Border Configuration | C187951 | Invasive Margin;Tumor Border Configuration;Tumor Margin Configuration | An evaluation of the morphologic appearance at the point where the tumor meets adjacent, non-tumor tissue. | Tumor Margin Configuration Assessment | ||
Tumor Differentiation | C187949 | Tumor Differentiation | An evaluation of the tissue architecture of the tumor in comparison to the non-pathological tissue the tumor arose from. | Tumor Differentiation Assessment | ||
Tumor Infiltration Pattern | C187950 | Tumor Infiltration Pattern | An evaluation of the tumor infiltration pattern in a biological specimen. | Tumor Infiltration Pattern Assessment | ||
Tumor Protein p53 | C186205 | Tumor Protein p53 | A measurement of the tumor protein p53 in a biological specimen. | Cellular Tumor Antigen p53 Measurement | ||
Tumor Regression | C178046 | Tumor Regression | An evaluation of tumor regression in a biological specimen. | Tumor Regression Assessment | ||
Ulceration | C176333 | Ulceration | An evaluation of ulceration in a biological specimen. | Ulceration Assessment | ||
Vascular Fibrous Intimal Thickening | C135476 | Vascular Fibrous Intimal Thickening | An evaluation of the fibrointimal thickening of vessels in a biological specimen. | Vascular Fibrous Intimal Thickening Assessment | ||
Vascular Invasion | C127772 | Vascular Invasion | An evaluation of vascular invasion in a biological specimen. | Vascular Invasion Assessment | ||
Back to top | ||||||
CL.C160923.SDTMVRS | SDTM Version Response
(SDTMVRS) | text
Extensible: Yes | C160923 | SDTM Version Response | Terminology relevant to the version of the study data tabulation model used in the study. | CDISC SDTM Model Version ResponseTerminology |
1.1 | C161425 | SDTM Version 1.1 | Version 1.1 of the CDISC Study Data Tabulation Model (SDTM). | CDISC SDTM Model Version 1.1 | ||
1.2 | C161426 | SDTM Version 1.2 | Version 1.2 of the CDISC Study Data Tabulation Model (SDTM). | CDISC SDTM Model Version 1.2 | ||
1.3 | C161427 | SDTM Version 1.3 | Version 1.3 of the CDISC Study Data Tabulation Model (SDTM). | CDISC SDTM Model Version 1.3 | ||
1.4 | C161428 | SDTM Version 1.4 | Version 1.4 of the CDISC Study Data Tabulation Model (SDTM). | CDISC SDTM Model Version 1.4 | ||
1.5 | C161429 | SDTM Version 1.5 | Version 1.5 of the CDISC Study Data Tabulation Model (SDTM). | CDISC SDTM Model Version 1.5 | ||
1.6 | C161430 | SDTM Version 1.6 | Version 1.6 of the CDISC Study Data Tabulation Model (SDTM). | CDISC SDTM Model Version 1.6 | ||
1.7 | C161431 | SDTM Version 1.7 | Version 1.7 of the CDISC Study Data Tabulation Model (SDTM). | CDISC SDTM Model Version 1.7 | ||
2.0 | C189639 | SDTM Version 2.0 | Version 2.0 of the CDISC Study Data Tabulation Model (SDTM). | CDISC SDTM Model Version 2.0 | ||
Back to top | ||||||
CL.C189266.SDTMDVRS | SDTMIG Medical Device Version Response
(SDTMDVRS) | text
Extensible: Yes | C189266 | SDTMIG Medical Device Version Response | Terminology relevant to the version of the study data tabulation model implementation guide for medical devices used in the study. | CDISC SDTM SDTMIG Medical Device Version Response Terminology |
1.0 | C189636 | SDTMIG Medical Device Version 1.0;SDTMIG-MD Version 1.0 | Version 1.0 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide for medical devices. | CDISC SDTM Implementation Guide Medical Device Version 1.0 | ||
1.1 | C189637 | SDTMIG Medical Device Version 1.1;SDTMIG-MD Version 1.1 | Version 1.1 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide for medical devices. | CDISC SDTM Implementation Guide Medical Device Version 1.1 | ||
Back to top | ||||||
CL.C160924.SDTMIGRS | SDTMIG Version Response
(SDTMIGRS) | text
Extensible: Yes | C160924 | SDTMIG Version Response | Terminology relevant to the version of the study data tabulation model implementation guide used in the study. | CDISC SDTM Implementation Guide Version Response Terminology |
3.1.1 | C161432 | SDTMIG Version 3.1.1 | Version 3.1.1 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. | CDISC SDTM Implementation Guide Version 3.1.1 | ||
3.1.2 | C161433 | SDTMIG Version 3.1.2 | Version 3.1.2 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. | CDISC SDTM Implementation Guide Version 3.1.2 | ||
3.1.3 | C161435 | SDTMIG Version 3.1.3 | Version 3.1.3 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. | CDISC SDTM Implementation Guide Version 3.1.3 | ||
3.2 | C161436 | SDTMIG Version 3.2 | Version 3.2 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. | CDISC SDTM Implementation Guide Version 3.2 | ||
3.3 | C161437 | SDTMIG Version 3.3 | Version 3.3 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. | CDISC SDTM Implementation Guide Version 3.3 | ||
3.4 | C189638 | SDTMIG Version 3.4 | Version 3.4 of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. | CDISC SDTM Implementation Guide Version 3.4 | ||
Version 3.1.2 Amendment 1 | C161434 | SDTMIG Version 3.1.2 Amendment 1 | Amendment 1 of the 3.1.2 version of the CDISC Study Data Tabulation Model (SDTM) Implementation Guide. | CDISC SDTM Implementation Guide Version 3.1.2 Amendment 1 | ||
Back to top | ||||||
CL.C165643.SEVRS | Severity Response
(SEVRS) | text
Extensible: Yes | C165643 | Severity Response | Terminology relevant to a severity scale that describes the degree or intensity of a notable event or finding. | CDISC SDTM Severity Response Terminology |
MAJOR | C45368 | Greater or bigger in degree, quality, significance, or extent. | Major | |||
MILD | C70666 | Slight in degree, quality, or extent. | Mild | |||
MINIMAL | C25570 | The smallest value in quantity or degree in a set of values. | Minimum | |||
MINOR | C45367 | Lesser or smaller in degree, quality, significance, or extent. | Minor | |||
MODERATE | C61376 | Middling or intermediate in degree, quality or extent. | Moderate | |||
SEVERE | C70667 | Intensely bad in degree, quality, or extent. | Severe | |||
U | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C66769.AESEV | Severity/Intensity Scale for Adverse Events
(AESEV) | text
Extensible: No | C66769 | Severity/Intensity Scale for Adverse Events | A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI) | CDISC SDTM Severity Intensity Scale for Adverse Event Terminology |
MILD | C41338 | 1;Grade 1 | A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living. | Mild Adverse Event | ||
MODERATE | C41339 | 2;Grade 2 | A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant. | Moderate Adverse Event | ||
SEVERE | C41340 | 3;Grade 3 | A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention. | Severe Adverse Event | ||
Back to top | ||||||
CL.C66731.SEX | Sex
(SEX) | text
Extensible: No | C66731 | Sex | The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI) | CDISC SDTM Sex of Individual Terminology |
F | C16576 | Female | A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI) | Female | ||
M | C20197 | Male | A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI) | Male | ||
U | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
UNDIFFERENTIATED | C45908 | A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI) | Intersex | |||
Back to top | ||||||
CL.C66732.SEXPOP | Sex of Participants Response
(SEXPOP) | text
Extensible: No | C66732 | Sex of Participants Response | A terminology codelist relevant to the specific sex, either male, female, or mixed of the subject group being studied. | CDISC SDTM Sex of Study Group Terminology |
BOTH | C49636 | One and the other; relating to or being two in conjunction. (NCI) | Both | |||
F | C16576 | Female | A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI) | Female | ||
M | C20197 | Male | A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI) | Male | ||
Back to top | ||||||
CL.C185740.SF6D2TC | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire Test Code
(SF6D2TC) | text
Extensible: No | C185740 | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire Test Code | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 test code. | CDISC Questionnaire SF6D Version 2.0 Acute Test Code Terminology |
SF6D201 | C185763 | SF6D2-Health Limit Physical Activities | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Does your health now limit you in your physical activities? | SF6D Version 2.0 Acute - Health Limit Physical Activities | ||
SF6D202 | C185764 | SF6D2-Accomplished Less Due to Problems | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week how much of the time have you accomplished less than you would like at work or during other regular daily activities as a result of your physical health or emotional problems? | SF6D Version 2.0 Acute - Accomplished Less Due to Problems | ||
SF6D203 | C185765 | SF6D2-How Much Bodily Pain Have You Had | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much bodily pain have you had? | SF6D Version 2.0 Acute - How Much Bodily Pain Have You Had | ||
SF6D204 | C185766 | SF6D2-Time Have You Felt Worn Out | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time have you felt worn out? | SF6D Version 2.0 Acute - Time Have You Felt Worn Out | ||
SF6D205 | C185767 | SF6D2-Interfered With Social Activities | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | SF6D Version 2.0 Acute - Interfered With Social Activities | ||
SF6D206 | C185768 | SF6D2-Time Felt Depressed/Very Nervous | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time have you felt depressed or very nervous? | SF6D Version 2.0 Acute - Time Felt Depressed/Very Nervous | ||
SF6D207 | C185769 | SF6D2-Utility Index Score UK Weights | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score United Kingdom weights. | SF6D Version 2.0 Acute - Utility Index Score UK Weights | ||
SF6D208 | C185770 | SF6D2-Utility Index Score CN Weights | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score Canada weights. | SF6D Version 2.0 Acute - Utility Index Score CN Weights | ||
SF6D209 | C185771 | SF6D2-Utility Index Score AU Weights | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score Australia weights. | SF6D Version 2.0 Acute - Utility Index Score AU Weights | ||
SF6D210 | C185772 | SF6D2-Utility Index Score US Weights | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score United States weights. | SF6D Version 2.0 Acute - Utility Index Score US Weights | ||
Back to top | ||||||
CL.C185739.SF6D2TN | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire Test Name
(SF6D2TN) | text
Extensible: No | C185739 | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 Questionnaire Test Name | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 test name. | CDISC Questionnaire SF6D Version 2.0 Acute Test Name Terminology |
SF6D2-Accomplished Less Due to Problems | C185764 | SF6D2-Accomplished Less Due to Problems | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week how much of the time have you accomplished less than you would like at work or during other regular daily activities as a result of your physical health or emotional problems? | SF6D Version 2.0 Acute - Accomplished Less Due to Problems | ||
SF6D2-Health Limit Physical Activities | C185763 | SF6D2-Health Limit Physical Activities | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Does your health now limit you in your physical activities? | SF6D Version 2.0 Acute - Health Limit Physical Activities | ||
SF6D2-How Much Bodily Pain Have You Had | C185765 | SF6D2-How Much Bodily Pain Have You Had | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much bodily pain have you had? | SF6D Version 2.0 Acute - How Much Bodily Pain Have You Had | ||
SF6D2-Interfered With Social Activities | C185767 | SF6D2-Interfered With Social Activities | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | SF6D Version 2.0 Acute - Interfered With Social Activities | ||
SF6D2-Time Felt Depressed/Very Nervous | C185768 | SF6D2-Time Felt Depressed/Very Nervous | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time have you felt depressed or very nervous? | SF6D Version 2.0 Acute - Time Felt Depressed/Very Nervous | ||
SF6D2-Time Have You Felt Worn Out | C185766 | SF6D2-Time Have You Felt Worn Out | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - During the past week, how much of the time have you felt worn out? | SF6D Version 2.0 Acute - Time Have You Felt Worn Out | ||
SF6D2-Utility Index Score AU Weights | C185771 | SF6D2-Utility Index Score AU Weights | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score Australia weights. | SF6D Version 2.0 Acute - Utility Index Score AU Weights | ||
SF6D2-Utility Index Score CN Weights | C185770 | SF6D2-Utility Index Score CN Weights | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score Canada weights. | SF6D Version 2.0 Acute - Utility Index Score CN Weights | ||
SF6D2-Utility Index Score UK Weights | C185769 | SF6D2-Utility Index Score UK Weights | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score United Kingdom weights. | SF6D Version 2.0 Acute - Utility Index Score UK Weights | ||
SF6D2-Utility Index Score US Weights | C185772 | SF6D2-Utility Index Score US Weights | SF-6Dv2 Health Utility Survey Acute, English Version 2.0 (SF6D V2.0 ACUTE) - Utility index score United States weights. | SF6D Version 2.0 Acute - Utility Index Score US Weights | ||
Back to top | ||||||
CL.C185742.SF6D1TC | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire Test Code
(SF6D1TC) | text
Extensible: No | C185742 | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire Test Code | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 test code. | CDISC Questionnaire SF6D Version 2.0 Standard Test Code Terminology |
SF6D101 | C185773 | SF6D1-Health Limit Physical Activities | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Does your health now limit you in your physical activities? | SF6D Version 2.0 Standard - Health Limit Physical Activities | ||
SF6D102 | C185774 | SF6D1-Accomplished Less Due to Problems | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you accomplished less than you would like at work or during other regular daily activities as a result of your physical health or emotional problems? | SF6D Version 2.0 Standard - Accomplished Less Due to Problems | ||
SF6D103 | C185775 | SF6D1-How Much Bodily Pain Have You Had | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much bodily pain have you had? | SF6D Version 2.0 Standard - How Much Bodily Pain Have You Had | ||
SF6D104 | C185776 | SF6D1-Time Have You Felt Worn Out | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you felt worn out? | SF6D Version 2.0 Standard - Time Have You Felt Worn Out | ||
SF6D105 | C185777 | SF6D1-Interfered With Social Activities | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | SF6D Version 2.0 Standard - Interfered With Social Activities | ||
SF6D106 | C185778 | SF6D1-Time Felt Depressed/Very Nervous | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you felt depressed or very nervous? | SF6D Version 2.0 Standard - Time Felt Depressed/Very Nervous | ||
SF6D107 | C185779 | SF6D1-Utility Index Score UK Weights | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score United Kingdom weights. | SF6D Version 2.0 Standard - Utility Index Score UK Weights | ||
SF6D108 | C185780 | SF6D1-Utility Index Score CN Weights | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score Canada weights. | SF6D Version 2.0 Standard - Utility Index Score CN Weights | ||
SF6D109 | C185781 | SF6D1-Utility Index Score AU Weights | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score Australia weights. | SF6D Version 2.0 Standard - Utility Index Score AU Weights | ||
SF6D110 | C185782 | SF6D1-Utility Index Score US Weights | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score United States weights. | SF6D Version 2.0 Standard - Utility Index Score US Weights | ||
Back to top | ||||||
CL.C185741.SF6D1TN | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire Test Name
(SF6D1TN) | text
Extensible: No | C185741 | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 Questionnaire Test Name | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 test name. | CDISC Questionnaire SF6D Version 2.0 Standard Test Name Terminology |
SF6D1-Accomplished Less Due to Problems | C185774 | SF6D1-Accomplished Less Due to Problems | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you accomplished less than you would like at work or during other regular daily activities as a result of your physical health or emotional problems? | SF6D Version 2.0 Standard - Accomplished Less Due to Problems | ||
SF6D1-Health Limit Physical Activities | C185773 | SF6D1-Health Limit Physical Activities | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Does your health now limit you in your physical activities? | SF6D Version 2.0 Standard - Health Limit Physical Activities | ||
SF6D1-How Much Bodily Pain Have You Had | C185775 | SF6D1-How Much Bodily Pain Have You Had | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much bodily pain have you had? | SF6D Version 2.0 Standard - How Much Bodily Pain Have You Had | ||
SF6D1-Interfered With Social Activities | C185777 | SF6D1-Interfered With Social Activities | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | SF6D Version 2.0 Standard - Interfered With Social Activities | ||
SF6D1-Time Felt Depressed/Very Nervous | C185778 | SF6D1-Time Felt Depressed/Very Nervous | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you felt depressed or very nervous? | SF6D Version 2.0 Standard - Time Felt Depressed/Very Nervous | ||
SF6D1-Time Have You Felt Worn Out | C185776 | SF6D1-Time Have You Felt Worn Out | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - During the past 4 weeks, how much of the time have you felt worn out? | SF6D Version 2.0 Standard - Time Have You Felt Worn Out | ||
SF6D1-Utility Index Score AU Weights | C185781 | SF6D1-Utility Index Score AU Weights | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score Australia weights. | SF6D Version 2.0 Standard - Utility Index Score AU Weights | ||
SF6D1-Utility Index Score CN Weights | C185780 | SF6D1-Utility Index Score CN Weights | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score Canada weights. | SF6D Version 2.0 Standard - Utility Index Score CN Weights | ||
SF6D1-Utility Index Score UK Weights | C185779 | SF6D1-Utility Index Score UK Weights | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score United Kingdom weights. | SF6D Version 2.0 Standard - Utility Index Score UK Weights | ||
SF6D1-Utility Index Score US Weights | C185782 | SF6D1-Utility Index Score US Weights | SF-6Dv2 Health Utility Survey Standard, English Version 2.0 (SF6D V2.0 STANDARD) - Utility index score United States weights. | SF6D Version 2.0 Standard - Utility Index Score US Weights | ||
Back to top | ||||||
CL.C111350.SDS01TC | Sheehan Disability Scale Questionnaire Test Code
(SDS01TC) | text
Extensible: No | C111350 | Sheehan Disability Scale Questionnaire Test Code | Sheehan Disability Scale test code. | CDISC Questionnaire SDS Test Code Terminology |
SDS0101 | C111521 | SDS01-Work/School | Sheehan Disability Scale - The symptoms have disrupted your work/school work. | SDS - Symptoms Disrupted Work/School Work | ||
SDS0101A | C111522 | SDS01-No Work/Study - Unrelated Disorder | Sheehan Disability Scale - I have not worked/studied at all during the past week for reasons unrelated to the disorder. | SDS - Not Worked/Studied in Past Week for Reason Unrelated to Disorder | ||
SDS0102 | C111523 | SDS01-Social Life | Sheehan Disability Scale - The symptoms have disrupted your social life/leisure activities. | SDS - Symptoms Disrupted Social Life/Leisure Activities | ||
SDS0103 | C111524 | SDS01-Family Life/Home Responsibilities | Sheehan Disability Scale - The symptoms have disrupted your family life/home responsibilities. | SDS - Symptoms Disrupted Family Life/Home Responsibilities | ||
SDS0104 | C111525 | SDS01-Days Lost | Sheehan Disability Scale - On how many days in the last week did your symptoms cause you to miss school or work or leave you unable to carry out your normal daily responsibilities? | SDS - Days Lost | ||
SDS0105 | C111526 | SDS01-Days Underproductive | Sheehan Disability Scale - On how many days in the last week did you feel so impaired by your symptoms, that even though you went to school or work or had other daily responsibilities, your productivity was reduced? | SDS - Days Underproductive | ||
Back to top | ||||||
CL.C111349.SDS01TN | Sheehan Disability Scale Questionnaire Test Name
(SDS01TN) | text
Extensible: No | C111349 | Sheehan Disability Scale Questionnaire Test Name | Sheehan Disability Scale test name. | CDISC Questionnaire SDS Test Name Terminology |
SDS01-Days Lost | C111525 | SDS01-Days Lost | Sheehan Disability Scale - On how many days in the last week did your symptoms cause you to miss school or work or leave you unable to carry out your normal daily responsibilities? | SDS - Days Lost | ||
SDS01-Days Underproductive | C111526 | SDS01-Days Underproductive | Sheehan Disability Scale - On how many days in the last week did you feel so impaired by your symptoms, that even though you went to school or work or had other daily responsibilities, your productivity was reduced? | SDS - Days Underproductive | ||
SDS01-Family Life/Home Responsibilities | C111524 | SDS01-Family Life/Home Responsibilities | Sheehan Disability Scale - The symptoms have disrupted your family life/home responsibilities. | SDS - Symptoms Disrupted Family Life/Home Responsibilities | ||
SDS01-No Work/Study - Unrelated Disorder | C111522 | SDS01-No Work/Study - Unrelated Disorder | Sheehan Disability Scale - I have not worked/studied at all during the past week for reasons unrelated to the disorder. | SDS - Not Worked/Studied in Past Week for Reason Unrelated to Disorder | ||
SDS01-Social Life | C111523 | SDS01-Social Life | Sheehan Disability Scale - The symptoms have disrupted your social life/leisure activities. | SDS - Symptoms Disrupted Social Life/Leisure Activities | ||
SDS01-Work/School | C111521 | SDS01-Work/School | Sheehan Disability Scale - The symptoms have disrupted your work/school work. | SDS - Symptoms Disrupted Work/School Work | ||
Back to top | ||||||
CL.C177710.SF102TC | Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire Test Code
(SF102TC) | text
Extensible: No | C177710 | Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire Test Code | Short Form 10 Health Survey for Children Acute, US Version 1.0 test code. | CDISC Questionnaire SF10 v1.0 Children Acute Test Code Terminology |
SF10201 | C177827 | SF102-In General You Say Child Health Is | The Short Form 10 Health Survey Children Acute, US Version 1.0 - In general, would you say your child's health is. | SF10 v1.0 Children Acute - In General You Say Child Health Is | ||
SF10202A | C177828 | SF102-Doing Things That Take Some Energy | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in any of the following activities due to HEALTH problems - Doing things that take some energy such as riding a bike or skating? | SF10 v1.0 Children Acute - Doing Things That Take Some Energy | ||
SF10202B | C177829 | SF102-Bending/Lifting/Stooping | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in any of the following activities due to HEALTH problems - bending, lifting, or stooping? | SF10 v1.0 Children Acute - Bending, Lifting, Stooping | ||
SF10203 | C177830 | SF102-Physical: Schoolwork/Activities | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of PHYSICAL health problems? | SF10 v1.0 Children Acute - Physical: Schoolwork, Activities | ||
SF10204 | C177831 | SF102-Emotional: Schoolwork/Activities | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of EMOTIONAL or BEHAVIORAL problems? | SF10 v1.0 Children Acute - Emotional: Schoolwork, Activities | ||
SF10205 | C177832 | SF102-How Much Bodily Pain Child Had | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how much bodily pain or discomfort has your child had? | SF10 v1.0 Children Acute - How Much Bodily Pain Child Had | ||
SF10206 | C177833 | SF102-Felt About His/Her Friendships | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how satisfied do you think your child has felt about his/her friendships? | SF10 v1.0 Children Acute - Felt About His/Her Friendships | ||
SF10207 | C177834 | SF102-Felt About His/Her Life Overall | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how satisfied do you think your child has felt about his/her life overall? | SF10 v1.0 Children Acute - Felt About His/Her Life Overall | ||
SF10208 | C177835 | SF102-Acted Bothered or Upset | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how much of the time do you think your child acted bothered or upset? | SF10 v1.0 Children Acute - Acted Bothered or Upset | ||
SF10209 | C177836 | SF102-His/Her Behavior Is | The Short Form 10 Health Survey Children Acute, US Version 1.0 - Compared to other children your child's age, in general would you say his/her behavior is. | SF10 v1.0 Children Acute - His/Her Behavior Is | ||
Back to top | ||||||
CL.C177709.SF102TN | Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire Test Name
(SF102TN) | text
Extensible: No | C177709 | Short Form 10 Health Survey for Children Acute, US Version 1.0 Questionnaire Test Name | Short Form 10 Health Survey for Children Acute, US Version 1.0 test name. | CDISC Questionnaire SF10 v1.0 Children Acute Test Name Terminology |
SF102-Acted Bothered or Upset | C177835 | SF102-Acted Bothered or Upset | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how much of the time do you think your child acted bothered or upset? | SF10 v1.0 Children Acute - Acted Bothered or Upset | ||
SF102-Bending/Lifting/Stooping | C177829 | SF102-Bending/Lifting/Stooping | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in any of the following activities due to HEALTH problems - bending, lifting, or stooping? | SF10 v1.0 Children Acute - Bending, Lifting, Stooping | ||
SF102-Doing Things That Take Some Energy | C177828 | SF102-Doing Things That Take Some Energy | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in any of the following activities due to HEALTH problems - Doing things that take some energy such as riding a bike or skating? | SF10 v1.0 Children Acute - Doing Things That Take Some Energy | ||
SF102-Emotional: Schoolwork/Activities | C177831 | SF102-Emotional: Schoolwork/Activities | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of EMOTIONAL or BEHAVIORAL problems? | SF10 v1.0 Children Acute - Emotional: Schoolwork, Activities | ||
SF102-Felt About His/Her Friendships | C177833 | SF102-Felt About His/Her Friendships | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how satisfied do you think your child has felt about his/her friendships? | SF10 v1.0 Children Acute - Felt About His/Her Friendships | ||
SF102-Felt About His/Her Life Overall | C177834 | SF102-Felt About His/Her Life Overall | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how satisfied do you think your child has felt about his/her life overall? | SF10 v1.0 Children Acute - Felt About His/Her Life Overall | ||
SF102-His/Her Behavior Is | C177836 | SF102-His/Her Behavior Is | The Short Form 10 Health Survey Children Acute, US Version 1.0 - Compared to other children your child's age, in general would you say his/her behavior is. | SF10 v1.0 Children Acute - His/Her Behavior Is | ||
SF102-How Much Bodily Pain Child Had | C177832 | SF102-How Much Bodily Pain Child Had | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, how much bodily pain or discomfort has your child had? | SF10 v1.0 Children Acute - How Much Bodily Pain Child Had | ||
SF102-In General You Say Child Health Is | C177827 | SF102-In General You Say Child Health Is | The Short Form 10 Health Survey Children Acute, US Version 1.0 - In general, would you say your child's health is. | SF10 v1.0 Children Acute - In General You Say Child Health Is | ||
SF102-Physical: Schoolwork/Activities | C177830 | SF102-Physical: Schoolwork/Activities | The Short Form 10 Health Survey Children Acute, US Version 1.0 - During the past week, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of PHYSICAL health problems? | SF10 v1.0 Children Acute - Physical: Schoolwork, Activities | ||
Back to top | ||||||
CL.C177712.SF101TC | Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire Test Code
(SF101TC) | text
Extensible: No | C177712 | Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire Test Code | Short Form 10 Health Survey for Children Standard, US Version 1.0 test code. | CDISC Questionnaire SF10 v1.0 Children Standard Test Code Terminology |
SF10101 | C177837 | SF101-In General You Say Child Health Is | The Short Form 10 Health Survey Children Standard, US Version 1.0 - In general, would you say your child's health is. | SF10 v1.0 Children Standard - In General You Say Child Health Is | ||
SF10102A | C177838 | SF101-Doing Things That Take Some Energy | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in any activities due to HEALTH problems - Doing things that take some energy such as riding a bike or skating? | SF10 v1.0 Children Standard - Doing Things That Take Some Energy | ||
SF10102B | C177839 | SF101-Bending/Lifting/Stooping | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in any activities due to HEALTH problems - bending, lifting, or stooping? | SF10 v1.0 Children Standard - Bending, Lifting, Stooping | ||
SF10103 | C177840 | SF101-Physical: Schoolwork/Activities | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of PHYSICAL health problems? | SF10 v1.0 Children Standard - Physical: Schoolwork, Activities | ||
SF10104 | C177841 | SF101-Emotional: Schoolwork/Activities | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of EMOTIONAL or BEHAVIORAL problems?. | SF10 v1.0 Children Standard - Emotional: Schoolwork, Activities | ||
SF10105 | C177842 | SF101-How Much Bodily Pain Child Had | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how much bodily pain or discomfort has your child had? | SF10 v1.0 Children Standard - How Much Bodily Pain Child Had | ||
SF10106 | C177843 | SF101-Felt About His/Her Friendships | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how satisfied do you think your child has felt about his/her friendships? | SF10 v1.0 Children Standard - Felt About His/Her Friendships | ||
SF10107 | C177844 | SF101-Felt About His/Her Life Overall | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how satisfied do you think your child has felt about his/her life overall? | SF10 v1.0 Children Standard - Felt About His/Her Life Overall | ||
SF10108 | C177845 | SF101-Acted Bothered or Upset | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how much of the time do you think your child acted bothered or upset? | SF10 v1.0 Children Standard - Acted Bothered or Upset | ||
SF10109 | C177846 | SF101-His/Her Behavior Is | The Short Form 10 Health Survey Children Standard, US Version 1.0 - Compared to other children your child's age, in general would you say his/her behavior is. | SF10 v1.0 Children Standard - His/Her Behavior Is | ||
Back to top | ||||||
CL.C177711.SF101TN | Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire Test Name
(SF101TN) | text
Extensible: No | C177711 | Short Form 10 Health Survey for Children Standard, US Version 1.0 Questionnaire Test Name | Short Form 10 Health Survey for Children Standard, US Version 1.0 test name. | CDISC Questionnaire SF10 v1.0 Children Standard Test Name Terminology |
SF101-Acted Bothered or Upset | C177845 | SF101-Acted Bothered or Upset | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how much of the time do you think your child acted bothered or upset? | SF10 v1.0 Children Standard - Acted Bothered or Upset | ||
SF101-Bending/Lifting/Stooping | C177839 | SF101-Bending/Lifting/Stooping | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in any activities due to HEALTH problems - bending, lifting, or stooping? | SF10 v1.0 Children Standard - Bending, Lifting, Stooping | ||
SF101-Doing Things That Take Some Energy | C177838 | SF101-Doing Things That Take Some Energy | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in any activities due to HEALTH problems - Doing things that take some energy such as riding a bike or skating? | SF10 v1.0 Children Standard - Doing Things That Take Some Energy | ||
SF101-Emotional: Schoolwork/Activities | C177841 | SF101-Emotional: Schoolwork/Activities | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of EMOTIONAL or BEHAVIORAL problems?. | SF10 v1.0 Children Standard - Emotional: Schoolwork, Activities | ||
SF101-Felt About His/Her Friendships | C177843 | SF101-Felt About His/Her Friendships | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how satisfied do you think your child has felt about his/her friendships? | SF10 v1.0 Children Standard - Felt About His/Her Friendships | ||
SF101-Felt About His/Her Life Overall | C177844 | SF101-Felt About His/Her Life Overall | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how satisfied do you think your child has felt about his/her life overall? | SF10 v1.0 Children Standard - Felt About His/Her Life Overall | ||
SF101-His/Her Behavior Is | C177846 | SF101-His/Her Behavior Is | The Short Form 10 Health Survey Children Standard, US Version 1.0 - Compared to other children your child's age, in general would you say his/her behavior is. | SF10 v1.0 Children Standard - His/Her Behavior Is | ||
SF101-How Much Bodily Pain Child Had | C177842 | SF101-How Much Bodily Pain Child Had | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, how much bodily pain or discomfort has your child had? | SF10 v1.0 Children Standard - How Much Bodily Pain Child Had | ||
SF101-In General You Say Child Health Is | C177837 | SF101-In General You Say Child Health Is | The Short Form 10 Health Survey Children Standard, US Version 1.0 - In general, would you say your child's health is. | SF10 v1.0 Children Standard - In General You Say Child Health Is | ||
SF101-Physical: Schoolwork/Activities | C177840 | SF101-Physical: Schoolwork/Activities | The Short Form 10 Health Survey Children Standard, US Version 1.0 - During the past 4 weeks, has your child been limited in the KIND of schoolwork or activities with friends he/she could do because of PHYSICAL health problems? | SF10 v1.0 Children Standard - Physical: Schoolwork, Activities | ||
Back to top | ||||||
CL.C177714.SF122TC | Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire Test Code
(SF122TC) | text
Extensible: No | C177714 | Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire Test Code | Short Form 12 Health Survey Acute, US Version 1.0 test code. | CDISC Questionnaire SF12 v1.0 Acute Test Code Terminology |
SF12201 | C177847 | SF122-In General You Say Your Health Is | The Short Form 12 Health Survey Acute, US Version 1.0 - In general, would you say your health is. | SF12 v1.0 Acute - In General You Say Your Health Is | ||
SF12202A | C177848 | SF122-Limit Moderate Activities | The Short Form 12 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF12 v1.0 Acute - Limit Moderate Activities | ||
SF12202B | C177849 | SF122-Limit Climbing Several Flights | The Short Form 12 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. | SF12 v1.0 Acute - Limit Climbing Several Flights | ||
SF12203A | C177850 | SF122-Physical: Accomplished Less | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF12 v1.0 Acute - Physical: Accomplished Less | ||
SF12203B | C177851 | SF122-Physical: Limited Kind of Work | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF12 v1.0 Acute - Physical: Limited Kind of Work | ||
SF12204A | C177852 | SF122-Emotional: Accomplished Less | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF12 v1.0 Acute - Emotional: Accomplished Less | ||
SF12204B | C177853 | SF122-Emotional: Did Work Less Carefully | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF12 v1.0 Acute - Emotional: Did Work Less Carefully | ||
SF12205 | C177854 | SF122-Pain Interfere With Normal Work | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF12 v1.0 Acute - Pain Interfere With Normal Work | ||
SF12206A | C177855 | SF122-Have You Felt Calm and Peaceful | The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful? | SF12 v1.0 Acute - Have You Felt Calm and Peaceful | ||
SF12206B | C177856 | SF122-Did You Have a Lot of Energy | The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy? | SF12 v1.0 Acute - Did You Have a Lot of Energy | ||
SF12206C | C177857 | SF122-You Felt Downhearted and Blue | The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and blue? | SF12 v1.0 Acute - You Felt Downhearted and Blue | ||
SF12207 | C177858 | SF122-Time Phys/Emotional Interfered | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF12 v1.0 Acute - Time Physical Health, Emotional Interfered | ||
SF12208 | C180454 | SF122-Physical Component Score | The Short Form 12 Health Survey Acute, US Version 1.0 - Physical component score. | SF12 v1.0 Acute - Physical Component Score | ||
SF12209 | C180455 | SF122-Mental Component Score | The Short Form 12 Health Survey Acute, US Version 1.0 - Mental component score. | SF12 v1.0 Acute - Mental Component Score | ||
SF12210 | C180456 | SF122-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 12 Health Survey Acute, US Version 1.0 - SF-6D_R2 (utility index release 2) score. | SF12 v1.0 Acute - SF-6D_R2 Score | ||
Back to top | ||||||
CL.C177713.SF122TN | Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire Test Name
(SF122TN) | text
Extensible: No | C177713 | Short Form 12 Health Survey Acute, US Version 1.0 Questionnaire Test Name | Short Form 12 Health Survey Acute, US Version 1.0 test name. | CDISC Questionnaire SF12 v1.0 Acute Test Name Terminology |
SF122-Did You Have a Lot of Energy | C177856 | SF122-Did You Have a Lot of Energy | The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy? | SF12 v1.0 Acute - Did You Have a Lot of Energy | ||
SF122-Emotional: Accomplished Less | C177852 | SF122-Emotional: Accomplished Less | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF12 v1.0 Acute - Emotional: Accomplished Less | ||
SF122-Emotional: Did Work Less Carefully | C177853 | SF122-Emotional: Did Work Less Carefully | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF12 v1.0 Acute - Emotional: Did Work Less Carefully | ||
SF122-Have You Felt Calm and Peaceful | C177855 | SF122-Have You Felt Calm and Peaceful | The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful? | SF12 v1.0 Acute - Have You Felt Calm and Peaceful | ||
SF122-In General You Say Your Health Is | C177847 | SF122-In General You Say Your Health Is | The Short Form 12 Health Survey Acute, US Version 1.0 - In general, would you say your health is. | SF12 v1.0 Acute - In General You Say Your Health Is | ||
SF122-Limit Climbing Several Flights | C177849 | SF122-Limit Climbing Several Flights | The Short Form 12 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. | SF12 v1.0 Acute - Limit Climbing Several Flights | ||
SF122-Limit Moderate Activities | C177848 | SF122-Limit Moderate Activities | The Short Form 12 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF12 v1.0 Acute - Limit Moderate Activities | ||
SF122-Mental Component Score | C180455 | SF122-Mental Component Score | The Short Form 12 Health Survey Acute, US Version 1.0 - Mental component score. | SF12 v1.0 Acute - Mental Component Score | ||
SF122-Pain Interfere With Normal Work | C177854 | SF122-Pain Interfere With Normal Work | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF12 v1.0 Acute - Pain Interfere With Normal Work | ||
SF122-Physical Component Score | C180454 | SF122-Physical Component Score | The Short Form 12 Health Survey Acute, US Version 1.0 - Physical component score. | SF12 v1.0 Acute - Physical Component Score | ||
SF122-Physical: Accomplished Less | C177850 | SF122-Physical: Accomplished Less | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF12 v1.0 Acute - Physical: Accomplished Less | ||
SF122-Physical: Limited Kind of Work | C177851 | SF122-Physical: Limited Kind of Work | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF12 v1.0 Acute - Physical: Limited Kind of Work | ||
SF122-SF-6D_R2 (Util Index Rel 2) Score | C180456 | SF122-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 12 Health Survey Acute, US Version 1.0 - SF-6D_R2 (utility index release 2) score. | SF12 v1.0 Acute - SF-6D_R2 Score | ||
SF122-Time Phys/Emotional Interfered | C177858 | SF122-Time Phys/Emotional Interfered | The Short Form 12 Health Survey Acute, US Version 1.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF12 v1.0 Acute - Time Physical Health, Emotional Interfered | ||
SF122-You Felt Downhearted and Blue | C177857 | SF122-You Felt Downhearted and Blue | The Short Form 12 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and blue? | SF12 v1.0 Acute - You Felt Downhearted and Blue | ||
Back to top | ||||||
CL.C177718.SF124TC | Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire Test Code
(SF124TC) | text
Extensible: No | C177718 | Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire Test Code | Short Form 12 Health Survey Acute, US Version 2.0 test code. | CDISC Questionnaire SF12 v2.0 Acute Test Code Terminology |
SF12401 | C177871 | SF124-In General You Say Your Health Is | The Short Form 12 Health Survey Acute, US Version 2.0 - In general, would you say your health is. | SF12 v2.0 Acute - In General You Say Your Health Is | ||
SF12402A | C177872 | SF124-Limit Moderate Activities | The Short Form 12 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF12 v2.0 Acute - Limit Moderate Activities | ||
SF12402B | C177873 | SF124-Limit Climbing Several Flights | The Short Form 12 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. | SF12 v2.0 Acute - Limit Climbing Several Flights | ||
SF12403A | C177874 | SF124-Physical: Accomplished Less | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF12 v2.0 Acute - Physical: Accomplished Less | ||
SF12403B | C177875 | SF124-Physical: Limited Kind of Work | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF12 v2.0 Acute - Physical: Limited Kind of Work | ||
SF12404A | C177876 | SF124-Emotional: Accomplished Less | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF12 v2.0 Acute - Emotional: Accomplished Less | ||
SF12404B | C177877 | SF124-Emotional: Did Work Less Carefully | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF12 v2.0 Acute - Emotional: Did Work Less Carefully | ||
SF12405 | C177878 | SF124-Pain Interfere With Normal Work | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF12 v2.0 Acute - Pain Interfere With Normal Work | ||
SF12406A | C177879 | SF124-Have You Felt Calm and Peaceful | The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful? | SF12 v2.0 Acute - Have You Felt Calm and Peaceful | ||
SF12406B | C177880 | SF124-Did You Have a Lot of Energy | The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy? | SF12 v2.0 Acute - Did You Have a Lot of Energy | ||
SF12406C | C177881 | SF124-You Felt Downhearted and Depressed | The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and depressed? | SF12 v2.0 Acute - You Felt Downhearted and Depressed | ||
SF12407 | C177882 | SF124-Time Phys/Emotional Interfered | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | SF12 v2.0 Acute - Time Physical Health, Emotional Interfered | ||
SF12408 | C180460 | SF124-Physical Functioning 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Physical functioning 0-100 score. | SF12 v2.0 Acute - Physical Functioning 0-100 Score | ||
SF12409 | C180461 | SF124-Role Physical 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Role physical 0-100 score. | SF12 v2.0 Acute - Role Physical 0-100 Score | ||
SF12410 | C180462 | SF124-Bodily Pain 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Bodily pain 0-100 score. | SF12 v2.0 Acute - Bodily Pain 0-100 Score | ||
SF12411 | C180463 | SF124-General Health 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - General health 0-100 score. | SF12 v2.0 Acute - General Health 0-100 Score | ||
SF12412 | C180464 | SF124-Vitality 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Vitality 0-100 score. | SF12 v2.0 Acute - Vitality 0-100 Score | ||
SF12413 | C180465 | SF124-Social Functioning 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Social functioning 0-100 score. | SF12 v2.0 Acute - Social Functioning 0-100 Score | ||
SF12414 | C180466 | SF124-Role Emotional 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Role emotional 0-100 score. | SF12 v2.0 Acute - Role Emotional 0-100 Score | ||
SF12415 | C180467 | SF124-Mental Health 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Mental health 0-100 score. | SF12 v2.0 Acute - Mental Health 0-100 Score | ||
SF12416 | C180468 | SF124-Phys Functioning Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Physical functioning norm-based score. | SF12 v2.0 Acute - Phys Functioning Norm-Based Score | ||
SF12417 | C180469 | SF124-Role Physical Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Role physical norm-based score. | SF12 v2.0 Acute - Role Physical Norm-Based Score | ||
SF12418 | C180470 | SF124-Bodily Pain Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Bodily pain norm-based score. | SF12 v2.0 Acute - Bodily Pain Norm-Based Score | ||
SF12419 | C180471 | SF124-General Health Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - General health norm-based score. | SF12 v2.0 Acute - General Health Norm-Based Score | ||
SF12420 | C180472 | SF124-Vitality Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Vitality norm-based score. | SF12 v2.0 Acute - Vitality Norm-Based Score | ||
SF12421 | C180473 | SF124-Social Function Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Social function norm-based score. | SF12 v2.0 Acute - Social Function Norm-Based Score | ||
SF12422 | C180474 | SF124-Role Emotional Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Role emotional norm-based score. | SF12 v2.0 Acute - Role Emotional Norm-Based Score | ||
SF12423 | C180475 | SF124-Mental Health Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Mental health norm-based score. | SF12 v2.0 Acute - Mental Health Norm-Based Score | ||
SF12424 | C180476 | SF124-Physical Component Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Physical component score. | SF12 v2.0 Acute - Physical Component Score | ||
SF12425 | C180477 | SF124-Mental Component Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Mental component score. | SF12 v2.0 Acute - Mental Component Score | ||
SF12426 | C180478 | SF124-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 12 Health Survey Acute, US Version 2.0 - SF-6D_R2 (utility index release 2) score. | SF12 v2.0 Acute - SF-6D_R2 (Util Index Rel 2) Score | ||
Back to top | ||||||
CL.C177717.SF124TN | Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire Test Name
(SF124TN) | text
Extensible: No | C177717 | Short Form 12 Health Survey Acute, US Version 2.0 Questionnaire Test Name | Short Form 12 Health Survey Acute, US Version 2.0 test name. | CDISC Questionnaire SF12 v2.0 Acute Test Name Terminology |
SF124-Bodily Pain 0-100 Score | C180462 | SF124-Bodily Pain 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Bodily pain 0-100 score. | SF12 v2.0 Acute - Bodily Pain 0-100 Score | ||
SF124-Bodily Pain Norm-Based Score | C180470 | SF124-Bodily Pain Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Bodily pain norm-based score. | SF12 v2.0 Acute - Bodily Pain Norm-Based Score | ||
SF124-Did You Have a Lot of Energy | C177880 | SF124-Did You Have a Lot of Energy | The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy? | SF12 v2.0 Acute - Did You Have a Lot of Energy | ||
SF124-Emotional: Accomplished Less | C177876 | SF124-Emotional: Accomplished Less | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF12 v2.0 Acute - Emotional: Accomplished Less | ||
SF124-Emotional: Did Work Less Carefully | C177877 | SF124-Emotional: Did Work Less Carefully | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF12 v2.0 Acute - Emotional: Did Work Less Carefully | ||
SF124-General Health 0-100 Score | C180463 | SF124-General Health 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - General health 0-100 score. | SF12 v2.0 Acute - General Health 0-100 Score | ||
SF124-General Health Norm-Based Score | C180471 | SF124-General Health Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - General health norm-based score. | SF12 v2.0 Acute - General Health Norm-Based Score | ||
SF124-Have You Felt Calm and Peaceful | C177879 | SF124-Have You Felt Calm and Peaceful | The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful? | SF12 v2.0 Acute - Have You Felt Calm and Peaceful | ||
SF124-In General You Say Your Health Is | C177871 | SF124-In General You Say Your Health Is | The Short Form 12 Health Survey Acute, US Version 2.0 - In general, would you say your health is. | SF12 v2.0 Acute - In General You Say Your Health Is | ||
SF124-Limit Climbing Several Flights | C177873 | SF124-Limit Climbing Several Flights | The Short Form 12 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. | SF12 v2.0 Acute - Limit Climbing Several Flights | ||
SF124-Limit Moderate Activities | C177872 | SF124-Limit Moderate Activities | The Short Form 12 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF12 v2.0 Acute - Limit Moderate Activities | ||
SF124-Mental Component Score | C180477 | SF124-Mental Component Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Mental component score. | SF12 v2.0 Acute - Mental Component Score | ||
SF124-Mental Health 0-100 Score | C180467 | SF124-Mental Health 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Mental health 0-100 score. | SF12 v2.0 Acute - Mental Health 0-100 Score | ||
SF124-Mental Health Norm-Based Score | C180475 | SF124-Mental Health Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Mental health norm-based score. | SF12 v2.0 Acute - Mental Health Norm-Based Score | ||
SF124-Pain Interfere With Normal Work | C177878 | SF124-Pain Interfere With Normal Work | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF12 v2.0 Acute - Pain Interfere With Normal Work | ||
SF124-Phys Functioning Norm-Based Score | C180468 | SF124-Phys Functioning Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Physical functioning norm-based score. | SF12 v2.0 Acute - Phys Functioning Norm-Based Score | ||
SF124-Physical Component Score | C180476 | SF124-Physical Component Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Physical component score. | SF12 v2.0 Acute - Physical Component Score | ||
SF124-Physical Functioning 0-100 Score | C180460 | SF124-Physical Functioning 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Physical functioning 0-100 score. | SF12 v2.0 Acute - Physical Functioning 0-100 Score | ||
SF124-Physical: Accomplished Less | C177874 | SF124-Physical: Accomplished Less | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF12 v2.0 Acute - Physical: Accomplished Less | ||
SF124-Physical: Limited Kind of Work | C177875 | SF124-Physical: Limited Kind of Work | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF12 v2.0 Acute - Physical: Limited Kind of Work | ||
SF124-Role Emotional 0-100 Score | C180466 | SF124-Role Emotional 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Role emotional 0-100 score. | SF12 v2.0 Acute - Role Emotional 0-100 Score | ||
SF124-Role Emotional Norm-Based Score | C180474 | SF124-Role Emotional Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Role emotional norm-based score. | SF12 v2.0 Acute - Role Emotional Norm-Based Score | ||
SF124-Role Physical 0-100 Score | C180461 | SF124-Role Physical 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Role physical 0-100 score. | SF12 v2.0 Acute - Role Physical 0-100 Score | ||
SF124-Role Physical Norm-Based Score | C180469 | SF124-Role Physical Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Role physical norm-based score. | SF12 v2.0 Acute - Role Physical Norm-Based Score | ||
SF124-SF-6D_R2 (Util Index Rel 2) Score | C180478 | SF124-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 12 Health Survey Acute, US Version 2.0 - SF-6D_R2 (utility index release 2) score. | SF12 v2.0 Acute - SF-6D_R2 (Util Index Rel 2) Score | ||
SF124-Social Function Norm-Based Score | C180473 | SF124-Social Function Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Social function norm-based score. | SF12 v2.0 Acute - Social Function Norm-Based Score | ||
SF124-Social Functioning 0-100 Score | C180465 | SF124-Social Functioning 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Social functioning 0-100 score. | SF12 v2.0 Acute - Social Functioning 0-100 Score | ||
SF124-Time Phys/Emotional Interfered | C177882 | SF124-Time Phys/Emotional Interfered | The Short Form 12 Health Survey Acute, US Version 2.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | SF12 v2.0 Acute - Time Physical Health, Emotional Interfered | ||
SF124-Vitality 0-100 Score | C180464 | SF124-Vitality 0-100 Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Vitality 0-100 score. | SF12 v2.0 Acute - Vitality 0-100 Score | ||
SF124-Vitality Norm-Based Score | C180472 | SF124-Vitality Norm-Based Score | The Short Form 12 Health Survey Acute, US Version 2.0 - Vitality norm-based score. | SF12 v2.0 Acute - Vitality Norm-Based Score | ||
SF124-You Felt Downhearted and Depressed | C177881 | SF124-You Felt Downhearted and Depressed | The Short Form 12 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and depressed? | SF12 v2.0 Acute - You Felt Downhearted and Depressed | ||
Back to top | ||||||
CL.C177716.SF121TC | Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire Test Code
(SF121TC) | text
Extensible: No | C177716 | Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire Test Code | Short Form 12 Health Survey Standard, US Version 1.0 test code. | CDISC Questionnaire SF12 v1.0 Standard Test Code Terminology |
SF12101 | C177859 | SF121-In General You Say Your Health Is | The Short Form 12 Health Survey Standard, US Version 1.0 - In general, would you say your health is. | SF12 v1.0 Standard - In General You Say Your Health Is | ||
SF12102A | C177860 | SF121-Limit Moderate Activities | The Short Form 12 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF12 v1.0 Standard - Limit Moderate Activities | ||
SF12102B | C177861 | SF121-Limit Climbing Several Flights | The Short Form 12 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. | SF12 v1.0 Standard - Limit Climbing Several Flights | ||
SF12103A | C177862 | SF121-Physical: Accomplished Less | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF12 v1.0 Standard - Physical: Accomplished Less | ||
SF12103B | C177863 | SF121-Physical: Limited Kind of Work | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF12 v1.0 Standard - Physical: Limited Kind of Work | ||
SF12104A | C177864 | SF121-Emotional: Accomplished Less | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF12 v1.0 Standard - Emotional: Accomplished Less | ||
SF12104B | C177865 | SF121-Emotional: Did Work Less Carefully | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF12 v1.0 Standard - Emotional: Did Work Less Carefully | ||
SF12105 | C177866 | SF121-Pain Interfere With Normal Work | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF12 v1.0 Standard - Pain Interfere With Normal Work | ||
SF12106A | C177867 | SF121-Have You Felt Calm and Peaceful | The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful? | SF12 v1.0 Standard - Have You Felt Calm and Peaceful | ||
SF12106B | C177868 | SF121-Did You Have a Lot of Energy | The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy? | SF12 v1.0 Standard - Did You Have a Lot of Energy | ||
SF12106C | C177869 | SF121-You Felt Downhearted and Blue | The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and blue? | SF12 v1.0 Standard - You Felt Downhearted and Blue | ||
SF12107 | C177870 | SF121-Time Phys/Emotional Interfered | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF12 v1.0 Standard - Time Physical Health, Emotional Interfered | ||
SF12108 | C180457 | SF121-Physical Component Score | The Short Form 12 Health Survey Standard, US Version 1.0 - Physical component score. | SF12 v1.0 Standard - Physical Component Score | ||
SF12109 | C180458 | SF121-Mental Component Score | The Short Form 12 Health Survey Standard, US Version 1.0 - Mental component score. | SF12 v1.0 Standard - Mental Component Score | ||
SF12110 | C180459 | SF121-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 12 Health Survey Standard, US Version 1.0 - SF-6D_R2 (utility index release 2) score. | SF12 v1.0 Standard - SF-6D_R2 Score | ||
Back to top | ||||||
CL.C177715.SF121TN | Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire Test Name
(SF121TN) | text
Extensible: No | C177715 | Short Form 12 Health Survey Standard, US Version 1.0 Questionnaire Test Name | Short Form 12 Health Survey Standard, US Version 1.0 test name. | CDISC Questionnaire SF12 v1.0 Standard Test Name Terminology |
SF121-Did You Have a Lot of Energy | C177868 | SF121-Did You Have a Lot of Energy | The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy? | SF12 v1.0 Standard - Did You Have a Lot of Energy | ||
SF121-Emotional: Accomplished Less | C177864 | SF121-Emotional: Accomplished Less | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF12 v1.0 Standard - Emotional: Accomplished Less | ||
SF121-Emotional: Did Work Less Carefully | C177865 | SF121-Emotional: Did Work Less Carefully | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF12 v1.0 Standard - Emotional: Did Work Less Carefully | ||
SF121-Have You Felt Calm and Peaceful | C177867 | SF121-Have You Felt Calm and Peaceful | The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful? | SF12 v1.0 Standard - Have You Felt Calm and Peaceful | ||
SF121-In General You Say Your Health Is | C177859 | SF121-In General You Say Your Health Is | The Short Form 12 Health Survey Standard, US Version 1.0 - In general, would you say your health is. | SF12 v1.0 Standard - In General You Say Your Health Is | ||
SF121-Limit Climbing Several Flights | C177861 | SF121-Limit Climbing Several Flights | The Short Form 12 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. | SF12 v1.0 Standard - Limit Climbing Several Flights | ||
SF121-Limit Moderate Activities | C177860 | SF121-Limit Moderate Activities | The Short Form 12 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF12 v1.0 Standard - Limit Moderate Activities | ||
SF121-Mental Component Score | C180458 | SF121-Mental Component Score | The Short Form 12 Health Survey Standard, US Version 1.0 - Mental component score. | SF12 v1.0 Standard - Mental Component Score | ||
SF121-Pain Interfere With Normal Work | C177866 | SF121-Pain Interfere With Normal Work | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF12 v1.0 Standard - Pain Interfere With Normal Work | ||
SF121-Physical Component Score | C180457 | SF121-Physical Component Score | The Short Form 12 Health Survey Standard, US Version 1.0 - Physical component score. | SF12 v1.0 Standard - Physical Component Score | ||
SF121-Physical: Accomplished Less | C177862 | SF121-Physical: Accomplished Less | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF12 v1.0 Standard - Physical: Accomplished Less | ||
SF121-Physical: Limited Kind of Work | C177863 | SF121-Physical: Limited Kind of Work | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF12 v1.0 Standard - Physical: Limited Kind of Work | ||
SF121-SF-6D_R2 (Util Index Rel 2) Score | C180459 | SF121-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 12 Health Survey Standard, US Version 1.0 - SF-6D_R2 (utility index release 2) score. | SF12 v1.0 Standard - SF-6D_R2 Score | ||
SF121-Time Phys/Emotional Interfered | C177870 | SF121-Time Phys/Emotional Interfered | The Short Form 12 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF12 v1.0 Standard - Time Physical Health, Emotional Interfered | ||
SF121-You Felt Downhearted and Blue | C177869 | SF121-You Felt Downhearted and Blue | The Short Form 12 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and blue? | SF12 v1.0 Standard - You Felt Downhearted and Blue | ||
Back to top | ||||||
CL.C177720.SF123TC | Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire Test Code
(SF123TC) | text
Extensible: No | C177720 | Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire Test Code | Short Form 12 Health Survey Standard, US Version 2.0 test code. | CDISC Questionnaire SF12 v2.0 Standard Test Code Terminology |
SF12301 | C177883 | SF123-In General You Say Your Health Is | The Short Form 12 Health Survey Standard, US Version 2.0 - In general, would you say your health is. | SF12 v2.0 Standard - In General You Say Your Health Is | ||
SF12302A | C177884 | SF123-Limit Moderate Activities | The Short Form 12 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF12 v2.0 Standard - Limit Moderate Activities | ||
SF12302B | C177885 | SF123-Limit Climbing Several Flights | The Short Form 12 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. | SF12 v2.0 Standard - Limit Climbing Several Flights | ||
SF12303A | C177886 | SF123-Physical: Accomplished Less | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF12 v2.0 Standard - Physical: Accomplished Less | ||
SF12303B | C177887 | SF123-Physical: Limited Kind of Work | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF12 v2.0 Standard - Physical: Limited Kind of Work | ||
SF12304A | C177888 | SF123-Emotional: Accomplished Less | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF12 v2.0 Standard - Emotional: Accomplished Less | ||
SF12304B | C177889 | SF123-Emotional: Did Work Less Carefully | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF12 v2.0 Standard - Emotional: Did Work Less Carefully | ||
SF12305 | C177890 | SF123-Pain Interfere With Normal Work | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF12 v2.0 Standard - Pain Interfere With Normal Work | ||
SF12306A | C177891 | SF123-Have You Felt Calm and Peaceful | The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful? | SF12 v2.0 Standard - Have You Felt Calm and Peaceful | ||
SF12306B | C177892 | SF123-Did You Have a Lot of Energy | The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy? | SF12 v2.0 Standard - Did You Have a Lot of Energy | ||
SF12306C | C177893 | SF123-You Felt Downhearted and Depressed | The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and depressed? | SF12 v2.0 Standard - You Felt Downhearted and Depressed | ||
SF12307 | C177894 | SF123-Time Phys/Emotional Interfered | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | SF12 v2.0 Standard - Time Physical Health, Emotional Interfered | ||
SF12308 | C180479 | SF123-Physical Functioning 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Physical functioning 0-100 score. | SF12 v2.0 Standard - Physical Functioning 0-100 Score | ||
SF12309 | C180480 | SF123-Role Physical 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Role physical 0-100 score. | SF12 v2.0 Standard - Role Physical 0-100 Score | ||
SF12310 | C180481 | SF123-Bodily Pain 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Bodily pain 0-100 score. | SF12 v2.0 Standard - Bodily Pain 0-100 Score | ||
SF12311 | C180482 | SF123-General Health 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - General health 0-100 score. | SF12 v2.0 Standard - General Health 0-100 Score | ||
SF12312 | C180483 | SF123-Vitality 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Vitality 0-100 score. | SF12 v2.0 Standard - Vitality 0-100 Score | ||
SF12313 | C180484 | SF123-Social Functioning 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Social functioning 0-100 score. | SF12 v2.0 Standard - Social Functioning 0-100 Score | ||
SF12314 | C180485 | SF123-Role Emotional 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Role emotional 0-100 score. | SF12 v2.0 Standard - Role Emotional 0-100 Score | ||
SF12315 | C180486 | SF123-Mental Health 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Mental health 0-100 score. | SF12 v2.0 Standard - Mental Health 0-100 Score | ||
SF12316 | C180487 | SF123-Phys Functioning Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Physical functioning norm-based score. | SF12 v2.0 Standard - Phys Functioning Norm-Based Score | ||
SF12317 | C180488 | SF123-Role Physical Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Role physical norm-based score. | SF12 v2.0 Standard - Role Physical Norm-Based Score | ||
SF12318 | C180489 | SF123-Bodily Pain Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Bodily pain norm-based score. | SF12 v2.0 Standard - Bodily Pain Norm-Based Score | ||
SF12319 | C180490 | SF123-General Health Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - General health norm-based score. | SF12 v2.0 Standard - General Health Norm-Based Score | ||
SF12320 | C180491 | SF123-Vitality Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Vitality norm-based score. | SF12 v2.0 Standard - Vitality Norm-Based Score | ||
SF12321 | C180492 | SF123-Social Function Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Social function norm-based score. | SF12 v2.0 Standard - Social Function Norm-Based Score | ||
SF12322 | C180493 | SF123-Role Emotional Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Role emotional norm-based score. | SF12 v2.0 Standard - Role Emotional Norm-Based Score | ||
SF12323 | C180494 | SF123-Mental Health Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Mental health norm-based score. | SF12 v2.0 Standard - Mental Health Norm-Based Score | ||
SF12324 | C180495 | SF123-Physical Component Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Physical component score. | SF12 v2.0 Standard - Physical Component Score | ||
SF12325 | C180496 | SF123-Mental Component Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Mental component score. | SF12 v2.0 Standard - Mental Component Score | ||
SF12326 | C180497 | SF123-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 12 Health Survey Standard, US Version 2.0 - SF-6D_R2 (utility index release 2) score. | SF12 v2.0 Standard - SF-6D_R2 (Util Index Rel 2) Score | ||
Back to top | ||||||
CL.C177719.SF123TN | Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire Test Name
(SF123TN) | text
Extensible: No | C177719 | Short Form 12 Health Survey Standard, US Version 2.0 Questionnaire Test Name | Short Form 12 Health Survey Standard, US Version 2.0 test name. | CDISC Questionnaire SF12 v2.0 Standard Test Name Terminology |
SF123-Bodily Pain 0-100 Score | C180481 | SF123-Bodily Pain 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Bodily pain 0-100 score. | SF12 v2.0 Standard - Bodily Pain 0-100 Score | ||
SF123-Bodily Pain Norm-Based Score | C180489 | SF123-Bodily Pain Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Bodily pain norm-based score. | SF12 v2.0 Standard - Bodily Pain Norm-Based Score | ||
SF123-Did You Have a Lot of Energy | C177892 | SF123-Did You Have a Lot of Energy | The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy? | SF12 v2.0 Standard - Did You Have a Lot of Energy | ||
SF123-Emotional: Accomplished Less | C177888 | SF123-Emotional: Accomplished Less | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF12 v2.0 Standard - Emotional: Accomplished Less | ||
SF123-Emotional: Did Work Less Carefully | C177889 | SF123-Emotional: Did Work Less Carefully | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF12 v2.0 Standard - Emotional: Did Work Less Carefully | ||
SF123-General Health 0-100 Score | C180482 | SF123-General Health 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - General health 0-100 score. | SF12 v2.0 Standard - General Health 0-100 Score | ||
SF123-General Health Norm-Based Score | C180490 | SF123-General Health Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - General health norm-based score. | SF12 v2.0 Standard - General Health Norm-Based Score | ||
SF123-Have You Felt Calm and Peaceful | C177891 | SF123-Have You Felt Calm and Peaceful | The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful? | SF12 v2.0 Standard - Have You Felt Calm and Peaceful | ||
SF123-In General You Say Your Health Is | C177883 | SF123-In General You Say Your Health Is | The Short Form 12 Health Survey Standard, US Version 2.0 - In general, would you say your health is. | SF12 v2.0 Standard - In General You Say Your Health Is | ||
SF123-Limit Climbing Several Flights | C177885 | SF123-Limit Climbing Several Flights | The Short Form 12 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. | SF12 v2.0 Standard - Limit Climbing Several Flights | ||
SF123-Limit Moderate Activities | C177884 | SF123-Limit Moderate Activities | The Short Form 12 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF12 v2.0 Standard - Limit Moderate Activities | ||
SF123-Mental Component Score | C180496 | SF123-Mental Component Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Mental component score. | SF12 v2.0 Standard - Mental Component Score | ||
SF123-Mental Health 0-100 Score | C180486 | SF123-Mental Health 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Mental health 0-100 score. | SF12 v2.0 Standard - Mental Health 0-100 Score | ||
SF123-Mental Health Norm-Based Score | C180494 | SF123-Mental Health Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Mental health norm-based score. | SF12 v2.0 Standard - Mental Health Norm-Based Score | ||
SF123-Pain Interfere With Normal Work | C177890 | SF123-Pain Interfere With Normal Work | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF12 v2.0 Standard - Pain Interfere With Normal Work | ||
SF123-Phys Functioning Norm-Based Score | C180487 | SF123-Phys Functioning Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Physical functioning norm-based score. | SF12 v2.0 Standard - Phys Functioning Norm-Based Score | ||
SF123-Physical Component Score | C180495 | SF123-Physical Component Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Physical component score. | SF12 v2.0 Standard - Physical Component Score | ||
SF123-Physical Functioning 0-100 Score | C180479 | SF123-Physical Functioning 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Physical functioning 0-100 score. | SF12 v2.0 Standard - Physical Functioning 0-100 Score | ||
SF123-Physical: Accomplished Less | C177886 | SF123-Physical: Accomplished Less | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF12 v2.0 Standard - Physical: Accomplished Less | ||
SF123-Physical: Limited Kind of Work | C177887 | SF123-Physical: Limited Kind of Work | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF12 v2.0 Standard - Physical: Limited Kind of Work | ||
SF123-Role Emotional 0-100 Score | C180485 | SF123-Role Emotional 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Role emotional 0-100 score. | SF12 v2.0 Standard - Role Emotional 0-100 Score | ||
SF123-Role Emotional Norm-Based Score | C180493 | SF123-Role Emotional Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Role emotional norm-based score. | SF12 v2.0 Standard - Role Emotional Norm-Based Score | ||
SF123-Role Physical 0-100 Score | C180480 | SF123-Role Physical 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Role physical 0-100 score. | SF12 v2.0 Standard - Role Physical 0-100 Score | ||
SF123-Role Physical Norm-Based Score | C180488 | SF123-Role Physical Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Role physical norm-based score. | SF12 v2.0 Standard - Role Physical Norm-Based Score | ||
SF123-SF-6D_R2 (Util Index Rel 2) Score | C180497 | SF123-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 12 Health Survey Standard, US Version 2.0 - SF-6D_R2 (utility index release 2) score. | SF12 v2.0 Standard - SF-6D_R2 (Util Index Rel 2) Score | ||
SF123-Social Function Norm-Based Score | C180492 | SF123-Social Function Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Social function norm-based score. | SF12 v2.0 Standard - Social Function Norm-Based Score | ||
SF123-Social Functioning 0-100 Score | C180484 | SF123-Social Functioning 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Social functioning 0-100 score. | SF12 v2.0 Standard - Social Functioning 0-100 Score | ||
SF123-Time Phys/Emotional Interfered | C177894 | SF123-Time Phys/Emotional Interfered | The Short Form 12 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? | SF12 v2.0 Standard - Time Physical Health, Emotional Interfered | ||
SF123-Vitality 0-100 Score | C180483 | SF123-Vitality 0-100 Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Vitality 0-100 score. | SF12 v2.0 Standard - Vitality 0-100 Score | ||
SF123-Vitality Norm-Based Score | C180491 | SF123-Vitality Norm-Based Score | The Short Form 12 Health Survey Standard, US Version 2.0 - Vitality norm-based score. | SF12 v2.0 Standard - Vitality Norm-Based Score | ||
SF123-You Felt Downhearted and Depressed | C177893 | SF123-You Felt Downhearted and Depressed | The Short Form 12 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and depressed? | SF12 v2.0 Standard - You Felt Downhearted and Depressed | ||
Back to top | ||||||
CL.C177706.SF82TC | Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire Test Code
(SF82TC) | text
Extensible: No | C177706 | Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire Test Code | Short Form 8 Health Survey Acute, US Version 1.0 test code. | CDISC Questionnaire SF8 v1.0 Acute Test Code Terminology |
SF8201 | C177811 | SF82-Overall How You Rate Your Health | The Short Form 8 Health Survey Acute, US Version 1.0 - Overall, how would you rate your health during the past week? | SF8 v1.0 Acute - Overall How You Rate Your Health | ||
SF8202 | C177812 | SF82-How Much Limit Physical Activities | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did physical health problems limit your usual physical activities (walking, climbing stairs)? | SF8 v1.0 Acute - How Much Limit Physical Activities | ||
SF8203 | C177813 | SF82-Difficulty Doing Daily Work | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much difficulty did you have doing your daily work, both at home and away from home, because of your physical health? | SF8 v1.0 Acute - Difficulty Doing Daily Work | ||
SF8204 | C177814 | SF82-How Much Bodily Pain Have You Had | The Short Form 8 Health Survey Acute, US Version 1.0 - How much bodily pain have you had during the past week? | SF8 v1.0 Acute - How Much Bodily Pain Have You Had | ||
SF8205 | C177815 | SF82-How Much Energy Did You Have | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much energy did you have? | SF8 v1.0 Acute - How Much Energy Did You Have | ||
SF8206 | C177816 | SF82-Physical/Emotional Limit Activities | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did your physical health or emotional problems limit your usual social activities with family or friends? | SF8 v1.0 Acute - Physical, Emotional Limit Activities | ||
SF8207 | C177817 | SF82-Bothered by Emotional Problems | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much have you been bothered by emotional problems (such as feeling anxious, depressed or irritable)? | SF8 v1.0 Acute - Bothered by Emotional Problems | ||
SF8208 | C177818 | SF82-Emotional Problems Keep From Work | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did personal or emotional problems keep you from doing your usual work, school or other daily activities? | SF8 v1.0 Acute - Emotional Problems Keep From Work | ||
SF8209 | C180434 | SF82-Phys. Functioning Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Physical functioning norm-based score. | SF8 v1.0 Acute - Physical Functioning Norm-Based Score | ||
SF8210 | C180435 | SF82-Role Physical Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Role physical norm-based score. | SF8 v1.0 Acute - Role Physical Norm-Based Score | ||
SF8211 | C180436 | SF82-Bodily Pain Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Bodily pain norm-based score. | SF8 v1.0 Acute - Bodily Pain Norm-Based Score | ||
SF8212 | C180437 | SF82-General Health Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - General health norm-based score. | SF8 v1.0 Acute - General Health Norm-Based Score | ||
SF8213 | C180438 | SF82-Vitality Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Vitality norm-based score. | SF8 v1.0 Acute - Vitality Norm-Based Score | ||
SF8214 | C180439 | SF82-Social Functioning Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Social functioning norm-based score. | SF8 v1.0 Acute - Social Functioning Norm-Based Score | ||
SF8215 | C180440 | SF82-Role Emotional Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Role emotional norm-based score. | SF8 v1.0 Acute - Role Emotional Norm-Based Score | ||
SF8216 | C180441 | SF82-Mental Health Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Mental health norm-based score. | SF8 v1.0 Acute - Mental Health Norm-Based Score | ||
SF8217 | C180442 | SF82-Physical Component Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Physical component score. | SF8 v1.0 Acute - Physical Component Score | ||
SF8218 | C180443 | SF82-Mental Component Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Mental component score. | SF8 v1.0 Acute - Mental Component Score | ||
Back to top | ||||||
CL.C177705.SF82TN | Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire Test Name
(SF82TN) | text
Extensible: No | C177705 | Short Form 8 Health Survey Acute, US Version 1.0 Questionnaire Test Name | Short Form 8 Health Survey Acute, US Version 1.0 test name. | CDISC Questionnaire SF8 v1.0 Acute Test Name Terminology |
SF82-Bodily Pain Norm-Based Score | C180436 | SF82-Bodily Pain Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Bodily pain norm-based score. | SF8 v1.0 Acute - Bodily Pain Norm-Based Score | ||
SF82-Bothered by Emotional Problems | C177817 | SF82-Bothered by Emotional Problems | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much have you been bothered by emotional problems (such as feeling anxious, depressed or irritable)? | SF8 v1.0 Acute - Bothered by Emotional Problems | ||
SF82-Difficulty Doing Daily Work | C177813 | SF82-Difficulty Doing Daily Work | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much difficulty did you have doing your daily work, both at home and away from home, because of your physical health? | SF8 v1.0 Acute - Difficulty Doing Daily Work | ||
SF82-Emotional Problems Keep From Work | C177818 | SF82-Emotional Problems Keep From Work | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did personal or emotional problems keep you from doing your usual work, school or other daily activities? | SF8 v1.0 Acute - Emotional Problems Keep From Work | ||
SF82-General Health Norm-Based Score | C180437 | SF82-General Health Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - General health norm-based score. | SF8 v1.0 Acute - General Health Norm-Based Score | ||
SF82-How Much Bodily Pain Have You Had | C177814 | SF82-How Much Bodily Pain Have You Had | The Short Form 8 Health Survey Acute, US Version 1.0 - How much bodily pain have you had during the past week? | SF8 v1.0 Acute - How Much Bodily Pain Have You Had | ||
SF82-How Much Energy Did You Have | C177815 | SF82-How Much Energy Did You Have | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much energy did you have? | SF8 v1.0 Acute - How Much Energy Did You Have | ||
SF82-How Much Limit Physical Activities | C177812 | SF82-How Much Limit Physical Activities | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did physical health problems limit your usual physical activities (walking, climbing stairs)? | SF8 v1.0 Acute - How Much Limit Physical Activities | ||
SF82-Mental Component Score | C180443 | SF82-Mental Component Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Mental component score. | SF8 v1.0 Acute - Mental Component Score | ||
SF82-Mental Health Norm-Based Score | C180441 | SF82-Mental Health Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Mental health norm-based score. | SF8 v1.0 Acute - Mental Health Norm-Based Score | ||
SF82-Overall How You Rate Your Health | C177811 | SF82-Overall How You Rate Your Health | The Short Form 8 Health Survey Acute, US Version 1.0 - Overall, how would you rate your health during the past week? | SF8 v1.0 Acute - Overall How You Rate Your Health | ||
SF82-Phys. Functioning Norm-Based Score | C180434 | SF82-Phys. Functioning Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Physical functioning norm-based score. | SF8 v1.0 Acute - Physical Functioning Norm-Based Score | ||
SF82-Physical Component Score | C180442 | SF82-Physical Component Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Physical component score. | SF8 v1.0 Acute - Physical Component Score | ||
SF82-Physical/Emotional Limit Activities | C177816 | SF82-Physical/Emotional Limit Activities | The Short Form 8 Health Survey Acute, US Version 1.0 - During the past week, how much did your physical health or emotional problems limit your usual social activities with family or friends? | SF8 v1.0 Acute - Physical, Emotional Limit Activities | ||
SF82-Role Emotional Norm-Based Score | C180440 | SF82-Role Emotional Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Role emotional norm-based score. | SF8 v1.0 Acute - Role Emotional Norm-Based Score | ||
SF82-Role Physical Norm-Based Score | C180435 | SF82-Role Physical Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Role physical norm-based score. | SF8 v1.0 Acute - Role Physical Norm-Based Score | ||
SF82-Social Functioning Norm-Based Score | C180439 | SF82-Social Functioning Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Social functioning norm-based score. | SF8 v1.0 Acute - Social Functioning Norm-Based Score | ||
SF82-Vitality Norm-Based Score | C180438 | SF82-Vitality Norm-Based Score | The Short Form 8 Health Survey Acute, US Version 1.0 - Vitality norm-based score. | SF8 v1.0 Acute - Vitality Norm-Based Score | ||
Back to top | ||||||
CL.C177708.SF81TC | Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire Test Code
(SF81TC) | text
Extensible: No | C177708 | Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire Test Code | Short Form 8 Health Survey Standard, US Version 1.0 test code. | CDISC Questionnaire SF8 v1.0 Standard Test Code Terminology |
SF8101 | C177819 | SF81-Overall How You Rate Your Health | The Short Form 8 Health Survey Standard, US Version 1.0 - Overall, how would you rate your health during the past 4 weeks? | SF8 v1.0 Standard - Overall How You Rate Your Health | ||
SF8102 | C177820 | SF81-How Much Limit Physical Activities | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did physical health problems limit your usual physical activities (walking, climbing stairs)?. | SF8 v1.0 Standard - How Much Limit Physical Activities | ||
SF8103 | C177821 | SF81-Difficulty Doing Daily Work | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much difficulty did you have doing your daily work, both at home and away from home, because of your physical health? | SF8 v1.0 Standard - Difficulty Doing Daily Work | ||
SF8104 | C177822 | SF81-How Much Bodily Pain You Have Had | The Short Form 8 Health Survey Standard, US Version 1.0 - How much bodily pain have you had during the past 4 weeks? | SF8 v1.0 Standard - How Much Bodily Pain You Have Had | ||
SF8105 | C177823 | SF81-How Much Energy Did You Have | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much energy did you have? | SF8 v1.0 Standard - How Much Energy Did You Have | ||
SF8106 | C177824 | SF81-Physical/Emotional Limit Activities | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did your physical health or emotional problems limit your usual social activities with family or friends? | SF8 v1.0 Standard - Physical, Emotional Limit Activities | ||
SF8107 | C177825 | SF81-Bothered by Emotional Problems | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much have you been bothered by emotional problems (such as feeling anxious, depressed or irritable)? | SF8 v1.0 Standard - Bothered by Emotional Problems | ||
SF8108 | C177826 | SF81-Emotional Problems Keep From Work | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did personal or emotional problems keep you from doing your usual work, school or other daily activities? | SF8 v1.0 Standard - Emotional Problems Keep From Work | ||
SF8109 | C180444 | SF81-Phys. Functioning Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Physical functioning norm-based score. | SF8 v1.0 Standard - Physical Functioning Norm-Based Score | ||
SF8110 | C180445 | SF81-Role Physical Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Role physical norm-based score. | SF8 v1.0 Standard - Role Physical Norm-Based Score | ||
SF8111 | C180446 | SF81-Bodily Pain Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Bodily pain norm-based score. | SF8 v1.0 Standard - Bodily Pain Norm-Based Score | ||
SF8112 | C180447 | SF81-General Health Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - General health norm-based score. | SF8 v1.0 Standard - General Health Norm-Based Score | ||
SF8113 | C180448 | SF81-Vitality Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Vitality norm-based score. | SF8 v1.0 Standard - Vitality Norm-Based Score | ||
SF8114 | C180449 | SF81-Social Functioning Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Social functioning norm-based score. | SF8 v1.0 Standard - Social Functioning Norm-Based Score | ||
SF8115 | C180450 | SF81-Role Emotional Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Role emotional norm-based score. | SF8 v1.0 Standard - Role Emotional Norm-Based Score | ||
SF8116 | C180451 | SF81-Mental Health Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Mental health norm-based score. | SF8 v1.0 Standard - Mental Health Norm-Based Score | ||
SF8117 | C180452 | SF81-Physical Component Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Physical component score. | SF8 v1.0 Standard - Physical Component Score | ||
SF8118 | C180453 | SF81-Mental Component Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Mental component score. | SF8 v1.0 Standard - Mental Component Score | ||
Back to top | ||||||
CL.C177707.SF81TN | Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire Test Name
(SF81TN) | text
Extensible: No | C177707 | Short Form 8 Health Survey Standard, US Version 1.0 Questionnaire Test Name | Short Form 8 Health Survey Standard, US Version 1.0 test name. | CDISC Questionnaire SF8 v1.0 Standard Test Name Terminology |
SF81-Bodily Pain Norm-Based Score | C180446 | SF81-Bodily Pain Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Bodily pain norm-based score. | SF8 v1.0 Standard - Bodily Pain Norm-Based Score | ||
SF81-Bothered by Emotional Problems | C177825 | SF81-Bothered by Emotional Problems | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much have you been bothered by emotional problems (such as feeling anxious, depressed or irritable)? | SF8 v1.0 Standard - Bothered by Emotional Problems | ||
SF81-Difficulty Doing Daily Work | C177821 | SF81-Difficulty Doing Daily Work | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much difficulty did you have doing your daily work, both at home and away from home, because of your physical health? | SF8 v1.0 Standard - Difficulty Doing Daily Work | ||
SF81-Emotional Problems Keep From Work | C177826 | SF81-Emotional Problems Keep From Work | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did personal or emotional problems keep you from doing your usual work, school or other daily activities? | SF8 v1.0 Standard - Emotional Problems Keep From Work | ||
SF81-General Health Norm-Based Score | C180447 | SF81-General Health Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - General health norm-based score. | SF8 v1.0 Standard - General Health Norm-Based Score | ||
SF81-How Much Bodily Pain You Have Had | C177822 | SF81-How Much Bodily Pain You Have Had | The Short Form 8 Health Survey Standard, US Version 1.0 - How much bodily pain have you had during the past 4 weeks? | SF8 v1.0 Standard - How Much Bodily Pain You Have Had | ||
SF81-How Much Energy Did You Have | C177823 | SF81-How Much Energy Did You Have | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much energy did you have? | SF8 v1.0 Standard - How Much Energy Did You Have | ||
SF81-How Much Limit Physical Activities | C177820 | SF81-How Much Limit Physical Activities | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did physical health problems limit your usual physical activities (walking, climbing stairs)?. | SF8 v1.0 Standard - How Much Limit Physical Activities | ||
SF81-Mental Component Score | C180453 | SF81-Mental Component Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Mental component score. | SF8 v1.0 Standard - Mental Component Score | ||
SF81-Mental Health Norm-Based Score | C180451 | SF81-Mental Health Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Mental health norm-based score. | SF8 v1.0 Standard - Mental Health Norm-Based Score | ||
SF81-Overall How You Rate Your Health | C177819 | SF81-Overall How You Rate Your Health | The Short Form 8 Health Survey Standard, US Version 1.0 - Overall, how would you rate your health during the past 4 weeks? | SF8 v1.0 Standard - Overall How You Rate Your Health | ||
SF81-Phys. Functioning Norm-Based Score | C180444 | SF81-Phys. Functioning Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Physical functioning norm-based score. | SF8 v1.0 Standard - Physical Functioning Norm-Based Score | ||
SF81-Physical Component Score | C180452 | SF81-Physical Component Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Physical component score. | SF8 v1.0 Standard - Physical Component Score | ||
SF81-Physical/Emotional Limit Activities | C177824 | SF81-Physical/Emotional Limit Activities | The Short Form 8 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did your physical health or emotional problems limit your usual social activities with family or friends? | SF8 v1.0 Standard - Physical, Emotional Limit Activities | ||
SF81-Role Emotional Norm-Based Score | C180450 | SF81-Role Emotional Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Role emotional norm-based score. | SF8 v1.0 Standard - Role Emotional Norm-Based Score | ||
SF81-Role Physical Norm-Based Score | C180445 | SF81-Role Physical Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Role physical norm-based score. | SF8 v1.0 Standard - Role Physical Norm-Based Score | ||
SF81-Social Functioning Norm-Based Score | C180449 | SF81-Social Functioning Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Social functioning norm-based score. | SF8 v1.0 Standard - Social Functioning Norm-Based Score | ||
SF81-Vitality Norm-Based Score | C180448 | SF81-Vitality Norm-Based Score | The Short Form 8 Health Survey Standard, US Version 1.0 - Vitality norm-based score. | SF8 v1.0 Standard - Vitality Norm-Based Score | ||
Back to top | ||||||
CL.C170527.SPPB1TC | Short Physical Performance Battery Version 1.2 Functional Test Test Code
(SPPB1TC) | text
Extensible: No | C170527 | Short Physical Performance Battery Version 1.2 Functional Test Test Code | Short Physical Performance Battery Version 1.2 test code. | CDISC Functional Test SPPB Version 1.2 Test Code Terminology |
SPPB101 | C170693 | SPPB1-Side-by-Side Score | Short Physical Performance Battery V1.2 - Side-By-Side Stand: Side-by-side score. | SPPB Version 1.2 - Side-by-Side Score | ||
SPPB101A | C170694 | SPPB1-Side-by-Side Seconds Held If <10 | Short Physical Performance Battery V1.2 - Side-By-Side Stand: Number of seconds held if less than 10 sec. | SPPB Version 1.2 - Side-by-Side Seconds Held If <10 | ||
SPPB102 | C170695 | SPPB1-Semi-Tandem Stand Score | Short Physical Performance Battery V1.2 - Semi-Tandem Stand: Semi-tandem stand score. | SPPB Version 1.2 - Semi-Tandem Stand Score | ||
SPPB102A | C170696 | SPPB1-Semi-Tandem Seconds Held If <10 | Short Physical Performance Battery V1.2 - Semi-Tandem Stand: Number of seconds held if less than 10 sec. | SPPB Version 1.2 - Semi-Tandem Seconds Held If <10 | ||
SPPB103 | C170697 | SPPB1-Tandem Stand Score | Short Physical Performance Battery V1.2 - Tandem Stand: Tandem stand score. | SPPB Version 1.2 - Tandem Stand Score | ||
SPPB103A | C170698 | SPPB1-Tandem Seconds If <10 | Short Physical Performance Battery V1.2 - Tandem Stand: Number of seconds if less than 10 sec. | SPPB Version 1.2 - Tandem Seconds If <10 | ||
SPPB104 | C170699 | SPPB1-Did Not Attempt Test Balance | Short Physical Performance Battery V1.2 - Balance Tests: If participant did not attempt test. | SPPB Version 1.2 - Did Not Attempt Test Balance | ||
SPPB104A | C170700 | SPPB1-Did Not Attempt Balance Specify | Short Physical Performance Battery V1.2 - Balance Tests: If participant did not attempt test: Other (specify). | SPPB Version 1.2 - Did Not Attempt Balance Specify | ||
SPPB105 | C170701 | SPPB1-Total Balance Tests Score | Short Physical Performance Battery V1.2 - Total balance tests score. | SPPB Version 1.2 - Total Balance Tests Score | ||
SPPB106 | C170702 | SPPB1-Length of Walk Test Course | Short Physical Performance Battery V1.2 - Gait Speed Test: Length of walk test course. | SPPB Version 1.2 - Length of Walk Test Course | ||
SPPB107 | C170703 | SPPB1-Time for 3 or 4 Meters 1st Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Time for 3 or 4 meters. | SPPB Version 1.2 - Time for 3 or 4 Meters 1st Gait | ||
SPPB107A | C170704 | SPPB1-Did Not Attempt 1st Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: If participant did not attempt test. | SPPB Version 1.2 - Did Not Attempt 1st Gait | ||
SPPB107B | C170705 | SPPB1-Did Not Attempt 1st Gait Specify | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: If participant did not attempt test: Other (specify). | SPPB Version 1.2 - Did Not Attempt 1st Gait Specify | ||
SPPB107C | C170706 | SPPB1-Aids Used 1st Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Aids used for first walk. | SPPB Version 1.2 - Aids Used 1st Gait | ||
SPPB107D | C170707 | SPPB1-Aids Used 1st Gait Specify | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Aids used for first walk: Other (specify). | SPPB Version 1.2 - Aids Used 1st Gait Specify | ||
SPPB108 | C170708 | SPPB1-Time for 3 or 4 Meters - 2nd Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Time for 3 or 4 meters. | SPPB Version 1.2 - Time for 3 or 4 Meters - 2nd Gait | ||
SPPB108A | C170709 | SPPB1-Did Not Attempt or Failed 2nd Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: If participant did not attempt or failed. | SPPB Version 1.2 - Did Not Attempt or Failed 2nd Gait | ||
SPPB108B | C170710 | SPPB1-Did Not Attempt 2nd Gait Specify | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: If participant did not attempt or failed: Other (specify). | SPPB Version 1.2 - Did Not Attempt 2nd Gait Specify | ||
SPPB108C | C170711 | SPPB1-Aids Used 2nd Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Aids used for second walk. | SPPB Version 1.2 - Aids Used 2nd Gait | ||
SPPB108D | C170712 | SPPB1-Aids Used 2nd Gait Specify | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Aids used for second walk: Other (specify). | SPPB Version 1.2 - Aids Used 2nd Gait Specify | ||
SPPB109A | C170713 | SPPB1-For 4-Meter Walk | Short Physical Performance Battery V1.2 - Gait Speed Test: For 4-meter walk. | SPPB Version 1.2 - For 4-Meter Walk | ||
SPPB109B | C170714 | SPPB1-For 3-Meter Walk | Short Physical Performance Battery V1.2 - Gait Speed Test: For 3-meter walk. | SPPB Version 1.2 - For 3-Meter Walk | ||
SPPB110 | C170715 | SPPB1-Safe to Stand Without Help | Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: Safe to stand without help. | SPPB Version 1.2 - Safe to Stand Without Help | ||
SPPB111 | C170716 | SPPB1-Results Single Chair | Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: Results. | SPPB Version 1.2 - Results Single Chair | ||
SPPB111A | C170717 | SPPB1-Did Not Attempt Single Chair | Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: If participant did not attempt or failed. | SPPB Version 1.2 - Did Not Attempt Single Chair | ||
SPPB111B | C170718 | SPPB1-Not Attempt Single Chair Specify | Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: If participant did not attempt or failed: Other (specify). | SPPB Version 1.2 - Not Attempt Single Chair Specify | ||
SPPB112 | C170719 | SPPB1-Safe to Stand Five Times | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Safe to stand five times. | SPPB Version 1.2 - Safe to Stand Five Times | ||
SPPB113 | C170720 | SPPB1-Time to Complete Five Stands | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Time to complete five stands. | SPPB Version 1.2 - Time to Complete Five Stands | ||
SPPB113A | C170721 | SPPB1-Did Not Attempt Repeated Chair | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: If participant did not attempt test or failed. | SPPB Version 1.2 - Did Not Attempt Repeated Chair | ||
SPPB113B | C170722 | SPPB1-Not Attempt Repeated Chair Specify | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: If participant did not attempt test or failed: Other (specify). | SPPB Version 1.2 - Not Attempt Repeated Chair Specify | ||
SPPB113C | C170723 | SPPB1-Chair Stand Score Repeated | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Chair stand score. | SPPB Version 1.2 - Chair Stand Score Repeated | ||
SPPB114 | C170724 | SPPB1-Total Score | Short Physical Performance Battery V1.2 - Total score. | SPPB Version 1.2 - Total Score | ||
Back to top | ||||||
CL.C170526.SPPB1TN | Short Physical Performance Battery Version 1.2 Functional Test Test Name
(SPPB1TN) | text
Extensible: No | C170526 | Short Physical Performance Battery Version 1.2 Functional Test Test Name | Short Physical Performance Battery Version 1.2 test name. | CDISC Functional Test SPPB Version 1.2 Test Name Terminology |
SPPB1-Aids Used 1st Gait Specify | C170707 | SPPB1-Aids Used 1st Gait Specify | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Aids used for first walk: Other (specify). | SPPB Version 1.2 - Aids Used 1st Gait Specify | ||
SPPB1-Aids Used 1st Gait | C170706 | SPPB1-Aids Used 1st Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Aids used for first walk. | SPPB Version 1.2 - Aids Used 1st Gait | ||
SPPB1-Aids Used 2nd Gait Specify | C170712 | SPPB1-Aids Used 2nd Gait Specify | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Aids used for second walk: Other (specify). | SPPB Version 1.2 - Aids Used 2nd Gait Specify | ||
SPPB1-Aids Used 2nd Gait | C170711 | SPPB1-Aids Used 2nd Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Aids used for second walk. | SPPB Version 1.2 - Aids Used 2nd Gait | ||
SPPB1-Chair Stand Score Repeated | C170723 | SPPB1-Chair Stand Score Repeated | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Chair stand score. | SPPB Version 1.2 - Chair Stand Score Repeated | ||
SPPB1-Did Not Attempt 1st Gait Specify | C170705 | SPPB1-Did Not Attempt 1st Gait Specify | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: If participant did not attempt test: Other (specify). | SPPB Version 1.2 - Did Not Attempt 1st Gait Specify | ||
SPPB1-Did Not Attempt 1st Gait | C170704 | SPPB1-Did Not Attempt 1st Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: If participant did not attempt test. | SPPB Version 1.2 - Did Not Attempt 1st Gait | ||
SPPB1-Did Not Attempt 2nd Gait Specify | C170710 | SPPB1-Did Not Attempt 2nd Gait Specify | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: If participant did not attempt or failed: Other (specify). | SPPB Version 1.2 - Did Not Attempt 2nd Gait Specify | ||
SPPB1-Did Not Attempt Balance Specify | C170700 | SPPB1-Did Not Attempt Balance Specify | Short Physical Performance Battery V1.2 - Balance Tests: If participant did not attempt test: Other (specify). | SPPB Version 1.2 - Did Not Attempt Balance Specify | ||
SPPB1-Did Not Attempt or Failed 2nd Gait | C170709 | SPPB1-Did Not Attempt or Failed 2nd Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: If participant did not attempt or failed. | SPPB Version 1.2 - Did Not Attempt or Failed 2nd Gait | ||
SPPB1-Did Not Attempt Repeated Chair | C170721 | SPPB1-Did Not Attempt Repeated Chair | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: If participant did not attempt test or failed. | SPPB Version 1.2 - Did Not Attempt Repeated Chair | ||
SPPB1-Did Not Attempt Single Chair | C170717 | SPPB1-Did Not Attempt Single Chair | Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: If participant did not attempt or failed. | SPPB Version 1.2 - Did Not Attempt Single Chair | ||
SPPB1-Did Not Attempt Test Balance | C170699 | SPPB1-Did Not Attempt Test Balance | Short Physical Performance Battery V1.2 - Balance Tests: If participant did not attempt test. | SPPB Version 1.2 - Did Not Attempt Test Balance | ||
SPPB1-For 3-Meter Walk | C170714 | SPPB1-For 3-Meter Walk | Short Physical Performance Battery V1.2 - Gait Speed Test: For 3-meter walk. | SPPB Version 1.2 - For 3-Meter Walk | ||
SPPB1-For 4-Meter Walk | C170713 | SPPB1-For 4-Meter Walk | Short Physical Performance Battery V1.2 - Gait Speed Test: For 4-meter walk. | SPPB Version 1.2 - For 4-Meter Walk | ||
SPPB1-Length of Walk Test Course | C170702 | SPPB1-Length of Walk Test Course | Short Physical Performance Battery V1.2 - Gait Speed Test: Length of walk test course. | SPPB Version 1.2 - Length of Walk Test Course | ||
SPPB1-Not Attempt Repeated Chair Specify | C170722 | SPPB1-Not Attempt Repeated Chair Specify | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: If participant did not attempt test or failed: Other (specify). | SPPB Version 1.2 - Not Attempt Repeated Chair Specify | ||
SPPB1-Not Attempt Single Chair Specify | C170718 | SPPB1-Not Attempt Single Chair Specify | Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: If participant did not attempt or failed: Other (specify). | SPPB Version 1.2 - Not Attempt Single Chair Specify | ||
SPPB1-Results Single Chair | C170716 | SPPB1-Results Single Chair | Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: Results. | SPPB Version 1.2 - Results Single Chair | ||
SPPB1-Safe to Stand Five Times | C170719 | SPPB1-Safe to Stand Five Times | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Safe to stand five times. | SPPB Version 1.2 - Safe to Stand Five Times | ||
SPPB1-Safe to Stand Without Help | C170715 | SPPB1-Safe to Stand Without Help | Short Physical Performance Battery V1.2 - Chair Stand Test - Single Chair Stand Test: Safe to stand without help. | SPPB Version 1.2 - Safe to Stand Without Help | ||
SPPB1-Semi-Tandem Seconds Held If <10 | C170696 | SPPB1-Semi-Tandem Seconds Held If <10 | Short Physical Performance Battery V1.2 - Semi-Tandem Stand: Number of seconds held if less than 10 sec. | SPPB Version 1.2 - Semi-Tandem Seconds Held If <10 | ||
SPPB1-Semi-Tandem Stand Score | C170695 | SPPB1-Semi-Tandem Stand Score | Short Physical Performance Battery V1.2 - Semi-Tandem Stand: Semi-tandem stand score. | SPPB Version 1.2 - Semi-Tandem Stand Score | ||
SPPB1-Side-by-Side Score | C170693 | SPPB1-Side-by-Side Score | Short Physical Performance Battery V1.2 - Side-By-Side Stand: Side-by-side score. | SPPB Version 1.2 - Side-by-Side Score | ||
SPPB1-Side-by-Side Seconds Held If <10 | C170694 | SPPB1-Side-by-Side Seconds Held If <10 | Short Physical Performance Battery V1.2 - Side-By-Side Stand: Number of seconds held if less than 10 sec. | SPPB Version 1.2 - Side-by-Side Seconds Held If <10 | ||
SPPB1-Tandem Seconds If <10 | C170698 | SPPB1-Tandem Seconds If <10 | Short Physical Performance Battery V1.2 - Tandem Stand: Number of seconds if less than 10 sec. | SPPB Version 1.2 - Tandem Seconds If <10 | ||
SPPB1-Tandem Stand Score | C170697 | SPPB1-Tandem Stand Score | Short Physical Performance Battery V1.2 - Tandem Stand: Tandem stand score. | SPPB Version 1.2 - Tandem Stand Score | ||
SPPB1-Time for 3 or 4 Meters - 2nd Gait | C170708 | SPPB1-Time for 3 or 4 Meters - 2nd Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - Second Gait Speed Test: Time for 3 or 4 meters. | SPPB Version 1.2 - Time for 3 or 4 Meters - 2nd Gait | ||
SPPB1-Time for 3 or 4 Meters 1st Gait | C170703 | SPPB1-Time for 3 or 4 Meters 1st Gait | Short Physical Performance Battery V1.2 - Gait Speed Test - First Gait Speed Test: Time for 3 or 4 meters. | SPPB Version 1.2 - Time for 3 or 4 Meters 1st Gait | ||
SPPB1-Time to Complete Five Stands | C170720 | SPPB1-Time to Complete Five Stands | Short Physical Performance Battery V1.2 - Chair Stand Test - Repeated Chair Stand Test: Time to complete five stands. | SPPB Version 1.2 - Time to Complete Five Stands | ||
SPPB1-Total Balance Tests Score | C170701 | SPPB1-Total Balance Tests Score | Short Physical Performance Battery V1.2 - Total balance tests score. | SPPB Version 1.2 - Total Balance Tests Score | ||
SPPB1-Total Score | C170724 | SPPB1-Total Score | Short Physical Performance Battery V1.2 - Total score. | SPPB Version 1.2 - Total Score | ||
Back to top | ||||||
CL.C100156.SFMP2TC | Short-Form McGill Pain Questionnaire-2 Questionnaire Test Code
(SFMP2TC) | text
Extensible: No | C100156 | Short-Form McGill Pain Questionnaire-2 Questionnaire Test Code | Short-Form McGill Pain Questionnaire-2 test code. | CDISC Questionnaire Short-Form MPQ-2 Test Code Terminology |
SFMP201 | C100849 | SFMP2-Throbbing Pain | Short-Form McGill Pain Questionnaire-2 - Throbbing pain. | SF-MPQ-2 - Throbbing Pain | ||
SFMP202 | C100850 | SFMP2-Shooting Pain | Short-Form McGill Pain Questionnaire-2 - Shooting pain. | SF-MPQ-2 - Shooting Pain | ||
SFMP203 | C100851 | SFMP2-Stabbing Pain | Short-Form McGill Pain Questionnaire-2 - Stabbing pain. | SF-MPQ-2 - Stabbing Pain | ||
SFMP204 | C100852 | SFMP2-Sharp Pain | Short-Form McGill Pain Questionnaire-2 - Sharp pain. | SF-MPQ-2 - Sharp Pain | ||
SFMP205 | C100853 | SFMP2-Cramping Pain | Short-Form McGill Pain Questionnaire-2 - Cramping pain. | SF-MPQ-2 - Cramping Pain | ||
SFMP206 | C100854 | SFMP2-Gnawing Pain | Short-Form McGill Pain Questionnaire-2 - Gnawing pain. | SF-MPQ-2 - Gnawing Pain | ||
SFMP207 | C100855 | SFMP2-Hot-burning Pain | Short-Form McGill Pain Questionnaire-2 - Hot-burning pain. | SF-MPQ-2 - Hot-burning Pain | ||
SFMP208 | C100856 | SFMP2-Aching Pain | Short-Form McGill Pain Questionnaire-2 - Aching pain. | SF-MPQ-2 - Aching Pain | ||
SFMP209 | C100857 | SFMP2-Heavy Pain | Short-Form McGill Pain Questionnaire-2 - Heavy pain. | SF-MPQ-2 - Heavy Pain | ||
SFMP210 | C100858 | SFMP2-Tender | Short-Form McGill Pain Questionnaire-2 - Tender. | SF-MPQ-2 - Tender | ||
SFMP211 | C100859 | SFMP2-Splitting Pain | Short-Form McGill Pain Questionnaire-2 - Splitting pain. | SF-MPQ-2 - Splitting Pain | ||
SFMP212 | C100860 | SFMP2-Tiring-Exhausting | Short-Form McGill Pain Questionnaire-2 - Tiring-exhausting. | SF-MPQ-2 - Tiring-Exhausting | ||
SFMP213 | C100861 | SFMP2-Sickening | Short-Form McGill Pain Questionnaire-2 - Sickening. | SF-MPQ-2 - Sickening | ||
SFMP214 | C100862 | SFMP2-Fearful | Short-Form McGill Pain Questionnaire-2 - Fearful. | SF-MPQ-2 - Fearful | ||
SFMP215 | C100863 | SFMP2-Punishing-Cruel | Short-Form McGill Pain Questionnaire-2 - Punishing-cruel. | SF-MPQ-2 - Punishing-Cruel | ||
SFMP216 | C100864 | SFMP2-Electric-Shock Pain | Short-Form McGill Pain Questionnaire-2 - Electric-shock pain. | SF-MPQ-2 - Electric-Shock Pain | ||
SFMP217 | C100865 | SFMP2-Cold-Freezing Pain | Short-Form McGill Pain Questionnaire-2 - Cold-freezing pain. | SF-MPQ-2 - Cold-Freezing Pain | ||
SFMP218 | C100866 | SFMP2-Piercing | Short-Form McGill Pain Questionnaire-2 - Piercing. | SF-MPQ-2 - Piercing | ||
SFMP219 | C100867 | SFMP2-Pain Caused by Light Touch | Short-Form McGill Pain Questionnaire-2 - Pain caused by light touch. | SF-MPQ-2 - Pain Caused by Light Touch | ||
SFMP220 | C100868 | SFMP2-Itching | Short-Form McGill Pain Questionnaire-2 - Itching. | SF-MPQ-2 - Itching | ||
SFMP221 | C101021 | SFMP2-Tingling or 'Pins and Needles' | Short-Form McGill Pain Questionnaire-2 - Tingling or 'pins and needles'. | SF-MPQ-2 - Tingling or 'Pins and Needles' | ||
SFMP222 | C100869 | SFMP2-Numbness | Short-Form McGill Pain Questionnaire-2 - Numbness. | SF-MPQ-2 - Numbness | ||
Back to top | ||||||
CL.C100155.SFMP2TN | Short-Form McGill Pain Questionnaire-2 Questionnaire Test Name
(SFMP2TN) | text
Extensible: No | C100155 | Short-Form McGill Pain Questionnaire-2 Questionnaire Test Name | Short-Form McGill Pain Questionnaire-2 test name. | CDISC Questionnaire Short-Form MPQ-2 Test Name Terminology |
SFMP2-Aching Pain | C100856 | SFMP2-Aching Pain | Short-Form McGill Pain Questionnaire-2 - Aching pain. | SF-MPQ-2 - Aching Pain | ||
SFMP2-Cold-Freezing Pain | C100865 | SFMP2-Cold-Freezing Pain | Short-Form McGill Pain Questionnaire-2 - Cold-freezing pain. | SF-MPQ-2 - Cold-Freezing Pain | ||
SFMP2-Cramping Pain | C100853 | SFMP2-Cramping Pain | Short-Form McGill Pain Questionnaire-2 - Cramping pain. | SF-MPQ-2 - Cramping Pain | ||
SFMP2-Electric-Shock Pain | C100864 | SFMP2-Electric-Shock Pain | Short-Form McGill Pain Questionnaire-2 - Electric-shock pain. | SF-MPQ-2 - Electric-Shock Pain | ||
SFMP2-Fearful | C100862 | SFMP2-Fearful | Short-Form McGill Pain Questionnaire-2 - Fearful. | SF-MPQ-2 - Fearful | ||
SFMP2-Gnawing Pain | C100854 | SFMP2-Gnawing Pain | Short-Form McGill Pain Questionnaire-2 - Gnawing pain. | SF-MPQ-2 - Gnawing Pain | ||
SFMP2-Heavy Pain | C100857 | SFMP2-Heavy Pain | Short-Form McGill Pain Questionnaire-2 - Heavy pain. | SF-MPQ-2 - Heavy Pain | ||
SFMP2-Hot-burning Pain | C100855 | SFMP2-Hot-burning Pain | Short-Form McGill Pain Questionnaire-2 - Hot-burning pain. | SF-MPQ-2 - Hot-burning Pain | ||
SFMP2-Itching | C100868 | SFMP2-Itching | Short-Form McGill Pain Questionnaire-2 - Itching. | SF-MPQ-2 - Itching | ||
SFMP2-Numbness | C100869 | SFMP2-Numbness | Short-Form McGill Pain Questionnaire-2 - Numbness. | SF-MPQ-2 - Numbness | ||
SFMP2-Pain Caused by Light Touch | C100867 | SFMP2-Pain Caused by Light Touch | Short-Form McGill Pain Questionnaire-2 - Pain caused by light touch. | SF-MPQ-2 - Pain Caused by Light Touch | ||
SFMP2-Piercing | C100866 | SFMP2-Piercing | Short-Form McGill Pain Questionnaire-2 - Piercing. | SF-MPQ-2 - Piercing | ||
SFMP2-Punishing-Cruel | C100863 | SFMP2-Punishing-Cruel | Short-Form McGill Pain Questionnaire-2 - Punishing-cruel. | SF-MPQ-2 - Punishing-Cruel | ||
SFMP2-Sharp Pain | C100852 | SFMP2-Sharp Pain | Short-Form McGill Pain Questionnaire-2 - Sharp pain. | SF-MPQ-2 - Sharp Pain | ||
SFMP2-Shooting Pain | C100850 | SFMP2-Shooting Pain | Short-Form McGill Pain Questionnaire-2 - Shooting pain. | SF-MPQ-2 - Shooting Pain | ||
SFMP2-Sickening | C100861 | SFMP2-Sickening | Short-Form McGill Pain Questionnaire-2 - Sickening. | SF-MPQ-2 - Sickening | ||
SFMP2-Splitting Pain | C100859 | SFMP2-Splitting Pain | Short-Form McGill Pain Questionnaire-2 - Splitting pain. | SF-MPQ-2 - Splitting Pain | ||
SFMP2-Stabbing Pain | C100851 | SFMP2-Stabbing Pain | Short-Form McGill Pain Questionnaire-2 - Stabbing pain. | SF-MPQ-2 - Stabbing Pain | ||
SFMP2-Tender | C100858 | SFMP2-Tender | Short-Form McGill Pain Questionnaire-2 - Tender. | SF-MPQ-2 - Tender | ||
SFMP2-Throbbing Pain | C100849 | SFMP2-Throbbing Pain | Short-Form McGill Pain Questionnaire-2 - Throbbing pain. | SF-MPQ-2 - Throbbing Pain | ||
SFMP2-Tingling or 'Pins and Needles' | C101021 | SFMP2-Tingling or 'Pins and Needles' | Short-Form McGill Pain Questionnaire-2 - Tingling or 'pins and needles'. | SF-MPQ-2 - Tingling or 'Pins and Needles' | ||
SFMP2-Tiring-Exhausting | C100860 | SFMP2-Tiring-Exhausting | Short-Form McGill Pain Questionnaire-2 - Tiring-exhausting. | SF-MPQ-2 - Tiring-Exhausting | ||
Back to top | ||||||
CL.C176051.SES01TC | Simple Endoscopic Score for Crohn's Disease Version 1 Clinical Classification Test Code
(SES01TC) | text
Extensible: No | C176051 | Simple Endoscopic Score for Crohn's Disease Version 1 Clinical Classification Test Code | Simple Endoscopic Score for Crohn's Disease Version 1 test code. | CDISC Clinical Classification SES-CD Version 1 Test Code Terminology |
SES0101 | C176090 | SES01-Ileum: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was ileum explored? | SES-CD Version 1 - Ileum: Explored | ||
SES0102 | C176091 | SES01-Ileum: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - ileum. | SES-CD Version 1 - Ileum: Size of Ulcers | ||
SES0103 | C176092 | SES01-Ileum: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - ileum. | SES-CD Version 1 - Ileum: Ulcerated Surface | ||
SES0104 | C176093 | SES01-Ileum: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - ileum. | SES-CD Version 1 - Ileum: Affected Surface | ||
SES0105 | C176094 | SES01-Ileum: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - ileum. | SES-CD Version 1 - Ileum: Presence of Narrowing | ||
SES0106 | C176095 | SES01-Right Colon: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was right colon explored? | SES-CD Version 1 - Right Colon: Explored | ||
SES0107 | C176096 | SES01-Right Colon: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - right colon. | SES-CD Version 1 - Right Colon: Size of Ulcers | ||
SES0108 | C176097 | SES01-Right Colon: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - right colon. | SES-CD Version 1 - Right Colon: Ulcerated Surface | ||
SES0109 | C176098 | SES01-Right Colon: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - right colon. | SES-CD Version 1 - Right Colon: Affected Surface | ||
SES0110 | C176099 | SES01-Right Colon: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - right colon. | SES-CD Version 1 - Right Colon: Presence of Narrowing | ||
SES0111 | C176100 | SES01-Trans Colon: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was transverse colon explored? | SES-CD Version 1 - Trans Colon: Explored | ||
SES0112 | C176101 | SES01-Trans Colon: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - transverse colon. | SES-CD Version 1 - Trans Colon: Size of Ulcers | ||
SES0113 | C176102 | SES01-Trans Colon: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - transverse colon. | SES-CD Version 1 - Trans Colon: Ulcerated Surface | ||
SES0114 | C176103 | SES01-Trans Colon: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - transverse colon. | SES-CD Version 1 - Trans Colon: Affected Surface | ||
SES0115 | C176104 | SES01-Trans Colon: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - transverse colon. | SES-CD Version 1 - Trans Colon: Presence of Narrowing | ||
SES0116 | C176105 | SES01-Left Colon: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was sigmoid and left colon explored? | SES-CD Version 1 - Left Colon: Explored | ||
SES0117 | C176106 | SES01-Left Colon: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - sigmoid and left colon. | SES-CD Version 1 - Left Colon: Size of Ulcers | ||
SES0118 | C176107 | SES01-Left Colon: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - sigmoid and left colon. | SES-CD Version 1 - Left Colon: Ulcerated Surface | ||
SES0119 | C176108 | SES01-Left Colon: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - sigmoid and left colon. | SES-CD Version 1 - Left Colon: Affected Surface | ||
SES0120 | C176109 | SES01-Left Colon: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - sigmoid and left colon. | SES-CD Version 1 - Left Colon: Presence of Narrowing | ||
SES0121 | C176110 | SES01-Rectum: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was rectum explored? | SES-CD Version 1 - Rectum: Explored | ||
SES0122 | C176111 | SES01-Rectum: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - rectum. | SES-CD Version 1 - Rectum: Size of Ulcers | ||
SES0123 | C176112 | SES01-Rectum: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - rectum. | SES-CD Version 1 - Rectum: Ulcerated Surface | ||
SES0124 | C176113 | SES01-Rectum: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - rectum. | SES-CD Version 1 - Rectum: Affected Surface | ||
SES0125 | C176114 | SES01-Rectum: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - rectum. | SES-CD Version 1 - Rectum: Presence of Narrowing | ||
SES0126 | C176115 | SES01-Ileum Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Ileum subscore. | SES-CD Version 1 - Ileum Subscore | ||
SES0127 | C176116 | SES01-Right Colon Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Right colon subscore. | SES-CD Version 1 - Right Colon Subscore | ||
SES0128 | C176117 | SES01-Trans Colon Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Transverse colon subscore. | SES-CD Version 1 - Trans Colon Subscore | ||
SES0129 | C176118 | SES01-Left Colon Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Sigmoid and left colon subscore. | SES-CD Version 1 - Left Colon Subscore | ||
SES0130 | C176119 | SES01-Rectum Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Rectum subscore. | SES-CD Version 1 - Rectum Subscore | ||
SES0131 | C176120 | SES01-Total Score | Simple Endoscopic Score for Crohn's Disease Version 1 - SES-CD total score. | SES-CD Version 1 - Total Score | ||
Back to top | ||||||
CL.C176050.SES01TN | Simple Endoscopic Score for Crohn's Disease Version 1 Clinical Classification Test Name
(SES01TN) | text
Extensible: No | C176050 | Simple Endoscopic Score for Crohn's Disease Version 1 Clinical Classification Test Name | Simple Endoscopic Score for Crohn's Disease Version 1 test name. | CDISC Clinical Classification SES-CD Version 1 Test Name Terminology |
SES01-Ileum Subscore | C176115 | SES01-Ileum Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Ileum subscore. | SES-CD Version 1 - Ileum Subscore | ||
SES01-Ileum: Affected Surface | C176093 | SES01-Ileum: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - ileum. | SES-CD Version 1 - Ileum: Affected Surface | ||
SES01-Ileum: Explored | C176090 | SES01-Ileum: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was ileum explored? | SES-CD Version 1 - Ileum: Explored | ||
SES01-Ileum: Presence of Narrowing | C176094 | SES01-Ileum: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - ileum. | SES-CD Version 1 - Ileum: Presence of Narrowing | ||
SES01-Ileum: Size of Ulcers | C176091 | SES01-Ileum: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - ileum. | SES-CD Version 1 - Ileum: Size of Ulcers | ||
SES01-Ileum: Ulcerated Surface | C176092 | SES01-Ileum: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - ileum. | SES-CD Version 1 - Ileum: Ulcerated Surface | ||
SES01-Left Colon Subscore | C176118 | SES01-Left Colon Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Sigmoid and left colon subscore. | SES-CD Version 1 - Left Colon Subscore | ||
SES01-Left Colon: Affected Surface | C176108 | SES01-Left Colon: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - sigmoid and left colon. | SES-CD Version 1 - Left Colon: Affected Surface | ||
SES01-Left Colon: Explored | C176105 | SES01-Left Colon: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was sigmoid and left colon explored? | SES-CD Version 1 - Left Colon: Explored | ||
SES01-Left Colon: Presence of Narrowing | C176109 | SES01-Left Colon: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - sigmoid and left colon. | SES-CD Version 1 - Left Colon: Presence of Narrowing | ||
SES01-Left Colon: Size of Ulcers | C176106 | SES01-Left Colon: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - sigmoid and left colon. | SES-CD Version 1 - Left Colon: Size of Ulcers | ||
SES01-Left Colon: Ulcerated Surface | C176107 | SES01-Left Colon: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - sigmoid and left colon. | SES-CD Version 1 - Left Colon: Ulcerated Surface | ||
SES01-Rectum Subscore | C176119 | SES01-Rectum Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Rectum subscore. | SES-CD Version 1 - Rectum Subscore | ||
SES01-Rectum: Affected Surface | C176113 | SES01-Rectum: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - rectum. | SES-CD Version 1 - Rectum: Affected Surface | ||
SES01-Rectum: Explored | C176110 | SES01-Rectum: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was rectum explored? | SES-CD Version 1 - Rectum: Explored | ||
SES01-Rectum: Presence of Narrowing | C176114 | SES01-Rectum: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - rectum. | SES-CD Version 1 - Rectum: Presence of Narrowing | ||
SES01-Rectum: Size of Ulcers | C176111 | SES01-Rectum: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - rectum. | SES-CD Version 1 - Rectum: Size of Ulcers | ||
SES01-Rectum: Ulcerated Surface | C176112 | SES01-Rectum: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - rectum. | SES-CD Version 1 - Rectum: Ulcerated Surface | ||
SES01-Right Colon Subscore | C176116 | SES01-Right Colon Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Right colon subscore. | SES-CD Version 1 - Right Colon Subscore | ||
SES01-Right Colon: Affected Surface | C176098 | SES01-Right Colon: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - right colon. | SES-CD Version 1 - Right Colon: Affected Surface | ||
SES01-Right Colon: Explored | C176095 | SES01-Right Colon: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was right colon explored? | SES-CD Version 1 - Right Colon: Explored | ||
SES01-Right Colon: Presence of Narrowing | C176099 | SES01-Right Colon: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - right colon. | SES-CD Version 1 - Right Colon: Presence of Narrowing | ||
SES01-Right Colon: Size of Ulcers | C176096 | SES01-Right Colon: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - right colon. | SES-CD Version 1 - Right Colon: Size of Ulcers | ||
SES01-Right Colon: Ulcerated Surface | C176097 | SES01-Right Colon: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - right colon. | SES-CD Version 1 - Right Colon: Ulcerated Surface | ||
SES01-Total Score | C176120 | SES01-Total Score | Simple Endoscopic Score for Crohn's Disease Version 1 - SES-CD total score. | SES-CD Version 1 - Total Score | ||
SES01-Trans Colon Subscore | C176117 | SES01-Trans Colon Subscore | Simple Endoscopic Score for Crohn's Disease Version 1 - Transverse colon subscore. | SES-CD Version 1 - Trans Colon Subscore | ||
SES01-Trans Colon: Affected Surface | C176103 | SES01-Trans Colon: Affected Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Affected surface - transverse colon. | SES-CD Version 1 - Trans Colon: Affected Surface | ||
SES01-Trans Colon: Explored | C176100 | SES01-Trans Colon: Explored | Simple Endoscopic Score for Crohn's Disease Version 1 - Was transverse colon explored? | SES-CD Version 1 - Trans Colon: Explored | ||
SES01-Trans Colon: Presence of Narrowing | C176104 | SES01-Trans Colon: Presence of Narrowing | Simple Endoscopic Score for Crohn's Disease Version 1 - Presence of narrowing - transverse colon. | SES-CD Version 1 - Trans Colon: Presence of Narrowing | ||
SES01-Trans Colon: Size of Ulcers | C176101 | SES01-Trans Colon: Size of Ulcers | Simple Endoscopic Score for Crohn's Disease Version 1 - Size of ulcers - transverse colon. | SES-CD Version 1 - Trans Colon: Size of Ulcers | ||
SES01-Trans Colon: Ulcerated Surface | C176102 | SES01-Trans Colon: Ulcerated Surface | Simple Endoscopic Score for Crohn's Disease Version 1 - Ulcerated surface - transverse colon. | SES-CD Version 1 - Trans Colon: Ulcerated Surface | ||
Back to top | ||||||
CL.C66733.SIZE | Size Response
(SIZE) | text
Extensible: Yes | C66733 | Size Response | A terminology codelist relevant to the physical magnitude of something. | CDISC SDTM Size Terminology |
LARGE | C49508 | Of considerable or relatively great size, extent, or capacity. (NCI) | Large | |||
MEDIUM | C49507 | Mid-way between small and large in number, quantity, magnitude or extent. (NCI) | Medium | |||
SMALL | C25376 | Limited in number, quantity, magnitude or extent. (NCI) | Small | |||
Back to top | ||||||
CL.C112024.SRTESTCD | Skin Response Test Code
(SRTESTCD) | text
Extensible: Yes | C112024 | Skin Response Test Code | A terminology codelist based on the test codes for dermal responses to antigens. | CDISC SDTM Skin Response Test Code Terminology |
ASRINDEX | C112221 | Allergen Skin Response Index | A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test. | Allergen Skin Response Index | ||
ASRINT | C112222 | Allergen Skin Response Intensity | A semi-quantitative assessment of the intensity of the wheal and flare reaction. | Allergen Skin Response Intensity | ||
BLISTIND | C122195 | Blistering Indicator | An indication as to whether blistering occurred. | Blistering Indicator | ||
FLARESZ | C112283 | Flare Size | The size of the area of redness that forms around the site of an antigenic challenge to the skin. | Antigenic Skin Flare Size | ||
FLRLDIAM | C112281 | Flare Longest Diameter | The longest diameter of the area of redness that forms around the site of an antigenic challenge to the skin. | Antigenic Skin Flare Longest Diameter | ||
FLRMDIAM | C112282 | Flare Mean Diameter | The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin. | Antigenic Skin Flare Mean Diameter | ||
IDRLDIAM | C122196 | Induration Longest Diameter | The longest diameter of an area of hardness in the skin. (NCI) | Induration Longest Diameter | ||
INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
REACTGR | C179819 | Reaction Grade | The position on a scale to assess the degree of the response to a stimulus or intervention. | Reaction Grade | ||
WHEALSZ | C112429 | Wheal Size | A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Size | ||
WHLINT | C130186 | Wheal Diameter Interpretation | The process of evaluating the wheal diameter in response to an allergen, based on a threshold size. | Wheal Diameter Interpretation | ||
WHLLDIAM | C112427 | Wheal Longest Diameter | The longest diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Longest Diameter | ||
WHLMDIAM | C112428 | Wheal Mean Diameter | The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Mean Diameter | ||
Back to top | ||||||
CL.C112023.SRTEST | Skin Response Test Name
(SRTEST) | text
Extensible: Yes | C112023 | Skin Response Test Name | A terminology codelist based on the test names for dermal responses to antigens. | CDISC SDTM Skin Response Test Name Terminology |
Allergen Skin Response Index | C112221 | Allergen Skin Response Index | A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test. | Allergen Skin Response Index | ||
Allergen Skin Response Intensity | C112222 | Allergen Skin Response Intensity | A semi-quantitative assessment of the intensity of the wheal and flare reaction. | Allergen Skin Response Intensity | ||
Blistering Indicator | C122195 | Blistering Indicator | An indication as to whether blistering occurred. | Blistering Indicator | ||
Flare Longest Diameter | C112281 | Flare Longest Diameter | The longest diameter of the area of redness that forms around the site of an antigenic challenge to the skin. | Antigenic Skin Flare Longest Diameter | ||
Flare Mean Diameter | C112282 | Flare Mean Diameter | The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin. | Antigenic Skin Flare Mean Diameter | ||
Flare Size | C112283 | Flare Size | The size of the area of redness that forms around the site of an antigenic challenge to the skin. | Antigenic Skin Flare Size | ||
Induration Longest Diameter | C122196 | Induration Longest Diameter | The longest diameter of an area of hardness in the skin. (NCI) | Induration Longest Diameter | ||
Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
Reaction Grade | C179819 | Reaction Grade | The position on a scale to assess the degree of the response to a stimulus or intervention. | Reaction Grade | ||
Wheal Diameter Interpretation | C130186 | Wheal Diameter Interpretation | The process of evaluating the wheal diameter in response to an allergen, based on a threshold size. | Wheal Diameter Interpretation | ||
Wheal Longest Diameter | C112427 | Wheal Longest Diameter | The longest diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Longest Diameter | ||
Wheal Mean Diameter | C112428 | Wheal Mean Diameter | The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Mean Diameter | ||
Wheal Size | C112429 | Wheal Size | A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Size | ||
Back to top | ||||||
CL.C74561.SKINTYP | Skin Type Response
(SKINTYP) | text
Extensible: Yes | C74561 | Skin Type Response | A terminology codelist relevant to the relative oiliness of the skin. | CDISC SDTM Skin Type Terminology |
DRY | C74592 | The pores are generally fine with a papery thin texture that feels dry to the touch. Usually flaky and dull looking. | Dry Skin | |||
NORMAL | C74593 | The pores are visible but not large. The texture is neither fine or thick and it neither feels dry or oily to the touch. | Normal Skin | |||
OILY | C74591 | The pores of the skin are generally large and visible with a coarse or thick texture. It has a tendency to look dull and greasy and feels oily to the touch. | Oily Skin | |||
Back to top | ||||||
CL.C102587.RISKSOC | Social Risk Factor
(RISKSOC) | text
Extensible: Yes | C102587 | Social Risk Factor | Terminology relevant to the social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease. | CDISC SDTM Social Risk Factor Terminology |
CONTACT WITH TUBERCULOSIS SOURCE | C102714 | An individual that came into contact with a source of Tuberculosis. | Subject in Contact With Tuberculosis Source | |||
CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN HOMELESS SHELTER | C102613 | An individual who is presently or not long ago worked or offered to assist without pay at a temporary housing facility for persons without a stable or permanent residence. | Current or Recent Employee or Volunteer in Homeless Shelter | |||
CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN JAIL OR PRISON | C102614 | An individual who is presently or not long ago worked or offered to assist without pay at an institution where persons are confined for punishment and to protect the public. | Current or Recent Employee or Volunteer in Jail or Prison | |||
CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN NURSING HOME | C102615 | An individual who is presently or not long ago worked or offered to assist without pay at a residential health care facility for persons with chronic illness or disability. | Current or Recent Employee or Volunteer in Nursing Home | |||
HOMELESS DURING PAST YEAR | C102645 | An individual without a stable or permanent residence within the last 365 days. | Homeless During Past Year | |||
IMMIGRANT FROM HIGH TUBERCULOSIS PREVALENT AREA | C102648 | An individual that has migrated from a country with a high occurrence of tuberculosis. | Immigrant From High Tuberculosis Prevalent Area | |||
INCARCERATION | C85521 | The state of being confined to jail or prison. | Incarceration | |||
LIVED IN REFUGEE CAMP | C102657 | An individual that resided in a camp for those displaced from their homeland. | Lived in Refugee Camp | |||
LONG-TERM FACILITY RESIDENT | C102660 | An individual that lives at a healthcare facility that provides rehabilitative, restorative, and/or ongoing skilled nursing care to patients or residents in need of assistance with activities of daily living. | Long-term Facility Resident | |||
MIGRATORY WORKER | C102670 | An individual who moves from one location to another location within or outside of their homeland for work. | Migratory Worker | |||
REFUGEE FROM HIGH TUBERCULOSIS PREVALENT AREA | C102705 | An individual that has fled a country for their own safety which has a high occurrence of tuberculosis. | Refugee From High Tuberculosis Prevalent Area | |||
TRAVEL TO HIGH BURDEN COUNTRY | C102719 | Entry into one or more of the 22 countries that have a relatively high prevalence of tuberculosis cases. | Travel To High Burden Tuberculosis Country | |||
UNEMPLOYMENT | C75563 | The state of not having a job. | Unemployed | |||
Back to top | ||||||
CL.C132314.CLMETH | Specimen Collection Method
(CLMETH) | text
Extensible: Yes | C132314 | Specimen Collection Method | Terminology relevant to the method used in specimen collection. | CDISC SDTM Specimen Collection Method Terminology |
ASPIRATION | C15631 | A technique in which suction is used to remove bodily fluid or tissue. | Aspiration | |||
BIOPSY | C15189 | The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis. | Biopsy | |||
CLEAN CATCH MID-STREAM | C189366 | A type of urine collection method in which a sterile wipe is applied to the area around the urethra and the collection cup is placed into the urine mid-stream, after urination has begun. | Clean Catch Mid-Stream | |||
CURETTAGE | C15216 | The removal of tissue with a curette (a spoon-shaped instrument with a sharp edge). | Curettage Procedure | |||
EXPECTORATION | C85859 | A technique in which material is cleared from the throat or lungs by coughing it up and spitting it out. | Expectorate | |||
FINE NEEDLE ASPIRATION | C15361 | The removal of tissue specimens or fluid from the living body with a thin needle. | Fine-Needle Aspiration | |||
FINGERSTICK | C85551 | A technique in which the tip of a finger is pricked with a lancing device to obtain a small quantity of capillary blood. | Finger Stick | |||
GRAVITY DRIP | C184398 | A technique in which a specimen flows out of the body through a tube due to the force of gravity. | Gravity Drip Collection Method | |||
IMPRESSION CYTOLOGY | C179749 | A non-invasive specimen collection technique where cellulose acetate filter paper is applied to a body surface (e.g., ocular surface) to collect superficial epithelial cells, which can be air-dried or fixed and then stained for histological, immunohistological, or molecular analysis. | Impression Cytology | |||
INDUCED EXPECTORATION | C132353 | A technique in which hypotonic saline is inhaled, followed by expectoration. | Induced Expectoration Technique | |||
LAVAGE | C38068 | Wash | A technique in which a fluid is introduced and collected from a body cavity or location. | Lavage | ||
SURGICAL RESECTION | C158758 | A surgical procedure in which tissue is removed from the body. | Resection | |||
SWAB | C17627 | A technique in which a tufted material on the end of a stick is rubbed against a surface. | Swab | |||
TAPE ADHESION | C179750 | Adhesive Tape Method | A technique for specimen collection that utilizes an adhesive-based ribbon. | Tape Adhesion Specimen Collection Method | ||
Back to top | ||||||
CL.C78733.SPECCOND | Specimen Condition
(SPECCOND) | text
Extensible: Yes | C78733 | Specimen Condition | The physical state or quality of a biological specimen. | CDISC SDTM Specimen Condition Terminology |
AGGLUTINATED | C166094 | Agglutinated Specimen | A specimen that has undergone agglutination, a process by which particles collect to form a cohesive mass or cluster. | Agglutinated Specimen | ||
AUTOLYZED | C78725 | Autolyzed Specimen | A specimen that has undergone autolysis, or self-digestion by the specimen's own digestive enzymes. (NCI) | Autolyzed Specimen | ||
CALCIFIED | C78723 | Calcified Specimen | A specimen that has undergone calcification. (NCI) | Calcified Specimen | ||
CAUTERIZED | C184709 | A specimen that has been cauterized. | Cauterized Specimen | |||
CLOTTED | C78724 | Clotted Specimen;Coagulated Specimen | A specimen that has become coagulated. (NCI) | Clotted Specimen | ||
CONCENTRATED | C128999 | Concentrated Specimen | A specimen that has undergone concentration to increase the content of a targeted entity. | Concentrated Specimen | ||
CONTAMINATED | C68768 | Contaminated Specimen | The presence of any substance or organism that makes a preparation impure. (NCI) | Contamination | ||
DRIED | C84516 | Dried Specimen | A specimen that has become desiccated or dehydrated. | Dried Specimen | ||
FRESH | C84517 | Fresh Specimen | A specimen that is analyzed in the state that it was collected. | Fresh Specimen | ||
FROZEN | C70717 | Frozen Specimen | A specimen that has been subjected to and immobilized by severe cold. (NCI) | Frozen Specimen | ||
GELLED | C135503 | Gelled Specimen | A specimen that has a gelatinous consistency. (NCI) | Gelatinous Specimen | ||
HEMOLYZED | C70720 | Hemolysis in Specimen | A specimen that has undergone the destruction of red blood cells followed by the release of the hemoglobin. (NCI) | Hemolysis in Specimen | ||
ICTERIC | C98744 | Icteric Specimen | A specimen that exhibits a yellowish pigmentation due to jaundice. (NCI) | Icteric Specimen | ||
LACTESCENT | C158278 | Lactescent Specimen | A specimen that has become or appears milky. | Lactescent Specimen | ||
LIPEMIC | C70715 | Lipemic Specimen | A specimen that consists of or contains excessive amounts of fat and fatty substances. (NCI) | Lipemic Specimen | ||
NON-HEMOLYZED | C158279 | Non-Hemolyzed Specimen | A specimen that has not undergone the destruction of red blood cells followed by the release of the hemoglobin. | Non-Hemolyzed Specimen | ||
PARAFFIN-EMBEDDED | C19597 | Paraffin Block;Paraffin-Embedded Specimen | A specimen that has been fixed and preserved in paraffin. | Paraffin Embedded Tissue | ||
REFRIGERATED | C70718 | Refrigerated Specimen | A specimen that has been kept or preserved at a low temperature in a refrigerator. (NCI) | Refrigerated Specimen | ||
ROOM TEMPERATURE | C70719 | Ambient Temperature;Specimen at Room Temperature | A specimen that has been subjected to and adjusted to the average ambient temperature of a room, usually considered to be around 20 degrees C (68 degrees F). (NCI) | Specimen at Room Temperature | ||
SOLIDIFIED | C135504 | Solidified Specimen | A specimen that has a regular, firm consistency and retains a definite size and shape. | Solidified Specimen | ||
THAWED | C158280 | Thawed Specimen | A specimen that has changed from a frozen to a liquid or semi-liquid state. | Thawed Specimen | ||
UNEXPECTED ODOR | C135505 | Specimen with Unexpected Odor | A specimen that has an unanticipated odor. | Specimen with Unexpected Odor | ||
Back to top | ||||||
CL.C78734.SPECTYPE | Specimen Type
(SPECTYPE) | text
Extensible: Yes | C78734 | Specimen Type | The name and description of a biological specimen. | CDISC SDTM Specimen Type Terminology |
ABSCESS FLUID | C150890 | The fluid that is abnormally collected in localized areas of damaged tissue within the body, usually composed of living and dead white blood cells, bacteria, and dead tissue. | Abscess Fluid | |||
ADIPOSE TISSUE | C12472 | Body Fat;Fat Tissue | Connective tissue consisting primarily of adipocytes (fat cells) and supporting structural matrix. | Adipose Tissue | ||
ALVEOLAR AIR | C150891 | The gas from the alveoli of the lungs. | Alveolar Air | |||
AMNIOTIC FLUID | C13188 | Aqua Amnii | The fluid within the amniotic cavity which surrounds and protects the developing embryo. (NCI) | Amniotic Fluid | ||
AQUEOUS HUMOR | C13190 | Aqueous Humour | The watery fluid which is present in the anterior and posterior chambers of the eye. (NCI) | Aqueous Humor | ||
ARTERIAL BLOOD | C78729 | Oxygenated blood which is transported with nutrients to body tissues through the arterial system. The exception is blood within the pulmonary artery which carries deoxygenated blood to the lungs. (NCI) | Arterial Blood | |||
ARTERIAL CORD BLOOD | C120838 | Blood present in the umbilical arteries at the time of delivery. | Arterial Cord Blood | |||
ARTERIALIZED CAPILLARY BLOOD | C176369 | Capillary blood collected from a puncture site that has been warmed or treated with creams containing a hyperemic or vasodilatory agent to increase arterial blood flow. | Arterialized Capillary Blood | |||
ATHEROSCLEROTIC PLAQUE | C78739 | Fatty tissue which is deposited in the inner lining of the arterial wall. (NCI) | Atherosclerotic Plaque | |||
BASAL TEAR | C176366 | A type of tear produced continually to keep the cornea moist; contains salts, water, and mucus. | Basal Tear | |||
BILE | C13192 | Fluid composed of waste products, bile acids, salts, cholesterol, and electrolytes. It is produced by the liver and may be stored in the gallbladder (if present). | Bile | |||
BLOOD | C12434 | Peripheral Blood;Whole Blood | A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. | Blood | ||
BONE MARROW MONONUCLEAR CELL | C156591 | BMMC | Any cell with a single nucleus found in the bone marrow, for example lymphocytes, monocytes, mesenchymal stem cells and hematopoietic progenitor cells. | Bone Marrow Mononuclear Cell | ||
BONE MARROW | C12431 | The tissue occupying the spaces of some bones. It consists of blood vessel sinuses and a network of hematopoietic cells. | Bone Marrow | |||
BONE MARROW, CORE | C159488 | The solid, spongey portion of bone marrow, consisting of blood vessel sinuses, hematopoietic cells, and trabecular bone. | Bone Marrow Core Biopsy Sample | |||
BONE MARROW, LIQUID | C133261 | Bone Marrow Aspirate | The liquid portion of bone marrow, consisting of small tissue fragments, hematopoietic cells, and peripheral blood. | Bone Marrow Aspirate | ||
BONE | C12366 | Calcified connective tissue that forms the skeletal components of the body. (NCI) | Bone | |||
BREAST MILK | C13257 | A liquid produced by the mammary gland. | Breast Milk | |||
BUFFY COAT | C84507 | The middle fraction of an anticoagulated blood specimen following separation by centrifugation. It contains most of the white blood cells and platelets. | Buffy Coat | |||
CALCULUS | C35708 | Calculi | A concretion of material in the body, usually composed of mineral salts. Representative examples include gallbladder stones, kidney stones, and salivary gland stones. | Stone | ||
CAPILLARY BLOOD | C112235 | A mixture of arterial blood, venous blood and interstitial fluid, which is found in the capillaries. | Capillary Blood | |||
CAPILLARY PLASMA | C132461 | A plasma sample that is prepared from capillary blood. | Capillary Plasma | |||
CARDIAC MUSCLE TISSUE | C12371 | Myocardium | The striated muscle tissue of the heart enveloped by the epicardium and the endocardium. (NCI) | Myocardium | ||
CELL PELLET | C113745 | A cell sample that has been compacted by centrifugation. | Cell Pellet | |||
CEREBROSPINAL FLUID | C12692 | CSF | The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (NCI) | Cerebrospinal Fluid | ||
CERUMEN | C32293 | A wax secreted by glands in the ear canal. | Cerumen | |||
CERVICOVAGINAL SECRETION | C150892 | The watery fluid secreted from the glands and associated structures of the cervicovaginal region. | Cervicovaginal Secretion | |||
CIRCULATING TUMOR CELL | C63797 | CTC | A metastatic cancer cell found in the peripheral blood. (NCI) | Circulating Tumor Cell | ||
COLOSTRUM | C32348 | A thick, protein-rich substance secreted by the breasts during the second half of pregnancy and for a few days after birth before the breast milk comes in. | Human Colostrum | |||
CORD BLOOD | C13300 | Umbilical Cord Blood | Blood present in the umbilical vessels at the time of delivery. | Umbilical Cord Blood | ||
CORD PLASMA | C189641 | Umbilical Cord Plasma | The fluid (acellular) portion of the circulating blood with retained clotting components from the cord blood of a newborn baby. | Umbilical Cord Plasma | ||
CORD SERUM | C119550 | Umbilical Cord Serum | The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins from the cord blood of a newborn baby. | Umbilical Cord Serum | ||
DERMAL TISSUE | C12701 | The cells and connective tissue from the inner layer of the two main layers of the skin. The dermis has connective tissue, blood vessels, oil and sweat glands, nerves, hair follicles, and other structures. It is made up of a thin upper layer called the papillary dermis, and a thick lower layer called the reticular dermis. | Dermis | |||
DIALYSIS FLUID | C106515 | Dialysate | The fluid which runs through a dialysis machine and captures, for discard or analysis, the excess water and waste from the blood stream through diffusion and ultrafiltration. (NCI) | Dialysis Fluid | ||
DIALYSIS FLUID, PERITONEAL | C154852 | PD Fluid;Peritoneal Dialysate | The dialysis fluid which is collected from the peritoneal space and captures, for discard or analysis, the excess water and waste from the blood stream through diffusion and ultrafiltration. (NCI) | Peritoneal Dialysis Fluid | ||
DISCHARGE | C142366 | Normal or abnormal secretions expelled from a body location. | Discharge Body Fluid | |||
DISTAL RESPIRATORY EXHALED PARTICLES | C198365 | Endogenously generated droplets present in exhaled air, containing water and non-volatile material, which originate from the surfactant and respiratory tract lining fluid from the most distal airways. | Distal Respiratory Exhaled Particles | |||
EMESIS | C77666 | Emesis;Vomitus | Partially digested gastric contents that are returned to the mouth or beyond via the vomit reflex present in some species. | Vomitus | ||
EMOTIONAL TEAR | C176368 | Psychic Tear | A type of tear produced in response to negative or positive emotions; contains higher amounts of proteins and stress-related hormones in comparison to other tear types. | Emotional Tear | ||
ENDOMETRIAL TISSUE | C176371 | A specimen that consists of the cells and connective tissue of the endometrium. | Endometrial Tissue | |||
ENDOTRACHEAL FLUID | C171504 | Endotracheal Aspirate Fluid;ETA Fluid;Tracheal Aspirate;Tracheal Aspirate Fluid | The fluid collected from the lumen of the trachea. | Endotracheal Fluid | ||
EPIDERMAL TISSUE | C12708 | The cells and connective tissue from the epithelial portion of the skin (cutis). It consists of the following layers: stratum corneum (horny layer), stratum granulosum (granular layer), stratum spinosum (prickle cell layer), and stratum basale (basal cell layer). | Epidermis | |||
EPITHELIAL CELL | C12578 | Any of the cells of the epithelium, which covers the body and lines its cavities and glands. | Epithelial Cell | |||
ERYTHROCYTES | C12521 | RBC;Red Blood Cells | Cell specialized for oxygen transport, having a high concentration of hemoglobin in the cytoplasm and little else; biconcave, anucleate discs, 7nm diameter in mammals. | Erythrocyte | ||
EXHALED BREATH CONDENSATE | C126053 | Expired air that has been condensed. | Exhaled Breath Condensate | |||
EXPIRED AIR | C78741 | Exhaled Breath;Expired Breath | The air that moves out of the chest during expiration. It contains a higher percentage of carbon dioxide and a lower percentage of oxygen compared to the inhaled air. (NCI) | Expired Air | ||
EXUDATE | C13233 | Accumulation of extravasated fluid containing inflammatory cells and fibrin. Necrotic debris and/or other cellular and extracellular components may also be present. | Exudate | |||
FIBROBLAST | C12482 | A connective tissue cell that secretes collagen, a component of the extracellular matrix. | Fibroblast | |||
FLUID | C13236 | Liquid substances produced by the body. | Body Fluid or Substance | |||
GASTRIC CONTENTS | C77614 | Stomach Contents | The contents of the stomach that may include undigested food mixed with juices secreted by the gastric mucosal glands. (NCI) | Gastric Content | ||
GASTRIC FLUID | C86998 | The fluid produced by the stomach glands, composed of gastric acids and enzymes. (NCI) | Gastric Fluid | |||
GRANULOCYTE | C12530 | A type of leukocyte containing a nucleus and cytoplasmic granules. Granulocytes are subdivided according to the staining properties of their granules into eosinophils, basophils, and neutrophils. | Granulocyte | |||
HAIR FOLLICLE | C13317 | A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (NCI) | Hair Follicle | |||
HAIR | C32705 | Hair | The filamentous outgrowth of the epidermis. (NCI) | Hair | ||
INFRANATANT, PLASMA | C106554 | The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI) | Plasma Infranatant | |||
INFRANATANT, PLEURAL FLUID | C106558 | The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI) | Pleural Fluid Infranatant | |||
INFRANATANT, SERUM | C106565 | The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI) | Serum Infranatant | |||
INTERSTITIAL FLUID | C120839 | The extracellular fluid component found in the spaces between tissues. This excludes plasma and transcellular fluid. | Interstitial Fluid | |||
ISOLATE | C53471 | Microbial Isolate | A specific individual microbe and its genetically identical progeny separated on a single occasion from a sample taken from a host or culture system. | Isolate | ||
KERATINOCYTE | C12589 | The keratin-producing cell of the epidermis that forms in the deep basal layer of the stratified epithelium. | Keratinocyte | |||
LAVAGE FLUID | C103411 | Wash Fluid | Fluid introduced and collected from a body cavity or location by lavage or wash procedure. | Lavage Fluid | ||
LEUKOCYTE | C12529 | Blood cells that are devoid of hemoglobin, capable of amoeboid motion and phagocytosis, and act as the principal components of the immune system. | Leukocyte | |||
LOCHIA | C78742 | Vaginal discharge occurring during the post-partum period. It consists of a mixture of blood, mucus, and placental remnants. (NCI) | Lochia | |||
LUNG SURFACTANT | C13273 | Pulmonary surfactant lines the lung epithelium and lowers surface tension to prevent collapse at end-expiration. Deficiency of pulmonary surfactant results in respiratory distress syndrome (RDS) in premature infants. Lung surfactant is synthesized in alveolar type II cells, stored in lamellar bodies and secreted via exocytosis. (NCI) | Lung Surfactant | |||
LYMPH | C13252 | A clear, transparent, sometimes faintly yellow and slightly opalescent fluid that is collected from the tissues throughout the body, flows in the lymphatic vessels (through the lymph nodes), and is eventually added to the venous blood circulation. Lymph consists of a clear liquid portion, varying numbers of white blood cells (chiefly lymphocytes), and a few red blood cells. (NCI) | Lymph | |||
LYMPHOCYTE | C12535 | White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. | Lymphocyte | |||
LYSATE | C62004 | The cellular debris and fluid produced by lysis of cells. | Lysate | |||
MECONIUM | C78743 | The newborn's first intestinal discharge. It is a dark-green, thick substance composed of mucus, intestinal secretions, hair, and intestinal mucosa cells. (NCI) | Meconium | |||
MENSTRUAL BLOOD | C78740 | The discharged blood from the uterus during the reproductive years. The discharge occurs approximately once a month. (NCI) | Menstrual Blood | |||
MIXED VENOUS BLOOD | C158281 | The de-oxygenated blood flowing into the right side of the heart, composed of a mixture of venous blood from the entirety of the systemic circulation. | Mixed Venous Blood | |||
MONOCYTE | C12547 | A large, phagocytic mononuclear leukocyte produced in the vertebrate bone marrow and released into the blood; containing a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. | Monocyte | |||
MUCUS | C13259 | The thick fluid secreted by the mucus glands in the aerodigestive tract and the vagina. (NCI) | Mucus | |||
MUSCLE TISSUE | C12435 | Tissue responsible for body and internal organ movement. Muscle tissue is composed of specialized contractile cells. | Muscle Tissue | |||
NAIL | C33156 | Nail | The cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI) | Nail | ||
NATURAL KILLER CELL | C12536 | Cells resembling large granular lymphocytes that do not express markers of either T or B cell lineage. These cells express Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody, and may occur without previous sensitization. | Natural Killer Cell | |||
PERIPHERAL BLOOD MONONUCLEAR CELL | C12954 | PBMC | A peripheral blood cell with a single nucleus, for example lymphocytes and monocytes. | Peripheral Blood Mononuclear Cell | ||
PERITONEAL FLUID | C77612 | The fluid within the peritoneal cavity. | Peritoneal Fluid | |||
PERSPIRATION | C13280 | Sweat | The liquid secreted by the sweat glands. (NCI) | Sweat | ||
PLASMA ULTRAFILTRATE | C176370 | The fluid that is produced from the movement of whole blood across a semipermeable membrane in response to a pressure gradient, removing blood cells and large proteins. | Plasma Ultrafiltrate | |||
PLASMA | C13356 | The fluid (acellular) portion of the circulating blood with retained clotting components. | Plasma | |||
PLATELET POOR PLASMA | C106556 | PPP | A plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to decrease the amount of platelets. (NCI) | Platelet-poor Plasma | ||
PLATELET RICH PLASMA | C106557 | PRP | A plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to concentrate the amount of platelets. (NCI) | Platelet-rich Plasma | ||
PLATELET | C12520 | Thrombocyte | An irregular, disc-shaped structure in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes. (NCI) | Platelet | ||
PLEURAL FLUID | C77613 | The fluid within the pleural cavity. | Pleural Fluid | |||
PLEURAL TISSUE | C12469 | The serous membrane that lines the wall of the thoracic cavity and the surface of the lungs. | Pleura | |||
PROSTATIC FLUID | C100896 | A slightly alkaline, white fluid secreted from the prostate and is a constituent of semen. | Prostatic Fluid | |||
PUS | C50718 | A yellowish substance produced during bacterial inflammation. It contains necrotic cells and cells fighting the infection. (NCI) | Pus | |||
REFLEX TEAR | C176367 | A type of tear produced in response to irritation from foreign particles, vapors, bright lights, or peppery substances; contains higher amounts of antibodies in comparison to other tear types. | Reflex Tear | |||
RETICULOCYTES | C12528 | Immature erythrocytes that have just undergone extrusion of their cell nucleus. They still contain some organelles that gradually decrease in number as the cells mature. | Reticulocyte | |||
SALIVA | C13275 | A clear liquid secreted by the salivary glands. | Saliva | |||
SEBUM | C13276 | A thick, oily substance produced by the sebaceous glands located in the dermis. (NCI) | Sebum | |||
SEMEN | C13277 | The fluid containing the spermatozoa, secreted by the testes and accessory reproductive glands of the male. | Semen | |||
SEMINAL FLUID | C33529 | Part of the ejaculated fluid. It contains secretions from the seminal vesicles, Cowper gland, and prostate gland. | Seminal Fluid | |||
SERUM OR PLASMA OR BLOOD | C170628 | Ser/Plas/Bld | A specimen type consisting of serum or plasma or blood. | Serum or Plasma or Blood | ||
SERUM OR PLASMA | C105706 | Ser/Plas | The non-cellular portion of the circulating blood, with or without the clotting proteins present. | Serum or Plasma | ||
SERUM | C13325 | Sera | The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins. (NCI) | Serum | ||
SKELETAL MUSCLE TISSUE | C13050 | Voluntary, striated muscle tissue predominantly associated with the skeleton. | Skeletal Muscle Tissue | |||
SKIN TISSUE | C33563 | Tissue composed of three layers, epidermis, dermis and subcutis which protect underlying muscles and organs. | Skin Tissue | |||
SMEGMA | C33574 | A white secretion of the sebaceous glands of the foreskin. (NCI) | Smegma | |||
SMOOTH MUSCLE TISSUE | C12437 | Primarily involuntary, non-striated muscle tissue of the internal organs and blood vessels. | Smooth Muscle Tissue | |||
SOFT TISSUE | C12471 | Soft Tissue | Refers to muscle, fat, fibrous tissue, blood vessels, organ parenchyma, or other supporting tissue of the body. | Soft Tissue | ||
SPERMATOZOON | C12602 | Sperm Cell | The male reproductive cell that is formed in the testicle. A sperm consists of a head, a body, and a tail that provides propulsion. | Spermatozoon | ||
SPUTUM | C13278 | Material containing mucus, cellular debris, microorganisms and sometimes blood or pus. It is ejected through the mouth from the lungs, bronchi, and trachea. (NCI) | Sputum | |||
STOOL | C13234 | Feces | The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria. (NCI) | Feces | ||
STRIATED MUSCLE TISSUE | C12436 | Striated muscles are appendicular and axial muscles typically connected at either or both ends to the bony skeleton of the body. Striated muscle fibers contain a highly organized, contractile cytoskeletal apparatus with a striated microscopic appearance; muscle contraction is typically under voluntary control. (NCI) | Striated Muscle Tissue | |||
SUPERNATANT, CEREBROSPINAL FLUID | C150894 | The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a cerebrospinal fluid sample. (NCI) | Cerebrospinal Fluid Supernatant | |||
SUPERNATANT, LAVAGE FLUID | C189640 | The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a lavage fluid sample. | Lavage Fluid Supernatant | |||
SUPERNATANT, PLASMA | C106555 | The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI) | Plasma Supernatant | |||
SUPERNATANT, PLEURAL FLUID | C106559 | The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI) | Pleural Fluid Supernatant | |||
SUPERNATANT, SERUM OR PLASMA | C150893 | The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a serum or plasma sample. (NCI) | Serum or Plasma Supernatant | |||
SUPERNATANT, SERUM | C106566 | The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI) | Serum Supernatant | |||
SWABBED MATERIAL | C150895 | A heterogeneous and variable aggregate of body fluids, tissues, cells, microorganisms, and other materials that are collected from a swab biospecimen collection procedure. | Swabbed Material | |||
SYNOVIAL FLUID | C33718 | Synovia | The fluid within a joint capsule. | Synovial Fluid | ||
TEAR | C33739 | The fluid secreted by the lacrimal apparatus. | Tear | |||
TISSUE | C12801 | An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function. (NCI) | Tissue | |||
TRANSUDATE | C78744 | The fluid that passes through the wall of the veins and capillaries to the surrounding tissues because of increased intravascular pressure. It has low protein content. (NCI) | Transudate | |||
TUMOR TISSUE | C18009 | A tumor sample, or entire tumor that is removed for examination. | Tumor Tissue | |||
URINE SEDIMENT | C158282 | Material separated from urine. | Urine Sediment | |||
URINE | C13283 | The fluid produced by the kidneys. | Urine | |||
VENOUS BLOOD | C78730 | Deoxygenated blood containing urea and other waste products which is transported through the venous system to the heart and lungs. The exception is blood within the pulmonary vein which is oxygenated and travels from the lungs to the left atrium of the heart. (NCI) | Venous Blood | |||
VENOUS CORD BLOOD | C120840 | Blood present in the umbilical vein at the time of delivery. | Venous Cord Blood | |||
VENOUS PLASMA | C132462 | A plasma sample that is prepared from venous blood. | Venous Plasma | |||
VITREOUS HUMOR | C13323 | The clear colorless transparent jelly that fills the posterior chamber of the eyeball. (NCI) | Vitreous Humor | |||
WHITE MATTER TISSUE | C33892 | The nerve tissue forming the bulk of the deep parts of the brain and the superficial parts of the spinal cord. It is composed of nerve cell processes, i.e. extensions (axons), which connect various gray matter areas of the brain to each other and carry nerve impulses to and from the nerve cell bodies within the central nervous system (neurons). (NCI) | White Matter | |||
Back to top | ||||||
CL.C106671.SGRQC1TC | St. George's Respiratory Questionnaire for COPD Patients Questionnaire Test Code
(SGRQC1TC) | text
Extensible: No | C106671 | St. George's Respiratory Questionnaire for COPD Patients Questionnaire Test Code | St. George's Respiratory Questionnaire for COPD Patients test code. | CDISC Questionnaire SGRQ-C Test Code Terminology |
SGRQC101 | C106853 | SGRQC1-Describe Your Current Health | St. George's Respiratory Questionnaire - Please check one box to show how you describe your current health. | SGRQ-C - Description of Your Current Health | ||
SGRQC102 | C106854 | SGRQC1-I Cough | St. George's Respiratory Questionnaire - I cough. | SGRQ-C - Cough | ||
SGRQC103 | C106855 | SGRQC1-I Bring Up Phlegm | St. George's Respiratory Questionnaire - I bring up phlegm (sputum). | SGRQ-C - Bring Up Phlegm | ||
SGRQC104 | C106856 | SGRQC1-I Have Shortness of Breath | St. George's Respiratory Questionnaire - I have shortness of breath. | SGRQ-C - Have Shortness of Breath | ||
SGRQC105 | C106857 | SGRQC1-I Have Attacks of Wheezing | St. George's Respiratory Questionnaire - I have attacks of wheezing. | SGRQ-C - Have Attacks of Wheezing | ||
SGRQC106 | C106858 | SGRQC1-How Many Respiratory Attacks | St. George's Respiratory Questionnaire - How many respiratory attacks did you have during the last year? | SGRQ-C - Number of Respiratory Attacks Last Year | ||
SGRQC107 | C106859 | SGRQC1-How Often Do You Have Good Days | St. George's Respiratory Questionnaire - How often do you have good days (with few respiratory problems)? | SGRQ-C - Good Days with Few Respiratory Problems | ||
SGRQC108 | C106860 | SGRQC1-Wheeze Worse in the Morning | St. George's Respiratory Questionnaire - If you wheeze, is it worse when you get up in the morning? | SGRQ-C - Wheezing Worse In the Morning | ||
SGRQC109 | C106861 | SGRQC1-Describe Your Resp Problems | St. George's Respiratory Questionnaire - How would you describe your respiratory problems? | SGRQ-C - Description of Your Respiratory Problems | ||
SGRQC110 | C106862 | SGRQC1-Washing or Dressing Yourself | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Washing or dressing yourself. | SGRQ-C - Feel Breathless Washing or Dressing Yourself | ||
SGRQC111 | C106863 | SGRQC1-Walking Around the House | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking around the house. | SGRQ-C - Feel Breathless Walking Around the House | ||
SGRQC112 | C106864 | SGRQC1-Walking Outside on Level Ground | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking outside on level ground. | SGRQ-C - Feel Breathless Walking Outside on Level Ground | ||
SGRQC113 | C106865 | SGRQC1-Walking Up a Flight of Stairs | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking up a flight of stairs. | SGRQ-C - Feel Breathless Walking Up a Flight of Stairs | ||
SGRQC114 | C106866 | SGRQC1-Walking Up Hills | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking up hills. | SGRQ-C - Feel Breathless Walking Up Hills | ||
SGRQC115 | C106867 | SGRQC1-Coughing Hurts | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: Coughing hurts. | SGRQ-C - Coughing Hurts | ||
SGRQC116 | C106868 | SGRQC1-Coughing Makes Me Tired | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: Coughing makes me tired. | SGRQ-C - Coughing Makes Me Tired | ||
SGRQC117 | C106869 | SGRQC1-Short of Breath When Talk | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I am short of breath when I talk. | SGRQ-C - Short of Breath When Talk | ||
SGRQC118 | C106870 | SGRQC1-Short of Breath When Bend Over | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I am short of breath when I bend over. | SGRQ-C - Short of Breath When Bend Over | ||
SGRQC119 | C106871 | SGRQC1-Coughing Disturbs My Sleep | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: My coughing or breathing disturbs my sleep. | SGRQ-C - Coughing Disturbs My Sleep | ||
SGRQC120 | C106872 | SGRQC1-Get Exhausted Easily | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I get exhausted easily. | SGRQ-C - Get Exhausted Easily | ||
SGRQC121 | C106873 | SGRQC1-Cough Is Embarrassing in Public | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: My cough or breathing is embarrassing in public. | SGRQ-C - Cough Is Embarrassing in Public | ||
SGRQC122 | C107021 | SGRQC1-Respiratory Problems a Nuisance | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: My respiratory problems are a nuisance to my family, friends or neighbours. | SGRQ-C - Respiratory Problems a Nuisance to Family, Friends or Neighbours | ||
SGRQC123 | C106874 | SGRQC1-Afraid When Cannot Catch Breath | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I get afraid or panic when I cannot catch my breath. | SGRQ-C - Afraid or Panic When Cannot Catch Breath | ||
SGRQC124 | C106875 | SGRQC1-Not in Control of Resp Problems | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I feel that I am not in control of my respiratory problems. | SGRQ-C - Not in Control of Respiratory Problems | ||
SGRQC125 | C106876 | SGRQC1-Frail Because of Resp Problems | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I have become frail or an invalid because of my respiratory problems. | SGRQ-C - Become Frail Because of Respiratory Problems | ||
SGRQC126 | C106877 | SGRQC1-Exercise Is Not Safe for Me | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: Exercise is not safe for me. | SGRQ-C - Exercise Is Not Safe for Me | ||
SGRQC127 | C106878 | SGRQC1-Everything Too Much Effort | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: Everything seems too much of an effort. | SGRQ-C - Everything Seems Too Much Effort | ||
SGRQC128 | C106879 | SGRQC1-Take a Long Time to Get Washed | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. | SGRQ-C - Take a Long Time to Get Washed or Dressed | ||
SGRQC129 | C106880 | SGRQC1-Cannot Take a Bath or Shower | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. | SGRQ-C - Cannot Take a Bath or Shower | ||
SGRQC130 | C106881 | SGRQC1-Walk Slow Than Others My Age | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. | SGRQ-C - Walk Slower Than Other People My Age | ||
SGRQC131 | C106882 | SGRQC1-Jobs Take a Long Time | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. | SGRQ-C - Jobs Take a Long Time | ||
SGRQC132 | C106883 | SGRQC1-Walk Up Flight of Stairs Slowly | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. | SGRQ-C - Walk Up Flight of Stairs Slowly | ||
SGRQC133 | C106884 | SGRQC1-If I Hurry, I Have to Stop | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. | SGRQ-C - If Walk Fast Have to Stop | ||
SGRQC134 | C106885 | SGRQC1-Difficult to Walk Up Hills | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. | SGRQ-C - Difficult to Walk Up Hills | ||
SGRQC135 | C106886 | SGRQC1-Difficult to Carry Heavy Loads | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. | SGRQ-C - Difficult to Carry Heavy Loads | ||
SGRQC136 | C107022 | SGRQC1-Cannot Play Sports | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Play Sports | ||
SGRQC137 | C107023 | SGRQC1-Cannot Go Out for Entertainment | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Go Out for Entertainment | ||
SGRQC138 | C107024 | SGRQC1-Cannot Go Out to Do Shopping | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Go Out to Do Shopping | ||
SGRQC139 | C107025 | SGRQC1-Cannot Do Household Chores | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Do Household Chores | ||
SGRQC140 | C107026 | SGRQC1-Cannot Move Far From My Bed | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Move Far From Bed | ||
SGRQC141 | C106887 | SGRQC1-How Resp Problems Affect You | St. George's Respiratory Questionnaire - How do your respiratory problems affect you? | SGRQ-C - How Respiratory Problems Affect You | ||
Back to top | ||||||
CL.C106670.SGRQC1TN | St. George's Respiratory Questionnaire for COPD Patients Questionnaire Test Name
(SGRQC1TN) | text
Extensible: No | C106670 | St. George's Respiratory Questionnaire for COPD Patients Questionnaire Test Name | St. George's Respiratory Questionnaire for COPD Patients test name. | CDISC Questionnaire SGRQ-C Test Name Terminology |
SGRQC1-Afraid When Cannot Catch Breath | C106874 | SGRQC1-Afraid When Cannot Catch Breath | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I get afraid or panic when I cannot catch my breath. | SGRQ-C - Afraid or Panic When Cannot Catch Breath | ||
SGRQC1-Cannot Do Household Chores | C107025 | SGRQC1-Cannot Do Household Chores | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Do Household Chores | ||
SGRQC1-Cannot Go Out for Entertainment | C107023 | SGRQC1-Cannot Go Out for Entertainment | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Go Out for Entertainment | ||
SGRQC1-Cannot Go Out to Do Shopping | C107024 | SGRQC1-Cannot Go Out to Do Shopping | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Go Out to Do Shopping | ||
SGRQC1-Cannot Move Far From My Bed | C107026 | SGRQC1-Cannot Move Far From My Bed | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Move Far From Bed | ||
SGRQC1-Cannot Play Sports | C107022 | SGRQC1-Cannot Play Sports | St. George's Respiratory Questionnaire - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. | SGRQ-C - Respiratory Problems Affect Daily Life: Cannot Play Sports | ||
SGRQC1-Cannot Take a Bath or Shower | C106880 | SGRQC1-Cannot Take a Bath or Shower | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. | SGRQ-C - Cannot Take a Bath or Shower | ||
SGRQC1-Cough Is Embarrassing in Public | C106873 | SGRQC1-Cough Is Embarrassing in Public | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: My cough or breathing is embarrassing in public. | SGRQ-C - Cough Is Embarrassing in Public | ||
SGRQC1-Coughing Disturbs My Sleep | C106871 | SGRQC1-Coughing Disturbs My Sleep | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: My coughing or breathing disturbs my sleep. | SGRQ-C - Coughing Disturbs My Sleep | ||
SGRQC1-Coughing Hurts | C106867 | SGRQC1-Coughing Hurts | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: Coughing hurts. | SGRQ-C - Coughing Hurts | ||
SGRQC1-Coughing Makes Me Tired | C106868 | SGRQC1-Coughing Makes Me Tired | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: Coughing makes me tired. | SGRQ-C - Coughing Makes Me Tired | ||
SGRQC1-Describe Your Current Health | C106853 | SGRQC1-Describe Your Current Health | St. George's Respiratory Questionnaire - Please check one box to show how you describe your current health. | SGRQ-C - Description of Your Current Health | ||
SGRQC1-Describe Your Resp Problems | C106861 | SGRQC1-Describe Your Resp Problems | St. George's Respiratory Questionnaire - How would you describe your respiratory problems? | SGRQ-C - Description of Your Respiratory Problems | ||
SGRQC1-Difficult to Carry Heavy Loads | C106886 | SGRQC1-Difficult to Carry Heavy Loads | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. | SGRQ-C - Difficult to Carry Heavy Loads | ||
SGRQC1-Difficult to Walk Up Hills | C106885 | SGRQC1-Difficult to Walk Up Hills | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. | SGRQ-C - Difficult to Walk Up Hills | ||
SGRQC1-Everything Too Much Effort | C106878 | SGRQC1-Everything Too Much Effort | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: Everything seems too much of an effort. | SGRQ-C - Everything Seems Too Much Effort | ||
SGRQC1-Exercise Is Not Safe for Me | C106877 | SGRQC1-Exercise Is Not Safe for Me | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: Exercise is not safe for me. | SGRQ-C - Exercise Is Not Safe for Me | ||
SGRQC1-Frail Because of Resp Problems | C106876 | SGRQC1-Frail Because of Resp Problems | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I have become frail or an invalid because of my respiratory problems. | SGRQ-C - Become Frail Because of Respiratory Problems | ||
SGRQC1-Get Exhausted Easily | C106872 | SGRQC1-Get Exhausted Easily | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I get exhausted easily. | SGRQ-C - Get Exhausted Easily | ||
SGRQC1-How Many Respiratory Attacks | C106858 | SGRQC1-How Many Respiratory Attacks | St. George's Respiratory Questionnaire - How many respiratory attacks did you have during the last year? | SGRQ-C - Number of Respiratory Attacks Last Year | ||
SGRQC1-How Often Do You Have Good Days | C106859 | SGRQC1-How Often Do You Have Good Days | St. George's Respiratory Questionnaire - How often do you have good days (with few respiratory problems)? | SGRQ-C - Good Days with Few Respiratory Problems | ||
SGRQC1-How Resp Problems Affect You | C106887 | SGRQC1-How Resp Problems Affect You | St. George's Respiratory Questionnaire - How do your respiratory problems affect you? | SGRQ-C - How Respiratory Problems Affect You | ||
SGRQC1-I Bring Up Phlegm | C106855 | SGRQC1-I Bring Up Phlegm | St. George's Respiratory Questionnaire - I bring up phlegm (sputum). | SGRQ-C - Bring Up Phlegm | ||
SGRQC1-I Cough | C106854 | SGRQC1-I Cough | St. George's Respiratory Questionnaire - I cough. | SGRQ-C - Cough | ||
SGRQC1-I Have Attacks of Wheezing | C106857 | SGRQC1-I Have Attacks of Wheezing | St. George's Respiratory Questionnaire - I have attacks of wheezing. | SGRQ-C - Have Attacks of Wheezing | ||
SGRQC1-I Have Shortness of Breath | C106856 | SGRQC1-I Have Shortness of Breath | St. George's Respiratory Questionnaire - I have shortness of breath. | SGRQ-C - Have Shortness of Breath | ||
SGRQC1-If I Hurry, I Have to Stop | C106884 | SGRQC1-If I Hurry, I Have to Stop | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. | SGRQ-C - If Walk Fast Have to Stop | ||
SGRQC1-Jobs Take a Long Time | C106882 | SGRQC1-Jobs Take a Long Time | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. | SGRQ-C - Jobs Take a Long Time | ||
SGRQC1-Not in Control of Resp Problems | C106875 | SGRQC1-Not in Control of Resp Problems | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: I feel that I am not in control of my respiratory problems. | SGRQ-C - Not in Control of Respiratory Problems | ||
SGRQC1-Respiratory Problems a Nuisance | C107021 | SGRQC1-Respiratory Problems a Nuisance | St. George's Respiratory Questionnaire - Questions about other effects that your respiratory problems may have on you: My respiratory problems are a nuisance to my family, friends or neighbours. | SGRQ-C - Respiratory Problems a Nuisance to Family, Friends or Neighbours | ||
SGRQC1-Short of Breath When Bend Over | C106870 | SGRQC1-Short of Breath When Bend Over | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I am short of breath when I bend over. | SGRQ-C - Short of Breath When Bend Over | ||
SGRQC1-Short of Breath When Talk | C106869 | SGRQC1-Short of Breath When Talk | St. George's Respiratory Questionnaire - Some more questions about your cough and breathlessness: I am short of breath when I talk. | SGRQ-C - Short of Breath When Talk | ||
SGRQC1-Take a Long Time to Get Washed | C106879 | SGRQC1-Take a Long Time to Get Washed | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. | SGRQ-C - Take a Long Time to Get Washed or Dressed | ||
SGRQC1-Walk Slow Than Others My Age | C106881 | SGRQC1-Walk Slow Than Others My Age | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. | SGRQ-C - Walk Slower Than Other People My Age | ||
SGRQC1-Walk Up Flight of Stairs Slowly | C106883 | SGRQC1-Walk Up Flight of Stairs Slowly | St. George's Respiratory Questionnaire - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. | SGRQ-C - Walk Up Flight of Stairs Slowly | ||
SGRQC1-Walking Around the House | C106863 | SGRQC1-Walking Around the House | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking around the house. | SGRQ-C - Feel Breathless Walking Around the House | ||
SGRQC1-Walking Outside on Level Ground | C106864 | SGRQC1-Walking Outside on Level Ground | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking outside on level ground. | SGRQ-C - Feel Breathless Walking Outside on Level Ground | ||
SGRQC1-Walking Up a Flight of Stairs | C106865 | SGRQC1-Walking Up a Flight of Stairs | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking up a flight of stairs. | SGRQ-C - Feel Breathless Walking Up a Flight of Stairs | ||
SGRQC1-Walking Up Hills | C106866 | SGRQC1-Walking Up Hills | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Walking up hills. | SGRQ-C - Feel Breathless Walking Up Hills | ||
SGRQC1-Washing or Dressing Yourself | C106862 | SGRQC1-Washing or Dressing Yourself | St. George's Respiratory Questionnaire - Questions about what activities usually make you feel breathless: Washing or dressing yourself. | SGRQ-C - Feel Breathless Washing or Dressing Yourself | ||
SGRQC1-Wheeze Worse in the Morning | C106860 | SGRQC1-Wheeze Worse in the Morning | St. George's Respiratory Questionnaire - If you wheeze, is it worse when you get up in the morning? | SGRQ-C - Wheezing Worse In the Morning | ||
Back to top | ||||||
CL.C112449.SGRQ01TC | St. George's Respiratory Questionnaire Past 3 Months Version Questionnaire Test Code
(SGRQ01TC) | text
Extensible: No | C112449 | St. George's Respiratory Questionnaire Past 3 Months Version Questionnaire Test Code | St. George's Respiratory Questionnaire Past 3 Months Version test code. | CDISC Questionnaire SGRQ Past 3 Months Version Test Code Terminology |
SGRQ0101 | C112627 | SGRQ01-Describe Your Current Health | St. George's Respiratory Questionnaire Past 3 Months Version - Please check one box to show how you describe your current health. | SGRQ Past 3 Months Version - Describe Your Current Health | ||
SGRQ0102 | C112628 | SGRQ01-I Have Coughed | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have coughed. | SGRQ Past 3 Months Version - I Have Coughed | ||
SGRQ0103 | C112629 | SGRQ01-I Have Brought Up Phlegm | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have brought up phlegm (sputum). | SGRQ Past 3 Months Version - I Have Brought Up Phlegm | ||
SGRQ0104 | C112630 | SGRQ01-I Have Had Shortness of Breath | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have had shortness of breath. | SGRQ Past 3 Months Version - I Have Had Shortness of Breath | ||
SGRQ0105 | C112631 | SGRQ01-I Have Had Wheezing Attacks | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have had wheezing attacks. | SGRQ Past 3 Months Version - I Have Had Wheezing Attacks | ||
SGRQ0106 | C112632 | SGRQ01-Times Suffered Sev Resp Attacks | St. George's Respiratory Questionnaire Past 3 Months Version - How many times during the past 3 months have you suffered from severe or very unpleasant respiratory attacks? | SGRQ Past 3 Months Version - Times Suffered From Severe Respiratory Attacks | ||
SGRQ0107 | C112633 | SGRQ01-How Long Worst Resp Attack Last | St. George's Respiratory Questionnaire Past 3 Months Version - How long did the worst respiratory attack last? | SGRQ Past 3 Months Version - How Long Did Worst Respiratory Attack Last | ||
SGRQ0108 | C112634 | SGRQ01-How Many Good Days Have You Had | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, in a typical week, how many good days (with few respiratory problems) have you had? | SGRQ Past 3 Months Version - How Many Good Days You Had | ||
SGRQ0109 | C112635 | SGRQ01-Wheeze Worse in the Morning | St. George's Respiratory Questionnaire Past 3 Months Version - If you wheeze, is it worse when you get up in the morning? | SGRQ Past 3 Months Version - Wheeze Worse When Get Up in the Morning | ||
SGRQ0110 | C112636 | SGRQ01-Describe Your Resp Condition | St. George's Respiratory Questionnaire Past 3 Months Version - How would you describe your respiratory condition? | SGRQ Past 3 Months Version - Describe Your Respiratory Condition | ||
SGRQ0111 | C112637 | SGRQ01-If You Have Ever Held a Job | St. George's Respiratory Questionnaire Past 3 Months Version - If you have ever held a job. | SGRQ Past 3 Months Version - Held a Job | ||
SGRQ0112 | C112638 | SGRQ01-Sitting or Lying Still | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Sitting or lying still. | SGRQ Past 3 Months Version - Sitting or Lying Still | ||
SGRQ0113 | C112639 | SGRQ01-Washing or Dressing Yourself | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Washing or dressing yourself. | SGRQ Past 3 Months Version - Washing or Dressing Yourself | ||
SGRQ0114 | C112640 | SGRQ01-Walking Around the House | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking around the house. | SGRQ Past 3 Months Version - Walking Around the House | ||
SGRQ0115 | C112641 | SGRQ01-Walking Outside on Level Ground | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking outside on level ground. | SGRQ Past 3 Months Version - Walking Outside on Level Ground | ||
SGRQ0116 | C112642 | SGRQ01-Walking Up a Flight of Stairs | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking up a flight of stairs. | SGRQ Past 3 Months Version - Walking Up a Flight of Stairs | ||
SGRQ0117 | C112643 | SGRQ01-Walking Up Hills | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking up hills. | SGRQ Past 3 Months Version - Walking Up Hills | ||
SGRQ0118 | C112644 | SGRQ01-Playing Sports | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Playing sports or other physical activities. | SGRQ Past 3 Months Version - Playing Sports or Other Physical Activities | ||
SGRQ0119 | C112645 | SGRQ01-Coughing Hurts | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: Coughing hurts. | SGRQ Past 3 Months Version - Coughing Hurts | ||
SGRQ0120 | C112646 | SGRQ01-Coughing Makes Me Tired | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: Coughing makes me tired. | SGRQ Past 3 Months Version - Coughing Makes Me Tired | ||
SGRQ0121 | C112647 | SGRQ01-Short of Breath When I Talk | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I talk. | SGRQ Past 3 Months Version - Short of Breath When I Talk | ||
SGRQ0122 | C112648 | SGRQ01-Short of Breath When Bend Over | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I bend over. | SGRQ Past 3 Months Version - Short of Breath When Bend Over | ||
SGRQ0123 | C112649 | SGRQ01-Coughing Disturbs My Sleep | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: My coughing or breathing disturbs my sleep. | SGRQ Past 3 Months Version - Coughing Disturbs My Sleep | ||
SGRQ0124 | C112650 | SGRQ01-I Get Exhausted Easily | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I get exhausted easily. | SGRQ Past 3 Months Version - I Get Exhausted Easily | ||
SGRQ0125 | C112651 | SGRQ01-Cough Is Embarrassing in Public | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: My cough or breathing is embarrassing in public. | SGRQ Past 3 Months Version - My Cough is Embarrassing in Public | ||
SGRQ0126 | C112652 | SGRQ01-Respiratory Problems a Nuisance | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: My respiratory problems are a nuisance to my family, friends or neighbors. | SGRQ Past 3 Months Version - Respiratory Problems a Nuisance to Family | ||
SGRQ0127 | C112653 | SGRQ01-Afraid When Cannot Catch Breath | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I get afraid or panic when I cannot catch my breath. | SGRQ Past 3 Months Version - Get Afraid When Cannot Catch My Breath | ||
SGRQ0128 | C112654 | SGRQ01-Not in Control of Resp Problems | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I feel that I am not in control of my respiratory problems. | SGRQ Past 3 Months Version - Not in Control of My Respiratory Problems | ||
SGRQ0129 | C112655 | SGRQ01-Not Expect Probs to Get Better | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I do not expect my respiratory problems to get any better. | SGRQ Past 3 Months Version - Not Expect Respiratory Problems Get Better | ||
SGRQ0130 | C112656 | SGRQ01-I Have Become Frail | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I have become frail or an invalid because of my respiratory problems. | SGRQ Past 3 Months Version - Become Frail or Invalid Because of My Respiratory Problems | ||
SGRQ0131 | C112657 | SGRQ01-Exercise Is Not Safe for Me | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: Exercise is not safe for me. | SGRQ Past 3 Months Version - Exercise Is Not Safe for Me | ||
SGRQ0132 | C112658 | SGRQ01-Everything Too Much Effort | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: Everything seems too much of an effort. | SGRQ Past 3 Months Version - Everything Too Much Effort | ||
SGRQ0133 | C112659 | SGRQ01-Treatment Does Not Help Me Much | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: My treatment does not help me very much. | SGRQ Past 3 Months Version - Treatment Does Not Help Me Much | ||
SGRQ0134 | C112660 | SGRQ01-Embarrassed Using Med in Public | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: I get embarrassed using my medication in public. | SGRQ Past 3 Months Version - Embarrassed Using Medication in Public | ||
SGRQ0135 | C112661 | SGRQ01-Unpleasant Side Effect From Med | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: I have unpleasant side effects from my medication. | SGRQ Past 3 Months Version - Unpleasant Side Effects From Medication | ||
SGRQ0136 | C112662 | SGRQ01-Treatment Interferes With Life | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: My treatment interferes with my life a lot. | SGRQ Past 3 Months Version - Treatment Interferes With My Life | ||
SGRQ0137 | C112663 | SGRQ01-Take a Long Time to Get Washed | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. | SGRQ Past 3 Months Version - Take Long Time to Get Washed or Dressed | ||
SGRQ0138 | C112664 | SGRQ01-I Cannot Take a Bath or Shower | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. | SGRQ Past 3 Months Version - Cannot Take a Bath or Shower | ||
SGRQ0139 | C112665 | SGRQ01-I Walk Slower Than Other People | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. | SGRQ Past 3 Months Version - Walk Slower Than Other People My Age | ||
SGRQ0140 | C112666 | SGRQ01-Jobs Take a Long Time | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. | SGRQ Past 3 Months Version - Jobs Take Long Time or I Have to Stop | ||
SGRQ0141 | C112667 | SGRQ01-Walk Up Flight of Stairs Slowly | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. | SGRQ Past 3 Months Version - If Walk Up One Flight of Stairs I Have to Go Slow | ||
SGRQ0142 | C112668 | SGRQ01-If I Hurry, I Have to Stop | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. | SGRQ Past 3 Months Version - If Walk Fast I Have to Stop or Slow Down | ||
SGRQ0143 | C112669 | SGRQ01-Difficult to Walk Up Hills | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. | SGRQ Past 3 Months Version - Breathing Makes Difficult to Walk Up Hills | ||
SGRQ0144 | C112670 | SGRQ01-Difficult to Carry Heavy Loads | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. | SGRQ Past 3 Months Version - Breathing Makes Difficult to Carry Heavy Loads | ||
SGRQ0145 | C112671 | SGRQ01-Difficult to Do Very Heavy Work | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as very heavy manual work, ride a bike, run, swim fast, or play competitive sports. | SGRQ Past 3 Months Version - Breathing Makes Difficult to Do Heavy Manual Work | ||
SGRQ0146 | C112672 | SGRQ01-I Cannot Play Sports | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. | SGRQ Past 3 Months Version - Cannot Play Sports or Do Physical Activities | ||
SGRQ0147 | C112673 | SGRQ01-Cannot Go Out for Entertainment | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. | SGRQ Past 3 Months Version - Cannot Go Out for Entertainment | ||
SGRQ0148 | C112674 | SGRQ01-Cannot Go Out to Do Shopping | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. | SGRQ Past 3 Months Version - Cannot Go Out to Do Shopping | ||
SGRQ0149 | C112675 | SGRQ01-I Cannot Do Household Chores | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. | SGRQ Past 3 Months Version - Cannot Do Household Chores | ||
SGRQ0150 | C112676 | SGRQ01-I Cannot Move Far From My Bed | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. | SGRQ Past 3 Months Version - Cannot Move Far From Bed or Chair | ||
SGRQ0151 | C112677 | SGRQ01-How Resp Problems Affect You | St. George's Respiratory Questionnaire Past 3 Months Version - Best describe how your respiratory problems affect you. | SGRQ Past 3 Months Version - How Respiratory Problems Affect You | ||
Back to top | ||||||
CL.C112448.SGRQ01TN | St. George's Respiratory Questionnaire Past 3 Months Version Questionnaire Test Name
(SGRQ01TN) | text
Extensible: No | C112448 | St. George's Respiratory Questionnaire Past 3 Months Version Questionnaire Test Name | St. George's Respiratory Questionnaire Past 3 Months Version test name. | CDISC Questionnaire SGRQ Past 3 Months Version Test Name Terminology |
SGRQ01-Afraid When Cannot Catch Breath | C112653 | SGRQ01-Afraid When Cannot Catch Breath | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I get afraid or panic when I cannot catch my breath. | SGRQ Past 3 Months Version - Get Afraid When Cannot Catch My Breath | ||
SGRQ01-Cannot Go Out for Entertainment | C112673 | SGRQ01-Cannot Go Out for Entertainment | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. | SGRQ Past 3 Months Version - Cannot Go Out for Entertainment | ||
SGRQ01-Cannot Go Out to Do Shopping | C112674 | SGRQ01-Cannot Go Out to Do Shopping | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. | SGRQ Past 3 Months Version - Cannot Go Out to Do Shopping | ||
SGRQ01-Cough Is Embarrassing in Public | C112651 | SGRQ01-Cough Is Embarrassing in Public | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: My cough or breathing is embarrassing in public. | SGRQ Past 3 Months Version - My Cough is Embarrassing in Public | ||
SGRQ01-Coughing Disturbs My Sleep | C112649 | SGRQ01-Coughing Disturbs My Sleep | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: My coughing or breathing disturbs my sleep. | SGRQ Past 3 Months Version - Coughing Disturbs My Sleep | ||
SGRQ01-Coughing Hurts | C112645 | SGRQ01-Coughing Hurts | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: Coughing hurts. | SGRQ Past 3 Months Version - Coughing Hurts | ||
SGRQ01-Coughing Makes Me Tired | C112646 | SGRQ01-Coughing Makes Me Tired | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: Coughing makes me tired. | SGRQ Past 3 Months Version - Coughing Makes Me Tired | ||
SGRQ01-Describe Your Current Health | C112627 | SGRQ01-Describe Your Current Health | St. George's Respiratory Questionnaire Past 3 Months Version - Please check one box to show how you describe your current health. | SGRQ Past 3 Months Version - Describe Your Current Health | ||
SGRQ01-Describe Your Resp Condition | C112636 | SGRQ01-Describe Your Resp Condition | St. George's Respiratory Questionnaire Past 3 Months Version - How would you describe your respiratory condition? | SGRQ Past 3 Months Version - Describe Your Respiratory Condition | ||
SGRQ01-Difficult to Carry Heavy Loads | C112670 | SGRQ01-Difficult to Carry Heavy Loads | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. | SGRQ Past 3 Months Version - Breathing Makes Difficult to Carry Heavy Loads | ||
SGRQ01-Difficult to Do Very Heavy Work | C112671 | SGRQ01-Difficult to Do Very Heavy Work | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as very heavy manual work, ride a bike, run, swim fast, or play competitive sports. | SGRQ Past 3 Months Version - Breathing Makes Difficult to Do Heavy Manual Work | ||
SGRQ01-Difficult to Walk Up Hills | C112669 | SGRQ01-Difficult to Walk Up Hills | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. | SGRQ Past 3 Months Version - Breathing Makes Difficult to Walk Up Hills | ||
SGRQ01-Embarrassed Using Med in Public | C112660 | SGRQ01-Embarrassed Using Med in Public | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: I get embarrassed using my medication in public. | SGRQ Past 3 Months Version - Embarrassed Using Medication in Public | ||
SGRQ01-Everything Too Much Effort | C112658 | SGRQ01-Everything Too Much Effort | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: Everything seems too much of an effort. | SGRQ Past 3 Months Version - Everything Too Much Effort | ||
SGRQ01-Exercise Is Not Safe for Me | C112657 | SGRQ01-Exercise Is Not Safe for Me | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: Exercise is not safe for me. | SGRQ Past 3 Months Version - Exercise Is Not Safe for Me | ||
SGRQ01-How Long Worst Resp Attack Last | C112633 | SGRQ01-How Long Worst Resp Attack Last | St. George's Respiratory Questionnaire Past 3 Months Version - How long did the worst respiratory attack last? | SGRQ Past 3 Months Version - How Long Did Worst Respiratory Attack Last | ||
SGRQ01-How Many Good Days Have You Had | C112634 | SGRQ01-How Many Good Days Have You Had | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, in a typical week, how many good days (with few respiratory problems) have you had? | SGRQ Past 3 Months Version - How Many Good Days You Had | ||
SGRQ01-How Resp Problems Affect You | C112677 | SGRQ01-How Resp Problems Affect You | St. George's Respiratory Questionnaire Past 3 Months Version - Best describe how your respiratory problems affect you. | SGRQ Past 3 Months Version - How Respiratory Problems Affect You | ||
SGRQ01-I Cannot Do Household Chores | C112675 | SGRQ01-I Cannot Do Household Chores | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. | SGRQ Past 3 Months Version - Cannot Do Household Chores | ||
SGRQ01-I Cannot Move Far From My Bed | C112676 | SGRQ01-I Cannot Move Far From My Bed | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. | SGRQ Past 3 Months Version - Cannot Move Far From Bed or Chair | ||
SGRQ01-I Cannot Play Sports | C112672 | SGRQ01-I Cannot Play Sports | St. George's Respiratory Questionnaire Past 3 Months Version - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. | SGRQ Past 3 Months Version - Cannot Play Sports or Do Physical Activities | ||
SGRQ01-I Cannot Take a Bath or Shower | C112664 | SGRQ01-I Cannot Take a Bath or Shower | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. | SGRQ Past 3 Months Version - Cannot Take a Bath or Shower | ||
SGRQ01-I Get Exhausted Easily | C112650 | SGRQ01-I Get Exhausted Easily | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I get exhausted easily. | SGRQ Past 3 Months Version - I Get Exhausted Easily | ||
SGRQ01-I Have Become Frail | C112656 | SGRQ01-I Have Become Frail | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I have become frail or an invalid because of my respiratory problems. | SGRQ Past 3 Months Version - Become Frail or Invalid Because of My Respiratory Problems | ||
SGRQ01-I Have Brought Up Phlegm | C112629 | SGRQ01-I Have Brought Up Phlegm | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have brought up phlegm (sputum). | SGRQ Past 3 Months Version - I Have Brought Up Phlegm | ||
SGRQ01-I Have Coughed | C112628 | SGRQ01-I Have Coughed | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have coughed. | SGRQ Past 3 Months Version - I Have Coughed | ||
SGRQ01-I Have Had Shortness of Breath | C112630 | SGRQ01-I Have Had Shortness of Breath | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have had shortness of breath. | SGRQ Past 3 Months Version - I Have Had Shortness of Breath | ||
SGRQ01-I Have Had Wheezing Attacks | C112631 | SGRQ01-I Have Had Wheezing Attacks | St. George's Respiratory Questionnaire Past 3 Months Version - Over the past 3 months, I have had wheezing attacks. | SGRQ Past 3 Months Version - I Have Had Wheezing Attacks | ||
SGRQ01-I Walk Slower Than Other People | C112665 | SGRQ01-I Walk Slower Than Other People | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. | SGRQ Past 3 Months Version - Walk Slower Than Other People My Age | ||
SGRQ01-If I Hurry, I Have to Stop | C112668 | SGRQ01-If I Hurry, I Have to Stop | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. | SGRQ Past 3 Months Version - If Walk Fast I Have to Stop or Slow Down | ||
SGRQ01-If You Have Ever Held a Job | C112637 | SGRQ01-If You Have Ever Held a Job | St. George's Respiratory Questionnaire Past 3 Months Version - If you have ever held a job. | SGRQ Past 3 Months Version - Held a Job | ||
SGRQ01-Jobs Take a Long Time | C112666 | SGRQ01-Jobs Take a Long Time | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. | SGRQ Past 3 Months Version - Jobs Take Long Time or I Have to Stop | ||
SGRQ01-Not Expect Probs to Get Better | C112655 | SGRQ01-Not Expect Probs to Get Better | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I do not expect my respiratory problems to get any better. | SGRQ Past 3 Months Version - Not Expect Respiratory Problems Get Better | ||
SGRQ01-Not in Control of Resp Problems | C112654 | SGRQ01-Not in Control of Resp Problems | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: I feel that I am not in control of my respiratory problems. | SGRQ Past 3 Months Version - Not in Control of My Respiratory Problems | ||
SGRQ01-Playing Sports | C112644 | SGRQ01-Playing Sports | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Playing sports or other physical activities. | SGRQ Past 3 Months Version - Playing Sports or Other Physical Activities | ||
SGRQ01-Respiratory Problems a Nuisance | C112652 | SGRQ01-Respiratory Problems a Nuisance | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about other effects that your respiratory problems may have on you these days: My respiratory problems are a nuisance to my family, friends or neighbors. | SGRQ Past 3 Months Version - Respiratory Problems a Nuisance to Family | ||
SGRQ01-Short of Breath When Bend Over | C112648 | SGRQ01-Short of Breath When Bend Over | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I bend over. | SGRQ Past 3 Months Version - Short of Breath When Bend Over | ||
SGRQ01-Short of Breath When I Talk | C112647 | SGRQ01-Short of Breath When I Talk | St. George's Respiratory Questionnaire Past 3 Months Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I talk. | SGRQ Past 3 Months Version - Short of Breath When I Talk | ||
SGRQ01-Sitting or Lying Still | C112638 | SGRQ01-Sitting or Lying Still | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Sitting or lying still. | SGRQ Past 3 Months Version - Sitting or Lying Still | ||
SGRQ01-Take a Long Time to Get Washed | C112663 | SGRQ01-Take a Long Time to Get Washed | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. | SGRQ Past 3 Months Version - Take Long Time to Get Washed or Dressed | ||
SGRQ01-Times Suffered Sev Resp Attacks | C112632 | SGRQ01-Times Suffered Sev Resp Attacks | St. George's Respiratory Questionnaire Past 3 Months Version - How many times during the past 3 months have you suffered from severe or very unpleasant respiratory attacks? | SGRQ Past 3 Months Version - Times Suffered From Severe Respiratory Attacks | ||
SGRQ01-Treatment Does Not Help Me Much | C112659 | SGRQ01-Treatment Does Not Help Me Much | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: My treatment does not help me very much. | SGRQ Past 3 Months Version - Treatment Does Not Help Me Much | ||
SGRQ01-Treatment Interferes With Life | C112662 | SGRQ01-Treatment Interferes With Life | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: My treatment interferes with my life a lot. | SGRQ Past 3 Months Version - Treatment Interferes With My Life | ||
SGRQ01-Unpleasant Side Effect From Med | C112661 | SGRQ01-Unpleasant Side Effect From Med | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about your respiratory treatment: I have unpleasant side effects from my medication. | SGRQ Past 3 Months Version - Unpleasant Side Effects From Medication | ||
SGRQ01-Walk Up Flight of Stairs Slowly | C112667 | SGRQ01-Walk Up Flight of Stairs Slowly | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. | SGRQ Past 3 Months Version - If Walk Up One Flight of Stairs I Have to Go Slow | ||
SGRQ01-Walking Around the House | C112640 | SGRQ01-Walking Around the House | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking around the house. | SGRQ Past 3 Months Version - Walking Around the House | ||
SGRQ01-Walking Outside on Level Ground | C112641 | SGRQ01-Walking Outside on Level Ground | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking outside on level ground. | SGRQ Past 3 Months Version - Walking Outside on Level Ground | ||
SGRQ01-Walking Up a Flight of Stairs | C112642 | SGRQ01-Walking Up a Flight of Stairs | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking up a flight of stairs. | SGRQ Past 3 Months Version - Walking Up a Flight of Stairs | ||
SGRQ01-Walking Up Hills | C112643 | SGRQ01-Walking Up Hills | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Walking up hills. | SGRQ Past 3 Months Version - Walking Up Hills | ||
SGRQ01-Washing or Dressing Yourself | C112639 | SGRQ01-Washing or Dressing Yourself | St. George's Respiratory Questionnaire Past 3 Months Version - These are questions about what activities usually make you feel short of breath these days: Washing or dressing yourself. | SGRQ Past 3 Months Version - Washing or Dressing Yourself | ||
SGRQ01-Wheeze Worse in the Morning | C112635 | SGRQ01-Wheeze Worse in the Morning | St. George's Respiratory Questionnaire Past 3 Months Version - If you wheeze, is it worse when you get up in the morning? | SGRQ Past 3 Months Version - Wheeze Worse When Get Up in the Morning | ||
Back to top | ||||||
CL.C112451.SGRQ02TC | St. George's Respiratory Questionnaire Past 4 Weeks Version Questionnaire Test Code
(SGRQ02TC) | text
Extensible: No | C112451 | St. George's Respiratory Questionnaire Past 4 Weeks Version Questionnaire Test Code | St. George's Respiratory Questionnaire Past 4 Weeks Version test code. | CDISC Questionnaire SGRQ Past 4 Weeks Version Test Code Terminology |
SGRQ0201 | C112678 | SGRQ02-Describe Your Current Health | St. George's Respiratory Questionnaire Past 4 Weeks Version - Please check one box to show how you describe your current health. | SGRQ Past 4 Weeks Version - Describe Your Current Health | ||
SGRQ0202 | C112679 | SGRQ02-I Have Coughed | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have coughed. | SGRQ Past 4 Weeks Version - I Have Coughed | ||
SGRQ0203 | C112680 | SGRQ02-I Have Brought Up Phlegm | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have brought up phlegm (sputum). | SGRQ Past 4 Weeks Version - I Have Brought Up Phlegm | ||
SGRQ0204 | C112681 | SGRQ02-I Have Had Shortness of Breath | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have had shortness of breath. | SGRQ Past 4 Weeks Version - I Have Had Shortness of Breath | ||
SGRQ0205 | C112682 | SGRQ02-I Have Had Wheezing Attacks | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have had wheezing attacks. | SGRQ Past 4 Weeks Version - I Have Had Wheezing Attacks | ||
SGRQ0206 | C112683 | SGRQ02-Times Suffered Sev Resp Attacks | St. George's Respiratory Questionnaire Past 4 Weeks Version - How many times during the past 4 weeks have you suffered from severe or very unpleasant respiratory attacks? | SGRQ Past 4 Weeks Version - Times Suffered From Severe Respiratory Attacks | ||
SGRQ0207 | C112684 | SGRQ02-How Long Worst Resp Attack Last | St. George's Respiratory Questionnaire Past 4 Weeks Version - How long did the worst respiratory attack last? | SGRQ Past 4 Weeks Version - How Long Did Worst Respiratory Attack Last | ||
SGRQ0208 | C112685 | SGRQ02-How Many Good Days Have You Had | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, in a typical week, how many good days (with few respiratory problems) have you had? | SGRQ Past 4 Weeks Version - How Many Good Days You Had | ||
SGRQ0209 | C112686 | SGRQ02-Wheeze Worse in the Morning | St. George's Respiratory Questionnaire Past 4 Weeks Version - If you wheeze, is it worse when you get up in the morning? | SGRQ Past 4 Weeks Version - Wheeze Worse When Get Up in the Morning | ||
SGRQ0210 | C112687 | SGRQ02-Describe Your Resp Condition | St. George's Respiratory Questionnaire Past 4 Weeks Version - How would you describe your respiratory condition? | SGRQ Past 4 Weeks Version - Describe Your Respiratory Condition | ||
SGRQ0211 | C112688 | SGRQ02-If You Have Ever Held a Job | St. George's Respiratory Questionnaire Past 4 Weeks Version - If you have ever held a job. | SGRQ Past 4 Weeks Version - Held a Job | ||
SGRQ0212 | C112689 | SGRQ02-Sitting or Lying Still | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Sitting or lying still. | SGRQ Past 4 Weeks Version - Sitting or Lying Still | ||
SGRQ0213 | C112690 | SGRQ02-Washing or Dressing Yourself | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Washing or dressing yourself. | SGRQ Past 4 Weeks Version - Washing or Dressing Yourself | ||
SGRQ0214 | C112691 | SGRQ02-Walking Around the House | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking around the house. | SGRQ Past 4 Weeks Version - Walking Around the House | ||
SGRQ0215 | C112692 | SGRQ02-Walking Outside on Level Ground | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking outside on level ground. | SGRQ Past 4 Weeks Version - Walking Outside on Level Ground | ||
SGRQ0216 | C112693 | SGRQ02-Walking Up a Flight of Stairs | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking up a flight of stairs. | SGRQ Past 4 Weeks Version - Walking Up a Flight of Stairs | ||
SGRQ0217 | C112694 | SGRQ02-Walking Up Hills | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking up hills. | SGRQ Past 4 Weeks Version - Walking Up Hills | ||
SGRQ0218 | C112695 | SGRQ02-Playing Sports | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Playing sports or other physical activities. | SGRQ Past 4 Weeks Version - Playing Sports or Other Physical Activities | ||
SGRQ0219 | C112696 | SGRQ02-Coughing Hurts | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: Coughing hurts. | SGRQ Past 4 Weeks Version - Coughing Hurts | ||
SGRQ0220 | C112697 | SGRQ02-Coughing Makes Me Tired | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: Coughing makes me tired. | SGRQ Past 4 Weeks Version - Coughing Makes Me Tired | ||
SGRQ0221 | C112698 | SGRQ02-Short of Breath When I Talk | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I talk. | SGRQ Past 4 Weeks Version - Short of Breath When I Talk | ||
SGRQ0222 | C112699 | SGRQ02-Short of Breath When Bend Over | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I bend over. | SGRQ Past 4 Weeks Version - Short of Breath When Bend Over | ||
SGRQ0223 | C112700 | SGRQ02-Coughing Disturbs My Sleep | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: My coughing or breathing disturbs my sleep. | SGRQ Past 4 Weeks Version - Coughing Disturbs My Sleep | ||
SGRQ0224 | C112701 | SGRQ02-I Get Exhausted Easily | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I get exhausted easily. | SGRQ Past 4 Weeks Version - I Get Exhausted Easily | ||
SGRQ0225 | C112702 | SGRQ02-Cough Is Embarrassing in Public | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: My cough or breathing is embarrassing in public. | SGRQ Past 4 Weeks Version - My Cough is Embarrassing in Public | ||
SGRQ0226 | C112703 | SGRQ02-Respiratory Problems a Nuisance | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: My respiratory problems are a nuisance to my family, friends or neighbors. | SGRQ Past 4 Weeks Version - Respiratory Problems a Nuisance to Family | ||
SGRQ0227 | C112704 | SGRQ02-Afraid When Cannot Catch Breath | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I get afraid or panic when I cannot catch my breath. | SGRQ Past 4 Weeks Version - Get Afraid When Cannot Catch My Breath | ||
SGRQ0228 | C112705 | SGRQ02-Not in Control of Resp Problems | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I feel that I am not in control of my respiratory problems. | SGRQ Past 4 Weeks Version - Not in Control of My Respiratory Problems | ||
SGRQ0229 | C112706 | SGRQ02-Not Expect Probs to Get Better | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I do not expect my respiratory problems to get any better. | SGRQ Past 4 Weeks Version - Not Expect Respiratory Problems Get Better | ||
SGRQ0230 | C112707 | SGRQ02-I Have Become Frail | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I have become frail or an invalid because of my respiratory problems. | SGRQ Past 4 Weeks Version - Become Frail or Invalid Because of My Respiratory Problems | ||
SGRQ0231 | C112708 | SGRQ02-Exercise Is Not Safe for Me | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: Exercise is not safe for me. | SGRQ Past 4 Weeks Version - Exercise Is Not Safe for Me | ||
SGRQ0232 | C112709 | SGRQ02-Everything Too Much Effort | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: Everything seems too much of an effort. | SGRQ Past 4 Weeks Version - Everything Too Much Effort | ||
SGRQ0233 | C112710 | SGRQ02-Treatment Does Not Help Me Much | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: My treatment does not help me very much. | SGRQ Past 4 Weeks Version - Treatment Does Not Help Me Much | ||
SGRQ0234 | C112711 | SGRQ02-Embarrassed Using Med in Public | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: I get embarrassed using my medication in public. | SGRQ Past 4 Weeks Version - Embarrassed Using Medication in Public | ||
SGRQ0235 | C112712 | SGRQ02-Unpleasant Side Effect From Med | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: I have unpleasant side effects from my medication. | SGRQ Past 4 Weeks Version - Unpleasant Side Effects From Medication | ||
SGRQ0236 | C112713 | SGRQ02-Treatment Interferes With Life | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: My treatment interferes with my life a lot. | SGRQ Past 4 Weeks Version - Treatment Interferes With My Life | ||
SGRQ0237 | C112714 | SGRQ02-Take a Long Time to Get Washed | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. | SGRQ Past 4 Weeks Version - Take Long Time to Get Washed or Dressed | ||
SGRQ0238 | C112715 | SGRQ02-I Cannot Take a Bath or Shower | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. | SGRQ Past 4 Weeks Version - Cannot Take A Bath or Shower | ||
SGRQ0239 | C112716 | SGRQ02-I Walk Slower Than Other People | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. | SGRQ Past 4 Weeks Version - Walk Slower Than Other People My Age | ||
SGRQ0240 | C112717 | SGRQ02-Jobs Take a Long Time | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. | SGRQ Past 4 Weeks Version - Jobs Take Long Time or I Have to Stop | ||
SGRQ0241 | C112718 | SGRQ02-Walk Up Flight of Stairs Slowly | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. | SGRQ Past 4 Weeks Version - If Walk Up One Flight of Stairs I Have to Go Slow | ||
SGRQ0242 | C112719 | SGRQ02-If I Hurry, I Have to Stop | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. | SGRQ Past 4 Weeks Version - If Walk Fast I Have to Stop or Slow Down | ||
SGRQ0243 | C112720 | SGRQ02-Difficult to Walk Up Hills | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. | SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Walk Up Hills | ||
SGRQ0244 | C112721 | SGRQ02-Difficult to Carry Heavy Loads | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. | SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Carry Heavy Loads | ||
SGRQ0245 | C112722 | SGRQ02-Difficult to Do Very Heavy Work | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as very heavy manual work, ride a bike, run, swim fast, or play competitive sports. | SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Do Heavy Manual Work | ||
SGRQ0246 | C112723 | SGRQ02-I Cannot Play Sports | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. | SGRQ Past 4 Weeks Version - Cannot Play Sports or Do Physical Activities | ||
SGRQ0247 | C112724 | SGRQ02-Cannot Go Out for Entertainment | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. | SGRQ Past 4 Weeks Version - Cannot Go Out for Entertainment | ||
SGRQ0248 | C112725 | SGRQ02-Cannot Go Out to Do Shopping | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. | SGRQ Past 4 Weeks Version - Cannot Go Out to Do Shopping | ||
SGRQ0249 | C112726 | SGRQ02-I Cannot Do Household Chores | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. | SGRQ Past 4 Weeks Version - Cannot Do Household Chores | ||
SGRQ0250 | C112727 | SGRQ02-I Cannot Move Far From My Bed | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. | SGRQ Past 4 Weeks Version - Cannot Move Far From Bed or Chair | ||
SGRQ0251 | C112728 | SGRQ02-How Resp Problems Affect You | St. George's Respiratory Questionnaire Past 4 Weeks Version - Best describe how your respiratory problems affect you. | SGRQ Past 4 Weeks Version - How Respiratory Problems Affect You | ||
Back to top | ||||||
CL.C112450.SGRQ02TN | St. George's Respiratory Questionnaire Past 4 Weeks Version Questionnaire Test Name
(SGRQ02TN) | text
Extensible: No | C112450 | St. George's Respiratory Questionnaire Past 4 Weeks Version Questionnaire Test Name | St. George's Respiratory Questionnaire Past 4 Weeks Version test name. | CDISC Questionnaire SGRQ Past 4 Weeks Version Test Name Terminology |
SGRQ02-Afraid When Cannot Catch Breath | C112704 | SGRQ02-Afraid When Cannot Catch Breath | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I get afraid or panic when I cannot catch my breath. | SGRQ Past 4 Weeks Version - Get Afraid When Cannot Catch My Breath | ||
SGRQ02-Cannot Go Out for Entertainment | C112724 | SGRQ02-Cannot Go Out for Entertainment | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out for entertainment or recreation. | SGRQ Past 4 Weeks Version - Cannot Go Out for Entertainment | ||
SGRQ02-Cannot Go Out to Do Shopping | C112725 | SGRQ02-Cannot Go Out to Do Shopping | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot go out of the house to do the shopping. | SGRQ Past 4 Weeks Version - Cannot Go Out to Do Shopping | ||
SGRQ02-Cough Is Embarrassing in Public | C112702 | SGRQ02-Cough Is Embarrassing in Public | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: My cough or breathing is embarrassing in public. | SGRQ Past 4 Weeks Version - My Cough is Embarrassing in Public | ||
SGRQ02-Coughing Disturbs My Sleep | C112700 | SGRQ02-Coughing Disturbs My Sleep | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: My coughing or breathing disturbs my sleep. | SGRQ Past 4 Weeks Version - Coughing Disturbs My Sleep | ||
SGRQ02-Coughing Hurts | C112696 | SGRQ02-Coughing Hurts | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: Coughing hurts. | SGRQ Past 4 Weeks Version - Coughing Hurts | ||
SGRQ02-Coughing Makes Me Tired | C112697 | SGRQ02-Coughing Makes Me Tired | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: Coughing makes me tired. | SGRQ Past 4 Weeks Version - Coughing Makes Me Tired | ||
SGRQ02-Describe Your Current Health | C112678 | SGRQ02-Describe Your Current Health | St. George's Respiratory Questionnaire Past 4 Weeks Version - Please check one box to show how you describe your current health. | SGRQ Past 4 Weeks Version - Describe Your Current Health | ||
SGRQ02-Describe Your Resp Condition | C112687 | SGRQ02-Describe Your Resp Condition | St. George's Respiratory Questionnaire Past 4 Weeks Version - How would you describe your respiratory condition? | SGRQ Past 4 Weeks Version - Describe Your Respiratory Condition | ||
SGRQ02-Difficult to Carry Heavy Loads | C112721 | SGRQ02-Difficult to Carry Heavy Loads | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as carry heavy loads, dig in the garden or shovel snow, jog or walk briskly (5 miles per hour), play tennis or swim. | SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Carry Heavy Loads | ||
SGRQ02-Difficult to Do Very Heavy Work | C112722 | SGRQ02-Difficult to Do Very Heavy Work | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as very heavy manual work, ride a bike, run, swim fast, or play competitive sports. | SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Do Heavy Manual Work | ||
SGRQ02-Difficult to Walk Up Hills | C112720 | SGRQ02-Difficult to Walk Up Hills | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: My breathing makes it difficult to do things such as walk up hills, carry things up stairs, light gardening such as weeding, dance, bowl or play golf. | SGRQ Past 4 Weeks Version - Breathing Makes Difficult to Walk Up Hills | ||
SGRQ02-Embarrassed Using Med in Public | C112711 | SGRQ02-Embarrassed Using Med in Public | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: I get embarrassed using my medication in public. | SGRQ Past 4 Weeks Version - Embarrassed Using Medication in Public | ||
SGRQ02-Everything Too Much Effort | C112709 | SGRQ02-Everything Too Much Effort | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: Everything seems too much of an effort. | SGRQ Past 4 Weeks Version - Everything Too Much Effort | ||
SGRQ02-Exercise Is Not Safe for Me | C112708 | SGRQ02-Exercise Is Not Safe for Me | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: Exercise is not safe for me. | SGRQ Past 4 Weeks Version - Exercise Is Not Safe for Me | ||
SGRQ02-How Long Worst Resp Attack Last | C112684 | SGRQ02-How Long Worst Resp Attack Last | St. George's Respiratory Questionnaire Past 4 Weeks Version - How long did the worst respiratory attack last? | SGRQ Past 4 Weeks Version - How Long Did Worst Respiratory Attack Last | ||
SGRQ02-How Many Good Days Have You Had | C112685 | SGRQ02-How Many Good Days Have You Had | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, in a typical week, how many good days (with few respiratory problems) have you had? | SGRQ Past 4 Weeks Version - How Many Good Days You Had | ||
SGRQ02-How Resp Problems Affect You | C112728 | SGRQ02-How Resp Problems Affect You | St. George's Respiratory Questionnaire Past 4 Weeks Version - Best describe how your respiratory problems affect you. | SGRQ Past 4 Weeks Version - How Respiratory Problems Affect You | ||
SGRQ02-I Cannot Do Household Chores | C112726 | SGRQ02-I Cannot Do Household Chores | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot do household chores. | SGRQ Past 4 Weeks Version - Cannot Do Household Chores | ||
SGRQ02-I Cannot Move Far From My Bed | C112727 | SGRQ02-I Cannot Move Far From My Bed | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot move far from my bed or chair. | SGRQ Past 4 Weeks Version - Cannot Move Far From Bed or Chair | ||
SGRQ02-I Cannot Play Sports | C112723 | SGRQ02-I Cannot Play Sports | St. George's Respiratory Questionnaire Past 4 Weeks Version - We would like to know how your respiratory problems usually affect your daily life: I cannot play sports or do other physical activities. | SGRQ Past 4 Weeks Version - Cannot Play Sports or Do Physical Activities | ||
SGRQ02-I Cannot Take a Bath or Shower | C112715 | SGRQ02-I Cannot Take a Bath or Shower | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I cannot take a bath or shower, or I take a long time to do it. | SGRQ Past 4 Weeks Version - Cannot Take A Bath or Shower | ||
SGRQ02-I Get Exhausted Easily | C112701 | SGRQ02-I Get Exhausted Easily | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I get exhausted easily. | SGRQ Past 4 Weeks Version - I Get Exhausted Easily | ||
SGRQ02-I Have Become Frail | C112707 | SGRQ02-I Have Become Frail | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I have become frail or an invalid because of my respiratory problems. | SGRQ Past 4 Weeks Version - Become Frail or Invalid Because of My Respiratory Problems | ||
SGRQ02-I Have Brought Up Phlegm | C112680 | SGRQ02-I Have Brought Up Phlegm | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have brought up phlegm (sputum). | SGRQ Past 4 Weeks Version - I Have Brought Up Phlegm | ||
SGRQ02-I Have Coughed | C112679 | SGRQ02-I Have Coughed | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have coughed. | SGRQ Past 4 Weeks Version - I Have Coughed | ||
SGRQ02-I Have Had Shortness of Breath | C112681 | SGRQ02-I Have Had Shortness of Breath | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have had shortness of breath. | SGRQ Past 4 Weeks Version - I Have Had Shortness of Breath | ||
SGRQ02-I Have Had Wheezing Attacks | C112682 | SGRQ02-I Have Had Wheezing Attacks | St. George's Respiratory Questionnaire Past 4 Weeks Version - Over the past 4 weeks, I have had wheezing attacks. | SGRQ Past 4 Weeks Version - I Have Had Wheezing Attacks | ||
SGRQ02-I Walk Slower Than Other People | C112716 | SGRQ02-I Walk Slower Than Other People | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I walk slower than other people my age, or I stop to rest. | SGRQ Past 4 Weeks Version - Walk Slower Than Other People My Age | ||
SGRQ02-If I Hurry, I Have to Stop | C112719 | SGRQ02-If I Hurry, I Have to Stop | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: If I hurry or walk fast, I have to stop or slow down. | SGRQ Past 4 Weeks Version - If Walk Fast I Have to Stop or Slow Down | ||
SGRQ02-If You Have Ever Held a Job | C112688 | SGRQ02-If You Have Ever Held a Job | St. George's Respiratory Questionnaire Past 4 Weeks Version - If you have ever held a job. | SGRQ Past 4 Weeks Version - Held a Job | ||
SGRQ02-Jobs Take a Long Time | C112717 | SGRQ02-Jobs Take a Long Time | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: Jobs such as household chores take a long time, or I have to stop to rest. | SGRQ Past 4 Weeks Version - Jobs Take Long Time or I Have to Stop | ||
SGRQ02-Not Expect Probs to Get Better | C112706 | SGRQ02-Not Expect Probs to Get Better | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I do not expect my respiratory problems to get any better. | SGRQ Past 4 Weeks Version - Not Expect Respiratory Problems Get Better | ||
SGRQ02-Not in Control of Resp Problems | C112705 | SGRQ02-Not in Control of Resp Problems | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: I feel that I am not in control of my respiratory problems. | SGRQ Past 4 Weeks Version - Not in Control of My Respiratory Problems | ||
SGRQ02-Playing Sports | C112695 | SGRQ02-Playing Sports | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Playing sports or other physical activities. | SGRQ Past 4 Weeks Version - Playing Sports or Other Physical Activities | ||
SGRQ02-Respiratory Problems a Nuisance | C112703 | SGRQ02-Respiratory Problems a Nuisance | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about other effects that your respiratory problems may have on you these days: My respiratory problems are a nuisance to my family, friends or neighbors. | SGRQ Past 4 Weeks Version - Respiratory Problems a Nuisance to Family | ||
SGRQ02-Short of Breath When Bend Over | C112699 | SGRQ02-Short of Breath When Bend Over | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I bend over. | SGRQ Past 4 Weeks Version - Short of Breath When Bend Over | ||
SGRQ02-Short of Breath When I Talk | C112698 | SGRQ02-Short of Breath When I Talk | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are more questions about your cough and shortness of breath these days: I am short of breath when I talk. | SGRQ Past 4 Weeks Version - Short of Breath When I Talk | ||
SGRQ02-Sitting or Lying Still | C112689 | SGRQ02-Sitting or Lying Still | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Sitting or lying still. | SGRQ Past 4 Weeks Version - Sitting or Lying Still | ||
SGRQ02-Take a Long Time to Get Washed | C112714 | SGRQ02-Take a Long Time to Get Washed | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: I take a long time to get washed or dressed. | SGRQ Past 4 Weeks Version - Take Long Time to Get Washed or Dressed | ||
SGRQ02-Times Suffered Sev Resp Attacks | C112683 | SGRQ02-Times Suffered Sev Resp Attacks | St. George's Respiratory Questionnaire Past 4 Weeks Version - How many times during the past 4 weeks have you suffered from severe or very unpleasant respiratory attacks? | SGRQ Past 4 Weeks Version - Times Suffered From Severe Respiratory Attacks | ||
SGRQ02-Treatment Does Not Help Me Much | C112710 | SGRQ02-Treatment Does Not Help Me Much | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: My treatment does not help me very much. | SGRQ Past 4 Weeks Version - Treatment Does Not Help Me Much | ||
SGRQ02-Treatment Interferes With Life | C112713 | SGRQ02-Treatment Interferes With Life | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: My treatment interferes with my life a lot. | SGRQ Past 4 Weeks Version - Treatment Interferes With My Life | ||
SGRQ02-Unpleasant Side Effect From Med | C112712 | SGRQ02-Unpleasant Side Effect From Med | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about your respiratory treatment: I have unpleasant side effects from my medication. | SGRQ Past 4 Weeks Version - Unpleasant Side Effects From Medication | ||
SGRQ02-Walk Up Flight of Stairs Slowly | C112718 | SGRQ02-Walk Up Flight of Stairs Slowly | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about how your activities might be affected by your respiratory problems: If I walk up one flight of stairs, I have to go slowly or stop. | SGRQ Past 4 Weeks Version - If Walk Up One Flight of Stairs I Have to Go Slow | ||
SGRQ02-Walking Around the House | C112691 | SGRQ02-Walking Around the House | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking around the house. | SGRQ Past 4 Weeks Version - Walking Around the House | ||
SGRQ02-Walking Outside on Level Ground | C112692 | SGRQ02-Walking Outside on Level Ground | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking outside on level ground. | SGRQ Past 4 Weeks Version - Walking Outside on Level Ground | ||
SGRQ02-Walking Up a Flight of Stairs | C112693 | SGRQ02-Walking Up a Flight of Stairs | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking up a flight of stairs. | SGRQ Past 4 Weeks Version - Walking Up a Flight of Stairs | ||
SGRQ02-Walking Up Hills | C112694 | SGRQ02-Walking Up Hills | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Walking up hills. | SGRQ Past 4 Weeks Version - Walking Up Hills | ||
SGRQ02-Washing or Dressing Yourself | C112690 | SGRQ02-Washing or Dressing Yourself | St. George's Respiratory Questionnaire Past 4 Weeks Version - These are questions about what activities usually make you feel short of breath these days: Washing or dressing yourself. | SGRQ Past 4 Weeks Version - Washing or Dressing Yourself | ||
SGRQ02-Wheeze Worse in the Morning | C112686 | SGRQ02-Wheeze Worse in the Morning | St. George's Respiratory Questionnaire Past 4 Weeks Version - If you wheeze, is it worse when you get up in the morning? | SGRQ Past 4 Weeks Version - Wheeze Worse When Get Up in the Morning | ||
Back to top | ||||||
CL.C187462.SSS0101OR | Stanford Sleepiness Scale Questionnaire ORRES for SSS0101 TN/TC
(SSS0101OR) | text
Extensible: No | C187462 | Stanford Sleepiness Scale Questionnaire ORRES for SSS0101 TN/TC | Stanford Sleepiness Scale original result for SSS0101 test and test code. | CDISC Questionnaire Stanford Sleepiness Scale SSS0101 Original Response Terminology |
A little foggy; not at peak; let down. | C187498 | SSS0101-A little foggy;not at peak;let down | Stanford Sleepiness Scale original result for SSS0101-A little foggy; not at peak; let down. | Stanford Sleepiness Scale SSS0101 Original Result - A Little Foggy; Not at Peak; Let Down | ||
Almost in reverie; sleep onset soon; lost struggle to remain awake. | C187501 | SSS0101-Almost in reverie;sleep onset soon;lost struggle to remain awake | Stanford Sleepiness Scale original result for SSS0101-Almost in reverie; sleep onset soon; lost struggle to remain awake. | Stanford Sleepiness Scale SSS0101 Original Result - Almost in Reverie; Sleep Onset Soon; Lost Struggle to Remain Awake | ||
Feeling active and vital; alert; wide awake. | C187495 | SSS0101-Feeling active and vital;alert;wide awake | Stanford Sleepiness Scale original result for SSS0101-Feeling active and vital; alert; wide awake. | Stanford Sleepiness Scale SSS0101 Original Result - Feeling Active and Vital; Alert; Wide Awake | ||
Fogginess; beginning to lose interest in remaining awake; slowed down. | C187499 | SSS0101-Fogginess;beginning to lose interest in remaining awake;slowed down | Stanford Sleepiness Scale original result for SSS0101-Fogginess; beginning to lose interest in remaining awake; slowed down. | Stanford Sleepiness Scale SSS0101 Original Result - Fogginess; Beginning to Lose Interest in Remaining Awake; Slowed Down | ||
Functioning at a high level, but not at peak; able to concentrate. | C187496 | SSS0101-Functioning at a high level, but not at peak;able to concentrate | Stanford Sleepiness Scale original result for SSS0101-Functioning at a high level, but not at peak; able to concentrate. | Stanford Sleepiness Scale SSS0101 Original Result - Functioning at a High Level, But Not at Peak; Able to Concentrate | ||
Relaxed; awake; not at full alertness; responsive. | C187497 | SSS0101-Relaxed;awake;not at full alertness;responsive | Stanford Sleepiness Scale original result for SSS0101-Relaxed; awake; not at full alertness; responsive. | Stanford Sleepiness Scale SSS0101 Original Result - Relaxed; Awake; Not at Full Alertness; Responsive | ||
Sleepiness; prefer to be lying down; fighting sleep; woozy. | C187500 | SSS0101-Sleepiness;prefer to be lying down;fighting sleep;woozy | Stanford Sleepiness Scale original result for SSS0101-Sleepiness; prefer to be lying down; fighting sleep; woozy. | Stanford Sleepiness Scale SSS0101 Original Result - Sleepiness; Prefer to Be Lying Down; Fighting Sleep; Woozy | ||
Back to top | ||||||
CL.C187463.SSS0101STR | Stanford Sleepiness Scale Questionnaire STRESC for SSS0101 TN/TC
(SSS0101STR) | text
Extensible: No | C187463 | Stanford Sleepiness Scale Questionnaire STRESC for SSS0101 TN/TC | Stanford Sleepiness Scale standardized character result for SSS0101 test and test code. | CDISC Questionnaire Stanford Sleepiness Scale SSS0101 Standardized Character Response Terminology |
1 | C187502 | SSS0101-1 | Stanford Sleepiness Scale standardized character result for SSS0101-Feeling active and vital; alert; wide awake. | Stanford Sleepiness Scale SSS0101 Standardized Character Result 1 | ||
2 | C187503 | SSS0101-2 | Stanford Sleepiness Scale standardized character result for SSS0101-Functioning at a high level, but not at peak; able to concentrate. | Stanford Sleepiness Scale SSS0101 Standardized Character Result 2 | ||
3 | C187504 | SSS0101-3 | Stanford Sleepiness Scale standardized character result for SSS0101-Relaxed; awake; not at full alertness; responsive. | Stanford Sleepiness Scale SSS0101 Standardized Character Result 3 | ||
4 | C187505 | SSS0101-4 | Stanford Sleepiness Scale standardized character result for SSS0101-A little foggy; not at peak; let down. | Stanford Sleepiness Scale SSS0101 Standardized Character Result 4 | ||
5 | C187506 | SSS0101-5 | Stanford Sleepiness Scale standardized character result for SSS0101-Fogginess; beginning to lose interest in remaining awake; slowed down. | Stanford Sleepiness Scale SSS0101 Standardized Character Result 5 | ||
6 | C187507 | SSS0101-6 | Stanford Sleepiness Scale standardized character result for SSS0101-Sleepiness; prefer to be lying down; fighting sleep; woozy. | Stanford Sleepiness Scale SSS0101 Standardized Character Result 6 | ||
7 | C187508 | SSS0101-7 | Stanford Sleepiness Scale standardized character result for SSS0101-Almost in reverie; sleep onset soon; lost struggle to remain awake. | Stanford Sleepiness Scale SSS0101 Standardized Character Result 7 | ||
Back to top | ||||||
CL.C187454.SSS01TC | Stanford Sleepiness Scale Questionnaire Test Code
(SSS01TC) | text
Extensible: No | C187454 | Stanford Sleepiness Scale Questionnaire Test Code | Stanford Sleepiness Scale test code. | CDISC Questionnaire Stanford Sleepiness Scale Test Code Terminology |
SSS0101 | C187621 | SSS01-Degree of Sleepiness | Stanford Sleepiness Scale - Degree of sleepiness. | SSS - Degree of Sleepiness | ||
Back to top | ||||||
CL.C187453.SSS01TN | Stanford Sleepiness Scale Questionnaire Test Name
(SSS01TN) | text
Extensible: No | C187453 | Stanford Sleepiness Scale Questionnaire Test Name | Stanford Sleepiness Scale test name. | CDISC Questionnaire Stanford Sleepiness Scale Test Name Terminology |
SSS01-Degree of Sleepiness | C187621 | SSS01-Degree of Sleepiness | Stanford Sleepiness Scale - Degree of sleepiness. | SSS - Degree of Sleepiness | ||
Back to top | ||||||
CL.C119080.STCG01TC | Stent Thrombosis Coronary ARC Grade Clinical Classification Test Code
(STCG01TC) | text
Extensible: No | C119080 | Stent Thrombosis Coronary ARC Grade Clinical Classification Test Code | Stent Thrombosis Coronary ARC Grade test code. | CDISC Clinical Classification ARC STC Grade Test Code Terminology |
STCG0101 | C119198 | STCG01-STC ARC Grade | Stent Thrombosis Coronary ARC Grade - A grading system to describe the coronary stent thrombosis per the classification schema described by the Academic Research Consortium. | ARC STC Grade - Stent Thrombosis Coronary ARC Grade | ||
Back to top | ||||||
CL.C119079.STCG01TN | Stent Thrombosis Coronary ARC Grade Clinical Classification Test Name
(STCG01TN) | text
Extensible: No | C119079 | Stent Thrombosis Coronary ARC Grade Clinical Classification Test Name | Stent Thrombosis Coronary ARC Grade test name. | CDISC Clinical Classification ARC STC Grade Test Name Terminology |
STCG01-STC ARC Grade | C119198 | STCG01-STC ARC Grade | Stent Thrombosis Coronary ARC Grade - A grading system to describe the coronary stent thrombosis per the classification schema described by the Academic Research Consortium. | ARC STC Grade - Stent Thrombosis Coronary ARC Grade | ||
Back to top | ||||||
CL.C119020.STCARCRS | Stent Thrombosis, Coronary ARC Grade Responses
(STCARCRS) | text
Extensible: No | C119020 | Stent Thrombosis, Coronary ARC Grade Responses | A terminology codelist relevant to the Academic Research Council grade for the probability that coronary artery stent thrombosis has occurred. | CDISC SDTM ARC Coronary Stent Thrombosis Grade Responses Terminology |
STENT THROMBOSIS ARC GRADE DEFINITE | C119598 | Includes acute ischemic symptoms at rest, acute post ischemic ECG, positive biomarkers and pathological evidence. Definite stent thrombosis is considered to have occurred when there is either angiographic or pathological confirmation. Angiographic confirmation is the presence of a thrombus at coronary angiography that originates in the stent or in the segment 5 mm proximal or distal to the stent, with the presence of at least 1 of 3 clinical criteria within a 48-hour time window: 1) acute onset of ischemic symptoms at rest; 2) new ischemic ECG changes that suggest acute ischemia; or 3) typical rise and fall in cardiac biomarkers. Pathological confirmation is evidence of recent thrombus within the stent determined at autopsy or via examination of tissue retrieved following thrombectomy. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Definite Stent Thrombosis | |||
STENT THROMBOSIS ARC GRADE POSSIBLE | C119600 | Possible stent thrombosis is considered to have occurred with any unexplained death more than 30 days after intracoronary stenting. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Possible Stent Thrombosis | |||
STENT THROMBOSIS ARC GRADE PROBABLE | C119599 | Includes death within 30 days and myocardial infarction of stent territory. Probable stent thrombosis is considered to have occurred after intracoronary stenting in the following situations: 1) any unexplained death within the first 30 days; or 2) irrespective of the time after the index procedure, any MI that is related to documented acute ischemia in the territory of the implanted stent without angiographic confirmation of stent thrombosis and in the absence of any other obvious cause. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Probable Stent Thrombosis | |||
Back to top | ||||||
CL.C119019.STCTIMRS | Stent Thrombosis, Coronary, ARC Timing Responses
(STCTIMRS) | text
Extensible: No | C119019 | Stent Thrombosis, Coronary, ARC Timing Responses | A terminology codelist relevant to the Academic Research Council grade for the timing of the stent thrombosis after stent implantation. | CDISC SDTM ARC Coronary Stent Thrombosis Timing Terminology |
STENT THROMBOSIS ARC ACUTE | C119594 | 0 to 24 hours after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Stent Thrombosis Timing Acute | |||
STENT THROMBOSIS ARC LATE | C119596 | Greater than 30 days to 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Stent Thrombosis Timing Late | |||
STENT THROMBOSIS ARC SUBACUTE | C119595 | Greater than 24 hours to 30 days after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Stent Thrombosis Timing Subacute | |||
STENT THROMBOSIS ARC VERY LATE | C119597 | Greater than 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Stent Thrombosis Timing Very Late | |||
Back to top | ||||||
CL.C99077.STYPE | Study Type Response
(STYPE) | text
Extensible: No | C99077 | Study Type Response | A terminology codelist relevant to the role the study plays in determining the interventions a subject receives. | CDISC SDTM Study Type Terminology |
EXPANDED ACCESS | C98722 | Compassionate Use | Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clinical study. | Expanded Access Study | ||
INTERVENTIONAL | C98388 | Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed. | Interventional Study | |||
OBSERVATIONAL | C16084 | Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study. | Observational Study | |||
PATIENT REGISTRY | C129000 | Observational studies which include an organized system that uses observational methods to collect uniform data (clinical and other) prospectively for a population defined by a particular disorder/disease, condition (including susceptibility to a disorder), or exposure (including products, health care services, and/or procedures) and that serves a predetermined scientific, clinical, or policy purpose. Patient registries may be single purpose or on-going data collection programs that address one or more questions. (AHRQ) | Patient Registry Study | |||
Back to top | ||||||
CL.C170443.DSSCAT | Subcategory for Disposition Event
(DSSCAT) | text
Extensible: Yes | C170443 | Subcategory for Disposition Event | Terminology relevant to the subcategory for disposition events. | CDISC SDTM Subcategory for Disposition Event Terminology |
STUDY PARTICIPATION | C170569 | The act of taking part in a study. | Study Participation | |||
STUDY TREATMENT | C170570 | The act of taking part in the treatment phase of a study. | Study Treatment Phase Participation | |||
Back to top | ||||||
CL.C74559.SCTESTCD | Subject Characteristic Test Code
(SCTESTCD) | text
Extensible: Yes | C74559 | Subject Characteristic Test Code | The test code representing each subject characteristic. | CDISC SDTM Subject Characteristic Test Code Terminology |
ADEVAIND | C171499 | Appropriate Development For Age Indicator;Appropriate Developmental Age Indicator | An indication as to whether the subject's chronological age matches their physical, emotional, social, and cognitive functioning. | Appropriate Developmental Age Indicator | ||
BIO1DRN | C198360 | Num 1st Degree Relatives, Biological;Number of First Degree Relatives, Biological | The number of first degree relatives that are biologically related to the subject. | Number of First Degree Biological Relatives | ||
BIOBRON | C135500 | Number of Brothers, Biological | The number of brothers that are biologically related to the subject. (NCI) | Number of Biological Brothers | ||
BIOSISN | C135501 | Number of Sisters, Biological | The number of sisters that are biologically related to the subject. (NCI) | Number of Biological Sisters | ||
BRFEDIND | C112233 | Breast Fed Indicator | An indication as to whether the subject was breast fed (received mother's milk) as an infant. | Breast Fed Indicator | ||
BTHPLRTY | C198361 | Birth Plurality | The number of fetuses delivered live or dead at any time in the pregnancy, regardless of gestational age or if the fetuses were delivered at different dates in the pregnancy. (CDC) | Birth Plurality | ||
CHLDHSHN | C19309 | Number of Children in Household | The number of children (including neonates) residing in the household. | Number of Children in Household | ||
CNTCINV | C102625 | Contact Investigation | A public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified, usually for the purpose of identifying additional cases of the illness, or to offer some form of prophylactic intervention to either prevent or ameliorate disease in the exposed individual. | Disease Contact Investigation | ||
CNTYPAD | C176362 | County of Permanent Address | The county identified as the individual's permanent residence. | County of Permanent Address | ||
CTRYDDTC | C102631 | Entry Date from Ptntl Cntry Disease Exp | The date on which the subject arrived in the reporting country from the country of potential disease exposure. | Entry Date from Country of Potential Disease Exposure | ||
CTRYDEXP | C102612 | Country of Potential Disease Exposure | System of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides. | Country of Potential Disease Exposure | ||
CTRYPAD | C176365 | Country of Permanent Address | The country identified as the individual's permanent residence. | Country of Permanent Address | ||
DAYCRIND | C198362 | Day Care Indicator;Daycare Indicator | An indication as to whether the individual is enrolled at a daycare facility. | Enrolled in Daycare Indicator | ||
DDDTYPE | C139270 | Deceased Donor Donation Type | The conditions under which an organ is harvested from a dead donor, including the condition of the donor and the environment. | Deceased Donor Donation Condition | ||
DISTDEXP | C174364 | District of Potential Disease Exposure | The district in which the individual was potentially exposed to a disease. | District of Potential Disease Exposure | ||
DISTPAD | C176363 | District of Permanent Address | The district identified as the individual's permanent residence. | District of Permanent Address | ||
DSTATTOD | C139269 | Donor Status at Time of Organ Donation | The donor's state or condition of being either living or brain dead at the time of organ harvesting. | Donor Status at Time of Organ Donation | ||
EDLVRDTC | C81247 | Estimated Date of Delivery | An approximate calculation of the delivery date. | Expected Date of Confinement | ||
EDULEVEL | C17953 | Level of Education Attained | Highest level of education that a person has attained. | Education Level | ||
EDUYRNUM | C122393 | Number of Years of Education | The number of years of education that a person has completed. | Number of Years of Education | ||
EGESTAGE | C122188 | Estimated Gestational Age | An approximate calculation of the gestational age of the fetus, neonate, or infant. | Estimated Gestational Age | ||
EMPJOB | C25193 | Employee Job | A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc. | Occupation | ||
FRTLSTAT | C186214 | Fertility Status | The status of an individual with respect to their ability to produce offspring. | Fertility Status | ||
GENIDENT | C158277 | Gender Identity | A person's internally held sense of their gender, which may or may not correspond to the individual's genotypic or phenotypic sex. | Gender Identity | ||
GPSDEXP | C174365 | GPS Coord of Potential Disease Exposure;GPS Coordinates of Potential Disease Exposure | The global position system (GPS) coordinates for the location at which an individual was potentially exposed to a disease. | GPS Coordinates of Potential Disease Exposure | ||
GSTABRTH | C124435 | Gestational Age at Birth | The gestational age of the subject at birth. | Gestational Age at Birth | ||
HANDDOM | C114182 | Dominant Hand | The preferred hand of use for controlled and efficient performance of motor tasks. | Dominant Hand | ||
HIVHRIND | C139271 | CDC HIV High Risk Donor Indicator | An indication as to whether an organ donor may fall into one or more behavioral categories associated with increased risk of human immunodeficiency virus (HIV) infection, as defined by the 1994 Centers for Disease Control (CDC) Public Health Service Criteria for High Risk Behavior (Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994; 43: 1-17). | CDC HIV High Risk Donor Indicator | ||
INCMLVL | C154890 | Income Level | An indication of the position on a scale measuring revenue or monetary support. | Income Level | ||
INL1YIND | C171513 | Infant Less Than One Year Indicator | An indication as to whether the subject is less than one year of age. | Infant Less Than One Year Indicator | ||
JOBCLAS | C74565 | Employee Job Class;Employment Status | A code qualifying the employment in various ways, such as, full-time vs. part time, etc. | Employee Job Class | ||
LNGSPP | C132459 | Primary Language Spoken | The main language that is spoken by the subject most frequently or dominantly. | Primary Language Spoken | ||
LNGSPS | C132460 | Secondary Language Spoken | Additional language(s) that is spoken by the subject but not considered the primary language. | Secondary Language Spoken | ||
LVSBJIND | C135502 | Living with Subject Indicator | An indication as to whether the associated person is living with the subject. (NCI) | Living with Subject Indicator | ||
MARISTAT | C25188 | Marital Status | A demographic parameter indicating a person's current conjugal status. | Marital Status | ||
NATORIG | C28407 | National Origin | System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides. | National Origin | ||
PHYACLFS | C179818 | Physical Activity Lifestyle | A description of the subject's lifestyle with respect to physical activity. | Physical Activity Lifestyle | ||
PPLHSHN | C198363 | Number of People in Household | The total number of people residing in the household. | Number of People in Household | ||
PREMBRTH | C112400 | Premature Birth Indicator | An indication as to whether the subject was born prior to 37 weeks and 0 days gestation. | Premature Birth Indicator | ||
PRICON | C102699 | Priority of Disease Contact | The categorization of individuals with or without the potential for having a particular disease. | Priority of Disease Contact | ||
RISKPOP | C102666 | Member of High Risk Population | An indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder. | Member of High Risk Population | ||
RISKSOC | C102711 | Social Risk Factor | Social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease. | Social Risk Factor | ||
SALTYP | C74566 | Employee Salary Type | A code specifying the method used by the employer to compute the employee's salary or wages. For example, hourly, annual, or commission. | Employee Salary Type | ||
SETCON | C102708 | Setting of Contact | The environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier. | Setting of Disease Contact | ||
SEXRBRTH | C124436 | Sex Reported at Birth | The physical sexual characteristics of the neonate at birth. | Sex at Birth | ||
SKINCLAS | C74563 | Fitzpatrick Skin Classification;Skin Classification | Test to categorize the sensitivity of a subject's skin to sunlight. (Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871.) | Fitzpatrick Classification Scale | ||
SMGAIND | C156662 | Small for Gestational Age Indicator | An indication as to whether the fetus or infant is small for the gestational age. | Small for Gestational Age Indicator | ||
SOCECCLS | C198364 | Socioeconomic Class;Socioeconomic Classification | A characterization or classification of an individual that takes into account economics, demographics, and social interactions, used to stratify individual behaviors within a society or culture. | Socioeconomic Classification | ||
SRCCSINV | C102713 | Source Case Investigation | A public health activity for the determination of who transmitted a disease to another subject and whether this person: is still infectious; was reported to the health department as a disease case or suspect; or has infected others. | Source Case Investigation | ||
STDNTIND | C147485 | Student Indicator | An indication as to whether the subject or associated person is enrolled in school. | Student Indicator | ||
SYMPTOM | C4876 | Symptom | Subjective evidence of disease perceived by the patient. | Symptom | ||
TWINTYP | C112424 | Twin Type | The classification of the two offspring born from the same pregnancy. | Twin Type | ||
TYPCON | C102723 | Type of Contact | Identification and clinical investigation of disease contacts. | Type of Contagion Contact | ||
VILLPAD | C176364 | Village of Permanent Address | The village identified as the individual's permanent residence. | Village of Permanent Address | ||
Back to top | ||||||
CL.C103330.SCTEST | Subject Characteristic Test Name
(SCTEST) | text
Extensible: Yes | C103330 | Subject Characteristic Test Name | The test name representing each subject characteristic. | CDISC SDTM Subject Characteristic Test Name Terminology |
Appropriate Developmental Age Indicator | C171499 | Appropriate Development For Age Indicator;Appropriate Developmental Age Indicator | An indication as to whether the subject's chronological age matches their physical, emotional, social, and cognitive functioning. | Appropriate Developmental Age Indicator | ||
Birth Plurality | C198361 | Birth Plurality | The number of fetuses delivered live or dead at any time in the pregnancy, regardless of gestational age or if the fetuses were delivered at different dates in the pregnancy. (CDC) | Birth Plurality | ||
Breast Fed Indicator | C112233 | Breast Fed Indicator | An indication as to whether the subject was breast fed (received mother's milk) as an infant. | Breast Fed Indicator | ||
CDC HIV High Risk Donor Indicator | C139271 | CDC HIV High Risk Donor Indicator | An indication as to whether an organ donor may fall into one or more behavioral categories associated with increased risk of human immunodeficiency virus (HIV) infection, as defined by the 1994 Centers for Disease Control (CDC) Public Health Service Criteria for High Risk Behavior (Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994; 43: 1-17). | CDC HIV High Risk Donor Indicator | ||
Contact Investigation | C102625 | Contact Investigation | A public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified, usually for the purpose of identifying additional cases of the illness, or to offer some form of prophylactic intervention to either prevent or ameliorate disease in the exposed individual. | Disease Contact Investigation | ||
Country of Permanent Address | C176365 | Country of Permanent Address | The country identified as the individual's permanent residence. | Country of Permanent Address | ||
Country of Potential Disease Exposure | C102612 | Country of Potential Disease Exposure | System of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides. | Country of Potential Disease Exposure | ||
County of Permanent Address | C176362 | County of Permanent Address | The county identified as the individual's permanent residence. | County of Permanent Address | ||
Daycare Indicator | C198362 | Day Care Indicator;Daycare Indicator | An indication as to whether the individual is enrolled at a daycare facility. | Enrolled in Daycare Indicator | ||
Deceased Donor Donation Type | C139270 | Deceased Donor Donation Type | The conditions under which an organ is harvested from a dead donor, including the condition of the donor and the environment. | Deceased Donor Donation Condition | ||
District of Permanent Address | C176363 | District of Permanent Address | The district identified as the individual's permanent residence. | District of Permanent Address | ||
District of Potential Disease Exposure | C174364 | District of Potential Disease Exposure | The district in which the individual was potentially exposed to a disease. | District of Potential Disease Exposure | ||
Dominant Hand | C114182 | Dominant Hand | The preferred hand of use for controlled and efficient performance of motor tasks. | Dominant Hand | ||
Donor Status at Time of Organ Donation | C139269 | Donor Status at Time of Organ Donation | The donor's state or condition of being either living or brain dead at the time of organ harvesting. | Donor Status at Time of Organ Donation | ||
Employee Job Class | C74565 | Employee Job Class;Employment Status | A code qualifying the employment in various ways, such as, full-time vs. part time, etc. | Employee Job Class | ||
Employee Job | C25193 | Employee Job | A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc. | Occupation | ||
Employee Salary Type | C74566 | Employee Salary Type | A code specifying the method used by the employer to compute the employee's salary or wages. For example, hourly, annual, or commission. | Employee Salary Type | ||
Entry Date from Ptntl Cntry Disease Exp | C102631 | Entry Date from Ptntl Cntry Disease Exp | The date on which the subject arrived in the reporting country from the country of potential disease exposure. | Entry Date from Country of Potential Disease Exposure | ||
Estimated Date of Delivery | C81247 | Estimated Date of Delivery | An approximate calculation of the delivery date. | Expected Date of Confinement | ||
Estimated Gestational Age | C122188 | Estimated Gestational Age | An approximate calculation of the gestational age of the fetus, neonate, or infant. | Estimated Gestational Age | ||
Fertility Status | C186214 | Fertility Status | The status of an individual with respect to their ability to produce offspring. | Fertility Status | ||
Gender Identity | C158277 | Gender Identity | A person's internally held sense of their gender, which may or may not correspond to the individual's genotypic or phenotypic sex. | Gender Identity | ||
Gestational Age at Birth | C124435 | Gestational Age at Birth | The gestational age of the subject at birth. | Gestational Age at Birth | ||
GPS Coord of Potential Disease Exposure | C174365 | GPS Coord of Potential Disease Exposure;GPS Coordinates of Potential Disease Exposure | The global position system (GPS) coordinates for the location at which an individual was potentially exposed to a disease. | GPS Coordinates of Potential Disease Exposure | ||
Income Level | C154890 | Income Level | An indication of the position on a scale measuring revenue or monetary support. | Income Level | ||
Infant Less Than One Year Indicator | C171513 | Infant Less Than One Year Indicator | An indication as to whether the subject is less than one year of age. | Infant Less Than One Year Indicator | ||
Level of Education Attained | C17953 | Level of Education Attained | Highest level of education that a person has attained. | Education Level | ||
Living with Subject Indicator | C135502 | Living with Subject Indicator | An indication as to whether the associated person is living with the subject. (NCI) | Living with Subject Indicator | ||
Marital Status | C25188 | Marital Status | A demographic parameter indicating a person's current conjugal status. | Marital Status | ||
Member of High Risk Population | C102666 | Member of High Risk Population | An indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder. | Member of High Risk Population | ||
National Origin | C28407 | National Origin | System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides. | National Origin | ||
Num 1st Degree Relatives, Biological | C198360 | Num 1st Degree Relatives, Biological;Number of First Degree Relatives, Biological | The number of first degree relatives that are biologically related to the subject. | Number of First Degree Biological Relatives | ||
Number of Brothers, Biological | C135500 | Number of Brothers, Biological | The number of brothers that are biologically related to the subject. (NCI) | Number of Biological Brothers | ||
Number of Children in Household | C19309 | Number of Children in Household | The number of children (including neonates) residing in the household. | Number of Children in Household | ||
Number of People in Household | C198363 | Number of People in Household | The total number of people residing in the household. | Number of People in Household | ||
Number of Sisters, Biological | C135501 | Number of Sisters, Biological | The number of sisters that are biologically related to the subject. (NCI) | Number of Biological Sisters | ||
Number of Years of Education | C122393 | Number of Years of Education | The number of years of education that a person has completed. | Number of Years of Education | ||
Physical Activity Lifestyle | C179818 | Physical Activity Lifestyle | A description of the subject's lifestyle with respect to physical activity. | Physical Activity Lifestyle | ||
Premature Birth Indicator | C112400 | Premature Birth Indicator | An indication as to whether the subject was born prior to 37 weeks and 0 days gestation. | Premature Birth Indicator | ||
Primary Language Spoken | C132459 | Primary Language Spoken | The main language that is spoken by the subject most frequently or dominantly. | Primary Language Spoken | ||
Priority of Disease Contact | C102699 | Priority of Disease Contact | The categorization of individuals with or without the potential for having a particular disease. | Priority of Disease Contact | ||
Secondary Language Spoken | C132460 | Secondary Language Spoken | Additional language(s) that is spoken by the subject but not considered the primary language. | Secondary Language Spoken | ||
Setting of Contact | C102708 | Setting of Contact | The environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier. | Setting of Disease Contact | ||
Sex Reported at Birth | C124436 | Sex Reported at Birth | The physical sexual characteristics of the neonate at birth. | Sex at Birth | ||
Skin Classification | C74563 | Fitzpatrick Skin Classification;Skin Classification | Test to categorize the sensitivity of a subject's skin to sunlight. (Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871.) | Fitzpatrick Classification Scale | ||
Small for Gestational Age Indicator | C156662 | Small for Gestational Age Indicator | An indication as to whether the fetus or infant is small for the gestational age. | Small for Gestational Age Indicator | ||
Social Risk Factor | C102711 | Social Risk Factor | Social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease. | Social Risk Factor | ||
Socioeconomic Classification | C198364 | Socioeconomic Class;Socioeconomic Classification | A characterization or classification of an individual that takes into account economics, demographics, and social interactions, used to stratify individual behaviors within a society or culture. | Socioeconomic Classification | ||
Source Case Investigation | C102713 | Source Case Investigation | A public health activity for the determination of who transmitted a disease to another subject and whether this person: is still infectious; was reported to the health department as a disease case or suspect; or has infected others. | Source Case Investigation | ||
Student Indicator | C147485 | Student Indicator | An indication as to whether the subject or associated person is enrolled in school. | Student Indicator | ||
Symptom | C4876 | Symptom | Subjective evidence of disease perceived by the patient. | Symptom | ||
Twin Type | C112424 | Twin Type | The classification of the two offspring born from the same pregnancy. | Twin Type | ||
Type of Contact | C102723 | Type of Contact | Identification and clinical investigation of disease contacts. | Type of Contagion Contact | ||
Village of Permanent Address | C176364 | Village of Permanent Address | The village identified as the individual's permanent residence. | Village of Permanent Address | ||
Back to top | ||||||
CL.C124304.SSTATRS | Subject Status Response
(SSTATRS) | text
Extensible: Yes | C124304 | Subject Status Response | Terminology relevant to subject status responses. | CDISC SDTM Subject Status Response Terminology |
ALIVE | C37987 | Living; showing characteristics of life. | Alive | |||
DEAD | C28554 | Died | The absence of life or state of being dead. (NCI) | Dead | ||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C124305.SSTESTCD | Subject Status Test Code
(SSTESTCD) | text
Extensible: Yes | C124305 | Subject Status Test Code | Terminology relevant to test codes for the subject's status, which is evaluated periodically to determine if it has changed. | CDISC SDTM Subject Status Test Code Terminology |
FUAVSTAT | C186215 | Follow-Up Availability Status | The state or condition of the subject's availability to provide information about their health status after they are no longer receiving study treatment. | Follow-Up Availability Status | ||
SURVSTAT | C25717 | Survival Status | The state or condition of being living or deceased; also includes the case where the vital status is unknown. | Vital Status | ||
Back to top | ||||||
CL.C124306.SSTEST | Subject Status Test Name
(SSTEST) | text
Extensible: Yes | C124306 | Subject Status Test Name | Terminology relevant to test names for the subject's status, which is evaluated periodically to determine if it has changed. | CDISC SDTM Subject Status Test Name Terminology |
Follow-Up Availability Status | C186215 | Follow-Up Availability Status | The state or condition of the subject's availability to provide information about their health status after they are no longer receiving study treatment. | Follow-Up Availability Status | ||
Survival Status | C25717 | Survival Status | The state or condition of being living or deceased; also includes the case where the vital status is unknown. | Vital Status | ||
Back to top | ||||||
CL.C101828.SOWSA1TC | Subjective Opiate Withdrawal Scale Questionnaire Test Code
(SOWSA1TC) | text
Extensible: No | C101828 | Subjective Opiate Withdrawal Scale Questionnaire Test Code | Subjective Opiate Withdrawal Scale test code. | CDISC Questionnaire SOWS Subjective Test Code Terminology |
SOWSA101 | C102409 | SOWSA1-I Feel Anxious | Subjective Opiate Withdrawal Scale - I feel anxious. | SOWS Subjective (Handelsman) - I Feel Anxious | ||
SOWSA102 | C102410 | SOWSA1-I Feel Like Yawning | Subjective Opiate Withdrawal Scale - I feel like yawning. | SOWS Subjective (Handelsman) - I Feel Like Yawning | ||
SOWSA103 | C102411 | SOWSA1-I'm Perspiring | Subjective Opiate Withdrawal Scale - I'm perspiring. | SOWS Subjective (Handelsman) - I'm Perspiring | ||
SOWSA104 | C102412 | SOWSA1-My Eyes Are Tearing | Subjective Opiate Withdrawal Scale - My eyes are tearing. | SOWS Subjective (Handelsman) - My Eyes Are Tearing | ||
SOWSA105 | C102413 | SOWSA1-My Nose is Running | Subjective Opiate Withdrawal Scale - My nose is running. | SOWS Subjective (Handelsman) - My Nose is Running | ||
SOWSA106 | C102414 | SOWSA1-I Have Goose Flesh | Subjective Opiate Withdrawal Scale - I have goose flesh. | SOWS Subjective (Handelsman) - I Have Goose Flesh | ||
SOWSA107 | C102415 | SOWSA1-I Am Shaking | Subjective Opiate Withdrawal Scale - I am shaking. | SOWS Subjective (Handelsman) - I Am Shaking | ||
SOWSA108 | C102416 | SOWSA1-I Have Hot Flashes | Subjective Opiate Withdrawal Scale - I have hot flashes. | SOWS Subjective (Handelsman) - I Have Hot Flashes | ||
SOWSA109 | C102417 | SOWSA1-I Have Cold Flashes | Subjective Opiate Withdrawal Scale - I have cold flashes. | SOWS Subjective (Handelsman) - I Have Cold Flashes | ||
SOWSA110 | C102418 | SOWSA1-My Bones and Muscles Ache | Subjective Opiate Withdrawal Scale - My bones and muscles ache. | SOWS Subjective (Handelsman) - My Bones and Muscles Ache | ||
SOWSA111 | C102419 | SOWSA1-I Feel Restless | Subjective Opiate Withdrawal Scale - I feel restless. | SOWS Subjective (Handelsman) - I Feel Restless | ||
SOWSA112 | C102420 | SOWSA1-I Feel Nauseous | Subjective Opiate Withdrawal Scale - I feel nauseous. | SOWS Subjective (Handelsman) - I Feel Nauseous | ||
SOWSA113 | C102421 | SOWSA1-I Feel Like Vomiting | Subjective Opiate Withdrawal Scale - I feel like vomiting. | SOWS Subjective (Handelsman) - I Feel Like Vomiting | ||
SOWSA114 | C102422 | SOWSA1-My Muscles Twitch | Subjective Opiate Withdrawal Scale - My muscles twitch. | SOWS Subjective (Handelsman) - My Muscles Twitch | ||
SOWSA115 | C102423 | SOWSA1-I Have Cramps in My Stomach | Subjective Opiate Withdrawal Scale - I have cramps in my stomach. | SOWS Subjective (Handelsman) - I Have Cramps in My Stomach | ||
SOWSA116 | C102424 | SOWSA1-I Feel Like Shooting Up Now | Subjective Opiate Withdrawal Scale - I feel like shooting up now. | SOWS Subjective (Handelsman) - I Feel Like Shooting Up Now | ||
Back to top | ||||||
CL.C101829.SOWSA1TN | Subjective Opiate Withdrawal Scale Questionnaire Test Name
(SOWSA1TN) | text
Extensible: No | C101829 | Subjective Opiate Withdrawal Scale Questionnaire Test Name | Subjective Opiate Withdrawal Scale test name. | CDISC Questionnaire SOWS Subjective Test Name Terminology |
SOWSA1-I Am Shaking | C102415 | SOWSA1-I Am Shaking | Subjective Opiate Withdrawal Scale - I am shaking. | SOWS Subjective (Handelsman) - I Am Shaking | ||
SOWSA1-I Feel Anxious | C102409 | SOWSA1-I Feel Anxious | Subjective Opiate Withdrawal Scale - I feel anxious. | SOWS Subjective (Handelsman) - I Feel Anxious | ||
SOWSA1-I Feel Like Shooting Up Now | C102424 | SOWSA1-I Feel Like Shooting Up Now | Subjective Opiate Withdrawal Scale - I feel like shooting up now. | SOWS Subjective (Handelsman) - I Feel Like Shooting Up Now | ||
SOWSA1-I Feel Like Vomiting | C102421 | SOWSA1-I Feel Like Vomiting | Subjective Opiate Withdrawal Scale - I feel like vomiting. | SOWS Subjective (Handelsman) - I Feel Like Vomiting | ||
SOWSA1-I Feel Like Yawning | C102410 | SOWSA1-I Feel Like Yawning | Subjective Opiate Withdrawal Scale - I feel like yawning. | SOWS Subjective (Handelsman) - I Feel Like Yawning | ||
SOWSA1-I Feel Nauseous | C102420 | SOWSA1-I Feel Nauseous | Subjective Opiate Withdrawal Scale - I feel nauseous. | SOWS Subjective (Handelsman) - I Feel Nauseous | ||
SOWSA1-I Feel Restless | C102419 | SOWSA1-I Feel Restless | Subjective Opiate Withdrawal Scale - I feel restless. | SOWS Subjective (Handelsman) - I Feel Restless | ||
SOWSA1-I Have Cold Flashes | C102417 | SOWSA1-I Have Cold Flashes | Subjective Opiate Withdrawal Scale - I have cold flashes. | SOWS Subjective (Handelsman) - I Have Cold Flashes | ||
SOWSA1-I Have Cramps in My Stomach | C102423 | SOWSA1-I Have Cramps in My Stomach | Subjective Opiate Withdrawal Scale - I have cramps in my stomach. | SOWS Subjective (Handelsman) - I Have Cramps in My Stomach | ||
SOWSA1-I Have Goose Flesh | C102414 | SOWSA1-I Have Goose Flesh | Subjective Opiate Withdrawal Scale - I have goose flesh. | SOWS Subjective (Handelsman) - I Have Goose Flesh | ||
SOWSA1-I Have Hot Flashes | C102416 | SOWSA1-I Have Hot Flashes | Subjective Opiate Withdrawal Scale - I have hot flashes. | SOWS Subjective (Handelsman) - I Have Hot Flashes | ||
SOWSA1-I'm Perspiring | C102411 | SOWSA1-I'm Perspiring | Subjective Opiate Withdrawal Scale - I'm perspiring. | SOWS Subjective (Handelsman) - I'm Perspiring | ||
SOWSA1-My Bones and Muscles Ache | C102418 | SOWSA1-My Bones and Muscles Ache | Subjective Opiate Withdrawal Scale - My bones and muscles ache. | SOWS Subjective (Handelsman) - My Bones and Muscles Ache | ||
SOWSA1-My Eyes Are Tearing | C102412 | SOWSA1-My Eyes Are Tearing | Subjective Opiate Withdrawal Scale - My eyes are tearing. | SOWS Subjective (Handelsman) - My Eyes Are Tearing | ||
SOWSA1-My Muscles Twitch | C102422 | SOWSA1-My Muscles Twitch | Subjective Opiate Withdrawal Scale - My muscles twitch. | SOWS Subjective (Handelsman) - My Muscles Twitch | ||
SOWSA1-My Nose is Running | C102413 | SOWSA1-My Nose is Running | Subjective Opiate Withdrawal Scale - My nose is running. | SOWS Subjective (Handelsman) - My Nose is Running | ||
Back to top | ||||||
CL.C101852.SDTHSDTP | Sudden Death Syndrome Type
(SDTHSDTP) | text
Extensible: No | C101852 | Sudden Death Syndrome Type | A terminology codelist that describes syndromes or conditions that put a subject at risk for sudden death. | CDISC SDTM Sudden Death Syndrome Type Terminology |
BRUGADA SYNDROME | C71059 | Ventricular arrhythmia associated with Brugada syndrome | Polymorphic ventricular tachycardia in the absence of structural heart disease, associated with a baseline ECG pattern during sinus rhythm showing right bundle branch block with ST segment elevation in leads V1 through V3. It can also be characterized by documentation of ECG patterns associated with Brugada Syndrome, some of which may be unmasked when provoked with drugs. The most common genetic mutations identified for Brugada syndrome are in the sodium channel gene SCN5A. | Brugada Syndrome Ventricular Arrhythmia by ECG Finding | ||
CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA | C99936 | Ventricular Tachycardia associated with syncope and/or cardiac arrest triggered by emotion or exercise in patients whose baseline ECG is normal. | Catecholaminergic Polymorphic Ventricular Tachycardia by ECG Finding | |||
IDIOPATHIC PRIMARY VENTRICULAR TACHYCARDIA/VENTRICULAR FLUTTER | C100036 | Ventricular tachycardia or ventricular fibrillation whose cause is unknown. | Idiopathic Primary Ventricular Tachycardia/Ventricular Flutter by ECG Finding | |||
LONG QT SYNDROME | C34786 | Ventricular arrhythmia associated with long QT syndrome | Long QT Syndrome includes prolongation of the corrected QT interval beyond 440 ms for adult males, 460 ms for adult females and 50 ms in the presence of ventricular depolarization abnormalities (i.e., bundle branch blocks or IVCB more than 120 ms. A normal QT interval in a resting ECG with a failure to shorten with an increase in heart rate qualifies as Long QT Syndrome. | Long QT Syndrome | ||
OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
SHORT QT SYNDROME | C71060 | Ventricular arrhythmia associated with short QT syndrome | Short QT Syndrome is characterized by a QT interval of less than or equal to 300 ms. | Short QT Syndrome | ||
Back to top | ||||||
CL.C150790.SIQ01TC | Suicidal Ideation Questionnaire Test Code
(SIQ01TC) | text
Extensible: No | C150790 | Suicidal Ideation Questionnaire Test Code | Suicidal Ideation Questionnaire test code. | CDISC Questionnaire SIQ Test Code Terminology |
SIQ0101 | C151326 | SIQ01-Would Be Better If I Was Not Alive | Suicidal Ideation Questionnaire - I thought it would be better if I was not alive. | SIQ - Would Be Better If I Was Not Alive | ||
SIQ0102 | C151327 | SIQ01-I Thought About Killing Myself | Suicidal Ideation Questionnaire - I thought about killing myself. | SIQ - I Thought About Killing Myself | ||
SIQ0103 | C151328 | SIQ01-I Thought How I Would Kill Myself | Suicidal Ideation Questionnaire - I thought about how I would kill myself. | SIQ - I Thought How I Would Kill Myself | ||
SIQ0104 | C151329 | SIQ01-I Thought When I Would Kill Myself | Suicidal Ideation Questionnaire - I thought about when I would kill myself. | SIQ - I Thought When I Would Kill Myself | ||
SIQ0105 | C151330 | SIQ01-I Thought About People Dying | Suicidal Ideation Questionnaire - I thought about people dying. | SIQ - I Thought About People Dying | ||
SIQ0106 | C151331 | SIQ01-I Thought About Death | Suicidal Ideation Questionnaire - I thought about death. | SIQ - I Thought About Death | ||
SIQ0107 | C151332 | SIQ01-What to Write in a Suicide Note | Suicidal Ideation Questionnaire - I thought about what to write in a suicide note. | SIQ - What to Write in a Suicide Note | ||
SIQ0108 | C151333 | SIQ01-I Thought About Writing a Will | Suicidal Ideation Questionnaire - I thought about writing a will. | SIQ - I Thought About Writing a Will | ||
SIQ0109 | C151334 | SIQ01-Tell People I Plan to Kill Myself | Suicidal Ideation Questionnaire - I thought about telling people I plan to kill myself. | SIQ - Tell People I Plan to Kill Myself | ||
SIQ0110 | C151335 | SIQ01-People Happier If Not Around | Suicidal Ideation Questionnaire - I thought that people would be happier if I were not around. | SIQ - People Happier If Not Around | ||
SIQ0111 | C151336 | SIQ01-How People Feel If I Killed Myself | Suicidal Ideation Questionnaire - I thought about how people would feel if I killed myself. | SIQ - How People Feel If I Killed Myself | ||
SIQ0112 | C151337 | SIQ01-I Wished I Were Dead | Suicidal Ideation Questionnaire - I wished I were dead. | SIQ - I Wished I Were Dead | ||
SIQ0113 | C151338 | SIQ01-How Easy It Would Be to End It All | Suicidal Ideation Questionnaire - I thought about how easy it would be to end it all. | SIQ - How Easy It Would Be to End It All | ||
SIQ0114 | C151339 | SIQ01-Killing Myself Would Solve Problem | Suicidal Ideation Questionnaire - I thought that killing myself would solve my problems. | SIQ - Killing Myself Would Solve Problem | ||
SIQ0115 | C151340 | SIQ01-Others Better Off If I Was Dead | Suicidal Ideation Questionnaire - I thought others would be better off if I was dead. | SIQ - Others Better Off If I Was Dead | ||
SIQ0116 | C151341 | SIQ01-Wished I Had the Nerve Kill Myself | Suicidal Ideation Questionnaire - I wished I had the nerve to kill myself. | SIQ - Wished I Had the Nerve Kill Myself | ||
SIQ0117 | C151342 | SIQ01-Wished I Had Never Been Born | Suicidal Ideation Questionnaire - I wished that I had never been born. | SIQ - Wished I Had Never Been Born | ||
SIQ0118 | C151343 | SIQ01-If Had Chance I Would Kill Myself | Suicidal Ideation Questionnaire - I thought if I had the chance I would kill myself. | SIQ - If Had Chance I Would Kill Myself | ||
SIQ0119 | C151344 | SIQ01-Thought Way People Kill Themselves | Suicidal Ideation Questionnaire - I thought about ways people kill themselves. | SIQ - Thought Way People Kill Themselves | ||
SIQ0120 | C151345 | SIQ01-Thought Killing Myself Not Do It | Suicidal Ideation Questionnaire - I thought about killing myself, but would not do it. | SIQ - Thought Killing Myself Not Do It | ||
SIQ0121 | C151346 | SIQ01-Thought About Having Bad Accident | Suicidal Ideation Questionnaire - I thought about having a bad accident. | SIQ - Thought About Having Bad Accident | ||
SIQ0122 | C151347 | SIQ01-Thought Life Was Not Worth Living | Suicidal Ideation Questionnaire - I thought that life was not worth living. | SIQ - Thought Life Was Not Worth Living | ||
SIQ0123 | C151348 | SIQ01-My Life Was Too Rotten to Continue | Suicidal Ideation Questionnaire - I thought that my life was too rotten to continue. | SIQ - My Life Was Too Rotten to Continue | ||
SIQ0124 | C151349 | SIQ01-Only Way Be Noticed Is Kill Myself | Suicidal Ideation Questionnaire - I thought that the only way to be noticed is to kill myself. | SIQ - Only Way Be Noticed Is Kill Myself | ||
SIQ0125 | C151350 | SIQ01-People Realize Worth Caring About | Suicidal Ideation Questionnaire - I thought that if I killed myself people would realize I was worth caring about. | SIQ - People Realize Worth Caring About | ||
SIQ0126 | C151351 | SIQ01-No One Cared If I Lived or Died | Suicidal Ideation Questionnaire - I thought that no one cared if I lived or died. | SIQ - No One Cared If I Lived or Died | ||
SIQ0127 | C151352 | SIQ01-Hurting Myself but Not Kill Myself | Suicidal Ideation Questionnaire - I thought about hurting myself but not really killing myself. | SIQ - Hurting Myself but Not Kill Myself | ||
SIQ0128 | C151353 | SIQ01-Wondered If Had Nerve Kill Myself | Suicidal Ideation Questionnaire - I wondered if I had the nerve to kill myself. | SIQ - Wondered If Had Nerve Kill Myself | ||
SIQ0129 | C151354 | SIQ01-If Things Not Better I Kill Myself | Suicidal Ideation Questionnaire - I thought that if things did not get better I would kill myself. | SIQ - If Things Not Better I Kill Myself | ||
SIQ0130 | C151355 | SIQ01-Wished I Had Right to Kill Myself | Suicidal Ideation Questionnaire - I wished that I had the right to kill myself. | SIQ - Wished I Had Right to Kill Myself | ||
SIQ0131 | C151356 | SIQ01-TS | Suicidal Ideation Questionnaire - TS (total raw score). | SIQ - TS | ||
SIQ0132 | C151357 | SIQ01-Total % | Suicidal Ideation Questionnaire - Total standardization sample %. | SIQ - Total % | ||
SIQ0133 | C151358 | SIQ01-Specific %: Standard Sample 1 | Suicidal Ideation Questionnaire - Specific standardization %: Sample 1. | SIQ - Specific %: Standard Sample 1 | ||
SIQ0134 | C151359 | SIQ01-Specific %: Standard Sample 2 | Suicidal Ideation Questionnaire - Specific standardization %: Sample 2. | SIQ - Specific %: Standard Sample 2 | ||
SIQ0135 | C151360 | SIQ01-Specific %: Standard Sample 3 | Suicidal Ideation Questionnaire - Specific standardization %: Sample 3. | SIQ - Specific %: Standard Sample 3 | ||
SIQ0136 | C151361 | SIQ01-Critical Item 1 | Suicidal Ideation Questionnaire - Critical item 1. | SIQ - Critical Item 1 | ||
SIQ0137 | C151362 | SIQ01-Critical Item 2 | Suicidal Ideation Questionnaire - Critical item 2. | SIQ - Critical Item 2 | ||
SIQ0138 | C151363 | SIQ01-Critical Item 3 | Suicidal Ideation Questionnaire - Critical item 3. | SIQ - Critical Item 3 | ||
SIQ0139 | C151364 | SIQ01-Critical Item 4 | Suicidal Ideation Questionnaire - Critical item 4. | SIQ - Critical Item 4 | ||
SIQ0140 | C151365 | SIQ01-Critical Item 5 | Suicidal Ideation Questionnaire - Critical item 5. | SIQ - Critical Item 5 | ||
SIQ0141 | C151366 | SIQ01-Critical Item 6 | Suicidal Ideation Questionnaire - Critical item 6. | SIQ - Critical Item 6 | ||
SIQ0142 | C151367 | SIQ01-Critical Item 7 | Suicidal Ideation Questionnaire - Critical item 7. | SIQ - Critical Item 7 | ||
SIQ0143 | C151368 | SIQ01-Critical Item 8 | Suicidal Ideation Questionnaire - Critical item 8. | SIQ - Critical Item 8 | ||
Back to top | ||||||
CL.C150789.SIQ01TN | Suicidal Ideation Questionnaire Test Name
(SIQ01TN) | text
Extensible: No | C150789 | Suicidal Ideation Questionnaire Test Name | Suicidal Ideation Questionnaire test name. | CDISC Questionnaire SIQ Test Name Terminology |
SIQ01-Critical Item 1 | C151361 | SIQ01-Critical Item 1 | Suicidal Ideation Questionnaire - Critical item 1. | SIQ - Critical Item 1 | ||
SIQ01-Critical Item 2 | C151362 | SIQ01-Critical Item 2 | Suicidal Ideation Questionnaire - Critical item 2. | SIQ - Critical Item 2 | ||
SIQ01-Critical Item 3 | C151363 | SIQ01-Critical Item 3 | Suicidal Ideation Questionnaire - Critical item 3. | SIQ - Critical Item 3 | ||
SIQ01-Critical Item 4 | C151364 | SIQ01-Critical Item 4 | Suicidal Ideation Questionnaire - Critical item 4. | SIQ - Critical Item 4 | ||
SIQ01-Critical Item 5 | C151365 | SIQ01-Critical Item 5 | Suicidal Ideation Questionnaire - Critical item 5. | SIQ - Critical Item 5 | ||
SIQ01-Critical Item 6 | C151366 | SIQ01-Critical Item 6 | Suicidal Ideation Questionnaire - Critical item 6. | SIQ - Critical Item 6 | ||
SIQ01-Critical Item 7 | C151367 | SIQ01-Critical Item 7 | Suicidal Ideation Questionnaire - Critical item 7. | SIQ - Critical Item 7 | ||
SIQ01-Critical Item 8 | C151368 | SIQ01-Critical Item 8 | Suicidal Ideation Questionnaire - Critical item 8. | SIQ - Critical Item 8 | ||
SIQ01-How Easy It Would Be to End It All | C151338 | SIQ01-How Easy It Would Be to End It All | Suicidal Ideation Questionnaire - I thought about how easy it would be to end it all. | SIQ - How Easy It Would Be to End It All | ||
SIQ01-How People Feel If I Killed Myself | C151336 | SIQ01-How People Feel If I Killed Myself | Suicidal Ideation Questionnaire - I thought about how people would feel if I killed myself. | SIQ - How People Feel If I Killed Myself | ||
SIQ01-Hurting Myself but Not Kill Myself | C151352 | SIQ01-Hurting Myself but Not Kill Myself | Suicidal Ideation Questionnaire - I thought about hurting myself but not really killing myself. | SIQ - Hurting Myself but Not Kill Myself | ||
SIQ01-I Thought About Death | C151331 | SIQ01-I Thought About Death | Suicidal Ideation Questionnaire - I thought about death. | SIQ - I Thought About Death | ||
SIQ01-I Thought About Killing Myself | C151327 | SIQ01-I Thought About Killing Myself | Suicidal Ideation Questionnaire - I thought about killing myself. | SIQ - I Thought About Killing Myself | ||
SIQ01-I Thought About People Dying | C151330 | SIQ01-I Thought About People Dying | Suicidal Ideation Questionnaire - I thought about people dying. | SIQ - I Thought About People Dying | ||
SIQ01-I Thought About Writing a Will | C151333 | SIQ01-I Thought About Writing a Will | Suicidal Ideation Questionnaire - I thought about writing a will. | SIQ - I Thought About Writing a Will | ||
SIQ01-I Thought How I Would Kill Myself | C151328 | SIQ01-I Thought How I Would Kill Myself | Suicidal Ideation Questionnaire - I thought about how I would kill myself. | SIQ - I Thought How I Would Kill Myself | ||
SIQ01-I Thought When I Would Kill Myself | C151329 | SIQ01-I Thought When I Would Kill Myself | Suicidal Ideation Questionnaire - I thought about when I would kill myself. | SIQ - I Thought When I Would Kill Myself | ||
SIQ01-I Wished I Were Dead | C151337 | SIQ01-I Wished I Were Dead | Suicidal Ideation Questionnaire - I wished I were dead. | SIQ - I Wished I Were Dead | ||
SIQ01-If Had Chance I Would Kill Myself | C151343 | SIQ01-If Had Chance I Would Kill Myself | Suicidal Ideation Questionnaire - I thought if I had the chance I would kill myself. | SIQ - If Had Chance I Would Kill Myself | ||
SIQ01-If Things Not Better I Kill Myself | C151354 | SIQ01-If Things Not Better I Kill Myself | Suicidal Ideation Questionnaire - I thought that if things did not get better I would kill myself. | SIQ - If Things Not Better I Kill Myself | ||
SIQ01-Killing Myself Would Solve Problem | C151339 | SIQ01-Killing Myself Would Solve Problem | Suicidal Ideation Questionnaire - I thought that killing myself would solve my problems. | SIQ - Killing Myself Would Solve Problem | ||
SIQ01-My Life Was Too Rotten to Continue | C151348 | SIQ01-My Life Was Too Rotten to Continue | Suicidal Ideation Questionnaire - I thought that my life was too rotten to continue. | SIQ - My Life Was Too Rotten to Continue | ||
SIQ01-No One Cared If I Lived or Died | C151351 | SIQ01-No One Cared If I Lived or Died | Suicidal Ideation Questionnaire - I thought that no one cared if I lived or died. | SIQ - No One Cared If I Lived or Died | ||
SIQ01-Only Way Be Noticed Is Kill Myself | C151349 | SIQ01-Only Way Be Noticed Is Kill Myself | Suicidal Ideation Questionnaire - I thought that the only way to be noticed is to kill myself. | SIQ - Only Way Be Noticed Is Kill Myself | ||
SIQ01-Others Better Off If I Was Dead | C151340 | SIQ01-Others Better Off If I Was Dead | Suicidal Ideation Questionnaire - I thought others would be better off if I was dead. | SIQ - Others Better Off If I Was Dead | ||
SIQ01-People Happier If Not Around | C151335 | SIQ01-People Happier If Not Around | Suicidal Ideation Questionnaire - I thought that people would be happier if I were not around. | SIQ - People Happier If Not Around | ||
SIQ01-People Realize Worth Caring About | C151350 | SIQ01-People Realize Worth Caring About | Suicidal Ideation Questionnaire - I thought that if I killed myself people would realize I was worth caring about. | SIQ - People Realize Worth Caring About | ||
SIQ01-Specific %: Standard Sample 1 | C151358 | SIQ01-Specific %: Standard Sample 1 | Suicidal Ideation Questionnaire - Specific standardization %: Sample 1. | SIQ - Specific %: Standard Sample 1 | ||
SIQ01-Specific %: Standard Sample 2 | C151359 | SIQ01-Specific %: Standard Sample 2 | Suicidal Ideation Questionnaire - Specific standardization %: Sample 2. | SIQ - Specific %: Standard Sample 2 | ||
SIQ01-Specific %: Standard Sample 3 | C151360 | SIQ01-Specific %: Standard Sample 3 | Suicidal Ideation Questionnaire - Specific standardization %: Sample 3. | SIQ - Specific %: Standard Sample 3 | ||
SIQ01-Tell People I Plan to Kill Myself | C151334 | SIQ01-Tell People I Plan to Kill Myself | Suicidal Ideation Questionnaire - I thought about telling people I plan to kill myself. | SIQ - Tell People I Plan to Kill Myself | ||
SIQ01-Thought About Having Bad Accident | C151346 | SIQ01-Thought About Having Bad Accident | Suicidal Ideation Questionnaire - I thought about having a bad accident. | SIQ - Thought About Having Bad Accident | ||
SIQ01-Thought Killing Myself Not Do It | C151345 | SIQ01-Thought Killing Myself Not Do It | Suicidal Ideation Questionnaire - I thought about killing myself, but would not do it. | SIQ - Thought Killing Myself Not Do It | ||
SIQ01-Thought Life Was Not Worth Living | C151347 | SIQ01-Thought Life Was Not Worth Living | Suicidal Ideation Questionnaire - I thought that life was not worth living. | SIQ - Thought Life Was Not Worth Living | ||
SIQ01-Thought Way People Kill Themselves | C151344 | SIQ01-Thought Way People Kill Themselves | Suicidal Ideation Questionnaire - I thought about ways people kill themselves. | SIQ - Thought Way People Kill Themselves | ||
SIQ01-Total % | C151357 | SIQ01-Total % | Suicidal Ideation Questionnaire - Total standardization sample %. | SIQ - Total % | ||
SIQ01-TS | C151356 | SIQ01-TS | Suicidal Ideation Questionnaire - TS (total raw score). | SIQ - TS | ||
SIQ01-What to Write in a Suicide Note | C151332 | SIQ01-What to Write in a Suicide Note | Suicidal Ideation Questionnaire - I thought about what to write in a suicide note. | SIQ - What to Write in a Suicide Note | ||
SIQ01-Wished I Had Never Been Born | C151342 | SIQ01-Wished I Had Never Been Born | Suicidal Ideation Questionnaire - I wished that I had never been born. | SIQ - Wished I Had Never Been Born | ||
SIQ01-Wished I Had Right to Kill Myself | C151355 | SIQ01-Wished I Had Right to Kill Myself | Suicidal Ideation Questionnaire - I wished that I had the right to kill myself. | SIQ - Wished I Had Right to Kill Myself | ||
SIQ01-Wished I Had the Nerve Kill Myself | C151341 | SIQ01-Wished I Had the Nerve Kill Myself | Suicidal Ideation Questionnaire - I wished I had the nerve to kill myself. | SIQ - Wished I Had the Nerve Kill Myself | ||
SIQ01-Wondered If Had Nerve Kill Myself | C151353 | SIQ01-Wondered If Had Nerve Kill Myself | Suicidal Ideation Questionnaire - I wondered if I had the nerve to kill myself. | SIQ - Wondered If Had Nerve Kill Myself | ||
SIQ01-Would Be Better If I Was Not Alive | C151326 | SIQ01-Would Be Better If I Was Not Alive | Suicidal Ideation Questionnaire - I thought it would be better if I was not alive. | SIQ - Would Be Better If I Was Not Alive | ||
Back to top | ||||||
CL.C150792.SIQ02TC | Suicidal Ideation Questionnaire-JR Questionnaire Test Code
(SIQ02TC) | text
Extensible: No | C150792 | Suicidal Ideation Questionnaire-JR Questionnaire Test Code | Suicidal Ideation Questionnaire-JR test code. | CDISC Questionnaire SIQ-JR Test Code Terminology |
SIQ0201 | C151369 | SIQ02-Would Be Better If I Was Not Alive | Suicidal Ideation Questionnaire-JR - I thought it would be better if I was not live. | SIQ-JR - Would Be Better If I Was Not Alive | ||
SIQ0202 | C151370 | SIQ02-I Thought About Killing Myself | Suicidal Ideation Questionnaire-JR - I thought about killing myself. | SIQ-JR - I Thought About Killing Myself | ||
SIQ0203 | C151371 | SIQ02-I Thought How I Would Kill Myself | Suicidal Ideation Questionnaire-JR - I thought about how I would kill myself. | SIQ-JR - I Thought How I Would Kill Myself | ||
SIQ0204 | C151372 | SIQ02-I Thought When I Would Kill Myself | Suicidal Ideation Questionnaire-JR - I thought about when I would kill myself. | SIQ-JR - I Thought When I Would Kill Myself | ||
SIQ0205 | C151373 | SIQ02-I Thought About People Dying | Suicidal Ideation Questionnaire-JR - I thought about people dying. | SIQ-JR - I Thought About People Dying | ||
SIQ0206 | C151374 | SIQ02-I Thought About Death | Suicidal Ideation Questionnaire-JR - I thought about death. | SIQ-JR - I Thought About Death | ||
SIQ0207 | C151375 | SIQ02-What to Write in a Suicide Note | Suicidal Ideation Questionnaire-JR - I thought about what to write in a suicide note. | SIQ-JR - What to Write in a Suicide Note | ||
SIQ0208 | C151376 | SIQ02-I Thought About Writing a Will | Suicidal Ideation Questionnaire-JR - I thought about writing a will. | SIQ-JR - I Thought About Writing a Will | ||
SIQ0209 | C151377 | SIQ02-Tell People I Plan to Kill Myself | Suicidal Ideation Questionnaire-JR - I thought about telling people I plan to kill myself. | SIQ-JR - Tell People I Plan to Kill Myself | ||
SIQ0210 | C151378 | SIQ02-How People Feel If I Killed Myself | Suicidal Ideation Questionnaire-JR - I thought about how people would feel if I killed myself. | SIQ-JR - How People Feel If I Killed Myself | ||
SIQ0211 | C151379 | SIQ02-I Wished I Were Dead | Suicidal Ideation Questionnaire-JR - I wished I were dead. | SIQ-JR - I Wished I Were Dead | ||
SIQ0212 | C151380 | SIQ02-Killing Myself Would Solve Problem | Suicidal Ideation Questionnaire-JR - I thought that killing myself would solve my problems. | SIQ-JR - Killing Myself Would Solve Problem | ||
SIQ0213 | C151381 | SIQ02-Others Be Happier If I Was Dead | Suicidal Ideation Questionnaire-JR - I thought that others would be happier if I was dead. | SIQ-JR - Others Be Happier If I Was Dead | ||
SIQ0214 | C151382 | SIQ02-Wished I Had Never Been Born | Suicidal Ideation Questionnaire-JR - I wished that I had never been born. | SIQ-JR - Wished I Had Never Been Born | ||
SIQ0215 | C151383 | SIQ02-No One Cared If I Lived or Died | Suicidal Ideation Questionnaire-JR - I thought that no one cared if I lived or died. | SIQ-JR - No One Cared If I Lived or Died | ||
SIQ0216 | C151384 | SIQ02-TS | Suicidal Ideation Questionnaire-JR - TS (total raw score). | SIQ-JR - TS | ||
SIQ0217 | C151385 | SIQ02-Total % | Suicidal Ideation Questionnaire-JR - Total standardization sample %. | SIQ-JR - Total % | ||
SIQ0218 | C151386 | SIQ02-Specific %: Standard Sample 1 | Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 1. | SIQ-JR - Specific %: Standard Sample 1 | ||
SIQ0219 | C151387 | SIQ02-Specific %: Standard Sample 2 | Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 2. | SIQ-JR - Specific %: Standard Sample 2 | ||
SIQ0220 | C151388 | SIQ02-Specific %: Standard Sample 3 | Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 3. | SIQ-JR - Specific %: Standard Sample 3 | ||
SIQ0221 | C151389 | SIQ02-Critical Item 1 | Suicidal Ideation Questionnaire-JR - Critical item 1. | SIQ-JR - Critical Item 1 | ||
SIQ0222 | C151390 | SIQ02-Critical Item 2 | Suicidal Ideation Questionnaire-JR - Critical item 2. | SIQ-JR - Critical Item 2 | ||
SIQ0223 | C151391 | SIQ02-Critical Item 3 | Suicidal Ideation Questionnaire-JR - Critical item 3. | SIQ-JR - Critical Item 3 | ||
SIQ0224 | C151392 | SIQ02-Critical Item 4 | Suicidal Ideation Questionnaire-JR - Critical item 4. | SIQ-JR - Critical Item 4 | ||
SIQ0225 | C151393 | SIQ02-Critical Item 5 | Suicidal Ideation Questionnaire-JR - Critical item 5. | SIQ-JR - Critical Item 5 | ||
SIQ0226 | C151394 | SIQ02-Critical Item 6 | Suicidal Ideation Questionnaire-JR - Critical item 6. | SIQ-JR - Critical Item 6 | ||
Back to top | ||||||
CL.C150791.SIQ02TN | Suicidal Ideation Questionnaire-JR Questionnaire Test Name
(SIQ02TN) | text
Extensible: No | C150791 | Suicidal Ideation Questionnaire-JR Questionnaire Test Name | Suicidal Ideation Questionnaire-JR test name. | CDISC Questionnaire SIQ-JR Test Name Terminology |
SIQ02-Critical Item 1 | C151389 | SIQ02-Critical Item 1 | Suicidal Ideation Questionnaire-JR - Critical item 1. | SIQ-JR - Critical Item 1 | ||
SIQ02-Critical Item 2 | C151390 | SIQ02-Critical Item 2 | Suicidal Ideation Questionnaire-JR - Critical item 2. | SIQ-JR - Critical Item 2 | ||
SIQ02-Critical Item 3 | C151391 | SIQ02-Critical Item 3 | Suicidal Ideation Questionnaire-JR - Critical item 3. | SIQ-JR - Critical Item 3 | ||
SIQ02-Critical Item 4 | C151392 | SIQ02-Critical Item 4 | Suicidal Ideation Questionnaire-JR - Critical item 4. | SIQ-JR - Critical Item 4 | ||
SIQ02-Critical Item 5 | C151393 | SIQ02-Critical Item 5 | Suicidal Ideation Questionnaire-JR - Critical item 5. | SIQ-JR - Critical Item 5 | ||
SIQ02-Critical Item 6 | C151394 | SIQ02-Critical Item 6 | Suicidal Ideation Questionnaire-JR - Critical item 6. | SIQ-JR - Critical Item 6 | ||
SIQ02-How People Feel If I Killed Myself | C151378 | SIQ02-How People Feel If I Killed Myself | Suicidal Ideation Questionnaire-JR - I thought about how people would feel if I killed myself. | SIQ-JR - How People Feel If I Killed Myself | ||
SIQ02-I Thought About Death | C151374 | SIQ02-I Thought About Death | Suicidal Ideation Questionnaire-JR - I thought about death. | SIQ-JR - I Thought About Death | ||
SIQ02-I Thought About Killing Myself | C151370 | SIQ02-I Thought About Killing Myself | Suicidal Ideation Questionnaire-JR - I thought about killing myself. | SIQ-JR - I Thought About Killing Myself | ||
SIQ02-I Thought About People Dying | C151373 | SIQ02-I Thought About People Dying | Suicidal Ideation Questionnaire-JR - I thought about people dying. | SIQ-JR - I Thought About People Dying | ||
SIQ02-I Thought About Writing a Will | C151376 | SIQ02-I Thought About Writing a Will | Suicidal Ideation Questionnaire-JR - I thought about writing a will. | SIQ-JR - I Thought About Writing a Will | ||
SIQ02-I Thought How I Would Kill Myself | C151371 | SIQ02-I Thought How I Would Kill Myself | Suicidal Ideation Questionnaire-JR - I thought about how I would kill myself. | SIQ-JR - I Thought How I Would Kill Myself | ||
SIQ02-I Thought When I Would Kill Myself | C151372 | SIQ02-I Thought When I Would Kill Myself | Suicidal Ideation Questionnaire-JR - I thought about when I would kill myself. | SIQ-JR - I Thought When I Would Kill Myself | ||
SIQ02-I Wished I Were Dead | C151379 | SIQ02-I Wished I Were Dead | Suicidal Ideation Questionnaire-JR - I wished I were dead. | SIQ-JR - I Wished I Were Dead | ||
SIQ02-Killing Myself Would Solve Problem | C151380 | SIQ02-Killing Myself Would Solve Problem | Suicidal Ideation Questionnaire-JR - I thought that killing myself would solve my problems. | SIQ-JR - Killing Myself Would Solve Problem | ||
SIQ02-No One Cared If I Lived or Died | C151383 | SIQ02-No One Cared If I Lived or Died | Suicidal Ideation Questionnaire-JR - I thought that no one cared if I lived or died. | SIQ-JR - No One Cared If I Lived or Died | ||
SIQ02-Others Be Happier If I Was Dead | C151381 | SIQ02-Others Be Happier If I Was Dead | Suicidal Ideation Questionnaire-JR - I thought that others would be happier if I was dead. | SIQ-JR - Others Be Happier If I Was Dead | ||
SIQ02-Specific %: Standard Sample 1 | C151386 | SIQ02-Specific %: Standard Sample 1 | Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 1. | SIQ-JR - Specific %: Standard Sample 1 | ||
SIQ02-Specific %: Standard Sample 2 | C151387 | SIQ02-Specific %: Standard Sample 2 | Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 2. | SIQ-JR - Specific %: Standard Sample 2 | ||
SIQ02-Specific %: Standard Sample 3 | C151388 | SIQ02-Specific %: Standard Sample 3 | Suicidal Ideation Questionnaire-JR - Specific standardization %: Sample 3. | SIQ-JR - Specific %: Standard Sample 3 | ||
SIQ02-Tell People I Plan to Kill Myself | C151377 | SIQ02-Tell People I Plan to Kill Myself | Suicidal Ideation Questionnaire-JR - I thought about telling people I plan to kill myself. | SIQ-JR - Tell People I Plan to Kill Myself | ||
SIQ02-Total % | C151385 | SIQ02-Total % | Suicidal Ideation Questionnaire-JR - Total standardization sample %. | SIQ-JR - Total % | ||
SIQ02-TS | C151384 | SIQ02-TS | Suicidal Ideation Questionnaire-JR - TS (total raw score). | SIQ-JR - TS | ||
SIQ02-What to Write in a Suicide Note | C151375 | SIQ02-What to Write in a Suicide Note | Suicidal Ideation Questionnaire-JR - I thought about what to write in a suicide note. | SIQ-JR - What to Write in a Suicide Note | ||
SIQ02-Wished I Had Never Been Born | C151382 | SIQ02-Wished I Had Never Been Born | Suicidal Ideation Questionnaire-JR - I wished that I had never been born. | SIQ-JR - Wished I Had Never Been Born | ||
SIQ02-Would Be Better If I Was Not Alive | C151369 | SIQ02-Would Be Better If I Was Not Alive | Suicidal Ideation Questionnaire-JR - I thought it would be better if I was not live. | SIQ-JR - Would Be Better If I Was Not Alive | ||
Back to top | ||||||
CL.C102579.EVDRETRT | Supporting Evidence for Re-Treatment
(EVDRETRT) | text
Extensible: Yes | C102579 | Supporting Evidence for Re-Treatment | Terminology relevant to the clinical evidence to support reason for re-treatment of disease. | CDISC SDTM Supporting Evidence for Re-Treatment Terminology |
BACTERIOLOGICAL FINDING | C102602 | Objective evidence of bacterial infection perceptible to the examiner by laboratory procedure. | Bacteriological Finding | |||
CLINICAL FINDING | C100104 | Clinical Signs | Objective evidence of disease perceptible to the examiner (sign) and subjective evidence of disease perceived by the subject (symptom). | Sign or Symptom | ||
RADIOLOGIC FINDING | C35869 | Objective evidence of disease perceptible to the examiner by radiological procedure. | Radiologic Finding | |||
Back to top | ||||||
CL.C115396.SDMT01TC | Symbol Digit Modalities Test Functional Test Test Code
(SDMT01TC) | text
Extensible: No | C115396 | Symbol Digit Modalities Test Functional Test Test Code | Symbol Digit Modalities Test test code. | CDISC Functional Test SDMT Test Code Terminology |
SDMT0101 | C115816 | SDMT01-Total Score | Symbol Digit Modalities Test - Total score. | SDMT - Total Score | ||
Back to top | ||||||
CL.C115395.SDMT01TN | Symbol Digit Modalities Test Functional Test Test Name
(SDMT01TN) | text
Extensible: No | C115395 | Symbol Digit Modalities Test Functional Test Test Name | Symbol Digit Modalities Test test name. | CDISC Functional Test SDMT Test Name Terminology |
SDMT01-Total Score | C115816 | SDMT01-Total Score | Symbol Digit Modalities Test - Total score. | SDMT - Total Score | ||
Back to top | ||||||
CL.C103485.SIQR01TC | Symptom Impact Questionnaire Questionnaire Test Code
(SIQR01TC) | text
Extensible: No | C103485 | Symptom Impact Questionnaire Questionnaire Test Code | Symptom Impact Questionnaire test code. | CDISC Questionnaire SIQR Test Code Terminology |
SIQR0101 | C103730 | SIQR01-Brush or Comb Your Hair | Symptom Impact Questionnaire - Brush or comb your hair. | SIQR - Brush or Comb Your Hair | ||
SIQR0102 | C103731 | SIQR01-Walk Continuously for 20 Minutes | Symptom Impact Questionnaire - Walk continuously for 20 minutes. | SIQR - Walk Continuously for 20 Minutes | ||
SIQR0103 | C103732 | SIQR01-Prepare a Homemade Meal | Symptom Impact Questionnaire - Prepare a homemade meal. | SIQR - Prepare a Homemade Meal | ||
SIQR0104 | C103733 | SIQR01-Vacuum Scrub or Sweep Floors | Symptom Impact Questionnaire - Vacuum, scrub or sweep floors. | SIQR - Vacuum Scrub or Sweep Floors | ||
SIQR0105 | C103734 | SIQR01-Lift/Carry Bag Full of Groceries | Symptom Impact Questionnaire - Lift and carry a bag full of groceries. | SIQR - Lift and Carry a Bag Full of Groceries | ||
SIQR0106 | C103735 | SIQR01-Climb One Flight of Stairs | Symptom Impact Questionnaire - Climb one flight of stairs. | SIQR - Climb One Flight of Stairs | ||
SIQR0107 | C103736 | SIQR01-Change Bed Sheets | Symptom Impact Questionnaire - Change bed sheets. | SIQR - Change Bed Sheets | ||
SIQR0108 | C103737 | SIQR01-Sit in a Chair for 45 Minutes | Symptom Impact Questionnaire - Sit in a chair for 45 minutes. | SIQR - Sit in a Chair for 45 Minutes | ||
SIQR0109 | C103738 | SIQR01-Go Shopping for Groceries | Symptom Impact Questionnaire - Go shopping for groceries. | SIQR - Go Shopping for Groceries | ||
SIQR0110 | C103739 | SIQR01-Prevent from Accomplishing Goals | Symptom Impact Questionnaire - My medical problems prevented me from accomplishing goals for week. | SIQR - My Medical Problem Prevented Me from Accomplishing Goals for the Week | ||
SIQR0111 | C103740 | SIQR01-Overwhelmed by Medical Problems | Symptom Impact Questionnaire - I was completely overwhelmed by my medical problems. | SIQR - I was Completely Overwhelmed by My Medical Problem | ||
SIQR0112 | C103741 | SIQR01-Pain | Symptom Impact Questionnaire - Please rate your level of pain. | SIQR - Pain | ||
SIQR0113 | C103742 | SIQR01-Energy | Symptom Impact Questionnaire - Please rate your level of energy. | SIQR - Energy | ||
SIQR0114 | C103743 | SIQR01-Stiffness | Symptom Impact Questionnaire - Please rate your level of stiffness. | SIQR - Stiffness | ||
SIQR0115 | C103744 | SIQR01-Your Sleep | Symptom Impact Questionnaire - Please rate the quality of your sleep. | SIQR - Your Sleep | ||
SIQR0116 | C103745 | SIQR01-Depression | Symptom Impact Questionnaire - Please rate your level of depression. | SIQR - Depression | ||
SIQR0117 | C103746 | SIQR01-Memory Problems | Symptom Impact Questionnaire - Please rate your level of memory problems. | SIQR - Memory Problems | ||
SIQR0118 | C103747 | SIQR01-Anxiety | Symptom Impact Questionnaire - Please rate your level of anxiety. | SIQR - Anxiety | ||
SIQR0119 | C103748 | SIQR01-Tenderness to Touch | Symptom Impact Questionnaire - Please rate your level of tenderness to touch. | SIQR - Tenderness to Touch | ||
SIQR0120 | C103749 | SIQR01-Balance Problems | Symptom Impact Questionnaire - Please rate your level of balance problems. | SIQR - Balance Problems | ||
SIQR0121 | C103750 | SIQR01-Sensitivity Noise/Light/Odor/Cold | Symptom Impact Questionnaire - Please rate your level of sensitivity to loud noises, bright lights, odors and cold. | SIQR - Sensitivity to Loud Noises, Bright Lights, Odors and Cold | ||
Back to top | ||||||
CL.C103484.SIQR01TN | Symptom Impact Questionnaire Questionnaire Test Name
(SIQR01TN) | text
Extensible: No | C103484 | Symptom Impact Questionnaire Questionnaire Test Name | Symptom Impact Questionnaire test name. | CDISC Questionnaire SIQR Test Name Terminology |
SIQR01-Anxiety | C103747 | SIQR01-Anxiety | Symptom Impact Questionnaire - Please rate your level of anxiety. | SIQR - Anxiety | ||
SIQR01-Balance Problems | C103749 | SIQR01-Balance Problems | Symptom Impact Questionnaire - Please rate your level of balance problems. | SIQR - Balance Problems | ||
SIQR01-Brush or Comb Your Hair | C103730 | SIQR01-Brush or Comb Your Hair | Symptom Impact Questionnaire - Brush or comb your hair. | SIQR - Brush or Comb Your Hair | ||
SIQR01-Change Bed Sheets | C103736 | SIQR01-Change Bed Sheets | Symptom Impact Questionnaire - Change bed sheets. | SIQR - Change Bed Sheets | ||
SIQR01-Climb One Flight of Stairs | C103735 | SIQR01-Climb One Flight of Stairs | Symptom Impact Questionnaire - Climb one flight of stairs. | SIQR - Climb One Flight of Stairs | ||
SIQR01-Depression | C103745 | SIQR01-Depression | Symptom Impact Questionnaire - Please rate your level of depression. | SIQR - Depression | ||
SIQR01-Energy | C103742 | SIQR01-Energy | Symptom Impact Questionnaire - Please rate your level of energy. | SIQR - Energy | ||
SIQR01-Go Shopping for Groceries | C103738 | SIQR01-Go Shopping for Groceries | Symptom Impact Questionnaire - Go shopping for groceries. | SIQR - Go Shopping for Groceries | ||
SIQR01-Lift/Carry Bag Full of Groceries | C103734 | SIQR01-Lift/Carry Bag Full of Groceries | Symptom Impact Questionnaire - Lift and carry a bag full of groceries. | SIQR - Lift and Carry a Bag Full of Groceries | ||
SIQR01-Memory Problems | C103746 | SIQR01-Memory Problems | Symptom Impact Questionnaire - Please rate your level of memory problems. | SIQR - Memory Problems | ||
SIQR01-Overwhelmed by Medical Problems | C103740 | SIQR01-Overwhelmed by Medical Problems | Symptom Impact Questionnaire - I was completely overwhelmed by my medical problems. | SIQR - I was Completely Overwhelmed by My Medical Problem | ||
SIQR01-Pain | C103741 | SIQR01-Pain | Symptom Impact Questionnaire - Please rate your level of pain. | SIQR - Pain | ||
SIQR01-Prepare a Homemade Meal | C103732 | SIQR01-Prepare a Homemade Meal | Symptom Impact Questionnaire - Prepare a homemade meal. | SIQR - Prepare a Homemade Meal | ||
SIQR01-Prevent from Accomplishing Goals | C103739 | SIQR01-Prevent from Accomplishing Goals | Symptom Impact Questionnaire - My medical problems prevented me from accomplishing goals for week. | SIQR - My Medical Problem Prevented Me from Accomplishing Goals for the Week | ||
SIQR01-Sensitivity Noise/Light/Odor/Cold | C103750 | SIQR01-Sensitivity Noise/Light/Odor/Cold | Symptom Impact Questionnaire - Please rate your level of sensitivity to loud noises, bright lights, odors and cold. | SIQR - Sensitivity to Loud Noises, Bright Lights, Odors and Cold | ||
SIQR01-Sit in a Chair for 45 Minutes | C103737 | SIQR01-Sit in a Chair for 45 Minutes | Symptom Impact Questionnaire - Sit in a chair for 45 minutes. | SIQR - Sit in a Chair for 45 Minutes | ||
SIQR01-Stiffness | C103743 | SIQR01-Stiffness | Symptom Impact Questionnaire - Please rate your level of stiffness. | SIQR - Stiffness | ||
SIQR01-Tenderness to Touch | C103748 | SIQR01-Tenderness to Touch | Symptom Impact Questionnaire - Please rate your level of tenderness to touch. | SIQR - Tenderness to Touch | ||
SIQR01-Vacuum Scrub or Sweep Floors | C103733 | SIQR01-Vacuum Scrub or Sweep Floors | Symptom Impact Questionnaire - Vacuum, scrub or sweep floors. | SIQR - Vacuum Scrub or Sweep Floors | ||
SIQR01-Walk Continuously for 20 Minutes | C103731 | SIQR01-Walk Continuously for 20 Minutes | Symptom Impact Questionnaire - Walk continuously for 20 minutes. | SIQR - Walk Continuously for 20 Minutes | ||
SIQR01-Your Sleep | C103744 | SIQR01-Your Sleep | Symptom Impact Questionnaire - Please rate the quality of your sleep. | SIQR - Your Sleep | ||
Back to top | ||||||
CL.C154457.SMDDS1TC | Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire Test Code
(SMDDS1TC) | text
Extensible: No | C154457 | Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire Test Code | Symptoms of Major Depressive Disorder Scale v1.0 test code. | CDISC Questionnaire SMDDS Version 1.0 Test Code Terminology |
SMDDS101 | C155629 | SMDDS1-How Sad Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how sad have you felt? | SMDDS Version 1.0 - How Sad Have You Felt | ||
SMDDS102 | C155630 | SMDDS1-How Hopeless Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how hopeless have you felt? | SMDDS Version 1.0 - How Hopeless Have You Felt | ||
SMDDS103 | C155631 | SMDDS1-How Irritable Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how irritable have you felt? | SMDDS Version 1.0 - How Irritable Have You Felt | ||
SMDDS104 | C155632 | SMDDS1-How Overwhelmed Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how overwhelmed have you felt? | SMDDS Version 1.0 - How Overwhelmed Have You Felt | ||
SMDDS105 | C155633 | SMDDS1-How Worried Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how worried have you felt? | SMDDS Version 1.0 - How Worried Have You Felt | ||
SMDDS106 | C155634 | SMDDS1-How Tired Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how tired have you felt? | SMDDS Version 1.0 - How Tired Have You Felt | ||
SMDDS107 | C155635 | SMDDS1-How Difficult Stop Think Problems | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to stop thinking about your problems? | SMDDS Version 1.0 - How Difficult Stop Think Problems | ||
SMDDS108 | C155636 | SMDDS1-How Difficult to Concentrate | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to concentrate? | SMDDS Version 1.0 - How Difficult to Concentrate | ||
SMDDS109 | C155637 | SMDDS1-How Difficult to Enjoy Daily Life | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to enjoy your daily life? | SMDDS Version 1.0 - How Difficult to Enjoy Daily Life | ||
SMDDS110 | C155638 | SMDDS1-How Often Problem With Sleep | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you have a problem with your sleep (falling asleep, staying asleep, or sleeping too much)? | SMDDS Version 1.0 - How Often Problem With Sleep | ||
SMDDS111 | C155639 | SMDDS1-How Often Have Poor Appetite | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you have a poor appetite? | SMDDS Version 1.0 - How Often Have Poor Appetite | ||
SMDDS112 | C155640 | SMDDS1-How Often Did You Over Eat | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you over eat? | SMDDS Version 1.0 - How Often Did You Over Eat | ||
SMDDS113 | C155641 | SMDDS1-How Much Push Yourself Do Things | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you have to push yourself to do things? | SMDDS Version 1.0 - How Much Push Yourself Do Things | ||
SMDDS114 | C155642 | SMDDS1-How Much Feel Like Doing Nothing | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you feel like doing nothing? | SMDDS Version 1.0 - How Much Feel Like Doing Nothing | ||
SMDDS115 | C155643 | SMDDS1-How Much Blame Yourself Bad Thing | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you blame yourself when bad things happened? | SMDDS Version 1.0 - How Much Blame Yourself Bad Thing | ||
SMDDS116 | C155644 | SMDDS1-How Much Feel Not Worth Living | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you feel that life is not worth living? | SMDDS Version 1.0 - How Much Feel Not Worth Living | ||
SMDDS117 | C176211 | SMDDS1-Negative Emotions/Mood Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Negative emotions/mood subscore. | SMDDS Version 1.0 - Negative Emotions/Mood Subscore | ||
SMDDS118 | C176212 | SMDDS1-Anxiety Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Anxiety subscore. | SMDDS Version 1.0 - Anxiety Subscore | ||
SMDDS119 | C176213 | SMDDDS1-Low Energy Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Low energy subscore. | SMDDS Version 1.0 - SMDDDS1-Low Energy Subscore | ||
SMDDS120 | C176214 | SMDDS1-Cognition Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Cognition subscore. | SMDDS Version 1.0 - Cognition Subscore | ||
SMDDS121 | C176215 | SMDDS1-Sleep Disturbances Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Sleep disturbances subscore. | SMDDS Version 1.0 - Sleep Disturbances Subscore | ||
SMDDS122 | C176216 | SMDDS1-Eating Behavior Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Eating behavior subscore. | SMDDS Version 1.0 - Eating Behavior Subscore | ||
SMDDS123 | C176217 | SMDDS1-Low Motivation Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Low motivation subscore. | SMDDS Version 1.0 - Low Motivation Subscore | ||
SMDDS124 | C176218 | SMDDS1-Sense of Self Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Sense of self subscore. | SMDDS Version 1.0 - Sense of Self Subscore | ||
SMDDS125 | C176219 | SMDDS1-Self-Harm/Suicide Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Self-harm/suicide subscore. | SMDDS Version 1.0 - Self-Harm/Suicide Subscore | ||
SMDDS126 | C155645 | SMDDS1-Total Score | Symptoms of Major Depressive Disorder Scale v1.0 - Total score. | SMDDS Version 1.0 - Total Score | ||
Back to top | ||||||
CL.C154456.SMDDS1TN | Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire Test Name
(SMDDS1TN) | text
Extensible: No | C154456 | Symptoms of Major Depressive Disorder Scale v1.0 Questionnaire Test Name | Symptoms of Major Depressive Disorder Scale v1.0 test name. | CDISC Questionnaire SMDDS Version 1.0 Test Name Terminology |
SMDDDS1-Low Energy Subscore | C176213 | SMDDDS1-Low Energy Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Low energy subscore. | SMDDS Version 1.0 - SMDDDS1-Low Energy Subscore | ||
SMDDS1-Anxiety Subscore | C176212 | SMDDS1-Anxiety Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Anxiety subscore. | SMDDS Version 1.0 - Anxiety Subscore | ||
SMDDS1-Cognition Subscore | C176214 | SMDDS1-Cognition Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Cognition subscore. | SMDDS Version 1.0 - Cognition Subscore | ||
SMDDS1-Eating Behavior Subscore | C176216 | SMDDS1-Eating Behavior Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Eating behavior subscore. | SMDDS Version 1.0 - Eating Behavior Subscore | ||
SMDDS1-How Difficult Stop Think Problems | C155635 | SMDDS1-How Difficult Stop Think Problems | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to stop thinking about your problems? | SMDDS Version 1.0 - How Difficult Stop Think Problems | ||
SMDDS1-How Difficult to Concentrate | C155636 | SMDDS1-How Difficult to Concentrate | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to concentrate? | SMDDS Version 1.0 - How Difficult to Concentrate | ||
SMDDS1-How Difficult to Enjoy Daily Life | C155637 | SMDDS1-How Difficult to Enjoy Daily Life | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how difficult was it for you to enjoy your daily life? | SMDDS Version 1.0 - How Difficult to Enjoy Daily Life | ||
SMDDS1-How Hopeless Have You Felt | C155630 | SMDDS1-How Hopeless Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how hopeless have you felt? | SMDDS Version 1.0 - How Hopeless Have You Felt | ||
SMDDS1-How Irritable Have You Felt | C155631 | SMDDS1-How Irritable Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how irritable have you felt? | SMDDS Version 1.0 - How Irritable Have You Felt | ||
SMDDS1-How Much Blame Yourself Bad Thing | C155643 | SMDDS1-How Much Blame Yourself Bad Thing | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you blame yourself when bad things happened? | SMDDS Version 1.0 - How Much Blame Yourself Bad Thing | ||
SMDDS1-How Much Feel Like Doing Nothing | C155642 | SMDDS1-How Much Feel Like Doing Nothing | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you feel like doing nothing? | SMDDS Version 1.0 - How Much Feel Like Doing Nothing | ||
SMDDS1-How Much Feel Not Worth Living | C155644 | SMDDS1-How Much Feel Not Worth Living | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you feel that life is not worth living? | SMDDS Version 1.0 - How Much Feel Not Worth Living | ||
SMDDS1-How Much Push Yourself Do Things | C155641 | SMDDS1-How Much Push Yourself Do Things | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how much of the time did you have to push yourself to do things? | SMDDS Version 1.0 - How Much Push Yourself Do Things | ||
SMDDS1-How Often Did You Over Eat | C155640 | SMDDS1-How Often Did You Over Eat | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you over eat? | SMDDS Version 1.0 - How Often Did You Over Eat | ||
SMDDS1-How Often Have Poor Appetite | C155639 | SMDDS1-How Often Have Poor Appetite | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you have a poor appetite? | SMDDS Version 1.0 - How Often Have Poor Appetite | ||
SMDDS1-How Often Problem With Sleep | C155638 | SMDDS1-How Often Problem With Sleep | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how often did you have a problem with your sleep (falling asleep, staying asleep, or sleeping too much)? | SMDDS Version 1.0 - How Often Problem With Sleep | ||
SMDDS1-How Overwhelmed Have You Felt | C155632 | SMDDS1-How Overwhelmed Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how overwhelmed have you felt? | SMDDS Version 1.0 - How Overwhelmed Have You Felt | ||
SMDDS1-How Sad Have You Felt | C155629 | SMDDS1-How Sad Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how sad have you felt? | SMDDS Version 1.0 - How Sad Have You Felt | ||
SMDDS1-How Tired Have You Felt | C155634 | SMDDS1-How Tired Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how tired have you felt? | SMDDS Version 1.0 - How Tired Have You Felt | ||
SMDDS1-How Worried Have You Felt | C155633 | SMDDS1-How Worried Have You Felt | Symptoms of Major Depressive Disorder Scale v1.0 - Over the past 7 days, how worried have you felt? | SMDDS Version 1.0 - How Worried Have You Felt | ||
SMDDS1-Low Motivation Subscore | C176217 | SMDDS1-Low Motivation Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Low motivation subscore. | SMDDS Version 1.0 - Low Motivation Subscore | ||
SMDDS1-Negative Emotions/Mood Subscore | C176211 | SMDDS1-Negative Emotions/Mood Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Negative emotions/mood subscore. | SMDDS Version 1.0 - Negative Emotions/Mood Subscore | ||
SMDDS1-Self-Harm/Suicide Subscore | C176219 | SMDDS1-Self-Harm/Suicide Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Self-harm/suicide subscore. | SMDDS Version 1.0 - Self-Harm/Suicide Subscore | ||
SMDDS1-Sense of Self Subscore | C176218 | SMDDS1-Sense of Self Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Sense of self subscore. | SMDDS Version 1.0 - Sense of Self Subscore | ||
SMDDS1-Sleep Disturbances Subscore | C176215 | SMDDS1-Sleep Disturbances Subscore | Symptoms of Major Depressive Disorder Scale v1.0 - Sleep disturbances subscore. | SMDDS Version 1.0 - Sleep Disturbances Subscore | ||
SMDDS1-Total Score | C155645 | SMDDS1-Total Score | Symptoms of Major Depressive Disorder Scale v1.0 - Total score. | SMDDS Version 1.0 - Total Score | ||
Back to top | ||||||
CL.C193261.TANN0201OR | Tanner Scale Boy Clinical Classification ORRES for TANN0201 TN/TC
(TANN0201OR) | text
Extensible: No | C193261 | Tanner Scale Boy Clinical Classification ORRES for TANN0201 TN/TC | Tanner Scale Boy original result for TANN0201 test and test code. | CDISC Clinical Classification Tanner Scale Boy TANN0201 Original Response Terminology |
Stage 1 | C193304 | TANN0201-Stage 1 | Tanner Scale Boy original result for TANN0201-Stage 1: Pre-adolescent. Testes, scrotum, and penis are of about the same size and proportion as in early childhood. | Tanner Scale Boy TANN0201 Original Result - Stage 1 | ||
Stage 2 | C193305 | TANN0201-Stage 2 | Tanner Scale Boy original result for TANN0201-Stage 2: The scrotum and testes have enlarged and there is a change in the texture of the scrotal skin. There is also some reddening of the scrotal skin but this cannot be detected on black and white photographs. | Tanner Scale Boy TANN0201 Original Result - Stage 2 | ||
Stage 3 | C193306 | TANN0201-Stage 3 | Tanner Scale Boy original result for TANN0201-Stage 3: Growth of the penis has occurred, at first mainly in length but with some increase in breadth. There has been further growth of testes and scrotum. | Tanner Scale Boy TANN0201 Original Result - Stage 3 | ||
Stage 4 | C193307 | TANN0201-Stage 4 | Tanner Scale Boy original result for TANN0201-Stage 4: Penis further enlarged in length and breadth with development of glans. Testes and scrotum further enlarged. There is also further darkening of the scrotal skin, but this is difficult to detect on photographs. | Tanner Scale Boy TANN0201 Original Result - Stage 4 | ||
Stage 5 | C193308 | TANN0201-Stage 5 | Tanner Scale Boy original result for TANN0201-Stage 5: Genitalia adult in size and shape. No further enlargement takes place after Stage 5 is reached. | Tanner Scale Boy TANN0201 Original Result - Stage 5 | ||
Back to top | ||||||
CL.C193263.TANN0202OR | Tanner Scale Boy Clinical Classification ORRES for TANN0202 TN/TC
(TANN0202OR) | text
Extensible: No | C193263 | Tanner Scale Boy Clinical Classification ORRES for TANN0202 TN/TC | Tanner Scale Boy original result for TANN0202 test and test code. | CDISC Clinical Classification Tanner Scale Boy TANN0202 Original Response Terminology |
Stage 1 | C193314 | TANN0202-Stage 1 | Tanner Scale Boy original result for TANN0202-Stage 1: Pre-adolescent. The velus over the pubes is no further developed than that over the abdominal wall, i.e. no pubic hair. | Tanner Scale Boy TANN0202 Original Result - Stage 1 | ||
Stage 2 | C193315 | TANN0202-Stage 2 | Tanner Scale Boy original result for TANN0202-Stage 2: Sparse growth of long, slightly pigmented, downy hair, straight or only slightly curled, appearing chiefly at the base of the penis. This stage is difficult to see on photographs, particularly of fair-haired subjects. Although the rating 'Stage 2' was used in this study, it cannot be regarded as reliable, and the ages at which subjects are said to have reached Stage 2 are almost certainly too late. | Tanner Scale Boy TANN0202 Original Result - Stage 2 | ||
Stage 3 | C193316 | TANN0202-Stage 3 | Tanner Scale Boy original result for TANN0202-Stage 3: Considerably darker, coarser, and more curled. The hair spreads sparsely over the junction of the pubes. This and subsequent stages were clearly recognizable on the photographs. | Tanner Scale Boy TANN0202 Original Result - Stage 3 | ||
Stage 4 | C193317 | TANN0202-Stage 4 | Tanner Scale Boy original result for TANN0202-Stage 4: Hair is now adult in type, but the area covered by it is still considerably smaller than in most adults. There is no spread to the medial surface of the thighs. | Tanner Scale Boy TANN0202 Original Result - Stage 4 | ||
Stage 5 | C193318 | TANN0202-Stage 5 | Tanner Scale Boy original result for TANN0202-Stage 5: Adult in quantity and type, distributed as an inverse triangle of the classically feminine pattern. Spread to the medial surface of the thighs but not up the linea alba or elsewhere above the base of the inverse triangle. | Tanner Scale Boy TANN0202 Original Result - Stage 5 | ||
Back to top | ||||||
CL.C193262.TANN0201STR | Tanner Scale Boy Clinical Classification STRESC for TANN0201 TN/TC
(TANN0201STR) | text
Extensible: No | C193262 | Tanner Scale Boy Clinical Classification STRESC for TANN0201 TN/TC | Tanner Scale Boy standardized character result for TANN0201 test and test code. | CDISC Clinical Classification Tanner Scale Boy TANN0201 Standardized Character Response Terminology |
Stage 1 | C193309 | TANN0201-Stage 1 | Tanner Scale Boy standardized character result for TANN0201-Stage 1: Pre-adolescent. Testes, scrotum, and penis are of about the same size and proportion as in early childhood. | Tanner Scale Boy TANN0201 Standardized Character Result Stage 1 | ||
Stage 2 | C193310 | TANN0201-Stage 2 | Tanner Scale Boy standardized character result for TANN0201-Stage 2: The scrotum and testes have enlarged and there is a change in the texture of the scrotal skin. There is also some reddening of the scrotal skin but this cannot be detected on black and white photographs. | Tanner Scale Boy TANN0201 Standardized Character Result Stage 2 | ||
Stage 3 | C193311 | TANN0201-Stage 3 | Tanner Scale Boy standardized character result for TANN0201-Stage 3: Growth of the penis has occurred, at first mainly in length but with some increase in breadth. There has been further growth of testes and scrotum. | Tanner Scale Boy TANN0201 Standardized Character Result Stage 3 | ||
Stage 4 | C193312 | TANN0201-Stage 4 | Tanner Scale Boy standardized character result for TANN0201-Stage 4: Penis further enlarged in length and breadth with development of glans. Testes and scrotum further enlarged. There is also further darkening of the scrotal skin, but this is difficult to detect on photographs. | Tanner Scale Boy TANN0201 Standardized Character Result Stage 4 | ||
Stage 5 | C193313 | TANN0201-Stage 5 | Tanner Scale Boy standardized character result for TANN0201-Stage 5: Genitalia adult in size and shape. No further enlargement takes place after Stage 5 is reached. | Tanner Scale Boy TANN0201 Standardized Character Result Stage 5 | ||
Back to top | ||||||
CL.C193264.TANN0202STR | Tanner Scale Boy Clinical Classification STRESC for TANN0202 TN/TC
(TANN0202STR) | text
Extensible: No | C193264 | Tanner Scale Boy Clinical Classification STRESC for TANN0202 TN/TC | Tanner Scale Boy standardized character result for TANN0202 test and test code. | CDISC Clinical Classification Tanner Scale Boy TANN0202 Standardized Character Response Terminology |
Stage 1 | C193319 | TANN0202-Stage 1 | Tanner Scale Boy standardized character result for TANN0202-Stage 1: Pre-adolescent. The velus over the pubes is no further developed than that over the abdominal wall, i.e. no pubic hair. | Tanner Scale Boy TANN0202 Standardized Character Result Stage 1 | ||
Stage 2 | C193320 | TANN0202-Stage 2 | Tanner Scale Boy standardized character result for TANN0202-Stage 2: Sparse growth of long, slightly pigmented, downy hair, straight or only slightly curled, appearing chiefly at the base of the penis. This stage is difficult to see on photographs, particularly of fair-haired subjects. Although the rating 'Stage 2' was used in this study, it cannot be regarded as reliable, and the ages at which subjects are said to have reached Stage 2 are almost certainly too late. | Tanner Scale Boy TANN0202 Standardized Character Result Stage 2 | ||
Stage 3 | C193321 | TANN0202-Stage 3 | Tanner Scale Boy standardized character result for TANN0202-Stage 3: Considerably darker, coarser, and more curled. The hair spreads sparsely over the junction of the pubes. This and subsequent stages were clearly recognizable on the photographs. | Tanner Scale Boy TANN0202 Standardized Character Result Stage 3 | ||
Stage 4 | C193322 | TANN0202-Stage 4 | Tanner Scale Boy standardized character result for TANN0202-Stage 4: Hair is now adult in type, but the area covered by it is still considerably smaller than in most adults. There is no spread to the medial surface of the thighs. | Tanner Scale Boy TANN0202 Standardized Character Result Stage 4 | ||
Stage 5 | C193323 | TANN0202-Stage 5 | Tanner Scale Boy standardized character result for TANN0202-Stage 5: Adult in quantity and type, distributed as an inverse triangle of the classically feminine pattern. Spread to the medial surface of the thighs but not up the linea alba or elsewhere above the base of the inverse triangle. | Tanner Scale Boy TANN0202 Standardized Character Result Stage 5 | ||
Back to top | ||||||
CL.C124662.TANN02TC | Tanner Scale Boy Clinical Classification Test Code
(TANN02TC) | text
Extensible: No | C124662 | Tanner Scale Boy Clinical Classification Test Code | Tanner Scale Boy test code. | CDISC Clinical Classification Tanner Scale-Boy Test Code Terminology |
TANN0201 | C124716 | TANN02-Genitalia Stages | Tanner Scale Boy - Genitalia stages. | Tanner Scale-Boy - Genitalia Stages | ||
TANN0202 | C124717 | TANN02-Pubic Hair Stages | Tanner Scale Boy - Pubic hair stages. | Tanner Scale-Boy - Pubic Hair Stages | ||
Back to top | ||||||
CL.C124661.TANN02TN | Tanner Scale Boy Clinical Classification Test Name
(TANN02TN) | text
Extensible: No | C124661 | Tanner Scale Boy Clinical Classification Test Name | Tanner Scale Boy test name. | CDISC Clinical Classification Tanner Scale-Boy Test Name Terminology |
TANN02-Genitalia Stages | C124716 | TANN02-Genitalia Stages | Tanner Scale Boy - Genitalia stages. | Tanner Scale-Boy - Genitalia Stages | ||
TANN02-Pubic Hair Stages | C124717 | TANN02-Pubic Hair Stages | Tanner Scale Boy - Pubic hair stages. | Tanner Scale-Boy - Pubic Hair Stages | ||
Back to top | ||||||
CL.C193257.TANN0101OR | Tanner Scale Girl Clinical Classification ORRES for TANN0101 TN/TC
(TANN0101OR) | text
Extensible: No | C193257 | Tanner Scale Girl Clinical Classification ORRES for TANN0101 TN/TC | Tanner Scale Girl original result for TANN0101 test and test code. | CDISC Clinical Classification Tanner Scale Girl TANN0101 Original Response Terminology |
Stage 1 | C193284 | TANN0101-Stage 1 | Tanner Scale Girl original result for TANN0101-Stage 1: Pre-adolescent; elevation of papilla only. | Tanner Scale Girl TANN0101 Original Result - Stage 1 | ||
Stage 2 | C193285 | TANN0101-Stage 2 | Tanner Scale Girl original result for TANN0101-Stage 2: Breast bud stage; elevation of breast and papilla as a small mound, enlargement of areola diameter. | Tanner Scale Girl TANN0101 Original Result - Stage 2 | ||
Stage 3 | C193286 | TANN0101-Stage 3 | Tanner Scale Girl original result for TANN0101-Stage 3: Further enlargement of breast and areola, with no separation of their contours. | Tanner Scale Girl TANN0101 Original Result - Stage 3 | ||
Stage 4 | C193287 | TANN0101-Stage 4 | Tanner Scale Girl original result for TANN0101-Stage 4: Projection of areola and papilla to form a secondary mound above the level of the breast. | Tanner Scale Girl TANN0101 Original Result - Stage 4 | ||
Stage 5 | C193288 | TANN0101-Stage 5 | Tanner Scale Girl original result for TANN0101-Stage 5: Mature stage; projection of papilla only, due to recession of the areola to the general contour of the breast. | Tanner Scale Girl TANN0101 Original Result - Stage 5 | ||
Back to top | ||||||
CL.C193259.TANN0102OR | Tanner Scale Girl Clinical Classification ORRES for TANN0102 TN/TC
(TANN0102OR) | text
Extensible: No | C193259 | Tanner Scale Girl Clinical Classification ORRES for TANN0102 TN/TC | Tanner Scale Girl original result for TANN0102 test and test code. | CDISC Clinical Classification Tanner Scale Girl TANN0102 Original Response Terminology |
Stage 1 | C193294 | TANN0102-Stage 1 | Tanner Scale Girl original result for TANN0102-Stage 1: Pre-adolescent; the vellus over the pubes is not further developed than that over the anterior abdominal wall, i.e. no pubic hair. | Tanner Scale Girl TANN0102 Original Result - Stage 1 | ||
Stage 2 | C193295 | TANN0102-Stage 2 | Tanner Scale Girl original result for TANN0102-Stage 2: Sparse growth of long, slightly pigmented, downy hair, straight or only slightly curled, appearing chiefly along the labia. This stage is difficult to see on photographs, particularly of fair-haired subjects. Though Stage 2 rating was used in this study, it cannot be regarded as reliable, and the ages at which subjects are said to have reached Stage 2 are almost certainly too late. | Tanner Scale Girl TANN0102 Original Result - Stage 2 | ||
Stage 3 | C193296 | TANN0102-Stage 3 | Tanner Scale Girl original result for TANN0102-Stage 3: Considerably darker, coarser, and more curled. The hair spreads sparsely over the junction of the pubes. This and subsequent stages were clearly recognizable on the photographs. | Tanner Scale Girl TANN0102 Original Result - Stage 3 | ||
Stage 4 | C193297 | TANN0102-Stage 4 | Tanner Scale Girl original result for TANN0102-Stage 4: Hair is now adult in type, but the area covered by it is still considerably smaller than in most adults. There is no spread to the medial surface of the thighs. | Tanner Scale Girl TANN0102 Original Result - Stage 4 | ||
Stage 5 | C193298 | TANN0102-Stage 5 | Tanner Scale Girl original result for TANN0102-Stage 5: Adult in quantity and type, distributed as an inverse triangle of the classically feminine pattern. Spread to the medial surface of the thighs, but not up the linea alba or elsewhere above the base of the inverse triangle. | Tanner Scale Girl TANN0102 Original Result - Stage 5 | ||
Back to top | ||||||
CL.C193258.TANN0101STR | Tanner Scale Girl Clinical Classification STRESC for TANN0101 TN/TC
(TANN0101STR) | text
Extensible: No | C193258 | Tanner Scale Girl Clinical Classification STRESC for TANN0101 TN/TC | Tanner Scale Girl standardized character result for TANN0101 test and test code. | CDISC Clinical Classification Tanner Scale Girl TANN0101 Standardized Character Response Terminology |
Stage 1 | C193289 | TANN0101-Stage 1 | Tanner Scale Girl standardized character result for TANN0101-Stage 1: Pre-adolescent; elevation of papilla only. | Tanner Scale Girl TANN0101 Standardized Character Result Stage 1 | ||
Stage 2 | C193290 | TANN0101-Stage 2 | Tanner Scale Girl standardized character result for TANN0101-Stage 2: Breast bud stage; elevation of breast and papilla as a small mound, enlargement of areola diameter. | Tanner Scale Girl TANN0101 Standardized Character Result Stage 2 | ||
Stage 3 | C193291 | TANN0101-Stage 3 | Tanner Scale Girl standardized character result for TANN0101-Stage 3: Further enlargement of breast and areola, with no separation of their contours. | Tanner Scale Girl TANN0101 Standardized Character Result Stage 3 | ||
Stage 4 | C193292 | TANN0101-Stage 4 | Tanner Scale Girl standardized character result for TANN0101-Stage 4: Projection of areola and papilla to form a secondary mound above the level of the breast. | Tanner Scale Girl TANN0101 Standardized Character Result Stage 4 | ||
Stage 5 | C193293 | TANN0101-Stage 5 | Tanner Scale Girl standardized character result for TANN0101-Stage 5: Mature stage; projection of papilla only, due to recession of the areola to the general contour of the breast. | Tanner Scale Girl TANN0101 Standardized Character Result Stage 5 | ||
Back to top | ||||||
CL.C193260.TANN0102STR | Tanner Scale Girl Clinical Classification STRESC for TANN0102 TN/TC
(TANN0102STR) | text
Extensible: No | C193260 | Tanner Scale Girl Clinical Classification STRESC for TANN0102 TN/TC | Tanner Scale Girl standardized character result for TANN0102 test and test code. | CDISC Clinical Classification Tanner Scale Girl TANN0102 Standardized Character Response Terminology |
Stage 1 | C193299 | TANN0102-Stage 1 | Tanner Scale Girl standardized character result for TANN0102-Stage 1: Pre-adolescent; the vellus over the pubes is not further developed than that over the anterior abdominal wall, i.e. no pubic hair. | Tanner Scale Girl TANN0102 Standardized Character Result Stage 1 | ||
Stage 2 | C193300 | TANN0102-Stage 2 | Tanner Scale Girl standardized character result for TANN0102-Stage 2: Sparse growth of long, slightly pigmented, downy hair, straight or only slightly curled, appearing chiefly along the labia. This stage is difficult to see on photographs, particularly of fair-haired subjects. Though Stage 2 rating was used in this study, it cannot be regarded as reliable, and the ages at which subjects are said to have reached Stage 2 are almost certainly too late. | Tanner Scale Girl TANN0102 Standardized Character Result Stage 2 | ||
Stage 3 | C193301 | TANN0102-Stage 3 | Tanner Scale Girl standardized character result for TANN0102-Stage 3: Considerably darker, coarser, and more curled. The hair spreads sparsely over the junction of the pubes. This and subsequent stages were clearly recognizable on the photographs. | Tanner Scale Girl TANN0102 Standardized Character Result Stage 3 | ||
Stage 4 | C193302 | TANN0102-Stage 4 | Tanner Scale Girl standardized character result for TANN0102-Stage 4: Hair is now adult in type, but the area covered by it is still considerably smaller than in most adults. There is no spread to the medial surface of the thighs. | Tanner Scale Girl TANN0102 Standardized Character Result Stage 4 | ||
Stage 5 | C193303 | TANN0102-Stage 5 | Tanner Scale Girl standardized character result for TANN0102-Stage 5: Adult in quantity and type, distributed as an inverse triangle of the classically feminine pattern. Spread to the medial surface of the thighs, but not up the linea alba or elsewhere above the base of the inverse triangle. | Tanner Scale Girl TANN0102 Standardized Character Result Stage 5 | ||
Back to top | ||||||
CL.C124664.TANN01TC | Tanner Scale Girl Clinical Classification Test Code
(TANN01TC) | text
Extensible: No | C124664 | Tanner Scale Girl Clinical Classification Test Code | Tanner Scale Girl test code. | CDISC Clinical Classification Tanner Scale-Girl Test Code Terminology |
TANN0101 | C124718 | TANN01-Breast Stages | Tanner Scale Girl - Breast stages. | Tanner Scale-Girl - Breast Stages | ||
TANN0102 | C124719 | TANN01-Pubic Hair Stages | Tanner Scale Girl - Pubic hair stages. | Tanner Scale-Girl - Pubic Hair Stages | ||
Back to top | ||||||
CL.C124663.TANN01TN | Tanner Scale Girl Clinical Classification Test Name
(TANN01TN) | text
Extensible: No | C124663 | Tanner Scale Girl Clinical Classification Test Name | Tanner Scale Girl test name. | CDISC Clinical Classification Tanner Scale-Girl Test Name Terminology |
TANN01-Breast Stages | C124718 | TANN01-Breast Stages | Tanner Scale Girl - Breast stages. | Tanner Scale-Girl - Breast Stages | ||
TANN01-Pubic Hair Stages | C124719 | TANN01-Pubic Hair Stages | Tanner Scale Girl - Pubic hair stages. | Tanner Scale-Girl - Pubic Hair Stages | ||
Back to top | ||||||
CL.C181175.TESTCOND | Test Condition Response
(TESTCOND) | text
Extensible: Yes | C181175 | Test Condition Response | Terminology relevant to the values that describe a textual description of any planned condition imposed on the test system at the time the test is performed. | CDISC Test Condition Response Terminology |
SATURATED CONDITION WITH BINDING AGENT | C181540 | The test system contains excess amount of the binding agent. | Saturated Condition With Binding Agent | |||
WITH STIMULATING AGENT | C181541 | The test system contains stimulating agent. | With Stimulating Agent | |||
WITHOUT BINDING AGENT | C181543 | The test system does not contain binding agent. | Without Binding Agent | |||
WITHOUT STIMULATING AGENT | C181542 | The test system does not contain stimulating agent. | Without Stimulating Agent | |||
Back to top | ||||||
CL.C179589.TSTMTHSN | Test Method Sensitivity
(TSTMTHSN) | text
Extensible: Yes | C179589 | Test Method Sensitivity | Terminology relevant to the values that describe the sensitivity of the methodology with respect to observation, detection, or quantification. | CDISC SDTM Test Method Sensitivity Terminology |
HIGH SENSITIVITY | C179820 | Any test methodology that is able to detect or quantify a finding at a high sensitivity level, as compared to the sensitivities of other concurrently available methods. | High Sensitivity Method | |||
LOW SENSITIVITY | C179821 | Any test methodology that is able to detect or quantify a finding at a low sensitivity level, as compared to the sensitivities of other concurrently available methods. | Low Sensitivity Method | |||
ULTRA-HIGH SENSITIVITY | C179822 | Any test methodology that is able to detect or quantify a finding at an ultra-high sensitivity level, as compared to the sensitivities of other concurrently available methods. | Ultra-High Sensitivity Method | |||
Back to top | ||||||
CL.C181170.TSTOPOBJ | Test Operational Objective
(TSTOPOBJ) | text
Extensible: No | C181170 | Test Operational Objective | A terminology codelist relevant to the description of the high-level purpose of the test at the operational level. | CDISC Test Operational Objective Terminology |
CONFIRM | C181549 | A test whose operational purpose is to verify the presence or absence of a substance or organism. | Confirmatory Test | |||
QUANTIFY | C181550 | A test whose operational purpose is to determine the amount or concentration of a substance or organism. | Quantification Test | |||
SCREEN | C181548 | A test whose operational purpose is to determine the presence or absence of a substance or organism. | Screening Test | |||
Back to top | ||||||
CL.C120987.BODE01TC | The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index Clinical Classification Test Code
(BODE01TC) | text
Extensible: No | C120987 | The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index Clinical Classification Test Code | The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index test code. | CDISC Clinical Classification BODE Index Test Code Terminology |
BODE0101 | C121063 | BODE01-Body-mass Index | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - Body-mass index. | BODE Index - Body-mass Index | ||
BODE0102 | C121064 | BODE01-FEV1 % Predicted | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - FEV1 (% of predicted). | BODE Index - FEV1 Percent Predicted | ||
BODE0103 | C121065 | BODE01-MMRC Dyspnea Scale | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - MMRC dyspnea scale. | BODE Index - MMRC Dyspnea Scale | ||
BODE0104 | C121066 | BODE01-Distance Walked in 6 Minutes | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - Distance walked in 6 min (in meter). | BODE Index - Distance Walked in 6 Minutes | ||
BODE0105 | C121067 | BODE01-BODE Score | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - BODE score. | BODE Index - Score | ||
Back to top | ||||||
CL.C120986.BODE01TN | The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index Clinical Classification Test Name
(BODE01TN) | text
Extensible: No | C120986 | The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index Clinical Classification Test Name | The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index test name. | CDISC Clinical Classification BODE Index Test Name Terminology |
BODE01-BODE Score | C121067 | BODE01-BODE Score | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - BODE score. | BODE Index - Score | ||
BODE01-Body-mass Index | C121063 | BODE01-Body-mass Index | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - Body-mass index. | BODE Index - Body-mass Index | ||
BODE01-Distance Walked in 6 Minutes | C121066 | BODE01-Distance Walked in 6 Minutes | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - Distance walked in 6 min (in meter). | BODE Index - Distance Walked in 6 Minutes | ||
BODE01-FEV1 % Predicted | C121064 | BODE01-FEV1 % Predicted | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - FEV1 (% of predicted). | BODE Index - FEV1 Percent Predicted | ||
BODE01-MMRC Dyspnea Scale | C121065 | BODE01-MMRC Dyspnea Scale | Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index - MMRC dyspnea scale. | BODE Index - MMRC Dyspnea Scale | ||
Back to top | ||||||
CL.C127352.EPIC2TC | The Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire Test Code
(EPIC2TC) | text
Extensible: No | C127352 | The Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire Test Code | The Expanded Prostate Cancer Index Composite for Clinical Practice test code. | CDISC Questionnaire EPIC-CP Test Code Terminology |
EPIC201 | C127399 | EPIC2-Overall Problem Urinary Function | Expanded Prostate Cancer Index Composite for Clinical Practice - Overall, how much of a problem has your urinary function been for you? | EPIC-CP - Overall Problem Urinary Function | ||
EPIC202 | C127400 | EPIC2-Best Describes Urinary Control | Expanded Prostate Cancer Index Composite for Clinical Practice - Which of the following best describes your urinary control? | EPIC-CP - Best Describes Urinary Control | ||
EPIC203 | C127401 | EPIC2-Pads or Adult Diapers per Day | Expanded Prostate Cancer Index Composite for Clinical Practice - How many pads or adult diapers per day have you been using for urinary leakage? | EPIC-CP - Adult Diapers Used per Day | ||
EPIC204 | C127402 | EPIC2-Problem Urinary Dripping/Leakage | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has urinary dripping or leakage been for you? | EPIC-CP - Problem Urinary Dripping/Leakage | ||
EPIC205A | C127403 | EPIC2-Problem Pain/Burning w/Urination | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Pain or burning with urination. | EPIC-CP - Pain or Burning With Urination | ||
EPIC205B | C127404 | EPIC2-Problem Weak Stream/Incompl Empty | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Weak urine stream/incomplete bladder emptying. | EPIC-CP - Weak Urine Stream or Incomplete Bladder Emptying | ||
EPIC205C | C127405 | EPIC2-Problem Need to Urinate Frequently | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Need to urinate frequently. | EPIC-CP - Need to Urinate Frequently | ||
EPIC206A | C127406 | EPIC2-Problem Rectal Pain/Urgent Bowel | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Rectal pain or urgency of bowel movements. | EPIC-CP - Rectal Pain or Urgency of Bowel Movements | ||
EPIC206B | C127407 | EPIC2-Problem Increased Freq Bowel Move | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Increased frequency of your bowel movements. | EPIC-CP - Increased Frequency of Bowel Movements | ||
EPIC206C | C127408 | EPIC2-Overall Problem Bowel Habits | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Overall problems with your bowel habits. | EPIC-CP - Overall Problems With Bowel Habits | ||
EPIC207 | C127409 | EPIC2-Rate Ability to Reach Orgasm | Expanded Prostate Cancer Index Composite for Clinical Practice - How would you rate your ability to reach orgasm (climax)? | EPIC-CP - Rate Ability to Reach Orgasm | ||
EPIC208 | C127410 | EPIC2-Quality of Your Erections | Expanded Prostate Cancer Index Composite for Clinical Practice - How would you describe the usual quality of your erections? | EPIC-CP - Quality of Erections | ||
EPIC209 | C127411 | EPIC2-Overall Problem Sexual Function | Expanded Prostate Cancer Index Composite for Clinical Practice - Overall, how much of a problem has your sexual function or lack of sexual function been for you? | EPIC-CP - Problem Lack of Sexual Function | ||
EPIC210A | C127412 | EPIC2-Problem Hot Flash/Breast Tender | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Hot flashes or breast tenderness/enlargement. | EPIC-CP - Hot Flashes or Breast Tenderness | ||
EPIC210B | C127413 | EPIC2-Problem Feeling Depressed | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Feeling depressed. | EPIC-CP - Feeling Depressed | ||
EPIC210C | C127414 | EPIC2-Problem Lack of Energy | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Lack of energy. | EPIC-CP - Lack of Energy | ||
EPIC211 | C127415 | EPIC2-Urinary Incontinence Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Urinary incontinence symptom score. | EPIC-CP - Urinary Incontinence Symptom Score | ||
EPIC212 | C127416 | EPIC2-Urinary Irrit/Obstr Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Urinary irritation/obstruction symptom score. | EPIC-CP - Urinary Irritation/Obstruction Symptom Score | ||
EPIC213 | C127417 | EPIC2-Bowel Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Bowel symptom score. | EPIC-CP - Bowel Symptom Score | ||
EPIC214 | C127418 | EPIC2-Sexual Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Sexual symptom score. | EPIC-CP - Sexual Symptom Score | ||
EPIC215 | C127419 | EPIC2-Vitality/Hormonal Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Vitality/hormonal symptom score. | EPIC-CP - Vitality/Hormonal Symptom Score | ||
EPIC216 | C127420 | EPIC2-Overall Prostate Cancer QOL Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Overall prostate cancer QOL score. | EPIC-CP - Overall Score | ||
Back to top | ||||||
CL.C127351.EPIC2TN | The Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire Test Name
(EPIC2TN) | text
Extensible: No | C127351 | The Expanded Prostate Cancer Index Composite for Clinical Practice Questionnaire Test Name | The Expanded Prostate Cancer Index Composite for Clinical Practice test name. | CDISC Questionnaire EPIC-CP Test Name Terminology |
EPIC2-Best Describes Urinary Control | C127400 | EPIC2-Best Describes Urinary Control | Expanded Prostate Cancer Index Composite for Clinical Practice - Which of the following best describes your urinary control? | EPIC-CP - Best Describes Urinary Control | ||
EPIC2-Bowel Symptom Score | C127417 | EPIC2-Bowel Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Bowel symptom score. | EPIC-CP - Bowel Symptom Score | ||
EPIC2-Overall Problem Bowel Habits | C127408 | EPIC2-Overall Problem Bowel Habits | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Overall problems with your bowel habits. | EPIC-CP - Overall Problems With Bowel Habits | ||
EPIC2-Overall Problem Sexual Function | C127411 | EPIC2-Overall Problem Sexual Function | Expanded Prostate Cancer Index Composite for Clinical Practice - Overall, how much of a problem has your sexual function or lack of sexual function been for you? | EPIC-CP - Problem Lack of Sexual Function | ||
EPIC2-Overall Problem Urinary Function | C127399 | EPIC2-Overall Problem Urinary Function | Expanded Prostate Cancer Index Composite for Clinical Practice - Overall, how much of a problem has your urinary function been for you? | EPIC-CP - Overall Problem Urinary Function | ||
EPIC2-Overall Prostate Cancer QOL Score | C127420 | EPIC2-Overall Prostate Cancer QOL Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Overall prostate cancer QOL score. | EPIC-CP - Overall Score | ||
EPIC2-Pads or Adult Diapers per Day | C127401 | EPIC2-Pads or Adult Diapers per Day | Expanded Prostate Cancer Index Composite for Clinical Practice - How many pads or adult diapers per day have you been using for urinary leakage? | EPIC-CP - Adult Diapers Used per Day | ||
EPIC2-Problem Feeling Depressed | C127413 | EPIC2-Problem Feeling Depressed | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Feeling depressed. | EPIC-CP - Feeling Depressed | ||
EPIC2-Problem Hot Flash/Breast Tender | C127412 | EPIC2-Problem Hot Flash/Breast Tender | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Hot flashes or breast tenderness/enlargement. | EPIC-CP - Hot Flashes or Breast Tenderness | ||
EPIC2-Problem Increased Freq Bowel Move | C127407 | EPIC2-Problem Increased Freq Bowel Move | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Increased frequency of your bowel movements. | EPIC-CP - Increased Frequency of Bowel Movements | ||
EPIC2-Problem Lack of Energy | C127414 | EPIC2-Problem Lack of Energy | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Lack of energy. | EPIC-CP - Lack of Energy | ||
EPIC2-Problem Need to Urinate Frequently | C127405 | EPIC2-Problem Need to Urinate Frequently | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Need to urinate frequently. | EPIC-CP - Need to Urinate Frequently | ||
EPIC2-Problem Pain/Burning w/Urination | C127403 | EPIC2-Problem Pain/Burning w/Urination | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Pain or burning with urination. | EPIC-CP - Pain or Burning With Urination | ||
EPIC2-Problem Rectal Pain/Urgent Bowel | C127406 | EPIC2-Problem Rectal Pain/Urgent Bowel | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Rectal pain or urgency of bowel movements. | EPIC-CP - Rectal Pain or Urgency of Bowel Movements | ||
EPIC2-Problem Urinary Dripping/Leakage | C127402 | EPIC2-Problem Urinary Dripping/Leakage | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has urinary dripping or leakage been for you? | EPIC-CP - Problem Urinary Dripping/Leakage | ||
EPIC2-Problem Weak Stream/Incompl Empty | C127404 | EPIC2-Problem Weak Stream/Incompl Empty | Expanded Prostate Cancer Index Composite for Clinical Practice - How big a problem, if any, has each of the following been for you? Weak urine stream/incomplete bladder emptying. | EPIC-CP - Weak Urine Stream or Incomplete Bladder Emptying | ||
EPIC2-Quality of Your Erections | C127410 | EPIC2-Quality of Your Erections | Expanded Prostate Cancer Index Composite for Clinical Practice - How would you describe the usual quality of your erections? | EPIC-CP - Quality of Erections | ||
EPIC2-Rate Ability to Reach Orgasm | C127409 | EPIC2-Rate Ability to Reach Orgasm | Expanded Prostate Cancer Index Composite for Clinical Practice - How would you rate your ability to reach orgasm (climax)? | EPIC-CP - Rate Ability to Reach Orgasm | ||
EPIC2-Sexual Symptom Score | C127418 | EPIC2-Sexual Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Sexual symptom score. | EPIC-CP - Sexual Symptom Score | ||
EPIC2-Urinary Incontinence Symptom Score | C127415 | EPIC2-Urinary Incontinence Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Urinary incontinence symptom score. | EPIC-CP - Urinary Incontinence Symptom Score | ||
EPIC2-Urinary Irrit/Obstr Symptom Score | C127416 | EPIC2-Urinary Irrit/Obstr Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Urinary irritation/obstruction symptom score. | EPIC-CP - Urinary Irritation/Obstruction Symptom Score | ||
EPIC2-Vitality/Hormonal Symptom Score | C127419 | EPIC2-Vitality/Hormonal Symptom Score | Expanded Prostate Cancer Index Composite for Clinical Practice - Vitality/hormonal symptom score. | EPIC-CP - Vitality/Hormonal Symptom Score | ||
Back to top | ||||||
CL.C127350.EPIC1TC | The Expanded Prostate Cancer Index Composite Short Form Questionnaire Test Code
(EPIC1TC) | text
Extensible: No | C127350 | The Expanded Prostate Cancer Index Composite Short Form Questionnaire Test Code | The Expanded Prostate Cancer Index Composite Short Form test code. | CDISC Questionnaire EPIC-26 Test Code Terminology |
EPIC101 | C127373 | EPIC1-How Often Have You Leaked Urine | The Expanded Prostate Cancer Index Composite Short Form - Over the past 4 weeks, how often have you leaked urine? | EPIC-26 - How Often Have You Leaked Urine | ||
EPIC102 | C127374 | EPIC1-Best Describes Urinary Control | The Expanded Prostate Cancer Index Composite Short Form - Which of the following best describes your urinary control during the last 4 weeks? | EPIC-26 - Best Describes Urinary Control | ||
EPIC103 | C127375 | EPIC1-Pads or Adult Diapers per Day | The Expanded Prostate Cancer Index Composite Short Form - How many pads or adult diapers per day did you usually use to control leakage during the last 4 weeks? | EPIC-26 - Pads or Adult Diapers per Day | ||
EPIC104A | C127376 | EPIC1-Problem Dripping or Leaking Urine | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Dripping or leaking urine. | EPIC-26 - Dripping or Leaking Urine | ||
EPIC104B | C127377 | EPIC1-Problem Pain/Burning on Urination | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Pain or burning on urination. | EPIC-26 - Pain or Burning on Urination | ||
EPIC104C | C127378 | EPIC1-Problem Bleeding With Urination | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Bleeding with urination. | EPIC-26 - Bleeding With Urination | ||
EPIC104D | C127379 | EPIC1-Problem Weak Urine Stream/Emptying | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Weak urine stream or incomplete emptying. | EPIC-26 - Weak Urine Stream or Incomplete Emptying | ||
EPIC104E | C127380 | EPIC1-Problem Need to Urinate Frequently | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Need to urinate frequently during the day. | EPIC-26 - Urinate Frequently During the Day | ||
EPIC105 | C127381 | EPIC1-Overall Problem Urinary Function | The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem has your urinary function been for you during the last 4 weeks? | EPIC-26 - Overall Problem Urinary Function | ||
EPIC106A | C127382 | EPIC1-Problem Urgency of Bowel Movement | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Urgency to have a bowel movement. | EPIC-26 - Urgency to Have a Bowel Movement | ||
EPIC106B | C127383 | EPIC1-Problem Increased Freq Bowel Move | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Increased frequency of bowel movements. | EPIC-26 - Increased Frequency of Bowel Movements | ||
EPIC106C | C127384 | EPIC1-Problem Losing Control of Stools | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Losing control of your stools. | EPIC-26 - Losing Control of Stools | ||
EPIC106D | C127385 | EPIC1-Problem Bloody Stools | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Bloody stools. | EPIC-26 - Bloody Stools | ||
EPIC106E | C127386 | EPIC1-Problem Abdom/Pelvic/Rectal Pain | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Abdominal/pelvic/rectal pain. | EPIC-26 - Abdominal or Pelvic or Rectal Pain | ||
EPIC107 | C127387 | EPIC1-Overall Problem Bowel Habits | The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem have your bowel habits been for you during the last 4 weeks? | EPIC-26 - Overall Problem Bowel Habits | ||
EPIC108A | C127388 | EPIC1-Rate Ability to Have an Erection | The Expanded Prostate Cancer Index Composite Short Form - How would you rate each of the following during the last 4 weeks? Your ability to have an erection? | EPIC-26 - Ability to Have an Erection | ||
EPIC108B | C127389 | EPIC1-Rate Ability to Reach Orgasm | The Expanded Prostate Cancer Index Composite Short Form - How would you rate each of the following during the last 4 weeks? Your ability to reach orgasm (climax)? | EPIC-26 - Ability to Reach Orgasm | ||
EPIC109 | C127390 | EPIC1-Quality of Your Erections | The Expanded Prostate Cancer Index Composite Short Form - How would you describe the usual quality of your erections during the last 4 weeks? | EPIC-26 - Quality of Erections | ||
EPIC110 | C127391 | EPIC1-Frequency of Your Erections | The Expanded Prostate Cancer Index Composite Short Form - How would you describe the frequency of your erections during the last 4 weeks? | EPIC-26 - Frequency of Erections | ||
EPIC111 | C127392 | EPIC1-Rate Ability to Function Sexually | The Expanded Prostate Cancer Index Composite Short Form - Overall, how would you rate your ability to function sexually during the last 4 weeks? | EPIC-26 - Ability to Function Sexually | ||
EPIC112 | C127393 | EPIC1-Overall Problem Sexual Function | The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem has your sexual function or lack of sexual function been for you during the last 4 weeks? | EPIC-26 - Overall Problem Sexual Function | ||
EPIC113A | C127394 | EPIC1-Problem Hot Flashes | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Hot flashes. | EPIC-26 - Hot Flashes | ||
EPIC113B | C127395 | EPIC1-Problem Breast Tender/Enlargement | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Breast tenderness/enlargement. | EPIC-26 - Breast Tender or Enlargement | ||
EPIC113C | C127396 | EPIC1-Problem Feeling Depressed | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Feeling depressed. | EPIC-26 - Feeling Depressed | ||
EPIC113D | C127397 | EPIC1-Problem Lack of Energy | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Lack of energy. | EPIC-26 - Lack of Energy | ||
EPIC113E | C127398 | EPIC1-Problem Change in Body Weight | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Change in body weight. | EPIC-26 - Change in Body Weight | ||
Back to top | ||||||
CL.C127349.EPIC1TN | The Expanded Prostate Cancer Index Composite Short Form Questionnaire Test Name
(EPIC1TN) | text
Extensible: No | C127349 | The Expanded Prostate Cancer Index Composite Short Form Questionnaire Test Name | The Expanded Prostate Cancer Index Composite Short Form test name. | CDISC Questionnaire EPIC-26 Test Name Terminology |
EPIC1-Best Describes Urinary Control | C127374 | EPIC1-Best Describes Urinary Control | The Expanded Prostate Cancer Index Composite Short Form - Which of the following best describes your urinary control during the last 4 weeks? | EPIC-26 - Best Describes Urinary Control | ||
EPIC1-Frequency of Your Erections | C127391 | EPIC1-Frequency of Your Erections | The Expanded Prostate Cancer Index Composite Short Form - How would you describe the frequency of your erections during the last 4 weeks? | EPIC-26 - Frequency of Erections | ||
EPIC1-How Often Have You Leaked Urine | C127373 | EPIC1-How Often Have You Leaked Urine | The Expanded Prostate Cancer Index Composite Short Form - Over the past 4 weeks, how often have you leaked urine? | EPIC-26 - How Often Have You Leaked Urine | ||
EPIC1-Overall Problem Bowel Habits | C127387 | EPIC1-Overall Problem Bowel Habits | The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem have your bowel habits been for you during the last 4 weeks? | EPIC-26 - Overall Problem Bowel Habits | ||
EPIC1-Overall Problem Sexual Function | C127393 | EPIC1-Overall Problem Sexual Function | The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem has your sexual function or lack of sexual function been for you during the last 4 weeks? | EPIC-26 - Overall Problem Sexual Function | ||
EPIC1-Overall Problem Urinary Function | C127381 | EPIC1-Overall Problem Urinary Function | The Expanded Prostate Cancer Index Composite Short Form - Overall, how big a problem has your urinary function been for you during the last 4 weeks? | EPIC-26 - Overall Problem Urinary Function | ||
EPIC1-Pads or Adult Diapers per Day | C127375 | EPIC1-Pads or Adult Diapers per Day | The Expanded Prostate Cancer Index Composite Short Form - How many pads or adult diapers per day did you usually use to control leakage during the last 4 weeks? | EPIC-26 - Pads or Adult Diapers per Day | ||
EPIC1-Problem Abdom/Pelvic/Rectal Pain | C127386 | EPIC1-Problem Abdom/Pelvic/Rectal Pain | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Abdominal/pelvic/rectal pain. | EPIC-26 - Abdominal or Pelvic or Rectal Pain | ||
EPIC1-Problem Bleeding With Urination | C127378 | EPIC1-Problem Bleeding With Urination | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Bleeding with urination. | EPIC-26 - Bleeding With Urination | ||
EPIC1-Problem Bloody Stools | C127385 | EPIC1-Problem Bloody Stools | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Bloody stools. | EPIC-26 - Bloody Stools | ||
EPIC1-Problem Breast Tender/Enlargement | C127395 | EPIC1-Problem Breast Tender/Enlargement | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Breast tenderness/enlargement. | EPIC-26 - Breast Tender or Enlargement | ||
EPIC1-Problem Change in Body Weight | C127398 | EPIC1-Problem Change in Body Weight | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Change in body weight. | EPIC-26 - Change in Body Weight | ||
EPIC1-Problem Dripping or Leaking Urine | C127376 | EPIC1-Problem Dripping or Leaking Urine | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Dripping or leaking urine. | EPIC-26 - Dripping or Leaking Urine | ||
EPIC1-Problem Feeling Depressed | C127396 | EPIC1-Problem Feeling Depressed | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Feeling depressed. | EPIC-26 - Feeling Depressed | ||
EPIC1-Problem Hot Flashes | C127394 | EPIC1-Problem Hot Flashes | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Hot flashes. | EPIC-26 - Hot Flashes | ||
EPIC1-Problem Increased Freq Bowel Move | C127383 | EPIC1-Problem Increased Freq Bowel Move | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Increased frequency of bowel movements. | EPIC-26 - Increased Frequency of Bowel Movements | ||
EPIC1-Problem Lack of Energy | C127397 | EPIC1-Problem Lack of Energy | The Expanded Prostate Cancer Index Composite Short Form - How big a problem during the last 4 weeks, if any, has each of the following been for you? Lack of energy. | EPIC-26 - Lack of Energy | ||
EPIC1-Problem Losing Control of Stools | C127384 | EPIC1-Problem Losing Control of Stools | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Losing control of your stools. | EPIC-26 - Losing Control of Stools | ||
EPIC1-Problem Need to Urinate Frequently | C127380 | EPIC1-Problem Need to Urinate Frequently | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Need to urinate frequently during the day. | EPIC-26 - Urinate Frequently During the Day | ||
EPIC1-Problem Pain/Burning on Urination | C127377 | EPIC1-Problem Pain/Burning on Urination | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Pain or burning on urination. | EPIC-26 - Pain or Burning on Urination | ||
EPIC1-Problem Urgency of Bowel Movement | C127382 | EPIC1-Problem Urgency of Bowel Movement | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you? Urgency to have a bowel movement. | EPIC-26 - Urgency to Have a Bowel Movement | ||
EPIC1-Problem Weak Urine Stream/Emptying | C127379 | EPIC1-Problem Weak Urine Stream/Emptying | The Expanded Prostate Cancer Index Composite Short Form - How big a problem, if any, has each of the following been for you during the last 4 weeks? Weak urine stream or incomplete emptying. | EPIC-26 - Weak Urine Stream or Incomplete Emptying | ||
EPIC1-Quality of Your Erections | C127390 | EPIC1-Quality of Your Erections | The Expanded Prostate Cancer Index Composite Short Form - How would you describe the usual quality of your erections during the last 4 weeks? | EPIC-26 - Quality of Erections | ||
EPIC1-Rate Ability to Function Sexually | C127392 | EPIC1-Rate Ability to Function Sexually | The Expanded Prostate Cancer Index Composite Short Form - Overall, how would you rate your ability to function sexually during the last 4 weeks? | EPIC-26 - Ability to Function Sexually | ||
EPIC1-Rate Ability to Have an Erection | C127388 | EPIC1-Rate Ability to Have an Erection | The Expanded Prostate Cancer Index Composite Short Form - How would you rate each of the following during the last 4 weeks? Your ability to have an erection? | EPIC-26 - Ability to Have an Erection | ||
EPIC1-Rate Ability to Reach Orgasm | C127389 | EPIC1-Rate Ability to Reach Orgasm | The Expanded Prostate Cancer Index Composite Short Form - How would you rate each of the following during the last 4 weeks? Your ability to reach orgasm (climax)? | EPIC-26 - Ability to Reach Orgasm | ||
Back to top | ||||||
CL.C127354.FAC001TC | The Functional Assessment of Cancer Therapy-General Version 4 Questionnaire Test Code
(FAC001TC) | text
Extensible: No | C127354 | The Functional Assessment of Cancer Therapy-General Version 4 Questionnaire Test Code | The Functional Assessment of Cancer Therapy-General Version 4 test code. | CDISC Questionnaire FACT-G Version 4 Test Code Terminology |
FAC00101 | C127421 | FAC001-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have a lack of energy. | FACT-G Version 4 - I Have a Lack of Energy | ||
FAC00102 | C127422 | FAC001-I Have Nausea | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have nausea. | FACT-G Version 4 - I Have Nausea | ||
FAC00103 | C127423 | FAC001-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-G Version 4 - Trouble Meeting Needs of Family | ||
FAC00104 | C127424 | FAC001-I Have Pain | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have pain. | FACT-G Version 4 - I have pain | ||
FAC00105 | C127425 | FAC001-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-G Version 4 - Bothered by Treatment Side Effect | ||
FAC00106 | C127426 | FAC001-I Feel Ill | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I feel ill. | FACT-G Version 4 - I Feel Ill | ||
FAC00107 | C127427 | FAC001-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-G Version 4 - I Am Forced to Spend Time in Bed | ||
FAC00108 | C127428 | FAC001-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-G Version 4 - I Feel Close to My Friends | ||
FAC00109 | C127429 | FAC001-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-G Version 4 - I Get Emotional Support From My Family | ||
FAC00110 | C127430 | FAC001-I Get Support From My Friends | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-G Version 4 - I Get Support From My Friends | ||
FAC00111 | C127431 | FAC001-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-G Version 4 - My Family Has Accepted My Illness | ||
FAC00112 | C127432 | FAC001-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-G Version 4 - Satisfied With Family Communication | ||
FAC00113 | C127433 | FAC001-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-G Version 4 - I Feel Close to My Partner | ||
FAC00114 | C127434 | FAC001-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-G Version 4 - I Am Satisfied With My Sex Life | ||
FAC00115 | C127435 | FAC001-I Feel Sad | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I feel sad. | FACT-G Version 4 - I Feel Sad | ||
FAC00116 | C127436 | FAC001-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-G Version 4 - Satisfied With How I Am Coping With Illness | ||
FAC00117 | C127437 | FAC001-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-G Version 4 - Losing Hope Against Illness | ||
FAC00118 | C127438 | FAC001-I Feel Nervous | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I feel nervous. | FACT-G Version 4 - I Feel Nervous | ||
FAC00119 | C127439 | FAC001-I Worry About Dying | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I worry about dying. | FACT-G Version 4 - I Worry About Dying | ||
FAC00120 | C127440 | FAC001-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-G Version 4 - Worry My Condition Will Get Worse | ||
FAC00121 | C127441 | FAC001-I Am Able to Work | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-G Version 4 - I Am Able to Work | ||
FAC00122 | C127442 | FAC001-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-G Version 4 - My Work Is Fulfilling | ||
FAC00123 | C127443 | FAC001-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-G Version 4 - I Am Able to Enjoy Life | ||
FAC00124 | C127444 | FAC001-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I have accepted my illness. | FACT-G Version 4 - I Have Accepted My Illness | ||
FAC00125 | C127445 | FAC001-I Am Sleeping Well | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am sleeping well. | FACT-G Version 4 - I Am Sleeping Well | ||
FAC00126 | C127446 | FAC001-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-G Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC00127 | C127447 | FAC001-Content With Quality of My Life | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-G Version 4 - Content With Quality of My Life | ||
FAC00128 | C180189 | FAC001-Physical Subscale Score | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: Subscale score. | FACT-G Version 4 - Physical Subscale Score | ||
FAC00129 | C180190 | FAC001-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: Subscale score. | FACT-G Version 4 - Social/Family Subscale Score | ||
FAC00130 | C180191 | FAC001-Emotional Subscale Score | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: Subscale score. | FACT-G Version 4 - Emotional Subscale Score | ||
FAC00131 | C180192 | FAC001-Functional Subscale Score | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: Subscale score. | FACT-G Version 4 - Functional Subscale Score | ||
FAC00132 | C180193 | FAC001-Total Score | Functional Assessment of Cancer Therapy-General Version 4 - FACT-G total score. | FACT-G Version 4 - Total Score | ||
Back to top | ||||||
CL.C127353.FAC001TN | The Functional Assessment of Cancer Therapy-General Version 4 Questionnaire Test Name
(FAC001TN) | text
Extensible: No | C127353 | The Functional Assessment of Cancer Therapy-General Version 4 Questionnaire Test Name | The Functional Assessment of Cancer Therapy-General Version 4 test name. | CDISC Questionnaire FACT-G Version 4 Test Name Terminology |
FAC001-Bothered by Treatment Side Effect | C127425 | FAC001-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-G Version 4 - Bothered by Treatment Side Effect | ||
FAC001-Content With Quality of My Life | C127447 | FAC001-Content With Quality of My Life | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-G Version 4 - Content With Quality of My Life | ||
FAC001-Emotional Subscale Score | C180191 | FAC001-Emotional Subscale Score | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: Subscale score. | FACT-G Version 4 - Emotional Subscale Score | ||
FAC001-Enjoy Things I Usually Do for Fun | C127446 | FAC001-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-G Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC001-Functional Subscale Score | C180192 | FAC001-Functional Subscale Score | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: Subscale score. | FACT-G Version 4 - Functional Subscale Score | ||
FAC001-Get Emotional Support From Family | C127429 | FAC001-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-G Version 4 - I Get Emotional Support From My Family | ||
FAC001-I Am Able to Enjoy Life | C127443 | FAC001-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-G Version 4 - I Am Able to Enjoy Life | ||
FAC001-I Am Able to Work | C127441 | FAC001-I Am Able to Work | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-G Version 4 - I Am Able to Work | ||
FAC001-I Am Forced to Spend Time in Bed | C127427 | FAC001-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-G Version 4 - I Am Forced to Spend Time in Bed | ||
FAC001-I Am Satisfied With My Sex Life | C127434 | FAC001-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-G Version 4 - I Am Satisfied With My Sex Life | ||
FAC001-I Am Sleeping Well | C127445 | FAC001-I Am Sleeping Well | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I am sleeping well. | FACT-G Version 4 - I Am Sleeping Well | ||
FAC001-I Feel Close to My Friends | C127428 | FAC001-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-G Version 4 - I Feel Close to My Friends | ||
FAC001-I Feel Close to My Partner | C127433 | FAC001-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-G Version 4 - I Feel Close to My Partner | ||
FAC001-I Feel Ill | C127426 | FAC001-I Feel Ill | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I feel ill. | FACT-G Version 4 - I Feel Ill | ||
FAC001-I Feel Nervous | C127438 | FAC001-I Feel Nervous | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I feel nervous. | FACT-G Version 4 - I Feel Nervous | ||
FAC001-I Feel Sad | C127435 | FAC001-I Feel Sad | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I feel sad. | FACT-G Version 4 - I Feel Sad | ||
FAC001-I Get Support From My Friends | C127430 | FAC001-I Get Support From My Friends | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-G Version 4 - I Get Support From My Friends | ||
FAC001-I Have a Lack of Energy | C127421 | FAC001-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have a lack of energy. | FACT-G Version 4 - I Have a Lack of Energy | ||
FAC001-I Have Accepted My Illness | C127444 | FAC001-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: I have accepted my illness. | FACT-G Version 4 - I Have Accepted My Illness | ||
FAC001-I Have Nausea | C127422 | FAC001-I Have Nausea | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have nausea. | FACT-G Version 4 - I Have Nausea | ||
FAC001-I Have Pain | C127424 | FAC001-I Have Pain | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: I have pain. | FACT-G Version 4 - I have pain | ||
FAC001-I Worry About Dying | C127439 | FAC001-I Worry About Dying | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I worry about dying. | FACT-G Version 4 - I Worry About Dying | ||
FAC001-Losing Hope Against Illness | C127437 | FAC001-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-G Version 4 - Losing Hope Against Illness | ||
FAC001-My Family Has Accepted My Illness | C127431 | FAC001-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-G Version 4 - My Family Has Accepted My Illness | ||
FAC001-My Work Is Fulfilling | C127442 | FAC001-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-General Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-G Version 4 - My Work Is Fulfilling | ||
FAC001-Physical Subscale Score | C180189 | FAC001-Physical Subscale Score | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: Subscale score. | FACT-G Version 4 - Physical Subscale Score | ||
FAC001-Satisfied Communication Illness | C127432 | FAC001-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-G Version 4 - Satisfied With Family Communication | ||
FAC001-Satisfied With How I Am Coping | C127436 | FAC001-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-G Version 4 - Satisfied With How I Am Coping With Illness | ||
FAC001-Social/Family Subscale Score | C180190 | FAC001-Social/Family Subscale Score | Functional Assessment of Cancer Therapy-General Version 4 - Social/Family Well-Being: Subscale score. | FACT-G Version 4 - Social/Family Subscale Score | ||
FAC001-Total Score | C180193 | FAC001-Total Score | Functional Assessment of Cancer Therapy-General Version 4 - FACT-G total score. | FACT-G Version 4 - Total Score | ||
FAC001-Trouble Meeting Needs of Family | C127423 | FAC001-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-General Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-G Version 4 - Trouble Meeting Needs of Family | ||
FAC001-Worry My Condition Will Get Worse | C127440 | FAC001-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-General Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-G Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C127358.FAC023TC | The Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire Test Code
(FAC023TC) | text
Extensible: No | C127358 | The Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire Test Code | The Functional Assessment of Cancer Therapy-Prostate Version 4 test code. | CDISC Questionnaire FACT-P Version 4 Test Code Terminology |
FAC02301 | C127465 | FAC023-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have a lack of energy. | FACT-P Version 4 - I Have a Lack of Energy | ||
FAC02302 | C127466 | FAC023-I Have Nausea | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have nausea. | FACT-P Version 4 - I Have Nausea | ||
FAC02303 | C127467 | FAC023-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-P Version 4 - Trouble Meeting Needs of Family | ||
FAC02304 | C127468 | FAC023-I Have Pain | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have pain. | FACT-P Version 4 - I Have Pain | ||
FAC02305 | C127469 | FAC023-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-P Version 4 - Bothered by Treatment Side Effect | ||
FAC02306 | C127470 | FAC023-I Feel Ill | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I feel ill. | FACT-P Version 4 - I Feel Ill | ||
FAC02307 | C127471 | FAC023-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-P Version 4 - I Am Forced to Spend Time in Bed | ||
FAC02308 | C127472 | FAC023-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-P Version 4 - I Feel Close to My Friends | ||
FAC02309 | C127473 | FAC023-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-P Version 4 - Get Emotional Support From Family | ||
FAC02310 | C127474 | FAC023-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-P Version 4 - I Get Support From My Friends | ||
FAC02311 | C127475 | FAC023-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-P Version 4 - My Family Has Accepted My Illness | ||
FAC02312 | C127476 | FAC023-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-P Version 4 - Satisfied With Family Communication | ||
FAC02313 | C127477 | FAC023-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-P Version 4 - I Feel Close to My Partner | ||
FAC02314 | C127478 | FAC023-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-P Version 4 - I Am Satisfied With My Sex Life | ||
FAC02315 | C127479 | FAC023-I Feel Sad | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I feel sad. | FACT-P Version 4 - I Feel Sad | ||
FAC02316 | C127480 | FAC023-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-P Version 4 - Satisfied With How I Am Coping | ||
FAC02317 | C127481 | FAC023-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-P Version 4 - Losing Hope Against Illness | ||
FAC02318 | C127482 | FAC023-I Feel Nervous | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I feel nervous. | FACT-P Version 4 - I Feel Nervous | ||
FAC02319 | C127483 | FAC023-I Worry About Dying | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I worry about dying. | FACT-P Version 4 - I Worry About Dying | ||
FAC02320 | C127484 | FAC023-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-P Version 4 - Worry My Condition Will Get Worse | ||
FAC02321 | C127485 | FAC023-I Am Able to Work | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-P Version 4 - I Am Able to Work | ||
FAC02322 | C127486 | FAC023-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-P Version 4 - My Work Is Fulfilling | ||
FAC02323 | C127487 | FAC023-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-P Version 4 - I Am Able to Enjoy Life | ||
FAC02324 | C127488 | FAC023-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I have accepted my illness. | FACT-P Version 4 - I Have Accepted My Illness | ||
FAC02325 | C127489 | FAC023-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am sleeping well. | FACT-P Version 4 - I Am Sleeping Well | ||
FAC02326 | C127490 | FAC023-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-P Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC02327 | C127491 | FAC023-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-P Version 4 - Content With Quality of My Life | ||
FAC02328 | C127492 | FAC023-I Am Losing Weight | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am losing weight. | FACT-P Version 4 - I Am Losing Weight | ||
FAC02329 | C127493 | FAC023-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have a good appetite. | FACT-P Version 4 - I Have a Good Appetite | ||
FAC02330 | C127494 | FAC023-Have Aches/Pains That Bother Me | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have aches and pains that bother me. | FACT-P Version 4 - Have Aches and Pains That Bother Me | ||
FAC02331 | C127495 | FAC023-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. | FACT-P Version 4 - Certain Parts of Body Experience Pain | ||
FAC02332 | C127496 | FAC023-Pain Keeps Me From Doing Things | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: My pain keeps me from doing things I want to do. | FACT-P Version 4 - Pain Keeps Me From Doing Things | ||
FAC02333 | C127497 | FAC023-Satisfied With Comfort Level | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am satisfied with my present comfort level. | FACT-P Version 4 - Satisfied With Comfort Level | ||
FAC02334 | C127498 | FAC023-I Am Able to Feel Like a Man | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am able to feel like a man. | FACT-P Version 4 - I Am Able to Feel Like a Man | ||
FAC02335 | C127499 | FAC023-I Have Trouble Moving My Bowels | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have trouble moving my bowels. | FACT-P Version 4 - I Have Trouble Moving My Bowels | ||
FAC02336 | C127500 | FAC023-I Have Difficulty Urinating | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have difficulty urinating. | FACT-P Version 4 - I Have Difficulty Urinating | ||
FAC02337 | C127501 | FAC023-I Urinate More Frequently | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I urinate more frequently than usual. | FACT-P Version 4 - I Urinate More Frequently | ||
FAC02338 | C127502 | FAC023-Problem Urinating Limits Activity | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: My problems with urinating limit my activities. | FACT-P Version 4 - Problem Urinating Limits Activity | ||
FAC02339 | C127503 | FAC023-Able to Have/Maintain Erection | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am able to have and maintain an erection. | FACT-P Version 4 - Able to Have and Maintain an Erection | ||
Back to top | ||||||
CL.C127357.FAC023TN | The Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire Test Name
(FAC023TN) | text
Extensible: No | C127357 | The Functional Assessment of Cancer Therapy-Prostate Version 4 Questionnaire Test Name | The Functional Assessment of Cancer Therapy-Prostate Version 4 test name. | CDISC Questionnaire FACT-P Version 4 Test Name Terminology |
FAC023-Able to Have/Maintain Erection | C127503 | FAC023-Able to Have/Maintain Erection | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am able to have and maintain an erection. | FACT-P Version 4 - Able to Have and Maintain an Erection | ||
FAC023-Bothered by Treatment Side Effect | C127469 | FAC023-Bothered by Treatment Side Effect | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I am bothered by side effects of treatment. | FACT-P Version 4 - Bothered by Treatment Side Effect | ||
FAC023-Certain Parts of Body Have Pain | C127495 | FAC023-Certain Parts of Body Have Pain | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have certain parts of my body where I experience pain. | FACT-P Version 4 - Certain Parts of Body Experience Pain | ||
FAC023-Content With Quality of My Life | C127491 | FAC023-Content With Quality of My Life | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am content with the quality of my life right now. | FACT-P Version 4 - Content With Quality of My Life | ||
FAC023-Enjoy Things I Usually Do for Fun | C127490 | FAC023-Enjoy Things I Usually Do for Fun | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am enjoying the things I usually do for fun. | FACT-P Version 4 - Enjoy Things I Usually Do for Fun | ||
FAC023-Get Emotional Support From Family | C127473 | FAC023-Get Emotional Support From Family | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I get emotional support from my family. | FACT-P Version 4 - Get Emotional Support From Family | ||
FAC023-Have Aches/Pains That Bother Me | C127494 | FAC023-Have Aches/Pains That Bother Me | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have aches and pains that bother me. | FACT-P Version 4 - Have Aches and Pains That Bother Me | ||
FAC023-I Am Able to Enjoy Life | C127487 | FAC023-I Am Able to Enjoy Life | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am able to enjoy life. | FACT-P Version 4 - I Am Able to Enjoy Life | ||
FAC023-I Am Able to Feel Like a Man | C127498 | FAC023-I Am Able to Feel Like a Man | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am able to feel like a man. | FACT-P Version 4 - I Am Able to Feel Like a Man | ||
FAC023-I Am Able to Work | C127485 | FAC023-I Am Able to Work | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am able to work (include work at home). | FACT-P Version 4 - I Am Able to Work | ||
FAC023-I Am Forced to Spend Time in Bed | C127471 | FAC023-I Am Forced to Spend Time in Bed | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I am forced to spend time in bed. | FACT-P Version 4 - I Am Forced to Spend Time in Bed | ||
FAC023-I Am Losing Weight | C127492 | FAC023-I Am Losing Weight | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am losing weight. | FACT-P Version 4 - I Am Losing Weight | ||
FAC023-I Am Satisfied With My Sex Life | C127478 | FAC023-I Am Satisfied With My Sex Life | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I am satisfied with my sex life. | FACT-P Version 4 - I Am Satisfied With My Sex Life | ||
FAC023-I Am Sleeping Well | C127489 | FAC023-I Am Sleeping Well | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I am sleeping well. | FACT-P Version 4 - I Am Sleeping Well | ||
FAC023-I Feel Close to My Friends | C127472 | FAC023-I Feel Close to My Friends | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I feel close to my friends. | FACT-P Version 4 - I Feel Close to My Friends | ||
FAC023-I Feel Close to My Partner | C127477 | FAC023-I Feel Close to My Partner | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I feel close to my partner (or the person who is my main support). | FACT-P Version 4 - I Feel Close to My Partner | ||
FAC023-I Feel Ill | C127470 | FAC023-I Feel Ill | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I feel ill. | FACT-P Version 4 - I Feel Ill | ||
FAC023-I Feel Nervous | C127482 | FAC023-I Feel Nervous | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I feel nervous. | FACT-P Version 4 - I Feel Nervous | ||
FAC023-I Feel Sad | C127479 | FAC023-I Feel Sad | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I feel sad. | FACT-P Version 4 - I Feel Sad | ||
FAC023-I Get Support From My Friends | C127474 | FAC023-I Get Support From My Friends | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I get support from my friends. | FACT-P Version 4 - I Get Support From My Friends | ||
FAC023-I Have a Good Appetite | C127493 | FAC023-I Have a Good Appetite | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have a good appetite. | FACT-P Version 4 - I Have a Good Appetite | ||
FAC023-I Have a Lack of Energy | C127465 | FAC023-I Have a Lack of Energy | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have a lack of energy. | FACT-P Version 4 - I Have a Lack of Energy | ||
FAC023-I Have Accepted My Illness | C127488 | FAC023-I Have Accepted My Illness | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: I have accepted my illness. | FACT-P Version 4 - I Have Accepted My Illness | ||
FAC023-I Have Difficulty Urinating | C127500 | FAC023-I Have Difficulty Urinating | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have difficulty urinating. | FACT-P Version 4 - I Have Difficulty Urinating | ||
FAC023-I Have Nausea | C127466 | FAC023-I Have Nausea | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have nausea. | FACT-P Version 4 - I Have Nausea | ||
FAC023-I Have Pain | C127468 | FAC023-I Have Pain | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: I have pain. | FACT-P Version 4 - I Have Pain | ||
FAC023-I Have Trouble Moving My Bowels | C127499 | FAC023-I Have Trouble Moving My Bowels | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I have trouble moving my bowels. | FACT-P Version 4 - I Have Trouble Moving My Bowels | ||
FAC023-I Urinate More Frequently | C127501 | FAC023-I Urinate More Frequently | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I urinate more frequently than usual. | FACT-P Version 4 - I Urinate More Frequently | ||
FAC023-I Worry About Dying | C127483 | FAC023-I Worry About Dying | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I worry about dying. | FACT-P Version 4 - I Worry About Dying | ||
FAC023-Losing Hope Against Illness | C127481 | FAC023-Losing Hope Against Illness | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I am losing hope in the fight against my illness. | FACT-P Version 4 - Losing Hope Against Illness | ||
FAC023-My Family Has Accepted My Illness | C127475 | FAC023-My Family Has Accepted My Illness | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: My family has accepted my illness. | FACT-P Version 4 - My Family Has Accepted My Illness | ||
FAC023-My Work Is Fulfilling | C127486 | FAC023-My Work Is Fulfilling | Functional Assessment of Cancer Therapy-Prostate Version 4 - Functional Well-Being: My work (include work at home) is fulfilling. | FACT-P Version 4 - My Work Is Fulfilling | ||
FAC023-Pain Keeps Me From Doing Things | C127496 | FAC023-Pain Keeps Me From Doing Things | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: My pain keeps me from doing things I want to do. | FACT-P Version 4 - Pain Keeps Me From Doing Things | ||
FAC023-Problem Urinating Limits Activity | C127502 | FAC023-Problem Urinating Limits Activity | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: My problems with urinating limit my activities. | FACT-P Version 4 - Problem Urinating Limits Activity | ||
FAC023-Satisfied Communication Illness | C127476 | FAC023-Satisfied Communication Illness | Functional Assessment of Cancer Therapy-Prostate Version 4 - Social/Family Well-Being: I am satisfied with family communication about my illness. | FACT-P Version 4 - Satisfied With Family Communication | ||
FAC023-Satisfied With Comfort Level | C127497 | FAC023-Satisfied With Comfort Level | Functional Assessment of Cancer Therapy-Prostate Version 4 - Additional Concerns: I am satisfied with my present comfort level. | FACT-P Version 4 - Satisfied With Comfort Level | ||
FAC023-Satisfied With How I Am Coping | C127480 | FAC023-Satisfied With How I Am Coping | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I am satisfied with how I am coping with my illness. | FACT-P Version 4 - Satisfied With How I Am Coping | ||
FAC023-Trouble Meeting Needs of Family | C127467 | FAC023-Trouble Meeting Needs of Family | Functional Assessment of Cancer Therapy-Prostate Version 4 - Physical Well-Being: Because of my physical condition, I have trouble meeting the needs of my family. | FACT-P Version 4 - Trouble Meeting Needs of Family | ||
FAC023-Worry My Condition Will Get Worse | C127484 | FAC023-Worry My Condition Will Get Worse | Functional Assessment of Cancer Therapy-Prostate Version 4 - Emotional Well-Being: I worry that my condition will get worse. | FACT-P Version 4 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C163391.GMSS01TC | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes Questionnaire Test Code
(GMSS01TC) | text
Extensible: No | C163391 | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes Questionnaire Test Code | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes test code. | CDISC Questionnaire GMSS Version Type 1 Diabetes Test Code Terminology |
GMSS0101 | C163840 | GMSS01-More Satisfied With My Diabetes | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me feel more satisfied with how things are going with my diabetes. | GMSS Version Type 1 Diabetes - More Satisfied With My Diabetes | ||
GMSS0102 | C163841 | GMSS01-Think About Diabetes More | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me think about diabetes more than I want to. | GMSS Version Type 1 Diabetes - Think About Diabetes More | ||
GMSS0103 | C163842 | GMSS01-Takes Too Much Time to Use | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Takes too much time to use. | GMSS Version Type 1 Diabetes - Takes Too Much Time to Use | ||
GMSS0104 | C163843 | GMSS01-Doesn't Seem as Accurate | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Doesn't seem to be as accurate as I would like it to be. | GMSS Version Type 1 Diabetes - Doesn't Seem as Accurate | ||
GMSS0105 | C163844 | GMSS01-Makes Me Worry a Lot | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me worry a lot. | GMSS Version Type 1 Diabetes - Makes Me Worry a Lot | ||
GMSS0106 | C163845 | GMSS01-Is Too Much of a Hassle to Use | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Is too much of a hassle to use. | GMSS Version Type 1 Diabetes - Is Too Much of a Hassle to Use | ||
GMSS0107 | C163846 | GMSS01-Gives Me Numbers I Don't Trust | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Gives me numbers that I don't entirely trust. | GMSS Version Type 1 Diabetes - Gives Me Numbers I Don't Trust | ||
GMSS0108 | C163847 | GMSS01-Feel Less Restricted by Diabetes | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me feel less restricted by diabetes. | GMSS Version Type 1 Diabetes - Feel Less Restricted by Diabetes | ||
GMSS0109 | C163848 | GMSS01-More Frustrated With My Diabetes | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me feel more frustrated with my diabetes. | GMSS Version Type 1 Diabetes - More Frustrated With My Diabetes | ||
GMSS0110 | C163849 | GMSS01-Be More Spontaneous in My Life | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me be more spontaneous in my life. | GMSS Version Type 1 Diabetes - Be More Spontaneous in My Life | ||
GMSS0111 | C163850 | GMSS01-Too Many Skin Irritations/Bruises | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Causes too many skin irritations or bruises. | GMSS Version Type 1 Diabetes - Too Many Skin Irritations/Bruises | ||
GMSS0112 | C163851 | GMSS01-Gives Me Results Don't Make Sense | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Often gives me results that don't make sense. | GMSS Version Type 1 Diabetes - Gives Me Results Don't Make Sense | ||
GMSS0113 | C163852 | GMSS01-Feel More Down and Depressed | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me feel more down and depressed. | GMSS Version Type 1 Diabetes - Feel More Down and Depressed | ||
GMSS0114 | C163853 | GMSS01-More Open to New Experiences | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me be more open to new experiences in life. | GMSS Version Type 1 Diabetes - More Open to New Experiences | ||
GMSS0115 | C163854 | GMSS01-Is Too Painful to Use | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Is too painful to use. | GMSS Version Type 1 Diabetes - Is Too Painful to Use | ||
GMSS0116 | C163855 | GMSS01-Subscale: Openness | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Openness. | GMSS Version Type 1 Diabetes - Subscale: Openness | ||
GMSS0117 | C163856 | GMSS01-Subscale: Emotional Burden | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Emotional burden. | GMSS Version Type 1 Diabetes - Subscale: Emotional Burden | ||
GMSS0118 | C163857 | GMSS01-Subscale: Behavioral Burden | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Behavioral burden. | GMSS Version Type 1 Diabetes - Subscale: Behavioral Burden | ||
GMSS0119 | C163858 | GMSS01-Subscale: Trust | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Trust. | GMSS Version Type 1 Diabetes - Subscale: Trust | ||
GMSS0120 | C163859 | GMSS01-Total Scale | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Total scale. | GMSS Version Type 1 Diabetes - Total Scale | ||
Back to top | ||||||
CL.C163390.GMSS01TN | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes Questionnaire Test Name
(GMSS01TN) | text
Extensible: No | C163390 | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes Questionnaire Test Name | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes test name. | CDISC Questionnaire GMSS Version Type 1 Diabetes Test Name Terminology |
GMSS01-Be More Spontaneous in My Life | C163849 | GMSS01-Be More Spontaneous in My Life | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me be more spontaneous in my life. | GMSS Version Type 1 Diabetes - Be More Spontaneous in My Life | ||
GMSS01-Doesn't Seem as Accurate | C163843 | GMSS01-Doesn't Seem as Accurate | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Doesn't seem to be as accurate as I would like it to be. | GMSS Version Type 1 Diabetes - Doesn't Seem as Accurate | ||
GMSS01-Feel Less Restricted by Diabetes | C163847 | GMSS01-Feel Less Restricted by Diabetes | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me feel less restricted by diabetes. | GMSS Version Type 1 Diabetes - Feel Less Restricted by Diabetes | ||
GMSS01-Feel More Down and Depressed | C163852 | GMSS01-Feel More Down and Depressed | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me feel more down and depressed. | GMSS Version Type 1 Diabetes - Feel More Down and Depressed | ||
GMSS01-Gives Me Numbers I Don't Trust | C163846 | GMSS01-Gives Me Numbers I Don't Trust | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Gives me numbers that I don't entirely trust. | GMSS Version Type 1 Diabetes - Gives Me Numbers I Don't Trust | ||
GMSS01-Gives Me Results Don't Make Sense | C163851 | GMSS01-Gives Me Results Don't Make Sense | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Often gives me results that don't make sense. | GMSS Version Type 1 Diabetes - Gives Me Results Don't Make Sense | ||
GMSS01-Is Too Much of a Hassle to Use | C163845 | GMSS01-Is Too Much of a Hassle to Use | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Is too much of a hassle to use. | GMSS Version Type 1 Diabetes - Is Too Much of a Hassle to Use | ||
GMSS01-Is Too Painful to Use | C163854 | GMSS01-Is Too Painful to Use | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Is too painful to use. | GMSS Version Type 1 Diabetes - Is Too Painful to Use | ||
GMSS01-Makes Me Worry a Lot | C163844 | GMSS01-Makes Me Worry a Lot | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me worry a lot. | GMSS Version Type 1 Diabetes - Makes Me Worry a Lot | ||
GMSS01-More Frustrated With My Diabetes | C163848 | GMSS01-More Frustrated With My Diabetes | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me feel more frustrated with my diabetes. | GMSS Version Type 1 Diabetes - More Frustrated With My Diabetes | ||
GMSS01-More Open to New Experiences | C163853 | GMSS01-More Open to New Experiences | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me be more open to new experiences in life. | GMSS Version Type 1 Diabetes - More Open to New Experiences | ||
GMSS01-More Satisfied With My Diabetes | C163840 | GMSS01-More Satisfied With My Diabetes | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Helps me feel more satisfied with how things are going with my diabetes. | GMSS Version Type 1 Diabetes - More Satisfied With My Diabetes | ||
GMSS01-Subscale: Behavioral Burden | C163857 | GMSS01-Subscale: Behavioral Burden | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Behavioral burden. | GMSS Version Type 1 Diabetes - Subscale: Behavioral Burden | ||
GMSS01-Subscale: Emotional Burden | C163856 | GMSS01-Subscale: Emotional Burden | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Emotional burden. | GMSS Version Type 1 Diabetes - Subscale: Emotional Burden | ||
GMSS01-Subscale: Openness | C163855 | GMSS01-Subscale: Openness | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Openness. | GMSS Version Type 1 Diabetes - Subscale: Openness | ||
GMSS01-Subscale: Trust | C163858 | GMSS01-Subscale: Trust | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Subscale: Trust. | GMSS Version Type 1 Diabetes - Subscale: Trust | ||
GMSS01-Takes Too Much Time to Use | C163842 | GMSS01-Takes Too Much Time to Use | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Takes too much time to use. | GMSS Version Type 1 Diabetes - Takes Too Much Time to Use | ||
GMSS01-Think About Diabetes More | C163841 | GMSS01-Think About Diabetes More | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Makes me think about diabetes more than I want to. | GMSS Version Type 1 Diabetes - Think About Diabetes More | ||
GMSS01-Too Many Skin Irritations/Bruises | C163850 | GMSS01-Too Many Skin Irritations/Bruises | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - My current monitor: Causes too many skin irritations or bruises. | GMSS Version Type 1 Diabetes - Too Many Skin Irritations/Bruises | ||
GMSS01-Total Scale | C163859 | GMSS01-Total Scale | The Glucose Monitoring System Satisfaction Survey Version: Type 1 Diabetes - Total scale. | GMSS Version Type 1 Diabetes - Total Scale | ||
Back to top | ||||||
CL.C127356.FAC052TC | The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire Test Code
(FAC052TC) | text
Extensible: No | C127356 | The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire Test Code | The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 test code. | CDISC Questionnaire NCCN-FACT-FPSI 17 Version 2 Test Code Terminology |
FAC05201 | C127448 | FAC052-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have a lack of energy. | NCCN-FACT-FPSI 17 Version 2 - I Have a Lack of Energy | ||
FAC05202 | C127449 | FAC052-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have pain. | NCCN-FACT-FPSI 17 Version 2 - I Have Pain | ||
FAC05203 | C127450 | FAC052-I Have Difficulty Urinating | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have difficulty urinating. | NCCN-FACT-FPSI 17 Version 2 - I Have Difficulty Urinating | ||
FAC05204 | C127451 | FAC052-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am losing weight. | NCCN-FACT-FPSI 17 Version 2 - I Am Losing Weight | ||
FAC05205 | C127452 | FAC052-I Have Bone Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have bone pain. | NCCN-FACT-FPSI 17 Version 2 - I Have Bone Pain | ||
FAC05206 | C127453 | FAC052-I Feel Fatigued | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I feel fatigued. | NCCN-FACT-FPSI 17 Version 2 - I Feel Fatigued | ||
FAC05207 | C127454 | FAC052-I Have Weakness in My Legs | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have weakness in my legs. | NCCN-FACT-FPSI 17 Version 2 - I Have Weakness in My Legs | ||
FAC05208 | C127455 | FAC052-Pain Keeps Me From Doing Things | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - My pain keeps me from doing things I want to do. | NCCN-FACT-FPSI 17 Version 2 - Pain Keeps Me From Doing Things | ||
FAC05209 | C127456 | FAC052-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have a good appetite. | NCCN-FACT-FPSI 17 Version 2 - I Have a Good Appetite | ||
FAC05210 | C127457 | FAC052-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am sleeping well. | NCCN-FACT-FPSI 17 Version 2 - I Am Sleeping Well | ||
FAC05211 | C127458 | FAC052-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I worry that my condition will get worse. | NCCN-FACT-FPSI 17 Version 2 - Worry My Condition Will Get Worse | ||
FAC05212 | C127459 | FAC052-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have nausea. | NCCN-FACT-FPSI 17 Version 2 - I Have Nausea | ||
FAC05213 | C127460 | FAC052-I Have Trouble Moving My Bowels | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have trouble moving my bowels. | NCCN-FACT-FPSI 17 Version 2 - I Have Trouble Moving My Bowels | ||
FAC05214 | C127461 | FAC052-I Am Satisfied With My Sex Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am satisfied with my sex life. | NCCN-FACT-FPSI 17 Version 2 - I Am Satisfied With My Sex Life | ||
FAC05215 | C127462 | FAC052-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT-FPSI 17 Version 2 - Bothered by Treatment Side Effect | ||
FAC05216 | C127463 | FAC052-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am able to enjoy life. | NCCN-FACT-FPSI 17 Version 2 - I Am Able to Enjoy Life | ||
FAC05217 | C127464 | FAC052-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am content with the quality of my life right now. | NCCN-FACT-FPSI 17 Version 2 - Content With Quality of My Life | ||
Back to top | ||||||
CL.C127355.FAC052TN | The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire Test Name
(FAC052TN) | text
Extensible: No | C127355 | The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 Questionnaire Test Name | The National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 test name. | CDISC Questionnaire NCCN-FACT-FPSI 17 Version 2 Test Name Terminology |
FAC052-Bothered by Treatment Side Effect | C127462 | FAC052-Bothered by Treatment Side Effect | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am bothered by side effects of treatment. | NCCN-FACT-FPSI 17 Version 2 - Bothered by Treatment Side Effect | ||
FAC052-Content With Quality of My Life | C127464 | FAC052-Content With Quality of My Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am content with the quality of my life right now. | NCCN-FACT-FPSI 17 Version 2 - Content With Quality of My Life | ||
FAC052-I Am Able to Enjoy Life | C127463 | FAC052-I Am Able to Enjoy Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am able to enjoy life. | NCCN-FACT-FPSI 17 Version 2 - I Am Able to Enjoy Life | ||
FAC052-I Am Losing Weight | C127451 | FAC052-I Am Losing Weight | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am losing weight. | NCCN-FACT-FPSI 17 Version 2 - I Am Losing Weight | ||
FAC052-I Am Satisfied With My Sex Life | C127461 | FAC052-I Am Satisfied With My Sex Life | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am satisfied with my sex life. | NCCN-FACT-FPSI 17 Version 2 - I Am Satisfied With My Sex Life | ||
FAC052-I Am Sleeping Well | C127457 | FAC052-I Am Sleeping Well | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I am sleeping well. | NCCN-FACT-FPSI 17 Version 2 - I Am Sleeping Well | ||
FAC052-I Feel Fatigued | C127453 | FAC052-I Feel Fatigued | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I feel fatigued. | NCCN-FACT-FPSI 17 Version 2 - I Feel Fatigued | ||
FAC052-I Have a Good Appetite | C127456 | FAC052-I Have a Good Appetite | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have a good appetite. | NCCN-FACT-FPSI 17 Version 2 - I Have a Good Appetite | ||
FAC052-I Have a Lack of Energy | C127448 | FAC052-I Have a Lack of Energy | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have a lack of energy. | NCCN-FACT-FPSI 17 Version 2 - I Have a Lack of Energy | ||
FAC052-I Have Bone Pain | C127452 | FAC052-I Have Bone Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have bone pain. | NCCN-FACT-FPSI 17 Version 2 - I Have Bone Pain | ||
FAC052-I Have Difficulty Urinating | C127450 | FAC052-I Have Difficulty Urinating | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have difficulty urinating. | NCCN-FACT-FPSI 17 Version 2 - I Have Difficulty Urinating | ||
FAC052-I Have Nausea | C127459 | FAC052-I Have Nausea | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have nausea. | NCCN-FACT-FPSI 17 Version 2 - I Have Nausea | ||
FAC052-I Have Pain | C127449 | FAC052-I Have Pain | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have pain. | NCCN-FACT-FPSI 17 Version 2 - I Have Pain | ||
FAC052-I Have Trouble Moving My Bowels | C127460 | FAC052-I Have Trouble Moving My Bowels | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have trouble moving my bowels. | NCCN-FACT-FPSI 17 Version 2 - I Have Trouble Moving My Bowels | ||
FAC052-I Have Weakness in My Legs | C127454 | FAC052-I Have Weakness in My Legs | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I have weakness in my legs. | NCCN-FACT-FPSI 17 Version 2 - I Have Weakness in My Legs | ||
FAC052-Pain Keeps Me From Doing Things | C127455 | FAC052-Pain Keeps Me From Doing Things | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - My pain keeps me from doing things I want to do. | NCCN-FACT-FPSI 17 Version 2 - Pain Keeps Me From Doing Things | ||
FAC052-Worry My Condition Will Get Worse | C127458 | FAC052-Worry My Condition Will Get Worse | National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy-Prostate Symptom Index 17 Version 2 - I worry that my condition will get worse. | NCCN-FACT-FPSI 17 Version 2 - Worry My Condition Will Get Worse | ||
Back to top | ||||||
CL.C103479.ODI01TC | The Oswestry Disability Index Version 2.1a Questionnaire Test Code
(ODI01TC) | text
Extensible: No | C103479 | The Oswestry Disability Index Version 2.1a Questionnaire Test Code | The Oswestry Disability Index Version 2.1a test code. | CDISC Questionnaire ODI v2.1a Test Code Terminology |
ODI0101 | C103762 | ODI01-Pain Intensity | The Oswestry Disability Index Version 2.1a - Section 1 - Pain intensity. | ODI v2.1a - Pain Intensity | ||
ODI0102 | C103763 | ODI01-Personal Care | The Oswestry Disability Index Version 2.1a - Section 2 - Personal care (washing, dressing, etc.). | ODI v2.1a - Personal Care | ||
ODI0103 | C103764 | ODI01-Lifting | The Oswestry Disability Index Version 2.1a - Section 3 - Lifting. | ODI v2.1a - Lifting | ||
ODI0104 | C103765 | ODI01-Walking | The Oswestry Disability Index Version 2.1a - Section 4 - Walking. | ODI v2.1a - Walking | ||
ODI0105 | C103766 | ODI01-Sitting | The Oswestry Disability Index Version 2.1a - Section 5 - Sitting. | ODI v2.1a - Sitting | ||
ODI0106 | C103767 | ODI01-Standing | The Oswestry Disability Index Version 2.1a - Section 6 - Standing. | ODI v2.1a - Standing | ||
ODI0107 | C103768 | ODI01-Sleeping | The Oswestry Disability Index Version 2.1a - Section 7 - Sleeping. | ODI v2.1a - Sleeping | ||
ODI0108 | C103769 | ODI01-Sex Life | The Oswestry Disability Index Version 2.1a - Section 8 - Sex life (if applicable). | ODI v2.1a - Sex Life | ||
ODI0109 | C103770 | ODI01-Social Life | The Oswestry Disability Index Version 2.1a - Section 9 - Social life. | ODI v2.1a - Social Life | ||
ODI0110 | C103771 | ODI01-Travelling | The Oswestry Disability Index Version 2.1a - Section 10 - Travelling. | ODI v2.1a - Travelling | ||
ODI0111 | C125762 | ODI01-Oswestry Disability Index | The Oswestry Disability Index Version 2.1a - Your ODI. | ODI v2.1a - Oswestry Disability Index | ||
Back to top | ||||||
CL.C103478.ODI01TN | The Oswestry Disability Index Version 2.1a Questionnaire Test Name
(ODI01TN) | text
Extensible: No | C103478 | The Oswestry Disability Index Version 2.1a Questionnaire Test Name | The Oswestry Disability Index Version 2.1a test name. | CDISC Questionnaire ODI v2.1a Test Name Terminology |
ODI01-Lifting | C103764 | ODI01-Lifting | The Oswestry Disability Index Version 2.1a - Section 3 - Lifting. | ODI v2.1a - Lifting | ||
ODI01-Oswestry Disability Index | C125762 | ODI01-Oswestry Disability Index | The Oswestry Disability Index Version 2.1a - Your ODI. | ODI v2.1a - Oswestry Disability Index | ||
ODI01-Pain Intensity | C103762 | ODI01-Pain Intensity | The Oswestry Disability Index Version 2.1a - Section 1 - Pain intensity. | ODI v2.1a - Pain Intensity | ||
ODI01-Personal Care | C103763 | ODI01-Personal Care | The Oswestry Disability Index Version 2.1a - Section 2 - Personal care (washing, dressing, etc.). | ODI v2.1a - Personal Care | ||
ODI01-Sex Life | C103769 | ODI01-Sex Life | The Oswestry Disability Index Version 2.1a - Section 8 - Sex life (if applicable). | ODI v2.1a - Sex Life | ||
ODI01-Sitting | C103766 | ODI01-Sitting | The Oswestry Disability Index Version 2.1a - Section 5 - Sitting. | ODI v2.1a - Sitting | ||
ODI01-Sleeping | C103768 | ODI01-Sleeping | The Oswestry Disability Index Version 2.1a - Section 7 - Sleeping. | ODI v2.1a - Sleeping | ||
ODI01-Social Life | C103770 | ODI01-Social Life | The Oswestry Disability Index Version 2.1a - Section 9 - Social life. | ODI v2.1a - Social Life | ||
ODI01-Standing | C103767 | ODI01-Standing | The Oswestry Disability Index Version 2.1a - Section 6 - Standing. | ODI v2.1a - Standing | ||
ODI01-Travelling | C103771 | ODI01-Travelling | The Oswestry Disability Index Version 2.1a - Section 10 - Travelling. | ODI v2.1a - Travelling | ||
ODI01-Walking | C103765 | ODI01-Walking | The Oswestry Disability Index Version 2.1a - Section 4 - Walking. | ODI v2.1a - Walking | ||
Back to top | ||||||
CL.C103475.OABQ01TC | The Overactive Bladder Questionnaire Questionnaire Test Code
(OABQ01TC) | text
Extensible: No | C103475 | The Overactive Bladder Questionnaire Questionnaire Test Code | The Overactive Bladder Questionnaire test code. | CDISC Questionnaire OAB-q Test Code Terminology |
OABQ0101 | C103653 | OABQ01-Frequent Urination During Daytime | The Overactive Bladder Questionnaire - Frequent urination during the daytime hours? | OAB-q - Frequent Urination During the Daytime | ||
OABQ0102 | C103654 | OABQ01-Uncomfortable Urge to Urinate | The Overactive Bladder Questionnaire - An uncomfortable urge to urinate? | OAB-q - Uncomfortable Urge to Urinate | ||
OABQ0103 | C103655 | OABQ01-Sudden Urge to Urinate No Warning | The Overactive Bladder Questionnaire - A sudden urge to urinate with little or no warning? | OAB-q - Sudden Urge to Urinate with Little or No Warning | ||
OABQ0104 | C103656 | OABQ01-Accidental Loss of Urine | The Overactive Bladder Questionnaire - Accidental loss of small amounts of urine? | OAB-q - Accidental Loss of Urine | ||
OABQ0105 | C103657 | OABQ01-Nighttime Urination | The Overactive Bladder Questionnaire - Nighttime urination? | OAB-q - Nighttime Urination | ||
OABQ0106 | C103658 | OABQ01-Waking Up at Night had to Urinate | The Overactive Bladder Questionnaire - Waking up at night because you had to urinate? | OAB-q - Waking Up at Night Because You had to Urinate | ||
OABQ0107 | C103659 | OABQ01-Uncontrollable Urge to Urinate | The Overactive Bladder Questionnaire - An uncontrollable urge to urinate? | OAB-q - Uncontrollable Urge to Urinate | ||
OABQ0108 | C103660 | OABQ01-Urine Loss Strong Desire Urinate | The Overactive Bladder Questionnaire - Urine loss associated with a strong desire to urinate? | OAB-q - Urine Loss Associated with a Strong Desire to Urinate | ||
OABQ0109 | C103661 | OABQ01-Carefully Plan Your Commute | The Overactive Bladder Questionnaire - Made you carefully plan your commute? | OAB-q - Carefully Plan Your Commute | ||
OABQ0110 | C103662 | OABQ01-Feel Drowsy or Sleepy During Day | The Overactive Bladder Questionnaire - Caused you to feel drowsy or sleepy during the day? | OAB-q - Feel Drowsy or Sleepy During the Day | ||
OABQ0111 | C103663 | OABQ01-Plan 'Escape Routes' to Restrooms | The Overactive Bladder Questionnaire - Caused you to plan "escape routes" to restrooms in public places? | OAB-q - Plan 'Escape Routes' to Restrooms | ||
OABQ0112 | C103664 | OABQ01-Caused You Distress | The Overactive Bladder Questionnaire - Caused you distress? | OAB-q - Caused You Distress | ||
OABQ0113 | C103665 | OABQ01-Frustrated You | The Overactive Bladder Questionnaire - Frustrated you? | OAB-q - Frustrated You | ||
OABQ0114 | C103666 | OABQ01-Feel Something Wrong with You | The Overactive Bladder Questionnaire - Made you feel like there is something wrong with you? | OAB-q - Feel Like There is Something Wrong with You | ||
OABQ0115 | C103667 | OABQ01-Interfered with Good Night's Rest | The Overactive Bladder Questionnaire - Interfered with your ability to get a good night's rest? | OAB-q - Interfered with a Good Night's Rest | ||
OABQ0116 | C103668 | OABQ01-Decrease Your Physical Activities | The Overactive Bladder Questionnaire - Caused you to decrease your physical activities (exercising, sports, etc.)? | OAB-q - Decrease Your Physical Activities | ||
OABQ0117 | C103669 | OABQ01-Prevented From Feeling Rested | The Overactive Bladder Questionnaire - Prevented you from feeling rested upon waking in the morning? | OAB-q - Prevented You From Feeling Rested Upon Waking | ||
OABQ0118 | C103670 | OABQ01-Frustrated Family and Friends | The Overactive Bladder Questionnaire - Frustrated your family and friends? | OAB-q - Frustrated Your Family and Friends | ||
OABQ0119 | C103671 | OABQ01-Caused You Anxiety or Worry | The Overactive Bladder Questionnaire - Caused you anxiety or worry? | OAB-q - Caused You Anxiety or Worry | ||
OABQ0120 | C103672 | OABQ01-Stay Home More Often Than Prefer | The Overactive Bladder Questionnaire - Caused you to stay home more often than you would prefer? | OAB-q - Stay Home More Often Than You Would Prefer | ||
OABQ0121 | C103673 | OABQ01-Adjust Travel Plans Near Restroom | The Overactive Bladder Questionnaire - Caused you to adjust your travel plans so that you are always near a restroom? | OAB-q - Adjust Your Travel Plans so That You are Always Near a Restroom | ||
OABQ0122 | C103674 | OABQ01-Avoid Act Away From Restroom | The Overactive Bladder Questionnaire - Made you avoid activities away from restrooms (i.e., walks, running, hiking)? | OAB-q - Avoid Activities Away From Restrooms | ||
OABQ0123 | C103675 | OABQ01-Amount of Time Spend in Restroom | The Overactive Bladder Questionnaire - Made you frustrated or annoyed about the amount of time you spend in the restroom? | OAB-q - Frustrated or Annoyed About the Amount of Time You Spend in the Restroom | ||
OABQ0124 | C103676 | OABQ01-Awakened You During Sleep | The Overactive Bladder Questionnaire - Awakened you during sleep? | OAB-q - Awakened You During Sleep | ||
OABQ0125 | C103677 | OABQ01-Worry About Odor or Hygiene | The Overactive Bladder Questionnaire - Made you worry about odor or hygiene? | OAB-q - Made You Worry About Odor or Hygiene | ||
OABQ0126 | C103678 | OABQ01-Uncomfortable Travel with Others | The Overactive Bladder Questionnaire - Made you uncomfortable while traveling with others because of needing to stop for a restroom? | OAB-q - Uncomfortable While Traveling With Others | ||
OABQ0127 | C103679 | OABQ01-Affected Relationships | The Overactive Bladder Questionnaire - Affected your relationships with family and friends? | OAB-q - Affected Your Relationships with Family and Friends | ||
OABQ0128 | C103680 | OABQ01-Decrease Participating Gatherings | The Overactive Bladder Questionnaire - Caused you to decrease participating in social gatherings, such as parties or visits with family or friends? | OAB-q - Decrease Participating in Social Gatherings | ||
OABQ0129 | C103681 | OABQ01-Caused You Embarrassment | The Overactive Bladder Questionnaire - Caused you embarrassment? | OAB-q - Caused You Embarrassment | ||
OABQ0130 | C103682 | OABQ01-Interfered with Getting Sleep | The Overactive Bladder Questionnaire - Interfered with getting the amount of sleep you needed? | OAB-q - Interfered with Getting Sleep | ||
OABQ0131 | C103683 | OABQ01-Caused Problems Partner/Spouse | The Overactive Bladder Questionnaire - Caused you to have problems with your partner or spouse? | OAB-q - Caused Problems with Your Partner or Spouse | ||
OABQ0132 | C103684 | OABQ01-Plan Activities More Carefully | The Overactive Bladder Questionnaire - Caused you to plan activities more carefully? | OAB-q - Plan Activities More Carefully | ||
OABQ0133 | C103685 | OABQ01-Locate Closest Restroom | The Overactive Bladder Questionnaire - Caused you to locate the closest restroom as soon as you arrive at a place you have never been? | OAB-q - Locate Closest Restroom as Soon as You Arrive | ||
Back to top | ||||||
CL.C103474.OABQ01TN | The Overactive Bladder Questionnaire Questionnaire Test Name
(OABQ01TN) | text
Extensible: No | C103474 | The Overactive Bladder Questionnaire Questionnaire Test Name | The Overactive Bladder Questionnaire test name. | CDISC Questionnaire OAB-q Test Name Terminology |
OABQ01-Accidental Loss of Urine | C103656 | OABQ01-Accidental Loss of Urine | The Overactive Bladder Questionnaire - Accidental loss of small amounts of urine? | OAB-q - Accidental Loss of Urine | ||
OABQ01-Adjust Travel Plans Near Restroom | C103673 | OABQ01-Adjust Travel Plans Near Restroom | The Overactive Bladder Questionnaire - Caused you to adjust your travel plans so that you are always near a restroom? | OAB-q - Adjust Your Travel Plans so That You are Always Near a Restroom | ||
OABQ01-Affected Relationships | C103679 | OABQ01-Affected Relationships | The Overactive Bladder Questionnaire - Affected your relationships with family and friends? | OAB-q - Affected Your Relationships with Family and Friends | ||
OABQ01-Amount of Time Spend in Restroom | C103675 | OABQ01-Amount of Time Spend in Restroom | The Overactive Bladder Questionnaire - Made you frustrated or annoyed about the amount of time you spend in the restroom? | OAB-q - Frustrated or Annoyed About the Amount of Time You Spend in the Restroom | ||
OABQ01-Avoid Act Away From Restroom | C103674 | OABQ01-Avoid Act Away From Restroom | The Overactive Bladder Questionnaire - Made you avoid activities away from restrooms (i.e., walks, running, hiking)? | OAB-q - Avoid Activities Away From Restrooms | ||
OABQ01-Awakened You During Sleep | C103676 | OABQ01-Awakened You During Sleep | The Overactive Bladder Questionnaire - Awakened you during sleep? | OAB-q - Awakened You During Sleep | ||
OABQ01-Carefully Plan Your Commute | C103661 | OABQ01-Carefully Plan Your Commute | The Overactive Bladder Questionnaire - Made you carefully plan your commute? | OAB-q - Carefully Plan Your Commute | ||
OABQ01-Caused Problems Partner/Spouse | C103683 | OABQ01-Caused Problems Partner/Spouse | The Overactive Bladder Questionnaire - Caused you to have problems with your partner or spouse? | OAB-q - Caused Problems with Your Partner or Spouse | ||
OABQ01-Caused You Anxiety or Worry | C103671 | OABQ01-Caused You Anxiety or Worry | The Overactive Bladder Questionnaire - Caused you anxiety or worry? | OAB-q - Caused You Anxiety or Worry | ||
OABQ01-Caused You Distress | C103664 | OABQ01-Caused You Distress | The Overactive Bladder Questionnaire - Caused you distress? | OAB-q - Caused You Distress | ||
OABQ01-Caused You Embarrassment | C103681 | OABQ01-Caused You Embarrassment | The Overactive Bladder Questionnaire - Caused you embarrassment? | OAB-q - Caused You Embarrassment | ||
OABQ01-Decrease Participating Gatherings | C103680 | OABQ01-Decrease Participating Gatherings | The Overactive Bladder Questionnaire - Caused you to decrease participating in social gatherings, such as parties or visits with family or friends? | OAB-q - Decrease Participating in Social Gatherings | ||
OABQ01-Decrease Your Physical Activities | C103668 | OABQ01-Decrease Your Physical Activities | The Overactive Bladder Questionnaire - Caused you to decrease your physical activities (exercising, sports, etc.)? | OAB-q - Decrease Your Physical Activities | ||
OABQ01-Feel Drowsy or Sleepy During Day | C103662 | OABQ01-Feel Drowsy or Sleepy During Day | The Overactive Bladder Questionnaire - Caused you to feel drowsy or sleepy during the day? | OAB-q - Feel Drowsy or Sleepy During the Day | ||
OABQ01-Feel Something Wrong with You | C103666 | OABQ01-Feel Something Wrong with You | The Overactive Bladder Questionnaire - Made you feel like there is something wrong with you? | OAB-q - Feel Like There is Something Wrong with You | ||
OABQ01-Frequent Urination During Daytime | C103653 | OABQ01-Frequent Urination During Daytime | The Overactive Bladder Questionnaire - Frequent urination during the daytime hours? | OAB-q - Frequent Urination During the Daytime | ||
OABQ01-Frustrated Family and Friends | C103670 | OABQ01-Frustrated Family and Friends | The Overactive Bladder Questionnaire - Frustrated your family and friends? | OAB-q - Frustrated Your Family and Friends | ||
OABQ01-Frustrated You | C103665 | OABQ01-Frustrated You | The Overactive Bladder Questionnaire - Frustrated you? | OAB-q - Frustrated You | ||
OABQ01-Interfered with Getting Sleep | C103682 | OABQ01-Interfered with Getting Sleep | The Overactive Bladder Questionnaire - Interfered with getting the amount of sleep you needed? | OAB-q - Interfered with Getting Sleep | ||
OABQ01-Interfered with Good Night's Rest | C103667 | OABQ01-Interfered with Good Night's Rest | The Overactive Bladder Questionnaire - Interfered with your ability to get a good night's rest? | OAB-q - Interfered with a Good Night's Rest | ||
OABQ01-Locate Closest Restroom | C103685 | OABQ01-Locate Closest Restroom | The Overactive Bladder Questionnaire - Caused you to locate the closest restroom as soon as you arrive at a place you have never been? | OAB-q - Locate Closest Restroom as Soon as You Arrive | ||
OABQ01-Nighttime Urination | C103657 | OABQ01-Nighttime Urination | The Overactive Bladder Questionnaire - Nighttime urination? | OAB-q - Nighttime Urination | ||
OABQ01-Plan 'Escape Routes' to Restrooms | C103663 | OABQ01-Plan 'Escape Routes' to Restrooms | The Overactive Bladder Questionnaire - Caused you to plan "escape routes" to restrooms in public places? | OAB-q - Plan 'Escape Routes' to Restrooms | ||
OABQ01-Plan Activities More Carefully | C103684 | OABQ01-Plan Activities More Carefully | The Overactive Bladder Questionnaire - Caused you to plan activities more carefully? | OAB-q - Plan Activities More Carefully | ||
OABQ01-Prevented From Feeling Rested | C103669 | OABQ01-Prevented From Feeling Rested | The Overactive Bladder Questionnaire - Prevented you from feeling rested upon waking in the morning? | OAB-q - Prevented You From Feeling Rested Upon Waking | ||
OABQ01-Stay Home More Often Than Prefer | C103672 | OABQ01-Stay Home More Often Than Prefer | The Overactive Bladder Questionnaire - Caused you to stay home more often than you would prefer? | OAB-q - Stay Home More Often Than You Would Prefer | ||
OABQ01-Sudden Urge to Urinate No Warning | C103655 | OABQ01-Sudden Urge to Urinate No Warning | The Overactive Bladder Questionnaire - A sudden urge to urinate with little or no warning? | OAB-q - Sudden Urge to Urinate with Little or No Warning | ||
OABQ01-Uncomfortable Travel with Others | C103678 | OABQ01-Uncomfortable Travel with Others | The Overactive Bladder Questionnaire - Made you uncomfortable while traveling with others because of needing to stop for a restroom? | OAB-q - Uncomfortable While Traveling With Others | ||
OABQ01-Uncomfortable Urge to Urinate | C103654 | OABQ01-Uncomfortable Urge to Urinate | The Overactive Bladder Questionnaire - An uncomfortable urge to urinate? | OAB-q - Uncomfortable Urge to Urinate | ||
OABQ01-Uncontrollable Urge to Urinate | C103659 | OABQ01-Uncontrollable Urge to Urinate | The Overactive Bladder Questionnaire - An uncontrollable urge to urinate? | OAB-q - Uncontrollable Urge to Urinate | ||
OABQ01-Urine Loss Strong Desire Urinate | C103660 | OABQ01-Urine Loss Strong Desire Urinate | The Overactive Bladder Questionnaire - Urine loss associated with a strong desire to urinate? | OAB-q - Urine Loss Associated with a Strong Desire to Urinate | ||
OABQ01-Waking Up at Night had to Urinate | C103658 | OABQ01-Waking Up at Night had to Urinate | The Overactive Bladder Questionnaire - Waking up at night because you had to urinate? | OAB-q - Waking Up at Night Because You had to Urinate | ||
OABQ01-Worry About Odor or Hygiene | C103677 | OABQ01-Worry About Odor or Hygiene | The Overactive Bladder Questionnaire - Made you worry about odor or hygiene? | OAB-q - Made You Worry About Odor or Hygiene | ||
Back to top | ||||||
CL.C103477.OABQ02TC | The Overactive Bladder Questionnaire Short Form Questionnaire Test Code
(OABQ02TC) | text
Extensible: No | C103477 | The Overactive Bladder Questionnaire Short Form Questionnaire Test Code | The Overactive Bladder Questionnaire Short Form test code. | CDISC Questionnaire OAB-q Short Form Test Code Terminology |
OABQ0201 | C103686 | OABQ02-Uncomfortable Urge to Urinate | The Overactive Bladder Questionnaire Short Form - An uncomfortable urge to urinate? | OAB-q Short Form - Uncomfortable Urge to Urinate | ||
OABQ0202 | C103687 | OABQ02-Sudden Urge to Urinate No Warning | The Overactive Bladder Questionnaire Short Form - A sudden urge to urinate with little or no warning? | OAB-q Short Form - Sudden Urge to Urinate with Little or No Warning | ||
OABQ0203 | C103688 | OABQ02-Accidental Loss of Urine | The Overactive Bladder Questionnaire Short Form - Accidental loss of small amounts of urine? | OAB-q Short Form - Accidental Loss of Urine | ||
OABQ0204 | C103689 | OABQ02-Nighttime Urination | The Overactive Bladder Questionnaire Short Form - Nighttime urination? | OAB-q Short Form - Nighttime Urination | ||
OABQ0205 | C103690 | OABQ02-Waking Up at Night had to Urinate | The Overactive Bladder Questionnaire Short Form - Waking up at night because you had to urinate? | OAB-q Short Form - Waking Up at Night Because You had to Urinate | ||
OABQ0206 | C103691 | OABQ02-Urine Loss Strong Desire Urinate | The Overactive Bladder Questionnaire Short Form - Urine loss associated with strong desire to urinate? | OAB-q Short Form - Urine Loss Associated with a Strong Desire to Urinate | ||
OABQ0207 | C103692 | OABQ02-Plan 'Escape Routes' to Restrooms | The Overactive Bladder Questionnaire Short Form - Caused you to plan "escape routes" to restrooms in public places? | OAB-q Short Form - Plan 'Escape Routes' to Restrooms | ||
OABQ0208 | C103693 | OABQ02-Feel Something is Wrong with You | The Overactive Bladder Questionnaire Short Form - Made you feel like there is something wrong with you? | OAB-q Short Form - Feel Like There is Something Wrong with You | ||
OABQ0209 | C103694 | OABQ02-Interfered with Good Night's Rest | The Overactive Bladder Questionnaire Short Form - Interfered with your ability to get a good night's rest? | OAB-q Short Form - Interfered with a Good Night's Rest | ||
OABQ0210 | C103695 | OABQ02-Frustrated about Time in Restroom | The Overactive Bladder Questionnaire Short Form - Made you frustrated or annoyed about the amount of time you spend in the restroom? | OAB-q Short Form - Frustrated or Annoyed About the Amount of Time You Spend in the Restroom | ||
OABQ0211 | C103696 | OABQ02-Avoid Activ Away From Restroom | The Overactive Bladder Questionnaire Short Form - Made you avoid activities away from restrooms (i.e., walks, running, hiking)? | OAB-q Short Form - Avoid Activities Away From Restrooms | ||
OABQ0212 | C103697 | OABQ02-Awakened You During Sleep | The Overactive Bladder Questionnaire Short Form - Awakened you during sleep? | OAB-q Short Form - Awakened You During Sleep | ||
OABQ0213 | C103698 | OABQ02-Decrease Physical Activities | The Overactive Bladder Questionnaire Short Form - Caused you to decrease your physical activities (exercising, sports, etc.)? | OAB-q Short Form - Decrease Your Physical Activities | ||
OABQ0214 | C103699 | OABQ02-Caused Problems Partner/Spouse | The Overactive Bladder Questionnaire Short Form - Caused you to have problems with your partner or spouse? | OAB-q Short Form - Caused Problems with Your Partner or Spouse | ||
OABQ0215 | C103700 | OABQ02-Uncomfortable Travel with Others | The Overactive Bladder Questionnaire Short Form - Made you uncomfortable while travelling with others because of needing to stop for a restroom? | OAB-q Short Form - Uncomfortable While Traveling With Others | ||
OABQ0216 | C103701 | OABQ02-Affected Relationships | The Overactive Bladder Questionnaire Short Form - Affected your relationships with family and friends? | OAB-q Short Form - Affected Your Relationships with Family and Friends | ||
OABQ0217 | C103702 | OABQ02-Interfered with Getting Sleep | The Overactive Bladder Questionnaire Short Form - Interfered with getting the amount of sleep you needed? | OAB-q Short Form - Interfered with Getting Sleep | ||
OABQ0218 | C103703 | OABQ02-Caused You Embarrassment | The Overactive Bladder Questionnaire Short Form - Caused you embarrassment? | OAB-q Short Form - Caused You Embarrassment | ||
OABQ0219 | C103704 | OABQ02-Locate Closest Restroom | The Overactive Bladder Questionnaire Short Form - Caused you to locate the closest restroom as soon as you arrive at a place you have never been? | OAB-q Short Form - Locate Closest Restroom as Soon as You Arrive | ||
Back to top | ||||||
CL.C103476.OABQ02TN | The Overactive Bladder Questionnaire Short Form Questionnaire Test Name
(OABQ02TN) | text
Extensible: No | C103476 | The Overactive Bladder Questionnaire Short Form Questionnaire Test Name | The Overactive Bladder Questionnaire Short Form test name. | CDISC Questionnaire OAB-q Short Form Test Name Terminology |
OABQ02-Accidental Loss of Urine | C103688 | OABQ02-Accidental Loss of Urine | The Overactive Bladder Questionnaire Short Form - Accidental loss of small amounts of urine? | OAB-q Short Form - Accidental Loss of Urine | ||
OABQ02-Affected Relationships | C103701 | OABQ02-Affected Relationships | The Overactive Bladder Questionnaire Short Form - Affected your relationships with family and friends? | OAB-q Short Form - Affected Your Relationships with Family and Friends | ||
OABQ02-Avoid Activ Away From Restroom | C103696 | OABQ02-Avoid Activ Away From Restroom | The Overactive Bladder Questionnaire Short Form - Made you avoid activities away from restrooms (i.e., walks, running, hiking)? | OAB-q Short Form - Avoid Activities Away From Restrooms | ||
OABQ02-Awakened You During Sleep | C103697 | OABQ02-Awakened You During Sleep | The Overactive Bladder Questionnaire Short Form - Awakened you during sleep? | OAB-q Short Form - Awakened You During Sleep | ||
OABQ02-Caused Problems Partner/Spouse | C103699 | OABQ02-Caused Problems Partner/Spouse | The Overactive Bladder Questionnaire Short Form - Caused you to have problems with your partner or spouse? | OAB-q Short Form - Caused Problems with Your Partner or Spouse | ||
OABQ02-Caused You Embarrassment | C103703 | OABQ02-Caused You Embarrassment | The Overactive Bladder Questionnaire Short Form - Caused you embarrassment? | OAB-q Short Form - Caused You Embarrassment | ||
OABQ02-Decrease Physical Activities | C103698 | OABQ02-Decrease Physical Activities | The Overactive Bladder Questionnaire Short Form - Caused you to decrease your physical activities (exercising, sports, etc.)? | OAB-q Short Form - Decrease Your Physical Activities | ||
OABQ02-Feel Something is Wrong with You | C103693 | OABQ02-Feel Something is Wrong with You | The Overactive Bladder Questionnaire Short Form - Made you feel like there is something wrong with you? | OAB-q Short Form - Feel Like There is Something Wrong with You | ||
OABQ02-Frustrated about Time in Restroom | C103695 | OABQ02-Frustrated about Time in Restroom | The Overactive Bladder Questionnaire Short Form - Made you frustrated or annoyed about the amount of time you spend in the restroom? | OAB-q Short Form - Frustrated or Annoyed About the Amount of Time You Spend in the Restroom | ||
OABQ02-Interfered with Getting Sleep | C103702 | OABQ02-Interfered with Getting Sleep | The Overactive Bladder Questionnaire Short Form - Interfered with getting the amount of sleep you needed? | OAB-q Short Form - Interfered with Getting Sleep | ||
OABQ02-Interfered with Good Night's Rest | C103694 | OABQ02-Interfered with Good Night's Rest | The Overactive Bladder Questionnaire Short Form - Interfered with your ability to get a good night's rest? | OAB-q Short Form - Interfered with a Good Night's Rest | ||
OABQ02-Locate Closest Restroom | C103704 | OABQ02-Locate Closest Restroom | The Overactive Bladder Questionnaire Short Form - Caused you to locate the closest restroom as soon as you arrive at a place you have never been? | OAB-q Short Form - Locate Closest Restroom as Soon as You Arrive | ||
OABQ02-Nighttime Urination | C103689 | OABQ02-Nighttime Urination | The Overactive Bladder Questionnaire Short Form - Nighttime urination? | OAB-q Short Form - Nighttime Urination | ||
OABQ02-Plan 'Escape Routes' to Restrooms | C103692 | OABQ02-Plan 'Escape Routes' to Restrooms | The Overactive Bladder Questionnaire Short Form - Caused you to plan "escape routes" to restrooms in public places? | OAB-q Short Form - Plan 'Escape Routes' to Restrooms | ||
OABQ02-Sudden Urge to Urinate No Warning | C103687 | OABQ02-Sudden Urge to Urinate No Warning | The Overactive Bladder Questionnaire Short Form - A sudden urge to urinate with little or no warning? | OAB-q Short Form - Sudden Urge to Urinate with Little or No Warning | ||
OABQ02-Uncomfortable Travel with Others | C103700 | OABQ02-Uncomfortable Travel with Others | The Overactive Bladder Questionnaire Short Form - Made you uncomfortable while travelling with others because of needing to stop for a restroom? | OAB-q Short Form - Uncomfortable While Traveling With Others | ||
OABQ02-Uncomfortable Urge to Urinate | C103686 | OABQ02-Uncomfortable Urge to Urinate | The Overactive Bladder Questionnaire Short Form - An uncomfortable urge to urinate? | OAB-q Short Form - Uncomfortable Urge to Urinate | ||
OABQ02-Urine Loss Strong Desire Urinate | C103691 | OABQ02-Urine Loss Strong Desire Urinate | The Overactive Bladder Questionnaire Short Form - Urine loss associated with strong desire to urinate? | OAB-q Short Form - Urine Loss Associated with a Strong Desire to Urinate | ||
OABQ02-Waking Up at Night had to Urinate | C103690 | OABQ02-Waking Up at Night had to Urinate | The Overactive Bladder Questionnaire Short Form - Waking up at night because you had to urinate? | OAB-q Short Form - Waking Up at Night Because You had to Urinate | ||
Back to top | ||||||
CL.C127360.PROS01TC | The Prostate Cancer Specific Quality of Life Instrument Questionnaire Test Code
(PROS01TC) | text
Extensible: No | C127360 | The Prostate Cancer Specific Quality of Life Instrument Questionnaire Test Code | The Prostate Cancer Specific Quality of Life Instrument test code. | CDISC Questionnaire PROSQOLI Test Code Terminology |
PROS0101 | C127504 | PROS01-Pain | Prostate Cancer Specific Quality of Life Instrument - Pain. | PROSQOLI - Pain | ||
PROS0102 | C127505 | PROS01-Physical Activity | Prostate Cancer Specific Quality of Life Instrument - Physical activity. | PROSQOLI - Physical Activity | ||
PROS0103 | C127506 | PROS01-Fatigue | Prostate Cancer Specific Quality of Life Instrument - Fatigue. | PROSQOLI - Fatigue | ||
PROS0104 | C127507 | PROS01-Appetite | Prostate Cancer Specific Quality of Life Instrument - Appetite. | PROSQOLI - Appetite | ||
PROS0105 | C127508 | PROS01-Constipation | Prostate Cancer Specific Quality of Life Instrument - Constipation. | PROSQOLI - Constipation | ||
PROS0106 | C127509 | PROS01-Urinary Problems | Prostate Cancer Specific Quality of Life Instrument - Urinary problems. | PROSQOLI - Urinary Problems | ||
PROS0107 | C127510 | PROS01-Enjoying Time Friends/Family | Prostate Cancer Specific Quality of Life Instrument - Enjoying time with friends and family. | PROSQOLI - Enjoying Time with Friends and Family | ||
PROS0108 | C127511 | PROS01-Mood | Prostate Cancer Specific Quality of Life Instrument - Mood. | PROSQOLI - Mood | ||
PROS0109 | C127512 | PROS01-Overall Well-Being | Prostate Cancer Specific Quality of Life Instrument - Overall Well-Being (How do you feel?). | PROSQOLI - Overall Well-Being | ||
PROS0110 | C127513 | PROS01-Present Pain Intensity | Prostate Cancer Specific Quality of Life Instrument - Present pain intensity: Please circle the appropriate number according to how much pain you felt on average during the past 24 hours. | PROSQOLI - Present Pain Intensity | ||
Back to top | ||||||
CL.C127359.PROS01TN | The Prostate Cancer Specific Quality of Life Instrument Questionnaire Test Name
(PROS01TN) | text
Extensible: No | C127359 | The Prostate Cancer Specific Quality of Life Instrument Questionnaire Test Name | The Prostate Cancer Specific Quality of Life Instrument test name. | CDISC Questionnaire PROSQOLI Test Name Terminology |
PROS01-Appetite | C127507 | PROS01-Appetite | Prostate Cancer Specific Quality of Life Instrument - Appetite. | PROSQOLI - Appetite | ||
PROS01-Constipation | C127508 | PROS01-Constipation | Prostate Cancer Specific Quality of Life Instrument - Constipation. | PROSQOLI - Constipation | ||
PROS01-Enjoying Time Friends/Family | C127510 | PROS01-Enjoying Time Friends/Family | Prostate Cancer Specific Quality of Life Instrument - Enjoying time with friends and family. | PROSQOLI - Enjoying Time with Friends and Family | ||
PROS01-Fatigue | C127506 | PROS01-Fatigue | Prostate Cancer Specific Quality of Life Instrument - Fatigue. | PROSQOLI - Fatigue | ||
PROS01-Mood | C127511 | PROS01-Mood | Prostate Cancer Specific Quality of Life Instrument - Mood. | PROSQOLI - Mood | ||
PROS01-Overall Well-Being | C127512 | PROS01-Overall Well-Being | Prostate Cancer Specific Quality of Life Instrument - Overall Well-Being (How do you feel?). | PROSQOLI - Overall Well-Being | ||
PROS01-Pain | C127504 | PROS01-Pain | Prostate Cancer Specific Quality of Life Instrument - Pain. | PROSQOLI - Pain | ||
PROS01-Physical Activity | C127505 | PROS01-Physical Activity | Prostate Cancer Specific Quality of Life Instrument - Physical activity. | PROSQOLI - Physical Activity | ||
PROS01-Present Pain Intensity | C127513 | PROS01-Present Pain Intensity | Prostate Cancer Specific Quality of Life Instrument - Present pain intensity: Please circle the appropriate number according to how much pain you felt on average during the past 24 hours. | PROSQOLI - Present Pain Intensity | ||
PROS01-Urinary Problems | C127509 | PROS01-Urinary Problems | Prostate Cancer Specific Quality of Life Instrument - Urinary problems. | PROSQOLI - Urinary Problems | ||
Back to top | ||||||
CL.C135692.PCL01TC | The PTSD Checklist for DSM-5 Questionnaire Test Code
(PCL01TC) | text
Extensible: No | C135692 | The PTSD Checklist for DSM-5 Questionnaire Test Code | The PTSD Checklist for DSM-5 test code. | CDISC Questionnaire PCL-5 Test Code Terminology |
PCL0101 | C135922 | PCL01-Repeated Disturbing Memories | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Repeated, disturbing, and unwanted memories of the stressful experience? | PCL-5 - Repeated Disturbing Memories | ||
PCL0102 | C135923 | PCL01-Repeated Disturbing Dreams | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Repeated, disturbing dreams of the stressful experience? | PCL-5 - Repeated Disturbing Dreams | ||
PCL0103 | C135924 | PCL01-Suddenly Feeling Happening Again | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Suddenly feeling or acting as if the stressful experience were actually happening again (as if you were actually back there reliving it)? | PCL-5 - Suddenly Feeling Happening Again | ||
PCL0104 | C135925 | PCL01-Feel Upset When Reminded | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling very upset when something reminded you of the stressful experience? | PCL-5 - Feel Upset When Reminded | ||
PCL0105 | C135926 | PCL01-Strong Physical Reactions | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong physical reactions when something reminded you of the stressful experience (for example, heart pounding, trouble breathing, sweating)? | PCL-5 - Strong Physical Reactions | ||
PCL0106 | C135927 | PCL01-Avoid Memories/Thoughts/Feelings | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Avoiding memories, thoughts, or feelings related to the stressful experience? | PCL-5 - Avoid Memories, Thoughts or Feelings | ||
PCL0107 | C135928 | PCL01-Avoid External Reminders | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Avoiding external reminders of the stressful experience (for example, people, places, conversations, activities, objects, or situations)? | PCL-5 - Avoid External Reminders | ||
PCL0108 | C135929 | PCL01-Trouble Remembering Important Part | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble remembering important parts of the stressful experience? | PCL-5 - Trouble Remembering Important Parts | ||
PCL0109 | C135930 | PCL01-Strong Negative Beliefs | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong negative beliefs about yourself, other people, or the world (for example, having thoughts such as: I am bad, there is something seriously wrong with me, no one can be trusted, the world is completely dangerous)? | PCL-5 - Strong Negative Beliefs | ||
PCL0110 | C135931 | PCL01-Blaming Yourself/Someone Else | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Blaming yourself or someone else for the stressful experience or what happened after it? | PCL-5 - Blaming Yourself or Someone Else | ||
PCL0111 | C135932 | PCL01-Strong Negative Feelings | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong negative feelings such as fear, horror, anger, guilt, or shame? | PCL-5 - Strong Negative Feelings | ||
PCL0112 | C135933 | PCL01-Loss of Interest in Activities | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Loss of interest in activities that you used to enjoy? | PCL-5 - Loss of Interest in Activities | ||
PCL0113 | C135934 | PCL01-Feeling Distant From People | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling distant or cut off from other people? | PCL-5 - Feeling Distant From People | ||
PCL0114 | C135935 | PCL01-Trouble Experiencing Pos Feelings | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble experiencing positive feelings (for example, being unable to feel happiness or have loving feelings for people close to you)? | PCL-5 - Trouble Experiencing Positive Feelings | ||
PCL0115 | C135936 | PCL01-Irritable Behavior/Angry Outbursts | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Irritable behavior, angry outbursts, or acting aggressively? | PCL-5 - Irritable Behavior or Angry Outbursts | ||
PCL0116 | C135937 | PCL01-Taking Too Many Risks/Cause Harm | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Taking too many risks or doing things that could cause you harm? | PCL-5 - Taking Too Many Risks or Cause Harm | ||
PCL0117 | C135938 | PCL01-Being Superalert/Watchful/on Guard | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Being "superalert" or watchful or on guard? | PCL-5 - Being Super Alert or Watchful | ||
PCL0118 | C135939 | PCL01-Feeling Jumpy or Easily Startled | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling jumpy or easily startled? | PCL-5 - Feeling Jumpy or Easily Startled | ||
PCL0119 | C135940 | PCL01-Having Difficulty Concentrating | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having difficulty concentrating? | PCL-5 - Having Difficulty Concentrating | ||
PCL0120 | C135941 | PCL01-Trouble Falling or Staying Asleep | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble falling or staying asleep? | PCL-5 - Trouble Falling or Staying Asleep | ||
Back to top | ||||||
CL.C135691.PCL01TN | The PTSD Checklist for DSM-5 Questionnaire Test Name
(PCL01TN) | text
Extensible: No | C135691 | The PTSD Checklist for DSM-5 Questionnaire Test Name | The PTSD Checklist for DSM-5 test name. | CDISC Questionnaire PCL-5 Test Name Terminology |
PCL01-Avoid External Reminders | C135928 | PCL01-Avoid External Reminders | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Avoiding external reminders of the stressful experience (for example, people, places, conversations, activities, objects, or situations)? | PCL-5 - Avoid External Reminders | ||
PCL01-Avoid Memories/Thoughts/Feelings | C135927 | PCL01-Avoid Memories/Thoughts/Feelings | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Avoiding memories, thoughts, or feelings related to the stressful experience? | PCL-5 - Avoid Memories, Thoughts or Feelings | ||
PCL01-Being Superalert/Watchful/on Guard | C135938 | PCL01-Being Superalert/Watchful/on Guard | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Being "superalert" or watchful or on guard? | PCL-5 - Being Super Alert or Watchful | ||
PCL01-Blaming Yourself/Someone Else | C135931 | PCL01-Blaming Yourself/Someone Else | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Blaming yourself or someone else for the stressful experience or what happened after it? | PCL-5 - Blaming Yourself or Someone Else | ||
PCL01-Feel Upset When Reminded | C135925 | PCL01-Feel Upset When Reminded | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling very upset when something reminded you of the stressful experience? | PCL-5 - Feel Upset When Reminded | ||
PCL01-Feeling Distant From People | C135934 | PCL01-Feeling Distant From People | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling distant or cut off from other people? | PCL-5 - Feeling Distant From People | ||
PCL01-Feeling Jumpy or Easily Startled | C135939 | PCL01-Feeling Jumpy or Easily Startled | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Feeling jumpy or easily startled? | PCL-5 - Feeling Jumpy or Easily Startled | ||
PCL01-Having Difficulty Concentrating | C135940 | PCL01-Having Difficulty Concentrating | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having difficulty concentrating? | PCL-5 - Having Difficulty Concentrating | ||
PCL01-Irritable Behavior/Angry Outbursts | C135936 | PCL01-Irritable Behavior/Angry Outbursts | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Irritable behavior, angry outbursts, or acting aggressively? | PCL-5 - Irritable Behavior or Angry Outbursts | ||
PCL01-Loss of Interest in Activities | C135933 | PCL01-Loss of Interest in Activities | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Loss of interest in activities that you used to enjoy? | PCL-5 - Loss of Interest in Activities | ||
PCL01-Repeated Disturbing Dreams | C135923 | PCL01-Repeated Disturbing Dreams | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Repeated, disturbing dreams of the stressful experience? | PCL-5 - Repeated Disturbing Dreams | ||
PCL01-Repeated Disturbing Memories | C135922 | PCL01-Repeated Disturbing Memories | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Repeated, disturbing, and unwanted memories of the stressful experience? | PCL-5 - Repeated Disturbing Memories | ||
PCL01-Strong Negative Beliefs | C135930 | PCL01-Strong Negative Beliefs | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong negative beliefs about yourself, other people, or the world (for example, having thoughts such as: I am bad, there is something seriously wrong with me, no one can be trusted, the world is completely dangerous)? | PCL-5 - Strong Negative Beliefs | ||
PCL01-Strong Negative Feelings | C135932 | PCL01-Strong Negative Feelings | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong negative feelings such as fear, horror, anger, guilt, or shame? | PCL-5 - Strong Negative Feelings | ||
PCL01-Strong Physical Reactions | C135926 | PCL01-Strong Physical Reactions | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Having strong physical reactions when something reminded you of the stressful experience (for example, heart pounding, trouble breathing, sweating)? | PCL-5 - Strong Physical Reactions | ||
PCL01-Suddenly Feeling Happening Again | C135924 | PCL01-Suddenly Feeling Happening Again | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Suddenly feeling or acting as if the stressful experience were actually happening again (as if you were actually back there reliving it)? | PCL-5 - Suddenly Feeling Happening Again | ||
PCL01-Taking Too Many Risks/Cause Harm | C135937 | PCL01-Taking Too Many Risks/Cause Harm | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Taking too many risks or doing things that could cause you harm? | PCL-5 - Taking Too Many Risks or Cause Harm | ||
PCL01-Trouble Experiencing Pos Feelings | C135935 | PCL01-Trouble Experiencing Pos Feelings | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble experiencing positive feelings (for example, being unable to feel happiness or have loving feelings for people close to you)? | PCL-5 - Trouble Experiencing Positive Feelings | ||
PCL01-Trouble Falling or Staying Asleep | C135941 | PCL01-Trouble Falling or Staying Asleep | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble falling or staying asleep? | PCL-5 - Trouble Falling or Staying Asleep | ||
PCL01-Trouble Remembering Important Part | C135929 | PCL01-Trouble Remembering Important Part | The PTSD Checklist for DSM-5 - In the past month, how much were you bothered by: Trouble remembering important parts of the stressful experience? | PCL-5 - Trouble Remembering Important Parts | ||
Back to top | ||||||
CL.C101823.SF362TC | The Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire Test Code
(SF362TC) | text
Extensible: No | C101823 | The Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire Test Code | The Short Form 36 Health Survey Acute, US Version 1.0 test code. | CDISC Questionnaire SF36 v1.0 Acute Test Code Terminology |
SF36201 | C102125 | SF362-In General You Say Your Health Is | The Short Form 36 Health Survey Acute, US Version 1.0 - In general, would you say your health is. | SF-36 v1.0 Acute - In General You Say Your Health Is | ||
SF36202 | C102126 | SF362-Comp Week Ago Rate Gen Health Now | The Short Form 36 Health Survey Acute, US Version 1.0 - Compared to one week ago, how would you rate your health in general now? | SF-36 v1.0 Acute - Comp Week Ago Rate Gen Health Now | ||
SF36203A | C102127 | SF362-Limit Vigorous Activities | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | SF-36 v1.0 Acute - Limit Vigorous Activities | ||
SF36203B | C102128 | SF362-Limit Moderate Activities | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF-36 v1.0 Acute - Limit Moderate Activities | ||
SF36203C | C102129 | SF362-Limit Lifting or Carrying | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - lifting or carrying groceries. | SF-36 v1.0 Acute - Limit Lifting or Carrying | ||
SF36203D | C102130 | SF362-Limit Climbing Several Flights | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. | SF-36 v1.0 Acute - Limit Climbing Several Flights | ||
SF36203E | C102131 | SF362-Limit Climbing One Flight Stairs | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing one flight of stairs. | SF-36 v1.0 Acute - Limit Climbing One Flight Stairs | ||
SF36203F | C102132 | SF362-Limit Bending/Kneeling/Stooping | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - bending, kneeling, or stooping. | SF-36 v1.0 Acute - Limit Bending/Kneeling/Stooping | ||
SF36203G | C102133 | SF362-Limit Walking More Than a Mile | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking more than a mile. | SF-36 v1.0 Acute - Limit Walking More Than a Mile | ||
SF36203H | C102134 | SF362-Limit Walking Several Blocks | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking several blocks. | SF-36 v1.0 Acute - Limit Walking Several Blocks | ||
SF36203I | C102135 | SF362-Limit Walking One Block | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking one block. | SF-36 v1.0 Acute - Limit Walking One Block | ||
SF36203J | C102136 | SF362-Limit Bathing or Dressing Yourself | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - bathing or dressing yourself. | SF-36 v1.0 Acute - Limit Bathing or Dressing Yourself | ||
SF36204A | C102137 | SF362-Physical: Cut Down Time on Work | The Short Form 36 Health Survey Acute, US Version 1.0 (SF36 V1.0 ACUTE) -During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. | SF-36 v1.0 Acute - Physical: Cut Down Time on Work | ||
SF36204B | C102138 | SF362-Physical: Accomplished Less | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF-36 v1.0 Acute - Physical: Accomplished Less | ||
SF36204C | C102139 | SF362-Physical: Limited Kind of Work | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF-36 v1.0 Acute - Physical: Limited Kind of Work | ||
SF36204D | C102140 | SF362-Physical: Difficulty Perform Work | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). | SF-36 v1.0 Acute - Physical: Difficulty Perform Work | ||
SF36205A | C102141 | SF362-Emotional: Cut Down Time on Work | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. | SF-36 v1.0 Acute - Emotional: Cut Down Time on Work | ||
SF36205B | C102142 | SF362-Emotional: Accomplished Less | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF-36 v1.0 Acute - Emotional: Accomplished Less | ||
SF36205C | C102143 | SF362-Emotional: Did Work Less Carefully | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF-36 v1.0 Acute - Emotional: Did Work Less Carefully | ||
SF36206 | C102144 | SF362-Extent Phys/Emotional Interfered | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | SF-36 v1.0 Acute - Extent Phys/Emotional Interfered | ||
SF36207 | C102145 | SF362-How Much Bodily Pain Have You Had | The Short Form 36 Health Survey Acute, US Version 1.0 - How much bodily pain have you had during the past week? | SF-36 v1.0 Acute - How Much Bodily Pain Have You Had | ||
SF36208 | C102146 | SF362-Pain Interfere With Normal Work | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF-36 v1.0 Acute - Pain Interfere With Normal Work | ||
SF36209A | C102147 | SF362-Did You Feel Full of Pep | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel full of pep. | SF-36 v1.0 Acute - Did You Feel Full of Pep | ||
SF36209B | C102148 | SF362-Have You Been Very Nervous Person | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been a very nervous person. | SF-36 v1.0 Acute - Have You Been Very Nervous Person | ||
SF36209C | C102149 | SF362-Felt Down Nothing Cheer You Up | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt so down in the dumps that nothing could cheer you up. | SF-36 v1.0 Acute - Felt Down Nothing Cheer You Up | ||
SF36209D | C102150 | SF362-Have You Felt Calm and Peaceful | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful. | SF-36 v1.0 Acute - Have You Felt Calm and Peaceful | ||
SF36209E | C102151 | SF362-Did You Have a Lot of Energy | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy. | SF-36 v1.0 Acute - Did You Have a Lot of Energy | ||
SF36209F | C102152 | SF362-You Felt Downhearted and Blue | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and blue. | SF-36 v1.0 Acute - You Felt Downhearted and Blue | ||
SF36209G | C102153 | SF362-Did You Feel Worn Out | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel worn out. | SF-36 v1.0 Acute - Did You Feel Worn Out | ||
SF36209H | C102154 | SF362-Have You Been a Happy Person | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been a happy person. | SF-36 v1.0 Acute - Have You Been a Happy Person | ||
SF36209I | C102155 | SF362-Did You Feel Tired | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel tired. | SF-36 v1.0 Acute - Did You Feel Tired | ||
SF36210 | C102156 | SF362-Time Phys/Emotional Interfered | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF-36 v1.0 Acute - Time Phys/Emotional Interfered | ||
SF36211A | C102157 | SF362-Get Sick Little Easier Than Other | The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. | SF-36 v1.0 Acute - Get Sick Little Easier Than Other | ||
SF36211B | C102158 | SF362-I Am as Healthy as Anybody I Know | The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. | SF-36 v1.0 Acute - I Am as Healthy as Anybody I Know | ||
SF36211C | C102159 | SF362-I Expect My Health to Get Worse | The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. | SF-36 v1.0 Acute - I Expect My Health to Get Worse | ||
SF36211D | C102160 | SF362-My Health is Excellent | The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - my health is excellent | SF-36 v1.0 Acute - My Health is Excellent | ||
SF36212 | C176121 | SF362-Physical Functioning 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Physical functioning 0-100 score. | SF-36 v1.0 Acute - Physical Functioning 0-100 Score | ||
SF36213 | C176122 | SF362-Role Physical 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Role physical 0-100 score. | SF-36 v1.0 Acute - Role Physical 0-100 Score | ||
SF36214 | C176123 | SF362-Bodily Pain 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Bodily pain 0-100 score. | SF-36 v1.0 Acute - Bodily Pain 0-100 Score | ||
SF36215 | C176124 | SF362-General Health 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - General health 0-100 score. | SF-36 v1.0 Acute - General Health 0-100 Score | ||
SF36216 | C176125 | SF362-Vitality 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Vitality 0-100 score. | SF-36 v1.0 Acute - Vitality 0-100 Score | ||
SF36217 | C176126 | SF362-Social Functioning 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Social functioning 0-100 score. | SF-36 v1.0 Acute - Social Functioning 0-100 Score | ||
SF36218 | C176127 | SF362-Role Emotional 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Role emotional 0-100 score. | SF-36 v1.0 Acute - Role Emotional 0-100 Score | ||
SF36219 | C176128 | SF362-Mental Health 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Mental health 0-100 score. | SF-36 v1.0 Acute - Mental Health 0-100 Score | ||
SF36220 | C176129 | SF362-Phys Functioning Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Phys functioning norm-based score. | SF-36 v1.0 Acute - Phys Functioning Norm-Based Score | ||
SF36221 | C176130 | SF362-Role Physical Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Role physical norm-based score. | SF-36 v1.0 Acute - Role Physical Norm-Based Score | ||
SF36222 | C176131 | SF362-Bodily Pain Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Bodily pain norm-based score. | SF-36 v1.0 Acute - Bodily Pain Norm-Based Score | ||
SF36223 | C176132 | SF362-General Health Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - General health norm-based score. | SF-36 v1.0 Acute - General Health Norm-Based Score | ||
SF36224 | C176133 | SF362-Vitality Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Vitality norm-based score. | SF-36 v1.0 Acute - Vitality Norm-Based Score | ||
SF36225 | C176134 | SF362-Social Function Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Social function norm-based score. | SF-36 v1.0 Acute - Social Function Norm-Based Score | ||
SF36226 | C176135 | SF362-Role Emotional Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Role emotional norm-based score. | SF-36 v1.0 Acute - Role Emotional Norm-Based Score | ||
SF36227 | C176136 | SF362-Mental Health Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Mental health norm-based score. | SF-36 v1.0 Acute - Mental Health Norm-Based Score | ||
SF36228 | C176137 | SF362-Physical Component Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Physical component score. | SF-36 v1.0 Acute - Physical Component Score | ||
SF36229 | C176138 | SF362-Mental Component Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Mental component score. | SF-36 v1.0 Acute - Mental Component Score | ||
SF36230 | C176139 | SF362-SF-6D (Utility Index) Score | The Short Form 36 Health Survey Acute, US Version 1.0 - 6D (utility index) score. | SF-36 v1.0 Acute - SF-6D (Utility Index) Score | ||
SF36231 | C176140 | SF362-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 36 Health Survey Acute, US Version 1.0 - 6D_R2 (util index rel 2) score. | SF-36 v1.0 Acute - SF-6D_R2 (Util Index Rel 2) Score | ||
SF36232 | C176141 | SF362-Response Consistency Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Response consistency score. | SF-36 v1.0 Acute - Response Consistency Score | ||
Back to top | ||||||
CL.C101824.SF362TN | The Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire Test Name
(SF362TN) | text
Extensible: No | C101824 | The Short Form 36 Health Survey Acute, US Version 1.0 Questionnaire Test Name | The Short Form 36 Health Survey Acute, US Version 1.0 test name. | CDISC Questionnaire SF36 v1.0 Acute Test Name Terminology |
SF362-Bodily Pain 0-100 Score | C176123 | SF362-Bodily Pain 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Bodily pain 0-100 score. | SF-36 v1.0 Acute - Bodily Pain 0-100 Score | ||
SF362-Bodily Pain Norm-Based Score | C176131 | SF362-Bodily Pain Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Bodily pain norm-based score. | SF-36 v1.0 Acute - Bodily Pain Norm-Based Score | ||
SF362-Comp Week Ago Rate Gen Health Now | C102126 | SF362-Comp Week Ago Rate Gen Health Now | The Short Form 36 Health Survey Acute, US Version 1.0 - Compared to one week ago, how would you rate your health in general now? | SF-36 v1.0 Acute - Comp Week Ago Rate Gen Health Now | ||
SF362-Did You Feel Full of Pep | C102147 | SF362-Did You Feel Full of Pep | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel full of pep. | SF-36 v1.0 Acute - Did You Feel Full of Pep | ||
SF362-Did You Feel Tired | C102155 | SF362-Did You Feel Tired | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel tired. | SF-36 v1.0 Acute - Did You Feel Tired | ||
SF362-Did You Feel Worn Out | C102153 | SF362-Did You Feel Worn Out | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel worn out. | SF-36 v1.0 Acute - Did You Feel Worn Out | ||
SF362-Did You Have a Lot of Energy | C102151 | SF362-Did You Have a Lot of Energy | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy. | SF-36 v1.0 Acute - Did You Have a Lot of Energy | ||
SF362-Emotional: Accomplished Less | C102142 | SF362-Emotional: Accomplished Less | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF-36 v1.0 Acute - Emotional: Accomplished Less | ||
SF362-Emotional: Cut Down Time on Work | C102141 | SF362-Emotional: Cut Down Time on Work | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. | SF-36 v1.0 Acute - Emotional: Cut Down Time on Work | ||
SF362-Emotional: Did Work Less Carefully | C102143 | SF362-Emotional: Did Work Less Carefully | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF-36 v1.0 Acute - Emotional: Did Work Less Carefully | ||
SF362-Extent Phys/Emotional Interfered | C102144 | SF362-Extent Phys/Emotional Interfered | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | SF-36 v1.0 Acute - Extent Phys/Emotional Interfered | ||
SF362-Felt Down Nothing Cheer You Up | C102149 | SF362-Felt Down Nothing Cheer You Up | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt so down in the dumps that nothing could cheer you up. | SF-36 v1.0 Acute - Felt Down Nothing Cheer You Up | ||
SF362-General Health 0-100 Score | C176124 | SF362-General Health 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - General health 0-100 score. | SF-36 v1.0 Acute - General Health 0-100 Score | ||
SF362-General Health Norm-Based Score | C176132 | SF362-General Health Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - General health norm-based score. | SF-36 v1.0 Acute - General Health Norm-Based Score | ||
SF362-Get Sick Little Easier Than Other | C102157 | SF362-Get Sick Little Easier Than Other | The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. | SF-36 v1.0 Acute - Get Sick Little Easier Than Other | ||
SF362-Have You Been a Happy Person | C102154 | SF362-Have You Been a Happy Person | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been a happy person. | SF-36 v1.0 Acute - Have You Been a Happy Person | ||
SF362-Have You Been Very Nervous Person | C102148 | SF362-Have You Been Very Nervous Person | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been a very nervous person. | SF-36 v1.0 Acute - Have You Been Very Nervous Person | ||
SF362-Have You Felt Calm and Peaceful | C102150 | SF362-Have You Felt Calm and Peaceful | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful. | SF-36 v1.0 Acute - Have You Felt Calm and Peaceful | ||
SF362-How Much Bodily Pain Have You Had | C102145 | SF362-How Much Bodily Pain Have You Had | The Short Form 36 Health Survey Acute, US Version 1.0 - How much bodily pain have you had during the past week? | SF-36 v1.0 Acute - How Much Bodily Pain Have You Had | ||
SF362-I Am as Healthy as Anybody I Know | C102158 | SF362-I Am as Healthy as Anybody I Know | The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. | SF-36 v1.0 Acute - I Am as Healthy as Anybody I Know | ||
SF362-I Expect My Health to Get Worse | C102159 | SF362-I Expect My Health to Get Worse | The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. | SF-36 v1.0 Acute - I Expect My Health to Get Worse | ||
SF362-In General You Say Your Health Is | C102125 | SF362-In General You Say Your Health Is | The Short Form 36 Health Survey Acute, US Version 1.0 - In general, would you say your health is. | SF-36 v1.0 Acute - In General You Say Your Health Is | ||
SF362-Limit Bathing or Dressing Yourself | C102136 | SF362-Limit Bathing or Dressing Yourself | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - bathing or dressing yourself. | SF-36 v1.0 Acute - Limit Bathing or Dressing Yourself | ||
SF362-Limit Bending/Kneeling/Stooping | C102132 | SF362-Limit Bending/Kneeling/Stooping | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - bending, kneeling, or stooping. | SF-36 v1.0 Acute - Limit Bending/Kneeling/Stooping | ||
SF362-Limit Climbing One Flight Stairs | C102131 | SF362-Limit Climbing One Flight Stairs | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing one flight of stairs. | SF-36 v1.0 Acute - Limit Climbing One Flight Stairs | ||
SF362-Limit Climbing Several Flights | C102130 | SF362-Limit Climbing Several Flights | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. | SF-36 v1.0 Acute - Limit Climbing Several Flights | ||
SF362-Limit Lifting or Carrying | C102129 | SF362-Limit Lifting or Carrying | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - lifting or carrying groceries. | SF-36 v1.0 Acute - Limit Lifting or Carrying | ||
SF362-Limit Moderate Activities | C102128 | SF362-Limit Moderate Activities | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF-36 v1.0 Acute - Limit Moderate Activities | ||
SF362-Limit Vigorous Activities | C102127 | SF362-Limit Vigorous Activities | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | SF-36 v1.0 Acute - Limit Vigorous Activities | ||
SF362-Limit Walking More Than a Mile | C102133 | SF362-Limit Walking More Than a Mile | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking more than a mile. | SF-36 v1.0 Acute - Limit Walking More Than a Mile | ||
SF362-Limit Walking One Block | C102135 | SF362-Limit Walking One Block | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking one block. | SF-36 v1.0 Acute - Limit Walking One Block | ||
SF362-Limit Walking Several Blocks | C102134 | SF362-Limit Walking Several Blocks | The Short Form 36 Health Survey Acute, US Version 1.0 - How much does your health now limit you in - walking several blocks. | SF-36 v1.0 Acute - Limit Walking Several Blocks | ||
SF362-Mental Component Score | C176138 | SF362-Mental Component Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Mental component score. | SF-36 v1.0 Acute - Mental Component Score | ||
SF362-Mental Health 0-100 Score | C176128 | SF362-Mental Health 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Mental health 0-100 score. | SF-36 v1.0 Acute - Mental Health 0-100 Score | ||
SF362-Mental Health Norm-Based Score | C176136 | SF362-Mental Health Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Mental health norm-based score. | SF-36 v1.0 Acute - Mental Health Norm-Based Score | ||
SF362-My Health is Excellent | C102160 | SF362-My Health is Excellent | The Short Form 36 Health Survey Acute, US Version 1.0 - How TRUE or FALSE is the following statement for you - my health is excellent | SF-36 v1.0 Acute - My Health is Excellent | ||
SF362-Pain Interfere With Normal Work | C102146 | SF362-Pain Interfere With Normal Work | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF-36 v1.0 Acute - Pain Interfere With Normal Work | ||
SF362-Phys Functioning Norm-Based Score | C176129 | SF362-Phys Functioning Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Phys functioning norm-based score. | SF-36 v1.0 Acute - Phys Functioning Norm-Based Score | ||
SF362-Physical Component Score | C176137 | SF362-Physical Component Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Physical component score. | SF-36 v1.0 Acute - Physical Component Score | ||
SF362-Physical Functioning 0-100 Score | C176121 | SF362-Physical Functioning 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Physical functioning 0-100 score. | SF-36 v1.0 Acute - Physical Functioning 0-100 Score | ||
SF362-Physical: Accomplished Less | C102138 | SF362-Physical: Accomplished Less | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF-36 v1.0 Acute - Physical: Accomplished Less | ||
SF362-Physical: Cut Down Time on Work | C102137 | SF362-Physical: Cut Down Time on Work | The Short Form 36 Health Survey Acute, US Version 1.0 (SF36 V1.0 ACUTE) -During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. | SF-36 v1.0 Acute - Physical: Cut Down Time on Work | ||
SF362-Physical: Difficulty Perform Work | C102140 | SF362-Physical: Difficulty Perform Work | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). | SF-36 v1.0 Acute - Physical: Difficulty Perform Work | ||
SF362-Physical: Limited Kind of Work | C102139 | SF362-Physical: Limited Kind of Work | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, have you had any of the following problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF-36 v1.0 Acute - Physical: Limited Kind of Work | ||
SF362-Response Consistency Score | C176141 | SF362-Response Consistency Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Response consistency score. | SF-36 v1.0 Acute - Response Consistency Score | ||
SF362-Role Emotional 0-100 Score | C176127 | SF362-Role Emotional 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Role emotional 0-100 score. | SF-36 v1.0 Acute - Role Emotional 0-100 Score | ||
SF362-Role Emotional Norm-Based Score | C176135 | SF362-Role Emotional Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Role emotional norm-based score. | SF-36 v1.0 Acute - Role Emotional Norm-Based Score | ||
SF362-Role Physical 0-100 Score | C176122 | SF362-Role Physical 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Role physical 0-100 score. | SF-36 v1.0 Acute - Role Physical 0-100 Score | ||
SF362-Role Physical Norm-Based Score | C176130 | SF362-Role Physical Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Role physical norm-based score. | SF-36 v1.0 Acute - Role Physical Norm-Based Score | ||
SF362-SF-6D (Utility Index) Score | C176139 | SF362-SF-6D (Utility Index) Score | The Short Form 36 Health Survey Acute, US Version 1.0 - 6D (utility index) score. | SF-36 v1.0 Acute - SF-6D (Utility Index) Score | ||
SF362-SF-6D_R2 (Util Index Rel 2) Score | C176140 | SF362-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 36 Health Survey Acute, US Version 1.0 - 6D_R2 (util index rel 2) score. | SF-36 v1.0 Acute - SF-6D_R2 (Util Index Rel 2) Score | ||
SF362-Social Function Norm-Based Score | C176134 | SF362-Social Function Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Social function norm-based score. | SF-36 v1.0 Acute - Social Function Norm-Based Score | ||
SF362-Social Functioning 0-100 Score | C176126 | SF362-Social Functioning 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Social functioning 0-100 score. | SF-36 v1.0 Acute - Social Functioning 0-100 Score | ||
SF362-Time Phys/Emotional Interfered | C102156 | SF362-Time Phys/Emotional Interfered | The Short Form 36 Health Survey Acute, US Version 1.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF-36 v1.0 Acute - Time Phys/Emotional Interfered | ||
SF362-Vitality 0-100 Score | C176125 | SF362-Vitality 0-100 Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Vitality 0-100 score. | SF-36 v1.0 Acute - Vitality 0-100 Score | ||
SF362-Vitality Norm-Based Score | C176133 | SF362-Vitality Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 1.0 - Vitality norm-based score. | SF-36 v1.0 Acute - Vitality Norm-Based Score | ||
SF362-You Felt Downhearted and Blue | C102152 | SF362-You Felt Downhearted and Blue | The Short Form 36 Health Survey Acute, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and blue. | SF-36 v1.0 Acute - You Felt Downhearted and Blue | ||
Back to top | ||||||
CL.C101884.SF364TC | The Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire Test Code
(SF364TC) | text
Extensible: No | C101884 | The Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire Test Code | The Short Form 36 Health Survey Acute, US Version 2.0 test code. | CDISC Questionnaire SF36 v2.0 Acute Test Code Terminology |
SF36401 | C102161 | SF364-In General You Say Your Health Is | The Short Form 36 Health Survey Acute, US Version 2.0 - In general, would you say your health is. | SF-36 v2.0 Acute - In General You Say Your Health Is | ||
SF36402 | C102162 | SF364-Comp Week Ago Rate Gen Health Now | The Short Form 36 Health Survey Acute, US Version 2.0 - Compared to one week ago, how would you rate your health in general now? | SF-36 v2.0 Acute - Comp Week Ago Rate Gen Health Now | ||
SF36403A | C102163 | SF364-Limit Vigorous Activities | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | SF-36 v2.0 Acute - Limit Vigorous Activities | ||
SF36403B | C102164 | SF364-Limit Moderate Activities | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF-36 v2.0 Acute - Limit Moderate Activities | ||
SF36403C | C102165 | SF364-Limit Lifting or Carrying | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - lifting or carrying groceries. | SF-36 v2.0 Acute - Limit Lifting or Carrying | ||
SF36403D | C102166 | SF364-Limit Climbing Several Flights | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. | SF-36 v2.0 Acute - Limit Climbing Several Flights | ||
SF36403E | C102167 | SF364-Limit Climbing One Flight Stairs | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing one flight of stairs. | SF-36 v2.0 Acute - Limit Climbing One Flight Stairs | ||
SF36403F | C102168 | SF364-Limit Bending/Kneeling/Stooping | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - bending, kneeling, or stooping. | SF-36 v2.0 Acute - Limit Bending/Kneeling/Stooping | ||
SF36403G | C102169 | SF364-Limit Walking More Than a Mile | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking more than a mile. | SF-36 v2.0 Acute - Limit Walking More Than a Mile | ||
SF36403H | C102170 | SF364-Limit Walking Several Hundred Yds | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking several hundred yards. | SF-36 v2.0 Acute - Limit Walking Several Hundred Yds | ||
SF36403I | C102171 | SF364-Limit Walking One Hundred Yards | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking one hundred yards. | SF-36 v2.0 Acute - Limit Walking One Hundred Yards | ||
SF36403J | C102172 | SF364-Limit Bathing or Dressing Yourself | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - bathing or dressing yourself. | SF-36 v2.0 Acute - Limit Bathing or Dressing Yourself | ||
SF36404A | C102173 | SF364-Physical: Cut Down Time on Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. | SF-36 v2.0 Acute - Physical: Cut Down Time on Work | ||
SF36404B | C102174 | SF364-Physical: Accomplished Less | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF-36 v2.0 Acute - Physical: Accomplished Less | ||
SF36404C | C102175 | SF364-Physical: Limited Kind of Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF-36 v2.0 Acute - Physical: Limited Kind of Work | ||
SF36404D | C102176 | SF364-Physical: Difficulty Perform Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). | SF-36 v2.0 Acute - Physical: Difficulty Perform Work | ||
SF36405A | C102177 | SF364-Emotional: Cut Down Time on Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. | SF-36 v2.0 Acute - Emotional: Cut Down Time on Work | ||
SF36405B | C102178 | SF364-Emotional: Accomplished Less | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF-36 v2.0 Acute - Emotional: Accomplished Less | ||
SF36405C | C102179 | SF364-Emotional: Did Work Less Carefully | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF-36 v2.0 Acute - Emotional: Did Work Less Carefully | ||
SF36406 | C102180 | SF364-Extent Phys/Emotional Interfered | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | SF-36 v2.0 Acute - Extent Phys/Emotional Interfered | ||
SF36407 | C102181 | SF364-How Much Bodily Pain Have You Had | The Short Form 36 Health Survey Acute, US Version 2.0 - How much bodily pain have you had during the past week? | SF-36 v2.0 Acute - How Much Bodily Pain Have You Had | ||
SF36408 | C102182 | SF364-Pain Interfere With Normal Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF-36 v2.0 Acute - Pain Interfere With Normal Work | ||
SF36409A | C102183 | SF364-Did You Feel Full of Life | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel full of life. | SF-36 v2.0 Acute - Did You Feel Full of Life | ||
SF36409B | C102184 | SF364-Have You Been Very Nervous | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been very nervous. | SF-36 v2.0 Acute - Have You Been Very Nervous | ||
SF36409C | C102185 | SF364-Felt Down Nothing Cheer You Up | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt so down in the dumps that nothing could cheer you up. | SF-36 v2.0 Acute - Felt Down Nothing Cheer You Up | ||
SF36409D | C102186 | SF364-Have You Felt Calm and Peaceful | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful. | SF-36 v2.0 Acute - Have You Felt Calm and Peaceful | ||
SF36409E | C102187 | SF364-Did You Have a Lot of Energy | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy. | SF-36 v2.0 Acute - Did You Have a Lot of Energy | ||
SF36409F | C102188 | SF364-You Felt Downhearted and Depressed | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and depressed. | SF-36 v2.0 Acute - You Felt Downhearted and Depressed | ||
SF36409G | C102189 | SF364-Did You Feel Worn Out | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel worn out. | SF-36 v2.0 Acute - Did You Feel Worn Out | ||
SF36409H | C102190 | SF364-Have You Been Happy | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been happy. | SF-36 v2.0 Acute - Have You Been Happy | ||
SF36409I | C102191 | SF364-Did You Feel Tired | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel tired. | SF-36 v2.0 Acute - Did You Feel Tired | ||
SF36410 | C102192 | SF364-Time Phys/Emotional Interfered | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF-36 v2.0 Acute - Time Phys/Emotional Interfered | ||
SF36411A | C102193 | SF364-Get Sick Little Easier Than Other | The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. | SF-36 v2.0 Acute - Get Sick Little Easier Than Other | ||
SF36411B | C102194 | SF364-I Am as Healthy as Anybody I Know | The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. | SF-36 v2.0 Acute - I Am as Healthy as Anybody I Know | ||
SF36411C | C102195 | SF364-I Expect My Health to Get Worse | The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. | SF-36 v2.0 Acute - I Expect My Health to Get Worse | ||
SF36411D | C102196 | SF364-My Health is Excellent | The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - my health is excellent | SF-36 v2.0 Acute - My Health is Excellent | ||
SF36412 | C176163 | SF364-Physical Functioning 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Physical functioning 0-100 score. | SF-36 v2.0 Acute - Physical Functioning 0-100 Score | ||
SF36413 | C176164 | SF364-Role Physical 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Role physical 0-100 score. | SF-36 v2.0 Acute - Role Physical 0-100 Score | ||
SF36414 | C176165 | SF364-Bodily Pain 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Bodily pain 0-100 score. | SF-36 v2.0 Acute - Bodily Pain 0-100 Score | ||
SF36415 | C176166 | SF364-General Health 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - General health 0-100 score. | SF-36 v2.0 Acute - General Health 0-100 Score | ||
SF36416 | C176167 | SF364-Vitality 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Vitality 0-100 score. | SF-36 v2.0 Acute - Vitality 0-100 Score | ||
SF36417 | C176168 | SF364-Social Functioning 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Social functioning 0-100 score. | SF-36 v2.0 Acute - Social Functioning 0-100 Score | ||
SF36418 | C176169 | SF364-Role Emotional 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Role emotional 0-100 score. | SF-36 v2.0 Acute - Role Emotional 0-100 Score | ||
SF36419 | C176170 | SF364-Mental Health 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health 0-100 score. | SF-36 v2.0 Acute - Mental Health 0-100 Score | ||
SF36420 | C176171 | SF364-Phys Functioning Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Phys functioning norm-based score. | SF-36 v2.0 Acute - Phys Functioning Norm-Based Score | ||
SF36421 | C176172 | SF364-Role Physical Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Role physical norm-based score. | SF-36 v2.0 Acute - Role Physical Norm-Based Score | ||
SF36422 | C176173 | SF364-Bodily Pain Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Bodily pain norm-based score. | SF-36 v2.0 Acute - Bodily Pain Norm-Based Score | ||
SF36423 | C176174 | SF364-General Health Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - General health norm-based score. | SF-36 v2.0 Acute - General Health Norm-Based Score | ||
SF36424 | C176175 | SF364-Vitality Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Vitality norm-based score. | SF-36 v2.0 Acute - Vitality Norm-Based Score | ||
SF36425 | C176176 | SF364-Social Function Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Social function norm-based score. | SF-36 v2.0 Acute - Social Function Norm-Based Score | ||
SF36426 | C176177 | SF364-Role Emotional Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Role emotional norm-based score. | SF-36 v2.0 Acute - Role Emotional Norm-Based Score | ||
SF36427 | C176178 | SF364-Mental Health Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health norm-based score. | SF-36 v2.0 Acute - Mental Health Norm-Based Score | ||
SF36428 | C176179 | SF364-Physical Component Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Physical component score. | SF-36 v2.0 Acute - Physical Component Score | ||
SF36429 | C176180 | SF364-Mental Component Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Mental component score. | SF-36 v2.0 Acute - Mental Component Score | ||
SF36430 | C176181 | SF364-SF-6D (Utility Index) Score | The Short Form 36 Health Survey Acute, US Version 2.0 - 6D (utility index) score. | SF-36 v2.0 Acute - SF-6D (Utility Index) Score | ||
SF36431 | C176182 | SF364-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 36 Health Survey Acute, US Version 2.0 - 6D_R2 (util index rel 2) score. | SF-36 v2.0 Acute - SF-6D_R2 (Util Index Rel 2) Score | ||
SF36432 | C176183 | SF364-Mental Health Enhanced Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health enhanced score. | SF-36 v2.0 Acute - Mental Health Enhanced Score | ||
SF36433 | C180247 | SF364-Response Consistency Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Response consistency score. | SF-36 v2.0 Acute - Response Consistency Score | ||
SF36434 | C185783 | SF364-Utility Index Score UK Weights | The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score United Kingdom weights. | SF-36 v2.0 Acute - Utility Index Score UK Weights | ||
SF36435 | C185784 | SF364-Utility Index Score CN Weights | The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score Canada weights. | SF-36 v2.0 Acute - Utility Index Score CN Weights | ||
SF36436 | C185785 | SF364-Utility Index Score AU Weights | The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score Australia weights. | SF-36 v2.0 Acute - Utility Index Score AU Weights | ||
SF36437 | C185786 | SF364-Utility Index Score US Weights | The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score United States weights. | SF-36 v2.0 Acute - Utility Index Score US Weights | ||
Back to top | ||||||
CL.C101825.SF364TN | The Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire Test Name
(SF364TN) | text
Extensible: No | C101825 | The Short Form 36 Health Survey Acute, US Version 2.0 Questionnaire Test Name | The Short Form 36 Health Survey Acute, US Version 2.0 test name. | CDISC Questionnaire SF36 v2.0 Acute Test Name Terminology |
SF364-Bodily Pain 0-100 Score | C176165 | SF364-Bodily Pain 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Bodily pain 0-100 score. | SF-36 v2.0 Acute - Bodily Pain 0-100 Score | ||
SF364-Bodily Pain Norm-Based Score | C176173 | SF364-Bodily Pain Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Bodily pain norm-based score. | SF-36 v2.0 Acute - Bodily Pain Norm-Based Score | ||
SF364-Comp Week Ago Rate Gen Health Now | C102162 | SF364-Comp Week Ago Rate Gen Health Now | The Short Form 36 Health Survey Acute, US Version 2.0 - Compared to one week ago, how would you rate your health in general now? | SF-36 v2.0 Acute - Comp Week Ago Rate Gen Health Now | ||
SF364-Did You Feel Full of Life | C102183 | SF364-Did You Feel Full of Life | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel full of life. | SF-36 v2.0 Acute - Did You Feel Full of Life | ||
SF364-Did You Feel Tired | C102191 | SF364-Did You Feel Tired | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel tired. | SF-36 v2.0 Acute - Did You Feel Tired | ||
SF364-Did You Feel Worn Out | C102189 | SF364-Did You Feel Worn Out | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you feel worn out. | SF-36 v2.0 Acute - Did You Feel Worn Out | ||
SF364-Did You Have a Lot of Energy | C102187 | SF364-Did You Have a Lot of Energy | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - did you have a lot of energy. | SF-36 v2.0 Acute - Did You Have a Lot of Energy | ||
SF364-Emotional: Accomplished Less | C102178 | SF364-Emotional: Accomplished Less | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF-36 v2.0 Acute - Emotional: Accomplished Less | ||
SF364-Emotional: Cut Down Time on Work | C102177 | SF364-Emotional: Cut Down Time on Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. | SF-36 v2.0 Acute - Emotional: Cut Down Time on Work | ||
SF364-Emotional: Did Work Less Carefully | C102179 | SF364-Emotional: Did Work Less Carefully | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF-36 v2.0 Acute - Emotional: Did Work Less Carefully | ||
SF364-Extent Phys/Emotional Interfered | C102180 | SF364-Extent Phys/Emotional Interfered | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | SF-36 v2.0 Acute - Extent Phys/Emotional Interfered | ||
SF364-Felt Down Nothing Cheer You Up | C102185 | SF364-Felt Down Nothing Cheer You Up | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt so down in the dumps that nothing could cheer you up. | SF-36 v2.0 Acute - Felt Down Nothing Cheer You Up | ||
SF364-General Health 0-100 Score | C176166 | SF364-General Health 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - General health 0-100 score. | SF-36 v2.0 Acute - General Health 0-100 Score | ||
SF364-General Health Norm-Based Score | C176174 | SF364-General Health Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - General health norm-based score. | SF-36 v2.0 Acute - General Health Norm-Based Score | ||
SF364-Get Sick Little Easier Than Other | C102193 | SF364-Get Sick Little Easier Than Other | The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. | SF-36 v2.0 Acute - Get Sick Little Easier Than Other | ||
SF364-Have You Been Happy | C102190 | SF364-Have You Been Happy | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been happy. | SF-36 v2.0 Acute - Have You Been Happy | ||
SF364-Have You Been Very Nervous | C102184 | SF364-Have You Been Very Nervous | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you been very nervous. | SF-36 v2.0 Acute - Have You Been Very Nervous | ||
SF364-Have You Felt Calm and Peaceful | C102186 | SF364-Have You Felt Calm and Peaceful | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt calm and peaceful. | SF-36 v2.0 Acute - Have You Felt Calm and Peaceful | ||
SF364-How Much Bodily Pain Have You Had | C102181 | SF364-How Much Bodily Pain Have You Had | The Short Form 36 Health Survey Acute, US Version 2.0 - How much bodily pain have you had during the past week? | SF-36 v2.0 Acute - How Much Bodily Pain Have You Had | ||
SF364-I Am as Healthy as Anybody I Know | C102194 | SF364-I Am as Healthy as Anybody I Know | The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. | SF-36 v2.0 Acute - I Am as Healthy as Anybody I Know | ||
SF364-I Expect My Health to Get Worse | C102195 | SF364-I Expect My Health to Get Worse | The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. | SF-36 v2.0 Acute - I Expect My Health to Get Worse | ||
SF364-In General You Say Your Health Is | C102161 | SF364-In General You Say Your Health Is | The Short Form 36 Health Survey Acute, US Version 2.0 - In general, would you say your health is. | SF-36 v2.0 Acute - In General You Say Your Health Is | ||
SF364-Limit Bathing or Dressing Yourself | C102172 | SF364-Limit Bathing or Dressing Yourself | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - bathing or dressing yourself. | SF-36 v2.0 Acute - Limit Bathing or Dressing Yourself | ||
SF364-Limit Bending/Kneeling/Stooping | C102168 | SF364-Limit Bending/Kneeling/Stooping | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - bending, kneeling, or stooping. | SF-36 v2.0 Acute - Limit Bending/Kneeling/Stooping | ||
SF364-Limit Climbing One Flight Stairs | C102167 | SF364-Limit Climbing One Flight Stairs | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing one flight of stairs. | SF-36 v2.0 Acute - Limit Climbing One Flight Stairs | ||
SF364-Limit Climbing Several Flights | C102166 | SF364-Limit Climbing Several Flights | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. | SF-36 v2.0 Acute - Limit Climbing Several Flights | ||
SF364-Limit Lifting or Carrying | C102165 | SF364-Limit Lifting or Carrying | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - lifting or carrying groceries. | SF-36 v2.0 Acute - Limit Lifting or Carrying | ||
SF364-Limit Moderate Activities | C102164 | SF364-Limit Moderate Activities | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF-36 v2.0 Acute - Limit Moderate Activities | ||
SF364-Limit Vigorous Activities | C102163 | SF364-Limit Vigorous Activities | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | SF-36 v2.0 Acute - Limit Vigorous Activities | ||
SF364-Limit Walking More Than a Mile | C102169 | SF364-Limit Walking More Than a Mile | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking more than a mile. | SF-36 v2.0 Acute - Limit Walking More Than a Mile | ||
SF364-Limit Walking One Hundred Yards | C102171 | SF364-Limit Walking One Hundred Yards | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking one hundred yards. | SF-36 v2.0 Acute - Limit Walking One Hundred Yards | ||
SF364-Limit Walking Several Hundred Yds | C102170 | SF364-Limit Walking Several Hundred Yds | The Short Form 36 Health Survey Acute, US Version 2.0 - How much does your health now limit you in - walking several hundred yards. | SF-36 v2.0 Acute - Limit Walking Several Hundred Yds | ||
SF364-Mental Component Score | C176180 | SF364-Mental Component Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Mental component score. | SF-36 v2.0 Acute - Mental Component Score | ||
SF364-Mental Health 0-100 Score | C176170 | SF364-Mental Health 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health 0-100 score. | SF-36 v2.0 Acute - Mental Health 0-100 Score | ||
SF364-Mental Health Enhanced Score | C176183 | SF364-Mental Health Enhanced Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health enhanced score. | SF-36 v2.0 Acute - Mental Health Enhanced Score | ||
SF364-Mental Health Norm-Based Score | C176178 | SF364-Mental Health Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Mental health norm-based score. | SF-36 v2.0 Acute - Mental Health Norm-Based Score | ||
SF364-My Health is Excellent | C102196 | SF364-My Health is Excellent | The Short Form 36 Health Survey Acute, US Version 2.0 - How TRUE or FALSE is the following statement for you - my health is excellent | SF-36 v2.0 Acute - My Health is Excellent | ||
SF364-Pain Interfere With Normal Work | C102182 | SF364-Pain Interfere With Normal Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF-36 v2.0 Acute - Pain Interfere With Normal Work | ||
SF364-Phys Functioning Norm-Based Score | C176171 | SF364-Phys Functioning Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Phys functioning norm-based score. | SF-36 v2.0 Acute - Phys Functioning Norm-Based Score | ||
SF364-Physical Component Score | C176179 | SF364-Physical Component Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Physical component score. | SF-36 v2.0 Acute - Physical Component Score | ||
SF364-Physical Functioning 0-100 Score | C176163 | SF364-Physical Functioning 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Physical functioning 0-100 score. | SF-36 v2.0 Acute - Physical Functioning 0-100 Score | ||
SF364-Physical: Accomplished Less | C102174 | SF364-Physical: Accomplished Less | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF-36 v2.0 Acute - Physical: Accomplished Less | ||
SF364-Physical: Cut Down Time on Work | C102173 | SF364-Physical: Cut Down Time on Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. | SF-36 v2.0 Acute - Physical: Cut Down Time on Work | ||
SF364-Physical: Difficulty Perform Work | C102176 | SF364-Physical: Difficulty Perform Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). | SF-36 v2.0 Acute - Physical: Difficulty Perform Work | ||
SF364-Physical: Limited Kind of Work | C102175 | SF364-Physical: Limited Kind of Work | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF-36 v2.0 Acute - Physical: Limited Kind of Work | ||
SF364-Response Consistency Score | C180247 | SF364-Response Consistency Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Response consistency score. | SF-36 v2.0 Acute - Response Consistency Score | ||
SF364-Role Emotional 0-100 Score | C176169 | SF364-Role Emotional 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Role emotional 0-100 score. | SF-36 v2.0 Acute - Role Emotional 0-100 Score | ||
SF364-Role Emotional Norm-Based Score | C176177 | SF364-Role Emotional Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Role emotional norm-based score. | SF-36 v2.0 Acute - Role Emotional Norm-Based Score | ||
SF364-Role Physical 0-100 Score | C176164 | SF364-Role Physical 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Role physical 0-100 score. | SF-36 v2.0 Acute - Role Physical 0-100 Score | ||
SF364-Role Physical Norm-Based Score | C176172 | SF364-Role Physical Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Role physical norm-based score. | SF-36 v2.0 Acute - Role Physical Norm-Based Score | ||
SF364-SF-6D (Utility Index) Score | C176181 | SF364-SF-6D (Utility Index) Score | The Short Form 36 Health Survey Acute, US Version 2.0 - 6D (utility index) score. | SF-36 v2.0 Acute - SF-6D (Utility Index) Score | ||
SF364-SF-6D_R2 (Util Index Rel 2) Score | C176182 | SF364-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 36 Health Survey Acute, US Version 2.0 - 6D_R2 (util index rel 2) score. | SF-36 v2.0 Acute - SF-6D_R2 (Util Index Rel 2) Score | ||
SF364-Social Function Norm-Based Score | C176176 | SF364-Social Function Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Social function norm-based score. | SF-36 v2.0 Acute - Social Function Norm-Based Score | ||
SF364-Social Functioning 0-100 Score | C176168 | SF364-Social Functioning 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Social functioning 0-100 score. | SF-36 v2.0 Acute - Social Functioning 0-100 Score | ||
SF364-Time Phys/Emotional Interfered | C102192 | SF364-Time Phys/Emotional Interfered | The Short Form 36 Health Survey Acute, US Version 2.0 - During the past week, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF-36 v2.0 Acute - Time Phys/Emotional Interfered | ||
SF364-Utility Index Score AU Weights | C185785 | SF364-Utility Index Score AU Weights | The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score Australia weights. | SF-36 v2.0 Acute - Utility Index Score AU Weights | ||
SF364-Utility Index Score CN Weights | C185784 | SF364-Utility Index Score CN Weights | The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score Canada weights. | SF-36 v2.0 Acute - Utility Index Score CN Weights | ||
SF364-Utility Index Score UK Weights | C185783 | SF364-Utility Index Score UK Weights | The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score United Kingdom weights. | SF-36 v2.0 Acute - Utility Index Score UK Weights | ||
SF364-Utility Index Score US Weights | C185786 | SF364-Utility Index Score US Weights | The Short Form 36 Health Survey Acute, US Version 2.0 - Utility index score United States weights. | SF-36 v2.0 Acute - Utility Index Score US Weights | ||
SF364-Vitality 0-100 Score | C176167 | SF364-Vitality 0-100 Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Vitality 0-100 score. | SF-36 v2.0 Acute - Vitality 0-100 Score | ||
SF364-Vitality Norm-Based Score | C176175 | SF364-Vitality Norm-Based Score | The Short Form 36 Health Survey Acute, US Version 2.0 - Vitality norm-based score. | SF-36 v2.0 Acute - Vitality Norm-Based Score | ||
SF364-You Felt Downhearted and Depressed | C102188 | SF364-You Felt Downhearted and Depressed | The Short Form 36 Health Survey Acute, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past week - have you felt downhearted and depressed. | SF-36 v2.0 Acute - You Felt Downhearted and Depressed | ||
Back to top | ||||||
CL.C100174.SF361TC | The Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire Test Code
(SF361TC) | text
Extensible: No | C100174 | The Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire Test Code | The Short Form 36 Health Survey Standard, US Version 1.0 test code. | CDISC Questionnaire SF36 v1.0 Standard Test Code Terminology |
SF36101 | C100813 | SF361-In General You Say Your Health Is | The Short Form 36 Health Survey Standard, US Version 1.0 - In general, would you say your health is. | SF36 v1.0 Standard - In General You Say Your Health Is | ||
SF36102 | C100814 | SF361-Comp Year Ago Rate Gen Health Now | The Short Form 36 Health Survey Standard, US Version 1.0 - Compared to one year ago, how would you rate your health in general now? | SF36 v1.0 Standard - Comp Year Ago Rate Gen Health Now | ||
SF36103A | C100815 | SF361-Limit Vigorous Activities | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | SF36 v1.0 Standard - Limit Vigorous Activities | ||
SF36103B | C100816 | SF361-Limit Moderate Activities | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF36 v1.0 Standard - Limit Moderate Activities | ||
SF36103C | C100817 | SF361-Limit Lifting or Carrying | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - lifting or carrying groceries. | SF36 v1.0 Standard - Limit Lifting or Carrying | ||
SF36103D | C100818 | SF361-Limit Climbing Several Flights | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. | SF36 v1.0 Standard - Limit Climbing Several Flights | ||
SF36103E | C100819 | SF361-Limit Climbing One Flight Stairs | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing one flight of stairs. | SF36 v1.0 Standard - Limit Climbing One Flight Stairs | ||
SF36103F | C100820 | SF361-Limit Bending/Kneeling/Stooping | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - bending, kneeling, or stooping. | SF36 v1.0 Standard - Limit Bending/Kneeling/Stooping | ||
SF36103G | C100821 | SF361-Limit Walking More Than a Mile | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking more than a mile. | SF36 v1.0 Standard - Limit Walking More Than a Mile | ||
SF36103H | C100822 | SF361-Limit Walking Several Blocks | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking several blocks. | SF36 v1.0 Standard - Limit Walking Several Blocks | ||
SF36103I | C100823 | SF361-Limit Walking One Block | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking one block. | SF36 v1.0 Standard - Limit Walking One Block | ||
SF36103J | C100824 | SF361-Limit Bathing or Dressing Yourself | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - bathing or dressing yourself. | SF36 v1.0 Standard - Limit Bathing or Dressing Yourself | ||
SF36104A | C100825 | SF361-Physical: Cut Down Time on Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. | SF36 v1.0 Standard - Physical: Cut Down Time on Work | ||
SF36104B | C100826 | SF361-Physical: Accomplished Less | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF36 v1.0 Standard - Physical: Accomplished Less | ||
SF36104C | C100827 | SF361-Physical: Limited Kind of Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF36 v1.0 Standard - Physical: Limited Kind of Work | ||
SF36104D | C100828 | SF361-Physical: Difficulty Perform Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). | SF36 v1.0 Standard - Physical: Difficulty Perform Work | ||
SF36105A | C100829 | SF361-Emotional: Cut Down Time on Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. | SF36 v1.0 Standard - Emotional: Cut Down Time on Work | ||
SF36105B | C100830 | SF361-Emotional: Accomplished Less | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF36 v1.0 Standard - Emotional: Accomplished Less | ||
SF36105C | C100831 | SF361-Emotional: Did Work Less Carefully | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF36 v1.0 Standard - Emotional: Did Work Less Carefully | ||
SF36106 | C100832 | SF361-Extent Phys/Emotional Interfered | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | SF36 v1.0 Standard - Extent Phys/Emotional Interfered | ||
SF36107 | C100833 | SF361-How Much Bodily Pain Have You Had | The Short Form 36 Health Survey Standard, US Version 1.0 - How much bodily pain have you had during the past 4 weeks? | SF36 v1.0 Standard - How Much Bodily Pain Have You Had | ||
SF36108 | C100834 | SF361-Pain Interfere With Normal Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF36 v1.0 Standard - Pain Interfere With Normal Work | ||
SF36109A | C100835 | SF361-Did You Feel Full of Pep | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel full of pep. | SF36 v1.0 Standard - Did You Feel Full of Pep | ||
SF36109B | C100836 | SF361-Have You Been Very Nervous Person | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been a very nervous person. | SF36 v1.0 Standard - Have You Been Very Nervous Person | ||
SF36109C | C100837 | SF361-Felt Down Nothing Cheer You Up | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt so down in the dumps that nothing could cheer you up. | SF36 v1.0 Standard - Felt Down Nothing Cheer You Up | ||
SF36109D | C100838 | SF361-Have You Felt Calm and Peaceful | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful. | SF36 v1.0 Standard - Have You Felt Calm and Peaceful | ||
SF36109E | C100839 | SF361-Did You Have a Lot of Energy | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy. | SF36 v1.0 Standard - Did You Have a Lot of Energy | ||
SF36109F | C100840 | SF361-You Felt Downhearted and Blue | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and blue. | SF36 v1.0 Standard - You Felt Downhearted and Blue | ||
SF36109G | C100841 | SF361-Did You Feel Worn Out | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel worn out. | SF36 v1.0 Standard - Did You Feel Worn Out | ||
SF36109H | C100842 | SF361-Have You Been Happy Person | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been a happy person. | SF36 v1.0 Standard - Have You Been Happy Person | ||
SF36109I | C100843 | SF361-Did You Feel Tired | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel tired. | SF36 v1.0 Standard - Did You Feel Tired | ||
SF36110 | C100844 | SF361-Time Phys/Emotional Interfered | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF36 v1.0 Standard - Time Phys/Emotional Interfered | ||
SF36111A | C100845 | SF361-Get Sick Little Easier Than Other | The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. | SF36 v1.0 Standard - Get Sick Little Easier Than Other | ||
SF36111B | C100846 | SF361-I Am as Healthy as Anybody I Know | The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. | SF36 v1.0 Standard - I Am as Healthy as Anybody I Know | ||
SF36111C | C100847 | SF361-I Expect My Health to Get Worse | The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. | SF36 v1.0 Standard - I Expect My Health to Get Worse | ||
SF36111D | C100848 | SF361-My Health is Excellent | The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - my health is excellent | SF36 v1.0 Standard - My Health is Excellent | ||
SF36112 | C176142 | SF361-Physical Functioning 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Physical functioning 0-100 score. | SF36 v1.0 Standard - Physical Functioning 0-100 Score | ||
SF36113 | C176143 | SF361-Role Physical 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Role physical 0-100 score. | SF36 v1.0 Standard - Role Physical 0-100 Score | ||
SF36114 | C176144 | SF361-Bodily Pain 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Bodily pain 0-100 score. | SF36 v1.0 Standard - Bodily Pain 0-100 Score | ||
SF36115 | C176145 | SF361-General Health 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - General health 0-100 score. | SF36 v1.0 Standard - General Health 0-100 Score | ||
SF36116 | C176146 | SF361-Vitality 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Vitality 0-100 score. | SF36 v1.0 Standard - Vitality 0-100 Score | ||
SF36117 | C176147 | SF361-Social Functioning 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Social functioning 0-100 score. | SF36 v1.0 Standard - Social Functioning 0-100 Score | ||
SF36118 | C176148 | SF361-Role Emotional 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Role emotional 0-100 score. | SF36 v1.0 Standard - Role Emotional 0-100 Score | ||
SF36119 | C176149 | SF361-Mental Health 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Mental health 0-100 score. | SF36 v1.0 Standard - Mental Health 0-100 Score | ||
SF36120 | C176150 | SF361-Phys Functioning Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Phys functioning norm-based score. | SF36 v1.0 Standard - Phys Functioning Norm-Based Score | ||
SF36121 | C176151 | SF361-Role Physical Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Role physical norm-based score. | SF36 v1.0 Standard - Role Physical Norm-Based Score | ||
SF36122 | C176152 | SF361-Bodily Pain Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Bodily pain norm-based score. | SF36 v1.0 Standard - Bodily Pain Norm-Based Score | ||
SF36123 | C176153 | SF361-General Health Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - General health norm-based score. | SF36 v1.0 Standard - General Health Norm-Based Score | ||
SF36124 | C176154 | SF361-Vitality Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Vitality norm-based score. | SF36 v1.0 Standard - Vitality Norm-Based Score | ||
SF36125 | C176155 | SF361-Social Function Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Social function norm-based score. | SF36 v1.0 Standard - Social Function Norm-Based Score | ||
SF36126 | C176156 | SF361-Role Emotional Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Role emotional norm-based score. | SF36 v1.0 Standard - Role Emotional Norm-Based Score | ||
SF36127 | C176157 | SF361-Mental Health Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Mental health norm-based score. | SF36 v1.0 Standard - Mental Health Norm-Based Score | ||
SF36128 | C176158 | SF361-Physical Component Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Physical component score. | SF36 v1.0 Standard - Physical Component Score | ||
SF36129 | C176159 | SF361-Mental Component Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Mental component score. | SF36 v1.0 Standard - Mental Component Score | ||
SF36130 | C176160 | SF361-SF-6D (Utility Index) Score | The Short Form 36 Health Survey Standard, US Version 1.0 - 6D (utility index) score. | SF36 v1.0 Standard - SF-6D (Utility Index) Score | ||
SF36131 | C176161 | SF361-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 36 Health Survey Standard, US Version 1.0 - 6D_R2 (util index rel 2) score. | SF36 v1.0 Standard - SF-6D_R2 (Util Index Rel 2) Score | ||
SF36132 | C176162 | SF361-Response Consistency Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Response consistency score. | SF36 v1.0 Standard - Response Consistency Score | ||
Back to top | ||||||
CL.C100173.SF361TN | The Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire Test Name
(SF361TN) | text
Extensible: No | C100173 | The Short Form 36 Health Survey Standard, US Version 1.0 Questionnaire Test Name | The Short Form 36 Health Survey Standard, US Version 1.0 test name. | CDISC Questionnaire SF36 v1.0 Standard Test Name Terminology |
SF361-Bodily Pain 0-100 Score | C176144 | SF361-Bodily Pain 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Bodily pain 0-100 score. | SF36 v1.0 Standard - Bodily Pain 0-100 Score | ||
SF361-Bodily Pain Norm-Based Score | C176152 | SF361-Bodily Pain Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Bodily pain norm-based score. | SF36 v1.0 Standard - Bodily Pain Norm-Based Score | ||
SF361-Comp Year Ago Rate Gen Health Now | C100814 | SF361-Comp Year Ago Rate Gen Health Now | The Short Form 36 Health Survey Standard, US Version 1.0 - Compared to one year ago, how would you rate your health in general now? | SF36 v1.0 Standard - Comp Year Ago Rate Gen Health Now | ||
SF361-Did You Feel Full of Pep | C100835 | SF361-Did You Feel Full of Pep | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel full of pep. | SF36 v1.0 Standard - Did You Feel Full of Pep | ||
SF361-Did You Feel Tired | C100843 | SF361-Did You Feel Tired | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel tired. | SF36 v1.0 Standard - Did You Feel Tired | ||
SF361-Did You Feel Worn Out | C100841 | SF361-Did You Feel Worn Out | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel worn out. | SF36 v1.0 Standard - Did You Feel Worn Out | ||
SF361-Did You Have a Lot of Energy | C100839 | SF361-Did You Have a Lot of Energy | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy. | SF36 v1.0 Standard - Did You Have a Lot of Energy | ||
SF361-Emotional: Accomplished Less | C100830 | SF361-Emotional: Accomplished Less | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF36 v1.0 Standard - Emotional: Accomplished Less | ||
SF361-Emotional: Cut Down Time on Work | C100829 | SF361-Emotional: Cut Down Time on Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. | SF36 v1.0 Standard - Emotional: Cut Down Time on Work | ||
SF361-Emotional: Did Work Less Carefully | C100831 | SF361-Emotional: Did Work Less Carefully | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF36 v1.0 Standard - Emotional: Did Work Less Carefully | ||
SF361-Extent Phys/Emotional Interfered | C100832 | SF361-Extent Phys/Emotional Interfered | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | SF36 v1.0 Standard - Extent Phys/Emotional Interfered | ||
SF361-Felt Down Nothing Cheer You Up | C100837 | SF361-Felt Down Nothing Cheer You Up | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt so down in the dumps that nothing could cheer you up. | SF36 v1.0 Standard - Felt Down Nothing Cheer You Up | ||
SF361-General Health 0-100 Score | C176145 | SF361-General Health 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - General health 0-100 score. | SF36 v1.0 Standard - General Health 0-100 Score | ||
SF361-General Health Norm-Based Score | C176153 | SF361-General Health Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - General health norm-based score. | SF36 v1.0 Standard - General Health Norm-Based Score | ||
SF361-Get Sick Little Easier Than Other | C100845 | SF361-Get Sick Little Easier Than Other | The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. | SF36 v1.0 Standard - Get Sick Little Easier Than Other | ||
SF361-Have You Been Happy Person | C100842 | SF361-Have You Been Happy Person | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been a happy person. | SF36 v1.0 Standard - Have You Been Happy Person | ||
SF361-Have You Been Very Nervous Person | C100836 | SF361-Have You Been Very Nervous Person | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been a very nervous person. | SF36 v1.0 Standard - Have You Been Very Nervous Person | ||
SF361-Have You Felt Calm and Peaceful | C100838 | SF361-Have You Felt Calm and Peaceful | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful. | SF36 v1.0 Standard - Have You Felt Calm and Peaceful | ||
SF361-How Much Bodily Pain Have You Had | C100833 | SF361-How Much Bodily Pain Have You Had | The Short Form 36 Health Survey Standard, US Version 1.0 - How much bodily pain have you had during the past 4 weeks? | SF36 v1.0 Standard - How Much Bodily Pain Have You Had | ||
SF361-I Am as Healthy as Anybody I Know | C100846 | SF361-I Am as Healthy as Anybody I Know | The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. | SF36 v1.0 Standard - I Am as Healthy as Anybody I Know | ||
SF361-I Expect My Health to Get Worse | C100847 | SF361-I Expect My Health to Get Worse | The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. | SF36 v1.0 Standard - I Expect My Health to Get Worse | ||
SF361-In General You Say Your Health Is | C100813 | SF361-In General You Say Your Health Is | The Short Form 36 Health Survey Standard, US Version 1.0 - In general, would you say your health is. | SF36 v1.0 Standard - In General You Say Your Health Is | ||
SF361-Limit Bathing or Dressing Yourself | C100824 | SF361-Limit Bathing or Dressing Yourself | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - bathing or dressing yourself. | SF36 v1.0 Standard - Limit Bathing or Dressing Yourself | ||
SF361-Limit Bending/Kneeling/Stooping | C100820 | SF361-Limit Bending/Kneeling/Stooping | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - bending, kneeling, or stooping. | SF36 v1.0 Standard - Limit Bending/Kneeling/Stooping | ||
SF361-Limit Climbing One Flight Stairs | C100819 | SF361-Limit Climbing One Flight Stairs | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing one flight of stairs. | SF36 v1.0 Standard - Limit Climbing One Flight Stairs | ||
SF361-Limit Climbing Several Flights | C100818 | SF361-Limit Climbing Several Flights | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - climbing several flights of stairs. | SF36 v1.0 Standard - Limit Climbing Several Flights | ||
SF361-Limit Lifting or Carrying | C100817 | SF361-Limit Lifting or Carrying | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - lifting or carrying groceries. | SF36 v1.0 Standard - Limit Lifting or Carrying | ||
SF361-Limit Moderate Activities | C100816 | SF361-Limit Moderate Activities | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF36 v1.0 Standard - Limit Moderate Activities | ||
SF361-Limit Vigorous Activities | C100815 | SF361-Limit Vigorous Activities | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | SF36 v1.0 Standard - Limit Vigorous Activities | ||
SF361-Limit Walking More Than a Mile | C100821 | SF361-Limit Walking More Than a Mile | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking more than a mile. | SF36 v1.0 Standard - Limit Walking More Than a Mile | ||
SF361-Limit Walking One Block | C100823 | SF361-Limit Walking One Block | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking one block. | SF36 v1.0 Standard - Limit Walking One Block | ||
SF361-Limit Walking Several Blocks | C100822 | SF361-Limit Walking Several Blocks | The Short Form 36 Health Survey Standard, US Version 1.0 - How much does your health now limit you in - walking several blocks. | SF36 v1.0 Standard - Limit Walking Several Blocks | ||
SF361-Mental Component Score | C176159 | SF361-Mental Component Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Mental component score. | SF36 v1.0 Standard - Mental Component Score | ||
SF361-Mental Health 0-100 Score | C176149 | SF361-Mental Health 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Mental health 0-100 score. | SF36 v1.0 Standard - Mental Health 0-100 Score | ||
SF361-Mental Health Norm-Based Score | C176157 | SF361-Mental Health Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Mental health norm-based score. | SF36 v1.0 Standard - Mental Health Norm-Based Score | ||
SF361-My Health is Excellent | C100848 | SF361-My Health is Excellent | The Short Form 36 Health Survey Standard, US Version 1.0 - How TRUE or FALSE is the following statement for you - my health is excellent | SF36 v1.0 Standard - My Health is Excellent | ||
SF361-Pain Interfere With Normal Work | C100834 | SF361-Pain Interfere With Normal Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF36 v1.0 Standard - Pain Interfere With Normal Work | ||
SF361-Phys Functioning Norm-Based Score | C176150 | SF361-Phys Functioning Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Phys functioning norm-based score. | SF36 v1.0 Standard - Phys Functioning Norm-Based Score | ||
SF361-Physical Component Score | C176158 | SF361-Physical Component Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Physical component score. | SF36 v1.0 Standard - Physical Component Score | ||
SF361-Physical Functioning 0-100 Score | C176142 | SF361-Physical Functioning 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Physical functioning 0-100 score. | SF36 v1.0 Standard - Physical Functioning 0-100 Score | ||
SF361-Physical: Accomplished Less | C100826 | SF361-Physical: Accomplished Less | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF36 v1.0 Standard - Physical: Accomplished Less | ||
SF361-Physical: Cut Down Time on Work | C100825 | SF361-Physical: Cut Down Time on Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. | SF36 v1.0 Standard - Physical: Cut Down Time on Work | ||
SF361-Physical: Difficulty Perform Work | C100828 | SF361-Physical: Difficulty Perform Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). | SF36 v1.0 Standard - Physical: Difficulty Perform Work | ||
SF361-Physical: Limited Kind of Work | C100827 | SF361-Physical: Limited Kind of Work | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF36 v1.0 Standard - Physical: Limited Kind of Work | ||
SF361-Response Consistency Score | C176162 | SF361-Response Consistency Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Response consistency score. | SF36 v1.0 Standard - Response Consistency Score | ||
SF361-Role Emotional 0-100 Score | C176148 | SF361-Role Emotional 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Role emotional 0-100 score. | SF36 v1.0 Standard - Role Emotional 0-100 Score | ||
SF361-Role Emotional Norm-Based Score | C176156 | SF361-Role Emotional Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Role emotional norm-based score. | SF36 v1.0 Standard - Role Emotional Norm-Based Score | ||
SF361-Role Physical 0-100 Score | C176143 | SF361-Role Physical 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Role physical 0-100 score. | SF36 v1.0 Standard - Role Physical 0-100 Score | ||
SF361-Role Physical Norm-Based Score | C176151 | SF361-Role Physical Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Role physical norm-based score. | SF36 v1.0 Standard - Role Physical Norm-Based Score | ||
SF361-SF-6D (Utility Index) Score | C176160 | SF361-SF-6D (Utility Index) Score | The Short Form 36 Health Survey Standard, US Version 1.0 - 6D (utility index) score. | SF36 v1.0 Standard - SF-6D (Utility Index) Score | ||
SF361-SF-6D_R2 (Util Index Rel 2) Score | C176161 | SF361-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 36 Health Survey Standard, US Version 1.0 - 6D_R2 (util index rel 2) score. | SF36 v1.0 Standard - SF-6D_R2 (Util Index Rel 2) Score | ||
SF361-Social Function Norm-Based Score | C176155 | SF361-Social Function Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Social function norm-based score. | SF36 v1.0 Standard - Social Function Norm-Based Score | ||
SF361-Social Functioning 0-100 Score | C176147 | SF361-Social Functioning 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Social functioning 0-100 score. | SF36 v1.0 Standard - Social Functioning 0-100 Score | ||
SF361-Time Phys/Emotional Interfered | C100844 | SF361-Time Phys/Emotional Interfered | The Short Form 36 Health Survey Standard, US Version 1.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF36 v1.0 Standard - Time Phys/Emotional Interfered | ||
SF361-Vitality 0-100 Score | C176146 | SF361-Vitality 0-100 Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Vitality 0-100 score. | SF36 v1.0 Standard - Vitality 0-100 Score | ||
SF361-Vitality Norm-Based Score | C176154 | SF361-Vitality Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 1.0 - Vitality norm-based score. | SF36 v1.0 Standard - Vitality Norm-Based Score | ||
SF361-You Felt Downhearted and Blue | C100840 | SF361-You Felt Downhearted and Blue | The Short Form 36 Health Survey Standard, US Version 1.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and blue. | SF36 v1.0 Standard - You Felt Downhearted and Blue | ||
Back to top | ||||||
CL.C101826.SF363TC | The Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire Test Code
(SF363TC) | text
Extensible: No | C101826 | The Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire Test Code | The Short Form 36 Health Survey Standard, US Version 2.0 test code. | CDISC Questionnaire SF36 v2.0 Standard Test Code Terminology |
SF36301 | C102197 | SF363-In General You Say Your Health Is | The Short Form 36 Health Survey Standard, US Version 2.0 - In general, would you say your health is. | SF-36 v2.0 Standard - In General You Say Your Health Is | ||
SF36302 | C102198 | SF363-Comp Year Ago Rate Gen Health Now | The Short Form 36 Health Survey Standard, US Version 2.0 - Compared to one year ago, how would you rate your health in general now? | SF-36 v2.0 Standard - Comp Year Ago Rate Gen Health Now | ||
SF36303A | C102199 | SF363-Limit Vigorous Activities | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | SF-36 v2.0 Standard - Limit Vigorous Activities | ||
SF36303B | C102200 | SF363-Limit Moderate Activities | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF-36 v2.0 Standard - Limit Moderate Activities | ||
SF36303C | C102201 | SF363-Limit Lifting or Carrying | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - lifting or carrying groceries. | SF-36 v2.0 Standard - Limit Lifting or Carrying | ||
SF36303D | C102202 | SF363-Limit Climbing Several Flights | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. | SF-36 v2.0 Standard - Limit Climbing Several Flights | ||
SF36303E | C102203 | SF363-Limit Climbing One Flight Stairs | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing one flight of stairs. | SF-36 v2.0 Standard - Limit Climbing One Flight Stairs | ||
SF36303F | C102204 | SF363-Limit Bending/Kneeling/Stooping | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - bending, kneeling, or stooping. | SF-36 v2.0 Standard - Limit Bending/Kneeling/Stooping | ||
SF36303G | C102205 | SF363-Limit Walking More Than a Mile | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking more than a mile. | SF-36 v2.0 Standard - Limit Walking More Than a Mile | ||
SF36303H | C102206 | SF363-Limit Walking Several Hundred Yds | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking several hundred yards. | SF-36 v2.0 Standard - Limit Walking Several Hundred Yds | ||
SF36303I | C102207 | SF363-Limit Walking One Hundred Yards | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking one hundred yards. | SF-36 v2.0 Standard - Limit Walking One Hundred Yards | ||
SF36303J | C102208 | SF363-Limit Bathing or Dressing Yourself | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - bathing or dressing yourself. | SF-36 v2.0 Standard - Limit Bathing or Dressing Yourself | ||
SF36304A | C102209 | SF363-Physical: Cut Down Time on Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. | SF-36 v2.0 Standard - Physical: Cut Down Time on Work | ||
SF36304B | C102210 | SF363-Physical: Accomplished Less | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF-36 v2.0 Standard - Physical: Accomplished Less | ||
SF36304C | C102211 | SF363-Physical: Limited Kind of Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF-36 v2.0 Standard - Physical: Limited Kind of Work | ||
SF36304D | C102212 | SF363-Physical: Difficulty Perform Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). | SF-36 v2.0 Standard - Physical: Difficulty Perform Work | ||
SF36305A | C102213 | SF363-Emotional: Cut Down Time on Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. | SF-36 v2.0 Standard - Emotional: Cut Down Time on Work | ||
SF36305B | C102214 | SF363-Emotional: Accomplished Less | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF-36 v2.0 Standard - Emotional: Accomplished Less | ||
SF36305C | C102215 | SF363-Emotional: Did Work Less Carefully | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF-36 v2.0 Standard - Emotional: Did Work Less Carefully | ||
SF36306 | C102216 | SF363-Extent Phys/Emotional Interfered | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | SF-36 v2.0 Standard - Extent Phys/Emotional Interfered | ||
SF36307 | C102217 | SF363-How Much Bodily Pain Have You Had | The Short Form 36 Health Survey Standard, US Version 2.0 - How much bodily pain have you had during the past 4 weeks? | SF-36 v2.0 Standard - How Much Bodily Pain Have You Had | ||
SF36308 | C102218 | SF363-Pain Interfere With Normal Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF-36 v2.0 Standard - Pain Interfere With Normal Work | ||
SF36309A | C102219 | SF363-Did You Feel Full of Life | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel full of life. | SF-36 v2.0 Standard - Did You Feel Full of Life | ||
SF36309B | C102220 | SF363-Have You Been Very Nervous | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been very nervous. | SF-36 v2.0 Standard - Have You Been Very Nervous | ||
SF36309C | C102221 | SF363-Felt Down Nothing Cheer You Up | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt so down in the dumps that nothing could cheer you up. | SF-36 v2.0 Standard - Felt Down Nothing Cheer You Up | ||
SF36309D | C102222 | SF363-Have You Felt Calm and Peaceful | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful. | SF-36 v2.0 Standard - Have You Felt Calm and Peaceful | ||
SF36309E | C102223 | SF363-Did You Have a Lot of Energy | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy. | SF-36 v2.0 Standard - Did You Have a Lot of Energy | ||
SF36309F | C102224 | SF363-You Felt Downhearted and Depressed | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and depressed. | SF-36 v2.0 Standard - You Felt Downhearted and Depressed | ||
SF36309G | C102225 | SF363-Did You Feel Worn Out | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel worn out. | SF-36 v2.0 Standard - Did You Feel Worn Out | ||
SF36309H | C102226 | SF363-Have You Been Happy | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been happy. | SF-36 v2.0 Standard - Have You Been Happy | ||
SF36309I | C102227 | SF363-Did You Feel Tired | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel tired. | SF-36 v2.0 Standard - Did You Feel Tired | ||
SF36310 | C102228 | SF363-Time Phys/Emotional Interfered | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF-36 v2.0 Standard - Time Phys/Emotional Interfered | ||
SF36311A | C102229 | SF363-Get Sick Little Easier Than Other | The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. | SF-36 v2.0 Standard - Get Sick Little Easier Than Other | ||
SF36311B | C102230 | SF363-I Am as Healthy as Anybody I Know | The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. | SF-36 v2.0 Standard - I Am as Healthy as Anybody I Know | ||
SF36311C | C102231 | SF363-I Expect My Health to Get Worse | The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. | SF-36 v2.0 Standard - I Expect My Health to Get Worse | ||
SF36311D | C102232 | SF363-My Health is Excellent | The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - my health is excellent | SF-36 v2.0 Standard - My Health is Excellent | ||
SF36312 | C176184 | SF363-Physical Functioning 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Physical functioning 0-100 score. | SF-36 v2.0 Standard - Physical Functioning 0-100 Score | ||
SF36313 | C176185 | SF363-Role Physical 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Role physical 0-100 score. | SF-36 v2.0 Standard - Role Physical 0-100 Score | ||
SF36314 | C176186 | SF363-Bodily Pain 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Bodily pain 0-100 score. | SF-36 v2.0 Standard - Bodily Pain 0-100 Score | ||
SF36315 | C176187 | SF363-General Health 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - General health 0-100 score. | SF-36 v2.0 Standard - General Health 0-100 Score | ||
SF36316 | C176188 | SF363-Vitality 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Vitality 0-100 score. | SF-36 v2.0 Standard - Vitality 0-100 Score | ||
SF36317 | C176189 | SF363-Social Functioning 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Social functioning 0-100 score. | SF-36 v2.0 Standard - Social Functioning 0-100 Score | ||
SF36318 | C176190 | SF363-Role Emotional 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Role emotional 0-100 score. | SF-36 v2.0 Standard - Role Emotional 0-100 Score | ||
SF36319 | C176191 | SF363-Mental Health 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health 0-100 score. | SF-36 v2.0 Standard - Mental Health 0-100 Score | ||
SF36320 | C176192 | SF363-Phys Functioning Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Phys functioning norm-based score. | SF-36 v2.0 Standard - Phys Functioning Norm-Based Score | ||
SF36321 | C176193 | SF363-Role Physical Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Role physical norm-based score. | SF-36 v2.0 Standard - Role Physical Norm-Based Score | ||
SF36322 | C176194 | SF363-Bodily Pain Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Bodily pain norm-based score. | SF-36 v2.0 Standard - Bodily Pain Norm-Based Score | ||
SF36323 | C176195 | SF363-General Health Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - General health norm-based score. | SF-36 v2.0 Standard - General Health Norm-Based Score | ||
SF36324 | C176196 | SF363-Vitality Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Vitality norm-based score. | SF-36 v2.0 Standard - Vitality Norm-Based Score | ||
SF36325 | C176197 | SF363-Social Function Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Social function norm-based score. | SF-36 v2.0 Standard - Social Function Norm-Based Score | ||
SF36326 | C176198 | SF363-Role Emotional Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Role emotional norm-based score. | SF-36 v2.0 Standard - Role Emotional Norm-Based Score | ||
SF36327 | C176199 | SF363-Mental Health Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health norm-based score. | SF-36 v2.0 Standard - Mental Health Norm-Based Score | ||
SF36328 | C176200 | SF363-Physical Component Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Physical component score. | SF-36 v2.0 Standard - Physical Component Score | ||
SF36329 | C176201 | SF363-Mental Component Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Mental component score. | SF-36 v2.0 Standard - Mental Component Score | ||
SF36330 | C176202 | SF363-SF-6D (Utility Index) Score | The Short Form 36 Health Survey Standard, US Version 2.0 - 6D (utility index) score. | SF-36 v2.0 Standard - SF-6D (Utility Index) Score | ||
SF36331 | C176203 | SF363-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 36 Health Survey Standard, US Version 2.0 - 6D_R2 (util index rel 2) score. | SF-36 v2.0 Standard - SF-6D_R2 (Util Index Rel 2) Score | ||
SF36332 | C176204 | SF363-Mental Health Enhanced Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health enhanced score. | SF-36 v2.0 Standard - Mental Health Enhanced Score | ||
SF36333 | C180248 | SF363-Response Consistency Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Response consistency score. | SF-36 v2.0 Standard - Response Consistency Score | ||
SF36334 | C185787 | SF363-Utility Index Score UK Weights | The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score United Kingdom weights. | SF-36 v2.0 Standard - Utility Index Score UK Weights | ||
SF36335 | C185788 | SF363-Utility Index Score CN Weights | The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score Canada weights. | SF-36 v2.0 Standard - Utility Index Score CN Weights | ||
SF36336 | C185789 | SF363-Utility Index Score AU Weights | The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score Australia weights. | SF-36 v2.0 Standard - Utility Index Score AU Weights | ||
SF36337 | C185790 | SF363-Utility Index Score US Weights | The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score United States weights. | SF-36 v2.0 Standard - Utility Index Score US Weights | ||
Back to top | ||||||
CL.C101827.SF363TN | The Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire Test Name
(SF363TN) | text
Extensible: No | C101827 | The Short Form 36 Health Survey Standard, US Version 2.0 Questionnaire Test Name | The Short Form 36 Health Survey Standard, US Version 2.0 test name. | CDISC Questionnaire SF36 v2.0 Standard Test Name Terminology |
SF363-Bodily Pain 0-100 Score | C176186 | SF363-Bodily Pain 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Bodily pain 0-100 score. | SF-36 v2.0 Standard - Bodily Pain 0-100 Score | ||
SF363-Bodily Pain Norm-Based Score | C176194 | SF363-Bodily Pain Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Bodily pain norm-based score. | SF-36 v2.0 Standard - Bodily Pain Norm-Based Score | ||
SF363-Comp Year Ago Rate Gen Health Now | C102198 | SF363-Comp Year Ago Rate Gen Health Now | The Short Form 36 Health Survey Standard, US Version 2.0 - Compared to one year ago, how would you rate your health in general now? | SF-36 v2.0 Standard - Comp Year Ago Rate Gen Health Now | ||
SF363-Did You Feel Full of Life | C102219 | SF363-Did You Feel Full of Life | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel full of life. | SF-36 v2.0 Standard - Did You Feel Full of Life | ||
SF363-Did You Feel Tired | C102227 | SF363-Did You Feel Tired | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel tired. | SF-36 v2.0 Standard - Did You Feel Tired | ||
SF363-Did You Feel Worn Out | C102225 | SF363-Did You Feel Worn Out | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you feel worn out. | SF-36 v2.0 Standard - Did You Feel Worn Out | ||
SF363-Did You Have a Lot of Energy | C102223 | SF363-Did You Have a Lot of Energy | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - did you have a lot of energy. | SF-36 v2.0 Standard - Did You Have a Lot of Energy | ||
SF363-Emotional: Accomplished Less | C102214 | SF363-Emotional: Accomplished Less | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - accomplished less than you would like. | SF-36 v2.0 Standard - Emotional: Accomplished Less | ||
SF363-Emotional: Cut Down Time on Work | C102213 | SF363-Emotional: Cut Down Time on Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - cut down on the amount of time you spent on work or other activities. | SF-36 v2.0 Standard - Emotional: Cut Down Time on Work | ||
SF363-Emotional: Did Work Less Carefully | C102215 | SF363-Emotional: Did Work Less Carefully | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had problems with your work or other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious) - did work or other activities less carefully than usual. | SF-36 v2.0 Standard - Emotional: Did Work Less Carefully | ||
SF363-Extent Phys/Emotional Interfered | C102216 | SF363-Extent Phys/Emotional Interfered | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors, or groups? | SF-36 v2.0 Standard - Extent Phys/Emotional Interfered | ||
SF363-Felt Down Nothing Cheer You Up | C102221 | SF363-Felt Down Nothing Cheer You Up | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt so down in the dumps that nothing could cheer you up. | SF-36 v2.0 Standard - Felt Down Nothing Cheer You Up | ||
SF363-General Health 0-100 Score | C176187 | SF363-General Health 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - General health 0-100 score. | SF-36 v2.0 Standard - General Health 0-100 Score | ||
SF363-General Health Norm-Based Score | C176195 | SF363-General Health Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - General health norm-based score. | SF-36 v2.0 Standard - General Health Norm-Based Score | ||
SF363-Get Sick Little Easier Than Other | C102229 | SF363-Get Sick Little Easier Than Other | The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I seem to get sick a little easier than other people. | SF-36 v2.0 Standard - Get Sick Little Easier Than Other | ||
SF363-Have You Been Happy | C102226 | SF363-Have You Been Happy | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been happy. | SF-36 v2.0 Standard - Have You Been Happy | ||
SF363-Have You Been Very Nervous | C102220 | SF363-Have You Been Very Nervous | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you been very nervous. | SF-36 v2.0 Standard - Have You Been Very Nervous | ||
SF363-Have You Felt Calm and Peaceful | C102222 | SF363-Have You Felt Calm and Peaceful | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt calm and peaceful. | SF-36 v2.0 Standard - Have You Felt Calm and Peaceful | ||
SF363-How Much Bodily Pain Have You Had | C102217 | SF363-How Much Bodily Pain Have You Had | The Short Form 36 Health Survey Standard, US Version 2.0 - How much bodily pain have you had during the past 4 weeks? | SF-36 v2.0 Standard - How Much Bodily Pain Have You Had | ||
SF363-I Am as Healthy as Anybody I Know | C102230 | SF363-I Am as Healthy as Anybody I Know | The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I am as healthy as anybody I know. | SF-36 v2.0 Standard - I Am as Healthy as Anybody I Know | ||
SF363-I Expect My Health to Get Worse | C102231 | SF363-I Expect My Health to Get Worse | The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - I expect my health to get worse. | SF-36 v2.0 Standard - I Expect My Health to Get Worse | ||
SF363-In General You Say Your Health Is | C102197 | SF363-In General You Say Your Health Is | The Short Form 36 Health Survey Standard, US Version 2.0 - In general, would you say your health is. | SF-36 v2.0 Standard - In General You Say Your Health Is | ||
SF363-Limit Bathing or Dressing Yourself | C102208 | SF363-Limit Bathing or Dressing Yourself | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - bathing or dressing yourself. | SF-36 v2.0 Standard - Limit Bathing or Dressing Yourself | ||
SF363-Limit Bending/Kneeling/Stooping | C102204 | SF363-Limit Bending/Kneeling/Stooping | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - bending, kneeling, or stooping. | SF-36 v2.0 Standard - Limit Bending/Kneeling/Stooping | ||
SF363-Limit Climbing One Flight Stairs | C102203 | SF363-Limit Climbing One Flight Stairs | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing one flight of stairs. | SF-36 v2.0 Standard - Limit Climbing One Flight Stairs | ||
SF363-Limit Climbing Several Flights | C102202 | SF363-Limit Climbing Several Flights | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - climbing several flights of stairs. | SF-36 v2.0 Standard - Limit Climbing Several Flights | ||
SF363-Limit Lifting or Carrying | C102201 | SF363-Limit Lifting or Carrying | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - lifting or carrying groceries. | SF-36 v2.0 Standard - Limit Lifting or Carrying | ||
SF363-Limit Moderate Activities | C102200 | SF363-Limit Moderate Activities | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf. | SF-36 v2.0 Standard - Limit Moderate Activities | ||
SF363-Limit Vigorous Activities | C102199 | SF363-Limit Vigorous Activities | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - vigorous activities, such as running, lifting heavy objects, participating in strenuous sports. | SF-36 v2.0 Standard - Limit Vigorous Activities | ||
SF363-Limit Walking More Than a Mile | C102205 | SF363-Limit Walking More Than a Mile | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking more than a mile. | SF-36 v2.0 Standard - Limit Walking More Than a Mile | ||
SF363-Limit Walking One Hundred Yards | C102207 | SF363-Limit Walking One Hundred Yards | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking one hundred yards. | SF-36 v2.0 Standard - Limit Walking One Hundred Yards | ||
SF363-Limit Walking Several Hundred Yds | C102206 | SF363-Limit Walking Several Hundred Yds | The Short Form 36 Health Survey Standard, US Version 2.0 - How much does your health now limit you in - walking several hundred yards. | SF-36 v2.0 Standard - Limit Walking Several Hundred Yds | ||
SF363-Mental Component Score | C176201 | SF363-Mental Component Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Mental component score. | SF-36 v2.0 Standard - Mental Component Score | ||
SF363-Mental Health 0-100 Score | C176191 | SF363-Mental Health 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health 0-100 score. | SF-36 v2.0 Standard - Mental Health 0-100 Score | ||
SF363-Mental Health Enhanced Score | C176204 | SF363-Mental Health Enhanced Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health enhanced score. | SF-36 v2.0 Standard - Mental Health Enhanced Score | ||
SF363-Mental Health Norm-Based Score | C176199 | SF363-Mental Health Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Mental health norm-based score. | SF-36 v2.0 Standard - Mental Health Norm-Based Score | ||
SF363-My Health is Excellent | C102232 | SF363-My Health is Excellent | The Short Form 36 Health Survey Standard, US Version 2.0 - How TRUE or FALSE is the following statement for you - my health is excellent | SF-36 v2.0 Standard - My Health is Excellent | ||
SF363-Pain Interfere With Normal Work | C102218 | SF363-Pain Interfere With Normal Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and housework)? | SF-36 v2.0 Standard - Pain Interfere With Normal Work | ||
SF363-Phys Functioning Norm-Based Score | C176192 | SF363-Phys Functioning Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Phys functioning norm-based score. | SF-36 v2.0 Standard - Phys Functioning Norm-Based Score | ||
SF363-Physical Component Score | C176200 | SF363-Physical Component Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Physical component score. | SF-36 v2.0 Standard - Physical Component Score | ||
SF363-Physical Functioning 0-100 Score | C176184 | SF363-Physical Functioning 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Physical functioning 0-100 score. | SF-36 v2.0 Standard - Physical Functioning 0-100 Score | ||
SF363-Physical: Accomplished Less | C102210 | SF363-Physical: Accomplished Less | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - accomplished less than you would like. | SF-36 v2.0 Standard - Physical: Accomplished Less | ||
SF363-Physical: Cut Down Time on Work | C102209 | SF363-Physical: Cut Down Time on Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - cut down on the amount of time you spent on work or other activities. | SF-36 v2.0 Standard - Physical: Cut Down Time on Work | ||
SF363-Physical: Difficulty Perform Work | C102212 | SF363-Physical: Difficulty Perform Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - had difficulty performing the work or other activities (for example, it took extra effort). | SF-36 v2.0 Standard - Physical: Difficulty Perform Work | ||
SF363-Physical: Limited Kind of Work | C102211 | SF363-Physical: Limited Kind of Work | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time have you had any problems with your work or other regular daily activities as a result of your physical health - were limited in the kind of work or other activities. | SF-36 v2.0 Standard - Physical: Limited Kind of Work | ||
SF363-Response Consistency Score | C180248 | SF363-Response Consistency Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Response consistency score. | SF-36 v2.0 Standard - Response Consistency Score | ||
SF363-Role Emotional 0-100 Score | C176190 | SF363-Role Emotional 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Role emotional 0-100 score. | SF-36 v2.0 Standard - Role Emotional 0-100 Score | ||
SF363-Role Emotional Norm-Based Score | C176198 | SF363-Role Emotional Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Role emotional norm-based score. | SF-36 v2.0 Standard - Role Emotional Norm-Based Score | ||
SF363-Role Physical 0-100 Score | C176185 | SF363-Role Physical 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Role physical 0-100 score. | SF-36 v2.0 Standard - Role Physical 0-100 Score | ||
SF363-Role Physical Norm-Based Score | C176193 | SF363-Role Physical Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Role physical norm-based score. | SF-36 v2.0 Standard - Role Physical Norm-Based Score | ||
SF363-SF-6D (Utility Index) Score | C176202 | SF363-SF-6D (Utility Index) Score | The Short Form 36 Health Survey Standard, US Version 2.0 - 6D (utility index) score. | SF-36 v2.0 Standard - SF-6D (Utility Index) Score | ||
SF363-SF-6D_R2 (Util Index Rel 2) Score | C176203 | SF363-SF-6D_R2 (Util Index Rel 2) Score | The Short Form 36 Health Survey Standard, US Version 2.0 - 6D_R2 (util index rel 2) score. | SF-36 v2.0 Standard - SF-6D_R2 (Util Index Rel 2) Score | ||
SF363-Social Function Norm-Based Score | C176197 | SF363-Social Function Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Social function norm-based score. | SF-36 v2.0 Standard - Social Function Norm-Based Score | ||
SF363-Social Functioning 0-100 Score | C176189 | SF363-Social Functioning 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Social functioning 0-100 score. | SF-36 v2.0 Standard - Social Functioning 0-100 Score | ||
SF363-Time Phys/Emotional Interfered | C102228 | SF363-Time Phys/Emotional Interfered | The Short Form 36 Health Survey Standard, US Version 2.0 - During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting friends, relatives, etc.)? | SF-36 v2.0 Standard - Time Phys/Emotional Interfered | ||
SF363-Utility Index Score AU Weights | C185789 | SF363-Utility Index Score AU Weights | The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score Australia weights. | SF-36 v2.0 Standard - Utility Index Score AU Weights | ||
SF363-Utility Index Score CN Weights | C185788 | SF363-Utility Index Score CN Weights | The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score Canada weights. | SF-36 v2.0 Standard - Utility Index Score CN Weights | ||
SF363-Utility Index Score UK Weights | C185787 | SF363-Utility Index Score UK Weights | The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score United Kingdom weights. | SF-36 v2.0 Standard - Utility Index Score UK Weights | ||
SF363-Utility Index Score US Weights | C185790 | SF363-Utility Index Score US Weights | The Short Form 36 Health Survey Standard, US Version 2.0 - Utility index score United States weights. | SF-36 v2.0 Standard - Utility Index Score US Weights | ||
SF363-Vitality 0-100 Score | C176188 | SF363-Vitality 0-100 Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Vitality 0-100 score. | SF-36 v2.0 Standard - Vitality 0-100 Score | ||
SF363-Vitality Norm-Based Score | C176196 | SF363-Vitality Norm-Based Score | The Short Form 36 Health Survey Standard, US Version 2.0 - Vitality norm-based score. | SF-36 v2.0 Standard - Vitality Norm-Based Score | ||
SF363-You Felt Downhearted and Depressed | C102224 | SF363-You Felt Downhearted and Depressed | The Short Form 36 Health Survey Standard, US Version 2.0 - Please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4 weeks - have you felt downhearted and depressed. | SF-36 v2.0 Standard - You Felt Downhearted and Depressed | ||
Back to top | ||||||
CL.C166186.WPAI02TC | The Work Productivity and Activity Impairment - General Health Version 2.0 Questionnaire Test Code
(WPAI02TC) | text
Extensible: No | C166186 | The Work Productivity and Activity Impairment - General Health Version 2.0 Questionnaire Test Code | The Work Productivity and Activity Impairment - General Health Version 2.0 test code. | CDISC Questionnaire WPAI-GH Version 2 Test Code Terminology |
WPAI0201 | C166321 | WPAI02-Currently Employed | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Are you currently employed (working for pay)? | WPAI-GH Version 2 - Currently Employed | ||
WPAI0202 | C166322 | WPAI02-Hours Miss Work Health Problems | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you miss from work because of your health problems? | WPAI-GH Version 2 - Hours Miss Work Health Problems | ||
WPAI0203 | C166323 | WPAI02-Hours Miss Work Other Reason | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you miss from work because of any other reason, such as vacation, holidays, time off to participate in this study? | WPAI-GH Version 2 - Hours Miss Work Other Reason | ||
WPAI0204 | C166324 | WPAI02-Hours Actually Work | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you actually work? | WPAI-GH Version 2 - Hours Actually Work | ||
WPAI0205 | C166325 | WPAI02-Problems Affect Productivity | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how much did your health problems affect your productivity while you were working? | WPAI-GH Version 2 - Problems Affect Productivity | ||
WPAI0206 | C166326 | WPAI02-Problems Affect Daily Activities | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how much did your health problems affect your ability to do your regular daily activities, other than work at a job? | WPAI-GH Version 2 - Problems Affect Daily Activities | ||
WPAI0207 | C166327 | WPAI02-Absenteeism Score | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Absenteeism score. | WPAI-GH Version 2 - Absenteeism Score | ||
WPAI0208 | C166328 | WPAI02-Presenteeism Score | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Presenteeism score. | WPAI-GH Version 2 - Presenteeism Score | ||
WPAI0209 | C166329 | WPAI02-Work Productivity Loss Score | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Work productivity loss score. | WPAI-GH Version 2 - Work Productivity Loss Score | ||
WPAI0210 | C166330 | WPAI02-Activity Impairment Score | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Activity impairment score. | WPAI-GH Version 2 - Activity Impairment Score | ||
Back to top | ||||||
CL.C166185.WPAI02TN | The Work Productivity and Activity Impairment - General Health Version 2.0 Questionnaire Test Name
(WPAI02TN) | text
Extensible: No | C166185 | The Work Productivity and Activity Impairment - General Health Version 2.0 Questionnaire Test Name | The Work Productivity and Activity Impairment - General Health Version 2.0 test name. | CDISC Questionnaire WPAI-GH Version 2 Test Name Terminology |
WPAI02-Absenteeism Score | C166327 | WPAI02-Absenteeism Score | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Absenteeism score. | WPAI-GH Version 2 - Absenteeism Score | ||
WPAI02-Activity Impairment Score | C166330 | WPAI02-Activity Impairment Score | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Activity impairment score. | WPAI-GH Version 2 - Activity Impairment Score | ||
WPAI02-Currently Employed | C166321 | WPAI02-Currently Employed | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Are you currently employed (working for pay)? | WPAI-GH Version 2 - Currently Employed | ||
WPAI02-Hours Actually Work | C166324 | WPAI02-Hours Actually Work | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you actually work? | WPAI-GH Version 2 - Hours Actually Work | ||
WPAI02-Hours Miss Work Health Problems | C166322 | WPAI02-Hours Miss Work Health Problems | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you miss from work because of your health problems? | WPAI-GH Version 2 - Hours Miss Work Health Problems | ||
WPAI02-Hours Miss Work Other Reason | C166323 | WPAI02-Hours Miss Work Other Reason | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how many hours did you miss from work because of any other reason, such as vacation, holidays, time off to participate in this study? | WPAI-GH Version 2 - Hours Miss Work Other Reason | ||
WPAI02-Presenteeism Score | C166328 | WPAI02-Presenteeism Score | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Presenteeism score. | WPAI-GH Version 2 - Presenteeism Score | ||
WPAI02-Problems Affect Daily Activities | C166326 | WPAI02-Problems Affect Daily Activities | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how much did your health problems affect your ability to do your regular daily activities, other than work at a job? | WPAI-GH Version 2 - Problems Affect Daily Activities | ||
WPAI02-Problems Affect Productivity | C166325 | WPAI02-Problems Affect Productivity | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - During the past seven days, how much did your health problems affect your productivity while you were working? | WPAI-GH Version 2 - Problems Affect Productivity | ||
WPAI02-Work Productivity Loss Score | C166329 | WPAI02-Work Productivity Loss Score | Work Productivity and Activity Impairment Questionnaire - General Health V2.0 - Work productivity loss score. | WPAI-GH Version 2 - Work Productivity Loss Score | ||
Back to top | ||||||
CL.C115398.T25FW1TC | Timed 25-Foot Walk Test Functional Test Test Code
(T25FW1TC) | text
Extensible: No | C115398 | Timed 25-Foot Walk Test Functional Test Test Code | Timed 25-Foot Walk Test test code. | CDISC Functional Test T25FW Test Code Terminology |
T25FW101 | C115817 | T25FW1-Time to Complete 25-Foot Walk | Timed 25-Foot Walk - Time in seconds to complete 25-foot walk. | T25FW - Time to Complete 25-Foot Walk | ||
T25FW102 | C115818 | T25FW1-More Than Two Attempts | Timed 25-Foot Walk - Did it take more than two attempts to get two successful trials? | T25FW - More Than Two Attempts | ||
T25FW103 | C151074 | T25FW1-Did Patient Wear AFO | Timed 25-Foot Walk - Did patient wear an AFO? | T25FW - Did Patient Wear AFO | ||
T25FW104 | C151075 | T25FW1-Was Assistive Device Used | Timed 25-Foot Walk - Was assistive device used? | T25FW - Was Assistive Device Used | ||
Back to top | ||||||
CL.C115397.T25FW1TN | Timed 25-Foot Walk Test Functional Test Test Name
(T25FW1TN) | text
Extensible: No | C115397 | Timed 25-Foot Walk Test Functional Test Test Name | Timed 25-Foot Walk Test test name. | CDISC Functional Test T25FW Test Name Terminology |
T25FW1-Did Patient Wear AFO | C151074 | T25FW1-Did Patient Wear AFO | Timed 25-Foot Walk - Did patient wear an AFO? | T25FW - Did Patient Wear AFO | ||
T25FW1-More Than Two Attempts | C115818 | T25FW1-More Than Two Attempts | Timed 25-Foot Walk - Did it take more than two attempts to get two successful trials? | T25FW - More Than Two Attempts | ||
T25FW1-Time to Complete 25-Foot Walk | C115817 | T25FW1-Time to Complete 25-Foot Walk | Timed 25-Foot Walk - Time in seconds to complete 25-foot walk. | T25FW - Time to Complete 25-Foot Walk | ||
T25FW1-Was Assistive Device Used | C151075 | T25FW1-Was Assistive Device Used | Timed 25-Foot Walk - Was assistive device used? | T25FW - Was Assistive Device Used | ||
Back to top | ||||||
CL.C115400.TUG01TC | Timed Up and Go Test Functional Test Test Code
(TUG01TC) | text
Extensible: No | C115400 | Timed Up and Go Test Functional Test Test Code | Timed Up and Go Test test code. | CDISC Functional Test TUG Test Code Terminology |
TUG0101 | C115819 | TUG01-Time to Complete TUG Test | Timed Up and Go - Time in seconds to complete TUG test. | TUG - Time to Complete TUG Test | ||
Back to top | ||||||
CL.C115399.TUG01TN | Timed Up and Go Test Functional Test Test Name
(TUG01TN) | text
Extensible: No | C115399 | Timed Up and Go Test Functional Test Test Name | Timed Up and Go Test test name. | CDISC Functional Test TUG Test Name Terminology |
TUG01-Time to Complete TUG Test | C115819 | TUG01-Time to Complete TUG Test | Timed Up and Go - Time in seconds to complete TUG test. | TUG - Time to Complete TUG Test | ||
Back to top | ||||||
CL.C101841.TIMIFLRS | TIMI Flow Responses
(TIMIFLRS) | text
Extensible: No | C101841 | TIMI Flow Responses | A terminology codelist of acceptable values to describe TIMI Flow. | CDISC SDTM Thrombolysis in Myocardial Infarction Flow Responses Terminology |
TIMI GRADE 0 | C100040 | Thrombolysis in Myocardial Infarction Flow - 0 | No perfusion. There is no antegrade flow beyond the point of occlusion. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) | Thrombolysis in Myocardial Infarction Flow-0 | ||
TIMI GRADE 1 | C100041 | Thrombolysis in Myocardial Infarction Flow - 1 | Penetration without perfusion. Contrast material passes beyond the area of obstruction but "hangs up" and fails to opacify the entire coronary bed distal to the obstruction for the duration of the cineangiographic filming sequence. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) | Thrombolysis in Myocardial Infarction Flow-1 | ||
TIMI GRADE 2 | C100042 | Thrombolysis in Myocardial Infarction Flow - 2 | Partial perfusion. The contrast material passes across the obstruction and opacifies the coronary bed distal to the obstruction. However, the rate of entry of contrast material into the vessel distal to the obstruction or its rate of clearance from the distal bed (or both) is perceptibly slower than its entry into or clearance from comparable areas not perfused by the previously occluded vessel (e.g., the opposite coronary artery or the coronary bed proximal to the obstruction). (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) | Thrombolysis in Myocardial Infarction Flow-2 | ||
TIMI GRADE 3 | C100043 | Thrombolysis in Myocardial Infarction Flow - 3 | Complete perfusion. Antegrade flow into the bed distal to the obstruction occurs as promptly as into the bed from the involved bed and is as rapid as clearance from an uninvolved bed in the same vessel or the opposite artery. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) | Thrombolysis in Myocardial Infarction Flow-3 | ||
Back to top | ||||||
CL.C124688.TMT01TC | Trail Making Test Functional Test Test Code
(TMT01TC) | text
Extensible: No | C124688 | Trail Making Test Functional Test Test Code | Trail Making Test test code. | CDISC Functional Test TMT Test Code Terminology |
TMT0101 | C124780 | TMT01-Time to Complete Trails A | Trail Making Test - Time (in seconds) to complete Trails A. | TMT - Time to Complete Trails A | ||
TMT0102 | C124781 | TMT01-Time to Complete Trails B | Trail Making Test - Time (in seconds) to complete Trails B. | TMT - Time to Complete Trails B | ||
Back to top | ||||||
CL.C124687.TMT01TN | Trail Making Test Functional Test Test Name
(TMT01TN) | text
Extensible: No | C124687 | Trail Making Test Functional Test Test Name | Trail Making Test test name. | CDISC Functional Test TMT Test Name Terminology |
TMT01-Time to Complete Trails A | C124780 | TMT01-Time to Complete Trails A | Trail Making Test - Time (in seconds) to complete Trails A. | TMT - Time to Complete Trails A | ||
TMT01-Time to Complete Trails B | C124781 | TMT01-Time to Complete Trails B | Trail Making Test - Time (in seconds) to complete Trails B. | TMT - Time to Complete Trails B | ||
Back to top | ||||||
CL.C106657.TDI01TC | Transition Dyspnea Index Clinical Classification Test Code
(TDI01TC) | text
Extensible: No | C106657 | Transition Dyspnea Index Clinical Classification Test Code | Transition Dyspnea Index test code. | CDISC Clinical Classification TDI Test Code Terminology |
TDI0101 | C106704 | TDI01-Change in Functional Impairment | Transition Dyspnea Index - Change in functional impairment. | TDI - Change in Functional Impairment | ||
TDI0102 | C106705 | TDI01-Change in Magnitude of Task | Transition Dyspnea Index - Change in magnitude of task. | TDI - Change in Magnitude of Task | ||
TDI0103 | C106706 | TDI01-Change in Magnitude of Effort | Transition Dyspnea Index - Change in magnitude of effort. | TDI - Change in Magnitude of Effort | ||
TDI0104 | C161763 | TDI01-Transition Focal Score | Transition Dyspnea Index - Transition focal score. | TDI - Transition Focal Score | ||
Back to top | ||||||
CL.C106656.TDI01TN | Transition Dyspnea Index Clinical Classification Test Name
(TDI01TN) | text
Extensible: No | C106656 | Transition Dyspnea Index Clinical Classification Test Name | Transition Dyspnea Index test name. | CDISC Clinical Classification TDI Test Name Terminology |
TDI01-Change in Functional Impairment | C106704 | TDI01-Change in Functional Impairment | Transition Dyspnea Index - Change in functional impairment. | TDI - Change in Functional Impairment | ||
TDI01-Change in Magnitude of Effort | C106706 | TDI01-Change in Magnitude of Effort | Transition Dyspnea Index - Change in magnitude of effort. | TDI - Change in Magnitude of Effort | ||
TDI01-Change in Magnitude of Task | C106705 | TDI01-Change in Magnitude of Task | Transition Dyspnea Index - Change in magnitude of task. | TDI - Change in Magnitude of Task | ||
TDI01-Transition Focal Score | C161763 | TDI01-Transition Focal Score | Transition Dyspnea Index - Transition focal score. | TDI - Transition Focal Score | ||
Back to top | ||||||
CL.C147548.TSCC01TC | Trauma Symptom Checklist for Children Questionnaire Test Code
(TSCC01TC) | text
Extensible: No | C147548 | Trauma Symptom Checklist for Children Questionnaire Test Code | Trauma Symptom Checklist for Children test code. | CDISC Questionnaire TSCC Test Code Terminology |
TSCC0101 | C147699 | TSCC01-Bad Dreams or Nightmares | Trauma Symptom Checklist for Children - Bad dreams or nightmares. | TSCC - Bad Dreams or Nightmares | ||
TSCC0102 | C147700 | TSCC01-Afraid Something Bad Might Happen | Trauma Symptom Checklist for Children - Feeling afraid something bad might happen. | TSCC - Afraid Something Bad Might Happen | ||
TSCC0103 | C147701 | TSCC01-Scary Ideas Just Pop Into My Head | Trauma Symptom Checklist for Children - Scary ideas or pictures just pop into my head. | TSCC - Scary Ideas Just Pop Into My Head | ||
TSCC0104 | C147702 | TSCC01-Wanting to Say Dirty Words | Trauma Symptom Checklist for Children - Wanting to say dirty words. | TSCC - Wanting to Say Dirty Words | ||
TSCC0105 | C147703 | TSCC01-Pretending I am Someone Else | Trauma Symptom Checklist for Children - Pretending I am someone else. | TSCC - Pretending I am Someone Else | ||
TSCC0106 | C147704 | TSCC01-Arguing Too Much | Trauma Symptom Checklist for Children - Arguing too much. | TSCC - Arguing Too Much | ||
TSCC0107 | C147705 | TSCC01-Feeling Lonely | Trauma Symptom Checklist for Children - Feeling lonely. | TSCC - Feeling Lonely | ||
TSCC0108 | C147706 | TSCC01-Touching Private Parts Too Much | Trauma Symptom Checklist for Children - Touching my private parts too much. | TSCC - Touching Private Parts Too Much | ||
TSCC0109 | C147707 | TSCC01-Feeling Sad or Unhappy | Trauma Symptom Checklist for Children - Feeling sad or unhappy. | TSCC - Feeling Sad or Unhappy | ||
TSCC0110 | C147708 | TSCC01-Remembering Things I Didn't Like | Trauma Symptom Checklist for Children - Remembering things that happened that I didn't like. | TSCC - Remembering Things I Didn't Like | ||
TSCC0111 | C147709 | TSCC01-Going Away in My Mind | Trauma Symptom Checklist for Children - Going away in my mind, trying not to think. | TSCC - Going Away in My Mind | ||
TSCC0112 | C147710 | TSCC01-Remembering Scary Things | Trauma Symptom Checklist for Children - Remembering scary things. | TSCC - Remembering Scary Things | ||
TSCC0113 | C147711 | TSCC01-Wanting to Yell and Break Things | Trauma Symptom Checklist for Children - Wanting to yell and break things. | TSCC - Wanting to Yell and Break Things | ||
TSCC0114 | C147712 | TSCC01-Crying | Trauma Symptom Checklist for Children - Crying. | TSCC - Crying | ||
TSCC0115 | C147713 | TSCC01-Getting Scared All of Sudden | Trauma Symptom Checklist for Children - Getting scared all of a sudden and don't know why. | TSCC - Getting Scared All of Sudden | ||
TSCC0116 | C147714 | TSCC01-Getting Mad and Can't Calm Down | Trauma Symptom Checklist for Children - Getting mad and can't calm down. | TSCC - Getting Mad and Can't Calm Down | ||
TSCC0117 | C147715 | TSCC01-Thinking About Having Sex | Trauma Symptom Checklist for Children - Thinking about having sex. | TSCC - Thinking About Having Sex | ||
TSCC0118 | C147716 | TSCC01-Feeling Dizzy | Trauma Symptom Checklist for Children - Feeling dizzy. | TSCC - Feeling Dizzy | ||
TSCC0119 | C147717 | TSCC01-Wanting to Yell at People | Trauma Symptom Checklist for Children - Wanting to yell at people. | TSCC - Wanting to Yell at People | ||
TSCC0120 | C147718 | TSCC01-Wanting to Hurt Myself | Trauma Symptom Checklist for Children - Wanting to hurt myself. | TSCC - Wanting to Hurt Myself | ||
TSCC0121 | C147719 | TSCC01-Wanting to Hurt Other People | Trauma Symptom Checklist for Children - Wanting to hurt other people. | TSCC - Wanting to Hurt Other People | ||
TSCC0122 | C147720 | TSCC01-Think Touch People Private Parts | Trauma Symptom Checklist for Children - Thinking about touching other people's private parts. | TSCC - Think Touch People Private Parts | ||
TSCC0123 | C147721 | TSCC01-Think About Sex When Don't Want | Trauma Symptom Checklist for Children - Thinking about sex when I don't want to. | TSCC - Think About Sex When Don't Want | ||
TSCC0124 | C147722 | TSCC01-Feeling Scared of Men | Trauma Symptom Checklist for Children - Feeling scared of men. | TSCC - Feeling Scared of Men | ||
TSCC0125 | C147723 | TSCC01-Feeling Scared of Women | Trauma Symptom Checklist for Children - Feeling scared of women. | TSCC - Feeling Scared of Women | ||
TSCC0126 | C147724 | TSCC01-Washing Myself Because Feel Dirty | Trauma Symptom Checklist for Children - Washing myself because I feel dirty on the inside. | TSCC - Washing Myself Because Feel Dirty | ||
TSCC0127 | C147725 | TSCC01-Feeling Stupid or Bad | Trauma Symptom Checklist for Children - Feeling stupid or bad. | TSCC - Feeling Stupid or Bad | ||
TSCC0128 | C147726 | TSCC01-Feeling Like Did Something Wrong | Trauma Symptom Checklist for Children - Feeling like I did something wrong. | TSCC - Feeling Like Did Something Wrong | ||
TSCC0129 | C147727 | TSCC01-Feeling Like Things Aren't Real | Trauma Symptom Checklist for Children - Feeling like things aren't real. | TSCC - Feeling Like Things Aren't Real | ||
TSCC0130 | C147728 | TSCC01-Forgetting Things | Trauma Symptom Checklist for Children - Forgetting things, can't remember things. | TSCC - Forgetting Things | ||
TSCC0131 | C147729 | TSCC01-Feeling Like I'm Not in My Body | Trauma Symptom Checklist for Children - Feeling like I'm not in my body. | TSCC - Feeling Like I'm Not in My Body | ||
TSCC0132 | C147730 | TSCC01-Feeling Nervous or Jumpy Inside | Trauma Symptom Checklist for Children - Feeling nervous or jumpy inside. | TSCC - Feeling Nervous or Jumpy Inside | ||
TSCC0133 | C147731 | TSCC01-Feeling Afraid | Trauma Symptom Checklist for Children - Feeling afraid. | TSCC - Feeling Afraid | ||
TSCC0134 | C147732 | TSCC01-Not Trusting People Because Sex | Trauma Symptom Checklist for Children - Not trusting people because they might want sex. | TSCC - Not Trusting People Because Sex | ||
TSCC0135 | C147733 | TSCC01-Can't Stop Thinking Something Bad | Trauma Symptom Checklist for Children - Can't stop thinking about something bad that happened to me. | TSCC - Can't Stop Thinking Something Bad | ||
TSCC0136 | C147734 | TSCC01-Getting Into Fights | Trauma Symptom Checklist for Children - Getting into fights. | TSCC - Getting Into Fights | ||
TSCC0137 | C147735 | TSCC01-Feeling Mean | Trauma Symptom Checklist for Children - Feeling mean. | TSCC - Feeling Mean | ||
TSCC0138 | C147736 | TSCC01-Pretending I'm Somewhere Else | Trauma Symptom Checklist for Children - Pretending I'm somewhere else. | TSCC - Pretending I'm Somewhere Else | ||
TSCC0139 | C147737 | TSCC01-Being Afraid of the Dark | Trauma Symptom Checklist for Children - Being afraid of the dark. | TSCC - Being Afraid of the Dark | ||
TSCC0140 | C147738 | TSCC01-Scared When Think About Sex | Trauma Symptom Checklist for Children - Getting scared or upset when I think about sex. | TSCC - Scared When Think About Sex | ||
TSCC0141 | C147739 | TSCC01-Worrying About Things | Trauma Symptom Checklist for Children - Worrying about things. | TSCC - Worrying About Things | ||
TSCC0142 | C147740 | TSCC01-Feeling Like Nobody Likes Me | Trauma Symptom Checklist for Children - Feeling like nobody likes me. | TSCC - Feeling Like Nobody Likes Me | ||
TSCC0143 | C147741 | TSCC01-Remembering Things Don't Want To | Trauma Symptom Checklist for Children - Remembering things I don't want to remember. | TSCC - Remembering Things Don't Want To | ||
TSCC0144 | C147742 | TSCC01-Having Sex Feelings in My Body | Trauma Symptom Checklist for Children - Having sex feelings in my body. | TSCC - Having Sex Feelings in My Body | ||
TSCC0145 | C147743 | TSCC01-My Mind Going Empty or Blank | Trauma Symptom Checklist for Children - My mind going empty or blank. | TSCC - My Mind Going Empty or Blank | ||
TSCC0146 | C147744 | TSCC01-Feeling Like I Hate People | Trauma Symptom Checklist for Children - Feeling like I hate people. | TSCC - Feeling Like I Hate People | ||
TSCC0147 | C147745 | TSCC01-Can't Stop Thinking About Sex | Trauma Symptom Checklist for Children - Can't stop thinking about sex. | TSCC - Can't Stop Thinking About Sex | ||
TSCC0148 | C147746 | TSCC01-Trying Not to Have Any Feelings | Trauma Symptom Checklist for Children - Trying not to have any feelings. | TSCC - Trying Not to Have Any Feelings | ||
TSCC0149 | C147747 | TSCC01-Feeling Mad | Trauma Symptom Checklist for Children - Feeling mad. | TSCC - Feeling Mad | ||
TSCC0150 | C147748 | TSCC01-Feeling Afraid Somebody Kill Me | Trauma Symptom Checklist for Children - Feeling afraid somebody will kill me. | TSCC - Feeling Afraid Somebody Kill Me | ||
TSCC0151 | C147749 | TSCC01-Wishing Bad Things Never Happened | Trauma Symptom Checklist for Children - Wishing bad things had never happened. | TSCC - Wishing Bad Things Never Happened | ||
TSCC0152 | C147750 | TSCC01-Wanting to Kill Myself | Trauma Symptom Checklist for Children - Wanting to kill myself. | TSCC - Wanting to Kill Myself | ||
TSCC0153 | C147751 | TSCC01-Daydreaming | Trauma Symptom Checklist for Children - Daydreaming. | TSCC - Daydreaming | ||
TSCC0154 | C147752 | TSCC01-Getting Upset People Talk Sex | Trauma Symptom Checklist for Children - Getting upset when people talk about sex. | TSCC - Getting Upset People Talk Sex | ||
Back to top | ||||||
CL.C147547.TSCC01TN | Trauma Symptom Checklist for Children Questionnaire Test Name
(TSCC01TN) | text
Extensible: No | C147547 | Trauma Symptom Checklist for Children Questionnaire Test Name | Trauma Symptom Checklist for Children test name. | CDISC Questionnaire TSCC Test Name Terminology |
TSCC01-Afraid Something Bad Might Happen | C147700 | TSCC01-Afraid Something Bad Might Happen | Trauma Symptom Checklist for Children - Feeling afraid something bad might happen. | TSCC - Afraid Something Bad Might Happen | ||
TSCC01-Arguing Too Much | C147704 | TSCC01-Arguing Too Much | Trauma Symptom Checklist for Children - Arguing too much. | TSCC - Arguing Too Much | ||
TSCC01-Bad Dreams or Nightmares | C147699 | TSCC01-Bad Dreams or Nightmares | Trauma Symptom Checklist for Children - Bad dreams or nightmares. | TSCC - Bad Dreams or Nightmares | ||
TSCC01-Being Afraid of the Dark | C147737 | TSCC01-Being Afraid of the Dark | Trauma Symptom Checklist for Children - Being afraid of the dark. | TSCC - Being Afraid of the Dark | ||
TSCC01-Can't Stop Thinking About Sex | C147745 | TSCC01-Can't Stop Thinking About Sex | Trauma Symptom Checklist for Children - Can't stop thinking about sex. | TSCC - Can't Stop Thinking About Sex | ||
TSCC01-Can't Stop Thinking Something Bad | C147733 | TSCC01-Can't Stop Thinking Something Bad | Trauma Symptom Checklist for Children - Can't stop thinking about something bad that happened to me. | TSCC - Can't Stop Thinking Something Bad | ||
TSCC01-Crying | C147712 | TSCC01-Crying | Trauma Symptom Checklist for Children - Crying. | TSCC - Crying | ||
TSCC01-Daydreaming | C147751 | TSCC01-Daydreaming | Trauma Symptom Checklist for Children - Daydreaming. | TSCC - Daydreaming | ||
TSCC01-Feeling Afraid Somebody Kill Me | C147748 | TSCC01-Feeling Afraid Somebody Kill Me | Trauma Symptom Checklist for Children - Feeling afraid somebody will kill me. | TSCC - Feeling Afraid Somebody Kill Me | ||
TSCC01-Feeling Afraid | C147731 | TSCC01-Feeling Afraid | Trauma Symptom Checklist for Children - Feeling afraid. | TSCC - Feeling Afraid | ||
TSCC01-Feeling Dizzy | C147716 | TSCC01-Feeling Dizzy | Trauma Symptom Checklist for Children - Feeling dizzy. | TSCC - Feeling Dizzy | ||
TSCC01-Feeling Like Did Something Wrong | C147726 | TSCC01-Feeling Like Did Something Wrong | Trauma Symptom Checklist for Children - Feeling like I did something wrong. | TSCC - Feeling Like Did Something Wrong | ||
TSCC01-Feeling Like I Hate People | C147744 | TSCC01-Feeling Like I Hate People | Trauma Symptom Checklist for Children - Feeling like I hate people. | TSCC - Feeling Like I Hate People | ||
TSCC01-Feeling Like I'm Not in My Body | C147729 | TSCC01-Feeling Like I'm Not in My Body | Trauma Symptom Checklist for Children - Feeling like I'm not in my body. | TSCC - Feeling Like I'm Not in My Body | ||
TSCC01-Feeling Like Nobody Likes Me | C147740 | TSCC01-Feeling Like Nobody Likes Me | Trauma Symptom Checklist for Children - Feeling like nobody likes me. | TSCC - Feeling Like Nobody Likes Me | ||
TSCC01-Feeling Like Things Aren't Real | C147727 | TSCC01-Feeling Like Things Aren't Real | Trauma Symptom Checklist for Children - Feeling like things aren't real. | TSCC - Feeling Like Things Aren't Real | ||
TSCC01-Feeling Lonely | C147705 | TSCC01-Feeling Lonely | Trauma Symptom Checklist for Children - Feeling lonely. | TSCC - Feeling Lonely | ||
TSCC01-Feeling Mad | C147747 | TSCC01-Feeling Mad | Trauma Symptom Checklist for Children - Feeling mad. | TSCC - Feeling Mad | ||
TSCC01-Feeling Mean | C147735 | TSCC01-Feeling Mean | Trauma Symptom Checklist for Children - Feeling mean. | TSCC - Feeling Mean | ||
TSCC01-Feeling Nervous or Jumpy Inside | C147730 | TSCC01-Feeling Nervous or Jumpy Inside | Trauma Symptom Checklist for Children - Feeling nervous or jumpy inside. | TSCC - Feeling Nervous or Jumpy Inside | ||
TSCC01-Feeling Sad or Unhappy | C147707 | TSCC01-Feeling Sad or Unhappy | Trauma Symptom Checklist for Children - Feeling sad or unhappy. | TSCC - Feeling Sad or Unhappy | ||
TSCC01-Feeling Scared of Men | C147722 | TSCC01-Feeling Scared of Men | Trauma Symptom Checklist for Children - Feeling scared of men. | TSCC - Feeling Scared of Men | ||
TSCC01-Feeling Scared of Women | C147723 | TSCC01-Feeling Scared of Women | Trauma Symptom Checklist for Children - Feeling scared of women. | TSCC - Feeling Scared of Women | ||
TSCC01-Feeling Stupid or Bad | C147725 | TSCC01-Feeling Stupid or Bad | Trauma Symptom Checklist for Children - Feeling stupid or bad. | TSCC - Feeling Stupid or Bad | ||
TSCC01-Forgetting Things | C147728 | TSCC01-Forgetting Things | Trauma Symptom Checklist for Children - Forgetting things, can't remember things. | TSCC - Forgetting Things | ||
TSCC01-Getting Into Fights | C147734 | TSCC01-Getting Into Fights | Trauma Symptom Checklist for Children - Getting into fights. | TSCC - Getting Into Fights | ||
TSCC01-Getting Mad and Can't Calm Down | C147714 | TSCC01-Getting Mad and Can't Calm Down | Trauma Symptom Checklist for Children - Getting mad and can't calm down. | TSCC - Getting Mad and Can't Calm Down | ||
TSCC01-Getting Scared All of Sudden | C147713 | TSCC01-Getting Scared All of Sudden | Trauma Symptom Checklist for Children - Getting scared all of a sudden and don't know why. | TSCC - Getting Scared All of Sudden | ||
TSCC01-Getting Upset People Talk Sex | C147752 | TSCC01-Getting Upset People Talk Sex | Trauma Symptom Checklist for Children - Getting upset when people talk about sex. | TSCC - Getting Upset People Talk Sex | ||
TSCC01-Going Away in My Mind | C147709 | TSCC01-Going Away in My Mind | Trauma Symptom Checklist for Children - Going away in my mind, trying not to think. | TSCC - Going Away in My Mind | ||
TSCC01-Having Sex Feelings in My Body | C147742 | TSCC01-Having Sex Feelings in My Body | Trauma Symptom Checklist for Children - Having sex feelings in my body. | TSCC - Having Sex Feelings in My Body | ||
TSCC01-My Mind Going Empty or Blank | C147743 | TSCC01-My Mind Going Empty or Blank | Trauma Symptom Checklist for Children - My mind going empty or blank. | TSCC - My Mind Going Empty or Blank | ||
TSCC01-Not Trusting People Because Sex | C147732 | TSCC01-Not Trusting People Because Sex | Trauma Symptom Checklist for Children - Not trusting people because they might want sex. | TSCC - Not Trusting People Because Sex | ||
TSCC01-Pretending I am Someone Else | C147703 | TSCC01-Pretending I am Someone Else | Trauma Symptom Checklist for Children - Pretending I am someone else. | TSCC - Pretending I am Someone Else | ||
TSCC01-Pretending I'm Somewhere Else | C147736 | TSCC01-Pretending I'm Somewhere Else | Trauma Symptom Checklist for Children - Pretending I'm somewhere else. | TSCC - Pretending I'm Somewhere Else | ||
TSCC01-Remembering Scary Things | C147710 | TSCC01-Remembering Scary Things | Trauma Symptom Checklist for Children - Remembering scary things. | TSCC - Remembering Scary Things | ||
TSCC01-Remembering Things Don't Want To | C147741 | TSCC01-Remembering Things Don't Want To | Trauma Symptom Checklist for Children - Remembering things I don't want to remember. | TSCC - Remembering Things Don't Want To | ||
TSCC01-Remembering Things I Didn't Like | C147708 | TSCC01-Remembering Things I Didn't Like | Trauma Symptom Checklist for Children - Remembering things that happened that I didn't like. | TSCC - Remembering Things I Didn't Like | ||
TSCC01-Scared When Think About Sex | C147738 | TSCC01-Scared When Think About Sex | Trauma Symptom Checklist for Children - Getting scared or upset when I think about sex. | TSCC - Scared When Think About Sex | ||
TSCC01-Scary Ideas Just Pop Into My Head | C147701 | TSCC01-Scary Ideas Just Pop Into My Head | Trauma Symptom Checklist for Children - Scary ideas or pictures just pop into my head. | TSCC - Scary Ideas Just Pop Into My Head | ||
TSCC01-Think About Sex When Don't Want | C147721 | TSCC01-Think About Sex When Don't Want | Trauma Symptom Checklist for Children - Thinking about sex when I don't want to. | TSCC - Think About Sex When Don't Want | ||
TSCC01-Think Touch People Private Parts | C147720 | TSCC01-Think Touch People Private Parts | Trauma Symptom Checklist for Children - Thinking about touching other people's private parts. | TSCC - Think Touch People Private Parts | ||
TSCC01-Thinking About Having Sex | C147715 | TSCC01-Thinking About Having Sex | Trauma Symptom Checklist for Children - Thinking about having sex. | TSCC - Thinking About Having Sex | ||
TSCC01-Touching Private Parts Too Much | C147706 | TSCC01-Touching Private Parts Too Much | Trauma Symptom Checklist for Children - Touching my private parts too much. | TSCC - Touching Private Parts Too Much | ||
TSCC01-Trying Not to Have Any Feelings | C147746 | TSCC01-Trying Not to Have Any Feelings | Trauma Symptom Checklist for Children - Trying not to have any feelings. | TSCC - Trying Not to Have Any Feelings | ||
TSCC01-Wanting to Hurt Myself | C147718 | TSCC01-Wanting to Hurt Myself | Trauma Symptom Checklist for Children - Wanting to hurt myself. | TSCC - Wanting to Hurt Myself | ||
TSCC01-Wanting to Hurt Other People | C147719 | TSCC01-Wanting to Hurt Other People | Trauma Symptom Checklist for Children - Wanting to hurt other people. | TSCC - Wanting to Hurt Other People | ||
TSCC01-Wanting to Kill Myself | C147750 | TSCC01-Wanting to Kill Myself | Trauma Symptom Checklist for Children - Wanting to kill myself. | TSCC - Wanting to Kill Myself | ||
TSCC01-Wanting to Say Dirty Words | C147702 | TSCC01-Wanting to Say Dirty Words | Trauma Symptom Checklist for Children - Wanting to say dirty words. | TSCC - Wanting to Say Dirty Words | ||
TSCC01-Wanting to Yell and Break Things | C147711 | TSCC01-Wanting to Yell and Break Things | Trauma Symptom Checklist for Children - Wanting to yell and break things. | TSCC - Wanting to Yell and Break Things | ||
TSCC01-Wanting to Yell at People | C147717 | TSCC01-Wanting to Yell at People | Trauma Symptom Checklist for Children - Wanting to yell at people. | TSCC - Wanting to Yell at People | ||
TSCC01-Washing Myself Because Feel Dirty | C147724 | TSCC01-Washing Myself Because Feel Dirty | Trauma Symptom Checklist for Children - Washing myself because I feel dirty on the inside. | TSCC - Washing Myself Because Feel Dirty | ||
TSCC01-Wishing Bad Things Never Happened | C147749 | TSCC01-Wishing Bad Things Never Happened | Trauma Symptom Checklist for Children - Wishing bad things had never happened. | TSCC - Wishing Bad Things Never Happened | ||
TSCC01-Worrying About Things | C147739 | TSCC01-Worrying About Things | Trauma Symptom Checklist for Children - Worrying about things. | TSCC - Worrying About Things | ||
Back to top | ||||||
CL.C147550.TSCYC1TC | Trauma Symptom Checklist for Young Children Questionnaire Test Code
(TSCYC1TC) | text
Extensible: No | C147550 | Trauma Symptom Checklist for Young Children Questionnaire Test Code | Trauma Symptom Checklist for Young Children test code. | CDISC Questionnaire TSCYC Test Code Terminology |
TSCYC101 | C147753 | TSCYC1-Temper Tantrums | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Temper tantrums. | TSCYC - Temper Tantrums | ||
TSCYC102 | C147754 | TSCYC1-Looking Sad | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Looking sad. | TSCYC - Looking Sad | ||
TSCYC103 | C147755 | TSCYC1-Telling a Lie | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Telling a lie. | TSCYC - Telling a Lie | ||
TSCYC104 | C147756 | TSCYC1-Bad Dreams or Nightmares | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Bad dreams or nightmares. | TSCYC - Bad Dreams or Nightmares | ||
TSCYC105 | C147757 | TSCYC1-Living in a Fantasy World | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Living in a fantasy world. | TSCYC - Living in a Fantasy World | ||
TSCYC106 | C147758 | TSCYC1-Seeming to Know More About Sex | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Seeming to know more about sex than he or she should. | TSCYC - Seeming to Know More About Sex | ||
TSCYC107 | C147759 | TSCYC1-Being Easily Scared | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being easily scared. | TSCYC - Being Easily Scared | ||
TSCYC108 | C147760 | TSCYC1-Not Wanting to Go Somewhere | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not wanting to go somewhere that reminded him or her of a bad thing from the past. | TSCYC - Not Wanting to Go Somewhere | ||
TSCYC109 | C147761 | TSCYC1-Worrying Food Was Poisoned | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that his or her food was poisoned. | TSCYC - Worrying Food Was Poisoned | ||
TSCYC110 | C147762 | TSCYC1-Flinching When Someone Moved | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Flinching or jumping when someone moved quickly or there was a loud noise. | TSCYC - Flinching When Someone Moved | ||
TSCYC111 | C147763 | TSCYC1-Being Bothered by Memories | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being bothered by memories of something that happened to him or her. | TSCYC - Being Bothered by Memories | ||
TSCYC112 | C147764 | TSCYC1-Worrying Someone Might Be Sexual | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that someone might be sexual with him or her. | TSCYC - Worrying Someone Might Be Sexual | ||
TSCYC113 | C147765 | TSCYC1-Not Wanting to Talk | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not wanting to talk about something that happened to him or her. | TSCYC - Not Wanting to Talk | ||
TSCYC114 | C147766 | TSCYC1-Not Do Something Supposed to Do | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not doing something he or she was supposed to do. | TSCYC - Not Do Something Supposed to Do | ||
TSCYC115 | C147767 | TSCYC1-Breaking Things on Purpose | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Breaking things on purpose. | TSCYC - Breaking Things on Purpose | ||
TSCYC116 | C147768 | TSCYC1-Talking About Sexual Things | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Talking about sexual things. | TSCYC - Talking About Sexual Things | ||
TSCYC117 | C147769 | TSCYC1-Having Trouble Concentrating | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble concentrating. | TSCYC - Having Trouble Concentrating | ||
TSCYC118 | C147770 | TSCYC1-Blaming for Things Weren't Fault | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Blaming himself or herself for things that weren't his or her fault. | TSCYC - Blaming for Things Weren't Fault | ||
TSCYC119 | C147771 | TSCYC1-Acting Frightened Reminded Past | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Acting frightened when he or she was reminded of something that happened in the past. | TSCYC - Acting Frightened Reminded Past | ||
TSCYC120 | C147772 | TSCYC1-Pretending to Have Sex | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Pretending to have sex. | TSCYC - Pretending to Have Sex | ||
TSCYC121 | C147773 | TSCYC1-Worrying Bad Things in Future | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that bad things would happen in the future. | TSCYC - Worrying Bad Things in Future | ||
TSCYC122 | C147774 | TSCYC1-Arguing | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Arguing. | TSCYC - Arguing | ||
TSCYC123 | C147775 | TSCYC1-Getting Into Physical Fights | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Getting into physical fights. | TSCYC - Getting Into Physical Fights | ||
TSCYC124 | C147776 | TSCYC1-Drawing Pictures Upsetting Thing | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Drawing pictures about an upsetting thing that happened to him or her. | TSCYC - Drawing Pictures Upsetting Thing | ||
TSCYC125 | C147777 | TSCYC1-Not Noticing What He or She Doing | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not noticing what he or she was doing. | TSCYC - Not Noticing What He or She Doing | ||
TSCYC126 | C147778 | TSCYC1-Having Trouble Sitting Still | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble sitting still. | TSCYC - Having Trouble Sitting Still | ||
TSCYC127 | C147779 | TSCYC1-Playing Games Something Bad Past | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Playing games about something bad that actually happened to him or her in the past. | TSCYC - Playing Games Something Bad Past | ||
TSCYC128 | C147780 | TSCYC1-Seeming to Be in a Daze | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Seeming to be in a daze. | TSCYC - Seeming to Be in a Daze | ||
TSCYC129 | C147781 | TSCYC1-Trouble Remember Upsetting Thing | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble remembering an upsetting thing that happened in the past. | TSCYC - Trouble Remember Upsetting Thing | ||
TSCYC130 | C147782 | TSCYC1-Using Drugs | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Using drugs. | TSCYC - Using Drugs | ||
TSCYC131 | C147783 | TSCYC1-Fear of the Dark | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Fear of the dark. | TSCYC - Fear of the Dark | ||
TSCYC132 | C147784 | TSCYC1-Being Afraid to Be Alone | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being afraid to be alone. | TSCYC - Being Afraid to Be Alone | ||
TSCYC133 | C147785 | TSCYC1-Spacing Out | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Spacing out. | TSCYC - Spacing Out | ||
TSCYC134 | C147786 | TSCYC1-Being Too Aggressive | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being too aggressive. | TSCYC - Being Too Aggressive | ||
TSCYC135 | C147787 | TSCYC1-Touching Other Private Parts | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Touching other children's or adults' private parts (under or over clothes). | TSCYC - Touching Other Private Parts | ||
TSCYC136 | C147788 | TSCYC1-Seeing Bad Happened in the Past | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Suddenly seeing, feeling, or hearing something bad that happened in the past. | TSCYC - Seeing Bad Happened in the Past | ||
TSCYC137 | C147789 | TSCYC1-Hearing Voices to Hurt Someone | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hearing voices telling him or her to hurt someone. | TSCYC - Hearing Voices to Hurt Someone | ||
TSCYC138 | C147790 | TSCYC1-Staring Off Into Space | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Staring off into space. | TSCYC - Staring Off Into Space | ||
TSCYC139 | C147791 | TSCYC1-Changing Subject About Bad Thing | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Changing the subject or not answering when he or she was asked about a bad thing that happened to him or her. | TSCYC - Changing Subject About Bad Thing | ||
TSCYC140 | C147792 | TSCYC1-Having a Nervous Breakdown | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Having a nervous breakdown. | TSCYC - Having a Nervous Breakdown | ||
TSCYC141 | C147793 | TSCYC1-Not Happy Like Other Children | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not laughing or being happy like other children. | TSCYC - Not Happy Like Other Children | ||
TSCYC142 | C147794 | TSCYC1-Crying at Night Frightened | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying at night because he or she was frightened. | TSCYC - Crying at Night Frightened | ||
TSCYC143 | C147795 | TSCYC1-Hitting Adults | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hitting adults (including parents). | TSCYC - Hitting Adults | ||
TSCYC144 | C147796 | TSCYC1-Being Frightened of Men | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being frightened of men. | TSCYC - Being Frightened of Men | ||
TSCYC145 | C147797 | TSCYC1-Not Being Able to Pay Attention | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not being able to pay attention. | TSCYC - Not Being Able to Pay Attention | ||
TSCYC146 | C147798 | TSCYC1-Seeming to Be Million Miles Away | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Seeming to be a million miles away. | TSCYC - Seeming to Be Million Miles Away | ||
TSCYC147 | C147799 | TSCYC1-Being Easily Startled | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being easily startled. | TSCYC - Being Easily Startled | ||
TSCYC148 | C147800 | TSCYC1-Watching Out for Possible Danger | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Watching out everywhere for possible danger. | TSCYC - Watching Out for Possible Danger | ||
TSCYC149 | C147801 | TSCYC1-No Longer Doing Things Enjoy | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: No longer doing things that he or she used to enjoy. | TSCYC - No Longer Doing Things Enjoy | ||
TSCYC150 | C147802 | TSCYC1-Frightened Something Sexual Seen | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Becoming frightened or disturbed when something sexual was mentioned or seen. | TSCYC - Frightened Something Sexual Seen | ||
TSCYC151 | C147803 | TSCYC1-Not Sleeping for Two or More Days | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not sleeping for two or more days. | TSCYC - Not Sleeping for Two or More Days | ||
TSCYC152 | C147804 | TSCYC1-Not Paying Attention in Own World | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not paying attention because he or she was in his or her own world. | TSCYC - Not Paying Attention in Own World | ||
TSCYC153 | C147805 | TSCYC1-Making Mistakes | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Making mistakes. | TSCYC - Making Mistakes | ||
TSCYC154 | C147806 | TSCYC1-Crying for No Obvious Reason | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying for no obvious reason. | TSCYC - Crying for No Obvious Reason | ||
TSCYC155 | C147807 | TSCYC1-Not Wanting to Be Around Someone | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not wanting to be around someone who did something bad to him or her or reminded him or her of something bad. | TSCYC - Not Wanting to Be Around Someone | ||
TSCYC156 | C147808 | TSCYC1-Being Tense | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being tense. | TSCYC - Being Tense | ||
TSCYC157 | C147809 | TSCYC1-Worrying About People's Safety | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Worrying about other people's safety. | TSCYC - Worrying About People's Safety | ||
TSCYC158 | C147810 | TSCYC1-Very Angry Over a Little Thing | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Becoming very angry over a little thing. | TSCYC - Very Angry Over a Little Thing | ||
TSCYC159 | C147811 | TSCYC1-Drawing Pictures About Sex Things | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Drawing pictures about sexual things. | TSCYC - Drawing Pictures About Sex Things | ||
TSCYC160 | C147812 | TSCYC1-Pulling His or Her Hair Out | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Pulling his or her hair out. | TSCYC - Pulling His or Her Hair Out | ||
TSCYC161 | C147813 | TSCYC1-Calling Himself or Herself Bad | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Calling himself or herself bad, stupid, or ugly. | TSCYC - Calling Himself or Herself Bad | ||
TSCYC162 | C147814 | TSCYC1-Throwing Things at Friends/Family | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Throwing things at friends or family members. | TSCYC - Throwing Things at Friends/Family | ||
TSCYC163 | C147815 | TSCYC1-Getting Upset About the Past | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset about something in the past. | TSCYC - Getting Upset About the Past | ||
TSCYC164 | C147816 | TSCYC1-Temporary Blindness or Paralysis | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Temporary blindness or paralysis. | TSCYC - Temporary Blindness or Paralysis | ||
TSCYC165 | C147817 | TSCYC1-Getting Upset Something Sexual | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset about something sexual. | TSCYC - Getting Upset Something Sexual | ||
TSCYC166 | C147818 | TSCYC1-Not Going to Bed First Time Asked | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not going to bed at night the first time he or she was asked. | TSCYC - Not Going to Bed First Time Asked | ||
TSCYC167 | C147819 | TSCYC1-Fear He or She Killed by Someone | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Fear that he or she would be killed by someone. | TSCYC - Fear He or She Killed by Someone | ||
TSCYC168 | C147820 | TSCYC1-Saying Nobody Liked Him or Her | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying that nobody liked him or her. | TSCYC - Saying Nobody Liked Him or Her | ||
TSCYC169 | C147821 | TSCYC1-Crying When Reminded From Past | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying when he or she was reminded of something from the past. | TSCYC - Crying When Reminded From Past | ||
TSCYC170 | C147822 | TSCYC1-Saying Bad Didn't Happen | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying that something bad didn't happen to him or her even though it did happen. | TSCYC - Saying Bad Didn't Happen | ||
TSCYC171 | C147823 | TSCYC1-Saying He or She Wanted to Die | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying he or she wanted to die or be killed. | TSCYC - Saying He or She Wanted to Die | ||
TSCYC172 | C147824 | TSCYC1-Acting as If Didn't Have Feelings | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting as if he or she didn't have any feelings about something bad that happened to him or her. | TSCYC - Acting as If Didn't Have Feelings | ||
TSCYC173 | C147825 | TSCYC1-Whining | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Whining. | TSCYC - Whining | ||
TSCYC174 | C147826 | TSCYC1-Not Sleeping Well | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not sleeping well. | TSCYC - Not Sleeping Well | ||
TSCYC175 | C147827 | TSCYC1-Worrying About Sexual Things | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Worrying about sexual things. | TSCYC - Worrying About Sexual Things | ||
TSCYC176 | C147828 | TSCYC1-Being Frightened by Things | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being frightened by things that didn't used to scare him or her. | TSCYC - Being Frightened by Things | ||
TSCYC177 | C147829 | TSCYC1-Hallucinating | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hallucinating. | TSCYC - Hallucinating | ||
TSCYC178 | C147830 | TSCYC1-Acting Like He/She Was in Trance | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting like he or she was in a trance. | TSCYC - Acting Like He or She Was in Trance | ||
TSCYC179 | C147831 | TSCYC1-Forgetting His or Her Own Name | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Forgetting his or her own name. | TSCYC - Forgetting His or Her Own Name | ||
TSCYC180 | C147832 | TSCYC1-Upset When Reminded Bad Happened | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset when he or she was reminded of something bad that happened. | TSCYC - Upset When Reminded Bad Happened | ||
TSCYC181 | C147833 | TSCYC1-Avoiding Bad Happened in Past | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Avoiding things that reminded him or her of a bad thing that had happened in the past. | TSCYC - Avoiding Bad Happened in Past | ||
TSCYC182 | C147834 | TSCYC1-Acting Jumpy | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting jumpy. | TSCYC - Acting Jumpy | ||
TSCYC183 | C147835 | TSCYC1-Making a Mess | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Making a mess. | TSCYC - Making a Mess | ||
TSCYC184 | C147836 | TSCYC1-Acting Sad or Depressed | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting sad or depressed. | TSCYC - Acting Sad or Depressed | ||
TSCYC185 | C147837 | TSCYC1-Being Absent-minded | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being so absent-minded that he or she didn't notice what was going on around him or her. | TSCYC - Being Absent-minded | ||
TSCYC186 | C147838 | TSCYC1-Not Wanting to Eat Certain Foods | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not wanting to eat certain foods. | TSCYC - Not Wanting to Eat Certain Foods | ||
TSCYC187 | C147839 | TSCYC1-Yelling at Family/Friend/Teachers | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Yelling at family, friends, or teachers. | TSCYC - Yelling at Family, Friends or Teachers | ||
TSCYC188 | C147840 | TSCYC1-Not Playing Because Depressed | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not playing because he or she was depressed. | TSCYC - Not Playing Because Depressed | ||
TSCYC189 | C147841 | TSCYC1-Being Disobedient | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being disobedient. | TSCYC - Being Disobedient | ||
TSCYC190 | C147842 | TSCYC1-Intentionally Hurt Other Children | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Intentionally hurting other children or family members. | TSCYC - Intentionally Hurt Other Children | ||
Back to top | ||||||
CL.C147549.TSCYC1TN | Trauma Symptom Checklist for Young Children Questionnaire Test Name
(TSCYC1TN) | text
Extensible: No | C147549 | Trauma Symptom Checklist for Young Children Questionnaire Test Name | Trauma Symptom Checklist for Young Children test name. | CDISC Questionnaire TSCYC Test Name Terminology |
TSCYC1-Acting as If Didn't Have Feelings | C147824 | TSCYC1-Acting as If Didn't Have Feelings | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting as if he or she didn't have any feelings about something bad that happened to him or her. | TSCYC - Acting as If Didn't Have Feelings | ||
TSCYC1-Acting Frightened Reminded Past | C147771 | TSCYC1-Acting Frightened Reminded Past | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Acting frightened when he or she was reminded of something that happened in the past. | TSCYC - Acting Frightened Reminded Past | ||
TSCYC1-Acting Jumpy | C147834 | TSCYC1-Acting Jumpy | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting jumpy. | TSCYC - Acting Jumpy | ||
TSCYC1-Acting Like He/She Was in Trance | C147830 | TSCYC1-Acting Like He/She Was in Trance | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting like he or she was in a trance. | TSCYC - Acting Like He or She Was in Trance | ||
TSCYC1-Acting Sad or Depressed | C147836 | TSCYC1-Acting Sad or Depressed | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Acting sad or depressed. | TSCYC - Acting Sad or Depressed | ||
TSCYC1-Arguing | C147774 | TSCYC1-Arguing | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Arguing. | TSCYC - Arguing | ||
TSCYC1-Avoiding Bad Happened in Past | C147833 | TSCYC1-Avoiding Bad Happened in Past | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Avoiding things that reminded him or her of a bad thing that had happened in the past. | TSCYC - Avoiding Bad Happened in Past | ||
TSCYC1-Bad Dreams or Nightmares | C147756 | TSCYC1-Bad Dreams or Nightmares | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Bad dreams or nightmares. | TSCYC - Bad Dreams or Nightmares | ||
TSCYC1-Being Absent-minded | C147837 | TSCYC1-Being Absent-minded | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being so absent-minded that he or she didn't notice what was going on around him or her. | TSCYC - Being Absent-minded | ||
TSCYC1-Being Afraid to Be Alone | C147784 | TSCYC1-Being Afraid to Be Alone | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being afraid to be alone. | TSCYC - Being Afraid to Be Alone | ||
TSCYC1-Being Bothered by Memories | C147763 | TSCYC1-Being Bothered by Memories | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being bothered by memories of something that happened to him or her. | TSCYC - Being Bothered by Memories | ||
TSCYC1-Being Disobedient | C147841 | TSCYC1-Being Disobedient | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being disobedient. | TSCYC - Being Disobedient | ||
TSCYC1-Being Easily Scared | C147759 | TSCYC1-Being Easily Scared | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being easily scared. | TSCYC - Being Easily Scared | ||
TSCYC1-Being Easily Startled | C147799 | TSCYC1-Being Easily Startled | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being easily startled. | TSCYC - Being Easily Startled | ||
TSCYC1-Being Frightened by Things | C147828 | TSCYC1-Being Frightened by Things | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being frightened by things that didn't used to scare him or her. | TSCYC - Being Frightened by Things | ||
TSCYC1-Being Frightened of Men | C147796 | TSCYC1-Being Frightened of Men | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being frightened of men. | TSCYC - Being Frightened of Men | ||
TSCYC1-Being Tense | C147808 | TSCYC1-Being Tense | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Being tense. | TSCYC - Being Tense | ||
TSCYC1-Being Too Aggressive | C147786 | TSCYC1-Being Too Aggressive | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Being too aggressive. | TSCYC - Being Too Aggressive | ||
TSCYC1-Blaming for Things Weren't Fault | C147770 | TSCYC1-Blaming for Things Weren't Fault | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Blaming himself or herself for things that weren't his or her fault. | TSCYC - Blaming for Things Weren't Fault | ||
TSCYC1-Breaking Things on Purpose | C147767 | TSCYC1-Breaking Things on Purpose | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Breaking things on purpose. | TSCYC - Breaking Things on Purpose | ||
TSCYC1-Calling Himself or Herself Bad | C147813 | TSCYC1-Calling Himself or Herself Bad | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Calling himself or herself bad, stupid, or ugly. | TSCYC - Calling Himself or Herself Bad | ||
TSCYC1-Changing Subject About Bad Thing | C147791 | TSCYC1-Changing Subject About Bad Thing | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Changing the subject or not answering when he or she was asked about a bad thing that happened to him or her. | TSCYC - Changing Subject About Bad Thing | ||
TSCYC1-Crying at Night Frightened | C147794 | TSCYC1-Crying at Night Frightened | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying at night because he or she was frightened. | TSCYC - Crying at Night Frightened | ||
TSCYC1-Crying for No Obvious Reason | C147806 | TSCYC1-Crying for No Obvious Reason | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying for no obvious reason. | TSCYC - Crying for No Obvious Reason | ||
TSCYC1-Crying When Reminded From Past | C147821 | TSCYC1-Crying When Reminded From Past | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Crying when he or she was reminded of something from the past. | TSCYC - Crying When Reminded From Past | ||
TSCYC1-Drawing Pictures About Sex Things | C147811 | TSCYC1-Drawing Pictures About Sex Things | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Drawing pictures about sexual things. | TSCYC - Drawing Pictures About Sex Things | ||
TSCYC1-Drawing Pictures Upsetting Thing | C147776 | TSCYC1-Drawing Pictures Upsetting Thing | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Drawing pictures about an upsetting thing that happened to him or her. | TSCYC - Drawing Pictures Upsetting Thing | ||
TSCYC1-Fear He or She Killed by Someone | C147819 | TSCYC1-Fear He or She Killed by Someone | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Fear that he or she would be killed by someone. | TSCYC - Fear He or She Killed by Someone | ||
TSCYC1-Fear of the Dark | C147783 | TSCYC1-Fear of the Dark | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Fear of the dark. | TSCYC - Fear of the Dark | ||
TSCYC1-Flinching When Someone Moved | C147762 | TSCYC1-Flinching When Someone Moved | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Flinching or jumping when someone moved quickly or there was a loud noise. | TSCYC - Flinching When Someone Moved | ||
TSCYC1-Forgetting His or Her Own Name | C147831 | TSCYC1-Forgetting His or Her Own Name | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Forgetting his or her own name. | TSCYC - Forgetting His or Her Own Name | ||
TSCYC1-Frightened Something Sexual Seen | C147802 | TSCYC1-Frightened Something Sexual Seen | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Becoming frightened or disturbed when something sexual was mentioned or seen. | TSCYC - Frightened Something Sexual Seen | ||
TSCYC1-Getting Into Physical Fights | C147775 | TSCYC1-Getting Into Physical Fights | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Getting into physical fights. | TSCYC - Getting Into Physical Fights | ||
TSCYC1-Getting Upset About the Past | C147815 | TSCYC1-Getting Upset About the Past | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset about something in the past. | TSCYC - Getting Upset About the Past | ||
TSCYC1-Getting Upset Something Sexual | C147817 | TSCYC1-Getting Upset Something Sexual | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset about something sexual. | TSCYC - Getting Upset Something Sexual | ||
TSCYC1-Hallucinating | C147829 | TSCYC1-Hallucinating | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hallucinating. | TSCYC - Hallucinating | ||
TSCYC1-Having a Nervous Breakdown | C147792 | TSCYC1-Having a Nervous Breakdown | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Having a nervous breakdown. | TSCYC - Having a Nervous Breakdown | ||
TSCYC1-Having Trouble Concentrating | C147769 | TSCYC1-Having Trouble Concentrating | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble concentrating. | TSCYC - Having Trouble Concentrating | ||
TSCYC1-Having Trouble Sitting Still | C147778 | TSCYC1-Having Trouble Sitting Still | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble sitting still. | TSCYC - Having Trouble Sitting Still | ||
TSCYC1-Hearing Voices to Hurt Someone | C147789 | TSCYC1-Hearing Voices to Hurt Someone | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hearing voices telling him or her to hurt someone. | TSCYC - Hearing Voices to Hurt Someone | ||
TSCYC1-Hitting Adults | C147795 | TSCYC1-Hitting Adults | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Hitting adults (including parents). | TSCYC - Hitting Adults | ||
TSCYC1-Intentionally Hurt Other Children | C147842 | TSCYC1-Intentionally Hurt Other Children | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Intentionally hurting other children or family members. | TSCYC - Intentionally Hurt Other Children | ||
TSCYC1-Living in a Fantasy World | C147757 | TSCYC1-Living in a Fantasy World | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Living in a fantasy world. | TSCYC - Living in a Fantasy World | ||
TSCYC1-Looking Sad | C147754 | TSCYC1-Looking Sad | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Looking sad. | TSCYC - Looking Sad | ||
TSCYC1-Making a Mess | C147835 | TSCYC1-Making a Mess | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Making a mess. | TSCYC - Making a Mess | ||
TSCYC1-Making Mistakes | C147805 | TSCYC1-Making Mistakes | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Making mistakes. | TSCYC - Making Mistakes | ||
TSCYC1-No Longer Doing Things Enjoy | C147801 | TSCYC1-No Longer Doing Things Enjoy | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: No longer doing things that he or she used to enjoy. | TSCYC - No Longer Doing Things Enjoy | ||
TSCYC1-Not Being Able to Pay Attention | C147797 | TSCYC1-Not Being Able to Pay Attention | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not being able to pay attention. | TSCYC - Not Being Able to Pay Attention | ||
TSCYC1-Not Do Something Supposed to Do | C147766 | TSCYC1-Not Do Something Supposed to Do | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not doing something he or she was supposed to do. | TSCYC - Not Do Something Supposed to Do | ||
TSCYC1-Not Going to Bed First Time Asked | C147818 | TSCYC1-Not Going to Bed First Time Asked | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not going to bed at night the first time he or she was asked. | TSCYC - Not Going to Bed First Time Asked | ||
TSCYC1-Not Happy Like Other Children | C147793 | TSCYC1-Not Happy Like Other Children | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not laughing or being happy like other children. | TSCYC - Not Happy Like Other Children | ||
TSCYC1-Not Noticing What He or She Doing | C147777 | TSCYC1-Not Noticing What He or She Doing | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not noticing what he or she was doing. | TSCYC - Not Noticing What He or She Doing | ||
TSCYC1-Not Paying Attention in Own World | C147804 | TSCYC1-Not Paying Attention in Own World | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not paying attention because he or she was in his or her own world. | TSCYC - Not Paying Attention in Own World | ||
TSCYC1-Not Playing Because Depressed | C147840 | TSCYC1-Not Playing Because Depressed | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not playing because he or she was depressed. | TSCYC - Not Playing Because Depressed | ||
TSCYC1-Not Sleeping for Two or More Days | C147803 | TSCYC1-Not Sleeping for Two or More Days | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not sleeping for two or more days. | TSCYC - Not Sleeping for Two or More Days | ||
TSCYC1-Not Sleeping Well | C147826 | TSCYC1-Not Sleeping Well | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not sleeping well. | TSCYC - Not Sleeping Well | ||
TSCYC1-Not Wanting to Be Around Someone | C147807 | TSCYC1-Not Wanting to Be Around Someone | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not wanting to be around someone who did something bad to him or her or reminded him or her of something bad. | TSCYC - Not Wanting to Be Around Someone | ||
TSCYC1-Not Wanting to Eat Certain Foods | C147838 | TSCYC1-Not Wanting to Eat Certain Foods | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Not wanting to eat certain foods. | TSCYC - Not Wanting to Eat Certain Foods | ||
TSCYC1-Not Wanting to Go Somewhere | C147760 | TSCYC1-Not Wanting to Go Somewhere | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not wanting to go somewhere that reminded him or her of a bad thing from the past. | TSCYC - Not Wanting to Go Somewhere | ||
TSCYC1-Not Wanting to Talk | C147765 | TSCYC1-Not Wanting to Talk | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Not wanting to talk about something that happened to him or her. | TSCYC - Not Wanting to Talk | ||
TSCYC1-Playing Games Something Bad Past | C147779 | TSCYC1-Playing Games Something Bad Past | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Playing games about something bad that actually happened to him or her in the past. | TSCYC - Playing Games Something Bad Past | ||
TSCYC1-Pretending to Have Sex | C147772 | TSCYC1-Pretending to Have Sex | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Pretending to have sex. | TSCYC - Pretending to Have Sex | ||
TSCYC1-Pulling His or Her Hair Out | C147812 | TSCYC1-Pulling His or Her Hair Out | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Pulling his or her hair out. | TSCYC - Pulling His or Her Hair Out | ||
TSCYC1-Saying Bad Didn't Happen | C147822 | TSCYC1-Saying Bad Didn't Happen | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying that something bad didn't happen to him or her even though it did happen. | TSCYC - Saying Bad Didn't Happen | ||
TSCYC1-Saying He or She Wanted to Die | C147823 | TSCYC1-Saying He or She Wanted to Die | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying he or she wanted to die or be killed. | TSCYC - Saying He or She Wanted to Die | ||
TSCYC1-Saying Nobody Liked Him or Her | C147820 | TSCYC1-Saying Nobody Liked Him or Her | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Saying that nobody liked him or her. | TSCYC - Saying Nobody Liked Him or Her | ||
TSCYC1-Seeing Bad Happened in the Past | C147788 | TSCYC1-Seeing Bad Happened in the Past | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Suddenly seeing, feeling, or hearing something bad that happened in the past. | TSCYC - Seeing Bad Happened in the Past | ||
TSCYC1-Seeming to Be in a Daze | C147780 | TSCYC1-Seeming to Be in a Daze | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Seeming to be in a daze. | TSCYC - Seeming to Be in a Daze | ||
TSCYC1-Seeming to Be Million Miles Away | C147798 | TSCYC1-Seeming to Be Million Miles Away | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Seeming to be a million miles away. | TSCYC - Seeming to Be Million Miles Away | ||
TSCYC1-Seeming to Know More About Sex | C147758 | TSCYC1-Seeming to Know More About Sex | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Seeming to know more about sex than he or she should. | TSCYC - Seeming to Know More About Sex | ||
TSCYC1-Spacing Out | C147785 | TSCYC1-Spacing Out | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Spacing out. | TSCYC - Spacing Out | ||
TSCYC1-Staring Off Into Space | C147790 | TSCYC1-Staring Off Into Space | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Staring off into space. | TSCYC - Staring Off Into Space | ||
TSCYC1-Talking About Sexual Things | C147768 | TSCYC1-Talking About Sexual Things | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Talking about sexual things. | TSCYC - Talking About Sexual Things | ||
TSCYC1-Telling a Lie | C147755 | TSCYC1-Telling a Lie | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Telling a lie. | TSCYC - Telling a Lie | ||
TSCYC1-Temper Tantrums | C147753 | TSCYC1-Temper Tantrums | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Temper tantrums. | TSCYC - Temper Tantrums | ||
TSCYC1-Temporary Blindness or Paralysis | C147816 | TSCYC1-Temporary Blindness or Paralysis | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Temporary blindness or paralysis. | TSCYC - Temporary Blindness or Paralysis | ||
TSCYC1-Throwing Things at Friends/Family | C147814 | TSCYC1-Throwing Things at Friends/Family | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Throwing things at friends or family members. | TSCYC - Throwing Things at Friends/Family | ||
TSCYC1-Touching Other Private Parts | C147787 | TSCYC1-Touching Other Private Parts | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Touching other children's or adults' private parts (under or over clothes). | TSCYC - Touching Other Private Parts | ||
TSCYC1-Trouble Remember Upsetting Thing | C147781 | TSCYC1-Trouble Remember Upsetting Thing | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Having trouble remembering an upsetting thing that happened in the past. | TSCYC - Trouble Remember Upsetting Thing | ||
TSCYC1-Upset When Reminded Bad Happened | C147832 | TSCYC1-Upset When Reminded Bad Happened | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Getting upset when he or she was reminded of something bad that happened. | TSCYC - Upset When Reminded Bad Happened | ||
TSCYC1-Using Drugs | C147782 | TSCYC1-Using Drugs | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Using drugs. | TSCYC - Using Drugs | ||
TSCYC1-Very Angry Over a Little Thing | C147810 | TSCYC1-Very Angry Over a Little Thing | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Becoming very angry over a little thing. | TSCYC - Very Angry Over a Little Thing | ||
TSCYC1-Watching Out for Possible Danger | C147800 | TSCYC1-Watching Out for Possible Danger | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Watching out everywhere for possible danger. | TSCYC - Watching Out for Possible Danger | ||
TSCYC1-Whining | C147825 | TSCYC1-Whining | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Whining. | TSCYC - Whining | ||
TSCYC1-Worrying About People's Safety | C147809 | TSCYC1-Worrying About People's Safety | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Worrying about other people's safety. | TSCYC - Worrying About People's Safety | ||
TSCYC1-Worrying About Sexual Things | C147827 | TSCYC1-Worrying About Sexual Things | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Worrying about sexual things. | TSCYC - Worrying About Sexual Things | ||
TSCYC1-Worrying Bad Things in Future | C147773 | TSCYC1-Worrying Bad Things in Future | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that bad things would happen in the future. | TSCYC - Worrying Bad Things in Future | ||
TSCYC1-Worrying Food Was Poisoned | C147761 | TSCYC1-Worrying Food Was Poisoned | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that his or her food was poisoned. | TSCYC - Worrying Food Was Poisoned | ||
TSCYC1-Worrying Someone Might Be Sexual | C147764 | TSCYC1-Worrying Someone Might Be Sexual | Trauma Symptom Checklist for Young Children - Please indicate how often he or she has done, felt, or experienced each of the following things in the last month: Worrying that someone might be sexual with him or her. | TSCYC - Worrying Someone Might Be Sexual | ||
TSCYC1-Yelling at Family/Friend/Teachers | C147839 | TSCYC1-Yelling at Family/Friend/Teachers | Trauma Symptom Checklist for Young Children - Please indicate how often the child has done, felt, or experienced each of the following things in the last month: Yelling at family, friends, or teachers. | TSCYC - Yelling at Family, Friends or Teachers | ||
Back to top | ||||||
CL.C124307.TRTINTNT | Treatment Intent
(TRTINTNT) | text
Extensible: Yes | C124307 | Treatment Intent | Terminology relevant to the intended disease outcome for which the treatment is given. | CDISC SDTM Treatment Intent Terminology |
CURATIVE | C62220 | Any action or response that serves to eliminate disease and prevent recurrence. | Cure | |||
PALLIATIVE | C101516 | Any action or response, without curative intent, that mitigates some or all of the unpleasant effects of a disease or condition. | Palliative | |||
PREVENTATIVE | C15843 | Prophylaxis | Any action or response to modify or stop the development of a disease. | Preventive Intervention | ||
SUPPORTIVE CARE | C15747 | Any action or process to maximize comfort, minimize side effects, or mitigate against a decline in the participant's health or function. (clinicaltrials.gov) | Supportive Care | |||
Back to top | ||||||
CL.C132525.TSQM01TC | Treatment Satisfaction Questionnaire for Medication Version 1.4 Questionnaire Test Code
(TSQM01TC) | text
Extensible: No | C132525 | Treatment Satisfaction Questionnaire for Medication Version 1.4 Questionnaire Test Code | Treatment Satisfaction Questionnaire for Medication Version 1.4 test code. | CDISC Questionnaire TSQM Version 1.4 Test Code Terminology |
TSQM0101 | C132618 | TSQM01-Med to Prevent/Treat Condition | Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the ability of the medication to prevent or treat your condition? | TSQM Version 1.4 - Medication to Prevent or Treat Condition | ||
TSQM0102 | C132619 | TSQM01-Way Medication Relieves Symptoms | Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the way the medication relieves your symptoms? | TSQM Version 1.4 - Way Medication Relieves Symptoms | ||
TSQM0103 | C132620 | TSQM01-Time Takes Med to Start Working | Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the amount of time it takes the medication to start working? | TSQM Version 1.4 - Time Takes Medication to Start Working | ||
TSQM0104 | C132621 | TSQM01-Experience Any Side Effect at All | Treatment Satisfaction Questionnaire for Medication - As a result of taking this medication, do you experience any side effects at all? | TSQM Version 1.4 - Experience Any Side Effect at All | ||
TSQM0105 | C132622 | TSQM01-How Bothersome Are Side Effects | Treatment Satisfaction Questionnaire for Medication - How bothersome are the side effects of the medication you take to treat your condition? | TSQM Version 1.4 - How Bothersome Are Side Effects | ||
TSQM0106 | C132623 | TSQM01-Interfere With Physical Health | Treatment Satisfaction Questionnaire for Medication - To what extent do the side effects interfere with your physical health and ability to function (i.e., strength, energy levels, etc.)? | TSQM Version 1.4 - Interfere With Physical Health | ||
TSQM0107 | C132624 | TSQM01-Interfere With Mental Function | Treatment Satisfaction Questionnaire for Medication - To what extent do the side effects interfere with your mental function (i.e., ability to think clearly, stay awake, etc.)? | TSQM Version 1.4 - Interfere With Mental Function | ||
TSQM0108 | C132625 | TSQM01-Side Effect Affect Overall Satisf | Treatment Satisfaction Questionnaire for Medication - To what degree have medication side effects affected your overall satisfaction with the medication? | TSQM Version 1.4 - Side Effect Affect Overall Satisfaction | ||
TSQM0109 | C132626 | TSQM01-Easy/Difficult Use Medication | Treatment Satisfaction Questionnaire for Medication - How easy or difficult is it to use the medication in its current form? | TSQM Version 1.4 - Easy or Difficult Use Medication | ||
TSQM0110 | C132627 | TSQM01-Easy/Difficult to Plan Use of Med | Treatment Satisfaction Questionnaire for Medication - How easy or difficult is it to plan when you will use the medication each time? | TSQM Version 1.4 - Easy or Difficult to Plan Use of Medication | ||
TSQM0111 | C132628 | TSQM01-Convenient/Inconvenient Take Med | Treatment Satisfaction Questionnaire for Medication - How convenient or inconvenient is it to take the medication as instructed? | TSQM Version 1.4 - Convenient or Inconvenient Take Medication | ||
TSQM0112 | C132629 | TSQM01-Confident Med Is Good for You | Treatment Satisfaction Questionnaire for Medication - Overall, how confident are you that taking this medication is a good thing for you? | TSQM Version 1.4 - Confident Medication Is Good for You | ||
TSQM0113 | C132630 | TSQM01-Certain Good Things Outweigh Bad | Treatment Satisfaction Questionnaire for Medication - How certain are you that the good things about your medication outweigh the bad things? | TSQM Version 1.4 - Certain Good Things Outweigh Bad | ||
TSQM0114 | C132631 | TSQM01-Satisfied/Dissatisfied With Med | Treatment Satisfaction Questionnaire for Medication - Taking all things into account, how satisfied or dissatisfied are you with this medication? | TSQM Version 1.4 - Satisfied or Dissatisfied With Medication | ||
Back to top | ||||||
CL.C132524.TSQM01TN | Treatment Satisfaction Questionnaire for Medication Version 1.4 Questionnaire Test Name
(TSQM01TN) | text
Extensible: No | C132524 | Treatment Satisfaction Questionnaire for Medication Version 1.4 Questionnaire Test Name | Treatment Satisfaction Questionnaire for Medication Version 1.4 test name. | CDISC Questionnaire TSQM Version 1.4 Test Name Terminology |
TSQM01-Certain Good Things Outweigh Bad | C132630 | TSQM01-Certain Good Things Outweigh Bad | Treatment Satisfaction Questionnaire for Medication - How certain are you that the good things about your medication outweigh the bad things? | TSQM Version 1.4 - Certain Good Things Outweigh Bad | ||
TSQM01-Confident Med Is Good for You | C132629 | TSQM01-Confident Med Is Good for You | Treatment Satisfaction Questionnaire for Medication - Overall, how confident are you that taking this medication is a good thing for you? | TSQM Version 1.4 - Confident Medication Is Good for You | ||
TSQM01-Convenient/Inconvenient Take Med | C132628 | TSQM01-Convenient/Inconvenient Take Med | Treatment Satisfaction Questionnaire for Medication - How convenient or inconvenient is it to take the medication as instructed? | TSQM Version 1.4 - Convenient or Inconvenient Take Medication | ||
TSQM01-Easy/Difficult to Plan Use of Med | C132627 | TSQM01-Easy/Difficult to Plan Use of Med | Treatment Satisfaction Questionnaire for Medication - How easy or difficult is it to plan when you will use the medication each time? | TSQM Version 1.4 - Easy or Difficult to Plan Use of Medication | ||
TSQM01-Easy/Difficult Use Medication | C132626 | TSQM01-Easy/Difficult Use Medication | Treatment Satisfaction Questionnaire for Medication - How easy or difficult is it to use the medication in its current form? | TSQM Version 1.4 - Easy or Difficult Use Medication | ||
TSQM01-Experience Any Side Effect at All | C132621 | TSQM01-Experience Any Side Effect at All | Treatment Satisfaction Questionnaire for Medication - As a result of taking this medication, do you experience any side effects at all? | TSQM Version 1.4 - Experience Any Side Effect at All | ||
TSQM01-How Bothersome Are Side Effects | C132622 | TSQM01-How Bothersome Are Side Effects | Treatment Satisfaction Questionnaire for Medication - How bothersome are the side effects of the medication you take to treat your condition? | TSQM Version 1.4 - How Bothersome Are Side Effects | ||
TSQM01-Interfere With Mental Function | C132624 | TSQM01-Interfere With Mental Function | Treatment Satisfaction Questionnaire for Medication - To what extent do the side effects interfere with your mental function (i.e., ability to think clearly, stay awake, etc.)? | TSQM Version 1.4 - Interfere With Mental Function | ||
TSQM01-Interfere With Physical Health | C132623 | TSQM01-Interfere With Physical Health | Treatment Satisfaction Questionnaire for Medication - To what extent do the side effects interfere with your physical health and ability to function (i.e., strength, energy levels, etc.)? | TSQM Version 1.4 - Interfere With Physical Health | ||
TSQM01-Med to Prevent/Treat Condition | C132618 | TSQM01-Med to Prevent/Treat Condition | Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the ability of the medication to prevent or treat your condition? | TSQM Version 1.4 - Medication to Prevent or Treat Condition | ||
TSQM01-Satisfied/Dissatisfied With Med | C132631 | TSQM01-Satisfied/Dissatisfied With Med | Treatment Satisfaction Questionnaire for Medication - Taking all things into account, how satisfied or dissatisfied are you with this medication? | TSQM Version 1.4 - Satisfied or Dissatisfied With Medication | ||
TSQM01-Side Effect Affect Overall Satisf | C132625 | TSQM01-Side Effect Affect Overall Satisf | Treatment Satisfaction Questionnaire for Medication - To what degree have medication side effects affected your overall satisfaction with the medication? | TSQM Version 1.4 - Side Effect Affect Overall Satisfaction | ||
TSQM01-Time Takes Med to Start Working | C132620 | TSQM01-Time Takes Med to Start Working | Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the amount of time it takes the medication to start working? | TSQM Version 1.4 - Time Takes Medication to Start Working | ||
TSQM01-Way Medication Relieves Symptoms | C132619 | TSQM01-Way Medication Relieves Symptoms | Treatment Satisfaction Questionnaire for Medication - How satisfied or dissatisfied are you with the way the medication relieves your symptoms? | TSQM Version 1.4 - Way Medication Relieves Symptoms | ||
Back to top | ||||||
CL.C124308.TRTSET | Treatment Setting
(TRTSET) | text
Extensible: Yes | C124308 | Treatment Setting | Terminology relevant to the clinical trial or treatment setting for the therapy of interest. | CDISC SDTM Treatment Setting Terminology |
ADJUVANT | C124450 | A clinical trial or treatment setting in which the therapy of interest is considered adjuvant. | Adjuvant Therapy Clinical Trial Setting | |||
CONDITIONING | C156597 | A clinical trial or treatment setting in which the therapy of interest is considered conditioning therapy. | Conditioning Clinical Trial Setting | |||
CONSOLIDATION | C156599 | A clinical trial or treatment setting in which the therapy of interest is considered consolidation therapy. | Consolidation Clinical Trial Setting | |||
INDUCTION | C156595 | A clinical trial or treatment setting in which the therapy of interest is considered induction therapy. | Induction Clinical Trial Setting | |||
LOCALLY ADVANCED | C124451 | A clinical trial or treatment setting in which the therapy of interest is used to treat locally advanced disease. | Locally Advanced Disease Clinical Trial Setting | |||
MAINTENANCE | C156598 | A clinical trial or treatment setting in which the therapy of interest is considered maintenance therapy. | Maintenance Clinical Trial Setting | |||
METASTATIC | C124452 | A clinical trial or treatment setting in which the therapy of interest is used to treat metastatic disease. | Metastatic Disease Clinical Trial Setting | |||
MOBILIZATION | C156596 | A clinical trial or treatment setting in which the therapy of interest is considered mobilization therapy. | Mobilization Clinical Trial Setting | |||
NEO-ADJUVANT | C124453 | A clinical trial or treatment setting in which the therapy of interest is considered neo-adjuvant. | Neoadjuvant Therapy Clinical Trial Setting | |||
PREVENTATIVE | C124454 | A clinical trial or treatment setting in which the therapy of interest is considered preventative. | Preventative Therapy Clinical Trial Setting | |||
RADIOSENSITIZATION | C15464 | Any action that serves to increase the toxic or lethal effect of radiation therapy on cells, through physical, chemical, or pharmaceutical intervention. | Radiosensitization | |||
SALVAGE | C156600 | A clinical trial or treatment setting in which the therapy of interest is considered salvage therapy. | Salvage Clinical Trial Setting | |||
Back to top | ||||||
CL.C66735.TBLIND | Trial Blinding Schema Response
(TBLIND) | text
Extensible: Yes | C66735 | Trial Blinding Schema Response | A terminology codelist relevant to the type of blinding for the trial. | CDISC SDTM Trial Blinding Schema Terminology |
DOUBLE BLIND | C15228 | Double Masked;Double-Masked | A study in which neither the subject nor the study personnel interacting with the subject or data during the study knows what intervention a subject is receiving. | Double Blind Study | ||
OBSERVER BLIND | C187674 | A study in which the study personnel who measure, record, or assess the subject do not know which intervention the subject is receiving or, in the context of observational studies, do not know the external factors to which a subject has been exposed. | Observer Blind Study | |||
OPEN LABEL TO TREATMENT AND DOUBLE BLIND TO IMP DOSE | C156592 | A study in which the therapeutic treatment is open label but the dosing information of the investigational medicinal product (IMP) is double-blinded. | Open Label for Treatment And Double Blind to Dose | |||
OPEN LABEL | C49659 | A study in which subjects and study personnel know which intervention each subject is receiving. | Open Label Study | |||
SINGLE BLIND | C28233 | Single Masked;Single-Masked | A study in which one party, either the subject or study personnel, does not know which intervention is administered to the subject. | Single Blind Study | ||
Back to top | ||||||
CL.C66736.TINDTP | Trial Intent Type Response
(TINDTP) | text
Extensible: Yes | C66736 | Trial Intent Type Response | A terminology codelist relevant to the responses for the planned purpose of the therapy, device, or agent under study in the clinical trial. | CDISC SDTM Trial Indication Type Terminology |
BASIC SCIENCE | C15714 | Basic Research | A type of study designed to examine the basic mechanism of action (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov) | Basic Research | ||
CURE | C49654 | A type of study designed to evaluate intervention(s) aimed to cure a disease or condition. | Cure Study | |||
DEVICE FEASIBILITY | C139174 | An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial. (ClinicalTrials.gov) | Device Feasibility Study | |||
DIAGNOSIS | C49653 | A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition. | Diagnosis Study | |||
DISEASE MODIFYING | C170629 | A type of study designed to evaluate the effects of treatment(s) intended to cause a change in disease, syndrome, or condition beyond the point of treatment administration. | Disease Modifying Treatment Study | |||
HEALTH SERVICES RESEARCH | C15245 | A type of study designed to evaluate the delivery, processes, management, organization or financing of health care. (ClinicalTrials.gov) | Health Services Research | |||
MITIGATION | C49655 | A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen. (NCI) | Adverse Effect Mitigation Study | |||
PREVENTION | C49657 | Prophylaxis Study | A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen. | Prevention Study | ||
SCREENING | C71485 | A type of study designed to assess or examine methods of identifying a condition (or risk factors for a condition) in people who are not yet known to have the condition (or risk factor). (Clinicaltrials.gov) | Screening Study | |||
SUPPORTIVE CARE | C71486 | A type of study designed to evaluate one or more interventions where the primary intent is to maximize comfort, minimize side effects or mitigate against a decline in the subject's health or function. In general, supportive care interventions are not intended to cure a disease. (ClinicalTrials.gov) | Supportive Care Study | |||
TREATMENT | C49656 | Therapy Trial | A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition. | Treatment Study | ||
Back to top | ||||||
CL.C66737.TPHASE | Trial Phase Response
(TPHASE) | text
Extensible: Yes | C66737 | Trial Phase Response | A terminology codelist relevant to the phase, or stage, of the clinical trial. | CDISC SDTM Trial Phase Terminology |
NOT APPLICABLE | C48660 | NA;Not Applicable | Determination of a value is not relevant in the current context. (NCI) | Not Applicable | ||
PHASE 0 TRIAL | C54721 | 0;Pre-clinical Trial;Trial Phase 0 | First-in-human trials, in a small number of subjects, that are conducted before Phase 1 trials and are intended to assess new candidate therapeutic and imaging agents. The study agent is administered at a low dose for a limited time, and there is no therapeutic or diagnostic intent. NOTE: FDA Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies, January 2006 classifies such studies as Phase 1. NOTE: A Phase 0 study might not include any drug delivery but may be an exploration of human material from a study (e.g., tissue samples or biomarker determinations). [Improving the Quality of Cancer Clinical Trials: Workshop summary-Proceedings of the National Cancer Policy Forum Workshop, improving the Quality of Cancer Clinical Trials (Washington, DC, Oct 2007)] (CDISC glossary) | Phase 0 Trial | ||
PHASE I TRIAL | C15600 | 1;Trial Phase 1 | The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary) | Phase I Trial | ||
PHASE I/II TRIAL | C15693 | 1-2;Trial Phase 1-2 | A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II. | Phase I/II Trial | ||
PHASE I/II/III TRIAL | C198366 | 1/2/3;Trial Phase 1/2/3 | A study that begins as a Phase I study and transitions into Phases II and III based upon successful completion of each previous portion. | Phase I/II/III Trial | ||
PHASE I/III TRIAL | C198367 | 1/3;Trial Phase 1/3 | A study that begins as a Phase I study and transitions into a Phase III study upon successful completion of the Phase I portion. | Phase I/III Trial | ||
PHASE II TRIAL | C15601 | 2;Trial Phase 2 | Phase that includes the controlled clinical trials conducted to evaluate the safety and efficacy of the drug in a limited number of patients with the disease or condition under study. Objectives can be dose-ranging (dose-response, frequency of dosing), type of patients, or numerous other characteristics of safety and efficacy. [After 21 CRF Part 312.21 Phases of an investigation] See also phase, phase 2a, phase 2b. (CDISC Glossary) | Phase II Trial | ||
PHASE II/III TRIAL | C15694 | 2-3;Trial Phase 2-3 | A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials. | Phase II/III Trial | ||
PHASE IIA TRIAL | C49686 | 2A;Trial Phase 2A | A clinical research protocol generally referred to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI) | Phase IIa Trial | ||
PHASE IIB TRIAL | C49688 | 2B;Trial Phase 2B | A clinical research protocol generally referred to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI) | Phase IIb Trial | ||
PHASE III TRIAL | C15602 | 3;Trial Phase 3 | Phase that includes the controlled clinical trials intended to confirm safety and effectiveness, evaluate the overall benefit-risk relationship, and to provide substantial evidence for regulatory approval and labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After ICH E8; Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Draft Guidance for Industry. December 2019] See also phase, phase 3b. (CDISC Glossary) | Phase III Trial | ||
PHASE IIIA TRIAL | C49687 | 3A;Trial Phase 3A | A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial. (NCI) | Phase IIIa Trial | ||
PHASE IIIB TRIAL | C49689 | 3B;Trial Phase 3B | A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval. | Phase IIIb Trial | ||
PHASE IV TRIAL | C15603 | 4;Trial Phase 4 | Post-approval studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: Phase 4 studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [after FDA CDER handbook, ICH E8] See also phase. (CDISC Glossary) | Phase IV Trial | ||
PHASE V TRIAL | C47865 | 5;Trial Phase 5 | Postmarketing surveillance is sometimes referred to as Phase V. | Phase V Trial | ||
Back to top | ||||||
CL.C66738.TSPARMCD | Trial Summary Parameter Test Code
(TSPARMCD) | text
Extensible: Yes | C66738 | Trial Summary Parameter Test Code | The test code for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. | CDISC SDTM Trial Summary Parameter Short Name Terminology |
ACTSUB | C98703 | Actual Number of Subjects | Actual number of subjects enrolled; may include subjects who were not randomized. | Actual Subject Number | ||
ADAPT | C146995 | Adaptive Design | Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study. | Adaptive Study Design Indicator | ||
ADDON | C49703 | Added on to Existing Treatments | The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products. | Test Product Added to Existing Treatment | ||
AGEMAX | C49694 | Planned Maximum Age of Subjects | The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI) | Planned Maximum Age of Subjects | ||
AGEMIN | C49693 | Planned Minimum Age of Subjects | The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI) | Planned Minimum Age of Subjects | ||
BIOSPRET | C126058 | Biospecimen Retention Contains DNA | A textual description as to whether a biospecimen is retained and/or contains DNA. | Biospecimen Retained and/or Contains DNA Indicator | ||
CITNSTDY | C127788 | Citation Used in Study | A bibliographical reference related to a particular study. | Clinical Study Citation | ||
CMSPSTAT | C127789 | Commercial Sponsor Status | The state or condition of the sponsor as pertains to whether the sponsor is considered a commercial entity. | Sponsor Commercial Status | ||
COMPTRT | C68612 | Comparative Treatment Name | A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial. | Active Comparator Drug | ||
CONEMAIL | C176375 | Contact E-Mail Address | E-mail address of study contact. | Study Contact E-mail Address | ||
CONMAIL | C176376 | Contact Mailing Address | Mailing address of study contact. | Study Contact Postal Address | ||
CONNAME | C176373 | Contact Name | Name of study contact. | Study Contact Name | ||
CONPHONE | C176374 | Contact Phone Number | Phone number of study contact. | Study Contact Telephone Number | ||
CONROLE | C176372 | Contact Role | Role of study contact. | Study Contact Role | ||
CRMDUR | C98715 | Confirmed Response Minimum Duration | The protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment. | Confirmed Response Minimum Duration | ||
CSRARDTC | C139273 | Clinical Study Report Archive Date | The date when the clinical study report was archived. | Clinical Study Report Archive Date | ||
CTAUG | C156602 | CDISC Therapeutic Area User Guide | The name and version of the CDISC therapeutic area user guide that is being used in the study submission. | CDISC Therapeutic Area User Guide Name and Version | ||
CURTRT | C85582 | Current Therapy or Treatment | The literal identifier of the therapy or medication that is currently being given per protocol. | Current Therapy | ||
DCUTDESC | C98718 | Data Cutoff Description | Text that describes the cutoff date. | Data Cutoff Date Description | ||
DCUTDTC | C98717 | Data Cutoff Date | A date which indicates any data collected by this date will be used for analysis. | Data Cutoff Date | ||
DGFCRIT | C135514 | Delayed Graft Function Diagnostic Criteria;Delayed Graft Function Dx Criteria | A standard by which the determination of delayed graft function (DGF) is established. | Delayed Graft Function Diagnostic Criteria Name | ||
DMCIND | C127790 | Data Monitoring Committee Indicator | An indication as to whether the clinical trial has an appointed data monitoring committee. | Data Monitoring Committee Indicator | ||
DOSE | C25488 | Dose Level;Dose per Administration | The amount of study drug (or placebo) administered to a patient or test subject to be taken at one time or at stated intervals. | Dose | ||
DOSFRM | C42636 | Dose Form | The physical form in which active and/or inert ingredient(s) are presented. | Pharmaceutical Dosage Form | ||
DOSFRQ | C89081 | Dosing Frequency | The number of doses administered per a specific interval. | Dose Frequency | ||
DOSRGM | C71137 | Dose Regimen | The planned schedule for the administration of an agent (such as a drug, substance or radiation). | Dose Regimen | ||
DOSU | C73558 | Dose Units | The unit of measure for the dosage form. | Dosage Form Unit | ||
DXCRIT | C117960 | Diagnostic Criteria | A standard from which a judgment concerning a medical diagnosis can be established. | Diagnostic Criteria | ||
EGBLIND | C119560 | ECG Reading Blinded | Indicates whether assessors of ECGs for this study were blinded to subject identity, timing and treatment. | ECG Evaluator Blinding Parameters | ||
EGCTMON | C119561 | ECG Continuous Monitoring | Indicates whether the 10-second ECGs for this study were extracted from a continuous recording. | ECG Continuous Monitoring Indicator | ||
EGLEADPR | C119562 | ECG Planned Primary Lead | The ECG lead which was planned to be used for ECG interval measurements for this study. | ECG Planned Primary Lead for Study | ||
EGLEADSM | C119563 | ECG Used Same Lead | Indicates whether all ECG interval measurements for the study were based on the same lead. | ECG Used Same Lead Indicator | ||
EGRDMETH | C119564 | ECG Read Method | The degree of automation involved in assessing the ECGs for this study. | ECG Read Method Degree of Automation | ||
EGREPLBL | C119565 | ECG Replicates at Baseline | Indicates whether this study includes replicate ECGs for time points during the baseline portion of the study. | ECG Replicates at Baseline Indicator | ||
EGREPLTR | C119566 | ECG Replicates On-Treatment | Indicates whether this study includes replicate ECGs for time points during the on-treatment portion of the study. | ECG Replicates On-Treatment Indicator | ||
EGTWVALG | C119582 | ECG Twave Algorithm | The algorithm used to identify the end of the T wave for ECGs for this study. | ECG T Wave Algorithm | ||
EMAILXML | C127791 | Email Address for XML File | The Email address to which copies of the XML format of the EudraCT application should be sent. | E-mail Address for XML File Feedback | ||
EMPIPDCN | C126059 | EMA Decision Number for PIP | An alphanumeric code assigned by the European Medicines Agency (EMA) to an EMA regulatory decision for a pediatric investigation plan (PIP). | EMA Decision Number for Pediatric Investigation Plan | ||
EPDISIND | C171505 | Epi/Pandemic Related Disruption Ind;Epidemic Related Disruption Indicator | An indication as to whether the study disruption was caused by the epidemic or pandemic. | Epidemic or Pandemic Related Disruption Indicator | ||
EPIDEMIC | C171506 | Name of Epi/Pandemic;Name of Epidemic and/or Pandemic | The literal identifier of the epidemic and/or pandemic. | Name of Epidemic or Pandemic | ||
EURSBIND | C126060 | EudraCT Resubmission Indicator | An indication as to whether the trial being submitted to the EudraCT is a trial that has been previously submitted to the EudraCT system. | EudraCT Resubmission Indicator | ||
EVSNDID | C126061 | EudraVigilance Sender ID | A unique identifier assigned to the organization that is transmitting an adverse drug reaction report to the EudraVigilance system. | EudraVigilance Sender Identifier | ||
EVSNDORG | C126090 | EudraVigilance Sender Organization | The name of the group or institution that is transmitting an adverse drug reaction report to the EudraVigilance system. | EudraVigilance Sender Organization | ||
EXPARECN | C127792 | Expanded Access Record NCT Number | The unique alphanumeric identifier for the study with associated expanded access record, as assigned by the clinicaltrials.gov protocol registration and results system (PRS). | Clinicaltrials.gov NCT Number for the Expanded Access Record | ||
EXPASTAT | C127793 | Expanded Access Status | Status indicating availability of an experimental drug or device outside any clinical trial protocol. (clinicaltrials.gov) | Trial Expanded Access Status | ||
EXTTIND | C139274 | Extension Trial Indicator | An indication as to whether the clinical trial is an extension trial. | Extension Trial Indicator | ||
FCNTRY | C98770 | Planned Country of Investigational Sites | The country name of planned study facility which has received IRB approval. | Planned Country of Investigational Site | ||
FDADEIND | C123629 | FDA-Regulated Device Study Indicator | An indication as to whether the study involves an FDA-regulated device. | FDA-Regulated Device Study Indicator | ||
FDADRIND | C123630 | FDA-Regulated Drug Study Indicator | An indication as to whether the study involves an FDA-regulated drug. | FDA-Regulated Drug Study Indicator | ||
FDATCHSP | C156603 | FDA Technical Specification | The name and version of the FDA technical specification that is being used in the study submission. | FDA Technical Specification Name and Version | ||
HLTSUBJI | C98737 | Healthy Subject Indicator | Indicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study. | Healthy Subject Indicator | ||
INDIC | C112038 | Trial Disease/Condition Indication;Trial Disease/Condition Indication Description | The textual representation of the condition, disease or disorder that the clinical trial is intended to investigate or address. | Trial Indication | ||
INTMODEL | C98746 | Intervention Model | The general design of the strategy for assigning interventions to participants in a clinical study. (clinicaltrials.gov) | Intervention Model | ||
INTTYPE | C98747 | Intervention Type | The kind of product or procedure studied in a trial. | Intervention Type | ||
KEYWORD | C126062 | Protocol Keyword | A word or small set of words designed to convey the focus of the protocol. | Protocol Keyword | ||
LENGTH | C49697 | Trial Length | Planned length of observation for a single subject. | Trial Length | ||
MNFCNTRY | C124455 | Country of Manufacture | The name of the country within which the final product under study is produced. | Country of Manufacture | ||
MSEUTIND | C127794 | Multiple Site EU State Trial Indicator | An indication as to whether the clinical study is being conducted at multiple sites within the European Union member state concerned by the application. | Multiple Site European Union State Trial Indicator | ||
NARMS | C98771 | Planned Number of Arms | The planned number of intervention groups. | Planned Number of Arms | ||
NCOHORT | C126063 | Number of Groups/Cohorts | The number of groups or cohorts that are part of the study. | Number of Groups or Cohorts | ||
NUMSEUST | C127795 | Number of Trial Sites EU State | The total number of trial sites within the European Union member state concerned by the application. | Number of Trial Sites within European Union State | ||
OBJEXP | C163559 | Trial Exploratory Objective | The exploratory purpose of the trial. | Trial Exploratory Objective | ||
OBJPRIM | C85826 | Study Primary Objective;Trial Primary Objective | A principle objective of the study. | Trial Primary Objective | ||
OBJSEC | C85827 | Study Secondary Objective;Trial Secondary Objective | An auxiliary objective of the study. | Trial Secondary Objective | ||
OBSMODEL | C126064 | Observational Model | The trial design developed to compare biomedical and/or health outcomes in pre-defined and non-assigned groups of individuals. | Observational Model | ||
OBSTIMP | C126065 | Observational Time Perspective | The temporal relationship between the observation period and time of subject enrollment. (ClinicalTrials.gov) | Observational Time Perspective of Study | ||
OBSTPOPD | C126066 | Obs Study Population Description | A description of the population from which the groups or cohorts will be selected within an observational study. | Observational Study Population Description | ||
OBSTSMM | C126067 | Observational Study Sampling Method | The sampling method used to assign study participants into groups or cohorts within an observational study. | Observational Study Sampling Method | ||
OBSTSMMD | C126068 | Obs Study Sampling Method Description | A textual description of the sampling method used to assign study participants into groups or cohorts within an observational study. | Observational Study Sampling Method Description | ||
OUTMSADD | C156601 | Additional Outcome Measure | Additional key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures not used to assess primary or secondary objectives. | Additional Outcome Measure | ||
OUTMSEXP | C98724 | Exploratory Outcome Measure | The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the exploratory endpoint(s) associated with exploratory study objective(s) and/or any other measures, excluding post-hoc measures, that are a focus of the study. (After clinicaltrials.gov) | Exploratory Outcome Measure | ||
OUTMSPRI | C98772 | Primary Outcome Measure | The outcome measure(s) of greatest importance specified in the protocol, usually the one(s) used in the power calculation, to evaluate the primary endpoint(s) associated with the primary study objective(s). (After Clinicaltrials.gov) | Primary Outcome Measure | ||
OUTMSSEC | C98781 | Secondary Outcome Measure | The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the secondary endpoint(s) associated with secondary study objective(s) and/or used to evaluate any measure(s) ancillary to the primary or secondary endpoint(s). (After Clinicaltrials.gov). | Secondary Outcome Measure | ||
PASSIND | C139275 | Post Authorization Safety Study Ind | An indication as to whether the clinical study is a post authorization safety study. | Post Authorization Safety Study Indicator | ||
PCLAS | C98768 | Pharmacologic Class | The pharmacological class of the investigational product. | Pharmacological Class of Investigational Therapy | ||
PDPSTIND | C123631 | Pediatric Postmarket Study Indicator | An indication as to whether the study is a pediatric postmarket study. | Pediatric Postmarket Study Indicator | ||
PDSTIND | C123632 | Pediatric Study Indicator | An indication as to whether the study is a pediatric study. | Pediatric Study Indicator | ||
PIPIND | C126069 | Pediatric Investigation Plan Indicator | An indication as to whether the trial is part of a pediatric investigation plan (PIP). | Pediatric Investigation Plan Indicator | ||
PLANSUB | C49692 | Anticipated Enrollment;Planned Enrollment;Planned Number of Subjects;Target Enrollment | The planned number of subjects to be entered in a clinical trial. (NCI) | Planned Subject Number | ||
PLNTRDUR | C127796 | Planned Trial Duration | The approximate period of time over which the clinical trial is expected to occur. | Planned Trial Duration | ||
PROTRSK | C139277 | Protocol Risk Assessment | The potential future harm that may arise from a protocol-related activity. | Protocol Risk Assessment | ||
PTRTDUR | C139276 | Planned Treatment Duration | The period of time during which the treatment is intended to be given. | Planned Treatment Duration | ||
PUBMEDID | C127797 | PubMed ID for Citation Used in Study | A globally unique identifier for a biomedical article, as assigned by PubMed. | PubMed Unique Identifier | ||
RANDOM | C25196 | Trial is Randomized | The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary) | Randomization | ||
RANDQT | C98775 | Randomization Quotient | The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects. | Randomization Quotient | ||
RDIND | C126070 | Rare Disease Indicator | An indication as to whether the condition under study is considered a rare disease. | Rare Disease Indicator | ||
REGID | C98714 | Registry Identifier | Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries. | Clinical Trial Registry Identifier | ||
RESUBLTR | C126071 | Resubmission Letter | An alphabetic character that describes the incremental order of trial resubmissions. | Resubmission Letter | ||
RLPSCRIT | C117961 | Relapse Criteria | A standard from which a judgment concerning a disease relapse can be established. | Relapse Criteria | ||
ROUTE | C38114 | Route of Administration | The pathway by which a substance is administered in order to reach the site of action in the body. | Route of Administration | ||
RTSPCDES | C126072 | Retained Biospecimen Description | A textual description of the specimen types that are retained as reserve samples. | Retained Biospecimen Description | ||
RXMLCIND | C127798 | Request for XML Copy of Study Indicator | An indication as to whether the registrant would like to receive an XML copy of their study as saved on EudraCT. | Study Saved as XML Indicator | ||
SDMDUR | C98783 | Stable Disease Minimum Duration | The protocol specified minimum amount of time needed to meet the definition of stable disease. | Stable Disease Minimum Duration | ||
SDTIGVER | C156604 | SDTM IG Version;SDTM Implementation Guide Version;SDTMIG Version | The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission. | Study Data Tabulation Model Implementation Guide Version | ||
SDTMDVER | C189317 | SDTM IG Medical Device Version;SDTM Implementation Guide Medical Device Version;SDTMIG Medical Device Version;SDTMIG-MD Version | The version of the CDISC Study Data Tabulation Model implementation guide for medical devices that is being used in the study submission. | SDTM Implementation Guide Medical Device Version | ||
SDTMVER | C156605 | SDTM Version | The version of the CDISC Study Data Tabulation Model that is being used in the study submission. | Study Data Tabulation Model Version | ||
SDXMLIND | C127799 | Secure Delivery XML Required Indicator | An indication as to whether the XML copy of the EudraCT application requires secure E-mail delivery. | Requires Secure Email Delivery of XML Indicator | ||
SENDTC | C90462 | Study End Date | The date on which the final data item for a clinical study was collected from the last study participant (that is, last subject, last visit, or as otherwise defined in the study protocol). (CDISC Glossary) | Clinical Study End Date | ||
SEVCRIT | C117962 | Severity Criteria | A standard from which a judgment concerning the severity of an event, disease or condition can be established. | Severity Criteria | ||
SEXPOP | C49696 | Sex of Participants | The specific sex, either male, female, or mixed of the subject group being studied. (NCI) | Sex of Study Group | ||
SPONSOR | C70793 | Clinical Study Sponsor;Sponsor;Study Sponsor | An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] | Clinical Study Sponsor | ||
SPREFID | C135009 | Sponsor's Study Reference ID | The reference identifier by which the study is known to the sponsor. This may be different from the STUDYID if the data were collected under a different identifier (e.g., used in a situation where a contract facility performs the study and provides a final report). | Sponsor Study Reference Identifier | ||
SREVIND | C126073 | SUSAR Reporting to EVCTM Indicator | An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to a EudraVigiliance clinical trial module (EVCTM). | SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator | ||
SRNCAIND | C126074 | SUSAR Reporting to NCA Indicator | An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to national competent authorities (NCA). | SUSAR Reporting to National Competent Authority Indicator | ||
SSEUTIND | C127800 | Single Site EU State Trial Indicator | An indication as to whether the clinical study is being conducted at only one site within the European Union member state concerned by the application. | Single Site European Union State Trial Indicator | ||
SSTDTC | C69208 | Study Start Date | The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen failures are not included. | Study Start Date | ||
SSTDYDTL | C126075 | Substudy Details | A textual description of the substudy. | Substudy Details | ||
SSTDYIND | C126076 | Substudy Planned Indicator | An indication as to whether a study performed on a subgroup of subjects included in the original trial (substudy) is planned for the current study. | Substudy Planned Indicator | ||
STOPRULE | C49698 | Study Stop Rules | The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI) | Study Stop Rule | ||
STRATFCT | C16153 | Stratification Factor | Selected factors that are used during randomization to ensure there is balance of these factors across all subjects within each arm of a study. The subject level values of these factors may be used as fixed effects in statistical models and for sensitivity analyses. | Stratification Factors | ||
STYPE | C142175 | Study Type;Study Type Classification | The nature of the investigation for which study information is being collected. (After clinicaltrials.gov) | Study Type | ||
TBLIND | C49658 | Study Blinding Design;Study Blinding Schema;Study Masking Design;Trial Blinding Design;Trial Blinding Schema;Trial Masking Design | The type of experimental design used to describe the level of awareness of the study subjects and/ or study personnel as it relates to the respective intervention(s) or assessments being observed, received or administered. | Trial Blinding Schema | ||
TCNTRL | C49647 | Control Type | Comparator against which the study treatment is evaluated. | Control Type | ||
TDIGRP | C49650 | Diagnosis Group | A grouping of individuals on the basis of a shared procedure or disease, or lack thereof. | Diagnosis Group | ||
THERAREA | C101302 | Therapeutic Area | A knowledge field that focuses on research and development of specific treatments for diseases and pathologic findings, as well as prevention of conditions that negatively impact the health of an individual. (NCI) | Therapeutic Area | ||
TINDTP | C49652 | Trial Intent Type | The planned purpose of the therapy, device, or agent under study in the clinical trial. | Clinical Study by Intent | ||
TITLE | C49802 | Official Study Title;Study Title;Trial Title | The sponsor-defined name of the clinical study. | Trial Title | ||
TPHASE | C48281 | Trial Phase;Trial Phase Classification | A step in the clinical research and development of a therapy from initial clinical trials to post-approval studies. NOTE: Clinical trials are generally categorized into four (sometimes five) phases. A therapeutic intervention may be evaluated in two or more phases simultaneously in different trials, and some trials may overlap two different phases. [21 CFR section 312.21; After ICH Topic E8 NOTE FOR GUIDANCE ON GENERAL CONSIDERATIONS FOR CLINICAL TRIALS, CPMP/ICH/291/95 March 1998] | Trial Phase | ||
TRGFUDUR | C126077 | Target Follow-Up Duration | The anticipated time period over which each study participant is to be followed. (ClinicalTrials.gov) | Planned Follow-Up Duration | ||
TRT | C41161 | Investigational Therapy or Treatment | The investigational product under study. | Protocol Agent | ||
TTYPE | C49660 | Trial Scope;Trial Type | The nature of the interventional study for which information is being collected. | Trial Type | ||
URLSTDY | C127801 | URL Related to Study | The uniform resource locator (URL) related to a particular study. | Study Protocol Uniform Resource Locator | ||
URLSTDYD | C127802 | URL Related to Study Description | A textual description of the uniform resource locator (URL) related to a particular study. | Study Protocol Uniform Resource Locator Description | ||
Back to top | ||||||
CL.C67152.TSPARM | Trial Summary Parameter Test Name
(TSPARM) | text
Extensible: Yes | C67152 | Trial Summary Parameter Test Name | The test name for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. | CDISC SDTM Trial Summary Parameter Long Name Terminology |
Actual Number of Subjects | C98703 | Actual Number of Subjects | Actual number of subjects enrolled; may include subjects who were not randomized. | Actual Subject Number | ||
Adaptive Design | C146995 | Adaptive Design | Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study. | Adaptive Study Design Indicator | ||
Added on to Existing Treatments | C49703 | Added on to Existing Treatments | The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products. | Test Product Added to Existing Treatment | ||
Additional Outcome Measure | C156601 | Additional Outcome Measure | Additional key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures not used to assess primary or secondary objectives. | Additional Outcome Measure | ||
Biospecimen Retention Contains DNA | C126058 | Biospecimen Retention Contains DNA | A textual description as to whether a biospecimen is retained and/or contains DNA. | Biospecimen Retained and/or Contains DNA Indicator | ||
CDISC Therapeutic Area User Guide | C156602 | CDISC Therapeutic Area User Guide | The name and version of the CDISC therapeutic area user guide that is being used in the study submission. | CDISC Therapeutic Area User Guide Name and Version | ||
Citation Used in Study | C127788 | Citation Used in Study | A bibliographical reference related to a particular study. | Clinical Study Citation | ||
Clinical Study Report Archive Date | C139273 | Clinical Study Report Archive Date | The date when the clinical study report was archived. | Clinical Study Report Archive Date | ||
Clinical Study Sponsor | C70793 | Clinical Study Sponsor;Sponsor;Study Sponsor | An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] | Clinical Study Sponsor | ||
Commercial Sponsor Status | C127789 | Commercial Sponsor Status | The state or condition of the sponsor as pertains to whether the sponsor is considered a commercial entity. | Sponsor Commercial Status | ||
Comparative Treatment Name | C68612 | Comparative Treatment Name | A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial. | Active Comparator Drug | ||
Confirmed Response Minimum Duration | C98715 | Confirmed Response Minimum Duration | The protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment. | Confirmed Response Minimum Duration | ||
Contact E-Mail Address | C176375 | Contact E-Mail Address | E-mail address of study contact. | Study Contact E-mail Address | ||
Contact Mailing Address | C176376 | Contact Mailing Address | Mailing address of study contact. | Study Contact Postal Address | ||
Contact Name | C176373 | Contact Name | Name of study contact. | Study Contact Name | ||
Contact Phone Number | C176374 | Contact Phone Number | Phone number of study contact. | Study Contact Telephone Number | ||
Contact Role | C176372 | Contact Role | Role of study contact. | Study Contact Role | ||
Control Type | C49647 | Control Type | Comparator against which the study treatment is evaluated. | Control Type | ||
Country of Manufacture | C124455 | Country of Manufacture | The name of the country within which the final product under study is produced. | Country of Manufacture | ||
Current Therapy or Treatment | C85582 | Current Therapy or Treatment | The literal identifier of the therapy or medication that is currently being given per protocol. | Current Therapy | ||
Data Cutoff Date | C98717 | Data Cutoff Date | A date which indicates any data collected by this date will be used for analysis. | Data Cutoff Date | ||
Data Cutoff Description | C98718 | Data Cutoff Description | Text that describes the cutoff date. | Data Cutoff Date Description | ||
Data Monitoring Committee Indicator | C127790 | Data Monitoring Committee Indicator | An indication as to whether the clinical trial has an appointed data monitoring committee. | Data Monitoring Committee Indicator | ||
Delayed Graft Function Dx Criteria | C135514 | Delayed Graft Function Diagnostic Criteria;Delayed Graft Function Dx Criteria | A standard by which the determination of delayed graft function (DGF) is established. | Delayed Graft Function Diagnostic Criteria Name | ||
Diagnosis Group | C49650 | Diagnosis Group | A grouping of individuals on the basis of a shared procedure or disease, or lack thereof. | Diagnosis Group | ||
Diagnostic Criteria | C117960 | Diagnostic Criteria | A standard from which a judgment concerning a medical diagnosis can be established. | Diagnostic Criteria | ||
Dose Form | C42636 | Dose Form | The physical form in which active and/or inert ingredient(s) are presented. | Pharmaceutical Dosage Form | ||
Dose per Administration | C25488 | Dose Level;Dose per Administration | The amount of study drug (or placebo) administered to a patient or test subject to be taken at one time or at stated intervals. | Dose | ||
Dose Regimen | C71137 | Dose Regimen | The planned schedule for the administration of an agent (such as a drug, substance or radiation). | Dose Regimen | ||
Dose Units | C73558 | Dose Units | The unit of measure for the dosage form. | Dosage Form Unit | ||
Dosing Frequency | C89081 | Dosing Frequency | The number of doses administered per a specific interval. | Dose Frequency | ||
ECG Continuous Monitoring | C119561 | ECG Continuous Monitoring | Indicates whether the 10-second ECGs for this study were extracted from a continuous recording. | ECG Continuous Monitoring Indicator | ||
ECG Planned Primary Lead | C119562 | ECG Planned Primary Lead | The ECG lead which was planned to be used for ECG interval measurements for this study. | ECG Planned Primary Lead for Study | ||
ECG Read Method | C119564 | ECG Read Method | The degree of automation involved in assessing the ECGs for this study. | ECG Read Method Degree of Automation | ||
ECG Reading Blinded | C119560 | ECG Reading Blinded | Indicates whether assessors of ECGs for this study were blinded to subject identity, timing and treatment. | ECG Evaluator Blinding Parameters | ||
ECG Replicates at Baseline | C119565 | ECG Replicates at Baseline | Indicates whether this study includes replicate ECGs for time points during the baseline portion of the study. | ECG Replicates at Baseline Indicator | ||
ECG Replicates On-Treatment | C119566 | ECG Replicates On-Treatment | Indicates whether this study includes replicate ECGs for time points during the on-treatment portion of the study. | ECG Replicates On-Treatment Indicator | ||
ECG Twave Algorithm | C119582 | ECG Twave Algorithm | The algorithm used to identify the end of the T wave for ECGs for this study. | ECG T Wave Algorithm | ||
ECG Used Same Lead | C119563 | ECG Used Same Lead | Indicates whether all ECG interval measurements for the study were based on the same lead. | ECG Used Same Lead Indicator | ||
EMA Decision Number for PIP | C126059 | EMA Decision Number for PIP | An alphanumeric code assigned by the European Medicines Agency (EMA) to an EMA regulatory decision for a pediatric investigation plan (PIP). | EMA Decision Number for Pediatric Investigation Plan | ||
Email Address for XML File | C127791 | Email Address for XML File | The Email address to which copies of the XML format of the EudraCT application should be sent. | E-mail Address for XML File Feedback | ||
Epi/Pandemic Related Disruption Ind | C171505 | Epi/Pandemic Related Disruption Ind;Epidemic Related Disruption Indicator | An indication as to whether the study disruption was caused by the epidemic or pandemic. | Epidemic or Pandemic Related Disruption Indicator | ||
EudraCT Resubmission Indicator | C126060 | EudraCT Resubmission Indicator | An indication as to whether the trial being submitted to the EudraCT is a trial that has been previously submitted to the EudraCT system. | EudraCT Resubmission Indicator | ||
EudraVigilance Sender ID | C126061 | EudraVigilance Sender ID | A unique identifier assigned to the organization that is transmitting an adverse drug reaction report to the EudraVigilance system. | EudraVigilance Sender Identifier | ||
EudraVigilance Sender Organization | C126090 | EudraVigilance Sender Organization | The name of the group or institution that is transmitting an adverse drug reaction report to the EudraVigilance system. | EudraVigilance Sender Organization | ||
Expanded Access Record NCT Number | C127792 | Expanded Access Record NCT Number | The unique alphanumeric identifier for the study with associated expanded access record, as assigned by the clinicaltrials.gov protocol registration and results system (PRS). | Clinicaltrials.gov NCT Number for the Expanded Access Record | ||
Expanded Access Status | C127793 | Expanded Access Status | Status indicating availability of an experimental drug or device outside any clinical trial protocol. (clinicaltrials.gov) | Trial Expanded Access Status | ||
Exploratory Outcome Measure | C98724 | Exploratory Outcome Measure | The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the exploratory endpoint(s) associated with exploratory study objective(s) and/or any other measures, excluding post-hoc measures, that are a focus of the study. (After clinicaltrials.gov) | Exploratory Outcome Measure | ||
Extension Trial Indicator | C139274 | Extension Trial Indicator | An indication as to whether the clinical trial is an extension trial. | Extension Trial Indicator | ||
FDA Technical Specification | C156603 | FDA Technical Specification | The name and version of the FDA technical specification that is being used in the study submission. | FDA Technical Specification Name and Version | ||
FDA-Regulated Device Study Indicator | C123629 | FDA-Regulated Device Study Indicator | An indication as to whether the study involves an FDA-regulated device. | FDA-Regulated Device Study Indicator | ||
FDA-Regulated Drug Study Indicator | C123630 | FDA-Regulated Drug Study Indicator | An indication as to whether the study involves an FDA-regulated drug. | FDA-Regulated Drug Study Indicator | ||
Healthy Subject Indicator | C98737 | Healthy Subject Indicator | Indicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study. | Healthy Subject Indicator | ||
Intervention Model | C98746 | Intervention Model | The general design of the strategy for assigning interventions to participants in a clinical study. (clinicaltrials.gov) | Intervention Model | ||
Intervention Type | C98747 | Intervention Type | The kind of product or procedure studied in a trial. | Intervention Type | ||
Investigational Therapy or Treatment | C41161 | Investigational Therapy or Treatment | The investigational product under study. | Protocol Agent | ||
Multiple Site EU State Trial Indicator | C127794 | Multiple Site EU State Trial Indicator | An indication as to whether the clinical study is being conducted at multiple sites within the European Union member state concerned by the application. | Multiple Site European Union State Trial Indicator | ||
Name of Epi/Pandemic | C171506 | Name of Epi/Pandemic;Name of Epidemic and/or Pandemic | The literal identifier of the epidemic and/or pandemic. | Name of Epidemic or Pandemic | ||
Number of Groups/Cohorts | C126063 | Number of Groups/Cohorts | The number of groups or cohorts that are part of the study. | Number of Groups or Cohorts | ||
Number of Trial Sites EU State | C127795 | Number of Trial Sites EU State | The total number of trial sites within the European Union member state concerned by the application. | Number of Trial Sites within European Union State | ||
Obs Study Population Description | C126066 | Obs Study Population Description | A description of the population from which the groups or cohorts will be selected within an observational study. | Observational Study Population Description | ||
Obs Study Sampling Method Description | C126068 | Obs Study Sampling Method Description | A textual description of the sampling method used to assign study participants into groups or cohorts within an observational study. | Observational Study Sampling Method Description | ||
Observational Model | C126064 | Observational Model | The trial design developed to compare biomedical and/or health outcomes in pre-defined and non-assigned groups of individuals. | Observational Model | ||
Observational Study Sampling Method | C126067 | Observational Study Sampling Method | The sampling method used to assign study participants into groups or cohorts within an observational study. | Observational Study Sampling Method | ||
Observational Time Perspective | C126065 | Observational Time Perspective | The temporal relationship between the observation period and time of subject enrollment. (ClinicalTrials.gov) | Observational Time Perspective of Study | ||
Pediatric Investigation Plan Indicator | C126069 | Pediatric Investigation Plan Indicator | An indication as to whether the trial is part of a pediatric investigation plan (PIP). | Pediatric Investigation Plan Indicator | ||
Pediatric Postmarket Study Indicator | C123631 | Pediatric Postmarket Study Indicator | An indication as to whether the study is a pediatric postmarket study. | Pediatric Postmarket Study Indicator | ||
Pediatric Study Indicator | C123632 | Pediatric Study Indicator | An indication as to whether the study is a pediatric study. | Pediatric Study Indicator | ||
Pharmacologic Class | C98768 | Pharmacologic Class | The pharmacological class of the investigational product. | Pharmacological Class of Investigational Therapy | ||
Planned Country of Investigational Sites | C98770 | Planned Country of Investigational Sites | The country name of planned study facility which has received IRB approval. | Planned Country of Investigational Site | ||
Planned Maximum Age of Subjects | C49694 | Planned Maximum Age of Subjects | The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI) | Planned Maximum Age of Subjects | ||
Planned Minimum Age of Subjects | C49693 | Planned Minimum Age of Subjects | The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI) | Planned Minimum Age of Subjects | ||
Planned Number of Arms | C98771 | Planned Number of Arms | The planned number of intervention groups. | Planned Number of Arms | ||
Planned Number of Subjects | C49692 | Anticipated Enrollment;Planned Enrollment;Planned Number of Subjects;Target Enrollment | The planned number of subjects to be entered in a clinical trial. (NCI) | Planned Subject Number | ||
Planned Treatment Duration | C139276 | Planned Treatment Duration | The period of time during which the treatment is intended to be given. | Planned Treatment Duration | ||
Planned Trial Duration | C127796 | Planned Trial Duration | The approximate period of time over which the clinical trial is expected to occur. | Planned Trial Duration | ||
Post Authorization Safety Study Ind | C139275 | Post Authorization Safety Study Ind | An indication as to whether the clinical study is a post authorization safety study. | Post Authorization Safety Study Indicator | ||
Primary Outcome Measure | C98772 | Primary Outcome Measure | The outcome measure(s) of greatest importance specified in the protocol, usually the one(s) used in the power calculation, to evaluate the primary endpoint(s) associated with the primary study objective(s). (After Clinicaltrials.gov) | Primary Outcome Measure | ||
Protocol Keyword | C126062 | Protocol Keyword | A word or small set of words designed to convey the focus of the protocol. | Protocol Keyword | ||
Protocol Risk Assessment | C139277 | Protocol Risk Assessment | The potential future harm that may arise from a protocol-related activity. | Protocol Risk Assessment | ||
PubMed ID for Citation Used in Study | C127797 | PubMed ID for Citation Used in Study | A globally unique identifier for a biomedical article, as assigned by PubMed. | PubMed Unique Identifier | ||
Randomization Quotient | C98775 | Randomization Quotient | The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects. | Randomization Quotient | ||
Rare Disease Indicator | C126070 | Rare Disease Indicator | An indication as to whether the condition under study is considered a rare disease. | Rare Disease Indicator | ||
Registry Identifier | C98714 | Registry Identifier | Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries. | Clinical Trial Registry Identifier | ||
Relapse Criteria | C117961 | Relapse Criteria | A standard from which a judgment concerning a disease relapse can be established. | Relapse Criteria | ||
Request for XML Copy of Study Indicator | C127798 | Request for XML Copy of Study Indicator | An indication as to whether the registrant would like to receive an XML copy of their study as saved on EudraCT. | Study Saved as XML Indicator | ||
Resubmission Letter | C126071 | Resubmission Letter | An alphabetic character that describes the incremental order of trial resubmissions. | Resubmission Letter | ||
Retained Biospecimen Description | C126072 | Retained Biospecimen Description | A textual description of the specimen types that are retained as reserve samples. | Retained Biospecimen Description | ||
Route of Administration | C38114 | Route of Administration | The pathway by which a substance is administered in order to reach the site of action in the body. | Route of Administration | ||
SDTM IG Version | C156604 | SDTM IG Version;SDTM Implementation Guide Version;SDTMIG Version | The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission. | Study Data Tabulation Model Implementation Guide Version | ||
SDTM Version | C156605 | SDTM Version | The version of the CDISC Study Data Tabulation Model that is being used in the study submission. | Study Data Tabulation Model Version | ||
SDTMIG Medical Device Version | C189317 | SDTM IG Medical Device Version;SDTM Implementation Guide Medical Device Version;SDTMIG Medical Device Version;SDTMIG-MD Version | The version of the CDISC Study Data Tabulation Model implementation guide for medical devices that is being used in the study submission. | SDTM Implementation Guide Medical Device Version | ||
Secondary Outcome Measure | C98781 | Secondary Outcome Measure | The outcome measure(s) that is part of a pre-specified analysis plan used to evaluate the secondary endpoint(s) associated with secondary study objective(s) and/or used to evaluate any measure(s) ancillary to the primary or secondary endpoint(s). (After Clinicaltrials.gov). | Secondary Outcome Measure | ||
Secure Delivery XML Required Indicator | C127799 | Secure Delivery XML Required Indicator | An indication as to whether the XML copy of the EudraCT application requires secure E-mail delivery. | Requires Secure Email Delivery of XML Indicator | ||
Severity Criteria | C117962 | Severity Criteria | A standard from which a judgment concerning the severity of an event, disease or condition can be established. | Severity Criteria | ||
Sex of Participants | C49696 | Sex of Participants | The specific sex, either male, female, or mixed of the subject group being studied. (NCI) | Sex of Study Group | ||
Single Site EU State Trial Indicator | C127800 | Single Site EU State Trial Indicator | An indication as to whether the clinical study is being conducted at only one site within the European Union member state concerned by the application. | Single Site European Union State Trial Indicator | ||
Sponsor's Study Reference ID | C135009 | Sponsor's Study Reference ID | The reference identifier by which the study is known to the sponsor. This may be different from the STUDYID if the data were collected under a different identifier (e.g., used in a situation where a contract facility performs the study and provides a final report). | Sponsor Study Reference Identifier | ||
Stable Disease Minimum Duration | C98783 | Stable Disease Minimum Duration | The protocol specified minimum amount of time needed to meet the definition of stable disease. | Stable Disease Minimum Duration | ||
Stratification Factor | C16153 | Stratification Factor | Selected factors that are used during randomization to ensure there is balance of these factors across all subjects within each arm of a study. The subject level values of these factors may be used as fixed effects in statistical models and for sensitivity analyses. | Stratification Factors | ||
Study End Date | C90462 | Study End Date | The date on which the final data item for a clinical study was collected from the last study participant (that is, last subject, last visit, or as otherwise defined in the study protocol). (CDISC Glossary) | Clinical Study End Date | ||
Study Start Date | C69208 | Study Start Date | The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen failures are not included. | Study Start Date | ||
Study Stop Rules | C49698 | Study Stop Rules | The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI) | Study Stop Rule | ||
Study Type | C142175 | Study Type;Study Type Classification | The nature of the investigation for which study information is being collected. (After clinicaltrials.gov) | Study Type | ||
Substudy Details | C126075 | Substudy Details | A textual description of the substudy. | Substudy Details | ||
Substudy Planned Indicator | C126076 | Substudy Planned Indicator | An indication as to whether a study performed on a subgroup of subjects included in the original trial (substudy) is planned for the current study. | Substudy Planned Indicator | ||
SUSAR Reporting to EVCTM Indicator | C126073 | SUSAR Reporting to EVCTM Indicator | An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to a EudraVigiliance clinical trial module (EVCTM). | SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator | ||
SUSAR Reporting to NCA Indicator | C126074 | SUSAR Reporting to NCA Indicator | An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to national competent authorities (NCA). | SUSAR Reporting to National Competent Authority Indicator | ||
Target Follow-Up Duration | C126077 | Target Follow-Up Duration | The anticipated time period over which each study participant is to be followed. (ClinicalTrials.gov) | Planned Follow-Up Duration | ||
Therapeutic Area | C101302 | Therapeutic Area | A knowledge field that focuses on research and development of specific treatments for diseases and pathologic findings, as well as prevention of conditions that negatively impact the health of an individual. (NCI) | Therapeutic Area | ||
Trial Blinding Schema | C49658 | Study Blinding Design;Study Blinding Schema;Study Masking Design;Trial Blinding Design;Trial Blinding Schema;Trial Masking Design | The type of experimental design used to describe the level of awareness of the study subjects and/ or study personnel as it relates to the respective intervention(s) or assessments being observed, received or administered. | Trial Blinding Schema | ||
Trial Disease/Condition Indication | C112038 | Trial Disease/Condition Indication;Trial Disease/Condition Indication Description | The textual representation of the condition, disease or disorder that the clinical trial is intended to investigate or address. | Trial Indication | ||
Trial Exploratory Objective | C163559 | Trial Exploratory Objective | The exploratory purpose of the trial. | Trial Exploratory Objective | ||
Trial Intent Type | C49652 | Trial Intent Type | The planned purpose of the therapy, device, or agent under study in the clinical trial. | Clinical Study by Intent | ||
Trial is Randomized | C25196 | Trial is Randomized | The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary) | Randomization | ||
Trial Length | C49697 | Trial Length | Planned length of observation for a single subject. | Trial Length | ||
Trial Phase Classification | C48281 | Trial Phase;Trial Phase Classification | A step in the clinical research and development of a therapy from initial clinical trials to post-approval studies. NOTE: Clinical trials are generally categorized into four (sometimes five) phases. A therapeutic intervention may be evaluated in two or more phases simultaneously in different trials, and some trials may overlap two different phases. [21 CFR section 312.21; After ICH Topic E8 NOTE FOR GUIDANCE ON GENERAL CONSIDERATIONS FOR CLINICAL TRIALS, CPMP/ICH/291/95 March 1998] | Trial Phase | ||
Trial Primary Objective | C85826 | Study Primary Objective;Trial Primary Objective | A principle objective of the study. | Trial Primary Objective | ||
Trial Secondary Objective | C85827 | Study Secondary Objective;Trial Secondary Objective | An auxiliary objective of the study. | Trial Secondary Objective | ||
Trial Title | C49802 | Official Study Title;Study Title;Trial Title | The sponsor-defined name of the clinical study. | Trial Title | ||
Trial Type | C49660 | Trial Scope;Trial Type | The nature of the interventional study for which information is being collected. | Trial Type | ||
URL Related to Study Description | C127802 | URL Related to Study Description | A textual description of the uniform resource locator (URL) related to a particular study. | Study Protocol Uniform Resource Locator Description | ||
URL Related to Study | C127801 | URL Related to Study | The uniform resource locator (URL) related to a particular study. | Study Protocol Uniform Resource Locator | ||
Back to top | ||||||
CL.C66739.TTYPE | Trial Type Response
(TTYPE) | text
Extensible: Yes | C66739 | Trial Type Response | A terminology codelist relevant to the type of primary outcome or endpoint that the protocol is designed to evaluate. | CDISC SDTM Trial Type Terminology |
ADHESION PERFORMANCE | C158283 | A type of study designed to evaluate the strength of the bond between an adhesive and the application surface. | Adhesion Performance Study | |||
ALCOHOL EFFECT | C158284 | A type of study designed to evaluate the effects of alcohol on investigational product safety and/or efficacy. | Alcohol Effect Study | |||
BIO-AVAILABILITY | C49664 | A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI) | Bioavailability Study | |||
BIO-EQUIVALENCE | C49665 | A study most often used to compare the efficacy of different formulations to treat a given disease. It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI) | Therapeutic Equivalency Study | |||
BIOSIMILARITY | C158288 | A type of study designed to evaluate whether a biologic test article is highly similar in function and effect to an existing biologic that has already been clinically tested and approved for use. | Biosimilarity Study | |||
DEVICE-DRUG INTERACTION | C158285 | A type of study designed to evaluate the interaction between a device and a drug, where the use of one may affect the disposition, function, efficacy, or safety of the other. | Device-Drug Interaction Study | |||
DIAGNOSIS | C49653 | A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition. | Diagnosis Study | |||
DOSE FINDING | C158289 | An early phase clinical study with the objective of determining the optimal dose of an investigational product. | Dose Finding Study | |||
DOSE PROPORTIONALITY | C158290 | A type of study designed to evaluate the relationship between dose and resulting exposure. | Dose Proportionality Study | |||
DOSE RESPONSE | C127803 | A study of the effect of dose changes on the efficacy of a drug in order to determine the dose-response relationship and optimal dose of a therapy. | Dose Response Study | |||
DRUG-DRUG INTERACTION | C158286 | A type of study designed to evaluate the interaction between drugs, where the use of one may affect the disposition, efficacy, or safety of the other. | Drug-Drug Interaction Study | |||
ECG | C178057 | Electrocardiographic Study | A study that evaluates the effect of a treatment on cardiac electrical activity, as assessed by electrocardiography. | Electrocardiographic Study | ||
EFFICACY | C49666 | A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI) | Efficacy Study | |||
FOOD EFFECT | C98729 | Studies that are conducted to assess the effect of food on the rate and extent of absorption of a drug, either compared to a fasted state or to a reference drug. | Food Effect Study | |||
IMMUNOGENICITY | C120842 | A study that assesses an agent's ability to provoke an immune response. | Immunogenicity Study | |||
PHARMACODYNAMIC | C49662 | A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI) | Pharmacodynamic Study | |||
PHARMACOECONOMIC | C39493 | A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI) | Pharmacoeconomic Study | |||
PHARMACOGENETIC | C129001 | A study that assesses variation in DNA sequence, usually within a single gene, and its effect on drug response. | Pharmacogenetic Study | |||
PHARMACOGENOMIC | C49661 | A study that identifies or assesses variations within the entire genome, including DNA, RNA, or transcriptional elements, and its effects on drug response. | Pharmacogenomic Study | |||
PHARMACOKINETIC | C49663 | A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI) | Pharmacokinetic Study | |||
POSITION EFFECT | C161477 | A type of study designed to evaluate the effect of body position during and/or after administration of the investigational product. | Position Effect Trial | |||
PREVENTION | C49657 | Prophylaxis Study | A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen. | Prevention Study | ||
REACTOGENICITY | C174366 | A type of study designed to evaluate the expected, acute types of immunological responses, sometimes considered excessive, following agent administration. | Reactogenicity Study | |||
SAFETY | C49667 | A study that assesses the medical risks to a subject. Safety is usually assessed by examining a wide range of clinical parameters, including adverse events, vital signs, physical exam, laboratory tests. | Safety Study | |||
SWALLOWING FUNCTION | C161478 | A type of study designed to evaluate the effect of the investigational product on the physiologic act of swallowing. | Swallowing Function Trial | |||
THOROUGH QT | C158287 | TQT Study | A type of study designed to evaluate the ability of an investigational product and/or approved drug to delay cardiac ventricular repolarization as detected by QT prolongation and other ECG parameters. | Thorough QT Study | ||
TOLERABILITY | C98791 | A type of safety study that assesses the degree to which overt adverse effects can be tolerated by the subject. | Tolerability Study | |||
TREATMENT | C49656 | Therapy Trial | A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition. | Treatment Study | ||
USABILITY TESTING | C161479 | A type of study designed to evaluate the user experience with a product. | Usability Testing Study | |||
WATER EFFECT | C161480 | A type of study designed to evaluate the effects of water on investigational product safety and/or efficacy. | Water Effect Trial | |||
Back to top | ||||||
CL.C127266.TBFATSCD | Tuberculosis Findings About Test Code
(TBFATSCD) | text
Extensible: Yes | C127266 | Tuberculosis Findings About Test Code | Terminology relevant to the test codes that describe findings about a tuberculosis event or intervention. | CDISC SDTM Tuberculosis Findings About Test Code Terminology |
DRSTAT | C102626 | Drug Resistance Status | The state or condition of not responding to a pharmacological agent. | Drug Resistance Status | ||
LDIAM | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
TOTNUM | C127787 | Total Number | A measurement of the total number of entities. | Total Number | ||
Back to top | ||||||
CL.C127267.TBFATS | Tuberculosis Findings About Test Name
(TBFATS) | text
Extensible: Yes | C127267 | Tuberculosis Findings About Test Name | Terminology relevant to the test names that describe findings about a tuberculosis event or intervention. | CDISC SDTM Tuberculosis Findings About Test Name Terminology |
Drug Resistance Status | C102626 | Drug Resistance Status | The state or condition of not responding to a pharmacological agent. | Drug Resistance Status | ||
Longest Diameter | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Total Number | C127787 | Total Number | A measurement of the total number of entities. | Total Number | ||
Back to top | ||||||
CL.C96784.TUTESTCD | Tumor or Lesion Identification Test Code
(TUTESTCD) | text
Extensible: Yes | C96784 | Tumor or Lesion Identification Test Code | Terminology relevant to the test codes that describe tumor or lesion assessments for identification purposes. | CDISC SDTM Tumor Identification Test Code Terminology |
CVLIND | C161485 | Cardiovascular Lesion Indicator | An indication as to whether a cardiovascular lesion is present. | Cardiovascular Lesion Indicator | ||
DRCRLTLC | C123633 | Disease Recurrence Relative Location | A description of the region or relative location for the disease recurrence. | Disease Recurrence Relative Location | ||
FIBLIND | C161484 | Fibrotic Lesion Indicator | An indication as to whether a fibrotic lesion is present. | Fibrotic Lesion Indicator | ||
GRLIDENT | C119567 | Graft Lesion Identification | An indication that a graft with a lesion has been located and characterized. | Graft Lesion Identification | ||
LESIDENT | C94189 | Lesion Identification | An indication that a lesion has been located and characterized. | Lesion Identification | ||
LMLIDENT | C119568 | Limb Lesion Identification | An indication that a limb containing a lesion has been selected and characterized. | Limb Associated Lesion Identification | ||
MEASIND | C161482 | Measurable Tumor Indicator | An indication as to whether a measurable tumor is present. | Measurable Tumor Indicator | ||
METIND | C154853 | Metastatic Tumor Site Indicator | An indication as to whether an anatomical location contains metastases. | Metastatic Tumor Site Indicator | ||
NTIND | C161483 | Non-Target Indicator | An indication as to whether a non-target tumor, lesion, or site of disease is present. | Non-Target Indicator | ||
PTSIND | C172602 | Primary Tumor Site Indicator | An indication as to whether an anatomical location is the primary tumor site of disease. | Primary Tumor Site Indicator | ||
TIND | C178053 | Target Indicator | An indication as to whether a target tumor, lesion, or site of disease is present. | Target Indicator | ||
TUBNIND | C186217 | Bone Tumors Indicator | An indication as to whether bone tumors are present. | Bone Tumors Indicator | ||
TUEXMIND | C186218 | Extramedullary Disease Indicator | An indication as to whether extramedullary disease is present. | Extramedullary Disease Indicator | ||
TUMERGE | C94525 | Tumor Merged | An indication that multiple tumors have coalesced into one tumor. | Matted Tumor Mass Present | ||
TUMIDENT | C94523 | Tumor Identification | A classification of malignant disease manifestation as part of the response assessment. | Tumor Identification | ||
TUSPLIT | C96642 | Tumor Split | An indication that a single tumor has divided into two or more tumors. | Tumor Fragmentation | ||
VSLIDENT | C119569 | Vessel Lesion Identification | An indication that a vessel with a lesion has been located and characterized. | Vessel Lesion Identification | ||
Back to top | ||||||
CL.C96783.TUTEST | Tumor or Lesion Identification Test Name
(TUTEST) | text
Extensible: Yes | C96783 | Tumor or Lesion Identification Test Name | Terminology relevant to the test names that describe tumor or lesion assessments for identification purposes. | CDISC SDTM Tumor Identification Test Name Terminology |
Bone Tumors Indicator | C186217 | Bone Tumors Indicator | An indication as to whether bone tumors are present. | Bone Tumors Indicator | ||
Cardiovascular Lesion Indicator | C161485 | Cardiovascular Lesion Indicator | An indication as to whether a cardiovascular lesion is present. | Cardiovascular Lesion Indicator | ||
Disease Recurrence Relative Location | C123633 | Disease Recurrence Relative Location | A description of the region or relative location for the disease recurrence. | Disease Recurrence Relative Location | ||
Extramedullary Disease Indicator | C186218 | Extramedullary Disease Indicator | An indication as to whether extramedullary disease is present. | Extramedullary Disease Indicator | ||
Fibrotic Lesion Indicator | C161484 | Fibrotic Lesion Indicator | An indication as to whether a fibrotic lesion is present. | Fibrotic Lesion Indicator | ||
Graft Lesion Identification | C119567 | Graft Lesion Identification | An indication that a graft with a lesion has been located and characterized. | Graft Lesion Identification | ||
Lesion Identification | C94189 | Lesion Identification | An indication that a lesion has been located and characterized. | Lesion Identification | ||
Limb Lesion Identification | C119568 | Limb Lesion Identification | An indication that a limb containing a lesion has been selected and characterized. | Limb Associated Lesion Identification | ||
Measurable Tumor Indicator | C161482 | Measurable Tumor Indicator | An indication as to whether a measurable tumor is present. | Measurable Tumor Indicator | ||
Metastatic Tumor Site Indicator | C154853 | Metastatic Tumor Site Indicator | An indication as to whether an anatomical location contains metastases. | Metastatic Tumor Site Indicator | ||
Non-Target Indicator | C161483 | Non-Target Indicator | An indication as to whether a non-target tumor, lesion, or site of disease is present. | Non-Target Indicator | ||
Primary Tumor Site Indicator | C172602 | Primary Tumor Site Indicator | An indication as to whether an anatomical location is the primary tumor site of disease. | Primary Tumor Site Indicator | ||
Target Indicator | C178053 | Target Indicator | An indication as to whether a target tumor, lesion, or site of disease is present. | Target Indicator | ||
Tumor Identification | C94523 | Tumor Identification | A classification of malignant disease manifestation as part of the response assessment. | Tumor Identification | ||
Tumor Merged | C94525 | Tumor Merged | An indication that multiple tumors have coalesced into one tumor. | Matted Tumor Mass Present | ||
Tumor Split | C96642 | Tumor Split | An indication that a single tumor has divided into two or more tumors. | Tumor Fragmentation | ||
Vessel Lesion Identification | C119569 | Vessel Lesion Identification | An indication that a vessel with a lesion has been located and characterized. | Vessel Lesion Identification | ||
Back to top | ||||||
CL.C123650.TUIDRS | Tumor or Lesion Identification Test Results
(TUIDRS) | text
Extensible: Yes | C123650 | Tumor or Lesion Identification Test Results | Terminology relevant to tumor or lesion identification test results. | CDISC SDTM Tumor and Lesion Identification Test Result Terminology |
BENIGN | C14172 | Benign | For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health. (NCI) | Benign | ||
BONE LESION | C132466 | A localized pathological or traumatic structural change, damage, deformity, or discontinuity of the bone. | Bone Lesion Identification | |||
DISEASE SITE | C173263 | Site of Disease | The anatomical location at which the disease is present. | Disease Involvement Site | ||
DISTANT | C25321 | Of or belonging to an area on the body that is far apart in relation to a point of origin. | Distant | |||
LOCAL | C67263 | Of or belonging to a restricted area on the body in relation to a point of origin. | Local | |||
LOCATION OF INTEREST | C161481 | The identification of an anatomical location that may contain a tumor, lesion or site of disease, and is part of the assessment of the response to the therapeutic intervention. | Anatomical Location of Interest | |||
LOCOREGIONAL | C25388 | Of or belonging to either a local and/or regional area of the body in relation to a point of origin. | Local-Regional | |||
MEASURED | C103416 | The identification of a tumor, lesion, or site of disease that is present at baseline and will be quantifiably measured. | Measured Tumor Identification | |||
NEW BONE LESION | C132467 | A localized pathological or traumatic structural change, damage, deformity, or discontinuity of the bone, which has not been previously seen or characterized. | New Bone Lesion Lesion Identification | |||
NEW EXTRA NODAL | C191354 | The identification of a tumor, lesion, or site of disease, located outside of or independent of any lymph nodes, which was not detected at baseline. | New Extranodal Lesion Identification | |||
NEW NODAL | C191353 | The identification of a tumor, lesion, or site of disease, located at or near the lymph node, which was not detected at baseline. | New Nodal Lesion Identification | |||
NEW NON-TARGET | C139126 | New Non-Index | The identification of a tumor, lesion, or site of disease that will be assessed qualitatively over time, and which was not detected at baseline. | New Non-Target Lesion Identification | ||
NEW TARGET | C139127 | New Index | The identification of a tumor, lesion, or site of disease that will be assessed quantitatively over time, and which was not detected at baseline. | New Target Lesion Identification | ||
NEW | C94522 | The identification of a tumor, lesion, or site of disease which has not been previously seen or characterized. | New Lesion Identification | |||
NON-MEASURABLE | C103423 | The identification of a tumor, lesion, or site of disease that is incapable of being measured at baseline. | Non-Measurable Tumor Identification | |||
NON-TARGET ENHANCING | C132468 | The identification of a contrast-enhancing tumor, lesion, or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention. | Non-target Enhancing Lesion Identification | |||
NON-TARGET EXTRA NODAL | C132469 | The identification of a tumor or lesion located outside of or independent of any lymph nodes that is present at baseline and not considered a target, but may be part of the assessment of the response to the therapeutic intervention. | Non-Target Extra Nodal Lesion Identification | |||
NON-TARGET NODAL | C132470 | The identification of a tumor or lesion located at or near the lymph node that is present at baseline and not considered a target, but may be part of the assessment of the response to the therapeutic intervention. | Non-Target Nodal Lesion Identification | |||
NON-TARGET NON-ENHANCING | C132471 | The identification of a non-contrast-enhancing tumor, lesion, or site of disease that is present at baseline and not considered a target, but may be part of the assessment of the response to the therapeutic intervention. | Non-target Non-enhancing Lesion Identification | |||
NON-TARGET | C94521 | Non-Index | The identification of a tumor, lesion or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention. | Non-Target Lesion Identification | ||
NOT MEASURED | C103425 | The identification of a tumor, lesion, or site of disease that is present at baseline and will not be quantifiably measured. | Not Measured Tumor Identification | |||
PRIMARY | C40558 | The identification of a tumor, lesion, or site of disease that is present at the site of origin. | Primary Lesion | |||
REGIONAL | C25643 | Of or belonging to a broader area or region of the body in relation to a point of origin. | Regional | |||
TARGET EXTRA NODAL | C103442 | The identification of a tumor or lesion that is present at baseline, located outside of or independent of any lymph nodes, and is the target of the therapeutic intervention. | Target Extra Nodal Tumor Identification | |||
TARGET NODAL | C103443 | The identification of a tumor or lesion located at or near the lymph node that is present at baseline and is the target of the therapeutic intervention. | Target Nodal Tumor Identification | |||
TARGET NODULE | C103444 | The identification of a nodule that is the target of the therapeutic intervention. | Target Nodule Tumor Identification | |||
TARGET | C94520 | Index | The identification of a tumor, lesion, or site of disease that is present at baseline and is the target of the therapeutic intervention. | Target Lesion Identification | ||
UNKNOWN | C17998 | U;UNK;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
Back to top | ||||||
CL.C96779.TRTESTCD | Tumor or Lesion Properties Test Code
(TRTESTCD) | text
Extensible: Yes | C96779 | Tumor or Lesion Properties Test Code | Terminology relevant to the test codes that describe the assessment or measurement of a tumor, lesion or site of disease. | CDISC SDTM Tumor or Lesion Properties Test Code Terminology |
ACHNAD | C103347 | Absolute Change From Nadir | The current value minus the lowest value previously recorded. | Absolute Change From Nadir | ||
ACNDOREN | C135506 | Absolute Change Nadir in Organ Enlarge;Absolute Change Nadir in Organ Enlargement | The current organ enlargement minus the lowest organ enlargement previously recorded. (NCI) | Absolute Change from Nadir in Organ Enlargement | ||
ACNSD | C112218 | Absolute Change Nadir in Sum of Diam | The current sum of diameters minus the lowest sum of diameters previously recorded. | Absolute Change From Nadir in Sum of Diameter | ||
ACPPDNLD | C147488 | Absolute Change From PPD Nadir in LDIAM | The absolute change (positive or negative) in the longest diameter of the lesion from the timepoint at which the product of perpendicular diameters of the lesion is the smallest. | Absolute Change in Longest Diameter From Nadir Product of Perpendicular Diameters Timepoint | ||
ACPPDNLP | C147489 | Absolute Change From PPD Nadir in LPERP | The absolute change (positive or negative) in the longest perpendicular of the lesion from the timepoint at which the product of perpendicular diameters of the lesion is the smallest. | Absolute Change in Longest Perpendicular from Nadir Product of Perpendicular Diameters Timepoint | ||
AREA | C25244 | Area | The extent of a 2-dimensional surface enclosed within a boundary. (NCI) | Area | ||
BMUPTAKE | C147490 | Bone Marrow Tracer Uptake | A visually assessed combination of extent and intensity of tracer uptake within the bone marrow. | Bone Marrow Tracer Uptake | ||
BNLNUM | C132463 | Number of Bone Lesions | The number of lesions within the bone. | Number of Bone Lesions | ||
CALCFIND | C126056 | Calcification Indicator | An indication as to whether calcification is present. | Calcification Indicator | ||
DIAMETER | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
FDPL5PS | C99723 | FDG PET Lymphoma 5PS Score | A 5 point scale devised to assess the response to treatment of Hodgkin and aggressive Non-Hodgkin lymphoma. (Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58.) | London Deauville Criteria Point Scale | ||
LDIAM | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
LESELESV | C174369 | Lesion Elevation Severity/Intensity | An assessment of the severity of a lesion that is heightened or raised above the surface plane of the body. | Severity of Elevated Lesion | ||
LESERYSV | C174367 | Lesion Erythema Severity/Intensity | An assessment of the severity of a lesion that has red discoloration. | Severity of Erythematous Lesion | ||
LESFLIND | C119551 | Lesion Failure Indicator | An indication as to whether lesion failure occurred. | Lesion Failure Indicator | ||
LESRVIND | C119552 | Lesion Revascularization Indicator | An indication as to whether repeat revascularization of a lesion occurred. | Lesion Revascularization Indicator | ||
LESSCIND | C119553 | Lesion Success Indicator | An indication as to whether a performed procedure of a target lesion is considered successful. | Lesion Success Indicator | ||
LESSCLSV | C174368 | Lesion Scaling Severity/Intensity | An assessment of the severity of a lesion that has flaking dead skin and an increase of keratin in the stratum corneum of the lesion. | Severity of Scaling Lesion | ||
LESTHICK | C186216 | Lesion Thickness | A measurement of the distance between two opposite surfaces of a lesion. | Lesion Thickness | ||
LMBFLIND | C119554 | Limb Failure Indicator | An indication as to whether limb failure occurred. | Limb Failure Indicator | ||
LMNDEXAM | C124446 | Number of Lymph Nodes Examined | The number of lymph nodes that were examined. | Number of Lymph Nodes Examined | ||
LMNDPNUM | C124447 | Number of Lymph Nodes Positive | The number of subject lymph nodes that were positive for presence of disease. | Number of Lymph Nodes Positive | ||
LNSTATE | C124448 | Lymph Node State | A condition or state of a lymph node at a particular time. | Lymph Node State | ||
LPERP | C96685 | Longest Perpendicular;Short Axis Diameter | The longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane. | Longest Perpendicular | ||
LRISCIND | C119555 | Lesion Revas Ischemia Indicator | An indication as to whether clinical or functional ischemia is present before lesion revascularization occurred. | Lesion Revascularization Ischemia Indicator | ||
LRVCLIND | C119556 | Lesion Revas Clinical Indicator | An indication as to whether an appropriate clinical context was present before lesion revascularization occurred. | Lesion Revascularization Clinical Indicator | ||
NBNL2IND | C132490 | Two or More New Bone Lesions Indicator | An indication as to whether there are two or more new bone lesions, in comparison to a reference timepoint. | Two or More New Bone Lesions Indicator | ||
NBNLNUM | C132464 | Number of New Bone Lesions | The number of new lesions within the bone, in comparison to a reference timepoint. | Number of New Bone Lesions | ||
NEWCONF | C103421 | New Tumor Confirmed | The verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject. | New Tumor Confirmation | ||
ORENLQN | C135507 | Organ Enlargement, Quantitative | A quantitative measurement of the increase in organ size or dimension, relative to a defined value. | Quantitative Organ Enlargement Assessment | ||
ORSTATE | C135508 | Organ State | A condition or state of an organ at a particular time. | Organ State | ||
ORVERLN | C135509 | Organ Vertical Length | The linear extent along the craniocaudal axis from one end of an organ to the other end. (NCI) | Organ Craniocaudal Length Measurement | ||
OTRCUPCB | C139128 | Overall Tracer Uptake Compared to Baseline;Overall Tracer Uptake Compared to BL | A visually assessed combination of extent and intensity of tracer uptake, as compared to baseline. | Overall Tracer Uptake Compared to Baseline | ||
OTRCUPCN | C150896 | Overall Tracer Uptake Compared to Nadir | A visually assessed combination of extent and intensity of tracer uptake, as compared to nadir. | Overall Tracer Uptake Compared to Nadir | ||
PALPSTAT | C124449 | Palpable State | A condition or state of the lesion with regards to its palpability status at a particular point in time. | Palpable State | ||
PBNL2IND | C132465 | Two or More Persist New Bone Lesions Ind;Two or More Persisting New Bone Lesions Indicator | An indication as to whether there are two or more bone lesions previously identified as new and are considered to be persisting. | Two or More Persisting New Bone Lesions Indicator | ||
PCBSD | C112370 | Percent Change Baseline in Sum of Diam | The (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100. | Percent Change From Baseline in Sum of Diameter | ||
PCBSLD | C112371 | Percent Change Baseline Sum Longest Diam | The (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100. | Percent Change From Baseline in Sum of Longest Diameter | ||
PCBSOREN | C135510 | Percent Change Baseline in Organ Enlarge;Percent Change Baseline in Organ Enlargement | The (current organ enlargement minus the baseline organ enlargement) divided by the baseline organ enlargement, multiplied by 100. (NCI) | Percent Change from Baseline in Organ Enlargement | ||
PCBSPPD | C132264 | Percent Change Baseline in Sum of PPD | The (current sum of products of perpendicular diameters minus the baseline sum of products of perpendicular diameters) divided by the baseline sum of products of perpendicular diameters, multiplied by 100. | Percent Change From Baseline in Sum of Products of Perpendicular Diameter | ||
PCBSV | C112372 | Percent Change Baseline in Sum of Volume | The (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100. | Percent Change From Baseline in Sum of Volume | ||
PCHGBL | C96621 | Percent Change From Baseline | The (current value minus the baseline value) divided by the baseline value, multiplied by 100. | Percent Change From Baseline | ||
PCHGNAD | C96622 | Percent Change From Nadir | The (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100. | Percent Change From Nadir | ||
PCNDOREN | C135511 | Percent Change Nadir in Organ Enlarge;Percent Change Nadir in Organ Enlargement | The (current organ enlargement minus the lowest organ enlargement previously recorded) divided by the lowest organ enlargement previously recorded, multiplied by 100. (NCI) | Percent Change from Nadir in Organ Enlargement | ||
PCNPPD | C135512 | Percent Change Nadir in PPD | The (current product of perpendicular diameters minus the lowest product of perpendicular diameters previously recorded) divided by the lowest product of perpendicular diameters previously recorded, multiplied by 100. | Percent Change from Nadir in Product of Perpendicular Diameters | ||
PCNSD | C112373 | Percent Change Nadir in Sum of Diam | The (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Diameter | ||
PCNSLD | C112374 | Percent Change Nadir in Sum Longest Diam | The (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Longest Diameter | ||
PCNSPPD | C132265 | Percent Change Nadir in Sum of PPD | The (current sum of products of perpendicular diameters minus the lowest sum of products of perpendicular diameters previously recorded) divided by the lowest sum of products of perpendicular diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Products of Perpendicular Diameters | ||
PCNSV | C178054 | Percent Change Nadir in Sum of Volume | The (current sum of volumes minus the lowest sum of volumes previously recorded) divided by the lowest sum of volumes previously recorded, multiplied by 100. | Percent Change Nadir in Sum of Volume | ||
PPD | C135513 | PPD;Product of Perpendicular Diameters | The longest diameter multiplied by its longest perpendicular diameter. | Product of Perpendicular Diameters | ||
RADIODEN | C96627 | Radiodensity | The transparency of a material to the passage of X-rays and other forms of radiation. | Radiodensity | ||
SULMAX | C181545 | Standardized Uptake Value Maximum Corrected for Lean Body Mass;SUV Maximum Corrected for Lean Body Mass | The standardized uptake value corrected for lean body mass of the pixel or voxel with the strongest signal, within a defined area or volume of interest (VOI). | Maximum Standardized Uptake Value Corrected for Lean Body Mass | ||
SULMEAN | C181546 | Standardized Uptake Value Mean Corrected for Lean Body Mass;SUV Mean Corrected for Lean Body Mass | The arithmetic mean of a group of standardized uptake values corrected for lean body mass within a defined area or volume of interest (VOI). | Mean Standardized Uptake Value Corrected for Lean Body Mass | ||
SULPEAK | C181547 | Standardized Uptake Value Peak Corrected for Lean Body Mass;SUV Peak Corrected for Lean Body Mass | The peak of standardized uptake value corrected for lean body mass distribution, generated by a histogram of all SUV values, across a defined area or volume of interest (VOI). | Peak Standardized Uptake Value Corrected for Lean Body Mass | ||
SUMDIAM | C96631 | Sum of Diameter | A calculation of the aggregated diameter values. | Sum of Diameters | ||
SUMLDIAM | C96632 | Sum of Longest Diameter | A calculation of the aggregated longest diameter values. | Sum of Longest Diameters | ||
SUMLPERP | C96633 | Sum of Longest Perpendicular | A calculation of the aggregated longest perpendicular values. | Sum of Longest Perpendiculars | ||
SUMNLNLD | C103441 | Sum Diameters of Non Lymph Node Tumors | A calculation of the aggregated diameter values for tumors other than the lymph nodes. | Sum of Diameters of Non Lymph Node Tumors | ||
SUMPPD | C132261 | SPD;Sum of Products of Perpendicular Diam;Sum of Products of Perpendicular Diameters | The result of the addition of the products of perpendicular diameters. | Sum of Products of Perpendicular Diameters | ||
SUMVDIAM | C96634 | Sum of Viable Diameter | A calculation of the aggregated diameter values taken from the viable portion of the tumor mass. | Sum of Viable Diameters | ||
SUMVOL | C96635 | Sum of Volume | A calculation of the aggregated volume values. | Sum of Volumes | ||
SUVMAX | C95012 | Standardized Uptake Value Maximum | The standardized (by total body weight) uptake value of the pixel or voxel with the strongest signal, within a defined area or volume of interest (VOI). | Standardized Uptake Value Maximum | ||
SUVMEAN | C181544 | Average Metabolic Standard Uptake Value;Standardized Uptake Value Mean | The arithmetic mean of a group of standardized (by total body weight) uptake values within a defined area or volume of interest (VOI). | Standardized Uptake Value Mean | ||
SUVMIN | C191352 | The standardized (by total body weight) uptake value of the pixel or voxel with the lowest signal, within a defined area or volume of interest (VOI). | Standardized Uptake Value Minimum | |||
SUVPEAK | C95013 | Standardized Uptake Value Peak | The maximum average (peak) of standardized (by total body weight) uptake value distribution, generated by a histogram of all SUV values, across a defined area or volume of interest (VOI). | Standardized Uptake Value Peak | ||
TUMSTATE | C96643 | Tumor State | A condition or state of a tumor at a particular time. | Tumor Status | ||
VDIAM | C96646 | Viable Diameter | The diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis. | Viable Tumor Diameter | ||
VOLUME | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
VSLFLIND | C119557 | Vessel Failure Indicator | An indication as to whether vessel failure occurred. | Vessel Failure Indicator | ||
VSLPIND | C119558 | Vessel Patency Indicator | An indication as to whether an artery is patent (free of TLR or restenosis) following intervention. | Vessel Patency Indicator | ||
VSLRVIND | C119559 | Vessel Revascularization Indicator | An indication as to whether repeat revascularization of an artery containing a lesion occurred. | Vessel Revascularization Indicator | ||
Back to top | ||||||
CL.C96778.TRTEST | Tumor or Lesion Properties Test Name
(TRTEST) | text
Extensible: Yes | C96778 | Tumor or Lesion Properties Test Name | Terminology relevant to the test names that describe the assessment or measurement of a tumor, lesion or site of disease. | CDISC SDTM Tumor or Lesion Properties Test Name Terminology |
Absolute Change From Nadir | C103347 | Absolute Change From Nadir | The current value minus the lowest value previously recorded. | Absolute Change From Nadir | ||
Absolute Change From PPD Nadir in LDIAM | C147488 | Absolute Change From PPD Nadir in LDIAM | The absolute change (positive or negative) in the longest diameter of the lesion from the timepoint at which the product of perpendicular diameters of the lesion is the smallest. | Absolute Change in Longest Diameter From Nadir Product of Perpendicular Diameters Timepoint | ||
Absolute Change From PPD Nadir in LPERP | C147489 | Absolute Change From PPD Nadir in LPERP | The absolute change (positive or negative) in the longest perpendicular of the lesion from the timepoint at which the product of perpendicular diameters of the lesion is the smallest. | Absolute Change in Longest Perpendicular from Nadir Product of Perpendicular Diameters Timepoint | ||
Absolute Change Nadir in Organ Enlarge | C135506 | Absolute Change Nadir in Organ Enlarge;Absolute Change Nadir in Organ Enlargement | The current organ enlargement minus the lowest organ enlargement previously recorded. (NCI) | Absolute Change from Nadir in Organ Enlargement | ||
Absolute Change Nadir in Sum of Diam | C112218 | Absolute Change Nadir in Sum of Diam | The current sum of diameters minus the lowest sum of diameters previously recorded. | Absolute Change From Nadir in Sum of Diameter | ||
Area | C25244 | Area | The extent of a 2-dimensional surface enclosed within a boundary. (NCI) | Area | ||
Bone Marrow Tracer Uptake | C147490 | Bone Marrow Tracer Uptake | A visually assessed combination of extent and intensity of tracer uptake within the bone marrow. | Bone Marrow Tracer Uptake | ||
Calcification Indicator | C126056 | Calcification Indicator | An indication as to whether calcification is present. | Calcification Indicator | ||
Diameter | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
FDG PET Lymphoma 5PS Score | C99723 | FDG PET Lymphoma 5PS Score | A 5 point scale devised to assess the response to treatment of Hodgkin and aggressive Non-Hodgkin lymphoma. (Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014 Sep 20;32(27):3048-58.) | London Deauville Criteria Point Scale | ||
Lesion Elevation Severity/Intensity | C174369 | Lesion Elevation Severity/Intensity | An assessment of the severity of a lesion that is heightened or raised above the surface plane of the body. | Severity of Elevated Lesion | ||
Lesion Erythema Severity/Intensity | C174367 | Lesion Erythema Severity/Intensity | An assessment of the severity of a lesion that has red discoloration. | Severity of Erythematous Lesion | ||
Lesion Failure Indicator | C119551 | Lesion Failure Indicator | An indication as to whether lesion failure occurred. | Lesion Failure Indicator | ||
Lesion Revas Clinical Indicator | C119556 | Lesion Revas Clinical Indicator | An indication as to whether an appropriate clinical context was present before lesion revascularization occurred. | Lesion Revascularization Clinical Indicator | ||
Lesion Revas Ischemia Indicator | C119555 | Lesion Revas Ischemia Indicator | An indication as to whether clinical or functional ischemia is present before lesion revascularization occurred. | Lesion Revascularization Ischemia Indicator | ||
Lesion Revascularization Indicator | C119552 | Lesion Revascularization Indicator | An indication as to whether repeat revascularization of a lesion occurred. | Lesion Revascularization Indicator | ||
Lesion Scaling Severity/Intensity | C174368 | Lesion Scaling Severity/Intensity | An assessment of the severity of a lesion that has flaking dead skin and an increase of keratin in the stratum corneum of the lesion. | Severity of Scaling Lesion | ||
Lesion Success Indicator | C119553 | Lesion Success Indicator | An indication as to whether a performed procedure of a target lesion is considered successful. | Lesion Success Indicator | ||
Lesion Thickness | C186216 | Lesion Thickness | A measurement of the distance between two opposite surfaces of a lesion. | Lesion Thickness | ||
Limb Failure Indicator | C119554 | Limb Failure Indicator | An indication as to whether limb failure occurred. | Limb Failure Indicator | ||
Longest Diameter | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
Longest Perpendicular | C96685 | Longest Perpendicular;Short Axis Diameter | The longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane. | Longest Perpendicular | ||
Lymph Node State | C124448 | Lymph Node State | A condition or state of a lymph node at a particular time. | Lymph Node State | ||
New Tumor Confirmed | C103421 | New Tumor Confirmed | The verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject. | New Tumor Confirmation | ||
Number of Bone Lesions | C132463 | Number of Bone Lesions | The number of lesions within the bone. | Number of Bone Lesions | ||
Number of Lymph Nodes Examined | C124446 | Number of Lymph Nodes Examined | The number of lymph nodes that were examined. | Number of Lymph Nodes Examined | ||
Number of Lymph Nodes Positive | C124447 | Number of Lymph Nodes Positive | The number of subject lymph nodes that were positive for presence of disease. | Number of Lymph Nodes Positive | ||
Number of New Bone Lesions | C132464 | Number of New Bone Lesions | The number of new lesions within the bone, in comparison to a reference timepoint. | Number of New Bone Lesions | ||
Organ Enlargement, Quantitative | C135507 | Organ Enlargement, Quantitative | A quantitative measurement of the increase in organ size or dimension, relative to a defined value. | Quantitative Organ Enlargement Assessment | ||
Organ State | C135508 | Organ State | A condition or state of an organ at a particular time. | Organ State | ||
Organ Vertical Length | C135509 | Organ Vertical Length | The linear extent along the craniocaudal axis from one end of an organ to the other end. (NCI) | Organ Craniocaudal Length Measurement | ||
Overall Tracer Uptake Compared to BL | C139128 | Overall Tracer Uptake Compared to Baseline;Overall Tracer Uptake Compared to BL | A visually assessed combination of extent and intensity of tracer uptake, as compared to baseline. | Overall Tracer Uptake Compared to Baseline | ||
Overall Tracer Uptake Compared to Nadir | C150896 | Overall Tracer Uptake Compared to Nadir | A visually assessed combination of extent and intensity of tracer uptake, as compared to nadir. | Overall Tracer Uptake Compared to Nadir | ||
Palpable State | C124449 | Palpable State | A condition or state of the lesion with regards to its palpability status at a particular point in time. | Palpable State | ||
Percent Change Baseline in Organ Enlarge | C135510 | Percent Change Baseline in Organ Enlarge;Percent Change Baseline in Organ Enlargement | The (current organ enlargement minus the baseline organ enlargement) divided by the baseline organ enlargement, multiplied by 100. (NCI) | Percent Change from Baseline in Organ Enlargement | ||
Percent Change Baseline in Sum of Diam | C112370 | Percent Change Baseline in Sum of Diam | The (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100. | Percent Change From Baseline in Sum of Diameter | ||
Percent Change Baseline in Sum of PPD | C132264 | Percent Change Baseline in Sum of PPD | The (current sum of products of perpendicular diameters minus the baseline sum of products of perpendicular diameters) divided by the baseline sum of products of perpendicular diameters, multiplied by 100. | Percent Change From Baseline in Sum of Products of Perpendicular Diameter | ||
Percent Change Baseline in Sum of Volume | C112372 | Percent Change Baseline in Sum of Volume | The (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100. | Percent Change From Baseline in Sum of Volume | ||
Percent Change Baseline Sum Longest Diam | C112371 | Percent Change Baseline Sum Longest Diam | The (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100. | Percent Change From Baseline in Sum of Longest Diameter | ||
Percent Change From Baseline | C96621 | Percent Change From Baseline | The (current value minus the baseline value) divided by the baseline value, multiplied by 100. | Percent Change From Baseline | ||
Percent Change From Nadir | C96622 | Percent Change From Nadir | The (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100. | Percent Change From Nadir | ||
Percent Change Nadir in Organ Enlarge | C135511 | Percent Change Nadir in Organ Enlarge;Percent Change Nadir in Organ Enlargement | The (current organ enlargement minus the lowest organ enlargement previously recorded) divided by the lowest organ enlargement previously recorded, multiplied by 100. (NCI) | Percent Change from Nadir in Organ Enlargement | ||
Percent Change Nadir in PPD | C135512 | Percent Change Nadir in PPD | The (current product of perpendicular diameters minus the lowest product of perpendicular diameters previously recorded) divided by the lowest product of perpendicular diameters previously recorded, multiplied by 100. | Percent Change from Nadir in Product of Perpendicular Diameters | ||
Percent Change Nadir in Sum Longest Diam | C112374 | Percent Change Nadir in Sum Longest Diam | The (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Longest Diameter | ||
Percent Change Nadir in Sum of Diam | C112373 | Percent Change Nadir in Sum of Diam | The (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Diameter | ||
Percent Change Nadir in Sum of PPD | C132265 | Percent Change Nadir in Sum of PPD | The (current sum of products of perpendicular diameters minus the lowest sum of products of perpendicular diameters previously recorded) divided by the lowest sum of products of perpendicular diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Products of Perpendicular Diameters | ||
Percent Change Nadir in Sum of Volume | C178054 | Percent Change Nadir in Sum of Volume | The (current sum of volumes minus the lowest sum of volumes previously recorded) divided by the lowest sum of volumes previously recorded, multiplied by 100. | Percent Change Nadir in Sum of Volume | ||
Product of Perpendicular Diameters | C135513 | PPD;Product of Perpendicular Diameters | The longest diameter multiplied by its longest perpendicular diameter. | Product of Perpendicular Diameters | ||
Radiodensity | C96627 | Radiodensity | The transparency of a material to the passage of X-rays and other forms of radiation. | Radiodensity | ||
Standardized Uptake Value Maximum | C95012 | Standardized Uptake Value Maximum | The standardized (by total body weight) uptake value of the pixel or voxel with the strongest signal, within a defined area or volume of interest (VOI). | Standardized Uptake Value Maximum | ||
Standardized Uptake Value Mean | C181544 | Average Metabolic Standard Uptake Value;Standardized Uptake Value Mean | The arithmetic mean of a group of standardized (by total body weight) uptake values within a defined area or volume of interest (VOI). | Standardized Uptake Value Mean | ||
Standardized Uptake Value Minimum | C191352 | The standardized (by total body weight) uptake value of the pixel or voxel with the lowest signal, within a defined area or volume of interest (VOI). | Standardized Uptake Value Minimum | |||
Standardized Uptake Value Peak | C95013 | Standardized Uptake Value Peak | The maximum average (peak) of standardized (by total body weight) uptake value distribution, generated by a histogram of all SUV values, across a defined area or volume of interest (VOI). | Standardized Uptake Value Peak | ||
Sum Diameters of Non Lymph Node Tumors | C103441 | Sum Diameters of Non Lymph Node Tumors | A calculation of the aggregated diameter values for tumors other than the lymph nodes. | Sum of Diameters of Non Lymph Node Tumors | ||
Sum of Diameter | C96631 | Sum of Diameter | A calculation of the aggregated diameter values. | Sum of Diameters | ||
Sum of Longest Diameter | C96632 | Sum of Longest Diameter | A calculation of the aggregated longest diameter values. | Sum of Longest Diameters | ||
Sum of Longest Perpendicular | C96633 | Sum of Longest Perpendicular | A calculation of the aggregated longest perpendicular values. | Sum of Longest Perpendiculars | ||
Sum of Products of Perpendicular Diam | C132261 | SPD;Sum of Products of Perpendicular Diam;Sum of Products of Perpendicular Diameters | The result of the addition of the products of perpendicular diameters. | Sum of Products of Perpendicular Diameters | ||
Sum of Viable Diameter | C96634 | Sum of Viable Diameter | A calculation of the aggregated diameter values taken from the viable portion of the tumor mass. | Sum of Viable Diameters | ||
Sum of Volume | C96635 | Sum of Volume | A calculation of the aggregated volume values. | Sum of Volumes | ||
SUV Maximum Corrected for Lean Body Mass | C181545 | Standardized Uptake Value Maximum Corrected for Lean Body Mass;SUV Maximum Corrected for Lean Body Mass | The standardized uptake value corrected for lean body mass of the pixel or voxel with the strongest signal, within a defined area or volume of interest (VOI). | Maximum Standardized Uptake Value Corrected for Lean Body Mass | ||
SUV Mean Corrected for Lean Body Mass | C181546 | Standardized Uptake Value Mean Corrected for Lean Body Mass;SUV Mean Corrected for Lean Body Mass | The arithmetic mean of a group of standardized uptake values corrected for lean body mass within a defined area or volume of interest (VOI). | Mean Standardized Uptake Value Corrected for Lean Body Mass | ||
SUV Peak Corrected for Lean Body Mass | C181547 | Standardized Uptake Value Peak Corrected for Lean Body Mass;SUV Peak Corrected for Lean Body Mass | The peak of standardized uptake value corrected for lean body mass distribution, generated by a histogram of all SUV values, across a defined area or volume of interest (VOI). | Peak Standardized Uptake Value Corrected for Lean Body Mass | ||
Tumor State | C96643 | Tumor State | A condition or state of a tumor at a particular time. | Tumor Status | ||
Two or More New Bone Lesions Indicator | C132490 | Two or More New Bone Lesions Indicator | An indication as to whether there are two or more new bone lesions, in comparison to a reference timepoint. | Two or More New Bone Lesions Indicator | ||
Two or More Persist New Bone Lesions Ind | C132465 | Two or More Persist New Bone Lesions Ind;Two or More Persisting New Bone Lesions Indicator | An indication as to whether there are two or more bone lesions previously identified as new and are considered to be persisting. | Two or More Persisting New Bone Lesions Indicator | ||
Vessel Failure Indicator | C119557 | Vessel Failure Indicator | An indication as to whether vessel failure occurred. | Vessel Failure Indicator | ||
Vessel Patency Indicator | C119558 | Vessel Patency Indicator | An indication as to whether an artery is patent (free of TLR or restenosis) following intervention. | Vessel Patency Indicator | ||
Vessel Revascularization Indicator | C119559 | Vessel Revascularization Indicator | An indication as to whether repeat revascularization of an artery containing a lesion occurred. | Vessel Revascularization Indicator | ||
Viable Diameter | C96646 | Viable Diameter | The diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis. | Viable Tumor Diameter | ||
Volume | C74720 | Volume | A measurement of the amount of three dimensional space occupied by an object or the capacity of a space or container. | Volume Measurement | ||
Back to top | ||||||
CL.C124309.TRPROPRS | Tumor or Lesion Properties Test Result
(TRPROPRS) | text
Extensible: Yes | C124309 | Tumor or Lesion Properties Test Result | Terminology relevant to the results from the assessment or measurement of a tumor, lesion or site of disease. | CDISC SDTM Tumor or Lesion Properties Test Result Terminology |
ABSENT | C48190 | Not existing in a specified place at a specified time. (NCI) | Absent | |||
DECREASED | C25640 | Reduced | Made less in size, amount, degree, or extent. | Reduced | ||
DIFFUSELY INCREASED | C147486 | An indication that the increase is homogenously dispersed. | Diffusely Increased | |||
ENLARGEMENT FROM NADIR | C156593 | An increase in size, volume, or quantity in comparison to nadir. | Enlargement from Nadir | |||
ENLARGEMENT | C73432 | An increase in size, volume, quantity or scope in comparison to normal or previous state. | Enlargement | |||
EQUIVOCAL | C86071 | Open to question. | Equivocal | |||
FOCALLY INCREASED | C147487 | An indication that the increase is concentrated in a specific area(s). | Focally Increased | |||
FURTHER ENLARGEMENT FROM NADIR | C156594 | An increase in size, volume, or quantity in comparison to a previous state that was enlarged from nadir. | Further Enlargement from Nadir | |||
FURTHER ENLARGEMENT | C142367 | An increase in size, volume, quantity or scope in comparison to a previous enlarged state. | Further Enlargement | |||
INCREASED | C25533 | A process of becoming larger, more intense, more extensive, more numerous, more important, or more likely. | Increase | |||
NON-PATHOLOGICAL | C126054 | The absence of disease or pathology. (NCI) | Non-Pathological | |||
NONPALPABLE | C124445 | Incapable of being handled, touched or felt through palpation. (NCI) | Non-Palpable | |||
NORMAL | C14165 | Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI) | Normal | |||
PALPABLE | C25606 | Capable of being handled, touched or felt through palpation. (NCI) | Palpable | |||
PATHOLOGICAL | C25610 | Manifesting disease or pathology. | Pathologic | |||
PRESENT | C25626 | Being or existing in a specified place or at the specified time. (NCI) | Present | |||
TUMOR MERGED | C94525 | Tumor Merged | An indication that multiple tumors have coalesced into one tumor. | Matted Tumor Mass Present | ||
UNCHANGED | C71687 | In an unchanged or similar condition. | Unchanged | |||
UNEQUIVOCAL | C123645 | Leaving no doubt; not open to question. (NCI) | Unequivocal | |||
Back to top | ||||||
CL.C163027.D1FATSCD | Type 1 Diabetes Findings About Test Code
(D1FATSCD) | text
Extensible: Yes | C163027 | Type 1 Diabetes Findings About Test Code | Terminology relevant to the test codes that describe findings about Type 1 Diabetes event or intervention. | CDISC SDTM Type 1 Diabetes Findings About Test Code Terminology |
ACNDEV | C117037 | Action Taken With Device | Action taken with respect to a device in a study, which may or may not be the device under study. | Action Taken with Device | ||
ACNSBJ | C163412 | Action Taken With Subject | Action taken with respect to a subject in a study. | Action Taken With Subject | ||
ALCDRKN | C184464 | Number of Alcoholic Drinks | The total number of alcoholic drinks. | Number of Alcoholic Drinks Measurement | ||
CALBURN | C172476 | Calories Burned | A measurement of the number of calories expended. | Calories Burned | ||
CUMEXP | C94596 | Cumulative Exposure | The total amount that a subject is exposed to over time. | Cumulative Exposure | ||
DACARO | C184449 | Dietary Alpha Carotene | A determination of the alpha carotene in a nutritional product or meal, or a portion thereof. | Dietary Alpha Carotene Measurement | ||
DADDSUG | C172463 | Dietary Added Sugar | A determination of the total added sugars in a nutritional product or meal, or a portion thereof. | Dietary Added Sugar Measurement | ||
DALCOHOL | C184463 | Dietary Alcohol;Dietary Ethanol | A determination of the total amount of alcohol in a nutritional product or meal, or a portion thereof. | Dietary Alcohol Measurement | ||
DARAC | C184441 | Dietary 20:4 Arachidonate;Dietary 20:4 Arachidonic Acid;Dietary Arachidonic Acid | A determination of the total 20:4 arachidonic acid in a nutritional product or meal, or a portion thereof. | Dietary Arachidonic Acid Measurement | ||
DATOCO | C184450 | Dietary Alpha Tocopherol | A determination of the alpha tocopherol in a nutritional product or meal, or a portion thereof. | Dietary Alpha Tocopherol Measurement | ||
DAVITB12 | C184461 | Dietary Added Vitamin B12 | A determination of the total added vitamin B12 in a nutritional product or meal, or a portion thereof. | Dietary Added Vitamin B12 Measurement | ||
DAVITE | C184462 | Dietary Added Vitamin E | A determination of the total added vitamin E in a nutritional product or meal, or a portion thereof. | Dietary Added Vitamin E Measurement | ||
DBCARO | C184451 | Dietary Beta Carotene | A determination of the beta carotene in a nutritional product or meal, or a portion thereof. | Dietary Beta Carotene Measurement | ||
DBEANPEA | C184465 | Dietary Beans and Peas | A determination of the total beans and peas in a nutritional product or meal, or a portion thereof. | Dietary Beans and Peas Measurement | ||
DBUTR | C184446 | Dietary 4:0 Butyrate;Dietary 4:0 Butyric Acid;Dietary Butyric Acid | A determination of the total 4:0 butyric acid in a nutritional product or meal, or a portion thereof. | Dietary Butyric Acid Measurement | ||
DCA | C184453 | Dietary Calcium | A determination of the total calcium in a nutritional product or meal, or a portion thereof. | Dietary Calcium Measurement | ||
DCAFFEIN | C184452 | Dietary Caffeine | A determination of the caffeine in a nutritional product or meal, or a portion thereof. | Dietary Caffeine Measurement | ||
DCAL | C172464 | Dietary Calories | A determination of the total dietary calories in a nutritional product or meal, or a portion thereof. | Dietary Calories Measurement | ||
DCAPO | C184447 | Dietary 6:0 Caproate;Dietary 6:0 Caproic Acid;Dietary Caproic Acid | A determination of the total 6:0 caproic acid in a nutritional product or meal, or a portion thereof. | Dietary Caproic Acid Measurement | ||
DCAPR | C184430 | Dietary 10:0 Caprate;Dietary 10:0 Capric Acid;Dietary Capric Acid | A determination of the total 10:0 capric acid in a nutritional product or meal, or a portion thereof. | Dietary Capric Acid Measurement | ||
DCAPY | C184448 | Dietary 8:0 Caprylate;Dietary 8:0 Caprylic Acid;Dietary Caprylic Acid | A determination of the total 8:0 caprylic acid in a nutritional product or meal, or a portion thereof. | Dietary Caprylic Acid Measurement | ||
DCARBT | C172461 | Dietary Total Carbohydrate | A determination of the total carbohydrate in a nutritional product or meal, or a portion thereof. | Total Dietary Carbohydrate Measurement | ||
DCHEESE | C184454 | Dietary Cheese | A determination of the total cheese in a nutritional product or meal, or a portion thereof. | Dietary Cheese Measurement | ||
DCHOLEST | C184466 | Dietary Cholesterol | A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. | Dietary Cholesterol Measurement | ||
DCHOLINE | C184467 | Dietary Choline | A determination of the choline in a nutritional product or meal, or a portion thereof. | Dietary Choline Measurement | ||
DCITMELB | C184468 | Dietary Citrus, Melons, and Berries | A determination of the total citrus, melons, and berries in a nutritional product or meal, or a portion thereof. | Dietary Citrus, Melons, and Berries Measurement | ||
DCPND | C184444 | Dietary 22:5 Clupanodonate;Dietary 22:5 Clupanodonic Acid;Dietary Clupanodonic Acid | A determination of the total 22:5 clupanodonic acid in a nutritional product or meal, or a portion thereof. | Dietary Clupanodonic Acid Measurement | ||
DCRXANB | C186015 | Dietary Beta-Cryptoxanthin | A determination of the beta-cryptoxanthin in a nutritional product or meal, or a portion thereof. | Dietary Beta-Cryptoxanthin Measurement | ||
DCU | C184455 | Dietary Copper | A determination of the total copper in a nutritional product or meal, or a portion thereof. | Dietary Copper Measurement | ||
DDAIRYT | C184337 | Dietary Total Dairy | A determination of the total dairy (food products produced from or containing milk) in a nutritional product or meal, or a portion thereof. | Dietary Dairy Measurement | ||
DDCHX | C184445 | Dietary 22:6 Docosahexaenoate;Dietary 22:6 Docosahexaenoic Acid;Dietary Docosahexaenoic Acid | A determination of the total 22:6 docosahexaenoic acid in a nutritional product or meal, or a portion thereof. | Dietary Docosahexaenoic Acid Measurement | ||
DEGGS | C184471 | Dietary Eggs | A determination of the eggs in a nutritional product or meal, or a portion thereof. | Dietary Eggs Measurement | ||
DERUC | C184443 | Dietary 22:1 Erucate;Dietary 22:1 Erucic Acid;Dietary Erucic Acid | A determination of the total 22:1 erucic acid in a nutritional product or meal, or a portion thereof. | Dietary Erucic Acid Measurement | ||
DFATM | C172471 | Dietary Fat, Monounsaturated | A determination of the total monounsaturated fat in a nutritional product or meal, or a portion thereof. | Dietary Monounsaturated Fat Measurement | ||
DFATP | C172472 | Dietary Fat, Polyunsaturated | A determination of the total polyunsaturated fat in a nutritional product or meal, or a portion thereof. | Dietary Polyunsaturated Fat Measurement | ||
DFATS | C172470 | Dietary Fat, Saturated | A determination of the total saturated fat in a nutritional product or meal, or a portion thereof. | Dietary Saturated Fat Measurement | ||
DFATT | C172460 | Dietary Fat, Total | A determination of the total fat in a nutritional product or meal, or a portion thereof. | Total Dietary Fat Measurement | ||
DFE | C184456 | Dietary Iron | A determination of the total iron in a nutritional product or meal, or a portion thereof. | Dietary Iron Measurement | ||
DFEQ | C186016 | DFE;Dietary Folate Equivalents | The sum of food folate and normalized folic acid (as food folate equivalents) in a nutritional product or meal, or a portion thereof. | Dietary Folate Equivalents Measurement | ||
DFIBER | C172469 | Dietary Fiber | A determination of the total fiber in a nutritional product or meal, or a portion thereof. | Dietary Fiber Measurement | ||
DFOLFD | C186017 | Dietary Food Folate | A determination of the naturally occurring folate in a nutritional product or meal, or a portion thereof. | Dietary Food Folate Measurement | ||
DFOLIC | C186018 | Dietary Folic Acid | A determination of the folic acid in a nutritional product or meal, or a portion thereof. | Dietary Folic Acid Measurement | ||
DFOLTOT | C186019 | Dietary Total Folate | A determination of the total folate (supplemental folic acid + food folate) in a nutritional product or meal, or a portion thereof. | Dietary Total Folate Measurement | ||
DFRTJUCE | C184472 | Dietary Fruit Juice | A determination of the fruit juice in a nutritional product or meal, or a portion thereof. | Dietary Fruit Juice Measurement | ||
DFRUIT | C172465 | Dietary Fruit | A determination of the total fruit in a nutritional product or meal, or a portion thereof. | Dietary Fruit Measurement | ||
DGADL | C184440 | Dietary 20:1 Gadoleate;Dietary 20:1 Gadoleic Acid;Dietary Gadoleic Acid | A determination of the total 20:1 gadoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Gadoleic Acid Measurement | ||
DGRAIN | C172467 | Dietary Grain | A determination of the total grain in a nutritional product or meal, or a portion thereof. | Dietary Grain Measurement | ||
DGRAINRF | C184484 | Dietary Grain, Refined | A determination of the total refined grains in a nutritional product or meal, or a portion thereof. | Dietary Grain, Refined Measurement | ||
DGRAINWH | C184502 | Dietary Whole Grains | A determination of the whole grains in a nutritional product or meal, or a portion thereof. | Dietary Whole Grains Measurement | ||
DISPAMT | C78721 | Dispensed Amount | The quantity of a product that has been dispensed. (NCI) | Dispensed Amount | ||
DISTANCE | C25167 | Distance | The actual or calculated span between two points (real or virtual). | Distance | ||
DK | C184457 | Dietary Potassium | A determination of the total potassium in a nutritional product or meal, or a portion thereof. | Dietary Potassium Measurement | ||
DLAUR | C184431 | Dietary 12:0 Laurate;Dietary 12:0 Lauric Acid;Dietary Lauric Acid | A determination of the total 12:0 lauric acid in a nutritional product or meal, or a portion thereof. | Dietary Lauric Acid Measurement | ||
DLINO | C184437 | Dietary 18:2 Linoleate;Dietary 18:2 Linoleic Acid;Dietary Linoleic Acid | A determination of the total 18:2 linoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Linoleic Acid Measurement | ||
DLINOL | C184438 | Dietary 18:3 Linolenate;Dietary 18:3 Linolenic Acid;Dietary Linolenic Acid | A determination of the total 18:3 linolenic acid in a nutritional product or meal, or a portion thereof. | Dietary Linolenic Acid Measurement | ||
DLUTZXAN | C184473 | Dietary Lutein and Zeaxanthin | A determination of the lutein and zeaxanthin in a nutritional product or meal, or a portion thereof. | Dietary Lutein and Zeaxanthin Measurement | ||
DLYCOP | C184474 | Dietary Lycopene | A determination of the lycopene in a nutritional product or meal, or a portion thereof. | Dietary Lycopene Measurement | ||
DMEAT | C172468 | Dietary Meat | A determination of the total meat in a nutritional product or meal, or a portion thereof. | Dietary Meat Measurement | ||
DMEATCUR | C184469 | Dietary Meat, Cured | A determination of the cured meat in a nutritional product or meal, or a portion thereof. | Dietary Meat, Cured Measurement | ||
DMEATORG | C184480 | Dietary Meat, Organ | A determination of the organ meat in a nutritional product or meal, or a portion thereof. | Dietary Meat, Organ Measurement | ||
DMEATPLS | C184504 | Dietary Meat, Poultry, and Seafood | A determination of the total meat, poultry, and seafood in a nutritional product or meal, or a portion thereof. | Dietary Meat, Poultry, and Seafood Measurement | ||
DMG | C172462 | Dietary Magnesium | A determination of the total magnesium in a nutritional product or meal, or a portion thereof. | Dietary Magnesium Measurement | ||
DMILK | C184475 | Dietary Milk | A determination of the milk in a nutritional product or meal, or a portion thereof. | Dietary Milk Measurement | ||
DMOISTUR | C184476 | Dietary Moisture | A determination of the moisture content in a nutritional product or meal, or a portion thereof. | Dietary Moisture Measurement | ||
DMYRST | C184432 | Dietary 14:0 Myristate;Dietary 14:0 Myristic Acid;Dietary Myristic Acid | A determination of the total 14:0 myristic acid in a nutritional product or meal, or a portion thereof. | Dietary Myristic Acid Measurement | ||
DNA | C184459 | Dietary Sodium | A determination of the total sodium in a nutritional product or meal, or a portion thereof. | Dietary Sodium Measurement | ||
DNIACIN | C184477 | Dietary Niacin;Dietary Vitamin B3 | A determination of the niacin in a nutritional product or meal, or a portion thereof. | Dietary Niacin Measurement | ||
DNUTSEED | C184478 | Dietary Nuts and Seeds | A determination of the total nuts and seeds in a nutritional product or meal, or a portion thereof. | Dietary Nuts and Seeds Measurement | ||
DOILS | C184479 | Dietary Oils | A determination of the oils in a nutritional product or meal, or a portion thereof. | Dietary Oils Measurement | ||
DOLE | C184436 | Dietary 18:1 Oleate;Dietary 18:1 Oleic Acid;Dietary Oleic Acid | A determination of the total 18:1 oleic acid in a nutritional product or meal, or a portion thereof. | Dietary Oleic Acid Measurement | ||
DP | C184481 | Dietary Phosphorus | A determination of the phosphorus in a nutritional product or meal, or a portion thereof. | Dietary Phosphorus Measurement | ||
DPALM | C184433 | Dietary 16:0 Palmitate;Dietary 16:0 Palmitic Acid;Dietary Palmitic Acid | A determination of the total 16:0 palmitic acid in a nutritional product or meal, or a portion thereof. | Dietary Palmitic Acid Measurement | ||
DPALMO | C184434 | Dietary 16:1 Palmitoleate;Dietary 16:1 Palmitoleic Acid;Dietary Palmitoleic Acid | A determination of the total 16:1 palmitoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Palmitoleic Acid Measurement | ||
DPARN | C184439 | Dietary 18:4 Parinarate;Dietary 18:4 Parinaric Acid;Dietary Parinaric Acid | A determination of the total 18:4 parinaric acid in a nutritional product or meal, or a portion thereof. | Dietary Parinaric Acid Measurement | ||
DPOTATO | C184482 | Dietary Potatoes | A determination of the potatoes in a nutritional product or meal, or a portion thereof. | Dietary Potatoes Measurement | ||
DPOULTRY | C184483 | Dietary Poultry | A determination of the poultry in a nutritional product or meal, or a portion thereof. | Dietary Poultry Measurement | ||
DPROT | C172459 | Dietary Protein | A determination of the total protein in a nutritional product or meal, or a portion thereof. | Dietary Protein Measurement | ||
DPROTFD | C184494 | Dietary Protein Foods | A determination of the protein-rich food in a nutritional product or meal, or a portion thereof. | Dietary Protein Foods Measurement | ||
DRETINOL | C184485 | Dietary Retinol;Dietary Vitamin A | A determination of the retinol in a nutritional product or meal, or a portion thereof. | Dietary Retinol Measurement | ||
DRIBFLVN | C184486 | Dietary Riboflavin;Dietary Vitamin B2 | A determination of the riboflavin in a nutritional product or meal, or a portion thereof. | Dietary Riboflavin Measurement | ||
DSE | C184458 | Dietary Selenium | A determination of the total selenium in a nutritional product or meal, or a portion thereof. | Dietary Selenium Measurement | ||
DSFHN3FA | C184487 | Dietary Seafood High in n-3 Fatty Acids | A determination of the seafood high in n-3 fatty acids in a nutritional product or meal, or a portion thereof. | Dietary Seafood High in n-3 Fatty Acids Measurement | ||
DSFLN3FA | C184488 | Dietary Seafood Low in n-3 Fatty Acids | A determination of the seafood low in n-3 fatty acids in a nutritional product or meal, or a portion thereof. | Dietary Seafood Low in n-3 Fatty Acids Measurement | ||
DSLDFAT | C184489 | Dietary Solid Fats | A determination of the solid fats in a nutritional product or meal, or a portion thereof. | Dietary Solid Fats Measurement | ||
DSOYPROD | C184490 | Dietary Soy Products | A determination of the soy-containing products in a nutritional product or meal, or a portion thereof. | Dietary Soy Products Measurement | ||
DSTER | C184435 | Dietary 18:0 Stearate;Dietary 18:0 Stearic Acid;Dietary Stearic Acid | A determination of the total 18:0 stearic acid in a nutritional product or meal, or a portion thereof. | Dietary Stearic Acid Measurement | ||
DSUGART | C184338 | Dietary Total Sugars | A determination of the total sugars in a nutritional product or meal, or a portion thereof. | Dietary Sugar Measurement | ||
DTHEOBR | C184491 | Dietary Theobromine | A determination of the theobromine in a nutritional product or meal, or a portion thereof. | Dietary Theobromine Measurement | ||
DTHIAMIN | C184492 | Dietary Thiamin;Dietary Thiamine;Dietary Vitamin B1 | A determination of the thiamine in a nutritional product or meal, or a portion thereof. | Dietary Thiamine Measurement | ||
DTMND | C184442 | Dietary 20:5 Timnodonate;Dietary 20:5 Timnodonic Acid;Dietary Timnodonic Acid | A determination of the total 20:5 timnodonic acid in a nutritional product or meal, or a portion thereof. | Dietary Timnodonic Acid Measurement | ||
DTOMATO | C184493 | Dietary Tomatoes | A determination of the tomatoes in a nutritional product or meal, or a portion thereof. | Dietary Tomatoes Measurement | ||
DVEG | C172466 | Dietary Vegetable | A determination of the total vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetable Measurement | ||
DVEGDG | C184470 | Dietary Vegetables, Dark Green | A determination of the total dark green vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Dark Green Measurement | ||
DVEGRO | C184495 | Dietary Vegetables, Red and Orange | A determination of the total red and orange vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Red and Orange Measurement | ||
DVEGSTAR | C184496 | Dietary Vegetables, Starchy | A determination of the total starchy vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Starchy Measurement | ||
DVITA | C184497 | Dietary Vitamin A | A determination of the total vitamin A in a nutritional product or meal, or a portion thereof. | Dietary Vitamin A Measurement | ||
DVITB12 | C184353 | Dietary Vitamin B12 | A determination of the total vitamin B12 in a nutritional product or meal, or a portion thereof. | Dietary Vitamin B12 Measurement | ||
DVITB6 | C184498 | Dietary Vitamin B6 | A determination of the total vitamin B6 in a nutritional product or meal, or a portion thereof. | Dietary Vitamin B6 Measurement | ||
DVITC | C184499 | Dietary Vitamin C | A determination of the total vitamin C in a nutritional product or meal, or a portion thereof. | Dietary Vitamin C Measurement | ||
DVITD | C184500 | Dietary Vitamin D | A determination of the total vitamin D in a nutritional product or meal, or a portion thereof. | Dietary Vitamin D Measurement | ||
DVITK | C184501 | Dietary Vitamin K | A determination of the total vitamin K in a nutritional product or meal, or a portion thereof. | Dietary Vitamin K Measurement | ||
DYOGURT | C184503 | Dietary Yogurt | A determination of the yogurt in a nutritional product or meal, or a portion thereof. | Dietary Yogurt Measurement | ||
DZN | C184460 | Dietary Zinc | A determination of the total Zinc in a nutritional product or meal, or a portion thereof. | Dietary Zinc Measurement | ||
EPSDNUM | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
ESTWT | C174282 | Estimated Entity Weight;Estimated Weight | An approximate determination of the weight of the entity. | Estimated Weight | ||
EXCDUR | C172475 | Exercise Duration | The length of time an individual spends exercising. | Exercise Duration | ||
EXCINTSY | C172473 | Exercise Intensity | A determination or assessment of the degree or magnitude of an individual's exertion during physical activity. | Exercise Intensity | ||
EXCMPLNC | C172474 | Exercise Compliance | A determination or assessment of the extent to which an individual adheres to a fitness program. | Exercise Compliance | ||
LAPCOMPN | C172478 | Number of Laps Completed | The number of laps completed around a course or circuit. | Number of Laps Completed | ||
PPTFCT | C163413 | Precipitating Factor | The factor that causes or triggers the onset of an occurrence. | Precipitating Factor | ||
PREPAMT | C170562 | Prepared Amount | The quantity of a product that has been made ready for use. | Prepared Amount | ||
REMAMT | C170563 | Remaining Amount | The quantity of a product that remains after dosing, consumption, or use. | Remaining Amount | ||
RETAMT | C78722 | Returned Amount | The quantity of a product that has been returned. (NCI) | Returned Amount | ||
RLDEV | C163414 | Relationship to Device | The relationship of an event to a device, which may or may not be a device under study. | Relationship to Device | ||
SPEED | C41146 | Speed | A scalar measure of the rate of movement of the object expressed as the distance traveled divided by the elapsed time. | Speed | ||
STEPSTN | C172479 | Number of Steps Taken | The number of footsteps taken by an individual. | Number of Steps Taken | ||
TTIMPAUS | C172477 | Total Time Paused | The total amount of time during which an event, operation or activity has been interrupted or stopped. | Total Time Paused | ||
TTIMPHAC | C172480 | Total Time Physically Active | The total amount of time during which an individual was actively engaged in physical activity. | Total Time Physically Active | ||
Back to top | ||||||
CL.C163028.D1FATS | Type 1 Diabetes Findings About Test Name
(D1FATS) | text
Extensible: Yes | C163028 | Type 1 Diabetes Findings About Test Name | Terminology relevant to the test names that describe findings about Type 1 Diabetes event or intervention. | CDISC SDTM Type 1 Diabetes Findings About Test Name Terminology |
Action Taken With Device | C117037 | Action Taken With Device | Action taken with respect to a device in a study, which may or may not be the device under study. | Action Taken with Device | ||
Action Taken With Subject | C163412 | Action Taken With Subject | Action taken with respect to a subject in a study. | Action Taken With Subject | ||
Calories Burned | C172476 | Calories Burned | A measurement of the number of calories expended. | Calories Burned | ||
Cumulative Exposure | C94596 | Cumulative Exposure | The total amount that a subject is exposed to over time. | Cumulative Exposure | ||
Dietary Added Sugar | C172463 | Dietary Added Sugar | A determination of the total added sugars in a nutritional product or meal, or a portion thereof. | Dietary Added Sugar Measurement | ||
Dietary Added Vitamin B12 | C184461 | Dietary Added Vitamin B12 | A determination of the total added vitamin B12 in a nutritional product or meal, or a portion thereof. | Dietary Added Vitamin B12 Measurement | ||
Dietary Added Vitamin E | C184462 | Dietary Added Vitamin E | A determination of the total added vitamin E in a nutritional product or meal, or a portion thereof. | Dietary Added Vitamin E Measurement | ||
Dietary Alcohol | C184463 | Dietary Alcohol;Dietary Ethanol | A determination of the total amount of alcohol in a nutritional product or meal, or a portion thereof. | Dietary Alcohol Measurement | ||
Dietary Alpha Carotene | C184449 | Dietary Alpha Carotene | A determination of the alpha carotene in a nutritional product or meal, or a portion thereof. | Dietary Alpha Carotene Measurement | ||
Dietary Alpha Tocopherol | C184450 | Dietary Alpha Tocopherol | A determination of the alpha tocopherol in a nutritional product or meal, or a portion thereof. | Dietary Alpha Tocopherol Measurement | ||
Dietary Arachidonic Acid | C184441 | Dietary 20:4 Arachidonate;Dietary 20:4 Arachidonic Acid;Dietary Arachidonic Acid | A determination of the total 20:4 arachidonic acid in a nutritional product or meal, or a portion thereof. | Dietary Arachidonic Acid Measurement | ||
Dietary Beans and Peas | C184465 | Dietary Beans and Peas | A determination of the total beans and peas in a nutritional product or meal, or a portion thereof. | Dietary Beans and Peas Measurement | ||
Dietary Beta Carotene | C184451 | Dietary Beta Carotene | A determination of the beta carotene in a nutritional product or meal, or a portion thereof. | Dietary Beta Carotene Measurement | ||
Dietary Beta-Cryptoxanthin | C186015 | Dietary Beta-Cryptoxanthin | A determination of the beta-cryptoxanthin in a nutritional product or meal, or a portion thereof. | Dietary Beta-Cryptoxanthin Measurement | ||
Dietary Butyric Acid | C184446 | Dietary 4:0 Butyrate;Dietary 4:0 Butyric Acid;Dietary Butyric Acid | A determination of the total 4:0 butyric acid in a nutritional product or meal, or a portion thereof. | Dietary Butyric Acid Measurement | ||
Dietary Caffeine | C184452 | Dietary Caffeine | A determination of the caffeine in a nutritional product or meal, or a portion thereof. | Dietary Caffeine Measurement | ||
Dietary Calcium | C184453 | Dietary Calcium | A determination of the total calcium in a nutritional product or meal, or a portion thereof. | Dietary Calcium Measurement | ||
Dietary Calories | C172464 | Dietary Calories | A determination of the total dietary calories in a nutritional product or meal, or a portion thereof. | Dietary Calories Measurement | ||
Dietary Capric Acid | C184430 | Dietary 10:0 Caprate;Dietary 10:0 Capric Acid;Dietary Capric Acid | A determination of the total 10:0 capric acid in a nutritional product or meal, or a portion thereof. | Dietary Capric Acid Measurement | ||
Dietary Caproic Acid | C184447 | Dietary 6:0 Caproate;Dietary 6:0 Caproic Acid;Dietary Caproic Acid | A determination of the total 6:0 caproic acid in a nutritional product or meal, or a portion thereof. | Dietary Caproic Acid Measurement | ||
Dietary Caprylic Acid | C184448 | Dietary 8:0 Caprylate;Dietary 8:0 Caprylic Acid;Dietary Caprylic Acid | A determination of the total 8:0 caprylic acid in a nutritional product or meal, or a portion thereof. | Dietary Caprylic Acid Measurement | ||
Dietary Cheese | C184454 | Dietary Cheese | A determination of the total cheese in a nutritional product or meal, or a portion thereof. | Dietary Cheese Measurement | ||
Dietary Cholesterol | C184466 | Dietary Cholesterol | A determination of the total cholesterol in a nutritional product or meal, or a portion thereof. | Dietary Cholesterol Measurement | ||
Dietary Choline | C184467 | Dietary Choline | A determination of the choline in a nutritional product or meal, or a portion thereof. | Dietary Choline Measurement | ||
Dietary Citrus, Melons, and Berries | C184468 | Dietary Citrus, Melons, and Berries | A determination of the total citrus, melons, and berries in a nutritional product or meal, or a portion thereof. | Dietary Citrus, Melons, and Berries Measurement | ||
Dietary Clupanodonic Acid | C184444 | Dietary 22:5 Clupanodonate;Dietary 22:5 Clupanodonic Acid;Dietary Clupanodonic Acid | A determination of the total 22:5 clupanodonic acid in a nutritional product or meal, or a portion thereof. | Dietary Clupanodonic Acid Measurement | ||
Dietary Copper | C184455 | Dietary Copper | A determination of the total copper in a nutritional product or meal, or a portion thereof. | Dietary Copper Measurement | ||
Dietary Docosahexaenoic Acid | C184445 | Dietary 22:6 Docosahexaenoate;Dietary 22:6 Docosahexaenoic Acid;Dietary Docosahexaenoic Acid | A determination of the total 22:6 docosahexaenoic acid in a nutritional product or meal, or a portion thereof. | Dietary Docosahexaenoic Acid Measurement | ||
Dietary Eggs | C184471 | Dietary Eggs | A determination of the eggs in a nutritional product or meal, or a portion thereof. | Dietary Eggs Measurement | ||
Dietary Erucic Acid | C184443 | Dietary 22:1 Erucate;Dietary 22:1 Erucic Acid;Dietary Erucic Acid | A determination of the total 22:1 erucic acid in a nutritional product or meal, or a portion thereof. | Dietary Erucic Acid Measurement | ||
Dietary Fat, Monounsaturated | C172471 | Dietary Fat, Monounsaturated | A determination of the total monounsaturated fat in a nutritional product or meal, or a portion thereof. | Dietary Monounsaturated Fat Measurement | ||
Dietary Fat, Polyunsaturated | C172472 | Dietary Fat, Polyunsaturated | A determination of the total polyunsaturated fat in a nutritional product or meal, or a portion thereof. | Dietary Polyunsaturated Fat Measurement | ||
Dietary Fat, Saturated | C172470 | Dietary Fat, Saturated | A determination of the total saturated fat in a nutritional product or meal, or a portion thereof. | Dietary Saturated Fat Measurement | ||
Dietary Fat, Total | C172460 | Dietary Fat, Total | A determination of the total fat in a nutritional product or meal, or a portion thereof. | Total Dietary Fat Measurement | ||
Dietary Fiber | C172469 | Dietary Fiber | A determination of the total fiber in a nutritional product or meal, or a portion thereof. | Dietary Fiber Measurement | ||
Dietary Folate Equivalents | C186016 | DFE;Dietary Folate Equivalents | The sum of food folate and normalized folic acid (as food folate equivalents) in a nutritional product or meal, or a portion thereof. | Dietary Folate Equivalents Measurement | ||
Dietary Folic Acid | C186018 | Dietary Folic Acid | A determination of the folic acid in a nutritional product or meal, or a portion thereof. | Dietary Folic Acid Measurement | ||
Dietary Food Folate | C186017 | Dietary Food Folate | A determination of the naturally occurring folate in a nutritional product or meal, or a portion thereof. | Dietary Food Folate Measurement | ||
Dietary Fruit Juice | C184472 | Dietary Fruit Juice | A determination of the fruit juice in a nutritional product or meal, or a portion thereof. | Dietary Fruit Juice Measurement | ||
Dietary Fruit | C172465 | Dietary Fruit | A determination of the total fruit in a nutritional product or meal, or a portion thereof. | Dietary Fruit Measurement | ||
Dietary Gadoleic Acid | C184440 | Dietary 20:1 Gadoleate;Dietary 20:1 Gadoleic Acid;Dietary Gadoleic Acid | A determination of the total 20:1 gadoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Gadoleic Acid Measurement | ||
Dietary Grain | C172467 | Dietary Grain | A determination of the total grain in a nutritional product or meal, or a portion thereof. | Dietary Grain Measurement | ||
Dietary Grain, Refined | C184484 | Dietary Grain, Refined | A determination of the total refined grains in a nutritional product or meal, or a portion thereof. | Dietary Grain, Refined Measurement | ||
Dietary Iron | C184456 | Dietary Iron | A determination of the total iron in a nutritional product or meal, or a portion thereof. | Dietary Iron Measurement | ||
Dietary Lauric Acid | C184431 | Dietary 12:0 Laurate;Dietary 12:0 Lauric Acid;Dietary Lauric Acid | A determination of the total 12:0 lauric acid in a nutritional product or meal, or a portion thereof. | Dietary Lauric Acid Measurement | ||
Dietary Linoleic Acid | C184437 | Dietary 18:2 Linoleate;Dietary 18:2 Linoleic Acid;Dietary Linoleic Acid | A determination of the total 18:2 linoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Linoleic Acid Measurement | ||
Dietary Linolenic Acid | C184438 | Dietary 18:3 Linolenate;Dietary 18:3 Linolenic Acid;Dietary Linolenic Acid | A determination of the total 18:3 linolenic acid in a nutritional product or meal, or a portion thereof. | Dietary Linolenic Acid Measurement | ||
Dietary Lutein and Zeaxanthin | C184473 | Dietary Lutein and Zeaxanthin | A determination of the lutein and zeaxanthin in a nutritional product or meal, or a portion thereof. | Dietary Lutein and Zeaxanthin Measurement | ||
Dietary Lycopene | C184474 | Dietary Lycopene | A determination of the lycopene in a nutritional product or meal, or a portion thereof. | Dietary Lycopene Measurement | ||
Dietary Magnesium | C172462 | Dietary Magnesium | A determination of the total magnesium in a nutritional product or meal, or a portion thereof. | Dietary Magnesium Measurement | ||
Dietary Meat | C172468 | Dietary Meat | A determination of the total meat in a nutritional product or meal, or a portion thereof. | Dietary Meat Measurement | ||
Dietary Meat, Cured | C184469 | Dietary Meat, Cured | A determination of the cured meat in a nutritional product or meal, or a portion thereof. | Dietary Meat, Cured Measurement | ||
Dietary Meat, Organ | C184480 | Dietary Meat, Organ | A determination of the organ meat in a nutritional product or meal, or a portion thereof. | Dietary Meat, Organ Measurement | ||
Dietary Meat, Poultry, and Seafood | C184504 | Dietary Meat, Poultry, and Seafood | A determination of the total meat, poultry, and seafood in a nutritional product or meal, or a portion thereof. | Dietary Meat, Poultry, and Seafood Measurement | ||
Dietary Milk | C184475 | Dietary Milk | A determination of the milk in a nutritional product or meal, or a portion thereof. | Dietary Milk Measurement | ||
Dietary Moisture | C184476 | Dietary Moisture | A determination of the moisture content in a nutritional product or meal, or a portion thereof. | Dietary Moisture Measurement | ||
Dietary Myristic Acid | C184432 | Dietary 14:0 Myristate;Dietary 14:0 Myristic Acid;Dietary Myristic Acid | A determination of the total 14:0 myristic acid in a nutritional product or meal, or a portion thereof. | Dietary Myristic Acid Measurement | ||
Dietary Niacin | C184477 | Dietary Niacin;Dietary Vitamin B3 | A determination of the niacin in a nutritional product or meal, or a portion thereof. | Dietary Niacin Measurement | ||
Dietary Nuts and Seeds | C184478 | Dietary Nuts and Seeds | A determination of the total nuts and seeds in a nutritional product or meal, or a portion thereof. | Dietary Nuts and Seeds Measurement | ||
Dietary Oils | C184479 | Dietary Oils | A determination of the oils in a nutritional product or meal, or a portion thereof. | Dietary Oils Measurement | ||
Dietary Oleic Acid | C184436 | Dietary 18:1 Oleate;Dietary 18:1 Oleic Acid;Dietary Oleic Acid | A determination of the total 18:1 oleic acid in a nutritional product or meal, or a portion thereof. | Dietary Oleic Acid Measurement | ||
Dietary Palmitic Acid | C184433 | Dietary 16:0 Palmitate;Dietary 16:0 Palmitic Acid;Dietary Palmitic Acid | A determination of the total 16:0 palmitic acid in a nutritional product or meal, or a portion thereof. | Dietary Palmitic Acid Measurement | ||
Dietary Palmitoleic Acid | C184434 | Dietary 16:1 Palmitoleate;Dietary 16:1 Palmitoleic Acid;Dietary Palmitoleic Acid | A determination of the total 16:1 palmitoleic acid in a nutritional product or meal, or a portion thereof. | Dietary Palmitoleic Acid Measurement | ||
Dietary Parinaric Acid | C184439 | Dietary 18:4 Parinarate;Dietary 18:4 Parinaric Acid;Dietary Parinaric Acid | A determination of the total 18:4 parinaric acid in a nutritional product or meal, or a portion thereof. | Dietary Parinaric Acid Measurement | ||
Dietary Phosphorus | C184481 | Dietary Phosphorus | A determination of the phosphorus in a nutritional product or meal, or a portion thereof. | Dietary Phosphorus Measurement | ||
Dietary Potassium | C184457 | Dietary Potassium | A determination of the total potassium in a nutritional product or meal, or a portion thereof. | Dietary Potassium Measurement | ||
Dietary Potatoes | C184482 | Dietary Potatoes | A determination of the potatoes in a nutritional product or meal, or a portion thereof. | Dietary Potatoes Measurement | ||
Dietary Poultry | C184483 | Dietary Poultry | A determination of the poultry in a nutritional product or meal, or a portion thereof. | Dietary Poultry Measurement | ||
Dietary Protein Foods | C184494 | Dietary Protein Foods | A determination of the protein-rich food in a nutritional product or meal, or a portion thereof. | Dietary Protein Foods Measurement | ||
Dietary Protein | C172459 | Dietary Protein | A determination of the total protein in a nutritional product or meal, or a portion thereof. | Dietary Protein Measurement | ||
Dietary Retinol | C184485 | Dietary Retinol;Dietary Vitamin A | A determination of the retinol in a nutritional product or meal, or a portion thereof. | Dietary Retinol Measurement | ||
Dietary Riboflavin | C184486 | Dietary Riboflavin;Dietary Vitamin B2 | A determination of the riboflavin in a nutritional product or meal, or a portion thereof. | Dietary Riboflavin Measurement | ||
Dietary Seafood High in n-3 Fatty Acids | C184487 | Dietary Seafood High in n-3 Fatty Acids | A determination of the seafood high in n-3 fatty acids in a nutritional product or meal, or a portion thereof. | Dietary Seafood High in n-3 Fatty Acids Measurement | ||
Dietary Seafood Low in n-3 Fatty Acids | C184488 | Dietary Seafood Low in n-3 Fatty Acids | A determination of the seafood low in n-3 fatty acids in a nutritional product or meal, or a portion thereof. | Dietary Seafood Low in n-3 Fatty Acids Measurement | ||
Dietary Selenium | C184458 | Dietary Selenium | A determination of the total selenium in a nutritional product or meal, or a portion thereof. | Dietary Selenium Measurement | ||
Dietary Sodium | C184459 | Dietary Sodium | A determination of the total sodium in a nutritional product or meal, or a portion thereof. | Dietary Sodium Measurement | ||
Dietary Solid Fats | C184489 | Dietary Solid Fats | A determination of the solid fats in a nutritional product or meal, or a portion thereof. | Dietary Solid Fats Measurement | ||
Dietary Soy Products | C184490 | Dietary Soy Products | A determination of the soy-containing products in a nutritional product or meal, or a portion thereof. | Dietary Soy Products Measurement | ||
Dietary Stearic Acid | C184435 | Dietary 18:0 Stearate;Dietary 18:0 Stearic Acid;Dietary Stearic Acid | A determination of the total 18:0 stearic acid in a nutritional product or meal, or a portion thereof. | Dietary Stearic Acid Measurement | ||
Dietary Theobromine | C184491 | Dietary Theobromine | A determination of the theobromine in a nutritional product or meal, or a portion thereof. | Dietary Theobromine Measurement | ||
Dietary Thiamine | C184492 | Dietary Thiamin;Dietary Thiamine;Dietary Vitamin B1 | A determination of the thiamine in a nutritional product or meal, or a portion thereof. | Dietary Thiamine Measurement | ||
Dietary Timnodonic Acid | C184442 | Dietary 20:5 Timnodonate;Dietary 20:5 Timnodonic Acid;Dietary Timnodonic Acid | A determination of the total 20:5 timnodonic acid in a nutritional product or meal, or a portion thereof. | Dietary Timnodonic Acid Measurement | ||
Dietary Tomatoes | C184493 | Dietary Tomatoes | A determination of the tomatoes in a nutritional product or meal, or a portion thereof. | Dietary Tomatoes Measurement | ||
Dietary Total Carbohydrate | C172461 | Dietary Total Carbohydrate | A determination of the total carbohydrate in a nutritional product or meal, or a portion thereof. | Total Dietary Carbohydrate Measurement | ||
Dietary Total Dairy | C184337 | Dietary Total Dairy | A determination of the total dairy (food products produced from or containing milk) in a nutritional product or meal, or a portion thereof. | Dietary Dairy Measurement | ||
Dietary Total Folate | C186019 | Dietary Total Folate | A determination of the total folate (supplemental folic acid + food folate) in a nutritional product or meal, or a portion thereof. | Dietary Total Folate Measurement | ||
Dietary Total Sugars | C184338 | Dietary Total Sugars | A determination of the total sugars in a nutritional product or meal, or a portion thereof. | Dietary Sugar Measurement | ||
Dietary Vegetable | C172466 | Dietary Vegetable | A determination of the total vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetable Measurement | ||
Dietary Vegetables, Dark Green | C184470 | Dietary Vegetables, Dark Green | A determination of the total dark green vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Dark Green Measurement | ||
Dietary Vegetables, Red and Orange | C184495 | Dietary Vegetables, Red and Orange | A determination of the total red and orange vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Red and Orange Measurement | ||
Dietary Vegetables, Starchy | C184496 | Dietary Vegetables, Starchy | A determination of the total starchy vegetables in a nutritional product or meal, or a portion thereof. | Dietary Vegetables, Starchy Measurement | ||
Dietary Vitamin A | C184497 | Dietary Vitamin A | A determination of the total vitamin A in a nutritional product or meal, or a portion thereof. | Dietary Vitamin A Measurement | ||
Dietary Vitamin B12 | C184353 | Dietary Vitamin B12 | A determination of the total vitamin B12 in a nutritional product or meal, or a portion thereof. | Dietary Vitamin B12 Measurement | ||
Dietary Vitamin B6 | C184498 | Dietary Vitamin B6 | A determination of the total vitamin B6 in a nutritional product or meal, or a portion thereof. | Dietary Vitamin B6 Measurement | ||
Dietary Vitamin C | C184499 | Dietary Vitamin C | A determination of the total vitamin C in a nutritional product or meal, or a portion thereof. | Dietary Vitamin C Measurement | ||
Dietary Vitamin D | C184500 | Dietary Vitamin D | A determination of the total vitamin D in a nutritional product or meal, or a portion thereof. | Dietary Vitamin D Measurement | ||
Dietary Vitamin K | C184501 | Dietary Vitamin K | A determination of the total vitamin K in a nutritional product or meal, or a portion thereof. | Dietary Vitamin K Measurement | ||
Dietary Whole Grains | C184502 | Dietary Whole Grains | A determination of the whole grains in a nutritional product or meal, or a portion thereof. | Dietary Whole Grains Measurement | ||
Dietary Yogurt | C184503 | Dietary Yogurt | A determination of the yogurt in a nutritional product or meal, or a portion thereof. | Dietary Yogurt Measurement | ||
Dietary Zinc | C184460 | Dietary Zinc | A determination of the total Zinc in a nutritional product or meal, or a portion thereof. | Dietary Zinc Measurement | ||
Dispensed Amount | C78721 | Dispensed Amount | The quantity of a product that has been dispensed. (NCI) | Dispensed Amount | ||
Distance | C25167 | Distance | The actual or calculated span between two points (real or virtual). | Distance | ||
Estimated Weight | C174282 | Estimated Entity Weight;Estimated Weight | An approximate determination of the weight of the entity. | Estimated Weight | ||
Exercise Compliance | C172474 | Exercise Compliance | A determination or assessment of the extent to which an individual adheres to a fitness program. | Exercise Compliance | ||
Exercise Duration | C172475 | Exercise Duration | The length of time an individual spends exercising. | Exercise Duration | ||
Exercise Intensity | C172473 | Exercise Intensity | A determination or assessment of the degree or magnitude of an individual's exertion during physical activity. | Exercise Intensity | ||
Number of Alcoholic Drinks | C184464 | Number of Alcoholic Drinks | The total number of alcoholic drinks. | Number of Alcoholic Drinks Measurement | ||
Number of Episodes | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
Number of Laps Completed | C172478 | Number of Laps Completed | The number of laps completed around a course or circuit. | Number of Laps Completed | ||
Number of Steps Taken | C172479 | Number of Steps Taken | The number of footsteps taken by an individual. | Number of Steps Taken | ||
Precipitating Factor | C163413 | Precipitating Factor | The factor that causes or triggers the onset of an occurrence. | Precipitating Factor | ||
Prepared Amount | C170562 | Prepared Amount | The quantity of a product that has been made ready for use. | Prepared Amount | ||
Relationship to Device | C163414 | Relationship to Device | The relationship of an event to a device, which may or may not be a device under study. | Relationship to Device | ||
Remaining Amount | C170563 | Remaining Amount | The quantity of a product that remains after dosing, consumption, or use. | Remaining Amount | ||
Returned Amount | C78722 | Returned Amount | The quantity of a product that has been returned. (NCI) | Returned Amount | ||
Speed | C41146 | Speed | A scalar measure of the rate of movement of the object expressed as the distance traveled divided by the elapsed time. | Speed | ||
Total Time Paused | C172477 | Total Time Paused | The total amount of time during which an event, operation or activity has been interrupted or stopped. | Total Time Paused | ||
Total Time Physically Active | C172480 | Total Time Physically Active | The total amount of time during which an individual was actively engaged in physical activity. | Total Time Physically Active | ||
Back to top | ||||||
CL.C154449.UHDR1TC | Unified Huntington's Disease Rating Scale '99 Clinical Classification Test Code
(UHDR1TC) | text
Extensible: No | C154449 | Unified Huntington's Disease Rating Scale '99 Clinical Classification Test Code | Unified Huntington's Disease Rating Scale '99 test code. | CDISC Clinical Classification UHDRS 1999 Version Test Code Terminology |
UHDR101A | C155370 | UHDR1-Ocular Pursuit: Horizontal | Unified Huntington's Disease Rating Scale '99 - Ocular pursuit, horizontal. | UHDRS 1999 Version - Ocular Pursuit: Horizontal | ||
UHDR101B | C155371 | UHDR1-Ocular Pursuit: Vertical | Unified Huntington's Disease Rating Scale '99 - Ocular pursuit, vertical. | UHDRS 1999 Version - Ocular Pursuit: Vertical | ||
UHDR102A | C155372 | UHDR1-Saccade Initiation: Horizontal | Unified Huntington's Disease Rating Scale '99 - Saccade initiation, horizontal. | UHDRS 1999 Version - Saccade Initiation: Horizontal | ||
UHDR102B | C155373 | UHDR1-Saccade Initiation: Vertical | Unified Huntington's Disease Rating Scale '99 - Saccade initiation, vertical. | UHDRS 1999 Version - Saccade Initiation: Vertical | ||
UHDR103A | C155374 | UHDR1-Saccade Velocity: Horizontal | Unified Huntington's Disease Rating Scale '99 - Saccade velocity, horizontal. | UHDRS 1999 Version - Saccade Velocity: Horizontal | ||
UHDR103B | C155375 | UHDR1-Saccade Velocity: Vertical | Unified Huntington's Disease Rating Scale '99 - Saccade velocity, vertical. | UHDRS 1999 Version - Saccade Velocity: Vertical | ||
UHDR104 | C155376 | UHDR1-Dysarthria | Unified Huntington's Disease Rating Scale '99 - Dysarthria. | UHDRS 1999 Version - Dysarthria | ||
UHDR105 | C155377 | UHDR1-Tongue Protrusion | Unified Huntington's Disease Rating Scale '99 - Tongue protrusion. | UHDRS 1999 Version - Tongue Protrusion | ||
UHDR106A | C155378 | UHDR1-Finger Taps: Right | Unified Huntington's Disease Rating Scale '99 - Finger taps, right. | UHDRS 1999 Version - Finger Taps: Right | ||
UHDR106B | C155379 | UHDR1-Finger Taps: Left | Unified Huntington's Disease Rating Scale '99 - Finger taps, left. | UHDRS 1999 Version - Finger Taps: Left | ||
UHDR107A | C155380 | UHDR1-Pronate/Supinate: Hands: Right | Unified Huntington's Disease Rating Scale '99 - Pronate/supinate-hands, right. | UHDRS 1999 Version - Pronate/Supinate: Hands: Right | ||
UHDR107B | C155381 | UHDR1-Pronate/Supinate: Hands: Left | Unified Huntington's Disease Rating Scale '99 - Pronate/supinate-hands, left. | UHDRS 1999 Version - Pronate/Supinate: Hands: Left | ||
UHDR108 | C155382 | UHDR1-Luria | Unified Huntington's Disease Rating Scale '99 - Luria (fist-hand palm test). | UHDRS 1999 Version - Luria | ||
UHDR109A | C155383 | UHDR1-Rigidity: Arms: Right | Unified Huntington's Disease Rating Scale '99 - Rigidity-arms, right. | UHDRS 1999 Version - Rigidity: Arms: Right | ||
UHDR109B | C155384 | UHDR1-Rigidity: Arms: Left | Unified Huntington's Disease Rating Scale '99 - Rigidity-arms, left. | UHDRS 1999 Version - Rigidity: Arms: Left | ||
UHDR110 | C155385 | UHDR1-Bradykinesia: Body | Unified Huntington's Disease Rating Scale '99 - Bradykinesia-body. | UHDRS 1999 Version - Bradykinesia: Body | ||
UHDR111A | C155386 | UHDR1-Maximal Dystonia: Trunk | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-Trunk. | UHDRS 1999 Version - Maximal Dystonia: Trunk | ||
UHDR111B | C155387 | UHDR1-Maximal Dystonia: RUE | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-RUE. | UHDRS 1999 Version - Maximal Dystonia: RUE | ||
UHDR111C | C155388 | UHDR1-Maximal Dystonia: LUE | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-LUE. | UHDRS 1999 Version - Maximal Dystonia: LUE | ||
UHDR111D | C155389 | UHDR1-Maximal Dystonia: RLE | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-RLE. | UHDRS 1999 Version - Maximal Dystonia: RLE | ||
UHDR111E | C155390 | UHDR1-Maximal Dystonia: LLE | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-LLE. | UHDRS 1999 Version - Maximal Dystonia: LLE | ||
UHDR112A | C155391 | UHDR1-Maximal Chorea: Face | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-Face. | UHDRS 1999 Version - Maximal Chorea: Face | ||
UHDR112B | C155392 | UHDR1-Maximal Chorea: BOL | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-BOL. | UHDRS 1999 Version - Maximal Chorea: BOL | ||
UHDR112C | C155393 | UHDR1-Maximal Chorea: Trunk | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-Trunk. | UHDRS 1999 Version - Maximal Chorea: Trunk | ||
UHDR112D | C155394 | UHDR1-Maximal Chorea: RUE | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-RUE. | UHDRS 1999 Version - Maximal Chorea: RUE | ||
UHDR112E | C155395 | UHDR1-Maximal Chorea: LUE | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-LUE. | UHDRS 1999 Version - Maximal Chorea: LUE | ||
UHDR112F | C155396 | UHDR1-Maximal Chorea: RLE | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-RLE. | UHDRS 1999 Version - Maximal Chorea: RLE | ||
UHDR112G | C155397 | UHDR1-Maximal Chorea: LLE | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-LLE. | UHDRS 1999 Version - Maximal Chorea: LLE | ||
UHDR113 | C155398 | UHDR1-Gait | Unified Huntington's Disease Rating Scale '99 - Gait. | UHDRS 1999 Version - Gait | ||
UHDR114 | C155399 | UHDR1-Tandem Walking | Unified Huntington's Disease Rating Scale '99 - Tandem walking. | UHDRS 1999 Version - Tandem Walking | ||
UHDR115 | C155400 | UHDR1-Retropulsion Pull Test | Unified Huntington's Disease Rating Scale '99 - Retropulsion pull test. | UHDRS 1999 Version - Retropulsion Pull Test | ||
UHDR117 | C155401 | UHDR1-Diagnosis Confidence Level | Unified Huntington's Disease Rating Scale '99 - Diagnosis confidence level: To what degree are you confident that this person meets the operational definition of the unequivocal presence of an otherwise unexplained extrapyramidal movement disorder (e.g., chorea, dystonia, bradykinesia, rigidity) in a subject at risk of HD? | UHDRS 1999 Version - Diagnosis Confidence Level | ||
UHDR119 | C155402 | UHDR1-Verbal Fluency Test | Unified Huntington's Disease Rating Scale '99 - Verbal fluency test (raw score). | UHDRS 1999 Version - Verbal Fluency Test | ||
UHDR120 | C155403 | UHDR1-Symbol Digit Modalities Test | Unified Huntington's Disease Rating Scale '99 - Symbol digit modalities test (raw score). | UHDRS 1999 Version - Symbol Digit Modalities Test | ||
UHDR125A | C155404 | UHDR1-Depressed Mood: Frequency | Unified Huntington's Disease Rating Scale '99 - Depressed mood: Frequency: Within the past month, how often have you been feeling sad, down or "blue"? | UHDRS 1999 Version - Depressed Mood: Frequency | ||
UHDR125B | C155405 | UHDR1-Depressed Mood: Severity | Unified Huntington's Disease Rating Scale '99 - Depressed mood: Severity: How has your mood affected your daily activities? [Evidence of sad mood from behavioral observation includes sad voice or expression, tearfulness.]. | UHDRS 1999 Version - Depressed Mood: Severity | ||
UHDR126A | C155406 | UHDR1-Apathy: Frequency | Unified Huntington's Disease Rating Scale '99 - Apathy: Frequency: Within the past month, how often have you found that you have lost interest in things that used to be important to you? | UHDRS 1999 Version - Apathy: Frequency | ||
UHDR126B | C155407 | UHDR1-Apathy: Severity | Unified Huntington's Disease Rating Scale '99 - Apathy: Severity: How has apathy impacted your ability to carry out daily activities? | UHDRS 1999 Version - Apathy: Severity | ||
UHDR127A | C155408 | UHDR1-Self-esteem/Guilt: Frequency | Unified Huntington's Disease Rating Scale '99 - Self-esteem/guilt: Frequency: Within the past month, how often have you been feeling badly about yourself? | UHDRS 1999 Version - Self-esteem/Guilt: Frequency | ||
UHDR127B | C155409 | UHDR1-Self-esteem/Guilt: Severity | Unified Huntington's Disease Rating Scale '99 - Self-esteem/guilt: Severity: How have these feelings affected your daily activities? | UHDRS 1999 Version - Self-esteem/Guilt: Severity | ||
UHDR128A | C155410 | UHDR1-Suicidal Thoughts: Frequency | Unified Huntington's Disease Rating Scale '99 - Suicidal thoughts: Frequency: Within the past month, how often have you thought about hurting yourself or ending it all? | UHDRS 1999 Version - Suicidal Thoughts: Frequency | ||
UHDR128B | C155411 | UHDR1-Suicidal Thoughts: Severity | Unified Huntington's Disease Rating Scale '99 - Suicidal thoughts: Severity: Do you have a plan in mind to end it all? Have you taken any steps toward carrying out your plan? | UHDRS 1999 Version - Suicidal Thoughts: Severity | ||
UHDR129A | C155412 | UHDR1-Anxiety: Frequency | Unified Huntington's Disease Rating Scale '99 - Anxiety: Frequency: Within the past month, how often have you found yourself worrying about things? | UHDRS 1999 Version - Anxiety: Frequency | ||
UHDR129B | C155413 | UHDR1-Anxiety: Severity | Unified Huntington's Disease Rating Scale '99 - Anxiety: Severity: How much has nervousness or worry affected your daily activities? | UHDRS 1999 Version - Anxiety: Severity | ||
UHDR130A | C155414 | UHDR1-Irritable Behavior: Frequency | Unified Huntington's Disease Rating Scale '99 - Irritable behavior: Frequency: In the past month, how often have you felt impatient, irritable, or "cranky"? | UHDRS 1999 Version - Irritable Behavior: Frequency | ||
UHDR130B | C155415 | UHDR1-Irritable Behavior: Severity | Unified Huntington's Disease Rating Scale '99 - Irritable behavior: Severity: How has irritability impacted your ability to get along with others? | UHDRS 1999 Version - Irritable Behavior: Severity | ||
UHDR131A | C155416 | UHDR1-Disruptive Behavior: Frequency | Unified Huntington's Disease Rating Scale '99 - Disruptive or aggressive behavior: Frequency: Within the past month, how often have you had emotional or temper outbursts? How often have you had times when you lost control of yourself? | UHDRS 1999 Version - Disruptive Behavior: Frequency | ||
UHDR131B | C155417 | UDHR1-Disruptive Behavior: Severity | Unified Huntington's Disease Rating Scale '99 - Disruptive or aggressive behavior: Severity: Have you used threats or hostile words? Have you hit or shoved or thrown things or expressed your temper in a physical way? | UHDRS 1999 Version - UDHR1-Disruptive Behavior: Severity | ||
UHDR132A | C155418 | UHDR1-Perseverative Thinking: Frequency | Unified Huntington's Disease Rating Scale '99 - Perseverative/obsessional thinking: Frequency: Within the past month, how often have you found yourself getting stuck on certain ideas? How often have you been bothered by thoughts, images, or fears that keep coming back even if you try not to have them? | UHDRS 1999 Version - Perseverative Thinking: Frequency | ||
UHDR132B | C155419 | UDHR1-Perseverative Thinking: Severity | Unified Huntington's Disease Rating Scale '99 - Perseverative/obsessional thinking: Severity: Have do repeated thoughts impact your daily life? | UHDRS 1999 Version - UDHR1-Perseverative Thinking: Severity | ||
UHDR133A | C155420 | UHDR1-Compulsive Behavior: Frequency | Unified Huntington's Disease Rating Scale '99 - Compulsive behavior: Frequency: Within the past month, how often have you found yourself doing certain things over and over again (counting, washing, checking)? | UHDRS 1999 Version - Compulsive Behavior: Frequency | ||
UHDR133B | C155421 | UDHR1-Compulsive Behavior: Severity | Unified Huntington's Disease Rating Scale '99 - Compulsive behavior: Severity: Are you unable to resist doing some of these things? | UHDRS 1999 Version - UDHR1-Compulsive Behavior: Severity | ||
UHDR134A | C155422 | UHDR1-Delusions: Frequency | Unified Huntington's Disease Rating Scale '99 - Delusions: Frequency: How often does it seem like people are out to get you, people are controlling you, or you are very suspicious of others? Do you have special powers or importance? | UHDRS 1999 Version - Delusions: Frequency | ||
UHDR134B | C155423 | UDHR1-Delusions: Severity | Unified Huntington's Disease Rating Scale '99 - Delusions: Severity: When you feel suspicious (insert delusion here), are you able to convince yourself that it is not rational? [Severity should reflect the behavior's impact on the individual's ability to carry out daily activities as indicated by response choices.]. | UHDRS 1999 Version - UDHR1-Delusions: Severity | ||
UHDR135A | C155424 | UHDR1-Hallucinations: Frequency | Unified Huntington's Disease Rating Scale '99 - Hallucinations: Frequency: How often have you heard things that other people couldn't hear, or seen things that other people couldn't see? | UHDRS 1999 Version - Hallucinations: Frequency | ||
UHDR135B | C155425 | UDHR1-Hallucinations: Severity | Unified Huntington's Disease Rating Scale '99 - Hallucinations: Severity: When you see or hear things (insert hallucination here), are you able to convince yourself that it is not rational? [Severity should reflect the behavior's impact on the individual's ability to carry out daily activities as indicated by response choices.]. | UHDRS 1999 Version - UDHR1-Hallucinations: Severity | ||
UHDR136 | C155426 | UDHR1-Examiner Believe Subject Confused | Unified Huntington's Disease Rating Scale '99 - Confusion is defined as intermittent or persistent disorganized thinking, perceptual disturbances or disorientation to time, place, or person. Does the examiner believe the subject is confused? | UHDRS 1999 Version - UDHR1-Examiner Believe Subject Confused | ||
UHDR136A | C155427 | UDHR1-Confusion Altered Performance | Unified Huntington's Disease Rating Scale '99 - If yes: Does the examiner believe that this has altered the performance on the UHDRS? | UHDRS 1999 Version - UDHR1-Confusion Altered Performance | ||
UHDR137 | C155428 | UDHR1-Examiner Believe Signs of Dementia | Unified Huntington's Disease Rating Scale '99 - Dementia is defined as progressive impairment in memory, abstract thinking or judgment that interferes with work or usual social activities and relationships. Does the examiner believe that the participant is showing signs of dementia? | UHDRS 1999 Version - UDHR1-Examiner Believe Signs of Dementia | ||
UHDR137A | C155429 | UDHR1-Dementia Altered Performance | Unified Huntington's Disease Rating Scale '99 - If yes: Does the examiner believe that this has altered the performance on the UHDRS? | UHDRS 1999 Version - UDHR1-Dementia Altered Performance | ||
UHDR138 | C155430 | UDHR1-Examiner Believe Signs Depression | Unified Huntington's Disease Rating Scale '99 - Depression is defined as persistent depressed mood, anhedonia, or vegetative signs sufficient to interfere with daily functioning. Does the examiner believe that the participant is showing signs of depression? | UHDRS 1999 Version - UDHR1-Examiner Believe Signs Depression | ||
UHDR139 | C155431 | UHDR1-Pharmacotherapy of Depression | Unified Huntington's Disease Rating Scale '99 - In the opinion of the examiner, is a clinical evaluation or follow up warranted for possible pharmacotherapy of depression? | UHDRS 1999 Version - Pharmacotherapy of Depression | ||
UHDR140 | C155432 | UHDR1-Pharmacotherapy of Irritability | Unified Huntington's Disease Rating Scale '99 - In the opinion of the examiner, is a clinical evaluation or follow up warranted for possible pharmacotherapy of irritability? | UHDRS 1999 Version - Pharmacotherapy of Irritability | ||
UHDR141 | C155433 | UHDR1-Behavior Assessment Obtained From | Unified Huntington's Disease Rating Scale '99 - Was the Behavioral Assessment information obtained from. | UHDRS 1999 Version - Behavior Assessment Obtained From | ||
UHDR143 | C155434 | UHDR1-Gainful Employment Accustomed Work | Unified Huntington's Disease Rating Scale '99 - Could the subject engage in gainful employment in his/her accustomed work? | UHDRS 1999 Version - Gainful Employment Accustomed Work | ||
UHDR144 | C155435 | UHDR1-Any Gainful Employment | Unified Huntington's Disease Rating Scale '99 - Could the subject engage in any kind of gainful employment? | UHDRS 1999 Version - Any Gainful Employment | ||
UHDR145 | C155436 | UHDR1-Volunteer or Non Gainful Work | Unified Huntington's Disease Rating Scale '99 - Could the subject engage in any kind of volunteer or non gainful work? | UHDRS 1999 Version - Volunteer or Non Gainful Work | ||
UHDR146 | C155437 | UHDR1-Manage Finances Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject manage his/her finances (monthly) without any help? | UHDRS 1999 Version - Manage Finances Without Help | ||
UHDR147 | C155438 | UHDR1-Shop for Groceries Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject shop for groceries without help? | UHDRS 1999 Version - Shop for Groceries Without Help | ||
UHDR148 | C155439 | UHDR1-Handle Money as Purchaser | Unified Huntington's Disease Rating Scale '99 - Could the subject handle money as a purchaser in a simple cash (store) transaction? | UHDRS 1999 Version - Handle Money as Purchaser | ||
UHDR149 | C155440 | UHDR1-Supervise Children Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject supervise children without help? | UHDRS 1999 Version - Supervise Children Without Help | ||
UHDR150 | C155441 | UHDR1-Operate Automobile Safely | Unified Huntington's Disease Rating Scale '99 - Could the subject operate an automobile safely and independently? | UHDRS 1999 Version - Operate Automobile Safely | ||
UHDR151 | C155442 | UHDR1-Do Housework Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject do his/her own housework without help? | UHDRS 1999 Version - Do Housework Without Help | ||
UHDR152 | C155443 | UHDR1-Do Laundry Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject do his/her own laundry (wash/dry) without help? | UHDRS 1999 Version - Do Laundry Without Help | ||
UHDR153 | C155444 | UHDR1-Prepare Own Meals Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject prepare his/her own meals without help? | UHDRS 1999 Version - Prepare Own Meals Without Help | ||
UHDR154 | C155445 | UHDR1-Use Telephone Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject use the telephone without help? | UHDRS 1999 Version - Use Telephone Without Help | ||
UHDR155 | C155446 | UHDR1-Take Medications Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject take his/her own medications without help? | UHDRS 1999 Version - Take Medications Without Help | ||
UHDR156 | C155447 | UHDR1-Feed Himself/Herself Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject feed himself/herself without help? | UHDRS 1999 Version - Feed Himself/Herself Without Help | ||
UHDR157 | C155448 | UHDR1-Dress Himself/Herself Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject dress himself/herself without help? | UHDRS 1999 Version - Dress Himself/Herself Without Help | ||
UHDR158 | C155449 | UHDR1-Bathe Himself/Herself Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject bathe himself/herself without help? | UHDRS 1999 Version - Bathe Himself/Herself Without Help | ||
UHDR159 | C155450 | UHDR1-Public Transportation Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject use public transportation to get places without help? | UHDRS 1999 Version - Public Transportation Without Help | ||
UHDR160 | C155451 | UHDR1-Walk Own Neighborhood Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject walk to places in his/her own neighborhood without help? | UHDRS 1999 Version - Walk Own Neighborhood Without Help | ||
UHDR161 | C155452 | UHDR1-Walk Without Falling | Unified Huntington's Disease Rating Scale '99 - Could the subject walk without falling? | UHDRS 1999 Version - Walk Without Falling | ||
UHDR162 | C155453 | UHDR1-Walk Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject walk without help? | UHDRS 1999 Version - Walk Without Help | ||
UHDR163 | C155454 | UHDR1-Comb Hair Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject comb hair without help? | UHDRS 1999 Version - Comb Hair Without Help | ||
UHDR164 | C155455 | UHDR1-Transfer Chair Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject transfer between chairs without help? | UHDRS 1999 Version - Transfer Chair Without Help | ||
UHDR165 | C155456 | UHDR1-Get in and Out of Bed Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject get in and out of bed without help? | UHDRS 1999 Version - Get in and Out of Bed Without Help | ||
UHDR166 | C155457 | UHDR1-Use Toilet/Commode Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject use the toilet/commode without help? | UHDRS 1999 Version - Use Toilet/Commode Without Help | ||
UHDR167 | C155458 | UHDR1-Care Provided at Home | Unified Huntington's Disease Rating Scale '99 - Could the subject's care still be provided at home? | UHDRS 1999 Version - Care Provided at Home | ||
UHDR168 | C155459 | UHDR1-Functional Assess Obtained From | Unified Huntington's Disease Rating Scale '99 - Was the Functional Assessment information obtained from. | UHDRS 1999 Version - Functional Assess Obtained From | ||
UHDR169 | C155460 | UHDR1-Current Level Subject Independence | Unified Huntington's Disease Rating Scale '99 - Please indicate the most accurate current level of subject's independence (only increments of 5 are acceptable). | UHDRS 1999 Version - Current Level Subject Independence | ||
UHDR170 | C155461 | UHDR1-Occupation | Unified Huntington's Disease Rating Scale '99 - Occupation. | UHDRS 1999 Version - Occupation | ||
UHDR171 | C155462 | UHDR1-Finances | Unified Huntington's Disease Rating Scale '99 - Finances. | UHDRS 1999 Version - Finances | ||
UHDR172 | C155463 | UHDR1-Domestic Chores | Unified Huntington's Disease Rating Scale '99 - Domestic Chores. | UHDRS 1999 Version - Domestic Chores | ||
UHDR173 | C155464 | UHDR1-ADL | Unified Huntington's Disease Rating Scale '99 - ADL. | UHDRS 1999 Version - ADL | ||
UHDR174 | C155465 | UHDR1-Care Level | Unified Huntington's Disease Rating Scale '99 - Care Level. | UHDRS 1999 Version - Care Level | ||
UHDR175 | C155466 | UHDR1-Functional Capacity Obtained From | Unified Huntington's Disease Rating Scale '99 - Was the Functional Capacity information obtained from. | UHDRS 1999 Version - Functional Capacity Obtained From | ||
UHDR177 | C155467 | UHDR1-Purpose of This Visit | Unified Huntington's Disease Rating Scale '99 - What was the purpose of this visit? | UHDRS 1999 Version - Purpose of This Visit | ||
UHDR178 | C155468 | UHDR1-Since Last Assessment Opinion | Unified Huntington's Disease Rating Scale '99 - Since your last assessment of the subject, in your opinion, has the subject. | UHDRS 1999 Version - Since Last Assessment Opinion | ||
UHDR179 | C155469 | UHDR1-Since Last Assessment Feel | Unified Huntington's Disease Rating Scale '99 - Since your last assessment does the subject feel. | UHDRS 1999 Version - Since Last Assessment Feel | ||
UHDR180 | C155470 | UHDR1-Believe Subject Has Manifest HD | Unified Huntington's Disease Rating Scale '99 - Based on the entire UHDRS (Motor, Cognitive, Behavioral and Functional components) do you believe with a confidence level >= 99% that this subject has manifest HD? | UHDRS 1999 Version - Believe Subject Has Manifest HD | ||
UHDR183A | C155471 | UHDR1-Permanently Institutionalized | Unified Huntington's Disease Rating Scale '99 - Since the last visit, has the subject been permanently institutionalized? | UHDRS 1999 Version - Permanently Institutionalized | ||
UHDR183B | C155472 | UHDR1-Continue to Be Assessed for Study | Unified Huntington's Disease Rating Scale '99 - If the subject was institutionalized will the subject continue to be assessed for this study? | UHDRS 1999 Version - Continue to Be Assessed for Study | ||
UHDR184 | C155473 | UHDR1-Total Motor Score | Unified Huntington's Disease Rating Scale '99 - Total Motor score. | UHDRS 1999 Version - Total Motor Score | ||
UHDR185 | C155474 | UHDR1-Total Behavior Score | Unified Huntington's Disease Rating Scale '99 - Total Behavior score. | UHDRS 1999 Version - Total Behavior Score | ||
UHDR186 | C155475 | UHDR1-Mood Subscale Score | Unified Huntington's Disease Rating Scale '99 - Mood subscale score of the total behavior score. | UHDRS 1999 Version - Mood Subscale Score | ||
UHDR187 | C155476 | UHDR1-Behavior Subscale Score | Unified Huntington's Disease Rating Scale '99 - Behavior subscale score of the total behavior score. | UHDRS 1999 Version - Behavior Subscale Score | ||
UHDR188 | C155477 | UHDR1-Psychosis Subscale Score | Unified Huntington's Disease Rating Scale '99 - Psychosis subscale score of the total behavior score. | UHDRS 1999 Version - Psychosis Subscale Score | ||
UHDR189 | C155478 | UHDR1-Obsessive Subscale Score | Unified Huntington's Disease Rating Scale '99 - Obsessive subscale score of the total behavior score. | UHDRS 1999 Version - Obsessive Subscale Score | ||
UHDR190 | C155479 | UHDR1-Total Functional Capacity Score | Unified Huntington's Disease Rating Scale '99 - Total functional capacity score. | UHDRS 1999 Version - Total Functional Capacity Score | ||
UHDR191 | C155480 | UHDR1-Independence Scale Score | Unified Huntington's Disease Rating Scale '99 - Independence scale score. | UHDRS 1999 Version - Independence Scale Score | ||
UHDR192 | C155481 | UHDR1-Functional Checklist Score | Unified Huntington's Disease Rating Scale '99 - Functional checklist score. | UHDRS 1999 Version - Functional Checklist Score | ||
Back to top | ||||||
CL.C154448.UHDR1TN | Unified Huntington's Disease Rating Scale '99 Clinical Classification Test Name
(UHDR1TN) | text
Extensible: No | C154448 | Unified Huntington's Disease Rating Scale '99 Clinical Classification Test Name | Unified Huntington's Disease Rating Scale '99 test name. | CDISC Clinical Classification UHDRS 1999 Version Test Name Terminology |
UDHR1-Compulsive Behavior: Severity | C155421 | UDHR1-Compulsive Behavior: Severity | Unified Huntington's Disease Rating Scale '99 - Compulsive behavior: Severity: Are you unable to resist doing some of these things? | UHDRS 1999 Version - UDHR1-Compulsive Behavior: Severity | ||
UDHR1-Confusion Altered Performance | C155427 | UDHR1-Confusion Altered Performance | Unified Huntington's Disease Rating Scale '99 - If yes: Does the examiner believe that this has altered the performance on the UHDRS? | UHDRS 1999 Version - UDHR1-Confusion Altered Performance | ||
UDHR1-Delusions: Severity | C155423 | UDHR1-Delusions: Severity | Unified Huntington's Disease Rating Scale '99 - Delusions: Severity: When you feel suspicious (insert delusion here), are you able to convince yourself that it is not rational? [Severity should reflect the behavior's impact on the individual's ability to carry out daily activities as indicated by response choices.]. | UHDRS 1999 Version - UDHR1-Delusions: Severity | ||
UDHR1-Dementia Altered Performance | C155429 | UDHR1-Dementia Altered Performance | Unified Huntington's Disease Rating Scale '99 - If yes: Does the examiner believe that this has altered the performance on the UHDRS? | UHDRS 1999 Version - UDHR1-Dementia Altered Performance | ||
UDHR1-Disruptive Behavior: Severity | C155417 | UDHR1-Disruptive Behavior: Severity | Unified Huntington's Disease Rating Scale '99 - Disruptive or aggressive behavior: Severity: Have you used threats or hostile words? Have you hit or shoved or thrown things or expressed your temper in a physical way? | UHDRS 1999 Version - UDHR1-Disruptive Behavior: Severity | ||
UDHR1-Examiner Believe Signs Depression | C155430 | UDHR1-Examiner Believe Signs Depression | Unified Huntington's Disease Rating Scale '99 - Depression is defined as persistent depressed mood, anhedonia, or vegetative signs sufficient to interfere with daily functioning. Does the examiner believe that the participant is showing signs of depression? | UHDRS 1999 Version - UDHR1-Examiner Believe Signs Depression | ||
UDHR1-Examiner Believe Signs of Dementia | C155428 | UDHR1-Examiner Believe Signs of Dementia | Unified Huntington's Disease Rating Scale '99 - Dementia is defined as progressive impairment in memory, abstract thinking or judgment that interferes with work or usual social activities and relationships. Does the examiner believe that the participant is showing signs of dementia? | UHDRS 1999 Version - UDHR1-Examiner Believe Signs of Dementia | ||
UDHR1-Examiner Believe Subject Confused | C155426 | UDHR1-Examiner Believe Subject Confused | Unified Huntington's Disease Rating Scale '99 - Confusion is defined as intermittent or persistent disorganized thinking, perceptual disturbances or disorientation to time, place, or person. Does the examiner believe the subject is confused? | UHDRS 1999 Version - UDHR1-Examiner Believe Subject Confused | ||
UDHR1-Hallucinations: Severity | C155425 | UDHR1-Hallucinations: Severity | Unified Huntington's Disease Rating Scale '99 - Hallucinations: Severity: When you see or hear things (insert hallucination here), are you able to convince yourself that it is not rational? [Severity should reflect the behavior's impact on the individual's ability to carry out daily activities as indicated by response choices.]. | UHDRS 1999 Version - UDHR1-Hallucinations: Severity | ||
UDHR1-Perseverative Thinking: Severity | C155419 | UDHR1-Perseverative Thinking: Severity | Unified Huntington's Disease Rating Scale '99 - Perseverative/obsessional thinking: Severity: Have do repeated thoughts impact your daily life? | UHDRS 1999 Version - UDHR1-Perseverative Thinking: Severity | ||
UHDR1-ADL | C155464 | UHDR1-ADL | Unified Huntington's Disease Rating Scale '99 - ADL. | UHDRS 1999 Version - ADL | ||
UHDR1-Anxiety: Frequency | C155412 | UHDR1-Anxiety: Frequency | Unified Huntington's Disease Rating Scale '99 - Anxiety: Frequency: Within the past month, how often have you found yourself worrying about things? | UHDRS 1999 Version - Anxiety: Frequency | ||
UHDR1-Anxiety: Severity | C155413 | UHDR1-Anxiety: Severity | Unified Huntington's Disease Rating Scale '99 - Anxiety: Severity: How much has nervousness or worry affected your daily activities? | UHDRS 1999 Version - Anxiety: Severity | ||
UHDR1-Any Gainful Employment | C155435 | UHDR1-Any Gainful Employment | Unified Huntington's Disease Rating Scale '99 - Could the subject engage in any kind of gainful employment? | UHDRS 1999 Version - Any Gainful Employment | ||
UHDR1-Apathy: Frequency | C155406 | UHDR1-Apathy: Frequency | Unified Huntington's Disease Rating Scale '99 - Apathy: Frequency: Within the past month, how often have you found that you have lost interest in things that used to be important to you? | UHDRS 1999 Version - Apathy: Frequency | ||
UHDR1-Apathy: Severity | C155407 | UHDR1-Apathy: Severity | Unified Huntington's Disease Rating Scale '99 - Apathy: Severity: How has apathy impacted your ability to carry out daily activities? | UHDRS 1999 Version - Apathy: Severity | ||
UHDR1-Bathe Himself/Herself Without Help | C155449 | UHDR1-Bathe Himself/Herself Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject bathe himself/herself without help? | UHDRS 1999 Version - Bathe Himself/Herself Without Help | ||
UHDR1-Behavior Assessment Obtained From | C155433 | UHDR1-Behavior Assessment Obtained From | Unified Huntington's Disease Rating Scale '99 - Was the Behavioral Assessment information obtained from. | UHDRS 1999 Version - Behavior Assessment Obtained From | ||
UHDR1-Behavior Subscale Score | C155476 | UHDR1-Behavior Subscale Score | Unified Huntington's Disease Rating Scale '99 - Behavior subscale score of the total behavior score. | UHDRS 1999 Version - Behavior Subscale Score | ||
UHDR1-Believe Subject Has Manifest HD | C155470 | UHDR1-Believe Subject Has Manifest HD | Unified Huntington's Disease Rating Scale '99 - Based on the entire UHDRS (Motor, Cognitive, Behavioral and Functional components) do you believe with a confidence level >= 99% that this subject has manifest HD? | UHDRS 1999 Version - Believe Subject Has Manifest HD | ||
UHDR1-Bradykinesia: Body | C155385 | UHDR1-Bradykinesia: Body | Unified Huntington's Disease Rating Scale '99 - Bradykinesia-body. | UHDRS 1999 Version - Bradykinesia: Body | ||
UHDR1-Care Level | C155465 | UHDR1-Care Level | Unified Huntington's Disease Rating Scale '99 - Care Level. | UHDRS 1999 Version - Care Level | ||
UHDR1-Care Provided at Home | C155458 | UHDR1-Care Provided at Home | Unified Huntington's Disease Rating Scale '99 - Could the subject's care still be provided at home? | UHDRS 1999 Version - Care Provided at Home | ||
UHDR1-Comb Hair Without Help | C155454 | UHDR1-Comb Hair Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject comb hair without help? | UHDRS 1999 Version - Comb Hair Without Help | ||
UHDR1-Compulsive Behavior: Frequency | C155420 | UHDR1-Compulsive Behavior: Frequency | Unified Huntington's Disease Rating Scale '99 - Compulsive behavior: Frequency: Within the past month, how often have you found yourself doing certain things over and over again (counting, washing, checking)? | UHDRS 1999 Version - Compulsive Behavior: Frequency | ||
UHDR1-Continue to Be Assessed for Study | C155472 | UHDR1-Continue to Be Assessed for Study | Unified Huntington's Disease Rating Scale '99 - If the subject was institutionalized will the subject continue to be assessed for this study? | UHDRS 1999 Version - Continue to Be Assessed for Study | ||
UHDR1-Current Level Subject Independence | C155460 | UHDR1-Current Level Subject Independence | Unified Huntington's Disease Rating Scale '99 - Please indicate the most accurate current level of subject's independence (only increments of 5 are acceptable). | UHDRS 1999 Version - Current Level Subject Independence | ||
UHDR1-Delusions: Frequency | C155422 | UHDR1-Delusions: Frequency | Unified Huntington's Disease Rating Scale '99 - Delusions: Frequency: How often does it seem like people are out to get you, people are controlling you, or you are very suspicious of others? Do you have special powers or importance? | UHDRS 1999 Version - Delusions: Frequency | ||
UHDR1-Depressed Mood: Frequency | C155404 | UHDR1-Depressed Mood: Frequency | Unified Huntington's Disease Rating Scale '99 - Depressed mood: Frequency: Within the past month, how often have you been feeling sad, down or "blue"? | UHDRS 1999 Version - Depressed Mood: Frequency | ||
UHDR1-Depressed Mood: Severity | C155405 | UHDR1-Depressed Mood: Severity | Unified Huntington's Disease Rating Scale '99 - Depressed mood: Severity: How has your mood affected your daily activities? [Evidence of sad mood from behavioral observation includes sad voice or expression, tearfulness.]. | UHDRS 1999 Version - Depressed Mood: Severity | ||
UHDR1-Diagnosis Confidence Level | C155401 | UHDR1-Diagnosis Confidence Level | Unified Huntington's Disease Rating Scale '99 - Diagnosis confidence level: To what degree are you confident that this person meets the operational definition of the unequivocal presence of an otherwise unexplained extrapyramidal movement disorder (e.g., chorea, dystonia, bradykinesia, rigidity) in a subject at risk of HD? | UHDRS 1999 Version - Diagnosis Confidence Level | ||
UHDR1-Disruptive Behavior: Frequency | C155416 | UHDR1-Disruptive Behavior: Frequency | Unified Huntington's Disease Rating Scale '99 - Disruptive or aggressive behavior: Frequency: Within the past month, how often have you had emotional or temper outbursts? How often have you had times when you lost control of yourself? | UHDRS 1999 Version - Disruptive Behavior: Frequency | ||
UHDR1-Do Housework Without Help | C155442 | UHDR1-Do Housework Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject do his/her own housework without help? | UHDRS 1999 Version - Do Housework Without Help | ||
UHDR1-Do Laundry Without Help | C155443 | UHDR1-Do Laundry Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject do his/her own laundry (wash/dry) without help? | UHDRS 1999 Version - Do Laundry Without Help | ||
UHDR1-Domestic Chores | C155463 | UHDR1-Domestic Chores | Unified Huntington's Disease Rating Scale '99 - Domestic Chores. | UHDRS 1999 Version - Domestic Chores | ||
UHDR1-Dress Himself/Herself Without Help | C155448 | UHDR1-Dress Himself/Herself Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject dress himself/herself without help? | UHDRS 1999 Version - Dress Himself/Herself Without Help | ||
UHDR1-Dysarthria | C155376 | UHDR1-Dysarthria | Unified Huntington's Disease Rating Scale '99 - Dysarthria. | UHDRS 1999 Version - Dysarthria | ||
UHDR1-Feed Himself/Herself Without Help | C155447 | UHDR1-Feed Himself/Herself Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject feed himself/herself without help? | UHDRS 1999 Version - Feed Himself/Herself Without Help | ||
UHDR1-Finances | C155462 | UHDR1-Finances | Unified Huntington's Disease Rating Scale '99 - Finances. | UHDRS 1999 Version - Finances | ||
UHDR1-Finger Taps: Left | C155379 | UHDR1-Finger Taps: Left | Unified Huntington's Disease Rating Scale '99 - Finger taps, left. | UHDRS 1999 Version - Finger Taps: Left | ||
UHDR1-Finger Taps: Right | C155378 | UHDR1-Finger Taps: Right | Unified Huntington's Disease Rating Scale '99 - Finger taps, right. | UHDRS 1999 Version - Finger Taps: Right | ||
UHDR1-Functional Assess Obtained From | C155459 | UHDR1-Functional Assess Obtained From | Unified Huntington's Disease Rating Scale '99 - Was the Functional Assessment information obtained from. | UHDRS 1999 Version - Functional Assess Obtained From | ||
UHDR1-Functional Capacity Obtained From | C155466 | UHDR1-Functional Capacity Obtained From | Unified Huntington's Disease Rating Scale '99 - Was the Functional Capacity information obtained from. | UHDRS 1999 Version - Functional Capacity Obtained From | ||
UHDR1-Functional Checklist Score | C155481 | UHDR1-Functional Checklist Score | Unified Huntington's Disease Rating Scale '99 - Functional checklist score. | UHDRS 1999 Version - Functional Checklist Score | ||
UHDR1-Gainful Employment Accustomed Work | C155434 | UHDR1-Gainful Employment Accustomed Work | Unified Huntington's Disease Rating Scale '99 - Could the subject engage in gainful employment in his/her accustomed work? | UHDRS 1999 Version - Gainful Employment Accustomed Work | ||
UHDR1-Gait | C155398 | UHDR1-Gait | Unified Huntington's Disease Rating Scale '99 - Gait. | UHDRS 1999 Version - Gait | ||
UHDR1-Get in and Out of Bed Without Help | C155456 | UHDR1-Get in and Out of Bed Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject get in and out of bed without help? | UHDRS 1999 Version - Get in and Out of Bed Without Help | ||
UHDR1-Hallucinations: Frequency | C155424 | UHDR1-Hallucinations: Frequency | Unified Huntington's Disease Rating Scale '99 - Hallucinations: Frequency: How often have you heard things that other people couldn't hear, or seen things that other people couldn't see? | UHDRS 1999 Version - Hallucinations: Frequency | ||
UHDR1-Handle Money as Purchaser | C155439 | UHDR1-Handle Money as Purchaser | Unified Huntington's Disease Rating Scale '99 - Could the subject handle money as a purchaser in a simple cash (store) transaction? | UHDRS 1999 Version - Handle Money as Purchaser | ||
UHDR1-Independence Scale Score | C155480 | UHDR1-Independence Scale Score | Unified Huntington's Disease Rating Scale '99 - Independence scale score. | UHDRS 1999 Version - Independence Scale Score | ||
UHDR1-Irritable Behavior: Frequency | C155414 | UHDR1-Irritable Behavior: Frequency | Unified Huntington's Disease Rating Scale '99 - Irritable behavior: Frequency: In the past month, how often have you felt impatient, irritable, or "cranky"? | UHDRS 1999 Version - Irritable Behavior: Frequency | ||
UHDR1-Irritable Behavior: Severity | C155415 | UHDR1-Irritable Behavior: Severity | Unified Huntington's Disease Rating Scale '99 - Irritable behavior: Severity: How has irritability impacted your ability to get along with others? | UHDRS 1999 Version - Irritable Behavior: Severity | ||
UHDR1-Luria | C155382 | UHDR1-Luria | Unified Huntington's Disease Rating Scale '99 - Luria (fist-hand palm test). | UHDRS 1999 Version - Luria | ||
UHDR1-Manage Finances Without Help | C155437 | UHDR1-Manage Finances Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject manage his/her finances (monthly) without any help? | UHDRS 1999 Version - Manage Finances Without Help | ||
UHDR1-Maximal Chorea: BOL | C155392 | UHDR1-Maximal Chorea: BOL | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-BOL. | UHDRS 1999 Version - Maximal Chorea: BOL | ||
UHDR1-Maximal Chorea: Face | C155391 | UHDR1-Maximal Chorea: Face | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-Face. | UHDRS 1999 Version - Maximal Chorea: Face | ||
UHDR1-Maximal Chorea: LLE | C155397 | UHDR1-Maximal Chorea: LLE | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-LLE. | UHDRS 1999 Version - Maximal Chorea: LLE | ||
UHDR1-Maximal Chorea: LUE | C155395 | UHDR1-Maximal Chorea: LUE | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-LUE. | UHDRS 1999 Version - Maximal Chorea: LUE | ||
UHDR1-Maximal Chorea: RLE | C155396 | UHDR1-Maximal Chorea: RLE | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-RLE. | UHDRS 1999 Version - Maximal Chorea: RLE | ||
UHDR1-Maximal Chorea: RUE | C155394 | UHDR1-Maximal Chorea: RUE | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-RUE. | UHDRS 1999 Version - Maximal Chorea: RUE | ||
UHDR1-Maximal Chorea: Trunk | C155393 | UHDR1-Maximal Chorea: Trunk | Unified Huntington's Disease Rating Scale '99 - Maximal chorea-Trunk. | UHDRS 1999 Version - Maximal Chorea: Trunk | ||
UHDR1-Maximal Dystonia: LLE | C155390 | UHDR1-Maximal Dystonia: LLE | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-LLE. | UHDRS 1999 Version - Maximal Dystonia: LLE | ||
UHDR1-Maximal Dystonia: LUE | C155388 | UHDR1-Maximal Dystonia: LUE | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-LUE. | UHDRS 1999 Version - Maximal Dystonia: LUE | ||
UHDR1-Maximal Dystonia: RLE | C155389 | UHDR1-Maximal Dystonia: RLE | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-RLE. | UHDRS 1999 Version - Maximal Dystonia: RLE | ||
UHDR1-Maximal Dystonia: RUE | C155387 | UHDR1-Maximal Dystonia: RUE | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-RUE. | UHDRS 1999 Version - Maximal Dystonia: RUE | ||
UHDR1-Maximal Dystonia: Trunk | C155386 | UHDR1-Maximal Dystonia: Trunk | Unified Huntington's Disease Rating Scale '99 - Maximal dystonia-Trunk. | UHDRS 1999 Version - Maximal Dystonia: Trunk | ||
UHDR1-Mood Subscale Score | C155475 | UHDR1-Mood Subscale Score | Unified Huntington's Disease Rating Scale '99 - Mood subscale score of the total behavior score. | UHDRS 1999 Version - Mood Subscale Score | ||
UHDR1-Obsessive Subscale Score | C155478 | UHDR1-Obsessive Subscale Score | Unified Huntington's Disease Rating Scale '99 - Obsessive subscale score of the total behavior score. | UHDRS 1999 Version - Obsessive Subscale Score | ||
UHDR1-Occupation | C155461 | UHDR1-Occupation | Unified Huntington's Disease Rating Scale '99 - Occupation. | UHDRS 1999 Version - Occupation | ||
UHDR1-Ocular Pursuit: Horizontal | C155370 | UHDR1-Ocular Pursuit: Horizontal | Unified Huntington's Disease Rating Scale '99 - Ocular pursuit, horizontal. | UHDRS 1999 Version - Ocular Pursuit: Horizontal | ||
UHDR1-Ocular Pursuit: Vertical | C155371 | UHDR1-Ocular Pursuit: Vertical | Unified Huntington's Disease Rating Scale '99 - Ocular pursuit, vertical. | UHDRS 1999 Version - Ocular Pursuit: Vertical | ||
UHDR1-Operate Automobile Safely | C155441 | UHDR1-Operate Automobile Safely | Unified Huntington's Disease Rating Scale '99 - Could the subject operate an automobile safely and independently? | UHDRS 1999 Version - Operate Automobile Safely | ||
UHDR1-Permanently Institutionalized | C155471 | UHDR1-Permanently Institutionalized | Unified Huntington's Disease Rating Scale '99 - Since the last visit, has the subject been permanently institutionalized? | UHDRS 1999 Version - Permanently Institutionalized | ||
UHDR1-Perseverative Thinking: Frequency | C155418 | UHDR1-Perseverative Thinking: Frequency | Unified Huntington's Disease Rating Scale '99 - Perseverative/obsessional thinking: Frequency: Within the past month, how often have you found yourself getting stuck on certain ideas? How often have you been bothered by thoughts, images, or fears that keep coming back even if you try not to have them? | UHDRS 1999 Version - Perseverative Thinking: Frequency | ||
UHDR1-Pharmacotherapy of Depression | C155431 | UHDR1-Pharmacotherapy of Depression | Unified Huntington's Disease Rating Scale '99 - In the opinion of the examiner, is a clinical evaluation or follow up warranted for possible pharmacotherapy of depression? | UHDRS 1999 Version - Pharmacotherapy of Depression | ||
UHDR1-Pharmacotherapy of Irritability | C155432 | UHDR1-Pharmacotherapy of Irritability | Unified Huntington's Disease Rating Scale '99 - In the opinion of the examiner, is a clinical evaluation or follow up warranted for possible pharmacotherapy of irritability? | UHDRS 1999 Version - Pharmacotherapy of Irritability | ||
UHDR1-Prepare Own Meals Without Help | C155444 | UHDR1-Prepare Own Meals Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject prepare his/her own meals without help? | UHDRS 1999 Version - Prepare Own Meals Without Help | ||
UHDR1-Pronate/Supinate: Hands: Left | C155381 | UHDR1-Pronate/Supinate: Hands: Left | Unified Huntington's Disease Rating Scale '99 - Pronate/supinate-hands, left. | UHDRS 1999 Version - Pronate/Supinate: Hands: Left | ||
UHDR1-Pronate/Supinate: Hands: Right | C155380 | UHDR1-Pronate/Supinate: Hands: Right | Unified Huntington's Disease Rating Scale '99 - Pronate/supinate-hands, right. | UHDRS 1999 Version - Pronate/Supinate: Hands: Right | ||
UHDR1-Psychosis Subscale Score | C155477 | UHDR1-Psychosis Subscale Score | Unified Huntington's Disease Rating Scale '99 - Psychosis subscale score of the total behavior score. | UHDRS 1999 Version - Psychosis Subscale Score | ||
UHDR1-Public Transportation Without Help | C155450 | UHDR1-Public Transportation Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject use public transportation to get places without help? | UHDRS 1999 Version - Public Transportation Without Help | ||
UHDR1-Purpose of This Visit | C155467 | UHDR1-Purpose of This Visit | Unified Huntington's Disease Rating Scale '99 - What was the purpose of this visit? | UHDRS 1999 Version - Purpose of This Visit | ||
UHDR1-Retropulsion Pull Test | C155400 | UHDR1-Retropulsion Pull Test | Unified Huntington's Disease Rating Scale '99 - Retropulsion pull test. | UHDRS 1999 Version - Retropulsion Pull Test | ||
UHDR1-Rigidity: Arms: Left | C155384 | UHDR1-Rigidity: Arms: Left | Unified Huntington's Disease Rating Scale '99 - Rigidity-arms, left. | UHDRS 1999 Version - Rigidity: Arms: Left | ||
UHDR1-Rigidity: Arms: Right | C155383 | UHDR1-Rigidity: Arms: Right | Unified Huntington's Disease Rating Scale '99 - Rigidity-arms, right. | UHDRS 1999 Version - Rigidity: Arms: Right | ||
UHDR1-Saccade Initiation: Horizontal | C155372 | UHDR1-Saccade Initiation: Horizontal | Unified Huntington's Disease Rating Scale '99 - Saccade initiation, horizontal. | UHDRS 1999 Version - Saccade Initiation: Horizontal | ||
UHDR1-Saccade Initiation: Vertical | C155373 | UHDR1-Saccade Initiation: Vertical | Unified Huntington's Disease Rating Scale '99 - Saccade initiation, vertical. | UHDRS 1999 Version - Saccade Initiation: Vertical | ||
UHDR1-Saccade Velocity: Horizontal | C155374 | UHDR1-Saccade Velocity: Horizontal | Unified Huntington's Disease Rating Scale '99 - Saccade velocity, horizontal. | UHDRS 1999 Version - Saccade Velocity: Horizontal | ||
UHDR1-Saccade Velocity: Vertical | C155375 | UHDR1-Saccade Velocity: Vertical | Unified Huntington's Disease Rating Scale '99 - Saccade velocity, vertical. | UHDRS 1999 Version - Saccade Velocity: Vertical | ||
UHDR1-Self-esteem/Guilt: Frequency | C155408 | UHDR1-Self-esteem/Guilt: Frequency | Unified Huntington's Disease Rating Scale '99 - Self-esteem/guilt: Frequency: Within the past month, how often have you been feeling badly about yourself? | UHDRS 1999 Version - Self-esteem/Guilt: Frequency | ||
UHDR1-Self-esteem/Guilt: Severity | C155409 | UHDR1-Self-esteem/Guilt: Severity | Unified Huntington's Disease Rating Scale '99 - Self-esteem/guilt: Severity: How have these feelings affected your daily activities? | UHDRS 1999 Version - Self-esteem/Guilt: Severity | ||
UHDR1-Shop for Groceries Without Help | C155438 | UHDR1-Shop for Groceries Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject shop for groceries without help? | UHDRS 1999 Version - Shop for Groceries Without Help | ||
UHDR1-Since Last Assessment Feel | C155469 | UHDR1-Since Last Assessment Feel | Unified Huntington's Disease Rating Scale '99 - Since your last assessment does the subject feel. | UHDRS 1999 Version - Since Last Assessment Feel | ||
UHDR1-Since Last Assessment Opinion | C155468 | UHDR1-Since Last Assessment Opinion | Unified Huntington's Disease Rating Scale '99 - Since your last assessment of the subject, in your opinion, has the subject. | UHDRS 1999 Version - Since Last Assessment Opinion | ||
UHDR1-Suicidal Thoughts: Frequency | C155410 | UHDR1-Suicidal Thoughts: Frequency | Unified Huntington's Disease Rating Scale '99 - Suicidal thoughts: Frequency: Within the past month, how often have you thought about hurting yourself or ending it all? | UHDRS 1999 Version - Suicidal Thoughts: Frequency | ||
UHDR1-Suicidal Thoughts: Severity | C155411 | UHDR1-Suicidal Thoughts: Severity | Unified Huntington's Disease Rating Scale '99 - Suicidal thoughts: Severity: Do you have a plan in mind to end it all? Have you taken any steps toward carrying out your plan? | UHDRS 1999 Version - Suicidal Thoughts: Severity | ||
UHDR1-Supervise Children Without Help | C155440 | UHDR1-Supervise Children Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject supervise children without help? | UHDRS 1999 Version - Supervise Children Without Help | ||
UHDR1-Symbol Digit Modalities Test | C155403 | UHDR1-Symbol Digit Modalities Test | Unified Huntington's Disease Rating Scale '99 - Symbol digit modalities test (raw score). | UHDRS 1999 Version - Symbol Digit Modalities Test | ||
UHDR1-Take Medications Without Help | C155446 | UHDR1-Take Medications Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject take his/her own medications without help? | UHDRS 1999 Version - Take Medications Without Help | ||
UHDR1-Tandem Walking | C155399 | UHDR1-Tandem Walking | Unified Huntington's Disease Rating Scale '99 - Tandem walking. | UHDRS 1999 Version - Tandem Walking | ||
UHDR1-Tongue Protrusion | C155377 | UHDR1-Tongue Protrusion | Unified Huntington's Disease Rating Scale '99 - Tongue protrusion. | UHDRS 1999 Version - Tongue Protrusion | ||
UHDR1-Total Behavior Score | C155474 | UHDR1-Total Behavior Score | Unified Huntington's Disease Rating Scale '99 - Total Behavior score. | UHDRS 1999 Version - Total Behavior Score | ||
UHDR1-Total Functional Capacity Score | C155479 | UHDR1-Total Functional Capacity Score | Unified Huntington's Disease Rating Scale '99 - Total functional capacity score. | UHDRS 1999 Version - Total Functional Capacity Score | ||
UHDR1-Total Motor Score | C155473 | UHDR1-Total Motor Score | Unified Huntington's Disease Rating Scale '99 - Total Motor score. | UHDRS 1999 Version - Total Motor Score | ||
UHDR1-Transfer Chair Without Help | C155455 | UHDR1-Transfer Chair Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject transfer between chairs without help? | UHDRS 1999 Version - Transfer Chair Without Help | ||
UHDR1-Use Telephone Without Help | C155445 | UHDR1-Use Telephone Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject use the telephone without help? | UHDRS 1999 Version - Use Telephone Without Help | ||
UHDR1-Use Toilet/Commode Without Help | C155457 | UHDR1-Use Toilet/Commode Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject use the toilet/commode without help? | UHDRS 1999 Version - Use Toilet/Commode Without Help | ||
UHDR1-Verbal Fluency Test | C155402 | UHDR1-Verbal Fluency Test | Unified Huntington's Disease Rating Scale '99 - Verbal fluency test (raw score). | UHDRS 1999 Version - Verbal Fluency Test | ||
UHDR1-Volunteer or Non Gainful Work | C155436 | UHDR1-Volunteer or Non Gainful Work | Unified Huntington's Disease Rating Scale '99 - Could the subject engage in any kind of volunteer or non gainful work? | UHDRS 1999 Version - Volunteer or Non Gainful Work | ||
UHDR1-Walk Own Neighborhood Without Help | C155451 | UHDR1-Walk Own Neighborhood Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject walk to places in his/her own neighborhood without help? | UHDRS 1999 Version - Walk Own Neighborhood Without Help | ||
UHDR1-Walk Without Falling | C155452 | UHDR1-Walk Without Falling | Unified Huntington's Disease Rating Scale '99 - Could the subject walk without falling? | UHDRS 1999 Version - Walk Without Falling | ||
UHDR1-Walk Without Help | C155453 | UHDR1-Walk Without Help | Unified Huntington's Disease Rating Scale '99 - Could the subject walk without help? | UHDRS 1999 Version - Walk Without Help | ||
Back to top | ||||||
CL.C100148.UPD1TC | Unified Parkinson's Disease Rating Scale Clinical Classification Test Code
(UPD1TC) | text
Extensible: No | C100148 | Unified Parkinson's Disease Rating Scale Clinical Classification Test Code | Unified Parkinson's Disease Rating Scale test code. | CDISC Clinical Classification UPDRS Test Code Terminology |
UPD101 | C100901 | UPD1-Mentation:Intellectual Impairment | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Intellectual impairment. | UPDRS - Mentation, Behavior and Mood: Intellectual Impairment | ||
UPD102 | C100902 | UPD1-Mentation:Thought Disorder | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Thought disorder. | UPDRS - Mentation, Behavior and Mood: Thought Disorder | ||
UPD103 | C100903 | UPD1-Mentation:Depression | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Depression. | UPDRS - Mentation, Behavior and Mood: Depression | ||
UPD104 | C100904 | UPD1-Mentation:Motivation/Initiative | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Motivation/Initiative. | UPDRS - Mentation, Behavior and Mood: Motivation/Initiative | ||
UPD105 | C100905 | UPD1-Activities:Speech | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Speech. | UPDRS - Activities of Daily Living: Speech | ||
UPD106 | C100906 | UPD1-Activities:Salivation | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Salivation. | UPDRS - Activities of Daily Living: Salivation | ||
UPD107 | C100907 | UPD1-Activities:Swallowing | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Swallowing. | UPDRS - Activities of Daily Living: Swallowing | ||
UPD108 | C100908 | UPD1-Activities:Handwriting | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Handwriting. | UPDRS - Activities of Daily Living: Handwriting | ||
UPD109 | C100909 | UPD1-Activities:Cut Food/Handle Utensil | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Cutting food and handling utensils. | UPDRS - Activities of Daily Living: Cutting Food and Handling Utensils | ||
UPD110 | C100910 | UPD1-Activities:Dressing | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Dressing. | UPDRS - Activities of Daily Living: Dressing | ||
UPD111 | C100911 | UPD1-Activities:Hygiene | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Hygiene. | UPDRS - Activities of Daily Living: Hygiene | ||
UPD112 | C100912 | UPD1-Activities:Turn Bed/Adj Clothes | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Turning in bed and adjusting bed clothes. | UPDRS - Activities of Daily Living: Turning in Bed and Adjusting Bed Clothes | ||
UPD113 | C100913 | UPD1-Activities:Falling | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Falling (unrelated to freezing). | UPDRS - Activities of Daily Living: Falling | ||
UPD114 | C100914 | UPD1-Activities:Freezing When Walking | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Freezing when walking. | UPDRS - Activities of Daily Living: Freezing When Walking | ||
UPD115 | C100915 | UPD1-Activities:Walking | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Walking. | UPDRS - Activities of Daily Living: Walking | ||
UPD116 | C100916 | UPD1-Activities:Tremor | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Tremor (Symptomatic complaint of tremor in any part of body.). | UPDRS - Activities of Daily Living: Tremor | ||
UPD117 | C100917 | UPD1-Activities:Sensory Complaints | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Sensory complaints related to Parkinsonism. | UPDRS - Activities of Daily Living: Sensory Complaints Related to Parkinsonism | ||
UPD118 | C100918 | UPD1-Motor:Speech | Unified Parkinson's Disease Rating Scale - Motor examination: Speech. | UPDRS - Motor Examination: Speech | ||
UPD119 | C100919 | UPD1-Motor:Facial Expression | Unified Parkinson's Disease Rating Scale - Motor examination: Facial expression. | UPDRS - Motor Examination: Facial Expression | ||
UPD120A | C111585 | UPD1-Motor:Tremor at Rest:Face Lips Chin | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: face, lips, chin. | UPDRS - Motor Examination: Tremor at Rest, Face, Lips, Chin | ||
UPD120B | C111586 | UPD1-Motor:Tremor at Rest:Hands: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Hands: Right. | UPDRS - Motor Examination: Tremor at Rest, Hands, Right | ||
UPD120C | C111587 | UPD1-Motor:Tremor at Rest:Hands: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Hands: Left. | UPDRS - Motor Examination: Tremor at Rest, Hands, Left | ||
UPD120D | C111588 | UPD1-Motor:Tremor at Rest:Feet: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Feet: Right. | UPDRS - Motor Examination: Tremor at Rest, Feet, Right | ||
UPD120E | C111589 | UPD1-Motor:Tremor at Rest:Feet: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Feet: Left. | UPDRS - Motor Examination: Tremor at Rest, Feet, Left | ||
UPD121A | C111590 | UPD1--Motor:Action Tremor:Hand: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Action tremor: Hand: Right. | UPDRS - Motor Examination: Action Tremor, Hand, Right | ||
UPD121B | C111591 | UPD1--Motor:Action Tremor:Hand: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Action tremor: Hand: Left. | UPDRS - Motor Examination: Action Tremor, Hand, Left | ||
UPD122A | C111592 | UPD1-Motor:Rigidity Neck | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity neck. | UPDRS - Motor Examination: Rigidity Neck | ||
UPD122B | C111593 | UPD1-Motor:Rigidity Upper Extrem: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity upper extremity: Right. | UPDRS - Motor Examination: Rigidity Upper Extremity, Right | ||
UPD122C | C111594 | UPD1-Motor:Rigidity Upper Extrem: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity upper extremity: Left. | UPDRS - Motor Examination: Rigidity Upper Extremity, Left | ||
UPD122D | C111595 | UPD1-Motor:Rigidity Lower Extrem: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity lower extremity: Right. | UPDRS - Motor Examination: Rigidity Lower Extremity, Right | ||
UPD122E | C111596 | UPD1-Motor:Rigidity Lower Extrem: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity lower extremity: Left. | UPDRS - Motor Examination: Rigidity Lower Extremity, Left | ||
UPD123A | C111597 | UPD1-Motor:Finger Taps: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Finger taps: Right. | UPDRS - Motor Examination: Finger Taps, Right | ||
UPD123B | C111598 | UPD1-Motor:Finger Taps: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Finger taps: Left. | UPDRS - Motor Examination: Finger Taps, Left | ||
UPD124A | C111599 | UPD1-Motor:Hand Grips: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Hand grips: Right. | UPDRS - Motor Examination: Hand Grips, Right | ||
UPD124B | C111600 | UPD1-Motor:Hand Grips: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Hand grips: Left. | UPDRS - Motor Examination: Hand Grips, Left | ||
UPD125A | C111601 | UPD1-Motor:Hand Pronate/Supinate: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Hand pronate/supinate: Right. | UPDRS - Motor Examination: Hand Pronate/Supinate, Right | ||
UPD125B | C111602 | UPD1-Motor:Hand Pronate/Supinate: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Hand pronate/supinate: Left. | UPDRS - Motor Examination: Hand Pronate/Supinate, Left | ||
UPD126A | C111603 | UPD1-Motor:Leg Agility: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Leg agility: Right. | UPDRS - Motor Examination: Leg Agility, Right | ||
UPD126B | C111604 | UPD1-Motor:Leg Agility: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Leg agility: Left. | UPDRS - Motor Examination: Leg Agility, Left | ||
UPD127 | C100927 | UPD1-Motor:Arising from Chair | Unified Parkinson's Disease Rating Scale - Motor examination: Arising from chair (Patient attempts to rise from a straightbacked chair, with arms folded across chest.). | UPDRS - Motor Examination: Arising from Chair | ||
UPD128 | C100928 | UPD1-Motor:Posture | Unified Parkinson's Disease Rating Scale - Motor examination: Posture. | UPDRS - Motor Examination: Posture | ||
UPD129 | C100929 | UPD1-Motor:Gait | Unified Parkinson's Disease Rating Scale - Motor examination: Gait. | UPDRS - Motor Examination: Gait | ||
UPD130 | C100930 | UPD1-Motor:Postural Stability | Unified Parkinson's Disease Rating Scale - Motor examination: Postural stability (Response to sudden, strong posterior displacement produced by pull on shoulders while patient erect with eyes open and feet slightly apart. Patient is prepared.). | UPDRS - Motor Examination: Postural Stability | ||
UPD131 | C100931 | UPD1-Motor:Bradykinesia and Hypokinesia | Unified Parkinson's Disease Rating Scale - Motor examination: Body bradykinesia and hypokinesia (Combining slowness, hesitancy, decreased arm swing, small amplitude, and poverty of movement in general.). | UPDRS - Motor Examination: Body Bradykinesia and Hypokinesia | ||
UPD132 | C100932 | UPD1-Complications:Dyskinesias Duration | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Duration: What proportion of the waking day are dyskinesias present? (Historical information.). | UPDRS - Complications of Therapy: Dyskinesias - Duration | ||
UPD133 | C100933 | UPD1-Complications:Dyskinesias Disable | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Disability: How disabling are the dyskinesias? (Historical information; may be modified by office examination.). | UPDRS - Complications of Therapy: Dyskinesias - Disability | ||
UPD134 | C100934 | UPD1-Complications:Dyskinesias Painful | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Painful dyskinesias: How painful are the dyskinesias? | UPDRS - Complications of Therapy: Dyskinesias - Painful Dyskinesias | ||
UPD135 | C100935 | UPD1-Complications:Dyskinesias Dystonia | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Presence of early morning dystonia (Historical information.). | UPDRS - Complications of Therapy: Dyskinesias - Presence of Early Morning Dystonia | ||
UPD136 | C100936 | UPD1-Complications:Fluct Predictable | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Are 'off' periods predictable? | UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Predictable | ||
UPD137 | C100937 | UPD1-Complications:Fluct Unpredictable | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Are 'off' periods unpredictable? | UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Unpredictable | ||
UPD138 | C100938 | UPD1-Complications:Fluct Suddenly | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Do 'off' periods come on suddenly, within a few seconds? | UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Sudden | ||
UPD139 | C100939 | UPD1-Complications:Fluct Average | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, What proportion of the waking day is the patient 'off' on average? | UPDRS - Complications of Therapy: Clinical Fluctuations - Average Off Periods Per Day | ||
UPD140 | C100940 | UPD1-Complications:Anorex Nausea Vomit | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Does the patient have anorexia, nausea, or vomiting? | UPDRS - Complications of Therapy: Other Complications - Anorexia, Nausea, or Vomiting | ||
UPD141 | C100941 | UPD1-Complications:Insomnia Hypersomnol | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Any sleep disturbances, such as insomnia or hypersomnolence? | UPDRS - Complications of Therapy: Other Complications - Sleep Disturbances | ||
UPD142 | C100942 | UPD1-Complications:Symptom Orthostasis | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Does the patient have symptomatic orthostasis? (Record the patient's blood pressure, height and weight on the scoring form). | UPDRS - Complications of Therapy: Other Complications - Symptomatic Orthostasis | ||
UPD142A | C111605 | UPD1-Blood Pressure: Seated | Unified Parkinson's Disease Rating Scale - Blood pressure: Seated. | UPDRS - Symptomatic Orthostasis: Blood Pressure, Seated | ||
UPD142B | C111606 | UPD1-Blood Pressure: Supine | Unified Parkinson's Disease Rating Scale - Blood pressure: Supine. | UPDRS - Symptomatic Orthostasis: Blood Pressure, Supine | ||
UPD142C | C111607 | UPD1-Blood Pressure: Standing | Unified Parkinson's Disease Rating Scale - Blood pressure: Standing. | UPDRS - Symptomatic Orthostasis: Blood Pressure, Standing | ||
UPD142D | C111608 | UPD1-Weight | Unified Parkinson's Disease Rating Scale - Weight. | UPDRS - Symptomatic Orthostasis: Weight | ||
UPD142E | C111609 | UPD1-Pulse: Seated | Unified Parkinson's Disease Rating Scale - Pulse: Seated. | UPDRS - Symptomatic Orthostasis: Pulse, Seated | ||
UPD142F | C111610 | UPD1-Pulse: Standing | Unified Parkinson's Disease Rating Scale - Pulse: Standing. | UPDRS - Symptomatic Orthostasis: Pulse, Standing | ||
UPD143 | C100943 | UPD1-Modified Hoehn and Yahr Staging | Unified Parkinson's Disease Rating Scale - Modified Hoehn and Yahr Staging. | UPDRS - Modified Hoehn and Yahr Staging | ||
UPD144A | C111611 | UPD1-Schwab/England % ADL Score (PD) | Unified Parkinson's Disease Rating Scale - Schwab and England % ADL Score (PD). | UPDRS - Schwab and England % ADL Score (PD) | ||
UPD144B | C111612 | UPD1-Schwab/England % ADL (Dyskinesia) | Unified Parkinson's Disease Rating Scale - Schwab and England % ADL (with dyskinesia). | UPDRS - Schwab and England % ADL (With Dyskinesia) | ||
UPD145 | C111613 | UPD1-Mentation, Behavior, Mood Sub-Total | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood sub-total. | UPDRS - Mentation, Behavior and Mood Sub-total | ||
UPD146 | C111614 | UPD1-Activities Daily Living Sub-Total | Unified Parkinson's Disease Rating Scale - Activities of daily living sub-total. | UPDRS - Activities of Daily Living Sub-total | ||
UPD147 | C111615 | UPD1-Motor Examination Sub-Total | Unified Parkinson's Disease Rating Scale - Motor examination sub-total. | UPDRS - Motor Examination Sub-total | ||
UPD148 | C111616 | UPD1-UPDRS Total | Unified Parkinson's Disease Rating Scale - UPDRS total. | UPDRS - UPDRS Total | ||
Back to top | ||||||
CL.C100147.UPD1TN | Unified Parkinson's Disease Rating Scale Clinical Classification Test Name
(UPD1TN) | text
Extensible: No | C100147 | Unified Parkinson's Disease Rating Scale Clinical Classification Test Name | Unified Parkinson's Disease Rating Scale test name. | CDISC Clinical Classification UPDRS Test Name Terminology |
UPD1--Motor:Action Tremor:Hand: Left | C111591 | UPD1--Motor:Action Tremor:Hand: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Action tremor: Hand: Left. | UPDRS - Motor Examination: Action Tremor, Hand, Left | ||
UPD1--Motor:Action Tremor:Hand: Right | C111590 | UPD1--Motor:Action Tremor:Hand: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Action tremor: Hand: Right. | UPDRS - Motor Examination: Action Tremor, Hand, Right | ||
UPD1-Activities Daily Living Sub-Total | C111614 | UPD1-Activities Daily Living Sub-Total | Unified Parkinson's Disease Rating Scale - Activities of daily living sub-total. | UPDRS - Activities of Daily Living Sub-total | ||
UPD1-Activities:Cut Food/Handle Utensil | C100909 | UPD1-Activities:Cut Food/Handle Utensil | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Cutting food and handling utensils. | UPDRS - Activities of Daily Living: Cutting Food and Handling Utensils | ||
UPD1-Activities:Dressing | C100910 | UPD1-Activities:Dressing | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Dressing. | UPDRS - Activities of Daily Living: Dressing | ||
UPD1-Activities:Falling | C100913 | UPD1-Activities:Falling | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Falling (unrelated to freezing). | UPDRS - Activities of Daily Living: Falling | ||
UPD1-Activities:Freezing When Walking | C100914 | UPD1-Activities:Freezing When Walking | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Freezing when walking. | UPDRS - Activities of Daily Living: Freezing When Walking | ||
UPD1-Activities:Handwriting | C100908 | UPD1-Activities:Handwriting | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Handwriting. | UPDRS - Activities of Daily Living: Handwriting | ||
UPD1-Activities:Hygiene | C100911 | UPD1-Activities:Hygiene | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Hygiene. | UPDRS - Activities of Daily Living: Hygiene | ||
UPD1-Activities:Salivation | C100906 | UPD1-Activities:Salivation | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Salivation. | UPDRS - Activities of Daily Living: Salivation | ||
UPD1-Activities:Sensory Complaints | C100917 | UPD1-Activities:Sensory Complaints | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Sensory complaints related to Parkinsonism. | UPDRS - Activities of Daily Living: Sensory Complaints Related to Parkinsonism | ||
UPD1-Activities:Speech | C100905 | UPD1-Activities:Speech | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Speech. | UPDRS - Activities of Daily Living: Speech | ||
UPD1-Activities:Swallowing | C100907 | UPD1-Activities:Swallowing | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Swallowing. | UPDRS - Activities of Daily Living: Swallowing | ||
UPD1-Activities:Tremor | C100916 | UPD1-Activities:Tremor | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Tremor (Symptomatic complaint of tremor in any part of body.). | UPDRS - Activities of Daily Living: Tremor | ||
UPD1-Activities:Turn Bed/Adj Clothes | C100912 | UPD1-Activities:Turn Bed/Adj Clothes | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Turning in bed and adjusting bed clothes. | UPDRS - Activities of Daily Living: Turning in Bed and Adjusting Bed Clothes | ||
UPD1-Activities:Walking | C100915 | UPD1-Activities:Walking | Unified Parkinson's Disease Rating Scale - Activities of daily living (for both 'on' and 'off'): Walking. | UPDRS - Activities of Daily Living: Walking | ||
UPD1-Blood Pressure: Seated | C111605 | UPD1-Blood Pressure: Seated | Unified Parkinson's Disease Rating Scale - Blood pressure: Seated. | UPDRS - Symptomatic Orthostasis: Blood Pressure, Seated | ||
UPD1-Blood Pressure: Standing | C111607 | UPD1-Blood Pressure: Standing | Unified Parkinson's Disease Rating Scale - Blood pressure: Standing. | UPDRS - Symptomatic Orthostasis: Blood Pressure, Standing | ||
UPD1-Blood Pressure: Supine | C111606 | UPD1-Blood Pressure: Supine | Unified Parkinson's Disease Rating Scale - Blood pressure: Supine. | UPDRS - Symptomatic Orthostasis: Blood Pressure, Supine | ||
UPD1-Complications:Anorex Nausea Vomit | C100940 | UPD1-Complications:Anorex Nausea Vomit | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Does the patient have anorexia, nausea, or vomiting? | UPDRS - Complications of Therapy: Other Complications - Anorexia, Nausea, or Vomiting | ||
UPD1-Complications:Dyskinesias Disable | C100933 | UPD1-Complications:Dyskinesias Disable | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Disability: How disabling are the dyskinesias? (Historical information; may be modified by office examination.). | UPDRS - Complications of Therapy: Dyskinesias - Disability | ||
UPD1-Complications:Dyskinesias Duration | C100932 | UPD1-Complications:Dyskinesias Duration | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Duration: What proportion of the waking day are dyskinesias present? (Historical information.). | UPDRS - Complications of Therapy: Dyskinesias - Duration | ||
UPD1-Complications:Dyskinesias Dystonia | C100935 | UPD1-Complications:Dyskinesias Dystonia | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Presence of early morning dystonia (Historical information.). | UPDRS - Complications of Therapy: Dyskinesias - Presence of Early Morning Dystonia | ||
UPD1-Complications:Dyskinesias Painful | C100934 | UPD1-Complications:Dyskinesias Painful | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Dyskinesias, Painful dyskinesias: How painful are the dyskinesias? | UPDRS - Complications of Therapy: Dyskinesias - Painful Dyskinesias | ||
UPD1-Complications:Fluct Average | C100939 | UPD1-Complications:Fluct Average | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, What proportion of the waking day is the patient 'off' on average? | UPDRS - Complications of Therapy: Clinical Fluctuations - Average Off Periods Per Day | ||
UPD1-Complications:Fluct Predictable | C100936 | UPD1-Complications:Fluct Predictable | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Are 'off' periods predictable? | UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Predictable | ||
UPD1-Complications:Fluct Suddenly | C100938 | UPD1-Complications:Fluct Suddenly | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Do 'off' periods come on suddenly, within a few seconds? | UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Sudden | ||
UPD1-Complications:Fluct Unpredictable | C100937 | UPD1-Complications:Fluct Unpredictable | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Clinical fluctuations, Are 'off' periods unpredictable? | UPDRS - Complications of Therapy: Clinical Fluctuations - Off Periods Unpredictable | ||
UPD1-Complications:Insomnia Hypersomnol | C100941 | UPD1-Complications:Insomnia Hypersomnol | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Any sleep disturbances, such as insomnia or hypersomnolence? | UPDRS - Complications of Therapy: Other Complications - Sleep Disturbances | ||
UPD1-Complications:Symptom Orthostasis | C100942 | UPD1-Complications:Symptom Orthostasis | Unified Parkinson's Disease Rating Scale - Complications of therapy (in the past week): Other complications, Does the patient have symptomatic orthostasis? (Record the patient's blood pressure, height and weight on the scoring form). | UPDRS - Complications of Therapy: Other Complications - Symptomatic Orthostasis | ||
UPD1-Mentation, Behavior, Mood Sub-Total | C111613 | UPD1-Mentation, Behavior, Mood Sub-Total | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood sub-total. | UPDRS - Mentation, Behavior and Mood Sub-total | ||
UPD1-Mentation:Depression | C100903 | UPD1-Mentation:Depression | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Depression. | UPDRS - Mentation, Behavior and Mood: Depression | ||
UPD1-Mentation:Intellectual Impairment | C100901 | UPD1-Mentation:Intellectual Impairment | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Intellectual impairment. | UPDRS - Mentation, Behavior and Mood: Intellectual Impairment | ||
UPD1-Mentation:Motivation/Initiative | C100904 | UPD1-Mentation:Motivation/Initiative | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Motivation/Initiative. | UPDRS - Mentation, Behavior and Mood: Motivation/Initiative | ||
UPD1-Mentation:Thought Disorder | C100902 | UPD1-Mentation:Thought Disorder | Unified Parkinson's Disease Rating Scale - Mentation, behavior and mood: Thought disorder. | UPDRS - Mentation, Behavior and Mood: Thought Disorder | ||
UPD1-Modified Hoehn and Yahr Staging | C100943 | UPD1-Modified Hoehn and Yahr Staging | Unified Parkinson's Disease Rating Scale - Modified Hoehn and Yahr Staging. | UPDRS - Modified Hoehn and Yahr Staging | ||
UPD1-Motor Examination Sub-Total | C111615 | UPD1-Motor Examination Sub-Total | Unified Parkinson's Disease Rating Scale - Motor examination sub-total. | UPDRS - Motor Examination Sub-total | ||
UPD1-Motor:Arising from Chair | C100927 | UPD1-Motor:Arising from Chair | Unified Parkinson's Disease Rating Scale - Motor examination: Arising from chair (Patient attempts to rise from a straightbacked chair, with arms folded across chest.). | UPDRS - Motor Examination: Arising from Chair | ||
UPD1-Motor:Bradykinesia and Hypokinesia | C100931 | UPD1-Motor:Bradykinesia and Hypokinesia | Unified Parkinson's Disease Rating Scale - Motor examination: Body bradykinesia and hypokinesia (Combining slowness, hesitancy, decreased arm swing, small amplitude, and poverty of movement in general.). | UPDRS - Motor Examination: Body Bradykinesia and Hypokinesia | ||
UPD1-Motor:Facial Expression | C100919 | UPD1-Motor:Facial Expression | Unified Parkinson's Disease Rating Scale - Motor examination: Facial expression. | UPDRS - Motor Examination: Facial Expression | ||
UPD1-Motor:Finger Taps: Left | C111598 | UPD1-Motor:Finger Taps: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Finger taps: Left. | UPDRS - Motor Examination: Finger Taps, Left | ||
UPD1-Motor:Finger Taps: Right | C111597 | UPD1-Motor:Finger Taps: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Finger taps: Right. | UPDRS - Motor Examination: Finger Taps, Right | ||
UPD1-Motor:Gait | C100929 | UPD1-Motor:Gait | Unified Parkinson's Disease Rating Scale - Motor examination: Gait. | UPDRS - Motor Examination: Gait | ||
UPD1-Motor:Hand Grips: Left | C111600 | UPD1-Motor:Hand Grips: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Hand grips: Left. | UPDRS - Motor Examination: Hand Grips, Left | ||
UPD1-Motor:Hand Grips: Right | C111599 | UPD1-Motor:Hand Grips: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Hand grips: Right. | UPDRS - Motor Examination: Hand Grips, Right | ||
UPD1-Motor:Hand Pronate/Supinate: Left | C111602 | UPD1-Motor:Hand Pronate/Supinate: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Hand pronate/supinate: Left. | UPDRS - Motor Examination: Hand Pronate/Supinate, Left | ||
UPD1-Motor:Hand Pronate/Supinate: Right | C111601 | UPD1-Motor:Hand Pronate/Supinate: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Hand pronate/supinate: Right. | UPDRS - Motor Examination: Hand Pronate/Supinate, Right | ||
UPD1-Motor:Leg Agility: Left | C111604 | UPD1-Motor:Leg Agility: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Leg agility: Left. | UPDRS - Motor Examination: Leg Agility, Left | ||
UPD1-Motor:Leg Agility: Right | C111603 | UPD1-Motor:Leg Agility: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Leg agility: Right. | UPDRS - Motor Examination: Leg Agility, Right | ||
UPD1-Motor:Postural Stability | C100930 | UPD1-Motor:Postural Stability | Unified Parkinson's Disease Rating Scale - Motor examination: Postural stability (Response to sudden, strong posterior displacement produced by pull on shoulders while patient erect with eyes open and feet slightly apart. Patient is prepared.). | UPDRS - Motor Examination: Postural Stability | ||
UPD1-Motor:Posture | C100928 | UPD1-Motor:Posture | Unified Parkinson's Disease Rating Scale - Motor examination: Posture. | UPDRS - Motor Examination: Posture | ||
UPD1-Motor:Rigidity Lower Extrem: Left | C111596 | UPD1-Motor:Rigidity Lower Extrem: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity lower extremity: Left. | UPDRS - Motor Examination: Rigidity Lower Extremity, Left | ||
UPD1-Motor:Rigidity Lower Extrem: Right | C111595 | UPD1-Motor:Rigidity Lower Extrem: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity lower extremity: Right. | UPDRS - Motor Examination: Rigidity Lower Extremity, Right | ||
UPD1-Motor:Rigidity Neck | C111592 | UPD1-Motor:Rigidity Neck | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity neck. | UPDRS - Motor Examination: Rigidity Neck | ||
UPD1-Motor:Rigidity Upper Extrem: Left | C111594 | UPD1-Motor:Rigidity Upper Extrem: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity upper extremity: Left. | UPDRS - Motor Examination: Rigidity Upper Extremity, Left | ||
UPD1-Motor:Rigidity Upper Extrem: Right | C111593 | UPD1-Motor:Rigidity Upper Extrem: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Rigidity upper extremity: Right. | UPDRS - Motor Examination: Rigidity Upper Extremity, Right | ||
UPD1-Motor:Speech | C100918 | UPD1-Motor:Speech | Unified Parkinson's Disease Rating Scale - Motor examination: Speech. | UPDRS - Motor Examination: Speech | ||
UPD1-Motor:Tremor at Rest:Face Lips Chin | C111585 | UPD1-Motor:Tremor at Rest:Face Lips Chin | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: face, lips, chin. | UPDRS - Motor Examination: Tremor at Rest, Face, Lips, Chin | ||
UPD1-Motor:Tremor at Rest:Feet: Left | C111589 | UPD1-Motor:Tremor at Rest:Feet: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Feet: Left. | UPDRS - Motor Examination: Tremor at Rest, Feet, Left | ||
UPD1-Motor:Tremor at Rest:Feet: Right | C111588 | UPD1-Motor:Tremor at Rest:Feet: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Feet: Right. | UPDRS - Motor Examination: Tremor at Rest, Feet, Right | ||
UPD1-Motor:Tremor at Rest:Hands: Left | C111587 | UPD1-Motor:Tremor at Rest:Hands: Left | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Hands: Left. | UPDRS - Motor Examination: Tremor at Rest, Hands, Left | ||
UPD1-Motor:Tremor at Rest:Hands: Right | C111586 | UPD1-Motor:Tremor at Rest:Hands: Right | Unified Parkinson's Disease Rating Scale - Motor examination: Tremor at rest: Hands: Right. | UPDRS - Motor Examination: Tremor at Rest, Hands, Right | ||
UPD1-Pulse: Seated | C111609 | UPD1-Pulse: Seated | Unified Parkinson's Disease Rating Scale - Pulse: Seated. | UPDRS - Symptomatic Orthostasis: Pulse, Seated | ||
UPD1-Pulse: Standing | C111610 | UPD1-Pulse: Standing | Unified Parkinson's Disease Rating Scale - Pulse: Standing. | UPDRS - Symptomatic Orthostasis: Pulse, Standing | ||
UPD1-Schwab/England % ADL (Dyskinesia) | C111612 | UPD1-Schwab/England % ADL (Dyskinesia) | Unified Parkinson's Disease Rating Scale - Schwab and England % ADL (with dyskinesia). | UPDRS - Schwab and England % ADL (With Dyskinesia) | ||
UPD1-Schwab/England % ADL Score (PD) | C111611 | UPD1-Schwab/England % ADL Score (PD) | Unified Parkinson's Disease Rating Scale - Schwab and England % ADL Score (PD). | UPDRS - Schwab and England % ADL Score (PD) | ||
UPD1-UPDRS Total | C111616 | UPD1-UPDRS Total | Unified Parkinson's Disease Rating Scale - UPDRS total. | UPDRS - UPDRS Total | ||
UPD1-Weight | C111608 | UPD1-Weight | Unified Parkinson's Disease Rating Scale - Weight. | UPDRS - Symptomatic Orthostasis: Weight | ||
Back to top | ||||||
CL.C71620.UNIT | Unit
(UNIT) | text
Extensible: Yes | C71620 | Unit | Terminology codelist used for units within CDISC. | CDISC SDTM Unit of Measure Terminology |
% INHIBITION | C117963 | Percent Inhibition | The rate of measured normal activity minus inhibited activity, divided by the rate of normal activity of a given object. It is expressed as a percentage. | Percent Inhibition | ||
% | C25613 | Percentage | One hundred times the quotient of one quantity divided by another, with the same units of measurement. | Percentage | ||
%(v/v) | C48571 | Percent Volume per Volume;vol% | A percent ratio of volume to volume, defined by the equation: [volume of solute (in ml)/ volume of solution (in ml)](100), typically used for admixtures of solutions.(NCI) | Percent Volume per Volume | ||
%(w/v) | C48527 | Percent Weight per Volume | A percent ratio of weight to volume, defined by the equation: [weight of solute (in gm)/volume of solution (in dl)](100). Since the numerator and denominator of this ratio have different units, it is not a true percentage. A 1% w/v solution is defined as being 1 gram of solute dissolved in 100 milliliters of solvent.(NCI) | Percent Mass per Volume | ||
%(w/w) | C48528 | Percent Weight per Weight | A percent ratio of weight to weight, defined by the equation: [weight of solute (in gm)/weight of solution (in gm)](100).(NCI) | Percent Mass per Mass | ||
%*min/h | C187981 | min*%/h | A unit of measurement expressed as the percentage times minutes divided by hours. | Percentage times Minute per Hour | ||
%/min | C114240 | Percent per Minute | A unit of frequency expressed as the percentage of entities or events per minute. | Percent per Minute | ||
%/s | C163560 | Percent per Second | A unit of frequency expressed as the percentage of entities or events per second. | Percent per Second | ||
/10 HPFs | C158699 | Per 10 High Powered Fields | A unit of measurement of the number of entities per unit of area equal to ten high powered fields. | Per 10 High Powered Fields | ||
/100 HPFs | C102695 | Per 100 High Powered Fields | A unit of measurement of the number of entities per unit of area equal to one hundred high powered fields. | Per 100 High Powered Fields | ||
/100 RBC | C191358 | Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per one hundred red blood cells. | Per 100 Red Blood Cells | |||
/100 WBC | C67219 | Per 100 White Blood Cells | Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 100 white blood cells. | Per 100 White Blood Cells | ||
/10^3 RBC | C191359 | /1000 RBC | Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per one thousand red blood cells. | Per Thousand Red Blood Cells | ||
/10^3 | C123634 | A unit equal to one thousand entities used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Thousand | |||
/10^4 | C135515 | A unit equal to ten thousand entities used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Ten Thousand | |||
/10^5 | C135516 | A unit equal to one hundred thousand entities used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Hundred Thousand | |||
/10^6 | C184719 | A unit equal to one million entities used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Million | |||
/2 mm2 | C189646 | A unit equal to two square millimeters used as a denominator to build a derived unit expressed as a ratio. | Per Two Square Millimeters | |||
/200 HPFs | C132472 | Per 200 High Powered Fields | A unit of measurement of the number of entities per unit of area equal to 200 high powered fields. | Per 200 High Powered Fields | ||
/2000 RBC | C132473 | /2x10^3 RBC | Natural number unit of measurement for a portion of a particular type of cell (excluding red blood cell subtypes) per 2000 red blood cells. | Per 2000 Red Blood Cells | ||
/2500 WBC | C132474 | Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 2500 white blood cells. | Per 2500 White Blood Cells | |||
/4.0 mL | C122197 | A volume unit equal to 4.0 milliliters used as a denominator to build a derived unit expressed as a ratio. | per 4.0 Milliliters | |||
/40 HPFs | C132475 | Per 40 High Powered Fields | A unit of measurement of the number of entities per unit of area equal to 40 high powered fields. | Per 40 High Powered Fields | ||
/400 Cells | C191355 | Natural number unit of measurement for a portion of a particular type of entities per 400 total cells. | Per 400 Cells | |||
/500 WBC | C132476 | Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 500 white blood cells. | Per 500 White Blood Cells | |||
/5x10^4 WBC | C170636 | Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 50,000 white blood cells. | Per 50,000 White Blood Cells | |||
/7.5 mL | C122198 | A volume unit equal to 7.5 milliliters used as a denominator to build a derived unit expressed as a ratio. | per 7.5 Milliliters | |||
/animal | C198368 | Per Animal | A unit equal to one animal used as a denominator to build a derived unit expressed as a ratio. | Per Animal | ||
/cmH2O | C135517 | A unit of pressure equal to one centimeter of water used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Centimeter of Water | |||
/day | C25473 | /day;Daily;Per Day | A rate of occurrences within a period of time equal to one day. | Daily | ||
/g | C198369 | Per Gram | A unit equal to one gram used as a denominator to build a derived unit expressed as a ratio. | Per Gram | ||
/h | C66966 | Per Hour | A rate of occurrences within a period of time equal to one hour. | Per Hour | ||
/HPF | C96619 | Per High Powered Field | A unit of measure equal to the instances of an entity per visual field of a microscope set to a high magnification power. | Per High Powered Field | ||
/kg | C120844 | A unit equal to one kilogram used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Kilogram | |||
/LPF | C96620 | Per Low Powered Field | A unit of measure equal to the instances of an entity per visual field of a microscope set to a low magnification power. | Per Low Powered Field | ||
/LSQN | C130187 | /Large Square Neubauer | A unit of measure equal to the instances of an entity per large square (with a 1 mm2 area) in a Neubauer chamber. | Per Large Square Neubauer Chamber | ||
/MBP | C176387 | /10^6 BP;/Mb;/Mbp;Per Megabase Pair | A unit equal to one million base pairs used as a denominator to build a derived unit expressed as a ratio. | Per Megabase Pair | ||
/min | C66967 | A rate of occurrences within a period of time equal to one minute. | Per Minute | |||
/mm | C130188 | A unit of length equal to one millimeter used as a denominator to build a derived unit expressed as a ratio. | Per Millimeter | |||
/mm2 | C122199 | An area unit equal to one millimeter squared used as a denominator to build a derived unit expressed as a ratio. | per Square Millimeter | |||
/month | C64498 | Every Month;Per Month | Every month. (NCI) | Monthly | ||
/ms | C161490 | 1/ms;ms^-1;Reciprocal of Millisecond | A rate of occurrences within a period of time equal to one second. | Per Millisecond | ||
/s | C66965 | /sec | A rate of occurrences within a period of time equal to one second. | Per Second | ||
/VF | C105516 | Per Visual Field | A unit of measure equal to the instances of an entity per visual field of a microscope. (NCI) | Per Visual Field | ||
/wk | C67069 | Every week;Per Week;QS | Every week. (NCI) | Weekly | ||
1/(s*kPa) | C127804 | /(s*kPa) | A unit of resistance equal to the inverse of one second times one kilopascal. | One per Second Times Kilopascal | ||
100 IU/mL | C71185 | 100 International units/Milliliter | A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one hundred international units per one milliliter of system volume.(NCI) | 100 International Units per Milliliter | ||
10^10 copies/mL | C198370 | Ten Billion Copies per Milliliter | The unit of concentration expressed as the number of 10 to the tenth power copies in unit volume equal to one milliliter. (NCI) | Ten Billion Copies per Milliliter | ||
10^10 IU/mL | C198371 | Ten Billion International Units per Milliliter | A unit of measurement equal to 10 to the tenth power of the number of international units of an entity per unit of volume equal to one milliliter. | Ten Billion International Units per Milliliter | ||
10^10 vp/dose | C198372 | 10^10 Viral Particles/dose | A unit for virus amount equal to 10 to the tenth power of the number of viral particles per dose. | Ten Billion Viral Particles per Dose | ||
10^10 vp/mL | C198373 | 10^10 Viral Particles/mL | A unit for virus concentration equal to 10 to the tenth power of the number of viral particles per milliliter. | Ten Billion Viral Particles per Milliliter | ||
10^10/L | C105517 | 10^4/mm3;10^4/uL;10^7/mL | A unit of measurement equal to 10 to the tenth power of entities per unit of volume equal to one liter. (NCI) | Ten Billion Per Liter | ||
10^11/L | C105488 | 10^5/mm3;10^5/uL;10^8/mL | A unit of measurement equal to 10 to the eleventh power of entities per unit of volume equal to one liter. | Hundred Billion Per Liter | ||
10^12 IU/L | C105518 | Tera International Unit per Liter;TIU/L | Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of 10^12 international unit per one liter of system volume.(NCI) | Tera International Unit Per Liter | ||
10^12/L | C67308 | /pL;1/pL;10^6/mm3;10^6/uL;M/uL;Mill/mcL;T/L;Tera/L;TI/L | A unit of measurement equal to 10 to the twelfth power of the number of entities per unit of volume equal to one liter. | Million per Microliter | ||
10^3 CFU | C68895 | Thousand CFU;Thousand Colony Forming Units | A unit of measurement of colony forming cells or microorganisms equal to 10 to the third power colony forming units. | Thousand Colony Forming Units | ||
10^3 CFU/g | C68899 | Thousand CFU/g;Thousand Colony Forming Units per Gram | A unit of measurement of colony forming cells or microorganisms equal to 10 to the third power colony forming units. | Thousand Colony Forming Units per Gram | ||
10^3 CFU/mL | C68903 | Thousand CFU/mL;Thousand Colony Forming Units per Milliliter | A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the third power colony forming units in one milliliter of substance. | Thousand Colony Forming Units per Milliliter | ||
10^3 copies/mL | C100897 | The unit of concentration expressed as the number of 10 to the third power copies in unit volume equal to one milliliter. (NCI) | Thousand Copies per Milliliter | |||
10^3 DNA copies/mL | C98788 | A unit of measurement equal to 10 to the third power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter. | Thousand DNA Copies per Milliliter | |||
10^3 IU/mL | C198374 | Thousand International Units per Milliliter | A unit of measurement equal to 10 to the third power of the number of international units of an entity per unit of volume equal to one milliliter. | Thousand International Units per Milliliter | ||
10^3 organisms | C71187 | Thousand Organisms | A unit of measure of quantity of organisms expressed in 10 to the third power of organisms. | Thousand Organisms | ||
10^3 organisms/g | C71190 | Thousand Organisms per Gram;Thousand Organisms/g | A unit of measure of organism content expressed in 10 to the third power of organisms per unit of mass equal to one gram. | Thousand Organisms per Gram | ||
10^3 organisms/mL | C71195 | Thousand Organisms per Milliliter;Thousand Organisms/mL | A unit of measure of organism concentration expressed in 10 to the third power of organisms per unit of volume equal to one milliliter. | Thousand Organisms per Milliliter | ||
10^3 RNA copies/mL | C98790 | A unit of measurement equal to 10 to the third power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter. | Thousand RNA Copies per Milliliter | |||
10^3 Therapeutic Cells | C187975 | A dosing unit for the number of therapeutic cells administered, expressed as 10 to the third power. | Thousand Therapeutic Cells Dosing Unit | |||
10^3/hpf | C98789 | A unit of measurement equal to 10 to the third power of the number of entities per unit of area equal to one high powered field. | Thousand per High Powered Field | |||
10^3/L | C105519 | /mL;1/mL | A unit of measurement equal to 10 to the third power of entities per unit of volume equal to one liter. | Thousand Per Liter | ||
10^4 CFU | C158293 | Ten Thousand CFU;Ten Thousand Colony Forming Units | A unit of measurement of colony forming cells or microorganisms equal to 10 to the fourth power colony forming units. | Ten Thousand Colony Forming Units | ||
10^4 CFU/mL | C166095 | Ten Thousand CFU/mL;Ten Thousand Colony Forming Units per Milliliter | A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the fourth power colony forming units in one milliliter of substance. | Ten Thousand Colony Forming Units Per Liter | ||
10^4 copies/mL | C198375 | Ten Thousand Copies per Milliliter | The unit of concentration expressed as the number of 10 to the fourth power copies in unit volume equal to one milliliter. (NCI) | Ten Thousand Copies per Milliliter | ||
10^4 IU/mL | C198376 | Ten Thousand International Units per Milliliter | A unit of measurement equal to 10 to the fourth power of the number of international units of an entity per unit of volume equal to one milliliter. | Ten Thousand International Units per Milliliter | ||
10^4/hpf | C98787 | A unit of measurement equal to 10 to the fourth power of the number of entities per unit of area equal to one high powered field. | Ten Thousand per High Powered Field | |||
10^4/L | C73771 | A unit of measurement equal to 10 to the fourth power of entities per unit of volume equal to one liter. | Thousand per Deciliter | |||
10^5 CFU | C198377 | Hundred Thousand CFU;Hundred Thousand Colony Forming Units | A unit of measurement of colony forming cells or microorganisms equal to 10 to the fifth power colony forming units. (NCI) | Hundred Thousand Colony Forming Units | ||
10^5 CFU/mL | C181551 | Hundred Thousand CFU/mL;Hundred Thousand Colony Forming Units per Milliliter | A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the fifth power colony forming units in one milliliter of substance. | Hundred Thousand Colony Forming Units per Milliliter | ||
10^5 copies/mL | C198378 | Hundred Thousand copies per Milliliter | The unit of concentration expressed as the number of 10 to the fifth power copies in unit volume equal to one milliliter. (NCI) | Hundred Thousand Copies per Milliliter | ||
10^5 IU/mL | C198379 | Hundred Thousand International Units | A unit of measurement equal to 10 to the fifth power of the number of international units of an entity per unit of volume equal to one milliliter. (NCI) | Hundred Thousand International Units | ||
10^5 Therapeutic Cells | C187971 | A dosing unit for the number of therapeutic cells administered, expressed as 10 to the fifth power. | Hundred Thousand Therapeutic Cells Dosing Unit | |||
10^5/hpf | C98743 | A unit of measurement equal to 10 to the fifth power of the number of entities per unit of area equal to one high powered field. | Hundred Thousand per High Powered Field | |||
10^5/kg | C184715 | 10^2/g;10^5/kg | A unit of measurement equal to 10 to the fifth power of the number of entities per unit of mass equal to one kilogram. | Hundred Thousand Per Kilogram | ||
10^5/L | C105490 | 10^2/mL | A unit of measurement equal to 10 to the fifth power of entities per unit of volume equal to one liter. | Hundred Thousand Per Liter | ||
10^6 CFU | C68896 | Million CFU;Million Colony Forming Units | A unit of measurement of colony forming cells or microorganisms equal to 10 to the sixth power colony forming units. | Million Colony Forming Units | ||
10^6 CFU/g | C68900 | Million CFU/g;Million Colony Forming Units per Gram | A unit of measurement of colony forming cells or microorganisms in a unit mass of substance of interest defined as the number of 10 to the sixth power colony forming units in one gram of substance. | Million Colony Forming Units per Gram | ||
10^6 CFU/mL | C68904 | Million CFU/mL;Million Colony Forming Units per Milliliter | A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the sixth power colony forming units in one milliliter of substance. | Million Colony Forming Units per Milliliter | ||
10^6 copies/mL | C100898 | The unit of concentration expressed as the number of 10 to the sixth power copies in unit volume equal to one milliliter. (NCI) | Million Copies per Milliliter | |||
10^6 DNA copies/mL | C98756 | A unit of measurement equal to 10 to the sixth power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter. | Million DNA Copies per Milliliter | |||
10^6 IU | C67335 | Million International Units;Million IU | A unit of biological activity equal to 10 to the sixth power international units. | Million International Units | ||
10^6 IU/mL | C98757 | A unit of measurement equal to 10 to the sixth power of the number of international units of an entity per unit of volume equal to one milliliter. | Million International Units per Milliliter | |||
10^6 organisms | C71188 | Million Organisms | A unit of measure of quantity of organisms expressed in 10 to the sixth power of organisms. | Million Organisms | ||
10^6 organisms/g | C71191 | Million Organisms per Gram;Million Organisms/g | A unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one gram. | Million Organisms per Gram | ||
10^6 organisms/mg | C71193 | Million Organisms per Milligram;Million Organisms/mg | A unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one milligram. | Million Organisms per Milligram | ||
10^6 organisms/mL | C71196 | Million Organisms per Milliliter;Million Organisms/mL | A unit of measure of organism concentration expressed in 10 to the sixth power of organisms per unit of volume equal to one milliliter. | Million Organisms per Milliliter | ||
10^6 PFU | C67268 | One Million PFU;One Million Plaque Forming Units | A unit of measurement of infectious entities with numbers equal to 10 to the sixth power plaque forming units. | Million Plaque Forming Units | ||
10^6 RNA copies/mL | C98760 | A unit of measurement equal to 10 to the sixth power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter. | Million RNA Copies per Milliliter | |||
10^6 TCID 50/dose | C150415 | 10^6 50 Percent Tissue Culture Infective Dose per Dose | A potency unit equal to the potency at which one dose of preparation contains one million (10^6) 50 percent tissue culture infective doses. | Million Tissue Culture Infectious Dose 50% | ||
10^6 Therapeutic Cells | C187973 | A dosing unit for the number of therapeutic cells administered, expressed as 10 to the sixth power. | Million Therapeutic Cells Dosing Unit | |||
10^6 U | C67310 | Million U;Million Units | A unit of measure equal to 10 to the sixth power of arbitrary units. | Million Units | ||
10^6/Ejaculate U | C130189 | A unit of measurement equal to 10 to the sixth power of entities per unit equal to one ejaculation. | Million Per Ejaculate Unit | |||
10^6/g | C98758 | /ug;1/ug;10^3/mg;10^9/kg | A unit of measurement equal to 10 to the sixth power of the number of entities per unit of mass equal to one gram. | Million per Gram | ||
10^6/hpf | C98759 | A unit of measurement equal to 10 to the sixth power of the number of entities per unit of area equal to one high powered field. | Million per High Powered Field | |||
10^6/kg | C198380 | 10^3/g | A unit of measurement equal to 10 to the sixth power of the number of entities per unit of mass equal to one kilogram. | Million per Kilogram | ||
10^6/L | C67452 | /mm3;/uL;1/mm3;1/uL;10^3/mL;M/L;Mega/L | A unit of measurement equal to 10 to the sixth power of the number of entities per unit of volume equal to one liter. | Thousand per Milliliter | ||
10^7 CFU | C158294 | Ten Million CFU;Ten Million Colony Forming Units | A unit of measurement of colony forming cells or microorganisms equal to 10 to the seventh power colony forming units. | Ten Million Colony Forming Units | ||
10^7 CFU/mL | C166096 | Ten Million CFU/mL;Ten Million Colony Forming Units per Milliliter | A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the seventh power colony forming units in one milliliter of substance. | Ten Million Colony Forming Units Per Liter | ||
10^7 copies/mL | C198381 | Ten Million copies per Milliliter | The unit of concentration expressed as the number of 10 to the seventh power copies in unit volume equal to one milliliter. (NCI) | Ten Million Copies per Milliliter | ||
10^7 IU/mL | C198382 | Ten Million International Units per Milliliter | A unit of measurement equal to 10 to the seventh power of the number of international units of an entity per unit of volume equal to one milliliter. (NCI) | Ten Million International Units per Milliliter | ||
10^7 PFU | C67265 | Ten Million PFU;Ten Million Plaque Forming Units | A unit of measurement of plaque forming cells or microorganisms with numbers equal to 10 to the seventh power plaque forming units. | Ten Million Plaque Forming Units | ||
10^7 TCID 50/dose | C150416 | 10^7 50 Percent Tissue Culture Infective Dose per Dose | A potency unit equal to the potency at which one dose of preparation contains ten million (10^7) 50 percent tissue culture infective doses. | Ten Million Tissue Culture Infectious Dose 50% | ||
10^7/kg | C184717 | 10/mg;10^4/g | A unit of measurement equal to 10 to the seventh power of the number of entities per unit of mass equal to one kilogram. | Ten Million Per Kilogram | ||
10^7/L | C98786 | 10^6/dL | A unit of measurement equal to 10 to the seventh power of the number of entities per unit of volume equal to one liter. | Ten Million per Liter | ||
10^8 CFU | C198383 | Hundred Million CFU;Hundred Million Colony Forming Units | A unit of measurement of colony forming cells or microorganisms equal to 10 to the eighth power colony forming units. (NCI) | Hundred Million Colony Forming Units | ||
10^8 copies/mL | C198384 | One Hundred Million Copies per Milliliter | The unit of concentration expressed as the number of 10 to the eight power copies in unit volume equal to one milliliter. (NCI) | One Hundred Million Copies per Milliliter | ||
10^8 IU | C156119 | One Hundred Million International Units;One Hundred Million IU | A unit of biological activity equal to 10 to the eighth power international units. | Hundred Million International Units | ||
10^8 IU/mL | C198385 | One Hundred Million International Units per Milliliter | A unit of measurement equal to 10 to the eight power of the number of international units of an entity per unit of volume equal to one milliliter. (NCI) | One Hundred Million International Units per Milliliter | ||
10^8 PFU | C67266 | Hundred Million PFU;Hundred Million Plaque Forming Units | A unit of measurement of plaque forming cells or microorganisms with numbers equal to 10 to the eighth power of plaque forming units. | Hundred Million Plaque Forming Units | ||
10^8 TCID 50/dose | C150417 | 10^8 50 Percent Tissue Culture Infective Dose per Dose | A potency unit equal to the potency at which one dose of preparation contains one million (10^8) 50 percent tissue culture infective doses. | Hundred Million Tissue Culture Infectious Dose 50% | ||
10^8/L | C105489 | 10^2/mm3;10^2/uL;10^5/mL | A unit of measurement equal to 10 to the eighth power of entities per unit of volume equal to one liter. | Hundred Million Per Liter | ||
10^9 CFU | C68897 | Billion CFU;Billion Colony Forming Units | A unit of measurement of colony forming cells or microorganisms equal to 10 to the ninth power colony forming units. | Billion Colony Forming Units | ||
10^9 CFU/g | C68901 | Billion CFU/g;Billion Colony Forming Units per Gram | A unit of measurement of colony forming cells or microorganisms in a unit mass of substance of interest defined as the number of 10 to the ninth power colony forming units in one gram of substance. | Billion Colony Forming Units per Gram | ||
10^9 CFU/mL | C68905 | Billion CFU/mL;Billion Colony Forming Units per Milliliter | A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of 10 to the ninth power colony forming units in one milliliter of substance. | Billion Colony Forming Units per Milliliter | ||
10^9 copies/mL | C198386 | Billion Copies per Milliliter | The unit of concentration expressed as the number of 10 to the ninth power copies in unit volume equal to one milliliter. (NCI) | Billion Copies per Milliliter | ||
10^9 IU/mL | C198387 | Billion International Units per Milliliter | A unit of measurement equal to 10 to the ninth power of the number of international units of an entity per unit of volume equal to one milliliter. (NCI) | Billion International Units per Milliliter | ||
10^9 organisms | C71189 | Billion Organisms | A unit of measure of quantity of organisms expressed in 10 to the ninth power of organisms. | Billion Organisms | ||
10^9 organisms/g | C71192 | Billion Organisms per Gram;Billion Organisms/g | A unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one gram. | Billion Organisms per Gram | ||
10^9 organisms/mg | C71194 | Billion Organisms per Milligram;Billion Organisms/mg | A unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one milligram. | Billion Organisms per Milligram | ||
10^9 organisms/mL | C71197 | Billion Organisms per Milliliter;Billion Organisms/mL | A unit of measure of organism concentration expressed in 10 to the ninth power of organisms per unit of volume equal to one milliliter. | Billion Organisms per Milliliter | ||
10^9 PFU | C67267 | Billion PFU;Billion Plaque Forming Units | A unit of measurement of infectious entities with numbers equal to 10 to the ninth power of plaque forming units. | Billion Plaque Forming Units | ||
10^9 Therapeutic Cells | C187998 | A dosing unit for the number of therapeutic cells administered, expressed as 10 to the ninth power. | Billion Therapeutic Cells Dosing Unit | |||
10^9/dose | C163561 | A dose calculation unit equal to 10 to the ninth power of the number of entities per single dose. | Billion per Dose | |||
10^9/g | C122200 | /ng;1/ng;10^12/kg;10^3/ug;10^6/mg | A unit of measurement equal to 10 to the ninth power of the number of entities per unit of mass equal to one gram. | Billion per Gram | ||
10^9/L | C67255 | /nL;1/nL;10^3/mm3;10^3/uL;10^6/mL;G/L;GI/L;Giga per Liter;K/cumm;Thou/mcL | A unit of measurement equal to 10 to the ninth power of the number of entities per unit of volume equal to one liter. | Billion per Liter | ||
10^9/uL | C198388 | 10^12/mL;10^15/L;10^3/pL;10^6/nL | A unit of measurement equal to 10 to the ninth power of entities per unit of volume equal to one microliter. | Billion per Microliter | ||
Absorbance U | C73686 | Absorbance Unit | A unit of optical density expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance. | Absorbance Unit | ||
Absorbance U/min | C73687 | Absorbance Unit per Minute | A unit of a speed of optical density change expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance per minute. (NCI) | Absorbance Unit per Minute | ||
Absorbance U/mL | C126078 | A unit of optical density expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance per unit of volume equal to one milliliter. | Absorbance Unit per Milliliter | |||
AFU | C77534 | Arbitrary Fluorescence Unit | Arbitrary unit(s) of fluorescent luminescence. (NCI) | Arbitrary Fluorescence Units | ||
ag | C64553 | Attogram | A unit of mass equal to one quintillionth of a gram (1E-18 gram). (NCI) | Attogram | ||
AgU/mL | C70500 | Antigen Unit per Milliliter | A measure of an antigen potency defined as a number of antigen units per one milliliter of product.(NCI) | Antigen Unit per Milliliter | ||
aMFI | C163562 | Arithmetic Mean Fluorescence Intensity Unit | A unit of measure for the arithmetic mean fluorescence intensity. | Arithmetic Mean Fluorescence Intensity Unit | ||
amol | C68855 | Attomole | A unit of amount of substance equal to one quintillionth of a mole (1E-18 mole). (NCI) | Attomole | ||
amp | C42536 | Ampere | A unit of electric current, named after the French physicist Andre Ampere. It is that constant current which, if maintained in two straight parallel conductors of infinite length and zero diameter separated by one meter in a vacuum, would produce between these conductors a force equal to 2(1E7) Newton per meter of length. This is dependent upon the definitions of the meter, kilogram, and second. One Ampere represents 6.24 x 1(E18) unit electric charge carriers, such as electrons, passing a specified fixed point in one second. (NCI) | Ampere | ||
AMPULE | C48473 | Ampule Dosing Unit | A dosing measurement based on the ampule unit.(NCI) | Ampule Dosing Unit | ||
amu | C64559 | Atomic Mass Unit | A small unit of mass used to express atomic and molecular masses. (NCI) | Atomic Mass Unit | ||
Anson U | C122201 | A unit of enzyme concentration which is defined as the amount of enzyme that can digest urea-denatured hemoglobin at the same initial rate as one milliequivalent of tyrosine at standard conditions. | Anson Unit | |||
anti-Xa IU | C70497 | Anti-Xa Activity International Unit | A unit of unfractionated or low molecular weight heparin anticoagulation potency determined as the amount that neutralizes one unit of coagulation factor Xa preparation defined as an international biological standard by WHO (World Health Organization) First International Low Molecular Weight Heparin Reference Standard.(NCI) | Anti-Xa Activity International Unit | ||
anti-Xa IU/mL | C70498 | Anti-Xa Activity International Unit per Milliliter | A specific anticoagulation activity of unfractionated or low molecular weight heparin on factor Xa, expressed as a number of international anti-Xa heparin units per one milliliter of plasma.(NCI) | Anti-Xa Activity International Unit per Milliliter | ||
Antibody Unit | C111129 | A unit of antibody concentration measured by comparison against a known concentration of antibodies in a standard reference specimen. | Antibody Unit | |||
APL U | C122202 | [APL'U];Immunoglobin A Phospholipid Units | A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard. | IgA Phospholipid Unit | ||
APL U/mL | C117965 | Immunoglobin A Phospholipid Units per Milliliter | A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter. | Immunoglobin A Phospholipid Unit per Milliliter | ||
APPLICATION | C25397 | Application Dosing Unit | A dosing measurement based on the amount of substance applied. | Application Unit | ||
APS U | C161498 | Immunoglobin A Phosphatidylserine Units;Phosphatidylserine IgA Antibody Unit | A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard. (NCI) | Phosphatidylserine IgA Antibody Unit | ||
APS U/mL | C186219 | Immunoglobin A Phosphatidylserine Units/mL;Phosphatidylserine IgA Antibody Unit/mL | Unit of measure of potency of allergenic product expressed as a number of immunoglobin A phosphatidylserine units per one milliliter of formulation. | Phosphatidylserine IgA Antibody Unit per Milliliter | ||
Arbitrary U | C75765 | A unit based on or subject to individual judgment, preference, or predetermined reference. (NCI) | Arbitrary Unit | |||
Arbitrary U/mL | C191361 | A unit based on or subject to individual judgment, preference, or predetermined reference per unit of volume equal to one milliliter. | Arbitrary Unit per Milliliter | |||
ARMOUR UNIT | C189642 | AU | A unit of proteolytic activity for trypsin and/or chymotrypsin that, upon incubation with the hemoglobin substrate, will release a quantity of phenolic substances that react with Folin-Ciocalteu phenol reagent to produce a colorimetric change of equal intensity to that produced from the reaction of one microgram of tyrosine with Folin-Ciocalteu phenol reagent. | Armour Unit | ||
atm | C54711 | Atmosphere | A unit of pressure, equal to a barometer reading of 760 mm Hg. 1 atmosphere is 101325 Pascals and 1.01325 bar. This unit of pressure is roughly equal to the average atmospheric pressure at sea level on the earth.(NCI) | Atmosphere | ||
AU/mL | C70504 | Allergy Unit per Milliliter | Unit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.(NCI) | Allergy Unit per Milliliter | ||
BAG | C48474 | Bag Dosing Unit | A dosing measurement based on the bag unit.(NCI) | Bag Dosing Unit | ||
BAR | C48475 | Bar Dosing Unit | A dosing measurement based on the bar unit.(NCI) | Bar Dosing Unit | ||
BAU | C70505 | BAU;Bioequivalent Allergy Unit | A unit used for standardization of an allergenic product based on evaluation of product potency against reference standard in combined in vivo (skin test) and in vitro (IgE-based ELISA) testing.(NCI) | Bioequivalent Allergy Unit | ||
BAU/mL | C116235 | BAU/mL;Bioequivalent Allergy Unit per Milliliter | Unit of measure of potency of allergenic product expressed as a number of bioequivalent allergy units per one milliliter of formulation. | Bioequivalent Allergy Unit per Milliliter | ||
BE/mL | C116231 | Biological Unit per Milliliter | Unit of measure of potency of allergenic product expressed as a number of biological units per one milliliter of formulation. | Biological Allergy Unit per Milliliter | ||
BEAM BREAKS | C129002 | The unit of measure for the number of times in which light paths are interrupted by movement. | Beam Break Unit | |||
beats/min | C49673 | Beats per Minute;BPM;bpm | The number of heartbeats measured per minute time. (NCI) | Beats per Minute | ||
bel | C71200 | Bel | A logarithmic ratio unit (base-10 logarithms) used to express relative magnitude of a physical quantity (usually power or intensity) in comparison with a specified or implied reference level. Particularly, Bel is used as a unit of relative sound intensity. In the latter context it is equal to ten decibels or to approximately 1.151293 nepers.(NCI) | Bel | ||
Binding Ab Unit | C189120 | BAU;Binding Antibody Unit | A unit of measure defined by WHO used for the comparison of antibody binding assays that detect the same class of immunoglobulins with the same specificity. | Binding Antibody Unit | ||
Binding Ab Unit/mL | C189647 | BAU/mL;Binding Antibody Unit per Milliliter | A unit of concentration expressed as the number of binding antibody units per one milliliter. | Binding Antibody Unit per Milliliter | ||
BISCUIT | C111139 | Biscuit Dosing Unit | A measurement based on the biscuit unit. | Biscuit Dosing Unit | ||
BLOCKS | C111140 | A unit of measure to quantify the number of rectangular areas in a city surrounded by streets. | Block Unit of Distance | |||
BOLUS | C48476 | Bolus Dosing Unit | A dosing measurement based on the bolus unit.(NCI) | Bolus Dosing Unit | ||
BOTTLE | C48477 | Bottle Dosing Unit | A dosing measurement based on the bottle unit.(NCI) | Bottle Dosing Unit | ||
BOWL | C151970 | Bowl Dosing Unit | A dosing measurement based on the bowl unit. | Bowl Dosing Unit | ||
BOX | C48478 | Box Dosing Unit | A dosing measurement based on the box unit.(NCI) | Box Dosing Unit | ||
BP | C132477 | BASE PAIRS | A number representing the paired nucleotides in a DNA or RNA sequence. | Base Pair Unit | ||
Bq | C42562 | Becquerel | A unit of activity of a radionuclide, equal to one nuclear disintegration or other nuclear transition from a particular energy state occurring in an amount of a radionuclide during one second-long time interval.(NCI) | Becquerel | ||
Bq/g | C70522 | Becquerel per Gram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one gram.(NCI) | Becquerel per Gram | ||
Bq/kg | C70521 | Becquerel per Kilogram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one kilogram.(NCI) | Becquerel per Kilogram | ||
Bq/L | C71165 | Becquerel per Liter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one liter.(NCI) | Becquerel per Liter | ||
Bq/mg | C70524 | Becquerel per Milligram;kBq/g;Kilobecquerel per Gram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one milligram.(NCI) | Becquerel per Milligram | ||
Bq/mL | C71167 | Becquerel per Milliliter;kBq/L;Kilobecquerel per Liter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one milliliter or one kilobecquerel per liter.(NCI) | Becquerel per Milliliter | ||
Bq/ug | C70523 | Becquerel per Microgram;Bq/mcg;Bq/ug;kBq/mg;Kilobecquerel per Milligram;MBq/g;Megabecquerel per Gram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one microgram, or equal to activity of one kilobecquerel of the sample with total mass of one milligram. | Becquerel per Microgram | ||
Bq/uL | C71166 | Becquerel per Microliter;kBq/mL;Kilobecquerel per Milliliter;MBq/L;Megabecquerel per Liter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one millionth of a liter.(NCI) | Becquerel per Microliter | ||
breaths/30 s | C176382 | Breaths per 30 Seconds;breaths/30s | The number of breaths (inhalation and exhalation) taken within a period of time equal to thirty seconds. | Breaths per Thirty Seconds | ||
breaths/min | C49674 | Breaths per Minute | The number of breaths (inhalation and exhalation) taken per minute time. (NCI) | Breaths per Minute | ||
BU | C117966 | Bethesda Unit | A unit of measurement for blood coagulation inhibitor activity, expressed in the amount of an inhibitor neutralizing 50% of a coagulant during the incubation period. | Bethesda Unit | ||
BU/mL | C117967 | Bethesda Unit per Milliliter | A unit of measurement for blood coagulation inhibitor activity, expressed as a Bethesda Unit per unit of volume equal to one milliliter. (NCI) | Bethesda Unit per Milliliter | ||
C | C42559 | Degree Celsius | A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI) | Degree Celsius | ||
CAE Unit | C67270 | Complement Activity Enzyme Unit | A unit of measurement for enzymatic activity of plasma and membrane-bound proteins that comprise a complement system and their split products. | Complement Activity Enzyme Unit | ||
cal | C67193 | Calorie | A measurement of nutritional energy. The quantity of thermal energy required to raise one gram of water one degree Centigrade under standard conditions. 1 calorie equals 4.186 joules. (NCI) | calorie | ||
CAN | C48479 | Can Dosing Unit | A dosing measurement based on the can unit.(NCI) | Can Dosing Unit | ||
CAPFUL | C102405 | Capful Dosing Unit | A unit of measure equal to the amount that the cap on the bottle can contain. | Capful Dosing Unit | ||
CAPLET | C64696 | Caplet Dosing Unit | A dosing measurement based on the caplet unit. | Caplet Dosing Unit | ||
CAPSULE | C48480 | cap;Capsule Dosing Unit | A dosing measurement based on the capsule unit.(NCI) | Capsule Dosing Unit | ||
CARTRIDGE | C48481 | Cartridge Dosing Unit | A dosing measurement based on the cartridge unit.(NCI) | Cartridge Dosing Unit | ||
CCID 50/dose | C70535 | 50 Percent Cell Culture Infective Dose per Dose | A potency unit equal to the potency at which one dose of preparation contains one 50 percent cell culture infective dose.(NCI) | 50 Percent Cell Culture Infective Dose per Dose | ||
CCID 50/mL | C120845 | 50 Percent Cell Culture Infective Dose per Milliliter | A potency unit equal to the potency at which one milliliter of preparation contains one 50 percent cell culture infective dose. (NCI) | 50 Percent Cell Culture Infective Dose per Milliliter | ||
cd | C42538 | Candela | The candela is the basic unit of luminous intensity. It is the luminous intensity in a given direction of a small monochromatic light source at 540 terahertz emitting 1/683 watt per steradian in that direction. This is dependent upon the definitions of the meter, kilogram, and second.(NCI) | Candela | ||
cd*s/m2 | C122203 | A unit of luminous intensity expressed as one candela in one second of light emittance per square meter of area. | Candela Second per Square Meter | |||
cd/m2 | C122204 | A unit of luminous intensity expressed as one candela per square meter of area. | Candela per Square Meter | |||
CFU/g | C68898 | Colony Forming Unit per Gram | A unit of measurement of colony forming cells or microorganisms in a unit mass of substance of interest defined as the number of colony forming units in one gram of substance. | Colony Forming Unit per Gram | ||
CFU/mL | C68902 | Colony Forming Unit per Milliliter | A unit of measurement of colony forming cells or microorganisms in a unit volume of substance of interest defined as the number of colony forming units in one milliliter of substance. | Colony Forming Unit per Milliliter | ||
cg | C64554 | Centigram | A unit of mass equal to one hundredth of a gram.(NCI) | Centigram | ||
CGE | C128269 | Cobalt Gray Equivalent | A unit of relative biological effectiveness of protons equivalent to cobalt-60 gamma rays. | Cobalt Gray Equivalent | ||
cGy | C64693 | Centigray | The metric unit of absorbed radiation dose equal to the absorption of one hundredth of joule of radiation energy per kilogram of matter. | Centigray | ||
Ci | C48466 | Curie | A unit of radioactivity defined as 3.7 E10 atomic disintegrations or other nuclear transformations per second. One Curie is equal to 37 gigabecquerels.(NCI) | Curie | ||
Ci/g | C70528 | Curie per Gram;mCi/mg;Microcurie per Microgram;Millicurie per Milligram;uCi/ug | A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one gram.(NCI) | Curie per Gram | ||
Ci/kg | C70529 | Curie per Kilogram;mCi/g;Microcurie per Milligram;Millicurie per Gram;uCi/mg | A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one kilogram.(NCI) | Curie per Kilogram | ||
Ci/L | C71170 | Curie per Liter;Microcurie per Microliter;uCi/uL | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one liter.(NCI) | Curie per Liter | ||
Ci/mg | C70531 | Curie per Milligram;mCi/ug;Millicurie per Microgram | A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one milligram.(NCI) | Curie per Milligram | ||
Ci/mL | C71172 | Curie per Milliliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one milliliter.(NCI) | Curie per Milliliter | ||
Ci/ug | C70530 | Ci/mcg;Curie per Microgram | A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one microgram.(NCI) | Curie per Microgram | ||
Ci/uL | C71171 | Ci/mcL;Curie per Microliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one millionth of a liter.(NCI) | Curie per Microliter | ||
CIGAR | C116244 | Cigar Dosing Unit | A dosing measurement based on the cigar unit. | Cigar Dosing Unit | ||
CIGARETTE | C116245 | Cigarette Dosing Unit | A dosing measurement based on the cigarette unit. | Cigarette Dosing Unit | ||
cL | C69087 | Centiliter | The unit of volume equal to one hundredth of a liter or 10 milliliters or 10 cubic centimeters or 0.6102 cubic inch. | Centiliter | ||
cm H2O | C91060 | A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation. | Centimeters of Water | |||
cm | C49668 | Centimeter | A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch. | Centimeter | ||
cm/min | C105481 | Centimeters per Minute | A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one minute. (NCI) | Centimeter Per Minute | ||
cm/s | C102406 | cm/sec | A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one second. (NCI) | Centimeter per Second | ||
cm2 | C48460 | Square Centimeter | A unit of area measurement equal to a square measuring one centimeter on each side. One square centimeter is equal to 1E-4 square meter. (NCI) | Square Centimeter | ||
cmH2O*s/mL | C135518 | A unit of pressure defined as centimeters of water times seconds per unit of volume equal to one milliliter. | Centimeter of Water Times Second per Milliliter | |||
cmH2O*s2/mL | C135519 | A unit of pressure defined as centimeters of water times seconds squared per unit of volume equal to one milliliter. | Centimeter of Water Times Second Squared per Milliliter | |||
cmH2O/mL | C135520 | A unit of pressure defined as centimeters of water per unit of volume equal to one milliliter. | Centimeter of Water per Milliliter | |||
cmHg | C147129 | Centimeter of Mercury | A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one centimeter rise of mercury in a barometer at the Earth's surface. | Centimeters of Mercury | ||
cmol | C68687 | Centimole | A unit of amount of substance equal to one hundredth of a mole (1E-2 mole). (NCI) | Centimole | ||
cmol/L | C68886 | Millimoles per Deciliter;mmol/dL | A unit of concentration (molarity unit) equal to one centimole of solute in one liter of solution. (NCI) | Centimole per Liter | ||
COAT | C48483 | Coat Dosing Unit | A dosing measurement based on the coat unit.(NCI) | Coat Dosing Unit | ||
CONTAINER | C48484 | Container Dosing Unit | A dosing measurement based on the container unit.(NCI) | Container Dosing Unit | ||
copies/cell | C198389 | A unit of concentration expressed as a number of copies per cell. (NCI) | Copies per Cell | |||
copies/mL | C100900 | A unit of concentration expressed as a number of copies per unit volume equal to one milliliter. | Copies per Milliliter | |||
copies/ug | C126079 | A unit of concentration expressed as a number of copies per unit volume equal to one microgram. | Copies per Microgram | |||
copies/uL | C116237 | A unit of concentration expressed as a number of copies per unit volume equal to one microliter. | Copies per Microliter | |||
Coulomb | C42550 | Coulomb | A unit of quantity of electricity, equal to the quantity of charge transferred in one second across a conductor in which there is a constant current of one Ampere.(NCI) | Coulomb | ||
cP | C69092 | Centipoise | A unit of dynamic viscosity equal to one hundredth of a poise. | Centipoise | ||
cpm | C73688 | Counts per Minute | A unit of frequency expressed as the detection rate of ionization events per minute. | Count per Minute | ||
cs | C105482 | 10^-2 sec;Centisecond;csec | A unit of time equal to one hundredth of a second (1E-2 seconds). (NCI) | Centisecond | ||
cup eq | C172604 | Cup Equivalent;cup-eq | A unit of relative amount of a substance equal to one cup. | Cup Equivalent | ||
CUP | C54703 | Cup Dosing Unit | A dosing measurement based on the cup unit.(NCI) | Cup Dosing Unit | ||
cy/cm | C114242 | cpcm;Grating Cycles per Centimeter | A unit of measure for the number of repeating vertical or horizontal bars per unit of length equal to one centimeter on a visual acuity testing card. | Grating Cycles per Centimeter | ||
cycle/min | C71176 | Cycle per Minute | A unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one minute.(NCI) | Cycle per Minute | ||
CYLINDER | C48489 | Cylinder Dosing Unit | A dosing measurement based on the cylinder unit.(NCI) | Cylinder Dosing Unit | ||
DAgU | C70501 | D Antigen Unit | A unit of potency of poliovirus vaccine used for poliomyelitis prevention. The unit is poliovirus type-specific.(NCI) | D Antigen Unit | ||
DAgU/mL | C70502 | D Antigen Unit per Milliliter | A unit of potency of poliovirus vaccine expressed as a number of D antigen units per one milliliter of vaccine formulation.(NCI) | D Antigen Unit per Milliliter | ||
damol/L | C105483 | Decamole per Liter;mol/dL;Moles per Deciliter | A unit of concentration (molarity unit) equal to one decamole of solute in one liter of solution. (NCI) | Decamole Per Liter | ||
daPa | C191360 | Decapascal | A SI derived unit of pressure equivalent to ten pascals. | Decapascal | ||
day*ng/mL/(mg/kg) | C198211 | Days times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Day Times Nanogram Per Milliliter Per Milligram Per Kilogram | |||
DAYS | C25301 | A unit of measurement of time equal to 24 hours. | Day | |||
days/month | C170634 | A unit of measurement equal to the number of days within a period of time equal to one month. | Days Per Month | |||
days/wk | C170633 | days/week | A unit of measurement equal to the number of days within a period of time equal to one week. | Days Per Week | ||
dB | C102407 | Decibel | A unit of measure representing the intensity of an electrical signal or sound which is equal to ten times the logarithm of the ratio of two signals. | Decibel | ||
DDU | C161494 | A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of D-dimers contained within that sample. (NCI) | D-Dimer Unit | |||
deg | C68667 | Degree Unit of Plane Angle;Degrees | A unit of plane angle measurement equal to the length of the arc cut out by the angle, divided by the circumference of the circle, and multiplied by 360. The symbol for degrees is a small superscript circle. One radian is about 57 degrees and one degree is pi/180 radians.(NCI) | Degree Unit of Plane Angle | ||
deg/mm | C161488 | A unit of rotation expressed as the number of degrees per unit of length equal to one millimeter. | Degree Per Millimeter | |||
deg/s | C166097 | A unit of angular velocity defined as the number of degrees per unit of time equal to one second. | Degrees Per Second | |||
deg2 | C166098 | sq. deg. | A unit of solid angle equal to approximately 3.0462x10^-4 steradians. | Degrees Squared | ||
DIOPTER | C100899 | Diopter | A unit of measurement of the optical power of a curved mirror or lens represented by the inverse of the focal length in meters. | Diopter | ||
DIP | C82483 | Dip Dosing Unit;Snuff Dosing Unit | A dosing measurement based on the dip unit. | Dip Dosing Unit | ||
DISK | C48490 | Disk Dosing Unit | A dosing measurement based on the disk unit.(NCI) | Disk Dosing Unit | ||
dL | C64697 | Deciliter | The unit of volume equal to one tenth of a liter. Accepted for use with the SI. (NCI) | Deciliter | ||
dmol | C68685 | Decimole | A unit of amount of substance equal to one tenth of a mole (1E-1 mole). (NCI) | Decimole | ||
DNA copies/mL | C98719 | DNA Copies per Milliliter | The unit of concentration of deoxyribonucleic acid (DNA) copies expressed as a number of copies in unit volume equal to one milliliter. | DNA Copies per Milliliter | ||
DNA copies/ug | C170632 | A unit of measurement equal to the number of deoxyribonucleic acid (DNA) copies per unit of mass equal to one microgram. | DNA Copies Per Microgram | |||
DPM | C73710 | Disintegrations per Minute | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds. (NCI) | Disintegration per Minute | ||
dpm/0.5 mL | C120846 | Disintegrations per Minute per 0.5 Milliliter | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to a half milliliter. | Disintegrations per Minute per 0.5 Milliliter | ||
dpm/100 mg | C117968 | Disintegrations per Minute per 100 milligrams;dpm/cg | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one hundred milligrams. | Disintegration per Minute per 100 milligrams | ||
dpm/g | C187969 | Disintegrations per Minute per Gram | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one gram. | Disintegration per Minute per Gram | ||
dpm/mg | C117969 | Disintegrations per Minute per Milligram | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one milligram. | Disintegration per Minute per Milligram | ||
dpm/mL | C117970 | Disintegrations per Minute per Milliliter | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to one milliliter. | Disintegration per Minute per Milliliter | ||
dram | C64564 | Dram | A unit of mass equal to 1/16 Avoirdupois ounce or 1/256 Avoirdupois pound. One dram equals approximately 1.7718451953125 grams.(NCI) | Dram Mass Unit | ||
DRINK | C161487 | Drink Dosing Unit | A dosing measurement based on the drink unit. | Drink Dosing Unit | ||
DROP | C69441 | Drip | A unit of measure of volume defined as the amount of liquid dispensed as one drop from a dropper dispenser. The volume of a drop depends on the physical properties of the liquid dispensed, the dispenser device, and the technique used to produce the drop. (NCI) | Drop | ||
DRUM | C48492 | Drum Dosing Unit | A dosing measurement based on the drum unit.(NCI) | Drum Dosing Unit | ||
dyn | C70470 | Dyne | A unit of force defined as the force that accelerates a mass of one gram at the rate of one centimeter per second squared. One dyne is equal to 1E-5 Newton and 2.248E-6 pounds of force. (NCI) | Dyne | ||
ECL unit | C161491 | Electrochemiluminescence Unit | A unit for measuring concentration or/and reactivity of a test substance as defined in the literature reference standard for the particular quantitative electrochemiluminescent method. (NCI) | Electrochemiluminescence Unit | ||
EIA unit | C122205 | EIA value;Enzyme Immunoassay Unit | A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme immunoassay method. | Enzyme Immunoassay Unit | ||
EID 50/dose | C70533 | 50 Percent Embryo Infective Dose per Dose | A potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI) | 50 Percent Embryo Infective Dose per Dose | ||
EID 50/mL | C120847 | 50 Percent Embryo Infective Dose per Milliliter | A potency unit equal to the potency at which one milliliter of preparation contains one 50 percent embryo infective dose. | 50 Percent Embryo Infective Dose per Milliliter | ||
Ejaculate U | C130046 | A unit of volume equal to the amount of seminal fluid produced by a single ejaculation event. | Ejaculate Unit | |||
ELISA unit | C68875 | Enzyme-Linked Immunosorbent Assay Unit | A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme-linked immunosorbent assay method. The enzyme-linked immunosorbent assay unit is used to express potency of immunologically active substances and products, e.g. vaccines.(NCI) | Enzyme-Linked Immunosorbent Assay Unit | ||
ELISA unit/dose | C68876 | Enzyme-Linked Immunosorbent Assay Unit per Dose | A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.(NCI) | Enzyme-Linked Immunosorbent Assay Unit per Dose | ||
ELISA unit/mL | C68877 | Enzyme-Linked Immunosorbent Assay Unit per Milliliter | A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per unit volume equal to one milliliter.(NCI) | Enzyme-Linked Immunosorbent Assay Unit per Milliliter | ||
ENVELOPE | C186220 | Envelope Dosing Unit | A dosing measurement based on the envelope unit. | Envelope Dosing Unit | ||
Enzyme U | C64778 | Enzyme Unit | A unit of catalytic activity measurement defined as the quantity of a particular enzyme that catalyzes the transformation of one micromole of the substrate per minute under standard conditions for specified assay system. | Enzyme Unit | ||
Enzyme U/g Hb | C154856 | Enzyme Unit per Gram of Hemoglobin | A unit of concentration (biologic activity) equal to one enzyme unit of substance per gram of hemoglobin. | Enzyme Unit per Gram Hemoglobin | ||
Enzyme U/L | C147130 | Enzyme Unit/L | Unit of catalytic activity concentration defined as activity equal to one enzyme unit per one liter of system volume. | Enzyme Unit per Liter | ||
Enzyme U/m2 | C156467 | A unit of concentration (catalytic activity) equal to one enzyme unit of substance per one square meter of surface area. | Enzyme Unit per Meter Squared | |||
EP U | C176384 | European Pharmacopoeia Unit | An arbitrary unit established by the European Pharmacopoeia. | European Pharmacopoeia Unit | ||
eq | C67273 | Equivalent Weight | A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.(NCI) | Equivalent Weight | ||
EU | C96599 | Ehrlich Units;EU/dL | A unit of measure equal to one milligram of urobilinogen per deciliter. | Ehrlich Unit | ||
EVENTS | C150901 | A unit of measurement for the number of specified occurrences. | Event Unit | |||
F | C44277 | Degree Fahrenheit | The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI) | Degree Fahrenheit | ||
Farad | C42552 | Farad | A unit of capacitance equal to the capacitance of a capacitor having an equal and opposite charge of one coulomb on each plate and a potential difference of one volt between the plates.(NCI) | Farad | ||
FEU | C96649 | Fibrinogen Equivalent Units | A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of fibrinogen contained within that sample. | Fibrinogen Equivalent Unit | ||
FFU | C75303 | Focus-forming Units | A unit of measurement of the number of visible clusters of transformed or infected cells. | Focus Forming Unit | ||
FFU/mL | C189650 | Focus Forming Units/mL | A unit of measure expressed in focus forming unit(s) per milliliter of dosing volume. | Focus Forming Unit per Milliliter | ||
fg | C64552 | Femtogram | A unit of mass equal to one quadrillionth of a gram (1E-15 gram). (NCI) | Femtogram | ||
FINGERTIP UNIT | C71321 | Fingertip Dosing Unit | An arbitrary dosing unit used predominantly for semisolid topical formulations such as cream, ointment, paste, etc. One fingertip unit is the amount of a product that is squeezed out from a standard tube with 5-millimeter diameter nozzle along an adult's fingertip. A fingertip length is defined from the tip of the index finger to the first finger crease. A fingertip dosing unit varies with age and size of the body. The average fingertip unit is equal to approximately 0.5 gram for an adult male and 0.4 gram for an adult female.(NCI) | Fingertip Dosing Unit | ||
FIU | C163045 | Fluorescence Intensity Unit;MFI | A unit of measure for the fluorescence intensity when the mathematic calculation is unspecified or unknown. | Fluorescence Intensity Unit | ||
fL | C64780 | Cubic Micrometer;Cubic Micron;Femtoliter;um3 | The unit of volume equal 1E-15 liter. | Femtoliter | ||
fmol | C68854 | Femtomole | A unit of amount of substance equal to one quadrillionth of a mole (1E-15 mole). (NCI) | Femtomole | ||
fmol/g | C73711 | Femtomole per Gram | A molality unit that describes the amount of substance, expressed in femtomole(s) per gram. (NCI) | Femtomole per Gram | ||
fmol/L | C68887 | Femtomole per Liter | A unit of concentration (molarity unit) equal to one quadrillionth of a mole (1E-15 mole) of solute in one liter of solution. (NCI) | Femtomole per Liter | ||
fmol/L/s | C122206 | Femtomoles per Liter per Second;fmol/L/sec | A concentration unit equal to one femtomole of solute in one liter of solution per unit of time equal to one second. (NCI) | Femtomole per Liter per Second | ||
foz_br | C48577 | Fluid Ounce Imperial | A traditional unit of liquid volume equal in the British Imperial system to 1/20 pint, or 1.733871 cubic inches or 28.413063 milliliters. | Fluid Ounce British | ||
foz_us | C48494 | Fluid Ounce US | A traditional unit of liquid volume equal in the US customary system to 1/16 pint, or 1.804687 cubic inches or 29.573531 milliliters. | Fluid Ounce US | ||
fraction of 1 | C105484 | Proportion of 1 | A unit for expressing a percentage as a decimal whereby the total value is measured as a fraction of the numeric 1. | Fraction of 1 | ||
Frames/s | C106524 | F/s;FPS;Frames per Second;Frames/sec | A unit of measure equal to the number of visual frames per unit of time equal to one second. (NCI) | Frames Per Second | ||
ft | C71253 | Foot | A unit of length defined by the U.S. National Bureau of Standards as 30.48 centimeters. It is equal to 0.3048 meter, 12 inches, or to approximately 0.999998 survey foot.(NCI) | International Foot | ||
ft2 | C48461 | Square Foot | A unit of area equal to 144 square inches, 929.0304 square centimeters, or 9.290304E-2 square meters.(NCI) | Square Foot | ||
ft3 | C68859 | Standard Cubic Foot | A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic foot at 60 degrees Fahrenheit and pressure of one atmosphere.(NCI) | Standard Cubic Foot | ||
g | C48155 | Gram | A unit of mass equal to one thousandth (1E-3) of a kilogram, the kilogram being the base unit of mass in the International System of Units (SI). | Gram | ||
g/animal | C73713 | Gram per Animal | A unit of measure expressed in gram(s) per animal. | Gram per Animal | ||
g/animal/day | C73714 | Gram per Animal per Day | A unit of measure expressed in gram(s) per animal per period of time equal to twenty-four hours. | Gram per Animal per Day | ||
g/animal/wk | C73715 | Gram per Animal per Week | A unit of measure expressed in gram(s) per animal per period of time equal to seven days. | Gram per Animal per Week | ||
g/cage | C73716 | Gram per Cage | A unit of measure expressed in gram(s) per cage. | Gram per Cage | ||
g/cage/day | C73717 | Gram per Cage per Day | A unit of measure expressed in gram(s) per cage per period of time equal to twenty-four hours. | Gram per Cage per Day | ||
g/cage/wk | C73718 | Gram per Cage per Week | A unit of measure expressed in gram(s) per cage per period of time equal to seven days. | Gram per Cage per Week | ||
g/cm2 | C71201 | Gram per Square Centimeter | A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit.(NCI) | Gram per Square Centimeter | ||
g/day | C67372 | g/24h | A unit of mass flow rate equal to one gram per day. | Gram per 24 Hours | ||
g/dL | C64783 | g%;Gram per Deciliter | A unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.(NCI) | Gram per Deciliter | ||
g/g | C70453 | kg/kg;mcg/mcg;mg/mg;ug/ug | A unit of a mass fraction expressed as a number of grams of substance per gram of mixture. | Gram per Gram | ||
g/g/day | C73720 | Gram per Gram per Day | A unit of measure expressed in gram(s) per gram per period of time equal to twenty-four hours. | Gram per Gram per Day | ||
g/kg | C69104 | Gram per Kilogram;mg/g;Microgram per Milligram;Milligram per Gram;ug/mg | Grams (weight), divided by kilograms (weight) or micrograms (weight) per milligrams (weight). | Gram per Kilogram | ||
g/kg/day | C66975 | Gram per Kilogram per Day;mg/g/day;Milligram per Gram per Day | A dose administration rate unit equal to the rate at which one gram of a product per kilogram of body mass is delivered or administered over the period of one day. (NCI) | Gram per Kilogram per Day | ||
g/L | C42576 | g/L;Gram per Liter;kg/m3;Kilogram per Cubic Meter;mg/mL;Microgram per Microliter;Milligram per Milliliter;ug/uL | A unit of concentration or mass density equal to one milligram of substance per milliliter of solution or one gram of substance per liter of solution. | Kilogram per Cubic Meter | ||
g/m2 | C67282 | Gram per Square Meter | A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square meter. It is equal to approximately 0.029 4935 ounce per square yard. Also used as a dose calculation unit.(NCI) | Gram per Square Meter | ||
g/m2*h | C187982 | g/h*m2 | A unit of measurement expressed as grams per square meter times a unit of time equal to one hour. | Gram per Hour times Square Meter | ||
g/m2/day | C73722 | Gram per Square Meter per Day | A dose calculation unit expressed in gram(s) per square meter per period of time equal to twenty-four hours. | Gram per Square Meter per Day | ||
g/mol | C73721 | mg/mmol | A unit of mass commonly used to express the molar mass of a substance in gram(s) per mole. (NCI) | Gram per Mole | ||
g/ston_av | C198390 | g/2000lb;g/Short ton;g/US ton | A unit of measure expressed in gram(s) per short ton (US). | Gram per Short Ton | ||
g/U | C166099 | A unit of concentration or mass density equal to one gram of substance per unit(s) of substance. | Gram Per Unit | |||
g/wk | C89829 | Gram per Week | A unit of mass flow rate equal to one gram per week or a dose administration rate unit equal to the rate at which a gram of a product is delivered or administered over the time period of one week. | Gram per Week | ||
Gauss | C68915 | Gauss | The unit of magnetic flux density. A field of one Gauss exerts a force on a conductor, placed in the field of 0.1 dyne per Ampere of current per centimeter of conductor. One Gauss represents a magnetic flux of one Maxwell per square centimeter of cross-section perpendicular to the field. One Gauss equals 10-4 Tesla.(NCI) | Gauss | ||
GBq | C70513 | Gigabecquerel | A unit of radioactivity equal to one billion nuclear disintegrations or other nuclear transformations per second, or to 1E9 Becquerels. (NCI) | Gigabecquerel | ||
GBq/g | C70525 | GBq/g;Gigabecquerel per Gram;kBq/ug;Kilobecquerel per Microgram;MBq/mg;Megabecquerel per Milligram | A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one gram, or equal to activity of one megabecquerel of the sample with total mass of one milligram. | Gigabecquerel per Gram | ||
GBq/mg | C70527 | Gigabecquerel per Milligram;MBq/mcg;MBq/ug;Megabecquerel per Microgram | A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one milligram.(NCI) | Gigabecquerel per Milligram | ||
GBq/ug | C70526 | GBq/mcg;Gigabecquerel per Microgram;MBq/ng;Megabecquerel per nanogram | A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one microgram.(NCI) | Gigabecquerel per Microgram | ||
genEq | C161493 | GE;Genomic Equivalents | A unit defined as the number of whole organism genomes in a sample. (NCI) | Genomic Equivalents | ||
genEq/mL | C161492 | GE/mL;Genomic Equivalents per Milliliter | A unit of concentration defined as the number of genomic equivalents per milliliter. (NCI) | Genomic Equivalents per Milliliter | ||
GLASS | C198391 | Glass Dosing Unit | A dosing measurement based on the glass unit. (NCI) | Glass Dosing Unit | ||
GLOBULE | C91803 | A dosing measurement based on the globule unit. | Globule Unit | |||
gMFI | C163563 | Geometric Mean Fluorescence Intensity Unit | A unit of measure for the geometric mean fluorescence intensity. | Geometric Mean Fluorescence Intensity Unit | ||
gpELISA unit/mL | C130190 | A unit for measuring potency of immunologically active substance in a product determined as reactivity in a glycoprotein enzyme-linked immunosorbent assay for particular antigen or antibody and expressed per unit volume equal to one milliliter. | Glycoprotein-ELISA Unit Per Milliliter | |||
GPL U | C67347 | [GPL'U];Immunoglobin G Phospholipid Units | A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard. (NCI) | IgG Phospholipid Unit | ||
GPL U/mL | C117971 | Immunoglobin G Phospholipid Units per Milliliter | A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter. | Immunoglobin G Phospholipid Unit per Milliliter | ||
GPS U | C161497 | Immunoglobin G Phosphatidylserine Units;Phosphatidylserine IgG Antibody Unit | A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard. (NCI) | Phosphatidylserine IgG Antibody Unit | ||
GPS U/mL | C186221 | Immunoglobin G Phosphatidylserine Units/mL;Phosphatidylserine IgG Antibody Unit/mL | Unit of measure of potency of allergenic product expressed as a number of immunoglobin G phosphatidylserine units per one milliliter of formulation. | Phosphatidylserine IgG Antibody Unit per Milliliter | ||
grain | C48497 | Grain | A unit of mass derived from the weight of a grain and equal to one seven-thousandth of a pound, or 1/480 troy ounce, or 64.79891 milligrams. The original English grain unit based on the mass of a ripe grain barleycorn was larger the corresponding grain units of France and other European nations which were based on the weight of the smaller wheat grain.(NCI) | Grain | ||
Gravitational Unit | C73772 | A unit of acceleration expressed as a multiple of the force of gravity on earth (1 gravitational unit = 9.81m/s2). | Unit of Gravity | |||
gtt | C48491 | Metric Drop | A unit of volume equal to 0.05 milliliter (20 drops/ml).(NCI) | Metric Drop | ||
GUMMY | C186222 | Gummy Dosing Unit | A dosing measurement based on the gummy unit. | Chewable Gel Dosing Unit | ||
Gy | C18063 | Gray | A unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.(NCI) | Gray | ||
Gy/h | C158295 | Gray/Hour | A unit of absorbed radiation dose rate defined as the number of Grays per hour. | Gray per Hour | ||
Gy/min | C158296 | Gray/Minute | A unit of absorbed radiation dose rate defined as the number of Grays per minute. | Gray per Minute | ||
h*% | C139131 | A unit of measure for the area under an effect curve (AUEC) defined as hours times percent. | Hour Times Percent | |||
h/wk | C170635 | hours/week | A unit of measurement equal to the number of hours within a period of time equal to one week. | Hours Per Week | ||
Henry | C42558 | Henry | A unit of electric inductance. A coil with an inductance of one Henry requires a flux of one Weber for each Ampere of induced current. If it is the current which changes, then the induced field will generate a potential difference within the coil: if the inductance is one Henry a current change of one Ampere per second generates a potential difference of one volt. The Henry is a large unit; inductances in practical circuits are measured in millihenrys or microhenrys.(NCI) | Henry | ||
HEP | C116232 | Histamine Equivalent Prick Unit | Unit of measure of potency of allergenic product expressed as a number of histamine equivalent prick units. | Histamine Equivalent Prick Unit | ||
HOMEOPATHIC DILUTION | C48498 | Homeopathic Dilution Unit | A dosing measurement based on the homeopathic dilution unit.(NCI) | Homeopathic Dilution Unit | ||
Hounsfield Unit | C94908 | HU | The unit of measure for the radiodensity of a substance. The radiodensity of distilled water at standard temperature and pressure is zero on the Hounsfield scale. | Hounsfield Unit | ||
HOURS | C25529 | h;Hours;hr | A unit of measurement of time equal to 60 minutes. | Hour | ||
hPa | C105487 | Hectopascal | A SI derived unit of pressure equivalent to one hundred pascals, 1 millibar or 0.0145 pounds per square inch. | Hectopascal | ||
hr/day | C176380 | Hours per Day | A unit of measurement equal to the number of hours within a period of time equal to one day. | Hour per Day | ||
Hz | C42545 | Cycle per Second;cycle/sec;Hertz | A unit of frequency equal to one cycle per second.(NCI) | Hertz | ||
Hz/s | C154854 | Hz/sec | A unit of frequency rate change defined as the number of Hertz per unit of time equal to one second. | Hertz Per Second | ||
IMPLANT | C48499 | Implant Dosing Unit | A dosing measurement based on the implant unit.(NCI) | Implant Dosing Unit | ||
in | C48500 | Inch | A traditional unit of length equal to 2.54 centimeters. (NCI) | Inch | ||
in2 | C68871 | Square Inch | A unit of area equal to the area of a square with sides of one inch. It is equal to 6.4516 square centimeters.(NCI) | Square Inch | ||
INHALATION | C48501 | Inhalation Dosing Unit | A dosing measurement based on the inhalation unit.(NCI) | Inhalation Dosing Unit | ||
IU | C48579 | IE;International Unit | The unitage assigned by the WHO (World Health Organization) to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization, to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.(NCI) | International Unit | ||
IU/day | C85645 | A unit of substance (biologic activity) flow rate equal to one international unit per day. | International Unit per Day | |||
IU/dL | C120848 | Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one international unit per one deciliter of system volume. | International Unit per Deciliter | |||
IU/g Hb | C122207 | A unit of concentration (biologic activity) equal to one international unit of substance per gram of hemoglobin. | International Unit per Gram Hemoglobin | |||
IU/g | C70493 | International Unit per Gram | A unit of measure of quantity of substance per unit mass, expressed in terms of the International Unit per grams.(NCI) | International Unit per Gram | ||
IU/h | C85646 | IU/h | A unit of substance (biologic activity) flow rate equal to one international unit per hour. | International Unit per Hour | ||
IU/kg | C67379 | International Unit per Kilogram | An arbitrary unit of substance content expressed in international units of biological activity per one kilogram of mass of the system. It is also used as a dose calculation unit expressed in international units of biological activity per one kilogram of body mass.(NCI) | International Unit per Kilogram | ||
IU/kg/h | C71209 | International units per Kilogram per Hour | A dose calculation unit equal to one international unit (an arbitrary unit of biological activity) of a product per one kilogram of body mass administered per unit of time equal to one hour.(NCI) | International Unit per Kilogram per Hour | ||
IU/L | C67376 | IE/L;International Unit per Liter;IU/L;mIU/mL | A unit of concentration (biologic activity) equal to one milli-international unit of substance per milliliter of solution or one international unit of substance per liter of solution. | International Unit per Liter | ||
IU/mg | C67380 | International Unit per Milligram | A unit of measure of quantity of substance per unit mass, expressed in terms of international units per milligram. | International Unit per Milligram | ||
IU/mL | C67377 | IE/mL;International Unit per Milliliter;Kilo International Unit per Liter;kIU/L | A unit of concentration (biologic activity) equal to one international unit of substance per milliliter of solution. | International Unit per Milliliter | ||
IU/mmol | C122208 | A unit of concentration (biologic activity) equal to one international unit of substance per millimole of substance. | International Unit per Millimole | |||
J/cm2 | C67357 | A unit of radiant exposure defined as a unit of energy equal to one Joule applied to a unit of area equal to one square centimeter. | Joule per Square Centimeter | |||
JAR | C48502 | Jar Dosing Unit | A dosing measurement based on the jar unit.(NCI) | Jar Dosing Unit | ||
JDF Unit | C172606 | JDF U;Juvenile Diabetes Foundation Unit | A unit of measure, defined by the Juvenile Diabetes Foundation, used to quantify islet cell antibodies in a biological sample. | Juvenile Diabetes Foundation Unit | ||
Joule | C42548 | Joule | A unit of electrical, mechanical, and thermal energy (as well as work and quantity of heat), equal to the work done when the point of application of a force of one Newton is displaced through a distance of one meter in the direction of the force or the work done when a current of one Ampere passes through a resistance of one ohm for one second. One joule is equal to 0.23889 gram-calorie (mean).(NCI) | Joule | ||
K | C42537 | Kelvin | A basic unit of thermodynamic temperature, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). It is 1/273.16th of the thermodynamic temperature of the triple point of water. This sets the size of the kelvin unit for temperature differences and defines the thermodynamic temperature of an equilibrium mixture of waters ice-liquid-vapor as 273.16 K, where 0 K is the lowest possible temperature ("absolute zero"). | Kelvin | ||
ka_u/dL | C122209 | A unit of phosphatase concentration that can free one milligram of phenol from disodium phenylphosphate at standard conditions, per unit volume of the mixture equal to one deciliter. (NCI) | King-Armstrong Unit per Deciliter | |||
KALLIKREIN INHIBITOR UNIT | C48503 | Kallikrein Inhibitor Unit | A dosing measurement based on the Kallikrein inhibitor unit.(NCI) | Kallikrein Inhibitor Unit | ||
kat | C42566 | Katal | A unit for measuring catalytic (e.g. enzymatic) activity, the ability of the compound to accelerate the chemical reaction by providing a lower energy pathway between the reactants and the products. One katal is that catalytic activity which will raise the rate of reaction by one mole per second in a specified assay system. When the katal is used, the measurand should be specified by reference to the measurement procedure; the measurement procedure must identify the indicator reaction. The katal is not used to express a rate of reaction itself, which should be expressed in moles per second.(NCI) | Katal | ||
kBq | C70511 | Kilobecquerel | A unit of radioactivity equal to one thousand nuclear disintegrations or other nuclear transformations per second, or to 1E3 Becquerels. (NCI) | Kilobecquerel | ||
kBq/uL | C71168 | GBq/L;Gigabecquerel per Liter;Kilobecquerel per Microliter;MBq/mL;Megabecquerel per Milliliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousand Becquerels per unit volume equal to one millionth of a liter.(NCI) | Kilobecquerel per Microliter | ||
kcal | C67194 | Kilogram-Calorie | A unit of energy defined as the amount of heat required to raise the temperature of one kilogram of pure water by one degree Centigrade under standard conditions (the specific heat of the water at 15 degrees Celsius and the constant pressure of 101.325 kilopascals or one atm being defined as unity), equal to approximately 4.1855 kJ. It is also is used by nutritionists in measuring the energy-producing potential of food as a unit of potential energy contained by a substance, which can be liberated when the material is oxidized, usually by combustion in the presence of oxygen.(NCI) | Calorie | ||
kcal/day | C139135 | A unit of energy equal to one kilocalorie per day. (NCI) | Kilocalorie per Day | |||
kDa | C105491 | Kilodalton;Kilounified Atomic Mass Unit;ku | A mass unit equal to one thousand daltons. | Kilodalton | ||
keV | C67276 | KeV;Kiloelectronvolt | A unit of energy equal to 1000 electronvolts, or (approximately) 1,602 177 x 10-16 joule. | Kiloelectronvolt | ||
kg | C28252 | Kilogram | The base unit of mass in the International System of Units (SI) equal to the mass of the international prototype kilogram, a platinum-iridium cylinder in the custody of the International Bureau of Weights and Measures. | Kilogram | ||
kg/cm | C120849 | A unit of measure equal to kilograms per length unit equal to one centimeter. | Kilogram per Centimeter | |||
kg/cm2 | C69094 | Kilogram per Square Centimeter | A unit of spread rate of a substance by mass expressed in kilograms per area unit equal to one square centimeter, used also as a measure of area density and as a dose calculation unit.(NCI) | Kilogram per Square Centimeter | ||
kg/L | C64566 | g/mL;Gram per Milliliter;gram/mL;kg/L;Kilogram per Liter;mg/uL | A unit of concentration or mass density equal to one gram of substance per milliliter of solution or one kilogram of substance per liter of solution. | Kilogram per Liter | ||
kg/m2 | C49671 | Kilogram per Square Meter | A unit expressed as kilogram of mass per square meter of area.(NCI) | Kilogram per Square Meter | ||
kg/mol | C122210 | g/mmol | A unit of mass commonly used to express the molar mass of a substance in kilogram(s) per mole. | Kilogram per Mole | ||
kHz | C67279 | kilohertz | A unit of measure denoting the frequency equal to 1000 cycles per second meaning e.g. that the cylical waveform changes from one state to the other (from one polarity to the other) 1000 times per second. (NCI) | Kilohertz | ||
KIT | C48504 | Kit Dosing Unit | A dosing measurement based on the kit unit.(NCI) | Kit Dosing Unit | ||
kIU | C70492 | Kilo International Unit | A unit equal to one thousand international units.(NCI) | Kilointernational Unit | ||
km | C71177 | Kilometer | A unit of distance equal to 1000 meters, 0.621 miles, 1094 yards, or 3281 feet.(NCI) | Kilometer | ||
km/h | C71203 | Kilometer Per Hour | A unit of both speed (scalar) and velocity (vector), defined as the distance of one thousand meters travelled per unit time equal to one hour.(NCI) | Kilometer per Hour | ||
kN/cm2 | C92615 | kdyn/cm2;Kilonewton per Centimeter Squared | The kilonewton per centimeter squared is an SI derived unit of pressure; one newton is computed as the force necessary to accelerate a mass of one gram at the rate of one centimeter per second squared. One kilonewton per centimeter squared is descriptive of the amount of force exerted in a particular area. This measurement is frequently used when describing conditions of cellular movement. (NCI) | Kilonewton per Centimeter Squared | ||
kPa | C67284 | Kilopascal | A SI derived unit of pressure equivalent to 1000 newtons per square meter or 10000 bars or to 0.145 pound per square inch. (NCI) | Kilopascal | ||
kPa/L/s | C105492 | kPa/L/sec;Pa/mL/sec | A unit of resistance equal to the number of kilopascals per unit of volume equal to one liter per unit of time equal to one second. (NCI) | Kilopascal Per Liter Per Second | ||
ks | C105493 | 10^3 sec;Kilosecond;ksec | A unit of time equal to one thousand seconds (1E3 seconds). (NCI) | Kilosecond | ||
kUSP | C71202 | Kilo United States Pharmacopeia Unit | A unit of potency equal to one thousand US Pharmacopoeia Units.(NCI) | Kilo United States Pharmacopeia Unit | ||
kV | C170630 | Kilovolt | A unit of electric potential and electromotive force equal to one thousand volts. | Kilovolt | ||
L | C48505 | Liter | A unit of volume equal to one thousandth (1E-3) of a cubic meter, the cubic meter being the standard derived unit of volume in the International System of Units (SI). | Liter | ||
L/day | C69110 | A unit of flow rate equal to one liter per day. | Liter per Day | |||
L/h | C69160 | A unit of flow rate equal to one liter per hour. | Liter per Hour | |||
L/h/m2 | C105494 | (L/h)/m2;L/h/m2 | Liters per hour (flow rate), divided by meters squared (surface area). | Liter Per Hour Per Square Meter | ||
L/kg | C73725 | L/kg;mL/g | Liters (volume) divided by kilograms (weight) or milliliters (volume), divided by grams (weight). | Liter per Kilogram | ||
L/L | C105495 | dL/dL;Liter per Liter;mL/mL;uL/uL | A unit of volume concentration equal to the number of liters per unit of volume equal to one liter. | Liter Per Liter | ||
L/min | C67388 | A unit of flow rate equal to one liter per minute. | Liter per Minute | |||
L/min/m2 | C105496 | (L/min)/m2;L/min/m2 | Liters per minute (flow rate), divided by meters squared (surface area). | Liter Per Minute Per Square Meter | ||
L/s | C67390 | L/sec | Liters per second. | Liter per Second | ||
L/s/kPa | C139133 | A unit of conductance equal to the number of liters per unit of time equal to one second per unit of pressure equal to one kilopascal. | Liter per Second per Kilopascal | |||
LB | C48531 | lb;lb_av;Pound | A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI) | Pound | ||
LENS | C170638 | Lens Dosing Unit | A dosing measurement based on the lens unit. | Lens Dosing Unit | ||
Linear ft*LB | C139134 | Linear Foot-pound;Linear ft*lbf;Linear Pounds Feet | A unit of measure that equals the work required to move one pound a linear distance of one foot in the direction of the applied force. | Linear Foot Pound | ||
Lipase Units | C178059 | A dosing unit based on lipase activity. | Lipase Unit | |||
Lipase Units/kg | C178058 | A dosing unit based on lipase activity per kilogram of body mass. | Lipase Units per Kilogram | |||
lm | C42560 | Lumen | A unit of luminous flux. It is the amount of light that falls on a unit area at unit distance from a source of one candela.(NCI) | Lumen | ||
log EID 50/dose | C70480 | Log10 50 Percent Embryo Infective Dose per Dose | A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI) | Log10 50 Percent Embryo Infective Dose per Dose | ||
log10 CCID 50/dose | C70485 | Log10 50 Percent Cell Culture Infective Dose per Dose | A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent cell culture infective dose.(NCI) | Log10 50 Percent Cell Culture Infective Dose per Dose | ||
log10 CFU/g | C102658 | A logarithmic-scale (base 10) unit for measuring colony forming units per unit of mass equal to one gram. | Log10 Colony Forming Units per Gram | |||
log10 CFU/mL | C102659 | A logarithmic-scale (base 10) unit for measuring colony forming units per unit of volume equal to one milliliter. | Log10 Colony Forming Units per Milliliter | |||
log10 copies/mL | C117972 | A logarithmic-scale (base 10) unit for measuring copies per unit of volume equal to one milliliter. | Log10 Copies per Milliliter | |||
Log10 ELISA unit | C68878 | Log10 Enzyme-Linked Immunosorbent Assay Unit | A logarithmic-scale (base 10) unit for measuring concentration and/or reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference for the particular quantitative enzyme-linked immunosorbent assay method.(NCI) | Log10 Enzyme-Linked Immunosorbent Assay Unit | ||
Log10 ELISA unit/dose | C68879 | Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose | A logarithmic-scale (base 10) unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.(NCI) | Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose | ||
log10 IU/mL | C116238 | A logarithmic-scale (base 10) unit for measuring international units per unit of volume equal to one milliliter. | Log10 International Units per Milliliter | |||
log10 minutes of arc | C198392 | log10 arcmin;log10 arcminutes | A logarithmic-scale (base 10) unit for measuring angular equal to 1/60 degree or to 60 arcseconds. | Log10 Arcminutes | ||
log10 PFU | C73568 | A logarithmic-scale (base 10) unit for measuring plaque forming units. | Log10 Plaque Forming Unit | |||
log10 PFU/mL | C170631 | A logarithmic-scale (base 10) unit for measuring plaque forming units per unit of volume equal to one milliliter. | log10 Plaque Forming Units Per Milliliter | |||
log10 TCID 50/dose | C70489 | Log10 50 Percent Tissue Culture Infective Dose per Dose | A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent tissue culture infective dose.(NCI) | Log10 50 Percent Tissue Culture Infective Dose per Dose | ||
log10 TCID 50/mL | C132478 | Log10 50 Percent Tissue Culture Infective Dose per Milliliter | A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one milliliter of infectious material contains one 50 percent tissue culture infective dose. | Log10 50 Percent Tissue Culture Infective Dose per Milliliter | ||
log10 TCID 50/uL | C132479 | Log10 50 Percent Tissue Culture Infective Dose per Microliter | A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one microliter of infectious material contains one 50 percent tissue culture infective dose. | Log10 50 Percent Tissue Culture Infective Dose per Microliter | ||
log10 U/mL | C198393 | Log10 Arbitrary Units per Milliliter | A logarithmic-scale (base 10) unit for measuring arbitrary units per unit of volume equal to one milliliter. | Log10 Arbitrary Units per Milliliter | ||
LOZENGE | C48506 | Lozenge Dosing Unit | A dosing measurement based on the lozenge unit.(NCI) | Lozenge Dosing Unit | ||
lton_av | C198394 | Imperial ton;Long ton;UK ton | A traditional unit of mass in the United Kingdom equal to 2,240 pounds or 1.017 metric tons. | Long Ton | ||
lx | C42561 | Lux | A unit of illuminance equal to the direct illumination on a surface that is everywhere one meter from a uniform point source of one candela; a unit of illuminance that is equal to one lumen per square meter.(NCI) | Lux | ||
m | C41139 | Meter | A meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards.(NCI) | Meter | ||
m*% | C184713 | m% | A unit of measure for the distance saturation product (DSP) defined as meters walked times percent oxygen saturation. | Meters Times Percent | ||
m/s | C42571 | m/sec;Meter Per Second | A unit of both speed (scalar) and velocity (vector), defined as the distance of one meter travelled per unit time equal to one second.(NCI) | Meter per Second | ||
m/s2 | C42572 | m/sec2 | A unit of acceleration equal to one meter per unit of time equal to one second squared. | Meter per Second Squared | ||
m2 | C42569 | Square Meter | The standard derived unit of area in the International System of Units (SI) equal to the area of a square whose sides are one meter long. | Square Meter | ||
m3 | C42570 | Cubic Meter | A unit of volume or capacity equal to the volume of a cube with edges one meter in length. It is equal to 1,000 liters; 1,000 cubic decimeters; 10(E6) cubic centimeters; 25.3 cubic feet; 6.29 barrels.(NCI) | Cubic Meter | ||
MAC50 | C139130 | Minimum Alveolar Concentration 50% | A unit of potency for inhalational gases defined as the concentration of gas in the lung required to immobilize 50 percent of individuals in response to a stimulus, such as pain. | Minimum Alveolar Concentration 50 Percent | ||
mAmp | C97343 | Milliampere | A unit of electric current equal to one thousandth of an ampere. (NCI) | Milliampere | ||
mAnson U/mL | C122211 | A unit of enzymatic activity defined a one milli-Anson unit per unit volume equal to one milliliter. | Milli-Anson Unit per Milliliter | |||
MASK | C170637 | Mask Dosing Unit | A dosing measurement based on the mask unit. | Mask Dosing Unit | ||
MBP | C176388 | Mb;Mbp;Megabase Pair | A number representing one million paired nucleotides in a DNA or RNA sequence. | Megabase Pair | ||
MBq | C70512 | Megabecquerel | A unit of radioactivity equal to one million nuclear disintegrations or other nuclear transformations per second, or to 1E6 Becquerels. (NCI) | Megabecquerel | ||
MBq/uL | C71169 | GBq/mL;Gigabecquerel per Milliliter;MBq/uL;Megabecquerel per Microliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one million Becquerels per unit volume equal to one millionth of a liter, or defined as a concentration of a radionuclide with an activity equal to one billion Becquerels per unit volume equal to one thousandth of a liter. | Megabecquerel per Microliter | ||
mCi | C48511 | Millicurie | A unit of radioactivity equal to one thousandth of a Curie or 37 megabecquerels, and corresponding to a radioactivity of 37 millions of atomic disintegrations per second.(NCI) | Millicurie | ||
mCi/kg | C70570 | Microcurie per Gram;Millicurie per Kilogram;uCi/g | A unit of specific radioactivity (massic activity) equal to activity of one millicurie of the sample with total mass of one kilogram.(NCI) | Millicurie per Kilogram | ||
mCi/L | C71174 | Microcurie per Milliliter;Millicurie per Liter;uCi/mL | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousandth of a Curie per unit volume equal to one liter.(NCI) | Millicurie per Liter | ||
MdFI | C96687 | Median Fluorescence Intensity Unit;MFI | A unit of measure for the median fluorescence intensity. | Median Fluorescence Intensity Unit | ||
mEq | C48512 | Milliequivalent | A unit of relative amount of a substance equal to one thousandth of an equivalent weight.(NCI) | Milliequivalent | ||
mEq/day | C67471 | Milliequivalents per Day | A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance travels to a given object or space over a period of time equal to twenty four hours.(NCI) | Milliequivalent per 24 Hours | ||
mEq/dL | C67473 | Milliequivalent per Deciliter | A concentration unit measured as a number of milliequivalents of solute per deciliter of solution. (NCI) | Milliequivalent per Deciliter | ||
mEq/g | C70580 | Milliequivalent Per Gram | A unit of relative amount of substance content equivalent to the content at which one gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI) | Milliequivalent per Gram | ||
meq/h | C67472 | Milliequivalents per Hour | A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance travels to a given object or space over a period of time equal to one hour. (NCI) | Milliequivalent per Hour | ||
mEq/kg | C67475 | Milliequivalent Per Kilogram | A unit of relative amount of substance content equivalent to the content at which one kilogram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI) | Milliequivalent per Kilogram | ||
mEq/L | C67474 | Milliequivalent Per Liter;Millivalent per Liter;mval/L | A concentration unit measured as a number of milliequivalents of solute per liter of solution.(NCI) | Milliequivalent per Liter | ||
mEq/mL | C73737 | Milliequivalent per Milliliter | A concentration unit expressed in milliequivalent(s) of solute per milliliter of solution. (NCI) | Milliequivalent per Milliliter | ||
mEq/mmol | C92616 | Milliequivalent per Millimole | A concentration unit measured as a number of one thousandth of an equivalent weight per millimole of substance. (NCI) | Milliequivalent per Millimole | ||
mEq/ug | C70581 | mEq/mcg;Milliequivalent Per Microgram | A unit of relative amount of substance content equivalent to the content at which one millionth of a gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI) | Milliequivalent per Microgram | ||
mEq/uL | C70578 | Milliequivalent Per Microliter | A concentration unit measured as a number of milliequivalents of solute per microliter of solution.(NCI) | Milliequivalent per Microliter | ||
MESF | C96691 | Molecules of Equivalent Soluble Fluorochromes | A unit of measure of the fluorescence intensity of a fluorochrome-labeled sample, which is equivalent to the fluorescence intensity of a solution containing an equivalent number of molecules of free fluorochrome in solution, under identical experimental conditions. | Molecule of Equivalent Soluble Fluorochrome | ||
MET | C127805 | Metabolic Equivalent of Task | A unit of energy expenditure equal to the ratio of metabolic rate during physical activity versus a reference metabolic rate. | Metabolic Equivalent of Task Unit | ||
MET*h | C127806 | A unit of energy expenditure equal to the number of metabolic equivalent of task units times the number of hours of performed activity. | Metabolic Equivalent of Task Hours | |||
MET*min | C127807 | A unit of energy expenditure equal to the number of metabolic equivalent of task units times the number of minutes of performed activity. | Metabolic Equivalent of Task Minute | |||
MeV | C152057 | 10^6 Electronvolts;10^6 eV;Megaelectronvolt | A unit of energy equal to 1,000,000 electronvolts, or (approximately) 1,602 177 x 10-13 joule. | Megaelectronvolt | ||
mg | C28253 | Milligram | A unit of mass equal to one thousandth (1E-3) of a gram. | Milligram | ||
mg/animal | C73738 | Milligram per Animal | A unit of measure expressed in milligram(s) per animal. | Milligram per Animal | ||
mg/breath | C184723 | A unit of measure expressed in milligram(s) per inspiration or expiration of breath. | Milligram Per Breath | |||
mg/CAPSULE | C73739 | A unit of measure expressed in milligram(s) per capsule. | Milligram per Capsule | |||
mg/cm2 | C124456 | A unit of area density defined as a spread rate at which one milligram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit. | Milligram per Squared Centimeter | |||
mg/day | C67399 | A unit of mass flow rate equal to one milligram per day. | Milligram per 24 Hours | |||
mg/dL | C67015 | mg%;Milligram per Deciliter | A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.(NCI) | Milligram per Deciliter | ||
mg/dose | C124457 | A unit of measure expressed in milligram(s) per dose. | Milligram per Dose | |||
mg/g/h | C73740 | Milligram per Gram per Hour | A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty minutes. (NCI) | Milligram per Gram per Hour | ||
mg/g/min | C73741 | Milligram per Gram per Minute | A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty seconds. (NCI) | Milligram per Gram per Minute | ||
mg/h | C66969 | A unit of mass flow rate equal to one milligram per hour. | Milligram per Hour | |||
mg/kg | C67401 | Milligram per Kilogram;Nanogram per Milligram;ng/mg;ug/g | Milligrams (weight), divided by kilograms (weight) or nanograms (weight) per milligrams (weight). | Milligram per Kilogram | ||
mg/kg/day | C66976 | Milligram per Kilogram per Day | A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to twenty-four hours. (NCI) | Milligram per Kilogram per Day | ||
mg/kg/dose | C124458 | A dose calculation unit expressed in milligram(s) per kilogram per single dose. | Milligram per Kilogram per Dose | |||
mg/kg/h | C71362 | Milligram per Kilogram per Hour | A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one hour.(NCI) | Milligram per Kilogram per Hour | ||
mg/kg/min | C71207 | Milligram per Kilogram per Minute | A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI) | Milligram per Kilogram per Minute | ||
mg/kg/week | C161486 | Milligram per Kilogram per Week | A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to seven days. (NCI) | Milligram Per Kilogram Per Week | ||
mg/L FEU | C158291 | FEU mg/L;mg FEU/L;mg-L-FEU | A unit of equivalent concentration equal to the number of milligrams of fibrinogen per unit volume equal to one liter. | Milligram per Liter Fibrinogen Equivalent Units | ||
mg/L | C64572 | g/m3;Gram per Cubic Meter;mcg/mL;mg/L;Microgram per Milliliter;Milligram per Liter;ng/uL;ug/mL | A unit of concentration or mass density equal to one microgram of substance per milliliter of solution or one milligram of substance per liter of solution. | Microgram per Milliliter | ||
mg/m2 | C67402 | Milligram per Square Meter | A unit of area density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit.(NCI) | Milligram per Square Meter | ||
mg/m2/day | C66974 | Milligram per Square Meter per Day | A dose calculation unit expressed in milligram(s) per square meter per period of time equal to twenty-four hours. (NCI) | Milligram per Square Meter per Day | ||
mg/m2/h | C73743 | Milligram per Square Meter per Hour | A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty minutes. (NCI) | Milligram per Square Meter per Hour | ||
mg/m2/min | C73744 | Milligram per Square Meter per Minute | A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty seconds. (NCI) | Milligram per Square Meter per Minute | ||
mg/m2/wk | C88148 | Milligram per Square Meter per Week | A dose calculation unit expressed in milligram(s) per square meter per period of time equal to seven days. | Milligram per Square Meter per Week | ||
mg/min | C73742 | A unit of mass flow rate equal to one milligram per minute. | Milligram per Minute | |||
mg/mL/day | C176378 | g/L/24 Hours;g/L/day;mg/mL/24 Hours | A dose calculation unit expressed in milligrams per milliliter per day. | Gram per Liter per Day | ||
mg/mL/min | C67403 | Milligram per Milliliter per Minute | A unit expressed in milligrams per milliliter per period of time equal to sixty seconds. | Milligram per Milliliter per Minute | ||
mg/mol | C120843 | ug/mmol | A unit of mass commonly used to express the molar mass of a substance in milligram(s) per mole. | Milligram per Mole | ||
mg/wk | C67404 | Milligram per Week | A unit of mass flow rate equal to one milligram per week or a dose administration rate unit equal to the rate at which a milligram of a product is delivered or administered over the time period of one week. | Milligram per Week | ||
mg2/dL2 | C122212 | A unit of mass concentration defined as one square milligram of a substance in unit volume of the mixture equal to one square deciliter. | Square Milligram per Square Deciliter | |||
mgEq | C156468 | Milligram Equivalent | A unit of relative amount of substance equal to one thousandth of a gram of an equivalent weight. | Milligram Equivalent | ||
MHz | C67314 | Megahertz | The SI derived unit of frequency; equal to one million oscillations per second or to 1E6 hertz. (NCI) | Megahertz | ||
Mile | C71183 | International Mile | A unit of distance equal to 5280 international feet, 1760 international yards, or 1609.344 meters.(NCI) | Mile | ||
min | C48154 | Minute | A unit of measurement of time equal to 60 seconds. | Minute | ||
min*mg/mL | C85729 | Minutes times milligrams per milliliter (area under the curve). | Minute Times Milligram per Milliliter | |||
min/day | C176381 | Minutes per Day | A unit of measurement equal to the number of minutes within a period of time equal to one day. | Minute per Day | ||
mIU/L | C67405 | mcIU/mL;Micro-International Unit per milliliter;mIE/L;mIU/L;uIU/mL | A unit of concentration (biologic activity) equal to one micro-international unit of substance per milliliter of solution or one milli-international unit of substance per liter of solution. | Microinternational Unit per Milliliter | ||
mIU/m2 | C67409 | Milli-International Unit per Square Meter | A unit expressed as a number of milli-international units per one square meter of a body surface area. | Milliinternational Unit per Square Meter | ||
mJoule/cm2 | C116241 | A unit of radiant exposure defined as a unit of energy equal to one millijoule applied to a unit of area equal to one square centimeter. | Millijoules per Square Centimeter | |||
mkat | C70507 | Millikatal | A unit of catalytic activity measurement equal to one thousandth of one katal (1E-3 katal). (NCI) | Millikatal | ||
mkat/L | C189643 | Millikatal/Liter | A unit of catalytic activity measurement equal to one thousandth of one katal (1E-3 katal) per liter. | Millikatal per Liter | ||
mL | C28254 | cm3;Milliliter | A unit of volume equal to one thousandth (1E-3) of a liter. | Milliliter | ||
mL*cmH2O | C135521 | A unit of volume defined as milliliters times centimeter of water. | Milliliter Times Centimeter of Water | |||
mL/(min*100mL) | C130191 | A unit of flow rate expressed as the number of milliliters, divided by the number of minutes times a unit of volume equal to 100 milliliters. | Milliliter Per Minute Times One Hundred Milliliters | |||
mL/100g/min | C154855 | A unit of flow rate expressed as the number of milliliters per 100g of material (e.g., tissue) per minute. | Milliliter per 100 Grams per Minute | |||
mL/animal | C73746 | Milliliter per Animal | A unit of measure expressed in milliliter(s) per animal. | Milliliter per Animal | ||
mL/animal/day | C73747 | Milliliter per Animal per Day | A unit of measure expressed in milliliter(s) per animal per period of time equal to twenty-four hours. | Milliliter per Animal per Day | ||
mL/animal/wk | C73748 | Milliliter per Animal per Week | A unit of measure expressed in milliliter(s) per animal per period of time equal to seven days. | Milliliter per Animal per Week | ||
mL/beat | C127808 | A unit of measure expressed in milliliter(s) per heart beat. | Milliliter per Heartbeat | |||
mL/breath | C73749 | Milliliter per Breath | A unit of measure expressed in milliliter(s) per inspiration or expiration of breath. | Milliliter per Breath | ||
mL/cage | C73750 | Milliliter per Cage | A unit of measure expressed in milliliter(s) per cage. | Milliliter per Cage | ||
mL/cage/day | C73751 | Milliliter per Cage per Day | A unit of measure expressed in milliliter(s) per cage per period of time equal to twenty-four hours. | Milliliter per Cage per Day | ||
mL/cage/wk | C73752 | Milliliter per Cage per Week | A unit of measure expressed in milliliter(s) per cage expressed per period of time equal to seven days. | Milliliter per Cage per Week | ||
mL/cm H2O | C98755 | A unit of pressure expressed in milliliter(s) per centimeter of water. (NCI) | Milliliter per Centimeter of Water | |||
mL/cm | C105503 | dL/m;Milliliter per Centimeter | A unit of measure equal to the number of milliliters per unit of length equal to one centimeter. (NCI) | Milliliter per Centimeter | ||
mL/cm3/min | C163564 | mL/mL/min | A unit of flow rate equal to one milliliter per cubic centimeter per unit of time equal to one minute. | Milliliter per Cubic Centimeter per Minute | ||
mL/day | C67410 | mL/24h | A unit of flow rate equal to one milliliter per day. | Milliliter per 24 Hours | ||
mL/dL | C105504 | Milliliters per Deciliter | A unit of volume concentration equal to the number of milliliters per unit of volume equal to one deciliter. | Milliliter per Deciliter | ||
mL/dose | C124459 | A unit of measure expressed in milliliter(s) per dose. | Milliliter per Dose | |||
mL/g/day | C73755 | (L/day)/kg;(mL/day)/g;mL/g/day | Milliliters per gram per day or liters per day (flow rate), divided by kilograms (weight) or milliliters per day (flow rate), divided by grams (weight). | Milliliter per Gram per Day | ||
mL/g/h | C73756 | (L/h)/kg;(mL/h)/g;mL/g/h | Milliliters per gram per hour or liters per hour (flow rate), divided by kilograms (weight) or milliliters per hour (flow rate), divided by grams (weight). | Milliliter per Gram per Hour | ||
mL/g/min | C73757 | (L/min)/kg;(mL/min)/g;mL/g/min | Milliliters per gram per minute or liters per minute (flow rate), divided by kilograms (weight) or milliliters per minute (flow rate), divided by grams (weight). | Milliliter per Gram per Minute | ||
mL/h | C66962 | cc/hr;cm3/h | A unit of flow rate equal to one milliliter per hour. | Milliliter per Hour | ||
mL/kg | C67411 | Milliliters (volume) divided by kilograms (weight). | Milliliter per Kilogram | |||
mL/kg/day | C73758 | (mL/day)/kg;mL/kg/day | Milliliters per kilogram per day or milliliters per day (flow rate), divided by kilograms (weight). | Milliliter per Kilogram per Day | ||
mL/kg/h | C73759 | (mL/h)/kg;mL/kg/h | Milliliters per kilogram per hour or milliliters per hour (flow rate), divided by kilograms (weight). | Milliliter per Kilogram per Hour | ||
mL/kg/min | C73760 | (mL/min)/kg;mL/kg/min | Milliliters per kilogram per minute or milliliters per minute (flow rate), divided by kilograms (weight). | Milliliter per Kilogram per Minute | ||
mL/m2 | C73761 | Milliliters (volume) divided by meters squared (surface area). | Milliliter per Square Meter | |||
mL/m2/day | C66977 | Milliliter per Square Meter per Day | A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to twenty-four hours. (NCI) | Milliliter per Square Meter per Day | ||
mL/m2/h | C73762 | Milliliter per Square Meter per Hour | A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty minutes. (NCI) | Milliliter per Square Meter per Hour | ||
mL/m2/min | C73763 | Milliliter per Square Meter per Minute;mL/min/m2 | A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty seconds. (NCI) | Milliliter per Square Meter per Minute | ||
mL/min | C64777 | A unit of flow rate equal to one milliliter per minute. | Milliliter per Minute | |||
mL/min/1.73 m2 | C67412 | mL/min/1.73m2 | A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute per 1.73 meters squared of body surface area. | Milliliter per Minute per 1.73 m2 of Body Surface Area | ||
mL/min/mmHg | C67417 | Milliliter per Minute per Torr | A unit of measure equal to the number of milliliters per unit of time equal to one minute per unit of pressure equal to one milliter of mercury (mmHg). | Milliliter per Minute per Millimeters of Mercury | ||
mL/mmHg | C106542 | Milliliters per Millimeter of Mercury | A unit equal to the volume in milliliters per one millimeter rise of mercury in a barometer at the Earth's surface. (NCI) | Milliliters Per Millimeter of Mercury | ||
mL/mmHg/min/L | C67418 | A unit of gas diffusion capacity equal to one milliliter per millimeter of mercury per minute per liter of volume. | Milliliter per Minute per Millimeters of Mercury per Liter | |||
mL/s | C69073 | mL/sec | Milliliters per second. | Milliliter per Second | ||
mL/s/1.73 m2 | C105505 | mL/sec/1.73m2 | A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per 1.73 meters squared of body surface area. | Milliliter Per Second Per 1.73 Meter Squared | ||
mL/s/kg | C85715 | mL/kg/s | A metric unit of volumetric flow rate defined as the rate at which one milliliter of substance travels during the period of time equal to one second per kilogram. | Milliliter per Kilogram per Second | ||
mL/s/m2 | C166100 | mL/sec/m2 | A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per meter squared. | Milliliter Per Second Per Square Meter | ||
mm | C28251 | Millimeter | A unit of measure equal to one thousandth of a meter. (NCI) | Millimeter | ||
mm/2h | C105509 | Millimeters per Two Hours | A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to two hours. (NCI) | Millimeter per Two Hours | ||
mm/h | C67419 | Millimeter per Hour | A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travels per unit time equal to one hour.(NCI) | Millimeter per Hour | ||
mm/min | C105507 | Millimeters per Minute | A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one minute. (NCI) | Millimeter Per Minute | ||
mm/s | C105508 | Millimeters per Second;mm/sec | A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one second. (NCI) | Millimeter Per Second | ||
mm2 | C65104 | Square Millimeter | A unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter.(NCI) | Square Millimeter | ||
mm2/us | C189649 | Square Millimeters per Microsecond | A SI derived metric unit of kinematic viscosity expressed as millimeters squared per microsecond. | Square Millimeter per Microsecond | ||
mm3/mm2/year | C126080 | A unit defined as the volume, in cubic millimeters, per area equal to one square millimeter per unit of time equal to one year. | Cubic Millimeter per Square Millimeter per Year | |||
mmAL | C150898 | Millimeters of Aluminum Equivalents | A unit defined as the thickness, in millimeters, of aluminum that has the equivalent degree of attenuation, under specified conditions, as the material that is the target of the procedure. | Millimeters of Aluminum Equivalents | ||
mmHg | C49670 | Millimeter of Mercury | A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI) | Millimeter of Mercury | ||
mmHg*beats/min | C187972 | A unit of pressure equal to millimeters of mercury times the number of heartbeats measured per minute unit of time. | Millimeters of Mercury times Beats per Minute | |||
mmHg*min/L | C150900 | Hybrid Resistance Units;Wood Units | A unit of resistance equal to the number of millimeters of mercury times minutes, per unit of volume equal to one liter. | Hybrid Resistance Units | ||
mmHg/L/min | C105506 | A unit of resistance equal to the number of millimeters of mercury per unit of volume equal to one liter per unit of time equal to one minute. | Millimeter Mercury Per Liter Per Minute | |||
mmHg/s | C73764 | Millimeter of Mercury per Second;mmHg/sec | A rate of inflation or deflation of a manometric device based on the unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere during period of time equal to one sixtieth of a minute. (NCI) | Millimeter of Mercury per Second | ||
mmol | C48513 | Millimole | A unit of amount of substance equal to one thousandth (1E-3) of a mole. | Millimole | ||
mmol/day | C67420 | mmol/24h | A unit of substance flow rate equal to one millimole per day. | Millimole per 24 Hours | ||
mmol/g | C68740 | Millimole per Gram | A unit amount of substance content (molality unit) defined as one mole of solute per one kilogram of solvent.(NCI) | Mole per Kilogram | ||
mmol/h | C85720 | A unit of substance flow rate equal to one millimole per hour. | Millimole per Hour | |||
mmol/kg | C68892 | Millimole per Kilogram | A unit of amount of substance content (molality unit) defined as one thousandth of mole (1E-3 mole) of solute per one kilogram of solvent. (NCI) | Millimole per Kilogram | ||
mmol/L | C64387 | mcmol/mL;Micromole per Milliliter;Millimole per Liter;mmol/L;mol/m3;Mole per Cubic Meter;nmol/uL;umol/mL | A unit of concentration (molarity unit) equal to one millimole of solute per liter of solution. | Millimole per Liter | ||
mmol/L/day | C189648 | mmol/(day*L);mmol/(L*day);mmol/day/L | A concentration unit equal to one millimole of solute in one liter of solution per unit of time equal to 24 hours. | Millimole per Liter per Day | ||
mmol/L/h | C189644 | mmol/(h*L);mmol/(L*h);mmol/h/L;umol/(h*mL);umol/(mL*h);umol/h/mL;umol/mL/h | A concentration unit equal to one millimole of solute in one liter of solution per unit of time equal to one hour. | Millimole per Liter per Hour | ||
mmol/min/kPa | C116242 | A unit of gas diffusion capacity equal to one millimole per minute per kilopascal. | Millimoles per Minute per Kilopascal | |||
mmol/min/kPa/L | C67423 | A unit of gas diffusion capacity equal to one millimole per minute per kilopascal per liter of volume. | Millimole per Minute per Thousand Pascal per Liter | |||
mmol/mol | C111253 | umol/mmol | A unit of fraction expressed as the ratio of the amount of a substance in solution, in millimoles, to the amount of a different substance in the mixture, in moles. | Millimole per Mole | ||
mmol/s | C85723 | Millimoles per Second;mmol/sec | A unit of substance flow rate equal to one millimole per second. | Millimole per Second | ||
mmol2/L2 | C122213 | A unit of concentration (molarity unit) equal to one square millimole of solute per square liter of solution. | Square Millimole per Square Liter | |||
mMU/mL | C132480 | MilliMerck Unit per Milliliter | A unit of concentration based on the vaccine specific number of titers that are the geometric mean titer at which an individual is considered to convert from a seronegative to a seropositive response due to the vaccine. | MilliMerck Unit per Milliliter | ||
mN | C127809 | Millinewton | A unit of force equal to one thousandth of a Newton. | Millinewton | ||
MnFI | C163046 | Mean Fluorescence Intensity Unit;MFI | A unit of measure for the mean fluorescence intensity when the mathematic calculation is unspecified or unknown. | Mean Fluorescence Intensity Unit | ||
mol | C42539 | Mole | The base unit of amount of substance in the International System of Units (SI). It is equal to the same number of elementary units as there are atoms in 0.012 kg of carbon-12. | Mole | ||
mol/day | C85737 | A unit of substance flow rate equal to one mole per day. | Mole per Day | |||
mol/g | C68893 | mmol/mg | A unit of amount of substance content (molality unit) defined as one mole of solute per one gram of solvent.(NCI) | Mole per Gram | ||
mol/L | C48555 | mmol/mL;mol/L;Mole per Liter | A unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI) | Mole per Liter | ||
mol/mg | C68894 | Mole per Milligram | A unit of amount of substance content (molality unit) defined as one mole of solute per one milligram of solvent.(NCI) | Mole per Milligram | ||
mol/mL | C68891 | Mole per Milliliter | A unit of concentration (molarity unit) equal to one mole of solute in one milliliter of solution.(NCI) | Mole per Milliliter | ||
mol/mol | C70455 | mmol/mmol;Mole per Mole | A unit of fraction expressed as the ratio of the amount of substance of solute in moles to the amount of substance of the mixture in moles.(NCI) | Mole per Mole | ||
MONTHS | C29846 | Month | One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI) | Month | ||
mOsm | C67318 | Milliosmole | A unit of osmotic pressure equal to one thousandth of an osmole or osmotic pressure of 0.001 molar solution of a substance that does not dissociate. (NCI) | Milliosmole | ||
mOsm/kg | C67427 | Milliosmole per Kilogram | A unit of osmotic pressure equal to one thousandth of an osmole per kilogram substance. | Milliosmole per Kilogram | ||
mOsm/L | C122214 | A unit of osmotic pressure equal to one thousandth of an osmole per unit of volume equal to one Liter. | Milliosmole per Liter | |||
mPa | C73765 | Millipascal | A SI derived unit of pressure equivalent to one thousandth of one pascal. (NCI) | Millipascal | ||
mph | C105500 | Miles per Hour | A unit of both speed (scalar) and velocity (vector), defined as the distance of one mile travelled per unit time equal to one hour. (NCI) | Mile Per Hour | ||
MPL U | C67348 | [MPL'U];Immunoglobin M Phospholipid Units | A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard. | IgM Phospholipid Unit | ||
MPL U/mL | C117973 | Immunoglobin M Phospholipid Units per Milliliter | A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter. | Immunoglobin M Phospholipid Unit per Milliliter | ||
MPS U | C161496 | Immunoglobin M Phosphatidylserine Units;Phosphatidylserine IgM Antibody Unit | A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with phosphatidylserine evaluated against an established reference standard. (NCI) | Phosphatidylserine IgM Antibody Unit | ||
MPS U/mL | C186223 | Immunoglobin M Phosphatidylserine Units/mL;Phosphatidylserine IgM Antibody Unit/mL | Unit of measure of potency of allergenic product expressed as a number of immunoglobin M phosphatidylserine units per one milliliter of formulation. | Phosphatidylserine IgM Antibody Unit per Milliliter | ||
Mrad | C67349 | Megarad;Mrd | A unit of absorbed radiation dose equal to one million rad (10E6 rad), or 10000 Gy (10E4 Gy). | Megarad | ||
ms | C41140 | Millisecond;ms;msec | A unit of time, which is equal to one thousandth of a second.(NCI) | Millisecond | ||
ms/mmHg | C163565 | A unit of measure equal to one millisecond per one millimeter of mercury (mmHg). | Millisecond per Millimeter Mercury | |||
ms2 | C161489 | A unit of time, which is equal to one thousandth of a second squared. | Square Millisecond | |||
mU | C67315 | Milliunit | A quantity equivalent to one thousandth of a unit (10E-3 unit). | Milliunit | ||
mU/g | C122215 | An arbitrary unit of substance content expressed in milliunit(s) per gram. | Milliunit per Gram | |||
mU/L | C67408 | uU/mL | An arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one thousandth of a unit of a substance. | Microunit per Milliliter | ||
mV | C67324 | Millivolt | A unit of electric potential and electromotive force equal to one thousandth of a volt.(NCI) | Millivolt | ||
mV*min | C105512 | Millivolt * Minutes | A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one millivolt, when the flux is uniformly reduced to zero within one minute. (NCI) | Millivolt Minute | ||
mV/s | C122216 | mV/sec;uV/msec | A SI derived rate unit equal to one millivolt per unit of time equal to one second. | Millivolt per Second | ||
mV2/Hz | C114241 | Millivolt Squared per Hertz;Millivolt^2/Hertz | A unit equal to one thousandth of a volt squared per unit of frequency equal to one Hertz. | Millivolt Squared per Hertz | ||
nCi | C67352 | Nanocurie | A unit of radioactivity equal to one billionth of Curie or 37 Becquerels, and corresponding to a radioactivity of 37 atomic disintegrations per second.(NCI) | Nanocurie | ||
NEBULE | C71204 | Nebule Dosing Unit | A unit of measurement based on the nebule dosing unit.(NCI) | Nebule Dosing Unit | ||
Newton | C42546 | Newton | A unit of force which, when applied in a vacuum to a body having a mass of one kilogram, causes an acceleration of one meter per second squared. It is equal to 1E5 dynes. (NCI) | Newton | ||
NFIU | C154680 | NFIU;NIU;Normalized Fluorescence Intensity Unit;Normalized Intensity Unit | A relative fluorescence intensity unit that is adjusted to a reference standard. (NCI) | Normalized Fluorescence Intensity Unit | ||
ng | C48516 | Nanogram | A unit of mass equal to one billionth (1E-9) of a gram. | Nanogram | ||
ng/day | C85741 | A unit of mass flow rate equal to one nanogram per day. | Nanogram per Day | |||
ng/dL | C67326 | Nanogram per Deciliter | A unit of mass concentration defined as the concentration of one nanogram of a substance in unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume one deciliter.(NCI) | Nanogram per Deciliter | ||
ng/kg | C67429 | fg/mg;Nanogram per Kilogram;pg/g | A unit expressed as the number of nanogram(s) per kilogram. | Nanogram per Kilogram | ||
ng/L | C67327 | Microgram per Cubic Meter;ng/L;pg/mL;ug/m3 | A unit of concentration or mass density equal to one picogram of substance per milliliter of solution or one nanogram of substance per liter of solution. | Nanogram per Liter | ||
ng/mol | C176386 | fg/umol;pg/mmol | A unit of mass commonly used to express the molar mass of a substance in nanogram(s) per mole. | Nanogram per Mole | ||
ngEq | C184705 | Nanogram Equivalent | A unit of relative amount of substance equal to one billionth of a gram of an equivalent weight. | Nanogram Equivalents | ||
ngEq/g | C166082 | Nanogram equivalents of a radiolabeled substance per gram of matrix or tissue. | Nanogram Equivalents Per Gram | |||
ngEq/L | C130192 | pgEq/mL | A concentration unit measured as a number of nanogram equivalent of solute per liter of solution. | Nanogram Equivalents Per Liter | ||
nkat | C70508 | Nanokatal | A unit of catalytic activity measurement equal to one billionth of one katal (1E-9 katal). (NCI) | Nanokatal | ||
nkat/g Hb | C176383 | Nanokatals per Gram Hemoglobin | A unit of catalytic activity equal to one billionth of one katal (10E-9 katal) per gram of hemoglobin. | Nanokatal per Gram Hemoglobin | ||
nkat/L | C70510 | Nanokatal per Liter | A unit of catalytic activity concentration defined as the catalytic activity of the component equal to one billionth of one katal (1E-9 katal) in the unit volume of the system equal to one liter. (NCI) | Nanokatal per Liter | ||
nL | C69188 | Nanoliter | A unit of volume equal to one billionth of a liter (1E-9 liter). (NCI) | Nanoliter | ||
nm | C67328 | Nanometer | A unit of length equal to one billionth of a meter (1E-9 meter). Nanometer is used as a unit for light wavelength measurement. (NCI) | Nanometer | ||
nm/min | C191362 | Nanometers per Minute | A unit of both speed (scalar) and velocity (vector), defined as the distance of one nanometer travelled per unit time equal to one minute. | Nanometer Per Minute | ||
nmol BCE/L | C117974 | Nanomoles Bone Collagen Equivalents per Liter | A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of volume equal to one liter. | Nanomole Bone Collagen Equivalent per Liter | ||
nmol BCE/mmol | C118137 | Nanomoles Bone Collagen Equivalents per Millimole | A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one millimole. | Nanomole Bone Collagen Equivalent per Millimole | ||
nmol BCE/nmol | C122217 | Nanomoles Bone Collagen Equivalents per Nanomole | A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one nanomole. | Nanomole Bone Collagen Equivalents per Nanomole | ||
nmol | C48517 | Nanomole | A unit of amount of substance equal to one billionth (1E-9) of a mole. (NCI) | Nanomole | ||
nmol/day | C85751 | A unit of substance flow rate equal to one nanomole per day. | Nanomole per Day | |||
nmol/dL | C198395 | A unit of concentration (molarity unit) equal to one nanomole of solute in one deciliter of solution. | Nanomole per Deciliter | |||
nmol/g | C85752 | nmol/g;pmol/mg;umol/kg | Nanomoles per gram. | Nanomole per Gram | ||
nmol/kg/day | C176379 | pmol/g/day | A dose calculation unit expressed in nanomole(s) per kilogram per period of time equal to twenty-four hours. | Nanomole per Kilogram per Day | ||
nmol/L | C67432 | Nanomole per Liter;pmol/mL | A unit of concentration (molarity unit) equal to one nanomole of solute per liter of solution. | Nanomole per Liter | ||
nmol/L/h | C122218 | pmol/mL/h | A rate unit expressed in nanomole(s) per liter of solution per period of time equal to sixty minutes. | Nanomole per Liter per Hour | ||
nmol/L/min | C122219 | nmol*min/L;pmol/mL/min | A rate unit equal to the number of nanomoles per unit of volume equal to one liter per unit of time equal to one minute. | Nanomole per Liter per Minute | ||
nmol/L/s | C189645 | nmol/(L*s);nmol/(s*L);nmol/s/L | A concentration unit equal to one nanomole of solute in one liter of solution per unit of time equal to one second. | Nanomole per Liter per Second | ||
nmol/mg/h | C198396 | mmol/kg/h;umol/g/h | A dose calculation unit expressed in nanomole(s) per milligram per period of time equal to one hour. | Nanomole per Milligram per Hour | ||
nmol/mg/min | C198397 | mmol/kg/min;umol/g/min | A dose calculation unit expressed in nanomole(s) per milligram per period of time equal to one minute. | Nanomole per Milligram per Minute | ||
nmol/mL/min | C92613 | Nanomole per Milliliter per Minute | A unit of concentration (molarity unit) equal to one billionth of a mole (1E-9 mole) of solute in one milliliter of solution to be administered per minute of time. | Nanomole per Minute per Milliliter | ||
nmol/mol | C122220 | pmol/mmol | A unit of fraction expressed as the ratio of the amount of a substance in solution, in nanomoles, to the amount of a different substance in the mixture, in moles. | Nanomole per Mole | ||
ns | C73767 | Nanosecond;nsec | A unit of time equal to one billionth of a second. (NCI) | Nanosecond | ||
nU/cL | C105513 | Nanounit per Centiliter | An arbitrary unit of substance content expressed in nanounit(s) per centiliter. (NCI) | Nanounit Per Centiliter | ||
OD Unit | C73681 | OD;OD_Unit;Optical Density Unit | A unit of optical density expressed as the degree of absorption of light at a specified wavelength by a solution or suspension. | Unit of Optical Density | ||
ohm | C42554 | Ohm | A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one Ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in Siemens. (NCI) | Ohm | ||
OI50 | C130193 | Opsonization Index 50% | A potency unit equal to the dilution of serum that causes opsonization and phagocytosis of 50% of the bacteria in a sample. (NCI) | Opsonization Index 50% | ||
Organisms | C71186 | A unit of measure of quantity of organisms. | Organism-Based Unit | |||
Organisms/g | C198398 | Organisms Per Gram | A unit of measure of organism content expressed in organisms per unit of mass equal to one gram. | Organism Per Gram | ||
Organisms/mL | C198399 | Organisms Per Milliliter | A unit of measure of organism concentration expressed in organisms per unit of volume equal to one milliliter. | Organism Per Milliliter | ||
Osm | C67330 | Osmole | A unit of osmotic pressure equal to that of an ideal solution of a nondissociating substance that has a concentration of one mole of solute per liter of solution.(NCI) | Osmole | ||
oz eq | C172605 | Ounce Equivalent;oz-eq | A unit of relative amount of a substance equal to one ounce. | Ounce Equivalent | ||
oz | C48519 | Ounce | A unit of mass, the avoirdupois ounce is equal to 1/16 pound, or 28.3495 grams, or 0.911 457 troy ounce.(NCI) | Ounce | ||
P | C154857 | Poise | A unit of dynamic viscosity equal to one pascal-second. | Poise | ||
Pa | C42547 | Pascal | A unit of pressure equivalent to one Newton per square meter or 10 bars or to 1.45x10(E-4) pounds per square inch.(NCI) | Pascal | ||
PA | C74924 | /Year;Every Year;Per Annum;Per Year | A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days. | Per Year | ||
Pack Year | C73993 | A quantification of lifetime tobacco exposure defined as (number of cigarettes smoked per day x number of years smoked)/20. One pack-year is smoking 20 cigarettes a day for one year. | Pack Year | |||
PACK | C62653 | A number of individual items packaged as a unit. | Pack Dosage Form | |||
PACKAGE | C48520 | Pack Dosing Unit;Package Dosing Unit | A dosing measurement based on the package unit.(NCI) | Package Dosing Unit | ||
PACKET | C48521 | Packet Dosing Unit | A dosing measurement based on the packet unit.(NCI) | Packet Dosing Unit | ||
PATCH | C48524 | Patch Dosing Unit | A dosing measurement based on the patch unit.(NCI) | Patch Dosing Unit | ||
PELLET | C48525 | Pellet Dosing Unit | A dosing measurement based on the pellet unit.(NCI) | Pellet Dosing Unit | ||
PFU | C67264 | Plaque Forming Unit | A unit of measurement of plaque forming cells or microorganisms. | Plaque Forming Unit | ||
PFU/animal | C122221 | A unit of measure expressed in plaque forming unit(s) per animal. | Plaque Forming Units per Animal | |||
PFU/dose | C71198 | Plaque Forming Unit per Dose | A unit of measure expressed in plaque forming unit(s) per dose. | Plaque Forming Unit per Dose | ||
PFU/mL | C71199 | Plaque Forming Unit per Milliliter | A unit of measure expressed in plaque forming unit(s) per milliliter of dosing volume. | Plaque Forming Unit per Milliliter | ||
pg | C64551 | Picogram | A unit of mass equal to one trillionth of a gram (1E-12 gram). (NCI) | Picogram | ||
pg/cell | C176377 | A unit of mass equal to one trillionth of a gram (1E-12 gram) per cell. | Picogram Per Cell | |||
pg/dL | C67331 | Picogram per Deciliter | Picograms per deciliter. | Picogram per Deciliter | ||
pg/L | C85597 | fg/mL;pg/L | A unit of concentration or mass density equal to one femtogram of substance per milliliter of solution or one picogram of substance per liter of solution. | Femtogram per Milliliter | ||
PHERESIS UNIT | C127810 | An arbitrary unit of substance concentration equal to the yield from a blood pheresis procedure. | Pheresis Unit | |||
PILL | C122634 | Pill Dosing Unit | A dosing measurement based on the pill unit. | Pill Dosing Unit | ||
PIPE | C116246 | Pipe Dosing Unit | A dosing measurement based on the pipe unit. | Pipe Dosing Unit | ||
PIXEL | C48367 | The smallest resolvable rectangular area of an image, either on a screen or stored in memory. (NCI) | Pixel | |||
PIXELS/cm | C114238 | Pixels per Centimeter;PPCM | A unit of image resolution expressed in the numbers of pixels per centimeter in the horizontal or vertical direction. | Pixels per Centimeter | ||
PIXELS/in | C114239 | Pixels per Inch;PPI | A unit of image resolution expressed in the numbers of pixels per inch in the horizontal or vertical direction. | Pixels per Inch | ||
pkat | C70509 | Picokatal | A unit of catalytic activity measurement equal to trillionth of one katal (1E-12 katal). (NCI) | Picokatal | ||
pkat/L | C122222 | Picokatal per Liter | Unit of catalytic activity concentration defined as activity equal to a picokatal per one liter of the system volume. | Picokatal per Liter | ||
pL | C69189 | Picoliter | A unit of volume equal to one trillionth of a liter (1E-12 liter). (NCI) | Picoliter | ||
PLUG | C149763 | Plug Dosing Unit | A dosing measurement based on the plug unit. | Plug Dosing Unit | ||
pm | C69148 | Picometer | A unit of length equal to one trillionth of a meter (1E-12 meter). (NCI) | Picometer | ||
pmol | C65045 | Picomole | A unit of amount of substance equal to a trillionth (1E-12) of a mole. (NCI) | Picomole | ||
pmol/10^10 cells | C122223 | A unit of concentration (molarity unit) equal to one picomole of substance per 10^10 cells. | Picomole per Ten Billion Cells | |||
pmol/10^9 cells | C122224 | A unit of concentration (molarity unit) equal to one picomole of substance per 10^9 cells. | Picomole per Billion Cells | |||
pmol/day | C122225 | A unit of substance flow rate equal to one picomole per day. | Picomole per Day | |||
pmol/dL | C122226 | Picomoles per Deciliter | A unit of concentration (molarity unit) equal to one picomole of solute per deciliter of solution. | Picomole per Deciliter | ||
pmol/g | C85754 | nmol/kg;pmol/g | Nanomoles (amount), divided by kilograms (weight) or picomoles per gram. | Nanomole per Kilogram | ||
pmol/L | C67434 | Femtomole per Milliliter;fmol/mL;Picomole per Liter | A unit of concentration (molarity unit) equal to one picomole of solute per liter of solution. | Picomole per Liter | ||
pmol/L/h | C122227 | Picomoles per Liter per Hour | A rate unit expressed in picomole(s) per liter of solution per period of time equal to sixty minutes. | Picomole per Liter per Hour | ||
PNU/mL | C116236 | Protein Nitrogen Unit per Milliliter | Unit of measure of potency of an allergenic product expressed as a number of protein nitrogen units per one milliliter of formulation. | Allergenic Protein Nitrogen Unit per Milliliter | ||
POINT | C113499 | A numeric unit used to quantify a score. | Point | |||
POUCH | C48530 | Pouch Dosing Unit | A dosing measurement based on the pouch unit.(NCI) | Pouch Dosing Unit | ||
ppb | C70565 | Part per Billion | A unit of measure referring to one entity counted per one billion entities.(NCI) | Part Per Billion | ||
ppm | C48523 | Part per Million | A unit of measurement referring to one entity counted per one million entities.(NCI) | Part Per Million | ||
ppth | C69112 | Part per Thousand;per mil;per mille;permil | A unit of proportion equal to 1E-3. (NCI) | Part per Thousand | ||
pptr | C70566 | Parts per Trillion | A unit of measure referring to one entity counted per one trillion entities.(NCI) | Part Per Trillion | ||
PRESSOR UNITS | C48532 | Pressor Unit | A dosing measurement based on the pressor unit.(NCI) | Pressor Unit | ||
ps | C73768 | Picosecond;psec | A unit of time equal to one trillionth of a second. (NCI) | Picosecond | ||
psi | C67334 | Pounds per Square Inch | A unit of pressure equivalent to 6.894757 kilopascals, or 703.0696 kilograms per square meter, or 51.71507 millimeters of mercury.(NCI) | Pound per Square Inch | ||
pt_br | C69114 | British Pint;Imperial Pint | A traditional unit of volume equal to 20 British fluid ounces, 34.678 cubic inches or approximately 568.261 milliliters. | Pint British | ||
pt_us | C48529 | US Pint | A United States liquid unit equal to 16 US fluid ounces or 28.875 cubic inches or approximately 473.177 milliliters. | Pint | ||
PUFF | C65060 | Puff Dosing Unit | A means of delivering a defined dose of a therapeutic aerolized solution into either the upper or lower respiratory tract. Metered-dose inhalers or spray pumps are devices that provide a puff dose for delivery into either the oral or the nasal cavity.(NCI) | Puff Dosing Unit | ||
PUMP | C111984 | Pump Dosing Unit | A dosing measurement based on the pump unit. | Pump Dosing Unit | ||
QUANTITY SUFFICIENT | C48590 | Quantity Sufficient | A quantity of an ingredient or product needed to bring up a volume or weight of the preparation to a final amount as it is indicated in the prescription; also refers to a determination of an adequate supply of medicine to fulfill either a prescribed amount or a sufficient quantity to provide treatment over a specified time frame.(NCI) | Quantity Sufficient | ||
Rad | C18064 | Rad | The special unit for absorbed radiation dose, which is the amount of energy from any type of ionizing radiation (e.g., alpha, beta, gamma, neutrons, etc.) deposited in any medium (e.g., water, tissue, air). A dose of one rad means the absorption of 100 ergs per gram of absorbing tissue. One rad is equal to 0.01 gray.(NCI) | Rad | ||
rad/s | C184714 | radian/s;Radians Per Second | A unit of angular velocity equal to one radian per second. | Radians Per Second | ||
RADIOACTIVE SEED IMPLANT | C67446 | Radioactive Seed Implant Dosing Unit | A dosing measurement based on the radioactive seed implant unit. | Radioactive Seed Implant Dosing Unit | ||
RAE | C67436 | Retinol Activity Equivalent | A unit of biological activity expressed in equivalents of retinol activity. | Retinol Equivalent | ||
RATIO | C44256 | The quotient of one quantity divided by another, with the same units of measurement. | Ratio | |||
RFU | C77535 | Relative Fluorescence Intensity Unit;Relative Fluorescence Unit;Relative Intensity Unit;RFIU;RIU | An arbitrary unit used to measure the intensity of the emitted fluorescent light in a sample; it is dependent on instrument and measurement parameters. | Relative Fluorescence Intensity Unit | ||
RING | C62609 | Ring Dosing Unit | A dosing measurement based on the ring unit.(NCI) | Ring Dosing Unit | ||
RLU | C184722 | Light Unit;LU;Luminometer Unit;Relative Light Unit;Relative Luminescence Unit | An arbitrary unit used to measure the intensity of the emitted light from a sample; it is dependent on instrument and measurement parameters. | Relative Luminescence Unit | ||
RNA copies/mL | C67441 | RNA Copies per Milliliter | The unit of concentration of Ribonucleic Acid (RNA) copies expressed as a number of copies in unit volume equal to one milliliter.(NCI) | RNA Copy per Milliliter | ||
Roentgen | C70575 | Roentgen | A unit of exposure to ionizing radiation. One Roentgen is the amount of gamma or x-rays required to produce ions resulting in a charge of 2.58E-4 Coulombs/kilogram of air under standard conditions.(NCI) | Roentgen | ||
rpm | C70469 | Revolution per Minute | A unit of frequency equal to one revolution per unit of time equal to one minute.(NCI) | Revolution per Minute | ||
s | C42535 | sec;Second | The base unit of time in the International System of Units (SI) equal to the duration of 9,192,631,770 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the cesium 133 atom in its ground state at 0 K. | Second | ||
s*kPa | C139132 | A unit of resistance equal to one second times one kilopascal. | Second Times Kilopascal | |||
s/h | C150899 | sec/hr;Seconds per Hour | A rate unit expressed in seconds per period of time equal to sixty minutes. | Seconds Per Hour | ||
s^-1(%O2)^-1 | C130194 | A unit of oxygen transfer function expressed as the reciprocal of time in seconds, times the reciprocal of oxygen concentration. | Reciprocal of Seconds Times Percent O2 Concentration | |||
SACHET | C71324 | Sachet dosing unit | A dosing unit that contains a solid pharmaceutical preparation in the form of a small packet or bag made from a flexible, often porous material.(NCI) | Sachet Dosing Unit | ||
SBE/mL | C116233 | Standardized Biological Unit per Milliliter | Unit of measure of potency of allergenic product expressed as a number of standardized biological units per one milliliter of formulation. | Standardized Allergy Biological Unit per Milliliter | ||
scm | C68858 | Standard Cubic Meter | A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic meter at standard conditions: temperature 273.15 K and pressure of one atmosphere (101.325 kilopascals).(NCI) | Standard Cubic Meter | ||
SCOOPFUL | C48536 | Scoopful Dosing Unit | A dosing measurement based on the scoopful unit.(NCI) | Scoopful Dosing Unit | ||
SERVING | C184720 | A dosing measurement based on the serving unit. | Serving Dosing Unit | |||
SFC/10^5 PBMC | C191356 | SFU/10^5 PBMC;Spots/10^5 PBMC | A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per one hundred thousand peripheral blood mononuclear cells. | Spot Forming Units Per Ten Thousand Peripheral Blood Mononuclear Cells | ||
SFC/10^6 PBMC | C120850 | SFU/10^6 PBMC;Spots/10^6 PBMC | A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per million peripheral blood mononuclear cells. | Spot Forming Units Per Million Peripheral Blood Mononuclear Cells | ||
SFC/2x10^5 PBMC | C191357 | SFU/2x10^5 PBMC;Spots/2x10^5 PBMC | A unit of activity of cell-mediated immunity expressed as a quantity of spot forming cells per two hundred thousand peripheral blood mononuclear cells. | Spot Forming Units Per Twenty Thousand Peripheral Blood Mononuclear Cells | ||
Shock Wave | C112433 | Shockwave Dosing Unit | A dosing measurement based on the shock wave unit. | Shockwave Dosing Unit | ||
Siemens | C42555 | Siemens | A unit of electrical conductance, admittance, and susceptance. A conductor has a conductance of one Siemens if an electrical potential difference of one volt produces a one Ampere current in it. The conductance in Siemens is the reciprocal of its resistance in ohms.(NCI) | Siemens | ||
SPRAY | C48537 | Spray Dosing Unit | A dosing measurement based on the spray unit.(NCI) | Spray Dosing Unit | ||
SQU/mL | C116234 | SQ-u/mL;Standardized Quality Unit per Milliliter;Standardized Quality Unit/mL | Unit of measure of potency of allergenic product expressed as a number of standardized quality units per one milliliter of formulation. | Standardized Allergy Quality Unit per Milliliter | ||
STEPS | C111318 | A unit of measure to quantify the number of strides taken during a normal walking gait. | Step Unit of Distance | |||
steps/min | C166101 | The number of steps, picking up one foot and putting it back down, occurring within a minute unit of time. | Steps Per Minute | |||
ston_av | C198400 | Short ton;US ton | A traditional unit of mass in the United States equal to 2,000 pounds or 0.907 metric tons. | Short Ton | ||
STRIP | C48538 | Strip Dosing Unit | A dosing measurement based on the strip unit.(NCI) | Strip Dosing Unit | ||
SUPPOSITORY | C48539 | Suppository Dosing Unit | A dosing measurement based on the suppository unit.(NCI) | Suppository Dosing Unit | ||
Sv | C42553 | Sievert | A unit of equivalent radiation dose. One Sv is received when the actual absorbed dose of ionizing radiation, after being multiplied by the dimensionless factors Q (the relative biological efficiency or quality factor) and N (the product of any other multiplying factors that takes into account the distribution of energy throughout the dose), is one joule per kilogram. In this scheme, the relationship between the absorbed dose of radiation D and the dose equivalent H is, therefore, given by H = QND. Both Q and N are stipulated by the International Commission on Radiological Protection. One Sv is equal to 100 rem.(NCI) | Sievert | ||
SYRINGE | C48540 | Syringe Dosing Unit | A dosing measurement based on the syringe unit.(NCI) | Syringe Dosing Unit | ||
TABLET | C48542 | tab;Tablet Dosing Unit | A dosing measurement based on the tablet unit.(NCI) | Tablet Dosing Unit | ||
TAMPON | C48543 | Tampon Dosing Unit | A dosing measurement based on the tampon unit.(NCI) | Tampon Dosing Unit | ||
Tbsp | C48541 | Tablespoon Dosing Unit | A dosing measurement based on the tablespoon unit. | Tablespoon Dosing Unit | ||
TCID 50/dose | C70537 | 50 Percent Tissue Culture Infective Dose per Dose | A potency unit equal to the potency at which one dose of preparation contains one 50 percent tissue culture infective dose.(NCI) | 50 Percent Tissue Culture Infective Dose per Dose | ||
Tesla | C42557 | Tesla | A unit of magnetic flux density equal to the magnitude of the magnetic field vector necessary to produce a force of one Newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one Weber per square meter.(NCI) | Tesla | ||
Therapeutic Cells | C187669 | A dosing unit for the number of therapeutic cells administered. | Therapeutic Cells Dosing Unit | |||
Therapeutic Cells/m2 | C186224 | A dosing unit for the number of therapeutic cells given per meter squared of body surface area. | Therapeutic Cells per Square Meter | |||
titer | C67454 | Titr;Titre | Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent. | Titer | ||
tonne | C48546 | Metric ton | A metric unit of mass equal to 1,000 kilograms, or 0.984 long tons and 1.102 short tons. | Ton | ||
Torr | C112423 | Torr | A non-SI manometric unit of pressure equal to 1/760 of a standard atmosphere (a standard atmosphere being defined as equal to 101325 pascals). One Torr is equal to 133.3223684 pascals. | Torr | ||
TRACE | C48547 | Trace Dosing Unit | An extremely small amount.(NCI) | Trace Dosing Unit | ||
TRANSDUCING UNIT | C124460 | A unit of biological activity described as the number of viral particles in solution that are capable of infecting a cell and stimulating expression of a transgene. | Transducing Unit | |||
TRANSDUCING UNIT/mL | C124461 | Unit of measure of potency expressed as a number of transducing units per one milliliter of solution. | Transducing Unit per Milliliter | |||
TROCHE | C48548 | Troche Dosing Unit | A dosing measurement based on the troche unit.(NCI) | Troche Dosing Unit | ||
tsp eq | C172603 | Teaspoon Equivalent;tsp-eq | A unit of relative amount of a substance equal to one teaspoon. | Teaspoon Equivalent | ||
tsp | C48544 | Teaspoon Dosing Unit | A dosing measurement based on the teaspoon unit. | Teaspoon Dosing Unit | ||
TUBE | C48549 | Tube Dosing Unit | A dosing measurement based on the tube unit.(NCI) | Tube Dosing Unit | ||
tuberculin unit | C65132 | Tuberculin Unit | An arbitrary unit of tuberculin dosage defined by comparison of clinical response with a preparation of the purified protein derivative standardized for use in humans for tuberculin skin test reaction.(NCI) | Tuberculin Unit | ||
tuberculin unit/0.1mL | C184721 | Tuberculin Unit per 100 Microliters | A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in 0.1mL, or 100uL, of preparation. | Tuberculin Unit per 100 Microliters | ||
tuberculin unit/mL | C70506 | Tuberculin Unit per Milliliter | A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in one milliliter of preparation.(NCI) | Tuberculin Unit per Milliliter | ||
U | C44278 | Unit | A single undivided thing occurring in the composition of something else; a unit representing equivalence with a reference measurement. | Unit | ||
U.CARR | C120851 | CARR U;Carratelli Unit | An arbitrary unit of substance concentration expressed in milligrams per a volume of hydrogen peroxide. One Carratelli unit is equal to 0.8mg substance per liter of hydrogen peroxide. | Carratelli Unit | ||
U/10^12 RBC | C122228 | A unit of substance content expressed in units of biological activity per 10^12 red blood cells. | Unit per Trillion Red Blood Cells | |||
U/animal | C73773 | Unit per Animal | A dosing unit expressed in unit(s) per animal. | Unit per Animal | ||
U/cL | C105520 | Unit per Centiliter | A unit of substance content expressed in unit(s) per centiliter. | Unit Per Centiliter | ||
U/dL | C105521 | Unit per Deciliter | A unit of substance content expressed in unit(s) per deciliter. | Unit Per Deciliter | ||
U/g Hb | C105522 | A unit of concentration (biologic activity) equal to one unit of substance per gram of hemoglobin. | Unit Per Gram Hemoglobin | |||
U/g | C77606 | Unit per Gram | A unit of substance content expressed in unit(s) per gram. | Unit per Gram | ||
U/g/day | C73774 | Unit per Gram per Day | A unit of substance rate expressed in unit(s) per gram per period of time equal to twenty-four hours. | Unit per Gram per Day | ||
U/g/h | C73775 | Unit per Gram per Hour | A unit of substance rate expressed in unit(s) per gram per period of time equal to sixty minutes. | Unit per Gram per Hour | ||
U/g/min | C73776 | Unit per Gram per Minute | A unit of substance rate expressed in unit(s) per gram per period of time equal to sixty seconds. | Unit per Gram per Minute | ||
U/h | C66970 | Unit per Hour;Unit/h | A unit of measure equal to unit(s) per period of time equal to sixty minutes. | Unit per Hour | ||
U/kg | C67465 | Unit per Kilogram | A unit of substance content expressed in units of biological activity per unit of mass equal to one kilogram. Unit per kilogram is also used as a dose calculation unit expressed in arbitrary units per one kilogram of body mass. | Unit per Kilogram | ||
U/kg/day | C73777 | Unit per Kilogram per Day | A unit of substance rate expressed in unit(s) per kilogram per period of time equal to twenty-four hours. | Unit per Kilogram per Day | ||
U/kg/h | C73778 | Unit per Kilogram per Hour | A unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty minutes. | Unit per Kilogram per Hour | ||
U/kg/min | C73779 | Unit per Kilogram per Minute | A unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty seconds. | Unit per Kilogram per Minute | ||
U/L | C67456 | mU/mL;Unit per Liter | A unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance. | Unit per Liter | ||
U/m2 | C67467 | Unit per Square Meter | A unit expressed as a number of arbitrary units of substance per one square meter of a body surface area. | Unit per Square Meter | ||
U/m2/day | C73783 | Unit per Square Meter per Day | A unit of substance rate expressed in unit(s) per square meter per period of time equal to twenty-four hours. | Unit per Square Meter per Day | ||
U/m2/h | C73784 | Unit per Square Meter per Hour | A unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty minutes. | Unit per Square Meter per Hour | ||
U/m2/min | C73785 | Unit per Square Meter per Minute | A unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty seconds. | Unit per Square Meter per Minute | ||
U/mg | C73780 | Unit per Milligram | A unit of substance content expressed in unit(s) per milligram. | Unit per Milligram | ||
U/mL | C77607 | kU/L;Unit per Milliliter | A unit of substance content expressed in unit(s) per milliliter. | Unit per Milliliter | ||
U/mmol | C92618 | Unit per Millimole | A unit of substance concentration equal to the concentration at which one millimole of a mixture contains one unit of a substance. | Unit per Millimole | ||
uCi | C48507 | mcCi;Microcurie | A unit of radioactivity equal to one millionth of a Curie or 37 kilobecquerels, and corresponding to a radioactivity of 37 000 atomic disintegrations per second.(NCI) | Microcurie | ||
uCi/kg | C70571 | mcCi/kg;Microcurie per Kilogram | A unit of specific radioactivity (massic activity) equal to activity of one microcurie of the sample with total mass of one kilogram.(NCI) | Microcurie per Kilogram | ||
uCi/L | C71173 | mcCi/L;Microcurie per Liter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one millionth of a Curie per unit volume equal to one liter.(NCI) | Microcurie per Liter | ||
uEq | C73726 | Microequivalent | A unit of relative amount of a substance equal to one millionth of an equivalent weight.(NCI) | Microequivalent | ||
uEq/L | C117975 | Microequivalent per Liter;Nanoequivalent per Milliliter;nEq/mL | A concentration unit measured as a number of microequivalents of solute per liter of solution. | Microequivalent per Liter | ||
ug | C48152 | mcg;Microgram | A unit of mass equal to one millionth (1E-6) of a gram. | Microgram | ||
ug/animal | C73728 | Microgram per Animal | A unit of measure expressed in microgram(s) per animal. | Microgram per Animal | ||
ug/cm2 | C67311 | mcg/cm2 | A unit of area density defined as a spread rate at which one microgram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit. | Microgram per Square Centimeter | ||
ug/day | C71205 | mcg/day | A unit of mass flow rate equal to one microgram per day. | Microgram per Day | ||
ug/dL | C67305 | Microgram per Deciliter | A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one microgram occupies the volume one deciliter. (NCI) | Microgram per Deciliter | ||
ug/dose | C124462 | A unit of measure expressed in microgram(s) per dose. | Microgram per Dose | |||
ug/g/day | C74921 | Microgram per Gram per Day | A dose calculation unit expressed in microgram(s) per gram per period of time equal to twenty-four hours. (NCI) | Microgram per Gram per Day | ||
ug/g/h | C74922 | Microgram per Gram per Hour | A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty minutes. (NCI) | Microgram per Gram per Hour | ||
ug/g/min | C74923 | Microgram per Gram per Minute | A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty seconds. (NCI) | Microgram per Gram per Minute | ||
ug/h | C67394 | mcg/h | A unit of mass flow rate equal to one microgram per hour. | Microgram per Hour | ||
ug/kg | C67396 | mcg/kg;Microgram per Kilogram;ng/g;pg/mg;ug/kg | A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) | Microgram per Kilogram | ||
ug/kg/day | C73729 | Microgram per Kilogram per Day | A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to twenty-four hours. (NCI) | Microgram per Kilogram per Day | ||
ug/kg/h | C73730 | Microgram per Kilogram per Hour | A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to sixty minutes. (NCI) | Microgram per Kilogram per Hour | ||
ug/kg/min | C71210 | Gamma per Kilogram per Minute;gamma/kg/min;mcg/kg/min;Microgram per Kilogram per Minute | A dose calculation unit equal to one millionth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI) | Microgram per Kilogram per Minute | ||
ug/kg/wk | C89830 | Microgram per Kilogram per Week | A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to seven days. | Microgram per Kilogram per Week | ||
ug/L DDU | C161495 | A unit of equivalent concentration equal to the number of micrograms of D-dimer per unit volume equal to one liter. (NCI) | Micrograms DDU Per Liter | |||
ug/L FEU | C158292 | FEU ug/L;ng/mL FEU;ug FEU/L;ug-L-FEU | A unit of equivalent concentration equal to the number of micrograms of fibrinogen per unit volume equal to one liter. | Microgram per Liter Fibrinogen Equivalent Units | ||
ug/L | C67306 | mcg/L;mg/m3;Microgram per Liter;Milligram per Cubic Meter;Nanogram per Milliliter;ng/mL;ug/L | A unit of concentration or mass density equal to one nanogram of substance per milliliter of solution or one microgram of substance per liter of solution. | Microgram per Liter | ||
ug/L/h | C122229 | ng/mL/h | A rate unit equal to the number of micrograms per unit of volume equal to one liter per unit of time equal to one hour. | Microgram per Liter per Hour | ||
ug/m2 | C67312 | Microgram per Square Meter | A dose calculation unit expressed in microgram(s) per square meter. | Microgram per Square Meter | ||
ug/m2/day | C73787 | Microgram per Square Meter per Day | A dose calculation unit expressed in microgram(s) per square meter per period of time equal to twenty-four hours. (NCI) | Microgram per Square Meter per Day | ||
ug/m2/h | C73727 | Microgram per Square Meter per Hour | A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty minutes. (NCI) | Microgram per Square Meter per Hour | ||
ug/m2/min | C73733 | Microgram per Square Meter per Minute | A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty seconds. (NCI) | Microgram per Square Meter per Minute | ||
ug/min | C71211 | mcg/min | A unit of mass flow rate equal to one microgram per minute. | Microgram per Minute | ||
ug/mL/h | C75905 | Microgram per Milliliter per Hour | A dose calculation unit expressed in microgram(s) per milliliter of solution per period of time equal to sixty minutes. (NCI) | Microgram per Milliliter per Hour | ||
ug/mol | C176385 | ng/mmol;pg/umol | A unit of mass commonly used to express the molar mass of a substance in microgram(s) per mole. | Microgram per Mole | ||
ugEq | C105497 | Microgram Equivalent | A unit of relative amount of substance equal to one millionth of a gram of an equivalent weight. | Microgram Equivalent | ||
ugEq/L | C122230 | ngEq/mL;ugEq/L | A concentration unit measured as the number of microgram equivalents of solute per liter of solution, or as the number of nanogram equivalents of solute per milliliter of solution. | Microgram Equivalent per Liter | ||
uIU/dL | C124463 | A unit of concentration (biologic activity) equal to one micro-international unit of substance per deciliter of solution. | Micro-International Unit per Deciliter | |||
uIU/L | C124464 | A unit of concentration (biologic activity) equal to one micro-international unit of substance per liter of solution. | Micro-International Unit per Liter | |||
ukat | C70562 | mckat;Microkatal | A unit of catalytic activity measurement equal to one millionth of katal (1E-6 katal). (NCI) | Microkatal | ||
ukat/10^12 RBC | C124465 | mckat/10^12 RBC | Unit of catalytic activity concentration defined as activity equal to one millionth of katal per 10^12 erythrocytes. | Microkatal per Trillion Erythrocytes | ||
ukat/g Hb | C189651 | Microkatals per Gram Hemoglobin | A unit of catalytic activity equal to one millionth of one katal (10E-6 katal) per gram of hemoglobin. | Microkatal per Gram Hemoglobin | ||
ukat/L | C67397 | mckat/L;Microkatal per Liter | Unit of catalytic activity concentration defined as activity equal to one millionth of katal per one liter of the system volume.(NCI) | Microkatal per Liter | ||
uL | C48153 | mcL;Microliter;mm3 | A unit of volume accepted for use with the SI and equal to one millionth of a liter (1E-6 liter). (NCI) | Microliter | ||
uL/dose | C124466 | A unit of measure expressed in microliter(s) per dose. | Microliter per Dose | |||
uL/kg/day | C132481 | (uL/day)/kg;uL/kg/day | Microliters per kilogram per day or microliters per day (flow rate), divided by kilograms (weight). | Microliter per Kilogram per Day | ||
uL/mL | C69175 | mcL/mL;Microliter per Milliliter;mL/L | A unit of volume fraction expressed as a number of microliters of the constituent per the volume of the system represented in milliliters.(NCI) | Microliter per Milliliter | ||
um | C48510 | mcm;Micron | A unit of length in metric system equal to 1E-6 meter, or micrometer. (NCI) | Micron | ||
um/day | C126081 | A unit of length equal to one micrometer per unit of time equal to one day. | Micrometer per Day | |||
um/s | C154858 | Micrometers per Second;micron/sec;um/sec | A unit of both speed (scalar) and velocity (vector), defined as the distance of one micrometer travelled per unit time equal to one second. | Micrometer per Second | ||
um2 | C73770 | MicroSquare Meter | A SI unit of area measurement equal to a square whose sides are one micrometer long. (NCI) | Square Micrometer | ||
umol | C48509 | mcmol;Micromole | A unit of amount of substance equal to one millionth (1E-6) of a mole. (NCI) | Micromole | ||
umol/day | C67406 | mcmol/day | A unit of substance flow rate equal to one micromole per day. | Micromole per 24 Hours | ||
umol/dL | C67407 | A unit of concentration (molarity unit) equal to one micromole of solute per deciliter of solution. (NCI) | Micromole per Deciliter | |||
umol/h/mmol | C124467 | A unit of fraction expressed as the ratio of the number of micromoles of substance per unit of time equal to one hour, to the amount of a different substance, in millimoles. | Micromole per Hour per Millimole | |||
umol/kg/min | C126082 | A unit of concentration (molarity unit) equal to one millionth of a mole (1E-6 mole) per kilogram of a substance per period of time equal to sixty seconds. | Micromole per Kilogram per Minute | |||
umol/L | C48508 | nmol/mL | A unit of concentration (molarity unit) equal to one micromole of solute per liter of solution. | Micromole per Liter | ||
umol/L/h | C124468 | A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one hour. | Micromole per Liter per Hour | |||
umol/L/min | C120852 | A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one minute. | Micromole per Liter per Minute | |||
umol/L/s | C105498 | Micromoles per Liter per Second;umol/(L*s);umol/(s*L);umol/L/sec;umol/s/L | A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one second. (NCI) | Micromole Per Liter Per Second | ||
umol/mg/min | C73735 | Micromole per Milligram per Minute | A unit of concentration (molarity unit) equal to one millionth of a mole (1E-6 mole) per milligram of a substance per period of time equal to sixty seconds. (NCI) | Micromole per Milligram per Minute | ||
umol/min | C85708 | mcmol/min | A unit of substance flow rate equal to one micromole per minute. | Micromole per Minute | ||
umol/mol | C122231 | nmol/mmol | A unit of fraction expressed as the ratio of the amount of a substance in solution, in micromoles, to the amount of a different substance in the mixture, in moles. | Micromole per Mole | ||
uOsm | C73736 | Microosmole | A unit of osmotic pressure equal to one millionth of an osmole or the osmotic pressure of a 1E-6 molar solution of a substance that does not dissociate. (NCI) | Microosmole | ||
us | C69149 | Microsecond;usec | A unit of time equal to one millionth of a second. (NCI) | Microsecond | ||
uSiemens | C154859 | uS | A unit of electrical conductance, admittance, and susceptance equal to one millionth of a Siemens (10E-6 Siemens). (NCI) | Microsiemens | ||
USP U | C48469 | United States Pharmacopeia Unit | An arbitrary unit established and approved by the United States Pharmacopeia. | United States Pharmacopeia Unit | ||
uU/dL | C124469 | An arbitrary unit of substance content expressed in microunit(s) per deciliter. | Micro-Unit per Deciliter | |||
uU/L | C124470 | An arbitrary unit of substance content expressed in microunit(s) per liter. | Micro-Unit per Liter | |||
uV | C71175 | mcV;Microvolt | A unit of an electric potential and electromotive force equal to one millionth of a volt.(NCI) | Microvolt | ||
uV*s | C105499 | Microvolt * Seconds;uV*sec | A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one microvolt, when the flux is uniformly reduced to zero within one second. (NCI) | Microvolt Second | ||
uV2 | C166102 | A unit of electromotive force equal to a microvolt squared. | Microvolts Squared | |||
V | C42551 | Volt | A unit of electric potential and electromotive force, equal to the difference of electric potential between two points on a conducting wire carrying a constant current of one Ampere when the power dissipated between the points is one watt. This is equivalent to the potential difference across a resistance of one ohm when one Ampere of current flows through it.(NCI) | Volt | ||
V/s | C105524 | V/s;V/sec;Volt per Second | A SI derived rate unit equal to one volt per unit of time equal to one second. | Volt Per Second | ||
vg/dose | C124471 | Vector Genomes/dose;Vector Genomic Copies/dose;VGC/dose | A unit for cloning vector amount expressed as the number of vector genomes per dose. | Vector Genomes per Dose | ||
vg/kg | C163566 | Vector Genomes per Kilogram;Vector Genomic Copies/kg;VGC/kg | A unit for the vector amount expressed as the number of vector genomes per kilogram of body weight. | Vector Genomes per Kilogram | ||
vg/mL | C124472 | Vector Genomes/mL;Vector Genomic Copies/mL;VGC/mL | A unit for cloning vector concentration expressed as the number of vector genomes per milliliter. | Vector Genomes per Milliliter | ||
VIAL | C48551 | Vial Dosing Unit | A dosing measurement based on the vial unit.(NCI) | Vial Dosing Unit | ||
VIRTUAL PIXEL | C114237 | A type of pixel created from overlying two adjacent real pixels to create an additional virtual image of a pixel that is visible to the human eye. | Virtual Pixel | |||
VOXEL | C79424 | Volume Pixel | The smallest distinguishable part or element of a three-dimensional space or image. | Voxel | ||
vp/dose | C124473 | Viral Particles/dose | A unit for virus amount expressed as the number of viral particles per dose. | Viral Particles per Dose | ||
vp/mL | C124474 | Viral Particles/mL | A unit for virus concentration expressed as the number of viral particles per milliliter. | Viral Particles per Milliliter | ||
WAFER | C48552 | Wafer Dosing Unit | A dosing measurement based on the wafer unit.(NCI) | Wafer Dosing Unit | ||
Watt | C42549 | A unit of power equal to the power which in one second produces or transfers the energy of one joule. The unit is used in measurements of power emitted, transferred or received as radiation, sound waves, heat flow rate, and rate of energy transfer. Equal to 1/746 of horsepower.(NCI) | Watt | |||
Weber | C42556 | V*s;V*sec;Volt Second;Volt-second;Weber | A unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one volt, when the flux is uniformly reduced to zero within one second.(NCI) | Weber | ||
WEEKS | C29844 | Week | Any period of seven consecutive days. (NCI) | Week | ||
yd | C48553 | Yard | A unit of length equal to 3 feet, or 36 inches, or 0.9144 meter.(NCI) | Yard | ||
YEARS | C29848 | Year | The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI) | Year | ||
Back to top | ||||||
CL.C66770.VSRESU | Units for Vital Signs Results
(VSRESU) | text
Extensible: Yes | C66770 | Units for Vital Signs Results | The unit used to record and describe the result of a test investigating a vital sign. (NCI) | CDISC SDTM Unit for Vital Sign Result Terminology |
% | C25613 | Percentage | One hundred times the quotient of one quantity divided by another, with the same units of measurement. | Percentage | ||
beats/min | C49673 | Beats per Minute;BPM;bpm | The number of heartbeats measured per minute time. (NCI) | Beats per Minute | ||
breaths/min | C49674 | Breaths per Minute | The number of breaths (inhalation and exhalation) taken per minute time. (NCI) | Breaths per Minute | ||
C | C42559 | Degree Celsius | A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI) | Degree Celsius | ||
cm | C49668 | Centimeter | A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch. | Centimeter | ||
cmHg | C147129 | Centimeter of Mercury | A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one centimeter rise of mercury in a barometer at the Earth's surface. | Centimeters of Mercury | ||
F | C44277 | Degree Fahrenheit | The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI) | Degree Fahrenheit | ||
g | C48155 | Gram | A unit of mass equal to one thousandth (1E-3) of a kilogram, the kilogram being the base unit of mass in the International System of Units (SI). | Gram | ||
Hz | C42545 | Cycle per Second;cycle/sec;Hertz | A unit of frequency equal to one cycle per second.(NCI) | Hertz | ||
in | C48500 | Inch | A traditional unit of length equal to 2.54 centimeters. (NCI) | Inch | ||
K | C42537 | Kelvin | A basic unit of thermodynamic temperature, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). It is 1/273.16th of the thermodynamic temperature of the triple point of water. This sets the size of the kelvin unit for temperature differences and defines the thermodynamic temperature of an equilibrium mixture of waters ice-liquid-vapor as 273.16 K, where 0 K is the lowest possible temperature ("absolute zero"). | Kelvin | ||
kcal/day | C139135 | A unit of energy equal to one kilocalorie per day. (NCI) | Kilocalorie per Day | |||
kg | C28252 | Kilogram | The base unit of mass in the International System of Units (SI) equal to the mass of the international prototype kilogram, a platinum-iridium cylinder in the custody of the International Bureau of Weights and Measures. | Kilogram | ||
kg/m2 | C49671 | Kilogram per Square Meter | A unit expressed as kilogram of mass per square meter of area.(NCI) | Kilogram per Square Meter | ||
LB | C48531 | lb;lb_av;Pound | A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI) | Pound | ||
m | C41139 | Meter | A meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards.(NCI) | Meter | ||
m2 | C42569 | Square Meter | The standard derived unit of area in the International System of Units (SI) equal to the area of a square whose sides are one meter long. | Square Meter | ||
MET | C127805 | Metabolic Equivalent of Task | A unit of energy expenditure equal to the ratio of metabolic rate during physical activity versus a reference metabolic rate. | Metabolic Equivalent of Task Unit | ||
mm | C28251 | Millimeter | A unit of measure equal to one thousandth of a meter. (NCI) | Millimeter | ||
mmHg | C49670 | Millimeter of Mercury | A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI) | Millimeter of Mercury | ||
Pa | C42547 | Pascal | A unit of pressure equivalent to one Newton per square meter or 10 bars or to 1.45x10(E-4) pounds per square inch.(NCI) | Pascal | ||
RATIO | C44256 | The quotient of one quantity divided by another, with the same units of measurement. | Ratio | |||
Watt | C42549 | A unit of power equal to the power which in one second produces or transfers the energy of one joule. The unit is used in measurements of power emitted, transferred or received as radiation, sound waves, heat flow rate, and rate of energy transfer. Equal to 1/746 of horsepower.(NCI) | Watt | |||
Back to top | ||||||
CL.C103489.UPS01TC | Urgency Perception Scale Questionnaire Test Code
(UPS01TC) | text
Extensible: No | C103489 | Urgency Perception Scale Questionnaire Test Code | Urgency Perception Scale test code. | CDISC Questionnaire UPS Test Code Terminology |
UPS0101 | C103761 | UPS01-Describe Your Desire to Urinate | Urgency Perception Scale - Which of the following would typically describe your experience when you have a desire to urinate. | UPS - Describe Your Experience When You Desire to Urinate | ||
Back to top | ||||||
CL.C103488.UPS01TN | Urgency Perception Scale Questionnaire Test Name
(UPS01TN) | text
Extensible: No | C103488 | Urgency Perception Scale Questionnaire Test Name | Urgency Perception Scale test name. | CDISC Questionnaire UPS Test Name Terminology |
UPS01-Describe Your Desire to Urinate | C103761 | UPS01-Describe Your Desire to Urinate | Urgency Perception Scale - Which of the following would typically describe your experience when you have a desire to urinate. | UPS - Describe Your Experience When You Desire to Urinate | ||
Back to top | ||||||
CL.C129942.URNSTSCD | Urinary System Test Code
(URNSTSCD) | text
Extensible: Yes | C129942 | Urinary System Test Code | A terminology codelist to describe the test code for examinations of the urinary system. | CDISC SDTM Urinary System Test Code Terminology |
BLDFLRT | C94866 | Blood Flow Rate | The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. | Blood Flow Rate | ||
COLOR | C64546 | Color | A measurement of the color of a biological specimen. | Color Assessment | ||
GRFTSTAT | C135522 | Graft Status | The condition of the donated organ or tissue. (NCI) | Graft Status | ||
HEMAIND | C179823 | Hematoma Indicator | An indication as to whether hematoma has occurred. | Hematoma Indicator | ||
LENGTH | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
RNLANUM | C130195 | Number of Renal Arteries | A measurement of the total number of renal arteries. | Number of Renal Arteries | ||
RNLVNUM | C130196 | Number of Renal Veins | A measurement of the total number of renal veins. | Number of Renal Veins | ||
SGDMGIND | C179824 | Surgical Damage Indicator | An indication as to whether surgical damage has occurred. | Surgical Damage Indicator | ||
UREXAM | C198401 | Urinary System Examination | An observation, assessment or examination of the urinary system. | Urinary System Examination | ||
Back to top | ||||||
CL.C129941.URNSTS | Urinary System Test Name
(URNSTS) | text
Extensible: Yes | C129941 | Urinary System Test Name | A terminology codelist to describe the test name for examinations of the urinary system. | CDISC SDTM Urinary System Test Name Terminology |
Blood Flow Rate | C94866 | Blood Flow Rate | The volume of blood per unit time passing through a specified location, such as a point in a blood vessel or an entire organ. | Blood Flow Rate | ||
Color | C64546 | Color | A measurement of the color of a biological specimen. | Color Assessment | ||
Graft Status | C135522 | Graft Status | The condition of the donated organ or tissue. (NCI) | Graft Status | ||
Hematoma Indicator | C179823 | Hematoma Indicator | An indication as to whether hematoma has occurred. | Hematoma Indicator | ||
Length | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
Number of Renal Arteries | C130195 | Number of Renal Arteries | A measurement of the total number of renal arteries. | Number of Renal Arteries | ||
Number of Renal Veins | C130196 | Number of Renal Veins | A measurement of the total number of renal veins. | Number of Renal Veins | ||
Surgical Damage Indicator | C179824 | Surgical Damage Indicator | An indication as to whether surgical damage has occurred. | Surgical Damage Indicator | ||
Urinary System Examination | C198401 | Urinary System Examination | An observation, assessment or examination of the urinary system. | Urinary System Examination | ||
Back to top | ||||||
CL.C102590.VCNEVD | Vaccination Evidence Source
(VCNEVD) | text
Extensible: Yes | C102590 | Vaccination Evidence Source | Terminology relevant to the source of information regarding the subject's vaccination status. | CDISC SDTM Vaccination Evidence Source Terminology |
SCAR | C34483 | A mark left (usually on the skin) by the healing of injured tissue. | Scar | |||
SELF-REPORT | C74528 | An individual's perspective or subjective interpretation of an event or information. | Self-Report | |||
WRITTEN DOCUMENTATION | C86042 | The collecting, abstracting, and coding of printed or written information for future reference. | Written Documentation | |||
Back to top | ||||||
CL.C142187.VNFATSCD | Vaccines Findings About Test Code
(VNFATSCD) | text
Extensible: Yes | C142187 | Vaccines Findings About Test Code | Terminology relevant to the test codes that describe findings about a vaccines event or intervention. | CDISC SDTM Vaccines Findings About Test Code Terminology |
APPEAR | C25377 | Aper | The outward or visible aspect of an entity. | Appearance | ||
DISTR | C198212 | Distribution | Description of the distribution pattern of a finding within the examined area. | Distribution Pattern Finding Description | ||
EPSDNUM | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
GCIRCPI | C187676 | Greatest Circ at Point of Interest;Greatest Circumference at Point of Interest;Largest Circumference at Point of Interest | The circumferential measurement of an entity or object of interest at its widest point. | Greatest Circumference at Point of Interest | ||
LDIAM | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
LESNUM | C174277 | Number of Lesions | The number of lesions observed. | Number of Lesions | ||
NDLGAUGE | C101687 | Needle Gauge | A number representing the outer diameter of a needle. (NCI) | Needle Gauge | ||
NEARJNT | C187675 | Nearest Joint | The anatomical joint in closest proximity to the entity or object of interest. | Nearest Joint | ||
OCCUR | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
PDAIND | C184724 | Prevents Daily Activities Indicator | An indication as to whether the event or intervention prevents or has prevented the performance of daily activities. | Prevents Daily Activities Indicator | ||
PRURIND | C198213 | Pruritus Indicator | An indicator as to whether the subject has symptoms of itchiness. | Pruritus Indicator | ||
SEV | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
TOXGR | C82528 | Toxicity Grade | A standardized categorical classification of the severity of an event or finding. | Toxicity Grade | ||
Back to top | ||||||
CL.C142189.VNFATS | Vaccines Findings About Test Name
(VNFATS) | text
Extensible: Yes | C142189 | Vaccines Findings About Test Name | Terminology relevant to the test names that describe findings about a vaccines event or intervention. | CDISC SDTM Vaccines Findings About Test Name Terminology |
Appearance | C25377 | Aper | The outward or visible aspect of an entity. | Appearance | ||
Distribution | C198212 | Distribution | Description of the distribution pattern of a finding within the examined area. | Distribution Pattern Finding Description | ||
Greatest Circ at Point of Interest | C187676 | Greatest Circ at Point of Interest;Greatest Circumference at Point of Interest;Largest Circumference at Point of Interest | The circumferential measurement of an entity or object of interest at its widest point. | Greatest Circumference at Point of Interest | ||
Longest Diameter | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
Nearest Joint | C187675 | Nearest Joint | The anatomical joint in closest proximity to the entity or object of interest. | Nearest Joint | ||
Needle Gauge | C101687 | Needle Gauge | A number representing the outer diameter of a needle. (NCI) | Needle Gauge | ||
Number of Episodes | C124281 | Number of Episodes | The total number of episodes that have occurred for the condition. | Number of Episodes | ||
Number of Lesions | C174277 | Number of Lesions | The number of lesions observed. | Number of Lesions | ||
Occurrence Indicator | C127786 | Occurrence Indicator | An indication as to whether something has happened, such as an event or incident. | Occurrence Indicator | ||
Prevents Daily Activities Indicator | C184724 | Prevents Daily Activities Indicator | An indication as to whether the event or intervention prevents or has prevented the performance of daily activities. | Prevents Daily Activities Indicator | ||
Pruritus Indicator | C198213 | Pruritus Indicator | An indicator as to whether the subject has symptoms of itchiness. | Pruritus Indicator | ||
Severity/Intensity | C25676 | Severity/Intensity | The degree of something undesirable. | Severity | ||
Toxicity Grade | C82528 | Toxicity Grade | A standardized categorical classification of the severity of an event or finding. | Toxicity Grade | ||
Back to top | ||||||
CL.C141653.VALG01TC | Veterans Administration Lung Study Group Clinical Classification Test Code
(VALG01TC) | text
Extensible: No | C141653 | Veterans Administration Lung Study Group Clinical Classification Test Code | Veterans Administration Lung Study Group test code. | CDISC Clinical Classification VALG Test Code Terminology |
VALG0101 | C141695 | VALG01-Cancer Stage | Veterans Administration Lung Study Group - Cancer stage. | VALG - Cancer Stage | ||
Back to top | ||||||
CL.C141652.VALG01TN | Veterans Administration Lung Study Group Clinical Classification Test Name
(VALG01TN) | text
Extensible: No | C141652 | Veterans Administration Lung Study Group Clinical Classification Test Name | Veterans Administration Lung Study Group test name. | CDISC Clinical Classification VALG Test Name Terminology |
VALG01-Cancer Stage | C141695 | VALG01-Cancer Stage | Veterans Administration Lung Study Group - Cancer stage. | VALG - Cancer Stage | ||
Back to top | ||||||
CL.C130241.VLERS1TC | Vignos Lower Extremity Rating Scale Clinical Classification Test Code
(VLERS1TC) | text
Extensible: No | C130241 | Vignos Lower Extremity Rating Scale Clinical Classification Test Code | Vignos Lower Extremity Rating Scale test code. | CDISC Clinical Classification VLERS Test Code Terminology |
VLERS101 | C130327 | VLERS1-Vignos Lower Extremity Rating | Vignos Lower Extremity Rating Scale - Vignos rating scale. | VLERS - Vignos Lower Extremity Rating | ||
Back to top | ||||||
CL.C130240.VLERS1TN | Vignos Lower Extremity Rating Scale Clinical Classification Test Name
(VLERS1TN) | text
Extensible: No | C130240 | Vignos Lower Extremity Rating Scale Clinical Classification Test Name | Vignos Lower Extremity Rating Scale test name. | CDISC Clinical Classification VLERS Test Name Terminology |
VLERS1-Vignos Lower Extremity Rating | C130327 | VLERS1-Vignos Lower Extremity Rating | Vignos Lower Extremity Rating Scale - Vignos rating scale. | VLERS - Vignos Lower Extremity Rating | ||
Back to top | ||||||
CL.C66741.VSTESTCD | Vital Signs Test Code
(VSTESTCD) | text
Extensible: Yes | C66741 | Vital Signs Test Code | The test code given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure. | CDISC SDTM Vital Sign Test Code Terminology |
ABSKNF | C103346 | Abdominal Skinfold Thickness | A measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI) | Abdominal Skinfold Thickness | ||
ARMSPAN | C181553 | Arm Span;Armspan;Reach;Wingspan | A measurement of the length from the tip of the middle finger on one hand to the tip of the middle finger on the other hand with the individual standing against the wall with both arms abducted to 90 degrees, the elbows and wrists extended, and the palms facing directly forward. (Philip H. Quanjer, Andre Capderou, Mumtaz M. Mazicioglu, Ashutosh N. Aggarwal, Sudip Datta Banik, Stevo Popovic, Francis A.K. Tayie, Mohammad Golshan, Mary S.M. Ip, Marc Zelter. European Respiratory Journal 2014 44: 905-912) | Arm Span | ||
BMI | C16358 | Body Mass Index | A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI) | Body Mass Index | ||
BMIAPCTL | C163567 | BMI-for-Age Percentile | An assessed relationship of an individual's body mass index and age to that of a reference population, expressed as a percentile. | BMI-for-Age Percentile | ||
BMR | C126083 | Basal Metabolic Rate | The measurement of a subject's energy expenditure when at rest. | Basal Metabolic Rate | ||
BODLNGTH | C81298 | Body Length | The linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end. | Total Body Length | ||
BODYFATM | C122232 | Body Fat Measurement | A measurement of the total fat mass within the subject's body. (NCI) | Body Fat Measurement | ||
BRTHWT | C76325 | Birth Weight | A measurement of the weight of a neonate at birth. | Birth Weight | ||
BSA | C25157 | Body Surface Area | A measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI) | Body Surface Area | ||
CALFCIR | C178060 | Calf Circumference | A circumferential measurement of the lower leg in the region of the calf at the widest point. | Calf Circumference | ||
CHESTCIR | C156606 | Chest Circumference | The distance around an individual's chest. | Chest Circumference | ||
CPLRFLT | C168125 | Capillary Refill Time | The amount of time it takes for a capillary bed to refill with blood after pressure blanching. | Capillary Refill Test | ||
CRWNHEEL | C170639 | Crown-to-Heel Length | A measurement of the length of the body from the crown of the head to the bottom of the heel. | Crown to Heel Length | ||
DBPAPCTL | C172610 | Diastolic Blood Pressure-for-Age Percentile;Diastolic BP-for-Age Percentile | An assessed relationship of an individual's diastolic blood pressure and age to that of a reference population, expressed as a percentile. | Diastolic Blood Pressure-for-Age Percentile | ||
DBPHPCTL | C172609 | Diastolic Blood Pressure-for-Height Percentile;Diastolic BP-for-Height Percentile | An assessed relationship of an individual's diastolic blood pressure and height to that of a reference population, expressed as a percentile. | Diastolic Blood Pressure-for-Height Percentile | ||
DIABP | C25299 | Diastolic Blood Pressure | The minimum blood pressure in the systemic arterial circulation during the cardiac cycle. | Diastolic Blood Pressure | ||
ECW | C191364 | A measurement of the quantity of water in the extracellular compartments within the body. | Extracellular Water Measurement | |||
ECWTBW | C191363 | ECW/TBW;Extracellular Water/Total Body Water | A relative measurement (ratio or percentage) of the quantity of water in extracellular compartments to the total quantity of water within the body. | Extracellular Water to Total Body Water Ratio Measurement | ||
ENRGEXP | C147491 | Energy Expenditure | A measurement of the amount of energy used to carry out a physiological or physical function. | Energy Expenditure | ||
EWEIGHT | C132482 | Estimated Body Weight;Estimated Weight | An approximate determination of the body weight of the subject. | Estimated Body Weight | ||
FARMCIR | C100946 | Forearm Circumference | The distance around an individual's forearm. | Forearm Circumference | ||
FIO2 | C38082 | Fraction of Inspired Oxygen | A measurement of the volumetric fraction of oxygen in the inhaled gas. | Fraction of Inspired Oxygen | ||
FRMSIZE | C49680 | Body Frame Size | The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI) | Body Frame Size | ||
FTEWT | C174372 | Fetal Estimated Weight | An approximate determination of the weight of the fetus. | Fetal Estimated Weight | ||
FTHDCIRC | C158297 | Fetal Head Circumference | A circumferential measurement of the fetal head at the widest point. | Fetal Head Circumference | ||
FTHR | C92716 | Fetal Heart Rate;Fetal HR | The number of fetal heartbeats per unit of time. | Fetal Heart Rate | ||
FTMANDL | C174375 | Fetal Mandibular Length | A measurement of the length of the fetal mandible. | Fetal Mandibular Length | ||
FTSAD | C174373 | Fetal SAD;Fetal Sagittal Abdominal Diameter | A measurement of the sagittal abdominal diameter of the fetus. | Fetal Sagittal Abdominal Diameter | ||
FTWTGAPL | C174374 | Fetal Weight-for-Gest Age Percentile;Fetal Weight-for-Gestational Age Percentile | An assessed relationship of the fetal weight and gestational age to that of a reference population, expressed as a percentile. | Fetal Weight-for-Gestational Age Percentile | ||
HDCIRC | C81255 | Head Circumference | A circumferential measurement of the head at the widest point. | Head Circumference | ||
HEIGHT | C25347 | Height | The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI) | Height | ||
HIPCIR | C100947 | Hip Circumference | The distance around an individual's pelvic area or hips. | Hip Circumference | ||
HR | C49677 | Heart Rate | The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI) | Heart Rate | ||
HTAPCTL | C163568 | Height-for-Age Percentile | An assessed relationship of an individual's height and age to that of a reference population, expressed as a percentile. | Height-for-Age Percentile | ||
IDEALWT | C117976 | Ideal Body Weight | A person's optimum weight as calculated by a standard methodology. | Ideal Body Weight | ||
INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
KNEEHEEL | C84372 | Knee to Heel Length | A measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI) | Knee to Heel Length Measurement | ||
LBM | C71258 | Lean Body Mass | The weight of all organs and tissue in an individual less the weight of the individual's body fat. | Lean Body Mass | ||
LBMTBMR | C139219 | Lean Body Mass to Total Body Mass Ratio | The proportion of an individual's lean body mass to his total body weight. Lean body mass is calculated by subtracting body fat from total body weight. | Lean Body Mass to Total Body Mass Ratio | ||
MANDL | C174233 | Mandibular Length | A measurement of the length of the mandible. | Mandibular Length | ||
MAP | C49679 | Mean Arterial Pressure | The mean pressure of the blood within the arterial circulation. | Mean Arterial Pressure | ||
MAXPREHR | C147492 | Maximum Predicted Heart Rate | The predicted upper limit for an individual's heart rate, which is calculated as 220 minus the subject's age for men, and 210 minus the subject's age for women. | Maximum Predicted Heart Rate | ||
MUARMCIR | C124475 | Mid-Upper Arm Circumference | The distance around an individual's upper arm, at the widest point. | Mid-Upper Arm Circumference | ||
NECKCIR | C154891 | Neck Circumference | A circumferential measurement of the neck, just below the larynx. | Neck Circumference | ||
OXYSAT | C60832 | Oxygen Saturation | A measurement of the oxygen-hemoglobin saturation of a volume of blood. | Oxygen Saturation Measurement | ||
PULSE | C49676 | Pulse Rate | The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI) | Pulse Rate | ||
PULSEPR | C100945 | Pulse Pressure | The change in systolic to diastolic pressure which produces a pulse. | Pulse Pressure | ||
RESP | C49678 | Respiratory Rate | The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI) | Respiratory Rate | ||
SAD | C87054 | Sagittal Abdominal Diameter | A standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI) | Sagittal Abdominal Diameter | ||
SAO2FIO2 | C174311 | Oxygen Saturation/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. | Oxygen Saturation/Fraction Inspired O2 | ||
SBPAPCTL | C172608 | Systolic Blood Pressure-for-Age Percentile;Systolic BP-for-Age Percentile | An assessed relationship of an individual's systolic blood pressure and age to that of a reference population, expressed as a percentile. | Systolic Blood Pressure-for-Age Percentile | ||
SBPHPCTL | C172607 | Systolic Blood Pressure-for-Height Percentile;Systolic BP-for-Height Percentile | An assessed relationship of an individual's systolic blood pressure and height to that of a reference population, expressed as a percentile. | Systolic Blood Pressure-for-Height Percentile | ||
SSSKNF | C98785 | Subscapular Skinfold Thickness | A measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI) | Subscapular Skinfold Thickness | ||
SYSBP | C25298 | Systolic Blood Pressure | The maximum blood pressure in the systemic arterial circulation during the cardiac cycle. | Systolic Blood Pressure | ||
TBW | C104622 | Total Body Water | A measurement of the quantity of water within the body, including both the intracellular and extracellular compartments. | Total Body Water Measurement | ||
TEMP | C174446 | Body Temperature;Temperature | A measurement of the temperature of the body. | Body Temperature | ||
TEMPCB | C174370 | Core Body Temperature | A measurement of the temperature within the deep tissues of the body. | Core Body Temperature | ||
TEMPPB | C174371 | Peripheral Body Temperature | A measurement of the temperature of the body at or near its surface. | Peripheral Body Temperature | ||
TIBIAL | C191365 | Tibial Length | A measurement of the length of the tibia. | Tibial Length | ||
TRSKNF | C98793 | Triceps Skinfold Thickness | A measurement of the thickness of a pinch of skin on the triceps. (NCI) | Triceps Skinfold Thickness | ||
ULNARL | C174376 | Ulnar Length | A measurement of the length of the ulna. | Ulnar Length | ||
WAISTHIP | C17651 | Waist to Hip Ratio | A relative measurement (ratio) of the waist circumference to the hip circumference. | Waist-Hip Ratio | ||
WASTHEEL | C181552 | Waist to Heel Length | A measurement from the top of the waist to the bottom of the heel. | Waist to Heel Length | ||
WEIGHT | C25208 | Weight | The vertical force exerted by a mass as a result of gravity. (NCI) | Weight | ||
WSTCIR | C100948 | Waist Circumference | The distance around an individual's midsection or waist. | Waist Circumference | ||
WTAPCTL | C163569 | Weight-for-Age Percentile | An assessed relationship of an individual's weight and age to that of a reference population, expressed as a percentile. | Weight-for-Age Percentile | ||
WTHTPCTL | C163570 | Weight-for-Height Percentile | An assessed relationship of an individual's weight and height to that of a reference population, expressed as a percentile. | Weight-for-Height Percentile | ||
Back to top | ||||||
CL.C67153.VSTEST | Vital Signs Test Name
(VSTEST) | text
Extensible: Yes | C67153 | Vital Signs Test Name | The test name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure. | CDISC SDTM Vital Sign Test Name Terminology |
Abdominal Skinfold Thickness | C103346 | Abdominal Skinfold Thickness | A measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI) | Abdominal Skinfold Thickness | ||
Arm Span | C181553 | Arm Span;Armspan;Reach;Wingspan | A measurement of the length from the tip of the middle finger on one hand to the tip of the middle finger on the other hand with the individual standing against the wall with both arms abducted to 90 degrees, the elbows and wrists extended, and the palms facing directly forward. (Philip H. Quanjer, Andre Capderou, Mumtaz M. Mazicioglu, Ashutosh N. Aggarwal, Sudip Datta Banik, Stevo Popovic, Francis A.K. Tayie, Mohammad Golshan, Mary S.M. Ip, Marc Zelter. European Respiratory Journal 2014 44: 905-912) | Arm Span | ||
Basal Metabolic Rate | C126083 | Basal Metabolic Rate | The measurement of a subject's energy expenditure when at rest. | Basal Metabolic Rate | ||
Birth Weight | C76325 | Birth Weight | A measurement of the weight of a neonate at birth. | Birth Weight | ||
BMI-for-Age Percentile | C163567 | BMI-for-Age Percentile | An assessed relationship of an individual's body mass index and age to that of a reference population, expressed as a percentile. | BMI-for-Age Percentile | ||
Body Fat Measurement | C122232 | Body Fat Measurement | A measurement of the total fat mass within the subject's body. (NCI) | Body Fat Measurement | ||
Body Frame Size | C49680 | Body Frame Size | The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI) | Body Frame Size | ||
Body Length | C81298 | Body Length | The linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end. | Total Body Length | ||
Body Mass Index | C16358 | Body Mass Index | A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI) | Body Mass Index | ||
Body Surface Area | C25157 | Body Surface Area | A measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI) | Body Surface Area | ||
Calf Circumference | C178060 | Calf Circumference | A circumferential measurement of the lower leg in the region of the calf at the widest point. | Calf Circumference | ||
Capillary Refill Time | C168125 | Capillary Refill Time | The amount of time it takes for a capillary bed to refill with blood after pressure blanching. | Capillary Refill Test | ||
Chest Circumference | C156606 | Chest Circumference | The distance around an individual's chest. | Chest Circumference | ||
Core Body Temperature | C174370 | Core Body Temperature | A measurement of the temperature within the deep tissues of the body. | Core Body Temperature | ||
Crown-to-Heel Length | C170639 | Crown-to-Heel Length | A measurement of the length of the body from the crown of the head to the bottom of the heel. | Crown to Heel Length | ||
Diastolic Blood Pressure | C25299 | Diastolic Blood Pressure | The minimum blood pressure in the systemic arterial circulation during the cardiac cycle. | Diastolic Blood Pressure | ||
Diastolic BP-for-Age Percentile | C172610 | Diastolic Blood Pressure-for-Age Percentile;Diastolic BP-for-Age Percentile | An assessed relationship of an individual's diastolic blood pressure and age to that of a reference population, expressed as a percentile. | Diastolic Blood Pressure-for-Age Percentile | ||
Diastolic BP-for-Height Percentile | C172609 | Diastolic Blood Pressure-for-Height Percentile;Diastolic BP-for-Height Percentile | An assessed relationship of an individual's diastolic blood pressure and height to that of a reference population, expressed as a percentile. | Diastolic Blood Pressure-for-Height Percentile | ||
Energy Expenditure | C147491 | Energy Expenditure | A measurement of the amount of energy used to carry out a physiological or physical function. | Energy Expenditure | ||
Estimated Weight | C132482 | Estimated Body Weight;Estimated Weight | An approximate determination of the body weight of the subject. | Estimated Body Weight | ||
Extracellular Water | C191364 | A measurement of the quantity of water in the extracellular compartments within the body. | Extracellular Water Measurement | |||
Extracellular Water/Total Body Water | C191363 | ECW/TBW;Extracellular Water/Total Body Water | A relative measurement (ratio or percentage) of the quantity of water in extracellular compartments to the total quantity of water within the body. | Extracellular Water to Total Body Water Ratio Measurement | ||
Fetal Estimated Weight | C174372 | Fetal Estimated Weight | An approximate determination of the weight of the fetus. | Fetal Estimated Weight | ||
Fetal Head Circumference | C158297 | Fetal Head Circumference | A circumferential measurement of the fetal head at the widest point. | Fetal Head Circumference | ||
Fetal Heart Rate | C92716 | Fetal Heart Rate;Fetal HR | The number of fetal heartbeats per unit of time. | Fetal Heart Rate | ||
Fetal Mandibular Length | C174375 | Fetal Mandibular Length | A measurement of the length of the fetal mandible. | Fetal Mandibular Length | ||
Fetal Sagittal Abdominal Diameter | C174373 | Fetal SAD;Fetal Sagittal Abdominal Diameter | A measurement of the sagittal abdominal diameter of the fetus. | Fetal Sagittal Abdominal Diameter | ||
Fetal Weight-for-Gest Age Percentile | C174374 | Fetal Weight-for-Gest Age Percentile;Fetal Weight-for-Gestational Age Percentile | An assessed relationship of the fetal weight and gestational age to that of a reference population, expressed as a percentile. | Fetal Weight-for-Gestational Age Percentile | ||
Forearm Circumference | C100946 | Forearm Circumference | The distance around an individual's forearm. | Forearm Circumference | ||
Fraction of Inspired Oxygen | C38082 | Fraction of Inspired Oxygen | A measurement of the volumetric fraction of oxygen in the inhaled gas. | Fraction of Inspired Oxygen | ||
Head Circumference | C81255 | Head Circumference | A circumferential measurement of the head at the widest point. | Head Circumference | ||
Heart Rate | C49677 | Heart Rate | The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI) | Heart Rate | ||
Height | C25347 | Height | The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI) | Height | ||
Height-for-Age Percentile | C163568 | Height-for-Age Percentile | An assessed relationship of an individual's height and age to that of a reference population, expressed as a percentile. | Height-for-Age Percentile | ||
Hip Circumference | C100947 | Hip Circumference | The distance around an individual's pelvic area or hips. | Hip Circumference | ||
Ideal Body Weight | C117976 | Ideal Body Weight | A person's optimum weight as calculated by a standard methodology. | Ideal Body Weight | ||
Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
Knee to Heel Length | C84372 | Knee to Heel Length | A measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI) | Knee to Heel Length Measurement | ||
Lean Body Mass to Total Body Mass Ratio | C139219 | Lean Body Mass to Total Body Mass Ratio | The proportion of an individual's lean body mass to his total body weight. Lean body mass is calculated by subtracting body fat from total body weight. | Lean Body Mass to Total Body Mass Ratio | ||
Lean Body Mass | C71258 | Lean Body Mass | The weight of all organs and tissue in an individual less the weight of the individual's body fat. | Lean Body Mass | ||
Mandibular Length | C174233 | Mandibular Length | A measurement of the length of the mandible. | Mandibular Length | ||
Maximum Predicted Heart Rate | C147492 | Maximum Predicted Heart Rate | The predicted upper limit for an individual's heart rate, which is calculated as 220 minus the subject's age for men, and 210 minus the subject's age for women. | Maximum Predicted Heart Rate | ||
Mean Arterial Pressure | C49679 | Mean Arterial Pressure | The mean pressure of the blood within the arterial circulation. | Mean Arterial Pressure | ||
Mid-Upper Arm Circumference | C124475 | Mid-Upper Arm Circumference | The distance around an individual's upper arm, at the widest point. | Mid-Upper Arm Circumference | ||
Neck Circumference | C154891 | Neck Circumference | A circumferential measurement of the neck, just below the larynx. | Neck Circumference | ||
Oxygen Saturation | C60832 | Oxygen Saturation | A measurement of the oxygen-hemoglobin saturation of a volume of blood. | Oxygen Saturation Measurement | ||
Oxygen Saturation/Fraction Inspired O2 | C174311 | Oxygen Saturation/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the oxygen-hemoglobin saturation of a volume of blood to the volumetric fraction of oxygen in the inhaled gas. | Oxygen Saturation/Fraction Inspired O2 | ||
Peripheral Body Temperature | C174371 | Peripheral Body Temperature | A measurement of the temperature of the body at or near its surface. | Peripheral Body Temperature | ||
Pulse Pressure | C100945 | Pulse Pressure | The change in systolic to diastolic pressure which produces a pulse. | Pulse Pressure | ||
Pulse Rate | C49676 | Pulse Rate | The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI) | Pulse Rate | ||
Respiratory Rate | C49678 | Respiratory Rate | The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI) | Respiratory Rate | ||
Sagittal Abdominal Diameter | C87054 | Sagittal Abdominal Diameter | A standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI) | Sagittal Abdominal Diameter | ||
Subscapular Skinfold Thickness | C98785 | Subscapular Skinfold Thickness | A measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI) | Subscapular Skinfold Thickness | ||
Systolic Blood Pressure | C25298 | Systolic Blood Pressure | The maximum blood pressure in the systemic arterial circulation during the cardiac cycle. | Systolic Blood Pressure | ||
Systolic BP-for-Age Percentile | C172608 | Systolic Blood Pressure-for-Age Percentile;Systolic BP-for-Age Percentile | An assessed relationship of an individual's systolic blood pressure and age to that of a reference population, expressed as a percentile. | Systolic Blood Pressure-for-Age Percentile | ||
Systolic BP-for-Height Percentile | C172607 | Systolic Blood Pressure-for-Height Percentile;Systolic BP-for-Height Percentile | An assessed relationship of an individual's systolic blood pressure and height to that of a reference population, expressed as a percentile. | Systolic Blood Pressure-for-Height Percentile | ||
Temperature | C174446 | Body Temperature;Temperature | A measurement of the temperature of the body. | Body Temperature | ||
Tibial Length | C191365 | Tibial Length | A measurement of the length of the tibia. | Tibial Length | ||
Total Body Water | C104622 | Total Body Water | A measurement of the quantity of water within the body, including both the intracellular and extracellular compartments. | Total Body Water Measurement | ||
Triceps Skinfold Thickness | C98793 | Triceps Skinfold Thickness | A measurement of the thickness of a pinch of skin on the triceps. (NCI) | Triceps Skinfold Thickness | ||
Ulnar Length | C174376 | Ulnar Length | A measurement of the length of the ulna. | Ulnar Length | ||
Waist Circumference | C100948 | Waist Circumference | The distance around an individual's midsection or waist. | Waist Circumference | ||
Waist to Heel Length | C181552 | Waist to Heel Length | A measurement from the top of the waist to the bottom of the heel. | Waist to Heel Length | ||
Waist to Hip Ratio | C17651 | Waist to Hip Ratio | A relative measurement (ratio) of the waist circumference to the hip circumference. | Waist-Hip Ratio | ||
Weight | C25208 | Weight | The vertical force exerted by a mass as a result of gravity. (NCI) | Weight | ||
Weight-for-Age Percentile | C163569 | Weight-for-Age Percentile | An assessed relationship of an individual's weight and age to that of a reference population, expressed as a percentile. | Weight-for-Age Percentile | ||
Weight-for-Height Percentile | C163570 | Weight-for-Height Percentile | An assessed relationship of an individual's weight and height to that of a reference population, expressed as a percentile. | Weight-for-Height Percentile | ||
Back to top | ||||||
CL.C190942.VHI01TC | Voice Handicap Index Questionnaire Test Code
(VHI01TC) | text
Extensible: No | C190942 | Voice Handicap Index Questionnaire Test Code | Voice Handicap Index test code. | CDISC Questionnaire Voice Handicap Index Test Code Terminology |
VHI0101 | C191163 | VHI01-Voice Makes Difficult to Hear Me | Voice Handicap Index - My voice makes it difficult for people to hear me. | VHI - Voice Makes Difficult to Hear Me | ||
VHI0102 | C191164 | VHI01-People Difficulty Understanding Me | Voice Handicap Index - People have difficulty understanding me in a noisy room. | VHI - People Difficulty Understanding Me | ||
VHI0103 | C191165 | VHI01-Family Has Difficulty Hearing Me | Voice Handicap Index - My family has difficulty hearing me when I call them throughout the house. | VHI - Family Has Difficulty Hearing Me | ||
VHI0104 | C191166 | VHI01-Use Phone Less Often | Voice Handicap Index - I use the phone less often than I would like to. | VHI - Use Phone Less Often | ||
VHI0105 | C191167 | VHI01-Avoid People Because of My Voice | Voice Handicap Index - I tend to avoid groups of people because of my voice. | VHI - Avoid People Because of My Voice | ||
VHI0106 | C191168 | VHI01-Speak Friends Less Often B/c Voice | Voice Handicap Index - I speak with friends, neighbors, or relatives less often because of my voice. | VHI - Speak Friends Less Often Because Voice | ||
VHI0107 | C191169 | VHI01-Repeat Myself Speak Face-to-Face | Voice Handicap Index - People ask me to repeat myself when speaking face-to-face. | VHI - Repeat Myself Speak Face-to-Face | ||
VHI0108 | C191170 | VHI01-Voice Difficulties Restrict Life | Voice Handicap Index - My voice difficulties restrict my personal and social life. | VHI - Voice Difficulties Restrict Life | ||
VHI0109 | C191171 | VHI01-Left Out of Conversation B/c Voice | Voice Handicap Index - I feel left out of conversations because of my voice. | VHI - Left Out of Conversation Because Voice | ||
VHI0110 | C191172 | VHI01-Voice Problem Causes Lose Income | Voice Handicap Index - My voice problem causes me to lose income. | VHI - Voice Problem Causes Lose Income | ||
VHI0111 | C191173 | VHI01-I Run Out of Air When I Talk | Voice Handicap Index - I run out of air when I talk. | VHI - I Run Out of Air When I Talk | ||
VHI0112 | C191174 | VHI01-Sound Voice Varies Throughout Day | Voice Handicap Index - The sound of my voice varies throughout the day. | VHI - Sound Voice Varies Throughout Day | ||
VHI0113 | C191175 | VHI01-People Ask What's Wrong w/ Voice | Voice Handicap Index - People ask, "What's wrong with your voice?" | VHI - People Ask What's Wrong With Voice | ||
VHI0114 | C191176 | VHI01-My Voice Sounds Creaky and Dry | Voice Handicap Index - My voice sounds creaky and dry. | VHI - My Voice Sounds Creaky and Dry | ||
VHI0115 | C191177 | VHI01-Have to Strain to Produce Voice | Voice Handicap Index - I feel as though I have to strain to produce voice. | VHI - Have to Strain to Produce Voice | ||
VHI0116 | C191178 | VHI01-Clarity of Voice is Unpredictable | Voice Handicap Index - The clarity of my voice is unpredictable. | VHI - Clarity of Voice is Unpredictable | ||
VHI0117 | C191179 | VHI01-Change Voice to Sound Different | Voice Handicap Index - I try to change my voice to sound different. | VHI - Change Voice to Sound Different | ||
VHI0118 | C191180 | VHI01-Use Great Deal of Effort to Speak | Voice Handicap Index - I use a great deal of effort to speak. | VHI - Use Great Deal of Effort to Speak | ||
VHI0119 | C191181 | VHI01-My Voice is Worse in the Evening | Voice Handicap Index - My voice is worse in the evening. | VHI - My Voice is Worse in the Evening | ||
VHI0120 | C191182 | VHI01-Voice Gives Out on Me Speaking | Voice Handicap Index - My voice "gives out" on me in the middle of speaking. | VHI - Voice Gives Out on Me Speaking | ||
VHI0121 | C191183 | VHI01-Tense Talking to Others B/c Voice | Voice Handicap Index - I am tense when talking to others because of my voice. | VHI - Tense Talking to Others Because Voice | ||
VHI0122 | C191184 | VHI01-People Seem Irritated w/ My Voice | Voice Handicap Index - People seem irritated with my voice. | VHI - People Seem Irritated With My Voice | ||
VHI0123 | C191185 | VHI01-People Don't Understand Voice Prob | Voice Handicap Index - I find other people don't understand my voice problem. | VHI - People Don't Understand Voice Problem | ||
VHI0124 | C191186 | VHI01-My Voice Problem Upsets Me | Voice Handicap Index - My voice problem upsets me. | VHI - My Voice Problem Upsets Me | ||
VHI0125 | C191187 | VHI01-Less Outgoing B/c of Voice Problem | Voice Handicap Index - I am less outgoing because of my voice problem. | VHI - Less Outgoing Because of Voice Problem | ||
VHI0126 | C191188 | VHI01-Voice Makes Me Feel Handicapped | Voice Handicap Index - My voice makes me feels handicapped. | VHI - Voice Makes Me Feel Handicapped | ||
VHI0127 | C191189 | VHI01-Feel Annoyed People Ask Me Repeat | Voice Handicap Index - I feel annoyed when people ask me to repeat. | VHI - Feel Annoyed People Ask Me Repeat | ||
VHI0128 | C191190 | VHI01-Embarrassed People Ask Me Repeat | Voice Handicap Index - I feel embarrassed when people ask me to repeat. | VHI - Embarrassed People Ask Me Repeat | ||
VHI0129 | C191191 | VHI01-Voice Makes Me Feel Incompetent | Voice Handicap Index - My voice makes me feel incompetent. | VHI - Voice Makes Me Feel Incompetent | ||
VHI0130 | C191192 | VHI01-I Am Ashamed of My Voice Problem | Voice Handicap Index - I am ashamed of my voice problem. | VHI - I Am Ashamed of My Voice Problem | ||
VHI0131 | C191193 | VHI01-Part I-F Subtotal | Voice Handicap Index - Part I-F subtotal. | VHI - Part I-F Subtotal | ||
VHI0132 | C191194 | VHI01-Part II-P Subtotal | Voice Handicap Index - Part II-P subtotal. | VHI - Part II-P Subtotal | ||
VHI0133 | C191195 | VHI01-Part III-E Subtotal | Voice Handicap Index - Part III-E subtotal. | VHI - Part III-E Subtotal | ||
VHI0134 | C191196 | VHI01-Total Score | Voice Handicap Index - Total score. | VHI - Total Score | ||
Back to top | ||||||
CL.C190941.VHI01TN | Voice Handicap Index Questionnaire Test Name
(VHI01TN) | text
Extensible: No | C190941 | Voice Handicap Index Questionnaire Test Name | Voice Handicap Index test name. | CDISC Questionnaire Voice Handicap Index Test Name Terminology |
VHI01-Avoid People Because of My Voice | C191167 | VHI01-Avoid People Because of My Voice | Voice Handicap Index - I tend to avoid groups of people because of my voice. | VHI - Avoid People Because of My Voice | ||
VHI01-Change Voice to Sound Different | C191179 | VHI01-Change Voice to Sound Different | Voice Handicap Index - I try to change my voice to sound different. | VHI - Change Voice to Sound Different | ||
VHI01-Clarity of Voice is Unpredictable | C191178 | VHI01-Clarity of Voice is Unpredictable | Voice Handicap Index - The clarity of my voice is unpredictable. | VHI - Clarity of Voice is Unpredictable | ||
VHI01-Embarrassed People Ask Me Repeat | C191190 | VHI01-Embarrassed People Ask Me Repeat | Voice Handicap Index - I feel embarrassed when people ask me to repeat. | VHI - Embarrassed People Ask Me Repeat | ||
VHI01-Family Has Difficulty Hearing Me | C191165 | VHI01-Family Has Difficulty Hearing Me | Voice Handicap Index - My family has difficulty hearing me when I call them throughout the house. | VHI - Family Has Difficulty Hearing Me | ||
VHI01-Feel Annoyed People Ask Me Repeat | C191189 | VHI01-Feel Annoyed People Ask Me Repeat | Voice Handicap Index - I feel annoyed when people ask me to repeat. | VHI - Feel Annoyed People Ask Me Repeat | ||
VHI01-Have to Strain to Produce Voice | C191177 | VHI01-Have to Strain to Produce Voice | Voice Handicap Index - I feel as though I have to strain to produce voice. | VHI - Have to Strain to Produce Voice | ||
VHI01-I Am Ashamed of My Voice Problem | C191192 | VHI01-I Am Ashamed of My Voice Problem | Voice Handicap Index - I am ashamed of my voice problem. | VHI - I Am Ashamed of My Voice Problem | ||
VHI01-I Run Out of Air When I Talk | C191173 | VHI01-I Run Out of Air When I Talk | Voice Handicap Index - I run out of air when I talk. | VHI - I Run Out of Air When I Talk | ||
VHI01-Left Out of Conversation B/c Voice | C191171 | VHI01-Left Out of Conversation B/c Voice | Voice Handicap Index - I feel left out of conversations because of my voice. | VHI - Left Out of Conversation Because Voice | ||
VHI01-Less Outgoing B/c of Voice Problem | C191187 | VHI01-Less Outgoing B/c of Voice Problem | Voice Handicap Index - I am less outgoing because of my voice problem. | VHI - Less Outgoing Because of Voice Problem | ||
VHI01-My Voice is Worse in the Evening | C191181 | VHI01-My Voice is Worse in the Evening | Voice Handicap Index - My voice is worse in the evening. | VHI - My Voice is Worse in the Evening | ||
VHI01-My Voice Problem Upsets Me | C191186 | VHI01-My Voice Problem Upsets Me | Voice Handicap Index - My voice problem upsets me. | VHI - My Voice Problem Upsets Me | ||
VHI01-My Voice Sounds Creaky and Dry | C191176 | VHI01-My Voice Sounds Creaky and Dry | Voice Handicap Index - My voice sounds creaky and dry. | VHI - My Voice Sounds Creaky and Dry | ||
VHI01-Part I-F Subtotal | C191193 | VHI01-Part I-F Subtotal | Voice Handicap Index - Part I-F subtotal. | VHI - Part I-F Subtotal | ||
VHI01-Part II-P Subtotal | C191194 | VHI01-Part II-P Subtotal | Voice Handicap Index - Part II-P subtotal. | VHI - Part II-P Subtotal | ||
VHI01-Part III-E Subtotal | C191195 | VHI01-Part III-E Subtotal | Voice Handicap Index - Part III-E subtotal. | VHI - Part III-E Subtotal | ||
VHI01-People Ask What's Wrong w/ Voice | C191175 | VHI01-People Ask What's Wrong w/ Voice | Voice Handicap Index - People ask, "What's wrong with your voice?" | VHI - People Ask What's Wrong With Voice | ||
VHI01-People Difficulty Understanding Me | C191164 | VHI01-People Difficulty Understanding Me | Voice Handicap Index - People have difficulty understanding me in a noisy room. | VHI - People Difficulty Understanding Me | ||
VHI01-People Don't Understand Voice Prob | C191185 | VHI01-People Don't Understand Voice Prob | Voice Handicap Index - I find other people don't understand my voice problem. | VHI - People Don't Understand Voice Problem | ||
VHI01-People Seem Irritated w/ My Voice | C191184 | VHI01-People Seem Irritated w/ My Voice | Voice Handicap Index - People seem irritated with my voice. | VHI - People Seem Irritated With My Voice | ||
VHI01-Repeat Myself Speak Face-to-Face | C191169 | VHI01-Repeat Myself Speak Face-to-Face | Voice Handicap Index - People ask me to repeat myself when speaking face-to-face. | VHI - Repeat Myself Speak Face-to-Face | ||
VHI01-Sound Voice Varies Throughout Day | C191174 | VHI01-Sound Voice Varies Throughout Day | Voice Handicap Index - The sound of my voice varies throughout the day. | VHI - Sound Voice Varies Throughout Day | ||
VHI01-Speak Friends Less Often B/c Voice | C191168 | VHI01-Speak Friends Less Often B/c Voice | Voice Handicap Index - I speak with friends, neighbors, or relatives less often because of my voice. | VHI - Speak Friends Less Often Because Voice | ||
VHI01-Tense Talking to Others B/c Voice | C191183 | VHI01-Tense Talking to Others B/c Voice | Voice Handicap Index - I am tense when talking to others because of my voice. | VHI - Tense Talking to Others Because Voice | ||
VHI01-Total Score | C191196 | VHI01-Total Score | Voice Handicap Index - Total score. | VHI - Total Score | ||
VHI01-Use Great Deal of Effort to Speak | C191180 | VHI01-Use Great Deal of Effort to Speak | Voice Handicap Index - I use a great deal of effort to speak. | VHI - Use Great Deal of Effort to Speak | ||
VHI01-Use Phone Less Often | C191166 | VHI01-Use Phone Less Often | Voice Handicap Index - I use the phone less often than I would like to. | VHI - Use Phone Less Often | ||
VHI01-Voice Difficulties Restrict Life | C191170 | VHI01-Voice Difficulties Restrict Life | Voice Handicap Index - My voice difficulties restrict my personal and social life. | VHI - Voice Difficulties Restrict Life | ||
VHI01-Voice Gives Out on Me Speaking | C191182 | VHI01-Voice Gives Out on Me Speaking | Voice Handicap Index - My voice "gives out" on me in the middle of speaking. | VHI - Voice Gives Out on Me Speaking | ||
VHI01-Voice Makes Difficult to Hear Me | C191163 | VHI01-Voice Makes Difficult to Hear Me | Voice Handicap Index - My voice makes it difficult for people to hear me. | VHI - Voice Makes Difficult to Hear Me | ||
VHI01-Voice Makes Me Feel Handicapped | C191188 | VHI01-Voice Makes Me Feel Handicapped | Voice Handicap Index - My voice makes me feels handicapped. | VHI - Voice Makes Me Feel Handicapped | ||
VHI01-Voice Makes Me Feel Incompetent | C191191 | VHI01-Voice Makes Me Feel Incompetent | Voice Handicap Index - My voice makes me feel incompetent. | VHI - Voice Makes Me Feel Incompetent | ||
VHI01-Voice Problem Causes Lose Income | C191172 | VHI01-Voice Problem Causes Lose Income | Voice Handicap Index - My voice problem causes me to lose income. | VHI - Voice Problem Causes Lose Income | ||
Back to top | ||||||
CL.C117746.HEPENCGR | West Haven Hepatic Encephalopathy Grade
(HEPENCGR) | text
Extensible: No | C117746 | West Haven Hepatic Encephalopathy Grade | A grading system to describe the severity of hepatic encephalopathy based on the level of mental status by the West Haven Hepatic Encephalopathy Grade. | CDISC SDTM West Haven Hepatic Encephalopathy Grade Terminology |
GRADE 0 | C117824 | Minimal - symptoms or pathological characteristics include minimal hepatic encephalopathy, lack of detectable changes in personality or behavior, minimal changes in memory, concentration and intellectual function, and absence of coordination asterixis. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview) | West Haven Hepatic Encephalopathy Grade 0 | |||
GRADE 1 | C117825 | Mild - symptoms or pathological characteristics include trivial lack of awareness, shortened attention span, impaired ability to perform addition or subtraction, hypersomnia, insomnia, or inversion of sleep pattern, euphoria, depression or irritability, mild confusion, slowing of ability to perform mental tasks. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) | West Haven Hepatic Encephalopathy Grade 1 | |||
GRADE 2 | C117826 | Moderate - symptoms or pathological characteristics include lethargy or apathy, disorientation, inappropriate behavior, slurred speech, obvious asterixis, drowsiness, lethargy, gross deficits in ability to perform mental tasks, obvious personality changes, inappropriate behavior, and intermittent disorientation, unsurely regarding time. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) | West Haven Hepatic Encephalopathy Grade 2 | |||
GRADE 3 | C117827 | Severe - symptoms or pathological characteristics include somnolence with some arousability, inability to perform mental tasks, disorientation about time and place, marked confusion, amnesia, occasional fits of rage, present but incomprehensible speech. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) | West Haven Hepatic Encephalopathy Grade 3 | |||
GRADE 4 | C117828 | Coma - symptoms or pathological characteristics include coma with or without response to painful stimuli. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) | West Haven Hepatic Encephalopathy Grade 4 | |||
Back to top | ||||||
CL.C124680.WHEG01TC | West Haven Hepatic Encephalopathy Grade Clinical Classification Test Code
(WHEG01TC) | text
Extensible: No | C124680 | West Haven Hepatic Encephalopathy Grade Clinical Classification Test Code | West Haven Hepatic Encephalopathy Grade test code. | CDISC Clinical Classification West Haven Criteria Test Code Terminology |
WHEG0101 | C117747 | WHEG01-WH Hepatic Encephalopathy Grade | West Haven Hepatic Encephalopathy Grade - Grade. | West Haven Criteria - West Haven Hepatic Encephalopathy Grade | ||
Back to top | ||||||
CL.C124679.WHEG01TN | West Haven Hepatic Encephalopathy Grade Clinical Classification Test Name
(WHEG01TN) | text
Extensible: No | C124679 | West Haven Hepatic Encephalopathy Grade Clinical Classification Test Name | West Haven Hepatic Encephalopathy Grade test name. | CDISC Clinical Classification West Haven Criteria Test Name Terminology |
WHEG01-WH Hepatic Encephalopathy Grade | C117747 | WHEG01-WH Hepatic Encephalopathy Grade | West Haven Hepatic Encephalopathy Grade - Grade. | West Haven Criteria - West Haven Hepatic Encephalopathy Grade | ||
Back to top | ||||||
CL.C124674.WHIVS1TC | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification Test Code
(WHIVS1TC) | text
Extensible: No | C124674 | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification Test Code | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents test code. | CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Test Code Terminology |
WHIVS101 | C124777 | WHIVS1-WHO Clinical Stage of HIV/AIDS | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO clinical stage of HIV/AIDS. | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO Clinical Stage of HIV/AIDS | ||
Back to top | ||||||
CL.C124673.WHIVS1TN | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification Test Name
(WHIVS1TN) | text
Extensible: No | C124673 | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Clinical Classification Test Name | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents test name. | CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Adults and Adolescents Test Name Terminology |
WHIVS1-WHO Clinical Stage of HIV/AIDS | C124777 | WHIVS1-WHO Clinical Stage of HIV/AIDS | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO clinical stage of HIV/AIDS. | WHO Clinical Staging of HIV/AIDS for Adults and Adolescents - WHO Clinical Stage of HIV/AIDS | ||
Back to top | ||||||
CL.C124676.WHIVS2TC | WHO Clinical Staging of HIV/AIDS for Children Clinical Classification Test Code
(WHIVS2TC) | text
Extensible: No | C124676 | WHO Clinical Staging of HIV/AIDS for Children Clinical Classification Test Code | WHO Clinical Staging of HIV/AIDS for Children test code. | CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Children Test Code Terminology |
WHIVS201 | C124778 | WHIVS2-WHO Clinical Stage of HIV/AIDS | WHO Clinical Staging of HIV/AIDS for Children - WHO clinical stage of HIV/AIDS. | WHO Clinical Staging of HIV/AIDS for Children - WHO Clinical Stage of HIV/AIDS | ||
Back to top | ||||||
CL.C124675.WHIVS2TN | WHO Clinical Staging of HIV/AIDS for Children Clinical Classification Test Name
(WHIVS2TN) | text
Extensible: No | C124675 | WHO Clinical Staging of HIV/AIDS for Children Clinical Classification Test Name | WHO Clinical Staging of HIV/AIDS for Children test name. | CDISC Clinical Classification WHO Clinical Staging of HIV/AIDS for Children Test Name Terminology |
WHIVS2-WHO Clinical Stage of HIV/AIDS | C124778 | WHIVS2-WHO Clinical Stage of HIV/AIDS | WHO Clinical Staging of HIV/AIDS for Children - WHO clinical stage of HIV/AIDS. | WHO Clinical Staging of HIV/AIDS for Children - WHO Clinical Stage of HIV/AIDS | ||
Back to top | ||||||
CL.C100176.WPAI01TC | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 Questionnaire Test Code
(WPAI01TC) | text
Extensible: No | C100176 | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 Questionnaire Test Code | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 test code. | CDISC Questionnaire WPAI:SHP v2.0 Test Code Terminology |
WPAI0101 | C100949 | WPAI01-Currently Employed | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Are you currently employed (working for pay)? | WPAI:SHP v2.0 - Currently Employed | ||
WPAI0102 | C100950 | WPAI01-Missed Work Hours Due to Problem | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you miss from work because of problems associated with your problem? | WPAI:SHP v2.0 - Missed Work Hours Due to Problem | ||
WPAI0103 | C100951 | WPAI01-Missed Work Hours Due to Other | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you miss from work because of any other reason, such as vacation, holidays, time off to participate in this study? | WPAI:SHP v2.0 - Missed Work Hours Due to Other Reasons | ||
WPAI0104 | C100952 | WPAI01-Hours Actually Worked | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you actually work? | WPAI:SHP v2.0 - Hours Actually Worked | ||
WPAI0105 | C100953 | WPAI01-Problem Affect Productivity | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how much did your problem affect your productivity while you were working? | WPAI:SHP v2.0 - Problem Affects Productivity | ||
WPAI0106 | C100954 | WPAI01-Problem Affect Reg Daily Activity | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how much did your problem affect your ability to do your regular daily activities, other than work at a job? | WPAI:SHP v2.0 - Problem Affects Regular Daily Activity | ||
WPAI0107 | C166349 | WPAI01-Absenteeism Score | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Absenteeism score. | WPAI:SHP v2.0 - Absenteeism Score | ||
WPAI0108 | C166350 | WPAI01-Presenteeism Score | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Presenteeism score. | WPAI:SHP v2.0 - Presenteeism Score | ||
WPAI0109 | C166351 | WPAI01-Work Productivity Loss Score | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Work productivity loss score. | WPAI:SHP v2.0 - Work Productivity Loss Score | ||
WPAI0110 | C166352 | WPAI01-Activity Impairment Score | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Activity impairment score. | WPAI:SHP v2.0 - Activity Impairment Score | ||
Back to top | ||||||
CL.C100175.WPAI01TN | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 Questionnaire Test Name
(WPAI01TN) | text
Extensible: No | C100175 | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 Questionnaire Test Name | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 test name. | CDISC Questionnaire WPAI:SHP v2.0 Test Name Terminology |
WPAI01-Absenteeism Score | C166349 | WPAI01-Absenteeism Score | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Absenteeism score. | WPAI:SHP v2.0 - Absenteeism Score | ||
WPAI01-Activity Impairment Score | C166352 | WPAI01-Activity Impairment Score | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Activity impairment score. | WPAI:SHP v2.0 - Activity Impairment Score | ||
WPAI01-Currently Employed | C100949 | WPAI01-Currently Employed | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Are you currently employed (working for pay)? | WPAI:SHP v2.0 - Currently Employed | ||
WPAI01-Hours Actually Worked | C100952 | WPAI01-Hours Actually Worked | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you actually work? | WPAI:SHP v2.0 - Hours Actually Worked | ||
WPAI01-Missed Work Hours Due to Other | C100951 | WPAI01-Missed Work Hours Due to Other | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you miss from work because of any other reason, such as vacation, holidays, time off to participate in this study? | WPAI:SHP v2.0 - Missed Work Hours Due to Other Reasons | ||
WPAI01-Missed Work Hours Due to Problem | C100950 | WPAI01-Missed Work Hours Due to Problem | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how many hours did you miss from work because of problems associated with your problem? | WPAI:SHP v2.0 - Missed Work Hours Due to Problem | ||
WPAI01-Presenteeism Score | C166350 | WPAI01-Presenteeism Score | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Presenteeism score. | WPAI:SHP v2.0 - Presenteeism Score | ||
WPAI01-Problem Affect Productivity | C100953 | WPAI01-Problem Affect Productivity | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how much did your problem affect your productivity while you were working? | WPAI:SHP v2.0 - Problem Affects Productivity | ||
WPAI01-Problem Affect Reg Daily Activity | C100954 | WPAI01-Problem Affect Reg Daily Activity | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - During the past seven days, how much did your problem affect your ability to do your regular daily activities, other than work at a job? | WPAI:SHP v2.0 - Problem Affects Regular Daily Activity | ||
WPAI01-Work Productivity Loss Score | C166351 | WPAI01-Work Productivity Loss Score | Work Productivity and Activity Impairment Questionnaire - Specific Health Problem V2.0 - Work productivity loss score. | WPAI:SHP v2.0 - Work Productivity Loss Score | ||
Back to top | ||||||
CL.C130281.WD4TC | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer Questionnaire Test Code
(WD4TC) | text
Extensible: No | C130281 | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer Questionnaire Test Code | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer test code. | CDISC Questionnaire WHODAS 2.0 12+24-item Version Interviewer-administered Test Code Terminology |
WD4A1 | C130850 | WD4-Sex as Observed | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Record sex as observed. | WHODAS 2.0 12+24-item Version Interviewer-administered - Observed Sex | ||
WD4A2 | C130851 | WD4-How Old Are You Now | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - How old are you now? | WHODAS 2.0 12+24-item Version Interviewer-administered - How Old Are You Now | ||
WD4A3 | C130852 | WD4-Years Studying in School/College | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - How many years in all did you spend studying in school, college or university? | WHODAS 2.0 12+24-item Version Interviewer-administered - Years Studying in School or College | ||
WD4A4 | C130853 | WD4-Current Marital Status | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - What is your current marital status? | WHODAS 2.0 12+24-item Version Interviewer-administered - Current Marital Status | ||
WD4A5 | C130854 | WD4-Describes Main Work Status Best | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Which describes your main work status best? | WHODAS 2.0 12+24-item Version Interviewer-administered - Describes Main Work Status Best | ||
WD4D1_2 | C130867 | WD4-Remembering to Do Important Things | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Remembering to do important things? | WHODAS 2.0 12+24-item Version Interviewer-administered - Remembering to Do Important Things | ||
WD4D1_3 | C130868 | WD4-Finding Solutions to Problems | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? | WHODAS 2.0 12+24-item Version Interviewer-administered - Finding Solutions to Problems | ||
WD4D1_5 | C130869 | WD4-Understanding What People Say | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? | WHODAS 2.0 12+24-item Version Interviewer-administered - Understanding What People Say | ||
WD4D1_6 | C130870 | WD4-Starting/Maintaining Conversation | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? | WHODAS 2.0 12+24-item Version Interviewer-administered - Starting or Maintaining Conversation | ||
WD4D2_2 | C130871 | WD4-Standing Up From Sitting Down | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? | WHODAS 2.0 12+24-item Version Interviewer-administered - Standing Up From Sitting Down | ||
WD4D2_3 | C130872 | WD4-Moving Around Inside Your Home | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Moving around inside your home? | WHODAS 2.0 12+24-item Version Interviewer-administered - Moving Around Inside Your Home | ||
WD4D2_4 | C130873 | WD4-Getting Out of Your Home | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting out of your home? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Out of Your Home | ||
WD4D3_3 | C130874 | WD4-Eating | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Eating? | WHODAS 2.0 12+24-item Version Interviewer-administered - Eating | ||
WD4D3_4 | C130875 | WD4-Staying By Yourself for a Few Days | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? | WHODAS 2.0 12+24-item Version Interviewer-administered - Staying By Yourself for a Few Days | ||
WD4D4_3 | C130876 | WD4-Get Along with People Close to You | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? | WHODAS 2.0 12+24-item Version Interviewer-administered - Get Along with People Close to You | ||
WD4D4_4 | C130877 | WD4-Making New Friends | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Making new friends? | WHODAS 2.0 12+24-item Version Interviewer-administered - Making New Friends | ||
WD4D4_5 | C130878 | WD4-Sexual Activities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Sexual activities? | WHODAS 2.0 12+24-item Version Interviewer-administered - Sexual Activities | ||
WD4D5_01 | C130882 | WD4-Reduce or Miss Household Work | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, on how many days did you reduce or completely miss household work because of your health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Reduce or Miss Household Work | ||
WD4D5_02 | C130888 | WD4-Miss Work Half Day or More | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, on how many days did you miss work for half a day or more because of your health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Miss Work Half Day or More | ||
WD4D5_10 | C130887 | WD4-Earn Less Money | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Did you earn less money as the result of a health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Earn Less Money | ||
WD4D5_2 | C130879 | WD4-Doing Important Household Tasks | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important household tasks well? | WHODAS 2.0 12+24-item Version Interviewer-administered - Doing Important Household Tasks | ||
WD4D5_3 | C130880 | WD4-Getting Household Work Done Needed | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Household Work Done Needed | ||
WD4D5_4 | C130881 | WD4-Getting Household Work Done Quickly | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Household Work Done Quickly | ||
WD4D5_6 | C130883 | WD4-Doing Important Work/School Tasks | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Doing your most important work/school tasks well? | WHODAS 2.0 12+24-item Version Interviewer-administered - Doing Important Work or School Tasks | ||
WD4D5_7 | C130884 | WD4-Getting All Work Done You Need | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting all the work done that you need to do? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting All Work Done You Need | ||
WD4D5_8 | C130885 | WD4-Getting Work Done Quickly as Needed | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting your work done as quickly as needed? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Work Done Quickly as Needed | ||
WD4D5_9 | C130886 | WD4-Had to Work at a Lower Level | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Have you had to work at a lower level because of a health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Had to Work at a Lower Level | ||
WD4D6_2 | C130889 | WD4-Problem Because of Barriers in World | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Because of Barriers in World | ||
WD4D6_3 | C130890 | WD4-Problem Living With Dignity | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Living With Dignity | ||
WD4D6_4 | C130891 | WD4-Time Spend on Your Health Condition | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much time did you spend on your health condition, or its consequences? | WHODAS 2.0 12+24-item Version Interviewer-administered - Time Spend on Your Health Condition | ||
WD4D6_6 | C130892 | WD4-Drain on Financial Resources | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? | WHODAS 2.0 12+24-item Version Interviewer-administered - Drain on Financial Resources | ||
WD4D6_7 | C130893 | WD4-Problem Did Your Family Have | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did your family have because of your health problems? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Did Your Family Have | ||
WD4D6_8 | C130894 | WD4-Problem Doing Things for Relaxation | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Doing Things for Relaxation | ||
WD4F5 | C130849 | WD4-Living Situation at Interview | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Living situation at time of interview. | WHODAS 2.0 12+24-item Version Interviewer-administered - Living Situation at Interview | ||
WD4H1 | C130895 | WD4-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 12+24-item Version Interviewer-administered - How Many Days Difficulties Present | ||
WD4H2 | C130896 | WD4-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Days Unable to Carry Out Activities | ||
WD4H3 | C130897 | WD4-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - How Many Days Reduce Activities | ||
WD4S1 | C130855 | WD4-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 12+24-item Version Interviewer-administered - Standing for Long Periods | ||
WD4S10 | C130864 | WD4-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 12+24-item Version Interviewer-administered - Dealing With People You Do Not Know | ||
WD4S11 | C130865 | WD4-Maintaining a Fiendship | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 12+24-item Version Interviewer-administered - Maintaining a Fiendship | ||
WD4S12 | C130866 | WD4-Your Day-to-Day Work | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Your day-to-day work? | WHODAS 2.0 12+24-item Version Interviewer-administered - Your Day-to-Day Work | ||
WD4S2 | C130856 | WD4-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 12+24-item Version Interviewer-administered - Care of Household Responsibilities | ||
WD4S3 | C130857 | WD4-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 12+24-item Version Interviewer-administered - Learning a New Task | ||
WD4S4 | C130858 | WD4-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Joining Community Activities | ||
WD4S5 | C130859 | WD4-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? | WHODAS 2.0 12+24-item Version Interviewer-administered - Emotionally Affected by Health | ||
WD4S6 | C130860 | WD4-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 12+24-item Version Interviewer-administered - Concentrating for Ten Minutes | ||
WD4S7 | C130861 | WD4-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 12+24-item Version Interviewer-administered - Walking a Long Distance | ||
WD4S8 | C130862 | WD4-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 12+24-item Version Interviewer-administered - Washing Your Whole Body | ||
WD4S9 | C130863 | WD4-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Dressed | ||
Back to top | ||||||
CL.C130280.WD4TN | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer Questionnaire Test Name
(WD4TN) | text
Extensible: No | C130280 | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer Questionnaire Test Name | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer test name. | CDISC Questionnaire WHODAS 2.0 12+24-item Version Interviewer-administered Test Name Terminology |
WD4-Care of Household Responsibilities | C130856 | WD4-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 12+24-item Version Interviewer-administered - Care of Household Responsibilities | ||
WD4-Concentrating for Ten Minutes | C130860 | WD4-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 12+24-item Version Interviewer-administered - Concentrating for Ten Minutes | ||
WD4-Current Marital Status | C130853 | WD4-Current Marital Status | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - What is your current marital status? | WHODAS 2.0 12+24-item Version Interviewer-administered - Current Marital Status | ||
WD4-Days Unable to Carry Out Activities | C130896 | WD4-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Days Unable to Carry Out Activities | ||
WD4-Dealing With People You Do Not Know | C130864 | WD4-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 12+24-item Version Interviewer-administered - Dealing With People You Do Not Know | ||
WD4-Describes Main Work Status Best | C130854 | WD4-Describes Main Work Status Best | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Which describes your main work status best? | WHODAS 2.0 12+24-item Version Interviewer-administered - Describes Main Work Status Best | ||
WD4-Doing Important Household Tasks | C130879 | WD4-Doing Important Household Tasks | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important household tasks well? | WHODAS 2.0 12+24-item Version Interviewer-administered - Doing Important Household Tasks | ||
WD4-Doing Important Work/School Tasks | C130883 | WD4-Doing Important Work/School Tasks | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Doing your most important work/school tasks well? | WHODAS 2.0 12+24-item Version Interviewer-administered - Doing Important Work or School Tasks | ||
WD4-Drain on Financial Resources | C130892 | WD4-Drain on Financial Resources | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? | WHODAS 2.0 12+24-item Version Interviewer-administered - Drain on Financial Resources | ||
WD4-Earn Less Money | C130887 | WD4-Earn Less Money | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Did you earn less money as the result of a health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Earn Less Money | ||
WD4-Eating | C130874 | WD4-Eating | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Eating? | WHODAS 2.0 12+24-item Version Interviewer-administered - Eating | ||
WD4-Emotionally Affected by Health | C130859 | WD4-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? | WHODAS 2.0 12+24-item Version Interviewer-administered - Emotionally Affected by Health | ||
WD4-Finding Solutions to Problems | C130868 | WD4-Finding Solutions to Problems | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? | WHODAS 2.0 12+24-item Version Interviewer-administered - Finding Solutions to Problems | ||
WD4-Get Along with People Close to You | C130876 | WD4-Get Along with People Close to You | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? | WHODAS 2.0 12+24-item Version Interviewer-administered - Get Along with People Close to You | ||
WD4-Getting All Work Done You Need | C130884 | WD4-Getting All Work Done You Need | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting all the work done that you need to do? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting All Work Done You Need | ||
WD4-Getting Dressed | C130863 | WD4-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Dressed | ||
WD4-Getting Household Work Done Needed | C130880 | WD4-Getting Household Work Done Needed | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Household Work Done Needed | ||
WD4-Getting Household Work Done Quickly | C130881 | WD4-Getting Household Work Done Quickly | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Household Work Done Quickly | ||
WD4-Getting Out of Your Home | C130873 | WD4-Getting Out of Your Home | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting out of your home? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Out of Your Home | ||
WD4-Getting Work Done Quickly as Needed | C130885 | WD4-Getting Work Done Quickly as Needed | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting your work done as quickly as needed? | WHODAS 2.0 12+24-item Version Interviewer-administered - Getting Work Done Quickly as Needed | ||
WD4-Had to Work at a Lower Level | C130886 | WD4-Had to Work at a Lower Level | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Have you had to work at a lower level because of a health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Had to Work at a Lower Level | ||
WD4-How Many Days Difficulties Present | C130895 | WD4-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 12+24-item Version Interviewer-administered - How Many Days Difficulties Present | ||
WD4-How Many Days Reduce Activities | C130897 | WD4-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - How Many Days Reduce Activities | ||
WD4-How Old Are You Now | C130851 | WD4-How Old Are You Now | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - How old are you now? | WHODAS 2.0 12+24-item Version Interviewer-administered - How Old Are You Now | ||
WD4-Learning a New Task | C130857 | WD4-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 12+24-item Version Interviewer-administered - Learning a New Task | ||
WD4-Living Situation at Interview | C130849 | WD4-Living Situation at Interview | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Living situation at time of interview. | WHODAS 2.0 12+24-item Version Interviewer-administered - Living Situation at Interview | ||
WD4-Maintaining a Fiendship | C130865 | WD4-Maintaining a Fiendship | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 12+24-item Version Interviewer-administered - Maintaining a Fiendship | ||
WD4-Making New Friends | C130877 | WD4-Making New Friends | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Making new friends? | WHODAS 2.0 12+24-item Version Interviewer-administered - Making New Friends | ||
WD4-Miss Work Half Day or More | C130888 | WD4-Miss Work Half Day or More | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, on how many days did you miss work for half a day or more because of your health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Miss Work Half Day or More | ||
WD4-Moving Around Inside Your Home | C130872 | WD4-Moving Around Inside Your Home | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Moving around inside your home? | WHODAS 2.0 12+24-item Version Interviewer-administered - Moving Around Inside Your Home | ||
WD4-Problem Because of Barriers in World | C130889 | WD4-Problem Because of Barriers in World | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Because of Barriers in World | ||
WD4-Problem Did Your Family Have | C130893 | WD4-Problem Did Your Family Have | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did your family have because of your health problems? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Did Your Family Have | ||
WD4-Problem Doing Things for Relaxation | C130894 | WD4-Problem Doing Things for Relaxation | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Doing Things for Relaxation | ||
WD4-Problem Joining Community Activities | C130858 | WD4-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Joining Community Activities | ||
WD4-Problem Living With Dignity | C130890 | WD4-Problem Living With Dignity | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? | WHODAS 2.0 12+24-item Version Interviewer-administered - Problem Living With Dignity | ||
WD4-Reduce or Miss Household Work | C130882 | WD4-Reduce or Miss Household Work | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, on how many days did you reduce or completely miss household work because of your health condition? | WHODAS 2.0 12+24-item Version Interviewer-administered - Reduce or Miss Household Work | ||
WD4-Remembering to Do Important Things | C130867 | WD4-Remembering to Do Important Things | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Remembering to do important things? | WHODAS 2.0 12+24-item Version Interviewer-administered - Remembering to Do Important Things | ||
WD4-Sex as Observed | C130850 | WD4-Sex as Observed | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - Record sex as observed. | WHODAS 2.0 12+24-item Version Interviewer-administered - Observed Sex | ||
WD4-Sexual Activities | C130878 | WD4-Sexual Activities | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Sexual activities? | WHODAS 2.0 12+24-item Version Interviewer-administered - Sexual Activities | ||
WD4-Standing for Long Periods | C130855 | WD4-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 12+24-item Version Interviewer-administered - Standing for Long Periods | ||
WD4-Standing Up From Sitting Down | C130871 | WD4-Standing Up From Sitting Down | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? | WHODAS 2.0 12+24-item Version Interviewer-administered - Standing Up From Sitting Down | ||
WD4-Starting/Maintaining Conversation | C130870 | WD4-Starting/Maintaining Conversation | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? | WHODAS 2.0 12+24-item Version Interviewer-administered - Starting or Maintaining Conversation | ||
WD4-Staying By Yourself for a Few Days | C130875 | WD4-Staying By Yourself for a Few Days | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? | WHODAS 2.0 12+24-item Version Interviewer-administered - Staying By Yourself for a Few Days | ||
WD4-Time Spend on Your Health Condition | C130891 | WD4-Time Spend on Your Health Condition | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days: How much time did you spend on your health condition, or its consequences? | WHODAS 2.0 12+24-item Version Interviewer-administered - Time Spend on Your Health Condition | ||
WD4-Understanding What People Say | C130869 | WD4-Understanding What People Say | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? | WHODAS 2.0 12+24-item Version Interviewer-administered - Understanding What People Say | ||
WD4-Walking a Long Distance | C130861 | WD4-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 12+24-item Version Interviewer-administered - Walking a Long Distance | ||
WD4-Washing Your Whole Body | C130862 | WD4-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 12+24-item Version Interviewer-administered - Washing Your Whole Body | ||
WD4-Years Studying in School/College | C130852 | WD4-Years Studying in School/College | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - How many years in all did you spend studying in school, college or university? | WHODAS 2.0 12+24-item Version Interviewer-administered - Years Studying in School or College | ||
WD4-Your Day-to-Day Work | C130866 | WD4-Your Day-to-Day Work | World Health Organization Disability Assessment Schedule 2.0 - 12 + 24-Item Interviewer - In the past 30 days, how much difficulty did you have in: Your day-to-day work? | WHODAS 2.0 12+24-item Version Interviewer-administered - Your Day-to-Day Work | ||
Back to top | ||||||
CL.C130275.WD1TC | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer Questionnaire Test Code
(WD1TC) | text
Extensible: No | C130275 | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer Questionnaire Test Code | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer test code. | CDISC Questionnaire WHODAS 2.0 12-item Version Interviewer-administered Test Code Terminology |
WD1A1 | C130899 | WD1-Sex as Observed | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Record sex as observed. | WHODAS 2.0 12-item Version Interviewer-administered - Observed Sex | ||
WD1A2 | C130900 | WD1-How Old Are You Now | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - How old are you now? | WHODAS 2.0 12-item Version Interviewer-administered - How Old Are You Now | ||
WD1A3 | C130901 | WD1-Years Studying in School/College | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - How many years in all did you spend studying in school, college or university? | WHODAS 2.0 12-item Version Interviewer-administered - Years Studying in School or College | ||
WD1A4 | C130902 | WD1-Current Marital Status | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - What is your current marital status? | WHODAS 2.0 12-item Version Interviewer-administered - Current Marital Status | ||
WD1A5 | C130903 | WD1-Describes Main Work Status Best | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Which describes your main work status best? | WHODAS 2.0 12-item Version Interviewer-administered - Describes Main Work Status Best | ||
WD1F5 | C130898 | WD1-Living Situation at Interview | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Living situation at time of interview. | WHODAS 2.0 12-item Version Interviewer-administered - Living Situation at Interview | ||
WD1H1 | C130916 | WD1-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 12-item Version Interviewer-administered - How Many Days Difficulties Present | ||
WD1H2 | C130917 | WD1-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Interviewer-administered - Days Unable to Carry Out Activities | ||
WD1H3 | C130918 | WD1-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Interviewer-administered - How Many Days Reduce Activities | ||
WD1S1 | C130904 | WD1-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 12-item Version Interviewer-administered - Standing for Long Periods | ||
WD1S10 | C130913 | WD1-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 12-item Version Interviewer-administered - Dealing With People You Do Not Know | ||
WD1S11 | C130914 | WD1-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 12-item Version Interviewer-administered - Maintaining a Friendship | ||
WD1S12 | C130915 | WD1-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Your day-to-day work/school? | WHODAS 2.0 12-item Version Interviewer-administered - Your Day-to-Day Work or School | ||
WD1S2 | C130905 | WD1-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 12-item Version Interviewer-administered - Care of Household Responsibilities | ||
WD1S3 | C130906 | WD1-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 12-item Version Interviewer-administered - Learning a New Task | ||
WD1S4 | C130907 | WD1-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 12-item Version Interviewer-administered - Problem Joining Community Activities | ||
WD1S5 | C130908 | WD1-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? | WHODAS 2.0 12-item Version Interviewer-administered - Emotionally Affected by Health | ||
WD1S6 | C130909 | WD1-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 12-item Version Interviewer-administered - Concentrating for Ten Minutes | ||
WD1S7 | C130910 | WD1-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 12-item Version Interviewer-administered - Walking a Long Distance | ||
WD1S8 | C130911 | WD1-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 12-item Version Interviewer-administered - Washing Your Whole Body | ||
WD1S9 | C130912 | WD1-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 12-item Version Interviewer-administered - Getting Dressed | ||
Back to top | ||||||
CL.C130274.WD1TN | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer Questionnaire Test Name
(WD1TN) | text
Extensible: No | C130274 | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer Questionnaire Test Name | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer test name. | CDISC Questionnaire WHODAS 2.0 12-item Version Interviewer-administered Test Name Terminology |
WD1-Care of Household Responsibilities | C130905 | WD1-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 12-item Version Interviewer-administered - Care of Household Responsibilities | ||
WD1-Concentrating for Ten Minutes | C130909 | WD1-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 12-item Version Interviewer-administered - Concentrating for Ten Minutes | ||
WD1-Current Marital Status | C130902 | WD1-Current Marital Status | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - What is your current marital status? | WHODAS 2.0 12-item Version Interviewer-administered - Current Marital Status | ||
WD1-Days Unable to Carry Out Activities | C130917 | WD1-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Interviewer-administered - Days Unable to Carry Out Activities | ||
WD1-Dealing With People You Do Not Know | C130913 | WD1-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 12-item Version Interviewer-administered - Dealing With People You Do Not Know | ||
WD1-Describes Main Work Status Best | C130903 | WD1-Describes Main Work Status Best | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Which describes your main work status best? | WHODAS 2.0 12-item Version Interviewer-administered - Describes Main Work Status Best | ||
WD1-Emotionally Affected by Health | C130908 | WD1-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? | WHODAS 2.0 12-item Version Interviewer-administered - Emotionally Affected by Health | ||
WD1-Getting Dressed | C130912 | WD1-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 12-item Version Interviewer-administered - Getting Dressed | ||
WD1-How Many Days Difficulties Present | C130916 | WD1-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 12-item Version Interviewer-administered - How Many Days Difficulties Present | ||
WD1-How Many Days Reduce Activities | C130918 | WD1-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Interviewer-administered - How Many Days Reduce Activities | ||
WD1-How Old Are You Now | C130900 | WD1-How Old Are You Now | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - How old are you now? | WHODAS 2.0 12-item Version Interviewer-administered - How Old Are You Now | ||
WD1-Learning a New Task | C130906 | WD1-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 12-item Version Interviewer-administered - Learning a New Task | ||
WD1-Living Situation at Interview | C130898 | WD1-Living Situation at Interview | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Living situation at time of interview. | WHODAS 2.0 12-item Version Interviewer-administered - Living Situation at Interview | ||
WD1-Maintaining a Friendship | C130914 | WD1-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 12-item Version Interviewer-administered - Maintaining a Friendship | ||
WD1-Problem Joining Community Activities | C130907 | WD1-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 12-item Version Interviewer-administered - Problem Joining Community Activities | ||
WD1-Sex as Observed | C130899 | WD1-Sex as Observed | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - Record sex as observed. | WHODAS 2.0 12-item Version Interviewer-administered - Observed Sex | ||
WD1-Standing for Long Periods | C130904 | WD1-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 12-item Version Interviewer-administered - Standing for Long Periods | ||
WD1-Walking a Long Distance | C130910 | WD1-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 12-item Version Interviewer-administered - Walking a Long Distance | ||
WD1-Washing Your Whole Body | C130911 | WD1-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 12-item Version Interviewer-administered - Washing Your Whole Body | ||
WD1-Years Studying in School/College | C130901 | WD1-Years Studying in School/College | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - How many years in all did you spend studying in school, college or university? | WHODAS 2.0 12-item Version Interviewer-administered - Years Studying in School or College | ||
WD1-Your Day-to-Day Work/School | C130915 | WD1-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Interviewer - In the past 30 days, how much difficulty did you have in: Your day-to-day work/school? | WHODAS 2.0 12-item Version Interviewer-administered - Your Day-to-Day Work or School | ||
Back to top | ||||||
CL.C130277.WD2TC | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy Questionnaire Test Code
(WD2TC) | text
Extensible: No | C130277 | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy Questionnaire Test Code | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy test code. | CDISC Questionnaire WHODAS 2.0 12-item Version Proxy-administered Test Code Terminology |
WD2H1 | C130932 | WD2-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 12-item Version Proxy-administered - How Many Days Difficulties Present | ||
WD2H2 | C130933 | WD2-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Proxy-administered - Days Unable to Carry Out Activities | ||
WD2H3 | C130934 | WD2-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Proxy-administered - How Many Days Reduce Activities | ||
WD2H4 | C130919 | WD2-I Am (Fill in Blank) of This Person | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - I am the (Fill in the Blank) of this person. | WHODAS 2.0 12-item Version Proxy-administered - I Am the (Fill in the Blank) of This Person | ||
WD2S1 | C130920 | WD2-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 12-item Version Proxy-administered - Standing for Long Periods | ||
WD2S10 | C130929 | WD2-Dealing With People Does Not Know | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Dealing with people he or she does not know? | WHODAS 2.0 12-item Version Proxy-administered - Dealing With People Does Not Know | ||
WD2S11 | C130930 | WD2-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Maintaining a friendship? | WHODAS 2.0 12-item Version Proxy-administered - Maintaining a Friendship | ||
WD2S12 | C130931 | WD2-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: His or her day-to-day work? | WHODAS 2.0 12-item Version Proxy-administered - Your Day-to-Day Work or School | ||
WD2S2 | C130921 | WD2-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Taking care of his or her household responsibilities? | WHODAS 2.0 12-item Version Proxy-administered - Care of Household Responsibilities | ||
WD2S3 | C130922 | WD2-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 12-item Version Proxy-administered - Learning a New Task | ||
WD2S4 | C130923 | WD2-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: How much of a problem did your relative have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 12-item Version Proxy-administered - Problem Joining Community Activities | ||
WD2S5 | C130924 | WD2-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: How much has your relative been emotionally affected by his or her health condition? | WHODAS 2.0 12-item Version Proxy-administered - Emotionally Affected by Health | ||
WD2S6 | C130925 | WD2-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 12-item Version Proxy-administered - Concentrating for Ten Minutes | ||
WD2S7 | C130926 | WD2-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 12-item Version Proxy-administered - Walking a Long Distance | ||
WD2S8 | C130927 | WD2-Washing His/Her Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Washing his or her whole body? | WHODAS 2.0 12-item Version Proxy-administered - Washing His or Her Whole Body | ||
WD2S9 | C130928 | WD2-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting dressed? | WHODAS 2.0 12-item Version Proxy-administered - Getting Dressed | ||
Back to top | ||||||
CL.C130276.WD2TN | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy Questionnaire Test Name
(WD2TN) | text
Extensible: No | C130276 | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy Questionnaire Test Name | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy test name. | CDISC Questionnaire WHODAS 2.0 12-item Version Proxy-administered Test Name Terminology |
WD2-Care of Household Responsibilities | C130921 | WD2-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Taking care of his or her household responsibilities? | WHODAS 2.0 12-item Version Proxy-administered - Care of Household Responsibilities | ||
WD2-Concentrating for Ten Minutes | C130925 | WD2-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 12-item Version Proxy-administered - Concentrating for Ten Minutes | ||
WD2-Days Unable to Carry Out Activities | C130933 | WD2-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Proxy-administered - Days Unable to Carry Out Activities | ||
WD2-Dealing With People Does Not Know | C130929 | WD2-Dealing With People Does Not Know | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Dealing with people he or she does not know? | WHODAS 2.0 12-item Version Proxy-administered - Dealing With People Does Not Know | ||
WD2-Emotionally Affected by Health | C130924 | WD2-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: How much has your relative been emotionally affected by his or her health condition? | WHODAS 2.0 12-item Version Proxy-administered - Emotionally Affected by Health | ||
WD2-Getting Dressed | C130928 | WD2-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting dressed? | WHODAS 2.0 12-item Version Proxy-administered - Getting Dressed | ||
WD2-How Many Days Difficulties Present | C130932 | WD2-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 12-item Version Proxy-administered - How Many Days Difficulties Present | ||
WD2-How Many Days Reduce Activities | C130934 | WD2-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Proxy-administered - How Many Days Reduce Activities | ||
WD2-I Am (Fill in Blank) of This Person | C130919 | WD2-I Am (Fill in Blank) of This Person | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - I am the (Fill in the Blank) of this person. | WHODAS 2.0 12-item Version Proxy-administered - I Am the (Fill in the Blank) of This Person | ||
WD2-Learning a New Task | C130922 | WD2-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 12-item Version Proxy-administered - Learning a New Task | ||
WD2-Maintaining a Friendship | C130930 | WD2-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Maintaining a friendship? | WHODAS 2.0 12-item Version Proxy-administered - Maintaining a Friendship | ||
WD2-Problem Joining Community Activities | C130923 | WD2-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: How much of a problem did your relative have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 12-item Version Proxy-administered - Problem Joining Community Activities | ||
WD2-Standing for Long Periods | C130920 | WD2-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 12-item Version Proxy-administered - Standing for Long Periods | ||
WD2-Walking a Long Distance | C130926 | WD2-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 12-item Version Proxy-administered - Walking a Long Distance | ||
WD2-Washing His/Her Whole Body | C130927 | WD2-Washing His/Her Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Washing his or her whole body? | WHODAS 2.0 12-item Version Proxy-administered - Washing His or Her Whole Body | ||
WD2-Your Day-to-Day Work/School | C130931 | WD2-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Proxy - In the past 30 days, how much difficulty did your relative have in: His or her day-to-day work? | WHODAS 2.0 12-item Version Proxy-administered - Your Day-to-Day Work or School | ||
Back to top | ||||||
CL.C130279.WD3TC | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self Questionnaire Test Code
(WD3TC) | text
Extensible: No | C130279 | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self Questionnaire Test Code | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self test code. | CDISC Questionnaire WHODAS 2.0 12-item Version Self-administered Test Code Terminology |
WD3H1 | C130947 | WD3-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 12-item Version Self-administered - How Many Days Difficulties Present | ||
WD3H2 | C130948 | WD3-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Self-administered - Days Unable to Carry Out Activities | ||
WD3H3 | C130949 | WD3-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Self-administered - How Many Days Reduce Activities | ||
WD3S1 | C130935 | WD3-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 12-item Version Self-administered - Standing for Long Periods | ||
WD3S10 | C130944 | WD3-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 12-item Version Self-administered - Dealing With People You Do Not Know | ||
WD3S11 | C130945 | WD3-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 12-item Version Self-administered - Maintaining a Friendship | ||
WD3S12 | C130946 | WD3-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Your day-to-day work? | WHODAS 2.0 12-item Version Self-administered - Your Day-to-Day Work or School | ||
WD3S2 | C130936 | WD3-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 12-item Version Self-administered - Care of Household Responsibilities | ||
WD3S3 | C130937 | WD3-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 12-item Version Self-administered - Learning a New Task | ||
WD3S4 | C130938 | WD3-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 12-item Version Self-administered - Problem Joining Community Activities | ||
WD3S5 | C130939 | WD3-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? | WHODAS 2.0 12-item Version Self-administered - Emotionally Affected by Health | ||
WD3S6 | C130940 | WD3-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 12-item Version Self-administered - Concentrating for Ten Minutes | ||
WD3S7 | C130941 | WD3-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 12-item Version Self-administered - Walking a Long Distance | ||
WD3S8 | C130942 | WD3-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 12-item Version Self-administered - Washing Your Whole Body | ||
WD3S9 | C130943 | WD3-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 12-item Version Self-administered - Getting Dressed | ||
Back to top | ||||||
CL.C130278.WD3TN | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self Questionnaire Test Name
(WD3TN) | text
Extensible: No | C130278 | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self Questionnaire Test Name | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self test name. | CDISC Questionnaire WHODAS 2.0 12-item Version Self-administered Test Name Terminology |
WD3-Care of Household Responsibilities | C130936 | WD3-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 12-item Version Self-administered - Care of Household Responsibilities | ||
WD3-Concentrating for Ten Minutes | C130940 | WD3-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 12-item Version Self-administered - Concentrating for Ten Minutes | ||
WD3-Days Unable to Carry Out Activities | C130948 | WD3-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Self-administered - Days Unable to Carry Out Activities | ||
WD3-Dealing With People You Do Not Know | C130944 | WD3-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 12-item Version Self-administered - Dealing With People You Do Not Know | ||
WD3-Emotionally Affected by Health | C130939 | WD3-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: How much have you been emotionally affected by your health problems? | WHODAS 2.0 12-item Version Self-administered - Emotionally Affected by Health | ||
WD3-Getting Dressed | C130943 | WD3-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 12-item Version Self-administered - Getting Dressed | ||
WD3-How Many Days Difficulties Present | C130947 | WD3-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 12-item Version Self-administered - How Many Days Difficulties Present | ||
WD3-How Many Days Reduce Activities | C130949 | WD3-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 12-item Version Self-administered - How Many Days Reduce Activities | ||
WD3-Learning a New Task | C130937 | WD3-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 12-item Version Self-administered - Learning a New Task | ||
WD3-Maintaining a Friendship | C130945 | WD3-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 12-item Version Self-administered - Maintaining a Friendship | ||
WD3-Problem Joining Community Activities | C130938 | WD3-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 12-item Version Self-administered - Problem Joining Community Activities | ||
WD3-Standing for Long Periods | C130935 | WD3-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 12-item Version Self-administered - Standing for Long Periods | ||
WD3-Walking a Long Distance | C130941 | WD3-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 12-item Version Self-administered - Walking a Long Distance | ||
WD3-Washing Your Whole Body | C130942 | WD3-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 12-item Version Self-administered - Washing Your Whole Body | ||
WD3-Your Day-to-Day Work/School | C130946 | WD3-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 12-Item Self - In the past 30 days, how much difficulty did you have in: Your day-to-day work? | WHODAS 2.0 12-item Version Self-administered - Your Day-to-Day Work or School | ||
Back to top | ||||||
CL.C130269.WD5TC | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer Questionnaire Test Code
(WD5TC) | text
Extensible: No | C130269 | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer Questionnaire Test Code | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer test code. | CDISC Questionnaire WHODAS 2.0 36-item Version Interviewer-administered Test Code Terminology |
WD5A1 | C130722 | WD5-Sex as Observed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Record sex as observed. | WHODAS 2.0 36-item Version Interviewer-administered - Sex as Observed | ||
WD5A2 | C130723 | WD5-How Old Are You Now | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - How old are you now? | WHODAS 2.0 36-item Version Interviewer-administered - How Old Are You Now | ||
WD5A3 | C130724 | WD5-Years Studying in School/College | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - How many years in all did you spend studying in school, college or university? | WHODAS 2.0 36-item Version Interviewer-administered - Years Studying in School or College | ||
WD5A4 | C130725 | WD5-Current Marital Status | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - What is your current marital status? | WHODAS 2.0 36-item Version Interviewer-administered - Current Marital Status | ||
WD5A5 | C130726 | WD5-Describes Main Work Status Best | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Which describes your main work status best? | WHODAS 2.0 36-item Version Interviewer-administered - Describes Main Work Status Best | ||
WD5D1_1 | C130727 | WD5-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 36-item Version Interviewer-administered - Concentrating for Ten Minutes | ||
WD5D1_2 | C130728 | WD5-Remembering to Do Important Things | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Remembering to do important things? | WHODAS 2.0 36-item Version Interviewer-administered - Remembering to Do Important Things | ||
WD5D1_3 | C130729 | WD5-Finding Solutions to Problems | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? | WHODAS 2.0 36-item Version Interviewer-administered - Finding Solutions to Problems | ||
WD5D1_4 | C130730 | WD5-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 36-item Version Interviewer-administered - Learning a New Task | ||
WD5D1_5 | C130731 | WD5-Understanding What People Say | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? | WHODAS 2.0 36-item Version Interviewer-administered - Understanding What People Say | ||
WD5D1_6 | C130732 | WD5-Starting/Maintaining Conversation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? | WHODAS 2.0 36-item Version Interviewer-administered - Starting or Maintaining Conversation | ||
WD5D2_1 | C130733 | WD5-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 36-item Version Interviewer-administered - Standing for Long Periods | ||
WD5D2_2 | C130734 | WD5-Standing Up From Sitting Down | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? | WHODAS 2.0 36-item Version Interviewer-administered - Standing Up From Sitting Down | ||
WD5D2_3 | C130735 | WD5-Moving Around Inside Your Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Moving around inside your home? | WHODAS 2.0 36-item Version Interviewer-administered - Moving Around Inside Your Home | ||
WD5D3_1 | C130738 | WD5-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 36-item Version Interviewer-administered - Washing Your Whole Body | ||
WD5D3_2 | C130739 | WD5-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Dressed | ||
WD5D3_3 | C130740 | WD5-Eating | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Eating? | WHODAS 2.0 36-item Version Interviewer-administered - Eating | ||
WD5D3_4 | C130741 | WD5-Staying by Yourself for a Few Days | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? | WHODAS 2.0 36-item Version Interviewer-administered - Staying by Yourself for a Few Days | ||
WD5D4_1 | C130742 | WD5-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 36-item Version Interviewer-administered - Dealing With People You Do Not Know | ||
WD5D4_2 | C130743 | WD5-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 36-item Version Interviewer-administered - Maintaining a Friendship | ||
WD5D4_3 | C130744 | WD5-Get Along With People Close to You | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? | WHODAS 2.0 36-item Version Interviewer-administered - Get Along With People Close to You | ||
WD5D4_4 | C130745 | WD5-Making New Friends | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Making new friends? | WHODAS 2.0 36-item Version Interviewer-administered - Making New Friends | ||
WD5D4_5 | C130746 | WD5-Sexual Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Sexual activities? | WHODAS 2.0 36-item Version Interviewer-administered - Sexual Activities | ||
WD5D5_01 | C130751 | WD5-Days Reduce or Miss Household Work | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, on how many days did you reduce or completely miss household work because of your health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Days Reduce or Miss Household Work | ||
WD5D5_02 | C130758 | WD5-How Many Days Did You Miss Work | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, on how many days did you miss work for half a day or more because of your health condition? | WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Did You Miss Work | ||
WD5D5_1 | C130747 | WD5-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 36-item Version Interviewer-administered - Care of Household Responsibilities | ||
WD5D5_10 | C130757 | WD5-Earn Less Money | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Did you earn less money as the result of a health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Earn Less Money | ||
WD5D5_2 | C130748 | WD5-Doing Important Household Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important household tasks well? | WHODAS 2.0 36-item Version Interviewer-administered - Doing Important Household Tasks | ||
WD5D5_3 | C130749 | WD5-Getting Household Work Done Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Household Work Done Needed | ||
WD5D5_4 | C130750 | WD5-Getting Household Work Done Quickly | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Household Work Done Quickly | ||
WD5D5_5 | C130752 | WD5-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Your day-to-day work/school? | WHODAS 2.0 36-item Version Interviewer-administered - Your Day-to-Day Work or School | ||
WD5D5_6 | C130753 | WD5-Doing Important Work/School Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Doing your most important work/school tasks well? | WHODAS 2.0 36-item Version Interviewer-administered - Doing Important Work or School Tasks | ||
WD5D5_7 | C130754 | WD5-Getting All Work Done You Need | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting all the work done that you need to do? | WHODAS 2.0 36-item Version Interviewer-administered - Getting All Work Done You Need to Do | ||
WD5D5_8 | C130755 | WD5-Getting Work Done Quickly as Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting your work done as quickly as needed? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Work Done Quickly as Needed | ||
WD5D5_9 | C130756 | WD5-Had to Work at a Lower Level | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Have you had to work at a lower level because of a health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Had to Work at a Lower Level | ||
WD5D6_1 | C130759 | WD5-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 36-item Version Interviewer-administered - Problem Joining Community Activities | ||
WD5D6_2 | C130760 | WD5-Problem Because of Barriers in World | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? | WHODAS 2.0 36-item Version Interviewer-administered - Problem Because of Barriers in World | ||
WD5D6_3 | C130761 | WD5-Problem Living with Dignity | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? | WHODAS 2.0 36-item Version Interviewer-administered - Problem Living with Dignity | ||
WD5D6_4 | C130762 | WD5-Time Spend on Your Health Condition | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much time did you spend on your health condition or its consequences? | WHODAS 2.0 36-item Version Interviewer-administered - Time Spend on Your Health Condition | ||
WD5D6_5 | C130763 | WD5-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much have you been emotionally affected by your health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Emotionally Affected by Health | ||
WD5D6_6 | C130764 | WD5-Drain on Financial Resources | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? | WHODAS 2.0 36-item Version Interviewer-administered - Drain on Financial Resources | ||
WD5D6_7 | C130765 | WD5-Problem Did Your Family Have | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did your family have because of your health problems? | WHODAS 2.0 36-item Version Interviewer-administered - How Much Problem Did Your Family Have | ||
WD5D6_8 | C130766 | WD5-Problem Doing Things for Relaxation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? | WHODAS 2.0 36-item Version Interviewer-administered - Problem Doing Things for Relaxation | ||
WD5F5 | C130721 | WD5-Living Situation at Interview | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Living situation at time of interview. | WHODAS 2.0 36-item Version Interviewer-administered - Living Situation at Interview | ||
WD5H1 | C130767 | WD5-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Difficulties Present | ||
WD5H2 | C130768 | WD5-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Days Unable to Carry Out Activities | ||
WD5H3 | C130769 | WD5-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Reduce Activities | ||
WD5SD2_4 | C130736 | WD5-Getting Out of Your Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting out of your home? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Out of Your Home | ||
WD5SD2_5 | C130737 | WD5-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 36-item Version Interviewer-administered - Walking a Long Distance | ||
Back to top | ||||||
CL.C130268.WD5TN | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer Questionnaire Test Name
(WD5TN) | text
Extensible: No | C130268 | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer Questionnaire Test Name | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer test name. | CDISC Questionnaire WHODAS 2.0 36-item Version Interviewer-administered Test Name Terminology |
WD5-Care of Household Responsibilities | C130747 | WD5-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 36-item Version Interviewer-administered - Care of Household Responsibilities | ||
WD5-Concentrating for Ten Minutes | C130727 | WD5-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 36-item Version Interviewer-administered - Concentrating for Ten Minutes | ||
WD5-Current Marital Status | C130725 | WD5-Current Marital Status | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - What is your current marital status? | WHODAS 2.0 36-item Version Interviewer-administered - Current Marital Status | ||
WD5-Days Reduce or Miss Household Work | C130751 | WD5-Days Reduce or Miss Household Work | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, on how many days did you reduce or completely miss household work because of your health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Days Reduce or Miss Household Work | ||
WD5-Days Unable to Carry Out Activities | C130768 | WD5-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Days Unable to Carry Out Activities | ||
WD5-Dealing With People You Do Not Know | C130742 | WD5-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 36-item Version Interviewer-administered - Dealing With People You Do Not Know | ||
WD5-Describes Main Work Status Best | C130726 | WD5-Describes Main Work Status Best | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Which describes your main work status best? | WHODAS 2.0 36-item Version Interviewer-administered - Describes Main Work Status Best | ||
WD5-Doing Important Household Tasks | C130748 | WD5-Doing Important Household Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important household tasks well? | WHODAS 2.0 36-item Version Interviewer-administered - Doing Important Household Tasks | ||
WD5-Doing Important Work/School Tasks | C130753 | WD5-Doing Important Work/School Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Doing your most important work/school tasks well? | WHODAS 2.0 36-item Version Interviewer-administered - Doing Important Work or School Tasks | ||
WD5-Drain on Financial Resources | C130764 | WD5-Drain on Financial Resources | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? | WHODAS 2.0 36-item Version Interviewer-administered - Drain on Financial Resources | ||
WD5-Earn Less Money | C130757 | WD5-Earn Less Money | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Did you earn less money as the result of a health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Earn Less Money | ||
WD5-Eating | C130740 | WD5-Eating | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Eating? | WHODAS 2.0 36-item Version Interviewer-administered - Eating | ||
WD5-Emotionally Affected by Health | C130763 | WD5-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much have you been emotionally affected by your health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Emotionally Affected by Health | ||
WD5-Finding Solutions to Problems | C130729 | WD5-Finding Solutions to Problems | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? | WHODAS 2.0 36-item Version Interviewer-administered - Finding Solutions to Problems | ||
WD5-Get Along With People Close to You | C130744 | WD5-Get Along With People Close to You | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? | WHODAS 2.0 36-item Version Interviewer-administered - Get Along With People Close to You | ||
WD5-Getting All Work Done You Need | C130754 | WD5-Getting All Work Done You Need | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting all the work done that you need to do? | WHODAS 2.0 36-item Version Interviewer-administered - Getting All Work Done You Need to Do | ||
WD5-Getting Dressed | C130739 | WD5-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Dressed | ||
WD5-Getting Household Work Done Needed | C130749 | WD5-Getting Household Work Done Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Household Work Done Needed | ||
WD5-Getting Household Work Done Quickly | C130750 | WD5-Getting Household Work Done Quickly | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Household Work Done Quickly | ||
WD5-Getting Out of Your Home | C130736 | WD5-Getting Out of Your Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Getting out of your home? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Out of Your Home | ||
WD5-Getting Work Done Quickly as Needed | C130755 | WD5-Getting Work Done Quickly as Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Getting your work done as quickly as needed? | WHODAS 2.0 36-item Version Interviewer-administered - Getting Work Done Quickly as Needed | ||
WD5-Had to Work at a Lower Level | C130756 | WD5-Had to Work at a Lower Level | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Have you had to work at a lower level because of a health condition? | WHODAS 2.0 36-item Version Interviewer-administered - Had to Work at a Lower Level | ||
WD5-How Many Days Did You Miss Work | C130758 | WD5-How Many Days Did You Miss Work | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, on how many days did you miss work for half a day or more because of your health condition? | WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Did You Miss Work | ||
WD5-How Many Days Difficulties Present | C130767 | WD5-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Difficulties Present | ||
WD5-How Many Days Reduce Activities | C130769 | WD5-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Interviewer-administered - How Many Days Reduce Activities | ||
WD5-How Old Are You Now | C130723 | WD5-How Old Are You Now | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - How old are you now? | WHODAS 2.0 36-item Version Interviewer-administered - How Old Are You Now | ||
WD5-Learning a New Task | C130730 | WD5-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 36-item Version Interviewer-administered - Learning a New Task | ||
WD5-Living Situation at Interview | C130721 | WD5-Living Situation at Interview | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Living situation at time of interview. | WHODAS 2.0 36-item Version Interviewer-administered - Living Situation at Interview | ||
WD5-Maintaining a Friendship | C130743 | WD5-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 36-item Version Interviewer-administered - Maintaining a Friendship | ||
WD5-Making New Friends | C130745 | WD5-Making New Friends | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Making new friends? | WHODAS 2.0 36-item Version Interviewer-administered - Making New Friends | ||
WD5-Moving Around Inside Your Home | C130735 | WD5-Moving Around Inside Your Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Moving around inside your home? | WHODAS 2.0 36-item Version Interviewer-administered - Moving Around Inside Your Home | ||
WD5-Problem Because of Barriers in World | C130760 | WD5-Problem Because of Barriers in World | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? | WHODAS 2.0 36-item Version Interviewer-administered - Problem Because of Barriers in World | ||
WD5-Problem Did Your Family Have | C130765 | WD5-Problem Did Your Family Have | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did your family have because of your health problems? | WHODAS 2.0 36-item Version Interviewer-administered - How Much Problem Did Your Family Have | ||
WD5-Problem Doing Things for Relaxation | C130766 | WD5-Problem Doing Things for Relaxation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? | WHODAS 2.0 36-item Version Interviewer-administered - Problem Doing Things for Relaxation | ||
WD5-Problem Joining Community Activities | C130759 | WD5-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 36-item Version Interviewer-administered - Problem Joining Community Activities | ||
WD5-Problem Living with Dignity | C130761 | WD5-Problem Living with Dignity | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? | WHODAS 2.0 36-item Version Interviewer-administered - Problem Living with Dignity | ||
WD5-Remembering to Do Important Things | C130728 | WD5-Remembering to Do Important Things | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Remembering to do important things? | WHODAS 2.0 36-item Version Interviewer-administered - Remembering to Do Important Things | ||
WD5-Sex as Observed | C130722 | WD5-Sex as Observed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Record sex as observed. | WHODAS 2.0 36-item Version Interviewer-administered - Sex as Observed | ||
WD5-Sexual Activities | C130746 | WD5-Sexual Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Sexual activities? | WHODAS 2.0 36-item Version Interviewer-administered - Sexual Activities | ||
WD5-Standing for Long Periods | C130733 | WD5-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 36-item Version Interviewer-administered - Standing for Long Periods | ||
WD5-Standing Up From Sitting Down | C130734 | WD5-Standing Up From Sitting Down | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? | WHODAS 2.0 36-item Version Interviewer-administered - Standing Up From Sitting Down | ||
WD5-Starting/Maintaining Conversation | C130732 | WD5-Starting/Maintaining Conversation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? | WHODAS 2.0 36-item Version Interviewer-administered - Starting or Maintaining Conversation | ||
WD5-Staying by Yourself for a Few Days | C130741 | WD5-Staying by Yourself for a Few Days | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? | WHODAS 2.0 36-item Version Interviewer-administered - Staying by Yourself for a Few Days | ||
WD5-Time Spend on Your Health Condition | C130762 | WD5-Time Spend on Your Health Condition | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days: How much time did you spend on your health condition or its consequences? | WHODAS 2.0 36-item Version Interviewer-administered - Time Spend on Your Health Condition | ||
WD5-Understanding What People Say | C130731 | WD5-Understanding What People Say | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? | WHODAS 2.0 36-item Version Interviewer-administered - Understanding What People Say | ||
WD5-Walking a Long Distance | C130737 | WD5-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 36-item Version Interviewer-administered - Walking a Long Distance | ||
WD5-Washing Your Whole Body | C130738 | WD5-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - In the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 36-item Version Interviewer-administered - Washing Your Whole Body | ||
WD5-Years Studying in School/College | C130724 | WD5-Years Studying in School/College | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - How many years in all did you spend studying in school, college or university? | WHODAS 2.0 36-item Version Interviewer-administered - Years Studying in School or College | ||
WD5-Your Day-to-Day Work/School | C130752 | WD5-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Interviewer - Because of your health condition, in the past 30 days how much difficulty did you have in: Your day-to-day work/school? | WHODAS 2.0 36-item Version Interviewer-administered - Your Day-to-Day Work or School | ||
Back to top | ||||||
CL.C130271.WD6TC | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy Questionnaire Test Code
(WD6TC) | text
Extensible: No | C130271 | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy Questionnaire Test Code | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy test code. | CDISC Questionnaire WHODAS 2.0 36-item Version Proxy-administered Test Code Terminology |
WD6D1_1 | C130771 | WD6-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 36-item Version Proxy-administered - Concentrating for Ten Minutes | ||
WD6D1_2 | C130772 | WD6-Remembering to Do Important Things | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Remembering to do important things? | WHODAS 2.0 36-item Version Proxy-administered - Remembering to Do Important Things | ||
WD6D1_3 | C130773 | WD6-Finding Solutions to Problems | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Analysing and finding solutions to problems in day-to-day life? | WHODAS 2.0 36-item Version Proxy-administered - Finding Solutions to Problems | ||
WD6D1_4 | C130774 | WD6-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 36-item Version Proxy-administered - Learning a New Task | ||
WD6D1_5 | C130775 | WD6-Understanding What People Say | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Generally understanding what people say? | WHODAS 2.0 36-item Version Proxy-administered - Understanding What People Say | ||
WD6D1_6 | C130776 | WD6-Starting/Maintaining Conversation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Starting and maintaining a conversation? | WHODAS 2.0 36-item Version Proxy-administered - Starting or Maintaining Conversation | ||
WD6D2_1 | C130777 | WD6-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 36-item Version Proxy-administered - Standing for Long Periods | ||
WD6D2_2 | C130778 | WD6-Standing Up From Sitting Down | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing up from sitting down? | WHODAS 2.0 36-item Version Proxy-administered - Standing Up From Sitting Down | ||
WD6D2_3 | C130779 | WD6-Moving Around Inside Their Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Moving around inside their home? | WHODAS 2.0 36-item Version Proxy-administered - Moving Around Inside Their Home | ||
WD6D3_1 | C130782 | WD6-Washing His/Her Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Washing his or her whole body? | WHODAS 2.0 36-item Version Proxy-administered - Washing His or Her Whole Body | ||
WD6D3_2 | C130783 | WD6-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting dressed? | WHODAS 2.0 36-item Version Proxy-administered - Getting Dressed | ||
WD6D3_3 | C130784 | WD6-Eating | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Eating? | WHODAS 2.0 36-item Version Proxy-administered - Eating | ||
WD6D3_4 | C130785 | WD6-Staying by Him/Herself a Few Days | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Staying by himself or herself for a few days? | WHODAS 2.0 36-item Version Proxy-administered - Staying by Him or Herself a Few Days | ||
WD6D4_1 | C130786 | WD6-Dealing With People Does Not Know | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Dealing with people he or she does not know? | WHODAS 2.0 36-item Version Proxy-administered - Dealing With People Does Not Know | ||
WD6D4_2 | C130787 | WD6-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Maintaining a friendship? | WHODAS 2.0 36-item Version Proxy-administered - Maintaining a Friendship | ||
WD6D4_3 | C130788 | WD6-Get Along With People Close to Him | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting along with people who are close to him or her? | WHODAS 2.0 36-item Version Proxy-administered - Get Along With People Close to Him | ||
WD6D4_4 | C130789 | WD6-Making New Friends | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Making new friends? | WHODAS 2.0 36-item Version Proxy-administered - Making New Friends | ||
WD6D4_5 | C130790 | WD6-Sexual Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Sexual activities? | WHODAS 2.0 36-item Version Proxy-administered - Sexual Activities | ||
WD6D5_1 | C130791 | WD6-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Taking care of his or her household responsibilities? | WHODAS 2.0 36-item Version Proxy-administered - Care of Household Responsibilities | ||
WD6D5_2 | C130792 | WD6-Doing Important Household Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Doing his or her most important household tasks well? | WHODAS 2.0 36-item Version Proxy-administered - Doing Important Household Tasks | ||
WD6D5_3 | C130793 | WD6-Getting Household Work Done Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting all the household work done that is needed? | WHODAS 2.0 36-item Version Proxy-administered - Getting Household Work Done Needed | ||
WD6D5_4 | C130794 | WD6-Getting Household Work Done Quickly | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting the household work done as quickly as needed? | WHODAS 2.0 36-item Version Proxy-administered - Getting Household Work Done Quickly | ||
WD6D5_5 | C130795 | WD6-Their Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: His or her day-to-day work/school? | WHODAS 2.0 36-item Version Proxy-administered - Their Day-to-Day Work or School | ||
WD6D5_6 | C130796 | WD6-Doing Important Work/School Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Doing his or her most important work/school tasks well? | WHODAS 2.0 36-item Version Proxy-administered - Doing Important Work or School Tasks | ||
WD6D5_7 | C130797 | WD6-Getting All Work Done You Need | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting all the work done that is needed? | WHODAS 2.0 36-item Version Proxy-administered - Getting All Work Done You Need | ||
WD6D5_8 | C130798 | WD6-Getting Work Done Quickly as Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting the work done as quickly as needed? | WHODAS 2.0 36-item Version Proxy-administered - Getting Work Done Quickly as Needed | ||
WD6D6_1 | C130799 | WD6-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have in joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 36-item Version Proxy-administered - Problem Joining Community Activities | ||
WD6D6_2 | C130800 | WD6-Problem Because of Barriers in World | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have because of barriers or hindrances in the world around him or her? | WHODAS 2.0 36-item Version Proxy-administered - Problem Because of Barriers in World | ||
WD6D6_3 | C130801 | WD6-Problem Living with Dignity | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have living with dignity because of the attitudes and actions of others? | WHODAS 2.0 36-item Version Proxy-administered - Problem Living with Dignity | ||
WD6D6_4 | C130802 | WD6-Time Spend on Your Health Condition | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much time did your relative spend on his or her health condition, or its consequences? | WHODAS 2.0 36-item Version Proxy-administered - Time Spend on Your Health Condition | ||
WD6D6_5 | C130803 | WD6-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much has your relative been emotionally affected by his or her health condition? | WHODAS 2.0 36-item Version Proxy-administered - Emotionally Affected by Health | ||
WD6D6_6 | C130804 | WD6-Drain on Financial Resources | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much has his or her health been a drain on his or her financial resources or on the financial resources of other relatives? | WHODAS 2.0 36-item Version Proxy-administered - Drain on Financial Resources | ||
WD6D6_7 | C130805 | WD6-Problem Did Your Family Have | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did you or the rest of his or her family have because of his or her health problems? | WHODAS 2.0 36-item Version Proxy-administered - Problem Did Your Family Have | ||
WD6D6_8 | C130806 | WD6-Problem Doing Things for Relaxation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have in doing things by himself or herself for relaxation or pleasure? | WHODAS 2.0 36-item Version Proxy-administered - Problem Doing Things for Relaxation | ||
WD6H1 | C130807 | WD6-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 36-item Version Proxy-administered - How Many Days Difficulties Present | ||
WD6H2 | C130808 | WD6-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, for how many days was your relative totally unable to carry out his or her usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Proxy-administered - Days Unable to Carry Out Activities | ||
WD6H3 | C130809 | WD6-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, not counting the days that your relative was totally unable, for how many days did your relative cut back or reduce his or her usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Proxy-administered - How Many Days Reduce Activities | ||
WD6H4 | C130770 | WD6-I Am (Fill in Blank) of This Person | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - I am the (Fill in the Blank) of this person. | WHODAS 2.0 36-item Version Proxy-administered - I Am (Fill in the Blank) of this Person | ||
WD6SD2_4 | C130780 | WD6-Getting Out of Their Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting out of their home? | WHODAS 2.0 36-item Version Proxy-administered - Getting Out of Their Home | ||
WD6SD2_5 | C130781 | WD6-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 36-item Version Proxy-administered - Walking a Long Distance | ||
Back to top | ||||||
CL.C130270.WD6TN | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy Questionnaire Test Name
(WD6TN) | text
Extensible: No | C130270 | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy Questionnaire Test Name | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy test name. | CDISC Questionnaire WHODAS 2.0 36-item Version Proxy-administered Test Name Terminology |
WD6-Care of Household Responsibilities | C130791 | WD6-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Taking care of his or her household responsibilities? | WHODAS 2.0 36-item Version Proxy-administered - Care of Household Responsibilities | ||
WD6-Concentrating for Ten Minutes | C130771 | WD6-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 36-item Version Proxy-administered - Concentrating for Ten Minutes | ||
WD6-Days Unable to Carry Out Activities | C130808 | WD6-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, for how many days was your relative totally unable to carry out his or her usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Proxy-administered - Days Unable to Carry Out Activities | ||
WD6-Dealing With People Does Not Know | C130786 | WD6-Dealing With People Does Not Know | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Dealing with people he or she does not know? | WHODAS 2.0 36-item Version Proxy-administered - Dealing With People Does Not Know | ||
WD6-Doing Important Household Tasks | C130792 | WD6-Doing Important Household Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Doing his or her most important household tasks well? | WHODAS 2.0 36-item Version Proxy-administered - Doing Important Household Tasks | ||
WD6-Doing Important Work/School Tasks | C130796 | WD6-Doing Important Work/School Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Doing his or her most important work/school tasks well? | WHODAS 2.0 36-item Version Proxy-administered - Doing Important Work or School Tasks | ||
WD6-Drain on Financial Resources | C130804 | WD6-Drain on Financial Resources | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much has his or her health been a drain on his or her financial resources or on the financial resources of other relatives? | WHODAS 2.0 36-item Version Proxy-administered - Drain on Financial Resources | ||
WD6-Eating | C130784 | WD6-Eating | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Eating? | WHODAS 2.0 36-item Version Proxy-administered - Eating | ||
WD6-Emotionally Affected by Health | C130803 | WD6-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much has your relative been emotionally affected by his or her health condition? | WHODAS 2.0 36-item Version Proxy-administered - Emotionally Affected by Health | ||
WD6-Finding Solutions to Problems | C130773 | WD6-Finding Solutions to Problems | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Analysing and finding solutions to problems in day-to-day life? | WHODAS 2.0 36-item Version Proxy-administered - Finding Solutions to Problems | ||
WD6-Get Along With People Close to Him | C130788 | WD6-Get Along With People Close to Him | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting along with people who are close to him or her? | WHODAS 2.0 36-item Version Proxy-administered - Get Along With People Close to Him | ||
WD6-Getting All Work Done You Need | C130797 | WD6-Getting All Work Done You Need | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting all the work done that is needed? | WHODAS 2.0 36-item Version Proxy-administered - Getting All Work Done You Need | ||
WD6-Getting Dressed | C130783 | WD6-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting dressed? | WHODAS 2.0 36-item Version Proxy-administered - Getting Dressed | ||
WD6-Getting Household Work Done Needed | C130793 | WD6-Getting Household Work Done Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting all the household work done that is needed? | WHODAS 2.0 36-item Version Proxy-administered - Getting Household Work Done Needed | ||
WD6-Getting Household Work Done Quickly | C130794 | WD6-Getting Household Work Done Quickly | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Getting the household work done as quickly as needed? | WHODAS 2.0 36-item Version Proxy-administered - Getting Household Work Done Quickly | ||
WD6-Getting Out of Their Home | C130780 | WD6-Getting Out of Their Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting out of their home? | WHODAS 2.0 36-item Version Proxy-administered - Getting Out of Their Home | ||
WD6-Getting Work Done Quickly as Needed | C130798 | WD6-Getting Work Done Quickly as Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Getting the work done as quickly as needed? | WHODAS 2.0 36-item Version Proxy-administered - Getting Work Done Quickly as Needed | ||
WD6-How Many Days Difficulties Present | C130807 | WD6-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 36-item Version Proxy-administered - How Many Days Difficulties Present | ||
WD6-How Many Days Reduce Activities | C130809 | WD6-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, not counting the days that your relative was totally unable, for how many days did your relative cut back or reduce his or her usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Proxy-administered - How Many Days Reduce Activities | ||
WD6-I Am (Fill in Blank) of This Person | C130770 | WD6-I Am (Fill in Blank) of This Person | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - I am the (Fill in the Blank) of this person. | WHODAS 2.0 36-item Version Proxy-administered - I Am (Fill in the Blank) of this Person | ||
WD6-Learning a New Task | C130774 | WD6-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 36-item Version Proxy-administered - Learning a New Task | ||
WD6-Maintaining a Friendship | C130787 | WD6-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Maintaining a friendship? | WHODAS 2.0 36-item Version Proxy-administered - Maintaining a Friendship | ||
WD6-Making New Friends | C130789 | WD6-Making New Friends | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Making new friends? | WHODAS 2.0 36-item Version Proxy-administered - Making New Friends | ||
WD6-Moving Around Inside Their Home | C130779 | WD6-Moving Around Inside Their Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Moving around inside their home? | WHODAS 2.0 36-item Version Proxy-administered - Moving Around Inside Their Home | ||
WD6-Problem Because of Barriers in World | C130800 | WD6-Problem Because of Barriers in World | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have because of barriers or hindrances in the world around him or her? | WHODAS 2.0 36-item Version Proxy-administered - Problem Because of Barriers in World | ||
WD6-Problem Did Your Family Have | C130805 | WD6-Problem Did Your Family Have | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did you or the rest of his or her family have because of his or her health problems? | WHODAS 2.0 36-item Version Proxy-administered - Problem Did Your Family Have | ||
WD6-Problem Doing Things for Relaxation | C130806 | WD6-Problem Doing Things for Relaxation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have in doing things by himself or herself for relaxation or pleasure? | WHODAS 2.0 36-item Version Proxy-administered - Problem Doing Things for Relaxation | ||
WD6-Problem Joining Community Activities | C130799 | WD6-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have in joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 36-item Version Proxy-administered - Problem Joining Community Activities | ||
WD6-Problem Living with Dignity | C130801 | WD6-Problem Living with Dignity | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much of a problem did your relative have living with dignity because of the attitudes and actions of others? | WHODAS 2.0 36-item Version Proxy-administered - Problem Living with Dignity | ||
WD6-Remembering to Do Important Things | C130772 | WD6-Remembering to Do Important Things | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Remembering to do important things? | WHODAS 2.0 36-item Version Proxy-administered - Remembering to Do Important Things | ||
WD6-Sexual Activities | C130790 | WD6-Sexual Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Sexual activities? | WHODAS 2.0 36-item Version Proxy-administered - Sexual Activities | ||
WD6-Standing for Long Periods | C130777 | WD6-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 36-item Version Proxy-administered - Standing for Long Periods | ||
WD6-Standing Up From Sitting Down | C130778 | WD6-Standing Up From Sitting Down | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Standing up from sitting down? | WHODAS 2.0 36-item Version Proxy-administered - Standing Up From Sitting Down | ||
WD6-Starting/Maintaining Conversation | C130776 | WD6-Starting/Maintaining Conversation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Starting and maintaining a conversation? | WHODAS 2.0 36-item Version Proxy-administered - Starting or Maintaining Conversation | ||
WD6-Staying by Him/Herself a Few Days | C130785 | WD6-Staying by Him/Herself a Few Days | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Staying by himself or herself for a few days? | WHODAS 2.0 36-item Version Proxy-administered - Staying by Him or Herself a Few Days | ||
WD6-Their Day-to-Day Work/School | C130795 | WD6-Their Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: His or her day-to-day work/school? | WHODAS 2.0 36-item Version Proxy-administered - Their Day-to-Day Work or School | ||
WD6-Time Spend on Your Health Condition | C130802 | WD6-Time Spend on Your Health Condition | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Participation in society in the past 30 days: How much time did your relative spend on his or her health condition, or its consequences? | WHODAS 2.0 36-item Version Proxy-administered - Time Spend on Your Health Condition | ||
WD6-Understanding What People Say | C130775 | WD6-Understanding What People Say | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Generally understanding what people say? | WHODAS 2.0 36-item Version Proxy-administered - Understanding What People Say | ||
WD6-Walking a Long Distance | C130781 | WD6-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - In the past 30 days, how much difficulty did your relative have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 36-item Version Proxy-administered - Walking a Long Distance | ||
WD6-Washing His/Her Whole Body | C130782 | WD6-Washing His/Her Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Proxy - Because of their health condition, in the past 30 days, how much difficulty did your relative have in: Washing his or her whole body? | WHODAS 2.0 36-item Version Proxy-administered - Washing His or Her Whole Body | ||
Back to top | ||||||
CL.C130273.WD7TC | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self Questionnaire Test Code
(WD7TC) | text
Extensible: No | C130273 | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self Questionnaire Test Code | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self test code. | CDISC Questionnaire WHODAS 2.0 36-item Version Self-administered Test Code Terminology |
WD7D1_1 | C130810 | WD7-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 36-item Version Self-administered - Concentrating for Ten Minutes | ||
WD7D1_2 | C130811 | WD7-Remembering to Do Important Things | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Remembering to do important things? | WHODAS 2.0 36-item Version Self-administered - Remembering to Do Important Things | ||
WD7D1_3 | C130812 | WD7-Finding Solutions to Problems | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? | WHODAS 2.0 36-item Version Self-administered - Finding Solutions to Problems | ||
WD7D1_4 | C130813 | WD7-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 36-item Version Self-administered - Learning a New Task | ||
WD7D1_5 | C130814 | WD7-Understanding What People Say | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? | WHODAS 2.0 36-item Version Self-administered - Understanding What People Say | ||
WD7D1_6 | C130815 | WD7-Starting/Maintaining Conversation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? | WHODAS 2.0 36-item Version Self-administered - Starting or Maintaining Conversation | ||
WD7D2_1 | C130816 | WD7-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 36-item Version Self-administered - Standing for Long Periods | ||
WD7D2_2 | C130817 | WD7-Standing Up From Sitting Down | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? | WHODAS 2.0 36-item Version Self-administered - Standing Up From Sitting Down | ||
WD7D2_3 | C130818 | WD7-Moving Around Inside Your Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Moving around inside your home? | WHODAS 2.0 36-item Version Self-administered - Moving Around Inside Your Home | ||
WD7D2_4 | C130819 | WD7-Getting Out of Your Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting out of your home? | WHODAS 2.0 36-item Version Self-administered - Getting Out of Your Home | ||
WD7D2_5 | C130820 | WD7-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 36-item Version Self-administered - Walking a Long Distance | ||
WD7D3_1 | C130821 | WD7-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - in the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 36-item Version Self-administered - Washing Your Whole Body | ||
WD7D3_2 | C130822 | WD7-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 36-item Version Self-administered - Getting Dressed | ||
WD7D3_3 | C130823 | WD7-Eating | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Eating? | WHODAS 2.0 36-item Version Self-administered - Eating | ||
WD7D3_4 | C130824 | WD7-Staying by Yourself for a Few Days | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? | WHODAS 2.0 36-item Version Self-administered - Staying by Yourself for a Few Days | ||
WD7D4_1 | C130825 | WD7-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 36-item Version Self-administered - Dealing With People You Do Not Know | ||
WD7D4_2 | C130826 | WD7-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 36-item Version Self-administered - Maintaining a Friendship | ||
WD7D4_3 | C130827 | WD7-Get Along With People Close to You | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? | WHODAS 2.0 36-item Version Self-administered - Get Along With People Close to You | ||
WD7D4_4 | C130828 | WD7-Making New Friends | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Making new friends? | WHODAS 2.0 36-item Version Self-administered - Making New Friends | ||
WD7D4_5 | C130829 | WD7-Sexual Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Sexual activities? | WHODAS 2.0 36-item Version Self-administered - Sexual Activities | ||
WD7D5_1 | C130830 | WD7-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 36-item Version Self-administered - Care of Household Responsibilities | ||
WD7D5_2 | C130831 | WD7-Doing Important Household Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Doing most important household tasks well? | WHODAS 2.0 36-item Version Self-administered - Doing Important Household Tasks | ||
WD7D5_3 | C130832 | WD7-Getting Household Work Done Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? | WHODAS 2.0 36-item Version Self-administered - Getting Household Work Done Needed | ||
WD7D5_4 | C130833 | WD7-Getting Household Work Done Quickly | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? | WHODAS 2.0 36-item Version Self-administered - Getting Household Work Done Quickly | ||
WD7D5_5 | C130834 | WD7-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: your day-to-day work/school? | WHODAS 2.0 36-item Version Self-administered - Your Day-to-Day Work or School | ||
WD7D5_6 | C130835 | WD7-Doing Important Work/School Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important work/school tasks well? | WHODAS 2.0 36-item Version Self-administered - Doing Important Work or School Tasks | ||
WD7D5_7 | C130836 | WD7-Getting All Work Done You Need | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the work done that you need to do? | WHODAS 2.0 36-item Version Self-administered - Getting All Work Done You Need | ||
WD7D5_8 | C130837 | WD7-Getting Work Done Quickly as Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your work done as quickly as needed? | WHODAS 2.0 36-item Version Self-administered - Getting Work Done Quickly as Needed | ||
WD7D6_1 | C130838 | WD7-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have in joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 36-item Version Self-administered - Problem Joining Community Activities | ||
WD7D6_2 | C130839 | WD7-Problem Because of Barriers in World | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? | WHODAS 2.0 36-item Version Self-administered - Problem Because of Barriers in World | ||
WD7D6_3 | C130840 | WD7-Problem Living with Dignity | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? | WHODAS 2.0 36-item Version Self-administered - Problem Living with Dignity | ||
WD7D6_4 | C130841 | WD7-Time Spend on Your Health Condition | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much time did you spend on your health condition, or its consequences? | WHODAS 2.0 36-item Version Self-administered - Time Spend on Your Health Condition | ||
WD7D6_5 | C130842 | WD7-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much have you been emotionally affected by your health condition? | WHODAS 2.0 36-item Version Self-administered - Emotionally Affected by Health | ||
WD7D6_6 | C130843 | WD7-Drain on Financial Resources | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? | WHODAS 2.0 36-item Version Self-administered - Drain on Financial Resources | ||
WD7D6_7 | C130844 | WD7-Problem Did Your Family Have | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did your family have because of your health problems? | WHODAS 2.0 36-item Version Self-administered - Problem Did Your Family Have | ||
WD7D6_8 | C130845 | WD7-Problem Doing Things for Relaxation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? | WHODAS 2.0 36-item Version Self-administered - Problem Doing Things for Relaxation | ||
WD7H1 | C130846 | WD7-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 36-item Version Self-administered - How Many Days Difficulties Present | ||
WD7H2 | C130847 | WD7-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Self-administered - Days Unable to Carry Out Activities | ||
WD7H3 | C130848 | WD7-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Self-administered - How Many Days Reduce Activities | ||
Back to top | ||||||
CL.C130272.WD7TN | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self Questionnaire Test Name
(WD7TN) | text
Extensible: No | C130272 | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self Questionnaire Test Name | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self test name. | CDISC Questionnaire WHODAS 2.0 36-item Version Self-administered Test Name Terminology |
WD7-Care of Household Responsibilities | C130830 | WD7-Care of Household Responsibilities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Taking care of your household responsibilities? | WHODAS 2.0 36-item Version Self-administered - Care of Household Responsibilities | ||
WD7-Concentrating for Ten Minutes | C130810 | WD7-Concentrating for Ten Minutes | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Concentrating on doing something for ten minutes? | WHODAS 2.0 36-item Version Self-administered - Concentrating for Ten Minutes | ||
WD7-Days Unable to Carry Out Activities | C130847 | WD7-Days Unable to Carry Out Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, for how many days were you totally unable to carry out your usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Self-administered - Days Unable to Carry Out Activities | ||
WD7-Dealing With People You Do Not Know | C130825 | WD7-Dealing With People You Do Not Know | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Dealing with people you do not know? | WHODAS 2.0 36-item Version Self-administered - Dealing With People You Do Not Know | ||
WD7-Doing Important Household Tasks | C130831 | WD7-Doing Important Household Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Doing most important household tasks well? | WHODAS 2.0 36-item Version Self-administered - Doing Important Household Tasks | ||
WD7-Doing Important Work/School Tasks | C130835 | WD7-Doing Important Work/School Tasks | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Doing your most important work/school tasks well? | WHODAS 2.0 36-item Version Self-administered - Doing Important Work or School Tasks | ||
WD7-Drain on Financial Resources | C130843 | WD7-Drain on Financial Resources | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much has your health been a drain on the financial resources of you or your family? | WHODAS 2.0 36-item Version Self-administered - Drain on Financial Resources | ||
WD7-Eating | C130823 | WD7-Eating | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Eating? | WHODAS 2.0 36-item Version Self-administered - Eating | ||
WD7-Emotionally Affected by Health | C130842 | WD7-Emotionally Affected by Health | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much have you been emotionally affected by your health condition? | WHODAS 2.0 36-item Version Self-administered - Emotionally Affected by Health | ||
WD7-Finding Solutions to Problems | C130812 | WD7-Finding Solutions to Problems | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Analysing and finding solutions to problems in day-to-day life? | WHODAS 2.0 36-item Version Self-administered - Finding Solutions to Problems | ||
WD7-Get Along With People Close to You | C130827 | WD7-Get Along With People Close to You | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting along with people who are close to you? | WHODAS 2.0 36-item Version Self-administered - Get Along With People Close to You | ||
WD7-Getting All Work Done You Need | C130836 | WD7-Getting All Work Done You Need | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting all the work done that you need to do? | WHODAS 2.0 36-item Version Self-administered - Getting All Work Done You Need | ||
WD7-Getting Dressed | C130822 | WD7-Getting Dressed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting dressed? | WHODAS 2.0 36-item Version Self-administered - Getting Dressed | ||
WD7-Getting Household Work Done Needed | C130832 | WD7-Getting Household Work Done Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting all the household work done that you needed to do? | WHODAS 2.0 36-item Version Self-administered - Getting Household Work Done Needed | ||
WD7-Getting Household Work Done Quickly | C130833 | WD7-Getting Household Work Done Quickly | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting your household work done as quickly as needed? | WHODAS 2.0 36-item Version Self-administered - Getting Household Work Done Quickly | ||
WD7-Getting Out of Your Home | C130819 | WD7-Getting Out of Your Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Getting out of your home? | WHODAS 2.0 36-item Version Self-administered - Getting Out of Your Home | ||
WD7-Getting Work Done Quickly as Needed | C130837 | WD7-Getting Work Done Quickly as Needed | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: Getting your work done as quickly as needed? | WHODAS 2.0 36-item Version Self-administered - Getting Work Done Quickly as Needed | ||
WD7-How Many Days Difficulties Present | C130846 | WD7-How Many Days Difficulties Present | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Overall, in the past 30 days, how many days were these difficulties present? | WHODAS 2.0 36-item Version Self-administered - How Many Days Difficulties Present | ||
WD7-How Many Days Reduce Activities | C130848 | WD7-How Many Days Reduce Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, not counting the days that you were totally unable, for how many days did you cut back or reduce your usual activities or work because of any health condition? | WHODAS 2.0 36-item Version Self-administered - How Many Days Reduce Activities | ||
WD7-Learning a New Task | C130813 | WD7-Learning a New Task | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Learning a new task, for example, learning how to get to a new place? | WHODAS 2.0 36-item Version Self-administered - Learning a New Task | ||
WD7-Maintaining a Friendship | C130826 | WD7-Maintaining a Friendship | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Maintaining a friendship? | WHODAS 2.0 36-item Version Self-administered - Maintaining a Friendship | ||
WD7-Making New Friends | C130828 | WD7-Making New Friends | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Making new friends? | WHODAS 2.0 36-item Version Self-administered - Making New Friends | ||
WD7-Moving Around Inside Your Home | C130818 | WD7-Moving Around Inside Your Home | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Moving around inside your home? | WHODAS 2.0 36-item Version Self-administered - Moving Around Inside Your Home | ||
WD7-Problem Because of Barriers in World | C130839 | WD7-Problem Because of Barriers in World | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have because of barriers or hindrances in the world around you? | WHODAS 2.0 36-item Version Self-administered - Problem Because of Barriers in World | ||
WD7-Problem Did Your Family Have | C130844 | WD7-Problem Did Your Family Have | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did your family have because of your health problems? | WHODAS 2.0 36-item Version Self-administered - Problem Did Your Family Have | ||
WD7-Problem Doing Things for Relaxation | C130845 | WD7-Problem Doing Things for Relaxation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have in doing things by yourself for relaxation or pleasure? | WHODAS 2.0 36-item Version Self-administered - Problem Doing Things for Relaxation | ||
WD7-Problem Joining Community Activities | C130838 | WD7-Problem Joining Community Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have in joining in community activities (for example, festivities, religious or other activities) in the same way as anyone else can? | WHODAS 2.0 36-item Version Self-administered - Problem Joining Community Activities | ||
WD7-Problem Living with Dignity | C130840 | WD7-Problem Living with Dignity | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much of a problem did you have living with dignity because of the attitudes and actions of others? | WHODAS 2.0 36-item Version Self-administered - Problem Living with Dignity | ||
WD7-Remembering to Do Important Things | C130811 | WD7-Remembering to Do Important Things | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Remembering to do important things? | WHODAS 2.0 36-item Version Self-administered - Remembering to Do Important Things | ||
WD7-Sexual Activities | C130829 | WD7-Sexual Activities | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Sexual activities? | WHODAS 2.0 36-item Version Self-administered - Sexual Activities | ||
WD7-Standing for Long Periods | C130816 | WD7-Standing for Long Periods | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Standing for long periods such as 30 minutes? | WHODAS 2.0 36-item Version Self-administered - Standing for Long Periods | ||
WD7-Standing Up From Sitting Down | C130817 | WD7-Standing Up From Sitting Down | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Standing up from sitting down? | WHODAS 2.0 36-item Version Self-administered - Standing Up From Sitting Down | ||
WD7-Starting/Maintaining Conversation | C130815 | WD7-Starting/Maintaining Conversation | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Starting and maintaining a conversation? | WHODAS 2.0 36-item Version Self-administered - Starting or Maintaining Conversation | ||
WD7-Staying by Yourself for a Few Days | C130824 | WD7-Staying by Yourself for a Few Days | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Staying by yourself for a few days? | WHODAS 2.0 36-item Version Self-administered - Staying by Yourself for a Few Days | ||
WD7-Time Spend on Your Health Condition | C130841 | WD7-Time Spend on Your Health Condition | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days: How much time did you spend on your health condition, or its consequences? | WHODAS 2.0 36-item Version Self-administered - Time Spend on Your Health Condition | ||
WD7-Understanding What People Say | C130814 | WD7-Understanding What People Say | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Generally understanding what people say? | WHODAS 2.0 36-item Version Self-administered - Understanding What People Say | ||
WD7-Walking a Long Distance | C130820 | WD7-Walking a Long Distance | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - In the past 30 days, how much difficulty did you have in: Walking a long distance such as a kilometre [or equivalent]? | WHODAS 2.0 36-item Version Self-administered - Walking a Long Distance | ||
WD7-Washing Your Whole Body | C130821 | WD7-Washing Your Whole Body | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - in the past 30 days, how much difficulty did you have in: Washing your whole body? | WHODAS 2.0 36-item Version Self-administered - Washing Your Whole Body | ||
WD7-Your Day-to-Day Work/School | C130834 | WD7-Your Day-to-Day Work/School | World Health Organization Disability Assessment Schedule 2.0 - 36-Item Self - Because of your health condition, in the past 30 days, how much difficulty did you have in: your day-to-day work/school? | WHODAS 2.0 36-item Version Self-administered - Your Day-to-Day Work or School | ||
Back to top |